T@@	B-Disease	D014262	6794356
r@@	I-Disease	-1	6794356
ic@@	I-Disease	-1	6794356
us@@	I-Disease	-1	6794356
pid	I-Disease	-1	6794356
val@@	I-Disease	-1	6794356
ve	I-Disease	-1	6794356
reg@@	I-Disease	-1	6794356
ur@@	I-Disease	-1	6794356
g@@	I-Disease	-1	6794356
it@@	I-Disease	-1	6794356
ation	I-Disease	-1	6794356
and	O	-1	6794356
lithium	B-Chemical	D016651	6794356
carb@@	I-Chemical	-1	6794356
on@@	I-Chemical	-1	6794356
ate	I-Chemical	-1	6794356
toxicity	B-Disease	D064420	6794356
in	O	-1	6794356
a	O	-1	6794356
ne@@	O	-1	6794356
w@@	O	-1	6794356
b@@	O	-1	6794356
or@@	O	-1	6794356
n	O	-1	6794356
inf@@	O	-1	6794356
ant@@	O	-1	6794356
.	O	-1	6794356
A	O	-1	6794356
ne@@	O	-1	6794356
w@@	O	-1	6794356
b@@	O	-1	6794356
or@@	O	-1	6794356
n	O	-1	6794356
with	O	-1	6794356
mas@@	O	-1	6794356
sive	O	-1	6794356
tr@@	B-Disease	D014262	6794356
ic@@	I-Disease	-1	6794356
us@@	I-Disease	-1	6794356
pid	I-Disease	-1	6794356
reg@@	I-Disease	-1	6794356
ur@@	I-Disease	-1	6794356
g@@	I-Disease	-1	6794356
it@@	I-Disease	-1	6794356
ation	I-Disease	-1	6794356
,	O	-1	6794356
atrial	B-Disease	D001282	6794356
f@@	I-Disease	-1	6794356
l@@	I-Disease	-1	6794356
ut@@	I-Disease	-1	6794356
ter	I-Disease	-1	6794356
,	O	-1	6794356
con@@	B-Disease	D006333	6794356
g@@	I-Disease	-1	6794356
es@@	I-Disease	-1	6794356
tive	I-Disease	-1	6794356
heart	I-Disease	-1	6794356
failure	I-Disease	-1	6794356
,	O	-1	6794356
and	O	-1	6794356
a	O	-1	6794356
high	O	-1	6794356
serum	O	-1	6794356
lithium	B-Chemical	D008094	6794356
level	O	-1	6794356
is	O	-1	6794356
descri@@	O	-1	6794356
be@@	O	-1	6794356
d.	O	-1	6794356
This	O	-1	6794356
is	O	-1	6794356
the	O	-1	6794356
first	O	-1	6794356
patient	O	-1	6794356
to	O	-1	6794356
initi@@	O	-1	6794356
ally	O	-1	6794356
man@@	O	-1	6794356
if@@	O	-1	6794356
est	O	-1	6794356
tr@@	B-Disease	D014262	6794356
ic@@	I-Disease	-1	6794356
us@@	I-Disease	-1	6794356
pid	I-Disease	-1	6794356
reg@@	I-Disease	-1	6794356
ur@@	I-Disease	-1	6794356
g@@	I-Disease	-1	6794356
it@@	I-Disease	-1	6794356
ation	I-Disease	-1	6794356
and	O	-1	6794356
atrial	B-Disease	D001282	6794356
f@@	I-Disease	-1	6794356
l@@	I-Disease	-1	6794356
ut@@	I-Disease	-1	6794356
ter	I-Disease	-1	6794356
,	O	-1	6794356
and	O	-1	6794356
the	O	-1	6794356
1@@	O	-1	6794356
1@@	O	-1	6794356
th	O	-1	6794356
descri@@	O	-1	6794356
bed	O	-1	6794356
patient	O	-1	6794356
with	O	-1	6794356
cardiac	B-Disease	D006331	6794356
disease	I-Disease	-1	6794356
among	O	-1	6794356
inf@@	O	-1	6794356
ants	O	-1	6794356
exposed	O	-1	6794356
to	O	-1	6794356
lithium	B-Chemical	D008094	6794356
comp@@	O	-1	6794356
oun@@	O	-1	6794356
ds	O	-1	6794356
in	O	-1	6794356
the	O	-1	6794356
first	O	-1	6794356
tri@@	O	-1	6794356
me@@	O	-1	6794356
st@@	O	-1	6794356
er	O	-1	6794356
of	O	-1	6794356
pregn@@	O	-1	6794356
anc@@	O	-1	6794356
y.	O	-1	6794356
Si@@	O	-1	6794356
x@@	O	-1	6794356
ty-@@	O	-1	6794356
three	O	-1	6794356
perc@@	O	-1	6794356
ent	O	-1	6794356
of	O	-1	6794356
these	O	-1	6794356
inf@@	O	-1	6794356
ants	O	-1	6794356
had	O	-1	6794356
tr@@	O	-1	6794356
ic@@	O	-1	6794356
us@@	O	-1	6794356
pid	O	-1	6794356
val@@	O	-1	6794356
ve	O	-1	6794356
invol@@	O	-1	6794356
ve@@	O	-1	6794356
ment.	O	-1	6794356
L@@	B-Chemical	D016651	6794356
i@@	I-Chemical	-1	6794356
thi@@	I-Chemical	-1	6794356
um	I-Chemical	-1	6794356
carb@@	I-Chemical	-1	6794356
on@@	I-Chemical	-1	6794356
ate	I-Chemical	-1	6794356
may	O	-1	6794356
be	O	-1	6794356
a	O	-1	6794356
factor	O	-1	6794356
in	O	-1	6794356
the	O	-1	6794356
increas@@	O	-1	6794356
ing	O	-1	6794356
incidence	O	-1	6794356
of	O	-1	6794356
con@@	B-Disease	D006331	6794356
gen@@	I-Disease	-1	6794356
it@@	I-Disease	-1	6794356
al	I-Disease	-1	6794356
heart	I-Disease	-1	6794356
disease	I-Disease	-1	6794356
when	O	-1	6794356
tak@@	O	-1	6794356
en	O	-1	6794356
during	O	-1	6794356
early	O	-1	6794356
pregn@@	O	-1	6794356
anc@@	O	-1	6794356
y.	O	-1	6794356
It	O	-1	6794356
also	O	-1	6794356
causes	O	-1	6794356
neurolog@@	B-Disease	D003866	6794356
ic	I-Disease	-1	6794356
de@@	I-Disease	-1	6794356
pression	I-Disease	-1	6794356
,	O	-1	6794356
cy@@	B-Disease	D003490	6794356
an@@	I-Disease	-1	6794356
o@@	I-Disease	-1	6794356
sis	I-Disease	-1	6794356
,	O	-1	6794356
and	O	-1	6794356
cardiac	B-Disease	D001145	6794356
arrhyth@@	I-Disease	-1	6794356
mia	I-Disease	-1	6794356
when	O	-1	6794356
consum@@	O	-1	6794356
ed	O	-1	6794356
prior	O	-1	6794356
to	O	-1	6794356
de@@	O	-1	6794356
li@@	O	-1	6794356
ver@@	O	-1	6794356
y.	O	-1	6794356

Ph@@	B-Chemical	D010634	6504332
en@@	I-Chemical	-1	6504332
obarbit@@	I-Chemical	-1	6504332
al	I-Chemical	-1	6504332
-induced	O	-1	6504332
dyskine@@	B-Disease	D004409	6504332
sia	I-Disease	-1	6504332
in	O	-1	6504332
a	O	-1	6504332
neurolog@@	B-Disease	D009422	6504332
ic@@	I-Disease	-1	6504332
all@@	I-Disease	-1	6504332
y-@@	I-Disease	-1	6504332
impaired	I-Disease	-1	6504332
ch@@	O	-1	6504332
il@@	O	-1	6504332
d.	O	-1	6504332
A	O	-1	6504332
2-@@	O	-1	6504332
year-old	O	-1	6504332
ch@@	O	-1	6504332
il@@	O	-1	6504332
d	O	-1	6504332
with	O	-1	6504332
known	O	-1	6504332
neurolog@@	B-Disease	D009422	6504332
ic	I-Disease	-1	6504332
impair@@	I-Disease	-1	6504332
ment	I-Disease	-1	6504332
developed	O	-1	6504332
a	O	-1	6504332
dyskine@@	B-Disease	D004409	6504332
sia	I-Disease	-1	6504332
so@@	O	-1	6504332
on	O	-1	6504332
after	O	-1	6504332
star@@	O	-1	6504332
ting	O	-1	6504332
phenobarbit@@	B-Chemical	D010634	6504332
al	I-Chemical	-1	6504332
therapy	O	-1	6504332
for	O	-1	6504332
seizures	B-Disease	D012640	6504332
.	O	-1	6504332
K@@	O	-1	6504332
now@@	O	-1	6504332
n	O	-1	6504332
causes	O	-1	6504332
of	O	-1	6504332
mo@@	B-Disease	D009069	6504332
vement	I-Disease	-1	6504332
disorder@@	I-Disease	-1	6504332
s	I-Disease	-1	6504332
were	O	-1	6504332
el@@	O	-1	6504332
im@@	O	-1	6504332
in@@	O	-1	6504332
ated	O	-1	6504332
after	O	-1	6504332
evalu@@	O	-1	6504332
ation.	O	-1	6504332
O@@	O	-1	6504332
n	O	-1	6504332
repe@@	O	-1	6504332
at	O	-1	6504332
ch@@	O	-1	6504332
all@@	O	-1	6504332
enge	O	-1	6504332
with	O	-1	6504332
phenobarbit@@	B-Chemical	D010634	6504332
al	I-Chemical	-1	6504332
,	O	-1	6504332
the	O	-1	6504332
dyskine@@	B-Disease	D004409	6504332
sia	I-Disease	-1	6504332
recur@@	O	-1	6504332
red.	O	-1	6504332
Ph@@	B-Chemical	D010634	6504332
en@@	I-Chemical	-1	6504332
obarbit@@	I-Chemical	-1	6504332
al	I-Chemical	-1	6504332
should	O	-1	6504332
be	O	-1	6504332
ad@@	O	-1	6504332
ded	O	-1	6504332
to	O	-1	6504332
the	O	-1	6504332
l@@	O	-1	6504332
ist	O	-1	6504332
of	O	-1	6504332
anti@@	O	-1	6504332
convul@@	O	-1	6504332
s@@	O	-1	6504332
ant	O	-1	6504332
drugs	O	-1	6504332
that	O	-1	6504332
can	O	-1	6504332
cause	O	-1	6504332
mo@@	B-Disease	D009069	6504332
vement	I-Disease	-1	6504332
disorder@@	I-Disease	-1	6504332
s	I-Disease	-1	6504332
.	O	-1	6504332

Ac@@	O	-1	6436733
ute	O	-1	6436733
changes	O	-1	6436733
of	O	-1	6436733
blood	O	-1	6436733
am@@	B-Chemical	D000641	6436733
mon@@	I-Chemical	-1	6436733
ia	I-Chemical	-1	6436733
may	O	-1	6436733
predic@@	O	-1	6436733
t	O	-1	6436733
sh@@	O	-1	6436733
ort@@	O	-1	6436733
-term	O	-1	6436733
adverse	O	-1	6436733
effects	O	-1	6436733
of	O	-1	6436733
valpro@@	B-Chemical	D014635	6436733
ic	I-Chemical	-1	6436733
acid	I-Chemical	-1	6436733
.	O	-1	6436733
V@@	B-Chemical	D014635	6436733
al@@	I-Chemical	-1	6436733
pro@@	I-Chemical	-1	6436733
ic	I-Chemical	-1	6436733
acid	I-Chemical	-1	6436733
(	O	-1	6436733
V@@	B-Chemical	D014635	6436733
P@@	I-Chemical	-1	6436733
A	I-Chemical	-1	6436733
)	O	-1	6436733
was	O	-1	6436733
given	O	-1	6436733
to	O	-1	6436733
24	O	-1	6436733
epileptic	B-Disease	D004827	6436733
patients	O	-1	6436733
who	O	-1	6436733
were	O	-1	6436733
al@@	O	-1	6436733
re@@	O	-1	6436733
ad@@	O	-1	6436733
y	O	-1	6436733
being	O	-1	6436733
treated	O	-1	6436733
with	O	-1	6436733
other	O	-1	6436733
anti@@	O	-1	6436733
epileptic	O	-1	6436733
drug@@	O	-1	6436733
s.	O	-1	6436733
A	O	-1	6436733
stand@@	O	-1	6436733
ardi@@	O	-1	6436733
zed	O	-1	6436733
lo@@	O	-1	6436733
ad@@	O	-1	6436733
ing	O	-1	6436733
dose	O	-1	6436733
of	O	-1	6436733
V@@	B-Chemical	D014635	6436733
P@@	I-Chemical	-1	6436733
A	I-Chemical	-1	6436733
was	O	-1	6436733
administ@@	O	-1	6436733
e@@	O	-1	6436733
re@@	O	-1	6436733
d,	O	-1	6436733
and	O	-1	6436733
venous	O	-1	6436733
blood	O	-1	6436733
was	O	-1	6436733
sam@@	O	-1	6436733
pl@@	O	-1	6436733
ed	O	-1	6436733
at	O	-1	6436733
0@@	O	-1	6436733
,	O	-1	6436733
1,	O	-1	6436733
2,	O	-1	6436733
3,	O	-1	6436733
and	O	-1	6436733
4	O	-1	6436733
hour@@	O	-1	6436733
s.	O	-1	6436733
A@@	B-Chemical	D000641	6436733
m@@	I-Chemical	-1	6436733
mon@@	I-Chemical	-1	6436733
ia	I-Chemical	-1	6436733
(	O	-1	6436733
N@@	B-Chemical	D000641	6436733
H@@	I-Chemical	-1	6436733
3	I-Chemical	-1	6436733
)	O	-1	6436733
was	O	-1	6436733
higher	O	-1	6436733
in	O	-1	6436733
patients	O	-1	6436733
who@@	O	-1	6436733
,	O	-1	6436733
during	O	-1	6436733
continu@@	O	-1	6436733
ous	O	-1	6436733
therapy,	O	-1	6436733
com@@	O	-1	6436733
pl@@	O	-1	6436733
ained	O	-1	6436733
of	O	-1	6436733
dro@@	B-Disease	D006970	6436733
w@@	I-Disease	-1	6436733
s@@	I-Disease	-1	6436733
in@@	I-Disease	-1	6436733
ess	I-Disease	-1	6436733
(@@	O	-1	6436733
7	O	-1	6436733
patient@@	O	-1	6436733
s)	O	-1	6436733
than	O	-1	6436733
in	O	-1	6436733
those	O	-1	6436733
who	O	-1	6436733
were	O	-1	6436733
symptom@@	O	-1	6436733
-@@	O	-1	6436733
free	O	-1	6436733
(1@@	O	-1	6436733
7	O	-1	6436733
patient@@	O	-1	6436733
s),	O	-1	6436733
although	O	-1	6436733
V@@	B-Chemical	D014635	6436733
P@@	I-Chemical	-1	6436733
A	I-Chemical	-1	6436733
plasma	O	-1	6436733
levels	O	-1	6436733
were	O	-1	6436733
similar	O	-1	6436733
in	O	-1	6436733
both	O	-1	6436733
groups.	O	-1	6436733
B@@	O	-1	6436733
y	O	-1	6436733
meas@@	O	-1	6436733
uring	O	-1	6436733
V@@	B-Chemical	D014635	6436733
P@@	I-Chemical	-1	6436733
A	I-Chemical	-1	6436733
-induced	O	-1	6436733
changes	O	-1	6436733
of	O	-1	6436733
blood	O	-1	6436733
N@@	B-Chemical	D000641	6436733
H@@	I-Chemical	-1	6436733
3	I-Chemical	-1	6436733
cont@@	O	-1	6436733
ent@@	O	-1	6436733
,	O	-1	6436733
it	O	-1	6436733
may	O	-1	6436733
be	O	-1	6436733
possible	O	-1	6436733
to	O	-1	6436733
identi@@	O	-1	6436733
f@@	O	-1	6436733
y	O	-1	6436733
patients	O	-1	6436733
at	O	-1	6436733
higher	O	-1	6436733
risk	O	-1	6436733
of	O	-1	6436733
obt@@	O	-1	6436733
und@@	O	-1	6436733
ation	O	-1	6436733
when	O	-1	6436733
V@@	B-Chemical	D014635	6436733
P@@	I-Chemical	-1	6436733
A	I-Chemical	-1	6436733
is	O	-1	6436733
given	O	-1	6436733
chron@@	O	-1	6436733
ic@@	O	-1	6436733
all@@	O	-1	6436733
y.	O	-1	6436733

Eff@@	O	-1	6293644
ects	O	-1	6293644
of	O	-1	6293644
calc@@	O	-1	6293644
it@@	O	-1	6293644
on@@	O	-1	6293644
in	O	-1	6293644
on	O	-1	6293644
rat	O	-1	6293644
ext@@	O	-1	6293644
ra@@	O	-1	6293644
py@@	O	-1	6293644
ram@@	O	-1	6293644
idal	O	-1	6293644
motor	O	-1	6293644
system@@	O	-1	6293644
:	O	-1	6293644
behavioral	O	-1	6293644
and	O	-1	6293644
bio@@	O	-1	6293644
chemical	O	-1	6293644
dat@@	O	-1	6293644
a.	O	-1	6293644
The	O	-1	6293644
effects	O	-1	6293644
of	O	-1	6293644
i.v@@	O	-1	6293644
.@@	O	-1	6293644
c@@	O	-1	6293644
.	O	-1	6293644
injection	O	-1	6293644
of	O	-1	6293644
human	O	-1	6293644
and	O	-1	6293644
sal@@	O	-1	6293644
m@@	O	-1	6293644
on	O	-1	6293644
calc@@	O	-1	6293644
it@@	O	-1	6293644
on@@	O	-1	6293644
in	O	-1	6293644
on	O	-1	6293644
bio@@	O	-1	6293644
chemical	O	-1	6293644
and	O	-1	6293644
behavioral	O	-1	6293644
par@@	O	-1	6293644
ame@@	O	-1	6293644
ters	O	-1	6293644
related	O	-1	6293644
to	O	-1	6293644
the	O	-1	6293644
ext@@	O	-1	6293644
ra@@	O	-1	6293644
py@@	O	-1	6293644
ram@@	O	-1	6293644
idal	O	-1	6293644
motor	O	-1	6293644
system@@	O	-1	6293644
,	O	-1	6293644
were	O	-1	6293644
investigated	O	-1	6293644
in	O	-1	6293644
male	O	-1	6293644
rats.	O	-1	6293644
C@@	O	-1	6293644
al@@	O	-1	6293644
cit@@	O	-1	6293644
on@@	O	-1	6293644
in	O	-1	6293644
injection	O	-1	6293644
resulted	O	-1	6293644
in	O	-1	6293644
a	O	-1	6293644
potenti@@	O	-1	6293644
ation	O	-1	6293644
of	O	-1	6293644
haloperidol	B-Chemical	D006220	6293644
-induced	O	-1	6293644
cat@@	B-Disease	D002375	6293644
al@@	I-Disease	-1	6293644
ep@@	I-Disease	-1	6293644
sy	I-Disease	-1	6293644
and	O	-1	6293644
a	O	-1	6293644
partial	O	-1	6293644
pre@@	O	-1	6293644
ven@@	O	-1	6293644
tion	O	-1	6293644
of	O	-1	6293644
apo@@	B-Chemical	D001058	6293644
morphine	I-Chemical	-1	6293644
-induced	O	-1	6293644
hyperactivity	B-Disease	D006948	6293644
.	O	-1	6293644
M@@	O	-1	6293644
ore@@	O	-1	6293644
over	O	-1	6293644
calc@@	O	-1	6293644
it@@	O	-1	6293644
on@@	O	-1	6293644
in	O	-1	6293644
induced	O	-1	6293644
a	O	-1	6293644
significant	O	-1	6293644
decrease	O	-1	6293644
in	O	-1	6293644
n@@	O	-1	6293644
ig@@	O	-1	6293644
ral	O	-1	6293644
G@@	O	-1	6293644
A@@	O	-1	6293644
D	O	-1	6293644
activity	O	-1	6293644
but	O	-1	6293644
no	O	-1	6293644
change	O	-1	6293644
in	O	-1	6293644
stri@@	O	-1	6293644
atal	O	-1	6293644
D@@	B-Chemical	D004298	6293644
A	I-Chemical	-1	6293644
and	O	-1	6293644
DO@@	B-Chemical	D015102	6293644
PA@@	I-Chemical	-1	6293644
C	I-Chemical	-1	6293644
concentration	O	-1	6293644
or	O	-1	6293644
G@@	O	-1	6293644
A@@	O	-1	6293644
D	O	-1	6293644
activ@@	O	-1	6293644
ity.	O	-1	6293644
The	O	-1	6293644
results	O	-1	6293644
are	O	-1	6293644
discus@@	O	-1	6293644
sed	O	-1	6293644
in	O	-1	6293644
vie@@	O	-1	6293644
w	O	-1	6293644
of	O	-1	6293644
a	O	-1	6293644
prim@@	O	-1	6293644
ary	O	-1	6293644
action	O	-1	6293644
of	O	-1	6293644
calc@@	O	-1	6293644
it@@	O	-1	6293644
on@@	O	-1	6293644
in	O	-1	6293644
on	O	-1	6293644
the	O	-1	6293644
striat@@	O	-1	6293644
oni@@	O	-1	6293644
g@@	O	-1	6293644
ral	O	-1	6293644
G@@	O	-1	6293644
A@@	O	-1	6293644
BA@@	O	-1	6293644
ergic	O	-1	6293644
path@@	O	-1	6293644
w@@	O	-1	6293644
ay	O	-1	6293644
medi@@	O	-1	6293644
ating	O	-1	6293644
the	O	-1	6293644
D@@	B-Chemical	D004298	6293644
A	I-Chemical	-1	6293644
-@@	O	-1	6293644
related	O	-1	6293644
behavioral	O	-1	6293644
m@@	O	-1	6293644
ess@@	O	-1	6293644
ages	O	-1	6293644
of	O	-1	6293644
stri@@	O	-1	6293644
atal	O	-1	6293644
or@@	O	-1	6293644
ig@@	O	-1	6293644
in.	O	-1	6293644

De@@	O	-1	6203632
ve@@	O	-1	6203632
lop@@	O	-1	6203632
ment	O	-1	6203632
of	O	-1	6203632
isoproteren@@	B-Chemical	D007545	6203632
ol	I-Chemical	-1	6203632
-induced	O	-1	6203632
cardiac	B-Disease	D006332	6203632
hyper@@	I-Disease	-1	6203632
tro@@	I-Disease	-1	6203632
ph@@	I-Disease	-1	6203632
y	I-Disease	-1	6203632
.	O	-1	6203632
The	O	-1	6203632
development	O	-1	6203632
of	O	-1	6203632
cardiac	B-Disease	D006332	6203632
hyper@@	I-Disease	-1	6203632
tro@@	I-Disease	-1	6203632
ph@@	I-Disease	-1	6203632
y	I-Disease	-1	6203632
was	O	-1	6203632
studied	O	-1	6203632
in	O	-1	6203632
ad@@	O	-1	6203632
ult	O	-1	6203632
female	O	-1	6203632
Wistar	O	-1	6203632
rats	O	-1	6203632
following	O	-1	6203632
daily	O	-1	6203632
sub@@	O	-1	6203632
c@@	O	-1	6203632
utaneous	O	-1	6203632
injec@@	O	-1	6203632
tions	O	-1	6203632
of	O	-1	6203632
isoproteren@@	B-Chemical	D007545	6203632
ol	I-Chemical	-1	6203632
(	O	-1	6203632
I@@	B-Chemical	D007545	6203632
S@@	I-Chemical	-1	6203632
O	I-Chemical	-1	6203632
)	O	-1	6203632
(0.@@	O	-1	6203632
3	O	-1	6203632
mg/kg	O	-1	6203632
body	O	-1	6203632
weigh@@	O	-1	6203632
t@@	O	-1	6203632
).	O	-1	6203632
A	O	-1	6203632
time	O	-1	6203632
course	O	-1	6203632
was	O	-1	6203632
est@@	O	-1	6203632
abl@@	O	-1	6203632
ished	O	-1	6203632
for	O	-1	6203632
the	O	-1	6203632
change	O	-1	6203632
in	O	-1	6203632
tissue	O	-1	6203632
mas@@	O	-1	6203632
s,	O	-1	6203632
R@@	O	-1	6203632
NA	O	-1	6203632
and	O	-1	6203632
D@@	O	-1	6203632
NA	O	-1	6203632
cont@@	O	-1	6203632
ent@@	O	-1	6203632
,	O	-1	6203632
as	O	-1	6203632
well	O	-1	6203632
as	O	-1	6203632
hydrox@@	B-Chemical	D006909	6203632
y@@	I-Chemical	-1	6203632
prol@@	I-Chemical	-1	6203632
ine	I-Chemical	-1	6203632
cont@@	O	-1	6203632
ent@@	O	-1	6203632
.	O	-1	6203632
H@@	O	-1	6203632
ear@@	O	-1	6203632
t	O	-1	6203632
weight	O	-1	6203632
increased	O	-1	6203632
4@@	O	-1	6203632
4@@	O	-1	6203632
%	O	-1	6203632
after	O	-1	6203632
8	O	-1	6203632
days	O	-1	6203632
of	O	-1	6203632
treatment	O	-1	6203632
with	O	-1	6203632
a	O	-1	6203632
h@@	O	-1	6203632
al@@	O	-1	6203632
f	O	-1	6203632
time	O	-1	6203632
of	O	-1	6203632
3.@@	O	-1	6203632
4	O	-1	6203632
days.	O	-1	6203632
V@@	O	-1	6203632
entr@@	O	-1	6203632
ic@@	O	-1	6203632
ular	O	-1	6203632
R@@	O	-1	6203632
NA	O	-1	6203632
cont@@	O	-1	6203632
ent	O	-1	6203632
was	O	-1	6203632
elevated	O	-1	6203632
2@@	O	-1	6203632
6%	O	-1	6203632
after	O	-1	6203632
24	O	-1	6203632
h	O	-1	6203632
of	O	-1	6203632
a	O	-1	6203632
single	O	-1	6203632
injection	O	-1	6203632
and	O	-1	6203632
reac@@	O	-1	6203632
h@@	O	-1	6203632
ed	O	-1	6203632
a	O	-1	6203632
maxim@@	O	-1	6203632
al	O	-1	6203632
level	O	-1	6203632
following	O	-1	6203632
8	O	-1	6203632
days	O	-1	6203632
of	O	-1	6203632
therapy.	O	-1	6203632
The	O	-1	6203632
h@@	O	-1	6203632
al@@	O	-1	6203632
f	O	-1	6203632
time	O	-1	6203632
for	O	-1	6203632
R@@	O	-1	6203632
NA	O	-1	6203632
accum@@	O	-1	6203632
ulation	O	-1	6203632
was	O	-1	6203632
2.@@	O	-1	6203632
0	O	-1	6203632
days.	O	-1	6203632
The	O	-1	6203632
total	O	-1	6203632
cont@@	O	-1	6203632
ent	O	-1	6203632
of	O	-1	6203632
hydrox@@	B-Chemical	D006909	6203632
y@@	I-Chemical	-1	6203632
prol@@	I-Chemical	-1	6203632
ine	I-Chemical	-1	6203632
remained	O	-1	6203632
st@@	O	-1	6203632
able	O	-1	6203632
during	O	-1	6203632
the	O	-1	6203632
first	O	-1	6203632
2	O	-1	6203632
days	O	-1	6203632
of	O	-1	6203632
treatment	O	-1	6203632
but	O	-1	6203632
increased	O	-1	6203632
4@@	O	-1	6203632
6%	O	-1	6203632
after	O	-1	6203632
4	O	-1	6203632
days	O	-1	6203632
of	O	-1	6203632
therapy.	O	-1	6203632
V@@	O	-1	6203632
entr@@	O	-1	6203632
ic@@	O	-1	6203632
ular	O	-1	6203632
D@@	O	-1	6203632
NA	O	-1	6203632
cont@@	O	-1	6203632
ent	O	-1	6203632
was	O	-1	6203632
un@@	O	-1	6203632
chang@@	O	-1	6203632
ed	O	-1	6203632
during	O	-1	6203632
the	O	-1	6203632
early	O	-1	6203632
st@@	O	-1	6203632
age	O	-1	6203632
(1@@	O	-1	6203632
-@@	O	-1	6203632
4	O	-1	6203632
da@@	O	-1	6203632
ys@@	O	-1	6203632
)	O	-1	6203632
of	O	-1	6203632
hyper@@	B-Disease	D006984	6203632
tro@@	I-Disease	-1	6203632
ph@@	I-Disease	-1	6203632
ic	I-Disease	-1	6203632
growth	O	-1	6203632
but	O	-1	6203632
increased	O	-1	6203632
to	O	-1	6203632
a	O	-1	6203632
new	O	-1	6203632
ste@@	O	-1	6203632
ad@@	O	-1	6203632
y-@@	O	-1	6203632
state	O	-1	6203632
level	O	-1	6203632
19@@	O	-1	6203632
%	O	-1	6203632
ab@@	O	-1	6203632
o@@	O	-1	6203632
ve	O	-1	6203632
the	O	-1	6203632
controls	O	-1	6203632
after	O	-1	6203632
8	O	-1	6203632
days	O	-1	6203632
of	O	-1	6203632
treatment.	O	-1	6203632
In@@	O	-1	6203632
tra@@	O	-1	6203632
ventricular	O	-1	6203632
pressu@@	O	-1	6203632
res	O	-1	6203632
and	O	-1	6203632
coronary	O	-1	6203632
flow	O	-1	6203632
meas@@	O	-1	6203632
ures	O	-1	6203632
were	O	-1	6203632
similar	O	-1	6203632
for	O	-1	6203632
control	O	-1	6203632
and	O	-1	6203632
experimental	O	-1	6203632
animals	O	-1	6203632
following	O	-1	6203632
4	O	-1	6203632
days	O	-1	6203632
of	O	-1	6203632
developed	O	-1	6203632
hyper@@	B-Disease	D006984	6203632
tro@@	I-Disease	-1	6203632
ph@@	I-Disease	-1	6203632
y	I-Disease	-1	6203632
.	O	-1	6203632
However,	O	-1	6203632
d@@	O	-1	6203632
P@@	O	-1	6203632
/@@	O	-1	6203632
d@@	O	-1	6203632
t	O	-1	6203632
in	O	-1	6203632
the	O	-1	6203632
I@@	B-Chemical	D007545	6203632
S@@	I-Chemical	-1	6203632
O	I-Chemical	-1	6203632
-treated	O	-1	6203632
hear@@	O	-1	6203632
ts	O	-1	6203632
was	O	-1	6203632
s@@	O	-1	6203632
li@@	O	-1	6203632
gh@@	O	-1	6203632
tly	O	-1	6203632
but	O	-1	6203632
significantly	O	-1	6203632
(P	O	-1	6203632
less	O	-1	6203632
than	O	-1	6203632
0.05@@	O	-1	6203632
)	O	-1	6203632
elev@@	O	-1	6203632
ated.	O	-1	6203632
These	O	-1	6203632
data	O	-1	6203632
indicate	O	-1	6203632
that	O	-1	6203632
the	O	-1	6203632
ad@@	O	-1	6203632
ap@@	O	-1	6203632
tive	O	-1	6203632
response	O	-1	6203632
to	O	-1	6203632
I@@	B-Chemical	D007545	6203632
S@@	I-Chemical	-1	6203632
O	I-Chemical	-1	6203632
show@@	O	-1	6203632
s	O	-1	6203632
an	O	-1	6203632
early	O	-1	6203632
hyper@@	B-Disease	D006984	6203632
tro@@	I-Disease	-1	6203632
ph@@	I-Disease	-1	6203632
ic	I-Disease	-1	6203632
phase	O	-1	6203632
(1@@	O	-1	6203632
-@@	O	-1	6203632
4	O	-1	6203632
da@@	O	-1	6203632
ys@@	O	-1	6203632
)	O	-1	6203632
character@@	O	-1	6203632
ized	O	-1	6203632
by	O	-1	6203632
a	O	-1	6203632
subst@@	O	-1	6203632
anti@@	O	-1	6203632
al	O	-1	6203632
increase	O	-1	6203632
in	O	-1	6203632
R@@	O	-1	6203632
NA	O	-1	6203632
cont@@	O	-1	6203632
ent	O	-1	6203632
and	O	-1	6203632
cardiac	O	-1	6203632
mas@@	O	-1	6203632
s	O	-1	6203632
in	O	-1	6203632
the	O	-1	6203632
absence	O	-1	6203632
of	O	-1	6203632
changes	O	-1	6203632
in	O	-1	6203632
D@@	O	-1	6203632
N@@	O	-1	6203632
A@@	O	-1	6203632
.	O	-1	6203632
However,	O	-1	6203632
prolonged	O	-1	6203632
stimulation	O	-1	6203632
(@@	O	-1	6203632
8@@	O	-1	6203632
-1@@	O	-1	6203632
2	O	-1	6203632
da@@	O	-1	6203632
ys@@	O	-1	6203632
)	O	-1	6203632
appear@@	O	-1	6203632
s	O	-1	6203632
to	O	-1	6203632
re@@	O	-1	6203632
present	O	-1	6203632
a	O	-1	6203632
comple@@	O	-1	6203632
x	O	-1	6203632
in@@	O	-1	6203632
te@@	O	-1	6203632
g@@	O	-1	6203632
ration	O	-1	6203632
of	O	-1	6203632
both	O	-1	6203632
cell@@	O	-1	6203632
ular	O	-1	6203632
hyper@@	B-Disease	D006984	6203632
tro@@	I-Disease	-1	6203632
ph@@	I-Disease	-1	6203632
y	I-Disease	-1	6203632
and	O	-1	6203632
hyper@@	B-Disease	D006965	6203632
pl@@	I-Disease	-1	6203632
a@@	I-Disease	-1	6203632
sia	I-Disease	-1	6203632
within	O	-1	6203632
the	O	-1	6203632
hear@@	O	-1	6203632
t.	O	-1	6203632

C@@	O	-1	3131282
o@@	O	-1	3131282
-	O	-1	3131282
carcino@@	B-Disease	D063646	3131282
genic	I-Disease	-1	3131282
effect	O	-1	3131282
of	O	-1	3131282
ret@@	B-Chemical	C009166	3131282
in@@	I-Chemical	-1	3131282
yl	I-Chemical	-1	3131282
acet@@	I-Chemical	-1	3131282
ate	I-Chemical	-1	3131282
on	O	-1	3131282
fo@@	B-Disease	D013274	3131282
rest@@	I-Disease	-1	3131282
om@@	I-Disease	-1	3131282
ach	I-Disease	-1	3131282
carcino@@	I-Disease	-1	3131282
genesis	I-Disease	-1	3131282
of	O	-1	3131282
male	O	-1	3131282
F@@	O	-1	3131282
34@@	O	-1	3131282
4	O	-1	3131282
rats	O	-1	3131282
induced	O	-1	3131282
with	O	-1	3131282
but@@	B-Chemical	D002083	3131282
yl@@	I-Chemical	-1	3131282
ated	I-Chemical	-1	3131282
hydrox@@	I-Chemical	-1	3131282
y@@	I-Chemical	-1	3131282
an@@	I-Chemical	-1	3131282
isol@@	I-Chemical	-1	3131282
e	I-Chemical	-1	3131282
.	O	-1	3131282
The	O	-1	3131282
potential	O	-1	3131282
mo@@	O	-1	3131282
di@@	O	-1	3131282
f@@	O	-1	3131282
y@@	O	-1	3131282
ing	O	-1	3131282
effect	O	-1	3131282
of	O	-1	3131282
ret@@	B-Chemical	C009166	3131282
in@@	I-Chemical	-1	3131282
yl	I-Chemical	-1	3131282
acet@@	I-Chemical	-1	3131282
ate	I-Chemical	-1	3131282
(	O	-1	3131282
R@@	B-Chemical	C009166	3131282
A	I-Chemical	-1	3131282
)	O	-1	3131282
on	O	-1	3131282
but@@	B-Chemical	D002083	3131282
yl@@	I-Chemical	-1	3131282
ated	I-Chemical	-1	3131282
hydrox@@	I-Chemical	-1	3131282
y@@	I-Chemical	-1	3131282
an@@	I-Chemical	-1	3131282
isol@@	I-Chemical	-1	3131282
e	I-Chemical	-1	3131282
(	O	-1	3131282
B@@	B-Chemical	D002083	3131282
H@@	I-Chemical	-1	3131282
A	I-Chemical	-1	3131282
)@@	O	-1	3131282
-induced	O	-1	3131282
rat	O	-1	3131282
fo@@	B-Disease	D013274	3131282
rest@@	I-Disease	-1	3131282
om@@	I-Disease	-1	3131282
ach	I-Disease	-1	3131282
tu@@	I-Disease	-1	3131282
mor@@	I-Disease	-1	3131282
i@@	I-Disease	-1	3131282
genesis	I-Disease	-1	3131282
was	O	-1	3131282
ex@@	O	-1	3131282
am@@	O	-1	3131282
ine@@	O	-1	3131282
d.	O	-1	3131282
M@@	O	-1	3131282
al@@	O	-1	3131282
e	O	-1	3131282
F@@	O	-1	3131282
34@@	O	-1	3131282
4	O	-1	3131282
rats,	O	-1	3131282
5	O	-1	3131282
weeks	O	-1	3131282
of	O	-1	3131282
age,	O	-1	3131282
were	O	-1	3131282
maint@@	O	-1	3131282
ained	O	-1	3131282
on	O	-1	3131282
diet	O	-1	3131282
containing	O	-1	3131282
1@@	O	-1	3131282
%	O	-1	3131282
or	O	-1	3131282
2@@	O	-1	3131282
%	O	-1	3131282
B@@	B-Chemical	D002083	3131282
H@@	I-Chemical	-1	3131282
A	I-Chemical	-1	3131282
by	O	-1	3131282
weight	O	-1	3131282
and	O	-1	3131282
sim@@	O	-1	3131282
ult@@	O	-1	3131282
ane@@	O	-1	3131282
ously	O	-1	3131282
on	O	-1	3131282
d@@	O	-1	3131282
r@@	O	-1	3131282
in@@	O	-1	3131282
king	O	-1	3131282
w@@	O	-1	3131282
at@@	O	-1	3131282
er	O	-1	3131282
sup@@	O	-1	3131282
ple@@	O	-1	3131282
ment@@	O	-1	3131282
ed	O	-1	3131282
with	O	-1	3131282
R@@	B-Chemical	C009166	3131282
A	I-Chemical	-1	3131282
at	O	-1	3131282
various	O	-1	3131282
concentrations	O	-1	3131282
(@@	O	-1	3131282
w@@	O	-1	3131282
/@@	O	-1	3131282
v@@	O	-1	3131282
)	O	-1	3131282
for	O	-1	3131282
5@@	O	-1	3131282
2	O	-1	3131282
week@@	O	-1	3131282
s.	O	-1	3131282
In	O	-1	3131282
groups	O	-1	3131282
given	O	-1	3131282
2@@	O	-1	3131282
%	O	-1	3131282
B@@	B-Chemical	D002083	3131282
H@@	I-Chemical	-1	3131282
A	I-Chemical	-1	3131282
,	O	-1	3131282
although	O	-1	3131282
mark@@	O	-1	3131282
ed	O	-1	3131282
hyper@@	O	-1	3131282
plas@@	O	-1	3131282
tic	O	-1	3131282
changes	O	-1	3131282
of	O	-1	3131282
the	O	-1	3131282
fo@@	O	-1	3131282
rest@@	O	-1	3131282
om@@	O	-1	3131282
ach	O	-1	3131282
epi@@	O	-1	3131282
the@@	O	-1	3131282
li@@	O	-1	3131282
um	O	-1	3131282
were	O	-1	3131282
observed	O	-1	3131282
in	O	-1	3131282
all	O	-1	3131282
anim@@	O	-1	3131282
al@@	O	-1	3131282
s,	O	-1	3131282
co-@@	O	-1	3131282
administration	O	-1	3131282
of	O	-1	3131282
0.@@	O	-1	3131282
2@@	O	-1	3131282
5%	O	-1	3131282
R@@	B-Chemical	C009166	3131282
A	I-Chemical	-1	3131282
significantly	O	-1	3131282
(P	O	-1	3131282
less	O	-1	3131282
than	O	-1	3131282
0.05@@	O	-1	3131282
)	O	-1	3131282
increased	O	-1	3131282
the	O	-1	3131282
incidence	O	-1	3131282
of	O	-1	3131282
fo@@	B-Disease	D013274	3131282
rest@@	I-Disease	-1	3131282
om@@	I-Disease	-1	3131282
ach	I-Disease	-1	3131282
tu@@	I-Disease	-1	3131282
mor@@	I-Disease	-1	3131282
s	I-Disease	-1	3131282
(	O	-1	3131282
s@@	B-Disease	D010212	3131282
qu@@	I-Disease	-1	3131282
am@@	I-Disease	-1	3131282
ous	I-Disease	-1	3131282
cell	I-Disease	-1	3131282
pap@@	I-Disease	-1	3131282
il@@	I-Disease	-1	3131282
lo@@	I-Disease	-1	3131282
ma	I-Disease	-1	3131282
and	O	-1	3131282
carcin@@	B-Disease	D002277	3131282
oma	I-Disease	-1	3131282
)	O	-1	3131282
to	O	-1	3131282
6@@	O	-1	3131282
0%	O	-1	3131282
(@@	O	-1	3131282
9@@	O	-1	3131282
/@@	O	-1	3131282
1@@	O	-1	3131282
5,	O	-1	3131282
2	O	-1	3131282
rats	O	-1	3131282
with	O	-1	3131282
carcin@@	B-Disease	D002277	3131282
oma	I-Disease	-1	3131282
)	O	-1	3131282
from	O	-1	3131282
1@@	O	-1	3131282
5%	O	-1	3131282
(3@@	O	-1	3131282
/@@	O	-1	3131282
20@@	O	-1	3131282
,	O	-1	3131282
one	O	-1	3131282
rat	O	-1	3131282
with	O	-1	3131282
carcin@@	B-Disease	D002277	3131282
oma	I-Disease	-1	3131282
)	O	-1	3131282
in	O	-1	3131282
the	O	-1	3131282
group	O	-1	3131282
given	O	-1	3131282
R@@	B-Chemical	C009166	3131282
A	I-Chemical	-1	3131282
-@@	O	-1	3131282
free	O	-1	3131282
w@@	O	-1	3131282
at@@	O	-1	3131282
er.	O	-1	3131282
In	O	-1	3131282
rats	O	-1	3131282
given	O	-1	3131282
1@@	O	-1	3131282
%	O	-1	3131282
B@@	B-Chemical	D002083	3131282
H@@	I-Chemical	-1	3131282
A	I-Chemical	-1	3131282
,	O	-1	3131282
R@@	B-Chemical	C009166	3131282
A	I-Chemical	-1	3131282
co-@@	O	-1	3131282
administered	O	-1	3131282
at	O	-1	3131282
a	O	-1	3131282
dose	O	-1	3131282
of	O	-1	3131282
0.05@@	O	-1	3131282
,	O	-1	3131282
0.@@	O	-1	3131282
1,	O	-1	3131282
0.@@	O	-1	3131282
2	O	-1	3131282
or	O	-1	3131282
0.@@	O	-1	3131282
2@@	O	-1	3131282
5%	O	-1	3131282
showed	O	-1	3131282
a	O	-1	3131282
dose-@@	O	-1	3131282
dependent	O	-1	3131282
enh@@	O	-1	3131282
anc@@	O	-1	3131282
ing	O	-1	3131282
effect	O	-1	3131282
on	O	-1	3131282
the	O	-1	3131282
development	O	-1	3131282
of	O	-1	3131282
the	O	-1	3131282
B@@	B-Chemical	D002083	3131282
H@@	I-Chemical	-1	3131282
A	I-Chemical	-1	3131282
-induced	O	-1	3131282
epi@@	B-Disease	D017573	3131282
thelial	I-Disease	-1	3131282
hyper@@	I-Disease	-1	3131282
pl@@	I-Disease	-1	3131282
a@@	I-Disease	-1	3131282
sia	I-Disease	-1	3131282
.	O	-1	3131282
T@@	B-Disease	D009369	3131282
u@@	I-Disease	-1	3131282
mor@@	I-Disease	-1	3131282
s	I-Disease	-1	3131282
,	O	-1	3131282
all	O	-1	3131282
pap@@	B-Disease	D010212	3131282
il@@	I-Disease	-1	3131282
lo@@	I-Disease	-1	3131282
m@@	I-Disease	-1	3131282
as	I-Disease	-1	3131282
,	O	-1	3131282
were	O	-1	3131282
induced	O	-1	3131282
in	O	-1	3131282
3	O	-1	3131282
rats	O	-1	3131282
(1@@	O	-1	3131282
7@@	O	-1	3131282
%)	O	-1	3131282
with	O	-1	3131282
0.@@	O	-1	3131282
2@@	O	-1	3131282
5%	O	-1	3131282
R@@	B-Chemical	C009166	3131282
A	I-Chemical	-1	3131282
and	O	-1	3131282
in	O	-1	3131282
one	O	-1	3131282
rat	O	-1	3131282
(@@	O	-1	3131282
10@@	O	-1	3131282
%)	O	-1	3131282
with	O	-1	3131282
0.0@@	O	-1	3131282
5%	O	-1	3131282
R@@	B-Chemical	C009166	3131282
A	I-Chemical	-1	3131282
co-@@	O	-1	3131282
administr@@	O	-1	3131282
ation.	O	-1	3131282
R@@	B-Chemical	C009166	3131282
A	I-Chemical	-1	3131282
alone	O	-1	3131282
did	O	-1	3131282
not	O	-1	3131282
induce	O	-1	3131282
hyper@@	O	-1	3131282
plas@@	O	-1	3131282
tic	O	-1	3131282
changes	O	-1	3131282
in	O	-1	3131282
the	O	-1	3131282
fo@@	O	-1	3131282
rest@@	O	-1	3131282
om@@	O	-1	3131282
ac@@	O	-1	3131282
h@@	O	-1	3131282
.	O	-1	3131282
These	O	-1	3131282
findings	O	-1	3131282
indicate	O	-1	3131282
that	O	-1	3131282
R@@	B-Chemical	C009166	3131282
A	I-Chemical	-1	3131282
ac@@	O	-1	3131282
ted	O	-1	3131282
as	O	-1	3131282
a	O	-1	3131282
co-@@	O	-1	3131282
carcino@@	O	-1	3131282
gen	O	-1	3131282
in	O	-1	3131282
the	O	-1	3131282
B@@	B-Chemical	D002083	3131282
H@@	I-Chemical	-1	3131282
A	I-Chemical	-1	3131282
fo@@	B-Disease	D013274	3131282
rest@@	I-Disease	-1	3131282
om@@	I-Disease	-1	3131282
ach	I-Disease	-1	3131282
carcino@@	I-Disease	-1	3131282
genesis	I-Disease	-1	3131282
of	O	-1	3131282
the	O	-1	3131282
rat@@	O	-1	3131282
.	O	-1	3131282

K@@	B-Chemical	D007650	3115150
et@@	I-Chemical	-1	3115150
an@@	I-Chemical	-1	3115150
ser@@	I-Chemical	-1	3115150
in	I-Chemical	-1	3115150
pretreatment	O	-1	3115150
rever@@	O	-1	3115150
ses	O	-1	3115150
al@@	B-Chemical	D015760	3115150
f@@	I-Chemical	-1	3115150
entan@@	I-Chemical	-1	3115150
il	I-Chemical	-1	3115150
-induced	O	-1	3115150
musc@@	B-Disease	D009127	3115150
le	I-Disease	-1	3115150
rig@@	I-Disease	-1	3115150
idity	I-Disease	-1	3115150
.	O	-1	3115150
S@@	O	-1	3115150
y@@	O	-1	3115150
st@@	O	-1	3115150
em@@	O	-1	3115150
ic	O	-1	3115150
pretreatment	O	-1	3115150
with	O	-1	3115150
k@@	B-Chemical	D007650	3115150
et@@	I-Chemical	-1	3115150
an@@	I-Chemical	-1	3115150
ser@@	I-Chemical	-1	3115150
in	I-Chemical	-1	3115150
,	O	-1	3115150
a	O	-1	3115150
rel@@	O	-1	3115150
atively	O	-1	3115150
specific	O	-1	3115150
ty@@	O	-1	3115150
pe@@	O	-1	3115150
-@@	O	-1	3115150
2	O	-1	3115150
seroton@@	B-Chemical	D012701	3115150
in	I-Chemical	-1	3115150
receptor	O	-1	3115150
antagonist@@	O	-1	3115150
,	O	-1	3115150
significantly	O	-1	3115150
attenu@@	O	-1	3115150
ated	O	-1	3115150
the	O	-1	3115150
musc@@	B-Disease	D009127	3115150
le	I-Disease	-1	3115150
rig@@	I-Disease	-1	3115150
idity	I-Disease	-1	3115150
produced	O	-1	3115150
in	O	-1	3115150
rats	O	-1	3115150
by	O	-1	3115150
the	O	-1	3115150
pot@@	O	-1	3115150
ent	O	-1	3115150
sh@@	O	-1	3115150
ort@@	O	-1	3115150
-@@	O	-1	3115150
act@@	O	-1	3115150
ing	O	-1	3115150
o@@	O	-1	3115150
pi@@	O	-1	3115150
ate	O	-1	3115150
agon@@	O	-1	3115150
ist	O	-1	3115150
al@@	B-Chemical	D015760	3115150
f@@	I-Chemical	-1	3115150
entan@@	I-Chemical	-1	3115150
il	I-Chemical	-1	3115150
.	O	-1	3115150
F@@	O	-1	3115150
ol@@	O	-1	3115150
low@@	O	-1	3115150
ing	O	-1	3115150
pl@@	O	-1	3115150
ac@@	O	-1	3115150
ement	O	-1	3115150
of	O	-1	3115150
sub@@	O	-1	3115150
c@@	O	-1	3115150
utaneous	O	-1	3115150
electro@@	O	-1	3115150
des	O	-1	3115150
in	O	-1	3115150
each	O	-1	3115150
anim@@	O	-1	3115150
al@@	O	-1	3115150
's	O	-1	3115150
left	O	-1	3115150
gast@@	O	-1	3115150
ro@@	O	-1	3115150
c@@	O	-1	3115150
ne@@	O	-1	3115150
mi@@	O	-1	3115150
us	O	-1	3115150
musc@@	O	-1	3115150
le@@	O	-1	3115150
,	O	-1	3115150
rig@@	B-Disease	D009127	3115150
idity	I-Disease	-1	3115150
was	O	-1	3115150
assessed	O	-1	3115150
by	O	-1	3115150
analy@@	O	-1	3115150
z@@	O	-1	3115150
ing	O	-1	3115150
ro@@	O	-1	3115150
ot@@	O	-1	3115150
-@@	O	-1	3115150
me@@	O	-1	3115150
an@@	O	-1	3115150
-@@	O	-1	3115150
s@@	O	-1	3115150
qu@@	O	-1	3115150
are	O	-1	3115150
elect@@	O	-1	3115150
rom@@	O	-1	3115150
y@@	O	-1	3115150
ograph@@	O	-1	3115150
ic	O	-1	3115150
activ@@	O	-1	3115150
ity.	O	-1	3115150
In@@	O	-1	3115150
tra@@	O	-1	3115150
per@@	O	-1	3115150
it@@	O	-1	3115150
one@@	O	-1	3115150
al	O	-1	3115150
k@@	B-Chemical	D007650	3115150
et@@	I-Chemical	-1	3115150
an@@	I-Chemical	-1	3115150
ser@@	I-Chemical	-1	3115150
in	I-Chemical	-1	3115150
administration	O	-1	3115150
at	O	-1	3115150
doses	O	-1	3115150
of	O	-1	3115150
0.@@	O	-1	3115150
6@@	O	-1	3115150
3	O	-1	3115150
and	O	-1	3115150
2.@@	O	-1	3115150
5	O	-1	3115150
mg/kg	O	-1	3115150
prevent@@	O	-1	3115150
ed	O	-1	3115150
the	O	-1	3115150
al@@	B-Chemical	D015760	3115150
f@@	I-Chemical	-1	3115150
entan@@	I-Chemical	-1	3115150
il	I-Chemical	-1	3115150
-induced	O	-1	3115150
increase	O	-1	3115150
in	O	-1	3115150
elect@@	O	-1	3115150
rom@@	O	-1	3115150
y@@	O	-1	3115150
ograph@@	O	-1	3115150
ic	O	-1	3115150
activity	O	-1	3115150
compared	O	-1	3115150
with	O	-1	3115150
animals	O	-1	3115150
pre@@	O	-1	3115150
treated	O	-1	3115150
with	O	-1	3115150
sal@@	O	-1	3115150
ine.	O	-1	3115150
Ch@@	B-Chemical	D002707	3115150
lor@@	I-Chemical	-1	3115150
di@@	I-Chemical	-1	3115150
az@@	I-Chemical	-1	3115150
e@@	I-Chemical	-1	3115150
po@@	I-Chemical	-1	3115150
x@@	I-Chemical	-1	3115150
ide	I-Chemical	-1	3115150
at	O	-1	3115150
doses	O	-1	3115150
up	O	-1	3115150
to	O	-1	3115150
10	O	-1	3115150
mg/kg	O	-1	3115150
fail@@	O	-1	3115150
ed	O	-1	3115150
to	O	-1	3115150
significantly	O	-1	3115150
influence	O	-1	3115150
the	O	-1	3115150
rig@@	B-Disease	D009127	3115150
idity	I-Disease	-1	3115150
produced	O	-1	3115150
by	O	-1	3115150
al@@	B-Chemical	D015760	3115150
f@@	I-Chemical	-1	3115150
entan@@	I-Chemical	-1	3115150
il	I-Chemical	-1	3115150
.	O	-1	3115150
D@@	O	-1	3115150
es@@	O	-1	3115150
pit@@	O	-1	3115150
e	O	-1	3115150
the	O	-1	3115150
absence	O	-1	3115150
of	O	-1	3115150
rig@@	B-Disease	D009127	3115150
idity	I-Disease	-1	3115150
,	O	-1	3115150
animals	O	-1	3115150
that	O	-1	3115150
received	O	-1	3115150
k@@	B-Chemical	D007650	3115150
et@@	I-Chemical	-1	3115150
an@@	I-Chemical	-1	3115150
ser@@	I-Chemical	-1	3115150
in	I-Chemical	-1	3115150
(@@	O	-1	3115150
greater	O	-1	3115150
than	O	-1	3115150
0.@@	O	-1	3115150
3@@	O	-1	3115150
1	O	-1	3115150
mg/kg	O	-1	3115150
i.p.@@	O	-1	3115150
)	O	-1	3115150
followed	O	-1	3115150
by	O	-1	3115150
al@@	B-Chemical	D015760	3115150
f@@	I-Chemical	-1	3115150
entan@@	I-Chemical	-1	3115150
il	I-Chemical	-1	3115150
were	O	-1	3115150
mo@@	O	-1	3115150
tion@@	O	-1	3115150
l@@	O	-1	3115150
es@@	O	-1	3115150
s,	O	-1	3115150
f@@	O	-1	3115150
l@@	O	-1	3115150
ac@@	O	-1	3115150
c@@	O	-1	3115150
id@@	O	-1	3115150
,	O	-1	3115150
and	O	-1	3115150
less	O	-1	3115150
respon@@	O	-1	3115150
sive	O	-1	3115150
to	O	-1	3115150
ex@@	O	-1	3115150
tern@@	O	-1	3115150
al	O	-1	3115150
stimul@@	O	-1	3115150
i	O	-1	3115150
than	O	-1	3115150
were	O	-1	3115150
animals	O	-1	3115150
receiving	O	-1	3115150
al@@	B-Chemical	D015760	3115150
f@@	I-Chemical	-1	3115150
entan@@	I-Chemical	-1	3115150
il	I-Chemical	-1	3115150
al@@	O	-1	3115150
one.	O	-1	3115150
R@@	O	-1	3115150
at@@	O	-1	3115150
s	O	-1	3115150
that	O	-1	3115150
received	O	-1	3115150
k@@	B-Chemical	D007650	3115150
et@@	I-Chemical	-1	3115150
an@@	I-Chemical	-1	3115150
ser@@	I-Chemical	-1	3115150
in	I-Chemical	-1	3115150
and	O	-1	3115150
al@@	B-Chemical	D015760	3115150
f@@	I-Chemical	-1	3115150
entan@@	I-Chemical	-1	3115150
il	I-Chemical	-1	3115150
ex@@	O	-1	3115150
hib@@	O	-1	3115150
ited	O	-1	3115150
less	O	-1	3115150
re@@	O	-1	3115150
ar@@	O	-1	3115150
ing	O	-1	3115150
and	O	-1	3115150
expl@@	O	-1	3115150
or@@	O	-1	3115150
atory	O	-1	3115150
behavi@@	O	-1	3115150
or	O	-1	3115150
at	O	-1	3115150
the	O	-1	3115150
end	O	-1	3115150
of	O	-1	3115150
the	O	-1	3115150
6@@	O	-1	3115150
0-@@	O	-1	3115150
min	O	-1	3115150
recor@@	O	-1	3115150
ding	O	-1	3115150
period	O	-1	3115150
than	O	-1	3115150
did	O	-1	3115150
animals	O	-1	3115150
that	O	-1	3115150
received	O	-1	3115150
k@@	B-Chemical	D007650	3115150
et@@	I-Chemical	-1	3115150
an@@	I-Chemical	-1	3115150
ser@@	I-Chemical	-1	3115150
in	I-Chemical	-1	3115150
al@@	O	-1	3115150
one.	O	-1	3115150
These	O	-1	3115150
result@@	O	-1	3115150
s,	O	-1	3115150
in	O	-1	3115150
combination	O	-1	3115150
with	O	-1	3115150
previ@@	O	-1	3115150
ous	O	-1	3115150
wor@@	O	-1	3115150
k@@	O	-1	3115150
,	O	-1	3115150
suggest	O	-1	3115150
that	O	-1	3115150
musc@@	B-Disease	D009127	3115150
le	I-Disease	-1	3115150
rig@@	I-Disease	-1	3115150
idity	I-Disease	-1	3115150
,	O	-1	3115150
a	O	-1	3115150
clin@@	O	-1	3115150
ically	O	-1	3115150
re@@	O	-1	3115150
lev@@	O	-1	3115150
ant	O	-1	3115150
side@@	O	-1	3115150
-@@	O	-1	3115150
effect	O	-1	3115150
of	O	-1	3115150
pa@@	O	-1	3115150
ren@@	O	-1	3115150
ter@@	O	-1	3115150
al	O	-1	3115150
n@@	O	-1	3115150
ar@@	O	-1	3115150
co@@	O	-1	3115150
tic	O	-1	3115150
administr@@	O	-1	3115150
ation,	O	-1	3115150
may	O	-1	3115150
be	O	-1	3115150
part@@	O	-1	3115150
ly	O	-1	3115150
mediated	O	-1	3115150
vi@@	O	-1	3115150
a	O	-1	3115150
seroton@@	O	-1	3115150
ergic	O	-1	3115150
path@@	O	-1	3115150
w@@	O	-1	3115150
ay@@	O	-1	3115150
s.	O	-1	3115150
Pre@@	O	-1	3115150
treatment	O	-1	3115150
with	O	-1	3115150
ty@@	O	-1	3115150
pe@@	O	-1	3115150
-@@	O	-1	3115150
2	O	-1	3115150
seroton@@	B-Chemical	D012701	3115150
in	I-Chemical	-1	3115150
antagonist@@	O	-1	3115150
s	O	-1	3115150
may	O	-1	3115150
be	O	-1	3115150
clin@@	O	-1	3115150
ically	O	-1	3115150
use@@	O	-1	3115150
ful	O	-1	3115150
in	O	-1	3115150
attenu@@	O	-1	3115150
ating	O	-1	3115150
o@@	O	-1	3115150
pi@@	O	-1	3115150
ate@@	O	-1	3115150
-induced	O	-1	3115150
rig@@	B-Disease	D009127	3115150
idity	I-Disease	-1	3115150
,	O	-1	3115150
although	O	-1	3115150
further	O	-1	3115150
studies	O	-1	3115150
wil@@	O	-1	3115150
l	O	-1	3115150
be	O	-1	3115150
nec@@	O	-1	3115150
ess@@	O	-1	3115150
ary	O	-1	3115150
to	O	-1	3115150
ass@@	O	-1	3115150
ess	O	-1	3115150
the	O	-1	3115150
inter@@	O	-1	3115150
action	O	-1	3115150
of	O	-1	3115150
possib@@	O	-1	3115150
ly	O	-1	3115150
enhanced	O	-1	3115150
C@@	O	-1	3115150
N@@	O	-1	3115150
S@@	O	-1	3115150
,	O	-1	3115150
cardio@@	B-Disease	D002318	3115150
vas@@	I-Disease	-1	3115150
cul@@	I-Disease	-1	3115150
ar@@	I-Disease	-1	3115150
,	I-Disease	-1	3115150
and	I-Disease	-1	3115150
respiratory	I-Disease	-1	3115150
de@@	I-Disease	-1	3115150
pression	I-Disease	-1	3115150
cardio@@	B-Disease	D012131	3115150
vas@@	I-Disease	-1	3115150
cul@@	I-Disease	-1	3115150
ar@@	I-Disease	-1	3115150
,	I-Disease	-1	3115150
and	I-Disease	-1	3115150
respiratory	I-Disease	-1	3115150
de@@	I-Disease	-1	3115150
pression	I-Disease	-1	3115150
.	O	-1	3115150

G@@	B-Chemical	D006024	2917114
ly@@	I-Chemical	-1	2917114
co@@	I-Chemical	-1	2917114
py@@	I-Chemical	-1	2917114
r@@	I-Chemical	-1	2917114
ron@@	I-Chemical	-1	2917114
i@@	I-Chemical	-1	2917114
um	I-Chemical	-1	2917114
requ@@	O	-1	2917114
i@@	O	-1	2917114
re@@	O	-1	2917114
ments	O	-1	2917114
for	O	-1	2917114
antagon@@	O	-1	2917114
ism	O	-1	2917114
of	O	-1	2917114
the	O	-1	2917114
mus@@	O	-1	2917114
car@@	O	-1	2917114
inic	O	-1	2917114
side	O	-1	2917114
effects	O	-1	2917114
of	O	-1	2917114
ed@@	B-Chemical	D004491	2917114
ro@@	I-Chemical	-1	2917114
ph@@	I-Chemical	-1	2917114
oni@@	I-Chemical	-1	2917114
um	I-Chemical	-1	2917114
.	O	-1	2917114
We	O	-1	2917114
have	O	-1	2917114
com@@	O	-1	2917114
pa@@	O	-1	2917114
re@@	O	-1	2917114
d,	O	-1	2917114
in	O	-1	2917114
60	O	-1	2917114
ad@@	O	-1	2917114
ult	O	-1	2917114
patients,	O	-1	2917114
the	O	-1	2917114
cardiovascular	O	-1	2917114
effects	O	-1	2917114
of	O	-1	2917114
gly@@	B-Chemical	D006024	2917114
co@@	I-Chemical	-1	2917114
py@@	I-Chemical	-1	2917114
r@@	I-Chemical	-1	2917114
ron@@	I-Chemical	-1	2917114
i@@	I-Chemical	-1	2917114
um	I-Chemical	-1	2917114
5	O	-1	2917114
microgram@@	O	-1	2917114
s	O	-1	2917114
kg@@	O	-1	2917114
-1	O	-1	2917114
and	O	-1	2917114
10	O	-1	2917114
microgram@@	O	-1	2917114
s	O	-1	2917114
kg@@	O	-1	2917114
-1	O	-1	2917114
given	O	-1	2917114
either	O	-1	2917114
sim@@	O	-1	2917114
ult@@	O	-1	2917114
ane@@	O	-1	2917114
ously	O	-1	2917114
or	O	-1	2917114
1	O	-1	2917114
min	O	-1	2917114
before	O	-1	2917114
ed@@	B-Chemical	D004491	2917114
ro@@	I-Chemical	-1	2917114
ph@@	I-Chemical	-1	2917114
oni@@	I-Chemical	-1	2917114
um	I-Chemical	-1	2917114
1	O	-1	2917114
mg	O	-1	2917114
kg@@	O	-1	2917114
-1@@	O	-1	2917114
.	O	-1	2917114
Si@@	O	-1	2917114
gn@@	O	-1	2917114
ific@@	O	-1	2917114
ant	O	-1	2917114
differences	O	-1	2917114
between	O	-1	2917114
the	O	-1	2917114
four	O	-1	2917114
groups	O	-1	2917114
were	O	-1	2917114
det@@	O	-1	2917114
ected	O	-1	2917114
(P	O	-1	2917114
less	O	-1	2917114
than	O	-1	2917114
0.00@@	O	-1	2917114
1).	O	-1	2917114
B@@	O	-1	2917114
oth	O	-1	2917114
groups	O	-1	2917114
receiving	O	-1	2917114
10	O	-1	2917114
microgram@@	O	-1	2917114
s	O	-1	2917114
kg@@	O	-1	2917114
-1	O	-1	2917114
showed	O	-1	2917114
increases	O	-1	2917114
in	O	-1	2917114
heart	O	-1	2917114
rate	O	-1	2917114
of	O	-1	2917114
up	O	-1	2917114
to	O	-1	2917114
30	O	-1	2917114
be@@	O	-1	2917114
at	O	-1	2917114
min@@	O	-1	2917114
-1	O	-1	2917114
(@@	O	-1	2917114
95%	O	-1	2917114
conf@@	O	-1	2917114
idence	O	-1	2917114
lim@@	O	-1	2917114
its	O	-1	2917114
2@@	O	-1	2917114
8@@	O	-1	2917114
-@@	O	-1	2917114
3@@	O	-1	2917114
2	O	-1	2917114
be@@	O	-1	2917114
at	O	-1	2917114
min@@	O	-1	2917114
-1@@	O	-1	2917114
).	O	-1	2917114
U@@	O	-1	2917114
se	O	-1	2917114
of	O	-1	2917114
gly@@	B-Chemical	D006024	2917114
co@@	I-Chemical	-1	2917114
py@@	I-Chemical	-1	2917114
r@@	I-Chemical	-1	2917114
ron@@	I-Chemical	-1	2917114
i@@	I-Chemical	-1	2917114
um	I-Chemical	-1	2917114
5	O	-1	2917114
microgram@@	O	-1	2917114
s	O	-1	2917114
kg@@	O	-1	2917114
-1	O	-1	2917114
pro@@	O	-1	2917114
vid@@	O	-1	2917114
ed	O	-1	2917114
greater	O	-1	2917114
cardiovascular	O	-1	2917114
st@@	O	-1	2917114
ability	O	-1	2917114
and@@	O	-1	2917114
,	O	-1	2917114
given	O	-1	2917114
1	O	-1	2917114
min	O	-1	2917114
before	O	-1	2917114
the	O	-1	2917114
ed@@	B-Chemical	D004491	2917114
ro@@	I-Chemical	-1	2917114
ph@@	I-Chemical	-1	2917114
oni@@	I-Chemical	-1	2917114
um	I-Chemical	-1	2917114
,	O	-1	2917114
was	O	-1	2917114
suffici@@	O	-1	2917114
ent	O	-1	2917114
to	O	-1	2917114
minim@@	O	-1	2917114
iz@@	O	-1	2917114
e	O	-1	2917114
ear@@	O	-1	2917114
ly,	O	-1	2917114
ed@@	B-Chemical	D004491	2917114
ro@@	I-Chemical	-1	2917114
ph@@	I-Chemical	-1	2917114
oni@@	I-Chemical	-1	2917114
um	I-Chemical	-1	2917114
-induced	O	-1	2917114
brady@@	B-Disease	D001919	2917114
cardi@@	I-Disease	-1	2917114
as	I-Disease	-1	2917114
.	O	-1	2917114
This	O	-1	2917114
low	O	-1	2917114
dose	O	-1	2917114
of	O	-1	2917114
gly@@	B-Chemical	D006024	2917114
co@@	I-Chemical	-1	2917114
py@@	I-Chemical	-1	2917114
r@@	I-Chemical	-1	2917114
ron@@	I-Chemical	-1	2917114
i@@	I-Chemical	-1	2917114
um	I-Chemical	-1	2917114
pro@@	O	-1	2917114
vid@@	O	-1	2917114
ed	O	-1	2917114
go@@	O	-1	2917114
od	O	-1	2917114
control	O	-1	2917114
of	O	-1	2917114
o@@	O	-1	2917114
ro@@	O	-1	2917114
ph@@	O	-1	2917114
ar@@	O	-1	2917114
yn@@	O	-1	2917114
ge@@	O	-1	2917114
al	O	-1	2917114
secre@@	O	-1	2917114
tions.	O	-1	2917114

In@@	O	-1	2564649
vol@@	O	-1	2564649
vement	O	-1	2564649
of	O	-1	2564649
loc@@	O	-1	2564649
us	O	-1	2564649
co@@	O	-1	2564649
er@@	O	-1	2564649
ul@@	O	-1	2564649
e@@	O	-1	2564649
us	O	-1	2564649
and	O	-1	2564649
nor@@	O	-1	2564649
adrenergic	O	-1	2564649
neuro@@	O	-1	2564649
trans@@	O	-1	2564649
mission	O	-1	2564649
in	O	-1	2564649
f@@	B-Chemical	D005283	2564649
entan@@	I-Chemical	-1	2564649
yl	I-Chemical	-1	2564649
-induced	O	-1	2564649
mus@@	B-Disease	D009127	2564649
cular	I-Disease	-1	2564649
rig@@	I-Disease	-1	2564649
idity	I-Disease	-1	2564649
in	O	-1	2564649
the	O	-1	2564649
rat@@	O	-1	2564649
.	O	-1	2564649
Whe@@	O	-1	2564649
reas	O	-1	2564649
mus@@	B-Disease	D009127	2564649
cular	I-Disease	-1	2564649
rig@@	I-Disease	-1	2564649
idity	I-Disease	-1	2564649
is	O	-1	2564649
a	O	-1	2564649
we@@	O	-1	2564649
ll@@	O	-1	2564649
-@@	O	-1	2564649
known	O	-1	2564649
side	O	-1	2564649
effect	O	-1	2564649
that	O	-1	2564649
is	O	-1	2564649
associated	O	-1	2564649
with	O	-1	2564649
high-dose	O	-1	2564649
f@@	B-Chemical	D005283	2564649
entan@@	I-Chemical	-1	2564649
yl	I-Chemical	-1	2564649
anesthe@@	O	-1	2564649
si@@	O	-1	2564649
a,	O	-1	2564649
a	O	-1	2564649
pa@@	O	-1	2564649
uc@@	O	-1	2564649
ity	O	-1	2564649
of	O	-1	2564649
inf@@	O	-1	2564649
orm@@	O	-1	2564649
ation	O	-1	2564649
ex@@	O	-1	2564649
ist@@	O	-1	2564649
s	O	-1	2564649
with	O	-1	2564649
reg@@	O	-1	2564649
ard	O	-1	2564649
to	O	-1	2564649
its	O	-1	2564649
underlying	O	-1	2564649
mechanis@@	O	-1	2564649
m@@	O	-1	2564649
(@@	O	-1	2564649
s@@	O	-1	2564649
).	O	-1	2564649
We	O	-1	2564649
investigated	O	-1	2564649
in	O	-1	2564649
this	O	-1	2564649
study	O	-1	2564649
the	O	-1	2564649
possible	O	-1	2564649
en@@	O	-1	2564649
g@@	O	-1	2564649
ag@@	O	-1	2564649
ement	O	-1	2564649
of	O	-1	2564649
loc@@	O	-1	2564649
us	O	-1	2564649
co@@	O	-1	2564649
er@@	O	-1	2564649
ul@@	O	-1	2564649
e@@	O	-1	2564649
us	O	-1	2564649
of	O	-1	2564649
the	O	-1	2564649
p@@	O	-1	2564649
ons	O	-1	2564649
in	O	-1	2564649
this	O	-1	2564649
phen@@	O	-1	2564649
om@@	O	-1	2564649
en@@	O	-1	2564649
on@@	O	-1	2564649
,	O	-1	2564649
using	O	-1	2564649
male	O	-1	2564649
S@@	O	-1	2564649
pra@@	O	-1	2564649
gu@@	O	-1	2564649
e-@@	O	-1	2564649
D@@	O	-1	2564649
aw@@	O	-1	2564649
le@@	O	-1	2564649
y	O	-1	2564649
rats	O	-1	2564649
anesthe@@	O	-1	2564649
tiz@@	O	-1	2564649
ed	O	-1	2564649
with	O	-1	2564649
k@@	B-Chemical	D007649	2564649
et@@	I-Chemical	-1	2564649
amine	I-Chemical	-1	2564649
.	O	-1	2564649
U@@	O	-1	2564649
n@@	O	-1	2564649
der	O	-1	2564649
pro@@	O	-1	2564649
per	O	-1	2564649
control	O	-1	2564649
of	O	-1	2564649
res@@	O	-1	2564649
pi@@	O	-1	2564649
r@@	O	-1	2564649
ation,	O	-1	2564649
body	O	-1	2564649
tem@@	O	-1	2564649
per@@	O	-1	2564649
at@@	O	-1	2564649
ure	O	-1	2564649
and	O	-1	2564649
en@@	O	-1	2564649
d-@@	O	-1	2564649
tid@@	O	-1	2564649
al	O	-1	2564649
CO@@	B-Chemical	D002245	2564649
2	I-Chemical	-1	2564649
,	O	-1	2564649
intravenous	O	-1	2564649
administration	O	-1	2564649
of	O	-1	2564649
f@@	B-Chemical	D005283	2564649
entan@@	I-Chemical	-1	2564649
yl	I-Chemical	-1	2564649
(@@	O	-1	2564649
50	O	-1	2564649
or	O	-1	2564649
100	O	-1	2564649
microgram@@	O	-1	2564649
s/@@	O	-1	2564649
kg@@	O	-1	2564649
)	O	-1	2564649
consist@@	O	-1	2564649
ently	O	-1	2564649
pro@@	O	-1	2564649
m@@	O	-1	2564649
ot@@	O	-1	2564649
ed	O	-1	2564649
an	O	-1	2564649
increase	O	-1	2564649
in	O	-1	2564649
elect@@	O	-1	2564649
rom@@	O	-1	2564649
y@@	O	-1	2564649
ograph@@	O	-1	2564649
ic	O	-1	2564649
activity	O	-1	2564649
recor@@	O	-1	2564649
ded	O	-1	2564649
from	O	-1	2564649
the	O	-1	2564649
gast@@	O	-1	2564649
ro@@	O	-1	2564649
c@@	O	-1	2564649
ne@@	O	-1	2564649
mi@@	O	-1	2564649
us	O	-1	2564649
and	O	-1	2564649
ab@@	O	-1	2564649
domin@@	O	-1	2564649
al	O	-1	2564649
rec@@	O	-1	2564649
t@@	O	-1	2564649
us	O	-1	2564649
mus@@	O	-1	2564649
cl@@	O	-1	2564649
es.	O	-1	2564649
S@@	O	-1	2564649
uc@@	O	-1	2564649
h	O	-1	2564649
an	O	-1	2564649
induced	O	-1	2564649
mus@@	B-Disease	D009127	2564649
cular	I-Disease	-1	2564649
rig@@	I-Disease	-1	2564649
idity	I-Disease	-1	2564649
by	O	-1	2564649
the	O	-1	2564649
n@@	O	-1	2564649
ar@@	O	-1	2564649
co@@	O	-1	2564649
tic	O	-1	2564649
agent	O	-1	2564649
was	O	-1	2564649
significantly	O	-1	2564649
antagon@@	O	-1	2564649
ized	O	-1	2564649
or	O	-1	2564649
even	O	-1	2564649
reduced	O	-1	2564649
by	O	-1	2564649
prior	O	-1	2564649
electro@@	O	-1	2564649
ly@@	O	-1	2564649
tic	O	-1	2564649
lesions	O	-1	2564649
of	O	-1	2564649
the	O	-1	2564649
loc@@	O	-1	2564649
us	O	-1	2564649
co@@	O	-1	2564649
er@@	O	-1	2564649
ul@@	O	-1	2564649
e@@	O	-1	2564649
us	O	-1	2564649
or	O	-1	2564649
pretreatment	O	-1	2564649
with	O	-1	2564649
the	O	-1	2564649
alpha-@@	O	-1	2564649
adren@@	O	-1	2564649
oc@@	O	-1	2564649
e@@	O	-1	2564649
pt@@	O	-1	2564649
or	O	-1	2564649
block@@	O	-1	2564649
er,	O	-1	2564649
praz@@	B-Chemical	D011224	2564649
os@@	I-Chemical	-1	2564649
in	I-Chemical	-1	2564649
.	O	-1	2564649
M@@	O	-1	2564649
ic@@	O	-1	2564649
ro@@	O	-1	2564649
injection	O	-1	2564649
of	O	-1	2564649
f@@	B-Chemical	D005283	2564649
entan@@	I-Chemical	-1	2564649
yl	I-Chemical	-1	2564649
(2@@	O	-1	2564649
.@@	O	-1	2564649
5	O	-1	2564649
microgram@@	O	-1	2564649
s/@@	O	-1	2564649
50	O	-1	2564649
n@@	O	-1	2564649
l@@	O	-1	2564649
)	O	-1	2564649
direc@@	O	-1	2564649
tly	O	-1	2564649
into	O	-1	2564649
this	O	-1	2564649
p@@	O	-1	2564649
ont@@	O	-1	2564649
ine	O	-1	2564649
nucle@@	O	-1	2564649
us,	O	-1	2564649
on	O	-1	2564649
the	O	-1	2564649
other	O	-1	2564649
h@@	O	-1	2564649
and@@	O	-1	2564649
,	O	-1	2564649
el@@	O	-1	2564649
ic@@	O	-1	2564649
ited	O	-1	2564649
disc@@	O	-1	2564649
er@@	O	-1	2564649
n@@	O	-1	2564649
i@@	O	-1	2564649
ble	O	-1	2564649
elect@@	O	-1	2564649
rom@@	O	-1	2564649
y@@	O	-1	2564649
ograph@@	O	-1	2564649
ic	O	-1	2564649
ex@@	O	-1	2564649
cit@@	O	-1	2564649
ation.	O	-1	2564649
It	O	-1	2564649
is	O	-1	2564649
spec@@	O	-1	2564649
ul@@	O	-1	2564649
ated	O	-1	2564649
that	O	-1	2564649
the	O	-1	2564649
induction	O	-1	2564649
of	O	-1	2564649
mus@@	B-Disease	D009127	2564649
cular	I-Disease	-1	2564649
rig@@	I-Disease	-1	2564649
idity	I-Disease	-1	2564649
by	O	-1	2564649
f@@	B-Chemical	D005283	2564649
entan@@	I-Chemical	-1	2564649
yl	I-Chemical	-1	2564649
may	O	-1	2564649
invol@@	O	-1	2564649
ve	O	-1	2564649
the	O	-1	2564649
co@@	O	-1	2564649
er@@	O	-1	2564649
ulo@@	O	-1	2564649
spinal	O	-1	2564649
nor@@	O	-1	2564649
adrenergic	O	-1	2564649
fib@@	O	-1	2564649
ers	O	-1	2564649
to	O	-1	2564649
the	O	-1	2564649
spinal	O	-1	2564649
m@@	O	-1	2564649
ot@@	O	-1	2564649
one@@	O	-1	2564649
uron@@	O	-1	2564649
s.	O	-1	2564649

C@@	B-Disease	D012851	2339463
e@@	I-Disease	-1	2339463
rebral	I-Disease	-1	2339463
s@@	I-Disease	-1	2339463
in@@	I-Disease	-1	2339463
us	I-Disease	-1	2339463
thrombo@@	I-Disease	-1	2339463
sis	I-Disease	-1	2339463
as	O	-1	2339463
a	O	-1	2339463
potential	O	-1	2339463
ha@@	O	-1	2339463
z@@	O	-1	2339463
ard	O	-1	2339463
of	O	-1	2339463
anti@@	O	-1	2339463
fib@@	O	-1	2339463
r@@	O	-1	2339463
in@@	O	-1	2339463
oly@@	O	-1	2339463
tic	O	-1	2339463
treatment	O	-1	2339463
in	O	-1	2339463
men@@	B-Disease	D008595	2339463
or@@	I-Disease	-1	2339463
rh@@	I-Disease	-1	2339463
ag@@	I-Disease	-1	2339463
ia	I-Disease	-1	2339463
.	O	-1	2339463
We	O	-1	2339463
describe	O	-1	2339463
a	O	-1	2339463
4@@	O	-1	2339463
2-@@	O	-1	2339463
year-old	O	-1	2339463
woman	O	-1	2339463
who	O	-1	2339463
developed	O	-1	2339463
su@@	O	-1	2339463
peri@@	O	-1	2339463
or	O	-1	2339463
s@@	B-Disease	D020225	2339463
ag@@	I-Disease	-1	2339463
it@@	I-Disease	-1	2339463
t@@	I-Disease	-1	2339463
al	I-Disease	-1	2339463
and	I-Disease	-1	2339463
left	I-Disease	-1	2339463
trans@@	I-Disease	-1	2339463
verse	I-Disease	-1	2339463
s@@	I-Disease	-1	2339463
in@@	I-Disease	-1	2339463
us	I-Disease	-1	2339463
thrombo@@	I-Disease	-1	2339463
sis	I-Disease	-1	2339463
s@@	B-Disease	D020227	2339463
ag@@	I-Disease	-1	2339463
it@@	I-Disease	-1	2339463
t@@	I-Disease	-1	2339463
al	I-Disease	-1	2339463
and	I-Disease	-1	2339463
left	I-Disease	-1	2339463
trans@@	I-Disease	-1	2339463
verse	I-Disease	-1	2339463
s@@	I-Disease	-1	2339463
in@@	I-Disease	-1	2339463
us	I-Disease	-1	2339463
thrombo@@	I-Disease	-1	2339463
sis	I-Disease	-1	2339463
associated	O	-1	2339463
with	O	-1	2339463
prolonged	O	-1	2339463
ep@@	B-Chemical	D015119	2339463
si@@	I-Chemical	-1	2339463
lon@@	I-Chemical	-1	2339463
-@@	I-Chemical	-1	2339463
amin@@	I-Chemical	-1	2339463
oc@@	I-Chemical	-1	2339463
a@@	I-Chemical	-1	2339463
pro@@	I-Chemical	-1	2339463
ic	I-Chemical	-1	2339463
acid	I-Chemical	-1	2339463
therapy	O	-1	2339463
for	O	-1	2339463
men@@	B-Disease	D008595	2339463
or@@	I-Disease	-1	2339463
rh@@	I-Disease	-1	2339463
ag@@	I-Disease	-1	2339463
ia	I-Disease	-1	2339463
.	O	-1	2339463
This	O	-1	2339463
anti@@	O	-1	2339463
fib@@	O	-1	2339463
r@@	O	-1	2339463
in@@	O	-1	2339463
oly@@	O	-1	2339463
tic	O	-1	2339463
agent	O	-1	2339463
has	O	-1	2339463
been	O	-1	2339463
used	O	-1	2339463
in	O	-1	2339463
women	O	-1	2339463
with	O	-1	2339463
men@@	B-Disease	D008595	2339463
or@@	I-Disease	-1	2339463
rh@@	I-Disease	-1	2339463
ag@@	I-Disease	-1	2339463
ia	I-Disease	-1	2339463
to	O	-1	2339463
pro@@	O	-1	2339463
m@@	O	-1	2339463
ot@@	O	-1	2339463
e	O	-1	2339463
clo@@	O	-1	2339463
t@@	O	-1	2339463
ting	O	-1	2339463
and	O	-1	2339463
re@@	O	-1	2339463
duce	O	-1	2339463
blood	B-Disease	D006473	2339463
loss	I-Disease	-1	2339463
.	O	-1	2339463
Although	O	-1	2339463
increased	O	-1	2339463
risk	O	-1	2339463
of	O	-1	2339463
thrombo@@	B-Disease	D013923	2339463
emb@@	I-Disease	-1	2339463
olic	I-Disease	-1	2339463
disease	I-Disease	-1	2339463
has	O	-1	2339463
been	O	-1	2339463
reported	O	-1	2339463
during	O	-1	2339463
treatment	O	-1	2339463
with	O	-1	2339463
ep@@	B-Chemical	D015119	2339463
si@@	I-Chemical	-1	2339463
lon@@	I-Chemical	-1	2339463
-@@	I-Chemical	-1	2339463
amin@@	I-Chemical	-1	2339463
oc@@	I-Chemical	-1	2339463
a@@	I-Chemical	-1	2339463
pro@@	I-Chemical	-1	2339463
ic	I-Chemical	-1	2339463
acid	I-Chemical	-1	2339463
,	O	-1	2339463
cerebral	B-Disease	D012851	2339463
s@@	I-Disease	-1	2339463
in@@	I-Disease	-1	2339463
us	I-Disease	-1	2339463
thrombo@@	I-Disease	-1	2339463
sis	I-Disease	-1	2339463
has	O	-1	2339463
not	O	-1	2339463
been	O	-1	2339463
previously	O	-1	2339463
descri@@	O	-1	2339463
be@@	O	-1	2339463
d.	O	-1	2339463
Ca@@	O	-1	2339463
ref@@	O	-1	2339463
u@@	O	-1	2339463
l	O	-1	2339463
use	O	-1	2339463
of	O	-1	2339463
ep@@	B-Chemical	D015119	2339463
si@@	I-Chemical	-1	2339463
lon@@	I-Chemical	-1	2339463
-@@	I-Chemical	-1	2339463
amin@@	I-Chemical	-1	2339463
oc@@	I-Chemical	-1	2339463
a@@	I-Chemical	-1	2339463
pro@@	I-Chemical	-1	2339463
ic	I-Chemical	-1	2339463
acid	I-Chemical	-1	2339463
therapy	O	-1	2339463
is	O	-1	2339463
recomm@@	O	-1	2339463
en@@	O	-1	2339463
de@@	O	-1	2339463
d.	O	-1	2339463

H@@	B-Disease	D006470	1545575
em@@	I-Disease	-1	1545575
or@@	I-Disease	-1	1545575
rh@@	I-Disease	-1	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
H@@	B-Disease	D003556	1545575
em@@	I-Disease	-1	1545575
or@@	I-Disease	-1	1545575
rh@@	I-Disease	-1	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
complic@@	O	-1	1545575
ating	O	-1	1545575
b@@	O	-1	1545575
one	O	-1	1545575
m@@	O	-1	1545575
ar@@	O	-1	1545575
ro@@	O	-1	1545575
w	O	-1	1545575
transplant@@	O	-1	1545575
ation.	O	-1	1545575
H@@	B-Disease	D006470	1545575
em@@	I-Disease	-1	1545575
or@@	I-Disease	-1	1545575
rh@@	I-Disease	-1	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
H@@	B-Disease	D003556	1545575
em@@	I-Disease	-1	1545575
or@@	I-Disease	-1	1545575
rh@@	I-Disease	-1	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
is	O	-1	1545575
a	O	-1	1545575
potenti@@	O	-1	1545575
ally	O	-1	1545575
seri@@	O	-1	1545575
ous	O	-1	1545575
complication	O	-1	1545575
of	O	-1	1545575
high-dose	O	-1	1545575
cyclophosph@@	B-Chemical	D003520	1545575
amide	I-Chemical	-1	1545575
therapy	O	-1	1545575
administered	O	-1	1545575
before	O	-1	1545575
b@@	O	-1	1545575
one	O	-1	1545575
m@@	O	-1	1545575
ar@@	O	-1	1545575
ro@@	O	-1	1545575
w	O	-1	1545575
transplant@@	O	-1	1545575
ation.	O	-1	1545575
A@@	O	-1	1545575
s	O	-1	1545575
standard	O	-1	1545575
p@@	O	-1	1545575
rac@@	O	-1	1545575
ti@@	O	-1	1545575
ce	O	-1	1545575
at	O	-1	1545575
our	O	-1	1545575
insti@@	O	-1	1545575
tu@@	O	-1	1545575
tion,	O	-1	1545575
patients	O	-1	1545575
who	O	-1	1545575
are	O	-1	1545575
sch@@	O	-1	1545575
ed@@	O	-1	1545575
ul@@	O	-1	1545575
ed	O	-1	1545575
to	O	-1	1545575
recei@@	O	-1	1545575
ve	O	-1	1545575
a	O	-1	1545575
b@@	O	-1	1545575
one	O	-1	1545575
m@@	O	-1	1545575
ar@@	O	-1	1545575
ro@@	O	-1	1545575
w	O	-1	1545575
transplant	O	-1	1545575
are	O	-1	1545575
treated	O	-1	1545575
pro@@	O	-1	1545575
phyl@@	O	-1	1545575
ac@@	O	-1	1545575
tically	O	-1	1545575
with	O	-1	1545575
for@@	O	-1	1545575
c@@	O	-1	1545575
ed	O	-1	1545575
hy@@	O	-1	1545575
d@@	O	-1	1545575
ration	O	-1	1545575
and	O	-1	1545575
bladder	O	-1	1545575
ir@@	O	-1	1545575
rig@@	O	-1	1545575
ation.	O	-1	1545575
In	O	-1	1545575
an	O	-1	1545575
at@@	O	-1	1545575
tem@@	O	-1	1545575
p@@	O	-1	1545575
t	O	-1	1545575
to	O	-1	1545575
ob@@	O	-1	1545575
vi@@	O	-1	1545575
ate	O	-1	1545575
the	O	-1	1545575
in@@	O	-1	1545575
con@@	O	-1	1545575
ven@@	O	-1	1545575
i@@	O	-1	1545575
ence	O	-1	1545575
of	O	-1	1545575
bladder	O	-1	1545575
ir@@	O	-1	1545575
rig@@	O	-1	1545575
ation,	O	-1	1545575
we	O	-1	1545575
con@@	O	-1	1545575
duc@@	O	-1	1545575
ted	O	-1	1545575
a	O	-1	1545575
fe@@	O	-1	1545575
a@@	O	-1	1545575
sib@@	O	-1	1545575
ility	O	-1	1545575
trial	O	-1	1545575
of	O	-1	1545575
uro@@	O	-1	1545575
pro@@	O	-1	1545575
phyl@@	O	-1	1545575
ax@@	O	-1	1545575
is	O	-1	1545575
with	O	-1	1545575
m@@	B-Chemical	D015080	1545575
es@@	I-Chemical	-1	1545575
n@@	I-Chemical	-1	1545575
a	I-Chemical	-1	1545575
,	O	-1	1545575
which	O	-1	1545575
ne@@	O	-1	1545575
ut@@	O	-1	1545575
r@@	O	-1	1545575
al@@	O	-1	1545575
iz@@	O	-1	1545575
es	O	-1	1545575
the	O	-1	1545575
hepatic	O	-1	1545575
metabol@@	O	-1	1545575
ite	O	-1	1545575
of	O	-1	1545575
cyclophosph@@	B-Chemical	D003520	1545575
amide	I-Chemical	-1	1545575
that	O	-1	1545575
causes	O	-1	1545575
hemorrh@@	B-Disease	D006470	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
hemorrh@@	B-Disease	D003556	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
.	O	-1	1545575
Of	O	-1	1545575
9@@	O	-1	1545575
7	O	-1	1545575
patients	O	-1	1545575
who	O	-1	1545575
received	O	-1	1545575
standard	O	-1	1545575
pro@@	O	-1	1545575
phyl@@	O	-1	1545575
ax@@	O	-1	1545575
is@@	O	-1	1545575
,	O	-1	1545575
4	O	-1	1545575
had	O	-1	1545575
symptom@@	O	-1	1545575
atic	O	-1	1545575
hemorrh@@	B-Disease	D006470	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
hemorrh@@	B-Disease	D003556	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
.	O	-1	1545575
In	O	-1	1545575
contrast@@	O	-1	1545575
,	O	-1	1545575
two	O	-1	1545575
of	O	-1	1545575
four	O	-1	1545575
con@@	O	-1	1545575
sec@@	O	-1	1545575
utive	O	-1	1545575
patients	O	-1	1545575
who	O	-1	1545575
received	O	-1	1545575
m@@	B-Chemical	D015080	1545575
es@@	I-Chemical	-1	1545575
n@@	I-Chemical	-1	1545575
a	I-Chemical	-1	1545575
uro@@	O	-1	1545575
pro@@	O	-1	1545575
phyl@@	O	-1	1545575
ax@@	O	-1	1545575
is	O	-1	1545575
before	O	-1	1545575
al@@	O	-1	1545575
log@@	O	-1	1545575
en@@	O	-1	1545575
e@@	O	-1	1545575
ic	O	-1	1545575
b@@	O	-1	1545575
one	O	-1	1545575
m@@	O	-1	1545575
ar@@	O	-1	1545575
ro@@	O	-1	1545575
w	O	-1	1545575
transplant@@	O	-1	1545575
ation	O	-1	1545575
had	O	-1	1545575
severe	O	-1	1545575
hemorrh@@	B-Disease	D006470	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
hemorrh@@	B-Disease	D003556	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
for	O	-1	1545575
at	O	-1	1545575
le@@	O	-1	1545575
ast	O	-1	1545575
2	O	-1	1545575
week@@	O	-1	1545575
s.	O	-1	1545575
B@@	O	-1	1545575
ecause	O	-1	1545575
of	O	-1	1545575
this	O	-1	1545575
sub@@	O	-1	1545575
op@@	O	-1	1545575
tim@@	O	-1	1545575
al	O	-1	1545575
result@@	O	-1	1545575
,	O	-1	1545575
we	O	-1	1545575
res@@	O	-1	1545575
um@@	O	-1	1545575
ed	O	-1	1545575
the	O	-1	1545575
use	O	-1	1545575
of	O	-1	1545575
bladder	O	-1	1545575
ir@@	O	-1	1545575
rig@@	O	-1	1545575
ation	O	-1	1545575
and	O	-1	1545575
for@@	O	-1	1545575
c@@	O	-1	1545575
ed	O	-1	1545575
hy@@	O	-1	1545575
d@@	O	-1	1545575
ration	O	-1	1545575
to	O	-1	1545575
minim@@	O	-1	1545575
iz@@	O	-1	1545575
e	O	-1	1545575
the	O	-1	1545575
risk	O	-1	1545575
of	O	-1	1545575
hemorrh@@	B-Disease	D006470	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
hemorrh@@	B-Disease	D003556	1545575
ag@@	I-Disease	-1	1545575
ic	I-Disease	-1	1545575
cys@@	I-Disease	-1	1545575
ti@@	I-Disease	-1	1545575
tis	I-Disease	-1	1545575
.	O	-1	1545575

Re@@	O	-1	1286498
ver@@	O	-1	1286498
s@@	O	-1	1286498
al	O	-1	1286498
of	O	-1	1286498
central	O	-1	1286498
b@@	B-Chemical	D001569	1286498
enz@@	I-Chemical	-1	1286498
odi@@	I-Chemical	-1	1286498
azepine	I-Chemical	-1	1286498
effects	O	-1	1286498
by	O	-1	1286498
flu@@	B-Chemical	D005442	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
after	O	-1	1286498
intravenous	O	-1	1286498
con@@	O	-1	1286498
s@@	O	-1	1286498
ci@@	O	-1	1286498
ous	O	-1	1286498
sed@@	O	-1	1286498
ation	O	-1	1286498
with	O	-1	1286498
di@@	B-Chemical	D003975	1286498
az@@	I-Chemical	-1	1286498
epam	I-Chemical	-1	1286498
and	O	-1	1286498
o@@	O	-1	1286498
pi@@	O	-1	1286498
oid@@	O	-1	1286498
s:	O	-1	1286498
report	O	-1	1286498
of	O	-1	1286498
a	O	-1	1286498
double-bl@@	O	-1	1286498
ind	O	-1	1286498
mul@@	O	-1	1286498
tic@@	O	-1	1286498
ent@@	O	-1	1286498
er	O	-1	1286498
study.	O	-1	1286498
The	O	-1	1286498
F@@	B-Chemical	D005442	1286498
lu@@	I-Chemical	-1	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
in	O	-1	1286498
In@@	O	-1	1286498
tra@@	O	-1	1286498
venous	O	-1	1286498
Con@@	O	-1	1286498
s@@	O	-1	1286498
ci@@	O	-1	1286498
ous	O	-1	1286498
S@@	O	-1	1286498
ed@@	O	-1	1286498
ation	O	-1	1286498
with	O	-1	1286498
Di@@	B-Chemical	D003975	1286498
az@@	I-Chemical	-1	1286498
epam	I-Chemical	-1	1286498
M@@	O	-1	1286498
ul@@	O	-1	1286498
tic@@	O	-1	1286498
ent@@	O	-1	1286498
er	O	-1	1286498
S@@	O	-1	1286498
t@@	O	-1	1286498
ud@@	O	-1	1286498
y	O	-1	1286498
Group	O	-1	1286498
II@@	O	-1	1286498
.	O	-1	1286498
The	O	-1	1286498
efficacy	O	-1	1286498
and	O	-1	1286498
safety	O	-1	1286498
of	O	-1	1286498
a	O	-1	1286498
new	O	-1	1286498
b@@	B-Chemical	D001569	1286498
enz@@	I-Chemical	-1	1286498
odi@@	I-Chemical	-1	1286498
azepine	I-Chemical	-1	1286498
antagonist@@	O	-1	1286498
,	O	-1	1286498
flu@@	B-Chemical	D005442	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
,	O	-1	1286498
were	O	-1	1286498
assessed	O	-1	1286498
in	O	-1	1286498
a	O	-1	1286498
double-bl@@	O	-1	1286498
ind	O	-1	1286498
mul@@	O	-1	1286498
tic@@	O	-1	1286498
ent@@	O	-1	1286498
er	O	-1	1286498
study.	O	-1	1286498
F@@	B-Chemical	D005442	1286498
lu@@	I-Chemical	-1	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
(@@	O	-1	1286498
mean	O	-1	1286498
dose@@	O	-1	1286498
,	O	-1	1286498
0.@@	O	-1	1286498
7@@	O	-1	1286498
6	O	-1	1286498
mg@@	O	-1	1286498
)	O	-1	1286498
or	O	-1	1286498
placebo	O	-1	1286498
(@@	O	-1	1286498
mean	O	-1	1286498
dose@@	O	-1	1286498
,	O	-1	1286498
8.@@	O	-1	1286498
9	O	-1	1286498
ml@@	O	-1	1286498
)	O	-1	1286498
was	O	-1	1286498
administered	O	-1	1286498
intra@@	O	-1	1286498
ven@@	O	-1	1286498
ously	O	-1	1286498
to	O	-1	1286498
1@@	O	-1	1286498
30	O	-1	1286498
and	O	-1	1286498
6@@	O	-1	1286498
7	O	-1	1286498
patients,	O	-1	1286498
respectivel@@	O	-1	1286498
y,	O	-1	1286498
who	O	-1	1286498
had	O	-1	1286498
been	O	-1	1286498
given	O	-1	1286498
di@@	B-Chemical	D003975	1286498
az@@	I-Chemical	-1	1286498
epam	I-Chemical	-1	1286498
in	O	-1	1286498
con@@	O	-1	1286498
j@@	O	-1	1286498
unc@@	O	-1	1286498
tion	O	-1	1286498
with	O	-1	1286498
an	O	-1	1286498
o@@	O	-1	1286498
pi@@	O	-1	1286498
oid	O	-1	1286498
(	O	-1	1286498
f@@	B-Chemical	D005283	1286498
entan@@	I-Chemical	-1	1286498
yl	I-Chemical	-1	1286498
,	O	-1	1286498
me@@	B-Chemical	D008614	1286498
perid@@	I-Chemical	-1	1286498
ine	I-Chemical	-1	1286498
,	O	-1	1286498
or	O	-1	1286498
morphine	B-Chemical	D009020	1286498
)	O	-1	1286498
for	O	-1	1286498
the	O	-1	1286498
induction	O	-1	1286498
and	O	-1	1286498
maint@@	O	-1	1286498
en@@	O	-1	1286498
ance	O	-1	1286498
of	O	-1	1286498
intravenous	O	-1	1286498
con@@	O	-1	1286498
s@@	O	-1	1286498
ci@@	O	-1	1286498
ous	O	-1	1286498
sed@@	O	-1	1286498
ation	O	-1	1286498
for	O	-1	1286498
diagnos@@	O	-1	1286498
tic	O	-1	1286498
or	O	-1	1286498
therapeutic	O	-1	1286498
surg@@	O	-1	1286498
ical	O	-1	1286498
proce@@	O	-1	1286498
du@@	O	-1	1286498
res@@	O	-1	1286498
.	O	-1	1286498
The	O	-1	1286498
group	O	-1	1286498
assess@@	O	-1	1286498
able	O	-1	1286498
for	O	-1	1286498
efficacy	O	-1	1286498
comp@@	O	-1	1286498
ris@@	O	-1	1286498
ed	O	-1	1286498
12@@	O	-1	1286498
2	O	-1	1286498
patients	O	-1	1286498
treated	O	-1	1286498
with	O	-1	1286498
flu@@	B-Chemical	D005442	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
and	O	-1	1286498
6@@	O	-1	1286498
4	O	-1	1286498
patients	O	-1	1286498
given	O	-1	1286498
placebo@@	O	-1	1286498
.	O	-1	1286498
After	O	-1	1286498
5	O	-1	1286498
minut@@	O	-1	1286498
es,	O	-1	1286498
80@@	O	-1	1286498
/@@	O	-1	1286498
1@@	O	-1	1286498
15	O	-1	1286498
(@@	O	-1	1286498
7@@	O	-1	1286498
0@@	O	-1	1286498
%)	O	-1	1286498
flu@@	B-Chemical	D005442	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
-treated	O	-1	1286498
patients,	O	-1	1286498
compared	O	-1	1286498
with	O	-1	1286498
2@@	O	-1	1286498
1@@	O	-1	1286498
/@@	O	-1	1286498
6@@	O	-1	1286498
3	O	-1	1286498
(3@@	O	-1	1286498
3@@	O	-1	1286498
%)	O	-1	1286498
placebo@@	O	-1	1286498
-treated	O	-1	1286498
patients,	O	-1	1286498
were	O	-1	1286498
complete@@	O	-1	1286498
ly	O	-1	1286498
aw@@	O	-1	1286498
ake	O	-1	1286498
and	O	-1	1286498
al@@	O	-1	1286498
er@@	O	-1	1286498
t,	O	-1	1286498
as	O	-1	1286498
indic@@	O	-1	1286498
ated	O	-1	1286498
by	O	-1	1286498
a	O	-1	1286498
scor@@	O	-1	1286498
e	O	-1	1286498
of	O	-1	1286498
5	O	-1	1286498
on	O	-1	1286498
the	O	-1	1286498
O@@	O	-1	1286498
b@@	O	-1	1286498
ser@@	O	-1	1286498
ver@@	O	-1	1286498
's	O	-1	1286498
A@@	O	-1	1286498
s@@	O	-1	1286498
s@@	O	-1	1286498
ess@@	O	-1	1286498
ment	O	-1	1286498
of	O	-1	1286498
Al@@	O	-1	1286498
er@@	O	-1	1286498
t@@	O	-1	1286498
n@@	O	-1	1286498
ess@@	O	-1	1286498
/@@	O	-1	1286498
S@@	O	-1	1286498
ed@@	O	-1	1286498
ation	O	-1	1286498
S@@	O	-1	1286498
cal@@	O	-1	1286498
e.	O	-1	1286498
N@@	O	-1	1286498
ine@@	O	-1	1286498
ty-@@	O	-1	1286498
five	O	-1	1286498
perc@@	O	-1	1286498
ent	O	-1	1286498
of	O	-1	1286498
patients	O	-1	1286498
in	O	-1	1286498
each	O	-1	1286498
group	O	-1	1286498
who	O	-1	1286498
at@@	O	-1	1286498
t@@	O	-1	1286498
ained	O	-1	1286498
a	O	-1	1286498
scor@@	O	-1	1286498
e	O	-1	1286498
of	O	-1	1286498
5	O	-1	1286498
at	O	-1	1286498
the	O	-1	1286498
5-@@	O	-1	1286498
min@@	O	-1	1286498
ute	O	-1	1286498
assess@@	O	-1	1286498
ment	O	-1	1286498
showed	O	-1	1286498
no	O	-1	1286498
loss	O	-1	1286498
of	O	-1	1286498
al@@	O	-1	1286498
er@@	O	-1	1286498
t@@	O	-1	1286498
ness	O	-1	1286498
throu@@	O	-1	1286498
gh@@	O	-1	1286498
out	O	-1	1286498
the	O	-1	1286498
18@@	O	-1	1286498
0-@@	O	-1	1286498
min@@	O	-1	1286498
ute	O	-1	1286498
assess@@	O	-1	1286498
ment	O	-1	1286498
perio@@	O	-1	1286498
d.	O	-1	1286498
F@@	B-Chemical	D005442	1286498
lu@@	I-Chemical	-1	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
-treated	O	-1	1286498
patients	O	-1	1286498
also	O	-1	1286498
performed	O	-1	1286498
significantly	O	-1	1286498
bet@@	O	-1	1286498
ter	O	-1	1286498
on	O	-1	1286498
the	O	-1	1286498
F@@	O	-1	1286498
ing@@	O	-1	1286498
er@@	O	-1	1286498
-@@	O	-1	1286498
to@@	O	-1	1286498
-@@	O	-1	1286498
N@@	O	-1	1286498
ose	O	-1	1286498
T@@	O	-1	1286498
est	O	-1	1286498
and	O	-1	1286498
the	O	-1	1286498
rec@@	O	-1	1286498
all	O	-1	1286498
of	O	-1	1286498
p@@	O	-1	1286498
ic@@	O	-1	1286498
t@@	O	-1	1286498
ures	O	-1	1286498
shown	O	-1	1286498
at	O	-1	1286498
the	O	-1	1286498
5-@@	O	-1	1286498
min@@	O	-1	1286498
ute	O	-1	1286498
assess@@	O	-1	1286498
ment.	O	-1	1286498
F@@	B-Chemical	D005442	1286498
lu@@	I-Chemical	-1	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
was	O	-1	1286498
well	O	-1	1286498
toler@@	O	-1	1286498
at@@	O	-1	1286498
ed,	O	-1	1286498
with	O	-1	1286498
no	O	-1	1286498
seri@@	O	-1	1286498
ous	O	-1	1286498
adverse	O	-1	1286498
effects	O	-1	1286498
repor@@	O	-1	1286498
ted.	O	-1	1286498
Th@@	O	-1	1286498
ir@@	O	-1	1286498
ty-@@	O	-1	1286498
n@@	O	-1	1286498
ine	O	-1	1286498
(3@@	O	-1	1286498
0@@	O	-1	1286498
%)	O	-1	1286498
of	O	-1	1286498
flu@@	B-Chemical	D005442	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
-treated	O	-1	1286498
patients,	O	-1	1286498
compared	O	-1	1286498
with	O	-1	1286498
17	O	-1	1286498
(2@@	O	-1	1286498
5@@	O	-1	1286498
%)	O	-1	1286498
of	O	-1	1286498
placebo@@	O	-1	1286498
-treated	O	-1	1286498
patients	O	-1	1286498
had	O	-1	1286498
one	O	-1	1286498
or	O	-1	1286498
more	O	-1	1286498
drug@@	O	-1	1286498
-@@	O	-1	1286498
related	O	-1	1286498
adverse	O	-1	1286498
experienc@@	O	-1	1286498
es.	O	-1	1286498
The	O	-1	1286498
most	O	-1	1286498
common	O	-1	1286498
adverse	O	-1	1286498
effects	O	-1	1286498
were	O	-1	1286498
nausea	B-Disease	D009325	1286498
and	O	-1	1286498
v@@	B-Disease	D014839	1286498
om@@	I-Disease	-1	1286498
it@@	I-Disease	-1	1286498
ing	I-Disease	-1	1286498
in	O	-1	1286498
the	O	-1	1286498
flu@@	B-Chemical	D005442	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
group	O	-1	1286498
and	O	-1	1286498
nausea	B-Disease	D009325	1286498
and	O	-1	1286498
injec@@	O	-1	1286498
tion@@	O	-1	1286498
-@@	O	-1	1286498
sit@@	O	-1	1286498
e	O	-1	1286498
pain	B-Disease	D010146	1286498
in	O	-1	1286498
the	O	-1	1286498
placebo	O	-1	1286498
group.	O	-1	1286498
F@@	B-Chemical	D005442	1286498
lu@@	I-Chemical	-1	1286498
ma@@	I-Chemical	-1	1286498
z@@	I-Chemical	-1	1286498
en@@	I-Chemical	-1	1286498
il	I-Chemical	-1	1286498
was	O	-1	1286498
found	O	-1	1286498
to	O	-1	1286498
pro@@	O	-1	1286498
m@@	O	-1	1286498
pt@@	O	-1	1286498
ly	O	-1	1286498
re@@	O	-1	1286498
verse	O	-1	1286498
sed@@	O	-1	1286498
ation	O	-1	1286498
induced	O	-1	1286498
by	O	-1	1286498
di@@	B-Chemical	D003975	1286498
az@@	I-Chemical	-1	1286498
epam	I-Chemical	-1	1286498
in	O	-1	1286498
the	O	-1	1286498
presence	O	-1	1286498
of	O	-1	1286498
o@@	O	-1	1286498
pi@@	O	-1	1286498
oid@@	O	-1	1286498
s.	O	-1	1286498

He@@	O	-1	839274
pati@@	O	-1	839274
c	O	-1	839274
aden@@	B-Disease	D000236	839274
om@@	I-Disease	-1	839274
as	I-Disease	-1	839274
and	O	-1	839274
foc@@	B-Disease	D020518	839274
al	I-Disease	-1	839274
no@@	I-Disease	-1	839274
d@@	I-Disease	-1	839274
ular	I-Disease	-1	839274
hyper@@	I-Disease	-1	839274
pl@@	I-Disease	-1	839274
a@@	I-Disease	-1	839274
sia	I-Disease	-1	839274
of	O	-1	839274
the	O	-1	839274
liver	O	-1	839274
in	O	-1	839274
youn@@	O	-1	839274
g	O	-1	839274
women	O	-1	839274
on	O	-1	839274
oral	B-Chemical	D003276	839274
contrac@@	I-Chemical	-1	839274
ep@@	I-Chemical	-1	839274
tiv@@	I-Chemical	-1	839274
es	I-Chemical	-1	839274
:	O	-1	839274
case	O	-1	839274
repor@@	O	-1	839274
t@@	O	-1	839274
s.	O	-1	839274
Two	O	-1	839274
cases	O	-1	839274
of	O	-1	839274
hepatic	O	-1	839274
aden@@	B-Disease	D000236	839274
oma	I-Disease	-1	839274
and	O	-1	839274
one	O	-1	839274
of	O	-1	839274
foc@@	B-Disease	D020518	839274
al	I-Disease	-1	839274
no@@	I-Disease	-1	839274
d@@	I-Disease	-1	839274
ular	I-Disease	-1	839274
hyper@@	I-Disease	-1	839274
pl@@	I-Disease	-1	839274
a@@	I-Disease	-1	839274
sia	I-Disease	-1	839274
pres@@	O	-1	839274
um@@	O	-1	839274
ably	O	-1	839274
associated	O	-1	839274
with	O	-1	839274
the	O	-1	839274
use	O	-1	839274
of	O	-1	839274
oral	B-Chemical	D003276	839274
contrac@@	I-Chemical	-1	839274
ep@@	I-Chemical	-1	839274
tiv@@	I-Chemical	-1	839274
es	I-Chemical	-1	839274
,	O	-1	839274
are	O	-1	839274
repor@@	O	-1	839274
ted.	O	-1	839274
S@@	O	-1	839274
p@@	O	-1	839274
ec@@	O	-1	839274
ial	O	-1	839274
ref@@	O	-1	839274
e@@	O	-1	839274
rence	O	-1	839274
is	O	-1	839274
m@@	O	-1	839274
ade	O	-1	839274
to	O	-1	839274
their	O	-1	839274
clinical	O	-1	839274
present@@	O	-1	839274
ation,	O	-1	839274
which	O	-1	839274
may	O	-1	839274
be	O	-1	839274
tot@@	O	-1	839274
ally	O	-1	839274
as@@	O	-1	839274
ym@@	O	-1	839274
pto@@	O	-1	839274
m@@	O	-1	839274
ati@@	O	-1	839274
c@@	O	-1	839274
.	O	-1	839274
L@@	O	-1	839274
i@@	O	-1	839274
ver@@	O	-1	839274
-@@	O	-1	839274
function	O	-1	839274
tests	O	-1	839274
are	O	-1	839274
of	O	-1	839274
lit@@	O	-1	839274
t@@	O	-1	839274
le	O	-1	839274
diagnos@@	O	-1	839274
tic	O	-1	839274
valu@@	O	-1	839274
e,	O	-1	839274
but	O	-1	839274
valu@@	O	-1	839274
able	O	-1	839274
inf@@	O	-1	839274
orm@@	O	-1	839274
ation	O	-1	839274
may	O	-1	839274
be	O	-1	839274
obtained	O	-1	839274
from	O	-1	839274
both	O	-1	839274
liver	O	-1	839274
s@@	O	-1	839274
can@@	O	-1	839274
ning	O	-1	839274
and	O	-1	839274
hepatic	O	-1	839274
angio@@	O	-1	839274
graph@@	O	-1	839274
y.	O	-1	839274
H@@	O	-1	839274
ist@@	O	-1	839274
ologic	O	-1	839274
differences	O	-1	839274
and	O	-1	839274
clinical	O	-1	839274
simil@@	O	-1	839274
ar@@	O	-1	839274
ities	O	-1	839274
between	O	-1	839274
hepatic	O	-1	839274
aden@@	B-Disease	D000236	839274
oma	I-Disease	-1	839274
and	O	-1	839274
foc@@	B-Disease	D020518	839274
al	I-Disease	-1	839274
no@@	I-Disease	-1	839274
d@@	I-Disease	-1	839274
ular	I-Disease	-1	839274
hyper@@	I-Disease	-1	839274
pl@@	I-Disease	-1	839274
a@@	I-Disease	-1	839274
sia	I-Disease	-1	839274
of	O	-1	839274
the	O	-1	839274
liver	O	-1	839274
are	O	-1	839274
discus@@	O	-1	839274
sed.	O	-1	839274

A@@	O	-1	591536
r@@	O	-1	591536
ter@@	O	-1	591536
ial	O	-1	591536
thrombo@@	B-Disease	D013923	591536
emb@@	I-Disease	-1	591536
ol@@	I-Disease	-1	591536
ism	I-Disease	-1	591536
in	O	-1	591536
patients	O	-1	591536
receiving	O	-1	591536
systemic	O	-1	591536
hepar@@	B-Chemical	D006493	591536
in	I-Chemical	-1	591536
therap@@	O	-1	591536
y@@	O	-1	591536
:	O	-1	591536
a	O	-1	591536
complication	O	-1	591536
associated	O	-1	591536
with	O	-1	591536
hepar@@	B-Chemical	D006493	591536
in	I-Chemical	-1	591536
-induced	O	-1	591536
throm@@	B-Disease	D013921	591536
b@@	I-Disease	-1	591536
ocyto@@	I-Disease	-1	591536
pen@@	I-Disease	-1	591536
ia	I-Disease	-1	591536
.	O	-1	591536
A@@	O	-1	591536
r@@	O	-1	591536
ter@@	O	-1	591536
ial	O	-1	591536
thrombo@@	B-Disease	D013923	591536
emb@@	I-Disease	-1	591536
ol@@	I-Disease	-1	591536
ism	I-Disease	-1	591536
is	O	-1	591536
a	O	-1	591536
reco@@	O	-1	591536
gn@@	O	-1	591536
ized	O	-1	591536
complication	O	-1	591536
of	O	-1	591536
systemic	O	-1	591536
hepar@@	B-Chemical	D006493	591536
in	I-Chemical	-1	591536
therapy.	O	-1	591536
Ch@@	O	-1	591536
aracter@@	O	-1	591536
istic	O	-1	591536
of	O	-1	591536
the	O	-1	591536
enti@@	O	-1	591536
t@@	O	-1	591536
y	O	-1	591536
is	O	-1	591536
arterial	B-Disease	D001157	591536
oc@@	I-Disease	-1	591536
cl@@	I-Disease	-1	591536
usion	I-Disease	-1	591536
by	O	-1	591536
platele@@	O	-1	591536
t-@@	O	-1	591536
fib@@	O	-1	591536
rin	O	-1	591536
throm@@	B-Disease	D013927	591536
b@@	I-Disease	-1	591536
i	I-Disease	-1	591536
with	O	-1	591536
dist@@	O	-1	591536
al	O	-1	591536
ischem@@	B-Disease	D007511	591536
ia	I-Disease	-1	591536
occur@@	O	-1	591536
r@@	O	-1	591536
ing	O	-1	591536
four	O	-1	591536
to	O	-1	591536
tw@@	O	-1	591536
ent@@	O	-1	591536
y	O	-1	591536
days	O	-1	591536
after	O	-1	591536
the	O	-1	591536
initi@@	O	-1	591536
ation	O	-1	591536
of	O	-1	591536
hepar@@	B-Chemical	D006493	591536
in	I-Chemical	-1	591536
therapy,	O	-1	591536
pre@@	O	-1	591536
ce@@	O	-1	591536
ded	O	-1	591536
by	O	-1	591536
pro@@	O	-1	591536
found	O	-1	591536
throm@@	B-Disease	D013921	591536
b@@	I-Disease	-1	591536
ocyto@@	I-Disease	-1	591536
pen@@	I-Disease	-1	591536
ia	I-Disease	-1	591536
with	O	-1	591536
platele@@	O	-1	591536
t	O	-1	591536
coun@@	O	-1	591536
ts	O	-1	591536
in	O	-1	591536
the	O	-1	591536
range	O	-1	591536
of	O	-1	591536
3@@	O	-1	591536
0@@	O	-1	591536
,@@	O	-1	591536
0@@	O	-1	591536
00	O	-1	591536
to	O	-1	591536
4@@	O	-1	591536
0@@	O	-1	591536
,@@	O	-1	591536
0@@	O	-1	591536
00	O	-1	591536
per	O	-1	591536
c@@	O	-1	591536
ub@@	O	-1	591536
ic	O	-1	591536
mil@@	O	-1	591536
li@@	O	-1	591536
me@@	O	-1	591536
ter@@	O	-1	591536
.	O	-1	591536
The	O	-1	591536
clin@@	O	-1	591536
ically	O	-1	591536
appa@@	O	-1	591536
rent	O	-1	591536
oc@@	O	-1	591536
cl@@	O	-1	591536
usion	O	-1	591536
may	O	-1	591536
be	O	-1	591536
pre@@	O	-1	591536
ce@@	O	-1	591536
ded	O	-1	591536
by	O	-1	591536
gast@@	B-Disease	D005767	591536
ro@@	I-Disease	-1	591536
in@@	I-Disease	-1	591536
test@@	I-Disease	-1	591536
inal	I-Disease	-1	591536
and	I-Disease	-1	591536
musc@@	I-Disease	-1	591536
u@@	I-Disease	-1	591536
los@@	I-Disease	-1	591536
ke@@	I-Disease	-1	591536
le@@	I-Disease	-1	591536
t@@	I-Disease	-1	591536
al	I-Disease	-1	591536
symptoms	I-Disease	-1	591536
gast@@	B-Disease	D009140	591536
ro@@	I-Disease	-1	591536
in@@	I-Disease	-1	591536
test@@	I-Disease	-1	591536
inal	I-Disease	-1	591536
and	I-Disease	-1	591536
musc@@	I-Disease	-1	591536
u@@	I-Disease	-1	591536
los@@	I-Disease	-1	591536
ke@@	I-Disease	-1	591536
le@@	I-Disease	-1	591536
t@@	I-Disease	-1	591536
al	I-Disease	-1	591536
symptoms	I-Disease	-1	591536
that	O	-1	591536
appe@@	O	-1	591536
ar	O	-1	591536
to	O	-1	591536
be	O	-1	591536
ischem@@	B-Disease	D007511	591536
ic	I-Disease	-1	591536
in	O	-1	591536
or@@	O	-1	591536
ig@@	O	-1	591536
in,	O	-1	591536
and	O	-1	591536
might	O	-1	591536
ser@@	O	-1	591536
ve	O	-1	591536
to	O	-1	591536
war@@	O	-1	591536
n	O	-1	591536
the	O	-1	591536
clin@@	O	-1	591536
ici@@	O	-1	591536
an	O	-1	591536
of	O	-1	591536
these	O	-1	591536
complic@@	O	-1	591536
ations.	O	-1	591536
Pre@@	O	-1	591536
vi@@	O	-1	591536
ous	O	-1	591536
reports	O	-1	591536
of	O	-1	591536
these	O	-1	591536
phen@@	O	-1	591536
om@@	O	-1	591536
en@@	O	-1	591536
a	O	-1	591536
as	O	-1	591536
well	O	-1	591536
as	O	-1	591536
rec@@	O	-1	591536
ent	O	-1	591536
studies	O	-1	591536
of	O	-1	591536
the	O	-1	591536
effect	O	-1	591536
of	O	-1	591536
hepar@@	B-Chemical	D006493	591536
in	I-Chemical	-1	591536
are	O	-1	591536
revie@@	O	-1	591536
we@@	O	-1	591536
d.	O	-1	591536
The	O	-1	591536
common	O	-1	591536
factor	O	-1	591536
rel@@	O	-1	591536
ating	O	-1	591536
thrombo@@	B-Disease	D013923	591536
emb@@	I-Disease	-1	591536
ol@@	I-Disease	-1	591536
ism	I-Disease	-1	591536
and	O	-1	591536
throm@@	B-Disease	D013921	591536
b@@	I-Disease	-1	591536
ocyto@@	I-Disease	-1	591536
pen@@	I-Disease	-1	591536
ia	I-Disease	-1	591536
is	O	-1	591536
hepar@@	B-Chemical	D006493	591536
in	I-Chemical	-1	591536
-induced	O	-1	591536
platele@@	B-Disease	D001791	591536
t	I-Disease	-1	591536
ag@@	I-Disease	-1	591536
g@@	I-Disease	-1	591536
reg@@	I-Disease	-1	591536
ation	I-Disease	-1	591536
.	O	-1	591536
A@@	O	-1	591536
p@@	O	-1	591536
pro@@	O	-1	591536
pri@@	O	-1	591536
ate	O	-1	591536
treatment	O	-1	591536
consist@@	O	-1	591536
s	O	-1	591536
of	O	-1	591536
discontinu@@	O	-1	591536
ation	O	-1	591536
of	O	-1	591536
hepar@@	B-Chemical	D006493	591536
in	I-Chemical	-1	591536
,	O	-1	591536
and	O	-1	591536
anti@@	O	-1	591536
co@@	O	-1	591536
ag@@	O	-1	591536
ulation	O	-1	591536
with	O	-1	591536
sodium	B-Chemical	D014859	591536
war@@	I-Chemical	-1	591536
farin	I-Chemical	-1	591536
if	O	-1	591536
nec@@	O	-1	591536
ess@@	O	-1	591536
ar@@	O	-1	591536
y.	O	-1	591536
V@@	O	-1	591536
as@@	O	-1	591536
cular	O	-1	591536
proce@@	O	-1	591536
d@@	O	-1	591536
ures	O	-1	591536
are	O	-1	591536
performed	O	-1	591536
as	O	-1	591536
indic@@	O	-1	591536
ated.	O	-1	591536

L@@	O	-1	20735774
on@@	O	-1	20735774
g@@	O	-1	20735774
-term	O	-1	20735774
pro@@	O	-1	20735774
g@@	O	-1	20735774
no@@	O	-1	20735774
sis	O	-1	20735774
for	O	-1	20735774
transplant@@	O	-1	20735774
-@@	O	-1	20735774
free	O	-1	20735774
sur@@	O	-1	20735774
viv@@	O	-1	20735774
ors	O	-1	20735774
of	O	-1	20735774
par@@	B-Chemical	D000082	20735774
acet@@	I-Chemical	-1	20735774
am@@	I-Chemical	-1	20735774
ol	I-Chemical	-1	20735774
-induced	O	-1	20735774
acute	B-Disease	D017114	20735774
liver	I-Disease	-1	20735774
failure	I-Disease	-1	20735774
.	O	-1	20735774
BACKGROUND:	O	-1	20735774
The	O	-1	20735774
pro@@	O	-1	20735774
g@@	O	-1	20735774
no@@	O	-1	20735774
sis	O	-1	20735774
for	O	-1	20735774
transplant@@	O	-1	20735774
-@@	O	-1	20735774
free	O	-1	20735774
sur@@	O	-1	20735774
viv@@	O	-1	20735774
ors	O	-1	20735774
of	O	-1	20735774
par@@	B-Chemical	D000082	20735774
acet@@	I-Chemical	-1	20735774
am@@	I-Chemical	-1	20735774
ol	I-Chemical	-1	20735774
-induced	O	-1	20735774
acute	B-Disease	D017114	20735774
liver	I-Disease	-1	20735774
failure	I-Disease	-1	20735774
remain@@	O	-1	20735774
s	O	-1	20735774
un@@	O	-1	20735774
know@@	O	-1	20735774
n@@	O	-1	20735774
.	O	-1	20735774
A@@	O	-1	20735774
I@@	O	-1	20735774
M@@	O	-1	20735774
:	O	-1	20735774
To	O	-1	20735774
ex@@	O	-1	20735774
amine	O	-1	20735774
whether	O	-1	20735774
par@@	B-Chemical	D000082	20735774
acet@@	I-Chemical	-1	20735774
am@@	I-Chemical	-1	20735774
ol	I-Chemical	-1	20735774
-induced	O	-1	20735774
acute	B-Disease	D017114	20735774
liver	I-Disease	-1	20735774
failure	I-Disease	-1	20735774
increases	O	-1	20735774
long-term	O	-1	20735774
mor@@	O	-1	20735774
t@@	O	-1	20735774
al@@	O	-1	20735774
ity.	O	-1	20735774
METHODS:	O	-1	20735774
We	O	-1	20735774
followed	O	-1	20735774
up	O	-1	20735774
all	O	-1	20735774
transplant@@	O	-1	20735774
-@@	O	-1	20735774
free	O	-1	20735774
sur@@	O	-1	20735774
viv@@	O	-1	20735774
ors	O	-1	20735774
of	O	-1	20735774
par@@	B-Chemical	D000082	20735774
acet@@	I-Chemical	-1	20735774
am@@	I-Chemical	-1	20735774
ol	I-Chemical	-1	20735774
-induced	O	-1	20735774
acute	B-Disease	D056486	20735774
liver	I-Disease	-1	20735774
injury	I-Disease	-1	20735774
,	O	-1	20735774
hospit@@	O	-1	20735774
al@@	O	-1	20735774
ized	O	-1	20735774
in	O	-1	20735774
a	O	-1	20735774
D@@	O	-1	20735774
an@@	O	-1	20735774
is@@	O	-1	20735774
h	O	-1	20735774
n@@	O	-1	20735774
ation@@	O	-1	20735774
al	O	-1	20735774
ref@@	O	-1	20735774
er@@	O	-1	20735774
ral	O	-1	20735774
centr@@	O	-1	20735774
e	O	-1	20735774
during	O	-1	20735774
19@@	O	-1	20735774
8@@	O	-1	20735774
4-@@	O	-1	20735774
20@@	O	-1	20735774
0@@	O	-1	20735774
4@@	O	-1	20735774
.	O	-1	20735774
We	O	-1	20735774
compared	O	-1	20735774
ag@@	O	-1	20735774
e-@@	O	-1	20735774
specific	O	-1	20735774
mor@@	O	-1	20735774
t@@	O	-1	20735774
ality	O	-1	20735774
rat@@	O	-1	20735774
es	O	-1	20735774
from	O	-1	20735774
1	O	-1	20735774
year	O	-1	20735774
post@@	O	-1	20735774
-@@	O	-1	20735774
dis@@	O	-1	20735774
ch@@	O	-1	20735774
arg@@	O	-1	20735774
e	O	-1	20735774
through	O	-1	20735774
20@@	O	-1	20735774
0@@	O	-1	20735774
8	O	-1	20735774
between	O	-1	20735774
those	O	-1	20735774
in	O	-1	20735774
whom	O	-1	20735774
the	O	-1	20735774
liver	B-Disease	D056486	20735774
injury	I-Disease	-1	20735774
l@@	O	-1	20735774
ed	O	-1	20735774
to	O	-1	20735774
an	O	-1	20735774
acute	B-Disease	D017114	20735774
liver	I-Disease	-1	20735774
failure	I-Disease	-1	20735774
and	O	-1	20735774
those	O	-1	20735774
in	O	-1	20735774
whom	O	-1	20735774
it	O	-1	20735774
did	O	-1	20735774
not@@	O	-1	20735774
.	O	-1	20735774
RESULTS:	O	-1	20735774
We	O	-1	20735774
included	O	-1	20735774
6@@	O	-1	20735774
4@@	O	-1	20735774
1	O	-1	20735774
patients.	O	-1	20735774
O@@	O	-1	20735774
n	O	-1	20735774
aver@@	O	-1	20735774
age,	O	-1	20735774
ag@@	O	-1	20735774
e-@@	O	-1	20735774
specific	O	-1	20735774
mor@@	O	-1	20735774
t@@	O	-1	20735774
ality	O	-1	20735774
rat@@	O	-1	20735774
es	O	-1	20735774
were	O	-1	20735774
s@@	O	-1	20735774
li@@	O	-1	20735774
gh@@	O	-1	20735774
tly	O	-1	20735774
higher	O	-1	20735774
for	O	-1	20735774
the	O	-1	20735774
10@@	O	-1	20735774
1	O	-1	20735774
patients	O	-1	20735774
wh@@	O	-1	20735774
ose	O	-1	20735774
par@@	B-Chemical	D000082	20735774
acet@@	I-Chemical	-1	20735774
am@@	I-Chemical	-1	20735774
ol	I-Chemical	-1	20735774
-induced	O	-1	20735774
liver	B-Disease	D056486	20735774
injury	I-Disease	-1	20735774
had	O	-1	20735774
caused	O	-1	20735774
an	O	-1	20735774
acute	B-Disease	D017114	20735774
liver	I-Disease	-1	20735774
failure	I-Disease	-1	20735774
(@@	O	-1	20735774
adjust@@	O	-1	20735774
ed	O	-1	20735774
mor@@	O	-1	20735774
t@@	O	-1	20735774
ality	O	-1	20735774
rate	O	-1	20735774
rati@@	O	-1	20735774
o	O	-1	20735774
=	O	-1	20735774
1.@@	O	-1	20735774
7@@	O	-1	20735774
0@@	O	-1	20735774
,	O	-1	20735774
95%	O	-1	20735774
C@@	O	-1	20735774
I	O	-1	20735774
1.@@	O	-1	20735774
0@@	O	-1	20735774
2-@@	O	-1	20735774
2.@@	O	-1	20735774
8@@	O	-1	20735774
5@@	O	-1	20735774
),	O	-1	20735774
but	O	-1	20735774
the	O	-1	20735774
association	O	-1	20735774
was	O	-1	20735774
ag@@	O	-1	20735774
e-@@	O	-1	20735774
depend@@	O	-1	20735774
ent@@	O	-1	20735774
,	O	-1	20735774
and	O	-1	20735774
no	O	-1	20735774
sur@@	O	-1	20735774
viv@@	O	-1	20735774
ors	O	-1	20735774
of	O	-1	20735774
acute	B-Disease	D017114	20735774
liver	I-Disease	-1	20735774
failure	I-Disease	-1	20735774
di@@	O	-1	20735774
ed	O	-1	20735774
of	O	-1	20735774
liver	B-Disease	D008107	20735774
disease	I-Disease	-1	20735774
,	O	-1	20735774
whereas	O	-1	20735774
su@@	O	-1	20735774
ici@@	O	-1	20735774
des	O	-1	20735774
were	O	-1	20735774
frequent	O	-1	20735774
in	O	-1	20735774
both	O	-1	20735774
groups.	O	-1	20735774
These	O	-1	20735774
observ@@	O	-1	20735774
ations	O	-1	20735774
sp@@	O	-1	20735774
e@@	O	-1	20735774
a@@	O	-1	20735774
k	O	-1	20735774
against	O	-1	20735774
long-term	O	-1	20735774
effects	O	-1	20735774
of	O	-1	20735774
acute	B-Disease	D017114	20735774
liver	I-Disease	-1	20735774
failure	I-Disease	-1	20735774
.	O	-1	20735774
M@@	O	-1	20735774
or@@	O	-1	20735774
e	O	-1	20735774
lik@@	O	-1	20735774
el@@	O	-1	20735774
y,	O	-1	20735774
the	O	-1	20735774
elevated	O	-1	20735774
mor@@	O	-1	20735774
t@@	O	-1	20735774
ality	O	-1	20735774
rate	O	-1	20735774
rati@@	O	-1	20735774
o	O	-1	20735774
resulted	O	-1	20735774
from	O	-1	20735774
in@@	O	-1	20735774
complete	O	-1	20735774
adjust@@	O	-1	20735774
ment	O	-1	20735774
for	O	-1	20735774
the	O	-1	20735774
greater	O	-1	20735774
prev@@	O	-1	20735774
al@@	O	-1	20735774
ence	O	-1	20735774
of	O	-1	20735774
subst@@	B-Disease	D019966	20735774
ance	I-Disease	-1	20735774
ab@@	I-Disease	-1	20735774
use	I-Disease	-1	20735774
among	O	-1	20735774
sur@@	O	-1	20735774
viv@@	O	-1	20735774
ors	O	-1	20735774
of	O	-1	20735774
acute	B-Disease	D017114	20735774
liver	I-Disease	-1	20735774
failure	I-Disease	-1	20735774
.	O	-1	20735774
CONCLUSIONS:	O	-1	20735774
P@@	B-Chemical	D000082	20735774
ar@@	I-Chemical	-1	20735774
acet@@	I-Chemical	-1	20735774
am@@	I-Chemical	-1	20735774
ol	I-Chemical	-1	20735774
-induced	O	-1	20735774
acute	B-Disease	D017114	20735774
liver	I-Disease	-1	20735774
failure	I-Disease	-1	20735774
did	O	-1	20735774
not	O	-1	20735774
aff@@	O	-1	20735774
ect	O	-1	20735774
long-term	O	-1	20735774
mor@@	O	-1	20735774
t@@	O	-1	20735774
al@@	O	-1	20735774
ity.	O	-1	20735774
Clin@@	O	-1	20735774
ical	O	-1	20735774
follow-up	O	-1	20735774
may	O	-1	20735774
be	O	-1	20735774
j@@	O	-1	20735774
us@@	O	-1	20735774
ti@@	O	-1	20735774
fied	O	-1	20735774
by	O	-1	20735774
the	O	-1	20735774
cause	O	-1	20735774
of	O	-1	20735774
the	O	-1	20735774
liver	B-Disease	D017093	20735774
failure	I-Disease	-1	20735774
,	O	-1	20735774
but	O	-1	20735774
not	O	-1	20735774
by	O	-1	20735774
the	O	-1	20735774
liver	B-Disease	D017093	20735774
failure	I-Disease	-1	20735774
it@@	O	-1	20735774
sel@@	O	-1	20735774
f@@	O	-1	20735774
.	O	-1	20735774

S@@	B-Chemical	D012701	20705401
er@@	I-Chemical	-1	20705401
oton@@	I-Chemical	-1	20705401
in	I-Chemical	-1	20705401
6	O	-1	20705401
receptor	O	-1	20705401
gen@@	O	-1	20705401
e	O	-1	20705401
is	O	-1	20705401
associated	O	-1	20705401
with	O	-1	20705401
meth@@	B-Chemical	D008694	20705401
amphetamine	I-Chemical	-1	20705401
-induced	O	-1	20705401
psycho@@	B-Disease	D011605	20705401
sis	I-Disease	-1	20705401
in	O	-1	20705401
a	O	-1	20705401
J@@	O	-1	20705401
ap@@	O	-1	20705401
an@@	O	-1	20705401
ese	O	-1	20705401
po@@	O	-1	20705401
pul@@	O	-1	20705401
ation.	O	-1	20705401
BACKGROUND:	O	-1	20705401
Al@@	O	-1	20705401
te@@	O	-1	20705401
red	O	-1	20705401
seroton@@	O	-1	20705401
ergic	O	-1	20705401
ne@@	O	-1	20705401
ural	O	-1	20705401
trans@@	O	-1	20705401
mission	O	-1	20705401
is	O	-1	20705401
hypo@@	O	-1	20705401
the@@	O	-1	20705401
si@@	O	-1	20705401
zed	O	-1	20705401
to	O	-1	20705401
be	O	-1	20705401
a	O	-1	20705401
sus@@	O	-1	20705401
cep@@	O	-1	20705401
ti@@	O	-1	20705401
b@@	O	-1	20705401
ility	O	-1	20705401
factor	O	-1	20705401
for	O	-1	20705401
psycho@@	B-Disease	D011605	20705401
tic	I-Disease	-1	20705401
disorder@@	I-Disease	-1	20705401
s	I-Disease	-1	20705401
such	O	-1	20705401
as	O	-1	20705401
sch@@	B-Disease	D012559	20705401
iz@@	I-Disease	-1	20705401
oph@@	I-Disease	-1	20705401
ren@@	I-Disease	-1	20705401
ia	I-Disease	-1	20705401
.	O	-1	20705401
The	O	-1	20705401
seroton@@	B-Chemical	D012701	20705401
in	I-Chemical	-1	20705401
6	O	-1	20705401
(	O	-1	20705401
5-@@	B-Chemical	D012701	20705401
H@@	I-Chemical	-1	20705401
T	I-Chemical	-1	20705401
6@@	O	-1	20705401
)	O	-1	20705401
receptor	O	-1	20705401
is	O	-1	20705401
therapeu@@	O	-1	20705401
tically	O	-1	20705401
t@@	O	-1	20705401
arg@@	O	-1	20705401
et@@	O	-1	20705401
ed	O	-1	20705401
by	O	-1	20705401
several	O	-1	20705401
second	O	-1	20705401
generation	O	-1	20705401
anti@@	O	-1	20705401
psycho@@	O	-1	20705401
tic@@	O	-1	20705401
s,	O	-1	20705401
such	O	-1	20705401
as	O	-1	20705401
cloz@@	B-Chemical	D003024	20705401
apine	I-Chemical	-1	20705401
and	O	-1	20705401
ol@@	B-Chemical	C076029	20705401
an@@	I-Chemical	-1	20705401
z@@	I-Chemical	-1	20705401
apine	I-Chemical	-1	20705401
,	O	-1	20705401
and	O	-1	20705401
d-@@	B-Chemical	D003913	20705401
amphetamine	I-Chemical	-1	20705401
-induced	O	-1	20705401
hyperactivity	B-Disease	D006948	20705401
in	O	-1	20705401
rats	O	-1	20705401
is	O	-1	20705401
cor@@	O	-1	20705401
rec@@	O	-1	20705401
ted	O	-1	20705401
with	O	-1	20705401
the	O	-1	20705401
use	O	-1	20705401
of	O	-1	20705401
a	O	-1	20705401
selective	O	-1	20705401
5-@@	B-Chemical	D012701	20705401
H@@	I-Chemical	-1	20705401
T	I-Chemical	-1	20705401
6	O	-1	20705401
receptor	O	-1	20705401
antagonist@@	O	-1	20705401
.	O	-1	20705401
In	O	-1	20705401
addi@@	O	-1	20705401
tion,	O	-1	20705401
the	O	-1	20705401
dis@@	O	-1	20705401
ru@@	O	-1	20705401
pt@@	O	-1	20705401
ed	O	-1	20705401
pre@@	O	-1	20705401
pul@@	O	-1	20705401
se	O	-1	20705401
inhibition	O	-1	20705401
induced	O	-1	20705401
by	O	-1	20705401
d-@@	B-Chemical	D003913	20705401
amphetamine	I-Chemical	-1	20705401
or	O	-1	20705401
ph@@	B-Chemical	D010622	20705401
enc@@	I-Chemical	-1	20705401
y@@	I-Chemical	-1	20705401
cl@@	I-Chemical	-1	20705401
idine	I-Chemical	-1	20705401
was	O	-1	20705401
re@@	O	-1	20705401
sto@@	O	-1	20705401
red	O	-1	20705401
by	O	-1	20705401
5-@@	B-Chemical	D012701	20705401
H@@	I-Chemical	-1	20705401
T	I-Chemical	-1	20705401
6	O	-1	20705401
receptor	O	-1	20705401
antagonist	O	-1	20705401
in	O	-1	20705401
an	O	-1	20705401
anim@@	O	-1	20705401
al	O	-1	20705401
study	O	-1	20705401
using	O	-1	20705401
rats.	O	-1	20705401
These	O	-1	20705401
anim@@	O	-1	20705401
al	O	-1	20705401
models	O	-1	20705401
were	O	-1	20705401
considered	O	-1	20705401
to	O	-1	20705401
ref@@	O	-1	20705401
l@@	O	-1	20705401
ect	O	-1	20705401
the	O	-1	20705401
positive	O	-1	20705401
symptoms	O	-1	20705401
of	O	-1	20705401
sch@@	B-Disease	D012559	20705401
iz@@	I-Disease	-1	20705401
oph@@	I-Disease	-1	20705401
ren@@	I-Disease	-1	20705401
ia	I-Disease	-1	20705401
,	O	-1	20705401
and	O	-1	20705401
the	O	-1	20705401
ab@@	O	-1	20705401
o@@	O	-1	20705401
ve	O	-1	20705401
evidence	O	-1	20705401
suggests	O	-1	20705401
that	O	-1	20705401
al@@	O	-1	20705401
te@@	O	-1	20705401
red	O	-1	20705401
5-@@	B-Chemical	D012701	20705401
H@@	I-Chemical	-1	20705401
T	I-Chemical	-1	20705401
6	O	-1	20705401
receptors	O	-1	20705401
are	O	-1	20705401
involved	O	-1	20705401
in	O	-1	20705401
the	O	-1	20705401
path@@	O	-1	20705401
oph@@	O	-1	20705401
ysi@@	O	-1	20705401
ology	O	-1	20705401
of	O	-1	20705401
psycho@@	B-Disease	D011605	20705401
tic	I-Disease	-1	20705401
disorder@@	I-Disease	-1	20705401
s	I-Disease	-1	20705401
.	O	-1	20705401
The	O	-1	20705401
symptoms	O	-1	20705401
of	O	-1	20705401
meth@@	B-Chemical	D008694	20705401
amphetamine	I-Chemical	-1	20705401
(	O	-1	20705401
MET@@	B-Chemical	D008694	20705401
H	I-Chemical	-1	20705401
)@@	O	-1	20705401
-induced	O	-1	20705401
psycho@@	B-Disease	D011605	20705401
sis	I-Disease	-1	20705401
are	O	-1	20705401
similar	O	-1	20705401
to	O	-1	20705401
those	O	-1	20705401
of	O	-1	20705401
par@@	B-Disease	D012563	20705401
an@@	I-Disease	-1	20705401
oid	I-Disease	-1	20705401
type	I-Disease	-1	20705401
sch@@	I-Disease	-1	20705401
iz@@	I-Disease	-1	20705401
oph@@	I-Disease	-1	20705401
ren@@	I-Disease	-1	20705401
ia	I-Disease	-1	20705401
.	O	-1	20705401
The@@	O	-1	20705401
refore,	O	-1	20705401
we	O	-1	20705401
con@@	O	-1	20705401
duc@@	O	-1	20705401
ted	O	-1	20705401
an	O	-1	20705401
analysis	O	-1	20705401
of	O	-1	20705401
the	O	-1	20705401
association	O	-1	20705401
of	O	-1	20705401
the	O	-1	20705401
5-@@	B-Chemical	D012701	20705401
H@@	I-Chemical	-1	20705401
T	I-Chemical	-1	20705401
6	O	-1	20705401
gen@@	O	-1	20705401
e	O	-1	20705401
(@@	O	-1	20705401
H@@	O	-1	20705401
TR@@	O	-1	20705401
6@@	O	-1	20705401
)	O	-1	20705401
with	O	-1	20705401
MET@@	B-Chemical	D008694	20705401
H	I-Chemical	-1	20705401
-induced	O	-1	20705401
psycho@@	B-Disease	D011605	20705401
sis	I-Disease	-1	20705401
.	O	-1	20705401
METHOD@@	O	-1	20705401
:	O	-1	20705401
U@@	O	-1	20705401
s@@	O	-1	20705401
ing	O	-1	20705401
five	O	-1	20705401
t@@	O	-1	20705401
ag@@	O	-1	20705401
g@@	O	-1	20705401
ing	O	-1	20705401
S@@	O	-1	20705401
N@@	O	-1	20705401
P@@	O	-1	20705401
s	O	-1	20705401
(@@	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
6@@	O	-1	20705401
6@@	O	-1	20705401
9@@	O	-1	20705401
3@@	O	-1	20705401
50@@	O	-1	20705401
3,	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
18@@	O	-1	20705401
0@@	O	-1	20705401
50@@	O	-1	20705401
5@@	O	-1	20705401
4@@	O	-1	20705401
,	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
4@@	O	-1	20705401
9@@	O	-1	20705401
12@@	O	-1	20705401
13@@	O	-1	20705401
8@@	O	-1	20705401
,	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
3@@	O	-1	20705401
7@@	O	-1	20705401
9@@	O	-1	20705401
0@@	O	-1	20705401
7@@	O	-1	20705401
5@@	O	-1	20705401
7	O	-1	20705401
and	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
9@@	O	-1	20705401
6@@	O	-1	20705401
5@@	O	-1	20705401
9@@	O	-1	20705401
9@@	O	-1	20705401
9@@	O	-1	20705401
7@@	O	-1	20705401
),	O	-1	20705401
we	O	-1	20705401
con@@	O	-1	20705401
duc@@	O	-1	20705401
ted	O	-1	20705401
a	O	-1	20705401
gene@@	O	-1	20705401
tic	O	-1	20705401
association	O	-1	20705401
analysis	O	-1	20705401
of	O	-1	20705401
cas@@	O	-1	20705401
e-@@	O	-1	20705401
control	O	-1	20705401
sam@@	O	-1	20705401
ple@@	O	-1	20705401
s	O	-1	20705401
(1@@	O	-1	20705401
9@@	O	-1	20705401
7	O	-1	20705401
MET@@	B-Chemical	D008694	20705401
H	I-Chemical	-1	20705401
-induced	O	-1	20705401
psycho@@	B-Disease	D011605	20705401
sis	I-Disease	-1	20705401
patients	O	-1	20705401
and	O	-1	20705401
3@@	O	-1	20705401
3@@	O	-1	20705401
7	O	-1	20705401
control@@	O	-1	20705401
s)	O	-1	20705401
in	O	-1	20705401
the	O	-1	20705401
J@@	O	-1	20705401
ap@@	O	-1	20705401
an@@	O	-1	20705401
ese	O	-1	20705401
po@@	O	-1	20705401
pul@@	O	-1	20705401
ation.	O	-1	20705401
The	O	-1	20705401
age	O	-1	20705401
and	O	-1	20705401
se@@	O	-1	20705401
x	O	-1	20705401
of	O	-1	20705401
the	O	-1	20705401
control	O	-1	20705401
subjects	O	-1	20705401
did	O	-1	20705401
not	O	-1	20705401
diff@@	O	-1	20705401
er	O	-1	20705401
from	O	-1	20705401
those	O	-1	20705401
of	O	-1	20705401
the	O	-1	20705401
meth@@	B-Chemical	D008694	20705401
amphetamine	I-Chemical	-1	20705401
depend@@	O	-1	20705401
ence	O	-1	20705401
patients.	O	-1	20705401
RESULTS:	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
6@@	O	-1	20705401
6@@	O	-1	20705401
9@@	O	-1	20705401
3@@	O	-1	20705401
50@@	O	-1	20705401
3	O	-1	20705401
was	O	-1	20705401
associated	O	-1	20705401
with	O	-1	20705401
MET@@	B-Chemical	D008694	20705401
H	I-Chemical	-1	20705401
-induced	O	-1	20705401
psycho@@	B-Disease	D011605	20705401
sis	I-Disease	-1	20705401
patients	O	-1	20705401
in	O	-1	20705401
the	O	-1	20705401
al@@	O	-1	20705401
le@@	O	-1	20705401
le@@	O	-1	20705401
/@@	O	-1	20705401
gen@@	O	-1	20705401
ot@@	O	-1	20705401
y@@	O	-1	20705401
pe@@	O	-1	20705401
-@@	O	-1	20705401
w@@	O	-1	20705401
is@@	O	-1	20705401
e	O	-1	20705401
analy@@	O	-1	20705401
sis.	O	-1	20705401
M@@	O	-1	20705401
ore@@	O	-1	20705401
o@@	O	-1	20705401
ver,	O	-1	20705401
this	O	-1	20705401
association	O	-1	20705401
remained	O	-1	20705401
significant	O	-1	20705401
after	O	-1	20705401
B@@	O	-1	20705401
on@@	O	-1	20705401
fer@@	O	-1	20705401
ron@@	O	-1	20705401
i	O	-1	20705401
cor@@	O	-1	20705401
rec@@	O	-1	20705401
tion.	O	-1	20705401
In	O	-1	20705401
the	O	-1	20705401
h@@	O	-1	20705401
ap@@	O	-1	20705401
lo@@	O	-1	20705401
ty@@	O	-1	20705401
pe@@	O	-1	20705401
-@@	O	-1	20705401
w@@	O	-1	20705401
is@@	O	-1	20705401
e	O	-1	20705401
analy@@	O	-1	20705401
sis,	O	-1	20705401
we	O	-1	20705401
det@@	O	-1	20705401
ected	O	-1	20705401
an	O	-1	20705401
association	O	-1	20705401
between	O	-1	20705401
two	O	-1	20705401
mark@@	O	-1	20705401
ers	O	-1	20705401
(@@	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
6@@	O	-1	20705401
6@@	O	-1	20705401
9@@	O	-1	20705401
3@@	O	-1	20705401
50@@	O	-1	20705401
3	O	-1	20705401
and	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
18@@	O	-1	20705401
0@@	O	-1	20705401
50@@	O	-1	20705401
5@@	O	-1	20705401
4@@	O	-1	20705401
)	O	-1	20705401
and	O	-1	20705401
three	O	-1	20705401
mark@@	O	-1	20705401
ers	O	-1	20705401
(@@	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
6@@	O	-1	20705401
6@@	O	-1	20705401
9@@	O	-1	20705401
3@@	O	-1	20705401
50@@	O	-1	20705401
3,	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
18@@	O	-1	20705401
0@@	O	-1	20705401
50@@	O	-1	20705401
5@@	O	-1	20705401
4	O	-1	20705401
and	O	-1	20705401
r@@	O	-1	20705401
s@@	O	-1	20705401
4@@	O	-1	20705401
9@@	O	-1	20705401
12@@	O	-1	20705401
13@@	O	-1	20705401
8@@	O	-1	20705401
)	O	-1	20705401
in	O	-1	20705401
H@@	O	-1	20705401
TR@@	O	-1	20705401
6	O	-1	20705401
and	O	-1	20705401
MET@@	B-Chemical	D008694	20705401
H	I-Chemical	-1	20705401
-induced	O	-1	20705401
psycho@@	B-Disease	D011605	20705401
sis	I-Disease	-1	20705401
patients,	O	-1	20705401
respectively.	O	-1	20705401
CONCLUSION:	O	-1	20705401
H@@	O	-1	20705401
TR@@	O	-1	20705401
6	O	-1	20705401
may	O	-1	20705401
pl@@	O	-1	20705401
ay	O	-1	20705401
an	O	-1	20705401
important	O	-1	20705401
role	O	-1	20705401
in	O	-1	20705401
the	O	-1	20705401
path@@	O	-1	20705401
oph@@	O	-1	20705401
ysi@@	O	-1	20705401
ology	O	-1	20705401
of	O	-1	20705401
MET@@	B-Chemical	D008694	20705401
H	I-Chemical	-1	20705401
-induced	O	-1	20705401
psycho@@	B-Disease	D011605	20705401
sis	I-Disease	-1	20705401
in	O	-1	20705401
the	O	-1	20705401
J@@	O	-1	20705401
ap@@	O	-1	20705401
an@@	O	-1	20705401
ese	O	-1	20705401
po@@	O	-1	20705401
pul@@	O	-1	20705401
ation.	O	-1	20705401

Eff@@	O	-1	19105845
ect	O	-1	19105845
of	O	-1	19105845
increas@@	O	-1	19105845
ing	O	-1	19105845
intra@@	O	-1	19105845
per@@	O	-1	19105845
it@@	O	-1	19105845
one@@	O	-1	19105845
al	O	-1	19105845
infusion	O	-1	19105845
rat@@	O	-1	19105845
es	O	-1	19105845
on	O	-1	19105845
bu@@	B-Chemical	D016642	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
hydro@@	I-Chemical	-1	19105845
chlor@@	I-Chemical	-1	19105845
ide	I-Chemical	-1	19105845
-induced	O	-1	19105845
seizures	B-Disease	D012640	19105845
in	O	-1	19105845
mice.	O	-1	19105845
BACKGROUND:	O	-1	19105845
It	O	-1	19105845
is	O	-1	19105845
not	O	-1	19105845
known	O	-1	19105845
if	O	-1	19105845
there	O	-1	19105845
is	O	-1	19105845
a	O	-1	19105845
rel@@	O	-1	19105845
ationship	O	-1	19105845
between	O	-1	19105845
in@@	O	-1	19105845
pu@@	O	-1	19105845
t	O	-1	19105845
rate	O	-1	19105845
and	O	-1	19105845
incidence	O	-1	19105845
of	O	-1	19105845
bu@@	B-Chemical	D016642	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
-induced	O	-1	19105845
seizures	B-Disease	D012640	19105845
.	O	-1	19105845
This	O	-1	19105845
is	O	-1	19105845
import@@	O	-1	19105845
ant@@	O	-1	19105845
,	O	-1	19105845
s@@	O	-1	19105845
inc@@	O	-1	19105845
e	O	-1	19105845
different	O	-1	19105845
controlled	O	-1	19105845
release	O	-1	19105845
form@@	O	-1	19105845
ul@@	O	-1	19105845
ations	O	-1	19105845
of	O	-1	19105845
bu@@	B-Chemical	D016642	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
release	O	-1	19105845
the	O	-1	19105845
active	O	-1	19105845
drug	O	-1	19105845
at	O	-1	19105845
different	O	-1	19105845
rat@@	O	-1	19105845
es.	O	-1	19105845
METHODS:	O	-1	19105845
We	O	-1	19105845
investigated	O	-1	19105845
the	O	-1	19105845
effect	O	-1	19105845
of	O	-1	19105845
v@@	O	-1	19105845
ar@@	O	-1	19105845
y@@	O	-1	19105845
ing	O	-1	19105845
the	O	-1	19105845
intra@@	O	-1	19105845
per@@	O	-1	19105845
it@@	O	-1	19105845
one@@	O	-1	19105845
al	O	-1	19105845
infusion	O	-1	19105845
rat@@	O	-1	19105845
es	O	-1	19105845
of	O	-1	19105845
bu@@	B-Chemical	D016642	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
HC@@	I-Chemical	-1	19105845
l	I-Chemical	-1	19105845
1@@	O	-1	19105845
20	O	-1	19105845
mg/kg@@	O	-1	19105845
,	O	-1	19105845
a	O	-1	19105845
known	O	-1	19105845
convul@@	B-Disease	D012640	19105845
sive	I-Disease	-1	19105845
dose	O	-1	19105845
50	O	-1	19105845
(C@@	O	-1	19105845
D@@	O	-1	19105845
50@@	O	-1	19105845
),	O	-1	19105845
on	O	-1	19105845
the	O	-1	19105845
incidence	O	-1	19105845
and	O	-1	19105845
severity	O	-1	19105845
of	O	-1	19105845
bu@@	B-Chemical	D016642	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
-induced	O	-1	19105845
convul@@	B-Disease	D012640	19105845
sions	I-Disease	-1	19105845
in	O	-1	19105845
the	O	-1	19105845
S@@	O	-1	19105845
w@@	O	-1	19105845
is@@	O	-1	19105845
s	O	-1	19105845
al@@	O	-1	19105845
bin@@	O	-1	19105845
o	O	-1	19105845
mice.	O	-1	19105845
A	O	-1	19105845
total	O	-1	19105845
of	O	-1	19105845
6@@	O	-1	19105845
9	O	-1	19105845
mic@@	O	-1	19105845
e,	O	-1	19105845
appro@@	O	-1	19105845
xim@@	O	-1	19105845
ately	O	-1	19105845
7	O	-1	19105845
weeks	O	-1	19105845
of	O	-1	19105845
age,	O	-1	19105845
and	O	-1	19105845
weigh@@	O	-1	19105845
ing	O	-1	19105845
2@@	O	-1	19105845
1.@@	O	-1	19105845
0	O	-1	19105845
to	O	-1	19105845
2@@	O	-1	19105845
9.@@	O	-1	19105845
1	O	-1	19105845
g	O	-1	19105845
were	O	-1	19105845
random@@	O	-1	19105845
ly	O	-1	19105845
as@@	O	-1	19105845
signed	O	-1	19105845
to	O	-1	19105845
bu@@	B-Chemical	D016642	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
HC@@	I-Chemical	-1	19105845
l	I-Chemical	-1	19105845
1@@	O	-1	19105845
20	O	-1	19105845
mg/kg	O	-1	19105845
treatment	O	-1	19105845
by	O	-1	19105845
intra@@	O	-1	19105845
per@@	O	-1	19105845
it@@	O	-1	19105845
one@@	O	-1	19105845
al	O	-1	19105845
(@@	O	-1	19105845
I@@	O	-1	19105845
P)	O	-1	19105845
administration	O	-1	19105845
in	O	-1	19105845
7	O	-1	19105845
groups	O	-1	19105845
(@@	O	-1	19105845
9	O	-1	19105845
to	O	-1	19105845
10	O	-1	19105845
animals	O	-1	19105845
per	O	-1	19105845
group@@	O	-1	19105845
).	O	-1	19105845
B@@	B-Chemical	D016642	19105845
u@@	I-Chemical	-1	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
HC@@	I-Chemical	-1	19105845
l	I-Chemical	-1	19105845
was	O	-1	19105845
inf@@	O	-1	19105845
used	O	-1	19105845
through	O	-1	19105845
a	O	-1	19105845
surg@@	O	-1	19105845
ically	O	-1	19105845
im@@	O	-1	19105845
pl@@	O	-1	19105845
ant@@	O	-1	19105845
ed	O	-1	19105845
I@@	O	-1	19105845
P	O	-1	19105845
dos@@	O	-1	19105845
ing	O	-1	19105845
ca@@	O	-1	19105845
the@@	O	-1	19105845
ter	O	-1	19105845
with	O	-1	19105845
infu@@	O	-1	19105845
sions	O	-1	19105845
in	O	-1	19105845
each	O	-1	19105845
group	O	-1	19105845
of	O	-1	19105845
0	O	-1	19105845
min@@	O	-1	19105845
,	O	-1	19105845
15	O	-1	19105845
min@@	O	-1	19105845
,	O	-1	19105845
30	O	-1	19105845
min@@	O	-1	19105845
,	O	-1	19105845
60	O	-1	19105845
min@@	O	-1	19105845
,	O	-1	19105845
9@@	O	-1	19105845
0	O	-1	19105845
min@@	O	-1	19105845
,	O	-1	19105845
1@@	O	-1	19105845
20	O	-1	19105845
min@@	O	-1	19105845
,	O	-1	19105845
and	O	-1	19105845
2@@	O	-1	19105845
40	O	-1	19105845
min@@	O	-1	19105845
.	O	-1	19105845
The	O	-1	19105845
numb@@	O	-1	19105845
er,	O	-1	19105845
time	O	-1	19105845
of	O	-1	19105845
on@@	O	-1	19105845
se@@	O	-1	19105845
t,	O	-1	19105845
duration	O	-1	19105845
and	O	-1	19105845
the	O	-1	19105845
int@@	O	-1	19105845
ensity	O	-1	19105845
of	O	-1	19105845
the	O	-1	19105845
convul@@	B-Disease	D012640	19105845
sions	I-Disease	-1	19105845
or	O	-1	19105845
absence	O	-1	19105845
of	O	-1	19105845
convul@@	B-Disease	D012640	19105845
sions	I-Disease	-1	19105845
were	O	-1	19105845
recor@@	O	-1	19105845
de@@	O	-1	19105845
d.	O	-1	19105845
RESULTS:	O	-1	19105845
The	O	-1	19105845
results	O	-1	19105845
showed	O	-1	19105845
that	O	-1	19105845
I@@	O	-1	19105845
P	O	-1	19105845
administration	O	-1	19105845
of	O	-1	19105845
bu@@	B-Chemical	D016642	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
HC@@	I-Chemical	-1	19105845
l	I-Chemical	-1	19105845
1@@	O	-1	19105845
20	O	-1	19105845
mg/kg	O	-1	19105845
by	O	-1	19105845
b@@	O	-1	19105845
ol@@	O	-1	19105845
us	O	-1	19105845
injection	O	-1	19105845
induced	O	-1	19105845
convul@@	B-Disease	D012640	19105845
sions	I-Disease	-1	19105845
in	O	-1	19105845
6	O	-1	19105845
out	O	-1	19105845
of	O	-1	19105845
10	O	-1	19105845
mice	O	-1	19105845
(6@@	O	-1	19105845
0%	O	-1	19105845
of	O	-1	19105845
convul@@	O	-1	19105845
s@@	O	-1	19105845
ing	O	-1	19105845
mic@@	O	-1	19105845
e@@	O	-1	19105845
)	O	-1	19105845
in	O	-1	19105845
group	O	-1	19105845
1@@	O	-1	19105845
.	O	-1	19105845
L@@	O	-1	19105845
o@@	O	-1	19105845
g@@	O	-1	19105845
istic	O	-1	19105845
reg@@	O	-1	19105845
res@@	O	-1	19105845
sion	O	-1	19105845
analysis	O	-1	19105845
revealed	O	-1	19105845
that	O	-1	19105845
infusion	O	-1	19105845
time	O	-1	19105845
was	O	-1	19105845
significant	O	-1	19105845
(p	O	-1	19105845
=	O	-1	19105845
0.00@@	O	-1	19105845
0@@	O	-1	19105845
4@@	O	-1	19105845
;	O	-1	19105845
o@@	O	-1	19105845
d@@	O	-1	19105845
ds	O	-1	19105845
rati@@	O	-1	19105845
o	O	-1	19105845
=	O	-1	19105845
0.@@	O	-1	19105845
9@@	O	-1	19105845
7@@	O	-1	19105845
4@@	O	-1	19105845
)	O	-1	19105845
and	O	-1	19105845
increas@@	O	-1	19105845
ing	O	-1	19105845
the	O	-1	19105845
I@@	O	-1	19105845
P	O	-1	19105845
infusion	O	-1	19105845
time	O	-1	19105845
of	O	-1	19105845
bu@@	B-Chemical	D016642	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
HC@@	I-Chemical	-1	19105845
l	I-Chemical	-1	19105845
1@@	O	-1	19105845
20	O	-1	19105845
mg/kg	O	-1	19105845
was	O	-1	19105845
associated	O	-1	19105845
with	O	-1	19105845
a	O	-1	19105845
9@@	O	-1	19105845
1@@	O	-1	19105845
%	O	-1	19105845
reduced	O	-1	19105845
o@@	O	-1	19105845
d@@	O	-1	19105845
ds	O	-1	19105845
of	O	-1	19105845
convul@@	B-Disease	D012640	19105845
sions	I-Disease	-1	19105845
at	O	-1	19105845
infusion	O	-1	19105845
times	O	-1	19105845
of	O	-1	19105845
15	O	-1	19105845
to	O	-1	19105845
9@@	O	-1	19105845
0	O	-1	19105845
min	O	-1	19105845
compared	O	-1	19105845
to	O	-1	19105845
b@@	O	-1	19105845
ol@@	O	-1	19105845
us	O	-1	19105845
injec@@	O	-1	19105845
tion.	O	-1	19105845
F@@	O	-1	19105845
urther	O	-1	19105845
increase	O	-1	19105845
in	O	-1	19105845
infusion	O	-1	19105845
time	O	-1	19105845
resulted	O	-1	19105845
in	O	-1	19105845
further	O	-1	19105845
reduction	O	-1	19105845
in	O	-1	19105845
the	O	-1	19105845
o@@	O	-1	19105845
d@@	O	-1	19105845
ds	O	-1	19105845
of	O	-1	19105845
convul@@	B-Disease	D012640	19105845
sions	I-Disease	-1	19105845
to	O	-1	19105845
9@@	O	-1	19105845
9.@@	O	-1	19105845
8@@	O	-1	19105845
%	O	-1	19105845
reduction	O	-1	19105845
at	O	-1	19105845
2@@	O	-1	19105845
40	O	-1	19105845
min@@	O	-1	19105845
.	O	-1	19105845
CONCLUSION:	O	-1	19105845
In	O	-1	19105845
concl@@	O	-1	19105845
u@@	O	-1	19105845
sion,	O	-1	19105845
the	O	-1	19105845
demon@@	O	-1	19105845
st@@	O	-1	19105845
ration	O	-1	19105845
of	O	-1	19105845
an	O	-1	19105845
in@@	O	-1	19105845
verse	O	-1	19105845
rel@@	O	-1	19105845
ationship	O	-1	19105845
between	O	-1	19105845
infusion	O	-1	19105845
time	O	-1	19105845
of	O	-1	19105845
a	O	-1	19105845
fi@@	O	-1	19105845
x@@	O	-1	19105845
ed	O	-1	19105845
and	O	-1	19105845
convul@@	B-Disease	D012640	19105845
sive	I-Disease	-1	19105845
dose	O	-1	19105845
of	O	-1	19105845
bu@@	B-Chemical	D016642	19105845
pro@@	I-Chemical	-1	19105845
pi@@	I-Chemical	-1	19105845
on	I-Chemical	-1	19105845
and	O	-1	19105845
the	O	-1	19105845
risk	O	-1	19105845
of	O	-1	19105845
convul@@	B-Disease	D012640	19105845
sions	I-Disease	-1	19105845
in	O	-1	19105845
a	O	-1	19105845
pro@@	O	-1	19105845
sp@@	O	-1	19105845
ective	O	-1	19105845
study	O	-1	19105845
is	O	-1	19105845
no@@	O	-1	19105845
vel@@	O	-1	19105845
.	O	-1	19105845

D@@	O	-1	18657397
et@@	O	-1	18657397
ail@@	O	-1	18657397
ed	O	-1	18657397
sp@@	O	-1	18657397
ect@@	O	-1	18657397
ral	O	-1	18657397
prof@@	O	-1	18657397
ile	O	-1	18657397
analysis	O	-1	18657397
of	O	-1	18657397
pen@@	B-Chemical	D010406	18657397
icill@@	I-Chemical	-1	18657397
in	I-Chemical	-1	18657397
-induced	O	-1	18657397
epilep@@	B-Disease	D004827	18657397
ti@@	I-Disease	-1	18657397
form	I-Disease	-1	18657397
activity	I-Disease	-1	18657397
in	O	-1	18657397
anesthe@@	O	-1	18657397
tiz@@	O	-1	18657397
ed	O	-1	18657397
rats.	O	-1	18657397
P@@	B-Chemical	D010406	18657397
en@@	I-Chemical	-1	18657397
icill@@	I-Chemical	-1	18657397
in	I-Chemical	-1	18657397
model	O	-1	18657397
is	O	-1	18657397
a	O	-1	18657397
wi@@	O	-1	18657397
de@@	O	-1	18657397
ly	O	-1	18657397
used	O	-1	18657397
experimental	O	-1	18657397
model	O	-1	18657397
for	O	-1	18657397
epilep@@	B-Disease	D004827	18657397
sy	I-Disease	-1	18657397
re@@	O	-1	18657397
se@@	O	-1	18657397
ar@@	O	-1	18657397
ch@@	O	-1	18657397
.	O	-1	18657397
In	O	-1	18657397
the	O	-1	18657397
present	O	-1	18657397
study	O	-1	18657397
we	O	-1	18657397
a@@	O	-1	18657397
im@@	O	-1	18657397
ed	O	-1	18657397
to	O	-1	18657397
port@@	O	-1	18657397
ra@@	O	-1	18657397
y	O	-1	18657397
a	O	-1	18657397
det@@	O	-1	18657397
ail@@	O	-1	18657397
ed	O	-1	18657397
sp@@	O	-1	18657397
ect@@	O	-1	18657397
ral	O	-1	18657397
analysis	O	-1	18657397
of	O	-1	18657397
pen@@	B-Chemical	D010406	18657397
icill@@	I-Chemical	-1	18657397
in	I-Chemical	-1	18657397
-induced	O	-1	18657397
epilep@@	B-Disease	D004827	18657397
ti@@	I-Disease	-1	18657397
form	I-Disease	-1	18657397
activity	I-Disease	-1	18657397
in	O	-1	18657397
compar@@	O	-1	18657397
ison	O	-1	18657397
with	O	-1	18657397
bas@@	O	-1	18657397
al	O	-1	18657397
brain	O	-1	18657397
activity	O	-1	18657397
in	O	-1	18657397
anesthe@@	O	-1	18657397
tiz@@	O	-1	18657397
ed	O	-1	18657397
Wistar	O	-1	18657397
rats.	O	-1	18657397
M@@	O	-1	18657397
al@@	O	-1	18657397
e	O	-1	18657397
Wistar	O	-1	18657397
rats	O	-1	18657397
were	O	-1	18657397
anesthe@@	O	-1	18657397
tiz@@	O	-1	18657397
ed	O	-1	18657397
with	O	-1	18657397
i.@@	O	-1	18657397
p@@	O	-1	18657397
.	O	-1	18657397
ure@@	B-Chemical	D014520	18657397
th@@	I-Chemical	-1	18657397
ane	I-Chemical	-1	18657397
and	O	-1	18657397
con@@	O	-1	18657397
n@@	O	-1	18657397
ected	O	-1	18657397
to	O	-1	18657397
an	O	-1	18657397
electro@@	O	-1	18657397
cortico@@	O	-1	18657397
gra@@	O	-1	18657397
m	O	-1	18657397
se@@	O	-1	18657397
t@@	O	-1	18657397
up@@	O	-1	18657397
.	O	-1	18657397
After	O	-1	18657397
a	O	-1	18657397
sh@@	O	-1	18657397
ort	O	-1	18657397
period	O	-1	18657397
of	O	-1	18657397
bas@@	O	-1	18657397
al	O	-1	18657397
activity	O	-1	18657397
recor@@	O	-1	18657397
d@@	O	-1	18657397
ing,	O	-1	18657397
epileptic	B-Disease	D004827	18657397
foc@@	O	-1	18657397
us	O	-1	18657397
was	O	-1	18657397
induced	O	-1	18657397
by	O	-1	18657397
inj@@	O	-1	18657397
ect@@	O	-1	18657397
ing	O	-1	18657397
4@@	O	-1	18657397
0@@	O	-1	18657397
0@@	O	-1	18657397
I@@	O	-1	18657397
U@@	O	-1	18657397
/@@	O	-1	18657397
2	O	-1	18657397
micro@@	O	-1	18657397
l	O	-1	18657397
pen@@	B-Chemical	D010400	18657397
icill@@	I-Chemical	-1	18657397
in-@@	I-Chemical	-1	18657397
G	I-Chemical	-1	18657397
pot@@	I-Chemical	-1	18657397
assi@@	I-Chemical	-1	18657397
um	I-Chemical	-1	18657397
into	O	-1	18657397
the	O	-1	18657397
left	O	-1	18657397
lat@@	O	-1	18657397
eral	O	-1	18657397
ventric@@	O	-1	18657397
le	O	-1	18657397
while	O	-1	18657397
the	O	-1	18657397
cor@@	O	-1	18657397
tical	O	-1	18657397
activity	O	-1	18657397
was	O	-1	18657397
continu@@	O	-1	18657397
ously	O	-1	18657397
recor@@	O	-1	18657397
de@@	O	-1	18657397
d.	O	-1	18657397
B@@	O	-1	18657397
as@@	O	-1	18657397
al	O	-1	18657397
activ@@	O	-1	18657397
ity,	O	-1	18657397
lat@@	O	-1	18657397
ent	O	-1	18657397
period	O	-1	18657397
and	O	-1	18657397
the	O	-1	18657397
pen@@	B-Chemical	D010406	18657397
icill@@	I-Chemical	-1	18657397
in	I-Chemical	-1	18657397
-induced	O	-1	18657397
epilep@@	B-Disease	D004827	18657397
ti@@	I-Disease	-1	18657397
form	I-Disease	-1	18657397
activity	I-Disease	-1	18657397
perio@@	O	-1	18657397
ds	O	-1	18657397
were	O	-1	18657397
then	O	-1	18657397
analy@@	O	-1	18657397
zed	O	-1	18657397
using	O	-1	18657397
both	O	-1	18657397
con@@	O	-1	18657397
ven@@	O	-1	18657397
tional	O	-1	18657397
meth@@	O	-1	18657397
o@@	O	-1	18657397
ds	O	-1	18657397
and	O	-1	18657397
sp@@	O	-1	18657397
ect@@	O	-1	18657397
ral	O	-1	18657397
analy@@	O	-1	18657397
sis.	O	-1	18657397
S@@	O	-1	18657397
p@@	O	-1	18657397
ect@@	O	-1	18657397
ral	O	-1	18657397
analy@@	O	-1	18657397
ses	O	-1	18657397
were	O	-1	18657397
con@@	O	-1	18657397
duc@@	O	-1	18657397
ted	O	-1	18657397
by	O	-1	18657397
divid@@	O	-1	18657397
ing	O	-1	18657397
the	O	-1	18657397
wh@@	O	-1	18657397
ole	O	-1	18657397
sp@@	O	-1	18657397
ect@@	O	-1	18657397
ru@@	O	-1	18657397
m	O	-1	18657397
into	O	-1	18657397
different	O	-1	18657397
frequency	O	-1	18657397
b@@	O	-1	18657397
and@@	O	-1	18657397
s	O	-1	18657397
including	O	-1	18657397
del@@	O	-1	18657397
t@@	O	-1	18657397
a,	O	-1	18657397
the@@	O	-1	18657397
t@@	O	-1	18657397
a	O	-1	18657397
(@@	O	-1	18657397
s@@	O	-1	18657397
low	O	-1	18657397
and	O	-1	18657397
f@@	O	-1	18657397
ast@@	O	-1	18657397
),	O	-1	18657397
alpha-@@	O	-1	18657397
si@@	O	-1	18657397
g@@	O	-1	18657397
ma@@	O	-1	18657397
,	O	-1	18657397
bet@@	O	-1	18657397
a	O	-1	18657397
(@@	O	-1	18657397
1	O	-1	18657397
and	O	-1	18657397
2)	O	-1	18657397
and	O	-1	18657397
gam@@	O	-1	18657397
ma	O	-1	18657397
(@@	O	-1	18657397
1	O	-1	18657397
and	O	-1	18657397
2)	O	-1	18657397
b@@	O	-1	18657397
and@@	O	-1	18657397
s.	O	-1	18657397
Our	O	-1	18657397
results	O	-1	18657397
show	O	-1	18657397
that	O	-1	18657397
the	O	-1	18657397
most	O	-1	18657397
affected	O	-1	18657397
frequency	O	-1	18657397
b@@	O	-1	18657397
and@@	O	-1	18657397
s	O	-1	18657397
were	O	-1	18657397
del@@	O	-1	18657397
t@@	O	-1	18657397
a,	O	-1	18657397
the@@	O	-1	18657397
t@@	O	-1	18657397
a,	O	-1	18657397
beta-@@	O	-1	18657397
2	O	-1	18657397
and	O	-1	18657397
gamma@@	O	-1	18657397
-@@	O	-1	18657397
2	O	-1	18657397
b@@	O	-1	18657397
and@@	O	-1	18657397
s	O	-1	18657397
during	O	-1	18657397
the	O	-1	18657397
epilep@@	B-Disease	D004827	18657397
ti@@	I-Disease	-1	18657397
form	I-Disease	-1	18657397
activity	I-Disease	-1	18657397
and	O	-1	18657397
there	O	-1	18657397
were	O	-1	18657397
mark@@	O	-1	18657397
ed	O	-1	18657397
differences	O	-1	18657397
in	O	-1	18657397
ter@@	O	-1	18657397
ms	O	-1	18657397
of	O	-1	18657397
sp@@	O	-1	18657397
ect@@	O	-1	18657397
ral	O	-1	18657397
d@@	O	-1	18657397
en@@	O	-1	18657397
si@@	O	-1	18657397
ties	O	-1	18657397
between	O	-1	18657397
three	O	-1	18657397
investigated	O	-1	18657397
episo@@	O	-1	18657397
des	O	-1	18657397
(@@	O	-1	18657397
bas@@	O	-1	18657397
al	O	-1	18657397
activ@@	O	-1	18657397
ity,	O	-1	18657397
lat@@	O	-1	18657397
ent	O	-1	18657397
period	O	-1	18657397
and	O	-1	18657397
epilep@@	B-Disease	D004827	18657397
ti@@	I-Disease	-1	18657397
form	I-Disease	-1	18657397
activity	I-Disease	-1	18657397
).	O	-1	18657397
Our	O	-1	18657397
results	O	-1	18657397
may	O	-1	18657397
he@@	O	-1	18657397
l@@	O	-1	18657397
p	O	-1	18657397
to	O	-1	18657397
analy@@	O	-1	18657397
ze	O	-1	18657397
novel	O	-1	18657397
data	O	-1	18657397
obtained	O	-1	18657397
using	O	-1	18657397
similar	O	-1	18657397
experimental	O	-1	18657397
models	O	-1	18657397
and	O	-1	18657397
the	O	-1	18657397
sim@@	O	-1	18657397
ple	O	-1	18657397
analysis	O	-1	18657397
meth@@	O	-1	18657397
od	O	-1	18657397
descri@@	O	-1	18657397
bed	O	-1	18657397
h@@	O	-1	18657397
ere	O	-1	18657397
can	O	-1	18657397
be	O	-1	18657397
used	O	-1	18657397
in	O	-1	18657397
similar	O	-1	18657397
studies	O	-1	18657397
to	O	-1	18657397
investigate	O	-1	18657397
the	O	-1	18657397
b@@	O	-1	18657397
a@@	O	-1	18657397
sic	O	-1	18657397
neuron@@	O	-1	18657397
al	O	-1	18657397
mechanism	O	-1	18657397
of	O	-1	18657397
this	O	-1	18657397
or	O	-1	18657397
other	O	-1	18657397
typ@@	O	-1	18657397
es	O	-1	18657397
of	O	-1	18657397
experimental	O	-1	18657397
epilep@@	B-Disease	D004827	18657397
si@@	I-Disease	-1	18657397
es	I-Disease	-1	18657397
.	O	-1	18657397

H@@	O	-1	18363626
i@@	O	-1	18363626
gh	O	-1	18363626
dose	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
as	O	-1	18363626
the	O	-1	18363626
sol@@	O	-1	18363626
e	O	-1	18363626
sed@@	O	-1	18363626
ative	O	-1	18363626
for	O	-1	18363626
pe@@	O	-1	18363626
di@@	O	-1	18363626
atric	O	-1	18363626
MR@@	O	-1	18363626
I@@	O	-1	18363626
.	O	-1	18363626
OBJECTIVE:	O	-1	18363626
This	O	-1	18363626
larg@@	O	-1	18363626
e-@@	O	-1	18363626
s@@	O	-1	18363626
cal@@	O	-1	18363626
e	O	-1	18363626
ret@@	O	-1	18363626
ro@@	O	-1	18363626
sp@@	O	-1	18363626
ective	O	-1	18363626
revie@@	O	-1	18363626
w	O	-1	18363626
evalu@@	O	-1	18363626
ates	O	-1	18363626
the	O	-1	18363626
sed@@	O	-1	18363626
ation	O	-1	18363626
prof@@	O	-1	18363626
ile	O	-1	18363626
of	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
.	O	-1	18363626
A@@	O	-1	18363626
I@@	O	-1	18363626
M@@	O	-1	18363626
:	O	-1	18363626
To	O	-1	18363626
determine	O	-1	18363626
the	O	-1	18363626
hemo@@	O	-1	18363626
dynam@@	O	-1	18363626
ic	O	-1	18363626
respon@@	O	-1	18363626
s@@	O	-1	18363626
es,	O	-1	18363626
efficacy	O	-1	18363626
and	O	-1	18363626
adverse	O	-1	18363626
events	O	-1	18363626
associated	O	-1	18363626
with	O	-1	18363626
the	O	-1	18363626
use	O	-1	18363626
of	O	-1	18363626
high	O	-1	18363626
dose	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
as	O	-1	18363626
the	O	-1	18363626
sol@@	O	-1	18363626
e	O	-1	18363626
sed@@	O	-1	18363626
ative	O	-1	18363626
for	O	-1	18363626
mag@@	O	-1	18363626
ne@@	O	-1	18363626
tic	O	-1	18363626
res@@	O	-1	18363626
on@@	O	-1	18363626
ance	O	-1	18363626
imaging	O	-1	18363626
(@@	O	-1	18363626
MR@@	O	-1	18363626
I@@	O	-1	18363626
)	O	-1	18363626
studi@@	O	-1	18363626
es.	O	-1	18363626
BACKGROUND:	O	-1	18363626
D@@	B-Chemical	D020927	18363626
ex@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
has	O	-1	18363626
been	O	-1	18363626
used	O	-1	18363626
at	O	-1	18363626
our	O	-1	18363626
insti@@	O	-1	18363626
tu@@	O	-1	18363626
tion	O	-1	18363626
s@@	O	-1	18363626
inc@@	O	-1	18363626
e	O	-1	18363626
20@@	O	-1	18363626
0@@	O	-1	18363626
5	O	-1	18363626
to	O	-1	18363626
prov@@	O	-1	18363626
ide	O	-1	18363626
sed@@	O	-1	18363626
ation	O	-1	18363626
for	O	-1	18363626
pe@@	O	-1	18363626
di@@	O	-1	18363626
atric	O	-1	18363626
radi@@	O	-1	18363626
ological	O	-1	18363626
imaging	O	-1	18363626
studi@@	O	-1	18363626
es.	O	-1	18363626
O@@	O	-1	18363626
ver	O	-1	18363626
ti@@	O	-1	18363626
me,	O	-1	18363626
an	O	-1	18363626
effective	O	-1	18363626
pro@@	O	-1	18363626
to@@	O	-1	18363626
co@@	O	-1	18363626
l	O	-1	18363626
u@@	O	-1	18363626
ti@@	O	-1	18363626
li@@	O	-1	18363626
z@@	O	-1	18363626
ing	O	-1	18363626
high	O	-1	18363626
dose	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
as	O	-1	18363626
the	O	-1	18363626
sol@@	O	-1	18363626
e	O	-1	18363626
sed@@	O	-1	18363626
ative	O	-1	18363626
agent	O	-1	18363626
has	O	-1	18363626
ev@@	O	-1	18363626
ol@@	O	-1	18363626
ved.	O	-1	18363626
METHOD@@	O	-1	18363626
S@@	O	-1	18363626
/@@	O	-1	18363626
M@@	O	-1	18363626
AT@@	O	-1	18363626
E@@	O	-1	18363626
R@@	O	-1	18363626
I@@	O	-1	18363626
AL@@	O	-1	18363626
S:	O	-1	18363626
A@@	O	-1	18363626
s	O	-1	18363626
par@@	O	-1	18363626
t	O	-1	18363626
of	O	-1	18363626
the	O	-1	18363626
on@@	O	-1	18363626
go@@	O	-1	18363626
ing	O	-1	18363626
Q@@	O	-1	18363626
u@@	O	-1	18363626
ality	O	-1	18363626
A@@	O	-1	18363626
s@@	O	-1	18363626
sur@@	O	-1	18363626
ance	O	-1	18363626
pro@@	O	-1	18363626
ces@@	O	-1	18363626
s,	O	-1	18363626
data	O	-1	18363626
on	O	-1	18363626
all	O	-1	18363626
sed@@	O	-1	18363626
ations	O	-1	18363626
are	O	-1	18363626
revie@@	O	-1	18363626
w@@	O	-1	18363626
ed	O	-1	18363626
month@@	O	-1	18363626
ly	O	-1	18363626
and	O	-1	18363626
pro@@	O	-1	18363626
to@@	O	-1	18363626
co@@	O	-1	18363626
l@@	O	-1	18363626
s	O	-1	18363626
mo@@	O	-1	18363626
di@@	O	-1	18363626
fied	O	-1	18363626
as	O	-1	18363626
ne@@	O	-1	18363626
e@@	O	-1	18363626
de@@	O	-1	18363626
d.	O	-1	18363626
D@@	O	-1	18363626
at@@	O	-1	18363626
a	O	-1	18363626
were	O	-1	18363626
analy@@	O	-1	18363626
zed	O	-1	18363626
from	O	-1	18363626
all	O	-1	18363626
7@@	O	-1	18363626
4@@	O	-1	18363626
7	O	-1	18363626
con@@	O	-1	18363626
sec@@	O	-1	18363626
utive	O	-1	18363626
patients	O	-1	18363626
who	O	-1	18363626
received	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
for	O	-1	18363626
MR@@	O	-1	18363626
I	O	-1	18363626
sed@@	O	-1	18363626
ation	O	-1	18363626
from	O	-1	18363626
A@@	O	-1	18363626
pri@@	O	-1	18363626
l	O	-1	18363626
20@@	O	-1	18363626
0@@	O	-1	18363626
5	O	-1	18363626
to	O	-1	18363626
A@@	O	-1	18363626
pri@@	O	-1	18363626
l	O	-1	18363626
20@@	O	-1	18363626
0@@	O	-1	18363626
7@@	O	-1	18363626
.	O	-1	18363626
RESULTS:	O	-1	18363626
S@@	O	-1	18363626
inc@@	O	-1	18363626
e	O	-1	18363626
20@@	O	-1	18363626
0@@	O	-1	18363626
5,	O	-1	18363626
the	O	-1	18363626
10-@@	O	-1	18363626
min	O	-1	18363626
lo@@	O	-1	18363626
ad@@	O	-1	18363626
ing	O	-1	18363626
dose	O	-1	18363626
of	O	-1	18363626
our	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
pro@@	O	-1	18363626
to@@	O	-1	18363626
co@@	O	-1	18363626
l	O	-1	18363626
increased	O	-1	18363626
from	O	-1	18363626
2	O	-1	18363626
to	O	-1	18363626
3	O	-1	18363626
micro@@	O	-1	18363626
g@@	O	-1	18363626
.@@	O	-1	18363626
kg@@	O	-1	18363626
(@@	O	-1	18363626
-1@@	O	-1	18363626
),	O	-1	18363626
and	O	-1	18363626
the	O	-1	18363626
infusion	O	-1	18363626
rate	O	-1	18363626
increased	O	-1	18363626
from	O	-1	18363626
1	O	-1	18363626
to	O	-1	18363626
1.@@	O	-1	18363626
5	O	-1	18363626
to	O	-1	18363626
2	O	-1	18363626
micro@@	O	-1	18363626
g@@	O	-1	18363626
.@@	O	-1	18363626
kg@@	O	-1	18363626
(@@	O	-1	18363626
-1@@	O	-1	18363626
)@@	O	-1	18363626
.@@	O	-1	18363626
h@@	O	-1	18363626
(@@	O	-1	18363626
-1@@	O	-1	18363626
).	O	-1	18363626
The	O	-1	18363626
current	O	-1	18363626
sed@@	O	-1	18363626
ation	O	-1	18363626
pro@@	O	-1	18363626
to@@	O	-1	18363626
co@@	O	-1	18363626
l	O	-1	18363626
progres@@	O	-1	18363626
si@@	O	-1	18363626
vely	O	-1	18363626
increased	O	-1	18363626
the	O	-1	18363626
rate	O	-1	18363626
of	O	-1	18363626
suc@@	O	-1	18363626
cess@@	O	-1	18363626
ful	O	-1	18363626
sed@@	O	-1	18363626
ation	O	-1	18363626
(@@	O	-1	18363626
able	O	-1	18363626
to	O	-1	18363626
complete	O	-1	18363626
the	O	-1	18363626
imaging	O	-1	18363626
stud@@	O	-1	18363626
y@@	O	-1	18363626
)	O	-1	18363626
when	O	-1	18363626
using	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
alone	O	-1	18363626
from	O	-1	18363626
9@@	O	-1	18363626
1.@@	O	-1	18363626
8@@	O	-1	18363626
%	O	-1	18363626
to	O	-1	18363626
9@@	O	-1	18363626
7.@@	O	-1	18363626
6%	O	-1	18363626
(P	O	-1	18363626
=	O	-1	18363626
0.00@@	O	-1	18363626
9@@	O	-1	18363626
),	O	-1	18363626
reduc@@	O	-1	18363626
ing	O	-1	18363626
the	O	-1	18363626
requ@@	O	-1	18363626
i@@	O	-1	18363626
re@@	O	-1	18363626
ment	O	-1	18363626
for	O	-1	18363626
adj@@	O	-1	18363626
u@@	O	-1	18363626
v@@	O	-1	18363626
ant	O	-1	18363626
pent@@	B-Chemical	D010424	18363626
obarbit@@	I-Chemical	-1	18363626
al	I-Chemical	-1	18363626
in	O	-1	18363626
the	O	-1	18363626
ev@@	O	-1	18363626
ent	O	-1	18363626
of	O	-1	18363626
sed@@	O	-1	18363626
ation	O	-1	18363626
failure	O	-1	18363626
with	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
alone	O	-1	18363626
and	O	-1	18363626
decreased	O	-1	18363626
the	O	-1	18363626
mean	O	-1	18363626
recovery	O	-1	18363626
time	O	-1	18363626
by	O	-1	18363626
10	O	-1	18363626
min	O	-1	18363626
(P	O	-1	18363626
<	O	-1	18363626
0.00@@	O	-1	18363626
1).	O	-1	18363626
Although	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
sed@@	O	-1	18363626
ation	O	-1	18363626
was	O	-1	18363626
associated	O	-1	18363626
with	O	-1	18363626
a	O	-1	18363626
1@@	O	-1	18363626
6%	O	-1	18363626
incidence	O	-1	18363626
of	O	-1	18363626
brady@@	B-Disease	D001919	18363626
cardia	I-Disease	-1	18363626
,	O	-1	18363626
all	O	-1	18363626
concomit@@	O	-1	18363626
ant	O	-1	18363626
mean	O	-1	18363626
arterial	O	-1	18363626
blood	O	-1	18363626
pressu@@	O	-1	18363626
res	O	-1	18363626
were	O	-1	18363626
within	O	-1	18363626
20@@	O	-1	18363626
%	O	-1	18363626
of	O	-1	18363626
ag@@	O	-1	18363626
e-@@	O	-1	18363626
adjust@@	O	-1	18363626
ed	O	-1	18363626
normal	O	-1	18363626
range	O	-1	18363626
and	O	-1	18363626
oxy@@	B-Chemical	D010100	18363626
gen	I-Chemical	-1	18363626
s@@	O	-1	18363626
at@@	O	-1	18363626
ur@@	O	-1	18363626
ations	O	-1	18363626
were	O	-1	18363626
95%	O	-1	18363626
or	O	-1	18363626
high@@	O	-1	18363626
er.	O	-1	18363626
CONCLUSION:	O	-1	18363626
D@@	B-Chemical	D020927	18363626
ex@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
in	O	-1	18363626
high	O	-1	18363626
doses	O	-1	18363626
pro@@	O	-1	18363626
vi@@	O	-1	18363626
des	O	-1	18363626
ade@@	O	-1	18363626
qu@@	O	-1	18363626
ate	O	-1	18363626
sed@@	O	-1	18363626
ation	O	-1	18363626
for	O	-1	18363626
pe@@	O	-1	18363626
di@@	O	-1	18363626
atric	O	-1	18363626
MR@@	O	-1	18363626
I	O	-1	18363626
studi@@	O	-1	18363626
es.	O	-1	18363626
W@@	O	-1	18363626
h@@	O	-1	18363626
ile	O	-1	18363626
use	O	-1	18363626
of	O	-1	18363626
high	O	-1	18363626
dose	O	-1	18363626
de@@	B-Chemical	D020927	18363626
x@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
is	O	-1	18363626
associated	O	-1	18363626
with	O	-1	18363626
decreas@@	O	-1	18363626
es	O	-1	18363626
in	O	-1	18363626
heart	O	-1	18363626
rate	O	-1	18363626
and	O	-1	18363626
blood	O	-1	18363626
pressure	O	-1	18363626
out@@	O	-1	18363626
side	O	-1	18363626
the	O	-1	18363626
est@@	O	-1	18363626
abl@@	O	-1	18363626
ished	O	-1	18363626
'@@	O	-1	18363626
aw@@	O	-1	18363626
ak@@	O	-1	18363626
e@@	O	-1	18363626
'	O	-1	18363626
norm@@	O	-1	18363626
s,	O	-1	18363626
this	O	-1	18363626
de@@	O	-1	18363626
vi@@	O	-1	18363626
ation	O	-1	18363626
is	O	-1	18363626
gener@@	O	-1	18363626
ally	O	-1	18363626
within	O	-1	18363626
20@@	O	-1	18363626
%	O	-1	18363626
of	O	-1	18363626
norm@@	O	-1	18363626
s,	O	-1	18363626
and	O	-1	18363626
is	O	-1	18363626
not	O	-1	18363626
associated	O	-1	18363626
with	O	-1	18363626
adverse	O	-1	18363626
sequ@@	O	-1	18363626
el@@	O	-1	18363626
a@@	O	-1	18363626
e.	O	-1	18363626
D@@	B-Chemical	D020927	18363626
ex@@	I-Chemical	-1	18363626
me@@	I-Chemical	-1	18363626
de@@	I-Chemical	-1	18363626
to@@	I-Chemical	-1	18363626
m@@	I-Chemical	-1	18363626
idine	I-Chemical	-1	18363626
is	O	-1	18363626
use@@	O	-1	18363626
ful	O	-1	18363626
as	O	-1	18363626
the	O	-1	18363626
sol@@	O	-1	18363626
e	O	-1	18363626
sed@@	O	-1	18363626
ative	O	-1	18363626
for	O	-1	18363626
pe@@	O	-1	18363626
di@@	O	-1	18363626
atric	O	-1	18363626
MR@@	O	-1	18363626
I@@	O	-1	18363626
.	O	-1	18363626

M@@	B-Chemical	D008694	16192988
eth@@	I-Chemical	-1	16192988
amphetamine	I-Chemical	-1	16192988
causes	O	-1	16192988
al@@	O	-1	16192988
ter@@	O	-1	16192988
ations	O	-1	16192988
in	O	-1	16192988
the	O	-1	16192988
MA@@	O	-1	16192988
P	O	-1	16192988
kin@@	O	-1	16192988
as@@	O	-1	16192988
e-@@	O	-1	16192988
related	O	-1	16192988
path@@	O	-1	16192988
w@@	O	-1	16192988
ays	O	-1	16192988
in	O	-1	16192988
the	O	-1	16192988
bra@@	O	-1	16192988
ins	O	-1	16192988
of	O	-1	16192988
mice	O	-1	16192988
that	O	-1	16192988
dis@@	O	-1	16192988
pl@@	O	-1	16192988
ay	O	-1	16192988
increased	O	-1	16192988
ag@@	B-Disease	D001523	16192988
gres@@	I-Disease	-1	16192988
si@@	I-Disease	-1	16192988
ven@@	I-Disease	-1	16192988
ess	I-Disease	-1	16192988
.	O	-1	16192988
A@@	B-Disease	D001523	16192988
g@@	I-Disease	-1	16192988
gres@@	I-Disease	-1	16192988
sive	I-Disease	-1	16192988
behavi@@	I-Disease	-1	16192988
ors	I-Disease	-1	16192988
have	O	-1	16192988
been	O	-1	16192988
reported	O	-1	16192988
in	O	-1	16192988
patients	O	-1	16192988
who	O	-1	16192988
suff@@	O	-1	16192988
er	O	-1	16192988
from	O	-1	16192988
some	O	-1	16192988
psych@@	B-Disease	D001523	16192988
i@@	I-Disease	-1	16192988
atric	I-Disease	-1	16192988
disorder@@	I-Disease	-1	16192988
s	I-Disease	-1	16192988
,	O	-1	16192988
and	O	-1	16192988
are	O	-1	16192988
common	O	-1	16192988
in	O	-1	16192988
meth@@	B-Chemical	D008694	16192988
amphetamine	I-Chemical	-1	16192988
(	O	-1	16192988
MET@@	B-Chemical	D008694	16192988
H	I-Chemical	-1	16192988
)	O	-1	16192988
ab@@	O	-1	16192988
us@@	O	-1	16192988
ers.	O	-1	16192988
He@@	O	-1	16192988
re@@	O	-1	16192988
in,	O	-1	16192988
we	O	-1	16192988
report	O	-1	16192988
that	O	-1	16192988
multiple	O	-1	16192988
(@@	O	-1	16192988
but	O	-1	16192988
not	O	-1	16192988
sing@@	O	-1	16192988
le@@	O	-1	16192988
)	O	-1	16192988
injec@@	O	-1	16192988
tions	O	-1	16192988
of	O	-1	16192988
MET@@	B-Chemical	D008694	16192988
H	I-Chemical	-1	16192988
significantly	O	-1	16192988
increased	O	-1	16192988
ag@@	B-Disease	D001523	16192988
gres@@	I-Disease	-1	16192988
si@@	I-Disease	-1	16192988
ven@@	I-Disease	-1	16192988
ess	I-Disease	-1	16192988
in	O	-1	16192988
male	O	-1	16192988
C@@	O	-1	16192988
D@@	O	-1	16192988
-1	O	-1	16192988
mice.	O	-1	16192988
This	O	-1	16192988
increase	O	-1	16192988
in	O	-1	16192988
ag@@	B-Disease	D001523	16192988
gres@@	I-Disease	-1	16192988
si@@	I-Disease	-1	16192988
ven@@	I-Disease	-1	16192988
ess	I-Disease	-1	16192988
was	O	-1	16192988
not	O	-1	16192988
secondary	O	-1	16192988
to	O	-1	16192988
MET@@	B-Chemical	D008694	16192988
H	I-Chemical	-1	16192988
-induced	O	-1	16192988
hyperactivity	B-Disease	D006948	16192988
.	O	-1	16192988
An@@	O	-1	16192988
aly@@	O	-1	16192988
sis	O	-1	16192988
of	O	-1	16192988
protein	O	-1	16192988
expression	O	-1	16192988
using	O	-1	16192988
anti@@	O	-1	16192988
body	O	-1	16192988
micro@@	O	-1	16192988
ar@@	O	-1	16192988
ra@@	O	-1	16192988
ys	O	-1	16192988
and	O	-1	16192988
W@@	O	-1	16192988
est@@	O	-1	16192988
er@@	O	-1	16192988
n	O	-1	16192988
blo@@	O	-1	16192988
t@@	O	-1	16192988
ting	O	-1	16192988
revealed	O	-1	16192988
differen@@	O	-1	16192988
tial	O	-1	16192988
changes	O	-1	16192988
in	O	-1	16192988
MA@@	O	-1	16192988
P	O	-1	16192988
kin@@	O	-1	16192988
as@@	O	-1	16192988
e-@@	O	-1	16192988
related	O	-1	16192988
path@@	O	-1	16192988
w@@	O	-1	16192988
ays	O	-1	16192988
after	O	-1	16192988
multiple	O	-1	16192988
and	O	-1	16192988
single	O	-1	16192988
MET@@	B-Chemical	D008694	16192988
H	I-Chemical	-1	16192988
injec@@	O	-1	16192988
tions.	O	-1	16192988
There	O	-1	16192988
were	O	-1	16192988
statis@@	O	-1	16192988
tically	O	-1	16192988
significant	O	-1	16192988
(p@@	O	-1	16192988
<@@	O	-1	16192988
0.05@@	O	-1	16192988
)	O	-1	16192988
decreas@@	O	-1	16192988
es	O	-1	16192988
in	O	-1	16192988
M@@	O	-1	16192988
E@@	O	-1	16192988
K@@	O	-1	16192988
1,	O	-1	16192988
E@@	O	-1	16192988
r@@	O	-1	16192988
k@@	O	-1	16192988
2@@	O	-1	16192988
p@@	O	-1	16192988
,	O	-1	16192988
G@@	O	-1	16192988
S@@	O	-1	16192988
K@@	O	-1	16192988
3@@	O	-1	16192988
alpha@@	O	-1	16192988
,	O	-1	16192988
1@@	O	-1	16192988
4-@@	O	-1	16192988
3-@@	O	-1	16192988
3@@	O	-1	16192988
e,	O	-1	16192988
and	O	-1	16192988
M@@	O	-1	16192988
E@@	O	-1	16192988
K@@	O	-1	16192988
7	O	-1	16192988
in	O	-1	16192988
the	O	-1	16192988
striat@@	O	-1	16192988
a	O	-1	16192988
of	O	-1	16192988
mice	O	-1	16192988
after	O	-1	16192988
multiple	O	-1	16192988
injec@@	O	-1	16192988
tions	O	-1	16192988
of	O	-1	16192988
MET@@	B-Chemical	D008694	16192988
H	I-Chemical	-1	16192988
.	O	-1	16192988
M@@	O	-1	16192988
E@@	O	-1	16192988
K@@	O	-1	16192988
1	O	-1	16192988
was	O	-1	16192988
significantly	O	-1	16192988
decreased	O	-1	16192988
also	O	-1	16192988
after	O	-1	16192988
a	O	-1	16192988
single	O	-1	16192988
injection	O	-1	16192988
of	O	-1	16192988
MET@@	B-Chemical	D008694	16192988
H	I-Chemical	-1	16192988
,	O	-1	16192988
but	O	-1	16192988
to	O	-1	16192988
a	O	-1	16192988
m@@	O	-1	16192988
uc@@	O	-1	16192988
h	O	-1	16192988
l@@	O	-1	16192988
ess@@	O	-1	16192988
er	O	-1	16192988
de@@	O	-1	16192988
g@@	O	-1	16192988
ree	O	-1	16192988
than	O	-1	16192988
after	O	-1	16192988
multiple	O	-1	16192988
injec@@	O	-1	16192988
tions	O	-1	16192988
of	O	-1	16192988
MET@@	B-Chemical	D008694	16192988
H	I-Chemical	-1	16192988
.	O	-1	16192988
In	O	-1	16192988
the	O	-1	16192988
fron@@	O	-1	16192988
t@@	O	-1	16192988
al	O	-1	16192988
cor@@	O	-1	16192988
t@@	O	-1	16192988
ex@@	O	-1	16192988
,	O	-1	16192988
there	O	-1	16192988
was	O	-1	16192988
a	O	-1	16192988
statis@@	O	-1	16192988
tically	O	-1	16192988
significant	O	-1	16192988
decrease	O	-1	16192988
in	O	-1	16192988
G@@	O	-1	16192988
S@@	O	-1	16192988
K@@	O	-1	16192988
3@@	O	-1	16192988
al@@	O	-1	16192988
ph@@	O	-1	16192988
a	O	-1	16192988
after	O	-1	16192988
multiple	O	-1	16192988
(@@	O	-1	16192988
but	O	-1	16192988
not	O	-1	16192988
sing@@	O	-1	16192988
le@@	O	-1	16192988
)	O	-1	16192988
injec@@	O	-1	16192988
tions	O	-1	16192988
of	O	-1	16192988
MET@@	B-Chemical	D008694	16192988
H	I-Chemical	-1	16192988
.	O	-1	16192988
These	O	-1	16192988
findings	O	-1	16192988
suggest	O	-1	16192988
that	O	-1	16192988
al@@	O	-1	16192988
ter@@	O	-1	16192988
ations	O	-1	16192988
in	O	-1	16192988
MA@@	O	-1	16192988
P	O	-1	16192988
kin@@	O	-1	16192988
as@@	O	-1	16192988
e-@@	O	-1	16192988
related	O	-1	16192988
path@@	O	-1	16192988
w@@	O	-1	16192988
ays	O	-1	16192988
in	O	-1	16192988
the	O	-1	16192988
pre@@	O	-1	16192988
fron@@	O	-1	16192988
to@@	O	-1	16192988
-@@	O	-1	16192988
stri@@	O	-1	16192988
atal	O	-1	16192988
cir@@	O	-1	16192988
c@@	O	-1	16192988
u@@	O	-1	16192988
it@@	O	-1	16192988
ri@@	O	-1	16192988
es	O	-1	16192988
might	O	-1	16192988
be	O	-1	16192988
involved	O	-1	16192988
in	O	-1	16192988
the	O	-1	16192988
man@@	O	-1	16192988
if@@	O	-1	16192988
est@@	O	-1	16192988
ation	O	-1	16192988
of	O	-1	16192988
ag@@	B-Disease	D001523	16192988
gres@@	I-Disease	-1	16192988
sive	I-Disease	-1	16192988
behavi@@	I-Disease	-1	16192988
ors	I-Disease	-1	16192988
in	O	-1	16192988
mice.	O	-1	16192988

L@@	B-Chemical	C047781	16157917
am@@	I-Chemical	-1	16157917
ot@@	I-Chemical	-1	16157917
rig@@	I-Chemical	-1	16157917
ine	I-Chemical	-1	16157917
associated	O	-1	16157917
with	O	-1	16157917
ex@@	O	-1	16157917
ac@@	O	-1	16157917
er@@	O	-1	16157917
b@@	O	-1	16157917
ation	O	-1	16157917
or	O	-1	16157917
de	O	-1	16157917
no@@	O	-1	16157917
v@@	O	-1	16157917
o	O	-1	16157917
my@@	B-Disease	D009207	16157917
oc@@	I-Disease	-1	16157917
lon@@	I-Disease	-1	16157917
us	I-Disease	-1	16157917
in	O	-1	16157917
i@@	B-Disease	C562694	16157917
di@@	I-Disease	-1	16157917
o@@	I-Disease	-1	16157917
path@@	I-Disease	-1	16157917
ic	I-Disease	-1	16157917
gener@@	I-Disease	-1	16157917
al@@	I-Disease	-1	16157917
ized	I-Disease	-1	16157917
epilep@@	I-Disease	-1	16157917
si@@	I-Disease	-1	16157917
es	I-Disease	-1	16157917
.	O	-1	16157917
F@@	O	-1	16157917
i@@	O	-1	16157917
ve	O	-1	16157917
patients	O	-1	16157917
with	O	-1	16157917
i@@	B-Disease	C562694	16157917
di@@	I-Disease	-1	16157917
o@@	I-Disease	-1	16157917
path@@	I-Disease	-1	16157917
ic	I-Disease	-1	16157917
gener@@	I-Disease	-1	16157917
al@@	I-Disease	-1	16157917
ized	I-Disease	-1	16157917
epilep@@	I-Disease	-1	16157917
si@@	I-Disease	-1	16157917
es	I-Disease	-1	16157917
(	O	-1	16157917
I@@	B-Disease	C562694	16157917
G@@	I-Disease	-1	16157917
E	I-Disease	-1	16157917
)	O	-1	16157917
treated	O	-1	16157917
with	O	-1	16157917
lam@@	B-Chemical	C047781	16157917
ot@@	I-Chemical	-1	16157917
rig@@	I-Chemical	-1	16157917
ine	I-Chemical	-1	16157917
(	O	-1	16157917
LT@@	B-Chemical	C047781	16157917
G	I-Chemical	-1	16157917
)	O	-1	16157917
experienced	O	-1	16157917
ex@@	O	-1	16157917
ac@@	O	-1	16157917
er@@	O	-1	16157917
b@@	O	-1	16157917
ation	O	-1	16157917
or	O	-1	16157917
de	O	-1	16157917
no@@	O	-1	16157917
v@@	O	-1	16157917
o	O	-1	16157917
appear@@	O	-1	16157917
ance	O	-1	16157917
of	O	-1	16157917
my@@	B-Disease	D009207	16157917
oc@@	I-Disease	-1	16157917
lon@@	I-Disease	-1	16157917
ic	I-Disease	-1	16157917
j@@	I-Disease	-1	16157917
er@@	I-Disease	-1	16157917
k@@	I-Disease	-1	16157917
s	I-Disease	-1	16157917
(	O	-1	16157917
M@@	B-Disease	D009207	16157917
J	I-Disease	-1	16157917
).	O	-1	16157917
In	O	-1	16157917
three	O	-1	16157917
patients,	O	-1	16157917
LT@@	B-Chemical	C047781	16157917
G	I-Chemical	-1	16157917
ex@@	O	-1	16157917
ac@@	O	-1	16157917
er@@	O	-1	16157917
b@@	O	-1	16157917
ated	O	-1	16157917
M@@	B-Disease	D009207	16157917
J	I-Disease	-1	16157917
in	O	-1	16157917
a	O	-1	16157917
dose-@@	O	-1	16157917
dependent	O	-1	16157917
man@@	O	-1	16157917
n@@	O	-1	16157917
er	O	-1	16157917
with	O	-1	16157917
early	O	-1	16157917
ag@@	O	-1	16157917
gra@@	O	-1	16157917
v@@	O	-1	16157917
ation	O	-1	16157917
during	O	-1	16157917
ti@@	O	-1	16157917
tr@@	O	-1	16157917
ation.	O	-1	16157917
M@@	B-Disease	D009207	16157917
J	I-Disease	-1	16157917
dis@@	O	-1	16157917
appe@@	O	-1	16157917
a@@	O	-1	16157917
red	O	-1	16157917
when	O	-1	16157917
LT@@	B-Chemical	C047781	16157917
G	I-Chemical	-1	16157917
dose	O	-1	16157917
was	O	-1	16157917
decreased	O	-1	16157917
by	O	-1	16157917
25	O	-1	16157917
to	O	-1	16157917
50@@	O	-1	16157917
%.	O	-1	16157917
In	O	-1	16157917
two	O	-1	16157917
patients,	O	-1	16157917
LT@@	B-Chemical	C047781	16157917
G	I-Chemical	-1	16157917
ex@@	O	-1	16157917
ac@@	O	-1	16157917
er@@	O	-1	16157917
b@@	O	-1	16157917
ated	O	-1	16157917
M@@	B-Disease	D009207	16157917
J	I-Disease	-1	16157917
in	O	-1	16157917
a	O	-1	16157917
del@@	O	-1	16157917
ayed	O	-1	16157917
but	O	-1	16157917
more	O	-1	16157917
severe	O	-1	16157917
man@@	O	-1	16157917
ner@@	O	-1	16157917
,	O	-1	16157917
with	O	-1	16157917
my@@	B-Disease	D009207	16157917
oc@@	I-Disease	-1	16157917
lon@@	I-Disease	-1	16157917
ic	I-Disease	-1	16157917
status	I-Disease	-1	16157917
that	O	-1	16157917
only	O	-1	16157917
ce@@	O	-1	16157917
as@@	O	-1	16157917
ed	O	-1	16157917
after	O	-1	16157917
LT@@	B-Chemical	C047781	16157917
G	I-Chemical	-1	16157917
withdraw@@	O	-1	16157917
al.	O	-1	16157917

r@@	O	-1	16116131
T@@	O	-1	16116131
M@@	O	-1	16116131
S	O	-1	16116131
of	O	-1	16116131
sup@@	O	-1	16116131
ple@@	O	-1	16116131
ment@@	O	-1	16116131
ary	O	-1	16116131
motor	O	-1	16116131
a@@	O	-1	16116131
re@@	O	-1	16116131
a	O	-1	16116131
mod@@	O	-1	16116131
ul@@	O	-1	16116131
ates	O	-1	16116131
therap@@	O	-1	16116131
y@@	O	-1	16116131
-induced	O	-1	16116131
dyskine@@	B-Disease	D004409	16116131
si@@	I-Disease	-1	16116131
as	I-Disease	-1	16116131
in	O	-1	16116131
Park@@	B-Disease	D010300	16116131
in@@	I-Disease	-1	16116131
s@@	I-Disease	-1	16116131
on	I-Disease	-1	16116131
disease	I-Disease	-1	16116131
.	O	-1	16116131
The	O	-1	16116131
ne@@	O	-1	16116131
ural	O	-1	16116131
mechanisms	O	-1	16116131
and	O	-1	16116131
cir@@	O	-1	16116131
c@@	O	-1	16116131
u@@	O	-1	16116131
it@@	O	-1	16116131
r@@	O	-1	16116131
y	O	-1	16116131
involved	O	-1	16116131
in	O	-1	16116131
levo@@	B-Chemical	D007980	16116131
dopa	I-Chemical	-1	16116131
-induced	O	-1	16116131
dyskine@@	B-Disease	D004409	16116131
sia	I-Disease	-1	16116131
are	O	-1	16116131
unc@@	O	-1	16116131
lear@@	O	-1	16116131
.	O	-1	16116131
U@@	O	-1	16116131
s@@	O	-1	16116131
ing	O	-1	16116131
repe@@	O	-1	16116131
ti@@	O	-1	16116131
tive	O	-1	16116131
trans@@	O	-1	16116131
c@@	O	-1	16116131
ranial	O	-1	16116131
mag@@	O	-1	16116131
ne@@	O	-1	16116131
tic	O	-1	16116131
stimulation	O	-1	16116131
(@@	O	-1	16116131
r@@	O	-1	16116131
T@@	O	-1	16116131
M@@	O	-1	16116131
S)	O	-1	16116131
over	O	-1	16116131
the	O	-1	16116131
sup@@	O	-1	16116131
ple@@	O	-1	16116131
ment@@	O	-1	16116131
ary	O	-1	16116131
motor	O	-1	16116131
a@@	O	-1	16116131
re@@	O	-1	16116131
a	O	-1	16116131
(S@@	O	-1	16116131
MA@@	O	-1	16116131
)	O	-1	16116131
in	O	-1	16116131
a	O	-1	16116131
group	O	-1	16116131
of	O	-1	16116131
patients	O	-1	16116131
with	O	-1	16116131
adv@@	O	-1	16116131
anced	O	-1	16116131
Park@@	B-Disease	D010300	16116131
in@@	I-Disease	-1	16116131
s@@	I-Disease	-1	16116131
on	I-Disease	-1	16116131
disease	I-Disease	-1	16116131
,	O	-1	16116131
the	O	-1	16116131
au@@	O	-1	16116131
th@@	O	-1	16116131
ors	O	-1	16116131
investigated	O	-1	16116131
whether	O	-1	16116131
mod@@	O	-1	16116131
ulation	O	-1	16116131
of	O	-1	16116131
S@@	O	-1	16116131
M@@	O	-1	16116131
A	O	-1	16116131
ex@@	O	-1	16116131
cit@@	O	-1	16116131
ability	O	-1	16116131
may	O	-1	16116131
result	O	-1	16116131
in	O	-1	16116131
a	O	-1	16116131
mo@@	O	-1	16116131
di@@	O	-1	16116131
fic@@	O	-1	16116131
ation	O	-1	16116131
of	O	-1	16116131
a	O	-1	16116131
dyskine@@	B-Disease	D004409	16116131
tic	I-Disease	-1	16116131
state	O	-1	16116131
induced	O	-1	16116131
by	O	-1	16116131
continu@@	O	-1	16116131
ous	O	-1	16116131
apo@@	B-Chemical	D001058	16116131
morphine	I-Chemical	-1	16116131
infu@@	O	-1	16116131
sion.	O	-1	16116131
r@@	O	-1	16116131
T@@	O	-1	16116131
M@@	O	-1	16116131
S	O	-1	16116131
at	O	-1	16116131
1	O	-1	16116131
H@@	O	-1	16116131
z	O	-1	16116131
was	O	-1	16116131
observed	O	-1	16116131
to	O	-1	16116131
mark@@	O	-1	16116131
ed@@	O	-1	16116131
ly	O	-1	16116131
re@@	O	-1	16116131
duce	O	-1	16116131
drug@@	B-Disease	D004409	16116131
-induced	I-Disease	-1	16116131
dyskine@@	I-Disease	-1	16116131
si@@	I-Disease	-1	16116131
as	I-Disease	-1	16116131
,	O	-1	16116131
whereas	O	-1	16116131
5-@@	O	-1	16116131
H@@	O	-1	16116131
z	O	-1	16116131
r@@	O	-1	16116131
T@@	O	-1	16116131
M@@	O	-1	16116131
S	O	-1	16116131
induced	O	-1	16116131
a	O	-1	16116131
s@@	O	-1	16116131
li@@	O	-1	16116131
ght	O	-1	16116131
but	O	-1	16116131
not	O	-1	16116131
significant	O	-1	16116131
increas@@	O	-1	16116131
e.	O	-1	16116131

A@@	O	-1	15930398
s@@	O	-1	15930398
s@@	O	-1	15930398
ess@@	O	-1	15930398
ment	O	-1	15930398
of	O	-1	15930398
the	O	-1	15930398
onset	O	-1	15930398
and	O	-1	15930398
per@@	O	-1	15930398
sist@@	O	-1	15930398
ence	O	-1	15930398
of	O	-1	15930398
am@@	B-Disease	D000647	15930398
ne@@	I-Disease	-1	15930398
sia	I-Disease	-1	15930398
during	O	-1	15930398
proce@@	O	-1	15930398
dur@@	O	-1	15930398
al	O	-1	15930398
sed@@	O	-1	15930398
ation	O	-1	15930398
with	O	-1	15930398
pro@@	B-Chemical	D015742	15930398
po@@	I-Chemical	-1	15930398
f@@	I-Chemical	-1	15930398
ol	I-Chemical	-1	15930398
.	O	-1	15930398
OBJECTIV@@	O	-1	15930398
E@@	O	-1	15930398
S:	O	-1	15930398
To	O	-1	15930398
ass@@	O	-1	15930398
ess	O	-1	15930398
patient@@	O	-1	15930398
s@@	O	-1	15930398
'	O	-1	15930398
ability	O	-1	15930398
to	O	-1	15930398
repe@@	O	-1	15930398
at	O	-1	15930398
and	O	-1	15930398
rec@@	O	-1	15930398
all	O	-1	15930398
wor@@	O	-1	15930398
ds	O	-1	15930398
presented	O	-1	15930398
to	O	-1	15930398
the@@	O	-1	15930398
m	O	-1	15930398
while	O	-1	15930398
under@@	O	-1	15930398
go@@	O	-1	15930398
ing	O	-1	15930398
proce@@	O	-1	15930398
dur@@	O	-1	15930398
al	O	-1	15930398
sed@@	O	-1	15930398
ation	O	-1	15930398
with	O	-1	15930398
pro@@	B-Chemical	D015742	15930398
po@@	I-Chemical	-1	15930398
f@@	I-Chemical	-1	15930398
ol	I-Chemical	-1	15930398
,	O	-1	15930398
and	O	-1	15930398
correl@@	O	-1	15930398
ate	O	-1	15930398
their	O	-1	15930398
rec@@	O	-1	15930398
all	O	-1	15930398
with	O	-1	15930398
their	O	-1	15930398
level	O	-1	15930398
of	O	-1	15930398
aw@@	O	-1	15930398
a@@	O	-1	15930398
ren@@	O	-1	15930398
ess	O	-1	15930398
as	O	-1	15930398
measured	O	-1	15930398
by	O	-1	15930398
b@@	O	-1	15930398
is@@	O	-1	15930398
p@@	O	-1	15930398
ect@@	O	-1	15930398
ral	O	-1	15930398
in@@	O	-1	15930398
de@@	O	-1	15930398
x	O	-1	15930398
(B@@	O	-1	15930398
I@@	O	-1	15930398
S)	O	-1	15930398
monit@@	O	-1	15930398
or@@	O	-1	15930398
ing.	O	-1	15930398
METHODS:	O	-1	15930398
This	O	-1	15930398
was	O	-1	15930398
a	O	-1	15930398
pro@@	O	-1	15930398
sp@@	O	-1	15930398
ecti@@	O	-1	15930398
ve,	O	-1	15930398
sing@@	O	-1	15930398
le@@	O	-1	15930398
-@@	O	-1	15930398
inter@@	O	-1	15930398
ven@@	O	-1	15930398
tion	O	-1	15930398
study	O	-1	15930398
of	O	-1	15930398
con@@	O	-1	15930398
s@@	O	-1	15930398
ent@@	O	-1	15930398
ing	O	-1	15930398
ad@@	O	-1	15930398
ult	O	-1	15930398
patients	O	-1	15930398
under@@	O	-1	15930398
go@@	O	-1	15930398
ing	O	-1	15930398
proce@@	O	-1	15930398
dur@@	O	-1	15930398
al	O	-1	15930398
sed@@	O	-1	15930398
ation	O	-1	15930398
with	O	-1	15930398
pro@@	B-Chemical	D015742	15930398
po@@	I-Chemical	-1	15930398
f@@	I-Chemical	-1	15930398
ol	I-Chemical	-1	15930398
between	O	-1	15930398
D@@	O	-1	15930398
ec@@	O	-1	15930398
emb@@	O	-1	15930398
er	O	-1	15930398
2@@	O	-1	15930398
8@@	O	-1	15930398
,	O	-1	15930398
20@@	O	-1	15930398
0@@	O	-1	15930398
2,	O	-1	15930398
and	O	-1	15930398
O@@	O	-1	15930398
c@@	O	-1	15930398
to@@	O	-1	15930398
b@@	O	-1	15930398
er	O	-1	15930398
3@@	O	-1	15930398
1,	O	-1	15930398
20@@	O	-1	15930398
0@@	O	-1	15930398
3@@	O	-1	15930398
.	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
monit@@	O	-1	15930398
or@@	O	-1	15930398
ing	O	-1	15930398
was	O	-1	15930398
initi@@	O	-1	15930398
ated	O	-1	15930398
star@@	O	-1	15930398
ting	O	-1	15930398
3	O	-1	15930398
minutes	O	-1	15930398
before	O	-1	15930398
the	O	-1	15930398
proce@@	O	-1	15930398
d@@	O	-1	15930398
ure	O	-1	15930398
and	O	-1	15930398
continu@@	O	-1	15930398
ing	O	-1	15930398
un@@	O	-1	15930398
ti@@	O	-1	15930398
l	O	-1	15930398
the	O	-1	15930398
patient	O	-1	15930398
had	O	-1	15930398
reg@@	O	-1	15930398
ained	O	-1	15930398
baseline	O	-1	15930398
mental	O	-1	15930398
stat@@	O	-1	15930398
us.	O	-1	15930398
A@@	O	-1	15930398
t	O	-1	15930398
1-@@	O	-1	15930398
min@@	O	-1	15930398
ute	O	-1	15930398
interv@@	O	-1	15930398
als	O	-1	15930398
during	O	-1	15930398
the	O	-1	15930398
proce@@	O	-1	15930398
dur@@	O	-1	15930398
al	O	-1	15930398
sed@@	O	-1	15930398
ation,	O	-1	15930398
un@@	O	-1	15930398
ti@@	O	-1	15930398
l	O	-1	15930398
the	O	-1	15930398
patient	O	-1	15930398
reg@@	O	-1	15930398
ained	O	-1	15930398
baseline	O	-1	15930398
mental	O	-1	15930398
status	O	-1	15930398
at	O	-1	15930398
the	O	-1	15930398
end	O	-1	15930398
of	O	-1	15930398
the	O	-1	15930398
proce@@	O	-1	15930398
d@@	O	-1	15930398
ure,	O	-1	15930398
a	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
from	O	-1	15930398
a	O	-1	15930398
stand@@	O	-1	15930398
ardi@@	O	-1	15930398
zed	O	-1	15930398
l@@	O	-1	15930398
ist	O	-1	15930398
was	O	-1	15930398
re@@	O	-1	15930398
ad	O	-1	15930398
al@@	O	-1	15930398
ou@@	O	-1	15930398
d,	O	-1	15930398
and	O	-1	15930398
the	O	-1	15930398
patient	O	-1	15930398
was	O	-1	15930398
as@@	O	-1	15930398
ked	O	-1	15930398
to	O	-1	15930398
immedi@@	O	-1	15930398
ately	O	-1	15930398
repe@@	O	-1	15930398
at	O	-1	15930398
the	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
to	O	-1	15930398
the	O	-1	15930398
investig@@	O	-1	15930398
at@@	O	-1	15930398
or@@	O	-1	15930398
.	O	-1	15930398
The	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
scor@@	O	-1	15930398
e	O	-1	15930398
at	O	-1	15930398
the	O	-1	15930398
time	O	-1	15930398
the	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
was	O	-1	15930398
re@@	O	-1	15930398
ad	O	-1	15930398
and	O	-1	15930398
the	O	-1	15930398
patient@@	O	-1	15930398
's	O	-1	15930398
ability	O	-1	15930398
to	O	-1	15930398
repe@@	O	-1	15930398
at	O	-1	15930398
the	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
were	O	-1	15930398
recor@@	O	-1	15930398
de@@	O	-1	15930398
d.	O	-1	15930398
After	O	-1	15930398
the	O	-1	15930398
proce@@	O	-1	15930398
d@@	O	-1	15930398
ure,	O	-1	15930398
the	O	-1	15930398
patient	O	-1	15930398
was	O	-1	15930398
as@@	O	-1	15930398
ked	O	-1	15930398
to	O	-1	15930398
state	O	-1	15930398
all	O	-1	15930398
of	O	-1	15930398
the	O	-1	15930398
wor@@	O	-1	15930398
ds	O	-1	15930398
from	O	-1	15930398
the	O	-1	15930398
l@@	O	-1	15930398
ist	O	-1	15930398
that	O	-1	15930398
he	O	-1	15930398
or	O	-1	15930398
sh@@	O	-1	15930398
e	O	-1	15930398
could	O	-1	15930398
rec@@	O	-1	15930398
all@@	O	-1	15930398
,	O	-1	15930398
and	O	-1	15930398
to	O	-1	15930398
identi@@	O	-1	15930398
f@@	O	-1	15930398
y	O	-1	15930398
the	O	-1	15930398
las@@	O	-1	15930398
t	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
rec@@	O	-1	15930398
all@@	O	-1	15930398
ed	O	-1	15930398
from	O	-1	15930398
prior	O	-1	15930398
to	O	-1	15930398
the	O	-1	15930398
star@@	O	-1	15930398
t	O	-1	15930398
of	O	-1	15930398
the	O	-1	15930398
proce@@	O	-1	15930398
d@@	O	-1	15930398
ure	O	-1	15930398
and	O	-1	15930398
the	O	-1	15930398
first	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
rec@@	O	-1	15930398
all@@	O	-1	15930398
ed	O	-1	15930398
from	O	-1	15930398
after	O	-1	15930398
the	O	-1	15930398
proce@@	O	-1	15930398
d@@	O	-1	15930398
ure	O	-1	15930398
was	O	-1	15930398
comple@@	O	-1	15930398
ted.	O	-1	15930398
RESULTS:	O	-1	15930398
S@@	O	-1	15930398
event@@	O	-1	15930398
y-@@	O	-1	15930398
five	O	-1	15930398
con@@	O	-1	15930398
s@@	O	-1	15930398
ent@@	O	-1	15930398
ing	O	-1	15930398
patients	O	-1	15930398
were	O	-1	15930398
en@@	O	-1	15930398
ro@@	O	-1	15930398
l@@	O	-1	15930398
le@@	O	-1	15930398
d@@	O	-1	15930398
;	O	-1	15930398
one	O	-1	15930398
patient	O	-1	15930398
was	O	-1	15930398
ex@@	O	-1	15930398
cl@@	O	-1	15930398
uded	O	-1	15930398
from	O	-1	15930398
data	O	-1	15930398
analysis	O	-1	15930398
for	O	-1	15930398
a	O	-1	15930398
pro@@	O	-1	15930398
to@@	O	-1	15930398
co@@	O	-1	15930398
l	O	-1	15930398
vi@@	O	-1	15930398
ol@@	O	-1	15930398
ation.	O	-1	15930398
No	O	-1	15930398
seri@@	O	-1	15930398
ous	O	-1	15930398
adverse	O	-1	15930398
events	O	-1	15930398
were	O	-1	15930398
not@@	O	-1	15930398
ed	O	-1	15930398
during	O	-1	15930398
the	O	-1	15930398
proce@@	O	-1	15930398
dur@@	O	-1	15930398
al	O	-1	15930398
sed@@	O	-1	15930398
ations.	O	-1	15930398
The	O	-1	15930398
mean	O	-1	15930398
(@@	O	-1	15930398
+/-@@	O	-1	15930398
standard	O	-1	15930398
de@@	O	-1	15930398
vi@@	O	-1	15930398
ation@@	O	-1	15930398
)	O	-1	15930398
time	O	-1	15930398
of	O	-1	15930398
data	O	-1	15930398
coll@@	O	-1	15930398
ection	O	-1	15930398
was	O	-1	15930398
1@@	O	-1	15930398
6.@@	O	-1	15930398
4	O	-1	15930398
minutes	O	-1	15930398
(@@	O	-1	15930398
+/-@@	O	-1	15930398
7.@@	O	-1	15930398
1@@	O	-1	15930398
;	O	-1	15930398
range	O	-1	15930398
5	O	-1	15930398
to	O	-1	15930398
3@@	O	-1	15930398
4	O	-1	15930398
minut@@	O	-1	15930398
es@@	O	-1	15930398
).	O	-1	15930398
The	O	-1	15930398
mean	O	-1	15930398
initial	O	-1	15930398
(@@	O	-1	15930398
pre@@	O	-1	15930398
proce@@	O	-1	15930398
d@@	O	-1	15930398
ure@@	O	-1	15930398
)	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
scor@@	O	-1	15930398
e	O	-1	15930398
was	O	-1	15930398
9@@	O	-1	15930398
7.@@	O	-1	15930398
1	O	-1	15930398
(@@	O	-1	15930398
+/-@@	O	-1	15930398
2.@@	O	-1	15930398
3@@	O	-1	15930398
;	O	-1	15930398
range	O	-1	15930398
9@@	O	-1	15930398
2	O	-1	15930398
to	O	-1	15930398
9@@	O	-1	15930398
9@@	O	-1	15930398
).	O	-1	15930398
The	O	-1	15930398
mean	O	-1	15930398
low@@	O	-1	15930398
est	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
scor@@	O	-1	15930398
e	O	-1	15930398
occur@@	O	-1	15930398
r@@	O	-1	15930398
ing	O	-1	15930398
during	O	-1	15930398
these	O	-1	15930398
proce@@	O	-1	15930398
dur@@	O	-1	15930398
al	O	-1	15930398
sed@@	O	-1	15930398
ations	O	-1	15930398
was	O	-1	15930398
6@@	O	-1	15930398
6.@@	O	-1	15930398
9	O	-1	15930398
(@@	O	-1	15930398
+/@@	O	-1	15930398
-1@@	O	-1	15930398
4.@@	O	-1	15930398
4@@	O	-1	15930398
;	O	-1	15930398
range	O	-1	15930398
3@@	O	-1	15930398
3	O	-1	15930398
to	O	-1	15930398
9@@	O	-1	15930398
1).	O	-1	15930398
The	O	-1	15930398
mean	O	-1	15930398
low@@	O	-1	15930398
est	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
scor@@	O	-1	15930398
e	O	-1	15930398
cor@@	O	-1	15930398
respon@@	O	-1	15930398
ding	O	-1	15930398
to	O	-1	15930398
the	O	-1	15930398
ability	O	-1	15930398
of	O	-1	15930398
the	O	-1	15930398
patient	O	-1	15930398
to	O	-1	15930398
immedi@@	O	-1	15930398
ately	O	-1	15930398
repe@@	O	-1	15930398
at	O	-1	15930398
wor@@	O	-1	15930398
ds	O	-1	15930398
re@@	O	-1	15930398
ad	O	-1	15930398
from	O	-1	15930398
the	O	-1	15930398
l@@	O	-1	15930398
ist	O	-1	15930398
was	O	-1	15930398
7@@	O	-1	15930398
7.@@	O	-1	15930398
1	O	-1	15930398
(@@	O	-1	15930398
95%	O	-1	15930398
C@@	O	-1	15930398
I	O	-1	15930398
=	O	-1	15930398
7@@	O	-1	15930398
4.@@	O	-1	15930398
3	O	-1	15930398
to	O	-1	15930398
8@@	O	-1	15930398
0.0@@	O	-1	15930398
).	O	-1	15930398
The	O	-1	15930398
mean	O	-1	15930398
high@@	O	-1	15930398
est	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
scor@@	O	-1	15930398
e	O	-1	15930398
cor@@	O	-1	15930398
respon@@	O	-1	15930398
ding	O	-1	15930398
to	O	-1	15930398
the	O	-1	15930398
in@@	B-Disease	D000647	15930398
ability	I-Disease	-1	15930398
to	I-Disease	-1	15930398
repe@@	I-Disease	-1	15930398
at	I-Disease	-1	15930398
wor@@	I-Disease	-1	15930398
ds	I-Disease	-1	15930398
was	O	-1	15930398
8@@	O	-1	15930398
1.@@	O	-1	15930398
5	O	-1	15930398
(@@	O	-1	15930398
95%	O	-1	15930398
C@@	O	-1	15930398
I	O	-1	15930398
=	O	-1	15930398
7@@	O	-1	15930398
8.@@	O	-1	15930398
1	O	-1	15930398
to	O	-1	15930398
8@@	O	-1	15930398
4.@@	O	-1	15930398
8@@	O	-1	15930398
).	O	-1	15930398
The	O	-1	15930398
mean	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
scor@@	O	-1	15930398
e	O	-1	15930398
cor@@	O	-1	15930398
respon@@	O	-1	15930398
ding	O	-1	15930398
to	O	-1	15930398
the	O	-1	15930398
las@@	O	-1	15930398
t	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
rec@@	O	-1	15930398
all@@	O	-1	15930398
ed	O	-1	15930398
from	O	-1	15930398
prior	O	-1	15930398
to	O	-1	15930398
the	O	-1	15930398
initi@@	O	-1	15930398
ation	O	-1	15930398
of	O	-1	15930398
the	O	-1	15930398
sed@@	O	-1	15930398
ation	O	-1	15930398
was	O	-1	15930398
9@@	O	-1	15930398
6.@@	O	-1	15930398
7	O	-1	15930398
(@@	O	-1	15930398
+/-@@	O	-1	15930398
2.@@	O	-1	15930398
4@@	O	-1	15930398
;	O	-1	15930398
range	O	-1	15930398
8@@	O	-1	15930398
4	O	-1	15930398
to	O	-1	15930398
9@@	O	-1	15930398
8@@	O	-1	15930398
).	O	-1	15930398
The	O	-1	15930398
mean	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
scor@@	O	-1	15930398
e	O	-1	15930398
cor@@	O	-1	15930398
respon@@	O	-1	15930398
ding	O	-1	15930398
to	O	-1	15930398
the	O	-1	15930398
first	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
rec@@	O	-1	15930398
all@@	O	-1	15930398
ed	O	-1	15930398
after	O	-1	15930398
the	O	-1	15930398
proce@@	O	-1	15930398
d@@	O	-1	15930398
ure	O	-1	15930398
was	O	-1	15930398
comple@@	O	-1	15930398
ted	O	-1	15930398
was	O	-1	15930398
9@@	O	-1	15930398
1.@@	O	-1	15930398
2	O	-1	15930398
(@@	O	-1	15930398
95%	O	-1	15930398
C@@	O	-1	15930398
I	O	-1	15930398
=	O	-1	15930398
8@@	O	-1	15930398
8.@@	O	-1	15930398
1	O	-1	15930398
to	O	-1	15930398
9@@	O	-1	15930398
4.@@	O	-1	15930398
3@@	O	-1	15930398
).	O	-1	15930398
All	O	-1	15930398
patients	O	-1	15930398
rec@@	O	-1	15930398
all@@	O	-1	15930398
ed	O	-1	15930398
at	O	-1	15930398
le@@	O	-1	15930398
ast	O	-1	15930398
one	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
that	O	-1	15930398
had	O	-1	15930398
been	O	-1	15930398
re@@	O	-1	15930398
ad	O	-1	15930398
to	O	-1	15930398
the@@	O	-1	15930398
m	O	-1	15930398
during	O	-1	15930398
the	O	-1	15930398
pro@@	O	-1	15930398
to@@	O	-1	15930398
co@@	O	-1	15930398
l@@	O	-1	15930398
.	O	-1	15930398
The	O	-1	15930398
mean	O	-1	15930398
low@@	O	-1	15930398
est	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
scor@@	O	-1	15930398
e	O	-1	15930398
for	O	-1	15930398
any	O	-1	15930398
rec@@	O	-1	15930398
all@@	O	-1	15930398
ed	O	-1	15930398
wor@@	O	-1	15930398
d	O	-1	15930398
was	O	-1	15930398
9@@	O	-1	15930398
1.@@	O	-1	15930398
5	O	-1	15930398
(@@	O	-1	15930398
+/@@	O	-1	15930398
-1@@	O	-1	15930398
1.@@	O	-1	15930398
1@@	O	-1	15930398
;	O	-1	15930398
range	O	-1	15930398
7@@	O	-1	15930398
9	O	-1	15930398
to	O	-1	15930398
9@@	O	-1	15930398
8@@	O	-1	15930398
),	O	-1	15930398
and	O	-1	15930398
no	O	-1	15930398
wor@@	O	-1	15930398
ds	O	-1	15930398
were	O	-1	15930398
rec@@	O	-1	15930398
all@@	O	-1	15930398
ed	O	-1	15930398
when	O	-1	15930398
the	O	-1	15930398
cor@@	O	-1	15930398
respon@@	O	-1	15930398
ding	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
scor@@	O	-1	15930398
e	O	-1	15930398
was	O	-1	15930398
less	O	-1	15930398
than	O	-1	15930398
9@@	O	-1	15930398
0@@	O	-1	15930398
.	O	-1	15930398
CONCLUSIONS:	O	-1	15930398
There	O	-1	15930398
is	O	-1	15930398
a	O	-1	15930398
range	O	-1	15930398
of	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
sco@@	O	-1	15930398
res	O	-1	15930398
during	O	-1	15930398
which	O	-1	15930398
sed@@	O	-1	15930398
ated	O	-1	15930398
patients	O	-1	15930398
are	O	-1	15930398
able	O	-1	15930398
to	O	-1	15930398
repe@@	O	-1	15930398
at	O	-1	15930398
wor@@	O	-1	15930398
ds	O	-1	15930398
re@@	O	-1	15930398
ad	O	-1	15930398
to	O	-1	15930398
the@@	O	-1	15930398
m	O	-1	15930398
but	O	-1	15930398
are	O	-1	15930398
not	O	-1	15930398
able	O	-1	15930398
to	O	-1	15930398
subsequ@@	O	-1	15930398
ently	O	-1	15930398
rec@@	O	-1	15930398
all	O	-1	15930398
these	O	-1	15930398
wor@@	O	-1	15930398
d@@	O	-1	15930398
s.	O	-1	15930398
F@@	O	-1	15930398
ur@@	O	-1	15930398
ther@@	O	-1	15930398
mo@@	O	-1	15930398
re,	O	-1	15930398
patients	O	-1	15930398
had	O	-1	15930398
no	O	-1	15930398
rec@@	O	-1	15930398
all	O	-1	15930398
of	O	-1	15930398
wor@@	O	-1	15930398
ds	O	-1	15930398
repe@@	O	-1	15930398
ated	O	-1	15930398
prior	O	-1	15930398
to	O	-1	15930398
proce@@	O	-1	15930398
dur@@	O	-1	15930398
al	O	-1	15930398
sed@@	O	-1	15930398
ation	O	-1	15930398
in	O	-1	15930398
B@@	O	-1	15930398
I@@	O	-1	15930398
S	O	-1	15930398
rang@@	O	-1	15930398
es	O	-1	15930398
associated	O	-1	15930398
with	O	-1	15930398
rec@@	O	-1	15930398
all	O	-1	15930398
after	O	-1	15930398
proce@@	O	-1	15930398
dur@@	O	-1	15930398
al	O	-1	15930398
sed@@	O	-1	15930398
ation,	O	-1	15930398
sugg@@	O	-1	15930398
es@@	O	-1	15930398
tive	O	-1	15930398
of	O	-1	15930398
ret@@	B-Disease	D000648	15930398
ro@@	I-Disease	-1	15930398
gra@@	I-Disease	-1	15930398
de	I-Disease	-1	15930398
am@@	I-Disease	-1	15930398
ne@@	I-Disease	-1	15930398
sia	I-Disease	-1	15930398
.	O	-1	15930398

A@@	O	-1	15867025
s@@	O	-1	15867025
s@@	O	-1	15867025
ess@@	O	-1	15867025
ment	O	-1	15867025
of	O	-1	15867025
per@@	O	-1	15867025
in@@	O	-1	15867025
atal	O	-1	15867025
hepatitis	B-Disease	D006509	15867025
B	I-Disease	-1	15867025
and	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
pre@@	O	-1	15867025
ven@@	O	-1	15867025
tion	O	-1	15867025
in	O	-1	15867025
Ne@@	O	-1	15867025
w	O	-1	15867025
H@@	O	-1	15867025
amp@@	O	-1	15867025
shi@@	O	-1	15867025
r@@	O	-1	15867025
e	O	-1	15867025
de@@	O	-1	15867025
li@@	O	-1	15867025
very	O	-1	15867025
hospit@@	O	-1	15867025
al@@	O	-1	15867025
s.	O	-1	15867025
OBJECTIVE:	O	-1	15867025
To	O	-1	15867025
evalu@@	O	-1	15867025
ate	O	-1	15867025
current	O	-1	15867025
perform@@	O	-1	15867025
ance	O	-1	15867025
on	O	-1	15867025
recomm@@	O	-1	15867025
en@@	O	-1	15867025
ded	O	-1	15867025
per@@	O	-1	15867025
in@@	O	-1	15867025
atal	O	-1	15867025
hepatitis	B-Disease	D006509	15867025
B	I-Disease	-1	15867025
and	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
pre@@	O	-1	15867025
ven@@	O	-1	15867025
tion	O	-1	15867025
p@@	O	-1	15867025
rac@@	O	-1	15867025
tic@@	O	-1	15867025
es	O	-1	15867025
in	O	-1	15867025
Ne@@	O	-1	15867025
w	O	-1	15867025
H@@	O	-1	15867025
amp@@	O	-1	15867025
shi@@	O	-1	15867025
re.	O	-1	15867025
METHODS:	O	-1	15867025
D@@	O	-1	15867025
at@@	O	-1	15867025
a	O	-1	15867025
were	O	-1	15867025
extrac@@	O	-1	15867025
ted	O	-1	15867025
from	O	-1	15867025
20@@	O	-1	15867025
21	O	-1	15867025
pa@@	O	-1	15867025
ired	O	-1	15867025
mo@@	O	-1	15867025
ther@@	O	-1	15867025
-@@	O	-1	15867025
inf@@	O	-1	15867025
ant	O	-1	15867025
recor@@	O	-1	15867025
ds	O	-1	15867025
for	O	-1	15867025
the	O	-1	15867025
year	O	-1	15867025
20@@	O	-1	15867025
00	O	-1	15867025
b@@	O	-1	15867025
ir@@	O	-1	15867025
th	O	-1	15867025
co@@	O	-1	15867025
h@@	O	-1	15867025
ort	O	-1	15867025
in	O	-1	15867025
Ne@@	O	-1	15867025
w	O	-1	15867025
H@@	O	-1	15867025
amp@@	O	-1	15867025
shi@@	O	-1	15867025
re@@	O	-1	15867025
's	O	-1	15867025
25	O	-1	15867025
de@@	O	-1	15867025
li@@	O	-1	15867025
very	O	-1	15867025
hospit@@	O	-1	15867025
al@@	O	-1	15867025
s.	O	-1	15867025
A@@	O	-1	15867025
s@@	O	-1	15867025
s@@	O	-1	15867025
ess@@	O	-1	15867025
ment	O	-1	15867025
was	O	-1	15867025
d@@	O	-1	15867025
one	O	-1	15867025
on	O	-1	15867025
the	O	-1	15867025
follow@@	O	-1	15867025
ing@@	O	-1	15867025
:	O	-1	15867025
p@@	O	-1	15867025
ren@@	O	-1	15867025
atal	O	-1	15867025
s@@	O	-1	15867025
cre@@	O	-1	15867025
en@@	O	-1	15867025
ing	O	-1	15867025
for	O	-1	15867025
hepatitis	B-Disease	D006509	15867025
B	I-Disease	-1	15867025
and	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
,	O	-1	15867025
administration	O	-1	15867025
of	O	-1	15867025
the	O	-1	15867025
hepatitis	B-Disease	D006509	15867025
B	I-Disease	-1	15867025
vac@@	O	-1	15867025
c@@	O	-1	15867025
ine	O	-1	15867025
b@@	O	-1	15867025
ir@@	O	-1	15867025
th	O	-1	15867025
dose	O	-1	15867025
to	O	-1	15867025
all	O	-1	15867025
inf@@	O	-1	15867025
ant@@	O	-1	15867025
s,	O	-1	15867025
administration	O	-1	15867025
of	O	-1	15867025
hepatitis	B-Disease	D006509	15867025
B	I-Disease	-1	15867025
immun@@	O	-1	15867025
e	O	-1	15867025
glo@@	O	-1	15867025
b@@	O	-1	15867025
ul@@	O	-1	15867025
in	O	-1	15867025
to	O	-1	15867025
inf@@	O	-1	15867025
ants	O	-1	15867025
who	O	-1	15867025
were	O	-1	15867025
b@@	O	-1	15867025
or@@	O	-1	15867025
n	O	-1	15867025
to	O	-1	15867025
hepatitis	B-Chemical	D006514	15867025
B	I-Chemical	-1	15867025
sur@@	I-Chemical	-1	15867025
fac@@	I-Chemical	-1	15867025
e	I-Chemical	-1	15867025
anti@@	I-Chemical	-1	15867025
gen	I-Chemical	-1	15867025
-@@	O	-1	15867025
positive	O	-1	15867025
mo@@	O	-1	15867025
ther@@	O	-1	15867025
s,	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
immun@@	O	-1	15867025
ity,	O	-1	15867025
and	O	-1	15867025
administration	O	-1	15867025
of	O	-1	15867025
in-@@	O	-1	15867025
hospit@@	O	-1	15867025
al	O	-1	15867025
post@@	O	-1	15867025
part@@	O	-1	15867025
um	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
vac@@	O	-1	15867025
c@@	O	-1	15867025
ine	O	-1	15867025
to	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
non@@	O	-1	15867025
immun@@	O	-1	15867025
e	O	-1	15867025
wom@@	O	-1	15867025
en@@	O	-1	15867025
.	O	-1	15867025
RESULTS:	O	-1	15867025
P@@	O	-1	15867025
ren@@	O	-1	15867025
atal	O	-1	15867025
s@@	O	-1	15867025
cre@@	O	-1	15867025
en@@	O	-1	15867025
ing	O	-1	15867025
rat@@	O	-1	15867025
es	O	-1	15867025
for	O	-1	15867025
hepatitis	B-Disease	D006509	15867025
B	I-Disease	-1	15867025
(@@	O	-1	15867025
9@@	O	-1	15867025
8.@@	O	-1	15867025
8@@	O	-1	15867025
%)	O	-1	15867025
and	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
(@@	O	-1	15867025
9@@	O	-1	15867025
9.@@	O	-1	15867025
4@@	O	-1	15867025
%)	O	-1	15867025
were	O	-1	15867025
high@@	O	-1	15867025
.	O	-1	15867025
He@@	B-Disease	D006509	15867025
pati@@	I-Disease	-1	15867025
tis	I-Disease	-1	15867025
B	I-Disease	-1	15867025
vac@@	O	-1	15867025
c@@	O	-1	15867025
ine	O	-1	15867025
b@@	O	-1	15867025
ir@@	O	-1	15867025
th	O	-1	15867025
dose	O	-1	15867025
was	O	-1	15867025
administered	O	-1	15867025
to	O	-1	15867025
7@@	O	-1	15867025
6.@@	O	-1	15867025
2@@	O	-1	15867025
%	O	-1	15867025
of	O	-1	15867025
all	O	-1	15867025
inf@@	O	-1	15867025
ant@@	O	-1	15867025
s.	O	-1	15867025
All	O	-1	15867025
inf@@	O	-1	15867025
ants	O	-1	15867025
who	O	-1	15867025
were	O	-1	15867025
b@@	O	-1	15867025
or@@	O	-1	15867025
n	O	-1	15867025
to	O	-1	15867025
hepatitis	B-Chemical	D006514	15867025
B	I-Chemical	-1	15867025
sur@@	I-Chemical	-1	15867025
fac@@	I-Chemical	-1	15867025
e	I-Chemical	-1	15867025
anti@@	I-Chemical	-1	15867025
gen	I-Chemical	-1	15867025
-@@	O	-1	15867025
positive	O	-1	15867025
mo@@	O	-1	15867025
ther@@	O	-1	15867025
s	O	-1	15867025
also	O	-1	15867025
received	O	-1	15867025
hepatitis	B-Disease	D006509	15867025
B	I-Disease	-1	15867025
immun@@	O	-1	15867025
e	O	-1	15867025
glo@@	O	-1	15867025
b@@	O	-1	15867025
ul@@	O	-1	15867025
in.	O	-1	15867025
M@@	O	-1	15867025
ul@@	O	-1	15867025
tiv@@	O	-1	15867025
ari@@	O	-1	15867025
ate	O	-1	15867025
log@@	O	-1	15867025
istic	O	-1	15867025
reg@@	O	-1	15867025
res@@	O	-1	15867025
sion	O	-1	15867025
showed	O	-1	15867025
that	O	-1	15867025
the	O	-1	15867025
mon@@	O	-1	15867025
th	O	-1	15867025
of	O	-1	15867025
de@@	O	-1	15867025
li@@	O	-1	15867025
very	O	-1	15867025
and	O	-1	15867025
inf@@	O	-1	15867025
ant	O	-1	15867025
b@@	O	-1	15867025
ir@@	O	-1	15867025
th	O	-1	15867025
weight	O	-1	15867025
were	O	-1	15867025
in@@	O	-1	15867025
dependent	O	-1	15867025
predic@@	O	-1	15867025
t@@	O	-1	15867025
ors	O	-1	15867025
of	O	-1	15867025
hepatitis	B-Disease	D006509	15867025
B	I-Disease	-1	15867025
vac@@	O	-1	15867025
cin@@	O	-1	15867025
ation.	O	-1	15867025
The	O	-1	15867025
pro@@	O	-1	15867025
por@@	O	-1	15867025
tion	O	-1	15867025
of	O	-1	15867025
inf@@	O	-1	15867025
ants	O	-1	15867025
who	O	-1	15867025
were	O	-1	15867025
vac@@	O	-1	15867025
cin@@	O	-1	15867025
ated	O	-1	15867025
in	O	-1	15867025
J@@	O	-1	15867025
an@@	O	-1	15867025
u@@	O	-1	15867025
ary	O	-1	15867025
and	O	-1	15867025
F@@	O	-1	15867025
e@@	O	-1	15867025
b@@	O	-1	15867025
ru@@	O	-1	15867025
ary	O	-1	15867025
20@@	O	-1	15867025
00	O	-1	15867025
(4@@	O	-1	15867025
8.@@	O	-1	15867025
5%	O	-1	15867025
and	O	-1	15867025
6@@	O	-1	15867025
7.@@	O	-1	15867025
5@@	O	-1	15867025
%,	O	-1	15867025
respectivel@@	O	-1	15867025
y@@	O	-1	15867025
)	O	-1	15867025
was	O	-1	15867025
less	O	-1	15867025
than	O	-1	15867025
any	O	-1	15867025
other	O	-1	15867025
month@@	O	-1	15867025
s,	O	-1	15867025
whereas	O	-1	15867025
the	O	-1	15867025
pro@@	O	-1	15867025
por@@	O	-1	15867025
tion	O	-1	15867025
who	O	-1	15867025
were	O	-1	15867025
vac@@	O	-1	15867025
cin@@	O	-1	15867025
ated	O	-1	15867025
in	O	-1	15867025
D@@	O	-1	15867025
ec@@	O	-1	15867025
emb@@	O	-1	15867025
er	O	-1	15867025
20@@	O	-1	15867025
00	O	-1	15867025
(@@	O	-1	15867025
8@@	O	-1	15867025
8.@@	O	-1	15867025
2@@	O	-1	15867025
%)	O	-1	15867025
was	O	-1	15867025
the	O	-1	15867025
hi@@	O	-1	15867025
g@@	O	-1	15867025
he@@	O	-1	15867025
st@@	O	-1	15867025
.	O	-1	15867025
W@@	O	-1	15867025
o@@	O	-1	15867025
men	O	-1	15867025
who	O	-1	15867025
were	O	-1	15867025
b@@	O	-1	15867025
or@@	O	-1	15867025
n	O	-1	15867025
between	O	-1	15867025
19@@	O	-1	15867025
7@@	O	-1	15867025
1	O	-1	15867025
and	O	-1	15867025
19@@	O	-1	15867025
7@@	O	-1	15867025
5	O	-1	15867025
had	O	-1	15867025
the	O	-1	15867025
high@@	O	-1	15867025
est	O	-1	15867025
rate	O	-1	15867025
of	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
non@@	O	-1	15867025
immun@@	O	-1	15867025
ity	O	-1	15867025
(@@	O	-1	15867025
9.@@	O	-1	15867025
5@@	O	-1	15867025
%).	O	-1	15867025
In@@	O	-1	15867025
-@@	O	-1	15867025
hospit@@	O	-1	15867025
al	O	-1	15867025
post@@	O	-1	15867025
part@@	O	-1	15867025
um	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
vac@@	O	-1	15867025
c@@	O	-1	15867025
ine	O	-1	15867025
administration	O	-1	15867025
was	O	-1	15867025
doc@@	O	-1	15867025
um@@	O	-1	15867025
ent@@	O	-1	15867025
ed	O	-1	15867025
for	O	-1	15867025
7@@	O	-1	15867025
5.@@	O	-1	15867025
6%	O	-1	15867025
of	O	-1	15867025
non@@	O	-1	15867025
immun@@	O	-1	15867025
e	O	-1	15867025
wom@@	O	-1	15867025
en@@	O	-1	15867025
.	O	-1	15867025
CONCLUSION:	O	-1	15867025
This	O	-1	15867025
study	O	-1	15867025
doc@@	O	-1	15867025
um@@	O	-1	15867025
ents	O	-1	15867025
go@@	O	-1	15867025
od	O	-1	15867025
com@@	O	-1	15867025
pl@@	O	-1	15867025
i@@	O	-1	15867025
ance	O	-1	15867025
in	O	-1	15867025
Ne@@	O	-1	15867025
w	O	-1	15867025
H@@	O	-1	15867025
amp@@	O	-1	15867025
shi@@	O	-1	15867025
re@@	O	-1	15867025
's	O	-1	15867025
b@@	O	-1	15867025
ir@@	O	-1	15867025
th@@	O	-1	15867025
ing	O	-1	15867025
hospit@@	O	-1	15867025
als	O	-1	15867025
with	O	-1	15867025
n@@	O	-1	15867025
ation@@	O	-1	15867025
al	O	-1	15867025
gu@@	O	-1	15867025
ide@@	O	-1	15867025
lin@@	O	-1	15867025
es	O	-1	15867025
for	O	-1	15867025
per@@	O	-1	15867025
in@@	O	-1	15867025
atal	O	-1	15867025
hepatitis	B-Disease	D006509	15867025
B	I-Disease	-1	15867025
and	O	-1	15867025
ru@@	B-Disease	D012409	15867025
bell@@	I-Disease	-1	15867025
a	I-Disease	-1	15867025
pre@@	O	-1	15867025
ven@@	O	-1	15867025
tion	O	-1	15867025
and	O	-1	15867025
high@@	O	-1	15867025
li@@	O	-1	15867025
gh@@	O	-1	15867025
ts	O	-1	15867025
potential	O	-1	15867025
a@@	O	-1	15867025
reas	O	-1	15867025
for	O	-1	15867025
impro@@	O	-1	15867025
ve@@	O	-1	15867025
ment.	O	-1	15867025

E@@	O	-1	14975762
x@@	O	-1	14975762
pression	O	-1	14975762
of	O	-1	14975762
p@@	O	-1	14975762
3@@	O	-1	14975762
00	O	-1	14975762
prot@@	O	-1	14975762
ects	O	-1	14975762
cardiac	O	-1	14975762
my@@	O	-1	14975762
ocy@@	O	-1	14975762
tes	O	-1	14975762
from	O	-1	14975762
apo@@	O	-1	14975762
pto@@	O	-1	14975762
sis	O	-1	14975762
in	O	-1	14975762
viv@@	O	-1	14975762
o@@	O	-1	14975762
.	O	-1	14975762
D@@	B-Chemical	D004317	14975762
ox@@	I-Chemical	-1	14975762
orub@@	I-Chemical	-1	14975762
icin	I-Chemical	-1	14975762
is	O	-1	14975762
an	O	-1	14975762
anti@@	O	-1	14975762
-	O	-1	14975762
tumor	B-Disease	D009369	14975762
agent	O	-1	14975762
that	O	-1	14975762
re@@	O	-1	14975762
pres@@	O	-1	14975762
ses	O	-1	14975762
cardi@@	O	-1	14975762
ac@@	O	-1	14975762
-@@	O	-1	14975762
specific	O	-1	14975762
gen@@	O	-1	14975762
e	O	-1	14975762
expression	O	-1	14975762
and	O	-1	14975762
induc@@	O	-1	14975762
es	O	-1	14975762
myocardial	O	-1	14975762
cell	O	-1	14975762
apo@@	O	-1	14975762
pto@@	O	-1	14975762
sis.	O	-1	14975762
D@@	B-Chemical	D004317	14975762
ox@@	I-Chemical	-1	14975762
orub@@	I-Chemical	-1	14975762
icin	I-Chemical	-1	14975762
deple@@	O	-1	14975762
tes	O	-1	14975762
cardiac	O	-1	14975762
p@@	O	-1	14975762
3@@	O	-1	14975762
0@@	O	-1	14975762
0@@	O	-1	14975762
,	O	-1	14975762
a	O	-1	14975762
trans@@	O	-1	14975762
cri@@	O	-1	14975762
p@@	O	-1	14975762
tional	O	-1	14975762
co@@	O	-1	14975762
activ@@	O	-1	14975762
at@@	O	-1	14975762
or	O	-1	14975762
that	O	-1	14975762
is	O	-1	14975762
requ@@	O	-1	14975762
ired	O	-1	14975762
for	O	-1	14975762
the	O	-1	14975762
maint@@	O	-1	14975762
en@@	O	-1	14975762
ance	O	-1	14975762
of	O	-1	14975762
the	O	-1	14975762
differen@@	O	-1	14975762
ti@@	O	-1	14975762
ated	O	-1	14975762
phen@@	O	-1	14975762
ot@@	O	-1	14975762
yp@@	O	-1	14975762
e	O	-1	14975762
of	O	-1	14975762
cardiac	O	-1	14975762
my@@	O	-1	14975762
ocy@@	O	-1	14975762
t@@	O	-1	14975762
es.	O	-1	14975762
However,	O	-1	14975762
the	O	-1	14975762
role	O	-1	14975762
of	O	-1	14975762
p@@	O	-1	14975762
3@@	O	-1	14975762
00	O	-1	14975762
in	O	-1	14975762
prot@@	O	-1	14975762
ection	O	-1	14975762
against	O	-1	14975762
dox@@	B-Chemical	D004317	14975762
orub@@	I-Chemical	-1	14975762
icin	I-Chemical	-1	14975762
-induced	O	-1	14975762
apo@@	O	-1	14975762
pto@@	O	-1	14975762
sis	O	-1	14975762
is	O	-1	14975762
un@@	O	-1	14975762
know@@	O	-1	14975762
n@@	O	-1	14975762
.	O	-1	14975762
T@@	O	-1	14975762
ran@@	O	-1	14975762
s@@	O	-1	14975762
genic	O	-1	14975762
mice	O	-1	14975762
o@@	O	-1	14975762
ve@@	O	-1	14975762
re@@	O	-1	14975762
x@@	O	-1	14975762
press@@	O	-1	14975762
ing	O	-1	14975762
p@@	O	-1	14975762
3@@	O	-1	14975762
00	O	-1	14975762
in	O	-1	14975762
the	O	-1	14975762
heart	O	-1	14975762
and	O	-1	14975762
wil@@	O	-1	14975762
d-@@	O	-1	14975762
type	O	-1	14975762
mice	O	-1	14975762
were	O	-1	14975762
subj@@	O	-1	14975762
ected	O	-1	14975762
to	O	-1	14975762
dox@@	B-Chemical	D004317	14975762
orub@@	I-Chemical	-1	14975762
icin	I-Chemical	-1	14975762
treatment.	O	-1	14975762
Com@@	O	-1	14975762
pared	O	-1	14975762
with	O	-1	14975762
wil@@	O	-1	14975762
d-@@	O	-1	14975762
type	O	-1	14975762
mic@@	O	-1	14975762
e,	O	-1	14975762
trans@@	O	-1	14975762
genic	O	-1	14975762
mice	O	-1	14975762
ex@@	O	-1	14975762
hib@@	O	-1	14975762
ited	O	-1	14975762
higher	O	-1	14975762
sur@@	O	-1	14975762
viv@@	O	-1	14975762
al	O	-1	14975762
rate	O	-1	14975762
as	O	-1	14975762
well	O	-1	14975762
as	O	-1	14975762
more	O	-1	14975762
pres@@	O	-1	14975762
er@@	O	-1	14975762
ved	O	-1	14975762
left	O	-1	14975762
ventricular	O	-1	14975762
function	O	-1	14975762
and	O	-1	14975762
cardiac	O	-1	14975762
expression	O	-1	14975762
of	O	-1	14975762
alpha-@@	O	-1	14975762
s@@	O	-1	14975762
ar@@	O	-1	14975762
com@@	O	-1	14975762
er@@	O	-1	14975762
ic	O	-1	14975762
act@@	O	-1	14975762
in.	O	-1	14975762
D@@	B-Chemical	D004317	14975762
ox@@	I-Chemical	-1	14975762
orub@@	I-Chemical	-1	14975762
icin	I-Chemical	-1	14975762
induced	O	-1	14975762
myocardial	O	-1	14975762
cell	O	-1	14975762
apo@@	O	-1	14975762
pto@@	O	-1	14975762
sis	O	-1	14975762
in	O	-1	14975762
wil@@	O	-1	14975762
d-@@	O	-1	14975762
type	O	-1	14975762
mice	O	-1	14975762
but	O	-1	14975762
not	O	-1	14975762
in	O	-1	14975762
trans@@	O	-1	14975762
genic	O	-1	14975762
mice.	O	-1	14975762
E@@	O	-1	14975762
x@@	O	-1	14975762
pression	O	-1	14975762
of	O	-1	14975762
p@@	O	-1	14975762
3@@	O	-1	14975762
00	O	-1	14975762
increased	O	-1	14975762
the	O	-1	14975762
cardiac	O	-1	14975762
level	O	-1	14975762
of	O	-1	14975762
b@@	O	-1	14975762
cl@@	O	-1	14975762
-@@	O	-1	14975762
2	O	-1	14975762
and	O	-1	14975762
m@@	O	-1	14975762
d@@	O	-1	14975762
m@@	O	-1	14975762
-@@	O	-1	14975762
2,	O	-1	14975762
but	O	-1	14975762
not	O	-1	14975762
that	O	-1	14975762
of	O	-1	14975762
p@@	O	-1	14975762
5@@	O	-1	14975762
3	O	-1	14975762
or	O	-1	14975762
other	O	-1	14975762
memb@@	O	-1	14975762
ers	O	-1	14975762
of	O	-1	14975762
the	O	-1	14975762
b@@	O	-1	14975762
cl@@	O	-1	14975762
-@@	O	-1	14975762
2	O	-1	14975762
f@@	O	-1	14975762
am@@	O	-1	14975762
il@@	O	-1	14975762
y.	O	-1	14975762
These	O	-1	14975762
findings	O	-1	14975762
demon@@	O	-1	14975762
st@@	O	-1	14975762
rate	O	-1	14975762
that	O	-1	14975762
o@@	O	-1	14975762
ve@@	O	-1	14975762
re@@	O	-1	14975762
x@@	O	-1	14975762
pression	O	-1	14975762
of	O	-1	14975762
p@@	O	-1	14975762
3@@	O	-1	14975762
00	O	-1	14975762
prot@@	O	-1	14975762
ects	O	-1	14975762
cardiac	O	-1	14975762
my@@	O	-1	14975762
ocy@@	O	-1	14975762
tes	O	-1	14975762
from	O	-1	14975762
dox@@	B-Chemical	D004317	14975762
orub@@	I-Chemical	-1	14975762
icin	I-Chemical	-1	14975762
-induced	O	-1	14975762
apo@@	O	-1	14975762
pto@@	O	-1	14975762
sis	O	-1	14975762
and	O	-1	14975762
reduc@@	O	-1	14975762
es	O	-1	14975762
the	O	-1	14975762
ext@@	O	-1	14975762
ent	O	-1	14975762
of	O	-1	14975762
acute	O	-1	14975762
heart	B-Disease	D006333	14975762
failure	I-Disease	-1	14975762
in	O	-1	14975762
ad@@	O	-1	14975762
ult	O	-1	14975762
mice	O	-1	14975762
in	O	-1	14975762
viv@@	O	-1	14975762
o@@	O	-1	14975762
.	O	-1	14975762

M@@	O	-1	14736955
it@@	O	-1	14736955
ochond@@	O	-1	14736955
rial	O	-1	14736955
D@@	O	-1	14736955
NA	O	-1	14736955
and	O	-1	14736955
its	O	-1	14736955
respiratory	O	-1	14736955
ch@@	O	-1	14736955
ain	O	-1	14736955
produc@@	O	-1	14736955
ts	O	-1	14736955
are	O	-1	14736955
def@@	O	-1	14736955
ective	O	-1	14736955
in	O	-1	14736955
dox@@	B-Chemical	D004317	14736955
orub@@	I-Chemical	-1	14736955
icin	I-Chemical	-1	14736955
nephro@@	B-Disease	D009401	14736955
sis	I-Disease	-1	14736955
.	O	-1	14736955
BACKGROUND:	O	-1	14736955
D@@	B-Chemical	D004317	14736955
ox@@	I-Chemical	-1	14736955
orub@@	I-Chemical	-1	14736955
icin	I-Chemical	-1	14736955
induc@@	O	-1	14736955
es	O	-1	14736955
a	O	-1	14736955
sel@@	O	-1	14736955
f@@	O	-1	14736955
-@@	O	-1	14736955
per@@	O	-1	14736955
p@@	O	-1	14736955
et@@	O	-1	14736955
u@@	O	-1	14736955
ating	O	-1	14736955
nephro@@	B-Disease	D007674	14736955
pathy	I-Disease	-1	14736955
character@@	O	-1	14736955
ized	O	-1	14736955
by	O	-1	14736955
early	O	-1	14736955
glomerular	B-Disease	D007674	14736955
and	I-Disease	-1	14736955
lat@@	I-Disease	-1	14736955
e-@@	I-Disease	-1	14736955
onset	I-Disease	-1	14736955
tub@@	I-Disease	-1	14736955
ular	I-Disease	-1	14736955
lesions	I-Disease	-1	14736955
in	O	-1	14736955
rats.	O	-1	14736955
We	O	-1	14736955
investigated	O	-1	14736955
the	O	-1	14736955
potential	O	-1	14736955
role	O	-1	14736955
of	O	-1	14736955
mitochondrial	B-Disease	D028361	14736955
injury	I-Disease	-1	14736955
in	O	-1	14736955
the	O	-1	14736955
onset	O	-1	14736955
of	O	-1	14736955
these	O	-1	14736955
le@@	O	-1	14736955
sion@@	O	-1	14736955
s.	O	-1	14736955
METHODS:	O	-1	14736955
R@@	O	-1	14736955
at@@	O	-1	14736955
s	O	-1	14736955
were	O	-1	14736955
treated	O	-1	14736955
with	O	-1	14736955
intravenous	O	-1	14736955
dox@@	B-Chemical	D004317	14736955
orub@@	I-Chemical	-1	14736955
icin	I-Chemical	-1	14736955
(@@	O	-1	14736955
1	O	-1	14736955
mg	O	-1	14736955
kg@@	O	-1	14736955
(@@	O	-1	14736955
-1@@	O	-1	14736955
)	O	-1	14736955
week@@	O	-1	14736955
(@@	O	-1	14736955
-1@@	O	-1	14736955
)@@	O	-1	14736955
)	O	-1	14736955
for	O	-1	14736955
7	O	-1	14736955
weeks	O	-1	14736955
and	O	-1	14736955
were	O	-1	14736955
s@@	O	-1	14736955
ac@@	O	-1	14736955
ri@@	O	-1	14736955
fic@@	O	-1	14736955
ed	O	-1	14736955
either	O	-1	14736955
1	O	-1	14736955
week	O	-1	14736955
(@@	O	-1	14736955
'@@	O	-1	14736955
sh@@	O	-1	14736955
ort@@	O	-1	14736955
-@@	O	-1	14736955
ter@@	O	-1	14736955
m@@	O	-1	14736955
'@@	O	-1	14736955
)	O	-1	14736955
or	O	-1	14736955
30	O	-1	14736955
weeks	O	-1	14736955
(@@	O	-1	14736955
'@@	O	-1	14736955
long@@	O	-1	14736955
-@@	O	-1	14736955
ter@@	O	-1	14736955
m@@	O	-1	14736955
'@@	O	-1	14736955
)	O	-1	14736955
following	O	-1	14736955
the	O	-1	14736955
las@@	O	-1	14736955
t	O	-1	14736955
dose.	O	-1	14736955
Ad@@	O	-1	14736955
di@@	O	-1	14736955
tional	O	-1	14736955
rats	O	-1	14736955
received	O	-1	14736955
a	O	-1	14736955
single	O	-1	14736955
dose	O	-1	14736955
either	O	-1	14736955
6	O	-1	14736955
days	O	-1	14736955
or	O	-1	14736955
2	O	-1	14736955
h	O	-1	14736955
prior	O	-1	14736955
to	O	-1	14736955
eu@@	O	-1	14736955
th@@	O	-1	14736955
ana@@	O	-1	14736955
sia.	O	-1	14736955
All	O	-1	14736955
rats	O	-1	14736955
were	O	-1	14736955
k@@	O	-1	14736955
ill@@	O	-1	14736955
ed	O	-1	14736955
at	O	-1	14736955
4@@	O	-1	14736955
8	O	-1	14736955
weeks	O	-1	14736955
of	O	-1	14736955
age.	O	-1	14736955
G@@	B-Disease	D007674	14736955
lo@@	I-Disease	-1	14736955
mer@@	I-Disease	-1	14736955
ular	I-Disease	-1	14736955
and	I-Disease	-1	14736955
tub@@	I-Disease	-1	14736955
ular	I-Disease	-1	14736955
injury	I-Disease	-1	14736955
was	O	-1	14736955
monit@@	O	-1	14736955
o@@	O	-1	14736955
red	O	-1	14736955
and	O	-1	14736955
cor@@	O	-1	14736955
related	O	-1	14736955
to	O	-1	14736955
the	O	-1	14736955
activity	O	-1	14736955
or	O	-1	14736955
expression	O	-1	14736955
of	O	-1	14736955
respiratory	O	-1	14736955
ch@@	O	-1	14736955
ain	O	-1	14736955
comp@@	O	-1	14736955
on@@	O	-1	14736955
ent@@	O	-1	14736955
s.	O	-1	14736955
F@@	O	-1	14736955
in@@	O	-1	14736955
ally,	O	-1	14736955
we	O	-1	14736955
qu@@	O	-1	14736955
anti@@	O	-1	14736955
fied	O	-1	14736955
both	O	-1	14736955
nucle@@	O	-1	14736955
ar	O	-1	14736955
and	O	-1	14736955
mitochondrial	O	-1	14736955
D@@	O	-1	14736955
NA	O	-1	14736955
(@@	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
N@@	O	-1	14736955
A@@	O	-1	14736955
)	O	-1	14736955
as	O	-1	14736955
well	O	-1	14736955
as	O	-1	14736955
su@@	B-Chemical	D013481	14736955
per@@	I-Chemical	-1	14736955
ox@@	I-Chemical	-1	14736955
ide	I-Chemical	-1	14736955
pro@@	O	-1	14736955
duction	O	-1	14736955
and	O	-1	14736955
the	O	-1	14736955
4@@	O	-1	14736955
8@@	O	-1	14736955
3@@	O	-1	14736955
4	O	-1	14736955
b@@	O	-1	14736955
ase	O	-1	14736955
pa@@	O	-1	14736955
ir	O	-1	14736955
'@@	O	-1	14736955
common@@	O	-1	14736955
'	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
NA	O	-1	14736955
de@@	O	-1	14736955
le@@	O	-1	14736955
tion.	O	-1	14736955
RESULTS:	O	-1	14736955
The	O	-1	14736955
'@@	O	-1	14736955
long@@	O	-1	14736955
-@@	O	-1	14736955
ter@@	O	-1	14736955
m@@	O	-1	14736955
'	O	-1	14736955
group	O	-1	14736955
had	O	-1	14736955
significant	O	-1	14736955
glomerular	B-Disease	D007674	14736955
and	I-Disease	-1	14736955
tub@@	I-Disease	-1	14736955
ular	I-Disease	-1	14736955
lesions	I-Disease	-1	14736955
,	O	-1	14736955
depress@@	O	-1	14736955
ed	O	-1	14736955
ac@@	O	-1	14736955
ti@@	O	-1	14736955
vi@@	O	-1	14736955
ties	O	-1	14736955
of	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
N@@	O	-1	14736955
A@@	O	-1	14736955
-@@	O	-1	14736955
en@@	O	-1	14736955
co@@	O	-1	14736955
ded	O	-1	14736955
N@@	O	-1	14736955
AD@@	O	-1	14736955
H	O	-1	14736955
de@@	O	-1	14736955
hydro@@	O	-1	14736955
gen@@	O	-1	14736955
ase	O	-1	14736955
and	O	-1	14736955
cyto@@	O	-1	14736955
ch@@	O	-1	14736955
ro@@	O	-1	14736955
me@@	O	-1	14736955
-@@	O	-1	14736955
c	O	-1	14736955
oxid@@	O	-1	14736955
ase	O	-1	14736955
(C@@	O	-1	14736955
O@@	O	-1	14736955
X@@	O	-1	14736955
)	O	-1	14736955
and	O	-1	14736955
increased	O	-1	14736955
cit@@	B-Chemical	C102006	14736955
rate	I-Chemical	-1	14736955
syn@@	O	-1	14736955
th@@	O	-1	14736955
ase	O	-1	14736955
activ@@	O	-1	14736955
ity.	O	-1	14736955
In	O	-1	14736955
addi@@	O	-1	14736955
tion,	O	-1	14736955
expression	O	-1	14736955
of	O	-1	14736955
the	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
N@@	O	-1	14736955
A@@	O	-1	14736955
-@@	O	-1	14736955
en@@	O	-1	14736955
co@@	O	-1	14736955
ded	O	-1	14736955
CO@@	O	-1	14736955
X	O	-1	14736955
sub@@	O	-1	14736955
un@@	O	-1	14736955
it	O	-1	14736955
I	O	-1	14736955
was	O	-1	14736955
reduced	O	-1	14736955
and	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
NA	O	-1	14736955
levels	O	-1	14736955
were	O	-1	14736955
decreas@@	O	-1	14736955
ed.	O	-1	14736955
In	O	-1	14736955
'@@	O	-1	14736955
sh@@	O	-1	14736955
ort@@	O	-1	14736955
-@@	O	-1	14736955
ter@@	O	-1	14736955
m@@	O	-1	14736955
'	O	-1	14736955
rats,	O	-1	14736955
there	O	-1	14736955
were	O	-1	14736955
fe@@	O	-1	14736955
w@@	O	-1	14736955
er	O	-1	14736955
tub@@	B-Disease	D007674	14736955
ular	I-Disease	-1	14736955
lesions	I-Disease	-1	14736955
,	O	-1	14736955
but	O	-1	14736955
similar	O	-1	14736955
numb@@	O	-1	14736955
ers	O	-1	14736955
of	O	-1	14736955
glomerular	B-Disease	D007674	14736955
lesions	I-Disease	-1	14736955
activ@@	O	-1	14736955
ity.	O	-1	14736955
A@@	O	-1	14736955
mon@@	O	-1	14736955
g	O	-1	14736955
all	O	-1	14736955
anim@@	O	-1	14736955
al@@	O	-1	14736955
s,	O	-1	14736955
glomerular	B-Disease	D007674	14736955
and	I-Disease	-1	14736955
tub@@	I-Disease	-1	14736955
ular	I-Disease	-1	14736955
injury	I-Disease	-1	14736955
were	O	-1	14736955
in@@	O	-1	14736955
ver@@	O	-1	14736955
se@@	O	-1	14736955
ly	O	-1	14736955
cor@@	O	-1	14736955
related	O	-1	14736955
with	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
NA	O	-1	14736955
level@@	O	-1	14736955
s,	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
N@@	O	-1	14736955
A@@	O	-1	14736955
-@@	O	-1	14736955
en@@	O	-1	14736955
co@@	O	-1	14736955
ded	O	-1	14736955
respiratory	O	-1	14736955
ch@@	O	-1	14736955
ain	O	-1	14736955
ac@@	O	-1	14736955
ti@@	O	-1	14736955
vi@@	O	-1	14736955
ties	O	-1	14736955
and	O	-1	14736955
with	O	-1	14736955
the	O	-1	14736955
expression	O	-1	14736955
of	O	-1	14736955
the	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
N@@	O	-1	14736955
A@@	O	-1	14736955
-@@	O	-1	14736955
en@@	O	-1	14736955
co@@	O	-1	14736955
ded	O	-1	14736955
respiratory	O	-1	14736955
ch@@	O	-1	14736955
ain	O	-1	14736955
sub@@	O	-1	14736955
un@@	O	-1	14736955
it	O	-1	14736955
CO@@	O	-1	14736955
X@@	O	-1	14736955
-@@	O	-1	14736955
I@@	O	-1	14736955
.	O	-1	14736955
In@@	O	-1	14736955
j@@	O	-1	14736955
ur@@	O	-1	14736955
y	O	-1	14736955
was	O	-1	14736955
posi@@	O	-1	14736955
ti@@	O	-1	14736955
vely	O	-1	14736955
cor@@	O	-1	14736955
related	O	-1	14736955
with	O	-1	14736955
su@@	B-Chemical	D013481	14736955
per@@	I-Chemical	-1	14736955
ox@@	I-Chemical	-1	14736955
ide	I-Chemical	-1	14736955
pro@@	O	-1	14736955
duction	O	-1	14736955
and	O	-1	14736955
the	O	-1	14736955
ac@@	O	-1	14736955
ti@@	O	-1	14736955
vi@@	O	-1	14736955
ties	O	-1	14736955
of	O	-1	14736955
nucle@@	O	-1	14736955
us@@	O	-1	14736955
-@@	O	-1	14736955
en@@	O	-1	14736955
co@@	O	-1	14736955
ded	O	-1	14736955
mitochondrial	O	-1	14736955
or	O	-1	14736955
cyto@@	O	-1	14736955
plas@@	O	-1	14736955
mic	O	-1	14736955
enzym@@	O	-1	14736955
es.	O	-1	14736955
K@@	O	-1	14736955
idne@@	O	-1	14736955
ys	O	-1	14736955
from	O	-1	14736955
the	O	-1	14736955
'@@	O	-1	14736955
long@@	O	-1	14736955
-@@	O	-1	14736955
ter@@	O	-1	14736955
m@@	O	-1	14736955
'	O	-1	14736955
group	O	-1	14736955
showed	O	-1	14736955
more	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
NA	O	-1	14736955
de@@	O	-1	14736955
le@@	O	-1	14736955
tions	O	-1	14736955
than	O	-1	14736955
in	O	-1	14736955
'@@	O	-1	14736955
sh@@	O	-1	14736955
ort@@	O	-1	14736955
-@@	O	-1	14736955
ter@@	O	-1	14736955
m@@	O	-1	14736955
'	O	-1	14736955
animals	O	-1	14736955
and	O	-1	14736955
these	O	-1	14736955
were	O	-1	14736955
not	O	-1	14736955
observed	O	-1	14736955
in	O	-1	14736955
the	O	-1	14736955
other	O	-1	14736955
groups.	O	-1	14736955
CONCLUSIONS:	O	-1	14736955
These	O	-1	14736955
results	O	-1	14736955
suggest	O	-1	14736955
an	O	-1	14736955
important	O	-1	14736955
role	O	-1	14736955
for	O	-1	14736955
qu@@	O	-1	14736955
anti@@	O	-1	14736955
t@@	O	-1	14736955
ative	O	-1	14736955
and	O	-1	14736955
qu@@	O	-1	14736955
al@@	O	-1	14736955
it@@	O	-1	14736955
ative	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
NA	O	-1	14736955
al@@	O	-1	14736955
ter@@	O	-1	14736955
ations	O	-1	14736955
through	O	-1	14736955
the	O	-1	14736955
reduction	O	-1	14736955
of	O	-1	14736955
m@@	O	-1	14736955
t@@	O	-1	14736955
D@@	O	-1	14736955
N@@	O	-1	14736955
A@@	O	-1	14736955
-@@	O	-1	14736955
en@@	O	-1	14736955
co@@	O	-1	14736955
ded	O	-1	14736955
respiratory	O	-1	14736955
ch@@	O	-1	14736955
ain	O	-1	14736955
function	O	-1	14736955
and	O	-1	14736955
induction	O	-1	14736955
of	O	-1	14736955
su@@	B-Chemical	D013481	14736955
per@@	I-Chemical	-1	14736955
ox@@	I-Chemical	-1	14736955
ide	I-Chemical	-1	14736955
in	O	-1	14736955
dox@@	B-Chemical	D004317	14736955
orub@@	I-Chemical	-1	14736955
icin	I-Chemical	-1	14736955
-induced	O	-1	14736955
renal	B-Disease	D007674	14736955
lesions	I-Disease	-1	14736955
.	O	-1	14736955

A@@	B-Chemical	D000666	11573852
m@@	I-Chemical	-1	11573852
ph@@	I-Chemical	-1	11573852
ot@@	I-Chemical	-1	11573852
er@@	I-Chemical	-1	11573852
icin	I-Chemical	-1	11573852
B	I-Chemical	-1	11573852
-induced	O	-1	11573852
seizures	B-Disease	D012640	11573852
in	O	-1	11573852
a	O	-1	11573852
patient	O	-1	11573852
with	O	-1	11573852
A@@	B-Disease	D000163	11573852
I@@	I-Disease	-1	11573852
D@@	I-Disease	-1	11573852
S	I-Disease	-1	11573852
.	O	-1	11573852
OBJECTIVE:	O	-1	11573852
To	O	-1	11573852
report	O	-1	11573852
a	O	-1	11573852
case	O	-1	11573852
of	O	-1	11573852
multiple	O	-1	11573852
episo@@	O	-1	11573852
des	O	-1	11573852
of	O	-1	11573852
seizure	B-Disease	D012640	11573852
activity	O	-1	11573852
in	O	-1	11573852
an	O	-1	11573852
A@@	B-Disease	D000163	11573852
I@@	I-Disease	-1	11573852
D@@	I-Disease	-1	11573852
S	I-Disease	-1	11573852
pat@@	O	-1	11573852
ent	O	-1	11573852
following	O	-1	11573852
amph@@	B-Chemical	D000666	11573852
ot@@	I-Chemical	-1	11573852
er@@	I-Chemical	-1	11573852
icin	I-Chemical	-1	11573852
B	I-Chemical	-1	11573852
infu@@	O	-1	11573852
sion.	O	-1	11573852
CA@@	O	-1	11573852
S@@	O	-1	11573852
E	O	-1	11573852
S@@	O	-1	11573852
U@@	O	-1	11573852
M@@	O	-1	11573852
MA@@	O	-1	11573852
R@@	O	-1	11573852
Y@@	O	-1	11573852
:	O	-1	11573852
A	O	-1	11573852
4@@	O	-1	11573852
6-@@	O	-1	11573852
year-old	O	-1	11573852
Af@@	O	-1	11573852
r@@	O	-1	11573852
ic@@	O	-1	11573852
an@@	O	-1	11573852
-@@	O	-1	11573852
A@@	O	-1	11573852
mer@@	O	-1	11573852
ic@@	O	-1	11573852
an	O	-1	11573852
man	O	-1	11573852
experienced	O	-1	11573852
recur@@	O	-1	11573852
rent	O	-1	11573852
g@@	B-Disease	D004830	11573852
r@@	I-Disease	-1	11573852
and	I-Disease	-1	11573852
m@@	I-Disease	-1	11573852
al	I-Disease	-1	11573852
seizures	I-Disease	-1	11573852
during	O	-1	11573852
intravenous	O	-1	11573852
infusion	O	-1	11573852
of	O	-1	11573852
amph@@	B-Chemical	D000666	11573852
ot@@	I-Chemical	-1	11573852
er@@	I-Chemical	-1	11573852
icin	I-Chemical	-1	11573852
B	I-Chemical	-1	11573852
,	O	-1	11573852
then	O	-1	11573852
pe@@	O	-1	11573852
ti@@	O	-1	11573852
t	O	-1	11573852
m@@	O	-1	11573852
al	O	-1	11573852
seizures	B-Disease	D012640	11573852
as	O	-1	11573852
the	O	-1	11573852
infusion	O	-1	11573852
was	O	-1	11573852
sto@@	O	-1	11573852
pp@@	O	-1	11573852
ed	O	-1	11573852
and	O	-1	11573852
the	O	-1	11573852
drug	O	-1	11573852
concentrations	O	-1	11573852
decreased	O	-1	11573852
with	O	-1	11573852
ti@@	O	-1	11573852
me.	O	-1	11573852
The	O	-1	11573852
patients	O	-1	11573852
con@@	O	-1	11573852
current	O	-1	11573852
medic@@	O	-1	11573852
ations	O	-1	11573852
included	O	-1	11573852
di@@	B-Chemical	D016049	11573852
d@@	I-Chemical	-1	11573852
an@@	I-Chemical	-1	11573852
os@@	I-Chemical	-1	11573852
ine	I-Chemical	-1	11573852
,	O	-1	11573852
hydrox@@	B-Chemical	D006919	11573852
y@@	I-Chemical	-1	11573852
z@@	I-Chemical	-1	11573852
ine	I-Chemical	-1	11573852
,	O	-1	11573852
pro@@	B-Chemical	D011398	11573852
meth@@	I-Chemical	-1	11573852
az@@	I-Chemical	-1	11573852
ine	I-Chemical	-1	11573852
,	O	-1	11573852
hydro@@	B-Chemical	D006854	11573852
cor@@	I-Chemical	-1	11573852
tis@@	I-Chemical	-1	11573852
one	I-Chemical	-1	11573852
,	O	-1	11573852
and	O	-1	11573852
pro@@	B-Chemical	D011346	11573852
chlor@@	I-Chemical	-1	11573852
per@@	I-Chemical	-1	11573852
az@@	I-Chemical	-1	11573852
ine	I-Chemical	-1	11573852
.	O	-1	11573852
D@@	O	-1	11573852
es@@	O	-1	11573852
pit@@	O	-1	11573852
e	O	-1	11573852
administration	O	-1	11573852
of	O	-1	11573852
pheny@@	B-Chemical	D010672	11573852
to@@	I-Chemical	-1	11573852
in	I-Chemical	-1	11573852
and	O	-1	11573852
lor@@	B-Chemical	D008140	11573852
az@@	I-Chemical	-1	11573852
epam	I-Chemical	-1	11573852
,	O	-1	11573852
the	O	-1	11573852
seizures	B-Disease	D012640	11573852
per@@	O	-1	11573852
sist@@	O	-1	11573852
ed	O	-1	11573852
and	O	-1	11573852
occurred	O	-1	11573852
only	O	-1	11573852
during	O	-1	11573852
amph@@	B-Chemical	D000666	11573852
ot@@	I-Chemical	-1	11573852
er@@	I-Chemical	-1	11573852
c@@	I-Chemical	-1	11573852
in	I-Chemical	-1	11573852
B	I-Chemical	-1	11573852
administr@@	O	-1	11573852
ation.	O	-1	11573852
D@@	O	-1	11573852
I@@	O	-1	11573852
S@@	O	-1	11573852
C@@	O	-1	11573852
US@@	O	-1	11573852
S@@	O	-1	11573852
ION@@	O	-1	11573852
:	O	-1	11573852
A@@	B-Disease	D000163	11573852
I@@	I-Disease	-1	11573852
D@@	I-Disease	-1	11573852
S	I-Disease	-1	11573852
and	O	-1	11573852
c@@	B-Disease	D016919	11573852
r@@	I-Disease	-1	11573852
y@@	I-Disease	-1	11573852
pto@@	I-Disease	-1	11573852
co@@	I-Disease	-1	11573852
c@@	I-Disease	-1	11573852
c@@	I-Disease	-1	11573852
al	I-Disease	-1	11573852
men@@	I-Disease	-1	11573852
ing@@	I-Disease	-1	11573852
iti@@	I-Disease	-1	11573852
s	I-Disease	-1	11573852
,	O	-1	11573852
both	O	-1	11573852
of	O	-1	11573852
which	O	-1	11573852
the	O	-1	11573852
patient	O	-1	11573852
h@@	O	-1	11573852
ad@@	O	-1	11573852
,	O	-1	11573852
can	O	-1	11573852
potenti@@	O	-1	11573852
ally	O	-1	11573852
cause	O	-1	11573852
seizures	B-Disease	D012640	11573852
.	O	-1	11573852
The	O	-1	11573852
patient	O	-1	11573852
had	O	-1	11573852
a	O	-1	11573852
hist@@	O	-1	11573852
ory	O	-1	11573852
of	O	-1	11573852
alco@@	B-Disease	D000437	11573852
hol	I-Disease	-1	11573852
ab@@	I-Disease	-1	11573852
use	I-Disease	-1	11573852
;	O	-1	11573852
alco@@	B-Chemical	D000431	11573852
hol	I-Chemical	-1	11573852
int@@	O	-1	11573852
ake	O	-1	11573852
as	O	-1	11573852
well	O	-1	11573852
as	O	-1	11573852
withdrawal	O	-1	11573852
can	O	-1	11573852
also	O	-1	11573852
cause	O	-1	11573852
seizures	B-Disease	D012640	11573852
.	O	-1	11573852
D@@	B-Chemical	D016049	11573852
id@@	I-Chemical	-1	11573852
an@@	I-Chemical	-1	11573852
os@@	I-Chemical	-1	11573852
ine	I-Chemical	-1	11573852
also	O	-1	11573852
has	O	-1	11573852
a	O	-1	11573852
potential	O	-1	11573852
for	O	-1	11573852
induc@@	O	-1	11573852
ing	O	-1	11573852
seizures	B-Disease	D012640	11573852
.	O	-1	11573852
However,	O	-1	11573852
these	O	-1	11573852
other	O	-1	11573852
potential	O	-1	11573852
causes	O	-1	11573852
of	O	-1	11573852
seizure	B-Disease	D012640	11573852
were	O	-1	11573852
r@@	O	-1	11573852
ul@@	O	-1	11573852
ed	O	-1	11573852
out@@	O	-1	11573852
.	O	-1	11573852
The	O	-1	11573852
time	O	-1	11573852
course	O	-1	11573852
of	O	-1	11573852
events	O	-1	11573852
suggested	O	-1	11573852
that	O	-1	11573852
amph@@	B-Chemical	D000666	11573852
ot@@	I-Chemical	-1	11573852
er@@	I-Chemical	-1	11573852
icin	I-Chemical	-1	11573852
B	I-Chemical	-1	11573852
was	O	-1	11573852
the	O	-1	11573852
cause	O	-1	11573852
of	O	-1	11573852
the	O	-1	11573852
seizures	B-Disease	D012640	11573852
in	O	-1	11573852
this	O	-1	11573852
A@@	B-Disease	D000163	11573852
I@@	I-Disease	-1	11573852
D@@	I-Disease	-1	11573852
S	I-Disease	-1	11573852
patient@@	O	-1	11573852
.	O	-1	11573852
CONCLUSIONS:	O	-1	11573852
A@@	B-Chemical	D000666	11573852
m@@	I-Chemical	-1	11573852
ph@@	I-Chemical	-1	11573852
ot@@	I-Chemical	-1	11573852
er@@	I-Chemical	-1	11573852
icin	I-Chemical	-1	11573852
B	I-Chemical	-1	11573852
se@@	O	-1	11573852
em@@	O	-1	11573852
s	O	-1	11573852
to	O	-1	11573852
be	O	-1	11573852
the	O	-1	11573852
prob@@	O	-1	11573852
able	O	-1	11573852
cause	O	-1	11573852
of	O	-1	11573852
the	O	-1	11573852
seizures	B-Disease	D012640	11573852
.	O	-1	11573852
To	O	-1	11573852
dat@@	O	-1	11573852
e,	O	-1	11573852
only	O	-1	11573852
three	O	-1	11573852
cases	O	-1	11573852
of	O	-1	11573852
seizures	B-Disease	D012640	11573852
associated	O	-1	11573852
with	O	-1	11573852
amph@@	B-Chemical	D000666	11573852
ot@@	I-Chemical	-1	11573852
er@@	I-Chemical	-1	11573852
icin	I-Chemical	-1	11573852
B	I-Chemical	-1	11573852
have	O	-1	11573852
been	O	-1	11573852
reported	O	-1	11573852
in	O	-1	11573852
the	O	-1	11573852
literat@@	O	-1	11573852
ure,	O	-1	11573852
but	O	-1	11573852
health@@	O	-1	11573852
car@@	O	-1	11573852
e	O	-1	11573852
pro@@	O	-1	11573852
vid@@	O	-1	11573852
ers	O	-1	11573852
should	O	-1	11573852
be	O	-1	11573852
aw@@	O	-1	11573852
are	O	-1	11573852
of	O	-1	11573852
the	O	-1	11573852
potential	O	-1	11573852
for	O	-1	11573852
this	O	-1	11573852
r@@	O	-1	11573852
are	O	-1	11573852
adverse	O	-1	11573852
effect@@	O	-1	11573852
.	O	-1	11573852

Th@@	O	-1	9875685
er@@	O	-1	9875685
ap@@	O	-1	9875685
eu@@	O	-1	9875685
tic	O	-1	9875685
drug	O	-1	9875685
monit@@	O	-1	9875685
or@@	O	-1	9875685
ing	O	-1	9875685
of	O	-1	9875685
to@@	B-Chemical	D014031	9875685
b@@	I-Chemical	-1	9875685
ram@@	I-Chemical	-1	9875685
ycin	I-Chemical	-1	9875685
:	O	-1	9875685
on@@	O	-1	9875685
ce@@	O	-1	9875685
-@@	O	-1	9875685
daily	O	-1	9875685
versus	O	-1	9875685
tw@@	O	-1	9875685
ic@@	O	-1	9875685
e-@@	O	-1	9875685
daily	O	-1	9875685
dos@@	O	-1	9875685
age	O	-1	9875685
sch@@	O	-1	9875685
ed@@	O	-1	9875685
ul@@	O	-1	9875685
es.	O	-1	9875685
OBJECTIVE:	O	-1	9875685
To	O	-1	9875685
evalu@@	O	-1	9875685
ate	O	-1	9875685
the	O	-1	9875685
effect	O	-1	9875685
of	O	-1	9875685
dos@@	O	-1	9875685
age	O	-1	9875685
regi@@	O	-1	9875685
men	O	-1	9875685
(@@	O	-1	9875685
on@@	O	-1	9875685
ce@@	O	-1	9875685
-@@	O	-1	9875685
daily	O	-1	9875685
vs.	O	-1	9875685
tw@@	O	-1	9875685
ic@@	O	-1	9875685
e-@@	O	-1	9875685
da@@	O	-1	9875685
il@@	O	-1	9875685
y@@	O	-1	9875685
)	O	-1	9875685
of	O	-1	9875685
to@@	B-Chemical	D014031	9875685
b@@	I-Chemical	-1	9875685
ram@@	I-Chemical	-1	9875685
ic@@	I-Chemical	-1	9875685
y@@	I-Chemical	-1	9875685
n	I-Chemical	-1	9875685
on	O	-1	9875685
ste@@	O	-1	9875685
ad@@	O	-1	9875685
y-@@	O	-1	9875685
state	O	-1	9875685
serum	O	-1	9875685
concentrations	O	-1	9875685
and	O	-1	9875685
toxicity	B-Disease	D064420	9875685
.	O	-1	9875685
M@@	O	-1	9875685
AT@@	O	-1	9875685
E@@	O	-1	9875685
R@@	O	-1	9875685
I@@	O	-1	9875685
AL@@	O	-1	9875685
S	O	-1	9875685
AN@@	O	-1	9875685
D	O	-1	9875685
METHODS:	O	-1	9875685
Patients	O	-1	9875685
under@@	O	-1	9875685
go@@	O	-1	9875685
ing	O	-1	9875685
treatment	O	-1	9875685
with	O	-1	9875685
i.v@@	O	-1	9875685
.	O	-1	9875685
to@@	B-Chemical	D014031	9875685
b@@	I-Chemical	-1	9875685
ram@@	I-Chemical	-1	9875685
ycin	I-Chemical	-1	9875685
(@@	O	-1	9875685
4	O	-1	9875685
mg/k@@	O	-1	9875685
g/@@	O	-1	9875685
day@@	O	-1	9875685
)	O	-1	9875685
were	O	-1	9875685
random@@	O	-1	9875685
is@@	O	-1	9875685
ed	O	-1	9875685
to	O	-1	9875685
two	O	-1	9875685
groups.	O	-1	9875685
Group	O	-1	9875685
O@@	O	-1	9875685
D	O	-1	9875685
(n	O	-1	9875685
=	O	-1	9875685
2@@	O	-1	9875685
2)	O	-1	9875685
received	O	-1	9875685
a	O	-1	9875685
on@@	O	-1	9875685
ce@@	O	-1	9875685
-@@	O	-1	9875685
daily	O	-1	9875685
dose	O	-1	9875685
of	O	-1	9875685
to@@	B-Chemical	D014031	9875685
b@@	I-Chemical	-1	9875685
ram@@	I-Chemical	-1	9875685
ycin	I-Chemical	-1	9875685
and	O	-1	9875685
group	O	-1	9875685
T@@	O	-1	9875685
D	O	-1	9875685
(n	O	-1	9875685
=	O	-1	9875685
2@@	O	-1	9875685
1)	O	-1	9875685
received	O	-1	9875685
the	O	-1	9875685
same	O	-1	9875685
dose	O	-1	9875685
divid@@	O	-1	9875685
ed	O	-1	9875685
into	O	-1	9875685
two	O	-1	9875685
doses	O	-1	9875685
da@@	O	-1	9875685
il@@	O	-1	9875685
y.	O	-1	9875685
T@@	B-Chemical	D014031	9875685
ob@@	I-Chemical	-1	9875685
ram@@	I-Chemical	-1	9875685
ycin	I-Chemical	-1	9875685
serum	O	-1	9875685
concentrations	O	-1	9875685
(@@	O	-1	9875685
pe@@	O	-1	9875685
a@@	O	-1	9875685
k	O	-1	9875685
and	O	-1	9875685
t@@	O	-1	9875685
rou@@	O	-1	9875685
gh@@	O	-1	9875685
)	O	-1	9875685
were	O	-1	9875685
measured	O	-1	9875685
by	O	-1	9875685
enzyme	O	-1	9875685
multi@@	O	-1	9875685
pl@@	O	-1	9875685
ied	O	-1	9875685
immuno@@	O	-1	9875685
ass@@	O	-1	9875685
a@@	O	-1	9875685
y.	O	-1	9875685
The	O	-1	9875685
renal	O	-1	9875685
and	O	-1	9875685
a@@	O	-1	9875685
ud@@	O	-1	9875685
it@@	O	-1	9875685
ory	O	-1	9875685
func@@	O	-1	9875685
tions	O	-1	9875685
of	O	-1	9875685
the	O	-1	9875685
patients	O	-1	9875685
were	O	-1	9875685
monit@@	O	-1	9875685
o@@	O	-1	9875685
red	O	-1	9875685
be@@	O	-1	9875685
fo@@	O	-1	9875685
re,	O	-1	9875685
during	O	-1	9875685
and	O	-1	9875685
immedi@@	O	-1	9875685
ately	O	-1	9875685
after	O	-1	9875685
treatment.	O	-1	9875685
RESULTS:	O	-1	9875685
The	O	-1	9875685
two	O	-1	9875685
groups	O	-1	9875685
were	O	-1	9875685
compar@@	O	-1	9875685
able	O	-1	9875685
with	O	-1	9875685
resp@@	O	-1	9875685
ect	O	-1	9875685
to	O	-1	9875685
sex@@	O	-1	9875685
,	O	-1	9875685
age,	O	-1	9875685
body	O	-1	9875685
weight	O	-1	9875685
and	O	-1	9875685
renal	O	-1	9875685
func@@	O	-1	9875685
tion.	O	-1	9875685
No	O	-1	9875685
statis@@	O	-1	9875685
tically	O	-1	9875685
significant	O	-1	9875685
differences	O	-1	9875685
were	O	-1	9875685
found	O	-1	9875685
in	O	-1	9875685
mean	O	-1	9875685
daily	O	-1	9875685
dose@@	O	-1	9875685
,	O	-1	9875685
duration	O	-1	9875685
of	O	-1	9875685
treatment,	O	-1	9875685
or	O	-1	9875685
cum@@	O	-1	9875685
ul@@	O	-1	9875685
ative	O	-1	9875685
dose.	O	-1	9875685
T@@	O	-1	9875685
rou@@	O	-1	9875685
gh	O	-1	9875685
concentrations	O	-1	9875685
were	O	-1	9875685
<	O	-1	9875685
2	O	-1	9875685
g/@@	O	-1	9875685
m@@	O	-1	9875685
l	O	-1	9875685
in	O	-1	9875685
the	O	-1	9875685
two	O	-1	9875685
groups	O	-1	9875685
(@@	O	-1	9875685
10@@	O	-1	9875685
0@@	O	-1	9875685
%).	O	-1	9875685
P@@	O	-1	9875685
e@@	O	-1	9875685
a@@	O	-1	9875685
k	O	-1	9875685
concentrations	O	-1	9875685
were	O	-1	9875685
>	O	-1	9875685
6	O	-1	9875685
micro@@	O	-1	9875685
g/@@	O	-1	9875685
m@@	O	-1	9875685
l	O	-1	9875685
in	O	-1	9875685
10@@	O	-1	9875685
0%	O	-1	9875685
of	O	-1	9875685
the	O	-1	9875685
O@@	O	-1	9875685
D	O	-1	9875685
group	O	-1	9875685
and	O	-1	9875685
in	O	-1	9875685
6@@	O	-1	9875685
7@@	O	-1	9875685
%	O	-1	9875685
of	O	-1	9875685
the	O	-1	9875685
T@@	O	-1	9875685
D	O	-1	9875685
group	O	-1	9875685
(P@@	O	-1	9875685
<	O	-1	9875685
0.0@@	O	-1	9875685
1).	O	-1	9875685
M@@	O	-1	9875685
e@@	O	-1	9875685
an	O	-1	9875685
pe@@	O	-1	9875685
a@@	O	-1	9875685
k	O	-1	9875685
concentrations	O	-1	9875685
were	O	-1	9875685
mark@@	O	-1	9875685
ed@@	O	-1	9875685
ly	O	-1	9875685
differen@@	O	-1	9875685
t@@	O	-1	9875685
:	O	-1	9875685
1@@	O	-1	9875685
1.@@	O	-1	9875685
0@@	O	-1	9875685
0@@	O	-1	9875685
+/-@@	O	-1	9875685
2.@@	O	-1	9875685
8@@	O	-1	9875685
9	O	-1	9875685
micro@@	O	-1	9875685
g/@@	O	-1	9875685
m@@	O	-1	9875685
l	O	-1	9875685
in	O	-1	9875685
O@@	O	-1	9875685
D	O	-1	9875685
vs.	O	-1	9875685
6.@@	O	-1	9875685
5@@	O	-1	9875685
3@@	O	-1	9875685
+/-@@	O	-1	9875685
1.@@	O	-1	9875685
4@@	O	-1	9875685
5	O	-1	9875685
micro@@	O	-1	9875685
g/@@	O	-1	9875685
m@@	O	-1	9875685
l	O	-1	9875685
in	O	-1	9875685
T@@	O	-1	9875685
D	O	-1	9875685
(P@@	O	-1	9875685
<	O	-1	9875685
0.0@@	O	-1	9875685
1).	O	-1	9875685
The	O	-1	9875685
pharmac@@	O	-1	9875685
o@@	O	-1	9875685
kine@@	O	-1	9875685
tics	O	-1	9875685
par@@	O	-1	9875685
ame@@	O	-1	9875685
ters	O	-1	9875685
we@@	O	-1	9875685
re@@	O	-1	9875685
:	O	-1	9875685
K@@	O	-1	9875685
e,	O	-1	9875685
(0.@@	O	-1	9875685
1@@	O	-1	9875685
5@@	O	-1	9875685
+/-@@	O	-1	9875685
0.0@@	O	-1	9875685
3@@	O	-1	9875685
/@@	O	-1	9875685
h	O	-1	9875685
in	O	-1	9875685
O@@	O	-1	9875685
D	O	-1	9875685
vs.	O	-1	9875685
0.@@	O	-1	9875685
2@@	O	-1	9875685
4@@	O	-1	9875685
+/-@@	O	-1	9875685
0.0@@	O	-1	9875685
6@@	O	-1	9875685
/@@	O	-1	9875685
h	O	-1	9875685
in	O	-1	9875685
T@@	O	-1	9875685
D@@	O	-1	9875685
),	O	-1	9875685
t@@	O	-1	9875685
1@@	O	-1	9875685
/@@	O	-1	9875685
2,	O	-1	9875685
(@@	O	-1	9875685
4.@@	O	-1	9875685
9@@	O	-1	9875685
5@@	O	-1	9875685
+/-@@	O	-1	9875685
1.@@	O	-1	9875685
4@@	O	-1	9875685
1	O	-1	9875685
h	O	-1	9875685
in	O	-1	9875685
O@@	O	-1	9875685
D	O	-1	9875685
vs.	O	-1	9875685
3.@@	O	-1	9875685
0@@	O	-1	9875685
7@@	O	-1	9875685
+/-@@	O	-1	9875685
0.@@	O	-1	9875685
7@@	O	-1	9875685
1	O	-1	9875685
h	O	-1	9875685
in	O	-1	9875685
T@@	O	-1	9875685
D@@	O	-1	9875685
),	O	-1	9875685
V@@	O	-1	9875685
d	O	-1	9875685
(0.@@	O	-1	9875685
3@@	O	-1	9875685
5@@	O	-1	9875685
+/-@@	O	-1	9875685
0.@@	O	-1	9875685
11	O	-1	9875685
l@@	O	-1	9875685
/@@	O	-1	9875685
k@@	O	-1	9875685
g	O	-1	9875685
in	O	-1	9875685
O@@	O	-1	9875685
D	O	-1	9875685
vs.	O	-1	9875685
0.@@	O	-1	9875685
3@@	O	-1	9875685
3@@	O	-1	9875685
+/-@@	O	-1	9875685
0.0@@	O	-1	9875685
9	O	-1	9875685
l@@	O	-1	9875685
/@@	O	-1	9875685
k@@	O	-1	9875685
g	O	-1	9875685
in	O	-1	9875685
T@@	O	-1	9875685
D@@	O	-1	9875685
),	O	-1	9875685
C@@	O	-1	9875685
l	O	-1	9875685
(0.@@	O	-1	9875685
8@@	O	-1	9875685
6@@	O	-1	9875685
+/-@@	O	-1	9875685
0.@@	O	-1	9875685
2@@	O	-1	9875685
9	O	-1	9875685
ml@@	O	-1	9875685
/@@	O	-1	9875685
min@@	O	-1	9875685
/@@	O	-1	9875685
k@@	O	-1	9875685
g	O	-1	9875685
in	O	-1	9875685
O@@	O	-1	9875685
D	O	-1	9875685
vs.	O	-1	9875685
1.@@	O	-1	9875685
2@@	O	-1	9875685
8@@	O	-1	9875685
+/-@@	O	-1	9875685
0.@@	O	-1	9875685
3@@	O	-1	9875685
3	O	-1	9875685
ml@@	O	-1	9875685
/@@	O	-1	9875685
min@@	O	-1	9875685
/@@	O	-1	9875685
k@@	O	-1	9875685
g	O	-1	9875685
in	O	-1	9875685
T@@	O	-1	9875685
D@@	O	-1	9875685
).	O	-1	9875685
In@@	O	-1	9875685
c@@	O	-1	9875685
reas@@	O	-1	9875685
ed	O	-1	9875685
serum	O	-1	9875685
creatinine	B-Chemical	D003404	9875685
was	O	-1	9875685
observed	O	-1	9875685
in	O	-1	9875685
7@@	O	-1	9875685
3@@	O	-1	9875685
%	O	-1	9875685
of	O	-1	9875685
patients	O	-1	9875685
in	O	-1	9875685
O@@	O	-1	9875685
D	O	-1	9875685
versus	O	-1	9875685
5@@	O	-1	9875685
7@@	O	-1	9875685
%	O	-1	9875685
of	O	-1	9875685
patients	O	-1	9875685
in	O	-1	9875685
T@@	O	-1	9875685
D@@	O	-1	9875685
,	O	-1	9875685
without	O	-1	9875685
evidence	O	-1	9875685
of	O	-1	9875685
nephro@@	B-Disease	D007674	9875685
toxicity	I-Disease	-1	9875685
.	O	-1	9875685
In	O	-1	9875685
T@@	O	-1	9875685
D	O	-1	9875685
group@@	O	-1	9875685
,	O	-1	9875685
three	O	-1	9875685
patients	O	-1	9875685
developed	O	-1	9875685
decreased	B-Disease	D034381	9875685
a@@	I-Disease	-1	9875685
ud@@	I-Disease	-1	9875685
it@@	I-Disease	-1	9875685
ory	I-Disease	-1	9875685
function	I-Disease	-1	9875685
,	O	-1	9875685
of	O	-1	9875685
which	O	-1	9875685
one	O	-1	9875685
presented	O	-1	9875685
with	O	-1	9875685
an	O	-1	9875685
a@@	B-Disease	D034381	9875685
ud@@	I-Disease	-1	9875685
it@@	I-Disease	-1	9875685
ory	I-Disease	-1	9875685
loss	I-Disease	-1	9875685
of	O	-1	9875685
-@@	O	-1	9875685
30	O	-1	9875685
d@@	O	-1	9875685
B@@	O	-1	9875685
,	O	-1	9875685
whereas	O	-1	9875685
in	O	-1	9875685
the	O	-1	9875685
O@@	O	-1	9875685
D	O	-1	9875685
group	O	-1	9875685
only	O	-1	9875685
one	O	-1	9875685
patient	O	-1	9875685
presented	O	-1	9875685
decreased	B-Disease	D034381	9875685
a@@	I-Disease	-1	9875685
ud@@	I-Disease	-1	9875685
it@@	I-Disease	-1	9875685
ory	I-Disease	-1	9875685
function	I-Disease	-1	9875685
.	O	-1	9875685
CONCLUSION:	O	-1	9875685
This	O	-1	9875685
sm@@	O	-1	9875685
all	O	-1	9875685
study	O	-1	9875685
suggests	O	-1	9875685
that	O	-1	9875685
a	O	-1	9875685
on@@	O	-1	9875685
ce@@	O	-1	9875685
-@@	O	-1	9875685
daily	O	-1	9875685
dos@@	O	-1	9875685
ing	O	-1	9875685
regi@@	O	-1	9875685
men	O	-1	9875685
of	O	-1	9875685
to@@	B-Chemical	D014031	9875685
b@@	I-Chemical	-1	9875685
ram@@	I-Chemical	-1	9875685
ycin	I-Chemical	-1	9875685
is	O	-1	9875685
at	O	-1	9875685
le@@	O	-1	9875685
ast	O	-1	9875685
as	O	-1	9875685
effective	O	-1	9875685
as	O	-1	9875685
and	O	-1	9875685
is	O	-1	9875685
no	O	-1	9875685
more	O	-1	9875685
and	O	-1	9875685
possib@@	O	-1	9875685
ly	O	-1	9875685
less	O	-1	9875685
toxic	O	-1	9875685
than	O	-1	9875685
the	O	-1	9875685
tw@@	O	-1	9875685
ic@@	O	-1	9875685
e-@@	O	-1	9875685
daily	O	-1	9875685
regimen@@	O	-1	9875685
.	O	-1	9875685
U@@	O	-1	9875685
s@@	O	-1	9875685
ing	O	-1	9875685
a	O	-1	9875685
sing@@	O	-1	9875685
le@@	O	-1	9875685
-@@	O	-1	9875685
dose	O	-1	9875685
therapy,	O	-1	9875685
pe@@	O	-1	9875685
a@@	O	-1	9875685
k	O	-1	9875685
concentration	O	-1	9875685
determin@@	O	-1	9875685
ation	O	-1	9875685
is	O	-1	9875685
not	O	-1	9875685
nec@@	O	-1	9875685
ess@@	O	-1	9875685
ar@@	O	-1	9875685
y,	O	-1	9875685
only	O	-1	9875685
t@@	O	-1	9875685
rou@@	O	-1	9875685
gh	O	-1	9875685
sam@@	O	-1	9875685
ple@@	O	-1	9875685
s	O	-1	9875685
should	O	-1	9875685
be	O	-1	9875685
monit@@	O	-1	9875685
o@@	O	-1	9875685
red	O	-1	9875685
to	O	-1	9875685
ens@@	O	-1	9875685
ure	O	-1	9875685
levels	O	-1	9875685
be@@	O	-1	9875685
low	O	-1	9875685
2	O	-1	9875685
micro@@	O	-1	9875685
g/@@	O	-1	9875685
ml@@	O	-1	9875685
.	O	-1	9875685

Ch@@	O	-1	9848575
ron@@	O	-1	9848575
ic	O	-1	9848575
effects	O	-1	9848575
of	O	-1	9848575
a	O	-1	9848575
novel	O	-1	9848575
syn@@	O	-1	9848575
thetic	O	-1	9848575
an@@	B-Chemical	D018943	9848575
th@@	I-Chemical	-1	9848575
rac@@	I-Chemical	-1	9848575
y@@	I-Chemical	-1	9848575
cl@@	I-Chemical	-1	9848575
ine	I-Chemical	-1	9848575
der@@	O	-1	9848575
i@@	O	-1	9848575
v@@	O	-1	9848575
ative	O	-1	9848575
(	O	-1	9848575
S@@	B-Chemical	C055866	9848575
M@@	I-Chemical	-1	9848575
-@@	I-Chemical	-1	9848575
5@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
7	I-Chemical	-1	9848575
)	O	-1	9848575
on	O	-1	9848575
normal	O	-1	9848575
heart	O	-1	9848575
and	O	-1	9848575
dox@@	B-Chemical	D004317	9848575
orub@@	I-Chemical	-1	9848575
icin	I-Chemical	-1	9848575
-induced	O	-1	9848575
cardi@@	B-Disease	D009202	9848575
om@@	I-Disease	-1	9848575
yo@@	I-Disease	-1	9848575
pathy	I-Disease	-1	9848575
in	O	-1	9848575
be@@	O	-1	9848575
ag@@	O	-1	9848575
le	O	-1	9848575
dog@@	O	-1	9848575
s.	O	-1	9848575
This	O	-1	9848575
study	O	-1	9848575
was	O	-1	9848575
de@@	O	-1	9848575
signed	O	-1	9848575
to	O	-1	9848575
investigate	O	-1	9848575
the	O	-1	9848575
chronic	O	-1	9848575
cardi@@	B-Disease	D066126	9848575
ot@@	I-Disease	-1	9848575
ox@@	I-Disease	-1	9848575
ic	I-Disease	-1	9848575
potential	O	-1	9848575
of	O	-1	9848575
S@@	B-Chemical	C055866	9848575
M@@	I-Chemical	-1	9848575
-@@	I-Chemical	-1	9848575
5@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
7	I-Chemical	-1	9848575
and	O	-1	9848575
a	O	-1	9848575
possible	O	-1	9848575
deter@@	O	-1	9848575
i@@	O	-1	9848575
or@@	O	-1	9848575
ating	O	-1	9848575
effect	O	-1	9848575
of	O	-1	9848575
S@@	B-Chemical	C055866	9848575
M@@	I-Chemical	-1	9848575
-@@	I-Chemical	-1	9848575
5@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
7	I-Chemical	-1	9848575
on	O	-1	9848575
low@@	O	-1	9848575
-@@	O	-1	9848575
gra@@	O	-1	9848575
de	O	-1	9848575
cardi@@	B-Disease	D066126	9848575
otoxicity	I-Disease	-1	9848575
pre@@	O	-1	9848575
-induced	O	-1	9848575
by	O	-1	9848575
dox@@	B-Chemical	D004317	9848575
orub@@	I-Chemical	-1	9848575
icin	I-Chemical	-1	9848575
in	O	-1	9848575
be@@	O	-1	9848575
ag@@	O	-1	9848575
le	O	-1	9848575
dog@@	O	-1	9848575
s.	O	-1	9848575
In	O	-1	9848575
the	O	-1	9848575
chronic	O	-1	9848575
treatment,	O	-1	9848575
be@@	O	-1	9848575
ag@@	O	-1	9848575
le	O	-1	9848575
dog@@	O	-1	9848575
s	O	-1	9848575
of	O	-1	9848575
each	O	-1	9848575
se@@	O	-1	9848575
x	O	-1	9848575
were	O	-1	9848575
given	O	-1	9848575
intra@@	O	-1	9848575
ven@@	O	-1	9848575
ously	O	-1	9848575
on@@	O	-1	9848575
ce	O	-1	9848575
every	O	-1	9848575
3	O	-1	9848575
week@@	O	-1	9848575
s,	O	-1	9848575
either	O	-1	9848575
a	O	-1	9848575
sub@@	O	-1	9848575
le@@	O	-1	9848575
th@@	O	-1	9848575
al	O	-1	9848575
dose	O	-1	9848575
of	O	-1	9848575
dox@@	B-Chemical	D004317	9848575
orub@@	I-Chemical	-1	9848575
icin	I-Chemical	-1	9848575
(1@@	O	-1	9848575
.@@	O	-1	9848575
5	O	-1	9848575
mg/kg)	O	-1	9848575
or	O	-1	9848575
S@@	B-Chemical	C055866	9848575
M@@	I-Chemical	-1	9848575
-@@	I-Chemical	-1	9848575
5@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
7	I-Chemical	-1	9848575
(2@@	O	-1	9848575
.@@	O	-1	9848575
5	O	-1	9848575
mg/kg@@	O	-1	9848575
).	O	-1	9848575
The	O	-1	9848575
experim@@	O	-1	9848575
ent	O	-1	9848575
was	O	-1	9848575
ter@@	O	-1	9848575
min@@	O	-1	9848575
ated	O	-1	9848575
3	O	-1	9848575
weeks	O	-1	9848575
after	O	-1	9848575
the	O	-1	9848575
n@@	O	-1	9848575
int@@	O	-1	9848575
h	O	-1	9848575
dos@@	O	-1	9848575
ing.	O	-1	9848575
An@@	O	-1	9848575
im@@	O	-1	9848575
als	O	-1	9848575
which	O	-1	9848575
received	O	-1	9848575
over	O	-1	9848575
six	O	-1	9848575
cour@@	O	-1	9848575
ses	O	-1	9848575
of	O	-1	9848575
dox@@	B-Chemical	D004317	9848575
orub@@	I-Chemical	-1	9848575
icin	I-Chemical	-1	9848575
demonstrated	O	-1	9848575
the	O	-1	9848575
electro@@	O	-1	9848575
cardio@@	O	-1	9848575
gra@@	O	-1	9848575
m	O	-1	9848575
(@@	O	-1	9848575
EC@@	O	-1	9848575
G@@	O	-1	9848575
)	O	-1	9848575
chang@@	O	-1	9848575
es,	O	-1	9848575
decrease	O	-1	9848575
of	O	-1	9848575
blood	O	-1	9848575
pressure	O	-1	9848575
and	O	-1	9848575
high-@@	O	-1	9848575
gra@@	O	-1	9848575
de	O	-1	9848575
histo@@	O	-1	9848575
path@@	O	-1	9848575
ological	O	-1	9848575
cardi@@	B-Disease	D009202	9848575
om@@	I-Disease	-1	9848575
yo@@	I-Disease	-1	9848575
pathy	I-Disease	-1	9848575
,	O	-1	9848575
while	O	-1	9848575
animals	O	-1	9848575
which	O	-1	9848575
were	O	-1	9848575
ter@@	O	-1	9848575
min@@	O	-1	9848575
ally	O	-1	9848575
s@@	O	-1	9848575
ac@@	O	-1	9848575
ri@@	O	-1	9848575
fic@@	O	-1	9848575
ed	O	-1	9848575
after	O	-1	9848575
the	O	-1	9848575
S@@	B-Chemical	C055866	9848575
M@@	I-Chemical	-1	9848575
-@@	I-Chemical	-1	9848575
5@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
7	I-Chemical	-1	9848575
administration	O	-1	9848575
did	O	-1	9848575
not	O	-1	9848575
show	O	-1	9848575
any	O	-1	9848575
changes	O	-1	9848575
in	O	-1	9848575
EC@@	O	-1	9848575
G@@	O	-1	9848575
,	O	-1	9848575
blood	O	-1	9848575
pressure	O	-1	9848575
and	O	-1	9848575
histo@@	O	-1	9848575
path@@	O	-1	9848575
ological	O	-1	9848575
examin@@	O	-1	9848575
ations.	O	-1	9848575
To	O	-1	9848575
ex@@	O	-1	9848575
amine	O	-1	9848575
a	O	-1	9848575
possib@@	O	-1	9848575
ly	O	-1	9848575
deter@@	O	-1	9848575
i@@	O	-1	9848575
or@@	O	-1	9848575
ating	O	-1	9848575
cardi@@	B-Disease	D066126	9848575
ot@@	I-Disease	-1	9848575
ox@@	I-Disease	-1	9848575
ic	I-Disease	-1	9848575
effect	O	-1	9848575
of	O	-1	9848575
S@@	B-Chemical	C055866	9848575
M@@	I-Chemical	-1	9848575
-@@	I-Chemical	-1	9848575
5@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
7	I-Chemical	-1	9848575
,	O	-1	9848575
low@@	O	-1	9848575
-@@	O	-1	9848575
gra@@	O	-1	9848575
de	O	-1	9848575
cardi@@	B-Disease	D009202	9848575
om@@	I-Disease	-1	9848575
yo@@	I-Disease	-1	9848575
pathy	I-Disease	-1	9848575
was	O	-1	9848575
induced	O	-1	9848575
in	O	-1	9848575
dog@@	O	-1	9848575
s	O	-1	9848575
by	O	-1	9848575
four	O	-1	9848575
cour@@	O	-1	9848575
ses	O	-1	9848575
of	O	-1	9848575
dox@@	B-Chemical	D004317	9848575
orub@@	I-Chemical	-1	9848575
icin	I-Chemical	-1	9848575
(1@@	O	-1	9848575
.@@	O	-1	9848575
5	O	-1	9848575
mg/kg@@	O	-1	9848575
).	O	-1	9848575
N@@	O	-1	9848575
ine	O	-1	9848575
weeks	O	-1	9848575
after	O	-1	9848575
pre-@@	O	-1	9848575
treatment,	O	-1	9848575
dog@@	O	-1	9848575
s	O	-1	9848575
were	O	-1	9848575
given	O	-1	9848575
four	O	-1	9848575
cour@@	O	-1	9848575
ses	O	-1	9848575
of	O	-1	9848575
either	O	-1	9848575
dox@@	B-Chemical	D004317	9848575
orub@@	I-Chemical	-1	9848575
icin	I-Chemical	-1	9848575
(1@@	O	-1	9848575
.@@	O	-1	9848575
5	O	-1	9848575
mg/kg)	O	-1	9848575
or	O	-1	9848575
S@@	B-Chemical	C055866	9848575
M@@	I-Chemical	-1	9848575
-@@	I-Chemical	-1	9848575
5@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
7	I-Chemical	-1	9848575
(2@@	O	-1	9848575
.@@	O	-1	9848575
5	O	-1	9848575
mg/kg)	O	-1	9848575
on@@	O	-1	9848575
ce	O	-1	9848575
every	O	-1	9848575
3	O	-1	9848575
week@@	O	-1	9848575
s.	O	-1	9848575
The	O	-1	9848575
low@@	O	-1	9848575
-@@	O	-1	9848575
gra@@	O	-1	9848575
de	O	-1	9848575
cardi@@	B-Disease	D066126	9848575
ot@@	I-Disease	-1	9848575
ox@@	I-Disease	-1	9848575
ic	I-Disease	-1	9848575
changes	O	-1	9848575
were	O	-1	9848575
enhanced	O	-1	9848575
by	O	-1	9848575
the	O	-1	9848575
addi@@	O	-1	9848575
tional	O	-1	9848575
dox@@	B-Chemical	D004317	9848575
orub@@	I-Chemical	-1	9848575
icin	I-Chemical	-1	9848575
treatment.	O	-1	9848575
O@@	O	-1	9848575
n	O	-1	9848575
the	O	-1	9848575
contr@@	O	-1	9848575
ar@@	O	-1	9848575
y,	O	-1	9848575
the	O	-1	9848575
S@@	B-Chemical	C055866	9848575
M@@	I-Chemical	-1	9848575
-@@	I-Chemical	-1	9848575
5@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
7	I-Chemical	-1	9848575
treatment	O	-1	9848575
did	O	-1	9848575
not	O	-1	9848575
progres@@	O	-1	9848575
s	O	-1	9848575
the	O	-1	9848575
gra@@	O	-1	9848575
de	O	-1	9848575
of	O	-1	9848575
cardi@@	B-Disease	D009202	9848575
om@@	I-Disease	-1	9848575
yo@@	I-Disease	-1	9848575
pathy	I-Disease	-1	9848575
.	O	-1	9848575
In	O	-1	9848575
concl@@	O	-1	9848575
u@@	O	-1	9848575
sion,	O	-1	9848575
S@@	B-Chemical	C055866	9848575
M@@	I-Chemical	-1	9848575
-@@	I-Chemical	-1	9848575
5@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
8@@	I-Chemical	-1	9848575
7	I-Chemical	-1	9848575
does	O	-1	9848575
not	O	-1	9848575
have	O	-1	9848575
any	O	-1	9848575
potential	O	-1	9848575
of	O	-1	9848575
chronic	O	-1	9848575
cardi@@	B-Disease	D066126	9848575
otoxicity	I-Disease	-1	9848575
and	O	-1	9848575
deter@@	O	-1	9848575
i@@	O	-1	9848575
or@@	O	-1	9848575
ating	O	-1	9848575
effect	O	-1	9848575
on	O	-1	9848575
dox@@	B-Chemical	D004317	9848575
orub@@	I-Chemical	-1	9848575
icin	I-Chemical	-1	9848575
-induced	O	-1	9848575
cardi@@	B-Disease	D066126	9848575
otoxicity	I-Disease	-1	9848575
in	O	-1	9848575
dog@@	O	-1	9848575
s.	O	-1	9848575

P@@	O	-1	9321531
o@@	O	-1	9321531
ster@@	O	-1	9321531
o@@	O	-1	9321531
ventr@@	O	-1	9321531
al	O	-1	9321531
medi@@	O	-1	9321531
al	O	-1	9321531
p@@	O	-1	9321531
all@@	O	-1	9321531
id@@	O	-1	9321531
ot@@	O	-1	9321531
om@@	O	-1	9321531
y	O	-1	9321531
in	O	-1	9321531
adv@@	O	-1	9321531
anced	O	-1	9321531
Parkinson's	B-Disease	D010300	9321531
disease	I-Disease	-1	9321531
.	O	-1	9321531
BACKGROUND:	O	-1	9321531
P@@	O	-1	9321531
o@@	O	-1	9321531
ster@@	O	-1	9321531
o@@	O	-1	9321531
ventr@@	O	-1	9321531
al	O	-1	9321531
medi@@	O	-1	9321531
al	O	-1	9321531
p@@	O	-1	9321531
all@@	O	-1	9321531
id@@	O	-1	9321531
ot@@	O	-1	9321531
om@@	O	-1	9321531
y	O	-1	9321531
so@@	O	-1	9321531
me@@	O	-1	9321531
times	O	-1	9321531
produc@@	O	-1	9321531
es	O	-1	9321531
stri@@	O	-1	9321531
king	O	-1	9321531
impro@@	O	-1	9321531
vement	O	-1	9321531
in	O	-1	9321531
patients	O	-1	9321531
with	O	-1	9321531
adv@@	O	-1	9321531
anced	O	-1	9321531
Parkinson's	B-Disease	D010300	9321531
disease	I-Disease	-1	9321531
,	O	-1	9321531
but	O	-1	9321531
the	O	-1	9321531
studies	O	-1	9321531
to	O	-1	9321531
d@@	O	-1	9321531
ate	O	-1	9321531
have	O	-1	9321531
involved	O	-1	9321531
sm@@	O	-1	9321531
all	O	-1	9321531
numb@@	O	-1	9321531
ers	O	-1	9321531
of	O	-1	9321531
patients	O	-1	9321531
and	O	-1	9321531
sh@@	O	-1	9321531
ort@@	O	-1	9321531
-term	O	-1	9321531
follow-@@	O	-1	9321531
up@@	O	-1	9321531
.	O	-1	9321531
METHODS:	O	-1	9321531
F@@	O	-1	9321531
ort@@	O	-1	9321531
y	O	-1	9321531
patients	O	-1	9321531
with	O	-1	9321531
Parkinson's	B-Disease	D010300	9321531
disease	I-Disease	-1	9321531
under@@	O	-1	9321531
w@@	O	-1	9321531
ent	O	-1	9321531
seri@@	O	-1	9321531
al,	O	-1	9321531
det@@	O	-1	9321531
ail@@	O	-1	9321531
ed	O	-1	9321531
assess@@	O	-1	9321531
ments	O	-1	9321531
both	O	-1	9321531
after	O	-1	9321531
drug	O	-1	9321531
withdrawal	O	-1	9321531
(@@	O	-1	9321531
"@@	O	-1	9321531
o@@	O	-1	9321531
ff@@	O	-1	9321531
"	O	-1	9321531
perio@@	O	-1	9321531
d@@	O	-1	9321531
)	O	-1	9321531
and	O	-1	9321531
while	O	-1	9321531
taking	O	-1	9321531
their	O	-1	9321531
op@@	O	-1	9321531
tim@@	O	-1	9321531
al	O	-1	9321531
med@@	O	-1	9321531
ical	O	-1	9321531
regimen@@	O	-1	9321531
s	O	-1	9321531
(@@	O	-1	9321531
"@@	O	-1	9321531
on@@	O	-1	9321531
"	O	-1	9321531
perio@@	O	-1	9321531
d@@	O	-1	9321531
).	O	-1	9321531
All	O	-1	9321531
patients	O	-1	9321531
were	O	-1	9321531
examined	O	-1	9321531
pre@@	O	-1	9321531
o@@	O	-1	9321531
per@@	O	-1	9321531
atively	O	-1	9321531
and	O	-1	9321531
3@@	O	-1	9321531
9	O	-1	9321531
were	O	-1	9321531
examined	O	-1	9321531
at	O	-1	9321531
six	O	-1	9321531
month@@	O	-1	9321531
s;	O	-1	9321531
2@@	O	-1	9321531
7	O	-1	9321531
of	O	-1	9321531
the	O	-1	9321531
patients	O	-1	9321531
were	O	-1	9321531
also	O	-1	9321531
examined	O	-1	9321531
at	O	-1	9321531
one	O	-1	9321531
year@@	O	-1	9321531
,	O	-1	9321531
and	O	-1	9321531
11	O	-1	9321531
at	O	-1	9321531
two	O	-1	9321531
year@@	O	-1	9321531
s.	O	-1	9321531
RESULTS:	O	-1	9321531
The	O	-1	9321531
perc@@	O	-1	9321531
ent	O	-1	9321531
impro@@	O	-1	9321531
ve@@	O	-1	9321531
ments	O	-1	9321531
at	O	-1	9321531
six	O	-1	9321531
months	O	-1	9321531
were	O	-1	9321531
as	O	-1	9321531
follow@@	O	-1	9321531
s:	O	-1	9321531
o@@	O	-1	9321531
ff@@	O	-1	9321531
-@@	O	-1	9321531
period	O	-1	9321531
scor@@	O	-1	9321531
e	O	-1	9321531
for	O	-1	9321531
over@@	O	-1	9321531
all	O	-1	9321531
motor	O	-1	9321531
func@@	O	-1	9321531
tion,	O	-1	9321531
2@@	O	-1	9321531
8	O	-1	9321531
perc@@	O	-1	9321531
ent	O	-1	9321531
(@@	O	-1	9321531
9@@	O	-1	9321531
5	O	-1	9321531
perc@@	O	-1	9321531
ent	O	-1	9321531
conf@@	O	-1	9321531
idence	O	-1	9321531
inter@@	O	-1	9321531
val@@	O	-1	9321531
,	O	-1	9321531
1@@	O	-1	9321531
9	O	-1	9321531
to	O	-1	9321531
3@@	O	-1	9321531
8	O	-1	9321531
perc@@	O	-1	9321531
ent@@	O	-1	9321531
),	O	-1	9321531
with	O	-1	9321531
most	O	-1	9321531
of	O	-1	9321531
the	O	-1	9321531
impro@@	O	-1	9321531
vement	O	-1	9321531
in	O	-1	9321531
the	O	-1	9321531
contr@@	O	-1	9321531
al@@	O	-1	9321531
ateral	O	-1	9321531
lim@@	O	-1	9321531
b@@	O	-1	9321531
s;	O	-1	9321531
o@@	O	-1	9321531
ff@@	O	-1	9321531
-@@	O	-1	9321531
period	O	-1	9321531
scor@@	O	-1	9321531
e	O	-1	9321531
for	O	-1	9321531
ac@@	O	-1	9321531
ti@@	O	-1	9321531
vi@@	O	-1	9321531
ties	O	-1	9321531
of	O	-1	9321531
daily	O	-1	9321531
li@@	O	-1	9321531
v@@	O	-1	9321531
ing,	O	-1	9321531
2@@	O	-1	9321531
9	O	-1	9321531
perc@@	O	-1	9321531
ent	O	-1	9321531
(@@	O	-1	9321531
9@@	O	-1	9321531
5	O	-1	9321531
perc@@	O	-1	9321531
ent	O	-1	9321531
conf@@	O	-1	9321531
idence	O	-1	9321531
inter@@	O	-1	9321531
val@@	O	-1	9321531
,	O	-1	9321531
1@@	O	-1	9321531
9	O	-1	9321531
to	O	-1	9321531
3@@	O	-1	9321531
9	O	-1	9321531
perc@@	O	-1	9321531
ent@@	O	-1	9321531
);	O	-1	9321531
on@@	O	-1	9321531
-@@	O	-1	9321531
period	O	-1	9321531
scor@@	O	-1	9321531
e	O	-1	9321531
for	O	-1	9321531
contr@@	O	-1	9321531
al@@	O	-1	9321531
ateral	O	-1	9321531
dyskine@@	B-Disease	D004409	9321531
si@@	I-Disease	-1	9321531
as	I-Disease	-1	9321531
,	O	-1	9321531
8@@	O	-1	9321531
2	O	-1	9321531
perc@@	O	-1	9321531
ent	O	-1	9321531
(@@	O	-1	9321531
9@@	O	-1	9321531
5	O	-1	9321531
perc@@	O	-1	9321531
ent	O	-1	9321531
conf@@	O	-1	9321531
idence	O	-1	9321531
inter@@	O	-1	9321531
val@@	O	-1	9321531
,	O	-1	9321531
7@@	O	-1	9321531
2	O	-1	9321531
to	O	-1	9321531
9@@	O	-1	9321531
1	O	-1	9321531
perc@@	O	-1	9321531
ent@@	O	-1	9321531
);	O	-1	9321531
and	O	-1	9321531
on@@	O	-1	9321531
-@@	O	-1	9321531
period	O	-1	9321531
scor@@	O	-1	9321531
e	O	-1	9321531
for	O	-1	9321531
ip@@	O	-1	9321531
si@@	O	-1	9321531
lat@@	O	-1	9321531
eral	O	-1	9321531
dyskine@@	B-Disease	D004409	9321531
si@@	I-Disease	-1	9321531
as	I-Disease	-1	9321531
,	O	-1	9321531
4@@	O	-1	9321531
4	O	-1	9321531
perc@@	O	-1	9321531
ent	O	-1	9321531
(@@	O	-1	9321531
9@@	O	-1	9321531
5	O	-1	9321531
perc@@	O	-1	9321531
ent	O	-1	9321531
conf@@	O	-1	9321531
idence	O	-1	9321531
inter@@	O	-1	9321531
val@@	O	-1	9321531
,	O	-1	9321531
2@@	O	-1	9321531
9	O	-1	9321531
to	O	-1	9321531
5@@	O	-1	9321531
9	O	-1	9321531
perc@@	O	-1	9321531
ent@@	O	-1	9321531
).	O	-1	9321531
The	O	-1	9321531
impro@@	O	-1	9321531
ve@@	O	-1	9321531
ments	O	-1	9321531
in	O	-1	9321531
dyskine@@	B-Disease	D004409	9321531
si@@	I-Disease	-1	9321531
as	I-Disease	-1	9321531
and	O	-1	9321531
the	O	-1	9321531
total	O	-1	9321531
sco@@	O	-1	9321531
res	O	-1	9321531
for	O	-1	9321531
o@@	O	-1	9321531
ff@@	O	-1	9321531
-@@	O	-1	9321531
period	O	-1	9321531
par@@	B-Disease	D010300	9321531
k@@	I-Disease	-1	9321531
inson@@	I-Disease	-1	9321531
ism	I-Disease	-1	9321531
,	O	-1	9321531
contr@@	O	-1	9321531
al@@	O	-1	9321531
ateral	O	-1	9321531
brady@@	B-Disease	D018476	9321531
kine@@	I-Disease	-1	9321531
sia	I-Disease	-1	9321531
,	O	-1	9321531
and	O	-1	9321531
rig@@	B-Disease	D009127	9321531
idity	I-Disease	-1	9321531
were	O	-1	9321531
su@@	O	-1	9321531
st@@	O	-1	9321531
ained	O	-1	9321531
in	O	-1	9321531
the	O	-1	9321531
11	O	-1	9321531
patients	O	-1	9321531
examined	O	-1	9321531
at	O	-1	9321531
two	O	-1	9321531
year@@	O	-1	9321531
s.	O	-1	9321531
The	O	-1	9321531
impro@@	O	-1	9321531
vement	O	-1	9321531
in	O	-1	9321531
ip@@	O	-1	9321531
si@@	O	-1	9321531
lat@@	O	-1	9321531
eral	O	-1	9321531
dyskine@@	B-Disease	D004409	9321531
si@@	I-Disease	-1	9321531
as	I-Disease	-1	9321531
was	O	-1	9321531
lo@@	O	-1	9321531
st	O	-1	9321531
after	O	-1	9321531
one	O	-1	9321531
year@@	O	-1	9321531
,	O	-1	9321531
and	O	-1	9321531
the	O	-1	9321531
impro@@	O	-1	9321531
ve@@	O	-1	9321531
ments	O	-1	9321531
in	O	-1	9321531
post@@	O	-1	9321531
ural	O	-1	9321531
st@@	O	-1	9321531
ability	O	-1	9321531
and	O	-1	9321531
g@@	O	-1	9321531
a@@	O	-1	9321531
it	O	-1	9321531
l@@	O	-1	9321531
ast@@	O	-1	9321531
ed	O	-1	9321531
only	O	-1	9321531
three	O	-1	9321531
to	O	-1	9321531
six	O	-1	9321531
months.	O	-1	9321531
A@@	O	-1	9321531
p@@	O	-1	9321531
pro@@	O	-1	9321531
xim@@	O	-1	9321531
ately	O	-1	9321531
h@@	O	-1	9321531
al@@	O	-1	9321531
f	O	-1	9321531
the	O	-1	9321531
patients	O	-1	9321531
who	O	-1	9321531
had	O	-1	9321531
been	O	-1	9321531
dependent	O	-1	9321531
on	O	-1	9321531
as@@	O	-1	9321531
sist@@	O	-1	9321531
ance	O	-1	9321531
in	O	-1	9321531
ac@@	O	-1	9321531
ti@@	O	-1	9321531
vi@@	O	-1	9321531
ties	O	-1	9321531
of	O	-1	9321531
daily	O	-1	9321531
li@@	O	-1	9321531
ving	O	-1	9321531
in	O	-1	9321531
the	O	-1	9321531
of@@	O	-1	9321531
f	O	-1	9321531
period	O	-1	9321531
before	O	-1	9321531
surger@@	O	-1	9321531
y	O	-1	9321531
b@@	O	-1	9321531
ec@@	O	-1	9321531
am@@	O	-1	9321531
e	O	-1	9321531
in@@	O	-1	9321531
dependent	O	-1	9321531
after	O	-1	9321531
surger@@	O	-1	9321531
y.	O	-1	9321531
The	O	-1	9321531
complications	O	-1	9321531
of	O	-1	9321531
surger@@	O	-1	9321531
y	O	-1	9321531
were	O	-1	9321531
gener@@	O	-1	9321531
ally	O	-1	9321531
well	O	-1	9321531
toler@@	O	-1	9321531
at@@	O	-1	9321531
ed,	O	-1	9321531
and	O	-1	9321531
there	O	-1	9321531
were	O	-1	9321531
no	O	-1	9321531
significant	O	-1	9321531
changes	O	-1	9321531
in	O	-1	9321531
the	O	-1	9321531
use	O	-1	9321531
of	O	-1	9321531
medic@@	O	-1	9321531
ation.	O	-1	9321531
CONCLUSIONS:	O	-1	9321531
In	O	-1	9321531
lat@@	O	-1	9321531
e-@@	O	-1	9321531
st@@	O	-1	9321531
age	O	-1	9321531
Parkinson's	B-Disease	D010300	9321531
disease	I-Disease	-1	9321531
,	O	-1	9321531
p@@	O	-1	9321531
all@@	O	-1	9321531
id@@	O	-1	9321531
ot@@	O	-1	9321531
om@@	O	-1	9321531
y	O	-1	9321531
significantly	O	-1	9321531
reduc@@	O	-1	9321531
es	O	-1	9321531
levo@@	B-Chemical	D007980	9321531
dopa	I-Chemical	-1	9321531
-induced	O	-1	9321531
dyskine@@	B-Disease	D004409	9321531
si@@	I-Disease	-1	9321531
as	I-Disease	-1	9321531
and	O	-1	9321531
o@@	O	-1	9321531
ff@@	O	-1	9321531
-@@	O	-1	9321531
period	O	-1	9321531
dis@@	O	-1	9321531
abil@@	O	-1	9321531
ity.	O	-1	9321531
M@@	O	-1	9321531
uc@@	O	-1	9321531
h	O	-1	9321531
of	O	-1	9321531
the	O	-1	9321531
ben@@	O	-1	9321531
e@@	O	-1	9321531
fi@@	O	-1	9321531
t	O	-1	9321531
is	O	-1	9321531
su@@	O	-1	9321531
st@@	O	-1	9321531
ained	O	-1	9321531
at	O	-1	9321531
two	O	-1	9321531
year@@	O	-1	9321531
s,	O	-1	9321531
although	O	-1	9321531
some	O	-1	9321531
impro@@	O	-1	9321531
ve@@	O	-1	9321531
ment@@	O	-1	9321531
s,	O	-1	9321531
such	O	-1	9321531
as	O	-1	9321531
those	O	-1	9321531
on	O	-1	9321531
the	O	-1	9321531
ip@@	O	-1	9321531
si@@	O	-1	9321531
lat@@	O	-1	9321531
eral	O	-1	9321531
side	O	-1	9321531
and	O	-1	9321531
in	O	-1	9321531
ax@@	O	-1	9321531
ial	O	-1	9321531
symptom@@	O	-1	9321531
s,	O	-1	9321531
w@@	O	-1	9321531
ane	O	-1	9321531
within	O	-1	9321531
the	O	-1	9321531
first	O	-1	9321531
year@@	O	-1	9321531
.	O	-1	9321531
The	O	-1	9321531
on@@	O	-1	9321531
-@@	O	-1	9321531
period	O	-1	9321531
symptoms	O	-1	9321531
that	O	-1	9321531
are	O	-1	9321531
resist@@	O	-1	9321531
ant	O	-1	9321531
to	O	-1	9321531
dop@@	O	-1	9321531
aminergic	O	-1	9321531
therapy	O	-1	9321531
d@@	O	-1	9321531
o	O	-1	9321531
not	O	-1	9321531
respon@@	O	-1	9321531
d	O	-1	9321531
to	O	-1	9321531
p@@	O	-1	9321531
all@@	O	-1	9321531
id@@	O	-1	9321531
ot@@	O	-1	9321531
om@@	O	-1	9321531
y.	O	-1	9321531

Ne@@	O	-1	9305828
uro@@	O	-1	9305828
p@@	O	-1	9305828
ep@@	O	-1	9305828
ti@@	O	-1	9305828
de@@	O	-1	9305828
-@@	O	-1	9305828
Y	O	-1	9305828
immuno@@	O	-1	9305828
re@@	O	-1	9305828
activity	O	-1	9305828
in	O	-1	9305828
the	O	-1	9305828
pilocar@@	B-Chemical	D010862	9305828
pine	I-Chemical	-1	9305828
model	O	-1	9305828
of	O	-1	9305828
tempor@@	B-Disease	D004833	9305828
al	I-Disease	-1	9305828
lo@@	I-Disease	-1	9305828
be	I-Disease	-1	9305828
epilep@@	I-Disease	-1	9305828
sy	I-Disease	-1	9305828
.	O	-1	9305828
Ne@@	O	-1	9305828
uro@@	O	-1	9305828
p@@	O	-1	9305828
ep@@	O	-1	9305828
ti@@	O	-1	9305828
de@@	O	-1	9305828
-@@	O	-1	9305828
Y	O	-1	9305828
(N@@	O	-1	9305828
P@@	O	-1	9305828
Y@@	O	-1	9305828
)	O	-1	9305828
is	O	-1	9305828
ex@@	O	-1	9305828
press@@	O	-1	9305828
ed	O	-1	9305828
by	O	-1	9305828
gran@@	O	-1	9305828
ul@@	O	-1	9305828
e	O	-1	9305828
cells	O	-1	9305828
and	O	-1	9305828
m@@	O	-1	9305828
os@@	O	-1	9305828
sy	O	-1	9305828
fib@@	O	-1	9305828
res	O	-1	9305828
of	O	-1	9305828
the	O	-1	9305828
hippocamp@@	O	-1	9305828
al	O	-1	9305828
d@@	O	-1	9305828
ent@@	O	-1	9305828
ate	O	-1	9305828
g@@	O	-1	9305828
y@@	O	-1	9305828
ru@@	O	-1	9305828
s	O	-1	9305828
during	O	-1	9305828
experimental	O	-1	9305828
tempor@@	B-Disease	D004833	9305828
al	I-Disease	-1	9305828
lo@@	I-Disease	-1	9305828
be	I-Disease	-1	9305828
epilep@@	I-Disease	-1	9305828
sy	I-Disease	-1	9305828
(	O	-1	9305828
T@@	B-Disease	D004833	9305828
L@@	I-Disease	-1	9305828
E	I-Disease	-1	9305828
).	O	-1	9305828
This	O	-1	9305828
expression	O	-1	9305828
may	O	-1	9305828
re@@	O	-1	9305828
present	O	-1	9305828
an	O	-1	9305828
endo@@	O	-1	9305828
gen@@	O	-1	9305828
ous	O	-1	9305828
dam@@	O	-1	9305828
p@@	O	-1	9305828
ing	O	-1	9305828
mechanism	O	-1	9305828
s@@	O	-1	9305828
inc@@	O	-1	9305828
e	O	-1	9305828
N@@	O	-1	9305828
P@@	O	-1	9305828
Y	O	-1	9305828
has	O	-1	9305828
been	O	-1	9305828
shown	O	-1	9305828
to	O	-1	9305828
bloc@@	O	-1	9305828
k	O	-1	9305828
seizure	B-Disease	D012640	9305828
-@@	O	-1	9305828
like	O	-1	9305828
events	O	-1	9305828
following	O	-1	9305828
high-@@	O	-1	9305828
frequency	O	-1	9305828
stimulation	O	-1	9305828
in	O	-1	9305828
hippocamp@@	O	-1	9305828
al	O	-1	9305828
s@@	O	-1	9305828
l@@	O	-1	9305828
ic@@	O	-1	9305828
es.	O	-1	9305828
The	O	-1	9305828
pilocar@@	B-Chemical	D010862	9305828
pine	I-Chemical	-1	9305828
(	O	-1	9305828
P@@	B-Chemical	D010862	9305828
I@@	I-Chemical	-1	9305828
L@@	I-Chemical	-1	9305828
O	I-Chemical	-1	9305828
)	O	-1	9305828
model	O	-1	9305828
of	O	-1	9305828
epilep@@	B-Disease	D004827	9305828
sy	I-Disease	-1	9305828
is	O	-1	9305828
character@@	O	-1	9305828
ized	O	-1	9305828
by	O	-1	9305828
an	O	-1	9305828
acute	O	-1	9305828
period	O	-1	9305828
of	O	-1	9305828
status	B-Disease	D013226	9305828
epilep@@	I-Disease	-1	9305828
tic@@	I-Disease	-1	9305828
us	I-Disease	-1	9305828
followed	O	-1	9305828
by	O	-1	9305828
spont@@	O	-1	9305828
aneous	O	-1	9305828
recur@@	O	-1	9305828
rent	O	-1	9305828
seizures	B-Disease	D012640	9305828
and	O	-1	9305828
related	O	-1	9305828
brain	B-Disease	D001930	9305828
damage	I-Disease	-1	9305828
.	O	-1	9305828
We	O	-1	9305828
report	O	-1	9305828
per@@	O	-1	9305828
oxid@@	O	-1	9305828
as@@	O	-1	9305828
e-@@	O	-1	9305828
anti@@	O	-1	9305828
per@@	O	-1	9305828
oxid@@	O	-1	9305828
ase	O	-1	9305828
immun@@	O	-1	9305828
ost@@	O	-1	9305828
aining	O	-1	9305828
for	O	-1	9305828
N@@	O	-1	9305828
P@@	O	-1	9305828
Y	O	-1	9305828
in	O	-1	9305828
several	O	-1	9305828
brain	O	-1	9305828
regi@@	O	-1	9305828
ons	O	-1	9305828
in	O	-1	9305828
this	O	-1	9305828
model@@	O	-1	9305828
.	O	-1	9305828
P@@	B-Chemical	D010862	9305828
I@@	I-Chemical	-1	9305828
L@@	I-Chemical	-1	9305828
O	I-Chemical	-1	9305828
-@@	O	-1	9305828
injected	O	-1	9305828
animals	O	-1	9305828
ex@@	O	-1	9305828
hib@@	O	-1	9305828
ited	O	-1	9305828
N@@	O	-1	9305828
P@@	O	-1	9305828
Y	O	-1	9305828
immuno@@	O	-1	9305828
re@@	O	-1	9305828
activity	O	-1	9305828
in	O	-1	9305828
the	O	-1	9305828
regi@@	O	-1	9305828
on	O	-1	9305828
of	O	-1	9305828
the	O	-1	9305828
m@@	O	-1	9305828
os@@	O	-1	9305828
sy	O	-1	9305828
fib@@	O	-1	9305828
r@@	O	-1	9305828
e	O	-1	9305828
ter@@	O	-1	9305828
min@@	O	-1	9305828
al@@	O	-1	9305828
s,	O	-1	9305828
in	O	-1	9305828
the	O	-1	9305828
d@@	O	-1	9305828
ent@@	O	-1	9305828
ate	O	-1	9305828
g@@	O	-1	9305828
y@@	O	-1	9305828
ru@@	O	-1	9305828
s	O	-1	9305828
in@@	O	-1	9305828
n@@	O	-1	9305828
er	O	-1	9305828
mol@@	O	-1	9305828
ec@@	O	-1	9305828
ular	O	-1	9305828
l@@	O	-1	9305828
ay@@	O	-1	9305828
er	O	-1	9305828
and@@	O	-1	9305828
,	O	-1	9305828
in	O	-1	9305828
a	O	-1	9305828
fe@@	O	-1	9305828
w	O	-1	9305828
cas@@	O	-1	9305828
es,	O	-1	9305828
within	O	-1	9305828
pres@@	O	-1	9305828
um@@	O	-1	9305828
ed	O	-1	9305828
gran@@	O	-1	9305828
ul@@	O	-1	9305828
e	O	-1	9305828
cell@@	O	-1	9305828
s.	O	-1	9305828
N@@	O	-1	9305828
P@@	O	-1	9305828
Y	O	-1	9305828
immuno@@	O	-1	9305828
re@@	O	-1	9305828
activity	O	-1	9305828
was	O	-1	9305828
also	O	-1	9305828
d@@	O	-1	9305828
ram@@	O	-1	9305828
ati@@	O	-1	9305828
c@@	O	-1	9305828
ally	O	-1	9305828
chang@@	O	-1	9305828
ed	O	-1	9305828
in	O	-1	9305828
the	O	-1	9305828
ent@@	O	-1	9305828
or@@	O	-1	9305828
h@@	O	-1	9305828
inal	O	-1	9305828
cor@@	O	-1	9305828
t@@	O	-1	9305828
ex@@	O	-1	9305828
,	O	-1	9305828
am@@	O	-1	9305828
y@@	O	-1	9305828
g@@	O	-1	9305828
d@@	O	-1	9305828
al@@	O	-1	9305828
a	O	-1	9305828
and	O	-1	9305828
sens@@	O	-1	9305828
or@@	O	-1	9305828
im@@	O	-1	9305828
otor	O	-1	9305828
a@@	O	-1	9305828
reas@@	O	-1	9305828
.	O	-1	9305828
In	O	-1	9305828
addi@@	O	-1	9305828
tion,	O	-1	9305828
P@@	B-Chemical	D010862	9305828
I@@	I-Chemical	-1	9305828
L@@	I-Chemical	-1	9305828
O	I-Chemical	-1	9305828
injected	O	-1	9305828
animals	O	-1	9305828
ex@@	O	-1	9305828
hib@@	O	-1	9305828
ited	O	-1	9305828
a	O	-1	9305828
reduction	O	-1	9305828
in	O	-1	9305828
the	O	-1	9305828
number	O	-1	9305828
of	O	-1	9305828
N@@	O	-1	9305828
P@@	O	-1	9305828
Y@@	O	-1	9305828
-@@	O	-1	9305828
immuno@@	O	-1	9305828
reac@@	O	-1	9305828
tive	O	-1	9305828
inter@@	O	-1	9305828
neuron@@	O	-1	9305828
s	O	-1	9305828
compared	O	-1	9305828
with	O	-1	9305828
controls.	O	-1	9305828
The	O	-1	9305828
results	O	-1	9305828
demon@@	O	-1	9305828
st@@	O	-1	9305828
rate	O	-1	9305828
that	O	-1	9305828
changes	O	-1	9305828
in	O	-1	9305828
N@@	O	-1	9305828
P@@	O	-1	9305828
Y	O	-1	9305828
ex@@	O	-1	9305828
pres@@	O	-1	9305828
sion,	O	-1	9305828
including	O	-1	9305828
expression	O	-1	9305828
in	O	-1	9305828
the	O	-1	9305828
gran@@	O	-1	9305828
ul@@	O	-1	9305828
e	O	-1	9305828
cells	O	-1	9305828
and	O	-1	9305828
m@@	O	-1	9305828
os@@	O	-1	9305828
sy	O	-1	9305828
fib@@	O	-1	9305828
res	O	-1	9305828
and	O	-1	9305828
the	O	-1	9305828
loss	O	-1	9305828
of	O	-1	9305828
vul@@	O	-1	9305828
ner@@	O	-1	9305828
able	O	-1	9305828
N@@	O	-1	9305828
P@@	O	-1	9305828
Y	O	-1	9305828
neuron@@	O	-1	9305828
s,	O	-1	9305828
are	O	-1	9305828
present	O	-1	9305828
in	O	-1	9305828
the	O	-1	9305828
P@@	B-Chemical	D010862	9305828
I@@	I-Chemical	-1	9305828
L@@	I-Chemical	-1	9305828
O	I-Chemical	-1	9305828
model	O	-1	9305828
of	O	-1	9305828
T@@	B-Disease	D004833	9305828
L@@	I-Disease	-1	9305828
E	I-Disease	-1	9305828
.	O	-1	9305828
However,	O	-1	9305828
the	O	-1	9305828
signific@@	O	-1	9305828
ance	O	-1	9305828
of	O	-1	9305828
this	O	-1	9305828
chang@@	O	-1	9305828
ed	O	-1	9305828
syn@@	O	-1	9305828
thesis	O	-1	9305828
of	O	-1	9305828
N@@	O	-1	9305828
P@@	O	-1	9305828
Y	O	-1	9305828
remain@@	O	-1	9305828
s	O	-1	9305828
to	O	-1	9305828
be	O	-1	9305828
deter@@	O	-1	9305828
m@@	O	-1	9305828
ine@@	O	-1	9305828
d.	O	-1	9305828

Eff@@	O	-1	9041081
ect	O	-1	9041081
of	O	-1	9041081
my@@	O	-1	9041081
op@@	O	-1	9041081
ic	O	-1	9041081
ex@@	O	-1	9041081
c@@	O	-1	9041081
im@@	O	-1	9041081
er	O	-1	9041081
las@@	O	-1	9041081
er	O	-1	9041081
ph@@	O	-1	9041081
ot@@	O	-1	9041081
o@@	O	-1	9041081
ref@@	O	-1	9041081
rac@@	O	-1	9041081
tive	O	-1	9041081
k@@	O	-1	9041081
er@@	O	-1	9041081
at@@	O	-1	9041081
ect@@	O	-1	9041081
om@@	O	-1	9041081
y	O	-1	9041081
on	O	-1	9041081
the	O	-1	9041081
electro@@	O	-1	9041081
physi@@	O	-1	9041081
ologic	O	-1	9041081
function	O	-1	9041081
of	O	-1	9041081
the	O	-1	9041081
ret@@	O	-1	9041081
in@@	O	-1	9041081
a	O	-1	9041081
and	O	-1	9041081
op@@	O	-1	9041081
tic	O	-1	9041081
ner@@	O	-1	9041081
ve.	O	-1	9041081
P@@	O	-1	9041081
U@@	O	-1	9041081
R@@	O	-1	9041081
P@@	O	-1	9041081
O@@	O	-1	9041081
S@@	O	-1	9041081
E:	O	-1	9041081
To	O	-1	9041081
ass@@	O	-1	9041081
ess	O	-1	9041081
by	O	-1	9041081
electro@@	O	-1	9041081
physi@@	O	-1	9041081
ologic	O	-1	9041081
test@@	O	-1	9041081
ing	O	-1	9041081
the	O	-1	9041081
effect	O	-1	9041081
of	O	-1	9041081
ph@@	O	-1	9041081
ot@@	O	-1	9041081
o@@	O	-1	9041081
ref@@	O	-1	9041081
rac@@	O	-1	9041081
tive	O	-1	9041081
k@@	O	-1	9041081
er@@	O	-1	9041081
at@@	O	-1	9041081
ect@@	O	-1	9041081
om@@	O	-1	9041081
y	O	-1	9041081
(P@@	O	-1	9041081
R@@	O	-1	9041081
K@@	O	-1	9041081
)	O	-1	9041081
on	O	-1	9041081
the	O	-1	9041081
ret@@	O	-1	9041081
in@@	O	-1	9041081
a	O	-1	9041081
and	O	-1	9041081
op@@	O	-1	9041081
tic	O	-1	9041081
ner@@	O	-1	9041081
ve.	O	-1	9041081
S@@	O	-1	9041081
ET@@	O	-1	9041081
TI@@	O	-1	9041081
N@@	O	-1	9041081
G@@	O	-1	9041081
:	O	-1	9041081
E@@	O	-1	9041081
y@@	O	-1	9041081
e	O	-1	9041081
Clin@@	O	-1	9041081
ic@@	O	-1	9041081
,	O	-1	9041081
S@@	O	-1	9041081
.	O	-1	9041081
S@@	O	-1	9041081
al@@	O	-1	9041081
v@@	O	-1	9041081
at@@	O	-1	9041081
or@@	O	-1	9041081
e	O	-1	9041081
H@@	O	-1	9041081
ospit@@	O	-1	9041081
al,	O	-1	9041081
L@@	O	-1	9041081
'@@	O	-1	9041081
A@@	O	-1	9041081
qu@@	O	-1	9041081
il@@	O	-1	9041081
a	O	-1	9041081
U@@	O	-1	9041081
n@@	O	-1	9041081
i@@	O	-1	9041081
ver@@	O	-1	9041081
s@@	O	-1	9041081
ity,	O	-1	9041081
I@@	O	-1	9041081
t@@	O	-1	9041081
al@@	O	-1	9041081
y.	O	-1	9041081
METHODS:	O	-1	9041081
S@@	O	-1	9041081
t@@	O	-1	9041081
and@@	O	-1	9041081
ard	O	-1	9041081
pat@@	O	-1	9041081
ter@@	O	-1	9041081
n	O	-1	9041081
electro@@	O	-1	9041081
ret@@	O	-1	9041081
ino@@	O	-1	9041081
gram@@	O	-1	9041081
s	O	-1	9041081
(P@@	O	-1	9041081
-@@	O	-1	9041081
E@@	O	-1	9041081
R@@	O	-1	9041081
G@@	O	-1	9041081
s)	O	-1	9041081
and	O	-1	9041081
standard	O	-1	9041081
pat@@	O	-1	9041081
ter@@	O	-1	9041081
n	O	-1	9041081
visual	O	-1	9041081
evoked	O	-1	9041081
potenti@@	O	-1	9041081
als	O	-1	9041081
(P@@	O	-1	9041081
-@@	O	-1	9041081
V@@	O	-1	9041081
EP@@	O	-1	9041081
s)	O	-1	9041081
were	O	-1	9041081
d@@	O	-1	9041081
one	O	-1	9041081
in	O	-1	9041081
25	O	-1	9041081
e@@	O	-1	9041081
y@@	O	-1	9041081
es	O	-1	9041081
of	O	-1	9041081
25	O	-1	9041081
patients	O	-1	9041081
who	O	-1	9041081
had	O	-1	9041081
my@@	O	-1	9041081
op@@	O	-1	9041081
ic	O	-1	9041081
P@@	O	-1	9041081
R@@	O	-1	9041081
K	O	-1	9041081
for	O	-1	9041081
an	O	-1	9041081
at@@	O	-1	9041081
tem@@	O	-1	9041081
pt@@	O	-1	9041081
ed	O	-1	9041081
cor@@	O	-1	9041081
rec@@	O	-1	9041081
tion	O	-1	9041081
between	O	-1	9041081
5.@@	O	-1	9041081
00	O	-1	9041081
and	O	-1	9041081
1@@	O	-1	9041081
5.@@	O	-1	9041081
00	O	-1	9041081
di@@	O	-1	9041081
op@@	O	-1	9041081
ters	O	-1	9041081
(D@@	O	-1	9041081
)	O	-1	9041081
(@@	O	-1	9041081
mean	O	-1	9041081
8.@@	O	-1	9041081
00	O	-1	9041081
D@@	O	-1	9041081
).	O	-1	9041081
T@@	O	-1	9041081
est@@	O	-1	9041081
ing	O	-1	9041081
was	O	-1	9041081
d@@	O	-1	9041081
one	O	-1	9041081
pre@@	O	-1	9041081
o@@	O	-1	9041081
per@@	O	-1	9041081
atively	O	-1	9041081
and	O	-1	9041081
3,	O	-1	9041081
6,	O	-1	9041081
12@@	O	-1	9041081
,	O	-1	9041081
and	O	-1	9041081
1@@	O	-1	9041081
8	O	-1	9041081
months	O	-1	9041081
posto@@	O	-1	9041081
per@@	O	-1	9041081
ati@@	O	-1	9041081
vel@@	O	-1	9041081
y.	O	-1	9041081
The	O	-1	9041081
contr@@	O	-1	9041081
al@@	O	-1	9041081
ateral	O	-1	9041081
e@@	O	-1	9041081
y@@	O	-1	9041081
es	O	-1	9041081
ser@@	O	-1	9041081
ved	O	-1	9041081
as	O	-1	9041081
controls.	O	-1	9041081
D@@	O	-1	9041081
uring	O	-1	9041081
the	O	-1	9041081
follow-@@	O	-1	9041081
up@@	O	-1	9041081
,	O	-1	9041081
3	O	-1	9041081
patients	O	-1	9041081
(1@@	O	-1	9041081
2@@	O	-1	9041081
%)	O	-1	9041081
developed	O	-1	9041081
ster@@	B-Chemical	D013256	9041081
oid	I-Chemical	-1	9041081
-induced	O	-1	9041081
elevated	B-Disease	D009798	9041081
intra@@	I-Disease	-1	9041081
oc@@	I-Disease	-1	9041081
ular	I-Disease	-1	9041081
pressure	I-Disease	-1	9041081
(@@	O	-1	9041081
I@@	O	-1	9041081
O@@	O	-1	9041081
P)	O	-1	9041081
that	O	-1	9041081
resol@@	O	-1	9041081
ved	O	-1	9041081
after	O	-1	9041081
cortico@@	B-Chemical	D000305	9041081
ster@@	I-Chemical	-1	9041081
oid	I-Chemical	-1	9041081
therapy	O	-1	9041081
was	O	-1	9041081
discontinu@@	O	-1	9041081
ed.	O	-1	9041081
RESULTS:	O	-1	9041081
No	O	-1	9041081
statis@@	O	-1	9041081
tically	O	-1	9041081
significant	O	-1	9041081
differences	O	-1	9041081
were	O	-1	9041081
seen	O	-1	9041081
between	O	-1	9041081
treated	O	-1	9041081
and	O	-1	9041081
control	O	-1	9041081
e@@	O	-1	9041081
y@@	O	-1	9041081
es	O	-1	9041081
n@@	O	-1	9041081
or	O	-1	9041081
between	O	-1	9041081
treated	O	-1	9041081
e@@	O	-1	9041081
y@@	O	-1	9041081
es	O	-1	9041081
pre@@	O	-1	9041081
o@@	O	-1	9041081
per@@	O	-1	9041081
atively	O	-1	9041081
and	O	-1	9041081
posto@@	O	-1	9041081
per@@	O	-1	9041081
ati@@	O	-1	9041081
vel@@	O	-1	9041081
y.	O	-1	9041081
CONCLUSION:	O	-1	9041081
M@@	O	-1	9041081
y@@	O	-1	9041081
op@@	O	-1	9041081
ic	O	-1	9041081
ex@@	O	-1	9041081
c@@	O	-1	9041081
im@@	O	-1	9041081
er	O	-1	9041081
las@@	O	-1	9041081
er	O	-1	9041081
P@@	O	-1	9041081
R@@	O	-1	9041081
K	O	-1	9041081
did	O	-1	9041081
not	O	-1	9041081
se@@	O	-1	9041081
em	O	-1	9041081
to	O	-1	9041081
aff@@	O	-1	9041081
ect	O	-1	9041081
the	O	-1	9041081
po@@	O	-1	9041081
ster@@	O	-1	9041081
ior	O	-1	9041081
seg@@	O	-1	9041081
ment.	O	-1	9041081
The	O	-1	9041081
transi@@	O	-1	9041081
ent	O	-1	9041081
ster@@	B-Chemical	D013256	9041081
oid	I-Chemical	-1	9041081
-induced	O	-1	9041081
I@@	B-Disease	D009798	9041081
O@@	I-Disease	-1	9041081
P	I-Disease	-1	9041081
ri@@	I-Disease	-1	9041081
se	I-Disease	-1	9041081
did	O	-1	9041081
not	O	-1	9041081
se@@	O	-1	9041081
em	O	-1	9041081
to	O	-1	9041081
cause	O	-1	9041081
functional	O	-1	9041081
impair@@	O	-1	9041081
ment.	O	-1	9041081

L@@	O	-1	8305357
i@@	O	-1	8305357
pos@@	O	-1	8305357
om@@	O	-1	8305357
al	O	-1	8305357
da@@	B-Chemical	D003630	8305357
un@@	I-Chemical	-1	8305357
orub@@	I-Chemical	-1	8305357
icin	I-Chemical	-1	8305357
in	O	-1	8305357
adv@@	O	-1	8305357
anced	O	-1	8305357
K@@	B-Disease	D012514	8305357
apo@@	I-Disease	-1	8305357
si@@	I-Disease	-1	8305357
's	I-Disease	-1	8305357
s@@	I-Disease	-1	8305357
ar@@	I-Disease	-1	8305357
com@@	I-Disease	-1	8305357
a	I-Disease	-1	8305357
:	O	-1	8305357
a	O	-1	8305357
phase	O	-1	8305357
II	O	-1	8305357
study.	O	-1	8305357
We	O	-1	8305357
report	O	-1	8305357
a	O	-1	8305357
non-@@	O	-1	8305357
randomized	O	-1	8305357
Ph@@	O	-1	8305357
ase	O	-1	8305357
II	O	-1	8305357
clinical	O	-1	8305357
trial	O	-1	8305357
to	O	-1	8305357
ass@@	O	-1	8305357
ess	O	-1	8305357
the	O	-1	8305357
efficacy	O	-1	8305357
and	O	-1	8305357
safety	O	-1	8305357
of	O	-1	8305357
li@@	O	-1	8305357
pos@@	O	-1	8305357
om@@	O	-1	8305357
al	O	-1	8305357
da@@	B-Chemical	D003630	8305357
un@@	I-Chemical	-1	8305357
orub@@	I-Chemical	-1	8305357
icin	I-Chemical	-1	8305357
(D@@	O	-1	8305357
a@@	O	-1	8305357
un@@	O	-1	8305357
o@@	O	-1	8305357
X@@	O	-1	8305357
o@@	O	-1	8305357
me@@	O	-1	8305357
)	O	-1	8305357
in	O	-1	8305357
the	O	-1	8305357
treatment	O	-1	8305357
of	O	-1	8305357
A@@	B-Disease	D000163	8305357
I@@	I-Disease	-1	8305357
D@@	I-Disease	-1	8305357
S	I-Disease	-1	8305357
related	O	-1	8305357
K@@	B-Disease	D012514	8305357
apo@@	I-Disease	-1	8305357
si@@	I-Disease	-1	8305357
's	I-Disease	-1	8305357
s@@	I-Disease	-1	8305357
ar@@	I-Disease	-1	8305357
com@@	I-Disease	-1	8305357
a	I-Disease	-1	8305357
.	O	-1	8305357
E@@	O	-1	8305357
le@@	O	-1	8305357
ven	O	-1	8305357
ho@@	O	-1	8305357
mo@@	O	-1	8305357
sex@@	O	-1	8305357
ual	O	-1	8305357
men	O	-1	8305357
with	O	-1	8305357
adv@@	O	-1	8305357
anced	O	-1	8305357
K@@	B-Disease	D012514	8305357
apo@@	I-Disease	-1	8305357
si@@	I-Disease	-1	8305357
's	I-Disease	-1	8305357
s@@	I-Disease	-1	8305357
ar@@	I-Disease	-1	8305357
com@@	I-Disease	-1	8305357
a	I-Disease	-1	8305357
were	O	-1	8305357
ent@@	O	-1	8305357
ered	O	-1	8305357
in	O	-1	8305357
the	O	-1	8305357
tri@@	O	-1	8305357
al.	O	-1	8305357
Ch@@	O	-1	8305357
ang@@	O	-1	8305357
es	O	-1	8305357
in	O	-1	8305357
si@@	O	-1	8305357
z@@	O	-1	8305357
e,	O	-1	8305357
co@@	O	-1	8305357
lo@@	O	-1	8305357
ur	O	-1	8305357
and	O	-1	8305357
associated	O	-1	8305357
o@@	B-Disease	D004487	8305357
e@@	I-Disease	-1	8305357
de@@	I-Disease	-1	8305357
ma	I-Disease	-1	8305357
of	O	-1	8305357
sel@@	O	-1	8305357
ected	O	-1	8305357
'@@	O	-1	8305357
t@@	O	-1	8305357
arg@@	O	-1	8305357
et@@	O	-1	8305357
'	O	-1	8305357
lesions	O	-1	8305357
were	O	-1	8305357
meas@@	O	-1	8305357
ure@@	O	-1	8305357
d.	O	-1	8305357
Clin@@	O	-1	8305357
ic@@	O	-1	8305357
al,	O	-1	8305357
bio@@	O	-1	8305357
chemical	O	-1	8305357
and	O	-1	8305357
haem@@	O	-1	8305357
at@@	O	-1	8305357
ological	O	-1	8305357
toxic@@	B-Disease	D064420	8305357
ities	I-Disease	-1	8305357
were	O	-1	8305357
ass@@	O	-1	8305357
es@@	O	-1	8305357
sed.	O	-1	8305357
T@@	O	-1	8305357
en	O	-1	8305357
subjects	O	-1	8305357
were	O	-1	8305357
evalu@@	O	-1	8305357
ated.	O	-1	8305357
A	O	-1	8305357
partial	O	-1	8305357
response	O	-1	8305357
was	O	-1	8305357
achi@@	O	-1	8305357
ev@@	O	-1	8305357
ed	O	-1	8305357
in	O	-1	8305357
fo@@	O	-1	8305357
ur@@	O	-1	8305357
,	O	-1	8305357
of	O	-1	8305357
whom	O	-1	8305357
two	O	-1	8305357
subsequ@@	O	-1	8305357
ently	O	-1	8305357
rel@@	O	-1	8305357
ap@@	O	-1	8305357
sed.	O	-1	8305357
S@@	O	-1	8305357
t@@	O	-1	8305357
abil@@	O	-1	8305357
ization	O	-1	8305357
of	O	-1	8305357
K@@	B-Disease	D012514	8305357
apo@@	I-Disease	-1	8305357
si@@	I-Disease	-1	8305357
's	I-Disease	-1	8305357
s@@	I-Disease	-1	8305357
ar@@	I-Disease	-1	8305357
com@@	I-Disease	-1	8305357
a	I-Disease	-1	8305357
occurred	O	-1	8305357
in	O	-1	8305357
the	O	-1	8305357
remain@@	O	-1	8305357
ing	O	-1	8305357
si@@	O	-1	8305357
x@@	O	-1	8305357
,	O	-1	8305357
maint@@	O	-1	8305357
ained	O	-1	8305357
un@@	O	-1	8305357
ti@@	O	-1	8305357
l	O	-1	8305357
the	O	-1	8305357
end	O	-1	8305357
of	O	-1	8305357
the	O	-1	8305357
trial	O	-1	8305357
period	O	-1	8305357
in	O	-1	8305357
fo@@	O	-1	8305357
ur@@	O	-1	8305357
.	O	-1	8305357
The	O	-1	8305357
drug	O	-1	8305357
was	O	-1	8305357
gener@@	O	-1	8305357
ally	O	-1	8305357
well	O	-1	8305357
toler@@	O	-1	8305357
at@@	O	-1	8305357
ed,	O	-1	8305357
with	O	-1	8305357
fe@@	O	-1	8305357
w	O	-1	8305357
mil@@	O	-1	8305357
d	O	-1	8305357
symptoms	O	-1	8305357
of	O	-1	8305357
toxicity	B-Disease	D064420	8305357
.	O	-1	8305357
The	O	-1	8305357
ma@@	O	-1	8305357
in	O	-1	8305357
pro@@	O	-1	8305357
ble@@	O	-1	8305357
m	O	-1	8305357
en@@	O	-1	8305357
coun@@	O	-1	8305357
te@@	O	-1	8305357
red	O	-1	8305357
was	O	-1	8305357
haem@@	O	-1	8305357
at@@	O	-1	8305357
ological	O	-1	8305357
toxicity	B-Disease	D064420	8305357
,	O	-1	8305357
with	O	-1	8305357
three	O	-1	8305357
subjects	O	-1	8305357
experienc@@	O	-1	8305357
ing	O	-1	8305357
severe	O	-1	8305357
ne@@	B-Disease	D009503	8305357
ut@@	I-Disease	-1	8305357
ro@@	I-Disease	-1	8305357
pen@@	I-Disease	-1	8305357
ia	I-Disease	-1	8305357
(@@	O	-1	8305357
ne@@	O	-1	8305357
ut@@	O	-1	8305357
ro@@	O	-1	8305357
ph@@	O	-1	8305357
il	O	-1	8305357
coun@@	O	-1	8305357
t	O	-1	8305357
<	O	-1	8305357
0.@@	O	-1	8305357
5	O	-1	8305357
x	O	-1	8305357
10@@	O	-1	8305357
(@@	O	-1	8305357
9@@	O	-1	8305357
)@@	O	-1	8305357
/@@	O	-1	8305357
l@@	O	-1	8305357
).	O	-1	8305357
There	O	-1	8305357
was	O	-1	8305357
no	O	-1	8305357
evidence	O	-1	8305357
of	O	-1	8305357
cardi@@	B-Disease	D066126	8305357
otoxicity	I-Disease	-1	8305357
.	O	-1	8305357
In	O	-1	8305357
this	O	-1	8305357
sm@@	O	-1	8305357
all	O	-1	8305357
patient	O	-1	8305357
sam@@	O	-1	8305357
ple@@	O	-1	8305357
,	O	-1	8305357
li@@	O	-1	8305357
pos@@	O	-1	8305357
om@@	O	-1	8305357
al	O	-1	8305357
da@@	B-Chemical	D003630	8305357
un@@	I-Chemical	-1	8305357
orub@@	I-Chemical	-1	8305357
icin	I-Chemical	-1	8305357
was	O	-1	8305357
an	O	-1	8305357
effective	O	-1	8305357
and	O	-1	8305357
well	O	-1	8305357
toler@@	O	-1	8305357
ated	O	-1	8305357
agent	O	-1	8305357
in	O	-1	8305357
the	O	-1	8305357
treatment	O	-1	8305357
of	O	-1	8305357
K@@	B-Disease	D012514	8305357
apo@@	I-Disease	-1	8305357
si@@	I-Disease	-1	8305357
's	I-Disease	-1	8305357
s@@	I-Disease	-1	8305357
ar@@	I-Disease	-1	8305357
com@@	I-Disease	-1	8305357
a	I-Disease	-1	8305357
.	O	-1	8305357

F@@	O	-1	8012887
ail@@	O	-1	8012887
ure	O	-1	8012887
of	O	-1	8012887
anc@@	O	-1	8012887
ro@@	O	-1	8012887
d	O	-1	8012887
in	O	-1	8012887
the	O	-1	8012887
treatment	O	-1	8012887
of	O	-1	8012887
hepar@@	B-Chemical	D006493	8012887
in	I-Chemical	-1	8012887
-induced	O	-1	8012887
arterial	O	-1	8012887
thrombo@@	B-Disease	D013927	8012887
sis	I-Disease	-1	8012887
.	O	-1	8012887
The	O	-1	8012887
mor@@	O	-1	8012887
b@@	O	-1	8012887
idity	O	-1	8012887
and	O	-1	8012887
mor@@	O	-1	8012887
t@@	O	-1	8012887
ality	O	-1	8012887
associated	O	-1	8012887
with	O	-1	8012887
hepar@@	B-Chemical	D006493	8012887
in	I-Chemical	-1	8012887
-induced	O	-1	8012887
thrombo@@	B-Disease	D013927	8012887
sis	I-Disease	-1	8012887
re@@	O	-1	8012887
ma@@	O	-1	8012887
in	O	-1	8012887
high	O	-1	8012887
des@@	O	-1	8012887
pit@@	O	-1	8012887
e	O	-1	8012887
n@@	O	-1	8012887
um@@	O	-1	8012887
er@@	O	-1	8012887
ous	O	-1	8012887
em@@	O	-1	8012887
pi@@	O	-1	8012887
r@@	O	-1	8012887
ical	O	-1	8012887
therap@@	O	-1	8012887
i@@	O	-1	8012887
es.	O	-1	8012887
An@@	O	-1	8012887
c@@	O	-1	8012887
ro@@	O	-1	8012887
d	O	-1	8012887
has	O	-1	8012887
been	O	-1	8012887
used	O	-1	8012887
suc@@	O	-1	8012887
cess@@	O	-1	8012887
ful@@	O	-1	8012887
ly	O	-1	8012887
for	O	-1	8012887
pro@@	O	-1	8012887
phyl@@	O	-1	8012887
ax@@	O	-1	8012887
is	O	-1	8012887
against	O	-1	8012887
development	O	-1	8012887
of	O	-1	8012887
thrombo@@	B-Disease	D013927	8012887
sis	I-Disease	-1	8012887
in	O	-1	8012887
patients	O	-1	8012887
with	O	-1	8012887
hepar@@	B-Chemical	D006493	8012887
in	I-Chemical	-1	8012887
induced	O	-1	8012887
platele@@	B-Disease	D001791	8012887
t	I-Disease	-1	8012887
ag@@	I-Disease	-1	8012887
g@@	I-Disease	-1	8012887
reg@@	I-Disease	-1	8012887
ation	I-Disease	-1	8012887
who	O	-1	8012887
requ@@	O	-1	8012887
ir@@	O	-1	8012887
e	O	-1	8012887
b@@	O	-1	8012887
ri@@	O	-1	8012887
e@@	O	-1	8012887
f	O	-1	8012887
re@@	O	-1	8012887
exposure	O	-1	8012887
to	O	-1	8012887
hepar@@	B-Chemical	D006493	8012887
in	I-Chemical	-1	8012887
,	O	-1	8012887
but	O	-1	8012887
its	O	-1	8012887
suc@@	O	-1	8012887
cess	O	-1	8012887
in	O	-1	8012887
patients	O	-1	8012887
who	O	-1	8012887
have	O	-1	8012887
developed	O	-1	8012887
the	O	-1	8012887
thrombo@@	B-Disease	D013927	8012887
sis	I-Disease	-1	8012887
syndrome	O	-1	8012887
is	O	-1	8012887
not	O	-1	8012887
well	O	-1	8012887
def@@	O	-1	8012887
ine@@	O	-1	8012887
d.	O	-1	8012887
The	O	-1	8012887
au@@	O	-1	8012887
th@@	O	-1	8012887
ors	O	-1	8012887
present	O	-1	8012887
a	O	-1	8012887
case	O	-1	8012887
of	O	-1	8012887
failure	O	-1	8012887
of	O	-1	8012887
anc@@	O	-1	8012887
ro@@	O	-1	8012887
d	O	-1	8012887
treatment	O	-1	8012887
in	O	-1	8012887
a	O	-1	8012887
patient	O	-1	8012887
with	O	-1	8012887
hepar@@	B-Chemical	D006493	8012887
in	I-Chemical	-1	8012887
-induced	O	-1	8012887
thrombo@@	B-Disease	D013927	8012887
sis	I-Disease	-1	8012887
.	O	-1	8012887

S@@	B-Disease	D012640	7651879
e@@	I-Disease	-1	7651879
iz@@	I-Disease	-1	7651879
ure	I-Disease	-1	7651879
after	O	-1	7651879
flu@@	B-Chemical	D005442	7651879
ma@@	I-Chemical	-1	7651879
z@@	I-Chemical	-1	7651879
en@@	I-Chemical	-1	7651879
il	I-Chemical	-1	7651879
administration	O	-1	7651879
in	O	-1	7651879
a	O	-1	7651879
pe@@	O	-1	7651879
di@@	O	-1	7651879
atric	O	-1	7651879
patient@@	O	-1	7651879
.	O	-1	7651879
F@@	B-Chemical	D005442	7651879
lu@@	I-Chemical	-1	7651879
ma@@	I-Chemical	-1	7651879
z@@	I-Chemical	-1	7651879
en@@	I-Chemical	-1	7651879
il	I-Chemical	-1	7651879
is	O	-1	7651879
a	O	-1	7651879
b@@	B-Chemical	D001569	7651879
enz@@	I-Chemical	-1	7651879
odi@@	I-Chemical	-1	7651879
azepine	I-Chemical	-1	7651879
receptor	O	-1	7651879
antagonist	O	-1	7651879
used	O	-1	7651879
to	O	-1	7651879
re@@	O	-1	7651879
verse	O	-1	7651879
sed@@	O	-1	7651879
ation	O	-1	7651879
and	O	-1	7651879
respiratory	B-Disease	D012131	7651879
de@@	I-Disease	-1	7651879
pression	I-Disease	-1	7651879
induced	O	-1	7651879
by	O	-1	7651879
b@@	B-Chemical	D001569	7651879
enz@@	I-Chemical	-1	7651879
odi@@	I-Chemical	-1	7651879
azep@@	I-Chemical	-1	7651879
in@@	I-Chemical	-1	7651879
es	I-Chemical	-1	7651879
.	O	-1	7651879
S@@	B-Disease	D012640	7651879
e@@	I-Disease	-1	7651879
iz@@	I-Disease	-1	7651879
ures	I-Disease	-1	7651879
and	O	-1	7651879
cardiac	B-Disease	D001145	7651879
arrhyth@@	I-Disease	-1	7651879
mi@@	I-Disease	-1	7651879
as	I-Disease	-1	7651879
have	O	-1	7651879
complic@@	O	-1	7651879
ated	O	-1	7651879
its	O	-1	7651879
use	O	-1	7651879
in	O	-1	7651879
ad@@	O	-1	7651879
ult	O	-1	7651879
patients.	O	-1	7651879
O@@	B-Disease	D062787	7651879
ver@@	I-Disease	-1	7651879
dose	I-Disease	-1	7651879
patients	O	-1	7651879
who	O	-1	7651879
have	O	-1	7651879
co@@	O	-1	7651879
ing@@	O	-1	7651879
est@@	O	-1	7651879
ed	O	-1	7651879
tr@@	O	-1	7651879
ic@@	O	-1	7651879
y@@	O	-1	7651879
cl@@	O	-1	7651879
ic	O	-1	7651879
antidepress@@	O	-1	7651879
ants	O	-1	7651879
have	O	-1	7651879
a	O	-1	7651879
higher	O	-1	7651879
risk	O	-1	7651879
of	O	-1	7651879
these	O	-1	7651879
complic@@	O	-1	7651879
ations.	O	-1	7651879
L@@	O	-1	7651879
it@@	O	-1	7651879
t@@	O	-1	7651879
le	O	-1	7651879
inf@@	O	-1	7651879
orm@@	O	-1	7651879
ation	O	-1	7651879
ex@@	O	-1	7651879
ist@@	O	-1	7651879
s	O	-1	7651879
con@@	O	-1	7651879
cer@@	O	-1	7651879
ning	O	-1	7651879
adverse	O	-1	7651879
effects	O	-1	7651879
of	O	-1	7651879
flu@@	B-Chemical	D005442	7651879
ma@@	I-Chemical	-1	7651879
z@@	I-Chemical	-1	7651879
en@@	I-Chemical	-1	7651879
il	I-Chemical	-1	7651879
in	O	-1	7651879
child@@	O	-1	7651879
ren@@	O	-1	7651879
.	O	-1	7651879
We	O	-1	7651879
report	O	-1	7651879
the	O	-1	7651879
occur@@	O	-1	7651879
rence	O	-1	7651879
of	O	-1	7651879
a	O	-1	7651879
gener@@	O	-1	7651879
al@@	O	-1	7651879
ized	O	-1	7651879
t@@	B-Disease	D012640	7651879
on@@	I-Disease	-1	7651879
ic@@	I-Disease	-1	7651879
-@@	I-Disease	-1	7651879
clon@@	I-Disease	-1	7651879
ic	I-Disease	-1	7651879
seizure	I-Disease	-1	7651879
in	O	-1	7651879
a	O	-1	7651879
pe@@	O	-1	7651879
di@@	O	-1	7651879
atric	O	-1	7651879
patient	O	-1	7651879
following	O	-1	7651879
the	O	-1	7651879
administration	O	-1	7651879
of	O	-1	7651879
flu@@	B-Chemical	D005442	7651879
ma@@	I-Chemical	-1	7651879
z@@	I-Chemical	-1	7651879
en@@	I-Chemical	-1	7651879
il	I-Chemical	-1	7651879
.	O	-1	7651879

R@@	O	-1	3015327
em@@	O	-1	3015327
o@@	O	-1	3015327
de@@	O	-1	3015327
ll@@	O	-1	3015327
ing	O	-1	3015327
of	O	-1	3015327
nerve	O	-1	3015327
struct@@	O	-1	3015327
ure	O	-1	3015327
in	O	-1	3015327
experimental	O	-1	3015327
is@@	B-Chemical	D007538	3015327
oni@@	I-Chemical	-1	3015327
az@@	I-Chemical	-1	3015327
id	I-Chemical	-1	3015327
neuropathy	B-Disease	D009422	3015327
in	O	-1	3015327
the	O	-1	3015327
rat@@	O	-1	3015327
.	O	-1	3015327
The	O	-1	3015327
neuropathy	B-Disease	D009422	3015327
caused	O	-1	3015327
by	O	-1	3015327
a	O	-1	3015327
single	O	-1	3015327
dose	O	-1	3015327
of	O	-1	3015327
is@@	B-Chemical	D007538	3015327
oni@@	I-Chemical	-1	3015327
az@@	I-Chemical	-1	3015327
id	I-Chemical	-1	3015327
in	O	-1	3015327
rats	O	-1	3015327
was	O	-1	3015327
studied	O	-1	3015327
with	O	-1	3015327
a	O	-1	3015327
comp@@	O	-1	3015327
u@@	O	-1	3015327
ter@@	O	-1	3015327
-@@	O	-1	3015327
as@@	O	-1	3015327
sist@@	O	-1	3015327
ed	O	-1	3015327
morph@@	O	-1	3015327
o@@	O	-1	3015327
me@@	O	-1	3015327
tri@@	O	-1	3015327
c	O	-1	3015327
meth@@	O	-1	3015327
o@@	O	-1	3015327
d.	O	-1	3015327
S@@	O	-1	3015327
cat@@	O	-1	3015327
ter	O	-1	3015327
diag@@	O	-1	3015327
ram@@	O	-1	3015327
s	O	-1	3015327
of	O	-1	3015327
the	O	-1	3015327
g	O	-1	3015327
rati@@	O	-1	3015327
o	O	-1	3015327
(@@	O	-1	3015327
qu@@	O	-1	3015327
o@@	O	-1	3015327
ti@@	O	-1	3015327
ent	O	-1	3015327
fib@@	O	-1	3015327
r@@	O	-1	3015327
e	O	-1	3015327
di@@	O	-1	3015327
ame@@	O	-1	3015327
ter@@	O	-1	3015327
/@@	O	-1	3015327
ax@@	O	-1	3015327
on	O	-1	3015327
di@@	O	-1	3015327
ame@@	O	-1	3015327
ter@@	O	-1	3015327
)	O	-1	3015327
def@@	O	-1	3015327
ine	O	-1	3015327
re@@	O	-1	3015327
gener@@	O	-1	3015327
ating	O	-1	3015327
fib@@	O	-1	3015327
res	O	-1	3015327
as	O	-1	3015327
a	O	-1	3015327
dist@@	O	-1	3015327
inc@@	O	-1	3015327
t	O	-1	3015327
po@@	O	-1	3015327
pul@@	O	-1	3015327
ation,	O	-1	3015327
dist@@	O	-1	3015327
ing@@	O	-1	3015327
u@@	O	-1	3015327
ish@@	O	-1	3015327
able	O	-1	3015327
from	O	-1	3015327
the	O	-1	3015327
sur@@	O	-1	3015327
vi@@	O	-1	3015327
ving	O	-1	3015327
fib@@	O	-1	3015327
res	O	-1	3015327
by	O	-1	3015327
reduced	O	-1	3015327
s@@	O	-1	3015327
he@@	O	-1	3015327
ath	O	-1	3015327
th@@	O	-1	3015327
ic@@	O	-1	3015327
k@@	O	-1	3015327
ness	O	-1	3015327
and	O	-1	3015327
reduced	O	-1	3015327
ax@@	O	-1	3015327
on	O	-1	3015327
cal@@	O	-1	3015327
i@@	O	-1	3015327
b@@	O	-1	3015327
re.	O	-1	3015327
There	O	-1	3015327
was	O	-1	3015327
also	O	-1	3015327
evidence	O	-1	3015327
of	O	-1	3015327
a	O	-1	3015327
sub@@	O	-1	3015327
t@@	O	-1	3015327
le	O	-1	3015327
direct	O	-1	3015327
toxic	O	-1	3015327
effect	O	-1	3015327
on	O	-1	3015327
the	O	-1	3015327
enti@@	O	-1	3015327
r@@	O	-1	3015327
e	O	-1	3015327
fib@@	O	-1	3015327
r@@	O	-1	3015327
e	O	-1	3015327
po@@	O	-1	3015327
pul@@	O	-1	3015327
ation,	O	-1	3015327
ca@@	O	-1	3015327
using	O	-1	3015327
ax@@	O	-1	3015327
on	O	-1	3015327
sh@@	O	-1	3015327
r@@	O	-1	3015327
in@@	O	-1	3015327
k@@	O	-1	3015327
age	O	-1	3015327
mas@@	O	-1	3015327
ked	O	-1	3015327
by	O	-1	3015327
re@@	O	-1	3015327
adjust@@	O	-1	3015327
ment	O	-1	3015327
of	O	-1	3015327
the	O	-1	3015327
my@@	O	-1	3015327
el@@	O	-1	3015327
in	O	-1	3015327
s@@	O	-1	3015327
he@@	O	-1	3015327
ath@@	O	-1	3015327
.	O	-1	3015327

S@@	O	-1	2980315
el@@	O	-1	2980315
ective	O	-1	2980315
injection	O	-1	2980315
of	O	-1	2980315
io@@	B-Chemical	C053571	2980315
pent@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
,	O	-1	2980315
io@@	B-Chemical	D007472	2980315
he@@	I-Chemical	-1	2980315
x@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
and	O	-1	2980315
me@@	B-Chemical	D008794	2980315
tri@@	I-Chemical	-1	2980315
z@@	I-Chemical	-1	2980315
o@@	I-Chemical	-1	2980315
ate	I-Chemical	-1	2980315
into	O	-1	2980315
the	O	-1	2980315
left	O	-1	2980315
coronary	O	-1	2980315
artery	O	-1	2980315
of	O	-1	2980315
the	O	-1	2980315
dog@@	O	-1	2980315
.	O	-1	2980315
In@@	O	-1	2980315
duction	O	-1	2980315
of	O	-1	2980315
ventricular	B-Disease	D014693	2980315
fibrill@@	I-Disease	-1	2980315
ation	I-Disease	-1	2980315
and	O	-1	2980315
decrease	O	-1	2980315
of	O	-1	2980315
a@@	O	-1	2980315
or@@	O	-1	2980315
tic	O	-1	2980315
pressu@@	O	-1	2980315
re.	O	-1	2980315
In	O	-1	2980315
tw@@	O	-1	2980315
ent@@	O	-1	2980315
y	O	-1	2980315
be@@	O	-1	2980315
ag@@	O	-1	2980315
le	O	-1	2980315
dog@@	O	-1	2980315
s	O	-1	2980315
selective	O	-1	2980315
injec@@	O	-1	2980315
tions	O	-1	2980315
were	O	-1	2980315
m@@	O	-1	2980315
ade	O	-1	2980315
into	O	-1	2980315
the	O	-1	2980315
left	O	-1	2980315
coronary	O	-1	2980315
artery	O	-1	2980315
with	O	-1	2980315
io@@	B-Chemical	C053571	2980315
pent@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
,	O	-1	2980315
io@@	B-Chemical	D007472	2980315
he@@	I-Chemical	-1	2980315
x@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
and	O	-1	2980315
me@@	B-Chemical	D008794	2980315
tri@@	I-Chemical	-1	2980315
z@@	I-Chemical	-1	2980315
o@@	I-Chemical	-1	2980315
ate	I-Chemical	-1	2980315
in	O	-1	2980315
doses	O	-1	2980315
of	O	-1	2980315
4	O	-1	2980315
ml@@	O	-1	2980315
,	O	-1	2980315
8	O	-1	2980315
m@@	O	-1	2980315
l	O	-1	2980315
and	O	-1	2980315
16	O	-1	2980315
ml@@	O	-1	2980315
.	O	-1	2980315
Th@@	O	-1	2980315
ir@@	O	-1	2980315
ty-@@	O	-1	2980315
six	O	-1	2980315
io@@	B-Chemical	C053571	2980315
pent@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
injec@@	O	-1	2980315
tion@@	O	-1	2980315
s,	O	-1	2980315
3@@	O	-1	2980315
5	O	-1	2980315
io@@	B-Chemical	D007472	2980315
he@@	I-Chemical	-1	2980315
x@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
injec@@	O	-1	2980315
tions	O	-1	2980315
and	O	-1	2980315
3@@	O	-1	2980315
7	O	-1	2980315
me@@	B-Chemical	D008794	2980315
tri@@	I-Chemical	-1	2980315
z@@	I-Chemical	-1	2980315
o@@	I-Chemical	-1	2980315
ate	I-Chemical	-1	2980315
injec@@	O	-1	2980315
tions	O	-1	2980315
were	O	-1	2980315
ma@@	O	-1	2980315
de@@	O	-1	2980315
.	O	-1	2980315
F@@	O	-1	2980315
requ@@	O	-1	2980315
en@@	O	-1	2980315
ci@@	O	-1	2980315
es	O	-1	2980315
of	O	-1	2980315
ventricular	B-Disease	D014693	2980315
fibrill@@	I-Disease	-1	2980315
ation	I-Disease	-1	2980315
were	O	-1	2980315
significantly	O	-1	2980315
lower	O	-1	2980315
(p	O	-1	2980315
less	O	-1	2980315
than	O	-1	2980315
0.05@@	O	-1	2980315
)	O	-1	2980315
after	O	-1	2980315
io@@	B-Chemical	C053571	2980315
pent@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
(@@	O	-1	2980315
0@@	O	-1	2980315
%)	O	-1	2980315
and	O	-1	2980315
io@@	B-Chemical	D007472	2980315
he@@	I-Chemical	-1	2980315
x@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
(3@@	O	-1	2980315
%)	O	-1	2980315
than	O	-1	2980315
after	O	-1	2980315
me@@	B-Chemical	D008794	2980315
tri@@	I-Chemical	-1	2980315
z@@	I-Chemical	-1	2980315
o@@	I-Chemical	-1	2980315
ate	I-Chemical	-1	2980315
(2@@	O	-1	2980315
2@@	O	-1	2980315
%).	O	-1	2980315
I@@	B-Chemical	C053571	2980315
op@@	I-Chemical	-1	2980315
ent@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
and	O	-1	2980315
io@@	B-Chemical	D007472	2980315
he@@	I-Chemical	-1	2980315
x@@	I-Chemical	-1	2980315
ol	I-Chemical	-1	2980315
also	O	-1	2980315
produced	O	-1	2980315
significantly	O	-1	2980315
less	O	-1	2980315
decrease	O	-1	2980315
in	O	-1	2980315
a@@	O	-1	2980315
or@@	O	-1	2980315
tic	O	-1	2980315
blood	O	-1	2980315
pressure	O	-1	2980315
than	O	-1	2980315
me@@	B-Chemical	D008794	2980315
tri@@	I-Chemical	-1	2980315
z@@	I-Chemical	-1	2980315
o@@	I-Chemical	-1	2980315
ate	I-Chemical	-1	2980315
at	O	-1	2980315
the	O	-1	2980315
different	O	-1	2980315
dos@@	O	-1	2980315
es.	O	-1	2980315

M@@	O	-1	2819587
ag@@	O	-1	2819587
ne@@	O	-1	2819587
tic	O	-1	2819587
res@@	O	-1	2819587
on@@	O	-1	2819587
ance	O	-1	2819587
imaging	O	-1	2819587
of	O	-1	2819587
cerebral	O	-1	2819587
venous	B-Disease	D020246	2819587
thrombo@@	I-Disease	-1	2819587
sis	I-Disease	-1	2819587
secondary	O	-1	2819587
to	O	-1	2819587
"@@	O	-1	2819587
low@@	O	-1	2819587
-@@	O	-1	2819587
dose@@	O	-1	2819587
"	O	-1	2819587
b@@	O	-1	2819587
ir@@	O	-1	2819587
th	O	-1	2819587
control	O	-1	2819587
p@@	O	-1	2819587
ill@@	O	-1	2819587
s.	O	-1	2819587
The	O	-1	2819587
clinical	O	-1	2819587
and	O	-1	2819587
radi@@	O	-1	2819587
ograph@@	O	-1	2819587
ic	O	-1	2819587
feat@@	O	-1	2819587
ures	O	-1	2819587
of	O	-1	2819587
cerebral	O	-1	2819587
de@@	B-Disease	D020246	2819587
ep	I-Disease	-1	2819587
venous	I-Disease	-1	2819587
thrombo@@	I-Disease	-1	2819587
sis	I-Disease	-1	2819587
in	O	-1	2819587
a	O	-1	2819587
2@@	O	-1	2819587
1-@@	O	-1	2819587
year-old	O	-1	2819587
wh@@	O	-1	2819587
ite	O	-1	2819587
woman	O	-1	2819587
are	O	-1	2819587
present@@	O	-1	2819587
ed.	O	-1	2819587
This	O	-1	2819587
n@@	O	-1	2819587
ul@@	O	-1	2819587
li@@	O	-1	2819587
pa@@	O	-1	2819587
rou@@	O	-1	2819587
s	O	-1	2819587
patient	O	-1	2819587
presented	O	-1	2819587
with	O	-1	2819587
rel@@	O	-1	2819587
atively	O	-1	2819587
mil@@	O	-1	2819587
d	O	-1	2819587
clinical	O	-1	2819587
symptoms	O	-1	2819587
and	O	-1	2819587
progres@@	O	-1	2819587
s@@	O	-1	2819587
ing	O	-1	2819587
mental	O	-1	2819587
status	O	-1	2819587
chang@@	O	-1	2819587
es.	O	-1	2819587
The	O	-1	2819587
only	O	-1	2819587
known	O	-1	2819587
risk	O	-1	2819587
factor	O	-1	2819587
was	O	-1	2819587
"@@	O	-1	2819587
low@@	O	-1	2819587
-@@	O	-1	2819587
dose@@	O	-1	2819587
"	O	-1	2819587
oral	B-Chemical	D003276	2819587
contrac@@	I-Chemical	-1	2819587
ep@@	I-Chemical	-1	2819587
tive	I-Chemical	-1	2819587
p@@	O	-1	2819587
ill@@	O	-1	2819587
s.	O	-1	2819587
The	O	-1	2819587
mag@@	O	-1	2819587
ne@@	O	-1	2819587
tic	O	-1	2819587
res@@	O	-1	2819587
on@@	O	-1	2819587
ance	O	-1	2819587
im@@	O	-1	2819587
age	O	-1	2819587
(@@	O	-1	2819587
MR@@	O	-1	2819587
I@@	O	-1	2819587
)	O	-1	2819587
showed	O	-1	2819587
increased	O	-1	2819587
sign@@	O	-1	2819587
al	O	-1	2819587
int@@	O	-1	2819587
ensity	O	-1	2819587
from	O	-1	2819587
the	O	-1	2819587
inter@@	O	-1	2819587
n@@	O	-1	2819587
al	O	-1	2819587
cerebral	O	-1	2819587
ve@@	O	-1	2819587
in@@	O	-1	2819587
s,	O	-1	2819587
ve@@	O	-1	2819587
in	O	-1	2819587
of	O	-1	2819587
G@@	O	-1	2819587
al@@	O	-1	2819587
en@@	O	-1	2819587
,	O	-1	2819587
and	O	-1	2819587
stra@@	O	-1	2819587
ight	O	-1	2819587
s@@	O	-1	2819587
in@@	O	-1	2819587
us.	O	-1	2819587
The	O	-1	2819587
diagnosis	O	-1	2819587
was	O	-1	2819587
con@@	O	-1	2819587
fir@@	O	-1	2819587
m@@	O	-1	2819587
ed	O	-1	2819587
by	O	-1	2819587
arterial	O	-1	2819587
angio@@	O	-1	2819587
graph@@	O	-1	2819587
y.	O	-1	2819587

R@@	O	-1	1564236
el@@	O	-1	1564236
ation	O	-1	1564236
of	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
def@@	O	-1	1564236
ects	O	-1	1564236
observed	O	-1	1564236
with	O	-1	1564236
myocardial	O	-1	1564236
contr@@	O	-1	1564236
ast	O	-1	1564236
echocardiograph@@	O	-1	1564236
y	O	-1	1564236
to	O	-1	1564236
the	O	-1	1564236
severity	O	-1	1564236
of	O	-1	1564236
coronary	B-Disease	D023921	1564236
st@@	I-Disease	-1	1564236
en@@	I-Disease	-1	1564236
o@@	I-Disease	-1	1564236
sis	I-Disease	-1	1564236
:	O	-1	1564236
correl@@	O	-1	1564236
ation	O	-1	1564236
with	O	-1	1564236
thal@@	B-Chemical	D013793	1564236
li@@	I-Chemical	-1	1564236
um	I-Chemical	-1	1564236
-@@	O	-1	1564236
20@@	O	-1	1564236
1	O	-1	1564236
sing@@	O	-1	1564236
le@@	O	-1	1564236
-@@	O	-1	1564236
ph@@	O	-1	1564236
ot@@	O	-1	1564236
on	O	-1	1564236
em@@	O	-1	1564236
is@@	O	-1	1564236
sion	O	-1	1564236
to@@	O	-1	1564236
mo@@	O	-1	1564236
graph@@	O	-1	1564236
y.	O	-1	1564236
It	O	-1	1564236
has	O	-1	1564236
been	O	-1	1564236
previously	O	-1	1564236
shown	O	-1	1564236
that	O	-1	1564236
myocardial	O	-1	1564236
contr@@	O	-1	1564236
ast	O	-1	1564236
echocardiograph@@	O	-1	1564236
y	O	-1	1564236
is	O	-1	1564236
a	O	-1	1564236
valu@@	O	-1	1564236
able	O	-1	1564236
t@@	O	-1	1564236
ech@@	O	-1	1564236
n@@	O	-1	1564236
i@@	O	-1	1564236
qu@@	O	-1	1564236
e	O	-1	1564236
for	O	-1	1564236
del@@	O	-1	1564236
ine@@	O	-1	1564236
ating	O	-1	1564236
regi@@	O	-1	1564236
ons	O	-1	1564236
of	O	-1	1564236
myocardial	O	-1	1564236
under@@	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
secondary	O	-1	1564236
to	O	-1	1564236
coronary	B-Disease	D054059	1564236
oc@@	I-Disease	-1	1564236
cl@@	I-Disease	-1	1564236
usion	I-Disease	-1	1564236
and	O	-1	1564236
to	O	-1	1564236
cri@@	O	-1	1564236
tical	O	-1	1564236
coronary	B-Disease	D023921	1564236
st@@	I-Disease	-1	1564236
en@@	I-Disease	-1	1564236
o@@	I-Disease	-1	1564236
ses	I-Disease	-1	1564236
in	O	-1	1564236
the	O	-1	1564236
presence	O	-1	1564236
of	O	-1	1564236
hy@@	B-Disease	D006940	1564236
pe@@	I-Disease	-1	1564236
re@@	I-Disease	-1	1564236
mic	I-Disease	-1	1564236
stimul@@	O	-1	1564236
ation.	O	-1	1564236
The	O	-1	1564236
a@@	O	-1	1564236
im	O	-1	1564236
of	O	-1	1564236
this	O	-1	1564236
study	O	-1	1564236
was	O	-1	1564236
to	O	-1	1564236
determine	O	-1	1564236
whether	O	-1	1564236
myocardial	O	-1	1564236
contr@@	O	-1	1564236
ast	O	-1	1564236
echocardiograph@@	O	-1	1564236
y	O	-1	1564236
performed	O	-1	1564236
with	O	-1	1564236
a	O	-1	1564236
st@@	O	-1	1564236
able	O	-1	1564236
sol@@	O	-1	1564236
u@@	O	-1	1564236
tion	O	-1	1564236
of	O	-1	1564236
son@@	O	-1	1564236
ic@@	O	-1	1564236
ated	O	-1	1564236
al@@	O	-1	1564236
b@@	O	-1	1564236
um@@	O	-1	1564236
in	O	-1	1564236
could	O	-1	1564236
det@@	O	-1	1564236
ect	O	-1	1564236
regi@@	O	-1	1564236
ons	O	-1	1564236
of	O	-1	1564236
myocardial	O	-1	1564236
under@@	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
result@@	O	-1	1564236
ing	O	-1	1564236
from	O	-1	1564236
various	O	-1	1564236
de@@	O	-1	1564236
gre@@	O	-1	1564236
es	O	-1	1564236
of	O	-1	1564236
coronary	B-Disease	D023921	1564236
st@@	I-Disease	-1	1564236
en@@	I-Disease	-1	1564236
o@@	I-Disease	-1	1564236
sis	I-Disease	-1	1564236
.	O	-1	1564236
The	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
def@@	O	-1	1564236
ect	O	-1	1564236
produced	O	-1	1564236
in	O	-1	1564236
16	O	-1	1564236
op@@	O	-1	1564236
en	O	-1	1564236
ch@@	O	-1	1564236
est	O	-1	1564236
dog@@	O	-1	1564236
s	O	-1	1564236
was	O	-1	1564236
compared	O	-1	1564236
with	O	-1	1564236
the	O	-1	1564236
an@@	O	-1	1564236
at@@	O	-1	1564236
om@@	O	-1	1564236
ic	O	-1	1564236
a@@	O	-1	1564236
re@@	O	-1	1564236
a	O	-1	1564236
at	O	-1	1564236
risk	O	-1	1564236
measured	O	-1	1564236
by	O	-1	1564236
the	O	-1	1564236
post@@	O	-1	1564236
mor@@	O	-1	1564236
te@@	O	-1	1564236
m	O	-1	1564236
du@@	O	-1	1564236
al@@	O	-1	1564236
-@@	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
t@@	O	-1	1564236
ech@@	O	-1	1564236
n@@	O	-1	1564236
i@@	O	-1	1564236
qu@@	O	-1	1564236
e	O	-1	1564236
and	O	-1	1564236
with	O	-1	1564236
thal@@	B-Chemical	D013793	1564236
li@@	I-Chemical	-1	1564236
um	I-Chemical	-1	1564236
-@@	O	-1	1564236
20@@	O	-1	1564236
1	O	-1	1564236
sing@@	O	-1	1564236
le@@	O	-1	1564236
-@@	O	-1	1564236
ph@@	O	-1	1564236
ot@@	O	-1	1564236
on	O	-1	1564236
em@@	O	-1	1564236
is@@	O	-1	1564236
sion	O	-1	1564236
to@@	O	-1	1564236
mo@@	O	-1	1564236
graph@@	O	-1	1564236
y	O	-1	1564236
(S@@	O	-1	1564236
P@@	O	-1	1564236
EC@@	O	-1	1564236
T@@	O	-1	1564236
).	O	-1	1564236
D@@	O	-1	1564236
uring	O	-1	1564236
a	O	-1	1564236
transi@@	O	-1	1564236
ent	O	-1	1564236
(2@@	O	-1	1564236
0-@@	O	-1	1564236
s)	O	-1	1564236
coronary	B-Disease	D054059	1564236
oc@@	I-Disease	-1	1564236
cl@@	I-Disease	-1	1564236
usion	I-Disease	-1	1564236
,	O	-1	1564236
a	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
def@@	O	-1	1564236
ect	O	-1	1564236
was	O	-1	1564236
observed	O	-1	1564236
with	O	-1	1564236
contr@@	O	-1	1564236
ast	O	-1	1564236
echocardiograph@@	O	-1	1564236
y	O	-1	1564236
in	O	-1	1564236
14	O	-1	1564236
of	O	-1	1564236
the	O	-1	1564236
15	O	-1	1564236
dog@@	O	-1	1564236
s	O	-1	1564236
in	O	-1	1564236
which	O	-1	1564236
the	O	-1	1564236
oc@@	O	-1	1564236
cl@@	O	-1	1564236
usion	O	-1	1564236
was	O	-1	1564236
produc@@	O	-1	1564236
ed.	O	-1	1564236
The	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
def@@	O	-1	1564236
ect	O	-1	1564236
cor@@	O	-1	1564236
related	O	-1	1564236
significantly	O	-1	1564236
with	O	-1	1564236
the	O	-1	1564236
an@@	O	-1	1564236
at@@	O	-1	1564236
om@@	O	-1	1564236
ic	O	-1	1564236
a@@	O	-1	1564236
re@@	O	-1	1564236
a	O	-1	1564236
at	O	-1	1564236
risk	O	-1	1564236
(@@	O	-1	1564236
r	O	-1	1564236
=	O	-1	1564236
0.@@	O	-1	1564236
7@@	O	-1	1564236
4@@	O	-1	1564236
;	O	-1	1564236
p	O	-1	1564236
less	O	-1	1564236
than	O	-1	1564236
0.00@@	O	-1	1564236
2@@	O	-1	1564236
).	O	-1	1564236
D@@	O	-1	1564236
uring	O	-1	1564236
di@@	B-Chemical	D004176	1564236
pyri@@	I-Chemical	-1	1564236
dam@@	I-Chemical	-1	1564236
ole	I-Chemical	-1	1564236
-induced	O	-1	1564236
hy@@	B-Disease	D006940	1564236
pe@@	I-Disease	-1	1564236
re@@	I-Disease	-1	1564236
mia	I-Disease	-1	1564236
,	O	-1	1564236
12	O	-1	1564236
of	O	-1	1564236
the	O	-1	1564236
16	O	-1	1564236
dog@@	O	-1	1564236
s	O	-1	1564236
with	O	-1	1564236
a	O	-1	1564236
partial	O	-1	1564236
coronary	B-Disease	D023921	1564236
st@@	I-Disease	-1	1564236
en@@	I-Disease	-1	1564236
o@@	I-Disease	-1	1564236
sis	I-Disease	-1	1564236
had	O	-1	1564236
a	O	-1	1564236
vi@@	O	-1	1564236
sible	O	-1	1564236
a@@	O	-1	1564236
re@@	O	-1	1564236
a	O	-1	1564236
of	O	-1	1564236
hypo@@	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
by	O	-1	1564236
contr@@	O	-1	1564236
ast	O	-1	1564236
echocardiograph@@	O	-1	1564236
y.	O	-1	1564236
The	O	-1	1564236
four	O	-1	1564236
dog@@	O	-1	1564236
s	O	-1	1564236
without	O	-1	1564236
a	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
def@@	O	-1	1564236
ect	O	-1	1564236
had	O	-1	1564236
a	O	-1	1564236
st@@	O	-1	1564236
en@@	O	-1	1564236
o@@	O	-1	1564236
sis	O	-1	1564236
that	O	-1	1564236
resulted	O	-1	1564236
in	O	-1	1564236
a	O	-1	1564236
mil@@	O	-1	1564236
d	O	-1	1564236
(@@	O	-1	1564236
0%	O	-1	1564236
to	O	-1	1564236
50@@	O	-1	1564236
%)	O	-1	1564236
reduction	O	-1	1564236
in	O	-1	1564236
di@@	B-Chemical	D004176	1564236
pyri@@	I-Chemical	-1	1564236
dam@@	I-Chemical	-1	1564236
ole	I-Chemical	-1	1564236
-induced	O	-1	1564236
hy@@	B-Disease	D006940	1564236
pe@@	I-Disease	-1	1564236
re@@	I-Disease	-1	1564236
mia	I-Disease	-1	1564236
.	O	-1	1564236
The	O	-1	1564236
size	O	-1	1564236
of	O	-1	1564236
the	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
def@@	O	-1	1564236
ect	O	-1	1564236
during	O	-1	1564236
st@@	O	-1	1564236
en@@	O	-1	1564236
o@@	O	-1	1564236
sis	O	-1	1564236
cor@@	O	-1	1564236
related	O	-1	1564236
significantly	O	-1	1564236
with	O	-1	1564236
the	O	-1	1564236
an@@	O	-1	1564236
at@@	O	-1	1564236
om@@	O	-1	1564236
ic	O	-1	1564236
a@@	O	-1	1564236
re@@	O	-1	1564236
a	O	-1	1564236
at	O	-1	1564236
risk	O	-1	1564236
(@@	O	-1	1564236
r	O	-1	1564236
=	O	-1	1564236
0.@@	O	-1	1564236
6@@	O	-1	1564236
1@@	O	-1	1564236
;	O	-1	1564236
p	O	-1	1564236
=	O	-1	1564236
0.0@@	O	-1	1564236
2@@	O	-1	1564236
).	O	-1	1564236
Th@@	B-Chemical	D013793	1564236
al@@	I-Chemical	-1	1564236
li@@	I-Chemical	-1	1564236
um	I-Chemical	-1	1564236
-@@	O	-1	1564236
20@@	O	-1	1564236
1	O	-1	1564236
S@@	O	-1	1564236
P@@	O	-1	1564236
EC@@	O	-1	1564236
T	O	-1	1564236
demonstrated	O	-1	1564236
a	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
def@@	O	-1	1564236
ect	O	-1	1564236
in	O	-1	1564236
all	O	-1	1564236
14	O	-1	1564236
dog@@	O	-1	1564236
s	O	-1	1564236
analy@@	O	-1	1564236
zed	O	-1	1564236
during	O	-1	1564236
di@@	B-Chemical	D004176	1564236
pyri@@	I-Chemical	-1	1564236
dam@@	I-Chemical	-1	1564236
ole	I-Chemical	-1	1564236
-induced	O	-1	1564236
hy@@	B-Disease	D006940	1564236
pe@@	I-Disease	-1	1564236
re@@	I-Disease	-1	1564236
mia	I-Disease	-1	1564236
;	O	-1	1564236
the	O	-1	1564236
size	O	-1	1564236
of	O	-1	1564236
the	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
def@@	O	-1	1564236
ect	O	-1	1564236
cor@@	O	-1	1564236
related	O	-1	1564236
with	O	-1	1564236
the	O	-1	1564236
an@@	O	-1	1564236
at@@	O	-1	1564236
om@@	O	-1	1564236
ic	O	-1	1564236
a@@	O	-1	1564236
re@@	O	-1	1564236
a	O	-1	1564236
at	O	-1	1564236
risk	O	-1	1564236
(@@	O	-1	1564236
r	O	-1	1564236
=	O	-1	1564236
0.@@	O	-1	1564236
5@@	O	-1	1564236
8@@	O	-1	1564236
;	O	-1	1564236
p	O	-1	1564236
less	O	-1	1564236
than	O	-1	1564236
0.0@@	O	-1	1564236
3@@	O	-1	1564236
)	O	-1	1564236
and	O	-1	1564236
with	O	-1	1564236
the	O	-1	1564236
per@@	O	-1	1564236
f@@	O	-1	1564236
usion	O	-1	1564236
def@@	O	-1	1564236
ect	O	-1	1564236
by	O	-1	1564236
contr@@	O	-1	1564236
ast	O	-1	1564236
echocardiograph@@	O	-1	1564236
y	O	-1	1564236
(@@	O	-1	1564236
r	O	-1	1564236
=	O	-1	1564236
0.@@	O	-1	1564236
5@@	O	-1	1564236
8@@	O	-1	1564236
;	O	-1	1564236
p	O	-1	1564236
less	O	-1	1564236
than	O	-1	1564236
0.0@@	O	-1	1564236
3@@	O	-1	1564236
).	O	-1	1564236
Th@@	O	-1	1564236
us,	O	-1	1564236
myocardial	O	-1	1564236
contr@@	O	-1	1564236
ast	O	-1	1564236
echocardiograph@@	O	-1	1564236
y	O	-1	1564236
can	O	-1	1564236
be	O	-1	1564236
used	O	-1	1564236
to	O	-1	1564236
vi@@	O	-1	1564236
su@@	O	-1	1564236
al@@	O	-1	1564236
iz@@	O	-1	1564236
e	O	-1	1564236
and	O	-1	1564236
qu@@	O	-1	1564236
anti@@	O	-1	1564236
t@@	O	-1	1564236
ate	O	-1	1564236
the	O	-1	1564236
amoun@@	O	-1	1564236
t	O	-1	1564236
of	O	-1	1564236
j@@	O	-1	1564236
e@@	O	-1	1564236
o@@	O	-1	1564236
par@@	O	-1	1564236
di@@	O	-1	1564236
zed	O	-1	1564236
myocardi@@	O	-1	1564236
um	O	-1	1564236
during	O	-1	1564236
moder@@	O	-1	1564236
ate	O	-1	1564236
to	O	-1	1564236
severe	O	-1	1564236
de@@	O	-1	1564236
gre@@	O	-1	1564236
es	O	-1	1564236
of	O	-1	1564236
coronary	B-Disease	D023921	1564236
st@@	I-Disease	-1	1564236
en@@	I-Disease	-1	1564236
o@@	I-Disease	-1	1564236
sis	I-Disease	-1	1564236
.	O	-1	1564236
The	O	-1	1564236
results	O	-1	1564236
obtained	O	-1	1564236
show	O	-1	1564236
a	O	-1	1564236
correl@@	O	-1	1564236
ation	O	-1	1564236
with	O	-1	1564236
the	O	-1	1564236
an@@	O	-1	1564236
at@@	O	-1	1564236
om@@	O	-1	1564236
ic	O	-1	1564236
a@@	O	-1	1564236
re@@	O	-1	1564236
a	O	-1	1564236
at	O	-1	1564236
risk	O	-1	1564236
similar	O	-1	1564236
to	O	-1	1564236
that	O	-1	1564236
obtained	O	-1	1564236
with	O	-1	1564236
thal@@	B-Chemical	D013793	1564236
li@@	I-Chemical	-1	1564236
um	I-Chemical	-1	1564236
-@@	O	-1	1564236
20@@	O	-1	1564236
1	O	-1	1564236
S@@	O	-1	1564236
P@@	O	-1	1564236
EC@@	O	-1	1564236
T@@	O	-1	1564236
.	O	-1	1564236

P@@	O	-1	1300436
oten@@	O	-1	1300436
tial	O	-1	1300436
de@@	O	-1	1300436
le@@	O	-1	1300436
ter@@	O	-1	1300436
i@@	O	-1	1300436
ous	O	-1	1300436
effect	O	-1	1300436
of	O	-1	1300436
f@@	B-Chemical	D005665	1300436
uro@@	I-Chemical	-1	1300436
se@@	I-Chemical	-1	1300436
m@@	I-Chemical	-1	1300436
ide	I-Chemical	-1	1300436
in	O	-1	1300436
radi@@	O	-1	1300436
o@@	O	-1	1300436
contr@@	O	-1	1300436
ast	O	-1	1300436
nephro@@	B-Disease	D007674	1300436
pathy	I-Disease	-1	1300436
.	O	-1	1300436
The	O	-1	1300436
pur@@	O	-1	1300436
p@@	O	-1	1300436
ose	O	-1	1300436
of	O	-1	1300436
the	O	-1	1300436
study	O	-1	1300436
was	O	-1	1300436
to	O	-1	1300436
determine	O	-1	1300436
the	O	-1	1300436
efficacy	O	-1	1300436
of	O	-1	1300436
f@@	B-Chemical	D005665	1300436
uro@@	I-Chemical	-1	1300436
se@@	I-Chemical	-1	1300436
m@@	I-Chemical	-1	1300436
ide	I-Chemical	-1	1300436
in	O	-1	1300436
addition	O	-1	1300436
to	O	-1	1300436
intravenous	O	-1	1300436
flu@@	O	-1	1300436
id@@	O	-1	1300436
s	O	-1	1300436
in	O	-1	1300436
the	O	-1	1300436
pre@@	O	-1	1300436
ven@@	O	-1	1300436
tion	O	-1	1300436
of	O	-1	1300436
radi@@	O	-1	1300436
o@@	O	-1	1300436
contr@@	O	-1	1300436
ast	O	-1	1300436
nephro@@	B-Disease	D007674	1300436
pathy	I-Disease	-1	1300436
.	O	-1	1300436
1@@	O	-1	1300436
8	O	-1	1300436
patients,	O	-1	1300436
ref@@	O	-1	1300436
er@@	O	-1	1300436
red	O	-1	1300436
to	O	-1	1300436
a	O	-1	1300436
radi@@	O	-1	1300436
o@@	O	-1	1300436
contr@@	O	-1	1300436
ast	O	-1	1300436
study,	O	-1	1300436
considered	O	-1	1300436
at	O	-1	1300436
risk	O	-1	1300436
because	O	-1	1300436
of	O	-1	1300436
pre@@	O	-1	1300436
ex@@	O	-1	1300436
ist@@	O	-1	1300436
ing	O	-1	1300436
renal	B-Disease	D051437	1300436
in@@	I-Disease	-1	1300436
suffici@@	I-Disease	-1	1300436
ency	I-Disease	-1	1300436
,	O	-1	1300436
were	O	-1	1300436
en@@	O	-1	1300436
ro@@	O	-1	1300436
lled	O	-1	1300436
in	O	-1	1300436
a	O	-1	1300436
pro@@	O	-1	1300436
sp@@	O	-1	1300436
ecti@@	O	-1	1300436
ve,	O	-1	1300436
random@@	O	-1	1300436
iz@@	O	-1	1300436
ed,	O	-1	1300436
controlled	O	-1	1300436
tri@@	O	-1	1300436
al,	O	-1	1300436
performed	O	-1	1300436
at	O	-1	1300436
the	O	-1	1300436
secondary	O	-1	1300436
car@@	O	-1	1300436
e	O	-1	1300436
c@@	O	-1	1300436
ent@@	O	-1	1300436
er	O	-1	1300436
of	O	-1	1300436
a	O	-1	1300436
1@@	O	-1	1300436
,@@	O	-1	1300436
10@@	O	-1	1300436
0-@@	O	-1	1300436
bed	O	-1	1300436
pri@@	O	-1	1300436
v@@	O	-1	1300436
ate	O	-1	1300436
un@@	O	-1	1300436
i@@	O	-1	1300436
ver@@	O	-1	1300436
s@@	O	-1	1300436
ity	O	-1	1300436
hospit@@	O	-1	1300436
al.	O	-1	1300436
In	O	-1	1300436
addition	O	-1	1300436
to	O	-1	1300436
flu@@	O	-1	1300436
id@@	O	-1	1300436
s,	O	-1	1300436
the	O	-1	1300436
treatment	O	-1	1300436
group	O	-1	1300436
received	O	-1	1300436
f@@	B-Chemical	D005665	1300436
uro@@	I-Chemical	-1	1300436
se@@	I-Chemical	-1	1300436
m@@	I-Chemical	-1	1300436
ide	I-Chemical	-1	1300436
(@@	O	-1	1300436
mean	O	-1	1300436
dose	O	-1	1300436
1@@	O	-1	1300436
10	O	-1	1300436
mg@@	O	-1	1300436
)	O	-1	1300436
intra@@	O	-1	1300436
ven@@	O	-1	1300436
ously	O	-1	1300436
30	O	-1	1300436
min	O	-1	1300436
prior	O	-1	1300436
to	O	-1	1300436
the	O	-1	1300436
injection	O	-1	1300436
of	O	-1	1300436
contr@@	O	-1	1300436
ast	O	-1	1300436
mat@@	O	-1	1300436
er@@	O	-1	1300436
i@@	O	-1	1300436
al.	O	-1	1300436
The	O	-1	1300436
control	O	-1	1300436
group	O	-1	1300436
received	O	-1	1300436
flu@@	O	-1	1300436
id@@	O	-1	1300436
s	O	-1	1300436
(@@	O	-1	1300436
mean	O	-1	1300436
3	O	-1	1300436
liter@@	O	-1	1300436
s@@	O	-1	1300436
).	O	-1	1300436
R@@	O	-1	1300436
a@@	O	-1	1300436
di@@	O	-1	1300436
ological	O	-1	1300436
studies	O	-1	1300436
were	O	-1	1300436
mo@@	O	-1	1300436
st@@	O	-1	1300436
ly	O	-1	1300436
angio@@	O	-1	1300436
graph@@	O	-1	1300436
i@@	O	-1	1300436
es	O	-1	1300436
performed	O	-1	1300436
with	O	-1	1300436
both	O	-1	1300436
i@@	O	-1	1300436
onic	O	-1	1300436
and	O	-1	1300436
non-@@	O	-1	1300436
i@@	O	-1	1300436
onic	O	-1	1300436
contr@@	O	-1	1300436
ast	O	-1	1300436
mat@@	O	-1	1300436
er@@	O	-1	1300436
i@@	O	-1	1300436
al,	O	-1	1300436
at	O	-1	1300436
an	O	-1	1300436
average	O	-1	1300436
dose	O	-1	1300436
of	O	-1	1300436
2@@	O	-1	1300436
4@@	O	-1	1300436
5	O	-1	1300436
ml@@	O	-1	1300436
.	O	-1	1300436
R@@	B-Disease	D058186	1300436
en@@	I-Disease	-1	1300436
al	I-Disease	-1	1300436
function	I-Disease	-1	1300436
significantly	I-Disease	-1	1300436
deter@@	I-Disease	-1	1300436
i@@	I-Disease	-1	1300436
or@@	I-Disease	-1	1300436
ated	I-Disease	-1	1300436
in	O	-1	1300436
the	O	-1	1300436
group	O	-1	1300436
pre@@	O	-1	1300436
treated	O	-1	1300436
with	O	-1	1300436
f@@	B-Chemical	D005665	1300436
uro@@	I-Chemical	-1	1300436
se@@	I-Chemical	-1	1300436
m@@	I-Chemical	-1	1300436
ide	I-Chemical	-1	1300436
(p	O	-1	1300436
<	O	-1	1300436
0.00@@	O	-1	1300436
5	O	-1	1300436
by	O	-1	1300436
AN@@	O	-1	1300436
O@@	O	-1	1300436
V@@	O	-1	1300436
A@@	O	-1	1300436
),	O	-1	1300436
with	O	-1	1300436
a	O	-1	1300436
ri@@	O	-1	1300436
se	O	-1	1300436
in	O	-1	1300436
serum	O	-1	1300436
creatinine	B-Chemical	D003404	1300436
from	O	-1	1300436
14@@	O	-1	1300436
5	O	-1	1300436
+/-	O	-1	1300436
13	O	-1	1300436
to	O	-1	1300436
18@@	O	-1	1300436
2	O	-1	1300436
+/-	O	-1	1300436
16	O	-1	1300436
m@@	O	-1	1300436
um@@	O	-1	1300436
ol@@	O	-1	1300436
/@@	O	-1	1300436
l	O	-1	1300436
at	O	-1	1300436
24	O	-1	1300436
h@@	O	-1	1300436
,	O	-1	1300436
while	O	-1	1300436
no	O	-1	1300436
change	O	-1	1300436
occurred	O	-1	1300436
in	O	-1	1300436
the	O	-1	1300436
control	O	-1	1300436
group	O	-1	1300436
(@@	O	-1	1300436
from	O	-1	1300436
14@@	O	-1	1300436
1	O	-1	1300436
+/-	O	-1	1300436
6	O	-1	1300436
to	O	-1	1300436
14@@	O	-1	1300436
2	O	-1	1300436
+/-	O	-1	1300436
7	O	-1	1300436
m@@	O	-1	1300436
um@@	O	-1	1300436
ol@@	O	-1	1300436
/@@	O	-1	1300436
l@@	O	-1	1300436
).	O	-1	1300436
R@@	B-Disease	D051437	1300436
en@@	I-Disease	-1	1300436
al	I-Disease	-1	1300436
failure	I-Disease	-1	1300436
was	O	-1	1300436
associated	O	-1	1300436
with	O	-1	1300436
weight	B-Disease	D015431	1300436
loss	I-Disease	-1	1300436
in	O	-1	1300436
the	O	-1	1300436
f@@	B-Chemical	D005665	1300436
uro@@	I-Chemical	-1	1300436
se@@	I-Chemical	-1	1300436
m@@	I-Chemical	-1	1300436
ide	I-Chemical	-1	1300436
-treated	O	-1	1300436
group.	O	-1	1300436
F@@	B-Chemical	D005665	1300436
uro@@	I-Chemical	-1	1300436
se@@	I-Chemical	-1	1300436
m@@	I-Chemical	-1	1300436
ide	I-Chemical	-1	1300436
may	O	-1	1300436
be	O	-1	1300436
de@@	O	-1	1300436
le@@	O	-1	1300436
ter@@	O	-1	1300436
i@@	O	-1	1300436
ous	O	-1	1300436
in	O	-1	1300436
the	O	-1	1300436
pre@@	O	-1	1300436
ven@@	O	-1	1300436
tion	O	-1	1300436
of	O	-1	1300436
radi@@	O	-1	1300436
o@@	O	-1	1300436
contr@@	O	-1	1300436
ast	O	-1	1300436
nephro@@	B-Disease	D007674	1300436
pathy	I-Disease	-1	1300436
.	O	-1	1300436

The	O	-1	1141447
renal	O	-1	1141447
path@@	O	-1	1141447
ology	O	-1	1141447
in	O	-1	1141447
a	O	-1	1141447
case	O	-1	1141447
of	O	-1	1141447
lithium	B-Chemical	D008094	1141447
-induced	O	-1	1141447
dia@@	B-Disease	D003919	1141447
bet@@	I-Disease	-1	1141447
es	I-Disease	-1	1141447
in@@	I-Disease	-1	1141447
si@@	I-Disease	-1	1141447
pid@@	I-Disease	-1	1141447
us	I-Disease	-1	1141447
.	O	-1	1141447
A	O	-1	1141447
case	O	-1	1141447
of	O	-1	1141447
lithium	B-Chemical	D008094	1141447
-induced	O	-1	1141447
dia@@	B-Disease	D003919	1141447
bet@@	I-Disease	-1	1141447
es	I-Disease	-1	1141447
in@@	I-Disease	-1	1141447
si@@	I-Disease	-1	1141447
pid@@	I-Disease	-1	1141447
us	I-Disease	-1	1141447
is	O	-1	1141447
repor@@	O	-1	1141447
ted.	O	-1	1141447
A@@	O	-1	1141447
t	O	-1	1141447
necro@@	O	-1	1141447
p@@	O	-1	1141447
sy	O	-1	1141447
micro@@	O	-1	1141447
sco@@	O	-1	1141447
p@@	O	-1	1141447
y	O	-1	1141447
sho@@	O	-1	1141447
ed	O	-1	1141447
un@@	O	-1	1141447
i@@	O	-1	1141447
qu@@	O	-1	1141447
e	O	-1	1141447
and	O	-1	1141447
exten@@	O	-1	1141447
sive	O	-1	1141447
damage	O	-1	1141447
to	O	-1	1141447
cells	O	-1	1141447
lin@@	O	-1	1141447
ing	O	-1	1141447
the	O	-1	1141447
dist@@	O	-1	1141447
al	O	-1	1141447
neph@@	O	-1	1141447
ron@@	O	-1	1141447
.	O	-1	1141447
It	O	-1	1141447
is	O	-1	1141447
suggested	O	-1	1141447
that	O	-1	1141447
these	O	-1	1141447
changes	O	-1	1141447
re@@	O	-1	1141447
present	O	-1	1141447
a	O	-1	1141447
specific	O	-1	1141447
toxic	O	-1	1141447
effect	O	-1	1141447
of	O	-1	1141447
lithium	B-Chemical	D008094	1141447
,	O	-1	1141447
reported	O	-1	1141447
h@@	O	-1	1141447
ere	O	-1	1141447
for	O	-1	1141447
the	O	-1	1141447
first	O	-1	1141447
time	O	-1	1141447
in	O	-1	1141447
man@@	O	-1	1141447
.	O	-1	1141447

E@@	O	-1	188339
ti@@	O	-1	188339
ologic	O	-1	188339
factors	O	-1	188339
in	O	-1	188339
the	O	-1	188339
path@@	O	-1	188339
o@@	O	-1	188339
genesis	O	-1	188339
of	O	-1	188339
liver	B-Disease	D008113	188339
tu@@	I-Disease	-1	188339
mor@@	I-Disease	-1	188339
s	I-Disease	-1	188339
associated	O	-1	188339
with	O	-1	188339
oral	B-Chemical	D003276	188339
contrac@@	I-Chemical	-1	188339
ep@@	I-Chemical	-1	188339
tiv@@	I-Chemical	-1	188339
es	I-Chemical	-1	188339
.	O	-1	188339
W@@	O	-1	188339
i@@	O	-1	188339
th@@	O	-1	188339
in	O	-1	188339
the	O	-1	188339
las@@	O	-1	188339
t	O	-1	188339
several	O	-1	188339
year@@	O	-1	188339
s,	O	-1	188339
previously	O	-1	188339
r@@	O	-1	188339
are	O	-1	188339
liver	B-Disease	D008113	188339
tu@@	I-Disease	-1	188339
mor@@	I-Disease	-1	188339
s	I-Disease	-1	188339
have	O	-1	188339
been	O	-1	188339
seen	O	-1	188339
in	O	-1	188339
youn@@	O	-1	188339
g	O	-1	188339
women	O	-1	188339
using	O	-1	188339
oral	B-Chemical	D003276	188339
contrac@@	I-Chemical	-1	188339
ep@@	I-Chemical	-1	188339
tive	I-Chemical	-1	188339
steroid@@	B-Chemical	D013256	188339
s	I-Chemical	-1	188339
.	O	-1	188339
The	O	-1	188339
Re@@	O	-1	188339
g@@	O	-1	188339
ist@@	O	-1	188339
r@@	O	-1	188339
y	O	-1	188339
for	O	-1	188339
L@@	B-Disease	D008113	188339
i@@	I-Disease	-1	188339
ver	I-Disease	-1	188339
T@@	I-Disease	-1	188339
u@@	I-Disease	-1	188339
mor@@	I-Disease	-1	188339
s	I-Disease	-1	188339
A@@	O	-1	188339
s@@	O	-1	188339
s@@	O	-1	188339
oci@@	O	-1	188339
ated	O	-1	188339
with	O	-1	188339
O@@	B-Chemical	D003276	188339
ral	I-Chemical	-1	188339
C@@	I-Chemical	-1	188339
ont@@	I-Chemical	-1	188339
rac@@	I-Chemical	-1	188339
ep@@	I-Chemical	-1	188339
tiv@@	I-Chemical	-1	188339
es	I-Chemical	-1	188339
at	O	-1	188339
the	O	-1	188339
U@@	O	-1	188339
n@@	O	-1	188339
i@@	O	-1	188339
ver@@	O	-1	188339
s@@	O	-1	188339
ity	O	-1	188339
of	O	-1	188339
C@@	O	-1	188339
al@@	O	-1	188339
if@@	O	-1	188339
or@@	O	-1	188339
n@@	O	-1	188339
ia,	O	-1	188339
I@@	O	-1	188339
r@@	O	-1	188339
v@@	O	-1	188339
ine,	O	-1	188339
has	O	-1	188339
clear@@	O	-1	188339
ly	O	-1	188339
identi@@	O	-1	188339
fied	O	-1	188339
2@@	O	-1	188339
7	O	-1	188339
cas@@	O	-1	188339
es.	O	-1	188339
The	O	-1	188339
rec@@	O	-1	188339
ent	O	-1	188339
literat@@	O	-1	188339
ure	O	-1	188339
cont@@	O	-1	188339
ain@@	O	-1	188339
s	O	-1	188339
4@@	O	-1	188339
4	O	-1	188339
case	O	-1	188339
repor@@	O	-1	188339
t@@	O	-1	188339
s.	O	-1	188339
Com@@	O	-1	188339
m@@	O	-1	188339
on	O	-1	188339
to	O	-1	188339
these	O	-1	188339
7@@	O	-1	188339
1	O	-1	188339
cases	O	-1	188339
has	O	-1	188339
been	O	-1	188339
a	O	-1	188339
histo@@	O	-1	188339
path@@	O	-1	188339
ologic	O	-1	188339
diagnosis	O	-1	188339
of	O	-1	188339
foc@@	B-Disease	D020518	188339
al	I-Disease	-1	188339
no@@	I-Disease	-1	188339
d@@	I-Disease	-1	188339
ular	I-Disease	-1	188339
hyper@@	I-Disease	-1	188339
pl@@	I-Disease	-1	188339
a@@	I-Disease	-1	188339
sia	I-Disease	-1	188339
,	O	-1	188339
aden@@	B-Disease	D000236	188339
oma	I-Disease	-1	188339
,	O	-1	188339
h@@	B-Disease	D006222	188339
am@@	I-Disease	-1	188339
ar@@	I-Disease	-1	188339
to@@	I-Disease	-1	188339
ma	I-Disease	-1	188339
,	O	-1	188339
and	O	-1	188339
hepat@@	B-Disease	D006528	188339
oma	I-Disease	-1	188339
.	O	-1	188339
Si@@	O	-1	188339
gn@@	O	-1	188339
ific@@	O	-1	188339
ant	O	-1	188339
statis@@	O	-1	188339
tical	O	-1	188339
e@@	O	-1	188339
ti@@	O	-1	188339
ologic	O	-1	188339
factors	O	-1	188339
includ@@	O	-1	188339
e	O	-1	188339
prolonged	O	-1	188339
un@@	O	-1	188339
inter@@	O	-1	188339
ru@@	O	-1	188339
pt@@	O	-1	188339
ed	O	-1	188339
us@@	O	-1	188339
age	O	-1	188339
of	O	-1	188339
oral	B-Chemical	D003276	188339
contrac@@	I-Chemical	-1	188339
ep@@	I-Chemical	-1	188339
tive	I-Chemical	-1	188339
steroid@@	B-Chemical	D013256	188339
s	I-Chemical	-1	188339
.	O	-1	188339
E@@	O	-1	188339
ight	O	-1	188339
de@@	O	-1	188339
ath@@	O	-1	188339
s	O	-1	188339
and	O	-1	188339
liver	O	-1	188339
ru@@	B-Disease	D012421	188339
pt@@	I-Disease	-1	188339
ure	I-Disease	-1	188339
in	O	-1	188339
1@@	O	-1	188339
8	O	-1	188339
patients	O	-1	188339
at@@	O	-1	188339
test	O	-1	188339
to	O	-1	188339
the	O	-1	188339
seri@@	O	-1	188339
ous@@	O	-1	188339
ness	O	-1	188339
of	O	-1	188339
this	O	-1	188339
new	O	-1	188339
potenti@@	O	-1	188339
ally	O	-1	188339
le@@	O	-1	188339
th@@	O	-1	188339
al	O	-1	188339
adverse	O	-1	188339
phen@@	O	-1	188339
om@@	O	-1	188339
en@@	O	-1	188339
on@@	O	-1	188339
.	O	-1	188339

G@@	B-Disease	D006086	19135948
ra@@	I-Disease	-1	19135948
f@@	I-Disease	-1	19135948
t-@@	I-Disease	-1	19135948
ver@@	I-Disease	-1	19135948
sus@@	I-Disease	-1	19135948
-@@	I-Disease	-1	19135948
h@@	I-Disease	-1	19135948
ost	I-Disease	-1	19135948
disease	I-Disease	-1	19135948
pro@@	O	-1	19135948
phyl@@	O	-1	19135948
ax@@	O	-1	19135948
is	O	-1	19135948
with	O	-1	19135948
e@@	B-Chemical	C107135	19135948
ver@@	I-Chemical	-1	19135948
ol@@	I-Chemical	-1	19135948
im@@	I-Chemical	-1	19135948
us	I-Chemical	-1	19135948
and	O	-1	19135948
tacrolimus	B-Chemical	D016559	19135948
is	O	-1	19135948
associated	O	-1	19135948
with	O	-1	19135948
a	O	-1	19135948
high	O	-1	19135948
incidence	O	-1	19135948
of	O	-1	19135948
s@@	B-Disease	D006504	19135948
in@@	I-Disease	-1	19135948
us@@	I-Disease	-1	19135948
oid@@	I-Disease	-1	19135948
al	I-Disease	-1	19135948
ob@@	I-Disease	-1	19135948
struc@@	I-Disease	-1	19135948
tion	I-Disease	-1	19135948
syndrome	I-Disease	-1	19135948
and	O	-1	19135948
microangio@@	B-Disease	D014652	19135948
pathy	I-Disease	-1	19135948
:	O	-1	19135948
results	O	-1	19135948
of	O	-1	19135948
the	O	-1	19135948
E@@	O	-1	19135948
V@@	O	-1	19135948
TA@@	O	-1	19135948
C	O	-1	19135948
tri@@	O	-1	19135948
al.	O	-1	19135948
A	O	-1	19135948
calc@@	O	-1	19135948
ine@@	O	-1	19135948
ur@@	O	-1	19135948
in	O	-1	19135948
inhibitor	O	-1	19135948
combined	O	-1	19135948
with	O	-1	19135948
meth@@	B-Chemical	D008727	19135948
ot@@	I-Chemical	-1	19135948
re@@	I-Chemical	-1	19135948
x@@	I-Chemical	-1	19135948
ate	I-Chemical	-1	19135948
is	O	-1	19135948
the	O	-1	19135948
standard	O	-1	19135948
pro@@	O	-1	19135948
phyl@@	O	-1	19135948
ax@@	O	-1	19135948
is	O	-1	19135948
for	O	-1	19135948
gra@@	B-Disease	D006086	19135948
f@@	I-Disease	-1	19135948
t-@@	I-Disease	-1	19135948
ver@@	I-Disease	-1	19135948
sus@@	I-Disease	-1	19135948
-@@	I-Disease	-1	19135948
h@@	I-Disease	-1	19135948
ost	I-Disease	-1	19135948
disease	I-Disease	-1	19135948
(	O	-1	19135948
G@@	B-Disease	D006086	19135948
V@@	I-Disease	-1	19135948
H@@	I-Disease	-1	19135948
D	I-Disease	-1	19135948
)	O	-1	19135948
after	O	-1	19135948
al@@	O	-1	19135948
log@@	O	-1	19135948
en@@	O	-1	19135948
e@@	O	-1	19135948
ic	O	-1	19135948
hemat@@	O	-1	19135948
o@@	O	-1	19135948
po@@	O	-1	19135948
i@@	O	-1	19135948
e@@	O	-1	19135948
tic	O	-1	19135948
st@@	O	-1	19135948
em	O	-1	19135948
cell	O	-1	19135948
transplant@@	O	-1	19135948
ation	O	-1	19135948
(@@	O	-1	19135948
H@@	O	-1	19135948
S@@	O	-1	19135948
C@@	O	-1	19135948
T@@	O	-1	19135948
).	O	-1	19135948
E@@	B-Chemical	C107135	19135948
ver@@	I-Chemical	-1	19135948
ol@@	I-Chemical	-1	19135948
im@@	I-Chemical	-1	19135948
us	I-Chemical	-1	19135948
,	O	-1	19135948
a	O	-1	19135948
der@@	O	-1	19135948
i@@	O	-1	19135948
v@@	O	-1	19135948
ative	O	-1	19135948
of	O	-1	19135948
sirolimus	B-Chemical	D020123	19135948
,	O	-1	19135948
se@@	O	-1	19135948
em@@	O	-1	19135948
s	O	-1	19135948
to	O	-1	19135948
medi@@	O	-1	19135948
ate	O	-1	19135948
anti@@	O	-1	19135948
leuk@@	O	-1	19135948
emia	O	-1	19135948
effects.	O	-1	19135948
We	O	-1	19135948
report	O	-1	19135948
on	O	-1	19135948
a	O	-1	19135948
combination	O	-1	19135948
of	O	-1	19135948
e@@	B-Chemical	C107135	19135948
ver@@	I-Chemical	-1	19135948
ol@@	I-Chemical	-1	19135948
im@@	I-Chemical	-1	19135948
us	I-Chemical	-1	19135948
and	O	-1	19135948
tacrolimus	B-Chemical	D016559	19135948
in	O	-1	19135948
24	O	-1	19135948
patients	O	-1	19135948
(@@	O	-1	19135948
median	O	-1	19135948
age,	O	-1	19135948
6@@	O	-1	19135948
2	O	-1	19135948
year@@	O	-1	19135948
s)	O	-1	19135948
with	O	-1	19135948
either	O	-1	19135948
my@@	B-Disease	D009190	19135948
e@@	I-Disease	-1	19135948
lo@@	I-Disease	-1	19135948
dys@@	I-Disease	-1	19135948
plas@@	I-Disease	-1	19135948
tic	I-Disease	-1	19135948
syndrome	I-Disease	-1	19135948
(	O	-1	19135948
MD@@	B-Disease	D009190	19135948
S	I-Disease	-1	19135948
;	O	-1	19135948
n	O	-1	19135948
=	O	-1	19135948
17@@	O	-1	19135948
)	O	-1	19135948
or	O	-1	19135948
acute	B-Disease	D015470	19135948
my@@	I-Disease	-1	19135948
e@@	I-Disease	-1	19135948
lo@@	I-Disease	-1	19135948
id	I-Disease	-1	19135948
leuk@@	I-Disease	-1	19135948
emia	I-Disease	-1	19135948
(	O	-1	19135948
AM@@	B-Disease	D015470	19135948
L	I-Disease	-1	19135948
;	O	-1	19135948
n	O	-1	19135948
=	O	-1	19135948
7@@	O	-1	19135948
)	O	-1	19135948
under@@	O	-1	19135948
go@@	O	-1	19135948
ing	O	-1	19135948
int@@	O	-1	19135948
en@@	O	-1	19135948
sive	O	-1	19135948
condi@@	O	-1	19135948
tion@@	O	-1	19135948
ing	O	-1	19135948
followed	O	-1	19135948
by	O	-1	19135948
H@@	O	-1	19135948
S@@	O	-1	19135948
C@@	O	-1	19135948
T	O	-1	19135948
from	O	-1	19135948
related	O	-1	19135948
(n	O	-1	19135948
=	O	-1	19135948
4@@	O	-1	19135948
)	O	-1	19135948
or	O	-1	19135948
un@@	O	-1	19135948
related	O	-1	19135948
(n	O	-1	19135948
=	O	-1	19135948
20@@	O	-1	19135948
)	O	-1	19135948
d@@	O	-1	19135948
on@@	O	-1	19135948
or@@	O	-1	19135948
s.	O	-1	19135948
All	O	-1	19135948
patients	O	-1	19135948
en@@	O	-1	19135948
gra@@	O	-1	19135948
f@@	O	-1	19135948
te@@	O	-1	19135948
d,	O	-1	19135948
and	O	-1	19135948
only	O	-1	19135948
1	O	-1	19135948
patient	O	-1	19135948
experienced	O	-1	19135948
gra@@	O	-1	19135948
de	O	-1	19135948
IV	O	-1	19135948
m@@	B-Disease	D052016	19135948
u@@	I-Disease	-1	19135948
co@@	I-Disease	-1	19135948
si@@	I-Disease	-1	19135948
tis	I-Disease	-1	19135948
.	O	-1	19135948
N@@	O	-1	19135948
ine	O	-1	19135948
patients	O	-1	19135948
(3@@	O	-1	19135948
7@@	O	-1	19135948
%)	O	-1	19135948
developed	O	-1	19135948
acute	O	-1	19135948
gra@@	O	-1	19135948
de	O	-1	19135948
II@@	O	-1	19135948
-@@	O	-1	19135948
IV	O	-1	19135948
G@@	B-Disease	D006086	19135948
V@@	I-Disease	-1	19135948
H@@	I-Disease	-1	19135948
D	I-Disease	-1	19135948
,	O	-1	19135948
and	O	-1	19135948
11	O	-1	19135948
of	O	-1	19135948
17	O	-1	19135948
evalu@@	O	-1	19135948
able	O	-1	19135948
patients	O	-1	19135948
(6@@	O	-1	19135948
4@@	O	-1	19135948
%)	O	-1	19135948
developed	O	-1	19135948
chronic	O	-1	19135948
exten@@	O	-1	19135948
sive	O	-1	19135948
G@@	B-Disease	D006086	19135948
V@@	I-Disease	-1	19135948
H@@	I-Disease	-1	19135948
D	I-Disease	-1	19135948
.	O	-1	19135948
T@@	B-Disease	D014652	19135948
ran@@	I-Disease	-1	19135948
s@@	I-Disease	-1	19135948
pl@@	I-Disease	-1	19135948
ant@@	I-Disease	-1	19135948
ation@@	I-Disease	-1	19135948
-@@	I-Disease	-1	19135948
associated	I-Disease	-1	19135948
microangio@@	I-Disease	-1	19135948
pathy	I-Disease	-1	19135948
(	O	-1	19135948
T@@	B-Disease	D014652	19135948
M@@	I-Disease	-1	19135948
A	I-Disease	-1	19135948
)	O	-1	19135948
occurred	O	-1	19135948
in	O	-1	19135948
7	O	-1	19135948
patients	O	-1	19135948
(2@@	O	-1	19135948
9@@	O	-1	19135948
%),	O	-1	19135948
with	O	-1	19135948
2	O	-1	19135948
cases	O	-1	19135948
of	O	-1	19135948
acute	B-Disease	D058186	19135948
renal	I-Disease	-1	19135948
failure	I-Disease	-1	19135948
.	O	-1	19135948
The	O	-1	19135948
study	O	-1	19135948
was	O	-1	19135948
ter@@	O	-1	19135948
min@@	O	-1	19135948
ated	O	-1	19135948
pre@@	O	-1	19135948
mat@@	O	-1	19135948
ure@@	O	-1	19135948
ly	O	-1	19135948
because	O	-1	19135948
an	O	-1	19135948
addi@@	O	-1	19135948
tional	O	-1	19135948
6	O	-1	19135948
patients	O	-1	19135948
(2@@	O	-1	19135948
5@@	O	-1	19135948
%)	O	-1	19135948
developed	O	-1	19135948
s@@	B-Disease	D006504	19135948
in@@	I-Disease	-1	19135948
us@@	I-Disease	-1	19135948
oid@@	I-Disease	-1	19135948
al	I-Disease	-1	19135948
ob@@	I-Disease	-1	19135948
struc@@	I-Disease	-1	19135948
tion	I-Disease	-1	19135948
syndrome	I-Disease	-1	19135948
(	O	-1	19135948
S@@	B-Disease	D006504	19135948
O@@	I-Disease	-1	19135948
S	I-Disease	-1	19135948
),	O	-1	19135948
which	O	-1	19135948
was	O	-1	19135948
f@@	O	-1	19135948
atal	O	-1	19135948
in	O	-1	19135948
2	O	-1	19135948
cas@@	O	-1	19135948
es.	O	-1	19135948
W@@	O	-1	19135948
it@@	O	-1	19135948
h	O	-1	19135948
a	O	-1	19135948
median	O	-1	19135948
follow-up	O	-1	19135948
of	O	-1	19135948
2@@	O	-1	19135948
6	O	-1	19135948
month@@	O	-1	19135948
s,	O	-1	19135948
the	O	-1	19135948
2-@@	O	-1	19135948
year	O	-1	19135948
over@@	O	-1	19135948
all	O	-1	19135948
sur@@	O	-1	19135948
viv@@	O	-1	19135948
al	O	-1	19135948
rate	O	-1	19135948
was	O	-1	19135948
4@@	O	-1	19135948
7@@	O	-1	19135948
%.	O	-1	19135948
Although	O	-1	19135948
this	O	-1	19135948
new	O	-1	19135948
combination	O	-1	19135948
appear@@	O	-1	19135948
s	O	-1	19135948
to	O	-1	19135948
be	O	-1	19135948
effective	O	-1	19135948
as	O	-1	19135948
a	O	-1	19135948
pro@@	O	-1	19135948
phyl@@	O	-1	19135948
ac@@	O	-1	19135948
tic	O	-1	19135948
regi@@	O	-1	19135948
men	O	-1	19135948
for	O	-1	19135948
acute	O	-1	19135948
G@@	B-Disease	D006086	19135948
V@@	I-Disease	-1	19135948
H@@	I-Disease	-1	19135948
D	I-Disease	-1	19135948
,	O	-1	19135948
the	O	-1	19135948
incidence	O	-1	19135948
of	O	-1	19135948
T@@	B-Disease	D014652	19135948
M@@	I-Disease	-1	19135948
A	I-Disease	-1	19135948
and	O	-1	19135948
S@@	B-Disease	D006504	19135948
O@@	I-Disease	-1	19135948
S	I-Disease	-1	19135948
is	O	-1	19135948
con@@	O	-1	19135948
si@@	O	-1	19135948
der@@	O	-1	19135948
ably	O	-1	19135948
higher	O	-1	19135948
than	O	-1	19135948
seen	O	-1	19135948
with	O	-1	19135948
other	O	-1	19135948
regimen@@	O	-1	19135948
s.	O	-1	19135948

Eff@@	O	-1	14704468
ect	O	-1	14704468
of	O	-1	14704468
some	O	-1	14704468
convul@@	O	-1	14704468
s@@	O	-1	14704468
ants	O	-1	14704468
on	O	-1	14704468
the	O	-1	14704468
protective	O	-1	14704468
activity	O	-1	14704468
of	O	-1	14704468
lo@@	B-Chemical	C066440	14704468
rec@@	I-Chemical	-1	14704468
le@@	I-Chemical	-1	14704468
z@@	I-Chemical	-1	14704468
ole	I-Chemical	-1	14704468
and	O	-1	14704468
its	O	-1	14704468
combin@@	O	-1	14704468
ations	O	-1	14704468
with	O	-1	14704468
valpro@@	B-Chemical	D014635	14704468
ate	I-Chemical	-1	14704468
or	O	-1	14704468
clon@@	B-Chemical	D002998	14704468
az@@	I-Chemical	-1	14704468
epam	I-Chemical	-1	14704468
in	O	-1	14704468
am@@	O	-1	14704468
y@@	O	-1	14704468
g@@	O	-1	14704468
d@@	O	-1	14704468
al@@	O	-1	14704468
a@@	O	-1	14704468
-@@	O	-1	14704468
k@@	O	-1	14704468
ind@@	O	-1	14704468
l@@	O	-1	14704468
ed	O	-1	14704468
rats.	O	-1	14704468
L@@	B-Chemical	C066440	14704468
o@@	I-Chemical	-1	14704468
rec@@	I-Chemical	-1	14704468
le@@	I-Chemical	-1	14704468
z@@	I-Chemical	-1	14704468
ole	I-Chemical	-1	14704468
(@@	O	-1	14704468
5	O	-1	14704468
mg/kg)	O	-1	14704468
ex@@	O	-1	14704468
er@@	O	-1	14704468
ted	O	-1	14704468
a	O	-1	14704468
significant	O	-1	14704468
protective	O	-1	14704468
action	O	-1	14704468
in	O	-1	14704468
am@@	O	-1	14704468
y@@	O	-1	14704468
g@@	O	-1	14704468
d@@	O	-1	14704468
al@@	O	-1	14704468
a@@	O	-1	14704468
-@@	O	-1	14704468
k@@	O	-1	14704468
ind@@	O	-1	14704468
l@@	O	-1	14704468
ed	O	-1	14704468
rats,	O	-1	14704468
reduc@@	O	-1	14704468
ing	O	-1	14704468
both	O	-1	14704468
seizure	B-Disease	D012640	14704468
and	O	-1	14704468
af@@	O	-1	14704468
ter@@	O	-1	14704468
dis@@	O	-1	14704468
ch@@	O	-1	14704468
arg@@	O	-1	14704468
e	O	-1	14704468
dur@@	O	-1	14704468
ations.	O	-1	14704468
The	O	-1	14704468
combin@@	O	-1	14704468
ations	O	-1	14704468
of	O	-1	14704468
lo@@	B-Chemical	C066440	14704468
rec@@	I-Chemical	-1	14704468
le@@	I-Chemical	-1	14704468
z@@	I-Chemical	-1	14704468
ole	I-Chemical	-1	14704468
(2@@	O	-1	14704468
.@@	O	-1	14704468
5	O	-1	14704468
mg/kg)	O	-1	14704468
with	O	-1	14704468
valpro@@	B-Chemical	D014635	14704468
ate	I-Chemical	-1	14704468
,	O	-1	14704468
clon@@	B-Chemical	D002998	14704468
az@@	I-Chemical	-1	14704468
epam	I-Chemical	-1	14704468
,	O	-1	14704468
or	O	-1	14704468
carbamazepine	B-Chemical	D002220	14704468
(@@	O	-1	14704468
ap@@	O	-1	14704468
pl@@	O	-1	14704468
ied	O	-1	14704468
at	O	-1	14704468
their	O	-1	14704468
sub@@	O	-1	14704468
protective	O	-1	14704468
dos@@	O	-1	14704468
es@@	O	-1	14704468
)	O	-1	14704468
also	O	-1	14704468
ex@@	O	-1	14704468
hib@@	O	-1	14704468
ited	O	-1	14704468
anti@@	O	-1	14704468
seizure	O	-1	14704468
effect	O	-1	14704468
in	O	-1	14704468
this	O	-1	14704468
test@@	O	-1	14704468
.	O	-1	14704468
However,	O	-1	14704468
only	O	-1	14704468
two	O	-1	14704468
first	O	-1	14704468
combin@@	O	-1	14704468
ations	O	-1	14704468
occurred	O	-1	14704468
to	O	-1	14704468
be	O	-1	14704468
of	O	-1	14704468
pharmac@@	O	-1	14704468
o@@	O	-1	14704468
dynam@@	O	-1	14704468
ic	O	-1	14704468
n@@	O	-1	14704468
at@@	O	-1	14704468
ure.	O	-1	14704468
A@@	O	-1	14704468
mon@@	O	-1	14704468
g	O	-1	14704468
several	O	-1	14704468
chemo@@	O	-1	14704468
convul@@	O	-1	14704468
s@@	O	-1	14704468
ant@@	O	-1	14704468
s,	O	-1	14704468
b@@	B-Chemical	D001640	14704468
ic@@	I-Chemical	-1	14704468
uc@@	I-Chemical	-1	14704468
ul@@	I-Chemical	-1	14704468
line	I-Chemical	-1	14704468
,	O	-1	14704468
N@@	B-Chemical	D016202	14704468
-@@	I-Chemical	-1	14704468
methyl@@	I-Chemical	-1	14704468
-@@	I-Chemical	-1	14704468
D-@@	I-Chemical	-1	14704468
as@@	I-Chemical	-1	14704468
par@@	I-Chemical	-1	14704468
tic	I-Chemical	-1	14704468
acid	I-Chemical	-1	14704468
and	O	-1	14704468
BA@@	B-Chemical	D001498	14704468
Y	I-Chemical	-1	14704468
k@@	I-Chemical	-1	14704468
-@@	I-Chemical	-1	14704468
8@@	I-Chemical	-1	14704468
6@@	I-Chemical	-1	14704468
4@@	I-Chemical	-1	14704468
4	I-Chemical	-1	14704468
(@@	O	-1	14704468
the	O	-1	14704468
o@@	O	-1	14704468
pen@@	O	-1	14704468
er	O	-1	14704468
of	O	-1	14704468
L-@@	O	-1	14704468
type	O	-1	14704468
calcium	B-Chemical	D002118	14704468
channe@@	O	-1	14704468
l@@	O	-1	14704468
s)	O	-1	14704468
reversed	O	-1	14704468
the	O	-1	14704468
protective	O	-1	14704468
activity	O	-1	14704468
of	O	-1	14704468
lo@@	B-Chemical	C066440	14704468
rec@@	I-Chemical	-1	14704468
le@@	I-Chemical	-1	14704468
z@@	I-Chemical	-1	14704468
ole	I-Chemical	-1	14704468
alone	O	-1	14704468
and	O	-1	14704468
its	O	-1	14704468
combination	O	-1	14704468
with	O	-1	14704468
valpro@@	B-Chemical	D014635	14704468
ate	I-Chemical	-1	14704468
.	O	-1	14704468
O@@	O	-1	14704468
n	O	-1	14704468
the	O	-1	14704468
other	O	-1	14704468
h@@	O	-1	14704468
and@@	O	-1	14704468
,	O	-1	14704468
b@@	B-Chemical	D001640	14704468
ic@@	I-Chemical	-1	14704468
uc@@	I-Chemical	-1	14704468
ul@@	I-Chemical	-1	14704468
line	I-Chemical	-1	14704468
,	O	-1	14704468
aminoph@@	B-Chemical	D000628	14704468
yl@@	I-Chemical	-1	14704468
line	I-Chemical	-1	14704468
and	O	-1	14704468
BA@@	B-Chemical	D001498	14704468
Y	I-Chemical	-1	14704468
k@@	I-Chemical	-1	14704468
-@@	I-Chemical	-1	14704468
8@@	I-Chemical	-1	14704468
6@@	I-Chemical	-1	14704468
4@@	I-Chemical	-1	14704468
4	I-Chemical	-1	14704468
inhibited	O	-1	14704468
the	O	-1	14704468
anti@@	O	-1	14704468
convul@@	O	-1	14704468
sive	O	-1	14704468
action	O	-1	14704468
of	O	-1	14704468
lo@@	B-Chemical	C066440	14704468
rec@@	I-Chemical	-1	14704468
le@@	I-Chemical	-1	14704468
z@@	I-Chemical	-1	14704468
ole	I-Chemical	-1	14704468
combined	O	-1	14704468
with	O	-1	14704468
clon@@	B-Chemical	D002998	14704468
az@@	I-Chemical	-1	14704468
epam	I-Chemical	-1	14704468
.	O	-1	14704468
The	O	-1	14704468
results	O	-1	14704468
suppor@@	O	-1	14704468
t	O	-1	14704468
the	O	-1	14704468
hypo@@	O	-1	14704468
thesis	O	-1	14704468
that	O	-1	14704468
the	O	-1	14704468
protective	O	-1	14704468
activity	O	-1	14704468
of	O	-1	14704468
lo@@	B-Chemical	C066440	14704468
rec@@	I-Chemical	-1	14704468
le@@	I-Chemical	-1	14704468
z@@	I-Chemical	-1	14704468
ole	I-Chemical	-1	14704468
and	O	-1	14704468
its	O	-1	14704468
combin@@	O	-1	14704468
ations	O	-1	14704468
with	O	-1	14704468
other	O	-1	14704468
anti@@	O	-1	14704468
epilep@@	O	-1	14704468
tics	O	-1	14704468
may	O	-1	14704468
invol@@	O	-1	14704468
ve	O	-1	14704468
potenti@@	O	-1	14704468
ation	O	-1	14704468
of	O	-1	14704468
G@@	O	-1	14704468
A@@	O	-1	14704468
BA@@	O	-1	14704468
ergic	O	-1	14704468
neuro@@	O	-1	14704468
trans@@	O	-1	14704468
mission	O	-1	14704468
and	O	-1	14704468
block@@	O	-1	14704468
ade	O	-1	14704468
of	O	-1	14704468
L-@@	O	-1	14704468
type	O	-1	14704468
of	O	-1	14704468
calcium	B-Chemical	D002118	14704468
channe@@	O	-1	14704468
l@@	O	-1	14704468
s.	O	-1	14704468

Ac@@	B-Disease	D017114	12549952
ute	I-Disease	-1	12549952
liver	I-Disease	-1	12549952
failure	I-Disease	-1	12549952
with	O	-1	12549952
con@@	O	-1	12549952
current	O	-1	12549952
bu@@	B-Chemical	D016642	12549952
pro@@	I-Chemical	-1	12549952
pi@@	I-Chemical	-1	12549952
on	I-Chemical	-1	12549952
and	O	-1	12549952
carb@@	B-Chemical	D002231	12549952
im@@	I-Chemical	-1	12549952
azole	I-Chemical	-1	12549952
therapy.	O	-1	12549952
OBJECTIVE:	O	-1	12549952
To	O	-1	12549952
report	O	-1	12549952
a	O	-1	12549952
case	O	-1	12549952
of	O	-1	12549952
f@@	O	-1	12549952
atal	O	-1	12549952
liver	B-Disease	D017093	12549952
failure	I-Disease	-1	12549952
possib@@	O	-1	12549952
ly	O	-1	12549952
associated	O	-1	12549952
with	O	-1	12549952
con@@	O	-1	12549952
current	O	-1	12549952
use	O	-1	12549952
of	O	-1	12549952
bu@@	B-Chemical	D016642	12549952
pro@@	I-Chemical	-1	12549952
pi@@	I-Chemical	-1	12549952
on	I-Chemical	-1	12549952
and	O	-1	12549952
carb@@	B-Chemical	D002231	12549952
im@@	I-Chemical	-1	12549952
azole	I-Chemical	-1	12549952
.	O	-1	12549952
CA@@	O	-1	12549952
S@@	O	-1	12549952
E	O	-1	12549952
S@@	O	-1	12549952
U@@	O	-1	12549952
M@@	O	-1	12549952
MA@@	O	-1	12549952
R@@	O	-1	12549952
Y@@	O	-1	12549952
:	O	-1	12549952
A	O	-1	12549952
4@@	O	-1	12549952
1-@@	O	-1	12549952
year-old	O	-1	12549952
Ch@@	O	-1	12549952
in@@	O	-1	12549952
ese	O	-1	12549952
man	O	-1	12549952
with	O	-1	12549952
a	O	-1	12549952
hist@@	O	-1	12549952
ory	O	-1	12549952
of	O	-1	12549952
hyper@@	B-Disease	D006980	12549952
th@@	I-Disease	-1	12549952
yro@@	I-Disease	-1	12549952
i@@	I-Disease	-1	12549952
dis@@	I-Disease	-1	12549952
m	I-Disease	-1	12549952
had	O	-1	12549952
been	O	-1	12549952
treated	O	-1	12549952
with	O	-1	12549952
carb@@	B-Chemical	D002231	12549952
im@@	I-Chemical	-1	12549952
azole	I-Chemical	-1	12549952
and	O	-1	12549952
prop@@	B-Chemical	D011433	12549952
ran@@	I-Chemical	-1	12549952
o@@	I-Chemical	-1	12549952
lol	I-Chemical	-1	12549952
for	O	-1	12549952
the	O	-1	12549952
p@@	O	-1	12549952
ast	O	-1	12549952
5	O	-1	12549952
year@@	O	-1	12549952
s.	O	-1	12549952
H@@	O	-1	12549952
e	O	-1	12549952
received	O	-1	12549952
a	O	-1	12549952
10-@@	O	-1	12549952
day	O	-1	12549952
course	O	-1	12549952
of	O	-1	12549952
bu@@	B-Chemical	D016642	12549952
pro@@	I-Chemical	-1	12549952
pi@@	I-Chemical	-1	12549952
on	I-Chemical	-1	12549952
as	O	-1	12549952
an	O	-1	12549952
a@@	O	-1	12549952
id	O	-1	12549952
for	O	-1	12549952
smo@@	O	-1	12549952
king	O	-1	12549952
cess@@	O	-1	12549952
ation	O	-1	12549952
10	O	-1	12549952
weeks	O	-1	12549952
prior	O	-1	12549952
to	O	-1	12549952
present@@	O	-1	12549952
ation.	O	-1	12549952
H@@	O	-1	12549952
e	O	-1	12549952
developed	O	-1	12549952
acute	B-Disease	D017114	12549952
liver	I-Disease	-1	12549952
failure	I-Disease	-1	12549952
with	O	-1	12549952
ra@@	O	-1	12549952
pid	O	-1	12549952
deter@@	O	-1	12549952
i@@	O	-1	12549952
or@@	O	-1	12549952
ation	O	-1	12549952
of	O	-1	12549952
renal	O	-1	12549952
func@@	O	-1	12549952
tion.	O	-1	12549952
L@@	O	-1	12549952
i@@	O	-1	12549952
ver	O	-1	12549952
biop@@	O	-1	12549952
sy	O	-1	12549952
showed	O	-1	12549952
evidence	O	-1	12549952
of	O	-1	12549952
non@@	O	-1	12549952
specific	O	-1	12549952
drug@@	B-Disease	D056486	12549952
-induced	I-Disease	-1	12549952
acute	I-Disease	-1	12549952
liver	I-Disease	-1	12549952
injury	I-Disease	-1	12549952
.	O	-1	12549952
H@@	O	-1	12549952
is	O	-1	12549952
condi@@	O	-1	12549952
tion	O	-1	12549952
was	O	-1	12549952
further	O	-1	12549952
complic@@	O	-1	12549952
ated	O	-1	12549952
by	O	-1	12549952
se@@	B-Disease	D018805	12549952
p@@	I-Disease	-1	12549952
sis	I-Disease	-1	12549952
and	O	-1	12549952
co@@	B-Disease	D001778	12549952
ag@@	I-Disease	-1	12549952
ulo@@	I-Disease	-1	12549952
pathy	I-Disease	-1	12549952
.	O	-1	12549952
De@@	O	-1	12549952
ath	O	-1	12549952
resulted	O	-1	12549952
1@@	O	-1	12549952
9	O	-1	12549952
days	O	-1	12549952
after	O	-1	12549952
the	O	-1	12549952
onset	O	-1	12549952
of	O	-1	12549952
symptom@@	O	-1	12549952
s.	O	-1	12549952
The	O	-1	12549952
lik@@	O	-1	12549952
e@@	O	-1	12549952
li@@	O	-1	12549952
ho@@	O	-1	12549952
od	O	-1	12549952
that	O	-1	12549952
bu@@	B-Chemical	D016642	12549952
pro@@	I-Chemical	-1	12549952
pi@@	I-Chemical	-1	12549952
on	I-Chemical	-1	12549952
induced	O	-1	12549952
hepat@@	B-Disease	D056486	12549952
otoxicity	I-Disease	-1	12549952
in	O	-1	12549952
our	O	-1	12549952
patient	O	-1	12549952
was	O	-1	12549952
possib@@	O	-1	12549952
le@@	O	-1	12549952
,	O	-1	12549952
bas@@	O	-1	12549952
ed	O	-1	12549952
on	O	-1	12549952
the	O	-1	12549952
N@@	O	-1	12549952
ar@@	O	-1	12549952
an@@	O	-1	12549952
j@@	O	-1	12549952
o	O	-1	12549952
prob@@	O	-1	12549952
ability	O	-1	12549952
s@@	O	-1	12549952
cal@@	O	-1	12549952
e.	O	-1	12549952
D@@	O	-1	12549952
I@@	O	-1	12549952
S@@	O	-1	12549952
C@@	O	-1	12549952
US@@	O	-1	12549952
S@@	O	-1	12549952
ION@@	O	-1	12549952
:	O	-1	12549952
Although	O	-1	12549952
there	O	-1	12549952
is	O	-1	12549952
increas@@	O	-1	12549952
ing	O	-1	12549952
evidence	O	-1	12549952
of	O	-1	12549952
hepat@@	B-Disease	D056486	12549952
otoxicity	I-Disease	-1	12549952
induced	O	-1	12549952
by	O	-1	12549952
bu@@	B-Chemical	D016642	12549952
pro@@	I-Chemical	-1	12549952
pi@@	I-Chemical	-1	12549952
on	I-Chemical	-1	12549952
,	O	-1	12549952
this	O	-1	12549952
is	O	-1	12549952
the	O	-1	12549952
first	O	-1	12549952
case	O	-1	12549952
of	O	-1	12549952
f@@	O	-1	12549952
at@@	O	-1	12549952
ality	O	-1	12549952
that	O	-1	12549952
could	O	-1	12549952
have	O	-1	12549952
resulted	O	-1	12549952
from	O	-1	12549952
acute	B-Disease	D017114	12549952
liver	I-Disease	-1	12549952
failure	I-Disease	-1	12549952
in	O	-1	12549952
a	O	-1	12549952
patient	O	-1	12549952
receiving	O	-1	12549952
bu@@	B-Chemical	D016642	12549952
pro@@	I-Chemical	-1	12549952
pi@@	I-Chemical	-1	12549952
on	I-Chemical	-1	12549952
while	O	-1	12549952
on	O	-1	12549952
concomit@@	O	-1	12549952
ant	O	-1	12549952
treatment	O	-1	12549952
with	O	-1	12549952
carb@@	B-Chemical	D002231	12549952
im@@	I-Chemical	-1	12549952
azole	I-Chemical	-1	12549952
.	O	-1	12549952
CONCLUSIONS:	O	-1	12549952
Clin@@	O	-1	12549952
ici@@	O	-1	12549952
ans	O	-1	12549952
should	O	-1	12549952
be	O	-1	12549952
aw@@	O	-1	12549952
are	O	-1	12549952
of	O	-1	12549952
the	O	-1	12549952
possib@@	O	-1	12549952
ility	O	-1	12549952
of	O	-1	12549952
acute	B-Disease	D017114	12549952
liver	I-Disease	-1	12549952
in@@	I-Disease	-1	12549952
s@@	I-Disease	-1	12549952
ult	I-Disease	-1	12549952
induced	O	-1	12549952
by	O	-1	12549952
bu@@	B-Chemical	D016642	12549952
pro@@	I-Chemical	-1	12549952
pi@@	I-Chemical	-1	12549952
on	I-Chemical	-1	12549952
given	O	-1	12549952
con@@	O	-1	12549952
cur@@	O	-1	12549952
ren@@	O	-1	12549952
tly	O	-1	12549952
with	O	-1	12549952
other	O	-1	12549952
hepat@@	B-Disease	D056486	12549952
ot@@	I-Disease	-1	12549952
ox@@	I-Disease	-1	12549952
ic	I-Disease	-1	12549952
drug@@	O	-1	12549952
s.	O	-1	12549952

L@@	O	-1	19370593
ong	O	-1	19370593
term	O	-1	19370593
h@@	O	-1	19370593
orm@@	O	-1	19370593
one	O	-1	19370593
therapy	O	-1	19370593
for	O	-1	19370593
per@@	O	-1	19370593
imen@@	O	-1	19370593
o@@	O	-1	19370593
pa@@	O	-1	19370593
us@@	O	-1	19370593
al	O	-1	19370593
and	O	-1	19370593
post@@	O	-1	19370593
men@@	O	-1	19370593
o@@	O	-1	19370593
pa@@	O	-1	19370593
us@@	O	-1	19370593
al	O	-1	19370593
wom@@	O	-1	19370593
en@@	O	-1	19370593
.	O	-1	19370593
BACKGROUND:	O	-1	19370593
H@@	O	-1	19370593
orm@@	O	-1	19370593
one	O	-1	19370593
therapy	O	-1	19370593
(@@	O	-1	19370593
H@@	O	-1	19370593
T)	O	-1	19370593
is	O	-1	19370593
wi@@	O	-1	19370593
de@@	O	-1	19370593
ly	O	-1	19370593
used	O	-1	19370593
for	O	-1	19370593
contro@@	O	-1	19370593
ll@@	O	-1	19370593
ing	O	-1	19370593
men@@	O	-1	19370593
o@@	O	-1	19370593
pa@@	O	-1	19370593
us@@	O	-1	19370593
al	O	-1	19370593
symptoms	O	-1	19370593
and	O	-1	19370593
has	O	-1	19370593
also	O	-1	19370593
been	O	-1	19370593
used	O	-1	19370593
for	O	-1	19370593
the	O	-1	19370593
man@@	O	-1	19370593
ag@@	O	-1	19370593
ement	O	-1	19370593
and	O	-1	19370593
pre@@	O	-1	19370593
ven@@	O	-1	19370593
tion	O	-1	19370593
of	O	-1	19370593
cardiovascular	B-Disease	D002318	19370593
disease	I-Disease	-1	19370593
,	O	-1	19370593
ost@@	B-Disease	D010024	19370593
e@@	I-Disease	-1	19370593
o@@	I-Disease	-1	19370593
po@@	I-Disease	-1	19370593
ro@@	I-Disease	-1	19370593
sis	I-Disease	-1	19370593
and	O	-1	19370593
de@@	B-Disease	D003704	19370593
m@@	I-Disease	-1	19370593
enti@@	I-Disease	-1	19370593
a	I-Disease	-1	19370593
in	O	-1	19370593
ol@@	O	-1	19370593
der	O	-1	19370593
wom@@	O	-1	19370593
en@@	O	-1	19370593
.	O	-1	19370593
This	O	-1	19370593
is	O	-1	19370593
an	O	-1	19370593
up@@	O	-1	19370593
d@@	O	-1	19370593
ated	O	-1	19370593
ver@@	O	-1	19370593
sion	O	-1	19370593
of	O	-1	19370593
the	O	-1	19370593
or@@	O	-1	19370593
ig@@	O	-1	19370593
inal	O	-1	19370593
C@@	O	-1	19370593
och@@	O	-1	19370593
ran@@	O	-1	19370593
e	O	-1	19370593
revie@@	O	-1	19370593
w	O	-1	19370593
first	O	-1	19370593
pu@@	O	-1	19370593
bl@@	O	-1	19370593
ished	O	-1	19370593
in	O	-1	19370593
20@@	O	-1	19370593
0@@	O	-1	19370593
5@@	O	-1	19370593
.	O	-1	19370593
OBJECTIV@@	O	-1	19370593
E@@	O	-1	19370593
S:	O	-1	19370593
To	O	-1	19370593
ass@@	O	-1	19370593
ess	O	-1	19370593
the	O	-1	19370593
effect	O	-1	19370593
of	O	-1	19370593
long-term	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
on	O	-1	19370593
mor@@	O	-1	19370593
t@@	O	-1	19370593
al@@	O	-1	19370593
ity,	O	-1	19370593
cardiovascular	O	-1	19370593
outcom@@	O	-1	19370593
es,	O	-1	19370593
cancer	B-Disease	D009369	19370593
,	O	-1	19370593
g@@	B-Disease	D005705	19370593
all@@	I-Disease	-1	19370593
bladder	I-Disease	-1	19370593
disease	I-Disease	-1	19370593
,	O	-1	19370593
cogn@@	O	-1	19370593
i@@	O	-1	19370593
tion,	O	-1	19370593
frac@@	B-Disease	D050723	19370593
t@@	I-Disease	-1	19370593
ures	I-Disease	-1	19370593
and	O	-1	19370593
qu@@	O	-1	19370593
ality	O	-1	19370593
of	O	-1	19370593
lif@@	O	-1	19370593
e.	O	-1	19370593
S@@	O	-1	19370593
E@@	O	-1	19370593
A@@	O	-1	19370593
R@@	O	-1	19370593
C@@	O	-1	19370593
H	O	-1	19370593
S@@	O	-1	19370593
TR@@	O	-1	19370593
AT@@	O	-1	19370593
E@@	O	-1	19370593
G@@	O	-1	19370593
Y@@	O	-1	19370593
:	O	-1	19370593
We	O	-1	19370593
se@@	O	-1	19370593
ar@@	O	-1	19370593
ch@@	O	-1	19370593
ed	O	-1	19370593
the	O	-1	19370593
following	O	-1	19370593
dat@@	O	-1	19370593
ab@@	O	-1	19370593
as@@	O	-1	19370593
es	O	-1	19370593
to	O	-1	19370593
N@@	O	-1	19370593
o@@	O	-1	19370593
ve@@	O	-1	19370593
mb@@	O	-1	19370593
er	O	-1	19370593
20@@	O	-1	19370593
0@@	O	-1	19370593
7@@	O	-1	19370593
:	O	-1	19370593
T@@	O	-1	19370593
ri@@	O	-1	19370593
als	O	-1	19370593
Re@@	O	-1	19370593
g@@	O	-1	19370593
ist@@	O	-1	19370593
er	O	-1	19370593
of	O	-1	19370593
the	O	-1	19370593
C@@	O	-1	19370593
och@@	O	-1	19370593
ran@@	O	-1	19370593
e	O	-1	19370593
M@@	B-Disease	D008599	19370593
en@@	I-Disease	-1	19370593
st@@	I-Disease	-1	19370593
ru@@	I-Disease	-1	19370593
al	I-Disease	-1	19370593
D@@	I-Disease	-1	19370593
is@@	I-Disease	-1	19370593
or@@	I-Disease	-1	19370593
der@@	I-Disease	-1	19370593
s	I-Disease	-1	19370593
and	O	-1	19370593
S@@	O	-1	19370593
ub@@	O	-1	19370593
fer@@	O	-1	19370593
til@@	O	-1	19370593
ity	O	-1	19370593
Grou@@	O	-1	19370593
p@@	O	-1	19370593
,	O	-1	19370593
C@@	O	-1	19370593
och@@	O	-1	19370593
ran@@	O	-1	19370593
e	O	-1	19370593
C@@	O	-1	19370593
entr@@	O	-1	19370593
al	O	-1	19370593
Re@@	O	-1	19370593
g@@	O	-1	19370593
ist@@	O	-1	19370593
er	O	-1	19370593
of	O	-1	19370593
C@@	O	-1	19370593
ont@@	O	-1	19370593
ro@@	O	-1	19370593
lled	O	-1	19370593
T@@	O	-1	19370593
ri@@	O	-1	19370593
al@@	O	-1	19370593
s,	O	-1	19370593
M@@	O	-1	19370593
E@@	O	-1	19370593
D@@	O	-1	19370593
L@@	O	-1	19370593
IN@@	O	-1	19370593
E@@	O	-1	19370593
,	O	-1	19370593
E@@	O	-1	19370593
M@@	O	-1	19370593
BA@@	O	-1	19370593
S@@	O	-1	19370593
E@@	O	-1	19370593
,	O	-1	19370593
B@@	O	-1	19370593
io@@	O	-1	19370593
log@@	O	-1	19370593
ical	O	-1	19370593
A@@	O	-1	19370593
b@@	O	-1	19370593
st@@	O	-1	19370593
rac@@	O	-1	19370593
t@@	O	-1	19370593
s.	O	-1	19370593
Al@@	O	-1	19370593
so	O	-1	19370593
re@@	O	-1	19370593
lev@@	O	-1	19370593
ant	O	-1	19370593
non-@@	O	-1	19370593
in@@	O	-1	19370593
de@@	O	-1	19370593
x@@	O	-1	19370593
ed	O	-1	19370593
j@@	O	-1	19370593
o@@	O	-1	19370593
ur@@	O	-1	19370593
n@@	O	-1	19370593
als	O	-1	19370593
and	O	-1	19370593
con@@	O	-1	19370593
fe@@	O	-1	19370593
rence	O	-1	19370593
ab@@	O	-1	19370593
st@@	O	-1	19370593
rac@@	O	-1	19370593
t@@	O	-1	19370593
s.	O	-1	19370593
S@@	O	-1	19370593
E@@	O	-1	19370593
L@@	O	-1	19370593
EC@@	O	-1	19370593
TI@@	O	-1	19370593
O@@	O	-1	19370593
N	O	-1	19370593
CR@@	O	-1	19370593
I@@	O	-1	19370593
TE@@	O	-1	19370593
R@@	O	-1	19370593
I@@	O	-1	19370593
A@@	O	-1	19370593
:	O	-1	19370593
R@@	O	-1	19370593
an@@	O	-1	19370593
dom@@	O	-1	19370593
is@@	O	-1	19370593
ed	O	-1	19370593
double-bl@@	O	-1	19370593
ind	O	-1	19370593
tri@@	O	-1	19370593
als	O	-1	19370593
of	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
versus	O	-1	19370593
placebo@@	O	-1	19370593
,	O	-1	19370593
tak@@	O	-1	19370593
en	O	-1	19370593
for	O	-1	19370593
at	O	-1	19370593
le@@	O	-1	19370593
ast	O	-1	19370593
one	O	-1	19370593
year	O	-1	19370593
by	O	-1	19370593
per@@	O	-1	19370593
imen@@	O	-1	19370593
o@@	O	-1	19370593
pa@@	O	-1	19370593
us@@	O	-1	19370593
al	O	-1	19370593
or	O	-1	19370593
post@@	O	-1	19370593
men@@	O	-1	19370593
o@@	O	-1	19370593
pa@@	O	-1	19370593
us@@	O	-1	19370593
al	O	-1	19370593
wom@@	O	-1	19370593
en@@	O	-1	19370593
.	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
included	O	-1	19370593
o@@	B-Chemical	D004967	19370593
est@@	I-Chemical	-1	19370593
ro@@	I-Chemical	-1	19370593
gen@@	I-Chemical	-1	19370593
s	I-Chemical	-1	19370593
,	O	-1	19370593
with	O	-1	19370593
or	O	-1	19370593
without	O	-1	19370593
pro@@	B-Chemical	D011374	19370593
g@@	I-Chemical	-1	19370593
est@@	I-Chemical	-1	19370593
o@@	I-Chemical	-1	19370593
gen@@	I-Chemical	-1	19370593
s	I-Chemical	-1	19370593
,	O	-1	19370593
vi@@	O	-1	19370593
a	O	-1	19370593
or@@	O	-1	19370593
al,	O	-1	19370593
trans@@	O	-1	19370593
der@@	O	-1	19370593
mal@@	O	-1	19370593
,	O	-1	19370593
sub@@	O	-1	19370593
c@@	O	-1	19370593
utaneous	O	-1	19370593
or	O	-1	19370593
trans@@	O	-1	19370593
n@@	O	-1	19370593
as@@	O	-1	19370593
al	O	-1	19370593
ro@@	O	-1	19370593
ut@@	O	-1	19370593
es.	O	-1	19370593
D@@	O	-1	19370593
AT@@	O	-1	19370593
A	O	-1	19370593
CO@@	O	-1	19370593
L@@	O	-1	19370593
L@@	O	-1	19370593
EC@@	O	-1	19370593
TI@@	O	-1	19370593
O@@	O	-1	19370593
N	O	-1	19370593
AN@@	O	-1	19370593
D	O	-1	19370593
AN@@	O	-1	19370593
AL@@	O	-1	19370593
Y@@	O	-1	19370593
S@@	O	-1	19370593
I@@	O	-1	19370593
S:	O	-1	19370593
Two	O	-1	19370593
au@@	O	-1	19370593
th@@	O	-1	19370593
ors	O	-1	19370593
in@@	O	-1	19370593
depend@@	O	-1	19370593
ently	O	-1	19370593
assessed	O	-1	19370593
trial	O	-1	19370593
qu@@	O	-1	19370593
ality	O	-1	19370593
and	O	-1	19370593
extrac@@	O	-1	19370593
ted	O	-1	19370593
dat@@	O	-1	19370593
a.	O	-1	19370593
MA@@	O	-1	19370593
I@@	O	-1	19370593
N	O	-1	19370593
RESULTS:	O	-1	19370593
N@@	O	-1	19370593
ine@@	O	-1	19370593
te@@	O	-1	19370593
en	O	-1	19370593
tri@@	O	-1	19370593
als	O	-1	19370593
invol@@	O	-1	19370593
ving	O	-1	19370593
4@@	O	-1	19370593
1@@	O	-1	19370593
,@@	O	-1	19370593
9@@	O	-1	19370593
0@@	O	-1	19370593
4	O	-1	19370593
women	O	-1	19370593
were	O	-1	19370593
inc@@	O	-1	19370593
lu@@	O	-1	19370593
de@@	O	-1	19370593
d.	O	-1	19370593
In	O	-1	19370593
rel@@	O	-1	19370593
atively	O	-1	19370593
healthy	O	-1	19370593
wom@@	O	-1	19370593
en@@	O	-1	19370593
,	O	-1	19370593
combined	O	-1	19370593
continu@@	O	-1	19370593
ous	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
significantly	O	-1	19370593
increased	O	-1	19370593
the	O	-1	19370593
risk	O	-1	19370593
of	O	-1	19370593
venous	B-Disease	D054556	19370593
thrombo@@	I-Disease	-1	19370593
-@@	I-Disease	-1	19370593
emb@@	I-Disease	-1	19370593
ol@@	I-Disease	-1	19370593
ism	I-Disease	-1	19370593
or	O	-1	19370593
coronary	O	-1	19370593
ev@@	O	-1	19370593
ent	O	-1	19370593
(@@	O	-1	19370593
after	O	-1	19370593
one	O	-1	19370593
year@@	O	-1	19370593
's	O	-1	19370593
use@@	O	-1	19370593
),	O	-1	19370593
strok@@	B-Disease	D020521	19370593
e	I-Disease	-1	19370593
(@@	O	-1	19370593
after	O	-1	19370593
three	O	-1	19370593
year@@	O	-1	19370593
s),	O	-1	19370593
b@@	B-Disease	D001943	19370593
reas@@	I-Disease	-1	19370593
t	I-Disease	-1	19370593
cancer	I-Disease	-1	19370593
and	O	-1	19370593
g@@	B-Disease	D005705	19370593
all@@	I-Disease	-1	19370593
bladder	I-Disease	-1	19370593
disease	I-Disease	-1	19370593
.	O	-1	19370593
L@@	O	-1	19370593
on@@	O	-1	19370593
g@@	O	-1	19370593
-term	O	-1	19370593
o@@	B-Chemical	D004967	19370593
est@@	I-Chemical	-1	19370593
ro@@	I-Chemical	-1	19370593
gen	I-Chemical	-1	19370593
-@@	O	-1	19370593
only	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
significantly	O	-1	19370593
increased	O	-1	19370593
the	O	-1	19370593
risk	O	-1	19370593
of	O	-1	19370593
venous	B-Disease	D054556	19370593
thrombo@@	I-Disease	-1	19370593
-@@	I-Disease	-1	19370593
emb@@	I-Disease	-1	19370593
ol@@	I-Disease	-1	19370593
ism	I-Disease	-1	19370593
,	O	-1	19370593
strok@@	B-Disease	D020521	19370593
e	I-Disease	-1	19370593
and	O	-1	19370593
g@@	B-Disease	D005705	19370593
all@@	I-Disease	-1	19370593
bladder	I-Disease	-1	19370593
disease	I-Disease	-1	19370593
(@@	O	-1	19370593
after	O	-1	19370593
one	O	-1	19370593
to	O	-1	19370593
two	O	-1	19370593
year@@	O	-1	19370593
s,	O	-1	19370593
three	O	-1	19370593
years	O	-1	19370593
and	O	-1	19370593
seven	O	-1	19370593
year@@	O	-1	19370593
s@@	O	-1	19370593
'	O	-1	19370593
use	O	-1	19370593
respectivel@@	O	-1	19370593
y@@	O	-1	19370593
),	O	-1	19370593
but	O	-1	19370593
did	O	-1	19370593
not	O	-1	19370593
significantly	O	-1	19370593
increase	O	-1	19370593
the	O	-1	19370593
risk	O	-1	19370593
of	O	-1	19370593
b@@	B-Disease	D001943	19370593
reas@@	I-Disease	-1	19370593
t	I-Disease	-1	19370593
cancer	I-Disease	-1	19370593
.	O	-1	19370593
The	O	-1	19370593
only	O	-1	19370593
statis@@	O	-1	19370593
tically	O	-1	19370593
significant	O	-1	19370593
ben@@	O	-1	19370593
e@@	O	-1	19370593
f@@	O	-1	19370593
its	O	-1	19370593
of	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
were	O	-1	19370593
a	O	-1	19370593
decreased	O	-1	19370593
incidence	O	-1	19370593
of	O	-1	19370593
frac@@	B-Disease	D050723	19370593
t@@	I-Disease	-1	19370593
ures	I-Disease	-1	19370593
and	O	-1	19370593
(@@	O	-1	19370593
for	O	-1	19370593
combined	O	-1	19370593
H@@	O	-1	19370593
T)	O	-1	19370593
co@@	B-Disease	D003110	19370593
l@@	I-Disease	-1	19370593
on	I-Disease	-1	19370593
cancer	I-Disease	-1	19370593
,	O	-1	19370593
with	O	-1	19370593
long-term	O	-1	19370593
use.	O	-1	19370593
A@@	O	-1	19370593
mon@@	O	-1	19370593
g	O	-1	19370593
women	O	-1	19370593
aged	O	-1	19370593
over	O	-1	19370593
6@@	O	-1	19370593
5	O	-1	19370593
who	O	-1	19370593
were	O	-1	19370593
rel@@	O	-1	19370593
atively	O	-1	19370593
healthy	O	-1	19370593
(@@	O	-1	19370593
i.@@	O	-1	19370593
e.	O	-1	19370593
gener@@	O	-1	19370593
ally	O	-1	19370593
f@@	O	-1	19370593
it@@	O	-1	19370593
,	O	-1	19370593
without	O	-1	19370593
over@@	O	-1	19370593
t	O	-1	19370593
diseas@@	O	-1	19370593
e@@	O	-1	19370593
)	O	-1	19370593
and	O	-1	19370593
taking	O	-1	19370593
continu@@	O	-1	19370593
ous	O	-1	19370593
combined	O	-1	19370593
H@@	O	-1	19370593
T@@	O	-1	19370593
,	O	-1	19370593
there	O	-1	19370593
was	O	-1	19370593
a	O	-1	19370593
statis@@	O	-1	19370593
tically	O	-1	19370593
significant	O	-1	19370593
increase	O	-1	19370593
in	O	-1	19370593
the	O	-1	19370593
incidence	O	-1	19370593
of	O	-1	19370593
de@@	B-Disease	D003704	19370593
m@@	I-Disease	-1	19370593
enti@@	I-Disease	-1	19370593
a	I-Disease	-1	19370593
.	O	-1	19370593
A@@	O	-1	19370593
mon@@	O	-1	19370593
g	O	-1	19370593
women	O	-1	19370593
with	O	-1	19370593
cardiovascular	B-Disease	D002318	19370593
disease	I-Disease	-1	19370593
,	O	-1	19370593
long-term	O	-1	19370593
use	O	-1	19370593
of	O	-1	19370593
combined	O	-1	19370593
continu@@	O	-1	19370593
ous	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
significantly	O	-1	19370593
increased	O	-1	19370593
the	O	-1	19370593
risk	O	-1	19370593
of	O	-1	19370593
venous	B-Disease	D054556	19370593
thrombo@@	I-Disease	-1	19370593
-@@	I-Disease	-1	19370593
emb@@	I-Disease	-1	19370593
ol@@	I-Disease	-1	19370593
ism	I-Disease	-1	19370593
.@@	O	-1	19370593
One	O	-1	19370593
trial	O	-1	19370593
an@@	O	-1	19370593
al@@	O	-1	19370593
ys@@	O	-1	19370593
ed	O	-1	19370593
sub@@	O	-1	19370593
groups	O	-1	19370593
of	O	-1	19370593
2@@	O	-1	19370593
8@@	O	-1	19370593
3@@	O	-1	19370593
9	O	-1	19370593
rel@@	O	-1	19370593
atively	O	-1	19370593
healthy	O	-1	19370593
50	O	-1	19370593
to	O	-1	19370593
5@@	O	-1	19370593
9	O	-1	19370593
year	O	-1	19370593
old	O	-1	19370593
women	O	-1	19370593
taking	O	-1	19370593
combined	O	-1	19370593
continu@@	O	-1	19370593
ous	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
and	O	-1	19370593
1@@	O	-1	19370593
6@@	O	-1	19370593
3@@	O	-1	19370593
7	O	-1	19370593
taking	O	-1	19370593
o@@	B-Chemical	D004967	19370593
est@@	I-Chemical	-1	19370593
ro@@	I-Chemical	-1	19370593
gen	I-Chemical	-1	19370593
-@@	O	-1	19370593
only	O	-1	19370593
H@@	O	-1	19370593
T@@	O	-1	19370593
,	O	-1	19370593
versus	O	-1	19370593
simil@@	O	-1	19370593
ar@@	O	-1	19370593
-@@	O	-1	19370593
si@@	O	-1	19370593
zed	O	-1	19370593
placebo	O	-1	19370593
groups.	O	-1	19370593
The	O	-1	19370593
only	O	-1	19370593
significantly	O	-1	19370593
increased	O	-1	19370593
risk	O	-1	19370593
reported	O	-1	19370593
was	O	-1	19370593
for	O	-1	19370593
venous	B-Disease	D054556	19370593
thrombo@@	I-Disease	-1	19370593
-@@	I-Disease	-1	19370593
emb@@	I-Disease	-1	19370593
ol@@	I-Disease	-1	19370593
ism	I-Disease	-1	19370593
in	O	-1	19370593
women	O	-1	19370593
taking	O	-1	19370593
combined	O	-1	19370593
continu@@	O	-1	19370593
ous	O	-1	19370593
H@@	O	-1	19370593
T@@	O	-1	19370593
:	O	-1	19370593
their	O	-1	19370593
abs@@	O	-1	19370593
ol@@	O	-1	19370593
ute	O	-1	19370593
risk	O	-1	19370593
remained	O	-1	19370593
low@@	O	-1	19370593
,	O	-1	19370593
at	O	-1	19370593
less	O	-1	19370593
than	O	-1	19370593
1@@	O	-1	19370593
/@@	O	-1	19370593
50@@	O	-1	19370593
0@@	O	-1	19370593
.	O	-1	19370593
However,	O	-1	19370593
this	O	-1	19370593
study	O	-1	19370593
was	O	-1	19370593
not	O	-1	19370593
po@@	O	-1	19370593
we@@	O	-1	19370593
red	O	-1	19370593
to	O	-1	19370593
det@@	O	-1	19370593
ect	O	-1	19370593
differences	O	-1	19370593
between	O	-1	19370593
groups	O	-1	19370593
of	O	-1	19370593
youn@@	O	-1	19370593
g@@	O	-1	19370593
er	O	-1	19370593
wom@@	O	-1	19370593
en@@	O	-1	19370593
.	O	-1	19370593
A@@	O	-1	19370593
U@@	O	-1	19370593
T@@	O	-1	19370593
HO@@	O	-1	19370593
R@@	O	-1	19370593
S@@	O	-1	19370593
'	O	-1	19370593
CONCLUSIONS:	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
is	O	-1	19370593
not	O	-1	19370593
indic@@	O	-1	19370593
ated	O	-1	19370593
for	O	-1	19370593
the	O	-1	19370593
ro@@	O	-1	19370593
ut@@	O	-1	19370593
ine	O	-1	19370593
man@@	O	-1	19370593
ag@@	O	-1	19370593
ement	O	-1	19370593
of	O	-1	19370593
chronic	O	-1	19370593
disease.	O	-1	19370593
We	O	-1	19370593
need	O	-1	19370593
more	O	-1	19370593
evidence	O	-1	19370593
on	O	-1	19370593
the	O	-1	19370593
safety	O	-1	19370593
of	O	-1	19370593
H@@	O	-1	19370593
T	O	-1	19370593
for	O	-1	19370593
men@@	O	-1	19370593
o@@	O	-1	19370593
pa@@	O	-1	19370593
us@@	O	-1	19370593
al	O	-1	19370593
sympto@@	O	-1	19370593
m	O	-1	19370593
control@@	O	-1	19370593
,	O	-1	19370593
though	O	-1	19370593
sh@@	O	-1	19370593
ort@@	O	-1	19370593
-term	O	-1	19370593
use	O	-1	19370593
appear@@	O	-1	19370593
s	O	-1	19370593
to	O	-1	19370593
be	O	-1	19370593
rel@@	O	-1	19370593
atively	O	-1	19370593
saf@@	O	-1	19370593
e	O	-1	19370593
for	O	-1	19370593
healthy	O	-1	19370593
youn@@	O	-1	19370593
g@@	O	-1	19370593
er	O	-1	19370593
wom@@	O	-1	19370593
en@@	O	-1	19370593
.	O	-1	19370593

P@@	O	-1	17019386
ass@@	O	-1	17019386
age	O	-1	17019386
of	O	-1	17019386
man@@	B-Chemical	D008353	17019386
nit@@	I-Chemical	-1	17019386
ol	I-Chemical	-1	17019386
into	O	-1	17019386
the	O	-1	17019386
brain	O	-1	17019386
a@@	O	-1	17019386
ro@@	O	-1	17019386
un@@	O	-1	17019386
d	O	-1	17019386
g@@	B-Disease	D005910	17019386
li@@	I-Disease	-1	17019386
om@@	I-Disease	-1	17019386
as	I-Disease	-1	17019386
:	O	-1	17019386
a	O	-1	17019386
potential	O	-1	17019386
cause	O	-1	17019386
of	O	-1	17019386
reb@@	O	-1	17019386
ound	O	-1	17019386
phen@@	O	-1	17019386
om@@	O	-1	17019386
en@@	O	-1	17019386
on@@	O	-1	17019386
.	O	-1	17019386
A	O	-1	17019386
study	O	-1	17019386
on	O	-1	17019386
21	O	-1	17019386
patients.	O	-1	17019386
A@@	O	-1	17019386
I@@	O	-1	17019386
M@@	O	-1	17019386
:	O	-1	17019386
W@@	O	-1	17019386
id@@	O	-1	17019386
es@@	O	-1	17019386
pre@@	O	-1	17019386
ad	O	-1	17019386
use	O	-1	17019386
of	O	-1	17019386
man@@	B-Chemical	D008353	17019386
nit@@	I-Chemical	-1	17019386
ol	I-Chemical	-1	17019386
to	O	-1	17019386
re@@	O	-1	17019386
duce	O	-1	17019386
brain	B-Disease	D001929	17019386
e@@	I-Disease	-1	17019386
de@@	I-Disease	-1	17019386
ma	I-Disease	-1	17019386
and	O	-1	17019386
lower	O	-1	17019386
elevated	B-Disease	D019586	17019386
IC@@	I-Disease	-1	17019386
P	I-Disease	-1	17019386
in	O	-1	17019386
brain	B-Disease	D001932	17019386
tumor	I-Disease	-1	17019386
patients	O	-1	17019386
continu@@	O	-1	17019386
es	O	-1	17019386
to	O	-1	17019386
be	O	-1	17019386
aff@@	O	-1	17019386
l@@	O	-1	17019386
ic@@	O	-1	17019386
ted	O	-1	17019386
by	O	-1	17019386
the	O	-1	17019386
so@@	O	-1	17019386
-@@	O	-1	17019386
c@@	O	-1	17019386
all@@	O	-1	17019386
ed	O	-1	17019386
reb@@	O	-1	17019386
ound	O	-1	17019386
phen@@	O	-1	17019386
om@@	O	-1	17019386
en@@	O	-1	17019386
on@@	O	-1	17019386
.	O	-1	17019386
L@@	O	-1	17019386
e@@	O	-1	17019386
ak@@	O	-1	17019386
age	O	-1	17019386
of	O	-1	17019386
man@@	B-Chemical	D008353	17019386
nit@@	I-Chemical	-1	17019386
ol	I-Chemical	-1	17019386
into	O	-1	17019386
the	O	-1	17019386
brain	O	-1	17019386
pa@@	O	-1	17019386
ren@@	O	-1	17019386
ch@@	O	-1	17019386
y@@	O	-1	17019386
ma	O	-1	17019386
through	O	-1	17019386
an	O	-1	17019386
al@@	O	-1	17019386
te@@	O	-1	17019386
red	O	-1	17019386
B@@	O	-1	17019386
B@@	O	-1	17019386
B	O	-1	17019386
and	O	-1	17019386
secondary	O	-1	17019386
rever@@	O	-1	17019386
s@@	O	-1	17019386
al	O	-1	17019386
of	O	-1	17019386
os@@	O	-1	17019386
mo@@	O	-1	17019386
tic	O	-1	17019386
gra@@	O	-1	17019386
di@@	O	-1	17019386
ent	O	-1	17019386
is	O	-1	17019386
considered	O	-1	17019386
the	O	-1	17019386
major	O	-1	17019386
cause	O	-1	17019386
of	O	-1	17019386
reb@@	O	-1	17019386
ound	O	-1	17019386
.	O	-1	17019386
This	O	-1	17019386
has	O	-1	17019386
only	O	-1	17019386
been	O	-1	17019386
demonstrated	O	-1	17019386
experim@@	O	-1	17019386
ent@@	O	-1	17019386
ally	O	-1	17019386
in	O	-1	17019386
anim@@	O	-1	17019386
al@@	O	-1	17019386
s.	O	-1	17019386
A@@	O	-1	17019386
s	O	-1	17019386
a	O	-1	17019386
cont@@	O	-1	17019386
ri@@	O	-1	17019386
bu@@	O	-1	17019386
tion	O	-1	17019386
to	O	-1	17019386
this	O	-1	17019386
is@@	O	-1	17019386
su@@	O	-1	17019386
e	O	-1	17019386
we	O	-1	17019386
dec@@	O	-1	17019386
id@@	O	-1	17019386
ed	O	-1	17019386
to	O	-1	17019386
re@@	O	-1	17019386
se@@	O	-1	17019386
arc@@	O	-1	17019386
h	O	-1	17019386
the	O	-1	17019386
possible	O	-1	17019386
p@@	O	-1	17019386
ass@@	O	-1	17019386
age	O	-1	17019386
of	O	-1	17019386
man@@	B-Chemical	D008353	17019386
nit@@	I-Chemical	-1	17019386
ol	I-Chemical	-1	17019386
into	O	-1	17019386
the	O	-1	17019386
brain	O	-1	17019386
after	O	-1	17019386
administration	O	-1	17019386
to	O	-1	17019386
21	O	-1	17019386
brain	B-Disease	D001932	17019386
tumor	I-Disease	-1	17019386
patients.	O	-1	17019386
METHODS:	O	-1	17019386
M@@	B-Chemical	D008353	17019386
an@@	I-Chemical	-1	17019386
nit@@	I-Chemical	-1	17019386
ol	I-Chemical	-1	17019386
(1@@	O	-1	17019386
8@@	O	-1	17019386
%	O	-1	17019386
sol@@	O	-1	17019386
u@@	O	-1	17019386
tion@@	O	-1	17019386
;	O	-1	17019386
1	O	-1	17019386
g/@@	O	-1	17019386
kg@@	O	-1	17019386
)	O	-1	17019386
was	O	-1	17019386
administered	O	-1	17019386
as	O	-1	17019386
a	O	-1	17019386
b@@	O	-1	17019386
ol@@	O	-1	17019386
us	O	-1	17019386
to	O	-1	17019386
patients	O	-1	17019386
(@@	O	-1	17019386
ten	O	-1	17019386
had	O	-1	17019386
mal@@	B-Disease	D005910	17019386
i@@	I-Disease	-1	17019386
gn@@	I-Disease	-1	17019386
ant	I-Disease	-1	17019386
g@@	I-Disease	-1	17019386
li@@	I-Disease	-1	17019386
oma	I-Disease	-1	17019386
,	O	-1	17019386
seven	O	-1	17019386
brain	O	-1	17019386
met@@	B-Disease	D009362	17019386
ast@@	I-Disease	-1	17019386
as@@	I-Disease	-1	17019386
es	I-Disease	-1	17019386
and	O	-1	17019386
four	O	-1	17019386
men@@	B-Disease	D008579	17019386
ing@@	I-Disease	-1	17019386
i@@	I-Disease	-1	17019386
oma	I-Disease	-1	17019386
)	O	-1	17019386
about	O	-1	17019386
30	O	-1	17019386
minutes	O	-1	17019386
before	O	-1	17019386
c@@	O	-1	17019386
ran@@	O	-1	17019386
i@@	O	-1	17019386
ot@@	O	-1	17019386
om@@	O	-1	17019386
y.	O	-1	17019386
D@@	O	-1	17019386
uring	O	-1	17019386
res@@	O	-1	17019386
ec@@	O	-1	17019386
tion,	O	-1	17019386
a	O	-1	17019386
sam@@	O	-1	17019386
ple	O	-1	17019386
of	O	-1	17019386
the	O	-1	17019386
sur@@	O	-1	17019386
ro@@	O	-1	17019386
un@@	O	-1	17019386
ding	O	-1	17019386
e@@	B-Disease	D004487	17019386
de@@	I-Disease	-1	17019386
mat@@	I-Disease	-1	17019386
ous	I-Disease	-1	17019386
wh@@	O	-1	17019386
ite	O	-1	17019386
mat@@	O	-1	17019386
ter	O	-1	17019386
was	O	-1	17019386
tak@@	O	-1	17019386
en	O	-1	17019386
at	O	-1	17019386
the	O	-1	17019386
same	O	-1	17019386
time	O	-1	17019386
as	O	-1	17019386
a	O	-1	17019386
10	O	-1	17019386
m@@	O	-1	17019386
l	O	-1	17019386
venous	O	-1	17019386
blood	O	-1	17019386
sam@@	O	-1	17019386
ple@@	O	-1	17019386
.	O	-1	17019386
M@@	B-Chemical	D008353	17019386
an@@	I-Chemical	-1	17019386
nit@@	I-Chemical	-1	17019386
ol	I-Chemical	-1	17019386
concentrations	O	-1	17019386
were	O	-1	17019386
measured	O	-1	17019386
in	O	-1	17019386
plasma	O	-1	17019386
and	O	-1	17019386
wh@@	O	-1	17019386
ite	O	-1	17019386
mat@@	O	-1	17019386
ter	O	-1	17019386
by	O	-1	17019386
a	O	-1	17019386
mo@@	O	-1	17019386
di@@	O	-1	17019386
fied	O	-1	17019386
ver@@	O	-1	17019386
sion	O	-1	17019386
of	O	-1	17019386
the	O	-1	17019386
enzyme	O	-1	17019386
ass@@	O	-1	17019386
ay	O	-1	17019386
of	O	-1	17019386
B@@	O	-1	17019386
lon@@	O	-1	17019386
qu@@	O	-1	17019386
ist	O	-1	17019386
et	O	-1	17019386
al.	O	-1	17019386
RESULTS:	O	-1	17019386
In	O	-1	17019386
most	O	-1	17019386
g@@	B-Disease	D005910	17019386
li@@	I-Disease	-1	17019386
oma	I-Disease	-1	17019386
patients,	O	-1	17019386
man@@	B-Chemical	D008353	17019386
nit@@	I-Chemical	-1	17019386
ol	I-Chemical	-1	17019386
concentrations	O	-1	17019386
in	O	-1	17019386
wh@@	O	-1	17019386
ite	O	-1	17019386
mat@@	O	-1	17019386
ter	O	-1	17019386
were	O	-1	17019386
2	O	-1	17019386
to	O	-1	17019386
6	O	-1	17019386
times	O	-1	17019386
higher	O	-1	17019386
than	O	-1	17019386
in	O	-1	17019386
plasma	O	-1	17019386
(@@	O	-1	17019386
mean	O	-1	17019386
3.@@	O	-1	17019386
5	O	-1	17019386
tim@@	O	-1	17019386
es@@	O	-1	17019386
).	O	-1	17019386
In	O	-1	17019386
men@@	B-Disease	D008579	17019386
ing@@	I-Disease	-1	17019386
i@@	I-Disease	-1	17019386
oma	I-Disease	-1	17019386
and	O	-1	17019386
met@@	B-Disease	D009362	17019386
ast@@	I-Disease	-1	17019386
as@@	I-Disease	-1	17019386
es	I-Disease	-1	17019386
patients	O	-1	17019386
plasma	O	-1	17019386
concentrations	O	-1	17019386
of	O	-1	17019386
man@@	B-Chemical	D008353	17019386
nit@@	I-Chemical	-1	17019386
ol	I-Chemical	-1	17019386
were	O	-1	17019386
higher	O	-1	17019386
than	O	-1	17019386
wh@@	O	-1	17019386
ite	O	-1	17019386
mat@@	O	-1	17019386
ter	O	-1	17019386
concentrations	O	-1	17019386
ex@@	O	-1	17019386
cep@@	O	-1	17019386
t	O	-1	17019386
in	O	-1	17019386
three	O	-1	17019386
cases	O	-1	17019386
with	O	-1	17019386
inf@@	O	-1	17019386
iltration	O	-1	17019386
by	O	-1	17019386
ne@@	O	-1	17019386
o@@	O	-1	17019386
plas@@	O	-1	17019386
tic	O	-1	17019386
cell@@	O	-1	17019386
s.	O	-1	17019386
CONCLUSIONS:	O	-1	17019386
The	O	-1	17019386
results	O	-1	17019386
of	O	-1	17019386
our	O	-1	17019386
study	O	-1	17019386
show	O	-1	17019386
that	O	-1	17019386
even	O	-1	17019386
after	O	-1	17019386
a	O	-1	17019386
single	O	-1	17019386
b@@	O	-1	17019386
ol@@	O	-1	17019386
us,	O	-1	17019386
man@@	B-Chemical	D008353	17019386
nit@@	I-Chemical	-1	17019386
ol	I-Chemical	-1	17019386
may	O	-1	17019386
le@@	O	-1	17019386
a@@	O	-1	17019386
k	O	-1	17019386
through	O	-1	17019386
the	O	-1	17019386
al@@	O	-1	17019386
te@@	O	-1	17019386
red	O	-1	17019386
B@@	O	-1	17019386
B@@	O	-1	17019386
B	O	-1	17019386
ne@@	O	-1	17019386
ar	O	-1	17019386
g@@	B-Disease	D005910	17019386
li@@	I-Disease	-1	17019386
om@@	I-Disease	-1	17019386
as	I-Disease	-1	17019386
,	O	-1	17019386
rever@@	O	-1	17019386
s@@	O	-1	17019386
ing	O	-1	17019386
the	O	-1	17019386
initial	O	-1	17019386
plas@@	O	-1	17019386
ma@@	O	-1	17019386
-@@	O	-1	17019386
to@@	O	-1	17019386
-@@	O	-1	17019386
blood	O	-1	17019386
os@@	O	-1	17019386
mo@@	O	-1	17019386
tic	O	-1	17019386
gra@@	O	-1	17019386
di@@	O	-1	17019386
ent@@	O	-1	17019386
,	O	-1	17019386
ag@@	O	-1	17019386
gra@@	O	-1	17019386
v@@	O	-1	17019386
ating	O	-1	17019386
per@@	O	-1	17019386
it@@	O	-1	17019386
u@@	O	-1	17019386
mor@@	O	-1	17019386
al	O	-1	17019386
e@@	B-Disease	D004487	17019386
de@@	I-Disease	-1	17019386
ma	I-Disease	-1	17019386
and	O	-1	17019386
pro@@	O	-1	17019386
m@@	O	-1	17019386
ot@@	O	-1	17019386
ing	O	-1	17019386
reb@@	O	-1	17019386
ound	O	-1	17019386
of	O	-1	17019386
IC@@	O	-1	17019386
P@@	O	-1	17019386
.	O	-1	17019386

C@@	O	-1	12452237
an	O	-1	12452237
lidocaine	B-Chemical	D008012	12452237
re@@	O	-1	12452237
duce	O	-1	12452237
suc@@	B-Chemical	D013390	12452237
cin@@	I-Chemical	-1	12452237
ylcholine	I-Chemical	-1	12452237
induced	O	-1	12452237
postoperative	B-Disease	D010149	12452237
my@@	I-Disease	-1	12452237
al@@	I-Disease	-1	12452237
g@@	I-Disease	-1	12452237
ia	I-Disease	-1	12452237
?	O	-1	12452237
This	O	-1	12452237
study	O	-1	12452237
was	O	-1	12452237
under@@	O	-1	12452237
tak@@	O	-1	12452237
en	O	-1	12452237
to	O	-1	12452237
determine	O	-1	12452237
the	O	-1	12452237
effect	O	-1	12452237
of	O	-1	12452237
lidocaine	B-Chemical	D008012	12452237
pretreatment	O	-1	12452237
on	O	-1	12452237
reduction	O	-1	12452237
of	O	-1	12452237
suc@@	B-Chemical	D013390	12452237
cin@@	I-Chemical	-1	12452237
ylcholine	I-Chemical	-1	12452237
-induced	O	-1	12452237
my@@	B-Disease	D063806	12452237
al@@	I-Disease	-1	12452237
g@@	I-Disease	-1	12452237
ia	I-Disease	-1	12452237
in	O	-1	12452237
patients	O	-1	12452237
under@@	O	-1	12452237
go@@	O	-1	12452237
ing	O	-1	12452237
gener@@	O	-1	12452237
al	O	-1	12452237
anesthe@@	O	-1	12452237
sia	O	-1	12452237
for	O	-1	12452237
g@@	O	-1	12452237
y@@	O	-1	12452237
nec@@	O	-1	12452237
ological	O	-1	12452237
surger@@	O	-1	12452237
y.	O	-1	12452237
One	O	-1	12452237
h@@	O	-1	12452237
und@@	O	-1	12452237
red	O	-1	12452237
and	O	-1	12452237
thir@@	O	-1	12452237
ty-@@	O	-1	12452237
five	O	-1	12452237
patients	O	-1	12452237
were	O	-1	12452237
as@@	O	-1	12452237
signed	O	-1	12452237
to	O	-1	12452237
one	O	-1	12452237
of	O	-1	12452237
three	O	-1	12452237
groups	O	-1	12452237
in	O	-1	12452237
a	O	-1	12452237
pro@@	O	-1	12452237
sp@@	O	-1	12452237
ecti@@	O	-1	12452237
ve,	O	-1	12452237
dou@@	O	-1	12452237
ble	O	-1	12452237
bl@@	O	-1	12452237
ind@@	O	-1	12452237
,	O	-1	12452237
randomized	O	-1	12452237
man@@	O	-1	12452237
ner@@	O	-1	12452237
.	O	-1	12452237
Group	O	-1	12452237
P@@	O	-1	12452237
S@@	O	-1	12452237
,	O	-1	12452237
the	O	-1	12452237
control	O	-1	12452237
group@@	O	-1	12452237
,	O	-1	12452237
received	O	-1	12452237
normal	O	-1	12452237
saline	O	-1	12452237
and	O	-1	12452237
suc@@	B-Chemical	D013390	12452237
cin@@	I-Chemical	-1	12452237
ylcholine	I-Chemical	-1	12452237
1.@@	O	-1	12452237
5	O	-1	12452237
mg	O	-1	12452237
x	O	-1	12452237
kg@@	O	-1	12452237
(@@	O	-1	12452237
-1@@	O	-1	12452237
);	O	-1	12452237
Group	O	-1	12452237
L@@	O	-1	12452237
S@@	O	-1	12452237
,	O	-1	12452237
lidocaine	B-Chemical	D008012	12452237
1.@@	O	-1	12452237
5	O	-1	12452237
mg	O	-1	12452237
x	O	-1	12452237
kg@@	O	-1	12452237
(@@	O	-1	12452237
-1@@	O	-1	12452237
)	O	-1	12452237
and	O	-1	12452237
suc@@	B-Chemical	D013390	12452237
cin@@	I-Chemical	-1	12452237
ylcholine	I-Chemical	-1	12452237
1.@@	O	-1	12452237
5	O	-1	12452237
mg	O	-1	12452237
x	O	-1	12452237
kg@@	O	-1	12452237
(@@	O	-1	12452237
-1@@	O	-1	12452237
);	O	-1	12452237
Group	O	-1	12452237
P@@	O	-1	12452237
R@@	O	-1	12452237
,	O	-1	12452237
normal	O	-1	12452237
saline	O	-1	12452237
and	O	-1	12452237
ro@@	B-Chemical	C061870	12452237
cur@@	I-Chemical	-1	12452237
oni@@	I-Chemical	-1	12452237
um	I-Chemical	-1	12452237
0.@@	O	-1	12452237
6	O	-1	12452237
mg	O	-1	12452237
x	O	-1	12452237
kg@@	O	-1	12452237
(@@	O	-1	12452237
-1@@	O	-1	12452237
).	O	-1	12452237
M@@	B-Chemical	D009020	12452237
or@@	I-Chemical	-1	12452237
ph@@	I-Chemical	-1	12452237
ine	I-Chemical	-1	12452237
0.@@	O	-1	12452237
1	O	-1	12452237
mg	O	-1	12452237
x	O	-1	12452237
kg@@	O	-1	12452237
(@@	O	-1	12452237
-1@@	O	-1	12452237
)	O	-1	12452237
i@@	O	-1	12452237
v	O	-1	12452237
was	O	-1	12452237
given	O	-1	12452237
for	O	-1	12452237
pre@@	O	-1	12452237
medic@@	O	-1	12452237
ation	O	-1	12452237
and	O	-1	12452237
all	O	-1	12452237
patients	O	-1	12452237
were	O	-1	12452237
monit@@	O	-1	12452237
o@@	O	-1	12452237
red	O	-1	12452237
with	O	-1	12452237
a	O	-1	12452237
non@@	O	-1	12452237
inv@@	O	-1	12452237
a@@	O	-1	12452237
sive	O	-1	12452237
blood	O	-1	12452237
pressure	O	-1	12452237
monit@@	O	-1	12452237
or@@	O	-1	12452237
,	O	-1	12452237
EC@@	O	-1	12452237
G	O	-1	12452237
and	O	-1	12452237
pul@@	O	-1	12452237
se	O	-1	12452237
ox@@	O	-1	12452237
i@@	O	-1	12452237
met@@	O	-1	12452237
r@@	O	-1	12452237
y.	O	-1	12452237
An@@	O	-1	12452237
esthe@@	O	-1	12452237
sia	O	-1	12452237
was	O	-1	12452237
induced	O	-1	12452237
with	O	-1	12452237
5	O	-1	12452237
mg@@	O	-1	12452237
.@@	O	-1	12452237
kg@@	O	-1	12452237
(@@	O	-1	12452237
-1@@	O	-1	12452237
)	O	-1	12452237
th@@	B-Chemical	D013874	12452237
io@@	I-Chemical	-1	12452237
p@@	I-Chemical	-1	12452237
ental	I-Chemical	-1	12452237
i@@	O	-1	12452237
v@@	O	-1	12452237
.	O	-1	12452237
followed	O	-1	12452237
by	O	-1	12452237
suc@@	B-Chemical	D013390	12452237
cin@@	I-Chemical	-1	12452237
ylcholine	I-Chemical	-1	12452237
(@@	O	-1	12452237
Group	O	-1	12452237
P@@	O	-1	12452237
S@@	O	-1	12452237
,	O	-1	12452237
L@@	O	-1	12452237
S)	O	-1	12452237
or	O	-1	12452237
ro@@	B-Chemical	C061870	12452237
cur@@	I-Chemical	-1	12452237
oni@@	I-Chemical	-1	12452237
um	I-Chemical	-1	12452237
(@@	O	-1	12452237
Group	O	-1	12452237
P@@	O	-1	12452237
R@@	O	-1	12452237
)	O	-1	12452237
for	O	-1	12452237
trac@@	O	-1	12452237
he@@	O	-1	12452237
al	O	-1	12452237
int@@	O	-1	12452237
ub@@	O	-1	12452237
ation.	O	-1	12452237
F@@	O	-1	12452237
ol@@	O	-1	12452237
low@@	O	-1	12452237
ing	O	-1	12452237
administration	O	-1	12452237
of	O	-1	12452237
these	O	-1	12452237
agent@@	O	-1	12452237
s,	O	-1	12452237
the	O	-1	12452237
pres@@	O	-1	12452237
ence@@	O	-1	12452237
,	O	-1	12452237
and	O	-1	12452237
de@@	O	-1	12452237
g@@	O	-1	12452237
ree	O	-1	12452237
of	O	-1	12452237
f@@	B-Disease	D005207	12452237
as@@	I-Disease	-1	12452237
c@@	I-Disease	-1	12452237
ic@@	I-Disease	-1	12452237
ulation	I-Disease	-1	12452237
were	O	-1	12452237
assessed	O	-1	12452237
vi@@	O	-1	12452237
su@@	O	-1	12452237
ally	O	-1	12452237
on	O	-1	12452237
a	O	-1	12452237
four	O	-1	12452237
po@@	O	-1	12452237
in@@	O	-1	12452237
t	O	-1	12452237
s@@	O	-1	12452237
cal@@	O	-1	12452237
e	O	-1	12452237
by	O	-1	12452237
one	O	-1	12452237
investig@@	O	-1	12452237
at@@	O	-1	12452237
or	O	-1	12452237
who	O	-1	12452237
was	O	-1	12452237
bl@@	O	-1	12452237
ind@@	O	-1	12452237
ed	O	-1	12452237
to	O	-1	12452237
the	O	-1	12452237
drug	O	-1	12452237
administ@@	O	-1	12452237
e@@	O	-1	12452237
red.	O	-1	12452237
The	O	-1	12452237
blood	O	-1	12452237
pressure	O	-1	12452237
and	O	-1	12452237
heart	O	-1	12452237
rate	O	-1	12452237
of	O	-1	12452237
each	O	-1	12452237
patient	O	-1	12452237
were	O	-1	12452237
monit@@	O	-1	12452237
o@@	O	-1	12452237
red	O	-1	12452237
on	O	-1	12452237
n@@	O	-1	12452237
ine	O	-1	12452237
oc@@	O	-1	12452237
ca@@	O	-1	12452237
sion@@	O	-1	12452237
s.	O	-1	12452237
Tw@@	O	-1	12452237
ent@@	O	-1	12452237
y-@@	O	-1	12452237
four	O	-1	12452237
hours	O	-1	12452237
lat@@	O	-1	12452237
er,	O	-1	12452237
any	O	-1	12452237
my@@	B-Disease	D063806	12452237
al@@	I-Disease	-1	12452237
g@@	I-Disease	-1	12452237
ia	I-Disease	-1	12452237
experienced	O	-1	12452237
was	O	-1	12452237
assessed	O	-1	12452237
ac@@	O	-1	12452237
cor@@	O	-1	12452237
ding	O	-1	12452237
to	O	-1	12452237
a	O	-1	12452237
struct@@	O	-1	12452237
ured	O	-1	12452237
qu@@	O	-1	12452237
es@@	O	-1	12452237
tion@@	O	-1	12452237
a@@	O	-1	12452237
ir@@	O	-1	12452237
e	O	-1	12452237
and	O	-1	12452237
gra@@	O	-1	12452237
ded	O	-1	12452237
by	O	-1	12452237
a	O	-1	12452237
four	O	-1	12452237
po@@	O	-1	12452237
in@@	O	-1	12452237
t	O	-1	12452237
s@@	O	-1	12452237
cal@@	O	-1	12452237
e	O	-1	12452237
by	O	-1	12452237
one	O	-1	12452237
investig@@	O	-1	12452237
at@@	O	-1	12452237
or	O	-1	12452237
bl@@	O	-1	12452237
ind@@	O	-1	12452237
ed	O	-1	12452237
to	O	-1	12452237
the	O	-1	12452237
intra@@	O	-1	12452237
o@@	O	-1	12452237
perative	O	-1	12452237
man@@	O	-1	12452237
ag@@	O	-1	12452237
em@@	O	-1	12452237
ent@@	O	-1	12452237
.	O	-1	12452237
The	O	-1	12452237
results	O	-1	12452237
indicate	O	-1	12452237
that	O	-1	12452237
musc@@	B-Disease	D005207	12452237
le	I-Disease	-1	12452237
f@@	I-Disease	-1	12452237
as@@	I-Disease	-1	12452237
c@@	I-Disease	-1	12452237
ic@@	I-Disease	-1	12452237
ulation	I-Disease	-1	12452237
was	O	-1	12452237
not	O	-1	12452237
found	O	-1	12452237
in	O	-1	12452237
Group	O	-1	12452237
P@@	O	-1	12452237
R	O	-1	12452237
while	O	-1	12452237
the	O	-1	12452237
patients	O	-1	12452237
in	O	-1	12452237
Group	O	-1	12452237
L@@	O	-1	12452237
S	O	-1	12452237
had	O	-1	12452237
a	O	-1	12452237
lower	O	-1	12452237
incidence	O	-1	12452237
of	O	-1	12452237
musc@@	B-Disease	D005207	12452237
le	I-Disease	-1	12452237
f@@	I-Disease	-1	12452237
as@@	I-Disease	-1	12452237
c@@	I-Disease	-1	12452237
ic@@	I-Disease	-1	12452237
ulation	I-Disease	-1	12452237
than	O	-1	12452237
those	O	-1	12452237
in	O	-1	12452237
Group	O	-1	12452237
P@@	O	-1	12452237
S	O	-1	12452237
(p	O	-1	12452237
<	O	-1	12452237
0.00@@	O	-1	12452237
1).	O	-1	12452237
A@@	O	-1	12452237
t	O	-1	12452237
24	O	-1	12452237
h@@	O	-1	12452237
,	O	-1	12452237
the	O	-1	12452237
incidence	O	-1	12452237
of	O	-1	12452237
my@@	B-Disease	D063806	12452237
al@@	I-Disease	-1	12452237
g@@	I-Disease	-1	12452237
ia	I-Disease	-1	12452237
was	O	-1	12452237
higher	O	-1	12452237
in	O	-1	12452237
Group	O	-1	12452237
P@@	O	-1	12452237
S	O	-1	12452237
than	O	-1	12452237
in	O	-1	12452237
Group	O	-1	12452237
L@@	O	-1	12452237
S	O	-1	12452237
and	O	-1	12452237
P@@	O	-1	12452237
R	O	-1	12452237
(p	O	-1	12452237
<	O	-1	12452237
0.05@@	O	-1	12452237
).	O	-1	12452237
A	O	-1	12452237
correl@@	O	-1	12452237
ation	O	-1	12452237
was	O	-1	12452237
not	O	-1	12452237
found	O	-1	12452237
between	O	-1	12452237
the	O	-1	12452237
incidence	O	-1	12452237
of	O	-1	12452237
my@@	B-Disease	D063806	12452237
al@@	I-Disease	-1	12452237
g@@	I-Disease	-1	12452237
ia	I-Disease	-1	12452237
and	O	-1	12452237
the	O	-1	12452237
occur@@	O	-1	12452237
rence	O	-1	12452237
of	O	-1	12452237
musc@@	B-Disease	D005207	12452237
le	I-Disease	-1	12452237
f@@	I-Disease	-1	12452237
as@@	I-Disease	-1	12452237
c@@	I-Disease	-1	12452237
ic@@	I-Disease	-1	12452237
ulation	I-Disease	-1	12452237
.	O	-1	12452237
The	O	-1	12452237
changes	O	-1	12452237
in	O	-1	12452237
systolic	O	-1	12452237
and	O	-1	12452237
di@@	O	-1	12452237
ast@@	O	-1	12452237
olic	O	-1	12452237
blood	O	-1	12452237
pressure	O	-1	12452237
and	O	-1	12452237
heart	O	-1	12452237
rate	O	-1	12452237
were	O	-1	12452237
not	O	-1	12452237
significant	O	-1	12452237
among	O	-1	12452237
the	O	-1	12452237
three	O	-1	12452237
groups.	O	-1	12452237
In	O	-1	12452237
concl@@	O	-1	12452237
u@@	O	-1	12452237
sion,	O	-1	12452237
wh@@	O	-1	12452237
ere	O	-1	12452237
suc@@	B-Chemical	D013390	12452237
cin@@	I-Chemical	-1	12452237
ylcholine	I-Chemical	-1	12452237
is	O	-1	12452237
use@@	O	-1	12452237
d,	O	-1	12452237
lidocaine	B-Chemical	D008012	12452237
is	O	-1	12452237
pro@@	O	-1	12452237
ven	O	-1	12452237
to	O	-1	12452237
be	O	-1	12452237
the	O	-1	12452237
use@@	O	-1	12452237
ful	O	-1	12452237
pretreatment	O	-1	12452237
agent	O	-1	12452237
for	O	-1	12452237
the	O	-1	12452237
reduction	O	-1	12452237
of	O	-1	12452237
postoperative	B-Disease	D010149	12452237
my@@	I-Disease	-1	12452237
al@@	I-Disease	-1	12452237
g@@	I-Disease	-1	12452237
ia	I-Disease	-1	12452237
.	O	-1	12452237

O@@	O	-1	9564988
pen@@	O	-1	9564988
-@@	O	-1	9564988
l@@	O	-1	9564988
a@@	O	-1	9564988
be@@	O	-1	9564988
l	O	-1	9564988
assess@@	O	-1	9564988
ment	O	-1	9564988
of	O	-1	9564988
lev@@	B-Chemical	D064704	9564988
of@@	I-Chemical	-1	9564988
lo@@	I-Chemical	-1	9564988
x@@	I-Chemical	-1	9564988
ac@@	I-Chemical	-1	9564988
in	I-Chemical	-1	9564988
for	O	-1	9564988
the	O	-1	9564988
treatment	O	-1	9564988
of	O	-1	9564988
acute	O	-1	9564988
bac@@	O	-1	9564988
ter@@	O	-1	9564988
ial	O	-1	9564988
s@@	B-Disease	D012852	9564988
in@@	I-Disease	-1	9564988
u@@	I-Disease	-1	9564988
si@@	I-Disease	-1	9564988
tis	I-Disease	-1	9564988
in	O	-1	9564988
ad@@	O	-1	9564988
ult@@	O	-1	9564988
s.	O	-1	9564988
P@@	O	-1	9564988
U@@	O	-1	9564988
R@@	O	-1	9564988
P@@	O	-1	9564988
O@@	O	-1	9564988
S@@	O	-1	9564988
E:	O	-1	9564988
To	O	-1	9564988
evalu@@	O	-1	9564988
ate	O	-1	9564988
the	O	-1	9564988
efficacy	O	-1	9564988
and	O	-1	9564988
safety	O	-1	9564988
of	O	-1	9564988
lev@@	B-Chemical	D064704	9564988
of@@	I-Chemical	-1	9564988
lo@@	I-Chemical	-1	9564988
x@@	I-Chemical	-1	9564988
ac@@	I-Chemical	-1	9564988
in	I-Chemical	-1	9564988
(5@@	O	-1	9564988
00	O	-1	9564988
mg	O	-1	9564988
or@@	O	-1	9564988
ally	O	-1	9564988
on@@	O	-1	9564988
ce	O	-1	9564988
daily	O	-1	9564988
for	O	-1	9564988
10	O	-1	9564988
to	O	-1	9564988
14	O	-1	9564988
da@@	O	-1	9564988
ys@@	O	-1	9564988
)	O	-1	9564988
in	O	-1	9564988
treat@@	O	-1	9564988
ing	O	-1	9564988
ad@@	O	-1	9564988
ult	O	-1	9564988
out@@	O	-1	9564988
patients	O	-1	9564988
with	O	-1	9564988
acute	O	-1	9564988
bac@@	O	-1	9564988
ter@@	O	-1	9564988
ial	O	-1	9564988
s@@	B-Disease	D012852	9564988
in@@	I-Disease	-1	9564988
u@@	I-Disease	-1	9564988
si@@	I-Disease	-1	9564988
tis	I-Disease	-1	9564988
.	O	-1	9564988
PA@@	O	-1	9564988
TI@@	O	-1	9564988
E@@	O	-1	9564988
N@@	O	-1	9564988
T@@	O	-1	9564988
S	O	-1	9564988
AN@@	O	-1	9564988
D	O	-1	9564988
METHODS:	O	-1	9564988
A	O	-1	9564988
total	O	-1	9564988
of	O	-1	9564988
3@@	O	-1	9564988
2@@	O	-1	9564988
9	O	-1	9564988
patients	O	-1	9564988
en@@	O	-1	9564988
ro@@	O	-1	9564988
lled	O	-1	9564988
in	O	-1	9564988
the	O	-1	9564988
study	O	-1	9564988
at	O	-1	9564988
24	O	-1	9564988
c@@	O	-1	9564988
ent@@	O	-1	9564988
ers.	O	-1	9564988
All	O	-1	9564988
patients	O	-1	9564988
had	O	-1	9564988
a	O	-1	9564988
pre-@@	O	-1	9564988
therapy	O	-1	9564988
G@@	O	-1	9564988
ram@@	O	-1	9564988
's	O	-1	9564988
st@@	O	-1	9564988
ain	O	-1	9564988
and	O	-1	9564988
c@@	O	-1	9564988
ult@@	O	-1	9564988
ure	O	-1	9564988
of	O	-1	9564988
s@@	O	-1	9564988
in@@	O	-1	9564988
us	O	-1	9564988
ex@@	O	-1	9564988
ud@@	O	-1	9564988
ate	O	-1	9564988
obtained	O	-1	9564988
by	O	-1	9564988
ant@@	O	-1	9564988
ral	O	-1	9564988
p@@	O	-1	9564988
unc@@	O	-1	9564988
t@@	O	-1	9564988
ure	O	-1	9564988
or	O	-1	9564988
n@@	O	-1	9564988
as@@	O	-1	9564988
al	O	-1	9564988
en@@	O	-1	9564988
dos@@	O	-1	9564988
co@@	O	-1	9564988
p@@	O	-1	9564988
y.	O	-1	9564988
Clin@@	O	-1	9564988
ical	O	-1	9564988
response	O	-1	9564988
was	O	-1	9564988
assessed	O	-1	9564988
on	O	-1	9564988
the	O	-1	9564988
b@@	O	-1	9564988
asis	O	-1	9564988
of	O	-1	9564988
signs	O	-1	9564988
and	O	-1	9564988
symptoms	O	-1	9564988
and	O	-1	9564988
s@@	O	-1	9564988
in@@	O	-1	9564988
us	O	-1	9564988
radi@@	O	-1	9564988
o@@	O	-1	9564988
gra@@	O	-1	9564988
p@@	O	-1	9564988
h	O	-1	9564988
or	O	-1	9564988
comp@@	O	-1	9564988
ut@@	O	-1	9564988
ed	O	-1	9564988
to@@	O	-1	9564988
mo@@	O	-1	9564988
graph@@	O	-1	9564988
y	O	-1	9564988
result@@	O	-1	9564988
s.	O	-1	9564988
M@@	O	-1	9564988
ic@@	O	-1	9564988
ro@@	O	-1	9564988
bio@@	O	-1	9564988
log@@	O	-1	9564988
ic	O	-1	9564988
c@@	O	-1	9564988
ure	O	-1	9564988
rat@@	O	-1	9564988
es	O	-1	9564988
were	O	-1	9564988
determined	O	-1	9564988
on	O	-1	9564988
the	O	-1	9564988
b@@	O	-1	9564988
asis	O	-1	9564988
of	O	-1	9564988
pres@@	O	-1	9564988
um@@	O	-1	9564988
ed	O	-1	9564988
plus	O	-1	9564988
doc@@	O	-1	9564988
um@@	O	-1	9564988
ent@@	O	-1	9564988
ed	O	-1	9564988
er@@	O	-1	9564988
ad@@	O	-1	9564988
ic@@	O	-1	9564988
ation	O	-1	9564988
of	O	-1	9564988
the	O	-1	9564988
pre-@@	O	-1	9564988
therapy	O	-1	9564988
path@@	O	-1	9564988
o@@	O	-1	9564988
gen@@	O	-1	9564988
(@@	O	-1	9564988
s@@	O	-1	9564988
).	O	-1	9564988
RESULTS:	O	-1	9564988
The	O	-1	9564988
most	O	-1	9564988
common	O	-1	9564988
path@@	O	-1	9564988
o@@	O	-1	9564988
gen@@	O	-1	9564988
s	O	-1	9564988
were	O	-1	9564988
H@@	O	-1	9564988
a@@	O	-1	9564988
em@@	O	-1	9564988
oph@@	O	-1	9564988
il@@	O	-1	9564988
us	O	-1	9564988
influ@@	O	-1	9564988
enz@@	O	-1	9564988
a@@	O	-1	9564988
e,	O	-1	9564988
S@@	O	-1	9564988
tre@@	O	-1	9564988
pto@@	O	-1	9564988
co@@	O	-1	9564988
c@@	O	-1	9564988
c@@	O	-1	9564988
us	O	-1	9564988
p@@	O	-1	9564988
ne@@	O	-1	9564988
um@@	O	-1	9564988
on@@	O	-1	9564988
ia@@	O	-1	9564988
e,	O	-1	9564988
S@@	O	-1	9564988
t@@	O	-1	9564988
a@@	O	-1	9564988
ph@@	O	-1	9564988
y@@	O	-1	9564988
lo@@	O	-1	9564988
co@@	O	-1	9564988
c@@	O	-1	9564988
c@@	O	-1	9564988
us	O	-1	9564988
a@@	O	-1	9564988
ure@@	O	-1	9564988
us,	O	-1	9564988
and	O	-1	9564988
M@@	O	-1	9564988
or@@	O	-1	9564988
ax@@	O	-1	9564988
ell@@	O	-1	9564988
a	O	-1	9564988
cat@@	O	-1	9564988
ar@@	O	-1	9564988
rh@@	O	-1	9564988
al@@	O	-1	9564988
i@@	O	-1	9564988
s.	O	-1	9564988
Of	O	-1	9564988
3@@	O	-1	9564988
00	O	-1	9564988
clin@@	O	-1	9564988
ically	O	-1	9564988
evalu@@	O	-1	9564988
able	O	-1	9564988
patients,	O	-1	9564988
17@@	O	-1	9564988
5	O	-1	9564988
(5@@	O	-1	9564988
8@@	O	-1	9564988
%)	O	-1	9564988
were	O	-1	9564988
c@@	O	-1	9564988
ured	O	-1	9564988
and	O	-1	9564988
9@@	O	-1	9564988
0	O	-1	9564988
(3@@	O	-1	9564988
0@@	O	-1	9564988
%)	O	-1	9564988
were	O	-1	9564988
improved	O	-1	9564988
at	O	-1	9564988
the	O	-1	9564988
post@@	O	-1	9564988
-@@	O	-1	9564988
therapy	O	-1	9564988
evalu@@	O	-1	9564988
ation,	O	-1	9564988
result@@	O	-1	9564988
ing	O	-1	9564988
in	O	-1	9564988
a	O	-1	9564988
clinical	O	-1	9564988
suc@@	O	-1	9564988
cess	O	-1	9564988
rate	O	-1	9564988
of	O	-1	9564988
8@@	O	-1	9564988
8@@	O	-1	9564988
%.	O	-1	9564988
Th@@	O	-1	9564988
ir@@	O	-1	9564988
ty-@@	O	-1	9564988
five	O	-1	9564988
patients	O	-1	9564988
(1@@	O	-1	9564988
2@@	O	-1	9564988
%)	O	-1	9564988
clin@@	O	-1	9564988
ically	O	-1	9564988
fail@@	O	-1	9564988
ed	O	-1	9564988
treatment.	O	-1	9564988
The	O	-1	9564988
micro@@	O	-1	9564988
bio@@	O	-1	9564988
log@@	O	-1	9564988
ic	O	-1	9564988
er@@	O	-1	9564988
ad@@	O	-1	9564988
ic@@	O	-1	9564988
ation	O	-1	9564988
rate	O	-1	9564988
(@@	O	-1	9564988
pres@@	O	-1	9564988
um@@	O	-1	9564988
ed	O	-1	9564988
plus	O	-1	9564988
doc@@	O	-1	9564988
um@@	O	-1	9564988
ent@@	O	-1	9564988
ed@@	O	-1	9564988
)	O	-1	9564988
among	O	-1	9564988
13@@	O	-1	9564988
8	O	-1	9564988
micro@@	O	-1	9564988
bio@@	O	-1	9564988
log@@	O	-1	9564988
ically	O	-1	9564988
evalu@@	O	-1	9564988
able	O	-1	9564988
patients	O	-1	9564988
was	O	-1	9564988
9@@	O	-1	9564988
2@@	O	-1	9564988
%.	O	-1	9564988
M@@	O	-1	9564988
ic@@	O	-1	9564988
ro@@	O	-1	9564988
bio@@	O	-1	9564988
log@@	O	-1	9564988
ic	O	-1	9564988
er@@	O	-1	9564988
ad@@	O	-1	9564988
ic@@	O	-1	9564988
ation	O	-1	9564988
rat@@	O	-1	9564988
es	O	-1	9564988
(@@	O	-1	9564988
pres@@	O	-1	9564988
um@@	O	-1	9564988
ed	O	-1	9564988
plus	O	-1	9564988
doc@@	O	-1	9564988
um@@	O	-1	9564988
ent@@	O	-1	9564988
ed@@	O	-1	9564988
)	O	-1	9564988
of	O	-1	9564988
the	O	-1	9564988
most	O	-1	9564988
common	O	-1	9564988
path@@	O	-1	9564988
o@@	O	-1	9564988
gen@@	O	-1	9564988
s	O	-1	9564988
rang@@	O	-1	9564988
ed	O	-1	9564988
from	O	-1	9564988
9@@	O	-1	9564988
3@@	O	-1	9564988
%	O	-1	9564988
(@@	O	-1	9564988
M@@	O	-1	9564988
.	O	-1	9564988
cat@@	O	-1	9564988
ar@@	O	-1	9564988
rh@@	O	-1	9564988
al@@	O	-1	9564988
is@@	O	-1	9564988
)	O	-1	9564988
to	O	-1	9564988
10@@	O	-1	9564988
0%	O	-1	9564988
(S@@	O	-1	9564988
.	O	-1	9564988
p@@	O	-1	9564988
ne@@	O	-1	9564988
um@@	O	-1	9564988
on@@	O	-1	9564988
ia@@	O	-1	9564988
e@@	O	-1	9564988
)	O	-1	9564988
at	O	-1	9564988
the	O	-1	9564988
post@@	O	-1	9564988
-@@	O	-1	9564988
therapy	O	-1	9564988
v@@	O	-1	9564988
is@@	O	-1	9564988
it@@	O	-1	9564988
.	O	-1	9564988
All	O	-1	9564988
but	O	-1	9564988
one	O	-1	9564988
of	O	-1	9564988
the	O	-1	9564988
2@@	O	-1	9564988
6@@	O	-1	9564988
5	O	-1	9564988
patients	O	-1	9564988
who	O	-1	9564988
were	O	-1	9564988
c@@	O	-1	9564988
ured	O	-1	9564988
or	O	-1	9564988
improved	O	-1	9564988
at	O	-1	9564988
post@@	O	-1	9564988
-@@	O	-1	9564988
therapy	O	-1	9564988
retur@@	O	-1	9564988
n@@	O	-1	9564988
ed	O	-1	9564988
for	O	-1	9564988
a	O	-1	9564988
long-term	O	-1	9564988
follow-up	O	-1	9564988
v@@	O	-1	9564988
is@@	O	-1	9564988
it@@	O	-1	9564988
;	O	-1	9564988
2@@	O	-1	9564988
4@@	O	-1	9564988
3	O	-1	9564988
(@@	O	-1	9564988
9@@	O	-1	9564988
2@@	O	-1	9564988
%)	O	-1	9564988
remained	O	-1	9564988
well	O	-1	9564988
4	O	-1	9564988
to	O	-1	9564988
6	O	-1	9564988
weeks	O	-1	9564988
after	O	-1	9564988
therap@@	O	-1	9564988
y@@	O	-1	9564988
;	O	-1	9564988
and	O	-1	9564988
21	O	-1	9564988
(@@	O	-1	9564988
8@@	O	-1	9564988
%)	O	-1	9564988
had	O	-1	9564988
a	O	-1	9564988
rel@@	O	-1	9564988
ap@@	O	-1	9564988
se	O	-1	9564988
of	O	-1	9564988
symptom@@	O	-1	9564988
s.	O	-1	9564988
Ad@@	O	-1	9564988
verse	O	-1	9564988
events	O	-1	9564988
considered	O	-1	9564988
to	O	-1	9564988
be	O	-1	9564988
related	O	-1	9564988
to	O	-1	9564988
lev@@	B-Chemical	D064704	9564988
of@@	I-Chemical	-1	9564988
lo@@	I-Chemical	-1	9564988
x@@	I-Chemical	-1	9564988
ac@@	I-Chemical	-1	9564988
in	I-Chemical	-1	9564988
administration	O	-1	9564988
were	O	-1	9564988
reported	O	-1	9564988
by	O	-1	9564988
2@@	O	-1	9564988
9	O	-1	9564988
patients	O	-1	9564988
(@@	O	-1	9564988
9@@	O	-1	9564988
%).	O	-1	9564988
The	O	-1	9564988
most	O	-1	9564988
common	O	-1	9564988
drug@@	O	-1	9564988
-@@	O	-1	9564988
related	O	-1	9564988
adverse	O	-1	9564988
events	O	-1	9564988
were	O	-1	9564988
di@@	B-Disease	D003967	9564988
ar@@	I-Disease	-1	9564988
r@@	I-Disease	-1	9564988
he@@	I-Disease	-1	9564988
a	I-Disease	-1	9564988
,	O	-1	9564988
f@@	B-Disease	D005414	9564988
lat@@	I-Disease	-1	9564988
ul@@	I-Disease	-1	9564988
ence	I-Disease	-1	9564988
,	O	-1	9564988
and	O	-1	9564988
nausea	B-Disease	D009325	9564988
;	O	-1	9564988
most	O	-1	9564988
adverse	O	-1	9564988
events	O	-1	9564988
were	O	-1	9564988
mil@@	O	-1	9564988
d	O	-1	9564988
to	O	-1	9564988
moder@@	O	-1	9564988
ate	O	-1	9564988
in	O	-1	9564988
sever@@	O	-1	9564988
ity.	O	-1	9564988
CONCLUSION:	O	-1	9564988
The	O	-1	9564988
results	O	-1	9564988
of	O	-1	9564988
this	O	-1	9564988
study	O	-1	9564988
indicate	O	-1	9564988
that	O	-1	9564988
lev@@	B-Chemical	D064704	9564988
of@@	I-Chemical	-1	9564988
lo@@	I-Chemical	-1	9564988
x@@	I-Chemical	-1	9564988
ac@@	I-Chemical	-1	9564988
in	I-Chemical	-1	9564988
5@@	O	-1	9564988
00	O	-1	9564988
mg	O	-1	9564988
on@@	O	-1	9564988
ce	O	-1	9564988
daily	O	-1	9564988
is	O	-1	9564988
an	O	-1	9564988
effective	O	-1	9564988
and	O	-1	9564988
saf@@	O	-1	9564988
e	O	-1	9564988
treatment	O	-1	9564988
for	O	-1	9564988
acute	O	-1	9564988
bac@@	O	-1	9564988
ter@@	O	-1	9564988
ial	O	-1	9564988
s@@	B-Disease	D012852	9564988
in@@	I-Disease	-1	9564988
u@@	I-Disease	-1	9564988
si@@	I-Disease	-1	9564988
tis	I-Disease	-1	9564988
.	O	-1	9564988

Clin@@	O	-1	7596955
ical	O	-1	7596955
evalu@@	O	-1	7596955
ation	O	-1	7596955
on	O	-1	7596955
combined	O	-1	7596955
administration	O	-1	7596955
of	O	-1	7596955
oral	O	-1	7596955
pro@@	B-Chemical	D011464	7596955
st@@	I-Chemical	-1	7596955
ac@@	I-Chemical	-1	7596955
y@@	I-Chemical	-1	7596955
cl@@	I-Chemical	-1	7596955
in	I-Chemical	-1	7596955
an@@	O	-1	7596955
alo@@	O	-1	7596955
gu@@	O	-1	7596955
e	O	-1	7596955
b@@	B-Chemical	C048081	7596955
er@@	I-Chemical	-1	7596955
a@@	I-Chemical	-1	7596955
pro@@	I-Chemical	-1	7596955
st	I-Chemical	-1	7596955
and	O	-1	7596955
phosph@@	O	-1	7596955
odi@@	O	-1	7596955
est@@	O	-1	7596955
er@@	O	-1	7596955
ase	O	-1	7596955
inhibitor	O	-1	7596955
ci@@	B-Chemical	C045645	7596955
lo@@	I-Chemical	-1	7596955
st@@	I-Chemical	-1	7596955
az@@	I-Chemical	-1	7596955
ol	I-Chemical	-1	7596955
.	O	-1	7596955
A@@	O	-1	7596955
mon@@	O	-1	7596955
g	O	-1	7596955
various	O	-1	7596955
oral	O	-1	7596955
anti@@	O	-1	7596955
platele@@	O	-1	7596955
t@@	O	-1	7596955
s,	O	-1	7596955
a	O	-1	7596955
combination	O	-1	7596955
of	O	-1	7596955
a	O	-1	7596955
novel	O	-1	7596955
pro@@	B-Chemical	D011464	7596955
st@@	I-Chemical	-1	7596955
ac@@	I-Chemical	-1	7596955
y@@	I-Chemical	-1	7596955
cl@@	I-Chemical	-1	7596955
in	I-Chemical	-1	7596955
an@@	O	-1	7596955
alo@@	O	-1	7596955
gu@@	O	-1	7596955
e	O	-1	7596955
b@@	B-Chemical	C048081	7596955
er@@	I-Chemical	-1	7596955
a@@	I-Chemical	-1	7596955
pro@@	I-Chemical	-1	7596955
st	I-Chemical	-1	7596955
(	O	-1	7596955
B@@	B-Chemical	C048081	7596955
P@@	I-Chemical	-1	7596955
T	I-Chemical	-1	7596955
)	O	-1	7596955
and	O	-1	7596955
a	O	-1	7596955
pot@@	O	-1	7596955
ent	O	-1	7596955
phosph@@	O	-1	7596955
odi@@	O	-1	7596955
est@@	O	-1	7596955
er@@	O	-1	7596955
ase	O	-1	7596955
inhibitor	O	-1	7596955
ci@@	B-Chemical	C045645	7596955
lo@@	I-Chemical	-1	7596955
st@@	I-Chemical	-1	7596955
az@@	I-Chemical	-1	7596955
ol	I-Chemical	-1	7596955
(	O	-1	7596955
CL@@	B-Chemical	C045645	7596955
Z	I-Chemical	-1	7596955
)	O	-1	7596955
may	O	-1	7596955
result	O	-1	7596955
in	O	-1	7596955
un@@	O	-1	7596955
to@@	O	-1	7596955
war@@	O	-1	7596955
d	O	-1	7596955
clinical	O	-1	7596955
effects	O	-1	7596955
due	O	-1	7596955
to	O	-1	7596955
possible	O	-1	7596955
syn@@	O	-1	7596955
erg@@	O	-1	7596955
istic	O	-1	7596955
elev@@	O	-1	7596955
ation	O	-1	7596955
of	O	-1	7596955
intrac@@	O	-1	7596955
ell@@	O	-1	7596955
ular	O	-1	7596955
c@@	B-Chemical	D000242	7596955
AM@@	I-Chemical	-1	7596955
P	I-Chemical	-1	7596955
(	O	-1	7596955
cy@@	B-Chemical	D000242	7596955
cl@@	I-Chemical	-1	7596955
ic	I-Chemical	-1	7596955
aden@@	I-Chemical	-1	7596955
os@@	I-Chemical	-1	7596955
ine	I-Chemical	-1	7596955
3@@	I-Chemical	-1	7596955
'@@	I-Chemical	-1	7596955
,@@	I-Chemical	-1	7596955
5@@	I-Chemical	-1	7596955
'@@	I-Chemical	-1	7596955
-@@	I-Chemical	-1	7596955
mon@@	I-Chemical	-1	7596955
oph@@	I-Chemical	-1	7596955
osph@@	I-Chemical	-1	7596955
ate	I-Chemical	-1	7596955
).	O	-1	7596955
The@@	O	-1	7596955
reb@@	O	-1	7596955
y,	O	-1	7596955
a	O	-1	7596955
clinical	O	-1	7596955
study	O	-1	7596955
of	O	-1	7596955
the	O	-1	7596955
combined	O	-1	7596955
administration	O	-1	7596955
of	O	-1	7596955
the	O	-1	7596955
two	O	-1	7596955
agents	O	-1	7596955
was	O	-1	7596955
at@@	O	-1	7596955
tem@@	O	-1	7596955
p@@	O	-1	7596955
ted.	O	-1	7596955
T@@	O	-1	7596955
we@@	O	-1	7596955
l@@	O	-1	7596955
ve	O	-1	7596955
healthy	O	-1	7596955
vol@@	O	-1	7596955
un@@	O	-1	7596955
te@@	O	-1	7596955
ers	O	-1	7596955
were	O	-1	7596955
as@@	O	-1	7596955
signed	O	-1	7596955
to	O	-1	7596955
tak@@	O	-1	7596955
e	O	-1	7596955
B@@	B-Chemical	C048081	7596955
P@@	I-Chemical	-1	7596955
T	I-Chemical	-1	7596955
/	O	-1	7596955
CL@@	B-Chemical	C045645	7596955
Z	I-Chemical	-1	7596955
in	O	-1	7596955
the	O	-1	7596955
following	O	-1	7596955
sch@@	O	-1	7596955
ed@@	O	-1	7596955
ul@@	O	-1	7596955
e@@	O	-1	7596955
;	O	-1	7596955
B@@	B-Chemical	C048081	7596955
P@@	I-Chemical	-1	7596955
T	I-Chemical	-1	7596955
:	O	-1	7596955
40	O	-1	7596955
microgram@@	O	-1	7596955
s	O	-1	7596955
at	O	-1	7596955
day	O	-1	7596955
1	O	-1	7596955
and	O	-1	7596955
1@@	O	-1	7596955
20	O	-1	7596955
microgram@@	O	-1	7596955
s	O	-1	7596955
t@@	O	-1	7596955
.@@	O	-1	7596955
i.@@	O	-1	7596955
d.	O	-1	7596955
from	O	-1	7596955
day	O	-1	7596955
7	O	-1	7596955
to	O	-1	7596955
14@@	O	-1	7596955
,	O	-1	7596955
CL@@	B-Chemical	C045645	7596955
Z	I-Chemical	-1	7596955
:	O	-1	7596955
2@@	O	-1	7596955
00	O	-1	7596955
mg	O	-1	7596955
t@@	O	-1	7596955
.@@	O	-1	7596955
i.@@	O	-1	7596955
d.	O	-1	7596955
from	O	-1	7596955
day	O	-1	7596955
3	O	-1	7596955
to	O	-1	7596955
14@@	O	-1	7596955
.	O	-1	7596955
A@@	O	-1	7596955
t	O	-1	7596955
various	O	-1	7596955
time	O	-1	7596955
inter@@	O	-1	7596955
val@@	O	-1	7596955
s,	O	-1	7596955
physi@@	O	-1	7596955
c@@	O	-1	7596955
al	O	-1	7596955
examin@@	O	-1	7596955
ation	O	-1	7596955
and	O	-1	7596955
blood	O	-1	7596955
coll@@	O	-1	7596955
ection	O	-1	7596955
for	O	-1	7596955
e@@	O	-1	7596955
x	O	-1	7596955
viv@@	O	-1	7596955
o	O	-1	7596955
platele@@	B-Disease	D001791	7596955
t	I-Disease	-1	7596955
ag@@	I-Disease	-1	7596955
g@@	I-Disease	-1	7596955
reg@@	I-Disease	-1	7596955
ation	I-Disease	-1	7596955
and	O	-1	7596955
determin@@	O	-1	7596955
ation	O	-1	7596955
of	O	-1	7596955
intra@@	O	-1	7596955
platele@@	O	-1	7596955
t	O	-1	7596955
c@@	B-Chemical	D000242	7596955
AM@@	I-Chemical	-1	7596955
P	I-Chemical	-1	7596955
were	O	-1	7596955
per@@	O	-1	7596955
for@@	O	-1	7596955
me@@	O	-1	7596955
d.	O	-1	7596955
Th@@	O	-1	7596955
rou@@	O	-1	7596955
gh@@	O	-1	7596955
out	O	-1	7596955
the	O	-1	7596955
observ@@	O	-1	7596955
ation	O	-1	7596955
perio@@	O	-1	7596955
d,	O	-1	7596955
no	O	-1	7596955
significant	O	-1	7596955
al@@	O	-1	7596955
ter@@	O	-1	7596955
ation	O	-1	7596955
in	O	-1	7596955
vit@@	O	-1	7596955
al	O	-1	7596955
signs	O	-1	7596955
was	O	-1	7596955
obser@@	O	-1	7596955
ved.	O	-1	7596955
S@@	O	-1	7596955
even	O	-1	7596955
out	O	-1	7596955
of	O	-1	7596955
12	O	-1	7596955
subjects	O	-1	7596955
experienced	O	-1	7596955
headac@@	B-Disease	D006261	7596955
he	I-Disease	-1	7596955
of	O	-1	7596955
a	O	-1	7596955
sh@@	O	-1	7596955
ort	O	-1	7596955
duration	O	-1	7596955
ac@@	O	-1	7596955
comp@@	O	-1	7596955
an@@	O	-1	7596955
y@@	O	-1	7596955
ing	O	-1	7596955
fac@@	B-Disease	D005483	7596955
ial	I-Disease	-1	7596955
f@@	I-Disease	-1	7596955
l@@	I-Disease	-1	7596955
us@@	I-Disease	-1	7596955
h	I-Disease	-1	7596955
in	O	-1	7596955
one	O	-1	7596955
and	O	-1	7596955
nausea	B-Disease	D009325	7596955
in	O	-1	7596955
one,	O	-1	7596955
es@@	O	-1	7596955
p@@	O	-1	7596955
ec@@	O	-1	7596955
i@@	O	-1	7596955
ally	O	-1	7596955
after	O	-1	7596955
ing@@	O	-1	7596955
es@@	O	-1	7596955
tion	O	-1	7596955
of	O	-1	7596955
CL@@	B-Chemical	C045645	7596955
Z	I-Chemical	-1	7596955
.	O	-1	7596955
All	O	-1	7596955
of	O	-1	7596955
these	O	-1	7596955
symptom@@	O	-1	7596955
s,	O	-1	7596955
prob@@	O	-1	7596955
ably	O	-1	7596955
caused	O	-1	7596955
by	O	-1	7596955
the	O	-1	7596955
vas@@	O	-1	7596955
odi@@	O	-1	7596955
l@@	O	-1	7596955
ating	O	-1	7596955
effect	O	-1	7596955
of	O	-1	7596955
the	O	-1	7596955
two	O	-1	7596955
agent@@	O	-1	7596955
s,	O	-1	7596955
were	O	-1	7596955
of	O	-1	7596955
mil@@	O	-1	7596955
d	O	-1	7596955
de@@	O	-1	7596955
g@@	O	-1	7596955
ree	O	-1	7596955
and	O	-1	7596955
no	O	-1	7596955
spec@@	O	-1	7596955
ial	O	-1	7596955
treatment	O	-1	7596955
was	O	-1	7596955
requ@@	O	-1	7596955
i@@	O	-1	7596955
red.	O	-1	7596955
In@@	O	-1	7596955
tra@@	O	-1	7596955
platele@@	O	-1	7596955
t	O	-1	7596955
c@@	B-Chemical	D000242	7596955
AM@@	I-Chemical	-1	7596955
P	I-Chemical	-1	7596955
cont@@	O	-1	7596955
ent	O	-1	7596955
was	O	-1	7596955
gra@@	O	-1	7596955
du@@	O	-1	7596955
ally	O	-1	7596955
but	O	-1	7596955
significantly	O	-1	7596955
increased	O	-1	7596955
to	O	-1	7596955
9.@@	O	-1	7596955
8@@	O	-1	7596955
4	O	-1	7596955
+/-	O	-1	7596955
4.@@	O	-1	7596955
5@@	O	-1	7596955
9	O	-1	7596955
p@@	O	-1	7596955
mo@@	O	-1	7596955
l	O	-1	7596955
per	O	-1	7596955
10@@	O	-1	7596955
(@@	O	-1	7596955
9@@	O	-1	7596955
)	O	-1	7596955
platele@@	O	-1	7596955
ts	O	-1	7596955
at	O	-1	7596955
day	O	-1	7596955
14	O	-1	7596955
in	O	-1	7596955
compar@@	O	-1	7596955
ison	O	-1	7596955
with	O	-1	7596955
the	O	-1	7596955
initial	O	-1	7596955
valu@@	O	-1	7596955
e	O	-1	7596955
(@@	O	-1	7596955
6.@@	O	-1	7596955
8@@	O	-1	7596955
7	O	-1	7596955
+/-	O	-1	7596955
2.@@	O	-1	7596955
25	O	-1	7596955
p@@	O	-1	7596955
mol@@	O	-1	7596955
).	O	-1	7596955
The	O	-1	7596955
platele@@	O	-1	7596955
t	O	-1	7596955
ag@@	O	-1	7596955
g@@	O	-1	7596955
reg@@	O	-1	7596955
ability	O	-1	7596955
was	O	-1	7596955
significantly	O	-1	7596955
sup@@	O	-1	7596955
press@@	O	-1	7596955
ed	O	-1	7596955
at	O	-1	7596955
various	O	-1	7596955
time	O	-1	7596955
interv@@	O	-1	7596955
als	O	-1	7596955
but	O	-1	7596955
no	O	-1	7596955
addi@@	O	-1	7596955
tive	O	-1	7596955
or	O	-1	7596955
syn@@	O	-1	7596955
erg@@	O	-1	7596955
istic	O	-1	7596955
inhibit@@	O	-1	7596955
ory	O	-1	7596955
effect	O	-1	7596955
by	O	-1	7596955
the	O	-1	7596955
combined	O	-1	7596955
administration	O	-1	7596955
was	O	-1	7596955
not@@	O	-1	7596955
ed.	O	-1	7596955
In	O	-1	7596955
concl@@	O	-1	7596955
u@@	O	-1	7596955
sion,	O	-1	7596955
the	O	-1	7596955
combined	O	-1	7596955
administration	O	-1	7596955
of	O	-1	7596955
B@@	B-Chemical	C048081	7596955
P@@	I-Chemical	-1	7596955
T	I-Chemical	-1	7596955
/	O	-1	7596955
CL@@	B-Chemical	C045645	7596955
Z	I-Chemical	-1	7596955
is	O	-1	7596955
saf@@	O	-1	7596955
e	O	-1	7596955
at	O	-1	7596955
doses	O	-1	7596955
used	O	-1	7596955
in	O	-1	7596955
the	O	-1	7596955
study,	O	-1	7596955
though	O	-1	7596955
the	O	-1	7596955
ben@@	O	-1	7596955
e@@	O	-1	7596955
fic@@	O	-1	7596955
ial	O	-1	7596955
clinical	O	-1	7596955
effect	O	-1	7596955
of	O	-1	7596955
the	O	-1	7596955
combined	O	-1	7596955
administration	O	-1	7596955
has	O	-1	7596955
y@@	O	-1	7596955
et	O	-1	7596955
to	O	-1	7596955
be	O	-1	7596955
el@@	O	-1	7596955
uc@@	O	-1	7596955
id@@	O	-1	7596955
ated.	O	-1	7596955

G@@	O	-1	17965424
ast@@	O	-1	17965424
ro@@	O	-1	17965424
in@@	O	-1	17965424
test@@	O	-1	17965424
inal	O	-1	17965424
toler@@	O	-1	17965424
ability	O	-1	17965424
of	O	-1	17965424
et@@	B-Chemical	C422649	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
in	O	-1	17965424
r@@	B-Disease	D001172	17965424
he@@	I-Disease	-1	17965424
um@@	I-Disease	-1	17965424
at@@	I-Disease	-1	17965424
oid	I-Disease	-1	17965424
arth@@	I-Disease	-1	17965424
ritis	I-Disease	-1	17965424
patient@@	O	-1	17965424
s:	O	-1	17965424
results	O	-1	17965424
of	O	-1	17965424
the	O	-1	17965424
et@@	B-Chemical	C422649	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
v@@	O	-1	17965424
s	O	-1	17965424
dic@@	B-Chemical	D004008	17965424
lo@@	I-Chemical	-1	17965424
f@@	I-Chemical	-1	17965424
en@@	I-Chemical	-1	17965424
a@@	I-Chemical	-1	17965424
c	I-Chemical	-1	17965424
sodium	I-Chemical	-1	17965424
gast@@	O	-1	17965424
ro@@	O	-1	17965424
in@@	O	-1	17965424
test@@	O	-1	17965424
inal	O	-1	17965424
toler@@	O	-1	17965424
ability	O	-1	17965424
and	O	-1	17965424
eff@@	O	-1	17965424
ec@@	O	-1	17965424
tiv@@	O	-1	17965424
en@@	O	-1	17965424
ess	O	-1	17965424
trial	O	-1	17965424
(@@	O	-1	17965424
E@@	O	-1	17965424
D@@	O	-1	17965424
G@@	O	-1	17965424
E@@	O	-1	17965424
-@@	O	-1	17965424
II@@	O	-1	17965424
).	O	-1	17965424
OBJECTIVE:	O	-1	17965424
A	O	-1	17965424
ran@@	O	-1	17965424
do@@	O	-1	17965424
mi@@	O	-1	17965424
se@@	O	-1	17965424
d,	O	-1	17965424
double-bl@@	O	-1	17965424
ind	O	-1	17965424
study	O	-1	17965424
to	O	-1	17965424
compar@@	O	-1	17965424
e	O	-1	17965424
the	O	-1	17965424
gast@@	O	-1	17965424
ro@@	O	-1	17965424
in@@	O	-1	17965424
test@@	O	-1	17965424
inal	O	-1	17965424
(@@	O	-1	17965424
G@@	O	-1	17965424
I@@	O	-1	17965424
)	O	-1	17965424
toler@@	O	-1	17965424
abil@@	O	-1	17965424
ity,	O	-1	17965424
safety	O	-1	17965424
and	O	-1	17965424
efficacy	O	-1	17965424
of	O	-1	17965424
et@@	B-Chemical	C422649	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
and	O	-1	17965424
dic@@	B-Chemical	D004008	17965424
lo@@	I-Chemical	-1	17965424
f@@	I-Chemical	-1	17965424
en@@	I-Chemical	-1	17965424
a@@	I-Chemical	-1	17965424
c	I-Chemical	-1	17965424
in	O	-1	17965424
patients	O	-1	17965424
with	O	-1	17965424
r@@	B-Disease	D001172	17965424
he@@	I-Disease	-1	17965424
um@@	I-Disease	-1	17965424
at@@	I-Disease	-1	17965424
oid	I-Disease	-1	17965424
arth@@	I-Disease	-1	17965424
ritis	I-Disease	-1	17965424
(	O	-1	17965424
R@@	B-Disease	D001172	17965424
A	I-Disease	-1	17965424
).	O	-1	17965424
PA@@	O	-1	17965424
TI@@	O	-1	17965424
E@@	O	-1	17965424
N@@	O	-1	17965424
T@@	O	-1	17965424
S	O	-1	17965424
AN@@	O	-1	17965424
D	O	-1	17965424
METHODS:	O	-1	17965424
A	O	-1	17965424
total	O	-1	17965424
of	O	-1	17965424
4@@	O	-1	17965424
0@@	O	-1	17965424
8@@	O	-1	17965424
6	O	-1	17965424
patients	O	-1	17965424
(@@	O	-1	17965424
mean	O	-1	17965424
age	O	-1	17965424
6@@	O	-1	17965424
0.@@	O	-1	17965424
8	O	-1	17965424
year@@	O	-1	17965424
s)	O	-1	17965424
diagnos@@	O	-1	17965424
ed	O	-1	17965424
with	O	-1	17965424
R@@	B-Disease	D001172	17965424
A	I-Disease	-1	17965424
were	O	-1	17965424
en@@	O	-1	17965424
ro@@	O	-1	17965424
lled	O	-1	17965424
and	O	-1	17965424
received	O	-1	17965424
et@@	B-Chemical	C422649	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
9@@	O	-1	17965424
0	O	-1	17965424
mg	O	-1	17965424
daily	O	-1	17965424
(n	O	-1	17965424
=	O	-1	17965424
20@@	O	-1	17965424
3@@	O	-1	17965424
2)	O	-1	17965424
or	O	-1	17965424
dic@@	B-Chemical	D004008	17965424
lo@@	I-Chemical	-1	17965424
f@@	I-Chemical	-1	17965424
en@@	I-Chemical	-1	17965424
a@@	I-Chemical	-1	17965424
c	I-Chemical	-1	17965424
7@@	O	-1	17965424
5	O	-1	17965424
mg	O	-1	17965424
tw@@	O	-1	17965424
ic@@	O	-1	17965424
e	O	-1	17965424
daily	O	-1	17965424
(n	O	-1	17965424
=	O	-1	17965424
20@@	O	-1	17965424
5@@	O	-1	17965424
4@@	O	-1	17965424
).	O	-1	17965424
U@@	O	-1	17965424
se	O	-1	17965424
of	O	-1	17965424
gast@@	O	-1	17965424
ro@@	O	-1	17965424
protective	O	-1	17965424
agents	O	-1	17965424
and	O	-1	17965424
low@@	O	-1	17965424
-@@	O	-1	17965424
dose	O	-1	17965424
as@@	B-Chemical	D001241	17965424
pi@@	I-Chemical	-1	17965424
rin	I-Chemical	-1	17965424
was	O	-1	17965424
al@@	O	-1	17965424
lo@@	O	-1	17965424
we@@	O	-1	17965424
d.	O	-1	17965424
The	O	-1	17965424
pres@@	O	-1	17965424
p@@	O	-1	17965424
ec@@	O	-1	17965424
if@@	O	-1	17965424
ied	O	-1	17965424
prim@@	O	-1	17965424
ary	O	-1	17965424
end	O	-1	17965424
po@@	O	-1	17965424
in@@	O	-1	17965424
t	O	-1	17965424
consist@@	O	-1	17965424
ed	O	-1	17965424
of	O	-1	17965424
the	O	-1	17965424
cum@@	O	-1	17965424
ul@@	O	-1	17965424
ative	O	-1	17965424
rate	O	-1	17965424
of	O	-1	17965424
patient	O	-1	17965424
discontinu@@	O	-1	17965424
ations	O	-1	17965424
due	O	-1	17965424
to	O	-1	17965424
clinical	O	-1	17965424
and	O	-1	17965424
labor@@	O	-1	17965424
atory	O	-1	17965424
G@@	O	-1	17965424
I	O	-1	17965424
adverse	O	-1	17965424
experienc@@	O	-1	17965424
es	O	-1	17965424
(A@@	O	-1	17965424
E@@	O	-1	17965424
s@@	O	-1	17965424
).	O	-1	17965424
G@@	O	-1	17965424
en@@	O	-1	17965424
eral	O	-1	17965424
safety	O	-1	17965424
was	O	-1	17965424
also	O	-1	17965424
ass@@	O	-1	17965424
es@@	O	-1	17965424
se@@	O	-1	17965424
d,	O	-1	17965424
including	O	-1	17965424
adj@@	O	-1	17965424
ud@@	O	-1	17965424
ic@@	O	-1	17965424
ated	O	-1	17965424
thrombotic	B-Disease	D002318	17965424
cardiovascular	I-Disease	-1	17965424
ev@@	O	-1	17965424
ent	O	-1	17965424
dat@@	O	-1	17965424
a.	O	-1	17965424
Eff@@	O	-1	17965424
icac@@	O	-1	17965424
y	O	-1	17965424
was	O	-1	17965424
evaluated	O	-1	17965424
using	O	-1	17965424
the	O	-1	17965424
Pati@@	O	-1	17965424
ent	O	-1	17965424
G@@	O	-1	17965424
lo@@	O	-1	17965424
b@@	O	-1	17965424
al	O	-1	17965424
A@@	O	-1	17965424
s@@	O	-1	17965424
s@@	O	-1	17965424
ess@@	O	-1	17965424
ment	O	-1	17965424
of	O	-1	17965424
Di@@	O	-1	17965424
se@@	O	-1	17965424
ase	O	-1	17965424
S@@	O	-1	17965424
t@@	O	-1	17965424
at@@	O	-1	17965424
us	O	-1	17965424
(P@@	O	-1	17965424
G@@	O	-1	17965424
AD@@	O	-1	17965424
S@@	O	-1	17965424
;	O	-1	17965424
0-@@	O	-1	17965424
4	O	-1	17965424
po@@	O	-1	17965424
in@@	O	-1	17965424
t	O	-1	17965424
s@@	O	-1	17965424
cal@@	O	-1	17965424
e@@	O	-1	17965424
).	O	-1	17965424
RESULTS:	O	-1	17965424
M@@	O	-1	17965424
e@@	O	-1	17965424
an	O	-1	17965424
(S@@	O	-1	17965424
D@@	O	-1	17965424
;	O	-1	17965424
maxim@@	O	-1	17965424
um@@	O	-1	17965424
)	O	-1	17965424
duration	O	-1	17965424
of	O	-1	17965424
treatment	O	-1	17965424
was	O	-1	17965424
19@@	O	-1	17965424
.@@	O	-1	17965424
3	O	-1	17965424
(1@@	O	-1	17965424
0.@@	O	-1	17965424
3@@	O	-1	17965424
;	O	-1	17965424
3@@	O	-1	17965424
2.@@	O	-1	17965424
9@@	O	-1	17965424
)	O	-1	17965424
and	O	-1	17965424
19@@	O	-1	17965424
.@@	O	-1	17965424
1	O	-1	17965424
(1@@	O	-1	17965424
0.@@	O	-1	17965424
4@@	O	-1	17965424
;	O	-1	17965424
3@@	O	-1	17965424
3.@@	O	-1	17965424
1)	O	-1	17965424
months	O	-1	17965424
in	O	-1	17965424
the	O	-1	17965424
et@@	B-Chemical	C422649	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
and	O	-1	17965424
dic@@	B-Chemical	D004008	17965424
lo@@	I-Chemical	-1	17965424
f@@	I-Chemical	-1	17965424
en@@	I-Chemical	-1	17965424
a@@	I-Chemical	-1	17965424
c	I-Chemical	-1	17965424
group@@	O	-1	17965424
s,	O	-1	17965424
respectively.	O	-1	17965424
The	O	-1	17965424
cum@@	O	-1	17965424
ul@@	O	-1	17965424
ative	O	-1	17965424
discontinu@@	O	-1	17965424
ation	O	-1	17965424
rate	O	-1	17965424
due	O	-1	17965424
to	O	-1	17965424
G@@	B-Disease	D005767	17965424
I	I-Disease	-1	17965424
A@@	I-Disease	-1	17965424
E@@	I-Disease	-1	17965424
s	I-Disease	-1	17965424
was	O	-1	17965424
significantly	O	-1	17965424
lower	O	-1	17965424
with	O	-1	17965424
et@@	B-Chemical	C422649	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
than	O	-1	17965424
dic@@	B-Chemical	D004008	17965424
lo@@	I-Chemical	-1	17965424
f@@	I-Chemical	-1	17965424
en@@	I-Chemical	-1	17965424
a@@	I-Chemical	-1	17965424
c	I-Chemical	-1	17965424
(@@	O	-1	17965424
5.@@	O	-1	17965424
2	O	-1	17965424
v@@	O	-1	17965424
s	O	-1	17965424
8.@@	O	-1	17965424
5	O	-1	17965424
events	O	-1	17965424
per	O	-1	17965424
100	O	-1	17965424
patient@@	O	-1	17965424
-@@	O	-1	17965424
year@@	O	-1	17965424
s,	O	-1	17965424
respectivel@@	O	-1	17965424
y@@	O	-1	17965424
;	O	-1	17965424
ha@@	O	-1	17965424
z@@	O	-1	17965424
ard	O	-1	17965424
rati@@	O	-1	17965424
o	O	-1	17965424
0.@@	O	-1	17965424
6@@	O	-1	17965424
2	O	-1	17965424
(@@	O	-1	17965424
95%	O	-1	17965424
CI@@	O	-1	17965424
:	O	-1	17965424
0.@@	O	-1	17965424
4@@	O	-1	17965424
7@@	O	-1	17965424
,	O	-1	17965424
0.@@	O	-1	17965424
8@@	O	-1	17965424
1@@	O	-1	17965424
;	O	-1	17965424
p@@	O	-1	17965424
<@@	O	-1	17965424
or@@	O	-1	17965424
=@@	O	-1	17965424
0.00@@	O	-1	17965424
1@@	O	-1	17965424
)@@	O	-1	17965424
).	O	-1	17965424
The	O	-1	17965424
incidence	O	-1	17965424
of	O	-1	17965424
discontinu@@	O	-1	17965424
ations	O	-1	17965424
for	O	-1	17965424
hypertension	B-Disease	D006973	17965424
-@@	O	-1	17965424
related	O	-1	17965424
and	O	-1	17965424
o@@	B-Disease	D004487	17965424
e@@	I-Disease	-1	17965424
de@@	I-Disease	-1	17965424
ma	I-Disease	-1	17965424
-@@	O	-1	17965424
related	O	-1	17965424
A@@	O	-1	17965424
E@@	O	-1	17965424
s	O	-1	17965424
were	O	-1	17965424
significantly	O	-1	17965424
higher	O	-1	17965424
with	O	-1	17965424
et@@	B-Chemical	C422649	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
(2@@	O	-1	17965424
.@@	O	-1	17965424
5%	O	-1	17965424
and	O	-1	17965424
1.@@	O	-1	17965424
1@@	O	-1	17965424
%	O	-1	17965424
respectivel@@	O	-1	17965424
y@@	O	-1	17965424
)	O	-1	17965424
compared	O	-1	17965424
with	O	-1	17965424
dic@@	B-Chemical	D004008	17965424
lo@@	I-Chemical	-1	17965424
f@@	I-Chemical	-1	17965424
en@@	I-Chemical	-1	17965424
a@@	I-Chemical	-1	17965424
c	I-Chemical	-1	17965424
(1@@	O	-1	17965424
.@@	O	-1	17965424
5%	O	-1	17965424
and	O	-1	17965424
0.@@	O	-1	17965424
4@@	O	-1	17965424
%	O	-1	17965424
respectivel@@	O	-1	17965424
y@@	O	-1	17965424
;	O	-1	17965424
p@@	O	-1	17965424
<@@	O	-1	17965424
0.00@@	O	-1	17965424
1	O	-1	17965424
for	O	-1	17965424
hypertension	B-Disease	D006973	17965424
and	O	-1	17965424
p@@	O	-1	17965424
<@@	O	-1	17965424
0.0@@	O	-1	17965424
1	O	-1	17965424
for	O	-1	17965424
o@@	B-Disease	D004487	17965424
e@@	I-Disease	-1	17965424
de@@	I-Disease	-1	17965424
ma	I-Disease	-1	17965424
).	O	-1	17965424
E@@	B-Chemical	C422649	17965424
t@@	I-Chemical	-1	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
and	O	-1	17965424
dic@@	B-Chemical	D004008	17965424
lo@@	I-Chemical	-1	17965424
f@@	I-Chemical	-1	17965424
en@@	I-Chemical	-1	17965424
a@@	I-Chemical	-1	17965424
c	I-Chemical	-1	17965424
treatment	O	-1	17965424
resulted	O	-1	17965424
in	O	-1	17965424
similar	O	-1	17965424
efficacy	O	-1	17965424
(P@@	O	-1	17965424
G@@	O	-1	17965424
AD@@	O	-1	17965424
S	O	-1	17965424
mean	O	-1	17965424
changes	O	-1	17965424
from	O	-1	17965424
baseline	O	-1	17965424
-@@	O	-1	17965424
0.@@	O	-1	17965424
6@@	O	-1	17965424
2	O	-1	17965424
v@@	O	-1	17965424
s	O	-1	17965424
-@@	O	-1	17965424
0.@@	O	-1	17965424
5@@	O	-1	17965424
8@@	O	-1	17965424
,	O	-1	17965424
respectivel@@	O	-1	17965424
y@@	O	-1	17965424
).	O	-1	17965424
CONCLUSIONS:	O	-1	17965424
E@@	B-Chemical	C422649	17965424
t@@	I-Chemical	-1	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
9@@	O	-1	17965424
0	O	-1	17965424
mg	O	-1	17965424
demonstrated	O	-1	17965424
a	O	-1	17965424
significantly	O	-1	17965424
lower	O	-1	17965424
risk	O	-1	17965424
for	O	-1	17965424
discontinu@@	O	-1	17965424
ing	O	-1	17965424
treatment	O	-1	17965424
due	O	-1	17965424
to	O	-1	17965424
G@@	B-Disease	D005767	17965424
I	I-Disease	-1	17965424
A@@	I-Disease	-1	17965424
E@@	I-Disease	-1	17965424
s	I-Disease	-1	17965424
compared	O	-1	17965424
with	O	-1	17965424
dic@@	B-Chemical	D004008	17965424
lo@@	I-Chemical	-1	17965424
f@@	I-Chemical	-1	17965424
en@@	I-Chemical	-1	17965424
a@@	I-Chemical	-1	17965424
c	I-Chemical	-1	17965424
1@@	O	-1	17965424
50	O	-1	17965424
mg@@	O	-1	17965424
.	O	-1	17965424
D@@	O	-1	17965424
is@@	O	-1	17965424
continu@@	O	-1	17965424
ations	O	-1	17965424
from	O	-1	17965424
ren@@	O	-1	17965424
o@@	O	-1	17965424
vascular	O	-1	17965424
A@@	O	-1	17965424
E@@	O	-1	17965424
s,	O	-1	17965424
although	O	-1	17965424
less	O	-1	17965424
common	O	-1	17965424
than	O	-1	17965424
discontinu@@	O	-1	17965424
ations	O	-1	17965424
from	O	-1	17965424
G@@	B-Disease	D005767	17965424
I	I-Disease	-1	17965424
A@@	I-Disease	-1	17965424
E@@	I-Disease	-1	17965424
s	I-Disease	-1	17965424
,	O	-1	17965424
were	O	-1	17965424
significantly	O	-1	17965424
higher	O	-1	17965424
with	O	-1	17965424
et@@	B-Chemical	C422649	17965424
or@@	I-Chemical	-1	17965424
ic@@	I-Chemical	-1	17965424
ox@@	I-Chemical	-1	17965424
i@@	I-Chemical	-1	17965424
b	I-Chemical	-1	17965424
.	O	-1	17965424

P@@	O	-1	17042884
l@@	O	-1	17042884
ace@@	O	-1	17042884
bo@@	O	-1	17042884
-@@	O	-1	17042884
level	O	-1	17042884
incidence	O	-1	17042884
of	O	-1	17042884
ext@@	B-Disease	D001480	17042884
ra@@	I-Disease	-1	17042884
py@@	I-Disease	-1	17042884
ram@@	I-Disease	-1	17042884
idal	I-Disease	-1	17042884
symptoms	I-Disease	-1	17042884
(	O	-1	17042884
EP@@	B-Disease	D001480	17042884
S	I-Disease	-1	17042884
)	O	-1	17042884
with	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
in	O	-1	17042884
controlled	O	-1	17042884
studies	O	-1	17042884
of	O	-1	17042884
patients	O	-1	17042884
with	O	-1	17042884
b@@	B-Disease	D001714	17042884
ip@@	I-Disease	-1	17042884
ol@@	I-Disease	-1	17042884
ar	I-Disease	-1	17042884
man@@	I-Disease	-1	17042884
ia	I-Disease	-1	17042884
.	O	-1	17042884
OBJECTIV@@	O	-1	17042884
E@@	O	-1	17042884
S:	O	-1	17042884
To	O	-1	17042884
evalu@@	O	-1	17042884
ate	O	-1	17042884
ext@@	B-Disease	D001480	17042884
ra@@	I-Disease	-1	17042884
py@@	I-Disease	-1	17042884
ram@@	I-Disease	-1	17042884
idal	I-Disease	-1	17042884
symptoms	I-Disease	-1	17042884
(	O	-1	17042884
EP@@	B-Disease	D001480	17042884
S	I-Disease	-1	17042884
),	O	-1	17042884
including	O	-1	17042884
ak@@	B-Disease	D017109	17042884
athi@@	I-Disease	-1	17042884
sia	I-Disease	-1	17042884
,	O	-1	17042884
with	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
in	O	-1	17042884
patients	O	-1	17042884
with	O	-1	17042884
b@@	B-Disease	D001714	17042884
ip@@	I-Disease	-1	17042884
ol@@	I-Disease	-1	17042884
ar	I-Disease	-1	17042884
man@@	I-Disease	-1	17042884
ia	I-Disease	-1	17042884
.	O	-1	17042884
METHODS:	O	-1	17042884
D@@	O	-1	17042884
at@@	O	-1	17042884
a	O	-1	17042884
were	O	-1	17042884
analy@@	O	-1	17042884
zed	O	-1	17042884
from	O	-1	17042884
four	O	-1	17042884
simil@@	O	-1	17042884
arly	O	-1	17042884
desi@@	O	-1	17042884
g@@	O	-1	17042884
ne@@	O	-1	17042884
d,	O	-1	17042884
random@@	O	-1	17042884
iz@@	O	-1	17042884
ed,	O	-1	17042884
double-bl@@	O	-1	17042884
ind@@	O	-1	17042884
,	O	-1	17042884
3@@	O	-1	17042884
-	O	-1	17042884
to	O	-1	17042884
1@@	O	-1	17042884
2-@@	O	-1	17042884
week	O	-1	17042884
studi@@	O	-1	17042884
es.	O	-1	17042884
Two	O	-1	17042884
studies	O	-1	17042884
evaluated	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
mon@@	O	-1	17042884
o@@	O	-1	17042884
therapy	O	-1	17042884
(@@	O	-1	17042884
up	O	-1	17042884
to	O	-1	17042884
8@@	O	-1	17042884
00	O	-1	17042884
mg/@@	O	-1	17042884
day@@	O	-1	17042884
)	O	-1	17042884
(n	O	-1	17042884
=	O	-1	17042884
20@@	O	-1	17042884
9@@	O	-1	17042884
)	O	-1	17042884
versus	O	-1	17042884
placebo	O	-1	17042884
(n	O	-1	17042884
=	O	-1	17042884
19@@	O	-1	17042884
8@@	O	-1	17042884
),	O	-1	17042884
with	O	-1	17042884
lithium	B-Chemical	D008094	17042884
or	O	-1	17042884
haloperidol	B-Chemical	D006220	17042884
mon@@	O	-1	17042884
o@@	O	-1	17042884
therapy	O	-1	17042884
as	O	-1	17042884
resp@@	O	-1	17042884
ective	O	-1	17042884
active	O	-1	17042884
controls.	O	-1	17042884
Two	O	-1	17042884
studies	O	-1	17042884
evaluated	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
(@@	O	-1	17042884
up	O	-1	17042884
to	O	-1	17042884
8@@	O	-1	17042884
00	O	-1	17042884
mg/@@	O	-1	17042884
day@@	O	-1	17042884
)	O	-1	17042884
in	O	-1	17042884
combination	O	-1	17042884
with	O	-1	17042884
a	O	-1	17042884
mo@@	O	-1	17042884
od	O	-1	17042884
st@@	O	-1	17042884
abil@@	O	-1	17042884
iz@@	O	-1	17042884
er	O	-1	17042884
(	O	-1	17042884
lithium	B-Chemical	D008094	17042884
or	O	-1	17042884
di@@	B-Chemical	D014635	17042884
valpro@@	I-Chemical	-1	17042884
e@@	I-Chemical	-1	17042884
x	I-Chemical	-1	17042884
,	O	-1	17042884
Q@@	B-Chemical	C069541	17042884
T@@	I-Chemical	-1	17042884
P	I-Chemical	-1	17042884
+	O	-1	17042884
L@@	B-Chemical	D008094	17042884
i	I-Chemical	-1	17042884
/	O	-1	17042884
D@@	B-Chemical	D014635	17042884
V@@	I-Chemical	-1	17042884
P	I-Chemical	-1	17042884
)	O	-1	17042884
(n	O	-1	17042884
=	O	-1	17042884
19@@	O	-1	17042884
6@@	O	-1	17042884
)	O	-1	17042884
compared	O	-1	17042884
to	O	-1	17042884
placebo	O	-1	17042884
and	O	-1	17042884
mo@@	O	-1	17042884
od	O	-1	17042884
st@@	O	-1	17042884
abil@@	O	-1	17042884
iz@@	O	-1	17042884
er	O	-1	17042884
(P@@	O	-1	17042884
B@@	O	-1	17042884
O	O	-1	17042884
+	O	-1	17042884
L@@	B-Chemical	D008094	17042884
i	I-Chemical	-1	17042884
/	O	-1	17042884
D@@	B-Chemical	D014635	17042884
V@@	I-Chemical	-1	17042884
P	I-Chemical	-1	17042884
)	O	-1	17042884
(n	O	-1	17042884
=	O	-1	17042884
20@@	O	-1	17042884
3@@	O	-1	17042884
).	O	-1	17042884
E@@	B-Disease	D001480	17042884
x@@	I-Disease	-1	17042884
tra@@	I-Disease	-1	17042884
py@@	I-Disease	-1	17042884
ram@@	I-Disease	-1	17042884
idal	I-Disease	-1	17042884
symptoms	I-Disease	-1	17042884
were	O	-1	17042884
evaluated	O	-1	17042884
using	O	-1	17042884
the	O	-1	17042884
S@@	O	-1	17042884
im@@	O	-1	17042884
p@@	O	-1	17042884
son@@	O	-1	17042884
-@@	O	-1	17042884
An@@	O	-1	17042884
g@@	O	-1	17042884
us	O	-1	17042884
S@@	O	-1	17042884
cal@@	O	-1	17042884
e	O	-1	17042884
(S@@	O	-1	17042884
A@@	O	-1	17042884
S@@	O	-1	17042884
),	O	-1	17042884
the	O	-1	17042884
B@@	O	-1	17042884
ar@@	O	-1	17042884
n@@	O	-1	17042884
es	O	-1	17042884
A@@	O	-1	17042884
k@@	O	-1	17042884
athi@@	O	-1	17042884
sia	O	-1	17042884
R@@	O	-1	17042884
ating	O	-1	17042884
S@@	O	-1	17042884
cal@@	O	-1	17042884
e	O	-1	17042884
(@@	O	-1	17042884
BA@@	O	-1	17042884
R@@	O	-1	17042884
S@@	O	-1	17042884
),	O	-1	17042884
adverse	O	-1	17042884
ev@@	O	-1	17042884
ent	O	-1	17042884
reports	O	-1	17042884
and	O	-1	17042884
anti@@	O	-1	17042884
cholinergic	O	-1	17042884
drug	O	-1	17042884
us@@	O	-1	17042884
age.	O	-1	17042884
RESULTS:	O	-1	17042884
The	O	-1	17042884
incidence	O	-1	17042884
of	O	-1	17042884
EP@@	B-Disease	D001480	17042884
S	I-Disease	-1	17042884
-@@	O	-1	17042884
related	O	-1	17042884
adverse	O	-1	17042884
event@@	O	-1	17042884
s,	O	-1	17042884
including	O	-1	17042884
ak@@	B-Disease	D017109	17042884
athi@@	I-Disease	-1	17042884
sia	I-Disease	-1	17042884
,	O	-1	17042884
was	O	-1	17042884
no	O	-1	17042884
different	O	-1	17042884
with	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
mon@@	O	-1	17042884
o@@	O	-1	17042884
therapy	O	-1	17042884
(1@@	O	-1	17042884
2.@@	O	-1	17042884
9@@	O	-1	17042884
%)	O	-1	17042884
than	O	-1	17042884
with	O	-1	17042884
placebo	O	-1	17042884
(1@@	O	-1	17042884
3.@@	O	-1	17042884
1@@	O	-1	17042884
%).	O	-1	17042884
S@@	O	-1	17042884
im@@	O	-1	17042884
il@@	O	-1	17042884
ar@@	O	-1	17042884
ly,	O	-1	17042884
EP@@	B-Disease	D001480	17042884
S	I-Disease	-1	17042884
-@@	O	-1	17042884
related	O	-1	17042884
adverse	O	-1	17042884
events	O	-1	17042884
with	O	-1	17042884
Q@@	B-Chemical	C069541	17042884
T@@	I-Chemical	-1	17042884
P	I-Chemical	-1	17042884
+	O	-1	17042884
L@@	B-Chemical	D008094	17042884
i	I-Chemical	-1	17042884
/	O	-1	17042884
D@@	B-Chemical	D014635	17042884
V@@	I-Chemical	-1	17042884
P	I-Chemical	-1	17042884
(2@@	O	-1	17042884
1.@@	O	-1	17042884
4@@	O	-1	17042884
%)	O	-1	17042884
were	O	-1	17042884
no	O	-1	17042884
different	O	-1	17042884
than	O	-1	17042884
with	O	-1	17042884
P@@	O	-1	17042884
B@@	O	-1	17042884
O	O	-1	17042884
+	O	-1	17042884
L@@	B-Chemical	D008094	17042884
i	I-Chemical	-1	17042884
/	O	-1	17042884
D@@	B-Chemical	D014635	17042884
V@@	I-Chemical	-1	17042884
P	I-Chemical	-1	17042884
(1@@	O	-1	17042884
9.@@	O	-1	17042884
2@@	O	-1	17042884
%).	O	-1	17042884
Ad@@	O	-1	17042884
verse	O	-1	17042884
events	O	-1	17042884
related	O	-1	17042884
to	O	-1	17042884
EP@@	B-Disease	D001480	17042884
S	I-Disease	-1	17042884
occurred	O	-1	17042884
in	O	-1	17042884
5@@	O	-1	17042884
9.@@	O	-1	17042884
6%	O	-1	17042884
of	O	-1	17042884
patients	O	-1	17042884
treated	O	-1	17042884
with	O	-1	17042884
haloperidol	B-Chemical	D006220	17042884
(n	O	-1	17042884
=	O	-1	17042884
9@@	O	-1	17042884
9@@	O	-1	17042884
)	O	-1	17042884
mon@@	O	-1	17042884
o@@	O	-1	17042884
therapy,	O	-1	17042884
whereas	O	-1	17042884
2@@	O	-1	17042884
6.@@	O	-1	17042884
5%	O	-1	17042884
of	O	-1	17042884
patients	O	-1	17042884
treated	O	-1	17042884
with	O	-1	17042884
lithium	B-Chemical	D008094	17042884
(n	O	-1	17042884
=	O	-1	17042884
9@@	O	-1	17042884
8@@	O	-1	17042884
)	O	-1	17042884
mon@@	O	-1	17042884
o@@	O	-1	17042884
therapy	O	-1	17042884
experienced	O	-1	17042884
adverse	O	-1	17042884
events	O	-1	17042884
related	O	-1	17042884
to	O	-1	17042884
EP@@	B-Disease	D001480	17042884
S	I-Disease	-1	17042884
.	O	-1	17042884
The	O	-1	17042884
incidence	O	-1	17042884
of	O	-1	17042884
ak@@	B-Disease	D017109	17042884
athi@@	I-Disease	-1	17042884
sia	I-Disease	-1	17042884
was	O	-1	17042884
low	O	-1	17042884
and	O	-1	17042884
similar	O	-1	17042884
with	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
mon@@	O	-1	17042884
o@@	O	-1	17042884
therapy	O	-1	17042884
(@@	O	-1	17042884
3.@@	O	-1	17042884
3@@	O	-1	17042884
%)	O	-1	17042884
and	O	-1	17042884
placebo	O	-1	17042884
(@@	O	-1	17042884
6.@@	O	-1	17042884
1@@	O	-1	17042884
%),	O	-1	17042884
and	O	-1	17042884
with	O	-1	17042884
Q@@	B-Chemical	C069541	17042884
T@@	I-Chemical	-1	17042884
P	I-Chemical	-1	17042884
+	O	-1	17042884
L@@	B-Chemical	D008094	17042884
i	I-Chemical	-1	17042884
/	O	-1	17042884
D@@	B-Chemical	D014635	17042884
V@@	I-Chemical	-1	17042884
P	I-Chemical	-1	17042884
(@@	O	-1	17042884
3.@@	O	-1	17042884
6@@	O	-1	17042884
%)	O	-1	17042884
and	O	-1	17042884
P@@	O	-1	17042884
B@@	O	-1	17042884
O	O	-1	17042884
+	O	-1	17042884
L@@	B-Chemical	D008094	17042884
i	I-Chemical	-1	17042884
/	O	-1	17042884
D@@	B-Chemical	D014635	17042884
V@@	I-Chemical	-1	17042884
P	I-Chemical	-1	17042884
(@@	O	-1	17042884
4.@@	O	-1	17042884
9@@	O	-1	17042884
%).	O	-1	17042884
L@@	B-Chemical	D008094	17042884
i@@	I-Chemical	-1	17042884
thi@@	I-Chemical	-1	17042884
um	I-Chemical	-1	17042884
was	O	-1	17042884
associated	O	-1	17042884
with	O	-1	17042884
a	O	-1	17042884
significantly	O	-1	17042884
higher	O	-1	17042884
incidence	O	-1	17042884
(p	O	-1	17042884
<	O	-1	17042884
0.05@@	O	-1	17042884
)	O	-1	17042884
of	O	-1	17042884
trem@@	B-Disease	D014202	17042884
or	I-Disease	-1	17042884
(1@@	O	-1	17042884
8.@@	O	-1	17042884
4@@	O	-1	17042884
%)	O	-1	17042884
than	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
(@@	O	-1	17042884
5.@@	O	-1	17042884
6@@	O	-1	17042884
%@@	O	-1	17042884
);	O	-1	17042884
ce@@	O	-1	17042884
re@@	O	-1	17042884
bell@@	O	-1	17042884
ar	O	-1	17042884
trem@@	B-Disease	D014202	17042884
or	I-Disease	-1	17042884
,	O	-1	17042884
which	O	-1	17042884
is	O	-1	17042884
a	O	-1	17042884
known	O	-1	17042884
adverse	O	-1	17042884
effect	O	-1	17042884
of	O	-1	17042884
lithium	B-Chemical	D008094	17042884
,	O	-1	17042884
may	O	-1	17042884
have	O	-1	17042884
cont@@	O	-1	17042884
ri@@	O	-1	17042884
but@@	O	-1	17042884
ed	O	-1	17042884
to	O	-1	17042884
the	O	-1	17042884
elevated	O	-1	17042884
rate	O	-1	17042884
of	O	-1	17042884
trem@@	B-Disease	D014202	17042884
or	I-Disease	-1	17042884
in	O	-1	17042884
patients	O	-1	17042884
receiving	O	-1	17042884
lithium	B-Chemical	D008094	17042884
therapy.	O	-1	17042884
H@@	B-Chemical	D006220	17042884
alo@@	I-Chemical	-1	17042884
perid@@	I-Chemical	-1	17042884
ol	I-Chemical	-1	17042884
induced	O	-1	17042884
a	O	-1	17042884
significantly	O	-1	17042884
higher	O	-1	17042884
incidence	O	-1	17042884
(p	O	-1	17042884
<	O	-1	17042884
0.00@@	O	-1	17042884
1)	O	-1	17042884
of	O	-1	17042884
ak@@	B-Disease	D017109	17042884
athi@@	I-Disease	-1	17042884
sia	I-Disease	-1	17042884
(3@@	O	-1	17042884
3.@@	O	-1	17042884
3@@	O	-1	17042884
%	O	-1	17042884
versus	O	-1	17042884
5.@@	O	-1	17042884
9@@	O	-1	17042884
%),	O	-1	17042884
trem@@	B-Disease	D014202	17042884
or	I-Disease	-1	17042884
(3@@	O	-1	17042884
0.@@	O	-1	17042884
3@@	O	-1	17042884
%	O	-1	17042884
versus	O	-1	17042884
7.@@	O	-1	17042884
8@@	O	-1	17042884
%),	O	-1	17042884
and	O	-1	17042884
ext@@	B-Disease	D001480	17042884
ra@@	I-Disease	-1	17042884
py@@	I-Disease	-1	17042884
ram@@	I-Disease	-1	17042884
idal	I-Disease	-1	17042884
syndrome	I-Disease	-1	17042884
(3@@	O	-1	17042884
5.@@	O	-1	17042884
4@@	O	-1	17042884
%	O	-1	17042884
versus	O	-1	17042884
5.@@	O	-1	17042884
9@@	O	-1	17042884
%)	O	-1	17042884
than	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
.	O	-1	17042884
No	O	-1	17042884
significant	O	-1	17042884
differences	O	-1	17042884
were	O	-1	17042884
observed	O	-1	17042884
between	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
and	O	-1	17042884
placebo	O	-1	17042884
on	O	-1	17042884
S@@	O	-1	17042884
A@@	O	-1	17042884
S	O	-1	17042884
and	O	-1	17042884
BA@@	O	-1	17042884
R@@	O	-1	17042884
S	O	-1	17042884
sco@@	O	-1	17042884
res@@	O	-1	17042884
.	O	-1	17042884
An@@	O	-1	17042884
ti@@	O	-1	17042884
cholinergic	O	-1	17042884
use	O	-1	17042884
was	O	-1	17042884
low	O	-1	17042884
and	O	-1	17042884
similar	O	-1	17042884
with	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
or	O	-1	17042884
placebo@@	O	-1	17042884
.	O	-1	17042884
CONCLUSIONS:	O	-1	17042884
In	O	-1	17042884
b@@	B-Disease	D001714	17042884
ip@@	I-Disease	-1	17042884
ol@@	I-Disease	-1	17042884
ar	I-Disease	-1	17042884
man@@	I-Disease	-1	17042884
ia	I-Disease	-1	17042884
,	O	-1	17042884
the	O	-1	17042884
incidence	O	-1	17042884
of	O	-1	17042884
EP@@	B-Disease	D001480	17042884
S	I-Disease	-1	17042884
,	O	-1	17042884
including	O	-1	17042884
ak@@	B-Disease	D017109	17042884
athi@@	I-Disease	-1	17042884
sia	I-Disease	-1	17042884
,	O	-1	17042884
with	O	-1	17042884
qu@@	B-Chemical	C069541	17042884
e@@	I-Chemical	-1	17042884
ti@@	I-Chemical	-1	17042884
apine	I-Chemical	-1	17042884
therapy	O	-1	17042884
is	O	-1	17042884
similar	O	-1	17042884
to	O	-1	17042884
that	O	-1	17042884
with	O	-1	17042884
placebo@@	O	-1	17042884
.	O	-1	17042884

Con@@	O	-1	8586822
tri@@	O	-1	8586822
bu@@	O	-1	8586822
tion	O	-1	8586822
of	O	-1	8586822
the	O	-1	8586822
sym@@	O	-1	8586822
pa@@	O	-1	8586822
thetic	O	-1	8586822
ner@@	O	-1	8586822
v@@	O	-1	8586822
ous	O	-1	8586822
system	O	-1	8586822
to	O	-1	8586822
sal@@	O	-1	8586822
t-@@	O	-1	8586822
sensitivity	O	-1	8586822
in	O	-1	8586822
li@@	O	-1	8586822
fe@@	O	-1	8586822
time	O	-1	8586822
cap@@	B-Chemical	D002216	8586822
to@@	I-Chemical	-1	8586822
pri@@	I-Chemical	-1	8586822
l	I-Chemical	-1	8586822
-treated	O	-1	8586822
spont@@	O	-1	8586822
ane@@	O	-1	8586822
ously	O	-1	8586822
hypertensive	B-Disease	D006973	8586822
rats.	O	-1	8586822
OBJECTIVE:	O	-1	8586822
To	O	-1	8586822
test	O	-1	8586822
the	O	-1	8586822
hypo@@	O	-1	8586822
thesis	O	-1	8586822
th@@	O	-1	8586822
at@@	O	-1	8586822
,	O	-1	8586822
in	O	-1	8586822
li@@	O	-1	8586822
fe@@	O	-1	8586822
time	O	-1	8586822
cap@@	B-Chemical	D002216	8586822
to@@	I-Chemical	-1	8586822
pri@@	I-Chemical	-1	8586822
l	I-Chemical	-1	8586822
-treated	O	-1	8586822
spont@@	O	-1	8586822
ane@@	O	-1	8586822
ously	O	-1	8586822
hypertensive	B-Disease	D006973	8586822
rats	O	-1	8586822
(S@@	O	-1	8586822
H@@	O	-1	8586822
R@@	O	-1	8586822
),	O	-1	8586822
the	O	-1	8586822
sym@@	O	-1	8586822
pa@@	O	-1	8586822
thetic	O	-1	8586822
ner@@	O	-1	8586822
v@@	O	-1	8586822
ous	O	-1	8586822
system	O	-1	8586822
cont@@	O	-1	8586822
ri@@	O	-1	8586822
but@@	O	-1	8586822
es	O	-1	8586822
import@@	O	-1	8586822
ant@@	O	-1	8586822
ly	O	-1	8586822
to	O	-1	8586822
the	O	-1	8586822
hypertensive	B-Disease	D006973	8586822
effect	O	-1	8586822
of	O	-1	8586822
di@@	B-Chemical	D017673	8586822
et@@	I-Chemical	-1	8586822
ary	I-Chemical	-1	8586822
sodium	I-Chemical	-1	8586822
chlor@@	I-Chemical	-1	8586822
ide	I-Chemical	-1	8586822
sup@@	O	-1	8586822
ple@@	O	-1	8586822
ment@@	O	-1	8586822
ation.	O	-1	8586822
METHODS:	O	-1	8586822
M@@	O	-1	8586822
al@@	O	-1	8586822
e	O	-1	8586822
S@@	O	-1	8586822
H@@	O	-1	8586822
R	O	-1	8586822
(@@	O	-1	8586822
aged	O	-1	8586822
6	O	-1	8586822
week@@	O	-1	8586822
s)	O	-1	8586822
that	O	-1	8586822
had	O	-1	8586822
been	O	-1	8586822
treated	O	-1	8586822
from	O	-1	8586822
con@@	O	-1	8586822
ce@@	O	-1	8586822
ption	O	-1	8586822
on@@	O	-1	8586822
war@@	O	-1	8586822
d	O	-1	8586822
with	O	-1	8586822
either	O	-1	8586822
cap@@	B-Chemical	D002216	8586822
to@@	I-Chemical	-1	8586822
pri@@	I-Chemical	-1	8586822
l	I-Chemical	-1	8586822
or	O	-1	8586822
ve@@	O	-1	8586822
h@@	O	-1	8586822
ic@@	O	-1	8586822
le	O	-1	8586822
remained	O	-1	8586822
on	O	-1	8586822
a	O	-1	8586822
bas@@	O	-1	8586822
al	O	-1	8586822
sodium	B-Chemical	D012965	8586822
chlor@@	I-Chemical	-1	8586822
ide	I-Chemical	-1	8586822
diet	O	-1	8586822
or	O	-1	8586822
were	O	-1	8586822
f@@	O	-1	8586822
ed	O	-1	8586822
a	O	-1	8586822
high	O	-1	8586822
sodium	B-Chemical	D012965	8586822
chlor@@	I-Chemical	-1	8586822
ide	I-Chemical	-1	8586822
di@@	O	-1	8586822
et@@	O	-1	8586822
.	O	-1	8586822
After	O	-1	8586822
2	O	-1	8586822
week@@	O	-1	8586822
s,	O	-1	8586822
the	O	-1	8586822
rats	O	-1	8586822
were	O	-1	8586822
subj@@	O	-1	8586822
ected	O	-1	8586822
to	O	-1	8586822
g@@	O	-1	8586822
ang@@	O	-1	8586822
li@@	O	-1	8586822
onic	O	-1	8586822
block@@	O	-1	8586822
ade	O	-1	8586822
and	O	-1	8586822
2	O	-1	8586822
days	O	-1	8586822
lat@@	O	-1	8586822
er,	O	-1	8586822
an	O	-1	8586822
infusion	O	-1	8586822
of	O	-1	8586822
clonidine	B-Chemical	D003000	8586822
.	O	-1	8586822
RESULTS:	O	-1	8586822
L@@	O	-1	8586822
if@@	O	-1	8586822
e@@	O	-1	8586822
time	O	-1	8586822
cap@@	B-Chemical	D002216	8586822
to@@	I-Chemical	-1	8586822
pri@@	I-Chemical	-1	8586822
l	I-Chemical	-1	8586822
treatment	O	-1	8586822
significantly	O	-1	8586822
lo@@	O	-1	8586822
we@@	O	-1	8586822
red	O	-1	8586822
mean	O	-1	8586822
arterial	O	-1	8586822
pressure	O	-1	8586822
in	O	-1	8586822
both	O	-1	8586822
groups.	O	-1	8586822
In@@	O	-1	8586822
tra@@	O	-1	8586822
venous	O	-1	8586822
infusion	O	-1	8586822
of	O	-1	8586822
the	O	-1	8586822
g@@	O	-1	8586822
ang@@	O	-1	8586822
li@@	O	-1	8586822
onic	O	-1	8586822
block@@	O	-1	8586822
er	O	-1	8586822
he@@	B-Chemical	D018738	8586822
xameth@@	I-Chemical	-1	8586822
oni@@	I-Chemical	-1	8586822
um	I-Chemical	-1	8586822
resulted	O	-1	8586822
in	O	-1	8586822
a	O	-1	8586822
ra@@	O	-1	8586822
pid	O	-1	8586822
dec@@	O	-1	8586822
line	O	-1	8586822
in	O	-1	8586822
MA@@	O	-1	8586822
P	O	-1	8586822
that	O	-1	8586822
el@@	O	-1	8586822
im@@	O	-1	8586822
in@@	O	-1	8586822
ated	O	-1	8586822
the	O	-1	8586822
di@@	B-Chemical	D017673	8586822
et@@	I-Chemical	-1	8586822
ary	I-Chemical	-1	8586822
sodium	I-Chemical	-1	8586822
chlor@@	I-Chemical	-1	8586822
ide	I-Chemical	-1	8586822
-induced	O	-1	8586822
increase	B-Disease	D006973	8586822
in	I-Disease	-1	8586822
MA@@	I-Disease	-1	8586822
P	I-Disease	-1	8586822
in	O	-1	8586822
both	O	-1	8586822
groups.	O	-1	8586822
In@@	O	-1	8586822
f@@	O	-1	8586822
usion	O	-1	8586822
of	O	-1	8586822
the	O	-1	8586822
central	O	-1	8586822
ner@@	O	-1	8586822
v@@	O	-1	8586822
ous	O	-1	8586822
system	O	-1	8586822
alpha@@	B-Chemical	D058647	8586822
2-@@	I-Chemical	-1	8586822
adrenergic	I-Chemical	-1	8586822
receptor	I-Chemical	-1	8586822
agon@@	I-Chemical	-1	8586822
ist	I-Chemical	-1	8586822
clonidine	B-Chemical	D003000	8586822
also	O	-1	8586822
resulted	O	-1	8586822
in	O	-1	8586822
a	O	-1	8586822
greater	O	-1	8586822
reduction	O	-1	8586822
in	O	-1	8586822
MA@@	O	-1	8586822
P	O	-1	8586822
in	O	-1	8586822
both	O	-1	8586822
groups	O	-1	8586822
of	O	-1	8586822
S@@	O	-1	8586822
H@@	O	-1	8586822
R	O	-1	8586822
that	O	-1	8586822
were	O	-1	8586822
f@@	O	-1	8586822
ed	O	-1	8586822
the	O	-1	8586822
high	O	-1	8586822
(@@	O	-1	8586822
compared	O	-1	8586822
with	O	-1	8586822
the	O	-1	8586822
bas@@	O	-1	8586822
al@@	O	-1	8586822
)	O	-1	8586822
sodium	B-Chemical	D012965	8586822
chlor@@	I-Chemical	-1	8586822
ide	I-Chemical	-1	8586822
di@@	O	-1	8586822
et@@	O	-1	8586822
.	O	-1	8586822
CONCLUSIONS:	O	-1	8586822
In	O	-1	8586822
both	O	-1	8586822
li@@	O	-1	8586822
fe@@	O	-1	8586822
time	O	-1	8586822
cap@@	B-Chemical	D002216	8586822
to@@	I-Chemical	-1	8586822
pri@@	I-Chemical	-1	8586822
l	I-Chemical	-1	8586822
-treated	O	-1	8586822
and	O	-1	8586822
control	O	-1	8586822
S@@	O	-1	8586822
H@@	O	-1	8586822
R@@	O	-1	8586822
,	O	-1	8586822
the	O	-1	8586822
sym@@	O	-1	8586822
pa@@	O	-1	8586822
thetic	O	-1	8586822
ner@@	O	-1	8586822
v@@	O	-1	8586822
ous	O	-1	8586822
system	O	-1	8586822
cont@@	O	-1	8586822
ri@@	O	-1	8586822
but@@	O	-1	8586822
es	O	-1	8586822
to	O	-1	8586822
the	O	-1	8586822
press@@	O	-1	8586822
or	O	-1	8586822
effects	O	-1	8586822
of	O	-1	8586822
a	O	-1	8586822
high	O	-1	8586822
sodium	B-Chemical	D012965	8586822
chlor@@	I-Chemical	-1	8586822
ide	I-Chemical	-1	8586822
di@@	O	-1	8586822
et@@	O	-1	8586822
.	O	-1	8586822

D@@	O	-1	3961813
o@@	O	-1	3961813
se@@	O	-1	3961813
-@@	O	-1	3961813
related	O	-1	3961813
ben@@	O	-1	3961813
e@@	O	-1	3961813
fic@@	O	-1	3961813
ial	O	-1	3961813
and	O	-1	3961813
adverse	O	-1	3961813
effects	O	-1	3961813
of	O	-1	3961813
di@@	O	-1	3961813
et@@	O	-1	3961813
ary	O	-1	3961813
cortico@@	B-Chemical	D003345	3961813
sterone	I-Chemical	-1	3961813
on	O	-1	3961813
org@@	B-Chemical	D010755	3961813
an@@	I-Chemical	-1	3961813
oph@@	I-Chemical	-1	3961813
osph@@	I-Chemical	-1	3961813
or@@	I-Chemical	-1	3961813
us	I-Chemical	-1	3961813
-induced	O	-1	3961813
del@@	O	-1	3961813
ayed	O	-1	3961813
neuropathy	B-Disease	D009422	3961813
in	O	-1	3961813
ch@@	O	-1	3961813
ic@@	O	-1	3961813
k@@	O	-1	3961813
en@@	O	-1	3961813
s.	O	-1	3961813
T@@	B-Chemical	C025541	3961813
ri@@	I-Chemical	-1	3961813
-@@	I-Chemical	-1	3961813
or@@	I-Chemical	-1	3961813
th@@	I-Chemical	-1	3961813
o@@	I-Chemical	-1	3961813
-@@	I-Chemical	-1	3961813
t@@	I-Chemical	-1	3961813
oly@@	I-Chemical	-1	3961813
l	I-Chemical	-1	3961813
phosph@@	I-Chemical	-1	3961813
ate	I-Chemical	-1	3961813
(	O	-1	3961813
T@@	B-Chemical	C025541	3961813
O@@	I-Chemical	-1	3961813
T@@	I-Chemical	-1	3961813
P	I-Chemical	-1	3961813
),	O	-1	3961813
3@@	O	-1	3961813
60	O	-1	3961813
mg/kg@@	O	-1	3961813
,	O	-1	3961813
po@@	O	-1	3961813
,	O	-1	3961813
and	O	-1	3961813
0@@	B-Chemical	D007531	3961813
,@@	I-Chemical	-1	3961813
0@@	I-Chemical	-1	3961813
'@@	I-Chemical	-1	3961813
-@@	I-Chemical	-1	3961813
di@@	I-Chemical	-1	3961813
iso@@	I-Chemical	-1	3961813
pro@@	I-Chemical	-1	3961813
py@@	I-Chemical	-1	3961813
l	I-Chemical	-1	3961813
phosph@@	I-Chemical	-1	3961813
o@@	I-Chemical	-1	3961813
ro@@	I-Chemical	-1	3961813
flu@@	I-Chemical	-1	3961813
or@@	I-Chemical	-1	3961813
id@@	I-Chemical	-1	3961813
ate	I-Chemical	-1	3961813
(	O	-1	3961813
DF@@	B-Chemical	D007531	3961813
P	I-Chemical	-1	3961813
),	O	-1	3961813
1	O	-1	3961813
mg/kg	O	-1	3961813
s@@	O	-1	3961813
c@@	O	-1	3961813
,	O	-1	3961813
were	O	-1	3961813
administered	O	-1	3961813
to	O	-1	3961813
ad@@	O	-1	3961813
ult	O	-1	3961813
W@@	O	-1	3961813
h@@	O	-1	3961813
ite	O	-1	3961813
L@@	O	-1	3961813
e@@	O	-1	3961813
gh@@	O	-1	3961813
or@@	O	-1	3961813
n	O	-1	3961813
ch@@	O	-1	3961813
ic@@	O	-1	3961813
k@@	O	-1	3961813
en@@	O	-1	3961813
s	O	-1	3961813
24	O	-1	3961813
h@@	O	-1	3961813
r	O	-1	3961813
after	O	-1	3961813
they	O	-1	3961813
were	O	-1	3961813
pl@@	O	-1	3961813
ac@@	O	-1	3961813
ed	O	-1	3961813
on	O	-1	3961813
di@@	O	-1	3961813
et@@	O	-1	3961813
s	O	-1	3961813
containing	O	-1	3961813
0	O	-1	3961813
to	O	-1	3961813
3@@	O	-1	3961813
00	O	-1	3961813
pp@@	O	-1	3961813
m	O	-1	3961813
cortico@@	B-Chemical	D003345	3961813
sterone	I-Chemical	-1	3961813
.	O	-1	3961813
S@@	O	-1	3961813
up@@	O	-1	3961813
ple@@	O	-1	3961813
ment@@	O	-1	3961813
ed	O	-1	3961813
di@@	O	-1	3961813
et@@	O	-1	3961813
s	O	-1	3961813
were	O	-1	3961813
continu@@	O	-1	3961813
ed	O	-1	3961813
un@@	O	-1	3961813
ti@@	O	-1	3961813
l	O	-1	3961813
clinical	O	-1	3961813
signs	O	-1	3961813
and	O	-1	3961813
lesions	O	-1	3961813
of	O	-1	3961813
del@@	O	-1	3961813
ayed	O	-1	3961813
neuropathy	B-Disease	D009422	3961813
appe@@	O	-1	3961813
a@@	O	-1	3961813
red.	O	-1	3961813
Although	O	-1	3961813
low	O	-1	3961813
concentrations	O	-1	3961813
(@@	O	-1	3961813
less	O	-1	3961813
than	O	-1	3961813
or	O	-1	3961813
equ@@	O	-1	3961813
al	O	-1	3961813
to	O	-1	3961813
50	O	-1	3961813
pp@@	O	-1	3961813
m@@	O	-1	3961813
)	O	-1	3961813
of	O	-1	3961813
cortico@@	B-Chemical	D003345	3961813
sterone	I-Chemical	-1	3961813
had	O	-1	3961813
ben@@	O	-1	3961813
e@@	O	-1	3961813
fic@@	O	-1	3961813
ial	O	-1	3961813
effects	O	-1	3961813
on	O	-1	3961813
T@@	B-Chemical	C025541	3961813
O@@	I-Chemical	-1	3961813
T@@	I-Chemical	-1	3961813
P	I-Chemical	-1	3961813
-induced	O	-1	3961813
neuropathy	B-Disease	D009422	3961813
,	O	-1	3961813
greater	O	-1	3961813
than	O	-1	3961813
or	O	-1	3961813
equ@@	O	-1	3961813
al	O	-1	3961813
to	O	-1	3961813
2@@	O	-1	3961813
00	O	-1	3961813
pp@@	O	-1	3961813
m	O	-1	3961813
ex@@	O	-1	3961813
ac@@	O	-1	3961813
er@@	O	-1	3961813
b@@	O	-1	3961813
ated	O	-1	3961813
clinical	O	-1	3961813
signs	O	-1	3961813
in	O	-1	3961813
ch@@	O	-1	3961813
ic@@	O	-1	3961813
k@@	O	-1	3961813
en@@	O	-1	3961813
s	O	-1	3961813
given	O	-1	3961813
either	O	-1	3961813
T@@	B-Chemical	C025541	3961813
O@@	I-Chemical	-1	3961813
T@@	I-Chemical	-1	3961813
P	I-Chemical	-1	3961813
or	O	-1	3961813
DF@@	B-Chemical	D007531	3961813
P	I-Chemical	-1	3961813
.	O	-1	3961813
Ne@@	B-Disease	D020258	3961813
uro@@	I-Disease	-1	3961813
toxic	I-Disease	-1	3961813
est@@	O	-1	3961813
er@@	O	-1	3961813
ase	O	-1	3961813
ac@@	O	-1	3961813
ti@@	O	-1	3961813
vi@@	O	-1	3961813
ties	O	-1	3961813
24	O	-1	3961813
h@@	O	-1	3961813
r	O	-1	3961813
after	O	-1	3961813
T@@	B-Chemical	C025541	3961813
O@@	I-Chemical	-1	3961813
T@@	I-Chemical	-1	3961813
P	I-Chemical	-1	3961813
or	O	-1	3961813
DF@@	B-Chemical	D007531	3961813
P	I-Chemical	-1	3961813
were	O	-1	3961813
less	O	-1	3961813
than	O	-1	3961813
20@@	O	-1	3961813
%	O	-1	3961813
of	O	-1	3961813
values	O	-1	3961813
measured	O	-1	3961813
in	O	-1	3961813
ch@@	O	-1	3961813
ic@@	O	-1	3961813
k@@	O	-1	3961813
en@@	O	-1	3961813
s	O	-1	3961813
not	O	-1	3961813
given	O	-1	3961813
org@@	B-Chemical	D010755	3961813
an@@	I-Chemical	-1	3961813
oph@@	I-Chemical	-1	3961813
osph@@	I-Chemical	-1	3961813
o@@	I-Chemical	-1	3961813
rou@@	I-Chemical	-1	3961813
s	I-Chemical	-1	3961813
comp@@	O	-1	3961813
oun@@	O	-1	3961813
d@@	O	-1	3961813
s.	O	-1	3961813
Ch@@	O	-1	3961813
ic@@	O	-1	3961813
k@@	O	-1	3961813
en@@	O	-1	3961813
s	O	-1	3961813
given	O	-1	3961813
2@@	O	-1	3961813
00	O	-1	3961813
pp@@	O	-1	3961813
m	O	-1	3961813
cortico@@	B-Chemical	D003345	3961813
sterone	I-Chemical	-1	3961813
without	O	-1	3961813
T@@	B-Chemical	C025541	3961813
O@@	I-Chemical	-1	3961813
T@@	I-Chemical	-1	3961813
P	I-Chemical	-1	3961813
or	O	-1	3961813
DF@@	B-Chemical	D007531	3961813
P	I-Chemical	-1	3961813
had	O	-1	3961813
significantly	O	-1	3961813
elevated	O	-1	3961813
activity	O	-1	3961813
of	O	-1	3961813
plasma	O	-1	3961813
chol@@	O	-1	3961813
ine@@	O	-1	3961813
ster@@	O	-1	3961813
ase	O	-1	3961813
and	O	-1	3961813
significantly	O	-1	3961813
inhibited	O	-1	3961813
activity	O	-1	3961813
of	O	-1	3961813
liver	O	-1	3961813
carb@@	O	-1	3961813
oxy@@	O	-1	3961813
le@@	O	-1	3961813
ster@@	O	-1	3961813
as@@	O	-1	3961813
e.	O	-1	3961813
De@@	B-Disease	D009410	3961813
gener@@	I-Disease	-1	3961813
ating	I-Disease	-1	3961813
my@@	I-Disease	-1	3961813
el@@	I-Disease	-1	3961813
in@@	I-Disease	-1	3961813
ated	I-Disease	-1	3961813
fib@@	I-Disease	-1	3961813
ers	I-Disease	-1	3961813
were	O	-1	3961813
also	O	-1	3961813
ev@@	O	-1	3961813
id@@	O	-1	3961813
ent	O	-1	3961813
in	O	-1	3961813
dist@@	O	-1	3961813
al	O	-1	3961813
levels	O	-1	3961813
of	O	-1	3961813
the	O	-1	3961813
peripheral	O	-1	3961813
ner@@	O	-1	3961813
v@@	O	-1	3961813
es	O	-1	3961813
of	O	-1	3961813
ch@@	O	-1	3961813
ic@@	O	-1	3961813
k@@	O	-1	3961813
en@@	O	-1	3961813
s	O	-1	3961813
given	O	-1	3961813
T@@	B-Chemical	C025541	3961813
O@@	I-Chemical	-1	3961813
T@@	I-Chemical	-1	3961813
P	I-Chemical	-1	3961813
or	O	-1	3961813
DF@@	B-Chemical	D007531	3961813
P	I-Chemical	-1	3961813
.	O	-1	3961813

In	O	-1	20973483
viv@@	O	-1	20973483
o	O	-1	20973483
character@@	O	-1	20973483
ization	O	-1	20973483
of	O	-1	20973483
a	O	-1	20973483
du@@	O	-1	20973483
al	O	-1	20973483
aden@@	B-Chemical	D058915	20973483
os@@	I-Chemical	-1	20973483
ine	I-Chemical	-1	20973483
A@@	I-Chemical	-1	20973483
2@@	I-Chemical	-1	20973483
A@@	I-Chemical	-1	20973483
/@@	I-Chemical	-1	20973483
A@@	I-Chemical	-1	20973483
1	I-Chemical	-1	20973483
receptor	I-Chemical	-1	20973483
antagonist	I-Chemical	-1	20973483
in	O	-1	20973483
anim@@	O	-1	20973483
al	O	-1	20973483
models	O	-1	20973483
of	O	-1	20973483
Parkinson's	B-Disease	D010300	20973483
disease	I-Disease	-1	20973483
.	O	-1	20973483
The	O	-1	20973483
in	O	-1	20973483
viv@@	O	-1	20973483
o	O	-1	20973483
character@@	O	-1	20973483
ization	O	-1	20973483
of	O	-1	20973483
a	O	-1	20973483
du@@	O	-1	20973483
al	O	-1	20973483
aden@@	B-Chemical	D058915	20973483
os@@	I-Chemical	-1	20973483
ine	I-Chemical	-1	20973483
A@@	I-Chemical	-1	20973483
(2@@	I-Chemical	-1	20973483
A@@	I-Chemical	-1	20973483
)@@	I-Chemical	-1	20973483
/@@	I-Chemical	-1	20973483
A@@	I-Chemical	-1	20973483
(1@@	I-Chemical	-1	20973483
)	I-Chemical	-1	20973483
receptor	I-Chemical	-1	20973483
antagonist	I-Chemical	-1	20973483
in	O	-1	20973483
several	O	-1	20973483
anim@@	O	-1	20973483
al	O	-1	20973483
models	O	-1	20973483
of	O	-1	20973483
Parkinson's	B-Disease	D010300	20973483
disease	I-Disease	-1	20973483
is	O	-1	20973483
descri@@	O	-1	20973483
be@@	O	-1	20973483
d.	O	-1	20973483
D@@	O	-1	20973483
is@@	O	-1	20973483
co@@	O	-1	20973483
very	O	-1	20973483
and	O	-1	20973483
s@@	O	-1	20973483
cal@@	O	-1	20973483
e-@@	O	-1	20973483
up	O	-1	20973483
syn@@	O	-1	20973483
th@@	O	-1	20973483
es@@	O	-1	20973483
es	O	-1	20973483
of	O	-1	20973483
comp@@	O	-1	20973483
ound	O	-1	20973483
1	O	-1	20973483
are	O	-1	20973483
descri@@	O	-1	20973483
bed	O	-1	20973483
in	O	-1	20973483
det@@	O	-1	20973483
ail@@	O	-1	20973483
,	O	-1	20973483
high@@	O	-1	20973483
li@@	O	-1	20973483
gh@@	O	-1	20973483
ting	O	-1	20973483
op@@	O	-1	20973483
tim@@	O	-1	20973483
ization	O	-1	20973483
st@@	O	-1	20973483
ep@@	O	-1	20973483
s	O	-1	20973483
that	O	-1	20973483
increased	O	-1	20973483
the	O	-1	20973483
over@@	O	-1	20973483
all	O	-1	20973483
y@@	O	-1	20973483
i@@	O	-1	20973483
el@@	O	-1	20973483
d	O	-1	20973483
of	O	-1	20973483
1	O	-1	20973483
from	O	-1	20973483
1@@	O	-1	20973483
0.0@@	O	-1	20973483
%	O	-1	20973483
to	O	-1	20973483
3@@	O	-1	20973483
0.@@	O	-1	20973483
5@@	O	-1	20973483
%.	O	-1	20973483
Com@@	O	-1	20973483
p@@	O	-1	20973483
ound	O	-1	20973483
1	O	-1	20973483
is	O	-1	20973483
a	O	-1	20973483
pot@@	O	-1	20973483
ent	O	-1	20973483
A@@	O	-1	20973483
(2@@	O	-1	20973483
A@@	O	-1	20973483
)@@	O	-1	20973483
/@@	O	-1	20973483
A@@	O	-1	20973483
(1@@	O	-1	20973483
)	O	-1	20973483
receptor	O	-1	20973483
antagonist	O	-1	20973483
in	O	-1	20973483
vit@@	O	-1	20973483
r@@	O	-1	20973483
o	O	-1	20973483
(A@@	O	-1	20973483
(2@@	O	-1	20973483
A@@	O	-1	20973483
)	O	-1	20973483
K@@	O	-1	20973483
(@@	O	-1	20973483
i@@	O	-1	20973483
)	O	-1	20973483
=	O	-1	20973483
4.@@	O	-1	20973483
1	O	-1	20973483
n@@	O	-1	20973483
M@@	O	-1	20973483
;	O	-1	20973483
A@@	O	-1	20973483
(1@@	O	-1	20973483
)	O	-1	20973483
K@@	O	-1	20973483
(@@	O	-1	20973483
i@@	O	-1	20973483
)	O	-1	20973483
=	O	-1	20973483
1@@	O	-1	20973483
7.@@	O	-1	20973483
0	O	-1	20973483
n@@	O	-1	20973483
M@@	O	-1	20973483
)	O	-1	20973483
that	O	-1	20973483
has	O	-1	20973483
ex@@	O	-1	20973483
cell@@	O	-1	20973483
ent	O	-1	20973483
activ@@	O	-1	20973483
ity,	O	-1	20973483
after	O	-1	20973483
oral	O	-1	20973483
administr@@	O	-1	20973483
ation,	O	-1	20973483
ac@@	O	-1	20973483
ros@@	O	-1	20973483
s	O	-1	20973483
a	O	-1	20973483
number	O	-1	20973483
of	O	-1	20973483
anim@@	O	-1	20973483
al	O	-1	20973483
models	O	-1	20973483
of	O	-1	20973483
Parkinson's	B-Disease	D010300	20973483
disease	I-Disease	-1	20973483
including	O	-1	20973483
mouse	O	-1	20973483
and	O	-1	20973483
rat	O	-1	20973483
models	O	-1	20973483
of	O	-1	20973483
haloperidol	B-Chemical	D006220	20973483
-induced	O	-1	20973483
cat@@	B-Disease	D002375	20973483
al@@	I-Disease	-1	20973483
ep@@	I-Disease	-1	20973483
sy	I-Disease	-1	20973483
,	O	-1	20973483
mouse	O	-1	20973483
model	O	-1	20973483
of	O	-1	20973483
res@@	B-Chemical	D012110	20973483
er@@	I-Chemical	-1	20973483
pine	I-Chemical	-1	20973483
-induced	O	-1	20973483
ak@@	B-Disease	D004409	20973483
ine@@	I-Disease	-1	20973483
sia	I-Disease	-1	20973483
,	O	-1	20973483
rat	O	-1	20973483
6-@@	B-Chemical	D016627	20973483
hydrox@@	I-Chemical	-1	20973483
y@@	I-Chemical	-1	20973483
dopamine	I-Chemical	-1	20973483
(	O	-1	20973483
6-@@	B-Chemical	D016627	20973483
O@@	I-Chemical	-1	20973483
H@@	I-Chemical	-1	20973483
D@@	I-Chemical	-1	20973483
A	I-Chemical	-1	20973483
)	O	-1	20973483
le@@	O	-1	20973483
sion	O	-1	20973483
model	O	-1	20973483
of	O	-1	20973483
drug@@	O	-1	20973483
-induced	O	-1	20973483
ro@@	O	-1	20973483
t@@	O	-1	20973483
ation,	O	-1	20973483
and	O	-1	20973483
MP@@	B-Chemical	D015632	20973483
T@@	I-Chemical	-1	20973483
P	I-Chemical	-1	20973483
-treated	O	-1	20973483
non-@@	O	-1	20973483
human	O	-1	20973483
prim@@	O	-1	20973483
ate	O	-1	20973483
model@@	O	-1	20973483
.	O	-1	20973483

An	O	-1	17511042
ex@@	O	-1	17511042
tre@@	O	-1	17511042
me@@	O	-1	17511042
ly	O	-1	17511042
r@@	O	-1	17511042
are	O	-1	17511042
case	O	-1	17511042
of	O	-1	17511042
de@@	B-Disease	D063726	17511042
lu@@	I-Disease	-1	17511042
sion@@	I-Disease	-1	17511042
al	I-Disease	-1	17511042
par@@	I-Disease	-1	17511042
as@@	I-Disease	-1	17511042
it@@	I-Disease	-1	17511042
o@@	I-Disease	-1	17511042
sis	I-Disease	-1	17511042
in	O	-1	17511042
a	O	-1	17511042
chronic	B-Disease	D019698	17511042
hepatitis	I-Disease	-1	17511042
C	I-Disease	-1	17511042
patient	O	-1	17511042
during	O	-1	17511042
pe@@	B-Chemical	C417083	17511042
g@@	I-Chemical	-1	17511042
yl@@	I-Chemical	-1	17511042
ated	I-Chemical	-1	17511042
inter@@	I-Chemical	-1	17511042
fer@@	I-Chemical	-1	17511042
on	I-Chemical	-1	17511042
alpha-@@	I-Chemical	-1	17511042
2@@	I-Chemical	-1	17511042
b	I-Chemical	-1	17511042
and	O	-1	17511042
rib@@	B-Chemical	D012254	17511042
avi@@	I-Chemical	-1	17511042
rin	I-Chemical	-1	17511042
treatment.	O	-1	17511042
D@@	O	-1	17511042
uring	O	-1	17511042
treatment	O	-1	17511042
of	O	-1	17511042
chronic	B-Disease	D019698	17511042
hepatitis	I-Disease	-1	17511042
C	I-Disease	-1	17511042
patients	O	-1	17511042
with	O	-1	17511042
inter@@	O	-1	17511042
fer@@	O	-1	17511042
on	O	-1	17511042
and	O	-1	17511042
rib@@	B-Chemical	D012254	17511042
avi@@	I-Chemical	-1	17511042
rin	I-Chemical	-1	17511042
,	O	-1	17511042
a	O	-1	17511042
lo@@	O	-1	17511042
t	O	-1	17511042
of	O	-1	17511042
side	O	-1	17511042
effects	O	-1	17511042
are	O	-1	17511042
descri@@	O	-1	17511042
be@@	O	-1	17511042
d.	O	-1	17511042
Tw@@	O	-1	17511042
ent@@	O	-1	17511042
y-@@	O	-1	17511042
three	O	-1	17511042
perc@@	O	-1	17511042
ent	O	-1	17511042
to	O	-1	17511042
4@@	O	-1	17511042
4@@	O	-1	17511042
%	O	-1	17511042
of	O	-1	17511042
patients	O	-1	17511042
deve@@	O	-1	17511042
lo@@	O	-1	17511042
p	O	-1	17511042
de@@	B-Disease	D003866	17511042
pression	I-Disease	-1	17511042
.	O	-1	17511042
A	O	-1	17511042
min@@	O	-1	17511042
or@@	O	-1	17511042
ity	O	-1	17511042
of	O	-1	17511042
patients	O	-1	17511042
ev@@	O	-1	17511042
ol@@	O	-1	17511042
ve	O	-1	17511042
to	O	-1	17511042
psycho@@	B-Disease	D011605	17511042
sis	I-Disease	-1	17511042
.	O	-1	17511042
To	O	-1	17511042
the	O	-1	17511042
b@@	O	-1	17511042
est	O	-1	17511042
of	O	-1	17511042
our	O	-1	17511042
know@@	O	-1	17511042
le@@	O	-1	17511042
d@@	O	-1	17511042
g@@	O	-1	17511042
e,	O	-1	17511042
no	O	-1	17511042
cases	O	-1	17511042
of	O	-1	17511042
psycho@@	B-Disease	D063726	17511042
genic	I-Disease	-1	17511042
par@@	I-Disease	-1	17511042
as@@	I-Disease	-1	17511042
it@@	I-Disease	-1	17511042
o@@	I-Disease	-1	17511042
sis	I-Disease	-1	17511042
occur@@	O	-1	17511042
r@@	O	-1	17511042
ing	O	-1	17511042
during	O	-1	17511042
inter@@	O	-1	17511042
fer@@	O	-1	17511042
on	O	-1	17511042
therapy	O	-1	17511042
have	O	-1	17511042
been	O	-1	17511042
descri@@	O	-1	17511042
bed	O	-1	17511042
in	O	-1	17511042
the	O	-1	17511042
literat@@	O	-1	17511042
ure.	O	-1	17511042
We	O	-1	17511042
present	O	-1	17511042
a	O	-1	17511042
4@@	O	-1	17511042
9@@	O	-1	17511042
-@@	O	-1	17511042
year-old	O	-1	17511042
woman	O	-1	17511042
who	O	-1	17511042
developed	O	-1	17511042
a	O	-1	17511042
de@@	B-Disease	D063726	17511042
lu@@	I-Disease	-1	17511042
sion@@	I-Disease	-1	17511042
al	I-Disease	-1	17511042
par@@	I-Disease	-1	17511042
as@@	I-Disease	-1	17511042
it@@	I-Disease	-1	17511042
o@@	I-Disease	-1	17511042
sis	I-Disease	-1	17511042
during	O	-1	17511042
treatment	O	-1	17511042
with	O	-1	17511042
pe@@	B-Chemical	C417083	17511042
g@@	I-Chemical	-1	17511042
yl@@	I-Chemical	-1	17511042
ated	I-Chemical	-1	17511042
inter@@	I-Chemical	-1	17511042
fer@@	I-Chemical	-1	17511042
on	I-Chemical	-1	17511042
alpha-@@	I-Chemical	-1	17511042
2@@	I-Chemical	-1	17511042
b	I-Chemical	-1	17511042
week@@	O	-1	17511042
ly	O	-1	17511042
and	O	-1	17511042
rib@@	B-Chemical	D012254	17511042
avi@@	I-Chemical	-1	17511042
rin	I-Chemical	-1	17511042
.	O	-1	17511042
S@@	O	-1	17511042
he	O	-1	17511042
com@@	O	-1	17511042
pl@@	O	-1	17511042
ained	O	-1	17511042
of	O	-1	17511042
se@@	O	-1	17511042
e@@	O	-1	17511042
ing	O	-1	17511042
par@@	O	-1	17511042
as@@	O	-1	17511042
it@@	O	-1	17511042
es	O	-1	17511042
and	O	-1	17511042
the	O	-1	17511042
l@@	O	-1	17511042
ar@@	O	-1	17511042
v@@	O	-1	17511042
a@@	O	-1	17511042
e	O	-1	17511042
of	O	-1	17511042
f@@	O	-1	17511042
le@@	O	-1	17511042
as	O	-1	17511042
in	O	-1	17511042
h@@	O	-1	17511042
er	O	-1	17511042
sto@@	O	-1	17511042
ol@@	O	-1	17511042
s.	O	-1	17511042
This	O	-1	17511042
could	O	-1	17511042
not	O	-1	17511042
be	O	-1	17511042
con@@	O	-1	17511042
fir@@	O	-1	17511042
m@@	O	-1	17511042
ed	O	-1	17511042
by	O	-1	17511042
any	O	-1	17511042
t@@	O	-1	17511042
ech@@	O	-1	17511042
n@@	O	-1	17511042
ical	O	-1	17511042
examin@@	O	-1	17511042
ation.	O	-1	17511042
All	O	-1	17511042
the	O	-1	17511042
com@@	O	-1	17511042
pl@@	O	-1	17511042
a@@	O	-1	17511042
int@@	O	-1	17511042
s	O	-1	17511042
dis@@	O	-1	17511042
appe@@	O	-1	17511042
a@@	O	-1	17511042
red	O	-1	17511042
after	O	-1	17511042
sto@@	O	-1	17511042
pp@@	O	-1	17511042
ing	O	-1	17511042
pe@@	B-Chemical	C417083	17511042
g@@	I-Chemical	-1	17511042
yl@@	I-Chemical	-1	17511042
ated	I-Chemical	-1	17511042
inter@@	I-Chemical	-1	17511042
fer@@	I-Chemical	-1	17511042
on	I-Chemical	-1	17511042
alpha-@@	I-Chemical	-1	17511042
2@@	I-Chemical	-1	17511042
b	I-Chemical	-1	17511042
and	O	-1	17511042
re@@	O	-1	17511042
appe@@	O	-1	17511042
a@@	O	-1	17511042
red	O	-1	17511042
after	O	-1	17511042
re@@	O	-1	17511042
star@@	O	-1	17511042
ting	O	-1	17511042
it@@	O	-1	17511042
.	O	-1	17511042
S@@	O	-1	17511042
he	O	-1	17511042
had	O	-1	17511042
a	O	-1	17511042
complete	O	-1	17511042
su@@	O	-1	17511042
st@@	O	-1	17511042
ained	O	-1	17511042
viral	O	-1	17511042
respon@@	O	-1	17511042
se.	O	-1	17511042

P@@	O	-1	16720068
os@@	O	-1	16720068
sible	O	-1	16720068
neuro@@	B-Disease	D009459	16720068
le@@	I-Disease	-1	16720068
p@@	I-Disease	-1	16720068
tic	I-Disease	-1	16720068
mal@@	I-Disease	-1	16720068
i@@	I-Disease	-1	16720068
gn@@	I-Disease	-1	16720068
ant	I-Disease	-1	16720068
syndrome	I-Disease	-1	16720068
related	O	-1	16720068
to	O	-1	16720068
concomit@@	O	-1	16720068
ant	O	-1	16720068
treatment	O	-1	16720068
with	O	-1	16720068
pa@@	B-Chemical	D017374	16720068
ro@@	I-Chemical	-1	16720068
x@@	I-Chemical	-1	16720068
et@@	I-Chemical	-1	16720068
ine	I-Chemical	-1	16720068
and	O	-1	16720068
al@@	B-Chemical	D000525	16720068
praz@@	I-Chemical	-1	16720068
ol@@	I-Chemical	-1	16720068
am	I-Chemical	-1	16720068
.	O	-1	16720068
A	O	-1	16720068
7@@	O	-1	16720068
4-@@	O	-1	16720068
year-old	O	-1	16720068
man	O	-1	16720068
with	O	-1	16720068
de@@	B-Disease	D003866	16720068
pressive	I-Disease	-1	16720068
symptoms	I-Disease	-1	16720068
was	O	-1	16720068
ad@@	O	-1	16720068
mit@@	O	-1	16720068
ted	O	-1	16720068
to	O	-1	16720068
a	O	-1	16720068
psych@@	B-Disease	D001523	16720068
i@@	I-Disease	-1	16720068
atric	I-Disease	-1	16720068
hospit@@	O	-1	16720068
al	O	-1	16720068
due	O	-1	16720068
to	O	-1	16720068
in@@	B-Disease	D007319	16720068
s@@	I-Disease	-1	16720068
om@@	I-Disease	-1	16720068
n@@	I-Disease	-1	16720068
ia	I-Disease	-1	16720068
,	O	-1	16720068
loss	B-Disease	D001068	16720068
of	I-Disease	-1	16720068
appe@@	I-Disease	-1	16720068
ti@@	I-Disease	-1	16720068
te	I-Disease	-1	16720068
,	O	-1	16720068
ex@@	O	-1	16720068
ha@@	O	-1	16720068
us@@	O	-1	16720068
tion,	O	-1	16720068
and	O	-1	16720068
ag@@	B-Disease	D011595	16720068
it@@	I-Disease	-1	16720068
ation	I-Disease	-1	16720068
.	O	-1	16720068
M@@	O	-1	16720068
ed@@	O	-1	16720068
ical	O	-1	16720068
treatment	O	-1	16720068
was	O	-1	16720068
initi@@	O	-1	16720068
ated	O	-1	16720068
at	O	-1	16720068
a	O	-1	16720068
daily	O	-1	16720068
dose	O	-1	16720068
of	O	-1	16720068
20	O	-1	16720068
mg	O	-1	16720068
pa@@	B-Chemical	D017374	16720068
ro@@	I-Chemical	-1	16720068
x@@	I-Chemical	-1	16720068
et@@	I-Chemical	-1	16720068
ine	I-Chemical	-1	16720068
and	O	-1	16720068
1.@@	O	-1	16720068
2	O	-1	16720068
mg	O	-1	16720068
al@@	B-Chemical	D000525	16720068
praz@@	I-Chemical	-1	16720068
ol@@	I-Chemical	-1	16720068
am	I-Chemical	-1	16720068
.	O	-1	16720068
O@@	O	-1	16720068
n	O	-1	16720068
the	O	-1	16720068
10@@	O	-1	16720068
th	O	-1	16720068
day	O	-1	16720068
of	O	-1	16720068
pa@@	B-Chemical	D017374	16720068
ro@@	I-Chemical	-1	16720068
x@@	I-Chemical	-1	16720068
et@@	I-Chemical	-1	16720068
ine	I-Chemical	-1	16720068
and	O	-1	16720068
al@@	B-Chemical	D000525	16720068
praz@@	I-Chemical	-1	16720068
ol@@	I-Chemical	-1	16720068
am	I-Chemical	-1	16720068
treatment,	O	-1	16720068
the	O	-1	16720068
patient	O	-1	16720068
ex@@	O	-1	16720068
hib@@	O	-1	16720068
ited	O	-1	16720068
mark@@	O	-1	16720068
ed	O	-1	16720068
psych@@	B-Disease	D011596	16720068
om@@	I-Disease	-1	16720068
otor	I-Disease	-1	16720068
ret@@	I-Disease	-1	16720068
ar@@	I-Disease	-1	16720068
d@@	I-Disease	-1	16720068
ation	I-Disease	-1	16720068
,	O	-1	16720068
disor@@	O	-1	16720068
i@@	O	-1	16720068
ent@@	O	-1	16720068
ation,	O	-1	16720068
and	O	-1	16720068
severe	O	-1	16720068
musc@@	B-Disease	D009127	16720068
le	I-Disease	-1	16720068
rig@@	I-Disease	-1	16720068
idity	I-Disease	-1	16720068
with	O	-1	16720068
tre@@	B-Disease	D014202	16720068
mor@@	I-Disease	-1	16720068
s	I-Disease	-1	16720068
.	O	-1	16720068
The	O	-1	16720068
patient	O	-1	16720068
had	O	-1	16720068
a	O	-1	16720068
f@@	B-Disease	D005334	16720068
ev@@	I-Disease	-1	16720068
er	I-Disease	-1	16720068
(3@@	O	-1	16720068
8.@@	O	-1	16720068
2	O	-1	16720068
de@@	O	-1	16720068
gre@@	O	-1	16720068
es	O	-1	16720068
C@@	O	-1	16720068
),	O	-1	16720068
f@@	O	-1	16720068
l@@	O	-1	16720068
uc@@	O	-1	16720068
tu@@	O	-1	16720068
ating	O	-1	16720068
blood	O	-1	16720068
pressure	O	-1	16720068
(@@	O	-1	16720068
between	O	-1	16720068
1@@	O	-1	16720068
6@@	O	-1	16720068
5@@	O	-1	16720068
/@@	O	-1	16720068
9@@	O	-1	16720068
0	O	-1	16720068
and	O	-1	16720068
13@@	O	-1	16720068
0@@	O	-1	16720068
/@@	O	-1	16720068
7@@	O	-1	16720068
0	O	-1	16720068
mg	O	-1	16720068
mm	O	-1	16720068
H@@	O	-1	16720068
g@@	O	-1	16720068
),	O	-1	16720068
and	O	-1	16720068
severe	O	-1	16720068
ext@@	B-Disease	D001480	16720068
ra@@	I-Disease	-1	16720068
py@@	I-Disease	-1	16720068
ram@@	I-Disease	-1	16720068
idal	I-Disease	-1	16720068
symptoms	I-Disease	-1	16720068
.	O	-1	16720068
L@@	O	-1	16720068
abor@@	O	-1	16720068
atory	O	-1	16720068
tests	O	-1	16720068
showed	O	-1	16720068
an	O	-1	16720068
elev@@	O	-1	16720068
ation	O	-1	16720068
of	O	-1	16720068
creat@@	B-Chemical	D003401	16720068
ine	I-Chemical	-1	16720068
phosph@@	O	-1	16720068
o@@	O	-1	16720068
kin@@	O	-1	16720068
ase	O	-1	16720068
(2@@	O	-1	16720068
2@@	O	-1	16720068
1@@	O	-1	16720068
8	O	-1	16720068
I@@	O	-1	16720068
U@@	O	-1	16720068
/@@	O	-1	16720068
L@@	O	-1	16720068
),	O	-1	16720068
as@@	B-Chemical	D001224	16720068
part@@	I-Chemical	-1	16720068
ate	I-Chemical	-1	16720068
amin@@	O	-1	16720068
ot@@	O	-1	16720068
ran@@	O	-1	16720068
s@@	O	-1	16720068
fer@@	O	-1	16720068
ase	O	-1	16720068
(1@@	O	-1	16720068
3@@	O	-1	16720068
4	O	-1	16720068
I@@	O	-1	16720068
U@@	O	-1	16720068
/@@	O	-1	16720068
L@@	O	-1	16720068
),	O	-1	16720068
al@@	B-Chemical	D000409	16720068
an@@	I-Chemical	-1	16720068
ine	I-Chemical	-1	16720068
amin@@	O	-1	16720068
ot@@	O	-1	16720068
ran@@	O	-1	16720068
s@@	O	-1	16720068
fer@@	O	-1	16720068
ase	O	-1	16720068
(@@	O	-1	16720068
7@@	O	-1	16720068
8	O	-1	16720068
I@@	O	-1	16720068
U@@	O	-1	16720068
/@@	O	-1	16720068
L@@	O	-1	16720068
),	O	-1	16720068
and	O	-1	16720068
B@@	O	-1	16720068
U@@	O	-1	16720068
N	O	-1	16720068
(2@@	O	-1	16720068
7.@@	O	-1	16720068
9	O	-1	16720068
mg/m@@	O	-1	16720068
l@@	O	-1	16720068
)	O	-1	16720068
level@@	O	-1	16720068
s.	O	-1	16720068
The	O	-1	16720068
patient	O	-1	16720068
received	O	-1	16720068
brom@@	B-Chemical	D001971	16720068
oc@@	I-Chemical	-1	16720068
ript@@	I-Chemical	-1	16720068
ine	I-Chemical	-1	16720068
and	O	-1	16720068
di@@	B-Chemical	D003975	16720068
az@@	I-Chemical	-1	16720068
epam	I-Chemical	-1	16720068
to	O	-1	16720068
tre@@	O	-1	16720068
at	O	-1	16720068
h@@	O	-1	16720068
is	O	-1	16720068
symptom@@	O	-1	16720068
s.	O	-1	16720068
7	O	-1	16720068
days	O	-1	16720068
lat@@	O	-1	16720068
er,	O	-1	16720068
the	O	-1	16720068
f@@	B-Disease	D005334	16720068
ev@@	I-Disease	-1	16720068
er	I-Disease	-1	16720068
dis@@	O	-1	16720068
appe@@	O	-1	16720068
a@@	O	-1	16720068
red	O	-1	16720068
and	O	-1	16720068
the	O	-1	16720068
patient@@	O	-1	16720068
's	O	-1	16720068
serum	O	-1	16720068
C@@	O	-1	16720068
P@@	O	-1	16720068
K	O	-1	16720068
levels	O	-1	16720068
were	O	-1	16720068
normal@@	O	-1	16720068
ized	O	-1	16720068
(1@@	O	-1	16720068
7@@	O	-1	16720068
5	O	-1	16720068
I@@	O	-1	16720068
U@@	O	-1	16720068
/@@	O	-1	16720068
L@@	O	-1	16720068
).	O	-1	16720068
This	O	-1	16720068
patient	O	-1	16720068
presented	O	-1	16720068
with	O	-1	16720068
symptoms	O	-1	16720068
of	O	-1	16720068
neuro@@	B-Disease	D009459	16720068
le@@	I-Disease	-1	16720068
p@@	I-Disease	-1	16720068
tic	I-Disease	-1	16720068
mal@@	I-Disease	-1	16720068
i@@	I-Disease	-1	16720068
gn@@	I-Disease	-1	16720068
ant	I-Disease	-1	16720068
syndrome	I-Disease	-1	16720068
(	O	-1	16720068
N@@	B-Disease	D009459	16720068
M@@	I-Disease	-1	16720068
S	I-Disease	-1	16720068
),	O	-1	16720068
th@@	O	-1	16720068
us	O	-1	16720068
demon@@	O	-1	16720068
strat@@	O	-1	16720068
ing	O	-1	16720068
that	O	-1	16720068
N@@	B-Disease	D009459	16720068
M@@	I-Disease	-1	16720068
S	I-Disease	-1	16720068
-@@	O	-1	16720068
like	O	-1	16720068
symptoms	O	-1	16720068
can	O	-1	16720068
occ@@	O	-1	16720068
ur	O	-1	16720068
after	O	-1	16720068
combined	O	-1	16720068
pa@@	B-Chemical	D017374	16720068
ro@@	I-Chemical	-1	16720068
x@@	I-Chemical	-1	16720068
et@@	I-Chemical	-1	16720068
ine	I-Chemical	-1	16720068
and	O	-1	16720068
al@@	B-Chemical	D000525	16720068
praz@@	I-Chemical	-1	16720068
ol@@	I-Chemical	-1	16720068
am	I-Chemical	-1	16720068
treatment.	O	-1	16720068
The	O	-1	16720068
adverse	O	-1	16720068
drug	O	-1	16720068
reaction	O	-1	16720068
scor@@	O	-1	16720068
e	O	-1	16720068
obtained	O	-1	16720068
by	O	-1	16720068
the	O	-1	16720068
N@@	O	-1	16720068
ar@@	O	-1	16720068
an@@	O	-1	16720068
j@@	O	-1	16720068
o	O	-1	16720068
al@@	O	-1	16720068
g@@	O	-1	16720068
or@@	O	-1	16720068
i@@	O	-1	16720068
th@@	O	-1	16720068
m	O	-1	16720068
was	O	-1	16720068
6	O	-1	16720068
in	O	-1	16720068
our	O	-1	16720068
cas@@	O	-1	16720068
e,	O	-1	16720068
indicating	O	-1	16720068
a	O	-1	16720068
prob@@	O	-1	16720068
able	O	-1	16720068
rel@@	O	-1	16720068
ationship	O	-1	16720068
between	O	-1	16720068
the	O	-1	16720068
patient@@	O	-1	16720068
's	O	-1	16720068
N@@	B-Disease	D009459	16720068
M@@	I-Disease	-1	16720068
S	I-Disease	-1	16720068
-@@	O	-1	16720068
like	O	-1	16720068
adverse	O	-1	16720068
symptoms	O	-1	16720068
and	O	-1	16720068
the	O	-1	16720068
combined	O	-1	16720068
treatment	O	-1	16720068
used	O	-1	16720068
in	O	-1	16720068
this	O	-1	16720068
cas@@	O	-1	16720068
e.	O	-1	16720068
The	O	-1	16720068
invol@@	O	-1	16720068
vement	O	-1	16720068
of	O	-1	16720068
physi@@	O	-1	16720068
ologic	O	-1	16720068
and	O	-1	16720068
en@@	O	-1	16720068
vi@@	O	-1	16720068
ron@@	O	-1	16720068
mental	O	-1	16720068
as@@	O	-1	16720068
p@@	O	-1	16720068
ects	O	-1	16720068
specific	O	-1	16720068
to	O	-1	16720068
this	O	-1	16720068
patient	O	-1	16720068
was	O	-1	16720068
sus@@	O	-1	16720068
p@@	O	-1	16720068
ect@@	O	-1	16720068
ed.	O	-1	16720068
S@@	O	-1	16720068
e@@	O	-1	16720068
ver@@	O	-1	16720068
al	O	-1	16720068
risk	O	-1	16720068
factors	O	-1	16720068
for	O	-1	16720068
N@@	B-Disease	D009459	16720068
M@@	I-Disease	-1	16720068
S	I-Disease	-1	16720068
should	O	-1	16720068
be	O	-1	16720068
not@@	O	-1	16720068
ed	O	-1	16720068
in	O	-1	16720068
el@@	O	-1	16720068
der@@	O	-1	16720068
ly	O	-1	16720068
de@@	B-Disease	D003866	16720068
pressive	I-Disease	-1	16720068
patients	O	-1	16720068
wh@@	O	-1	16720068
ose	O	-1	16720068
symptoms	O	-1	16720068
often	O	-1	16720068
includ@@	O	-1	16720068
e	O	-1	16720068
de@@	B-Disease	D003681	16720068
hy@@	I-Disease	-1	16720068
d@@	I-Disease	-1	16720068
ration	I-Disease	-1	16720068
,	O	-1	16720068
ag@@	B-Disease	D011595	16720068
it@@	I-Disease	-1	16720068
ation	I-Disease	-1	16720068
,	O	-1	16720068
mal@@	B-Disease	D044342	16720068
n@@	I-Disease	-1	16720068
ut@@	I-Disease	-1	16720068
ri@@	I-Disease	-1	16720068
tion	I-Disease	-1	16720068
,	O	-1	16720068
and	O	-1	16720068
ex@@	O	-1	16720068
ha@@	O	-1	16720068
us@@	O	-1	16720068
tion.	O	-1	16720068
Ca@@	O	-1	16720068
ref@@	O	-1	16720068
u@@	O	-1	16720068
l	O	-1	16720068
therapeutic	O	-1	16720068
inter@@	O	-1	16720068
ven@@	O	-1	16720068
tion	O	-1	16720068
is	O	-1	16720068
nec@@	O	-1	16720068
ess@@	O	-1	16720068
ary	O	-1	16720068
in	O	-1	16720068
cases	O	-1	16720068
invol@@	O	-1	16720068
ving	O	-1	16720068
el@@	O	-1	16720068
der@@	O	-1	16720068
ly	O	-1	16720068
patients	O	-1	16720068
who	O	-1	16720068
suff@@	O	-1	16720068
er	O	-1	16720068
from	O	-1	16720068
de@@	B-Disease	D003866	16720068
pression	I-Disease	-1	16720068
.	O	-1	16720068

P@@	B-Chemical	D010862	16596970
i@@	I-Chemical	-1	16596970
lo@@	I-Chemical	-1	16596970
car@@	I-Chemical	-1	16596970
pine	I-Chemical	-1	16596970
seizures	B-Disease	D012640	16596970
cause	O	-1	16596970
ag@@	O	-1	16596970
e-@@	O	-1	16596970
dependent	O	-1	16596970
impair@@	B-Disease	D001308	16596970
ment	I-Disease	-1	16596970
in	I-Disease	-1	16596970
a@@	I-Disease	-1	16596970
ud@@	I-Disease	-1	16596970
it@@	I-Disease	-1	16596970
ory	I-Disease	-1	16596970
loc@@	I-Disease	-1	16596970
ation	I-Disease	-1	16596970
dis@@	I-Disease	-1	16596970
cri@@	I-Disease	-1	16596970
min@@	I-Disease	-1	16596970
ation	I-Disease	-1	16596970
.	O	-1	16596970
Ch@@	O	-1	16596970
ild@@	O	-1	16596970
ren	O	-1	16596970
who	O	-1	16596970
have	O	-1	16596970
status	B-Disease	D013226	16596970
epilep@@	I-Disease	-1	16596970
tic@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
have	O	-1	16596970
continu@@	O	-1	16596970
ous	O	-1	16596970
or	O	-1	16596970
ra@@	O	-1	16596970
pid@@	O	-1	16596970
ly	O	-1	16596970
repe@@	O	-1	16596970
ating	O	-1	16596970
seizures	B-Disease	D012640	16596970
that	O	-1	16596970
may	O	-1	16596970
be	O	-1	16596970
lif@@	O	-1	16596970
e-@@	O	-1	16596970
th@@	O	-1	16596970
reat@@	O	-1	16596970
en@@	O	-1	16596970
ing	O	-1	16596970
and	O	-1	16596970
may	O	-1	16596970
cause	O	-1	16596970
lif@@	O	-1	16596970
e-@@	O	-1	16596970
lon@@	O	-1	16596970
g	O	-1	16596970
changes	O	-1	16596970
in	O	-1	16596970
brain	O	-1	16596970
and	O	-1	16596970
behavi@@	O	-1	16596970
or@@	O	-1	16596970
.	O	-1	16596970
The	O	-1	16596970
ext@@	O	-1	16596970
ent	O	-1	16596970
to	O	-1	16596970
which	O	-1	16596970
status	B-Disease	D013226	16596970
epilep@@	I-Disease	-1	16596970
tic@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
causes	O	-1	16596970
defic@@	B-Disease	D001308	16596970
its	I-Disease	-1	16596970
in	I-Disease	-1	16596970
a@@	I-Disease	-1	16596970
ud@@	I-Disease	-1	16596970
it@@	I-Disease	-1	16596970
ory	I-Disease	-1	16596970
dis@@	I-Disease	-1	16596970
cri@@	I-Disease	-1	16596970
min@@	I-Disease	-1	16596970
ation	I-Disease	-1	16596970
is	O	-1	16596970
un@@	O	-1	16596970
know@@	O	-1	16596970
n@@	O	-1	16596970
.	O	-1	16596970
A	O	-1	16596970
n@@	O	-1	16596970
at@@	O	-1	16596970
ur@@	O	-1	16596970
al@@	O	-1	16596970
istic	O	-1	16596970
a@@	O	-1	16596970
ud@@	O	-1	16596970
it@@	O	-1	16596970
ory	O	-1	16596970
loc@@	O	-1	16596970
ation	O	-1	16596970
dis@@	O	-1	16596970
cri@@	O	-1	16596970
min@@	O	-1	16596970
ation	O	-1	16596970
meth@@	O	-1	16596970
od	O	-1	16596970
was	O	-1	16596970
used	O	-1	16596970
to	O	-1	16596970
evalu@@	O	-1	16596970
ate	O	-1	16596970
this	O	-1	16596970
qu@@	O	-1	16596970
es@@	O	-1	16596970
tion	O	-1	16596970
using	O	-1	16596970
an	O	-1	16596970
anim@@	O	-1	16596970
al	O	-1	16596970
model	O	-1	16596970
of	O	-1	16596970
status	B-Disease	D013226	16596970
epilep@@	I-Disease	-1	16596970
tic@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
.	O	-1	16596970
M@@	O	-1	16596970
al@@	O	-1	16596970
e	O	-1	16596970
S@@	O	-1	16596970
pra@@	O	-1	16596970
gu@@	O	-1	16596970
e-@@	O	-1	16596970
D@@	O	-1	16596970
aw@@	O	-1	16596970
le@@	O	-1	16596970
y	O	-1	16596970
rats	O	-1	16596970
were	O	-1	16596970
injected	O	-1	16596970
with	O	-1	16596970
saline	O	-1	16596970
on	O	-1	16596970
post@@	O	-1	16596970
n@@	O	-1	16596970
atal	O	-1	16596970
day	O	-1	16596970
(P@@	O	-1	16596970
)	O	-1	16596970
20@@	O	-1	16596970
,	O	-1	16596970
or	O	-1	16596970
a	O	-1	16596970
convul@@	O	-1	16596970
s@@	O	-1	16596970
ant	O	-1	16596970
dose	O	-1	16596970
of	O	-1	16596970
pilocar@@	B-Chemical	D010862	16596970
pine	I-Chemical	-1	16596970
on	O	-1	16596970
P@@	O	-1	16596970
20	O	-1	16596970
or	O	-1	16596970
P@@	O	-1	16596970
4@@	O	-1	16596970
5@@	O	-1	16596970
.	O	-1	16596970
P@@	B-Chemical	D010862	16596970
i@@	I-Chemical	-1	16596970
lo@@	I-Chemical	-1	16596970
car@@	I-Chemical	-1	16596970
pine	I-Chemical	-1	16596970
on	O	-1	16596970
either	O	-1	16596970
day	O	-1	16596970
induced	O	-1	16596970
status	B-Disease	D013226	16596970
epilep@@	I-Disease	-1	16596970
tic@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
;	O	-1	16596970
status	B-Disease	D013226	16596970
epilep@@	I-Disease	-1	16596970
tic@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
at	O	-1	16596970
P@@	O	-1	16596970
4@@	O	-1	16596970
5	O	-1	16596970
resulted	O	-1	16596970
in	O	-1	16596970
CA@@	O	-1	16596970
3	O	-1	16596970
cell	O	-1	16596970
loss	O	-1	16596970
and	O	-1	16596970
spont@@	O	-1	16596970
aneous	O	-1	16596970
seizures	B-Disease	D012640	16596970
,	O	-1	16596970
whereas	O	-1	16596970
P@@	O	-1	16596970
20	O	-1	16596970
rats	O	-1	16596970
had	O	-1	16596970
no	O	-1	16596970
cell	O	-1	16596970
loss	O	-1	16596970
or	O	-1	16596970
spont@@	O	-1	16596970
aneous	O	-1	16596970
seizures	B-Disease	D012640	16596970
.	O	-1	16596970
M@@	O	-1	16596970
at@@	O	-1	16596970
ure	O	-1	16596970
rats	O	-1	16596970
were	O	-1	16596970
tra@@	O	-1	16596970
in@@	O	-1	16596970
ed	O	-1	16596970
with	O	-1	16596970
s@@	O	-1	16596970
oun@@	O	-1	16596970
d-@@	O	-1	16596970
so@@	O	-1	16596970
ur@@	O	-1	16596970
ce	O	-1	16596970
loc@@	O	-1	16596970
ation	O	-1	16596970
and	O	-1	16596970
s@@	O	-1	16596970
oun@@	O	-1	16596970
d-@@	O	-1	16596970
si@@	O	-1	16596970
l@@	O	-1	16596970
ence	O	-1	16596970
dis@@	O	-1	16596970
cri@@	O	-1	16596970
min@@	O	-1	16596970
ations.	O	-1	16596970
C@@	O	-1	16596970
ont@@	O	-1	16596970
ro@@	O	-1	16596970
l	O	-1	16596970
(@@	O	-1	16596970
saline	O	-1	16596970
P@@	O	-1	16596970
20@@	O	-1	16596970
)	O	-1	16596970
rats	O	-1	16596970
ac@@	O	-1	16596970
qu@@	O	-1	16596970
ired	O	-1	16596970
both	O	-1	16596970
dis@@	O	-1	16596970
cri@@	O	-1	16596970
min@@	O	-1	16596970
ations	O	-1	16596970
immedi@@	O	-1	16596970
at@@	O	-1	16596970
el@@	O	-1	16596970
y.	O	-1	16596970
In	O	-1	16596970
status	B-Disease	D013226	16596970
epilep@@	I-Disease	-1	16596970
tic@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
(P@@	O	-1	16596970
20@@	O	-1	16596970
)	O	-1	16596970
rats,	O	-1	16596970
ac@@	O	-1	16596970
qu@@	O	-1	16596970
i@@	O	-1	16596970
si@@	O	-1	16596970
tion	O	-1	16596970
of	O	-1	16596970
the	O	-1	16596970
s@@	O	-1	16596970
oun@@	O	-1	16596970
d-@@	O	-1	16596970
so@@	O	-1	16596970
ur@@	O	-1	16596970
ce	O	-1	16596970
loc@@	O	-1	16596970
ation	O	-1	16596970
dis@@	O	-1	16596970
cri@@	O	-1	16596970
min@@	O	-1	16596970
ation	O	-1	16596970
was	O	-1	16596970
moder@@	O	-1	16596970
ately	O	-1	16596970
impa@@	O	-1	16596970
i@@	O	-1	16596970
red.	O	-1	16596970
S@@	B-Disease	D013226	16596970
t@@	I-Disease	-1	16596970
at@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
epilep@@	I-Disease	-1	16596970
tic@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
(P@@	O	-1	16596970
4@@	O	-1	16596970
5@@	O	-1	16596970
)	O	-1	16596970
rats	O	-1	16596970
fail@@	O	-1	16596970
ed	O	-1	16596970
to	O	-1	16596970
ac@@	O	-1	16596970
qu@@	O	-1	16596970
ir@@	O	-1	16596970
e	O	-1	16596970
either	O	-1	16596970
s@@	O	-1	16596970
oun@@	O	-1	16596970
d-@@	O	-1	16596970
so@@	O	-1	16596970
ur@@	O	-1	16596970
ce	O	-1	16596970
loc@@	O	-1	16596970
ation	O	-1	16596970
or	O	-1	16596970
s@@	O	-1	16596970
oun@@	O	-1	16596970
d-@@	O	-1	16596970
si@@	O	-1	16596970
l@@	O	-1	16596970
ence	O	-1	16596970
dis@@	O	-1	16596970
cri@@	O	-1	16596970
min@@	O	-1	16596970
ations.	O	-1	16596970
S@@	B-Disease	D013226	16596970
t@@	I-Disease	-1	16596970
at@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
epilep@@	I-Disease	-1	16596970
tic@@	I-Disease	-1	16596970
us	I-Disease	-1	16596970
in	O	-1	16596970
rat	O	-1	16596970
causes	O	-1	16596970
an	O	-1	16596970
ag@@	O	-1	16596970
e-@@	O	-1	16596970
depend@@	O	-1	16596970
ent@@	O	-1	16596970
,	O	-1	16596970
long-term	O	-1	16596970
impair@@	B-Disease	D001308	16596970
ment	I-Disease	-1	16596970
in	I-Disease	-1	16596970
a@@	I-Disease	-1	16596970
ud@@	I-Disease	-1	16596970
it@@	I-Disease	-1	16596970
ory	I-Disease	-1	16596970
dis@@	I-Disease	-1	16596970
cri@@	I-Disease	-1	16596970
min@@	I-Disease	-1	16596970
ation	I-Disease	-1	16596970
.	O	-1	16596970
This	O	-1	16596970
impair@@	O	-1	16596970
ment	O	-1	16596970
may	O	-1	16596970
expl@@	O	-1	16596970
ain	O	-1	16596970
one	O	-1	16596970
cause	O	-1	16596970
of	O	-1	16596970
impaired	B-Disease	D001308	16596970
a@@	I-Disease	-1	16596970
ud@@	I-Disease	-1	16596970
it@@	I-Disease	-1	16596970
ory	I-Disease	-1	16596970
loc@@	I-Disease	-1	16596970
ation	I-Disease	-1	16596970
dis@@	I-Disease	-1	16596970
cri@@	I-Disease	-1	16596970
min@@	I-Disease	-1	16596970
ation	I-Disease	-1	16596970
in	O	-1	16596970
hum@@	O	-1	16596970
an@@	O	-1	16596970
s.	O	-1	16596970

C@@	O	-1	16586083
ardi@@	O	-1	16586083
o@@	O	-1	16586083
vascular	O	-1	16586083
risk	O	-1	16586083
with	O	-1	16586083
cyclo@@	B-Chemical	D016861	16586083
oxy@@	I-Chemical	-1	16586083
gen@@	I-Chemical	-1	16586083
ase	I-Chemical	-1	16586083
inhibitors	I-Chemical	-1	16586083
:	O	-1	16586083
gener@@	O	-1	16586083
al	O	-1	16586083
pro@@	O	-1	16586083
ble@@	O	-1	16586083
m	O	-1	16586083
with	O	-1	16586083
subst@@	O	-1	16586083
ance	O	-1	16586083
specific	O	-1	16586083
differen@@	O	-1	16586083
ces@@	O	-1	16586083
?	O	-1	16586083
R@@	O	-1	16586083
an@@	O	-1	16586083
dom@@	O	-1	16586083
is@@	O	-1	16586083
ed	O	-1	16586083
clinical	O	-1	16586083
tri@@	O	-1	16586083
als	O	-1	16586083
and	O	-1	16586083
observ@@	O	-1	16586083
ation@@	O	-1	16586083
al	O	-1	16586083
studies	O	-1	16586083
have	O	-1	16586083
shown	O	-1	16586083
an	O	-1	16586083
increased	O	-1	16586083
risk	O	-1	16586083
of	O	-1	16586083
myocardial	B-Disease	D009203	16586083
infarction	I-Disease	-1	16586083
,	O	-1	16586083
strok@@	B-Disease	D020521	16586083
e	I-Disease	-1	16586083
,	O	-1	16586083
hypertension	B-Disease	D006973	16586083
and	O	-1	16586083
heart	B-Disease	D006333	16586083
failure	I-Disease	-1	16586083
during	O	-1	16586083
treatment	O	-1	16586083
with	O	-1	16586083
cyclo@@	B-Chemical	D016861	16586083
oxy@@	I-Chemical	-1	16586083
gen@@	I-Chemical	-1	16586083
ase	I-Chemical	-1	16586083
inhibitors	I-Chemical	-1	16586083
.	O	-1	16586083
Ad@@	O	-1	16586083
verse	O	-1	16586083
cardiovascular	O	-1	16586083
effects	O	-1	16586083
occurred	O	-1	16586083
main@@	O	-1	16586083
ly,	O	-1	16586083
but	O	-1	16586083
not	O	-1	16586083
ex@@	O	-1	16586083
cl@@	O	-1	16586083
u@@	O	-1	16586083
si@@	O	-1	16586083
vel@@	O	-1	16586083
y,	O	-1	16586083
in	O	-1	16586083
patients	O	-1	16586083
with	O	-1	16586083
concomit@@	O	-1	16586083
ant	O	-1	16586083
risk	O	-1	16586083
fact@@	O	-1	16586083
or@@	O	-1	16586083
s.	O	-1	16586083
C@@	B-Chemical	D016861	16586083
yc@@	I-Chemical	-1	16586083
lo@@	I-Chemical	-1	16586083
oxy@@	I-Chemical	-1	16586083
gen@@	I-Chemical	-1	16586083
ase	I-Chemical	-1	16586083
inhibitors	I-Chemical	-1	16586083
cause	O	-1	16586083
comple@@	O	-1	16586083
x	O	-1	16586083
changes	O	-1	16586083
in	O	-1	16586083
ren@@	O	-1	16586083
al,	O	-1	16586083
vascular	O	-1	16586083
and	O	-1	16586083
cardiac	O	-1	16586083
pro@@	O	-1	16586083
st@@	O	-1	16586083
an@@	O	-1	16586083
oid	O	-1	16586083
pro@@	O	-1	16586083
fi@@	O	-1	16586083
le@@	O	-1	16586083
s	O	-1	16586083
the@@	O	-1	16586083
re@@	O	-1	16586083
by	O	-1	16586083
increas@@	O	-1	16586083
ing	O	-1	16586083
vascular	O	-1	16586083
resist@@	O	-1	16586083
ance	O	-1	16586083
and	O	-1	16586083
flu@@	O	-1	16586083
id	O	-1	16586083
re@@	O	-1	16586083
ten@@	O	-1	16586083
tion.	O	-1	16586083
The	O	-1	16586083
incidence	O	-1	16586083
of	O	-1	16586083
cardiovascular	O	-1	16586083
adverse	O	-1	16586083
events	O	-1	16586083
ten@@	O	-1	16586083
ds	O	-1	16586083
to	O	-1	16586083
increase	O	-1	16586083
with	O	-1	16586083
the	O	-1	16586083
daily	O	-1	16586083
dose	O	-1	16586083
and	O	-1	16586083
total	O	-1	16586083
exposure	O	-1	16586083
ti@@	O	-1	16586083
me.	O	-1	16586083
A	O	-1	16586083
compar@@	O	-1	16586083
ison	O	-1	16586083
of	O	-1	16586083
individ@@	O	-1	16586083
ual	O	-1	16586083
selective	O	-1	16586083
and	O	-1	16586083
un@@	O	-1	16586083
selective	O	-1	16586083
cyclo@@	B-Chemical	D016861	16586083
oxy@@	I-Chemical	-1	16586083
gen@@	I-Chemical	-1	16586083
ase	I-Chemical	-1	16586083
inhibitors	I-Chemical	-1	16586083
suggests	O	-1	16586083
subst@@	O	-1	16586083
ance@@	O	-1	16586083
-@@	O	-1	16586083
specific	O	-1	16586083
differen@@	O	-1	16586083
c@@	O	-1	16586083
es,	O	-1	16586083
which	O	-1	16586083
may	O	-1	16586083
depen@@	O	-1	16586083
d	O	-1	16586083
on	O	-1	16586083
differences	O	-1	16586083
in	O	-1	16586083
pharmac@@	O	-1	16586083
o@@	O	-1	16586083
kine@@	O	-1	16586083
tic	O	-1	16586083
par@@	O	-1	16586083
ame@@	O	-1	16586083
ters	O	-1	16586083
or	O	-1	16586083
inhibit@@	O	-1	16586083
ory	O	-1	16586083
poten@@	O	-1	16586083
c@@	O	-1	16586083
y	O	-1	16586083
and	O	-1	16586083
may	O	-1	16586083
be	O	-1	16586083
cont@@	O	-1	16586083
ri@@	O	-1	16586083
but@@	O	-1	16586083
ed	O	-1	16586083
by	O	-1	16586083
pro@@	B-Chemical	D011453	16586083
st@@	I-Chemical	-1	16586083
ag@@	I-Chemical	-1	16586083
l@@	I-Chemical	-1	16586083
and@@	I-Chemical	-1	16586083
in	I-Chemical	-1	16586083
-@@	O	-1	16586083
in@@	O	-1	16586083
dependent	O	-1	16586083
effects.	O	-1	16586083
Di@@	O	-1	16586083
ag@@	O	-1	16586083
nos@@	O	-1	16586083
tic	O	-1	16586083
mark@@	O	-1	16586083
ers	O	-1	16586083
such	O	-1	16586083
as	O	-1	16586083
N@@	B-Chemical	C109794	16586083
-@@	I-Chemical	-1	16586083
ter@@	I-Chemical	-1	16586083
min@@	I-Chemical	-1	16586083
al	I-Chemical	-1	16586083
pr@@	I-Chemical	-1	16586083
o	I-Chemical	-1	16586083
brain	I-Chemical	-1	16586083
n@@	I-Chemical	-1	16586083
atri@@	I-Chemical	-1	16586083
ure@@	I-Chemical	-1	16586083
tic	I-Chemical	-1	16586083
p@@	I-Chemical	-1	16586083
ep@@	I-Chemical	-1	16586083
ti@@	I-Chemical	-1	16586083
de	I-Chemical	-1	16586083
(	O	-1	16586083
N@@	B-Chemical	C109794	16586083
T@@	I-Chemical	-1	16586083
-@@	I-Chemical	-1	16586083
pro@@	I-Chemical	-1	16586083
B@@	I-Chemical	-1	16586083
N@@	I-Chemical	-1	16586083
P	I-Chemical	-1	16586083
)	O	-1	16586083
or	O	-1	16586083
high-@@	O	-1	16586083
sensitive	O	-1	16586083
C@@	O	-1	16586083
-@@	O	-1	16586083
reac@@	O	-1	16586083
tive	O	-1	16586083
protein	O	-1	16586083
might	O	-1	16586083
he@@	O	-1	16586083
l@@	O	-1	16586083
p	O	-1	16586083
in	O	-1	16586083
the	O	-1	16586083
early	O	-1	16586083
identi@@	O	-1	16586083
fic@@	O	-1	16586083
ation	O	-1	16586083
of	O	-1	16586083
patients	O	-1	16586083
at	O	-1	16586083
ris@@	O	-1	16586083
k@@	O	-1	16586083
,	O	-1	16586083
th@@	O	-1	16586083
us	O	-1	16586083
avoid@@	O	-1	16586083
ing	O	-1	16586083
the	O	-1	16586083
occur@@	O	-1	16586083
rence	O	-1	16586083
of	O	-1	16586083
seri@@	O	-1	16586083
ous	O	-1	16586083
cardiovascular	B-Disease	D002318	16586083
toxicity	I-Disease	-1	16586083
.	O	-1	16586083

Pre@@	O	-1	10539815
dic@@	O	-1	10539815
t@@	O	-1	10539815
ors	O	-1	10539815
of	O	-1	10539815
decreased	B-Disease	D051437	10539815
renal	I-Disease	-1	10539815
function	I-Disease	-1	10539815
in	O	-1	10539815
patients	O	-1	10539815
with	O	-1	10539815
heart	B-Disease	D006333	10539815
failure	I-Disease	-1	10539815
during	O	-1	10539815
angiotens@@	B-Chemical	D000809	10539815
in	I-Chemical	-1	10539815
-@@	O	-1	10539815
conver@@	O	-1	10539815
ting	O	-1	10539815
enzyme	O	-1	10539815
inhibitor	O	-1	10539815
therap@@	O	-1	10539815
y@@	O	-1	10539815
:	O	-1	10539815
results	O	-1	10539815
from	O	-1	10539815
the	O	-1	10539815
studies	O	-1	10539815
of	O	-1	10539815
left	B-Disease	D018487	10539815
ventricular	I-Disease	-1	10539815
dysfunction	I-Disease	-1	10539815
(S@@	O	-1	10539815
O@@	O	-1	10539815
L@@	O	-1	10539815
V@@	O	-1	10539815
D)	O	-1	10539815
BACKGROUND:	O	-1	10539815
Although	O	-1	10539815
angiotens@@	B-Chemical	D000809	10539815
in	I-Chemical	-1	10539815
-@@	O	-1	10539815
conver@@	O	-1	10539815
ting	O	-1	10539815
enzyme	O	-1	10539815
inhibitor	O	-1	10539815
therapy	O	-1	10539815
reduc@@	O	-1	10539815
es	O	-1	10539815
mor@@	O	-1	10539815
t@@	O	-1	10539815
ality	O	-1	10539815
rat@@	O	-1	10539815
es	O	-1	10539815
in	O	-1	10539815
patients	O	-1	10539815
with	O	-1	10539815
con@@	B-Disease	D006333	10539815
g@@	I-Disease	-1	10539815
es@@	I-Disease	-1	10539815
tive	I-Disease	-1	10539815
heart	I-Disease	-1	10539815
failure	I-Disease	-1	10539815
(	O	-1	10539815
C@@	B-Disease	D006333	10539815
H@@	I-Disease	-1	10539815
F	I-Disease	-1	10539815
),	O	-1	10539815
it	O	-1	10539815
may	O	-1	10539815
also	O	-1	10539815
cause	O	-1	10539815
decreased	B-Disease	D051437	10539815
renal	I-Disease	-1	10539815
function	I-Disease	-1	10539815
.	O	-1	10539815
L@@	O	-1	10539815
it@@	O	-1	10539815
t@@	O	-1	10539815
le	O	-1	10539815
inf@@	O	-1	10539815
orm@@	O	-1	10539815
ation	O	-1	10539815
is	O	-1	10539815
av@@	O	-1	10539815
ail@@	O	-1	10539815
able	O	-1	10539815
to	O	-1	10539815
predic@@	O	-1	10539815
t	O	-1	10539815
which	O	-1	10539815
patients	O	-1	10539815
are	O	-1	10539815
at	O	-1	10539815
high@@	O	-1	10539815
est	O	-1	10539815
risk	O	-1	10539815
for	O	-1	10539815
this	O	-1	10539815
complic@@	O	-1	10539815
ation.	O	-1	10539815
OBJECTIVE:	O	-1	10539815
To	O	-1	10539815
qu@@	O	-1	10539815
anti@@	O	-1	10539815
f@@	O	-1	10539815
y	O	-1	10539815
specific	O	-1	10539815
clinical	O	-1	10539815
predic@@	O	-1	10539815
t@@	O	-1	10539815
ors	O	-1	10539815
of	O	-1	10539815
reduction	B-Disease	D051437	10539815
in	I-Disease	-1	10539815
renal	I-Disease	-1	10539815
function	I-Disease	-1	10539815
in	O	-1	10539815
patients	O	-1	10539815
with	O	-1	10539815
C@@	B-Disease	D006333	10539815
H@@	I-Disease	-1	10539815
F	I-Disease	-1	10539815
who	O	-1	10539815
are	O	-1	10539815
prescri@@	O	-1	10539815
bed	O	-1	10539815
angiotens@@	B-Chemical	D000809	10539815
in	I-Chemical	-1	10539815
-@@	O	-1	10539815
conver@@	O	-1	10539815
ting	O	-1	10539815
enzyme	O	-1	10539815
inhibitor	O	-1	10539815
therapy.	O	-1	10539815
METHOD@@	O	-1	10539815
:	O	-1	10539815
We	O	-1	10539815
analy@@	O	-1	10539815
zed	O	-1	10539815
data	O	-1	10539815
from	O	-1	10539815
the	O	-1	10539815
S@@	O	-1	10539815
t@@	O	-1	10539815
udi@@	O	-1	10539815
es	O	-1	10539815
of	O	-1	10539815
L@@	B-Disease	D018487	10539815
e@@	I-Disease	-1	10539815
ft	I-Disease	-1	10539815
V@@	I-Disease	-1	10539815
entr@@	I-Disease	-1	10539815
ic@@	I-Disease	-1	10539815
ular	I-Disease	-1	10539815
D@@	I-Disease	-1	10539815
ys@@	I-Disease	-1	10539815
function	I-Disease	-1	10539815
(S@@	O	-1	10539815
O@@	O	-1	10539815
L@@	O	-1	10539815
V@@	O	-1	10539815
D@@	O	-1	10539815
),	O	-1	10539815
a	O	-1	10539815
random@@	O	-1	10539815
iz@@	O	-1	10539815
ed,	O	-1	10539815
double-bl@@	O	-1	10539815
ind@@	O	-1	10539815
,	O	-1	10539815
placebo@@	O	-1	10539815
-@@	O	-1	10539815
controlled	O	-1	10539815
trial	O	-1	10539815
of	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
for	O	-1	10539815
the	O	-1	10539815
treatment	O	-1	10539815
of	O	-1	10539815
C@@	B-Disease	D006333	10539815
H@@	I-Disease	-1	10539815
F	I-Disease	-1	10539815
.	O	-1	10539815
There	O	-1	10539815
were	O	-1	10539815
3@@	O	-1	10539815
3@@	O	-1	10539815
7@@	O	-1	10539815
9	O	-1	10539815
patients	O	-1	10539815
random@@	O	-1	10539815
ly	O	-1	10539815
as@@	O	-1	10539815
signed	O	-1	10539815
to	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
with	O	-1	10539815
a	O	-1	10539815
median	O	-1	10539815
follow-up	O	-1	10539815
of	O	-1	10539815
9@@	O	-1	10539815
7@@	O	-1	10539815
4	O	-1	10539815
days	O	-1	10539815
and	O	-1	10539815
3@@	O	-1	10539815
3@@	O	-1	10539815
7@@	O	-1	10539815
9	O	-1	10539815
patients	O	-1	10539815
random@@	O	-1	10539815
ly	O	-1	10539815
as@@	O	-1	10539815
signed	O	-1	10539815
to	O	-1	10539815
placebo	O	-1	10539815
with	O	-1	10539815
a	O	-1	10539815
mean	O	-1	10539815
follow-up	O	-1	10539815
of	O	-1	10539815
9@@	O	-1	10539815
6@@	O	-1	10539815
7	O	-1	10539815
days.	O	-1	10539815
D@@	B-Disease	D051437	10539815
ec@@	I-Disease	-1	10539815
reas@@	I-Disease	-1	10539815
ed	I-Disease	-1	10539815
renal	I-Disease	-1	10539815
function	I-Disease	-1	10539815
was	O	-1	10539815
def@@	O	-1	10539815
in@@	O	-1	10539815
ed	O	-1	10539815
as	O	-1	10539815
a	O	-1	10539815
ri@@	O	-1	10539815
se	O	-1	10539815
in	O	-1	10539815
serum	O	-1	10539815
creatinine	B-Chemical	D003404	10539815
>@@	O	-1	10539815
/@@	O	-1	10539815
=@@	O	-1	10539815
0.@@	O	-1	10539815
5	O	-1	10539815
mg/d@@	O	-1	10539815
L	O	-1	10539815
(4@@	O	-1	10539815
4	O	-1	10539815
mic@@	O	-1	10539815
rom@@	O	-1	10539815
ol@@	O	-1	10539815
/@@	O	-1	10539815
L@@	O	-1	10539815
)	O	-1	10539815
from	O	-1	10539815
basel@@	O	-1	10539815
ine.	O	-1	10539815
We	O	-1	10539815
used	O	-1	10539815
ti@@	O	-1	10539815
me@@	O	-1	10539815
-@@	O	-1	10539815
to@@	O	-1	10539815
-@@	O	-1	10539815
ev@@	O	-1	10539815
ent	O	-1	10539815
analysis	O	-1	10539815
to	O	-1	10539815
identi@@	O	-1	10539815
f@@	O	-1	10539815
y	O	-1	10539815
potential	O	-1	10539815
predic@@	O	-1	10539815
t@@	O	-1	10539815
ors	O	-1	10539815
of	O	-1	10539815
decrease	O	-1	10539815
in	O	-1	10539815
renal	O	-1	10539815
function	O	-1	10539815
including	O	-1	10539815
age,	O	-1	10539815
baseline	O	-1	10539815
e@@	O	-1	10539815
j@@	O	-1	10539815
ection	O	-1	10539815
frac@@	O	-1	10539815
tion,	O	-1	10539815
baseline	O	-1	10539815
creatinine	B-Chemical	D003404	10539815
,	O	-1	10539815
low	O	-1	10539815
systolic	O	-1	10539815
blood	O	-1	10539815
pressure	O	-1	10539815
(@@	O	-1	10539815
<@@	O	-1	10539815
100	O	-1	10539815
mm	O	-1	10539815
H@@	O	-1	10539815
g@@	O	-1	10539815
),	O	-1	10539815
hist@@	O	-1	10539815
ory	O	-1	10539815
of	O	-1	10539815
hypertension	B-Disease	D006973	10539815
,	O	-1	10539815
dia@@	B-Disease	D003920	10539815
bet@@	I-Disease	-1	10539815
es	I-Disease	-1	10539815
,	O	-1	10539815
and	O	-1	10539815
use	O	-1	10539815
of	O	-1	10539815
anti@@	O	-1	10539815
platele@@	O	-1	10539815
t,	O	-1	10539815
di@@	B-Chemical	D004232	10539815
ure@@	I-Chemical	-1	10539815
tic	I-Chemical	-1	10539815
,	O	-1	10539815
and	O	-1	10539815
beta-@@	O	-1	10539815
block@@	O	-1	10539815
er	O	-1	10539815
therapy.	O	-1	10539815
RESULTS:	O	-1	10539815
Patients	O	-1	10539815
random@@	O	-1	10539815
ly	O	-1	10539815
as@@	O	-1	10539815
signed	O	-1	10539815
to	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
had	O	-1	10539815
a	O	-1	10539815
3@@	O	-1	10539815
3@@	O	-1	10539815
%	O	-1	10539815
greater	O	-1	10539815
lik@@	O	-1	10539815
e@@	O	-1	10539815
li@@	O	-1	10539815
ho@@	O	-1	10539815
od	O	-1	10539815
of	O	-1	10539815
decreased	B-Disease	D051437	10539815
renal	I-Disease	-1	10539815
function	I-Disease	-1	10539815
than	O	-1	10539815
controls	O	-1	10539815
(P	O	-1	10539815
=@@	O	-1	10539815
.@@	O	-1	10539815
0@@	O	-1	10539815
0@@	O	-1	10539815
3@@	O	-1	10539815
).	O	-1	10539815
B@@	O	-1	10539815
y	O	-1	10539815
mul@@	O	-1	10539815
tiv@@	O	-1	10539815
ari@@	O	-1	10539815
ate	O	-1	10539815
analy@@	O	-1	10539815
sis,	O	-1	10539815
in	O	-1	10539815
both	O	-1	10539815
the	O	-1	10539815
placebo	O	-1	10539815
and	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
groups	O	-1	10539815
ol@@	O	-1	10539815
der	O	-1	10539815
age,	O	-1	10539815
di@@	B-Chemical	D004232	10539815
ure@@	I-Chemical	-1	10539815
tic	I-Chemical	-1	10539815
therapy,	O	-1	10539815
and	O	-1	10539815
dia@@	B-Disease	D003920	10539815
bet@@	I-Disease	-1	10539815
es	I-Disease	-1	10539815
were	O	-1	10539815
associated	O	-1	10539815
with	O	-1	10539815
decreased	B-Disease	D051437	10539815
renal	I-Disease	-1	10539815
function	I-Disease	-1	10539815
,	O	-1	10539815
whereas	O	-1	10539815
beta-@@	O	-1	10539815
block@@	O	-1	10539815
er	O	-1	10539815
therapy	O	-1	10539815
and	O	-1	10539815
higher	O	-1	10539815
e@@	O	-1	10539815
j@@	O	-1	10539815
ection	O	-1	10539815
frac@@	O	-1	10539815
tion	O	-1	10539815
were	O	-1	10539815
ren@@	O	-1	10539815
o@@	O	-1	10539815
prot@@	O	-1	10539815
ecti@@	O	-1	10539815
ve.	O	-1	10539815
O@@	O	-1	10539815
l@@	O	-1	10539815
der	O	-1	10539815
age	O	-1	10539815
was	O	-1	10539815
associated	O	-1	10539815
with	O	-1	10539815
a	O	-1	10539815
greater	O	-1	10539815
risk	O	-1	10539815
of	O	-1	10539815
develop@@	O	-1	10539815
ing	O	-1	10539815
decreased	B-Disease	D051437	10539815
renal	I-Disease	-1	10539815
function	I-Disease	-1	10539815
in	O	-1	10539815
both	O	-1	10539815
group@@	O	-1	10539815
s,	O	-1	10539815
but	O	-1	10539815
significantly	O	-1	10539815
more	O	-1	10539815
so	O	-1	10539815
in	O	-1	10539815
the	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
group	O	-1	10539815
(	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
:	O	-1	10539815
risk	O	-1	10539815
rati@@	O	-1	10539815
o	O	-1	10539815
[@@	O	-1	10539815
R@@	O	-1	10539815
R@@	O	-1	10539815
]	O	-1	10539815
1.@@	O	-1	10539815
4@@	O	-1	10539815
2	O	-1	10539815
per	O	-1	10539815
10	O	-1	10539815
year@@	O	-1	10539815
s,	O	-1	10539815
95%	O	-1	10539815
conf@@	O	-1	10539815
idence	O	-1	10539815
interv@@	O	-1	10539815
al	O	-1	10539815
[@@	O	-1	10539815
CI@@	O	-1	10539815
]	O	-1	10539815
1.@@	O	-1	10539815
3@@	O	-1	10539815
2-@@	O	-1	10539815
1.@@	O	-1	10539815
5@@	O	-1	10539815
2	O	-1	10539815
with	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
;	O	-1	10539815
placebo@@	O	-1	10539815
:	O	-1	10539815
R@@	O	-1	10539815
R	O	-1	10539815
1.@@	O	-1	10539815
18@@	O	-1	10539815
,	O	-1	10539815
95%	O	-1	10539815
C@@	O	-1	10539815
I	O	-1	10539815
1.@@	O	-1	10539815
1@@	O	-1	10539815
2-@@	O	-1	10539815
1.@@	O	-1	10539815
25@@	O	-1	10539815
).	O	-1	10539815
Di@@	B-Chemical	D004232	10539815
ure@@	I-Chemical	-1	10539815
tic	I-Chemical	-1	10539815
therapy	O	-1	10539815
was	O	-1	10539815
lik@@	O	-1	10539815
e@@	O	-1	10539815
w@@	O	-1	10539815
is@@	O	-1	10539815
e	O	-1	10539815
associated	O	-1	10539815
with	O	-1	10539815
a	O	-1	10539815
greater	O	-1	10539815
risk	O	-1	10539815
of	O	-1	10539815
decreased	B-Disease	D051437	10539815
renal	I-Disease	-1	10539815
function	I-Disease	-1	10539815
in	O	-1	10539815
the	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
group	O	-1	10539815
(@@	O	-1	10539815
R@@	O	-1	10539815
R	O	-1	10539815
1.@@	O	-1	10539815
8@@	O	-1	10539815
9@@	O	-1	10539815
,	O	-1	10539815
95%	O	-1	10539815
C@@	O	-1	10539815
I	O	-1	10539815
1.@@	O	-1	10539815
7@@	O	-1	10539815
0-@@	O	-1	10539815
2.@@	O	-1	10539815
0@@	O	-1	10539815
8@@	O	-1	10539815
)	O	-1	10539815
than	O	-1	10539815
in	O	-1	10539815
the	O	-1	10539815
placebo	O	-1	10539815
group	O	-1	10539815
(@@	O	-1	10539815
R@@	O	-1	10539815
R	O	-1	10539815
1.@@	O	-1	10539815
3@@	O	-1	10539815
5,	O	-1	10539815
95%	O	-1	10539815
C@@	O	-1	10539815
I	O	-1	10539815
1.@@	O	-1	10539815
0@@	O	-1	10539815
9@@	O	-1	10539815
-@@	O	-1	10539815
1.@@	O	-1	10539815
6@@	O	-1	10539815
6@@	O	-1	10539815
).	O	-1	10539815
Con@@	O	-1	10539815
ver@@	O	-1	10539815
sel@@	O	-1	10539815
y,	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
had	O	-1	10539815
a	O	-1	10539815
rel@@	O	-1	10539815
ative	O	-1	10539815
ren@@	O	-1	10539815
o@@	O	-1	10539815
protective	O	-1	10539815
effect	O	-1	10539815
(@@	O	-1	10539815
R@@	O	-1	10539815
R	O	-1	10539815
1.@@	O	-1	10539815
3@@	O	-1	10539815
3,	O	-1	10539815
95%	O	-1	10539815
C@@	O	-1	10539815
I	O	-1	10539815
1.@@	O	-1	10539815
1@@	O	-1	10539815
3-@@	O	-1	10539815
1.@@	O	-1	10539815
5@@	O	-1	10539815
3@@	O	-1	10539815
)	O	-1	10539815
compared	O	-1	10539815
with	O	-1	10539815
placebo	O	-1	10539815
(@@	O	-1	10539815
R@@	O	-1	10539815
R	O	-1	10539815
1.@@	O	-1	10539815
9@@	O	-1	10539815
6,	O	-1	10539815
95%	O	-1	10539815
C@@	O	-1	10539815
I	O	-1	10539815
1.@@	O	-1	10539815
5@@	O	-1	10539815
7-@@	O	-1	10539815
2.@@	O	-1	10539815
4@@	O	-1	10539815
4@@	O	-1	10539815
)	O	-1	10539815
in	O	-1	10539815
patients	O	-1	10539815
with	O	-1	10539815
dia@@	B-Disease	D003920	10539815
bet@@	I-Disease	-1	10539815
es	I-Disease	-1	10539815
.	O	-1	10539815
A	O	-1	10539815
lower	O	-1	10539815
risk	O	-1	10539815
of	O	-1	10539815
renal	B-Disease	D051437	10539815
impair@@	I-Disease	-1	10539815
ment	I-Disease	-1	10539815
was	O	-1	10539815
seen	O	-1	10539815
in	O	-1	10539815
both	O	-1	10539815
groups	O	-1	10539815
with	O	-1	10539815
beta-@@	O	-1	10539815
block@@	O	-1	10539815
er	O	-1	10539815
therapy	O	-1	10539815
(@@	O	-1	10539815
R@@	O	-1	10539815
R	O	-1	10539815
0.@@	O	-1	10539815
7@@	O	-1	10539815
0@@	O	-1	10539815
,	O	-1	10539815
95%	O	-1	10539815
C@@	O	-1	10539815
I	O	-1	10539815
0.@@	O	-1	10539815
5@@	O	-1	10539815
7-@@	O	-1	10539815
0.@@	O	-1	10539815
8@@	O	-1	10539815
5@@	O	-1	10539815
)	O	-1	10539815
and	O	-1	10539815
higher	O	-1	10539815
baseline	O	-1	10539815
e@@	O	-1	10539815
j@@	O	-1	10539815
ection	O	-1	10539815
frac@@	O	-1	10539815
tion	O	-1	10539815
(@@	O	-1	10539815
R@@	O	-1	10539815
R	O	-1	10539815
0.@@	O	-1	10539815
9@@	O	-1	10539815
3	O	-1	10539815
per	O	-1	10539815
5%	O	-1	10539815
inc@@	O	-1	10539815
re@@	O	-1	10539815
ment@@	O	-1	10539815
,	O	-1	10539815
95%	O	-1	10539815
C@@	O	-1	10539815
I	O	-1	10539815
0.@@	O	-1	10539815
9@@	O	-1	10539815
1-@@	O	-1	10539815
0@@	O	-1	10539815
.	O	-1	10539815
9@@	O	-1	10539815
6@@	O	-1	10539815
).	O	-1	10539815
CONCLUSIONS:	O	-1	10539815
E@@	B-Chemical	D004656	10539815
n@@	I-Chemical	-1	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
use	O	-1	10539815
caused	O	-1	10539815
a	O	-1	10539815
3@@	O	-1	10539815
3@@	O	-1	10539815
%	O	-1	10539815
increase	O	-1	10539815
in	O	-1	10539815
the	O	-1	10539815
risk	O	-1	10539815
of	O	-1	10539815
decreased	B-Disease	D051437	10539815
renal	I-Disease	-1	10539815
function	I-Disease	-1	10539815
in	O	-1	10539815
patients	O	-1	10539815
with	O	-1	10539815
C@@	B-Disease	D006333	10539815
H@@	I-Disease	-1	10539815
F	I-Disease	-1	10539815
.	O	-1	10539815
Di@@	B-Chemical	D004232	10539815
ure@@	I-Chemical	-1	10539815
tic	I-Chemical	-1	10539815
use	O	-1	10539815
and	O	-1	10539815
adv@@	O	-1	10539815
anced	O	-1	10539815
age	O	-1	10539815
increased	O	-1	10539815
this	O	-1	10539815
ris@@	O	-1	10539815
k@@	O	-1	10539815
.	O	-1	10539815
D@@	B-Disease	D003920	10539815
ia@@	I-Disease	-1	10539815
bet@@	I-Disease	-1	10539815
es	I-Disease	-1	10539815
was	O	-1	10539815
associated	O	-1	10539815
with	O	-1	10539815
an	O	-1	10539815
increased	O	-1	10539815
risk	O	-1	10539815
of	O	-1	10539815
renal	B-Disease	D051437	10539815
impair@@	I-Disease	-1	10539815
ment	I-Disease	-1	10539815
in	O	-1	10539815
all	O	-1	10539815
patients	O	-1	10539815
with	O	-1	10539815
C@@	B-Disease	D006333	10539815
H@@	I-Disease	-1	10539815
F	I-Disease	-1	10539815
,	O	-1	10539815
but	O	-1	10539815
this	O	-1	10539815
risk	O	-1	10539815
was	O	-1	10539815
reduced	O	-1	10539815
in	O	-1	10539815
the	O	-1	10539815
en@@	B-Chemical	D004656	10539815
al@@	I-Chemical	-1	10539815
apri@@	I-Chemical	-1	10539815
l	I-Chemical	-1	10539815
group	O	-1	10539815
compared	O	-1	10539815
with	O	-1	10539815
the	O	-1	10539815
placebo	O	-1	10539815
group.	O	-1	10539815
beta-@@	O	-1	10539815
B@@	O	-1	10539815
loc@@	O	-1	10539815
k@@	O	-1	10539815
er	O	-1	10539815
therapy	O	-1	10539815
and	O	-1	10539815
higher	O	-1	10539815
e@@	O	-1	10539815
j@@	O	-1	10539815
ection	O	-1	10539815
frac@@	O	-1	10539815
tion	O	-1	10539815
were	O	-1	10539815
ren@@	O	-1	10539815
o@@	O	-1	10539815
protective	O	-1	10539815
in	O	-1	10539815
all	O	-1	10539815
patients	O	-1	10539815
reg@@	O	-1	10539815
ar@@	O	-1	10539815
d@@	O	-1	10539815
less	O	-1	10539815
of	O	-1	10539815
therapy.	O	-1	10539815

P@@	B-Chemical	D010389	9022662
em@@	I-Chemical	-1	9022662
ol@@	I-Chemical	-1	9022662
ine	I-Chemical	-1	9022662
induced	O	-1	9022662
acute	O	-1	9022662
ch@@	B-Disease	D002819	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
sis	I-Disease	-1	9022662
ch@@	B-Disease	D001264	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
sis	I-Disease	-1	9022662
:	O	-1	9022662
case	O	-1	9022662
report	O	-1	9022662
and	O	-1	9022662
revie@@	O	-1	9022662
w	O	-1	9022662
of	O	-1	9022662
the	O	-1	9022662
literat@@	O	-1	9022662
ure.	O	-1	9022662
BACKGROUND:	O	-1	9022662
P@@	B-Chemical	D010389	9022662
em@@	I-Chemical	-1	9022662
ol@@	I-Chemical	-1	9022662
ine	I-Chemical	-1	9022662
is	O	-1	9022662
an	O	-1	9022662
ox@@	B-Chemical	C064210	9022662
azol@@	I-Chemical	-1	9022662
idine	I-Chemical	-1	9022662
der@@	O	-1	9022662
i@@	O	-1	9022662
v@@	O	-1	9022662
ative	O	-1	9022662
that	O	-1	9022662
is	O	-1	9022662
struct@@	O	-1	9022662
ur@@	O	-1	9022662
ally	O	-1	9022662
different	O	-1	9022662
from	O	-1	9022662
amphet@@	B-Chemical	D000662	9022662
amin@@	I-Chemical	-1	9022662
es	I-Chemical	-1	9022662
and	O	-1	9022662
used	O	-1	9022662
in	O	-1	9022662
the	O	-1	9022662
treatment	O	-1	9022662
of	O	-1	9022662
atten@@	B-Disease	D001289	9022662
tion	I-Disease	-1	9022662
defic@@	I-Disease	-1	9022662
it	I-Disease	-1	9022662
disor@@	I-Disease	-1	9022662
der	I-Disease	-1	9022662
.	O	-1	9022662
P@@	B-Chemical	D010389	9022662
em@@	I-Chemical	-1	9022662
ol@@	I-Chemical	-1	9022662
ine	I-Chemical	-1	9022662
has	O	-1	9022662
not	O	-1	9022662
been	O	-1	9022662
common@@	O	-1	9022662
ly	O	-1	9022662
associated	O	-1	9022662
in	O	-1	9022662
the	O	-1	9022662
literat@@	O	-1	9022662
ure	O	-1	9022662
as	O	-1	9022662
a	O	-1	9022662
cause	O	-1	9022662
of	O	-1	9022662
acute	O	-1	9022662
mo@@	B-Disease	D009069	9022662
vement	I-Disease	-1	9022662
disorder@@	I-Disease	-1	9022662
s	I-Disease	-1	9022662
.	O	-1	9022662
The	O	-1	9022662
following	O	-1	9022662
case	O	-1	9022662
descri@@	O	-1	9022662
b@@	O	-1	9022662
es	O	-1	9022662
two	O	-1	9022662
children	O	-1	9022662
ac@@	O	-1	9022662
u@@	O	-1	9022662
te@@	O	-1	9022662
ly	O	-1	9022662
po@@	O	-1	9022662
is@@	O	-1	9022662
on@@	O	-1	9022662
ed	O	-1	9022662
with	O	-1	9022662
p@@	B-Chemical	D010389	9022662
em@@	I-Chemical	-1	9022662
ol@@	I-Chemical	-1	9022662
ine	I-Chemical	-1	9022662
who	O	-1	9022662
experienced	O	-1	9022662
pro@@	O	-1	9022662
found	O	-1	9022662
ch@@	B-Disease	D002819	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
sis	I-Disease	-1	9022662
ch@@	B-Disease	D001264	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
sis	I-Disease	-1	9022662
.	O	-1	9022662
CA@@	O	-1	9022662
S@@	O	-1	9022662
E	O	-1	9022662
R@@	O	-1	9022662
EP@@	O	-1	9022662
O@@	O	-1	9022662
R@@	O	-1	9022662
T@@	O	-1	9022662
:	O	-1	9022662
T@@	O	-1	9022662
wo@@	O	-1	9022662
,	O	-1	9022662
3-@@	O	-1	9022662
year-old	O	-1	9022662
mal@@	O	-1	9022662
e,	O	-1	9022662
id@@	O	-1	9022662
en@@	O	-1	9022662
tical	O	-1	9022662
tw@@	O	-1	9022662
in	O	-1	9022662
sib@@	O	-1	9022662
l@@	O	-1	9022662
ings	O	-1	9022662
presented	O	-1	9022662
to	O	-1	9022662
the	O	-1	9022662
em@@	O	-1	9022662
er@@	O	-1	9022662
gen@@	O	-1	9022662
c@@	O	-1	9022662
y	O	-1	9022662
de@@	O	-1	9022662
part@@	O	-1	9022662
ment	O	-1	9022662
after	O	-1	9022662
found	O	-1	9022662
pl@@	O	-1	9022662
ay@@	O	-1	9022662
ing	O	-1	9022662
with	O	-1	9022662
a	O	-1	9022662
an	O	-1	9022662
em@@	O	-1	9022662
pt@@	O	-1	9022662
y	O	-1	9022662
b@@	O	-1	9022662
ot@@	O	-1	9022662
t@@	O	-1	9022662
le	O	-1	9022662
of	O	-1	9022662
p@@	B-Chemical	D010389	9022662
em@@	I-Chemical	-1	9022662
ol@@	I-Chemical	-1	9022662
ine	I-Chemical	-1	9022662
or@@	O	-1	9022662
ig@@	O	-1	9022662
in@@	O	-1	9022662
ally	O	-1	9022662
containing	O	-1	9022662
5@@	O	-1	9022662
9	O	-1	9022662
t@@	O	-1	9022662
able@@	O	-1	9022662
t@@	O	-1	9022662
s.	O	-1	9022662
The	O	-1	9022662
children	O	-1	9022662
had	O	-1	9022662
a	O	-1	9022662
med@@	O	-1	9022662
ical	O	-1	9022662
hist@@	O	-1	9022662
ory	O	-1	9022662
significant	O	-1	9022662
for	O	-1	9022662
atten@@	B-Disease	D001289	9022662
tion	I-Disease	-1	9022662
defic@@	I-Disease	-1	9022662
it	I-Disease	-1	9022662
disor@@	I-Disease	-1	9022662
der	I-Disease	-1	9022662
previously	O	-1	9022662
treated	O	-1	9022662
with	O	-1	9022662
methyl@@	B-Chemical	D008774	9022662
phen@@	I-Chemical	-1	9022662
id@@	I-Chemical	-1	9022662
ate	I-Chemical	-1	9022662
without	O	-1	9022662
suc@@	O	-1	9022662
ces@@	O	-1	9022662
s.	O	-1	9022662
This	O	-1	9022662
was	O	-1	9022662
their	O	-1	9022662
first	O	-1	9022662
day	O	-1	9022662
of	O	-1	9022662
p@@	B-Chemical	D010389	9022662
em@@	I-Chemical	-1	9022662
ol@@	I-Chemical	-1	9022662
ine	I-Chemical	-1	9022662
therapy.	O	-1	9022662
The	O	-1	9022662
ch@@	B-Disease	D002819	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
id	I-Disease	-1	9022662
ch@@	B-Disease	D001264	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
id	I-Disease	-1	9022662
mo@@	O	-1	9022662
ve@@	O	-1	9022662
ments	O	-1	9022662
be@@	O	-1	9022662
g@@	O	-1	9022662
an	O	-1	9022662
4@@	O	-1	9022662
5	O	-1	9022662
min	O	-1	9022662
to	O	-1	9022662
1	O	-1	9022662
h	O	-1	9022662
after	O	-1	9022662
ing@@	O	-1	9022662
es@@	O	-1	9022662
tion.	O	-1	9022662
The	O	-1	9022662
children	O	-1	9022662
g@@	O	-1	9022662
a@@	O	-1	9022662
ve	O	-1	9022662
no	O	-1	9022662
hist@@	O	-1	9022662
ory	O	-1	9022662
of	O	-1	9022662
prior	O	-1	9022662
mo@@	B-Disease	D009069	9022662
vement	I-Disease	-1	9022662
disorder@@	I-Disease	-1	9022662
s	I-Disease	-1	9022662
and	O	-1	9022662
there	O	-1	9022662
was	O	-1	9022662
no	O	-1	9022662
f@@	O	-1	9022662
ami@@	O	-1	9022662
ly	O	-1	9022662
hist@@	O	-1	9022662
ory	O	-1	9022662
of	O	-1	9022662
mo@@	B-Disease	D009069	9022662
vement	I-Disease	-1	9022662
disorder@@	I-Disease	-1	9022662
s	I-Disease	-1	9022662
.	O	-1	9022662
The	O	-1	9022662
children	O	-1	9022662
received	O	-1	9022662
gast@@	O	-1	9022662
ro@@	O	-1	9022662
in@@	O	-1	9022662
test@@	O	-1	9022662
inal	O	-1	9022662
dec@@	O	-1	9022662
ont@@	O	-1	9022662
amin@@	O	-1	9022662
ation	O	-1	9022662
and	O	-1	9022662
high	O	-1	9022662
doses	O	-1	9022662
of	O	-1	9022662
intravenous	O	-1	9022662
b@@	B-Chemical	D001569	9022662
enz@@	I-Chemical	-1	9022662
odi@@	I-Chemical	-1	9022662
azep@@	I-Chemical	-1	9022662
in@@	I-Chemical	-1	9022662
es	I-Chemical	-1	9022662
in	O	-1	9022662
an	O	-1	9022662
at@@	O	-1	9022662
tem@@	O	-1	9022662
p@@	O	-1	9022662
t	O	-1	9022662
to	O	-1	9022662
control	O	-1	9022662
the	O	-1	9022662
ch@@	B-Disease	D002819	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
id	I-Disease	-1	9022662
ch@@	B-Disease	D001264	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
id	I-Disease	-1	9022662
mo@@	O	-1	9022662
ve@@	O	-1	9022662
ment@@	O	-1	9022662
s.	O	-1	9022662
D@@	O	-1	9022662
es@@	O	-1	9022662
pit@@	O	-1	9022662
e	O	-1	9022662
treatment,	O	-1	9022662
the	O	-1	9022662
children	O	-1	9022662
continu@@	O	-1	9022662
ed	O	-1	9022662
to	O	-1	9022662
have	O	-1	9022662
ch@@	B-Disease	D002819	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
sis	I-Disease	-1	9022662
ch@@	B-Disease	D001264	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
sis	I-Disease	-1	9022662
for	O	-1	9022662
appro@@	O	-1	9022662
xim@@	O	-1	9022662
ately	O	-1	9022662
24	O	-1	9022662
hour@@	O	-1	9022662
s.	O	-1	9022662
F@@	O	-1	9022662
or@@	O	-1	9022662
ty-@@	O	-1	9022662
e@@	O	-1	9022662
ight	O	-1	9022662
hours	O	-1	9022662
after	O	-1	9022662
ad@@	O	-1	9022662
mis@@	O	-1	9022662
sion,	O	-1	9022662
the	O	-1	9022662
children	O	-1	9022662
appe@@	O	-1	9022662
a@@	O	-1	9022662
red	O	-1	9022662
to	O	-1	9022662
be	O	-1	9022662
at	O	-1	9022662
their	O	-1	9022662
baseline	O	-1	9022662
and	O	-1	9022662
were	O	-1	9022662
dis@@	O	-1	9022662
ch@@	O	-1	9022662
arg@@	O	-1	9022662
ed	O	-1	9022662
ho@@	O	-1	9022662
me.	O	-1	9022662
CONCLUSION:	O	-1	9022662
P@@	B-Chemical	D010389	9022662
em@@	I-Chemical	-1	9022662
ol@@	I-Chemical	-1	9022662
ine	I-Chemical	-1	9022662
associated	O	-1	9022662
mo@@	B-Disease	D009069	9022662
vement	I-Disease	-1	9022662
disor@@	I-Disease	-1	9022662
der	I-Disease	-1	9022662
has	O	-1	9022662
been	O	-1	9022662
ra@@	O	-1	9022662
re@@	O	-1	9022662
ly	O	-1	9022662
reported	O	-1	9022662
in	O	-1	9022662
the	O	-1	9022662
acute	O	-1	9022662
toxic@@	O	-1	9022662
ology	O	-1	9022662
literat@@	O	-1	9022662
ure.	O	-1	9022662
The	O	-1	9022662
possib@@	O	-1	9022662
ility	O	-1	9022662
of	O	-1	9022662
ch@@	B-Disease	D002819	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
id	I-Disease	-1	9022662
ch@@	B-Disease	D001264	9022662
ore@@	I-Disease	-1	9022662
o@@	I-Disease	-1	9022662
a@@	I-Disease	-1	9022662
the@@	I-Disease	-1	9022662
to@@	I-Disease	-1	9022662
id	I-Disease	-1	9022662
mo@@	O	-1	9022662
ve@@	O	-1	9022662
ments	O	-1	9022662
should	O	-1	9022662
be	O	-1	9022662
considered	O	-1	9022662
in	O	-1	9022662
patients	O	-1	9022662
present@@	O	-1	9022662
ing	O	-1	9022662
after	O	-1	9022662
p@@	B-Chemical	D010389	9022662
em@@	I-Chemical	-1	9022662
ol@@	I-Chemical	-1	9022662
ine	I-Chemical	-1	9022662
over@@	B-Disease	D062787	9022662
dose	I-Disease	-1	9022662
.	O	-1	9022662

C@@	O	-1	8677458
ont@@	O	-1	8677458
in@@	O	-1	8677458
u@@	O	-1	8677458
ous	O	-1	8677458
sub@@	O	-1	8677458
c@@	O	-1	8677458
utaneous	O	-1	8677458
administration	O	-1	8677458
of	O	-1	8677458
m@@	B-Chemical	D015080	8677458
es@@	I-Chemical	-1	8677458
n@@	I-Chemical	-1	8677458
a	I-Chemical	-1	8677458
to	O	-1	8677458
prev@@	O	-1	8677458
ent	O	-1	8677458
if@@	B-Chemical	D007069	8677458
os@@	I-Chemical	-1	8677458
f@@	I-Chemical	-1	8677458
amide	I-Chemical	-1	8677458
-induced	O	-1	8677458
hemorrh@@	B-Disease	D006470	8677458
ag@@	I-Disease	-1	8677458
ic	I-Disease	-1	8677458
cys@@	I-Disease	-1	8677458
ti@@	I-Disease	-1	8677458
tis	I-Disease	-1	8677458
hemorrh@@	B-Disease	D003556	8677458
ag@@	I-Disease	-1	8677458
ic	I-Disease	-1	8677458
cys@@	I-Disease	-1	8677458
ti@@	I-Disease	-1	8677458
tis	I-Disease	-1	8677458
.	O	-1	8677458
H@@	B-Disease	D006470	8677458
em@@	I-Disease	-1	8677458
or@@	I-Disease	-1	8677458
rh@@	I-Disease	-1	8677458
ag@@	I-Disease	-1	8677458
ic	I-Disease	-1	8677458
cys@@	I-Disease	-1	8677458
ti@@	I-Disease	-1	8677458
tis	I-Disease	-1	8677458
H@@	B-Disease	D003556	8677458
em@@	I-Disease	-1	8677458
or@@	I-Disease	-1	8677458
rh@@	I-Disease	-1	8677458
ag@@	I-Disease	-1	8677458
ic	I-Disease	-1	8677458
cys@@	I-Disease	-1	8677458
ti@@	I-Disease	-1	8677458
tis	I-Disease	-1	8677458
is	O	-1	8677458
a	O	-1	8677458
major	O	-1	8677458
potential	O	-1	8677458
toxicity	B-Disease	D064420	8677458
of	O	-1	8677458
if@@	B-Chemical	D007069	8677458
os@@	I-Chemical	-1	8677458
f@@	I-Chemical	-1	8677458
amide	I-Chemical	-1	8677458
that	O	-1	8677458
can	O	-1	8677458
be	O	-1	8677458
prevent@@	O	-1	8677458
ed	O	-1	8677458
by	O	-1	8677458
administ@@	O	-1	8677458
ering	O	-1	8677458
m@@	B-Chemical	D015080	8677458
es@@	I-Chemical	-1	8677458
n@@	I-Chemical	-1	8677458
a	I-Chemical	-1	8677458
al@@	O	-1	8677458
ong	O	-1	8677458
with	O	-1	8677458
the	O	-1	8677458
cy@@	O	-1	8677458
tot@@	O	-1	8677458
ox@@	O	-1	8677458
ic	O	-1	8677458
agent@@	O	-1	8677458
.	O	-1	8677458
M@@	B-Chemical	D015080	8677458
es@@	I-Chemical	-1	8677458
n@@	I-Chemical	-1	8677458
a	I-Chemical	-1	8677458
is	O	-1	8677458
gener@@	O	-1	8677458
ally	O	-1	8677458
administered	O	-1	8677458
by	O	-1	8677458
the	O	-1	8677458
intravenous	O	-1	8677458
rou@@	O	-1	8677458
te@@	O	-1	8677458
,	O	-1	8677458
although	O	-1	8677458
experi@@	O	-1	8677458
ence	O	-1	8677458
with	O	-1	8677458
oral	O	-1	8677458
de@@	O	-1	8677458
li@@	O	-1	8677458
very	O	-1	8677458
of	O	-1	8677458
the	O	-1	8677458
drug	O	-1	8677458
has	O	-1	8677458
increas@@	O	-1	8677458
ed.	O	-1	8677458
The	O	-1	8677458
continu@@	O	-1	8677458
ous	O	-1	8677458
sub@@	O	-1	8677458
c@@	O	-1	8677458
utaneous	O	-1	8677458
administration	O	-1	8677458
of	O	-1	8677458
m@@	B-Chemical	D015080	8677458
es@@	I-Chemical	-1	8677458
n@@	I-Chemical	-1	8677458
a	I-Chemical	-1	8677458
has	O	-1	8677458
the	O	-1	8677458
adv@@	O	-1	8677458
ant@@	O	-1	8677458
age	O	-1	8677458
of	O	-1	8677458
not	O	-1	8677458
requ@@	O	-1	8677458
ir@@	O	-1	8677458
ing	O	-1	8677458
intravenous	O	-1	8677458
ac@@	O	-1	8677458
ces@@	O	-1	8677458
s.	O	-1	8677458
In	O	-1	8677458
addi@@	O	-1	8677458
tion,	O	-1	8677458
sub@@	O	-1	8677458
c@@	O	-1	8677458
utaneous	O	-1	8677458
de@@	O	-1	8677458
li@@	O	-1	8677458
very	O	-1	8677458
of	O	-1	8677458
the	O	-1	8677458
ne@@	O	-1	8677458
ut@@	O	-1	8677458
r@@	O	-1	8677458
al@@	O	-1	8677458
iz@@	O	-1	8677458
ing	O	-1	8677458
agent	O	-1	8677458
wil@@	O	-1	8677458
l	O	-1	8677458
not	O	-1	8677458
be	O	-1	8677458
associated	O	-1	8677458
with	O	-1	8677458
the	O	-1	8677458
risk	O	-1	8677458
of	O	-1	8677458
in@@	O	-1	8677458
ade@@	O	-1	8677458
qu@@	O	-1	8677458
ate	O	-1	8677458
urinary	O	-1	8677458
m@@	B-Chemical	D015080	8677458
es@@	I-Chemical	-1	8677458
n@@	I-Chemical	-1	8677458
a	I-Chemical	-1	8677458
concentr@@	O	-1	8677458
ation@@	O	-1	8677458
s,	O	-1	8677458
such	O	-1	8677458
as	O	-1	8677458
in	O	-1	8677458
a	O	-1	8677458
patient	O	-1	8677458
taking	O	-1	8677458
oral	O	-1	8677458
m@@	B-Chemical	D015080	8677458
es@@	I-Chemical	-1	8677458
n@@	I-Chemical	-1	8677458
a	I-Chemical	-1	8677458
who	O	-1	8677458
experienc@@	O	-1	8677458
es	O	-1	8677458
severe	O	-1	8677458
if@@	B-Chemical	D007069	8677458
os@@	I-Chemical	-1	8677458
f@@	I-Chemical	-1	8677458
amide	I-Chemical	-1	8677458
-induced	O	-1	8677458
e@@	B-Disease	D014839	8677458
me@@	I-Disease	-1	8677458
sis	I-Disease	-1	8677458
and	O	-1	8677458
is	O	-1	8677458
un@@	O	-1	8677458
able	O	-1	8677458
to	O	-1	8677458
abs@@	O	-1	8677458
or@@	O	-1	8677458
b	O	-1	8677458
the	O	-1	8677458
drug.	O	-1	8677458
L@@	O	-1	8677458
im@@	O	-1	8677458
ited	O	-1	8677458
clinical	O	-1	8677458
experi@@	O	-1	8677458
ence	O	-1	8677458
with	O	-1	8677458
continu@@	O	-1	8677458
ous	O	-1	8677458
sub@@	O	-1	8677458
c@@	O	-1	8677458
utaneous	O	-1	8677458
m@@	B-Chemical	D015080	8677458
es@@	I-Chemical	-1	8677458
n@@	I-Chemical	-1	8677458
a	I-Chemical	-1	8677458
administration	O	-1	8677458
suggests	O	-1	8677458
it	O	-1	8677458
is	O	-1	8677458
a	O	-1	8677458
saf@@	O	-1	8677458
e,	O	-1	8677458
p@@	O	-1	8677458
rac@@	O	-1	8677458
tic@@	O	-1	8677458
al,	O	-1	8677458
and	O	-1	8677458
ec@@	O	-1	8677458
on@@	O	-1	8677458
om@@	O	-1	8677458
ic	O	-1	8677458
meth@@	O	-1	8677458
od	O	-1	8677458
of	O	-1	8677458
drug	O	-1	8677458
de@@	O	-1	8677458
li@@	O	-1	8677458
very	O	-1	8677458
that	O	-1	8677458
per@@	O	-1	8677458
m@@	O	-1	8677458
its	O	-1	8677458
if@@	B-Chemical	D007069	8677458
os@@	I-Chemical	-1	8677458
f@@	I-Chemical	-1	8677458
amide	I-Chemical	-1	8677458
to	O	-1	8677458
be	O	-1	8677458
administered	O	-1	8677458
suc@@	O	-1	8677458
cess@@	O	-1	8677458
ful@@	O	-1	8677458
ly	O	-1	8677458
in	O	-1	8677458
the	O	-1	8677458
out@@	O	-1	8677458
patient	O	-1	8677458
se@@	O	-1	8677458
t@@	O	-1	8677458
t@@	O	-1	8677458
ing.	O	-1	8677458

M@@	O	-1	6323692
odi@@	O	-1	6323692
fic@@	O	-1	6323692
ation	O	-1	6323692
of	O	-1	6323692
drug	O	-1	6323692
action	O	-1	6323692
by	O	-1	6323692
hyper@@	B-Disease	D022124	6323692
am@@	I-Disease	-1	6323692
mon@@	I-Disease	-1	6323692
emia	I-Disease	-1	6323692
.	O	-1	6323692
Pre@@	O	-1	6323692
treatment	O	-1	6323692
with	O	-1	6323692
am@@	B-Chemical	C018824	6323692
mon@@	I-Chemical	-1	6323692
i@@	I-Chemical	-1	6323692
um	I-Chemical	-1	6323692
acet@@	I-Chemical	-1	6323692
ate	I-Chemical	-1	6323692
(	O	-1	6323692
N@@	B-Chemical	C018824	6323692
H@@	I-Chemical	-1	6323692
4@@	I-Chemical	-1	6323692
A@@	I-Chemical	-1	6323692
c	I-Chemical	-1	6323692
)	O	-1	6323692
(@@	O	-1	6323692
6	O	-1	6323692
m@@	O	-1	6323692
mol@@	O	-1	6323692
/@@	O	-1	6323692
k@@	O	-1	6323692
g	O	-1	6323692
s@@	O	-1	6323692
.@@	O	-1	6323692
c@@	O	-1	6323692
.)	O	-1	6323692
appro@@	O	-1	6323692
xim@@	O	-1	6323692
ately	O	-1	6323692
dou@@	O	-1	6323692
bl@@	O	-1	6323692
ed	O	-1	6323692
the	O	-1	6323692
time	O	-1	6323692
morphine	B-Chemical	D009020	6323692
-treated	O	-1	6323692
mice	O	-1	6323692
remained	O	-1	6323692
on	O	-1	6323692
a	O	-1	6323692
ho@@	O	-1	6323692
t	O	-1	6323692
sur@@	O	-1	6323692
fac@@	O	-1	6323692
e	O	-1	6323692
and	O	-1	6323692
simil@@	O	-1	6323692
arly	O	-1	6323692
increased	O	-1	6323692
mus@@	O	-1	6323692
cular	O	-1	6323692
in@@	B-Disease	D001259	6323692
co@@	I-Disease	-1	6323692
or@@	I-Disease	-1	6323692
d@@	I-Disease	-1	6323692
in@@	I-Disease	-1	6323692
ation	I-Disease	-1	6323692
by	O	-1	6323692
di@@	B-Chemical	D003975	6323692
az@@	I-Chemical	-1	6323692
epam	I-Chemical	-1	6323692
,	O	-1	6323692
but	O	-1	6323692
N@@	B-Chemical	C018824	6323692
H@@	I-Chemical	-1	6323692
4@@	I-Chemical	-1	6323692
A@@	I-Chemical	-1	6323692
c	I-Chemical	-1	6323692
treatment	O	-1	6323692
alone	O	-1	6323692
had	O	-1	6323692
no	O	-1	6323692
effect@@	O	-1	6323692
.	O	-1	6323692
Th@@	O	-1	6323692
us,	O	-1	6323692
hyper@@	B-Disease	D022124	6323692
am@@	I-Disease	-1	6323692
mon@@	I-Disease	-1	6323692
emia	I-Disease	-1	6323692
is	O	-1	6323692
cap@@	O	-1	6323692
able	O	-1	6323692
of	O	-1	6323692
al@@	O	-1	6323692
ter@@	O	-1	6323692
ing	O	-1	6323692
drug	O	-1	6323692
action	O	-1	6323692
and	O	-1	6323692
mus@@	O	-1	6323692
t	O	-1	6323692
be	O	-1	6323692
considered	O	-1	6323692
al@@	O	-1	6323692
ong	O	-1	6323692
with	O	-1	6323692
impaired	O	-1	6323692
drug	O	-1	6323692
metabol@@	O	-1	6323692
ism	O	-1	6323692
in	O	-1	6323692
enhanced	O	-1	6323692
drug	O	-1	6323692
responses	O	-1	6323692
associated	O	-1	6323692
with	O	-1	6323692
liver	B-Disease	D008107	6323692
disease	I-Disease	-1	6323692
.	O	-1	6323692
E@@	O	-1	6323692
x@@	O	-1	6323692
per@@	O	-1	6323692
im@@	O	-1	6323692
ents	O	-1	6323692
in	O	-1	6323692
vit@@	O	-1	6323692
r@@	O	-1	6323692
o	O	-1	6323692
showed	O	-1	6323692
that	O	-1	6323692
acet@@	B-Chemical	D000109	6323692
ylcholine	I-Chemical	-1	6323692
-induced	O	-1	6323692
cat@@	B-Chemical	D002395	6323692
ech@@	I-Chemical	-1	6323692
ol@@	I-Chemical	-1	6323692
amine	I-Chemical	-1	6323692
release	O	-1	6323692
from	O	-1	6323692
bo@@	O	-1	6323692
v@@	O	-1	6323692
ine	O	-1	6323692
ad@@	O	-1	6323692
renal	O	-1	6323692
med@@	O	-1	6323692
ul@@	O	-1	6323692
l@@	O	-1	6323692
a	O	-1	6323692
is	O	-1	6323692
depress@@	O	-1	6323692
ed	O	-1	6323692
as	O	-1	6323692
m@@	O	-1	6323692
uc@@	O	-1	6323692
h	O	-1	6323692
as	O	-1	6323692
50@@	O	-1	6323692
%	O	-1	6323692
by	O	-1	6323692
0.@@	O	-1	6323692
3	O	-1	6323692
m@@	O	-1	6323692
M	O	-1	6323692
N@@	B-Chemical	C018824	6323692
H@@	I-Chemical	-1	6323692
4@@	I-Chemical	-1	6323692
A@@	I-Chemical	-1	6323692
c	I-Chemical	-1	6323692
and	O	-1	6323692
K@@	B-Chemical	D011189	6323692
C@@	I-Chemical	-1	6323692
l	I-Chemical	-1	6323692
-induced	O	-1	6323692
contrac@@	O	-1	6323692
tions	O	-1	6323692
of	O	-1	6323692
gu@@	O	-1	6323692
ine@@	O	-1	6323692
a@@	O	-1	6323692
-@@	O	-1	6323692
pi@@	O	-1	6323692
g	O	-1	6323692
i@@	O	-1	6323692
le@@	O	-1	6323692
um	O	-1	6323692
were	O	-1	6323692
inhibited	O	-1	6323692
20@@	O	-1	6323692
%	O	-1	6323692
by	O	-1	6323692
5	O	-1	6323692
m@@	O	-1	6323692
M	O	-1	6323692
N@@	B-Chemical	C018824	6323692
H@@	I-Chemical	-1	6323692
4@@	I-Chemical	-1	6323692
A@@	I-Chemical	-1	6323692
c	I-Chemical	-1	6323692
.	O	-1	6323692
Ad@@	O	-1	6323692
di@@	O	-1	6323692
tion	O	-1	6323692
of	O	-1	6323692
ex@@	O	-1	6323692
cess	O	-1	6323692
calcium	B-Chemical	D002118	6323692
reversed	O	-1	6323692
the	O	-1	6323692
de@@	B-Disease	D003866	6323692
pression	I-Disease	-1	6323692
in	O	-1	6323692
both	O	-1	6323692
tissu@@	O	-1	6323692
es,	O	-1	6323692
but	O	-1	6323692
calcium	B-Chemical	D002118	6323692
-@@	O	-1	6323692
in@@	O	-1	6323692
dependent	O	-1	6323692
cat@@	B-Chemical	D002395	6323692
ech@@	I-Chemical	-1	6323692
ol@@	I-Chemical	-1	6323692
amine	I-Chemical	-1	6323692
release	O	-1	6323692
by	O	-1	6323692
acet@@	B-Chemical	D000079	6323692
al@@	I-Chemical	-1	6323692
de@@	I-Chemical	-1	6323692
hy@@	I-Chemical	-1	6323692
de	I-Chemical	-1	6323692
was	O	-1	6323692
not	O	-1	6323692
block@@	O	-1	6323692
ed	O	-1	6323692
by	O	-1	6323692
N@@	B-Chemical	C018824	6323692
H@@	I-Chemical	-1	6323692
4@@	I-Chemical	-1	6323692
A@@	I-Chemical	-1	6323692
c	I-Chemical	-1	6323692
.	O	-1	6323692
These	O	-1	6323692
results	O	-1	6323692
suggested	O	-1	6323692
that	O	-1	6323692
am@@	B-Chemical	D000641	6323692
mon@@	I-Chemical	-1	6323692
ia	I-Chemical	-1	6323692
block@@	O	-1	6323692
s	O	-1	6323692
calcium	B-Chemical	D002118	6323692
channe@@	O	-1	6323692
l@@	O	-1	6323692
s.	O	-1	6323692
P@@	O	-1	6323692
ar@@	O	-1	6323692
al@@	O	-1	6323692
le@@	O	-1	6323692
l@@	O	-1	6323692
s	O	-1	6323692
in	O	-1	6323692
the	O	-1	6323692
ac@@	O	-1	6323692
tions	O	-1	6323692
of	O	-1	6323692
N@@	B-Chemical	C018824	6323692
H@@	I-Chemical	-1	6323692
4@@	I-Chemical	-1	6323692
A@@	I-Chemical	-1	6323692
c	I-Chemical	-1	6323692
and	O	-1	6323692
the	O	-1	6323692
calcium	B-Chemical	D002118	6323692
channel	O	-1	6323692
block@@	O	-1	6323692
er	O	-1	6323692
verap@@	B-Chemical	D014700	6323692
ami@@	I-Chemical	-1	6323692
l	I-Chemical	-1	6323692
suppor@@	O	-1	6323692
t	O	-1	6323692
this	O	-1	6323692
con@@	O	-1	6323692
ce@@	O	-1	6323692
pt@@	O	-1	6323692
.	O	-1	6323692
B@@	O	-1	6323692
oth	O	-1	6323692
verap@@	B-Chemical	D014700	6323692
ami@@	I-Chemical	-1	6323692
l	I-Chemical	-1	6323692
(10	O	-1	6323692
mg/kg	O	-1	6323692
i.p.@@	O	-1	6323692
)	O	-1	6323692
and	O	-1	6323692
N@@	B-Chemical	C018824	6323692
H@@	I-Chemical	-1	6323692
4@@	I-Chemical	-1	6323692
A@@	I-Chemical	-1	6323692
c	I-Chemical	-1	6323692
pretreatment	O	-1	6323692
enhanced	O	-1	6323692
morphine	B-Chemical	D009020	6323692
analge@@	B-Disease	D000699	6323692
sia	I-Disease	-1	6323692
-	O	-1	6323692
and	O	-1	6323692
di@@	B-Chemical	D003975	6323692
az@@	I-Chemical	-1	6323692
epam	I-Chemical	-1	6323692
-induced	O	-1	6323692
mus@@	O	-1	6323692
cular	O	-1	6323692
in@@	B-Disease	D001259	6323692
co@@	I-Disease	-1	6323692
or@@	I-Disease	-1	6323692
d@@	I-Disease	-1	6323692
in@@	I-Disease	-1	6323692
ation	I-Disease	-1	6323692
and	O	-1	6323692
antagon@@	O	-1	6323692
ized	O	-1	6323692
amphetamine	B-Chemical	D000661	6323692
-induced	O	-1	6323692
motor	O	-1	6323692
activ@@	O	-1	6323692
ity,	O	-1	6323692
and	O	-1	6323692
ne@@	O	-1	6323692
ither	O	-1	6323692
verap@@	B-Chemical	D014700	6323692
ami@@	I-Chemical	-1	6323692
l	I-Chemical	-1	6323692
n@@	O	-1	6323692
or	O	-1	6323692
N@@	B-Chemical	C018824	6323692
H@@	I-Chemical	-1	6323692
4@@	I-Chemical	-1	6323692
A@@	I-Chemical	-1	6323692
c	I-Chemical	-1	6323692
affected	O	-1	6323692
the	O	-1	6323692
convul@@	O	-1	6323692
s@@	O	-1	6323692
ant	O	-1	6323692
action	O	-1	6323692
of	O	-1	6323692
met@@	B-Chemical	D010433	6323692
ra@@	I-Chemical	-1	6323692
z@@	I-Chemical	-1	6323692
ol	I-Chemical	-1	6323692
.	O	-1	6323692
The	O	-1	6323692
data	O	-1	6323692
suggest	O	-1	6323692
that	O	-1	6323692
hyper@@	B-Disease	D022124	6323692
am@@	I-Disease	-1	6323692
mon@@	I-Disease	-1	6323692
emia	I-Disease	-1	6323692
ex@@	O	-1	6323692
er@@	O	-1	6323692
ts	O	-1	6323692
a	O	-1	6323692
calcium	B-Chemical	D002118	6323692
channel	O	-1	6323692
block@@	O	-1	6323692
ing	O	-1	6323692
action	O	-1	6323692
which	O	-1	6323692
enh@@	O	-1	6323692
anc@@	O	-1	6323692
es	O	-1	6323692
the	O	-1	6323692
effects	O	-1	6323692
of	O	-1	6323692
central	O	-1	6323692
ner@@	O	-1	6323692
v@@	O	-1	6323692
ous	O	-1	6323692
system	O	-1	6323692
depress@@	O	-1	6323692
ants	O	-1	6323692
and	O	-1	6323692
cer@@	O	-1	6323692
t@@	O	-1	6323692
ain	O	-1	6323692
o@@	O	-1	6323692
pi@@	O	-1	6323692
oid	O	-1	6323692
analge@@	O	-1	6323692
si@@	O	-1	6323692
c@@	O	-1	6323692
s.	O	-1	6323692

R@@	O	-1	20195852
is@@	O	-1	20195852
k	O	-1	20195852
of	O	-1	20195852
nephro@@	B-Disease	D007674	20195852
pathy	I-Disease	-1	20195852
after	O	-1	20195852
consum@@	O	-1	20195852
ption	O	-1	20195852
of	O	-1	20195852
non@@	O	-1	20195852
i@@	O	-1	20195852
onic	O	-1	20195852
contr@@	B-Chemical	D003287	20195852
ast	I-Chemical	-1	20195852
medi@@	I-Chemical	-1	20195852
a	I-Chemical	-1	20195852
by	O	-1	20195852
children	O	-1	20195852
under@@	O	-1	20195852
go@@	O	-1	20195852
ing	O	-1	20195852
cardiac	O	-1	20195852
angio@@	O	-1	20195852
graph@@	O	-1	20195852
y@@	O	-1	20195852
:	O	-1	20195852
a	O	-1	20195852
pro@@	O	-1	20195852
sp@@	O	-1	20195852
ective	O	-1	20195852
study.	O	-1	20195852
D@@	O	-1	20195852
es@@	O	-1	20195852
pit@@	O	-1	20195852
e	O	-1	20195852
increas@@	O	-1	20195852
ing	O	-1	20195852
reports	O	-1	20195852
on	O	-1	20195852
non@@	O	-1	20195852
i@@	O	-1	20195852
onic	O	-1	20195852
contr@@	B-Chemical	D003287	20195852
ast	I-Chemical	-1	20195852
medi@@	I-Chemical	-1	20195852
a	I-Chemical	-1	20195852
-induced	O	-1	20195852
nephro@@	B-Disease	D007674	20195852
pathy	I-Disease	-1	20195852
(	O	-1	20195852
CI@@	B-Disease	D007674	20195852
N	I-Disease	-1	20195852
)	O	-1	20195852
in	O	-1	20195852
hospit@@	O	-1	20195852
al@@	O	-1	20195852
ized	O	-1	20195852
ad@@	O	-1	20195852
ult	O	-1	20195852
patients	O	-1	20195852
during	O	-1	20195852
cardiac	O	-1	20195852
proce@@	O	-1	20195852
du@@	O	-1	20195852
res@@	O	-1	20195852
,	O	-1	20195852
the	O	-1	20195852
studies	O	-1	20195852
in	O	-1	20195852
pe@@	O	-1	20195852
di@@	O	-1	20195852
at@@	O	-1	20195852
r@@	O	-1	20195852
ic@@	O	-1	20195852
s	O	-1	20195852
are	O	-1	20195852
lim@@	O	-1	20195852
it@@	O	-1	20195852
ed,	O	-1	20195852
with	O	-1	20195852
even	O	-1	20195852
less	O	-1	20195852
foc@@	O	-1	20195852
us	O	-1	20195852
on	O	-1	20195852
possible	O	-1	20195852
pre@@	O	-1	20195852
dis@@	O	-1	20195852
pos@@	O	-1	20195852
ing	O	-1	20195852
factors	O	-1	20195852
and	O	-1	20195852
pre@@	O	-1	20195852
ven@@	O	-1	20195852
tive	O	-1	20195852
meas@@	O	-1	20195852
ures	O	-1	20195852
for	O	-1	20195852
patients	O	-1	20195852
under@@	O	-1	20195852
go@@	O	-1	20195852
ing	O	-1	20195852
cardiac	O	-1	20195852
angio@@	O	-1	20195852
graph@@	O	-1	20195852
y.	O	-1	20195852
This	O	-1	20195852
pro@@	O	-1	20195852
sp@@	O	-1	20195852
ective	O	-1	20195852
study	O	-1	20195852
determined	O	-1	20195852
the	O	-1	20195852
incidence	O	-1	20195852
of	O	-1	20195852
CI@@	B-Disease	D007674	20195852
N	I-Disease	-1	20195852
for	O	-1	20195852
two	O	-1	20195852
non@@	O	-1	20195852
i@@	O	-1	20195852
onic	O	-1	20195852
contr@@	B-Chemical	D003287	20195852
ast	I-Chemical	-1	20195852
medi@@	I-Chemical	-1	20195852
a	I-Chemical	-1	20195852
(	O	-1	20195852
C@@	B-Chemical	D003287	20195852
M	I-Chemical	-1	20195852
),	O	-1	20195852
io@@	B-Chemical	C038192	20195852
pro@@	I-Chemical	-1	20195852
m@@	I-Chemical	-1	20195852
ide	I-Chemical	-1	20195852
and	O	-1	20195852
io@@	B-Chemical	D007472	20195852
he@@	I-Chemical	-1	20195852
x@@	I-Chemical	-1	20195852
ol	I-Chemical	-1	20195852
,	O	-1	20195852
among	O	-1	20195852
8@@	O	-1	20195852
0	O	-1	20195852
patients	O	-1	20195852
youn@@	O	-1	20195852
g@@	O	-1	20195852
er	O	-1	20195852
than	O	-1	20195852
1@@	O	-1	20195852
8	O	-1	20195852
years	O	-1	20195852
and	O	-1	20195852
compared	O	-1	20195852
the	O	-1	20195852
rat@@	O	-1	20195852
es	O	-1	20195852
for	O	-1	20195852
this	O	-1	20195852
complication	O	-1	20195852
in	O	-1	20195852
rel@@	O	-1	20195852
ation	O	-1	20195852
to	O	-1	20195852
the	O	-1	20195852
type	O	-1	20195852
and	O	-1	20195852
dos@@	O	-1	20195852
age	O	-1	20195852
of	O	-1	20195852
C@@	B-Chemical	D003287	20195852
M	I-Chemical	-1	20195852
and	O	-1	20195852
the	O	-1	20195852
presence	O	-1	20195852
of	O	-1	20195852
cy@@	B-Disease	D003490	20195852
an@@	I-Disease	-1	20195852
o@@	I-Disease	-1	20195852
sis	I-Disease	-1	20195852
.	O	-1	20195852
The	O	-1	20195852
8@@	O	-1	20195852
0	O	-1	20195852
patients	O	-1	20195852
in	O	-1	20195852
the	O	-1	20195852
study	O	-1	20195852
con@@	O	-1	20195852
sec@@	O	-1	20195852
u@@	O	-1	20195852
ti@@	O	-1	20195852
vely	O	-1	20195852
received	O	-1	20195852
either	O	-1	20195852
io@@	B-Chemical	C038192	20195852
pro@@	I-Chemical	-1	20195852
m@@	I-Chemical	-1	20195852
ide	I-Chemical	-1	20195852
(@@	O	-1	20195852
group	O	-1	20195852
A@@	O	-1	20195852
,	O	-1	20195852
n	O	-1	20195852
=	O	-1	20195852
4@@	O	-1	20195852
0@@	O	-1	20195852
)	O	-1	20195852
or	O	-1	20195852
io@@	B-Chemical	D007472	20195852
he@@	I-Chemical	-1	20195852
x@@	I-Chemical	-1	20195852
ol	I-Chemical	-1	20195852
(@@	O	-1	20195852
group	O	-1	20195852
B@@	O	-1	20195852
,	O	-1	20195852
n	O	-1	20195852
=	O	-1	20195852
4@@	O	-1	20195852
0@@	O	-1	20195852
).	O	-1	20195852
S@@	O	-1	20195852
er@@	O	-1	20195852
um	O	-1	20195852
sodium	B-Chemical	D012964	20195852
(	O	-1	20195852
N@@	B-Chemical	D012964	20195852
a	I-Chemical	-1	20195852
),	O	-1	20195852
pot@@	B-Chemical	D011188	20195852
assi@@	I-Chemical	-1	20195852
um	I-Chemical	-1	20195852
(	O	-1	20195852
K	B-Chemical	D011188	20195852
),	O	-1	20195852
and	O	-1	20195852
creatinine	B-Chemical	D003404	20195852
(	O	-1	20195852
C@@	B-Chemical	D003404	20195852
r	I-Chemical	-1	20195852
)	O	-1	20195852
were	O	-1	20195852
measured	O	-1	20195852
24	O	-1	20195852
h	O	-1	20195852
before	O	-1	20195852
angio@@	O	-1	20195852
graph@@	O	-1	20195852
y	O	-1	20195852
as	O	-1	20195852
baseline	O	-1	20195852
valu@@	O	-1	20195852
es,	O	-1	20195852
then	O	-1	20195852
measured	O	-1	20195852
ag@@	O	-1	20195852
ain	O	-1	20195852
at	O	-1	20195852
1@@	O	-1	20195852
2-@@	O	-1	20195852
,	O	-1	20195852
2@@	O	-1	20195852
4-@@	O	-1	20195852
,	O	-1	20195852
and	O	-1	20195852
4@@	O	-1	20195852
8@@	O	-1	20195852
-@@	O	-1	20195852
h	O	-1	20195852
interv@@	O	-1	20195852
als	O	-1	20195852
after	O	-1	20195852
C@@	B-Chemical	D003287	20195852
M	I-Chemical	-1	20195852
use.	O	-1	20195852
U@@	O	-1	20195852
rine	O	-1	20195852
sam@@	O	-1	20195852
ple@@	O	-1	20195852
s	O	-1	20195852
for	O	-1	20195852
N@@	B-Chemical	D012964	20195852
a	I-Chemical	-1	20195852
and	O	-1	20195852
C@@	B-Chemical	D003404	20195852
r	I-Chemical	-1	20195852
also	O	-1	20195852
were	O	-1	20195852
ch@@	O	-1	20195852
ec@@	O	-1	20195852
ked	O	-1	20195852
at	O	-1	20195852
the	O	-1	20195852
same	O	-1	20195852
inter@@	O	-1	20195852
val@@	O	-1	20195852
s.	O	-1	20195852
R@@	O	-1	20195852
is@@	O	-1	20195852
k	O	-1	20195852
of	O	-1	20195852
renal	B-Disease	D051437	20195852
failure	I-Disease	-1	20195852
,	O	-1	20195852
In@@	B-Disease	D058186	20195852
j@@	I-Disease	-1	20195852
ur@@	I-Disease	-1	20195852
y	I-Disease	-1	20195852
to	I-Disease	-1	20195852
the	I-Disease	-1	20195852
kidney	I-Disease	-1	20195852
,	O	-1	20195852
F@@	B-Disease	D051437	20195852
ail@@	I-Disease	-1	20195852
ure	I-Disease	-1	20195852
of	I-Disease	-1	20195852
kidney	I-Disease	-1	20195852
function	I-Disease	-1	20195852
,	O	-1	20195852
L@@	B-Disease	D051437	20195852
os@@	I-Disease	-1	20195852
s	I-Disease	-1	20195852
of	I-Disease	-1	20195852
kidney	I-Disease	-1	20195852
function	I-Disease	-1	20195852
,	O	-1	20195852
and	O	-1	20195852
E@@	O	-1	20195852
n@@	O	-1	20195852
d-@@	O	-1	20195852
st@@	O	-1	20195852
age	O	-1	20195852
renal	B-Disease	D007674	20195852
damage	I-Disease	-1	20195852
(@@	O	-1	20195852
R@@	O	-1	20195852
I@@	O	-1	20195852
F@@	O	-1	20195852
L@@	O	-1	20195852
E	O	-1	20195852
c@@	O	-1	20195852
rit@@	O	-1	20195852
er@@	O	-1	20195852
ia@@	O	-1	20195852
)	O	-1	20195852
were	O	-1	20195852
used	O	-1	20195852
to	O	-1	20195852
def@@	O	-1	20195852
ine	O	-1	20195852
CI@@	B-Disease	D007674	20195852
N	I-Disease	-1	20195852
and	O	-1	20195852
its	O	-1	20195852
incidence	O	-1	20195852
in	O	-1	20195852
the	O	-1	20195852
study	O	-1	20195852
po@@	O	-1	20195852
pul@@	O	-1	20195852
ation.	O	-1	20195852
Ac@@	O	-1	20195852
cor@@	O	-1	20195852
d@@	O	-1	20195852
ing@@	O	-1	20195852
ly,	O	-1	20195852
among	O	-1	20195852
the	O	-1	20195852
15	O	-1	20195852
CI@@	B-Disease	D007674	20195852
N	I-Disease	-1	20195852
patients	O	-1	20195852
(1@@	O	-1	20195852
8.@@	O	-1	20195852
7@@	O	-1	20195852
5@@	O	-1	20195852
%),	O	-1	20195852
7.@@	O	-1	20195852
5%	O	-1	20195852
of	O	-1	20195852
the	O	-1	20195852
patients	O	-1	20195852
in	O	-1	20195852
group	O	-1	20195852
A	O	-1	20195852
had	O	-1	20195852
increased	O	-1	20195852
risk	O	-1	20195852
and	O	-1	20195852
3.@@	O	-1	20195852
7@@	O	-1	20195852
5%	O	-1	20195852
had	O	-1	20195852
renal	B-Disease	D058186	20195852
injury	I-Disease	-1	20195852
,	O	-1	20195852
whereas	O	-1	20195852
5%	O	-1	20195852
of	O	-1	20195852
group	O	-1	20195852
B	O	-1	20195852
had	O	-1	20195852
increased	O	-1	20195852
risk	O	-1	20195852
and	O	-1	20195852
2.@@	O	-1	20195852
5%	O	-1	20195852
had	O	-1	20195852
renal	B-Disease	D058186	20195852
injury	I-Disease	-1	20195852
.	O	-1	20195852
Whe@@	O	-1	20195852
reas	O	-1	20195852
3@@	O	-1	20195852
3.@@	O	-1	20195852
3@@	O	-1	20195852
%	O	-1	20195852
of	O	-1	20195852
the	O	-1	20195852
patients	O	-1	20195852
with	O	-1	20195852
CI@@	B-Disease	D007674	20195852
N	I-Disease	-1	20195852
were	O	-1	20195852
among	O	-1	20195852
those	O	-1	20195852
who	O	-1	20195852
received	O	-1	20195852
the	O	-1	20195852
pro@@	O	-1	20195852
per	O	-1	20195852
dos@@	O	-1	20195852
age	O	-1	20195852
of	O	-1	20195852
C@@	B-Chemical	D003287	20195852
M	I-Chemical	-1	20195852
,	O	-1	20195852
the	O	-1	20195852
perc@@	O	-1	20195852
ent@@	O	-1	20195852
age	O	-1	20195852
increased	O	-1	20195852
to	O	-1	20195852
6@@	O	-1	20195852
6.@@	O	-1	20195852
6%	O	-1	20195852
among	O	-1	20195852
those	O	-1	20195852
who	O	-1	20195852
received	O	-1	20195852
larg@@	O	-1	20195852
er	O	-1	20195852
dos@@	O	-1	20195852
es,	O	-1	20195852
with	O	-1	20195852
a	O	-1	20195852
significant	O	-1	20195852
difference	O	-1	20195852
in	O	-1	20195852
the	O	-1	20195852
incidence	O	-1	20195852
of	O	-1	20195852
CI@@	B-Disease	D007674	20195852
N	I-Disease	-1	20195852
related	O	-1	20195852
to	O	-1	20195852
the	O	-1	20195852
different	O	-1	20195852
dos@@	O	-1	20195852
ages	O	-1	20195852
of	O	-1	20195852
C@@	B-Chemical	D003287	20195852
M	I-Chemical	-1	20195852
(p	O	-1	20195852
=	O	-1	20195852
0.0@@	O	-1	20195852
14@@	O	-1	20195852
).	O	-1	20195852
A@@	O	-1	20195852
mon@@	O	-1	20195852
g	O	-1	20195852
the	O	-1	20195852
15	O	-1	20195852
patients	O	-1	20195852
with	O	-1	20195852
CI@@	B-Disease	D007674	20195852
N	I-Disease	-1	20195852
,	O	-1	20195852
6	O	-1	20195852
had	O	-1	20195852
cy@@	O	-1	20195852
an@@	O	-1	20195852
o@@	O	-1	20195852
tic	O	-1	20195852
con@@	B-Disease	D006331	20195852
gen@@	I-Disease	-1	20195852
it@@	I-Disease	-1	20195852
al	I-Disease	-1	20195852
heart	I-Disease	-1	20195852
diseas@@	I-Disease	-1	20195852
es	I-Disease	-1	20195852
,	O	-1	20195852
but	O	-1	20195852
the	O	-1	20195852
incidence	O	-1	20195852
did	O	-1	20195852
not	O	-1	20195852
diff@@	O	-1	20195852
er	O	-1	20195852
significantly	O	-1	20195852
from	O	-1	20195852
that	O	-1	20195852
for	O	-1	20195852
the	O	-1	20195852
non@@	O	-1	20195852
cy@@	O	-1	20195852
an@@	O	-1	20195852
o@@	O	-1	20195852
tic	O	-1	20195852
patients	O	-1	20195852
(p	O	-1	20195852
=	O	-1	20195852
0.@@	O	-1	20195852
2@@	O	-1	20195852
4@@	O	-1	20195852
3@@	O	-1	20195852
).	O	-1	20195852
Although	O	-1	20195852
clin@@	O	-1	20195852
ically	O	-1	20195852
si@@	O	-1	20195852
l@@	O	-1	20195852
ent@@	O	-1	20195852
,	O	-1	20195852
CI@@	B-Disease	D007674	20195852
N	I-Disease	-1	20195852
is	O	-1	20195852
not	O	-1	20195852
r@@	O	-1	20195852
are	O	-1	20195852
in	O	-1	20195852
pe@@	O	-1	20195852
di@@	O	-1	20195852
at@@	O	-1	20195852
r@@	O	-1	20195852
ic@@	O	-1	20195852
s.	O	-1	20195852
The	O	-1	20195852
incidence	O	-1	20195852
depend@@	O	-1	20195852
s	O	-1	20195852
on	O	-1	20195852
dos@@	O	-1	20195852
age	O	-1	20195852
but	O	-1	20195852
not	O	-1	20195852
on	O	-1	20195852
the	O	-1	20195852
type	O	-1	20195852
of	O	-1	20195852
consum@@	O	-1	20195852
ed	O	-1	20195852
non@@	O	-1	20195852
i@@	O	-1	20195852
onic	O	-1	20195852
C@@	B-Chemical	D003287	20195852
M	I-Chemical	-1	20195852
,	O	-1	20195852
n@@	O	-1	20195852
or	O	-1	20195852
on	O	-1	20195852
the	O	-1	20195852
presence	O	-1	20195852
of	O	-1	20195852
cy@@	B-Disease	D003490	20195852
an@@	I-Disease	-1	20195852
o@@	I-Disease	-1	20195852
sis	I-Disease	-1	20195852
,	O	-1	20195852
and	O	-1	20195852
although	O	-1	20195852
CI@@	B-Disease	D007674	20195852
N	I-Disease	-1	20195852
us@@	O	-1	20195852
ually	O	-1	20195852
is	O	-1	20195852
rever@@	O	-1	20195852
sib@@	O	-1	20195852
le@@	O	-1	20195852
,	O	-1	20195852
more	O	-1	20195852
con@@	O	-1	20195852
cer@@	O	-1	20195852
n	O	-1	20195852
is	O	-1	20195852
ne@@	O	-1	20195852
ed@@	O	-1	20195852
ed	O	-1	20195852
for	O	-1	20195852
the	O	-1	20195852
pre@@	O	-1	20195852
ven@@	O	-1	20195852
tion	O	-1	20195852
of	O	-1	20195852
such	O	-1	20195852
a	O	-1	20195852
complication	O	-1	20195852
in	O	-1	20195852
child@@	O	-1	20195852
ren@@	O	-1	20195852
.	O	-1	20195852

A	O	-1	18997632
case	O	-1	18997632
of	O	-1	18997632
ventricular	B-Disease	D017180	18997632
tachycardia	I-Disease	-1	18997632
related	O	-1	18997632
to	O	-1	18997632
caffe@@	B-Chemical	D002110	18997632
ine	I-Chemical	-1	18997632
pre@@	O	-1	18997632
treatment.	O	-1	18997632
S@@	O	-1	18997632
u@@	O	-1	18997632
bo@@	O	-1	18997632
p@@	O	-1	18997632
tim@@	O	-1	18997632
al	O	-1	18997632
seizure	B-Disease	D012640	18997632
duration	O	-1	18997632
is	O	-1	18997632
common@@	O	-1	18997632
ly	O	-1	18997632
en@@	O	-1	18997632
coun@@	O	-1	18997632
te@@	O	-1	18997632
red	O	-1	18997632
in	O	-1	18997632
electro@@	O	-1	18997632
convul@@	O	-1	18997632
sive	O	-1	18997632
therapy	O	-1	18997632
p@@	O	-1	18997632
rac@@	O	-1	18997632
ti@@	O	-1	18997632
ce@@	O	-1	18997632
,	O	-1	18997632
es@@	O	-1	18997632
p@@	O	-1	18997632
ec@@	O	-1	18997632
i@@	O	-1	18997632
ally	O	-1	18997632
in	O	-1	18997632
ol@@	O	-1	18997632
der	O	-1	18997632
patients	O	-1	18997632
with	O	-1	18997632
higher	O	-1	18997632
seizure	B-Disease	D012640	18997632
th@@	O	-1	18997632
res@@	O	-1	18997632
h@@	O	-1	18997632
ol@@	O	-1	18997632
d@@	O	-1	18997632
s.	O	-1	18997632
In@@	O	-1	18997632
tra@@	O	-1	18997632
venous	O	-1	18997632
caffe@@	B-Chemical	D002110	18997632
ine	I-Chemical	-1	18997632
is	O	-1	18997632
common@@	O	-1	18997632
ly	O	-1	18997632
used	O	-1	18997632
to	O	-1	18997632
impro@@	O	-1	18997632
ve	O	-1	18997632
seizure	B-Disease	D012640	18997632
duration	O	-1	18997632
and	O	-1	18997632
qu@@	O	-1	18997632
ality	O	-1	18997632
in	O	-1	18997632
such	O	-1	18997632
patients	O	-1	18997632
and	O	-1	18997632
is	O	-1	18997632
gener@@	O	-1	18997632
ally	O	-1	18997632
well	O	-1	18997632
toler@@	O	-1	18997632
ated	O	-1	18997632
a@@	O	-1	18997632
side	O	-1	18997632
from	O	-1	18997632
oc@@	O	-1	18997632
ca@@	O	-1	18997632
sion@@	O	-1	18997632
al	O	-1	18997632
reports	O	-1	18997632
of	O	-1	18997632
rel@@	O	-1	18997632
atively	O	-1	18997632
ben@@	O	-1	18997632
ig@@	O	-1	18997632
n	O	-1	18997632
ventricular	B-Disease	D018879	18997632
ect@@	I-Disease	-1	18997632
op@@	I-Disease	-1	18997632
y	I-Disease	-1	18997632
.	O	-1	18997632
We	O	-1	18997632
describe	O	-1	18997632
a	O	-1	18997632
patient	O	-1	18997632
with	O	-1	18997632
no	O	-1	18997632
previ@@	O	-1	18997632
ous	O	-1	18997632
hist@@	O	-1	18997632
ory	O	-1	18997632
of	O	-1	18997632
cardiac	B-Disease	D006331	18997632
disease	I-Disease	-1	18997632
or	O	-1	18997632
arrhyth@@	B-Disease	D001145	18997632
mia	I-Disease	-1	18997632
who	O	-1	18997632
developed	O	-1	18997632
su@@	O	-1	18997632
st@@	O	-1	18997632
ained	O	-1	18997632
b@@	O	-1	18997632
ig@@	O	-1	18997632
em@@	O	-1	18997632
in@@	O	-1	18997632
y	O	-1	18997632
and	O	-1	18997632
2	O	-1	18997632
b@@	O	-1	18997632
ri@@	O	-1	18997632
e@@	O	-1	18997632
f	O	-1	18997632
r@@	O	-1	18997632
un@@	O	-1	18997632
s	O	-1	18997632
of	O	-1	18997632
ventricular	B-Disease	D017180	18997632
tachycardia	I-Disease	-1	18997632
after	O	-1	18997632
caffe@@	B-Chemical	D002110	18997632
ine	I-Chemical	-1	18997632
administr@@	O	-1	18997632
ation.	O	-1	18997632
Although	O	-1	18997632
intravenous	O	-1	18997632
caffe@@	B-Chemical	D002110	18997632
ine	I-Chemical	-1	18997632
is	O	-1	18997632
gener@@	O	-1	18997632
ally	O	-1	18997632
well	O	-1	18997632
toler@@	O	-1	18997632
at@@	O	-1	18997632
ed,	O	-1	18997632
the	O	-1	18997632
clin@@	O	-1	18997632
ici@@	O	-1	18997632
an	O	-1	18997632
should	O	-1	18997632
be	O	-1	18997632
aw@@	O	-1	18997632
are	O	-1	18997632
of	O	-1	18997632
the	O	-1	18997632
potential	O	-1	18997632
for	O	-1	18997632
un@@	O	-1	18997632
predic@@	O	-1	18997632
t@@	O	-1	18997632
able	O	-1	18997632
and	O	-1	18997632
seri@@	O	-1	18997632
ous	O	-1	18997632
ventricular	B-Disease	D001145	18997632
arrhyth@@	I-Disease	-1	18997632
mi@@	I-Disease	-1	18997632
as	I-Disease	-1	18997632
.	O	-1	18997632

O@@	O	-1	15565293
p@@	O	-1	15565293
tical	O	-1	15565293
co@@	O	-1	15565293
he@@	O	-1	15565293
rence	O	-1	15565293
to@@	O	-1	15565293
mo@@	O	-1	15565293
graph@@	O	-1	15565293
y	O	-1	15565293
can	O	-1	15565293
meas@@	O	-1	15565293
ure	O	-1	15565293
ax@@	O	-1	15565293
on@@	O	-1	15565293
al	O	-1	15565293
loss	O	-1	15565293
in	O	-1	15565293
patients	O	-1	15565293
with	O	-1	15565293
eth@@	B-Chemical	D004977	15565293
am@@	I-Chemical	-1	15565293
bu@@	I-Chemical	-1	15565293
to@@	I-Chemical	-1	15565293
l	I-Chemical	-1	15565293
-induced	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuropathy	I-Disease	-1	15565293
.	O	-1	15565293
P@@	O	-1	15565293
U@@	O	-1	15565293
R@@	O	-1	15565293
P@@	O	-1	15565293
O@@	O	-1	15565293
S@@	O	-1	15565293
E:	O	-1	15565293
To	O	-1	15565293
ma@@	O	-1	15565293
p	O	-1	15565293
and	O	-1	15565293
identi@@	O	-1	15565293
f@@	O	-1	15565293
y	O	-1	15565293
the	O	-1	15565293
pat@@	O	-1	15565293
tern@@	O	-1	15565293
,	O	-1	15565293
in	O	-1	15565293
viv@@	O	-1	15565293
o@@	O	-1	15565293
,	O	-1	15565293
of	O	-1	15565293
ax@@	B-Disease	D009410	15565293
on@@	I-Disease	-1	15565293
al	I-Disease	-1	15565293
de@@	I-Disease	-1	15565293
generation	I-Disease	-1	15565293
in	O	-1	15565293
eth@@	B-Chemical	D004977	15565293
am@@	I-Chemical	-1	15565293
bu@@	I-Chemical	-1	15565293
to@@	I-Chemical	-1	15565293
l	I-Chemical	-1	15565293
-induced	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuropathy	I-Disease	-1	15565293
using	O	-1	15565293
op@@	O	-1	15565293
tical	O	-1	15565293
co@@	O	-1	15565293
he@@	O	-1	15565293
rence	O	-1	15565293
to@@	O	-1	15565293
mo@@	O	-1	15565293
graph@@	O	-1	15565293
y	O	-1	15565293
(@@	O	-1	15565293
O@@	O	-1	15565293
C@@	O	-1	15565293
T@@	O	-1	15565293
).	O	-1	15565293
E@@	B-Chemical	D004977	15565293
th@@	I-Chemical	-1	15565293
am@@	I-Chemical	-1	15565293
bu@@	I-Chemical	-1	15565293
to@@	I-Chemical	-1	15565293
l	I-Chemical	-1	15565293
is	O	-1	15565293
an	O	-1	15565293
anti@@	O	-1	15565293
my@@	O	-1	15565293
co@@	O	-1	15565293
bac@@	O	-1	15565293
ter@@	O	-1	15565293
ial	O	-1	15565293
agent	O	-1	15565293
often	O	-1	15565293
used	O	-1	15565293
to	O	-1	15565293
tre@@	O	-1	15565293
at	O	-1	15565293
tub@@	B-Disease	D014376	15565293
er@@	I-Disease	-1	15565293
c@@	I-Disease	-1	15565293
ulo@@	I-Disease	-1	15565293
sis	I-Disease	-1	15565293
.	O	-1	15565293
A	O	-1	15565293
seri@@	O	-1	15565293
ous	O	-1	15565293
complication	O	-1	15565293
of	O	-1	15565293
eth@@	B-Chemical	D004977	15565293
am@@	I-Chemical	-1	15565293
bu@@	I-Chemical	-1	15565293
to@@	I-Chemical	-1	15565293
l	I-Chemical	-1	15565293
is	O	-1	15565293
an	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuropathy	I-Disease	-1	15565293
that	O	-1	15565293
impair@@	O	-1	15565293
s	O	-1	15565293
visual	O	-1	15565293
ac@@	O	-1	15565293
u@@	O	-1	15565293
ity,	O	-1	15565293
contr@@	O	-1	15565293
ast	O	-1	15565293
sensi@@	O	-1	15565293
tiv@@	O	-1	15565293
ity,	O	-1	15565293
and	O	-1	15565293
co@@	O	-1	15565293
lo@@	O	-1	15565293
r	O	-1	15565293
vi@@	O	-1	15565293
sion.	O	-1	15565293
However,	O	-1	15565293
early	O	-1	15565293
on@@	O	-1	15565293
,	O	-1	15565293
when	O	-1	15565293
the	O	-1	15565293
toxic	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuropathy	I-Disease	-1	15565293
is	O	-1	15565293
mil@@	O	-1	15565293
d	O	-1	15565293
and	O	-1	15565293
part@@	O	-1	15565293
ly	O	-1	15565293
rever@@	O	-1	15565293
sib@@	O	-1	15565293
le@@	O	-1	15565293
,	O	-1	15565293
the	O	-1	15565293
f@@	O	-1	15565293
und@@	O	-1	15565293
us@@	O	-1	15565293
co@@	O	-1	15565293
p@@	O	-1	15565293
ic	O	-1	15565293
findings	O	-1	15565293
are	O	-1	15565293
often	O	-1	15565293
sub@@	O	-1	15565293
t@@	O	-1	15565293
le	O	-1	15565293
and	O	-1	15565293
e@@	O	-1	15565293
as@@	O	-1	15565293
y	O	-1	15565293
to	O	-1	15565293
mis@@	O	-1	15565293
s.	O	-1	15565293
METHODS:	O	-1	15565293
Th@@	O	-1	15565293
ree	O	-1	15565293
subjects	O	-1	15565293
with	O	-1	15565293
a	O	-1	15565293
hist@@	O	-1	15565293
ory	O	-1	15565293
of	O	-1	15565293
eth@@	B-Chemical	D004977	15565293
am@@	I-Chemical	-1	15565293
bu@@	I-Chemical	-1	15565293
to@@	I-Chemical	-1	15565293
l	I-Chemical	-1	15565293
(	O	-1	15565293
E@@	B-Chemical	D004977	15565293
M@@	I-Chemical	-1	15565293
B	I-Chemical	-1	15565293
)@@	O	-1	15565293
-induced	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuropathy	I-Disease	-1	15565293
of	O	-1	15565293
sh@@	O	-1	15565293
ort@@	O	-1	15565293
-@@	O	-1	15565293
,	O	-1	15565293
inter@@	O	-1	15565293
medi@@	O	-1	15565293
at@@	O	-1	15565293
e-@@	O	-1	15565293
,	O	-1	15565293
and	O	-1	15565293
long-term	O	-1	15565293
visual	B-Disease	D014786	15565293
defic@@	I-Disease	-1	15565293
its	I-Disease	-1	15565293
were	O	-1	15565293
administered	O	-1	15565293
a	O	-1	15565293
ful@@	O	-1	15565293
l	O	-1	15565293
neuro@@	O	-1	15565293
-@@	O	-1	15565293
oph@@	O	-1	15565293
thal@@	O	-1	15565293
mo@@	O	-1	15565293
log@@	O	-1	15565293
ic	O	-1	15565293
examin@@	O	-1	15565293
ation	O	-1	15565293
including	O	-1	15565293
visual	O	-1	15565293
ac@@	O	-1	15565293
u@@	O	-1	15565293
ity,	O	-1	15565293
co@@	O	-1	15565293
lo@@	O	-1	15565293
r	O	-1	15565293
vi@@	O	-1	15565293
sion,	O	-1	15565293
contr@@	O	-1	15565293
ast	O	-1	15565293
sensi@@	O	-1	15565293
tiv@@	O	-1	15565293
ity,	O	-1	15565293
and	O	-1	15565293
f@@	O	-1	15565293
und@@	O	-1	15565293
us	O	-1	15565293
examin@@	O	-1	15565293
ation.	O	-1	15565293
In	O	-1	15565293
addi@@	O	-1	15565293
tion,	O	-1	15565293
O@@	O	-1	15565293
C@@	O	-1	15565293
T	O	-1	15565293
(@@	O	-1	15565293
O@@	O	-1	15565293
C@@	O	-1	15565293
T	O	-1	15565293
3@@	O	-1	15565293
0@@	O	-1	15565293
0@@	O	-1	15565293
0@@	O	-1	15565293
,	O	-1	15565293
H@@	O	-1	15565293
um@@	O	-1	15565293
ph@@	O	-1	15565293
re@@	O	-1	15565293
y-@@	O	-1	15565293
Z@@	O	-1	15565293
e@@	O	-1	15565293
is@@	O	-1	15565293
s,	O	-1	15565293
D@@	O	-1	15565293
u@@	O	-1	15565293
bl@@	O	-1	15565293
in,	O	-1	15565293
CA@@	O	-1	15565293
)	O	-1	15565293
was	O	-1	15565293
performed	O	-1	15565293
on	O	-1	15565293
both	O	-1	15565293
e@@	O	-1	15565293
y@@	O	-1	15565293
es	O	-1	15565293
of	O	-1	15565293
each	O	-1	15565293
subj@@	O	-1	15565293
ect	O	-1	15565293
using	O	-1	15565293
the	O	-1	15565293
ret@@	O	-1	15565293
inal	O	-1	15565293
nerve	O	-1	15565293
fib@@	O	-1	15565293
er	O	-1	15565293
l@@	O	-1	15565293
ay@@	O	-1	15565293
er	O	-1	15565293
(@@	O	-1	15565293
R@@	O	-1	15565293
N@@	O	-1	15565293
F@@	O	-1	15565293
L@@	O	-1	15565293
)	O	-1	15565293
analysis	O	-1	15565293
pro@@	O	-1	15565293
to@@	O	-1	15565293
co@@	O	-1	15565293
l@@	O	-1	15565293
.	O	-1	15565293
O@@	O	-1	15565293
C@@	O	-1	15565293
T	O	-1	15565293
inter@@	O	-1	15565293
pol@@	O	-1	15565293
ates	O	-1	15565293
data	O	-1	15565293
from	O	-1	15565293
100	O	-1	15565293
po@@	O	-1	15565293
int@@	O	-1	15565293
s	O	-1	15565293
a@@	O	-1	15565293
ro@@	O	-1	15565293
un@@	O	-1	15565293
d	O	-1	15565293
the	O	-1	15565293
op@@	O	-1	15565293
tic	O	-1	15565293
nerve	O	-1	15565293
to	O	-1	15565293
eff@@	O	-1	15565293
ectively	O	-1	15565293
ma@@	O	-1	15565293
p	O	-1	15565293
out	O	-1	15565293
the	O	-1	15565293
R@@	O	-1	15565293
N@@	O	-1	15565293
F@@	O	-1	15565293
L@@	O	-1	15565293
.	O	-1	15565293
RESULTS:	O	-1	15565293
The	O	-1	15565293
results	O	-1	15565293
were	O	-1	15565293
compared	O	-1	15565293
to	O	-1	15565293
the	O	-1	15565293
calc@@	O	-1	15565293
ul@@	O	-1	15565293
ated	O	-1	15565293
average	O	-1	15565293
R@@	O	-1	15565293
N@@	O	-1	15565293
F@@	O	-1	15565293
L	O	-1	15565293
of	O	-1	15565293
normal	O	-1	15565293
e@@	O	-1	15565293
y@@	O	-1	15565293
es	O	-1	15565293
accum@@	O	-1	15565293
ul@@	O	-1	15565293
ated	O	-1	15565293
from	O	-1	15565293
four	O	-1	15565293
prior	O	-1	15565293
studies	O	-1	15565293
using	O	-1	15565293
O@@	O	-1	15565293
C@@	O	-1	15565293
T@@	O	-1	15565293
,	O	-1	15565293
n@@	O	-1	15565293
=@@	O	-1	15565293
6@@	O	-1	15565293
6@@	O	-1	15565293
1@@	O	-1	15565293
.	O	-1	15565293
In	O	-1	15565293
all	O	-1	15565293
subjects	O	-1	15565293
with	O	-1	15565293
hist@@	O	-1	15565293
ory	O	-1	15565293
of	O	-1	15565293
E@@	B-Chemical	D004977	15565293
M@@	I-Chemical	-1	15565293
B	I-Chemical	-1	15565293
-induced	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuropathy	I-Disease	-1	15565293
,	O	-1	15565293
there	O	-1	15565293
was	O	-1	15565293
a	O	-1	15565293
mean	O	-1	15565293
loss	O	-1	15565293
of	O	-1	15565293
7@@	O	-1	15565293
2@@	O	-1	15565293
%	O	-1	15565293
nerve	O	-1	15565293
fib@@	O	-1	15565293
er	O	-1	15565293
l@@	O	-1	15565293
ay@@	O	-1	15565293
er	O	-1	15565293
th@@	O	-1	15565293
ic@@	O	-1	15565293
k@@	O	-1	15565293
ness	O	-1	15565293
in	O	-1	15565293
the	O	-1	15565293
tempor@@	O	-1	15565293
al	O	-1	15565293
qu@@	O	-1	15565293
ad@@	O	-1	15565293
ran@@	O	-1	15565293
t	O	-1	15565293
(@@	O	-1	15565293
patient	O	-1	15565293
A@@	O	-1	15565293
,	O	-1	15565293
with	O	-1	15565293
event@@	O	-1	15565293
ual	O	-1	15565293
recovery	O	-1	15565293
of	O	-1	15565293
visual	O	-1	15565293
ac@@	O	-1	15565293
u@@	O	-1	15565293
ity	O	-1	15565293
and	O	-1	15565293
fi@@	O	-1	15565293
el@@	O	-1	15565293
d@@	O	-1	15565293
s,	O	-1	15565293
5@@	O	-1	15565293
8@@	O	-1	15565293
%	O	-1	15565293
los@@	O	-1	15565293
s;	O	-1	15565293
patient	O	-1	15565293
B@@	O	-1	15565293
,	O	-1	15565293
with	O	-1	15565293
inter@@	O	-1	15565293
medi@@	O	-1	15565293
ate	O	-1	15565293
visual	B-Disease	D014786	15565293
defic@@	I-Disease	-1	15565293
its	I-Disease	-1	15565293
,	O	-1	15565293
6@@	O	-1	15565293
8@@	O	-1	15565293
%	O	-1	15565293
los@@	O	-1	15565293
s;	O	-1	15565293
patient	O	-1	15565293
C@@	O	-1	15565293
,	O	-1	15565293
with	O	-1	15565293
chronic	O	-1	15565293
visual	B-Disease	D014786	15565293
defic@@	I-Disease	-1	15565293
its	I-Disease	-1	15565293
,	O	-1	15565293
9@@	O	-1	15565293
0%	O	-1	15565293
los@@	O	-1	15565293
s),	O	-1	15565293
with	O	-1	15565293
an	O	-1	15565293
average	O	-1	15565293
mean	O	-1	15565293
op@@	O	-1	15565293
tic	O	-1	15565293
nerve	O	-1	15565293
th@@	O	-1	15565293
ic@@	O	-1	15565293
k@@	O	-1	15565293
ness	O	-1	15565293
of	O	-1	15565293
2@@	O	-1	15565293
6@@	O	-1	15565293
+/@@	O	-1	15565293
-1@@	O	-1	15565293
6	O	-1	15565293
mic@@	O	-1	15565293
rom@@	O	-1	15565293
.	O	-1	15565293
There	O	-1	15565293
was	O	-1	15565293
a	O	-1	15565293
combined	O	-1	15565293
mean	O	-1	15565293
loss	O	-1	15565293
of	O	-1	15565293
4@@	O	-1	15565293
6%	O	-1	15565293
of	O	-1	15565293
fib@@	O	-1	15565293
ers	O	-1	15565293
from	O	-1	15565293
the	O	-1	15565293
su@@	O	-1	15565293
peri@@	O	-1	15565293
or@@	O	-1	15565293
,	O	-1	15565293
inf@@	O	-1	15565293
er@@	O	-1	15565293
i@@	O	-1	15565293
or@@	O	-1	15565293
,	O	-1	15565293
and	O	-1	15565293
n@@	O	-1	15565293
as@@	O	-1	15565293
al	O	-1	15565293
qu@@	O	-1	15565293
ad@@	O	-1	15565293
ran@@	O	-1	15565293
ts	O	-1	15565293
in	O	-1	15565293
the	O	-1	15565293
(@@	O	-1	15565293
si@@	O	-1	15565293
x@@	O	-1	15565293
)	O	-1	15565293
e@@	O	-1	15565293
y@@	O	-1	15565293
es	O	-1	15565293
of	O	-1	15565293
all	O	-1	15565293
three	O	-1	15565293
subjects	O	-1	15565293
(@@	O	-1	15565293
mean	O	-1	15565293
average	O	-1	15565293
th@@	O	-1	15565293
ic@@	O	-1	15565293
k@@	O	-1	15565293
ness	O	-1	15565293
of	O	-1	15565293
55@@	O	-1	15565293
+/-@@	O	-1	15565293
2@@	O	-1	15565293
9	O	-1	15565293
mic@@	O	-1	15565293
rom@@	O	-1	15565293
).	O	-1	15565293
In	O	-1	15565293
both	O	-1	15565293
se@@	O	-1	15565293
ts	O	-1	15565293
(@@	O	-1	15565293
fo@@	O	-1	15565293
ur@@	O	-1	15565293
)	O	-1	15565293
of	O	-1	15565293
e@@	O	-1	15565293
y@@	O	-1	15565293
es	O	-1	15565293
of	O	-1	15565293
the	O	-1	15565293
subjects	O	-1	15565293
with	O	-1	15565293
per@@	O	-1	15565293
sist@@	O	-1	15565293
ent	O	-1	15565293
visual	B-Disease	D014786	15565293
defic@@	I-Disease	-1	15565293
its	I-Disease	-1	15565293
(@@	O	-1	15565293
patients	O	-1	15565293
B	O	-1	15565293
and	O	-1	15565293
C@@	O	-1	15565293
),	O	-1	15565293
there	O	-1	15565293
was	O	-1	15565293
an	O	-1	15565293
average	O	-1	15565293
loss	O	-1	15565293
of	O	-1	15565293
7@@	O	-1	15565293
9@@	O	-1	15565293
%	O	-1	15565293
of	O	-1	15565293
nerve	O	-1	15565293
fib@@	O	-1	15565293
er	O	-1	15565293
th@@	O	-1	15565293
ic@@	O	-1	15565293
k@@	O	-1	15565293
ness	O	-1	15565293
in	O	-1	15565293
the	O	-1	15565293
tempor@@	O	-1	15565293
al	O	-1	15565293
qu@@	O	-1	15565293
ad@@	O	-1	15565293
ran@@	O	-1	15565293
t.	O	-1	15565293
CONCLUSIONS:	O	-1	15565293
The	O	-1	15565293
O@@	O	-1	15565293
C@@	O	-1	15565293
T	O	-1	15565293
results	O	-1	15565293
in	O	-1	15565293
these	O	-1	15565293
patients	O	-1	15565293
with	O	-1	15565293
E@@	B-Chemical	D004977	15565293
M@@	I-Chemical	-1	15565293
B	I-Chemical	-1	15565293
-induced	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuropathy	I-Disease	-1	15565293
show	O	-1	15565293
con@@	O	-1	15565293
si@@	O	-1	15565293
der@@	O	-1	15565293
able	O	-1	15565293
loss	O	-1	15565293
es@@	O	-1	15565293
p@@	O	-1	15565293
ec@@	O	-1	15565293
i@@	O	-1	15565293
ally	O	-1	15565293
of	O	-1	15565293
the	O	-1	15565293
tempor@@	O	-1	15565293
al	O	-1	15565293
fib@@	O	-1	15565293
ers.	O	-1	15565293
This	O	-1	15565293
is	O	-1	15565293
consist@@	O	-1	15565293
ent	O	-1	15565293
with	O	-1	15565293
prior	O	-1	15565293
histo@@	O	-1	15565293
path@@	O	-1	15565293
ological	O	-1	15565293
studies	O	-1	15565293
that	O	-1	15565293
show	O	-1	15565293
pre@@	O	-1	15565293
domin@@	O	-1	15565293
ant	O	-1	15565293
loss	O	-1	15565293
of	O	-1	15565293
par@@	O	-1	15565293
v@@	O	-1	15565293
o@@	O	-1	15565293
-@@	O	-1	15565293
cell@@	O	-1	15565293
ular	O	-1	15565293
ax@@	O	-1	15565293
ons	O	-1	15565293
(@@	O	-1	15565293
or	O	-1	15565293
sm@@	O	-1	15565293
all@@	O	-1	15565293
-@@	O	-1	15565293
cal@@	O	-1	15565293
i@@	O	-1	15565293
b@@	O	-1	15565293
er	O	-1	15565293
ax@@	O	-1	15565293
on@@	O	-1	15565293
s)	O	-1	15565293
within	O	-1	15565293
the	O	-1	15565293
pap@@	O	-1	15565293
il@@	O	-1	15565293
lo@@	O	-1	15565293
-@@	O	-1	15565293
mac@@	O	-1	15565293
ular	O	-1	15565293
b@@	O	-1	15565293
und@@	O	-1	15565293
le	O	-1	15565293
in	O	-1	15565293
toxic	O	-1	15565293
or	O	-1	15565293
he@@	O	-1	15565293
re@@	O	-1	15565293
d@@	O	-1	15565293
it@@	O	-1	15565293
ary	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuro@@	I-Disease	-1	15565293
path@@	I-Disease	-1	15565293
i@@	I-Disease	-1	15565293
es	I-Disease	-1	15565293
.	O	-1	15565293
O@@	O	-1	15565293
C@@	O	-1	15565293
T	O	-1	15565293
can	O	-1	15565293
be	O	-1	15565293
a	O	-1	15565293
valu@@	O	-1	15565293
able	O	-1	15565293
to@@	O	-1	15565293
ol	O	-1	15565293
in	O	-1	15565293
the	O	-1	15565293
qu@@	O	-1	15565293
anti@@	O	-1	15565293
t@@	O	-1	15565293
ative	O	-1	15565293
analysis	O	-1	15565293
of	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuro@@	I-Disease	-1	15565293
path@@	I-Disease	-1	15565293
i@@	I-Disease	-1	15565293
es	I-Disease	-1	15565293
.	O	-1	15565293
Ad@@	O	-1	15565293
di@@	O	-1	15565293
tion@@	O	-1	15565293
ally,	O	-1	15565293
in	O	-1	15565293
ter@@	O	-1	15565293
ms	O	-1	15565293
of	O	-1	15565293
man@@	O	-1	15565293
ag@@	O	-1	15565293
ement	O	-1	15565293
of	O	-1	15565293
E@@	B-Chemical	D004977	15565293
M@@	I-Chemical	-1	15565293
B	I-Chemical	-1	15565293
-induced	O	-1	15565293
op@@	B-Disease	D009901	15565293
tic	I-Disease	-1	15565293
neuropathy	I-Disease	-1	15565293
,	O	-1	15565293
it	O	-1	15565293
is	O	-1	15565293
important	O	-1	15565293
to	O	-1	15565293
pro@@	O	-1	15565293
per@@	O	-1	15565293
ly	O	-1	15565293
man@@	O	-1	15565293
age	O	-1	15565293
eth@@	B-Chemical	D004977	15565293
am@@	I-Chemical	-1	15565293
bu@@	I-Chemical	-1	15565293
to@@	I-Chemical	-1	15565293
l	I-Chemical	-1	15565293
dos@@	O	-1	15565293
ing	O	-1	15565293
in	O	-1	15565293
patients	O	-1	15565293
with	O	-1	15565293
renal	B-Disease	D051437	15565293
impair@@	I-Disease	-1	15565293
ment	I-Disease	-1	15565293
and	O	-1	15565293
to	O	-1	15565293
achi@@	O	-1	15565293
e@@	O	-1	15565293
ve	O	-1	15565293
pro@@	O	-1	15565293
per	O	-1	15565293
transi@@	O	-1	15565293
tion	O	-1	15565293
to	O	-1	15565293
a	O	-1	15565293
maint@@	O	-1	15565293
en@@	O	-1	15565293
ance	O	-1	15565293
dose	O	-1	15565293
on@@	O	-1	15565293
ce	O	-1	15565293
an	O	-1	15565293
appro@@	O	-1	15565293
pri@@	O	-1	15565293
ate	O	-1	15565293
lo@@	O	-1	15565293
ad@@	O	-1	15565293
ing	O	-1	15565293
dose	O	-1	15565293
has	O	-1	15565293
been	O	-1	15565293
reac@@	O	-1	15565293
he@@	O	-1	15565293
d.	O	-1	15565293

Eff@@	O	-1	15266215
ects	O	-1	15266215
of	O	-1	15266215
the	O	-1	15266215
cyclo@@	O	-1	15266215
oxy@@	O	-1	15266215
gen@@	O	-1	15266215
as@@	O	-1	15266215
e-@@	O	-1	15266215
2	O	-1	15266215
specific	O	-1	15266215
inhibitor	O	-1	15266215
val@@	B-Chemical	C406224	15266215
dec@@	I-Chemical	-1	15266215
ox@@	I-Chemical	-1	15266215
i@@	I-Chemical	-1	15266215
b	I-Chemical	-1	15266215
versus	O	-1	15266215
non@@	O	-1	15266215
steroid@@	O	-1	15266215
al	O	-1	15266215
anti@@	O	-1	15266215
inflam@@	O	-1	15266215
mat@@	O	-1	15266215
ory	O	-1	15266215
agents	O	-1	15266215
and	O	-1	15266215
placebo	O	-1	15266215
on	O	-1	15266215
cardiovascular	O	-1	15266215
thrombotic	B-Disease	D013927	15266215
events	O	-1	15266215
in	O	-1	15266215
patients	O	-1	15266215
with	O	-1	15266215
arth@@	B-Disease	D001168	15266215
ritis	I-Disease	-1	15266215
.	O	-1	15266215
There	O	-1	15266215
have	O	-1	15266215
been	O	-1	15266215
con@@	O	-1	15266215
cer@@	O	-1	15266215
n@@	O	-1	15266215
s	O	-1	15266215
that	O	-1	15266215
the	O	-1	15266215
risk	O	-1	15266215
of	O	-1	15266215
cardiovascular	O	-1	15266215
thrombotic	B-Disease	D013927	15266215
events	O	-1	15266215
may	O	-1	15266215
be	O	-1	15266215
higher	O	-1	15266215
with	O	-1	15266215
cyclo@@	O	-1	15266215
oxy@@	O	-1	15266215
gen@@	O	-1	15266215
ase	O	-1	15266215
(C@@	O	-1	15266215
O@@	O	-1	15266215
X@@	O	-1	15266215
)-@@	O	-1	15266215
2-@@	O	-1	15266215
specific	O	-1	15266215
inhibitors	O	-1	15266215
than	O	-1	15266215
non@@	O	-1	15266215
selective	O	-1	15266215
non@@	O	-1	15266215
steroid@@	O	-1	15266215
al	O	-1	15266215
anti@@	O	-1	15266215
inflam@@	O	-1	15266215
mat@@	O	-1	15266215
ory	O	-1	15266215
drugs	O	-1	15266215
(N@@	O	-1	15266215
S@@	O	-1	15266215
A@@	O	-1	15266215
I@@	O	-1	15266215
D@@	O	-1	15266215
s@@	O	-1	15266215
).	O	-1	15266215
We	O	-1	15266215
evaluated	O	-1	15266215
cardiovascular	O	-1	15266215
ev@@	O	-1	15266215
ent	O	-1	15266215
data	O	-1	15266215
for	O	-1	15266215
val@@	B-Chemical	C406224	15266215
dec@@	I-Chemical	-1	15266215
ox@@	I-Chemical	-1	15266215
i@@	I-Chemical	-1	15266215
b	I-Chemical	-1	15266215
,	O	-1	15266215
a	O	-1	15266215
new	O	-1	15266215
CO@@	O	-1	15266215
X@@	O	-1	15266215
-@@	O	-1	15266215
2-@@	O	-1	15266215
specific	O	-1	15266215
inhibitor	O	-1	15266215
in	O	-1	15266215
appro@@	O	-1	15266215
xim@@	O	-1	15266215
ately	O	-1	15266215
80@@	O	-1	15266215
00	O	-1	15266215
patients	O	-1	15266215
with	O	-1	15266215
ost@@	B-Disease	D010003	15266215
e@@	I-Disease	-1	15266215
o@@	I-Disease	-1	15266215
arth@@	I-Disease	-1	15266215
ritis	I-Disease	-1	15266215
and	O	-1	15266215
r@@	B-Disease	D001172	15266215
he@@	I-Disease	-1	15266215
um@@	I-Disease	-1	15266215
at@@	I-Disease	-1	15266215
oid	I-Disease	-1	15266215
arth@@	I-Disease	-1	15266215
ritis	I-Disease	-1	15266215
treated	O	-1	15266215
with	O	-1	15266215
this	O	-1	15266215
agent	O	-1	15266215
in	O	-1	15266215
randomized	O	-1	15266215
clinical	O	-1	15266215
tri@@	O	-1	15266215
al@@	O	-1	15266215
s.	O	-1	15266215
The	O	-1	15266215
incidence	O	-1	15266215
of	O	-1	15266215
cardiovascular	O	-1	15266215
thrombotic	B-Disease	D013927	15266215
events	O	-1	15266215
(@@	O	-1	15266215
cardi@@	O	-1	15266215
ac@@	O	-1	15266215
,	O	-1	15266215
ce@@	O	-1	15266215
reb@@	O	-1	15266215
ro@@	O	-1	15266215
vascular	O	-1	15266215
and	O	-1	15266215
peripheral	O	-1	15266215
vas@@	O	-1	15266215
cul@@	O	-1	15266215
ar@@	O	-1	15266215
,	O	-1	15266215
or	O	-1	15266215
arterial	O	-1	15266215
thrombotic	B-Disease	D013927	15266215
)	O	-1	15266215
was	O	-1	15266215
determined	O	-1	15266215
by	O	-1	15266215
analy@@	O	-1	15266215
z@@	O	-1	15266215
ing	O	-1	15266215
po@@	O	-1	15266215
ol@@	O	-1	15266215
ed	O	-1	15266215
val@@	B-Chemical	C406224	15266215
dec@@	I-Chemical	-1	15266215
ox@@	I-Chemical	-1	15266215
i@@	I-Chemical	-1	15266215
b	I-Chemical	-1	15266215
(@@	O	-1	15266215
10-@@	O	-1	15266215
8@@	O	-1	15266215
0	O	-1	15266215
mg	O	-1	15266215
da@@	O	-1	15266215
il@@	O	-1	15266215
y@@	O	-1	15266215
),	O	-1	15266215
non@@	O	-1	15266215
selective	O	-1	15266215
N@@	O	-1	15266215
S@@	O	-1	15266215
A@@	O	-1	15266215
I@@	O	-1	15266215
D	O	-1	15266215
(	O	-1	15266215
dic@@	B-Chemical	D004008	15266215
lo@@	I-Chemical	-1	15266215
f@@	I-Chemical	-1	15266215
en@@	I-Chemical	-1	15266215
a@@	I-Chemical	-1	15266215
c	I-Chemical	-1	15266215
7@@	O	-1	15266215
5	O	-1	15266215
mg	O	-1	15266215
b@@	O	-1	15266215
id@@	O	-1	15266215
,	O	-1	15266215
i@@	B-Chemical	D007052	15266215
bu@@	I-Chemical	-1	15266215
prof@@	I-Chemical	-1	15266215
en	I-Chemical	-1	15266215
8@@	O	-1	15266215
00	O	-1	15266215
mg	O	-1	15266215
ti@@	O	-1	15266215
d,	O	-1	15266215
or	O	-1	15266215
na@@	B-Chemical	D009288	15266215
pro@@	I-Chemical	-1	15266215
x@@	I-Chemical	-1	15266215
en	I-Chemical	-1	15266215
5@@	O	-1	15266215
00	O	-1	15266215
mg	O	-1	15266215
b@@	O	-1	15266215
id@@	O	-1	15266215
)	O	-1	15266215
and	O	-1	15266215
placebo	O	-1	15266215
data	O	-1	15266215
from	O	-1	15266215
10	O	-1	15266215
randomized	O	-1	15266215
ost@@	B-Disease	D010003	15266215
e@@	I-Disease	-1	15266215
o@@	I-Disease	-1	15266215
arth@@	I-Disease	-1	15266215
ritis	I-Disease	-1	15266215
and	O	-1	15266215
r@@	B-Disease	D001172	15266215
he@@	I-Disease	-1	15266215
um@@	I-Disease	-1	15266215
at@@	I-Disease	-1	15266215
oid	I-Disease	-1	15266215
arth@@	I-Disease	-1	15266215
ritis	I-Disease	-1	15266215
tri@@	O	-1	15266215
als	O	-1	15266215
that	O	-1	15266215
were	O	-1	15266215
6-@@	O	-1	15266215
5@@	O	-1	15266215
2	O	-1	15266215
weeks	O	-1	15266215
in	O	-1	15266215
dur@@	O	-1	15266215
ation.	O	-1	15266215
The	O	-1	15266215
incidence	O	-1	15266215
rat@@	O	-1	15266215
es	O	-1	15266215
of	O	-1	15266215
events	O	-1	15266215
were	O	-1	15266215
determined	O	-1	15266215
in	O	-1	15266215
all	O	-1	15266215
patients	O	-1	15266215
(n	O	-1	15266215
=	O	-1	15266215
7@@	O	-1	15266215
9@@	O	-1	15266215
34@@	O	-1	15266215
)	O	-1	15266215
and	O	-1	15266215
in	O	-1	15266215
users	O	-1	15266215
of	O	-1	15266215
low@@	O	-1	15266215
-@@	O	-1	15266215
dose	O	-1	15266215
(@@	O	-1	15266215
<	O	-1	15266215
or	O	-1	15266215
=@@	O	-1	15266215
3@@	O	-1	15266215
25	O	-1	15266215
mg	O	-1	15266215
da@@	O	-1	15266215
il@@	O	-1	15266215
y@@	O	-1	15266215
)	O	-1	15266215
as@@	B-Chemical	D001241	15266215
pi@@	I-Chemical	-1	15266215
rin	I-Chemical	-1	15266215
(n	O	-1	15266215
=	O	-1	15266215
10@@	O	-1	15266215
5@@	O	-1	15266215
1)	O	-1	15266215
and	O	-1	15266215
non@@	O	-1	15266215
users	O	-1	15266215
of	O	-1	15266215
as@@	B-Chemical	D001241	15266215
pi@@	I-Chemical	-1	15266215
rin	I-Chemical	-1	15266215
(n	O	-1	15266215
=	O	-1	15266215
6@@	O	-1	15266215
8@@	O	-1	15266215
8@@	O	-1	15266215
3@@	O	-1	15266215
).	O	-1	15266215
C@@	O	-1	15266215
r@@	O	-1	15266215
ude	O	-1	15266215
and	O	-1	15266215
expos@@	O	-1	15266215
ure@@	O	-1	15266215
-@@	O	-1	15266215
adjust@@	O	-1	15266215
ed	O	-1	15266215
inc@@	O	-1	15266215
id@@	O	-1	15266215
enc@@	O	-1	15266215
es	O	-1	15266215
of	O	-1	15266215
thrombotic	B-Disease	D013927	15266215
events	O	-1	15266215
were	O	-1	15266215
similar	O	-1	15266215
for	O	-1	15266215
val@@	B-Chemical	C406224	15266215
dec@@	I-Chemical	-1	15266215
ox@@	I-Chemical	-1	15266215
i@@	I-Chemical	-1	15266215
b	I-Chemical	-1	15266215
,	O	-1	15266215
N@@	O	-1	15266215
S@@	O	-1	15266215
A@@	O	-1	15266215
I@@	O	-1	15266215
D@@	O	-1	15266215
s,	O	-1	15266215
and	O	-1	15266215
placebo@@	O	-1	15266215
.	O	-1	15266215
The	O	-1	15266215
risk	O	-1	15266215
of	O	-1	15266215
seri@@	O	-1	15266215
ous	O	-1	15266215
thrombotic	B-Disease	D013927	15266215
events	O	-1	15266215
was	O	-1	15266215
also	O	-1	15266215
similar	O	-1	15266215
for	O	-1	15266215
each	O	-1	15266215
val@@	B-Chemical	C406224	15266215
dec@@	I-Chemical	-1	15266215
ox@@	I-Chemical	-1	15266215
i@@	I-Chemical	-1	15266215
b	I-Chemical	-1	15266215
dose.	O	-1	15266215
Th@@	B-Disease	D013927	15266215
rom@@	I-Disease	-1	15266215
bo@@	I-Disease	-1	15266215
tic	I-Disease	-1	15266215
risk	O	-1	15266215
was	O	-1	15266215
consist@@	O	-1	15266215
ently	O	-1	15266215
higher	O	-1	15266215
for	O	-1	15266215
users	O	-1	15266215
of	O	-1	15266215
as@@	B-Chemical	D001241	15266215
pi@@	I-Chemical	-1	15266215
rin	I-Chemical	-1	15266215
users	O	-1	15266215
than	O	-1	15266215
non@@	O	-1	15266215
users	O	-1	15266215
of	O	-1	15266215
as@@	B-Chemical	D001241	15266215
pi@@	I-Chemical	-1	15266215
rin	I-Chemical	-1	15266215
(@@	O	-1	15266215
placebo@@	O	-1	15266215
,	O	-1	15266215
1.@@	O	-1	15266215
4@@	O	-1	15266215
%	O	-1	15266215
vs.	O	-1	15266215
0@@	O	-1	15266215
%@@	O	-1	15266215
;	O	-1	15266215
val@@	B-Chemical	C406224	15266215
dec@@	I-Chemical	-1	15266215
ox@@	I-Chemical	-1	15266215
i@@	I-Chemical	-1	15266215
b	I-Chemical	-1	15266215
,	O	-1	15266215
1.@@	O	-1	15266215
7@@	O	-1	15266215
%	O	-1	15266215
vs.	O	-1	15266215
0.@@	O	-1	15266215
2@@	O	-1	15266215
%@@	O	-1	15266215
;	O	-1	15266215
N@@	O	-1	15266215
S@@	O	-1	15266215
A@@	O	-1	15266215
I@@	O	-1	15266215
D@@	O	-1	15266215
s,	O	-1	15266215
1.@@	O	-1	15266215
9@@	O	-1	15266215
%	O	-1	15266215
vs.	O	-1	15266215
0.@@	O	-1	15266215
5@@	O	-1	15266215
%).	O	-1	15266215
The	O	-1	15266215
rat@@	O	-1	15266215
es	O	-1	15266215
of	O	-1	15266215
events	O	-1	15266215
in	O	-1	15266215
users	O	-1	15266215
of	O	-1	15266215
as@@	B-Chemical	D001241	15266215
pi@@	I-Chemical	-1	15266215
rin	I-Chemical	-1	15266215
were	O	-1	15266215
similar	O	-1	15266215
for	O	-1	15266215
all	O	-1	15266215
3	O	-1	15266215
treatment	O	-1	15266215
groups	O	-1	15266215
and	O	-1	15266215
ac@@	O	-1	15266215
ros@@	O	-1	15266215
s	O	-1	15266215
val@@	B-Chemical	C406224	15266215
dec@@	I-Chemical	-1	15266215
ox@@	I-Chemical	-1	15266215
i@@	I-Chemical	-1	15266215
b	I-Chemical	-1	15266215
dos@@	O	-1	15266215
es.	O	-1	15266215
S@@	O	-1	15266215
h@@	O	-1	15266215
ort@@	O	-1	15266215
-	O	-1	15266215
and	O	-1	15266215
inter@@	O	-1	15266215
medi@@	O	-1	15266215
at@@	O	-1	15266215
e-@@	O	-1	15266215
term	O	-1	15266215
treatment	O	-1	15266215
with	O	-1	15266215
therapeutic	O	-1	15266215
(10	O	-1	15266215
or	O	-1	15266215
20	O	-1	15266215
mg	O	-1	15266215
da@@	O	-1	15266215
il@@	O	-1	15266215
y@@	O	-1	15266215
)	O	-1	15266215
and	O	-1	15266215
sup@@	O	-1	15266215
ra@@	O	-1	15266215
therapeutic	O	-1	15266215
(@@	O	-1	15266215
40	O	-1	15266215
or	O	-1	15266215
8@@	O	-1	15266215
0	O	-1	15266215
mg	O	-1	15266215
da@@	O	-1	15266215
il@@	O	-1	15266215
y@@	O	-1	15266215
)	O	-1	15266215
val@@	B-Chemical	C406224	15266215
dec@@	I-Chemical	-1	15266215
ox@@	I-Chemical	-1	15266215
i@@	I-Chemical	-1	15266215
b	I-Chemical	-1	15266215
doses	O	-1	15266215
was	O	-1	15266215
not	O	-1	15266215
associated	O	-1	15266215
with	O	-1	15266215
an	O	-1	15266215
increased	O	-1	15266215
incidence	O	-1	15266215
of	O	-1	15266215
thrombotic	B-Disease	D013927	15266215
events	O	-1	15266215
rel@@	O	-1	15266215
ative	O	-1	15266215
to	O	-1	15266215
non@@	O	-1	15266215
selective	O	-1	15266215
N@@	O	-1	15266215
S@@	O	-1	15266215
A@@	O	-1	15266215
I@@	O	-1	15266215
D@@	O	-1	15266215
s	O	-1	15266215
or	O	-1	15266215
placebo	O	-1	15266215
in	O	-1	15266215
ost@@	B-Disease	D010003	15266215
e@@	I-Disease	-1	15266215
o@@	I-Disease	-1	15266215
arth@@	I-Disease	-1	15266215
ritis	I-Disease	-1	15266215
and	O	-1	15266215
r@@	B-Disease	D001172	15266215
he@@	I-Disease	-1	15266215
um@@	I-Disease	-1	15266215
at@@	I-Disease	-1	15266215
oid	I-Disease	-1	15266215
arth@@	I-Disease	-1	15266215
ritis	I-Disease	-1	15266215
patients	O	-1	15266215
in	O	-1	15266215
controlled	O	-1	15266215
clinical	O	-1	15266215
tri@@	O	-1	15266215
al@@	O	-1	15266215
s.	O	-1	15266215

A	O	-1	14742097
random@@	O	-1	14742097
iz@@	O	-1	14742097
ed,	O	-1	14742097
placebo@@	O	-1	14742097
-@@	O	-1	14742097
control@@	O	-1	14742097
le@@	O	-1	14742097
d,	O	-1	14742097
cros@@	O	-1	14742097
s@@	O	-1	14742097
over	O	-1	14742097
study	O	-1	14742097
of	O	-1	14742097
e@@	B-Chemical	D004809	14742097
ph@@	I-Chemical	-1	14742097
ed@@	I-Chemical	-1	14742097
rine	I-Chemical	-1	14742097
for	O	-1	14742097
S@@	O	-1	14742097
SR@@	O	-1	14742097
I@@	O	-1	14742097
-induced	O	-1	14742097
female	O	-1	14742097
sex@@	B-Disease	D020018	14742097
ual	I-Disease	-1	14742097
dysfunction	I-Disease	-1	14742097
.	O	-1	14742097
The	O	-1	14742097
ob@@	O	-1	14742097
j@@	O	-1	14742097
ective	O	-1	14742097
of	O	-1	14742097
this	O	-1	14742097
study	O	-1	14742097
was	O	-1	14742097
to	O	-1	14742097
determine	O	-1	14742097
whether	O	-1	14742097
e@@	B-Chemical	D004809	14742097
ph@@	I-Chemical	-1	14742097
ed@@	I-Chemical	-1	14742097
rine	I-Chemical	-1	14742097
,	O	-1	14742097
an	O	-1	14742097
alpha@@	O	-1	14742097
-	O	-1	14742097
and	O	-1	14742097
beta-@@	O	-1	14742097
adrenergic	O	-1	14742097
agon@@	O	-1	14742097
ist	O	-1	14742097
previously	O	-1	14742097
shown	O	-1	14742097
to	O	-1	14742097
enh@@	O	-1	14742097
ance	O	-1	14742097
gen@@	O	-1	14742097
it@@	O	-1	14742097
al	O	-1	14742097
blood	O	-1	14742097
flow	O	-1	14742097
in	O	-1	14742097
wom@@	O	-1	14742097
en@@	O	-1	14742097
,	O	-1	14742097
has	O	-1	14742097
ben@@	O	-1	14742097
e@@	O	-1	14742097
fic@@	O	-1	14742097
ial	O	-1	14742097
effects	O	-1	14742097
in	O	-1	14742097
rever@@	O	-1	14742097
s@@	O	-1	14742097
ing	O	-1	14742097
antidepress@@	O	-1	14742097
ant@@	O	-1	14742097
-induced	O	-1	14742097
sex@@	B-Disease	D020018	14742097
ual	I-Disease	-1	14742097
dysfunction	I-Disease	-1	14742097
.	O	-1	14742097
N@@	O	-1	14742097
ine@@	O	-1	14742097
te@@	O	-1	14742097
en	O	-1	14742097
sex@@	B-Disease	D020018	14742097
ually	I-Disease	-1	14742097
dysfunc@@	I-Disease	-1	14742097
tional	I-Disease	-1	14742097
women	O	-1	14742097
receiving	O	-1	14742097
either	O	-1	14742097
flu@@	B-Chemical	D005473	14742097
ox@@	I-Chemical	-1	14742097
et@@	I-Chemical	-1	14742097
ine	I-Chemical	-1	14742097
,	O	-1	14742097
ser@@	B-Chemical	D020280	14742097
tr@@	I-Chemical	-1	14742097
aline	I-Chemical	-1	14742097
,	O	-1	14742097
or	O	-1	14742097
pa@@	B-Chemical	D017374	14742097
ro@@	I-Chemical	-1	14742097
x@@	I-Chemical	-1	14742097
et@@	I-Chemical	-1	14742097
ine	I-Chemical	-1	14742097
partic@@	O	-1	14742097
ip@@	O	-1	14742097
ated	O	-1	14742097
in	O	-1	14742097
an	O	-1	14742097
e@@	O	-1	14742097
igh@@	O	-1	14742097
t-@@	O	-1	14742097
week@@	O	-1	14742097
,	O	-1	14742097
double-bl@@	O	-1	14742097
ind@@	O	-1	14742097
,	O	-1	14742097
placebo@@	O	-1	14742097
-@@	O	-1	14742097
control@@	O	-1	14742097
le@@	O	-1	14742097
d,	O	-1	14742097
cros@@	O	-1	14742097
s-@@	O	-1	14742097
over	O	-1	14742097
study	O	-1	14742097
of	O	-1	14742097
the	O	-1	14742097
effects	O	-1	14742097
of	O	-1	14742097
e@@	B-Chemical	D004809	14742097
ph@@	I-Chemical	-1	14742097
ed@@	I-Chemical	-1	14742097
rine	I-Chemical	-1	14742097
(@@	O	-1	14742097
50	O	-1	14742097
mg@@	O	-1	14742097
)	O	-1	14742097
on	O	-1	14742097
sel@@	O	-1	14742097
f@@	O	-1	14742097
-@@	O	-1	14742097
report	O	-1	14742097
meas@@	O	-1	14742097
ures	O	-1	14742097
of	O	-1	14742097
sex@@	O	-1	14742097
ual	O	-1	14742097
desi@@	O	-1	14742097
re,	O	-1	14742097
a@@	O	-1	14742097
ro@@	O	-1	14742097
us@@	O	-1	14742097
al,	O	-1	14742097
org@@	O	-1	14742097
as@@	O	-1	14742097
m@@	O	-1	14742097
,	O	-1	14742097
and	O	-1	14742097
sex@@	O	-1	14742097
ual	O	-1	14742097
s@@	O	-1	14742097
atis@@	O	-1	14742097
fac@@	O	-1	14742097
tion.	O	-1	14742097
Although	O	-1	14742097
there	O	-1	14742097
were	O	-1	14742097
significant	O	-1	14742097
impro@@	O	-1	14742097
ve@@	O	-1	14742097
ments	O	-1	14742097
rel@@	O	-1	14742097
ative	O	-1	14742097
to	O	-1	14742097
baseline	O	-1	14742097
in	O	-1	14742097
sex@@	O	-1	14742097
ual	O	-1	14742097
desi@@	O	-1	14742097
r@@	O	-1	14742097
e	O	-1	14742097
and	O	-1	14742097
org@@	O	-1	14742097
as@@	O	-1	14742097
m	O	-1	14742097
int@@	O	-1	14742097
en@@	O	-1	14742097
sit@@	O	-1	14742097
y@@	O	-1	14742097
/@@	O	-1	14742097
ple@@	O	-1	14742097
as@@	O	-1	14742097
ure	O	-1	14742097
on	O	-1	14742097
50	O	-1	14742097
mg	O	-1	14742097
e@@	B-Chemical	D004809	14742097
ph@@	I-Chemical	-1	14742097
ed@@	I-Chemical	-1	14742097
rine	I-Chemical	-1	14742097
1-@@	O	-1	14742097
h@@	O	-1	14742097
r	O	-1	14742097
prior	O	-1	14742097
to	O	-1	14742097
sex@@	O	-1	14742097
ual	O	-1	14742097
activ@@	O	-1	14742097
ity,	O	-1	14742097
significant	O	-1	14742097
impro@@	O	-1	14742097
ve@@	O	-1	14742097
ments	O	-1	14742097
in	O	-1	14742097
these	O	-1	14742097
meas@@	O	-1	14742097
ures@@	O	-1	14742097
,	O	-1	14742097
as	O	-1	14742097
well	O	-1	14742097
as	O	-1	14742097
in	O	-1	14742097
sex@@	O	-1	14742097
ual	O	-1	14742097
a@@	O	-1	14742097
ro@@	O	-1	14742097
us@@	O	-1	14742097
al	O	-1	14742097
and	O	-1	14742097
org@@	O	-1	14742097
as@@	O	-1	14742097
mic	O	-1	14742097
ability	O	-1	14742097
also	O	-1	14742097
were	O	-1	14742097
not@@	O	-1	14742097
ed	O	-1	14742097
with	O	-1	14742097
placebo@@	O	-1	14742097
.	O	-1	14742097
These	O	-1	14742097
findings	O	-1	14742097
high@@	O	-1	14742097
li@@	O	-1	14742097
ght	O	-1	14742097
the	O	-1	14742097
import@@	O	-1	14742097
ance	O	-1	14742097
of	O	-1	14742097
con@@	O	-1	14742097
duc@@	O	-1	14742097
ting	O	-1	14742097
placebo@@	O	-1	14742097
-@@	O	-1	14742097
controlled	O	-1	14742097
tri@@	O	-1	14742097
als	O	-1	14742097
for	O	-1	14742097
this	O	-1	14742097
condi@@	O	-1	14742097
tion.	O	-1	14742097

E@@	B-Disease	D007172	11890511
rec@@	I-Disease	-1	11890511
ti@@	I-Disease	-1	11890511
le	I-Disease	-1	11890511
dysfunction	I-Disease	-1	11890511
occur@@	O	-1	11890511
s	O	-1	11890511
following	O	-1	11890511
subst@@	O	-1	11890511
anti@@	O	-1	11890511
a	O	-1	11890511
n@@	O	-1	11890511
ig@@	O	-1	11890511
r@@	O	-1	11890511
a	O	-1	11890511
lesions	O	-1	11890511
in	O	-1	11890511
the	O	-1	11890511
rat@@	O	-1	11890511
.	O	-1	11890511
E@@	O	-1	11890511
rec@@	O	-1	11890511
ti@@	O	-1	11890511
le	O	-1	11890511
function	O	-1	11890511
was	O	-1	11890511
assessed	O	-1	11890511
6	O	-1	11890511
weeks	O	-1	11890511
following	O	-1	11890511
un@@	O	-1	11890511
i@@	O	-1	11890511
-	O	-1	11890511
and	O	-1	11890511
bil@@	O	-1	11890511
ateral	O	-1	11890511
injec@@	O	-1	11890511
tions	O	-1	11890511
of	O	-1	11890511
6-@@	B-Chemical	D016627	11890511
hydrox@@	I-Chemical	-1	11890511
y@@	I-Chemical	-1	11890511
dopamine	I-Chemical	-1	11890511
in	O	-1	11890511
the	O	-1	11890511
subst@@	O	-1	11890511
anti@@	O	-1	11890511
a	O	-1	11890511
n@@	O	-1	11890511
ig@@	O	-1	11890511
r@@	O	-1	11890511
a	O	-1	11890511
nucle@@	O	-1	11890511
us	O	-1	11890511
of	O	-1	11890511
the	O	-1	11890511
bra@@	O	-1	11890511
in.	O	-1	11890511
B@@	O	-1	11890511
e@@	O	-1	11890511
havi@@	O	-1	11890511
oral	O	-1	11890511
apo@@	B-Chemical	D001058	11890511
morphine	I-Chemical	-1	11890511
-induced	O	-1	11890511
pen@@	O	-1	11890511
ile	O	-1	11890511
e@@	O	-1	11890511
rec@@	O	-1	11890511
tions	O	-1	11890511
were	O	-1	11890511
reduced	O	-1	11890511
(5@@	O	-1	11890511
/@@	O	-1	11890511
8@@	O	-1	11890511
)	O	-1	11890511
and	O	-1	11890511
increased	O	-1	11890511
(3@@	O	-1	11890511
/@@	O	-1	11890511
8@@	O	-1	11890511
)	O	-1	11890511
in	O	-1	11890511
un@@	O	-1	11890511
i@@	O	-1	11890511
-	O	-1	11890511
and	O	-1	11890511
bil@@	O	-1	11890511
ateral	O	-1	11890511
le@@	O	-1	11890511
sion@@	O	-1	11890511
ed	O	-1	11890511
anim@@	O	-1	11890511
al@@	O	-1	11890511
s.	O	-1	11890511
In@@	O	-1	11890511
trac@@	O	-1	11890511
aver@@	O	-1	11890511
n@@	O	-1	11890511
ous	O	-1	11890511
pressu@@	O	-1	11890511
res@@	O	-1	11890511
,	O	-1	11890511
following	O	-1	11890511
elect@@	O	-1	11890511
r@@	O	-1	11890511
ical	O	-1	11890511
stimulation	O	-1	11890511
of	O	-1	11890511
the	O	-1	11890511
ca@@	O	-1	11890511
ver@@	O	-1	11890511
n@@	O	-1	11890511
ous	O	-1	11890511
ner@@	O	-1	11890511
ve,	O	-1	11890511
decreased	O	-1	11890511
in	O	-1	11890511
le@@	O	-1	11890511
sion@@	O	-1	11890511
ed	O	-1	11890511
anim@@	O	-1	11890511
al@@	O	-1	11890511
s.	O	-1	11890511
L@@	O	-1	11890511
e@@	O	-1	11890511
sions	O	-1	11890511
of	O	-1	11890511
the	O	-1	11890511
subst@@	O	-1	11890511
anti@@	O	-1	11890511
a	O	-1	11890511
n@@	O	-1	11890511
ig@@	O	-1	11890511
r@@	O	-1	11890511
a	O	-1	11890511
were	O	-1	11890511
con@@	O	-1	11890511
fir@@	O	-1	11890511
m@@	O	-1	11890511
ed	O	-1	11890511
by	O	-1	11890511
hist@@	O	-1	11890511
olog@@	O	-1	11890511
y.	O	-1	11890511
Con@@	O	-1	11890511
centr@@	O	-1	11890511
ation	O	-1	11890511
of	O	-1	11890511
dopamine	B-Chemical	D004298	11890511
and	O	-1	11890511
its	O	-1	11890511
metabol@@	O	-1	11890511
it@@	O	-1	11890511
es	O	-1	11890511
were	O	-1	11890511
decreased	O	-1	11890511
in	O	-1	11890511
the	O	-1	11890511
striat@@	O	-1	11890511
um	O	-1	11890511
of	O	-1	11890511
subst@@	O	-1	11890511
anti@@	O	-1	11890511
a	O	-1	11890511
n@@	O	-1	11890511
ig@@	O	-1	11890511
r@@	O	-1	11890511
a	O	-1	11890511
le@@	O	-1	11890511
sion@@	O	-1	11890511
ed	O	-1	11890511
rats.	O	-1	11890511
L@@	O	-1	11890511
e@@	O	-1	11890511
sions	O	-1	11890511
of	O	-1	11890511
the	O	-1	11890511
subst@@	O	-1	11890511
anti@@	O	-1	11890511
a	O	-1	11890511
n@@	O	-1	11890511
ig@@	O	-1	11890511
r@@	O	-1	11890511
a	O	-1	11890511
are	O	-1	11890511
the@@	O	-1	11890511
re@@	O	-1	11890511
fore	O	-1	11890511
associated	O	-1	11890511
with	O	-1	11890511
e@@	B-Disease	D007172	11890511
rec@@	I-Disease	-1	11890511
ti@@	I-Disease	-1	11890511
le	I-Disease	-1	11890511
dysfunction	I-Disease	-1	11890511
in	O	-1	11890511
rats	O	-1	11890511
and	O	-1	11890511
may	O	-1	11890511
ser@@	O	-1	11890511
ve	O	-1	11890511
as	O	-1	11890511
a	O	-1	11890511
model	O	-1	11890511
to	O	-1	11890511
study	O	-1	11890511
e@@	B-Disease	D007172	11890511
rec@@	I-Disease	-1	11890511
ti@@	I-Disease	-1	11890511
le	I-Disease	-1	11890511
dysfunction	I-Disease	-1	11890511
in	O	-1	11890511
Parkinson's	B-Disease	D010300	11890511
disease	I-Disease	-1	11890511
.	O	-1	11890511

P@@	O	-1	9270571
oten@@	O	-1	9270571
tial	O	-1	9270571
therapeutic	O	-1	9270571
use	O	-1	9270571
of	O	-1	9270571
the	O	-1	9270571
selective	O	-1	9270571
dopamine	B-Chemical	D004298	9270571
D@@	O	-1	9270571
1	O	-1	9270571
receptor	O	-1	9270571
agon@@	O	-1	9270571
ist@@	O	-1	9270571
,	O	-1	9270571
A@@	B-Chemical	C095427	9270571
-@@	I-Chemical	-1	9270571
8@@	I-Chemical	-1	9270571
6@@	I-Chemical	-1	9270571
9@@	I-Chemical	-1	9270571
2@@	I-Chemical	-1	9270571
9	I-Chemical	-1	9270571
:	O	-1	9270571
an	O	-1	9270571
acute	O	-1	9270571
study	O	-1	9270571
in	O	-1	9270571
par@@	B-Disease	D020734	9270571
k@@	I-Disease	-1	9270571
inson@@	I-Disease	-1	9270571
i@@	I-Disease	-1	9270571
an	I-Disease	-1	9270571
levo@@	B-Chemical	D007980	9270571
dopa	I-Chemical	-1	9270571
-@@	O	-1	9270571
prim@@	O	-1	9270571
ed	O	-1	9270571
mon@@	O	-1	9270571
ke@@	O	-1	9270571
y@@	O	-1	9270571
s.	O	-1	9270571
The	O	-1	9270571
clinical	O	-1	9270571
u@@	O	-1	9270571
til@@	O	-1	9270571
ity	O	-1	9270571
of	O	-1	9270571
dopamine	B-Chemical	D004298	9270571
(	O	-1	9270571
D@@	B-Chemical	D004298	9270571
A	I-Chemical	-1	9270571
)	O	-1	9270571
D@@	O	-1	9270571
1	O	-1	9270571
receptor	O	-1	9270571
agon@@	O	-1	9270571
ist@@	O	-1	9270571
s	O	-1	9270571
in	O	-1	9270571
the	O	-1	9270571
treatment	O	-1	9270571
of	O	-1	9270571
Parkinson's	B-Disease	D010300	9270571
disease	I-Disease	-1	9270571
(	O	-1	9270571
P@@	B-Disease	D010300	9270571
D	I-Disease	-1	9270571
)	O	-1	9270571
is	O	-1	9270571
sti@@	O	-1	9270571
ll	O	-1	9270571
unc@@	O	-1	9270571
lear@@	O	-1	9270571
.	O	-1	9270571
The	O	-1	9270571
therapeutic	O	-1	9270571
use	O	-1	9270571
of	O	-1	9270571
selective	O	-1	9270571
D@@	B-Chemical	D004298	9270571
A	I-Chemical	-1	9270571
D@@	O	-1	9270571
1	O	-1	9270571
receptor	O	-1	9270571
agon@@	O	-1	9270571
ist@@	O	-1	9270571
s	O	-1	9270571
such	O	-1	9270571
as	O	-1	9270571
S@@	B-Chemical	C071262	9270571
K@@	I-Chemical	-1	9270571
F@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
8@@	I-Chemical	-1	9270571
2@@	I-Chemical	-1	9270571
9@@	I-Chemical	-1	9270571
5@@	I-Chemical	-1	9270571
8	I-Chemical	-1	9270571
(	O	-1	9270571
6-@@	B-Chemical	C071262	9270571
ch@@	I-Chemical	-1	9270571
loro@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
8@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
di@@	I-Chemical	-1	9270571
hydrox@@	I-Chemical	-1	9270571
y-@@	I-Chemical	-1	9270571
3-@@	I-Chemical	-1	9270571
all@@	I-Chemical	-1	9270571
yl@@	I-Chemical	-1	9270571
-1@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
phenyl@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
2@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
3@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
4@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
5-@@	I-Chemical	-1	9270571
te@@	I-Chemical	-1	9270571
tra@@	I-Chemical	-1	9270571
hydro@@	I-Chemical	-1	9270571
-1@@	I-Chemical	-1	9270571
H@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
3-@@	I-Chemical	-1	9270571
b@@	I-Chemical	-1	9270571
enz@@	I-Chemical	-1	9270571
az@@	I-Chemical	-1	9270571
e	I-Chemical	-1	9270571
pine	I-Chemical	-1	9270571
hydro@@	I-Chemical	-1	9270571
brom@@	I-Chemical	-1	9270571
ide	I-Chemical	-1	9270571
)	O	-1	9270571
and	O	-1	9270571
A@@	B-Chemical	C079415	9270571
-@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
6@@	I-Chemical	-1	9270571
3@@	I-Chemical	-1	9270571
6	I-Chemical	-1	9270571
(	O	-1	9270571
[@@	B-Chemical	C079415	9270571
1@@	I-Chemical	-1	9270571
R@@	I-Chemical	-1	9270571
,	I-Chemical	-1	9270571
3@@	I-Chemical	-1	9270571
S@@	I-Chemical	-1	9270571
]	I-Chemical	-1	9270571
3-@@	I-Chemical	-1	9270571
[@@	I-Chemical	-1	9270571
1@@	I-Chemical	-1	9270571
'@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
ad@@	I-Chemical	-1	9270571
m@@	I-Chemical	-1	9270571
ant@@	I-Chemical	-1	9270571
yl@@	I-Chemical	-1	9270571
]@@	I-Chemical	-1	9270571
-1@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
amino@@	I-Chemical	-1	9270571
methyl@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
3@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
4-@@	I-Chemical	-1	9270571
di@@	I-Chemical	-1	9270571
hydro@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
5@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
6-@@	I-Chemical	-1	9270571
di@@	I-Chemical	-1	9270571
hydrox@@	I-Chemical	-1	9270571
y@@	I-Chemical	-1	9270571
-1@@	I-Chemical	-1	9270571
H@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
2-@@	I-Chemical	-1	9270571
b@@	I-Chemical	-1	9270571
enz@@	I-Chemical	-1	9270571
o	I-Chemical	-1	9270571
py@@	I-Chemical	-1	9270571
ra@@	I-Chemical	-1	9270571
n	I-Chemical	-1	9270571
hydro@@	I-Chemical	-1	9270571
chlor@@	I-Chemical	-1	9270571
ide	I-Chemical	-1	9270571
)	O	-1	9270571
se@@	O	-1	9270571
em@@	O	-1	9270571
s	O	-1	9270571
lim@@	O	-1	9270571
ited	O	-1	9270571
because	O	-1	9270571
of	O	-1	9270571
their	O	-1	9270571
duration	O	-1	9270571
of	O	-1	9270571
ac@@	O	-1	9270571
tion,	O	-1	9270571
which	O	-1	9270571
is	O	-1	9270571
to@@	O	-1	9270571
o	O	-1	9270571
sh@@	O	-1	9270571
ort	O	-1	9270571
for	O	-1	9270571
S@@	B-Chemical	C071262	9270571
K@@	I-Chemical	-1	9270571
F@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
8@@	I-Chemical	-1	9270571
2@@	I-Chemical	-1	9270571
9@@	I-Chemical	-1	9270571
5@@	I-Chemical	-1	9270571
8	I-Chemical	-1	9270571
(@@	O	-1	9270571
<	O	-1	9270571
1	O	-1	9270571
h@@	O	-1	9270571
r@@	O	-1	9270571
)	O	-1	9270571
and	O	-1	9270571
to@@	O	-1	9270571
o	O	-1	9270571
lon@@	O	-1	9270571
g	O	-1	9270571
for	O	-1	9270571
A@@	B-Chemical	C079415	9270571
-@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
6@@	I-Chemical	-1	9270571
3@@	I-Chemical	-1	9270571
6	I-Chemical	-1	9270571
(@@	O	-1	9270571
>	O	-1	9270571
20	O	-1	9270571
h@@	O	-1	9270571
r@@	O	-1	9270571
,	O	-1	9270571
lead@@	O	-1	9270571
ing	O	-1	9270571
to	O	-1	9270571
behavioral	O	-1	9270571
toler@@	O	-1	9270571
ance@@	O	-1	9270571
).	O	-1	9270571
We	O	-1	9270571
the@@	O	-1	9270571
re@@	O	-1	9270571
fore	O	-1	9270571
con@@	O	-1	9270571
duc@@	O	-1	9270571
ted	O	-1	9270571
the	O	-1	9270571
present	O	-1	9270571
acute	O	-1	9270571
dose-@@	O	-1	9270571
response	O	-1	9270571
study	O	-1	9270571
in	O	-1	9270571
four	O	-1	9270571
1-@@	B-Chemical	D015632	9270571
methyl@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
4-@@	I-Chemical	-1	9270571
phenyl@@	I-Chemical	-1	9270571
-1@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
2@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
3@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
6-@@	I-Chemical	-1	9270571
te@@	I-Chemical	-1	9270571
tra@@	I-Chemical	-1	9270571
hydro@@	I-Chemical	-1	9270571
pyri@@	I-Chemical	-1	9270571
d@@	I-Chemical	-1	9270571
ine	I-Chemical	-1	9270571
(	O	-1	9270571
MP@@	B-Chemical	D015632	9270571
T@@	I-Chemical	-1	9270571
P	I-Chemical	-1	9270571
)-@@	O	-1	9270571
exposed	O	-1	9270571
cy@@	O	-1	9270571
no@@	O	-1	9270571
mol@@	O	-1	9270571
g@@	O	-1	9270571
us	O	-1	9270571
mon@@	O	-1	9270571
ke@@	O	-1	9270571
ys	O	-1	9270571
prim@@	O	-1	9270571
ed	O	-1	9270571
to	O	-1	9270571
ex@@	O	-1	9270571
hib@@	O	-1	9270571
it	O	-1	9270571
levo@@	B-Chemical	D007980	9270571
dopa	I-Chemical	-1	9270571
-induced	O	-1	9270571
dyskine@@	B-Disease	D004409	9270571
si@@	I-Disease	-1	9270571
as	I-Disease	-1	9270571
to	O	-1	9270571
evalu@@	O	-1	9270571
ate	O	-1	9270571
the	O	-1	9270571
locomotor	O	-1	9270571
and	O	-1	9270571
dyskine@@	B-Disease	D004409	9270571
tic	I-Disease	-1	9270571
effects	O	-1	9270571
on	O	-1	9270571
ch@@	O	-1	9270571
all@@	O	-1	9270571
enge	O	-1	9270571
with	O	-1	9270571
four	O	-1	9270571
doses	O	-1	9270571
(@@	O	-1	9270571
from	O	-1	9270571
0.0@@	O	-1	9270571
3	O	-1	9270571
to	O	-1	9270571
1.@@	O	-1	9270571
0	O	-1	9270571
mg/kg)	O	-1	9270571
of	O	-1	9270571
A@@	B-Chemical	C095427	9270571
-@@	I-Chemical	-1	9270571
8@@	I-Chemical	-1	9270571
6@@	I-Chemical	-1	9270571
9@@	I-Chemical	-1	9270571
2@@	I-Chemical	-1	9270571
9	I-Chemical	-1	9270571
(	O	-1	9270571
[@@	B-Chemical	C095427	9270571
-@@	I-Chemical	-1	9270571
]@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
[@@	I-Chemical	-1	9270571
5@@	I-Chemical	-1	9270571
a@@	I-Chemical	-1	9270571
R@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
1@@	I-Chemical	-1	9270571
1@@	I-Chemical	-1	9270571
b@@	I-Chemical	-1	9270571
S@@	I-Chemical	-1	9270571
]@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
4@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
5@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
5@@	I-Chemical	-1	9270571
a@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
6@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
1@@	I-Chemical	-1	9270571
1@@	I-Chemical	-1	9270571
b@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
he@@	I-Chemical	-1	9270571
x@@	I-Chemical	-1	9270571
a@@	I-Chemical	-1	9270571
hydro@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
2-@@	I-Chemical	-1	9270571
prop@@	I-Chemical	-1	9270571
yl@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
3-@@	I-Chemical	-1	9270571
th@@	I-Chemical	-1	9270571
ia@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
5-@@	I-Chemical	-1	9270571
+	I-Chemical	-1	9270571
+@@	I-Chemical	-1	9270571
+@@	I-Chemical	-1	9270571
az@@	I-Chemical	-1	9270571
ac@@	I-Chemical	-1	9270571
yc@@	I-Chemical	-1	9270571
lop@@	I-Chemical	-1	9270571
ent@@	I-Chemical	-1	9270571
-1@@	I-Chemical	-1	9270571
-	I-Chemical	-1	9270571
en@@	I-Chemical	-1	9270571
a@@	I-Chemical	-1	9270571
[@@	I-Chemical	-1	9270571
c@@	I-Chemical	-1	9270571
]@@	I-Chemical	-1	9270571
phen@@	I-Chemical	-1	9270571
ath@@	I-Chemical	-1	9270571
re@@	I-Chemical	-1	9270571
ne@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
9@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
10-@@	I-Chemical	-1	9270571
di@@	I-Chemical	-1	9270571
ol	I-Chemical	-1	9270571
),	O	-1	9270571
a	O	-1	9270571
selective	O	-1	9270571
and	O	-1	9270571
ful@@	O	-1	9270571
l	O	-1	9270571
D@@	B-Chemical	D004298	9270571
A	I-Chemical	-1	9270571
D@@	O	-1	9270571
1-@@	O	-1	9270571
like	O	-1	9270571
receptor	O	-1	9270571
agon@@	O	-1	9270571
ist	O	-1	9270571
with	O	-1	9270571
an	O	-1	9270571
inter@@	O	-1	9270571
medi@@	O	-1	9270571
ate	O	-1	9270571
duration	O	-1	9270571
of	O	-1	9270571
ac@@	O	-1	9270571
tion.	O	-1	9270571
L@@	B-Chemical	D007980	9270571
evo@@	I-Chemical	-1	9270571
dopa	I-Chemical	-1	9270571
and	O	-1	9270571
the	O	-1	9270571
D@@	B-Chemical	D004298	9270571
A	I-Chemical	-1	9270571
D@@	O	-1	9270571
2-@@	O	-1	9270571
like	O	-1	9270571
receptor	O	-1	9270571
agon@@	O	-1	9270571
ist@@	O	-1	9270571
,	O	-1	9270571
L@@	B-Chemical	C416545	9270571
Y@@	I-Chemical	-1	9270571
-1@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
1@@	I-Chemical	-1	9270571
55@@	I-Chemical	-1	9270571
5	I-Chemical	-1	9270571
(	O	-1	9270571
[@@	B-Chemical	C416545	9270571
4@@	I-Chemical	-1	9270571
a@@	I-Chemical	-1	9270571
R@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
trans@@	I-Chemical	-1	9270571
]@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
4@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
4@@	I-Chemical	-1	9270571
a@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
5@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
6@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
8@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
8@@	I-Chemical	-1	9270571
a@@	I-Chemical	-1	9270571
,@@	I-Chemical	-1	9270571
9@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
o@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
di@@	I-Chemical	-1	9270571
hydro@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
5@@	I-Chemical	-1	9270571
n@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
prop@@	I-Chemical	-1	9270571
yl@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
2@@	I-Chemical	-1	9270571
H@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
py@@	I-Chemical	-1	9270571
ra@@	I-Chemical	-1	9270571
z@@	I-Chemical	-1	9270571
o	I-Chemical	-1	9270571
lo@@	I-Chemical	-1	9270571
-@@	I-Chemical	-1	9270571
3-@@	I-Chemical	-1	9270571
4-@@	I-Chemical	-1	9270571
qu@@	I-Chemical	-1	9270571
in@@	I-Chemical	-1	9270571
ol@@	I-Chemical	-1	9270571
ine	I-Chemical	-1	9270571
hydro@@	I-Chemical	-1	9270571
chlor@@	I-Chemical	-1	9270571
ide	I-Chemical	-1	9270571
)	O	-1	9270571
were	O	-1	9270571
also	O	-1	9270571
used	O	-1	9270571
for	O	-1	9270571
compar@@	O	-1	9270571
is@@	O	-1	9270571
on@@	O	-1	9270571
.	O	-1	9270571
Ac@@	O	-1	9270571
ute	O	-1	9270571
administration	O	-1	9270571
of	O	-1	9270571
A@@	B-Chemical	C095427	9270571
-@@	I-Chemical	-1	9270571
8@@	I-Chemical	-1	9270571
6@@	I-Chemical	-1	9270571
9@@	I-Chemical	-1	9270571
2@@	I-Chemical	-1	9270571
9	I-Chemical	-1	9270571
was	O	-1	9270571
as	O	-1	9270571
efficac@@	O	-1	9270571
i@@	O	-1	9270571
ous	O	-1	9270571
in	O	-1	9270571
al@@	O	-1	9270571
le@@	O	-1	9270571
vi@@	O	-1	9270571
ating	O	-1	9270571
MP@@	B-Chemical	D015632	9270571
T@@	I-Chemical	-1	9270571
P	I-Chemical	-1	9270571
-induced	O	-1	9270571
par@@	B-Disease	D020734	9270571
k@@	I-Disease	-1	9270571
inson@@	I-Disease	-1	9270571
ism	I-Disease	-1	9270571
as	O	-1	9270571
levo@@	B-Chemical	D007980	9270571
dopa	I-Chemical	-1	9270571
and	O	-1	9270571
L@@	B-Chemical	C416545	9270571
Y@@	I-Chemical	-1	9270571
-1@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
1@@	I-Chemical	-1	9270571
55@@	I-Chemical	-1	9270571
5	I-Chemical	-1	9270571
,	O	-1	9270571
but	O	-1	9270571
was	O	-1	9270571
less	O	-1	9270571
likely	O	-1	9270571
to	O	-1	9270571
re@@	O	-1	9270571
produce	O	-1	9270571
the	O	-1	9270571
levo@@	B-Chemical	D007980	9270571
dopa	I-Chemical	-1	9270571
-induced	O	-1	9270571
dyskine@@	B-Disease	D004409	9270571
si@@	I-Disease	-1	9270571
as	I-Disease	-1	9270571
in	O	-1	9270571
these	O	-1	9270571
animals	O	-1	9270571
than	O	-1	9270571
with	O	-1	9270571
either	O	-1	9270571
L@@	B-Chemical	C416545	9270571
Y@@	I-Chemical	-1	9270571
-1@@	I-Chemical	-1	9270571
7@@	I-Chemical	-1	9270571
1@@	I-Chemical	-1	9270571
55@@	I-Chemical	-1	9270571
5	I-Chemical	-1	9270571
or	O	-1	9270571
subsequ@@	O	-1	9270571
ent	O	-1	9270571
ch@@	O	-1	9270571
all@@	O	-1	9270571
enge	O	-1	9270571
of	O	-1	9270571
levo@@	B-Chemical	D007980	9270571
dopa	I-Chemical	-1	9270571
.	O	-1	9270571
S@@	O	-1	9270571
el@@	O	-1	9270571
ective	O	-1	9270571
stimulation	O	-1	9270571
of	O	-1	9270571
the	O	-1	9270571
D@@	B-Chemical	D004298	9270571
A	I-Chemical	-1	9270571
D@@	O	-1	9270571
1	O	-1	9270571
receptor	O	-1	9270571
may	O	-1	9270571
prov@@	O	-1	9270571
ide	O	-1	9270571
bet@@	O	-1	9270571
ter	O	-1	9270571
in@@	O	-1	9270571
te@@	O	-1	9270571
g@@	O	-1	9270571
ration	O	-1	9270571
of	O	-1	9270571
ne@@	O	-1	9270571
ural	O	-1	9270571
in@@	O	-1	9270571
p@@	O	-1	9270571
ut@@	O	-1	9270571
s	O	-1	9270571
trans@@	O	-1	9270571
mit@@	O	-1	9270571
ted	O	-1	9270571
to	O	-1	9270571
the	O	-1	9270571
inter@@	O	-1	9270571
n@@	O	-1	9270571
al	O	-1	9270571
seg@@	O	-1	9270571
ment	O	-1	9270571
of	O	-1	9270571
the	O	-1	9270571
glo@@	O	-1	9270571
bu@@	O	-1	9270571
s	O	-1	9270571
p@@	O	-1	9270571
all@@	O	-1	9270571
id@@	O	-1	9270571
us	O	-1	9270571
(@@	O	-1	9270571
ref@@	O	-1	9270571
er@@	O	-1	9270571
red	O	-1	9270571
to	O	-1	9270571
as	O	-1	9270571
the	O	-1	9270571
bas@@	O	-1	9270571
al	O	-1	9270571
g@@	O	-1	9270571
ang@@	O	-1	9270571
li@@	O	-1	9270571
a	O	-1	9270571
out@@	O	-1	9270571
p@@	O	-1	9270571
ut@@	O	-1	9270571
)	O	-1	9270571
compared	O	-1	9270571
with	O	-1	9270571
levo@@	B-Chemical	D007980	9270571
dopa	I-Chemical	-1	9270571
and	O	-1	9270571
selective	O	-1	9270571
D@@	B-Chemical	D004298	9270571
A	I-Chemical	-1	9270571
D2	O	-1	9270571
receptor	O	-1	9270571
agon@@	O	-1	9270571
ist@@	O	-1	9270571
.	O	-1	9270571
P@@	O	-1	9270571
ot@@	O	-1	9270571
ent	O	-1	9270571
D@@	B-Chemical	D004298	9270571
A	I-Chemical	-1	9270571
D@@	O	-1	9270571
1	O	-1	9270571
receptor	O	-1	9270571
agents	O	-1	9270571
with	O	-1	9270571
an	O	-1	9270571
inter@@	O	-1	9270571
medi@@	O	-1	9270571
ate	O	-1	9270571
duration	O	-1	9270571
of	O	-1	9270571
efficacy	O	-1	9270571
such	O	-1	9270571
as	O	-1	9270571
A@@	B-Chemical	C095427	9270571
-@@	I-Chemical	-1	9270571
8@@	I-Chemical	-1	9270571
6@@	I-Chemical	-1	9270571
9@@	I-Chemical	-1	9270571
2@@	I-Chemical	-1	9270571
9	I-Chemical	-1	9270571
(@@	O	-1	9270571
appro@@	O	-1	9270571
xim@@	O	-1	9270571
ately	O	-1	9270571
4	O	-1	9270571
h@@	O	-1	9270571
r	O	-1	9270571
at	O	-1	9270571
higher	O	-1	9270571
doses	O	-1	9270571
test@@	O	-1	9270571
ed@@	O	-1	9270571
)	O	-1	9270571
are	O	-1	9270571
potential	O	-1	9270571
therapeutic	O	-1	9270571
to@@	O	-1	9270571
ol@@	O	-1	9270571
s	O	-1	9270571
in	O	-1	9270571
P@@	B-Disease	D010300	9270571
D	I-Disease	-1	9270571
and	O	-1	9270571
mer@@	O	-1	9270571
it	O	-1	9270571
further	O	-1	9270571
atten@@	O	-1	9270571
tion.	O	-1	9270571

De@@	O	-1	7189975
ath@@	O	-1	7189975
s	O	-1	7189975
from	O	-1	7189975
loc@@	O	-1	7189975
al	O	-1	7189975
anesthe@@	O	-1	7189975
tic@@	O	-1	7189975
-induced	O	-1	7189975
convul@@	B-Disease	D012640	7189975
sions	I-Disease	-1	7189975
in	O	-1	7189975
mice.	O	-1	7189975
M@@	O	-1	7189975
edi@@	O	-1	7189975
an	O	-1	7189975
convul@@	O	-1	7189975
s@@	O	-1	7189975
ant	O	-1	7189975
(C@@	O	-1	7189975
D@@	O	-1	7189975
50@@	O	-1	7189975
)	O	-1	7189975
and	O	-1	7189975
median	O	-1	7189975
le@@	O	-1	7189975
th@@	O	-1	7189975
al	O	-1	7189975
(@@	O	-1	7189975
L@@	O	-1	7189975
D@@	O	-1	7189975
50@@	O	-1	7189975
)	O	-1	7189975
doses	O	-1	7189975
of	O	-1	7189975
three	O	-1	7189975
re@@	O	-1	7189975
present@@	O	-1	7189975
ative	O	-1	7189975
loc@@	O	-1	7189975
al	O	-1	7189975
anesthe@@	O	-1	7189975
tics	O	-1	7189975
were	O	-1	7189975
determined	O	-1	7189975
in	O	-1	7189975
ad@@	O	-1	7189975
ult	O	-1	7189975
mice	O	-1	7189975
to	O	-1	7189975
evalu@@	O	-1	7189975
ate	O	-1	7189975
the	O	-1	7189975
th@@	O	-1	7189975
re@@	O	-1	7189975
at	O	-1	7189975
to	O	-1	7189975
lif@@	O	-1	7189975
e	O	-1	7189975
of	O	-1	7189975
loc@@	O	-1	7189975
al	O	-1	7189975
anesthe@@	O	-1	7189975
tic@@	O	-1	7189975
-induced	O	-1	7189975
convul@@	B-Disease	D012640	7189975
sions	I-Disease	-1	7189975
.	O	-1	7189975
The	O	-1	7189975
C@@	O	-1	7189975
D@@	O	-1	7189975
50	O	-1	7189975
and	O	-1	7189975
L@@	O	-1	7189975
D@@	O	-1	7189975
50@@	O	-1	7189975
,	O	-1	7189975
respectivel@@	O	-1	7189975
y,	O	-1	7189975
were	O	-1	7189975
5@@	O	-1	7189975
7.@@	O	-1	7189975
7	O	-1	7189975
and	O	-1	7189975
5@@	O	-1	7189975
8.@@	O	-1	7189975
7	O	-1	7189975
mg/kg	O	-1	7189975
for	O	-1	7189975
bupivac@@	B-Chemical	D002045	7189975
aine	I-Chemical	-1	7189975
,	O	-1	7189975
1@@	O	-1	7189975
1@@	O	-1	7189975
1.@@	O	-1	7189975
0	O	-1	7189975
and	O	-1	7189975
13@@	O	-1	7189975
3.@@	O	-1	7189975
1	O	-1	7189975
mg/kg	O	-1	7189975
for	O	-1	7189975
lidocaine	B-Chemical	D008012	7189975
,	O	-1	7189975
and	O	-1	7189975
2@@	O	-1	7189975
4@@	O	-1	7189975
3.@@	O	-1	7189975
4	O	-1	7189975
and	O	-1	7189975
2@@	O	-1	7189975
6@@	O	-1	7189975
6.@@	O	-1	7189975
5	O	-1	7189975
mg/kg	O	-1	7189975
for	O	-1	7189975
ch@@	B-Chemical	C004616	7189975
loro@@	I-Chemical	-1	7189975
pro@@	I-Chemical	-1	7189975
ca@@	I-Chemical	-1	7189975
ine	I-Chemical	-1	7189975
.	O	-1	7189975
Whe@@	O	-1	7189975
n	O	-1	7189975
given	O	-1	7189975
intra@@	O	-1	7189975
per@@	O	-1	7189975
it@@	O	-1	7189975
one@@	O	-1	7189975
ally,	O	-1	7189975
bupivac@@	B-Chemical	D002045	7189975
aine	I-Chemical	-1	7189975
th@@	O	-1	7189975
us	O	-1	7189975
was	O	-1	7189975
only	O	-1	7189975
about	O	-1	7189975
tw@@	O	-1	7189975
ic@@	O	-1	7189975
e	O	-1	7189975
as	O	-1	7189975
toxic	O	-1	7189975
as	O	-1	7189975
lidocaine	B-Chemical	D008012	7189975
and	O	-1	7189975
four	O	-1	7189975
times	O	-1	7189975
as	O	-1	7189975
toxic	O	-1	7189975
as	O	-1	7189975
ch@@	B-Chemical	C004616	7189975
loro@@	I-Chemical	-1	7189975
pro@@	I-Chemical	-1	7189975
ca@@	I-Chemical	-1	7189975
ine	I-Chemical	-1	7189975
.	O	-1	7189975
Con@@	B-Disease	D012640	7189975
vul@@	I-Disease	-1	7189975
sions	I-Disease	-1	7189975
al@@	O	-1	7189975
w@@	O	-1	7189975
ays	O	-1	7189975
pre@@	O	-1	7189975
ce@@	O	-1	7189975
ded	O	-1	7189975
de@@	O	-1	7189975
ath@@	O	-1	7189975
,	O	-1	7189975
ex@@	O	-1	7189975
cep@@	O	-1	7189975
t	O	-1	7189975
after	O	-1	7189975
pre@@	O	-1	7189975
ci@@	O	-1	7189975
pit@@	O	-1	7189975
ous	O	-1	7189975
cardio@@	B-Disease	D006323	7189975
pulmonary	I-Disease	-1	7189975
ar@@	I-Disease	-1	7189975
res@@	I-Disease	-1	7189975
t	I-Disease	-1	7189975
from	O	-1	7189975
ex@@	O	-1	7189975
trem@@	O	-1	7189975
e	O	-1	7189975
dos@@	O	-1	7189975
es.	O	-1	7189975
A	O	-1	7189975
C@@	O	-1	7189975
D@@	O	-1	7189975
50	O	-1	7189975
dose	O	-1	7189975
of	O	-1	7189975
loc@@	O	-1	7189975
al	O	-1	7189975
anesthe@@	O	-1	7189975
tic	O	-1	7189975
(@@	O	-1	7189975
ca@@	O	-1	7189975
using	O	-1	7189975
convul@@	B-Disease	D012640	7189975
sions	I-Disease	-1	7189975
in	O	-1	7189975
50@@	O	-1	7189975
%	O	-1	7189975
of	O	-1	7189975
mic@@	O	-1	7189975
e@@	O	-1	7189975
)	O	-1	7189975
was	O	-1	7189975
f@@	O	-1	7189975
atal	O	-1	7189975
in	O	-1	7189975
9@@	O	-1	7189975
0%	O	-1	7189975
of	O	-1	7189975
bupivac@@	B-Chemical	D002045	7189975
aine	I-Chemical	-1	7189975
-induced	O	-1	7189975
seizures	B-Disease	D012640	7189975
,	O	-1	7189975
in	O	-1	7189975
5@@	O	-1	7189975
7@@	O	-1	7189975
%	O	-1	7189975
of	O	-1	7189975
the	O	-1	7189975
ch@@	B-Chemical	C004616	7189975
loro@@	I-Chemical	-1	7189975
pro@@	I-Chemical	-1	7189975
ca@@	I-Chemical	-1	7189975
ine	I-Chemical	-1	7189975
group@@	O	-1	7189975
,	O	-1	7189975
and	O	-1	7189975
in	O	-1	7189975
6%	O	-1	7189975
of	O	-1	7189975
the	O	-1	7189975
lidocaine	B-Chemical	D008012	7189975
group.	O	-1	7189975
The	O	-1	7189975
n@@	O	-1	7189975
ar@@	O	-1	7189975
ro@@	O	-1	7189975
w	O	-1	7189975
g@@	O	-1	7189975
a@@	O	-1	7189975
p	O	-1	7189975
between	O	-1	7189975
convul@@	O	-1	7189975
s@@	O	-1	7189975
ant	O	-1	7189975
and	O	-1	7189975
le@@	O	-1	7189975
th@@	O	-1	7189975
al	O	-1	7189975
doses	O	-1	7189975
of	O	-1	7189975
loc@@	O	-1	7189975
al	O	-1	7189975
anesthe@@	O	-1	7189975
tics	O	-1	7189975
indic@@	O	-1	7189975
ates	O	-1	7189975
that	O	-1	7189975
un@@	O	-1	7189975
treated	O	-1	7189975
convul@@	B-Disease	D012640	7189975
sions	I-Disease	-1	7189975
present	O	-1	7189975
m@@	O	-1	7189975
uc@@	O	-1	7189975
h	O	-1	7189975
more	O	-1	7189975
of	O	-1	7189975
a	O	-1	7189975
th@@	O	-1	7189975
re@@	O	-1	7189975
at	O	-1	7189975
to	O	-1	7189975
lif@@	O	-1	7189975
e	O	-1	7189975
than	O	-1	7189975
he@@	O	-1	7189975
re@@	O	-1	7189975
to@@	O	-1	7189975
fore	O	-1	7189975
ap@@	O	-1	7189975
pre@@	O	-1	7189975
ci@@	O	-1	7189975
ated.	O	-1	7189975

M@@	B-Disease	D004831	6415512
y@@	I-Disease	-1	6415512
oc@@	I-Disease	-1	6415512
lon@@	I-Disease	-1	6415512
ic@@	I-Disease	-1	6415512
,	I-Disease	-1	6415512
at@@	I-Disease	-1	6415512
on@@	I-Disease	-1	6415512
ic@@	I-Disease	-1	6415512
,	I-Disease	-1	6415512
and	I-Disease	-1	6415512
absence	I-Disease	-1	6415512
seizures	I-Disease	-1	6415512
M@@	B-Disease	D004832	6415512
y@@	I-Disease	-1	6415512
oc@@	I-Disease	-1	6415512
lon@@	I-Disease	-1	6415512
ic@@	I-Disease	-1	6415512
,	I-Disease	-1	6415512
at@@	I-Disease	-1	6415512
on@@	I-Disease	-1	6415512
ic@@	I-Disease	-1	6415512
,	I-Disease	-1	6415512
and	I-Disease	-1	6415512
absence	I-Disease	-1	6415512
seizures	I-Disease	-1	6415512
following	O	-1	6415512
insti@@	O	-1	6415512
tu@@	O	-1	6415512
tion	O	-1	6415512
of	O	-1	6415512
carbamazepine	B-Chemical	D002220	6415512
therapy	O	-1	6415512
in	O	-1	6415512
child@@	O	-1	6415512
ren@@	O	-1	6415512
.	O	-1	6415512
F@@	O	-1	6415512
i@@	O	-1	6415512
ve	O	-1	6415512
child@@	O	-1	6415512
ren@@	O	-1	6415512
,	O	-1	6415512
aged	O	-1	6415512
3	O	-1	6415512
to	O	-1	6415512
11	O	-1	6415512
year@@	O	-1	6415512
s,	O	-1	6415512
treated	O	-1	6415512
with	O	-1	6415512
carbamazepine	B-Chemical	D002220	6415512
for	O	-1	6415512
epilep@@	B-Disease	D004827	6415512
sy	I-Disease	-1	6415512
,	O	-1	6415512
had	O	-1	6415512
an	O	-1	6415512
acute	O	-1	6415512
ab@@	O	-1	6415512
er@@	O	-1	6415512
ran@@	O	-1	6415512
t	O	-1	6415512
reaction	O	-1	6415512
character@@	O	-1	6415512
ized	O	-1	6415512
by	O	-1	6415512
the	O	-1	6415512
onset	O	-1	6415512
of	O	-1	6415512
my@@	B-Disease	D004831	6415512
oc@@	I-Disease	-1	6415512
lon@@	I-Disease	-1	6415512
ic@@	I-Disease	-1	6415512
,	I-Disease	-1	6415512
at@@	I-Disease	-1	6415512
yp@@	I-Disease	-1	6415512
ical	I-Disease	-1	6415512
absence	I-Disease	-1	6415512
and/or	I-Disease	-1	6415512
at@@	I-Disease	-1	6415512
onic	I-Disease	-1	6415512
(@@	I-Disease	-1	6415512
min@@	I-Disease	-1	6415512
or	I-Disease	-1	6415512
m@@	I-Disease	-1	6415512
ot@@	I-Disease	-1	6415512
or@@	I-Disease	-1	6415512
)	I-Disease	-1	6415512
seizures	I-Disease	-1	6415512
my@@	B-Disease	D004832	6415512
oc@@	I-Disease	-1	6415512
lon@@	I-Disease	-1	6415512
ic@@	I-Disease	-1	6415512
,	I-Disease	-1	6415512
at@@	I-Disease	-1	6415512
yp@@	I-Disease	-1	6415512
ical	I-Disease	-1	6415512
absence	I-Disease	-1	6415512
and/or	I-Disease	-1	6415512
at@@	I-Disease	-1	6415512
onic	I-Disease	-1	6415512
(@@	I-Disease	-1	6415512
min@@	I-Disease	-1	6415512
or	I-Disease	-1	6415512
m@@	I-Disease	-1	6415512
ot@@	I-Disease	-1	6415512
or@@	I-Disease	-1	6415512
)	I-Disease	-1	6415512
seizures	I-Disease	-1	6415512
within	O	-1	6415512
a	O	-1	6415512
fe@@	O	-1	6415512
w	O	-1	6415512
days.	O	-1	6415512
Whe@@	O	-1	6415512
n	O	-1	6415512
the	O	-1	6415512
carbamazepine	B-Chemical	D002220	6415512
was	O	-1	6415512
discontinu@@	O	-1	6415512
ed,	O	-1	6415512
two	O	-1	6415512
of	O	-1	6415512
the	O	-1	6415512
children	O	-1	6415512
retur@@	O	-1	6415512
n@@	O	-1	6415512
ed	O	-1	6415512
to	O	-1	6415512
their	O	-1	6415512
form@@	O	-1	6415512
er	O	-1	6415512
state	O	-1	6415512
very	O	-1	6415512
qu@@	O	-1	6415512
ic@@	O	-1	6415512
k@@	O	-1	6415512
ly,	O	-1	6415512
two	O	-1	6415512
had	O	-1	6415512
the	O	-1	6415512
min@@	O	-1	6415512
or	O	-1	6415512
motor	O	-1	6415512
seizures	B-Disease	D012640	6415512
resol@@	O	-1	6415512
ve	O	-1	6415512
in	O	-1	6415512
3	O	-1	6415512
and	O	-1	6415512
6	O	-1	6415512
month@@	O	-1	6415512
s,	O	-1	6415512
and	O	-1	6415512
one	O	-1	6415512
had	O	-1	6415512
the	O	-1	6415512
seizures	B-Disease	D012640	6415512
per@@	O	-1	6415512
sist@@	O	-1	6415512
.	O	-1	6415512
The	O	-1	6415512
ch@@	O	-1	6415512
il@@	O	-1	6415512
d	O	-1	6415512
in	O	-1	6415512
whom	O	-1	6415512
the	O	-1	6415512
seizures	B-Disease	D012640	6415512
per@@	O	-1	6415512
sist@@	O	-1	6415512
ed	O	-1	6415512
was	O	-1	6415512
lat@@	O	-1	6415512
er	O	-1	6415512
found	O	-1	6415512
to	O	-1	6415512
have	O	-1	6415512
c@@	B-Disease	D009472	6415512
ero@@	I-Disease	-1	6415512
id	I-Disease	-1	6415512
li@@	I-Disease	-1	6415512
po@@	I-Disease	-1	6415512
f@@	I-Disease	-1	6415512
us@@	I-Disease	-1	6415512
cin@@	I-Disease	-1	6415512
o@@	I-Disease	-1	6415512
sis	I-Disease	-1	6415512
.	O	-1	6415512
The	O	-1	6415512
other	O	-1	6415512
children	O	-1	6415512
are	O	-1	6415512
do@@	O	-1	6415512
ing	O	-1	6415512
well	O	-1	6415512
on	O	-1	6415512
other	O	-1	6415512
anti@@	O	-1	6415512
convul@@	O	-1	6415512
s@@	O	-1	6415512
ant@@	O	-1	6415512
s.	O	-1	6415512

N@@	B-Chemical	D009270	1928887
al@@	I-Chemical	-1	1928887
ox@@	I-Chemical	-1	1928887
one	I-Chemical	-1	1928887
rever@@	O	-1	1928887
s@@	O	-1	1928887
al	O	-1	1928887
of	O	-1	1928887
hypotension	B-Disease	D007022	1928887
due	O	-1	1928887
to	O	-1	1928887
cap@@	B-Chemical	D002216	1928887
to@@	I-Chemical	-1	1928887
pri@@	I-Chemical	-1	1928887
l	I-Chemical	-1	1928887
over@@	B-Disease	D062787	1928887
dose	I-Disease	-1	1928887
.	O	-1	1928887
The	O	-1	1928887
hemo@@	O	-1	1928887
dynam@@	O	-1	1928887
ic	O	-1	1928887
effects	O	-1	1928887
of	O	-1	1928887
cap@@	B-Chemical	D002216	1928887
to@@	I-Chemical	-1	1928887
pri@@	I-Chemical	-1	1928887
l	I-Chemical	-1	1928887
and	O	-1	1928887
other	O	-1	1928887
angiotens@@	B-Chemical	D000806	1928887
in-@@	I-Chemical	-1	1928887
conver@@	I-Chemical	-1	1928887
ting	I-Chemical	-1	1928887
enzyme	I-Chemical	-1	1928887
inhibitors	I-Chemical	-1	1928887
may	O	-1	1928887
be	O	-1	1928887
mediated	O	-1	1928887
by	O	-1	1928887
the	O	-1	1928887
endo@@	O	-1	1928887
gen@@	O	-1	1928887
ous	O	-1	1928887
o@@	O	-1	1928887
pi@@	O	-1	1928887
oid	O	-1	1928887
system@@	O	-1	1928887
.	O	-1	1928887
The	O	-1	1928887
o@@	O	-1	1928887
pi@@	O	-1	1928887
oid	O	-1	1928887
antagonist	O	-1	1928887
n@@	B-Chemical	D009270	1928887
al@@	I-Chemical	-1	1928887
ox@@	I-Chemical	-1	1928887
one	I-Chemical	-1	1928887
has	O	-1	1928887
been	O	-1	1928887
shown	O	-1	1928887
to	O	-1	1928887
bloc@@	O	-1	1928887
k	O	-1	1928887
or	O	-1	1928887
re@@	O	-1	1928887
verse	O	-1	1928887
the	O	-1	1928887
hypoten@@	B-Disease	D007022	1928887
sive	I-Disease	-1	1928887
ac@@	O	-1	1928887
tions	O	-1	1928887
of	O	-1	1928887
cap@@	B-Chemical	D002216	1928887
to@@	I-Chemical	-1	1928887
pri@@	I-Chemical	-1	1928887
l	I-Chemical	-1	1928887
.	O	-1	1928887
We	O	-1	1928887
report	O	-1	1928887
a	O	-1	1928887
case	O	-1	1928887
of	O	-1	1928887
an	O	-1	1928887
int@@	O	-1	1928887
en@@	O	-1	1928887
tional	O	-1	1928887
cap@@	B-Chemical	D002216	1928887
to@@	I-Chemical	-1	1928887
pri@@	I-Chemical	-1	1928887
l	I-Chemical	-1	1928887
over@@	B-Disease	D062787	1928887
dose	I-Disease	-1	1928887
,	O	-1	1928887
man@@	O	-1	1928887
if@@	O	-1	1928887
est@@	O	-1	1928887
ed	O	-1	1928887
by	O	-1	1928887
mark@@	O	-1	1928887
ed	O	-1	1928887
hypotension	B-Disease	D007022	1928887
,	O	-1	1928887
that	O	-1	1928887
resol@@	O	-1	1928887
ved	O	-1	1928887
pro@@	O	-1	1928887
m@@	O	-1	1928887
pt@@	O	-1	1928887
ly	O	-1	1928887
with	O	-1	1928887
the	O	-1	1928887
administration	O	-1	1928887
of	O	-1	1928887
n@@	B-Chemical	D009270	1928887
al@@	I-Chemical	-1	1928887
ox@@	I-Chemical	-1	1928887
one	I-Chemical	-1	1928887
.	O	-1	1928887
To	O	-1	1928887
our	O	-1	1928887
know@@	O	-1	1928887
le@@	O	-1	1928887
d@@	O	-1	1928887
g@@	O	-1	1928887
e,	O	-1	1928887
this	O	-1	1928887
is	O	-1	1928887
the	O	-1	1928887
first	O	-1	1928887
reported	O	-1	1928887
case	O	-1	1928887
of	O	-1	1928887
cap@@	B-Chemical	D002216	1928887
to@@	I-Chemical	-1	1928887
pri@@	I-Chemical	-1	1928887
l	I-Chemical	-1	1928887
-induced	O	-1	1928887
hypotension	B-Disease	D007022	1928887
treated	O	-1	1928887
with	O	-1	1928887
n@@	B-Chemical	D009270	1928887
al@@	I-Chemical	-1	1928887
ox@@	I-Chemical	-1	1928887
one	I-Chemical	-1	1928887
.	O	-1	1928887
Our	O	-1	1928887
experi@@	O	-1	1928887
ence	O	-1	1928887
demon@@	O	-1	1928887
strat@@	O	-1	1928887
es	O	-1	1928887
a	O	-1	1928887
possible	O	-1	1928887
role	O	-1	1928887
of	O	-1	1928887
n@@	B-Chemical	D009270	1928887
al@@	I-Chemical	-1	1928887
ox@@	I-Chemical	-1	1928887
one	I-Chemical	-1	1928887
in	O	-1	1928887
the	O	-1	1928887
rever@@	O	-1	1928887
s@@	O	-1	1928887
al	O	-1	1928887
of	O	-1	1928887
hypotension	B-Disease	D007022	1928887
result@@	O	-1	1928887
ing	O	-1	1928887
from	O	-1	1928887
cap@@	B-Chemical	D002216	1928887
to@@	I-Chemical	-1	1928887
pri@@	I-Chemical	-1	1928887
l	I-Chemical	-1	1928887
.	O	-1	1928887

C@@	B-Chemical	D002220	1728915
arb@@	I-Chemical	-1	1728915
am@@	I-Chemical	-1	1728915
azepine	I-Chemical	-1	1728915
-induced	O	-1	1728915
cardiac	B-Disease	D006331	1728915
dysfunction	I-Disease	-1	1728915
.	O	-1	1728915
Ch@@	O	-1	1728915
aracter@@	O	-1	1728915
ization	O	-1	1728915
of	O	-1	1728915
two	O	-1	1728915
dist@@	O	-1	1728915
inc@@	O	-1	1728915
t	O	-1	1728915
clinical	O	-1	1728915
syndrom@@	O	-1	1728915
es.	O	-1	1728915
A	O	-1	1728915
patient	O	-1	1728915
with	O	-1	1728915
s@@	O	-1	1728915
in@@	O	-1	1728915
us	O	-1	1728915
brady@@	B-Disease	D001919	1728915
cardia	I-Disease	-1	1728915
and	O	-1	1728915
atri@@	B-Disease	D054537	1728915
o@@	I-Disease	-1	1728915
ventricular	I-Disease	-1	1728915
bloc@@	I-Disease	-1	1728915
k	I-Disease	-1	1728915
,	O	-1	1728915
induced	O	-1	1728915
by	O	-1	1728915
carbamazepine	B-Chemical	D002220	1728915
,	O	-1	1728915
pro@@	O	-1	1728915
m@@	O	-1	1728915
pt@@	O	-1	1728915
ed	O	-1	1728915
an	O	-1	1728915
exten@@	O	-1	1728915
sive	O	-1	1728915
literat@@	O	-1	1728915
ure	O	-1	1728915
revie@@	O	-1	1728915
w	O	-1	1728915
of	O	-1	1728915
all	O	-1	1728915
previously	O	-1	1728915
reported	O	-1	1728915
cas@@	O	-1	1728915
es.	O	-1	1728915
F@@	O	-1	1728915
rom	O	-1	1728915
the	O	-1	1728915
analysis	O	-1	1728915
of	O	-1	1728915
these	O	-1	1728915
cas@@	O	-1	1728915
es,	O	-1	1728915
two	O	-1	1728915
dist@@	O	-1	1728915
inc@@	O	-1	1728915
t	O	-1	1728915
form@@	O	-1	1728915
s	O	-1	1728915
of	O	-1	1728915
carbamazepine	B-Chemical	D002220	1728915
-@@	O	-1	1728915
associated	O	-1	1728915
cardiac	B-Disease	D006331	1728915
dysfunction	I-Disease	-1	1728915
em@@	O	-1	1728915
erg@@	O	-1	1728915
ed.	O	-1	1728915
One	O	-1	1728915
patient	O	-1	1728915
group	O	-1	1728915
developed	O	-1	1728915
s@@	B-Disease	D013616	1728915
in@@	I-Disease	-1	1728915
us	I-Disease	-1	1728915
tachy@@	I-Disease	-1	1728915
cardi@@	I-Disease	-1	1728915
as	I-Disease	-1	1728915
in	O	-1	1728915
the	O	-1	1728915
se@@	O	-1	1728915
t@@	O	-1	1728915
ting	O	-1	1728915
of	O	-1	1728915
a	O	-1	1728915
mas@@	O	-1	1728915
sive	O	-1	1728915
carbamazepine	B-Chemical	D002220	1728915
over@@	B-Disease	D062787	1728915
dose	I-Disease	-1	1728915
.	O	-1	1728915
The	O	-1	1728915
second	O	-1	1728915
group	O	-1	1728915
consist@@	O	-1	1728915
ed	O	-1	1728915
al@@	O	-1	1728915
most	O	-1	1728915
ex@@	O	-1	1728915
cl@@	O	-1	1728915
u@@	O	-1	1728915
si@@	O	-1	1728915
vely	O	-1	1728915
of	O	-1	1728915
el@@	O	-1	1728915
der@@	O	-1	1728915
ly	O	-1	1728915
women	O	-1	1728915
who	O	-1	1728915
developed	O	-1	1728915
potenti@@	O	-1	1728915
ally	O	-1	1728915
lif@@	O	-1	1728915
e-@@	O	-1	1728915
th@@	O	-1	1728915
reat@@	O	-1	1728915
en@@	O	-1	1728915
ing	O	-1	1728915
brady@@	B-Disease	D001919	1728915
arrhyth@@	I-Disease	-1	1728915
mi@@	I-Disease	-1	1728915
as	I-Disease	-1	1728915
or	O	-1	1728915
atri@@	B-Disease	D054537	1728915
o@@	I-Disease	-1	1728915
ventricular	I-Disease	-1	1728915
con@@	I-Disease	-1	1728915
duction	I-Disease	-1	1728915
del@@	I-Disease	-1	1728915
ay	I-Disease	-1	1728915
,	O	-1	1728915
associated	O	-1	1728915
with	O	-1	1728915
either	O	-1	1728915
therapeutic	O	-1	1728915
or	O	-1	1728915
mode@@	O	-1	1728915
st@@	O	-1	1728915
ly	O	-1	1728915
elevated	O	-1	1728915
carbamazepine	B-Chemical	D002220	1728915
serum	O	-1	1728915
level@@	O	-1	1728915
s.	O	-1	1728915
B@@	O	-1	1728915
ecause	O	-1	1728915
carbamazepine	B-Chemical	D002220	1728915
is	O	-1	1728915
wi@@	O	-1	1728915
de@@	O	-1	1728915
ly	O	-1	1728915
used	O	-1	1728915
in	O	-1	1728915
the	O	-1	1728915
treatment	O	-1	1728915
of	O	-1	1728915
man@@	O	-1	1728915
y	O	-1	1728915
neurolog@@	O	-1	1728915
ic	O	-1	1728915
and	O	-1	1728915
psych@@	B-Disease	D001523	1728915
i@@	I-Disease	-1	1728915
atric	I-Disease	-1	1728915
condi@@	O	-1	1728915
tion@@	O	-1	1728915
s,	O	-1	1728915
the	O	-1	1728915
reco@@	O	-1	1728915
gn@@	O	-1	1728915
ition	O	-1	1728915
of	O	-1	1728915
the	O	-1	1728915
lat@@	O	-1	1728915
ter	O	-1	1728915
syndrome	O	-1	1728915
has	O	-1	1728915
important	O	-1	1728915
implic@@	O	-1	1728915
ations	O	-1	1728915
for	O	-1	1728915
the	O	-1	1728915
use	O	-1	1728915
of	O	-1	1728915
this	O	-1	1728915
drug	O	-1	1728915
in	O	-1	1728915
el@@	O	-1	1728915
der@@	O	-1	1728915
ly	O	-1	1728915
patients.	O	-1	1728915

G@@	O	-1	20558148
l@@	O	-1	20558148
ut@@	O	-1	20558148
am@@	O	-1	20558148
at@@	O	-1	20558148
ergic	O	-1	20558148
neuro@@	O	-1	20558148
trans@@	O	-1	20558148
mission	O	-1	20558148
mediated	O	-1	20558148
by	O	-1	20558148
N@@	B-Chemical	D016202	20558148
MD@@	I-Chemical	-1	20558148
A	I-Chemical	-1	20558148
receptors	O	-1	20558148
in	O	-1	20558148
the	O	-1	20558148
inf@@	O	-1	20558148
er@@	O	-1	20558148
ior	O	-1	20558148
coll@@	O	-1	20558148
ic@@	O	-1	20558148
ul@@	O	-1	20558148
us	O	-1	20558148
can	O	-1	20558148
mod@@	O	-1	20558148
ul@@	O	-1	20558148
ate	O	-1	20558148
haloperidol	B-Chemical	D006220	20558148
-induced	O	-1	20558148
cat@@	B-Disease	D002375	20558148
al@@	I-Disease	-1	20558148
ep@@	I-Disease	-1	20558148
sy	I-Disease	-1	20558148
.	O	-1	20558148
The	O	-1	20558148
inf@@	O	-1	20558148
er@@	O	-1	20558148
ior	O	-1	20558148
coll@@	O	-1	20558148
ic@@	O	-1	20558148
ul@@	O	-1	20558148
us	O	-1	20558148
(@@	O	-1	20558148
IC@@	O	-1	20558148
)	O	-1	20558148
is	O	-1	20558148
prim@@	O	-1	20558148
ari@@	O	-1	20558148
ly	O	-1	20558148
involved	O	-1	20558148
in	O	-1	20558148
the	O	-1	20558148
pro@@	O	-1	20558148
cess@@	O	-1	20558148
ing	O	-1	20558148
of	O	-1	20558148
a@@	O	-1	20558148
ud@@	O	-1	20558148
it@@	O	-1	20558148
ory	O	-1	20558148
inf@@	O	-1	20558148
orm@@	O	-1	20558148
ation,	O	-1	20558148
but	O	-1	20558148
it	O	-1	20558148
is	O	-1	20558148
dist@@	O	-1	20558148
ing@@	O	-1	20558148
u@@	O	-1	20558148
ished	O	-1	20558148
from	O	-1	20558148
other	O	-1	20558148
a@@	O	-1	20558148
ud@@	O	-1	20558148
it@@	O	-1	20558148
ory	O	-1	20558148
nucle@@	O	-1	20558148
i	O	-1	20558148
in	O	-1	20558148
the	O	-1	20558148
bra@@	O	-1	20558148
in@@	O	-1	20558148
st@@	O	-1	20558148
em	O	-1	20558148
by	O	-1	20558148
its	O	-1	20558148
con@@	O	-1	20558148
nec@@	O	-1	20558148
tions	O	-1	20558148
with	O	-1	20558148
struct@@	O	-1	20558148
ures	O	-1	20558148
of	O	-1	20558148
the	O	-1	20558148
motor	O	-1	20558148
system@@	O	-1	20558148
.	O	-1	20558148
F@@	O	-1	20558148
unc@@	O	-1	20558148
tional	O	-1	20558148
evidence	O	-1	20558148
rel@@	O	-1	20558148
ating	O	-1	20558148
the	O	-1	20558148
I@@	O	-1	20558148
C	O	-1	20558148
to	O	-1	20558148
motor	O	-1	20558148
behavi@@	O	-1	20558148
or	O	-1	20558148
der@@	O	-1	20558148
i@@	O	-1	20558148
v@@	O	-1	20558148
es	O	-1	20558148
from	O	-1	20558148
experim@@	O	-1	20558148
ents	O	-1	20558148
show@@	O	-1	20558148
ing	O	-1	20558148
that	O	-1	20558148
activation	O	-1	20558148
of	O	-1	20558148
the	O	-1	20558148
I@@	O	-1	20558148
C	O	-1	20558148
by	O	-1	20558148
elect@@	O	-1	20558148
r@@	O	-1	20558148
ical	O	-1	20558148
stimulation	O	-1	20558148
or	O	-1	20558148
ex@@	O	-1	20558148
cit@@	O	-1	20558148
atory	O	-1	20558148
amin@@	B-Chemical	D000596	20558148
o	I-Chemical	-1	20558148
acid	I-Chemical	-1	20558148
micro@@	O	-1	20558148
injection	O	-1	20558148
causes	O	-1	20558148
f@@	O	-1	20558148
re@@	O	-1	20558148
e@@	O	-1	20558148
z@@	O	-1	20558148
ing,	O	-1	20558148
es@@	O	-1	20558148
cap@@	O	-1	20558148
e-@@	O	-1	20558148
like	O	-1	20558148
behavi@@	O	-1	20558148
or@@	O	-1	20558148
,	O	-1	20558148
and	O	-1	20558148
im@@	O	-1	20558148
mo@@	O	-1	20558148
bil@@	O	-1	20558148
ity.	O	-1	20558148
However,	O	-1	20558148
the	O	-1	20558148
n@@	O	-1	20558148
at@@	O	-1	20558148
ure	O	-1	20558148
of	O	-1	20558148
this	O	-1	20558148
im@@	O	-1	20558148
mo@@	O	-1	20558148
b@@	O	-1	20558148
ility	O	-1	20558148
is	O	-1	20558148
sti@@	O	-1	20558148
ll	O	-1	20558148
unc@@	O	-1	20558148
lear@@	O	-1	20558148
.	O	-1	20558148
The	O	-1	20558148
present	O	-1	20558148
study	O	-1	20558148
examined	O	-1	20558148
the	O	-1	20558148
influence	O	-1	20558148
of	O	-1	20558148
ex@@	O	-1	20558148
cit@@	O	-1	20558148
atory	O	-1	20558148
amin@@	B-Chemical	D000596	20558148
o	I-Chemical	-1	20558148
acid	I-Chemical	-1	20558148
-@@	O	-1	20558148
mediated	O	-1	20558148
mechanisms	O	-1	20558148
in	O	-1	20558148
the	O	-1	20558148
I@@	O	-1	20558148
C	O	-1	20558148
on	O	-1	20558148
the	O	-1	20558148
cat@@	B-Disease	D002375	20558148
al@@	I-Disease	-1	20558148
ep@@	I-Disease	-1	20558148
sy	I-Disease	-1	20558148
induced	O	-1	20558148
by	O	-1	20558148
the	O	-1	20558148
dopamine	B-Chemical	D004298	20558148
receptor	O	-1	20558148
block@@	O	-1	20558148
er	O	-1	20558148
haloperidol	B-Chemical	D006220	20558148
administered	O	-1	20558148
system@@	O	-1	20558148
ically	O	-1	20558148
(@@	O	-1	20558148
1	O	-1	20558148
or	O	-1	20558148
0.@@	O	-1	20558148
5	O	-1	20558148
mg/kg)	O	-1	20558148
in	O	-1	20558148
rats.	O	-1	20558148
H@@	B-Chemical	D006220	20558148
alo@@	I-Chemical	-1	20558148
perid@@	I-Chemical	-1	20558148
ol	I-Chemical	-1	20558148
-induced	O	-1	20558148
cat@@	B-Disease	D002375	20558148
al@@	I-Disease	-1	20558148
ep@@	I-Disease	-1	20558148
sy	I-Disease	-1	20558148
was	O	-1	20558148
ch@@	O	-1	20558148
all@@	O	-1	20558148
en@@	O	-1	20558148
g@@	O	-1	20558148
ed	O	-1	20558148
with	O	-1	20558148
prior	O	-1	20558148
intrac@@	O	-1	20558148
ol@@	O	-1	20558148
l@@	O	-1	20558148
ic@@	O	-1	20558148
ular	O	-1	20558148
micro@@	O	-1	20558148
injec@@	O	-1	20558148
tions	O	-1	20558148
of	O	-1	20558148
glutamate	B-Chemical	D018698	20558148
N@@	B-Chemical	D016202	20558148
MD@@	I-Chemical	-1	20558148
A	I-Chemical	-1	20558148
receptor	O	-1	20558148
antagonist@@	O	-1	20558148
s,	O	-1	20558148
M@@	B-Chemical	D016291	20558148
K@@	I-Chemical	-1	20558148
-@@	I-Chemical	-1	20558148
80@@	I-Chemical	-1	20558148
1	I-Chemical	-1	20558148
(1@@	O	-1	20558148
5	O	-1	20558148
or	O	-1	20558148
30	O	-1	20558148
m@@	O	-1	20558148
mol@@	O	-1	20558148
/@@	O	-1	20558148
0.@@	O	-1	20558148
5	O	-1	20558148
micro@@	O	-1	20558148
l@@	O	-1	20558148
)	O	-1	20558148
and	O	-1	20558148
A@@	B-Chemical	C031231	20558148
P@@	I-Chemical	-1	20558148
7	I-Chemical	-1	20558148
(10	O	-1	20558148
or	O	-1	20558148
20	O	-1	20558148
n@@	O	-1	20558148
mol@@	O	-1	20558148
/@@	O	-1	20558148
0.@@	O	-1	20558148
5	O	-1	20558148
micro@@	O	-1	20558148
l@@	O	-1	20558148
),	O	-1	20558148
or	O	-1	20558148
of	O	-1	20558148
the	O	-1	20558148
N@@	B-Chemical	D016202	20558148
MD@@	I-Chemical	-1	20558148
A	I-Chemical	-1	20558148
receptor	O	-1	20558148
agon@@	O	-1	20558148
ist	O	-1	20558148
N@@	B-Chemical	D016202	20558148
-@@	I-Chemical	-1	20558148
methyl@@	I-Chemical	-1	20558148
-@@	I-Chemical	-1	20558148
d-@@	I-Chemical	-1	20558148
as@@	I-Chemical	-1	20558148
part@@	I-Chemical	-1	20558148
ate	I-Chemical	-1	20558148
(	O	-1	20558148
N@@	B-Chemical	D016202	20558148
MD@@	I-Chemical	-1	20558148
A	I-Chemical	-1	20558148
,	O	-1	20558148
20	O	-1	20558148
or	O	-1	20558148
30	O	-1	20558148
n@@	O	-1	20558148
mol@@	O	-1	20558148
/@@	O	-1	20558148
0.@@	O	-1	20558148
5	O	-1	20558148
micro@@	O	-1	20558148
l@@	O	-1	20558148
).	O	-1	20558148
The	O	-1	20558148
results	O	-1	20558148
showed	O	-1	20558148
that	O	-1	20558148
intrac@@	O	-1	20558148
ol@@	O	-1	20558148
l@@	O	-1	20558148
ic@@	O	-1	20558148
ular	O	-1	20558148
micro@@	O	-1	20558148
injection	O	-1	20558148
of	O	-1	20558148
M@@	B-Chemical	D016291	20558148
K@@	I-Chemical	-1	20558148
-@@	I-Chemical	-1	20558148
80@@	I-Chemical	-1	20558148
1	I-Chemical	-1	20558148
and	O	-1	20558148
A@@	B-Chemical	C031231	20558148
P@@	I-Chemical	-1	20558148
7	I-Chemical	-1	20558148
previ@@	O	-1	20558148
ous	O	-1	20558148
to	O	-1	20558148
systemic	O	-1	20558148
injec@@	O	-1	20558148
tions	O	-1	20558148
of	O	-1	20558148
haloperidol	B-Chemical	D006220	20558148
significantly	O	-1	20558148
attenu@@	O	-1	20558148
ated	O	-1	20558148
the	O	-1	20558148
cat@@	B-Disease	D002375	20558148
al@@	I-Disease	-1	20558148
ep@@	I-Disease	-1	20558148
sy	I-Disease	-1	20558148
,	O	-1	20558148
as	O	-1	20558148
indic@@	O	-1	20558148
ated	O	-1	20558148
by	O	-1	20558148
a	O	-1	20558148
reduced	O	-1	20558148
lat@@	O	-1	20558148
ency	O	-1	20558148
to	O	-1	20558148
st@@	O	-1	20558148
ep	O	-1	20558148
do@@	O	-1	20558148
w@@	O	-1	20558148
n	O	-1	20558148
from	O	-1	20558148
a	O	-1	20558148
h@@	O	-1	20558148
or@@	O	-1	20558148
iz@@	O	-1	20558148
ont@@	O	-1	20558148
al	O	-1	20558148
bar@@	O	-1	20558148
.	O	-1	20558148
Ac@@	O	-1	20558148
cor@@	O	-1	20558148
d@@	O	-1	20558148
ing@@	O	-1	20558148
ly,	O	-1	20558148
intrac@@	O	-1	20558148
ol@@	O	-1	20558148
l@@	O	-1	20558148
ic@@	O	-1	20558148
ular	O	-1	20558148
micro@@	O	-1	20558148
injection	O	-1	20558148
of	O	-1	20558148
N@@	B-Chemical	D016202	20558148
MD@@	I-Chemical	-1	20558148
A	I-Chemical	-1	20558148
increased	O	-1	20558148
the	O	-1	20558148
lat@@	O	-1	20558148
ency	O	-1	20558148
to	O	-1	20558148
st@@	O	-1	20558148
ep	O	-1	20558148
do@@	O	-1	20558148
w@@	O	-1	20558148
n	O	-1	20558148
the	O	-1	20558148
bar@@	O	-1	20558148
.	O	-1	20558148
These	O	-1	20558148
findings	O	-1	20558148
suggest	O	-1	20558148
that	O	-1	20558148
glutamate	B-Chemical	D018698	20558148
-@@	O	-1	20558148
mediated	O	-1	20558148
mechanisms	O	-1	20558148
in	O	-1	20558148
the	O	-1	20558148
ne@@	O	-1	20558148
ural	O	-1	20558148
cir@@	O	-1	20558148
c@@	O	-1	20558148
u@@	O	-1	20558148
its	O	-1	20558148
at	O	-1	20558148
the	O	-1	20558148
I@@	O	-1	20558148
C	O	-1	20558148
level	O	-1	20558148
influence	O	-1	20558148
haloperidol	B-Chemical	D006220	20558148
-induced	O	-1	20558148
cat@@	B-Disease	D002375	20558148
al@@	I-Disease	-1	20558148
ep@@	I-Disease	-1	20558148
sy	I-Disease	-1	20558148
and	O	-1	20558148
partic@@	O	-1	20558148
ip@@	O	-1	20558148
ate	O	-1	20558148
in	O	-1	20558148
the	O	-1	20558148
reg@@	O	-1	20558148
ulation	O	-1	20558148
of	O	-1	20558148
motor	O	-1	20558148
activ@@	O	-1	20558148
ity.	O	-1	20558148

M@@	O	-1	19940105
et@@	O	-1	19940105
ab@@	O	-1	19940105
ot@@	O	-1	19940105
ro@@	O	-1	19940105
p@@	O	-1	19940105
ic	O	-1	19940105
glutamate	B-Chemical	D018698	19940105
7	O	-1	19940105
receptor	O	-1	19940105
sub@@	O	-1	19940105
type	O	-1	19940105
mod@@	O	-1	19940105
ul@@	O	-1	19940105
ates	O	-1	19940105
motor	O	-1	19940105
symptoms	O	-1	19940105
in	O	-1	19940105
ro@@	O	-1	19940105
d@@	O	-1	19940105
ent	O	-1	19940105
models	O	-1	19940105
of	O	-1	19940105
Parkinson's	B-Disease	D010300	19940105
disease	I-Disease	-1	19940105
.	O	-1	19940105
M@@	O	-1	19940105
et@@	O	-1	19940105
ab@@	O	-1	19940105
ot@@	O	-1	19940105
ro@@	O	-1	19940105
p@@	O	-1	19940105
ic	O	-1	19940105
glutamate	B-Chemical	D018698	19940105
(@@	O	-1	19940105
m@@	O	-1	19940105
G@@	O	-1	19940105
lu@@	O	-1	19940105
)	O	-1	19940105
receptors	O	-1	19940105
mod@@	O	-1	19940105
ul@@	O	-1	19940105
ate	O	-1	19940105
syn@@	O	-1	19940105
ap@@	O	-1	19940105
tic	O	-1	19940105
trans@@	O	-1	19940105
mission	O	-1	19940105
in	O	-1	19940105
the	O	-1	19940105
central	O	-1	19940105
ner@@	O	-1	19940105
v@@	O	-1	19940105
ous	O	-1	19940105
system	O	-1	19940105
and	O	-1	19940105
re@@	O	-1	19940105
present	O	-1	19940105
pro@@	O	-1	19940105
mis@@	O	-1	19940105
ing	O	-1	19940105
therapeutic	O	-1	19940105
t@@	O	-1	19940105
arg@@	O	-1	19940105
et@@	O	-1	19940105
s	O	-1	19940105
for	O	-1	19940105
symptom@@	O	-1	19940105
atic	O	-1	19940105
treatment	O	-1	19940105
of	O	-1	19940105
Parkinson's	B-Disease	D010300	19940105
disease	I-Disease	-1	19940105
(	O	-1	19940105
P@@	B-Disease	D010300	19940105
D	I-Disease	-1	19940105
).	O	-1	19940105
A@@	O	-1	19940105
mon@@	O	-1	19940105
g	O	-1	19940105
the	O	-1	19940105
e@@	O	-1	19940105
ight	O	-1	19940105
m@@	O	-1	19940105
G@@	O	-1	19940105
l@@	O	-1	19940105
u	O	-1	19940105
receptor	O	-1	19940105
sub@@	O	-1	19940105
typ@@	O	-1	19940105
es,	O	-1	19940105
m@@	O	-1	19940105
G@@	O	-1	19940105
lu@@	O	-1	19940105
7	O	-1	19940105
receptor	O	-1	19940105
is	O	-1	19940105
pro@@	O	-1	19940105
min@@	O	-1	19940105
ently	O	-1	19940105
ex@@	O	-1	19940105
press@@	O	-1	19940105
ed	O	-1	19940105
in	O	-1	19940105
the	O	-1	19940105
bas@@	O	-1	19940105
al	O	-1	19940105
g@@	O	-1	19940105
ang@@	O	-1	19940105
li@@	O	-1	19940105
a,	O	-1	19940105
but	O	-1	19940105
its	O	-1	19940105
role	O	-1	19940105
in	O	-1	19940105
rest@@	O	-1	19940105
or@@	O	-1	19940105
ing	O	-1	19940105
motor	O	-1	19940105
function	O	-1	19940105
in	O	-1	19940105
anim@@	O	-1	19940105
al	O	-1	19940105
models	O	-1	19940105
of	O	-1	19940105
P@@	B-Disease	D010300	19940105
D	I-Disease	-1	19940105
is	O	-1	19940105
not	O	-1	19940105
know@@	O	-1	19940105
n@@	O	-1	19940105
.	O	-1	19940105
The	O	-1	19940105
effects	O	-1	19940105
of	O	-1	19940105
N@@	B-Chemical	C507346	19940105
,@@	I-Chemical	-1	19940105
N@@	I-Chemical	-1	19940105
'@@	I-Chemical	-1	19940105
-@@	I-Chemical	-1	19940105
di@@	I-Chemical	-1	19940105
b@@	I-Chemical	-1	19940105
enz@@	I-Chemical	-1	19940105
hy@@	I-Chemical	-1	19940105
d@@	I-Chemical	-1	19940105
r@@	I-Chemical	-1	19940105
y@@	I-Chemical	-1	19940105
le@@	I-Chemical	-1	19940105
th@@	I-Chemical	-1	19940105
an@@	I-Chemical	-1	19940105
e-@@	I-Chemical	-1	19940105
1@@	I-Chemical	-1	19940105
,@@	I-Chemical	-1	19940105
2-@@	I-Chemical	-1	19940105
di@@	I-Chemical	-1	19940105
amine	I-Chemical	-1	19940105
di@@	I-Chemical	-1	19940105
hydro@@	I-Chemical	-1	19940105
chlor@@	I-Chemical	-1	19940105
ide	I-Chemical	-1	19940105
(	O	-1	19940105
AM@@	B-Chemical	C507346	19940105
N@@	I-Chemical	-1	19940105
0@@	I-Chemical	-1	19940105
8@@	I-Chemical	-1	19940105
2	I-Chemical	-1	19940105
),	O	-1	19940105
the	O	-1	19940105
first	O	-1	19940105
selective	O	-1	19940105
al@@	O	-1	19940105
lo@@	O	-1	19940105
ster@@	O	-1	19940105
ic	O	-1	19940105
activ@@	O	-1	19940105
at@@	O	-1	19940105
or	O	-1	19940105
of	O	-1	19940105
m@@	O	-1	19940105
G@@	O	-1	19940105
lu@@	O	-1	19940105
7	O	-1	19940105
receptor@@	O	-1	19940105
s,	O	-1	19940105
were	O	-1	19940105
th@@	O	-1	19940105
us	O	-1	19940105
tested	O	-1	19940105
in	O	-1	19940105
different	O	-1	19940105
ro@@	O	-1	19940105
d@@	O	-1	19940105
ent	O	-1	19940105
models	O	-1	19940105
of	O	-1	19940105
P@@	B-Disease	D010300	19940105
D	I-Disease	-1	19940105
.	O	-1	19940105
He@@	O	-1	19940105
re,	O	-1	19940105
we	O	-1	19940105
show	O	-1	19940105
that	O	-1	19940105
oral	O	-1	19940105
(@@	O	-1	19940105
5	O	-1	19940105
mg/kg)	O	-1	19940105
or	O	-1	19940105
intra@@	O	-1	19940105
stri@@	O	-1	19940105
atal	O	-1	19940105
administration	O	-1	19940105
(0.@@	O	-1	19940105
1	O	-1	19940105
and	O	-1	19940105
0.@@	O	-1	19940105
5	O	-1	19940105
n@@	O	-1	19940105
mol@@	O	-1	19940105
)	O	-1	19940105
of	O	-1	19940105
AM@@	B-Chemical	C507346	19940105
N@@	I-Chemical	-1	19940105
0@@	I-Chemical	-1	19940105
8@@	I-Chemical	-1	19940105
2	I-Chemical	-1	19940105
rever@@	O	-1	19940105
ses	O	-1	19940105
haloperidol	B-Chemical	D006220	19940105
-induced	O	-1	19940105
cat@@	B-Disease	D002375	19940105
al@@	I-Disease	-1	19940105
ep@@	I-Disease	-1	19940105
sy	I-Disease	-1	19940105
in	O	-1	19940105
rats.	O	-1	19940105
AM@@	B-Chemical	C507346	19940105
N@@	I-Chemical	-1	19940105
0@@	I-Chemical	-1	19940105
8@@	I-Chemical	-1	19940105
2	I-Chemical	-1	19940105
(2@@	O	-1	19940105
.@@	O	-1	19940105
5	O	-1	19940105
and	O	-1	19940105
5	O	-1	19940105
mg/kg)	O	-1	19940105
reduc@@	O	-1	19940105
es	O	-1	19940105
apo@@	B-Chemical	D001058	19940105
morphine	I-Chemical	-1	19940105
-induced	O	-1	19940105
ro@@	O	-1	19940105
t@@	O	-1	19940105
ations	O	-1	19940105
in	O	-1	19940105
un@@	O	-1	19940105
il@@	O	-1	19940105
ateral	O	-1	19940105
6-@@	B-Chemical	D016627	19940105
hydrox@@	I-Chemical	-1	19940105
y@@	I-Chemical	-1	19940105
dopamine	I-Chemical	-1	19940105
(	O	-1	19940105
6-@@	B-Chemical	D016627	19940105
O@@	I-Chemical	-1	19940105
H@@	I-Chemical	-1	19940105
D@@	I-Chemical	-1	19940105
A	I-Chemical	-1	19940105
)-@@	O	-1	19940105
le@@	O	-1	19940105
sion@@	O	-1	19940105
ed	O	-1	19940105
rats.	O	-1	19940105
In	O	-1	19940105
a	O	-1	19940105
more	O	-1	19940105
comple@@	O	-1	19940105
x	O	-1	19940105
t@@	O	-1	19940105
as@@	O	-1	19940105
k	O	-1	19940105
common@@	O	-1	19940105
ly	O	-1	19940105
used	O	-1	19940105
to	O	-1	19940105
evalu@@	O	-1	19940105
ate	O	-1	19940105
major	O	-1	19940105
ak@@	B-Disease	D018476	19940105
ine@@	I-Disease	-1	19940105
tic	I-Disease	-1	19940105
symptoms	O	-1	19940105
of	O	-1	19940105
P@@	B-Disease	D010300	19940105
D	I-Disease	-1	19940105
patients,	O	-1	19940105
5	O	-1	19940105
mg/kg	O	-1	19940105
AM@@	B-Chemical	C507346	19940105
N@@	I-Chemical	-1	19940105
0@@	I-Chemical	-1	19940105
8@@	I-Chemical	-1	19940105
2	I-Chemical	-1	19940105
rever@@	O	-1	19940105
ses	O	-1	19940105
the	O	-1	19940105
increased	O	-1	19940105
reaction	O	-1	19940105
time	O	-1	19940105
to	O	-1	19940105
respon@@	O	-1	19940105
d	O	-1	19940105
to	O	-1	19940105
a	O	-1	19940105
c@@	O	-1	19940105
u@@	O	-1	19940105
e	O	-1	19940105
of	O	-1	19940105
bil@@	O	-1	19940105
ateral	O	-1	19940105
6-@@	B-Chemical	D016627	19940105
O@@	I-Chemical	-1	19940105
H@@	I-Chemical	-1	19940105
D@@	I-Chemical	-1	19940105
A	I-Chemical	-1	19940105
-@@	O	-1	19940105
le@@	O	-1	19940105
sion@@	O	-1	19940105
ed	O	-1	19940105
rats.	O	-1	19940105
In	O	-1	19940105
addi@@	O	-1	19940105
tion,	O	-1	19940105
AM@@	B-Chemical	C507346	19940105
N@@	I-Chemical	-1	19940105
0@@	I-Chemical	-1	19940105
8@@	I-Chemical	-1	19940105
2	I-Chemical	-1	19940105
reduc@@	O	-1	19940105
es	O	-1	19940105
the	O	-1	19940105
duration	O	-1	19940105
of	O	-1	19940105
haloperidol	B-Chemical	D006220	19940105
-induced	O	-1	19940105
cat@@	B-Disease	D002375	19940105
al@@	I-Disease	-1	19940105
ep@@	I-Disease	-1	19940105
sy	I-Disease	-1	19940105
in	O	-1	19940105
a	O	-1	19940105
m@@	O	-1	19940105
G@@	O	-1	19940105
lu@@	O	-1	19940105
7	O	-1	19940105
receptor@@	O	-1	19940105
-@@	O	-1	19940105
dependent	O	-1	19940105
man@@	O	-1	19940105
n@@	O	-1	19940105
er	O	-1	19940105
in	O	-1	19940105
wil@@	O	-1	19940105
d-@@	O	-1	19940105
type	O	-1	19940105
but	O	-1	19940105
not	O	-1	19940105
m@@	O	-1	19940105
G@@	O	-1	19940105
lu@@	O	-1	19940105
7	O	-1	19940105
receptor	O	-1	19940105
k@@	O	-1	19940105
n@@	O	-1	19940105
oc@@	O	-1	19940105
k@@	O	-1	19940105
out	O	-1	19940105
mice.	O	-1	19940105
H@@	O	-1	19940105
igh@@	O	-1	19940105
er	O	-1	19940105
doses	O	-1	19940105
of	O	-1	19940105
AM@@	B-Chemical	C507346	19940105
N@@	I-Chemical	-1	19940105
0@@	I-Chemical	-1	19940105
8@@	I-Chemical	-1	19940105
2	I-Chemical	-1	19940105
(10	O	-1	19940105
and	O	-1	19940105
20	O	-1	19940105
mg/kg	O	-1	19940105
p.@@	O	-1	19940105
o@@	O	-1	19940105
.)	O	-1	19940105
have	O	-1	19940105
no	O	-1	19940105
effect	O	-1	19940105
on	O	-1	19940105
the	O	-1	19940105
same	O	-1	19940105
models	O	-1	19940105
of	O	-1	19940105
P@@	B-Disease	D010300	19940105
D	I-Disease	-1	19940105
.	O	-1	19940105
O@@	O	-1	19940105
ver@@	O	-1	19940105
all	O	-1	19940105
these	O	-1	19940105
findings	O	-1	19940105
suggest	O	-1	19940105
that	O	-1	19940105
m@@	O	-1	19940105
G@@	O	-1	19940105
lu@@	O	-1	19940105
7	O	-1	19940105
receptor	O	-1	19940105
activation	O	-1	19940105
can	O	-1	19940105
re@@	O	-1	19940105
verse	O	-1	19940105
motor	O	-1	19940105
dysfunction	O	-1	19940105
associated	O	-1	19940105
with	O	-1	19940105
reduced	O	-1	19940105
dopamine	B-Chemical	D004298	19940105
activ@@	O	-1	19940105
ity.	O	-1	19940105
S@@	O	-1	19940105
el@@	O	-1	19940105
ective	O	-1	19940105
li@@	O	-1	19940105
g@@	O	-1	19940105
and@@	O	-1	19940105
s	O	-1	19940105
of	O	-1	19940105
m@@	O	-1	19940105
G@@	O	-1	19940105
lu@@	O	-1	19940105
7	O	-1	19940105
receptor	O	-1	19940105
sub@@	O	-1	19940105
typ@@	O	-1	19940105
es	O	-1	19940105
may	O	-1	19940105
th@@	O	-1	19940105
us	O	-1	19940105
be	O	-1	19940105
considered	O	-1	19940105
as	O	-1	19940105
pro@@	O	-1	19940105
mis@@	O	-1	19940105
ing	O	-1	19940105
comp@@	O	-1	19940105
oun@@	O	-1	19940105
ds	O	-1	19940105
for	O	-1	19940105
the	O	-1	19940105
development	O	-1	19940105
of	O	-1	19940105
anti@@	O	-1	19940105
par@@	O	-1	19940105
k@@	O	-1	19940105
inson@@	O	-1	19940105
i@@	O	-1	19940105
an	O	-1	19940105
therapeutic	O	-1	19940105
strat@@	O	-1	19940105
e@@	O	-1	19940105
gi@@	O	-1	19940105
es.	O	-1	19940105

N@@	B-Chemical	D009553	19923525
im@@	I-Chemical	-1	19923525
odi@@	I-Chemical	-1	19923525
pine	I-Chemical	-1	19923525
prev@@	O	-1	19923525
ents	O	-1	19923525
memory	B-Disease	D008569	19923525
impair@@	I-Disease	-1	19923525
ment	I-Disease	-1	19923525
caused	O	-1	19923525
by	O	-1	19923525
nitro@@	B-Chemical	D005996	19923525
glycer@@	I-Chemical	-1	19923525
in	I-Chemical	-1	19923525
-induced	O	-1	19923525
hypotension	B-Disease	D007022	19923525
in	O	-1	19923525
ad@@	O	-1	19923525
ult	O	-1	19923525
mice.	O	-1	19923525
BACKGROUND:	O	-1	19923525
H@@	B-Disease	D007022	19923525
y@@	I-Disease	-1	19923525
poten@@	I-Disease	-1	19923525
sion	I-Disease	-1	19923525
and	O	-1	19923525
a	O	-1	19923525
result@@	O	-1	19923525
ant	O	-1	19923525
decrease	O	-1	19923525
in	O	-1	19923525
cerebral	O	-1	19923525
blood	O	-1	19923525
flow	O	-1	19923525
have	O	-1	19923525
been	O	-1	19923525
implic@@	O	-1	19923525
ated	O	-1	19923525
in	O	-1	19923525
the	O	-1	19923525
development	O	-1	19923525
of	O	-1	19923525
cognitive	B-Disease	D003072	19923525
dysfunction	I-Disease	-1	19923525
.	O	-1	19923525
We	O	-1	19923525
tested	O	-1	19923525
the	O	-1	19923525
hypo@@	O	-1	19923525
thesis	O	-1	19923525
that	O	-1	19923525
n@@	B-Chemical	D009553	19923525
im@@	I-Chemical	-1	19923525
odi@@	I-Chemical	-1	19923525
pine	I-Chemical	-1	19923525
(	O	-1	19923525
N@@	B-Chemical	D009553	19923525
I@@	I-Chemical	-1	19923525
M@@	I-Chemical	-1	19923525
O	I-Chemical	-1	19923525
)	O	-1	19923525
administered	O	-1	19923525
at	O	-1	19923525
the	O	-1	19923525
onset	O	-1	19923525
of	O	-1	19923525
nitro@@	B-Chemical	D005996	19923525
glycer@@	I-Chemical	-1	19923525
in	I-Chemical	-1	19923525
(	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
)@@	O	-1	19923525
-induced	O	-1	19923525
hypotension	B-Disease	D007022	19923525
wo@@	O	-1	19923525
uld	O	-1	19923525
pres@@	O	-1	19923525
er@@	O	-1	19923525
ve	O	-1	19923525
long-term	O	-1	19923525
associ@@	O	-1	19923525
ative	O	-1	19923525
memor@@	O	-1	19923525
y.	O	-1	19923525
METHODS:	O	-1	19923525
The	O	-1	19923525
p@@	O	-1	19923525
as@@	O	-1	19923525
sive	O	-1	19923525
avoid@@	O	-1	19923525
ance	O	-1	19923525
(@@	O	-1	19923525
PA@@	O	-1	19923525
)	O	-1	19923525
par@@	O	-1	19923525
a@@	O	-1	19923525
di@@	O	-1	19923525
g@@	O	-1	19923525
m	O	-1	19923525
was	O	-1	19923525
used	O	-1	19923525
to	O	-1	19923525
ass@@	O	-1	19923525
ess	O	-1	19923525
memory	O	-1	19923525
re@@	O	-1	19923525
ten@@	O	-1	19923525
tion.	O	-1	19923525
F@@	O	-1	19923525
or	O	-1	19923525
P@@	O	-1	19923525
A	O	-1	19923525
tra@@	O	-1	19923525
in@@	O	-1	19923525
ing,	O	-1	19923525
lat@@	O	-1	19923525
en@@	O	-1	19923525
ci@@	O	-1	19923525
es	O	-1	19923525
(@@	O	-1	19923525
second@@	O	-1	19923525
s)	O	-1	19923525
were	O	-1	19923525
recor@@	O	-1	19923525
ded	O	-1	19923525
for	O	-1	19923525
entr@@	O	-1	19923525
y	O	-1	19923525
from	O	-1	19923525
a	O	-1	19923525
sus@@	O	-1	19923525
pen@@	O	-1	19923525
ded	O	-1	19923525
pl@@	O	-1	19923525
at@@	O	-1	19923525
form	O	-1	19923525
into	O	-1	19923525
a	O	-1	19923525
P@@	O	-1	19923525
le@@	O	-1	19923525
xi@@	O	-1	19923525
gl@@	O	-1	19923525
as	O	-1	19923525
tu@@	O	-1	19923525
be	O	-1	19923525
wh@@	O	-1	19923525
ere	O	-1	19923525
a	O	-1	19923525
sh@@	O	-1	19923525
oc@@	O	-1	19923525
k	O	-1	19923525
was	O	-1	19923525
auto@@	O	-1	19923525
m@@	O	-1	19923525
ati@@	O	-1	19923525
c@@	O	-1	19923525
ally	O	-1	19923525
de@@	O	-1	19923525
li@@	O	-1	19923525
ve@@	O	-1	19923525
red.	O	-1	19923525
L@@	O	-1	19923525
at@@	O	-1	19923525
en@@	O	-1	19923525
ci@@	O	-1	19923525
es	O	-1	19923525
were	O	-1	19923525
recor@@	O	-1	19923525
ded	O	-1	19923525
4@@	O	-1	19923525
8	O	-1	19923525
h	O	-1	19923525
lat@@	O	-1	19923525
er	O	-1	19923525
for	O	-1	19923525
a	O	-1	19923525
test@@	O	-1	19923525
ing	O	-1	19923525
tri@@	O	-1	19923525
al.	O	-1	19923525
N@@	O	-1	19923525
ine@@	O	-1	19923525
ty-@@	O	-1	19923525
six	O	-1	19923525
S@@	O	-1	19923525
w@@	O	-1	19923525
is@@	O	-1	19923525
s-@@	O	-1	19923525
W@@	O	-1	19923525
e@@	O	-1	19923525
b@@	O	-1	19923525
st@@	O	-1	19923525
er	O	-1	19923525
mice	O	-1	19923525
(3@@	O	-1	19923525
0-@@	O	-1	19923525
3@@	O	-1	19923525
5	O	-1	19923525
g@@	O	-1	19923525
,	O	-1	19923525
6-@@	O	-1	19923525
8	O	-1	19923525
w@@	O	-1	19923525
k@@	O	-1	19923525
),	O	-1	19923525
were	O	-1	19923525
randomized	O	-1	19923525
into	O	-1	19923525
6	O	-1	19923525
groups	O	-1	19923525
1)	O	-1	19923525
saline	O	-1	19923525
(@@	O	-1	19923525
control@@	O	-1	19923525
),	O	-1	19923525
2)	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
immedi@@	O	-1	19923525
ately	O	-1	19923525
after	O	-1	19923525
lear@@	O	-1	19923525
n@@	O	-1	19923525
ing,	O	-1	19923525
3@@	O	-1	19923525
)	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
3	O	-1	19923525
h	O	-1	19923525
after	O	-1	19923525
lear@@	O	-1	19923525
n@@	O	-1	19923525
ing,	O	-1	19923525
4@@	O	-1	19923525
)	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
and	O	-1	19923525
N@@	B-Chemical	D009553	19923525
I@@	I-Chemical	-1	19923525
M@@	I-Chemical	-1	19923525
O	I-Chemical	-1	19923525
,	O	-1	19923525
5@@	O	-1	19923525
)	O	-1	19923525
ve@@	O	-1	19923525
h@@	O	-1	19923525
ic@@	O	-1	19923525
le@@	O	-1	19923525
,	O	-1	19923525
and	O	-1	19923525
6@@	O	-1	19923525
)	O	-1	19923525
N@@	B-Chemical	D009553	19923525
I@@	I-Chemical	-1	19923525
M@@	I-Chemical	-1	19923525
O	I-Chemical	-1	19923525
al@@	O	-1	19923525
one.	O	-1	19923525
The	O	-1	19923525
ext@@	O	-1	19923525
ent	O	-1	19923525
of	O	-1	19923525
hypotension	B-Disease	D007022	19923525
and	O	-1	19923525
changes	O	-1	19923525
in	O	-1	19923525
brain	O	-1	19923525
tissue	O	-1	19923525
oxy@@	O	-1	19923525
gen@@	O	-1	19923525
ation	O	-1	19923525
(P@@	O	-1	19923525
b@@	O	-1	19923525
t@@	O	-1	19923525
O@@	O	-1	19923525
(2@@	O	-1	19923525
)@@	O	-1	19923525
)	O	-1	19923525
and	O	-1	19923525
in	O	-1	19923525
cerebral	O	-1	19923525
blood	O	-1	19923525
flow	O	-1	19923525
were	O	-1	19923525
studied	O	-1	19923525
in	O	-1	19923525
a	O	-1	19923525
se@@	O	-1	19923525
par@@	O	-1	19923525
ate	O	-1	19923525
group	O	-1	19923525
of	O	-1	19923525
anim@@	O	-1	19923525
al@@	O	-1	19923525
s.	O	-1	19923525
RESULTS:	O	-1	19923525
All	O	-1	19923525
groups	O	-1	19923525
ex@@	O	-1	19923525
hib@@	O	-1	19923525
ited	O	-1	19923525
similar	O	-1	19923525
tra@@	O	-1	19923525
in@@	O	-1	19923525
ing	O	-1	19923525
lat@@	O	-1	19923525
en@@	O	-1	19923525
ci@@	O	-1	19923525
es	O	-1	19923525
(1@@	O	-1	19923525
7.@@	O	-1	19923525
0	O	-1	19923525
+/-	O	-1	19923525
4.@@	O	-1	19923525
6	O	-1	19923525
s@@	O	-1	19923525
).	O	-1	19923525
M@@	O	-1	19923525
ic@@	O	-1	19923525
e	O	-1	19923525
subj@@	O	-1	19923525
ected	O	-1	19923525
to	O	-1	19923525
hypoten@@	B-Disease	D007022	19923525
sive	I-Disease	-1	19923525
episo@@	O	-1	19923525
des	O	-1	19923525
showed	O	-1	19923525
a	O	-1	19923525
significant	O	-1	19923525
decrease	O	-1	19923525
in	O	-1	19923525
lat@@	O	-1	19923525
ency	O	-1	19923525
time	O	-1	19923525
(1@@	O	-1	19923525
7@@	O	-1	19923525
8	O	-1	19923525
+/-	O	-1	19923525
1@@	O	-1	19923525
5@@	O	-1	19923525
6	O	-1	19923525
s)	O	-1	19923525
compared	O	-1	19923525
with	O	-1	19923525
those	O	-1	19923525
injected	O	-1	19923525
with	O	-1	19923525
sal@@	O	-1	19923525
ine,	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
+	O	-1	19923525
N@@	B-Chemical	D009553	19923525
I@@	I-Chemical	-1	19923525
M@@	I-Chemical	-1	19923525
O	I-Chemical	-1	19923525
,	O	-1	19923525
or	O	-1	19923525
del@@	O	-1	19923525
ayed	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
(5@@	O	-1	19923525
8@@	O	-1	19923525
0	O	-1	19923525
+/-	O	-1	19923525
8@@	O	-1	19923525
1	O	-1	19923525
s,	O	-1	19923525
55@@	O	-1	19923525
7	O	-1	19923525
+/-	O	-1	19923525
6@@	O	-1	19923525
7	O	-1	19923525
s,	O	-1	19923525
and	O	-1	19923525
4@@	O	-1	19923525
9@@	O	-1	19923525
3	O	-1	19923525
+/-	O	-1	19923525
14@@	O	-1	19923525
6	O	-1	19923525
s,	O	-1	19923525
respectivel@@	O	-1	19923525
y@@	O	-1	19923525
).	O	-1	19923525
A	O	-1	19923525
K@@	O	-1	19923525
r@@	O	-1	19923525
us@@	O	-1	19923525
k@@	O	-1	19923525
al@@	O	-1	19923525
-@@	O	-1	19923525
W@@	O	-1	19923525
all@@	O	-1	19923525
is	O	-1	19923525
1-@@	O	-1	19923525
w@@	O	-1	19923525
ay	O	-1	19923525
analysis	O	-1	19923525
of	O	-1	19923525
vari@@	O	-1	19923525
ance	O	-1	19923525
indic@@	O	-1	19923525
ated	O	-1	19923525
a	O	-1	19923525
significant	O	-1	19923525
difference	O	-1	19923525
among	O	-1	19923525
the	O	-1	19923525
4	O	-1	19923525
treatment	O	-1	19923525
groups	O	-1	19923525
(@@	O	-1	19923525
H	O	-1	19923525
=	O	-1	19923525
1@@	O	-1	19923525
5.@@	O	-1	19923525
34@@	O	-1	19923525
;	O	-1	19923525
P	O	-1	19923525
<	O	-1	19923525
0.00@@	O	-1	19923525
1).	O	-1	19923525
In	O	-1	19923525
a	O	-1	19923525
se@@	O	-1	19923525
par@@	O	-1	19923525
ate	O	-1	19923525
group	O	-1	19923525
of	O	-1	19923525
mice	O	-1	19923525
not	O	-1	19923525
subj@@	O	-1	19923525
ected	O	-1	19923525
to	O	-1	19923525
behavioral	O	-1	19923525
studi@@	O	-1	19923525
es,	O	-1	19923525
the	O	-1	19923525
same	O	-1	19923525
dose	O	-1	19923525
of	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
(n	O	-1	19923525
=	O	-1	19923525
3@@	O	-1	19923525
)	O	-1	19923525
and	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
+	O	-1	19923525
N@@	B-Chemical	D009553	19923525
I@@	I-Chemical	-1	19923525
M@@	I-Chemical	-1	19923525
O	I-Chemical	-1	19923525
(n	O	-1	19923525
=	O	-1	19923525
3@@	O	-1	19923525
)	O	-1	19923525
caused	O	-1	19923525
mean	O	-1	19923525
arterial	O	-1	19923525
blood	O	-1	19923525
pressure	O	-1	19923525
to	O	-1	19923525
decrease	O	-1	19923525
from	O	-1	19923525
8@@	O	-1	19923525
5.@@	O	-1	19923525
9	O	-1	19923525
+/-	O	-1	19923525
3.@@	O	-1	19923525
8	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g	O	-1	19923525
se@@	O	-1	19923525
m	O	-1	19923525
to	O	-1	19923525
3@@	O	-1	19923525
1.@@	O	-1	19923525
6	O	-1	19923525
+/-	O	-1	19923525
0.@@	O	-1	19923525
8	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g	O	-1	19923525
se@@	O	-1	19923525
m	O	-1	19923525
and	O	-1	19923525
from	O	-1	19923525
8@@	O	-1	19923525
6.@@	O	-1	19923525
2	O	-1	19923525
+/-	O	-1	19923525
3.@@	O	-1	19923525
7	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g	O	-1	19923525
se@@	O	-1	19923525
m	O	-1	19923525
to	O	-1	19923525
3@@	O	-1	19923525
2.@@	O	-1	19923525
6	O	-1	19923525
+/-	O	-1	19923525
0.@@	O	-1	19923525
2	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g	O	-1	19923525
se@@	O	-1	19923525
m@@	O	-1	19923525
,	O	-1	19923525
respectively.	O	-1	19923525
M@@	O	-1	19923525
e@@	O	-1	19923525
an	O	-1	19923525
arterial	O	-1	19923525
blood	O	-1	19923525
pressure	O	-1	19923525
in	O	-1	19923525
mice	O	-1	19923525
treated	O	-1	19923525
with	O	-1	19923525
N@@	B-Chemical	D009553	19923525
I@@	I-Chemical	-1	19923525
M@@	I-Chemical	-1	19923525
O	I-Chemical	-1	19923525
alone	O	-1	19923525
decreased	O	-1	19923525
from	O	-1	19923525
8@@	O	-1	19923525
8.@@	O	-1	19923525
1	O	-1	19923525
+/-	O	-1	19923525
3.@@	O	-1	19923525
8	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g	O	-1	19923525
to	O	-1	19923525
8@@	O	-1	19923525
0.@@	O	-1	19923525
0	O	-1	19923525
+/-	O	-1	19923525
2.@@	O	-1	19923525
9	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g@@	O	-1	19923525
.	O	-1	19923525
The	O	-1	19923525
inter@@	O	-1	19923525
group	O	-1	19923525
difference	O	-1	19923525
was	O	-1	19923525
statis@@	O	-1	19923525
tically	O	-1	19923525
significant	O	-1	19923525
(P	O	-1	19923525
<	O	-1	19923525
0.05@@	O	-1	19923525
).	O	-1	19923525
P@@	O	-1	19923525
b@@	O	-1	19923525
t@@	O	-1	19923525
O@@	O	-1	19923525
(2@@	O	-1	19923525
)	O	-1	19923525
decreased	O	-1	19923525
from	O	-1	19923525
5@@	O	-1	19923525
1.@@	O	-1	19923525
7	O	-1	19923525
+/-	O	-1	19923525
4.@@	O	-1	19923525
5	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g	O	-1	19923525
se@@	O	-1	19923525
m	O	-1	19923525
to	O	-1	19923525
3@@	O	-1	19923525
3.@@	O	-1	19923525
8	O	-1	19923525
+/-	O	-1	19923525
5.@@	O	-1	19923525
2	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g	O	-1	19923525
se@@	O	-1	19923525
m	O	-1	19923525
in	O	-1	19923525
the	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
group	O	-1	19923525
and	O	-1	19923525
from	O	-1	19923525
3@@	O	-1	19923525
8.@@	O	-1	19923525
6	O	-1	19923525
+/-	O	-1	19923525
6.@@	O	-1	19923525
1	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g	O	-1	19923525
se@@	O	-1	19923525
m	O	-1	19923525
to	O	-1	19923525
2@@	O	-1	19923525
5.@@	O	-1	19923525
4	O	-1	19923525
+/-	O	-1	19923525
2.@@	O	-1	19923525
0	O	-1	19923525
mm	O	-1	19923525
H@@	O	-1	19923525
g	O	-1	19923525
se@@	O	-1	19923525
m	O	-1	19923525
in	O	-1	19923525
the	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
+	O	-1	19923525
N@@	B-Chemical	D009553	19923525
I@@	I-Chemical	-1	19923525
M@@	I-Chemical	-1	19923525
O	I-Chemical	-1	19923525
group@@	O	-1	19923525
s,	O	-1	19923525
respectively.	O	-1	19923525
There	O	-1	19923525
were	O	-1	19923525
no	O	-1	19923525
significant	O	-1	19923525
differences	O	-1	19923525
among	O	-1	19923525
groups.	O	-1	19923525
CONCLUSION:	O	-1	19923525
In	O	-1	19923525
a	O	-1	19923525
P@@	O	-1	19923525
A	O	-1	19923525
re@@	O	-1	19923525
ten@@	O	-1	19923525
tion	O	-1	19923525
par@@	O	-1	19923525
a@@	O	-1	19923525
di@@	O	-1	19923525
g@@	O	-1	19923525
m@@	O	-1	19923525
,	O	-1	19923525
the	O	-1	19923525
injection	O	-1	19923525
of	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
immedi@@	O	-1	19923525
ately	O	-1	19923525
after	O	-1	19923525
lear@@	O	-1	19923525
ning	O	-1	19923525
produced	O	-1	19923525
a	O	-1	19923525
significant	O	-1	19923525
impair@@	O	-1	19923525
ment	O	-1	19923525
of	O	-1	19923525
long-term	O	-1	19923525
associ@@	O	-1	19923525
ative	O	-1	19923525
memory	O	-1	19923525
in	O	-1	19923525
mic@@	O	-1	19923525
e,	O	-1	19923525
whereas	O	-1	19923525
del@@	O	-1	19923525
ayed	O	-1	19923525
induced	O	-1	19923525
hypotension	B-Disease	D007022	19923525
had	O	-1	19923525
no	O	-1	19923525
effect@@	O	-1	19923525
.	O	-1	19923525
N@@	B-Chemical	D009553	19923525
I@@	I-Chemical	-1	19923525
M@@	I-Chemical	-1	19923525
O	I-Chemical	-1	19923525
attenu@@	O	-1	19923525
ated	O	-1	19923525
the	O	-1	19923525
dis@@	O	-1	19923525
ru@@	O	-1	19923525
ption	O	-1	19923525
in	O	-1	19923525
con@@	O	-1	19923525
sol@@	O	-1	19923525
id@@	O	-1	19923525
ation	O	-1	19923525
of	O	-1	19923525
long-term	O	-1	19923525
memory	O	-1	19923525
caused	O	-1	19923525
by	O	-1	19923525
N@@	B-Chemical	D005996	19923525
T@@	I-Chemical	-1	19923525
G	I-Chemical	-1	19923525
but	O	-1	19923525
did	O	-1	19923525
not	O	-1	19923525
impro@@	O	-1	19923525
ve	O	-1	19923525
lat@@	O	-1	19923525
ency	O	-1	19923525
in	O	-1	19923525
the	O	-1	19923525
absence	O	-1	19923525
of	O	-1	19923525
hypotension	B-Disease	D007022	19923525
.	O	-1	19923525
The	O	-1	19923525
observed	O	-1	19923525
effect	O	-1	19923525
of	O	-1	19923525
N@@	B-Chemical	D009553	19923525
I@@	I-Chemical	-1	19923525
M@@	I-Chemical	-1	19923525
O	I-Chemical	-1	19923525
may	O	-1	19923525
have	O	-1	19923525
been	O	-1	19923525
at@@	O	-1	19923525
tri@@	O	-1	19923525
but@@	O	-1	19923525
able	O	-1	19923525
to	O	-1	19923525
the	O	-1	19923525
pres@@	O	-1	19923525
er@@	O	-1	19923525
v@@	O	-1	19923525
ation	O	-1	19923525
of	O	-1	19923525
calcium	B-Chemical	D002118	19923525
ho@@	O	-1	19923525
me@@	O	-1	19923525
ost@@	O	-1	19923525
asis	O	-1	19923525
during	O	-1	19923525
hypotension	B-Disease	D007022	19923525
,	O	-1	19923525
because	O	-1	19923525
there	O	-1	19923525
were	O	-1	19923525
no	O	-1	19923525
differences	O	-1	19923525
in	O	-1	19923525
the	O	-1	19923525
P@@	O	-1	19923525
b@@	O	-1	19923525
t@@	O	-1	19923525
O@@	O	-1	19923525
(2@@	O	-1	19923525
)	O	-1	19923525
indic@@	O	-1	19923525
es	O	-1	19923525
among	O	-1	19923525
groups.	O	-1	19923525

F@@	O	-1	19058474
atal	O	-1	19058474
haem@@	B-Disease	D010490	19058474
o@@	I-Disease	-1	19058474
per@@	I-Disease	-1	19058474
ic@@	I-Disease	-1	19058474
ardi@@	I-Disease	-1	19058474
um	I-Disease	-1	19058474
and	O	-1	19058474
gast@@	B-Disease	D006471	19058474
ro@@	I-Disease	-1	19058474
in@@	I-Disease	-1	19058474
test@@	I-Disease	-1	19058474
inal	I-Disease	-1	19058474
haem@@	I-Disease	-1	19058474
or@@	I-Disease	-1	19058474
rh@@	I-Disease	-1	19058474
age	I-Disease	-1	19058474
due	O	-1	19058474
to	O	-1	19058474
possible	O	-1	19058474
inter@@	O	-1	19058474
action	O	-1	19058474
of	O	-1	19058474
c@@	O	-1	19058474
ran@@	O	-1	19058474
b@@	O	-1	19058474
er@@	O	-1	19058474
r@@	O	-1	19058474
y	O	-1	19058474
j@@	O	-1	19058474
u@@	O	-1	19058474
ic@@	O	-1	19058474
e	O	-1	19058474
with	O	-1	19058474
war@@	B-Chemical	D014859	19058474
farin	I-Chemical	-1	19058474
.	O	-1	19058474
We	O	-1	19058474
report	O	-1	19058474
a	O	-1	19058474
case	O	-1	19058474
of	O	-1	19058474
f@@	O	-1	19058474
atal	O	-1	19058474
inter@@	O	-1	19058474
n@@	O	-1	19058474
al	O	-1	19058474
haem@@	B-Disease	D006470	19058474
or@@	I-Disease	-1	19058474
rh@@	I-Disease	-1	19058474
age	I-Disease	-1	19058474
in	O	-1	19058474
an	O	-1	19058474
el@@	O	-1	19058474
der@@	O	-1	19058474
ly	O	-1	19058474
man	O	-1	19058474
who	O	-1	19058474
consum@@	O	-1	19058474
ed	O	-1	19058474
only	O	-1	19058474
c@@	O	-1	19058474
ran@@	O	-1	19058474
b@@	O	-1	19058474
er@@	O	-1	19058474
r@@	O	-1	19058474
y	O	-1	19058474
j@@	O	-1	19058474
u@@	O	-1	19058474
ic@@	O	-1	19058474
e	O	-1	19058474
for	O	-1	19058474
two	O	-1	19058474
weeks	O	-1	19058474
while	O	-1	19058474
maint@@	O	-1	19058474
aining	O	-1	19058474
h@@	O	-1	19058474
is	O	-1	19058474
us@@	O	-1	19058474
ual	O	-1	19058474
dos@@	O	-1	19058474
age	O	-1	19058474
of	O	-1	19058474
war@@	B-Chemical	D014859	19058474
farin	I-Chemical	-1	19058474
.	O	-1	19058474
We	O	-1	19058474
prop@@	O	-1	19058474
ose	O	-1	19058474
that	O	-1	19058474
n@@	O	-1	19058474
at@@	O	-1	19058474
ur@@	O	-1	19058474
ally	O	-1	19058474
occur@@	O	-1	19058474
r@@	O	-1	19058474
ing	O	-1	19058474
comp@@	O	-1	19058474
oun@@	O	-1	19058474
ds	O	-1	19058474
such	O	-1	19058474
as	O	-1	19058474
f@@	B-Chemical	D005419	19058474
l@@	I-Chemical	-1	19058474
av@@	I-Chemical	-1	19058474
on@@	I-Chemical	-1	19058474
oid@@	I-Chemical	-1	19058474
s	I-Chemical	-1	19058474
,	O	-1	19058474
which	O	-1	19058474
are	O	-1	19058474
present	O	-1	19058474
in	O	-1	19058474
f@@	O	-1	19058474
ru@@	O	-1	19058474
it	O	-1	19058474
j@@	O	-1	19058474
u@@	O	-1	19058474
ic@@	O	-1	19058474
es,	O	-1	19058474
may	O	-1	19058474
increase	O	-1	19058474
the	O	-1	19058474
poten@@	O	-1	19058474
c@@	O	-1	19058474
y	O	-1	19058474
of	O	-1	19058474
war@@	B-Chemical	D014859	19058474
farin	I-Chemical	-1	19058474
by	O	-1	19058474
comp@@	O	-1	19058474
et@@	O	-1	19058474
ing	O	-1	19058474
for	O	-1	19058474
the	O	-1	19058474
enzym@@	O	-1	19058474
es	O	-1	19058474
that	O	-1	19058474
norm@@	O	-1	19058474
ally	O	-1	19058474
in@@	O	-1	19058474
activ@@	O	-1	19058474
ate	O	-1	19058474
war@@	B-Chemical	D014859	19058474
farin	I-Chemical	-1	19058474
.	O	-1	19058474
W@@	O	-1	19058474
h@@	O	-1	19058474
ile	O	-1	19058474
t@@	O	-1	19058474
radi@@	O	-1	19058474
tion@@	O	-1	19058474
ally	O	-1	19058474
reg@@	O	-1	19058474
ar@@	O	-1	19058474
ded	O	-1	19058474
as	O	-1	19058474
fo@@	O	-1	19058474
o@@	O	-1	19058474
d@@	O	-1	19058474
st@@	O	-1	19058474
u@@	O	-1	19058474
ff@@	O	-1	19058474
s,	O	-1	19058474
consum@@	O	-1	19058474
ption	O	-1	19058474
of	O	-1	19058474
f@@	O	-1	19058474
ru@@	O	-1	19058474
it	O	-1	19058474
j@@	O	-1	19058474
u@@	O	-1	19058474
ic@@	O	-1	19058474
es	O	-1	19058474
should	O	-1	19058474
be	O	-1	19058474
considered	O	-1	19058474
when	O	-1	19058474
patients	O	-1	19058474
deve@@	O	-1	19058474
lo@@	O	-1	19058474
p	O	-1	19058474
adverse	O	-1	19058474
drug	O	-1	19058474
reac@@	O	-1	19058474
tions.	O	-1	19058474

I@@	B-Chemical	D007545	18808529
so@@	I-Chemical	-1	18808529
proteren@@	I-Chemical	-1	18808529
ol	I-Chemical	-1	18808529
induc@@	O	-1	18808529
es	O	-1	18808529
prim@@	O	-1	18808529
ary	O	-1	18808529
loss	O	-1	18808529
of	O	-1	18808529
dy@@	O	-1	18808529
stro@@	O	-1	18808529
ph@@	O	-1	18808529
in	O	-1	18808529
in	O	-1	18808529
rat	O	-1	18808529
hear@@	O	-1	18808529
t@@	O	-1	18808529
s:	O	-1	18808529
correl@@	O	-1	18808529
ation	O	-1	18808529
with	O	-1	18808529
myocardial	B-Disease	D009202	18808529
injury	I-Disease	-1	18808529
.	O	-1	18808529
The	O	-1	18808529
mechanism	O	-1	18808529
of	O	-1	18808529
isoproteren@@	B-Chemical	D007545	18808529
ol	I-Chemical	-1	18808529
-induced	O	-1	18808529
myocardial	B-Disease	D009202	18808529
damage	I-Disease	-1	18808529
is	O	-1	18808529
un@@	O	-1	18808529
know@@	O	-1	18808529
n@@	O	-1	18808529
,	O	-1	18808529
but	O	-1	18808529
a	O	-1	18808529
mis@@	O	-1	18808529
mat@@	O	-1	18808529
ch	O	-1	18808529
of	O	-1	18808529
oxy@@	B-Chemical	D010100	18808529
gen	I-Chemical	-1	18808529
sup@@	O	-1	18808529
p@@	O	-1	18808529
ly	O	-1	18808529
vs.	O	-1	18808529
de@@	O	-1	18808529
m@@	O	-1	18808529
and	O	-1	18808529
following	O	-1	18808529
coronary	O	-1	18808529
hypotension	B-Disease	D007022	18808529
and	O	-1	18808529
myocardial	B-Disease	D009202	18808529
hyperactivity	I-Disease	-1	18808529
is	O	-1	18808529
the	O	-1	18808529
b@@	O	-1	18808529
est	O	-1	18808529
expl@@	O	-1	18808529
an@@	O	-1	18808529
ation	O	-1	18808529
for	O	-1	18808529
the	O	-1	18808529
comple@@	O	-1	18808529
x	O	-1	18808529
morph@@	O	-1	18808529
ological	O	-1	18808529
al@@	O	-1	18808529
ter@@	O	-1	18808529
ations	O	-1	18808529
obser@@	O	-1	18808529
ved.	O	-1	18808529
S@@	O	-1	18808529
ev@@	O	-1	18808529
ere	O	-1	18808529
al@@	O	-1	18808529
ter@@	O	-1	18808529
ations	O	-1	18808529
in	O	-1	18808529
the	O	-1	18808529
struct@@	O	-1	18808529
ural	O	-1	18808529
in@@	O	-1	18808529
te@@	O	-1	18808529
g@@	O	-1	18808529
r@@	O	-1	18808529
ity	O	-1	18808529
of	O	-1	18808529
the	O	-1	18808529
s@@	O	-1	18808529
ar@@	O	-1	18808529
co@@	O	-1	18808529
le@@	O	-1	18808529
m@@	O	-1	18808529
ma	O	-1	18808529
of	O	-1	18808529
cardi@@	O	-1	18808529
om@@	O	-1	18808529
y@@	O	-1	18808529
ocy@@	O	-1	18808529
tes	O	-1	18808529
have	O	-1	18808529
been	O	-1	18808529
demonstrated	O	-1	18808529
to	O	-1	18808529
be	O	-1	18808529
caused	O	-1	18808529
by	O	-1	18808529
isoproteren@@	B-Chemical	D007545	18808529
ol	I-Chemical	-1	18808529
.	O	-1	18808529
T@@	O	-1	18808529
ak@@	O	-1	18808529
ing	O	-1	18808529
into	O	-1	18808529
ac@@	O	-1	18808529
coun@@	O	-1	18808529
t	O	-1	18808529
that	O	-1	18808529
the	O	-1	18808529
s@@	O	-1	18808529
ar@@	O	-1	18808529
co@@	O	-1	18808529
le@@	O	-1	18808529
mm@@	O	-1	18808529
al	O	-1	18808529
in@@	O	-1	18808529
te@@	O	-1	18808529
g@@	O	-1	18808529
r@@	O	-1	18808529
ity	O	-1	18808529
is	O	-1	18808529
st@@	O	-1	18808529
abil@@	O	-1	18808529
ized	O	-1	18808529
by	O	-1	18808529
the	O	-1	18808529
dy@@	O	-1	18808529
stro@@	O	-1	18808529
ph@@	O	-1	18808529
in-@@	O	-1	18808529
gly@@	O	-1	18808529
co@@	O	-1	18808529
protein	O	-1	18808529
comple@@	O	-1	18808529
x	O	-1	18808529
(D@@	O	-1	18808529
G@@	O	-1	18808529
C@@	O	-1	18808529
)	O	-1	18808529
that	O	-1	18808529
con@@	O	-1	18808529
n@@	O	-1	18808529
ects	O	-1	18808529
actin	O	-1	18808529
and	O	-1	18808529
l@@	O	-1	18808529
amin@@	O	-1	18808529
in	O	-1	18808529
in	O	-1	18808529
contrac@@	O	-1	18808529
ti@@	O	-1	18808529
le	O	-1	18808529
mac@@	O	-1	18808529
h@@	O	-1	18808529
in@@	O	-1	18808529
er@@	O	-1	18808529
y	O	-1	18808529
and	O	-1	18808529
extrac@@	O	-1	18808529
ell@@	O	-1	18808529
ular	O	-1	18808529
mat@@	O	-1	18808529
ri@@	O	-1	18808529
x	O	-1	18808529
and	O	-1	18808529
by	O	-1	18808529
in@@	O	-1	18808529
te@@	O	-1	18808529
g@@	O	-1	18808529
r@@	O	-1	18808529
in@@	O	-1	18808529
s,	O	-1	18808529
this	O	-1	18808529
study	O	-1	18808529
tests	O	-1	18808529
the	O	-1	18808529
hypo@@	O	-1	18808529
thesis	O	-1	18808529
that	O	-1	18808529
isoproteren@@	B-Chemical	D007545	18808529
ol	I-Chemical	-1	18808529
aff@@	O	-1	18808529
ects	O	-1	18808529
s@@	O	-1	18808529
ar@@	O	-1	18808529
co@@	O	-1	18808529
le@@	O	-1	18808529
mm@@	O	-1	18808529
al	O	-1	18808529
st@@	O	-1	18808529
ability	O	-1	18808529
through	O	-1	18808529
changes	O	-1	18808529
in	O	-1	18808529
the	O	-1	18808529
D@@	O	-1	18808529
G@@	O	-1	18808529
C	O	-1	18808529
and	O	-1	18808529
in@@	O	-1	18808529
te@@	O	-1	18808529
g@@	O	-1	18808529
r@@	O	-1	18808529
in@@	O	-1	18808529
s.	O	-1	18808529
We	O	-1	18808529
found	O	-1	18808529
different	O	-1	18808529
sensitivity	O	-1	18808529
of	O	-1	18808529
the	O	-1	18808529
D@@	O	-1	18808529
G@@	O	-1	18808529
C	O	-1	18808529
and	O	-1	18808529
in@@	O	-1	18808529
te@@	O	-1	18808529
g@@	O	-1	18808529
rin	O	-1	18808529
to	O	-1	18808529
isoproteren@@	B-Chemical	D007545	18808529
ol	I-Chemical	-1	18808529
sub@@	O	-1	18808529
c@@	O	-1	18808529
utaneous	O	-1	18808529
administr@@	O	-1	18808529
ation.	O	-1	18808529
Im@@	O	-1	18808529
mun@@	O	-1	18808529
o@@	O	-1	18808529
fluo@@	O	-1	18808529
res@@	O	-1	18808529
c@@	O	-1	18808529
ent	O	-1	18808529
st@@	O	-1	18808529
aining	O	-1	18808529
revealed	O	-1	18808529
that	O	-1	18808529
dy@@	O	-1	18808529
stro@@	O	-1	18808529
ph@@	O	-1	18808529
in	O	-1	18808529
is	O	-1	18808529
the	O	-1	18808529
most	O	-1	18808529
sensitive	O	-1	18808529
among	O	-1	18808529
the	O	-1	18808529
struct@@	O	-1	18808529
ures	O	-1	18808529
con@@	O	-1	18808529
n@@	O	-1	18808529
ect@@	O	-1	18808529
ing	O	-1	18808529
the	O	-1	18808529
actin	O	-1	18808529
in	O	-1	18808529
the	O	-1	18808529
cardi@@	O	-1	18808529
om@@	O	-1	18808529
y@@	O	-1	18808529
ocyte	O	-1	18808529
cy@@	O	-1	18808529
t@@	O	-1	18808529
os@@	O	-1	18808529
ke@@	O	-1	18808529
le@@	O	-1	18808529
t@@	O	-1	18808529
on	O	-1	18808529
and	O	-1	18808529
the	O	-1	18808529
extrac@@	O	-1	18808529
ell@@	O	-1	18808529
ular	O	-1	18808529
mat@@	O	-1	18808529
ri@@	O	-1	18808529
x@@	O	-1	18808529
.	O	-1	18808529
The	O	-1	18808529
s@@	O	-1	18808529
ar@@	O	-1	18808529
com@@	O	-1	18808529
er@@	O	-1	18808529
ic	O	-1	18808529
actin	O	-1	18808529
dis@@	O	-1	18808529
sol@@	O	-1	18808529
u@@	O	-1	18808529
tion	O	-1	18808529
occurred	O	-1	18808529
after	O	-1	18808529
the	O	-1	18808529
reduction	O	-1	18808529
or	O	-1	18808529
loss	O	-1	18808529
of	O	-1	18808529
dy@@	O	-1	18808529
stro@@	O	-1	18808529
ph@@	O	-1	18808529
in.	O	-1	18808529
S@@	O	-1	18808529
ub@@	O	-1	18808529
sequ@@	O	-1	18808529
ent@@	O	-1	18808529
ly,	O	-1	18808529
after	O	-1	18808529
ly@@	O	-1	18808529
sis	O	-1	18808529
of	O	-1	18808529
my@@	O	-1	18808529
of@@	O	-1	18808529
il@@	O	-1	18808529
am@@	O	-1	18808529
ent@@	O	-1	18808529
s,	O	-1	18808529
gamma@@	O	-1	18808529
-@@	O	-1	18808529
s@@	O	-1	18808529
ar@@	O	-1	18808529
co@@	O	-1	18808529
glyc@@	O	-1	18808529
an@@	O	-1	18808529
,	O	-1	18808529
beta-@@	O	-1	18808529
dy@@	O	-1	18808529
stro@@	O	-1	18808529
glyc@@	O	-1	18808529
an@@	O	-1	18808529
,	O	-1	18808529
beta@@	O	-1	18808529
1-@@	O	-1	18808529
in@@	O	-1	18808529
te@@	O	-1	18808529
g@@	O	-1	18808529
r@@	O	-1	18808529
in,	O	-1	18808529
and	O	-1	18808529
l@@	O	-1	18808529
amin@@	O	-1	18808529
in	O	-1	18808529
alpha-@@	O	-1	18808529
2	O	-1	18808529
ex@@	O	-1	18808529
pres@@	O	-1	18808529
sions	O	-1	18808529
were	O	-1	18808529
reduced	O	-1	18808529
followed	O	-1	18808529
by	O	-1	18808529
their	O	-1	18808529
b@@	O	-1	18808529
re@@	O	-1	18808529
ak@@	O	-1	18808529
do@@	O	-1	18808529
w@@	O	-1	18808529
n@@	O	-1	18808529
,	O	-1	18808529
as	O	-1	18808529
epi@@	O	-1	18808529
phen@@	O	-1	18808529
om@@	O	-1	18808529
en@@	O	-1	18808529
a	O	-1	18808529
of	O	-1	18808529
the	O	-1	18808529
my@@	O	-1	18808529
ocy@@	O	-1	18808529
t@@	O	-1	18808529
oly@@	O	-1	18808529
tic	O	-1	18808529
pro@@	O	-1	18808529
ces@@	O	-1	18808529
s.	O	-1	18808529
In	O	-1	18808529
concl@@	O	-1	18808529
u@@	O	-1	18808529
sion,	O	-1	18808529
administration	O	-1	18808529
of	O	-1	18808529
isoproteren@@	B-Chemical	D007545	18808529
ol	I-Chemical	-1	18808529
to	O	-1	18808529
rats	O	-1	18808529
results	O	-1	18808529
in	O	-1	18808529
prim@@	O	-1	18808529
ary	O	-1	18808529
loss	O	-1	18808529
of	O	-1	18808529
dy@@	O	-1	18808529
stro@@	O	-1	18808529
ph@@	O	-1	18808529
in,	O	-1	18808529
the	O	-1	18808529
most	O	-1	18808529
sensitive	O	-1	18808529
among	O	-1	18808529
the	O	-1	18808529
struct@@	O	-1	18808529
ural	O	-1	18808529
protein@@	O	-1	18808529
s	O	-1	18808529
that	O	-1	18808529
form	O	-1	18808529
the	O	-1	18808529
D@@	O	-1	18808529
G@@	O	-1	18808529
C	O	-1	18808529
that	O	-1	18808529
con@@	O	-1	18808529
n@@	O	-1	18808529
ects	O	-1	18808529
the	O	-1	18808529
extrac@@	O	-1	18808529
ell@@	O	-1	18808529
ular	O	-1	18808529
mat@@	O	-1	18808529
ri@@	O	-1	18808529
x	O	-1	18808529
and	O	-1	18808529
the	O	-1	18808529
cy@@	O	-1	18808529
t@@	O	-1	18808529
os@@	O	-1	18808529
ke@@	O	-1	18808529
le@@	O	-1	18808529
t@@	O	-1	18808529
on	O	-1	18808529
in	O	-1	18808529
cardi@@	O	-1	18808529
om@@	O	-1	18808529
y@@	O	-1	18808529
ocy@@	O	-1	18808529
te@@	O	-1	18808529
.	O	-1	18808529
These	O	-1	18808529
chang@@	O	-1	18808529
es,	O	-1	18808529
related	O	-1	18808529
to	O	-1	18808529
is@@	B-Disease	D007511	18808529
ch@@	I-Disease	-1	18808529
a@@	I-Disease	-1	18808529
em@@	I-Disease	-1	18808529
ic	I-Disease	-1	18808529
injury	I-Disease	-1	18808529
,	O	-1	18808529
expl@@	O	-1	18808529
ain	O	-1	18808529
the	O	-1	18808529
severe	O	-1	18808529
al@@	O	-1	18808529
ter@@	O	-1	18808529
ations	O	-1	18808529
in	O	-1	18808529
the	O	-1	18808529
struct@@	O	-1	18808529
ural	O	-1	18808529
in@@	O	-1	18808529
te@@	O	-1	18808529
g@@	O	-1	18808529
r@@	O	-1	18808529
ity	O	-1	18808529
of	O	-1	18808529
the	O	-1	18808529
s@@	O	-1	18808529
ar@@	O	-1	18808529
co@@	O	-1	18808529
le@@	O	-1	18808529
m@@	O	-1	18808529
ma	O	-1	18808529
of	O	-1	18808529
cardi@@	O	-1	18808529
om@@	O	-1	18808529
y@@	O	-1	18808529
ocy@@	O	-1	18808529
tes	O	-1	18808529
and	O	-1	18808529
h@@	O	-1	18808529
ence	O	-1	18808529
severe	O	-1	18808529
and	O	-1	18808529
ir@@	O	-1	18808529
reversible	O	-1	18808529
injury	O	-1	18808529
induced	O	-1	18808529
by	O	-1	18808529
isoproteren@@	B-Chemical	D007545	18808529
ol	I-Chemical	-1	18808529
.	O	-1	18808529

H@@	O	-1	18674790
i@@	O	-1	18674790
gh	O	-1	18674790
f@@	B-Chemical	D004041	18674790
at	I-Chemical	-1	18674790
di@@	O	-1	18674790
et@@	O	-1	18674790
-@@	O	-1	18674790
f@@	O	-1	18674790
ed	O	-1	18674790
ob@@	B-Disease	D009765	18674790
ese	I-Disease	-1	18674790
rats	O	-1	18674790
are	O	-1	18674790
high@@	O	-1	18674790
ly	O	-1	18674790
sensitive	O	-1	18674790
to	O	-1	18674790
dox@@	B-Chemical	D004317	18674790
orub@@	I-Chemical	-1	18674790
icin	I-Chemical	-1	18674790
-induced	O	-1	18674790
cardi@@	B-Disease	D066126	18674790
otoxicity	I-Disease	-1	18674790
.	O	-1	18674790
O@@	O	-1	18674790
f@@	O	-1	18674790
ten@@	O	-1	18674790
,	O	-1	18674790
chemotherapy	O	-1	18674790
by	O	-1	18674790
dox@@	B-Chemical	D004317	18674790
orub@@	I-Chemical	-1	18674790
icin	I-Chemical	-1	18674790
(	O	-1	18674790
Ad@@	B-Chemical	D004317	18674790
riam@@	I-Chemical	-1	18674790
ycin	I-Chemical	-1	18674790
)	O	-1	18674790
is	O	-1	18674790
lim@@	O	-1	18674790
ited	O	-1	18674790
due	O	-1	18674790
to	O	-1	18674790
lif@@	O	-1	18674790
e	O	-1	18674790
th@@	O	-1	18674790
reat@@	O	-1	18674790
en@@	O	-1	18674790
ing	O	-1	18674790
cardi@@	B-Disease	D066126	18674790
otoxicity	I-Disease	-1	18674790
in	O	-1	18674790
patients	O	-1	18674790
during	O	-1	18674790
and	O	-1	18674790
post@@	O	-1	18674790
therapy.	O	-1	18674790
Rec@@	O	-1	18674790
ent@@	O	-1	18674790
ly,	O	-1	18674790
we	O	-1	18674790
have	O	-1	18674790
shown	O	-1	18674790
that	O	-1	18674790
moder@@	O	-1	18674790
ate	O	-1	18674790
diet	O	-1	18674790
re@@	O	-1	18674790
stric@@	O	-1	18674790
tion	O	-1	18674790
re@@	O	-1	18674790
mark@@	O	-1	18674790
ably	O	-1	18674790
prot@@	O	-1	18674790
ects	O	-1	18674790
against	O	-1	18674790
dox@@	B-Chemical	D004317	18674790
orub@@	I-Chemical	-1	18674790
icin	I-Chemical	-1	18674790
-induced	O	-1	18674790
cardi@@	B-Disease	D066126	18674790
otoxicity	I-Disease	-1	18674790
.	O	-1	18674790
This	O	-1	18674790
cardio@@	O	-1	18674790
prot@@	O	-1	18674790
ection	O	-1	18674790
is	O	-1	18674790
ac@@	O	-1	18674790
comp@@	O	-1	18674790
an@@	O	-1	18674790
ied	O	-1	18674790
by	O	-1	18674790
decreased	O	-1	18674790
cardiac	O	-1	18674790
oxid@@	O	-1	18674790
ative	O	-1	18674790
stres@@	O	-1	18674790
s	O	-1	18674790
and	O	-1	18674790
tri@@	B-Chemical	D014280	18674790
glycer@@	I-Chemical	-1	18674790
i@@	I-Chemical	-1	18674790
des	I-Chemical	-1	18674790
and	O	-1	18674790
increased	O	-1	18674790
cardiac	O	-1	18674790
f@@	O	-1	18674790
at@@	O	-1	18674790
ty-@@	O	-1	18674790
acid	O	-1	18674790
oxid@@	O	-1	18674790
ation,	O	-1	18674790
AT@@	B-Chemical	D000255	18674790
P	I-Chemical	-1	18674790
syn@@	O	-1	18674790
the@@	O	-1	18674790
sis,	O	-1	18674790
and	O	-1	18674790
u@@	O	-1	18674790
pre@@	O	-1	18674790
g@@	O	-1	18674790
ul@@	O	-1	18674790
ated	O	-1	18674790
J@@	O	-1	18674790
A@@	O	-1	18674790
K@@	O	-1	18674790
/@@	O	-1	18674790
S@@	O	-1	18674790
T@@	O	-1	18674790
AT@@	O	-1	18674790
3	O	-1	18674790
path@@	O	-1	18674790
w@@	O	-1	18674790
a@@	O	-1	18674790
y.	O	-1	18674790
In	O	-1	18674790
the	O	-1	18674790
current	O	-1	18674790
study,	O	-1	18674790
we	O	-1	18674790
investigated	O	-1	18674790
whether	O	-1	18674790
a	O	-1	18674790
physi@@	O	-1	18674790
ological	O	-1	18674790
inter@@	O	-1	18674790
ven@@	O	-1	18674790
tion	O	-1	18674790
by	O	-1	18674790
fe@@	O	-1	18674790
ed@@	O	-1	18674790
ing	O	-1	18674790
4@@	O	-1	18674790
0%	O	-1	18674790
high	O	-1	18674790
f@@	B-Chemical	D004041	18674790
at	I-Chemical	-1	18674790
diet	O	-1	18674790
(@@	O	-1	18674790
H@@	O	-1	18674790
F@@	O	-1	18674790
D@@	O	-1	18674790
),	O	-1	18674790
which	O	-1	18674790
induc@@	O	-1	18674790
es	O	-1	18674790
ob@@	B-Disease	D009765	18674790
es@@	I-Disease	-1	18674790
ity	I-Disease	-1	18674790
in	O	-1	18674790
male	O	-1	18674790
S@@	O	-1	18674790
pra@@	O	-1	18674790
gu@@	O	-1	18674790
e-@@	O	-1	18674790
D@@	O	-1	18674790
aw@@	O	-1	18674790
le@@	O	-1	18674790
y	O	-1	18674790
rats	O	-1	18674790
(2@@	O	-1	18674790
50@@	O	-1	18674790
-@@	O	-1	18674790
27@@	O	-1	18674790
5	O	-1	18674790
g@@	O	-1	18674790
),	O	-1	18674790
sensi@@	O	-1	18674790
tiz@@	O	-1	18674790
es	O	-1	18674790
to	O	-1	18674790
dox@@	B-Chemical	D004317	18674790
orub@@	I-Chemical	-1	18674790
icin	I-Chemical	-1	18674790
-induced	O	-1	18674790
cardi@@	B-Disease	D066126	18674790
otoxicity	I-Disease	-1	18674790
.	O	-1	18674790
A	O	-1	18674790
L@@	O	-1	18674790
D@@	O	-1	18674790
(@@	O	-1	18674790
10@@	O	-1	18674790
)	O	-1	18674790
dose	O	-1	18674790
(@@	O	-1	18674790
8	O	-1	18674790
mg	O	-1	18674790
dox@@	B-Chemical	D004317	18674790
orub@@	I-Chemical	-1	18674790
icin	I-Chemical	-1	18674790
/@@	O	-1	18674790
kg@@	O	-1	18674790
,	O	-1	18674790
ip@@	O	-1	18674790
)	O	-1	18674790
administered	O	-1	18674790
on	O	-1	18674790
day	O	-1	18674790
4@@	O	-1	18674790
3	O	-1	18674790
of	O	-1	18674790
the	O	-1	18674790
H@@	O	-1	18674790
F@@	O	-1	18674790
D	O	-1	18674790
fe@@	O	-1	18674790
ed@@	O	-1	18674790
ing	O	-1	18674790
regi@@	O	-1	18674790
men	O	-1	18674790
l@@	O	-1	18674790
ed	O	-1	18674790
to	O	-1	18674790
higher	O	-1	18674790
cardi@@	B-Disease	D066126	18674790
otoxicity	I-Disease	-1	18674790
,	O	-1	18674790
cardiac	B-Disease	D006331	18674790
dysfunction	I-Disease	-1	18674790
,	O	-1	18674790
li@@	O	-1	18674790
pid	O	-1	18674790
per@@	O	-1	18674790
oxid@@	O	-1	18674790
ation,	O	-1	18674790
and	O	-1	18674790
8@@	O	-1	18674790
0%	O	-1	18674790
mor@@	O	-1	18674790
t@@	O	-1	18674790
ality	O	-1	18674790
in	O	-1	18674790
the	O	-1	18674790
ob@@	B-Disease	D009765	18674790
ese	I-Disease	-1	18674790
(	O	-1	18674790
O@@	B-Disease	D009765	18674790
B	I-Disease	-1	18674790
)	O	-1	18674790
rats	O	-1	18674790
in	O	-1	18674790
the	O	-1	18674790
absence	O	-1	18674790
of	O	-1	18674790
any	O	-1	18674790
significant	O	-1	18674790
renal	B-Disease	D007674	18674790
or	I-Disease	-1	18674790
hepatic	I-Disease	-1	18674790
toxicity	I-Disease	-1	18674790
renal	B-Disease	D056486	18674790
or	I-Disease	-1	18674790
hepatic	I-Disease	-1	18674790
toxicity	I-Disease	-1	18674790
.	O	-1	18674790
D@@	B-Chemical	D004317	18674790
ox@@	I-Chemical	-1	18674790
orub@@	I-Chemical	-1	18674790
icin	I-Chemical	-1	18674790
toxic@@	O	-1	18674790
o@@	O	-1	18674790
kine@@	O	-1	18674790
tics	O	-1	18674790
studies	O	-1	18674790
revealed	O	-1	18674790
no	O	-1	18674790
change	O	-1	18674790
in	O	-1	18674790
accum@@	O	-1	18674790
ulation	O	-1	18674790
of	O	-1	18674790
dox@@	B-Chemical	D004317	18674790
orub@@	I-Chemical	-1	18674790
icin	I-Chemical	-1	18674790
and	O	-1	18674790
dox@@	B-Chemical	C010013	18674790
orub@@	I-Chemical	-1	18674790
ic@@	I-Chemical	-1	18674790
in@@	I-Chemical	-1	18674790
ol	I-Chemical	-1	18674790
(@@	O	-1	18674790
toxic	O	-1	18674790
metabol@@	O	-1	18674790
it@@	O	-1	18674790
e@@	O	-1	18674790
)	O	-1	18674790
in	O	-1	18674790
the	O	-1	18674790
normal	O	-1	18674790
di@@	O	-1	18674790
et@@	O	-1	18674790
-@@	O	-1	18674790
f@@	O	-1	18674790
ed	O	-1	18674790
(N@@	O	-1	18674790
D)	O	-1	18674790
and	O	-1	18674790
O@@	B-Disease	D009765	18674790
B	I-Disease	-1	18674790
hear@@	O	-1	18674790
t@@	O	-1	18674790
s.	O	-1	18674790
M@@	O	-1	18674790
echan@@	O	-1	18674790
istic	O	-1	18674790
studies	O	-1	18674790
revealed	O	-1	18674790
that	O	-1	18674790
O@@	B-Disease	D009765	18674790
B	I-Disease	-1	18674790
rats	O	-1	18674790
are	O	-1	18674790
sensi@@	O	-1	18674790
tiz@@	O	-1	18674790
ed	O	-1	18674790
due	O	-1	18674790
to@@	O	-1	18674790
:	O	-1	18674790
(1@@	O	-1	18674790
)	O	-1	18674790
higher	O	-1	18674790
oxy@@	O	-1	18674790
ra@@	O	-1	18674790
d@@	O	-1	18674790
ical	O	-1	18674790
stres@@	O	-1	18674790
s	O	-1	18674790
lead@@	O	-1	18674790
ing	O	-1	18674790
to	O	-1	18674790
u@@	O	-1	18674790
pre@@	O	-1	18674790
g@@	O	-1	18674790
ulation	O	-1	18674790
of	O	-1	18674790
un@@	O	-1	18674790
co@@	O	-1	18674790
u@@	O	-1	18674790
pl@@	O	-1	18674790
ing	O	-1	18674790
protein@@	O	-1	18674790
s	O	-1	18674790
2	O	-1	18674790
and	O	-1	18674790
3,	O	-1	18674790
(2@@	O	-1	18674790
)	O	-1	18674790
do@@	O	-1	18674790
w@@	O	-1	18674790
n@@	O	-1	18674790
reg@@	O	-1	18674790
ulation	O	-1	18674790
of	O	-1	18674790
cardiac	O	-1	18674790
per@@	O	-1	18674790
ox@@	O	-1	18674790
is@@	O	-1	18674790
ome	O	-1	18674790
pro@@	O	-1	18674790
li@@	O	-1	18674790
fer@@	O	-1	18674790
at@@	O	-1	18674790
ors	O	-1	18674790
activ@@	O	-1	18674790
ated	O	-1	18674790
receptor@@	O	-1	18674790
-@@	O	-1	18674790
alpha@@	O	-1	18674790
,	O	-1	18674790
(3@@	O	-1	18674790
)	O	-1	18674790
decreased	O	-1	18674790
plasma	O	-1	18674790
a@@	O	-1	18674790
di@@	O	-1	18674790
p@@	O	-1	18674790
on@@	O	-1	18674790
ecti@@	O	-1	18674790
n	O	-1	18674790
level@@	O	-1	18674790
s,	O	-1	18674790
(4@@	O	-1	18674790
)	O	-1	18674790
decreased	O	-1	18674790
cardiac	O	-1	18674790
f@@	O	-1	18674790
at@@	O	-1	18674790
ty-@@	O	-1	18674790
acid	O	-1	18674790
oxid@@	O	-1	18674790
ation	O	-1	18674790
(6@@	O	-1	18674790
6@@	O	-1	18674790
6.@@	O	-1	18674790
9@@	O	-1	18674790
+/@@	O	-1	18674790
-1@@	O	-1	18674790
4.@@	O	-1	18674790
0	O	-1	18674790
n@@	O	-1	18674790
mol@@	O	-1	18674790
/@@	O	-1	18674790
min@@	O	-1	18674790
/@@	O	-1	18674790
g	O	-1	18674790
heart	O	-1	18674790
in	O	-1	18674790
N@@	O	-1	18674790
D	O	-1	18674790
versus	O	-1	18674790
4@@	O	-1	18674790
0@@	O	-1	18674790
0.@@	O	-1	18674790
2@@	O	-1	18674790
+/@@	O	-1	18674790
-1@@	O	-1	18674790
1.@@	O	-1	18674790
8	O	-1	18674790
n@@	O	-1	18674790
mol@@	O	-1	18674790
/@@	O	-1	18674790
min@@	O	-1	18674790
/@@	O	-1	18674790
g	O	-1	18674790
heart	O	-1	18674790
in	O	-1	18674790
O@@	B-Disease	D009765	18674790
B	I-Disease	-1	18674790
),	O	-1	18674790
(5@@	O	-1	18674790
)	O	-1	18674790
decreased	O	-1	18674790
mitochondrial	O	-1	18674790
AM@@	B-Chemical	D000249	18674790
P	I-Chemical	-1	18674790
-@@	O	-1	18674790
alpha@@	O	-1	18674790
2	O	-1	18674790
protein	O	-1	18674790
kin@@	O	-1	18674790
ase,	O	-1	18674790
and	O	-1	18674790
(6@@	O	-1	18674790
)	O	-1	18674790
8@@	O	-1	18674790
6%	O	-1	18674790
dro@@	O	-1	18674790
p	O	-1	18674790
in	O	-1	18674790
cardiac	O	-1	18674790
AT@@	B-Chemical	D000255	18674790
P	I-Chemical	-1	18674790
levels	O	-1	18674790
ac@@	O	-1	18674790
comp@@	O	-1	18674790
an@@	O	-1	18674790
ied	O	-1	18674790
by	O	-1	18674790
decreased	O	-1	18674790
AT@@	B-Chemical	D000255	18674790
P	I-Chemical	-1	18674790
/	O	-1	18674790
AD@@	B-Chemical	D000244	18674790
P	I-Chemical	-1	18674790
rati@@	O	-1	18674790
o	O	-1	18674790
after	O	-1	18674790
dox@@	B-Chemical	D004317	18674790
orub@@	I-Chemical	-1	18674790
icin	I-Chemical	-1	18674790
administr@@	O	-1	18674790
ation.	O	-1	18674790
D@@	O	-1	18674790
ec@@	O	-1	18674790
reas@@	O	-1	18674790
ed	O	-1	18674790
cardiac	O	-1	18674790
erythro@@	O	-1	18674790
po@@	O	-1	18674790
i@@	O	-1	18674790
e@@	O	-1	18674790
tin	O	-1	18674790
and	O	-1	18674790
increased	O	-1	18674790
S@@	O	-1	18674790
O@@	O	-1	18674790
C@@	O	-1	18674790
S@@	O	-1	18674790
3	O	-1	18674790
further	O	-1	18674790
do@@	O	-1	18674790
w@@	O	-1	18674790
n@@	O	-1	18674790
reg@@	O	-1	18674790
ul@@	O	-1	18674790
ated	O	-1	18674790
the	O	-1	18674790
cardio@@	O	-1	18674790
protective	O	-1	18674790
J@@	O	-1	18674790
A@@	O	-1	18674790
K@@	O	-1	18674790
/@@	O	-1	18674790
S@@	O	-1	18674790
T@@	O	-1	18674790
AT@@	O	-1	18674790
3	O	-1	18674790
path@@	O	-1	18674790
w@@	O	-1	18674790
a@@	O	-1	18674790
y.	O	-1	18674790
In	O	-1	18674790
concl@@	O	-1	18674790
u@@	O	-1	18674790
sion,	O	-1	18674790
H@@	O	-1	18674790
F@@	O	-1	18674790
D@@	O	-1	18674790
-induced	O	-1	18674790
ob@@	B-Disease	D009765	18674790
ese	I-Disease	-1	18674790
rats	O	-1	18674790
are	O	-1	18674790
high@@	O	-1	18674790
ly	O	-1	18674790
sensi@@	O	-1	18674790
tiz@@	O	-1	18674790
ed	O	-1	18674790
to	O	-1	18674790
dox@@	B-Chemical	D004317	18674790
orub@@	I-Chemical	-1	18674790
icin	I-Chemical	-1	18674790
-induced	O	-1	18674790
cardi@@	B-Disease	D066126	18674790
otoxicity	I-Disease	-1	18674790
by	O	-1	18674790
subst@@	O	-1	18674790
anti@@	O	-1	18674790
ally	O	-1	18674790
do@@	O	-1	18674790
w@@	O	-1	18674790
n@@	O	-1	18674790
reg@@	O	-1	18674790
ul@@	O	-1	18674790
ating	O	-1	18674790
cardiac	O	-1	18674790
mitochondrial	O	-1	18674790
AT@@	B-Chemical	D000255	18674790
P	I-Chemical	-1	18674790
gener@@	O	-1	18674790
ation,	O	-1	18674790
increas@@	O	-1	18674790
ing	O	-1	18674790
oxid@@	O	-1	18674790
ative	O	-1	18674790
stres@@	O	-1	18674790
s	O	-1	18674790
and	O	-1	18674790
do@@	O	-1	18674790
w@@	O	-1	18674790
n@@	O	-1	18674790
reg@@	O	-1	18674790
ul@@	O	-1	18674790
ating	O	-1	18674790
the	O	-1	18674790
J@@	O	-1	18674790
A@@	O	-1	18674790
K@@	O	-1	18674790
/@@	O	-1	18674790
S@@	O	-1	18674790
T@@	O	-1	18674790
AT@@	O	-1	18674790
3	O	-1	18674790
path@@	O	-1	18674790
w@@	O	-1	18674790
a@@	O	-1	18674790
y.	O	-1	18674790

Com@@	O	-1	18441470
ple@@	O	-1	18441470
te	O	-1	18441470
atri@@	B-Disease	D054537	18441470
o@@	I-Disease	-1	18441470
ventricular	I-Disease	-1	18441470
bloc@@	I-Disease	-1	18441470
k	I-Disease	-1	18441470
secondary	O	-1	18441470
to	O	-1	18441470
lithium	B-Chemical	D008094	18441470
therapy.	O	-1	18441470
S@@	B-Disease	D012804	18441470
in@@	I-Disease	-1	18441470
us	I-Disease	-1	18441470
no@@	I-Disease	-1	18441470
de	I-Disease	-1	18441470
dysfunction	I-Disease	-1	18441470
has	O	-1	18441470
been	O	-1	18441470
reported	O	-1	18441470
most	O	-1	18441470
frequ@@	O	-1	18441470
ently	O	-1	18441470
among	O	-1	18441470
the	O	-1	18441470
adverse	O	-1	18441470
cardiovascular	O	-1	18441470
effects	O	-1	18441470
of	O	-1	18441470
lithium	B-Chemical	D008094	18441470
.	O	-1	18441470
In	O	-1	18441470
the	O	-1	18441470
present	O	-1	18441470
cas@@	O	-1	18441470
e,	O	-1	18441470
complete	O	-1	18441470
atri@@	B-Disease	D054537	18441470
o@@	I-Disease	-1	18441470
ventricular	I-Disease	-1	18441470
(A@@	I-Disease	-1	18441470
V@@	I-Disease	-1	18441470
)	I-Disease	-1	18441470
bloc@@	I-Disease	-1	18441470
k	I-Disease	-1	18441470
with	O	-1	18441470
syn@@	B-Disease	D013575	18441470
co@@	I-Disease	-1	18441470
p@@	I-Disease	-1	18441470
al	I-Disease	-1	18441470
at@@	I-Disease	-1	18441470
tac@@	I-Disease	-1	18441470
k@@	I-Disease	-1	18441470
s	I-Disease	-1	18441470
developed	O	-1	18441470
secondary	O	-1	18441470
to	O	-1	18441470
lithium	B-Chemical	D008094	18441470
therapy,	O	-1	18441470
nec@@	O	-1	18441470
ess@@	O	-1	18441470
it@@	O	-1	18441470
ating	O	-1	18441470
per@@	O	-1	18441470
man@@	O	-1	18441470
ent	O	-1	18441470
pac@@	O	-1	18441470
em@@	O	-1	18441470
ak@@	O	-1	18441470
er	O	-1	18441470
im@@	O	-1	18441470
pl@@	O	-1	18441470
ant@@	O	-1	18441470
ation.	O	-1	18441470
S@@	O	-1	18441470
er@@	O	-1	18441470
um	O	-1	18441470
lithium	B-Chemical	D008094	18441470
levels	O	-1	18441470
remained	O	-1	18441470
under	O	-1	18441470
or	O	-1	18441470
within	O	-1	18441470
the	O	-1	18441470
therapeutic	O	-1	18441470
range	O	-1	18441470
during	O	-1	18441470
the	O	-1	18441470
syn@@	B-Disease	D013575	18441470
co@@	I-Disease	-1	18441470
p@@	I-Disease	-1	18441470
al	I-Disease	-1	18441470
at@@	I-Disease	-1	18441470
tac@@	I-Disease	-1	18441470
k@@	I-Disease	-1	18441470
s	I-Disease	-1	18441470
.	O	-1	18441470
L@@	B-Chemical	D008094	18441470
i@@	I-Chemical	-1	18441470
thi@@	I-Chemical	-1	18441470
um	I-Chemical	-1	18441470
should	O	-1	18441470
be	O	-1	18441470
used	O	-1	18441470
with	O	-1	18441470
ex@@	O	-1	18441470
trem@@	O	-1	18441470
e	O	-1	18441470
cau@@	O	-1	18441470
tion,	O	-1	18441470
es@@	O	-1	18441470
p@@	O	-1	18441470
ec@@	O	-1	18441470
i@@	O	-1	18441470
ally	O	-1	18441470
in	O	-1	18441470
patients	O	-1	18441470
with	O	-1	18441470
mil@@	O	-1	18441470
d	O	-1	18441470
dist@@	O	-1	18441470
urb@@	O	-1	18441470
ance	O	-1	18441470
of	O	-1	18441470
A@@	O	-1	18441470
V	O	-1	18441470
con@@	O	-1	18441470
duc@@	O	-1	18441470
tion.	O	-1	18441470

Ne@@	B-Disease	D009459	17366349
uro@@	I-Disease	-1	17366349
le@@	I-Disease	-1	17366349
p@@	I-Disease	-1	17366349
tic	I-Disease	-1	17366349
mal@@	I-Disease	-1	17366349
i@@	I-Disease	-1	17366349
gn@@	I-Disease	-1	17366349
ant	I-Disease	-1	17366349
syndrome	I-Disease	-1	17366349
induced	O	-1	17366349
by	O	-1	17366349
z@@	B-Chemical	C092292	17366349
ip@@	I-Chemical	-1	17366349
ra@@	I-Chemical	-1	17366349
si@@	I-Chemical	-1	17366349
d@@	I-Chemical	-1	17366349
one	I-Chemical	-1	17366349
on	O	-1	17366349
the	O	-1	17366349
second	O	-1	17366349
day	O	-1	17366349
of	O	-1	17366349
treatment.	O	-1	17366349
Ne@@	B-Disease	D009459	17366349
uro@@	I-Disease	-1	17366349
le@@	I-Disease	-1	17366349
p@@	I-Disease	-1	17366349
tic	I-Disease	-1	17366349
mal@@	I-Disease	-1	17366349
i@@	I-Disease	-1	17366349
gn@@	I-Disease	-1	17366349
ant	I-Disease	-1	17366349
syndrome	I-Disease	-1	17366349
(	O	-1	17366349
N@@	B-Disease	D009459	17366349
M@@	I-Disease	-1	17366349
S	I-Disease	-1	17366349
)	O	-1	17366349
is	O	-1	17366349
the	O	-1	17366349
ra@@	O	-1	17366349
res@@	O	-1	17366349
t	O	-1	17366349
and	O	-1	17366349
most	O	-1	17366349
seri@@	O	-1	17366349
ous	O	-1	17366349
of	O	-1	17366349
the	O	-1	17366349
neuro@@	O	-1	17366349
le@@	O	-1	17366349
p@@	O	-1	17366349
tic@@	O	-1	17366349
-induced	O	-1	17366349
mo@@	B-Disease	D009069	17366349
vement	I-Disease	-1	17366349
disorder@@	I-Disease	-1	17366349
s	I-Disease	-1	17366349
.	O	-1	17366349
We	O	-1	17366349
describe	O	-1	17366349
a	O	-1	17366349
case	O	-1	17366349
of	O	-1	17366349
neuro@@	B-Disease	D009459	17366349
le@@	I-Disease	-1	17366349
p@@	I-Disease	-1	17366349
tic	I-Disease	-1	17366349
mal@@	I-Disease	-1	17366349
i@@	I-Disease	-1	17366349
gn@@	I-Disease	-1	17366349
ant	I-Disease	-1	17366349
syndrome	I-Disease	-1	17366349
(	O	-1	17366349
N@@	B-Disease	D009459	17366349
M@@	I-Disease	-1	17366349
S	I-Disease	-1	17366349
)	O	-1	17366349
associated	O	-1	17366349
with	O	-1	17366349
the	O	-1	17366349
use	O	-1	17366349
of	O	-1	17366349
z@@	B-Chemical	C092292	17366349
ip@@	I-Chemical	-1	17366349
ra@@	I-Chemical	-1	17366349
si@@	I-Chemical	-1	17366349
d@@	I-Chemical	-1	17366349
one	I-Chemical	-1	17366349
.	O	-1	17366349
Although	O	-1	17366349
con@@	O	-1	17366349
ven@@	O	-1	17366349
tional	O	-1	17366349
neuro@@	O	-1	17366349
le@@	O	-1	17366349
p@@	O	-1	17366349
tics	O	-1	17366349
are	O	-1	17366349
more	O	-1	17366349
frequ@@	O	-1	17366349
ently	O	-1	17366349
associated	O	-1	17366349
with	O	-1	17366349
N@@	B-Disease	D009459	17366349
M@@	I-Disease	-1	17366349
S	I-Disease	-1	17366349
,	O	-1	17366349
at@@	O	-1	17366349
yp@@	O	-1	17366349
ical	O	-1	17366349
anti@@	O	-1	17366349
psycho@@	O	-1	17366349
tic	O	-1	17366349
drugs	O	-1	17366349
like	O	-1	17366349
z@@	B-Chemical	C092292	17366349
ip@@	I-Chemical	-1	17366349
ra@@	I-Chemical	-1	17366349
si@@	I-Chemical	-1	17366349
d@@	I-Chemical	-1	17366349
one	I-Chemical	-1	17366349
may	O	-1	17366349
also	O	-1	17366349
be	O	-1	17366349
a	O	-1	17366349
ca@@	O	-1	17366349
use.	O	-1	17366349
The	O	-1	17366349
patient	O	-1	17366349
is	O	-1	17366349
a	O	-1	17366349
2@@	O	-1	17366349
4-@@	O	-1	17366349
year-old	O	-1	17366349
male	O	-1	17366349
with	O	-1	17366349
a	O	-1	17366349
hist@@	O	-1	17366349
ory	O	-1	17366349
of	O	-1	17366349
sch@@	B-Disease	D012559	17366349
iz@@	I-Disease	-1	17366349
oph@@	I-Disease	-1	17366349
ren@@	I-Disease	-1	17366349
ia	I-Disease	-1	17366349
who	O	-1	17366349
developed	O	-1	17366349
signs	O	-1	17366349
and	O	-1	17366349
symptoms	O	-1	17366349
of	O	-1	17366349
N@@	B-Disease	D009459	17366349
M@@	I-Disease	-1	17366349
S	I-Disease	-1	17366349
after	O	-1	17366349
2	O	-1	17366349
days	O	-1	17366349
of	O	-1	17366349
treatment	O	-1	17366349
with	O	-1	17366349
an	O	-1	17366349
8@@	O	-1	17366349
0-@@	O	-1	17366349
mg/@@	O	-1	17366349
day	O	-1	17366349
dose	O	-1	17366349
of	O	-1	17366349
or@@	O	-1	17366349
ally	O	-1	17366349
administr@@	O	-1	17366349
ated	O	-1	17366349
z@@	B-Chemical	C092292	17366349
ip@@	I-Chemical	-1	17366349
ra@@	I-Chemical	-1	17366349
si@@	I-Chemical	-1	17366349
d@@	I-Chemical	-1	17366349
one	I-Chemical	-1	17366349
.	O	-1	17366349
This	O	-1	17366349
case	O	-1	17366349
is	O	-1	17366349
the	O	-1	17366349
ear@@	O	-1	17366349
li@@	O	-1	17366349
est	O	-1	17366349
(@@	O	-1	17366349
second	O	-1	17366349
day	O	-1	17366349
of	O	-1	17366349
treatment@@	O	-1	17366349
)	O	-1	17366349
N@@	B-Disease	D009459	17366349
M@@	I-Disease	-1	17366349
S	I-Disease	-1	17366349
due	O	-1	17366349
to	O	-1	17366349
z@@	B-Chemical	C092292	17366349
ip@@	I-Chemical	-1	17366349
ra@@	I-Chemical	-1	17366349
si@@	I-Chemical	-1	17366349
d@@	I-Chemical	-1	17366349
one	I-Chemical	-1	17366349
reported	O	-1	17366349
in	O	-1	17366349
the	O	-1	17366349
literat@@	O	-1	17366349
ure.	O	-1	17366349

R@@	O	-1	16584858
ole	O	-1	16584858
of	O	-1	16584858
m@@	B-Chemical	C013592	16584858
ang@@	I-Chemical	-1	16584858
if@@	I-Chemical	-1	16584858
er@@	I-Chemical	-1	16584858
in	I-Chemical	-1	16584858
on	O	-1	16584858
bio@@	O	-1	16584858
chemical	O	-1	16584858
al@@	O	-1	16584858
ter@@	O	-1	16584858
ations	O	-1	16584858
and	O	-1	16584858
anti@@	O	-1	16584858
oxid@@	O	-1	16584858
ant	O	-1	16584858
status	O	-1	16584858
in	O	-1	16584858
isoproteren@@	B-Chemical	D007545	16584858
ol	I-Chemical	-1	16584858
-induced	O	-1	16584858
myocardial	B-Disease	D009203	16584858
infarction	I-Disease	-1	16584858
in	O	-1	16584858
rats.	O	-1	16584858
The	O	-1	16584858
current	O	-1	16584858
study	O	-1	16584858
de@@	O	-1	16584858
al@@	O	-1	16584858
t	O	-1	16584858
with	O	-1	16584858
the	O	-1	16584858
protective	O	-1	16584858
role	O	-1	16584858
of	O	-1	16584858
m@@	B-Chemical	C013592	16584858
ang@@	I-Chemical	-1	16584858
if@@	I-Chemical	-1	16584858
er@@	I-Chemical	-1	16584858
in	I-Chemical	-1	16584858
,	O	-1	16584858
a	O	-1	16584858
poly@@	B-Chemical	D059808	16584858
phen@@	I-Chemical	-1	16584858
ol	I-Chemical	-1	16584858
from	O	-1	16584858
M@@	O	-1	16584858
ang@@	O	-1	16584858
if@@	O	-1	16584858
er@@	O	-1	16584858
a	O	-1	16584858
indic@@	O	-1	16584858
a	O	-1	16584858
L@@	O	-1	16584858
in@@	O	-1	16584858
n@@	O	-1	16584858
.	O	-1	16584858
(A@@	O	-1	16584858
n@@	O	-1	16584858
ac@@	O	-1	16584858
ardi@@	O	-1	16584858
ace@@	O	-1	16584858
a@@	O	-1	16584858
e@@	O	-1	16584858
),	O	-1	16584858
on	O	-1	16584858
isoproteren@@	B-Chemical	D007545	16584858
ol	I-Chemical	-1	16584858
(	O	-1	16584858
I@@	B-Chemical	D007545	16584858
S@@	I-Chemical	-1	16584858
P@@	I-Chemical	-1	16584858
H	I-Chemical	-1	16584858
)@@	O	-1	16584858
-induced	O	-1	16584858
myocardial	B-Disease	D009203	16584858
infarction	I-Disease	-1	16584858
(	O	-1	16584858
M@@	B-Disease	D009203	16584858
I	I-Disease	-1	16584858
)	O	-1	16584858
in	O	-1	16584858
rats	O	-1	16584858
through	O	-1	16584858
its	O	-1	16584858
anti@@	O	-1	16584858
oxid@@	O	-1	16584858
ative	O	-1	16584858
mechanis@@	O	-1	16584858
m.	O	-1	16584858
S@@	O	-1	16584858
ub@@	O	-1	16584858
c@@	O	-1	16584858
utaneous	O	-1	16584858
injection	O	-1	16584858
of	O	-1	16584858
I@@	B-Chemical	D007545	16584858
S@@	I-Chemical	-1	16584858
P@@	I-Chemical	-1	16584858
H	I-Chemical	-1	16584858
(2@@	O	-1	16584858
00	O	-1	16584858
mg/kg	O	-1	16584858
body	O	-1	16584858
weight	O	-1	16584858
in	O	-1	16584858
1	O	-1	16584858
m@@	O	-1	16584858
l	O	-1	16584858
sal@@	O	-1	16584858
ine@@	O	-1	16584858
)	O	-1	16584858
to	O	-1	16584858
rats	O	-1	16584858
for	O	-1	16584858
2	O	-1	16584858
con@@	O	-1	16584858
sec@@	O	-1	16584858
utive	O	-1	16584858
days	O	-1	16584858
caused	O	-1	16584858
myocardial	B-Disease	D009202	16584858
damage	I-Disease	-1	16584858
in	O	-1	16584858
rat	O	-1	16584858
hear@@	O	-1	16584858
t,	O	-1	16584858
which	O	-1	16584858
was	O	-1	16584858
determined	O	-1	16584858
by	O	-1	16584858
the	O	-1	16584858
increased	O	-1	16584858
activity	O	-1	16584858
of	O	-1	16584858
serum	O	-1	16584858
l@@	B-Chemical	D019344	16584858
act@@	I-Chemical	-1	16584858
ate	I-Chemical	-1	16584858
de@@	O	-1	16584858
hydro@@	O	-1	16584858
gen@@	O	-1	16584858
ase	O	-1	16584858
(@@	O	-1	16584858
L@@	O	-1	16584858
D@@	O	-1	16584858
H@@	O	-1	16584858
)	O	-1	16584858
and	O	-1	16584858
creat@@	B-Chemical	D003401	16584858
ine	I-Chemical	-1	16584858
phosph@@	O	-1	16584858
o@@	O	-1	16584858
kin@@	O	-1	16584858
ase	O	-1	16584858
iso@@	O	-1	16584858
enzym@@	O	-1	16584858
es	O	-1	16584858
(C@@	O	-1	16584858
K@@	O	-1	16584858
-@@	O	-1	16584858
M@@	O	-1	16584858
B@@	O	-1	16584858
),	O	-1	16584858
increased	O	-1	16584858
ur@@	B-Chemical	D014527	16584858
ic	I-Chemical	-1	16584858
acid	I-Chemical	-1	16584858
level	O	-1	16584858
and	O	-1	16584858
reduced	O	-1	16584858
plasma	O	-1	16584858
i@@	B-Chemical	D007501	16584858
ro@@	I-Chemical	-1	16584858
n	I-Chemical	-1	16584858
b@@	O	-1	16584858
ind@@	O	-1	16584858
ing	O	-1	16584858
cap@@	O	-1	16584858
ac@@	O	-1	16584858
ity.	O	-1	16584858
The	O	-1	16584858
protective	O	-1	16584858
role	O	-1	16584858
of	O	-1	16584858
m@@	B-Chemical	C013592	16584858
ang@@	I-Chemical	-1	16584858
if@@	I-Chemical	-1	16584858
er@@	I-Chemical	-1	16584858
in	I-Chemical	-1	16584858
was	O	-1	16584858
analy@@	O	-1	16584858
zed	O	-1	16584858
by	O	-1	16584858
tri@@	B-Chemical	C009591	16584858
phen@@	I-Chemical	-1	16584858
yl	I-Chemical	-1	16584858
te@@	I-Chemical	-1	16584858
tra@@	I-Chemical	-1	16584858
z@@	I-Chemical	-1	16584858
ol@@	I-Chemical	-1	16584858
i@@	I-Chemical	-1	16584858
um	I-Chemical	-1	16584858
chlor@@	I-Chemical	-1	16584858
ide	I-Chemical	-1	16584858
(	O	-1	16584858
T@@	B-Chemical	C009591	16584858
T@@	I-Chemical	-1	16584858
C	I-Chemical	-1	16584858
)	O	-1	16584858
test	O	-1	16584858
used	O	-1	16584858
for	O	-1	16584858
mac@@	O	-1	16584858
ro@@	O	-1	16584858
sco@@	O	-1	16584858
p@@	O	-1	16584858
ic	O	-1	16584858
enzyme	O	-1	16584858
m@@	O	-1	16584858
app@@	O	-1	16584858
ing	O	-1	16584858
ass@@	O	-1	16584858
ay	O	-1	16584858
of	O	-1	16584858
the	O	-1	16584858
ischem@@	B-Disease	D017202	16584858
ic	I-Disease	-1	16584858
myocardi@@	I-Disease	-1	16584858
um	I-Disease	-1	16584858
.	O	-1	16584858
The	O	-1	16584858
heart	O	-1	16584858
tissue	O	-1	16584858
anti@@	O	-1	16584858
oxid@@	O	-1	16584858
ant	O	-1	16584858
enzym@@	O	-1	16584858
es	O	-1	16584858
such	O	-1	16584858
as	O	-1	16584858
su@@	B-Chemical	D013481	16584858
per@@	I-Chemical	-1	16584858
ox@@	I-Chemical	-1	16584858
ide	I-Chemical	-1	16584858
dis@@	O	-1	16584858
mut@@	O	-1	16584858
ase,	O	-1	16584858
cat@@	O	-1	16584858
al@@	O	-1	16584858
ase,	O	-1	16584858
glut@@	B-Chemical	D005978	16584858
athi@@	I-Chemical	-1	16584858
one	I-Chemical	-1	16584858
per@@	O	-1	16584858
oxid@@	O	-1	16584858
ase,	O	-1	16584858
glut@@	B-Chemical	D005978	16584858
athi@@	I-Chemical	-1	16584858
one	I-Chemical	-1	16584858
trans@@	O	-1	16584858
fer@@	O	-1	16584858
ase	O	-1	16584858
and	O	-1	16584858
glut@@	B-Chemical	D005978	16584858
athi@@	I-Chemical	-1	16584858
one	I-Chemical	-1	16584858
reduc@@	O	-1	16584858
t@@	O	-1	16584858
ase	O	-1	16584858
ac@@	O	-1	16584858
ti@@	O	-1	16584858
vi@@	O	-1	16584858
ti@@	O	-1	16584858
es,	O	-1	16584858
non-@@	O	-1	16584858
enzym@@	O	-1	16584858
ic	O	-1	16584858
anti@@	O	-1	16584858
oxid@@	O	-1	16584858
ants	O	-1	16584858
such	O	-1	16584858
as	O	-1	16584858
cer@@	O	-1	16584858
ru@@	O	-1	16584858
lo@@	O	-1	16584858
plas@@	O	-1	16584858
min@@	O	-1	16584858
,	O	-1	16584858
V@@	B-Chemical	D001205	16584858
it@@	I-Chemical	-1	16584858
amin	I-Chemical	-1	16584858
C	I-Chemical	-1	16584858
,	O	-1	16584858
V@@	B-Chemical	D014810	16584858
it@@	I-Chemical	-1	16584858
amin	I-Chemical	-1	16584858
E	I-Chemical	-1	16584858
and	O	-1	16584858
glut@@	B-Chemical	D005978	16584858
athi@@	I-Chemical	-1	16584858
one	I-Chemical	-1	16584858
levels	O	-1	16584858
were	O	-1	16584858
al@@	O	-1	16584858
te@@	O	-1	16584858
red	O	-1	16584858
in	O	-1	16584858
M@@	B-Disease	D009203	16584858
I	I-Disease	-1	16584858
rats.	O	-1	16584858
U@@	O	-1	16584858
p@@	O	-1	16584858
on	O	-1	16584858
pretreatment	O	-1	16584858
with	O	-1	16584858
m@@	B-Chemical	C013592	16584858
ang@@	I-Chemical	-1	16584858
if@@	I-Chemical	-1	16584858
er@@	I-Chemical	-1	16584858
in	I-Chemical	-1	16584858
(@@	O	-1	16584858
100	O	-1	16584858
mg/kg	O	-1	16584858
body	O	-1	16584858
weight	O	-1	16584858
sus@@	O	-1	16584858
pen@@	O	-1	16584858
ded	O	-1	16584858
in	O	-1	16584858
2	O	-1	16584858
m@@	O	-1	16584858
l	O	-1	16584858
of	O	-1	16584858
di@@	B-Chemical	D004121	16584858
meth@@	I-Chemical	-1	16584858
yl	I-Chemical	-1	16584858
sul@@	I-Chemical	-1	16584858
ph@@	I-Chemical	-1	16584858
ox@@	I-Chemical	-1	16584858
ide	I-Chemical	-1	16584858
)	O	-1	16584858
given	O	-1	16584858
intra@@	O	-1	16584858
per@@	O	-1	16584858
it@@	O	-1	16584858
one@@	O	-1	16584858
ally	O	-1	16584858
for	O	-1	16584858
2@@	O	-1	16584858
8	O	-1	16584858
days	O	-1	16584858
to	O	-1	16584858
M@@	B-Disease	D009203	16584858
I	I-Disease	-1	16584858
rats	O	-1	16584858
prot@@	O	-1	16584858
ected	O	-1	16584858
the	O	-1	16584858
ab@@	O	-1	16584858
o@@	O	-1	16584858
ve@@	O	-1	16584858
-@@	O	-1	16584858
men@@	O	-1	16584858
tion@@	O	-1	16584858
ed	O	-1	16584858
par@@	O	-1	16584858
ame@@	O	-1	16584858
ters	O	-1	16584858
to	O	-1	16584858
f@@	O	-1	16584858
all	O	-1	16584858
from	O	-1	16584858
the	O	-1	16584858
normal	O	-1	16584858
level@@	O	-1	16584858
s.	O	-1	16584858
Ac@@	O	-1	16584858
ti@@	O	-1	16584858
vi@@	O	-1	16584858
ties	O	-1	16584858
of	O	-1	16584858
heart	O	-1	16584858
tissue	O	-1	16584858
enzym@@	O	-1	16584858
ic	O	-1	16584858
anti@@	O	-1	16584858
oxid@@	O	-1	16584858
ants	O	-1	16584858
and	O	-1	16584858
serum	O	-1	16584858
non-@@	O	-1	16584858
enzym@@	O	-1	16584858
ic	O	-1	16584858
anti@@	O	-1	16584858
oxid@@	O	-1	16584858
ants	O	-1	16584858
levels	O	-1	16584858
ro@@	O	-1	16584858
se	O	-1	16584858
significantly	O	-1	16584858
up@@	O	-1	16584858
on	O	-1	16584858
m@@	B-Chemical	C013592	16584858
ang@@	I-Chemical	-1	16584858
if@@	I-Chemical	-1	16584858
er@@	I-Chemical	-1	16584858
in	I-Chemical	-1	16584858
administration	O	-1	16584858
as	O	-1	16584858
compared	O	-1	16584858
to	O	-1	16584858
I@@	B-Chemical	D007545	16584858
S@@	I-Chemical	-1	16584858
P@@	I-Chemical	-1	16584858
H	I-Chemical	-1	16584858
-induced	O	-1	16584858
M@@	B-Disease	D009203	16584858
I	I-Disease	-1	16584858
rats.	O	-1	16584858
F@@	O	-1	16584858
rom	O	-1	16584858
the	O	-1	16584858
present	O	-1	16584858
study	O	-1	16584858
it	O	-1	16584858
is	O	-1	16584858
concl@@	O	-1	16584858
uded	O	-1	16584858
that	O	-1	16584858
m@@	B-Chemical	C013592	16584858
ang@@	I-Chemical	-1	16584858
if@@	I-Chemical	-1	16584858
er@@	I-Chemical	-1	16584858
in	I-Chemical	-1	16584858
ex@@	O	-1	16584858
er@@	O	-1	16584858
ts	O	-1	16584858
a	O	-1	16584858
ben@@	O	-1	16584858
e@@	O	-1	16584858
fic@@	O	-1	16584858
ial	O	-1	16584858
effect	O	-1	16584858
against	O	-1	16584858
I@@	B-Chemical	D007545	16584858
S@@	I-Chemical	-1	16584858
P@@	I-Chemical	-1	16584858
H	I-Chemical	-1	16584858
-induced	O	-1	16584858
M@@	B-Disease	D009203	16584858
I	I-Disease	-1	16584858
due	O	-1	16584858
to	O	-1	16584858
its	O	-1	16584858
anti@@	O	-1	16584858
oxid@@	O	-1	16584858
ant	O	-1	16584858
potenti@@	O	-1	16584858
al,	O	-1	16584858
which	O	-1	16584858
reg@@	O	-1	16584858
ul@@	O	-1	16584858
ated	O	-1	16584858
the	O	-1	16584858
tissu@@	O	-1	16584858
es	O	-1	16584858
def@@	O	-1	16584858
en@@	O	-1	16584858
se	O	-1	16584858
system	O	-1	16584858
against	O	-1	16584858
cardiac	B-Disease	D006331	16584858
damage	I-Disease	-1	16584858
.	O	-1	16584858

R@@	B-Chemical	C071741	16563323
em@@	I-Chemical	-1	16563323
if@@	I-Chemical	-1	16563323
entan@@	I-Chemical	-1	16563323
il	I-Chemical	-1	16563323
pretreatment	O	-1	16563323
reduc@@	O	-1	16563323
es	O	-1	16563323
my@@	B-Disease	D009207	16563323
oc@@	I-Disease	-1	16563323
lon@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
after	O	-1	16563323
e@@	B-Chemical	D005045	16563323
to@@	I-Chemical	-1	16563323
mid@@	I-Chemical	-1	16563323
ate	I-Chemical	-1	16563323
.	O	-1	16563323
S@@	O	-1	16563323
T@@	O	-1	16563323
U@@	O	-1	16563323
D@@	O	-1	16563323
Y	O	-1	16563323
OBJECTIVE:	O	-1	16563323
The	O	-1	16563323
a@@	O	-1	16563323
im	O	-1	16563323
of	O	-1	16563323
the	O	-1	16563323
study	O	-1	16563323
was	O	-1	16563323
to	O	-1	16563323
compar@@	O	-1	16563323
e	O	-1	16563323
the	O	-1	16563323
effect	O	-1	16563323
of	O	-1	16563323
pretreatment	O	-1	16563323
with	O	-1	16563323
re@@	B-Chemical	C071741	16563323
m@@	I-Chemical	-1	16563323
if@@	I-Chemical	-1	16563323
entan@@	I-Chemical	-1	16563323
il	I-Chemical	-1	16563323
1	O	-1	16563323
micro@@	O	-1	16563323
g/@@	O	-1	16563323
k@@	O	-1	16563323
g	O	-1	16563323
and	O	-1	16563323
the	O	-1	16563323
effect	O	-1	16563323
of	O	-1	16563323
gen@@	O	-1	16563323
der	O	-1	16563323
on	O	-1	16563323
the	O	-1	16563323
incidence	O	-1	16563323
of	O	-1	16563323
my@@	B-Disease	D009207	16563323
oc@@	I-Disease	-1	16563323
lon@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
after	O	-1	16563323
anesthe@@	O	-1	16563323
sia	O	-1	16563323
induction	O	-1	16563323
with	O	-1	16563323
e@@	B-Chemical	D005045	16563323
to@@	I-Chemical	-1	16563323
mid@@	I-Chemical	-1	16563323
ate	I-Chemical	-1	16563323
.	O	-1	16563323
D@@	O	-1	16563323
ES@@	O	-1	16563323
I@@	O	-1	16563323
G@@	O	-1	16563323
N@@	O	-1	16563323
:	O	-1	16563323
This	O	-1	16563323
was	O	-1	16563323
a	O	-1	16563323
random@@	O	-1	16563323
iz@@	O	-1	16563323
ed,	O	-1	16563323
double-bl@@	O	-1	16563323
ind	O	-1	16563323
study.	O	-1	16563323
S@@	O	-1	16563323
ET@@	O	-1	16563323
TI@@	O	-1	16563323
N@@	O	-1	16563323
G@@	O	-1	16563323
:	O	-1	16563323
The	O	-1	16563323
study	O	-1	16563323
was	O	-1	16563323
con@@	O	-1	16563323
duc@@	O	-1	16563323
ted	O	-1	16563323
at	O	-1	16563323
a	O	-1	16563323
un@@	O	-1	16563323
i@@	O	-1	16563323
ver@@	O	-1	16563323
s@@	O	-1	16563323
ity	O	-1	16563323
hospit@@	O	-1	16563323
al.	O	-1	16563323
PA@@	O	-1	16563323
TI@@	O	-1	16563323
E@@	O	-1	16563323
N@@	O	-1	16563323
T@@	O	-1	16563323
S:	O	-1	16563323
Si@@	O	-1	16563323
x@@	O	-1	16563323
t@@	O	-1	16563323
y	O	-1	16563323
patients	O	-1	16563323
were	O	-1	16563323
pre@@	O	-1	16563323
treated	O	-1	16563323
in	O	-1	16563323
a	O	-1	16563323
randomized	O	-1	16563323
double-bl@@	O	-1	16563323
ind@@	O	-1	16563323
ed	O	-1	16563323
f@@	O	-1	16563323
as@@	O	-1	16563323
hi@@	O	-1	16563323
on	O	-1	16563323
with	O	-1	16563323
re@@	B-Chemical	C071741	16563323
m@@	I-Chemical	-1	16563323
if@@	I-Chemical	-1	16563323
entan@@	I-Chemical	-1	16563323
il	I-Chemical	-1	16563323
1	O	-1	16563323
micro@@	O	-1	16563323
g/@@	O	-1	16563323
k@@	O	-1	16563323
g	O	-1	16563323
or	O	-1	16563323
placebo@@	O	-1	16563323
.	O	-1	16563323
Two	O	-1	16563323
minutes	O	-1	16563323
after	O	-1	16563323
re@@	B-Chemical	C071741	16563323
m@@	I-Chemical	-1	16563323
if@@	I-Chemical	-1	16563323
entan@@	I-Chemical	-1	16563323
il	I-Chemical	-1	16563323
or	O	-1	16563323
placebo	O	-1	16563323
injec@@	O	-1	16563323
tion,	O	-1	16563323
e@@	B-Chemical	D005045	16563323
to@@	I-Chemical	-1	16563323
mid@@	I-Chemical	-1	16563323
ate	I-Chemical	-1	16563323
0.@@	O	-1	16563323
3	O	-1	16563323
mg/kg	O	-1	16563323
was	O	-1	16563323
gi@@	O	-1	16563323
ven@@	O	-1	16563323
.	O	-1	16563323
M@@	O	-1	16563323
E@@	O	-1	16563323
A@@	O	-1	16563323
S@@	O	-1	16563323
U@@	O	-1	16563323
R@@	O	-1	16563323
E@@	O	-1	16563323
M@@	O	-1	16563323
E@@	O	-1	16563323
N@@	O	-1	16563323
T@@	O	-1	16563323
S:	O	-1	16563323
M@@	B-Disease	D009207	16563323
y@@	I-Disease	-1	16563323
oc@@	I-Disease	-1	16563323
lon@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
was	O	-1	16563323
recor@@	O	-1	16563323
ded	O	-1	16563323
with	O	-1	16563323
a	O	-1	16563323
s@@	O	-1	16563323
cal@@	O	-1	16563323
e	O	-1	16563323
of	O	-1	16563323
0	O	-1	16563323
to	O	-1	16563323
3@@	O	-1	16563323
.	O	-1	16563323
The	O	-1	16563323
gra@@	O	-1	16563323
de	O	-1	16563323
of	O	-1	16563323
sed@@	O	-1	16563323
ation	O	-1	16563323
(@@	O	-1	16563323
non@@	O	-1	16563323
e,	O	-1	16563323
mil@@	O	-1	16563323
d,	O	-1	16563323
moder@@	O	-1	16563323
ate,	O	-1	16563323
se@@	O	-1	16563323
ve@@	O	-1	16563323
re@@	O	-1	16563323
),	O	-1	16563323
nausea	B-Disease	D009325	16563323
,	O	-1	16563323
pr@@	B-Disease	D011537	16563323
ur@@	I-Disease	-1	16563323
it@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
,	O	-1	16563323
and	O	-1	16563323
ap@@	B-Disease	D001049	16563323
ne@@	I-Disease	-1	16563323
a	I-Disease	-1	16563323
were	O	-1	16563323
recor@@	O	-1	16563323
ded	O	-1	16563323
after	O	-1	16563323
injection	O	-1	16563323
of	O	-1	16563323
both	O	-1	16563323
drug@@	O	-1	16563323
s.	O	-1	16563323
MA@@	O	-1	16563323
I@@	O	-1	16563323
N	O	-1	16563323
RESULTS:	O	-1	16563323
The	O	-1	16563323
incidence	O	-1	16563323
of	O	-1	16563323
my@@	B-Disease	D009207	16563323
oc@@	I-Disease	-1	16563323
lon@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
was	O	-1	16563323
significantly	O	-1	16563323
lower	O	-1	16563323
in	O	-1	16563323
the	O	-1	16563323
re@@	B-Chemical	C071741	16563323
m@@	I-Chemical	-1	16563323
if@@	I-Chemical	-1	16563323
entan@@	I-Chemical	-1	16563323
il	I-Chemical	-1	16563323
group	O	-1	16563323
(@@	O	-1	16563323
6.@@	O	-1	16563323
7@@	O	-1	16563323
%)	O	-1	16563323
than	O	-1	16563323
in	O	-1	16563323
the	O	-1	16563323
placebo	O	-1	16563323
group	O	-1	16563323
(@@	O	-1	16563323
7@@	O	-1	16563323
0@@	O	-1	16563323
%)	O	-1	16563323
(P	O	-1	16563323
<	O	-1	16563323
0.00@@	O	-1	16563323
1).	O	-1	16563323
N@@	O	-1	16563323
one	O	-1	16563323
of	O	-1	16563323
the	O	-1	16563323
patients	O	-1	16563323
experienced	O	-1	16563323
sed@@	O	-1	16563323
ation,	O	-1	16563323
ap@@	B-Disease	D001049	16563323
ne@@	I-Disease	-1	16563323
a	I-Disease	-1	16563323
,	O	-1	16563323
nausea	B-Disease	D009325	16563323
,	O	-1	16563323
or	O	-1	16563323
pr@@	B-Disease	D011537	16563323
ur@@	I-Disease	-1	16563323
it@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
after	O	-1	16563323
injection	O	-1	16563323
of	O	-1	16563323
both	O	-1	16563323
drug@@	O	-1	16563323
s.	O	-1	16563323
In	O	-1	16563323
the	O	-1	16563323
placebo	O	-1	16563323
group@@	O	-1	16563323
,	O	-1	16563323
male	O	-1	16563323
patients	O	-1	16563323
were	O	-1	16563323
associated	O	-1	16563323
with	O	-1	16563323
significantly	O	-1	16563323
increased	O	-1	16563323
incidence	O	-1	16563323
of	O	-1	16563323
my@@	B-Disease	D009207	16563323
oc@@	I-Disease	-1	16563323
lon@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
after	O	-1	16563323
e@@	B-Chemical	D005045	16563323
to@@	I-Chemical	-1	16563323
mid@@	I-Chemical	-1	16563323
ate	I-Chemical	-1	16563323
administr@@	O	-1	16563323
ation.	O	-1	16563323
CONCLUSION:	O	-1	16563323
Pre@@	O	-1	16563323
treatment	O	-1	16563323
with	O	-1	16563323
re@@	B-Chemical	C071741	16563323
m@@	I-Chemical	-1	16563323
if@@	I-Chemical	-1	16563323
entan@@	I-Chemical	-1	16563323
il	I-Chemical	-1	16563323
1	O	-1	16563323
micro@@	O	-1	16563323
g/@@	O	-1	16563323
k@@	O	-1	16563323
g	O	-1	16563323
reduced	O	-1	16563323
my@@	B-Disease	D009207	16563323
oc@@	I-Disease	-1	16563323
lon@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
after	O	-1	16563323
e@@	B-Chemical	D005045	16563323
to@@	I-Chemical	-1	16563323
mid@@	I-Chemical	-1	16563323
ate	I-Chemical	-1	16563323
induction	O	-1	16563323
without	O	-1	16563323
side	O	-1	16563323
effects	O	-1	16563323
such	O	-1	16563323
as	O	-1	16563323
sed@@	O	-1	16563323
ation,	O	-1	16563323
ap@@	B-Disease	D001049	16563323
ne@@	I-Disease	-1	16563323
a	I-Disease	-1	16563323
,	O	-1	16563323
nausea	B-Disease	D009325	16563323
,	O	-1	16563323
or	O	-1	16563323
pr@@	B-Disease	D011537	16563323
ur@@	I-Disease	-1	16563323
it@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
.	O	-1	16563323
M@@	O	-1	16563323
en	O	-1	16563323
experi@@	O	-1	16563323
ence	O	-1	16563323
increased	O	-1	16563323
incidence	O	-1	16563323
of	O	-1	16563323
my@@	B-Disease	D009207	16563323
oc@@	I-Disease	-1	16563323
lon@@	I-Disease	-1	16563323
us	I-Disease	-1	16563323
than	O	-1	16563323
women	O	-1	16563323
after	O	-1	16563323
e@@	B-Chemical	D005045	16563323
to@@	I-Chemical	-1	16563323
mid@@	I-Chemical	-1	16563323
ate	I-Chemical	-1	16563323
administr@@	O	-1	16563323
ation.	O	-1	16563323

D@@	B-Chemical	C004742	16428827
a@@	I-Chemical	-1	16428827
id@@	I-Chemical	-1	16428827
z@@	I-Chemical	-1	16428827
e@@	I-Chemical	-1	16428827
in	I-Chemical	-1	16428827
activ@@	O	-1	16428827
ates	O	-1	16428827
chol@@	B-Chemical	D002794	16428827
ine	I-Chemical	-1	16428827
acet@@	O	-1	16428827
yl@@	O	-1	16428827
trans@@	O	-1	16428827
fer@@	O	-1	16428827
ase	O	-1	16428827
from	O	-1	16428827
M@@	O	-1	16428827
C@@	O	-1	16428827
-@@	O	-1	16428827
I@@	O	-1	16428827
X@@	O	-1	16428827
C	O	-1	16428827
cells	O	-1	16428827
and	O	-1	16428827
impro@@	O	-1	16428827
v@@	O	-1	16428827
es	O	-1	16428827
drug@@	O	-1	16428827
-induced	O	-1	16428827
am@@	B-Disease	D000647	16428827
ne@@	I-Disease	-1	16428827
sia	I-Disease	-1	16428827
.	O	-1	16428827
The	O	-1	16428827
chol@@	B-Chemical	D002794	16428827
ine	I-Chemical	-1	16428827
acet@@	O	-1	16428827
yl@@	O	-1	16428827
trans@@	O	-1	16428827
fer@@	O	-1	16428827
ase	O	-1	16428827
(C@@	O	-1	16428827
h@@	O	-1	16428827
AT@@	O	-1	16428827
)	O	-1	16428827
activ@@	O	-1	16428827
at@@	O	-1	16428827
or@@	O	-1	16428827
,	O	-1	16428827
which	O	-1	16428827
enh@@	O	-1	16428827
anc@@	O	-1	16428827
es	O	-1	16428827
cholinergic	O	-1	16428827
trans@@	O	-1	16428827
mission	O	-1	16428827
vi@@	O	-1	16428827
a	O	-1	16428827
an	O	-1	16428827
au@@	O	-1	16428827
g@@	O	-1	16428827
ment@@	O	-1	16428827
ation	O	-1	16428827
of	O	-1	16428827
the	O	-1	16428827
enzym@@	O	-1	16428827
atic	O	-1	16428827
pro@@	O	-1	16428827
duction	O	-1	16428827
of	O	-1	16428827
acet@@	B-Chemical	D000109	16428827
ylcholine	I-Chemical	-1	16428827
(	O	-1	16428827
AC@@	B-Chemical	D000109	16428827
h	I-Chemical	-1	16428827
),	O	-1	16428827
is	O	-1	16428827
an	O	-1	16428827
important	O	-1	16428827
factor	O	-1	16428827
in	O	-1	16428827
the	O	-1	16428827
treatment	O	-1	16428827
of	O	-1	16428827
Al@@	B-Disease	D000544	16428827
z@@	I-Disease	-1	16428827
he@@	I-Disease	-1	16428827
im@@	I-Disease	-1	16428827
er@@	I-Disease	-1	16428827
's	I-Disease	-1	16428827
disease	I-Disease	-1	16428827
(	O	-1	16428827
A@@	B-Disease	D000544	16428827
D	I-Disease	-1	16428827
).	O	-1	16428827
M@@	O	-1	16428827
eth@@	O	-1	16428827
an@@	O	-1	16428827
olic	O	-1	16428827
extrac@@	O	-1	16428827
ts	O	-1	16428827
from	O	-1	16428827
P@@	O	-1	16428827
u@@	O	-1	16428827
er@@	O	-1	16428827
ar@@	O	-1	16428827
ia	O	-1	16428827
th@@	O	-1	16428827
un@@	O	-1	16428827
b@@	O	-1	16428827
er@@	O	-1	16428827
gi@@	O	-1	16428827
an@@	O	-1	16428827
a	O	-1	16428827
ex@@	O	-1	16428827
hib@@	O	-1	16428827
ited	O	-1	16428827
an	O	-1	16428827
activation	O	-1	16428827
effect	O	-1	16428827
(4@@	O	-1	16428827
6@@	O	-1	16428827
%)	O	-1	16428827
on	O	-1	16428827
Ch@@	O	-1	16428827
A@@	O	-1	16428827
T	O	-1	16428827
in	O	-1	16428827
vit@@	O	-1	16428827
ro@@	O	-1	16428827
.	O	-1	16428827
V@@	O	-1	16428827
ia	O	-1	16428827
the	O	-1	16428827
sequ@@	O	-1	16428827
en@@	O	-1	16428827
tial	O	-1	16428827
isol@@	O	-1	16428827
ation	O	-1	16428827
of	O	-1	16428827
P@@	O	-1	16428827
u@@	O	-1	16428827
er@@	O	-1	16428827
ar@@	O	-1	16428827
ia	O	-1	16428827
th@@	O	-1	16428827
un@@	O	-1	16428827
b@@	O	-1	16428827
er@@	O	-1	16428827
gi@@	O	-1	16428827
an@@	O	-1	16428827
a,	O	-1	16428827
the	O	-1	16428827
active	O	-1	16428827
comp@@	O	-1	16428827
on@@	O	-1	16428827
ent	O	-1	16428827
was	O	-1	16428827
ul@@	O	-1	16428827
tim@@	O	-1	16428827
ately	O	-1	16428827
identi@@	O	-1	16428827
fied	O	-1	16428827
as	O	-1	16428827
da@@	B-Chemical	C004742	16428827
id@@	I-Chemical	-1	16428827
z@@	I-Chemical	-1	16428827
e@@	I-Chemical	-1	16428827
in	I-Chemical	-1	16428827
(	O	-1	16428827
4@@	B-Chemical	C004742	16428827
'@@	I-Chemical	-1	16428827
,@@	I-Chemical	-1	16428827
7-@@	I-Chemical	-1	16428827
di@@	I-Chemical	-1	16428827
hydrox@@	I-Chemical	-1	16428827
y-@@	I-Chemical	-1	16428827
iso@@	I-Chemical	-1	16428827
f@@	I-Chemical	-1	16428827
l@@	I-Chemical	-1	16428827
av@@	I-Chemical	-1	16428827
one	I-Chemical	-1	16428827
).	O	-1	16428827
In	O	-1	16428827
or@@	O	-1	16428827
der	O	-1	16428827
to	O	-1	16428827
investigate	O	-1	16428827
the	O	-1	16428827
effects	O	-1	16428827
of	O	-1	16428827
da@@	B-Chemical	C004742	16428827
id@@	I-Chemical	-1	16428827
z@@	I-Chemical	-1	16428827
e@@	I-Chemical	-1	16428827
in	I-Chemical	-1	16428827
from	O	-1	16428827
P@@	O	-1	16428827
u@@	O	-1	16428827
er@@	O	-1	16428827
ar@@	O	-1	16428827
ia	O	-1	16428827
th@@	O	-1	16428827
un@@	O	-1	16428827
b@@	O	-1	16428827
er@@	O	-1	16428827
gi@@	O	-1	16428827
an@@	O	-1	16428827
a	O	-1	16428827
on	O	-1	16428827
scopol@@	B-Chemical	D012601	16428827
amine	I-Chemical	-1	16428827
-induced	O	-1	16428827
impair@@	B-Disease	D007859	16428827
ments	I-Disease	-1	16428827
of	I-Disease	-1	16428827
lear@@	I-Disease	-1	16428827
ning	I-Disease	-1	16428827
and	I-Disease	-1	16428827
memory	I-Disease	-1	16428827
impair@@	B-Disease	D008569	16428827
ments	I-Disease	-1	16428827
of	I-Disease	-1	16428827
lear@@	I-Disease	-1	16428827
ning	I-Disease	-1	16428827
and	I-Disease	-1	16428827
memory	I-Disease	-1	16428827
,	O	-1	16428827
we	O	-1	16428827
con@@	O	-1	16428827
duc@@	O	-1	16428827
ted	O	-1	16428827
a	O	-1	16428827
seri@@	O	-1	16428827
es	O	-1	16428827
of	O	-1	16428827
in	O	-1	16428827
viv@@	O	-1	16428827
o	O	-1	16428827
test@@	O	-1	16428827
s.	O	-1	16428827
Ad@@	O	-1	16428827
minist@@	O	-1	16428827
ration	O	-1	16428827
of	O	-1	16428827
da@@	B-Chemical	C004742	16428827
id@@	I-Chemical	-1	16428827
z@@	I-Chemical	-1	16428827
e@@	I-Chemical	-1	16428827
in	I-Chemical	-1	16428827
(@@	O	-1	16428827
4.@@	O	-1	16428827
5	O	-1	16428827
mg/kg	O	-1	16428827
body	O	-1	16428827
weigh@@	O	-1	16428827
t@@	O	-1	16428827
)	O	-1	16428827
to	O	-1	16428827
mice	O	-1	16428827
was	O	-1	16428827
shown	O	-1	16428827
significantly	O	-1	16428827
to	O	-1	16428827
re@@	O	-1	16428827
verse	O	-1	16428827
scopol@@	B-Chemical	D012601	16428827
amine	I-Chemical	-1	16428827
-induced	O	-1	16428827
am@@	B-Disease	D000647	16428827
ne@@	I-Disease	-1	16428827
sia	I-Disease	-1	16428827
,	O	-1	16428827
ac@@	O	-1	16428827
cor@@	O	-1	16428827
ding	O	-1	16428827
to	O	-1	16428827
the	O	-1	16428827
results	O	-1	16428827
of	O	-1	16428827
a	O	-1	16428827
Y@@	O	-1	16428827
-@@	O	-1	16428827
ma@@	O	-1	16428827
ze	O	-1	16428827
test@@	O	-1	16428827
.	O	-1	16428827
In@@	O	-1	16428827
j@@	O	-1	16428827
ec@@	O	-1	16428827
tions	O	-1	16428827
of	O	-1	16428827
scopol@@	B-Chemical	D012601	16428827
amine	I-Chemical	-1	16428827
into	O	-1	16428827
mice	O	-1	16428827
resulted	O	-1	16428827
in	O	-1	16428827
impaired	O	-1	16428827
perform@@	O	-1	16428827
ance	O	-1	16428827
on	O	-1	16428827
Y@@	O	-1	16428827
-@@	O	-1	16428827
ma@@	O	-1	16428827
ze	O	-1	16428827
tests	O	-1	16428827
(@@	O	-1	16428827
a	O	-1	16428827
3@@	O	-1	16428827
7@@	O	-1	16428827
%	O	-1	16428827
decreas@@	O	-1	16428827
es	O	-1	16428827
in	O	-1	16428827
al@@	O	-1	16428827
tern@@	O	-1	16428827
ation	O	-1	16428827
behavi@@	O	-1	16428827
or@@	O	-1	16428827
).	O	-1	16428827
B@@	O	-1	16428827
y	O	-1	16428827
w@@	O	-1	16428827
ay	O	-1	16428827
of	O	-1	16428827
contrast@@	O	-1	16428827
,	O	-1	16428827
mice	O	-1	16428827
treated	O	-1	16428827
with	O	-1	16428827
da@@	B-Chemical	C004742	16428827
id@@	I-Chemical	-1	16428827
z@@	I-Chemical	-1	16428827
e@@	I-Chemical	-1	16428827
in	I-Chemical	-1	16428827
prior	O	-1	16428827
to	O	-1	16428827
the	O	-1	16428827
scopol@@	B-Chemical	D012601	16428827
amine	I-Chemical	-1	16428827
injec@@	O	-1	16428827
tions	O	-1	16428827
were	O	-1	16428827
no@@	O	-1	16428827
ti@@	O	-1	16428827
ce@@	O	-1	16428827
ably	O	-1	16428827
prot@@	O	-1	16428827
ected	O	-1	16428827
from	O	-1	16428827
this	O	-1	16428827
perform@@	O	-1	16428827
ance	O	-1	16428827
impair@@	O	-1	16428827
ment	O	-1	16428827
(@@	O	-1	16428827
an	O	-1	16428827
appro@@	O	-1	16428827
xim@@	O	-1	16428827
ately	O	-1	16428827
12@@	O	-1	16428827
%@@	O	-1	16428827
-@@	O	-1	16428827
2@@	O	-1	16428827
1@@	O	-1	16428827
%	O	-1	16428827
decrease	O	-1	16428827
in	O	-1	16428827
al@@	O	-1	16428827
tern@@	O	-1	16428827
ation	O	-1	16428827
behavi@@	O	-1	16428827
or@@	O	-1	16428827
).	O	-1	16428827
These	O	-1	16428827
results	O	-1	16428827
indicate	O	-1	16428827
that	O	-1	16428827
da@@	B-Chemical	C004742	16428827
id@@	I-Chemical	-1	16428827
z@@	I-Chemical	-1	16428827
e@@	I-Chemical	-1	16428827
in	I-Chemical	-1	16428827
might	O	-1	16428827
pl@@	O	-1	16428827
ay	O	-1	16428827
a	O	-1	16428827
role	O	-1	16428827
in	O	-1	16428827
acet@@	B-Chemical	D000109	16428827
ylcholine	I-Chemical	-1	16428827
b@@	O	-1	16428827
i@@	O	-1	16428827
os@@	O	-1	16428827
yn@@	O	-1	16428827
thesis	O	-1	16428827
as	O	-1	16428827
a	O	-1	16428827
Ch@@	O	-1	16428827
A@@	O	-1	16428827
T	O	-1	16428827
activ@@	O	-1	16428827
at@@	O	-1	16428827
or@@	O	-1	16428827
,	O	-1	16428827
and	O	-1	16428827
that	O	-1	16428827
it	O	-1	16428827
also	O	-1	16428827
ame@@	O	-1	16428827
li@@	O	-1	16428827
or@@	O	-1	16428827
ates	O	-1	16428827
scopol@@	B-Chemical	D012601	16428827
amine	I-Chemical	-1	16428827
-induced	O	-1	16428827
am@@	B-Disease	D000647	16428827
ne@@	I-Disease	-1	16428827
sia	I-Disease	-1	16428827
.	O	-1	16428827

P@@	O	-1	15985056
os@@	O	-1	15985056
sible	O	-1	15985056
az@@	B-Chemical	D017963	15985056
i@@	I-Chemical	-1	15985056
throm@@	I-Chemical	-1	15985056
ycin	I-Chemical	-1	15985056
-@@	O	-1	15985056
associated	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
.	O	-1	15985056
OBJECTIVE:	O	-1	15985056
To	O	-1	15985056
report	O	-1	15985056
a	O	-1	15985056
case	O	-1	15985056
of	O	-1	15985056
per@@	O	-1	15985056
sist@@	O	-1	15985056
ent	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
associated	O	-1	15985056
by	O	-1	15985056
az@@	B-Chemical	D017963	15985056
i@@	I-Chemical	-1	15985056
throm@@	I-Chemical	-1	15985056
ycin	I-Chemical	-1	15985056
therapy.	O	-1	15985056
CA@@	O	-1	15985056
S@@	O	-1	15985056
E	O	-1	15985056
S@@	O	-1	15985056
U@@	O	-1	15985056
M@@	O	-1	15985056
MA@@	O	-1	15985056
R@@	O	-1	15985056
Y@@	O	-1	15985056
:	O	-1	15985056
A	O	-1	15985056
7@@	O	-1	15985056
6-@@	O	-1	15985056
year-old	O	-1	15985056
man	O	-1	15985056
presented	O	-1	15985056
with	O	-1	15985056
per@@	O	-1	15985056
sist@@	O	-1	15985056
ent	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
after	O	-1	15985056
be@@	O	-1	15985056
g@@	O	-1	15985056
in@@	O	-1	15985056
ning	O	-1	15985056
az@@	B-Chemical	D017963	15985056
i@@	I-Chemical	-1	15985056
throm@@	I-Chemical	-1	15985056
ycin	I-Chemical	-1	15985056
for	O	-1	15985056
the	O	-1	15985056
treatment	O	-1	15985056
of	O	-1	15985056
ph@@	B-Disease	D010612	15985056
ar@@	I-Disease	-1	15985056
yn@@	I-Disease	-1	15985056
gi@@	I-Disease	-1	15985056
tis	I-Disease	-1	15985056
.	O	-1	15985056
H@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
were	O	-1	15985056
per@@	O	-1	15985056
sist@@	O	-1	15985056
ent	O	-1	15985056
and	O	-1	15985056
ex@@	O	-1	15985056
ha@@	O	-1	15985056
ust@@	O	-1	15985056
ing.	O	-1	15985056
D@@	O	-1	15985056
is@@	O	-1	15985056
continu@@	O	-1	15985056
ation	O	-1	15985056
of	O	-1	15985056
az@@	B-Chemical	D017963	15985056
i@@	I-Chemical	-1	15985056
throm@@	I-Chemical	-1	15985056
ycin	I-Chemical	-1	15985056
and	O	-1	15985056
therapy	O	-1	15985056
with	O	-1	15985056
bac@@	B-Chemical	D001418	15985056
lo@@	I-Chemical	-1	15985056
f@@	I-Chemical	-1	15985056
en	I-Chemical	-1	15985056
f@@	O	-1	15985056
in@@	O	-1	15985056
ally	O	-1	15985056
resol@@	O	-1	15985056
ved	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
.	O	-1	15985056
No	O	-1	15985056
org@@	O	-1	15985056
anic	O	-1	15985056
cause	O	-1	15985056
of	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
was	O	-1	15985056
identi@@	O	-1	15985056
fied	O	-1	15985056
des@@	O	-1	15985056
pit@@	O	-1	15985056
e	O	-1	15985056
exten@@	O	-1	15985056
sive	O	-1	15985056
investig@@	O	-1	15985056
ation.	O	-1	15985056
D@@	O	-1	15985056
I@@	O	-1	15985056
S@@	O	-1	15985056
C@@	O	-1	15985056
US@@	O	-1	15985056
S@@	O	-1	15985056
ION@@	O	-1	15985056
:	O	-1	15985056
Ph@@	O	-1	15985056
armac@@	O	-1	15985056
o@@	O	-1	15985056
therapeutic	O	-1	15985056
agents	O	-1	15985056
have	O	-1	15985056
been	O	-1	15985056
un@@	O	-1	15985056
common@@	O	-1	15985056
ly	O	-1	15985056
associated	O	-1	15985056
with	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
.	O	-1	15985056
C@@	O	-1	15985056
or@@	O	-1	15985056
tico@@	O	-1	15985056
steroid@@	O	-1	15985056
s	O	-1	15985056
(	O	-1	15985056
de@@	B-Chemical	D003907	15985056
xameth@@	I-Chemical	-1	15985056
as@@	I-Chemical	-1	15985056
one	I-Chemical	-1	15985056
and	O	-1	15985056
methyl@@	B-Chemical	D008775	15985056
pre@@	I-Chemical	-1	15985056
d@@	I-Chemical	-1	15985056
n@@	I-Chemical	-1	15985056
isol@@	I-Chemical	-1	15985056
one	I-Chemical	-1	15985056
),	O	-1	15985056
b@@	B-Chemical	D001569	15985056
enz@@	I-Chemical	-1	15985056
odi@@	I-Chemical	-1	15985056
azep@@	I-Chemical	-1	15985056
in@@	I-Chemical	-1	15985056
es	I-Chemical	-1	15985056
(	O	-1	15985056
mid@@	B-Chemical	D008874	15985056
azol@@	I-Chemical	-1	15985056
am	I-Chemical	-1	15985056
)	O	-1	15985056
and	O	-1	15985056
gener@@	O	-1	15985056
al	O	-1	15985056
anaesthe@@	O	-1	15985056
sia	O	-1	15985056
have	O	-1	15985056
been	O	-1	15985056
the	O	-1	15985056
specific	O	-1	15985056
agents	O	-1	15985056
men@@	O	-1	15985056
tion@@	O	-1	15985056
ed	O	-1	15985056
most	O	-1	15985056
frequ@@	O	-1	15985056
ently	O	-1	15985056
in	O	-1	15985056
the	O	-1	15985056
literat@@	O	-1	15985056
ure	O	-1	15985056
as	O	-1	15985056
being	O	-1	15985056
associated	O	-1	15985056
with	O	-1	15985056
the	O	-1	15985056
development	O	-1	15985056
of	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
.	O	-1	15985056
F@@	O	-1	15985056
e@@	O	-1	15985056
w	O	-1	15985056
cases	O	-1	15985056
of	O	-1	15985056
drug@@	O	-1	15985056
-induced	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
have	O	-1	15985056
been	O	-1	15985056
reported	O	-1	15985056
related	O	-1	15985056
to	O	-1	15985056
mac@@	B-Chemical	D018942	15985056
ro@@	I-Chemical	-1	15985056
l@@	I-Chemical	-1	15985056
ide	I-Chemical	-1	15985056
anti@@	O	-1	15985056
micro@@	O	-1	15985056
b@@	O	-1	15985056
i@@	O	-1	15985056
al@@	O	-1	15985056
s.	O	-1	15985056
U@@	O	-1	15985056
s@@	O	-1	15985056
ing	O	-1	15985056
the	O	-1	15985056
N@@	O	-1	15985056
ar@@	O	-1	15985056
an@@	O	-1	15985056
j@@	O	-1	15985056
o	O	-1	15985056
adverse	O	-1	15985056
effect	O	-1	15985056
reaction	O	-1	15985056
prob@@	O	-1	15985056
ability	O	-1	15985056
s@@	O	-1	15985056
cal@@	O	-1	15985056
e	O	-1	15985056
this	O	-1	15985056
ev@@	O	-1	15985056
ent	O	-1	15985056
could	O	-1	15985056
be	O	-1	15985056
cl@@	O	-1	15985056
assi@@	O	-1	15985056
fied	O	-1	15985056
as	O	-1	15985056
possible	O	-1	15985056
(@@	O	-1	15985056
scor@@	O	-1	15985056
e	O	-1	15985056
5	O	-1	15985056
po@@	O	-1	15985056
int@@	O	-1	15985056
s),	O	-1	15985056
mo@@	O	-1	15985056
st@@	O	-1	15985056
ly	O	-1	15985056
because	O	-1	15985056
of	O	-1	15985056
the	O	-1	15985056
clo@@	O	-1	15985056
se	O	-1	15985056
tempor@@	O	-1	15985056
al	O	-1	15985056
sequ@@	O	-1	15985056
ence@@	O	-1	15985056
,	O	-1	15985056
previ@@	O	-1	15985056
ous	O	-1	15985056
reports	O	-1	15985056
on	O	-1	15985056
this	O	-1	15985056
reaction	O	-1	15985056
with	O	-1	15985056
other	O	-1	15985056
mac@@	B-Chemical	D018942	15985056
ro@@	I-Chemical	-1	15985056
li@@	I-Chemical	-1	15985056
des	I-Chemical	-1	15985056
and	O	-1	15985056
the	O	-1	15985056
absence	O	-1	15985056
of	O	-1	15985056
any	O	-1	15985056
al@@	O	-1	15985056
tern@@	O	-1	15985056
ative	O	-1	15985056
expl@@	O	-1	15985056
an@@	O	-1	15985056
ation	O	-1	15985056
for	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
.	O	-1	15985056
Our	O	-1	15985056
hypo@@	O	-1	15985056
thesis	O	-1	15985056
is	O	-1	15985056
that	O	-1	15985056
a	O	-1	15985056
v@@	O	-1	15985056
ag@@	O	-1	15985056
al	O	-1	15985056
mechanism	O	-1	15985056
mediated	O	-1	15985056
by	O	-1	15985056
az@@	B-Chemical	D017963	15985056
i@@	I-Chemical	-1	15985056
throm@@	I-Chemical	-1	15985056
ycin	I-Chemical	-1	15985056
could	O	-1	15985056
be	O	-1	15985056
the	O	-1	15985056
path@@	O	-1	15985056
o@@	O	-1	15985056
genesis	O	-1	15985056
of	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
in	O	-1	15985056
our	O	-1	15985056
patient@@	O	-1	15985056
.	O	-1	15985056
CONCLUSIONS:	O	-1	15985056
Di@@	O	-1	15985056
ag@@	O	-1	15985056
no@@	O	-1	15985056
sis	O	-1	15985056
of	O	-1	15985056
drug@@	O	-1	15985056
-induced	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
is	O	-1	15985056
diff@@	O	-1	15985056
ic@@	O	-1	15985056
ult	O	-1	15985056
and	O	-1	15985056
often	O	-1	15985056
achi@@	O	-1	15985056
ev@@	O	-1	15985056
ed	O	-1	15985056
only	O	-1	15985056
by	O	-1	15985056
a	O	-1	15985056
pro@@	O	-1	15985056
cess	O	-1	15985056
of	O	-1	15985056
el@@	O	-1	15985056
im@@	O	-1	15985056
in@@	O	-1	15985056
ation.	O	-1	15985056
However,	O	-1	15985056
mac@@	B-Chemical	D018942	15985056
ro@@	I-Chemical	-1	15985056
l@@	I-Chemical	-1	15985056
ide	I-Chemical	-1	15985056
anti@@	O	-1	15985056
micro@@	O	-1	15985056
b@@	O	-1	15985056
i@@	O	-1	15985056
als	O	-1	15985056
have	O	-1	15985056
been	O	-1	15985056
reported	O	-1	15985056
to	O	-1	15985056
be	O	-1	15985056
associated	O	-1	15985056
with	O	-1	15985056
h@@	B-Disease	D006606	15985056
ic@@	I-Disease	-1	15985056
c@@	I-Disease	-1	15985056
up@@	I-Disease	-1	15985056
s	I-Disease	-1	15985056
and	O	-1	15985056
v@@	O	-1	15985056
ag@@	O	-1	15985056
al	O	-1	15985056
mechanism	O	-1	15985056
could	O	-1	15985056
expl@@	O	-1	15985056
ain	O	-1	15985056
the	O	-1	15985056
development	O	-1	15985056
of	O	-1	15985056
this	O	-1	15985056
side@@	O	-1	15985056
-@@	O	-1	15985056
effect@@	O	-1	15985056
.	O	-1	15985056

T@@	O	-1	15276120
im@@	O	-1	15276120
e	O	-1	15276120
tre@@	O	-1	15276120
n@@	O	-1	15276120
ds	O	-1	15276120
in	O	-1	15276120
war@@	B-Chemical	D014859	15276120
farin	I-Chemical	-1	15276120
-@@	O	-1	15276120
associated	O	-1	15276120
hemorrh@@	B-Disease	D006470	15276120
age	I-Disease	-1	15276120
.	O	-1	15276120
The	O	-1	15276120
an@@	O	-1	15276120
n@@	O	-1	15276120
ual	O	-1	15276120
incidence	O	-1	15276120
of	O	-1	15276120
war@@	B-Chemical	D014859	15276120
farin	I-Chemical	-1	15276120
-@@	O	-1	15276120
related	O	-1	15276120
ble@@	B-Disease	D006470	15276120
ed@@	I-Disease	-1	15276120
ing	I-Disease	-1	15276120
at	O	-1	15276120
B@@	O	-1	15276120
rig@@	O	-1	15276120
ha@@	O	-1	15276120
m	O	-1	15276120
and	O	-1	15276120
W@@	O	-1	15276120
om@@	O	-1	15276120
en@@	O	-1	15276120
's	O	-1	15276120
H@@	O	-1	15276120
ospit@@	O	-1	15276120
al	O	-1	15276120
increased	O	-1	15276120
from	O	-1	15276120
0.@@	O	-1	15276120
9@@	O	-1	15276120
7@@	O	-1	15276120
/@@	O	-1	15276120
1@@	O	-1	15276120
,@@	O	-1	15276120
0@@	O	-1	15276120
00	O	-1	15276120
patient	O	-1	15276120
ad@@	O	-1	15276120
mis@@	O	-1	15276120
sions	O	-1	15276120
in	O	-1	15276120
the	O	-1	15276120
first	O	-1	15276120
time	O	-1	15276120
period	O	-1	15276120
(@@	O	-1	15276120
J@@	O	-1	15276120
an@@	O	-1	15276120
u@@	O	-1	15276120
ary	O	-1	15276120
19@@	O	-1	15276120
9@@	O	-1	15276120
5	O	-1	15276120
to	O	-1	15276120
O@@	O	-1	15276120
c@@	O	-1	15276120
to@@	O	-1	15276120
b@@	O	-1	15276120
er	O	-1	15276120
19@@	O	-1	15276120
9@@	O	-1	15276120
8@@	O	-1	15276120
)	O	-1	15276120
to	O	-1	15276120
1.@@	O	-1	15276120
19@@	O	-1	15276120
/@@	O	-1	15276120
1@@	O	-1	15276120
,@@	O	-1	15276120
0@@	O	-1	15276120
00	O	-1	15276120
patient	O	-1	15276120
ad@@	O	-1	15276120
mis@@	O	-1	15276120
sions	O	-1	15276120
in	O	-1	15276120
the	O	-1	15276120
second	O	-1	15276120
time	O	-1	15276120
period	O	-1	15276120
(N@@	O	-1	15276120
o@@	O	-1	15276120
ve@@	O	-1	15276120
mb@@	O	-1	15276120
er	O	-1	15276120
19@@	O	-1	15276120
9@@	O	-1	15276120
8	O	-1	15276120
to	O	-1	15276120
A@@	O	-1	15276120
u@@	O	-1	15276120
g@@	O	-1	15276120
us@@	O	-1	15276120
t	O	-1	15276120
20@@	O	-1	15276120
0@@	O	-1	15276120
2)	O	-1	15276120
of	O	-1	15276120
this	O	-1	15276120
study.	O	-1	15276120
The	O	-1	15276120
pro@@	O	-1	15276120
por@@	O	-1	15276120
tion	O	-1	15276120
of	O	-1	15276120
patients	O	-1	15276120
with	O	-1	15276120
major	O	-1	15276120
and	O	-1	15276120
intrac@@	B-Disease	D020300	15276120
ranial	I-Disease	-1	15276120
ble@@	I-Disease	-1	15276120
ed@@	I-Disease	-1	15276120
ing	I-Disease	-1	15276120
increased	O	-1	15276120
from	O	-1	15276120
2@@	O	-1	15276120
0.@@	O	-1	15276120
2@@	O	-1	15276120
%	O	-1	15276120
and	O	-1	15276120
1.@@	O	-1	15276120
9@@	O	-1	15276120
%,	O	-1	15276120
respectivel@@	O	-1	15276120
y,	O	-1	15276120
in	O	-1	15276120
the	O	-1	15276120
first	O	-1	15276120
time	O	-1	15276120
perio@@	O	-1	15276120
d,	O	-1	15276120
to	O	-1	15276120
3@@	O	-1	15276120
3.@@	O	-1	15276120
3@@	O	-1	15276120
%	O	-1	15276120
and	O	-1	15276120
7.@@	O	-1	15276120
8@@	O	-1	15276120
%,	O	-1	15276120
respectivel@@	O	-1	15276120
y,	O	-1	15276120
in	O	-1	15276120
the	O	-1	15276120
secon@@	O	-1	15276120
d.	O	-1	15276120

F@@	O	-1	11271907
atal	O	-1	11271907
haem@@	B-Disease	D006470	11271907
or@@	I-Disease	-1	11271907
rh@@	I-Disease	-1	11271907
ag@@	I-Disease	-1	11271907
ic	I-Disease	-1	11271907
myocardi@@	I-Disease	-1	11271907
tis	I-Disease	-1	11271907
haem@@	B-Disease	D009205	11271907
or@@	I-Disease	-1	11271907
rh@@	I-Disease	-1	11271907
ag@@	I-Disease	-1	11271907
ic	I-Disease	-1	11271907
myocardi@@	I-Disease	-1	11271907
tis	I-Disease	-1	11271907
secondary	O	-1	11271907
to	O	-1	11271907
cyclophosph@@	B-Chemical	D003520	11271907
amide	I-Chemical	-1	11271907
therapy.	O	-1	11271907
H@@	B-Disease	D006470	11271907
a@@	I-Disease	-1	11271907
em@@	I-Disease	-1	11271907
or@@	I-Disease	-1	11271907
rh@@	I-Disease	-1	11271907
ag@@	I-Disease	-1	11271907
ic	I-Disease	-1	11271907
myocardi@@	I-Disease	-1	11271907
tis	I-Disease	-1	11271907
H@@	B-Disease	D009205	11271907
a@@	I-Disease	-1	11271907
em@@	I-Disease	-1	11271907
or@@	I-Disease	-1	11271907
rh@@	I-Disease	-1	11271907
ag@@	I-Disease	-1	11271907
ic	I-Disease	-1	11271907
myocardi@@	I-Disease	-1	11271907
tis	I-Disease	-1	11271907
is	O	-1	11271907
a	O	-1	11271907
r@@	O	-1	11271907
are	O	-1	11271907
but	O	-1	11271907
important	O	-1	11271907
complication	O	-1	11271907
of	O	-1	11271907
cyclophosph@@	B-Chemical	D003520	11271907
amide	I-Chemical	-1	11271907
therapy.	O	-1	11271907
E@@	O	-1	11271907
ch@@	O	-1	11271907
ocardiograph@@	O	-1	11271907
ic	O	-1	11271907
identi@@	O	-1	11271907
fic@@	O	-1	11271907
ation	O	-1	11271907
of	O	-1	11271907
the	O	-1	11271907
disor@@	O	-1	11271907
der	O	-1	11271907
can	O	-1	11271907
be	O	-1	11271907
ma@@	O	-1	11271907
de@@	O	-1	11271907
.	O	-1	11271907
We	O	-1	11271907
be@@	O	-1	11271907
li@@	O	-1	11271907
e@@	O	-1	11271907
ve	O	-1	11271907
that	O	-1	11271907
the	O	-1	11271907
ult@@	O	-1	11271907
r@@	O	-1	11271907
as@@	O	-1	11271907
ound	O	-1	11271907
feat@@	O	-1	11271907
ures	O	-1	11271907
of	O	-1	11271907
this	O	-1	11271907
disor@@	O	-1	11271907
der	O	-1	11271907
have	O	-1	11271907
not	O	-1	11271907
been	O	-1	11271907
previously	O	-1	11271907
repor@@	O	-1	11271907
ted.	O	-1	11271907

G@@	B-Chemical	D005996	10524660
l@@	I-Chemical	-1	10524660
yc@@	I-Chemical	-1	10524660
ery@@	I-Chemical	-1	10524660
l	I-Chemical	-1	10524660
tr@@	I-Chemical	-1	10524660
in@@	I-Chemical	-1	10524660
it@@	I-Chemical	-1	10524660
rate	I-Chemical	-1	10524660
induc@@	O	-1	10524660
es	O	-1	10524660
at@@	O	-1	10524660
tac@@	O	-1	10524660
k@@	O	-1	10524660
s	O	-1	10524660
of	O	-1	10524660
migra@@	B-Disease	D020326	10524660
ine	I-Disease	-1	10524660
without	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
in	O	-1	10524660
su@@	O	-1	10524660
ffe@@	O	-1	10524660
re@@	O	-1	10524660
r@@	O	-1	10524660
s	O	-1	10524660
of	O	-1	10524660
migra@@	B-Disease	D020325	10524660
ine	I-Disease	-1	10524660
with	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
.	O	-1	10524660
M@@	B-Disease	D020325	10524660
i@@	I-Disease	-1	10524660
gra@@	I-Disease	-1	10524660
ine	I-Disease	-1	10524660
with	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
and	O	-1	10524660
migra@@	B-Disease	D020326	10524660
ine	I-Disease	-1	10524660
without	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
have	O	-1	10524660
the	O	-1	10524660
same	O	-1	10524660
pain	B-Disease	D010146	10524660
ph@@	O	-1	10524660
ase,	O	-1	10524660
th@@	O	-1	10524660
us	O	-1	10524660
indicating	O	-1	10524660
that	O	-1	10524660
migra@@	B-Disease	D020325	10524660
ine	I-Disease	-1	10524660
with	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
and	O	-1	10524660
migra@@	B-Disease	D020326	10524660
ine	I-Disease	-1	10524660
without	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
sh@@	O	-1	10524660
are	O	-1	10524660
a	O	-1	10524660
common	O	-1	10524660
path@@	O	-1	10524660
w@@	O	-1	10524660
ay	O	-1	10524660
of	O	-1	10524660
n@@	O	-1	10524660
ocicep@@	O	-1	10524660
tion.	O	-1	10524660
In	O	-1	10524660
rec@@	O	-1	10524660
ent	O	-1	10524660
year@@	O	-1	10524660
s,	O	-1	10524660
increas@@	O	-1	10524660
ing	O	-1	10524660
evidence	O	-1	10524660
has	O	-1	10524660
suggested	O	-1	10524660
that	O	-1	10524660
the	O	-1	10524660
m@@	O	-1	10524660
es@@	O	-1	10524660
sen@@	O	-1	10524660
g@@	O	-1	10524660
er	O	-1	10524660
mol@@	O	-1	10524660
ec@@	O	-1	10524660
ul@@	O	-1	10524660
e	O	-1	10524660
nit@@	B-Chemical	D009569	10524660
ric	I-Chemical	-1	10524660
ox@@	I-Chemical	-1	10524660
ide	I-Chemical	-1	10524660
(	O	-1	10524660
N@@	B-Chemical	D009569	10524660
O	I-Chemical	-1	10524660
)	O	-1	10524660
is	O	-1	10524660
involved	O	-1	10524660
in	O	-1	10524660
pain	B-Disease	D010146	10524660
mechanisms	O	-1	10524660
of	O	-1	10524660
migra@@	B-Disease	D020326	10524660
ine	I-Disease	-1	10524660
without	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
.	O	-1	10524660
In	O	-1	10524660
or@@	O	-1	10524660
der	O	-1	10524660
to	O	-1	10524660
cl@@	O	-1	10524660
ar@@	O	-1	10524660
if@@	O	-1	10524660
y	O	-1	10524660
whether	O	-1	10524660
the	O	-1	10524660
same	O	-1	10524660
is	O	-1	10524660
t@@	O	-1	10524660
ru@@	O	-1	10524660
e	O	-1	10524660
for	O	-1	10524660
migra@@	B-Disease	D020325	10524660
ine	I-Disease	-1	10524660
with	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
,	O	-1	10524660
in	O	-1	10524660
the	O	-1	10524660
present	O	-1	10524660
study	O	-1	10524660
we	O	-1	10524660
examined	O	-1	10524660
the	O	-1	10524660
headac@@	B-Disease	D006261	10524660
he	I-Disease	-1	10524660
response	O	-1	10524660
to	O	-1	10524660
intravenous	O	-1	10524660
infusion	O	-1	10524660
of	O	-1	10524660
glyc@@	B-Chemical	D005996	10524660
ery@@	I-Chemical	-1	10524660
l	I-Chemical	-1	10524660
tr@@	I-Chemical	-1	10524660
in@@	I-Chemical	-1	10524660
it@@	I-Chemical	-1	10524660
rate	I-Chemical	-1	10524660
(	O	-1	10524660
G@@	B-Chemical	D005996	10524660
T@@	I-Chemical	-1	10524660
N	I-Chemical	-1	10524660
)	O	-1	10524660
(0.@@	O	-1	10524660
5	O	-1	10524660
micro@@	O	-1	10524660
g/@@	O	-1	10524660
k@@	O	-1	10524660
g/@@	O	-1	10524660
min	O	-1	10524660
for	O	-1	10524660
20	O	-1	10524660
min@@	O	-1	10524660
)	O	-1	10524660
in	O	-1	10524660
12	O	-1	10524660
su@@	O	-1	10524660
ffe@@	O	-1	10524660
re@@	O	-1	10524660
r@@	O	-1	10524660
s	O	-1	10524660
of	O	-1	10524660
migra@@	B-Disease	D020325	10524660
ine	I-Disease	-1	10524660
with	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
.	O	-1	10524660
The	O	-1	10524660
specific	O	-1	10524660
a@@	O	-1	10524660
im	O	-1	10524660
was	O	-1	10524660
to	O	-1	10524660
el@@	O	-1	10524660
uc@@	O	-1	10524660
id@@	O	-1	10524660
ate	O	-1	10524660
whether	O	-1	10524660
an	O	-1	10524660
a@@	O	-1	10524660
ur@@	O	-1	10524660
a	O	-1	10524660
and/or	O	-1	10524660
an	O	-1	10524660
at@@	O	-1	10524660
tac@@	O	-1	10524660
k	O	-1	10524660
of	O	-1	10524660
migra@@	B-Disease	D020326	10524660
ine	I-Disease	-1	10524660
without	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
could	O	-1	10524660
be	O	-1	10524660
induc@@	O	-1	10524660
ed.	O	-1	10524660
F@@	O	-1	10524660
o@@	O	-1	10524660
ur@@	O	-1	10524660
te@@	O	-1	10524660
en	O	-1	10524660
healthy	O	-1	10524660
subjects	O	-1	10524660
ser@@	O	-1	10524660
ved	O	-1	10524660
as	O	-1	10524660
controls.	O	-1	10524660
A@@	O	-1	10524660
ur@@	O	-1	10524660
a	O	-1	10524660
symptoms	O	-1	10524660
were	O	-1	10524660
not	O	-1	10524660
el@@	O	-1	10524660
ic@@	O	-1	10524660
ited	O	-1	10524660
in	O	-1	10524660
any	O	-1	10524660
subj@@	O	-1	10524660
ect@@	O	-1	10524660
.	O	-1	10524660
He@@	B-Disease	D006261	10524660
ad@@	I-Disease	-1	10524660
ac@@	I-Disease	-1	10524660
he	I-Disease	-1	10524660
was	O	-1	10524660
more	O	-1	10524660
severe	O	-1	10524660
in	O	-1	10524660
migra@@	B-Disease	D008881	10524660
ine@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
s	I-Disease	-1	10524660
than	O	-1	10524660
in	O	-1	10524660
the	O	-1	10524660
controls	O	-1	10524660
during	O	-1	10524660
and	O	-1	10524660
immedi@@	O	-1	10524660
ately	O	-1	10524660
after	O	-1	10524660
G@@	B-Chemical	D005996	10524660
T@@	I-Chemical	-1	10524660
N	I-Chemical	-1	10524660
infusion	O	-1	10524660
(p@@	O	-1	10524660
=@@	O	-1	10524660
0.0@@	O	-1	10524660
3@@	O	-1	10524660
7@@	O	-1	10524660
)	O	-1	10524660
as	O	-1	10524660
well	O	-1	10524660
as	O	-1	10524660
during	O	-1	10524660
the	O	-1	10524660
following	O	-1	10524660
11	O	-1	10524660
h	O	-1	10524660
(p	O	-1	10524660
=	O	-1	10524660
0.00@@	O	-1	10524660
8@@	O	-1	10524660
).	O	-1	10524660
In	O	-1	10524660
the	O	-1	10524660
control@@	O	-1	10524660
s,	O	-1	10524660
the	O	-1	10524660
G@@	B-Chemical	D005996	10524660
T@@	I-Chemical	-1	10524660
N	I-Chemical	-1	10524660
-induced	O	-1	10524660
headac@@	B-Disease	D006261	10524660
he	I-Disease	-1	10524660
gra@@	O	-1	10524660
du@@	O	-1	10524660
ally	O	-1	10524660
dis@@	O	-1	10524660
appe@@	O	-1	10524660
a@@	O	-1	10524660
re@@	O	-1	10524660
d,	O	-1	10524660
whereas	O	-1	10524660
in	O	-1	10524660
migra@@	B-Disease	D008881	10524660
ine@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
s	I-Disease	-1	10524660
pe@@	O	-1	10524660
a@@	O	-1	10524660
k	O	-1	10524660
headac@@	B-Disease	D006261	10524660
he	I-Disease	-1	10524660
int@@	O	-1	10524660
ensity	O	-1	10524660
occurred	O	-1	10524660
at	O	-1	10524660
a	O	-1	10524660
mean	O	-1	10524660
time	O	-1	10524660
of	O	-1	10524660
2@@	O	-1	10524660
40	O	-1	10524660
min	O	-1	10524660
post@@	O	-1	10524660
-@@	O	-1	10524660
infu@@	O	-1	10524660
sion.	O	-1	10524660
A@@	O	-1	10524660
t	O	-1	10524660
this	O	-1	10524660
time	O	-1	10524660
the	O	-1	10524660
induced	O	-1	10524660
headac@@	B-Disease	D006261	10524660
he	I-Disease	-1	10524660
in	O	-1	10524660
6	O	-1	10524660
of	O	-1	10524660
12	O	-1	10524660
migra@@	B-Disease	D008881	10524660
ine@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
s	I-Disease	-1	10524660
ful@@	O	-1	10524660
f@@	O	-1	10524660
ill@@	O	-1	10524660
ed	O	-1	10524660
the	O	-1	10524660
diagnos@@	O	-1	10524660
tic	O	-1	10524660
c@@	O	-1	10524660
rit@@	O	-1	10524660
er@@	O	-1	10524660
ia	O	-1	10524660
for	O	-1	10524660
migra@@	B-Disease	D020326	10524660
ine	I-Disease	-1	10524660
without	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
of	O	-1	10524660
the	O	-1	10524660
In@@	O	-1	10524660
tern@@	O	-1	10524660
ation@@	O	-1	10524660
al	O	-1	10524660
He@@	B-Disease	D006261	10524660
ad@@	I-Disease	-1	10524660
ac@@	I-Disease	-1	10524660
he	I-Disease	-1	10524660
S@@	O	-1	10524660
oci@@	O	-1	10524660
et@@	O	-1	10524660
y.	O	-1	10524660
The	O	-1	10524660
results	O	-1	10524660
the@@	O	-1	10524660
re@@	O	-1	10524660
fore	O	-1	10524660
suggest	O	-1	10524660
that	O	-1	10524660
N@@	B-Chemical	D009569	10524660
O	I-Chemical	-1	10524660
is	O	-1	10524660
involved	O	-1	10524660
in	O	-1	10524660
the	O	-1	10524660
pain	B-Disease	D010146	10524660
mechanisms	O	-1	10524660
of	O	-1	10524660
migra@@	B-Disease	D020325	10524660
ine	I-Disease	-1	10524660
with	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
.	O	-1	10524660
S@@	O	-1	10524660
inc@@	O	-1	10524660
e	O	-1	10524660
cor@@	O	-1	10524660
tical	O	-1	10524660
s@@	O	-1	10524660
pre@@	O	-1	10524660
ad@@	O	-1	10524660
ing	O	-1	10524660
de@@	B-Disease	D003866	10524660
pression	I-Disease	-1	10524660
has	O	-1	10524660
been	O	-1	10524660
shown	O	-1	10524660
to	O	-1	10524660
li@@	O	-1	10524660
b@@	O	-1	10524660
er@@	O	-1	10524660
ate	O	-1	10524660
N@@	B-Chemical	D009569	10524660
O	I-Chemical	-1	10524660
in	O	-1	10524660
anim@@	O	-1	10524660
al@@	O	-1	10524660
s,	O	-1	10524660
this	O	-1	10524660
find@@	O	-1	10524660
ing	O	-1	10524660
may	O	-1	10524660
he@@	O	-1	10524660
l@@	O	-1	10524660
p	O	-1	10524660
our	O	-1	10524660
under@@	O	-1	10524660
stand@@	O	-1	10524660
ing	O	-1	10524660
of	O	-1	10524660
the	O	-1	10524660
co@@	O	-1	10524660
u@@	O	-1	10524660
pl@@	O	-1	10524660
ing	O	-1	10524660
between	O	-1	10524660
cor@@	O	-1	10524660
tical	O	-1	10524660
s@@	O	-1	10524660
pre@@	O	-1	10524660
ad@@	O	-1	10524660
ing	O	-1	10524660
de@@	B-Disease	D003866	10524660
pression	I-Disease	-1	10524660
and	O	-1	10524660
headac@@	B-Disease	D006261	10524660
he	I-Disease	-1	10524660
in	O	-1	10524660
migra@@	B-Disease	D020325	10524660
ine	I-Disease	-1	10524660
with	I-Disease	-1	10524660
a@@	I-Disease	-1	10524660
ur@@	I-Disease	-1	10524660
a	I-Disease	-1	10524660
.	O	-1	10524660

S@@	B-Disease	D020521	9799166
tro@@	I-Disease	-1	9799166
k@@	I-Disease	-1	9799166
e	I-Disease	-1	9799166
and	O	-1	9799166
cocaine	B-Chemical	D003042	9799166
or	O	-1	9799166
amphetamine	B-Chemical	D000661	9799166
use.	O	-1	9799166
The	O	-1	9799166
association	O	-1	9799166
of	O	-1	9799166
cocaine	B-Chemical	D003042	9799166
and	O	-1	9799166
amphetamine	B-Chemical	D000661	9799166
use	O	-1	9799166
with	O	-1	9799166
hemorrh@@	O	-1	9799166
ag@@	O	-1	9799166
ic	O	-1	9799166
and	O	-1	9799166
ischem@@	B-Disease	D007511	9799166
ic	I-Disease	-1	9799166
strok@@	B-Disease	D020521	9799166
e	I-Disease	-1	9799166
is	O	-1	9799166
bas@@	O	-1	9799166
ed	O	-1	9799166
al@@	O	-1	9799166
most	O	-1	9799166
sol@@	O	-1	9799166
ely	O	-1	9799166
on	O	-1	9799166
data	O	-1	9799166
from	O	-1	9799166
case	O	-1	9799166
seri@@	O	-1	9799166
es.	O	-1	9799166
The	O	-1	9799166
lim@@	O	-1	9799166
ited	O	-1	9799166
number	O	-1	9799166
of	O	-1	9799166
epi@@	O	-1	9799166
de@@	O	-1	9799166
m@@	O	-1	9799166
io@@	O	-1	9799166
log@@	O	-1	9799166
ic	O	-1	9799166
studies	O	-1	9799166
of	O	-1	9799166
strok@@	B-Disease	D020521	9799166
e	I-Disease	-1	9799166
and	O	-1	9799166
use	O	-1	9799166
of	O	-1	9799166
cocaine	B-Chemical	D003042	9799166
and/or	O	-1	9799166
amphetamine	B-Chemical	D000661	9799166
have	O	-1	9799166
been	O	-1	9799166
d@@	O	-1	9799166
one	O	-1	9799166
in	O	-1	9799166
se@@	O	-1	9799166
t@@	O	-1	9799166
t@@	O	-1	9799166
ings	O	-1	9799166
that	O	-1	9799166
ser@@	O	-1	9799166
ve	O	-1	9799166
mo@@	O	-1	9799166
st@@	O	-1	9799166
ly	O	-1	9799166
the	O	-1	9799166
po@@	O	-1	9799166
or	O	-1	9799166
and/or	O	-1	9799166
min@@	O	-1	9799166
or@@	O	-1	9799166
iti@@	O	-1	9799166
es.	O	-1	9799166
This	O	-1	9799166
cas@@	O	-1	9799166
e-@@	O	-1	9799166
control	O	-1	9799166
study	O	-1	9799166
was	O	-1	9799166
con@@	O	-1	9799166
duc@@	O	-1	9799166
ted	O	-1	9799166
in	O	-1	9799166
the	O	-1	9799166
def@@	O	-1	9799166
in@@	O	-1	9799166
ed	O	-1	9799166
po@@	O	-1	9799166
p@@	O	-1	9799166
ulation	O	-1	9799166
comp@@	O	-1	9799166
ris@@	O	-1	9799166
ing	O	-1	9799166
memb@@	O	-1	9799166
ers	O	-1	9799166
of	O	-1	9799166
K@@	O	-1	9799166
a@@	O	-1	9799166
is@@	O	-1	9799166
er	O	-1	9799166
P@@	O	-1	9799166
er@@	O	-1	9799166
man@@	O	-1	9799166
ent@@	O	-1	9799166
e	O	-1	9799166
of	O	-1	9799166
N@@	O	-1	9799166
or@@	O	-1	9799166
ther@@	O	-1	9799166
n	O	-1	9799166
and	O	-1	9799166
S@@	O	-1	9799166
ou@@	O	-1	9799166
ther@@	O	-1	9799166
n	O	-1	9799166
C@@	O	-1	9799166
al@@	O	-1	9799166
if@@	O	-1	9799166
or@@	O	-1	9799166
n@@	O	-1	9799166
ia.	O	-1	9799166
We	O	-1	9799166
at@@	O	-1	9799166
tem@@	O	-1	9799166
pt@@	O	-1	9799166
ed	O	-1	9799166
to	O	-1	9799166
identi@@	O	-1	9799166
f@@	O	-1	9799166
y	O	-1	9799166
all	O	-1	9799166
inc@@	O	-1	9799166
id@@	O	-1	9799166
ent	O	-1	9799166
strok@@	B-Disease	D020521	9799166
es	I-Disease	-1	9799166
in	O	-1	9799166
women	O	-1	9799166
ages	O	-1	9799166
1@@	O	-1	9799166
5-@@	O	-1	9799166
4@@	O	-1	9799166
4	O	-1	9799166
years	O	-1	9799166
during	O	-1	9799166
a	O	-1	9799166
3-@@	O	-1	9799166
year	O	-1	9799166
period	O	-1	9799166
using	O	-1	9799166
hospit@@	O	-1	9799166
al	O	-1	9799166
ad@@	O	-1	9799166
mission	O	-1	9799166
and	O	-1	9799166
dis@@	O	-1	9799166
ch@@	O	-1	9799166
arg@@	O	-1	9799166
e	O	-1	9799166
recor@@	O	-1	9799166
d@@	O	-1	9799166
s,	O	-1	9799166
em@@	O	-1	9799166
er@@	O	-1	9799166
gen@@	O	-1	9799166
c@@	O	-1	9799166
y	O	-1	9799166
de@@	O	-1	9799166
part@@	O	-1	9799166
ment	O	-1	9799166
log@@	O	-1	9799166
s,	O	-1	9799166
and	O	-1	9799166
pa@@	O	-1	9799166
y@@	O	-1	9799166
ment	O	-1	9799166
requ@@	O	-1	9799166
est@@	O	-1	9799166
s	O	-1	9799166
for	O	-1	9799166
out@@	O	-1	9799166
-@@	O	-1	9799166
of@@	O	-1	9799166
-@@	O	-1	9799166
pl@@	O	-1	9799166
an	O	-1	9799166
hospit@@	O	-1	9799166
al@@	O	-1	9799166
iz@@	O	-1	9799166
ations.	O	-1	9799166
We	O	-1	9799166
sel@@	O	-1	9799166
ected	O	-1	9799166
control@@	O	-1	9799166
s,	O	-1	9799166
mat@@	O	-1	9799166
ch@@	O	-1	9799166
ed	O	-1	9799166
on	O	-1	9799166
age	O	-1	9799166
and	O	-1	9799166
fac@@	O	-1	9799166
ility	O	-1	9799166
of	O	-1	9799166
us@@	O	-1	9799166
ual	O	-1	9799166
ca@@	O	-1	9799166
re,	O	-1	9799166
at	O	-1	9799166
ran@@	O	-1	9799166
do@@	O	-1	9799166
m	O	-1	9799166
from	O	-1	9799166
healthy	O	-1	9799166
memb@@	O	-1	9799166
ers	O	-1	9799166
of	O	-1	9799166
the	O	-1	9799166
heal@@	O	-1	9799166
th	O	-1	9799166
pl@@	O	-1	9799166
an@@	O	-1	9799166
.	O	-1	9799166
We	O	-1	9799166
obtained	O	-1	9799166
inf@@	O	-1	9799166
orm@@	O	-1	9799166
ation	O	-1	9799166
in	O	-1	9799166
fac@@	O	-1	9799166
e-@@	O	-1	9799166
to@@	O	-1	9799166
-@@	O	-1	9799166
fac@@	O	-1	9799166
e	O	-1	9799166
inter@@	O	-1	9799166
vie@@	O	-1	9799166
w@@	O	-1	9799166
s.	O	-1	9799166
There	O	-1	9799166
were	O	-1	9799166
34@@	O	-1	9799166
7	O	-1	9799166
con@@	O	-1	9799166
fir@@	O	-1	9799166
m@@	O	-1	9799166
ed	O	-1	9799166
strok@@	B-Disease	D020521	9799166
e	I-Disease	-1	9799166
cases	O	-1	9799166
and	O	-1	9799166
1@@	O	-1	9799166
,@@	O	-1	9799166
0@@	O	-1	9799166
21	O	-1	9799166
controls.	O	-1	9799166
The	O	-1	9799166
un@@	O	-1	9799166
i@@	O	-1	9799166
vari@@	O	-1	9799166
ate	O	-1	9799166
mat@@	O	-1	9799166
ch@@	O	-1	9799166
ed	O	-1	9799166
o@@	O	-1	9799166
d@@	O	-1	9799166
ds	O	-1	9799166
rati@@	O	-1	9799166
o	O	-1	9799166
for	O	-1	9799166
strok@@	B-Disease	D020521	9799166
e	I-Disease	-1	9799166
in	O	-1	9799166
women	O	-1	9799166
who	O	-1	9799166
ad@@	O	-1	9799166
mit@@	O	-1	9799166
ted	O	-1	9799166
to	O	-1	9799166
using	O	-1	9799166
cocaine	B-Chemical	D003042	9799166
and/or	O	-1	9799166
amphetamine	B-Chemical	D000661	9799166
was	O	-1	9799166
8.@@	O	-1	9799166
5	O	-1	9799166
(@@	O	-1	9799166
95%	O	-1	9799166
conf@@	O	-1	9799166
idence	O	-1	9799166
interv@@	O	-1	9799166
al	O	-1	9799166
=	O	-1	9799166
3.@@	O	-1	9799166
6-@@	O	-1	9799166
2@@	O	-1	9799166
0.0@@	O	-1	9799166
).	O	-1	9799166
After	O	-1	9799166
further	O	-1	9799166
adjust@@	O	-1	9799166
ment	O	-1	9799166
for	O	-1	9799166
potential	O	-1	9799166
conf@@	O	-1	9799166
oun@@	O	-1	9799166
der@@	O	-1	9799166
s,	O	-1	9799166
the	O	-1	9799166
o@@	O	-1	9799166
d@@	O	-1	9799166
ds	O	-1	9799166
rati@@	O	-1	9799166
o	O	-1	9799166
in	O	-1	9799166
women	O	-1	9799166
who	O	-1	9799166
reported	O	-1	9799166
using	O	-1	9799166
cocaine	B-Chemical	D003042	9799166
and/or	O	-1	9799166
amphetamine	B-Chemical	D000661	9799166
was	O	-1	9799166
7.@@	O	-1	9799166
0	O	-1	9799166
(@@	O	-1	9799166
95%	O	-1	9799166
conf@@	O	-1	9799166
idence	O	-1	9799166
interv@@	O	-1	9799166
al	O	-1	9799166
=	O	-1	9799166
2.@@	O	-1	9799166
8@@	O	-1	9799166
-1@@	O	-1	9799166
7.@@	O	-1	9799166
9@@	O	-1	9799166
).	O	-1	9799166
The	O	-1	9799166
use	O	-1	9799166
of	O	-1	9799166
cocaine	B-Chemical	D003042	9799166
and/or	O	-1	9799166
amphetamine	B-Chemical	D000661	9799166
is	O	-1	9799166
a	O	-1	9799166
st@@	O	-1	9799166
ron@@	O	-1	9799166
g	O	-1	9799166
risk	O	-1	9799166
factor	O	-1	9799166
for	O	-1	9799166
strok@@	B-Disease	D020521	9799166
e	I-Disease	-1	9799166
in	O	-1	9799166
this	O	-1	9799166
s@@	O	-1	9799166
oc@@	O	-1	9799166
io@@	O	-1	9799166
ec@@	O	-1	9799166
on@@	O	-1	9799166
om@@	O	-1	9799166
ically	O	-1	9799166
he@@	O	-1	9799166
ter@@	O	-1	9799166
o@@	O	-1	9799166
gene@@	O	-1	9799166
ou@@	O	-1	9799166
s,	O	-1	9799166
in@@	O	-1	9799166
su@@	O	-1	9799166
red	O	-1	9799166
urb@@	O	-1	9799166
an	O	-1	9799166
po@@	O	-1	9799166
pul@@	O	-1	9799166
ation.	O	-1	9799166

Pre@@	O	-1	9672273
ven@@	O	-1	9672273
tion	O	-1	9672273
of	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
with	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
:	O	-1	9672273
pre@@	O	-1	9672273
lim@@	O	-1	9672273
inary	O	-1	9672273
findings	O	-1	9672273
from	O	-1	9672273
the	O	-1	9672273
I@@	O	-1	9672273
t@@	O	-1	9672273
al@@	O	-1	9672273
i@@	O	-1	9672273
an	O	-1	9672273
random@@	O	-1	9672273
is@@	O	-1	9672273
ed	O	-1	9672273
trial	O	-1	9672273
among	O	-1	9672273
hy@@	O	-1	9672273
ste@@	O	-1	9672273
rec@@	O	-1	9672273
to@@	O	-1	9672273
mis@@	O	-1	9672273
ed	O	-1	9672273
wom@@	O	-1	9672273
en@@	O	-1	9672273
.	O	-1	9672273
I@@	O	-1	9672273
t@@	O	-1	9672273
al@@	O	-1	9672273
i@@	O	-1	9672273
an	O	-1	9672273
T@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
Pre@@	O	-1	9672273
ven@@	O	-1	9672273
tion	O	-1	9672273
S@@	O	-1	9672273
t@@	O	-1	9672273
ud@@	O	-1	9672273
y.	O	-1	9672273
BACKGROUND:	O	-1	9672273
T@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
is	O	-1	9672273
a	O	-1	9672273
can@@	O	-1	9672273
di@@	O	-1	9672273
d@@	O	-1	9672273
ate	O	-1	9672273
chemo@@	O	-1	9672273
pre@@	O	-1	9672273
ven@@	O	-1	9672273
tive	O	-1	9672273
agent	O	-1	9672273
in	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
,	O	-1	9672273
although	O	-1	9672273
the	O	-1	9672273
drug	O	-1	9672273
may	O	-1	9672273
be	O	-1	9672273
associated	O	-1	9672273
with	O	-1	9672273
the	O	-1	9672273
development	O	-1	9672273
of	O	-1	9672273
endo@@	B-Disease	D016889	9672273
me@@	I-Disease	-1	9672273
trial	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
.	O	-1	9672273
The@@	O	-1	9672273
re@@	O	-1	9672273
fore	O	-1	9672273
we	O	-1	9672273
did	O	-1	9672273
a	O	-1	9672273
trial	O	-1	9672273
in	O	-1	9672273
hy@@	O	-1	9672273
ste@@	O	-1	9672273
rec@@	O	-1	9672273
to@@	O	-1	9672273
mis@@	O	-1	9672273
ed	O	-1	9672273
women	O	-1	9672273
of	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
as	O	-1	9672273
a	O	-1	9672273
chemo@@	O	-1	9672273
pre@@	O	-1	9672273
ven@@	O	-1	9672273
ti@@	O	-1	9672273
ve.	O	-1	9672273
METHODS:	O	-1	9672273
In	O	-1	9672273
O@@	O	-1	9672273
c@@	O	-1	9672273
to@@	O	-1	9672273
b@@	O	-1	9672273
er,	O	-1	9672273
19@@	O	-1	9672273
9@@	O	-1	9672273
2,	O	-1	9672273
we	O	-1	9672273
star@@	O	-1	9672273
ted	O	-1	9672273
a	O	-1	9672273
double-bl@@	O	-1	9672273
ind	O	-1	9672273
placebo@@	O	-1	9672273
-@@	O	-1	9672273
control@@	O	-1	9672273
le@@	O	-1	9672273
d,	O	-1	9672273
random@@	O	-1	9672273
is@@	O	-1	9672273
ed	O	-1	9672273
trial	O	-1	9672273
of	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
in	O	-1	9672273
women	O	-1	9672273
(@@	O	-1	9672273
main@@	O	-1	9672273
ly	O	-1	9672273
in	O	-1	9672273
I@@	O	-1	9672273
t@@	O	-1	9672273
aly@@	O	-1	9672273
)	O	-1	9672273
who	O	-1	9672273
did	O	-1	9672273
not	O	-1	9672273
have	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
and	O	-1	9672273
who	O	-1	9672273
had	O	-1	9672273
had	O	-1	9672273
a	O	-1	9672273
hy@@	O	-1	9672273
ste@@	O	-1	9672273
rec@@	O	-1	9672273
to@@	O	-1	9672273
m@@	O	-1	9672273
y.	O	-1	9672273
W@@	O	-1	9672273
o@@	O	-1	9672273
men	O	-1	9672273
were	O	-1	9672273
random@@	O	-1	9672273
is@@	O	-1	9672273
ed	O	-1	9672273
to	O	-1	9672273
recei@@	O	-1	9672273
ve	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
20	O	-1	9672273
mg	O	-1	9672273
per	O	-1	9672273
day	O	-1	9672273
or	O	-1	9672273
placebo@@	O	-1	9672273
,	O	-1	9672273
both	O	-1	9672273
or@@	O	-1	9672273
ally	O	-1	9672273
for	O	-1	9672273
5	O	-1	9672273
year@@	O	-1	9672273
s.	O	-1	9672273
The	O	-1	9672273
or@@	O	-1	9672273
ig@@	O	-1	9672273
inal	O	-1	9672273
pl@@	O	-1	9672273
an	O	-1	9672273
was	O	-1	9672273
to	O	-1	9672273
fol@@	O	-1	9672273
low	O	-1	9672273
the	O	-1	9672273
inter@@	O	-1	9672273
ven@@	O	-1	9672273
tion	O	-1	9672273
phase	O	-1	9672273
by	O	-1	9672273
5	O	-1	9672273
year@@	O	-1	9672273
s@@	O	-1	9672273
'	O	-1	9672273
follow-@@	O	-1	9672273
up@@	O	-1	9672273
.	O	-1	9672273
In	O	-1	9672273
J@@	O	-1	9672273
un@@	O	-1	9672273
e,	O	-1	9672273
19@@	O	-1	9672273
9@@	O	-1	9672273
7@@	O	-1	9672273
,	O	-1	9672273
the	O	-1	9672273
tri@@	O	-1	9672273
al@@	O	-1	9672273
ist@@	O	-1	9672273
s	O	-1	9672273
and	O	-1	9672273
the	O	-1	9672273
dat@@	O	-1	9672273
a@@	O	-1	9672273
-@@	O	-1	9672273
monit@@	O	-1	9672273
or@@	O	-1	9672273
ing	O	-1	9672273
comm@@	O	-1	9672273
it@@	O	-1	9672273
te@@	O	-1	9672273
e	O	-1	9672273
dec@@	O	-1	9672273
id@@	O	-1	9672273
ed	O	-1	9672273
to	O	-1	9672273
end	O	-1	9672273
rec@@	O	-1	9672273
ru@@	O	-1	9672273
it@@	O	-1	9672273
ment	O	-1	9672273
prim@@	O	-1	9672273
ari@@	O	-1	9672273
ly	O	-1	9672273
because	O	-1	9672273
of	O	-1	9672273
the	O	-1	9672273
number	O	-1	9672273
of	O	-1	9672273
women	O	-1	9672273
dro@@	O	-1	9672273
pp@@	O	-1	9672273
ing	O	-1	9672273
out	O	-1	9672273
of	O	-1	9672273
the	O	-1	9672273
study.	O	-1	9672273
Rec@@	O	-1	9672273
ru@@	O	-1	9672273
it@@	O	-1	9672273
ment	O	-1	9672273
en@@	O	-1	9672273
ded	O	-1	9672273
on	O	-1	9672273
J@@	O	-1	9672273
ul@@	O	-1	9672273
y	O	-1	9672273
1@@	O	-1	9672273
1,	O	-1	9672273
19@@	O	-1	9672273
9@@	O	-1	9672273
7@@	O	-1	9672273
,	O	-1	9672273
and	O	-1	9672273
the	O	-1	9672273
study	O	-1	9672273
wil@@	O	-1	9672273
l	O	-1	9672273
continu@@	O	-1	9672273
e	O	-1	9672273
as	O	-1	9672273
pl@@	O	-1	9672273
an@@	O	-1	9672273
ne@@	O	-1	9672273
d.	O	-1	9672273
The	O	-1	9672273
prim@@	O	-1	9672273
ary	O	-1	9672273
en@@	O	-1	9672273
d@@	O	-1	9672273
po@@	O	-1	9672273
int@@	O	-1	9672273
s	O	-1	9672273
are	O	-1	9672273
the	O	-1	9672273
occur@@	O	-1	9672273
rence	O	-1	9672273
of	O	-1	9672273
and	O	-1	9672273
de@@	O	-1	9672273
ath@@	O	-1	9672273
s	O	-1	9672273
from	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
.	O	-1	9672273
This	O	-1	9672273
pre@@	O	-1	9672273
lim@@	O	-1	9672273
inary	O	-1	9672273
inter@@	O	-1	9672273
im	O	-1	9672273
analysis	O	-1	9672273
is	O	-1	9672273
bas@@	O	-1	9672273
ed	O	-1	9672273
on	O	-1	9672273
int@@	O	-1	9672273
en@@	O	-1	9672273
tion@@	O	-1	9672273
-@@	O	-1	9672273
to@@	O	-1	9672273
-@@	O	-1	9672273
treat@@	O	-1	9672273
.	O	-1	9672273
F@@	O	-1	9672273
IN@@	O	-1	9672273
D@@	O	-1	9672273
IN@@	O	-1	9672273
G@@	O	-1	9672273
S:	O	-1	9672273
5@@	O	-1	9672273
4@@	O	-1	9672273
0@@	O	-1	9672273
8	O	-1	9672273
women	O	-1	9672273
were	O	-1	9672273
ran@@	O	-1	9672273
do@@	O	-1	9672273
mi@@	O	-1	9672273
sed@@	O	-1	9672273
;	O	-1	9672273
partic@@	O	-1	9672273
ip@@	O	-1	9672273
ating	O	-1	9672273
women	O	-1	9672273
have	O	-1	9672273
a	O	-1	9672273
median	O	-1	9672273
follow-up	O	-1	9672273
of	O	-1	9672273
4@@	O	-1	9672273
6	O	-1	9672273
months	O	-1	9672273
for	O	-1	9672273
major	O	-1	9672273
en@@	O	-1	9672273
d@@	O	-1	9672273
po@@	O	-1	9672273
int@@	O	-1	9672273
s.	O	-1	9672273
4@@	O	-1	9672273
1	O	-1	9672273
cases	O	-1	9672273
of	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
occurred	O	-1	9672273
so	O	-1	9672273
far@@	O	-1	9672273
;	O	-1	9672273
there	O	-1	9672273
have	O	-1	9672273
been	O	-1	9672273
no	O	-1	9672273
de@@	O	-1	9672273
ath@@	O	-1	9672273
s	O	-1	9672273
from	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
.	O	-1	9672273
There	O	-1	9672273
is	O	-1	9672273
no	O	-1	9672273
difference	O	-1	9672273
in	O	-1	9672273
b@@	B-Disease	D001943	9672273
re@@	I-Disease	-1	9672273
ast@@	I-Disease	-1	9672273
-@@	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
frequency	O	-1	9672273
between	O	-1	9672273
the	O	-1	9672273
placebo	O	-1	9672273
(2@@	O	-1	9672273
2	O	-1	9672273
cas@@	O	-1	9672273
es@@	O	-1	9672273
)	O	-1	9672273
and	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
(1@@	O	-1	9672273
9@@	O	-1	9672273
)	O	-1	9672273
ar@@	O	-1	9672273
m@@	O	-1	9672273
s.	O	-1	9672273
There	O	-1	9672273
is	O	-1	9672273
a	O	-1	9672273
statis@@	O	-1	9672273
tically	O	-1	9672273
significant	O	-1	9672273
reduction	O	-1	9672273
of	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
among	O	-1	9672273
women	O	-1	9672273
receiving	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
who	O	-1	9672273
also	O	-1	9672273
used	O	-1	9672273
h@@	O	-1	9672273
orm@@	O	-1	9672273
on@@	O	-1	9672273
e-@@	O	-1	9672273
re@@	O	-1	9672273
pl@@	O	-1	9672273
ac@@	O	-1	9672273
ement	O	-1	9672273
therapy	O	-1	9672273
during	O	-1	9672273
the	O	-1	9672273
tri@@	O	-1	9672273
al@@	O	-1	9672273
:	O	-1	9672273
among	O	-1	9672273
3@@	O	-1	9672273
9@@	O	-1	9672273
0	O	-1	9672273
women	O	-1	9672273
on	O	-1	9672273
such	O	-1	9672273
therapy	O	-1	9672273
and	O	-1	9672273
al@@	O	-1	9672273
loc@@	O	-1	9672273
ated	O	-1	9672273
to	O	-1	9672273
placebo@@	O	-1	9672273
,	O	-1	9672273
we	O	-1	9672273
found	O	-1	9672273
e@@	O	-1	9672273
ight	O	-1	9672273
cases	O	-1	9672273
of	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
compared	O	-1	9672273
with	O	-1	9672273
one	O	-1	9672273
case	O	-1	9672273
among	O	-1	9672273
3@@	O	-1	9672273
6@@	O	-1	9672273
2	O	-1	9672273
women	O	-1	9672273
al@@	O	-1	9672273
loc@@	O	-1	9672273
ated	O	-1	9672273
to	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
.	O	-1	9672273
Com@@	O	-1	9672273
pared	O	-1	9672273
with	O	-1	9672273
the	O	-1	9672273
placebo	O	-1	9672273
group@@	O	-1	9672273
,	O	-1	9672273
there	O	-1	9672273
was	O	-1	9672273
a	O	-1	9672273
significantly	O	-1	9672273
increased	O	-1	9672273
risk	O	-1	9672273
of	O	-1	9672273
vascular	B-Disease	D014652	9672273
events	I-Disease	-1	9672273
and	O	-1	9672273
hyper@@	B-Disease	D015228	9672273
tri@@	I-Disease	-1	9672273
glycer@@	I-Disease	-1	9672273
id@@	I-Disease	-1	9672273
a@@	I-Disease	-1	9672273
emia	I-Disease	-1	9672273
among	O	-1	9672273
women	O	-1	9672273
on	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
.	O	-1	9672273
IN@@	O	-1	9672273
TE@@	O	-1	9672273
R@@	O	-1	9672273
P@@	O	-1	9672273
R@@	O	-1	9672273
ET@@	O	-1	9672273
AT@@	O	-1	9672273
ION@@	O	-1	9672273
:	O	-1	9672273
Although	O	-1	9672273
this	O	-1	9672273
pre@@	O	-1	9672273
lim@@	O	-1	9672273
inary	O	-1	9672273
analysis	O	-1	9672273
has	O	-1	9672273
low	O	-1	9672273
po@@	O	-1	9672273
w@@	O	-1	9672273
er,	O	-1	9672273
in	O	-1	9672273
this	O	-1	9672273
co@@	O	-1	9672273
h@@	O	-1	9672273
ort	O	-1	9672273
of	O	-1	9672273
women	O	-1	9672273
at	O	-1	9672273
low@@	O	-1	9672273
-@@	O	-1	9672273
to@@	O	-1	9672273
-@@	O	-1	9672273
normal	O	-1	9672273
risk	O	-1	9672273
of	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
,	O	-1	9672273
the	O	-1	9672273
post@@	O	-1	9672273
ul@@	O	-1	9672273
ated	O	-1	9672273
protective	O	-1	9672273
effects	O	-1	9672273
of	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
are	O	-1	9672273
not	O	-1	9672273
y@@	O	-1	9672273
et	O	-1	9672273
appa@@	O	-1	9672273
ren@@	O	-1	9672273
t.	O	-1	9672273
W@@	O	-1	9672273
o@@	O	-1	9672273
men	O	-1	9672273
using	O	-1	9672273
h@@	O	-1	9672273
orm@@	O	-1	9672273
on@@	O	-1	9672273
e-@@	O	-1	9672273
re@@	O	-1	9672273
pl@@	O	-1	9672273
ac@@	O	-1	9672273
ement	O	-1	9672273
therapy	O	-1	9672273
appe@@	O	-1	9672273
ar	O	-1	9672273
to	O	-1	9672273
have	O	-1	9672273
ben@@	O	-1	9672273
e@@	O	-1	9672273
f@@	O	-1	9672273
ited	O	-1	9672273
from	O	-1	9672273
use	O	-1	9672273
of	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
.	O	-1	9672273
There	O	-1	9672273
were	O	-1	9672273
no	O	-1	9672273
de@@	O	-1	9672273
ath@@	O	-1	9672273
s	O	-1	9672273
from	O	-1	9672273
b@@	B-Disease	D001943	9672273
reas@@	I-Disease	-1	9672273
t	I-Disease	-1	9672273
cancer	I-Disease	-1	9672273
recor@@	O	-1	9672273
ded	O	-1	9672273
in	O	-1	9672273
women	O	-1	9672273
in	O	-1	9672273
the	O	-1	9672273
study.	O	-1	9672273
It	O	-1	9672273
is	O	-1	9672273
es@@	O	-1	9672273
sen@@	O	-1	9672273
tial	O	-1	9672273
to	O	-1	9672273
continu@@	O	-1	9672273
e	O	-1	9672273
follow-up	O	-1	9672273
to	O	-1	9672273
qu@@	O	-1	9672273
anti@@	O	-1	9672273
f@@	O	-1	9672273
y	O	-1	9672273
the	O	-1	9672273
long-term	O	-1	9672273
ris@@	O	-1	9672273
k@@	O	-1	9672273
s	O	-1	9672273
and	O	-1	9672273
ben@@	O	-1	9672273
e@@	O	-1	9672273
f@@	O	-1	9672273
its	O	-1	9672273
of	O	-1	9672273
t@@	B-Chemical	D013629	9672273
am@@	I-Chemical	-1	9672273
oxif@@	I-Chemical	-1	9672273
en	I-Chemical	-1	9672273
therapy.	O	-1	9672273

A	O	-1	8854309
meas@@	O	-1	8854309
ure	O	-1	8854309
of	O	-1	8854309
p@@	B-Disease	D011681	8854309
up@@	I-Disease	-1	8854309
ill@@	I-Disease	-1	8854309
ary	I-Disease	-1	8854309
os@@	I-Disease	-1	8854309
c@@	I-Disease	-1	8854309
ill@@	I-Disease	-1	8854309
ation	I-Disease	-1	8854309
as	O	-1	8854309
a	O	-1	8854309
mark@@	O	-1	8854309
er	O	-1	8854309
of	O	-1	8854309
cocaine	B-Chemical	D003042	8854309
-induced	O	-1	8854309
par@@	B-Disease	D010259	8854309
an@@	I-Disease	-1	8854309
o@@	I-Disease	-1	8854309
ia	I-Disease	-1	8854309
.	O	-1	8854309
C@@	B-Chemical	D003042	8854309
oc@@	I-Chemical	-1	8854309
aine	I-Chemical	-1	8854309
-induced	O	-1	8854309
par@@	B-Disease	D010259	8854309
an@@	I-Disease	-1	8854309
o@@	I-Disease	-1	8854309
ia	I-Disease	-1	8854309
(	O	-1	8854309
CI@@	B-Disease	D010259	8854309
P	I-Disease	-1	8854309
)	O	-1	8854309
remain@@	O	-1	8854309
s	O	-1	8854309
an	O	-1	8854309
important	O	-1	8854309
drug@@	O	-1	8854309
-induced	O	-1	8854309
model	O	-1	8854309
of	O	-1	8854309
i@@	O	-1	8854309
di@@	O	-1	8854309
o@@	O	-1	8854309
path@@	O	-1	8854309
ic	O	-1	8854309
par@@	B-Disease	D010259	8854309
an@@	I-Disease	-1	8854309
o@@	I-Disease	-1	8854309
ia	I-Disease	-1	8854309
for	O	-1	8854309
which	O	-1	8854309
no	O	-1	8854309
psych@@	O	-1	8854309
oph@@	O	-1	8854309
ysi@@	O	-1	8854309
ologic	O	-1	8854309
mark@@	O	-1	8854309
er	O	-1	8854309
has	O	-1	8854309
y@@	O	-1	8854309
et	O	-1	8854309
em@@	O	-1	8854309
erg@@	O	-1	8854309
ed.	O	-1	8854309
M@@	O	-1	8854309
e@@	O	-1	8854309
as@@	O	-1	8854309
ures	O	-1	8854309
of	O	-1	8854309
p@@	B-Disease	D011681	8854309
up@@	I-Disease	-1	8854309
ill@@	I-Disease	-1	8854309
ary	I-Disease	-1	8854309
os@@	I-Disease	-1	8854309
c@@	I-Disease	-1	8854309
ill@@	I-Disease	-1	8854309
ation	I-Disease	-1	8854309
were	O	-1	8854309
able	O	-1	8854309
to	O	-1	8854309
significantly	O	-1	8854309
dist@@	O	-1	8854309
ing@@	O	-1	8854309
u@@	O	-1	8854309
is@@	O	-1	8854309
h	O	-1	8854309
a	O	-1	8854309
group	O	-1	8854309
of	O	-1	8854309
ab@@	O	-1	8854309
st@@	O	-1	8854309
in@@	O	-1	8854309
ent	O	-1	8854309
c@@	B-Chemical	D016578	8854309
rac@@	I-Chemical	-1	8854309
k	I-Chemical	-1	8854309
cocaine	I-Chemical	-1	8854309
ab@@	O	-1	8854309
users	O	-1	8854309
en@@	O	-1	8854309
d@@	O	-1	8854309
or@@	O	-1	8854309
s@@	O	-1	8854309
ing	O	-1	8854309
p@@	O	-1	8854309
ast	O	-1	8854309
CI@@	B-Disease	D010259	8854309
P	I-Disease	-1	8854309
(n	O	-1	8854309
=	O	-1	8854309
3@@	O	-1	8854309
2)	O	-1	8854309
from	O	-1	8854309
an@@	O	-1	8854309
other	O	-1	8854309
group	O	-1	8854309
of	O	-1	8854309
c@@	B-Chemical	D016578	8854309
rac@@	I-Chemical	-1	8854309
k	I-Chemical	-1	8854309
ad@@	O	-1	8854309
dic@@	O	-1	8854309
ts	O	-1	8854309
who	O	-1	8854309
d@@	O	-1	8854309
en@@	O	-1	8854309
ied	O	-1	8854309
p@@	O	-1	8854309
ast	O	-1	8854309
CI@@	B-Disease	D010259	8854309
P	I-Disease	-1	8854309
(n	O	-1	8854309
=	O	-1	8854309
2@@	O	-1	8854309
9@@	O	-1	8854309
).	O	-1	8854309

S@@	B-Disease	D012640	8473723
e@@	I-Disease	-1	8473723
iz@@	I-Disease	-1	8473723
ures	I-Disease	-1	8473723
induced	O	-1	8473723
by	O	-1	8473723
combined	O	-1	8473723
levo@@	B-Chemical	D008728	8473723
me@@	I-Chemical	-1	8473723
pro@@	I-Chemical	-1	8473723
ma@@	I-Chemical	-1	8473723
z@@	I-Chemical	-1	8473723
ine	I-Chemical	-1	8473723
-	O	-1	8473723
flu@@	B-Chemical	D016666	8473723
v@@	I-Chemical	-1	8473723
ox@@	I-Chemical	-1	8473723
amine	I-Chemical	-1	8473723
treatment.	O	-1	8473723
We	O	-1	8473723
report	O	-1	8473723
a	O	-1	8473723
case	O	-1	8473723
of	O	-1	8473723
combined	O	-1	8473723
levo@@	B-Chemical	D008728	8473723
me@@	I-Chemical	-1	8473723
pro@@	I-Chemical	-1	8473723
ma@@	I-Chemical	-1	8473723
z@@	I-Chemical	-1	8473723
ine	I-Chemical	-1	8473723
-	O	-1	8473723
flu@@	B-Chemical	D016666	8473723
v@@	I-Chemical	-1	8473723
ox@@	I-Chemical	-1	8473723
amine	I-Chemical	-1	8473723
treatment@@	O	-1	8473723
-induced	O	-1	8473723
seizures	B-Disease	D012640	8473723
.	O	-1	8473723
It	O	-1	8473723
se@@	O	-1	8473723
em@@	O	-1	8473723
s	O	-1	8473723
that	O	-1	8473723
combined	O	-1	8473723
treatment	O	-1	8473723
of	O	-1	8473723
flu@@	B-Chemical	D016666	8473723
v@@	I-Chemical	-1	8473723
ox@@	I-Chemical	-1	8473723
amine	I-Chemical	-1	8473723
with	O	-1	8473723
phen@@	B-Chemical	D010640	8473723
o@@	I-Chemical	-1	8473723
thi@@	I-Chemical	-1	8473723
az@@	I-Chemical	-1	8473723
in@@	I-Chemical	-1	8473723
es	I-Chemical	-1	8473723
may	O	-1	8473723
pos@@	O	-1	8473723
s@@	O	-1	8473723
ess	O	-1	8473723
pro@@	O	-1	8473723
convul@@	O	-1	8473723
sive	O	-1	8473723
activ@@	O	-1	8473723
ity.	O	-1	8473723

W@@	O	-1	6674249
h@@	O	-1	6674249
y	O	-1	6674249
may	O	-1	6674249
ep@@	B-Chemical	D015119	6674249
si@@	I-Chemical	-1	6674249
lon@@	I-Chemical	-1	6674249
-@@	I-Chemical	-1	6674249
amin@@	I-Chemical	-1	6674249
oc@@	I-Chemical	-1	6674249
a@@	I-Chemical	-1	6674249
pro@@	I-Chemical	-1	6674249
ic	I-Chemical	-1	6674249
acid	I-Chemical	-1	6674249
(	O	-1	6674249
E@@	B-Chemical	D015119	6674249
AC@@	I-Chemical	-1	6674249
A	I-Chemical	-1	6674249
)	O	-1	6674249
induce	O	-1	6674249
my@@	B-Disease	D009135	6674249
o@@	I-Disease	-1	6674249
pathy	I-Disease	-1	6674249
in	O	-1	6674249
man@@	O	-1	6674249
?	O	-1	6674249
Re@@	O	-1	6674249
por@@	O	-1	6674249
t	O	-1	6674249
of	O	-1	6674249
a	O	-1	6674249
case	O	-1	6674249
and	O	-1	6674249
literat@@	O	-1	6674249
ure	O	-1	6674249
revie@@	O	-1	6674249
w@@	O	-1	6674249
.	O	-1	6674249
A	O	-1	6674249
case	O	-1	6674249
of	O	-1	6674249
necro@@	B-Disease	D009336	6674249
tiz@@	I-Disease	-1	6674249
ing	I-Disease	-1	6674249
my@@	I-Disease	-1	6674249
o@@	I-Disease	-1	6674249
pathy	I-Disease	-1	6674249
necro@@	B-Disease	D009135	6674249
tiz@@	I-Disease	-1	6674249
ing	I-Disease	-1	6674249
my@@	I-Disease	-1	6674249
o@@	I-Disease	-1	6674249
pathy	I-Disease	-1	6674249
due	O	-1	6674249
to	O	-1	6674249
a	O	-1	6674249
sh@@	O	-1	6674249
ort	O	-1	6674249
ep@@	B-Chemical	D015119	6674249
si@@	I-Chemical	-1	6674249
lon@@	I-Chemical	-1	6674249
-@@	I-Chemical	-1	6674249
amin@@	I-Chemical	-1	6674249
oc@@	I-Chemical	-1	6674249
a@@	I-Chemical	-1	6674249
pro@@	I-Chemical	-1	6674249
ic	I-Chemical	-1	6674249
acid	I-Chemical	-1	6674249
(	O	-1	6674249
E@@	B-Chemical	D015119	6674249
AC@@	I-Chemical	-1	6674249
A	I-Chemical	-1	6674249
)	O	-1	6674249
treatment	O	-1	6674249
in	O	-1	6674249
a	O	-1	6674249
7@@	O	-1	6674249
2	O	-1	6674249
year-old	O	-1	6674249
patient	O	-1	6674249
with	O	-1	6674249
sub@@	B-Disease	D013345	6674249
arac@@	I-Disease	-1	6674249
h@@	I-Disease	-1	6674249
no@@	I-Disease	-1	6674249
id	I-Disease	-1	6674249
haem@@	I-Disease	-1	6674249
or@@	I-Disease	-1	6674249
rh@@	I-Disease	-1	6674249
age	I-Disease	-1	6674249
(	O	-1	6674249
S@@	B-Disease	D013345	6674249
A@@	I-Disease	-1	6674249
H	I-Disease	-1	6674249
)	O	-1	6674249
is	O	-1	6674249
descri@@	O	-1	6674249
be@@	O	-1	6674249
d.	O	-1	6674249
P@@	O	-1	6674249
ath@@	O	-1	6674249
o@@	O	-1	6674249
gene@@	O	-1	6674249
tic	O	-1	6674249
hypo@@	O	-1	6674249
th@@	O	-1	6674249
es@@	O	-1	6674249
es	O	-1	6674249
are	O	-1	6674249
discus@@	O	-1	6674249
sed.	O	-1	6674249

Com@@	O	-1	6150641
par@@	O	-1	6150641
ison	O	-1	6150641
of	O	-1	6150641
the	O	-1	6150641
eff@@	O	-1	6150641
ec@@	O	-1	6150641
tiv@@	O	-1	6150641
en@@	O	-1	6150641
ess	O	-1	6150641
of	O	-1	6150641
ran@@	B-Chemical	D011899	6150641
iti@@	I-Chemical	-1	6150641
d@@	I-Chemical	-1	6150641
ine	I-Chemical	-1	6150641
and	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
in	O	-1	6150641
inhibit@@	O	-1	6150641
ing	O	-1	6150641
acid	O	-1	6150641
secre@@	O	-1	6150641
tion	O	-1	6150641
in	O	-1	6150641
patients	O	-1	6150641
with	O	-1	6150641
gast@@	O	-1	6150641
ric	O	-1	6150641
hyper@@	O	-1	6150641
sec@@	O	-1	6150641
ret@@	O	-1	6150641
ory	O	-1	6150641
stat@@	O	-1	6150641
es.	O	-1	6150641
The	O	-1	6150641
H@@	O	-1	6150641
2@@	O	-1	6150641
-	O	-1	6150641
hist@@	B-Chemical	D006632	6150641
amine	I-Chemical	-1	6150641
receptor	O	-1	6150641
antagonist@@	O	-1	6150641
s	O	-1	6150641
ran@@	B-Chemical	D011899	6150641
iti@@	I-Chemical	-1	6150641
d@@	I-Chemical	-1	6150641
ine	I-Chemical	-1	6150641
and	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
were	O	-1	6150641
compared	O	-1	6150641
for	O	-1	6150641
their	O	-1	6150641
abil@@	O	-1	6150641
ities	O	-1	6150641
to	O	-1	6150641
control	O	-1	6150641
gast@@	O	-1	6150641
ric	O	-1	6150641
acid	O	-1	6150641
hyper@@	O	-1	6150641
secre@@	O	-1	6150641
tion	O	-1	6150641
on	O	-1	6150641
a	O	-1	6150641
sh@@	O	-1	6150641
ort@@	O	-1	6150641
-	O	-1	6150641
and	O	-1	6150641
long-term	O	-1	6150641
b@@	O	-1	6150641
asis	O	-1	6150641
in	O	-1	6150641
2@@	O	-1	6150641
2	O	-1	6150641
patients	O	-1	6150641
with	O	-1	6150641
gast@@	O	-1	6150641
ric	O	-1	6150641
acid	O	-1	6150641
hyper@@	O	-1	6150641
sec@@	O	-1	6150641
ret@@	O	-1	6150641
ory	O	-1	6150641
stat@@	O	-1	6150641
es.	O	-1	6150641
N@@	O	-1	6150641
ine@@	O	-1	6150641
te@@	O	-1	6150641
en	O	-1	6150641
patients	O	-1	6150641
had	O	-1	6150641
Z@@	B-Disease	D015043	6150641
ol@@	I-Disease	-1	6150641
l@@	I-Disease	-1	6150641
ing@@	I-Disease	-1	6150641
er@@	I-Disease	-1	6150641
-@@	I-Disease	-1	6150641
E@@	I-Disease	-1	6150641
ll@@	I-Disease	-1	6150641
ison	I-Disease	-1	6150641
syndrome	I-Disease	-1	6150641
,	O	-1	6150641
one	O	-1	6150641
patient	O	-1	6150641
had	O	-1	6150641
systemic	B-Disease	D034721	6150641
ma@@	I-Disease	-1	6150641
st@@	I-Disease	-1	6150641
ocyto@@	I-Disease	-1	6150641
sis	I-Disease	-1	6150641
,	O	-1	6150641
and	O	-1	6150641
two	O	-1	6150641
patients	O	-1	6150641
had	O	-1	6150641
i@@	O	-1	6150641
di@@	O	-1	6150641
o@@	O	-1	6150641
path@@	O	-1	6150641
ic	O	-1	6150641
hyper@@	O	-1	6150641
secre@@	O	-1	6150641
tion.	O	-1	6150641
The	O	-1	6150641
rat@@	O	-1	6150641
es	O	-1	6150641
of	O	-1	6150641
onset	O	-1	6150641
of	O	-1	6150641
the	O	-1	6150641
action	O	-1	6150641
of	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
and	O	-1	6150641
ran@@	B-Chemical	D011899	6150641
iti@@	I-Chemical	-1	6150641
d@@	I-Chemical	-1	6150641
ine	I-Chemical	-1	6150641
were	O	-1	6150641
the	O	-1	6150641
sam@@	O	-1	6150641
e.	O	-1	6150641
The	O	-1	6150641
ac@@	O	-1	6150641
tions	O	-1	6150641
of	O	-1	6150641
both	O	-1	6150641
drugs	O	-1	6150641
were	O	-1	6150641
increased	O	-1	6150641
by	O	-1	6150641
anti@@	O	-1	6150641
cholinergic	O	-1	6150641
agent@@	O	-1	6150641
s,	O	-1	6150641
and	O	-1	6150641
there	O	-1	6150641
was	O	-1	6150641
a	O	-1	6150641
clo@@	O	-1	6150641
se	O	-1	6150641
correl@@	O	-1	6150641
ation	O	-1	6150641
between	O	-1	6150641
the	O	-1	6150641
daily	O	-1	6150641
maint@@	O	-1	6150641
en@@	O	-1	6150641
ance	O	-1	6150641
dose	O	-1	6150641
of	O	-1	6150641
each	O	-1	6150641
drug	O	-1	6150641
ne@@	O	-1	6150641
ed@@	O	-1	6150641
ed	O	-1	6150641
to	O	-1	6150641
control	O	-1	6150641
acid	O	-1	6150641
secre@@	O	-1	6150641
tion.	O	-1	6150641
However,	O	-1	6150641
ran@@	B-Chemical	D011899	6150641
iti@@	I-Chemical	-1	6150641
d@@	I-Chemical	-1	6150641
ine	I-Chemical	-1	6150641
was	O	-1	6150641
th@@	O	-1	6150641
re@@	O	-1	6150641
e@@	O	-1	6150641
fol@@	O	-1	6150641
d	O	-1	6150641
more	O	-1	6150641
pot@@	O	-1	6150641
ent	O	-1	6150641
than	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
both	O	-1	6150641
in	O	-1	6150641
acute	O	-1	6150641
inhibition	O	-1	6150641
studies	O	-1	6150641
and	O	-1	6150641
in	O	-1	6150641
the	O	-1	6150641
median	O	-1	6150641
maint@@	O	-1	6150641
en@@	O	-1	6150641
ance	O	-1	6150641
dose	O	-1	6150641
ne@@	O	-1	6150641
ed@@	O	-1	6150641
ed	O	-1	6150641
(1@@	O	-1	6150641
.@@	O	-1	6150641
2	O	-1	6150641
g	O	-1	6150641
per	O	-1	6150641
day	O	-1	6150641
for	O	-1	6150641
ran@@	B-Chemical	D011899	6150641
iti@@	I-Chemical	-1	6150641
d@@	I-Chemical	-1	6150641
ine	I-Chemical	-1	6150641
and	O	-1	6150641
3.@@	O	-1	6150641
6	O	-1	6150641
g	O	-1	6150641
per	O	-1	6150641
day	O	-1	6150641
for	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
).	O	-1	6150641
Si@@	O	-1	6150641
x@@	O	-1	6150641
t@@	O	-1	6150641
y	O	-1	6150641
perc@@	O	-1	6150641
ent	O	-1	6150641
of	O	-1	6150641
the	O	-1	6150641
mal@@	O	-1	6150641
es	O	-1	6150641
developed	O	-1	6150641
b@@	O	-1	6150641
reas@@	O	-1	6150641
t	O	-1	6150641
changes	O	-1	6150641
or	O	-1	6150641
im@@	B-Disease	D007172	6150641
pot@@	I-Disease	-1	6150641
ence	I-Disease	-1	6150641
while	O	-1	6150641
taking	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
and	O	-1	6150641
in	O	-1	6150641
all	O	-1	6150641
cases	O	-1	6150641
these	O	-1	6150641
changes	O	-1	6150641
dis@@	O	-1	6150641
appe@@	O	-1	6150641
a@@	O	-1	6150641
red	O	-1	6150641
when	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
was	O	-1	6150641
re@@	O	-1	6150641
pl@@	O	-1	6150641
ac@@	O	-1	6150641
ed	O	-1	6150641
by	O	-1	6150641
ran@@	B-Chemical	D011899	6150641
iti@@	I-Chemical	-1	6150641
d@@	I-Chemical	-1	6150641
ine	I-Chemical	-1	6150641
.	O	-1	6150641
Treat@@	O	-1	6150641
ment	O	-1	6150641
with	O	-1	6150641
high	O	-1	6150641
doses	O	-1	6150641
of	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
(@@	O	-1	6150641
one	O	-1	6150641
to	O	-1	6150641
60	O	-1	6150641
month@@	O	-1	6150641
s;	O	-1	6150641
medi@@	O	-1	6150641
an@@	O	-1	6150641
,	O	-1	6150641
11	O	-1	6150641
month@@	O	-1	6150641
s)	O	-1	6150641
or	O	-1	6150641
ran@@	B-Chemical	D011899	6150641
iti@@	I-Chemical	-1	6150641
d@@	I-Chemical	-1	6150641
ine	I-Chemical	-1	6150641
(@@	O	-1	6150641
two	O	-1	6150641
to	O	-1	6150641
3@@	O	-1	6150641
1	O	-1	6150641
month@@	O	-1	6150641
s;	O	-1	6150641
medi@@	O	-1	6150641
an@@	O	-1	6150641
,	O	-1	6150641
14	O	-1	6150641
month@@	O	-1	6150641
s)	O	-1	6150641
was	O	-1	6150641
not	O	-1	6150641
associated	O	-1	6150641
with	O	-1	6150641
hepatic	B-Disease	D056486	6150641
or	I-Disease	-1	6150641
hemat@@	I-Disease	-1	6150641
ologic	I-Disease	-1	6150641
toxicity	I-Disease	-1	6150641
hepatic	B-Disease	D006402	6150641
or	I-Disease	-1	6150641
hemat@@	I-Disease	-1	6150641
ologic	I-Disease	-1	6150641
toxicity	I-Disease	-1	6150641
or	O	-1	6150641
al@@	O	-1	6150641
ter@@	O	-1	6150641
ations	O	-1	6150641
of	O	-1	6150641
serum	O	-1	6150641
gast@@	O	-1	6150641
rin	O	-1	6150641
concentr@@	O	-1	6150641
ation@@	O	-1	6150641
s,	O	-1	6150641
but	O	-1	6150641
ran@@	B-Chemical	D011899	6150641
iti@@	I-Chemical	-1	6150641
d@@	I-Chemical	-1	6150641
ine	I-Chemical	-1	6150641
therapy	O	-1	6150641
was	O	-1	6150641
associated	O	-1	6150641
with	O	-1	6150641
a	O	-1	6150641
significantly	O	-1	6150641
lower	O	-1	6150641
serum	O	-1	6150641
creatinine	B-Chemical	D003404	6150641
level	O	-1	6150641
than	O	-1	6150641
seen	O	-1	6150641
with	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
therapy.	O	-1	6150641
The	O	-1	6150641
results	O	-1	6150641
show	O	-1	6150641
that	O	-1	6150641
both	O	-1	6150641
drugs	O	-1	6150641
can	O	-1	6150641
ade@@	O	-1	6150641
qu@@	O	-1	6150641
ately	O	-1	6150641
inhib@@	O	-1	6150641
it	O	-1	6150641
acid	O	-1	6150641
secre@@	O	-1	6150641
tion	O	-1	6150641
in	O	-1	6150641
patients	O	-1	6150641
with	O	-1	6150641
gast@@	O	-1	6150641
ric	O	-1	6150641
hyper@@	O	-1	6150641
sec@@	O	-1	6150641
ret@@	O	-1	6150641
ory	O	-1	6150641
stat@@	O	-1	6150641
es.	O	-1	6150641
B@@	O	-1	6150641
oth	O	-1	6150641
are	O	-1	6150641
saf@@	O	-1	6150641
e	O	-1	6150641
at	O	-1	6150641
high	O	-1	6150641
dos@@	O	-1	6150641
es,	O	-1	6150641
but	O	-1	6150641
ran@@	B-Chemical	D011899	6150641
iti@@	I-Chemical	-1	6150641
d@@	I-Chemical	-1	6150641
ine	I-Chemical	-1	6150641
is	O	-1	6150641
th@@	O	-1	6150641
re@@	O	-1	6150641
e@@	O	-1	6150641
fol@@	O	-1	6150641
d	O	-1	6150641
more	O	-1	6150641
pot@@	O	-1	6150641
ent	O	-1	6150641
and	O	-1	6150641
does	O	-1	6150641
not	O	-1	6150641
cause	O	-1	6150641
the	O	-1	6150641
anti@@	O	-1	6150641
and@@	O	-1	6150641
ro@@	O	-1	6150641
gen	O	-1	6150641
side	O	-1	6150641
effects	O	-1	6150641
frequ@@	O	-1	6150641
ently	O	-1	6150641
seen	O	-1	6150641
with	O	-1	6150641
high	O	-1	6150641
doses	O	-1	6150641
of	O	-1	6150641
cimetid@@	B-Chemical	D002927	6150641
ine	I-Chemical	-1	6150641
.	O	-1	6150641

A	O	-1	3670965
cat@@	O	-1	3670965
ch	O	-1	3670965
in	O	-1	3670965
the	O	-1	3670965
Re@@	B-Disease	D012202	3670965
y@@	I-Disease	-1	3670965
e	I-Disease	-1	3670965
.	O	-1	3670965
Tw@@	O	-1	3670965
ent@@	O	-1	3670965
y-@@	O	-1	3670965
six	O	-1	3670965
cases	O	-1	3670965
of	O	-1	3670965
Re@@	B-Disease	D012202	3670965
y@@	I-Disease	-1	3670965
e	I-Disease	-1	3670965
syndrome	I-Disease	-1	3670965
from	O	-1	3670965
The	O	-1	3670965
Ch@@	O	-1	3670965
ild@@	O	-1	3670965
ren@@	O	-1	3670965
's	O	-1	3670965
H@@	O	-1	3670965
ospit@@	O	-1	3670965
al,	O	-1	3670965
C@@	O	-1	3670965
am@@	O	-1	3670965
per@@	O	-1	3670965
do@@	O	-1	3670965
w@@	O	-1	3670965
n@@	O	-1	3670965
,	O	-1	3670965
A@@	O	-1	3670965
u@@	O	-1	3670965
str@@	O	-1	3670965
al@@	O	-1	3670965
ia,	O	-1	3670965
occur@@	O	-1	3670965
r@@	O	-1	3670965
ing	O	-1	3670965
between	O	-1	3670965
19@@	O	-1	3670965
7@@	O	-1	3670965
3	O	-1	3670965
and	O	-1	3670965
19@@	O	-1	3670965
8@@	O	-1	3670965
2	O	-1	3670965
were	O	-1	3670965
revie@@	O	-1	3670965
we@@	O	-1	3670965
d.	O	-1	3670965
Of	O	-1	3670965
th@@	O	-1	3670965
es@@	O	-1	3670965
e,	O	-1	3670965
20	O	-1	3670965
cases	O	-1	3670965
me@@	O	-1	3670965
t	O	-1	3670965
the	O	-1	3670965
U@@	O	-1	3670965
S	O	-1	3670965
P@@	O	-1	3670965
u@@	O	-1	3670965
bl@@	O	-1	3670965
ic	O	-1	3670965
He@@	O	-1	3670965
al@@	O	-1	3670965
th	O	-1	3670965
S@@	O	-1	3670965
er@@	O	-1	3670965
v@@	O	-1	3670965
ic@@	O	-1	3670965
e	O	-1	3670965
C@@	O	-1	3670965
ent@@	O	-1	3670965
ers	O	-1	3670965
for	O	-1	3670965
Di@@	O	-1	3670965
se@@	O	-1	3670965
ase	O	-1	3670965
C@@	O	-1	3670965
ont@@	O	-1	3670965
ro@@	O	-1	3670965
l	O	-1	3670965
c@@	O	-1	3670965
rit@@	O	-1	3670965
er@@	O	-1	3670965
ia	O	-1	3670965
for	O	-1	3670965
the	O	-1	3670965
diagnosis	O	-1	3670965
of	O	-1	3670965
Re@@	B-Disease	D012202	3670965
y@@	I-Disease	-1	3670965
e	I-Disease	-1	3670965
syndrome	I-Disease	-1	3670965
.	O	-1	3670965
A@@	B-Chemical	D001241	3670965
s@@	I-Chemical	-1	3670965
pi@@	I-Chemical	-1	3670965
rin	I-Chemical	-1	3670965
or	O	-1	3670965
sal@@	B-Chemical	D012459	3670965
ic@@	I-Chemical	-1	3670965
yl@@	I-Chemical	-1	3670965
ate	I-Chemical	-1	3670965
ing@@	O	-1	3670965
es@@	O	-1	3670965
tion	O	-1	3670965
had	O	-1	3670965
occurred	O	-1	3670965
in	O	-1	3670965
only	O	-1	3670965
one	O	-1	3670965
of	O	-1	3670965
the	O	-1	3670965
20	O	-1	3670965
cases	O	-1	3670965
(5@@	O	-1	3670965
%),	O	-1	3670965
and	O	-1	3670965
par@@	B-Chemical	D000082	3670965
acet@@	I-Chemical	-1	3670965
am@@	I-Chemical	-1	3670965
ol	I-Chemical	-1	3670965
(	O	-1	3670965
acet@@	B-Chemical	D000082	3670965
aminoph@@	I-Chemical	-1	3670965
en	I-Chemical	-1	3670965
)	O	-1	3670965
had	O	-1	3670965
been	O	-1	3670965
administered	O	-1	3670965
in	O	-1	3670965
only	O	-1	3670965
six	O	-1	3670965
of	O	-1	3670965
the	O	-1	3670965
cases	O	-1	3670965
(3@@	O	-1	3670965
0@@	O	-1	3670965
%).	O	-1	3670965
P@@	O	-1	3670965
ath@@	O	-1	3670965
ologic	O	-1	3670965
con@@	O	-1	3670965
fir@@	O	-1	3670965
m@@	O	-1	3670965
ation	O	-1	3670965
of	O	-1	3670965
the	O	-1	3670965
diagnosis	O	-1	3670965
of	O	-1	3670965
Re@@	B-Disease	D012202	3670965
y@@	I-Disease	-1	3670965
e	I-Disease	-1	3670965
syndrome	I-Disease	-1	3670965
was	O	-1	3670965
ac@@	O	-1	3670965
com@@	O	-1	3670965
pl@@	O	-1	3670965
ished	O	-1	3670965
in	O	-1	3670965
9@@	O	-1	3670965
0%	O	-1	3670965
of	O	-1	3670965
the	O	-1	3670965
cas@@	O	-1	3670965
es.	O	-1	3670965
The	O	-1	3670965
incidence	O	-1	3670965
of	O	-1	3670965
Re@@	B-Disease	D012202	3670965
y@@	I-Disease	-1	3670965
e	I-Disease	-1	3670965
syndrome	I-Disease	-1	3670965
in	O	-1	3670965
Ne@@	O	-1	3670965
w	O	-1	3670965
S@@	O	-1	3670965
ou@@	O	-1	3670965
th	O	-1	3670965
W@@	O	-1	3670965
al@@	O	-1	3670965
es,	O	-1	3670965
A@@	O	-1	3670965
u@@	O	-1	3670965
str@@	O	-1	3670965
al@@	O	-1	3670965
ia,	O	-1	3670965
is	O	-1	3670965
estim@@	O	-1	3670965
ated	O	-1	3670965
from	O	-1	3670965
this	O	-1	3670965
study	O	-1	3670965
to	O	-1	3670965
be	O	-1	3670965
appro@@	O	-1	3670965
xim@@	O	-1	3670965
ately	O	-1	3670965
n@@	O	-1	3670965
ine	O	-1	3670965
cases	O	-1	3670965
per	O	-1	3670965
1	O	-1	3670965
mil@@	O	-1	3670965
li@@	O	-1	3670965
on	O	-1	3670965
children	O	-1	3670965
compared	O	-1	3670965
with	O	-1	3670965
rec@@	O	-1	3670965
ent	O	-1	3670965
U@@	O	-1	3670965
S	O	-1	3670965
data	O	-1	3670965
of	O	-1	3670965
ten	O	-1	3670965
to	O	-1	3670965
20	O	-1	3670965
cases	O	-1	3670965
per	O	-1	3670965
1	O	-1	3670965
mil@@	O	-1	3670965
li@@	O	-1	3670965
on	O	-1	3670965
children	O	-1	3670965
and	O	-1	3670965
three	O	-1	3670965
to	O	-1	3670965
seven	O	-1	3670965
cases	O	-1	3670965
per	O	-1	3670965
1	O	-1	3670965
mil@@	O	-1	3670965
li@@	O	-1	3670965
on	O	-1	3670965
children	O	-1	3670965
in	O	-1	3670965
G@@	O	-1	3670965
re@@	O	-1	3670965
at	O	-1	3670965
B@@	O	-1	3670965
rit@@	O	-1	3670965
ain@@	O	-1	3670965
.	O	-1	3670965
The	O	-1	3670965
mor@@	O	-1	3670965
t@@	O	-1	3670965
ality	O	-1	3670965
for	O	-1	3670965
these	O	-1	3670965
Re@@	B-Disease	D012202	3670965
y@@	I-Disease	-1	3670965
e	I-Disease	-1	3670965
syndrome	I-Disease	-1	3670965
cases	O	-1	3670965
in	O	-1	3670965
A@@	O	-1	3670965
u@@	O	-1	3670965
str@@	O	-1	3670965
al@@	O	-1	3670965
ia	O	-1	3670965
was	O	-1	3670965
4@@	O	-1	3670965
5%	O	-1	3670965
as	O	-1	3670965
compared	O	-1	3670965
with	O	-1	3670965
a	O	-1	3670965
3@@	O	-1	3670965
2@@	O	-1	3670965
%	O	-1	3670965
cas@@	O	-1	3670965
e-@@	O	-1	3670965
f@@	O	-1	3670965
at@@	O	-1	3670965
ality	O	-1	3670965
rate	O	-1	3670965
in	O	-1	3670965
the	O	-1	3670965
U@@	O	-1	3670965
nit@@	O	-1	3670965
ed	O	-1	3670965
S@@	O	-1	3670965
t@@	O	-1	3670965
at@@	O	-1	3670965
es.	O	-1	3670965
In	O	-1	3670965
A@@	O	-1	3670965
u@@	O	-1	3670965
str@@	O	-1	3670965
al@@	O	-1	3670965
ia,	O	-1	3670965
the	O	-1	3670965
pe@@	O	-1	3670965
di@@	O	-1	3670965
atric	O	-1	3670965
us@@	O	-1	3670965
age	O	-1	3670965
of	O	-1	3670965
as@@	B-Chemical	D001241	3670965
pi@@	I-Chemical	-1	3670965
rin	I-Chemical	-1	3670965
has	O	-1	3670965
been	O	-1	3670965
ex@@	O	-1	3670965
tre@@	O	-1	3670965
me@@	O	-1	3670965
ly	O	-1	3670965
low	O	-1	3670965
for	O	-1	3670965
the	O	-1	3670965
p@@	O	-1	3670965
ast	O	-1	3670965
25	O	-1	3670965
years	O	-1	3670965
(@@	O	-1	3670965
less	O	-1	3670965
than	O	-1	3670965
1@@	O	-1	3670965
%	O	-1	3670965
of	O	-1	3670965
total	O	-1	3670965
dos@@	O	-1	3670965
age	O	-1	3670965
un@@	O	-1	3670965
its	O	-1	3670965
sol@@	O	-1	3670965
d@@	O	-1	3670965
),	O	-1	3670965
with	O	-1	3670965
par@@	B-Chemical	D000082	3670965
acet@@	I-Chemical	-1	3670965
am@@	I-Chemical	-1	3670965
ol	I-Chemical	-1	3670965
(	O	-1	3670965
acet@@	B-Chemical	D000082	3670965
aminoph@@	I-Chemical	-1	3670965
en	I-Chemical	-1	3670965
)	O	-1	3670965
domin@@	O	-1	3670965
ating	O	-1	3670965
the	O	-1	3670965
pe@@	O	-1	3670965
di@@	O	-1	3670965
atric	O	-1	3670965
analge@@	O	-1	3670965
sic	O	-1	3670965
and	O	-1	3670965
anti@@	O	-1	3670965
py@@	O	-1	3670965
re@@	O	-1	3670965
tic	O	-1	3670965
mark@@	O	-1	3670965
et@@	O	-1	3670965
.	O	-1	3670965
Re@@	B-Disease	D012202	3670965
y@@	I-Disease	-1	3670965
e	I-Disease	-1	3670965
syndrome	I-Disease	-1	3670965
may	O	-1	3670965
be	O	-1	3670965
dis@@	O	-1	3670965
appear@@	O	-1	3670965
ing	O	-1	3670965
from	O	-1	3670965
A@@	O	-1	3670965
u@@	O	-1	3670965
str@@	O	-1	3670965
al@@	O	-1	3670965
ia	O	-1	3670965
des@@	O	-1	3670965
pit@@	O	-1	3670965
e	O	-1	3670965
a	O	-1	3670965
total	O	-1	3670965
l@@	O	-1	3670965
ac@@	O	-1	3670965
k	O	-1	3670965
of	O	-1	3670965
association	O	-1	3670965
with	O	-1	3670965
sal@@	B-Chemical	D012459	3670965
ic@@	I-Chemical	-1	3670965
yl@@	I-Chemical	-1	3670965
ates	I-Chemical	-1	3670965
or	O	-1	3670965
as@@	B-Chemical	D001241	3670965
pi@@	I-Chemical	-1	3670965
rin	I-Chemical	-1	3670965
ing@@	O	-1	3670965
es@@	O	-1	3670965
tion,	O	-1	3670965
s@@	O	-1	3670965
inc@@	O	-1	3670965
e	O	-1	3670965
there	O	-1	3670965
were	O	-1	3670965
no	O	-1	3670965
cases	O	-1	3670965
found	O	-1	3670965
at	O	-1	3670965
The	O	-1	3670965
Ch@@	O	-1	3670965
ild@@	O	-1	3670965
ren@@	O	-1	3670965
's	O	-1	3670965
H@@	O	-1	3670965
ospit@@	O	-1	3670965
al	O	-1	3670965
in	O	-1	3670965
19@@	O	-1	3670965
8@@	O	-1	3670965
3,	O	-1	3670965
19@@	O	-1	3670965
8@@	O	-1	3670965
4@@	O	-1	3670965
,	O	-1	3670965
or	O	-1	3670965
19@@	O	-1	3670965
8@@	O	-1	3670965
5@@	O	-1	3670965
.	O	-1	3670965

S@@	B-Disease	D004881	3300918
t.	I-Disease	-1	3300918
An@@	I-Disease	-1	3300918
th@@	I-Disease	-1	3300918
on@@	I-Disease	-1	3300918
y@@	I-Disease	-1	3300918
's	I-Disease	-1	3300918
fir@@	I-Disease	-1	3300918
e	I-Disease	-1	3300918
,	O	-1	3300918
then	O	-1	3300918
and	O	-1	3300918
now@@	O	-1	3300918
:	O	-1	3300918
a	O	-1	3300918
case	O	-1	3300918
report	O	-1	3300918
and	O	-1	3300918
hist@@	O	-1	3300918
or@@	O	-1	3300918
ical	O	-1	3300918
revie@@	O	-1	3300918
w@@	O	-1	3300918
.	O	-1	3300918
A	O	-1	3300918
r@@	O	-1	3300918
are	O	-1	3300918
case	O	-1	3300918
of	O	-1	3300918
mor@@	O	-1	3300918
b@@	O	-1	3300918
id	O	-1	3300918
vas@@	B-Disease	D014652	3300918
os@@	I-Disease	-1	3300918
p@@	I-Disease	-1	3300918
as@@	I-Disease	-1	3300918
m	I-Disease	-1	3300918
,	O	-1	3300918
to@@	O	-1	3300918
ge@@	O	-1	3300918
ther	O	-1	3300918
with	O	-1	3300918
stri@@	O	-1	3300918
king	O	-1	3300918
angio@@	O	-1	3300918
graph@@	O	-1	3300918
ic	O	-1	3300918
find@@	O	-1	3300918
ing@@	O	-1	3300918
s,	O	-1	3300918
is	O	-1	3300918
descri@@	O	-1	3300918
bed	O	-1	3300918
secondary	O	-1	3300918
to	O	-1	3300918
the	O	-1	3300918
ing@@	O	-1	3300918
es@@	O	-1	3300918
tion	O	-1	3300918
of	O	-1	3300918
meth@@	B-Chemical	D008784	3300918
y@@	I-Chemical	-1	3300918
ser@@	I-Chemical	-1	3300918
g@@	I-Chemical	-1	3300918
ide	I-Chemical	-1	3300918
by	O	-1	3300918
a	O	-1	3300918
4@@	O	-1	3300918
8@@	O	-1	3300918
-@@	O	-1	3300918
year-old	O	-1	3300918
wom@@	O	-1	3300918
an@@	O	-1	3300918
.	O	-1	3300918
A	O	-1	3300918
b@@	O	-1	3300918
ri@@	O	-1	3300918
e@@	O	-1	3300918
f	O	-1	3300918
revie@@	O	-1	3300918
w	O	-1	3300918
of	O	-1	3300918
the	O	-1	3300918
literat@@	O	-1	3300918
ure	O	-1	3300918
on	O	-1	3300918
similar	O	-1	3300918
cases	O	-1	3300918
is	O	-1	3300918
present@@	O	-1	3300918
ed.	O	-1	3300918
A	O	-1	3300918
discus@@	O	-1	3300918
sion	O	-1	3300918
of	O	-1	3300918
the	O	-1	3300918
hist@@	O	-1	3300918
ory	O	-1	3300918
of	O	-1	3300918
erg@@	B-Chemical	D004876	3300918
o@@	I-Chemical	-1	3300918
t	I-Chemical	-1	3300918
inc@@	O	-1	3300918
lu@@	O	-1	3300918
des	O	-1	3300918
its	O	-1	3300918
or@@	O	-1	3300918
ig@@	O	-1	3300918
inal	O	-1	3300918
dis@@	O	-1	3300918
co@@	O	-1	3300918
ver@@	O	-1	3300918
y,	O	-1	3300918
the	O	-1	3300918
epi@@	O	-1	3300918
de@@	O	-1	3300918
mic@@	O	-1	3300918
s	O	-1	3300918
of	O	-1	3300918
g@@	B-Disease	D005734	3300918
ang@@	I-Disease	-1	3300918
ren@@	I-Disease	-1	3300918
e	I-Disease	-1	3300918
that	O	-1	3300918
it	O	-1	3300918
has	O	-1	3300918
caused	O	-1	3300918
through	O	-1	3300918
the	O	-1	3300918
ages	O	-1	3300918
and	O	-1	3300918
its	O	-1	3300918
p@@	O	-1	3300918
ast	O	-1	3300918
and	O	-1	3300918
present	O	-1	3300918
role	O	-1	3300918
in	O	-1	3300918
the	O	-1	3300918
man@@	O	-1	3300918
ag@@	O	-1	3300918
ement	O	-1	3300918
of	O	-1	3300918
migra@@	B-Disease	D008881	3300918
ine	I-Disease	-1	3300918
headac@@	I-Disease	-1	3300918
he	I-Disease	-1	3300918
.	O	-1	3300918
D@@	O	-1	3300918
es@@	O	-1	3300918
pit@@	O	-1	3300918
e	O	-1	3300918
the	O	-1	3300918
adv@@	O	-1	3300918
ent	O	-1	3300918
of	O	-1	3300918
calcium	B-Chemical	D002118	3300918
channel	O	-1	3300918
block@@	O	-1	3300918
ers	O	-1	3300918
and	O	-1	3300918
beta-@@	O	-1	3300918
adrenergic	O	-1	3300918
antagonist@@	O	-1	3300918
s,	O	-1	3300918
erg@@	B-Chemical	D004876	3300918
o@@	I-Chemical	-1	3300918
t	I-Chemical	-1	3300918
pre@@	O	-1	3300918
par@@	O	-1	3300918
ations	O	-1	3300918
continu@@	O	-1	3300918
e	O	-1	3300918
to	O	-1	3300918
pl@@	O	-1	3300918
ay	O	-1	3300918
a	O	-1	3300918
major	O	-1	3300918
role	O	-1	3300918
in	O	-1	3300918
migra@@	B-Disease	D008881	3300918
ine	I-Disease	-1	3300918
therapy,	O	-1	3300918
so	O	-1	3300918
that	O	-1	3300918
the	O	-1	3300918
d@@	O	-1	3300918
ang@@	O	-1	3300918
er	O	-1	3300918
of	O	-1	3300918
S@@	B-Disease	D004881	3300918
t.	I-Disease	-1	3300918
An@@	I-Disease	-1	3300918
th@@	I-Disease	-1	3300918
on@@	I-Disease	-1	3300918
y@@	I-Disease	-1	3300918
's	I-Disease	-1	3300918
fir@@	I-Disease	-1	3300918
e	I-Disease	-1	3300918
per@@	O	-1	3300918
sist@@	O	-1	3300918
s.	O	-1	3300918

B@@	O	-1	2826064
et@@	O	-1	2826064
a@@	O	-1	2826064
-@@	O	-1	2826064
2-@@	O	-1	2826064
adren@@	O	-1	2826064
oc@@	O	-1	2826064
e@@	O	-1	2826064
pt@@	O	-1	2826064
or@@	O	-1	2826064
-@@	O	-1	2826064
mediated	O	-1	2826064
hypo@@	B-Disease	D007008	2826064
k@@	I-Disease	-1	2826064
al@@	I-Disease	-1	2826064
emia	I-Disease	-1	2826064
and	O	-1	2826064
its	O	-1	2826064
abol@@	O	-1	2826064
ish@@	O	-1	2826064
ment	O	-1	2826064
by	O	-1	2826064
ox@@	B-Chemical	D010096	2826064
p@@	I-Chemical	-1	2826064
ren@@	I-Chemical	-1	2826064
o@@	I-Chemical	-1	2826064
lol	I-Chemical	-1	2826064
.	O	-1	2826064
The	O	-1	2826064
time	O	-1	2826064
course	O	-1	2826064
and	O	-1	2826064
concentr@@	O	-1	2826064
ation@@	O	-1	2826064
-@@	O	-1	2826064
effect	O	-1	2826064
rel@@	O	-1	2826064
ationship	O	-1	2826064
of	O	-1	2826064
ter@@	B-Chemical	D013726	2826064
but@@	I-Chemical	-1	2826064
aline	I-Chemical	-1	2826064
-induced	O	-1	2826064
hypo@@	B-Disease	D007008	2826064
k@@	I-Disease	-1	2826064
al@@	I-Disease	-1	2826064
emia	I-Disease	-1	2826064
was	O	-1	2826064
studi@@	O	-1	2826064
ed,	O	-1	2826064
using	O	-1	2826064
comp@@	O	-1	2826064
u@@	O	-1	2826064
ter@@	O	-1	2826064
-@@	O	-1	2826064
a@@	O	-1	2826064
id@@	O	-1	2826064
ed	O	-1	2826064
pharmac@@	O	-1	2826064
o@@	O	-1	2826064
kine@@	O	-1	2826064
tic@@	O	-1	2826064
-@@	O	-1	2826064
dynam@@	O	-1	2826064
ic	O	-1	2826064
model@@	O	-1	2826064
ing.	O	-1	2826064
S@@	O	-1	2826064
ub@@	O	-1	2826064
sequ@@	O	-1	2826064
ently	O	-1	2826064
we	O	-1	2826064
investigated	O	-1	2826064
the	O	-1	2826064
efficacy	O	-1	2826064
of	O	-1	2826064
ox@@	B-Chemical	D010096	2826064
p@@	I-Chemical	-1	2826064
ren@@	I-Chemical	-1	2826064
o@@	I-Chemical	-1	2826064
lol	I-Chemical	-1	2826064
in	O	-1	2826064
antagon@@	O	-1	2826064
iz@@	O	-1	2826064
ing	O	-1	2826064
such	O	-1	2826064
hypo@@	B-Disease	D007008	2826064
k@@	I-Disease	-1	2826064
al@@	I-Disease	-1	2826064
emia	I-Disease	-1	2826064
,	O	-1	2826064
to@@	O	-1	2826064
ge@@	O	-1	2826064
ther	O	-1	2826064
with	O	-1	2826064
the	O	-1	2826064
pharmac@@	O	-1	2826064
o@@	O	-1	2826064
kine@@	O	-1	2826064
tic	O	-1	2826064
inter@@	O	-1	2826064
action	O	-1	2826064
between	O	-1	2826064
both	O	-1	2826064
drug@@	O	-1	2826064
s.	O	-1	2826064
Si@@	O	-1	2826064
x	O	-1	2826064
healthy	O	-1	2826064
subjects	O	-1	2826064
were	O	-1	2826064
given	O	-1	2826064
a	O	-1	2826064
0.@@	O	-1	2826064
5	O	-1	2826064
mg	O	-1	2826064
sub@@	O	-1	2826064
c@@	O	-1	2826064
utaneous	O	-1	2826064
dose	O	-1	2826064
of	O	-1	2826064
ter@@	B-Chemical	D013726	2826064
but@@	I-Chemical	-1	2826064
aline	I-Chemical	-1	2826064
on	O	-1	2826064
two	O	-1	2826064
oc@@	O	-1	2826064
ca@@	O	-1	2826064
sion@@	O	-1	2826064
s:	O	-1	2826064
1	O	-1	2826064
h@@	O	-1	2826064
our	O	-1	2826064
after	O	-1	2826064
oral	O	-1	2826064
administration	O	-1	2826064
of	O	-1	2826064
a	O	-1	2826064
placebo	O	-1	2826064
and	O	-1	2826064
1	O	-1	2826064
h@@	O	-1	2826064
our	O	-1	2826064
after	O	-1	2826064
8@@	O	-1	2826064
0	O	-1	2826064
mg	O	-1	2826064
ox@@	B-Chemical	D010096	2826064
p@@	I-Chemical	-1	2826064
ren@@	I-Chemical	-1	2826064
o@@	I-Chemical	-1	2826064
lol	I-Chemical	-1	2826064
or@@	O	-1	2826064
all@@	O	-1	2826064
y.	O	-1	2826064
In	O	-1	2826064
the	O	-1	2826064
7-@@	O	-1	2826064
h@@	O	-1	2826064
our	O	-1	2826064
period	O	-1	2826064
after	O	-1	2826064
ter@@	B-Chemical	D013726	2826064
but@@	I-Chemical	-1	2826064
aline	I-Chemical	-1	2826064
administr@@	O	-1	2826064
ation,	O	-1	2826064
plasma	O	-1	2826064
sam@@	O	-1	2826064
ple@@	O	-1	2826064
s	O	-1	2826064
were	O	-1	2826064
tak@@	O	-1	2826064
en	O	-1	2826064
for	O	-1	2826064
determin@@	O	-1	2826064
ation	O	-1	2826064
of	O	-1	2826064
plasma	O	-1	2826064
pot@@	B-Chemical	D011188	2826064
assi@@	I-Chemical	-1	2826064
um	I-Chemical	-1	2826064
levels	O	-1	2826064
and	O	-1	2826064
drug	O	-1	2826064
concentr@@	O	-1	2826064
ations.	O	-1	2826064
The	O	-1	2826064
si@@	O	-1	2826064
g@@	O	-1	2826064
mo@@	O	-1	2826064
id	O	-1	2826064
E@@	O	-1	2826064
ma@@	O	-1	2826064
x	O	-1	2826064
model	O	-1	2826064
o@@	O	-1	2826064
ffe@@	O	-1	2826064
red	O	-1	2826064
a	O	-1	2826064
go@@	O	-1	2826064
od	O	-1	2826064
descri@@	O	-1	2826064
ption	O	-1	2826064
of	O	-1	2826064
the	O	-1	2826064
rel@@	O	-1	2826064
ation	O	-1	2826064
between	O	-1	2826064
ter@@	B-Chemical	D013726	2826064
but@@	I-Chemical	-1	2826064
aline	I-Chemical	-1	2826064
concentrations	O	-1	2826064
and	O	-1	2826064
pot@@	B-Chemical	D011188	2826064
assi@@	I-Chemical	-1	2826064
um	I-Chemical	-1	2826064
effects.	O	-1	2826064
O@@	B-Chemical	D010096	2826064
x@@	I-Chemical	-1	2826064
p@@	I-Chemical	-1	2826064
ren@@	I-Chemical	-1	2826064
o@@	I-Chemical	-1	2826064
lol	I-Chemical	-1	2826064
caused	O	-1	2826064
decreas@@	O	-1	2826064
es	O	-1	2826064
of	O	-1	2826064
6@@	O	-1	2826064
5%	O	-1	2826064
and	O	-1	2826064
5@@	O	-1	2826064
6%	O	-1	2826064
of	O	-1	2826064
ter@@	B-Chemical	D013726	2826064
but@@	I-Chemical	-1	2826064
aline	I-Chemical	-1	2826064
volume	O	-1	2826064
of	O	-1	2826064
di@@	O	-1	2826064
stri@@	O	-1	2826064
bu@@	O	-1	2826064
tion	O	-1	2826064
and	O	-1	2826064
clear@@	O	-1	2826064
ance@@	O	-1	2826064
,	O	-1	2826064
respectivel@@	O	-1	2826064
y,	O	-1	2826064
and	O	-1	2826064
an	O	-1	2826064
increase	O	-1	2826064
of	O	-1	2826064
13@@	O	-1	2826064
0%	O	-1	2826064
of	O	-1	2826064
its	O	-1	2826064
A@@	O	-1	2826064
U@@	O	-1	2826064
C@@	O	-1	2826064
.	O	-1	2826064
In	O	-1	2826064
sp@@	O	-1	2826064
ite	O	-1	2826064
of	O	-1	2826064
higher	O	-1	2826064
ter@@	B-Chemical	D013726	2826064
but@@	I-Chemical	-1	2826064
aline	I-Chemical	-1	2826064
concentrations	O	-1	2826064
after	O	-1	2826064
ox@@	B-Chemical	D010096	2826064
p@@	I-Chemical	-1	2826064
ren@@	I-Chemical	-1	2826064
o@@	I-Chemical	-1	2826064
lol	I-Chemical	-1	2826064
pre@@	O	-1	2826064
treatment,	O	-1	2826064
the	O	-1	2826064
hypo@@	B-Disease	D007008	2826064
k@@	I-Disease	-1	2826064
al@@	I-Disease	-1	2826064
emia	I-Disease	-1	2826064
was	O	-1	2826064
al@@	O	-1	2826064
most	O	-1	2826064
complete@@	O	-1	2826064
ly	O	-1	2826064
antagon@@	O	-1	2826064
ized	O	-1	2826064
by	O	-1	2826064
the	O	-1	2826064
bet@@	O	-1	2826064
a	O	-1	2826064
2-@@	O	-1	2826064
block@@	O	-1	2826064
ing	O	-1	2826064
ac@@	O	-1	2826064
tion.	O	-1	2826064

M@@	O	-1	2422478
id@@	O	-1	2422478
line	O	-1	2422478
B@@	O	-1	2422478
3	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
ner@@	O	-1	2422478
v@@	O	-1	2422478
es	O	-1	2422478
in	O	-1	2422478
rat	O	-1	2422478
med@@	O	-1	2422478
ul@@	O	-1	2422478
l@@	O	-1	2422478
a	O	-1	2422478
are	O	-1	2422478
involved	O	-1	2422478
in	O	-1	2422478
hypoten@@	B-Disease	D007022	2422478
sive	I-Disease	-1	2422478
effect	O	-1	2422478
of	O	-1	2422478
methyl@@	B-Chemical	D008750	2422478
dopa	I-Chemical	-1	2422478
.	O	-1	2422478
Pre@@	O	-1	2422478
vi@@	O	-1	2422478
ous	O	-1	2422478
experim@@	O	-1	2422478
ents	O	-1	2422478
in	O	-1	2422478
this	O	-1	2422478
labor@@	O	-1	2422478
atory	O	-1	2422478
have	O	-1	2422478
shown	O	-1	2422478
that	O	-1	2422478
micro@@	O	-1	2422478
injection	O	-1	2422478
of	O	-1	2422478
methyl@@	B-Chemical	D008750	2422478
dopa	I-Chemical	-1	2422478
on@@	O	-1	2422478
to	O	-1	2422478
the	O	-1	2422478
v@@	O	-1	2422478
ent@@	O	-1	2422478
ro@@	O	-1	2422478
lat@@	O	-1	2422478
eral	O	-1	2422478
cells	O	-1	2422478
of	O	-1	2422478
the	O	-1	2422478
B@@	O	-1	2422478
3	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
neuron@@	O	-1	2422478
s	O	-1	2422478
in	O	-1	2422478
the	O	-1	2422478
med@@	O	-1	2422478
ul@@	O	-1	2422478
l@@	O	-1	2422478
a	O	-1	2422478
el@@	O	-1	2422478
ic@@	O	-1	2422478
its	O	-1	2422478
a	O	-1	2422478
hypoten@@	B-Disease	D007022	2422478
sive	I-Disease	-1	2422478
response	O	-1	2422478
mediated	O	-1	2422478
by	O	-1	2422478
a	O	-1	2422478
pro@@	O	-1	2422478
j@@	O	-1	2422478
ection	O	-1	2422478
des@@	O	-1	2422478
c@@	O	-1	2422478
en@@	O	-1	2422478
ding	O	-1	2422478
into	O	-1	2422478
the	O	-1	2422478
spinal	O	-1	2422478
cor@@	O	-1	2422478
d.	O	-1	2422478
The	O	-1	2422478
present	O	-1	2422478
experim@@	O	-1	2422478
ents	O	-1	2422478
were	O	-1	2422478
de@@	O	-1	2422478
signed	O	-1	2422478
to	O	-1	2422478
investigate	O	-1	2422478
the	O	-1	2422478
role	O	-1	2422478
of	O	-1	2422478
the	O	-1	2422478
mid@@	O	-1	2422478
line	O	-1	2422478
cells	O	-1	2422478
of	O	-1	2422478
the	O	-1	2422478
B@@	O	-1	2422478
3	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
neuron@@	O	-1	2422478
s	O	-1	2422478
in	O	-1	2422478
the	O	-1	2422478
med@@	O	-1	2422478
ul@@	O	-1	2422478
l@@	O	-1	2422478
a,	O	-1	2422478
co@@	O	-1	2422478
inc@@	O	-1	2422478
id@@	O	-1	2422478
ing	O	-1	2422478
with	O	-1	2422478
the	O	-1	2422478
ra@@	O	-1	2422478
ph@@	O	-1	2422478
e	O	-1	2422478
mag@@	O	-1	2422478
n@@	O	-1	2422478
us.	O	-1	2422478
In	O	-1	2422478
spont@@	O	-1	2422478
ane@@	O	-1	2422478
ously	O	-1	2422478
hypertensive	B-Disease	D006973	2422478
,	O	-1	2422478
strok@@	B-Disease	D020521	2422478
e	I-Disease	-1	2422478
-@@	O	-1	2422478
pr@@	O	-1	2422478
one	O	-1	2422478
rats,	O	-1	2422478
micro@@	O	-1	2422478
injection	O	-1	2422478
of	O	-1	2422478
methyl@@	B-Chemical	D008750	2422478
dopa	I-Chemical	-1	2422478
into	O	-1	2422478
the	O	-1	2422478
a@@	O	-1	2422478
re@@	O	-1	2422478
a	O	-1	2422478
of	O	-1	2422478
the	O	-1	2422478
mid@@	O	-1	2422478
line	O	-1	2422478
B@@	O	-1	2422478
3	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
cell	O	-1	2422478
group	O	-1	2422478
in	O	-1	2422478
the	O	-1	2422478
ventr@@	O	-1	2422478
al	O	-1	2422478
med@@	O	-1	2422478
ul@@	O	-1	2422478
l@@	O	-1	2422478
a	O	-1	2422478
caused	O	-1	2422478
a	O	-1	2422478
pot@@	O	-1	2422478
ent	O	-1	2422478
hypotension	B-Disease	D007022	2422478
of	O	-1	2422478
3@@	O	-1	2422478
0-@@	O	-1	2422478
40	O	-1	2422478
mm	O	-1	2422478
H@@	O	-1	2422478
g@@	O	-1	2422478
,	O	-1	2422478
which	O	-1	2422478
was	O	-1	2422478
maxim@@	O	-1	2422478
al	O	-1	2422478
2-@@	O	-1	2422478
3	O	-1	2422478
h	O	-1	2422478
after	O	-1	2422478
administration	O	-1	2422478
and	O	-1	2422478
was	O	-1	2422478
abol@@	O	-1	2422478
ished	O	-1	2422478
by	O	-1	2422478
the	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
neuro@@	O	-1	2422478
tox@@	O	-1	2422478
in	O	-1	2422478
5@@	B-Chemical	D015116	2422478
,@@	I-Chemical	-1	2422478
7-@@	I-Chemical	-1	2422478
di@@	I-Chemical	-1	2422478
hydrox@@	I-Chemical	-1	2422478
y@@	I-Chemical	-1	2422478
tr@@	I-Chemical	-1	2422478
y@@	I-Chemical	-1	2422478
pt@@	I-Chemical	-1	2422478
amine	I-Chemical	-1	2422478
(	O	-1	2422478
5@@	B-Chemical	D015116	2422478
,@@	I-Chemical	-1	2422478
7-@@	I-Chemical	-1	2422478
D@@	I-Chemical	-1	2422478
H@@	I-Chemical	-1	2422478
T	I-Chemical	-1	2422478
)	O	-1	2422478
injected	O	-1	2422478
intrac@@	O	-1	2422478
e@@	O	-1	2422478
reb@@	O	-1	2422478
ro@@	O	-1	2422478
ventric@@	O	-1	2422478
ul@@	O	-1	2422478
ar@@	O	-1	2422478
ly.	O	-1	2422478
However,	O	-1	2422478
int@@	O	-1	2422478
r@@	O	-1	2422478
as@@	O	-1	2422478
p@@	O	-1	2422478
inal	O	-1	2422478
injection	O	-1	2422478
of	O	-1	2422478
5@@	B-Chemical	D015116	2422478
,@@	I-Chemical	-1	2422478
7-@@	I-Chemical	-1	2422478
D@@	I-Chemical	-1	2422478
H@@	I-Chemical	-1	2422478
T	I-Chemical	-1	2422478
to	O	-1	2422478
produce	O	-1	2422478
a	O	-1	2422478
more	O	-1	2422478
selective	O	-1	2422478
le@@	O	-1	2422478
sion	O	-1	2422478
of	O	-1	2422478
only	O	-1	2422478
des@@	O	-1	2422478
c@@	O	-1	2422478
en@@	O	-1	2422478
ding	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
pro@@	O	-1	2422478
j@@	O	-1	2422478
ec@@	O	-1	2422478
tions	O	-1	2422478
in	O	-1	2422478
the	O	-1	2422478
spinal	O	-1	2422478
cor@@	O	-1	2422478
d	O	-1	2422478
did	O	-1	2422478
not	O	-1	2422478
aff@@	O	-1	2422478
ect	O	-1	2422478
this	O	-1	2422478
hypotension	B-Disease	D007022	2422478
.	O	-1	2422478
F@@	O	-1	2422478
ur@@	O	-1	2422478
ther@@	O	-1	2422478
,	O	-1	2422478
5@@	B-Chemical	D015116	2422478
,@@	I-Chemical	-1	2422478
7-@@	I-Chemical	-1	2422478
D@@	I-Chemical	-1	2422478
H@@	I-Chemical	-1	2422478
T	I-Chemical	-1	2422478
le@@	O	-1	2422478
sion	O	-1	2422478
of	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
ner@@	O	-1	2422478
v@@	O	-1	2422478
es	O	-1	2422478
tra@@	O	-1	2422478
ve@@	O	-1	2422478
ll@@	O	-1	2422478
ing	O	-1	2422478
in	O	-1	2422478
the	O	-1	2422478
median	O	-1	2422478
fo@@	O	-1	2422478
re@@	O	-1	2422478
brain	O	-1	2422478
b@@	O	-1	2422478
und@@	O	-1	2422478
le@@	O	-1	2422478
,	O	-1	2422478
one	O	-1	2422478
of	O	-1	2422478
the	O	-1	2422478
ma@@	O	-1	2422478
in	O	-1	2422478
as@@	O	-1	2422478
c@@	O	-1	2422478
en@@	O	-1	2422478
ding	O	-1	2422478
path@@	O	-1	2422478
w@@	O	-1	2422478
ays	O	-1	2422478
from	O	-1	2422478
the	O	-1	2422478
B@@	O	-1	2422478
3	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
cell@@	O	-1	2422478
s,	O	-1	2422478
did	O	-1	2422478
not	O	-1	2422478
aff@@	O	-1	2422478
ect	O	-1	2422478
the	O	-1	2422478
f@@	O	-1	2422478
all	O	-1	2422478
in	O	-1	2422478
blood	O	-1	2422478
pressure	O	-1	2422478
associated	O	-1	2422478
with	O	-1	2422478
a	O	-1	2422478
mid@@	O	-1	2422478
line	O	-1	2422478
B@@	O	-1	2422478
3	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
methyl@@	B-Chemical	D008750	2422478
dopa	I-Chemical	-1	2422478
injec@@	O	-1	2422478
tion.	O	-1	2422478
It	O	-1	2422478
is	O	-1	2422478
concl@@	O	-1	2422478
uded	O	-1	2422478
the@@	O	-1	2422478
re@@	O	-1	2422478
fore	O	-1	2422478
th@@	O	-1	2422478
at@@	O	-1	2422478
,	O	-1	2422478
un@@	O	-1	2422478
like	O	-1	2422478
the	O	-1	2422478
v@@	O	-1	2422478
ent@@	O	-1	2422478
ro@@	O	-1	2422478
lat@@	O	-1	2422478
eral	O	-1	2422478
B@@	O	-1	2422478
3	O	-1	2422478
cells	O	-1	2422478
which	O	-1	2422478
medi@@	O	-1	2422478
ate	O	-1	2422478
a	O	-1	2422478
methyl@@	B-Chemical	D008750	2422478
dopa	I-Chemical	-1	2422478
-induced	O	-1	2422478
hypotension	B-Disease	D007022	2422478
vi@@	O	-1	2422478
a	O	-1	2422478
des@@	O	-1	2422478
c@@	O	-1	2422478
en@@	O	-1	2422478
ding	O	-1	2422478
pro@@	O	-1	2422478
j@@	O	-1	2422478
ec@@	O	-1	2422478
tion@@	O	-1	2422478
s,	O	-1	2422478
the	O	-1	2422478
mid@@	O	-1	2422478
line	O	-1	2422478
seroton@@	B-Chemical	D012701	2422478
in	I-Chemical	-1	2422478
B@@	O	-1	2422478
3	O	-1	2422478
cells	O	-1	2422478
in	O	-1	2422478
the	O	-1	2422478
med@@	O	-1	2422478
ul@@	O	-1	2422478
l@@	O	-1	2422478
a	O	-1	2422478
cont@@	O	-1	2422478
rib@@	O	-1	2422478
ute	O	-1	2422478
to	O	-1	2422478
the	O	-1	2422478
hypoten@@	B-Disease	D007022	2422478
sive	I-Disease	-1	2422478
action	O	-1	2422478
of	O	-1	2422478
methyl@@	B-Chemical	D008750	2422478
dopa	I-Chemical	-1	2422478
,	O	-1	2422478
either	O	-1	2422478
by	O	-1	2422478
w@@	O	-1	2422478
ay	O	-1	2422478
of	O	-1	2422478
an	O	-1	2422478
as@@	O	-1	2422478
c@@	O	-1	2422478
en@@	O	-1	2422478
ding	O	-1	2422478
pro@@	O	-1	2422478
j@@	O	-1	2422478
ection	O	-1	2422478
which	O	-1	2422478
does	O	-1	2422478
not	O	-1	2422478
p@@	O	-1	2422478
as@@	O	-1	2422478
s	O	-1	2422478
through	O	-1	2422478
the	O	-1	2422478
median	O	-1	2422478
fo@@	O	-1	2422478
re@@	O	-1	2422478
brain	O	-1	2422478
b@@	O	-1	2422478
und@@	O	-1	2422478
le@@	O	-1	2422478
,	O	-1	2422478
or	O	-1	2422478
through	O	-1	2422478
a	O	-1	2422478
pro@@	O	-1	2422478
j@@	O	-1	2422478
ection	O	-1	2422478
re@@	O	-1	2422478
stric@@	O	-1	2422478
ted	O	-1	2422478
to	O	-1	2422478
the	O	-1	2422478
ca@@	O	-1	2422478
ud@@	O	-1	2422478
al	O	-1	2422478
bra@@	O	-1	2422478
in@@	O	-1	2422478
st@@	O	-1	2422478
em@@	O	-1	2422478
.	O	-1	2422478

Y@@	B-Chemical	D015016	1535072
o@@	I-Chemical	-1	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
treatment	O	-1	1535072
of	O	-1	1535072
sex@@	B-Disease	D020018	1535072
ual	I-Disease	-1	1535072
side	I-Disease	-1	1535072
effects	I-Disease	-1	1535072
induced	O	-1	1535072
by	O	-1	1535072
seroton@@	B-Chemical	D012701	1535072
in	I-Chemical	-1	1535072
re@@	O	-1	1535072
u@@	O	-1	1535072
pt@@	O	-1	1535072
ake	O	-1	1535072
block@@	O	-1	1535072
ers.	O	-1	1535072
BACKGROUND:	O	-1	1535072
Pre@@	O	-1	1535072
clinical	O	-1	1535072
and	O	-1	1535072
clinical	O	-1	1535072
studies	O	-1	1535072
suggest	O	-1	1535072
that	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
fac@@	O	-1	1535072
il@@	O	-1	1535072
it@@	O	-1	1535072
ates	O	-1	1535072
sex@@	O	-1	1535072
ual	O	-1	1535072
behavi@@	O	-1	1535072
or	O	-1	1535072
and	O	-1	1535072
may	O	-1	1535072
be	O	-1	1535072
he@@	O	-1	1535072
l@@	O	-1	1535072
p@@	O	-1	1535072
ful	O	-1	1535072
in	O	-1	1535072
the	O	-1	1535072
treatment	O	-1	1535072
of	O	-1	1535072
male	B-Disease	D007172	1535072
im@@	I-Disease	-1	1535072
pot@@	I-Disease	-1	1535072
ence	I-Disease	-1	1535072
.	O	-1	1535072
A	O	-1	1535072
single	O	-1	1535072
case	O	-1	1535072
report	O	-1	1535072
suggests	O	-1	1535072
that	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
may	O	-1	1535072
be	O	-1	1535072
used	O	-1	1535072
to	O	-1	1535072
tre@@	O	-1	1535072
at	O	-1	1535072
the	O	-1	1535072
sex@@	B-Disease	D020018	1535072
ual	I-Disease	-1	1535072
side	I-Disease	-1	1535072
effects	I-Disease	-1	1535072
of	O	-1	1535072
clo@@	B-Chemical	D002997	1535072
mi@@	I-Chemical	-1	1535072
pramine	I-Chemical	-1	1535072
.	O	-1	1535072
This	O	-1	1535072
study	O	-1	1535072
evaluated	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
as	O	-1	1535072
a	O	-1	1535072
treatment	O	-1	1535072
for	O	-1	1535072
the	O	-1	1535072
sex@@	B-Disease	D020018	1535072
ual	I-Disease	-1	1535072
side	I-Disease	-1	1535072
effects	I-Disease	-1	1535072
caused	O	-1	1535072
by	O	-1	1535072
seroton@@	B-Chemical	D012701	1535072
in	I-Chemical	-1	1535072
re@@	O	-1	1535072
u@@	O	-1	1535072
pt@@	O	-1	1535072
ake	O	-1	1535072
block@@	O	-1	1535072
ers.	O	-1	1535072
METHOD@@	O	-1	1535072
:	O	-1	1535072
Si@@	O	-1	1535072
x	O	-1	1535072
patients	O	-1	1535072
with	O	-1	1535072
either	O	-1	1535072
ob@@	B-Disease	D009771	1535072
s@@	I-Disease	-1	1535072
es@@	I-Disease	-1	1535072
sive	I-Disease	-1	1535072
comp@@	I-Disease	-1	1535072
ul@@	I-Disease	-1	1535072
sive	I-Disease	-1	1535072
disor@@	I-Disease	-1	1535072
der	I-Disease	-1	1535072
,	O	-1	1535072
tr@@	B-Disease	D014256	1535072
ic@@	I-Disease	-1	1535072
ho@@	I-Disease	-1	1535072
til@@	I-Disease	-1	1535072
lo@@	I-Disease	-1	1535072
man@@	I-Disease	-1	1535072
ia	I-Disease	-1	1535072
,	O	-1	1535072
an@@	B-Disease	D001008	1535072
xi@@	I-Disease	-1	1535072
ety	I-Disease	-1	1535072
,	O	-1	1535072
or	O	-1	1535072
aff@@	B-Disease	D019964	1535072
ective	I-Disease	-1	1535072
disorder@@	I-Disease	-1	1535072
s	I-Disease	-1	1535072
who	O	-1	1535072
su@@	O	-1	1535072
ffe@@	O	-1	1535072
red	O	-1	1535072
sex@@	B-Disease	D020018	1535072
ual	I-Disease	-1	1535072
side	I-Disease	-1	1535072
effects	I-Disease	-1	1535072
after	O	-1	1535072
treatment	O	-1	1535072
with	O	-1	1535072
seroton@@	B-Chemical	D012701	1535072
in	I-Chemical	-1	1535072
re@@	O	-1	1535072
u@@	O	-1	1535072
pt@@	O	-1	1535072
ake	O	-1	1535072
block@@	O	-1	1535072
ers	O	-1	1535072
were	O	-1	1535072
given	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
on	O	-1	1535072
a	O	-1	1535072
p.@@	O	-1	1535072
r@@	O	-1	1535072
.@@	O	-1	1535072
n@@	O	-1	1535072
.	O	-1	1535072
b@@	O	-1	1535072
asis	O	-1	1535072
in	O	-1	1535072
an	O	-1	1535072
op@@	O	-1	1535072
en	O	-1	1535072
clinical	O	-1	1535072
tri@@	O	-1	1535072
al.	O	-1	1535072
V@@	O	-1	1535072
ari@@	O	-1	1535072
ous	O	-1	1535072
doses	O	-1	1535072
of	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
were	O	-1	1535072
used	O	-1	1535072
to	O	-1	1535072
determine	O	-1	1535072
the	O	-1	1535072
ide@@	O	-1	1535072
al	O	-1	1535072
dose	O	-1	1535072
for	O	-1	1535072
each	O	-1	1535072
patient@@	O	-1	1535072
.	O	-1	1535072
RESULTS:	O	-1	1535072
F@@	O	-1	1535072
i@@	O	-1	1535072
ve	O	-1	1535072
of	O	-1	1535072
the	O	-1	1535072
six	O	-1	1535072
patients	O	-1	1535072
experienced	O	-1	1535072
improved	O	-1	1535072
sex@@	O	-1	1535072
ual	O	-1	1535072
func@@	O	-1	1535072
tion@@	O	-1	1535072
ing	O	-1	1535072
after	O	-1	1535072
taking	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
.	O	-1	1535072
One	O	-1	1535072
patient	O	-1	1535072
who	O	-1	1535072
fail@@	O	-1	1535072
ed	O	-1	1535072
to	O	-1	1535072
comp@@	O	-1	1535072
ly	O	-1	1535072
with	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
treatment	O	-1	1535072
had	O	-1	1535072
no	O	-1	1535072
therapeutic	O	-1	1535072
effects.	O	-1	1535072
S@@	O	-1	1535072
ide	O	-1	1535072
effects	O	-1	1535072
of	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
included	O	-1	1535072
ex@@	O	-1	1535072
ces@@	O	-1	1535072
sive	O	-1	1535072
s@@	O	-1	1535072
we@@	O	-1	1535072
at@@	O	-1	1535072
ing,	O	-1	1535072
increased	O	-1	1535072
an@@	B-Disease	D001008	1535072
xi@@	I-Disease	-1	1535072
ety	I-Disease	-1	1535072
,	O	-1	1535072
and	O	-1	1535072
a	O	-1	1535072
w@@	O	-1	1535072
oun@@	O	-1	1535072
d-@@	O	-1	1535072
up	O	-1	1535072
fe@@	O	-1	1535072
el@@	O	-1	1535072
ing	O	-1	1535072
in	O	-1	1535072
some	O	-1	1535072
patients.	O	-1	1535072
CONCLUSION:	O	-1	1535072
The	O	-1	1535072
results	O	-1	1535072
of	O	-1	1535072
this	O	-1	1535072
study	O	-1	1535072
indicate	O	-1	1535072
that	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
may	O	-1	1535072
be	O	-1	1535072
an	O	-1	1535072
effective	O	-1	1535072
treatment	O	-1	1535072
for	O	-1	1535072
the	O	-1	1535072
sex@@	B-Disease	D020018	1535072
ual	I-Disease	-1	1535072
side	I-Disease	-1	1535072
effects	I-Disease	-1	1535072
caused	O	-1	1535072
by	O	-1	1535072
seroton@@	B-Chemical	D012701	1535072
in	I-Chemical	-1	1535072
re@@	O	-1	1535072
u@@	O	-1	1535072
pt@@	O	-1	1535072
ake	O	-1	1535072
block@@	O	-1	1535072
ers.	O	-1	1535072
F@@	O	-1	1535072
ut@@	O	-1	1535072
ure	O	-1	1535072
controlled	O	-1	1535072
studies	O	-1	1535072
are	O	-1	1535072
ne@@	O	-1	1535072
ed@@	O	-1	1535072
ed	O	-1	1535072
to	O	-1	1535072
further	O	-1	1535072
investigate	O	-1	1535072
the	O	-1	1535072
eff@@	O	-1	1535072
ec@@	O	-1	1535072
tiv@@	O	-1	1535072
en@@	O	-1	1535072
ess	O	-1	1535072
and	O	-1	1535072
safety	O	-1	1535072
of	O	-1	1535072
yo@@	B-Chemical	D015016	1535072
h@@	I-Chemical	-1	1535072
im@@	I-Chemical	-1	1535072
b@@	I-Chemical	-1	1535072
ine	I-Chemical	-1	1535072
for	O	-1	1535072
this	O	-1	1535072
indic@@	O	-1	1535072
ation.	O	-1	1535072

H@@	B-Disease	D004342	1504402
y@@	I-Disease	-1	1504402
per@@	I-Disease	-1	1504402
sensitivity	I-Disease	-1	1504402
immun@@	O	-1	1504402
e	O	-1	1504402
reaction	O	-1	1504402
as	O	-1	1504402
a	O	-1	1504402
mechanism	O	-1	1504402
for	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
-@@	O	-1	1504402
associated	O	-1	1504402
hepatitis	B-Disease	D056486	1504402
.	O	-1	1504402
OBJECTIVE:	O	-1	1504402
To	O	-1	1504402
ass@@	O	-1	1504402
ess	O	-1	1504402
lymph@@	O	-1	1504402
ocyte	O	-1	1504402
re@@	O	-1	1504402
activity	O	-1	1504402
to	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
and	O	-1	1504402
to	O	-1	1504402
serum	O	-1	1504402
containing	O	-1	1504402
p@@	O	-1	1504402
ut@@	O	-1	1504402
ative	O	-1	1504402
e@@	O	-1	1504402
x	O	-1	1504402
viv@@	O	-1	1504402
o	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
anti@@	O	-1	1504402
gen@@	O	-1	1504402
s	O	-1	1504402
or	O	-1	1504402
metabol@@	O	-1	1504402
it@@	O	-1	1504402
es	O	-1	1504402
in	O	-1	1504402
a	O	-1	1504402
case	O	-1	1504402
of	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
-induced	O	-1	1504402
liver	B-Disease	D056486	1504402
injury	I-Disease	-1	1504402
.	O	-1	1504402
PA@@	O	-1	1504402
TI@@	O	-1	1504402
E@@	O	-1	1504402
N@@	O	-1	1504402
T@@	O	-1	1504402
:	O	-1	1504402
A	O	-1	1504402
5@@	O	-1	1504402
8@@	O	-1	1504402
-@@	O	-1	1504402
year-old	O	-1	1504402
woman	O	-1	1504402
with	O	-1	1504402
a	O	-1	1504402
clinical	O	-1	1504402
diagnosis	O	-1	1504402
of	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
-induced	O	-1	1504402
liver	B-Disease	D056486	1504402
injury	I-Disease	-1	1504402
.	O	-1	1504402
METHODS:	O	-1	1504402
P@@	O	-1	1504402
er@@	O	-1	1504402
i@@	O	-1	1504402
pheral	O	-1	1504402
blood	O	-1	1504402
mon@@	O	-1	1504402
on@@	O	-1	1504402
ucle@@	O	-1	1504402
ar	O	-1	1504402
cells	O	-1	1504402
coll@@	O	-1	1504402
ected	O	-1	1504402
from	O	-1	1504402
the	O	-1	1504402
patient	O	-1	1504402
were	O	-1	1504402
c@@	O	-1	1504402
ult@@	O	-1	1504402
ured	O	-1	1504402
in	O	-1	1504402
the	O	-1	1504402
presence	O	-1	1504402
of	O	-1	1504402
a	O	-1	1504402
sol@@	O	-1	1504402
u@@	O	-1	1504402
tion	O	-1	1504402
of	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
and	O	-1	1504402
also	O	-1	1504402
with	O	-1	1504402
ser@@	O	-1	1504402
a	O	-1	1504402
coll@@	O	-1	1504402
ected	O	-1	1504402
from	O	-1	1504402
a	O	-1	1504402
vol@@	O	-1	1504402
un@@	O	-1	1504402
te@@	O	-1	1504402
er	O	-1	1504402
before	O	-1	1504402
and	O	-1	1504402
after	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
int@@	O	-1	1504402
ak@@	O	-1	1504402
e.	O	-1	1504402
A	O	-1	1504402
similar	O	-1	1504402
pro@@	O	-1	1504402
to@@	O	-1	1504402
co@@	O	-1	1504402
l	O	-1	1504402
was	O	-1	1504402
performed	O	-1	1504402
with	O	-1	1504402
lymph@@	O	-1	1504402
ocy@@	O	-1	1504402
tes	O	-1	1504402
from	O	-1	1504402
a	O	-1	1504402
healthy	O	-1	1504402
subj@@	O	-1	1504402
ect@@	O	-1	1504402
.	O	-1	1504402
RESULTS:	O	-1	1504402
No	O	-1	1504402
lymph@@	O	-1	1504402
ocyte	O	-1	1504402
pro@@	O	-1	1504402
li@@	O	-1	1504402
fer@@	O	-1	1504402
ation	O	-1	1504402
was	O	-1	1504402
observed	O	-1	1504402
either	O	-1	1504402
in	O	-1	1504402
the	O	-1	1504402
patient	O	-1	1504402
or	O	-1	1504402
in	O	-1	1504402
the	O	-1	1504402
healthy	O	-1	1504402
vol@@	O	-1	1504402
un@@	O	-1	1504402
te@@	O	-1	1504402
er	O	-1	1504402
in	O	-1	1504402
the	O	-1	1504402
presence	O	-1	1504402
of	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
sol@@	O	-1	1504402
u@@	O	-1	1504402
tions.	O	-1	1504402
A	O	-1	1504402
significant	O	-1	1504402
pro@@	O	-1	1504402
li@@	O	-1	1504402
fer@@	O	-1	1504402
ative	O	-1	1504402
response	O	-1	1504402
to	O	-1	1504402
serum	O	-1	1504402
coll@@	O	-1	1504402
ected	O	-1	1504402
after	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
int@@	O	-1	1504402
ake	O	-1	1504402
was	O	-1	1504402
observed	O	-1	1504402
in	O	-1	1504402
the	O	-1	1504402
case	O	-1	1504402
of	O	-1	1504402
the	O	-1	1504402
patient	O	-1	1504402
compared	O	-1	1504402
with	O	-1	1504402
the	O	-1	1504402
pro@@	O	-1	1504402
li@@	O	-1	1504402
fer@@	O	-1	1504402
ative	O	-1	1504402
response	O	-1	1504402
to	O	-1	1504402
the	O	-1	1504402
serum	O	-1	1504402
coll@@	O	-1	1504402
ected	O	-1	1504402
before	O	-1	1504402
the	O	-1	1504402
drug	O	-1	1504402
int@@	O	-1	1504402
ak@@	O	-1	1504402
e.	O	-1	1504402
No	O	-1	1504402
re@@	O	-1	1504402
activity	O	-1	1504402
was	O	-1	1504402
found	O	-1	1504402
when	O	-1	1504402
lymph@@	O	-1	1504402
ocy@@	O	-1	1504402
tes	O	-1	1504402
from	O	-1	1504402
the	O	-1	1504402
healthy	O	-1	1504402
subj@@	O	-1	1504402
ect	O	-1	1504402
were	O	-1	1504402
tested	O	-1	1504402
under	O	-1	1504402
similar	O	-1	1504402
condi@@	O	-1	1504402
tions.	O	-1	1504402
CONCLUSIONS:	O	-1	1504402
The	O	-1	1504402
meth@@	O	-1	1504402
o@@	O	-1	1504402
do@@	O	-1	1504402
log@@	O	-1	1504402
y	O	-1	1504402
used	O	-1	1504402
al@@	O	-1	1504402
low@@	O	-1	1504402
ed	O	-1	1504402
the	O	-1	1504402
det@@	O	-1	1504402
ection	O	-1	1504402
of	O	-1	1504402
lymph@@	O	-1	1504402
ocyte	O	-1	1504402
sensi@@	O	-1	1504402
tiz@@	O	-1	1504402
ation	O	-1	1504402
to	O	-1	1504402
ser@@	O	-1	1504402
a	O	-1	1504402
containing	O	-1	1504402
e@@	O	-1	1504402
x	O	-1	1504402
viv@@	O	-1	1504402
o@@	O	-1	1504402
-@@	O	-1	1504402
pre@@	O	-1	1504402
pared	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
anti@@	O	-1	1504402
gen@@	O	-1	1504402
s,	O	-1	1504402
suggesting	O	-1	1504402
the	O	-1	1504402
invol@@	O	-1	1504402
vement	O	-1	1504402
of	O	-1	1504402
an	O	-1	1504402
immun@@	O	-1	1504402
ologic	O	-1	1504402
mechanism	O	-1	1504402
in	O	-1	1504402
di@@	B-Chemical	D007741	1504402
lev@@	I-Chemical	-1	1504402
al@@	I-Chemical	-1	1504402
ol	I-Chemical	-1	1504402
-induced	O	-1	1504402
liver	B-Disease	D056486	1504402
injury	I-Disease	-1	1504402
.	O	-1	1504402

Re@@	O	-1	19917396
ver@@	O	-1	19917396
sible	O	-1	19917396
myocardial	B-Disease	D006332	19917396
hyper@@	I-Disease	-1	19917396
tro@@	I-Disease	-1	19917396
ph@@	I-Disease	-1	19917396
y	I-Disease	-1	19917396
induced	O	-1	19917396
by	O	-1	19917396
tacrolimus	B-Chemical	D016559	19917396
in	O	-1	19917396
a	O	-1	19917396
pe@@	O	-1	19917396
di@@	O	-1	19917396
atric	O	-1	19917396
heart	O	-1	19917396
transplant	O	-1	19917396
re@@	O	-1	19917396
ci@@	O	-1	19917396
pi@@	O	-1	19917396
ent@@	O	-1	19917396
:	O	-1	19917396
case	O	-1	19917396
repor@@	O	-1	19917396
t.	O	-1	19917396
T@@	B-Chemical	D016559	19917396
ac@@	I-Chemical	-1	19917396
rolimus	I-Chemical	-1	19917396
is	O	-1	19917396
a	O	-1	19917396
pot@@	O	-1	19917396
ent	O	-1	19917396
immunosup@@	O	-1	19917396
press@@	O	-1	19917396
ant	O	-1	19917396
that	O	-1	19917396
is	O	-1	19917396
frequ@@	O	-1	19917396
ently	O	-1	19917396
used	O	-1	19917396
in	O	-1	19917396
org@@	O	-1	19917396
an	O	-1	19917396
transplant@@	O	-1	19917396
ation.	O	-1	19917396
However,	O	-1	19917396
adverse	O	-1	19917396
effects	O	-1	19917396
includ@@	O	-1	19917396
e	O	-1	19917396
cardiac	B-Disease	D066126	19917396
toxicity	I-Disease	-1	19917396
.	O	-1	19917396
He@@	O	-1	19917396
re@@	O	-1	19917396
in	O	-1	19917396
we	O	-1	19917396
describe	O	-1	19917396
transi@@	O	-1	19917396
ent	O	-1	19917396
myocardial	B-Disease	D006332	19917396
hyper@@	I-Disease	-1	19917396
tro@@	I-Disease	-1	19917396
ph@@	I-Disease	-1	19917396
y	I-Disease	-1	19917396
induced	O	-1	19917396
by	O	-1	19917396
tacrolimus	B-Chemical	D016559	19917396
after	O	-1	19917396
heart	O	-1	19917396
transplant@@	O	-1	19917396
ation.	O	-1	19917396
The	O	-1	19917396
hyper@@	B-Disease	D006984	19917396
tro@@	I-Disease	-1	19917396
ph@@	I-Disease	-1	19917396
y	I-Disease	-1	19917396
caused	O	-1	19917396
no	O	-1	19917396
clinical	O	-1	19917396
symptoms	O	-1	19917396
but	O	-1	19917396
was	O	-1	19917396
not@@	O	-1	19917396
ed	O	-1	19917396
because	O	-1	19917396
of	O	-1	19917396
elev@@	O	-1	19917396
ation	O	-1	19917396
of	O	-1	19917396
plasma	O	-1	19917396
brain	O	-1	19917396
n@@	O	-1	19917396
atri@@	O	-1	19917396
ure@@	O	-1	19917396
tic	O	-1	19917396
p@@	O	-1	19917396
ep@@	O	-1	19917396
ti@@	O	-1	19917396
de	O	-1	19917396
concentration	O	-1	19917396
and	O	-1	19917396
con@@	O	-1	19917396
fir@@	O	-1	19917396
m@@	O	-1	19917396
ed	O	-1	19917396
at	O	-1	19917396
echocardiograph@@	O	-1	19917396
y.	O	-1	19917396
In@@	O	-1	19917396
iti@@	O	-1	19917396
ally,	O	-1	19917396
allogra@@	O	-1	19917396
ft	O	-1	19917396
re@@	O	-1	19917396
j@@	O	-1	19917396
ection	O	-1	19917396
was	O	-1	19917396
fe@@	O	-1	19917396
a@@	O	-1	19917396
re@@	O	-1	19917396
d@@	O	-1	19917396
;	O	-1	19917396
however,	O	-1	19917396
myocardial	O	-1	19917396
biop@@	O	-1	19917396
sy	O	-1	19917396
sam@@	O	-1	19917396
ple@@	O	-1	19917396
s	O	-1	19917396
revealed	O	-1	19917396
only	O	-1	19917396
interstitial	O	-1	19917396
e@@	B-Disease	D004487	19917396
de@@	I-Disease	-1	19917396
ma	I-Disease	-1	19917396
and	O	-1	19917396
mil@@	O	-1	19917396
d	O	-1	19917396
myocardial	B-Disease	D006332	19917396
hyper@@	I-Disease	-1	19917396
tro@@	I-Disease	-1	19917396
ph@@	I-Disease	-1	19917396
y	I-Disease	-1	19917396
;	O	-1	19917396
ne@@	O	-1	19917396
ither	O	-1	19917396
cell@@	O	-1	19917396
ular	O	-1	19917396
n@@	O	-1	19917396
or	O	-1	19917396
h@@	O	-1	19917396
u@@	O	-1	19917396
mor@@	O	-1	19917396
al	O	-1	19917396
re@@	O	-1	19917396
j@@	O	-1	19917396
ection	O	-1	19917396
was	O	-1	19917396
det@@	O	-1	19917396
ect@@	O	-1	19917396
ed.	O	-1	19917396
The	O	-1	19917396
blood	O	-1	19917396
tacrolimus	B-Chemical	D016559	19917396
concentration	O	-1	19917396
was	O	-1	19917396
higher	O	-1	19917396
than	O	-1	19917396
us@@	O	-1	19917396
ual	O	-1	19917396
at	O	-1	19917396
that	O	-1	19917396
ti@@	O	-1	19917396
me@@	O	-1	19917396
;	O	-1	19917396
th@@	O	-1	19917396
us,	O	-1	19917396
tacrolimus	B-Chemical	D016559	19917396
dos@@	O	-1	19917396
age	O	-1	19917396
was	O	-1	19917396
reduc@@	O	-1	19917396
ed.	O	-1	19917396
M@@	B-Disease	D006332	19917396
y@@	I-Disease	-1	19917396
ocardi@@	I-Disease	-1	19917396
al	I-Disease	-1	19917396
hyper@@	I-Disease	-1	19917396
tro@@	I-Disease	-1	19917396
ph@@	I-Disease	-1	19917396
y	I-Disease	-1	19917396
complete@@	O	-1	19917396
ly	O	-1	19917396
resol@@	O	-1	19917396
ved	O	-1	19917396
up@@	O	-1	19917396
on	O	-1	19917396
reduc@@	O	-1	19917396
ing	O	-1	19917396
the	O	-1	19917396
t@@	O	-1	19917396
arg@@	O	-1	19917396
et	O	-1	19917396
concentration	O	-1	19917396
of	O	-1	19917396
tacrolimus	B-Chemical	D016559	19917396
and	O	-1	19917396
did	O	-1	19917396
not	O	-1	19917396
recur@@	O	-1	19917396
,	O	-1	19917396
as	O	-1	19917396
con@@	O	-1	19917396
fir@@	O	-1	19917396
m@@	O	-1	19917396
ed	O	-1	19917396
at	O	-1	19917396
echocardiograph@@	O	-1	19917396
y	O	-1	19917396
and	O	-1	19917396
myocardial	O	-1	19917396
bio@@	O	-1	19917396
psy@@	O	-1	19917396
.	O	-1	19917396
Th@@	O	-1	19917396
us,	O	-1	19917396
we	O	-1	19917396
concl@@	O	-1	19917396
ude	O	-1	19917396
that	O	-1	19917396
tacrolimus	B-Chemical	D016559	19917396
induc@@	O	-1	19917396
es	O	-1	19917396
reversible	O	-1	19917396
myocardial	B-Disease	D006332	19917396
hyper@@	I-Disease	-1	19917396
tro@@	I-Disease	-1	19917396
ph@@	I-Disease	-1	19917396
y	I-Disease	-1	19917396
.	O	-1	19917396
In	O	-1	19917396
patients	O	-1	19917396
receiving	O	-1	19917396
tacrolimus	B-Chemical	D016559	19917396
therapy,	O	-1	19917396
blood	O	-1	19917396
concentration	O	-1	19917396
should	O	-1	19917396
be	O	-1	19917396
ca@@	O	-1	19917396
ref@@	O	-1	19917396
ul@@	O	-1	19917396
ly	O	-1	19917396
controlled	O	-1	19917396
and	O	-1	19917396
ex@@	O	-1	19917396
trem@@	O	-1	19917396
e	O	-1	19917396
atten@@	O	-1	19917396
tion	O	-1	19917396
pa@@	O	-1	19917396
id	O	-1	19917396
to	O	-1	19917396
cardiac	O	-1	19917396
invol@@	O	-1	19917396
ve@@	O	-1	19917396
ment.	O	-1	19917396

Com@@	O	-1	19234905
par@@	O	-1	19234905
ison	O	-1	19234905
of	O	-1	19234905
un@@	O	-1	19234905
il@@	O	-1	19234905
ateral	O	-1	19234905
p@@	O	-1	19234905
all@@	O	-1	19234905
id@@	O	-1	19234905
ot@@	O	-1	19234905
om@@	O	-1	19234905
y	O	-1	19234905
and	O	-1	19234905
sub@@	O	-1	19234905
thal@@	O	-1	19234905
am@@	O	-1	19234905
ot@@	O	-1	19234905
om@@	O	-1	19234905
y	O	-1	19234905
findings	O	-1	19234905
in	O	-1	19234905
adv@@	O	-1	19234905
anced	O	-1	19234905
i@@	B-Disease	D010300	19234905
di@@	I-Disease	-1	19234905
o@@	I-Disease	-1	19234905
path@@	I-Disease	-1	19234905
ic	I-Disease	-1	19234905
Parkinson's	I-Disease	-1	19234905
disease	I-Disease	-1	19234905
.	O	-1	19234905
A	O	-1	19234905
pro@@	O	-1	19234905
sp@@	O	-1	19234905
ecti@@	O	-1	19234905
ve,	O	-1	19234905
random@@	O	-1	19234905
iz@@	O	-1	19234905
ed,	O	-1	19234905
double-bl@@	O	-1	19234905
ind	O	-1	19234905
pilo@@	O	-1	19234905
t	O	-1	19234905
study	O	-1	19234905
to	O	-1	19234905
compar@@	O	-1	19234905
e	O	-1	19234905
the	O	-1	19234905
results	O	-1	19234905
of	O	-1	19234905
ste@@	O	-1	19234905
re@@	O	-1	19234905
ot@@	O	-1	19234905
ac@@	O	-1	19234905
tic	O	-1	19234905
un@@	O	-1	19234905
il@@	O	-1	19234905
ateral	O	-1	19234905
p@@	O	-1	19234905
all@@	O	-1	19234905
id@@	O	-1	19234905
ot@@	O	-1	19234905
om@@	O	-1	19234905
y	O	-1	19234905
and	O	-1	19234905
sub@@	O	-1	19234905
thal@@	O	-1	19234905
am@@	O	-1	19234905
ot@@	O	-1	19234905
om@@	O	-1	19234905
y	O	-1	19234905
in	O	-1	19234905
adv@@	O	-1	19234905
anced	O	-1	19234905
i@@	B-Disease	D010300	19234905
di@@	I-Disease	-1	19234905
o@@	I-Disease	-1	19234905
path@@	I-Disease	-1	19234905
ic	I-Disease	-1	19234905
Parkinson's	I-Disease	-1	19234905
disease	I-Disease	-1	19234905
(	O	-1	19234905
P@@	B-Disease	D010300	19234905
D	I-Disease	-1	19234905
)	O	-1	19234905
ref@@	O	-1	19234905
rac@@	O	-1	19234905
t@@	O	-1	19234905
ory	O	-1	19234905
to	O	-1	19234905
med@@	O	-1	19234905
ical	O	-1	19234905
treatment	O	-1	19234905
was	O	-1	19234905
desi@@	O	-1	19234905
g@@	O	-1	19234905
ne@@	O	-1	19234905
d.	O	-1	19234905
T@@	O	-1	19234905
en	O	-1	19234905
con@@	O	-1	19234905
sec@@	O	-1	19234905
utive	O	-1	19234905
patients	O	-1	19234905
(@@	O	-1	19234905
mean	O	-1	19234905
age,	O	-1	19234905
5@@	O	-1	19234905
8.@@	O	-1	19234905
4	O	-1	19234905
+/-	O	-1	19234905
6.@@	O	-1	19234905
8	O	-1	19234905
year@@	O	-1	19234905
s;	O	-1	19234905
7	O	-1	19234905
men@@	O	-1	19234905
,	O	-1	19234905
3	O	-1	19234905
wom@@	O	-1	19234905
en@@	O	-1	19234905
)	O	-1	19234905
with	O	-1	19234905
similar	O	-1	19234905
character@@	O	-1	19234905
is@@	O	-1	19234905
tics	O	-1	19234905
at	O	-1	19234905
the	O	-1	19234905
duration	O	-1	19234905
of	O	-1	19234905
disease	O	-1	19234905
(@@	O	-1	19234905
mean	O	-1	19234905
disease	O	-1	19234905
ti@@	O	-1	19234905
me,	O	-1	19234905
8.@@	O	-1	19234905
4	O	-1	19234905
+/-	O	-1	19234905
3.@@	O	-1	19234905
5	O	-1	19234905
year@@	O	-1	19234905
s),	O	-1	19234905
dis@@	O	-1	19234905
abl@@	O	-1	19234905
ing	O	-1	19234905
motor	O	-1	19234905
f@@	O	-1	19234905
l@@	O	-1	19234905
uc@@	O	-1	19234905
tu@@	O	-1	19234905
ations	O	-1	19234905
(@@	O	-1	19234905
Ho@@	O	-1	19234905
e@@	O	-1	19234905
h@@	O	-1	19234905
n	O	-1	19234905
_	O	-1	19234905
Y@@	O	-1	19234905
a@@	O	-1	19234905
h@@	O	-1	19234905
r	O	-1	19234905
st@@	O	-1	19234905
age	O	-1	19234905
3-@@	O	-1	19234905
5	O	-1	19234905
in	O	-1	19234905
o@@	O	-1	19234905
ff@@	O	-1	19234905
-@@	O	-1	19234905
drug	O	-1	19234905
ph@@	O	-1	19234905
as@@	O	-1	19234905
es@@	O	-1	19234905
)	O	-1	19234905
and	O	-1	19234905
levo@@	B-Chemical	D007980	19234905
dopa	I-Chemical	-1	19234905
-induced	O	-1	19234905
dyskine@@	B-Disease	D004409	19234905
si@@	I-Disease	-1	19234905
as	I-Disease	-1	19234905
were	O	-1	19234905
sel@@	O	-1	19234905
ect@@	O	-1	19234905
ed.	O	-1	19234905
All	O	-1	19234905
patients	O	-1	19234905
had	O	-1	19234905
bil@@	O	-1	19234905
ateral	O	-1	19234905
symptoms	O	-1	19234905
and	O	-1	19234905
their	O	-1	19234905
levo@@	B-Chemical	D007980	19234905
dopa	I-Chemical	-1	19234905
equ@@	O	-1	19234905
i@@	O	-1	19234905
val@@	O	-1	19234905
ent	O	-1	19234905
dos@@	O	-1	19234905
ing	O	-1	19234905
were	O	-1	19234905
analy@@	O	-1	19234905
sed.	O	-1	19234905
Si@@	O	-1	19234905
x	O	-1	19234905
patients	O	-1	19234905
were	O	-1	19234905
o@@	O	-1	19234905
per@@	O	-1	19234905
ated	O	-1	19234905
on	O	-1	19234905
in	O	-1	19234905
the	O	-1	19234905
glo@@	O	-1	19234905
bu@@	O	-1	19234905
s	O	-1	19234905
p@@	O	-1	19234905
all@@	O	-1	19234905
id@@	O	-1	19234905
us	O	-1	19234905
inter@@	O	-1	19234905
n@@	O	-1	19234905
a	O	-1	19234905
(@@	O	-1	19234905
G@@	O	-1	19234905
P@@	O	-1	19234905
i@@	O	-1	19234905
)	O	-1	19234905
and	O	-1	19234905
four	O	-1	19234905
in	O	-1	19234905
the	O	-1	19234905
sub@@	O	-1	19234905
thal@@	O	-1	19234905
am@@	O	-1	19234905
ic	O	-1	19234905
nucle@@	O	-1	19234905
us	O	-1	19234905
(S@@	O	-1	19234905
T@@	O	-1	19234905
N@@	O	-1	19234905
).	O	-1	19234905
Clin@@	O	-1	19234905
ical	O	-1	19234905
evalu@@	O	-1	19234905
ation	O	-1	19234905
included	O	-1	19234905
the	O	-1	19234905
use	O	-1	19234905
of	O	-1	19234905
the	O	-1	19234905
U@@	O	-1	19234905
n@@	O	-1	19234905
if@@	O	-1	19234905
ied	O	-1	19234905
Parkinson's	B-Disease	D010300	19234905
Di@@	I-Disease	-1	19234905
se@@	I-Disease	-1	19234905
ase	I-Disease	-1	19234905
R@@	O	-1	19234905
ating	O	-1	19234905
S@@	O	-1	19234905
cal@@	O	-1	19234905
e	O	-1	19234905
(@@	O	-1	19234905
U@@	O	-1	19234905
P@@	O	-1	19234905
D@@	O	-1	19234905
R@@	O	-1	19234905
S@@	O	-1	19234905
),	O	-1	19234905
Ho@@	O	-1	19234905
e@@	O	-1	19234905
h@@	O	-1	19234905
n@@	O	-1	19234905
_@@	O	-1	19234905
Y@@	O	-1	19234905
a@@	O	-1	19234905
h@@	O	-1	19234905
r	O	-1	19234905
scor@@	O	-1	19234905
e	O	-1	19234905
and	O	-1	19234905
S@@	O	-1	19234905
ch@@	O	-1	19234905
w@@	O	-1	19234905
a@@	O	-1	19234905
b	O	-1	19234905
E@@	O	-1	19234905
n@@	O	-1	19234905
gl@@	O	-1	19234905
and	O	-1	19234905
ac@@	O	-1	19234905
ti@@	O	-1	19234905
vi@@	O	-1	19234905
ties	O	-1	19234905
of	O	-1	19234905
daily	O	-1	19234905
li@@	O	-1	19234905
ving	O	-1	19234905
(A@@	O	-1	19234905
D@@	O	-1	19234905
L@@	O	-1	19234905
)	O	-1	19234905
scor@@	O	-1	19234905
e	O	-1	19234905
in	O	-1	19234905
'@@	O	-1	19234905
on@@	O	-1	19234905
'@@	O	-1	19234905
-	O	-1	19234905
and	O	-1	19234905
'@@	O	-1	19234905
o@@	O	-1	19234905
ff@@	O	-1	19234905
'@@	O	-1	19234905
-@@	O	-1	19234905
drug	O	-1	19234905
condi@@	O	-1	19234905
tions	O	-1	19234905
before	O	-1	19234905
surger@@	O	-1	19234905
y	O	-1	19234905
and	O	-1	19234905
6	O	-1	19234905
months	O	-1	19234905
after	O	-1	19234905
surger@@	O	-1	19234905
y.	O	-1	19234905
There	O	-1	19234905
was	O	-1	19234905
statis@@	O	-1	19234905
tically	O	-1	19234905
significant	O	-1	19234905
impro@@	O	-1	19234905
vement	O	-1	19234905
in	O	-1	19234905
all	O	-1	19234905
contr@@	O	-1	19234905
al@@	O	-1	19234905
ateral	O	-1	19234905
major	O	-1	19234905
par@@	B-Disease	D010300	19234905
k@@	I-Disease	-1	19234905
inson@@	I-Disease	-1	19234905
i@@	I-Disease	-1	19234905
an	I-Disease	-1	19234905
motor	O	-1	19234905
signs	O	-1	19234905
in	O	-1	19234905
all	O	-1	19234905
patients	O	-1	19234905
followed	O	-1	19234905
for	O	-1	19234905
6	O	-1	19234905
months.	O	-1	19234905
L@@	B-Chemical	D007980	19234905
evo@@	I-Chemical	-1	19234905
dopa	I-Chemical	-1	19234905
equ@@	O	-1	19234905
i@@	O	-1	19234905
val@@	O	-1	19234905
ent	O	-1	19234905
daily	O	-1	19234905
int@@	O	-1	19234905
ake	O	-1	19234905
was	O	-1	19234905
significantly	O	-1	19234905
reduced	O	-1	19234905
in	O	-1	19234905
the	O	-1	19234905
S@@	O	-1	19234905
T@@	O	-1	19234905
N	O	-1	19234905
group.	O	-1	19234905
Ch@@	O	-1	19234905
ang@@	O	-1	19234905
es	O	-1	19234905
in	O	-1	19234905
U@@	O	-1	19234905
P@@	O	-1	19234905
D@@	O	-1	19234905
R@@	O	-1	19234905
S@@	O	-1	19234905
,	O	-1	19234905
Ho@@	O	-1	19234905
e@@	O	-1	19234905
h@@	O	-1	19234905
n	O	-1	19234905
_	O	-1	19234905
Y@@	O	-1	19234905
a@@	O	-1	19234905
h@@	O	-1	19234905
r	O	-1	19234905
and	O	-1	19234905
S@@	O	-1	19234905
ch@@	O	-1	19234905
w@@	O	-1	19234905
a@@	O	-1	19234905
b	O	-1	19234905
E@@	O	-1	19234905
n@@	O	-1	19234905
gl@@	O	-1	19234905
and	O	-1	19234905
AD@@	O	-1	19234905
L	O	-1	19234905
sco@@	O	-1	19234905
res	O	-1	19234905
were	O	-1	19234905
similar	O	-1	19234905
in	O	-1	19234905
both	O	-1	19234905
groups.	O	-1	19234905
C@@	O	-1	19234905
o@@	O	-1	19234905
gn@@	O	-1	19234905
itive	O	-1	19234905
func@@	O	-1	19234905
tions	O	-1	19234905
were	O	-1	19234905
un@@	O	-1	19234905
chang@@	O	-1	19234905
ed	O	-1	19234905
in	O	-1	19234905
both	O	-1	19234905
groups.	O	-1	19234905
Com@@	O	-1	19234905
plic@@	O	-1	19234905
ations	O	-1	19234905
were	O	-1	19234905
observed	O	-1	19234905
in	O	-1	19234905
two	O	-1	19234905
patient@@	O	-1	19234905
s:	O	-1	19234905
one	O	-1	19234905
had	O	-1	19234905
a	O	-1	19234905
left	O	-1	19234905
ho@@	B-Disease	D006423	19234905
mon@@	I-Disease	-1	19234905
ym@@	I-Disease	-1	19234905
ous	I-Disease	-1	19234905
he@@	I-Disease	-1	19234905
mi@@	I-Disease	-1	19234905
an@@	I-Disease	-1	19234905
op@@	I-Disease	-1	19234905
sia	I-Disease	-1	19234905
after	O	-1	19234905
p@@	O	-1	19234905
all@@	O	-1	19234905
id@@	O	-1	19234905
ot@@	O	-1	19234905
om@@	O	-1	19234905
y	O	-1	19234905
and	O	-1	19234905
an@@	O	-1	19234905
other	O	-1	19234905
one	O	-1	19234905
developed	O	-1	19234905
left	O	-1	19234905
he@@	O	-1	19234905
mi@@	O	-1	19234905
b@@	O	-1	19234905
all@@	O	-1	19234905
istic	O	-1	19234905
mo@@	O	-1	19234905
ve@@	O	-1	19234905
ments	O	-1	19234905
3	O	-1	19234905
days	O	-1	19234905
after	O	-1	19234905
sub@@	O	-1	19234905
thal@@	O	-1	19234905
am@@	O	-1	19234905
ot@@	O	-1	19234905
om@@	O	-1	19234905
y	O	-1	19234905
which	O	-1	19234905
part@@	O	-1	19234905
ly	O	-1	19234905
improved	O	-1	19234905
within	O	-1	19234905
1	O	-1	19234905
mon@@	O	-1	19234905
th	O	-1	19234905
with	O	-1	19234905
V@@	B-Chemical	D014635	19234905
al@@	I-Chemical	-1	19234905
pro@@	I-Chemical	-1	19234905
ate	I-Chemical	-1	19234905
10@@	O	-1	19234905
00	O	-1	19234905
mg/@@	O	-1	19234905
da@@	O	-1	19234905
y.	O	-1	19234905
The	O	-1	19234905
findings	O	-1	19234905
of	O	-1	19234905
this	O	-1	19234905
study	O	-1	19234905
suggest	O	-1	19234905
that	O	-1	19234905
lesions	O	-1	19234905
of	O	-1	19234905
the	O	-1	19234905
un@@	O	-1	19234905
il@@	O	-1	19234905
ateral	O	-1	19234905
S@@	O	-1	19234905
T@@	O	-1	19234905
N	O	-1	19234905
and	O	-1	19234905
G@@	O	-1	19234905
P@@	O	-1	19234905
i	O	-1	19234905
are	O	-1	19234905
equ@@	O	-1	19234905
ally	O	-1	19234905
effective	O	-1	19234905
treatment	O	-1	19234905
for	O	-1	19234905
patients	O	-1	19234905
with	O	-1	19234905
adv@@	O	-1	19234905
anced	O	-1	19234905
P@@	B-Disease	D010300	19234905
D	I-Disease	-1	19234905
ref@@	O	-1	19234905
rac@@	O	-1	19234905
t@@	O	-1	19234905
ory	O	-1	19234905
to	O	-1	19234905
med@@	O	-1	19234905
ical	O	-1	19234905
treatment.	O	-1	19234905

Pro@@	O	-1	18541230
t@@	O	-1	18541230
ective	O	-1	18541230
effects	O	-1	18541230
of	O	-1	18541230
anti@@	O	-1	18541230
throm@@	O	-1	18541230
bin	O	-1	18541230
on	O	-1	18541230
p@@	B-Chemical	D011692	18541230
uro@@	I-Chemical	-1	18541230
m@@	I-Chemical	-1	18541230
ycin	I-Chemical	-1	18541230
amin@@	I-Chemical	-1	18541230
on@@	I-Chemical	-1	18541230
ucle@@	I-Chemical	-1	18541230
o@@	I-Chemical	-1	18541230
side	I-Chemical	-1	18541230
nephro@@	B-Disease	D009401	18541230
sis	I-Disease	-1	18541230
in	O	-1	18541230
rats.	O	-1	18541230
We	O	-1	18541230
investigated	O	-1	18541230
the	O	-1	18541230
effects	O	-1	18541230
of	O	-1	18541230
anti@@	O	-1	18541230
throm@@	O	-1	18541230
bin@@	O	-1	18541230
,	O	-1	18541230
a	O	-1	18541230
plasma	O	-1	18541230
inhibitor	O	-1	18541230
of	O	-1	18541230
co@@	O	-1	18541230
ag@@	O	-1	18541230
ulation	O	-1	18541230
fact@@	O	-1	18541230
or@@	O	-1	18541230
s,	O	-1	18541230
in	O	-1	18541230
rats	O	-1	18541230
with	O	-1	18541230
p@@	B-Chemical	D011692	18541230
uro@@	I-Chemical	-1	18541230
m@@	I-Chemical	-1	18541230
ycin	I-Chemical	-1	18541230
amin@@	I-Chemical	-1	18541230
on@@	I-Chemical	-1	18541230
ucle@@	I-Chemical	-1	18541230
o@@	I-Chemical	-1	18541230
side	I-Chemical	-1	18541230
-induced	O	-1	18541230
nephro@@	B-Disease	D009401	18541230
sis	I-Disease	-1	18541230
,	O	-1	18541230
which	O	-1	18541230
is	O	-1	18541230
an	O	-1	18541230
experimental	O	-1	18541230
model	O	-1	18541230
of	O	-1	18541230
human	O	-1	18541230
nephro@@	B-Disease	D009404	18541230
tic	I-Disease	-1	18541230
syndrome	I-Disease	-1	18541230
.	O	-1	18541230
An@@	O	-1	18541230
ti@@	O	-1	18541230
throm@@	O	-1	18541230
bin	O	-1	18541230
(@@	O	-1	18541230
50	O	-1	18541230
or	O	-1	18541230
5@@	O	-1	18541230
00	O	-1	18541230
I@@	O	-1	18541230
U@@	O	-1	18541230
/@@	O	-1	18541230
k@@	O	-1	18541230
g/@@	O	-1	18541230
i.v@@	O	-1	18541230
.)	O	-1	18541230
was	O	-1	18541230
administered	O	-1	18541230
to	O	-1	18541230
rats	O	-1	18541230
on@@	O	-1	18541230
ce	O	-1	18541230
a	O	-1	18541230
day	O	-1	18541230
for	O	-1	18541230
10	O	-1	18541230
days	O	-1	18541230
immedi@@	O	-1	18541230
ately	O	-1	18541230
after	O	-1	18541230
the	O	-1	18541230
injection	O	-1	18541230
of	O	-1	18541230
p@@	B-Chemical	D011692	18541230
uro@@	I-Chemical	-1	18541230
m@@	I-Chemical	-1	18541230
ycin	I-Chemical	-1	18541230
amin@@	I-Chemical	-1	18541230
on@@	I-Chemical	-1	18541230
ucle@@	I-Chemical	-1	18541230
o@@	I-Chemical	-1	18541230
side	I-Chemical	-1	18541230
(@@	O	-1	18541230
50	O	-1	18541230
mg/k@@	O	-1	18541230
g/@@	O	-1	18541230
i.v@@	O	-1	18541230
.@@	O	-1	18541230
).	O	-1	18541230
Treat@@	O	-1	18541230
ment	O	-1	18541230
with	O	-1	18541230
anti@@	O	-1	18541230
throm@@	O	-1	18541230
bin	O	-1	18541230
attenu@@	O	-1	18541230
ated	O	-1	18541230
the	O	-1	18541230
p@@	B-Chemical	D011692	18541230
uro@@	I-Chemical	-1	18541230
m@@	I-Chemical	-1	18541230
ycin	I-Chemical	-1	18541230
amin@@	I-Chemical	-1	18541230
on@@	I-Chemical	-1	18541230
ucle@@	I-Chemical	-1	18541230
o@@	I-Chemical	-1	18541230
side	I-Chemical	-1	18541230
-induced	O	-1	18541230
hemat@@	B-Disease	D006402	18541230
ological	I-Disease	-1	18541230
abnormal@@	I-Disease	-1	18541230
ities	I-Disease	-1	18541230
.	O	-1	18541230
P@@	B-Chemical	D011692	18541230
uro@@	I-Chemical	-1	18541230
m@@	I-Chemical	-1	18541230
ycin	I-Chemical	-1	18541230
amin@@	I-Chemical	-1	18541230
on@@	I-Chemical	-1	18541230
ucle@@	I-Chemical	-1	18541230
o@@	I-Chemical	-1	18541230
side	I-Chemical	-1	18541230
-induced	O	-1	18541230
renal	B-Disease	D007674	18541230
dysfunction	I-Disease	-1	18541230
and	O	-1	18541230
hyper@@	B-Disease	D006949	18541230
li@@	I-Disease	-1	18541230
pi@@	I-Disease	-1	18541230
de@@	I-Disease	-1	18541230
mia	I-Disease	-1	18541230
were	O	-1	18541230
also	O	-1	18541230
sup@@	O	-1	18541230
pres@@	O	-1	18541230
sed.	O	-1	18541230
H@@	O	-1	18541230
ist@@	O	-1	18541230
o@@	O	-1	18541230
path@@	O	-1	18541230
ological	O	-1	18541230
examin@@	O	-1	18541230
ation	O	-1	18541230
revealed	O	-1	18541230
severe	O	-1	18541230
renal	B-Disease	D007674	18541230
damage	I-Disease	-1	18541230
such	O	-1	18541230
as	O	-1	18541230
protein@@	O	-1	18541230
ace@@	O	-1	18541230
ous	O	-1	18541230
ca@@	O	-1	18541230
st@@	O	-1	18541230
s	O	-1	18541230
in	O	-1	18541230
tub@@	O	-1	18541230
ul@@	O	-1	18541230
i	O	-1	18541230
and	O	-1	18541230
tub@@	O	-1	18541230
ular	O	-1	18541230
ex@@	O	-1	18541230
p@@	O	-1	18541230
an@@	O	-1	18541230
sion	O	-1	18541230
in	O	-1	18541230
the	O	-1	18541230
kidney	O	-1	18541230
of	O	-1	18541230
control	O	-1	18541230
rats,	O	-1	18541230
while	O	-1	18541230
an	O	-1	18541230
impro@@	O	-1	18541230
vement	O	-1	18541230
of	O	-1	18541230
the	O	-1	18541230
damage	O	-1	18541230
was	O	-1	18541230
seen	O	-1	18541230
in	O	-1	18541230
anti@@	O	-1	18541230
throm@@	O	-1	18541230
bin@@	O	-1	18541230
-treated	O	-1	18541230
rats.	O	-1	18541230
In	O	-1	18541230
addi@@	O	-1	18541230
tion,	O	-1	18541230
anti@@	O	-1	18541230
throm@@	O	-1	18541230
bin	O	-1	18541230
treatment	O	-1	18541230
mark@@	O	-1	18541230
ed@@	O	-1	18541230
ly	O	-1	18541230
sup@@	O	-1	18541230
press@@	O	-1	18541230
ed	O	-1	18541230
p@@	B-Chemical	D011692	18541230
uro@@	I-Chemical	-1	18541230
m@@	I-Chemical	-1	18541230
ycin	I-Chemical	-1	18541230
amin@@	I-Chemical	-1	18541230
on@@	I-Chemical	-1	18541230
ucle@@	I-Chemical	-1	18541230
o@@	I-Chemical	-1	18541230
side	I-Chemical	-1	18541230
-induced	O	-1	18541230
apo@@	O	-1	18541230
pto@@	O	-1	18541230
sis	O	-1	18541230
of	O	-1	18541230
renal	O	-1	18541230
tub@@	O	-1	18541230
ular	O	-1	18541230
epi@@	O	-1	18541230
thelial	O	-1	18541230
cell@@	O	-1	18541230
s.	O	-1	18541230
F@@	O	-1	18541230
ur@@	O	-1	18541230
ther@@	O	-1	18541230
mo@@	O	-1	18541230
re,	O	-1	18541230
p@@	B-Chemical	D011692	18541230
uro@@	I-Chemical	-1	18541230
m@@	I-Chemical	-1	18541230
ycin	I-Chemical	-1	18541230
amin@@	I-Chemical	-1	18541230
on@@	I-Chemical	-1	18541230
ucle@@	I-Chemical	-1	18541230
o@@	I-Chemical	-1	18541230
side	I-Chemical	-1	18541230
-induced	O	-1	18541230
increases	O	-1	18541230
in	O	-1	18541230
renal	O	-1	18541230
cyto@@	O	-1	18541230
k@@	O	-1	18541230
ine	O	-1	18541230
cont@@	O	-1	18541230
ent	O	-1	18541230
were	O	-1	18541230
also	O	-1	18541230
decreas@@	O	-1	18541230
ed.	O	-1	18541230
These	O	-1	18541230
findings	O	-1	18541230
suggest	O	-1	18541230
that	O	-1	18541230
throm@@	O	-1	18541230
bin	O	-1	18541230
pl@@	O	-1	18541230
ays	O	-1	18541230
an	O	-1	18541230
important	O	-1	18541230
role	O	-1	18541230
in	O	-1	18541230
the	O	-1	18541230
path@@	O	-1	18541230
o@@	O	-1	18541230
genesis	O	-1	18541230
of	O	-1	18541230
p@@	B-Chemical	D011692	18541230
uro@@	I-Chemical	-1	18541230
m@@	I-Chemical	-1	18541230
ycin	I-Chemical	-1	18541230
amin@@	I-Chemical	-1	18541230
on@@	I-Chemical	-1	18541230
ucle@@	I-Chemical	-1	18541230
o@@	I-Chemical	-1	18541230
side	I-Chemical	-1	18541230
-induced	O	-1	18541230
nephro@@	B-Disease	D009404	18541230
tic	I-Disease	-1	18541230
syndrome	I-Disease	-1	18541230
.	O	-1	18541230
Treat@@	O	-1	18541230
ment	O	-1	18541230
with	O	-1	18541230
anti@@	O	-1	18541230
throm@@	O	-1	18541230
bin	O	-1	18541230
may	O	-1	18541230
be	O	-1	18541230
clin@@	O	-1	18541230
ically	O	-1	18541230
effective	O	-1	18541230
in	O	-1	18541230
patients	O	-1	18541230
with	O	-1	18541230
nephro@@	B-Disease	D009404	18541230
tic	I-Disease	-1	18541230
syndrome	I-Disease	-1	18541230
.	O	-1	18541230

Re@@	O	-1	18177388
verse	O	-1	18177388
or	O	-1	18177388
in@@	O	-1	18177388
ver@@	O	-1	18177388
ted	O	-1	18177388
left	B-Disease	D054549	18177388
ventricular	I-Disease	-1	18177388
ap@@	I-Disease	-1	18177388
ical	I-Disease	-1	18177388
b@@	I-Disease	-1	18177388
al@@	I-Disease	-1	18177388
lo@@	I-Disease	-1	18177388
on@@	I-Disease	-1	18177388
ing	I-Disease	-1	18177388
syndrome	I-Disease	-1	18177388
(@@	O	-1	18177388
re@@	O	-1	18177388
verse	O	-1	18177388
T@@	B-Disease	D054549	18177388
ak@@	I-Disease	-1	18177388
ot@@	I-Disease	-1	18177388
sub@@	I-Disease	-1	18177388
o	I-Disease	-1	18177388
cardi@@	I-Disease	-1	18177388
om@@	I-Disease	-1	18177388
yo@@	I-Disease	-1	18177388
pathy	I-Disease	-1	18177388
)	O	-1	18177388
in	O	-1	18177388
a	O	-1	18177388
youn@@	O	-1	18177388
g	O	-1	18177388
woman	O	-1	18177388
in	O	-1	18177388
the	O	-1	18177388
se@@	O	-1	18177388
t@@	O	-1	18177388
ting	O	-1	18177388
of	O	-1	18177388
amphetamine	B-Chemical	D000661	18177388
use.	O	-1	18177388
T@@	O	-1	18177388
ran@@	O	-1	18177388
si@@	O	-1	18177388
ent	O	-1	18177388
left	B-Disease	D054549	18177388
ventricular	I-Disease	-1	18177388
ap@@	I-Disease	-1	18177388
ical	I-Disease	-1	18177388
b@@	I-Disease	-1	18177388
al@@	I-Disease	-1	18177388
lo@@	I-Disease	-1	18177388
on@@	I-Disease	-1	18177388
ing	I-Disease	-1	18177388
syndrome	I-Disease	-1	18177388
was	O	-1	18177388
first	O	-1	18177388
descri@@	O	-1	18177388
bed	O	-1	18177388
in	O	-1	18177388
J@@	O	-1	18177388
ap@@	O	-1	18177388
an	O	-1	18177388
as	O	-1	18177388
"	O	-1	18177388
T@@	B-Disease	D054549	18177388
ak@@	I-Disease	-1	18177388
ot@@	I-Disease	-1	18177388
sub@@	I-Disease	-1	18177388
o	I-Disease	-1	18177388
cardi@@	I-Disease	-1	18177388
om@@	I-Disease	-1	18177388
yo@@	I-Disease	-1	18177388
pathy	I-Disease	-1	18177388
.@@	O	-1	18177388
"	O	-1	18177388
This	O	-1	18177388
syndrome	O	-1	18177388
has	O	-1	18177388
been	O	-1	18177388
identi@@	O	-1	18177388
fied	O	-1	18177388
in	O	-1	18177388
man@@	O	-1	18177388
y	O	-1	18177388
other	O	-1	18177388
coun@@	O	-1	18177388
tri@@	O	-1	18177388
es.	O	-1	18177388
M@@	O	-1	18177388
any	O	-1	18177388
vari@@	O	-1	18177388
ations	O	-1	18177388
of	O	-1	18177388
this	O	-1	18177388
syndrome	O	-1	18177388
have	O	-1	18177388
been	O	-1	18177388
rec@@	O	-1	18177388
ently	O	-1	18177388
descri@@	O	-1	18177388
bed	O	-1	18177388
in	O	-1	18177388
the	O	-1	18177388
literat@@	O	-1	18177388
ure.	O	-1	18177388
One	O	-1	18177388
of	O	-1	18177388
the	O	-1	18177388
ra@@	O	-1	18177388
res@@	O	-1	18177388
t	O	-1	18177388
is	O	-1	18177388
the	O	-1	18177388
re@@	O	-1	18177388
verse	O	-1	18177388
type	O	-1	18177388
of	O	-1	18177388
this	O	-1	18177388
syndro@@	O	-1	18177388
me,	O	-1	18177388
with	O	-1	18177388
hyper@@	O	-1	18177388
dynam@@	O	-1	18177388
ic	O	-1	18177388
ap@@	O	-1	18177388
e@@	O	-1	18177388
x	O	-1	18177388
and	O	-1	18177388
complete	O	-1	18177388
ak@@	B-Disease	D004409	18177388
ine@@	I-Disease	-1	18177388
sia	I-Disease	-1	18177388
of	O	-1	18177388
the	O	-1	18177388
b@@	O	-1	18177388
ase	O	-1	18177388
(@@	O	-1	18177388
as	O	-1	18177388
op@@	O	-1	18177388
pos@@	O	-1	18177388
ed	O	-1	18177388
to	O	-1	18177388
the	O	-1	18177388
cl@@	O	-1	18177388
as@@	O	-1	18177388
sic	O	-1	18177388
ap@@	B-Disease	D054549	18177388
ical	I-Disease	-1	18177388
b@@	I-Disease	-1	18177388
al@@	I-Disease	-1	18177388
lo@@	I-Disease	-1	18177388
on@@	I-Disease	-1	18177388
ing	I-Disease	-1	18177388
).	O	-1	18177388
In	O	-1	18177388
this	O	-1	18177388
ar@@	O	-1	18177388
tic@@	O	-1	18177388
le@@	O	-1	18177388
,	O	-1	18177388
we	O	-1	18177388
report	O	-1	18177388
an	O	-1	18177388
in@@	O	-1	18177388
te@@	O	-1	18177388
rest@@	O	-1	18177388
ing	O	-1	18177388
case	O	-1	18177388
of	O	-1	18177388
a	O	-1	18177388
youn@@	O	-1	18177388
g	O	-1	18177388
woman	O	-1	18177388
who	O	-1	18177388
presented	O	-1	18177388
with	O	-1	18177388
this	O	-1	18177388
r@@	O	-1	18177388
are	O	-1	18177388
type	O	-1	18177388
of	O	-1	18177388
re@@	O	-1	18177388
verse	O	-1	18177388
ap@@	B-Disease	D054549	18177388
ical	I-Disease	-1	18177388
b@@	I-Disease	-1	18177388
al@@	I-Disease	-1	18177388
lo@@	I-Disease	-1	18177388
on@@	I-Disease	-1	18177388
ing	I-Disease	-1	18177388
syndrome	I-Disease	-1	18177388
occur@@	O	-1	18177388
r@@	O	-1	18177388
ing	O	-1	18177388
after	O	-1	18177388
amphetamine	B-Chemical	D000661	18177388
use.	O	-1	18177388
This	O	-1	18177388
report	O	-1	18177388
is	O	-1	18177388
followed	O	-1	18177388
by	O	-1	18177388
revie@@	O	-1	18177388
w	O	-1	18177388
of	O	-1	18177388
the	O	-1	18177388
literat@@	O	-1	18177388
ure.	O	-1	18177388

A@@	O	-1	17490864
t@@	O	-1	17490864
ten@@	O	-1	17490864
u@@	O	-1	17490864
ated	O	-1	17490864
dis@@	O	-1	17490864
ru@@	O	-1	17490864
ption	O	-1	17490864
of	O	-1	17490864
pre@@	O	-1	17490864
pul@@	O	-1	17490864
se	O	-1	17490864
inhibition	O	-1	17490864
by	O	-1	17490864
dop@@	O	-1	17490864
aminergic	O	-1	17490864
stimulation	O	-1	17490864
after	O	-1	17490864
mat@@	O	-1	17490864
er@@	O	-1	17490864
n@@	O	-1	17490864
al	O	-1	17490864
de@@	O	-1	17490864
pri@@	O	-1	17490864
v@@	O	-1	17490864
ation	O	-1	17490864
and	O	-1	17490864
ad@@	O	-1	17490864
ol@@	O	-1	17490864
es@@	O	-1	17490864
c@@	O	-1	17490864
ent	O	-1	17490864
cortico@@	B-Chemical	D003345	17490864
sterone	I-Chemical	-1	17490864
treatment	O	-1	17490864
in	O	-1	17490864
rats.	O	-1	17490864
The	O	-1	17490864
development	O	-1	17490864
of	O	-1	17490864
sch@@	B-Disease	D012559	17490864
iz@@	I-Disease	-1	17490864
oph@@	I-Disease	-1	17490864
ren@@	I-Disease	-1	17490864
ia	I-Disease	-1	17490864
may	O	-1	17490864
includ@@	O	-1	17490864
e	O	-1	17490864
an	O	-1	17490864
early	O	-1	17490864
neuro@@	O	-1	17490864
develop@@	O	-1	17490864
mental	O	-1	17490864
stres@@	O	-1	17490864
s	O	-1	17490864
comp@@	O	-1	17490864
on@@	O	-1	17490864
ent	O	-1	17490864
which	O	-1	17490864
increases	O	-1	17490864
vul@@	O	-1	17490864
ner@@	O	-1	17490864
ability	O	-1	17490864
to	O	-1	17490864
lat@@	O	-1	17490864
er	O	-1	17490864
stres@@	O	-1	17490864
s@@	O	-1	17490864
ful	O	-1	17490864
lif@@	O	-1	17490864
e	O	-1	17490864
event@@	O	-1	17490864
s,	O	-1	17490864
in	O	-1	17490864
combination	O	-1	17490864
lead@@	O	-1	17490864
ing	O	-1	17490864
to	O	-1	17490864
over@@	O	-1	17490864
t	O	-1	17490864
disease.	O	-1	17490864
We	O	-1	17490864
investigated	O	-1	17490864
the	O	-1	17490864
effect	O	-1	17490864
of	O	-1	17490864
an	O	-1	17490864
early	O	-1	17490864
stres@@	O	-1	17490864
s,	O	-1	17490864
in	O	-1	17490864
the	O	-1	17490864
form	O	-1	17490864
of	O	-1	17490864
mat@@	O	-1	17490864
er@@	O	-1	17490864
n@@	O	-1	17490864
al	O	-1	17490864
de@@	O	-1	17490864
pri@@	O	-1	17490864
v@@	O	-1	17490864
ation,	O	-1	17490864
combined	O	-1	17490864
with	O	-1	17490864
a	O	-1	17490864
lat@@	O	-1	17490864
er	O	-1	17490864
stres@@	O	-1	17490864
s,	O	-1	17490864
si@@	O	-1	17490864
mul@@	O	-1	17490864
ated	O	-1	17490864
by	O	-1	17490864
chronic	O	-1	17490864
peri@@	O	-1	17490864
ad@@	O	-1	17490864
ol@@	O	-1	17490864
es@@	O	-1	17490864
c@@	O	-1	17490864
ent	O	-1	17490864
cortico@@	B-Chemical	D003345	17490864
sterone	I-Chemical	-1	17490864
treatment,	O	-1	17490864
on	O	-1	17490864
behavi@@	O	-1	17490864
our	O	-1	17490864
in	O	-1	17490864
rats.	O	-1	17490864
Ac@@	O	-1	17490864
ute	O	-1	17490864
treatment	O	-1	17490864
with	O	-1	17490864
apo@@	B-Chemical	D001058	17490864
morphine	I-Chemical	-1	17490864
caused	O	-1	17490864
dis@@	O	-1	17490864
ru@@	O	-1	17490864
ption	O	-1	17490864
of	O	-1	17490864
pre@@	O	-1	17490864
pul@@	O	-1	17490864
se	O	-1	17490864
inhibition	O	-1	17490864
(P@@	O	-1	17490864
P@@	O	-1	17490864
I@@	O	-1	17490864
)	O	-1	17490864
in	O	-1	17490864
controls	O	-1	17490864
and	O	-1	17490864
in	O	-1	17490864
rats	O	-1	17490864
that	O	-1	17490864
had	O	-1	17490864
under@@	O	-1	17490864
g@@	O	-1	17490864
one	O	-1	17490864
either	O	-1	17490864
mat@@	O	-1	17490864
er@@	O	-1	17490864
n@@	O	-1	17490864
al	O	-1	17490864
de@@	O	-1	17490864
pri@@	O	-1	17490864
v@@	O	-1	17490864
ation	O	-1	17490864
or	O	-1	17490864
cortico@@	B-Chemical	D003345	17490864
sterone	I-Chemical	-1	17490864
treatment,	O	-1	17490864
but	O	-1	17490864
was	O	-1	17490864
sur@@	O	-1	17490864
p@@	O	-1	17490864
ris@@	O	-1	17490864
ing@@	O	-1	17490864
ly	O	-1	17490864
abs@@	O	-1	17490864
ent	O	-1	17490864
in	O	-1	17490864
rats	O	-1	17490864
that	O	-1	17490864
had	O	-1	17490864
under@@	O	-1	17490864
g@@	O	-1	17490864
one	O	-1	17490864
the	O	-1	17490864
combined	O	-1	17490864
early	O	-1	17490864
and	O	-1	17490864
l@@	O	-1	17490864
ate	O	-1	17490864
stres@@	O	-1	17490864
s.	O	-1	17490864
A@@	B-Chemical	D000661	17490864
m@@	I-Chemical	-1	17490864
ph@@	I-Chemical	-1	17490864
et@@	I-Chemical	-1	17490864
amine	I-Chemical	-1	17490864
treatment	O	-1	17490864
significantly	O	-1	17490864
dis@@	O	-1	17490864
ru@@	O	-1	17490864
pt@@	O	-1	17490864
ed	O	-1	17490864
P@@	O	-1	17490864
P@@	O	-1	17490864
I	O	-1	17490864
in	O	-1	17490864
both	O	-1	17490864
non-@@	O	-1	17490864
de@@	O	-1	17490864
pri@@	O	-1	17490864
ved	O	-1	17490864
group@@	O	-1	17490864
s,	O	-1	17490864
but	O	-1	17490864
was	O	-1	17490864
abs@@	O	-1	17490864
ent	O	-1	17490864
in	O	-1	17490864
both	O	-1	17490864
mat@@	O	-1	17490864
er@@	O	-1	17490864
n@@	O	-1	17490864
ally	O	-1	17490864
de@@	O	-1	17490864
pri@@	O	-1	17490864
ved	O	-1	17490864
groups.	O	-1	17490864
The	O	-1	17490864
seroton@@	B-Chemical	D012701	17490864
in	I-Chemical	-1	17490864
-1@@	O	-1	17490864
A	O	-1	17490864
receptor	O	-1	17490864
agon@@	O	-1	17490864
ist@@	O	-1	17490864
,	O	-1	17490864
8@@	B-Chemical	D017371	17490864
-@@	I-Chemical	-1	17490864
O@@	I-Chemical	-1	17490864
H@@	I-Chemical	-1	17490864
-@@	I-Chemical	-1	17490864
D@@	I-Chemical	-1	17490864
PA@@	I-Chemical	-1	17490864
T	I-Chemical	-1	17490864
,	O	-1	17490864
induced	O	-1	17490864
a	O	-1	17490864
significant	O	-1	17490864
dis@@	O	-1	17490864
ru@@	O	-1	17490864
ption	O	-1	17490864
of	O	-1	17490864
P@@	O	-1	17490864
P@@	O	-1	17490864
I	O	-1	17490864
in	O	-1	17490864
all	O	-1	17490864
groups.	O	-1	17490864
A@@	B-Chemical	D000661	17490864
m@@	I-Chemical	-1	17490864
ph@@	I-Chemical	-1	17490864
et@@	I-Chemical	-1	17490864
amine	I-Chemical	-1	17490864
-induced	O	-1	17490864
locomotor	B-Disease	D006948	17490864
hyperactivity	I-Disease	-1	17490864
was	O	-1	17490864
similar	O	-1	17490864
in	O	-1	17490864
all	O	-1	17490864
groups.	O	-1	17490864
These	O	-1	17490864
results	O	-1	17490864
show	O	-1	17490864
an	O	-1	17490864
inhibit@@	O	-1	17490864
ory	O	-1	17490864
inter@@	O	-1	17490864
action	O	-1	17490864
of	O	-1	17490864
early	O	-1	17490864
stres@@	O	-1	17490864
s,	O	-1	17490864
caused	O	-1	17490864
by	O	-1	17490864
mat@@	O	-1	17490864
er@@	O	-1	17490864
n@@	O	-1	17490864
al	O	-1	17490864
de@@	O	-1	17490864
pri@@	O	-1	17490864
v@@	O	-1	17490864
ation,	O	-1	17490864
combined	O	-1	17490864
with	O	-1	17490864
'@@	O	-1	17490864
ad@@	O	-1	17490864
ol@@	O	-1	17490864
es@@	O	-1	17490864
c@@	O	-1	17490864
ent@@	O	-1	17490864
'	O	-1	17490864
stres@@	O	-1	17490864
s,	O	-1	17490864
si@@	O	-1	17490864
mul@@	O	-1	17490864
ated	O	-1	17490864
by	O	-1	17490864
cortico@@	B-Chemical	D003345	17490864
sterone	I-Chemical	-1	17490864
treatment,	O	-1	17490864
on	O	-1	17490864
dop@@	O	-1	17490864
aminergic	O	-1	17490864
reg@@	O	-1	17490864
ulation	O	-1	17490864
of	O	-1	17490864
P@@	O	-1	17490864
P@@	O	-1	17490864
I@@	O	-1	17490864
.	O	-1	17490864
The	O	-1	17490864
al@@	O	-1	17490864
te@@	O	-1	17490864
red	O	-1	17490864
effects	O	-1	17490864
of	O	-1	17490864
apo@@	B-Chemical	D001058	17490864
morphine	I-Chemical	-1	17490864
and	O	-1	17490864
amphetamine	B-Chemical	D000661	17490864
could	O	-1	17490864
indicate	O	-1	17490864
differen@@	O	-1	17490864
tial	O	-1	17490864
changes	O	-1	17490864
in	O	-1	17490864
dopamine	B-Chemical	D004298	17490864
receptor	O	-1	17490864
sign@@	O	-1	17490864
all@@	O	-1	17490864
ing	O	-1	17490864
lead@@	O	-1	17490864
ing	O	-1	17490864
to	O	-1	17490864
functional	O	-1	17490864
des@@	O	-1	17490864
en@@	O	-1	17490864
si@@	O	-1	17490864
tis@@	O	-1	17490864
ation,	O	-1	17490864
or	O	-1	17490864
al@@	O	-1	17490864
te@@	O	-1	17490864
red	O	-1	17490864
mod@@	O	-1	17490864
ulation	O	-1	17490864
of	O	-1	17490864
sens@@	O	-1	17490864
ory	O	-1	17490864
g@@	O	-1	17490864
ating	O	-1	17490864
in	O	-1	17490864
the	O	-1	17490864
nucle@@	O	-1	17490864
us	O	-1	17490864
accum@@	O	-1	17490864
ben@@	O	-1	17490864
s	O	-1	17490864
by	O	-1	17490864
lim@@	O	-1	17490864
b@@	O	-1	17490864
ic	O	-1	17490864
struct@@	O	-1	17490864
ures	O	-1	17490864
such	O	-1	17490864
as	O	-1	17490864
the	O	-1	17490864
hippocamp@@	O	-1	17490864
us.	O	-1	17490864

P@@	O	-1	17490790
er@@	O	-1	17490790
i@@	O	-1	17490790
pheral	O	-1	17490790
i@@	B-Chemical	D007505	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
de@@	I-Chemical	-1	17490790
x@@	I-Chemical	-1	17490790
tra@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
induced	O	-1	17490790
de@@	B-Disease	D009410	17490790
generation	I-Disease	-1	17490790
of	I-Disease	-1	17490790
dop@@	I-Disease	-1	17490790
aminergic	I-Disease	-1	17490790
neuron@@	I-Disease	-1	17490790
s	I-Disease	-1	17490790
in	O	-1	17490790
rat	O	-1	17490790
subst@@	O	-1	17490790
anti@@	O	-1	17490790
a	O	-1	17490790
n@@	O	-1	17490790
i@@	O	-1	17490790
gra@@	O	-1	17490790
.	O	-1	17490790
I@@	B-Chemical	D007501	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
accum@@	O	-1	17490790
ulation	O	-1	17490790
is	O	-1	17490790
considered	O	-1	17490790
to	O	-1	17490790
be	O	-1	17490790
involved	O	-1	17490790
in	O	-1	17490790
the	O	-1	17490790
path@@	O	-1	17490790
o@@	O	-1	17490790
genesis	O	-1	17490790
of	O	-1	17490790
Parkinson's	B-Disease	D010300	17490790
disease	I-Disease	-1	17490790
.	O	-1	17490790
To	O	-1	17490790
demon@@	O	-1	17490790
st@@	O	-1	17490790
rate	O	-1	17490790
the	O	-1	17490790
rel@@	O	-1	17490790
ationship	O	-1	17490790
between	O	-1	17490790
peripheral	O	-1	17490790
i@@	B-Chemical	D007501	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
over@@	O	-1	17490790
lo@@	O	-1	17490790
ad	O	-1	17490790
and	O	-1	17490790
dop@@	O	-1	17490790
aminergic	O	-1	17490790
neuro@@	O	-1	17490790
n	O	-1	17490790
loss	O	-1	17490790
in	O	-1	17490790
rat	O	-1	17490790
subst@@	O	-1	17490790
anti@@	O	-1	17490790
a	O	-1	17490790
n@@	O	-1	17490790
ig@@	O	-1	17490790
r@@	O	-1	17490790
a	O	-1	17490790
(S@@	O	-1	17490790
N@@	O	-1	17490790
),	O	-1	17490790
in	O	-1	17490790
the	O	-1	17490790
present	O	-1	17490790
study	O	-1	17490790
we	O	-1	17490790
used	O	-1	17490790
f@@	O	-1	17490790
ast	O	-1	17490790
cy@@	O	-1	17490790
cl@@	O	-1	17490790
ic	O	-1	17490790
vol@@	O	-1	17490790
t@@	O	-1	17490790
am@@	O	-1	17490790
met@@	O	-1	17490790
r@@	O	-1	17490790
y,	O	-1	17490790
ty@@	B-Chemical	D014443	17490790
ros@@	I-Chemical	-1	17490790
ine	I-Chemical	-1	17490790
hydrox@@	O	-1	17490790
yl@@	O	-1	17490790
ase	O	-1	17490790
(T@@	O	-1	17490790
H@@	O	-1	17490790
)	O	-1	17490790
immuno@@	O	-1	17490790
histo@@	O	-1	17490790
chem@@	O	-1	17490790
ist@@	O	-1	17490790
r@@	O	-1	17490790
y,	O	-1	17490790
P@@	O	-1	17490790
er@@	O	-1	17490790
l@@	O	-1	17490790
s@@	O	-1	17490790
'	O	-1	17490790
i@@	B-Chemical	D007501	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
st@@	O	-1	17490790
ain@@	O	-1	17490790
ing,	O	-1	17490790
and	O	-1	17490790
high	O	-1	17490790
perform@@	O	-1	17490790
ance	O	-1	17490790
li@@	O	-1	17490790
qu@@	O	-1	17490790
id	O	-1	17490790
ch@@	O	-1	17490790
rom@@	O	-1	17490790
at@@	O	-1	17490790
ograph@@	O	-1	17490790
y-@@	O	-1	17490790
electro@@	O	-1	17490790
chemical	O	-1	17490790
det@@	O	-1	17490790
ection	O	-1	17490790
to	O	-1	17490790
study	O	-1	17490790
the	O	-1	17490790
de@@	B-Disease	D009410	17490790
generation	I-Disease	-1	17490790
of	I-Disease	-1	17490790
dop@@	I-Disease	-1	17490790
aminergic	I-Disease	-1	17490790
neuron@@	I-Disease	-1	17490790
s	I-Disease	-1	17490790
and	O	-1	17490790
increased	O	-1	17490790
i@@	B-Chemical	D007501	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
cont@@	O	-1	17490790
ent	O	-1	17490790
in	O	-1	17490790
the	O	-1	17490790
S@@	O	-1	17490790
N	O	-1	17490790
of	O	-1	17490790
i@@	B-Chemical	D007505	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
de@@	I-Chemical	-1	17490790
x@@	I-Chemical	-1	17490790
tra@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
over@@	O	-1	17490790
lo@@	O	-1	17490790
ad@@	O	-1	17490790
ed	O	-1	17490790
anim@@	O	-1	17490790
al@@	O	-1	17490790
s.	O	-1	17490790
The	O	-1	17490790
findings	O	-1	17490790
showed	O	-1	17490790
that	O	-1	17490790
peripheral	O	-1	17490790
i@@	B-Chemical	D007505	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
de@@	I-Chemical	-1	17490790
x@@	I-Chemical	-1	17490790
tra@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
over@@	O	-1	17490790
lo@@	O	-1	17490790
ad	O	-1	17490790
increased	O	-1	17490790
the	O	-1	17490790
i@@	B-Chemical	D007501	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
st@@	O	-1	17490790
aining	O	-1	17490790
positive	O	-1	17490790
cells	O	-1	17490790
and	O	-1	17490790
reduced	O	-1	17490790
the	O	-1	17490790
number	O	-1	17490790
of	O	-1	17490790
T@@	O	-1	17490790
H@@	O	-1	17490790
-@@	O	-1	17490790
immuno@@	O	-1	17490790
reac@@	O	-1	17490790
tive	O	-1	17490790
neuron@@	O	-1	17490790
s	O	-1	17490790
in	O	-1	17490790
the	O	-1	17490790
S@@	O	-1	17490790
N@@	O	-1	17490790
.	O	-1	17490790
A@@	O	-1	17490790
s	O	-1	17490790
a	O	-1	17490790
result@@	O	-1	17490790
,	O	-1	17490790
dopamine	B-Chemical	D004298	17490790
release	O	-1	17490790
and	O	-1	17490790
cont@@	O	-1	17490790
ent@@	O	-1	17490790
,	O	-1	17490790
as	O	-1	17490790
well	O	-1	17490790
as	O	-1	17490790
its	O	-1	17490790
metabol@@	O	-1	17490790
it@@	O	-1	17490790
es	O	-1	17490790
cont@@	O	-1	17490790
ents	O	-1	17490790
were	O	-1	17490790
decreased	O	-1	17490790
in	O	-1	17490790
ca@@	O	-1	17490790
ud@@	O	-1	17490790
ate	O	-1	17490790
p@@	O	-1	17490790
ut@@	O	-1	17490790
am@@	O	-1	17490790
en@@	O	-1	17490790
.	O	-1	17490790
E@@	O	-1	17490790
ven	O	-1	17490790
more	O	-1	17490790
d@@	O	-1	17490790
ram@@	O	-1	17490790
atic	O	-1	17490790
changes	O	-1	17490790
were	O	-1	17490790
found	O	-1	17490790
in	O	-1	17490790
chronic	O	-1	17490790
over@@	O	-1	17490790
lo@@	O	-1	17490790
ad	O	-1	17490790
group.	O	-1	17490790
These	O	-1	17490790
results	O	-1	17490790
suggest	O	-1	17490790
that	O	-1	17490790
peripheral	O	-1	17490790
i@@	B-Chemical	D007505	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
de@@	I-Chemical	-1	17490790
x@@	I-Chemical	-1	17490790
tra@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
can	O	-1	17490790
increase	O	-1	17490790
the	O	-1	17490790
i@@	B-Chemical	D007501	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
level	O	-1	17490790
in	O	-1	17490790
the	O	-1	17490790
S@@	O	-1	17490790
N@@	O	-1	17490790
,	O	-1	17490790
wh@@	O	-1	17490790
ere	O	-1	17490790
ex@@	O	-1	17490790
ces@@	O	-1	17490790
sive	O	-1	17490790
i@@	B-Chemical	D007501	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
causes	O	-1	17490790
the	O	-1	17490790
de@@	B-Disease	D009410	17490790
generation	I-Disease	-1	17490790
of	I-Disease	-1	17490790
dop@@	I-Disease	-1	17490790
aminergic	I-Disease	-1	17490790
neuron@@	I-Disease	-1	17490790
s	I-Disease	-1	17490790
.	O	-1	17490790
The	O	-1	17490790
chronic	O	-1	17490790
i@@	B-Chemical	D007501	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
over@@	O	-1	17490790
lo@@	O	-1	17490790
ad	O	-1	17490790
may	O	-1	17490790
be	O	-1	17490790
more	O	-1	17490790
de@@	O	-1	17490790
struc@@	O	-1	17490790
tive	O	-1	17490790
to	O	-1	17490790
dop@@	O	-1	17490790
aminergic	O	-1	17490790
neuron@@	O	-1	17490790
s	O	-1	17490790
than	O	-1	17490790
the	O	-1	17490790
acute	O	-1	17490790
i@@	B-Chemical	D007501	17490790
ro@@	I-Chemical	-1	17490790
n	I-Chemical	-1	17490790
over@@	O	-1	17490790
lo@@	O	-1	17490790
ad@@	O	-1	17490790
.	O	-1	17490790

W@@	B-Chemical	D014859	16047871
ar@@	I-Chemical	-1	16047871
farin	I-Chemical	-1	16047871
-induced	O	-1	16047871
leuk@@	B-Disease	C535509	16047871
ocy@@	I-Disease	-1	16047871
t@@	I-Disease	-1	16047871
oc@@	I-Disease	-1	16047871
las@@	I-Disease	-1	16047871
tic	I-Disease	-1	16047871
vas@@	I-Disease	-1	16047871
cul@@	I-Disease	-1	16047871
iti@@	I-Disease	-1	16047871
s	I-Disease	-1	16047871
.	O	-1	16047871
S@@	O	-1	16047871
k@@	O	-1	16047871
in	O	-1	16047871
reactions	O	-1	16047871
associated	O	-1	16047871
with	O	-1	16047871
oral	O	-1	16047871
co@@	B-Chemical	C030123	16047871
um@@	I-Chemical	-1	16047871
ar@@	I-Chemical	-1	16047871
in	I-Chemical	-1	16047871
-@@	O	-1	16047871
der@@	O	-1	16047871
i@@	O	-1	16047871
ved	O	-1	16047871
anti@@	O	-1	16047871
co@@	O	-1	16047871
ag@@	O	-1	16047871
ul@@	O	-1	16047871
ants	O	-1	16047871
are	O	-1	16047871
an	O	-1	16047871
un@@	O	-1	16047871
common	O	-1	16047871
occur@@	O	-1	16047871
ren@@	O	-1	16047871
ce@@	O	-1	16047871
.	O	-1	16047871
L@@	B-Disease	C535509	16047871
eu@@	I-Disease	-1	16047871
k@@	I-Disease	-1	16047871
ocy@@	I-Disease	-1	16047871
t@@	I-Disease	-1	16047871
oc@@	I-Disease	-1	16047871
las@@	I-Disease	-1	16047871
tic	I-Disease	-1	16047871
vas@@	I-Disease	-1	16047871
cul@@	I-Disease	-1	16047871
iti@@	I-Disease	-1	16047871
s	I-Disease	-1	16047871
(	O	-1	16047871
L@@	B-Disease	C535509	16047871
V	I-Disease	-1	16047871
)	O	-1	16047871
is	O	-1	16047871
prim@@	O	-1	16047871
ari@@	O	-1	16047871
ly	O	-1	16047871
a	O	-1	16047871
c@@	B-Disease	C565222	16047871
utaneous	I-Disease	-1	16047871
sm@@	I-Disease	-1	16047871
all	I-Disease	-1	16047871
v@@	I-Disease	-1	16047871
es@@	I-Disease	-1	16047871
se@@	I-Disease	-1	16047871
l	I-Disease	-1	16047871
vas@@	I-Disease	-1	16047871
cul@@	I-Disease	-1	16047871
iti@@	I-Disease	-1	16047871
s	I-Disease	-1	16047871
,	O	-1	16047871
though	O	-1	16047871
systemic	O	-1	16047871
invol@@	O	-1	16047871
vement	O	-1	16047871
may	O	-1	16047871
be	O	-1	16047871
en@@	O	-1	16047871
coun@@	O	-1	16047871
te@@	O	-1	16047871
red.	O	-1	16047871
We	O	-1	16047871
report	O	-1	16047871
4	O	-1	16047871
patients	O	-1	16047871
with	O	-1	16047871
lat@@	O	-1	16047871
e-@@	O	-1	16047871
onset	O	-1	16047871
L@@	B-Disease	C535509	16047871
V	I-Disease	-1	16047871
prob@@	O	-1	16047871
ably	O	-1	16047871
due	O	-1	16047871
to	O	-1	16047871
war@@	B-Chemical	D014859	16047871
farin	I-Chemical	-1	16047871
.	O	-1	16047871
All	O	-1	16047871
4	O	-1	16047871
patients	O	-1	16047871
presented	O	-1	16047871
with	O	-1	16047871
s@@	B-Disease	D012871	16047871
k@@	I-Disease	-1	16047871
in	I-Disease	-1	16047871
er@@	I-Disease	-1	16047871
up@@	I-Disease	-1	16047871
tions	I-Disease	-1	16047871
that	O	-1	16047871
developed	O	-1	16047871
after	O	-1	16047871
receiving	O	-1	16047871
war@@	B-Chemical	D014859	16047871
farin	I-Chemical	-1	16047871
for	O	-1	16047871
several	O	-1	16047871
year@@	O	-1	16047871
s.	O	-1	16047871
The	O	-1	16047871
results	O	-1	16047871
of	O	-1	16047871
s@@	B-Disease	D012871	16047871
k@@	I-Disease	-1	16047871
in	I-Disease	-1	16047871
le@@	I-Disease	-1	16047871
sion	I-Disease	-1	16047871
biop@@	O	-1	16047871
si@@	O	-1	16047871
es	O	-1	16047871
were	O	-1	16047871
av@@	O	-1	16047871
ail@@	O	-1	16047871
able	O	-1	16047871
in	O	-1	16047871
3	O	-1	16047871
patients,	O	-1	16047871
con@@	O	-1	16047871
fir@@	O	-1	16047871
m@@	O	-1	16047871
ing	O	-1	16047871
L@@	B-Disease	D018366	16047871
V	I-Disease	-1	16047871
C@@	I-Disease	-1	16047871
utaneous	I-Disease	-1	16047871
lesions	I-Disease	-1	16047871
resol@@	O	-1	16047871
ved	O	-1	16047871
in	O	-1	16047871
all	O	-1	16047871
patients	O	-1	16047871
after	O	-1	16047871
war@@	B-Chemical	D014859	16047871
farin	I-Chemical	-1	16047871
was	O	-1	16047871
discontinu@@	O	-1	16047871
ed.	O	-1	16047871
In	O	-1	16047871
2	O	-1	16047871
of	O	-1	16047871
the	O	-1	16047871
4	O	-1	16047871
patients,	O	-1	16047871
re@@	O	-1	16047871
ch@@	O	-1	16047871
all@@	O	-1	16047871
enge	O	-1	16047871
with	O	-1	16047871
war@@	B-Chemical	D014859	16047871
farin	I-Chemical	-1	16047871
l@@	O	-1	16047871
ed	O	-1	16047871
to	O	-1	16047871
recur@@	O	-1	16047871
rence	O	-1	16047871
of	O	-1	16047871
the	O	-1	16047871
le@@	O	-1	16047871
sion@@	O	-1	16047871
s.	O	-1	16047871
L@@	B-Disease	C535509	16047871
V	I-Disease	-1	16047871
may	O	-1	16047871
be	O	-1	16047871
a	O	-1	16047871
lat@@	O	-1	16047871
e-@@	O	-1	16047871
onset	O	-1	16047871
adverse	O	-1	16047871
reaction	O	-1	16047871
associated	O	-1	16047871
with	O	-1	16047871
war@@	B-Chemical	D014859	16047871
farin	I-Chemical	-1	16047871
therapy.	O	-1	16047871

The	O	-1	15673851
activation	O	-1	15673851
of	O	-1	15673851
spinal	O	-1	15673851
N@@	B-Chemical	D016202	15673851
-@@	I-Chemical	-1	15673851
methyl@@	I-Chemical	-1	15673851
-@@	I-Chemical	-1	15673851
D-@@	I-Chemical	-1	15673851
as@@	I-Chemical	-1	15673851
part@@	I-Chemical	-1	15673851
ate	I-Chemical	-1	15673851
receptors	O	-1	15673851
may	O	-1	15673851
cont@@	O	-1	15673851
rib@@	O	-1	15673851
ute	O	-1	15673851
to	O	-1	15673851
de@@	O	-1	15673851
generation	O	-1	15673851
of	O	-1	15673851
spinal	O	-1	15673851
motor	O	-1	15673851
neuron@@	O	-1	15673851
s	O	-1	15673851
induced	O	-1	15673851
by	O	-1	15673851
ne@@	O	-1	15673851
ur@@	O	-1	15673851
ax@@	O	-1	15673851
ial	O	-1	15673851
morphine	B-Chemical	D009020	15673851
after	O	-1	15673851
a	O	-1	15673851
non@@	O	-1	15673851
injur@@	O	-1	15673851
i@@	O	-1	15673851
ous	O	-1	15673851
interv@@	O	-1	15673851
al	O	-1	15673851
of	O	-1	15673851
spinal	B-Disease	D020760	15673851
cor@@	I-Disease	-1	15673851
d	I-Disease	-1	15673851
ischem@@	I-Disease	-1	15673851
ia	I-Disease	-1	15673851
.	O	-1	15673851
We	O	-1	15673851
investigated	O	-1	15673851
the	O	-1	15673851
rel@@	O	-1	15673851
ationship	O	-1	15673851
between	O	-1	15673851
the	O	-1	15673851
de@@	O	-1	15673851
generation	O	-1	15673851
of	O	-1	15673851
spinal	O	-1	15673851
motor	O	-1	15673851
neuron@@	O	-1	15673851
s	O	-1	15673851
and	O	-1	15673851
activation	O	-1	15673851
of	O	-1	15673851
N@@	B-Chemical	D016202	15673851
-@@	I-Chemical	-1	15673851
methyl@@	I-Chemical	-1	15673851
-@@	I-Chemical	-1	15673851
d-@@	I-Chemical	-1	15673851
as@@	I-Chemical	-1	15673851
part@@	I-Chemical	-1	15673851
ate	I-Chemical	-1	15673851
(	O	-1	15673851
N@@	B-Chemical	D016202	15673851
MD@@	I-Chemical	-1	15673851
A	I-Chemical	-1	15673851
)	O	-1	15673851
receptors	O	-1	15673851
after	O	-1	15673851
ne@@	O	-1	15673851
ur@@	O	-1	15673851
ax@@	O	-1	15673851
ial	O	-1	15673851
morphine	B-Chemical	D009020	15673851
following	O	-1	15673851
a	O	-1	15673851
non@@	O	-1	15673851
injur@@	O	-1	15673851
i@@	O	-1	15673851
ous	O	-1	15673851
interv@@	O	-1	15673851
al	O	-1	15673851
of	O	-1	15673851
a@@	B-Disease	D001157	15673851
or@@	I-Disease	-1	15673851
tic	I-Disease	-1	15673851
oc@@	I-Disease	-1	15673851
cl@@	I-Disease	-1	15673851
usion	I-Disease	-1	15673851
in	O	-1	15673851
rats.	O	-1	15673851
S@@	B-Disease	D020760	15673851
p@@	I-Disease	-1	15673851
inal	I-Disease	-1	15673851
cor@@	I-Disease	-1	15673851
d	I-Disease	-1	15673851
ischem@@	I-Disease	-1	15673851
ia	I-Disease	-1	15673851
was	O	-1	15673851
induced	O	-1	15673851
by	O	-1	15673851
a@@	B-Disease	D001157	15673851
or@@	I-Disease	-1	15673851
tic	I-Disease	-1	15673851
oc@@	I-Disease	-1	15673851
cl@@	I-Disease	-1	15673851
usion	I-Disease	-1	15673851
for	O	-1	15673851
6	O	-1	15673851
min	O	-1	15673851
with	O	-1	15673851
a	O	-1	15673851
b@@	O	-1	15673851
al@@	O	-1	15673851
lo@@	O	-1	15673851
on	O	-1	15673851
ca@@	O	-1	15673851
the@@	O	-1	15673851
ter@@	O	-1	15673851
.	O	-1	15673851
In	O	-1	15673851
a	O	-1	15673851
micro@@	O	-1	15673851
dialy@@	O	-1	15673851
sis	O	-1	15673851
study,	O	-1	15673851
10	O	-1	15673851
m@@	O	-1	15673851
u@@	O	-1	15673851
L	O	-1	15673851
of	O	-1	15673851
saline	O	-1	15673851
(@@	O	-1	15673851
group	O	-1	15673851
C@@	O	-1	15673851
;	O	-1	15673851
n	O	-1	15673851
=	O	-1	15673851
8@@	O	-1	15673851
)	O	-1	15673851
or	O	-1	15673851
30	O	-1	15673851
m@@	O	-1	15673851
u@@	O	-1	15673851
g	O	-1	15673851
of	O	-1	15673851
morphine	B-Chemical	D009020	15673851
(@@	O	-1	15673851
group	O	-1	15673851
M@@	O	-1	15673851
;	O	-1	15673851
n	O	-1	15673851
=	O	-1	15673851
8@@	O	-1	15673851
)	O	-1	15673851
was	O	-1	15673851
injected	O	-1	15673851
intra@@	O	-1	15673851
th@@	O	-1	15673851
ec@@	O	-1	15673851
ally	O	-1	15673851
(@@	O	-1	15673851
I@@	O	-1	15673851
T)	O	-1	15673851
0.@@	O	-1	15673851
5	O	-1	15673851
h	O	-1	15673851
after	O	-1	15673851
ref@@	O	-1	15673851
low@@	O	-1	15673851
,	O	-1	15673851
and	O	-1	15673851
30	O	-1	15673851
m@@	O	-1	15673851
u@@	O	-1	15673851
g	O	-1	15673851
of	O	-1	15673851
morphine	B-Chemical	D009020	15673851
(@@	O	-1	15673851
group	O	-1	15673851
S@@	O	-1	15673851
M@@	O	-1	15673851
;	O	-1	15673851
n	O	-1	15673851
=	O	-1	15673851
8@@	O	-1	15673851
)	O	-1	15673851
or	O	-1	15673851
10	O	-1	15673851
m@@	O	-1	15673851
u@@	O	-1	15673851
L	O	-1	15673851
of	O	-1	15673851
saline	O	-1	15673851
(@@	O	-1	15673851
group	O	-1	15673851
S@@	O	-1	15673851
C@@	O	-1	15673851
;	O	-1	15673851
n	O	-1	15673851
=	O	-1	15673851
8@@	O	-1	15673851
)	O	-1	15673851
was	O	-1	15673851
injected	O	-1	15673851
I@@	O	-1	15673851
T	O	-1	15673851
0.@@	O	-1	15673851
5	O	-1	15673851
h	O	-1	15673851
after	O	-1	15673851
s@@	O	-1	15673851
ha@@	O	-1	15673851
m	O	-1	15673851
o@@	O	-1	15673851
per@@	O	-1	15673851
ation.	O	-1	15673851
M@@	O	-1	15673851
ic@@	O	-1	15673851
ro@@	O	-1	15673851
dialy@@	O	-1	15673851
sis	O	-1	15673851
sam@@	O	-1	15673851
ple@@	O	-1	15673851
s	O	-1	15673851
were	O	-1	15673851
coll@@	O	-1	15673851
ected	O	-1	15673851
pre@@	O	-1	15673851
ischem@@	O	-1	15673851
ia,	O	-1	15673851
before	O	-1	15673851
I@@	O	-1	15673851
T	O	-1	15673851
injec@@	O	-1	15673851
tion,	O	-1	15673851
and	O	-1	15673851
at	O	-1	15673851
2,	O	-1	15673851
4@@	O	-1	15673851
,	O	-1	15673851
8@@	O	-1	15673851
,	O	-1	15673851
2@@	O	-1	15673851
4@@	O	-1	15673851
,	O	-1	15673851
and	O	-1	15673851
4@@	O	-1	15673851
8	O	-1	15673851
h	O	-1	15673851
of	O	-1	15673851
re@@	O	-1	15673851
per@@	O	-1	15673851
f@@	O	-1	15673851
usion	O	-1	15673851
(@@	O	-1	15673851
after	O	-1	15673851
I@@	O	-1	15673851
T	O	-1	15673851
injec@@	O	-1	15673851
tion@@	O	-1	15673851
).	O	-1	15673851
S@@	O	-1	15673851
ec@@	O	-1	15673851
on@@	O	-1	15673851
d,	O	-1	15673851
we	O	-1	15673851
investigated	O	-1	15673851
the	O	-1	15673851
effect	O	-1	15673851
of	O	-1	15673851
I@@	O	-1	15673851
T	O	-1	15673851
M@@	B-Chemical	D016291	15673851
K@@	I-Chemical	-1	15673851
-@@	I-Chemical	-1	15673851
80@@	I-Chemical	-1	15673851
1	I-Chemical	-1	15673851
(@@	O	-1	15673851
30	O	-1	15673851
m@@	O	-1	15673851
u@@	O	-1	15673851
g@@	O	-1	15673851
)	O	-1	15673851
on	O	-1	15673851
the	O	-1	15673851
histo@@	O	-1	15673851
path@@	O	-1	15673851
ologic	O	-1	15673851
changes	O	-1	15673851
in	O	-1	15673851
the	O	-1	15673851
spinal	O	-1	15673851
cor@@	O	-1	15673851
d	O	-1	15673851
after	O	-1	15673851
morphine	B-Chemical	D009020	15673851
-induced	O	-1	15673851
sp@@	B-Disease	D020336	15673851
as@@	I-Disease	-1	15673851
tic	I-Disease	-1	15673851
par@@	I-Disease	-1	15673851
ap@@	I-Disease	-1	15673851
a@@	I-Disease	-1	15673851
re@@	I-Disease	-1	15673851
sis	I-Disease	-1	15673851
.	O	-1	15673851
After	O	-1	15673851
I@@	O	-1	15673851
T	O	-1	15673851
morphine	B-Chemical	D009020	15673851
,	O	-1	15673851
the	O	-1	15673851
ce@@	O	-1	15673851
reb@@	O	-1	15673851
ro@@	O	-1	15673851
spinal	O	-1	15673851
flu@@	O	-1	15673851
id	O	-1	15673851
(C@@	O	-1	15673851
S@@	O	-1	15673851
F@@	O	-1	15673851
)	O	-1	15673851
glutamate	B-Chemical	D018698	15673851
concentration	O	-1	15673851
was	O	-1	15673851
increased	O	-1	15673851
in	O	-1	15673851
group	O	-1	15673851
M	O	-1	15673851
rel@@	O	-1	15673851
ative	O	-1	15673851
to	O	-1	15673851
both	O	-1	15673851
baseline	O	-1	15673851
and	O	-1	15673851
group	O	-1	15673851
C	O	-1	15673851
(P	O	-1	15673851
<	O	-1	15673851
0.05@@	O	-1	15673851
).	O	-1	15673851
This	O	-1	15673851
increase	O	-1	15673851
per@@	O	-1	15673851
sist@@	O	-1	15673851
ed	O	-1	15673851
for	O	-1	15673851
8	O	-1	15673851
h@@	O	-1	15673851
r@@	O	-1	15673851
s.	O	-1	15673851
I@@	O	-1	15673851
T	O	-1	15673851
M@@	B-Chemical	D016291	15673851
K@@	I-Chemical	-1	15673851
-@@	I-Chemical	-1	15673851
80@@	I-Chemical	-1	15673851
1	I-Chemical	-1	15673851
significantly	O	-1	15673851
reduced	O	-1	15673851
the	O	-1	15673851
number	O	-1	15673851
of	O	-1	15673851
d@@	O	-1	15673851
ark@@	O	-1	15673851
-@@	O	-1	15673851
st@@	O	-1	15673851
ained	O	-1	15673851
alpha-@@	O	-1	15673851
m@@	O	-1	15673851
ot@@	O	-1	15673851
one@@	O	-1	15673851
uron@@	O	-1	15673851
s	O	-1	15673851
after	O	-1	15673851
morphine	B-Chemical	D009020	15673851
-induced	O	-1	15673851
sp@@	B-Disease	D020336	15673851
as@@	I-Disease	-1	15673851
tic	I-Disease	-1	15673851
par@@	I-Disease	-1	15673851
ap@@	I-Disease	-1	15673851
a@@	I-Disease	-1	15673851
re@@	I-Disease	-1	15673851
sis	I-Disease	-1	15673851
compared	O	-1	15673851
with	O	-1	15673851
the	O	-1	15673851
saline	O	-1	15673851
group.	O	-1	15673851
These	O	-1	15673851
data	O	-1	15673851
indicate	O	-1	15673851
that	O	-1	15673851
I@@	O	-1	15673851
T	O	-1	15673851
morphine	B-Chemical	D009020	15673851
induc@@	O	-1	15673851
es	O	-1	15673851
sp@@	B-Disease	D020336	15673851
as@@	I-Disease	-1	15673851
tic	I-Disease	-1	15673851
par@@	I-Disease	-1	15673851
ap@@	I-Disease	-1	15673851
a@@	I-Disease	-1	15673851
re@@	I-Disease	-1	15673851
sis	I-Disease	-1	15673851
with	O	-1	15673851
a	O	-1	15673851
concomit@@	O	-1	15673851
ant	O	-1	15673851
increase	O	-1	15673851
in	O	-1	15673851
C@@	O	-1	15673851
S@@	O	-1	15673851
F	O	-1	15673851
glutamate	B-Chemical	D018698	15673851
,	O	-1	15673851
which	O	-1	15673851
is	O	-1	15673851
involved	O	-1	15673851
in	O	-1	15673851
N@@	B-Chemical	D016202	15673851
MD@@	I-Chemical	-1	15673851
A	I-Chemical	-1	15673851
receptor	O	-1	15673851
activ@@	O	-1	15673851
ation.	O	-1	15673851
We	O	-1	15673851
suggest	O	-1	15673851
that	O	-1	15673851
o@@	O	-1	15673851
pi@@	O	-1	15673851
oid@@	O	-1	15673851
s	O	-1	15673851
may	O	-1	15673851
be	O	-1	15673851
neuro@@	B-Disease	D020258	15673851
toxic	I-Disease	-1	15673851
in	O	-1	15673851
the	O	-1	15673851
se@@	O	-1	15673851
t@@	O	-1	15673851
ting	O	-1	15673851
of	O	-1	15673851
spinal	B-Disease	D020760	15673851
cor@@	I-Disease	-1	15673851
d	I-Disease	-1	15673851
ischem@@	I-Disease	-1	15673851
ia	I-Disease	-1	15673851
vi@@	O	-1	15673851
a	O	-1	15673851
N@@	B-Chemical	D016202	15673851
MD@@	I-Chemical	-1	15673851
A	I-Chemical	-1	15673851
receptor	O	-1	15673851
activ@@	O	-1	15673851
ation.	O	-1	15673851

Re@@	O	-1	12481039
duced	O	-1	12481039
sodium	B-Chemical	D012964	12481039
channel	O	-1	12481039
d@@	O	-1	12481039
ens@@	O	-1	12481039
ity,	O	-1	12481039
al@@	O	-1	12481039
te@@	O	-1	12481039
red	O	-1	12481039
vol@@	O	-1	12481039
t@@	O	-1	12481039
age	O	-1	12481039
depend@@	O	-1	12481039
ence	O	-1	12481039
of	O	-1	12481039
in@@	O	-1	12481039
activ@@	O	-1	12481039
ation,	O	-1	12481039
and	O	-1	12481039
increased	O	-1	12481039
sus@@	O	-1	12481039
cep@@	O	-1	12481039
ti@@	O	-1	12481039
b@@	O	-1	12481039
ility	O	-1	12481039
to	O	-1	12481039
seizures	B-Disease	D012640	12481039
in	O	-1	12481039
mice	O	-1	12481039
l@@	O	-1	12481039
ac@@	O	-1	12481039
king	O	-1	12481039
sodium	B-Chemical	D012964	12481039
channel	O	-1	12481039
bet@@	O	-1	12481039
a	O	-1	12481039
2-@@	O	-1	12481039
sub@@	O	-1	12481039
un@@	O	-1	12481039
it@@	O	-1	12481039
s.	O	-1	12481039
S@@	B-Chemical	D012964	12481039
odium	I-Chemical	-1	12481039
channel	O	-1	12481039
beta-@@	O	-1	12481039
sub@@	O	-1	12481039
un@@	O	-1	12481039
its	O	-1	12481039
mod@@	O	-1	12481039
ul@@	O	-1	12481039
ate	O	-1	12481039
channel	O	-1	12481039
g@@	O	-1	12481039
at@@	O	-1	12481039
ing,	O	-1	12481039
as@@	O	-1	12481039
se@@	O	-1	12481039
m@@	O	-1	12481039
bl@@	O	-1	12481039
y,	O	-1	12481039
and	O	-1	12481039
cell	O	-1	12481039
sur@@	O	-1	12481039
fac@@	O	-1	12481039
e	O	-1	12481039
expression	O	-1	12481039
in	O	-1	12481039
he@@	O	-1	12481039
ter@@	O	-1	12481039
olog@@	O	-1	12481039
ous	O	-1	12481039
cell	O	-1	12481039
system@@	O	-1	12481039
s.	O	-1	12481039
We	O	-1	12481039
gener@@	O	-1	12481039
ated	O	-1	12481039
beta@@	O	-1	12481039
2@@	O	-1	12481039
(-@@	O	-1	12481039
/@@	O	-1	12481039
-@@	O	-1	12481039
)	O	-1	12481039
mice	O	-1	12481039
to	O	-1	12481039
investigate	O	-1	12481039
the	O	-1	12481039
role	O	-1	12481039
of	O	-1	12481039
beta@@	O	-1	12481039
2	O	-1	12481039
in	O	-1	12481039
control	O	-1	12481039
of	O	-1	12481039
sodium	B-Chemical	D012964	12481039
channel	O	-1	12481039
d@@	O	-1	12481039
ens@@	O	-1	12481039
ity,	O	-1	12481039
lo@@	O	-1	12481039
cal@@	O	-1	12481039
iz@@	O	-1	12481039
ation,	O	-1	12481039
and	O	-1	12481039
function	O	-1	12481039
in	O	-1	12481039
neuron@@	O	-1	12481039
s	O	-1	12481039
in	O	-1	12481039
viv@@	O	-1	12481039
o@@	O	-1	12481039
.	O	-1	12481039
M@@	O	-1	12481039
e@@	O	-1	12481039
as@@	O	-1	12481039
ure@@	O	-1	12481039
ments	O	-1	12481039
of	O	-1	12481039
[@@	O	-1	12481039
(3@@	O	-1	12481039
)@@	O	-1	12481039
H@@	O	-1	12481039
]	O	-1	12481039
s@@	B-Chemical	D012530	12481039
ax@@	I-Chemical	-1	12481039
it@@	I-Chemical	-1	12481039
ox@@	I-Chemical	-1	12481039
in	I-Chemical	-1	12481039
(	O	-1	12481039
S@@	B-Chemical	D012530	12481039
T@@	I-Chemical	-1	12481039
X	I-Chemical	-1	12481039
)	O	-1	12481039
b@@	O	-1	12481039
ind@@	O	-1	12481039
ing	O	-1	12481039
showed	O	-1	12481039
a	O	-1	12481039
significant	O	-1	12481039
reduction	O	-1	12481039
in	O	-1	12481039
the	O	-1	12481039
level	O	-1	12481039
of	O	-1	12481039
plasma	O	-1	12481039
membran@@	O	-1	12481039
e	O	-1	12481039
sodium	B-Chemical	D012964	12481039
channe@@	O	-1	12481039
l@@	O	-1	12481039
s	O	-1	12481039
in	O	-1	12481039
beta@@	O	-1	12481039
2@@	O	-1	12481039
(-@@	O	-1	12481039
/@@	O	-1	12481039
-@@	O	-1	12481039
)	O	-1	12481039
neuron@@	O	-1	12481039
s.	O	-1	12481039
The	O	-1	12481039
loss	O	-1	12481039
of	O	-1	12481039
beta@@	O	-1	12481039
2	O	-1	12481039
resulted	O	-1	12481039
in	O	-1	12481039
negative	O	-1	12481039
shi@@	O	-1	12481039
f@@	O	-1	12481039
ts	O	-1	12481039
in	O	-1	12481039
the	O	-1	12481039
vol@@	O	-1	12481039
t@@	O	-1	12481039
age	O	-1	12481039
depend@@	O	-1	12481039
ence	O	-1	12481039
of	O	-1	12481039
in@@	O	-1	12481039
activation	O	-1	12481039
as	O	-1	12481039
well	O	-1	12481039
as	O	-1	12481039
significant	O	-1	12481039
decreas@@	O	-1	12481039
es	O	-1	12481039
in	O	-1	12481039
sodium	B-Chemical	D012964	12481039
current	O	-1	12481039
d@@	O	-1	12481039
ensity	O	-1	12481039
in	O	-1	12481039
ac@@	O	-1	12481039
u@@	O	-1	12481039
te@@	O	-1	12481039
ly	O	-1	12481039
dis@@	O	-1	12481039
s@@	O	-1	12481039
oci@@	O	-1	12481039
ated	O	-1	12481039
hippocamp@@	O	-1	12481039
al	O	-1	12481039
neuron@@	O	-1	12481039
s.	O	-1	12481039
The	O	-1	12481039
in@@	O	-1	12481039
te@@	O	-1	12481039
g@@	O	-1	12481039
ral	O	-1	12481039
of	O	-1	12481039
the	O	-1	12481039
comp@@	O	-1	12481039
ound	O	-1	12481039
action	O	-1	12481039
potential	O	-1	12481039
in	O	-1	12481039
op@@	O	-1	12481039
tic	O	-1	12481039
nerve	O	-1	12481039
was	O	-1	12481039
significantly	O	-1	12481039
reduc@@	O	-1	12481039
ed,	O	-1	12481039
and	O	-1	12481039
the	O	-1	12481039
th@@	O	-1	12481039
res@@	O	-1	12481039
h@@	O	-1	12481039
old	O	-1	12481039
for	O	-1	12481039
action	O	-1	12481039
potential	O	-1	12481039
generation	O	-1	12481039
was	O	-1	12481039
increas@@	O	-1	12481039
ed,	O	-1	12481039
indicating	O	-1	12481039
a	O	-1	12481039
reduction	O	-1	12481039
in	O	-1	12481039
the	O	-1	12481039
level	O	-1	12481039
of	O	-1	12481039
functional	O	-1	12481039
plasma	O	-1	12481039
membran@@	O	-1	12481039
e	O	-1	12481039
sodium	B-Chemical	D012964	12481039
channe@@	O	-1	12481039
l@@	O	-1	12481039
s.	O	-1	12481039
In	O	-1	12481039
contrast@@	O	-1	12481039
,	O	-1	12481039
the	O	-1	12481039
con@@	O	-1	12481039
duction	O	-1	12481039
ve@@	O	-1	12481039
loc@@	O	-1	12481039
ity,	O	-1	12481039
the	O	-1	12481039
number	O	-1	12481039
and	O	-1	12481039
size	O	-1	12481039
of	O	-1	12481039
ax@@	O	-1	12481039
ons	O	-1	12481039
in	O	-1	12481039
the	O	-1	12481039
op@@	O	-1	12481039
tic	O	-1	12481039
ner@@	O	-1	12481039
ve,	O	-1	12481039
and	O	-1	12481039
the	O	-1	12481039
specific	O	-1	12481039
lo@@	O	-1	12481039
cal@@	O	-1	12481039
ization	O	-1	12481039
of	O	-1	12481039
N@@	B-Chemical	D012964	12481039
a	I-Chemical	-1	12481039
(@@	O	-1	12481039
v@@	O	-1	12481039
)@@	O	-1	12481039
1.@@	O	-1	12481039
6	O	-1	12481039
channe@@	O	-1	12481039
l@@	O	-1	12481039
s	O	-1	12481039
in	O	-1	12481039
the	O	-1	12481039
no@@	O	-1	12481039
des	O	-1	12481039
of	O	-1	12481039
R@@	O	-1	12481039
an@@	O	-1	12481039
vi@@	O	-1	12481039
er	O	-1	12481039
were	O	-1	12481039
un@@	O	-1	12481039
chang@@	O	-1	12481039
ed.	O	-1	12481039
beta@@	O	-1	12481039
2@@	O	-1	12481039
(-@@	O	-1	12481039
/@@	O	-1	12481039
-@@	O	-1	12481039
)	O	-1	12481039
mice	O	-1	12481039
dis@@	O	-1	12481039
pl@@	O	-1	12481039
ayed	O	-1	12481039
increased	O	-1	12481039
sus@@	O	-1	12481039
cep@@	O	-1	12481039
ti@@	O	-1	12481039
b@@	O	-1	12481039
ility	O	-1	12481039
to	O	-1	12481039
seizures	B-Disease	D012640	12481039
,	O	-1	12481039
as	O	-1	12481039
indic@@	O	-1	12481039
ated	O	-1	12481039
by	O	-1	12481039
reduced	O	-1	12481039
lat@@	O	-1	12481039
ency	O	-1	12481039
and	O	-1	12481039
th@@	O	-1	12481039
res@@	O	-1	12481039
h@@	O	-1	12481039
old	O	-1	12481039
for	O	-1	12481039
pilocar@@	B-Chemical	D010862	12481039
pine	I-Chemical	-1	12481039
-induced	O	-1	12481039
seizures	B-Disease	D012640	12481039
,	O	-1	12481039
but	O	-1	12481039
se@@	O	-1	12481039
em@@	O	-1	12481039
ed	O	-1	12481039
normal	O	-1	12481039
in	O	-1	12481039
other	O	-1	12481039
neurolog@@	O	-1	12481039
ical	O	-1	12481039
test@@	O	-1	12481039
s.	O	-1	12481039
Our	O	-1	12481039
observ@@	O	-1	12481039
ations	O	-1	12481039
show	O	-1	12481039
that	O	-1	12481039
beta@@	O	-1	12481039
2-@@	O	-1	12481039
sub@@	O	-1	12481039
un@@	O	-1	12481039
its	O	-1	12481039
pl@@	O	-1	12481039
ay	O	-1	12481039
an	O	-1	12481039
important	O	-1	12481039
role	O	-1	12481039
in	O	-1	12481039
the	O	-1	12481039
reg@@	O	-1	12481039
ulation	O	-1	12481039
of	O	-1	12481039
sodium	B-Chemical	D012964	12481039
channel	O	-1	12481039
d@@	O	-1	12481039
ensity	O	-1	12481039
and	O	-1	12481039
function	O	-1	12481039
in	O	-1	12481039
neuron@@	O	-1	12481039
s	O	-1	12481039
in	O	-1	12481039
viv@@	O	-1	12481039
o	O	-1	12481039
and	O	-1	12481039
are	O	-1	12481039
requ@@	O	-1	12481039
ired	O	-1	12481039
for	O	-1	12481039
normal	O	-1	12481039
action	O	-1	12481039
potential	O	-1	12481039
generation	O	-1	12481039
and	O	-1	12481039
control	O	-1	12481039
of	O	-1	12481039
ex@@	O	-1	12481039
cit@@	O	-1	12481039
abil@@	O	-1	12481039
ity.	O	-1	12481039

S@@	O	-1	11185967
cre@@	O	-1	11185967
en@@	O	-1	11185967
ing	O	-1	11185967
for	O	-1	11185967
stimul@@	O	-1	11185967
ant	O	-1	11185967
use	O	-1	11185967
in	O	-1	11185967
ad@@	O	-1	11185967
ult	O	-1	11185967
em@@	O	-1	11185967
er@@	O	-1	11185967
gen@@	O	-1	11185967
c@@	O	-1	11185967
y	O	-1	11185967
de@@	O	-1	11185967
part@@	O	-1	11185967
ment	O	-1	11185967
seizure	B-Disease	D012640	11185967
patients.	O	-1	11185967
OBJECTIVE:	O	-1	11185967
The	O	-1	11185967
ob@@	O	-1	11185967
j@@	O	-1	11185967
ective	O	-1	11185967
of	O	-1	11185967
this	O	-1	11185967
study	O	-1	11185967
was	O	-1	11185967
to	O	-1	11185967
determine	O	-1	11185967
the	O	-1	11185967
prev@@	O	-1	11185967
al@@	O	-1	11185967
ence	O	-1	11185967
of	O	-1	11185967
positive	O	-1	11185967
plasma	O	-1	11185967
drug	O	-1	11185967
s@@	O	-1	11185967
cre@@	O	-1	11185967
en@@	O	-1	11185967
ing	O	-1	11185967
for	O	-1	11185967
cocaine	B-Chemical	D003042	11185967
or	O	-1	11185967
amphetamine	B-Chemical	D000661	11185967
in	O	-1	11185967
ad@@	O	-1	11185967
ult	O	-1	11185967
em@@	O	-1	11185967
er@@	O	-1	11185967
gen@@	O	-1	11185967
c@@	O	-1	11185967
y	O	-1	11185967
de@@	O	-1	11185967
part@@	O	-1	11185967
ment	O	-1	11185967
seizure	B-Disease	D012640	11185967
patients.	O	-1	11185967
METHODS:	O	-1	11185967
This	O	-1	11185967
pro@@	O	-1	11185967
sp@@	O	-1	11185967
ective	O	-1	11185967
study	O	-1	11185967
evaluated	O	-1	11185967
con@@	O	-1	11185967
sec@@	O	-1	11185967
utive	O	-1	11185967
e@@	O	-1	11185967
li@@	O	-1	11185967
gi@@	O	-1	11185967
ble	O	-1	11185967
seizure	B-Disease	D012640	11185967
patients	O	-1	11185967
who	O	-1	11185967
had	O	-1	11185967
a	O	-1	11185967
plasma	O	-1	11185967
sam@@	O	-1	11185967
ple	O	-1	11185967
coll@@	O	-1	11185967
ected	O	-1	11185967
as	O	-1	11185967
par@@	O	-1	11185967
t	O	-1	11185967
of	O	-1	11185967
their	O	-1	11185967
clinical	O	-1	11185967
evalu@@	O	-1	11185967
ation.	O	-1	11185967
P@@	O	-1	11185967
las@@	O	-1	11185967
ma	O	-1	11185967
was	O	-1	11185967
tested	O	-1	11185967
for	O	-1	11185967
amphetamine	B-Chemical	D000661	11185967
and	O	-1	11185967
the	O	-1	11185967
cocaine	B-Chemical	D003042	11185967
metabol@@	O	-1	11185967
ite	O	-1	11185967
b@@	B-Chemical	C005618	11185967
enz@@	I-Chemical	-1	11185967
o@@	I-Chemical	-1	11185967
yl@@	I-Chemical	-1	11185967
ec@@	I-Chemical	-1	11185967
g@@	I-Chemical	-1	11185967
on@@	I-Chemical	-1	11185967
ine	I-Chemical	-1	11185967
using	O	-1	11185967
enz@@	O	-1	11185967
y@@	O	-1	11185967
me@@	O	-1	11185967
-@@	O	-1	11185967
mediated	O	-1	11185967
immuno@@	O	-1	11185967
ass@@	O	-1	11185967
ay	O	-1	11185967
meth@@	O	-1	11185967
o@@	O	-1	11185967
do@@	O	-1	11185967
log@@	O	-1	11185967
y.	O	-1	11185967
P@@	O	-1	11185967
las@@	O	-1	11185967
ma	O	-1	11185967
sam@@	O	-1	11185967
ple@@	O	-1	11185967
s	O	-1	11185967
with	O	-1	11185967
b@@	B-Chemical	C005618	11185967
enz@@	I-Chemical	-1	11185967
o@@	I-Chemical	-1	11185967
yl@@	I-Chemical	-1	11185967
ec@@	I-Chemical	-1	11185967
g@@	I-Chemical	-1	11185967
on@@	I-Chemical	-1	11185967
ine	I-Chemical	-1	11185967
greater	O	-1	11185967
than	O	-1	11185967
1@@	O	-1	11185967
50	O	-1	11185967
n@@	O	-1	11185967
g/@@	O	-1	11185967
m@@	O	-1	11185967
L	O	-1	11185967
or	O	-1	11185967
an	O	-1	11185967
amphetamine	B-Chemical	D000661	11185967
greater	O	-1	11185967
than	O	-1	11185967
5@@	O	-1	11185967
00	O	-1	11185967
n@@	O	-1	11185967
g/@@	O	-1	11185967
m@@	O	-1	11185967
L	O	-1	11185967
were	O	-1	11185967
def@@	O	-1	11185967
in@@	O	-1	11185967
ed	O	-1	11185967
as	O	-1	11185967
posi@@	O	-1	11185967
ti@@	O	-1	11185967
ve.	O	-1	11185967
Pati@@	O	-1	11185967
ent	O	-1	11185967
de@@	O	-1	11185967
mo@@	O	-1	11185967
graph@@	O	-1	11185967
ic@@	O	-1	11185967
s,	O	-1	11185967
hist@@	O	-1	11185967
ory	O	-1	11185967
of	O	-1	11185967
underlying	O	-1	11185967
drug	O	-1	11185967
or	O	-1	11185967
alco@@	B-Chemical	D000431	11185967
hol	I-Chemical	-1	11185967
-@@	O	-1	11185967
related	O	-1	11185967
seizure	B-Disease	D012640	11185967
disorder@@	O	-1	11185967
,	O	-1	11185967
estim@@	O	-1	11185967
ated	O	-1	11185967
time	O	-1	11185967
from	O	-1	11185967
seizure	B-Disease	D012640	11185967
to	O	-1	11185967
sam@@	O	-1	11185967
ple	O	-1	11185967
coll@@	O	-1	11185967
ec@@	O	-1	11185967
tion,	O	-1	11185967
hist@@	O	-1	11185967
ory	O	-1	11185967
or	O	-1	11185967
sus@@	O	-1	11185967
p@@	O	-1	11185967
ici@@	O	-1	11185967
on	O	-1	11185967
of	O	-1	11185967
cocaine	B-Disease	D019970	11185967
or	I-Disease	-1	11185967
amphetamine	I-Disease	-1	11185967
ab@@	I-Disease	-1	11185967
use	I-Disease	-1	11185967
cocaine	B-Disease	D019969	11185967
or	I-Disease	-1	11185967
amphetamine	I-Disease	-1	11185967
ab@@	I-Disease	-1	11185967
use	I-Disease	-1	11185967
,	O	-1	11185967
results	O	-1	11185967
of	O	-1	11185967
clinical	O	-1	11185967
urine	O	-1	11185967
test@@	O	-1	11185967
ing	O	-1	11185967
for	O	-1	11185967
drugs	O	-1	11185967
of	O	-1	11185967
ab@@	O	-1	11185967
use@@	O	-1	11185967
,	O	-1	11185967
and	O	-1	11185967
ass@@	O	-1	11185967
ay	O	-1	11185967
results	O	-1	11185967
were	O	-1	11185967
recor@@	O	-1	11185967
ded	O	-1	11185967
without	O	-1	11185967
patient	O	-1	11185967
identi@@	O	-1	11185967
fi@@	O	-1	11185967
ers.	O	-1	11185967
RESULTS:	O	-1	11185967
F@@	O	-1	11185967
o@@	O	-1	11185967
ur@@	O	-1	11185967
te@@	O	-1	11185967
en	O	-1	11185967
of	O	-1	11185967
2@@	O	-1	11185967
4@@	O	-1	11185967
8	O	-1	11185967
(@@	O	-1	11185967
5.@@	O	-1	11185967
6@@	O	-1	11185967
%,	O	-1	11185967
95%	O	-1	11185967
C@@	O	-1	11185967
I	O	-1	11185967
2.@@	O	-1	11185967
7@@	O	-1	11185967
%@@	O	-1	11185967
-@@	O	-1	11185967
8.@@	O	-1	11185967
5@@	O	-1	11185967
%)	O	-1	11185967
plasma	O	-1	11185967
sam@@	O	-1	11185967
ple@@	O	-1	11185967
s	O	-1	11185967
were	O	-1	11185967
positive	O	-1	11185967
by	O	-1	11185967
immuno@@	O	-1	11185967
ass@@	O	-1	11185967
ay	O	-1	11185967
test@@	O	-1	11185967
ing	O	-1	11185967
for	O	-1	11185967
b@@	B-Chemical	C005618	11185967
enz@@	I-Chemical	-1	11185967
o@@	I-Chemical	-1	11185967
yl@@	I-Chemical	-1	11185967
ec@@	I-Chemical	-1	11185967
g@@	I-Chemical	-1	11185967
on@@	I-Chemical	-1	11185967
ine	I-Chemical	-1	11185967
and	O	-1	11185967
no	O	-1	11185967
sam@@	O	-1	11185967
ple@@	O	-1	11185967
s	O	-1	11185967
(@@	O	-1	11185967
0@@	O	-1	11185967
%,	O	-1	11185967
95%	O	-1	11185967
C@@	O	-1	11185967
I	O	-1	11185967
0-@@	O	-1	11185967
1.@@	O	-1	11185967
2@@	O	-1	11185967
%)	O	-1	11185967
were	O	-1	11185967
positive	O	-1	11185967
for	O	-1	11185967
amphetamine	B-Chemical	D000661	11185967
.	O	-1	11185967
P@@	O	-1	11185967
o@@	O	-1	11185967
si@@	O	-1	11185967
tive	O	-1	11185967
test	O	-1	11185967
results	O	-1	11185967
were	O	-1	11185967
more	O	-1	11185967
common	O	-1	11185967
in	O	-1	11185967
patient	O	-1	11185967
v@@	O	-1	11185967
is@@	O	-1	11185967
its	O	-1	11185967
wh@@	O	-1	11185967
ere	O	-1	11185967
there	O	-1	11185967
was	O	-1	11185967
a	O	-1	11185967
hist@@	O	-1	11185967
ory	O	-1	11185967
or	O	-1	11185967
sus@@	O	-1	11185967
p@@	O	-1	11185967
ici@@	O	-1	11185967
on	O	-1	11185967
of	O	-1	11185967
cocaine	B-Disease	D019970	11185967
or	I-Disease	-1	11185967
amphetamine	I-Disease	-1	11185967
ab@@	I-Disease	-1	11185967
use	I-Disease	-1	11185967
cocaine	B-Disease	D019969	11185967
or	I-Disease	-1	11185967
amphetamine	I-Disease	-1	11185967
ab@@	I-Disease	-1	11185967
use	I-Disease	-1	11185967
(p	O	-1	11185967
<	O	-1	11185967
0.00@@	O	-1	11185967
0@@	O	-1	11185967
5@@	O	-1	11185967
).	O	-1	11185967
CONCLUSIONS:	O	-1	11185967
D@@	O	-1	11185967
uring	O	-1	11185967
this	O	-1	11185967
study	O	-1	11185967
perio@@	O	-1	11185967
d,	O	-1	11185967
ro@@	O	-1	11185967
ut@@	O	-1	11185967
ine	O	-1	11185967
plasma	O	-1	11185967
s@@	O	-1	11185967
cre@@	O	-1	11185967
en@@	O	-1	11185967
ing	O	-1	11185967
for	O	-1	11185967
cocaine	B-Chemical	D003042	11185967
and	O	-1	11185967
amphet@@	B-Chemical	D000662	11185967
amin@@	I-Chemical	-1	11185967
es	I-Chemical	-1	11185967
in	O	-1	11185967
ad@@	O	-1	11185967
ult	O	-1	11185967
seizure	B-Disease	D012640	11185967
patients	O	-1	11185967
had	O	-1	11185967
a	O	-1	11185967
low	O	-1	11185967
y@@	O	-1	11185967
i@@	O	-1	11185967
el@@	O	-1	11185967
d.	O	-1	11185967
A@@	O	-1	11185967
s	O	-1	11185967
a	O	-1	11185967
result@@	O	-1	11185967
,	O	-1	11185967
ro@@	O	-1	11185967
ut@@	O	-1	11185967
ine	O	-1	11185967
plasma	O	-1	11185967
s@@	O	-1	11185967
cre@@	O	-1	11185967
en@@	O	-1	11185967
ing	O	-1	11185967
wo@@	O	-1	11185967
uld	O	-1	11185967
y@@	O	-1	11185967
i@@	O	-1	11185967
el@@	O	-1	11185967
d	O	-1	11185967
fe@@	O	-1	11185967
w	O	-1	11185967
cases	O	-1	11185967
of	O	-1	11185967
stimul@@	O	-1	11185967
ant	O	-1	11185967
drug	O	-1	11185967
in	O	-1	11185967
which	O	-1	11185967
there	O	-1	11185967
was	O	-1	11185967
ne@@	O	-1	11185967
ither	O	-1	11185967
a	O	-1	11185967
hist@@	O	-1	11185967
ory	O	-1	11185967
n@@	O	-1	11185967
or	O	-1	11185967
sus@@	O	-1	11185967
p@@	O	-1	11185967
ici@@	O	-1	11185967
on	O	-1	11185967
of	O	-1	11185967
drug	B-Disease	D019966	11185967
ab@@	I-Disease	-1	11185967
use	I-Disease	-1	11185967
in	O	-1	11185967
this	O	-1	11185967
po@@	O	-1	11185967
pul@@	O	-1	11185967
ation.	O	-1	11185967

E@@	O	-1	11099450
v@@	O	-1	11099450
idence	O	-1	11099450
of	O	-1	11099450
functional	O	-1	11099450
s@@	O	-1	11099450
om@@	O	-1	11099450
at@@	O	-1	11099450
ot@@	O	-1	11099450
op@@	O	-1	11099450
y	O	-1	11099450
in	O	-1	11099450
G@@	O	-1	11099450
P@@	O	-1	11099450
i	O	-1	11099450
from	O	-1	11099450
results	O	-1	11099450
of	O	-1	11099450
p@@	O	-1	11099450
all@@	O	-1	11099450
id@@	O	-1	11099450
ot@@	O	-1	11099450
om@@	O	-1	11099450
y.	O	-1	11099450
The	O	-1	11099450
ob@@	O	-1	11099450
j@@	O	-1	11099450
ective	O	-1	11099450
of	O	-1	11099450
this	O	-1	11099450
study	O	-1	11099450
was	O	-1	11099450
to	O	-1	11099450
expl@@	O	-1	11099450
or@@	O	-1	11099450
e	O	-1	11099450
the	O	-1	11099450
functional	O	-1	11099450
an@@	O	-1	11099450
at@@	O	-1	11099450
om@@	O	-1	11099450
y	O	-1	11099450
of	O	-1	11099450
the	O	-1	11099450
glo@@	O	-1	11099450
bu@@	O	-1	11099450
s	O	-1	11099450
p@@	O	-1	11099450
all@@	O	-1	11099450
id@@	O	-1	11099450
us	O	-1	11099450
inter@@	O	-1	11099450
n@@	O	-1	11099450
us	O	-1	11099450
(@@	O	-1	11099450
G@@	O	-1	11099450
P@@	O	-1	11099450
i@@	O	-1	11099450
)	O	-1	11099450
by	O	-1	11099450
stud@@	O	-1	11099450
y@@	O	-1	11099450
ing	O	-1	11099450
the	O	-1	11099450
effects	O	-1	11099450
of	O	-1	11099450
un@@	O	-1	11099450
il@@	O	-1	11099450
ateral	O	-1	11099450
p@@	O	-1	11099450
all@@	O	-1	11099450
id@@	O	-1	11099450
ot@@	O	-1	11099450
om@@	O	-1	11099450
y	O	-1	11099450
on	O	-1	11099450
par@@	B-Disease	D010300	11099450
k@@	I-Disease	-1	11099450
inson@@	I-Disease	-1	11099450
i@@	I-Disease	-1	11099450
an	I-Disease	-1	11099450
'@@	O	-1	11099450
o@@	O	-1	11099450
ff@@	O	-1	11099450
'	O	-1	11099450
signs	O	-1	11099450
and	O	-1	11099450
levo@@	B-Chemical	D007980	11099450
dopa	I-Chemical	-1	11099450
-induced	O	-1	11099450
dyskine@@	B-Disease	D004409	11099450
si@@	I-Disease	-1	11099450
as	I-Disease	-1	11099450
(	O	-1	11099450
L@@	B-Disease	D004409	11099450
I@@	I-Disease	-1	11099450
D	I-Disease	-1	11099450
).	O	-1	11099450
We	O	-1	11099450
found	O	-1	11099450
significant	O	-1	11099450
positive	O	-1	11099450
correl@@	O	-1	11099450
ations	O	-1	11099450
between	O	-1	11099450
the	O	-1	11099450
pre@@	O	-1	11099450
o@@	O	-1	11099450
perative	O	-1	11099450
levo@@	B-Chemical	D007980	11099450
dopa	I-Chemical	-1	11099450
respon@@	O	-1	11099450
si@@	O	-1	11099450
ven@@	O	-1	11099450
ess	O	-1	11099450
of	O	-1	11099450
motor	O	-1	11099450
signs	O	-1	11099450
and	O	-1	11099450
the	O	-1	11099450
levo@@	B-Chemical	D007980	11099450
dopa	I-Chemical	-1	11099450
respon@@	O	-1	11099450
si@@	O	-1	11099450
ven@@	O	-1	11099450
ess	O	-1	11099450
of	O	-1	11099450
sco@@	O	-1	11099450
res	O	-1	11099450
in	O	-1	11099450
tim@@	O	-1	11099450
ed	O	-1	11099450
tests	O	-1	11099450
(C@@	O	-1	11099450
or@@	O	-1	11099450
e	O	-1	11099450
A@@	O	-1	11099450
s@@	O	-1	11099450
s@@	O	-1	11099450
ess@@	O	-1	11099450
ment	O	-1	11099450
Pro@@	O	-1	11099450
gra@@	O	-1	11099450
m	O	-1	11099450
for	O	-1	11099450
In@@	O	-1	11099450
trac@@	O	-1	11099450
e@@	O	-1	11099450
rebral	O	-1	11099450
T@@	O	-1	11099450
ran@@	O	-1	11099450
s@@	O	-1	11099450
pl@@	O	-1	11099450
ant@@	O	-1	11099450
ation@@	O	-1	11099450
s)	O	-1	11099450
in	O	-1	11099450
the	O	-1	11099450
contr@@	O	-1	11099450
al@@	O	-1	11099450
ateral	O	-1	11099450
lim@@	O	-1	11099450
b@@	O	-1	11099450
s	O	-1	11099450
and	O	-1	11099450
the	O	-1	11099450
impro@@	O	-1	11099450
vement	O	-1	11099450
in	O	-1	11099450
these	O	-1	11099450
sco@@	O	-1	11099450
res	O	-1	11099450
after	O	-1	11099450
surger@@	O	-1	11099450
y,	O	-1	11099450
whereas	O	-1	11099450
there	O	-1	11099450
was	O	-1	11099450
no	O	-1	11099450
correl@@	O	-1	11099450
ation	O	-1	11099450
with	O	-1	11099450
the	O	-1	11099450
impro@@	O	-1	11099450
vement	O	-1	11099450
in	O	-1	11099450
L@@	B-Disease	D004409	11099450
I@@	I-Disease	-1	11099450
D	I-Disease	-1	11099450
.	O	-1	11099450
We	O	-1	11099450
also	O	-1	11099450
found	O	-1	11099450
a	O	-1	11099450
high@@	O	-1	11099450
ly	O	-1	11099450
significant	O	-1	11099450
correl@@	O	-1	11099450
ation	O	-1	11099450
(P@@	O	-1	11099450
:	O	-1	11099450
<	O	-1	11099450
0.00@@	O	-1	11099450
0@@	O	-1	11099450
1,	O	-1	11099450
r	O	-1	11099450
=	O	-1	11099450
0.@@	O	-1	11099450
8@@	O	-1	11099450
)	O	-1	11099450
between	O	-1	11099450
the	O	-1	11099450
volume	O	-1	11099450
of	O	-1	11099450
the	O	-1	11099450
ventr@@	O	-1	11099450
al	O	-1	11099450
le@@	O	-1	11099450
sion	O	-1	11099450
in	O	-1	11099450
the	O	-1	11099450
G@@	O	-1	11099450
P@@	O	-1	11099450
i	O	-1	11099450
and	O	-1	11099450
the	O	-1	11099450
impro@@	O	-1	11099450
vement	O	-1	11099450
in	O	-1	11099450
L@@	B-Disease	D004409	11099450
I@@	I-Disease	-1	11099450
D	I-Disease	-1	11099450
in	O	-1	11099450
the	O	-1	11099450
contr@@	O	-1	11099450
al@@	O	-1	11099450
ateral	O	-1	11099450
lim@@	O	-1	11099450
b@@	O	-1	11099450
s,	O	-1	11099450
whereas	O	-1	11099450
there	O	-1	11099450
was	O	-1	11099450
no	O	-1	11099450
correl@@	O	-1	11099450
ation	O	-1	11099450
between	O	-1	11099450
the	O	-1	11099450
ventr@@	O	-1	11099450
al	O	-1	11099450
volume	O	-1	11099450
and	O	-1	11099450
the	O	-1	11099450
impro@@	O	-1	11099450
vement	O	-1	11099450
in	O	-1	11099450
par@@	B-Disease	D010300	11099450
k@@	I-Disease	-1	11099450
inson@@	I-Disease	-1	11099450
i@@	I-Disease	-1	11099450
an	I-Disease	-1	11099450
'@@	O	-1	11099450
o@@	O	-1	11099450
ff@@	O	-1	11099450
'	O	-1	11099450
sign@@	O	-1	11099450
s.	O	-1	11099450
The	O	-1	11099450
volum@@	O	-1	11099450
es	O	-1	11099450
of	O	-1	11099450
the	O	-1	11099450
total	O	-1	11099450
le@@	O	-1	11099450
sion	O	-1	11099450
c@@	O	-1	11099450
yl@@	O	-1	11099450
ind@@	O	-1	11099450
er	O	-1	11099450
and	O	-1	11099450
the	O	-1	11099450
d@@	O	-1	11099450
or@@	O	-1	11099450
s@@	O	-1	11099450
al	O	-1	11099450
le@@	O	-1	11099450
sion	O	-1	11099450
did	O	-1	11099450
not	O	-1	11099450
correl@@	O	-1	11099450
ate	O	-1	11099450
with	O	-1	11099450
the	O	-1	11099450
outcom@@	O	-1	11099450
e	O	-1	11099450
of	O	-1	11099450
either	O	-1	11099450
dyskine@@	B-Disease	D004409	11099450
si@@	I-Disease	-1	11099450
as	I-Disease	-1	11099450
or	O	-1	11099450
par@@	B-Disease	D010300	11099450
k@@	I-Disease	-1	11099450
inson@@	I-Disease	-1	11099450
i@@	I-Disease	-1	11099450
an	I-Disease	-1	11099450
'@@	O	-1	11099450
o@@	O	-1	11099450
ff@@	O	-1	11099450
'	O	-1	11099450
sign@@	O	-1	11099450
s.	O	-1	11099450
The	O	-1	11099450
differen@@	O	-1	11099450
tial	O	-1	11099450
predic@@	O	-1	11099450
tive	O	-1	11099450
valu@@	O	-1	11099450
e	O	-1	11099450
of	O	-1	11099450
levo@@	B-Chemical	D007980	11099450
dopa	I-Chemical	-1	11099450
respon@@	O	-1	11099450
si@@	O	-1	11099450
ven@@	O	-1	11099450
ess	O	-1	11099450
for	O	-1	11099450
the	O	-1	11099450
outcom@@	O	-1	11099450
e	O	-1	11099450
of	O	-1	11099450
par@@	B-Disease	D010300	11099450
k@@	I-Disease	-1	11099450
inson@@	I-Disease	-1	11099450
i@@	I-Disease	-1	11099450
an	I-Disease	-1	11099450
'@@	O	-1	11099450
o@@	O	-1	11099450
ff@@	O	-1	11099450
'	O	-1	11099450
signs	O	-1	11099450
and	O	-1	11099450
L@@	B-Disease	D004409	11099450
I@@	I-Disease	-1	11099450
D	I-Disease	-1	11099450
and	O	-1	11099450
the	O	-1	11099450
different	O	-1	11099450
correl@@	O	-1	11099450
ations	O	-1	11099450
of	O	-1	11099450
ventr@@	O	-1	11099450
al	O	-1	11099450
le@@	O	-1	11099450
sion	O	-1	11099450
volume	O	-1	11099450
with	O	-1	11099450
dyskine@@	B-Disease	D004409	11099450
si@@	I-Disease	-1	11099450
as	I-Disease	-1	11099450
and	O	-1	11099450
par@@	B-Disease	D010300	11099450
k@@	I-Disease	-1	11099450
inson@@	I-Disease	-1	11099450
i@@	I-Disease	-1	11099450
an	I-Disease	-1	11099450
'@@	O	-1	11099450
o@@	O	-1	11099450
ff@@	O	-1	11099450
'	O	-1	11099450
signs	O	-1	11099450
indicate	O	-1	11099450
that	O	-1	11099450
different	O	-1	11099450
an@@	O	-1	11099450
at@@	O	-1	11099450
om@@	O	-1	11099450
ical	O	-1	11099450
or	O	-1	11099450
path@@	O	-1	11099450
oph@@	O	-1	11099450
ysi@@	O	-1	11099450
ological	O	-1	11099450
sub@@	O	-1	11099450
strat@@	O	-1	11099450
es	O	-1	11099450
may	O	-1	11099450
be	O	-1	11099450
respon@@	O	-1	11099450
sible	O	-1	11099450
for	O	-1	11099450
the	O	-1	11099450
generation	O	-1	11099450
of	O	-1	11099450
par@@	B-Disease	D010300	11099450
k@@	I-Disease	-1	11099450
inson@@	I-Disease	-1	11099450
i@@	I-Disease	-1	11099450
an	I-Disease	-1	11099450
'@@	O	-1	11099450
o@@	O	-1	11099450
ff@@	O	-1	11099450
'	O	-1	11099450
signs	O	-1	11099450
and	O	-1	11099450
dyskine@@	B-Disease	D004409	11099450
si@@	I-Disease	-1	11099450
as	I-Disease	-1	11099450
.	O	-1	11099450
Whe@@	O	-1	11099450
reas	O	-1	11099450
cells	O	-1	11099450
in	O	-1	11099450
a	O	-1	11099450
w@@	O	-1	11099450
id@@	O	-1	11099450
er	O	-1	11099450
a@@	O	-1	11099450
re@@	O	-1	11099450
a	O	-1	11099450
of	O	-1	11099450
the	O	-1	11099450
G@@	O	-1	11099450
P@@	O	-1	11099450
i	O	-1	11099450
may	O	-1	11099450
be	O	-1	11099450
implic@@	O	-1	11099450
ated	O	-1	11099450
in	O	-1	11099450
par@@	B-Disease	D010300	11099450
k@@	I-Disease	-1	11099450
inson@@	I-Disease	-1	11099450
ism	I-Disease	-1	11099450
,	O	-1	11099450
the	O	-1	11099450
ventr@@	O	-1	11099450
al	O	-1	11099450
G@@	O	-1	11099450
P@@	O	-1	11099450
i	O	-1	11099450
se@@	O	-1	11099450
em@@	O	-1	11099450
s	O	-1	11099450
to	O	-1	11099450
be	O	-1	11099450
c@@	O	-1	11099450
r@@	O	-1	11099450
uc@@	O	-1	11099450
ial	O	-1	11099450
for	O	-1	11099450
the	O	-1	11099450
man@@	O	-1	11099450
if@@	O	-1	11099450
est@@	O	-1	11099450
ation	O	-1	11099450
of	O	-1	11099450
L@@	B-Disease	D004409	11099450
I@@	I-Disease	-1	11099450
D	I-Disease	-1	11099450
.	O	-1	11099450
We	O	-1	11099450
suggest	O	-1	11099450
that	O	-1	11099450
our	O	-1	11099450
observ@@	O	-1	11099450
ations	O	-1	11099450
are	O	-1	11099450
addi@@	O	-1	11099450
tional	O	-1	11099450
pro@@	O	-1	11099450
of	O	-1	11099450
of	O	-1	11099450
the	O	-1	11099450
functional	O	-1	11099450
s@@	O	-1	11099450
om@@	O	-1	11099450
at@@	O	-1	11099450
ot@@	O	-1	11099450
op@@	O	-1	11099450
y	O	-1	11099450
of	O	-1	11099450
the	O	-1	11099450
system@@	O	-1	11099450
s	O	-1	11099450
within	O	-1	11099450
the	O	-1	11099450
G@@	O	-1	11099450
P@@	O	-1	11099450
i	O	-1	11099450
that	O	-1	11099450
medi@@	O	-1	11099450
ate	O	-1	11099450
par@@	B-Disease	D010300	11099450
k@@	I-Disease	-1	11099450
inson@@	I-Disease	-1	11099450
ism	I-Disease	-1	11099450
and	O	-1	11099450
dyskine@@	B-Disease	D004409	11099450
si@@	I-Disease	-1	11099450
as	I-Disease	-1	11099450
,	O	-1	11099450
es@@	O	-1	11099450
p@@	O	-1	11099450
ec@@	O	-1	11099450
i@@	O	-1	11099450
ally	O	-1	11099450
al@@	O	-1	11099450
ong	O	-1	11099450
the	O	-1	11099450
d@@	O	-1	11099450
or@@	O	-1	11099450
so@@	O	-1	11099450
ventr@@	O	-1	11099450
al	O	-1	11099450
tra@@	O	-1	11099450
j@@	O	-1	11099450
ect@@	O	-1	11099450
ory	O	-1	11099450
used	O	-1	11099450
in	O	-1	11099450
p@@	O	-1	11099450
all@@	O	-1	11099450
id@@	O	-1	11099450
ot@@	O	-1	11099450
om@@	O	-1	11099450
y.	O	-1	11099450
The	O	-1	11099450
outcom@@	O	-1	11099450
e	O	-1	11099450
of	O	-1	11099450
p@@	O	-1	11099450
all@@	O	-1	11099450
id@@	O	-1	11099450
ot@@	O	-1	11099450
om@@	O	-1	11099450
y	O	-1	11099450
in	O	-1	11099450
which	O	-1	11099450
the	O	-1	11099450
le@@	O	-1	11099450
sion	O	-1	11099450
invol@@	O	-1	11099450
v@@	O	-1	11099450
es	O	-1	11099450
the	O	-1	11099450
ventr@@	O	-1	11099450
al	O	-1	11099450
and	O	-1	11099450
d@@	O	-1	11099450
or@@	O	-1	11099450
s@@	O	-1	11099450
al	O	-1	11099450
G@@	O	-1	11099450
P@@	O	-1	11099450
i	O	-1	11099450
could	O	-1	11099450
be	O	-1	11099450
the	O	-1	11099450
ne@@	O	-1	11099450
t	O	-1	11099450
effect	O	-1	11099450
of	O	-1	11099450
al@@	O	-1	11099450
ter@@	O	-1	11099450
ation	O	-1	11099450
in	O	-1	11099450
the	O	-1	11099450
activity	O	-1	11099450
of	O	-1	11099450
path@@	O	-1	11099450
w@@	O	-1	11099450
ays	O	-1	11099450
which	O	-1	11099450
medi@@	O	-1	11099450
ate	O	-1	11099450
different	O	-1	11099450
symptom@@	O	-1	11099450
s,	O	-1	11099450
and	O	-1	11099450
h@@	O	-1	11099450
ence	O	-1	11099450
could	O	-1	11099450
be	O	-1	11099450
vari@@	O	-1	11099450
able@@	O	-1	11099450
.	O	-1	11099450

P@@	B-Disease	D010146	11027904
ain	I-Disease	-1	11027904
responses	O	-1	11027904
in	O	-1	11027904
meth@@	B-Chemical	D008691	11027904
ad@@	I-Chemical	-1	11027904
one	I-Chemical	-1	11027904
-@@	O	-1	11027904
maint@@	O	-1	11027904
ained	O	-1	11027904
o@@	O	-1	11027904
pi@@	O	-1	11027904
oid	O	-1	11027904
ab@@	O	-1	11027904
us@@	O	-1	11027904
ers.	O	-1	11027904
Pro@@	O	-1	11027904
vid@@	O	-1	11027904
ing	O	-1	11027904
pain	B-Disease	D010146	11027904
man@@	O	-1	11027904
ag@@	O	-1	11027904
ement	O	-1	11027904
for	O	-1	11027904
known	O	-1	11027904
o@@	O	-1	11027904
pi@@	O	-1	11027904
oid	O	-1	11027904
ab@@	O	-1	11027904
users	O	-1	11027904
is	O	-1	11027904
a	O	-1	11027904
ch@@	O	-1	11027904
all@@	O	-1	11027904
en@@	O	-1	11027904
g@@	O	-1	11027904
ing	O	-1	11027904
clinical	O	-1	11027904
t@@	O	-1	11027904
as@@	O	-1	11027904
k@@	O	-1	11027904
,	O	-1	11027904
in	O	-1	11027904
par@@	O	-1	11027904
t	O	-1	11027904
because	O	-1	11027904
lit@@	O	-1	11027904
t@@	O	-1	11027904
le	O	-1	11027904
is	O	-1	11027904
known	O	-1	11027904
about	O	-1	11027904
their	O	-1	11027904
pain	B-Disease	D010146	11027904
experi@@	O	-1	11027904
ence	O	-1	11027904
and	O	-1	11027904
analge@@	O	-1	11027904
sic	O	-1	11027904
requ@@	O	-1	11027904
i@@	O	-1	11027904
re@@	O	-1	11027904
ment@@	O	-1	11027904
s.	O	-1	11027904
This	O	-1	11027904
study	O	-1	11027904
was	O	-1	11027904
de@@	O	-1	11027904
signed	O	-1	11027904
to	O	-1	11027904
describe	O	-1	11027904
pain	B-Disease	D010146	11027904
toler@@	O	-1	11027904
ance	O	-1	11027904
and	O	-1	11027904
analge@@	O	-1	11027904
sic	O	-1	11027904
response	O	-1	11027904
in	O	-1	11027904
a	O	-1	11027904
sam@@	O	-1	11027904
ple	O	-1	11027904
of	O	-1	11027904
o@@	B-Disease	D009293	11027904
pi@@	I-Disease	-1	11027904
oid	I-Disease	-1	11027904
ad@@	I-Disease	-1	11027904
dic@@	I-Disease	-1	11027904
ts	I-Disease	-1	11027904
st@@	O	-1	11027904
abil@@	O	-1	11027904
ized	O	-1	11027904
in	O	-1	11027904
meth@@	B-Chemical	D008691	11027904
ad@@	I-Chemical	-1	11027904
one	I-Chemical	-1	11027904
-@@	O	-1	11027904
maint@@	O	-1	11027904
en@@	O	-1	11027904
ance	O	-1	11027904
(@@	O	-1	11027904
M@@	O	-1	11027904
M@@	O	-1	11027904
)	O	-1	11027904
treatment	O	-1	11027904
(n	O	-1	11027904
=	O	-1	11027904
6@@	O	-1	11027904
0@@	O	-1	11027904
)	O	-1	11027904
in	O	-1	11027904
compar@@	O	-1	11027904
ison	O	-1	11027904
to	O	-1	11027904
mat@@	O	-1	11027904
ch@@	O	-1	11027904
ed	O	-1	11027904
non@@	O	-1	11027904
dependent	O	-1	11027904
control	O	-1	11027904
subjects	O	-1	11027904
(n	O	-1	11027904
=	O	-1	11027904
6@@	O	-1	11027904
0@@	O	-1	11027904
).	O	-1	11027904
B@@	O	-1	11027904
y	O	-1	11027904
using	O	-1	11027904
a	O	-1	11027904
placebo@@	O	-1	11027904
-@@	O	-1	11027904
control@@	O	-1	11027904
le@@	O	-1	11027904
d,	O	-1	11027904
tw@@	O	-1	11027904
o@@	O	-1	11027904
-@@	O	-1	11027904
w@@	O	-1	11027904
ay	O	-1	11027904
fact@@	O	-1	11027904
or@@	O	-1	11027904
ial	O	-1	11027904
de@@	O	-1	11027904
sign@@	O	-1	11027904
,	O	-1	11027904
toler@@	O	-1	11027904
ance	O	-1	11027904
to	O	-1	11027904
co@@	O	-1	11027904
l@@	O	-1	11027904
d-@@	O	-1	11027904
press@@	O	-1	11027904
or	O	-1	11027904
(C@@	O	-1	11027904
P)	O	-1	11027904
pain	B-Disease	D010146	11027904
was	O	-1	11027904
ex@@	O	-1	11027904
am@@	O	-1	11027904
ine@@	O	-1	11027904
d,	O	-1	11027904
both	O	-1	11027904
before	O	-1	11027904
and	O	-1	11027904
after	O	-1	11027904
oral	O	-1	11027904
administration	O	-1	11027904
of	O	-1	11027904
therapeutic	O	-1	11027904
doses	O	-1	11027904
of	O	-1	11027904
common	O	-1	11027904
o@@	O	-1	11027904
pi@@	O	-1	11027904
oid	O	-1	11027904
(	O	-1	11027904
hydro@@	B-Chemical	D004091	11027904
morph@@	I-Chemical	-1	11027904
one	I-Chemical	-1	11027904
2	O	-1	11027904
mg@@	O	-1	11027904
)	O	-1	11027904
and	O	-1	11027904
non@@	O	-1	11027904
steroid@@	O	-1	11027904
al	O	-1	11027904
anti@@	O	-1	11027904
-@@	O	-1	11027904
inflam@@	O	-1	11027904
mat@@	O	-1	11027904
ory	O	-1	11027904
(	O	-1	11027904
ke@@	B-Chemical	D020910	11027904
to@@	I-Chemical	-1	11027904
ro@@	I-Chemical	-1	11027904
l@@	I-Chemical	-1	11027904
a@@	I-Chemical	-1	11027904
c	I-Chemical	-1	11027904
10	O	-1	11027904
mg@@	O	-1	11027904
)	O	-1	11027904
analge@@	O	-1	11027904
sic	O	-1	11027904
agent@@	O	-1	11027904
s.	O	-1	11027904
R@@	O	-1	11027904
es@@	O	-1	11027904
ult@@	O	-1	11027904
s	O	-1	11027904
showed	O	-1	11027904
that	O	-1	11027904
M@@	O	-1	11027904
M	O	-1	11027904
individ@@	O	-1	11027904
u@@	O	-1	11027904
als	O	-1	11027904
were	O	-1	11027904
significantly	O	-1	11027904
less	O	-1	11027904
toler@@	O	-1	11027904
ant	O	-1	11027904
of	O	-1	11027904
C@@	O	-1	11027904
P	O	-1	11027904
pain	B-Disease	D010146	11027904
than	O	-1	11027904
control	O	-1	11027904
subj@@	O	-1	11027904
ect@@	O	-1	11027904
s,	O	-1	11027904
re@@	O	-1	11027904
plic@@	O	-1	11027904
ating	O	-1	11027904
previ@@	O	-1	11027904
ous	O	-1	11027904
wor@@	O	-1	11027904
k@@	O	-1	11027904
.	O	-1	11027904
An@@	O	-1	11027904
alge@@	O	-1	11027904
sic	O	-1	11027904
effects	O	-1	11027904
were	O	-1	11027904
significant	O	-1	11027904
ne@@	O	-1	11027904
ither	O	-1	11027904
for	O	-1	11027904
medic@@	O	-1	11027904
ation	O	-1	11027904
n@@	O	-1	11027904
or	O	-1	11027904
group.	O	-1	11027904
These	O	-1	11027904
data	O	-1	11027904
indicate	O	-1	11027904
that	O	-1	11027904
M@@	O	-1	11027904
M	O	-1	11027904
o@@	O	-1	11027904
pi@@	O	-1	11027904
oid	O	-1	11027904
ab@@	O	-1	11027904
users	O	-1	11027904
re@@	O	-1	11027904
present	O	-1	11027904
a	O	-1	11027904
pa@@	B-Disease	D006930	11027904
in-@@	I-Disease	-1	11027904
int@@	I-Disease	-1	11027904
oler@@	I-Disease	-1	11027904
ant	I-Disease	-1	11027904
sub@@	O	-1	11027904
set	O	-1	11027904
of	O	-1	11027904
clinical	O	-1	11027904
patients.	O	-1	11027904
The@@	O	-1	11027904
ir	O	-1	11027904
com@@	O	-1	11027904
pl@@	O	-1	11027904
a@@	O	-1	11027904
int@@	O	-1	11027904
s	O	-1	11027904
of	O	-1	11027904
pain	B-Disease	D010146	11027904
should	O	-1	11027904
be	O	-1	11027904
evaluated	O	-1	11027904
seri@@	O	-1	11027904
ously	O	-1	11027904
and	O	-1	11027904
man@@	O	-1	11027904
aged	O	-1	11027904
ag@@	O	-1	11027904
gres@@	O	-1	11027904
si@@	O	-1	11027904
vel@@	O	-1	11027904
y.	O	-1	11027904

U@@	O	-1	10193809
rine	O	-1	10193809
N@@	O	-1	10193809
-@@	O	-1	10193809
acet@@	O	-1	10193809
yl@@	O	-1	10193809
-@@	O	-1	10193809
beta-@@	O	-1	10193809
D-@@	O	-1	10193809
g@@	O	-1	10193809
lu@@	O	-1	10193809
co@@	O	-1	10193809
s@@	O	-1	10193809
amin@@	O	-1	10193809
id@@	O	-1	10193809
as@@	O	-1	10193809
e-@@	O	-1	10193809
-@@	O	-1	10193809
a	O	-1	10193809
mark@@	O	-1	10193809
er	O	-1	10193809
of	O	-1	10193809
tub@@	O	-1	10193809
ular	O	-1	10193809
dam@@	O	-1	10193809
ag@@	O	-1	10193809
e@@	O	-1	10193809
?	O	-1	10193809
BACKGROUND:	O	-1	10193809
Although	O	-1	10193809
an	O	-1	10193809
indic@@	O	-1	10193809
at@@	O	-1	10193809
or	O	-1	10193809
of	O	-1	10193809
renal	B-Disease	D005198	10193809
tub@@	I-Disease	-1	10193809
ular	I-Disease	-1	10193809
dysfunction	I-Disease	-1	10193809
,	O	-1	10193809
an	O	-1	10193809
increased	O	-1	10193809
urinary	O	-1	10193809
N@@	O	-1	10193809
-@@	O	-1	10193809
acet@@	O	-1	10193809
yl@@	O	-1	10193809
-@@	O	-1	10193809
beta-@@	O	-1	10193809
D-@@	O	-1	10193809
g@@	O	-1	10193809
lu@@	O	-1	10193809
co@@	O	-1	10193809
s@@	O	-1	10193809
amin@@	O	-1	10193809
id@@	O	-1	10193809
ase	O	-1	10193809
(N@@	O	-1	10193809
A@@	O	-1	10193809
G@@	O	-1	10193809
)	O	-1	10193809
activity	O	-1	10193809
might	O	-1	10193809
ref@@	O	-1	10193809
l@@	O	-1	10193809
ect	O	-1	10193809
increased	O	-1	10193809
l@@	O	-1	10193809
ys@@	O	-1	10193809
os@@	O	-1	10193809
om@@	O	-1	10193809
al	O	-1	10193809
activity	O	-1	10193809
in	O	-1	10193809
renal	O	-1	10193809
tub@@	O	-1	10193809
ular	O	-1	10193809
cell@@	O	-1	10193809
s.	O	-1	10193809
METHODS:	O	-1	10193809
P@@	B-Chemical	D011692	10193809
uro@@	I-Chemical	-1	10193809
m@@	I-Chemical	-1	10193809
ycin	I-Chemical	-1	10193809
amin@@	I-Chemical	-1	10193809
on@@	I-Chemical	-1	10193809
ucle@@	I-Chemical	-1	10193809
o@@	I-Chemical	-1	10193809
side	I-Chemical	-1	10193809
(	O	-1	10193809
PA@@	B-Chemical	D011692	10193809
N	I-Chemical	-1	10193809
)	O	-1	10193809
was	O	-1	10193809
administered	O	-1	10193809
to	O	-1	10193809
S@@	O	-1	10193809
pra@@	O	-1	10193809
gu@@	O	-1	10193809
e	O	-1	10193809
D@@	O	-1	10193809
aw@@	O	-1	10193809
le@@	O	-1	10193809
y	O	-1	10193809
rats	O	-1	10193809
to	O	-1	10193809
induce	O	-1	10193809
proteinuria	B-Disease	D011507	10193809
.	O	-1	10193809
T@@	O	-1	10193809
ot@@	O	-1	10193809
al	O	-1	10193809
protein@@	O	-1	10193809
,	O	-1	10193809
al@@	O	-1	10193809
bu@@	O	-1	10193809
min@@	O	-1	10193809
,	O	-1	10193809
N@@	O	-1	10193809
A@@	O	-1	10193809
G	O	-1	10193809
activity	O	-1	10193809
and	O	-1	10193809
protein	O	-1	10193809
electro@@	O	-1	10193809
ph@@	O	-1	10193809
ore@@	O	-1	10193809
tic	O	-1	10193809
pat@@	O	-1	10193809
ter@@	O	-1	10193809
n	O	-1	10193809
were	O	-1	10193809
assessed	O	-1	10193809
in	O	-1	10193809
daily	O	-1	10193809
urine	O	-1	10193809
sam@@	O	-1	10193809
ple@@	O	-1	10193809
s	O	-1	10193809
for	O	-1	10193809
3@@	O	-1	10193809
3	O	-1	10193809
days.	O	-1	10193809
The	O	-1	10193809
morph@@	O	-1	10193809
ological	O	-1	10193809
appear@@	O	-1	10193809
ance	O	-1	10193809
of	O	-1	10193809
the	O	-1	10193809
kidne@@	O	-1	10193809
ys	O	-1	10193809
was	O	-1	10193809
examined	O	-1	10193809
on	O	-1	10193809
days	O	-1	10193809
th@@	O	-1	10193809
re@@	O	-1	10193809
e,	O	-1	10193809
fo@@	O	-1	10193809
ur@@	O	-1	10193809
,	O	-1	10193809
si@@	O	-1	10193809
x@@	O	-1	10193809
,	O	-1	10193809
e@@	O	-1	10193809
ight	O	-1	10193809
and	O	-1	10193809
thir@@	O	-1	10193809
t@@	O	-1	10193809
y	O	-1	10193809
three	O	-1	10193809
and	O	-1	10193809
the	O	-1	10193809
N@@	O	-1	10193809
A@@	O	-1	10193809
G	O	-1	10193809
iso@@	O	-1	10193809
enzyme	O	-1	10193809
pat@@	O	-1	10193809
tern@@	O	-1	10193809
s	O	-1	10193809
on	O	-1	10193809
days	O	-1	10193809
z@@	O	-1	10193809
ero@@	O	-1	10193809
,	O	-1	10193809
fo@@	O	-1	10193809
ur@@	O	-1	10193809
,	O	-1	10193809
e@@	O	-1	10193809
ight	O	-1	10193809
and	O	-1	10193809
thir@@	O	-1	10193809
t@@	O	-1	10193809
y	O	-1	10193809
th@@	O	-1	10193809
re@@	O	-1	10193809
e.	O	-1	10193809
RESULTS:	O	-1	10193809
F@@	O	-1	10193809
ol@@	O	-1	10193809
low@@	O	-1	10193809
ing	O	-1	10193809
intravenous	O	-1	10193809
PA@@	B-Chemical	D011692	10193809
N	I-Chemical	-1	10193809
urine	O	-1	10193809
volume	O	-1	10193809
and	O	-1	10193809
urine	O	-1	10193809
N@@	O	-1	10193809
A@@	O	-1	10193809
G	O	-1	10193809
activity	O	-1	10193809
increased	O	-1	10193809
significantly	O	-1	10193809
by	O	-1	10193809
day	O	-1	10193809
tw@@	O	-1	10193809
o@@	O	-1	10193809
,	O	-1	10193809
but	O	-1	10193809
retur@@	O	-1	10193809
n@@	O	-1	10193809
ed	O	-1	10193809
to	O	-1	10193809
normal	O	-1	10193809
by	O	-1	10193809
day	O	-1	10193809
fo@@	O	-1	10193809
ur@@	O	-1	10193809
.	O	-1	10193809
After	O	-1	10193809
day	O	-1	10193809
four	O	-1	10193809
all	O	-1	10193809
treated	O	-1	10193809
animals	O	-1	10193809
ex@@	O	-1	10193809
hib@@	O	-1	10193809
ited	O	-1	10193809
a	O	-1	10193809
mark@@	O	-1	10193809
ed	O	-1	10193809
ri@@	O	-1	10193809
se	O	-1	10193809
in	O	-1	10193809
urine	O	-1	10193809
al@@	O	-1	10193809
bu@@	O	-1	10193809
min@@	O	-1	10193809
,	O	-1	10193809
total	O	-1	10193809
protein	O	-1	10193809
ex@@	O	-1	10193809
cre@@	O	-1	10193809
tion	O	-1	10193809
and	O	-1	10193809
N@@	O	-1	10193809
A@@	O	-1	10193809
G	O	-1	10193809
activ@@	O	-1	10193809
ity.	O	-1	10193809
E@@	O	-1	10193809
l@@	O	-1	10193809
ect@@	O	-1	10193809
ro@@	O	-1	10193809
ph@@	O	-1	10193809
ore@@	O	-1	10193809
sis	O	-1	10193809
showed	O	-1	10193809
a	O	-1	10193809
gener@@	O	-1	10193809
al@@	O	-1	10193809
is@@	O	-1	10193809
ed	O	-1	10193809
increase	O	-1	10193809
in	O	-1	10193809
mid@@	O	-1	10193809
d@@	O	-1	10193809
le	O	-1	10193809
and	O	-1	10193809
high	O	-1	10193809
mol@@	O	-1	10193809
ec@@	O	-1	10193809
ular	O	-1	10193809
weight	O	-1	10193809
urine	O	-1	10193809
protein@@	O	-1	10193809
s	O	-1	10193809
from	O	-1	10193809
day	O	-1	10193809
four	O	-1	10193809
on@@	O	-1	10193809
war@@	O	-1	10193809
d@@	O	-1	10193809
s.	O	-1	10193809
Pro@@	O	-1	10193809
te@@	O	-1	10193809
in	O	-1	10193809
dro@@	O	-1	10193809
ple@@	O	-1	10193809
ts	O	-1	10193809
first	O	-1	10193809
appe@@	O	-1	10193809
a@@	O	-1	10193809
red	O	-1	10193809
pro@@	O	-1	10193809
min@@	O	-1	10193809
ent	O	-1	10193809
in	O	-1	10193809
tub@@	O	-1	10193809
ular	O	-1	10193809
cells	O	-1	10193809
on	O	-1	10193809
day	O	-1	10193809
fo@@	O	-1	10193809
ur@@	O	-1	10193809
.	O	-1	10193809
P@@	O	-1	10193809
e@@	O	-1	10193809
a@@	O	-1	10193809
k	O	-1	10193809
urine	O	-1	10193809
N@@	O	-1	10193809
A@@	O	-1	10193809
G	O	-1	10193809
activity	O	-1	10193809
and	O	-1	10193809
a	O	-1	10193809
change	O	-1	10193809
in	O	-1	10193809
N@@	O	-1	10193809
A@@	O	-1	10193809
G	O	-1	10193809
iso@@	O	-1	10193809
enzyme	O	-1	10193809
pat@@	O	-1	10193809
ter@@	O	-1	10193809
n	O	-1	10193809
co@@	O	-1	10193809
inc@@	O	-1	10193809
id@@	O	-1	10193809
ed	O	-1	10193809
with	O	-1	10193809
both	O	-1	10193809
the	O	-1	10193809
pe@@	O	-1	10193809
a@@	O	-1	10193809
k	O	-1	10193809
proteinuria	B-Disease	D011507	10193809
and	O	-1	10193809
the	O	-1	10193809
reduction	O	-1	10193809
in	O	-1	10193809
intrac@@	O	-1	10193809
ell@@	O	-1	10193809
ular	O	-1	10193809
protein	O	-1	10193809
and	O	-1	10193809
N@@	O	-1	10193809
A@@	O	-1	10193809
G	O	-1	10193809
dro@@	O	-1	10193809
ple@@	O	-1	10193809
ts	O	-1	10193809
(@@	O	-1	10193809
day	O	-1	10193809
six	O	-1	10193809
on@@	O	-1	10193809
war@@	O	-1	10193809
d@@	O	-1	10193809
s@@	O	-1	10193809
).	O	-1	10193809
CONCLUSIONS:	O	-1	10193809
This	O	-1	10193809
anim@@	O	-1	10193809
al	O	-1	10193809
model	O	-1	10193809
demon@@	O	-1	10193809
strat@@	O	-1	10193809
es	O	-1	10193809
that	O	-1	10193809
an	O	-1	10193809
increase	O	-1	10193809
in	O	-1	10193809
l@@	O	-1	10193809
ys@@	O	-1	10193809
os@@	O	-1	10193809
om@@	O	-1	10193809
al	O	-1	10193809
t@@	O	-1	10193809
ur@@	O	-1	10193809
no@@	O	-1	10193809
ver	O	-1	10193809
and	O	-1	10193809
h@@	O	-1	10193809
ence	O	-1	10193809
urine	O	-1	10193809
N@@	O	-1	10193809
A@@	O	-1	10193809
G	O	-1	10193809
activ@@	O	-1	10193809
ity,	O	-1	10193809
occur@@	O	-1	10193809
s	O	-1	10193809
when	O	-1	10193809
increased	O	-1	10193809
protein	O	-1	10193809
is	O	-1	10193809
presented	O	-1	10193809
to	O	-1	10193809
the	O	-1	10193809
tub@@	O	-1	10193809
ular	O	-1	10193809
cell@@	O	-1	10193809
s.	O	-1	10193809
U@@	O	-1	10193809
rine	O	-1	10193809
N@@	O	-1	10193809
A@@	O	-1	10193809
G	O	-1	10193809
activity	O	-1	10193809
is	O	-1	10193809
th@@	O	-1	10193809
us	O	-1	10193809
a	O	-1	10193809
meas@@	O	-1	10193809
ure	O	-1	10193809
of	O	-1	10193809
al@@	O	-1	10193809
te@@	O	-1	10193809
red	O	-1	10193809
function	O	-1	10193809
in	O	-1	10193809
the	O	-1	10193809
renal	O	-1	10193809
tub@@	O	-1	10193809
ul@@	O	-1	10193809
es	O	-1	10193809
and	O	-1	10193809
not	O	-1	10193809
sim@@	O	-1	10193809
p@@	O	-1	10193809
ly	O	-1	10193809
an	O	-1	10193809
indic@@	O	-1	10193809
at@@	O	-1	10193809
or	O	-1	10193809
of	O	-1	10193809
dam@@	O	-1	10193809
age.	O	-1	10193809

O@@	O	-1	9214597
ver	O	-1	9214597
expression	O	-1	9214597
of	O	-1	9214597
vascular	O	-1	9214597
endothelial	O	-1	9214597
growth	O	-1	9214597
factor	O	-1	9214597
and	O	-1	9214597
its	O	-1	9214597
receptor	O	-1	9214597
during	O	-1	9214597
the	O	-1	9214597
development	O	-1	9214597
of	O	-1	9214597
est@@	B-Chemical	D004967	9214597
ro@@	I-Chemical	-1	9214597
gen	I-Chemical	-1	9214597
-induced	O	-1	9214597
rat	O	-1	9214597
pit@@	B-Disease	D010911	9214597
u@@	I-Disease	-1	9214597
it@@	I-Disease	-1	9214597
ary	I-Disease	-1	9214597
tu@@	I-Disease	-1	9214597
mor@@	I-Disease	-1	9214597
s	I-Disease	-1	9214597
may	O	-1	9214597
medi@@	O	-1	9214597
ate	O	-1	9214597
est@@	B-Chemical	D004967	9214597
ro@@	I-Chemical	-1	9214597
gen	I-Chemical	-1	9214597
-@@	O	-1	9214597
initi@@	O	-1	9214597
ated	O	-1	9214597
tumor	B-Disease	D009369	9214597
angio@@	O	-1	9214597
gene@@	O	-1	9214597
sis.	O	-1	9214597
E@@	B-Chemical	D004967	9214597
stro@@	I-Chemical	-1	9214597
gen@@	I-Chemical	-1	9214597
s	I-Chemical	-1	9214597
,	O	-1	9214597
which	O	-1	9214597
have	O	-1	9214597
been	O	-1	9214597
associated	O	-1	9214597
with	O	-1	9214597
several	O	-1	9214597
typ@@	O	-1	9214597
es	O	-1	9214597
of	O	-1	9214597
human	O	-1	9214597
and	O	-1	9214597
anim@@	O	-1	9214597
al	O	-1	9214597
canc@@	B-Disease	D009369	9214597
ers	I-Disease	-1	9214597
,	O	-1	9214597
can	O	-1	9214597
induce	O	-1	9214597
tumor	B-Disease	D009369	9214597
angio@@	O	-1	9214597
genesis	O	-1	9214597
in	O	-1	9214597
the	O	-1	9214597
pit@@	O	-1	9214597
u@@	O	-1	9214597
it@@	O	-1	9214597
ary	O	-1	9214597
of	O	-1	9214597
F@@	O	-1	9214597
is@@	O	-1	9214597
ch@@	O	-1	9214597
er	O	-1	9214597
34@@	O	-1	9214597
4	O	-1	9214597
rats.	O	-1	9214597
The	O	-1	9214597
mechanis@@	O	-1	9214597
tic	O	-1	9214597
det@@	O	-1	9214597
ail@@	O	-1	9214597
s	O	-1	9214597
of	O	-1	9214597
tumor	B-Disease	D009369	9214597
angio@@	O	-1	9214597
genesis	O	-1	9214597
induc@@	O	-1	9214597
tion,	O	-1	9214597
during	O	-1	9214597
est@@	B-Chemical	D004967	9214597
ro@@	I-Chemical	-1	9214597
gen	I-Chemical	-1	9214597
carcino@@	B-Disease	D063646	9214597
genesis	I-Disease	-1	9214597
,	O	-1	9214597
are	O	-1	9214597
sti@@	O	-1	9214597
ll	O	-1	9214597
un@@	O	-1	9214597
know@@	O	-1	9214597
n@@	O	-1	9214597
.	O	-1	9214597
To	O	-1	9214597
el@@	O	-1	9214597
uc@@	O	-1	9214597
id@@	O	-1	9214597
ate	O	-1	9214597
the	O	-1	9214597
role	O	-1	9214597
of	O	-1	9214597
est@@	B-Chemical	D004967	9214597
ro@@	I-Chemical	-1	9214597
gen	I-Chemical	-1	9214597
in	O	-1	9214597
the	O	-1	9214597
reg@@	O	-1	9214597
ulation	O	-1	9214597
of	O	-1	9214597
tumor	B-Disease	D009369	9214597
angio@@	O	-1	9214597
genesis	O	-1	9214597
in	O	-1	9214597
the	O	-1	9214597
pit@@	O	-1	9214597
u@@	O	-1	9214597
it@@	O	-1	9214597
ary	O	-1	9214597
of	O	-1	9214597
female	O	-1	9214597
rats,	O	-1	9214597
the	O	-1	9214597
d@@	O	-1	9214597
ensity	O	-1	9214597
of	O	-1	9214597
blood	O	-1	9214597
v@@	O	-1	9214597
es@@	O	-1	9214597
sel@@	O	-1	9214597
s	O	-1	9214597
was	O	-1	9214597
an@@	O	-1	9214597
al@@	O	-1	9214597
ys@@	O	-1	9214597
ed	O	-1	9214597
using	O	-1	9214597
factor	O	-1	9214597
V@@	O	-1	9214597
I@@	O	-1	9214597
II	O	-1	9214597
related	O	-1	9214597
anti@@	O	-1	9214597
gen	O	-1	9214597
(@@	O	-1	9214597
F@@	O	-1	9214597
V@@	O	-1	9214597
II@@	O	-1	9214597
I@@	O	-1	9214597
R@@	O	-1	9214597
A@@	O	-1	9214597
g@@	O	-1	9214597
)	O	-1	9214597
immuno@@	O	-1	9214597
histo@@	O	-1	9214597
chem@@	O	-1	9214597
ist@@	O	-1	9214597
r@@	O	-1	9214597
y	O	-1	9214597
and	O	-1	9214597
the	O	-1	9214597
expression	O	-1	9214597
of	O	-1	9214597
vascular	O	-1	9214597
endothelial	O	-1	9214597
growth	O	-1	9214597
fact@@	O	-1	9214597
or@@	O	-1	9214597
/@@	O	-1	9214597
vascular	O	-1	9214597
per@@	O	-1	9214597
me@@	O	-1	9214597
ability	O	-1	9214597
factor	O	-1	9214597
(V@@	O	-1	9214597
E@@	O	-1	9214597
GF@@	O	-1	9214597
/@@	O	-1	9214597
V@@	O	-1	9214597
P@@	O	-1	9214597
F@@	O	-1	9214597
)	O	-1	9214597
was	O	-1	9214597
examined	O	-1	9214597
by	O	-1	9214597
W@@	O	-1	9214597
est@@	O	-1	9214597
er@@	O	-1	9214597
n	O	-1	9214597
blo@@	O	-1	9214597
t	O	-1	9214597
and	O	-1	9214597
immuno@@	O	-1	9214597
histo@@	O	-1	9214597
chemical	O	-1	9214597
analy@@	O	-1	9214597
sis.	O	-1	9214597
The	O	-1	9214597
expression	O	-1	9214597
of	O	-1	9214597
V@@	O	-1	9214597
E@@	O	-1	9214597
G@@	O	-1	9214597
F	O	-1	9214597
receptor	O	-1	9214597
(V@@	O	-1	9214597
E@@	O	-1	9214597
GF@@	O	-1	9214597
R@@	O	-1	9214597
-@@	O	-1	9214597
2@@	O	-1	9214597
/@@	O	-1	9214597
F@@	O	-1	9214597
l@@	O	-1	9214597
k@@	O	-1	9214597
-1@@	O	-1	9214597
/@@	O	-1	9214597
K@@	O	-1	9214597
D@@	O	-1	9214597
R@@	O	-1	9214597
)	O	-1	9214597
was	O	-1	9214597
also	O	-1	9214597
examined	O	-1	9214597
by	O	-1	9214597
immuno@@	O	-1	9214597
histo@@	O	-1	9214597
chem@@	O	-1	9214597
ist@@	O	-1	9214597
r@@	O	-1	9214597
y.	O	-1	9214597
The	O	-1	9214597
results	O	-1	9214597
demonstrated	O	-1	9214597
that	O	-1	9214597
17@@	B-Chemical	D004958	9214597
beta-@@	I-Chemical	-1	9214597
est@@	I-Chemical	-1	9214597
radi@@	I-Chemical	-1	9214597
ol	I-Chemical	-1	9214597
(	O	-1	9214597
E@@	B-Chemical	D004958	9214597
2	I-Chemical	-1	9214597
)	O	-1	9214597
induc@@	O	-1	9214597
es	O	-1	9214597
ne@@	O	-1	9214597
o@@	O	-1	9214597
vas@@	O	-1	9214597
cul@@	O	-1	9214597
ar@@	O	-1	9214597
iz@@	O	-1	9214597
ation,	O	-1	9214597
as	O	-1	9214597
well	O	-1	9214597
as	O	-1	9214597
the	O	-1	9214597
growth	O	-1	9214597
and	O	-1	9214597
en@@	O	-1	9214597
larg@@	O	-1	9214597
ement	O	-1	9214597
of	O	-1	9214597
blood	O	-1	9214597
v@@	O	-1	9214597
es@@	O	-1	9214597
sel@@	O	-1	9214597
s	O	-1	9214597
after	O	-1	9214597
7	O	-1	9214597
days	O	-1	9214597
of	O	-1	9214597
expos@@	O	-1	9214597
ure.	O	-1	9214597
The	O	-1	9214597
high	O	-1	9214597
tumor	B-Disease	D009369	9214597
angio@@	O	-1	9214597
genic	O	-1	9214597
potential	O	-1	9214597
was	O	-1	9214597
associated	O	-1	9214597
with	O	-1	9214597
an	O	-1	9214597
elevated	O	-1	9214597
V@@	O	-1	9214597
E@@	O	-1	9214597
GF@@	O	-1	9214597
/@@	O	-1	9214597
V@@	O	-1	9214597
P@@	O	-1	9214597
F	O	-1	9214597
protein	O	-1	9214597
expression	O	-1	9214597
in	O	-1	9214597
the	O	-1	9214597
E@@	B-Chemical	D004958	9214597
2	I-Chemical	-1	9214597
exposed	O	-1	9214597
pit@@	O	-1	9214597
u@@	O	-1	9214597
it@@	O	-1	9214597
ary	O	-1	9214597
of	O	-1	9214597
o@@	O	-1	9214597
vari@@	O	-1	9214597
ect@@	O	-1	9214597
om@@	O	-1	9214597
ized	O	-1	9214597
(@@	O	-1	9214597
O@@	O	-1	9214597
V@@	O	-1	9214597
E@@	O	-1	9214597
X@@	O	-1	9214597
)	O	-1	9214597
rats.	O	-1	9214597
V@@	O	-1	9214597
E@@	O	-1	9214597
GF@@	O	-1	9214597
/@@	O	-1	9214597
V@@	O	-1	9214597
P@@	O	-1	9214597
F	O	-1	9214597
and	O	-1	9214597
F@@	O	-1	9214597
V@@	O	-1	9214597
II@@	O	-1	9214597
I@@	O	-1	9214597
R@@	O	-1	9214597
A@@	O	-1	9214597
g	O	-1	9214597
immuno@@	O	-1	9214597
histo@@	O	-1	9214597
chem@@	O	-1	9214597
ist@@	O	-1	9214597
r@@	O	-1	9214597
y	O	-1	9214597
and	O	-1	9214597
endothelial	O	-1	9214597
specific	O	-1	9214597
l@@	O	-1	9214597
ecti@@	O	-1	9214597
n	O	-1	9214597
(@@	O	-1	9214597
U@@	O	-1	9214597
E@@	O	-1	9214597
A@@	O	-1	9214597
1)	O	-1	9214597
b@@	O	-1	9214597
ind@@	O	-1	9214597
ing	O	-1	9214597
studi@@	O	-1	9214597
es,	O	-1	9214597
indicate	O	-1	9214597
that	O	-1	9214597
the	O	-1	9214597
elev@@	O	-1	9214597
ation	O	-1	9214597
of	O	-1	9214597
V@@	O	-1	9214597
E@@	O	-1	9214597
G@@	O	-1	9214597
F	O	-1	9214597
protein	O	-1	9214597
expression	O	-1	9214597
initi@@	O	-1	9214597
ally	O	-1	9214597
occurred	O	-1	9214597
in	O	-1	9214597
both	O	-1	9214597
blood	O	-1	9214597
v@@	O	-1	9214597
es@@	O	-1	9214597
sel@@	O	-1	9214597
s	O	-1	9214597
and	O	-1	9214597
non-@@	O	-1	9214597
endothelial	O	-1	9214597
cell@@	O	-1	9214597
s.	O	-1	9214597
After	O	-1	9214597
15	O	-1	9214597
days	O	-1	9214597
of	O	-1	9214597
E@@	B-Chemical	D004958	9214597
2	I-Chemical	-1	9214597
expos@@	O	-1	9214597
ure,	O	-1	9214597
V@@	O	-1	9214597
E@@	O	-1	9214597
GF@@	O	-1	9214597
/@@	O	-1	9214597
V@@	O	-1	9214597
P@@	O	-1	9214597
F	O	-1	9214597
protein	O	-1	9214597
ex@@	O	-1	9214597
pres@@	O	-1	9214597
sion,	O	-1	9214597
in	O	-1	9214597
the	O	-1	9214597
non-@@	O	-1	9214597
endothelial	O	-1	9214597
cell	O	-1	9214597
po@@	O	-1	9214597
pul@@	O	-1	9214597
ation,	O	-1	9214597
sh@@	O	-1	9214597
ar@@	O	-1	9214597
p@@	O	-1	9214597
ly	O	-1	9214597
dec@@	O	-1	9214597
lin@@	O	-1	9214597
ed	O	-1	9214597
and	O	-1	9214597
was	O	-1	9214597
re@@	O	-1	9214597
stric@@	O	-1	9214597
ted	O	-1	9214597
to	O	-1	9214597
the	O	-1	9214597
blood	O	-1	9214597
v@@	O	-1	9214597
es@@	O	-1	9214597
sel@@	O	-1	9214597
s.	O	-1	9214597
The	O	-1	9214597
function	O	-1	9214597
of	O	-1	9214597
non-@@	O	-1	9214597
endo@@	O	-1	9214597
the@@	O	-1	9214597
li@@	O	-1	9214597
al@@	O	-1	9214597
-@@	O	-1	9214597
der@@	O	-1	9214597
i@@	O	-1	9214597
ved	O	-1	9214597
V@@	O	-1	9214597
E@@	O	-1	9214597
G@@	O	-1	9214597
F	O	-1	9214597
is	O	-1	9214597
not	O	-1	9214597
clear@@	O	-1	9214597
.	O	-1	9214597
F@@	O	-1	9214597
ur@@	O	-1	9214597
ther@@	O	-1	9214597
mo@@	O	-1	9214597
re,	O	-1	9214597
immuno@@	O	-1	9214597
histo@@	O	-1	9214597
chemical	O	-1	9214597
studies	O	-1	9214597
demonstrated	O	-1	9214597
that	O	-1	9214597
V@@	O	-1	9214597
E@@	O	-1	9214597
GF@@	O	-1	9214597
R@@	O	-1	9214597
-@@	O	-1	9214597
2	O	-1	9214597
(@@	O	-1	9214597
f@@	O	-1	9214597
l@@	O	-1	9214597
k@@	O	-1	9214597
-1@@	O	-1	9214597
/@@	O	-1	9214597
K@@	O	-1	9214597
D@@	O	-1	9214597
R@@	O	-1	9214597
),	O	-1	9214597
expression	O	-1	9214597
was	O	-1	9214597
elevated	O	-1	9214597
significantly	O	-1	9214597
in	O	-1	9214597
the	O	-1	9214597
endothelial	O	-1	9214597
cells	O	-1	9214597
of	O	-1	9214597
micro@@	O	-1	9214597
blood	O	-1	9214597
v@@	O	-1	9214597
es@@	O	-1	9214597
sel@@	O	-1	9214597
s	O	-1	9214597
after	O	-1	9214597
7	O	-1	9214597
days	O	-1	9214597
of	O	-1	9214597
E@@	B-Chemical	D004958	9214597
2	I-Chemical	-1	9214597
expos@@	O	-1	9214597
ure.	O	-1	9214597
These	O	-1	9214597
findings	O	-1	9214597
suggest	O	-1	9214597
that	O	-1	9214597
over	O	-1	9214597
expression	O	-1	9214597
of	O	-1	9214597
V@@	O	-1	9214597
E@@	O	-1	9214597
G@@	O	-1	9214597
F	O	-1	9214597
and	O	-1	9214597
its	O	-1	9214597
receptor	O	-1	9214597
(V@@	O	-1	9214597
E@@	O	-1	9214597
GF@@	O	-1	9214597
R@@	O	-1	9214597
-@@	O	-1	9214597
2)	O	-1	9214597
may	O	-1	9214597
pl@@	O	-1	9214597
ay	O	-1	9214597
an	O	-1	9214597
important	O	-1	9214597
role	O	-1	9214597
in	O	-1	9214597
the	O	-1	9214597
initial	O	-1	9214597
st@@	O	-1	9214597
ep	O	-1	9214597
of	O	-1	9214597
the	O	-1	9214597
reg@@	O	-1	9214597
ulation	O	-1	9214597
of	O	-1	9214597
est@@	B-Chemical	D004967	9214597
ro@@	I-Chemical	-1	9214597
gen	I-Chemical	-1	9214597
induced	O	-1	9214597
tumor	B-Disease	D009369	9214597
angio@@	O	-1	9214597
genesis	O	-1	9214597
in	O	-1	9214597
the	O	-1	9214597
rat	O	-1	9214597
pit@@	O	-1	9214597
u@@	O	-1	9214597
it@@	O	-1	9214597
ar@@	O	-1	9214597
y.	O	-1	9214597

P@@	B-Chemical	D017035	7604176
ra@@	I-Chemical	-1	7604176
vastatin	I-Chemical	-1	7604176
-@@	O	-1	7604176
associated	O	-1	7604176
my@@	B-Disease	D009135	7604176
o@@	I-Disease	-1	7604176
pathy	I-Disease	-1	7604176
.	O	-1	7604176
Re@@	O	-1	7604176
por@@	O	-1	7604176
t	O	-1	7604176
of	O	-1	7604176
a	O	-1	7604176
cas@@	O	-1	7604176
e.	O	-1	7604176
A	O	-1	7604176
case	O	-1	7604176
of	O	-1	7604176
acute	O	-1	7604176
inflam@@	B-Disease	D009220	7604176
mat@@	I-Disease	-1	7604176
ory	I-Disease	-1	7604176
my@@	I-Disease	-1	7604176
o@@	I-Disease	-1	7604176
pathy	I-Disease	-1	7604176
associated	O	-1	7604176
with	O	-1	7604176
the	O	-1	7604176
use	O	-1	7604176
of	O	-1	7604176
pra@@	B-Chemical	D017035	7604176
vastatin	I-Chemical	-1	7604176
,	O	-1	7604176
a	O	-1	7604176
new	O	-1	7604176
hydro@@	O	-1	7604176
ph@@	O	-1	7604176
il@@	O	-1	7604176
ic	O	-1	7604176
3-@@	O	-1	7604176
hydrox@@	O	-1	7604176
y-@@	O	-1	7604176
3	O	-1	7604176
methyl@@	O	-1	7604176
glut@@	O	-1	7604176
ari@@	O	-1	7604176
l	O	-1	7604176
co@@	O	-1	7604176
enzyme	O	-1	7604176
A	O	-1	7604176
reduc@@	O	-1	7604176
t@@	O	-1	7604176
ase	O	-1	7604176
inhibitor@@	O	-1	7604176
,	O	-1	7604176
is	O	-1	7604176
repor@@	O	-1	7604176
ted.	O	-1	7604176
The	O	-1	7604176
patient@@	O	-1	7604176
,	O	-1	7604176
a	O	-1	7604176
6@@	O	-1	7604176
9@@	O	-1	7604176
-@@	O	-1	7604176
year-old	O	-1	7604176
man	O	-1	7604176
was	O	-1	7604176
affected	O	-1	7604176
by	O	-1	7604176
non-@@	B-Disease	D003924	7604176
in@@	I-Disease	-1	7604176
sul@@	I-Disease	-1	7604176
in-@@	I-Disease	-1	7604176
dependent	I-Disease	-1	7604176
dia@@	I-Disease	-1	7604176
bet@@	I-Disease	-1	7604176
es	I-Disease	-1	7604176
me@@	I-Disease	-1	7604176
ll@@	I-Disease	-1	7604176
it@@	I-Disease	-1	7604176
us	I-Disease	-1	7604176
and	O	-1	7604176
hypertension	B-Disease	D006973	7604176
.	O	-1	7604176
H@@	O	-1	7604176
e	O	-1	7604176
as@@	O	-1	7604176
sum@@	O	-1	7604176
ed	O	-1	7604176
pra@@	B-Chemical	D017035	7604176
vastatin	I-Chemical	-1	7604176
(2@@	O	-1	7604176
0	O	-1	7604176
mg/@@	O	-1	7604176
day@@	O	-1	7604176
)	O	-1	7604176
because	O	-1	7604176
of	O	-1	7604176
hyper@@	B-Disease	D006937	7604176
cholester@@	I-Disease	-1	7604176
ol@@	I-Disease	-1	7604176
emia	I-Disease	-1	7604176
.	O	-1	7604176
H@@	O	-1	7604176
e	O	-1	7604176
was	O	-1	7604176
ad@@	O	-1	7604176
mit@@	O	-1	7604176
ted	O	-1	7604176
with	O	-1	7604176
acute	O	-1	7604176
my@@	B-Disease	D009135	7604176
o@@	I-Disease	-1	7604176
pathy	I-Disease	-1	7604176
of	O	-1	7604176
the	O	-1	7604176
lower	O	-1	7604176
lim@@	O	-1	7604176
b@@	O	-1	7604176
s	O	-1	7604176
which	O	-1	7604176
resol@@	O	-1	7604176
ved	O	-1	7604176
in	O	-1	7604176
a	O	-1	7604176
fe@@	O	-1	7604176
w	O	-1	7604176
days	O	-1	7604176
after	O	-1	7604176
pra@@	B-Chemical	D017035	7604176
vastatin	I-Chemical	-1	7604176
discontinu@@	O	-1	7604176
ation.	O	-1	7604176
A	O	-1	7604176
previously	O	-1	7604176
un@@	O	-1	7604176
known	O	-1	7604176
hypo@@	B-Disease	D007037	7604176
th@@	I-Disease	-1	7604176
yro@@	I-Disease	-1	7604176
i@@	I-Disease	-1	7604176
dis@@	I-Disease	-1	7604176
m	I-Disease	-1	7604176
,	O	-1	7604176
prob@@	O	-1	7604176
ably	O	-1	7604176
due	O	-1	7604176
to	O	-1	7604176
chronic	O	-1	7604176
auto@@	B-Disease	D013967	7604176
immun@@	I-Disease	-1	7604176
e	I-Disease	-1	7604176
th@@	I-Disease	-1	7604176
yro@@	I-Disease	-1	7604176
i@@	I-Disease	-1	7604176
di@@	I-Disease	-1	7604176
tis	I-Disease	-1	7604176
,	O	-1	7604176
was	O	-1	7604176
ev@@	O	-1	7604176
id@@	O	-1	7604176
ence@@	O	-1	7604176
d.	O	-1	7604176
M@@	O	-1	7604176
us@@	O	-1	7604176
c@@	O	-1	7604176
le	O	-1	7604176
biop@@	O	-1	7604176
sy	O	-1	7604176
(@@	O	-1	7604176
left	O	-1	7604176
gast@@	O	-1	7604176
ro@@	O	-1	7604176
c@@	O	-1	7604176
ne@@	O	-1	7604176
mi@@	O	-1	7604176
us@@	O	-1	7604176
)	O	-1	7604176
revealed	O	-1	7604176
a	O	-1	7604176
per@@	O	-1	7604176
im@@	O	-1	7604176
ysi@@	O	-1	7604176
al	O	-1	7604176
and	O	-1	7604176
endo@@	O	-1	7604176
my@@	O	-1	7604176
si@@	O	-1	7604176
al	O	-1	7604176
inflam@@	O	-1	7604176
mat@@	O	-1	7604176
ory	O	-1	7604176
inf@@	O	-1	7604176
ilt@@	O	-1	7604176
rate	O	-1	7604176
with	O	-1	7604176
a	O	-1	7604176
prev@@	O	-1	7604176
al@@	O	-1	7604176
ence	O	-1	7604176
of	O	-1	7604176
C@@	O	-1	7604176
D@@	O	-1	7604176
4@@	O	-1	7604176
+	O	-1	7604176
lymph@@	O	-1	7604176
ocy@@	O	-1	7604176
t@@	O	-1	7604176
es.	O	-1	7604176
W@@	O	-1	7604176
h@@	O	-1	7604176
ile	O	-1	7604176
lo@@	B-Chemical	D008148	7604176
vastatin	I-Chemical	-1	7604176
and	O	-1	7604176
sim@@	B-Chemical	D019821	7604176
vastatin	I-Chemical	-1	7604176
have	O	-1	7604176
been	O	-1	7604176
associated	O	-1	7604176
with	O	-1	7604176
toxic	O	-1	7604176
my@@	B-Disease	D009135	7604176
o@@	I-Disease	-1	7604176
pathy	I-Disease	-1	7604176
,	O	-1	7604176
pra@@	B-Chemical	D017035	7604176
vastatin	I-Chemical	-1	7604176
-@@	O	-1	7604176
associated	O	-1	7604176
my@@	B-Disease	D009135	7604176
o@@	I-Disease	-1	7604176
pathy	I-Disease	-1	7604176
could	O	-1	7604176
re@@	O	-1	7604176
present	O	-1	7604176
a	O	-1	7604176
dist@@	O	-1	7604176
inc@@	O	-1	7604176
t,	O	-1	7604176
inflam@@	O	-1	7604176
mat@@	O	-1	7604176
ory	O	-1	7604176
enti@@	O	-1	7604176
t@@	O	-1	7604176
y.	O	-1	7604176

D@@	O	-1	7282516
o@@	O	-1	7282516
se@@	O	-1	7282516
-@@	O	-1	7282516
effect	O	-1	7282516
and	O	-1	7282516
struct@@	O	-1	7282516
ure@@	O	-1	7282516
-@@	O	-1	7282516
function	O	-1	7282516
rel@@	O	-1	7282516
ation@@	O	-1	7282516
shi@@	O	-1	7282516
p@@	O	-1	7282516
s	O	-1	7282516
in	O	-1	7282516
dox@@	B-Chemical	D004317	7282516
orub@@	I-Chemical	-1	7282516
icin	I-Chemical	-1	7282516
cardi@@	B-Disease	D009202	7282516
om@@	I-Disease	-1	7282516
yo@@	I-Disease	-1	7282516
pathy	I-Disease	-1	7282516
.	O	-1	7282516
The	O	-1	7282516
cardi@@	B-Disease	D009202	7282516
om@@	I-Disease	-1	7282516
yo@@	I-Disease	-1	7282516
pathy	I-Disease	-1	7282516
(	O	-1	7282516
C@@	B-Disease	D009202	7282516
M	I-Disease	-1	7282516
)	O	-1	7282516
produced	O	-1	7282516
by	O	-1	7282516
the	O	-1	7282516
anti@@	O	-1	7282516
cancer	O	-1	7282516
drug	O	-1	7282516
dox@@	B-Chemical	D004317	7282516
orub@@	I-Chemical	-1	7282516
icin	I-Chemical	-1	7282516
(	O	-1	7282516
D@@	B-Chemical	D004317	7282516
X@@	I-Chemical	-1	7282516
R	I-Chemical	-1	7282516
)	O	-1	7282516
(	O	-1	7282516
Ad@@	B-Chemical	D004317	7282516
riam@@	I-Chemical	-1	7282516
ycin	I-Chemical	-1	7282516
)	O	-1	7282516
pro@@	O	-1	7282516
vi@@	O	-1	7282516
des	O	-1	7282516
a	O	-1	7282516
un@@	O	-1	7282516
i@@	O	-1	7282516
qu@@	O	-1	7282516
e	O	-1	7282516
op@@	O	-1	7282516
port@@	O	-1	7282516
un@@	O	-1	7282516
ity	O	-1	7282516
to	O	-1	7282516
analy@@	O	-1	7282516
ze	O	-1	7282516
dose-@@	O	-1	7282516
effect	O	-1	7282516
and	O	-1	7282516
struct@@	O	-1	7282516
ure@@	O	-1	7282516
-@@	O	-1	7282516
function	O	-1	7282516
rel@@	O	-1	7282516
ation@@	O	-1	7282516
shi@@	O	-1	7282516
p@@	O	-1	7282516
s	O	-1	7282516
during	O	-1	7282516
development	O	-1	7282516
of	O	-1	7282516
myocardial	B-Disease	D009202	7282516
disease	I-Disease	-1	7282516
.	O	-1	7282516
We	O	-1	7282516
measured	O	-1	7282516
the	O	-1	7282516
de@@	O	-1	7282516
g@@	O	-1	7282516
ree	O	-1	7282516
of	O	-1	7282516
morph@@	O	-1	7282516
ologic	O	-1	7282516
damage	O	-1	7282516
by	O	-1	7282516
ult@@	O	-1	7282516
ra@@	O	-1	7282516
struct@@	O	-1	7282516
ural	O	-1	7282516
examin@@	O	-1	7282516
ation	O	-1	7282516
of	O	-1	7282516
endo@@	O	-1	7282516
myocardial	O	-1	7282516
biop@@	O	-1	7282516
sy	O	-1	7282516
and	O	-1	7282516
the	O	-1	7282516
de@@	O	-1	7282516
g@@	O	-1	7282516
ree	O	-1	7282516
of	O	-1	7282516
perform@@	O	-1	7282516
ance	O	-1	7282516
ab@@	O	-1	7282516
norm@@	O	-1	7282516
ally	O	-1	7282516
by	O	-1	7282516
right	O	-1	7282516
heart	O	-1	7282516
ca@@	O	-1	7282516
the@@	O	-1	7282516
ter@@	O	-1	7282516
ization	O	-1	7282516
in	O	-1	7282516
patients	O	-1	7282516
receiving	O	-1	7282516
D@@	B-Chemical	D004317	7282516
X@@	I-Chemical	-1	7282516
R	I-Chemical	-1	7282516
.	O	-1	7282516
M@@	O	-1	7282516
or@@	O	-1	7282516
ph@@	O	-1	7282516
ologic	O	-1	7282516
damage	O	-1	7282516
was	O	-1	7282516
vari@@	O	-1	7282516
able	O	-1	7282516
but	O	-1	7282516
was	O	-1	7282516
pro@@	O	-1	7282516
por@@	O	-1	7282516
tional	O	-1	7282516
to	O	-1	7282516
the	O	-1	7282516
total	O	-1	7282516
cum@@	O	-1	7282516
ul@@	O	-1	7282516
ative	O	-1	7282516
D@@	B-Chemical	D004317	7282516
X@@	I-Chemical	-1	7282516
R	I-Chemical	-1	7282516
dose	O	-1	7282516
between	O	-1	7282516
100	O	-1	7282516
and	O	-1	7282516
6@@	O	-1	7282516
00	O	-1	7282516
mg/m@@	O	-1	7282516
2@@	O	-1	7282516
.	O	-1	7282516
P@@	O	-1	7282516
er@@	O	-1	7282516
form@@	O	-1	7282516
ance	O	-1	7282516
abnormal@@	O	-1	7282516
ities	O	-1	7282516
cor@@	O	-1	7282516
related	O	-1	7282516
we@@	O	-1	7282516
ak@@	O	-1	7282516
ly	O	-1	7282516
with	O	-1	7282516
dose@@	O	-1	7282516
,	O	-1	7282516
ex@@	O	-1	7282516
hib@@	O	-1	7282516
ited	O	-1	7282516
a	O	-1	7282516
cur@@	O	-1	7282516
v@@	O	-1	7282516
il@@	O	-1	7282516
ine@@	O	-1	7282516
ar	O	-1	7282516
rel@@	O	-1	7282516
ation@@	O	-1	7282516
shi@@	O	-1	7282516
p@@	O	-1	7282516
,	O	-1	7282516
and	O	-1	7282516
had	O	-1	7282516
a	O	-1	7282516
"@@	O	-1	7282516
th@@	O	-1	7282516
res@@	O	-1	7282516
h@@	O	-1	7282516
ol@@	O	-1	7282516
d@@	O	-1	7282516
"	O	-1	7282516
for	O	-1	7282516
ex@@	O	-1	7282516
pres@@	O	-1	7282516
sion.	O	-1	7282516
Ca@@	O	-1	7282516
the@@	O	-1	7282516
ter@@	O	-1	7282516
ization	O	-1	7282516
abnormal@@	O	-1	7282516
ities	O	-1	7282516
cor@@	O	-1	7282516
related	O	-1	7282516
well	O	-1	7282516
with	O	-1	7282516
morph@@	O	-1	7282516
ologic	O	-1	7282516
damage	O	-1	7282516
(@@	O	-1	7282516
r	O	-1	7282516
=	O	-1	7282516
0.@@	O	-1	7282516
5@@	O	-1	7282516
7	O	-1	7282516
to	O	-1	7282516
0.@@	O	-1	7282516
7@@	O	-1	7282516
8@@	O	-1	7282516
)	O	-1	7282516
in	O	-1	7282516
a	O	-1	7282516
sub@@	O	-1	7282516
group	O	-1	7282516
of	O	-1	7282516
patients	O	-1	7282516
in	O	-1	7282516
whom	O	-1	7282516
ex@@	O	-1	7282516
er@@	O	-1	7282516
cis@@	O	-1	7282516
e	O	-1	7282516
hemo@@	O	-1	7282516
dynam@@	O	-1	7282516
ic@@	O	-1	7282516
s	O	-1	7282516
were	O	-1	7282516
meas@@	O	-1	7282516
ure@@	O	-1	7282516
d,	O	-1	7282516
and	O	-1	7282516
this	O	-1	7282516
rel@@	O	-1	7282516
ationship	O	-1	7282516
also	O	-1	7282516
ex@@	O	-1	7282516
hib@@	O	-1	7282516
ited	O	-1	7282516
a	O	-1	7282516
cur@@	O	-1	7282516
v@@	O	-1	7282516
il@@	O	-1	7282516
ine@@	O	-1	7282516
ar@@	O	-1	7282516
,	O	-1	7282516
th@@	O	-1	7282516
res@@	O	-1	7282516
h@@	O	-1	7282516
old	O	-1	7282516
con@@	O	-1	7282516
fi@@	O	-1	7282516
g@@	O	-1	7282516
ur@@	O	-1	7282516
ation.	O	-1	7282516
In	O	-1	7282516
D@@	B-Chemical	D004317	7282516
X@@	I-Chemical	-1	7282516
R	I-Chemical	-1	7282516
-	O	-1	7282516
C@@	B-Disease	D009202	7282516
M	I-Disease	-1	7282516
myocardial	B-Disease	D009202	7282516
damage	I-Disease	-1	7282516
is	O	-1	7282516
pro@@	O	-1	7282516
por@@	O	-1	7282516
tional	O	-1	7282516
to	O	-1	7282516
the	O	-1	7282516
de@@	O	-1	7282516
g@@	O	-1	7282516
ree	O	-1	7282516
of	O	-1	7282516
cy@@	O	-1	7282516
tot@@	O	-1	7282516
ox@@	O	-1	7282516
ic	O	-1	7282516
in@@	O	-1	7282516
s@@	O	-1	7282516
ult	O	-1	7282516
(	O	-1	7282516
D@@	B-Chemical	D004317	7282516
X@@	I-Chemical	-1	7282516
R	I-Chemical	-1	7282516
dose@@	O	-1	7282516
)	O	-1	7282516
while	O	-1	7282516
myocardial	O	-1	7282516
function	O	-1	7282516
is	O	-1	7282516
pres@@	O	-1	7282516
er@@	O	-1	7282516
ved	O	-1	7282516
un@@	O	-1	7282516
ti@@	O	-1	7282516
l	O	-1	7282516
a	O	-1	7282516
cri@@	O	-1	7282516
tical	O	-1	7282516
dose	O	-1	7282516
or	O	-1	7282516
de@@	O	-1	7282516
g@@	O	-1	7282516
ree	O	-1	7282516
of	O	-1	7282516
damage	O	-1	7282516
is	O	-1	7282516
reac@@	O	-1	7282516
he@@	O	-1	7282516
d,	O	-1	7282516
after	O	-1	7282516
which	O	-1	7282516
myocardial	O	-1	7282516
perform@@	O	-1	7282516
ance	O	-1	7282516
deter@@	O	-1	7282516
i@@	O	-1	7282516
or@@	O	-1	7282516
ates	O	-1	7282516
ra@@	O	-1	7282516
pid@@	O	-1	7282516
ly.	O	-1	7282516

F@@	O	-1	7072798
atal	O	-1	7072798
ap@@	B-Disease	D000741	7072798
las@@	I-Disease	-1	7072798
tic	I-Disease	-1	7072798
anemia	I-Disease	-1	7072798
following	O	-1	7072798
to@@	O	-1	7072798
p@@	O	-1	7072798
ical	O	-1	7072798
administration	O	-1	7072798
of	O	-1	7072798
oph@@	O	-1	7072798
thal@@	O	-1	7072798
mic	O	-1	7072798
chlor@@	B-Chemical	D002701	7072798
am@@	I-Chemical	-1	7072798
phen@@	I-Chemical	-1	7072798
ic@@	I-Chemical	-1	7072798
ol	I-Chemical	-1	7072798
.	O	-1	7072798
A	O	-1	7072798
7@@	O	-1	7072798
3-@@	O	-1	7072798
year-old	O	-1	7072798
woman	O	-1	7072798
di@@	O	-1	7072798
ed	O	-1	7072798
of	O	-1	7072798
ap@@	B-Disease	D000741	7072798
las@@	I-Disease	-1	7072798
tic	I-Disease	-1	7072798
anemia	I-Disease	-1	7072798
less	O	-1	7072798
than	O	-1	7072798
two	O	-1	7072798
months	O	-1	7072798
after	O	-1	7072798
under@@	O	-1	7072798
go@@	O	-1	7072798
ing	O	-1	7072798
cat@@	B-Disease	D002386	7072798
arac@@	I-Disease	-1	7072798
t	I-Disease	-1	7072798
extrac@@	O	-1	7072798
tion	O	-1	7072798
and	O	-1	7072798
be@@	O	-1	7072798
g@@	O	-1	7072798
in@@	O	-1	7072798
ning	O	-1	7072798
to@@	O	-1	7072798
p@@	O	-1	7072798
ical	O	-1	7072798
therapy	O	-1	7072798
with	O	-1	7072798
chlor@@	B-Chemical	D002701	7072798
am@@	I-Chemical	-1	7072798
phen@@	I-Chemical	-1	7072798
ic@@	I-Chemical	-1	7072798
ol	I-Chemical	-1	7072798
.	O	-1	7072798
The	O	-1	7072798
first	O	-1	7072798
signs	O	-1	7072798
of	O	-1	7072798
p@@	B-Disease	D010198	7072798
anc@@	I-Disease	-1	7072798
y@@	I-Disease	-1	7072798
to@@	I-Disease	-1	7072798
pen@@	I-Disease	-1	7072798
ia	I-Disease	-1	7072798
be@@	O	-1	7072798
g@@	O	-1	7072798
an	O	-1	7072798
within	O	-1	7072798
one	O	-1	7072798
mon@@	O	-1	7072798
th	O	-1	7072798
of	O	-1	7072798
the	O	-1	7072798
surger@@	O	-1	7072798
y.	O	-1	7072798
The	O	-1	7072798
pat@@	O	-1	7072798
ter@@	O	-1	7072798
n	O	-1	7072798
of	O	-1	7072798
the	O	-1	7072798
ap@@	B-Disease	D000741	7072798
las@@	I-Disease	-1	7072798
tic	I-Disease	-1	7072798
anemia	I-Disease	-1	7072798
was	O	-1	7072798
associated	O	-1	7072798
with	O	-1	7072798
an	O	-1	7072798
i@@	O	-1	7072798
di@@	O	-1	7072798
os@@	O	-1	7072798
yn@@	O	-1	7072798
c@@	O	-1	7072798
r@@	O	-1	7072798
atic	O	-1	7072798
response	O	-1	7072798
to	O	-1	7072798
chlor@@	B-Chemical	D002701	7072798
am@@	I-Chemical	-1	7072798
phen@@	I-Chemical	-1	7072798
ic@@	I-Chemical	-1	7072798
ol	I-Chemical	-1	7072798
.	O	-1	7072798
This	O	-1	7072798
was	O	-1	7072798
the	O	-1	7072798
second	O	-1	7072798
report	O	-1	7072798
of	O	-1	7072798
f@@	O	-1	7072798
atal	O	-1	7072798
ap@@	B-Disease	D000741	7072798
las@@	I-Disease	-1	7072798
tic	I-Disease	-1	7072798
anemia	I-Disease	-1	7072798
after	O	-1	7072798
to@@	O	-1	7072798
p@@	O	-1	7072798
ical	O	-1	7072798
treatment	O	-1	7072798
with	O	-1	7072798
chlor@@	B-Chemical	D002701	7072798
am@@	I-Chemical	-1	7072798
phen@@	I-Chemical	-1	7072798
ic@@	I-Chemical	-1	7072798
ol	I-Chemical	-1	7072798
for	O	-1	7072798
oc@@	O	-1	7072798
ular	O	-1	7072798
condi@@	O	-1	7072798
tion@@	O	-1	7072798
s,	O	-1	7072798
although	O	-1	7072798
two	O	-1	7072798
cases	O	-1	7072798
of	O	-1	7072798
reversible	O	-1	7072798
b@@	B-Disease	D001855	7072798
one	I-Disease	-1	7072798
m@@	I-Disease	-1	7072798
ar@@	I-Disease	-1	7072798
ro@@	I-Disease	-1	7072798
w	I-Disease	-1	7072798
hypo@@	I-Disease	-1	7072798
pl@@	I-Disease	-1	7072798
a@@	I-Disease	-1	7072798
sia	I-Disease	-1	7072798
have	O	-1	7072798
also	O	-1	7072798
been	O	-1	7072798
repor@@	O	-1	7072798
ted.	O	-1	7072798
An@@	O	-1	7072798
y	O	-1	7072798
other	O	-1	7072798
sus@@	O	-1	7072798
p@@	O	-1	7072798
ected	O	-1	7072798
cases	O	-1	7072798
of	O	-1	7072798
oc@@	B-Disease	D005128	7072798
ular	I-Disease	-1	7072798
toxicity	I-Disease	-1	7072798
associated	O	-1	7072798
with	O	-1	7072798
to@@	O	-1	7072798
p@@	O	-1	7072798
ically	O	-1	7072798
ap@@	O	-1	7072798
pl@@	O	-1	7072798
ied	O	-1	7072798
chlor@@	B-Chemical	D002701	7072798
am@@	I-Chemical	-1	7072798
phen@@	I-Chemical	-1	7072798
ic@@	I-Chemical	-1	7072798
ol	I-Chemical	-1	7072798
should	O	-1	7072798
be	O	-1	7072798
reported	O	-1	7072798
to	O	-1	7072798
the	O	-1	7072798
N@@	O	-1	7072798
ation@@	O	-1	7072798
al	O	-1	7072798
Re@@	O	-1	7072798
g@@	O	-1	7072798
ist@@	O	-1	7072798
r@@	O	-1	7072798
y	O	-1	7072798
of	O	-1	7072798
D@@	O	-1	7072798
ru@@	O	-1	7072798
g@@	O	-1	7072798
-@@	O	-1	7072798
In@@	O	-1	7072798
duced	O	-1	7072798
O@@	O	-1	7072798
cular	O	-1	7072798
S@@	O	-1	7072798
ide	O	-1	7072798
Eff@@	O	-1	7072798
ect@@	O	-1	7072798
s,	O	-1	7072798
O@@	O	-1	7072798
reg@@	O	-1	7072798
on	O	-1	7072798
He@@	O	-1	7072798
al@@	O	-1	7072798
th	O	-1	7072798
S@@	O	-1	7072798
ci@@	O	-1	7072798
enc@@	O	-1	7072798
es	O	-1	7072798
U@@	O	-1	7072798
n@@	O	-1	7072798
i@@	O	-1	7072798
ver@@	O	-1	7072798
s@@	O	-1	7072798
ity,	O	-1	7072798
P@@	O	-1	7072798
ort@@	O	-1	7072798
l@@	O	-1	7072798
and@@	O	-1	7072798
,	O	-1	7072798
O@@	O	-1	7072798
R	O	-1	7072798
9@@	O	-1	7072798
7@@	O	-1	7072798
20@@	O	-1	7072798
1@@	O	-1	7072798
.	O	-1	7072798

B@@	B-Disease	D001919	3769769
ra@@	I-Disease	-1	3769769
dy@@	I-Disease	-1	3769769
cardia	I-Disease	-1	3769769
due	O	-1	3769769
to	O	-1	3769769
tri@@	B-Chemical	D014282	3769769
he@@	I-Chemical	-1	3769769
x@@	I-Chemical	-1	3769769
y@@	I-Chemical	-1	3769769
phen@@	I-Chemical	-1	3769769
id@@	I-Chemical	-1	3769769
yl	I-Chemical	-1	3769769
hydro@@	I-Chemical	-1	3769769
chlor@@	I-Chemical	-1	3769769
ide	I-Chemical	-1	3769769
.	O	-1	3769769
A	O	-1	3769769
chronic	O	-1	3769769
sch@@	B-Disease	D012559	3769769
iz@@	I-Disease	-1	3769769
oph@@	I-Disease	-1	3769769
ren@@	I-Disease	-1	3769769
ic	I-Disease	-1	3769769
patient	O	-1	3769769
was	O	-1	3769769
treated	O	-1	3769769
with	O	-1	3769769
an	O	-1	3769769
anti@@	O	-1	3769769
cholinergic	O	-1	3769769
drug@@	O	-1	3769769
,	O	-1	3769769
tri@@	B-Chemical	D014282	3769769
he@@	I-Chemical	-1	3769769
x@@	I-Chemical	-1	3769769
y@@	I-Chemical	-1	3769769
phen@@	I-Chemical	-1	3769769
id@@	I-Chemical	-1	3769769
yl	I-Chemical	-1	3769769
hydro@@	I-Chemical	-1	3769769
chlor@@	I-Chemical	-1	3769769
ide	I-Chemical	-1	3769769
.	O	-1	3769769
The	O	-1	3769769
patient	O	-1	3769769
develop@@	O	-1	3769769
ed,	O	-1	3769769
par@@	O	-1	3769769
ad@@	O	-1	3769769
oxic@@	O	-1	3769769
ally,	O	-1	3769769
s@@	O	-1	3769769
in@@	O	-1	3769769
us	O	-1	3769769
brady@@	B-Disease	D001919	3769769
cardia	I-Disease	-1	3769769
.	O	-1	3769769
The	O	-1	3769769
reaction	O	-1	3769769
was	O	-1	3769769
specific	O	-1	3769769
to	O	-1	3769769
tri@@	B-Chemical	D014282	3769769
he@@	I-Chemical	-1	3769769
x@@	I-Chemical	-1	3769769
y@@	I-Chemical	-1	3769769
phen@@	I-Chemical	-1	3769769
id@@	I-Chemical	-1	3769769
yl	I-Chemical	-1	3769769
and	O	-1	3769769
not	O	-1	3769769
to	O	-1	3769769
other	O	-1	3769769
anti@@	O	-1	3769769
cholinergic	O	-1	3769769
drug@@	O	-1	3769769
s.	O	-1	3769769
This	O	-1	3769769
anti@@	O	-1	3769769
dyskine@@	O	-1	3769769
tic	O	-1	3769769
drug	O	-1	3769769
is	O	-1	3769769
wi@@	O	-1	3769769
de@@	O	-1	3769769
ly	O	-1	3769769
used	O	-1	3769769
in	O	-1	3769769
clinical	O	-1	3769769
psych@@	B-Disease	D001523	3769769
i@@	I-Disease	-1	3769769
atric	I-Disease	-1	3769769
p@@	O	-1	3769769
rac@@	O	-1	3769769
ti@@	O	-1	3769769
ce	O	-1	3769769
and	O	-1	3769769
physi@@	O	-1	3769769
ci@@	O	-1	3769769
ans	O	-1	3769769
should	O	-1	3769769
be	O	-1	3769769
aw@@	O	-1	3769769
are	O	-1	3769769
of	O	-1	3769769
this	O	-1	3769769
side	O	-1	3769769
effect@@	O	-1	3769769
.	O	-1	3769769

E@@	O	-1	3708922
x@@	O	-1	3708922
per@@	O	-1	3708922
im@@	O	-1	3708922
ental	O	-1	3708922
cyclospor@@	B-Chemical	D016572	3708922
ine	I-Chemical	-1	3708922
nephro@@	B-Disease	D007674	3708922
toxicity	I-Disease	-1	3708922
:	O	-1	3708922
risk	O	-1	3708922
of	O	-1	3708922
concomit@@	O	-1	3708922
ant	O	-1	3708922
chemo@@	O	-1	3708922
therapy.	O	-1	3708922
The	O	-1	3708922
role	O	-1	3708922
of	O	-1	3708922
cyclospor@@	B-Chemical	D016572	3708922
ine	I-Chemical	-1	3708922
(	O	-1	3708922
C@@	B-Chemical	D016572	3708922
S@@	I-Chemical	-1	3708922
A	I-Chemical	-1	3708922
)	O	-1	3708922
alone	O	-1	3708922
or	O	-1	3708922
in	O	-1	3708922
combination	O	-1	3708922
with	O	-1	3708922
various	O	-1	3708922
chemo@@	O	-1	3708922
therapeu@@	O	-1	3708922
tics	O	-1	3708922
in	O	-1	3708922
the	O	-1	3708922
development	O	-1	3708922
of	O	-1	3708922
renal	B-Disease	D007674	3708922
toxicity	I-Disease	-1	3708922
was	O	-1	3708922
evaluated	O	-1	3708922
in	O	-1	3708922
rats.	O	-1	3708922
Ad@@	O	-1	3708922
minist@@	O	-1	3708922
ration	O	-1	3708922
of	O	-1	3708922
20	O	-1	3708922
mg/k@@	O	-1	3708922
g/@@	O	-1	3708922
day	O	-1	3708922
C@@	B-Chemical	D016572	3708922
S@@	I-Chemical	-1	3708922
A	I-Chemical	-1	3708922
for	O	-1	3708922
4	O	-1	3708922
weeks	O	-1	3708922
caused	O	-1	3708922
renal	O	-1	3708922
functional	O	-1	3708922
and	O	-1	3708922
struct@@	O	-1	3708922
ural	O	-1	3708922
changes	O	-1	3708922
similar	O	-1	3708922
to	O	-1	3708922
those	O	-1	3708922
reported	O	-1	3708922
in	O	-1	3708922
man@@	O	-1	3708922
.	O	-1	3708922
The	O	-1	3708922
combined	O	-1	3708922
administration	O	-1	3708922
of	O	-1	3708922
C@@	B-Chemical	D016572	3708922
S@@	I-Chemical	-1	3708922
A	I-Chemical	-1	3708922
and	O	-1	3708922
various	O	-1	3708922
chemo@@	O	-1	3708922
therapeutic	O	-1	3708922
drugs	O	-1	3708922
with	O	-1	3708922
a	O	-1	3708922
nephro@@	B-Disease	D007674	3708922
toxic	I-Disease	-1	3708922
potenti@@	O	-1	3708922
al,	O	-1	3708922
such	O	-1	3708922
as	O	-1	3708922
g@@	B-Chemical	D005839	3708922
ent@@	I-Chemical	-1	3708922
am@@	I-Chemical	-1	3708922
icin	I-Chemical	-1	3708922
(@@	O	-1	3708922
at	O	-1	3708922
therapeutic	O	-1	3708922
dos@@	O	-1	3708922
es@@	O	-1	3708922
),	O	-1	3708922
amph@@	B-Chemical	D000666	3708922
o@@	I-Chemical	-1	3708922
ther@@	I-Chemical	-1	3708922
icin	I-Chemical	-1	3708922
B	I-Chemical	-1	3708922
and	O	-1	3708922
ke@@	B-Chemical	D007654	3708922
to@@	I-Chemical	-1	3708922
con@@	I-Chemical	-1	3708922
azole	I-Chemical	-1	3708922
,	O	-1	3708922
which	O	-1	3708922
are	O	-1	3708922
frequ@@	O	-1	3708922
ently	O	-1	3708922
used	O	-1	3708922
in	O	-1	3708922
immunosup@@	O	-1	3708922
press@@	O	-1	3708922
ed	O	-1	3708922
patients,	O	-1	3708922
did	O	-1	3708922
not	O	-1	3708922
ag@@	O	-1	3708922
gra@@	O	-1	3708922
v@@	O	-1	3708922
ate	O	-1	3708922
the	O	-1	3708922
C@@	B-Chemical	D016572	3708922
S@@	I-Chemical	-1	3708922
A	I-Chemical	-1	3708922
induced	O	-1	3708922
toxicity	B-Disease	D064420	3708922
in	O	-1	3708922
the	O	-1	3708922
rat	O	-1	3708922
model@@	O	-1	3708922
.	O	-1	3708922
G@@	B-Chemical	D005839	3708922
ent@@	I-Chemical	-1	3708922
am@@	I-Chemical	-1	3708922
icin	I-Chemical	-1	3708922
at	O	-1	3708922
toxic	O	-1	3708922
dos@@	O	-1	3708922
es,	O	-1	3708922
however,	O	-1	3708922
increased	O	-1	3708922
C@@	B-Chemical	D016572	3708922
S@@	I-Chemical	-1	3708922
A	I-Chemical	-1	3708922
nephro@@	B-Disease	D007674	3708922
toxicity	I-Disease	-1	3708922
.	O	-1	3708922
Th@@	O	-1	3708922
us,	O	-1	3708922
the	O	-1	3708922
nephro@@	B-Disease	D007674	3708922
toxicity	I-Disease	-1	3708922
induced	O	-1	3708922
by	O	-1	3708922
C@@	B-Chemical	D016572	3708922
S@@	I-Chemical	-1	3708922
A	I-Chemical	-1	3708922
has	O	-1	3708922
a	O	-1	3708922
different	O	-1	3708922
path@@	O	-1	3708922
o@@	O	-1	3708922
gene@@	O	-1	3708922
tic	O	-1	3708922
mechanis@@	O	-1	3708922
m.	O	-1	3708922

Rec@@	O	-1	3220106
e@@	O	-1	3220106
pt@@	O	-1	3220106
or	O	-1	3220106
mechanisms	O	-1	3220106
of	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
-induced	O	-1	3220106
locomotor	B-Disease	D006948	3220106
hyperactivity	I-Disease	-1	3220106
in	O	-1	3220106
chronic	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
-treated	O	-1	3220106
rats.	O	-1	3220106
R@@	O	-1	3220106
at@@	O	-1	3220106
s	O	-1	3220106
were	O	-1	3220106
pre@@	O	-1	3220106
treated	O	-1	3220106
with	O	-1	3220106
saline	O	-1	3220106
or	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
(1@@	O	-1	3220106
.@@	O	-1	3220106
5	O	-1	3220106
mg/kg	O	-1	3220106
per	O	-1	3220106
day@@	O	-1	3220106
)	O	-1	3220106
by	O	-1	3220106
sub@@	O	-1	3220106
c@@	O	-1	3220106
ut@@	O	-1	3220106
ane@@	O	-1	3220106
ously	O	-1	3220106
im@@	O	-1	3220106
pl@@	O	-1	3220106
ant@@	O	-1	3220106
ing	O	-1	3220106
each	O	-1	3220106
anim@@	O	-1	3220106
al	O	-1	3220106
with	O	-1	3220106
an	O	-1	3220106
Al@@	O	-1	3220106
z@@	O	-1	3220106
et	O	-1	3220106
os@@	O	-1	3220106
mo@@	O	-1	3220106
tic	O	-1	3220106
min@@	O	-1	3220106
i@@	O	-1	3220106
-@@	O	-1	3220106
p@@	O	-1	3220106
um@@	O	-1	3220106
p	O	-1	3220106
which	O	-1	3220106
continu@@	O	-1	3220106
ously	O	-1	3220106
rele@@	O	-1	3220106
as@@	O	-1	3220106
ed	O	-1	3220106
saline	O	-1	3220106
or	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
for	O	-1	3220106
1,	O	-1	3220106
5	O	-1	3220106
and	O	-1	3220106
14	O	-1	3220106
days.	O	-1	3220106
A@@	O	-1	3220106
t	O	-1	3220106
the	O	-1	3220106
end	O	-1	3220106
of	O	-1	3220106
each	O	-1	3220106
pretreatment	O	-1	3220106
perio@@	O	-1	3220106
d,	O	-1	3220106
animals	O	-1	3220106
were	O	-1	3220106
used	O	-1	3220106
for	O	-1	3220106
(@@	O	-1	3220106
i@@	O	-1	3220106
)	O	-1	3220106
determin@@	O	-1	3220106
ing	O	-1	3220106
their	O	-1	3220106
locomotor	O	-1	3220106
response	O	-1	3220106
to	O	-1	3220106
ac@@	O	-1	3220106
u@@	O	-1	3220106
te@@	O	-1	3220106
ly	O	-1	3220106
injected	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
(0.@@	O	-1	3220106
2	O	-1	3220106
mg/kg@@	O	-1	3220106
,	O	-1	3220106
s@@	O	-1	3220106
.@@	O	-1	3220106
c@@	O	-1	3220106
.)	O	-1	3220106
and	O	-1	3220106
(@@	O	-1	3220106
i@@	O	-1	3220106
i@@	O	-1	3220106
)	O	-1	3220106
meas@@	O	-1	3220106
uring	O	-1	3220106
the	O	-1	3220106
d@@	O	-1	3220106
ensity	O	-1	3220106
of	O	-1	3220106
L-@@	O	-1	3220106
[@@	O	-1	3220106
3@@	O	-1	3220106
H@@	O	-1	3220106
]	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
and	O	-1	3220106
[@@	O	-1	3220106
3@@	O	-1	3220106
H@@	O	-1	3220106
]	O	-1	3220106
s@@	B-Chemical	D013134	3220106
pi@@	I-Chemical	-1	3220106
per@@	I-Chemical	-1	3220106
one	I-Chemical	-1	3220106
b@@	O	-1	3220106
ind@@	O	-1	3220106
ing	O	-1	3220106
sit@@	O	-1	3220106
es	O	-1	3220106
in	O	-1	3220106
the	O	-1	3220106
striat@@	O	-1	3220106
um@@	O	-1	3220106
.	O	-1	3220106
We	O	-1	3220106
observed	O	-1	3220106
no	O	-1	3220106
changes	O	-1	3220106
in	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
-induced	O	-1	3220106
locomotor	O	-1	3220106
respon@@	O	-1	3220106
se@@	O	-1	3220106
,	O	-1	3220106
stri@@	O	-1	3220106
atal	O	-1	3220106
L-@@	O	-1	3220106
[@@	O	-1	3220106
3@@	O	-1	3220106
H@@	O	-1	3220106
]	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
and	O	-1	3220106
[@@	O	-1	3220106
3@@	O	-1	3220106
H@@	O	-1	3220106
]	O	-1	3220106
s@@	B-Chemical	D013134	3220106
pi@@	I-Chemical	-1	3220106
per@@	I-Chemical	-1	3220106
one	I-Chemical	-1	3220106
b@@	O	-1	3220106
ind@@	O	-1	3220106
ing	O	-1	3220106
in	O	-1	3220106
the	O	-1	3220106
animals	O	-1	3220106
pre@@	O	-1	3220106
treated	O	-1	3220106
with	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
for	O	-1	3220106
1	O	-1	3220106
da@@	O	-1	3220106
y.	O	-1	3220106
In	O	-1	3220106
rats	O	-1	3220106
which	O	-1	3220106
were	O	-1	3220106
pre@@	O	-1	3220106
treated	O	-1	3220106
with	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
for	O	-1	3220106
5	O	-1	3220106
day@@	O	-1	3220106
s,	O	-1	3220106
there	O	-1	3220106
was	O	-1	3220106
a	O	-1	3220106
significant	O	-1	3220106
increase	O	-1	3220106
in	O	-1	3220106
the	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
-@@	O	-1	3220106
stimul@@	O	-1	3220106
ated	O	-1	3220106
locomotor	O	-1	3220106
response	O	-1	3220106
which	O	-1	3220106
was	O	-1	3220106
associated	O	-1	3220106
with	O	-1	3220106
an	O	-1	3220106
increase	O	-1	3220106
in	O	-1	3220106
the	O	-1	3220106
number	O	-1	3220106
of	O	-1	3220106
L-@@	O	-1	3220106
[@@	O	-1	3220106
3@@	O	-1	3220106
H@@	O	-1	3220106
]	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
b@@	O	-1	3220106
ind@@	O	-1	3220106
ing	O	-1	3220106
sit@@	O	-1	3220106
es	O	-1	3220106
and	O	-1	3220106
also	O	-1	3220106
with	O	-1	3220106
an	O	-1	3220106
elevated	O	-1	3220106
dopamine	B-Chemical	D004298	3220106
(	O	-1	3220106
D@@	B-Chemical	D004298	3220106
A	I-Chemical	-1	3220106
)	O	-1	3220106
level	O	-1	3220106
in	O	-1	3220106
the	O	-1	3220106
striat@@	O	-1	3220106
um@@	O	-1	3220106
.	O	-1	3220106
The	O	-1	3220106
number	O	-1	3220106
of	O	-1	3220106
stri@@	O	-1	3220106
atal	O	-1	3220106
[@@	O	-1	3220106
3@@	O	-1	3220106
H@@	O	-1	3220106
]	O	-1	3220106
s@@	B-Chemical	D013134	3220106
pi@@	I-Chemical	-1	3220106
per@@	I-Chemical	-1	3220106
one	I-Chemical	-1	3220106
b@@	O	-1	3220106
ind@@	O	-1	3220106
ing	O	-1	3220106
sit@@	O	-1	3220106
es	O	-1	3220106
was	O	-1	3220106
not	O	-1	3220106
aff@@	O	-1	3220106
ect@@	O	-1	3220106
ed.	O	-1	3220106
In	O	-1	3220106
animals	O	-1	3220106
pre@@	O	-1	3220106
treated	O	-1	3220106
with	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
for	O	-1	3220106
14	O	-1	3220106
day@@	O	-1	3220106
s,	O	-1	3220106
the	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
-induced	O	-1	3220106
locomotor	O	-1	3220106
response	O	-1	3220106
remained	O	-1	3220106
to	O	-1	3220106
be	O	-1	3220106
potenti@@	O	-1	3220106
ated.	O	-1	3220106
However,	O	-1	3220106
this	O	-1	3220106
response	O	-1	3220106
was	O	-1	3220106
cor@@	O	-1	3220106
related	O	-1	3220106
with	O	-1	3220106
an	O	-1	3220106
elevated	O	-1	3220106
number	O	-1	3220106
of	O	-1	3220106
stri@@	O	-1	3220106
atal	O	-1	3220106
[@@	O	-1	3220106
3@@	O	-1	3220106
H@@	O	-1	3220106
]	O	-1	3220106
s@@	B-Chemical	D013134	3220106
pi@@	I-Chemical	-1	3220106
per@@	I-Chemical	-1	3220106
one	I-Chemical	-1	3220106
b@@	O	-1	3220106
ind@@	O	-1	3220106
ing	O	-1	3220106
sit@@	O	-1	3220106
es,	O	-1	3220106
whereas	O	-1	3220106
the	O	-1	3220106
number	O	-1	3220106
of	O	-1	3220106
stri@@	O	-1	3220106
atal	O	-1	3220106
L-@@	O	-1	3220106
[@@	O	-1	3220106
3@@	O	-1	3220106
H@@	O	-1	3220106
]	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
b@@	O	-1	3220106
ind@@	O	-1	3220106
ing	O	-1	3220106
sit@@	O	-1	3220106
es	O	-1	3220106
and	O	-1	3220106
the	O	-1	3220106
stri@@	O	-1	3220106
atal	O	-1	3220106
D@@	B-Chemical	D004298	3220106
A	I-Chemical	-1	3220106
level	O	-1	3220106
were	O	-1	3220106
normal@@	O	-1	3220106
.	O	-1	3220106
These	O	-1	3220106
results	O	-1	3220106
suggest	O	-1	3220106
that	O	-1	3220106
chronic	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
-treated	O	-1	3220106
rats	O	-1	3220106
deve@@	O	-1	3220106
lo@@	O	-1	3220106
p	O	-1	3220106
locomotor	B-Disease	D006948	3220106
hyperactivity	I-Disease	-1	3220106
in	O	-1	3220106
response	O	-1	3220106
to	O	-1	3220106
nicotine	B-Chemical	D009538	3220106
initi@@	O	-1	3220106
ally	O	-1	3220106
due	O	-1	3220106
to	O	-1	3220106
increases	O	-1	3220106
of	O	-1	3220106
both	O	-1	3220106
the	O	-1	3220106
d@@	O	-1	3220106
ensity	O	-1	3220106
of	O	-1	3220106
nicot@@	O	-1	3220106
inic	O	-1	3220106
receptors	O	-1	3220106
and	O	-1	3220106
D@@	B-Chemical	D004298	3220106
A	I-Chemical	-1	3220106
concentr@@	O	-1	3220106
ation,	O	-1	3220106
followed	O	-1	3220106
by	O	-1	3220106
induc@@	O	-1	3220106
ing	O	-1	3220106
D@@	B-Chemical	D004298	3220106
A	I-Chemical	-1	3220106
receptor	O	-1	3220106
su@@	O	-1	3220106
per@@	O	-1	3220106
sensitivity	O	-1	3220106
in	O	-1	3220106
the	O	-1	3220106
striat@@	O	-1	3220106
um@@	O	-1	3220106
.	O	-1	3220106

H@@	B-Chemical	D006854	2722224
y@@	I-Chemical	-1	2722224
dro@@	I-Chemical	-1	2722224
cor@@	I-Chemical	-1	2722224
tis@@	I-Chemical	-1	2722224
one	I-Chemical	-1	2722224
-induced	O	-1	2722224
hypertension	B-Disease	D006973	2722224
in	O	-1	2722224
hum@@	O	-1	2722224
an@@	O	-1	2722224
s:	O	-1	2722224
press@@	O	-1	2722224
or	O	-1	2722224
respon@@	O	-1	2722224
si@@	O	-1	2722224
ven@@	O	-1	2722224
ess	O	-1	2722224
and	O	-1	2722224
sym@@	O	-1	2722224
pa@@	O	-1	2722224
thetic	O	-1	2722224
func@@	O	-1	2722224
tion.	O	-1	2722224
O@@	O	-1	2722224
ral	O	-1	2722224
hydro@@	B-Chemical	D006854	2722224
cor@@	I-Chemical	-1	2722224
tis@@	I-Chemical	-1	2722224
one	I-Chemical	-1	2722224
increases	O	-1	2722224
blood	O	-1	2722224
pressure	O	-1	2722224
and	O	-1	2722224
enh@@	O	-1	2722224
anc@@	O	-1	2722224
es	O	-1	2722224
press@@	O	-1	2722224
or	O	-1	2722224
respon@@	O	-1	2722224
si@@	O	-1	2722224
ven@@	O	-1	2722224
ess	O	-1	2722224
in	O	-1	2722224
normal	O	-1	2722224
human	O	-1	2722224
subj@@	O	-1	2722224
ect@@	O	-1	2722224
s.	O	-1	2722224
We	O	-1	2722224
studied	O	-1	2722224
the	O	-1	2722224
effects	O	-1	2722224
of	O	-1	2722224
1	O	-1	2722224
week	O	-1	2722224
of	O	-1	2722224
oral	O	-1	2722224
hydro@@	B-Chemical	D006854	2722224
cor@@	I-Chemical	-1	2722224
tis@@	I-Chemical	-1	2722224
one	I-Chemical	-1	2722224
(2@@	O	-1	2722224
00	O	-1	2722224
mg/@@	O	-1	2722224
day@@	O	-1	2722224
)	O	-1	2722224
on	O	-1	2722224
blood	O	-1	2722224
pressu@@	O	-1	2722224
re,	O	-1	2722224
cardiac	O	-1	2722224
out@@	O	-1	2722224
p@@	O	-1	2722224
ut@@	O	-1	2722224
,	O	-1	2722224
total	O	-1	2722224
peripheral	O	-1	2722224
resist@@	O	-1	2722224
ance@@	O	-1	2722224
,	O	-1	2722224
fo@@	O	-1	2722224
re@@	O	-1	2722224
ar@@	O	-1	2722224
m	O	-1	2722224
vascular	O	-1	2722224
resist@@	O	-1	2722224
ance@@	O	-1	2722224
,	O	-1	2722224
and	O	-1	2722224
no@@	B-Chemical	D009638	2722224
re@@	I-Chemical	-1	2722224
p@@	I-Chemical	-1	2722224
ine@@	I-Chemical	-1	2722224
phrine	I-Chemical	-1	2722224
sp@@	O	-1	2722224
il@@	O	-1	2722224
lo@@	O	-1	2722224
ver	O	-1	2722224
to	O	-1	2722224
plasma	O	-1	2722224
in	O	-1	2722224
e@@	O	-1	2722224
ight	O	-1	2722224
healthy	O	-1	2722224
male	O	-1	2722224
vol@@	O	-1	2722224
un@@	O	-1	2722224
te@@	O	-1	2722224
ers.	O	-1	2722224
Although	O	-1	2722224
di@@	O	-1	2722224
ast@@	O	-1	2722224
olic	O	-1	2722224
blood	O	-1	2722224
pressure	O	-1	2722224
remained	O	-1	2722224
un@@	O	-1	2722224
chang@@	O	-1	2722224
ed,	O	-1	2722224
systolic	O	-1	2722224
blood	O	-1	2722224
pressure	O	-1	2722224
increased	O	-1	2722224
from	O	-1	2722224
1@@	O	-1	2722224
1@@	O	-1	2722224
9	O	-1	2722224
to	O	-1	2722224
13@@	O	-1	2722224
5	O	-1	2722224
mm	O	-1	2722224
H@@	O	-1	2722224
g	O	-1	2722224
(S@@	O	-1	2722224
E@@	O	-1	2722224
D	O	-1	2722224
+/-	O	-1	2722224
3.@@	O	-1	2722224
4@@	O	-1	2722224
,	O	-1	2722224
p	O	-1	2722224
less	O	-1	2722224
than	O	-1	2722224
0.0@@	O	-1	2722224
1),	O	-1	2722224
associated	O	-1	2722224
with	O	-1	2722224
an	O	-1	2722224
increased	B-Disease	D016534	2722224
cardiac	I-Disease	-1	2722224
out@@	I-Disease	-1	2722224
pu@@	I-Disease	-1	2722224
t	I-Disease	-1	2722224
(@@	O	-1	2722224
5.@@	O	-1	2722224
8@@	O	-1	2722224
5-@@	O	-1	2722224
7.@@	O	-1	2722224
7@@	O	-1	2722224
3	O	-1	2722224
l@@	O	-1	2722224
/@@	O	-1	2722224
min@@	O	-1	2722224
,	O	-1	2722224
S@@	O	-1	2722224
E@@	O	-1	2722224
D	O	-1	2722224
+/-	O	-1	2722224
0.@@	O	-1	2722224
4@@	O	-1	2722224
6,	O	-1	2722224
p	O	-1	2722224
less	O	-1	2722224
than	O	-1	2722224
0.0@@	O	-1	2722224
1).	O	-1	2722224
T@@	O	-1	2722224
ot@@	O	-1	2722224
al	O	-1	2722224
peripheral	O	-1	2722224
vascular	O	-1	2722224
resist@@	O	-1	2722224
ance	O	-1	2722224
f@@	O	-1	2722224
el@@	O	-1	2722224
l	O	-1	2722224
from	O	-1	2722224
1@@	O	-1	2722224
5.@@	O	-1	2722224
1	O	-1	2722224
to	O	-1	2722224
1@@	O	-1	2722224
2.@@	O	-1	2722224
2	O	-1	2722224
mm	O	-1	2722224
H@@	O	-1	2722224
g/@@	O	-1	2722224
l@@	O	-1	2722224
/@@	O	-1	2722224
min	O	-1	2722224
(S@@	O	-1	2722224
E@@	O	-1	2722224
D	O	-1	2722224
+/-	O	-1	2722224
1.@@	O	-1	2722224
0@@	O	-1	2722224
3,	O	-1	2722224
p	O	-1	2722224
less	O	-1	2722224
than	O	-1	2722224
0.05@@	O	-1	2722224
).	O	-1	2722224
R@@	O	-1	2722224
est@@	O	-1	2722224
ing	O	-1	2722224
fo@@	O	-1	2722224
re@@	O	-1	2722224
ar@@	O	-1	2722224
m	O	-1	2722224
vascular	O	-1	2722224
resist@@	O	-1	2722224
ance	O	-1	2722224
remained	O	-1	2722224
un@@	O	-1	2722224
chang@@	O	-1	2722224
ed,	O	-1	2722224
but	O	-1	2722224
the	O	-1	2722224
ref@@	O	-1	2722224
le@@	O	-1	2722224
x	O	-1	2722224
response	O	-1	2722224
to	O	-1	2722224
the	O	-1	2722224
co@@	O	-1	2722224
l@@	O	-1	2722224
d	O	-1	2722224
press@@	O	-1	2722224
or	O	-1	2722224
test	O	-1	2722224
was	O	-1	2722224
ac@@	O	-1	2722224
c@@	O	-1	2722224
ent@@	O	-1	2722224
u@@	O	-1	2722224
at@@	O	-1	2722224
ed,	O	-1	2722224
the	O	-1	2722224
ri@@	O	-1	2722224
se	O	-1	2722224
in	O	-1	2722224
resist@@	O	-1	2722224
ance	O	-1	2722224
increas@@	O	-1	2722224
ing	O	-1	2722224
from	O	-1	2722224
1@@	O	-1	2722224
0.@@	O	-1	2722224
5	O	-1	2722224
mm	O	-1	2722224
H@@	O	-1	2722224
g/@@	O	-1	2722224
ml@@	O	-1	2722224
/@@	O	-1	2722224
100	O	-1	2722224
ml@@	O	-1	2722224
/@@	O	-1	2722224
min	O	-1	2722224
(@@	O	-1	2722224
R	O	-1	2722224
un@@	O	-1	2722224
it@@	O	-1	2722224
s)	O	-1	2722224
before	O	-1	2722224
treatment	O	-1	2722224
to	O	-1	2722224
3@@	O	-1	2722224
2.@@	O	-1	2722224
6	O	-1	2722224
R	O	-1	2722224
un@@	O	-1	2722224
its	O	-1	2722224
after	O	-1	2722224
treatment	O	-1	2722224
(S@@	O	-1	2722224
E@@	O	-1	2722224
D	O	-1	2722224
+/-	O	-1	2722224
6.@@	O	-1	2722224
4@@	O	-1	2722224
,	O	-1	2722224
p	O	-1	2722224
less	O	-1	2722224
than	O	-1	2722224
0.0@@	O	-1	2722224
25@@	O	-1	2722224
).	O	-1	2722224
The	O	-1	2722224
ri@@	O	-1	2722224
se	O	-1	2722224
in	O	-1	2722224
fo@@	O	-1	2722224
re@@	O	-1	2722224
ar@@	O	-1	2722224
m	O	-1	2722224
vascular	O	-1	2722224
resist@@	O	-1	2722224
ance	O	-1	2722224
ac@@	O	-1	2722224
comp@@	O	-1	2722224
an@@	O	-1	2722224
y@@	O	-1	2722224
ing	O	-1	2722224
intra@@	O	-1	2722224
-@@	O	-1	2722224
arterial	O	-1	2722224
no@@	B-Chemical	D009638	2722224
re@@	I-Chemical	-1	2722224
p@@	I-Chemical	-1	2722224
ine@@	I-Chemical	-1	2722224
phrine	I-Chemical	-1	2722224
(2@@	O	-1	2722224
5,	O	-1	2722224
50@@	O	-1	2722224
,	O	-1	2722224
and	O	-1	2722224
100	O	-1	2722224
n@@	O	-1	2722224
g/@@	O	-1	2722224
min@@	O	-1	2722224
)	O	-1	2722224
was	O	-1	2722224
also	O	-1	2722224
significantly	O	-1	2722224
greater	O	-1	2722224
after	O	-1	2722224
hydro@@	B-Chemical	D006854	2722224
cor@@	I-Chemical	-1	2722224
tis@@	I-Chemical	-1	2722224
one	I-Chemical	-1	2722224
,	O	-1	2722224
increas@@	O	-1	2722224
ing	O	-1	2722224
from	O	-1	2722224
an	O	-1	2722224
average	O	-1	2722224
of	O	-1	2722224
1@@	O	-1	2722224
4.@@	O	-1	2722224
9	O	-1	2722224
+/-	O	-1	2722224
2.@@	O	-1	2722224
4	O	-1	2722224
R	O	-1	2722224
un@@	O	-1	2722224
its	O	-1	2722224
before	O	-1	2722224
treatment	O	-1	2722224
to	O	-1	2722224
3@@	O	-1	2722224
5.@@	O	-1	2722224
1	O	-1	2722224
+/-	O	-1	2722224
5.@@	O	-1	2722224
5	O	-1	2722224
R	O	-1	2722224
un@@	O	-1	2722224
its	O	-1	2722224
after	O	-1	2722224
hydro@@	B-Chemical	D006854	2722224
cor@@	I-Chemical	-1	2722224
tis@@	I-Chemical	-1	2722224
one	I-Chemical	-1	2722224
(S@@	O	-1	2722224
E@@	O	-1	2722224
D	O	-1	2722224
+/-	O	-1	2722224
6.@@	O	-1	2722224
0@@	O	-1	2722224
,	O	-1	2722224
p	O	-1	2722224
less	O	-1	2722224
than	O	-1	2722224
0.05@@	O	-1	2722224
).	O	-1	2722224
A	O	-1	2722224
shi@@	O	-1	2722224
ft	O	-1	2722224
to	O	-1	2722224
the	O	-1	2722224
left	O	-1	2722224
in	O	-1	2722224
the	O	-1	2722224
dose-@@	O	-1	2722224
response	O	-1	2722224
rel@@	O	-1	2722224
ation	O	-1	2722224
and	O	-1	2722224
f@@	O	-1	2722224
all	O	-1	2722224
in	O	-1	2722224
th@@	O	-1	2722224
res@@	O	-1	2722224
h@@	O	-1	2722224
old	O	-1	2722224
suggested	O	-1	2722224
increased	O	-1	2722224
sensitivity	O	-1	2722224
to	O	-1	2722224
no@@	B-Chemical	D009638	2722224
re@@	I-Chemical	-1	2722224
p@@	I-Chemical	-1	2722224
ine@@	I-Chemical	-1	2722224
phrine	I-Chemical	-1	2722224
after	O	-1	2722224
treatment.	O	-1	2722224
M@@	O	-1	2722224
e@@	O	-1	2722224
as@@	O	-1	2722224
ure@@	O	-1	2722224
ment	O	-1	2722224
of	O	-1	2722224
rest@@	O	-1	2722224
ing	O	-1	2722224
no@@	B-Chemical	D009638	2722224
re@@	I-Chemical	-1	2722224
p@@	I-Chemical	-1	2722224
ine@@	I-Chemical	-1	2722224
phrine	I-Chemical	-1	2722224
sp@@	O	-1	2722224
il@@	O	-1	2722224
lo@@	O	-1	2722224
ver	O	-1	2722224
rate	O	-1	2722224
to	O	-1	2722224
plasma	O	-1	2722224
and	O	-1	2722224
no@@	B-Chemical	D009638	2722224
re@@	I-Chemical	-1	2722224
p@@	I-Chemical	-1	2722224
ine@@	I-Chemical	-1	2722224
phrine	I-Chemical	-1	2722224
u@@	O	-1	2722224
pt@@	O	-1	2722224
ake	O	-1	2722224
indic@@	O	-1	2722224
ated	O	-1	2722224
that	O	-1	2722224
over@@	O	-1	2722224
all	O	-1	2722224
rest@@	O	-1	2722224
ing	O	-1	2722224
sym@@	O	-1	2722224
pa@@	O	-1	2722224
thetic	O	-1	2722224
ner@@	O	-1	2722224
v@@	O	-1	2722224
ous	O	-1	2722224
system	O	-1	2722224
activity	O	-1	2722224
was	O	-1	2722224
not	O	-1	2722224
increas@@	O	-1	2722224
ed.	O	-1	2722224
The	O	-1	2722224
ri@@	B-Disease	D006973	2722224
se	I-Disease	-1	2722224
in	I-Disease	-1	2722224
rest@@	I-Disease	-1	2722224
ing	I-Disease	-1	2722224
blood	I-Disease	-1	2722224
pressure	I-Disease	-1	2722224
with	O	-1	2722224
hydro@@	B-Chemical	D006854	2722224
cor@@	I-Chemical	-1	2722224
tis@@	I-Chemical	-1	2722224
one	I-Chemical	-1	2722224
is	O	-1	2722224
associated	O	-1	2722224
with	O	-1	2722224
an	O	-1	2722224
increased	B-Disease	D016534	2722224
cardiac	I-Disease	-1	2722224
out@@	I-Disease	-1	2722224
pu@@	I-Disease	-1	2722224
t	I-Disease	-1	2722224
(@@	O	-1	2722224
pres@@	O	-1	2722224
um@@	O	-1	2722224
ably	O	-1	2722224
due	O	-1	2722224
to	O	-1	2722224
increased	O	-1	2722224
blood	O	-1	2722224
vol@@	O	-1	2722224
u@@	O	-1	2722224
me@@	O	-1	2722224
)@@	O	-1	2722224
.@@	O	-1	2722224
(A@@	O	-1	2722224
B@@	O	-1	2722224
S@@	O	-1	2722224
TR@@	O	-1	2722224
AC@@	O	-1	2722224
T	O	-1	2722224
TR@@	O	-1	2722224
UN@@	O	-1	2722224
C@@	O	-1	2722224
AT@@	O	-1	2722224
E@@	O	-1	2722224
D	O	-1	2722224
A@@	O	-1	2722224
T	O	-1	2722224
2@@	O	-1	2722224
50	O	-1	2722224
W@@	O	-1	2722224
O@@	O	-1	2722224
RD@@	O	-1	2722224
S)	O	-1	2722224

Eff@@	O	-1	1636026
ects	O	-1	1636026
of	O	-1	1636026
su@@	B-Chemical	D013496	1636026
prof@@	I-Chemical	-1	1636026
en	I-Chemical	-1	1636026
on	O	-1	1636026
the	O	-1	1636026
isol@@	O	-1	1636026
ated	O	-1	1636026
per@@	O	-1	1636026
f@@	O	-1	1636026
used	O	-1	1636026
rat	O	-1	1636026
kidne@@	O	-1	1636026
y.	O	-1	1636026
Although	O	-1	1636026
su@@	B-Chemical	D013496	1636026
prof@@	I-Chemical	-1	1636026
en	I-Chemical	-1	1636026
has	O	-1	1636026
been	O	-1	1636026
associated	O	-1	1636026
with	O	-1	1636026
the	O	-1	1636026
development	O	-1	1636026
of	O	-1	1636026
acute	B-Disease	D058186	1636026
renal	I-Disease	-1	1636026
failure	I-Disease	-1	1636026
in	O	-1	1636026
greater	O	-1	1636026
than	O	-1	1636026
100	O	-1	1636026
subj@@	O	-1	1636026
ect@@	O	-1	1636026
s,	O	-1	1636026
the	O	-1	1636026
mechanism	O	-1	1636026
of	O	-1	1636026
damage	O	-1	1636026
remain@@	O	-1	1636026
s	O	-1	1636026
unc@@	O	-1	1636026
lear@@	O	-1	1636026
.	O	-1	1636026
The	O	-1	1636026
direct	O	-1	1636026
nephro@@	B-Disease	D007674	1636026
toxic	I-Disease	-1	1636026
effects	O	-1	1636026
of	O	-1	1636026
a	O	-1	1636026
single	O	-1	1636026
dose	O	-1	1636026
of	O	-1	1636026
15	O	-1	1636026
mg	O	-1	1636026
of	O	-1	1636026
su@@	B-Chemical	D013496	1636026
prof@@	I-Chemical	-1	1636026
en	I-Chemical	-1	1636026
were	O	-1	1636026
compared	O	-1	1636026
in	O	-1	1636026
the	O	-1	1636026
re@@	O	-1	1636026
cir@@	O	-1	1636026
cul@@	O	-1	1636026
ating	O	-1	1636026
isol@@	O	-1	1636026
ated	O	-1	1636026
rat	O	-1	1636026
kidney	O	-1	1636026
per@@	O	-1	1636026
f@@	O	-1	1636026
used	O	-1	1636026
with	O	-1	1636026
cell@@	O	-1	1636026
-@@	O	-1	1636026
free	O	-1	1636026
bu@@	O	-1	1636026
ff@@	O	-1	1636026
er	O	-1	1636026
with	O	-1	1636026
or	O	-1	1636026
without	O	-1	1636026
the	O	-1	1636026
addition	O	-1	1636026
of	O	-1	1636026
5	O	-1	1636026
mg/d@@	O	-1	1636026
L	O	-1	1636026
of	O	-1	1636026
ur@@	B-Chemical	D014527	1636026
ic	I-Chemical	-1	1636026
acid	I-Chemical	-1	1636026
.	O	-1	1636026
There	O	-1	1636026
were	O	-1	1636026
no	O	-1	1636026
significant	O	-1	1636026
differences	O	-1	1636026
in	O	-1	1636026
renal	O	-1	1636026
sodium	B-Chemical	D012964	1636026
ex@@	O	-1	1636026
cre@@	O	-1	1636026
tion,	O	-1	1636026
oxy@@	B-Chemical	D010100	1636026
gen	I-Chemical	-1	1636026
consum@@	O	-1	1636026
p@@	O	-1	1636026
tion,	O	-1	1636026
or	O	-1	1636026
urinary	O	-1	1636026
flow	O	-1	1636026
rat@@	O	-1	1636026
es	O	-1	1636026
in	O	-1	1636026
kidne@@	O	-1	1636026
ys	O	-1	1636026
per@@	O	-1	1636026
f@@	O	-1	1636026
used	O	-1	1636026
with	O	-1	1636026
su@@	B-Chemical	D013496	1636026
prof@@	I-Chemical	-1	1636026
en	I-Chemical	-1	1636026
compared	O	-1	1636026
with	O	-1	1636026
the	O	-1	1636026
drug@@	O	-1	1636026
-@@	O	-1	1636026
free	O	-1	1636026
control	O	-1	1636026
groups.	O	-1	1636026
In	O	-1	1636026
contrast@@	O	-1	1636026
,	O	-1	1636026
a	O	-1	1636026
significant	O	-1	1636026
dec@@	O	-1	1636026
line	O	-1	1636026
in	O	-1	1636026
glomerular	O	-1	1636026
f@@	O	-1	1636026
iltration	O	-1	1636026
rate	O	-1	1636026
was	O	-1	1636026
found	O	-1	1636026
after	O	-1	1636026
the	O	-1	1636026
int@@	O	-1	1636026
ro@@	O	-1	1636026
duction	O	-1	1636026
of	O	-1	1636026
su@@	B-Chemical	D013496	1636026
prof@@	I-Chemical	-1	1636026
en	I-Chemical	-1	1636026
to	O	-1	1636026
the	O	-1	1636026
kidney	O	-1	1636026
per@@	O	-1	1636026
f@@	O	-1	1636026
used	O	-1	1636026
with	O	-1	1636026
ur@@	B-Chemical	D014527	1636026
ic	I-Chemical	-1	1636026
acid	I-Chemical	-1	1636026
;	O	-1	1636026
no	O	-1	1636026
changes	O	-1	1636026
were	O	-1	1636026
found	O	-1	1636026
with	O	-1	1636026
su@@	B-Chemical	D013496	1636026
prof@@	I-Chemical	-1	1636026
en	I-Chemical	-1	1636026
in	O	-1	1636026
the	O	-1	1636026
absence	O	-1	1636026
of	O	-1	1636026
ur@@	B-Chemical	D014527	1636026
ic	I-Chemical	-1	1636026
acid	I-Chemical	-1	1636026
.	O	-1	1636026
A	O	-1	1636026
significant	O	-1	1636026
decrease	O	-1	1636026
in	O	-1	1636026
the	O	-1	1636026
baseline	O	-1	1636026
ex@@	O	-1	1636026
cre@@	O	-1	1636026
tion	O	-1	1636026
rate	O	-1	1636026
of	O	-1	1636026
ur@@	B-Chemical	D014527	1636026
ic	I-Chemical	-1	1636026
acid	I-Chemical	-1	1636026
was	O	-1	1636026
found	O	-1	1636026
in	O	-1	1636026
rats	O	-1	1636026
given	O	-1	1636026
su@@	B-Chemical	D013496	1636026
prof@@	I-Chemical	-1	1636026
en	I-Chemical	-1	1636026
,	O	-1	1636026
compared	O	-1	1636026
with	O	-1	1636026
drug@@	O	-1	1636026
-@@	O	-1	1636026
free	O	-1	1636026
controls.	O	-1	1636026
However,	O	-1	1636026
the	O	-1	1636026
frac@@	O	-1	1636026
tional	O	-1	1636026
ex@@	O	-1	1636026
cre@@	O	-1	1636026
tion	O	-1	1636026
of	O	-1	1636026
ur@@	B-Chemical	D014527	1636026
ic	I-Chemical	-1	1636026
acid	I-Chemical	-1	1636026
was	O	-1	1636026
un@@	O	-1	1636026
chang@@	O	-1	1636026
ed	O	-1	1636026
between	O	-1	1636026
the	O	-1	1636026
groups	O	-1	1636026
over	O	-1	1636026
the	O	-1	1636026
experimental	O	-1	1636026
perio@@	O	-1	1636026
d.	O	-1	1636026
In	O	-1	1636026
su@@	O	-1	1636026
mm@@	O	-1	1636026
ar@@	O	-1	1636026
y,	O	-1	1636026
su@@	B-Chemical	D013496	1636026
prof@@	I-Chemical	-1	1636026
en	I-Chemical	-1	1636026
causes	O	-1	1636026
acute	B-Disease	D058186	1636026
dec@@	I-Disease	-1	1636026
lin@@	I-Disease	-1	1636026
es	I-Disease	-1	1636026
in	I-Disease	-1	1636026
renal	I-Disease	-1	1636026
function	I-Disease	-1	1636026
,	O	-1	1636026
most	O	-1	1636026
likely	O	-1	1636026
by	O	-1	1636026
direc@@	O	-1	1636026
tly	O	-1	1636026
al@@	O	-1	1636026
ter@@	O	-1	1636026
ing	O	-1	1636026
the	O	-1	1636026
intra@@	O	-1	1636026
renal	O	-1	1636026
di@@	O	-1	1636026
stri@@	O	-1	1636026
bu@@	O	-1	1636026
tion	O	-1	1636026
of	O	-1	1636026
ur@@	B-Chemical	D014527	1636026
ic	I-Chemical	-1	1636026
acid	I-Chemical	-1	1636026
.	O	-1	1636026

C@@	B-Chemical	D003042	1610717
oc@@	I-Chemical	-1	1610717
aine	I-Chemical	-1	1610717
-induced	O	-1	1610717
bra@@	O	-1	1610717
in@@	O	-1	1610717
st@@	O	-1	1610717
em	O	-1	1610717
seizures	B-Disease	D012640	1610717
and	O	-1	1610717
behavi@@	O	-1	1610717
or@@	O	-1	1610717
.	O	-1	1610717
A	O	-1	1610717
vari@@	O	-1	1610717
ety	O	-1	1610717
of	O	-1	1610717
ab@@	O	-1	1610717
normal	O	-1	1610717
sens@@	O	-1	1610717
or@@	O	-1	1610717
y@@	O	-1	1610717
/@@	O	-1	1610717
motor	O	-1	1610717
behavi@@	O	-1	1610717
ors	O	-1	1610717
associated	O	-1	1610717
with	O	-1	1610717
elect@@	O	-1	1610717
r@@	O	-1	1610717
ical	O	-1	1610717
dis@@	O	-1	1610717
ch@@	O	-1	1610717
arg@@	O	-1	1610717
es	O	-1	1610717
recor@@	O	-1	1610717
ded	O	-1	1610717
from	O	-1	1610717
the	O	-1	1610717
bil@@	O	-1	1610717
ateral	O	-1	1610717
bra@@	O	-1	1610717
in@@	O	-1	1610717
st@@	O	-1	1610717
em	O	-1	1610717
were	O	-1	1610717
induced	O	-1	1610717
in	O	-1	1610717
ad@@	O	-1	1610717
ult	O	-1	1610717
W@@	O	-1	1610717
K@@	O	-1	1610717
Y	O	-1	1610717
rats	O	-1	1610717
by	O	-1	1610717
mechan@@	O	-1	1610717
ical	O	-1	1610717
(@@	O	-1	1610717
electro@@	O	-1	1610717
de	O	-1	1610717
im@@	O	-1	1610717
pl@@	O	-1	1610717
ant@@	O	-1	1610717
s)	O	-1	1610717
and	O	-1	1610717
D@@	O	-1	1610717
C	O	-1	1610717
elect@@	O	-1	1610717
r@@	O	-1	1610717
ical	O	-1	1610717
current	O	-1	1610717
stimul@@	O	-1	1610717
ations	O	-1	1610717
and	O	-1	1610717
by	O	-1	1610717
acute	O	-1	1610717
and	O	-1	1610717
chronic	O	-1	1610717
administration	O	-1	1610717
of	O	-1	1610717
cocaine	B-Chemical	D003042	1610717
.	O	-1	1610717
The	O	-1	1610717
electro@@	O	-1	1610717
de	O	-1	1610717
im@@	O	-1	1610717
pl@@	O	-1	1610717
ant	O	-1	1610717
implic@@	O	-1	1610717
ated	O	-1	1610717
one	O	-1	1610717
side	O	-1	1610717
or	O	-1	1610717
the	O	-1	1610717
other	O	-1	1610717
of	O	-1	1610717
the	O	-1	1610717
re@@	O	-1	1610717
tic@@	O	-1	1610717
ular	O	-1	1610717
system	O	-1	1610717
of	O	-1	1610717
the	O	-1	1610717
bra@@	O	-1	1610717
in@@	O	-1	1610717
st@@	O	-1	1610717
em	O	-1	1610717
but	O	-1	1610717
subjects	O	-1	1610717
were	O	-1	1610717
not	O	-1	1610717
inc@@	O	-1	1610717
ap@@	O	-1	1610717
ac@@	O	-1	1610717
it@@	O	-1	1610717
ated	O	-1	1610717
by	O	-1	1610717
the	O	-1	1610717
stimul@@	O	-1	1610717
ations.	O	-1	1610717
C@@	B-Chemical	D003042	1610717
oc@@	I-Chemical	-1	1610717
aine	I-Chemical	-1	1610717
(@@	O	-1	1610717
40	O	-1	1610717
mg/kg)	O	-1	1610717
was	O	-1	1610717
injected	O	-1	1610717
sub@@	O	-1	1610717
c@@	O	-1	1610717
ut@@	O	-1	1610717
ane@@	O	-1	1610717
ously	O	-1	1610717
for	O	-1	1610717
an	O	-1	1610717
acute	O	-1	1610717
experim@@	O	-1	1610717
ent	O	-1	1610717
and	O	-1	1610717
subsequ@@	O	-1	1610717
ent	O	-1	1610717
20	O	-1	1610717
mg/kg	O	-1	1610717
doses	O	-1	1610717
tw@@	O	-1	1610717
ic@@	O	-1	1610717
e	O	-1	1610717
daily	O	-1	1610717
for	O	-1	1610717
3	O	-1	1610717
days	O	-1	1610717
in	O	-1	1610717
a	O	-1	1610717
chronic	O	-1	1610717
study.	O	-1	1610717
C@@	B-Chemical	D003042	1610717
oc@@	I-Chemical	-1	1610717
aine	I-Chemical	-1	1610717
gener@@	O	-1	1610717
ated	O	-1	1610717
more	O	-1	1610717
ab@@	O	-1	1610717
normal	O	-1	1610717
behavi@@	O	-1	1610717
ors	O	-1	1610717
in	O	-1	1610717
the	O	-1	1610717
bra@@	O	-1	1610717
in@@	O	-1	1610717
st@@	O	-1	1610717
em	O	-1	1610717
per@@	O	-1	1610717
t@@	O	-1	1610717
urb@@	O	-1	1610717
ation	O	-1	1610717
group@@	O	-1	1610717
,	O	-1	1610717
es@@	O	-1	1610717
p@@	O	-1	1610717
ec@@	O	-1	1610717
i@@	O	-1	1610717
ally	O	-1	1610717
the	O	-1	1610717
elect@@	O	-1	1610717
r@@	O	-1	1610717
ically	O	-1	1610717
per@@	O	-1	1610717
t@@	O	-1	1610717
urb@@	O	-1	1610717
ated	O	-1	1610717
subj@@	O	-1	1610717
ect@@	O	-1	1610717
s.	O	-1	1610717
The	O	-1	1610717
ab@@	O	-1	1610717
normal	O	-1	1610717
behavi@@	O	-1	1610717
ors	O	-1	1610717
were	O	-1	1610717
y@@	O	-1	1610717
aw@@	O	-1	1610717
n@@	O	-1	1610717
ing,	O	-1	1610717
ret@@	O	-1	1610717
ro@@	O	-1	1610717
coll@@	O	-1	1610717
is@@	O	-1	1610717
,	O	-1	1610717
hyperactivity	B-Disease	D006948	1610717
,	O	-1	1610717
hyper@@	B-Disease	D004342	1610717
sensitivity	I-Disease	-1	1610717
,	O	-1	1610717
"@@	O	-1	1610717
be@@	O	-1	1610717
ating	O	-1	1610717
dru@@	O	-1	1610717
m@@	O	-1	1610717
"	O	-1	1610717
behavi@@	O	-1	1610717
or@@	O	-1	1610717
,	O	-1	1610717
s@@	O	-1	1610717
qu@@	O	-1	1610717
e@@	O	-1	1610717
al@@	O	-1	1610717
ing,	O	-1	1610717
he@@	O	-1	1610717
ad	O	-1	1610717
b@@	O	-1	1610717
ob@@	O	-1	1610717
b@@	O	-1	1610717
ing,	O	-1	1610717
cir@@	O	-1	1610717
cl@@	O	-1	1610717
ing,	O	-1	1610717
s@@	O	-1	1610717
n@@	O	-1	1610717
i@@	O	-1	1610717
ff@@	O	-1	1610717
ing,	O	-1	1610717
ab@@	O	-1	1610717
normal	O	-1	1610717
post@@	O	-1	1610717
ur@@	O	-1	1610717
ing,	O	-1	1610717
and	O	-1	1610717
fac@@	O	-1	1610717
ial	O	-1	1610717
t@@	O	-1	1610717
witch@@	O	-1	1610717
ing.	O	-1	1610717
S@@	O	-1	1610717
hi@@	O	-1	1610717
f@@	O	-1	1610717
ts	O	-1	1610717
in	O	-1	1610717
the	O	-1	1610717
po@@	O	-1	1610717
w@@	O	-1	1610717
er	O	-1	1610717
frequency	O	-1	1610717
sp@@	O	-1	1610717
ect@@	O	-1	1610717
r@@	O	-1	1610717
a	O	-1	1610717
of	O	-1	1610717
the	O	-1	1610717
dis@@	O	-1	1610717
ch@@	O	-1	1610717
arg@@	O	-1	1610717
e	O	-1	1610717
pat@@	O	-1	1610717
tern@@	O	-1	1610717
s	O	-1	1610717
were	O	-1	1610717
not@@	O	-1	1610717
ed	O	-1	1610717
between	O	-1	1610717
qu@@	O	-1	1610717
i@@	O	-1	1610717
et	O	-1	1610717
and	O	-1	1610717
pac@@	O	-1	1610717
ing	O	-1	1610717
behavioral	O	-1	1610717
stat@@	O	-1	1610717
es.	O	-1	1610717
H@@	B-Disease	D004342	1610717
y@@	I-Disease	-1	1610717
per@@	I-Disease	-1	1610717
sensitivity	I-Disease	-1	1610717
to	O	-1	1610717
various	O	-1	1610717
a@@	O	-1	1610717
ud@@	O	-1	1610717
it@@	O	-1	1610717
or@@	O	-1	1610717
y,	O	-1	1610717
tac@@	O	-1	1610717
ti@@	O	-1	1610717
le@@	O	-1	1610717
,	O	-1	1610717
and	O	-1	1610717
visual	O	-1	1610717
stimulation	O	-1	1610717
was	O	-1	1610717
present	O	-1	1610717
and	O	-1	1610717
shi@@	O	-1	1610717
f@@	O	-1	1610717
ts	O	-1	1610717
in	O	-1	1610717
the	O	-1	1610717
bra@@	O	-1	1610717
in@@	O	-1	1610717
st@@	O	-1	1610717
em	O	-1	1610717
am@@	O	-1	1610717
b@@	O	-1	1610717
i@@	O	-1	1610717
ent	O	-1	1610717
po@@	O	-1	1610717
w@@	O	-1	1610717
er	O	-1	1610717
sp@@	O	-1	1610717
ect@@	O	-1	1610717
ral	O	-1	1610717
frequency	O	-1	1610717
occurred	O	-1	1610717
in	O	-1	1610717
response	O	-1	1610717
to	O	-1	1610717
tac@@	O	-1	1610717
ti@@	O	-1	1610717
le	O	-1	1610717
stimul@@	O	-1	1610717
ation.	O	-1	1610717
These	O	-1	1610717
findings	O	-1	1610717
suggest	O	-1	1610717
that	O	-1	1610717
the	O	-1	1610717
bra@@	O	-1	1610717
in@@	O	-1	1610717
st@@	O	-1	1610717
em	O	-1	1610717
gener@@	O	-1	1610717
ates	O	-1	1610717
and	O	-1	1610717
prop@@	O	-1	1610717
ag@@	O	-1	1610717
ates	O	-1	1610717
path@@	O	-1	1610717
ological	O	-1	1610717
dis@@	O	-1	1610717
ch@@	O	-1	1610717
arg@@	O	-1	1610717
es	O	-1	1610717
that	O	-1	1610717
can	O	-1	1610717
be	O	-1	1610717
el@@	O	-1	1610717
ic@@	O	-1	1610717
ited	O	-1	1610717
by	O	-1	1610717
mechan@@	O	-1	1610717
ical	O	-1	1610717
and	O	-1	1610717
D@@	O	-1	1610717
C	O	-1	1610717
elect@@	O	-1	1610717
r@@	O	-1	1610717
ical	O	-1	1610717
per@@	O	-1	1610717
t@@	O	-1	1610717
urb@@	O	-1	1610717
ation.	O	-1	1610717
C@@	B-Chemical	D003042	1610717
oc@@	I-Chemical	-1	1610717
aine	I-Chemical	-1	1610717
was	O	-1	1610717
found	O	-1	1610717
to	O	-1	1610717
activ@@	O	-1	1610717
ate	O	-1	1610717
the	O	-1	1610717
dis@@	O	-1	1610717
ch@@	O	-1	1610717
arg@@	O	-1	1610717
e	O	-1	1610717
system	O	-1	1610717
and	O	-1	1610717
th@@	O	-1	1610717
us	O	-1	1610717
induce	O	-1	1610717
ab@@	O	-1	1610717
normal	O	-1	1610717
behavi@@	O	-1	1610717
ors	O	-1	1610717
that	O	-1	1610717
are	O	-1	1610717
gener@@	O	-1	1610717
ated	O	-1	1610717
at	O	-1	1610717
the	O	-1	1610717
dis@@	O	-1	1610717
ch@@	O	-1	1610717
arg@@	O	-1	1610717
e	O	-1	1610717
sit@@	O	-1	1610717
e	O	-1	1610717
and	O	-1	1610717
at	O	-1	1610717
dist@@	O	-1	1610717
ant	O	-1	1610717
sit@@	O	-1	1610717
es	O	-1	1610717
to	O	-1	1610717
which	O	-1	1610717
the	O	-1	1610717
dis@@	O	-1	1610717
ch@@	O	-1	1610717
arg@@	O	-1	1610717
e	O	-1	1610717
prop@@	O	-1	1610717
ag@@	O	-1	1610717
at@@	O	-1	1610717
es.	O	-1	1610717
C@@	O	-1	1610717
o@@	O	-1	1610717
gn@@	O	-1	1610717
itive	O	-1	1610717
func@@	O	-1	1610717
tions	O	-1	1610717
may	O	-1	1610717
also	O	-1	1610717
be	O	-1	1610717
involved	O	-1	1610717
s@@	O	-1	1610717
inc@@	O	-1	1610717
e	O	-1	1610717
dop@@	O	-1	1610717
aminergic	O	-1	1610717
and	O	-1	1610717
seroton@@	O	-1	1610717
ergic	O	-1	1610717
cell@@	O	-1	1610717
ular	O	-1	1610717
e@@	O	-1	1610717
le@@	O	-1	1610717
ments	O	-1	1610717
at	O	-1	1610717
the	O	-1	1610717
bra@@	O	-1	1610717
in@@	O	-1	1610717
st@@	O	-1	1610717
em	O	-1	1610717
level	O	-1	1610717
are	O	-1	1610717
also	O	-1	1610717
implic@@	O	-1	1610717
ated.	O	-1	1610717

In@@	O	-1	873132
c@@	O	-1	873132
reas@@	O	-1	873132
ed	O	-1	873132
sulf@@	O	-1	873132
ation	O	-1	873132
and	O	-1	873132
decreased	O	-1	873132
7@@	O	-1	873132
alpha-@@	O	-1	873132
hydrox@@	O	-1	873132
yl@@	O	-1	873132
ation	O	-1	873132
of	O	-1	873132
de@@	B-Chemical	D003840	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
in	O	-1	873132
eth@@	B-Chemical	D004997	873132
in@@	I-Chemical	-1	873132
yl	I-Chemical	-1	873132
est@@	I-Chemical	-1	873132
radi@@	I-Chemical	-1	873132
ol	I-Chemical	-1	873132
-induced	O	-1	873132
cholest@@	B-Disease	D002779	873132
asis	I-Disease	-1	873132
in	O	-1	873132
rats.	O	-1	873132
De@@	B-Chemical	D003840	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
con@@	O	-1	873132
j@@	O	-1	873132
u@@	O	-1	873132
g@@	O	-1	873132
ation,	O	-1	873132
trans@@	O	-1	873132
por@@	O	-1	873132
t	O	-1	873132
cap@@	O	-1	873132
ac@@	O	-1	873132
ity,	O	-1	873132
and	O	-1	873132
metabol@@	O	-1	873132
ism	O	-1	873132
were	O	-1	873132
compared	O	-1	873132
in	O	-1	873132
control	O	-1	873132
and	O	-1	873132
eth@@	B-Chemical	D004997	873132
in@@	I-Chemical	-1	873132
yl	I-Chemical	-1	873132
est@@	I-Chemical	-1	873132
radi@@	I-Chemical	-1	873132
ol	I-Chemical	-1	873132
-treated	O	-1	873132
rats.	O	-1	873132
C@@	O	-1	873132
ont@@	O	-1	873132
ro@@	O	-1	873132
l	O	-1	873132
rats	O	-1	873132
were	O	-1	873132
found	O	-1	873132
to	O	-1	873132
have	O	-1	873132
a	O	-1	873132
lower	O	-1	873132
cap@@	O	-1	873132
ac@@	O	-1	873132
ity	O	-1	873132
to	O	-1	873132
trans@@	O	-1	873132
por@@	O	-1	873132
t	O	-1	873132
de@@	B-Chemical	D003840	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
than	O	-1	873132
t@@	B-Chemical	D013657	873132
a@@	I-Chemical	-1	873132
uro@@	I-Chemical	-1	873132
de@@	I-Chemical	-1	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
,	O	-1	873132
and	O	-1	873132
both	O	-1	873132
were	O	-1	873132
decreased	O	-1	873132
by	O	-1	873132
eth@@	B-Chemical	D004997	873132
in@@	I-Chemical	-1	873132
yl	I-Chemical	-1	873132
est@@	I-Chemical	-1	873132
radi@@	I-Chemical	-1	873132
ol	I-Chemical	-1	873132
treatment.	O	-1	873132
D@@	O	-1	873132
uring	O	-1	873132
[@@	O	-1	873132
2@@	O	-1	873132
4@@	O	-1	873132
-1@@	O	-1	873132
4@@	O	-1	873132
C@@	O	-1	873132
]	O	-1	873132
sodium	B-Chemical	D003840	873132
de@@	I-Chemical	-1	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ate	I-Chemical	-1	873132
infu@@	O	-1	873132
sion,	O	-1	873132
[@@	O	-1	873132
14@@	O	-1	873132
C@@	O	-1	873132
]@@	O	-1	873132
bil@@	O	-1	873132
i@@	O	-1	873132
ary	O	-1	873132
b@@	B-Chemical	D001647	873132
ile	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
secre@@	O	-1	873132
tion	O	-1	873132
increas@@	O	-1	873132
ed,	O	-1	873132
but	O	-1	873132
b@@	O	-1	873132
ile	O	-1	873132
flow	O	-1	873132
did	O	-1	873132
not	O	-1	873132
change	O	-1	873132
significantly	O	-1	873132
in	O	-1	873132
either	O	-1	873132
control	O	-1	873132
or	O	-1	873132
eth@@	B-Chemical	D004997	873132
in@@	I-Chemical	-1	873132
yl	I-Chemical	-1	873132
est@@	I-Chemical	-1	873132
radi@@	I-Chemical	-1	873132
ol	I-Chemical	-1	873132
-treated	O	-1	873132
rats.	O	-1	873132
E@@	B-Chemical	D004997	873132
th@@	I-Chemical	-1	873132
in@@	I-Chemical	-1	873132
yl	I-Chemical	-1	873132
est@@	I-Chemical	-1	873132
radi@@	I-Chemical	-1	873132
ol	I-Chemical	-1	873132
-treated	O	-1	873132
animals	O	-1	873132
ex@@	O	-1	873132
cre@@	O	-1	873132
ted	O	-1	873132
significantly	O	-1	873132
less	O	-1	873132
14@@	O	-1	873132
C	O	-1	873132
as	O	-1	873132
t@@	B-Chemical	D013656	873132
a@@	I-Chemical	-1	873132
uro@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
than	O	-1	873132
did	O	-1	873132
control	O	-1	873132
anim@@	O	-1	873132
al@@	O	-1	873132
s,	O	-1	873132
consist@@	O	-1	873132
ent	O	-1	873132
with	O	-1	873132
an	O	-1	873132
impair@@	O	-1	873132
ment	O	-1	873132
of	O	-1	873132
7@@	O	-1	873132
alpha-@@	O	-1	873132
hydrox@@	O	-1	873132
yl@@	O	-1	873132
ation	O	-1	873132
of	O	-1	873132
t@@	B-Chemical	D013657	873132
a@@	I-Chemical	-1	873132
uro@@	I-Chemical	-1	873132
de@@	I-Chemical	-1	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
.	O	-1	873132
E@@	B-Chemical	D004997	873132
th@@	I-Chemical	-1	873132
in@@	I-Chemical	-1	873132
yl	I-Chemical	-1	873132
est@@	I-Chemical	-1	873132
radi@@	I-Chemical	-1	873132
ol	I-Chemical	-1	873132
treatment	O	-1	873132
did	O	-1	873132
not	O	-1	873132
impa@@	O	-1	873132
ir	O	-1	873132
con@@	O	-1	873132
j@@	O	-1	873132
u@@	O	-1	873132
g@@	O	-1	873132
ation	O	-1	873132
of	O	-1	873132
de@@	B-Chemical	D003840	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
,	O	-1	873132
but	O	-1	873132
did	O	-1	873132
result	O	-1	873132
in	O	-1	873132
an	O	-1	873132
increase	O	-1	873132
in	O	-1	873132
sulf@@	O	-1	873132
ation	O	-1	873132
of	O	-1	873132
t@@	B-Chemical	D013657	873132
a@@	I-Chemical	-1	873132
uro@@	I-Chemical	-1	873132
de@@	I-Chemical	-1	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
from	O	-1	873132
1.@@	O	-1	873132
5%	O	-1	873132
in	O	-1	873132
controls	O	-1	873132
to	O	-1	873132
ne@@	O	-1	873132
arly	O	-1	873132
4.@@	O	-1	873132
0%	O	-1	873132
(P	O	-1	873132
less	O	-1	873132
than	O	-1	873132
0.0@@	O	-1	873132
1).	O	-1	873132
These	O	-1	873132
results	O	-1	873132
are	O	-1	873132
consist@@	O	-1	873132
ent	O	-1	873132
with	O	-1	873132
the	O	-1	873132
hypo@@	O	-1	873132
thesis	O	-1	873132
that	O	-1	873132
the	O	-1	873132
rat	O	-1	873132
has	O	-1	873132
a	O	-1	873132
po@@	O	-1	873132
ore@@	O	-1	873132
r	O	-1	873132
toler@@	O	-1	873132
ance	O	-1	873132
for	O	-1	873132
de@@	B-Chemical	D003840	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
than	O	-1	873132
d@@	O	-1	873132
o	O	-1	873132
cer@@	O	-1	873132
t@@	O	-1	873132
ain	O	-1	873132
other	O	-1	873132
spec@@	O	-1	873132
i@@	O	-1	873132
es.	O	-1	873132
F@@	O	-1	873132
ur@@	O	-1	873132
ther@@	O	-1	873132
mo@@	O	-1	873132
re,	O	-1	873132
the	O	-1	873132
rat	O	-1	873132
conver@@	O	-1	873132
ts	O	-1	873132
de@@	B-Chemical	D003840	873132
oxy@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
,	O	-1	873132
a	O	-1	873132
po@@	O	-1	873132
or	O	-1	873132
chol@@	O	-1	873132
e@@	O	-1	873132
re@@	O	-1	873132
tic@@	O	-1	873132
,	O	-1	873132
to	O	-1	873132
t@@	B-Chemical	D013656	873132
a@@	I-Chemical	-1	873132
uro@@	I-Chemical	-1	873132
chol@@	I-Chemical	-1	873132
ic	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
,	O	-1	873132
a	O	-1	873132
go@@	O	-1	873132
od	O	-1	873132
chol@@	O	-1	873132
e@@	O	-1	873132
re@@	O	-1	873132
tic@@	O	-1	873132
.	O	-1	873132
Whe@@	O	-1	873132
n	O	-1	873132
this	O	-1	873132
conver@@	O	-1	873132
sion	O	-1	873132
is	O	-1	873132
impaired	O	-1	873132
with	O	-1	873132
eth@@	B-Chemical	D004997	873132
in@@	I-Chemical	-1	873132
yl	I-Chemical	-1	873132
est@@	I-Chemical	-1	873132
radi@@	I-Chemical	-1	873132
ol	I-Chemical	-1	873132
treatment,	O	-1	873132
sulf@@	O	-1	873132
ation	O	-1	873132
may	O	-1	873132
be	O	-1	873132
an	O	-1	873132
important	O	-1	873132
al@@	O	-1	873132
tern@@	O	-1	873132
ate	O	-1	873132
path@@	O	-1	873132
w@@	O	-1	873132
ay	O	-1	873132
for	O	-1	873132
ex@@	O	-1	873132
cre@@	O	-1	873132
tion	O	-1	873132
of	O	-1	873132
this	O	-1	873132
potenti@@	O	-1	873132
ally	O	-1	873132
h@@	O	-1	873132
ar@@	O	-1	873132
m@@	O	-1	873132
ful	O	-1	873132
b@@	B-Chemical	D001647	873132
ile	I-Chemical	-1	873132
acid	I-Chemical	-1	873132
.	O	-1	873132

Eff@@	O	-1	783197
ects	O	-1	783197
of	O	-1	783197
ou@@	B-Chemical	D010042	783197
ab@@	I-Chemical	-1	783197
ain	I-Chemical	-1	783197
on	O	-1	783197
myocardial	O	-1	783197
oxy@@	B-Chemical	D010100	783197
gen	I-Chemical	-1	783197
sup@@	O	-1	783197
p@@	O	-1	783197
ly	O	-1	783197
and	O	-1	783197
de@@	O	-1	783197
m@@	O	-1	783197
and	O	-1	783197
in	O	-1	783197
patients	O	-1	783197
with	O	-1	783197
chronic	O	-1	783197
coronary	B-Disease	D003324	783197
artery	I-Disease	-1	783197
disease	I-Disease	-1	783197
.	O	-1	783197
A	O	-1	783197
hemo@@	O	-1	783197
dynam@@	O	-1	783197
ic@@	O	-1	783197
,	O	-1	783197
vol@@	O	-1	783197
u@@	O	-1	783197
met@@	O	-1	783197
r@@	O	-1	783197
ic@@	O	-1	783197
,	O	-1	783197
and	O	-1	783197
met@@	O	-1	783197
ab@@	O	-1	783197
olic	O	-1	783197
study	O	-1	783197
in	O	-1	783197
patients	O	-1	783197
without	O	-1	783197
heart	B-Disease	D006333	783197
failure	I-Disease	-1	783197
.	O	-1	783197
The	O	-1	783197
effects	O	-1	783197
of	O	-1	783197
di@@	B-Chemical	D004071	783197
g@@	I-Chemical	-1	783197
it@@	I-Chemical	-1	783197
al@@	I-Chemical	-1	783197
is	I-Chemical	-1	783197
gly@@	I-Chemical	-1	783197
co@@	I-Chemical	-1	783197
side@@	I-Chemical	-1	783197
s	I-Chemical	-1	783197
on	O	-1	783197
myocardial	O	-1	783197
oxy@@	B-Chemical	D010100	783197
gen	I-Chemical	-1	783197
sup@@	O	-1	783197
p@@	O	-1	783197
ly	O	-1	783197
and	O	-1	783197
de@@	O	-1	783197
m@@	O	-1	783197
and	O	-1	783197
are	O	-1	783197
of	O	-1	783197
partic@@	O	-1	783197
ular	O	-1	783197
in@@	O	-1	783197
te@@	O	-1	783197
res@@	O	-1	783197
t	O	-1	783197
in	O	-1	783197
the	O	-1	783197
presence	O	-1	783197
of	O	-1	783197
ob@@	O	-1	783197
struc@@	O	-1	783197
tive	O	-1	783197
coronary	B-Disease	D003324	783197
artery	I-Disease	-1	783197
disease	I-Disease	-1	783197
,	O	-1	783197
but	O	-1	783197
have	O	-1	783197
not	O	-1	783197
been	O	-1	783197
measured	O	-1	783197
previously	O	-1	783197
in	O	-1	783197
man@@	O	-1	783197
.	O	-1	783197
We	O	-1	783197
assessed	O	-1	783197
the	O	-1	783197
effects	O	-1	783197
of	O	-1	783197
ou@@	B-Chemical	D010042	783197
ab@@	I-Chemical	-1	783197
ain	I-Chemical	-1	783197
(@@	O	-1	783197
0.0@@	O	-1	783197
15	O	-1	783197
mg/kg	O	-1	783197
body	O	-1	783197
weigh@@	O	-1	783197
t@@	O	-1	783197
)	O	-1	783197
on	O	-1	783197
hemo@@	O	-1	783197
dynam@@	O	-1	783197
ic@@	O	-1	783197
,	O	-1	783197
vol@@	O	-1	783197
u@@	O	-1	783197
met@@	O	-1	783197
r@@	O	-1	783197
ic@@	O	-1	783197
,	O	-1	783197
and	O	-1	783197
met@@	O	-1	783197
ab@@	O	-1	783197
olic	O	-1	783197
par@@	O	-1	783197
ame@@	O	-1	783197
ters	O	-1	783197
in	O	-1	783197
11	O	-1	783197
patients	O	-1	783197
with	O	-1	783197
severe	O	-1	783197
chronic	O	-1	783197
coronary	B-Disease	D003324	783197
artery	I-Disease	-1	783197
disease	I-Disease	-1	783197
without	O	-1	783197
clinical	O	-1	783197
con@@	B-Disease	D006333	783197
g@@	I-Disease	-1	783197
es@@	I-Disease	-1	783197
tive	I-Disease	-1	783197
heart	I-Disease	-1	783197
failure	I-Disease	-1	783197
.	O	-1	783197
B@@	O	-1	783197
ecause	O	-1	783197
the	O	-1	783197
pro@@	O	-1	783197
to@@	O	-1	783197
co@@	O	-1	783197
l	O	-1	783197
was	O	-1	783197
lon@@	O	-1	783197
g	O	-1	783197
and	O	-1	783197
involved	O	-1	783197
inter@@	O	-1	783197
ven@@	O	-1	783197
tions	O	-1	783197
which	O	-1	783197
might	O	-1	783197
aff@@	O	-1	783197
ect	O	-1	783197
the	O	-1	783197
determin@@	O	-1	783197
ation@@	O	-1	783197
s,	O	-1	783197
we	O	-1	783197
also	O	-1	783197
studied	O	-1	783197
in	O	-1	783197
n@@	O	-1	783197
ine	O	-1	783197
patients	O	-1	783197
using	O	-1	783197
an	O	-1	783197
id@@	O	-1	783197
en@@	O	-1	783197
tical	O	-1	783197
pro@@	O	-1	783197
to@@	O	-1	783197
co@@	O	-1	783197
l	O	-1	783197
ex@@	O	-1	783197
cep@@	O	-1	783197
t	O	-1	783197
that	O	-1	783197
ou@@	B-Chemical	D010042	783197
ab@@	I-Chemical	-1	783197
ain	I-Chemical	-1	783197
administration	O	-1	783197
was	O	-1	783197
om@@	O	-1	783197
it@@	O	-1	783197
ted.	O	-1	783197
L@@	O	-1	783197
e@@	O	-1	783197
ft	O	-1	783197
ventricular	O	-1	783197
en@@	O	-1	783197
d-@@	O	-1	783197
di@@	O	-1	783197
ast@@	O	-1	783197
olic	O	-1	783197
pressure	O	-1	783197
and	O	-1	783197
left	O	-1	783197
ventricular	O	-1	783197
en@@	O	-1	783197
d-@@	O	-1	783197
di@@	O	-1	783197
ast@@	O	-1	783197
olic	O	-1	783197
volume	O	-1	783197
f@@	O	-1	783197
el@@	O	-1	783197
l	O	-1	783197
in	O	-1	783197
each	O	-1	783197
patient	O	-1	783197
given	O	-1	783197
ou@@	B-Chemical	D010042	783197
ab@@	I-Chemical	-1	783197
ain	I-Chemical	-1	783197
,	O	-1	783197
even	O	-1	783197
though	O	-1	783197
they	O	-1	783197
were	O	-1	783197
initi@@	O	-1	783197
ally	O	-1	783197
elevated	O	-1	783197
in	O	-1	783197
only	O	-1	783197
two	O	-1	783197
patients.	O	-1	783197
L@@	O	-1	783197
e@@	O	-1	783197
ft	O	-1	783197
ventricular	O	-1	783197
en@@	O	-1	783197
d-@@	O	-1	783197
di@@	O	-1	783197
ast@@	O	-1	783197
olic	O	-1	783197
pressure	O	-1	783197
f@@	O	-1	783197
el@@	O	-1	783197
l	O	-1	783197
from	O	-1	783197
1@@	O	-1	783197
1.@@	O	-1	783197
5@@	O	-1	783197
+/-@@	O	-1	783197
1.@@	O	-1	783197
4	O	-1	783197
(@@	O	-1	783197
me@@	O	-1	783197
an@@	O	-1	783197
+/-@@	O	-1	783197
S@@	O	-1	783197
E@@	O	-1	783197
)	O	-1	783197
to	O	-1	783197
5.@@	O	-1	783197
6@@	O	-1	783197
+/-@@	O	-1	783197
0.@@	O	-1	783197
9	O	-1	783197
mm	O	-1	783197
H@@	O	-1	783197
g	O	-1	783197
(P	O	-1	783197
less	O	-1	783197
than	O	-1	783197
0.00@@	O	-1	783197
1)	O	-1	783197
and	O	-1	783197
left	O	-1	783197
ventricular	O	-1	783197
en@@	O	-1	783197
d-@@	O	-1	783197
di@@	O	-1	783197
ast@@	O	-1	783197
olic	O	-1	783197
volume	O	-1	783197
f@@	O	-1	783197
el@@	O	-1	783197
l	O	-1	783197
from	O	-1	783197
10@@	O	-1	783197
0@@	O	-1	783197
+/@@	O	-1	783197
-1@@	O	-1	783197
7	O	-1	783197
to	O	-1	783197
8@@	O	-1	783197
2@@	O	-1	783197
+/@@	O	-1	783197
-1@@	O	-1	783197
2	O	-1	783197
ml@@	O	-1	783197
/@@	O	-1	783197
m@@	O	-1	783197
2	O	-1	783197
(P	O	-1	783197
less	O	-1	783197
than	O	-1	783197
0.0@@	O	-1	783197
1)	O	-1	783197
1	O	-1	783197
h	O	-1	783197
after	O	-1	783197
ou@@	B-Chemical	D010042	783197
ab@@	I-Chemical	-1	783197
ain	I-Chemical	-1	783197
infusion	O	-1	783197
was	O	-1	783197
comple@@	O	-1	783197
ted.	O	-1	783197
The	O	-1	783197
maxim@@	O	-1	783197
um	O	-1	783197
ve@@	O	-1	783197
loc@@	O	-1	783197
ity	O	-1	783197
of	O	-1	783197
contrac@@	O	-1	783197
ti@@	O	-1	783197
le	O	-1	783197
e@@	O	-1	783197
le@@	O	-1	783197
ment	O	-1	783197
sh@@	O	-1	783197
or@@	O	-1	783197
ten@@	O	-1	783197
ing	O	-1	783197
increased	O	-1	783197
from	O	-1	783197
1.@@	O	-1	783197
6@@	O	-1	783197
8@@	O	-1	783197
+/-@@	O	-1	783197
0.@@	O	-1	783197
11	O	-1	783197
ml@@	O	-1	783197
/@@	O	-1	783197
s	O	-1	783197
to	O	-1	783197
2.@@	O	-1	783197
18@@	O	-1	783197
+/-@@	O	-1	783197
0.@@	O	-1	783197
21	O	-1	783197
musc@@	O	-1	783197
le@@	O	-1	783197
-@@	O	-1	783197
l@@	O	-1	783197
en@@	O	-1	783197
g@@	O	-1	783197
th@@	O	-1	783197
s/@@	O	-1	783197
s	O	-1	783197
(P	O	-1	783197
less	O	-1	783197
than	O	-1	783197
0.05@@	O	-1	783197
)	O	-1	783197
and	O	-1	783197
is	O	-1	783197
consist@@	O	-1	783197
ent	O	-1	783197
with	O	-1	783197
an	O	-1	783197
increase	O	-1	783197
in	O	-1	783197
contrac@@	O	-1	783197
til@@	O	-1	783197
ity.	O	-1	783197
No	O	-1	783197
significant	O	-1	783197
change	O	-1	783197
in	O	-1	783197
these	O	-1	783197
par@@	O	-1	783197
ame@@	O	-1	783197
ters	O	-1	783197
occurred	O	-1	783197
in	O	-1	783197
the	O	-1	783197
control	O	-1	783197
patients.	O	-1	783197
No	O	-1	783197
significant	O	-1	783197
change	O	-1	783197
in	O	-1	783197
myocardial	O	-1	783197
oxy@@	B-Chemical	D010100	783197
gen	I-Chemical	-1	783197
consum@@	O	-1	783197
ption	O	-1	783197
occurred	O	-1	783197
after	O	-1	783197
ou@@	B-Chemical	D010042	783197
ab@@	I-Chemical	-1	783197
ain	I-Chemical	-1	783197
administration	O	-1	783197
but	O	-1	783197
this	O	-1	783197
may	O	-1	783197
be	O	-1	783197
related	O	-1	783197
to	O	-1	783197
a	O	-1	783197
greater	O	-1	783197
decrease	O	-1	783197
in	O	-1	783197
mean	O	-1	783197
arterial	O	-1	783197
pressure	O	-1	783197
in	O	-1	783197
the	O	-1	783197
ou@@	B-Chemical	D010042	783197
ab@@	I-Chemical	-1	783197
ain	I-Chemical	-1	783197
patients	O	-1	783197
than	O	-1	783197
in	O	-1	783197
the	O	-1	783197
control	O	-1	783197
patients.	O	-1	783197
We	O	-1	783197
concl@@	O	-1	783197
ude	O	-1	783197
that	O	-1	783197
in	O	-1	783197
patients	O	-1	783197
with	O	-1	783197
chronic	O	-1	783197
coronary	B-Disease	D003324	783197
artery	I-Disease	-1	783197
disease	I-Disease	-1	783197
who	O	-1	783197
are	O	-1	783197
not	O	-1	783197
in	O	-1	783197
clinical	O	-1	783197
con@@	B-Disease	D006333	783197
g@@	I-Disease	-1	783197
es@@	I-Disease	-1	783197
tive	I-Disease	-1	783197
heart	I-Disease	-1	783197
failure	I-Disease	-1	783197
left	B-Disease	D002303	783197
ventricular	I-Disease	-1	783197
en@@	I-Disease	-1	783197
d-@@	I-Disease	-1	783197
di@@	I-Disease	-1	783197
ast@@	I-Disease	-1	783197
olic	I-Disease	-1	783197
volume	I-Disease	-1	783197
f@@	I-Disease	-1	783197
all@@	I-Disease	-1	783197
s	I-Disease	-1	783197
after	O	-1	783197
ou@@	B-Chemical	D010042	783197
ab@@	I-Chemical	-1	783197
ain	I-Chemical	-1	783197
administration	O	-1	783197
even	O	-1	783197
when	O	-1	783197
it	O	-1	783197
is	O	-1	783197
initi@@	O	-1	783197
ally	O	-1	783197
normal@@	O	-1	783197
.	O	-1	783197
Th@@	O	-1	783197
ou@@	O	-1	783197
gh	O	-1	783197
this	O	-1	783197
f@@	O	-1	783197
all	O	-1	783197
wo@@	O	-1	783197
uld	O	-1	783197
be	O	-1	783197
associated	O	-1	783197
with	O	-1	783197
a	O	-1	783197
decrease	O	-1	783197
in	O	-1	783197
w@@	O	-1	783197
all	O	-1	783197
ten@@	O	-1	783197
sion,	O	-1	783197
and@@	O	-1	783197
,	O	-1	783197
the@@	O	-1	783197
refore,	O	-1	783197
of	O	-1	783197
myocardial	O	-1	783197
oxy@@	B-Chemical	D010100	783197
gen	I-Chemical	-1	783197
consum@@	O	-1	783197
p@@	O	-1	783197
tion,	O	-1	783197
it	O	-1	783197
may	O	-1	783197
not	O	-1	783197
be	O	-1	783197
of	O	-1	783197
suffici@@	O	-1	783197
ent	O	-1	783197
mag@@	O	-1	783197
nit@@	O	-1	783197
ude	O	-1	783197
to	O	-1	783197
prev@@	O	-1	783197
ent	O	-1	783197
a	O	-1	783197
ne@@	O	-1	783197
t	O	-1	783197
increase	O	-1	783197
in	O	-1	783197
myocardial	O	-1	783197
oxy@@	B-Chemical	D010100	783197
gen	I-Chemical	-1	783197
consum@@	O	-1	783197
p@@	O	-1	783197
tion.	O	-1	783197
Ne@@	O	-1	783197
ver@@	O	-1	783197
the@@	O	-1	783197
l@@	O	-1	783197
es@@	O	-1	783197
s,	O	-1	783197
com@@	O	-1	783197
pen@@	O	-1	783197
s@@	O	-1	783197
atory	O	-1	783197
mechanisms	O	-1	783197
prev@@	O	-1	783197
ent	O	-1	783197
a	O	-1	783197
deter@@	O	-1	783197
i@@	O	-1	783197
or@@	O	-1	783197
ation	O	-1	783197
of	O	-1	783197
rest@@	O	-1	783197
ing	O	-1	783197
myocardial	O	-1	783197
metabol@@	O	-1	783197
is@@	O	-1	783197
m.	O	-1	783197

Pro@@	B-Disease	D008133	9545159
long@@	I-Disease	-1	9545159
ation	I-Disease	-1	9545159
of	I-Disease	-1	9545159
the	I-Disease	-1	9545159
Q@@	I-Disease	-1	9545159
T	I-Disease	-1	9545159
interv@@	I-Disease	-1	9545159
al	I-Disease	-1	9545159
related	O	-1	9545159
to	O	-1	9545159
cis@@	B-Chemical	D020117	9545159
apri@@	I-Chemical	-1	9545159
de	I-Chemical	-1	9545159
-	O	-1	9545159
di@@	B-Chemical	D004110	9545159
l@@	I-Chemical	-1	9545159
ti@@	I-Chemical	-1	9545159
az@@	I-Chemical	-1	9545159
em	I-Chemical	-1	9545159
inter@@	O	-1	9545159
ac@@	O	-1	9545159
tion.	O	-1	9545159
C@@	B-Chemical	D020117	9545159
is@@	I-Chemical	-1	9545159
apri@@	I-Chemical	-1	9545159
de	I-Chemical	-1	9545159
,	O	-1	9545159
a	O	-1	9545159
cyto@@	O	-1	9545159
ch@@	O	-1	9545159
rom@@	O	-1	9545159
e	O	-1	9545159
P@@	O	-1	9545159
4@@	O	-1	9545159
50	O	-1	9545159
3@@	O	-1	9545159
A@@	O	-1	9545159
4	O	-1	9545159
(C@@	O	-1	9545159
Y@@	O	-1	9545159
P@@	O	-1	9545159
3@@	O	-1	9545159
A@@	O	-1	9545159
4@@	O	-1	9545159
)	O	-1	9545159
sub@@	O	-1	9545159
strat@@	O	-1	9545159
e,	O	-1	9545159
is	O	-1	9545159
wi@@	O	-1	9545159
de@@	O	-1	9545159
ly	O	-1	9545159
prescri@@	O	-1	9545159
bed	O	-1	9545159
for	O	-1	9545159
the	O	-1	9545159
treatment	O	-1	9545159
of	O	-1	9545159
gast@@	B-Disease	D015835	9545159
ro@@	I-Disease	-1	9545159
in@@	I-Disease	-1	9545159
test@@	I-Disease	-1	9545159
inal	I-Disease	-1	9545159
mo@@	I-Disease	-1	9545159
til@@	I-Disease	-1	9545159
ity	I-Disease	-1	9545159
disorder@@	I-Disease	-1	9545159
s	I-Disease	-1	9545159
.	O	-1	9545159
Pro@@	B-Disease	D008133	9545159
long@@	I-Disease	-1	9545159
ation	I-Disease	-1	9545159
of	I-Disease	-1	9545159
Q@@	I-Disease	-1	9545159
T	I-Disease	-1	9545159
interv@@	I-Disease	-1	9545159
al	I-Disease	-1	9545159
,	O	-1	9545159
t@@	B-Disease	D016171	9545159
or@@	I-Disease	-1	9545159
sa@@	I-Disease	-1	9545159
des	I-Disease	-1	9545159
de	I-Disease	-1	9545159
po@@	I-Disease	-1	9545159
int@@	I-Disease	-1	9545159
es	I-Disease	-1	9545159
,	O	-1	9545159
and	O	-1	9545159
su@@	B-Disease	D016757	9545159
d@@	I-Disease	-1	9545159
de@@	I-Disease	-1	9545159
n	I-Disease	-1	9545159
cardiac	I-Disease	-1	9545159
death	I-Disease	-1	9545159
have	O	-1	9545159
been	O	-1	9545159
reported	O	-1	9545159
after	O	-1	9545159
concomit@@	O	-1	9545159
ant	O	-1	9545159
administration	O	-1	9545159
with	O	-1	9545159
ery@@	B-Chemical	D004917	9545159
throm@@	I-Chemical	-1	9545159
ycin	I-Chemical	-1	9545159
or	O	-1	9545159
azole	B-Chemical	D001393	9545159
anti@@	O	-1	9545159
f@@	O	-1	9545159
un@@	O	-1	9545159
g@@	O	-1	9545159
al	O	-1	9545159
agent@@	O	-1	9545159
s,	O	-1	9545159
but	O	-1	9545159
not	O	-1	9545159
with	O	-1	9545159
other	O	-1	9545159
C@@	O	-1	9545159
Y@@	O	-1	9545159
P@@	O	-1	9545159
3@@	O	-1	9545159
A@@	O	-1	9545159
4	O	-1	9545159
inhibitor@@	O	-1	9545159
s.	O	-1	9545159
A	O	-1	9545159
possible	O	-1	9545159
drug	O	-1	9545159
inter@@	O	-1	9545159
action	O	-1	9545159
occurred	O	-1	9545159
in	O	-1	9545159
a	O	-1	9545159
4@@	O	-1	9545159
5-@@	O	-1	9545159
year-old	O	-1	9545159
woman	O	-1	9545159
who	O	-1	9545159
was	O	-1	9545159
taking	O	-1	9545159
cis@@	B-Chemical	D020117	9545159
apri@@	I-Chemical	-1	9545159
de	I-Chemical	-1	9545159
for	O	-1	9545159
gast@@	B-Disease	D005764	9545159
ro@@	I-Disease	-1	9545159
es@@	I-Disease	-1	9545159
oph@@	I-Disease	-1	9545159
ag@@	I-Disease	-1	9545159
e@@	I-Disease	-1	9545159
al	I-Disease	-1	9545159
ref@@	I-Disease	-1	9545159
lu@@	I-Disease	-1	9545159
x	I-Disease	-1	9545159
disor@@	I-Disease	-1	9545159
der	I-Disease	-1	9545159
and	O	-1	9545159
di@@	B-Chemical	D004110	9545159
l@@	I-Chemical	-1	9545159
ti@@	I-Chemical	-1	9545159
az@@	I-Chemical	-1	9545159
em	I-Chemical	-1	9545159
,	O	-1	9545159
an	O	-1	9545159
agent	O	-1	9545159
that	O	-1	9545159
has	O	-1	9545159
inhibit@@	O	-1	9545159
ory	O	-1	9545159
effect	O	-1	9545159
on	O	-1	9545159
C@@	O	-1	9545159
Y@@	O	-1	9545159
P@@	O	-1	9545159
3@@	O	-1	9545159
A@@	O	-1	9545159
4@@	O	-1	9545159
,	O	-1	9545159
for	O	-1	9545159
hypertension	B-Disease	D006973	9545159
.	O	-1	9545159
The	O	-1	9545159
patient	O	-1	9545159
was	O	-1	9545159
in	O	-1	9545159
ne@@	O	-1	9545159
ar	O	-1	9545159
syn@@	B-Disease	D013575	9545159
co@@	I-Disease	-1	9545159
p@@	I-Disease	-1	9545159
e	I-Disease	-1	9545159
and	O	-1	9545159
had	O	-1	9545159
Q@@	B-Disease	D008133	9545159
T@@	I-Disease	-1	9545159
-@@	I-Disease	-1	9545159
interv@@	I-Disease	-1	9545159
al	I-Disease	-1	9545159
prolong@@	I-Disease	-1	9545159
ation	I-Disease	-1	9545159
.	O	-1	9545159
After	O	-1	9545159
discontinu@@	O	-1	9545159
ing	O	-1	9545159
cis@@	B-Chemical	D020117	9545159
apri@@	I-Chemical	-1	9545159
de	I-Chemical	-1	9545159
,	O	-1	9545159
the	O	-1	9545159
Q@@	O	-1	9545159
T	O	-1	9545159
interv@@	O	-1	9545159
al	O	-1	9545159
retur@@	O	-1	9545159
n@@	O	-1	9545159
ed	O	-1	9545159
to	O	-1	9545159
normal	O	-1	9545159
and	O	-1	9545159
symptoms	O	-1	9545159
did	O	-1	9545159
not	O	-1	9545159
recur@@	O	-1	9545159
.	O	-1	9545159
We	O	-1	9545159
suggest	O	-1	9545159
that	O	-1	9545159
cau@@	O	-1	9545159
tion	O	-1	9545159
be	O	-1	9545159
tak@@	O	-1	9545159
en	O	-1	9545159
when	O	-1	9545159
cis@@	B-Chemical	D020117	9545159
apri@@	I-Chemical	-1	9545159
de	I-Chemical	-1	9545159
is	O	-1	9545159
prescri@@	O	-1	9545159
bed	O	-1	9545159
with	O	-1	9545159
any	O	-1	9545159
pot@@	O	-1	9545159
ent	O	-1	9545159
inhibitor	O	-1	9545159
of	O	-1	9545159
C@@	O	-1	9545159
Y@@	O	-1	9545159
P@@	O	-1	9545159
3@@	O	-1	9545159
A@@	O	-1	9545159
4@@	O	-1	9545159
,	O	-1	9545159
including	O	-1	9545159
di@@	B-Chemical	D004110	9545159
l@@	I-Chemical	-1	9545159
ti@@	I-Chemical	-1	9545159
az@@	I-Chemical	-1	9545159
em	I-Chemical	-1	9545159
.	O	-1	9545159

P@@	B-Chemical	D017239	8643973
ac@@	I-Chemical	-1	8643973
litax@@	I-Chemical	-1	8643973
el	I-Chemical	-1	8643973
combined	O	-1	8643973
with	O	-1	8643973
car@@	B-Chemical	D016190	8643973
bo@@	I-Chemical	-1	8643973
pl@@	I-Chemical	-1	8643973
atin	I-Chemical	-1	8643973
in	O	-1	8643973
the	O	-1	8643973
fir@@	O	-1	8643973
st@@	O	-1	8643973
-@@	O	-1	8643973
line	O	-1	8643973
treatment	O	-1	8643973
of	O	-1	8643973
adv@@	O	-1	8643973
anced	O	-1	8643973
o@@	B-Disease	D010051	8643973
vari@@	I-Disease	-1	8643973
an	I-Disease	-1	8643973
cancer	I-Disease	-1	8643973
.	O	-1	8643973
In	O	-1	8643973
a	O	-1	8643973
phase	O	-1	8643973
I	O	-1	8643973
study	O	-1	8643973
to	O	-1	8643973
determine	O	-1	8643973
the	O	-1	8643973
maxim@@	O	-1	8643973
um	O	-1	8643973
toler@@	O	-1	8643973
ated	O	-1	8643973
dose	O	-1	8643973
of	O	-1	8643973
paclitax@@	B-Chemical	D017239	8643973
el	I-Chemical	-1	8643973
(	O	-1	8643973
T@@	B-Chemical	D017239	8643973
ax@@	I-Chemical	-1	8643973
ol	I-Chemical	-1	8643973
;	O	-1	8643973
B@@	O	-1	8643973
ri@@	O	-1	8643973
st@@	O	-1	8643973
ol@@	O	-1	8643973
-@@	O	-1	8643973
M@@	O	-1	8643973
y@@	O	-1	8643973
ers	O	-1	8643973
S@@	O	-1	8643973
qu@@	O	-1	8643973
i@@	O	-1	8643973
b@@	O	-1	8643973
b	O	-1	8643973
Com@@	O	-1	8643973
p@@	O	-1	8643973
an@@	O	-1	8643973
y,	O	-1	8643973
P@@	O	-1	8643973
r@@	O	-1	8643973
in@@	O	-1	8643973
ce@@	O	-1	8643973
t@@	O	-1	8643973
on@@	O	-1	8643973
,	O	-1	8643973
N@@	O	-1	8643973
J@@	O	-1	8643973
)	O	-1	8643973
given	O	-1	8643973
as	O	-1	8643973
a	O	-1	8643973
3-@@	O	-1	8643973
h@@	O	-1	8643973
our	O	-1	8643973
infusion	O	-1	8643973
in	O	-1	8643973
combination	O	-1	8643973
with	O	-1	8643973
car@@	B-Chemical	D016190	8643973
bo@@	I-Chemical	-1	8643973
pl@@	I-Chemical	-1	8643973
atin	I-Chemical	-1	8643973
administered	O	-1	8643973
every	O	-1	8643973
21	O	-1	8643973
days	O	-1	8643973
to	O	-1	8643973
women	O	-1	8643973
with	O	-1	8643973
adv@@	O	-1	8643973
anced	O	-1	8643973
o@@	B-Disease	D010051	8643973
vari@@	I-Disease	-1	8643973
an	I-Disease	-1	8643973
cancer	I-Disease	-1	8643973
,	O	-1	8643973
paclitax@@	B-Chemical	D017239	8643973
el	I-Chemical	-1	8643973
doses	O	-1	8643973
were	O	-1	8643973
es@@	O	-1	8643973
cal@@	O	-1	8643973
ated	O	-1	8643973
as	O	-1	8643973
follow@@	O	-1	8643973
s:	O	-1	8643973
level	O	-1	8643973
1,	O	-1	8643973
13@@	O	-1	8643973
5	O	-1	8643973
mg/m@@	O	-1	8643973
2@@	O	-1	8643973
;	O	-1	8643973
level	O	-1	8643973
2,	O	-1	8643973
1@@	O	-1	8643973
60	O	-1	8643973
mg/m@@	O	-1	8643973
2@@	O	-1	8643973
;	O	-1	8643973
level	O	-1	8643973
3,	O	-1	8643973
18@@	O	-1	8643973
5	O	-1	8643973
mg/m@@	O	-1	8643973
2@@	O	-1	8643973
;	O	-1	8643973
and	O	-1	8643973
level	O	-1	8643973
4@@	O	-1	8643973
,@@	O	-1	8643973
2@@	O	-1	8643973
10	O	-1	8643973
mg/m@@	O	-1	8643973
2@@	O	-1	8643973
.	O	-1	8643973
The	O	-1	8643973
fi@@	O	-1	8643973
x@@	O	-1	8643973
ed	O	-1	8643973
dose	O	-1	8643973
of	O	-1	8643973
car@@	B-Chemical	D016190	8643973
bo@@	I-Chemical	-1	8643973
pl@@	I-Chemical	-1	8643973
atin	I-Chemical	-1	8643973
at	O	-1	8643973
levels	O	-1	8643973
1	O	-1	8643973
through	O	-1	8643973
4	O	-1	8643973
was	O	-1	8643973
given	O	-1	8643973
to	O	-1	8643973
achi@@	O	-1	8643973
e@@	O	-1	8643973
ve	O	-1	8643973
an	O	-1	8643973
a@@	O	-1	8643973
re@@	O	-1	8643973
a	O	-1	8643973
under	O	-1	8643973
the	O	-1	8643973
concentr@@	O	-1	8643973
ation@@	O	-1	8643973
-@@	O	-1	8643973
time	O	-1	8643973
cur@@	O	-1	8643973
ve	O	-1	8643973
(A@@	O	-1	8643973
U@@	O	-1	8643973
C@@	O	-1	8643973
)	O	-1	8643973
of	O	-1	8643973
5	O	-1	8643973
using	O	-1	8643973
the	O	-1	8643973
C@@	O	-1	8643973
al@@	O	-1	8643973
ver@@	O	-1	8643973
t	O	-1	8643973
form@@	O	-1	8643973
ul@@	O	-1	8643973
a.	O	-1	8643973
In	O	-1	8643973
levels	O	-1	8643973
5	O	-1	8643973
and	O	-1	8643973
6	O	-1	8643973
the	O	-1	8643973
car@@	B-Chemical	D016190	8643973
bo@@	I-Chemical	-1	8643973
pl@@	I-Chemical	-1	8643973
atin	I-Chemical	-1	8643973
dose	O	-1	8643973
was	O	-1	8643973
t@@	O	-1	8643973
arg@@	O	-1	8643973
et@@	O	-1	8643973
ed	O	-1	8643973
at	O	-1	8643973
A@@	O	-1	8643973
U@@	O	-1	8643973
C@@	O	-1	8643973
s	O	-1	8643973
of	O	-1	8643973
6	O	-1	8643973
and	O	-1	8643973
7.@@	O	-1	8643973
5,	O	-1	8643973
respectivel@@	O	-1	8643973
y,	O	-1	8643973
combined	O	-1	8643973
with	O	-1	8643973
a	O	-1	8643973
fi@@	O	-1	8643973
x@@	O	-1	8643973
ed	O	-1	8643973
paclitax@@	B-Chemical	D017239	8643973
el	I-Chemical	-1	8643973
dose	O	-1	8643973
of	O	-1	8643973
18@@	O	-1	8643973
5	O	-1	8643973
mg/m@@	O	-1	8643973
2@@	O	-1	8643973
.	O	-1	8643973
To	O	-1	8643973
dat@@	O	-1	8643973
e,	O	-1	8643973
30	O	-1	8643973
previously	O	-1	8643973
un@@	O	-1	8643973
treated	O	-1	8643973
patients,	O	-1	8643973
all	O	-1	8643973
with	O	-1	8643973
a	O	-1	8643973
go@@	O	-1	8643973
od	O	-1	8643973
perform@@	O	-1	8643973
ance	O	-1	8643973
status	O	-1	8643973
(@@	O	-1	8643973
E@@	O	-1	8643973
ast@@	O	-1	8643973
er@@	O	-1	8643973
n	O	-1	8643973
C@@	O	-1	8643973
o@@	O	-1	8643973
o@@	O	-1	8643973
perative	O	-1	8643973
On@@	O	-1	8643973
co@@	O	-1	8643973
log@@	O	-1	8643973
y	O	-1	8643973
Group	O	-1	8643973
0	O	-1	8643973
to	O	-1	8643973
2)	O	-1	8643973
have	O	-1	8643973
been	O	-1	8643973
ent@@	O	-1	8643973
ered	O	-1	8643973
into	O	-1	8643973
this	O	-1	8643973
on@@	O	-1	8643973
go@@	O	-1	8643973
ing	O	-1	8643973
study.	O	-1	8643973
The	O	-1	8643973
dose-@@	O	-1	8643973
lim@@	O	-1	8643973
it@@	O	-1	8643973
ing	O	-1	8643973
toxicity	B-Disease	D064420	8643973
of	O	-1	8643973
the	O	-1	8643973
combination	O	-1	8643973
was	O	-1	8643973
my@@	B-Disease	D001855	8643973
e@@	I-Disease	-1	8643973
lo@@	I-Disease	-1	8643973
sup@@	I-Disease	-1	8643973
pression	I-Disease	-1	8643973
(	O	-1	8643973
leuk@@	B-Disease	D007970	8643973
o@@	I-Disease	-1	8643973
pen@@	I-Disease	-1	8643973
ia	I-Disease	-1	8643973
,	O	-1	8643973
gran@@	B-Disease	D000380	8643973
ulo@@	I-Disease	-1	8643973
cyto@@	I-Disease	-1	8643973
pen@@	I-Disease	-1	8643973
ia	I-Disease	-1	8643973
,	O	-1	8643973
and	O	-1	8643973
throm@@	B-Disease	D013921	8643973
b@@	I-Disease	-1	8643973
ocyto@@	I-Disease	-1	8643973
pen@@	I-Disease	-1	8643973
ia	I-Disease	-1	8643973
).	O	-1	8643973
Ne@@	B-Disease	D020258	8643973
uro@@	I-Disease	-1	8643973
toxicity	I-Disease	-1	8643973
was	O	-1	8643973
larg@@	O	-1	8643973
ely	O	-1	8643973
moder@@	O	-1	8643973
at@@	O	-1	8643973
e.	O	-1	8643973
S@@	O	-1	8643973
o	O	-1	8643973
far@@	O	-1	8643973
,	O	-1	8643973
14	O	-1	8643973
patients	O	-1	8643973
are	O	-1	8643973
evalu@@	O	-1	8643973
able	O	-1	8643973
for	O	-1	8643973
respon@@	O	-1	8643973
se@@	O	-1	8643973
;	O	-1	8643973
of	O	-1	8643973
th@@	O	-1	8643973
es@@	O	-1	8643973
e,	O	-1	8643973
e@@	O	-1	8643973
ight	O	-1	8643973
(5@@	O	-1	8643973
7@@	O	-1	8643973
%)	O	-1	8643973
showed	O	-1	8643973
ob@@	O	-1	8643973
j@@	O	-1	8643973
ective	O	-1	8643973
(@@	O	-1	8643973
complete	O	-1	8643973
or	O	-1	8643973
par@@	O	-1	8643973
ti@@	O	-1	8643973
al@@	O	-1	8643973
)	O	-1	8643973
response	O	-1	8643973
and	O	-1	8643973
disease	O	-1	8643973
st@@	O	-1	8643973
abil@@	O	-1	8643973
ized	O	-1	8643973
in	O	-1	8643973
six	O	-1	8643973
patients.	O	-1	8643973
No	O	-1	8643973
patient	O	-1	8643973
had	O	-1	8643973
disease	O	-1	8643973
progres@@	O	-1	8643973
sion.	O	-1	8643973
We	O	-1	8643973
concl@@	O	-1	8643973
ude	O	-1	8643973
that	O	-1	8643973
the	O	-1	8643973
combination	O	-1	8643973
of	O	-1	8643973
paclitax@@	B-Chemical	D017239	8643973
el	I-Chemical	-1	8643973
18@@	O	-1	8643973
5	O	-1	8643973
mg/m@@	O	-1	8643973
2	O	-1	8643973
administered	O	-1	8643973
as	O	-1	8643973
a	O	-1	8643973
3-@@	O	-1	8643973
h@@	O	-1	8643973
our	O	-1	8643973
infusion	O	-1	8643973
followed	O	-1	8643973
immedi@@	O	-1	8643973
ately	O	-1	8643973
by	O	-1	8643973
a	O	-1	8643973
1-@@	O	-1	8643973
h@@	O	-1	8643973
our	O	-1	8643973
infusion	O	-1	8643973
of	O	-1	8643973
car@@	B-Chemical	D016190	8643973
bo@@	I-Chemical	-1	8643973
pl@@	I-Chemical	-1	8643973
atin	I-Chemical	-1	8643973
at	O	-1	8643973
an	O	-1	8643973
A@@	O	-1	8643973
U@@	O	-1	8643973
C	O	-1	8643973
of	O	-1	8643973
6	O	-1	8643973
can	O	-1	8643973
be	O	-1	8643973
administered	O	-1	8643973
saf@@	O	-1	8643973
ely	O	-1	8643973
in	O	-1	8643973
a	O	-1	8643973
2@@	O	-1	8643973
1-@@	O	-1	8643973
day	O	-1	8643973
sch@@	O	-1	8643973
ed@@	O	-1	8643973
ul@@	O	-1	8643973
e	O	-1	8643973
in	O	-1	8643973
the	O	-1	8643973
out@@	O	-1	8643973
patient	O	-1	8643973
se@@	O	-1	8643973
t@@	O	-1	8643973
t@@	O	-1	8643973
ing.	O	-1	8643973
The	O	-1	8643973
recomm@@	O	-1	8643973
en@@	O	-1	8643973
ded	O	-1	8643973
dose	O	-1	8643973
for	O	-1	8643973
phase	O	-1	8643973
I@@	O	-1	8643973
II	O	-1	8643973
studies	O	-1	8643973
is	O	-1	8643973
paclitax@@	B-Chemical	D017239	8643973
el	I-Chemical	-1	8643973
18@@	O	-1	8643973
5	O	-1	8643973
mg/m@@	O	-1	8643973
2	O	-1	8643973
and	O	-1	8643973
car@@	B-Chemical	D016190	8643973
bo@@	I-Chemical	-1	8643973
pl@@	I-Chemical	-1	8643973
atin	I-Chemical	-1	8643973
A@@	O	-1	8643973
U@@	O	-1	8643973
C	O	-1	8643973
6@@	O	-1	8643973
.	O	-1	8643973

Treat@@	O	-1	10743694
ment	O	-1	10743694
of	O	-1	10743694
tacrolimus	B-Chemical	D016559	10743694
-@@	O	-1	10743694
related	O	-1	10743694
adverse	O	-1	10743694
effects	O	-1	10743694
by	O	-1	10743694
conver@@	O	-1	10743694
sion	O	-1	10743694
to	O	-1	10743694
cyclospor@@	B-Chemical	D016572	10743694
ine	I-Chemical	-1	10743694
in	O	-1	10743694
liver	O	-1	10743694
transplant	O	-1	10743694
re@@	O	-1	10743694
ci@@	O	-1	10743694
pi@@	O	-1	10743694
ent@@	O	-1	10743694
s.	O	-1	10743694
Whe@@	O	-1	10743694
n	O	-1	10743694
tacrolimus	B-Chemical	D016559	10743694
side	O	-1	10743694
effects	O	-1	10743694
per@@	O	-1	10743694
si@@	O	-1	10743694
st	O	-1	10743694
des@@	O	-1	10743694
pit@@	O	-1	10743694
e	O	-1	10743694
dose	O	-1	10743694
reduc@@	O	-1	10743694
tion,	O	-1	10743694
conver@@	O	-1	10743694
sion	O	-1	10743694
to	O	-1	10743694
cyclospor@@	B-Chemical	D016572	10743694
ine	I-Chemical	-1	10743694
-@@	O	-1	10743694
bas@@	O	-1	10743694
ed	O	-1	10743694
immunosup@@	O	-1	10743694
pression	O	-1	10743694
(C@@	O	-1	10743694
y@@	O	-1	10743694
A@@	O	-1	10743694
)	O	-1	10743694
is	O	-1	10743694
nec@@	O	-1	10743694
ess@@	O	-1	10743694
ar@@	O	-1	10743694
y.	O	-1	10743694
We	O	-1	10743694
character@@	O	-1	10743694
ized	O	-1	10743694
tacrolimus	B-Chemical	D016559	10743694
side	O	-1	10743694
effects	O	-1	10743694
that	O	-1	10743694
war@@	O	-1	10743694
ran@@	O	-1	10743694
ted	O	-1	10743694
discontinu@@	O	-1	10743694
ation	O	-1	10743694
of	O	-1	10743694
the	O	-1	10743694
drug@@	O	-1	10743694
,	O	-1	10743694
and	O	-1	10743694
outcom@@	O	-1	10743694
es	O	-1	10743694
after	O	-1	10743694
conver@@	O	-1	10743694
sion.	O	-1	10743694
Of	O	-1	10743694
3@@	O	-1	10743694
8@@	O	-1	10743694
8	O	-1	10743694
liver	O	-1	10743694
re@@	O	-1	10743694
ci@@	O	-1	10743694
pi@@	O	-1	10743694
ents	O	-1	10743694
who	O	-1	10743694
received	O	-1	10743694
tacrolimus	B-Chemical	D016559	10743694
as	O	-1	10743694
prim@@	O	-1	10743694
ary	O	-1	10743694
immunosup@@	O	-1	10743694
pres@@	O	-1	10743694
sion,	O	-1	10743694
7@@	O	-1	10743694
0	O	-1	10743694
requ@@	O	-1	10743694
ired	O	-1	10743694
conver@@	O	-1	10743694
sion	O	-1	10743694
to	O	-1	10743694
C@@	O	-1	10743694
y@@	O	-1	10743694
A@@	O	-1	10743694
.	O	-1	10743694
We	O	-1	10743694
recor@@	O	-1	10743694
ded	O	-1	10743694
indic@@	O	-1	10743694
ation	O	-1	10743694
for	O	-1	10743694
conver@@	O	-1	10743694
sion,	O	-1	10743694
whether	O	-1	10743694
conver@@	O	-1	10743694
sion	O	-1	10743694
was	O	-1	10743694
early	O	-1	10743694
or	O	-1	10743694
l@@	O	-1	10743694
ate	O	-1	10743694
after	O	-1	10743694
transplant@@	O	-1	10743694
ation,	O	-1	10743694
tacrolimus	B-Chemical	D016559	10743694
dose	O	-1	10743694
and	O	-1	10743694
t@@	O	-1	10743694
rou@@	O	-1	10743694
gh	O	-1	10743694
blood	O	-1	10743694
level	O	-1	10743694
at	O	-1	10743694
conver@@	O	-1	10743694
sion,	O	-1	10743694
and	O	-1	10743694
incidence	O	-1	10743694
of	O	-1	10743694
re@@	O	-1	10743694
j@@	O	-1	10743694
ection	O	-1	10743694
after	O	-1	10743694
conver@@	O	-1	10743694
sion.	O	-1	10743694
Con@@	O	-1	10743694
ver@@	O	-1	10743694
sion	O	-1	10743694
was	O	-1	10743694
early	O	-1	10743694
in	O	-1	10743694
2@@	O	-1	10743694
9	O	-1	10743694
patients	O	-1	10743694
(4@@	O	-1	10743694
1.@@	O	-1	10743694
4@@	O	-1	10743694
%)	O	-1	10743694
and	O	-1	10743694
l@@	O	-1	10743694
ate	O	-1	10743694
in	O	-1	10743694
4@@	O	-1	10743694
1	O	-1	10743694
(5@@	O	-1	10743694
8.@@	O	-1	10743694
6@@	O	-1	10743694
%).	O	-1	10743694
In@@	O	-1	10743694
dic@@	O	-1	10743694
ations	O	-1	10743694
for	O	-1	10743694
early	O	-1	10743694
conver@@	O	-1	10743694
sion	O	-1	10743694
were	O	-1	10743694
neuro@@	B-Disease	D020258	10743694
toxicity	I-Disease	-1	10743694
(2@@	O	-1	10743694
0@@	O	-1	10743694
),	O	-1	10743694
(@@	B-Disease	D003922	10743694
in@@	I-Disease	-1	10743694
sul@@	I-Disease	-1	10743694
in-@@	I-Disease	-1	10743694
depend@@	I-Disease	-1	10743694
ent@@	I-Disease	-1	10743694
)	I-Disease	-1	10743694
dia@@	I-Disease	-1	10743694
bet@@	I-Disease	-1	10743694
es	I-Disease	-1	10743694
me@@	I-Disease	-1	10743694
ll@@	I-Disease	-1	10743694
it@@	I-Disease	-1	10743694
us	I-Disease	-1	10743694
(	O	-1	10743694
I@@	B-Disease	D003922	10743694
D@@	I-Disease	-1	10743694
D@@	I-Disease	-1	10743694
M	I-Disease	-1	10743694
)	O	-1	10743694
(5@@	O	-1	10743694
),	O	-1	10743694
nephro@@	B-Disease	D007674	10743694
toxicity	I-Disease	-1	10743694
(3@@	O	-1	10743694
),	O	-1	10743694
gast@@	B-Disease	D005767	10743694
ro@@	I-Disease	-1	10743694
in@@	I-Disease	-1	10743694
test@@	I-Disease	-1	10743694
inal	I-Disease	-1	10743694
(@@	I-Disease	-1	10743694
G@@	I-Disease	-1	10743694
I@@	I-Disease	-1	10743694
)	I-Disease	-1	10743694
toxicity	I-Disease	-1	10743694
(6@@	O	-1	10743694
),	O	-1	10743694
and	O	-1	10743694
cardi@@	B-Disease	D009202	10743694
om@@	I-Disease	-1	10743694
yo@@	I-Disease	-1	10743694
pathy	I-Disease	-1	10743694
(1@@	O	-1	10743694
),	O	-1	10743694
and	O	-1	10743694
for	O	-1	10743694
l@@	O	-1	10743694
ate	O	-1	10743694
conver@@	O	-1	10743694
sion	O	-1	10743694
were	O	-1	10743694
neuro@@	B-Disease	D020258	10743694
toxicity	I-Disease	-1	10743694
(1@@	O	-1	10743694
5@@	O	-1	10743694
),	O	-1	10743694
I@@	B-Disease	D003922	10743694
D@@	I-Disease	-1	10743694
D@@	I-Disease	-1	10743694
M	I-Disease	-1	10743694
(1@@	O	-1	10743694
2@@	O	-1	10743694
),	O	-1	10743694
nephro@@	B-Disease	D007674	10743694
toxicity	I-Disease	-1	10743694
(3@@	O	-1	10743694
),	O	-1	10743694
G@@	B-Disease	D005767	10743694
I	I-Disease	-1	10743694
toxicity	I-Disease	-1	10743694
(5@@	O	-1	10743694
),	O	-1	10743694
hepat@@	B-Disease	D056486	10743694
otoxicity	I-Disease	-1	10743694
(6@@	O	-1	10743694
),	O	-1	10743694
post@@	B-Disease	D008232	10743694
-@@	I-Disease	-1	10743694
transplant	I-Disease	-1	10743694
l@@	I-Disease	-1	10743694
m@@	I-Disease	-1	10743694
ph@@	I-Disease	-1	10743694
o@@	I-Disease	-1	10743694
pro@@	I-Disease	-1	10743694
li@@	I-Disease	-1	10743694
fer@@	I-Disease	-1	10743694
ate	I-Disease	-1	10743694
disease	I-Disease	-1	10743694
(	O	-1	10743694
P@@	B-Disease	D008232	10743694
T@@	I-Disease	-1	10743694
L@@	I-Disease	-1	10743694
D	I-Disease	-1	10743694
)	O	-1	10743694
(2@@	O	-1	10743694
),	O	-1	10743694
cardi@@	B-Disease	D009202	10743694
om@@	I-Disease	-1	10743694
yo@@	I-Disease	-1	10743694
pathy	I-Disease	-1	10743694
(1@@	O	-1	10743694
),	O	-1	10743694
hemolytic	B-Disease	D000743	10743694
anemia	I-Disease	-1	10743694
(1@@	O	-1	10743694
),	O	-1	10743694
and	O	-1	10743694
pr@@	B-Disease	D011537	10743694
ur@@	I-Disease	-1	10743694
it@@	I-Disease	-1	10743694
us	I-Disease	-1	10743694
(1@@	O	-1	10743694
).	O	-1	10743694
All	O	-1	10743694
ear@@	O	-1	10743694
l@@	O	-1	10743694
y-@@	O	-1	10743694
conver@@	O	-1	10743694
sion	O	-1	10743694
patients	O	-1	10743694
showed	O	-1	10743694
impro@@	O	-1	10743694
ve@@	O	-1	10743694
ment@@	O	-1	10743694
/@@	O	-1	10743694
resol@@	O	-1	10743694
u@@	O	-1	10743694
tion	O	-1	10743694
of	O	-1	10743694
symptom@@	O	-1	10743694
s.	O	-1	10743694
A@@	O	-1	10743694
mon@@	O	-1	10743694
g	O	-1	10743694
lat@@	O	-1	10743694
e-@@	O	-1	10743694
conver@@	O	-1	10743694
sion	O	-1	10743694
patients,	O	-1	10743694
3@@	O	-1	10743694
7	O	-1	10743694
(@@	O	-1	10743694
9@@	O	-1	10743694
0.@@	O	-1	10743694
2@@	O	-1	10743694
%)	O	-1	10743694
had	O	-1	10743694
impro@@	O	-1	10743694
ve@@	O	-1	10743694
ment@@	O	-1	10743694
/@@	O	-1	10743694
resol@@	O	-1	10743694
u@@	O	-1	10743694
tion@@	O	-1	10743694
;	O	-1	10743694
in	O	-1	10743694
4	O	-1	10743694
(@@	O	-1	10743694
9.@@	O	-1	10743694
8@@	O	-1	10743694
%),	O	-1	10743694
adverse	O	-1	10743694
effects	O	-1	10743694
per@@	O	-1	10743694
sist@@	O	-1	10743694
ed.	O	-1	10743694
The	O	-1	10743694
over@@	O	-1	10743694
all	O	-1	10743694
re@@	O	-1	10743694
j@@	O	-1	10743694
ection	O	-1	10743694
rate	O	-1	10743694
was	O	-1	10743694
3@@	O	-1	10743694
0@@	O	-1	10743694
%.	O	-1	10743694
Si@@	O	-1	10743694
x@@	O	-1	10743694
ty-@@	O	-1	10743694
two	O	-1	10743694
patients	O	-1	10743694
(@@	O	-1	10743694
8@@	O	-1	10743694
8.@@	O	-1	10743694
6@@	O	-1	10743694
%)	O	-1	10743694
are	O	-1	10743694
al@@	O	-1	10743694
i@@	O	-1	10743694
ve	O	-1	10743694
with	O	-1	10743694
func@@	O	-1	10743694
tion@@	O	-1	10743694
ing	O	-1	10743694
gra@@	O	-1	10743694
f@@	O	-1	10743694
ts	O	-1	10743694
6@@	O	-1	10743694
8@@	O	-1	10743694
6	O	-1	10743694
+/-	O	-1	10743694
3@@	O	-1	10743694
6@@	O	-1	10743694
2	O	-1	10743694
days	O	-1	10743694
(@@	O	-1	10743694
rang@@	O	-1	10743694
e,	O	-1	10743694
1@@	O	-1	10743694
5@@	O	-1	10743694
4@@	O	-1	10743694
-1@@	O	-1	10743694
4@@	O	-1	10743694
3@@	O	-1	10743694
3	O	-1	10743694
da@@	O	-1	10743694
ys@@	O	-1	10743694
)	O	-1	10743694
after	O	-1	10743694
conver@@	O	-1	10743694
sion.	O	-1	10743694
Whe@@	O	-1	10743694
n	O	-1	10743694
tacrolimus	B-Chemical	D016559	10743694
side	O	-1	10743694
effects	O	-1	10743694
are	O	-1	10743694
un@@	O	-1	10743694
respon@@	O	-1	10743694
sive	O	-1	10743694
to	O	-1	10743694
dose	O	-1	10743694
reduc@@	O	-1	10743694
tion,	O	-1	10743694
conver@@	O	-1	10743694
sion	O	-1	10743694
to	O	-1	10743694
C@@	O	-1	10743694
y@@	O	-1	10743694
A	O	-1	10743694
can	O	-1	10743694
be	O	-1	10743694
ac@@	O	-1	10743694
com@@	O	-1	10743694
pl@@	O	-1	10743694
ished	O	-1	10743694
saf@@	O	-1	10743694
el@@	O	-1	10743694
y,	O	-1	10743694
with	O	-1	10743694
no	O	-1	10743694
increased	O	-1	10743694
risk	O	-1	10743694
of	O	-1	10743694
re@@	O	-1	10743694
j@@	O	-1	10743694
ection	O	-1	10743694
and	O	-1	10743694
ex@@	O	-1	10743694
cell@@	O	-1	10743694
ent	O	-1	10743694
long-term	O	-1	10743694
out@@	O	-1	10743694
co@@	O	-1	10743694
me.	O	-1	10743694

R@@	O	-1	3535719
el@@	O	-1	3535719
ative	O	-1	3535719
efficacy	O	-1	3535719
and	O	-1	3535719
toxicity	B-Disease	D064420	3535719
of	O	-1	3535719
ne@@	B-Chemical	D009428	3535719
til@@	I-Chemical	-1	3535719
mic@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
and	O	-1	3535719
to@@	B-Chemical	D014031	3535719
b@@	I-Chemical	-1	3535719
ram@@	I-Chemical	-1	3535719
ycin	I-Chemical	-1	3535719
in	O	-1	3535719
on@@	O	-1	3535719
co@@	O	-1	3535719
log@@	O	-1	3535719
y	O	-1	3535719
patients.	O	-1	3535719
We	O	-1	3535719
pro@@	O	-1	3535719
sp@@	O	-1	3535719
ectively	O	-1	3535719
compared	O	-1	3535719
the	O	-1	3535719
efficacy	O	-1	3535719
and	O	-1	3535719
safety	O	-1	3535719
of	O	-1	3535719
ne@@	B-Chemical	D009428	3535719
til@@	I-Chemical	-1	3535719
mic@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
sulf@@	I-Chemical	-1	3535719
ate	I-Chemical	-1	3535719
or	O	-1	3535719
to@@	B-Chemical	D014031	3535719
b@@	I-Chemical	-1	3535719
ram@@	I-Chemical	-1	3535719
ycin	I-Chemical	-1	3535719
sulf@@	I-Chemical	-1	3535719
ate	I-Chemical	-1	3535719
in	O	-1	3535719
con@@	O	-1	3535719
j@@	O	-1	3535719
unc@@	O	-1	3535719
tion	O	-1	3535719
with	O	-1	3535719
pi@@	B-Chemical	D010878	3535719
per@@	I-Chemical	-1	3535719
ac@@	I-Chemical	-1	3535719
ill@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
sodium	I-Chemical	-1	3535719
in	O	-1	3535719
1@@	O	-1	3535719
1@@	O	-1	3535719
8	O	-1	3535719
immuno@@	O	-1	3535719
com@@	O	-1	3535719
pro@@	O	-1	3535719
mis@@	O	-1	3535719
ed	O	-1	3535719
patients	O	-1	3535719
with	O	-1	3535719
pres@@	O	-1	3535719
um@@	O	-1	3535719
ed	O	-1	3535719
severe	O	-1	3535719
inf@@	B-Disease	D007239	3535719
ec@@	I-Disease	-1	3535719
tions	I-Disease	-1	3535719
.	O	-1	3535719
The	O	-1	3535719
two	O	-1	3535719
treatment	O	-1	3535719
regimen@@	O	-1	3535719
s	O	-1	3535719
were	O	-1	3535719
equ@@	O	-1	3535719
ally	O	-1	3535719
efficac@@	O	-1	3535719
i@@	O	-1	3535719
ou@@	O	-1	3535719
s.	O	-1	3535719
Ne@@	B-Disease	D007674	3535719
ph@@	I-Disease	-1	3535719
ro@@	I-Disease	-1	3535719
toxicity	I-Disease	-1	3535719
occurred	O	-1	3535719
in	O	-1	3535719
a	O	-1	3535719
similar	O	-1	3535719
pro@@	O	-1	3535719
por@@	O	-1	3535719
tion	O	-1	3535719
in	O	-1	3535719
patients	O	-1	3535719
treated	O	-1	3535719
with	O	-1	3535719
ne@@	B-Chemical	D009428	3535719
til@@	I-Chemical	-1	3535719
mic@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
and	O	-1	3535719
to@@	B-Chemical	D014031	3535719
b@@	I-Chemical	-1	3535719
ram@@	I-Chemical	-1	3535719
ycin	I-Chemical	-1	3535719
(1@@	O	-1	3535719
7@@	O	-1	3535719
%	O	-1	3535719
v@@	O	-1	3535719
s	O	-1	3535719
1@@	O	-1	3535719
1@@	O	-1	3535719
%).	O	-1	3535719
O@@	B-Disease	D006311	3535719
tot@@	I-Disease	-1	3535719
oxic@@	I-Disease	-1	3535719
ity	I-Disease	-1	3535719
occurred	O	-1	3535719
in	O	-1	3535719
four	O	-1	3535719
(@@	O	-1	3535719
9.@@	O	-1	3535719
5@@	O	-1	3535719
%)	O	-1	3535719
of	O	-1	3535719
4@@	O	-1	3535719
2	O	-1	3535719
ne@@	B-Chemical	D009428	3535719
til@@	I-Chemical	-1	3535719
mic@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
and	O	-1	3535719
pi@@	B-Chemical	D010878	3535719
per@@	I-Chemical	-1	3535719
ac@@	I-Chemical	-1	3535719
ill@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
and	O	-1	3535719
in	O	-1	3535719
12	O	-1	3535719
(2@@	O	-1	3535719
2@@	O	-1	3535719
%)	O	-1	3535719
of	O	-1	3535719
5@@	O	-1	3535719
4	O	-1	3535719
to@@	B-Chemical	D014031	3535719
b@@	I-Chemical	-1	3535719
ram@@	I-Chemical	-1	3535719
ycin	I-Chemical	-1	3535719
and	O	-1	3535719
pi@@	B-Chemical	D010878	3535719
per@@	I-Chemical	-1	3535719
ac@@	I-Chemical	-1	3535719
ill@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
-treated	O	-1	3535719
patients.	O	-1	3535719
Of	O	-1	3535719
those	O	-1	3535719
evaluated	O	-1	3535719
with	O	-1	3535719
post@@	O	-1	3535719
therapy	O	-1	3535719
a@@	O	-1	3535719
udi@@	O	-1	3535719
o@@	O	-1	3535719
gram@@	O	-1	3535719
s,	O	-1	3535719
three	O	-1	3535719
of	O	-1	3535719
four	O	-1	3535719
ne@@	B-Chemical	D009428	3535719
til@@	I-Chemical	-1	3535719
mic@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
and	O	-1	3535719
pi@@	B-Chemical	D010878	3535719
per@@	I-Chemical	-1	3535719
ac@@	I-Chemical	-1	3535719
ill@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
-treated	O	-1	3535719
patients	O	-1	3535719
had	O	-1	3535719
a@@	O	-1	3535719
ud@@	O	-1	3535719
it@@	O	-1	3535719
ory	O	-1	3535719
th@@	O	-1	3535719
res@@	O	-1	3535719
h@@	O	-1	3535719
ol@@	O	-1	3535719
ds	O	-1	3535719
retur@@	O	-1	3535719
n	O	-1	3535719
to	O	-1	3535719
baseline	O	-1	3535719
compared	O	-1	3535719
with	O	-1	3535719
one	O	-1	3535719
of	O	-1	3535719
n@@	O	-1	3535719
ine	O	-1	3535719
to@@	B-Chemical	D014031	3535719
b@@	I-Chemical	-1	3535719
ram@@	I-Chemical	-1	3535719
ycin	I-Chemical	-1	3535719
and	O	-1	3535719
pi@@	B-Chemical	D010878	3535719
per@@	I-Chemical	-1	3535719
ac@@	I-Chemical	-1	3535719
ill@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
-treated	O	-1	3535719
patients.	O	-1	3535719
The	O	-1	3535719
number	O	-1	3535719
of	O	-1	3535719
greater	O	-1	3535719
than	O	-1	3535719
or	O	-1	3535719
equ@@	O	-1	3535719
al	O	-1	3535719
to	O	-1	3535719
1@@	O	-1	3535719
5-@@	O	-1	3535719
d@@	O	-1	3535719
B	O	-1	3535719
increases	O	-1	3535719
in	O	-1	3535719
a@@	O	-1	3535719
ud@@	O	-1	3535719
it@@	O	-1	3535719
ory	O	-1	3535719
th@@	O	-1	3535719
res@@	O	-1	3535719
h@@	O	-1	3535719
old	O	-1	3535719
as	O	-1	3535719
a	O	-1	3535719
pro@@	O	-1	3535719
por@@	O	-1	3535719
tion	O	-1	3535719
of	O	-1	3535719
total	O	-1	3535719
greater	O	-1	3535719
than	O	-1	3535719
or	O	-1	3535719
equ@@	O	-1	3535719
al	O	-1	3535719
to	O	-1	3535719
1@@	O	-1	3535719
5-@@	O	-1	3535719
d@@	O	-1	3535719
B	O	-1	3535719
changes	O	-1	3535719
(@@	O	-1	3535719
increases	O	-1	3535719
and	O	-1	3535719
decreas@@	O	-1	3535719
es@@	O	-1	3535719
)	O	-1	3535719
was	O	-1	3535719
significantly	O	-1	3535719
lower	O	-1	3535719
in	O	-1	3535719
ne@@	B-Chemical	D009428	3535719
til@@	I-Chemical	-1	3535719
mic@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
and	O	-1	3535719
pi@@	B-Chemical	D010878	3535719
per@@	I-Chemical	-1	3535719
ac@@	I-Chemical	-1	3535719
ill@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
-	O	-1	3535719
v@@	O	-1	3535719
s	O	-1	3535719
to@@	B-Chemical	D014031	3535719
b@@	I-Chemical	-1	3535719
ram@@	I-Chemical	-1	3535719
ycin	I-Chemical	-1	3535719
and	O	-1	3535719
pi@@	B-Chemical	D010878	3535719
per@@	I-Chemical	-1	3535719
ac@@	I-Chemical	-1	3535719
ill@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
-treated	O	-1	3535719
patients	O	-1	3535719
(1@@	O	-1	3535719
8	O	-1	3535719
of	O	-1	3535719
7@@	O	-1	3535719
8	O	-1	3535719
v@@	O	-1	3535719
s	O	-1	3535719
6@@	O	-1	3535719
7	O	-1	3535719
of	O	-1	3535719
1@@	O	-1	3535719
1@@	O	-1	3535719
5@@	O	-1	3535719
).	O	-1	3535719
We	O	-1	3535719
concl@@	O	-1	3535719
ude	O	-1	3535719
that	O	-1	3535719
amino@@	B-Chemical	D000617	3535719
gly@@	I-Chemical	-1	3535719
co@@	I-Chemical	-1	3535719
side	I-Chemical	-1	3535719
-@@	O	-1	3535719
associated	O	-1	3535719
ot@@	B-Disease	D006311	3535719
otoxicity	I-Disease	-1	3535719
was	O	-1	3535719
less	O	-1	3535719
severe	O	-1	3535719
and	O	-1	3535719
more	O	-1	3535719
often	O	-1	3535719
reversible	O	-1	3535719
with	O	-1	3535719
ne@@	B-Chemical	D009428	3535719
til@@	I-Chemical	-1	3535719
mic@@	I-Chemical	-1	3535719
in	I-Chemical	-1	3535719
than	O	-1	3535719
with	O	-1	3535719
to@@	B-Chemical	D014031	3535719
b@@	I-Chemical	-1	3535719
ram@@	I-Chemical	-1	3535719
ycin	I-Chemical	-1	3535719
.	O	-1	3535719

Eff@@	O	-1	6433367
ect	O	-1	6433367
of	O	-1	6433367
pro@@	B-Chemical	D011453	6433367
st@@	I-Chemical	-1	6433367
ag@@	I-Chemical	-1	6433367
l@@	I-Chemical	-1	6433367
and@@	I-Chemical	-1	6433367
in	I-Chemical	-1	6433367
syn@@	O	-1	6433367
the@@	O	-1	6433367
t@@	O	-1	6433367
ase	O	-1	6433367
inhibitors	O	-1	6433367
on	O	-1	6433367
experim@@	O	-1	6433367
ent@@	O	-1	6433367
ally	O	-1	6433367
induced	O	-1	6433367
convul@@	B-Disease	D012640	6433367
sions	I-Disease	-1	6433367
in	O	-1	6433367
rats.	O	-1	6433367
To	O	-1	6433367
investigate	O	-1	6433367
the	O	-1	6433367
rel@@	O	-1	6433367
ationship	O	-1	6433367
of	O	-1	6433367
pro@@	B-Chemical	D011453	6433367
st@@	I-Chemical	-1	6433367
ag@@	I-Chemical	-1	6433367
l@@	I-Chemical	-1	6433367
and@@	I-Chemical	-1	6433367
ins	I-Chemical	-1	6433367
(	O	-1	6433367
PG@@	B-Chemical	D011453	6433367
s	I-Chemical	-1	6433367
)	O	-1	6433367
to	O	-1	6433367
seizure	B-Disease	D012640	6433367
induc@@	O	-1	6433367
tion,	O	-1	6433367
the	O	-1	6433367
effects	O	-1	6433367
of	O	-1	6433367
six	O	-1	6433367
P@@	O	-1	6433367
G	O	-1	6433367
syn@@	O	-1	6433367
the@@	O	-1	6433367
t@@	O	-1	6433367
ase	O	-1	6433367
inhibitors	O	-1	6433367
on	O	-1	6433367
convul@@	B-Disease	D012640	6433367
sions	I-Disease	-1	6433367
induced	O	-1	6433367
by	O	-1	6433367
f@@	B-Chemical	D005481	6433367
l@@	I-Chemical	-1	6433367
uro@@	I-Chemical	-1	6433367
th@@	I-Chemical	-1	6433367
yl	I-Chemical	-1	6433367
,	O	-1	6433367
p@@	B-Chemical	D010852	6433367
ic@@	I-Chemical	-1	6433367
ro@@	I-Chemical	-1	6433367
tox@@	I-Chemical	-1	6433367
in	I-Chemical	-1	6433367
,	O	-1	6433367
pent@@	B-Chemical	D010433	6433367
et@@	I-Chemical	-1	6433367
ra@@	I-Chemical	-1	6433367
z@@	I-Chemical	-1	6433367
ol	I-Chemical	-1	6433367
(	O	-1	6433367
P@@	B-Chemical	D010433	6433367
T@@	I-Chemical	-1	6433367
Z	I-Chemical	-1	6433367
),	O	-1	6433367
electro@@	O	-1	6433367
sh@@	O	-1	6433367
oc@@	O	-1	6433367
k	O	-1	6433367
or	O	-1	6433367
b@@	B-Chemical	D001640	6433367
ic@@	I-Chemical	-1	6433367
uc@@	I-Chemical	-1	6433367
ul@@	I-Chemical	-1	6433367
line	I-Chemical	-1	6433367
were	O	-1	6433367
evalu@@	O	-1	6433367
ated.	O	-1	6433367
I@@	B-Chemical	D007052	6433367
bu@@	I-Chemical	-1	6433367
prof@@	I-Chemical	-1	6433367
en	I-Chemical	-1	6433367
,	O	-1	6433367
sul@@	B-Chemical	D013467	6433367
in@@	I-Chemical	-1	6433367
da@@	I-Chemical	-1	6433367
c	I-Chemical	-1	6433367
,	O	-1	6433367
me@@	B-Chemical	D008528	6433367
f@@	I-Chemical	-1	6433367
en@@	I-Chemical	-1	6433367
am@@	I-Chemical	-1	6433367
ic	I-Chemical	-1	6433367
acid	I-Chemical	-1	6433367
,	O	-1	6433367
and	O	-1	6433367
low	O	-1	6433367
dose	O	-1	6433367
m@@	B-Chemical	D008469	6433367
ec@@	I-Chemical	-1	6433367
lo@@	I-Chemical	-1	6433367
f@@	I-Chemical	-1	6433367
en@@	I-Chemical	-1	6433367
am@@	I-Chemical	-1	6433367
ic	I-Chemical	-1	6433367
acid	I-Chemical	-1	6433367
increased	O	-1	6433367
the	O	-1	6433367
lat@@	O	-1	6433367
enc@@	O	-1	6433367
y-@@	O	-1	6433367
to@@	O	-1	6433367
-@@	O	-1	6433367
onset	O	-1	6433367
in	O	-1	6433367
the	O	-1	6433367
f@@	B-Chemical	D005481	6433367
l@@	I-Chemical	-1	6433367
uro@@	I-Chemical	-1	6433367
th@@	I-Chemical	-1	6433367
yl	I-Chemical	-1	6433367
and/or	O	-1	6433367
P@@	B-Chemical	D010433	6433367
T@@	I-Chemical	-1	6433367
Z	I-Chemical	-1	6433367
model@@	O	-1	6433367
s;	O	-1	6433367
the	O	-1	6433367
electro@@	O	-1	6433367
sh@@	O	-1	6433367
oc@@	O	-1	6433367
k@@	O	-1	6433367
,	O	-1	6433367
p@@	B-Chemical	D010852	6433367
ic@@	I-Chemical	-1	6433367
ro@@	I-Chemical	-1	6433367
tox@@	I-Chemical	-1	6433367
in	I-Chemical	-1	6433367
and	O	-1	6433367
b@@	B-Chemical	D001640	6433367
ic@@	I-Chemical	-1	6433367
uc@@	I-Chemical	-1	6433367
ul@@	I-Chemical	-1	6433367
line	I-Chemical	-1	6433367
models	O	-1	6433367
were	O	-1	6433367
not	O	-1	6433367
significantly	O	-1	6433367
affected	O	-1	6433367
by	O	-1	6433367
any	O	-1	6433367
of	O	-1	6433367
the	O	-1	6433367
pretreatment	O	-1	6433367
agent@@	O	-1	6433367
s.	O	-1	6433367
These	O	-1	6433367
results	O	-1	6433367
suggest	O	-1	6433367
that	O	-1	6433367
PG@@	B-Chemical	D011453	6433367
s	I-Chemical	-1	6433367
are	O	-1	6433367
involved	O	-1	6433367
in	O	-1	6433367
the	O	-1	6433367
mechanis@@	O	-1	6433367
m@@	O	-1	6433367
(@@	O	-1	6433367
s)	O	-1	6433367
underlying	O	-1	6433367
flu@@	B-Chemical	D005481	6433367
or@@	I-Chemical	-1	6433367
th@@	I-Chemical	-1	6433367
yl	I-Chemical	-1	6433367
-	O	-1	6433367
and	O	-1	6433367
P@@	B-Chemical	D010433	6433367
T@@	I-Chemical	-1	6433367
Z	I-Chemical	-1	6433367
-induced	O	-1	6433367
convul@@	B-Disease	D012640	6433367
sions	I-Disease	-1	6433367
,	O	-1	6433367
but	O	-1	6433367
not	O	-1	6433367
p@@	B-Chemical	D010852	6433367
ic@@	I-Chemical	-1	6433367
ro@@	I-Chemical	-1	6433367
tox@@	I-Chemical	-1	6433367
in	I-Chemical	-1	6433367
-@@	O	-1	6433367
,	O	-1	6433367
electro@@	O	-1	6433367
sh@@	O	-1	6433367
oc@@	O	-1	6433367
k@@	O	-1	6433367
-@@	O	-1	6433367
,	O	-1	6433367
or	O	-1	6433367
b@@	B-Chemical	D001640	6433367
ic@@	I-Chemical	-1	6433367
uc@@	I-Chemical	-1	6433367
ul@@	I-Chemical	-1	6433367
line	I-Chemical	-1	6433367
-induced	O	-1	6433367
convul@@	B-Disease	D012640	6433367
sions	I-Disease	-1	6433367
.	O	-1	6433367

An@@	O	-1	17285209
gi@@	O	-1	17285209
otens@@	O	-1	17285209
in-@@	O	-1	17285209
conver@@	O	-1	17285209
ting	O	-1	17285209
enzyme	O	-1	17285209
(@@	O	-1	17285209
AC@@	O	-1	17285209
E@@	O	-1	17285209
)	O	-1	17285209
inhibitor@@	O	-1	17285209
-@@	O	-1	17285209
associated	O	-1	17285209
angio@@	B-Disease	D000799	17285209
e@@	I-Disease	-1	17285209
de@@	I-Disease	-1	17285209
ma	I-Disease	-1	17285209
of	O	-1	17285209
the	O	-1	17285209
st@@	O	-1	17285209
om@@	O	-1	17285209
ach	O	-1	17285209
and	O	-1	17285209
sm@@	O	-1	17285209
all	O	-1	17285209
in@@	O	-1	17285209
test@@	O	-1	17285209
ine@@	O	-1	17285209
:	O	-1	17285209
a	O	-1	17285209
case	O	-1	17285209
repor@@	O	-1	17285209
t.	O	-1	17285209
This	O	-1	17285209
is	O	-1	17285209
a	O	-1	17285209
case	O	-1	17285209
report	O	-1	17285209
on	O	-1	17285209
a	O	-1	17285209
4@@	O	-1	17285209
5-@@	O	-1	17285209
year	O	-1	17285209
old	O	-1	17285209
Af@@	O	-1	17285209
r@@	O	-1	17285209
ic@@	O	-1	17285209
an@@	O	-1	17285209
-@@	O	-1	17285209
A@@	O	-1	17285209
mer@@	O	-1	17285209
ic@@	O	-1	17285209
an	O	-1	17285209
female	O	-1	17285209
with	O	-1	17285209
ne@@	O	-1	17285209
w@@	O	-1	17285209
ly	O	-1	17285209
diagnos@@	O	-1	17285209
ed	O	-1	17285209
hypertension	B-Disease	D006973	17285209
,	O	-1	17285209
who	O	-1	17285209
was	O	-1	17285209
star@@	O	-1	17285209
ted	O	-1	17285209
on	O	-1	17285209
a	O	-1	17285209
combination	O	-1	17285209
p@@	O	-1	17285209
il@@	O	-1	17285209
l	O	-1	17285209
of	O	-1	17285209
am@@	B-Chemical	D017311	17285209
lo@@	I-Chemical	-1	17285209
di@@	I-Chemical	-1	17285209
pine	I-Chemical	-1	17285209
/	O	-1	17285209
ben@@	B-Chemical	C044946	17285209
az@@	I-Chemical	-1	17285209
apri@@	I-Chemical	-1	17285209
l	I-Chemical	-1	17285209
10@@	O	-1	17285209
/@@	O	-1	17285209
5	O	-1	17285209
mg@@	O	-1	17285209
.	O	-1	17285209
The	O	-1	17285209
very	O	-1	17285209
ne@@	O	-1	17285209
x@@	O	-1	17285209
t	O	-1	17285209
da@@	O	-1	17285209
y,	O	-1	17285209
sh@@	O	-1	17285209
e	O	-1	17285209
presented	O	-1	17285209
at	O	-1	17285209
the	O	-1	17285209
em@@	O	-1	17285209
er@@	O	-1	17285209
gen@@	O	-1	17285209
c@@	O	-1	17285209
y	O	-1	17285209
ro@@	O	-1	17285209
o@@	O	-1	17285209
m	O	-1	17285209
(@@	O	-1	17285209
E@@	O	-1	17285209
R@@	O	-1	17285209
)	O	-1	17285209
with	O	-1	17285209
ab@@	B-Disease	D015746	17285209
domin@@	I-Disease	-1	17285209
al	I-Disease	-1	17285209
pain	I-Disease	-1	17285209
,	O	-1	17285209
nausea	B-Disease	D009325	17285209
and	O	-1	17285209
v@@	B-Disease	D014839	17285209
om@@	I-Disease	-1	17285209
it@@	I-Disease	-1	17285209
ing	I-Disease	-1	17285209
.	O	-1	17285209
P@@	O	-1	17285209
hy@@	O	-1	17285209
si@@	O	-1	17285209
c@@	O	-1	17285209
al	O	-1	17285209
ex@@	O	-1	17285209
am@@	O	-1	17285209
,	O	-1	17285209
complete	O	-1	17285209
met@@	O	-1	17285209
ab@@	O	-1	17285209
olic	O	-1	17285209
p@@	O	-1	17285209
an@@	O	-1	17285209
el@@	O	-1	17285209
,	O	-1	17285209
and	O	-1	17285209
hemo@@	O	-1	17285209
gra@@	O	-1	17285209
m	O	-1	17285209
were	O	-1	17285209
in	O	-1	17285209
the	O	-1	17285209
normal	O	-1	17285209
rang@@	O	-1	17285209
e.	O	-1	17285209
S@@	O	-1	17285209
he	O	-1	17285209
was	O	-1	17285209
dis@@	O	-1	17285209
ch@@	O	-1	17285209
arg@@	O	-1	17285209
ed	O	-1	17285209
from	O	-1	17285209
the	O	-1	17285209
E@@	O	-1	17285209
R	O	-1	17285209
after	O	-1	17285209
a	O	-1	17285209
fe@@	O	-1	17285209
w	O	-1	17285209
hours	O	-1	17285209
of	O	-1	17285209
treatment	O	-1	17285209
with	O	-1	17285209
flu@@	O	-1	17285209
id	O	-1	17285209
and	O	-1	17285209
analge@@	O	-1	17285209
si@@	O	-1	17285209
c@@	O	-1	17285209
s.	O	-1	17285209
However,	O	-1	17285209
sh@@	O	-1	17285209
e	O	-1	17285209
retur@@	O	-1	17285209
n@@	O	-1	17285209
ed	O	-1	17285209
to	O	-1	17285209
the	O	-1	17285209
E@@	O	-1	17285209
R	O	-1	17285209
the	O	-1	17285209
ne@@	O	-1	17285209
x@@	O	-1	17285209
t	O	-1	17285209
day	O	-1	17285209
with	O	-1	17285209
the	O	-1	17285209
same	O	-1	17285209
com@@	O	-1	17285209
pl@@	O	-1	17285209
a@@	O	-1	17285209
int@@	O	-1	17285209
s.	O	-1	17285209
This	O	-1	17285209
time	O	-1	17285209
the	O	-1	17285209
physi@@	O	-1	17285209
c@@	O	-1	17285209
al	O	-1	17285209
ex@@	O	-1	17285209
am	O	-1	17285209
was	O	-1	17285209
significant	O	-1	17285209
for	O	-1	17285209
a	O	-1	17285209
dist@@	O	-1	17285209
en@@	O	-1	17285209
ded	O	-1	17285209
ab@@	O	-1	17285209
do@@	O	-1	17285209
men	O	-1	17285209
with	O	-1	17285209
d@@	O	-1	17285209
ul@@	O	-1	17285209
l@@	O	-1	17285209
ness	O	-1	17285209
to	O	-1	17285209
perc@@	O	-1	17285209
us@@	O	-1	17285209
sion.	O	-1	17285209
C@@	O	-1	17285209
T	O	-1	17285209
s@@	O	-1	17285209
can	O	-1	17285209
of	O	-1	17285209
the	O	-1	17285209
ab@@	O	-1	17285209
do@@	O	-1	17285209
men	O	-1	17285209
revealed	O	-1	17285209
mark@@	O	-1	17285209
ed@@	O	-1	17285209
ly	O	-1	17285209
th@@	O	-1	17285209
ic@@	O	-1	17285209
k@@	O	-1	17285209
en@@	O	-1	17285209
ed	O	-1	17285209
ant@@	O	-1	17285209
ru@@	O	-1	17285209
m	O	-1	17285209
of	O	-1	17285209
the	O	-1	17285209
st@@	O	-1	17285209
om@@	O	-1	17285209
ac@@	O	-1	17285209
h@@	O	-1	17285209
,	O	-1	17285209
du@@	O	-1	17285209
o@@	O	-1	17285209
d@@	O	-1	17285209
en@@	O	-1	17285209
um	O	-1	17285209
and	O	-1	17285209
j@@	O	-1	17285209
e@@	O	-1	17285209
j@@	O	-1	17285209
un@@	O	-1	17285209
um,	O	-1	17285209
al@@	O	-1	17285209
ong	O	-1	17285209
with	O	-1	17285209
flu@@	O	-1	17285209
id	O	-1	17285209
in	O	-1	17285209
the	O	-1	17285209
ab@@	O	-1	17285209
domin@@	O	-1	17285209
al	O	-1	17285209
and	O	-1	17285209
p@@	O	-1	17285209
el@@	O	-1	17285209
v@@	O	-1	17285209
ic	O	-1	17285209
ca@@	O	-1	17285209
v@@	O	-1	17285209
ity.	O	-1	17285209
An@@	O	-1	17285209
gi@@	O	-1	17285209
otens@@	O	-1	17285209
in-@@	O	-1	17285209
conver@@	O	-1	17285209
ting	O	-1	17285209
enzyme	O	-1	17285209
inhibitor	O	-1	17285209
(@@	O	-1	17285209
AC@@	O	-1	17285209
E@@	O	-1	17285209
I@@	O	-1	17285209
)@@	O	-1	17285209
-induced	O	-1	17285209
angio@@	B-Disease	D000799	17285209
e@@	I-Disease	-1	17285209
de@@	I-Disease	-1	17285209
ma	I-Disease	-1	17285209
was	O	-1	17285209
sus@@	O	-1	17285209
p@@	O	-1	17285209
ect@@	O	-1	17285209
ed,	O	-1	17285209
and	O	-1	17285209
anti@@	O	-1	17285209
-	O	-1	17285209
hypertensive	B-Disease	D006973	17285209
medic@@	O	-1	17285209
ations	O	-1	17285209
were	O	-1	17285209
discontinu@@	O	-1	17285209
ed.	O	-1	17285209
H@@	O	-1	17285209
er	O	-1	17285209
symptoms	O	-1	17285209
improved	O	-1	17285209
within	O	-1	17285209
the	O	-1	17285209
ne@@	O	-1	17285209
x@@	O	-1	17285209
t	O	-1	17285209
24	O	-1	17285209
hour@@	O	-1	17285209
s,	O	-1	17285209
and	O	-1	17285209
repe@@	O	-1	17285209
at	O	-1	17285209
C@@	O	-1	17285209
T	O	-1	17285209
after	O	-1	17285209
7@@	O	-1	17285209
2	O	-1	17285209
hours	O	-1	17285209
revealed	O	-1	17285209
mark@@	O	-1	17285209
ed	O	-1	17285209
impro@@	O	-1	17285209
vement	O	-1	17285209
in	O	-1	17285209
st@@	O	-1	17285209
om@@	O	-1	17285209
ach	O	-1	17285209
and	O	-1	17285209
sm@@	O	-1	17285209
all	O	-1	17285209
bo@@	O	-1	17285209
we@@	O	-1	17285209
l	O	-1	17285209
th@@	O	-1	17285209
ic@@	O	-1	17285209
k@@	O	-1	17285209
en@@	O	-1	17285209
ing	O	-1	17285209
and	O	-1	17285209
resol@@	O	-1	17285209
u@@	O	-1	17285209
tion	O	-1	17285209
of	O	-1	17285209
as@@	B-Disease	D001201	17285209
cit@@	I-Disease	-1	17285209
es	I-Disease	-1	17285209
.	O	-1	17285209
The	O	-1	17285209
reco@@	O	-1	17285209
gn@@	O	-1	17285209
ition	O	-1	17285209
of	O	-1	17285209
angiotens@@	B-Chemical	D000809	17285209
in	I-Chemical	-1	17285209
-@@	O	-1	17285209
conver@@	O	-1	17285209
ting	O	-1	17285209
enzyme	O	-1	17285209
(@@	O	-1	17285209
AC@@	O	-1	17285209
E@@	O	-1	17285209
)	O	-1	17285209
and	O	-1	17285209
angiotens@@	B-Chemical	D000809	17285209
in	I-Chemical	-1	17285209
receptor	O	-1	17285209
block@@	O	-1	17285209
er	O	-1	17285209
(A@@	O	-1	17285209
R@@	O	-1	17285209
B@@	O	-1	17285209
)	O	-1	17285209
in@@	B-Disease	D007410	17285209
test@@	I-Disease	-1	17285209
inal	I-Disease	-1	17285209
angio@@	I-Disease	-1	17285209
e@@	I-Disease	-1	17285209
de@@	I-Disease	-1	17285209
ma	I-Disease	-1	17285209
in@@	B-Disease	D000799	17285209
test@@	I-Disease	-1	17285209
inal	I-Disease	-1	17285209
angio@@	I-Disease	-1	17285209
e@@	I-Disease	-1	17285209
de@@	I-Disease	-1	17285209
ma	I-Disease	-1	17285209
con@@	O	-1	17285209
sti@@	O	-1	17285209
t@@	O	-1	17285209
ut@@	O	-1	17285209
es	O	-1	17285209
a	O	-1	17285209
ch@@	O	-1	17285209
all@@	O	-1	17285209
enge	O	-1	17285209
to	O	-1	17285209
prim@@	O	-1	17285209
ary	O	-1	17285209
car@@	O	-1	17285209
e	O	-1	17285209
physi@@	O	-1	17285209
ci@@	O	-1	17285209
an@@	O	-1	17285209
s,	O	-1	17285209
inter@@	O	-1	17285209
n@@	O	-1	17285209
ist@@	O	-1	17285209
s,	O	-1	17285209
em@@	O	-1	17285209
er@@	O	-1	17285209
gen@@	O	-1	17285209
c@@	O	-1	17285209
y	O	-1	17285209
ro@@	O	-1	17285209
o@@	O	-1	17285209
m	O	-1	17285209
per@@	O	-1	17285209
son@@	O	-1	17285209
al	O	-1	17285209
and	O	-1	17285209
sur@@	O	-1	17285209
ge@@	O	-1	17285209
on@@	O	-1	17285209
s.	O	-1	17285209

V@@	B-Chemical	D014635	15858223
al@@	I-Chemical	-1	15858223
pro@@	I-Chemical	-1	15858223
ic	I-Chemical	-1	15858223
acid	I-Chemical	-1	15858223
I@@	O	-1	15858223
:	O	-1	15858223
time	O	-1	15858223
course	O	-1	15858223
of	O	-1	15858223
li@@	O	-1	15858223
pid	O	-1	15858223
per@@	O	-1	15858223
oxid@@	O	-1	15858223
ation	O	-1	15858223
b@@	O	-1	15858223
i@@	O	-1	15858223
om@@	O	-1	15858223
ark@@	O	-1	15858223
er@@	O	-1	15858223
s,	O	-1	15858223
liver	B-Disease	D056486	15858223
toxicity	I-Disease	-1	15858223
,	O	-1	15858223
and	O	-1	15858223
valpro@@	B-Chemical	D014635	15858223
ic	I-Chemical	-1	15858223
acid	I-Chemical	-1	15858223
metabol@@	O	-1	15858223
ite	O	-1	15858223
levels	O	-1	15858223
in	O	-1	15858223
rats.	O	-1	15858223
A	O	-1	15858223
single	O	-1	15858223
dose	O	-1	15858223
of	O	-1	15858223
valpro@@	B-Chemical	D014635	15858223
ic	I-Chemical	-1	15858223
acid	I-Chemical	-1	15858223
(	O	-1	15858223
V@@	B-Chemical	D014635	15858223
P@@	I-Chemical	-1	15858223
A	I-Chemical	-1	15858223
),	O	-1	15858223
which	O	-1	15858223
is	O	-1	15858223
a	O	-1	15858223
wi@@	O	-1	15858223
de@@	O	-1	15858223
ly	O	-1	15858223
used	O	-1	15858223
anti@@	O	-1	15858223
epileptic	O	-1	15858223
drug@@	O	-1	15858223
,	O	-1	15858223
is	O	-1	15858223
associated	O	-1	15858223
with	O	-1	15858223
oxid@@	O	-1	15858223
ative	O	-1	15858223
stres@@	O	-1	15858223
s	O	-1	15858223
in	O	-1	15858223
rats,	O	-1	15858223
as	O	-1	15858223
rec@@	O	-1	15858223
ently	O	-1	15858223
demonstrated	O	-1	15858223
by	O	-1	15858223
elevated	O	-1	15858223
levels	O	-1	15858223
of	O	-1	15858223
1@@	B-Chemical	C075750	15858223
5-@@	I-Chemical	-1	15858223
F@@	I-Chemical	-1	15858223
(2@@	I-Chemical	-1	15858223
t@@	I-Chemical	-1	15858223
)-@@	I-Chemical	-1	15858223
iso@@	I-Chemical	-1	15858223
pro@@	I-Chemical	-1	15858223
st@@	I-Chemical	-1	15858223
ane	I-Chemical	-1	15858223
(	O	-1	15858223
1@@	B-Chemical	C075750	15858223
5-@@	I-Chemical	-1	15858223
F@@	I-Chemical	-1	15858223
(2@@	I-Chemical	-1	15858223
t@@	I-Chemical	-1	15858223
)-@@	I-Chemical	-1	15858223
I@@	I-Chemical	-1	15858223
so@@	I-Chemical	-1	15858223
P	I-Chemical	-1	15858223
).	O	-1	15858223
To	O	-1	15858223
determine	O	-1	15858223
whether	O	-1	15858223
there	O	-1	15858223
was	O	-1	15858223
a	O	-1	15858223
tempor@@	O	-1	15858223
al	O	-1	15858223
rel@@	O	-1	15858223
ationship	O	-1	15858223
between	O	-1	15858223
V@@	B-Chemical	D014635	15858223
P@@	I-Chemical	-1	15858223
A	I-Chemical	-1	15858223
-@@	O	-1	15858223
associated	O	-1	15858223
oxid@@	O	-1	15858223
ative	O	-1	15858223
stres@@	O	-1	15858223
s	O	-1	15858223
and	O	-1	15858223
hepat@@	B-Disease	D056486	15858223
otoxicity	I-Disease	-1	15858223
,	O	-1	15858223
ad@@	O	-1	15858223
ult	O	-1	15858223
male	O	-1	15858223
S@@	O	-1	15858223
pra@@	O	-1	15858223
gu@@	O	-1	15858223
e-@@	O	-1	15858223
D@@	O	-1	15858223
aw@@	O	-1	15858223
le@@	O	-1	15858223
y	O	-1	15858223
rats	O	-1	15858223
were	O	-1	15858223
treated	O	-1	15858223
i@@	O	-1	15858223
p	O	-1	15858223
with	O	-1	15858223
V@@	B-Chemical	D014635	15858223
P@@	I-Chemical	-1	15858223
A	I-Chemical	-1	15858223
(5@@	O	-1	15858223
00	O	-1	15858223
mg/kg)	O	-1	15858223
or	O	-1	15858223
0.@@	O	-1	15858223
9@@	O	-1	15858223
%	O	-1	15858223
saline	O	-1	15858223
(@@	O	-1	15858223
ve@@	O	-1	15858223
h@@	O	-1	15858223
ic@@	O	-1	15858223
le@@	O	-1	15858223
)	O	-1	15858223
on@@	O	-1	15858223
ce	O	-1	15858223
daily	O	-1	15858223
for	O	-1	15858223
2,	O	-1	15858223
4@@	O	-1	15858223
,	O	-1	15858223
7@@	O	-1	15858223
,	O	-1	15858223
10@@	O	-1	15858223
,	O	-1	15858223
or	O	-1	15858223
14	O	-1	15858223
days.	O	-1	15858223
O@@	O	-1	15858223
x@@	O	-1	15858223
id@@	O	-1	15858223
ative	O	-1	15858223
stres@@	O	-1	15858223
s	O	-1	15858223
was	O	-1	15858223
assessed	O	-1	15858223
by	O	-1	15858223
determin@@	O	-1	15858223
ing	O	-1	15858223
plasma	O	-1	15858223
and	O	-1	15858223
liver	O	-1	15858223
levels	O	-1	15858223
of	O	-1	15858223
1@@	B-Chemical	C075750	15858223
5-@@	I-Chemical	-1	15858223
F@@	I-Chemical	-1	15858223
(2@@	I-Chemical	-1	15858223
t@@	I-Chemical	-1	15858223
)-@@	I-Chemical	-1	15858223
I@@	I-Chemical	-1	15858223
so@@	I-Chemical	-1	15858223
P	I-Chemical	-1	15858223
,	O	-1	15858223
li@@	B-Chemical	D008054	15858223
pid	I-Chemical	-1	15858223
hydro@@	I-Chemical	-1	15858223
per@@	I-Chemical	-1	15858223
ox@@	I-Chemical	-1	15858223
i@@	I-Chemical	-1	15858223
des	I-Chemical	-1	15858223
(	O	-1	15858223
L@@	B-Chemical	D008054	15858223
P@@	I-Chemical	-1	15858223
O	I-Chemical	-1	15858223
),	O	-1	15858223
and	O	-1	15858223
th@@	B-Chemical	D017392	15858223
io@@	I-Chemical	-1	15858223
b@@	I-Chemical	-1	15858223
arbit@@	I-Chemical	-1	15858223
ur@@	I-Chemical	-1	15858223
ic	I-Chemical	-1	15858223
acid	I-Chemical	-1	15858223
reac@@	I-Chemical	-1	15858223
tive	I-Chemical	-1	15858223
subst@@	I-Chemical	-1	15858223
anc@@	I-Chemical	-1	15858223
es	I-Chemical	-1	15858223
(	O	-1	15858223
T@@	B-Chemical	D017392	15858223
BA@@	I-Chemical	-1	15858223
R@@	I-Chemical	-1	15858223
s	I-Chemical	-1	15858223
).	O	-1	15858223
P@@	O	-1	15858223
las@@	O	-1	15858223
ma	O	-1	15858223
and	O	-1	15858223
liver	O	-1	15858223
1@@	B-Chemical	C075750	15858223
5-@@	I-Chemical	-1	15858223
F@@	I-Chemical	-1	15858223
(2@@	I-Chemical	-1	15858223
t@@	I-Chemical	-1	15858223
)-@@	I-Chemical	-1	15858223
I@@	I-Chemical	-1	15858223
so@@	I-Chemical	-1	15858223
P	I-Chemical	-1	15858223
were	O	-1	15858223
elevated	O	-1	15858223
and	O	-1	15858223
reac@@	O	-1	15858223
h@@	O	-1	15858223
ed	O	-1	15858223
a	O	-1	15858223
plate@@	O	-1	15858223
a@@	O	-1	15858223
u	O	-1	15858223
after	O	-1	15858223
day	O	-1	15858223
2	O	-1	15858223
of	O	-1	15858223
V@@	B-Chemical	D014635	15858223
P@@	I-Chemical	-1	15858223
A	I-Chemical	-1	15858223
treatment	O	-1	15858223
compared	O	-1	15858223
to	O	-1	15858223
control@@	O	-1	15858223
.	O	-1	15858223
L@@	O	-1	15858223
i@@	O	-1	15858223
ver	O	-1	15858223
L@@	B-Chemical	D008054	15858223
P@@	I-Chemical	-1	15858223
O	I-Chemical	-1	15858223
levels	O	-1	15858223
were	O	-1	15858223
not	O	-1	15858223
elevated	O	-1	15858223
un@@	O	-1	15858223
ti@@	O	-1	15858223
l	O	-1	15858223
day	O	-1	15858223
7	O	-1	15858223
of	O	-1	15858223
treatment	O	-1	15858223
(1@@	O	-1	15858223
.@@	O	-1	15858223
8@@	O	-1	15858223
-@@	O	-1	15858223
fol@@	O	-1	15858223
d	O	-1	15858223
versus	O	-1	15858223
control@@	O	-1	15858223
,	O	-1	15858223
p	O	-1	15858223
<	O	-1	15858223
0.05@@	O	-1	15858223
).	O	-1	15858223
L@@	O	-1	15858223
i@@	O	-1	15858223
ver	O	-1	15858223
and	O	-1	15858223
plasma	O	-1	15858223
T@@	B-Chemical	D017392	15858223
BA@@	I-Chemical	-1	15858223
R@@	I-Chemical	-1	15858223
s	I-Chemical	-1	15858223
were	O	-1	15858223
not	O	-1	15858223
increased	O	-1	15858223
un@@	O	-1	15858223
ti@@	O	-1	15858223
l	O	-1	15858223
14	O	-1	15858223
days	O	-1	15858223
(2@@	O	-1	15858223
-@@	O	-1	15858223
fol@@	O	-1	15858223
d	O	-1	15858223
vs.	O	-1	15858223
control@@	O	-1	15858223
,	O	-1	15858223
p	O	-1	15858223
<	O	-1	15858223
0.05@@	O	-1	15858223
).	O	-1	15858223
L@@	B-Disease	D056486	15858223
i@@	I-Disease	-1	15858223
ver	I-Disease	-1	15858223
toxicity	I-Disease	-1	15858223
was	O	-1	15858223
evaluated	O	-1	15858223
bas@@	O	-1	15858223
ed	O	-1	15858223
on	O	-1	15858223
serum	O	-1	15858223
levels	O	-1	15858223
of	O	-1	15858223
alpha@@	O	-1	15858223
-	O	-1	15858223
glut@@	B-Chemical	D005978	15858223
athi@@	I-Chemical	-1	15858223
one	I-Chemical	-1	15858223
S@@	O	-1	15858223
-@@	O	-1	15858223
trans@@	O	-1	15858223
fer@@	O	-1	15858223
ase	O	-1	15858223
(@@	O	-1	15858223
alpha-@@	O	-1	15858223
G@@	O	-1	15858223
S@@	O	-1	15858223
T)	O	-1	15858223
and	O	-1	15858223
by	O	-1	15858223
hist@@	O	-1	15858223
olog@@	O	-1	15858223
y.	O	-1	15858223
S@@	O	-1	15858223
er@@	O	-1	15858223
um	O	-1	15858223
alpha-@@	O	-1	15858223
G@@	O	-1	15858223
S@@	O	-1	15858223
T	O	-1	15858223
levels	O	-1	15858223
were	O	-1	15858223
significantly	O	-1	15858223
elevated	O	-1	15858223
by	O	-1	15858223
day	O	-1	15858223
4@@	O	-1	15858223
,	O	-1	15858223
which	O	-1	15858223
cor@@	O	-1	15858223
respon@@	O	-1	15858223
ded	O	-1	15858223
to	O	-1	15858223
hepat@@	B-Disease	D056486	15858223
otoxicity	I-Disease	-1	15858223
as	O	-1	15858223
shown	O	-1	15858223
by	O	-1	15858223
the	O	-1	15858223
increas@@	O	-1	15858223
ing	O	-1	15858223
incidence	O	-1	15858223
of	O	-1	15858223
inflam@@	B-Disease	D007249	15858223
m@@	I-Disease	-1	15858223
ation	I-Disease	-1	15858223
of	O	-1	15858223
the	O	-1	15858223
liver	O	-1	15858223
cap@@	O	-1	15858223
sul@@	O	-1	15858223
e,	O	-1	15858223
necro@@	B-Disease	D009336	15858223
sis	I-Disease	-1	15858223
,	O	-1	15858223
and	O	-1	15858223
ste@@	B-Disease	D005234	15858223
at@@	I-Disease	-1	15858223
o@@	I-Disease	-1	15858223
sis	I-Disease	-1	15858223
throu@@	O	-1	15858223
gh@@	O	-1	15858223
out	O	-1	15858223
the	O	-1	15858223
study.	O	-1	15858223
The	O	-1	15858223
liver	O	-1	15858223
levels	O	-1	15858223
of	O	-1	15858223
beta-@@	O	-1	15858223
oxid@@	O	-1	15858223
ation	O	-1	15858223
metabol@@	O	-1	15858223
it@@	O	-1	15858223
es	O	-1	15858223
of	O	-1	15858223
V@@	B-Chemical	D014635	15858223
P@@	I-Chemical	-1	15858223
A	I-Chemical	-1	15858223
were	O	-1	15858223
decreased	O	-1	15858223
by	O	-1	15858223
day	O	-1	15858223
14@@	O	-1	15858223
,	O	-1	15858223
while	O	-1	15858223
the	O	-1	15858223
levels	O	-1	15858223
of	O	-1	15858223
4-@@	B-Chemical	C045022	15858223
en@@	I-Chemical	-1	15858223
e-@@	I-Chemical	-1	15858223
V@@	I-Chemical	-1	15858223
P@@	I-Chemical	-1	15858223
A	I-Chemical	-1	15858223
and	O	-1	15858223
(@@	O	-1	15858223
E@@	O	-1	15858223
)@@	O	-1	15858223
-	O	-1	15858223
2@@	B-Chemical	C556631	15858223
,@@	I-Chemical	-1	15858223
4-@@	I-Chemical	-1	15858223
di@@	I-Chemical	-1	15858223
en@@	I-Chemical	-1	15858223
e-@@	I-Chemical	-1	15858223
V@@	I-Chemical	-1	15858223
P@@	I-Chemical	-1	15858223
A	I-Chemical	-1	15858223
were	O	-1	15858223
not	O	-1	15858223
elevated	O	-1	15858223
throu@@	O	-1	15858223
gh@@	O	-1	15858223
out	O	-1	15858223
the	O	-1	15858223
study.	O	-1	15858223
O@@	O	-1	15858223
ver@@	O	-1	15858223
all@@	O	-1	15858223
,	O	-1	15858223
these	O	-1	15858223
findings	O	-1	15858223
indicate	O	-1	15858223
that	O	-1	15858223
V@@	B-Chemical	D014635	15858223
P@@	I-Chemical	-1	15858223
A	I-Chemical	-1	15858223
treatment	O	-1	15858223
results	O	-1	15858223
in	O	-1	15858223
oxid@@	O	-1	15858223
ative	O	-1	15858223
stres@@	O	-1	15858223
s,	O	-1	15858223
as	O	-1	15858223
measured	O	-1	15858223
by	O	-1	15858223
levels	O	-1	15858223
of	O	-1	15858223
1@@	B-Chemical	C075750	15858223
5-@@	I-Chemical	-1	15858223
F@@	I-Chemical	-1	15858223
(2@@	I-Chemical	-1	15858223
t@@	I-Chemical	-1	15858223
)-@@	I-Chemical	-1	15858223
I@@	I-Chemical	-1	15858223
so@@	I-Chemical	-1	15858223
P	I-Chemical	-1	15858223
,	O	-1	15858223
which	O	-1	15858223
pre@@	O	-1	15858223
ce@@	O	-1	15858223
des	O	-1	15858223
the	O	-1	15858223
onset	O	-1	15858223
of	O	-1	15858223
necro@@	B-Disease	D009336	15858223
sis	I-Disease	-1	15858223
,	O	-1	15858223
ste@@	B-Disease	D005234	15858223
at@@	I-Disease	-1	15858223
o@@	I-Disease	-1	15858223
sis	I-Disease	-1	15858223
,	O	-1	15858223
and	O	-1	15858223
elevated	O	-1	15858223
levels	O	-1	15858223
of	O	-1	15858223
serum	O	-1	15858223
alpha-@@	O	-1	15858223
G@@	O	-1	15858223
S@@	O	-1	15858223
T@@	O	-1	15858223
.	O	-1	15858223

P@@	B-Disease	D010673	15811908
he@@	I-Disease	-1	15811908
och@@	I-Disease	-1	15811908
rom@@	I-Disease	-1	15811908
ocyto@@	I-Disease	-1	15811908
ma	I-Disease	-1	15811908
un@@	O	-1	15811908
mas@@	O	-1	15811908
ked	O	-1	15811908
by	O	-1	15811908
am@@	B-Chemical	C012052	15811908
is@@	I-Chemical	-1	15811908
ul@@	I-Chemical	-1	15811908
pri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
and	O	-1	15811908
ti@@	B-Chemical	D063325	15811908
apri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
.	O	-1	15811908
OBJECTIVE:	O	-1	15811908
To	O	-1	15811908
describe	O	-1	15811908
the	O	-1	15811908
un@@	O	-1	15811908
mas@@	O	-1	15811908
king	O	-1	15811908
of	O	-1	15811908
ph@@	B-Disease	D010673	15811908
e@@	I-Disease	-1	15811908
och@@	I-Disease	-1	15811908
rom@@	I-Disease	-1	15811908
ocyto@@	I-Disease	-1	15811908
ma	I-Disease	-1	15811908
in	O	-1	15811908
a	O	-1	15811908
patient	O	-1	15811908
treated	O	-1	15811908
with	O	-1	15811908
am@@	B-Chemical	C012052	15811908
is@@	I-Chemical	-1	15811908
ul@@	I-Chemical	-1	15811908
pri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
and	O	-1	15811908
ti@@	B-Chemical	D063325	15811908
apri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
.	O	-1	15811908
CA@@	O	-1	15811908
S@@	O	-1	15811908
E	O	-1	15811908
S@@	O	-1	15811908
U@@	O	-1	15811908
M@@	O	-1	15811908
MA@@	O	-1	15811908
R@@	O	-1	15811908
Y@@	O	-1	15811908
:	O	-1	15811908
A	O	-1	15811908
4@@	O	-1	15811908
2-@@	O	-1	15811908
year-old	O	-1	15811908
wh@@	O	-1	15811908
ite	O	-1	15811908
man	O	-1	15811908
developed	O	-1	15811908
acute	O	-1	15811908
hypertension	B-Disease	D006973	15811908
with	O	-1	15811908
severe	O	-1	15811908
headac@@	B-Disease	D006261	15811908
he	I-Disease	-1	15811908
and	O	-1	15811908
v@@	B-Disease	D014839	15811908
om@@	I-Disease	-1	15811908
it@@	I-Disease	-1	15811908
ing	I-Disease	-1	15811908
2	O	-1	15811908
hours	O	-1	15811908
after	O	-1	15811908
the	O	-1	15811908
first	O	-1	15811908
doses	O	-1	15811908
of	O	-1	15811908
am@@	B-Chemical	C012052	15811908
is@@	I-Chemical	-1	15811908
ul@@	I-Chemical	-1	15811908
pri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
100	O	-1	15811908
mg	O	-1	15811908
and	O	-1	15811908
ti@@	B-Chemical	D063325	15811908
apri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
100	O	-1	15811908
mg@@	O	-1	15811908
.	O	-1	15811908
B@@	O	-1	15811908
oth	O	-1	15811908
drugs	O	-1	15811908
were	O	-1	15811908
immedi@@	O	-1	15811908
ately	O	-1	15811908
discontinu@@	O	-1	15811908
ed,	O	-1	15811908
and	O	-1	15811908
the	O	-1	15811908
patient	O	-1	15811908
reco@@	O	-1	15811908
vered	O	-1	15811908
after	O	-1	15811908
subsequ@@	O	-1	15811908
ent	O	-1	15811908
n@@	B-Chemical	D009529	15811908
ic@@	I-Chemical	-1	15811908
ardi@@	I-Chemical	-1	15811908
pine	I-Chemical	-1	15811908
and	O	-1	15811908
verap@@	B-Chemical	D014700	15811908
ami@@	I-Chemical	-1	15811908
l	I-Chemical	-1	15811908
treatment.	O	-1	15811908
A@@	O	-1	15811908
b@@	O	-1	15811908
domin@@	O	-1	15811908
al	O	-1	15811908
ult@@	O	-1	15811908
r@@	O	-1	15811908
as@@	O	-1	15811908
ound	O	-1	15811908
showed	O	-1	15811908
an	O	-1	15811908
ad@@	O	-1	15811908
renal	O	-1	15811908
mas@@	O	-1	15811908
s,	O	-1	15811908
and	O	-1	15811908
postoperative	O	-1	15811908
hist@@	O	-1	15811908
ologic	O	-1	15811908
examin@@	O	-1	15811908
ation	O	-1	15811908
con@@	O	-1	15811908
fir@@	O	-1	15811908
m@@	O	-1	15811908
ed	O	-1	15811908
the	O	-1	15811908
diagnosis	O	-1	15811908
of	O	-1	15811908
ph@@	B-Disease	D010673	15811908
e@@	I-Disease	-1	15811908
och@@	I-Disease	-1	15811908
rom@@	I-Disease	-1	15811908
ocyto@@	I-Disease	-1	15811908
ma	I-Disease	-1	15811908
.	O	-1	15811908
D@@	O	-1	15811908
I@@	O	-1	15811908
S@@	O	-1	15811908
C@@	O	-1	15811908
US@@	O	-1	15811908
S@@	O	-1	15811908
ION@@	O	-1	15811908
:	O	-1	15811908
D@@	O	-1	15811908
ru@@	O	-1	15811908
g@@	O	-1	15811908
-induced	O	-1	15811908
symptoms	O	-1	15811908
of	O	-1	15811908
ph@@	B-Disease	D010673	15811908
e@@	I-Disease	-1	15811908
och@@	I-Disease	-1	15811908
rom@@	I-Disease	-1	15811908
ocyto@@	I-Disease	-1	15811908
ma	I-Disease	-1	15811908
are	O	-1	15811908
often	O	-1	15811908
associated	O	-1	15811908
with	O	-1	15811908
the	O	-1	15811908
use	O	-1	15811908
of	O	-1	15811908
sub@@	O	-1	15811908
sti@@	O	-1	15811908
t@@	O	-1	15811908
ut@@	O	-1	15811908
ed	O	-1	15811908
b@@	B-Chemical	C037689	15811908
enz@@	I-Chemical	-1	15811908
amide	I-Chemical	-1	15811908
drug@@	O	-1	15811908
s,	O	-1	15811908
but	O	-1	15811908
the	O	-1	15811908
underlying	O	-1	15811908
mechanism	O	-1	15811908
is	O	-1	15811908
un@@	O	-1	15811908
know@@	O	-1	15811908
n@@	O	-1	15811908
.	O	-1	15811908
In	O	-1	15811908
our	O	-1	15811908
cas@@	O	-1	15811908
e,	O	-1	15811908
use	O	-1	15811908
of	O	-1	15811908
the	O	-1	15811908
N@@	O	-1	15811908
ar@@	O	-1	15811908
an@@	O	-1	15811908
j@@	O	-1	15811908
o	O	-1	15811908
prob@@	O	-1	15811908
ability	O	-1	15811908
s@@	O	-1	15811908
cal@@	O	-1	15811908
e	O	-1	15811908
indic@@	O	-1	15811908
ated	O	-1	15811908
a	O	-1	15811908
possible	O	-1	15811908
rel@@	O	-1	15811908
ationship	O	-1	15811908
between	O	-1	15811908
the	O	-1	15811908
hypertensive	B-Disease	D006973	15811908
cri@@	O	-1	15811908
sis	O	-1	15811908
and	O	-1	15811908
am@@	B-Chemical	C012052	15811908
is@@	I-Chemical	-1	15811908
ul@@	I-Chemical	-1	15811908
pri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
and	O	-1	15811908
ti@@	B-Chemical	D063325	15811908
apri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
therapy.	O	-1	15811908
CONCLUSIONS:	O	-1	15811908
A@@	O	-1	15811908
s	O	-1	15811908
of	O	-1	15811908
M@@	O	-1	15811908
arc@@	O	-1	15811908
h	O	-1	15811908
2@@	O	-1	15811908
4@@	O	-1	15811908
,	O	-1	15811908
20@@	O	-1	15811908
0@@	O	-1	15811908
5,	O	-1	15811908
this	O	-1	15811908
is	O	-1	15811908
the	O	-1	15811908
first	O	-1	15811908
reported	O	-1	15811908
case	O	-1	15811908
of	O	-1	15811908
am@@	B-Chemical	C012052	15811908
is@@	I-Chemical	-1	15811908
ul@@	I-Chemical	-1	15811908
pri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
-	O	-1	15811908
and	O	-1	15811908
ti@@	B-Chemical	D063325	15811908
apri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
-induced	O	-1	15811908
hypertensive	B-Disease	D006973	15811908
cri@@	O	-1	15811908
sis	O	-1	15811908
in	O	-1	15811908
a	O	-1	15811908
patient	O	-1	15811908
with	O	-1	15811908
ph@@	B-Disease	D010673	15811908
e@@	I-Disease	-1	15811908
och@@	I-Disease	-1	15811908
rom@@	I-Disease	-1	15811908
ocyto@@	I-Disease	-1	15811908
ma	I-Disease	-1	15811908
.	O	-1	15811908
P@@	O	-1	15811908
hy@@	O	-1	15811908
si@@	O	-1	15811908
ci@@	O	-1	15811908
ans	O	-1	15811908
and	O	-1	15811908
other	O	-1	15811908
health@@	O	-1	15811908
car@@	O	-1	15811908
e	O	-1	15811908
prof@@	O	-1	15811908
es@@	O	-1	15811908
sion@@	O	-1	15811908
als	O	-1	15811908
should	O	-1	15811908
be	O	-1	15811908
aw@@	O	-1	15811908
are	O	-1	15811908
of	O	-1	15811908
this	O	-1	15811908
potential	O	-1	15811908
adverse	O	-1	15811908
effect	O	-1	15811908
of	O	-1	15811908
ti@@	B-Chemical	D063325	15811908
apri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
and	O	-1	15811908
am@@	B-Chemical	C012052	15811908
is@@	I-Chemical	-1	15811908
ul@@	I-Chemical	-1	15811908
pri@@	I-Chemical	-1	15811908
de	I-Chemical	-1	15811908
.	O	-1	15811908

Q@@	O	-1	15764424
u@@	O	-1	15764424
anti@@	O	-1	15764424
t@@	O	-1	15764424
ative	O	-1	15764424
drug	O	-1	15764424
levels	O	-1	15764424
in	O	-1	15764424
stimul@@	O	-1	15764424
ant	O	-1	15764424
psycho@@	B-Disease	D011605	15764424
sis	I-Disease	-1	15764424
:	O	-1	15764424
rel@@	O	-1	15764424
ationship	O	-1	15764424
to	O	-1	15764424
sympto@@	O	-1	15764424
m	O	-1	15764424
sever@@	O	-1	15764424
ity,	O	-1	15764424
cat@@	B-Chemical	D002395	15764424
ech@@	I-Chemical	-1	15764424
ol@@	I-Chemical	-1	15764424
amin@@	I-Chemical	-1	15764424
es	I-Chemical	-1	15764424
and	O	-1	15764424
hyper@@	B-Disease	D006948	15764424
kine@@	I-Disease	-1	15764424
sia	I-Disease	-1	15764424
.	O	-1	15764424
To	O	-1	15764424
ex@@	O	-1	15764424
amine	O	-1	15764424
the	O	-1	15764424
rel@@	O	-1	15764424
ationship	O	-1	15764424
between	O	-1	15764424
qu@@	O	-1	15764424
anti@@	O	-1	15764424
t@@	O	-1	15764424
ative	O	-1	15764424
stimul@@	O	-1	15764424
ant	O	-1	15764424
drug	O	-1	15764424
level@@	O	-1	15764424
s,	O	-1	15764424
cat@@	B-Chemical	D002395	15764424
ech@@	I-Chemical	-1	15764424
ol@@	I-Chemical	-1	15764424
amin@@	I-Chemical	-1	15764424
es	I-Chemical	-1	15764424
,	O	-1	15764424
and	O	-1	15764424
psycho@@	B-Disease	D011605	15764424
tic	I-Disease	-1	15764424
symptoms	I-Disease	-1	15764424
,	O	-1	15764424
n@@	O	-1	15764424
ine@@	O	-1	15764424
te@@	O	-1	15764424
en	O	-1	15764424
patients	O	-1	15764424
in	O	-1	15764424
a	O	-1	15764424
psych@@	B-Disease	D001523	15764424
i@@	I-Disease	-1	15764424
atric	I-Disease	-1	15764424
em@@	O	-1	15764424
er@@	O	-1	15764424
gen@@	O	-1	15764424
c@@	O	-1	15764424
y	O	-1	15764424
ser@@	O	-1	15764424
v@@	O	-1	15764424
ic@@	O	-1	15764424
e	O	-1	15764424
with	O	-1	15764424
a	O	-1	15764424
diagnosis	O	-1	15764424
of	O	-1	15764424
amphetamine	B-Chemical	D000661	15764424
-	O	-1	15764424
or	O	-1	15764424
cocaine	B-Chemical	D003042	15764424
-induced	O	-1	15764424
psycho@@	B-Disease	D011605	15764424
sis	I-Disease	-1	15764424
were	O	-1	15764424
inter@@	O	-1	15764424
vie@@	O	-1	15764424
we@@	O	-1	15764424
d,	O	-1	15764424
and	O	-1	15764424
plasma	O	-1	15764424
and	O	-1	15764424
urine	O	-1	15764424
were	O	-1	15764424
coll@@	O	-1	15764424
ected	O	-1	15764424
for	O	-1	15764424
qu@@	O	-1	15764424
anti@@	O	-1	15764424
t@@	O	-1	15764424
ative	O	-1	15764424
ass@@	O	-1	15764424
ays	O	-1	15764424
of	O	-1	15764424
stimul@@	O	-1	15764424
ant	O	-1	15764424
drug	O	-1	15764424
and	O	-1	15764424
cat@@	B-Chemical	D002395	15764424
ech@@	I-Chemical	-1	15764424
ol@@	I-Chemical	-1	15764424
amine	I-Chemical	-1	15764424
metabol@@	O	-1	15764424
ite	O	-1	15764424
level@@	O	-1	15764424
s.	O	-1	15764424
M@@	B-Chemical	D008694	15764424
eth@@	I-Chemical	-1	15764424
amphetamine	I-Chemical	-1	15764424
or	O	-1	15764424
amphetamine	B-Chemical	D000661	15764424
levels	O	-1	15764424
were	O	-1	15764424
related	O	-1	15764424
to	O	-1	15764424
several	O	-1	15764424
psycho@@	O	-1	15764424
path@@	O	-1	15764424
ology	O	-1	15764424
sco@@	O	-1	15764424
res	O	-1	15764424
and	O	-1	15764424
the	O	-1	15764424
glo@@	O	-1	15764424
b@@	O	-1	15764424
al	O	-1	15764424
hyper@@	B-Disease	D006948	15764424
kine@@	I-Disease	-1	15764424
sia	I-Disease	-1	15764424
rat@@	O	-1	15764424
ing.	O	-1	15764424
H@@	O	-1	15764424
V@@	O	-1	15764424
A	O	-1	15764424
levels	O	-1	15764424
were	O	-1	15764424
related	O	-1	15764424
to	O	-1	15764424
glo@@	O	-1	15764424
b@@	O	-1	15764424
al	O	-1	15764424
hyper@@	B-Disease	D006948	15764424
kine@@	I-Disease	-1	15764424
sia	I-Disease	-1	15764424
but	O	-1	15764424
not	O	-1	15764424
to	O	-1	15764424
psycho@@	O	-1	15764424
path@@	O	-1	15764424
ology	O	-1	15764424
rat@@	O	-1	15764424
ing@@	O	-1	15764424
s.	O	-1	15764424
Although	O	-1	15764424
man@@	O	-1	15764424
y	O	-1	15764424
other	O	-1	15764424
factors	O	-1	15764424
such	O	-1	15764424
as	O	-1	15764424
sensi@@	O	-1	15764424
tiz@@	O	-1	15764424
ation	O	-1	15764424
may	O	-1	15764424
pl@@	O	-1	15764424
ay	O	-1	15764424
a	O	-1	15764424
ro@@	O	-1	15764424
le@@	O	-1	15764424
,	O	-1	15764424
int@@	O	-1	15764424
ensity	O	-1	15764424
of	O	-1	15764424
stimul@@	O	-1	15764424
ant@@	O	-1	15764424
-induced	O	-1	15764424
psycho@@	B-Disease	D011605	15764424
tic	I-Disease	-1	15764424
symptoms	I-Disease	-1	15764424
and	O	-1	15764424
ste@@	B-Disease	D019956	15764424
re@@	I-Disease	-1	15764424
ot@@	I-Disease	-1	15764424
y@@	I-Disease	-1	15764424
pi@@	I-Disease	-1	15764424
es	I-Disease	-1	15764424
appear@@	O	-1	15764424
s	O	-1	15764424
to	O	-1	15764424
be	O	-1	15764424
at	O	-1	15764424
le@@	O	-1	15764424
ast	O	-1	15764424
in	O	-1	15764424
par@@	O	-1	15764424
t	O	-1	15764424
dose-@@	O	-1	15764424
rel@@	O	-1	15764424
ated.	O	-1	15764424

D@@	O	-1	12101159
el@@	O	-1	12101159
ayed	O	-1	12101159
as@@	B-Disease	D006323	12101159
y@@	I-Disease	-1	12101159
st@@	I-Disease	-1	12101159
olic	I-Disease	-1	12101159
cardiac	B-Disease	D006323	12101159
ar@@	I-Disease	-1	12101159
res@@	I-Disease	-1	12101159
t	I-Disease	-1	12101159
after	O	-1	12101159
di@@	B-Chemical	D004110	12101159
l@@	I-Chemical	-1	12101159
ti@@	I-Chemical	-1	12101159
az@@	I-Chemical	-1	12101159
em	I-Chemical	-1	12101159
over@@	B-Disease	D062787	12101159
dose	I-Disease	-1	12101159
;	O	-1	12101159
res@@	O	-1	12101159
us@@	O	-1	12101159
cit@@	O	-1	12101159
ation	O	-1	12101159
with	O	-1	12101159
high	O	-1	12101159
dose	O	-1	12101159
intravenous	O	-1	12101159
calcium	B-Chemical	D002118	12101159
.	O	-1	12101159
A	O	-1	12101159
5@@	O	-1	12101159
1	O	-1	12101159
year	O	-1	12101159
old	O	-1	12101159
man	O	-1	12101159
to@@	O	-1	12101159
o@@	O	-1	12101159
k	O	-1	12101159
a	O	-1	12101159
mi@@	O	-1	12101159
x@@	O	-1	12101159
ed	O	-1	12101159
over@@	B-Disease	D062787	12101159
dose	I-Disease	-1	12101159
including	O	-1	12101159
1.@@	O	-1	12101159
8@@	O	-1	12101159
-@@	O	-1	12101159
3.@@	O	-1	12101159
6	O	-1	12101159
g	O	-1	12101159
of	O	-1	12101159
di@@	B-Chemical	D004110	12101159
l@@	I-Chemical	-1	12101159
ti@@	I-Chemical	-1	12101159
az@@	I-Chemical	-1	12101159
em	I-Chemical	-1	12101159
,	O	-1	12101159
par@@	B-Chemical	D000082	12101159
acet@@	I-Chemical	-1	12101159
am@@	I-Chemical	-1	12101159
ol	I-Chemical	-1	12101159
,	O	-1	12101159
as@@	B-Chemical	D001241	12101159
pi@@	I-Chemical	-1	12101159
rin	I-Chemical	-1	12101159
,	O	-1	12101159
is@@	B-Chemical	D007547	12101159
os@@	I-Chemical	-1	12101159
or@@	I-Chemical	-1	12101159
b@@	I-Chemical	-1	12101159
ide	I-Chemical	-1	12101159
nit@@	B-Chemical	D009566	12101159
rate	I-Chemical	-1	12101159
,	O	-1	12101159
and	O	-1	12101159
alco@@	B-Chemical	D000431	12101159
hol	I-Chemical	-1	12101159
.	O	-1	12101159
H@@	O	-1	12101159
e	O	-1	12101159
initi@@	O	-1	12101159
ally	O	-1	12101159
presented	O	-1	12101159
to	O	-1	12101159
hospit@@	O	-1	12101159
al	O	-1	12101159
after	O	-1	12101159
six	O	-1	12101159
hours	O	-1	12101159
with	O	-1	12101159
mil@@	O	-1	12101159
d	O	-1	12101159
hypotension	B-Disease	D007022	12101159
and	O	-1	12101159
was	O	-1	12101159
treated	O	-1	12101159
with	O	-1	12101159
activ@@	O	-1	12101159
ated	O	-1	12101159
ch@@	O	-1	12101159
ar@@	O	-1	12101159
co@@	O	-1	12101159
al	O	-1	12101159
and	O	-1	12101159
intravenous	O	-1	12101159
flu@@	O	-1	12101159
id@@	O	-1	12101159
s.	O	-1	12101159
E@@	O	-1	12101159
igh@@	O	-1	12101159
te@@	O	-1	12101159
en	O	-1	12101159
hours	O	-1	12101159
after	O	-1	12101159
the	O	-1	12101159
over@@	B-Disease	D062787	12101159
dose	I-Disease	-1	12101159
he	O	-1	12101159
had	O	-1	12101159
two	O	-1	12101159
gener@@	O	-1	12101159
al@@	O	-1	12101159
is@@	O	-1	12101159
ed	O	-1	12101159
t@@	B-Disease	D004830	12101159
on@@	I-Disease	-1	12101159
ic@@	I-Disease	-1	12101159
-@@	I-Disease	-1	12101159
clon@@	I-Disease	-1	12101159
ic	I-Disease	-1	12101159
seizures	I-Disease	-1	12101159
.	O	-1	12101159
The	O	-1	12101159
patient	O	-1	12101159
remained	O	-1	12101159
un@@	O	-1	12101159
respon@@	O	-1	12101159
sive	O	-1	12101159
with	O	-1	12101159
j@@	O	-1	12101159
unc@@	O	-1	12101159
tional	O	-1	12101159
brady@@	B-Disease	D001919	12101159
cardia	I-Disease	-1	12101159
,	O	-1	12101159
un@@	O	-1	12101159
recor@@	O	-1	12101159
d@@	O	-1	12101159
able	O	-1	12101159
blood	O	-1	12101159
pressu@@	O	-1	12101159
re,	O	-1	12101159
and	O	-1	12101159
then	O	-1	12101159
b@@	O	-1	12101159
ec@@	O	-1	12101159
am@@	O	-1	12101159
e	O	-1	12101159
as@@	B-Disease	D006323	12101159
y@@	I-Disease	-1	12101159
st@@	I-Disease	-1	12101159
olic	I-Disease	-1	12101159
.	O	-1	12101159
H@@	O	-1	12101159
e	O	-1	12101159
was	O	-1	12101159
res@@	O	-1	12101159
us@@	O	-1	12101159
cit@@	O	-1	12101159
ated	O	-1	12101159
with	O	-1	12101159
high	O	-1	12101159
dose	O	-1	12101159
(1@@	O	-1	12101159
3.@@	O	-1	12101159
5	O	-1	12101159
g@@	O	-1	12101159
)	O	-1	12101159
intravenous	O	-1	12101159
calcium	B-Chemical	D002118	12101159
and	O	-1	12101159
adren@@	B-Chemical	D004837	12101159
aline	I-Chemical	-1	12101159
(	O	-1	12101159
ep@@	B-Chemical	D004837	12101159
ine@@	I-Chemical	-1	12101159
phrine	I-Chemical	-1	12101159
).	O	-1	12101159
H@@	O	-1	12101159
e	O	-1	12101159
requ@@	O	-1	12101159
ired	O	-1	12101159
in@@	O	-1	12101159
ot@@	O	-1	12101159
ro@@	O	-1	12101159
p@@	O	-1	12101159
ic	O	-1	12101159
suppor@@	O	-1	12101159
t	O	-1	12101159
and	O	-1	12101159
tempor@@	O	-1	12101159
ary	O	-1	12101159
pac@@	O	-1	12101159
ing	O	-1	12101159
over	O	-1	12101159
the	O	-1	12101159
ne@@	O	-1	12101159
x@@	O	-1	12101159
t	O	-1	12101159
4@@	O	-1	12101159
8	O	-1	12101159
hour@@	O	-1	12101159
s.	O	-1	12101159
This	O	-1	12101159
case	O	-1	12101159
suggests	O	-1	12101159
there	O	-1	12101159
is	O	-1	12101159
a	O	-1	12101159
role	O	-1	12101159
for	O	-1	12101159
ag@@	O	-1	12101159
gres@@	O	-1	12101159
sive	O	-1	12101159
high	O	-1	12101159
dose	O	-1	12101159
intravenous	O	-1	12101159
calcium	B-Chemical	D002118	12101159
therapy	O	-1	12101159
in	O	-1	12101159
severe	O	-1	12101159
di@@	B-Chemical	D004110	12101159
l@@	I-Chemical	-1	12101159
ti@@	I-Chemical	-1	12101159
az@@	I-Chemical	-1	12101159
em	I-Chemical	-1	12101159
over@@	B-Disease	D062787	12101159
dose	I-Disease	-1	12101159
,	O	-1	12101159
partic@@	O	-1	12101159
ul@@	O	-1	12101159
arly	O	-1	12101159
with	O	-1	12101159
the	O	-1	12101159
onset	O	-1	12101159
of	O	-1	12101159
as@@	B-Disease	D006323	12101159
y@@	I-Disease	-1	12101159
st@@	I-Disease	-1	12101159
ole	I-Disease	-1	12101159
.	O	-1	12101159
It	O	-1	12101159
should	O	-1	12101159
be	O	-1	12101159
considered	O	-1	12101159
early	O	-1	12101159
in	O	-1	12101159
cases	O	-1	12101159
of	O	-1	12101159
cardiac	B-Disease	D006323	12101159
ar@@	I-Disease	-1	12101159
res@@	I-Disease	-1	12101159
t	I-Disease	-1	12101159
after	O	-1	12101159
di@@	B-Chemical	D004110	12101159
l@@	I-Chemical	-1	12101159
ti@@	I-Chemical	-1	12101159
az@@	I-Chemical	-1	12101159
em	I-Chemical	-1	12101159
over@@	B-Disease	D062787	12101159
dose	I-Disease	-1	12101159
.	O	-1	12101159
The	O	-1	12101159
case	O	-1	12101159
also	O	-1	12101159
high@@	O	-1	12101159
li@@	O	-1	12101159
gh@@	O	-1	12101159
ts	O	-1	12101159
the	O	-1	12101159
pro@@	O	-1	12101159
ble@@	O	-1	12101159
ms	O	-1	12101159
with	O	-1	12101159
del@@	O	-1	12101159
ayed	O	-1	12101159
toxicity	B-Disease	D064420	12101159
when	O	-1	12101159
wh@@	O	-1	12101159
ole	O	-1	12101159
bo@@	O	-1	12101159
we@@	O	-1	12101159
l	O	-1	12101159
ir@@	O	-1	12101159
rig@@	O	-1	12101159
ation	O	-1	12101159
is	O	-1	12101159
not	O	-1	12101159
administ@@	O	-1	12101159
e@@	O	-1	12101159
red.	O	-1	12101159

R@@	B-Disease	D007681	6699841
en@@	I-Disease	-1	6699841
al	I-Disease	-1	6699841
pap@@	I-Disease	-1	6699841
ill@@	I-Disease	-1	6699841
ary	I-Disease	-1	6699841
necro@@	I-Disease	-1	6699841
sis	I-Disease	-1	6699841
due	O	-1	6699841
to	O	-1	6699841
na@@	B-Chemical	D009288	6699841
pro@@	I-Chemical	-1	6699841
x@@	I-Chemical	-1	6699841
en	I-Chemical	-1	6699841
.	O	-1	6699841
A	O	-1	6699841
3@@	O	-1	6699841
1-@@	O	-1	6699841
year-old	O	-1	6699841
man	O	-1	6699841
with	O	-1	6699841
r@@	B-Disease	D001172	6699841
he@@	I-Disease	-1	6699841
um@@	I-Disease	-1	6699841
at@@	I-Disease	-1	6699841
oid	I-Disease	-1	6699841
arth@@	I-Disease	-1	6699841
ritis	I-Disease	-1	6699841
,	O	-1	6699841
who	O	-1	6699841
had	O	-1	6699841
previously	O	-1	6699841
been	O	-1	6699841
treated	O	-1	6699841
with	O	-1	6699841
sul@@	B-Chemical	D013467	6699841
in@@	I-Chemical	-1	6699841
da@@	I-Chemical	-1	6699841
c	I-Chemical	-1	6699841
,	O	-1	6699841
f@@	B-Chemical	D005279	6699841
en@@	I-Chemical	-1	6699841
o@@	I-Chemical	-1	6699841
prof@@	I-Chemical	-1	6699841
en	I-Chemical	-1	6699841
calcium	I-Chemical	-1	6699841
,	O	-1	6699841
high	O	-1	6699841
dose	O	-1	6699841
sal@@	B-Chemical	D012459	6699841
ic@@	I-Chemical	-1	6699841
yl@@	I-Chemical	-1	6699841
ates	I-Chemical	-1	6699841
and	O	-1	6699841
g@@	B-Chemical	D006046	6699841
old	I-Chemical	-1	6699841
sal@@	O	-1	6699841
t@@	O	-1	6699841
s,	O	-1	6699841
developed	O	-1	6699841
renal	B-Disease	D007681	6699841
pap@@	I-Disease	-1	6699841
ill@@	I-Disease	-1	6699841
ary	I-Disease	-1	6699841
necro@@	I-Disease	-1	6699841
sis	I-Disease	-1	6699841
(	O	-1	6699841
R@@	B-Disease	D007681	6699841
P@@	I-Disease	-1	6699841
N	I-Disease	-1	6699841
)	O	-1	6699841
4	O	-1	6699841
months	O	-1	6699841
after	O	-1	6699841
insti@@	O	-1	6699841
tu@@	O	-1	6699841
tion	O	-1	6699841
of	O	-1	6699841
na@@	B-Chemical	D009288	6699841
pro@@	I-Chemical	-1	6699841
x@@	I-Chemical	-1	6699841
en	I-Chemical	-1	6699841
therapy.	O	-1	6699841
No	O	-1	6699841
other	O	-1	6699841
factor	O	-1	6699841
pre@@	O	-1	6699841
dis@@	O	-1	6699841
pos@@	O	-1	6699841
ing	O	-1	6699841
to	O	-1	6699841
R@@	B-Disease	D007681	6699841
P@@	I-Disease	-1	6699841
N	I-Disease	-1	6699841
could	O	-1	6699841
be	O	-1	6699841
dis@@	O	-1	6699841
co@@	O	-1	6699841
ve@@	O	-1	6699841
red.	O	-1	6699841
S@@	B-Chemical	D013467	6699841
ul@@	I-Chemical	-1	6699841
in@@	I-Chemical	-1	6699841
da@@	I-Chemical	-1	6699841
c	I-Chemical	-1	6699841
was	O	-1	6699841
sub@@	O	-1	6699841
sti@@	O	-1	6699841
t@@	O	-1	6699841
ut@@	O	-1	6699841
ed	O	-1	6699841
for	O	-1	6699841
na@@	B-Chemical	D009288	6699841
pro@@	I-Chemical	-1	6699841
x@@	I-Chemical	-1	6699841
en	I-Chemical	-1	6699841
and	O	-1	6699841
no	O	-1	6699841
further	O	-1	6699841
adverse	O	-1	6699841
renal	O	-1	6699841
effects	O	-1	6699841
occurred	O	-1	6699841
over	O	-1	6699841
the	O	-1	6699841
ne@@	O	-1	6699841
x@@	O	-1	6699841
t	O	-1	6699841
12	O	-1	6699841
months.	O	-1	6699841
We	O	-1	6699841
revie@@	O	-1	6699841
w	O	-1	6699841
previ@@	O	-1	6699841
ous	O	-1	6699841
reports	O	-1	6699841
lin@@	O	-1	6699841
king	O	-1	6699841
R@@	B-Disease	D007681	6699841
P@@	I-Disease	-1	6699841
N	I-Disease	-1	6699841
to	O	-1	6699841
anti@@	O	-1	6699841
inflam@@	O	-1	6699841
mat@@	O	-1	6699841
ory	O	-1	6699841
drug	O	-1	6699841
use	O	-1	6699841
and	O	-1	6699841
discus@@	O	-1	6699841
s	O	-1	6699841
possible	O	-1	6699841
adv@@	O	-1	6699841
ant@@	O	-1	6699841
ages	O	-1	6699841
of	O	-1	6699841
sul@@	B-Chemical	D013467	6699841
in@@	I-Chemical	-1	6699841
da@@	I-Chemical	-1	6699841
c	I-Chemical	-1	6699841
in	O	-1	6699841
patients	O	-1	6699841
who	O	-1	6699841
have	O	-1	6699841
experienced	O	-1	6699841
renal	B-Disease	D007674	6699841
toxicity	I-Disease	-1	6699841
from	O	-1	6699841
other	O	-1	6699841
anti@@	O	-1	6699841
inflam@@	O	-1	6699841
mat@@	O	-1	6699841
ory	O	-1	6699841
agent@@	O	-1	6699841
s.	O	-1	6699841

Ad@@	O	-1	6127992
verse	O	-1	6127992
inter@@	O	-1	6127992
action	O	-1	6127992
between	O	-1	6127992
beta-@@	B-Chemical	D000319	6127992
adrenergic	I-Chemical	-1	6127992
block@@	I-Chemical	-1	6127992
ing	I-Chemical	-1	6127992
drugs	I-Chemical	-1	6127992
and	O	-1	6127992
verap@@	B-Chemical	D014700	6127992
ami@@	I-Chemical	-1	6127992
l	I-Chemical	-1	6127992
-@@	O	-1	6127992
-@@	O	-1	6127992
report	O	-1	6127992
of	O	-1	6127992
three	O	-1	6127992
cas@@	O	-1	6127992
es.	O	-1	6127992
Th@@	O	-1	6127992
ree	O	-1	6127992
patients	O	-1	6127992
with	O	-1	6127992
is@@	B-Disease	D017202	6127992
ch@@	I-Disease	-1	6127992
a@@	I-Disease	-1	6127992
em@@	I-Disease	-1	6127992
ic	I-Disease	-1	6127992
heart	I-Disease	-1	6127992
disease	I-Disease	-1	6127992
developed	O	-1	6127992
pro@@	O	-1	6127992
found	O	-1	6127992
cardiac	B-Disease	D006333	6127992
failure	I-Disease	-1	6127992
,	O	-1	6127992
hypotension	B-Disease	D007022	6127992
and	O	-1	6127992
brady@@	B-Disease	D001919	6127992
cardia	I-Disease	-1	6127992
during	O	-1	6127992
combined	O	-1	6127992
therapy	O	-1	6127992
with	O	-1	6127992
verap@@	B-Chemical	D014700	6127992
ami@@	I-Chemical	-1	6127992
l	I-Chemical	-1	6127992
and	O	-1	6127992
beta-@@	B-Chemical	D000319	6127992
adrenergic	I-Chemical	-1	6127992
block@@	I-Chemical	-1	6127992
ing	I-Chemical	-1	6127992
drugs	I-Chemical	-1	6127992
.	O	-1	6127992
This	O	-1	6127992
clinical	O	-1	6127992
p@@	O	-1	6127992
ic@@	O	-1	6127992
t@@	O	-1	6127992
ure	O	-1	6127992
resol@@	O	-1	6127992
ved	O	-1	6127992
complete@@	O	-1	6127992
ly	O	-1	6127992
with	O	-1	6127992
cess@@	O	-1	6127992
ation	O	-1	6127992
of	O	-1	6127992
the	O	-1	6127992
combined	O	-1	6127992
therapy.	O	-1	6127992
B@@	O	-1	6127992
as@@	O	-1	6127992
el@@	O	-1	6127992
ine	O	-1	6127992
left	O	-1	6127992
ventricular	O	-1	6127992
func@@	O	-1	6127992
tion,	O	-1	6127992
assessed	O	-1	6127992
by	O	-1	6127992
cardiac	O	-1	6127992
ca@@	O	-1	6127992
the@@	O	-1	6127992
ter@@	O	-1	6127992
is@@	O	-1	6127992
ation	O	-1	6127992
or	O	-1	6127992
nucle@@	O	-1	6127992
ar	O	-1	6127992
angio@@	O	-1	6127992
graph@@	O	-1	6127992
y,	O	-1	6127992
was	O	-1	6127992
normal	O	-1	6127992
in	O	-1	6127992
two	O	-1	6127992
patients	O	-1	6127992
and	O	-1	6127992
only	O	-1	6127992
mil@@	O	-1	6127992
d@@	O	-1	6127992
ly	O	-1	6127992
reduced	O	-1	6127992
in	O	-1	6127992
the	O	-1	6127992
o@@	O	-1	6127992
ther@@	O	-1	6127992
.	O	-1	6127992
S@@	O	-1	6127992
im@@	O	-1	6127992
ult@@	O	-1	6127992
ane@@	O	-1	6127992
ously	O	-1	6127992
administration	O	-1	6127992
of	O	-1	6127992
beta-@@	B-Chemical	D000319	6127992
adrenergic	I-Chemical	-1	6127992
block@@	I-Chemical	-1	6127992
ing	I-Chemical	-1	6127992
drugs	I-Chemical	-1	6127992
and	O	-1	6127992
verap@@	B-Chemical	D014700	6127992
ami@@	I-Chemical	-1	6127992
l	I-Chemical	-1	6127992
may	O	-1	6127992
result	O	-1	6127992
in	O	-1	6127992
pro@@	O	-1	6127992
found	O	-1	6127992
adverse	O	-1	6127992
inter@@	O	-1	6127992
ac@@	O	-1	6127992
tions	O	-1	6127992
and	O	-1	6127992
should	O	-1	6127992
only	O	-1	6127992
be	O	-1	6127992
administered	O	-1	6127992
with	O	-1	6127992
gre@@	O	-1	6127992
at	O	-1	6127992
cau@@	O	-1	6127992
tion.	O	-1	6127992

Ad@@	O	-1	6115999
verse	O	-1	6115999
reactions	O	-1	6115999
to	O	-1	6115999
ben@@	B-Chemical	D001539	6115999
dro@@	I-Chemical	-1	6115999
flu@@	I-Chemical	-1	6115999
az@@	I-Chemical	-1	6115999
ide	I-Chemical	-1	6115999
and	O	-1	6115999
prop@@	B-Chemical	D011433	6115999
ran@@	I-Chemical	-1	6115999
o@@	I-Chemical	-1	6115999
lol	I-Chemical	-1	6115999
for	O	-1	6115999
the	O	-1	6115999
treatment	O	-1	6115999
of	O	-1	6115999
mil@@	O	-1	6115999
d	O	-1	6115999
hypertension	B-Disease	D006973	6115999
.	O	-1	6115999
Re@@	O	-1	6115999
por@@	O	-1	6115999
t	O	-1	6115999
of	O	-1	6115999
M@@	O	-1	6115999
ed@@	O	-1	6115999
ical	O	-1	6115999
R@@	O	-1	6115999
es@@	O	-1	6115999
ear@@	O	-1	6115999
ch	O	-1	6115999
C@@	O	-1	6115999
oun@@	O	-1	6115999
ci@@	O	-1	6115999
l	O	-1	6115999
W@@	O	-1	6115999
or@@	O	-1	6115999
king	O	-1	6115999
P@@	O	-1	6115999
ar@@	O	-1	6115999
t@@	O	-1	6115999
y	O	-1	6115999
on	O	-1	6115999
M@@	O	-1	6115999
il@@	O	-1	6115999
d	O	-1	6115999
to	O	-1	6115999
M@@	O	-1	6115999
o@@	O	-1	6115999
der@@	O	-1	6115999
ate	O	-1	6115999
H@@	B-Disease	D006973	6115999
y@@	I-Disease	-1	6115999
per@@	I-Disease	-1	6115999
ten@@	I-Disease	-1	6115999
sion	I-Disease	-1	6115999
.	O	-1	6115999
P@@	O	-1	6115999
ar@@	O	-1	6115999
tic@@	O	-1	6115999
ip@@	O	-1	6115999
ants	O	-1	6115999
in	O	-1	6115999
the	O	-1	6115999
M@@	O	-1	6115999
ed@@	O	-1	6115999
ical	O	-1	6115999
R@@	O	-1	6115999
es@@	O	-1	6115999
ear@@	O	-1	6115999
ch	O	-1	6115999
C@@	O	-1	6115999
oun@@	O	-1	6115999
ci@@	O	-1	6115999
l	O	-1	6115999
treatment	O	-1	6115999
trial	O	-1	6115999
for	O	-1	6115999
mil@@	O	-1	6115999
d	O	-1	6115999
hypertension	B-Disease	D006973	6115999
are	O	-1	6115999
random@@	O	-1	6115999
ly	O	-1	6115999
al@@	O	-1	6115999
loc@@	O	-1	6115999
ated	O	-1	6115999
to	O	-1	6115999
one	O	-1	6115999
of	O	-1	6115999
four	O	-1	6115999
treatment	O	-1	6115999
group@@	O	-1	6115999
s:	O	-1	6115999
ben@@	B-Chemical	D001539	6115999
dro@@	I-Chemical	-1	6115999
flu@@	I-Chemical	-1	6115999
az@@	I-Chemical	-1	6115999
ide	I-Chemical	-1	6115999
,	O	-1	6115999
prop@@	B-Chemical	D011433	6115999
ran@@	I-Chemical	-1	6115999
o@@	I-Chemical	-1	6115999
lol	I-Chemical	-1	6115999
,	O	-1	6115999
or	O	-1	6115999
a	O	-1	6115999
placebo	O	-1	6115999
for	O	-1	6115999
either	O	-1	6115999
of	O	-1	6115999
these	O	-1	6115999
drug@@	O	-1	6115999
s.	O	-1	6115999
The	O	-1	6115999
trial	O	-1	6115999
is	O	-1	6115999
sing@@	O	-1	6115999
le@@	O	-1	6115999
-@@	O	-1	6115999
bl@@	O	-1	6115999
ind@@	O	-1	6115999
.	O	-1	6115999
2@@	O	-1	6115999
3	O	-1	6115999
5@@	O	-1	6115999
8@@	O	-1	6115999
2	O	-1	6115999
patient@@	O	-1	6115999
-@@	O	-1	6115999
years	O	-1	6115999
of	O	-1	6115999
observ@@	O	-1	6115999
ation	O	-1	6115999
have	O	-1	6115999
been	O	-1	6115999
comple@@	O	-1	6115999
ted	O	-1	6115999
so	O	-1	6115999
far@@	O	-1	6115999
,	O	-1	6115999
10	O	-1	6115999
6@@	O	-1	6115999
8@@	O	-1	6115999
4	O	-1	6115999
on	O	-1	6115999
active	O	-1	6115999
drugs	O	-1	6115999
and	O	-1	6115999
12	O	-1	6115999
8@@	O	-1	6115999
9@@	O	-1	6115999
8	O	-1	6115999
on	O	-1	6115999
placebo@@	O	-1	6115999
s.	O	-1	6115999
The	O	-1	6115999
results	O	-1	6115999
show	O	-1	6115999
an	O	-1	6115999
association	O	-1	6115999
between	O	-1	6115999
ben@@	B-Chemical	D001539	6115999
dro@@	I-Chemical	-1	6115999
flu@@	I-Chemical	-1	6115999
az@@	I-Chemical	-1	6115999
ide	I-Chemical	-1	6115999
treatment	O	-1	6115999
and	O	-1	6115999
im@@	B-Disease	D007172	6115999
pot@@	I-Disease	-1	6115999
ence	I-Disease	-1	6115999
,	O	-1	6115999
and	O	-1	6115999
im@@	B-Disease	D007172	6115999
pot@@	I-Disease	-1	6115999
ence	I-Disease	-1	6115999
also	O	-1	6115999
occurred	O	-1	6115999
more	O	-1	6115999
frequ@@	O	-1	6115999
ently	O	-1	6115999
in	O	-1	6115999
patients	O	-1	6115999
taking	O	-1	6115999
prop@@	B-Chemical	D011433	6115999
ran@@	I-Chemical	-1	6115999
o@@	I-Chemical	-1	6115999
lol	I-Chemical	-1	6115999
than	O	-1	6115999
in	O	-1	6115999
those	O	-1	6115999
taking	O	-1	6115999
placebo@@	O	-1	6115999
s.	O	-1	6115999
O@@	O	-1	6115999
ther	O	-1	6115999
adverse	O	-1	6115999
reactions	O	-1	6115999
significantly	O	-1	6115999
lin@@	O	-1	6115999
ked	O	-1	6115999
with	O	-1	6115999
active	O	-1	6115999
drugs	O	-1	6115999
includ@@	O	-1	6115999
e	O	-1	6115999
impaired	B-Disease	D018149	6115999
g@@	I-Disease	-1	6115999
lu@@	I-Disease	-1	6115999
co@@	I-Disease	-1	6115999
se	I-Disease	-1	6115999
toler@@	I-Disease	-1	6115999
ance	I-Disease	-1	6115999
in	O	-1	6115999
men	O	-1	6115999
and	O	-1	6115999
women	O	-1	6115999
and	O	-1	6115999
g@@	B-Disease	D006073	6115999
out	I-Disease	-1	6115999
in	O	-1	6115999
men@@	O	-1	6115999
,	O	-1	6115999
associated	O	-1	6115999
with	O	-1	6115999
ben@@	B-Chemical	D001539	6115999
dro@@	I-Chemical	-1	6115999
flu@@	I-Chemical	-1	6115999
az@@	I-Chemical	-1	6115999
ide	I-Chemical	-1	6115999
treatment,	O	-1	6115999
and	O	-1	6115999
R@@	B-Disease	D011928	6115999
ay@@	I-Disease	-1	6115999
na@@	I-Disease	-1	6115999
ud@@	I-Disease	-1	6115999
's	I-Disease	-1	6115999
phen@@	I-Disease	-1	6115999
om@@	I-Disease	-1	6115999
en@@	I-Disease	-1	6115999
on	I-Disease	-1	6115999
and	O	-1	6115999
dys@@	B-Disease	D004417	6115999
p@@	I-Disease	-1	6115999
no@@	I-Disease	-1	6115999
e@@	I-Disease	-1	6115999
a	I-Disease	-1	6115999
in	O	-1	6115999
men	O	-1	6115999
and	O	-1	6115999
women	O	-1	6115999
taking	O	-1	6115999
prop@@	B-Chemical	D011433	6115999
ran@@	I-Chemical	-1	6115999
o@@	I-Chemical	-1	6115999
lol	I-Chemical	-1	6115999
.	O	-1	6115999
No	O	-1	6115999
cor@@	B-Disease	D003316	6115999
ne@@	I-Disease	-1	6115999
al	I-Disease	-1	6115999
disease	I-Disease	-1	6115999
is	O	-1	6115999
known	O	-1	6115999
to	O	-1	6115999
have	O	-1	6115999
occurred	O	-1	6115999
in	O	-1	6115999
the	O	-1	6115999
prop@@	B-Chemical	D011433	6115999
ran@@	I-Chemical	-1	6115999
o@@	I-Chemical	-1	6115999
lol	I-Chemical	-1	6115999
group.	O	-1	6115999
M@@	O	-1	6115999
e@@	O	-1	6115999
an	O	-1	6115999
serum	O	-1	6115999
pot@@	B-Chemical	D011188	6115999
assi@@	I-Chemical	-1	6115999
um	I-Chemical	-1	6115999
level	O	-1	6115999
fe@@	O	-1	6115999
ll@@	O	-1	6115999
,	O	-1	6115999
and	O	-1	6115999
ure@@	B-Chemical	D014508	6115999
a	I-Chemical	-1	6115999
and	O	-1	6115999
ur@@	B-Chemical	D014527	6115999
ic	I-Chemical	-1	6115999
acid	I-Chemical	-1	6115999
levels	O	-1	6115999
ro@@	O	-1	6115999
se@@	O	-1	6115999
,	O	-1	6115999
in	O	-1	6115999
men	O	-1	6115999
and	O	-1	6115999
women	O	-1	6115999
taking	O	-1	6115999
ben@@	B-Chemical	D001539	6115999
dro@@	I-Chemical	-1	6115999
flu@@	I-Chemical	-1	6115999
az@@	I-Chemical	-1	6115999
ide	I-Chemical	-1	6115999
.	O	-1	6115999
In	O	-1	6115999
the	O	-1	6115999
prop@@	B-Chemical	D011433	6115999
ran@@	I-Chemical	-1	6115999
o@@	I-Chemical	-1	6115999
lol	I-Chemical	-1	6115999
group@@	O	-1	6115999
,	O	-1	6115999
serum	O	-1	6115999
pot@@	B-Chemical	D011188	6115999
assi@@	I-Chemical	-1	6115999
um	I-Chemical	-1	6115999
and	O	-1	6115999
ur@@	B-Chemical	D014527	6115999
ic	I-Chemical	-1	6115999
acid	I-Chemical	-1	6115999
levels	O	-1	6115999
ro@@	O	-1	6115999
se	O	-1	6115999
in	O	-1	6115999
both	O	-1	6115999
sex@@	O	-1	6115999
es,	O	-1	6115999
but	O	-1	6115999
the	O	-1	6115999
ure@@	B-Chemical	D014508	6115999
a	I-Chemical	-1	6115999
level	O	-1	6115999
ro@@	O	-1	6115999
se	O	-1	6115999
significantly	O	-1	6115999
in	O	-1	6115999
women	O	-1	6115999
on@@	O	-1	6115999
ly.	O	-1	6115999

D@@	B-Chemical	D020927	18086064
ex@@	I-Chemical	-1	18086064
me@@	I-Chemical	-1	18086064
de@@	I-Chemical	-1	18086064
to@@	I-Chemical	-1	18086064
m@@	I-Chemical	-1	18086064
idine	I-Chemical	-1	18086064
and	O	-1	18086064
cardiac	O	-1	18086064
prot@@	O	-1	18086064
ection	O	-1	18086064
for	O	-1	18086064
non-@@	O	-1	18086064
cardiac	O	-1	18086064
surg@@	O	-1	18086064
ery@@	O	-1	18086064
:	O	-1	18086064
a	O	-1	18086064
met@@	O	-1	18086064
a@@	O	-1	18086064
-@@	O	-1	18086064
analysis	O	-1	18086064
of	O	-1	18086064
random@@	O	-1	18086064
is@@	O	-1	18086064
ed	O	-1	18086064
controlled	O	-1	18086064
tri@@	O	-1	18086064
al@@	O	-1	18086064
s.	O	-1	18086064
We	O	-1	18086064
con@@	O	-1	18086064
duc@@	O	-1	18086064
ted	O	-1	18086064
a	O	-1	18086064
system@@	O	-1	18086064
atic	O	-1	18086064
revie@@	O	-1	18086064
w	O	-1	18086064
of	O	-1	18086064
the	O	-1	18086064
effects	O	-1	18086064
of	O	-1	18086064
de@@	B-Chemical	D020927	18086064
x@@	I-Chemical	-1	18086064
me@@	I-Chemical	-1	18086064
de@@	I-Chemical	-1	18086064
to@@	I-Chemical	-1	18086064
m@@	I-Chemical	-1	18086064
idine	I-Chemical	-1	18086064
on	O	-1	18086064
cardiac	O	-1	18086064
outcom@@	O	-1	18086064
es	O	-1	18086064
following	O	-1	18086064
non-@@	O	-1	18086064
cardiac	O	-1	18086064
surger@@	O	-1	18086064
y.	O	-1	18086064
We	O	-1	18086064
included	O	-1	18086064
pro@@	O	-1	18086064
sp@@	O	-1	18086064
ecti@@	O	-1	18086064
ve,	O	-1	18086064
random@@	O	-1	18086064
is@@	O	-1	18086064
ed	O	-1	18086064
peri@@	O	-1	18086064
-@@	O	-1	18086064
o@@	O	-1	18086064
perative	O	-1	18086064
studies	O	-1	18086064
of	O	-1	18086064
de@@	B-Chemical	D020927	18086064
x@@	I-Chemical	-1	18086064
me@@	I-Chemical	-1	18086064
de@@	I-Chemical	-1	18086064
to@@	I-Chemical	-1	18086064
m@@	I-Chemical	-1	18086064
idine	I-Chemical	-1	18086064
that	O	-1	18086064
reported	O	-1	18086064
mor@@	O	-1	18086064
t@@	O	-1	18086064
al@@	O	-1	18086064
ity,	O	-1	18086064
cardiac	O	-1	18086064
mor@@	O	-1	18086064
b@@	O	-1	18086064
idity	O	-1	18086064
or	O	-1	18086064
adverse	O	-1	18086064
drug	O	-1	18086064
event@@	O	-1	18086064
s.	O	-1	18086064
A	O	-1	18086064
P@@	O	-1	18086064
ub@@	O	-1	18086064
M@@	O	-1	18086064
ed	O	-1	18086064
C@@	O	-1	18086064
entr@@	O	-1	18086064
al	O	-1	18086064
and	O	-1	18086064
E@@	O	-1	18086064
M@@	O	-1	18086064
BA@@	O	-1	18086064
S@@	O	-1	18086064
E	O	-1	18086064
se@@	O	-1	18086064
arc@@	O	-1	18086064
h	O	-1	18086064
was	O	-1	18086064
con@@	O	-1	18086064
duc@@	O	-1	18086064
ted	O	-1	18086064
up	O	-1	18086064
to	O	-1	18086064
J@@	O	-1	18086064
ul@@	O	-1	18086064
y	O	-1	18086064
20@@	O	-1	18086064
0@@	O	-1	18086064
7@@	O	-1	18086064
.	O	-1	18086064
The	O	-1	18086064
ref@@	O	-1	18086064
e@@	O	-1	18086064
rence	O	-1	18086064
li@@	O	-1	18086064
st@@	O	-1	18086064
s	O	-1	18086064
of	O	-1	18086064
identi@@	O	-1	18086064
fied	O	-1	18086064
pa@@	O	-1	18086064
per@@	O	-1	18086064
s	O	-1	18086064
were	O	-1	18086064
examined	O	-1	18086064
for	O	-1	18086064
further	O	-1	18086064
tri@@	O	-1	18086064
al@@	O	-1	18086064
s.	O	-1	18086064
Of	O	-1	18086064
4@@	O	-1	18086064
25	O	-1	18086064
studies	O	-1	18086064
identi@@	O	-1	18086064
fi@@	O	-1	18086064
ed,	O	-1	18086064
20	O	-1	18086064
were	O	-1	18086064
included	O	-1	18086064
in	O	-1	18086064
the	O	-1	18086064
met@@	O	-1	18086064
a@@	O	-1	18086064
-@@	O	-1	18086064
analysis	O	-1	18086064
(@@	O	-1	18086064
8@@	O	-1	18086064
40	O	-1	18086064
patient@@	O	-1	18086064
s@@	O	-1	18086064
).	O	-1	18086064
D@@	B-Chemical	D020927	18086064
ex@@	I-Chemical	-1	18086064
me@@	I-Chemical	-1	18086064
de@@	I-Chemical	-1	18086064
to@@	I-Chemical	-1	18086064
m@@	I-Chemical	-1	18086064
idine	I-Chemical	-1	18086064
was	O	-1	18086064
associated	O	-1	18086064
with	O	-1	18086064
a	O	-1	18086064
tre@@	O	-1	18086064
n@@	O	-1	18086064
d	O	-1	18086064
to@@	O	-1	18086064
war@@	O	-1	18086064
ds	O	-1	18086064
improved	O	-1	18086064
cardiac	O	-1	18086064
outcom@@	O	-1	18086064
es@@	O	-1	18086064
;	O	-1	18086064
all@@	O	-1	18086064
-@@	O	-1	18086064
cause	O	-1	18086064
mor@@	O	-1	18086064
t@@	O	-1	18086064
ality	O	-1	18086064
(@@	O	-1	18086064
O@@	O	-1	18086064
R	O	-1	18086064
0.@@	O	-1	18086064
27@@	O	-1	18086064
,	O	-1	18086064
95%	O	-1	18086064
C@@	O	-1	18086064
I	O	-1	18086064
0.0@@	O	-1	18086064
1-@@	O	-1	18086064
7.@@	O	-1	18086064
13@@	O	-1	18086064
,	O	-1	18086064
p	O	-1	18086064
=	O	-1	18086064
0.@@	O	-1	18086064
4@@	O	-1	18086064
4@@	O	-1	18086064
),	O	-1	18086064
non-@@	O	-1	18086064
f@@	O	-1	18086064
atal	O	-1	18086064
myocardial	B-Disease	D009203	18086064
infarction	I-Disease	-1	18086064
(@@	O	-1	18086064
O@@	O	-1	18086064
R	O	-1	18086064
0.@@	O	-1	18086064
2@@	O	-1	18086064
6,	O	-1	18086064
95%	O	-1	18086064
C@@	O	-1	18086064
I	O	-1	18086064
0.0@@	O	-1	18086064
4-@@	O	-1	18086064
1.@@	O	-1	18086064
6@@	O	-1	18086064
0@@	O	-1	18086064
,	O	-1	18086064
p	O	-1	18086064
=	O	-1	18086064
0.@@	O	-1	18086064
14@@	O	-1	18086064
),	O	-1	18086064
and	O	-1	18086064
myocardial	B-Disease	D017202	18086064
is@@	I-Disease	-1	18086064
ch@@	I-Disease	-1	18086064
a@@	I-Disease	-1	18086064
emia	I-Disease	-1	18086064
(@@	O	-1	18086064
O@@	O	-1	18086064
R	O	-1	18086064
0.@@	O	-1	18086064
6@@	O	-1	18086064
5,	O	-1	18086064
95%	O	-1	18086064
C@@	O	-1	18086064
I	O	-1	18086064
0.@@	O	-1	18086064
2@@	O	-1	18086064
6-@@	O	-1	18086064
1.@@	O	-1	18086064
6@@	O	-1	18086064
3,	O	-1	18086064
p	O	-1	18086064
=	O	-1	18086064
0.@@	O	-1	18086064
3@@	O	-1	18086064
6@@	O	-1	18086064
).	O	-1	18086064
P@@	O	-1	18086064
er@@	O	-1	18086064
i@@	O	-1	18086064
-@@	O	-1	18086064
o@@	O	-1	18086064
perative	O	-1	18086064
hypotension	B-Disease	D007022	18086064
(2@@	O	-1	18086064
6@@	O	-1	18086064
%,	O	-1	18086064
O@@	O	-1	18086064
R	O	-1	18086064
3.@@	O	-1	18086064
80@@	O	-1	18086064
,	O	-1	18086064
95%	O	-1	18086064
C@@	O	-1	18086064
I	O	-1	18086064
1.@@	O	-1	18086064
9@@	O	-1	18086064
1-@@	O	-1	18086064
7.@@	O	-1	18086064
5@@	O	-1	18086064
4@@	O	-1	18086064
,	O	-1	18086064
p	O	-1	18086064
=	O	-1	18086064
0.00@@	O	-1	18086064
0@@	O	-1	18086064
1)	O	-1	18086064
and	O	-1	18086064
brady@@	B-Disease	D001919	18086064
cardia	I-Disease	-1	18086064
(1@@	O	-1	18086064
7@@	O	-1	18086064
%,	O	-1	18086064
O@@	O	-1	18086064
R	O	-1	18086064
5.@@	O	-1	18086064
4@@	O	-1	18086064
5,	O	-1	18086064
95%	O	-1	18086064
C@@	O	-1	18086064
I	O	-1	18086064
2.@@	O	-1	18086064
9@@	O	-1	18086064
8@@	O	-1	18086064
-@@	O	-1	18086064
9.@@	O	-1	18086064
9@@	O	-1	18086064
5,	O	-1	18086064
p	O	-1	18086064
<	O	-1	18086064
0.00@@	O	-1	18086064
0@@	O	-1	18086064
0@@	O	-1	18086064
1)	O	-1	18086064
were	O	-1	18086064
significantly	O	-1	18086064
increas@@	O	-1	18086064
ed.	O	-1	18086064
An	O	-1	18086064
anti@@	O	-1	18086064
cholinergic	O	-1	18086064
did	O	-1	18086064
not	O	-1	18086064
re@@	O	-1	18086064
duce	O	-1	18086064
the	O	-1	18086064
incidence	O	-1	18086064
of	O	-1	18086064
brady@@	B-Disease	D001919	18086064
cardia	I-Disease	-1	18086064
(p	O	-1	18086064
=	O	-1	18086064
0.@@	O	-1	18086064
4@@	O	-1	18086064
3@@	O	-1	18086064
).	O	-1	18086064
A	O	-1	18086064
random@@	O	-1	18086064
is@@	O	-1	18086064
ed	O	-1	18086064
placebo@@	O	-1	18086064
-@@	O	-1	18086064
controlled	O	-1	18086064
trial	O	-1	18086064
of	O	-1	18086064
de@@	B-Chemical	D020927	18086064
x@@	I-Chemical	-1	18086064
me@@	I-Chemical	-1	18086064
de@@	I-Chemical	-1	18086064
to@@	I-Chemical	-1	18086064
m@@	I-Chemical	-1	18086064
idine	I-Chemical	-1	18086064
is	O	-1	18086064
war@@	O	-1	18086064
ran@@	O	-1	18086064
ted.	O	-1	18086064

Di@@	O	-1	12739036
fferen@@	O	-1	12739036
tial	O	-1	12739036
diagnosis	O	-1	12739036
of	O	-1	12739036
high	O	-1	12739036
serum	O	-1	12739036
creat@@	B-Chemical	D003401	12739036
ine	I-Chemical	-1	12739036
kin@@	O	-1	12739036
ase	O	-1	12739036
levels	O	-1	12739036
in	O	-1	12739036
systemic	B-Disease	D008180	12739036
lu@@	I-Disease	-1	12739036
p@@	I-Disease	-1	12739036
us	I-Disease	-1	12739036
eryth@@	I-Disease	-1	12739036
em@@	I-Disease	-1	12739036
at@@	I-Disease	-1	12739036
os@@	I-Disease	-1	12739036
us	I-Disease	-1	12739036
.	O	-1	12739036
We	O	-1	12739036
report	O	-1	12739036
the	O	-1	12739036
clinical	O	-1	12739036
and	O	-1	12739036
biop@@	O	-1	12739036
tic	O	-1	12739036
findings	O	-1	12739036
for	O	-1	12739036
a	O	-1	12739036
5@@	O	-1	12739036
7-@@	O	-1	12739036
year-old	O	-1	12739036
woman	O	-1	12739036
with	O	-1	12739036
severe	O	-1	12739036
ch@@	B-Chemical	D002738	12739036
loro@@	I-Chemical	-1	12739036
qu@@	I-Chemical	-1	12739036
ine	I-Chemical	-1	12739036
-induced	O	-1	12739036
my@@	B-Disease	D009135	12739036
o@@	I-Disease	-1	12739036
pathy	I-Disease	-1	12739036
.	O	-1	12739036
S@@	O	-1	12739036
inc@@	O	-1	12739036
e	O	-1	12739036
19@@	O	-1	12739036
8@@	O	-1	12739036
9@@	O	-1	12739036
,	O	-1	12739036
sh@@	O	-1	12739036
e	O	-1	12739036
had	O	-1	12739036
been	O	-1	12739036
suff@@	O	-1	12739036
ering	O	-1	12739036
from	O	-1	12739036
systemic	B-Disease	D008180	12739036
lu@@	I-Disease	-1	12739036
p@@	I-Disease	-1	12739036
us	I-Disease	-1	12739036
eryth@@	I-Disease	-1	12739036
em@@	I-Disease	-1	12739036
at@@	I-Disease	-1	12739036
os@@	I-Disease	-1	12739036
us	I-Disease	-1	12739036
(	O	-1	12739036
S@@	B-Disease	D008180	12739036
L@@	I-Disease	-1	12739036
E	I-Disease	-1	12739036
)	O	-1	12739036
with	O	-1	12739036
renal	B-Disease	D007674	12739036
invol@@	I-Disease	-1	12739036
vement	I-Disease	-1	12739036
and	O	-1	12739036
under@@	O	-1	12739036
g@@	O	-1	12739036
one	O	-1	12739036
perio@@	O	-1	12739036
ds	O	-1	12739036
of	O	-1	12739036
treatment	O	-1	12739036
with	O	-1	12739036
az@@	B-Chemical	D001379	12739036
ath@@	I-Chemical	-1	12739036
io@@	I-Chemical	-1	12739036
p@@	I-Chemical	-1	12739036
rine	I-Chemical	-1	12739036
and	O	-1	12739036
cyclophosph@@	B-Chemical	D003520	12739036
amide	I-Chemical	-1	12739036
.	O	-1	12739036
Ad@@	O	-1	12739036
di@@	O	-1	12739036
tional	O	-1	12739036
therapy	O	-1	12739036
with	O	-1	12739036
ch@@	B-Chemical	D002738	12739036
loro@@	I-Chemical	-1	12739036
qu@@	I-Chemical	-1	12739036
ine	I-Chemical	-1	12739036
(	O	-1	12739036
C@@	B-Chemical	D002738	12739036
Q	I-Chemical	-1	12739036
)	O	-1	12739036
was	O	-1	12739036
star@@	O	-1	12739036
ted	O	-1	12739036
because	O	-1	12739036
of	O	-1	12739036
arth@@	B-Disease	D018771	12739036
r@@	I-Disease	-1	12739036
al@@	I-Disease	-1	12739036
g@@	I-Disease	-1	12739036
ia	I-Disease	-1	12739036
.	O	-1	12739036
A@@	O	-1	12739036
t	O	-1	12739036
the	O	-1	12739036
same	O	-1	12739036
ti@@	O	-1	12739036
me,	O	-1	12739036
s@@	O	-1	12739036
li@@	O	-1	12739036
gh@@	O	-1	12739036
tly	O	-1	12739036
increased	O	-1	12739036
creat@@	B-Chemical	D003401	12739036
ine	I-Chemical	-1	12739036
kin@@	O	-1	12739036
ase	O	-1	12739036
(C@@	O	-1	12739036
K@@	O	-1	12739036
)	O	-1	12739036
levels	O	-1	12739036
were	O	-1	12739036
not@@	O	-1	12739036
ed.	O	-1	12739036
M@@	B-Disease	D009220	12739036
yo@@	I-Disease	-1	12739036
si@@	I-Disease	-1	12739036
tis	I-Disease	-1	12739036
was	O	-1	12739036
sus@@	O	-1	12739036
p@@	O	-1	12739036
ect@@	O	-1	12739036
ed,	O	-1	12739036
and	O	-1	12739036
the	O	-1	12739036
patient	O	-1	12739036
was	O	-1	12739036
treated	O	-1	12739036
with	O	-1	12739036
steroid@@	B-Chemical	D013256	12739036
s	I-Chemical	-1	12739036
.	O	-1	12739036
The	O	-1	12739036
C@@	O	-1	12739036
K	O	-1	12739036
increase	O	-1	12739036
per@@	O	-1	12739036
sist@@	O	-1	12739036
ed,	O	-1	12739036
however,	O	-1	12739036
and	O	-1	12739036
sh@@	O	-1	12739036
e	O	-1	12739036
developed	O	-1	12739036
progressive	O	-1	12739036
mus@@	B-Disease	D018908	12739036
cular	I-Disease	-1	12739036
we@@	I-Disease	-1	12739036
ak@@	I-Disease	-1	12739036
ness	I-Disease	-1	12739036
and	O	-1	12739036
mus@@	B-Disease	D009133	12739036
cular	I-Disease	-1	12739036
atro@@	I-Disease	-1	12739036
ph@@	I-Disease	-1	12739036
y	I-Disease	-1	12739036
.	O	-1	12739036
R@@	O	-1	12739036
out@@	O	-1	12739036
ine	O	-1	12739036
controls	O	-1	12739036
revealed	O	-1	12739036
mark@@	O	-1	12739036
ed@@	O	-1	12739036
ly	O	-1	12739036
elevated	O	-1	12739036
C@@	O	-1	12739036
K	O	-1	12739036
levels	O	-1	12739036
of	O	-1	12739036
1@@	O	-1	12739036
,@@	O	-1	12739036
7@@	O	-1	12739036
00	O	-1	12739036
U@@	O	-1	12739036
/@@	O	-1	12739036
l@@	O	-1	12739036
.	O	-1	12739036
The	O	-1	12739036
neurolog@@	O	-1	12739036
ical	O	-1	12739036
and	O	-1	12739036
electro@@	O	-1	12739036
physi@@	O	-1	12739036
ological	O	-1	12739036
findings	O	-1	12739036
were	O	-1	12739036
not	O	-1	12739036
typ@@	O	-1	12739036
ical	O	-1	12739036
of	O	-1	12739036
my@@	B-Disease	D009220	12739036
o@@	I-Disease	-1	12739036
si@@	I-Disease	-1	12739036
tis	I-Disease	-1	12739036
.	O	-1	12739036
Th@@	O	-1	12739036
us,	O	-1	12739036
musc@@	O	-1	12739036
le	O	-1	12739036
biop@@	O	-1	12739036
sy	O	-1	12739036
of	O	-1	12739036
the	O	-1	12739036
del@@	O	-1	12739036
to@@	O	-1	12739036
id	O	-1	12739036
musc@@	O	-1	12739036
le	O	-1	12739036
was	O	-1	12739036
performed	O	-1	12739036
in	O	-1	12739036
or@@	O	-1	12739036
der	O	-1	12739036
to	O	-1	12739036
ex@@	O	-1	12739036
cl@@	O	-1	12739036
ude	O	-1	12739036
poly@@	B-Disease	D017285	12739036
my@@	I-Disease	-1	12739036
o@@	I-Disease	-1	12739036
si@@	I-Disease	-1	12739036
tis	I-Disease	-1	12739036
or	O	-1	12739036
toxic	O	-1	12739036
my@@	B-Disease	D009135	12739036
o@@	I-Disease	-1	12739036
pathy	I-Disease	-1	12739036
.	O	-1	12739036
A@@	O	-1	12739036
s	O	-1	12739036
it	O	-1	12739036
revealed	O	-1	12739036
ch@@	B-Chemical	D002738	12739036
loro@@	I-Chemical	-1	12739036
qu@@	I-Chemical	-1	12739036
ine	I-Chemical	-1	12739036
-induced	O	-1	12739036
my@@	B-Disease	D009135	12739036
o@@	I-Disease	-1	12739036
pathy	I-Disease	-1	12739036
,	O	-1	12739036
medic@@	O	-1	12739036
ation	O	-1	12739036
was	O	-1	12739036
sto@@	O	-1	12739036
pp@@	O	-1	12739036
ed.	O	-1	12739036
D@@	O	-1	12739036
is@@	O	-1	12739036
cri@@	O	-1	12739036
min@@	O	-1	12739036
ating	O	-1	12739036
between	O	-1	12739036
prim@@	O	-1	12739036
ary	O	-1	12739036
S@@	B-Disease	D008180	12739036
L@@	I-Disease	-1	12739036
E	I-Disease	-1	12739036
-induced	O	-1	12739036
aff@@	B-Disease	D009140	12739036
ection	I-Disease	-1	12739036
of	I-Disease	-1	12739036
the	I-Disease	-1	12739036
musc@@	I-Disease	-1	12739036
u@@	I-Disease	-1	12739036
los@@	I-Disease	-1	12739036
ke@@	I-Disease	-1	12739036
le@@	I-Disease	-1	12739036
t@@	I-Disease	-1	12739036
al	I-Disease	-1	12739036
system	I-Disease	-1	12739036
and	O	-1	12739036
drug@@	O	-1	12739036
-induced	O	-1	12739036
side	O	-1	12739036
effects	O	-1	12739036
is	O	-1	12739036
important	O	-1	12739036
for	O	-1	12739036
appro@@	O	-1	12739036
pri@@	O	-1	12739036
ate	O	-1	12739036
treatment	O	-1	12739036
of	O	-1	12739036
S@@	B-Disease	D008180	12739036
L@@	I-Disease	-1	12739036
E	I-Disease	-1	12739036
patients.	O	-1	12739036

In@@	O	-1	12093990
tra@@	O	-1	12093990
venous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
treatment	O	-1	12093990
for	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
in	O	-1	12093990
immuno@@	O	-1	12093990
com@@	O	-1	12093990
pro@@	O	-1	12093990
mis@@	O	-1	12093990
ed	O	-1	12093990
child@@	O	-1	12093990
ren@@	O	-1	12093990
.	O	-1	12093990
BACKGROUND:	O	-1	12093990
Ad@@	O	-1	12093990
en@@	O	-1	12093990
o@@	O	-1	12093990
vi@@	O	-1	12093990
ru@@	O	-1	12093990
s	O	-1	12093990
is	O	-1	12093990
an	O	-1	12093990
important	O	-1	12093990
cause	O	-1	12093990
of	O	-1	12093990
mor@@	O	-1	12093990
b@@	O	-1	12093990
idity	O	-1	12093990
and	O	-1	12093990
mor@@	O	-1	12093990
t@@	O	-1	12093990
ality	O	-1	12093990
in	O	-1	12093990
the	O	-1	12093990
immuno@@	O	-1	12093990
com@@	O	-1	12093990
pro@@	O	-1	12093990
mis@@	O	-1	12093990
ed	O	-1	12093990
ho@@	O	-1	12093990
st@@	O	-1	12093990
.	O	-1	12093990
The	O	-1	12093990
incidence	O	-1	12093990
of	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
in	O	-1	12093990
pe@@	O	-1	12093990
di@@	O	-1	12093990
at@@	O	-1	12093990
r@@	O	-1	12093990
ic@@	O	-1	12093990
s	O	-1	12093990
is	O	-1	12093990
increas@@	O	-1	12093990
ing	O	-1	12093990
in	O	-1	12093990
association	O	-1	12093990
with	O	-1	12093990
grow@@	O	-1	12093990
ing	O	-1	12093990
numb@@	O	-1	12093990
ers	O	-1	12093990
of	O	-1	12093990
immuno@@	O	-1	12093990
com@@	O	-1	12093990
pro@@	O	-1	12093990
mis@@	O	-1	12093990
ed	O	-1	12093990
child@@	O	-1	12093990
ren@@	O	-1	12093990
,	O	-1	12093990
wh@@	O	-1	12093990
ere	O	-1	12093990
case	O	-1	12093990
f@@	O	-1	12093990
at@@	O	-1	12093990
ality	O	-1	12093990
rat@@	O	-1	12093990
es	O	-1	12093990
as	O	-1	12093990
high	O	-1	12093990
as	O	-1	12093990
50@@	O	-1	12093990
%	O	-1	12093990
to	O	-1	12093990
8@@	O	-1	12093990
0%	O	-1	12093990
have	O	-1	12093990
been	O	-1	12093990
repor@@	O	-1	12093990
ted.	O	-1	12093990
There	O	-1	12093990
are	O	-1	12093990
no	O	-1	12093990
appro@@	O	-1	12093990
ved	O	-1	12093990
anti@@	O	-1	12093990
viral	O	-1	12093990
agents	O	-1	12093990
with	O	-1	12093990
pro@@	O	-1	12093990
ven	O	-1	12093990
efficacy	O	-1	12093990
for	O	-1	12093990
the	O	-1	12093990
treatment	O	-1	12093990
of	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
,	O	-1	12093990
n@@	O	-1	12093990
or	O	-1	12093990
are	O	-1	12093990
there	O	-1	12093990
any	O	-1	12093990
pro@@	O	-1	12093990
sp@@	O	-1	12093990
ective	O	-1	12093990
random@@	O	-1	12093990
iz@@	O	-1	12093990
ed,	O	-1	12093990
controlled	O	-1	12093990
tri@@	O	-1	12093990
als	O	-1	12093990
of	O	-1	12093990
potenti@@	O	-1	12093990
ally	O	-1	12093990
use@@	O	-1	12093990
ful	O	-1	12093990
anti@@	O	-1	12093990
-@@	O	-1	12093990
aden@@	O	-1	12093990
o@@	O	-1	12093990
vi@@	O	-1	12093990
ru@@	O	-1	12093990
s	O	-1	12093990
therap@@	O	-1	12093990
i@@	O	-1	12093990
es.	O	-1	12093990
A@@	O	-1	12093990
p@@	O	-1	12093990
pa@@	O	-1	12093990
rent	O	-1	12093990
clinical	O	-1	12093990
suc@@	O	-1	12093990
cess	O	-1	12093990
in	O	-1	12093990
the	O	-1	12093990
treatment	O	-1	12093990
of	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
is	O	-1	12093990
lim@@	O	-1	12093990
ited	O	-1	12093990
to	O	-1	12093990
a	O	-1	12093990
fe@@	O	-1	12093990
w	O	-1	12093990
case	O	-1	12093990
reports	O	-1	12093990
and	O	-1	12093990
sm@@	O	-1	12093990
all	O	-1	12093990
seri@@	O	-1	12093990
es.	O	-1	12093990
E@@	O	-1	12093990
x@@	O	-1	12093990
peri@@	O	-1	12093990
ence	O	-1	12093990
is	O	-1	12093990
great@@	O	-1	12093990
est	O	-1	12093990
with	O	-1	12093990
intravenous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
and	O	-1	12093990
c@@	B-Chemical	C059262	12093990
id@@	I-Chemical	-1	12093990
of@@	I-Chemical	-1	12093990
o@@	I-Chemical	-1	12093990
vi@@	I-Chemical	-1	12093990
r	I-Chemical	-1	12093990
.	O	-1	12093990
R@@	B-Chemical	D012254	12093990
i@@	I-Chemical	-1	12093990
b@@	I-Chemical	-1	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
,	O	-1	12093990
a	O	-1	12093990
gu@@	B-Chemical	D006151	12093990
an@@	I-Chemical	-1	12093990
os@@	I-Chemical	-1	12093990
ine	I-Chemical	-1	12093990
an@@	O	-1	12093990
alo@@	O	-1	12093990
gu@@	O	-1	12093990
e,	O	-1	12093990
has	O	-1	12093990
b@@	O	-1	12093990
ro@@	O	-1	12093990
ad	O	-1	12093990
anti@@	O	-1	12093990
viral	O	-1	12093990
activity	O	-1	12093990
against	O	-1	12093990
both	O	-1	12093990
R@@	O	-1	12093990
NA	O	-1	12093990
and	O	-1	12093990
D@@	O	-1	12093990
NA	O	-1	12093990
vi@@	O	-1	12093990
r@@	O	-1	12093990
us@@	O	-1	12093990
es,	O	-1	12093990
including	O	-1	12093990
doc@@	O	-1	12093990
um@@	O	-1	12093990
ent@@	O	-1	12093990
ed	O	-1	12093990
activity	O	-1	12093990
against	O	-1	12093990
aden@@	O	-1	12093990
o@@	O	-1	12093990
vi@@	O	-1	12093990
ru@@	O	-1	12093990
s	O	-1	12093990
in	O	-1	12093990
vit@@	O	-1	12093990
ro@@	O	-1	12093990
.	O	-1	12093990
R@@	B-Chemical	D012254	12093990
i@@	I-Chemical	-1	12093990
b@@	I-Chemical	-1	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
is	O	-1	12093990
l@@	O	-1	12093990
ic@@	O	-1	12093990
en@@	O	-1	12093990
sed	O	-1	12093990
in	O	-1	12093990
a@@	O	-1	12093990
er@@	O	-1	12093990
os@@	O	-1	12093990
ol	O	-1	12093990
form	O	-1	12093990
for	O	-1	12093990
the	O	-1	12093990
treatment	O	-1	12093990
of	O	-1	12093990
respiratory	B-Disease	D018357	12093990
syn@@	I-Disease	-1	12093990
cy@@	I-Disease	-1	12093990
tial	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
inf@@	I-Disease	-1	12093990
ection	I-Disease	-1	12093990
,	O	-1	12093990
and	O	-1	12093990
or@@	O	-1	12093990
ally	O	-1	12093990
in	O	-1	12093990
combination	O	-1	12093990
with	O	-1	12093990
inter@@	O	-1	12093990
fer@@	O	-1	12093990
on	O	-1	12093990
to	O	-1	12093990
tre@@	O	-1	12093990
at	O	-1	12093990
hepatitis	B-Disease	D006526	12093990
C	I-Disease	-1	12093990
.	O	-1	12093990
In@@	O	-1	12093990
tra@@	O	-1	12093990
venous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
is	O	-1	12093990
the	O	-1	12093990
treatment	O	-1	12093990
of	O	-1	12093990
ch@@	O	-1	12093990
o@@	O	-1	12093990
ic@@	O	-1	12093990
e	O	-1	12093990
for	O	-1	12093990
inf@@	B-Disease	D006482	12093990
ection	I-Disease	-1	12093990
with	I-Disease	-1	12093990
hemorrh@@	I-Disease	-1	12093990
ag@@	I-Disease	-1	12093990
ic	I-Disease	-1	12093990
f@@	I-Disease	-1	12093990
ev@@	I-Disease	-1	12093990
er	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
ses	I-Disease	-1	12093990
.	O	-1	12093990
The	O	-1	12093990
most	O	-1	12093990
common	O	-1	12093990
adverse	O	-1	12093990
effect	O	-1	12093990
of	O	-1	12093990
intravenous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
is	O	-1	12093990
reversible	O	-1	12093990
mil@@	O	-1	12093990
d	O	-1	12093990
anemia	B-Disease	D000740	12093990
.	O	-1	12093990
The	O	-1	12093990
use	O	-1	12093990
of	O	-1	12093990
c@@	B-Chemical	C059262	12093990
id@@	I-Chemical	-1	12093990
of@@	I-Chemical	-1	12093990
o@@	I-Chemical	-1	12093990
vi@@	I-Chemical	-1	12093990
r	I-Chemical	-1	12093990
in	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
inf@@	I-Disease	-1	12093990
ection	I-Disease	-1	12093990
has	O	-1	12093990
been	O	-1	12093990
lim@@	O	-1	12093990
ited	O	-1	12093990
by	O	-1	12093990
adverse	O	-1	12093990
effect@@	O	-1	12093990
s,	O	-1	12093990
the	O	-1	12093990
most	O	-1	12093990
significant	O	-1	12093990
of	O	-1	12093990
which	O	-1	12093990
is	O	-1	12093990
nephro@@	B-Disease	D007674	12093990
toxicity	I-Disease	-1	12093990
.	O	-1	12093990
OBJECTIVE:	O	-1	12093990
We	O	-1	12093990
report	O	-1	12093990
our	O	-1	12093990
experi@@	O	-1	12093990
ence	O	-1	12093990
with	O	-1	12093990
intravenous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
therapy	O	-1	12093990
for	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
in	O	-1	12093990
a	O	-1	12093990
seri@@	O	-1	12093990
es	O	-1	12093990
of	O	-1	12093990
immuno@@	O	-1	12093990
com@@	O	-1	12093990
pro@@	O	-1	12093990
mis@@	O	-1	12093990
ed	O	-1	12093990
children	O	-1	12093990
and	O	-1	12093990
revie@@	O	-1	12093990
w	O	-1	12093990
the	O	-1	12093990
literat@@	O	-1	12093990
ure.	O	-1	12093990
D@@	O	-1	12093990
ES@@	O	-1	12093990
I@@	O	-1	12093990
G@@	O	-1	12093990
N@@	O	-1	12093990
/@@	O	-1	12093990
METHODS:	O	-1	12093990
We	O	-1	12093990
ret@@	O	-1	12093990
ro@@	O	-1	12093990
sp@@	O	-1	12093990
ectively	O	-1	12093990
revie@@	O	-1	12093990
w@@	O	-1	12093990
ed	O	-1	12093990
the	O	-1	12093990
med@@	O	-1	12093990
ical	O	-1	12093990
recor@@	O	-1	12093990
ds	O	-1	12093990
of	O	-1	12093990
5	O	-1	12093990
children	O	-1	12093990
treated	O	-1	12093990
with	O	-1	12093990
intravenous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
for	O	-1	12093990
doc@@	O	-1	12093990
um@@	O	-1	12093990
ent@@	O	-1	12093990
ed	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
.	O	-1	12093990
Two	O	-1	12093990
patients	O	-1	12093990
developed	O	-1	12093990
aden@@	O	-1	12093990
o@@	O	-1	12093990
vi@@	O	-1	12093990
ru@@	O	-1	12093990
s	O	-1	12093990
hemorrh@@	B-Disease	D006470	12093990
ag@@	I-Disease	-1	12093990
ic	I-Disease	-1	12093990
cys@@	I-Disease	-1	12093990
ti@@	I-Disease	-1	12093990
tis	I-Disease	-1	12093990
hemorrh@@	B-Disease	D003556	12093990
ag@@	I-Disease	-1	12093990
ic	I-Disease	-1	12093990
cys@@	I-Disease	-1	12093990
ti@@	I-Disease	-1	12093990
tis	I-Disease	-1	12093990
after	O	-1	12093990
cardiac	O	-1	12093990
and	O	-1	12093990
b@@	O	-1	12093990
one	O	-1	12093990
m@@	O	-1	12093990
ar@@	O	-1	12093990
ro@@	O	-1	12093990
w	O	-1	12093990
transplant@@	O	-1	12093990
s,	O	-1	12093990
respectively.	O	-1	12093990
The	O	-1	12093990
b@@	O	-1	12093990
one	O	-1	12093990
m@@	O	-1	12093990
ar@@	O	-1	12093990
ro@@	O	-1	12093990
w	O	-1	12093990
transplant	O	-1	12093990
patient	O	-1	12093990
also	O	-1	12093990
received	O	-1	12093990
intravenous	O	-1	12093990
c@@	B-Chemical	C059262	12093990
id@@	I-Chemical	-1	12093990
of@@	I-Chemical	-1	12093990
o@@	I-Chemical	-1	12093990
vi@@	I-Chemical	-1	12093990
r	I-Chemical	-1	12093990
for	O	-1	12093990
progressive	O	-1	12093990
dis@@	O	-1	12093990
se@@	O	-1	12093990
min@@	O	-1	12093990
ated	O	-1	12093990
disease.	O	-1	12093990
An	O	-1	12093990
addi@@	O	-1	12093990
tional	O	-1	12093990
3	O	-1	12093990
children	O	-1	12093990
developed	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
p@@	I-Disease	-1	12093990
ne@@	I-Disease	-1	12093990
um@@	I-Disease	-1	12093990
on@@	I-Disease	-1	12093990
ia	I-Disease	-1	12093990
aden@@	B-Disease	D011024	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
p@@	I-Disease	-1	12093990
ne@@	I-Disease	-1	12093990
um@@	I-Disease	-1	12093990
on@@	I-Disease	-1	12093990
ia	I-Disease	-1	12093990
;	O	-1	12093990
2	O	-1	12093990
were	O	-1	12093990
ne@@	O	-1	12093990
on@@	O	-1	12093990
at@@	O	-1	12093990
es,	O	-1	12093990
1	O	-1	12093990
of	O	-1	12093990
whom	O	-1	12093990
had	O	-1	12093990
partial	O	-1	12093990
Di@@	B-Disease	D004062	12093990
G@@	I-Disease	-1	12093990
e@@	I-Disease	-1	12093990
or@@	I-Disease	-1	12093990
ge	I-Disease	-1	12093990
syndrome	I-Disease	-1	12093990
.	O	-1	12093990
The	O	-1	12093990
remain@@	O	-1	12093990
ing	O	-1	12093990
inf@@	O	-1	12093990
ant	O	-1	12093990
had	O	-1	12093990
rec@@	O	-1	12093990
ently	O	-1	12093990
under@@	O	-1	12093990
g@@	O	-1	12093990
one	O	-1	12093990
a	O	-1	12093990
cardiac	O	-1	12093990
transplant@@	O	-1	12093990
.	O	-1	12093990
In@@	O	-1	12093990
tra@@	O	-1	12093990
venous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
was	O	-1	12093990
administered	O	-1	12093990
on	O	-1	12093990
a	O	-1	12093990
comp@@	O	-1	12093990
as@@	O	-1	12093990
sion@@	O	-1	12093990
at@@	O	-1	12093990
e-@@	O	-1	12093990
use	O	-1	12093990
pro@@	O	-1	12093990
to@@	O	-1	12093990
co@@	O	-1	12093990
l@@	O	-1	12093990
.	O	-1	12093990
RESULTS:	O	-1	12093990
Com@@	O	-1	12093990
ple@@	O	-1	12093990
te	O	-1	12093990
clinical	O	-1	12093990
recovery	O	-1	12093990
followed	O	-1	12093990
lat@@	O	-1	12093990
er	O	-1	12093990
by	O	-1	12093990
viral	O	-1	12093990
clear@@	O	-1	12093990
ance	O	-1	12093990
was	O	-1	12093990
observed	O	-1	12093990
in	O	-1	12093990
2	O	-1	12093990
child@@	O	-1	12093990
ren@@	O	-1	12093990
:	O	-1	12093990
the	O	-1	12093990
cardiac	O	-1	12093990
transplant	O	-1	12093990
re@@	O	-1	12093990
ci@@	O	-1	12093990
pi@@	O	-1	12093990
ent	O	-1	12093990
with	O	-1	12093990
aden@@	O	-1	12093990
o@@	O	-1	12093990
vi@@	O	-1	12093990
ru@@	O	-1	12093990
s	O	-1	12093990
hemorrh@@	B-Disease	D006470	12093990
ag@@	I-Disease	-1	12093990
ic	I-Disease	-1	12093990
cys@@	I-Disease	-1	12093990
ti@@	I-Disease	-1	12093990
tis	I-Disease	-1	12093990
hemorrh@@	B-Disease	D003556	12093990
ag@@	I-Disease	-1	12093990
ic	I-Disease	-1	12093990
cys@@	I-Disease	-1	12093990
ti@@	I-Disease	-1	12093990
tis	I-Disease	-1	12093990
and	O	-1	12093990
the	O	-1	12093990
immuno@@	O	-1	12093990
comp@@	O	-1	12093990
et@@	O	-1	12093990
ent	O	-1	12093990
ne@@	O	-1	12093990
on@@	O	-1	12093990
ate	O	-1	12093990
with	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
p@@	I-Disease	-1	12093990
ne@@	I-Disease	-1	12093990
um@@	I-Disease	-1	12093990
on@@	I-Disease	-1	12093990
ia	I-Disease	-1	12093990
aden@@	B-Disease	D011024	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
p@@	I-Disease	-1	12093990
ne@@	I-Disease	-1	12093990
um@@	I-Disease	-1	12093990
on@@	I-Disease	-1	12093990
ia	I-Disease	-1	12093990
.	O	-1	12093990
The	O	-1	12093990
remain@@	O	-1	12093990
ing	O	-1	12093990
3	O	-1	12093990
children	O	-1	12093990
di@@	O	-1	12093990
ed	O	-1	12093990
of	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
.	O	-1	12093990
In@@	O	-1	12093990
tra@@	O	-1	12093990
venous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
therapy	O	-1	12093990
was	O	-1	12093990
well	O	-1	12093990
toler@@	O	-1	12093990
ated.	O	-1	12093990
U@@	O	-1	12093990
se	O	-1	12093990
of	O	-1	12093990
c@@	B-Chemical	C059262	12093990
id@@	I-Chemical	-1	12093990
of@@	I-Chemical	-1	12093990
o@@	I-Chemical	-1	12093990
vi@@	I-Chemical	-1	12093990
r	I-Chemical	-1	12093990
in	O	-1	12093990
1	O	-1	12093990
ch@@	O	-1	12093990
il@@	O	-1	12093990
d	O	-1	12093990
was	O	-1	12093990
associated	O	-1	12093990
with	O	-1	12093990
progressive	B-Disease	D058186	12093990
renal	I-Disease	-1	12093990
failure	I-Disease	-1	12093990
and	O	-1	12093990
ne@@	B-Disease	D009503	12093990
ut@@	I-Disease	-1	12093990
ro@@	I-Disease	-1	12093990
pen@@	I-Disease	-1	12093990
ia	I-Disease	-1	12093990
.	O	-1	12093990
D@@	O	-1	12093990
I@@	O	-1	12093990
S@@	O	-1	12093990
C@@	O	-1	12093990
US@@	O	-1	12093990
S@@	O	-1	12093990
ION@@	O	-1	12093990
:	O	-1	12093990
Our	O	-1	12093990
seri@@	O	-1	12093990
es	O	-1	12093990
of	O	-1	12093990
patients	O	-1	12093990
is	O	-1	12093990
re@@	O	-1	12093990
present@@	O	-1	12093990
ative	O	-1	12093990
of	O	-1	12093990
the	O	-1	12093990
sp@@	O	-1	12093990
ect@@	O	-1	12093990
ru@@	O	-1	12093990
m	O	-1	12093990
of	O	-1	12093990
immuno@@	O	-1	12093990
com@@	O	-1	12093990
pro@@	O	-1	12093990
mis@@	O	-1	12093990
ed	O	-1	12093990
children	O	-1	12093990
at	O	-1	12093990
great@@	O	-1	12093990
est	O	-1	12093990
risk	O	-1	12093990
for	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
,	O	-1	12093990
n@@	O	-1	12093990
ame@@	O	-1	12093990
ly	O	-1	12093990
sol@@	O	-1	12093990
id@@	O	-1	12093990
-@@	O	-1	12093990
org@@	O	-1	12093990
an	O	-1	12093990
and	O	-1	12093990
b@@	O	-1	12093990
one	O	-1	12093990
m@@	O	-1	12093990
ar@@	O	-1	12093990
ro@@	O	-1	12093990
w	O	-1	12093990
transplant	O	-1	12093990
re@@	O	-1	12093990
ci@@	O	-1	12093990
pi@@	O	-1	12093990
ent@@	O	-1	12093990
s,	O	-1	12093990
ne@@	O	-1	12093990
on@@	O	-1	12093990
at@@	O	-1	12093990
es,	O	-1	12093990
and	O	-1	12093990
children	O	-1	12093990
with	O	-1	12093990
immuno@@	B-Disease	D007153	12093990
defici@@	I-Disease	-1	12093990
ency	I-Disease	-1	12093990
.	O	-1	12093990
Although	O	-1	12093990
intravenous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
was	O	-1	12093990
not	O	-1	12093990
effective	O	-1	12093990
for	O	-1	12093990
all	O	-1	12093990
children	O	-1	12093990
with	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
in	O	-1	12093990
this	O	-1	12093990
seri@@	O	-1	12093990
es	O	-1	12093990
or	O	-1	12093990
in	O	-1	12093990
the	O	-1	12093990
literat@@	O	-1	12093990
ure,	O	-1	12093990
therapy	O	-1	12093990
is	O	-1	12093990
un@@	O	-1	12093990
likely	O	-1	12093990
to	O	-1	12093990
be	O	-1	12093990
of	O	-1	12093990
ben@@	O	-1	12093990
e@@	O	-1	12093990
fi@@	O	-1	12093990
t	O	-1	12093990
if	O	-1	12093990
be@@	O	-1	12093990
gu@@	O	-1	12093990
n	O	-1	12093990
l@@	O	-1	12093990
ate	O	-1	12093990
in	O	-1	12093990
the	O	-1	12093990
course	O	-1	12093990
of	O	-1	12093990
the	O	-1	12093990
inf@@	B-Disease	D007239	12093990
ection	I-Disease	-1	12093990
.	O	-1	12093990
E@@	O	-1	12093990
arly	O	-1	12093990
identi@@	O	-1	12093990
fic@@	O	-1	12093990
ation,	O	-1	12093990
e@@	O	-1	12093990
g	O	-1	12093990
by	O	-1	12093990
poly@@	O	-1	12093990
mer@@	O	-1	12093990
ase	O	-1	12093990
ch@@	O	-1	12093990
ain	O	-1	12093990
reaction	O	-1	12093990
of	O	-1	12093990
those	O	-1	12093990
patients	O	-1	12093990
at	O	-1	12093990
risk	O	-1	12093990
of	O	-1	12093990
dis@@	O	-1	12093990
se@@	O	-1	12093990
min@@	O	-1	12093990
ated	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
may	O	-1	12093990
per@@	O	-1	12093990
m@@	O	-1	12093990
it	O	-1	12093990
ear@@	O	-1	12093990
li@@	O	-1	12093990
er	O	-1	12093990
anti@@	O	-1	12093990
viral	O	-1	12093990
treatment	O	-1	12093990
and	O	-1	12093990
bet@@	O	-1	12093990
ter	O	-1	12093990
evalu@@	O	-1	12093990
ation	O	-1	12093990
of	O	-1	12093990
therapeutic	O	-1	12093990
respon@@	O	-1	12093990
se.	O	-1	12093990
CONCLUSIONS:	O	-1	12093990
Two	O	-1	12093990
of	O	-1	12093990
5	O	-1	12093990
children	O	-1	12093990
with	O	-1	12093990
severe	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
treated	O	-1	12093990
with	O	-1	12093990
intravenous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
reco@@	O	-1	12093990
ve@@	O	-1	12093990
red.	O	-1	12093990
The	O	-1	12093990
av@@	O	-1	12093990
ail@@	O	-1	12093990
ability	O	-1	12093990
of	O	-1	12093990
ne@@	O	-1	12093990
w@@	O	-1	12093990
er	O	-1	12093990
ra@@	O	-1	12093990
pid	O	-1	12093990
diagnos@@	O	-1	12093990
tic	O	-1	12093990
t@@	O	-1	12093990
ech@@	O	-1	12093990
n@@	O	-1	12093990
i@@	O	-1	12093990
qu@@	O	-1	12093990
es,	O	-1	12093990
such	O	-1	12093990
as	O	-1	12093990
poly@@	O	-1	12093990
mer@@	O	-1	12093990
ase	O	-1	12093990
ch@@	O	-1	12093990
ain	O	-1	12093990
reac@@	O	-1	12093990
tion,	O	-1	12093990
may	O	-1	12093990
ma@@	O	-1	12093990
k@@	O	-1	12093990
e	O	-1	12093990
ear@@	O	-1	12093990
li@@	O	-1	12093990
er,	O	-1	12093990
more	O	-1	12093990
effective	O	-1	12093990
treatment	O	-1	12093990
of	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
inf@@	I-Disease	-1	12093990
ection	I-Disease	-1	12093990
possib@@	O	-1	12093990
le@@	O	-1	12093990
.	O	-1	12093990
G@@	O	-1	12093990
i@@	O	-1	12093990
ven	O	-1	12093990
the	O	-1	12093990
seri@@	O	-1	12093990
ous@@	O	-1	12093990
ness	O	-1	12093990
and	O	-1	12093990
increas@@	O	-1	12093990
ing	O	-1	12093990
prev@@	O	-1	12093990
al@@	O	-1	12093990
ence	O	-1	12093990
of	O	-1	12093990
aden@@	B-Disease	D000257	12093990
o@@	I-Disease	-1	12093990
vi@@	I-Disease	-1	12093990
ru@@	I-Disease	-1	12093990
s	I-Disease	-1	12093990
disease	I-Disease	-1	12093990
in	O	-1	12093990
cer@@	O	-1	12093990
t@@	O	-1	12093990
ain	O	-1	12093990
ho@@	O	-1	12093990
st@@	O	-1	12093990
s,	O	-1	12093990
es@@	O	-1	12093990
p@@	O	-1	12093990
ec@@	O	-1	12093990
i@@	O	-1	12093990
ally	O	-1	12093990
child@@	O	-1	12093990
ren@@	O	-1	12093990
,	O	-1	12093990
a	O	-1	12093990
larg@@	O	-1	12093990
e,	O	-1	12093990
mul@@	O	-1	12093990
tic@@	O	-1	12093990
ent@@	O	-1	12093990
er	O	-1	12093990
clinical	O	-1	12093990
trial	O	-1	12093990
of	O	-1	12093990
potenti@@	O	-1	12093990
ally	O	-1	12093990
use@@	O	-1	12093990
ful	O	-1	12093990
anti@@	O	-1	12093990
-@@	O	-1	12093990
aden@@	O	-1	12093990
o@@	O	-1	12093990
viral	O	-1	12093990
therap@@	O	-1	12093990
i@@	O	-1	12093990
es,	O	-1	12093990
such	O	-1	12093990
as	O	-1	12093990
intravenous	O	-1	12093990
rib@@	B-Chemical	D012254	12093990
avi@@	I-Chemical	-1	12093990
rin	I-Chemical	-1	12093990
,	O	-1	12093990
is	O	-1	12093990
clear@@	O	-1	12093990
ly	O	-1	12093990
requ@@	O	-1	12093990
ired	O	-1	12093990
to	O	-1	12093990
demon@@	O	-1	12093990
st@@	O	-1	12093990
rate	O	-1	12093990
the	O	-1	12093990
most	O	-1	12093990
effective	O	-1	12093990
and	O	-1	12093990
le@@	O	-1	12093990
ast	O	-1	12093990
toxic	O	-1	12093990
therapy.	O	-1	12093990

H@@	B-Disease	D056486	3962737
ep@@	I-Disease	-1	3962737
at@@	I-Disease	-1	3962737
otoxicity	I-Disease	-1	3962737
of	O	-1	3962737
am@@	B-Chemical	D000638	3962737
iodar@@	I-Chemical	-1	3962737
one	I-Chemical	-1	3962737
.	O	-1	3962737
A@@	B-Chemical	D000638	3962737
m@@	I-Chemical	-1	3962737
iodar@@	I-Chemical	-1	3962737
one	I-Chemical	-1	3962737
has	O	-1	3962737
pro@@	O	-1	3962737
ved	O	-1	3962737
very	O	-1	3962737
effective	O	-1	3962737
in	O	-1	3962737
the	O	-1	3962737
treatment	O	-1	3962737
of	O	-1	3962737
o@@	O	-1	3962737
ther@@	O	-1	3962737
w@@	O	-1	3962737
is@@	O	-1	3962737
e	O	-1	3962737
resist@@	O	-1	3962737
ant	O	-1	3962737
cardiac	O	-1	3962737
tachy@@	B-Disease	D013610	3962737
arrhyth@@	I-Disease	-1	3962737
mi@@	I-Disease	-1	3962737
as	I-Disease	-1	3962737
.	O	-1	3962737
The	O	-1	3962737
use	O	-1	3962737
of	O	-1	3962737
am@@	B-Chemical	D000638	3962737
iodar@@	I-Chemical	-1	3962737
one	I-Chemical	-1	3962737
h@@	O	-1	3962737
as@@	O	-1	3962737
,	O	-1	3962737
however,	O	-1	3962737
been	O	-1	3962737
lim@@	O	-1	3962737
ited	O	-1	3962737
due	O	-1	3962737
to	O	-1	3962737
its	O	-1	3962737
seri@@	O	-1	3962737
ous	O	-1	3962737
side@@	O	-1	3962737
-@@	O	-1	3962737
effects.	O	-1	3962737
A	O	-1	3962737
patient	O	-1	3962737
with	O	-1	3962737
cholest@@	B-Disease	D002779	3962737
atic	I-Disease	-1	3962737
hepatitis	I-Disease	-1	3962737
cholest@@	B-Disease	D056486	3962737
atic	I-Disease	-1	3962737
hepatitis	I-Disease	-1	3962737
due	O	-1	3962737
to	O	-1	3962737
am@@	B-Chemical	D000638	3962737
iodar@@	I-Chemical	-1	3962737
one	I-Chemical	-1	3962737
treatment	O	-1	3962737
is	O	-1	3962737
presented	O	-1	3962737
be@@	O	-1	3962737
low	O	-1	3962737
and	O	-1	3962737
a	O	-1	3962737
revie@@	O	-1	3962737
w	O	-1	3962737
of	O	-1	3962737
the	O	-1	3962737
hepat@@	B-Disease	D056486	3962737
otoxicity	I-Disease	-1	3962737
of	O	-1	3962737
am@@	B-Chemical	D000638	3962737
iodar@@	I-Chemical	-1	3962737
one	I-Chemical	-1	3962737
is	O	-1	3962737
gi@@	O	-1	3962737
ven@@	O	-1	3962737
.	O	-1	3962737
It	O	-1	3962737
is	O	-1	3962737
concl@@	O	-1	3962737
uded	O	-1	3962737
that	O	-1	3962737
sol@@	O	-1	3962737
id	O	-1	3962737
evidence	O	-1	3962737
ex@@	O	-1	3962737
ist@@	O	-1	3962737
s	O	-1	3962737
of	O	-1	3962737
hepatic	B-Disease	D056486	3962737
injury	I-Disease	-1	3962737
due	O	-1	3962737
to	O	-1	3962737
am@@	B-Chemical	D000638	3962737
iodar@@	I-Chemical	-1	3962737
one	I-Chemical	-1	3962737
treatment,	O	-1	3962737
including	O	-1	3962737
ste@@	B-Disease	D005234	3962737
at@@	I-Disease	-1	3962737
o@@	I-Disease	-1	3962737
sis	I-Disease	-1	3962737
,	O	-1	3962737
al@@	O	-1	3962737
ter@@	O	-1	3962737
ations	O	-1	3962737
re@@	O	-1	3962737
se@@	O	-1	3962737
m@@	O	-1	3962737
bl@@	O	-1	3962737
ing	O	-1	3962737
alco@@	B-Disease	D006519	3962737
h@@	I-Disease	-1	3962737
olic	I-Disease	-1	3962737
hepatitis	I-Disease	-1	3962737
,	O	-1	3962737
cholest@@	B-Disease	D002779	3962737
atic	I-Disease	-1	3962737
hepatitis	I-Disease	-1	3962737
cholest@@	B-Disease	D056486	3962737
atic	I-Disease	-1	3962737
hepatitis	I-Disease	-1	3962737
and	O	-1	3962737
mic@@	O	-1	3962737
ron@@	O	-1	3962737
o@@	O	-1	3962737
d@@	O	-1	3962737
ular	O	-1	3962737
cir@@	B-Disease	D008103	3962737
r@@	I-Disease	-1	3962737
ho@@	I-Disease	-1	3962737
sis	I-Disease	-1	3962737
of	I-Disease	-1	3962737
the	I-Disease	-1	3962737
liver	I-Disease	-1	3962737
.	O	-1	3962737
Patients	O	-1	3962737
receiving	O	-1	3962737
am@@	B-Chemical	D000638	3962737
iodar@@	I-Chemical	-1	3962737
one	I-Chemical	-1	3962737
should	O	-1	3962737
be	O	-1	3962737
reg@@	O	-1	3962737
ul@@	O	-1	3962737
arly	O	-1	3962737
s@@	O	-1	3962737
cre@@	O	-1	3962737
en@@	O	-1	3962737
ed	O	-1	3962737
with	O	-1	3962737
resp@@	O	-1	3962737
ect	O	-1	3962737
to	O	-1	3962737
hepatic	O	-1	3962737
enzyme	O	-1	3962737
level@@	O	-1	3962737
s.	O	-1	3962737
Th@@	O	-1	3962737
er@@	O	-1	3962737
ap@@	O	-1	3962737
y	O	-1	3962737
should	O	-1	3962737
be	O	-1	3962737
discontinu@@	O	-1	3962737
ed	O	-1	3962737
on	O	-1	3962737
the	O	-1	3962737
sus@@	O	-1	3962737
p@@	O	-1	3962737
ici@@	O	-1	3962737
on	O	-1	3962737
of	O	-1	3962737
cholest@@	B-Disease	D002779	3962737
atic	I-Disease	-1	3962737
injury	I-Disease	-1	3962737
or	O	-1	3962737
hepat@@	B-Disease	D006529	3962737
o@@	I-Disease	-1	3962737
me@@	I-Disease	-1	3962737
g@@	I-Disease	-1	3962737
al@@	I-Disease	-1	3962737
y	I-Disease	-1	3962737
.	O	-1	3962737

C@@	B-Disease	D002375	2716967
at@@	I-Disease	-1	2716967
al@@	I-Disease	-1	2716967
ep@@	I-Disease	-1	2716967
sy	I-Disease	-1	2716967
induced	O	-1	2716967
by	O	-1	2716967
combin@@	O	-1	2716967
ations	O	-1	2716967
of	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
and	O	-1	2716967
morphine	B-Chemical	D009020	2716967
:	O	-1	2716967
potenti@@	O	-1	2716967
ation,	O	-1	2716967
antagon@@	O	-1	2716967
is@@	O	-1	2716967
m@@	O	-1	2716967
,	O	-1	2716967
toler@@	O	-1	2716967
ance	O	-1	2716967
and	O	-1	2716967
cros@@	O	-1	2716967
s-@@	O	-1	2716967
toler@@	O	-1	2716967
ance	O	-1	2716967
in	O	-1	2716967
the	O	-1	2716967
rat@@	O	-1	2716967
.	O	-1	2716967
Pre@@	O	-1	2716967
vi@@	O	-1	2716967
ous	O	-1	2716967
studies	O	-1	2716967
demonstrated	O	-1	2716967
that	O	-1	2716967
both	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
and	O	-1	2716967
morphine	B-Chemical	D009020	2716967
induced	O	-1	2716967
analge@@	B-Disease	D000699	2716967
sia	I-Disease	-1	2716967
and	O	-1	2716967
cat@@	B-Disease	D002375	2716967
al@@	I-Disease	-1	2716967
ep@@	I-Disease	-1	2716967
sy	I-Disease	-1	2716967
in	O	-1	2716967
the	O	-1	2716967
rat@@	O	-1	2716967
.	O	-1	2716967
Pre@@	O	-1	2716967
-@@	O	-1	2716967
treatment	O	-1	2716967
with	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
produced	O	-1	2716967
cros@@	O	-1	2716967
s-@@	O	-1	2716967
toler@@	O	-1	2716967
ance	O	-1	2716967
to	O	-1	2716967
morphine	B-Chemical	D009020	2716967
,	O	-1	2716967
whereas	O	-1	2716967
pretreatment	O	-1	2716967
with	O	-1	2716967
morphine	B-Chemical	D009020	2716967
did	O	-1	2716967
not	O	-1	2716967
induce	O	-1	2716967
cros@@	O	-1	2716967
s-@@	O	-1	2716967
toler@@	O	-1	2716967
ance	O	-1	2716967
to	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
but	O	-1	2716967
ra@@	O	-1	2716967
ther	O	-1	2716967
au@@	O	-1	2716967
g@@	O	-1	2716967
ment@@	O	-1	2716967
ed	O	-1	2716967
the	O	-1	2716967
cat@@	B-Disease	D002375	2716967
al@@	I-Disease	-1	2716967
ep@@	I-Disease	-1	2716967
tic	I-Disease	-1	2716967
respon@@	O	-1	2716967
se@@	O	-1	2716967
;	O	-1	2716967
this	O	-1	2716967
au@@	O	-1	2716967
g@@	O	-1	2716967
ment@@	O	-1	2716967
ation	O	-1	2716967
was	O	-1	2716967
at@@	O	-1	2716967
tri@@	O	-1	2716967
but@@	O	-1	2716967
ed	O	-1	2716967
to	O	-1	2716967
re@@	O	-1	2716967
si@@	O	-1	2716967
du@@	O	-1	2716967
al	O	-1	2716967
morphine	B-Chemical	D009020	2716967
in	O	-1	2716967
the	O	-1	2716967
bra@@	O	-1	2716967
in.	O	-1	2716967
The	O	-1	2716967
present	O	-1	2716967
studies	O	-1	2716967
ex@@	O	-1	2716967
p@@	O	-1	2716967
lo@@	O	-1	2716967
red	O	-1	2716967
the	O	-1	2716967
duration	O	-1	2716967
of	O	-1	2716967
the	O	-1	2716967
loss	O	-1	2716967
of	O	-1	2716967
ri@@	O	-1	2716967
gh@@	O	-1	2716967
ting	O	-1	2716967
ref@@	O	-1	2716967
le@@	O	-1	2716967
x	O	-1	2716967
induced	O	-1	2716967
by	O	-1	2716967
sub@@	O	-1	2716967
-@@	O	-1	2716967
effective	O	-1	2716967
doses	O	-1	2716967
of	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
and	O	-1	2716967
morphine	B-Chemical	D009020	2716967
,	O	-1	2716967
administered	O	-1	2716967
sim@@	O	-1	2716967
ult@@	O	-1	2716967
ane@@	O	-1	2716967
ous@@	O	-1	2716967
ly.	O	-1	2716967
There	O	-1	2716967
was	O	-1	2716967
mut@@	O	-1	2716967
ual	O	-1	2716967
potenti@@	O	-1	2716967
ation	O	-1	2716967
between	O	-1	2716967
sub@@	O	-1	2716967
-@@	O	-1	2716967
effective	O	-1	2716967
doses	O	-1	2716967
of	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
and	O	-1	2716967
morphine	B-Chemical	D009020	2716967
,	O	-1	2716967
but	O	-1	2716967
sub@@	O	-1	2716967
-@@	O	-1	2716967
effective	O	-1	2716967
doses	O	-1	2716967
of	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
part@@	O	-1	2716967
ly	O	-1	2716967
antagon@@	O	-1	2716967
ized	O	-1	2716967
ful@@	O	-1	2716967
l@@	O	-1	2716967
y-@@	O	-1	2716967
effective	O	-1	2716967
doses	O	-1	2716967
of	O	-1	2716967
morphine	B-Chemical	D009020	2716967
.	O	-1	2716967
L@@	O	-1	2716967
at@@	O	-1	2716967
ency	O	-1	2716967
to	O	-1	2716967
the	O	-1	2716967
loss	O	-1	2716967
of	O	-1	2716967
ri@@	O	-1	2716967
gh@@	O	-1	2716967
ting	O	-1	2716967
ref@@	O	-1	2716967
le@@	O	-1	2716967
x@@	O	-1	2716967
,	O	-1	2716967
rig@@	B-Disease	D009127	2716967
idity	I-Disease	-1	2716967
and	O	-1	2716967
behavi@@	O	-1	2716967
or	O	-1	2716967
on	O	-1	2716967
reco@@	O	-1	2716967
ver@@	O	-1	2716967
y,	O	-1	2716967
ref@@	O	-1	2716967
l@@	O	-1	2716967
ected	O	-1	2716967
the	O	-1	2716967
rel@@	O	-1	2716967
ative	O	-1	2716967
pre@@	O	-1	2716967
domin@@	O	-1	2716967
ance	O	-1	2716967
of	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
or	O	-1	2716967
morphine	B-Chemical	D009020	2716967
in	O	-1	2716967
each	O	-1	2716967
combin@@	O	-1	2716967
ation.	O	-1	2716967
N@@	B-Chemical	D009270	2716967
al@@	I-Chemical	-1	2716967
ox@@	I-Chemical	-1	2716967
one	I-Chemical	-1	2716967
inhibited	O	-1	2716967
the	O	-1	2716967
induced	O	-1	2716967
cat@@	B-Disease	D002375	2716967
al@@	I-Disease	-1	2716967
ep@@	I-Disease	-1	2716967
tic	I-Disease	-1	2716967
effects.	O	-1	2716967
The	O	-1	2716967
de@@	O	-1	2716967
g@@	O	-1	2716967
ree	O	-1	2716967
and	O	-1	2716967
time	O	-1	2716967
course	O	-1	2716967
of	O	-1	2716967
development	O	-1	2716967
of	O	-1	2716967
toler@@	O	-1	2716967
ance	O	-1	2716967
to	O	-1	2716967
daily	O	-1	2716967
administration	O	-1	2716967
of	O	-1	2716967
sub@@	O	-1	2716967
-@@	O	-1	2716967
effective	O	-1	2716967
dose	O	-1	2716967
combin@@	O	-1	2716967
ations	O	-1	2716967
of	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
and	O	-1	2716967
morphine	B-Chemical	D009020	2716967
were	O	-1	2716967
simil@@	O	-1	2716967
ar@@	O	-1	2716967
.	O	-1	2716967
R@@	O	-1	2716967
at@@	O	-1	2716967
s,	O	-1	2716967
toler@@	O	-1	2716967
ant	O	-1	2716967
to	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
-@@	O	-1	2716967
domin@@	O	-1	2716967
ant	O	-1	2716967
combin@@	O	-1	2716967
ation@@	O	-1	2716967
s,	O	-1	2716967
were	O	-1	2716967
cros@@	O	-1	2716967
s-@@	O	-1	2716967
toler@@	O	-1	2716967
ant	O	-1	2716967
to	O	-1	2716967
both	O	-1	2716967
drug@@	O	-1	2716967
s,	O	-1	2716967
while	O	-1	2716967
those	O	-1	2716967
toler@@	O	-1	2716967
ant	O	-1	2716967
to	O	-1	2716967
morphine	B-Chemical	D009020	2716967
-@@	O	-1	2716967
domin@@	O	-1	2716967
ant	O	-1	2716967
combin@@	O	-1	2716967
ations	O	-1	2716967
were	O	-1	2716967
cros@@	O	-1	2716967
s-@@	O	-1	2716967
toler@@	O	-1	2716967
ant	O	-1	2716967
to	O	-1	2716967
morphine	B-Chemical	D009020	2716967
but	O	-1	2716967
showed	O	-1	2716967
either	O	-1	2716967
no	O	-1	2716967
cros@@	O	-1	2716967
s-@@	O	-1	2716967
toler@@	O	-1	2716967
ance	O	-1	2716967
or	O	-1	2716967
an	O	-1	2716967
au@@	O	-1	2716967
g@@	O	-1	2716967
ment@@	O	-1	2716967
ed	O	-1	2716967
response	O	-1	2716967
to	O	-1	2716967
k@@	B-Chemical	D007649	2716967
et@@	I-Chemical	-1	2716967
amine	I-Chemical	-1	2716967
.	O	-1	2716967
W@@	O	-1	2716967
h@@	O	-1	2716967
ile	O	-1	2716967
the	O	-1	2716967
mut@@	O	-1	2716967
ual	O	-1	2716967
potenti@@	O	-1	2716967
ation,	O	-1	2716967
antagon@@	O	-1	2716967
ism	O	-1	2716967
and	O	-1	2716967
toler@@	O	-1	2716967
ance	O	-1	2716967
suggest	O	-1	2716967
common	O	-1	2716967
mechanisms	O	-1	2716967
for	O	-1	2716967
the	O	-1	2716967
induced	O	-1	2716967
cat@@	B-Disease	D002375	2716967
al@@	I-Disease	-1	2716967
ep@@	I-Disease	-1	2716967
sy	I-Disease	-1	2716967
,	O	-1	2716967
differences	O	-1	2716967
in	O	-1	2716967
lat@@	O	-1	2716967
enc@@	O	-1	2716967
y,	O	-1	2716967
rig@@	B-Disease	D009127	2716967
idity	I-Disease	-1	2716967
and	O	-1	2716967
behavi@@	O	-1	2716967
or@@	O	-1	2716967
,	O	-1	2716967
as@@	O	-1	2716967
ym@@	O	-1	2716967
met@@	O	-1	2716967
r@@	O	-1	2716967
y	O	-1	2716967
of	O	-1	2716967
cros@@	O	-1	2716967
s-@@	O	-1	2716967
toler@@	O	-1	2716967
ance	O	-1	2716967
and	O	-1	2716967
a	O	-1	2716967
wi@@	O	-1	2716967
del@@	O	-1	2716967
y-@@	O	-1	2716967
different	O	-1	2716967
I@@	O	-1	2716967
D@@	O	-1	2716967
50	O	-1	2716967
for	O	-1	2716967
n@@	B-Chemical	D009270	2716967
al@@	I-Chemical	-1	2716967
ox@@	I-Chemical	-1	2716967
one	I-Chemical	-1	2716967
wo@@	O	-1	2716967
uld	O	-1	2716967
arg@@	O	-1	2716967
u@@	O	-1	2716967
e	O	-1	2716967
against	O	-1	2716967
an	O	-1	2716967
action	O	-1	2716967
at	O	-1	2716967
a	O	-1	2716967
single	O	-1	2716967
o@@	O	-1	2716967
pi@@	O	-1	2716967
oid	O	-1	2716967
sit@@	O	-1	2716967
e.	O	-1	2716967

Ac@@	B-Disease	D058186	19642243
ute	I-Disease	-1	19642243
renal	I-Disease	-1	19642243
failure	I-Disease	-1	19642243
in	O	-1	19642243
patients	O	-1	19642243
with	O	-1	19642243
A@@	B-Disease	D000163	19642243
I@@	I-Disease	-1	19642243
D@@	I-Disease	-1	19642243
S	I-Disease	-1	19642243
on	O	-1	19642243
ten@@	B-Chemical	C096918	19642243
of@@	I-Chemical	-1	19642243
o@@	I-Chemical	-1	19642243
vi@@	I-Chemical	-1	19642243
r	I-Chemical	-1	19642243
while	O	-1	19642243
receiving	O	-1	19642243
prolonged	O	-1	19642243
v@@	B-Chemical	D014640	19642243
an@@	I-Chemical	-1	19642243
com@@	I-Chemical	-1	19642243
ycin	I-Chemical	-1	19642243
course	O	-1	19642243
for	O	-1	19642243
ost@@	B-Disease	D010019	19642243
e@@	I-Disease	-1	19642243
om@@	I-Disease	-1	19642243
ye@@	I-Disease	-1	19642243
li@@	I-Disease	-1	19642243
tis	I-Disease	-1	19642243
.	O	-1	19642243
R@@	B-Disease	D051437	19642243
en@@	I-Disease	-1	19642243
al	I-Disease	-1	19642243
failure	I-Disease	-1	19642243
developed	O	-1	19642243
after	O	-1	19642243
a	O	-1	19642243
prolonged	O	-1	19642243
course	O	-1	19642243
of	O	-1	19642243
v@@	B-Chemical	D014640	19642243
an@@	I-Chemical	-1	19642243
com@@	I-Chemical	-1	19642243
ycin	I-Chemical	-1	19642243
therapy	O	-1	19642243
in	O	-1	19642243
2	O	-1	19642243
patients	O	-1	19642243
who	O	-1	19642243
were	O	-1	19642243
receiving	O	-1	19642243
ten@@	B-Chemical	C418563	19642243
of@@	I-Chemical	-1	19642243
o@@	I-Chemical	-1	19642243
vi@@	I-Chemical	-1	19642243
r	I-Chemical	-1	19642243
dis@@	I-Chemical	-1	19642243
o@@	I-Chemical	-1	19642243
pro@@	I-Chemical	-1	19642243
x@@	I-Chemical	-1	19642243
il	I-Chemical	-1	19642243
f@@	I-Chemical	-1	19642243
um@@	I-Chemical	-1	19642243
ar@@	I-Chemical	-1	19642243
ate	I-Chemical	-1	19642243
as	O	-1	19642243
par@@	O	-1	19642243
t	O	-1	19642243
of	O	-1	19642243
an	O	-1	19642243
anti@@	O	-1	19642243
ret@@	O	-1	19642243
ro@@	O	-1	19642243
viral	O	-1	19642243
regimen@@	O	-1	19642243
.	O	-1	19642243
T@@	B-Chemical	C096918	19642243
en@@	I-Chemical	-1	19642243
of@@	I-Chemical	-1	19642243
o@@	I-Chemical	-1	19642243
vi@@	I-Chemical	-1	19642243
r	I-Chemical	-1	19642243
has	O	-1	19642243
been	O	-1	19642243
implic@@	O	-1	19642243
ated	O	-1	19642243
in	O	-1	19642243
the	O	-1	19642243
development	O	-1	19642243
of	O	-1	19642243
F@@	B-Disease	D005198	19642243
an@@	I-Disease	-1	19642243
con@@	I-Disease	-1	19642243
i	I-Disease	-1	19642243
syndrome	I-Disease	-1	19642243
and	O	-1	19642243
renal	B-Disease	D051437	19642243
in@@	I-Disease	-1	19642243
suffici@@	I-Disease	-1	19642243
ency	I-Disease	-1	19642243
because	O	-1	19642243
of	O	-1	19642243
its	O	-1	19642243
effects	O	-1	19642243
on	O	-1	19642243
the	O	-1	19642243
pro@@	O	-1	19642243
xim@@	O	-1	19642243
al	O	-1	19642243
renal	O	-1	19642243
tub@@	O	-1	19642243
ul@@	O	-1	19642243
e.	O	-1	19642243
V@@	B-Chemical	D014640	19642243
an@@	I-Chemical	-1	19642243
com@@	I-Chemical	-1	19642243
ycin	I-Chemical	-1	19642243
nephro@@	B-Disease	D007674	19642243
toxicity	I-Disease	-1	19642243
is	O	-1	19642243
inf@@	O	-1	19642243
requ@@	O	-1	19642243
ent	O	-1	19642243
but	O	-1	19642243
may	O	-1	19642243
result	O	-1	19642243
from	O	-1	19642243
co@@	O	-1	19642243
administration	O	-1	19642243
with	O	-1	19642243
a	O	-1	19642243
nephro@@	B-Disease	D007674	19642243
toxic	I-Disease	-1	19642243
agent@@	O	-1	19642243
.	O	-1	19642243
Clin@@	O	-1	19642243
ici@@	O	-1	19642243
ans	O	-1	19642243
should	O	-1	19642243
be	O	-1	19642243
aw@@	O	-1	19642243
are	O	-1	19642243
that	O	-1	19642243
ten@@	B-Chemical	C096918	19642243
of@@	I-Chemical	-1	19642243
o@@	I-Chemical	-1	19642243
vi@@	I-Chemical	-1	19642243
r	I-Chemical	-1	19642243
may	O	-1	19642243
ra@@	O	-1	19642243
is@@	O	-1	19642243
e	O	-1	19642243
the	O	-1	19642243
risk	O	-1	19642243
of	O	-1	19642243
renal	B-Disease	D051437	19642243
failure	I-Disease	-1	19642243
during	O	-1	19642243
prolonged	O	-1	19642243
administration	O	-1	19642243
of	O	-1	19642243
v@@	B-Chemical	D014640	19642243
an@@	I-Chemical	-1	19642243
com@@	I-Chemical	-1	19642243
ycin	I-Chemical	-1	19642243
.	O	-1	19642243

D@@	O	-1	17682013
el@@	O	-1	17682013
ayed	O	-1	17682013
leuk@@	B-Disease	D056784	17682013
o@@	I-Disease	-1	17682013
encephalo@@	I-Disease	-1	17682013
pathy	I-Disease	-1	17682013
with	O	-1	17682013
strok@@	B-Disease	D020521	17682013
e	I-Disease	-1	17682013
-@@	O	-1	17682013
like	O	-1	17682013
present@@	O	-1	17682013
ation	O	-1	17682013
in	O	-1	17682013
chemotherapy	O	-1	17682013
re@@	O	-1	17682013
ci@@	O	-1	17682013
pi@@	O	-1	17682013
ent@@	O	-1	17682013
s.	O	-1	17682013
BACKGROUND:	O	-1	17682013
A	O	-1	17682013
transi@@	O	-1	17682013
ent	O	-1	17682013
leuk@@	B-Disease	D056784	17682013
o@@	I-Disease	-1	17682013
encephalo@@	I-Disease	-1	17682013
pathy	I-Disease	-1	17682013
m@@	O	-1	17682013
im@@	O	-1	17682013
ic@@	O	-1	17682013
king	O	-1	17682013
ce@@	B-Disease	D002544	17682013
reb@@	I-Disease	-1	17682013
ro@@	I-Disease	-1	17682013
vascular	I-Disease	-1	17682013
ac@@	I-Disease	-1	17682013
c@@	I-Disease	-1	17682013
id@@	I-Disease	-1	17682013
ent	I-Disease	-1	17682013
has	O	-1	17682013
been	O	-1	17682013
descri@@	O	-1	17682013
bed	O	-1	17682013
as	O	-1	17682013
a	O	-1	17682013
complication	O	-1	17682013
of	O	-1	17682013
chemo@@	O	-1	17682013
therapy,	O	-1	17682013
most	O	-1	17682013
common@@	O	-1	17682013
ly	O	-1	17682013
in	O	-1	17682013
re@@	O	-1	17682013
ci@@	O	-1	17682013
pi@@	O	-1	17682013
ents	O	-1	17682013
of	O	-1	17682013
intra@@	O	-1	17682013
th@@	O	-1	17682013
ec@@	O	-1	17682013
al	O	-1	17682013
meth@@	B-Chemical	D008727	17682013
ot@@	I-Chemical	-1	17682013
re@@	I-Chemical	-1	17682013
x@@	I-Chemical	-1	17682013
ate	I-Chemical	-1	17682013
for	O	-1	17682013
child@@	O	-1	17682013
ho@@	O	-1	17682013
od	O	-1	17682013
leuk@@	B-Disease	D007938	17682013
a@@	I-Disease	-1	17682013
emia	I-Disease	-1	17682013
.	O	-1	17682013
Rec@@	O	-1	17682013
ently	O	-1	17682013
pu@@	O	-1	17682013
bl@@	O	-1	17682013
ished	O	-1	17682013
neuro@@	O	-1	17682013
imaging	O	-1	17682013
data	O	-1	17682013
suggest	O	-1	17682013
a	O	-1	17682013
common	O	-1	17682013
path@@	O	-1	17682013
oph@@	O	-1	17682013
ysi@@	O	-1	17682013
ology	O	-1	17682013
associated	O	-1	17682013
with	O	-1	17682013
a	O	-1	17682013
vari@@	O	-1	17682013
ety	O	-1	17682013
of	O	-1	17682013
chemotherapy	O	-1	17682013
agents	O	-1	17682013
and	O	-1	17682013
mode@@	O	-1	17682013
s	O	-1	17682013
of	O	-1	17682013
administr@@	O	-1	17682013
ation.	O	-1	17682013
METHODS:	O	-1	17682013
We	O	-1	17682013
revie@@	O	-1	17682013
w@@	O	-1	17682013
ed	O	-1	17682013
the	O	-1	17682013
med@@	O	-1	17682013
ical	O	-1	17682013
literat@@	O	-1	17682013
ure	O	-1	17682013
for	O	-1	17682013
single	O	-1	17682013
reports	O	-1	17682013
and	O	-1	17682013
case	O	-1	17682013
seri@@	O	-1	17682013
es	O	-1	17682013
of	O	-1	17682013
patients	O	-1	17682013
present@@	O	-1	17682013
ing	O	-1	17682013
with	O	-1	17682013
strok@@	B-Disease	D020521	17682013
e	I-Disease	-1	17682013
-@@	O	-1	17682013
like	O	-1	17682013
episo@@	O	-1	17682013
des	O	-1	17682013
while	O	-1	17682013
receiving	O	-1	17682013
systemic	O	-1	17682013
or	O	-1	17682013
intra@@	O	-1	17682013
th@@	O	-1	17682013
ec@@	O	-1	17682013
al	O	-1	17682013
chemo@@	O	-1	17682013
therapy.	O	-1	17682013
We	O	-1	17682013
only	O	-1	17682013
included	O	-1	17682013
studies	O	-1	17682013
pro@@	O	-1	17682013
vid@@	O	-1	17682013
ing	O	-1	17682013
det@@	O	-1	17682013
ail@@	O	-1	17682013
ed	O	-1	17682013
neuro@@	O	-1	17682013
imaging	O	-1	17682013
dat@@	O	-1	17682013
a.	O	-1	17682013
Patients	O	-1	17682013
with	O	-1	17682013
ce@@	B-Disease	D002544	17682013
reb@@	I-Disease	-1	17682013
ro@@	I-Disease	-1	17682013
vascular	I-Disease	-1	17682013
ac@@	I-Disease	-1	17682013
c@@	I-Disease	-1	17682013
id@@	I-Disease	-1	17682013
ents	I-Disease	-1	17682013
were	O	-1	17682013
ex@@	O	-1	17682013
cl@@	O	-1	17682013
u@@	O	-1	17682013
de@@	O	-1	17682013
d.	O	-1	17682013
RESULTS:	O	-1	17682013
We	O	-1	17682013
identi@@	O	-1	17682013
fied	O	-1	17682013
2@@	O	-1	17682013
7	O	-1	17682013
reports	O	-1	17682013
of	O	-1	17682013
toxic	O	-1	17682013
leuk@@	B-Disease	D056784	17682013
o@@	I-Disease	-1	17682013
encephalo@@	I-Disease	-1	17682013
pathy	I-Disease	-1	17682013
in	O	-1	17682013
patients	O	-1	17682013
treated	O	-1	17682013
with	O	-1	17682013
meth@@	B-Chemical	D008727	17682013
ot@@	I-Chemical	-1	17682013
re@@	I-Chemical	-1	17682013
x@@	I-Chemical	-1	17682013
ate	I-Chemical	-1	17682013
(@@	O	-1	17682013
intra@@	O	-1	17682013
th@@	O	-1	17682013
ec@@	O	-1	17682013
al,	O	-1	17682013
system@@	O	-1	17682013
ic@@	O	-1	17682013
),	O	-1	17682013
5-@@	B-Chemical	D005472	17682013
fluoro@@	I-Chemical	-1	17682013
urac@@	I-Chemical	-1	17682013
il	I-Chemical	-1	17682013
and	O	-1	17682013
its	O	-1	17682013
der@@	O	-1	17682013
i@@	O	-1	17682013
v@@	O	-1	17682013
ative	O	-1	17682013
car@@	B-Chemical	C017367	17682013
mo@@	I-Chemical	-1	17682013
fu@@	I-Chemical	-1	17682013
r	I-Chemical	-1	17682013
,	O	-1	17682013
and	O	-1	17682013
cap@@	B-Chemical	C110904	17682013
ec@@	I-Chemical	-1	17682013
it@@	I-Chemical	-1	17682013
ab@@	I-Chemical	-1	17682013
ine	I-Chemical	-1	17682013
.	O	-1	17682013
Di@@	O	-1	17682013
ff@@	O	-1	17682013
usion	O	-1	17682013
weigh@@	O	-1	17682013
ted	O	-1	17682013
imaging	O	-1	17682013
(D@@	O	-1	17682013
W@@	O	-1	17682013
I@@	O	-1	17682013
)	O	-1	17682013
of	O	-1	17682013
all	O	-1	17682013
patients	O	-1	17682013
revealed	O	-1	17682013
well	O	-1	17682013
de@@	O	-1	17682013
m@@	O	-1	17682013
arc@@	O	-1	17682013
ated	O	-1	17682013
hyper@@	O	-1	17682013
int@@	O	-1	17682013
en@@	O	-1	17682013
se	O	-1	17682013
lesions	B-Disease	D056784	17682013
within	I-Disease	-1	17682013
the	I-Disease	-1	17682013
sub@@	I-Disease	-1	17682013
cor@@	I-Disease	-1	17682013
tical	I-Disease	-1	17682013
wh@@	I-Disease	-1	17682013
ite	I-Disease	-1	17682013
mat@@	I-Disease	-1	17682013
ter	I-Disease	-1	17682013
of	O	-1	17682013
the	O	-1	17682013
cerebral	O	-1	17682013
he@@	O	-1	17682013
mis@@	O	-1	17682013
ph@@	O	-1	17682013
e@@	O	-1	17682013
res	O	-1	17682013
and	O	-1	17682013
the	O	-1	17682013
cor@@	O	-1	17682013
p@@	O	-1	17682013
us	O	-1	17682013
cal@@	O	-1	17682013
lo@@	O	-1	17682013
sum@@	O	-1	17682013
,	O	-1	17682013
cor@@	O	-1	17682013
respon@@	O	-1	17682013
ding	O	-1	17682013
to	O	-1	17682013
a@@	O	-1	17682013
reas	O	-1	17682013
of	O	-1	17682013
decreased	O	-1	17682013
prot@@	O	-1	17682013
on	O	-1	17682013
diff@@	O	-1	17682013
usion	O	-1	17682013
on	O	-1	17682013
appa@@	O	-1	17682013
rent	O	-1	17682013
diff@@	O	-1	17682013
usion	O	-1	17682013
co@@	O	-1	17682013
eff@@	O	-1	17682013
ici@@	O	-1	17682013
ent	O	-1	17682013
(A@@	O	-1	17682013
D@@	O	-1	17682013
C@@	O	-1	17682013
)	O	-1	17682013
m@@	O	-1	17682013
ap@@	O	-1	17682013
s	O	-1	17682013
(@@	O	-1	17682013
av@@	O	-1	17682013
ail@@	O	-1	17682013
able	O	-1	17682013
in	O	-1	17682013
2@@	O	-1	17682013
1@@	O	-1	17682013
/@@	O	-1	17682013
2@@	O	-1	17682013
7	O	-1	17682013
patient@@	O	-1	17682013
s@@	O	-1	17682013
).	O	-1	17682013
L@@	O	-1	17682013
e@@	O	-1	17682013
sions	O	-1	17682013
ex@@	O	-1	17682013
ce@@	O	-1	17682013
ed@@	O	-1	17682013
ed	O	-1	17682013
the	O	-1	17682013
conf@@	O	-1	17682013
in@@	O	-1	17682013
es	O	-1	17682013
of	O	-1	17682013
adj@@	O	-1	17682013
ac@@	O	-1	17682013
ent	O	-1	17682013
vascular	O	-1	17682013
ter@@	O	-1	17682013
rit@@	O	-1	17682013
or@@	O	-1	17682013
i@@	O	-1	17682013
es.	O	-1	17682013
Com@@	O	-1	17682013
ple@@	O	-1	17682013
te	O	-1	17682013
resol@@	O	-1	17682013
u@@	O	-1	17682013
tion	O	-1	17682013
of	O	-1	17682013
symptoms	O	-1	17682013
within	O	-1	17682013
1-@@	O	-1	17682013
4	O	-1	17682013
days	O	-1	17682013
was	O	-1	17682013
ac@@	O	-1	17682013
comp@@	O	-1	17682013
an@@	O	-1	17682013
ied	O	-1	17682013
by	O	-1	17682013
normal@@	O	-1	17682013
is@@	O	-1	17682013
ation	O	-1	17682013
of	O	-1	17682013
AD@@	O	-1	17682013
C	O	-1	17682013
abnormal@@	O	-1	17682013
iti@@	O	-1	17682013
es.	O	-1	17682013
However,	O	-1	17682013
flu@@	O	-1	17682013
id	O	-1	17682013
attenu@@	O	-1	17682013
ated	O	-1	17682013
in@@	O	-1	17682013
ver@@	O	-1	17682013
sion	O	-1	17682013
recovery	O	-1	17682013
(@@	O	-1	17682013
F@@	O	-1	17682013
L@@	O	-1	17682013
A@@	O	-1	17682013
I@@	O	-1	17682013
R@@	O	-1	17682013
)	O	-1	17682013
sequ@@	O	-1	17682013
enc@@	O	-1	17682013
es	O	-1	17682013
frequ@@	O	-1	17682013
ently	O	-1	17682013
revealed	O	-1	17682013
per@@	O	-1	17682013
sist@@	O	-1	17682013
ent	O	-1	17682013
wh@@	B-Disease	D056784	17682013
ite	I-Disease	-1	17682013
mat@@	I-Disease	-1	17682013
ter	I-Disease	-1	17682013
abnormal@@	I-Disease	-1	17682013
ities	I-Disease	-1	17682013
.	O	-1	17682013
CONCLUSIONS:	O	-1	17682013
S@@	O	-1	17682013
e@@	O	-1	17682013
ver@@	O	-1	17682013
al	O	-1	17682013
path@@	O	-1	17682013
oph@@	O	-1	17682013
ysi@@	O	-1	17682013
ological	O	-1	17682013
models	O	-1	17682013
of	O	-1	17682013
del@@	O	-1	17682013
ayed	O	-1	17682013
leuk@@	B-Disease	D056784	17682013
o@@	I-Disease	-1	17682013
encephalo@@	I-Disease	-1	17682013
pathy	I-Disease	-1	17682013
after	O	-1	17682013
exposure	O	-1	17682013
to	O	-1	17682013
intra@@	O	-1	17682013
th@@	O	-1	17682013
ec@@	O	-1	17682013
al	O	-1	17682013
or	O	-1	17682013
systemic	O	-1	17682013
chemotherapy	O	-1	17682013
have	O	-1	17682013
been	O	-1	17682013
pro@@	O	-1	17682013
po@@	O	-1	17682013
sed.	O	-1	17682013
D@@	O	-1	17682013
W@@	O	-1	17682013
I	O	-1	17682013
findings	O	-1	17682013
in	O	-1	17682013
this	O	-1	17682013
co@@	O	-1	17682013
h@@	O	-1	17682013
ort	O	-1	17682013
are	O	-1	17682013
indic@@	O	-1	17682013
ative	O	-1	17682013
of	O	-1	17682013
cy@@	B-Disease	D001929	17682013
tot@@	I-Disease	-1	17682013
ox@@	I-Disease	-1	17682013
ic	I-Disease	-1	17682013
o@@	I-Disease	-1	17682013
e@@	I-Disease	-1	17682013
de@@	I-Disease	-1	17682013
ma	I-Disease	-1	17682013
within	I-Disease	-1	17682013
cerebral	I-Disease	-1	17682013
wh@@	I-Disease	-1	17682013
ite	I-Disease	-1	17682013
mat@@	I-Disease	-1	17682013
ter	I-Disease	-1	17682013
and	O	-1	17682013
l@@	O	-1	17682013
end	O	-1	17682013
suppor@@	O	-1	17682013
t	O	-1	17682013
to	O	-1	17682013
an	O	-1	17682013
at	O	-1	17682013
le@@	O	-1	17682013
ast	O	-1	17682013
par@@	O	-1	17682013
ti@@	O	-1	17682013
ally	O	-1	17682013
reversible	O	-1	17682013
met@@	O	-1	17682013
ab@@	O	-1	17682013
olic	O	-1	17682013
der@@	O	-1	17682013
ang@@	O	-1	17682013
ement	O	-1	17682013
as	O	-1	17682013
the	O	-1	17682013
b@@	O	-1	17682013
asis	O	-1	17682013
for	O	-1	17682013
this	O	-1	17682013
syndro@@	O	-1	17682013
me.	O	-1	17682013

D@@	O	-1	16725121
o@@	O	-1	16725121
w@@	O	-1	16725121
n@@	O	-1	16725121
-@@	O	-1	16725121
reg@@	O	-1	16725121
ulation	O	-1	16725121
of	O	-1	16725121
no@@	B-Chemical	D009638	16725121
re@@	I-Chemical	-1	16725121
p@@	I-Chemical	-1	16725121
ine@@	I-Chemical	-1	16725121
phrine	I-Chemical	-1	16725121
trans@@	O	-1	16725121
por@@	O	-1	16725121
ter	O	-1	16725121
function	O	-1	16725121
induced	O	-1	16725121
by	O	-1	16725121
chronic	O	-1	16725121
administration	O	-1	16725121
of	O	-1	16725121
desi@@	B-Chemical	D003891	16725121
pramine	I-Chemical	-1	16725121
lin@@	O	-1	16725121
king	O	-1	16725121
to	O	-1	16725121
the	O	-1	16725121
al@@	O	-1	16725121
ter@@	O	-1	16725121
ation	O	-1	16725121
of	O	-1	16725121
sensitivity	O	-1	16725121
of	O	-1	16725121
lo@@	O	-1	16725121
cal@@	O	-1	16725121
-@@	O	-1	16725121
anesthe@@	O	-1	16725121
tic@@	O	-1	16725121
s@@	O	-1	16725121
-induced	O	-1	16725121
convul@@	B-Disease	D012640	16725121
sions	I-Disease	-1	16725121
and	O	-1	16725121
the	O	-1	16725121
coun@@	O	-1	16725121
ter@@	O	-1	16725121
action	O	-1	16725121
by	O	-1	16725121
co-@@	O	-1	16725121
administration	O	-1	16725121
with	O	-1	16725121
loc@@	O	-1	16725121
al	O	-1	16725121
anesthe@@	O	-1	16725121
tic@@	O	-1	16725121
s.	O	-1	16725121
Al@@	O	-1	16725121
ter@@	O	-1	16725121
ations	O	-1	16725121
of	O	-1	16725121
no@@	B-Chemical	D009638	16725121
re@@	I-Chemical	-1	16725121
p@@	I-Chemical	-1	16725121
ine@@	I-Chemical	-1	16725121
phrine	I-Chemical	-1	16725121
trans@@	O	-1	16725121
por@@	O	-1	16725121
ter	O	-1	16725121
(N@@	O	-1	16725121
ET@@	O	-1	16725121
)	O	-1	16725121
function	O	-1	16725121
by	O	-1	16725121
chronic	O	-1	16725121
inhibition	O	-1	16725121
of	O	-1	16725121
N@@	O	-1	16725121
E@@	O	-1	16725121
T	O	-1	16725121
in	O	-1	16725121
rel@@	O	-1	16725121
ation	O	-1	16725121
to	O	-1	16725121
sensi@@	O	-1	16725121
tiz@@	O	-1	16725121
ation	O	-1	16725121
to	O	-1	16725121
seizures	B-Disease	D012640	16725121
induce	O	-1	16725121
by	O	-1	16725121
cocaine	B-Chemical	D003042	16725121
and	O	-1	16725121
loc@@	O	-1	16725121
al	O	-1	16725121
anesthe@@	O	-1	16725121
tics	O	-1	16725121
were	O	-1	16725121
studied	O	-1	16725121
in	O	-1	16725121
mice.	O	-1	16725121
D@@	O	-1	16725121
a@@	O	-1	16725121
ily	O	-1	16725121
administration	O	-1	16725121
of	O	-1	16725121
desi@@	B-Chemical	D003891	16725121
pramine	I-Chemical	-1	16725121
,	O	-1	16725121
an	O	-1	16725121
inhibitor	O	-1	16725121
of	O	-1	16725121
the	O	-1	16725121
N@@	O	-1	16725121
ET@@	O	-1	16725121
,	O	-1	16725121
for	O	-1	16725121
5	O	-1	16725121
days	O	-1	16725121
decreased	O	-1	16725121
[@@	O	-1	16725121
(3@@	O	-1	16725121
)@@	O	-1	16725121
H@@	O	-1	16725121
]	O	-1	16725121
no@@	B-Chemical	D009638	16725121
re@@	I-Chemical	-1	16725121
p@@	I-Chemical	-1	16725121
ine@@	I-Chemical	-1	16725121
phrine	I-Chemical	-1	16725121
u@@	O	-1	16725121
pt@@	O	-1	16725121
ake	O	-1	16725121
in	O	-1	16725121
the	O	-1	16725121
P@@	O	-1	16725121
2	O	-1	16725121
frac@@	O	-1	16725121
tions	O	-1	16725121
of	O	-1	16725121
hippocamp@@	O	-1	16725121
us	O	-1	16725121
but	O	-1	16725121
not	O	-1	16725121
cor@@	O	-1	16725121
t@@	O	-1	16725121
ex@@	O	-1	16725121
,	O	-1	16725121
striat@@	O	-1	16725121
um	O	-1	16725121
or	O	-1	16725121
am@@	O	-1	16725121
y@@	O	-1	16725121
g@@	O	-1	16725121
d@@	O	-1	16725121
al@@	O	-1	16725121
a@@	O	-1	16725121
e.	O	-1	16725121
C@@	O	-1	16725121
o@@	O	-1	16725121
-@@	O	-1	16725121
administration	O	-1	16725121
of	O	-1	16725121
lidocaine	B-Chemical	D008012	16725121
,	O	-1	16725121
bupivac@@	B-Chemical	D002045	16725121
aine	I-Chemical	-1	16725121
or	O	-1	16725121
tr@@	B-Chemical	C003636	16725121
ic@@	I-Chemical	-1	16725121
aine	I-Chemical	-1	16725121
with	O	-1	16725121
desi@@	B-Chemical	D003891	16725121
pramine	I-Chemical	-1	16725121
reversed	O	-1	16725121
this	O	-1	16725121
effect@@	O	-1	16725121
.	O	-1	16725121
D@@	O	-1	16725121
a@@	O	-1	16725121
ily	O	-1	16725121
treatment	O	-1	16725121
of	O	-1	16725121
cocaine	B-Chemical	D003042	16725121
increased	O	-1	16725121
[@@	O	-1	16725121
(3@@	O	-1	16725121
)@@	O	-1	16725121
H@@	O	-1	16725121
]	O	-1	16725121
no@@	B-Chemical	D009638	16725121
re@@	I-Chemical	-1	16725121
p@@	I-Chemical	-1	16725121
ine@@	I-Chemical	-1	16725121
phrine	I-Chemical	-1	16725121
u@@	O	-1	16725121
pt@@	O	-1	16725121
ake	O	-1	16725121
into	O	-1	16725121
the	O	-1	16725121
hippocamp@@	O	-1	16725121
us.	O	-1	16725121
D@@	O	-1	16725121
a@@	O	-1	16725121
ily	O	-1	16725121
administration	O	-1	16725121
of	O	-1	16725121
desi@@	B-Chemical	D003891	16725121
pramine	I-Chemical	-1	16725121
increased	O	-1	16725121
the	O	-1	16725121
incidence	O	-1	16725121
of	O	-1	16725121
appear@@	O	-1	16725121
ance	O	-1	16725121
of	O	-1	16725121
lidocaine	B-Chemical	D008012	16725121
-induced	O	-1	16725121
convul@@	B-Disease	D012640	16725121
sions	I-Disease	-1	16725121
and	O	-1	16725121
decreased	O	-1	16725121
that	O	-1	16725121
of	O	-1	16725121
cocaine	B-Chemical	D003042	16725121
-induced	O	-1	16725121
convul@@	B-Disease	D012640	16725121
sions	I-Disease	-1	16725121
.	O	-1	16725121
C@@	O	-1	16725121
o@@	O	-1	16725121
-@@	O	-1	16725121
administration	O	-1	16725121
of	O	-1	16725121
lidocaine	B-Chemical	D008012	16725121
with	O	-1	16725121
desi@@	B-Chemical	D003891	16725121
pramine	I-Chemical	-1	16725121
reversed	O	-1	16725121
the	O	-1	16725121
changes	O	-1	16725121
of	O	-1	16725121
convul@@	B-Disease	D012640	16725121
sive	I-Disease	-1	16725121
activity	O	-1	16725121
of	O	-1	16725121
lidocaine	B-Chemical	D008012	16725121
and	O	-1	16725121
cocaine	B-Chemical	D003042	16725121
induced	O	-1	16725121
by	O	-1	16725121
repe@@	O	-1	16725121
ated	O	-1	16725121
administration	O	-1	16725121
of	O	-1	16725121
desi@@	B-Chemical	D003891	16725121
pramine	I-Chemical	-1	16725121
.	O	-1	16725121
These	O	-1	16725121
results	O	-1	16725121
suggest	O	-1	16725121
that	O	-1	16725121
do@@	O	-1	16725121
w@@	O	-1	16725121
n@@	O	-1	16725121
-@@	O	-1	16725121
reg@@	O	-1	16725121
ulation	O	-1	16725121
of	O	-1	16725121
hippocamp@@	O	-1	16725121
al	O	-1	16725121
N@@	O	-1	16725121
E@@	O	-1	16725121
T	O	-1	16725121
induced	O	-1	16725121
by	O	-1	16725121
chronic	O	-1	16725121
administration	O	-1	16725121
of	O	-1	16725121
desi@@	B-Chemical	D003891	16725121
pramine	I-Chemical	-1	16725121
may	O	-1	16725121
be	O	-1	16725121
re@@	O	-1	16725121
lev@@	O	-1	16725121
ant	O	-1	16725121
to	O	-1	16725121
desi@@	B-Chemical	D003891	16725121
pramine	I-Chemical	-1	16725121
-induced	O	-1	16725121
sensi@@	O	-1	16725121
tiz@@	O	-1	16725121
ation	O	-1	16725121
of	O	-1	16725121
lidocaine	B-Chemical	D008012	16725121
convul@@	B-Disease	D012640	16725121
sions	I-Disease	-1	16725121
.	O	-1	16725121
In@@	O	-1	16725121
hib@@	O	-1	16725121
ition	O	-1	16725121
of	O	-1	16725121
N@@	B-Chemical	D012964	16725121
a	I-Chemical	-1	16725121
(@@	O	-1	16725121
+@@	O	-1	16725121
)	O	-1	16725121
channe@@	O	-1	16725121
l@@	O	-1	16725121
s	O	-1	16725121
by	O	-1	16725121
loc@@	O	-1	16725121
al	O	-1	16725121
anesthe@@	O	-1	16725121
tics	O	-1	16725121
may	O	-1	16725121
reg@@	O	-1	16725121
ul@@	O	-1	16725121
ate	O	-1	16725121
desi@@	B-Chemical	D003891	16725121
pramine	I-Chemical	-1	16725121
-induced	O	-1	16725121
do@@	O	-1	16725121
w@@	O	-1	16725121
n@@	O	-1	16725121
-@@	O	-1	16725121
reg@@	O	-1	16725121
ulation	O	-1	16725121
of	O	-1	16725121
N@@	O	-1	16725121
E@@	O	-1	16725121
T	O	-1	16725121
func@@	O	-1	16725121
tion.	O	-1	16725121
R@@	O	-1	16725121
ep@@	O	-1	16725121
e@@	O	-1	16725121
ated	O	-1	16725121
administration	O	-1	16725121
of	O	-1	16725121
cocaine	B-Chemical	D003042	16725121
induc@@	O	-1	16725121
es	O	-1	16725121
up@@	O	-1	16725121
-@@	O	-1	16725121
reg@@	O	-1	16725121
ulation	O	-1	16725121
of	O	-1	16725121
hippocamp@@	O	-1	16725121
al	O	-1	16725121
N@@	O	-1	16725121
E@@	O	-1	16725121
T	O	-1	16725121
func@@	O	-1	16725121
tion.	O	-1	16725121
De@@	B-Chemical	D003891	16725121
si@@	I-Chemical	-1	16725121
pramine	I-Chemical	-1	16725121
-induced	O	-1	16725121
sensi@@	O	-1	16725121
tiz@@	O	-1	16725121
ation	O	-1	16725121
of	O	-1	16725121
lidocaine	B-Chemical	D008012	16725121
seizures	B-Disease	D012640	16725121
may	O	-1	16725121
have	O	-1	16725121
a	O	-1	16725121
mechanism	O	-1	16725121
dist@@	O	-1	16725121
inc@@	O	-1	16725121
t	O	-1	16725121
from	O	-1	16725121
k@@	O	-1	16725121
ind@@	O	-1	16725121
l@@	O	-1	16725121
ing	O	-1	16725121
result@@	O	-1	16725121
ing	O	-1	16725121
from	O	-1	16725121
repe@@	O	-1	16725121
ated	O	-1	16725121
administration	O	-1	16725121
of	O	-1	16725121
cocaine	B-Chemical	D003042	16725121
.	O	-1	16725121

De@@	O	-1	16629641
f@@	O	-1	16629641
in@@	O	-1	16629641
ition	O	-1	16629641
and	O	-1	16629641
man@@	O	-1	16629641
ag@@	O	-1	16629641
ement	O	-1	16629641
of	O	-1	16629641
anemia	B-Disease	D000740	16629641
in	O	-1	16629641
patients	O	-1	16629641
inf@@	B-Disease	D006526	16629641
ected	I-Disease	-1	16629641
with	I-Disease	-1	16629641
hepatitis	I-Disease	-1	16629641
C	I-Disease	-1	16629641
vi@@	I-Disease	-1	16629641
ru@@	I-Disease	-1	16629641
s	I-Disease	-1	16629641
.	O	-1	16629641
Ch@@	B-Disease	D019698	16629641
ron@@	I-Disease	-1	16629641
ic	I-Disease	-1	16629641
inf@@	I-Disease	-1	16629641
ection	I-Disease	-1	16629641
with	I-Disease	-1	16629641
hepatitis	I-Disease	-1	16629641
C	I-Disease	-1	16629641
vi@@	I-Disease	-1	16629641
ru@@	I-Disease	-1	16629641
s	I-Disease	-1	16629641
(@@	O	-1	16629641
HC@@	O	-1	16629641
V@@	O	-1	16629641
)	O	-1	16629641
can	O	-1	16629641
progres@@	O	-1	16629641
s	O	-1	16629641
to	O	-1	16629641
cir@@	B-Disease	D005355	16629641
r@@	I-Disease	-1	16629641
ho@@	I-Disease	-1	16629641
sis	I-Disease	-1	16629641
,	O	-1	16629641
hepat@@	B-Disease	D006528	16629641
oc@@	I-Disease	-1	16629641
ell@@	I-Disease	-1	16629641
ular	I-Disease	-1	16629641
carcin@@	I-Disease	-1	16629641
oma	I-Disease	-1	16629641
,	O	-1	16629641
and	O	-1	16629641
en@@	B-Disease	D058625	16629641
d-@@	I-Disease	-1	16629641
st@@	I-Disease	-1	16629641
age	I-Disease	-1	16629641
liver	I-Disease	-1	16629641
disease	I-Disease	-1	16629641
.	O	-1	16629641
The	O	-1	16629641
current	O	-1	16629641
b@@	O	-1	16629641
est	O	-1	16629641
treatment	O	-1	16629641
for	O	-1	16629641
HC@@	B-Disease	D006526	16629641
V	I-Disease	-1	16629641
inf@@	I-Disease	-1	16629641
ection	I-Disease	-1	16629641
is	O	-1	16629641
combination	O	-1	16629641
therapy	O	-1	16629641
with	O	-1	16629641
pe@@	O	-1	16629641
g@@	O	-1	16629641
yl@@	O	-1	16629641
ated	O	-1	16629641
inter@@	B-Chemical	D007372	16629641
fer@@	I-Chemical	-1	16629641
on	I-Chemical	-1	16629641
and	O	-1	16629641
rib@@	B-Chemical	D012254	16629641
avi@@	I-Chemical	-1	16629641
rin	I-Chemical	-1	16629641
.	O	-1	16629641
Although	O	-1	16629641
this	O	-1	16629641
regi@@	O	-1	16629641
men	O	-1	16629641
produc@@	O	-1	16629641
es	O	-1	16629641
su@@	O	-1	16629641
st@@	O	-1	16629641
ained	O	-1	16629641
vi@@	O	-1	16629641
ro@@	O	-1	16629641
log@@	O	-1	16629641
ic	O	-1	16629641
responses	O	-1	16629641
(S@@	O	-1	16629641
V@@	O	-1	16629641
R@@	O	-1	16629641
s)	O	-1	16629641
in	O	-1	16629641
appro@@	O	-1	16629641
xim@@	O	-1	16629641
ately	O	-1	16629641
50@@	O	-1	16629641
%	O	-1	16629641
of	O	-1	16629641
patients,	O	-1	16629641
it	O	-1	16629641
can	O	-1	16629641
be	O	-1	16629641
associated	O	-1	16629641
with	O	-1	16629641
a	O	-1	16629641
potenti@@	O	-1	16629641
ally	O	-1	16629641
dose-@@	O	-1	16629641
lim@@	O	-1	16629641
it@@	O	-1	16629641
ing	O	-1	16629641
hemolytic	B-Disease	D000743	16629641
anemia	I-Disease	-1	16629641
.	O	-1	16629641
H@@	O	-1	16629641
em@@	O	-1	16629641
o@@	O	-1	16629641
globin	O	-1	16629641
concentrations	O	-1	16629641
decrease	O	-1	16629641
main@@	O	-1	16629641
ly	O	-1	16629641
as	O	-1	16629641
a	O	-1	16629641
result	O	-1	16629641
of	O	-1	16629641
rib@@	B-Chemical	D012254	16629641
avi@@	I-Chemical	-1	16629641
rin	I-Chemical	-1	16629641
-induced	O	-1	16629641
hemoly@@	B-Disease	D006461	16629641
sis	I-Disease	-1	16629641
,	O	-1	16629641
and	O	-1	16629641
this	O	-1	16629641
anemia	B-Disease	D000740	16629641
can	O	-1	16629641
be	O	-1	16629641
pro@@	O	-1	16629641
ble@@	O	-1	16629641
m@@	O	-1	16629641
atic	O	-1	16629641
in	O	-1	16629641
patients	O	-1	16629641
with	O	-1	16629641
HC@@	B-Disease	D006526	16629641
V	I-Disease	-1	16629641
inf@@	I-Disease	-1	16629641
ection	I-Disease	-1	16629641
,	O	-1	16629641
es@@	O	-1	16629641
p@@	O	-1	16629641
ec@@	O	-1	16629641
i@@	O	-1	16629641
ally	O	-1	16629641
those	O	-1	16629641
who	O	-1	16629641
have	O	-1	16629641
com@@	O	-1	16629641
or@@	O	-1	16629641
b@@	O	-1	16629641
id	O	-1	16629641
renal	B-Disease	D007674	16629641
or	I-Disease	-1	16629641
cardiovascular	I-Disease	-1	16629641
disorder@@	I-Disease	-1	16629641
s	I-Disease	-1	16629641
renal	B-Disease	D002318	16629641
or	I-Disease	-1	16629641
cardiovascular	I-Disease	-1	16629641
disorder@@	I-Disease	-1	16629641
s	I-Disease	-1	16629641
.	O	-1	16629641
In	O	-1	16629641
gener@@	O	-1	16629641
al,	O	-1	16629641
anemia	B-Disease	D000740	16629641
can	O	-1	16629641
increase	O	-1	16629641
the	O	-1	16629641
risk	O	-1	16629641
of	O	-1	16629641
mor@@	O	-1	16629641
b@@	O	-1	16629641
idity	O	-1	16629641
and	O	-1	16629641
mor@@	O	-1	16629641
t@@	O	-1	16629641
al@@	O	-1	16629641
ity,	O	-1	16629641
and	O	-1	16629641
may	O	-1	16629641
have	O	-1	16629641
negative	O	-1	16629641
effects	O	-1	16629641
on	O	-1	16629641
cerebral	O	-1	16629641
function	O	-1	16629641
and	O	-1	16629641
qu@@	O	-1	16629641
ality	O	-1	16629641
of	O	-1	16629641
lif@@	O	-1	16629641
e.	O	-1	16629641
Although	O	-1	16629641
rib@@	B-Chemical	D012254	16629641
avi@@	I-Chemical	-1	16629641
rin	I-Chemical	-1	16629641
-@@	O	-1	16629641
associated	O	-1	16629641
anemia	B-Disease	D000740	16629641
can	O	-1	16629641
be	O	-1	16629641
reversed	O	-1	16629641
by	O	-1	16629641
dose	O	-1	16629641
reduction	O	-1	16629641
or	O	-1	16629641
discontinu@@	O	-1	16629641
ation,	O	-1	16629641
this	O	-1	16629641
appro@@	O	-1	16629641
ach	O	-1	16629641
com@@	O	-1	16629641
pro@@	O	-1	16629641
mi@@	O	-1	16629641
ses	O	-1	16629641
outcom@@	O	-1	16629641
es	O	-1	16629641
by	O	-1	16629641
significantly	O	-1	16629641
decreas@@	O	-1	16629641
ing	O	-1	16629641
S@@	O	-1	16629641
V@@	O	-1	16629641
R	O	-1	16629641
rat@@	O	-1	16629641
es.	O	-1	16629641
Rec@@	O	-1	16629641
om@@	O	-1	16629641
bin@@	O	-1	16629641
ant	O	-1	16629641
human	O	-1	16629641
erythro@@	O	-1	16629641
po@@	O	-1	16629641
i@@	O	-1	16629641
e@@	O	-1	16629641
tin	O	-1	16629641
has	O	-1	16629641
been	O	-1	16629641
used	O	-1	16629641
to	O	-1	16629641
man@@	O	-1	16629641
age	O	-1	16629641
rib@@	B-Chemical	D012254	16629641
avi@@	I-Chemical	-1	16629641
rin	I-Chemical	-1	16629641
-@@	O	-1	16629641
associated	O	-1	16629641
anemia	B-Disease	D000740	16629641
but	O	-1	16629641
has	O	-1	16629641
other	O	-1	16629641
potential	O	-1	16629641
dis@@	O	-1	16629641
adv@@	O	-1	16629641
ant@@	O	-1	16629641
ag@@	O	-1	16629641
es.	O	-1	16629641
V@@	B-Chemical	C026956	16629641
ir@@	I-Chemical	-1	16629641
am@@	I-Chemical	-1	16629641
idine	I-Chemical	-1	16629641
,	O	-1	16629641
a	O	-1	16629641
li@@	O	-1	16629641
ver@@	O	-1	16629641
-@@	O	-1	16629641
t@@	O	-1	16629641
arg@@	O	-1	16629641
et@@	O	-1	16629641
ing	O	-1	16629641
pro@@	O	-1	16629641
drug	O	-1	16629641
of	O	-1	16629641
rib@@	B-Chemical	D012254	16629641
avi@@	I-Chemical	-1	16629641
rin	I-Chemical	-1	16629641
,	O	-1	16629641
has	O	-1	16629641
the	O	-1	16629641
potential	O	-1	16629641
to	O	-1	16629641
maint@@	O	-1	16629641
ain	O	-1	16629641
the	O	-1	16629641
vi@@	O	-1	16629641
ro@@	O	-1	16629641
log@@	O	-1	16629641
ic	O	-1	16629641
efficacy	O	-1	16629641
of	O	-1	16629641
rib@@	B-Chemical	D012254	16629641
avi@@	I-Chemical	-1	16629641
rin	I-Chemical	-1	16629641
while	O	-1	16629641
decreas@@	O	-1	16629641
ing	O	-1	16629641
the	O	-1	16629641
risk	O	-1	16629641
of	O	-1	16629641
hemolytic	B-Disease	D000743	16629641
anemia	I-Disease	-1	16629641
in	O	-1	16629641
patients	O	-1	16629641
with	O	-1	16629641
chronic	B-Disease	D019698	16629641
hepatitis	I-Disease	-1	16629641
C	I-Disease	-1	16629641
.	O	-1	16629641

C@@	B-Chemical	D002119	16006300
al@@	I-Chemical	-1	16006300
ci@@	I-Chemical	-1	16006300
um	I-Chemical	-1	16006300
carb@@	I-Chemical	-1	16006300
on@@	I-Chemical	-1	16006300
ate	I-Chemical	-1	16006300
toxicity	B-Disease	D064420	16006300
:	O	-1	16006300
the	O	-1	16006300
up@@	O	-1	16006300
d@@	O	-1	16006300
ated	O	-1	16006300
mil@@	B-Disease	D006934	16006300
k@@	I-Disease	-1	16006300
-@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
k@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
i	I-Disease	-1	16006300
syndrome	I-Disease	-1	16006300
;	O	-1	16006300
report	O	-1	16006300
of	O	-1	16006300
3	O	-1	16006300
cases	O	-1	16006300
and	O	-1	16006300
revie@@	O	-1	16006300
w	O	-1	16006300
of	O	-1	16006300
the	O	-1	16006300
literat@@	O	-1	16006300
ure.	O	-1	16006300
OBJECTIVE:	O	-1	16006300
To	O	-1	16006300
describe	O	-1	16006300
3	O	-1	16006300
patients	O	-1	16006300
with	O	-1	16006300
calcium	B-Chemical	D002119	16006300
carb@@	I-Chemical	-1	16006300
on@@	I-Chemical	-1	16006300
ate	I-Chemical	-1	16006300
-induced	O	-1	16006300
hyper@@	B-Disease	D006934	16006300
cal@@	I-Disease	-1	16006300
ce@@	I-Disease	-1	16006300
mia	I-Disease	-1	16006300
and	O	-1	16006300
g@@	O	-1	16006300
ain	O	-1	16006300
in@@	O	-1	16006300
si@@	O	-1	16006300
gh@@	O	-1	16006300
ts	O	-1	16006300
into	O	-1	16006300
the	O	-1	16006300
cause	O	-1	16006300
and	O	-1	16006300
man@@	O	-1	16006300
ag@@	O	-1	16006300
ement	O	-1	16006300
of	O	-1	16006300
the	O	-1	16006300
mil@@	B-Disease	D006934	16006300
k@@	I-Disease	-1	16006300
-@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
k@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
i	I-Disease	-1	16006300
syndrome	I-Disease	-1	16006300
.	O	-1	16006300
METHODS:	O	-1	16006300
We	O	-1	16006300
report	O	-1	16006300
the	O	-1	16006300
clinical	O	-1	16006300
and	O	-1	16006300
labor@@	O	-1	16006300
atory	O	-1	16006300
data	O	-1	16006300
in	O	-1	16006300
3	O	-1	16006300
patients	O	-1	16006300
who	O	-1	16006300
presented	O	-1	16006300
with	O	-1	16006300
severe	O	-1	16006300
hyper@@	B-Disease	D006934	16006300
cal@@	I-Disease	-1	16006300
ce@@	I-Disease	-1	16006300
mia	I-Disease	-1	16006300
(@@	O	-1	16006300
cor@@	O	-1	16006300
rec@@	O	-1	16006300
ted	O	-1	16006300
serum	O	-1	16006300
calcium	B-Chemical	D002118	16006300
>	O	-1	16006300
or	O	-1	16006300
=	O	-1	16006300
14	O	-1	16006300
mg/d@@	O	-1	16006300
L@@	O	-1	16006300
)	O	-1	16006300
and	O	-1	16006300
revie@@	O	-1	16006300
w	O	-1	16006300
the	O	-1	16006300
per@@	O	-1	16006300
t@@	O	-1	16006300
in@@	O	-1	16006300
ent	O	-1	16006300
literat@@	O	-1	16006300
ure	O	-1	16006300
on	O	-1	16006300
mil@@	B-Disease	D006934	16006300
k@@	I-Disease	-1	16006300
-@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
k@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
i	I-Disease	-1	16006300
syndrome	I-Disease	-1	16006300
.	O	-1	16006300
RESULTS:	O	-1	16006300
The	O	-1	16006300
3	O	-1	16006300
patients	O	-1	16006300
had	O	-1	16006300
acute	B-Disease	D058186	16006300
renal	I-Disease	-1	16006300
in@@	I-Disease	-1	16006300
suffici@@	I-Disease	-1	16006300
ency	I-Disease	-1	16006300
,	O	-1	16006300
rel@@	O	-1	16006300
ative	O	-1	16006300
met@@	B-Disease	D000471	16006300
ab@@	I-Disease	-1	16006300
olic	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
k@@	I-Disease	-1	16006300
alo@@	I-Disease	-1	16006300
sis	I-Disease	-1	16006300
,	O	-1	16006300
and	O	-1	16006300
low	O	-1	16006300
par@@	O	-1	16006300
ath@@	O	-1	16006300
yro@@	O	-1	16006300
id	O	-1	16006300
h@@	O	-1	16006300
orm@@	O	-1	16006300
one	O	-1	16006300
(P@@	O	-1	16006300
T@@	O	-1	16006300
H@@	O	-1	16006300
),	O	-1	16006300
P@@	O	-1	16006300
T@@	O	-1	16006300
H@@	O	-1	16006300
-@@	O	-1	16006300
related	O	-1	16006300
p@@	O	-1	16006300
ep@@	O	-1	16006300
ti@@	O	-1	16006300
de@@	O	-1	16006300
,	O	-1	16006300
and	O	-1	16006300
1@@	B-Chemical	C097949	16006300
,@@	I-Chemical	-1	16006300
2@@	I-Chemical	-1	16006300
5-@@	I-Chemical	-1	16006300
di@@	I-Chemical	-1	16006300
hydrox@@	I-Chemical	-1	16006300
y@@	I-Chemical	-1	16006300
vitamin	I-Chemical	-1	16006300
D	I-Chemical	-1	16006300
concentr@@	O	-1	16006300
ations.	O	-1	16006300
No	O	-1	16006300
mal@@	O	-1	16006300
i@@	O	-1	16006300
gn@@	O	-1	16006300
ant	O	-1	16006300
le@@	O	-1	16006300
sion	O	-1	16006300
was	O	-1	16006300
f@@	O	-1	16006300
oun@@	O	-1	16006300
d.	O	-1	16006300
Treat@@	O	-1	16006300
ment	O	-1	16006300
included	O	-1	16006300
ag@@	O	-1	16006300
gres@@	O	-1	16006300
sive	O	-1	16006300
hy@@	O	-1	16006300
d@@	O	-1	16006300
ration	O	-1	16006300
and	O	-1	16006300
vari@@	O	-1	16006300
ed	O	-1	16006300
amoun@@	O	-1	16006300
ts	O	-1	16006300
of	O	-1	16006300
f@@	B-Chemical	D005665	16006300
uro@@	I-Chemical	-1	16006300
se@@	I-Chemical	-1	16006300
m@@	I-Chemical	-1	16006300
ide	I-Chemical	-1	16006300
.	O	-1	16006300
The	O	-1	16006300
2	O	-1	16006300
patients	O	-1	16006300
with	O	-1	16006300
the	O	-1	16006300
higher	O	-1	16006300
serum	O	-1	16006300
calcium	B-Chemical	D002118	16006300
concentrations	O	-1	16006300
received	O	-1	16006300
p@@	B-Chemical	C019248	16006300
am@@	I-Chemical	-1	16006300
id@@	I-Chemical	-1	16006300
ron@@	I-Chemical	-1	16006300
ate	I-Chemical	-1	16006300
intra@@	O	-1	16006300
ven@@	O	-1	16006300
ously	O	-1	16006300
(@@	O	-1	16006300
60	O	-1	16006300
and	O	-1	16006300
30	O	-1	16006300
mg@@	O	-1	16006300
,	O	-1	16006300
respectivel@@	O	-1	16006300
y@@	O	-1	16006300
),	O	-1	16006300
which	O	-1	16006300
caused	O	-1	16006300
severe	O	-1	16006300
hy@@	B-Disease	D006996	16006300
p@@	I-Disease	-1	16006300
oc@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
ce@@	I-Disease	-1	16006300
mia	I-Disease	-1	16006300
.	O	-1	16006300
Of	O	-1	16006300
the	O	-1	16006300
3	O	-1	16006300
patients,	O	-1	16006300
2	O	-1	16006300
were	O	-1	16006300
ing@@	O	-1	16006300
est@@	O	-1	16006300
ing	O	-1	16006300
ac@@	O	-1	16006300
ce@@	O	-1	16006300
pt@@	O	-1	16006300
able	O	-1	16006300
doses	O	-1	16006300
of	O	-1	16006300
e@@	O	-1	16006300
le@@	O	-1	16006300
mental	O	-1	16006300
calcium	B-Chemical	D002118	16006300
(@@	O	-1	16006300
1	O	-1	16006300
g	O	-1	16006300
and	O	-1	16006300
2	O	-1	16006300
g	O	-1	16006300
da@@	O	-1	16006300
il@@	O	-1	16006300
y,	O	-1	16006300
respectivel@@	O	-1	16006300
y@@	O	-1	16006300
)	O	-1	16006300
in	O	-1	16006300
the	O	-1	16006300
form	O	-1	16006300
of	O	-1	16006300
calcium	B-Chemical	D002119	16006300
carb@@	I-Chemical	-1	16006300
on@@	I-Chemical	-1	16006300
ate	I-Chemical	-1	16006300
.	O	-1	16006300
In	O	-1	16006300
addition	O	-1	16006300
to	O	-1	16006300
our	O	-1	16006300
high@@	O	-1	16006300
li@@	O	-1	16006300
gh@@	O	-1	16006300
ted	O	-1	16006300
cas@@	O	-1	16006300
es,	O	-1	16006300
we	O	-1	16006300
revie@@	O	-1	16006300
w	O	-1	16006300
the	O	-1	16006300
hist@@	O	-1	16006300
or@@	O	-1	16006300
y,	O	-1	16006300
cl@@	O	-1	16006300
assi@@	O	-1	16006300
fic@@	O	-1	16006300
ation,	O	-1	16006300
path@@	O	-1	16006300
oph@@	O	-1	16006300
ysi@@	O	-1	16006300
ologic	O	-1	16006300
feat@@	O	-1	16006300
ures@@	O	-1	16006300
,	O	-1	16006300
and	O	-1	16006300
treatment	O	-1	16006300
of	O	-1	16006300
mil@@	B-Disease	D006934	16006300
k@@	I-Disease	-1	16006300
-@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
k@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
i	I-Disease	-1	16006300
syndrome	I-Disease	-1	16006300
and	O	-1	16006300
su@@	O	-1	16006300
mm@@	O	-1	16006300
ar@@	O	-1	16006300
iz@@	O	-1	16006300
e	O	-1	16006300
the	O	-1	16006300
cases	O	-1	16006300
reported	O	-1	16006300
from	O	-1	16006300
early	O	-1	16006300
19@@	O	-1	16006300
9@@	O	-1	16006300
5	O	-1	16006300
to	O	-1	16006300
N@@	O	-1	16006300
o@@	O	-1	16006300
ve@@	O	-1	16006300
mb@@	O	-1	16006300
er	O	-1	16006300
20@@	O	-1	16006300
0@@	O	-1	16006300
3@@	O	-1	16006300
.	O	-1	16006300
CONCLUSION:	O	-1	16006300
M@@	B-Disease	D006934	16006300
il@@	I-Disease	-1	16006300
k@@	I-Disease	-1	16006300
-@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
k@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
i	I-Disease	-1	16006300
syndrome	I-Disease	-1	16006300
may	O	-1	16006300
be	O	-1	16006300
a	O	-1	16006300
common	O	-1	16006300
cause	O	-1	16006300
of	O	-1	16006300
un@@	O	-1	16006300
expl@@	O	-1	16006300
ained	O	-1	16006300
hyper@@	B-Disease	D006934	16006300
cal@@	I-Disease	-1	16006300
ce@@	I-Disease	-1	16006300
mia	I-Disease	-1	16006300
and	O	-1	16006300
can	O	-1	16006300
be	O	-1	16006300
pre@@	O	-1	16006300
ci@@	O	-1	16006300
pit@@	O	-1	16006300
ated	O	-1	16006300
by	O	-1	16006300
sm@@	O	-1	16006300
all	O	-1	16006300
amoun@@	O	-1	16006300
ts	O	-1	16006300
of	O	-1	16006300
or@@	O	-1	16006300
ally	O	-1	16006300
ing@@	O	-1	16006300
est@@	O	-1	16006300
ed	O	-1	16006300
calcium	B-Chemical	D002119	16006300
carb@@	I-Chemical	-1	16006300
on@@	I-Chemical	-1	16006300
ate	I-Chemical	-1	16006300
in	O	-1	16006300
sus@@	O	-1	16006300
cep@@	O	-1	16006300
ti@@	O	-1	16006300
ble	O	-1	16006300
per@@	O	-1	16006300
son@@	O	-1	16006300
s.	O	-1	16006300
Treat@@	O	-1	16006300
ment	O	-1	16006300
with	O	-1	16006300
hy@@	O	-1	16006300
d@@	O	-1	16006300
r@@	O	-1	16006300
ation,	O	-1	16006300
f@@	B-Chemical	D005665	16006300
uro@@	I-Chemical	-1	16006300
se@@	I-Chemical	-1	16006300
m@@	I-Chemical	-1	16006300
ide	I-Chemical	-1	16006300
,	O	-1	16006300
and	O	-1	16006300
discontinu@@	O	-1	16006300
ation	O	-1	16006300
of	O	-1	16006300
the	O	-1	16006300
calcium	B-Chemical	D002118	16006300
and	O	-1	16006300
vitamin	B-Chemical	D014807	16006300
D	I-Chemical	-1	16006300
so@@	O	-1	16006300
ur@@	O	-1	16006300
ce	O	-1	16006300
is	O	-1	16006300
ade@@	O	-1	16006300
qu@@	O	-1	16006300
at@@	O	-1	16006300
e.	O	-1	16006300
P@@	B-Chemical	C019248	16006300
am@@	I-Chemical	-1	16006300
id@@	I-Chemical	-1	16006300
ron@@	I-Chemical	-1	16006300
ate	I-Chemical	-1	16006300
treatment	O	-1	16006300
is	O	-1	16006300
associated	O	-1	16006300
with	O	-1	16006300
con@@	O	-1	16006300
si@@	O	-1	16006300
der@@	O	-1	16006300
able	O	-1	16006300
risk	O	-1	16006300
for	O	-1	16006300
hy@@	B-Disease	D006996	16006300
p@@	I-Disease	-1	16006300
oc@@	I-Disease	-1	16006300
al@@	I-Disease	-1	16006300
ce@@	I-Disease	-1	16006300
mia	I-Disease	-1	16006300
,	O	-1	16006300
even	O	-1	16006300
in	O	-1	16006300
cases	O	-1	16006300
of	O	-1	16006300
initi@@	O	-1	16006300
ally	O	-1	16006300
severe	O	-1	16006300
hyper@@	B-Disease	D006934	16006300
cal@@	I-Disease	-1	16006300
ce@@	I-Disease	-1	16006300
mia	I-Disease	-1	16006300
.	O	-1	16006300

M@@	O	-1	11705128
an@@	O	-1	11705128
ag@@	O	-1	11705128
ement	O	-1	11705128
strat@@	O	-1	11705128
e@@	O	-1	11705128
gi@@	O	-1	11705128
es	O	-1	11705128
for	O	-1	11705128
rib@@	B-Chemical	D012254	11705128
avi@@	I-Chemical	-1	11705128
rin	I-Chemical	-1	11705128
-induced	O	-1	11705128
hemolytic	B-Disease	D000743	11705128
anemia	I-Disease	-1	11705128
in	O	-1	11705128
the	O	-1	11705128
treatment	O	-1	11705128
of	O	-1	11705128
hepatitis	B-Disease	D006526	11705128
C	I-Disease	-1	11705128
:	O	-1	11705128
clinical	O	-1	11705128
and	O	-1	11705128
ec@@	O	-1	11705128
on@@	O	-1	11705128
om@@	O	-1	11705128
ic	O	-1	11705128
implic@@	O	-1	11705128
ations.	O	-1	11705128
OBJECTIV@@	O	-1	11705128
E@@	O	-1	11705128
S:	O	-1	11705128
Rec@@	O	-1	11705128
ently	O	-1	11705128
pu@@	O	-1	11705128
bl@@	O	-1	11705128
ished	O	-1	11705128
studies	O	-1	11705128
have	O	-1	11705128
demonstrated	O	-1	11705128
increased	O	-1	11705128
efficacy	O	-1	11705128
and	O	-1	11705128
co@@	O	-1	11705128
st@@	O	-1	11705128
-@@	O	-1	11705128
eff@@	O	-1	11705128
ec@@	O	-1	11705128
tiv@@	O	-1	11705128
en@@	O	-1	11705128
ess	O	-1	11705128
of	O	-1	11705128
combination	O	-1	11705128
therapy	O	-1	11705128
with	O	-1	11705128
inter@@	O	-1	11705128
fer@@	O	-1	11705128
on	O	-1	11705128
and	O	-1	11705128
alpha-@@	O	-1	11705128
2@@	O	-1	11705128
b@@	O	-1	11705128
/	O	-1	11705128
rib@@	B-Chemical	D012254	11705128
avi@@	I-Chemical	-1	11705128
rin	I-Chemical	-1	11705128
compared	O	-1	11705128
with	O	-1	11705128
inter@@	B-Chemical	D016898	11705128
fer@@	I-Chemical	-1	11705128
on@@	I-Chemical	-1	11705128
-@@	I-Chemical	-1	11705128
al@@	I-Chemical	-1	11705128
ph@@	I-Chemical	-1	11705128
a	I-Chemical	-1	11705128
mon@@	O	-1	11705128
o@@	O	-1	11705128
therapy	O	-1	11705128
in	O	-1	11705128
the	O	-1	11705128
treatment	O	-1	11705128
of	O	-1	11705128
chronic	B-Disease	D019698	11705128
hepatitis	I-Disease	-1	11705128
C	I-Disease	-1	11705128
(	O	-1	11705128
C@@	B-Disease	D019698	11705128
H@@	I-Disease	-1	11705128
C	I-Disease	-1	11705128
).	O	-1	11705128
Com@@	O	-1	11705128
bin@@	O	-1	11705128
ation	O	-1	11705128
therapy	O	-1	11705128
is	O	-1	11705128
associated	O	-1	11705128
with	O	-1	11705128
a	O	-1	11705128
clin@@	O	-1	11705128
ically	O	-1	11705128
important	O	-1	11705128
adverse	O	-1	11705128
effect@@	O	-1	11705128
:	O	-1	11705128
rib@@	B-Chemical	D012254	11705128
avi@@	I-Chemical	-1	11705128
rin	I-Chemical	-1	11705128
-induced	O	-1	11705128
hemolytic	B-Disease	D000743	11705128
anemia	I-Disease	-1	11705128
(	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
).	O	-1	11705128
The	O	-1	11705128
ob@@	O	-1	11705128
j@@	O	-1	11705128
ective	O	-1	11705128
of	O	-1	11705128
this	O	-1	11705128
study	O	-1	11705128
was	O	-1	11705128
to	O	-1	11705128
evalu@@	O	-1	11705128
ate	O	-1	11705128
the	O	-1	11705128
direct	O	-1	11705128
health@@	O	-1	11705128
-@@	O	-1	11705128
car@@	O	-1	11705128
e	O	-1	11705128
co@@	O	-1	11705128
st@@	O	-1	11705128
s	O	-1	11705128
and	O	-1	11705128
man@@	O	-1	11705128
ag@@	O	-1	11705128
ement	O	-1	11705128
of	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
during	O	-1	11705128
treatment	O	-1	11705128
of	O	-1	11705128
C@@	B-Disease	D019698	11705128
H@@	I-Disease	-1	11705128
C	I-Disease	-1	11705128
in	O	-1	11705128
a	O	-1	11705128
clinical	O	-1	11705128
trial	O	-1	11705128
se@@	O	-1	11705128
t@@	O	-1	11705128
t@@	O	-1	11705128
ing.	O	-1	11705128
METHODS:	O	-1	11705128
A	O	-1	11705128
system@@	O	-1	11705128
atic	O	-1	11705128
literat@@	O	-1	11705128
ure	O	-1	11705128
revie@@	O	-1	11705128
w	O	-1	11705128
was	O	-1	11705128
con@@	O	-1	11705128
duc@@	O	-1	11705128
ted	O	-1	11705128
to	O	-1	11705128
syn@@	O	-1	11705128
the@@	O	-1	11705128
size	O	-1	11705128
inf@@	O	-1	11705128
orm@@	O	-1	11705128
ation	O	-1	11705128
on	O	-1	11705128
the	O	-1	11705128
incidence	O	-1	11705128
and	O	-1	11705128
man@@	O	-1	11705128
ag@@	O	-1	11705128
ement	O	-1	11705128
of	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
.	O	-1	11705128
D@@	O	-1	11705128
ec@@	O	-1	11705128
i@@	O	-1	11705128
sion@@	O	-1	11705128
-@@	O	-1	11705128
analy@@	O	-1	11705128
tic	O	-1	11705128
t@@	O	-1	11705128
ech@@	O	-1	11705128
n@@	O	-1	11705128
i@@	O	-1	11705128
qu@@	O	-1	11705128
es	O	-1	11705128
were	O	-1	11705128
used	O	-1	11705128
to	O	-1	11705128
estim@@	O	-1	11705128
ate	O	-1	11705128
the	O	-1	11705128
co@@	O	-1	11705128
st	O	-1	11705128
of	O	-1	11705128
treat@@	O	-1	11705128
ing	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
.	O	-1	11705128
U@@	O	-1	11705128
n@@	O	-1	11705128
cer@@	O	-1	11705128
t@@	O	-1	11705128
a@@	O	-1	11705128
int@@	O	-1	11705128
y	O	-1	11705128
was	O	-1	11705128
evaluated	O	-1	11705128
using	O	-1	11705128
sensitivity	O	-1	11705128
an@@	O	-1	11705128
al@@	O	-1	11705128
ys@@	O	-1	11705128
es.	O	-1	11705128
RESULTS:	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
,	O	-1	11705128
def@@	O	-1	11705128
in@@	O	-1	11705128
ed	O	-1	11705128
as	O	-1	11705128
a	O	-1	11705128
reduction	O	-1	11705128
in	O	-1	11705128
hemo@@	O	-1	11705128
globin	O	-1	11705128
to	O	-1	11705128
less	O	-1	11705128
than	O	-1	11705128
100	O	-1	11705128
g/@@	O	-1	11705128
L@@	O	-1	11705128
,	O	-1	11705128
occur@@	O	-1	11705128
s	O	-1	11705128
in	O	-1	11705128
appro@@	O	-1	11705128
xim@@	O	-1	11705128
ately	O	-1	11705128
7@@	O	-1	11705128
%	O	-1	11705128
to	O	-1	11705128
9@@	O	-1	11705128
%	O	-1	11705128
of	O	-1	11705128
patients	O	-1	11705128
treated	O	-1	11705128
with	O	-1	11705128
combination	O	-1	11705128
therapy.	O	-1	11705128
The	O	-1	11705128
standard	O	-1	11705128
of	O	-1	11705128
car@@	O	-1	11705128
e	O	-1	11705128
for	O	-1	11705128
man@@	O	-1	11705128
ag@@	O	-1	11705128
ement	O	-1	11705128
of	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
is	O	-1	11705128
reduction	O	-1	11705128
or	O	-1	11705128
discontinu@@	O	-1	11705128
ation	O	-1	11705128
of	O	-1	11705128
the	O	-1	11705128
rib@@	B-Chemical	D012254	11705128
avi@@	I-Chemical	-1	11705128
rin	I-Chemical	-1	11705128
dos@@	O	-1	11705128
age.	O	-1	11705128
We	O	-1	11705128
estim@@	O	-1	11705128
ated	O	-1	11705128
the	O	-1	11705128
direct	O	-1	11705128
co@@	O	-1	11705128
st	O	-1	11705128
of	O	-1	11705128
treat@@	O	-1	11705128
ing	O	-1	11705128
clin@@	O	-1	11705128
ically	O	-1	11705128
significant	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
to	O	-1	11705128
be	O	-1	11705128
17@@	O	-1	11705128
0	O	-1	11705128
per	O	-1	11705128
patient	O	-1	11705128
receiving	O	-1	11705128
combination	O	-1	11705128
therapy	O	-1	11705128
per	O	-1	11705128
4@@	O	-1	11705128
8@@	O	-1	11705128
-@@	O	-1	11705128
week	O	-1	11705128
treatment	O	-1	11705128
course	O	-1	11705128
(@@	O	-1	11705128
range	O	-1	11705128
6@@	O	-1	11705128
8@@	O	-1	11705128
-	O	-1	11705128
6@@	O	-1	11705128
9@@	O	-1	11705128
2@@	O	-1	11705128
).	O	-1	11705128
The	O	-1	11705128
results	O	-1	11705128
of	O	-1	11705128
the	O	-1	11705128
on@@	O	-1	11705128
e-@@	O	-1	11705128
w@@	O	-1	11705128
ay	O	-1	11705128
sensitivity	O	-1	11705128
analy@@	O	-1	11705128
ses	O	-1	11705128
rang@@	O	-1	11705128
ed	O	-1	11705128
from	O	-1	11705128
5@@	O	-1	11705128
7	O	-1	11705128
to	O	-1	11705128
3@@	O	-1	11705128
17@@	O	-1	11705128
.	O	-1	11705128
In	O	-1	11705128
compar@@	O	-1	11705128
is@@	O	-1	11705128
on@@	O	-1	11705128
,	O	-1	11705128
the	O	-1	11705128
co@@	O	-1	11705128
st	O	-1	11705128
of	O	-1	11705128
4@@	O	-1	11705128
8	O	-1	11705128
weeks	O	-1	11705128
of	O	-1	11705128
combination	O	-1	11705128
therapy	O	-1	11705128
is	O	-1	11705128
1@@	O	-1	11705128
6@@	O	-1	11705128
,@@	O	-1	11705128
4@@	O	-1	11705128
5@@	O	-1	11705128
9@@	O	-1	11705128
.	O	-1	11705128
CONCLUSIONS:	O	-1	11705128
The	O	-1	11705128
direct	O	-1	11705128
co@@	O	-1	11705128
st	O	-1	11705128
of	O	-1	11705128
treat@@	O	-1	11705128
ing	O	-1	11705128
clin@@	O	-1	11705128
ically	O	-1	11705128
significant	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
is	O	-1	11705128
1@@	O	-1	11705128
%	O	-1	11705128
(	O	-1	11705128
17@@	O	-1	11705128
0@@	O	-1	11705128
/	O	-1	11705128
1@@	O	-1	11705128
6@@	O	-1	11705128
,@@	O	-1	11705128
4@@	O	-1	11705128
5@@	O	-1	11705128
9@@	O	-1	11705128
)	O	-1	11705128
of	O	-1	11705128
drug	O	-1	11705128
treatment	O	-1	11705128
co@@	O	-1	11705128
st@@	O	-1	11705128
s.	O	-1	11705128
Q@@	O	-1	11705128
u@@	O	-1	11705128
es@@	O	-1	11705128
tions	O	-1	11705128
re@@	O	-1	11705128
ma@@	O	-1	11705128
in	O	-1	11705128
about	O	-1	11705128
the	O	-1	11705128
op@@	O	-1	11705128
tim@@	O	-1	11705128
al	O	-1	11705128
dose	O	-1	11705128
of	O	-1	11705128
rib@@	B-Chemical	D012254	11705128
avi@@	I-Chemical	-1	11705128
rin	I-Chemical	-1	11705128
and	O	-1	11705128
the	O	-1	11705128
incidence	O	-1	11705128
of	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
in	O	-1	11705128
a	O	-1	11705128
re@@	O	-1	11705128
al@@	O	-1	11705128
-@@	O	-1	11705128
wor@@	O	-1	11705128
l@@	O	-1	11705128
d	O	-1	11705128
po@@	O	-1	11705128
pul@@	O	-1	11705128
ation.	O	-1	11705128
D@@	O	-1	11705128
es@@	O	-1	11705128
pit@@	O	-1	11705128
e	O	-1	11705128
these	O	-1	11705128
unc@@	O	-1	11705128
er@@	O	-1	11705128
t@@	O	-1	11705128
ain@@	O	-1	11705128
ti@@	O	-1	11705128
es,	O	-1	11705128
this	O	-1	11705128
initial	O	-1	11705128
evalu@@	O	-1	11705128
ation	O	-1	11705128
of	O	-1	11705128
the	O	-1	11705128
direct	O	-1	11705128
co@@	O	-1	11705128
st	O	-1	11705128
of	O	-1	11705128
treat@@	O	-1	11705128
ing	O	-1	11705128
R@@	B-Disease	D000743	11705128
I@@	I-Disease	-1	11705128
H@@	I-Disease	-1	11705128
A	I-Disease	-1	11705128
pro@@	O	-1	11705128
vi@@	O	-1	11705128
des	O	-1	11705128
an	O	-1	11705128
estim@@	O	-1	11705128
ate	O	-1	11705128
of	O	-1	11705128
the	O	-1	11705128
co@@	O	-1	11705128
st	O	-1	11705128
and	O	-1	11705128
man@@	O	-1	11705128
ag@@	O	-1	11705128
ement	O	-1	11705128
implic@@	O	-1	11705128
ations	O	-1	11705128
of	O	-1	11705128
this	O	-1	11705128
clin@@	O	-1	11705128
ically	O	-1	11705128
important	O	-1	11705128
adverse	O	-1	11705128
effect@@	O	-1	11705128
.	O	-1	11705128

Eff@@	O	-1	6540303
ects	O	-1	6540303
of	O	-1	6540303
amine	B-Chemical	D000588	6540303
pretreatment	O	-1	6540303
on	O	-1	6540303
k@@	B-Chemical	D007649	6540303
et@@	I-Chemical	-1	6540303
amine	I-Chemical	-1	6540303
cat@@	B-Disease	D002389	6540303
at@@	I-Disease	-1	6540303
on@@	I-Disease	-1	6540303
ia	I-Disease	-1	6540303
in	O	-1	6540303
p@@	O	-1	6540303
ine@@	O	-1	6540303
al@@	O	-1	6540303
ect@@	O	-1	6540303
om@@	O	-1	6540303
ized	O	-1	6540303
or	O	-1	6540303
hypo@@	O	-1	6540303
ph@@	O	-1	6540303
ys@@	O	-1	6540303
ect@@	O	-1	6540303
om@@	O	-1	6540303
ized	O	-1	6540303
anim@@	O	-1	6540303
al@@	O	-1	6540303
s.	O	-1	6540303
The	O	-1	6540303
present	O	-1	6540303
studies	O	-1	6540303
were	O	-1	6540303
de@@	O	-1	6540303
signed	O	-1	6540303
to	O	-1	6540303
cl@@	O	-1	6540303
ar@@	O	-1	6540303
if@@	O	-1	6540303
y	O	-1	6540303
the	O	-1	6540303
role	O	-1	6540303
of	O	-1	6540303
cat@@	B-Chemical	D002395	6540303
ech@@	I-Chemical	-1	6540303
ol@@	I-Chemical	-1	6540303
amin@@	I-Chemical	-1	6540303
es	I-Chemical	-1	6540303
and	O	-1	6540303
p@@	O	-1	6540303
ine@@	O	-1	6540303
al	O	-1	6540303
id@@	O	-1	6540303
ol@@	O	-1	6540303
amin@@	O	-1	6540303
es	O	-1	6540303
on	O	-1	6540303
k@@	B-Chemical	D007649	6540303
et@@	I-Chemical	-1	6540303
amine	I-Chemical	-1	6540303
-induced	O	-1	6540303
cat@@	B-Disease	D002389	6540303
at@@	I-Disease	-1	6540303
on@@	I-Disease	-1	6540303
ia	I-Disease	-1	6540303
in	O	-1	6540303
the	O	-1	6540303
int@@	O	-1	6540303
act@@	O	-1	6540303
,	O	-1	6540303
p@@	O	-1	6540303
ine@@	O	-1	6540303
al@@	O	-1	6540303
ect@@	O	-1	6540303
om@@	O	-1	6540303
ized	O	-1	6540303
or	O	-1	6540303
hypo@@	O	-1	6540303
ph@@	O	-1	6540303
ys@@	O	-1	6540303
ect@@	O	-1	6540303
om@@	O	-1	6540303
ized	O	-1	6540303
ch@@	O	-1	6540303
ic@@	O	-1	6540303
k	O	-1	6540303
and	O	-1	6540303
rat@@	O	-1	6540303
.	O	-1	6540303
In	O	-1	6540303
the	O	-1	6540303
p@@	O	-1	6540303
ine@@	O	-1	6540303
al@@	O	-1	6540303
ect@@	O	-1	6540303
om@@	O	-1	6540303
ized	O	-1	6540303
ch@@	O	-1	6540303
ic@@	O	-1	6540303
k@@	O	-1	6540303
,	O	-1	6540303
pretreatment	O	-1	6540303
with	O	-1	6540303
dopamine	B-Chemical	D004298	6540303
increased	O	-1	6540303
the	O	-1	6540303
duration	O	-1	6540303
of	O	-1	6540303
cat@@	B-Disease	D002389	6540303
at@@	I-Disease	-1	6540303
on@@	I-Disease	-1	6540303
ia	I-Disease	-1	6540303
(D@@	O	-1	6540303
O@@	O	-1	6540303
C@@	O	-1	6540303
)	O	-1	6540303
after	O	-1	6540303
k@@	B-Chemical	D007649	6540303
et@@	I-Chemical	-1	6540303
amine	I-Chemical	-1	6540303
,	O	-1	6540303
but	O	-1	6540303
pretreatment	O	-1	6540303
with	O	-1	6540303
no@@	B-Chemical	D009638	6540303
re@@	I-Chemical	-1	6540303
p@@	I-Chemical	-1	6540303
ine@@	I-Chemical	-1	6540303
phrine	I-Chemical	-1	6540303
did	O	-1	6540303
not@@	O	-1	6540303
.	O	-1	6540303
The	O	-1	6540303
p@@	O	-1	6540303
ine@@	O	-1	6540303
al	O	-1	6540303
ind@@	O	-1	6540303
ol@@	O	-1	6540303
amin@@	O	-1	6540303
es	O	-1	6540303
ex@@	O	-1	6540303
hib@@	O	-1	6540303
ited	O	-1	6540303
mi@@	O	-1	6540303
x@@	O	-1	6540303
ed	O	-1	6540303
ac@@	O	-1	6540303
tions.	O	-1	6540303
S@@	B-Chemical	D012701	6540303
er@@	I-Chemical	-1	6540303
oton@@	I-Chemical	-1	6540303
in	I-Chemical	-1	6540303
and	O	-1	6540303
N@@	B-Chemical	C006389	6540303
-@@	I-Chemical	-1	6540303
acet@@	I-Chemical	-1	6540303
yl	I-Chemical	-1	6540303
seroton@@	I-Chemical	-1	6540303
in	I-Chemical	-1	6540303
which	O	-1	6540303
au@@	O	-1	6540303
g@@	O	-1	6540303
ment@@	O	-1	6540303
ed	O	-1	6540303
k@@	B-Chemical	D007649	6540303
et@@	I-Chemical	-1	6540303
amine	I-Chemical	-1	6540303
DO@@	O	-1	6540303
C@@	O	-1	6540303
,	O	-1	6540303
did	O	-1	6540303
not	O	-1	6540303
d@@	O	-1	6540303
o	O	-1	6540303
so	O	-1	6540303
in	O	-1	6540303
the	O	-1	6540303
absence	O	-1	6540303
of	O	-1	6540303
the	O	-1	6540303
p@@	O	-1	6540303
ine@@	O	-1	6540303
al	O	-1	6540303
gl@@	O	-1	6540303
and@@	O	-1	6540303
,	O	-1	6540303
whereas	O	-1	6540303
me@@	B-Chemical	D008550	6540303
lat@@	I-Chemical	-1	6540303
on@@	I-Chemical	-1	6540303
in	I-Chemical	-1	6540303
potenti@@	O	-1	6540303
ated	O	-1	6540303
the	O	-1	6540303
k@@	B-Chemical	D007649	6540303
et@@	I-Chemical	-1	6540303
amine	I-Chemical	-1	6540303
DO@@	O	-1	6540303
C	O	-1	6540303
in	O	-1	6540303
both	O	-1	6540303
the	O	-1	6540303
int@@	O	-1	6540303
ac@@	O	-1	6540303
t	O	-1	6540303
and	O	-1	6540303
p@@	O	-1	6540303
ine@@	O	-1	6540303
al@@	O	-1	6540303
ect@@	O	-1	6540303
om@@	O	-1	6540303
ized	O	-1	6540303
ch@@	O	-1	6540303
ic@@	O	-1	6540303
k@@	O	-1	6540303
.	O	-1	6540303
K@@	B-Chemical	D007649	6540303
et@@	I-Chemical	-1	6540303
amine	I-Chemical	-1	6540303
was	O	-1	6540303
more	O	-1	6540303
pot@@	O	-1	6540303
ent	O	-1	6540303
in	O	-1	6540303
the	O	-1	6540303
hypo@@	O	-1	6540303
ph@@	O	-1	6540303
ys@@	O	-1	6540303
ect@@	O	-1	6540303
om@@	O	-1	6540303
ized	O	-1	6540303
ch@@	O	-1	6540303
ic@@	O	-1	6540303
k	O	-1	6540303
and	O	-1	6540303
the	O	-1	6540303
cir@@	O	-1	6540303
ca@@	O	-1	6540303
di@@	O	-1	6540303
an	O	-1	6540303
rhyth@@	O	-1	6540303
m	O	-1	6540303
not@@	O	-1	6540303
ed	O	-1	6540303
in	O	-1	6540303
the	O	-1	6540303
int@@	O	-1	6540303
ac@@	O	-1	6540303
t	O	-1	6540303
ch@@	O	-1	6540303
ic@@	O	-1	6540303
k	O	-1	6540303
was	O	-1	6540303
abs@@	O	-1	6540303
ent@@	O	-1	6540303
;	O	-1	6540303
f@@	O	-1	6540303
ur@@	O	-1	6540303
ther@@	O	-1	6540303
mo@@	O	-1	6540303
re,	O	-1	6540303
me@@	B-Chemical	D008550	6540303
lat@@	I-Chemical	-1	6540303
on@@	I-Chemical	-1	6540303
in	I-Chemical	-1	6540303
did	O	-1	6540303
not	O	-1	6540303
au@@	O	-1	6540303
g@@	O	-1	6540303
ment	O	-1	6540303
the	O	-1	6540303
k@@	B-Chemical	D007649	6540303
et@@	I-Chemical	-1	6540303
amine	I-Chemical	-1	6540303
DO@@	O	-1	6540303
C	O	-1	6540303
whereas	O	-1	6540303
dopamine	B-Chemical	D004298	6540303
continu@@	O	-1	6540303
ed	O	-1	6540303
to	O	-1	6540303
d@@	O	-1	6540303
o	O	-1	6540303
so@@	O	-1	6540303
.	O	-1	6540303
This	O	-1	6540303
study	O	-1	6540303
did	O	-1	6540303
not	O	-1	6540303
demon@@	O	-1	6540303
st@@	O	-1	6540303
rate	O	-1	6540303
a	O	-1	6540303
spec@@	O	-1	6540303
i@@	O	-1	6540303
es	O	-1	6540303
difference	O	-1	6540303
reg@@	O	-1	6540303
ar@@	O	-1	6540303
ding	O	-1	6540303
the	O	-1	6540303
role	O	-1	6540303
of	O	-1	6540303
the	O	-1	6540303
amin@@	B-Chemical	D000588	6540303
es	I-Chemical	-1	6540303
on	O	-1	6540303
the	O	-1	6540303
p@@	O	-1	6540303
ine@@	O	-1	6540303
al	O	-1	6540303
in	O	-1	6540303
sp@@	O	-1	6540303
ite	O	-1	6540303
of	O	-1	6540303
the	O	-1	6540303
im@@	O	-1	6540303
mat@@	O	-1	6540303
ure	O	-1	6540303
blo@@	O	-1	6540303
o@@	O	-1	6540303
d-@@	O	-1	6540303
brain	O	-1	6540303
bar@@	O	-1	6540303
ri@@	O	-1	6540303
er	O	-1	6540303
in	O	-1	6540303
the	O	-1	6540303
youn@@	O	-1	6540303
g	O	-1	6540303
ch@@	O	-1	6540303
ic@@	O	-1	6540303
k	O	-1	6540303
and	O	-1	6540303
the	O	-1	6540303
int@@	O	-1	6540303
ac@@	O	-1	6540303
t	O	-1	6540303
bar@@	O	-1	6540303
ri@@	O	-1	6540303
er	O	-1	6540303
in	O	-1	6540303
the	O	-1	6540303
rat@@	O	-1	6540303
.	O	-1	6540303
In	O	-1	6540303
addi@@	O	-1	6540303
tion,	O	-1	6540303
these	O	-1	6540303
data	O	-1	6540303
indicate	O	-1	6540303
a	O	-1	6540303
direct	O	-1	6540303
role	O	-1	6540303
of	O	-1	6540303
the	O	-1	6540303
pit@@	O	-1	6540303
u@@	O	-1	6540303
it@@	O	-1	6540303
ary	O	-1	6540303
in	O	-1	6540303
the	O	-1	6540303
au@@	O	-1	6540303
g@@	O	-1	6540303
ment@@	O	-1	6540303
ation	O	-1	6540303
of	O	-1	6540303
k@@	B-Chemical	D007649	6540303
et@@	I-Chemical	-1	6540303
amine	I-Chemical	-1	6540303
DO@@	O	-1	6540303
C	O	-1	6540303
induced	O	-1	6540303
by	O	-1	6540303
me@@	B-Chemical	D008550	6540303
lat@@	I-Chemical	-1	6540303
on@@	I-Chemical	-1	6540303
in	I-Chemical	-1	6540303
.	O	-1	6540303
F@@	O	-1	6540303
ur@@	O	-1	6540303
ther@@	O	-1	6540303
mo@@	O	-1	6540303
re,	O	-1	6540303
dopamine	B-Chemical	D004298	6540303
appe@@	O	-1	6540303
a@@	O	-1	6540303
red	O	-1	6540303
to	O	-1	6540303
ac@@	O	-1	6540303
t	O	-1	6540303
on	O	-1	6540303
system@@	O	-1	6540303
s	O	-1	6540303
more	O	-1	6540303
clo@@	O	-1	6540303
se@@	O	-1	6540303
ly	O	-1	6540303
involved	O	-1	6540303
with	O	-1	6540303
the	O	-1	6540303
induction	O	-1	6540303
of	O	-1	6540303
k@@	B-Chemical	D007649	6540303
et@@	I-Chemical	-1	6540303
amine	I-Chemical	-1	6540303
cat@@	B-Disease	D002389	6540303
at@@	I-Disease	-1	6540303
on@@	I-Disease	-1	6540303
ia	I-Disease	-1	6540303
ra@@	O	-1	6540303
ther	O	-1	6540303
than	O	-1	6540303
direc@@	O	-1	6540303
tly	O	-1	6540303
on	O	-1	6540303
the	O	-1	6540303
pit@@	O	-1	6540303
u@@	O	-1	6540303
it@@	O	-1	6540303
ar@@	O	-1	6540303
y.	O	-1	6540303

M@@	O	-1	3057041
ul@@	O	-1	3057041
tic@@	O	-1	3057041
ent@@	O	-1	3057041
er,	O	-1	3057041
double-bl@@	O	-1	3057041
ind@@	O	-1	3057041
,	O	-1	3057041
multi@@	O	-1	3057041
ple@@	O	-1	3057041
-@@	O	-1	3057041
dose@@	O	-1	3057041
,	O	-1	3057041
par@@	O	-1	3057041
al@@	O	-1	3057041
le@@	O	-1	3057041
l@@	O	-1	3057041
-@@	O	-1	3057041
groups	O	-1	3057041
efficacy	O	-1	3057041
and	O	-1	3057041
safety	O	-1	3057041
trial	O	-1	3057041
of	O	-1	3057041
az@@	B-Chemical	C020976	3057041
el@@	I-Chemical	-1	3057041
ast@@	I-Chemical	-1	3057041
ine	I-Chemical	-1	3057041
,	O	-1	3057041
chlor@@	B-Chemical	D002744	3057041
phen@@	I-Chemical	-1	3057041
ir@@	I-Chemical	-1	3057041
amine	I-Chemical	-1	3057041
,	O	-1	3057041
and	O	-1	3057041
placebo	O	-1	3057041
in	O	-1	3057041
the	O	-1	3057041
treatment	O	-1	3057041
of	O	-1	3057041
sp@@	B-Disease	D006255	3057041
r@@	I-Disease	-1	3057041
ing	I-Disease	-1	3057041
all@@	I-Disease	-1	3057041
ergic	I-Disease	-1	3057041
rh@@	I-Disease	-1	3057041
initi@@	I-Disease	-1	3057041
s	I-Disease	-1	3057041
.	O	-1	3057041
A@@	B-Chemical	C020976	3057041
z@@	I-Chemical	-1	3057041
el@@	I-Chemical	-1	3057041
ast@@	I-Chemical	-1	3057041
ine	I-Chemical	-1	3057041
,	O	-1	3057041
a	O	-1	3057041
novel	O	-1	3057041
anti@@	O	-1	3057041
all@@	O	-1	3057041
ergic	O	-1	3057041
medic@@	O	-1	3057041
ation,	O	-1	3057041
was	O	-1	3057041
compared	O	-1	3057041
with	O	-1	3057041
chlor@@	B-Chemical	D002744	3057041
phen@@	I-Chemical	-1	3057041
ir@@	I-Chemical	-1	3057041
amine	I-Chemical	-1	3057041
mal@@	I-Chemical	-1	3057041
e@@	I-Chemical	-1	3057041
ate	I-Chemical	-1	3057041
and	O	-1	3057041
placebo	O	-1	3057041
for	O	-1	3057041
efficacy	O	-1	3057041
and	O	-1	3057041
safety	O	-1	3057041
in	O	-1	3057041
the	O	-1	3057041
treatment	O	-1	3057041
of	O	-1	3057041
sp@@	B-Disease	D006255	3057041
r@@	I-Disease	-1	3057041
ing	I-Disease	-1	3057041
all@@	I-Disease	-1	3057041
ergic	I-Disease	-1	3057041
rh@@	I-Disease	-1	3057041
initi@@	I-Disease	-1	3057041
s	I-Disease	-1	3057041
in	O	-1	3057041
a	O	-1	3057041
mul@@	O	-1	3057041
tic@@	O	-1	3057041
ent@@	O	-1	3057041
er,	O	-1	3057041
double-bl@@	O	-1	3057041
ind@@	O	-1	3057041
,	O	-1	3057041
multi@@	O	-1	3057041
ple@@	O	-1	3057041
-@@	O	-1	3057041
dose@@	O	-1	3057041
,	O	-1	3057041
par@@	O	-1	3057041
al@@	O	-1	3057041
le@@	O	-1	3057041
l@@	O	-1	3057041
-@@	O	-1	3057041
groups	O	-1	3057041
study.	O	-1	3057041
One	O	-1	3057041
h@@	O	-1	3057041
und@@	O	-1	3057041
red	O	-1	3057041
f@@	O	-1	3057041
if@@	O	-1	3057041
ty-@@	O	-1	3057041
five	O	-1	3057041
subjects	O	-1	3057041
partic@@	O	-1	3057041
i@@	O	-1	3057041
pat@@	O	-1	3057041
ed.	O	-1	3057041
S@@	O	-1	3057041
ub@@	O	-1	3057041
j@@	O	-1	3057041
ects	O	-1	3057041
rang@@	O	-1	3057041
ed	O	-1	3057041
in	O	-1	3057041
age	O	-1	3057041
from	O	-1	3057041
1@@	O	-1	3057041
8	O	-1	3057041
to	O	-1	3057041
60	O	-1	3057041
years	O	-1	3057041
of	O	-1	3057041
age	O	-1	3057041
and	O	-1	3057041
had	O	-1	3057041
at	O	-1	3057041
le@@	O	-1	3057041
ast	O	-1	3057041
a	O	-1	3057041
2-@@	O	-1	3057041
year	O	-1	3057041
hist@@	O	-1	3057041
ory	O	-1	3057041
of	O	-1	3057041
sp@@	B-Disease	D006255	3057041
r@@	I-Disease	-1	3057041
ing	I-Disease	-1	3057041
all@@	I-Disease	-1	3057041
ergic	I-Disease	-1	3057041
rh@@	I-Disease	-1	3057041
initi@@	I-Disease	-1	3057041
s	I-Disease	-1	3057041
,	O	-1	3057041
con@@	O	-1	3057041
fir@@	O	-1	3057041
m@@	O	-1	3057041
ed	O	-1	3057041
by	O	-1	3057041
positive	O	-1	3057041
s@@	O	-1	3057041
k@@	O	-1	3057041
in	O	-1	3057041
test	O	-1	3057041
to	O	-1	3057041
sp@@	O	-1	3057041
r@@	O	-1	3057041
ing	O	-1	3057041
a@@	O	-1	3057041
ero@@	O	-1	3057041
all@@	O	-1	3057041
er@@	O	-1	3057041
gen@@	O	-1	3057041
s.	O	-1	3057041
M@@	O	-1	3057041
ed@@	O	-1	3057041
ic@@	O	-1	3057041
ations	O	-1	3057041
were	O	-1	3057041
given	O	-1	3057041
four	O	-1	3057041
times	O	-1	3057041
da@@	O	-1	3057041
il@@	O	-1	3057041
y@@	O	-1	3057041
;	O	-1	3057041
the	O	-1	3057041
az@@	B-Chemical	C020976	3057041
el@@	I-Chemical	-1	3057041
ast@@	I-Chemical	-1	3057041
ine	I-Chemical	-1	3057041
groups	O	-1	3057041
received	O	-1	3057041
0.@@	O	-1	3057041
5,	O	-1	3057041
1.@@	O	-1	3057041
0@@	O	-1	3057041
,	O	-1	3057041
or	O	-1	3057041
2.@@	O	-1	3057041
0	O	-1	3057041
mg	O	-1	3057041
in	O	-1	3057041
the	O	-1	3057041
mor@@	O	-1	3057041
ning	O	-1	3057041
and	O	-1	3057041
ev@@	O	-1	3057041
en@@	O	-1	3057041
ing	O	-1	3057041
with	O	-1	3057041
placebo	O	-1	3057041
in	O	-1	3057041
the	O	-1	3057041
early	O	-1	3057041
and	O	-1	3057041
l@@	O	-1	3057041
ate	O	-1	3057041
af@@	O	-1	3057041
ter@@	O	-1	3057041
no@@	O	-1	3057041
on@@	O	-1	3057041
;	O	-1	3057041
the	O	-1	3057041
chlor@@	B-Chemical	D002744	3057041
phen@@	I-Chemical	-1	3057041
ir@@	I-Chemical	-1	3057041
amine	I-Chemical	-1	3057041
group	O	-1	3057041
received	O	-1	3057041
4.@@	O	-1	3057041
0	O	-1	3057041
mg	O	-1	3057041
four	O	-1	3057041
times	O	-1	3057041
da@@	O	-1	3057041
il@@	O	-1	3057041
y.	O	-1	3057041
D@@	O	-1	3057041
a@@	O	-1	3057041
ily	O	-1	3057041
subj@@	O	-1	3057041
ect	O	-1	3057041
sympto@@	O	-1	3057041
m	O	-1	3057041
car@@	O	-1	3057041
ds	O	-1	3057041
were	O	-1	3057041
comple@@	O	-1	3057041
ted	O	-1	3057041
during	O	-1	3057041
a	O	-1	3057041
s@@	O	-1	3057041
cre@@	O	-1	3057041
en@@	O	-1	3057041
ing	O	-1	3057041
period	O	-1	3057041
to	O	-1	3057041
ass@@	O	-1	3057041
ess	O	-1	3057041
pretreatment	O	-1	3057041
symptoms	O	-1	3057041
and	O	-1	3057041
during	O	-1	3057041
a	O	-1	3057041
4-@@	O	-1	3057041
week	O	-1	3057041
treatment	O	-1	3057041
period	O	-1	3057041
while	O	-1	3057041
subjects	O	-1	3057041
received	O	-1	3057041
study	O	-1	3057041
medic@@	O	-1	3057041
ations.	O	-1	3057041
In@@	O	-1	3057041
divid@@	O	-1	3057041
ual	O	-1	3057041
symptom@@	O	-1	3057041
s,	O	-1	3057041
total	O	-1	3057041
symptom@@	O	-1	3057041
s,	O	-1	3057041
and	O	-1	3057041
major	O	-1	3057041
symptoms	O	-1	3057041
were	O	-1	3057041
compared	O	-1	3057041
to	O	-1	3057041
determine	O	-1	3057041
efficacy	O	-1	3057041
of	O	-1	3057041
medic@@	O	-1	3057041
ation.	O	-1	3057041
E@@	O	-1	3057041
l@@	O	-1	3057041
ic@@	O	-1	3057041
it@@	O	-1	3057041
ed,	O	-1	3057041
vol@@	O	-1	3057041
un@@	O	-1	3057041
te@@	O	-1	3057041
e@@	O	-1	3057041
re@@	O	-1	3057041
d,	O	-1	3057041
and	O	-1	3057041
observed	O	-1	3057041
adverse	O	-1	3057041
experienc@@	O	-1	3057041
es	O	-1	3057041
were	O	-1	3057041
recor@@	O	-1	3057041
ded	O	-1	3057041
for	O	-1	3057041
each	O	-1	3057041
subj@@	O	-1	3057041
ect	O	-1	3057041
and	O	-1	3057041
compared	O	-1	3057041
among	O	-1	3057041
groups.	O	-1	3057041
V@@	O	-1	3057041
it@@	O	-1	3057041
al	O	-1	3057041
sign@@	O	-1	3057041
s,	O	-1	3057041
body	O	-1	3057041
weigh@@	O	-1	3057041
t@@	O	-1	3057041
s,	O	-1	3057041
serum	O	-1	3057041
chem@@	O	-1	3057041
ist@@	O	-1	3057041
r@@	O	-1	3057041
y	O	-1	3057041
valu@@	O	-1	3057041
es,	O	-1	3057041
complete	O	-1	3057041
blood	O	-1	3057041
cell	O	-1	3057041
coun@@	O	-1	3057041
t@@	O	-1	3057041
s,	O	-1	3057041
urine	O	-1	3057041
studi@@	O	-1	3057041
es,	O	-1	3057041
and	O	-1	3057041
electro@@	O	-1	3057041
cardio@@	O	-1	3057041
gram@@	O	-1	3057041
s	O	-1	3057041
were	O	-1	3057041
obtained	O	-1	3057041
for	O	-1	3057041
each	O	-1	3057041
subj@@	O	-1	3057041
ect	O	-1	3057041
and	O	-1	3057041
compared	O	-1	3057041
among	O	-1	3057041
groups.	O	-1	3057041
S@@	O	-1	3057041
ym@@	O	-1	3057041
pto@@	O	-1	3057041
ms	O	-1	3057041
re@@	O	-1	3057041
li@@	O	-1	3057041
e@@	O	-1	3057041
f	O	-1	3057041
in	O	-1	3057041
the	O	-1	3057041
group	O	-1	3057041
receiving	O	-1	3057041
the	O	-1	3057041
high@@	O	-1	3057041
est	O	-1	3057041
concentration	O	-1	3057041
of	O	-1	3057041
az@@	B-Chemical	C020976	3057041
el@@	I-Chemical	-1	3057041
ast@@	I-Chemical	-1	3057041
ine	I-Chemical	-1	3057041
(2@@	O	-1	3057041
.@@	O	-1	3057041
0	O	-1	3057041
mg	O	-1	3057041
tw@@	O	-1	3057041
ic@@	O	-1	3057041
e	O	-1	3057041
da@@	O	-1	3057041
il@@	O	-1	3057041
y@@	O	-1	3057041
)	O	-1	3057041
was	O	-1	3057041
statis@@	O	-1	3057041
tically	O	-1	3057041
greater	O	-1	3057041
than	O	-1	3057041
in	O	-1	3057041
the	O	-1	3057041
placebo	O	-1	3057041
group	O	-1	3057041
during	O	-1	3057041
all	O	-1	3057041
weeks	O	-1	3057041
of	O	-1	3057041
the	O	-1	3057041
study.	O	-1	3057041
L@@	O	-1	3057041
o@@	O	-1	3057041
w@@	O	-1	3057041
er	O	-1	3057041
doses	O	-1	3057041
of	O	-1	3057041
az@@	B-Chemical	C020976	3057041
el@@	I-Chemical	-1	3057041
ast@@	I-Chemical	-1	3057041
ine	I-Chemical	-1	3057041
were	O	-1	3057041
statis@@	O	-1	3057041
tically	O	-1	3057041
more	O	-1	3057041
effective	O	-1	3057041
than	O	-1	3057041
placebo	O	-1	3057041
only	O	-1	3057041
during	O	-1	3057041
por@@	O	-1	3057041
tions	O	-1	3057041
of	O	-1	3057041
the	O	-1	3057041
first	O	-1	3057041
3	O	-1	3057041
weeks	O	-1	3057041
of	O	-1	3057041
the	O	-1	3057041
study.	O	-1	3057041
In	O	-1	3057041
contrast@@	O	-1	3057041
,	O	-1	3057041
although	O	-1	3057041
the	O	-1	3057041
chlor@@	B-Chemical	D002744	3057041
phen@@	I-Chemical	-1	3057041
ir@@	I-Chemical	-1	3057041
amine	I-Chemical	-1	3057041
group	O	-1	3057041
did	O	-1	3057041
have	O	-1	3057041
fe@@	O	-1	3057041
w@@	O	-1	3057041
er	O	-1	3057041
symptoms	O	-1	3057041
than	O	-1	3057041
the	O	-1	3057041
placebo	O	-1	3057041
group	O	-1	3057041
during	O	-1	3057041
the	O	-1	3057041
study,	O	-1	3057041
the	O	-1	3057041
difference	O	-1	3057041
ne@@	O	-1	3057041
ver	O	-1	3057041
reac@@	O	-1	3057041
h@@	O	-1	3057041
ed	O	-1	3057041
statis@@	O	-1	3057041
tical	O	-1	3057041
signific@@	O	-1	3057041
ance	O	-1	3057041
during	O	-1	3057041
any	O	-1	3057041
week	O	-1	3057041
of	O	-1	3057041
the	O	-1	3057041
study.	O	-1	3057041
There	O	-1	3057041
were	O	-1	3057041
no	O	-1	3057041
seri@@	O	-1	3057041
ous	O	-1	3057041
side	O	-1	3057041
effects	O	-1	3057041
in	O	-1	3057041
any	O	-1	3057041
of	O	-1	3057041
the	O	-1	3057041
treatment	O	-1	3057041
groups.	O	-1	3057041
D@@	B-Disease	D006970	3057041
row@@	I-Disease	-1	3057041
s@@	I-Disease	-1	3057041
in@@	I-Disease	-1	3057041
ess	I-Disease	-1	3057041
and	O	-1	3057041
al@@	B-Disease	D013651	3057041
te@@	I-Disease	-1	3057041
red	I-Disease	-1	3057041
t@@	I-Disease	-1	3057041
ast@@	I-Disease	-1	3057041
e	I-Disease	-1	3057041
per@@	I-Disease	-1	3057041
ce@@	I-Disease	-1	3057041
ption	I-Disease	-1	3057041
were	O	-1	3057041
increased	O	-1	3057041
significantly	O	-1	3057041
over	O	-1	3057041
placebo	O	-1	3057041
only	O	-1	3057041
in	O	-1	3057041
the	O	-1	3057041
high-dose	O	-1	3057041
az@@	B-Chemical	C020976	3057041
el@@	I-Chemical	-1	3057041
ast@@	I-Chemical	-1	3057041
ine	I-Chemical	-1	3057041
group.	O	-1	3057041
A@@	B-Chemical	C020976	3057041
z@@	I-Chemical	-1	3057041
el@@	I-Chemical	-1	3057041
ast@@	I-Chemical	-1	3057041
ine	I-Chemical	-1	3057041
appear@@	O	-1	3057041
s	O	-1	3057041
to	O	-1	3057041
be	O	-1	3057041
a	O	-1	3057041
saf@@	O	-1	3057041
e,	O	-1	3057041
efficac@@	O	-1	3057041
i@@	O	-1	3057041
ous	O	-1	3057041
medic@@	O	-1	3057041
ation	O	-1	3057041
for	O	-1	3057041
se@@	B-Disease	D006255	3057041
as@@	I-Disease	-1	3057041
on@@	I-Disease	-1	3057041
al	I-Disease	-1	3057041
all@@	I-Disease	-1	3057041
ergic	I-Disease	-1	3057041
rh@@	I-Disease	-1	3057041
initi@@	I-Disease	-1	3057041
s	I-Disease	-1	3057041
.	O	-1	3057041

O@@	O	-1	625456
b@@	O	-1	625456
sol@@	O	-1	625456
et@@	O	-1	625456
e	O	-1	625456
but	O	-1	625456
d@@	O	-1	625456
ang@@	O	-1	625456
er@@	O	-1	625456
ous	O	-1	625456
ant@@	O	-1	625456
acid	O	-1	625456
pre@@	O	-1	625456
par@@	O	-1	625456
ations.	O	-1	625456
One	O	-1	625456
case	O	-1	625456
of	O	-1	625456
acute	O	-1	625456
hyper@@	B-Disease	D006934	625456
cal@@	I-Disease	-1	625456
ca@@	I-Disease	-1	625456
emia	I-Disease	-1	625456
and	O	-1	625456
two	O	-1	625456
of	O	-1	625456
recur@@	O	-1	625456
rent	O	-1	625456
nephro@@	B-Disease	D053040	625456
li@@	I-Disease	-1	625456
th@@	I-Disease	-1	625456
ia@@	I-Disease	-1	625456
sis	I-Disease	-1	625456
are	O	-1	625456
reported	O	-1	625456
in	O	-1	625456
patients	O	-1	625456
who	O	-1	625456
had	O	-1	625456
reg@@	O	-1	625456
ul@@	O	-1	625456
arly	O	-1	625456
consum@@	O	-1	625456
ed	O	-1	625456
larg@@	O	-1	625456
e	O	-1	625456
amoun@@	O	-1	625456
ts	O	-1	625456
of	O	-1	625456
calcium	B-Chemical	D002119	625456
carb@@	I-Chemical	-1	625456
on@@	I-Chemical	-1	625456
-@@	I-Chemical	-1	625456
ate	I-Chemical	-1	625456
-	O	-1	625456
sodium	B-Chemical	D017693	625456
b@@	I-Chemical	-1	625456
ic@@	I-Chemical	-1	625456
arb@@	I-Chemical	-1	625456
on@@	I-Chemical	-1	625456
ate	I-Chemical	-1	625456
po@@	O	-1	625456
w@@	O	-1	625456
der@@	O	-1	625456
s	O	-1	625456
for	O	-1	625456
more	O	-1	625456
than	O	-1	625456
20	O	-1	625456
year@@	O	-1	625456
s.	O	-1	625456
The	O	-1	625456
po@@	O	-1	625456
w@@	O	-1	625456
der@@	O	-1	625456
s	O	-1	625456
had	O	-1	625456
been	O	-1	625456
obtained	O	-1	625456
from	O	-1	625456
pharmac@@	O	-1	625456
ist@@	O	-1	625456
s	O	-1	625456
un@@	O	-1	625456
known	O	-1	625456
to	O	-1	625456
the	O	-1	625456
patient@@	O	-1	625456
s@@	O	-1	625456
'	O	-1	625456
med@@	O	-1	625456
ical	O	-1	625456
p@@	O	-1	625456
rac@@	O	-1	625456
ti@@	O	-1	625456
tion@@	O	-1	625456
ers.	O	-1	625456
It	O	-1	625456
is	O	-1	625456
suggested	O	-1	625456
that	O	-1	625456
these	O	-1	625456
pre@@	O	-1	625456
par@@	O	-1	625456
ations	O	-1	625456
were	O	-1	625456
respon@@	O	-1	625456
sible	O	-1	625456
for	O	-1	625456
the	O	-1	625456
patient@@	O	-1	625456
's	O	-1	625456
pro@@	O	-1	625456
ble@@	O	-1	625456
m@@	O	-1	625456
s,	O	-1	625456
and	O	-1	625456
that	O	-1	625456
such	O	-1	625456
po@@	O	-1	625456
w@@	O	-1	625456
der@@	O	-1	625456
s	O	-1	625456
should	O	-1	625456
no	O	-1	625456
long@@	O	-1	625456
er	O	-1	625456
be	O	-1	625456
f@@	O	-1	625456
re@@	O	-1	625456
ely	O	-1	625456
obt@@	O	-1	625456
ain@@	O	-1	625456
able@@	O	-1	625456
.	O	-1	625456

Pro@@	O	-1	7910951
long@@	O	-1	7910951
ed	O	-1	7910951
par@@	B-Disease	D010243	7910951
aly@@	I-Disease	-1	7910951
sis	I-Disease	-1	7910951
due	O	-1	7910951
to	O	-1	7910951
non@@	B-Chemical	D003473	7910951
de@@	I-Chemical	-1	7910951
pol@@	I-Chemical	-1	7910951
ar@@	I-Chemical	-1	7910951
iz@@	I-Chemical	-1	7910951
ing	I-Chemical	-1	7910951
neuro@@	I-Chemical	-1	7910951
mus@@	I-Chemical	-1	7910951
cular	I-Chemical	-1	7910951
block@@	I-Chemical	-1	7910951
ing	I-Chemical	-1	7910951
agents	I-Chemical	-1	7910951
and	O	-1	7910951
cortico@@	B-Chemical	D000305	7910951
steroid@@	I-Chemical	-1	7910951
s	I-Chemical	-1	7910951
.	O	-1	7910951
The	O	-1	7910951
long-term	O	-1	7910951
use	O	-1	7910951
of	O	-1	7910951
non@@	B-Chemical	D003473	7910951
de@@	I-Chemical	-1	7910951
pol@@	I-Chemical	-1	7910951
ar@@	I-Chemical	-1	7910951
iz@@	I-Chemical	-1	7910951
ing	I-Chemical	-1	7910951
neuro@@	I-Chemical	-1	7910951
mus@@	I-Chemical	-1	7910951
cular	I-Chemical	-1	7910951
block@@	I-Chemical	-1	7910951
ing	I-Chemical	-1	7910951
agents	I-Chemical	-1	7910951
(	O	-1	7910951
N@@	B-Chemical	D003473	7910951
D-@@	I-Chemical	-1	7910951
N@@	I-Chemical	-1	7910951
M@@	I-Chemical	-1	7910951
B@@	I-Chemical	-1	7910951
A	I-Chemical	-1	7910951
)	O	-1	7910951
has	O	-1	7910951
rec@@	O	-1	7910951
ently	O	-1	7910951
been	O	-1	7910951
implic@@	O	-1	7910951
ated	O	-1	7910951
as	O	-1	7910951
a	O	-1	7910951
cause	O	-1	7910951
of	O	-1	7910951
prolonged	O	-1	7910951
musc@@	B-Disease	D018908	7910951
le	I-Disease	-1	7910951
we@@	I-Disease	-1	7910951
ak@@	I-Disease	-1	7910951
ness	I-Disease	-1	7910951
,	O	-1	7910951
although	O	-1	7910951
the	O	-1	7910951
sit@@	O	-1	7910951
e	O	-1	7910951
of	O	-1	7910951
the	O	-1	7910951
le@@	O	-1	7910951
sion	O	-1	7910951
and	O	-1	7910951
the	O	-1	7910951
pre@@	O	-1	7910951
dis@@	O	-1	7910951
pos@@	O	-1	7910951
ing	O	-1	7910951
factors	O	-1	7910951
have	O	-1	7910951
been	O	-1	7910951
unc@@	O	-1	7910951
lear@@	O	-1	7910951
.	O	-1	7910951
We	O	-1	7910951
report	O	-1	7910951
3	O	-1	7910951
patients	O	-1	7910951
(@@	O	-1	7910951
age	O	-1	7910951
3@@	O	-1	7910951
7-@@	O	-1	7910951
5@@	O	-1	7910951
2	O	-1	7910951
year@@	O	-1	7910951
s)	O	-1	7910951
with	O	-1	7910951
acute	O	-1	7910951
respiratory	B-Disease	D012131	7910951
in@@	I-Disease	-1	7910951
suffici@@	I-Disease	-1	7910951
ency	I-Disease	-1	7910951
who	O	-1	7910951
developed	O	-1	7910951
prolonged	O	-1	7910951
we@@	B-Disease	D018908	7910951
ak@@	I-Disease	-1	7910951
ness	I-Disease	-1	7910951
following	O	-1	7910951
the	O	-1	7910951
discontinu@@	O	-1	7910951
ation	O	-1	7910951
of	O	-1	7910951
N@@	B-Chemical	D003473	7910951
D-@@	I-Chemical	-1	7910951
N@@	I-Chemical	-1	7910951
M@@	I-Chemical	-1	7910951
BA@@	I-Chemical	-1	7910951
s	I-Chemical	-1	7910951
.	O	-1	7910951
Two	O	-1	7910951
patients	O	-1	7910951
also	O	-1	7910951
received	O	-1	7910951
intravenous	O	-1	7910951
cortico@@	B-Chemical	D000305	7910951
steroid@@	I-Chemical	-1	7910951
s	I-Chemical	-1	7910951
.	O	-1	7910951
R@@	O	-1	7910951
en@@	O	-1	7910951
al	O	-1	7910951
function	O	-1	7910951
was	O	-1	7910951
normal	O	-1	7910951
but	O	-1	7910951
hepatic	O	-1	7910951
function	O	-1	7910951
was	O	-1	7910951
impaired	O	-1	7910951
in	O	-1	7910951
all	O	-1	7910951
patients,	O	-1	7910951
and	O	-1	7910951
all	O	-1	7910951
had	O	-1	7910951
acid@@	B-Disease	D000138	7910951
o@@	I-Disease	-1	7910951
sis	I-Disease	-1	7910951
.	O	-1	7910951
E@@	O	-1	7910951
l@@	O	-1	7910951
ect@@	O	-1	7910951
ro@@	O	-1	7910951
physi@@	O	-1	7910951
ologic	O	-1	7910951
studies	O	-1	7910951
revealed	O	-1	7910951
low	O	-1	7910951
am@@	O	-1	7910951
pl@@	O	-1	7910951
it@@	O	-1	7910951
ude	O	-1	7910951
comp@@	O	-1	7910951
ound	O	-1	7910951
motor	O	-1	7910951
action	O	-1	7910951
potenti@@	O	-1	7910951
al@@	O	-1	7910951
s,	O	-1	7910951
normal	O	-1	7910951
sens@@	O	-1	7910951
ory	O	-1	7910951
studi@@	O	-1	7910951
es,	O	-1	7910951
and	O	-1	7910951
fibrill@@	O	-1	7910951
ations.	O	-1	7910951
R@@	O	-1	7910951
ep@@	O	-1	7910951
e@@	O	-1	7910951
ti@@	O	-1	7910951
tive	O	-1	7910951
stimulation	O	-1	7910951
at	O	-1	7910951
2	O	-1	7910951
H@@	O	-1	7910951
z	O	-1	7910951
showed	O	-1	7910951
a	O	-1	7910951
dec@@	O	-1	7910951
re@@	O	-1	7910951
mental	O	-1	7910951
response	O	-1	7910951
in	O	-1	7910951
2	O	-1	7910951
patients.	O	-1	7910951
The	O	-1	7910951
serum	O	-1	7910951
v@@	B-Chemical	D014673	7910951
ec@@	I-Chemical	-1	7910951
uron@@	I-Chemical	-1	7910951
i@@	I-Chemical	-1	7910951
um	I-Chemical	-1	7910951
level	O	-1	7910951
measured	O	-1	7910951
in	O	-1	7910951
1	O	-1	7910951
patient	O	-1	7910951
14	O	-1	7910951
days	O	-1	7910951
after	O	-1	7910951
the	O	-1	7910951
drug	O	-1	7910951
had	O	-1	7910951
been	O	-1	7910951
discontinu@@	O	-1	7910951
ed	O	-1	7910951
was	O	-1	7910951
17@@	O	-1	7910951
2	O	-1	7910951
n@@	O	-1	7910951
g/@@	O	-1	7910951
m@@	O	-1	7910951
L@@	O	-1	7910951
.	O	-1	7910951
A	O	-1	7910951
musc@@	O	-1	7910951
le	O	-1	7910951
biop@@	O	-1	7910951
sy	O	-1	7910951
in	O	-1	7910951
this	O	-1	7910951
patient	O	-1	7910951
showed	O	-1	7910951
loss	B-Disease	D009135	7910951
of	I-Disease	-1	7910951
th@@	I-Disease	-1	7910951
ic@@	I-Disease	-1	7910951
k@@	I-Disease	-1	7910951
,	I-Disease	-1	7910951
my@@	I-Disease	-1	7910951
os@@	I-Disease	-1	7910951
in	I-Disease	-1	7910951
f@@	I-Disease	-1	7910951
il@@	I-Disease	-1	7910951
am@@	I-Disease	-1	7910951
ents	I-Disease	-1	7910951
.	O	-1	7910951
The	O	-1	7910951
we@@	B-Disease	D018908	7910951
ak@@	I-Disease	-1	7910951
ness	I-Disease	-1	7910951
in	O	-1	7910951
these	O	-1	7910951
patients	O	-1	7910951
is	O	-1	7910951
due	O	-1	7910951
to	O	-1	7910951
path@@	B-Disease	D009468	7910951
ology	I-Disease	-1	7910951
at	I-Disease	-1	7910951
both	I-Disease	-1	7910951
the	I-Disease	-1	7910951
neuro@@	I-Disease	-1	7910951
mus@@	I-Disease	-1	7910951
cular	I-Disease	-1	7910951
j@@	I-Disease	-1	7910951
unc@@	I-Disease	-1	7910951
tion	I-Disease	-1	7910951
(@@	O	-1	7910951
most	O	-1	7910951
likely	O	-1	7910951
due	O	-1	7910951
to	O	-1	7910951
N@@	B-Chemical	D003473	7910951
D-@@	I-Chemical	-1	7910951
N@@	I-Chemical	-1	7910951
M@@	I-Chemical	-1	7910951
B@@	I-Chemical	-1	7910951
A	I-Chemical	-1	7910951
)	O	-1	7910951
and	O	-1	7910951
musc@@	O	-1	7910951
le	O	-1	7910951
(@@	O	-1	7910951
most	O	-1	7910951
likely	O	-1	7910951
due	O	-1	7910951
to	O	-1	7910951
cortico@@	B-Chemical	D000305	7910951
steroid@@	I-Chemical	-1	7910951
s	I-Chemical	-1	7910951
).	O	-1	7910951
He@@	B-Disease	D008107	7910951
pati@@	I-Disease	-1	7910951
c	I-Disease	-1	7910951
dysfunction	I-Disease	-1	7910951
and	O	-1	7910951
acid@@	B-Disease	D000138	7910951
o@@	I-Disease	-1	7910951
sis	I-Disease	-1	7910951
are	O	-1	7910951
cont@@	O	-1	7910951
ri@@	O	-1	7910951
but@@	O	-1	7910951
ing	O	-1	7910951
risk	O	-1	7910951
fact@@	O	-1	7910951
or@@	O	-1	7910951
s.	O	-1	7910951

Pro@@	B-Chemical	D015232	7752389
st@@	I-Chemical	-1	7752389
ag@@	I-Chemical	-1	7752389
l@@	I-Chemical	-1	7752389
and@@	I-Chemical	-1	7752389
in	I-Chemical	-1	7752389
E@@	I-Chemical	-1	7752389
2	I-Chemical	-1	7752389
-induced	O	-1	7752389
bladder	B-Disease	D053201	7752389
hyperactivity	I-Disease	-1	7752389
in	O	-1	7752389
normal@@	O	-1	7752389
,	O	-1	7752389
con@@	O	-1	7752389
s@@	O	-1	7752389
ci@@	O	-1	7752389
ous	O	-1	7752389
rat@@	O	-1	7752389
s:	O	-1	7752389
invol@@	O	-1	7752389
vement	O	-1	7752389
of	O	-1	7752389
tachy@@	B-Chemical	D015320	7752389
kin@@	I-Chemical	-1	7752389
ins	I-Chemical	-1	7752389
?	O	-1	7752389
In	O	-1	7752389
normal	O	-1	7752389
con@@	O	-1	7752389
s@@	O	-1	7752389
ci@@	O	-1	7752389
ous	O	-1	7752389
rats	O	-1	7752389
investigated	O	-1	7752389
by	O	-1	7752389
continu@@	O	-1	7752389
ous	O	-1	7752389
cy@@	O	-1	7752389
sto@@	O	-1	7752389
met@@	O	-1	7752389
r@@	O	-1	7752389
y,	O	-1	7752389
intra@@	O	-1	7752389
ve@@	O	-1	7752389
si@@	O	-1	7752389
c@@	O	-1	7752389
ally	O	-1	7752389
insti@@	O	-1	7752389
lled	O	-1	7752389
pro@@	B-Chemical	D015232	7752389
st@@	I-Chemical	-1	7752389
ag@@	I-Chemical	-1	7752389
l@@	I-Chemical	-1	7752389
and@@	I-Chemical	-1	7752389
in	I-Chemical	-1	7752389
(P@@	I-Chemical	-1	7752389
G@@	I-Chemical	-1	7752389
)	I-Chemical	-1	7752389
E@@	I-Chemical	-1	7752389
2	I-Chemical	-1	7752389
fac@@	O	-1	7752389
il@@	O	-1	7752389
it@@	O	-1	7752389
ated	O	-1	7752389
mic@@	O	-1	7752389
t@@	O	-1	7752389
ur@@	O	-1	7752389
ition	O	-1	7752389
and	O	-1	7752389
increased	O	-1	7752389
bas@@	O	-1	7752389
al	O	-1	7752389
intra@@	O	-1	7752389
ve@@	O	-1	7752389
si@@	O	-1	7752389
c@@	O	-1	7752389
al	O	-1	7752389
pressu@@	O	-1	7752389
re.	O	-1	7752389
The	O	-1	7752389
effect	O	-1	7752389
was	O	-1	7752389
attenu@@	O	-1	7752389
ated	O	-1	7752389
by	O	-1	7752389
both	O	-1	7752389
the	O	-1	7752389
N@@	O	-1	7752389
K@@	O	-1	7752389
1	O	-1	7752389
receptor	O	-1	7752389
selective	O	-1	7752389
antagonist	O	-1	7752389
R@@	B-Chemical	C071693	7752389
P	I-Chemical	-1	7752389
6@@	I-Chemical	-1	7752389
7@@	I-Chemical	-1	7752389
,@@	I-Chemical	-1	7752389
5@@	I-Chemical	-1	7752389
8@@	I-Chemical	-1	7752389
0	I-Chemical	-1	7752389
and	O	-1	7752389
the	O	-1	7752389
N@@	O	-1	7752389
K@@	O	-1	7752389
2	O	-1	7752389
receptor	O	-1	7752389
selective	O	-1	7752389
antagonist	O	-1	7752389
S@@	B-Chemical	C073839	7752389
R	I-Chemical	-1	7752389
4@@	I-Chemical	-1	7752389
8@@	I-Chemical	-1	7752389
,@@	I-Chemical	-1	7752389
9@@	I-Chemical	-1	7752389
6@@	I-Chemical	-1	7752389
8	I-Chemical	-1	7752389
,	O	-1	7752389
given	O	-1	7752389
intra@@	O	-1	7752389
-@@	O	-1	7752389
arter@@	O	-1	7752389
i@@	O	-1	7752389
ally,	O	-1	7752389
suggesting	O	-1	7752389
that	O	-1	7752389
it	O	-1	7752389
was	O	-1	7752389
mediated	O	-1	7752389
by	O	-1	7752389
stimulation	O	-1	7752389
of	O	-1	7752389
both	O	-1	7752389
N@@	O	-1	7752389
K@@	O	-1	7752389
1	O	-1	7752389
and	O	-1	7752389
N@@	O	-1	7752389
K@@	O	-1	7752389
2	O	-1	7752389
receptor@@	O	-1	7752389
s.	O	-1	7752389
In@@	O	-1	7752389
tra@@	O	-1	7752389
-@@	O	-1	7752389
arter@@	O	-1	7752389
i@@	O	-1	7752389
ally	O	-1	7752389
given	O	-1	7752389
PG@@	B-Chemical	D015232	7752389
E@@	I-Chemical	-1	7752389
2	I-Chemical	-1	7752389
produced	O	-1	7752389
a	O	-1	7752389
dist@@	O	-1	7752389
inc@@	O	-1	7752389
t	O	-1	7752389
increase	O	-1	7752389
in	O	-1	7752389
bladder	O	-1	7752389
pressure	O	-1	7752389
before	O	-1	7752389
initi@@	O	-1	7752389
ating	O	-1	7752389
a	O	-1	7752389
mic@@	O	-1	7752389
t@@	O	-1	7752389
ur@@	O	-1	7752389
ition	O	-1	7752389
ref@@	O	-1	7752389
le@@	O	-1	7752389
x@@	O	-1	7752389
,	O	-1	7752389
indicating	O	-1	7752389
that	O	-1	7752389
the	O	-1	7752389
P@@	B-Chemical	D011453	7752389
G	I-Chemical	-1	7752389
had	O	-1	7752389
a	O	-1	7752389
direct	O	-1	7752389
contrac@@	O	-1	7752389
t@@	O	-1	7752389
ant	O	-1	7752389
effect	O	-1	7752389
on	O	-1	7752389
the	O	-1	7752389
det@@	O	-1	7752389
r@@	O	-1	7752389
us@@	O	-1	7752389
or	O	-1	7752389
smo@@	O	-1	7752389
oth	O	-1	7752389
musc@@	O	-1	7752389
le@@	O	-1	7752389
.	O	-1	7752389
The	O	-1	7752389
effect	O	-1	7752389
of	O	-1	7752389
intra@@	O	-1	7752389
-@@	O	-1	7752389
arterial	O	-1	7752389
PG@@	B-Chemical	D015232	7752389
E@@	I-Chemical	-1	7752389
2	I-Chemical	-1	7752389
could	O	-1	7752389
not	O	-1	7752389
be	O	-1	7752389
block@@	O	-1	7752389
ed	O	-1	7752389
by	O	-1	7752389
intra@@	O	-1	7752389
-@@	O	-1	7752389
arterial	O	-1	7752389
R@@	B-Chemical	C071693	7752389
P	I-Chemical	-1	7752389
6@@	I-Chemical	-1	7752389
7@@	I-Chemical	-1	7752389
,@@	I-Chemical	-1	7752389
5@@	I-Chemical	-1	7752389
8@@	I-Chemical	-1	7752389
0	I-Chemical	-1	7752389
or	O	-1	7752389
S@@	B-Chemical	C073839	7752389
R	I-Chemical	-1	7752389
4@@	I-Chemical	-1	7752389
8@@	I-Chemical	-1	7752389
,@@	I-Chemical	-1	7752389
9@@	I-Chemical	-1	7752389
6@@	I-Chemical	-1	7752389
8	I-Chemical	-1	7752389
,	O	-1	7752389
which	O	-1	7752389
o@@	O	-1	7752389
pen@@	O	-1	7752389
s	O	-1	7752389
the	O	-1	7752389
possib@@	O	-1	7752389
ility	O	-1	7752389
that	O	-1	7752389
the	O	-1	7752389
mic@@	O	-1	7752389
t@@	O	-1	7752389
ur@@	O	-1	7752389
ition	O	-1	7752389
ref@@	O	-1	7752389
le@@	O	-1	7752389
x	O	-1	7752389
el@@	O	-1	7752389
ic@@	O	-1	7752389
ited	O	-1	7752389
by	O	-1	7752389
intra@@	O	-1	7752389
-@@	O	-1	7752389
arterial	O	-1	7752389
PG@@	B-Chemical	D015232	7752389
E@@	I-Chemical	-1	7752389
2	I-Chemical	-1	7752389
was	O	-1	7752389
mediated	O	-1	7752389
by	O	-1	7752389
path@@	O	-1	7752389
w@@	O	-1	7752389
ays	O	-1	7752389
other	O	-1	7752389
than	O	-1	7752389
the	O	-1	7752389
ref@@	O	-1	7752389
le@@	O	-1	7752389
x	O	-1	7752389
initi@@	O	-1	7752389
ated	O	-1	7752389
when	O	-1	7752389
the	O	-1	7752389
P@@	B-Chemical	D011453	7752389
G	I-Chemical	-1	7752389
was	O	-1	7752389
given	O	-1	7752389
intra@@	O	-1	7752389
ve@@	O	-1	7752389
si@@	O	-1	7752389
c@@	O	-1	7752389
all@@	O	-1	7752389
y.	O	-1	7752389
The	O	-1	7752389
present	O	-1	7752389
results	O	-1	7752389
th@@	O	-1	7752389
us	O	-1	7752389
suggest	O	-1	7752389
that	O	-1	7752389
intra@@	O	-1	7752389
-@@	O	-1	7752389
arterial	O	-1	7752389
PG@@	B-Chemical	D015232	7752389
E@@	I-Chemical	-1	7752389
2	I-Chemical	-1	7752389
,	O	-1	7752389
given	O	-1	7752389
ne@@	O	-1	7752389
ar	O	-1	7752389
the	O	-1	7752389
blad@@	O	-1	7752389
der@@	O	-1	7752389
,	O	-1	7752389
may	O	-1	7752389
initi@@	O	-1	7752389
ate	O	-1	7752389
mic@@	O	-1	7752389
t@@	O	-1	7752389
ur@@	O	-1	7752389
ition	O	-1	7752389
in	O	-1	7752389
the	O	-1	7752389
normal	O	-1	7752389
rat	O	-1	7752389
ch@@	O	-1	7752389
i@@	O	-1	7752389
e@@	O	-1	7752389
f@@	O	-1	7752389
ly	O	-1	7752389
by	O	-1	7752389
direc@@	O	-1	7752389
tly	O	-1	7752389
contrac@@	O	-1	7752389
ting	O	-1	7752389
the	O	-1	7752389
smo@@	O	-1	7752389
oth	O	-1	7752389
musc@@	O	-1	7752389
le	O	-1	7752389
of	O	-1	7752389
the	O	-1	7752389
det@@	O	-1	7752389
r@@	O	-1	7752389
us@@	O	-1	7752389
or@@	O	-1	7752389
.	O	-1	7752389
However,	O	-1	7752389
when	O	-1	7752389
given	O	-1	7752389
intra@@	O	-1	7752389
ve@@	O	-1	7752389
si@@	O	-1	7752389
c@@	O	-1	7752389
ally,	O	-1	7752389
PG@@	B-Chemical	D015232	7752389
E@@	I-Chemical	-1	7752389
2	I-Chemical	-1	7752389
may	O	-1	7752389
stimul@@	O	-1	7752389
ate	O	-1	7752389
mic@@	O	-1	7752389
t@@	O	-1	7752389
ur@@	O	-1	7752389
ition	O	-1	7752389
by	O	-1	7752389
rele@@	O	-1	7752389
as@@	O	-1	7752389
ing	O	-1	7752389
tachy@@	B-Chemical	D015320	7752389
kin@@	I-Chemical	-1	7752389
ins	I-Chemical	-1	7752389
from	O	-1	7752389
ner@@	O	-1	7752389
v@@	O	-1	7752389
es	O	-1	7752389
in	O	-1	7752389
and/or	O	-1	7752389
immedi@@	O	-1	7752389
ately	O	-1	7752389
be@@	O	-1	7752389
low	O	-1	7752389
the	O	-1	7752389
uro@@	O	-1	7752389
the@@	O	-1	7752389
li@@	O	-1	7752389
um@@	O	-1	7752389
.	O	-1	7752389
These	O	-1	7752389
tachy@@	B-Chemical	D015320	7752389
kin@@	I-Chemical	-1	7752389
ins	I-Chemical	-1	7752389
,	O	-1	7752389
in	O	-1	7752389
t@@	O	-1	7752389
ur@@	O	-1	7752389
n@@	O	-1	7752389
,	O	-1	7752389
initi@@	O	-1	7752389
ate	O	-1	7752389
a	O	-1	7752389
mic@@	O	-1	7752389
t@@	O	-1	7752389
ur@@	O	-1	7752389
ition	O	-1	7752389
ref@@	O	-1	7752389
le@@	O	-1	7752389
x	O	-1	7752389
by	O	-1	7752389
stimul@@	O	-1	7752389
ating	O	-1	7752389
N@@	O	-1	7752389
K@@	O	-1	7752389
1	O	-1	7752389
and	O	-1	7752389
N@@	O	-1	7752389
K@@	O	-1	7752389
2	O	-1	7752389
receptor@@	O	-1	7752389
s.	O	-1	7752389
Pro@@	B-Chemical	D011453	7752389
st@@	I-Chemical	-1	7752389
an@@	I-Chemical	-1	7752389
oid@@	I-Chemical	-1	7752389
s	I-Chemical	-1	7752389
ma@@	O	-1	7752389
y,	O	-1	7752389
vi@@	O	-1	7752389
a	O	-1	7752389
release	O	-1	7752389
of	O	-1	7752389
tachy@@	B-Chemical	D015320	7752389
kin@@	I-Chemical	-1	7752389
ins	I-Chemical	-1	7752389
,	O	-1	7752389
cont@@	O	-1	7752389
rib@@	O	-1	7752389
ute	O	-1	7752389
to	O	-1	7752389
both	O	-1	7752389
ur@@	O	-1	7752389
ge	O	-1	7752389
and	O	-1	7752389
bladder	B-Disease	D053201	7752389
hyperactivity	I-Disease	-1	7752389
seen	O	-1	7752389
in	O	-1	7752389
inflam@@	O	-1	7752389
mat@@	O	-1	7752389
ory	O	-1	7752389
condi@@	O	-1	7752389
tions	O	-1	7752389
of	O	-1	7752389
the	O	-1	7752389
lower	O	-1	7752389
urinary	O	-1	7752389
trac@@	O	-1	7752389
t.	O	-1	7752389

Th@@	B-Chemical	D049971	6942642
i@@	I-Chemical	-1	6942642
az@@	I-Chemical	-1	6942642
ide	I-Chemical	-1	6942642
di@@	O	-1	6942642
ure@@	O	-1	6942642
tic@@	O	-1	6942642
s,	O	-1	6942642
hypo@@	B-Disease	D007008	6942642
k@@	I-Disease	-1	6942642
al@@	I-Disease	-1	6942642
emia	I-Disease	-1	6942642
and	O	-1	6942642
cardiac	B-Disease	D001145	6942642
arrhyth@@	I-Disease	-1	6942642
mi@@	I-Disease	-1	6942642
as	I-Disease	-1	6942642
.	O	-1	6942642
Th@@	B-Chemical	D049971	6942642
i@@	I-Chemical	-1	6942642
az@@	I-Chemical	-1	6942642
ide	I-Chemical	-1	6942642
di@@	O	-1	6942642
ure@@	O	-1	6942642
tics	O	-1	6942642
are	O	-1	6942642
wi@@	O	-1	6942642
de@@	O	-1	6942642
ly	O	-1	6942642
ac@@	O	-1	6942642
ce@@	O	-1	6942642
pt@@	O	-1	6942642
ed	O	-1	6942642
as	O	-1	6942642
the	O	-1	6942642
cor@@	O	-1	6942642
ner@@	O	-1	6942642
st@@	O	-1	6942642
one	O	-1	6942642
of	O	-1	6942642
anti@@	O	-1	6942642
hypertensive	O	-1	6942642
treatment	O	-1	6942642
pro@@	O	-1	6942642
gram@@	O	-1	6942642
s.	O	-1	6942642
H@@	B-Disease	D007008	6942642
y@@	I-Disease	-1	6942642
po@@	I-Disease	-1	6942642
k@@	I-Disease	-1	6942642
al@@	I-Disease	-1	6942642
emia	I-Disease	-1	6942642
is	O	-1	6942642
a	O	-1	6942642
common@@	O	-1	6942642
ly	O	-1	6942642
en@@	O	-1	6942642
coun@@	O	-1	6942642
te@@	O	-1	6942642
red	O	-1	6942642
met@@	O	-1	6942642
ab@@	O	-1	6942642
olic	O	-1	6942642
con@@	O	-1	6942642
sequ@@	O	-1	6942642
ence	O	-1	6942642
of	O	-1	6942642
chronic	O	-1	6942642
thi@@	B-Chemical	D049971	6942642
az@@	I-Chemical	-1	6942642
ide	I-Chemical	-1	6942642
therapy.	O	-1	6942642
We	O	-1	6942642
treated	O	-1	6942642
3@@	O	-1	6942642
8	O	-1	6942642
patients	O	-1	6942642
(2@@	O	-1	6942642
2	O	-1	6942642
low	O	-1	6942642
ren@@	O	-1	6942642
in,	O	-1	6942642
16	O	-1	6942642
normal	O	-1	6942642
ren@@	O	-1	6942642
in@@	O	-1	6942642
)	O	-1	6942642
with	O	-1	6942642
moder@@	O	-1	6942642
ate	O	-1	6942642
di@@	B-Disease	C563897	6942642
ast@@	I-Disease	-1	6942642
olic	I-Disease	-1	6942642
hypertension	I-Disease	-1	6942642
with	O	-1	6942642
hydro@@	B-Chemical	D006852	6942642
ch@@	I-Chemical	-1	6942642
loro@@	I-Chemical	-1	6942642
thi@@	I-Chemical	-1	6942642
az@@	I-Chemical	-1	6942642
ide	I-Chemical	-1	6942642
(	O	-1	6942642
HC@@	B-Chemical	D006852	6942642
T@@	I-Chemical	-1	6942642
C	I-Chemical	-1	6942642
)	O	-1	6942642
administered	O	-1	6942642
on	O	-1	6942642
a	O	-1	6942642
tw@@	O	-1	6942642
ic@@	O	-1	6942642
e	O	-1	6942642
daily	O	-1	6942642
sch@@	O	-1	6942642
ed@@	O	-1	6942642
ul@@	O	-1	6942642
e.	O	-1	6942642
In@@	O	-1	6942642
iti@@	O	-1	6942642
al	O	-1	6942642
dose	O	-1	6942642
was	O	-1	6942642
50	O	-1	6942642
mg	O	-1	6942642
and	O	-1	6942642
the	O	-1	6942642
dose	O	-1	6942642
was	O	-1	6942642
increased	O	-1	6942642
at	O	-1	6942642
month@@	O	-1	6942642
ly	O	-1	6942642
interv@@	O	-1	6942642
als	O	-1	6942642
to	O	-1	6942642
100	O	-1	6942642
mg@@	O	-1	6942642
,	O	-1	6942642
1@@	O	-1	6942642
50	O	-1	6942642
mg	O	-1	6942642
and	O	-1	6942642
2@@	O	-1	6942642
00	O	-1	6942642
mg	O	-1	6942642
daily	O	-1	6942642
un@@	O	-1	6942642
ti@@	O	-1	6942642
l	O	-1	6942642
blood	O	-1	6942642
pressure	O	-1	6942642
normal@@	O	-1	6942642
iz@@	O	-1	6942642
ed.	O	-1	6942642
The	O	-1	6942642
serum	O	-1	6942642
K	B-Chemical	D011188	6942642
during	O	-1	6942642
the	O	-1	6942642
control	O	-1	6942642
period	O	-1	6942642
was	O	-1	6942642
4.@@	O	-1	6942642
5	O	-1	6942642
+/-	O	-1	6942642
0.@@	O	-1	6942642
2	O	-1	6942642
m@@	O	-1	6942642
E@@	O	-1	6942642
q@@	O	-1	6942642
/@@	O	-1	6942642
l	O	-1	6942642
an	O	-1	6942642
on	O	-1	6942642
50@@	O	-1	6942642
,	O	-1	6942642
10@@	O	-1	6942642
0@@	O	-1	6942642
,	O	-1	6942642
1@@	O	-1	6942642
50	O	-1	6942642
and	O	-1	6942642
2@@	O	-1	6942642
00	O	-1	6942642
mg	O	-1	6942642
HC@@	B-Chemical	D006852	6942642
T@@	I-Chemical	-1	6942642
Z	I-Chemical	-1	6942642
daily	O	-1	6942642
3.@@	O	-1	6942642
9	O	-1	6942642
+/-	O	-1	6942642
0.@@	O	-1	6942642
3,	O	-1	6942642
3.@@	O	-1	6942642
4	O	-1	6942642
+/-	O	-1	6942642
0.@@	O	-1	6942642
2,	O	-1	6942642
2.@@	O	-1	6942642
9	O	-1	6942642
+/-	O	-1	6942642
0.@@	O	-1	6942642
2,	O	-1	6942642
and	O	-1	6942642
2.@@	O	-1	6942642
4	O	-1	6942642
+/-	O	-1	6942642
0.@@	O	-1	6942642
3	O	-1	6942642
m@@	O	-1	6942642
E@@	O	-1	6942642
q@@	O	-1	6942642
/@@	O	-1	6942642
l@@	O	-1	6942642
,	O	-1	6942642
respectively.	O	-1	6942642
C@@	O	-1	6942642
or@@	O	-1	6942642
respon@@	O	-1	6942642
ding	O	-1	6942642
fi@@	O	-1	6942642
g@@	O	-1	6942642
ures	O	-1	6942642
for	O	-1	6942642
wh@@	O	-1	6942642
ole	O	-1	6942642
body	O	-1	6942642
K	B-Chemical	D011188	6942642
were	O	-1	6942642
4@@	O	-1	6942642
10@@	O	-1	6942642
7	O	-1	6942642
+/-	O	-1	6942642
20@@	O	-1	6942642
8@@	O	-1	6942642
,	O	-1	6942642
3@@	O	-1	6942642
7@@	O	-1	6942642
2@@	O	-1	6942642
2	O	-1	6942642
+/-	O	-1	6942642
3@@	O	-1	6942642
19@@	O	-1	6942642
,	O	-1	6942642
3@@	O	-1	6942642
6@@	O	-1	6942642
2@@	O	-1	6942642
8	O	-1	6942642
+/-	O	-1	6942642
25@@	O	-1	6942642
7@@	O	-1	6942642
,	O	-1	6942642
3@@	O	-1	6942642
55@@	O	-1	6942642
1	O	-1	6942642
+/-	O	-1	6942642
3@@	O	-1	6942642
3@@	O	-1	6942642
6,	O	-1	6942642
and	O	-1	6942642
3@@	O	-1	6942642
2@@	O	-1	6942642
6@@	O	-1	6942642
9	O	-1	6942642
+/-	O	-1	6942642
3@@	O	-1	6942642
8@@	O	-1	6942642
0	O	-1	6942642
m@@	O	-1	6942642
E@@	O	-1	6942642
q@@	O	-1	6942642
,	O	-1	6942642
respectively.	O	-1	6942642
In	O	-1	6942642
13	O	-1	6942642
patients	O	-1	6942642
we	O	-1	6942642
observed	O	-1	6942642
the	O	-1	6942642
effects	O	-1	6942642
of	O	-1	6942642
HC@@	B-Chemical	D006852	6942642
T@@	I-Chemical	-1	6942642
Z	I-Chemical	-1	6942642
therapy	O	-1	6942642
(@@	O	-1	6942642
100	O	-1	6942642
mg	O	-1	6942642
da@@	O	-1	6942642
il@@	O	-1	6942642
y@@	O	-1	6942642
)	O	-1	6942642
on	O	-1	6942642
the	O	-1	6942642
occur@@	O	-1	6942642
rence	O	-1	6942642
of	O	-1	6942642
P@@	O	-1	6942642
V@@	O	-1	6942642
C@@	O	-1	6942642
's	O	-1	6942642
during	O	-1	6942642
res@@	O	-1	6942642
t	O	-1	6942642
as	O	-1	6942642
well	O	-1	6942642
as	O	-1	6942642
during	O	-1	6942642
st@@	O	-1	6942642
atic	O	-1	6942642
and	O	-1	6942642
dynam@@	O	-1	6942642
ic	O	-1	6942642
ex@@	O	-1	6942642
er@@	O	-1	6942642
ci@@	O	-1	6942642
se.	O	-1	6942642
D@@	O	-1	6942642
uring	O	-1	6942642
res@@	O	-1	6942642
t	O	-1	6942642
we	O	-1	6942642
observed	O	-1	6942642
0.@@	O	-1	6942642
6	O	-1	6942642
+/-	O	-1	6942642
0.0@@	O	-1	6942642
8	O	-1	6942642
P@@	O	-1	6942642
V@@	O	-1	6942642
C	O	-1	6942642
be@@	O	-1	6942642
at@@	O	-1	6942642
s/@@	O	-1	6942642
min	O	-1	6942642
+/-	O	-1	6942642
S@@	O	-1	6942642
E@@	O	-1	6942642
M	O	-1	6942642
and	O	-1	6942642
during	O	-1	6942642
st@@	O	-1	6942642
atic	O	-1	6942642
and	O	-1	6942642
dynam@@	O	-1	6942642
ic	O	-1	6942642
ex@@	O	-1	6942642
er@@	O	-1	6942642
cis@@	O	-1	6942642
e	O	-1	6942642
0.@@	O	-1	6942642
6	O	-1	6942642
+/-	O	-1	6942642
0.0@@	O	-1	6942642
6	O	-1	6942642
and	O	-1	6942642
0.@@	O	-1	6942642
8	O	-1	6942642
+/-	O	-1	6942642
0.@@	O	-1	6942642
1@@	O	-1	6942642
5,	O	-1	6942642
respectively.	O	-1	6942642
C@@	O	-1	6942642
or@@	O	-1	6942642
respon@@	O	-1	6942642
ding	O	-1	6942642
fi@@	O	-1	6942642
g@@	O	-1	6942642
ures	O	-1	6942642
during	O	-1	6942642
HC@@	B-Chemical	D006852	6942642
T@@	I-Chemical	-1	6942642
Z	I-Chemical	-1	6942642
therapy	O	-1	6942642
100	O	-1	6942642
mg	O	-1	6942642
daily	O	-1	6942642
were	O	-1	6942642
1.@@	O	-1	6942642
4	O	-1	6942642
+/-	O	-1	6942642
0.@@	O	-1	6942642
1,	O	-1	6942642
3.@@	O	-1	6942642
6	O	-1	6942642
+/-	O	-1	6942642
0.@@	O	-1	6942642
7	O	-1	6942642
and	O	-1	6942642
5.@@	O	-1	6942642
7	O	-1	6942642
4@@	O	-1	6942642
/@@	O	-1	6942642
-	O	-1	6942642
0.@@	O	-1	6942642
8@@	O	-1	6942642
,	O	-1	6942642
respectively.	O	-1	6942642
The	O	-1	6942642
occur@@	O	-1	6942642
rence	O	-1	6942642
of	O	-1	6942642
P@@	O	-1	6942642
V@@	O	-1	6942642
C@@	O	-1	6942642
's	O	-1	6942642
cor@@	O	-1	6942642
related	O	-1	6942642
significantly	O	-1	6942642
with	O	-1	6942642
the	O	-1	6942642
f@@	O	-1	6942642
all	O	-1	6942642
in	O	-1	6942642
serum	O	-1	6942642
K	B-Chemical	D011188	6942642
+	O	-1	6942642
observed	O	-1	6942642
r	O	-1	6942642
=	O	-1	6942642
0.@@	O	-1	6942642
7@@	O	-1	6942642
2,	O	-1	6942642
p	O	-1	6942642
less	O	-1	6942642
than	O	-1	6942642
0.00@@	O	-1	6942642
1@@	O	-1	6942642
.	O	-1	6942642
In	O	-1	6942642
concl@@	O	-1	6942642
usion	O	-1	6942642
we	O	-1	6942642
found	O	-1	6942642
that	O	-1	6942642
thi@@	B-Chemical	D049971	6942642
az@@	I-Chemical	-1	6942642
ide	I-Chemical	-1	6942642
di@@	O	-1	6942642
ure@@	O	-1	6942642
tics	O	-1	6942642
cause	O	-1	6942642
hypo@@	B-Disease	D007008	6942642
k@@	I-Disease	-1	6942642
al@@	I-Disease	-1	6942642
emia	I-Disease	-1	6942642
and	O	-1	6942642
deple@@	O	-1	6942642
tion	O	-1	6942642
of	O	-1	6942642
body	O	-1	6942642
pot@@	B-Chemical	D011188	6942642
assi@@	I-Chemical	-1	6942642
um	I-Chemical	-1	6942642
.	O	-1	6942642
The	O	-1	6942642
more	O	-1	6942642
pro@@	O	-1	6942642
found	O	-1	6942642
hypo@@	B-Disease	D007008	6942642
k@@	I-Disease	-1	6942642
al@@	I-Disease	-1	6942642
emia	I-Disease	-1	6942642
,	O	-1	6942642
the	O	-1	6942642
greater	O	-1	6942642
the	O	-1	6942642
pro@@	O	-1	6942642
pen@@	O	-1	6942642
s@@	O	-1	6942642
ity	O	-1	6942642
for	O	-1	6942642
the	O	-1	6942642
occur@@	O	-1	6942642
rence	O	-1	6942642
of	O	-1	6942642
P@@	O	-1	6942642
V@@	O	-1	6942642
C@@	O	-1	6942642
'@@	O	-1	6942642
s.	O	-1	6942642

Di@@	O	-1	3732088
ure@@	O	-1	3732088
tic@@	O	-1	3732088
s,	O	-1	3732088
pot@@	B-Chemical	D011188	3732088
assi@@	I-Chemical	-1	3732088
um	I-Chemical	-1	3732088
and	O	-1	3732088
arrhyth@@	B-Disease	D001145	3732088
mi@@	I-Disease	-1	3732088
as	I-Disease	-1	3732088
in	O	-1	3732088
hypertensive	B-Disease	D006973	3732088
coronary	B-Disease	D003327	3732088
disease	I-Disease	-1	3732088
.	O	-1	3732088
It	O	-1	3732088
has	O	-1	3732088
been	O	-1	3732088
pro@@	O	-1	3732088
pos@@	O	-1	3732088
ed	O	-1	3732088
that	O	-1	3732088
mod@@	O	-1	3732088
est	O	-1	3732088
changes	O	-1	3732088
in	O	-1	3732088
plasma	O	-1	3732088
pot@@	B-Chemical	D011188	3732088
assi@@	I-Chemical	-1	3732088
um	I-Chemical	-1	3732088
can	O	-1	3732088
al@@	O	-1	3732088
ter	O	-1	3732088
the	O	-1	3732088
ten@@	O	-1	3732088
d@@	O	-1	3732088
ency	O	-1	3732088
to@@	O	-1	3732088
war@@	O	-1	3732088
ds	O	-1	3732088
cardiac	B-Disease	D001145	3732088
arrhyth@@	I-Disease	-1	3732088
mi@@	I-Disease	-1	3732088
as	I-Disease	-1	3732088
.	O	-1	3732088
I@@	O	-1	3732088
f	O	-1	3732088
this	O	-1	3732088
were	O	-1	3732088
so@@	O	-1	3732088
,	O	-1	3732088
patients	O	-1	3732088
with	O	-1	3732088
coronary	B-Disease	D003324	3732088
artery	I-Disease	-1	3732088
disease	I-Disease	-1	3732088
might	O	-1	3732088
be	O	-1	3732088
es@@	O	-1	3732088
p@@	O	-1	3732088
ec@@	O	-1	3732088
i@@	O	-1	3732088
ally	O	-1	3732088
sus@@	O	-1	3732088
cep@@	O	-1	3732088
ti@@	O	-1	3732088
ble@@	O	-1	3732088
.	O	-1	3732088
Th@@	O	-1	3732088
us,	O	-1	3732088
myocardial	O	-1	3732088
elect@@	O	-1	3732088
r@@	O	-1	3732088
ical	O	-1	3732088
ex@@	O	-1	3732088
cit@@	O	-1	3732088
ability	O	-1	3732088
was	O	-1	3732088
measured	O	-1	3732088
in	O	-1	3732088
patients	O	-1	3732088
with	O	-1	3732088
mil@@	O	-1	3732088
d	O	-1	3732088
es@@	O	-1	3732088
sen@@	O	-1	3732088
tial	O	-1	3732088
hypertension	B-Disease	D006973	3732088
and	O	-1	3732088
known	O	-1	3732088
coronary	B-Disease	D003324	3732088
artery	I-Disease	-1	3732088
disease	I-Disease	-1	3732088
after	O	-1	3732088
8	O	-1	3732088
weeks	O	-1	3732088
of	O	-1	3732088
treatment	O	-1	3732088
with	O	-1	3732088
a	O	-1	3732088
pot@@	B-Chemical	D011188	3732088
assi@@	I-Chemical	-1	3732088
um	I-Chemical	-1	3732088
-@@	O	-1	3732088
con@@	O	-1	3732088
ser@@	O	-1	3732088
ving	O	-1	3732088
di@@	O	-1	3732088
ure@@	O	-1	3732088
tic	O	-1	3732088
(	O	-1	3732088
am@@	B-Chemical	D000584	3732088
il@@	I-Chemical	-1	3732088
or@@	I-Chemical	-1	3732088
ide	I-Chemical	-1	3732088
)	O	-1	3732088
and	O	-1	3732088
a	O	-1	3732088
similar	O	-1	3732088
period	O	-1	3732088
on	O	-1	3732088
a	O	-1	3732088
pot@@	B-Chemical	D011188	3732088
assi@@	I-Chemical	-1	3732088
um	I-Chemical	-1	3732088
-@@	O	-1	3732088
los@@	O	-1	3732088
ing	O	-1	3732088
di@@	O	-1	3732088
ure@@	O	-1	3732088
tic	O	-1	3732088
(	O	-1	3732088
chlor@@	B-Chemical	D002752	3732088
thal@@	I-Chemical	-1	3732088
id@@	I-Chemical	-1	3732088
one	I-Chemical	-1	3732088
)	O	-1	3732088
in	O	-1	3732088
a	O	-1	3732088
random@@	O	-1	3732088
is@@	O	-1	3732088
ed	O	-1	3732088
study.	O	-1	3732088
P@@	O	-1	3732088
las@@	O	-1	3732088
ma	O	-1	3732088
pot@@	B-Chemical	D011188	3732088
assi@@	I-Chemical	-1	3732088
um	I-Chemical	-1	3732088
concentrations	O	-1	3732088
were	O	-1	3732088
on	O	-1	3732088
average	O	-1	3732088
1	O	-1	3732088
m@@	O	-1	3732088
mol@@	O	-1	3732088
/@@	O	-1	3732088
L	O	-1	3732088
lower	O	-1	3732088
during	O	-1	3732088
the	O	-1	3732088
chlor@@	B-Chemical	D002752	3732088
thal@@	I-Chemical	-1	3732088
id@@	I-Chemical	-1	3732088
one	I-Chemical	-1	3732088
phase	O	-1	3732088
compared	O	-1	3732088
to	O	-1	3732088
am@@	B-Chemical	D000584	3732088
il@@	I-Chemical	-1	3732088
or@@	I-Chemical	-1	3732088
ide	I-Chemical	-1	3732088
therapy.	O	-1	3732088
B@@	O	-1	3732088
lo@@	O	-1	3732088
od	O	-1	3732088
pressure	O	-1	3732088
and	O	-1	3732088
volume	O	-1	3732088
st@@	O	-1	3732088
ates	O	-1	3732088
as	O	-1	3732088
assessed	O	-1	3732088
by	O	-1	3732088
bo@@	O	-1	3732088
dy@@	O	-1	3732088
weigh@@	O	-1	3732088
t,	O	-1	3732088
plasma	O	-1	3732088
ren@@	O	-1	3732088
in	O	-1	3732088
and	O	-1	3732088
nor@@	B-Chemical	D009638	3732088
adren@@	I-Chemical	-1	3732088
aline	I-Chemical	-1	3732088
(	O	-1	3732088
no@@	B-Chemical	D009638	3732088
re@@	I-Chemical	-1	3732088
p@@	I-Chemical	-1	3732088
ine@@	I-Chemical	-1	3732088
phrine	I-Chemical	-1	3732088
)	O	-1	3732088
concentrations	O	-1	3732088
were	O	-1	3732088
similar	O	-1	3732088
on	O	-1	3732088
the	O	-1	3732088
2	O	-1	3732088
regimen@@	O	-1	3732088
s.	O	-1	3732088
Com@@	O	-1	3732088
pared	O	-1	3732088
to	O	-1	3732088
am@@	B-Chemical	D000584	3732088
il@@	I-Chemical	-1	3732088
or@@	I-Chemical	-1	3732088
ide	I-Chemical	-1	3732088
treatment,	O	-1	3732088
the	O	-1	3732088
chlor@@	B-Chemical	D002752	3732088
thal@@	I-Chemical	-1	3732088
id@@	I-Chemical	-1	3732088
one	I-Chemical	-1	3732088
phase	O	-1	3732088
was	O	-1	3732088
associated	O	-1	3732088
with	O	-1	3732088
an	O	-1	3732088
increased	O	-1	3732088
frequency	O	-1	3732088
of	O	-1	3732088
ventricular	B-Disease	D018879	3732088
ect@@	I-Disease	-1	3732088
op@@	I-Disease	-1	3732088
ic	I-Disease	-1	3732088
be@@	I-Disease	-1	3732088
at@@	I-Disease	-1	3732088
s	I-Disease	-1	3732088
(2@@	O	-1	3732088
4-@@	O	-1	3732088
h@@	O	-1	3732088
our	O	-1	3732088
H@@	O	-1	3732088
ol@@	O	-1	3732088
ter	O	-1	3732088
monit@@	O	-1	3732088
or@@	O	-1	3732088
ing@@	O	-1	3732088
)	O	-1	3732088
and	O	-1	3732088
a	O	-1	3732088
higher	O	-1	3732088
L@@	O	-1	3732088
o@@	O	-1	3732088
w@@	O	-1	3732088
n	O	-1	3732088
gra@@	O	-1	3732088
d@@	O	-1	3732088
ing,	O	-1	3732088
increased	O	-1	3732088
up@@	O	-1	3732088
s@@	O	-1	3732088
lop@@	O	-1	3732088
e	O	-1	3732088
and	O	-1	3732088
duration	O	-1	3732088
of	O	-1	3732088
the	O	-1	3732088
mon@@	O	-1	3732088
o@@	O	-1	3732088
pha@@	O	-1	3732088
sic	O	-1	3732088
action	O	-1	3732088
potenti@@	O	-1	3732088
al,	O	-1	3732088
prolonged	O	-1	3732088
ventricular	O	-1	3732088
effective	O	-1	3732088
ref@@	O	-1	3732088
rac@@	O	-1	3732088
t@@	O	-1	3732088
ory	O	-1	3732088
perio@@	O	-1	3732088
d,	O	-1	3732088
and	O	-1	3732088
increased	O	-1	3732088
elect@@	O	-1	3732088
r@@	O	-1	3732088
ical	O	-1	3732088
in@@	O	-1	3732088
st@@	O	-1	3732088
ability	O	-1	3732088
during	O	-1	3732088
pro@@	O	-1	3732088
gram@@	O	-1	3732088
m@@	O	-1	3732088
ed	O	-1	3732088
ventricular	O	-1	3732088
stimul@@	O	-1	3732088
ation.	O	-1	3732088
The	O	-1	3732088
ab@@	O	-1	3732088
o@@	O	-1	3732088
ve	O	-1	3732088
results	O	-1	3732088
indicate	O	-1	3732088
that	O	-1	3732088
because	O	-1	3732088
pot@@	B-Chemical	D011188	3732088
assi@@	I-Chemical	-1	3732088
um	I-Chemical	-1	3732088
-@@	O	-1	3732088
los@@	O	-1	3732088
ing	O	-1	3732088
di@@	O	-1	3732088
ure@@	O	-1	3732088
tic	O	-1	3732088
therapy	O	-1	3732088
can	O	-1	3732088
increase	O	-1	3732088
myocardial	O	-1	3732088
elect@@	O	-1	3732088
r@@	O	-1	3732088
ical	O	-1	3732088
ex@@	O	-1	3732088
cit@@	O	-1	3732088
ability	O	-1	3732088
in	O	-1	3732088
patients	O	-1	3732088
with	O	-1	3732088
is@@	B-Disease	D017202	3732088
ch@@	I-Disease	-1	3732088
a@@	I-Disease	-1	3732088
em@@	I-Disease	-1	3732088
ic	I-Disease	-1	3732088
heart	I-Disease	-1	3732088
disease	I-Disease	-1	3732088
,	O	-1	3732088
even	O	-1	3732088
min@@	O	-1	3732088
or	O	-1	3732088
f@@	O	-1	3732088
all@@	O	-1	3732088
s	O	-1	3732088
in	O	-1	3732088
plasma	O	-1	3732088
pot@@	B-Chemical	D011188	3732088
assi@@	I-Chemical	-1	3732088
um	I-Chemical	-1	3732088
concentrations	O	-1	3732088
are	O	-1	3732088
prob@@	O	-1	3732088
ably	O	-1	3732088
b@@	O	-1	3732088
est	O	-1	3732088
avoid@@	O	-1	3732088
ed	O	-1	3732088
in	O	-1	3732088
such	O	-1	3732088
patients.	O	-1	3732088

G@@	B-Chemical	D005680	2893236
A@@	I-Chemical	-1	2893236
B@@	I-Chemical	-1	2893236
A	I-Chemical	-1	2893236
invol@@	O	-1	2893236
vement	O	-1	2893236
in	O	-1	2893236
n@@	B-Chemical	D009270	2893236
al@@	I-Chemical	-1	2893236
ox@@	I-Chemical	-1	2893236
one	I-Chemical	-1	2893236
induced	O	-1	2893236
rever@@	O	-1	2893236
s@@	O	-1	2893236
al	O	-1	2893236
of	O	-1	2893236
respiratory	B-Disease	D012133	2893236
par@@	I-Disease	-1	2893236
aly@@	I-Disease	-1	2893236
sis	I-Disease	-1	2893236
produced	O	-1	2893236
by	O	-1	2893236
th@@	B-Chemical	D013874	2893236
io@@	I-Chemical	-1	2893236
p@@	I-Chemical	-1	2893236
ental	I-Chemical	-1	2893236
.	O	-1	2893236
No	O	-1	2893236
agent	O	-1	2893236
is	O	-1	2893236
y@@	O	-1	2893236
et	O	-1	2893236
av@@	O	-1	2893236
ail@@	O	-1	2893236
able	O	-1	2893236
to	O	-1	2893236
re@@	O	-1	2893236
verse	O	-1	2893236
respiratory	B-Disease	D012133	2893236
par@@	I-Disease	-1	2893236
aly@@	I-Disease	-1	2893236
sis	I-Disease	-1	2893236
produced	O	-1	2893236
by	O	-1	2893236
C@@	O	-1	2893236
N@@	O	-1	2893236
S	O	-1	2893236
depress@@	O	-1	2893236
ant@@	O	-1	2893236
s,	O	-1	2893236
such	O	-1	2893236
as	O	-1	2893236
gener@@	O	-1	2893236
al	O	-1	2893236
anesthe@@	O	-1	2893236
tic@@	O	-1	2893236
s.	O	-1	2893236
In	O	-1	2893236
this	O	-1	2893236
study	O	-1	2893236
n@@	B-Chemical	D009270	2893236
al@@	I-Chemical	-1	2893236
ox@@	I-Chemical	-1	2893236
one	I-Chemical	-1	2893236
reversed	O	-1	2893236
respiratory	B-Disease	D012133	2893236
par@@	I-Disease	-1	2893236
aly@@	I-Disease	-1	2893236
sis	I-Disease	-1	2893236
induced	O	-1	2893236
by	O	-1	2893236
th@@	B-Chemical	D013874	2893236
io@@	I-Chemical	-1	2893236
p@@	I-Chemical	-1	2893236
ental	I-Chemical	-1	2893236
in	O	-1	2893236
rats.	O	-1	2893236
25	O	-1	2893236
mg/kg@@	O	-1	2893236
,	O	-1	2893236
i.v@@	O	-1	2893236
.	O	-1	2893236
th@@	B-Chemical	D013874	2893236
io@@	I-Chemical	-1	2893236
p@@	I-Chemical	-1	2893236
ental	I-Chemical	-1	2893236
produced	O	-1	2893236
anesthe@@	O	-1	2893236
sia	O	-1	2893236
without	O	-1	2893236
al@@	O	-1	2893236
ter@@	O	-1	2893236
ing	O	-1	2893236
respiratory	O	-1	2893236
rat@@	O	-1	2893236
e,	O	-1	2893236
increased	O	-1	2893236
G@@	B-Chemical	D005680	2893236
A@@	I-Chemical	-1	2893236
B@@	I-Chemical	-1	2893236
A	I-Chemical	-1	2893236
,	O	-1	2893236
decreased	O	-1	2893236
glutamate	B-Chemical	D018698	2893236
,	O	-1	2893236
and	O	-1	2893236
had	O	-1	2893236
no	O	-1	2893236
effect	O	-1	2893236
on	O	-1	2893236
as@@	B-Chemical	D001224	2893236
part@@	I-Chemical	-1	2893236
ate	I-Chemical	-1	2893236
or	O	-1	2893236
glyc@@	B-Chemical	D005998	2893236
ine	I-Chemical	-1	2893236
levels	O	-1	2893236
compared	O	-1	2893236
to	O	-1	2893236
controls	O	-1	2893236
in	O	-1	2893236
rat	O	-1	2893236
cor@@	O	-1	2893236
te@@	O	-1	2893236
x	O	-1	2893236
and	O	-1	2893236
brain	O	-1	2893236
st@@	O	-1	2893236
em@@	O	-1	2893236
.	O	-1	2893236
Pre@@	O	-1	2893236
treatment	O	-1	2893236
of	O	-1	2893236
rats	O	-1	2893236
with	O	-1	2893236
th@@	B-Chemical	C005151	2893236
io@@	I-Chemical	-1	2893236
se@@	I-Chemical	-1	2893236
mic@@	I-Chemical	-1	2893236
arb@@	I-Chemical	-1	2893236
az@@	I-Chemical	-1	2893236
ide	I-Chemical	-1	2893236
for	O	-1	2893236
30	O	-1	2893236
minutes	O	-1	2893236
abol@@	O	-1	2893236
ished	O	-1	2893236
the	O	-1	2893236
anesthe@@	O	-1	2893236
tic	O	-1	2893236
action	O	-1	2893236
as	O	-1	2893236
well	O	-1	2893236
as	O	-1	2893236
the	O	-1	2893236
respiratory	O	-1	2893236
depress@@	O	-1	2893236
ant	O	-1	2893236
action	O	-1	2893236
of	O	-1	2893236
th@@	B-Chemical	D013874	2893236
io@@	I-Chemical	-1	2893236
p@@	I-Chemical	-1	2893236
ental	I-Chemical	-1	2893236
.	O	-1	2893236
50	O	-1	2893236
mg/kg@@	O	-1	2893236
,	O	-1	2893236
i.v@@	O	-1	2893236
.	O	-1	2893236
th@@	B-Chemical	D013874	2893236
io@@	I-Chemical	-1	2893236
p@@	I-Chemical	-1	2893236
ental	I-Chemical	-1	2893236
produced	O	-1	2893236
respiratory	B-Disease	D012131	2893236
ar@@	I-Disease	-1	2893236
res@@	I-Disease	-1	2893236
t	I-Disease	-1	2893236
with	O	-1	2893236
further	O	-1	2893236
increase	O	-1	2893236
in	O	-1	2893236
G@@	B-Chemical	D005680	2893236
A@@	I-Chemical	-1	2893236
B@@	I-Chemical	-1	2893236
A	I-Chemical	-1	2893236
and	O	-1	2893236
decrease	O	-1	2893236
in	O	-1	2893236
glutamate	B-Chemical	D018698	2893236
ag@@	O	-1	2893236
ain	O	-1	2893236
in	O	-1	2893236
cor@@	O	-1	2893236
te@@	O	-1	2893236
x	O	-1	2893236
and	O	-1	2893236
brain	O	-1	2893236
st@@	O	-1	2893236
em	O	-1	2893236
without	O	-1	2893236
aff@@	O	-1	2893236
ect@@	O	-1	2893236
ing	O	-1	2893236
any	O	-1	2893236
of	O	-1	2893236
the	O	-1	2893236
amin@@	B-Chemical	D000596	2893236
o	I-Chemical	-1	2893236
acid@@	I-Chemical	-1	2893236
s	I-Chemical	-1	2893236
studied	O	-1	2893236
in	O	-1	2893236
four	O	-1	2893236
regi@@	O	-1	2893236
ons	O	-1	2893236
of	O	-1	2893236
rat	O	-1	2893236
bra@@	O	-1	2893236
in.	O	-1	2893236
N@@	B-Chemical	D009270	2893236
al@@	I-Chemical	-1	2893236
ox@@	I-Chemical	-1	2893236
one	I-Chemical	-1	2893236
(2@@	O	-1	2893236
.@@	O	-1	2893236
5	O	-1	2893236
mg/kg@@	O	-1	2893236
,	O	-1	2893236
i.v@@	O	-1	2893236
.)	O	-1	2893236
reversed	O	-1	2893236
respiratory	B-Disease	D012133	2893236
par@@	I-Disease	-1	2893236
aly@@	I-Disease	-1	2893236
sis	I-Disease	-1	2893236
,	O	-1	2893236
glutamate	B-Chemical	D018698	2893236
and	O	-1	2893236
G@@	B-Chemical	D005680	2893236
A@@	I-Chemical	-1	2893236
B@@	I-Chemical	-1	2893236
A	I-Chemical	-1	2893236
levels	O	-1	2893236
to	O	-1	2893236
control	O	-1	2893236
values	O	-1	2893236
in	O	-1	2893236
brain	O	-1	2893236
st@@	O	-1	2893236
em	O	-1	2893236
and	O	-1	2893236
cor@@	O	-1	2893236
te@@	O	-1	2893236
x	O	-1	2893236
with	O	-1	2893236
no	O	-1	2893236
changes	O	-1	2893236
in	O	-1	2893236
ca@@	O	-1	2893236
ud@@	O	-1	2893236
ate	O	-1	2893236
or	O	-1	2893236
ce@@	O	-1	2893236
re@@	O	-1	2893236
bell@@	O	-1	2893236
um@@	O	-1	2893236
.	O	-1	2893236
These	O	-1	2893236
data	O	-1	2893236
suggest	O	-1	2893236
n@@	B-Chemical	D009270	2893236
al@@	I-Chemical	-1	2893236
ox@@	I-Chemical	-1	2893236
one	I-Chemical	-1	2893236
rever@@	O	-1	2893236
ses	O	-1	2893236
respiratory	B-Disease	D012133	2893236
par@@	I-Disease	-1	2893236
aly@@	I-Disease	-1	2893236
sis	I-Disease	-1	2893236
produced	O	-1	2893236
by	O	-1	2893236
th@@	B-Chemical	D013874	2893236
io@@	I-Chemical	-1	2893236
p@@	I-Chemical	-1	2893236
ental	I-Chemical	-1	2893236
and	O	-1	2893236
invol@@	O	-1	2893236
v@@	O	-1	2893236
es	O	-1	2893236
G@@	B-Chemical	D005680	2893236
A@@	I-Chemical	-1	2893236
B@@	I-Chemical	-1	2893236
A	I-Chemical	-1	2893236
in	O	-1	2893236
its	O	-1	2893236
ac@@	O	-1	2893236
tion.	O	-1	2893236

N@@	O	-1	2533791
ation@@	O	-1	2533791
al	O	-1	2533791
pro@@	O	-1	2533791
j@@	O	-1	2533791
ect	O	-1	2533791
on	O	-1	2533791
the	O	-1	2533791
pre@@	O	-1	2533791
ven@@	O	-1	2533791
tion	O	-1	2533791
of	O	-1	2533791
mo@@	O	-1	2533791
ther@@	O	-1	2533791
-@@	O	-1	2533791
to@@	O	-1	2533791
-@@	O	-1	2533791
inf@@	O	-1	2533791
ant	O	-1	2533791
inf@@	B-Disease	D006509	2533791
ection	I-Disease	-1	2533791
by	I-Disease	-1	2533791
hepatitis	I-Disease	-1	2533791
B	I-Disease	-1	2533791
vi@@	I-Disease	-1	2533791
ru@@	I-Disease	-1	2533791
s	I-Disease	-1	2533791
in	O	-1	2533791
J@@	O	-1	2533791
ap@@	O	-1	2533791
an@@	O	-1	2533791
.	O	-1	2533791
In	O	-1	2533791
J@@	O	-1	2533791
ap@@	O	-1	2533791
an@@	O	-1	2533791
,	O	-1	2533791
a	O	-1	2533791
n@@	O	-1	2533791
ation@@	O	-1	2533791
w@@	O	-1	2533791
ide	O	-1	2533791
pre@@	O	-1	2533791
ven@@	O	-1	2533791
tion	O	-1	2533791
pro@@	O	-1	2533791
gra@@	O	-1	2533791
m	O	-1	2533791
against	O	-1	2533791
mo@@	O	-1	2533791
ther@@	O	-1	2533791
-@@	O	-1	2533791
to@@	O	-1	2533791
-@@	O	-1	2533791
inf@@	O	-1	2533791
ant	O	-1	2533791
inf@@	B-Disease	D006509	2533791
ection	I-Disease	-1	2533791
by	I-Disease	-1	2533791
hepatitis	I-Disease	-1	2533791
B	I-Disease	-1	2533791
vi@@	I-Disease	-1	2533791
ru@@	I-Disease	-1	2533791
s	I-Disease	-1	2533791
(@@	O	-1	2533791
HB@@	O	-1	2533791
V@@	O	-1	2533791
)	O	-1	2533791
star@@	O	-1	2533791
ted	O	-1	2533791
in	O	-1	2533791
19@@	O	-1	2533791
8@@	O	-1	2533791
5@@	O	-1	2533791
.	O	-1	2533791
This	O	-1	2533791
pro@@	O	-1	2533791
gra@@	O	-1	2533791
m	O	-1	2533791
consist@@	O	-1	2533791
s	O	-1	2533791
of	O	-1	2533791
dou@@	O	-1	2533791
ble	O	-1	2533791
s@@	O	-1	2533791
cre@@	O	-1	2533791
en@@	O	-1	2533791
ings	O	-1	2533791
of	O	-1	2533791
pregn@@	O	-1	2533791
ant	O	-1	2533791
women	O	-1	2533791
and	O	-1	2533791
pro@@	O	-1	2533791
phyl@@	O	-1	2533791
ac@@	O	-1	2533791
tic	O	-1	2533791
treatment	O	-1	2533791
to	O	-1	2533791
the	O	-1	2533791
inf@@	O	-1	2533791
ants	O	-1	2533791
b@@	O	-1	2533791
or@@	O	-1	2533791
n	O	-1	2533791
to	O	-1	2533791
both	O	-1	2533791
hepatitis	B-Chemical	D006514	2533791
B	I-Chemical	-1	2533791
sur@@	I-Chemical	-1	2533791
fac@@	I-Chemical	-1	2533791
e	I-Chemical	-1	2533791
anti@@	I-Chemical	-1	2533791
gen	I-Chemical	-1	2533791
(	O	-1	2533791
HB@@	B-Chemical	D006514	2533791
s@@	I-Chemical	-1	2533791
A@@	I-Chemical	-1	2533791
g	I-Chemical	-1	2533791
)	O	-1	2533791
and	O	-1	2533791
hepatitis	B-Chemical	D006513	2533791
B	I-Chemical	-1	2533791
e	I-Chemical	-1	2533791
anti@@	I-Chemical	-1	2533791
gen	I-Chemical	-1	2533791
(	O	-1	2533791
HB@@	B-Chemical	D006513	2533791
e@@	I-Chemical	-1	2533791
A@@	I-Chemical	-1	2533791
g	I-Chemical	-1	2533791
)	O	-1	2533791
positive	O	-1	2533791
mo@@	O	-1	2533791
ther@@	O	-1	2533791
s.	O	-1	2533791
These	O	-1	2533791
inf@@	O	-1	2533791
ants	O	-1	2533791
are	O	-1	2533791
treated	O	-1	2533791
with	O	-1	2533791
two	O	-1	2533791
injec@@	O	-1	2533791
tions	O	-1	2533791
of	O	-1	2533791
hepatitis	B-Disease	D006509	2533791
B	I-Disease	-1	2533791
immun@@	O	-1	2533791
e	O	-1	2533791
glo@@	O	-1	2533791
b@@	O	-1	2533791
ul@@	O	-1	2533791
in	O	-1	2533791
(@@	O	-1	2533791
HB@@	O	-1	2533791
I@@	O	-1	2533791
G@@	O	-1	2533791
)	O	-1	2533791
and	O	-1	2533791
at	O	-1	2533791
le@@	O	-1	2533791
ast	O	-1	2533791
three	O	-1	2533791
injec@@	O	-1	2533791
tions	O	-1	2533791
of	O	-1	2533791
plasma	O	-1	2533791
der@@	O	-1	2533791
i@@	O	-1	2533791
ved	O	-1	2533791
hepatitis	B-Chemical	D017325	2533791
B	I-Chemical	-1	2533791
vac@@	I-Chemical	-1	2533791
c@@	I-Chemical	-1	2533791
ine	I-Chemical	-1	2533791
.	O	-1	2533791
We	O	-1	2533791
s@@	O	-1	2533791
ent	O	-1	2533791
qu@@	O	-1	2533791
es@@	O	-1	2533791
tion@@	O	-1	2533791
na@@	O	-1	2533791
i@@	O	-1	2533791
res	O	-1	2533791
about	O	-1	2533791
the	O	-1	2533791
numb@@	O	-1	2533791
ers	O	-1	2533791
of	O	-1	2533791
each	O	-1	2533791
proce@@	O	-1	2533791
d@@	O	-1	2533791
ure	O	-1	2533791
or	O	-1	2533791
examin@@	O	-1	2533791
ation	O	-1	2533791
during	O	-1	2533791
n@@	O	-1	2533791
ine	O	-1	2533791
months	O	-1	2533791
of	O	-1	2533791
investig@@	O	-1	2533791
ation	O	-1	2533791
period	O	-1	2533791
to	O	-1	2533791
each	O	-1	2533791
loc@@	O	-1	2533791
al	O	-1	2533791
g@@	O	-1	2533791
over@@	O	-1	2533791
n@@	O	-1	2533791
ment	O	-1	2533791
in	O	-1	2533791
19@@	O	-1	2533791
8@@	O	-1	2533791
6	O	-1	2533791
and	O	-1	2533791
19@@	O	-1	2533791
8@@	O	-1	2533791
7@@	O	-1	2533791
.	O	-1	2533791
9@@	O	-1	2533791
3.@@	O	-1	2533791
4@@	O	-1	2533791
%	O	-1	2533791
pregn@@	O	-1	2533791
ant	O	-1	2533791
women	O	-1	2533791
had	O	-1	2533791
the	O	-1	2533791
ch@@	O	-1	2533791
ance	O	-1	2533791
to	O	-1	2533791
be	O	-1	2533791
examined	O	-1	2533791
for	O	-1	2533791
HB@@	B-Chemical	D006514	2533791
s@@	I-Chemical	-1	2533791
A@@	I-Chemical	-1	2533791
g	I-Chemical	-1	2533791
,	O	-1	2533791
and	O	-1	2533791
the	O	-1	2533791
positive	O	-1	2533791
rate	O	-1	2533791
was	O	-1	2533791
1.@@	O	-1	2533791
4	O	-1	2533791
to	O	-1	2533791
1.@@	O	-1	2533791
5@@	O	-1	2533791
%.	O	-1	2533791
The	O	-1	2533791
HB@@	B-Chemical	D006513	2533791
e@@	I-Chemical	-1	2533791
A@@	I-Chemical	-1	2533791
g	I-Chemical	-1	2533791
positive	O	-1	2533791
rate	O	-1	2533791
in	O	-1	2533791
HB@@	B-Chemical	D006514	2533791
s@@	I-Chemical	-1	2533791
A@@	I-Chemical	-1	2533791
g	I-Chemical	-1	2533791
positive	O	-1	2533791
was	O	-1	2533791
2@@	O	-1	2533791
3	O	-1	2533791
to	O	-1	2533791
2@@	O	-1	2533791
6@@	O	-1	2533791
%.	O	-1	2533791
The	O	-1	2533791
HB@@	B-Chemical	D006514	2533791
s@@	I-Chemical	-1	2533791
A@@	I-Chemical	-1	2533791
g	I-Chemical	-1	2533791
positive	O	-1	2533791
rate	O	-1	2533791
in	O	-1	2533791
ne@@	O	-1	2533791
on@@	O	-1	2533791
ates	O	-1	2533791
and	O	-1	2533791
in	O	-1	2533791
inf@@	O	-1	2533791
ants	O	-1	2533791
before	O	-1	2533791
two	O	-1	2533791
months	O	-1	2533791
were	O	-1	2533791
3@@	O	-1	2533791
%	O	-1	2533791
and	O	-1	2533791
2@@	O	-1	2533791
%	O	-1	2533791
respectively.	O	-1	2533791
S@@	O	-1	2533791
ome	O	-1	2533791
pro@@	O	-1	2533791
ble@@	O	-1	2533791
ms	O	-1	2533791
may	O	-1	2533791
ari@@	O	-1	2533791
se@@	O	-1	2533791
,	O	-1	2533791
because	O	-1	2533791
2@@	O	-1	2533791
7	O	-1	2533791
to	O	-1	2533791
3@@	O	-1	2533791
0%	O	-1	2533791
of	O	-1	2533791
inf@@	O	-1	2533791
ants	O	-1	2533791
need	O	-1	2533791
the	O	-1	2533791
fo@@	O	-1	2533791
ur@@	O	-1	2533791
th	O	-1	2533791
vac@@	O	-1	2533791
cin@@	O	-1	2533791
ation	O	-1	2533791
in	O	-1	2533791
some	O	-1	2533791
re@@	O	-1	2533791
stric@@	O	-1	2533791
ted	O	-1	2533791
a@@	O	-1	2533791
reas@@	O	-1	2533791
.	O	-1	2533791

N@@	O	-1	2322844
ocicep@@	O	-1	2322844
tive	O	-1	2322844
effects	O	-1	2322844
induced	O	-1	2322844
by	O	-1	2322844
intra@@	O	-1	2322844
th@@	O	-1	2322844
ec@@	O	-1	2322844
al	O	-1	2322844
administration	O	-1	2322844
of	O	-1	2322844
pro@@	B-Chemical	D015230	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
D@@	I-Chemical	-1	2322844
2,	I-Chemical	-1	2322844
E@@	I-Chemical	-1	2322844
2,	I-Chemical	-1	2322844
or	I-Chemical	-1	2322844
F@@	I-Chemical	-1	2322844
2	I-Chemical	-1	2322844
al@@	I-Chemical	-1	2322844
ph@@	I-Chemical	-1	2322844
a	I-Chemical	-1	2322844
pro@@	B-Chemical	D015232	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
D@@	I-Chemical	-1	2322844
2,	I-Chemical	-1	2322844
E@@	I-Chemical	-1	2322844
2,	I-Chemical	-1	2322844
or	I-Chemical	-1	2322844
F@@	I-Chemical	-1	2322844
2	I-Chemical	-1	2322844
al@@	I-Chemical	-1	2322844
ph@@	I-Chemical	-1	2322844
a	I-Chemical	-1	2322844
pro@@	B-Chemical	D015237	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
D@@	I-Chemical	-1	2322844
2,	I-Chemical	-1	2322844
E@@	I-Chemical	-1	2322844
2,	I-Chemical	-1	2322844
or	I-Chemical	-1	2322844
F@@	I-Chemical	-1	2322844
2	I-Chemical	-1	2322844
al@@	I-Chemical	-1	2322844
ph@@	I-Chemical	-1	2322844
a	I-Chemical	-1	2322844
to	O	-1	2322844
con@@	O	-1	2322844
s@@	O	-1	2322844
ci@@	O	-1	2322844
ous	O	-1	2322844
mice.	O	-1	2322844
The	O	-1	2322844
effects	O	-1	2322844
of	O	-1	2322844
intra@@	O	-1	2322844
th@@	O	-1	2322844
ec@@	O	-1	2322844
al	O	-1	2322844
administration	O	-1	2322844
of	O	-1	2322844
pro@@	B-Chemical	D011453	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
ins	I-Chemical	-1	2322844
on	O	-1	2322844
pain	B-Disease	D010146	2322844
responses	O	-1	2322844
in	O	-1	2322844
con@@	O	-1	2322844
s@@	O	-1	2322844
ci@@	O	-1	2322844
ous	O	-1	2322844
mice	O	-1	2322844
were	O	-1	2322844
evaluated	O	-1	2322844
by	O	-1	2322844
using	O	-1	2322844
ho@@	O	-1	2322844
t	O	-1	2322844
pl@@	O	-1	2322844
ate	O	-1	2322844
and	O	-1	2322844
ace@@	B-Chemical	D019342	2322844
tic	I-Chemical	-1	2322844
acid	I-Chemical	-1	2322844
w@@	O	-1	2322844
ri@@	O	-1	2322844
th@@	O	-1	2322844
ing	O	-1	2322844
test@@	O	-1	2322844
s.	O	-1	2322844
Pro@@	B-Chemical	D015230	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
D2	I-Chemical	-1	2322844
(0.@@	O	-1	2322844
5-@@	O	-1	2322844
3	O	-1	2322844
n@@	O	-1	2322844
g/@@	O	-1	2322844
mou@@	O	-1	2322844
se@@	O	-1	2322844
)	O	-1	2322844
had	O	-1	2322844
a	O	-1	2322844
hyperalge@@	B-Disease	D006930	2322844
sic	I-Disease	-1	2322844
action	O	-1	2322844
on	O	-1	2322844
the	O	-1	2322844
response	O	-1	2322844
to	O	-1	2322844
a	O	-1	2322844
ho@@	O	-1	2322844
t	O	-1	2322844
pl@@	O	-1	2322844
ate	O	-1	2322844
during	O	-1	2322844
a	O	-1	2322844
3-@@	O	-1	2322844
60	O	-1	2322844
min	O	-1	2322844
period	O	-1	2322844
after	O	-1	2322844
injec@@	O	-1	2322844
tion.	O	-1	2322844
Pro@@	B-Chemical	D015232	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
E@@	I-Chemical	-1	2322844
2	I-Chemical	-1	2322844
showed	O	-1	2322844
a	O	-1	2322844
hyperalge@@	B-Disease	D006930	2322844
sic	I-Disease	-1	2322844
effect	O	-1	2322844
at	O	-1	2322844
doses	O	-1	2322844
of	O	-1	2322844
1	O	-1	2322844
p@@	B-Chemical	D011453	2322844
g	I-Chemical	-1	2322844
to	O	-1	2322844
10	O	-1	2322844
n@@	O	-1	2322844
g/@@	O	-1	2322844
mou@@	O	-1	2322844
se@@	O	-1	2322844
,	O	-1	2322844
but	O	-1	2322844
the	O	-1	2322844
effect	O	-1	2322844
l@@	O	-1	2322844
ast@@	O	-1	2322844
ed	O	-1	2322844
sh@@	O	-1	2322844
or@@	O	-1	2322844
ter	O	-1	2322844
(3@@	O	-1	2322844
-@@	O	-1	2322844
30	O	-1	2322844
min@@	O	-1	2322844
)	O	-1	2322844
than	O	-1	2322844
that	O	-1	2322844
of	O	-1	2322844
pro@@	B-Chemical	D015230	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
D2	I-Chemical	-1	2322844
.	O	-1	2322844
S@@	O	-1	2322844
im@@	O	-1	2322844
il@@	O	-1	2322844
ar	O	-1	2322844
results	O	-1	2322844
were	O	-1	2322844
obtained	O	-1	2322844
by	O	-1	2322844
ace@@	B-Chemical	D019342	2322844
tic	I-Chemical	-1	2322844
acid	I-Chemical	-1	2322844
w@@	O	-1	2322844
ri@@	O	-1	2322844
th@@	O	-1	2322844
ing	O	-1	2322844
test@@	O	-1	2322844
s.	O	-1	2322844
The	O	-1	2322844
hyperalge@@	B-Disease	D006930	2322844
sic	I-Disease	-1	2322844
effect	O	-1	2322844
of	O	-1	2322844
pro@@	B-Chemical	D015230	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
D2	I-Chemical	-1	2322844
was	O	-1	2322844
block@@	O	-1	2322844
ed	O	-1	2322844
by	O	-1	2322844
sim@@	O	-1	2322844
ult@@	O	-1	2322844
aneous	O	-1	2322844
injection	O	-1	2322844
of	O	-1	2322844
a	O	-1	2322844
subst@@	O	-1	2322844
ance	O	-1	2322844
P	O	-1	2322844
antagonist	O	-1	2322844
(@@	O	-1	2322844
greater	O	-1	2322844
than	O	-1	2322844
or	O	-1	2322844
equ@@	O	-1	2322844
al	O	-1	2322844
to	O	-1	2322844
100	O	-1	2322844
n@@	O	-1	2322844
g@@	O	-1	2322844
)	O	-1	2322844
but	O	-1	2322844
not	O	-1	2322844
by	O	-1	2322844
A@@	B-Chemical	C053876	2322844
H@@	I-Chemical	-1	2322844
6@@	I-Chemical	-1	2322844
80@@	I-Chemical	-1	2322844
9	I-Chemical	-1	2322844
,	O	-1	2322844
a	O	-1	2322844
pro@@	O	-1	2322844
st@@	O	-1	2322844
an@@	O	-1	2322844
oid	O	-1	2322844
EP@@	O	-1	2322844
1-@@	O	-1	2322844
receptor	O	-1	2322844
antagonist@@	O	-1	2322844
.	O	-1	2322844
Con@@	O	-1	2322844
ver@@	O	-1	2322844
sel@@	O	-1	2322844
y,	O	-1	2322844
pro@@	B-Chemical	D015232	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
E@@	I-Chemical	-1	2322844
2	I-Chemical	-1	2322844
-induced	O	-1	2322844
hyperalge@@	B-Disease	D006930	2322844
sia	I-Disease	-1	2322844
was	O	-1	2322844
block@@	O	-1	2322844
ed	O	-1	2322844
by	O	-1	2322844
A@@	B-Chemical	C053876	2322844
H@@	I-Chemical	-1	2322844
6@@	I-Chemical	-1	2322844
80@@	I-Chemical	-1	2322844
9	I-Chemical	-1	2322844
(@@	O	-1	2322844
greater	O	-1	2322844
than	O	-1	2322844
or	O	-1	2322844
equ@@	O	-1	2322844
al	O	-1	2322844
to	O	-1	2322844
5@@	O	-1	2322844
00	O	-1	2322844
n@@	O	-1	2322844
g@@	O	-1	2322844
)	O	-1	2322844
but	O	-1	2322844
not	O	-1	2322844
by	O	-1	2322844
the	O	-1	2322844
subst@@	O	-1	2322844
ance	O	-1	2322844
P	O	-1	2322844
antagonist@@	O	-1	2322844
.	O	-1	2322844
Pro@@	B-Chemical	D015237	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
F@@	I-Chemical	-1	2322844
2	I-Chemical	-1	2322844
al@@	I-Chemical	-1	2322844
ph@@	I-Chemical	-1	2322844
a	I-Chemical	-1	2322844
had	O	-1	2322844
lit@@	O	-1	2322844
t@@	O	-1	2322844
le	O	-1	2322844
effect	O	-1	2322844
on	O	-1	2322844
pain	B-Disease	D010146	2322844
respon@@	O	-1	2322844
s@@	O	-1	2322844
es.	O	-1	2322844
These	O	-1	2322844
results	O	-1	2322844
demon@@	O	-1	2322844
st@@	O	-1	2322844
rate	O	-1	2322844
that	O	-1	2322844
both	O	-1	2322844
pro@@	B-Chemical	D015230	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
D2	I-Chemical	-1	2322844
and	O	-1	2322844
pro@@	B-Chemical	D015232	2322844
st@@	I-Chemical	-1	2322844
ag@@	I-Chemical	-1	2322844
l@@	I-Chemical	-1	2322844
and@@	I-Chemical	-1	2322844
in	I-Chemical	-1	2322844
E@@	I-Chemical	-1	2322844
2	I-Chemical	-1	2322844
ex@@	O	-1	2322844
er@@	O	-1	2322844
t	O	-1	2322844
hyperalge@@	B-Disease	D006930	2322844
sia	I-Disease	-1	2322844
in	O	-1	2322844
the	O	-1	2322844
spinal	O	-1	2322844
cor@@	O	-1	2322844
d,	O	-1	2322844
but	O	-1	2322844
in	O	-1	2322844
different	O	-1	2322844
w@@	O	-1	2322844
ay@@	O	-1	2322844
s.	O	-1	2322844

S@@	O	-1	20552622
w@@	O	-1	20552622
al@@	O	-1	20552622
low@@	O	-1	20552622
ing@@	O	-1	20552622
-induced	O	-1	20552622
atrial	B-Disease	D013617	20552622
tachy@@	I-Disease	-1	20552622
arrhyth@@	I-Disease	-1	20552622
mia	I-Disease	-1	20552622
tri@@	O	-1	20552622
g@@	O	-1	20552622
ge@@	O	-1	20552622
red	O	-1	20552622
by	O	-1	20552622
sal@@	B-Chemical	D000420	20552622
but@@	I-Chemical	-1	20552622
am@@	I-Chemical	-1	20552622
ol	I-Chemical	-1	20552622
:	O	-1	20552622
case	O	-1	20552622
report	O	-1	20552622
and	O	-1	20552622
revie@@	O	-1	20552622
w	O	-1	20552622
of	O	-1	20552622
the	O	-1	20552622
literat@@	O	-1	20552622
ure.	O	-1	20552622
CA@@	O	-1	20552622
S@@	O	-1	20552622
E:	O	-1	20552622
A	O	-1	20552622
4@@	O	-1	20552622
9@@	O	-1	20552622
-@@	O	-1	20552622
year-old	O	-1	20552622
patient	O	-1	20552622
experienced	O	-1	20552622
ch@@	O	-1	20552622
est	O	-1	20552622
dis@@	O	-1	20552622
com@@	O	-1	20552622
for@@	O	-1	20552622
t	O	-1	20552622
while	O	-1	20552622
s@@	O	-1	20552622
w@@	O	-1	20552622
al@@	O	-1	20552622
low@@	O	-1	20552622
ing.	O	-1	20552622
O@@	O	-1	20552622
n	O	-1	20552622
electro@@	O	-1	20552622
cardio@@	O	-1	20552622
gram@@	O	-1	20552622
,	O	-1	20552622
episo@@	O	-1	20552622
des	O	-1	20552622
of	O	-1	20552622
atrial	B-Disease	D013617	20552622
tachy@@	I-Disease	-1	20552622
arrhyth@@	I-Disease	-1	20552622
mia	I-Disease	-1	20552622
were	O	-1	20552622
recor@@	O	-1	20552622
ded	O	-1	20552622
immedi@@	O	-1	20552622
ately	O	-1	20552622
after	O	-1	20552622
s@@	O	-1	20552622
w@@	O	-1	20552622
al@@	O	-1	20552622
low@@	O	-1	20552622
ing@@	O	-1	20552622
;	O	-1	20552622
2@@	O	-1	20552622
4-@@	O	-1	20552622
h@@	O	-1	20552622
our	O	-1	20552622
H@@	O	-1	20552622
ol@@	O	-1	20552622
ter	O	-1	20552622
monit@@	O	-1	20552622
or@@	O	-1	20552622
ing	O	-1	20552622
recor@@	O	-1	20552622
ded	O	-1	20552622
several	O	-1	20552622
event@@	O	-1	20552622
s.	O	-1	20552622
The	O	-1	20552622
arrhyth@@	B-Disease	D001145	20552622
mia	I-Disease	-1	20552622
resol@@	O	-1	20552622
ved	O	-1	20552622
after	O	-1	20552622
therapy	O	-1	20552622
with	O	-1	20552622
at@@	B-Chemical	D001262	20552622
en@@	I-Chemical	-1	20552622
o@@	I-Chemical	-1	20552622
lol	I-Chemical	-1	20552622
,	O	-1	20552622
but	O	-1	20552622
recur@@	O	-1	20552622
red	O	-1	20552622
a	O	-1	20552622
year	O	-1	20552622
lat@@	O	-1	20552622
er.	O	-1	20552622
The	O	-1	20552622
patient	O	-1	20552622
no@@	O	-1	20552622
tic@@	O	-1	20552622
ed	O	-1	20552622
that	O	-1	20552622
before	O	-1	20552622
these	O	-1	20552622
episo@@	O	-1	20552622
des	O	-1	20552622
he	O	-1	20552622
had	O	-1	20552622
been	O	-1	20552622
using	O	-1	20552622
an	O	-1	20552622
in@@	O	-1	20552622
h@@	O	-1	20552622
al@@	O	-1	20552622
at@@	O	-1	20552622
or	O	-1	20552622
of	O	-1	20552622
sal@@	B-Chemical	D000420	20552622
but@@	I-Chemical	-1	20552622
am@@	I-Chemical	-1	20552622
ol	I-Chemical	-1	20552622
.	O	-1	20552622
After	O	-1	20552622
sto@@	O	-1	20552622
pp@@	O	-1	20552622
ing	O	-1	20552622
the	O	-1	20552622
beta-@@	O	-1	20552622
agon@@	O	-1	20552622
ist@@	O	-1	20552622
,	O	-1	20552622
and	O	-1	20552622
after	O	-1	20552622
a	O	-1	20552622
week	O	-1	20552622
with	O	-1	20552622
the	O	-1	20552622
at@@	B-Chemical	D001262	20552622
en@@	I-Chemical	-1	20552622
o@@	I-Chemical	-1	20552622
lol	I-Chemical	-1	20552622
,	O	-1	20552622
the	O	-1	20552622
arrhyth@@	B-Disease	D001145	20552622
mia	I-Disease	-1	20552622
dis@@	O	-1	20552622
appe@@	O	-1	20552622
a@@	O	-1	20552622
red.	O	-1	20552622
D@@	O	-1	20552622
I@@	O	-1	20552622
S@@	O	-1	20552622
C@@	O	-1	20552622
US@@	O	-1	20552622
S@@	O	-1	20552622
ION@@	O	-1	20552622
:	O	-1	20552622
S@@	O	-1	20552622
w@@	O	-1	20552622
al@@	O	-1	20552622
low@@	O	-1	20552622
ing@@	O	-1	20552622
-induced	O	-1	20552622
atrial	B-Disease	D013617	20552622
tachy@@	I-Disease	-1	20552622
arrhyth@@	I-Disease	-1	20552622
mia	I-Disease	-1	20552622
(	O	-1	20552622
S@@	B-Disease	D013617	20552622
I@@	I-Disease	-1	20552622
A@@	I-Disease	-1	20552622
T	I-Disease	-1	20552622
)	O	-1	20552622
is	O	-1	20552622
a	O	-1	20552622
r@@	O	-1	20552622
are	O	-1	20552622
phen@@	O	-1	20552622
om@@	O	-1	20552622
en@@	O	-1	20552622
on@@	O	-1	20552622
.	O	-1	20552622
F@@	O	-1	20552622
e@@	O	-1	20552622
w@@	O	-1	20552622
er	O	-1	20552622
than	O	-1	20552622
50	O	-1	20552622
cases	O	-1	20552622
of	O	-1	20552622
S@@	B-Disease	D013617	20552622
I@@	I-Disease	-1	20552622
A@@	I-Disease	-1	20552622
T	I-Disease	-1	20552622
have	O	-1	20552622
been	O	-1	20552622
descri@@	O	-1	20552622
bed	O	-1	20552622
in	O	-1	20552622
the	O	-1	20552622
literat@@	O	-1	20552622
ure.	O	-1	20552622
This	O	-1	20552622
ar@@	O	-1	20552622
tic@@	O	-1	20552622
le	O	-1	20552622
su@@	O	-1	20552622
mm@@	O	-1	20552622
ar@@	O	-1	20552622
iz@@	O	-1	20552622
es	O	-1	20552622
all	O	-1	20552622
the	O	-1	20552622
cases	O	-1	20552622
pu@@	O	-1	20552622
bl@@	O	-1	20552622
is@@	O	-1	20552622
he@@	O	-1	20552622
d,	O	-1	20552622
creat@@	O	-1	20552622
ing	O	-1	20552622
a	O	-1	20552622
com@@	O	-1	20552622
pre@@	O	-1	20552622
h@@	O	-1	20552622
en@@	O	-1	20552622
sive	O	-1	20552622
revie@@	O	-1	20552622
w	O	-1	20552622
of	O	-1	20552622
the	O	-1	20552622
current	O	-1	20552622
know@@	O	-1	20552622
le@@	O	-1	20552622
d@@	O	-1	20552622
ge	O	-1	20552622
and	O	-1	20552622
appro@@	O	-1	20552622
ach	O	-1	20552622
to	O	-1	20552622
S@@	B-Disease	D013617	20552622
I@@	I-Disease	-1	20552622
A@@	I-Disease	-1	20552622
T	I-Disease	-1	20552622
.	O	-1	20552622
It	O	-1	20552622
discus@@	O	-1	20552622
ses	O	-1	20552622
de@@	O	-1	20552622
mo@@	O	-1	20552622
graph@@	O	-1	20552622
ic@@	O	-1	20552622
s,	O	-1	20552622
clinical	O	-1	20552622
character@@	O	-1	20552622
is@@	O	-1	20552622
tics	O	-1	20552622
and	O	-1	20552622
typ@@	O	-1	20552622
es	O	-1	20552622
of	O	-1	20552622
arrhyth@@	B-Disease	D001145	20552622
mia	I-Disease	-1	20552622
,	O	-1	20552622
post@@	O	-1	20552622
ul@@	O	-1	20552622
ated	O	-1	20552622
mechanisms	O	-1	20552622
of	O	-1	20552622
S@@	B-Disease	D013617	20552622
I@@	I-Disease	-1	20552622
A@@	I-Disease	-1	20552622
T	I-Disease	-1	20552622
,	O	-1	20552622
and	O	-1	20552622
different	O	-1	20552622
treatment	O	-1	20552622
possib@@	O	-1	20552622
il@@	O	-1	20552622
ities	O	-1	20552622
such	O	-1	20552622
as	O	-1	20552622
medic@@	O	-1	20552622
ation@@	O	-1	20552622
s,	O	-1	20552622
surger@@	O	-1	20552622
y,	O	-1	20552622
and	O	-1	20552622
radi@@	O	-1	20552622
o@@	O	-1	20552622
frequency	O	-1	20552622
ca@@	O	-1	20552622
the@@	O	-1	20552622
ter	O	-1	20552622
abl@@	O	-1	20552622
ation	O	-1	20552622
(@@	O	-1	20552622
R@@	O	-1	20552622
F@@	O	-1	20552622
CA@@	O	-1	20552622
).	O	-1	20552622
CONCLUSION:	O	-1	20552622
S@@	B-Chemical	D000420	20552622
al@@	I-Chemical	-1	20552622
but@@	I-Chemical	-1	20552622
am@@	I-Chemical	-1	20552622
ol	I-Chemical	-1	20552622
is	O	-1	20552622
presented	O	-1	20552622
h@@	O	-1	20552622
ere	O	-1	20552622
as	O	-1	20552622
a	O	-1	20552622
possible	O	-1	20552622
tri@@	O	-1	20552622
g@@	O	-1	20552622
g@@	O	-1	20552622
er	O	-1	20552622
for	O	-1	20552622
S@@	B-Disease	D013617	20552622
I@@	I-Disease	-1	20552622
A@@	I-Disease	-1	20552622
T	I-Disease	-1	20552622
.	O	-1	20552622
Although	O	-1	20552622
it	O	-1	20552622
is	O	-1	20552622
diff@@	O	-1	20552622
ic@@	O	-1	20552622
ult	O	-1	20552622
to	O	-1	20552622
def@@	O	-1	20552622
ine	O	-1	20552622
ca@@	O	-1	20552622
us@@	O	-1	20552622
ality	O	-1	20552622
in	O	-1	20552622
a	O	-1	20552622
case	O	-1	20552622
repor@@	O	-1	20552622
t,	O	-1	20552622
it	O	-1	20552622
is	O	-1	20552622
log@@	O	-1	20552622
ical	O	-1	20552622
to	O	-1	20552622
th@@	O	-1	20552622
in@@	O	-1	20552622
k	O	-1	20552622
that	O	-1	20552622
a	O	-1	20552622
beta-@@	O	-1	20552622
agon@@	O	-1	20552622
ist	O	-1	20552622
like	O	-1	20552622
sal@@	B-Chemical	D000420	20552622
but@@	I-Chemical	-1	20552622
am@@	I-Chemical	-1	20552622
ol	I-Chemical	-1	20552622
(@@	O	-1	20552622
known	O	-1	20552622
to	O	-1	20552622
induce	O	-1	20552622
tachycardia	B-Disease	D013610	20552622
)	O	-1	20552622
may	O	-1	20552622
be	O	-1	20552622
the	O	-1	20552622
tri@@	O	-1	20552622
g@@	O	-1	20552622
g@@	O	-1	20552622
er	O	-1	20552622
of	O	-1	20552622
adrenergic	O	-1	20552622
ref@@	O	-1	20552622
le@@	O	-1	20552622
x@@	O	-1	20552622
es	O	-1	20552622
or@@	O	-1	20552622
ig@@	O	-1	20552622
in@@	O	-1	20552622
ating	O	-1	20552622
in	O	-1	20552622
the	O	-1	20552622
es@@	O	-1	20552622
oph@@	O	-1	20552622
ag@@	O	-1	20552622
us	O	-1	20552622
while	O	-1	20552622
s@@	O	-1	20552622
w@@	O	-1	20552622
al@@	O	-1	20552622
low@@	O	-1	20552622
ing	O	-1	20552622
and	O	-1	20552622
that	O	-1	20552622
a	O	-1	20552622
beta-@@	O	-1	20552622
block@@	O	-1	20552622
er	O	-1	20552622
such	O	-1	20552622
as	O	-1	20552622
at@@	B-Chemical	D001262	20552622
en@@	I-Chemical	-1	20552622
o@@	I-Chemical	-1	20552622
lol	I-Chemical	-1	20552622
(@@	O	-1	20552622
that	O	-1	20552622
block@@	O	-1	20552622
s	O	-1	20552622
the	O	-1	20552622
adrenergic	O	-1	20552622
activ@@	O	-1	20552622
it@@	O	-1	20552622
y@@	O	-1	20552622
)	O	-1	20552622
may	O	-1	20552622
re@@	O	-1	20552622
li@@	O	-1	20552622
e@@	O	-1	20552622
ve	O	-1	20552622
it@@	O	-1	20552622
.	O	-1	20552622

C@@	B-Chemical	C024989	20510337
o@@	I-Chemical	-1	20510337
enzyme	I-Chemical	-1	20510337
Q@@	I-Chemical	-1	20510337
10	I-Chemical	-1	20510337
treatment	O	-1	20510337
ame@@	O	-1	20510337
li@@	O	-1	20510337
or@@	O	-1	20510337
ates	O	-1	20510337
acute	O	-1	20510337
cisplatin	B-Chemical	D002945	20510337
nephro@@	B-Disease	D007674	20510337
toxicity	I-Disease	-1	20510337
in	O	-1	20510337
mice.	O	-1	20510337
The	O	-1	20510337
nephro@@	O	-1	20510337
protective	O	-1	20510337
effect	O	-1	20510337
of	O	-1	20510337
co@@	B-Chemical	C024989	20510337
enzyme	I-Chemical	-1	20510337
Q@@	I-Chemical	-1	20510337
10	I-Chemical	-1	20510337
was	O	-1	20510337
investigated	O	-1	20510337
in	O	-1	20510337
mice	O	-1	20510337
with	O	-1	20510337
acute	B-Disease	D058186	20510337
renal	I-Disease	-1	20510337
injury	I-Disease	-1	20510337
induced	O	-1	20510337
by	O	-1	20510337
a	O	-1	20510337
single	O	-1	20510337
i.@@	O	-1	20510337
p@@	O	-1	20510337
.	O	-1	20510337
injection	O	-1	20510337
of	O	-1	20510337
cisplatin	B-Chemical	D002945	20510337
(@@	O	-1	20510337
5	O	-1	20510337
mg/kg@@	O	-1	20510337
).	O	-1	20510337
C@@	B-Chemical	C024989	20510337
o@@	I-Chemical	-1	20510337
enzyme	I-Chemical	-1	20510337
Q@@	I-Chemical	-1	20510337
10	I-Chemical	-1	20510337
treatment	O	-1	20510337
(10	O	-1	20510337
mg/k@@	O	-1	20510337
g/@@	O	-1	20510337
da@@	O	-1	20510337
y,	O	-1	20510337
i.p.@@	O	-1	20510337
)	O	-1	20510337
was	O	-1	20510337
ap@@	O	-1	20510337
pl@@	O	-1	20510337
ied	O	-1	20510337
for	O	-1	20510337
6	O	-1	20510337
con@@	O	-1	20510337
sec@@	O	-1	20510337
utive	O	-1	20510337
day@@	O	-1	20510337
s,	O	-1	20510337
star@@	O	-1	20510337
ting	O	-1	20510337
1	O	-1	20510337
day	O	-1	20510337
before	O	-1	20510337
cisplatin	B-Chemical	D002945	20510337
administr@@	O	-1	20510337
ation.	O	-1	20510337
C@@	B-Chemical	C024989	20510337
o@@	I-Chemical	-1	20510337
enzyme	I-Chemical	-1	20510337
Q@@	I-Chemical	-1	20510337
10	I-Chemical	-1	20510337
significantly	O	-1	20510337
reduced	O	-1	20510337
blood	B-Chemical	D001806	20510337
ure@@	I-Chemical	-1	20510337
a	I-Chemical	-1	20510337
nitro@@	I-Chemical	-1	20510337
gen	I-Chemical	-1	20510337
and	O	-1	20510337
serum	O	-1	20510337
creatinine	B-Chemical	D003404	20510337
levels	O	-1	20510337
which	O	-1	20510337
were	O	-1	20510337
increased	O	-1	20510337
by	O	-1	20510337
cisplatin	B-Chemical	D002945	20510337
.	O	-1	20510337
C@@	B-Chemical	C024989	20510337
o@@	I-Chemical	-1	20510337
enzyme	I-Chemical	-1	20510337
Q@@	I-Chemical	-1	20510337
10	I-Chemical	-1	20510337
significantly	O	-1	20510337
com@@	O	-1	20510337
pen@@	O	-1	20510337
s@@	O	-1	20510337
ated	O	-1	20510337
defic@@	O	-1	20510337
its	O	-1	20510337
in	O	-1	20510337
the	O	-1	20510337
anti@@	O	-1	20510337
oxid@@	O	-1	20510337
ant	O	-1	20510337
def@@	O	-1	20510337
en@@	O	-1	20510337
se	O	-1	20510337
mechanisms	O	-1	20510337
(	O	-1	20510337
reduced	B-Chemical	D005978	20510337
glut@@	I-Chemical	-1	20510337
athi@@	I-Chemical	-1	20510337
one	I-Chemical	-1	20510337
level	O	-1	20510337
and	O	-1	20510337
su@@	B-Chemical	D013481	20510337
per@@	I-Chemical	-1	20510337
ox@@	I-Chemical	-1	20510337
ide	I-Chemical	-1	20510337
dis@@	O	-1	20510337
mut@@	O	-1	20510337
ase	O	-1	20510337
activ@@	O	-1	20510337
it@@	O	-1	20510337
y@@	O	-1	20510337
),	O	-1	20510337
sup@@	O	-1	20510337
press@@	O	-1	20510337
ed	O	-1	20510337
li@@	O	-1	20510337
pid	O	-1	20510337
per@@	O	-1	20510337
oxid@@	O	-1	20510337
ation,	O	-1	20510337
decreased	O	-1	20510337
the	O	-1	20510337
elev@@	O	-1	20510337
ations	O	-1	20510337
of	O	-1	20510337
tumor	B-Disease	D009369	20510337
necro@@	B-Disease	D009336	20510337
sis	I-Disease	-1	20510337
fact@@	O	-1	20510337
or@@	O	-1	20510337
-@@	O	-1	20510337
alpha@@	O	-1	20510337
,	O	-1	20510337
nit@@	B-Chemical	D009569	20510337
ric	I-Chemical	-1	20510337
ox@@	I-Chemical	-1	20510337
ide	I-Chemical	-1	20510337
and	O	-1	20510337
pl@@	B-Chemical	D010984	20510337
at@@	I-Chemical	-1	20510337
in@@	I-Chemical	-1	20510337
um	I-Chemical	-1	20510337
i@@	O	-1	20510337
on	O	-1	20510337
concentr@@	O	-1	20510337
ation,	O	-1	20510337
and	O	-1	20510337
attenu@@	O	-1	20510337
ated	O	-1	20510337
the	O	-1	20510337
reduc@@	O	-1	20510337
tions	O	-1	20510337
of	O	-1	20510337
sel@@	B-Chemical	D012643	20510337
en@@	I-Chemical	-1	20510337
i@@	I-Chemical	-1	20510337
um	I-Chemical	-1	20510337
and	O	-1	20510337
z@@	B-Chemical	D015032	20510337
in@@	I-Chemical	-1	20510337
c	I-Chemical	-1	20510337
i@@	O	-1	20510337
ons	O	-1	20510337
in	O	-1	20510337
renal	O	-1	20510337
tissue	O	-1	20510337
resulted	O	-1	20510337
from	O	-1	20510337
cisplatin	B-Chemical	D002945	20510337
administr@@	O	-1	20510337
ation.	O	-1	20510337
Al@@	O	-1	20510337
so@@	O	-1	20510337
,	O	-1	20510337
histo@@	O	-1	20510337
path@@	O	-1	20510337
ological	O	-1	20510337
renal	B-Disease	D007674	20510337
tissue	I-Disease	-1	20510337
damage	I-Disease	-1	20510337
mediated	O	-1	20510337
by	O	-1	20510337
cisplatin	B-Chemical	D002945	20510337
was	O	-1	20510337
ame@@	O	-1	20510337
li@@	O	-1	20510337
or@@	O	-1	20510337
ated	O	-1	20510337
by	O	-1	20510337
co@@	B-Chemical	C024989	20510337
enzyme	I-Chemical	-1	20510337
Q@@	I-Chemical	-1	20510337
10	I-Chemical	-1	20510337
treatment.	O	-1	20510337
Im@@	O	-1	20510337
mun@@	O	-1	20510337
o@@	O	-1	20510337
histo@@	O	-1	20510337
chemical	O	-1	20510337
analysis	O	-1	20510337
revealed	O	-1	20510337
that	O	-1	20510337
co@@	B-Chemical	C024989	20510337
enzyme	I-Chemical	-1	20510337
Q@@	I-Chemical	-1	20510337
10	I-Chemical	-1	20510337
significantly	O	-1	20510337
decreased	O	-1	20510337
the	O	-1	20510337
cisplatin	B-Chemical	D002945	20510337
-induced	O	-1	20510337
o@@	O	-1	20510337
ve@@	O	-1	20510337
re@@	O	-1	20510337
x@@	O	-1	20510337
pression	O	-1	20510337
of	O	-1	20510337
induc@@	O	-1	20510337
i@@	O	-1	20510337
ble	O	-1	20510337
nit@@	B-Chemical	D009569	20510337
ric	I-Chemical	-1	20510337
ox@@	I-Chemical	-1	20510337
ide	I-Chemical	-1	20510337
syn@@	O	-1	20510337
th@@	O	-1	20510337
ase,	O	-1	20510337
nucle@@	O	-1	20510337
ar	O	-1	20510337
fact@@	O	-1	20510337
or@@	O	-1	20510337
-@@	O	-1	20510337
k@@	O	-1	20510337
appa@@	O	-1	20510337
B@@	O	-1	20510337
,	O	-1	20510337
cas@@	O	-1	20510337
p@@	O	-1	20510337
as@@	O	-1	20510337
e-@@	O	-1	20510337
3	O	-1	20510337
and	O	-1	20510337
p@@	O	-1	20510337
5@@	O	-1	20510337
3	O	-1	20510337
in	O	-1	20510337
renal	O	-1	20510337
tissu@@	O	-1	20510337
e.	O	-1	20510337
It	O	-1	20510337
was	O	-1	20510337
concl@@	O	-1	20510337
uded	O	-1	20510337
that	O	-1	20510337
co@@	B-Chemical	C024989	20510337
enzyme	I-Chemical	-1	20510337
Q@@	I-Chemical	-1	20510337
10	I-Chemical	-1	20510337
re@@	O	-1	20510337
pres@@	O	-1	20510337
ents	O	-1	20510337
a	O	-1	20510337
potential	O	-1	20510337
therapeutic	O	-1	20510337
op@@	O	-1	20510337
tion	O	-1	20510337
to	O	-1	20510337
prot@@	O	-1	20510337
ect	O	-1	20510337
against	O	-1	20510337
acute	O	-1	20510337
cisplatin	B-Chemical	D002945	20510337
nephro@@	B-Disease	D007674	20510337
toxicity	I-Disease	-1	20510337
common@@	O	-1	20510337
ly	O	-1	20510337
en@@	O	-1	20510337
coun@@	O	-1	20510337
te@@	O	-1	20510337
red	O	-1	20510337
in	O	-1	20510337
clinical	O	-1	20510337
p@@	O	-1	20510337
rac@@	O	-1	20510337
ti@@	O	-1	20510337
ce@@	O	-1	20510337
.	O	-1	20510337

M@@	B-Chemical	D008687	20164825
et@@	I-Chemical	-1	20164825
form@@	I-Chemical	-1	20164825
in	I-Chemical	-1	20164825
prev@@	O	-1	20164825
ents	O	-1	20164825
experimental	O	-1	20164825
g@@	B-Chemical	D005839	20164825
ent@@	I-Chemical	-1	20164825
am@@	I-Chemical	-1	20164825
icin	I-Chemical	-1	20164825
-induced	O	-1	20164825
nephro@@	B-Disease	D007674	20164825
pathy	I-Disease	-1	20164825
by	O	-1	20164825
a	O	-1	20164825
mitochond@@	O	-1	20164825
ri@@	O	-1	20164825
a@@	O	-1	20164825
-@@	O	-1	20164825
dependent	O	-1	20164825
path@@	O	-1	20164825
w@@	O	-1	20164825
a@@	O	-1	20164825
y.	O	-1	20164825
The	O	-1	20164825
anti@@	O	-1	20164825
dia@@	O	-1	20164825
be@@	O	-1	20164825
tic	O	-1	20164825
drug	O	-1	20164825
met@@	B-Chemical	D008687	20164825
form@@	I-Chemical	-1	20164825
in	I-Chemical	-1	20164825
can	O	-1	20164825
di@@	O	-1	20164825
min@@	O	-1	20164825
is@@	O	-1	20164825
h	O	-1	20164825
apo@@	O	-1	20164825
pto@@	O	-1	20164825
sis	O	-1	20164825
induced	O	-1	20164825
by	O	-1	20164825
oxid@@	O	-1	20164825
ative	O	-1	20164825
stres@@	O	-1	20164825
s	O	-1	20164825
in	O	-1	20164825
endothelial	O	-1	20164825
cells	O	-1	20164825
and	O	-1	20164825
prev@@	O	-1	20164825
ent	O	-1	20164825
vascular	B-Disease	D014652	20164825
dysfunction	I-Disease	-1	20164825
even	O	-1	20164825
in	O	-1	20164825
non@@	O	-1	20164825
dia@@	O	-1	20164825
be@@	O	-1	20164825
tic	O	-1	20164825
patients.	O	-1	20164825
H@@	O	-1	20164825
ere	O	-1	20164825
we	O	-1	20164825
tested	O	-1	20164825
whether	O	-1	20164825
it	O	-1	20164825
has	O	-1	20164825
a	O	-1	20164825
ben@@	O	-1	20164825
e@@	O	-1	20164825
fic@@	O	-1	20164825
ial	O	-1	20164825
effect	O	-1	20164825
in	O	-1	20164825
a	O	-1	20164825
rat	O	-1	20164825
model	O	-1	20164825
of	O	-1	20164825
g@@	B-Chemical	D005839	20164825
ent@@	I-Chemical	-1	20164825
am@@	I-Chemical	-1	20164825
icin	I-Chemical	-1	20164825
toxicity	B-Disease	D064420	20164825
.	O	-1	20164825
M@@	O	-1	20164825
it@@	O	-1	20164825
ochond@@	O	-1	20164825
rial	O	-1	20164825
analy@@	O	-1	20164825
sis,	O	-1	20164825
res@@	O	-1	20164825
pi@@	O	-1	20164825
ration	O	-1	20164825
int@@	O	-1	20164825
ens@@	O	-1	20164825
ity,	O	-1	20164825
levels	O	-1	20164825
of	O	-1	20164825
reac@@	O	-1	20164825
tive	O	-1	20164825
oxy@@	B-Chemical	D010100	20164825
gen	I-Chemical	-1	20164825
spec@@	O	-1	20164825
i@@	O	-1	20164825
es,	O	-1	20164825
per@@	O	-1	20164825
me@@	O	-1	20164825
ability	O	-1	20164825
transi@@	O	-1	20164825
tion,	O	-1	20164825
and	O	-1	20164825
cyto@@	O	-1	20164825
ch@@	O	-1	20164825
rom@@	O	-1	20164825
e	O	-1	20164825
c	O	-1	20164825
release	O	-1	20164825
were	O	-1	20164825
assessed	O	-1	20164825
3	O	-1	20164825
and	O	-1	20164825
6	O	-1	20164825
days	O	-1	20164825
after	O	-1	20164825
g@@	B-Chemical	D005839	20164825
ent@@	I-Chemical	-1	20164825
am@@	I-Chemical	-1	20164825
icin	I-Chemical	-1	20164825
administr@@	O	-1	20164825
ation.	O	-1	20164825
M@@	B-Chemical	D008687	20164825
et@@	I-Chemical	-1	20164825
form@@	I-Chemical	-1	20164825
in	I-Chemical	-1	20164825
treatment	O	-1	20164825
ful@@	O	-1	20164825
ly	O	-1	20164825
block@@	O	-1	20164825
ed	O	-1	20164825
g@@	B-Chemical	D005839	20164825
ent@@	I-Chemical	-1	20164825
am@@	I-Chemical	-1	20164825
icin	I-Chemical	-1	20164825
-@@	O	-1	20164825
mediated	O	-1	20164825
acute	B-Disease	D058186	20164825
renal	I-Disease	-1	20164825
failure	I-Disease	-1	20164825
.	O	-1	20164825
This	O	-1	20164825
was	O	-1	20164825
ac@@	O	-1	20164825
comp@@	O	-1	20164825
an@@	O	-1	20164825
ied	O	-1	20164825
by	O	-1	20164825
a	O	-1	20164825
lower	O	-1	20164825
activity	O	-1	20164825
of	O	-1	20164825
N@@	O	-1	20164825
-@@	O	-1	20164825
acet@@	O	-1	20164825
yl@@	O	-1	20164825
-@@	O	-1	20164825
beta-@@	O	-1	20164825
D-@@	O	-1	20164825
g@@	O	-1	20164825
lu@@	O	-1	20164825
co@@	O	-1	20164825
s@@	O	-1	20164825
amin@@	O	-1	20164825
id@@	O	-1	20164825
ase,	O	-1	20164825
to@@	O	-1	20164825
ge@@	O	-1	20164825
ther	O	-1	20164825
with	O	-1	20164825
a	O	-1	20164825
decrease	O	-1	20164825
of	O	-1	20164825
li@@	O	-1	20164825
pid	O	-1	20164825
per@@	O	-1	20164825
oxid@@	O	-1	20164825
ation	O	-1	20164825
and	O	-1	20164825
increase	O	-1	20164825
of	O	-1	20164825
anti@@	O	-1	20164825
oxid@@	O	-1	20164825
ant	O	-1	20164825
system@@	O	-1	20164825
s.	O	-1	20164825
M@@	B-Chemical	D008687	20164825
et@@	I-Chemical	-1	20164825
form@@	I-Chemical	-1	20164825
in	I-Chemical	-1	20164825
also	O	-1	20164825
prot@@	O	-1	20164825
ected	O	-1	20164825
the	O	-1	20164825
kidney	O	-1	20164825
from	O	-1	20164825
hist@@	O	-1	20164825
ological	O	-1	20164825
damage	O	-1	20164825
6	O	-1	20164825
days	O	-1	20164825
after	O	-1	20164825
g@@	B-Chemical	D005839	20164825
ent@@	I-Chemical	-1	20164825
am@@	I-Chemical	-1	20164825
icin	I-Chemical	-1	20164825
administr@@	O	-1	20164825
ation.	O	-1	20164825
These	O	-1	20164825
in	O	-1	20164825
viv@@	O	-1	20164825
o	O	-1	20164825
mark@@	O	-1	20164825
ers	O	-1	20164825
of	O	-1	20164825
kidney	B-Disease	D007674	20164825
dysfunction	I-Disease	-1	20164825
and	O	-1	20164825
their	O	-1	20164825
cor@@	O	-1	20164825
rec@@	O	-1	20164825
tion	O	-1	20164825
by	O	-1	20164825
met@@	B-Chemical	D008687	20164825
form@@	I-Chemical	-1	20164825
in	I-Chemical	-1	20164825
were	O	-1	20164825
comple@@	O	-1	20164825
ment@@	O	-1	20164825
ed	O	-1	20164825
by	O	-1	20164825
in	O	-1	20164825
vit@@	O	-1	20164825
r@@	O	-1	20164825
o	O	-1	20164825
studies	O	-1	20164825
of	O	-1	20164825
mitochondrial	O	-1	20164825
func@@	O	-1	20164825
tion.	O	-1	20164825
We	O	-1	20164825
found	O	-1	20164825
that	O	-1	20164825
g@@	B-Chemical	D005839	20164825
ent@@	I-Chemical	-1	20164825
am@@	I-Chemical	-1	20164825
icin	I-Chemical	-1	20164825
treatment	O	-1	20164825
deple@@	O	-1	20164825
ted	O	-1	20164825
respiratory	O	-1	20164825
comp@@	O	-1	20164825
on@@	O	-1	20164825
ents	O	-1	20164825
(@@	O	-1	20164825
cyto@@	O	-1	20164825
ch@@	O	-1	20164825
rom@@	O	-1	20164825
e	O	-1	20164825
c@@	O	-1	20164825
,	O	-1	20164825
N@@	O	-1	20164825
AD@@	O	-1	20164825
H@@	O	-1	20164825
),	O	-1	20164825
prob@@	O	-1	20164825
ably	O	-1	20164825
due	O	-1	20164825
to	O	-1	20164825
the	O	-1	20164825
o@@	O	-1	20164825
pen@@	O	-1	20164825
ing	O	-1	20164825
of	O	-1	20164825
mitochondrial	O	-1	20164825
transi@@	O	-1	20164825
tion	O	-1	20164825
po@@	O	-1	20164825
res@@	O	-1	20164825
.	O	-1	20164825
These	O	-1	20164825
injur@@	O	-1	20164825
i@@	O	-1	20164825
es,	O	-1	20164825
part@@	O	-1	20164825
ly	O	-1	20164825
mediated	O	-1	20164825
by	O	-1	20164825
a	O	-1	20164825
ri@@	O	-1	20164825
se	O	-1	20164825
in	O	-1	20164825
reac@@	O	-1	20164825
tive	O	-1	20164825
oxy@@	B-Chemical	D010100	20164825
gen	I-Chemical	-1	20164825
spec@@	O	-1	20164825
i@@	O	-1	20164825
es	O	-1	20164825
from	O	-1	20164825
the	O	-1	20164825
electro@@	O	-1	20164825
n	O	-1	20164825
trans@@	O	-1	20164825
f@@	O	-1	20164825
er	O	-1	20164825
ch@@	O	-1	20164825
ain@@	O	-1	20164825
,	O	-1	20164825
were	O	-1	20164825
significantly	O	-1	20164825
decreased	O	-1	20164825
by	O	-1	20164825
met@@	B-Chemical	D008687	20164825
form@@	I-Chemical	-1	20164825
in	I-Chemical	-1	20164825
.	O	-1	20164825
Th@@	O	-1	20164825
us,	O	-1	20164825
our	O	-1	20164825
study	O	-1	20164825
suggests	O	-1	20164825
that	O	-1	20164825
ple@@	O	-1	20164825
i@@	O	-1	20164825
ot@@	O	-1	20164825
ro@@	O	-1	20164825
p@@	O	-1	20164825
ic	O	-1	20164825
effects	O	-1	20164825
of	O	-1	20164825
met@@	B-Chemical	D008687	20164825
form@@	I-Chemical	-1	20164825
in	I-Chemical	-1	20164825
can	O	-1	20164825
l@@	O	-1	20164825
es@@	O	-1	20164825
se@@	O	-1	20164825
n	O	-1	20164825
g@@	B-Chemical	D005839	20164825
ent@@	I-Chemical	-1	20164825
am@@	I-Chemical	-1	20164825
icin	I-Chemical	-1	20164825
nephro@@	B-Disease	D007674	20164825
toxicity	I-Disease	-1	20164825
and	O	-1	20164825
impro@@	O	-1	20164825
ve	O	-1	20164825
mitochondrial	O	-1	20164825
ho@@	O	-1	20164825
me@@	O	-1	20164825
ost@@	O	-1	20164825
a@@	O	-1	20164825
sis.	O	-1	20164825

S@@	O	-1	20042557
ed@@	O	-1	20042557
ation	O	-1	20042557
de@@	O	-1	20042557
pt@@	O	-1	20042557
h	O	-1	20042557
during	O	-1	20042557
spinal	O	-1	20042557
anesthe@@	O	-1	20042557
sia	O	-1	20042557
and	O	-1	20042557
the	O	-1	20042557
development	O	-1	20042557
of	O	-1	20042557
postoperative	B-Disease	D011183	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
postoperative	B-Disease	D003693	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
in	O	-1	20042557
el@@	O	-1	20042557
der@@	O	-1	20042557
ly	O	-1	20042557
patients	O	-1	20042557
under@@	O	-1	20042557
go@@	O	-1	20042557
ing	O	-1	20042557
hi@@	B-Disease	D006620	20042557
p	I-Disease	-1	20042557
frac@@	I-Disease	-1	20042557
t@@	I-Disease	-1	20042557
ure	I-Disease	-1	20042557
re@@	O	-1	20042557
pa@@	O	-1	20042557
ir@@	O	-1	20042557
.	O	-1	20042557
OBJECTIVE:	O	-1	20042557
To	O	-1	20042557
determine	O	-1	20042557
whether	O	-1	20042557
lim@@	O	-1	20042557
it@@	O	-1	20042557
ing	O	-1	20042557
intra@@	O	-1	20042557
o@@	O	-1	20042557
perative	O	-1	20042557
sed@@	O	-1	20042557
ation	O	-1	20042557
de@@	O	-1	20042557
pt@@	O	-1	20042557
h	O	-1	20042557
during	O	-1	20042557
spinal	O	-1	20042557
anesthe@@	O	-1	20042557
sia	O	-1	20042557
for	O	-1	20042557
hi@@	B-Disease	D006620	20042557
p	I-Disease	-1	20042557
frac@@	I-Disease	-1	20042557
t@@	I-Disease	-1	20042557
ure	I-Disease	-1	20042557
re@@	O	-1	20042557
pa@@	O	-1	20042557
ir	O	-1	20042557
in	O	-1	20042557
el@@	O	-1	20042557
der@@	O	-1	20042557
ly	O	-1	20042557
patients	O	-1	20042557
can	O	-1	20042557
decrease	O	-1	20042557
the	O	-1	20042557
prev@@	O	-1	20042557
al@@	O	-1	20042557
ence	O	-1	20042557
of	O	-1	20042557
postoperative	B-Disease	D011183	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
postoperative	B-Disease	D003693	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
.	O	-1	20042557
PA@@	O	-1	20042557
TI@@	O	-1	20042557
E@@	O	-1	20042557
N@@	O	-1	20042557
T@@	O	-1	20042557
S	O	-1	20042557
AN@@	O	-1	20042557
D	O	-1	20042557
METHODS:	O	-1	20042557
We	O	-1	20042557
performed	O	-1	20042557
a	O	-1	20042557
double-bl@@	O	-1	20042557
ind@@	O	-1	20042557
,	O	-1	20042557
randomized	O	-1	20042557
controlled	O	-1	20042557
trial	O	-1	20042557
at	O	-1	20042557
an	O	-1	20042557
ac@@	O	-1	20042557
ade@@	O	-1	20042557
mic	O	-1	20042557
med@@	O	-1	20042557
ical	O	-1	20042557
c@@	O	-1	20042557
ent@@	O	-1	20042557
er	O	-1	20042557
of	O	-1	20042557
el@@	O	-1	20042557
der@@	O	-1	20042557
ly	O	-1	20042557
patients	O	-1	20042557
(@@	O	-1	20042557
>@@	O	-1	20042557
or@@	O	-1	20042557
=@@	O	-1	20042557
6@@	O	-1	20042557
5	O	-1	20042557
year@@	O	-1	20042557
s)	O	-1	20042557
without	O	-1	20042557
pre@@	O	-1	20042557
o@@	O	-1	20042557
perative	O	-1	20042557
de@@	B-Disease	D003693	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
or	O	-1	20042557
severe	O	-1	20042557
de@@	B-Disease	D003704	20042557
m@@	I-Disease	-1	20042557
enti@@	I-Disease	-1	20042557
a	I-Disease	-1	20042557
who	O	-1	20042557
under@@	O	-1	20042557
w@@	O	-1	20042557
ent	O	-1	20042557
hi@@	B-Disease	D006620	20042557
p	I-Disease	-1	20042557
frac@@	I-Disease	-1	20042557
t@@	I-Disease	-1	20042557
ure	I-Disease	-1	20042557
re@@	O	-1	20042557
pa@@	O	-1	20042557
ir	O	-1	20042557
under	O	-1	20042557
spinal	O	-1	20042557
anesthe@@	O	-1	20042557
sia	O	-1	20042557
with	O	-1	20042557
pro@@	B-Chemical	D015742	20042557
po@@	I-Chemical	-1	20042557
f@@	I-Chemical	-1	20042557
ol	I-Chemical	-1	20042557
sed@@	O	-1	20042557
ation.	O	-1	20042557
S@@	O	-1	20042557
ed@@	O	-1	20042557
ation	O	-1	20042557
de@@	O	-1	20042557
pt@@	O	-1	20042557
h	O	-1	20042557
was	O	-1	20042557
ti@@	O	-1	20042557
tr@@	O	-1	20042557
ated	O	-1	20042557
using	O	-1	20042557
pro@@	O	-1	20042557
cess@@	O	-1	20042557
ed	O	-1	20042557
electro@@	O	-1	20042557
encephalo@@	O	-1	20042557
graph@@	O	-1	20042557
y	O	-1	20042557
with	O	-1	20042557
the	O	-1	20042557
b@@	O	-1	20042557
is@@	O	-1	20042557
p@@	O	-1	20042557
ect@@	O	-1	20042557
ral	O	-1	20042557
in@@	O	-1	20042557
de@@	O	-1	20042557
x	O	-1	20042557
(B@@	O	-1	20042557
I@@	O	-1	20042557
S@@	O	-1	20042557
),	O	-1	20042557
and	O	-1	20042557
patients	O	-1	20042557
were	O	-1	20042557
randomized	O	-1	20042557
to	O	-1	20042557
recei@@	O	-1	20042557
ve	O	-1	20042557
either	O	-1	20042557
de@@	O	-1	20042557
ep	O	-1	20042557
(B@@	O	-1	20042557
I@@	O	-1	20042557
S@@	O	-1	20042557
,	O	-1	20042557
appro@@	O	-1	20042557
xim@@	O	-1	20042557
ately	O	-1	20042557
50@@	O	-1	20042557
)	O	-1	20042557
or	O	-1	20042557
li@@	O	-1	20042557
ght	O	-1	20042557
(B@@	O	-1	20042557
I@@	O	-1	20042557
S@@	O	-1	20042557
,	O	-1	20042557
>@@	O	-1	20042557
or@@	O	-1	20042557
=@@	O	-1	20042557
80@@	O	-1	20042557
)	O	-1	20042557
sed@@	O	-1	20042557
ation.	O	-1	20042557
P@@	B-Disease	D011183	20042557
o@@	I-Disease	-1	20042557
sto@@	I-Disease	-1	20042557
perative	I-Disease	-1	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
P@@	B-Disease	D003693	20042557
o@@	I-Disease	-1	20042557
sto@@	I-Disease	-1	20042557
perative	I-Disease	-1	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
was	O	-1	20042557
assessed	O	-1	20042557
as	O	-1	20042557
def@@	O	-1	20042557
in@@	O	-1	20042557
ed	O	-1	20042557
by	O	-1	20042557
Di@@	O	-1	20042557
ag@@	O	-1	20042557
nos@@	O	-1	20042557
tic	O	-1	20042557
and	O	-1	20042557
S@@	O	-1	20042557
t@@	O	-1	20042557
atis@@	O	-1	20042557
tical	O	-1	20042557
M@@	O	-1	20042557
an@@	O	-1	20042557
ual	O	-1	20042557
of	O	-1	20042557
M@@	B-Disease	D001523	20042557
ental	I-Disease	-1	20042557
D@@	I-Disease	-1	20042557
is@@	I-Disease	-1	20042557
or@@	I-Disease	-1	20042557
der@@	I-Disease	-1	20042557
s	I-Disease	-1	20042557
(@@	O	-1	20042557
Th@@	O	-1	20042557
ir@@	O	-1	20042557
d	O	-1	20042557
E@@	O	-1	20042557
di@@	O	-1	20042557
tion	O	-1	20042557
Re@@	O	-1	20042557
vi@@	O	-1	20042557
sed@@	O	-1	20042557
)	O	-1	20042557
c@@	O	-1	20042557
rit@@	O	-1	20042557
er@@	O	-1	20042557
ia	O	-1	20042557
using	O	-1	20042557
the	O	-1	20042557
Con@@	O	-1	20042557
f@@	O	-1	20042557
usion	O	-1	20042557
A@@	O	-1	20042557
s@@	O	-1	20042557
s@@	O	-1	20042557
ess@@	O	-1	20042557
ment	O	-1	20042557
M@@	O	-1	20042557
eth@@	O	-1	20042557
od	O	-1	20042557
be@@	O	-1	20042557
g@@	O	-1	20042557
in@@	O	-1	20042557
ning	O	-1	20042557
at	O	-1	20042557
any	O	-1	20042557
time	O	-1	20042557
from	O	-1	20042557
the	O	-1	20042557
second	O	-1	20042557
day	O	-1	20042557
after	O	-1	20042557
surger@@	O	-1	20042557
y.	O	-1	20042557
RESULTS:	O	-1	20042557
F@@	O	-1	20042557
rom	O	-1	20042557
A@@	O	-1	20042557
pri@@	O	-1	20042557
l	O	-1	20042557
2,	O	-1	20042557
20@@	O	-1	20042557
0@@	O	-1	20042557
5,	O	-1	20042557
through	O	-1	20042557
O@@	O	-1	20042557
c@@	O	-1	20042557
to@@	O	-1	20042557
b@@	O	-1	20042557
er	O	-1	20042557
3@@	O	-1	20042557
0@@	O	-1	20042557
,	O	-1	20042557
20@@	O	-1	20042557
0@@	O	-1	20042557
8@@	O	-1	20042557
,	O	-1	20042557
a	O	-1	20042557
total	O	-1	20042557
of	O	-1	20042557
1@@	O	-1	20042557
14	O	-1	20042557
patients	O	-1	20042557
were	O	-1	20042557
random@@	O	-1	20042557
iz@@	O	-1	20042557
ed.	O	-1	20042557
The	O	-1	20042557
prev@@	O	-1	20042557
al@@	O	-1	20042557
ence	O	-1	20042557
of	O	-1	20042557
postoperative	B-Disease	D011183	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
postoperative	B-Disease	D003693	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
was	O	-1	20042557
significantly	O	-1	20042557
lower	O	-1	20042557
in	O	-1	20042557
the	O	-1	20042557
li@@	O	-1	20042557
ght	O	-1	20042557
sed@@	O	-1	20042557
ation	O	-1	20042557
group	O	-1	20042557
(1@@	O	-1	20042557
1@@	O	-1	20042557
/@@	O	-1	20042557
5@@	O	-1	20042557
7	O	-1	20042557
[@@	O	-1	20042557
19@@	O	-1	20042557
%@@	O	-1	20042557
]	O	-1	20042557
v@@	O	-1	20042557
s	O	-1	20042557
2@@	O	-1	20042557
3@@	O	-1	20042557
/@@	O	-1	20042557
5@@	O	-1	20042557
7	O	-1	20042557
[@@	O	-1	20042557
4@@	O	-1	20042557
0@@	O	-1	20042557
%@@	O	-1	20042557
]	O	-1	20042557
in	O	-1	20042557
the	O	-1	20042557
de@@	O	-1	20042557
ep	O	-1	20042557
sed@@	O	-1	20042557
ation	O	-1	20042557
group@@	O	-1	20042557
;	O	-1	20042557
P@@	O	-1	20042557
=@@	O	-1	20042557
.@@	O	-1	20042557
0@@	O	-1	20042557
2@@	O	-1	20042557
),	O	-1	20042557
indicating	O	-1	20042557
that	O	-1	20042557
1	O	-1	20042557
inc@@	O	-1	20042557
id@@	O	-1	20042557
ent	O	-1	20042557
of	O	-1	20042557
de@@	B-Disease	D003693	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
wil@@	O	-1	20042557
l	O	-1	20042557
be	O	-1	20042557
prevent@@	O	-1	20042557
ed	O	-1	20042557
for	O	-1	20042557
every	O	-1	20042557
4.@@	O	-1	20042557
7	O	-1	20042557
patients	O	-1	20042557
treated	O	-1	20042557
with	O	-1	20042557
li@@	O	-1	20042557
ght	O	-1	20042557
sed@@	O	-1	20042557
ation.	O	-1	20042557
The	O	-1	20042557
mean	O	-1	20042557
+/-	O	-1	20042557
S@@	O	-1	20042557
D	O	-1	20042557
number	O	-1	20042557
of	O	-1	20042557
days	O	-1	20042557
of	O	-1	20042557
de@@	B-Disease	D003693	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
during	O	-1	20042557
hospit@@	O	-1	20042557
al@@	O	-1	20042557
ization	O	-1	20042557
was	O	-1	20042557
lower	O	-1	20042557
in	O	-1	20042557
the	O	-1	20042557
li@@	O	-1	20042557
ght	O	-1	20042557
sed@@	O	-1	20042557
ation	O	-1	20042557
group	O	-1	20042557
than	O	-1	20042557
in	O	-1	20042557
the	O	-1	20042557
de@@	O	-1	20042557
ep	O	-1	20042557
sed@@	O	-1	20042557
ation	O	-1	20042557
group	O	-1	20042557
(0.@@	O	-1	20042557
5@@	O	-1	20042557
+/-@@	O	-1	20042557
1.@@	O	-1	20042557
5	O	-1	20042557
days	O	-1	20042557
v@@	O	-1	20042557
s	O	-1	20042557
1.@@	O	-1	20042557
4@@	O	-1	20042557
+/-@@	O	-1	20042557
4.@@	O	-1	20042557
0	O	-1	20042557
da@@	O	-1	20042557
ys@@	O	-1	20042557
;	O	-1	20042557
P@@	O	-1	20042557
=@@	O	-1	20042557
.@@	O	-1	20042557
0@@	O	-1	20042557
1).	O	-1	20042557
CONCLUSION:	O	-1	20042557
The	O	-1	20042557
use	O	-1	20042557
of	O	-1	20042557
li@@	O	-1	20042557
ght	O	-1	20042557
pro@@	B-Chemical	D015742	20042557
po@@	I-Chemical	-1	20042557
f@@	I-Chemical	-1	20042557
ol	I-Chemical	-1	20042557
sed@@	O	-1	20042557
ation	O	-1	20042557
decreased	O	-1	20042557
the	O	-1	20042557
prev@@	O	-1	20042557
al@@	O	-1	20042557
ence	O	-1	20042557
of	O	-1	20042557
postoperative	B-Disease	D011183	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
postoperative	B-Disease	D003693	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
by	O	-1	20042557
50@@	O	-1	20042557
%	O	-1	20042557
compared	O	-1	20042557
with	O	-1	20042557
de@@	O	-1	20042557
ep	O	-1	20042557
sed@@	O	-1	20042557
ation.	O	-1	20042557
L@@	O	-1	20042557
im@@	O	-1	20042557
it@@	O	-1	20042557
ing	O	-1	20042557
de@@	O	-1	20042557
pt@@	O	-1	20042557
h	O	-1	20042557
of	O	-1	20042557
sed@@	O	-1	20042557
ation	O	-1	20042557
during	O	-1	20042557
spinal	O	-1	20042557
anesthe@@	O	-1	20042557
sia	O	-1	20042557
is	O	-1	20042557
a	O	-1	20042557
sim@@	O	-1	20042557
ple@@	O	-1	20042557
,	O	-1	20042557
saf@@	O	-1	20042557
e,	O	-1	20042557
and	O	-1	20042557
co@@	O	-1	20042557
st@@	O	-1	20042557
-@@	O	-1	20042557
effective	O	-1	20042557
inter@@	O	-1	20042557
ven@@	O	-1	20042557
tion	O	-1	20042557
for	O	-1	20042557
prevent@@	O	-1	20042557
ing	O	-1	20042557
postoperative	B-Disease	D011183	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
postoperative	B-Disease	D003693	20042557
de@@	I-Disease	-1	20042557
li@@	I-Disease	-1	20042557
ri@@	I-Disease	-1	20042557
um	I-Disease	-1	20042557
in	O	-1	20042557
el@@	O	-1	20042557
der@@	O	-1	20042557
ly	O	-1	20042557
patients	O	-1	20042557
that	O	-1	20042557
could	O	-1	20042557
be	O	-1	20042557
wi@@	O	-1	20042557
de@@	O	-1	20042557
ly	O	-1	20042557
and	O	-1	20042557
re@@	O	-1	20042557
a@@	O	-1	20042557
di@@	O	-1	20042557
ly	O	-1	20042557
ad@@	O	-1	20042557
op@@	O	-1	20042557
ted.	O	-1	20042557

S@@	B-Chemical	C471405	19944333
or@@	I-Chemical	-1	19944333
af@@	I-Chemical	-1	19944333
en@@	I-Chemical	-1	19944333
i@@	I-Chemical	-1	19944333
b	I-Chemical	-1	19944333
-induced	O	-1	19944333
acute	O	-1	19944333
myocardial	B-Disease	D009203	19944333
infarction	I-Disease	-1	19944333
due	O	-1	19944333
to	O	-1	19944333
coronary	B-Disease	D003329	19944333
artery	I-Disease	-1	19944333
sp@@	I-Disease	-1	19944333
as@@	I-Disease	-1	19944333
m	I-Disease	-1	19944333
.	O	-1	19944333
A	O	-1	19944333
6@@	O	-1	19944333
5-@@	O	-1	19944333
year-old	O	-1	19944333
man	O	-1	19944333
with	O	-1	19944333
adv@@	O	-1	19944333
anced	O	-1	19944333
renal	B-Disease	D002292	19944333
cell	I-Disease	-1	19944333
carcin@@	I-Disease	-1	19944333
oma	I-Disease	-1	19944333
was	O	-1	19944333
ad@@	O	-1	19944333
mit@@	O	-1	19944333
ted	O	-1	19944333
due	O	-1	19944333
to	O	-1	19944333
continu@@	O	-1	19944333
ing	O	-1	19944333
ch@@	B-Disease	D002637	19944333
est	I-Disease	-1	19944333
pain	I-Disease	-1	19944333
at	O	-1	19944333
rest@@	O	-1	19944333
.	O	-1	19944333
Two	O	-1	19944333
weeks	O	-1	19944333
before	O	-1	19944333
h@@	O	-1	19944333
is	O	-1	19944333
ad@@	O	-1	19944333
mis@@	O	-1	19944333
sion,	O	-1	19944333
s@@	B-Chemical	C471405	19944333
or@@	I-Chemical	-1	19944333
af@@	I-Chemical	-1	19944333
en@@	I-Chemical	-1	19944333
i@@	I-Chemical	-1	19944333
b	I-Chemical	-1	19944333
had	O	-1	19944333
been	O	-1	19944333
star@@	O	-1	19944333
ted.	O	-1	19944333
H@@	O	-1	19944333
e	O	-1	19944333
was	O	-1	19944333
diagnos@@	O	-1	19944333
ed	O	-1	19944333
with	O	-1	19944333
non-@@	O	-1	19944333
S@@	O	-1	19944333
T@@	O	-1	19944333
-@@	O	-1	19944333
elev@@	O	-1	19944333
ation	O	-1	19944333
myocardial	B-Disease	D009203	19944333
infarction	I-Disease	-1	19944333
by	O	-1	19944333
labor@@	O	-1	19944333
atory	O	-1	19944333
data	O	-1	19944333
and	O	-1	19944333
electro@@	O	-1	19944333
cardio@@	O	-1	19944333
gram@@	O	-1	19944333
.	O	-1	19944333
E@@	O	-1	19944333
n@@	O	-1	19944333
h@@	O	-1	19944333
anced	O	-1	19944333
heart	O	-1	19944333
mag@@	O	-1	19944333
ne@@	O	-1	19944333
tic	O	-1	19944333
res@@	O	-1	19944333
on@@	O	-1	19944333
ance	O	-1	19944333
imaging	O	-1	19944333
also	O	-1	19944333
showed	O	-1	19944333
sub@@	B-Disease	D009203	19944333
en@@	I-Disease	-1	19944333
d@@	I-Disease	-1	19944333
ocardi@@	I-Disease	-1	19944333
al	I-Disease	-1	19944333
infarction	I-Disease	-1	19944333
.	O	-1	19944333
However,	O	-1	19944333
there	O	-1	19944333
was	O	-1	19944333
no	O	-1	19944333
st@@	O	-1	19944333
en@@	O	-1	19944333
o@@	O	-1	19944333
sis	O	-1	19944333
in	O	-1	19944333
coronary	O	-1	19944333
arter@@	O	-1	19944333
i@@	O	-1	19944333
es	O	-1	19944333
on	O	-1	19944333
angio@@	O	-1	19944333
graph@@	O	-1	19944333
y.	O	-1	19944333
C@@	B-Disease	D003329	19944333
or@@	I-Disease	-1	19944333
onary	I-Disease	-1	19944333
artery	I-Disease	-1	19944333
sp@@	I-Disease	-1	19944333
as@@	I-Disease	-1	19944333
m	I-Disease	-1	19944333
was	O	-1	19944333
induced	O	-1	19944333
by	O	-1	19944333
a	O	-1	19944333
prov@@	O	-1	19944333
oc@@	O	-1	19944333
ative	O	-1	19944333
test@@	O	-1	19944333
.	O	-1	19944333
C@@	O	-1	19944333
ess@@	O	-1	19944333
ation	O	-1	19944333
of	O	-1	19944333
s@@	B-Chemical	C471405	19944333
or@@	I-Chemical	-1	19944333
af@@	I-Chemical	-1	19944333
en@@	I-Chemical	-1	19944333
i@@	I-Chemical	-1	19944333
b	I-Chemical	-1	19944333
and	O	-1	19944333
administration	O	-1	19944333
of	O	-1	19944333
C@@	B-Chemical	D002118	19944333
a	I-Chemical	-1	19944333
-@@	O	-1	19944333
channel	O	-1	19944333
block@@	O	-1	19944333
er	O	-1	19944333
and	O	-1	19944333
nit@@	B-Chemical	D009566	19944333
rat@@	I-Chemical	-1	19944333
es	I-Chemical	-1	19944333
ame@@	O	-1	19944333
li@@	O	-1	19944333
or@@	O	-1	19944333
ated	O	-1	19944333
h@@	O	-1	19944333
is	O	-1	19944333
symptom@@	O	-1	19944333
s,	O	-1	19944333
but	O	-1	19944333
rel@@	O	-1	19944333
ap@@	O	-1	19944333
se	O	-1	19944333
occurred	O	-1	19944333
after	O	-1	19944333
res@@	O	-1	19944333
um@@	O	-1	19944333
ption	O	-1	19944333
of	O	-1	19944333
s@@	B-Chemical	C471405	19944333
or@@	I-Chemical	-1	19944333
af@@	I-Chemical	-1	19944333
en@@	I-Chemical	-1	19944333
i@@	I-Chemical	-1	19944333
b	I-Chemical	-1	19944333
.	O	-1	19944333
Ad@@	O	-1	19944333
di@@	O	-1	19944333
tion	O	-1	19944333
of	O	-1	19944333
oral	O	-1	19944333
n@@	B-Chemical	D020108	19944333
ic@@	I-Chemical	-1	19944333
or@@	I-Chemical	-1	19944333
an@@	I-Chemical	-1	19944333
di@@	I-Chemical	-1	19944333
l	I-Chemical	-1	19944333
reduced	O	-1	19944333
h@@	O	-1	19944333
is	O	-1	19944333
symptoms	O	-1	19944333
and	O	-1	19944333
maint@@	O	-1	19944333
ained	O	-1	19944333
st@@	B-Disease	D060050	19944333
able	I-Disease	-1	19944333
ang@@	I-Disease	-1	19944333
in@@	I-Disease	-1	19944333
a	I-Disease	-1	19944333
stat@@	O	-1	19944333
us.	O	-1	19944333
We	O	-1	19944333
report	O	-1	19944333
the	O	-1	19944333
first	O	-1	19944333
case	O	-1	19944333
of	O	-1	19944333
s@@	B-Chemical	C471405	19944333
or@@	I-Chemical	-1	19944333
af@@	I-Chemical	-1	19944333
en@@	I-Chemical	-1	19944333
i@@	I-Chemical	-1	19944333
b	I-Chemical	-1	19944333
-induced	O	-1	19944333
coronary	B-Disease	D003329	19944333
artery	I-Disease	-1	19944333
sp@@	I-Disease	-1	19944333
as@@	I-Disease	-1	19944333
m	I-Disease	-1	19944333
.	O	-1	19944333
S@@	B-Chemical	C471405	19944333
or@@	I-Chemical	-1	19944333
af@@	I-Chemical	-1	19944333
en@@	I-Chemical	-1	19944333
i@@	I-Chemical	-1	19944333
b	I-Chemical	-1	19944333
is	O	-1	19944333
a	O	-1	19944333
multi@@	O	-1	19944333
kin@@	O	-1	19944333
ase	O	-1	19944333
inhibitor	O	-1	19944333
that	O	-1	19944333
t@@	O	-1	19944333
arg@@	O	-1	19944333
et@@	O	-1	19944333
s	O	-1	19944333
sign@@	O	-1	19944333
al@@	O	-1	19944333
ing	O	-1	19944333
path@@	O	-1	19944333
w@@	O	-1	19944333
ays	O	-1	19944333
nec@@	O	-1	19944333
ess@@	O	-1	19944333
ary	O	-1	19944333
for	O	-1	19944333
cell@@	O	-1	19944333
ular	O	-1	19944333
pro@@	O	-1	19944333
li@@	O	-1	19944333
fer@@	O	-1	19944333
ation	O	-1	19944333
and	O	-1	19944333
sur@@	O	-1	19944333
vi@@	O	-1	19944333
val@@	O	-1	19944333
.	O	-1	19944333
O@@	O	-1	19944333
n	O	-1	19944333
the	O	-1	19944333
other	O	-1	19944333
h@@	O	-1	19944333
and@@	O	-1	19944333
,	O	-1	19944333
the	O	-1	19944333
R@@	O	-1	19944333
ho@@	O	-1	19944333
/@@	O	-1	19944333
RO@@	O	-1	19944333
C@@	O	-1	19944333
K	O	-1	19944333
path@@	O	-1	19944333
w@@	O	-1	19944333
ay	O	-1	19944333
has	O	-1	19944333
an	O	-1	19944333
important	O	-1	19944333
role	O	-1	19944333
in	O	-1	19944333
the	O	-1	19944333
path@@	O	-1	19944333
o@@	O	-1	19944333
genesis	O	-1	19944333
of	O	-1	19944333
coronary	B-Disease	D003329	19944333
artery	I-Disease	-1	19944333
sp@@	I-Disease	-1	19944333
as@@	I-Disease	-1	19944333
m	I-Disease	-1	19944333
.	O	-1	19944333
Our	O	-1	19944333
report	O	-1	19944333
may	O	-1	19944333
show	O	-1	19944333
an	O	-1	19944333
adverse	O	-1	19944333
effect	O	-1	19944333
on	O	-1	19944333
the	O	-1	19944333
R@@	O	-1	19944333
ho@@	O	-1	19944333
/@@	O	-1	19944333
RO@@	O	-1	19944333
C@@	O	-1	19944333
K	O	-1	19944333
path@@	O	-1	19944333
w@@	O	-1	19944333
ay	O	-1	19944333
by	O	-1	19944333
s@@	B-Chemical	C471405	19944333
or@@	I-Chemical	-1	19944333
af@@	I-Chemical	-1	19944333
en@@	I-Chemical	-1	19944333
i@@	I-Chemical	-1	19944333
b	I-Chemical	-1	19944333
use.	O	-1	19944333

An@@	O	-1	17975693
x@@	O	-1	17975693
io@@	O	-1	17975693
genic	O	-1	17975693
potential	O	-1	17975693
of	O	-1	17975693
ci@@	B-Chemical	D002939	17975693
prof@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
and	O	-1	17975693
nor@@	B-Chemical	D009643	17975693
f@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
in	O	-1	17975693
rats.	O	-1	17975693
IN@@	O	-1	17975693
T@@	O	-1	17975693
RO@@	O	-1	17975693
D@@	O	-1	17975693
U@@	O	-1	17975693
C@@	O	-1	17975693
T@@	O	-1	17975693
ION@@	O	-1	17975693
:	O	-1	17975693
The	O	-1	17975693
possible	O	-1	17975693
an@@	O	-1	17975693
x@@	O	-1	17975693
io@@	O	-1	17975693
genic	O	-1	17975693
effects	O	-1	17975693
of	O	-1	17975693
fluoro@@	B-Chemical	D024841	17975693
qu@@	I-Chemical	-1	17975693
in@@	I-Chemical	-1	17975693
ol@@	I-Chemical	-1	17975693
on@@	I-Chemical	-1	17975693
es	I-Chemical	-1	17975693
,	O	-1	17975693
n@@	O	-1	17975693
ame@@	O	-1	17975693
ly	O	-1	17975693
ci@@	B-Chemical	D002939	17975693
prof@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
and	O	-1	17975693
nor@@	B-Chemical	D009643	17975693
f@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
,	O	-1	17975693
were	O	-1	17975693
investigated	O	-1	17975693
in	O	-1	17975693
ad@@	O	-1	17975693
ult	O	-1	17975693
Ch@@	O	-1	17975693
ar@@	O	-1	17975693
le@@	O	-1	17975693
s	O	-1	17975693
F@@	O	-1	17975693
ost@@	O	-1	17975693
er	O	-1	17975693
al@@	O	-1	17975693
bin@@	O	-1	17975693
o	O	-1	17975693
rats	O	-1	17975693
of	O	-1	17975693
either	O	-1	17975693
sex@@	O	-1	17975693
,	O	-1	17975693
weigh@@	O	-1	17975693
ing	O	-1	17975693
1@@	O	-1	17975693
50@@	O	-1	17975693
-@@	O	-1	17975693
2@@	O	-1	17975693
00	O	-1	17975693
g@@	O	-1	17975693
.	O	-1	17975693
METHODS:	O	-1	17975693
The	O	-1	17975693
drugs	O	-1	17975693
were	O	-1	17975693
given	O	-1	17975693
or@@	O	-1	17975693
ally,	O	-1	17975693
in	O	-1	17975693
doses	O	-1	17975693
of	O	-1	17975693
50	O	-1	17975693
mg/kg	O	-1	17975693
for	O	-1	17975693
five	O	-1	17975693
con@@	O	-1	17975693
sec@@	O	-1	17975693
utive	O	-1	17975693
days	O	-1	17975693
and	O	-1	17975693
the	O	-1	17975693
experim@@	O	-1	17975693
ents	O	-1	17975693
were	O	-1	17975693
performed	O	-1	17975693
on	O	-1	17975693
the	O	-1	17975693
f@@	O	-1	17975693
if@@	O	-1	17975693
th	O	-1	17975693
da@@	O	-1	17975693
y.	O	-1	17975693
The	O	-1	17975693
tests	O	-1	17975693
included	O	-1	17975693
o@@	O	-1	17975693
pen@@	O	-1	17975693
-@@	O	-1	17975693
fi@@	O	-1	17975693
el@@	O	-1	17975693
d	O	-1	17975693
expl@@	O	-1	17975693
or@@	O	-1	17975693
atory	O	-1	17975693
behavi@@	O	-1	17975693
o@@	O	-1	17975693
ur@@	O	-1	17975693
,	O	-1	17975693
elevated	O	-1	17975693
plus	O	-1	17975693
ma@@	O	-1	17975693
ze	O	-1	17975693
and	O	-1	17975693
elevated	O	-1	17975693
z@@	O	-1	17975693
er@@	O	-1	17975693
o	O	-1	17975693
ma@@	O	-1	17975693
z@@	O	-1	17975693
e,	O	-1	17975693
s@@	O	-1	17975693
oci@@	O	-1	17975693
al	O	-1	17975693
inter@@	O	-1	17975693
action	O	-1	17975693
and	O	-1	17975693
no@@	O	-1	17975693
vel@@	O	-1	17975693
ty-@@	O	-1	17975693
sup@@	O	-1	17975693
press@@	O	-1	17975693
ed	O	-1	17975693
fe@@	O	-1	17975693
ed@@	O	-1	17975693
ing	O	-1	17975693
lat@@	O	-1	17975693
ency	O	-1	17975693
behavi@@	O	-1	17975693
o@@	O	-1	17975693
ur@@	O	-1	17975693
.	O	-1	17975693
RESULTS:	O	-1	17975693
The	O	-1	17975693
results	O	-1	17975693
indicate	O	-1	17975693
that	O	-1	17975693
ci@@	B-Chemical	D002939	17975693
prof@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
-	O	-1	17975693
and	O	-1	17975693
nor@@	B-Chemical	D009643	17975693
f@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
-treated	O	-1	17975693
rats	O	-1	17975693
showed	O	-1	17975693
an@@	B-Disease	D001008	17975693
xi@@	I-Disease	-1	17975693
ous	I-Disease	-1	17975693
behavi@@	I-Disease	-1	17975693
our	I-Disease	-1	17975693
in	O	-1	17975693
compar@@	O	-1	17975693
ison	O	-1	17975693
to	O	-1	17975693
control	O	-1	17975693
rats	O	-1	17975693
in	O	-1	17975693
all	O	-1	17975693
the	O	-1	17975693
par@@	O	-1	17975693
ame@@	O	-1	17975693
ters	O	-1	17975693
studi@@	O	-1	17975693
ed.	O	-1	17975693
However,	O	-1	17975693
ci@@	B-Chemical	D002939	17975693
prof@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
-	O	-1	17975693
and	O	-1	17975693
nor@@	B-Chemical	D009643	17975693
f@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
-treated	O	-1	17975693
rats	O	-1	17975693
did	O	-1	17975693
not	O	-1	17975693
diff@@	O	-1	17975693
er	O	-1	17975693
significantly	O	-1	17975693
from	O	-1	17975693
each	O	-1	17975693
other	O	-1	17975693
in	O	-1	17975693
various	O	-1	17975693
behavi@@	O	-1	17975693
o@@	O	-1	17975693
ural	O	-1	17975693
par@@	O	-1	17975693
ame@@	O	-1	17975693
ter@@	O	-1	17975693
s.	O	-1	17975693
CONCLUSION:	O	-1	17975693
The	O	-1	17975693
present	O	-1	17975693
experimental	O	-1	17975693
findings	O	-1	17975693
subst@@	O	-1	17975693
anti@@	O	-1	17975693
ate	O	-1	17975693
the	O	-1	17975693
clin@@	O	-1	17975693
ically	O	-1	17975693
observed	O	-1	17975693
an@@	O	-1	17975693
x@@	O	-1	17975693
io@@	O	-1	17975693
genic	O	-1	17975693
potential	O	-1	17975693
of	O	-1	17975693
ci@@	B-Chemical	D002939	17975693
prof@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
and	O	-1	17975693
nor@@	B-Chemical	D009643	17975693
f@@	I-Chemical	-1	17975693
lo@@	I-Chemical	-1	17975693
x@@	I-Chemical	-1	17975693
ac@@	I-Chemical	-1	17975693
in	I-Chemical	-1	17975693
.	O	-1	17975693

M@@	O	-1	17943461
y@@	O	-1	17943461
ocardi@@	O	-1	17943461
al	O	-1	17943461
F@@	O	-1	17943461
as	O	-1	17943461
li@@	O	-1	17943461
g@@	O	-1	17943461
and	O	-1	17943461
expression	O	-1	17943461
increases	O	-1	17943461
sus@@	O	-1	17943461
cep@@	O	-1	17943461
ti@@	O	-1	17943461
b@@	O	-1	17943461
ility	O	-1	17943461
to	O	-1	17943461
A@@	B-Chemical	D015215	17943461
Z@@	I-Chemical	-1	17943461
T	I-Chemical	-1	17943461
-induced	O	-1	17943461
cardi@@	B-Disease	D009202	17943461
om@@	I-Disease	-1	17943461
yo@@	I-Disease	-1	17943461
pathy	I-Disease	-1	17943461
.	O	-1	17943461
BACKGROUND:	O	-1	17943461
D@@	B-Disease	D002311	17943461
il@@	I-Disease	-1	17943461
ated	I-Disease	-1	17943461
cardi@@	I-Disease	-1	17943461
om@@	I-Disease	-1	17943461
yo@@	I-Disease	-1	17943461
pathy	I-Disease	-1	17943461
(	O	-1	17943461
D@@	B-Disease	D002311	17943461
C@@	I-Disease	-1	17943461
M	I-Disease	-1	17943461
)	O	-1	17943461
and	O	-1	17943461
myocardi@@	B-Disease	D009205	17943461
tis	I-Disease	-1	17943461
occ@@	O	-1	17943461
ur	O	-1	17943461
in	O	-1	17943461
man@@	O	-1	17943461
y	O	-1	17943461
H@@	B-Disease	D015658	17943461
I@@	I-Disease	-1	17943461
V@@	I-Disease	-1	17943461
-@@	I-Disease	-1	17943461
inf@@	I-Disease	-1	17943461
ected	I-Disease	-1	17943461
individ@@	O	-1	17943461
u@@	O	-1	17943461
al@@	O	-1	17943461
s,	O	-1	17943461
result@@	O	-1	17943461
ing	O	-1	17943461
in	O	-1	17943461
symptom@@	O	-1	17943461
atic	O	-1	17943461
heart	B-Disease	D006333	17943461
failure	I-Disease	-1	17943461
in	O	-1	17943461
up	O	-1	17943461
to	O	-1	17943461
5%	O	-1	17943461
of	O	-1	17943461
patients.	O	-1	17943461
H@@	O	-1	17943461
igh@@	O	-1	17943461
ly	O	-1	17943461
active	O	-1	17943461
anti@@	O	-1	17943461
ret@@	O	-1	17943461
ro@@	O	-1	17943461
viral	O	-1	17943461
therapy	O	-1	17943461
(@@	O	-1	17943461
H@@	O	-1	17943461
A@@	O	-1	17943461
A@@	O	-1	17943461
R@@	O	-1	17943461
T)	O	-1	17943461
has	O	-1	17943461
significantly	O	-1	17943461
reduced	O	-1	17943461
mor@@	O	-1	17943461
b@@	O	-1	17943461
idity	O	-1	17943461
and	O	-1	17943461
mor@@	O	-1	17943461
t@@	O	-1	17943461
ality	O	-1	17943461
of	O	-1	17943461
ac@@	B-Disease	D000163	17943461
qu@@	I-Disease	-1	17943461
ired	I-Disease	-1	17943461
immuno@@	I-Disease	-1	17943461
defici@@	I-Disease	-1	17943461
ency	I-Disease	-1	17943461
syndrome	I-Disease	-1	17943461
(	O	-1	17943461
A@@	B-Disease	D000163	17943461
I@@	I-Disease	-1	17943461
D@@	I-Disease	-1	17943461
S	I-Disease	-1	17943461
),	O	-1	17943461
but	O	-1	17943461
has	O	-1	17943461
resulted	O	-1	17943461
in	O	-1	17943461
an	O	-1	17943461
increase	O	-1	17943461
in	O	-1	17943461
cardiac	B-Disease	C538496	17943461
and	I-Disease	-1	17943461
s@@	I-Disease	-1	17943461
ke@@	I-Disease	-1	17943461
le@@	I-Disease	-1	17943461
t@@	I-Disease	-1	17943461
al	I-Disease	-1	17943461
my@@	I-Disease	-1	17943461
o@@	I-Disease	-1	17943461
path@@	I-Disease	-1	17943461
i@@	I-Disease	-1	17943461
es	I-Disease	-1	17943461
.	O	-1	17943461
METHOD@@	O	-1	17943461
S	O	-1	17943461
AN@@	O	-1	17943461
D	O	-1	17943461
RESULTS:	O	-1	17943461
In	O	-1	17943461
or@@	O	-1	17943461
der	O	-1	17943461
to	O	-1	17943461
investigate	O	-1	17943461
whether	O	-1	17943461
the	O	-1	17943461
H@@	O	-1	17943461
A@@	O	-1	17943461
A@@	O	-1	17943461
R@@	O	-1	17943461
T	O	-1	17943461
comp@@	O	-1	17943461
on@@	O	-1	17943461
ent	O	-1	17943461
z@@	B-Chemical	D015215	17943461
id@@	I-Chemical	-1	17943461
o@@	I-Chemical	-1	17943461
vud@@	I-Chemical	-1	17943461
ine	I-Chemical	-1	17943461
(	O	-1	17943461
3@@	B-Chemical	D015215	17943461
'@@	I-Chemical	-1	17943461
-@@	I-Chemical	-1	17943461
az@@	I-Chemical	-1	17943461
id@@	I-Chemical	-1	17943461
o@@	I-Chemical	-1	17943461
-@@	I-Chemical	-1	17943461
2@@	I-Chemical	-1	17943461
'@@	I-Chemical	-1	17943461
,@@	I-Chemical	-1	17943461
3@@	I-Chemical	-1	17943461
'@@	I-Chemical	-1	17943461
-@@	I-Chemical	-1	17943461
de@@	I-Chemical	-1	17943461
oxy@@	I-Chemical	-1	17943461
th@@	I-Chemical	-1	17943461
ym@@	I-Chemical	-1	17943461
idine	I-Chemical	-1	17943461
;	O	-1	17943461
A@@	B-Chemical	D015215	17943461
Z@@	I-Chemical	-1	17943461
T	I-Chemical	-1	17943461
)	O	-1	17943461
tri@@	O	-1	17943461
g@@	O	-1	17943461
g@@	O	-1	17943461
ers	O	-1	17943461
the	O	-1	17943461
F@@	O	-1	17943461
as@@	O	-1	17943461
-@@	O	-1	17943461
dependent	O	-1	17943461
cell@@	O	-1	17943461
-@@	O	-1	17943461
death	O	-1	17943461
path@@	O	-1	17943461
w@@	O	-1	17943461
ay	O	-1	17943461
and	O	-1	17943461
cause	O	-1	17943461
cy@@	O	-1	17943461
t@@	O	-1	17943461
os@@	O	-1	17943461
ke@@	O	-1	17943461
le@@	O	-1	17943461
t@@	O	-1	17943461
al	O	-1	17943461
dis@@	O	-1	17943461
ru@@	O	-1	17943461
ption	O	-1	17943461
in	O	-1	17943461
a	O	-1	17943461
m@@	O	-1	17943461
urine	O	-1	17943461
model	O	-1	17943461
of	O	-1	17943461
D@@	B-Disease	D002311	17943461
C@@	I-Disease	-1	17943461
M	I-Disease	-1	17943461
,	O	-1	17943461
8@@	O	-1	17943461
-@@	O	-1	17943461
week@@	O	-1	17943461
-old	O	-1	17943461
trans@@	O	-1	17943461
genic	O	-1	17943461
(@@	O	-1	17943461
ex@@	O	-1	17943461
press@@	O	-1	17943461
ing	O	-1	17943461
F@@	O	-1	17943461
as	O	-1	17943461
li@@	O	-1	17943461
g@@	O	-1	17943461
and	O	-1	17943461
in	O	-1	17943461
the	O	-1	17943461
myocardi@@	O	-1	17943461
um@@	O	-1	17943461
:	O	-1	17943461
F@@	O	-1	17943461
as@@	O	-1	17943461
L	O	-1	17943461
T@@	O	-1	17943461
g@@	O	-1	17943461
)	O	-1	17943461
and	O	-1	17943461
non-@@	O	-1	17943461
trans@@	O	-1	17943461
genic	O	-1	17943461
(N@@	O	-1	17943461
T@@	O	-1	17943461
g@@	O	-1	17943461
)	O	-1	17943461
mice	O	-1	17943461
received	O	-1	17943461
w@@	O	-1	17943461
at@@	O	-1	17943461
er	O	-1	17943461
ad	O	-1	17943461
li@@	O	-1	17943461
b@@	O	-1	17943461
it@@	O	-1	17943461
um	O	-1	17943461
containing	O	-1	17943461
different	O	-1	17943461
concentrations	O	-1	17943461
of	O	-1	17943461
A@@	B-Chemical	D015215	17943461
Z@@	I-Chemical	-1	17943461
T	I-Chemical	-1	17943461
(@@	O	-1	17943461
0@@	O	-1	17943461
,	O	-1	17943461
0.0@@	O	-1	17943461
7@@	O	-1	17943461
,	O	-1	17943461
0.@@	O	-1	17943461
2,	O	-1	17943461
and	O	-1	17943461
0.@@	O	-1	17943461
7	O	-1	17943461
mg/m@@	O	-1	17943461
l@@	O	-1	17943461
).	O	-1	17943461
After	O	-1	17943461
6	O	-1	17943461
week@@	O	-1	17943461
s,	O	-1	17943461
cardiac	O	-1	17943461
function	O	-1	17943461
was	O	-1	17943461
assessed	O	-1	17943461
by	O	-1	17943461
echocardiograph@@	O	-1	17943461
y	O	-1	17943461
and	O	-1	17943461
morph@@	O	-1	17943461
ology	O	-1	17943461
was	O	-1	17943461
assessed	O	-1	17943461
by	O	-1	17943461
histo@@	O	-1	17943461
path@@	O	-1	17943461
ologic	O	-1	17943461
and	O	-1	17943461
immuno@@	O	-1	17943461
histo@@	O	-1	17943461
chemical	O	-1	17943461
meth@@	O	-1	17943461
o@@	O	-1	17943461
d@@	O	-1	17943461
s.	O	-1	17943461
N@@	O	-1	17943461
T@@	O	-1	17943461
g	O	-1	17943461
and	O	-1	17943461
un@@	O	-1	17943461
treated	O	-1	17943461
F@@	O	-1	17943461
as@@	O	-1	17943461
L	O	-1	17943461
T@@	O	-1	17943461
g	O	-1	17943461
mice	O	-1	17943461
showed	O	-1	17943461
lit@@	O	-1	17943461
t@@	O	-1	17943461
le	O	-1	17943461
or	O	-1	17943461
no	O	-1	17943461
change	O	-1	17943461
in	O	-1	17943461
cardiac	O	-1	17943461
struct@@	O	-1	17943461
ure	O	-1	17943461
or	O	-1	17943461
func@@	O	-1	17943461
tion.	O	-1	17943461
In	O	-1	17943461
contrast@@	O	-1	17943461
,	O	-1	17943461
A@@	B-Chemical	D015215	17943461
Z@@	I-Chemical	-1	17943461
T	I-Chemical	-1	17943461
-treated	O	-1	17943461
F@@	O	-1	17943461
as@@	O	-1	17943461
L	O	-1	17943461
T@@	O	-1	17943461
g	O	-1	17943461
mice	O	-1	17943461
developed	O	-1	17943461
cardiac	B-Disease	D002311	17943461
di@@	I-Disease	-1	17943461
l@@	I-Disease	-1	17943461
ation	I-Disease	-1	17943461
and	O	-1	17943461
depress@@	O	-1	17943461
ed	O	-1	17943461
cardiac	O	-1	17943461
function	O	-1	17943461
in	O	-1	17943461
a	O	-1	17943461
dose-@@	O	-1	17943461
dependent	O	-1	17943461
man@@	O	-1	17943461
ner@@	O	-1	17943461
,	O	-1	17943461
with	O	-1	17943461
concomit@@	O	-1	17943461
ant	O	-1	17943461
inflam@@	O	-1	17943461
mat@@	O	-1	17943461
ory	O	-1	17943461
inf@@	O	-1	17943461
iltration	O	-1	17943461
of	O	-1	17943461
both	O	-1	17943461
ventric@@	O	-1	17943461
l@@	O	-1	17943461
es.	O	-1	17943461
These	O	-1	17943461
changes	O	-1	17943461
were	O	-1	17943461
associated	O	-1	17943461
with	O	-1	17943461
an	O	-1	17943461
increased	O	-1	17943461
s@@	O	-1	17943461
ar@@	O	-1	17943461
co@@	O	-1	17943461
le@@	O	-1	17943461
mm@@	O	-1	17943461
al	O	-1	17943461
expression	O	-1	17943461
of	O	-1	17943461
F@@	O	-1	17943461
as	O	-1	17943461
and	O	-1	17943461
F@@	O	-1	17943461
as@@	O	-1	17943461
L@@	O	-1	17943461
,	O	-1	17943461
as	O	-1	17943461
well	O	-1	17943461
as	O	-1	17943461
increased	O	-1	17943461
activation	O	-1	17943461
of	O	-1	17943461
cas@@	O	-1	17943461
p@@	O	-1	17943461
ase	O	-1	17943461
3,	O	-1	17943461
trans@@	O	-1	17943461
loc@@	O	-1	17943461
ation	O	-1	17943461
of	O	-1	17943461
cal@@	O	-1	17943461
pain	O	-1	17943461
1	O	-1	17943461
to	O	-1	17943461
the	O	-1	17943461
s@@	O	-1	17943461
ar@@	O	-1	17943461
co@@	O	-1	17943461
le@@	O	-1	17943461
m@@	O	-1	17943461
ma	O	-1	17943461
and	O	-1	17943461
s@@	O	-1	17943461
ar@@	O	-1	17943461
co@@	O	-1	17943461
me@@	O	-1	17943461
re,	O	-1	17943461
and	O	-1	17943461
increased	O	-1	17943461
numb@@	O	-1	17943461
ers	O	-1	17943461
of	O	-1	17943461
cells	O	-1	17943461
under@@	O	-1	17943461
go@@	O	-1	17943461
ing	O	-1	17943461
apo@@	O	-1	17943461
pto@@	O	-1	17943461
sis.	O	-1	17943461
These	O	-1	17943461
were	O	-1	17943461
associated	O	-1	17943461
with	O	-1	17943461
changes	O	-1	17943461
in	O	-1	17943461
dy@@	O	-1	17943461
stro@@	O	-1	17943461
ph@@	O	-1	17943461
in	O	-1	17943461
and	O	-1	17943461
cardiac	O	-1	17943461
tro@@	O	-1	17943461
p@@	O	-1	17943461
on@@	O	-1	17943461
in	O	-1	17943461
I	O	-1	17943461
lo@@	O	-1	17943461
cal@@	O	-1	17943461
iz@@	O	-1	17943461
ation,	O	-1	17943461
as	O	-1	17943461
well	O	-1	17943461
as	O	-1	17943461
loss	O	-1	17943461
of	O	-1	17943461
s@@	O	-1	17943461
ar@@	O	-1	17943461
co@@	O	-1	17943461
le@@	O	-1	17943461
mm@@	O	-1	17943461
al	O	-1	17943461
in@@	O	-1	17943461
te@@	O	-1	17943461
g@@	O	-1	17943461
r@@	O	-1	17943461
ity.	O	-1	17943461
CONCLUSIONS:	O	-1	17943461
The	O	-1	17943461
expression	O	-1	17943461
of	O	-1	17943461
F@@	O	-1	17943461
as	O	-1	17943461
li@@	O	-1	17943461
g@@	O	-1	17943461
and	O	-1	17943461
in	O	-1	17943461
the	O	-1	17943461
myocardi@@	O	-1	17943461
um,	O	-1	17943461
as	O	-1	17943461
identi@@	O	-1	17943461
fied	O	-1	17943461
in	O	-1	17943461
H@@	O	-1	17943461
I@@	O	-1	17943461
V@@	O	-1	17943461
-@@	O	-1	17943461
positive	O	-1	17943461
patients,	O	-1	17943461
might	O	-1	17943461
increase	O	-1	17943461
the	O	-1	17943461
sus@@	O	-1	17943461
cep@@	O	-1	17943461
ti@@	O	-1	17943461
b@@	O	-1	17943461
ility	O	-1	17943461
to	O	-1	17943461
H@@	O	-1	17943461
A@@	O	-1	17943461
A@@	O	-1	17943461
R@@	O	-1	17943461
T@@	O	-1	17943461
-induced	O	-1	17943461
cardi@@	B-Disease	D009202	17943461
om@@	I-Disease	-1	17943461
yo@@	I-Disease	-1	17943461
pathy	I-Disease	-1	17943461
due	O	-1	17943461
to	O	-1	17943461
activation	O	-1	17943461
of	O	-1	17943461
apo@@	O	-1	17943461
pto@@	O	-1	17943461
tic	O	-1	17943461
path@@	O	-1	17943461
w@@	O	-1	17943461
ay@@	O	-1	17943461
s,	O	-1	17943461
result@@	O	-1	17943461
ing	O	-1	17943461
in	O	-1	17943461
cardiac	B-Disease	D002311	17943461
di@@	I-Disease	-1	17943461
l@@	I-Disease	-1	17943461
ation	I-Disease	-1	17943461
and	I-Disease	-1	17943461
dysfunction	I-Disease	-1	17943461
cardiac	B-Disease	D006331	17943461
di@@	I-Disease	-1	17943461
l@@	I-Disease	-1	17943461
ation	I-Disease	-1	17943461
and	I-Disease	-1	17943461
dysfunction	I-Disease	-1	17943461
.	O	-1	17943461

V@@	B-Chemical	D014635	17074608
al@@	I-Chemical	-1	17074608
pro@@	I-Chemical	-1	17074608
ate	I-Chemical	-1	17074608
-induced	O	-1	17074608
ch@@	B-Disease	D002819	17074608
ore@@	I-Disease	-1	17074608
a	I-Disease	-1	17074608
and	O	-1	17074608
encephalo@@	B-Disease	D001927	17074608
pathy	I-Disease	-1	17074608
in	O	-1	17074608
at@@	O	-1	17074608
yp@@	O	-1	17074608
ical	O	-1	17074608
non@@	B-Disease	D020158	17074608
ke@@	I-Disease	-1	17074608
to@@	I-Disease	-1	17074608
tic	I-Disease	-1	17074608
hyper@@	I-Disease	-1	17074608
glyc@@	I-Disease	-1	17074608
ine@@	I-Disease	-1	17074608
mia	I-Disease	-1	17074608
.	O	-1	17074608
N@@	B-Disease	D020158	17074608
on@@	I-Disease	-1	17074608
ke@@	I-Disease	-1	17074608
to@@	I-Disease	-1	17074608
tic	I-Disease	-1	17074608
hyper@@	I-Disease	-1	17074608
glyc@@	I-Disease	-1	17074608
ine@@	I-Disease	-1	17074608
mia	I-Disease	-1	17074608
is	O	-1	17074608
a	O	-1	17074608
disor@@	B-Disease	D000592	17074608
der	I-Disease	-1	17074608
of	I-Disease	-1	17074608
amin@@	I-Disease	-1	17074608
o	I-Disease	-1	17074608
acid	I-Disease	-1	17074608
metabol@@	I-Disease	-1	17074608
ism	I-Disease	-1	17074608
in	O	-1	17074608
which	O	-1	17074608
a	O	-1	17074608
def@@	O	-1	17074608
ect	O	-1	17074608
in	O	-1	17074608
the	O	-1	17074608
glyc@@	B-Chemical	D005998	17074608
ine	I-Chemical	-1	17074608
c@@	O	-1	17074608
le@@	O	-1	17074608
av@@	O	-1	17074608
age	O	-1	17074608
system	O	-1	17074608
lead@@	O	-1	17074608
s	O	-1	17074608
to	O	-1	17074608
an	O	-1	17074608
accum@@	O	-1	17074608
ulation	O	-1	17074608
of	O	-1	17074608
glyc@@	B-Chemical	D005998	17074608
ine	I-Chemical	-1	17074608
in	O	-1	17074608
the	O	-1	17074608
brain	O	-1	17074608
and	O	-1	17074608
other	O	-1	17074608
body	O	-1	17074608
compar@@	O	-1	17074608
t@@	O	-1	17074608
ment@@	O	-1	17074608
s.	O	-1	17074608
In	O	-1	17074608
the	O	-1	17074608
cl@@	O	-1	17074608
assi@@	O	-1	17074608
c@@	O	-1	17074608
al	O	-1	17074608
form	O	-1	17074608
it	O	-1	17074608
pres@@	O	-1	17074608
ents	O	-1	17074608
as	O	-1	17074608
ne@@	O	-1	17074608
on@@	O	-1	17074608
atal	O	-1	17074608
ap@@	B-Disease	D001049	17074608
ne@@	I-Disease	-1	17074608
a	I-Disease	-1	17074608
,	O	-1	17074608
intrac@@	O	-1	17074608
t@@	O	-1	17074608
able	O	-1	17074608
seizures	B-Disease	D012640	17074608
,	O	-1	17074608
and	O	-1	17074608
hy@@	B-Disease	D009123	17074608
pot@@	I-Disease	-1	17074608
on@@	I-Disease	-1	17074608
ia	I-Disease	-1	17074608
,	O	-1	17074608
followed	O	-1	17074608
by	O	-1	17074608
significant	O	-1	17074608
psych@@	B-Disease	D011596	17074608
om@@	I-Disease	-1	17074608
otor	I-Disease	-1	17074608
ret@@	I-Disease	-1	17074608
ar@@	I-Disease	-1	17074608
d@@	I-Disease	-1	17074608
ation	I-Disease	-1	17074608
.	O	-1	17074608
An	O	-1	17074608
important	O	-1	17074608
sub@@	O	-1	17074608
set	O	-1	17074608
of	O	-1	17074608
children	O	-1	17074608
with	O	-1	17074608
non@@	B-Disease	D020158	17074608
ke@@	I-Disease	-1	17074608
to@@	I-Disease	-1	17074608
tic	I-Disease	-1	17074608
hyper@@	I-Disease	-1	17074608
glyc@@	I-Disease	-1	17074608
ine@@	I-Disease	-1	17074608
mia	I-Disease	-1	17074608
are	O	-1	17074608
at@@	O	-1	17074608
yp@@	O	-1	17074608
ical	O	-1	17074608
vari@@	O	-1	17074608
ants	O	-1	17074608
who	O	-1	17074608
present	O	-1	17074608
in	O	-1	17074608
a	O	-1	17074608
he@@	O	-1	17074608
ter@@	O	-1	17074608
o@@	O	-1	17074608
gene@@	O	-1	17074608
ous	O	-1	17074608
man@@	O	-1	17074608
ner@@	O	-1	17074608
.	O	-1	17074608
This	O	-1	17074608
report	O	-1	17074608
descri@@	O	-1	17074608
b@@	O	-1	17074608
es	O	-1	17074608
a	O	-1	17074608
patient	O	-1	17074608
with	O	-1	17074608
mil@@	O	-1	17074608
d	O	-1	17074608
l@@	B-Disease	D007805	17074608
ang@@	I-Disease	-1	17074608
u@@	I-Disease	-1	17074608
age	I-Disease	-1	17074608
del@@	I-Disease	-1	17074608
ay	I-Disease	-1	17074608
and	O	-1	17074608
mental	B-Disease	D008607	17074608
ret@@	I-Disease	-1	17074608
ar@@	I-Disease	-1	17074608
d@@	I-Disease	-1	17074608
ation	I-Disease	-1	17074608
,	O	-1	17074608
who	O	-1	17074608
was	O	-1	17074608
found	O	-1	17074608
to	O	-1	17074608
have	O	-1	17074608
non@@	B-Disease	D020158	17074608
ke@@	I-Disease	-1	17074608
to@@	I-Disease	-1	17074608
tic	I-Disease	-1	17074608
hyper@@	I-Disease	-1	17074608
glyc@@	I-Disease	-1	17074608
ine@@	I-Disease	-1	17074608
mia	I-Disease	-1	17074608
following	O	-1	17074608
h@@	O	-1	17074608
er	O	-1	17074608
present@@	O	-1	17074608
ation	O	-1	17074608
with	O	-1	17074608
acute	O	-1	17074608
encephalo@@	B-Disease	D001927	17074608
pathy	I-Disease	-1	17074608
and	O	-1	17074608
ch@@	B-Disease	D002819	17074608
ore@@	I-Disease	-1	17074608
a	I-Disease	-1	17074608
sh@@	O	-1	17074608
ort@@	O	-1	17074608
ly	O	-1	17074608
after	O	-1	17074608
initi@@	O	-1	17074608
ation	O	-1	17074608
of	O	-1	17074608
valpro@@	B-Chemical	D014635	17074608
ate	I-Chemical	-1	17074608
therapy.	O	-1	17074608

M@@	O	-1	16364460
ic@@	O	-1	16364460
ro@@	O	-1	16364460
injection	O	-1	16364460
of	O	-1	16364460
rit@@	B-Chemical	D016713	16364460
an@@	I-Chemical	-1	16364460
ser@@	I-Chemical	-1	16364460
in	I-Chemical	-1	16364460
into	O	-1	16364460
the	O	-1	16364460
CA@@	O	-1	16364460
1	O	-1	16364460
regi@@	O	-1	16364460
on	O	-1	16364460
of	O	-1	16364460
hippocamp@@	O	-1	16364460
us	O	-1	16364460
impro@@	O	-1	16364460
v@@	O	-1	16364460
es	O	-1	16364460
scopol@@	B-Chemical	D012601	16364460
amine	I-Chemical	-1	16364460
-induced	O	-1	16364460
am@@	B-Disease	D000647	16364460
ne@@	I-Disease	-1	16364460
sia	I-Disease	-1	16364460
in	O	-1	16364460
ad@@	O	-1	16364460
ult	O	-1	16364460
male	O	-1	16364460
rats.	O	-1	16364460
The	O	-1	16364460
effect	O	-1	16364460
of	O	-1	16364460
rit@@	B-Chemical	D016713	16364460
an@@	I-Chemical	-1	16364460
ser@@	I-Chemical	-1	16364460
in	I-Chemical	-1	16364460
(@@	O	-1	16364460
5-@@	O	-1	16364460
H@@	O	-1	16364460
T@@	O	-1	16364460
2	O	-1	16364460
antagonist@@	O	-1	16364460
)	O	-1	16364460
on	O	-1	16364460
scopol@@	B-Chemical	D012601	16364460
amine	I-Chemical	-1	16364460
(@@	O	-1	16364460
mus@@	O	-1	16364460
car@@	O	-1	16364460
inic	O	-1	16364460
cholinergic	O	-1	16364460
antagonist@@	O	-1	16364460
)@@	O	-1	16364460
-induced	O	-1	16364460
am@@	B-Disease	D000647	16364460
ne@@	I-Disease	-1	16364460
sia	I-Disease	-1	16364460
in	O	-1	16364460
M@@	O	-1	16364460
or@@	O	-1	16364460
ri@@	O	-1	16364460
s	O	-1	16364460
w@@	O	-1	16364460
at@@	O	-1	16364460
er	O	-1	16364460
ma@@	O	-1	16364460
ze	O	-1	16364460
(@@	O	-1	16364460
M@@	O	-1	16364460
W@@	O	-1	16364460
M@@	O	-1	16364460
)	O	-1	16364460
was	O	-1	16364460
investig@@	O	-1	16364460
ated.	O	-1	16364460
R@@	O	-1	16364460
at@@	O	-1	16364460
s	O	-1	16364460
were	O	-1	16364460
divid@@	O	-1	16364460
ed	O	-1	16364460
into	O	-1	16364460
e@@	O	-1	16364460
ight	O	-1	16364460
groups	O	-1	16364460
and	O	-1	16364460
bil@@	O	-1	16364460
at@@	O	-1	16364460
er@@	O	-1	16364460
ally	O	-1	16364460
can@@	O	-1	16364460
n@@	O	-1	16364460
ul@@	O	-1	16364460
ated	O	-1	16364460
into	O	-1	16364460
CA@@	O	-1	16364460
1	O	-1	16364460
regi@@	O	-1	16364460
on	O	-1	16364460
of	O	-1	16364460
the	O	-1	16364460
hippocamp@@	O	-1	16364460
us.	O	-1	16364460
One	O	-1	16364460
week	O	-1	16364460
lat@@	O	-1	16364460
er,	O	-1	16364460
they	O	-1	16364460
received	O	-1	16364460
repe@@	O	-1	16364460
ated@@	O	-1	16364460
ly	O	-1	16364460
ve@@	O	-1	16364460
h@@	O	-1	16364460
ic@@	O	-1	16364460
le@@	O	-1	16364460
s	O	-1	16364460
(@@	O	-1	16364460
sal@@	O	-1	16364460
ine,	O	-1	16364460
D@@	B-Chemical	D004121	16364460
M@@	I-Chemical	-1	16364460
S@@	I-Chemical	-1	16364460
O	I-Chemical	-1	16364460
,	O	-1	16364460
sal@@	O	-1	16364460
ine@@	O	-1	16364460
+	O	-1	16364460
D@@	B-Chemical	D004121	16364460
M@@	I-Chemical	-1	16364460
S@@	I-Chemical	-1	16364460
O	I-Chemical	-1	16364460
),	O	-1	16364460
scopol@@	B-Chemical	D012601	16364460
amine	I-Chemical	-1	16364460
(@@	O	-1	16364460
2	O	-1	16364460
micro@@	O	-1	16364460
g/@@	O	-1	16364460
0.@@	O	-1	16364460
5	O	-1	16364460
micro@@	O	-1	16364460
l	O	-1	16364460
sal@@	O	-1	16364460
ine@@	O	-1	16364460
/@@	O	-1	16364460
side@@	O	-1	16364460
;	O	-1	16364460
30	O	-1	16364460
min	O	-1	16364460
before	O	-1	16364460
tra@@	O	-1	16364460
in@@	O	-1	16364460
ing@@	O	-1	16364460
),	O	-1	16364460
rit@@	B-Chemical	D016713	16364460
an@@	I-Chemical	-1	16364460
ser@@	I-Chemical	-1	16364460
in	I-Chemical	-1	16364460
(2@@	O	-1	16364460
,	O	-1	16364460
4	O	-1	16364460
and	O	-1	16364460
8	O	-1	16364460
micro@@	O	-1	16364460
g/@@	O	-1	16364460
0.@@	O	-1	16364460
5	O	-1	16364460
micro@@	O	-1	16364460
l	O	-1	16364460
D@@	B-Chemical	D004121	16364460
M@@	I-Chemical	-1	16364460
S@@	I-Chemical	-1	16364460
O	I-Chemical	-1	16364460
/@@	O	-1	16364460
side@@	O	-1	16364460
;	O	-1	16364460
20	O	-1	16364460
min	O	-1	16364460
before	O	-1	16364460
tra@@	O	-1	16364460
in@@	O	-1	16364460
ing@@	O	-1	16364460
)	O	-1	16364460
and	O	-1	16364460
scopol@@	B-Chemical	D012601	16364460
amine	I-Chemical	-1	16364460
(@@	O	-1	16364460
2	O	-1	16364460
micro@@	O	-1	16364460
g/@@	O	-1	16364460
0.@@	O	-1	16364460
5	O	-1	16364460
micro@@	O	-1	16364460
l@@	O	-1	16364460
;	O	-1	16364460
30	O	-1	16364460
min	O	-1	16364460
before	O	-1	16364460
rit@@	B-Chemical	D016713	16364460
an@@	I-Chemical	-1	16364460
ser@@	I-Chemical	-1	16364460
in	I-Chemical	-1	16364460
injec@@	O	-1	16364460
tion@@	O	-1	16364460
)@@	O	-1	16364460
+	O	-1	16364460
rit@@	B-Chemical	D016713	16364460
an@@	I-Chemical	-1	16364460
ser@@	I-Chemical	-1	16364460
in	I-Chemical	-1	16364460
(@@	O	-1	16364460
4	O	-1	16364460
micro@@	O	-1	16364460
g/@@	O	-1	16364460
0.@@	O	-1	16364460
5	O	-1	16364460
micro@@	O	-1	16364460
l	O	-1	16364460
D@@	B-Chemical	D004121	16364460
M@@	I-Chemical	-1	16364460
S@@	I-Chemical	-1	16364460
O	I-Chemical	-1	16364460
)	O	-1	16364460
through	O	-1	16364460
can@@	O	-1	16364460
n@@	O	-1	16364460
ul@@	O	-1	16364460
a@@	O	-1	16364460
e	O	-1	16364460
each	O	-1	16364460
da@@	O	-1	16364460
y.	O	-1	16364460
An@@	O	-1	16364460
im@@	O	-1	16364460
als	O	-1	16364460
were	O	-1	16364460
tested	O	-1	16364460
for	O	-1	16364460
four	O	-1	16364460
con@@	O	-1	16364460
sec@@	O	-1	16364460
utive	O	-1	16364460
days	O	-1	16364460
(@@	O	-1	16364460
4	O	-1	16364460
tri@@	O	-1	16364460
al@@	O	-1	16364460
/@@	O	-1	16364460
day@@	O	-1	16364460
)	O	-1	16364460
in	O	-1	16364460
M@@	O	-1	16364460
W@@	O	-1	16364460
M	O	-1	16364460
during	O	-1	16364460
which	O	-1	16364460
the	O	-1	16364460
posi@@	O	-1	16364460
tion	O	-1	16364460
of	O	-1	16364460
h@@	O	-1	16364460
id@@	O	-1	16364460
de@@	O	-1	16364460
n	O	-1	16364460
pl@@	O	-1	16364460
at@@	O	-1	16364460
form	O	-1	16364460
was	O	-1	16364460
un@@	O	-1	16364460
chang@@	O	-1	16364460
ed.	O	-1	16364460
In	O	-1	16364460
the	O	-1	16364460
f@@	O	-1	16364460
if@@	O	-1	16364460
th	O	-1	16364460
da@@	O	-1	16364460
y,	O	-1	16364460
the	O	-1	16364460
pl@@	O	-1	16364460
at@@	O	-1	16364460
form	O	-1	16364460
was	O	-1	16364460
elevated	O	-1	16364460
ab@@	O	-1	16364460
o@@	O	-1	16364460
ve	O	-1	16364460
the	O	-1	16364460
w@@	O	-1	16364460
at@@	O	-1	16364460
er	O	-1	16364460
sur@@	O	-1	16364460
fac@@	O	-1	16364460
e	O	-1	16364460
in	O	-1	16364460
an@@	O	-1	16364460
other	O	-1	16364460
posi@@	O	-1	16364460
tion	O	-1	16364460
to	O	-1	16364460
evalu@@	O	-1	16364460
ate	O	-1	16364460
the	O	-1	16364460
function	O	-1	16364460
of	O	-1	16364460
m@@	O	-1	16364460
ot@@	O	-1	16364460
or@@	O	-1	16364460
,	O	-1	16364460
mo@@	O	-1	16364460
tiv@@	O	-1	16364460
ation@@	O	-1	16364460
al	O	-1	16364460
and	O	-1	16364460
visual	O	-1	16364460
system@@	O	-1	16364460
s.	O	-1	16364460
The	O	-1	16364460
results	O	-1	16364460
showed	O	-1	16364460
a	O	-1	16364460
significant	O	-1	16364460
increase	O	-1	16364460
in	O	-1	16364460
es@@	O	-1	16364460
cap@@	O	-1	16364460
e	O	-1	16364460
lat@@	O	-1	16364460
en@@	O	-1	16364460
ci@@	O	-1	16364460
es	O	-1	16364460
and	O	-1	16364460
tra@@	O	-1	16364460
vel@@	O	-1	16364460
ed	O	-1	16364460
dist@@	O	-1	16364460
anc@@	O	-1	16364460
es	O	-1	16364460
to	O	-1	16364460
f@@	O	-1	16364460
ind	O	-1	16364460
pl@@	O	-1	16364460
at@@	O	-1	16364460
form	O	-1	16364460
in	O	-1	16364460
scopol@@	B-Chemical	D012601	16364460
amine	I-Chemical	-1	16364460
-treated	O	-1	16364460
group	O	-1	16364460
as	O	-1	16364460
compared	O	-1	16364460
to	O	-1	16364460
saline	O	-1	16364460
group.	O	-1	16364460
R@@	B-Chemical	D016713	16364460
it@@	I-Chemical	-1	16364460
an@@	I-Chemical	-1	16364460
ser@@	I-Chemical	-1	16364460
in	I-Chemical	-1	16364460
-treated	O	-1	16364460
rats	O	-1	16364460
(@@	O	-1	16364460
4	O	-1	16364460
micro@@	O	-1	16364460
g/@@	O	-1	16364460
0.@@	O	-1	16364460
5	O	-1	16364460
micro@@	O	-1	16364460
l@@	O	-1	16364460
/@@	O	-1	16364460
side@@	O	-1	16364460
)	O	-1	16364460
showed	O	-1	16364460
a	O	-1	16364460
significant	O	-1	16364460
decrease	O	-1	16364460
in	O	-1	16364460
the	O	-1	16364460
men@@	O	-1	16364460
tion@@	O	-1	16364460
ed	O	-1	16364460
par@@	O	-1	16364460
ame@@	O	-1	16364460
ters	O	-1	16364460
as	O	-1	16364460
compared	O	-1	16364460
to	O	-1	16364460
D@@	B-Chemical	D004121	16364460
M@@	I-Chemical	-1	16364460
S@@	I-Chemical	-1	16364460
O	I-Chemical	-1	16364460
-treated	O	-1	16364460
group.	O	-1	16364460
However,	O	-1	16364460
scopol@@	B-Chemical	D012601	16364460
amine	I-Chemical	-1	16364460
and	O	-1	16364460
rit@@	B-Chemical	D016713	16364460
an@@	I-Chemical	-1	16364460
ser@@	I-Chemical	-1	16364460
in	I-Chemical	-1	16364460
co-@@	O	-1	16364460
administration	O	-1	16364460
resulted	O	-1	16364460
in	O	-1	16364460
a	O	-1	16364460
significant	O	-1	16364460
decrease	O	-1	16364460
in	O	-1	16364460
es@@	O	-1	16364460
cap@@	O	-1	16364460
e	O	-1	16364460
lat@@	O	-1	16364460
en@@	O	-1	16364460
ci@@	O	-1	16364460
es	O	-1	16364460
and	O	-1	16364460
tra@@	O	-1	16364460
vel@@	O	-1	16364460
ed	O	-1	16364460
dist@@	O	-1	16364460
anc@@	O	-1	16364460
es	O	-1	16364460
as	O	-1	16364460
compared	O	-1	16364460
to	O	-1	16364460
the	O	-1	16364460
scopol@@	B-Chemical	D012601	16364460
amine	I-Chemical	-1	16364460
-treated	O	-1	16364460
rats.	O	-1	16364460
Our	O	-1	16364460
findings	O	-1	16364460
show	O	-1	16364460
that	O	-1	16364460
micro@@	O	-1	16364460
injection	O	-1	16364460
of	O	-1	16364460
rit@@	B-Chemical	D016713	16364460
an@@	I-Chemical	-1	16364460
ser@@	I-Chemical	-1	16364460
in	I-Chemical	-1	16364460
into	O	-1	16364460
the	O	-1	16364460
CA@@	O	-1	16364460
1	O	-1	16364460
regi@@	O	-1	16364460
on	O	-1	16364460
of	O	-1	16364460
the	O	-1	16364460
hippocamp@@	O	-1	16364460
us	O	-1	16364460
impro@@	O	-1	16364460
v@@	O	-1	16364460
es	O	-1	16364460
the	O	-1	16364460
scopol@@	B-Chemical	D012601	16364460
amine	I-Chemical	-1	16364460
-induced	O	-1	16364460
am@@	B-Disease	D000647	16364460
ne@@	I-Disease	-1	16364460
sia	I-Disease	-1	16364460
.	O	-1	16364460

H@@	B-Disease	D000860	15579441
y@@	I-Disease	-1	15579441
po@@	I-Disease	-1	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
in	O	-1	15579441
renal	B-Disease	D007674	15579441
disease	I-Disease	-1	15579441
with	O	-1	15579441
proteinuria	B-Disease	D011507	15579441
and/or	O	-1	15579441
glomerular	O	-1	15579441
hypertension	B-Disease	D006973	15579441
.	O	-1	15579441
D@@	O	-1	15579441
es@@	O	-1	15579441
pit@@	O	-1	15579441
e	O	-1	15579441
the	O	-1	15579441
increas@@	O	-1	15579441
ing	O	-1	15579441
need	O	-1	15579441
to	O	-1	15579441
identi@@	O	-1	15579441
f@@	O	-1	15579441
y	O	-1	15579441
and	O	-1	15579441
qu@@	O	-1	15579441
anti@@	O	-1	15579441
f@@	O	-1	15579441
y	O	-1	15579441
tissue	O	-1	15579441
oxy@@	O	-1	15579441
gen@@	O	-1	15579441
ation	O	-1	15579441
at	O	-1	15579441
the	O	-1	15579441
cell@@	O	-1	15579441
ular	O	-1	15579441
level@@	O	-1	15579441
,	O	-1	15579441
rel@@	O	-1	15579441
atively	O	-1	15579441
fe@@	O	-1	15579441
w	O	-1	15579441
meth@@	O	-1	15579441
o@@	O	-1	15579441
ds	O	-1	15579441
have	O	-1	15579441
been	O	-1	15579441
av@@	O	-1	15579441
ail@@	O	-1	15579441
able@@	O	-1	15579441
.	O	-1	15579441
In	O	-1	15579441
this	O	-1	15579441
study,	O	-1	15579441
we	O	-1	15579441
developed	O	-1	15579441
a	O	-1	15579441
new	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
-@@	O	-1	15579441
respon@@	O	-1	15579441
sive	O	-1	15579441
repor@@	O	-1	15579441
ter	O	-1	15579441
v@@	O	-1	15579441
ect@@	O	-1	15579441
or	O	-1	15579441
using	O	-1	15579441
a	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
-@@	O	-1	15579441
respon@@	O	-1	15579441
sive	O	-1	15579441
e@@	O	-1	15579441
le@@	O	-1	15579441
ment	O	-1	15579441
of	O	-1	15579441
the	O	-1	15579441
5@@	O	-1	15579441
'	O	-1	15579441
vascular	O	-1	15579441
endothelial	O	-1	15579441
growth	O	-1	15579441
factor	O	-1	15579441
un@@	O	-1	15579441
trans@@	O	-1	15579441
l@@	O	-1	15579441
ated	O	-1	15579441
regi@@	O	-1	15579441
on	O	-1	15579441
and	O	-1	15579441
gener@@	O	-1	15579441
ated	O	-1	15579441
a	O	-1	15579441
novel	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
-@@	O	-1	15579441
sens@@	O	-1	15579441
ing	O	-1	15579441
trans@@	O	-1	15579441
genic	O	-1	15579441
rat@@	O	-1	15579441
.	O	-1	15579441
We	O	-1	15579441
then	O	-1	15579441
ap@@	O	-1	15579441
pl@@	O	-1	15579441
ied	O	-1	15579441
this	O	-1	15579441
anim@@	O	-1	15579441
al	O	-1	15579441
model	O	-1	15579441
to	O	-1	15579441
the	O	-1	15579441
det@@	O	-1	15579441
ection	O	-1	15579441
of	O	-1	15579441
tu@@	O	-1	15579441
bu@@	O	-1	15579441
lo@@	O	-1	15579441
interstitial	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
in	O	-1	15579441
the	O	-1	15579441
diseas@@	B-Disease	D007674	15579441
ed	I-Disease	-1	15579441
kidney	I-Disease	-1	15579441
.	O	-1	15579441
W@@	O	-1	15579441
it@@	O	-1	15579441
h	O	-1	15579441
this	O	-1	15579441
model@@	O	-1	15579441
,	O	-1	15579441
we	O	-1	15579441
were	O	-1	15579441
able	O	-1	15579441
to	O	-1	15579441
identi@@	O	-1	15579441
f@@	O	-1	15579441
y	O	-1	15579441
diff@@	O	-1	15579441
use	O	-1	15579441
cor@@	O	-1	15579441
tical	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
in	O	-1	15579441
the	O	-1	15579441
p@@	B-Chemical	D011692	15579441
uro@@	I-Chemical	-1	15579441
m@@	I-Chemical	-1	15579441
ycin	I-Chemical	-1	15579441
amin@@	I-Chemical	-1	15579441
on@@	I-Chemical	-1	15579441
ucle@@	I-Chemical	-1	15579441
o@@	I-Chemical	-1	15579441
side	I-Chemical	-1	15579441
-induced	O	-1	15579441
nephro@@	B-Disease	D009404	15579441
tic	I-Disease	-1	15579441
syndrome	I-Disease	-1	15579441
and	O	-1	15579441
foc@@	O	-1	15579441
al	O	-1	15579441
and	O	-1	15579441
seg@@	O	-1	15579441
mental	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
in	O	-1	15579441
the	O	-1	15579441
re@@	O	-1	15579441
m@@	O	-1	15579441
n@@	O	-1	15579441
ant	O	-1	15579441
kidney	O	-1	15579441
model@@	O	-1	15579441
.	O	-1	15579441
E@@	O	-1	15579441
x@@	O	-1	15579441
pression	O	-1	15579441
of	O	-1	15579441
the	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
-@@	O	-1	15579441
respon@@	O	-1	15579441
sive	O	-1	15579441
trans@@	O	-1	15579441
gen@@	O	-1	15579441
e	O	-1	15579441
increased	O	-1	15579441
throu@@	O	-1	15579441
gh@@	O	-1	15579441
out	O	-1	15579441
the	O	-1	15579441
observ@@	O	-1	15579441
ation	O	-1	15579441
perio@@	O	-1	15579441
d,	O	-1	15579441
reac@@	O	-1	15579441
h@@	O	-1	15579441
ing	O	-1	15579441
2.@@	O	-1	15579441
2-@@	O	-1	15579441
fol@@	O	-1	15579441
d	O	-1	15579441
at	O	-1	15579441
2	O	-1	15579441
weeks	O	-1	15579441
in	O	-1	15579441
the	O	-1	15579441
p@@	B-Chemical	D011692	15579441
uro@@	I-Chemical	-1	15579441
m@@	I-Chemical	-1	15579441
ycin	I-Chemical	-1	15579441
amin@@	I-Chemical	-1	15579441
on@@	I-Chemical	-1	15579441
ucle@@	I-Chemical	-1	15579441
o@@	I-Chemical	-1	15579441
side	I-Chemical	-1	15579441
model	O	-1	15579441
and	O	-1	15579441
2.@@	O	-1	15579441
6-@@	O	-1	15579441
fol@@	O	-1	15579441
d	O	-1	15579441
at	O	-1	15579441
4	O	-1	15579441
weeks	O	-1	15579441
in	O	-1	15579441
the	O	-1	15579441
re@@	O	-1	15579441
m@@	O	-1	15579441
n@@	O	-1	15579441
ant	O	-1	15579441
kidney	O	-1	15579441
model@@	O	-1	15579441
,	O	-1	15579441
whereas	O	-1	15579441
that	O	-1	15579441
of	O	-1	15579441
vascular	O	-1	15579441
endothelial	O	-1	15579441
growth	O	-1	15579441
factor	O	-1	15579441
showed	O	-1	15579441
a	O	-1	15579441
mil@@	O	-1	15579441
d	O	-1	15579441
decreas@@	O	-1	15579441
e,	O	-1	15579441
ref@@	O	-1	15579441
l@@	O	-1	15579441
ect@@	O	-1	15579441
ing	O	-1	15579441
dist@@	O	-1	15579441
inc@@	O	-1	15579441
t	O	-1	15579441
behavi@@	O	-1	15579441
ors	O	-1	15579441
of	O	-1	15579441
the	O	-1	15579441
two	O	-1	15579441
gen@@	O	-1	15579441
es.	O	-1	15579441
The	O	-1	15579441
de@@	O	-1	15579441
g@@	O	-1	15579441
ree	O	-1	15579441
of	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
showed	O	-1	15579441
a	O	-1	15579441
positive	O	-1	15579441
correl@@	O	-1	15579441
ation	O	-1	15579441
with	O	-1	15579441
micro@@	O	-1	15579441
sco@@	O	-1	15579441
p@@	O	-1	15579441
ic	O	-1	15579441
tu@@	B-Disease	-1	15579441
bu@@	I-Disease	-1	15579441
lo@@	I-Disease	-1	15579441
interstitial	I-Disease	-1	15579441
injury	I-Disease	-1	15579441
in	O	-1	15579441
both	O	-1	15579441
model@@	O	-1	15579441
s.	O	-1	15579441
F@@	O	-1	15579441
in@@	O	-1	15579441
ally,	O	-1	15579441
we	O	-1	15579441
identi@@	O	-1	15579441
fied	O	-1	15579441
the	O	-1	15579441
lo@@	O	-1	15579441
cal@@	O	-1	15579441
ization	O	-1	15579441
of	O	-1	15579441
pro@@	O	-1	15579441
li@@	O	-1	15579441
fer@@	O	-1	15579441
ating	O	-1	15579441
cell	O	-1	15579441
nucle@@	O	-1	15579441
ar	O	-1	15579441
anti@@	O	-1	15579441
gen@@	O	-1	15579441
-@@	O	-1	15579441
posi@@	O	-1	15579441
ti@@	O	-1	15579441
ve,	O	-1	15579441
E@@	O	-1	15579441
D@@	O	-1	15579441
-1@@	O	-1	15579441
-@@	O	-1	15579441
posi@@	O	-1	15579441
ti@@	O	-1	15579441
ve,	O	-1	15579441
and	O	-1	15579441
ter@@	O	-1	15579441
min@@	O	-1	15579441
al	O	-1	15579441
d@@	O	-1	15579441
U@@	O	-1	15579441
T@@	O	-1	15579441
P	O	-1	15579441
n@@	O	-1	15579441
ic@@	O	-1	15579441
k@@	O	-1	15579441
-@@	O	-1	15579441
end	O	-1	15579441
l@@	O	-1	15579441
a@@	O	-1	15579441
be@@	O	-1	15579441
le@@	O	-1	15579441
d-@@	O	-1	15579441
positive	O	-1	15579441
cells	O	-1	15579441
in	O	-1	15579441
the	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ic	I-Disease	-1	15579441
cor@@	O	-1	15579441
tical	O	-1	15579441
a@@	O	-1	15579441
re@@	O	-1	15579441
a	O	-1	15579441
in	O	-1	15579441
the	O	-1	15579441
re@@	O	-1	15579441
m@@	O	-1	15579441
n@@	O	-1	15579441
ant	O	-1	15579441
kidney	O	-1	15579441
model@@	O	-1	15579441
.	O	-1	15579441
We	O	-1	15579441
prop@@	O	-1	15579441
ose	O	-1	15579441
h@@	O	-1	15579441
ere	O	-1	15579441
a	O	-1	15579441
possible	O	-1	15579441
path@@	O	-1	15579441
ological	O	-1	15579441
ti@@	O	-1	15579441
e	O	-1	15579441
between	O	-1	15579441
chronic	O	-1	15579441
tu@@	O	-1	15579441
bu@@	O	-1	15579441
lo@@	O	-1	15579441
interstitial	O	-1	15579441
hypo@@	B-Disease	D000860	15579441
x@@	I-Disease	-1	15579441
ia	I-Disease	-1	15579441
and	O	-1	15579441
progressive	O	-1	15579441
glomerular	B-Disease	D007674	15579441
diseas@@	I-Disease	-1	15579441
es	I-Disease	-1	15579441
.	O	-1	15579441

Con@@	O	-1	15517007
sen@@	O	-1	15517007
su@@	O	-1	15517007
s	O	-1	15517007
stat@@	O	-1	15517007
ement	O	-1	15517007
con@@	O	-1	15517007
cer@@	O	-1	15517007
ning	O	-1	15517007
cardi@@	B-Disease	D066126	15517007
otoxicity	I-Disease	-1	15517007
occur@@	O	-1	15517007
r@@	O	-1	15517007
ing	O	-1	15517007
during	O	-1	15517007
haem@@	O	-1	15517007
at@@	O	-1	15517007
o@@	O	-1	15517007
po@@	O	-1	15517007
i@@	O	-1	15517007
e@@	O	-1	15517007
tic	O	-1	15517007
st@@	O	-1	15517007
em	O	-1	15517007
cell	O	-1	15517007
transplant@@	O	-1	15517007
ation	O	-1	15517007
in	O	-1	15517007
the	O	-1	15517007
treatment	O	-1	15517007
of	O	-1	15517007
auto@@	B-Disease	D001327	15517007
immun@@	I-Disease	-1	15517007
e	I-Disease	-1	15517007
diseas@@	I-Disease	-1	15517007
es	I-Disease	-1	15517007
,	O	-1	15517007
with	O	-1	15517007
spec@@	O	-1	15517007
ial	O	-1	15517007
ref@@	O	-1	15517007
e@@	O	-1	15517007
rence	O	-1	15517007
to	O	-1	15517007
systemic	B-Disease	D012595	15517007
s@@	I-Disease	-1	15517007
clero@@	I-Disease	-1	15517007
sis	I-Disease	-1	15517007
and	O	-1	15517007
multiple	B-Disease	D009103	15517007
s@@	I-Disease	-1	15517007
clero@@	I-Disease	-1	15517007
sis	I-Disease	-1	15517007
.	O	-1	15517007
A@@	O	-1	15517007
u@@	O	-1	15517007
to@@	O	-1	15517007
log@@	O	-1	15517007
ous	O	-1	15517007
haem@@	O	-1	15517007
at@@	O	-1	15517007
o@@	O	-1	15517007
po@@	O	-1	15517007
i@@	O	-1	15517007
e@@	O	-1	15517007
tic	O	-1	15517007
st@@	O	-1	15517007
em	O	-1	15517007
cell	O	-1	15517007
transplant@@	O	-1	15517007
ation	O	-1	15517007
is	O	-1	15517007
no@@	O	-1	15517007
w	O	-1	15517007
a	O	-1	15517007
fe@@	O	-1	15517007
a@@	O	-1	15517007
sible	O	-1	15517007
and	O	-1	15517007
effective	O	-1	15517007
treatment	O	-1	15517007
for	O	-1	15517007
sel@@	O	-1	15517007
ected	O	-1	15517007
patients	O	-1	15517007
with	O	-1	15517007
severe	O	-1	15517007
auto@@	B-Disease	D001327	15517007
immun@@	I-Disease	-1	15517007
e	I-Disease	-1	15517007
diseas@@	I-Disease	-1	15517007
es	I-Disease	-1	15517007
.	O	-1	15517007
W@@	O	-1	15517007
or@@	O	-1	15517007
l@@	O	-1	15517007
d@@	O	-1	15517007
wi@@	O	-1	15517007
de@@	O	-1	15517007
,	O	-1	15517007
over	O	-1	15517007
6@@	O	-1	15517007
50	O	-1	15517007
patients	O	-1	15517007
have	O	-1	15517007
been	O	-1	15517007
transplant@@	O	-1	15517007
ed	O	-1	15517007
in	O	-1	15517007
the	O	-1	15517007
cont@@	O	-1	15517007
ex@@	O	-1	15517007
t	O	-1	15517007
of	O	-1	15517007
phase	O	-1	15517007
I	O	-1	15517007
and	O	-1	15517007
II	O	-1	15517007
clinical	O	-1	15517007
tri@@	O	-1	15517007
al@@	O	-1	15517007
s.	O	-1	15517007
The	O	-1	15517007
results	O	-1	15517007
are	O	-1	15517007
en@@	O	-1	15517007
cour@@	O	-1	15517007
ag@@	O	-1	15517007
ing	O	-1	15517007
en@@	O	-1	15517007
ou@@	O	-1	15517007
gh	O	-1	15517007
to	O	-1	15517007
be@@	O	-1	15517007
g@@	O	-1	15517007
in	O	-1	15517007
random@@	O	-1	15517007
is@@	O	-1	15517007
ed	O	-1	15517007
phase	O	-1	15517007
I@@	O	-1	15517007
II	O	-1	15517007
tri@@	O	-1	15517007
al@@	O	-1	15517007
s.	O	-1	15517007
However,	O	-1	15517007
as	O	-1	15517007
predic@@	O	-1	15517007
te@@	O	-1	15517007
d,	O	-1	15517007
significant	O	-1	15517007
transplant@@	O	-1	15517007
-@@	O	-1	15517007
related	O	-1	15517007
mor@@	O	-1	15517007
b@@	O	-1	15517007
idity	O	-1	15517007
and	O	-1	15517007
mor@@	O	-1	15517007
t@@	O	-1	15517007
ality	O	-1	15517007
have	O	-1	15517007
been	O	-1	15517007
obser@@	O	-1	15517007
ved.	O	-1	15517007
This	O	-1	15517007
is	O	-1	15517007
prim@@	O	-1	15517007
ari@@	O	-1	15517007
ly	O	-1	15517007
due	O	-1	15517007
to	O	-1	15517007
complications	O	-1	15517007
related	O	-1	15517007
to	O	-1	15517007
either	O	-1	15517007
the	O	-1	15517007
st@@	O	-1	15517007
age	O	-1	15517007
of	O	-1	15517007
the	O	-1	15517007
disease	O	-1	15517007
at	O	-1	15517007
transplant	O	-1	15517007
or	O	-1	15517007
due	O	-1	15517007
to	O	-1	15517007
inf@@	B-Disease	D007239	15517007
ec@@	I-Disease	-1	15517007
tions	I-Disease	-1	15517007
.	O	-1	15517007
The	O	-1	15517007
number	O	-1	15517007
of	O	-1	15517007
de@@	O	-1	15517007
ath@@	O	-1	15517007
s	O	-1	15517007
related	O	-1	15517007
to	O	-1	15517007
cardiac	B-Disease	D066126	15517007
toxicity	I-Disease	-1	15517007
is	O	-1	15517007
low@@	O	-1	15517007
.	O	-1	15517007
However,	O	-1	15517007
cau@@	O	-1	15517007
tion	O	-1	15517007
is	O	-1	15517007
requ@@	O	-1	15517007
ired	O	-1	15517007
when	O	-1	15517007
cyclophosph@@	B-Chemical	D003520	15517007
amide	I-Chemical	-1	15517007
or	O	-1	15517007
an@@	B-Chemical	D018943	15517007
th@@	I-Chemical	-1	15517007
rac@@	I-Chemical	-1	15517007
y@@	I-Chemical	-1	15517007
clin@@	I-Chemical	-1	15517007
es	I-Chemical	-1	15517007
such	O	-1	15517007
as	O	-1	15517007
mit@@	B-Chemical	D008942	15517007
ox@@	I-Chemical	-1	15517007
ant@@	I-Chemical	-1	15517007
r@@	I-Chemical	-1	15517007
one	I-Chemical	-1	15517007
are	O	-1	15517007
used	O	-1	15517007
in	O	-1	15517007
patients	O	-1	15517007
with	O	-1	15517007
a	O	-1	15517007
possible	O	-1	15517007
underlying	O	-1	15517007
heart	B-Disease	D006331	15517007
damage	I-Disease	-1	15517007
,	O	-1	15517007
for	O	-1	15517007
ex@@	O	-1	15517007
am@@	O	-1	15517007
ple@@	O	-1	15517007
,	O	-1	15517007
systemic	B-Disease	D012595	15517007
s@@	I-Disease	-1	15517007
clero@@	I-Disease	-1	15517007
sis	I-Disease	-1	15517007
patients.	O	-1	15517007
In	O	-1	15517007
N@@	O	-1	15517007
o@@	O	-1	15517007
ve@@	O	-1	15517007
mb@@	O	-1	15517007
er	O	-1	15517007
20@@	O	-1	15517007
0@@	O	-1	15517007
2,	O	-1	15517007
a	O	-1	15517007
me@@	O	-1	15517007
et@@	O	-1	15517007
ing	O	-1	15517007
was	O	-1	15517007
he@@	O	-1	15517007
l@@	O	-1	15517007
d	O	-1	15517007
in	O	-1	15517007
F@@	O	-1	15517007
lo@@	O	-1	15517007
ren@@	O	-1	15517007
ce@@	O	-1	15517007
,	O	-1	15517007
b@@	O	-1	15517007
r@@	O	-1	15517007
ing@@	O	-1	15517007
ing	O	-1	15517007
to@@	O	-1	15517007
ge@@	O	-1	15517007
ther	O	-1	15517007
a	O	-1	15517007
number	O	-1	15517007
of	O	-1	15517007
exper@@	O	-1	15517007
ts	O	-1	15517007
in	O	-1	15517007
various	O	-1	15517007
fi@@	O	-1	15517007
el@@	O	-1	15517007
d@@	O	-1	15517007
s,	O	-1	15517007
including	O	-1	15517007
r@@	O	-1	15517007
he@@	O	-1	15517007
um@@	O	-1	15517007
at@@	O	-1	15517007
olog@@	O	-1	15517007
y,	O	-1	15517007
cardi@@	O	-1	15517007
olog@@	O	-1	15517007
y,	O	-1	15517007
neurolog@@	O	-1	15517007
y,	O	-1	15517007
pharmac@@	O	-1	15517007
ology	O	-1	15517007
and	O	-1	15517007
transplant@@	O	-1	15517007
ation	O	-1	15517007
medic@@	O	-1	15517007
ine.	O	-1	15517007
The	O	-1	15517007
ob@@	O	-1	15517007
j@@	O	-1	15517007
ect	O	-1	15517007
of	O	-1	15517007
the	O	-1	15517007
me@@	O	-1	15517007
et@@	O	-1	15517007
ing	O	-1	15517007
was	O	-1	15517007
to	O	-1	15517007
analy@@	O	-1	15517007
se	O	-1	15517007
ex@@	O	-1	15517007
ist@@	O	-1	15517007
ing	O	-1	15517007
dat@@	O	-1	15517007
a,	O	-1	15517007
both	O	-1	15517007
pu@@	O	-1	15517007
bl@@	O	-1	15517007
ished	O	-1	15517007
or	O	-1	15517007
av@@	O	-1	15517007
ail@@	O	-1	15517007
able@@	O	-1	15517007
,	O	-1	15517007
in	O	-1	15517007
the	O	-1	15517007
E@@	O	-1	15517007
uro@@	O	-1	15517007
pe@@	O	-1	15517007
an	O	-1	15517007
Group	O	-1	15517007
for	O	-1	15517007
B@@	O	-1	15517007
lo@@	O	-1	15517007
od	O	-1	15517007
and	O	-1	15517007
M@@	O	-1	15517007
ar@@	O	-1	15517007
ro@@	O	-1	15517007
w	O	-1	15517007
T@@	O	-1	15517007
ran@@	O	-1	15517007
s@@	O	-1	15517007
pl@@	O	-1	15517007
ant@@	O	-1	15517007
ation	O	-1	15517007
auto@@	B-Disease	D001327	15517007
immun@@	I-Disease	-1	15517007
e	I-Disease	-1	15517007
disease	I-Disease	-1	15517007
dat@@	O	-1	15517007
ab@@	O	-1	15517007
ase,	O	-1	15517007
and	O	-1	15517007
to	O	-1	15517007
prop@@	O	-1	15517007
ose	O	-1	15517007
a	O	-1	15517007
saf@@	O	-1	15517007
e	O	-1	15517007
appro@@	O	-1	15517007
ach	O	-1	15517007
to	O	-1	15517007
such	O	-1	15517007
patients.	O	-1	15517007
A	O	-1	15517007
ful@@	O	-1	15517007
l	O	-1	15517007
cardi@@	O	-1	15517007
ological	O	-1	15517007
assess@@	O	-1	15517007
ment	O	-1	15517007
before	O	-1	15517007
and	O	-1	15517007
during	O	-1	15517007
the	O	-1	15517007
transplant	O	-1	15517007
em@@	O	-1	15517007
erg@@	O	-1	15517007
ed	O	-1	15517007
as	O	-1	15517007
the	O	-1	15517007
major	O	-1	15517007
recomm@@	O	-1	15517007
en@@	O	-1	15517007
d@@	O	-1	15517007
ation.	O	-1	15517007

Im@@	O	-1	12180796
mun@@	O	-1	12180796
o@@	O	-1	12180796
histo@@	O	-1	12180796
chemical	O	-1	12180796
study	O	-1	12180796
on	O	-1	12180796
induc@@	O	-1	12180796
i@@	O	-1	12180796
ble	O	-1	12180796
type	O	-1	12180796
of	O	-1	12180796
nit@@	B-Chemical	D009569	12180796
ric	I-Chemical	-1	12180796
ox@@	I-Chemical	-1	12180796
ide	I-Chemical	-1	12180796
(@@	O	-1	12180796
i@@	O	-1	12180796
NO@@	O	-1	12180796
S@@	O	-1	12180796
),	O	-1	12180796
b@@	O	-1	12180796
a@@	O	-1	12180796
sic	O	-1	12180796
fib@@	O	-1	12180796
ro@@	O	-1	12180796
bl@@	O	-1	12180796
ast	O	-1	12180796
growth	O	-1	12180796
factor	O	-1	12180796
(@@	O	-1	12180796
b@@	O	-1	12180796
F@@	O	-1	12180796
GF@@	O	-1	12180796
)	O	-1	12180796
and	O	-1	12180796
tumor	B-Disease	D009369	12180796
growth	O	-1	12180796
fact@@	O	-1	12180796
or@@	O	-1	12180796
-@@	O	-1	12180796
beta@@	O	-1	12180796
1	O	-1	12180796
(T@@	O	-1	12180796
GF@@	O	-1	12180796
-@@	O	-1	12180796
beta@@	O	-1	12180796
1)	O	-1	12180796
in	O	-1	12180796
arter@@	B-Disease	D001167	12180796
iti@@	I-Disease	-1	12180796
s	I-Disease	-1	12180796
induced	O	-1	12180796
in	O	-1	12180796
rats	O	-1	12180796
by	O	-1	12180796
f@@	B-Chemical	D018818	12180796
en@@	I-Chemical	-1	12180796
ol@@	I-Chemical	-1	12180796
do@@	I-Chemical	-1	12180796
pa@@	I-Chemical	-1	12180796
m	I-Chemical	-1	12180796
and	O	-1	12180796
the@@	B-Chemical	D013806	12180796
oph@@	I-Chemical	-1	12180796
yl@@	I-Chemical	-1	12180796
line	I-Chemical	-1	12180796
,	O	-1	12180796
vas@@	O	-1	12180796
odi@@	O	-1	12180796
lat@@	O	-1	12180796
or@@	O	-1	12180796
s.	O	-1	12180796
A@@	B-Disease	D001167	12180796
r@@	I-Disease	-1	12180796
ter@@	I-Disease	-1	12180796
iti@@	I-Disease	-1	12180796
s	I-Disease	-1	12180796
induced	O	-1	12180796
in	O	-1	12180796
rats	O	-1	12180796
by	O	-1	12180796
vas@@	O	-1	12180796
odi@@	O	-1	12180796
lat@@	O	-1	12180796
or@@	O	-1	12180796
s,	O	-1	12180796
f@@	B-Chemical	D018818	12180796
en@@	I-Chemical	-1	12180796
ol@@	I-Chemical	-1	12180796
do@@	I-Chemical	-1	12180796
pa@@	I-Chemical	-1	12180796
m	I-Chemical	-1	12180796
and	O	-1	12180796
the@@	B-Chemical	D013806	12180796
oph@@	I-Chemical	-1	12180796
yl@@	I-Chemical	-1	12180796
line	I-Chemical	-1	12180796
,	O	-1	12180796
was	O	-1	12180796
examined	O	-1	12180796
immuno@@	O	-1	12180796
histo@@	O	-1	12180796
chem@@	O	-1	12180796
ically	O	-1	12180796
for	O	-1	12180796
ex@@	O	-1	12180796
pres@@	O	-1	12180796
sions	O	-1	12180796
of	O	-1	12180796
induc@@	O	-1	12180796
i@@	O	-1	12180796
ble	O	-1	12180796
type	O	-1	12180796
of	O	-1	12180796
nit@@	B-Chemical	D009569	12180796
ric	I-Chemical	-1	12180796
ox@@	I-Chemical	-1	12180796
ide	I-Chemical	-1	12180796
syn@@	O	-1	12180796
th@@	O	-1	12180796
ase	O	-1	12180796
(@@	O	-1	12180796
i@@	O	-1	12180796
NO@@	O	-1	12180796
S@@	O	-1	12180796
),	O	-1	12180796
b@@	O	-1	12180796
a@@	O	-1	12180796
sic	O	-1	12180796
fib@@	O	-1	12180796
ro@@	O	-1	12180796
bl@@	O	-1	12180796
ast	O	-1	12180796
growth	O	-1	12180796
factor	O	-1	12180796
(@@	O	-1	12180796
b@@	O	-1	12180796
F@@	O	-1	12180796
GF@@	O	-1	12180796
)	O	-1	12180796
and	O	-1	12180796
tumor	B-Disease	D009369	12180796
growth	O	-1	12180796
fact@@	O	-1	12180796
or@@	O	-1	12180796
-@@	O	-1	12180796
beta@@	O	-1	12180796
1	O	-1	12180796
(T@@	O	-1	12180796
GF@@	O	-1	12180796
-@@	O	-1	12180796
beta@@	O	-1	12180796
1).	O	-1	12180796
R@@	O	-1	12180796
at@@	O	-1	12180796
s	O	-1	12180796
were	O	-1	12180796
administered	O	-1	12180796
f@@	B-Chemical	D018818	12180796
en@@	I-Chemical	-1	12180796
ol@@	I-Chemical	-1	12180796
do@@	I-Chemical	-1	12180796
pa@@	I-Chemical	-1	12180796
m	I-Chemical	-1	12180796
for	O	-1	12180796
24	O	-1	12180796
hours	O	-1	12180796
by	O	-1	12180796
intravenous	O	-1	12180796
infusion	O	-1	12180796
with	O	-1	12180796
or	O	-1	12180796
without	O	-1	12180796
following	O	-1	12180796
repe@@	O	-1	12180796
ated	O	-1	12180796
daily	O	-1	12180796
oral	O	-1	12180796
administr@@	O	-1	12180796
ations	O	-1	12180796
of	O	-1	12180796
the@@	B-Chemical	D013806	12180796
oph@@	I-Chemical	-1	12180796
yl@@	I-Chemical	-1	12180796
line	I-Chemical	-1	12180796
.	O	-1	12180796
I@@	O	-1	12180796
r@@	O	-1	12180796
resp@@	O	-1	12180796
ective	O	-1	12180796
of	O	-1	12180796
the@@	B-Chemical	D013806	12180796
oph@@	I-Chemical	-1	12180796
yl@@	I-Chemical	-1	12180796
line	I-Chemical	-1	12180796
administr@@	O	-1	12180796
ation,	O	-1	12180796
i@@	O	-1	12180796
NO@@	O	-1	12180796
S	O	-1	12180796
anti@@	O	-1	12180796
gen@@	O	-1	12180796
s	O	-1	12180796
were	O	-1	12180796
re@@	O	-1	12180796
mark@@	O	-1	12180796
ably	O	-1	12180796
ab@@	O	-1	12180796
und@@	O	-1	12180796
ant	O	-1	12180796
in	O	-1	12180796
E@@	O	-1	12180796
D@@	O	-1	12180796
-1@@	O	-1	12180796
-@@	O	-1	12180796
positive	O	-1	12180796
cells	O	-1	12180796
on	O	-1	12180796
day	O	-1	12180796
5	O	-1	12180796
and	O	-1	12180796
8	O	-1	12180796
post@@	O	-1	12180796
-	O	-1	12180796
f@@	B-Chemical	D018818	12180796
en@@	I-Chemical	-1	12180796
ol@@	I-Chemical	-1	12180796
do@@	I-Chemical	-1	12180796
pa@@	I-Chemical	-1	12180796
m	I-Chemical	-1	12180796
-@@	O	-1	12180796
infusion	O	-1	12180796
(D@@	O	-1	12180796
P@@	O	-1	12180796
I@@	O	-1	12180796
);	O	-1	12180796
b@@	O	-1	12180796
F@@	O	-1	12180796
G@@	O	-1	12180796
F	O	-1	12180796
anti@@	O	-1	12180796
gen@@	O	-1	12180796
s	O	-1	12180796
were	O	-1	12180796
re@@	O	-1	12180796
mark@@	O	-1	12180796
ably	O	-1	12180796
ab@@	O	-1	12180796
und@@	O	-1	12180796
ant	O	-1	12180796
in	O	-1	12180796
E@@	O	-1	12180796
D@@	O	-1	12180796
-1@@	O	-1	12180796
-@@	O	-1	12180796
positive	O	-1	12180796
cells	O	-1	12180796
on	O	-1	12180796
1	O	-1	12180796
and	O	-1	12180796
3	O	-1	12180796
D@@	O	-1	12180796
P@@	O	-1	12180796
I@@	O	-1	12180796
;	O	-1	12180796
T@@	O	-1	12180796
GF@@	O	-1	12180796
-@@	O	-1	12180796
beta@@	O	-1	12180796
1	O	-1	12180796
anti@@	O	-1	12180796
gen@@	O	-1	12180796
s	O	-1	12180796
were	O	-1	12180796
observed	O	-1	12180796
in	O	-1	12180796
E@@	O	-1	12180796
D@@	O	-1	12180796
-1@@	O	-1	12180796
-@@	O	-1	12180796
positive	O	-1	12180796
cells	O	-1	12180796
on	O	-1	12180796
and	O	-1	12180796
after	O	-1	12180796
5	O	-1	12180796
D@@	O	-1	12180796
P@@	O	-1	12180796
I@@	O	-1	12180796
.	O	-1	12180796
These	O	-1	12180796
results	O	-1	12180796
suggest	O	-1	12180796
that	O	-1	12180796
the	O	-1	12180796
pe@@	O	-1	12180796
a@@	O	-1	12180796
k	O	-1	12180796
expression	O	-1	12180796
of	O	-1	12180796
i@@	O	-1	12180796
NO@@	O	-1	12180796
S	O	-1	12180796
anti@@	O	-1	12180796
gen	O	-1	12180796
was	O	-1	12180796
followed	O	-1	12180796
by	O	-1	12180796
that	O	-1	12180796
of	O	-1	12180796
b@@	O	-1	12180796
F@@	O	-1	12180796
G@@	O	-1	12180796
F	O	-1	12180796
anti@@	O	-1	12180796
gen@@	O	-1	12180796
,	O	-1	12180796
and	O	-1	12180796
b@@	O	-1	12180796
F@@	O	-1	12180796
G@@	O	-1	12180796
F	O	-1	12180796
may	O	-1	12180796
have	O	-1	12180796
a	O	-1	12180796
sup@@	O	-1	12180796
pressive	O	-1	12180796
effect	O	-1	12180796
on	O	-1	12180796
i@@	O	-1	12180796
NO@@	O	-1	12180796
S	O	-1	12180796
expression	O	-1	12180796
in	O	-1	12180796
these	O	-1	12180796
rat	O	-1	12180796
arter@@	B-Disease	D001167	12180796
iti@@	I-Disease	-1	12180796
s	I-Disease	-1	12180796
model@@	O	-1	12180796
s.	O	-1	12180796
O@@	O	-1	12180796
n	O	-1	12180796
the	O	-1	12180796
other	O	-1	12180796
h@@	O	-1	12180796
and@@	O	-1	12180796
,	O	-1	12180796
T@@	O	-1	12180796
GF@@	O	-1	12180796
-@@	O	-1	12180796
beta@@	O	-1	12180796
1	O	-1	12180796
was	O	-1	12180796
not	O	-1	12180796
considered	O	-1	12180796
to	O	-1	12180796
have	O	-1	12180796
a	O	-1	12180796
sup@@	O	-1	12180796
pressive	O	-1	12180796
effect	O	-1	12180796
on	O	-1	12180796
i@@	O	-1	12180796
NO@@	O	-1	12180796
S	O	-1	12180796
expression	O	-1	12180796
in	O	-1	12180796
these	O	-1	12180796
model@@	O	-1	12180796
s.	O	-1	12180796

L@@	B-Chemical	D006495	12109865
o@@	I-Chemical	-1	12109865
w@@	I-Chemical	-1	12109865
-@@	I-Chemical	-1	12109865
mol@@	I-Chemical	-1	12109865
ec@@	I-Chemical	-1	12109865
ul@@	I-Chemical	-1	12109865
ar@@	I-Chemical	-1	12109865
-@@	I-Chemical	-1	12109865
weight	I-Chemical	-1	12109865
hepar@@	I-Chemical	-1	12109865
in	I-Chemical	-1	12109865
for	O	-1	12109865
the	O	-1	12109865
treatment	O	-1	12109865
of	O	-1	12109865
patients	O	-1	12109865
with	O	-1	12109865
mechan@@	O	-1	12109865
ical	O	-1	12109865
heart	O	-1	12109865
val@@	O	-1	12109865
v@@	O	-1	12109865
es.	O	-1	12109865
BACKGROUND:	O	-1	12109865
The	O	-1	12109865
inter@@	O	-1	12109865
ru@@	O	-1	12109865
ption	O	-1	12109865
of	O	-1	12109865
oral	O	-1	12109865
anti@@	O	-1	12109865
co@@	O	-1	12109865
ag@@	O	-1	12109865
ul@@	O	-1	12109865
ant	O	-1	12109865
(@@	O	-1	12109865
O@@	O	-1	12109865
AC@@	O	-1	12109865
)	O	-1	12109865
administration	O	-1	12109865
is	O	-1	12109865
so@@	O	-1	12109865
me@@	O	-1	12109865
times	O	-1	12109865
indic@@	O	-1	12109865
ated	O	-1	12109865
in	O	-1	12109865
patients	O	-1	12109865
with	O	-1	12109865
mechan@@	O	-1	12109865
ical	O	-1	12109865
heart	O	-1	12109865
val@@	O	-1	12109865
v@@	O	-1	12109865
es,	O	-1	12109865
main@@	O	-1	12109865
ly	O	-1	12109865
before	O	-1	12109865
non@@	O	-1	12109865
cardiac	O	-1	12109865
surger@@	O	-1	12109865
y,	O	-1	12109865
non-@@	O	-1	12109865
surg@@	O	-1	12109865
ical	O	-1	12109865
inter@@	O	-1	12109865
ven@@	O	-1	12109865
tion@@	O	-1	12109865
s,	O	-1	12109865
and	O	-1	12109865
pregn@@	O	-1	12109865
anc@@	O	-1	12109865
y.	O	-1	12109865
U@@	B-Chemical	D006493	12109865
n@@	I-Chemical	-1	12109865
frac@@	I-Chemical	-1	12109865
tion@@	I-Chemical	-1	12109865
ated	I-Chemical	-1	12109865
hepar@@	I-Chemical	-1	12109865
in	I-Chemical	-1	12109865
(	O	-1	12109865
U@@	B-Chemical	D006493	12109865
H	I-Chemical	-1	12109865
)	O	-1	12109865
is	O	-1	12109865
cur@@	O	-1	12109865
ren@@	O	-1	12109865
tly	O	-1	12109865
the	O	-1	12109865
sub@@	O	-1	12109865
sti@@	O	-1	12109865
t@@	O	-1	12109865
ute	O	-1	12109865
for	O	-1	12109865
sel@@	O	-1	12109865
ected	O	-1	12109865
patients.	O	-1	12109865
L@@	B-Chemical	D006495	12109865
o@@	I-Chemical	-1	12109865
w@@	I-Chemical	-1	12109865
-@@	I-Chemical	-1	12109865
mol@@	I-Chemical	-1	12109865
ec@@	I-Chemical	-1	12109865
ul@@	I-Chemical	-1	12109865
ar@@	I-Chemical	-1	12109865
-@@	I-Chemical	-1	12109865
weight	I-Chemical	-1	12109865
hepar@@	I-Chemical	-1	12109865
in	I-Chemical	-1	12109865
(	O	-1	12109865
L@@	B-Chemical	D006495	12109865
M@@	I-Chemical	-1	12109865
W@@	I-Chemical	-1	12109865
H	I-Chemical	-1	12109865
)	O	-1	12109865
o@@	O	-1	12109865
ff@@	O	-1	12109865
ers	O	-1	12109865
the@@	O	-1	12109865
ore@@	O	-1	12109865
tical	O	-1	12109865
adv@@	O	-1	12109865
ant@@	O	-1	12109865
ages	O	-1	12109865
over	O	-1	12109865
U@@	B-Chemical	D006493	12109865
H	I-Chemical	-1	12109865
,	O	-1	12109865
but	O	-1	12109865
is	O	-1	12109865
not	O	-1	12109865
cur@@	O	-1	12109865
ren@@	O	-1	12109865
tly	O	-1	12109865
considered	O	-1	12109865
in	O	-1	12109865
clinical	O	-1	12109865
gu@@	O	-1	12109865
ide@@	O	-1	12109865
lin@@	O	-1	12109865
es	O	-1	12109865
as	O	-1	12109865
an	O	-1	12109865
al@@	O	-1	12109865
tern@@	O	-1	12109865
ative	O	-1	12109865
to	O	-1	12109865
U@@	B-Chemical	D006493	12109865
H	I-Chemical	-1	12109865
in	O	-1	12109865
patients	O	-1	12109865
with	O	-1	12109865
pro@@	O	-1	12109865
s@@	O	-1	12109865
thetic	O	-1	12109865
val@@	O	-1	12109865
v@@	O	-1	12109865
es.	O	-1	12109865
H@@	O	-1	12109865
Y@@	O	-1	12109865
P@@	O	-1	12109865
O@@	O	-1	12109865
T@@	O	-1	12109865
H@@	O	-1	12109865
ES@@	O	-1	12109865
I@@	O	-1	12109865
S:	O	-1	12109865
The	O	-1	12109865
a@@	O	-1	12109865
im	O	-1	12109865
of	O	-1	12109865
the	O	-1	12109865
present	O	-1	12109865
study	O	-1	12109865
was	O	-1	12109865
to	O	-1	12109865
revie@@	O	-1	12109865
w	O	-1	12109865
the	O	-1	12109865
data	O	-1	12109865
accum@@	O	-1	12109865
ul@@	O	-1	12109865
ated	O	-1	12109865
so	O	-1	12109865
f@@	O	-1	12109865
ar	O	-1	12109865
on	O	-1	12109865
the	O	-1	12109865
use	O	-1	12109865
of	O	-1	12109865
L@@	B-Chemical	D006495	12109865
M@@	I-Chemical	-1	12109865
W@@	I-Chemical	-1	12109865
H	I-Chemical	-1	12109865
in	O	-1	12109865
this	O	-1	12109865
patient	O	-1	12109865
po@@	O	-1	12109865
p@@	O	-1	12109865
ulation	O	-1	12109865
and	O	-1	12109865
to	O	-1	12109865
discus@@	O	-1	12109865
s	O	-1	12109865
its	O	-1	12109865
ap@@	O	-1	12109865
plic@@	O	-1	12109865
ability	O	-1	12109865
in	O	-1	12109865
common	O	-1	12109865
p@@	O	-1	12109865
rac@@	O	-1	12109865
ti@@	O	-1	12109865
ce@@	O	-1	12109865
.	O	-1	12109865
METHODS:	O	-1	12109865
F@@	O	-1	12109865
or	O	-1	12109865
this	O	-1	12109865
pa@@	O	-1	12109865
per@@	O	-1	12109865
,	O	-1	12109865
the	O	-1	12109865
current	O	-1	12109865
med@@	O	-1	12109865
ical	O	-1	12109865
literat@@	O	-1	12109865
ure	O	-1	12109865
on	O	-1	12109865
L@@	B-Chemical	D006495	12109865
M@@	I-Chemical	-1	12109865
W@@	I-Chemical	-1	12109865
H	I-Chemical	-1	12109865
in	O	-1	12109865
patients	O	-1	12109865
with	O	-1	12109865
mechan@@	O	-1	12109865
ical	O	-1	12109865
heart	O	-1	12109865
val@@	O	-1	12109865
v@@	O	-1	12109865
es	O	-1	12109865
was	O	-1	12109865
exten@@	O	-1	12109865
si@@	O	-1	12109865
vely	O	-1	12109865
revie@@	O	-1	12109865
we@@	O	-1	12109865
d.	O	-1	12109865
RESULTS:	O	-1	12109865
There	O	-1	12109865
were	O	-1	12109865
e@@	O	-1	12109865
ight	O	-1	12109865
seri@@	O	-1	12109865
es	O	-1	12109865
and	O	-1	12109865
six	O	-1	12109865
case	O	-1	12109865
repor@@	O	-1	12109865
t@@	O	-1	12109865
s.	O	-1	12109865
N@@	O	-1	12109865
one	O	-1	12109865
of	O	-1	12109865
the	O	-1	12109865
studies	O	-1	12109865
was	O	-1	12109865
random@@	O	-1	12109865
iz@@	O	-1	12109865
ed,	O	-1	12109865
and	O	-1	12109865
only	O	-1	12109865
one	O	-1	12109865
was	O	-1	12109865
pro@@	O	-1	12109865
sp@@	O	-1	12109865
ecti@@	O	-1	12109865
ve.	O	-1	12109865
D@@	O	-1	12109865
at@@	O	-1	12109865
a	O	-1	12109865
to	O	-1	12109865
est@@	O	-1	12109865
abl@@	O	-1	12109865
is@@	O	-1	12109865
h	O	-1	12109865
the	O	-1	12109865
thrombo@@	B-Disease	D013923	12109865
emb@@	I-Disease	-1	12109865
olic	I-Disease	-1	12109865
risk	O	-1	12109865
were	O	-1	12109865
in@@	O	-1	12109865
complete@@	O	-1	12109865
.	O	-1	12109865
After	O	-1	12109865
ex@@	O	-1	12109865
cl@@	O	-1	12109865
ud@@	O	-1	12109865
ing	O	-1	12109865
case	O	-1	12109865
repor@@	O	-1	12109865
t@@	O	-1	12109865
s,	O	-1	12109865
the	O	-1	12109865
following	O	-1	12109865
groups	O	-1	12109865
were	O	-1	12109865
con@@	O	-1	12109865
struc@@	O	-1	12109865
te@@	O	-1	12109865
d@@	O	-1	12109865
:	O	-1	12109865
(@@	O	-1	12109865
a@@	O	-1	12109865
)	O	-1	12109865
sh@@	O	-1	12109865
ort@@	O	-1	12109865
-term	O	-1	12109865
administr@@	O	-1	12109865
ation,	O	-1	12109865
after	O	-1	12109865
val@@	O	-1	12109865
ve	O	-1	12109865
in@@	O	-1	12109865
ser@@	O	-1	12109865
tion	O	-1	12109865
(n	O	-1	12109865
=	O	-1	12109865
2@@	O	-1	12109865
12@@	O	-1	12109865
);	O	-1	12109865
(@@	O	-1	12109865
b@@	O	-1	12109865
)	O	-1	12109865
sh@@	O	-1	12109865
ort@@	O	-1	12109865
-@@	O	-1	12109865
ter@@	O	-1	12109865
m@@	O	-1	12109865
,	O	-1	12109865
perio@@	O	-1	12109865
perative	O	-1	12109865
(@@	O	-1	12109865
non@@	O	-1	12109865
cardi@@	O	-1	12109865
ac@@	O	-1	12109865
)@@	O	-1	12109865
/@@	O	-1	12109865
peri@@	O	-1	12109865
proce@@	O	-1	12109865
dur@@	O	-1	12109865
al	O	-1	12109865
(n	O	-1	12109865
=	O	-1	12109865
1@@	O	-1	12109865
14@@	O	-1	12109865
);	O	-1	12109865
(@@	O	-1	12109865
c@@	O	-1	12109865
)	O	-1	12109865
long@@	O	-1	12109865
-@@	O	-1	12109865
ter@@	O	-1	12109865
m@@	O	-1	12109865
,	O	-1	12109865
due	O	-1	12109865
to	O	-1	12109865
int@@	O	-1	12109865
oler@@	O	-1	12109865
ance	O	-1	12109865
to	O	-1	12109865
O@@	O	-1	12109865
A@@	O	-1	12109865
C	O	-1	12109865
(n	O	-1	12109865
=	O	-1	12109865
1@@	O	-1	12109865
6@@	O	-1	12109865
);	O	-1	12109865
(@@	O	-1	12109865
d@@	O	-1	12109865
)	O	-1	12109865
long@@	O	-1	12109865
-@@	O	-1	12109865
ter@@	O	-1	12109865
m@@	O	-1	12109865
,	O	-1	12109865
in	O	-1	12109865
pregn@@	O	-1	12109865
anc@@	O	-1	12109865
y	O	-1	12109865
(n	O	-1	12109865
=	O	-1	12109865
10@@	O	-1	12109865
).	O	-1	12109865
The	O	-1	12109865
incidence	O	-1	12109865
rate	O	-1	12109865
of	O	-1	12109865
thrombo@@	B-Disease	D013923	12109865
emb@@	I-Disease	-1	12109865
ol@@	I-Disease	-1	12109865
ism	I-Disease	-1	12109865
was	O	-1	12109865
0.@@	O	-1	12109865
9@@	O	-1	12109865
%	O	-1	12109865
for	O	-1	12109865
all	O	-1	12109865
the	O	-1	12109865
studies	O	-1	12109865
and	O	-1	12109865
0.@@	O	-1	12109865
5,	O	-1	12109865
0@@	O	-1	12109865
,	O	-1	12109865
20@@	O	-1	12109865
,	O	-1	12109865
and	O	-1	12109865
0%	O	-1	12109865
in	O	-1	12109865
groups	O	-1	12109865
a,	O	-1	12109865
b@@	O	-1	12109865
,	O	-1	12109865
c@@	O	-1	12109865
,	O	-1	12109865
and	O	-1	12109865
d,	O	-1	12109865
respectivel@@	O	-1	12109865
y@@	O	-1	12109865
;	O	-1	12109865
for	O	-1	12109865
hemorrh@@	B-Disease	D006470	12109865
age	I-Disease	-1	12109865
,	O	-1	12109865
the	O	-1	12109865
over@@	O	-1	12109865
all	O	-1	12109865
rate	O	-1	12109865
was	O	-1	12109865
3.@@	O	-1	12109865
4@@	O	-1	12109865
%	O	-1	12109865
(@@	O	-1	12109865
3.@@	O	-1	12109865
8@@	O	-1	12109865
,	O	-1	12109865
2.@@	O	-1	12109865
6,	O	-1	12109865
10@@	O	-1	12109865
,	O	-1	12109865
and	O	-1	12109865
0%	O	-1	12109865
for	O	-1	12109865
the	O	-1	12109865
resp@@	O	-1	12109865
ective	O	-1	12109865
group@@	O	-1	12109865
s@@	O	-1	12109865
).	O	-1	12109865
CONCLUSIONS:	O	-1	12109865
In	O	-1	12109865
patients	O	-1	12109865
with	O	-1	12109865
mechan@@	O	-1	12109865
ical	O	-1	12109865
heart	O	-1	12109865
val@@	O	-1	12109865
v@@	O	-1	12109865
es,	O	-1	12109865
sh@@	O	-1	12109865
ort@@	O	-1	12109865
-term	O	-1	12109865
L@@	B-Chemical	D006495	12109865
M@@	I-Chemical	-1	12109865
W@@	I-Chemical	-1	12109865
H	I-Chemical	-1	12109865
therapy	O	-1	12109865
com@@	O	-1	12109865
pa@@	O	-1	12109865
res	O	-1	12109865
f@@	O	-1	12109865
av@@	O	-1	12109865
or@@	O	-1	12109865
ably	O	-1	12109865
with	O	-1	12109865
U@@	B-Chemical	D006493	12109865
H	I-Chemical	-1	12109865
.	O	-1	12109865
D@@	O	-1	12109865
at@@	O	-1	12109865
a	O	-1	12109865
on	O	-1	12109865
mid@@	O	-1	12109865
-	O	-1	12109865
and	O	-1	12109865
long-term	O	-1	12109865
L@@	B-Chemical	D006495	12109865
M@@	I-Chemical	-1	12109865
W@@	I-Chemical	-1	12109865
H	I-Chemical	-1	12109865
administration	O	-1	12109865
in	O	-1	12109865
these	O	-1	12109865
patients	O	-1	12109865
are	O	-1	12109865
s@@	O	-1	12109865
par@@	O	-1	12109865
se.	O	-1	12109865
F@@	O	-1	12109865
urther	O	-1	12109865
randomized	O	-1	12109865
studies	O	-1	12109865
are	O	-1	12109865
ne@@	O	-1	12109865
ed@@	O	-1	12109865
ed	O	-1	12109865
to	O	-1	12109865
con@@	O	-1	12109865
fir@@	O	-1	12109865
m	O	-1	12109865
the	O	-1	12109865
safety	O	-1	12109865
and	O	-1	12109865
pre@@	O	-1	12109865
cis@@	O	-1	12109865
e	O	-1	12109865
indic@@	O	-1	12109865
ations	O	-1	12109865
for	O	-1	12109865
the	O	-1	12109865
use	O	-1	12109865
of	O	-1	12109865
L@@	B-Chemical	D006495	12109865
M@@	I-Chemical	-1	12109865
W@@	I-Chemical	-1	12109865
H	I-Chemical	-1	12109865
in	O	-1	12109865
patients	O	-1	12109865
with	O	-1	12109865
mechan@@	O	-1	12109865
ical	O	-1	12109865
heart	O	-1	12109865
val@@	O	-1	12109865
v@@	O	-1	12109865
es.	O	-1	12109865

T@@	B-Chemical	C052342	12042105
o@@	I-Chemical	-1	12042105
pi@@	I-Chemical	-1	12042105
ram@@	I-Chemical	-1	12042105
ate	I-Chemical	-1	12042105
-induced	O	-1	12042105
nephro@@	B-Disease	D053040	12042105
li@@	I-Disease	-1	12042105
th@@	I-Disease	-1	12042105
ia@@	I-Disease	-1	12042105
sis	I-Disease	-1	12042105
.	O	-1	12042105
T@@	B-Chemical	C052342	12042105
o@@	I-Chemical	-1	12042105
pi@@	I-Chemical	-1	12042105
ram@@	I-Chemical	-1	12042105
ate	I-Chemical	-1	12042105
is	O	-1	12042105
a	O	-1	12042105
rec@@	O	-1	12042105
ently	O	-1	12042105
developed	O	-1	12042105
anti@@	O	-1	12042105
epileptic	O	-1	12042105
medic@@	O	-1	12042105
ation	O	-1	12042105
that	O	-1	12042105
is	O	-1	12042105
b@@	O	-1	12042105
ec@@	O	-1	12042105
om@@	O	-1	12042105
ing	O	-1	12042105
more	O	-1	12042105
wi@@	O	-1	12042105
de@@	O	-1	12042105
ly	O	-1	12042105
prescri@@	O	-1	12042105
bed	O	-1	12042105
because	O	-1	12042105
of	O	-1	12042105
its	O	-1	12042105
efficacy	O	-1	12042105
in	O	-1	12042105
treat@@	O	-1	12042105
ing	O	-1	12042105
ref@@	B-Disease	D004827	12042105
rac@@	I-Disease	-1	12042105
t@@	I-Disease	-1	12042105
ory	I-Disease	-1	12042105
seizures	I-Disease	-1	12042105
.	O	-1	12042105
U@@	O	-1	12042105
ro@@	O	-1	12042105
log@@	O	-1	12042105
ist@@	O	-1	12042105
s	O	-1	12042105
should	O	-1	12042105
be	O	-1	12042105
aw@@	O	-1	12042105
are	O	-1	12042105
that	O	-1	12042105
this	O	-1	12042105
medic@@	O	-1	12042105
ation	O	-1	12042105
can	O	-1	12042105
cause	O	-1	12042105
met@@	B-Disease	D000138	12042105
ab@@	I-Disease	-1	12042105
olic	I-Disease	-1	12042105
acid@@	I-Disease	-1	12042105
o@@	I-Disease	-1	12042105
sis	I-Disease	-1	12042105
in	O	-1	12042105
patients	O	-1	12042105
secondary	O	-1	12042105
to	O	-1	12042105
inhibition	O	-1	12042105
of	O	-1	12042105
carb@@	O	-1	12042105
onic	O	-1	12042105
an@@	O	-1	12042105
hy@@	O	-1	12042105
d@@	O	-1	12042105
r@@	O	-1	12042105
as@@	O	-1	12042105
e.	O	-1	12042105
In	O	-1	12042105
addi@@	O	-1	12042105
tion,	O	-1	12042105
a	O	-1	12042105
dist@@	O	-1	12042105
al	O	-1	12042105
tub@@	O	-1	12042105
ular	O	-1	12042105
ac@@	O	-1	12042105
i@@	O	-1	12042105
di@@	O	-1	12042105
fic@@	O	-1	12042105
ation	O	-1	12042105
def@@	O	-1	12042105
ect	O	-1	12042105
may	O	-1	12042105
result@@	O	-1	12042105
,	O	-1	12042105
th@@	O	-1	12042105
us	O	-1	12042105
impair@@	O	-1	12042105
ing	O	-1	12042105
the	O	-1	12042105
normal	O	-1	12042105
com@@	O	-1	12042105
pen@@	O	-1	12042105
s@@	O	-1	12042105
atory	O	-1	12042105
dro@@	O	-1	12042105
p	O	-1	12042105
in	O	-1	12042105
urine	O	-1	12042105
p@@	O	-1	12042105
H@@	O	-1	12042105
.	O	-1	12042105
These	O	-1	12042105
factors	O	-1	12042105
can	O	-1	12042105
le@@	O	-1	12042105
ad	O	-1	12042105
to	O	-1	12042105
the	O	-1	12042105
development	O	-1	12042105
of	O	-1	12042105
calcium	B-Chemical	C020243	12042105
phosph@@	I-Chemical	-1	12042105
ate	I-Chemical	-1	12042105
nephro@@	B-Disease	D053040	12042105
li@@	I-Disease	-1	12042105
th@@	I-Disease	-1	12042105
ia@@	I-Disease	-1	12042105
sis	I-Disease	-1	12042105
.	O	-1	12042105
We	O	-1	12042105
report	O	-1	12042105
the	O	-1	12042105
first	O	-1	12042105
two	O	-1	12042105
cases	O	-1	12042105
of	O	-1	12042105
to@@	B-Chemical	C052342	12042105
pi@@	I-Chemical	-1	12042105
ram@@	I-Chemical	-1	12042105
ate	I-Chemical	-1	12042105
-induced	O	-1	12042105
nephro@@	B-Disease	D053040	12042105
li@@	I-Disease	-1	12042105
th@@	I-Disease	-1	12042105
ia@@	I-Disease	-1	12042105
sis	I-Disease	-1	12042105
in	O	-1	12042105
the	O	-1	12042105
uro@@	O	-1	12042105
log@@	O	-1	12042105
ic	O	-1	12042105
literat@@	O	-1	12042105
ure.	O	-1	12042105

S@@	B-Chemical	D013148	11868798
pi@@	I-Chemical	-1	11868798
ron@@	I-Chemical	-1	11868798
ol@@	I-Chemical	-1	11868798
act@@	I-Chemical	-1	11868798
one	I-Chemical	-1	11868798
:	O	-1	11868798
is	O	-1	11868798
it	O	-1	11868798
a	O	-1	11868798
novel	O	-1	11868798
drug	O	-1	11868798
for	O	-1	11868798
the	O	-1	11868798
pre@@	O	-1	11868798
ven@@	O	-1	11868798
tion	O	-1	11868798
of	O	-1	11868798
amph@@	B-Chemical	D000666	11868798
ot@@	I-Chemical	-1	11868798
er@@	I-Chemical	-1	11868798
icin	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
-@@	O	-1	11868798
related	O	-1	11868798
hypo@@	B-Disease	D007008	11868798
k@@	I-Disease	-1	11868798
al@@	I-Disease	-1	11868798
emia	I-Disease	-1	11868798
in	O	-1	11868798
cancer	B-Disease	D009369	11868798
patient@@	O	-1	11868798
s@@	O	-1	11868798
?	O	-1	11868798
OBJECTIVE:	O	-1	11868798
Ne@@	B-Disease	D007674	11868798
ph@@	I-Disease	-1	11868798
ro@@	I-Disease	-1	11868798
toxicity	I-Disease	-1	11868798
is	O	-1	11868798
the	O	-1	11868798
major	O	-1	11868798
adverse	O	-1	11868798
effect	O	-1	11868798
of	O	-1	11868798
amph@@	B-Chemical	D000666	11868798
ot@@	I-Chemical	-1	11868798
er@@	I-Chemical	-1	11868798
icin	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
(	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
),	O	-1	11868798
often	O	-1	11868798
lim@@	O	-1	11868798
it@@	O	-1	11868798
ing	O	-1	11868798
administration	O	-1	11868798
of	O	-1	11868798
ful@@	O	-1	11868798
l	O	-1	11868798
dos@@	O	-1	11868798
age.	O	-1	11868798
S@@	O	-1	11868798
el@@	O	-1	11868798
ective	O	-1	11868798
dist@@	O	-1	11868798
al	O	-1	11868798
tub@@	O	-1	11868798
ular	O	-1	11868798
epi@@	O	-1	11868798
thelial	O	-1	11868798
toxicity	B-Disease	D064420	11868798
se@@	O	-1	11868798
em@@	O	-1	11868798
s	O	-1	11868798
to	O	-1	11868798
be	O	-1	11868798
respon@@	O	-1	11868798
sible	O	-1	11868798
for	O	-1	11868798
the	O	-1	11868798
pro@@	O	-1	11868798
found	O	-1	11868798
pot@@	B-Chemical	D011188	11868798
assi@@	I-Chemical	-1	11868798
um	I-Chemical	-1	11868798
w@@	O	-1	11868798
ast@@	O	-1	11868798
ing	O	-1	11868798
that	O	-1	11868798
is	O	-1	11868798
a	O	-1	11868798
major	O	-1	11868798
clinical	O	-1	11868798
side	O	-1	11868798
effect	O	-1	11868798
of	O	-1	11868798
treatment	O	-1	11868798
with	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
.	O	-1	11868798
P@@	B-Chemical	D011188	11868798
ot@@	I-Chemical	-1	11868798
assi@@	I-Chemical	-1	11868798
um	I-Chemical	-1	11868798
deple@@	O	-1	11868798
tion	O	-1	11868798
also	O	-1	11868798
potenti@@	O	-1	11868798
ates	O	-1	11868798
the	O	-1	11868798
tub@@	O	-1	11868798
ular	O	-1	11868798
toxicity	B-Disease	D064420	11868798
of	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
.	O	-1	11868798
This	O	-1	11868798
study	O	-1	11868798
was	O	-1	11868798
de@@	O	-1	11868798
signed	O	-1	11868798
to	O	-1	11868798
ass@@	O	-1	11868798
ess	O	-1	11868798
the	O	-1	11868798
ability	O	-1	11868798
of	O	-1	11868798
s@@	B-Chemical	D013148	11868798
pi@@	I-Chemical	-1	11868798
ron@@	I-Chemical	-1	11868798
ol@@	I-Chemical	-1	11868798
act@@	I-Chemical	-1	11868798
one	I-Chemical	-1	11868798
to	O	-1	11868798
re@@	O	-1	11868798
duce	O	-1	11868798
pot@@	B-Chemical	D011188	11868798
assi@@	I-Chemical	-1	11868798
um	I-Chemical	-1	11868798
requ@@	O	-1	11868798
i@@	O	-1	11868798
re@@	O	-1	11868798
ments	O	-1	11868798
and	O	-1	11868798
to	O	-1	11868798
prev@@	O	-1	11868798
ent	O	-1	11868798
hypo@@	B-Disease	D007008	11868798
k@@	I-Disease	-1	11868798
al@@	I-Disease	-1	11868798
emia	I-Disease	-1	11868798
in	O	-1	11868798
ne@@	B-Disease	D009503	11868798
ut@@	I-Disease	-1	11868798
ro@@	I-Disease	-1	11868798
pen@@	I-Disease	-1	11868798
ic	I-Disease	-1	11868798
patients	O	-1	11868798
on	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
treatment.	O	-1	11868798
METHODS:	O	-1	11868798
In	O	-1	11868798
this	O	-1	11868798
study	O	-1	11868798
2@@	O	-1	11868798
6	O	-1	11868798
patients	O	-1	11868798
with	O	-1	11868798
various	O	-1	11868798
hemat@@	B-Disease	D006402	11868798
ological	I-Disease	-1	11868798
disorder@@	I-Disease	-1	11868798
s	I-Disease	-1	11868798
were	O	-1	11868798
randomized	O	-1	11868798
to	O	-1	11868798
recei@@	O	-1	11868798
ve	O	-1	11868798
either	O	-1	11868798
intravenous	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
alone	O	-1	11868798
or	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
and	O	-1	11868798
oral	O	-1	11868798
s@@	B-Chemical	D013148	11868798
pi@@	I-Chemical	-1	11868798
ron@@	I-Chemical	-1	11868798
ol@@	I-Chemical	-1	11868798
act@@	I-Chemical	-1	11868798
one	I-Chemical	-1	11868798
100	O	-1	11868798
mg	O	-1	11868798
tw@@	O	-1	11868798
ic@@	O	-1	11868798
e	O	-1	11868798
daily	O	-1	11868798
when	O	-1	11868798
develop@@	O	-1	11868798
ing	O	-1	11868798
a	O	-1	11868798
pro@@	O	-1	11868798
ven	O	-1	11868798
or	O	-1	11868798
sus@@	O	-1	11868798
p@@	O	-1	11868798
ected	O	-1	11868798
f@@	B-Disease	D009181	11868798
un@@	I-Disease	-1	11868798
g@@	I-Disease	-1	11868798
al	I-Disease	-1	11868798
inf@@	I-Disease	-1	11868798
ection	I-Disease	-1	11868798
.	O	-1	11868798
RESULTS:	O	-1	11868798
Patients	O	-1	11868798
receiving	O	-1	11868798
concomit@@	O	-1	11868798
ant	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
and	O	-1	11868798
s@@	B-Chemical	D013148	11868798
pi@@	I-Chemical	-1	11868798
ron@@	I-Chemical	-1	11868798
ol@@	I-Chemical	-1	11868798
act@@	I-Chemical	-1	11868798
one	I-Chemical	-1	11868798
had	O	-1	11868798
significantly	O	-1	11868798
higher	O	-1	11868798
plasma	O	-1	11868798
pot@@	B-Chemical	D011188	11868798
assi@@	I-Chemical	-1	11868798
um	I-Chemical	-1	11868798
levels	O	-1	11868798
than	O	-1	11868798
those	O	-1	11868798
receiving	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
alone	O	-1	11868798
(P	O	-1	11868798
=	O	-1	11868798
0.00@@	O	-1	11868798
27@@	O	-1	11868798
).	O	-1	11868798
Th@@	O	-1	11868798
ose	O	-1	11868798
patients	O	-1	11868798
receiving	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
and	O	-1	11868798
s@@	B-Chemical	D013148	11868798
pi@@	I-Chemical	-1	11868798
ron@@	I-Chemical	-1	11868798
ol@@	I-Chemical	-1	11868798
act@@	I-Chemical	-1	11868798
one	I-Chemical	-1	11868798
requ@@	O	-1	11868798
ired	O	-1	11868798
significantly	O	-1	11868798
less	O	-1	11868798
pot@@	B-Chemical	D011188	11868798
assi@@	I-Chemical	-1	11868798
um	I-Chemical	-1	11868798
sup@@	O	-1	11868798
ple@@	O	-1	11868798
ment@@	O	-1	11868798
ation	O	-1	11868798
to	O	-1	11868798
maint@@	O	-1	11868798
ain	O	-1	11868798
their	O	-1	11868798
plasma	O	-1	11868798
pot@@	B-Chemical	D011188	11868798
assi@@	I-Chemical	-1	11868798
um	I-Chemical	-1	11868798
within	O	-1	11868798
the	O	-1	11868798
normal	O	-1	11868798
range	O	-1	11868798
(P	O	-1	11868798
=	O	-1	11868798
0.0@@	O	-1	11868798
2@@	O	-1	11868798
2@@	O	-1	11868798
).	O	-1	11868798
M@@	O	-1	11868798
ore@@	O	-1	11868798
o@@	O	-1	11868798
ver,	O	-1	11868798
urinary	O	-1	11868798
pot@@	B-Chemical	D011188	11868798
assi@@	I-Chemical	-1	11868798
um	I-Chemical	-1	11868798
los@@	O	-1	11868798
ses	O	-1	11868798
were	O	-1	11868798
significantly	O	-1	11868798
less	O	-1	11868798
in	O	-1	11868798
patients	O	-1	11868798
receiving	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
and	O	-1	11868798
s@@	B-Chemical	D013148	11868798
pi@@	I-Chemical	-1	11868798
ron@@	I-Chemical	-1	11868798
ol@@	I-Chemical	-1	11868798
act@@	I-Chemical	-1	11868798
one	I-Chemical	-1	11868798
than	O	-1	11868798
those	O	-1	11868798
receiving	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
alone	O	-1	11868798
(P	O	-1	11868798
=	O	-1	11868798
0.0@@	O	-1	11868798
4@@	O	-1	11868798
0@@	O	-1	11868798
).	O	-1	11868798
CONCLUSION:	O	-1	11868798
This	O	-1	11868798
study	O	-1	11868798
showed	O	-1	11868798
that	O	-1	11868798
s@@	B-Chemical	D013148	11868798
pi@@	I-Chemical	-1	11868798
ron@@	I-Chemical	-1	11868798
ol@@	I-Chemical	-1	11868798
act@@	I-Chemical	-1	11868798
one	I-Chemical	-1	11868798
can	O	-1	11868798
re@@	O	-1	11868798
duce	O	-1	11868798
pot@@	B-Chemical	D011188	11868798
assi@@	I-Chemical	-1	11868798
um	I-Chemical	-1	11868798
requ@@	O	-1	11868798
i@@	O	-1	11868798
re@@	O	-1	11868798
ments	O	-1	11868798
and	O	-1	11868798
prev@@	O	-1	11868798
ent	O	-1	11868798
hypo@@	B-Disease	D007008	11868798
k@@	I-Disease	-1	11868798
al@@	I-Disease	-1	11868798
emia	I-Disease	-1	11868798
by	O	-1	11868798
reduc@@	O	-1	11868798
ing	O	-1	11868798
urinary	O	-1	11868798
pot@@	B-Chemical	D011188	11868798
assi@@	I-Chemical	-1	11868798
um	I-Chemical	-1	11868798
loss	O	-1	11868798
in	O	-1	11868798
ne@@	B-Disease	D009503	11868798
ut@@	I-Disease	-1	11868798
ro@@	I-Disease	-1	11868798
pen@@	I-Disease	-1	11868798
ic	I-Disease	-1	11868798
patients	O	-1	11868798
on	O	-1	11868798
A@@	B-Chemical	D000666	11868798
m@@	I-Chemical	-1	11868798
B	I-Chemical	-1	11868798
treatment.	O	-1	11868798

D@@	B-Chemical	D004298	11860278
op@@	I-Chemical	-1	11860278
amine	I-Chemical	-1	11860278
D2	O	-1	11860278
receptor	O	-1	11860278
sign@@	O	-1	11860278
al@@	O	-1	11860278
ing	O	-1	11860278
controls	O	-1	11860278
neuron@@	O	-1	11860278
al	O	-1	11860278
cell	O	-1	11860278
death	O	-1	11860278
induced	O	-1	11860278
by	O	-1	11860278
mus@@	O	-1	11860278
car@@	O	-1	11860278
inic	O	-1	11860278
and	O	-1	11860278
glutam@@	O	-1	11860278
at@@	O	-1	11860278
ergic	O	-1	11860278
drug@@	O	-1	11860278
s.	O	-1	11860278
D@@	B-Chemical	D004298	11860278
op@@	I-Chemical	-1	11860278
amine	I-Chemical	-1	11860278
(	O	-1	11860278
D@@	B-Chemical	D004298	11860278
A	I-Chemical	-1	11860278
),	O	-1	11860278
through	O	-1	11860278
D@@	O	-1	11860278
1@@	O	-1	11860278
/@@	O	-1	11860278
D2	O	-1	11860278
receptor@@	O	-1	11860278
-@@	O	-1	11860278
mediated	O	-1	11860278
sign@@	O	-1	11860278
al@@	O	-1	11860278
ing,	O	-1	11860278
pl@@	O	-1	11860278
ays	O	-1	11860278
a	O	-1	11860278
major	O	-1	11860278
role	O	-1	11860278
in	O	-1	11860278
the	O	-1	11860278
control	O	-1	11860278
of	O	-1	11860278
epileptic	B-Disease	D004827	11860278
seizures	I-Disease	-1	11860278
ar@@	O	-1	11860278
is@@	O	-1	11860278
ing	O	-1	11860278
in	O	-1	11860278
the	O	-1	11860278
lim@@	O	-1	11860278
b@@	O	-1	11860278
ic	O	-1	11860278
system@@	O	-1	11860278
.	O	-1	11860278
E@@	B-Disease	-1	11860278
x@@	I-Disease	-1	11860278
cit@@	I-Disease	-1	11860278
otoxicity	I-Disease	-1	11860278
lead@@	O	-1	11860278
ing	O	-1	11860278
to	O	-1	11860278
neuron@@	O	-1	11860278
al	O	-1	11860278
cell	O	-1	11860278
death	O	-1	11860278
in	O	-1	11860278
the	O	-1	11860278
affected	O	-1	11860278
a@@	O	-1	11860278
reas	O	-1	11860278
is	O	-1	11860278
a	O	-1	11860278
major	O	-1	11860278
con@@	O	-1	11860278
sequ@@	O	-1	11860278
ence	O	-1	11860278
of	O	-1	11860278
seizures	B-Disease	D012640	11860278
at	O	-1	11860278
the	O	-1	11860278
cell@@	O	-1	11860278
ular	O	-1	11860278
level@@	O	-1	11860278
.	O	-1	11860278
In	O	-1	11860278
this	O	-1	11860278
resp@@	O	-1	11860278
ect@@	O	-1	11860278
,	O	-1	11860278
lit@@	O	-1	11860278
t@@	O	-1	11860278
le	O	-1	11860278
is	O	-1	11860278
known	O	-1	11860278
about	O	-1	11860278
the	O	-1	11860278
role	O	-1	11860278
of	O	-1	11860278
D@@	B-Chemical	D004298	11860278
A	I-Chemical	-1	11860278
receptors	O	-1	11860278
in	O	-1	11860278
the	O	-1	11860278
occur@@	O	-1	11860278
rence	O	-1	11860278
of	O	-1	11860278
epilep@@	B-Disease	D004827	11860278
sy	I-Disease	-1	11860278
-induced	O	-1	11860278
neuron@@	O	-1	11860278
al	O	-1	11860278
cell	O	-1	11860278
de@@	O	-1	11860278
ath@@	O	-1	11860278
.	O	-1	11860278
H@@	O	-1	11860278
ere	O	-1	11860278
we	O	-1	11860278
analy@@	O	-1	11860278
ze	O	-1	11860278
the	O	-1	11860278
occur@@	O	-1	11860278
rence	O	-1	11860278
of	O	-1	11860278
seizures	B-Disease	D012640	11860278
and	O	-1	11860278
neuro@@	B-Disease	D020258	11860278
toxicity	I-Disease	-1	11860278
in	O	-1	11860278
D@@	O	-1	11860278
2@@	O	-1	11860278
R	O	-1	11860278
-@@	O	-1	11860278
/@@	O	-1	11860278
-	O	-1	11860278
mice	O	-1	11860278
treated	O	-1	11860278
with	O	-1	11860278
the	O	-1	11860278
cholinergic	O	-1	11860278
agon@@	O	-1	11860278
ist	O	-1	11860278
pilocar@@	B-Chemical	D010862	11860278
pine	I-Chemical	-1	11860278
.	O	-1	11860278
We	O	-1	11860278
compared	O	-1	11860278
these	O	-1	11860278
results	O	-1	11860278
with	O	-1	11860278
those	O	-1	11860278
previously	O	-1	11860278
obtained	O	-1	11860278
with	O	-1	11860278
k@@	B-Chemical	D007608	11860278
ain@@	I-Chemical	-1	11860278
ic	I-Chemical	-1	11860278
acid	I-Chemical	-1	11860278
(	O	-1	11860278
K@@	B-Chemical	D007608	11860278
A	I-Chemical	-1	11860278
),	O	-1	11860278
a	O	-1	11860278
pot@@	O	-1	11860278
ent	O	-1	11860278
glutamate	B-Chemical	D018698	11860278
agon@@	O	-1	11860278
ist@@	O	-1	11860278
.	O	-1	11860278
Im@@	O	-1	11860278
port@@	O	-1	11860278
ant@@	O	-1	11860278
ly,	O	-1	11860278
D@@	O	-1	11860278
2@@	O	-1	11860278
R	O	-1	11860278
-@@	O	-1	11860278
/@@	O	-1	11860278
-	O	-1	11860278
mice	O	-1	11860278
deve@@	O	-1	11860278
lo@@	O	-1	11860278
p	O	-1	11860278
seizures	B-Disease	D012640	11860278
at	O	-1	11860278
doses	O	-1	11860278
of	O	-1	11860278
both	O	-1	11860278
drugs	O	-1	11860278
that	O	-1	11860278
are	O	-1	11860278
not	O	-1	11860278
epile@@	O	-1	11860278
pto@@	O	-1	11860278
genic	O	-1	11860278
for	O	-1	11860278
W@@	O	-1	11860278
T	O	-1	11860278
lit@@	O	-1	11860278
ter@@	O	-1	11860278
mat@@	O	-1	11860278
es	O	-1	11860278
and	O	-1	11860278
show	O	-1	11860278
greater	O	-1	11860278
neuro@@	B-Disease	D020258	11860278
toxicity	I-Disease	-1	11860278
.	O	-1	11860278
However,	O	-1	11860278
pilocar@@	B-Chemical	D010862	11860278
pine	I-Chemical	-1	11860278
-induced	O	-1	11860278
seizures	B-Disease	D012640	11860278
result	O	-1	11860278
in	O	-1	11860278
a	O	-1	11860278
more	O	-1	11860278
w@@	O	-1	11860278
id@@	O	-1	11860278
es@@	O	-1	11860278
pre@@	O	-1	11860278
ad	O	-1	11860278
neuron@@	O	-1	11860278
al	O	-1	11860278
death	O	-1	11860278
in	O	-1	11860278
both	O	-1	11860278
W@@	O	-1	11860278
T	O	-1	11860278
and	O	-1	11860278
D@@	O	-1	11860278
2@@	O	-1	11860278
R	O	-1	11860278
-@@	O	-1	11860278
/@@	O	-1	11860278
-	O	-1	11860278
bra@@	O	-1	11860278
ins	O	-1	11860278
in	O	-1	11860278
compar@@	O	-1	11860278
ison	O	-1	11860278
to	O	-1	11860278
K@@	B-Chemical	D007608	11860278
A	I-Chemical	-1	11860278
.	O	-1	11860278
Th@@	O	-1	11860278
us,	O	-1	11860278
the	O	-1	11860278
absence	O	-1	11860278
of	O	-1	11860278
D@@	O	-1	11860278
2@@	O	-1	11860278
R	O	-1	11860278
low@@	O	-1	11860278
ers	O	-1	11860278
the	O	-1	11860278
th@@	O	-1	11860278
res@@	O	-1	11860278
h@@	O	-1	11860278
old	O	-1	11860278
for	O	-1	11860278
seizures	B-Disease	D012640	11860278
induced	O	-1	11860278
by	O	-1	11860278
both	O	-1	11860278
glutamate	B-Chemical	D018698	11860278
and	O	-1	11860278
acet@@	B-Chemical	D000109	11860278
ylcholine	I-Chemical	-1	11860278
.	O	-1	11860278
M@@	O	-1	11860278
ore@@	O	-1	11860278
o@@	O	-1	11860278
ver,	O	-1	11860278
the	O	-1	11860278
dop@@	O	-1	11860278
aminergic	O	-1	11860278
control	O	-1	11860278
of	O	-1	11860278
epilep@@	B-Disease	D004827	11860278
sy	I-Disease	-1	11860278
-induced	O	-1	11860278
neuro@@	B-Disease	D019636	11860278
de@@	I-Disease	-1	11860278
generation	I-Disease	-1	11860278
se@@	O	-1	11860278
em@@	O	-1	11860278
s	O	-1	11860278
to	O	-1	11860278
be	O	-1	11860278
mediated	O	-1	11860278
by	O	-1	11860278
dist@@	O	-1	11860278
inc@@	O	-1	11860278
t	O	-1	11860278
inter@@	O	-1	11860278
ac@@	O	-1	11860278
tions	O	-1	11860278
of	O	-1	11860278
D@@	O	-1	11860278
2@@	O	-1	11860278
R	O	-1	11860278
sign@@	O	-1	11860278
al@@	O	-1	11860278
ing	O	-1	11860278
with	O	-1	11860278
these	O	-1	11860278
two	O	-1	11860278
neuro@@	O	-1	11860278
trans@@	O	-1	11860278
mit@@	O	-1	11860278
ter@@	O	-1	11860278
s.	O	-1	11860278

Treat@@	O	-1	11838826
ment	O	-1	11838826
of	O	-1	11838826
ris@@	B-Chemical	D018967	11838826
perid@@	I-Chemical	-1	11838826
one	I-Chemical	-1	11838826
-induced	O	-1	11838826
hyper@@	B-Disease	D006966	11838826
prol@@	I-Disease	-1	11838826
act@@	I-Disease	-1	11838826
ine@@	I-Disease	-1	11838826
mia	I-Disease	-1	11838826
with	O	-1	11838826
a	O	-1	11838826
dopamine	B-Chemical	D004298	11838826
agon@@	O	-1	11838826
ist	O	-1	11838826
in	O	-1	11838826
child@@	O	-1	11838826
ren@@	O	-1	11838826
.	O	-1	11838826
BACKGROUND:	O	-1	11838826
R@@	B-Chemical	D018967	11838826
is@@	I-Chemical	-1	11838826
perid@@	I-Chemical	-1	11838826
one	I-Chemical	-1	11838826
,	O	-1	11838826
a	O	-1	11838826
pot@@	O	-1	11838826
ent	O	-1	11838826
antagonist	O	-1	11838826
of	O	-1	11838826
both	O	-1	11838826
seroton@@	O	-1	11838826
ergic	O	-1	11838826
(5@@	O	-1	11838826
H@@	O	-1	11838826
T@@	O	-1	11838826
2@@	O	-1	11838826
A@@	O	-1	11838826
)	O	-1	11838826
and	O	-1	11838826
dop@@	O	-1	11838826
aminergic	O	-1	11838826
D2	O	-1	11838826
receptors	O	-1	11838826
is	O	-1	11838826
associated	O	-1	11838826
with	O	-1	11838826
hyper@@	B-Disease	D006966	11838826
prol@@	I-Disease	-1	11838826
act@@	I-Disease	-1	11838826
ine@@	I-Disease	-1	11838826
mia	I-Disease	-1	11838826
in	O	-1	11838826
ad@@	O	-1	11838826
ult@@	O	-1	11838826
s	O	-1	11838826
and	O	-1	11838826
child@@	O	-1	11838826
ren@@	O	-1	11838826
.	O	-1	11838826
Ch@@	O	-1	11838826
ron@@	O	-1	11838826
ically	O	-1	11838826
elevated	O	-1	11838826
prolactin	O	-1	11838826
levels	O	-1	11838826
in	O	-1	11838826
children	O	-1	11838826
with	O	-1	11838826
prol@@	B-Disease	D015175	11838826
act@@	I-Disease	-1	11838826
in@@	I-Disease	-1	11838826
om@@	I-Disease	-1	11838826
as	I-Disease	-1	11838826
may	O	-1	11838826
be	O	-1	11838826
associated	O	-1	11838826
with	O	-1	11838826
ar@@	O	-1	11838826
rest@@	O	-1	11838826
ed	O	-1	11838826
growth	O	-1	11838826
and	O	-1	11838826
development	O	-1	11838826
result@@	O	-1	11838826
ing	O	-1	11838826
in	O	-1	11838826
either	O	-1	11838826
del@@	B-Disease	D011628	11838826
ayed	I-Disease	-1	11838826
p@@	I-Disease	-1	11838826
ub@@	I-Disease	-1	11838826
er@@	I-Disease	-1	11838826
t@@	I-Disease	-1	11838826
y	I-Disease	-1	11838826
or	O	-1	11838826
sh@@	O	-1	11838826
ort	O	-1	11838826
stat@@	O	-1	11838826
ure.	O	-1	11838826
These	O	-1	11838826
possib@@	O	-1	11838826
il@@	O	-1	11838826
ities	O	-1	11838826
stres@@	O	-1	11838826
s	O	-1	11838826
the	O	-1	11838826
import@@	O	-1	11838826
ance	O	-1	11838826
of	O	-1	11838826
develop@@	O	-1	11838826
ing	O	-1	11838826
a	O	-1	11838826
saf@@	O	-1	11838826
e	O	-1	11838826
and	O	-1	11838826
effective	O	-1	11838826
appro@@	O	-1	11838826
ach	O	-1	11838826
to	O	-1	11838826
drug@@	O	-1	11838826
-induced	O	-1	11838826
hyper@@	B-Disease	D006966	11838826
prol@@	I-Disease	-1	11838826
act@@	I-Disease	-1	11838826
ine@@	I-Disease	-1	11838826
mia	I-Disease	-1	11838826
in	O	-1	11838826
y@@	O	-1	11838826
ou@@	O	-1	11838826
th@@	O	-1	11838826
.	O	-1	11838826
We	O	-1	11838826
report	O	-1	11838826
the	O	-1	11838826
suc@@	O	-1	11838826
cess@@	O	-1	11838826
ful	O	-1	11838826
treatment	O	-1	11838826
of	O	-1	11838826
ris@@	B-Chemical	D018967	11838826
perid@@	I-Chemical	-1	11838826
one	I-Chemical	-1	11838826
-induced	O	-1	11838826
hyper@@	B-Disease	D006966	11838826
prol@@	I-Disease	-1	11838826
act@@	I-Disease	-1	11838826
ine@@	I-Disease	-1	11838826
mia	I-Disease	-1	11838826
with	O	-1	11838826
c@@	B-Chemical	C047047	11838826
ab@@	I-Chemical	-1	11838826
erg@@	I-Chemical	-1	11838826
ol@@	I-Chemical	-1	11838826
ine	I-Chemical	-1	11838826
in	O	-1	11838826
y@@	O	-1	11838826
ou@@	O	-1	11838826
th@@	O	-1	11838826
.	O	-1	11838826
METHODS:	O	-1	11838826
We	O	-1	11838826
under@@	O	-1	11838826
to@@	O	-1	11838826
o@@	O	-1	11838826
k	O	-1	11838826
a	O	-1	11838826
ret@@	O	-1	11838826
ro@@	O	-1	11838826
sp@@	O	-1	11838826
ective	O	-1	11838826
case	O	-1	11838826
revie@@	O	-1	11838826
w	O	-1	11838826
of	O	-1	11838826
four	O	-1	11838826
children	O	-1	11838826
with	O	-1	11838826
ris@@	B-Chemical	D018967	11838826
perid@@	I-Chemical	-1	11838826
one	I-Chemical	-1	11838826
-induced	O	-1	11838826
hyper@@	B-Disease	D006966	11838826
prol@@	I-Disease	-1	11838826
act@@	I-Disease	-1	11838826
ine@@	I-Disease	-1	11838826
mia	I-Disease	-1	11838826
treated	O	-1	11838826
with	O	-1	11838826
c@@	B-Chemical	C047047	11838826
ab@@	I-Chemical	-1	11838826
erg@@	I-Chemical	-1	11838826
ol@@	I-Chemical	-1	11838826
ine	I-Chemical	-1	11838826
.	O	-1	11838826
RESULTS:	O	-1	11838826
F@@	O	-1	11838826
our	O	-1	11838826
mal@@	O	-1	11838826
es	O	-1	11838826
(@@	O	-1	11838826
age	O	-1	11838826
6@@	O	-1	11838826
-1@@	O	-1	11838826
1	O	-1	11838826
year@@	O	-1	11838826
s)	O	-1	11838826
with	O	-1	11838826
Di@@	O	-1	11838826
ag@@	O	-1	11838826
nos@@	O	-1	11838826
tic	O	-1	11838826
and	O	-1	11838826
S@@	O	-1	11838826
t@@	O	-1	11838826
atis@@	O	-1	11838826
tical	O	-1	11838826
M@@	O	-1	11838826
an@@	O	-1	11838826
ual	O	-1	11838826
of	O	-1	11838826
M@@	B-Disease	D001523	11838826
ental	I-Disease	-1	11838826
D@@	I-Disease	-1	11838826
is@@	I-Disease	-1	11838826
or@@	I-Disease	-1	11838826
der@@	I-Disease	-1	11838826
s	I-Disease	-1	11838826
(@@	O	-1	11838826
fo@@	O	-1	11838826
ur@@	O	-1	11838826
th	O	-1	11838826
edi@@	O	-1	11838826
tion@@	O	-1	11838826
)	O	-1	11838826
b@@	B-Disease	D001714	11838826
ip@@	I-Disease	-1	11838826
ol@@	I-Disease	-1	11838826
ar	I-Disease	-1	11838826
disor@@	I-Disease	-1	11838826
der	I-Disease	-1	11838826
or	O	-1	11838826
psycho@@	B-Disease	D011605	11838826
ses	I-Disease	-1	11838826
,	O	-1	11838826
with	O	-1	11838826
ris@@	B-Chemical	D018967	11838826
perid@@	I-Chemical	-1	11838826
one	I-Chemical	-1	11838826
-induced	O	-1	11838826
elev@@	O	-1	11838826
ations	O	-1	11838826
in	O	-1	11838826
serum	O	-1	11838826
prolactin	O	-1	11838826
levels	O	-1	11838826
(5@@	O	-1	11838826
7.@@	O	-1	11838826
5-@@	O	-1	11838826
12@@	O	-1	11838826
9	O	-1	11838826
n@@	O	-1	11838826
g/@@	O	-1	11838826
m@@	O	-1	11838826
L@@	O	-1	11838826
,	O	-1	11838826
normal	O	-1	11838826
5-@@	O	-1	11838826
15	O	-1	11838826
n@@	O	-1	11838826
g/@@	O	-1	11838826
m@@	O	-1	11838826
L@@	O	-1	11838826
),	O	-1	11838826
were	O	-1	11838826
treated	O	-1	11838826
with	O	-1	11838826
c@@	B-Chemical	C047047	11838826
ab@@	I-Chemical	-1	11838826
erg@@	I-Chemical	-1	11838826
ol@@	I-Chemical	-1	11838826
ine	I-Chemical	-1	11838826
(@@	O	-1	11838826
mean	O	-1	11838826
dose	O	-1	11838826
2.@@	O	-1	11838826
13	O	-1	11838826
+/-	O	-1	11838826
0.0@@	O	-1	11838826
9	O	-1	11838826
mg/@@	O	-1	11838826
week@@	O	-1	11838826
).	O	-1	11838826
Whe@@	O	-1	11838826
n	O	-1	11838826
serum	O	-1	11838826
prolactin	O	-1	11838826
levels	O	-1	11838826
normal@@	O	-1	11838826
ized	O	-1	11838826
in	O	-1	11838826
all	O	-1	11838826
four	O	-1	11838826
subjects	O	-1	11838826
(@@	O	-1	11838826
mean	O	-1	11838826
1@@	O	-1	11838826
1.@@	O	-1	11838826
2	O	-1	11838826
+/-	O	-1	11838826
1@@	O	-1	11838826
0.@@	O	-1	11838826
9	O	-1	11838826
n@@	O	-1	11838826
g/@@	O	-1	11838826
m@@	O	-1	11838826
L@@	O	-1	11838826
),	O	-1	11838826
the	O	-1	11838826
c@@	B-Chemical	C047047	11838826
ab@@	I-Chemical	-1	11838826
erg@@	I-Chemical	-1	11838826
ol@@	I-Chemical	-1	11838826
ine	I-Chemical	-1	11838826
dose	O	-1	11838826
was	O	-1	11838826
reduced	O	-1	11838826
to	O	-1	11838826
1	O	-1	11838826
mg/@@	O	-1	11838826
week	O	-1	11838826
in	O	-1	11838826
three	O	-1	11838826
of	O	-1	11838826
four	O	-1	11838826
subj@@	O	-1	11838826
ect@@	O	-1	11838826
s.	O	-1	11838826
The	O	-1	11838826
mean	O	-1	11838826
duration	O	-1	11838826
of	O	-1	11838826
therapy	O	-1	11838826
with	O	-1	11838826
c@@	B-Chemical	C047047	11838826
ab@@	I-Chemical	-1	11838826
erg@@	I-Chemical	-1	11838826
ol@@	I-Chemical	-1	11838826
ine	I-Chemical	-1	11838826
was	O	-1	11838826
5@@	O	-1	11838826
2@@	O	-1	11838826
3.@@	O	-1	11838826
5	O	-1	11838826
+/-	O	-1	11838826
12@@	O	-1	11838826
9.@@	O	-1	11838826
7	O	-1	11838826
day@@	O	-1	11838826
s,	O	-1	11838826
and	O	-1	11838826
the	O	-1	11838826
mean	O	-1	11838826
duration	O	-1	11838826
of	O	-1	11838826
therapy	O	-1	11838826
with	O	-1	11838826
ris@@	B-Chemical	D018967	11838826
perid@@	I-Chemical	-1	11838826
one	I-Chemical	-1	11838826
was	O	-1	11838826
7@@	O	-1	11838826
8@@	O	-1	11838826
8.@@	O	-1	11838826
5	O	-1	11838826
+/-	O	-1	11838826
1@@	O	-1	11838826
6@@	O	-1	11838826
2.@@	O	-1	11838826
5	O	-1	11838826
days.	O	-1	11838826
C@@	B-Chemical	C047047	11838826
ab@@	I-Chemical	-1	11838826
erg@@	I-Chemical	-1	11838826
ol@@	I-Chemical	-1	11838826
ine	I-Chemical	-1	11838826
was	O	-1	11838826
well	O	-1	11838826
toler@@	O	-1	11838826
ated	O	-1	11838826
without	O	-1	11838826
adverse	O	-1	11838826
effects.	O	-1	11838826
CONCLUSIONS:	O	-1	11838826
C@@	B-Chemical	C047047	11838826
ab@@	I-Chemical	-1	11838826
erg@@	I-Chemical	-1	11838826
ol@@	I-Chemical	-1	11838826
ine	I-Chemical	-1	11838826
may	O	-1	11838826
be	O	-1	11838826
use@@	O	-1	11838826
ful	O	-1	11838826
for	O	-1	11838826
the	O	-1	11838826
treatment	O	-1	11838826
of	O	-1	11838826
ris@@	B-Chemical	D018967	11838826
perid@@	I-Chemical	-1	11838826
one	I-Chemical	-1	11838826
-induced	O	-1	11838826
hyper@@	B-Disease	D006966	11838826
prol@@	I-Disease	-1	11838826
act@@	I-Disease	-1	11838826
ine@@	I-Disease	-1	11838826
mia	I-Disease	-1	11838826
in	O	-1	11838826
y@@	O	-1	11838826
ou@@	O	-1	11838826
th@@	O	-1	11838826
;	O	-1	11838826
however,	O	-1	11838826
further	O	-1	11838826
re@@	O	-1	11838826
se@@	O	-1	11838826
arc@@	O	-1	11838826
h	O	-1	11838826
is	O	-1	11838826
ne@@	O	-1	11838826
e@@	O	-1	11838826
de@@	O	-1	11838826
d.	O	-1	11838826

Ch@@	B-Disease	D041781	11467664
ol@@	I-Disease	-1	11467664
est@@	I-Disease	-1	11467664
atic	I-Disease	-1	11467664
j@@	I-Disease	-1	11467664
a@@	I-Disease	-1	11467664
un@@	I-Disease	-1	11467664
dic@@	I-Disease	-1	11467664
e	I-Disease	-1	11467664
associated	O	-1	11467664
with	O	-1	11467664
the	O	-1	11467664
use	O	-1	11467664
of	O	-1	11467664
met@@	B-Chemical	D008687	11467664
form@@	I-Chemical	-1	11467664
in	I-Chemical	-1	11467664
.	O	-1	11467664
We	O	-1	11467664
report	O	-1	11467664
a	O	-1	11467664
patient	O	-1	11467664
who	O	-1	11467664
developed	O	-1	11467664
cholest@@	B-Disease	D041781	11467664
atic	I-Disease	-1	11467664
j@@	I-Disease	-1	11467664
a@@	I-Disease	-1	11467664
un@@	I-Disease	-1	11467664
dic@@	I-Disease	-1	11467664
e	I-Disease	-1	11467664
sh@@	O	-1	11467664
ort@@	O	-1	11467664
ly	O	-1	11467664
after	O	-1	11467664
initi@@	O	-1	11467664
ation	O	-1	11467664
of	O	-1	11467664
treatment	O	-1	11467664
with	O	-1	11467664
met@@	B-Chemical	D008687	11467664
form@@	I-Chemical	-1	11467664
in	I-Chemical	-1	11467664
hydro@@	I-Chemical	-1	11467664
chlor@@	I-Chemical	-1	11467664
ide	I-Chemical	-1	11467664
.	O	-1	11467664
U@@	O	-1	11467664
l@@	O	-1	11467664
tr@@	O	-1	11467664
as@@	O	-1	11467664
ound	O	-1	11467664
of	O	-1	11467664
the	O	-1	11467664
liver	O	-1	11467664
and	O	-1	11467664
ab@@	O	-1	11467664
domin@@	O	-1	11467664
al	O	-1	11467664
C@@	O	-1	11467664
T	O	-1	11467664
were	O	-1	11467664
normal@@	O	-1	11467664
.	O	-1	11467664
An	O	-1	11467664
E@@	O	-1	11467664
R@@	O	-1	11467664
C@@	O	-1	11467664
P	O	-1	11467664
showed	O	-1	11467664
normal	O	-1	11467664
bil@@	O	-1	11467664
i@@	O	-1	11467664
ary	O	-1	11467664
an@@	O	-1	11467664
at@@	O	-1	11467664
om@@	O	-1	11467664
y.	O	-1	11467664
A	O	-1	11467664
perc@@	O	-1	11467664
utaneous	O	-1	11467664
liver	O	-1	11467664
biop@@	O	-1	11467664
sy	O	-1	11467664
was	O	-1	11467664
obtained	O	-1	11467664
show@@	O	-1	11467664
ing	O	-1	11467664
mark@@	O	-1	11467664
ed	O	-1	11467664
cholest@@	B-Disease	D002779	11467664
asis	I-Disease	-1	11467664
,	O	-1	11467664
with	O	-1	11467664
port@@	O	-1	11467664
al	O	-1	11467664
e@@	B-Disease	D004487	11467664
de@@	I-Disease	-1	11467664
ma	I-Disease	-1	11467664
,	O	-1	11467664
duc@@	O	-1	11467664
t@@	O	-1	11467664
ular	O	-1	11467664
pro@@	O	-1	11467664
li@@	O	-1	11467664
fer@@	O	-1	11467664
ation,	O	-1	11467664
and	O	-1	11467664
acute	O	-1	11467664
inflam@@	B-Disease	D007249	11467664
m@@	I-Disease	-1	11467664
ation	I-Disease	-1	11467664
.	O	-1	11467664
M@@	B-Chemical	D008687	11467664
et@@	I-Chemical	-1	11467664
form@@	I-Chemical	-1	11467664
in	I-Chemical	-1	11467664
hydro@@	I-Chemical	-1	11467664
chlor@@	I-Chemical	-1	11467664
ide	I-Chemical	-1	11467664
was	O	-1	11467664
discontinu@@	O	-1	11467664
ed,	O	-1	11467664
and	O	-1	11467664
the	O	-1	11467664
patient@@	O	-1	11467664
's	O	-1	11467664
j@@	B-Disease	D007565	11467664
a@@	I-Disease	-1	11467664
un@@	I-Disease	-1	11467664
dic@@	I-Disease	-1	11467664
e	I-Disease	-1	11467664
resol@@	O	-1	11467664
ved	O	-1	11467664
s@@	O	-1	11467664
low@@	O	-1	11467664
ly	O	-1	11467664
over	O	-1	11467664
a	O	-1	11467664
period	O	-1	11467664
of	O	-1	11467664
several	O	-1	11467664
months.	O	-1	11467664
G@@	O	-1	11467664
i@@	O	-1	11467664
ven	O	-1	11467664
the	O	-1	11467664
onset	O	-1	11467664
of	O	-1	11467664
h@@	O	-1	11467664
is	O	-1	11467664
j@@	B-Disease	D007565	11467664
a@@	I-Disease	-1	11467664
un@@	I-Disease	-1	11467664
dic@@	I-Disease	-1	11467664
e	I-Disease	-1	11467664
2	O	-1	11467664
w@@	O	-1	11467664
k	O	-1	11467664
after	O	-1	11467664
the	O	-1	11467664
initi@@	O	-1	11467664
ation	O	-1	11467664
of	O	-1	11467664
met@@	B-Chemical	D008687	11467664
form@@	I-Chemical	-1	11467664
in	I-Chemical	-1	11467664
,	O	-1	11467664
we	O	-1	11467664
be@@	O	-1	11467664
li@@	O	-1	11467664
e@@	O	-1	11467664
ve	O	-1	11467664
that	O	-1	11467664
this	O	-1	11467664
case	O	-1	11467664
re@@	O	-1	11467664
pres@@	O	-1	11467664
ents	O	-1	11467664
an	O	-1	11467664
ex@@	O	-1	11467664
am@@	O	-1	11467664
ple	O	-1	11467664
of	O	-1	11467664
met@@	B-Chemical	D008687	11467664
form@@	I-Chemical	-1	11467664
in	I-Chemical	-1	11467664
-@@	O	-1	11467664
associated	O	-1	11467664
hepat@@	B-Disease	D056486	11467664
otoxicity	I-Disease	-1	11467664
,	O	-1	11467664
the	O	-1	11467664
first	O	-1	11467664
such	O	-1	11467664
case	O	-1	11467664
repor@@	O	-1	11467664
ted.	O	-1	11467664

E@@	O	-1	11077455
l@@	O	-1	11077455
ect@@	O	-1	11077455
ro@@	O	-1	11077455
-@@	O	-1	11077455
oc@@	O	-1	11077455
u@@	O	-1	11077455
logra@@	O	-1	11077455
ph@@	O	-1	11077455
y,	O	-1	11077455
electro@@	O	-1	11077455
ret@@	O	-1	11077455
in@@	O	-1	11077455
ograph@@	O	-1	11077455
y,	O	-1	11077455
visual	O	-1	11077455
evoked	O	-1	11077455
potenti@@	O	-1	11077455
al@@	O	-1	11077455
s,	O	-1	11077455
and	O	-1	11077455
multi@@	O	-1	11077455
foc@@	O	-1	11077455
al	O	-1	11077455
electro@@	O	-1	11077455
ret@@	O	-1	11077455
in@@	O	-1	11077455
ograph@@	O	-1	11077455
y	O	-1	11077455
in	O	-1	11077455
patients	O	-1	11077455
with	O	-1	11077455
vi@@	B-Chemical	D020888	11077455
g@@	I-Chemical	-1	11077455
ab@@	I-Chemical	-1	11077455
at@@	I-Chemical	-1	11077455
rin	I-Chemical	-1	11077455
-@@	O	-1	11077455
at@@	O	-1	11077455
tri@@	O	-1	11077455
but@@	O	-1	11077455
ed	O	-1	11077455
visual	B-Disease	D014786	11077455
fi@@	I-Disease	-1	11077455
el@@	I-Disease	-1	11077455
d	I-Disease	-1	11077455
con@@	I-Disease	-1	11077455
stric@@	I-Disease	-1	11077455
tion	I-Disease	-1	11077455
.	O	-1	11077455
P@@	O	-1	11077455
U@@	O	-1	11077455
R@@	O	-1	11077455
P@@	O	-1	11077455
O@@	O	-1	11077455
S@@	O	-1	11077455
E:	O	-1	11077455
S@@	O	-1	11077455
ym@@	O	-1	11077455
pto@@	O	-1	11077455
m@@	O	-1	11077455
atic	O	-1	11077455
visual	B-Disease	D014786	11077455
fi@@	I-Disease	-1	11077455
el@@	I-Disease	-1	11077455
d	I-Disease	-1	11077455
con@@	I-Disease	-1	11077455
stric@@	I-Disease	-1	11077455
tion	I-Disease	-1	11077455
thou@@	O	-1	11077455
ght	O	-1	11077455
to	O	-1	11077455
be	O	-1	11077455
associated	O	-1	11077455
with	O	-1	11077455
vi@@	B-Chemical	D020888	11077455
g@@	I-Chemical	-1	11077455
ab@@	I-Chemical	-1	11077455
at@@	I-Chemical	-1	11077455
rin	I-Chemical	-1	11077455
has	O	-1	11077455
been	O	-1	11077455
repor@@	O	-1	11077455
ted.	O	-1	11077455
The	O	-1	11077455
current	O	-1	11077455
study	O	-1	11077455
investigated	O	-1	11077455
the	O	-1	11077455
visual	O	-1	11077455
fi@@	O	-1	11077455
el@@	O	-1	11077455
ds	O	-1	11077455
and	O	-1	11077455
visual	O	-1	11077455
electro@@	O	-1	11077455
physi@@	O	-1	11077455
ology	O	-1	11077455
of	O	-1	11077455
e@@	O	-1	11077455
ight	O	-1	11077455
patients	O	-1	11077455
with	O	-1	11077455
known	O	-1	11077455
vi@@	B-Chemical	D020888	11077455
g@@	I-Chemical	-1	11077455
ab@@	I-Chemical	-1	11077455
at@@	I-Chemical	-1	11077455
rin	I-Chemical	-1	11077455
-@@	O	-1	11077455
at@@	O	-1	11077455
tri@@	O	-1	11077455
but@@	O	-1	11077455
ed	O	-1	11077455
visual	B-Disease	D014786	11077455
fi@@	I-Disease	-1	11077455
el@@	I-Disease	-1	11077455
d	I-Disease	-1	11077455
loss	I-Disease	-1	11077455
,	O	-1	11077455
three	O	-1	11077455
of	O	-1	11077455
whom	O	-1	11077455
were	O	-1	11077455
reported	O	-1	11077455
previ@@	O	-1	11077455
ous@@	O	-1	11077455
ly.	O	-1	11077455
Si@@	O	-1	11077455
x	O	-1	11077455
of	O	-1	11077455
the	O	-1	11077455
patients	O	-1	11077455
were	O	-1	11077455
no	O	-1	11077455
long@@	O	-1	11077455
er	O	-1	11077455
receiving	O	-1	11077455
vi@@	B-Chemical	D020888	11077455
g@@	I-Chemical	-1	11077455
ab@@	I-Chemical	-1	11077455
at@@	I-Chemical	-1	11077455
rin	I-Chemical	-1	11077455
.	O	-1	11077455
METHODS:	O	-1	11077455
The	O	-1	11077455
central	O	-1	11077455
and	O	-1	11077455
peripheral	O	-1	11077455
fi@@	O	-1	11077455
el@@	O	-1	11077455
ds	O	-1	11077455
were	O	-1	11077455
examined	O	-1	11077455
with	O	-1	11077455
the	O	-1	11077455
H@@	O	-1	11077455
um@@	O	-1	11077455
ph@@	O	-1	11077455
re@@	O	-1	11077455
y	O	-1	11077455
V@@	O	-1	11077455
i@@	O	-1	11077455
sual	O	-1	11077455
F@@	O	-1	11077455
i@@	O	-1	11077455
el@@	O	-1	11077455
d	O	-1	11077455
An@@	O	-1	11077455
aly@@	O	-1	11077455
z@@	O	-1	11077455
er.	O	-1	11077455
F@@	O	-1	11077455
ul@@	O	-1	11077455
l	O	-1	11077455
visual	O	-1	11077455
electro@@	O	-1	11077455
physi@@	O	-1	11077455
olog@@	O	-1	11077455
y,	O	-1	11077455
including	O	-1	11077455
f@@	O	-1	11077455
las@@	O	-1	11077455
h	O	-1	11077455
electro@@	O	-1	11077455
ret@@	O	-1	11077455
in@@	O	-1	11077455
ograph@@	O	-1	11077455
y	O	-1	11077455
(@@	O	-1	11077455
E@@	O	-1	11077455
R@@	O	-1	11077455
G@@	O	-1	11077455
),	O	-1	11077455
pat@@	O	-1	11077455
ter@@	O	-1	11077455
n	O	-1	11077455
electro@@	O	-1	11077455
ret@@	O	-1	11077455
in@@	O	-1	11077455
ograph@@	O	-1	11077455
y,	O	-1	11077455
multi@@	O	-1	11077455
foc@@	O	-1	11077455
al	O	-1	11077455
E@@	O	-1	11077455
R@@	O	-1	11077455
G	O	-1	11077455
using	O	-1	11077455
the	O	-1	11077455
V@@	O	-1	11077455
E@@	O	-1	11077455
R@@	O	-1	11077455
I@@	O	-1	11077455
S	O	-1	11077455
system@@	O	-1	11077455
,	O	-1	11077455
electro@@	O	-1	11077455
-@@	O	-1	11077455
oc@@	O	-1	11077455
u@@	O	-1	11077455
logra@@	O	-1	11077455
ph@@	O	-1	11077455
y,	O	-1	11077455
and	O	-1	11077455
f@@	O	-1	11077455
las@@	O	-1	11077455
h	O	-1	11077455
and	O	-1	11077455
pat@@	O	-1	11077455
ter@@	O	-1	11077455
n	O	-1	11077455
visual	O	-1	11077455
evoked	O	-1	11077455
potenti@@	O	-1	11077455
al@@	O	-1	11077455
s,	O	-1	11077455
was	O	-1	11077455
under@@	O	-1	11077455
tak@@	O	-1	11077455
en@@	O	-1	11077455
.	O	-1	11077455
RESULTS:	O	-1	11077455
S@@	O	-1	11077455
even	O	-1	11077455
patients	O	-1	11077455
showed	O	-1	11077455
mark@@	O	-1	11077455
ed	O	-1	11077455
visual	B-Disease	D014786	11077455
fi@@	I-Disease	-1	11077455
el@@	I-Disease	-1	11077455
d	I-Disease	-1	11077455
con@@	I-Disease	-1	11077455
stric@@	I-Disease	-1	11077455
tion	I-Disease	-1	11077455
with	O	-1	11077455
some	O	-1	11077455
s@@	O	-1	11077455
par@@	O	-1	11077455
ing	O	-1	11077455
of	O	-1	11077455
the	O	-1	11077455
tempor@@	O	-1	11077455
al	O	-1	11077455
visual	O	-1	11077455
fi@@	O	-1	11077455
el@@	O	-1	11077455
d.	O	-1	11077455
The	O	-1	11077455
e@@	O	-1	11077455
igh@@	O	-1	11077455
th	O	-1	11077455
ex@@	O	-1	11077455
hib@@	O	-1	11077455
ited	O	-1	11077455
con@@	O	-1	11077455
c@@	O	-1	11077455
ent@@	O	-1	11077455
ric	O	-1	11077455
con@@	O	-1	11077455
stric@@	O	-1	11077455
tion.	O	-1	11077455
M@@	O	-1	11077455
ost	O	-1	11077455
electro@@	O	-1	11077455
physi@@	O	-1	11077455
ological	O	-1	11077455
responses	O	-1	11077455
were	O	-1	11077455
us@@	O	-1	11077455
ually	O	-1	11077455
j@@	O	-1	11077455
us@@	O	-1	11077455
t	O	-1	11077455
within	O	-1	11077455
normal	O	-1	11077455
lim@@	O	-1	11077455
it@@	O	-1	11077455
s;	O	-1	11077455
two	O	-1	11077455
patients	O	-1	11077455
had	O	-1	11077455
sub@@	O	-1	11077455
normal	O	-1	11077455
A@@	O	-1	11077455
r@@	O	-1	11077455
de@@	O	-1	11077455
n	O	-1	11077455
electro@@	O	-1	11077455
-@@	O	-1	11077455
oc@@	O	-1	11077455
u@@	O	-1	11077455
logra@@	O	-1	11077455
ph@@	O	-1	11077455
y	O	-1	11077455
indic@@	O	-1	11077455
es@@	O	-1	11077455
;	O	-1	11077455
and	O	-1	11077455
one	O	-1	11077455
patient	O	-1	11077455
showed	O	-1	11077455
an	O	-1	11077455
ab@@	O	-1	11077455
norm@@	O	-1	11077455
ally	O	-1	11077455
del@@	O	-1	11077455
ayed	O	-1	11077455
ph@@	O	-1	11077455
ot@@	O	-1	11077455
op@@	O	-1	11077455
ic	O	-1	11077455
b	O	-1	11077455
w@@	O	-1	11077455
a@@	O	-1	11077455
ve.	O	-1	11077455
However,	O	-1	11077455
five	O	-1	11077455
patients	O	-1	11077455
showed	O	-1	11077455
del@@	O	-1	11077455
ayed	O	-1	11077455
3@@	O	-1	11077455
0-@@	O	-1	11077455
H@@	O	-1	11077455
z	O	-1	11077455
f@@	O	-1	11077455
l@@	O	-1	11077455
ic@@	O	-1	11077455
k@@	O	-1	11077455
er	O	-1	11077455
b	O	-1	11077455
w@@	O	-1	11077455
av@@	O	-1	11077455
es,	O	-1	11077455
and	O	-1	11077455
seven	O	-1	11077455
patients	O	-1	11077455
showed	O	-1	11077455
del@@	O	-1	11077455
ayed	O	-1	11077455
os@@	O	-1	11077455
c@@	O	-1	11077455
il@@	O	-1	11077455
lat@@	O	-1	11077455
ory	O	-1	11077455
potenti@@	O	-1	11077455
al@@	O	-1	11077455
s.	O	-1	11077455
M@@	O	-1	11077455
ul@@	O	-1	11077455
ti@@	O	-1	11077455
foc@@	O	-1	11077455
al	O	-1	11077455
E@@	O	-1	11077455
R@@	O	-1	11077455
G	O	-1	11077455
showed	O	-1	11077455
abnormal@@	O	-1	11077455
ities	O	-1	11077455
that	O	-1	11077455
so@@	O	-1	11077455
me@@	O	-1	11077455
times	O	-1	11077455
cor@@	O	-1	11077455
related	O	-1	11077455
with	O	-1	11077455
the	O	-1	11077455
visual	O	-1	11077455
fi@@	O	-1	11077455
el@@	O	-1	11077455
d	O	-1	11077455
appear@@	O	-1	11077455
ance	O	-1	11077455
and	O	-1	11077455
con@@	O	-1	11077455
fir@@	O	-1	11077455
m@@	O	-1	11077455
ed	O	-1	11077455
that	O	-1	11077455
the	O	-1	11077455
defic@@	O	-1	11077455
it	O	-1	11077455
occur@@	O	-1	11077455
s	O	-1	11077455
at	O	-1	11077455
the	O	-1	11077455
ret@@	O	-1	11077455
inal	O	-1	11077455
level@@	O	-1	11077455
.	O	-1	11077455
CONCLUSION:	O	-1	11077455
M@@	O	-1	11077455
ark@@	O	-1	11077455
ed	O	-1	11077455
visual	B-Disease	D014786	11077455
fi@@	I-Disease	-1	11077455
el@@	I-Disease	-1	11077455
d	I-Disease	-1	11077455
con@@	I-Disease	-1	11077455
stric@@	I-Disease	-1	11077455
tion	I-Disease	-1	11077455
appear@@	O	-1	11077455
s	O	-1	11077455
to	O	-1	11077455
be	O	-1	11077455
associated	O	-1	11077455
with	O	-1	11077455
vi@@	B-Chemical	D020888	11077455
g@@	I-Chemical	-1	11077455
ab@@	I-Chemical	-1	11077455
at@@	I-Chemical	-1	11077455
rin	I-Chemical	-1	11077455
therapy.	O	-1	11077455
The	O	-1	11077455
fi@@	O	-1	11077455
el@@	O	-1	11077455
d	O	-1	11077455
def@@	O	-1	11077455
ects	O	-1	11077455
and	O	-1	11077455
some	O	-1	11077455
electro@@	O	-1	11077455
physi@@	O	-1	11077455
ological	O	-1	11077455
abnormal@@	O	-1	11077455
ities	O	-1	11077455
per@@	O	-1	11077455
si@@	O	-1	11077455
st	O	-1	11077455
when	O	-1	11077455
vi@@	B-Chemical	D020888	11077455
g@@	I-Chemical	-1	11077455
ab@@	I-Chemical	-1	11077455
at@@	I-Chemical	-1	11077455
rin	I-Chemical	-1	11077455
therapy	O	-1	11077455
is	O	-1	11077455
withdraw@@	O	-1	11077455
n@@	O	-1	11077455
.	O	-1	11077455

Con@@	O	-1	11063349
ver@@	O	-1	11063349
sion	O	-1	11063349
to	O	-1	11063349
ra@@	B-Chemical	D020123	11063349
p@@	I-Chemical	-1	11063349
am@@	I-Chemical	-1	11063349
ycin	I-Chemical	-1	11063349
immunosup@@	O	-1	11063349
pression	O	-1	11063349
in	O	-1	11063349
renal	O	-1	11063349
transplant	O	-1	11063349
re@@	O	-1	11063349
ci@@	O	-1	11063349
pi@@	O	-1	11063349
ent@@	O	-1	11063349
s:	O	-1	11063349
report	O	-1	11063349
of	O	-1	11063349
an	O	-1	11063349
initial	O	-1	11063349
experi@@	O	-1	11063349
ence@@	O	-1	11063349
.	O	-1	11063349
BACKGROUND:	O	-1	11063349
The	O	-1	11063349
a@@	O	-1	11063349
im	O	-1	11063349
of	O	-1	11063349
this	O	-1	11063349
study	O	-1	11063349
is	O	-1	11063349
to	O	-1	11063349
evalu@@	O	-1	11063349
ate	O	-1	11063349
the	O	-1	11063349
effects	O	-1	11063349
of	O	-1	11063349
R@@	B-Chemical	D020123	11063349
A@@	I-Chemical	-1	11063349
P@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
conver@@	O	-1	11063349
sion	O	-1	11063349
in	O	-1	11063349
patients	O	-1	11063349
under@@	O	-1	11063349
go@@	O	-1	11063349
ing	O	-1	11063349
cyclospor@@	B-Chemical	D016572	11063349
ine	I-Chemical	-1	11063349
(	O	-1	11063349
C@@	B-Chemical	D016572	11063349
s@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
)	O	-1	11063349
or	O	-1	11063349
tacrolimus	B-Chemical	D016559	11063349
(	O	-1	11063349
T@@	B-Chemical	D016559	11063349
a@@	I-Chemical	-1	11063349
c	I-Chemical	-1	11063349
)	O	-1	11063349
toxicity	B-Disease	D064420	11063349
.	O	-1	11063349
METHODS:	O	-1	11063349
Tw@@	O	-1	11063349
ent@@	O	-1	11063349
y	O	-1	11063349
renal	O	-1	11063349
transplant	O	-1	11063349
re@@	O	-1	11063349
ci@@	O	-1	11063349
pi@@	O	-1	11063349
ents	O	-1	11063349
were	O	-1	11063349
switch@@	O	-1	11063349
ed	O	-1	11063349
to	O	-1	11063349
fi@@	O	-1	11063349
x@@	O	-1	11063349
ed	O	-1	11063349
dose	O	-1	11063349
ra@@	B-Chemical	D020123	11063349
p@@	I-Chemical	-1	11063349
am@@	I-Chemical	-1	11063349
ycin	I-Chemical	-1	11063349
(	O	-1	11063349
R@@	B-Chemical	D020123	11063349
A@@	I-Chemical	-1	11063349
P@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
)	O	-1	11063349
(@@	O	-1	11063349
5	O	-1	11063349
mg/@@	O	-1	11063349
day@@	O	-1	11063349
)	O	-1	11063349
0	O	-1	11063349
to	O	-1	11063349
20@@	O	-1	11063349
4	O	-1	11063349
months	O	-1	11063349
post@@	O	-1	11063349
transplant@@	O	-1	11063349
.	O	-1	11063349
D@@	O	-1	11063349
ru@@	O	-1	11063349
g	O	-1	11063349
monit@@	O	-1	11063349
or@@	O	-1	11063349
ing	O	-1	11063349
was	O	-1	11063349
not	O	-1	11063349
initi@@	O	-1	11063349
ally	O	-1	11063349
used	O	-1	11063349
to	O	-1	11063349
adj@@	O	-1	11063349
us@@	O	-1	11063349
t	O	-1	11063349
dos@@	O	-1	11063349
es.	O	-1	11063349
The	O	-1	11063349
indic@@	O	-1	11063349
ations	O	-1	11063349
for	O	-1	11063349
s@@	O	-1	11063349
wit@@	O	-1	11063349
ch	O	-1	11063349
were	O	-1	11063349
chronic	O	-1	11063349
C@@	B-Chemical	D016572	11063349
s@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
or	O	-1	11063349
T@@	B-Chemical	D016559	11063349
a@@	I-Chemical	-1	11063349
c	I-Chemical	-1	11063349
nephro@@	B-Disease	D007674	11063349
toxicity	I-Disease	-1	11063349
(1@@	O	-1	11063349
2@@	O	-1	11063349
),	O	-1	11063349
acute	O	-1	11063349
C@@	B-Chemical	D016572	11063349
s@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
or	O	-1	11063349
T@@	B-Chemical	D016559	11063349
a@@	I-Chemical	-1	11063349
c	I-Chemical	-1	11063349
toxicity	B-Disease	D064420	11063349
(3@@	O	-1	11063349
),	O	-1	11063349
severe	O	-1	11063349
fac@@	B-Disease	-1	11063349
ial	I-Disease	-1	11063349
dys@@	I-Disease	-1	11063349
morph@@	I-Disease	-1	11063349
ism	I-Disease	-1	11063349
(2@@	O	-1	11063349
),	O	-1	11063349
post@@	B-Disease	D008232	11063349
transplant	I-Disease	-1	11063349
lymph@@	I-Disease	-1	11063349
o@@	I-Disease	-1	11063349
pro@@	I-Disease	-1	11063349
li@@	I-Disease	-1	11063349
fer@@	I-Disease	-1	11063349
ative	I-Disease	-1	11063349
disor@@	I-Disease	-1	11063349
der	I-Disease	-1	11063349
(	O	-1	11063349
P@@	B-Disease	D008232	11063349
T@@	I-Disease	-1	11063349
L@@	I-Disease	-1	11063349
D	I-Disease	-1	11063349
)	O	-1	11063349
in	O	-1	11063349
re@@	O	-1	11063349
mission	O	-1	11063349
(2@@	O	-1	11063349
),	O	-1	11063349
and	O	-1	11063349
hepat@@	B-Disease	D056486	11063349
otoxicity	I-Disease	-1	11063349
in	O	-1	11063349
1@@	O	-1	11063349
.	O	-1	11063349
F@@	O	-1	11063349
ol@@	O	-1	11063349
low@@	O	-1	11063349
-@@	O	-1	11063349
up	O	-1	11063349
is	O	-1	11063349
7	O	-1	11063349
to	O	-1	11063349
24	O	-1	11063349
months.	O	-1	11063349
RESULTS:	O	-1	11063349
In	O	-1	11063349
the	O	-1	11063349
12	O	-1	11063349
patients	O	-1	11063349
switch@@	O	-1	11063349
ed	O	-1	11063349
because	O	-1	11063349
of	O	-1	11063349
chronic	O	-1	11063349
nephro@@	B-Disease	D007674	11063349
toxicity	I-Disease	-1	11063349
there	O	-1	11063349
was	O	-1	11063349
a	O	-1	11063349
significant	O	-1	11063349
decrease	O	-1	11063349
in	O	-1	11063349
serum	O	-1	11063349
creatinine	B-Chemical	D003404	11063349
[@@	O	-1	11063349
2@@	O	-1	11063349
3@@	O	-1	11063349
3@@	O	-1	11063349
+/-@@	O	-1	11063349
3@@	O	-1	11063349
4	O	-1	11063349
to	O	-1	11063349
2@@	O	-1	11063349
10@@	O	-1	11063349
+/-@@	O	-1	11063349
5@@	O	-1	11063349
6	O	-1	11063349
mic@@	O	-1	11063349
rom@@	O	-1	11063349
ol@@	O	-1	11063349
/@@	O	-1	11063349
lit@@	O	-1	11063349
er	O	-1	11063349
(P@@	O	-1	11063349
<@@	O	-1	11063349
0.05@@	O	-1	11063349
)	O	-1	11063349
at	O	-1	11063349
6	O	-1	11063349
month@@	O	-1	11063349
s@@	O	-1	11063349
]@@	O	-1	11063349
.	O	-1	11063349
F@@	B-Disease	-1	11063349
ac@@	I-Disease	-1	11063349
ial	I-Disease	-1	11063349
dys@@	I-Disease	-1	11063349
morph@@	I-Disease	-1	11063349
ism	I-Disease	-1	11063349
improved	O	-1	11063349
in	O	-1	11063349
two	O	-1	11063349
patients.	O	-1	11063349
No	O	-1	11063349
rel@@	O	-1	11063349
ap@@	O	-1	11063349
se	O	-1	11063349
of	O	-1	11063349
P@@	B-Disease	D008232	11063349
T@@	I-Disease	-1	11063349
L@@	I-Disease	-1	11063349
D	I-Disease	-1	11063349
was	O	-1	11063349
obser@@	O	-1	11063349
ved.	O	-1	11063349
F@@	O	-1	11063349
i@@	O	-1	11063349
ve	O	-1	11063349
patients	O	-1	11063349
developed	O	-1	11063349
p@@	B-Disease	D011014	11063349
ne@@	I-Disease	-1	11063349
um@@	I-Disease	-1	11063349
on@@	I-Disease	-1	11063349
ia	I-Disease	-1	11063349
(@@	O	-1	11063349
two	O	-1	11063349
P@@	B-Disease	D011020	11063349
ne@@	I-Disease	-1	11063349
um@@	I-Disease	-1	11063349
oc@@	I-Disease	-1	11063349
ys@@	I-Disease	-1	11063349
tis	I-Disease	-1	11063349
car@@	I-Disease	-1	11063349
in@@	I-Disease	-1	11063349
i@@	I-Disease	-1	11063349
i	I-Disease	-1	11063349
p@@	I-Disease	-1	11063349
ne@@	I-Disease	-1	11063349
um@@	I-Disease	-1	11063349
on@@	I-Disease	-1	11063349
ia	I-Disease	-1	11063349
,	O	-1	11063349
one	O	-1	11063349
inf@@	B-Disease	D007244	11063349
ecti@@	I-Disease	-1	11063349
ous	I-Disease	-1	11063349
mon@@	I-Disease	-1	11063349
on@@	I-Disease	-1	11063349
ucle@@	I-Disease	-1	11063349
o@@	I-Disease	-1	11063349
sis	I-Disease	-1	11063349
with	O	-1	11063349
poly@@	O	-1	11063349
clon@@	O	-1	11063349
al	O	-1	11063349
P@@	B-Disease	D008232	11063349
T@@	I-Disease	-1	11063349
L@@	I-Disease	-1	11063349
D	I-Disease	-1	11063349
l@@	O	-1	11063349
un@@	O	-1	11063349
g	O	-1	11063349
inf@@	O	-1	11063349
ilt@@	O	-1	11063349
rat@@	O	-1	11063349
e@@	O	-1	11063349
)	O	-1	11063349
and	O	-1	11063349
two	O	-1	11063349
had	O	-1	11063349
b@@	B-Disease	D001989	11063349
ron@@	I-Disease	-1	11063349
ch@@	I-Disease	-1	11063349
i@@	I-Disease	-1	11063349
ol@@	I-Disease	-1	11063349
iti@@	I-Disease	-1	11063349
s	I-Disease	-1	11063349
ob@@	I-Disease	-1	11063349
liter@@	I-Disease	-1	11063349
ans	I-Disease	-1	11063349
.	O	-1	11063349
There	O	-1	11063349
were	O	-1	11063349
no	O	-1	11063349
de@@	O	-1	11063349
ath@@	O	-1	11063349
s.	O	-1	11063349
R@@	B-Chemical	D020123	11063349
A@@	I-Chemical	-1	11063349
P@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
was	O	-1	11063349
discontinu@@	O	-1	11063349
ed	O	-1	11063349
in	O	-1	11063349
four	O	-1	11063349
patients,	O	-1	11063349
because	O	-1	11063349
of	O	-1	11063349
p@@	B-Disease	D011014	11063349
ne@@	I-Disease	-1	11063349
um@@	I-Disease	-1	11063349
on@@	I-Disease	-1	11063349
ia	I-Disease	-1	11063349
in	O	-1	11063349
tw@@	O	-1	11063349
o@@	O	-1	11063349
,	O	-1	11063349
P@@	B-Disease	D008232	11063349
T@@	I-Disease	-1	11063349
L@@	I-Disease	-1	11063349
D	I-Disease	-1	11063349
in	O	-1	11063349
one,	O	-1	11063349
and	O	-1	11063349
oral	O	-1	11063349
a@@	B-Disease	D013281	11063349
ph@@	I-Disease	-1	11063349
t@@	I-Disease	-1	11063349
ous	I-Disease	-1	11063349
ul@@	I-Disease	-1	11063349
c@@	I-Disease	-1	11063349
ers	I-Disease	-1	11063349
in	O	-1	11063349
one.	O	-1	11063349
R@@	B-Chemical	D020123	11063349
A@@	I-Chemical	-1	11063349
P@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
levels	O	-1	11063349
were	O	-1	11063349
high	O	-1	11063349
(@@	O	-1	11063349
>@@	O	-1	11063349
15	O	-1	11063349
n@@	O	-1	11063349
g/@@	O	-1	11063349
ml@@	O	-1	11063349
)	O	-1	11063349
in	O	-1	11063349
7	O	-1	11063349
of	O	-1	11063349
13	O	-1	11063349
(5@@	O	-1	11063349
4@@	O	-1	11063349
%)	O	-1	11063349
patients.	O	-1	11063349
CONCLUSIONS:	O	-1	11063349
R@@	B-Chemical	D020123	11063349
A@@	I-Chemical	-1	11063349
P@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
conver@@	O	-1	11063349
sion	O	-1	11063349
pro@@	O	-1	11063349
vi@@	O	-1	11063349
des	O	-1	11063349
ade@@	O	-1	11063349
qu@@	O	-1	11063349
ate	O	-1	11063349
immunosup@@	O	-1	11063349
pression	O	-1	11063349
to	O	-1	11063349
en@@	O	-1	11063349
able	O	-1	11063349
C@@	B-Chemical	D016572	11063349
s@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
withdraw@@	O	-1	11063349
al.	O	-1	11063349
However,	O	-1	11063349
when	O	-1	11063349
conver@@	O	-1	11063349
ting	O	-1	11063349
patients	O	-1	11063349
to	O	-1	11063349
R@@	B-Chemical	D020123	11063349
A@@	I-Chemical	-1	11063349
P@@	I-Chemical	-1	11063349
A	I-Chemical	-1	11063349
drug	O	-1	11063349
levels	O	-1	11063349
should	O	-1	11063349
be	O	-1	11063349
monit@@	O	-1	11063349
o@@	O	-1	11063349
red	O	-1	11063349
to	O	-1	11063349
av@@	O	-1	11063349
oid	O	-1	11063349
over@@	O	-1	11063349
-@@	O	-1	11063349
immunosup@@	O	-1	11063349
pression	O	-1	11063349
and	O	-1	11063349
ade@@	O	-1	11063349
qu@@	O	-1	11063349
ate	O	-1	11063349
anti@@	O	-1	11063349
viral	O	-1	11063349
and	O	-1	11063349
P@@	B-Disease	D011020	11063349
ne@@	I-Disease	-1	11063349
um@@	I-Disease	-1	11063349
oc@@	I-Disease	-1	11063349
ys@@	I-Disease	-1	11063349
tis	I-Disease	-1	11063349
car@@	I-Disease	-1	11063349
in@@	I-Disease	-1	11063349
i@@	I-Disease	-1	11063349
i	I-Disease	-1	11063349
p@@	I-Disease	-1	11063349
ne@@	I-Disease	-1	11063349
um@@	I-Disease	-1	11063349
on@@	I-Disease	-1	11063349
ia	I-Disease	-1	11063349
pro@@	O	-1	11063349
phyl@@	O	-1	11063349
ax@@	O	-1	11063349
is	O	-1	11063349
should	O	-1	11063349
be	O	-1	11063349
gi@@	O	-1	11063349
ven@@	O	-1	11063349
.	O	-1	11063349

W@@	O	-1	10091616
or@@	O	-1	10091616
sen@@	O	-1	10091616
ing	O	-1	10091616
of	O	-1	10091616
levo@@	B-Chemical	D007980	10091616
dopa	I-Chemical	-1	10091616
-induced	O	-1	10091616
dyskine@@	B-Disease	D004409	10091616
si@@	I-Disease	-1	10091616
as	I-Disease	-1	10091616
by	O	-1	10091616
motor	O	-1	10091616
and	O	-1	10091616
mental	O	-1	10091616
t@@	O	-1	10091616
as@@	O	-1	10091616
k@@	O	-1	10091616
s.	O	-1	10091616
T@@	O	-1	10091616
en	O	-1	10091616
patients	O	-1	10091616
who	O	-1	10091616
had	O	-1	10091616
Parkinson's	B-Disease	D010300	10091616
disease	I-Disease	-1	10091616
with	O	-1	10091616
dis@@	O	-1	10091616
abl@@	O	-1	10091616
ing	O	-1	10091616
dyskine@@	B-Disease	D004409	10091616
sia	I-Disease	-1	10091616
were	O	-1	10091616
included	O	-1	10091616
in	O	-1	10091616
this	O	-1	10091616
study	O	-1	10091616
to	O	-1	10091616
evalu@@	O	-1	10091616
ate	O	-1	10091616
the	O	-1	10091616
role	O	-1	10091616
of	O	-1	10091616
mental	O	-1	10091616
(@@	O	-1	10091616
mental	O	-1	10091616
calc@@	O	-1	10091616
ul@@	O	-1	10091616
ation@@	O	-1	10091616
)	O	-1	10091616
and	O	-1	10091616
motor	O	-1	10091616
(@@	O	-1	10091616
f@@	O	-1	10091616
le@@	O	-1	10091616
xi@@	O	-1	10091616
on@@	O	-1	10091616
/@@	O	-1	10091616
exten@@	O	-1	10091616
sion	O	-1	10091616
of	O	-1	10091616
right	O	-1	10091616
f@@	O	-1	10091616
ing@@	O	-1	10091616
er@@	O	-1	10091616
s,	O	-1	10091616
f@@	O	-1	10091616
le@@	O	-1	10091616
xi@@	O	-1	10091616
on@@	O	-1	10091616
/@@	O	-1	10091616
exten@@	O	-1	10091616
sion	O	-1	10091616
of	O	-1	10091616
left	O	-1	10091616
f@@	O	-1	10091616
ing@@	O	-1	10091616
er@@	O	-1	10091616
s,	O	-1	10091616
f@@	O	-1	10091616
le@@	O	-1	10091616
xi@@	O	-1	10091616
on@@	O	-1	10091616
/@@	O	-1	10091616
exten@@	O	-1	10091616
sion	O	-1	10091616
of	O	-1	10091616
the	O	-1	10091616
nec@@	O	-1	10091616
k@@	O	-1	10091616
,	O	-1	10091616
sp@@	O	-1	10091616
e@@	O	-1	10091616
ak@@	O	-1	10091616
ing	O	-1	10091616
al@@	O	-1	10091616
ou@@	O	-1	10091616
d@@	O	-1	10091616
)	O	-1	10091616
t@@	O	-1	10091616
as@@	O	-1	10091616
k@@	O	-1	10091616
s	O	-1	10091616
on	O	-1	10091616
the	O	-1	10091616
wor@@	O	-1	10091616
sen@@	O	-1	10091616
ing	O	-1	10091616
of	O	-1	10091616
pe@@	O	-1	10091616
ak@@	O	-1	10091616
-@@	O	-1	10091616
dose	O	-1	10091616
dyskine@@	B-Disease	D004409	10091616
sia	I-Disease	-1	10091616
following	O	-1	10091616
administration	O	-1	10091616
of	O	-1	10091616
an	O	-1	10091616
effective	O	-1	10091616
single	O	-1	10091616
dose	O	-1	10091616
of	O	-1	10091616
apo@@	B-Chemical	D001058	10091616
morphine	I-Chemical	-1	10091616
.	O	-1	10091616
Com@@	O	-1	10091616
pared	O	-1	10091616
with	O	-1	10091616
the	O	-1	10091616
scor@@	O	-1	10091616
e	O	-1	10091616
at	O	-1	10091616
res@@	O	-1	10091616
t	O	-1	10091616
(1@@	O	-1	10091616
.@@	O	-1	10091616
3@@	O	-1	10091616
+/-@@	O	-1	10091616
0.@@	O	-1	10091616
3@@	O	-1	10091616
),	O	-1	10091616
a	O	-1	10091616
significant	O	-1	10091616
ag@@	O	-1	10091616
gra@@	O	-1	10091616
v@@	O	-1	10091616
ation	O	-1	10091616
of	O	-1	10091616
the	O	-1	10091616
dyskine@@	B-Disease	D004409	10091616
sia	I-Disease	-1	10091616
scor@@	O	-1	10091616
e	O	-1	10091616
was	O	-1	10091616
observed	O	-1	10091616
during	O	-1	10091616
sp@@	O	-1	10091616
e@@	O	-1	10091616
ak@@	O	-1	10091616
ing	O	-1	10091616
al@@	O	-1	10091616
ou@@	O	-1	10091616
d	O	-1	10091616
(@@	O	-1	10091616
5.@@	O	-1	10091616
2@@	O	-1	10091616
+/-@@	O	-1	10091616
1.@@	O	-1	10091616
1,	O	-1	10091616
p@@	O	-1	10091616
<@@	O	-1	10091616
0.05@@	O	-1	10091616
),	O	-1	10091616
mo@@	O	-1	10091616
ve@@	O	-1	10091616
ments	O	-1	10091616
of	O	-1	10091616
right	O	-1	10091616
(@@	O	-1	10091616
4.@@	O	-1	10091616
5@@	O	-1	10091616
+/-@@	O	-1	10091616
1.@@	O	-1	10091616
0@@	O	-1	10091616
,	O	-1	10091616
p@@	O	-1	10091616
<@@	O	-1	10091616
0.05@@	O	-1	10091616
)	O	-1	10091616
and	O	-1	10091616
left	O	-1	10091616
(@@	O	-1	10091616
3.@@	O	-1	10091616
7@@	O	-1	10091616
+/-@@	O	-1	10091616
0.@@	O	-1	10091616
8@@	O	-1	10091616
,	O	-1	10091616
p@@	O	-1	10091616
<@@	O	-1	10091616
0.05@@	O	-1	10091616
)	O	-1	10091616
f@@	O	-1	10091616
ing@@	O	-1	10091616
er@@	O	-1	10091616
s,	O	-1	10091616
mo@@	O	-1	10091616
ve@@	O	-1	10091616
ments	O	-1	10091616
of	O	-1	10091616
the	O	-1	10091616
nec@@	O	-1	10091616
k	O	-1	10091616
(@@	O	-1	10091616
5.@@	O	-1	10091616
1@@	O	-1	10091616
+/-@@	O	-1	10091616
1.@@	O	-1	10091616
0@@	O	-1	10091616
,	O	-1	10091616
p@@	O	-1	10091616
<@@	O	-1	10091616
0.05@@	O	-1	10091616
),	O	-1	10091616
and	O	-1	10091616
mental	O	-1	10091616
calc@@	O	-1	10091616
ulation	O	-1	10091616
(@@	O	-1	10091616
3.@@	O	-1	10091616
1@@	O	-1	10091616
+/-@@	O	-1	10091616
1.@@	O	-1	10091616
0@@	O	-1	10091616
,	O	-1	10091616
p@@	O	-1	10091616
<@@	O	-1	10091616
0.05@@	O	-1	10091616
).	O	-1	10091616
These	O	-1	10091616
results	O	-1	10091616
suggest	O	-1	10091616
that	O	-1	10091616
activation	O	-1	10091616
t@@	O	-1	10091616
as@@	O	-1	10091616
k@@	O	-1	10091616
s	O	-1	10091616
such	O	-1	10091616
as	O	-1	10091616
"@@	O	-1	10091616
sp@@	O	-1	10091616
e@@	O	-1	10091616
ak@@	O	-1	10091616
ing	O	-1	10091616
al@@	O	-1	10091616
ou@@	O	-1	10091616
d@@	O	-1	10091616
"	O	-1	10091616
could	O	-1	10091616
be	O	-1	10091616
used	O	-1	10091616
for	O	-1	10091616
ob@@	O	-1	10091616
j@@	O	-1	10091616
ective	O	-1	10091616
assess@@	O	-1	10091616
ment	O	-1	10091616
of	O	-1	10091616
dyskine@@	B-Disease	D004409	10091616
sia	I-Disease	-1	10091616
sever@@	O	-1	10091616
ity.	O	-1	10091616

S@@	B-Disease	D028361	9952311
tr@@	I-Disease	-1	9952311
uc@@	I-Disease	-1	9952311
t@@	I-Disease	-1	9952311
ural	I-Disease	-1	9952311
and	I-Disease	-1	9952311
functional	I-Disease	-1	9952311
impair@@	I-Disease	-1	9952311
ment	I-Disease	-1	9952311
of	I-Disease	-1	9952311
mitochond@@	I-Disease	-1	9952311
ri@@	I-Disease	-1	9952311
a	I-Disease	-1	9952311
in	O	-1	9952311
adriam@@	B-Chemical	D004317	9952311
ycin	I-Chemical	-1	9952311
-induced	O	-1	9952311
cardi@@	B-Disease	D009202	9952311
om@@	I-Disease	-1	9952311
yo@@	I-Disease	-1	9952311
pathy	I-Disease	-1	9952311
in	O	-1	9952311
mic@@	O	-1	9952311
e@@	O	-1	9952311
:	O	-1	9952311
sup@@	O	-1	9952311
pression	O	-1	9952311
of	O	-1	9952311
cyto@@	O	-1	9952311
ch@@	O	-1	9952311
rom@@	O	-1	9952311
e	O	-1	9952311
c	O	-1	9952311
oxid@@	O	-1	9952311
ase	O	-1	9952311
II	O	-1	9952311
gen@@	O	-1	9952311
e	O	-1	9952311
ex@@	O	-1	9952311
pres@@	O	-1	9952311
sion.	O	-1	9952311
The	O	-1	9952311
use	O	-1	9952311
of	O	-1	9952311
adriam@@	B-Chemical	D004317	9952311
ycin	I-Chemical	-1	9952311
(	O	-1	9952311
AD@@	B-Chemical	D004317	9952311
R	I-Chemical	-1	9952311
)	O	-1	9952311
in	O	-1	9952311
cancer	B-Disease	D009369	9952311
chemotherapy	O	-1	9952311
has	O	-1	9952311
been	O	-1	9952311
lim@@	O	-1	9952311
ited	O	-1	9952311
due	O	-1	9952311
to	O	-1	9952311
its	O	-1	9952311
cum@@	O	-1	9952311
ul@@	O	-1	9952311
ative	O	-1	9952311
cardiovascular	B-Disease	D002318	9952311
toxicity	I-Disease	-1	9952311
.	O	-1	9952311
E@@	O	-1	9952311
ar@@	O	-1	9952311
li@@	O	-1	9952311
er	O	-1	9952311
observ@@	O	-1	9952311
ations	O	-1	9952311
that	O	-1	9952311
AD@@	B-Chemical	D004317	9952311
R	I-Chemical	-1	9952311
inter@@	O	-1	9952311
act@@	O	-1	9952311
s	O	-1	9952311
with	O	-1	9952311
mitochondrial	O	-1	9952311
cyto@@	O	-1	9952311
ch@@	O	-1	9952311
rom@@	O	-1	9952311
e	O	-1	9952311
c	O	-1	9952311
oxid@@	O	-1	9952311
ase	O	-1	9952311
(C@@	O	-1	9952311
O@@	O	-1	9952311
X@@	O	-1	9952311
)	O	-1	9952311
and	O	-1	9952311
sup@@	O	-1	9952311
pres@@	O	-1	9952311
ses	O	-1	9952311
its	O	-1	9952311
enzyme	O	-1	9952311
activity	O	-1	9952311
l@@	O	-1	9952311
ed	O	-1	9952311
us	O	-1	9952311
to	O	-1	9952311
investigate	O	-1	9952311
AD@@	B-Chemical	D004317	9952311
R	I-Chemical	-1	9952311
's	O	-1	9952311
action	O	-1	9952311
on	O	-1	9952311
the	O	-1	9952311
cardiovascular	O	-1	9952311
func@@	O	-1	9952311
tions	O	-1	9952311
and	O	-1	9952311
heart	O	-1	9952311
mitochondrial	O	-1	9952311
morph@@	O	-1	9952311
ology	O	-1	9952311
in	O	-1	9952311
B@@	O	-1	9952311
al@@	O	-1	9952311
b@@	O	-1	9952311
-@@	O	-1	9952311
c	O	-1	9952311
mice	O	-1	9952311
i.@@	O	-1	9952311
p@@	O	-1	9952311
.	O	-1	9952311
treated	O	-1	9952311
with	O	-1	9952311
AD@@	B-Chemical	D004317	9952311
R	I-Chemical	-1	9952311
for	O	-1	9952311
several	O	-1	9952311
week@@	O	-1	9952311
s.	O	-1	9952311
A@@	O	-1	9952311
t	O	-1	9952311
various	O	-1	9952311
times	O	-1	9952311
during	O	-1	9952311
treatment,	O	-1	9952311
the	O	-1	9952311
animals	O	-1	9952311
were	O	-1	9952311
assessed	O	-1	9952311
for	O	-1	9952311
cardiovascular	O	-1	9952311
func@@	O	-1	9952311
tions	O	-1	9952311
by	O	-1	9952311
electro@@	O	-1	9952311
cardio@@	O	-1	9952311
graph@@	O	-1	9952311
y	O	-1	9952311
and	O	-1	9952311
for	O	-1	9952311
heart	O	-1	9952311
tissue	O	-1	9952311
damage	O	-1	9952311
by	O	-1	9952311
electro@@	O	-1	9952311
n	O	-1	9952311
micro@@	O	-1	9952311
sco@@	O	-1	9952311
p@@	O	-1	9952311
y.	O	-1	9952311
In	O	-1	9952311
par@@	O	-1	9952311
al@@	O	-1	9952311
le@@	O	-1	9952311
l@@	O	-1	9952311
,	O	-1	9952311
total	O	-1	9952311
R@@	O	-1	9952311
NA	O	-1	9952311
was	O	-1	9952311
extrac@@	O	-1	9952311
ted	O	-1	9952311
from	O	-1	9952311
sam@@	O	-1	9952311
ple@@	O	-1	9952311
s	O	-1	9952311
of	O	-1	9952311
dis@@	O	-1	9952311
s@@	O	-1	9952311
ected	O	-1	9952311
heart	O	-1	9952311
and	O	-1	9952311
analy@@	O	-1	9952311
zed	O	-1	9952311
by	O	-1	9952311
N@@	O	-1	9952311
or@@	O	-1	9952311
ther@@	O	-1	9952311
n	O	-1	9952311
blo@@	O	-1	9952311
t	O	-1	9952311
hy@@	O	-1	9952311
b@@	O	-1	9952311
ri@@	O	-1	9952311
di@@	O	-1	9952311
z@@	O	-1	9952311
ation	O	-1	9952311
to	O	-1	9952311
determine	O	-1	9952311
the	O	-1	9952311
ste@@	O	-1	9952311
ad@@	O	-1	9952311
y-@@	O	-1	9952311
state	O	-1	9952311
level	O	-1	9952311
of	O	-1	9952311
three	O	-1	9952311
R@@	O	-1	9952311
NA	O	-1	9952311
trans@@	O	-1	9952311
cri@@	O	-1	9952311
pt@@	O	-1	9952311
s	O	-1	9952311
en@@	O	-1	9952311
co@@	O	-1	9952311
ded	O	-1	9952311
by	O	-1	9952311
the	O	-1	9952311
CO@@	O	-1	9952311
X@@	O	-1	9952311
II@@	O	-1	9952311
,	O	-1	9952311
CO@@	O	-1	9952311
X@@	O	-1	9952311
II@@	O	-1	9952311
I@@	O	-1	9952311
,	O	-1	9952311
and	O	-1	9952311
CO@@	O	-1	9952311
X@@	O	-1	9952311
IV	O	-1	9952311
gen@@	O	-1	9952311
es.	O	-1	9952311
S@@	O	-1	9952311
im@@	O	-1	9952311
il@@	O	-1	9952311
ar@@	O	-1	9952311
ly,	O	-1	9952311
sam@@	O	-1	9952311
ple@@	O	-1	9952311
s	O	-1	9952311
obtained	O	-1	9952311
from	O	-1	9952311
the	O	-1	9952311
liver	O	-1	9952311
of	O	-1	9952311
the	O	-1	9952311
same	O	-1	9952311
animals	O	-1	9952311
were	O	-1	9952311
analy@@	O	-1	9952311
zed	O	-1	9952311
for	O	-1	9952311
compar@@	O	-1	9952311
ative	O	-1	9952311
studi@@	O	-1	9952311
es.	O	-1	9952311
Our	O	-1	9952311
results	O	-1	9952311
indic@@	O	-1	9952311
ated	O	-1	9952311
that	O	-1	9952311
1)	O	-1	9952311
treatment	O	-1	9952311
of	O	-1	9952311
mice	O	-1	9952311
with	O	-1	9952311
AD@@	B-Chemical	D004317	9952311
R	I-Chemical	-1	9952311
caused	O	-1	9952311
cardiovascular	B-Disease	D001145	9952311
arrhyth@@	I-Disease	-1	9952311
mi@@	I-Disease	-1	9952311
as	I-Disease	-1	9952311
character@@	O	-1	9952311
ized	O	-1	9952311
by	O	-1	9952311
brady@@	B-Disease	D001919	9952311
cardia	I-Disease	-1	9952311
,	O	-1	9952311
exten@@	O	-1	9952311
sion	O	-1	9952311
of	O	-1	9952311
ventricular	O	-1	9952311
de@@	O	-1	9952311
pol@@	O	-1	9952311
ar@@	O	-1	9952311
ization	O	-1	9952311
time	O	-1	9952311
(@@	O	-1	9952311
t@@	O	-1	9952311
Q@@	O	-1	9952311
R@@	O	-1	9952311
S@@	O	-1	9952311
),	O	-1	9952311
and	O	-1	9952311
failure	O	-1	9952311
of	O	-1	9952311
Q@@	O	-1	9952311
R@@	O	-1	9952311
S	O	-1	9952311
at	O	-1	9952311
high	O	-1	9952311
concentrations	O	-1	9952311
(@@	O	-1	9952311
10@@	O	-1	9952311
-1@@	O	-1	9952311
4	O	-1	9952311
mg/kg	O	-1	9952311
body	O	-1	9952311
weight	O	-1	9952311
cum@@	O	-1	9952311
ul@@	O	-1	9952311
ative	O	-1	9952311
dose@@	O	-1	9952311
);	O	-1	9952311
2)	O	-1	9952311
the	O	-1	9952311
heart	O	-1	9952311
mitochond@@	O	-1	9952311
ri@@	O	-1	9952311
a	O	-1	9952311
under@@	O	-1	9952311
w@@	O	-1	9952311
ent	O	-1	9952311
s@@	B-Disease	D004487	9952311
we@@	I-Disease	-1	9952311
ll@@	I-Disease	-1	9952311
ing	I-Disease	-1	9952311
,	O	-1	9952311
fu@@	O	-1	9952311
sion,	O	-1	9952311
dis@@	O	-1	9952311
sol@@	O	-1	9952311
u@@	O	-1	9952311
tion,	O	-1	9952311
and/or	O	-1	9952311
dis@@	O	-1	9952311
ru@@	O	-1	9952311
ption	O	-1	9952311
of	O	-1	9952311
mitochondrial	O	-1	9952311
cri@@	O	-1	9952311
st@@	O	-1	9952311
a@@	O	-1	9952311
e	O	-1	9952311
after	O	-1	9952311
several	O	-1	9952311
weeks	O	-1	9952311
of	O	-1	9952311
treatment.	O	-1	9952311
S@@	O	-1	9952311
uc@@	O	-1	9952311
h	O	-1	9952311
abnormal@@	O	-1	9952311
ities	O	-1	9952311
were	O	-1	9952311
not	O	-1	9952311
observed	O	-1	9952311
in	O	-1	9952311
the	O	-1	9952311
mitochond@@	O	-1	9952311
ri@@	O	-1	9952311
a	O	-1	9952311
of	O	-1	9952311
liver	O	-1	9952311
tissu@@	O	-1	9952311
e@@	O	-1	9952311
;	O	-1	9952311
and	O	-1	9952311
3@@	O	-1	9952311
)	O	-1	9952311
among	O	-1	9952311
the	O	-1	9952311
three	O	-1	9952311
gen@@	O	-1	9952311
es	O	-1	9952311
of	O	-1	9952311
CO@@	O	-1	9952311
X	O	-1	9952311
enzyme	O	-1	9952311
ex@@	O	-1	9952311
am@@	O	-1	9952311
ine@@	O	-1	9952311
d,	O	-1	9952311
only	O	-1	9952311
CO@@	O	-1	9952311
X@@	O	-1	9952311
II	O	-1	9952311
gen@@	O	-1	9952311
e	O	-1	9952311
expression	O	-1	9952311
was	O	-1	9952311
sup@@	O	-1	9952311
press@@	O	-1	9952311
ed	O	-1	9952311
by	O	-1	9952311
AD@@	B-Chemical	D004317	9952311
R	I-Chemical	-1	9952311
treatment,	O	-1	9952311
main@@	O	-1	9952311
ly	O	-1	9952311
after	O	-1	9952311
8	O	-1	9952311
weeks	O	-1	9952311
in	O	-1	9952311
both	O	-1	9952311
heart	O	-1	9952311
and	O	-1	9952311
li@@	O	-1	9952311
ver@@	O	-1	9952311
.	O	-1	9952311
K@@	O	-1	9952311
now@@	O	-1	9952311
ing	O	-1	9952311
that	O	-1	9952311
heart	O	-1	9952311
mitochond@@	O	-1	9952311
ri@@	O	-1	9952311
a	O	-1	9952311
re@@	O	-1	9952311
present	O	-1	9952311
al@@	O	-1	9952311
most	O	-1	9952311
4@@	O	-1	9952311
0%	O	-1	9952311
of	O	-1	9952311
heart	O	-1	9952311
musc@@	O	-1	9952311
le	O	-1	9952311
by	O	-1	9952311
weigh@@	O	-1	9952311
t,	O	-1	9952311
we	O	-1	9952311
concl@@	O	-1	9952311
ude	O	-1	9952311
that	O	-1	9952311
the	O	-1	9952311
deter@@	O	-1	9952311
i@@	O	-1	9952311
or@@	O	-1	9952311
ating	O	-1	9952311
effects	O	-1	9952311
of	O	-1	9952311
AD@@	B-Chemical	D004317	9952311
R	I-Chemical	-1	9952311
on	O	-1	9952311
cardiovascular	O	-1	9952311
function	O	-1	9952311
invol@@	O	-1	9952311
ve	O	-1	9952311
mitochondrial	B-Disease	D028361	9952311
struct@@	I-Disease	-1	9952311
ural	I-Disease	-1	9952311
and	I-Disease	-1	9952311
functional	I-Disease	-1	9952311
impair@@	I-Disease	-1	9952311
ment	I-Disease	-1	9952311
.	O	-1	9952311

E@@	O	-1	9915601
n@@	O	-1	9915601
h@@	O	-1	9915601
anced	O	-1	9915601
brady@@	B-Disease	D001919	9915601
cardia	I-Disease	-1	9915601
induced	O	-1	9915601
by	O	-1	9915601
beta-@@	O	-1	9915601
adren@@	O	-1	9915601
oc@@	O	-1	9915601
e@@	O	-1	9915601
pt@@	O	-1	9915601
or	O	-1	9915601
antagonist@@	O	-1	9915601
s	O	-1	9915601
in	O	-1	9915601
rats	O	-1	9915601
pre@@	O	-1	9915601
treated	O	-1	9915601
with	O	-1	9915601
is@@	B-Chemical	D007538	9915601
oni@@	I-Chemical	-1	9915601
az@@	I-Chemical	-1	9915601
id	I-Chemical	-1	9915601
.	O	-1	9915601
H@@	O	-1	9915601
i@@	O	-1	9915601
gh	O	-1	9915601
doses	O	-1	9915601
of	O	-1	9915601
is@@	B-Chemical	D007538	9915601
oni@@	I-Chemical	-1	9915601
az@@	I-Chemical	-1	9915601
id	I-Chemical	-1	9915601
increase	O	-1	9915601
hypotension	B-Disease	D007022	9915601
induced	O	-1	9915601
by	O	-1	9915601
vas@@	O	-1	9915601
odi@@	O	-1	9915601
lat@@	O	-1	9915601
ors	O	-1	9915601
and	O	-1	9915601
change	O	-1	9915601
the	O	-1	9915601
ac@@	O	-1	9915601
comp@@	O	-1	9915601
an@@	O	-1	9915601
y@@	O	-1	9915601
ing	O	-1	9915601
ref@@	O	-1	9915601
le@@	O	-1	9915601
x	O	-1	9915601
tachycardia	B-Disease	D013610	9915601
to	O	-1	9915601
brady@@	B-Disease	D001919	9915601
cardia	I-Disease	-1	9915601
,	O	-1	9915601
an	O	-1	9915601
inter@@	O	-1	9915601
action	O	-1	9915601
at@@	O	-1	9915601
tri@@	O	-1	9915601
but@@	O	-1	9915601
ed	O	-1	9915601
to	O	-1	9915601
decreased	O	-1	9915601
syn@@	O	-1	9915601
thesis	O	-1	9915601
of	O	-1	9915601
brain	O	-1	9915601
gamma@@	B-Chemical	D005680	9915601
-@@	I-Chemical	-1	9915601
amin@@	I-Chemical	-1	9915601
ob@@	I-Chemical	-1	9915601
ut@@	I-Chemical	-1	9915601
y@@	I-Chemical	-1	9915601
ric	I-Chemical	-1	9915601
acid	I-Chemical	-1	9915601
(	O	-1	9915601
G@@	B-Chemical	D005680	9915601
A@@	I-Chemical	-1	9915601
B@@	I-Chemical	-1	9915601
A	I-Chemical	-1	9915601
).	O	-1	9915601
In	O	-1	9915601
the	O	-1	9915601
present	O	-1	9915601
study,	O	-1	9915601
the	O	-1	9915601
possible	O	-1	9915601
enh@@	O	-1	9915601
ance@@	O	-1	9915601
ment	O	-1	9915601
by	O	-1	9915601
is@@	B-Chemical	D007538	9915601
oni@@	I-Chemical	-1	9915601
az@@	I-Chemical	-1	9915601
id	I-Chemical	-1	9915601
of	O	-1	9915601
brady@@	B-Disease	D001919	9915601
cardia	I-Disease	-1	9915601
induced	O	-1	9915601
by	O	-1	9915601
beta-@@	O	-1	9915601
adren@@	O	-1	9915601
oc@@	O	-1	9915601
e@@	O	-1	9915601
pt@@	O	-1	9915601
or	O	-1	9915601
antagonist@@	O	-1	9915601
s	O	-1	9915601
was	O	-1	9915601
determined	O	-1	9915601
in	O	-1	9915601
rats	O	-1	9915601
anaesthe@@	O	-1	9915601
tis@@	O	-1	9915601
ed	O	-1	9915601
with	O	-1	9915601
chlor@@	B-Chemical	D002698	9915601
al@@	I-Chemical	-1	9915601
ose	I-Chemical	-1	9915601
-	O	-1	9915601
ure@@	B-Chemical	D014520	9915601
th@@	I-Chemical	-1	9915601
ane	I-Chemical	-1	9915601
.	O	-1	9915601
I@@	B-Chemical	D007538	9915601
son@@	I-Chemical	-1	9915601
i@@	I-Chemical	-1	9915601
az@@	I-Chemical	-1	9915601
id	I-Chemical	-1	9915601
significantly	O	-1	9915601
increased	O	-1	9915601
brady@@	B-Disease	D001919	9915601
cardia	I-Disease	-1	9915601
after	O	-1	9915601
prop@@	B-Chemical	D011433	9915601
ran@@	I-Chemical	-1	9915601
o@@	I-Chemical	-1	9915601
lol	I-Chemical	-1	9915601
,	O	-1	9915601
p@@	B-Chemical	D010869	9915601
in@@	I-Chemical	-1	9915601
do@@	I-Chemical	-1	9915601
lol	I-Chemical	-1	9915601
,	O	-1	9915601
l@@	B-Chemical	D007741	9915601
a@@	I-Chemical	-1	9915601
bet@@	I-Chemical	-1	9915601
al@@	I-Chemical	-1	9915601
ol	I-Chemical	-1	9915601
and	O	-1	9915601
at@@	B-Chemical	D001262	9915601
en@@	I-Chemical	-1	9915601
o@@	I-Chemical	-1	9915601
lol	I-Chemical	-1	9915601
,	O	-1	9915601
as	O	-1	9915601
well	O	-1	9915601
as	O	-1	9915601
after	O	-1	9915601
clonidine	B-Chemical	D003000	9915601
,	O	-1	9915601
but	O	-1	9915601
not	O	-1	9915601
after	O	-1	9915601
he@@	B-Chemical	D018738	9915601
xameth@@	I-Chemical	-1	9915601
oni@@	I-Chemical	-1	9915601
um	I-Chemical	-1	9915601
or	O	-1	9915601
carb@@	B-Chemical	D002217	9915601
ac@@	I-Chemical	-1	9915601
hol	I-Chemical	-1	9915601
.	O	-1	9915601
E@@	O	-1	9915601
n@@	O	-1	9915601
h@@	O	-1	9915601
ance@@	O	-1	9915601
ment	O	-1	9915601
was	O	-1	9915601
not	O	-1	9915601
observed	O	-1	9915601
in	O	-1	9915601
rats	O	-1	9915601
pre@@	O	-1	9915601
treated	O	-1	9915601
with	O	-1	9915601
methyl@@	B-Chemical	C006649	9915601
atro@@	I-Chemical	-1	9915601
pine	I-Chemical	-1	9915601
or	O	-1	9915601
previously	O	-1	9915601
v@@	O	-1	9915601
ag@@	O	-1	9915601
ot@@	O	-1	9915601
om@@	O	-1	9915601
i@@	O	-1	9915601
sed.	O	-1	9915601
These	O	-1	9915601
results	O	-1	9915601
are	O	-1	9915601
com@@	O	-1	9915601
pati@@	O	-1	9915601
ble	O	-1	9915601
with	O	-1	9915601
inter@@	O	-1	9915601
fe@@	O	-1	9915601
rence	O	-1	9915601
by	O	-1	9915601
is@@	B-Chemical	D007538	9915601
oni@@	I-Chemical	-1	9915601
az@@	I-Chemical	-1	9915601
id	I-Chemical	-1	9915601
with	O	-1	9915601
G@@	O	-1	9915601
A@@	O	-1	9915601
BA@@	O	-1	9915601
ergic	O	-1	9915601
inhibition	O	-1	9915601
of	O	-1	9915601
cardiac	O	-1	9915601
par@@	O	-1	9915601
as@@	O	-1	9915601
ym@@	O	-1	9915601
pa@@	O	-1	9915601
thetic	O	-1	9915601
t@@	O	-1	9915601
one.	O	-1	9915601
S@@	O	-1	9915601
uc@@	O	-1	9915601
h	O	-1	9915601
inter@@	O	-1	9915601
fe@@	O	-1	9915601
rence	O	-1	9915601
could	O	-1	9915601
be	O	-1	9915601
ex@@	O	-1	9915601
er@@	O	-1	9915601
ted	O	-1	9915601
centr@@	O	-1	9915601
ally,	O	-1	9915601
possib@@	O	-1	9915601
ly	O	-1	9915601
at	O	-1	9915601
the	O	-1	9915601
nucle@@	O	-1	9915601
us	O	-1	9915601
am@@	O	-1	9915601
b@@	O	-1	9915601
i@@	O	-1	9915601
gu@@	O	-1	9915601
us,	O	-1	9915601
or	O	-1	9915601
peri@@	O	-1	9915601
ph@@	O	-1	9915601
er@@	O	-1	9915601
ally	O	-1	9915601
at	O	-1	9915601
the	O	-1	9915601
s@@	O	-1	9915601
in@@	O	-1	9915601
us	O	-1	9915601
no@@	O	-1	9915601
de@@	O	-1	9915601
.	O	-1	9915601

E@@	O	-1	9758264
pi@@	O	-1	9758264
le@@	O	-1	9758264
pto@@	O	-1	9758264
genic	O	-1	9758264
activity	O	-1	9758264
of	O	-1	9758264
fol@@	B-Chemical	D005492	9758264
ic	I-Chemical	-1	9758264
acid	I-Chemical	-1	9758264
after	O	-1	9758264
drug	O	-1	9758264
induc@@	O	-1	9758264
es	O	-1	9758264
S@@	B-Disease	D008180	9758264
L@@	I-Disease	-1	9758264
E	I-Disease	-1	9758264
(	O	-1	9758264
fol@@	B-Chemical	D005492	9758264
ic	I-Chemical	-1	9758264
acid	I-Chemical	-1	9758264
and	O	-1	9758264
epilep@@	B-Disease	D004827	9758264
sy	I-Disease	-1	9758264
)	O	-1	9758264
OBJECTIVE:	O	-1	9758264
To	O	-1	9758264
study	O	-1	9758264
the	O	-1	9758264
effect	O	-1	9758264
of	O	-1	9758264
fol@@	B-Chemical	D005492	9758264
ic	I-Chemical	-1	9758264
acid	I-Chemical	-1	9758264
-@@	O	-1	9758264
containing	O	-1	9758264
mul@@	O	-1	9758264
tiv@@	O	-1	9758264
it@@	O	-1	9758264
amin	O	-1	9758264
sup@@	O	-1	9758264
ple@@	O	-1	9758264
ment@@	O	-1	9758264
ation	O	-1	9758264
in	O	-1	9758264
epileptic	B-Disease	D004827	9758264
women	O	-1	9758264
before	O	-1	9758264
and	O	-1	9758264
during	O	-1	9758264
pregn@@	O	-1	9758264
anc@@	O	-1	9758264
y	O	-1	9758264
in	O	-1	9758264
or@@	O	-1	9758264
der	O	-1	9758264
to	O	-1	9758264
determine	O	-1	9758264
the	O	-1	9758264
rate	O	-1	9758264
of	O	-1	9758264
struct@@	O	-1	9758264
ural	O	-1	9758264
b@@	B-Disease	D000014	9758264
ir@@	I-Disease	-1	9758264
th	I-Disease	-1	9758264
def@@	I-Disease	-1	9758264
ects	I-Disease	-1	9758264
and	O	-1	9758264
epilep@@	B-Disease	D004827	9758264
sy	I-Disease	-1	9758264
-@@	O	-1	9758264
related	O	-1	9758264
side	O	-1	9758264
effects.	O	-1	9758264
S@@	O	-1	9758264
T@@	O	-1	9758264
U@@	O	-1	9758264
D@@	O	-1	9758264
Y	O	-1	9758264
D@@	O	-1	9758264
ES@@	O	-1	9758264
I@@	O	-1	9758264
G@@	O	-1	9758264
N@@	O	-1	9758264
:	O	-1	9758264
F@@	O	-1	9758264
ir@@	O	-1	9758264
st	O	-1	9758264
a	O	-1	9758264
random@@	O	-1	9758264
is@@	O	-1	9758264
ed	O	-1	9758264
tri@@	O	-1	9758264
al,	O	-1	9758264
lat@@	O	-1	9758264
er	O	-1	9758264
per@@	O	-1	9758264
ic@@	O	-1	9758264
on@@	O	-1	9758264
ce@@	O	-1	9758264
ption	O	-1	9758264
car@@	O	-1	9758264
e	O	-1	9758264
including	O	-1	9758264
in	O	-1	9758264
total	O	-1	9758264
12@@	O	-1	9758264
2@@	O	-1	9758264
25	O	-1	9758264
femal@@	O	-1	9758264
es.	O	-1	9758264
RESULTS:	O	-1	9758264
Of	O	-1	9758264
60	O	-1	9758264
epileptic	B-Disease	D004827	9758264
women	O	-1	9758264
with	O	-1	9758264
per@@	O	-1	9758264
ic@@	O	-1	9758264
on@@	O	-1	9758264
cep@@	O	-1	9758264
tional	O	-1	9758264
fol@@	B-Chemical	D005492	9758264
ic	I-Chemical	-1	9758264
acid	I-Chemical	-1	9758264
(0.@@	O	-1	9758264
8	O	-1	9758264
mg@@	O	-1	9758264
)-@@	O	-1	9758264
containing	O	-1	9758264
mul@@	O	-1	9758264
tiv@@	O	-1	9758264
it@@	O	-1	9758264
amin	O	-1	9758264
sup@@	O	-1	9758264
ple@@	O	-1	9758264
ment@@	O	-1	9758264
ation,	O	-1	9758264
no	O	-1	9758264
one	O	-1	9758264
developed	O	-1	9758264
epilep@@	B-Disease	D004827	9758264
sy	I-Disease	-1	9758264
-@@	O	-1	9758264
related	O	-1	9758264
side	O	-1	9758264
effects	O	-1	9758264
during	O	-1	9758264
the	O	-1	9758264
per@@	O	-1	9758264
ic@@	O	-1	9758264
on@@	O	-1	9758264
ce@@	O	-1	9758264
ption	O	-1	9758264
perio@@	O	-1	9758264
d.	O	-1	9758264
One	O	-1	9758264
epileptic	B-Disease	D004827	9758264
woman	O	-1	9758264
de@@	O	-1	9758264
li@@	O	-1	9758264
vered	O	-1	9758264
a	O	-1	9758264
ne@@	O	-1	9758264
w@@	O	-1	9758264
b@@	O	-1	9758264
or@@	O	-1	9758264
n	O	-1	9758264
with	O	-1	9758264
c@@	B-Disease	D002971	9758264
left	I-Disease	-1	9758264
li@@	I-Disease	-1	9758264
p	I-Disease	-1	9758264
and	I-Disease	-1	9758264
p@@	I-Disease	-1	9758264
al@@	I-Disease	-1	9758264
ate	I-Disease	-1	9758264
c@@	B-Disease	D002972	9758264
left	I-Disease	-1	9758264
li@@	I-Disease	-1	9758264
p	I-Disease	-1	9758264
and	I-Disease	-1	9758264
p@@	I-Disease	-1	9758264
al@@	I-Disease	-1	9758264
ate	I-Disease	-1	9758264
.	O	-1	9758264
A@@	O	-1	9758264
no@@	O	-1	9758264
ther	O	-1	9758264
patient	O	-1	9758264
ex@@	O	-1	9758264
hib@@	O	-1	9758264
ited	O	-1	9758264
with	O	-1	9758264
a	O	-1	9758264
cl@@	O	-1	9758264
ust@@	O	-1	9758264
er	O	-1	9758264
of	O	-1	9758264
seizures	B-Disease	D012640	9758264
after	O	-1	9758264
the	O	-1	9758264
per@@	O	-1	9758264
ic@@	O	-1	9758264
on@@	O	-1	9758264
ce@@	O	-1	9758264
ption	O	-1	9758264
period	O	-1	9758264
using	O	-1	9758264
an@@	O	-1	9758264
other	O	-1	9758264
mul@@	O	-1	9758264
tiv@@	O	-1	9758264
it@@	O	-1	9758264
amin@@	O	-1	9758264
.	O	-1	9758264
This	O	-1	9758264
2@@	O	-1	9758264
2-@@	O	-1	9758264
year-old	O	-1	9758264
epileptic	B-Disease	D004827	9758264
woman	O	-1	9758264
was	O	-1	9758264
treated	O	-1	9758264
continu@@	O	-1	9758264
ously	O	-1	9758264
by	O	-1	9758264
carbamazepine	B-Chemical	D002220	9758264
and	O	-1	9758264
a	O	-1	9758264
fol@@	B-Chemical	D005492	9758264
ic	I-Chemical	-1	9758264
acid	I-Chemical	-1	9758264
(@@	O	-1	9758264
1	O	-1	9758264
mg@@	O	-1	9758264
)-@@	O	-1	9758264
containing	O	-1	9758264
mul@@	O	-1	9758264
tiv@@	O	-1	9758264
it@@	O	-1	9758264
amin	O	-1	9758264
from	O	-1	9758264
the	O	-1	9758264
20@@	O	-1	9758264
th	O	-1	9758264
week	O	-1	9758264
of	O	-1	9758264
g@@	O	-1	9758264
est@@	O	-1	9758264
ation.	O	-1	9758264
S@@	O	-1	9758264
he	O	-1	9758264
developed	O	-1	9758264
status	B-Disease	D013226	9758264
epilep@@	I-Disease	-1	9758264
tic@@	I-Disease	-1	9758264
us	I-Disease	-1	9758264
and	O	-1	9758264
lat@@	O	-1	9758264
er	O	-1	9758264
symptoms	O	-1	9758264
of	O	-1	9758264
systemic	B-Disease	D008180	9758264
lu@@	I-Disease	-1	9758264
p@@	I-Disease	-1	9758264
us	I-Disease	-1	9758264
eryth@@	I-Disease	-1	9758264
em@@	I-Disease	-1	9758264
at@@	I-Disease	-1	9758264
o@@	I-Disease	-1	9758264
des	I-Disease	-1	9758264
.	O	-1	9758264
H@@	O	-1	9758264
er	O	-1	9758264
pregn@@	O	-1	9758264
anc@@	O	-1	9758264
y	O	-1	9758264
en@@	O	-1	9758264
ded	O	-1	9758264
with	O	-1	9758264
sti@@	B-Disease	D050497	9758264
ll@@	I-Disease	-1	9758264
b@@	I-Disease	-1	9758264
ir@@	I-Disease	-1	9758264
th	I-Disease	-1	9758264
.	O	-1	9758264
CONCLUSIONS:	O	-1	9758264
The	O	-1	9758264
epileptic	B-Disease	D004827	9758264
pregn@@	O	-1	9758264
ant	O	-1	9758264
patient@@	O	-1	9758264
's	O	-1	9758264
auto@@	B-Disease	D001327	9758264
immun@@	I-Disease	-1	9758264
e	I-Disease	-1	9758264
disease	I-Disease	-1	9758264
(@@	O	-1	9758264
prob@@	O	-1	9758264
ably	O	-1	9758264
drug@@	O	-1	9758264
-induced	O	-1	9758264
lu@@	B-Disease	D008180	9758264
p@@	I-Disease	-1	9758264
us	I-Disease	-1	9758264
)	O	-1	9758264
could	O	-1	9758264
damage	O	-1	9758264
the	O	-1	9758264
blo@@	O	-1	9758264
o@@	O	-1	9758264
d-@@	O	-1	9758264
brain	O	-1	9758264
bar@@	O	-1	9758264
ri@@	O	-1	9758264
er,	O	-1	9758264
the@@	O	-1	9758264
re@@	O	-1	9758264
fore	O	-1	9758264
the	O	-1	9758264
therapeutic	O	-1	9758264
dose	O	-1	9758264
(@@	O	-1	9758264
>	O	-1	9758264
or	O	-1	9758264
=@@	O	-1	9758264
1	O	-1	9758264
mg@@	O	-1	9758264
)	O	-1	9758264
of	O	-1	9758264
fol@@	B-Chemical	D005492	9758264
ic	I-Chemical	-1	9758264
acid	I-Chemical	-1	9758264
tri@@	O	-1	9758264
g@@	O	-1	9758264
ge@@	O	-1	9758264
red	O	-1	9758264
a	O	-1	9758264
cl@@	O	-1	9758264
ust@@	O	-1	9758264
er	O	-1	9758264
of	O	-1	9758264
seizures	B-Disease	D012640	9758264
.	O	-1	9758264
P@@	O	-1	9758264
hy@@	O	-1	9758264
si@@	O	-1	9758264
ological	O	-1	9758264
dose	O	-1	9758264
(@@	O	-1	9758264
<@@	O	-1	9758264
1	O	-1	9758264
mg@@	O	-1	9758264
)	O	-1	9758264
of	O	-1	9758264
fol@@	B-Chemical	D005492	9758264
ic	I-Chemical	-1	9758264
acid	I-Chemical	-1	9758264
both	O	-1	9758264
in	O	-1	9758264
healthy	O	-1	9758264
and	O	-1	9758264
60	O	-1	9758264
epileptic	B-Disease	D004827	9758264
wom@@	O	-1	9758264
en@@	O	-1	9758264
,	O	-1	9758264
all	O	-1	9758264
without	O	-1	9758264
any	O	-1	9758264
auto@@	B-Disease	D001327	9758264
immun@@	I-Disease	-1	9758264
e	I-Disease	-1	9758264
disease	I-Disease	-1	9758264
,	O	-1	9758264
did	O	-1	9758264
not	O	-1	9758264
increase	O	-1	9758264
the	O	-1	9758264
risk	O	-1	9758264
for	O	-1	9758264
epileptic	B-Disease	D004827	9758264
seizures	I-Disease	-1	9758264
.	O	-1	9758264

Eff@@	O	-1	9669632
ects	O	-1	9669632
of	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
on	O	-1	9669632
symptoms	O	-1	9669632
and	O	-1	9669632
post@@	O	-1	9669632
ci@@	O	-1	9669632
b@@	O	-1	9669632
al	O	-1	9669632
sm@@	O	-1	9669632
all@@	O	-1	9669632
-@@	O	-1	9669632
bo@@	O	-1	9669632
we@@	O	-1	9669632
l	O	-1	9669632
motor	O	-1	9669632
function	O	-1	9669632
in	O	-1	9669632
patients	O	-1	9669632
with	O	-1	9669632
ir@@	B-Disease	D043183	9669632
rit@@	I-Disease	-1	9669632
able	I-Disease	-1	9669632
bo@@	I-Disease	-1	9669632
we@@	I-Disease	-1	9669632
l	I-Disease	-1	9669632
syndrome	I-Disease	-1	9669632
.	O	-1	9669632
BACKGROUND:	O	-1	9669632
I@@	B-Disease	D043183	9669632
r@@	I-Disease	-1	9669632
rit@@	I-Disease	-1	9669632
able	I-Disease	-1	9669632
bo@@	I-Disease	-1	9669632
we@@	I-Disease	-1	9669632
l	I-Disease	-1	9669632
syndrome	I-Disease	-1	9669632
is	O	-1	9669632
a	O	-1	9669632
common	O	-1	9669632
cause	O	-1	9669632
of	O	-1	9669632
ab@@	B-Disease	D015746	9669632
domin@@	I-Disease	-1	9669632
al	I-Disease	-1	9669632
pain	I-Disease	-1	9669632
and	O	-1	9669632
dis@@	O	-1	9669632
com@@	O	-1	9669632
for@@	O	-1	9669632
t	O	-1	9669632
and	O	-1	9669632
may	O	-1	9669632
be	O	-1	9669632
related	O	-1	9669632
to	O	-1	9669632
disor@@	B-Disease	D005767	9669632
de@@	I-Disease	-1	9669632
red	I-Disease	-1	9669632
gast@@	I-Disease	-1	9669632
ro@@	I-Disease	-1	9669632
in@@	I-Disease	-1	9669632
test@@	I-Disease	-1	9669632
inal	I-Disease	-1	9669632
mo@@	I-Disease	-1	9669632
til@@	I-Disease	-1	9669632
ity	I-Disease	-1	9669632
.	O	-1	9669632
Our	O	-1	9669632
a@@	O	-1	9669632
im	O	-1	9669632
was	O	-1	9669632
to	O	-1	9669632
ass@@	O	-1	9669632
ess	O	-1	9669632
the	O	-1	9669632
effects	O	-1	9669632
of	O	-1	9669632
long-term	O	-1	9669632
treatment	O	-1	9669632
with	O	-1	9669632
a	O	-1	9669632
pro@@	O	-1	9669632
kine@@	O	-1	9669632
tic	O	-1	9669632
agent@@	O	-1	9669632
,	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
,	O	-1	9669632
on	O	-1	9669632
post@@	O	-1	9669632
p@@	O	-1	9669632
ran@@	O	-1	9669632
di@@	O	-1	9669632
al	O	-1	9669632
j@@	O	-1	9669632
e@@	O	-1	9669632
j@@	O	-1	9669632
un@@	O	-1	9669632
al	O	-1	9669632
mo@@	O	-1	9669632
til@@	O	-1	9669632
ity	O	-1	9669632
and	O	-1	9669632
symptoms	O	-1	9669632
in	O	-1	9669632
the	O	-1	9669632
ir@@	B-Disease	D043183	9669632
rit@@	I-Disease	-1	9669632
able	I-Disease	-1	9669632
bo@@	I-Disease	-1	9669632
we@@	I-Disease	-1	9669632
l	I-Disease	-1	9669632
syndrome	I-Disease	-1	9669632
(	O	-1	9669632
I@@	B-Disease	D043183	9669632
B@@	I-Disease	-1	9669632
S	I-Disease	-1	9669632
).	O	-1	9669632
METHODS:	O	-1	9669632
Th@@	O	-1	9669632
ir@@	O	-1	9669632
ty-@@	O	-1	9669632
e@@	O	-1	9669632
ight	O	-1	9669632
patients	O	-1	9669632
with	O	-1	9669632
I@@	B-Disease	D043183	9669632
B@@	I-Disease	-1	9669632
S	I-Disease	-1	9669632
(	O	-1	9669632
con@@	B-Disease	D003248	9669632
sti@@	I-Disease	-1	9669632
p@@	I-Disease	-1	9669632
ation	I-Disease	-1	9669632
-@@	O	-1	9669632
pre@@	O	-1	9669632
domin@@	O	-1	9669632
ant@@	O	-1	9669632
,	O	-1	9669632
n	O	-1	9669632
=	O	-1	9669632
17@@	O	-1	9669632
;	O	-1	9669632
di@@	B-Disease	D003967	9669632
ar@@	I-Disease	-1	9669632
r@@	I-Disease	-1	9669632
ho@@	I-Disease	-1	9669632
e@@	I-Disease	-1	9669632
a	I-Disease	-1	9669632
-@@	O	-1	9669632
pre@@	O	-1	9669632
domin@@	O	-1	9669632
ant@@	O	-1	9669632
,	O	-1	9669632
n	O	-1	9669632
=	O	-1	9669632
2@@	O	-1	9669632
1)	O	-1	9669632
under@@	O	-1	9669632
w@@	O	-1	9669632
ent	O	-1	9669632
2@@	O	-1	9669632
4-@@	O	-1	9669632
h	O	-1	9669632
am@@	O	-1	9669632
b@@	O	-1	9669632
ul@@	O	-1	9669632
atory	O	-1	9669632
j@@	O	-1	9669632
e@@	O	-1	9669632
j@@	O	-1	9669632
un@@	O	-1	9669632
al	O	-1	9669632
man@@	O	-1	9669632
o@@	O	-1	9669632
met@@	O	-1	9669632
r@@	O	-1	9669632
y	O	-1	9669632
before	O	-1	9669632
and	O	-1	9669632
after	O	-1	9669632
12	O	-1	9669632
week@@	O	-1	9669632
's	O	-1	9669632
treatment	O	-1	9669632
[	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
,	O	-1	9669632
5	O	-1	9669632
mg	O	-1	9669632
three	O	-1	9669632
times	O	-1	9669632
daily	O	-1	9669632
(n	O	-1	9669632
=	O	-1	9669632
19@@	O	-1	9669632
)	O	-1	9669632
or	O	-1	9669632
placebo	O	-1	9669632
(n	O	-1	9669632
=	O	-1	9669632
19@@	O	-1	9669632
)@@	O	-1	9669632
]@@	O	-1	9669632
.	O	-1	9669632
RESULTS:	O	-1	9669632
In	O	-1	9669632
di@@	B-Disease	D003967	9669632
ar@@	I-Disease	-1	9669632
r@@	I-Disease	-1	9669632
ho@@	I-Disease	-1	9669632
e@@	I-Disease	-1	9669632
a	I-Disease	-1	9669632
-@@	O	-1	9669632
pre@@	O	-1	9669632
domin@@	O	-1	9669632
ant	O	-1	9669632
patients	O	-1	9669632
significant	O	-1	9669632
differences	O	-1	9669632
in	O	-1	9669632
contrac@@	O	-1	9669632
tion	O	-1	9669632
character@@	O	-1	9669632
is@@	O	-1	9669632
tics	O	-1	9669632
were	O	-1	9669632
observed	O	-1	9669632
between	O	-1	9669632
the	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
and	O	-1	9669632
placebo	O	-1	9669632
groups.	O	-1	9669632
In	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
-treated	O	-1	9669632
di@@	B-Disease	D003967	9669632
ar@@	I-Disease	-1	9669632
r@@	I-Disease	-1	9669632
ho@@	I-Disease	-1	9669632
e@@	I-Disease	-1	9669632
a	I-Disease	-1	9669632
-@@	O	-1	9669632
pre@@	O	-1	9669632
domin@@	O	-1	9669632
ant	O	-1	9669632
patients	O	-1	9669632
the	O	-1	9669632
mean	O	-1	9669632
contrac@@	O	-1	9669632
tion	O	-1	9669632
am@@	O	-1	9669632
pl@@	O	-1	9669632
it@@	O	-1	9669632
ude	O	-1	9669632
was	O	-1	9669632
higher	O	-1	9669632
(2@@	O	-1	9669632
9.@@	O	-1	9669632
3	O	-1	9669632
+/-	O	-1	9669632
3.@@	O	-1	9669632
2	O	-1	9669632
versus	O	-1	9669632
2@@	O	-1	9669632
4.@@	O	-1	9669632
9	O	-1	9669632
+/-	O	-1	9669632
2.@@	O	-1	9669632
6	O	-1	9669632
mm	O	-1	9669632
H@@	O	-1	9669632
g@@	O	-1	9669632
,	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
versus	O	-1	9669632
placebo	O	-1	9669632
(P	O	-1	9669632
<	O	-1	9669632
0.00@@	O	-1	9669632
1@@	O	-1	9669632
);	O	-1	9669632
pre@@	O	-1	9669632
treatment,	O	-1	9669632
2@@	O	-1	9669632
5.@@	O	-1	9669632
7	O	-1	9669632
+/-	O	-1	9669632
6.@@	O	-1	9669632
0	O	-1	9669632
mm	O	-1	9669632
H@@	O	-1	9669632
g@@	O	-1	9669632
),	O	-1	9669632
the	O	-1	9669632
mean	O	-1	9669632
contrac@@	O	-1	9669632
tion	O	-1	9669632
duration	O	-1	9669632
long@@	O	-1	9669632
er	O	-1	9669632
(@@	O	-1	9669632
3.@@	O	-1	9669632
4	O	-1	9669632
+/-	O	-1	9669632
0.@@	O	-1	9669632
2	O	-1	9669632
versus	O	-1	9669632
3.@@	O	-1	9669632
0	O	-1	9669632
+/-	O	-1	9669632
0.@@	O	-1	9669632
2	O	-1	9669632
sec@@	O	-1	9669632
,	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
versus	O	-1	9669632
placebo	O	-1	9669632
(P	O	-1	9669632
<	O	-1	9669632
0.00@@	O	-1	9669632
1@@	O	-1	9669632
);	O	-1	9669632
pre@@	O	-1	9669632
treatment,	O	-1	9669632
3.@@	O	-1	9669632
1	O	-1	9669632
+/-	O	-1	9669632
0.@@	O	-1	9669632
5	O	-1	9669632
sec@@	O	-1	9669632
),	O	-1	9669632
and	O	-1	9669632
the	O	-1	9669632
mean	O	-1	9669632
contrac@@	O	-1	9669632
tion	O	-1	9669632
frequency	O	-1	9669632
lower	O	-1	9669632
(2@@	O	-1	9669632
.@@	O	-1	9669632
0	O	-1	9669632
+/-	O	-1	9669632
0.@@	O	-1	9669632
2	O	-1	9669632
versus	O	-1	9669632
2.@@	O	-1	9669632
5	O	-1	9669632
+/-	O	-1	9669632
0.@@	O	-1	9669632
4	O	-1	9669632
cont@@	O	-1	9669632
.@@	O	-1	9669632
/@@	O	-1	9669632
min@@	O	-1	9669632
,	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
versus	O	-1	9669632
placebo	O	-1	9669632
(P	O	-1	9669632
<	O	-1	9669632
0.00@@	O	-1	9669632
1@@	O	-1	9669632
);	O	-1	9669632
pre@@	O	-1	9669632
treatment,	O	-1	9669632
2.@@	O	-1	9669632
5	O	-1	9669632
+/-	O	-1	9669632
1.@@	O	-1	9669632
1	O	-1	9669632
cont@@	O	-1	9669632
.@@	O	-1	9669632
/@@	O	-1	9669632
min@@	O	-1	9669632
]	O	-1	9669632
than	O	-1	9669632
patients	O	-1	9669632
treated	O	-1	9669632
with	O	-1	9669632
placebo@@	O	-1	9669632
.	O	-1	9669632
No	O	-1	9669632
significant	O	-1	9669632
differences	O	-1	9669632
in	O	-1	9669632
j@@	O	-1	9669632
e@@	O	-1	9669632
j@@	O	-1	9669632
un@@	O	-1	9669632
al	O	-1	9669632
mo@@	O	-1	9669632
til@@	O	-1	9669632
ity	O	-1	9669632
were	O	-1	9669632
found	O	-1	9669632
in	O	-1	9669632
the	O	-1	9669632
con@@	B-Disease	D003248	9669632
sti@@	I-Disease	-1	9669632
p@@	I-Disease	-1	9669632
ation	I-Disease	-1	9669632
-@@	O	-1	9669632
pre@@	O	-1	9669632
domin@@	O	-1	9669632
ant	O	-1	9669632
I@@	B-Disease	D043183	9669632
B@@	I-Disease	-1	9669632
S	I-Disease	-1	9669632
group.	O	-1	9669632
S@@	O	-1	9669632
ym@@	O	-1	9669632
pto@@	O	-1	9669632
ms	O	-1	9669632
were	O	-1	9669632
assessed	O	-1	9669632
by	O	-1	9669632
using	O	-1	9669632
a	O	-1	9669632
visual	O	-1	9669632
an@@	O	-1	9669632
alo@@	O	-1	9669632
gu@@	O	-1	9669632
e	O	-1	9669632
s@@	O	-1	9669632
cal@@	O	-1	9669632
e	O	-1	9669632
before	O	-1	9669632
and	O	-1	9669632
after	O	-1	9669632
treatment.	O	-1	9669632
S@@	O	-1	9669632
ym@@	O	-1	9669632
pto@@	O	-1	9669632
m	O	-1	9669632
sco@@	O	-1	9669632
res	O	-1	9669632
rel@@	O	-1	9669632
ating	O	-1	9669632
to	O	-1	9669632
the	O	-1	9669632
severity	O	-1	9669632
of	O	-1	9669632
con@@	B-Disease	D003248	9669632
sti@@	I-Disease	-1	9669632
p@@	I-Disease	-1	9669632
ation	I-Disease	-1	9669632
were	O	-1	9669632
lower	O	-1	9669632
in	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
-treated	O	-1	9669632
con@@	B-Disease	D003248	9669632
sti@@	I-Disease	-1	9669632
p@@	I-Disease	-1	9669632
ation	I-Disease	-1	9669632
-@@	O	-1	9669632
pre@@	O	-1	9669632
domin@@	O	-1	9669632
ant	O	-1	9669632
I@@	B-Disease	D043183	9669632
B@@	I-Disease	-1	9669632
S	I-Disease	-1	9669632
patients	O	-1	9669632
[@@	O	-1	9669632
sco@@	O	-1	9669632
re,	O	-1	9669632
5@@	O	-1	9669632
4	O	-1	9669632
+/-	O	-1	9669632
5	O	-1	9669632
versus	O	-1	9669632
6@@	O	-1	9669632
7	O	-1	9669632
+/-	O	-1	9669632
14	O	-1	9669632
mm@@	O	-1	9669632
,	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
versus	O	-1	9669632
placebo	O	-1	9669632
(P	O	-1	9669632
<	O	-1	9669632
0.05@@	O	-1	9669632
);	O	-1	9669632
pre@@	O	-1	9669632
treatment,	O	-1	9669632
6@@	O	-1	9669632
2	O	-1	9669632
+/-	O	-1	9669632
1@@	O	-1	9669632
9	O	-1	9669632
mm@@	O	-1	9669632
]@@	O	-1	9669632
.	O	-1	9669632
Di@@	B-Disease	D003967	9669632
ar@@	I-Disease	-1	9669632
r@@	I-Disease	-1	9669632
ho@@	I-Disease	-1	9669632
e@@	I-Disease	-1	9669632
a	I-Disease	-1	9669632
-@@	O	-1	9669632
pre@@	O	-1	9669632
domin@@	O	-1	9669632
ant	O	-1	9669632
I@@	B-Disease	D043183	9669632
B@@	I-Disease	-1	9669632
S	I-Disease	-1	9669632
patients	O	-1	9669632
had	O	-1	9669632
a	O	-1	9669632
higher	O	-1	9669632
pain	B-Disease	D010146	9669632
scor@@	O	-1	9669632
e	O	-1	9669632
after	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
therapy	O	-1	9669632
[@@	O	-1	9669632
sco@@	O	-1	9669632
re,	O	-1	9669632
5@@	O	-1	9669632
5	O	-1	9669632
+/-	O	-1	9669632
15	O	-1	9669632
versus	O	-1	9669632
3@@	O	-1	9669632
4	O	-1	9669632
+/-	O	-1	9669632
12	O	-1	9669632
mm@@	O	-1	9669632
,	O	-1	9669632
cis@@	B-Chemical	D020117	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
versus	O	-1	9669632
placebo	O	-1	9669632
(P	O	-1	9669632
<	O	-1	9669632
0.05@@	O	-1	9669632
);	O	-1	9669632
pre@@	O	-1	9669632
treatment,	O	-1	9669632
6@@	O	-1	9669632
7	O	-1	9669632
+/-	O	-1	9669632
1@@	O	-1	9669632
9	O	-1	9669632
mm@@	O	-1	9669632
]@@	O	-1	9669632
.	O	-1	9669632
CONCLUSION:	O	-1	9669632
C@@	B-Chemical	D020117	9669632
is@@	I-Chemical	-1	9669632
apri@@	I-Chemical	-1	9669632
de	I-Chemical	-1	9669632
aff@@	O	-1	9669632
ects	O	-1	9669632
j@@	O	-1	9669632
e@@	O	-1	9669632
j@@	O	-1	9669632
un@@	O	-1	9669632
al	O	-1	9669632
contrac@@	O	-1	9669632
tion	O	-1	9669632
character@@	O	-1	9669632
is@@	O	-1	9669632
tics	O	-1	9669632
and	O	-1	9669632
some	O	-1	9669632
symptoms	O	-1	9669632
in	O	-1	9669632
I@@	B-Disease	D043183	9669632
B@@	I-Disease	-1	9669632
S	I-Disease	-1	9669632
.	O	-1	9669632

Cl@@	B-Chemical	D017291	9326871
ari@@	I-Chemical	-1	9326871
throm@@	I-Chemical	-1	9326871
ycin	I-Chemical	-1	9326871
-induced	O	-1	9326871
ventricular	B-Disease	D017180	9326871
tachycardia	I-Disease	-1	9326871
.	O	-1	9326871
Cl@@	B-Chemical	D017291	9326871
ari@@	I-Chemical	-1	9326871
throm@@	I-Chemical	-1	9326871
ycin	I-Chemical	-1	9326871
is	O	-1	9326871
a	O	-1	9326871
rel@@	O	-1	9326871
atively	O	-1	9326871
new	O	-1	9326871
mac@@	B-Chemical	D018942	9326871
ro@@	I-Chemical	-1	9326871
l@@	I-Chemical	-1	9326871
ide	I-Chemical	-1	9326871
anti@@	O	-1	9326871
bio@@	O	-1	9326871
tic	O	-1	9326871
that	O	-1	9326871
o@@	O	-1	9326871
ff@@	O	-1	9326871
ers	O	-1	9326871
tw@@	O	-1	9326871
ic@@	O	-1	9326871
e-@@	O	-1	9326871
daily	O	-1	9326871
dos@@	O	-1	9326871
ing.	O	-1	9326871
It	O	-1	9326871
diff@@	O	-1	9326871
ers	O	-1	9326871
from	O	-1	9326871
ery@@	B-Chemical	D004917	9326871
throm@@	I-Chemical	-1	9326871
ycin	I-Chemical	-1	9326871
only	O	-1	9326871
in	O	-1	9326871
the	O	-1	9326871
methyl@@	O	-1	9326871
ation	O	-1	9326871
of	O	-1	9326871
the	O	-1	9326871
hydrox@@	O	-1	9326871
yl	O	-1	9326871
group	O	-1	9326871
at	O	-1	9326871
posi@@	O	-1	9326871
tion	O	-1	9326871
6@@	O	-1	9326871
.	O	-1	9326871
Although	O	-1	9326871
the	O	-1	9326871
side@@	O	-1	9326871
-@@	O	-1	9326871
effect	O	-1	9326871
prof@@	O	-1	9326871
ile	O	-1	9326871
of	O	-1	9326871
ery@@	B-Chemical	D004917	9326871
throm@@	I-Chemical	-1	9326871
ycin	I-Chemical	-1	9326871
is	O	-1	9326871
est@@	O	-1	9326871
abl@@	O	-1	9326871
is@@	O	-1	9326871
he@@	O	-1	9326871
d,	O	-1	9326871
including	O	-1	9326871
gast@@	B-Disease	D005759	9326871
ro@@	I-Disease	-1	9326871
ent@@	I-Disease	-1	9326871
er@@	I-Disease	-1	9326871
iti@@	I-Disease	-1	9326871
s	I-Disease	-1	9326871
and	O	-1	9326871
inter@@	O	-1	9326871
ac@@	O	-1	9326871
tions	O	-1	9326871
with	O	-1	9326871
other	O	-1	9326871
drugs	O	-1	9326871
subj@@	O	-1	9326871
ect	O	-1	9326871
to	O	-1	9326871
hepatic	O	-1	9326871
mi@@	O	-1	9326871
x@@	O	-1	9326871
ed@@	O	-1	9326871
-@@	O	-1	9326871
function	O	-1	9326871
oxid@@	O	-1	9326871
ase	O	-1	9326871
metabol@@	O	-1	9326871
is@@	O	-1	9326871
m@@	O	-1	9326871
,	O	-1	9326871
experi@@	O	-1	9326871
ence	O	-1	9326871
with	O	-1	9326871
the	O	-1	9326871
ne@@	O	-1	9326871
w@@	O	-1	9326871
er	O	-1	9326871
mac@@	B-Chemical	D018942	9326871
ro@@	I-Chemical	-1	9326871
li@@	I-Chemical	-1	9326871
des	I-Chemical	-1	9326871
is	O	-1	9326871
sti@@	O	-1	9326871
ll	O	-1	9326871
being	O	-1	9326871
recor@@	O	-1	9326871
de@@	O	-1	9326871
d.	O	-1	9326871
C@@	B-Disease	D066126	9326871
ardi@@	I-Disease	-1	9326871
otoxicity	I-Disease	-1	9326871
has	O	-1	9326871
been	O	-1	9326871
demonstrated	O	-1	9326871
after	O	-1	9326871
both	O	-1	9326871
intravenous	O	-1	9326871
and	O	-1	9326871
oral	O	-1	9326871
administration	O	-1	9326871
of	O	-1	9326871
ery@@	B-Chemical	D004917	9326871
throm@@	I-Chemical	-1	9326871
ycin	I-Chemical	-1	9326871
but	O	-1	9326871
has	O	-1	9326871
ne@@	O	-1	9326871
ver	O	-1	9326871
been	O	-1	9326871
reported	O	-1	9326871
with	O	-1	9326871
the	O	-1	9326871
ne@@	O	-1	9326871
w@@	O	-1	9326871
er	O	-1	9326871
mac@@	B-Chemical	D018942	9326871
ro@@	I-Chemical	-1	9326871
li@@	I-Chemical	-1	9326871
des	I-Chemical	-1	9326871
.	O	-1	9326871
We	O	-1	9326871
report	O	-1	9326871
a	O	-1	9326871
case	O	-1	9326871
of	O	-1	9326871
ventricular	B-Disease	D001145	9326871
dys@@	I-Disease	-1	9326871
rhyth@@	I-Disease	-1	9326871
mi@@	I-Disease	-1	9326871
as	I-Disease	-1	9326871
that	O	-1	9326871
occurred	O	-1	9326871
after	O	-1	9326871
six	O	-1	9326871
therapeutic	O	-1	9326871
doses	O	-1	9326871
of	O	-1	9326871
cl@@	B-Chemical	D017291	9326871
ari@@	I-Chemical	-1	9326871
throm@@	I-Chemical	-1	9326871
ycin	I-Chemical	-1	9326871
.	O	-1	9326871
The	O	-1	9326871
dys@@	B-Disease	D001145	9326871
rhyth@@	I-Disease	-1	9326871
mi@@	I-Disease	-1	9326871
as	I-Disease	-1	9326871
resol@@	O	-1	9326871
ved	O	-1	9326871
after	O	-1	9326871
discontinu@@	O	-1	9326871
ation	O	-1	9326871
of	O	-1	9326871
the	O	-1	9326871
drug.	O	-1	9326871

P@@	O	-1	9226773
er@@	O	-1	9226773
sist@@	O	-1	9226773
ent	O	-1	9226773
nephro@@	B-Disease	D018500	9226773
genic	I-Disease	-1	9226773
dia@@	I-Disease	-1	9226773
bet@@	I-Disease	-1	9226773
es	I-Disease	-1	9226773
in@@	I-Disease	-1	9226773
si@@	I-Disease	-1	9226773
pid@@	I-Disease	-1	9226773
us	I-Disease	-1	9226773
following	O	-1	9226773
lithium	B-Chemical	D008094	9226773
therapy.	O	-1	9226773
We	O	-1	9226773
report	O	-1	9226773
the	O	-1	9226773
case	O	-1	9226773
of	O	-1	9226773
a	O	-1	9226773
patient	O	-1	9226773
who	O	-1	9226773
developed	O	-1	9226773
severe	O	-1	9226773
hyper@@	O	-1	9226773
n@@	O	-1	9226773
at@@	O	-1	9226773
ra@@	O	-1	9226773
em@@	O	-1	9226773
ic	O	-1	9226773
de@@	B-Disease	D003681	9226773
hy@@	I-Disease	-1	9226773
d@@	I-Disease	-1	9226773
ration	I-Disease	-1	9226773
following	O	-1	9226773
a	O	-1	9226773
he@@	B-Disease	D006259	9226773
ad	I-Disease	-1	9226773
injury	I-Disease	-1	9226773
.	O	-1	9226773
T@@	O	-1	9226773
en	O	-1	9226773
years	O	-1	9226773
previously	O	-1	9226773
he	O	-1	9226773
had	O	-1	9226773
been	O	-1	9226773
diagnos@@	O	-1	9226773
ed	O	-1	9226773
to	O	-1	9226773
have	O	-1	9226773
lithium	B-Chemical	D008094	9226773
-induced	O	-1	9226773
nephro@@	B-Disease	D018500	9226773
genic	I-Disease	-1	9226773
dia@@	I-Disease	-1	9226773
bet@@	I-Disease	-1	9226773
es	I-Disease	-1	9226773
in@@	I-Disease	-1	9226773
si@@	I-Disease	-1	9226773
pid@@	I-Disease	-1	9226773
us	I-Disease	-1	9226773
,	O	-1	9226773
and	O	-1	9226773
lithium	B-Chemical	D008094	9226773
therapy	O	-1	9226773
had	O	-1	9226773
been	O	-1	9226773
discontinu@@	O	-1	9226773
ed.	O	-1	9226773
H@@	O	-1	9226773
e	O	-1	9226773
remained	O	-1	9226773
thir@@	O	-1	9226773
st@@	O	-1	9226773
y	O	-1	9226773
and	O	-1	9226773
poly@@	B-Disease	D011141	9226773
ur@@	I-Disease	-1	9226773
ic	I-Disease	-1	9226773
des@@	O	-1	9226773
pit@@	O	-1	9226773
e	O	-1	9226773
cess@@	O	-1	9226773
ation	O	-1	9226773
of	O	-1	9226773
lithium	B-Chemical	D008094	9226773
and	O	-1	9226773
investig@@	O	-1	9226773
ations	O	-1	9226773
on	O	-1	9226773
ad@@	O	-1	9226773
mission	O	-1	9226773
showed	O	-1	9226773
hi@@	O	-1	9226773
m	O	-1	9226773
to	O	-1	9226773
have	O	-1	9226773
normal	O	-1	9226773
os@@	O	-1	9226773
mo@@	O	-1	9226773
reg@@	O	-1	9226773
ul@@	O	-1	9226773
ated	O	-1	9226773
thir@@	O	-1	9226773
st	O	-1	9226773
and	O	-1	9226773
vas@@	B-Chemical	D014667	9226773
o@@	I-Chemical	-1	9226773
press@@	I-Chemical	-1	9226773
in	I-Chemical	-1	9226773
secre@@	O	-1	9226773
tion,	O	-1	9226773
with	O	-1	9226773
c@@	O	-1	9226773
le@@	O	-1	9226773
ar	O	-1	9226773
evidence	O	-1	9226773
of	O	-1	9226773
nephro@@	B-Disease	D018500	9226773
genic	I-Disease	-1	9226773
dia@@	I-Disease	-1	9226773
bet@@	I-Disease	-1	9226773
es	I-Disease	-1	9226773
in@@	I-Disease	-1	9226773
si@@	I-Disease	-1	9226773
pid@@	I-Disease	-1	9226773
us	I-Disease	-1	9226773
.	O	-1	9226773
L@@	B-Chemical	D008094	9226773
i@@	I-Chemical	-1	9226773
thi@@	I-Chemical	-1	9226773
um	I-Chemical	-1	9226773
induced	O	-1	9226773
nephro@@	B-Disease	D018500	9226773
genic	I-Disease	-1	9226773
dia@@	I-Disease	-1	9226773
bet@@	I-Disease	-1	9226773
es	I-Disease	-1	9226773
in@@	I-Disease	-1	9226773
si@@	I-Disease	-1	9226773
pid@@	I-Disease	-1	9226773
us	I-Disease	-1	9226773
is	O	-1	9226773
considered	O	-1	9226773
to	O	-1	9226773
be	O	-1	9226773
reversible	O	-1	9226773
on	O	-1	9226773
cess@@	O	-1	9226773
ation	O	-1	9226773
of	O	-1	9226773
therapy	O	-1	9226773
but	O	-1	9226773
poly@@	B-Disease	D011141	9226773
uria	I-Disease	-1	9226773
per@@	O	-1	9226773
sist@@	O	-1	9226773
ed	O	-1	9226773
in	O	-1	9226773
this	O	-1	9226773
patient	O	-1	9226773
for	O	-1	9226773
ten	O	-1	9226773
years	O	-1	9226773
after	O	-1	9226773
lithium	B-Chemical	D008094	9226773
was	O	-1	9226773
sto@@	O	-1	9226773
pp@@	O	-1	9226773
ed.	O	-1	9226773
We	O	-1	9226773
discus@@	O	-1	9226773
s	O	-1	9226773
the	O	-1	9226773
possible	O	-1	9226773
renal	O	-1	9226773
mechanisms	O	-1	9226773
and	O	-1	9226773
the	O	-1	9226773
implic@@	O	-1	9226773
ations	O	-1	9226773
for	O	-1	9226773
man@@	O	-1	9226773
ag@@	O	-1	9226773
ement	O	-1	9226773
of	O	-1	9226773
patients	O	-1	9226773
with	O	-1	9226773
lithium	B-Chemical	D008094	9226773
-induced	O	-1	9226773
nephro@@	B-Disease	D018500	9226773
genic	I-Disease	-1	9226773
dia@@	I-Disease	-1	9226773
bet@@	I-Disease	-1	9226773
es	I-Disease	-1	9226773
in@@	I-Disease	-1	9226773
si@@	I-Disease	-1	9226773
pid@@	I-Disease	-1	9226773
us	I-Disease	-1	9226773
.	O	-1	9226773

L@@	O	-1	8600333
ate	O	-1	8600333
cardi@@	B-Disease	D066126	8600333
otoxicity	I-Disease	-1	8600333
after	O	-1	8600333
treatment	O	-1	8600333
for	O	-1	8600333
a	O	-1	8600333
mal@@	O	-1	8600333
i@@	O	-1	8600333
gn@@	O	-1	8600333
ant	O	-1	8600333
b@@	B-Disease	D001859	8600333
one	I-Disease	-1	8600333
tumor	I-Disease	-1	8600333
.	O	-1	8600333
C@@	O	-1	8600333
ardi@@	O	-1	8600333
a@@	O	-1	8600333
c	O	-1	8600333
function	O	-1	8600333
was	O	-1	8600333
assessed	O	-1	8600333
in	O	-1	8600333
long-term	O	-1	8600333
sur@@	O	-1	8600333
viv@@	O	-1	8600333
ors	O	-1	8600333
of	O	-1	8600333
mal@@	O	-1	8600333
i@@	O	-1	8600333
gn@@	O	-1	8600333
ant	O	-1	8600333
b@@	B-Disease	D001859	8600333
one	I-Disease	-1	8600333
tu@@	I-Disease	-1	8600333
mor@@	I-Disease	-1	8600333
s	I-Disease	-1	8600333
who	O	-1	8600333
were	O	-1	8600333
treated	O	-1	8600333
ac@@	O	-1	8600333
cor@@	O	-1	8600333
ding	O	-1	8600333
to	O	-1	8600333
R@@	B-Chemical	C053519	8600333
os@@	I-Chemical	-1	8600333
en@@	I-Chemical	-1	8600333
's	I-Chemical	-1	8600333
T@@	I-Chemical	-1	8600333
5	I-Chemical	-1	8600333
or	I-Chemical	-1	8600333
T@@	I-Chemical	-1	8600333
10	I-Chemical	-1	8600333
pro@@	I-Chemical	-1	8600333
to@@	I-Chemical	-1	8600333
co@@	I-Chemical	-1	8600333
l	I-Chemical	-1	8600333
,	O	-1	8600333
both	O	-1	8600333
including	O	-1	8600333
dox@@	B-Chemical	D004317	8600333
orub@@	I-Chemical	-1	8600333
icin	I-Chemical	-1	8600333
.	O	-1	8600333
Th@@	O	-1	8600333
ir@@	O	-1	8600333
ty-@@	O	-1	8600333
one	O	-1	8600333
patients,	O	-1	8600333
age	O	-1	8600333
10-@@	O	-1	8600333
4@@	O	-1	8600333
5	O	-1	8600333
years	O	-1	8600333
(@@	O	-1	8600333
median	O	-1	8600333
age	O	-1	8600333
1@@	O	-1	8600333
7.@@	O	-1	8600333
8	O	-1	8600333
year@@	O	-1	8600333
s)	O	-1	8600333
were	O	-1	8600333
evaluated	O	-1	8600333
2.@@	O	-1	8600333
3@@	O	-1	8600333
-1@@	O	-1	8600333
4.@@	O	-1	8600333
1	O	-1	8600333
years	O	-1	8600333
(@@	O	-1	8600333
median	O	-1	8600333
8.@@	O	-1	8600333
9	O	-1	8600333
year@@	O	-1	8600333
s)	O	-1	8600333
following	O	-1	8600333
comple@@	O	-1	8600333
tion	O	-1	8600333
of	O	-1	8600333
treatment.	O	-1	8600333
C@@	O	-1	8600333
um@@	O	-1	8600333
ul@@	O	-1	8600333
ative	O	-1	8600333
doses	O	-1	8600333
of	O	-1	8600333
dox@@	B-Chemical	D004317	8600333
orub@@	I-Chemical	-1	8600333
icin	I-Chemical	-1	8600333
were	O	-1	8600333
2@@	O	-1	8600333
2@@	O	-1	8600333
5-@@	O	-1	8600333
5@@	O	-1	8600333
50	O	-1	8600333
mg/m@@	O	-1	8600333
2	O	-1	8600333
(@@	O	-1	8600333
median	O	-1	8600333
dose	O	-1	8600333
3@@	O	-1	8600333
6@@	O	-1	8600333
0@@	O	-1	8600333
).	O	-1	8600333
The	O	-1	8600333
evalu@@	O	-1	8600333
ation	O	-1	8600333
consist@@	O	-1	8600333
ed	O	-1	8600333
of	O	-1	8600333
a	O	-1	8600333
hist@@	O	-1	8600333
or@@	O	-1	8600333
y,	O	-1	8600333
physi@@	O	-1	8600333
c@@	O	-1	8600333
al	O	-1	8600333
examin@@	O	-1	8600333
ation,	O	-1	8600333
electro@@	O	-1	8600333
cardio@@	O	-1	8600333
gra@@	O	-1	8600333
m	O	-1	8600333
(@@	O	-1	8600333
EC@@	O	-1	8600333
G@@	O	-1	8600333
),	O	-1	8600333
sign@@	O	-1	8600333
al	O	-1	8600333
aver@@	O	-1	8600333
aged	O	-1	8600333
EC@@	O	-1	8600333
G@@	O	-1	8600333
,	O	-1	8600333
2@@	O	-1	8600333
4-@@	O	-1	8600333
h@@	O	-1	8600333
our	O	-1	8600333
am@@	O	-1	8600333
b@@	O	-1	8600333
ul@@	O	-1	8600333
atory	O	-1	8600333
EC@@	O	-1	8600333
G@@	O	-1	8600333
,	O	-1	8600333
echocardiograph@@	O	-1	8600333
y	O	-1	8600333
and	O	-1	8600333
radi@@	O	-1	8600333
on@@	O	-1	8600333
uc@@	O	-1	8600333
l@@	O	-1	8600333
ide	O	-1	8600333
angio@@	O	-1	8600333
graph@@	O	-1	8600333
y.	O	-1	8600333
E@@	O	-1	8600333
igh@@	O	-1	8600333
te@@	O	-1	8600333
en	O	-1	8600333
of	O	-1	8600333
3@@	O	-1	8600333
1	O	-1	8600333
(5@@	O	-1	8600333
8@@	O	-1	8600333
%)	O	-1	8600333
patients	O	-1	8600333
showed	O	-1	8600333
cardiac	B-Disease	D066126	8600333
toxicity	I-Disease	-1	8600333
,	O	-1	8600333
def@@	O	-1	8600333
in@@	O	-1	8600333
ed	O	-1	8600333
as	O	-1	8600333
ha@@	O	-1	8600333
ving	O	-1	8600333
one	O	-1	8600333
or	O	-1	8600333
more	O	-1	8600333
of	O	-1	8600333
the	O	-1	8600333
following	O	-1	8600333
abnormal@@	O	-1	8600333
iti@@	O	-1	8600333
es@@	O	-1	8600333
:	O	-1	8600333
l@@	O	-1	8600333
ate	O	-1	8600333
potenti@@	O	-1	8600333
al@@	O	-1	8600333
s,	O	-1	8600333
comple@@	O	-1	8600333
x	O	-1	8600333
ventricular	B-Disease	D001145	8600333
arrhyth@@	I-Disease	-1	8600333
mi@@	I-Disease	-1	8600333
as	I-Disease	-1	8600333
,	O	-1	8600333
left	O	-1	8600333
ventricular	B-Disease	D002311	8600333
di@@	I-Disease	-1	8600333
l@@	I-Disease	-1	8600333
ation	I-Disease	-1	8600333
,	O	-1	8600333
decreased	O	-1	8600333
sh@@	O	-1	8600333
or@@	O	-1	8600333
ten@@	O	-1	8600333
ing	O	-1	8600333
frac@@	O	-1	8600333
tion,	O	-1	8600333
or	O	-1	8600333
decreased	O	-1	8600333
e@@	O	-1	8600333
j@@	O	-1	8600333
ection	O	-1	8600333
frac@@	O	-1	8600333
tion.	O	-1	8600333
The	O	-1	8600333
incidence	O	-1	8600333
of	O	-1	8600333
cardiac	B-Disease	D006331	8600333
abnormal@@	I-Disease	-1	8600333
ities	I-Disease	-1	8600333
increased	O	-1	8600333
with	O	-1	8600333
l@@	O	-1	8600333
en@@	O	-1	8600333
g@@	O	-1	8600333
th	O	-1	8600333
of	O	-1	8600333
follow-up	O	-1	8600333
(P@@	O	-1	8600333
<	O	-1	8600333
or	O	-1	8600333
=	O	-1	8600333
.@@	O	-1	8600333
0@@	O	-1	8600333
5@@	O	-1	8600333
).	O	-1	8600333
No	O	-1	8600333
correl@@	O	-1	8600333
ation	O	-1	8600333
could	O	-1	8600333
be	O	-1	8600333
demonstrated	O	-1	8600333
between	O	-1	8600333
cum@@	O	-1	8600333
ul@@	O	-1	8600333
ative	O	-1	8600333
dose	O	-1	8600333
of	O	-1	8600333
dox@@	B-Chemical	D004317	8600333
orub@@	I-Chemical	-1	8600333
icin	I-Chemical	-1	8600333
and	O	-1	8600333
cardiac	O	-1	8600333
stat@@	O	-1	8600333
us,	O	-1	8600333
ex@@	O	-1	8600333
cep@@	O	-1	8600333
t	O	-1	8600333
for	O	-1	8600333
heart	O	-1	8600333
rate	O	-1	8600333
vari@@	O	-1	8600333
abil@@	O	-1	8600333
ity.	O	-1	8600333
Whe@@	O	-1	8600333
n	O	-1	8600333
adjust@@	O	-1	8600333
ed	O	-1	8600333
to	O	-1	8600333
body	O	-1	8600333
sur@@	O	-1	8600333
fac@@	O	-1	8600333
e	O	-1	8600333
a@@	O	-1	8600333
re@@	O	-1	8600333
a,	O	-1	8600333
the	O	-1	8600333
left	O	-1	8600333
ventricular	O	-1	8600333
po@@	O	-1	8600333
ster@@	O	-1	8600333
ior	O	-1	8600333
w@@	O	-1	8600333
all	O	-1	8600333
th@@	O	-1	8600333
ic@@	O	-1	8600333
k@@	O	-1	8600333
ness	O	-1	8600333
(@@	O	-1	8600333
L@@	O	-1	8600333
V@@	O	-1	8600333
P@@	O	-1	8600333
W	O	-1	8600333
in@@	O	-1	8600333
de@@	O	-1	8600333
x@@	O	-1	8600333
)	O	-1	8600333
was	O	-1	8600333
decreased	O	-1	8600333
in	O	-1	8600333
all	O	-1	8600333
patients.	O	-1	8600333
The	O	-1	8600333
incidence	O	-1	8600333
of	O	-1	8600333
dox@@	B-Chemical	D004317	8600333
orub@@	I-Chemical	-1	8600333
icin	I-Chemical	-1	8600333
-induced	O	-1	8600333
cardi@@	B-Disease	D066126	8600333
otoxicity	I-Disease	-1	8600333
is	O	-1	8600333
high	O	-1	8600333
and	O	-1	8600333
increases	O	-1	8600333
with	O	-1	8600333
follow-@@	O	-1	8600333
up@@	O	-1	8600333
,	O	-1	8600333
ir@@	O	-1	8600333
resp@@	O	-1	8600333
ective	O	-1	8600333
of	O	-1	8600333
cum@@	O	-1	8600333
ul@@	O	-1	8600333
ative	O	-1	8600333
dose.	O	-1	8600333
L@@	O	-1	8600333
if@@	O	-1	8600333
e-@@	O	-1	8600333
lon@@	O	-1	8600333
g	O	-1	8600333
cardiac	O	-1	8600333
follow-up	O	-1	8600333
in	O	-1	8600333
these	O	-1	8600333
patients	O	-1	8600333
is	O	-1	8600333
war@@	O	-1	8600333
ran@@	O	-1	8600333
ted.	O	-1	8600333
The	O	-1	8600333
results	O	-1	8600333
of	O	-1	8600333
our	O	-1	8600333
study	O	-1	8600333
suggest	O	-1	8600333
that	O	-1	8600333
heart	O	-1	8600333
rate	O	-1	8600333
vari@@	O	-1	8600333
ability	O	-1	8600333
and	O	-1	8600333
L@@	O	-1	8600333
V@@	O	-1	8600333
P@@	O	-1	8600333
W	O	-1	8600333
in@@	O	-1	8600333
de@@	O	-1	8600333
x	O	-1	8600333
could	O	-1	8600333
be	O	-1	8600333
sensitive	O	-1	8600333
indic@@	O	-1	8600333
at@@	O	-1	8600333
ors	O	-1	8600333
for	O	-1	8600333
cardi@@	B-Disease	D066126	8600333
otoxicity	I-Disease	-1	8600333
.	O	-1	8600333

V@@	B-Disease	D014652	8514073
en@@	I-Disease	-1	8514073
ous	I-Disease	-1	8514073
complications	I-Disease	-1	8514073
of	O	-1	8514073
mid@@	B-Chemical	D008874	8514073
azol@@	I-Chemical	-1	8514073
am	I-Chemical	-1	8514073
versus	O	-1	8514073
di@@	B-Chemical	D003975	8514073
az@@	I-Chemical	-1	8514073
epam	I-Chemical	-1	8514073
.	O	-1	8514073
Although	O	-1	8514073
some	O	-1	8514073
studies	O	-1	8514073
have	O	-1	8514073
suggested	O	-1	8514073
fe@@	O	-1	8514073
w@@	O	-1	8514073
er	O	-1	8514073
venous	B-Disease	D014652	8514073
complications	I-Disease	-1	8514073
are	O	-1	8514073
associated	O	-1	8514073
with	O	-1	8514073
mid@@	B-Chemical	D008874	8514073
azol@@	I-Chemical	-1	8514073
am	I-Chemical	-1	8514073
than	O	-1	8514073
with	O	-1	8514073
di@@	B-Chemical	D003975	8514073
az@@	I-Chemical	-1	8514073
epam	I-Chemical	-1	8514073
for	O	-1	8514073
en@@	O	-1	8514073
dos@@	O	-1	8514073
co@@	O	-1	8514073
p@@	O	-1	8514073
ic	O	-1	8514073
proce@@	O	-1	8514073
du@@	O	-1	8514073
res@@	O	-1	8514073
,	O	-1	8514073
this	O	-1	8514073
vari@@	O	-1	8514073
able	O	-1	8514073
has	O	-1	8514073
not	O	-1	8514073
been	O	-1	8514073
well	O	-1	8514073
doc@@	O	-1	8514073
um@@	O	-1	8514073
ent@@	O	-1	8514073
ed.	O	-1	8514073
We	O	-1	8514073
pro@@	O	-1	8514073
sp@@	O	-1	8514073
ectively	O	-1	8514073
evaluated	O	-1	8514073
the	O	-1	8514073
incidence	O	-1	8514073
of	O	-1	8514073
venous	B-Disease	D014652	8514073
complications	I-Disease	-1	8514073
after	O	-1	8514073
intravenous	O	-1	8514073
injection	O	-1	8514073
of	O	-1	8514073
di@@	B-Chemical	D003975	8514073
az@@	I-Chemical	-1	8514073
epam	I-Chemical	-1	8514073
or	O	-1	8514073
mid@@	B-Chemical	D008874	8514073
azol@@	I-Chemical	-1	8514073
am	I-Chemical	-1	8514073
in	O	-1	8514073
12@@	O	-1	8514073
2	O	-1	8514073
con@@	O	-1	8514073
sec@@	O	-1	8514073
utive	O	-1	8514073
patients	O	-1	8514073
under@@	O	-1	8514073
go@@	O	-1	8514073
ing	O	-1	8514073
co@@	O	-1	8514073
lon@@	O	-1	8514073
os@@	O	-1	8514073
co@@	O	-1	8514073
p@@	O	-1	8514073
y	O	-1	8514073
and	O	-1	8514073
es@@	O	-1	8514073
oph@@	O	-1	8514073
ag@@	O	-1	8514073
o@@	O	-1	8514073
gast@@	O	-1	8514073
ro@@	O	-1	8514073
du@@	O	-1	8514073
o@@	O	-1	8514073
d@@	O	-1	8514073
en@@	O	-1	8514073
os@@	O	-1	8514073
co@@	O	-1	8514073
p@@	O	-1	8514073
y.	O	-1	8514073
O@@	O	-1	8514073
ver@@	O	-1	8514073
all@@	O	-1	8514073
,	O	-1	8514073
venous	B-Disease	D014652	8514073
complications	I-Disease	-1	8514073
were	O	-1	8514073
more	O	-1	8514073
frequent	O	-1	8514073
with	O	-1	8514073
di@@	B-Chemical	D003975	8514073
az@@	I-Chemical	-1	8514073
epam	I-Chemical	-1	8514073
(2@@	O	-1	8514073
2	O	-1	8514073
of	O	-1	8514073
6@@	O	-1	8514073
2	O	-1	8514073
patient@@	O	-1	8514073
s)	O	-1	8514073
than	O	-1	8514073
with	O	-1	8514073
mid@@	B-Chemical	D008874	8514073
azol@@	I-Chemical	-1	8514073
am	I-Chemical	-1	8514073
(@@	O	-1	8514073
4	O	-1	8514073
of	O	-1	8514073
60	O	-1	8514073
patient@@	O	-1	8514073
s)	O	-1	8514073
(p	O	-1	8514073
<	O	-1	8514073
0.00@@	O	-1	8514073
1).	O	-1	8514073
A	O	-1	8514073
p@@	O	-1	8514073
al@@	O	-1	8514073
pa@@	O	-1	8514073
ble	O	-1	8514073
venous	O	-1	8514073
cor@@	O	-1	8514073
d	O	-1	8514073
was	O	-1	8514073
present	O	-1	8514073
in	O	-1	8514073
2@@	O	-1	8514073
3@@	O	-1	8514073
%	O	-1	8514073
(1@@	O	-1	8514073
4	O	-1	8514073
of	O	-1	8514073
6@@	O	-1	8514073
2)	O	-1	8514073
of	O	-1	8514073
patients	O	-1	8514073
in	O	-1	8514073
the	O	-1	8514073
di@@	B-Chemical	D003975	8514073
az@@	I-Chemical	-1	8514073
epam	I-Chemical	-1	8514073
group@@	O	-1	8514073
,	O	-1	8514073
compared	O	-1	8514073
with	O	-1	8514073
2@@	O	-1	8514073
%	O	-1	8514073
(@@	O	-1	8514073
1	O	-1	8514073
of	O	-1	8514073
60	O	-1	8514073
patient@@	O	-1	8514073
s)	O	-1	8514073
in	O	-1	8514073
the	O	-1	8514073
mid@@	B-Chemical	D008874	8514073
azol@@	I-Chemical	-1	8514073
am	I-Chemical	-1	8514073
group	O	-1	8514073
(p	O	-1	8514073
<	O	-1	8514073
0.00@@	O	-1	8514073
2@@	O	-1	8514073
).	O	-1	8514073
P@@	B-Disease	D010146	8514073
ain	I-Disease	-1	8514073
at	O	-1	8514073
the	O	-1	8514073
injection	O	-1	8514073
sit@@	O	-1	8514073
e	O	-1	8514073
occurred	O	-1	8514073
in	O	-1	8514073
3@@	O	-1	8514073
5%	O	-1	8514073
(2@@	O	-1	8514073
2	O	-1	8514073
of	O	-1	8514073
6@@	O	-1	8514073
2)	O	-1	8514073
of	O	-1	8514073
patients	O	-1	8514073
in	O	-1	8514073
the	O	-1	8514073
di@@	B-Chemical	D003975	8514073
az@@	I-Chemical	-1	8514073
epam	I-Chemical	-1	8514073
group	O	-1	8514073
compared	O	-1	8514073
with	O	-1	8514073
7@@	O	-1	8514073
%	O	-1	8514073
(@@	O	-1	8514073
4	O	-1	8514073
of	O	-1	8514073
60	O	-1	8514073
patient@@	O	-1	8514073
s)	O	-1	8514073
in	O	-1	8514073
the	O	-1	8514073
mid@@	B-Chemical	D008874	8514073
azol@@	I-Chemical	-1	8514073
am	I-Chemical	-1	8514073
group	O	-1	8514073
(p	O	-1	8514073
<	O	-1	8514073
0.00@@	O	-1	8514073
1).	O	-1	8514073
S@@	B-Disease	D004487	8514073
we@@	I-Disease	-1	8514073
ll@@	I-Disease	-1	8514073
ing	I-Disease	-1	8514073
and	O	-1	8514073
war@@	O	-1	8514073
m@@	O	-1	8514073
th	O	-1	8514073
at	O	-1	8514073
the	O	-1	8514073
injection	O	-1	8514073
sit@@	O	-1	8514073
e	O	-1	8514073
were	O	-1	8514073
not	O	-1	8514073
significantly	O	-1	8514073
different	O	-1	8514073
between	O	-1	8514073
the	O	-1	8514073
two	O	-1	8514073
groups.	O	-1	8514073
S@@	O	-1	8514073
mo@@	O	-1	8514073
k@@	O	-1	8514073
ing,	O	-1	8514073
non@@	O	-1	8514073
steroid@@	O	-1	8514073
al	O	-1	8514073
anti@@	O	-1	8514073
-@@	O	-1	8514073
inflam@@	O	-1	8514073
mat@@	O	-1	8514073
ory	O	-1	8514073
drug	O	-1	8514073
use@@	O	-1	8514073
,	O	-1	8514073
intravenous	O	-1	8514073
ca@@	O	-1	8514073
the@@	O	-1	8514073
ter	O	-1	8514073
sit@@	O	-1	8514073
e,	O	-1	8514073
d@@	O	-1	8514073
well	O	-1	8514073
time	O	-1	8514073
of	O	-1	8514073
the	O	-1	8514073
ne@@	O	-1	8514073
ed@@	O	-1	8514073
le@@	O	-1	8514073
,	O	-1	8514073
alco@@	B-Chemical	D000431	8514073
hol	I-Chemical	-1	8514073
use@@	O	-1	8514073
,	O	-1	8514073
and	O	-1	8514073
pain	B-Disease	D010146	8514073
during	O	-1	8514073
the	O	-1	8514073
injection	O	-1	8514073
had	O	-1	8514073
no	O	-1	8514073
effect	O	-1	8514073
on	O	-1	8514073
the	O	-1	8514073
incidence	O	-1	8514073
of	O	-1	8514073
venous	B-Disease	D014652	8514073
complications	I-Disease	-1	8514073
.	O	-1	8514073

T@@	B-Disease	D013746	8492347
et@@	I-Disease	-1	8492347
any	I-Disease	-1	8492347
and	O	-1	8492347
rh@@	B-Disease	D012206	8492347
ab@@	I-Disease	-1	8492347
do@@	I-Disease	-1	8492347
my@@	I-Disease	-1	8492347
oly@@	I-Disease	-1	8492347
sis	I-Disease	-1	8492347
due	O	-1	8492347
to	O	-1	8492347
sur@@	O	-1	8492347
re@@	O	-1	8492347
p@@	O	-1	8492347
ti@@	O	-1	8492347
ti@@	O	-1	8492347
ous	O	-1	8492347
f@@	B-Chemical	D005665	8492347
uro@@	I-Chemical	-1	8492347
se@@	I-Chemical	-1	8492347
m@@	I-Chemical	-1	8492347
ide	I-Chemical	-1	8492347
-@@	O	-1	8492347
-@@	O	-1	8492347
import@@	O	-1	8492347
ance	O	-1	8492347
of	O	-1	8492347
mag@@	B-Chemical	D008274	8492347
ne@@	I-Chemical	-1	8492347
si@@	I-Chemical	-1	8492347
um	I-Chemical	-1	8492347
sup@@	O	-1	8492347
ple@@	O	-1	8492347
ment@@	O	-1	8492347
ation.	O	-1	8492347
Di@@	O	-1	8492347
ure@@	O	-1	8492347
tics	O	-1	8492347
may	O	-1	8492347
induce	O	-1	8492347
hypo@@	B-Disease	D007008	8492347
k@@	I-Disease	-1	8492347
al@@	I-Disease	-1	8492347
emia	I-Disease	-1	8492347
,	O	-1	8492347
hy@@	B-Disease	D006996	8492347
p@@	I-Disease	-1	8492347
oc@@	I-Disease	-1	8492347
al@@	I-Disease	-1	8492347
ce@@	I-Disease	-1	8492347
mia	I-Disease	-1	8492347
and	O	-1	8492347
hypo@@	B-Disease	C537153	8492347
mag@@	I-Disease	-1	8492347
n@@	I-Disease	-1	8492347
es@@	I-Disease	-1	8492347
emia	I-Disease	-1	8492347
.	O	-1	8492347
W@@	O	-1	8492347
h@@	O	-1	8492347
ile	O	-1	8492347
severe	O	-1	8492347
hypo@@	B-Disease	D007008	8492347
k@@	I-Disease	-1	8492347
al@@	I-Disease	-1	8492347
emia	I-Disease	-1	8492347
may	O	-1	8492347
cause	O	-1	8492347
musc@@	B-Disease	D018908	8492347
le	I-Disease	-1	8492347
we@@	I-Disease	-1	8492347
ak@@	I-Disease	-1	8492347
ness	I-Disease	-1	8492347
,	O	-1	8492347
severe	O	-1	8492347
hypo@@	B-Disease	C537153	8492347
mag@@	I-Disease	-1	8492347
n@@	I-Disease	-1	8492347
es@@	I-Disease	-1	8492347
emia	I-Disease	-1	8492347
is	O	-1	8492347
associated	O	-1	8492347
with	O	-1	8492347
musc@@	B-Disease	D013035	8492347
le	I-Disease	-1	8492347
sp@@	I-Disease	-1	8492347
as@@	I-Disease	-1	8492347
ms	I-Disease	-1	8492347
and	O	-1	8492347
te@@	B-Disease	D013746	8492347
t@@	I-Disease	-1	8492347
any	I-Disease	-1	8492347
which	O	-1	8492347
can@@	O	-1	8492347
not	O	-1	8492347
be	O	-1	8492347
cor@@	O	-1	8492347
rec@@	O	-1	8492347
ted	O	-1	8492347
by	O	-1	8492347
pot@@	B-Chemical	D011188	8492347
assi@@	I-Chemical	-1	8492347
um	I-Chemical	-1	8492347
and	O	-1	8492347
calcium	B-Chemical	D002118	8492347
sup@@	O	-1	8492347
ple@@	O	-1	8492347
ment@@	O	-1	8492347
ation	O	-1	8492347
alone	O	-1	8492347
(1@@	O	-1	8492347
,@@	O	-1	8492347
2@@	O	-1	8492347
).	O	-1	8492347
S@@	O	-1	8492347
ur@@	O	-1	8492347
re@@	O	-1	8492347
p@@	O	-1	8492347
ti@@	O	-1	8492347
ti@@	O	-1	8492347
ous	O	-1	8492347
di@@	O	-1	8492347
ure@@	O	-1	8492347
tic	O	-1	8492347
ing@@	O	-1	8492347
es@@	O	-1	8492347
tion	O	-1	8492347
has	O	-1	8492347
been	O	-1	8492347
descri@@	O	-1	8492347
be@@	O	-1	8492347
d,	O	-1	8492347
main@@	O	-1	8492347
ly	O	-1	8492347
in	O	-1	8492347
women	O	-1	8492347
who	O	-1	8492347
are	O	-1	8492347
con@@	O	-1	8492347
cer@@	O	-1	8492347
n@@	O	-1	8492347
ed	O	-1	8492347
that	O	-1	8492347
they	O	-1	8492347
are	O	-1	8492347
ob@@	B-Disease	D009765	8492347
ese	I-Disease	-1	8492347
or	O	-1	8492347
e@@	B-Disease	D004487	8492347
de@@	I-Disease	-1	8492347
mat@@	I-Disease	-1	8492347
ous	I-Disease	-1	8492347
.	O	-1	8492347
S@@	O	-1	8492347
ym@@	O	-1	8492347
pto@@	O	-1	8492347
m@@	O	-1	8492347
atic	O	-1	8492347
hypo@@	B-Disease	D007008	8492347
k@@	I-Disease	-1	8492347
al@@	I-Disease	-1	8492347
emia	I-Disease	-1	8492347
has	O	-1	8492347
been	O	-1	8492347
reported	O	-1	8492347
in	O	-1	8492347
such	O	-1	8492347
patients	O	-1	8492347
(3@@	O	-1	8492347
-@@	O	-1	8492347
7@@	O	-1	8492347
)	O	-1	8492347
and	O	-1	8492347
in	O	-1	8492347
one	O	-1	8492347
case	O	-1	8492347
hy@@	B-Disease	D006996	8492347
p@@	I-Disease	-1	8492347
oc@@	I-Disease	-1	8492347
al@@	I-Disease	-1	8492347
ce@@	I-Disease	-1	8492347
mia	I-Disease	-1	8492347
was	O	-1	8492347
observed	O	-1	8492347
(@@	O	-1	8492347
8@@	O	-1	8492347
),	O	-1	8492347
but	O	-1	8492347
the	O	-1	8492347
effects	O	-1	8492347
of	O	-1	8492347
mag@@	B-Chemical	D008274	8492347
ne@@	I-Chemical	-1	8492347
si@@	I-Chemical	-1	8492347
um	I-Chemical	-1	8492347
deple@@	O	-1	8492347
tion	O	-1	8492347
were	O	-1	8492347
not	O	-1	8492347
not@@	O	-1	8492347
ed	O	-1	8492347
in	O	-1	8492347
these	O	-1	8492347
patients.	O	-1	8492347

L@@	O	-1	8410199
os@@	O	-1	8410199
s	O	-1	8410199
of	O	-1	8410199
glutamate	B-Chemical	D018698	8410199
dec@@	O	-1	8410199
arb@@	O	-1	8410199
ox@@	O	-1	8410199
yl@@	O	-1	8410199
ase	O	-1	8410199
mR@@	O	-1	8410199
N@@	O	-1	8410199
A@@	O	-1	8410199
-@@	O	-1	8410199
containing	O	-1	8410199
neuron@@	O	-1	8410199
s	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
rat	O	-1	8410199
d@@	O	-1	8410199
ent@@	O	-1	8410199
ate	O	-1	8410199
g@@	O	-1	8410199
y@@	O	-1	8410199
ru@@	O	-1	8410199
s	O	-1	8410199
following	O	-1	8410199
pilocar@@	B-Chemical	D010862	8410199
pine	I-Chemical	-1	8410199
-induced	O	-1	8410199
seizures	B-Disease	D012640	8410199
.	O	-1	8410199
In	O	-1	8410199
sit@@	O	-1	8410199
u	O	-1	8410199
hy@@	O	-1	8410199
b@@	O	-1	8410199
ri@@	O	-1	8410199
di@@	O	-1	8410199
z@@	O	-1	8410199
ation	O	-1	8410199
meth@@	O	-1	8410199
o@@	O	-1	8410199
ds	O	-1	8410199
were	O	-1	8410199
used	O	-1	8410199
to	O	-1	8410199
determine	O	-1	8410199
if	O	-1	8410199
glutam@@	B-Chemical	D018698	8410199
ic	I-Chemical	-1	8410199
acid	I-Chemical	-1	8410199
dec@@	O	-1	8410199
arb@@	O	-1	8410199
ox@@	O	-1	8410199
yl@@	O	-1	8410199
ase	O	-1	8410199
(@@	O	-1	8410199
G@@	O	-1	8410199
A@@	O	-1	8410199
D)	O	-1	8410199
mR@@	O	-1	8410199
N@@	O	-1	8410199
A@@	O	-1	8410199
-@@	O	-1	8410199
containing	O	-1	8410199
neuron@@	O	-1	8410199
s	O	-1	8410199
within	O	-1	8410199
the	O	-1	8410199
h@@	O	-1	8410199
il@@	O	-1	8410199
us	O	-1	8410199
of	O	-1	8410199
the	O	-1	8410199
d@@	O	-1	8410199
ent@@	O	-1	8410199
ate	O	-1	8410199
g@@	O	-1	8410199
y@@	O	-1	8410199
ru@@	O	-1	8410199
s	O	-1	8410199
are	O	-1	8410199
vul@@	O	-1	8410199
ner@@	O	-1	8410199
able	O	-1	8410199
to	O	-1	8410199
seizure	B-Disease	D012640	8410199
-induced	O	-1	8410199
damage	O	-1	8410199
in	O	-1	8410199
a	O	-1	8410199
model	O	-1	8410199
of	O	-1	8410199
chronic	O	-1	8410199
seizures	B-Disease	D012640	8410199
.	O	-1	8410199
S@@	O	-1	8410199
pra@@	O	-1	8410199
gu@@	O	-1	8410199
e-@@	O	-1	8410199
D@@	O	-1	8410199
aw@@	O	-1	8410199
le@@	O	-1	8410199
y	O	-1	8410199
rats	O	-1	8410199
were	O	-1	8410199
injected	O	-1	8410199
intra@@	O	-1	8410199
per@@	O	-1	8410199
it@@	O	-1	8410199
one@@	O	-1	8410199
ally	O	-1	8410199
with	O	-1	8410199
pilocar@@	B-Chemical	D010862	8410199
pine	I-Chemical	-1	8410199
,	O	-1	8410199
and	O	-1	8410199
the	O	-1	8410199
hippocamp@@	O	-1	8410199
al	O	-1	8410199
formation	O	-1	8410199
was	O	-1	8410199
studied	O	-1	8410199
hist@@	O	-1	8410199
olog@@	O	-1	8410199
ically	O	-1	8410199
at	O	-1	8410199
1,	O	-1	8410199
2,	O	-1	8410199
4@@	O	-1	8410199
,	O	-1	8410199
and	O	-1	8410199
8	O	-1	8410199
week	O	-1	8410199
interv@@	O	-1	8410199
als	O	-1	8410199
after	O	-1	8410199
pilocar@@	B-Chemical	D010862	8410199
pine	I-Chemical	-1	8410199
-induced	O	-1	8410199
seizures	B-Disease	D012640	8410199
.	O	-1	8410199
In	O	-1	8410199
sit@@	O	-1	8410199
u	O	-1	8410199
hy@@	O	-1	8410199
b@@	O	-1	8410199
ri@@	O	-1	8410199
di@@	O	-1	8410199
z@@	O	-1	8410199
ation	O	-1	8410199
histo@@	O	-1	8410199
chem@@	O	-1	8410199
ist@@	O	-1	8410199
r@@	O	-1	8410199
y,	O	-1	8410199
using	O	-1	8410199
a	O	-1	8410199
di@@	B-Chemical	D004076	8410199
g@@	I-Chemical	-1	8410199
ox@@	I-Chemical	-1	8410199
i@@	I-Chemical	-1	8410199
gen@@	I-Chemical	-1	8410199
in	I-Chemical	-1	8410199
-@@	O	-1	8410199
l@@	O	-1	8410199
a@@	O	-1	8410199
be@@	O	-1	8410199
l@@	O	-1	8410199
ed	O	-1	8410199
G@@	O	-1	8410199
A@@	O	-1	8410199
D	O	-1	8410199
c@@	O	-1	8410199
R@@	O	-1	8410199
NA	O	-1	8410199
pro@@	O	-1	8410199
be@@	O	-1	8410199
,	O	-1	8410199
demonstrated	O	-1	8410199
a	O	-1	8410199
subst@@	O	-1	8410199
anti@@	O	-1	8410199
al	O	-1	8410199
decrease	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
number	O	-1	8410199
of	O	-1	8410199
G@@	O	-1	8410199
A@@	O	-1	8410199
D	O	-1	8410199
mR@@	O	-1	8410199
N@@	O	-1	8410199
A@@	O	-1	8410199
-@@	O	-1	8410199
containing	O	-1	8410199
neuron@@	O	-1	8410199
s	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
h@@	O	-1	8410199
il@@	O	-1	8410199
us	O	-1	8410199
of	O	-1	8410199
the	O	-1	8410199
d@@	O	-1	8410199
ent@@	O	-1	8410199
ate	O	-1	8410199
g@@	O	-1	8410199
y@@	O	-1	8410199
ru@@	O	-1	8410199
s	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
pilocar@@	B-Chemical	D010862	8410199
pine	I-Chemical	-1	8410199
-treated	O	-1	8410199
rats	O	-1	8410199
as	O	-1	8410199
compared	O	-1	8410199
to	O	-1	8410199
controls	O	-1	8410199
at	O	-1	8410199
all	O	-1	8410199
time	O	-1	8410199
inter@@	O	-1	8410199
val@@	O	-1	8410199
s.	O	-1	8410199
Ad@@	O	-1	8410199
di@@	O	-1	8410199
tional	O	-1	8410199
neuron@@	O	-1	8410199
an@@	O	-1	8410199
at@@	O	-1	8410199
om@@	O	-1	8410199
ical	O	-1	8410199
studi@@	O	-1	8410199
es,	O	-1	8410199
including	O	-1	8410199
c@@	B-Chemical	C028911	8410199
res@@	I-Chemical	-1	8410199
yl	I-Chemical	-1	8410199
vi@@	I-Chemical	-1	8410199
ol@@	I-Chemical	-1	8410199
et	I-Chemical	-1	8410199
st@@	O	-1	8410199
ain@@	O	-1	8410199
ing,	O	-1	8410199
neuron@@	B-Disease	D009410	8410199
al	I-Disease	-1	8410199
de@@	I-Disease	-1	8410199
generation	I-Disease	-1	8410199
meth@@	O	-1	8410199
o@@	O	-1	8410199
d@@	O	-1	8410199
s,	O	-1	8410199
and	O	-1	8410199
histo@@	O	-1	8410199
chemical	O	-1	8410199
lo@@	O	-1	8410199
cal@@	O	-1	8410199
ization	O	-1	8410199
of	O	-1	8410199
g@@	O	-1	8410199
lial	O	-1	8410199
fibrill@@	O	-1	8410199
ary	O	-1	8410199
ac@@	O	-1	8410199
i@@	O	-1	8410199
di@@	O	-1	8410199
c	O	-1	8410199
protein@@	O	-1	8410199
,	O	-1	8410199
suggested	O	-1	8410199
that	O	-1	8410199
the	O	-1	8410199
decrease	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
number	O	-1	8410199
of	O	-1	8410199
G@@	O	-1	8410199
A@@	O	-1	8410199
D	O	-1	8410199
mR@@	O	-1	8410199
N@@	O	-1	8410199
A@@	O	-1	8410199
-@@	O	-1	8410199
containing	O	-1	8410199
neuron@@	O	-1	8410199
s	O	-1	8410199
was	O	-1	8410199
related	O	-1	8410199
to	O	-1	8410199
neuron@@	B-Disease	D009410	8410199
al	I-Disease	-1	8410199
loss	I-Disease	-1	8410199
ra@@	O	-1	8410199
ther	O	-1	8410199
than	O	-1	8410199
to	O	-1	8410199
a	O	-1	8410199
decrease	O	-1	8410199
in	O	-1	8410199
G@@	O	-1	8410199
A@@	O	-1	8410199
D	O	-1	8410199
mRNA	O	-1	8410199
level@@	O	-1	8410199
s.	O	-1	8410199
The	O	-1	8410199
loss	O	-1	8410199
of	O	-1	8410199
G@@	O	-1	8410199
A@@	O	-1	8410199
D	O	-1	8410199
mR@@	O	-1	8410199
N@@	O	-1	8410199
A@@	O	-1	8410199
-@@	O	-1	8410199
containing	O	-1	8410199
neuron@@	O	-1	8410199
s	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
h@@	O	-1	8410199
il@@	O	-1	8410199
us	O	-1	8410199
contrast@@	O	-1	8410199
ed	O	-1	8410199
with	O	-1	8410199
the	O	-1	8410199
rel@@	O	-1	8410199
ative	O	-1	8410199
pres@@	O	-1	8410199
er@@	O	-1	8410199
v@@	O	-1	8410199
ation	O	-1	8410199
of	O	-1	8410199
l@@	O	-1	8410199
a@@	O	-1	8410199
be@@	O	-1	8410199
l@@	O	-1	8410199
ed	O	-1	8410199
p@@	O	-1	8410199
ut@@	O	-1	8410199
ative	O	-1	8410199
bas@@	O	-1	8410199
k@@	O	-1	8410199
et	O	-1	8410199
cells	O	-1	8410199
al@@	O	-1	8410199
ong	O	-1	8410199
the	O	-1	8410199
in@@	O	-1	8410199
n@@	O	-1	8410199
er	O	-1	8410199
m@@	O	-1	8410199
arg@@	O	-1	8410199
in	O	-1	8410199
of	O	-1	8410199
the	O	-1	8410199
gran@@	O	-1	8410199
ul@@	O	-1	8410199
e	O	-1	8410199
cell	O	-1	8410199
l@@	O	-1	8410199
ay@@	O	-1	8410199
er.	O	-1	8410199
Q@@	O	-1	8410199
u@@	O	-1	8410199
anti@@	O	-1	8410199
t@@	O	-1	8410199
ative	O	-1	8410199
analy@@	O	-1	8410199
ses	O	-1	8410199
of	O	-1	8410199
l@@	O	-1	8410199
a@@	O	-1	8410199
be@@	O	-1	8410199
l@@	O	-1	8410199
ed	O	-1	8410199
neuron@@	O	-1	8410199
s	O	-1	8410199
in	O	-1	8410199
three	O	-1	8410199
regi@@	O	-1	8410199
ons	O	-1	8410199
of	O	-1	8410199
the	O	-1	8410199
d@@	O	-1	8410199
ent@@	O	-1	8410199
ate	O	-1	8410199
g@@	O	-1	8410199
y@@	O	-1	8410199
ru@@	O	-1	8410199
s	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
1	O	-1	8410199
and	O	-1	8410199
2	O	-1	8410199
week	O	-1	8410199
groups	O	-1	8410199
showed	O	-1	8410199
statis@@	O	-1	8410199
tically	O	-1	8410199
significant	O	-1	8410199
decreas@@	O	-1	8410199
es	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
mean	O	-1	8410199
number	O	-1	8410199
of	O	-1	8410199
G@@	O	-1	8410199
A@@	O	-1	8410199
D	O	-1	8410199
mR@@	O	-1	8410199
N@@	O	-1	8410199
A@@	O	-1	8410199
-@@	O	-1	8410199
containing	O	-1	8410199
neuron@@	O	-1	8410199
s	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
h@@	O	-1	8410199
il@@	O	-1	8410199
us	O	-1	8410199
of	O	-1	8410199
both	O	-1	8410199
groups	O	-1	8410199
of	O	-1	8410199
experimental	O	-1	8410199
anim@@	O	-1	8410199
al@@	O	-1	8410199
s.	O	-1	8410199
No	O	-1	8410199
significant	O	-1	8410199
differences	O	-1	8410199
were	O	-1	8410199
found	O	-1	8410199
in	O	-1	8410199
the	O	-1	8410199
mol@@	O	-1	8410199
ec@@	O	-1	8410199
ular	O	-1	8410199
l@@	O	-1	8410199
ay@@	O	-1	8410199
er	O	-1	8410199
or	O	-1	8410199
the	O	-1	8410199
gran@@	O	-1	8410199
ul@@	O	-1	8410199
e	O	-1	8410199
cell	O	-1	8410199
l@@	O	-1	8410199
ay@@	O	-1	8410199
er,	O	-1	8410199
which	O	-1	8410199
included	O	-1	8410199
l@@	O	-1	8410199
a@@	O	-1	8410199
be@@	O	-1	8410199
l@@	O	-1	8410199
ed	O	-1	8410199
neuron@@	O	-1	8410199
s	O	-1	8410199
al@@	O	-1	8410199
ong	O	-1	8410199
the	O	-1	8410199
lower	O	-1	8410199
m@@	O	-1	8410199
arg@@	O	-1	8410199
in	O	-1	8410199
of	O	-1	8410199
the	O	-1	8410199
gran@@	O	-1	8410199
ul@@	O	-1	8410199
e	O	-1	8410199
cell	O	-1	8410199
l@@	O	-1	8410199
ay@@	O	-1	8410199
er.	O	-1	8410199
The	O	-1	8410199
results	O	-1	8410199
indicate	O	-1	8410199
th@@	O	-1	8410199
at@@	O	-1	8410199
,	O	-1	8410199
in	O	-1	8410199
this	O	-1	8410199
model@@	O	-1	8410199
,	O	-1	8410199
a	O	-1	8410199
sub@@	O	-1	8410199
po@@	O	-1	8410199
p@@	O	-1	8410199
ulation	O	-1	8410199
of	O	-1	8410199
G@@	O	-1	8410199
A@@	O	-1	8410199
D	O	-1	8410199
mR@@	O	-1	8410199
N@@	O	-1	8410199
A@@	O	-1	8410199
-@@	O	-1	8410199
containing	O	-1	8410199
neuron@@	O	-1	8410199
s	O	-1	8410199
within	O	-1	8410199
the	O	-1	8410199
d@@	O	-1	8410199
ent@@	O	-1	8410199
ate	O	-1	8410199
g@@	O	-1	8410199
y@@	O	-1	8410199
ru@@	O	-1	8410199
s	O	-1	8410199
is	O	-1	8410199
sel@@	O	-1	8410199
ectively	O	-1	8410199
vul@@	O	-1	8410199
ner@@	O	-1	8410199
able	O	-1	8410199
to	O	-1	8410199
seizure	B-Disease	D012640	8410199
-induced	O	-1	8410199
dam@@	O	-1	8410199
age.	O	-1	8410199
S@@	O	-1	8410199
uc@@	O	-1	8410199
h	O	-1	8410199
differen@@	O	-1	8410199
tial	O	-1	8410199
vul@@	O	-1	8410199
ner@@	O	-1	8410199
ability	O	-1	8410199
appear@@	O	-1	8410199
s	O	-1	8410199
to	O	-1	8410199
be	O	-1	8410199
an@@	O	-1	8410199
other	O	-1	8410199
indic@@	O	-1	8410199
ation	O	-1	8410199
of	O	-1	8410199
the	O	-1	8410199
he@@	O	-1	8410199
ter@@	O	-1	8410199
o@@	O	-1	8410199
gene@@	O	-1	8410199
ity	O	-1	8410199
of	O	-1	8410199
G@@	B-Chemical	D005680	8410199
A@@	I-Chemical	-1	8410199
B@@	I-Chemical	-1	8410199
A	I-Chemical	-1	8410199
neuron@@	O	-1	8410199
s.	O	-1	8410199

Pro@@	O	-1	7791169
t@@	O	-1	7791169
ective	O	-1	7791169
effect	O	-1	7791169
of	O	-1	7791169
m@@	B-Chemical	D016595	7791169
iso@@	I-Chemical	-1	7791169
pro@@	I-Chemical	-1	7791169
st@@	I-Chemical	-1	7791169
ol	I-Chemical	-1	7791169
on	O	-1	7791169
in@@	B-Chemical	D007213	7791169
do@@	I-Chemical	-1	7791169
meth@@	I-Chemical	-1	7791169
ac@@	I-Chemical	-1	7791169
in	I-Chemical	-1	7791169
induced	O	-1	7791169
renal	B-Disease	D007674	7791169
dysfunction	I-Disease	-1	7791169
in	O	-1	7791169
el@@	O	-1	7791169
der@@	O	-1	7791169
ly	O	-1	7791169
patients.	O	-1	7791169
OBJECTIVE:	O	-1	7791169
To	O	-1	7791169
evalu@@	O	-1	7791169
ate	O	-1	7791169
the	O	-1	7791169
possible	O	-1	7791169
protective	O	-1	7791169
effects	O	-1	7791169
of	O	-1	7791169
m@@	B-Chemical	D016595	7791169
iso@@	I-Chemical	-1	7791169
pro@@	I-Chemical	-1	7791169
st@@	I-Chemical	-1	7791169
ol	I-Chemical	-1	7791169
on	O	-1	7791169
renal	O	-1	7791169
function	O	-1	7791169
in	O	-1	7791169
hospit@@	O	-1	7791169
al@@	O	-1	7791169
ized	O	-1	7791169
el@@	O	-1	7791169
der@@	O	-1	7791169
ly	O	-1	7791169
patients	O	-1	7791169
treated	O	-1	7791169
with	O	-1	7791169
in@@	B-Chemical	D007213	7791169
do@@	I-Chemical	-1	7791169
meth@@	I-Chemical	-1	7791169
ac@@	I-Chemical	-1	7791169
in	I-Chemical	-1	7791169
.	O	-1	7791169
METHODS:	O	-1	7791169
F@@	O	-1	7791169
or@@	O	-1	7791169
ty-@@	O	-1	7791169
five	O	-1	7791169
hospit@@	O	-1	7791169
al@@	O	-1	7791169
ized	O	-1	7791169
el@@	O	-1	7791169
der@@	O	-1	7791169
ly	O	-1	7791169
patients	O	-1	7791169
(@@	O	-1	7791169
>	O	-1	7791169
6@@	O	-1	7791169
5	O	-1	7791169
years	O	-1	7791169
ol@@	O	-1	7791169
d@@	O	-1	7791169
)	O	-1	7791169
who	O	-1	7791169
requ@@	O	-1	7791169
ired	O	-1	7791169
therapy	O	-1	7791169
with	O	-1	7791169
non@@	O	-1	7791169
steroid@@	O	-1	7791169
al	O	-1	7791169
anti@@	O	-1	7791169
inflam@@	O	-1	7791169
mat@@	O	-1	7791169
ory	O	-1	7791169
drugs	O	-1	7791169
(N@@	O	-1	7791169
S@@	O	-1	7791169
A@@	O	-1	7791169
I@@	O	-1	7791169
D)	O	-1	7791169
were	O	-1	7791169
random@@	O	-1	7791169
ly	O	-1	7791169
as@@	O	-1	7791169
signed	O	-1	7791169
to	O	-1	7791169
recei@@	O	-1	7791169
ve	O	-1	7791169
either	O	-1	7791169
in@@	B-Chemical	D007213	7791169
do@@	I-Chemical	-1	7791169
meth@@	I-Chemical	-1	7791169
ac@@	I-Chemical	-1	7791169
in	I-Chemical	-1	7791169
,	O	-1	7791169
1@@	O	-1	7791169
50	O	-1	7791169
mg/@@	O	-1	7791169
day	O	-1	7791169
(@@	O	-1	7791169
Group	O	-1	7791169
A@@	O	-1	7791169
),	O	-1	7791169
or	O	-1	7791169
in@@	B-Chemical	D007213	7791169
do@@	I-Chemical	-1	7791169
meth@@	I-Chemical	-1	7791169
ac@@	I-Chemical	-1	7791169
in	I-Chemical	-1	7791169
1@@	O	-1	7791169
50	O	-1	7791169
mg/@@	O	-1	7791169
day	O	-1	7791169
plus	O	-1	7791169
m@@	B-Chemical	D016595	7791169
iso@@	I-Chemical	-1	7791169
pro@@	I-Chemical	-1	7791169
st@@	I-Chemical	-1	7791169
ol	I-Chemical	-1	7791169
at	O	-1	7791169
0.@@	O	-1	7791169
6	O	-1	7791169
mg/@@	O	-1	7791169
day	O	-1	7791169
(@@	O	-1	7791169
Group	O	-1	7791169
B@@	O	-1	7791169
).	O	-1	7791169
L@@	O	-1	7791169
abor@@	O	-1	7791169
atory	O	-1	7791169
vari@@	O	-1	7791169
able@@	O	-1	7791169
s	O	-1	7791169
of	O	-1	7791169
renal	O	-1	7791169
function	O	-1	7791169
[@@	O	-1	7791169
serum	O	-1	7791169
creatinine	B-Chemical	D003404	7791169
,	O	-1	7791169
blood	B-Chemical	D001806	7791169
ure@@	I-Chemical	-1	7791169
a	I-Chemical	-1	7791169
nitro@@	I-Chemical	-1	7791169
gen	I-Chemical	-1	7791169
(	O	-1	7791169
B@@	B-Chemical	D001806	7791169
U@@	I-Chemical	-1	7791169
N	I-Chemical	-1	7791169
)	O	-1	7791169
and	O	-1	7791169
electro@@	O	-1	7791169
ly@@	O	-1	7791169
t@@	O	-1	7791169
es@@	O	-1	7791169
]	O	-1	7791169
were	O	-1	7791169
evaluated	O	-1	7791169
before	O	-1	7791169
initi@@	O	-1	7791169
ation	O	-1	7791169
of	O	-1	7791169
therapy	O	-1	7791169
and	O	-1	7791169
every	O	-1	7791169
2	O	-1	7791169
day@@	O	-1	7791169
s,	O	-1	7791169
un@@	O	-1	7791169
ti@@	O	-1	7791169
l	O	-1	7791169
ter@@	O	-1	7791169
min@@	O	-1	7791169
ation	O	-1	7791169
of	O	-1	7791169
the	O	-1	7791169
study	O	-1	7791169
(@@	O	-1	7791169
a	O	-1	7791169
period	O	-1	7791169
of	O	-1	7791169
at	O	-1	7791169
le@@	O	-1	7791169
ast	O	-1	7791169
6	O	-1	7791169
da@@	O	-1	7791169
ys@@	O	-1	7791169
).	O	-1	7791169
R@@	O	-1	7791169
es@@	O	-1	7791169
p@@	O	-1	7791169
on@@	O	-1	7791169
se	O	-1	7791169
to	O	-1	7791169
treatment	O	-1	7791169
was	O	-1	7791169
estim@@	O	-1	7791169
ated	O	-1	7791169
by	O	-1	7791169
the	O	-1	7791169
visual	O	-1	7791169
an@@	O	-1	7791169
alo@@	O	-1	7791169
g	O	-1	7791169
s@@	O	-1	7791169
cal@@	O	-1	7791169
e	O	-1	7791169
for	O	-1	7791169
severity	O	-1	7791169
of	O	-1	7791169
pain	B-Disease	D010146	7791169
.	O	-1	7791169
RESULTS:	O	-1	7791169
F@@	O	-1	7791169
or@@	O	-1	7791169
ty-@@	O	-1	7791169
two	O	-1	7791169
patients	O	-1	7791169
comple@@	O	-1	7791169
ted	O	-1	7791169
the	O	-1	7791169
study,	O	-1	7791169
2@@	O	-1	7791169
2	O	-1	7791169
in	O	-1	7791169
Group	O	-1	7791169
A	O	-1	7791169
and	O	-1	7791169
20	O	-1	7791169
in	O	-1	7791169
Group	O	-1	7791169
B@@	O	-1	7791169
.	O	-1	7791169
B@@	B-Chemical	D001806	7791169
U@@	I-Chemical	-1	7791169
N	I-Chemical	-1	7791169
and	O	-1	7791169
creatinine	B-Chemical	D003404	7791169
increased	O	-1	7791169
by	O	-1	7791169
>	O	-1	7791169
50@@	O	-1	7791169
%	O	-1	7791169
of	O	-1	7791169
baseline	O	-1	7791169
levels	O	-1	7791169
in	O	-1	7791169
5@@	O	-1	7791169
4	O	-1	7791169
and	O	-1	7791169
4@@	O	-1	7791169
5%	O	-1	7791169
of	O	-1	7791169
Group	O	-1	7791169
A	O	-1	7791169
patients,	O	-1	7791169
respectivel@@	O	-1	7791169
y,	O	-1	7791169
compared	O	-1	7791169
to	O	-1	7791169
only	O	-1	7791169
20	O	-1	7791169
and	O	-1	7791169
10@@	O	-1	7791169
%	O	-1	7791169
of	O	-1	7791169
Group	O	-1	7791169
B	O	-1	7791169
patients	O	-1	7791169
(p	O	-1	7791169
<	O	-1	7791169
0.05@@	O	-1	7791169
).	O	-1	7791169
P@@	B-Chemical	D011188	7791169
ot@@	I-Chemical	-1	7791169
assi@@	I-Chemical	-1	7791169
um	I-Chemical	-1	7791169
(	O	-1	7791169
K	B-Chemical	D011188	7791169
)	O	-1	7791169
inc@@	O	-1	7791169
re@@	O	-1	7791169
ment	O	-1	7791169
of	O	-1	7791169
0.@@	O	-1	7791169
6	O	-1	7791169
m@@	O	-1	7791169
E@@	O	-1	7791169
q@@	O	-1	7791169
/@@	O	-1	7791169
l	O	-1	7791169
or	O	-1	7791169
more	O	-1	7791169
was	O	-1	7791169
observed	O	-1	7791169
in	O	-1	7791169
50@@	O	-1	7791169
%	O	-1	7791169
of	O	-1	7791169
Group	O	-1	7791169
A@@	O	-1	7791169
,	O	-1	7791169
but	O	-1	7791169
in	O	-1	7791169
only	O	-1	7791169
1@@	O	-1	7791169
5%	O	-1	7791169
of	O	-1	7791169
Group	O	-1	7791169
B	O	-1	7791169
patients	O	-1	7791169
(p	O	-1	7791169
<	O	-1	7791169
0.05@@	O	-1	7791169
).	O	-1	7791169
The	O	-1	7791169
mean	O	-1	7791169
inc@@	O	-1	7791169
re@@	O	-1	7791169
ments	O	-1	7791169
in	O	-1	7791169
B@@	B-Chemical	D001806	7791169
U@@	I-Chemical	-1	7791169
N	I-Chemical	-1	7791169
,	O	-1	7791169
creatinine	B-Chemical	D003404	7791169
,	O	-1	7791169
and	O	-1	7791169
K	B-Chemical	D011188	7791169
were	O	-1	7791169
reduced	O	-1	7791169
by	O	-1	7791169
6@@	O	-1	7791169
3,	O	-1	7791169
80@@	O	-1	7791169
,	O	-1	7791169
and	O	-1	7791169
4@@	O	-1	7791169
2@@	O	-1	7791169
%,	O	-1	7791169
respectivel@@	O	-1	7791169
y,	O	-1	7791169
in	O	-1	7791169
Group	O	-1	7791169
B	O	-1	7791169
patients	O	-1	7791169
compared	O	-1	7791169
to	O	-1	7791169
Group	O	-1	7791169
A@@	O	-1	7791169
.	O	-1	7791169
R@@	O	-1	7791169
es@@	O	-1	7791169
p@@	O	-1	7791169
on@@	O	-1	7791169
se	O	-1	7791169
to	O	-1	7791169
treatment	O	-1	7791169
did	O	-1	7791169
not	O	-1	7791169
diff@@	O	-1	7791169
er	O	-1	7791169
significantly	O	-1	7791169
between	O	-1	7791169
the	O	-1	7791169
2	O	-1	7791169
groups.	O	-1	7791169
CONCLUSION:	O	-1	7791169
H@@	O	-1	7791169
ospit@@	O	-1	7791169
al@@	O	-1	7791169
ized	O	-1	7791169
el@@	O	-1	7791169
der@@	O	-1	7791169
ly	O	-1	7791169
patients	O	-1	7791169
are	O	-1	7791169
at	O	-1	7791169
risk	O	-1	7791169
for	O	-1	7791169
develop@@	O	-1	7791169
ing	O	-1	7791169
in@@	B-Chemical	D007213	7791169
do@@	I-Chemical	-1	7791169
meth@@	I-Chemical	-1	7791169
ac@@	I-Chemical	-1	7791169
in	I-Chemical	-1	7791169
related	O	-1	7791169
renal	B-Disease	D007674	7791169
dysfunction	I-Disease	-1	7791169
.	O	-1	7791169
Ad@@	O	-1	7791169
di@@	O	-1	7791169
tion	O	-1	7791169
of	O	-1	7791169
m@@	B-Chemical	D016595	7791169
iso@@	I-Chemical	-1	7791169
pro@@	I-Chemical	-1	7791169
st@@	I-Chemical	-1	7791169
ol	I-Chemical	-1	7791169
can	O	-1	7791169
minim@@	O	-1	7791169
iz@@	O	-1	7791169
e	O	-1	7791169
this	O	-1	7791169
renal	B-Disease	D007674	7791169
impair@@	I-Disease	-1	7791169
ment	I-Disease	-1	7791169
without	O	-1	7791169
aff@@	O	-1	7791169
ect@@	O	-1	7791169
ing	O	-1	7791169
pain	B-Disease	D010146	7791169
control@@	O	-1	7791169
.	O	-1	7791169

Ne@@	B-Disease	D007674	6728084
ph@@	I-Disease	-1	6728084
ro@@	I-Disease	-1	6728084
toxic	I-Disease	-1	6728084
effects	O	-1	6728084
of	O	-1	6728084
amino@@	B-Chemical	D000617	6728084
gly@@	I-Chemical	-1	6728084
co@@	I-Chemical	-1	6728084
side	I-Chemical	-1	6728084
treatment	O	-1	6728084
on	O	-1	6728084
renal	O	-1	6728084
protein	O	-1	6728084
re@@	O	-1	6728084
abs@@	O	-1	6728084
or@@	O	-1	6728084
ption	O	-1	6728084
and	O	-1	6728084
accum@@	O	-1	6728084
ul@@	O	-1	6728084
ation.	O	-1	6728084
To	O	-1	6728084
qu@@	O	-1	6728084
anti@@	O	-1	6728084
f@@	O	-1	6728084
y	O	-1	6728084
the	O	-1	6728084
effects	O	-1	6728084
of	O	-1	6728084
g@@	B-Chemical	D005839	6728084
ent@@	I-Chemical	-1	6728084
am@@	I-Chemical	-1	6728084
icin	I-Chemical	-1	6728084
,	O	-1	6728084
k@@	B-Chemical	D007612	6728084
an@@	I-Chemical	-1	6728084
am@@	I-Chemical	-1	6728084
ycin	I-Chemical	-1	6728084
and	O	-1	6728084
ne@@	B-Chemical	D009428	6728084
til@@	I-Chemical	-1	6728084
mic@@	I-Chemical	-1	6728084
in	I-Chemical	-1	6728084
on	O	-1	6728084
renal	O	-1	6728084
protein	O	-1	6728084
re@@	O	-1	6728084
abs@@	O	-1	6728084
or@@	O	-1	6728084
ption	O	-1	6728084
and	O	-1	6728084
accum@@	O	-1	6728084
ul@@	O	-1	6728084
ation,	O	-1	6728084
these	O	-1	6728084
drugs	O	-1	6728084
were	O	-1	6728084
administered	O	-1	6728084
to	O	-1	6728084
rats	O	-1	6728084
intra@@	O	-1	6728084
per@@	O	-1	6728084
it@@	O	-1	6728084
one@@	O	-1	6728084
ally	O	-1	6728084
(@@	O	-1	6728084
30	O	-1	6728084
mg/k@@	O	-1	6728084
g/@@	O	-1	6728084
day@@	O	-1	6728084
)	O	-1	6728084
for	O	-1	6728084
7@@	O	-1	6728084
,	O	-1	6728084
14	O	-1	6728084
or	O	-1	6728084
21	O	-1	6728084
days.	O	-1	6728084
S@@	O	-1	6728084
can@@	O	-1	6728084
ning	O	-1	6728084
electro@@	O	-1	6728084
n	O	-1	6728084
micro@@	O	-1	6728084
sco@@	O	-1	6728084
p@@	O	-1	6728084
y	O	-1	6728084
of	O	-1	6728084
the	O	-1	6728084
glomerular	O	-1	6728084
endo@@	O	-1	6728084
the@@	O	-1	6728084
li@@	O	-1	6728084
a,	O	-1	6728084
urinary	O	-1	6728084
meas@@	O	-1	6728084
ure@@	O	-1	6728084
ments	O	-1	6728084
of	O	-1	6728084
sodium	B-Chemical	D012964	6728084
,	O	-1	6728084
pot@@	B-Chemical	D011188	6728084
assi@@	I-Chemical	-1	6728084
um	I-Chemical	-1	6728084
,	O	-1	6728084
endo@@	O	-1	6728084
gen@@	O	-1	6728084
ous	O	-1	6728084
l@@	O	-1	6728084
ys@@	O	-1	6728084
o@@	O	-1	6728084
z@@	O	-1	6728084
y@@	O	-1	6728084
me,	O	-1	6728084
N@@	O	-1	6728084
-@@	O	-1	6728084
acet@@	O	-1	6728084
yl@@	O	-1	6728084
-@@	O	-1	6728084
beta-@@	O	-1	6728084
D-@@	O	-1	6728084
g@@	O	-1	6728084
lu@@	O	-1	6728084
co@@	O	-1	6728084
s@@	O	-1	6728084
amin@@	O	-1	6728084
id@@	O	-1	6728084
ase	O	-1	6728084
(N@@	O	-1	6728084
A@@	O	-1	6728084
G@@	O	-1	6728084
)	O	-1	6728084
as	O	-1	6728084
well	O	-1	6728084
as	O	-1	6728084
clear@@	O	-1	6728084
ance	O	-1	6728084
and	O	-1	6728084
accum@@	O	-1	6728084
ulation	O	-1	6728084
experim@@	O	-1	6728084
ents	O	-1	6728084
after	O	-1	6728084
i.v@@	O	-1	6728084
.	O	-1	6728084
administration	O	-1	6728084
of	O	-1	6728084
e@@	O	-1	6728084
g@@	O	-1	6728084
g@@	O	-1	6728084
-@@	O	-1	6728084
wh@@	O	-1	6728084
ite	O	-1	6728084
l@@	O	-1	6728084
ys@@	O	-1	6728084
o@@	O	-1	6728084
z@@	O	-1	6728084
ym@@	O	-1	6728084
e	O	-1	6728084
and	O	-1	6728084
meas@@	O	-1	6728084
ure@@	O	-1	6728084
ments	O	-1	6728084
of	O	-1	6728084
in@@	O	-1	6728084
ul@@	O	-1	6728084
in	O	-1	6728084
clear@@	O	-1	6728084
ance	O	-1	6728084
(@@	O	-1	6728084
GF@@	O	-1	6728084
R@@	O	-1	6728084
)	O	-1	6728084
were	O	-1	6728084
d@@	O	-1	6728084
one	O	-1	6728084
in	O	-1	6728084
each	O	-1	6728084
treatment	O	-1	6728084
group.	O	-1	6728084
G@@	B-Chemical	D005839	6728084
ent@@	I-Chemical	-1	6728084
am@@	I-Chemical	-1	6728084
icin	I-Chemical	-1	6728084
administration	O	-1	6728084
decreased	O	-1	6728084
di@@	O	-1	6728084
ame@@	O	-1	6728084
ter@@	O	-1	6728084
,	O	-1	6728084
d@@	O	-1	6728084
ensity	O	-1	6728084
and	O	-1	6728084
sh@@	O	-1	6728084
ap@@	O	-1	6728084
e	O	-1	6728084
of	O	-1	6728084
endothelial	O	-1	6728084
f@@	O	-1	6728084
en@@	O	-1	6728084
est@@	O	-1	6728084
ra@@	O	-1	6728084
e.	O	-1	6728084
K@@	B-Chemical	D007612	6728084
an@@	I-Chemical	-1	6728084
am@@	I-Chemical	-1	6728084
ycin	I-Chemical	-1	6728084
and	O	-1	6728084
ne@@	B-Chemical	D009428	6728084
til@@	I-Chemical	-1	6728084
mic@@	I-Chemical	-1	6728084
in	I-Chemical	-1	6728084
appe@@	O	-1	6728084
a@@	O	-1	6728084
red	O	-1	6728084
to	O	-1	6728084
have	O	-1	6728084
no	O	-1	6728084
effect	O	-1	6728084
at	O	-1	6728084
the	O	-1	6728084
dose	O	-1	6728084
use@@	O	-1	6728084
d.	O	-1	6728084
All	O	-1	6728084
three	O	-1	6728084
amino@@	B-Chemical	D000617	6728084
gly@@	I-Chemical	-1	6728084
co@@	I-Chemical	-1	6728084
side@@	I-Chemical	-1	6728084
s	I-Chemical	-1	6728084
decreased	O	-1	6728084
GF@@	O	-1	6728084
R	O	-1	6728084
and	O	-1	6728084
increased	O	-1	6728084
urinary	O	-1	6728084
ex@@	O	-1	6728084
cre@@	O	-1	6728084
tion	O	-1	6728084
of	O	-1	6728084
sodium	B-Chemical	D012964	6728084
and	O	-1	6728084
pot@@	B-Chemical	D011188	6728084
assi@@	I-Chemical	-1	6728084
um	I-Chemical	-1	6728084
.	O	-1	6728084
W@@	O	-1	6728084
h@@	O	-1	6728084
ile	O	-1	6728084
g@@	B-Chemical	D005839	6728084
ent@@	I-Chemical	-1	6728084
am@@	I-Chemical	-1	6728084
icin	I-Chemical	-1	6728084
and	O	-1	6728084
k@@	B-Chemical	D007612	6728084
an@@	I-Chemical	-1	6728084
am@@	I-Chemical	-1	6728084
ycin	I-Chemical	-1	6728084
decreased	O	-1	6728084
the	O	-1	6728084
perc@@	O	-1	6728084
ent@@	O	-1	6728084
age	O	-1	6728084
re@@	O	-1	6728084
abs@@	O	-1	6728084
or@@	O	-1	6728084
ption	O	-1	6728084
and	O	-1	6728084
accum@@	O	-1	6728084
ulation	O	-1	6728084
of	O	-1	6728084
l@@	O	-1	6728084
ys@@	O	-1	6728084
o@@	O	-1	6728084
z@@	O	-1	6728084
ym@@	O	-1	6728084
e	O	-1	6728084
after	O	-1	6728084
i.v@@	O	-1	6728084
.	O	-1	6728084
administration	O	-1	6728084
of	O	-1	6728084
e@@	O	-1	6728084
g@@	O	-1	6728084
g@@	O	-1	6728084
-@@	O	-1	6728084
wh@@	O	-1	6728084
ite	O	-1	6728084
l@@	O	-1	6728084
ys@@	O	-1	6728084
o@@	O	-1	6728084
z@@	O	-1	6728084
ym@@	O	-1	6728084
e	O	-1	6728084
ne@@	B-Chemical	D009428	6728084
til@@	I-Chemical	-1	6728084
mic@@	I-Chemical	-1	6728084
in	I-Chemical	-1	6728084
had	O	-1	6728084
no	O	-1	6728084
effect@@	O	-1	6728084
.	O	-1	6728084
D@@	O	-1	6728084
a@@	O	-1	6728084
ily	O	-1	6728084
ex@@	O	-1	6728084
cre@@	O	-1	6728084
tion	O	-1	6728084
of	O	-1	6728084
total	O	-1	6728084
protein@@	O	-1	6728084
,	O	-1	6728084
endo@@	O	-1	6728084
gen@@	O	-1	6728084
ous	O	-1	6728084
l@@	O	-1	6728084
ys@@	O	-1	6728084
o@@	O	-1	6728084
z@@	O	-1	6728084
ym@@	O	-1	6728084
e	O	-1	6728084
and	O	-1	6728084
N@@	O	-1	6728084
A@@	O	-1	6728084
G	O	-1	6728084
increased	O	-1	6728084
only	O	-1	6728084
after	O	-1	6728084
treatment	O	-1	6728084
with	O	-1	6728084
k@@	B-Chemical	D007612	6728084
an@@	I-Chemical	-1	6728084
am@@	I-Chemical	-1	6728084
ycin	I-Chemical	-1	6728084
and	O	-1	6728084
g@@	B-Chemical	D005839	6728084
ent@@	I-Chemical	-1	6728084
am@@	I-Chemical	-1	6728084
icin	I-Chemical	-1	6728084
.	O	-1	6728084
Th@@	O	-1	6728084
us,	O	-1	6728084
amino@@	B-Chemical	D000617	6728084
gly@@	I-Chemical	-1	6728084
co@@	I-Chemical	-1	6728084
side@@	I-Chemical	-1	6728084
s	I-Chemical	-1	6728084
may	O	-1	6728084
ac@@	O	-1	6728084
t	O	-1	6728084
as	O	-1	6728084
nephro@@	O	-1	6728084
toxic@@	O	-1	6728084
ants	O	-1	6728084
at	O	-1	6728084
glomerular	O	-1	6728084
and/or	O	-1	6728084
tub@@	O	-1	6728084
ular	O	-1	6728084
level	O	-1	6728084
induc@@	O	-1	6728084
ing	O	-1	6728084
impair@@	B-Disease	D007674	6728084
ment	I-Disease	-1	6728084
of	I-Disease	-1	6728084
renal	I-Disease	-1	6728084
re@@	I-Disease	-1	6728084
abs@@	I-Disease	-1	6728084
or@@	I-Disease	-1	6728084
ption	I-Disease	-1	6728084
and	O	-1	6728084
accum@@	O	-1	6728084
ulation	O	-1	6728084
of	O	-1	6728084
protein@@	O	-1	6728084
s.	O	-1	6728084

Ph@@	O	-1	6111982
armac@@	O	-1	6111982
ology	O	-1	6111982
of	O	-1	6111982
G@@	B-Chemical	C025725	6111982
Y@@	I-Chemical	-1	6111982
K@@	I-Chemical	-1	6111982
I@@	I-Chemical	-1	6111982
-@@	I-Chemical	-1	6111982
4@@	I-Chemical	-1	6111982
1	I-Chemical	-1	6111982
0@@	I-Chemical	-1	6111982
9@@	I-Chemical	-1	6111982
9	I-Chemical	-1	6111982
(	O	-1	6111982
chlor@@	B-Chemical	C025725	6111982
prop@@	I-Chemical	-1	6111982
an@@	I-Chemical	-1	6111982
ol	I-Chemical	-1	6111982
,	O	-1	6111982
T@@	B-Chemical	C025725	6111982
ob@@	I-Chemical	-1	6111982
an@@	I-Chemical	-1	6111982
um	I-Chemical	-1	6111982
)	O	-1	6111982
a	O	-1	6111982
new	O	-1	6111982
pot@@	O	-1	6111982
ent	O	-1	6111982
beta-@@	O	-1	6111982
adrenergic	O	-1	6111982
antagonist@@	O	-1	6111982
.	O	-1	6111982
The	O	-1	6111982
comp@@	O	-1	6111982
ound	O	-1	6111982
G@@	B-Chemical	C025725	6111982
Y@@	I-Chemical	-1	6111982
K@@	I-Chemical	-1	6111982
I@@	I-Chemical	-1	6111982
-@@	I-Chemical	-1	6111982
4@@	I-Chemical	-1	6111982
1	I-Chemical	-1	6111982
0@@	I-Chemical	-1	6111982
9@@	I-Chemical	-1	6111982
9	I-Chemical	-1	6111982
,	O	-1	6111982
as	O	-1	6111982
a	O	-1	6111982
beta-@@	O	-1	6111982
adrenergic	O	-1	6111982
antagonist@@	O	-1	6111982
,	O	-1	6111982
is	O	-1	6111982
3-@@	O	-1	6111982
8	O	-1	6111982
times	O	-1	6111982
more	O	-1	6111982
pot@@	O	-1	6111982
ent	O	-1	6111982
than	O	-1	6111982
prop@@	B-Chemical	D011433	6111982
ran@@	I-Chemical	-1	6111982
o@@	I-Chemical	-1	6111982
lol	I-Chemical	-1	6111982
in	O	-1	6111982
vit@@	O	-1	6111982
r@@	O	-1	6111982
o	O	-1	6111982
and	O	-1	6111982
in	O	-1	6111982
viv@@	O	-1	6111982
o@@	O	-1	6111982
.	O	-1	6111982
I@@	O	-1	6111982
ts	O	-1	6111982
anti@@	O	-1	6111982
arrhyth@@	O	-1	6111982
mic	O	-1	6111982
eff@@	O	-1	6111982
ec@@	O	-1	6111982
tiv@@	O	-1	6111982
en@@	O	-1	6111982
ess	O	-1	6111982
sur@@	O	-1	6111982
p@@	O	-1	6111982
as@@	O	-1	6111982
ses	O	-1	6111982
that	O	-1	6111982
of	O	-1	6111982
prop@@	B-Chemical	D011433	6111982
ran@@	I-Chemical	-1	6111982
o@@	I-Chemical	-1	6111982
lol	I-Chemical	-1	6111982
and	O	-1	6111982
p@@	B-Chemical	D010869	6111982
in@@	I-Chemical	-1	6111982
do@@	I-Chemical	-1	6111982
lol	I-Chemical	-1	6111982
inhibit@@	O	-1	6111982
ing	O	-1	6111982
the	O	-1	6111982
ou@@	B-Chemical	D010042	6111982
ab@@	I-Chemical	-1	6111982
ain	I-Chemical	-1	6111982
arrhyth@@	B-Disease	D001145	6111982
mia	I-Disease	-1	6111982
in	O	-1	6111982
dog@@	O	-1	6111982
s	O	-1	6111982
and	O	-1	6111982
cat@@	O	-1	6111982
s.	O	-1	6111982
G@@	B-Chemical	-1	6111982
Y@@	I-Chemical	-1	6111982
K@@	I-Chemical	-1	6111982
I@@	I-Chemical	-1	6111982
-@@	I-Chemical	-1	6111982
4@@	I-Chemical	-1	6111982
1	I-Chemical	-1	6111982
9@@	I-Chemical	-1	6111982
00	I-Chemical	-1	6111982
has	O	-1	6111982
a	O	-1	6111982
neg@@	O	-1	6111982
li@@	O	-1	6111982
gi@@	O	-1	6111982
ble	O	-1	6111982
cardio@@	O	-1	6111982
depress@@	O	-1	6111982
ant	O	-1	6111982
activ@@	O	-1	6111982
it@@	O	-1	6111982
y@@	O	-1	6111982
;	O	-1	6111982
it	O	-1	6111982
is	O	-1	6111982
not	O	-1	6111982
cardio@@	O	-1	6111982
sel@@	O	-1	6111982
ecti@@	O	-1	6111982
ve.	O	-1	6111982
The	O	-1	6111982
comp@@	O	-1	6111982
ound	O	-1	6111982
show@@	O	-1	6111982
s	O	-1	6111982
a	O	-1	6111982
ra@@	O	-1	6111982
pid	O	-1	6111982
and	O	-1	6111982
lon@@	O	-1	6111982
g	O	-1	6111982
l@@	O	-1	6111982
ast@@	O	-1	6111982
ing	O	-1	6111982
effect@@	O	-1	6111982
.	O	-1	6111982
There	O	-1	6111982
was	O	-1	6111982
a	O	-1	6111982
prolonged	O	-1	6111982
el@@	O	-1	6111982
im@@	O	-1	6111982
in@@	O	-1	6111982
ation	O	-1	6111982
of	O	-1	6111982
the	O	-1	6111982
radi@@	O	-1	6111982
o@@	O	-1	6111982
activity	O	-1	6111982
after	O	-1	6111982
the	O	-1	6111982
injection	O	-1	6111982
of	O	-1	6111982
14@@	B-Chemical	-1	6111982
C@@	I-Chemical	-1	6111982
-@@	I-Chemical	-1	6111982
4@@	I-Chemical	-1	6111982
1	I-Chemical	-1	6111982
0@@	I-Chemical	-1	6111982
9@@	I-Chemical	-1	6111982
9	I-Chemical	-1	6111982
to	O	-1	6111982
rats	O	-1	6111982
and	O	-1	6111982
dog@@	O	-1	6111982
s.	O	-1	6111982
The	O	-1	6111982
h@@	O	-1	6111982
al@@	O	-1	6111982
f	O	-1	6111982
lif@@	O	-1	6111982
e	O	-1	6111982
of	O	-1	6111982
the	O	-1	6111982
un@@	O	-1	6111982
l@@	O	-1	6111982
a@@	O	-1	6111982
be@@	O	-1	6111982
l@@	O	-1	6111982
ed	O	-1	6111982
subst@@	O	-1	6111982
ance	O	-1	6111982
in	O	-1	6111982
hum@@	O	-1	6111982
ans	O	-1	6111982
was	O	-1	6111982
more	O	-1	6111982
than	O	-1	6111982
10	O	-1	6111982
hour@@	O	-1	6111982
s.	O	-1	6111982

C@@	B-Disease	D002819	3123611
ho@@	I-Disease	-1	3123611
re@@	I-Disease	-1	3123611
a	I-Disease	-1	3123611
associated	O	-1	3123611
with	O	-1	3123611
oral	B-Chemical	D003276	3123611
contrac@@	I-Chemical	-1	3123611
ep@@	I-Chemical	-1	3123611
tion	I-Chemical	-1	3123611
.	O	-1	3123611
Th@@	O	-1	3123611
ree	O	-1	3123611
patients	O	-1	3123611
developed	O	-1	3123611
ch@@	B-Disease	D002819	3123611
ore@@	I-Disease	-1	3123611
a	I-Disease	-1	3123611
while	O	-1	3123611
receiving	O	-1	3123611
oral	B-Chemical	D003276	3123611
contrac@@	I-Chemical	-1	3123611
ep@@	I-Chemical	-1	3123611
tiv@@	I-Chemical	-1	3123611
es	I-Chemical	-1	3123611
.	O	-1	3123611
Two	O	-1	3123611
were	O	-1	3123611
youn@@	O	-1	3123611
g	O	-1	3123611
patients	O	-1	3123611
wh@@	O	-1	3123611
ose	O	-1	3123611
ch@@	B-Disease	D002819	3123611
ore@@	I-Disease	-1	3123611
a	I-Disease	-1	3123611
developed	O	-1	3123611
lon@@	O	-1	3123611
g	O	-1	3123611
after	O	-1	3123611
treatment	O	-1	3123611
had	O	-1	3123611
been	O	-1	3123611
star@@	O	-1	3123611
ted	O	-1	3123611
and	O	-1	3123611
dis@@	O	-1	3123611
appe@@	O	-1	3123611
a@@	O	-1	3123611
red	O	-1	3123611
so@@	O	-1	3123611
on	O	-1	3123611
after	O	-1	3123611
it	O	-1	3123611
had	O	-1	3123611
been	O	-1	3123611
discontinu@@	O	-1	3123611
ed.	O	-1	3123611
The	O	-1	3123611
thir@@	O	-1	3123611
d	O	-1	3123611
patient	O	-1	3123611
had	O	-1	3123611
acute	O	-1	3123611
amphetamine	B-Chemical	D000661	3123611
-induced	O	-1	3123611
ch@@	B-Disease	D002819	3123611
ore@@	I-Disease	-1	3123611
a	I-Disease	-1	3123611
after	O	-1	3123611
prolonged	O	-1	3123611
oral	B-Chemical	D003276	3123611
contrac@@	I-Chemical	-1	3123611
ep@@	I-Chemical	-1	3123611
tion	I-Chemical	-1	3123611
.	O	-1	3123611
Pro@@	O	-1	3123611
long@@	O	-1	3123611
ed	O	-1	3123611
administration	O	-1	3123611
of	O	-1	3123611
female	O	-1	3123611
se@@	O	-1	3123611
x	O	-1	3123611
h@@	O	-1	3123611
orm@@	O	-1	3123611
on@@	O	-1	3123611
es	O	-1	3123611
is	O	-1	3123611
a	O	-1	3123611
possible	O	-1	3123611
cause	O	-1	3123611
of	O	-1	3123611
ch@@	B-Disease	D002819	3123611
ore@@	I-Disease	-1	3123611
a	I-Disease	-1	3123611
in	O	-1	3123611
women	O	-1	3123611
who	O	-1	3123611
have	O	-1	3123611
not	O	-1	3123611
previously	O	-1	3123611
had	O	-1	3123611
ch@@	B-Disease	D002819	3123611
ore@@	I-Disease	-1	3123611
a	I-Disease	-1	3123611
or	O	-1	3123611
r@@	B-Disease	D012213	3123611
he@@	I-Disease	-1	3123611
um@@	I-Disease	-1	3123611
atic	I-Disease	-1	3123611
f@@	I-Disease	-1	3123611
ev@@	I-Disease	-1	3123611
er	I-Disease	-1	3123611
.	O	-1	3123611

Re@@	O	-1	761833
ver@@	O	-1	761833
s@@	O	-1	761833
al	O	-1	761833
of	O	-1	761833
am@@	B-Chemical	D000641	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
com@@	B-Disease	D003128	761833
a	I-Disease	-1	761833
in	O	-1	761833
rats	O	-1	761833
by	O	-1	761833
L-@@	B-Chemical	D007980	761833
dopa	I-Chemical	-1	761833
:	O	-1	761833
a	O	-1	761833
peripheral	O	-1	761833
effect@@	O	-1	761833
.	O	-1	761833
A@@	B-Chemical	D000641	761833
m@@	I-Chemical	-1	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
com@@	B-Disease	D003128	761833
a	I-Disease	-1	761833
was	O	-1	761833
produced	O	-1	761833
in	O	-1	761833
rats	O	-1	761833
within	O	-1	761833
10	O	-1	761833
to	O	-1	761833
15	O	-1	761833
minutes	O	-1	761833
of	O	-1	761833
an	O	-1	761833
intra@@	O	-1	761833
per@@	O	-1	761833
it@@	O	-1	761833
one@@	O	-1	761833
al@@	O	-1	761833
injection	O	-1	761833
of	O	-1	761833
1.@@	O	-1	761833
7	O	-1	761833
m@@	O	-1	761833
mo@@	O	-1	761833
l	O	-1	761833
N@@	B-Chemical	D000643	761833
H@@	I-Chemical	-1	761833
4@@	I-Chemical	-1	761833
C@@	I-Chemical	-1	761833
L	I-Chemical	-1	761833
.	O	-1	761833
This	O	-1	761833
com@@	B-Disease	D003128	761833
a	I-Disease	-1	761833
was	O	-1	761833
prevent@@	O	-1	761833
ed	O	-1	761833
with	O	-1	761833
1.@@	O	-1	761833
6@@	O	-1	761833
8	O	-1	761833
m@@	O	-1	761833
mo@@	O	-1	761833
l	O	-1	761833
L-@@	B-Chemical	D007980	761833
dopa	I-Chemical	-1	761833
given	O	-1	761833
by	O	-1	761833
gast@@	O	-1	761833
ric	O	-1	761833
int@@	O	-1	761833
ub@@	O	-1	761833
ation	O	-1	761833
15	O	-1	761833
minutes	O	-1	761833
before	O	-1	761833
the	O	-1	761833
am@@	B-Chemical	D064751	761833
mon@@	I-Chemical	-1	761833
i@@	I-Chemical	-1	761833
um	I-Chemical	-1	761833
sal@@	I-Chemical	-1	761833
t	I-Chemical	-1	761833
injec@@	O	-1	761833
tion.	O	-1	761833
The	O	-1	761833
effect	O	-1	761833
of	O	-1	761833
L-@@	B-Chemical	D007980	761833
dopa	I-Chemical	-1	761833
was	O	-1	761833
cor@@	O	-1	761833
related	O	-1	761833
with	O	-1	761833
a	O	-1	761833
decrease	O	-1	761833
in	O	-1	761833
blood	O	-1	761833
and	O	-1	761833
brain	O	-1	761833
am@@	B-Chemical	D000641	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
,	O	-1	761833
an	O	-1	761833
increase	O	-1	761833
in	O	-1	761833
brain	O	-1	761833
dopamine	B-Chemical	D004298	761833
,	O	-1	761833
and	O	-1	761833
an	O	-1	761833
increase	O	-1	761833
in	O	-1	761833
renal	O	-1	761833
ex@@	O	-1	761833
cre@@	O	-1	761833
tion	O	-1	761833
of	O	-1	761833
am@@	B-Chemical	D000641	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
and	O	-1	761833
ure@@	B-Chemical	D014508	761833
a	I-Chemical	-1	761833
.	O	-1	761833
In@@	O	-1	761833
tra@@	O	-1	761833
ventricular	O	-1	761833
infusion	O	-1	761833
of	O	-1	761833
dopamine	B-Chemical	D004298	761833
suffici@@	O	-1	761833
ent	O	-1	761833
to	O	-1	761833
ra@@	O	-1	761833
is@@	O	-1	761833
e	O	-1	761833
the	O	-1	761833
brain	O	-1	761833
dopamine	B-Chemical	D004298	761833
to	O	-1	761833
the	O	-1	761833
same	O	-1	761833
ext@@	O	-1	761833
ent	O	-1	761833
did	O	-1	761833
not	O	-1	761833
prev@@	O	-1	761833
ent	O	-1	761833
the	O	-1	761833
am@@	B-Chemical	D000641	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
com@@	B-Disease	D003128	761833
a	I-Disease	-1	761833
n@@	O	-1	761833
or	O	-1	761833
aff@@	O	-1	761833
ect	O	-1	761833
the	O	-1	761833
blood	O	-1	761833
and	O	-1	761833
brain	O	-1	761833
am@@	B-Chemical	D000641	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
concentr@@	O	-1	761833
ations.	O	-1	761833
B@@	O	-1	761833
il@@	O	-1	761833
ateral	O	-1	761833
neph@@	O	-1	761833
rec@@	O	-1	761833
to@@	O	-1	761833
m@@	O	-1	761833
y	O	-1	761833
el@@	O	-1	761833
im@@	O	-1	761833
in@@	O	-1	761833
ated	O	-1	761833
the	O	-1	761833
ben@@	O	-1	761833
e@@	O	-1	761833
fic@@	O	-1	761833
ial	O	-1	761833
effect	O	-1	761833
of	O	-1	761833
L-@@	B-Chemical	D007980	761833
dopa	I-Chemical	-1	761833
on	O	-1	761833
blood	O	-1	761833
and	O	-1	761833
brain	O	-1	761833
am@@	B-Chemical	D000641	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
and	O	-1	761833
the	O	-1	761833
am@@	B-Chemical	D000641	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
com@@	B-Disease	D003128	761833
a	I-Disease	-1	761833
was	O	-1	761833
not	O	-1	761833
prevent@@	O	-1	761833
ed.	O	-1	761833
Th@@	O	-1	761833
us,	O	-1	761833
the	O	-1	761833
reduction	O	-1	761833
in	O	-1	761833
blood	O	-1	761833
and	O	-1	761833
brain	O	-1	761833
am@@	B-Chemical	D000641	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
and	O	-1	761833
the	O	-1	761833
pre@@	O	-1	761833
ven@@	O	-1	761833
tion	O	-1	761833
of	O	-1	761833
am@@	B-Chemical	D000641	761833
mon@@	I-Chemical	-1	761833
ia	I-Chemical	-1	761833
com@@	B-Disease	D003128	761833
a	I-Disease	-1	761833
after	O	-1	761833
L-@@	B-Chemical	D007980	761833
dopa	I-Chemical	-1	761833
,	O	-1	761833
can	O	-1	761833
be	O	-1	761833
ac@@	O	-1	761833
coun@@	O	-1	761833
ted	O	-1	761833
for	O	-1	761833
by	O	-1	761833
the	O	-1	761833
peripheral	O	-1	761833
effect	O	-1	761833
of	O	-1	761833
dopamine	B-Chemical	D004298	761833
on	O	-1	761833
renal	O	-1	761833
function	O	-1	761833
ra@@	O	-1	761833
ther	O	-1	761833
than	O	-1	761833
its	O	-1	761833
central	O	-1	761833
ac@@	O	-1	761833
tion.	O	-1	761833
These	O	-1	761833
results	O	-1	761833
prov@@	O	-1	761833
ide	O	-1	761833
a	O	-1	761833
reas@@	O	-1	761833
on@@	O	-1	761833
able	O	-1	761833
expl@@	O	-1	761833
an@@	O	-1	761833
ation	O	-1	761833
for	O	-1	761833
the	O	-1	761833
ben@@	O	-1	761833
e@@	O	-1	761833
fic@@	O	-1	761833
ial	O	-1	761833
effects	O	-1	761833
observed	O	-1	761833
in	O	-1	761833
some	O	-1	761833
encephalo@@	B-Disease	D001927	761833
path@@	I-Disease	-1	761833
ic	I-Disease	-1	761833
patients	O	-1	761833
receiving	O	-1	761833
L-@@	B-Chemical	D007980	761833
dopa	I-Chemical	-1	761833
.	O	-1	761833

He@@	B-Chemical	D006493	18589141
par@@	I-Chemical	-1	18589141
in	I-Chemical	-1	18589141
-induced	O	-1	18589141
throm@@	B-Disease	D013921	18589141
b@@	I-Disease	-1	18589141
ocyto@@	I-Disease	-1	18589141
pen@@	I-Disease	-1	18589141
ia	I-Disease	-1	18589141
after	O	-1	18589141
liver	O	-1	18589141
transplant@@	O	-1	18589141
ation.	O	-1	18589141
BACKGROUND:	O	-1	18589141
U@@	B-Chemical	D006493	18589141
n@@	I-Chemical	-1	18589141
frac@@	I-Chemical	-1	18589141
tion@@	I-Chemical	-1	18589141
ated	I-Chemical	-1	18589141
hepar@@	I-Chemical	-1	18589141
in	I-Chemical	-1	18589141
sodium	I-Chemical	-1	18589141
(	O	-1	18589141
U@@	B-Chemical	D006493	18589141
F@@	I-Chemical	-1	18589141
H	I-Chemical	-1	18589141
)	O	-1	18589141
or	O	-1	18589141
low@@	B-Chemical	D006495	18589141
-@@	I-Chemical	-1	18589141
mol@@	I-Chemical	-1	18589141
ec@@	I-Chemical	-1	18589141
ular	I-Chemical	-1	18589141
weight	I-Chemical	-1	18589141
hepar@@	I-Chemical	-1	18589141
in	I-Chemical	-1	18589141
(@@	O	-1	18589141
L@@	O	-1	18589141
M@@	O	-1	18589141
W@@	O	-1	18589141
H@@	O	-1	18589141
)	O	-1	18589141
is	O	-1	18589141
used	O	-1	18589141
in	O	-1	18589141
anti@@	O	-1	18589141
co@@	O	-1	18589141
ag@@	O	-1	18589141
ul@@	O	-1	18589141
ant	O	-1	18589141
pro@@	O	-1	18589141
to@@	O	-1	18589141
co@@	O	-1	18589141
l@@	O	-1	18589141
s	O	-1	18589141
at	O	-1	18589141
several	O	-1	18589141
insti@@	O	-1	18589141
tu@@	O	-1	18589141
tions	O	-1	18589141
to	O	-1	18589141
prev@@	O	-1	18589141
ent	O	-1	18589141
thrombo@@	B-Disease	D013927	18589141
sis	I-Disease	-1	18589141
after	O	-1	18589141
liver	O	-1	18589141
transplant@@	O	-1	18589141
ation.	O	-1	18589141
He@@	B-Chemical	D006493	18589141
par@@	I-Chemical	-1	18589141
in	I-Chemical	-1	18589141
-induced	O	-1	18589141
throm@@	B-Disease	D013921	18589141
b@@	I-Disease	-1	18589141
ocyto@@	I-Disease	-1	18589141
pen@@	I-Disease	-1	18589141
ia	I-Disease	-1	18589141
(	O	-1	18589141
H@@	B-Disease	D013921	18589141
I@@	I-Disease	-1	18589141
T	I-Disease	-1	18589141
)	O	-1	18589141
is	O	-1	18589141
an	O	-1	18589141
adverse	O	-1	18589141
immun@@	O	-1	18589141
e-@@	O	-1	18589141
mediated	O	-1	18589141
reaction	O	-1	18589141
to	O	-1	18589141
hepar@@	B-Chemical	D006493	18589141
in	I-Chemical	-1	18589141
,	O	-1	18589141
result@@	O	-1	18589141
ing	O	-1	18589141
in	O	-1	18589141
platele@@	O	-1	18589141
t	O	-1	18589141
coun@@	O	-1	18589141
t	O	-1	18589141
decreas@@	O	-1	18589141
es	O	-1	18589141
of	O	-1	18589141
more	O	-1	18589141
than	O	-1	18589141
50@@	O	-1	18589141
%.	O	-1	18589141
The	O	-1	18589141
frequ@@	O	-1	18589141
en@@	O	-1	18589141
ci@@	O	-1	18589141
es	O	-1	18589141
of	O	-1	18589141
H@@	B-Disease	D013921	18589141
I@@	I-Disease	-1	18589141
T	I-Disease	-1	18589141
after	O	-1	18589141
liver	O	-1	18589141
transplant@@	O	-1	18589141
ation	O	-1	18589141
and	O	-1	18589141
platele@@	O	-1	18589141
t	O	-1	18589141
factor	O	-1	18589141
4@@	O	-1	18589141
/	O	-1	18589141
hepar@@	B-Chemical	D006493	18589141
in	I-Chemical	-1	18589141
-@@	O	-1	18589141
reac@@	O	-1	18589141
tive	O	-1	18589141
anti@@	O	-1	18589141
body	O	-1	18589141
(	O	-1	18589141
H@@	B-Disease	D013921	18589141
I@@	I-Disease	-1	18589141
T	I-Disease	-1	18589141
anti@@	O	-1	18589141
bo@@	O	-1	18589141
dy@@	O	-1	18589141
)	O	-1	18589141
posi@@	O	-1	18589141
tivity	O	-1	18589141
in	O	-1	18589141
liver	O	-1	18589141
transplant@@	O	-1	18589141
ation	O	-1	18589141
patients,	O	-1	18589141
however,	O	-1	18589141
are	O	-1	18589141
un@@	O	-1	18589141
know@@	O	-1	18589141
n@@	O	-1	18589141
.	O	-1	18589141
PA@@	O	-1	18589141
TI@@	O	-1	18589141
E@@	O	-1	18589141
N@@	O	-1	18589141
T@@	O	-1	18589141
S	O	-1	18589141
AN@@	O	-1	18589141
D	O	-1	18589141
METHODS:	O	-1	18589141
The	O	-1	18589141
3@@	O	-1	18589141
2	O	-1	18589141
men	O	-1	18589141
and	O	-1	18589141
20	O	-1	18589141
women	O	-1	18589141
under@@	O	-1	18589141
w@@	O	-1	18589141
ent	O	-1	18589141
li@@	O	-1	18589141
ving	O	-1	18589141
d@@	O	-1	18589141
on@@	O	-1	18589141
or	O	-1	18589141
liver	O	-1	18589141
transplant@@	O	-1	18589141
ation.	O	-1	18589141
We	O	-1	18589141
star@@	O	-1	18589141
ted	O	-1	18589141
L@@	O	-1	18589141
M@@	O	-1	18589141
W@@	O	-1	18589141
H	O	-1	18589141
(2@@	O	-1	18589141
5	O	-1	18589141
I@@	O	-1	18589141
U@@	O	-1	18589141
/@@	O	-1	18589141
k@@	O	-1	18589141
g/@@	O	-1	18589141
h@@	O	-1	18589141
)	O	-1	18589141
on	O	-1	18589141
postoperative	O	-1	18589141
day	O	-1	18589141
(P@@	O	-1	18589141
O@@	O	-1	18589141
D)	O	-1	18589141
1,	O	-1	18589141
switch@@	O	-1	18589141
ing	O	-1	18589141
to	O	-1	18589141
U@@	B-Chemical	D006493	18589141
F@@	I-Chemical	-1	18589141
H	I-Chemical	-1	18589141
(@@	O	-1	18589141
50@@	O	-1	18589141
00	O	-1	18589141
U@@	O	-1	18589141
/@@	O	-1	18589141
d@@	O	-1	18589141
)	O	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
2	O	-1	18589141
or	O	-1	18589141
3@@	O	-1	18589141
.	O	-1	18589141
The	O	-1	18589141
dose	O	-1	18589141
of	O	-1	18589141
U@@	B-Chemical	D006493	18589141
F@@	I-Chemical	-1	18589141
H	I-Chemical	-1	18589141
was	O	-1	18589141
chang@@	O	-1	18589141
ed	O	-1	18589141
ac@@	O	-1	18589141
cor@@	O	-1	18589141
ding	O	-1	18589141
to	O	-1	18589141
the	O	-1	18589141
activ@@	O	-1	18589141
ated	O	-1	18589141
clo@@	O	-1	18589141
t@@	O	-1	18589141
ting	O	-1	18589141
time	O	-1	18589141
level@@	O	-1	18589141
.	O	-1	18589141
H@@	B-Disease	D013921	18589141
I@@	I-Disease	-1	18589141
T	I-Disease	-1	18589141
anti@@	O	-1	18589141
body	O	-1	18589141
levels	O	-1	18589141
were	O	-1	18589141
measured	O	-1	18589141
the	O	-1	18589141
day	O	-1	18589141
before	O	-1	18589141
surger@@	O	-1	18589141
y	O	-1	18589141
and	O	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
7	O	-1	18589141
and	O	-1	18589141
14@@	O	-1	18589141
.	O	-1	18589141
P@@	O	-1	18589141
lat@@	O	-1	18589141
e@@	O	-1	18589141
le@@	O	-1	18589141
t	O	-1	18589141
coun@@	O	-1	18589141
t	O	-1	18589141
was	O	-1	18589141
measured	O	-1	18589141
daily	O	-1	18589141
for	O	-1	18589141
3	O	-1	18589141
week@@	O	-1	18589141
s.	O	-1	18589141
RESULTS:	O	-1	18589141
The	O	-1	18589141
average	O	-1	18589141
platele@@	O	-1	18589141
t	O	-1	18589141
coun@@	O	-1	18589141
ts	O	-1	18589141
pre@@	O	-1	18589141
o@@	O	-1	18589141
per@@	O	-1	18589141
ati@@	O	-1	18589141
vel@@	O	-1	18589141
y,	O	-1	18589141
and	O	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
7@@	O	-1	18589141
,	O	-1	18589141
14@@	O	-1	18589141
,	O	-1	18589141
and	O	-1	18589141
21	O	-1	18589141
were	O	-1	18589141
6@@	O	-1	18589141
5,	O	-1	18589141
8@@	O	-1	18589141
8@@	O	-1	18589141
,	O	-1	18589141
14@@	O	-1	18589141
9@@	O	-1	18589141
,	O	-1	18589141
and	O	-1	18589141
1@@	O	-1	18589141
6@@	O	-1	18589141
9	O	-1	18589141
x	O	-1	18589141
10@@	O	-1	18589141
(@@	O	-1	18589141
9@@	O	-1	18589141
)@@	O	-1	18589141
/@@	O	-1	18589141
L@@	O	-1	18589141
,	O	-1	18589141
respectively.	O	-1	18589141
Two	O	-1	18589141
patients	O	-1	18589141
developed	O	-1	18589141
hepatic	O	-1	18589141
artery	O	-1	18589141
thrombo@@	B-Disease	D013927	18589141
sis	I-Disease	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
11	O	-1	18589141
and	O	-1	18589141
19@@	O	-1	18589141
,	O	-1	18589141
respectivel@@	O	-1	18589141
y,	O	-1	18589141
although	O	-1	18589141
they	O	-1	18589141
were	O	-1	18589141
H@@	B-Disease	D013921	18589141
I@@	I-Disease	-1	18589141
T	I-Disease	-1	18589141
anti@@	O	-1	18589141
bo@@	O	-1	18589141
dy@@	O	-1	18589141
-@@	O	-1	18589141
negative	O	-1	18589141
and	O	-1	18589141
their	O	-1	18589141
platele@@	O	-1	18589141
t	O	-1	18589141
coun@@	O	-1	18589141
ts	O	-1	18589141
were	O	-1	18589141
st@@	O	-1	18589141
able@@	O	-1	18589141
.	O	-1	18589141
In	O	-1	18589141
2	O	-1	18589141
other	O	-1	18589141
patients,	O	-1	18589141
the	O	-1	18589141
platele@@	O	-1	18589141
t	O	-1	18589141
coun@@	O	-1	18589141
t	O	-1	18589141
decreased	O	-1	18589141
su@@	O	-1	18589141
d@@	O	-1	18589141
d@@	O	-1	18589141
en@@	O	-1	18589141
ly	O	-1	18589141
from	O	-1	18589141
10@@	O	-1	18589141
7	O	-1	18589141
x	O	-1	18589141
10@@	O	-1	18589141
(@@	O	-1	18589141
9@@	O	-1	18589141
)@@	O	-1	18589141
/@@	O	-1	18589141
L	O	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
4	O	-1	18589141
to	O	-1	18589141
6@@	O	-1	18589141
5	O	-1	18589141
x	O	-1	18589141
10@@	O	-1	18589141
(@@	O	-1	18589141
9@@	O	-1	18589141
)@@	O	-1	18589141
/@@	O	-1	18589141
L	O	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
6	O	-1	18589141
and	O	-1	18589141
from	O	-1	18589141
7@@	O	-1	18589141
6	O	-1	18589141
x	O	-1	18589141
10@@	O	-1	18589141
(@@	O	-1	18589141
9@@	O	-1	18589141
)@@	O	-1	18589141
/@@	O	-1	18589141
L	O	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
7	O	-1	18589141
to	O	-1	18589141
3@@	O	-1	18589141
3	O	-1	18589141
x	O	-1	18589141
10@@	O	-1	18589141
(@@	O	-1	18589141
9@@	O	-1	18589141
)@@	O	-1	18589141
/@@	O	-1	18589141
L	O	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
9@@	O	-1	18589141
,	O	-1	18589141
respectively.	O	-1	18589141
The	O	-1	18589141
hepar@@	B-Chemical	D006493	18589141
in	I-Chemical	-1	18589141
-induced	O	-1	18589141
platele@@	B-Disease	D001791	18589141
t	I-Disease	-1	18589141
ag@@	I-Disease	-1	18589141
g@@	I-Disease	-1	18589141
reg@@	I-Disease	-1	18589141
ation	I-Disease	-1	18589141
test	O	-1	18589141
was	O	-1	18589141
negative	O	-1	18589141
in	O	-1	18589141
these	O	-1	18589141
patients.	O	-1	18589141
The	O	-1	18589141
perc@@	O	-1	18589141
ent@@	O	-1	18589141
age	O	-1	18589141
of	O	-1	18589141
H@@	B-Disease	D013921	18589141
I@@	I-Disease	-1	18589141
T	I-Disease	-1	18589141
anti@@	O	-1	18589141
bo@@	O	-1	18589141
dy@@	O	-1	18589141
-@@	O	-1	18589141
positive	O	-1	18589141
patients	O	-1	18589141
was	O	-1	18589141
0.@@	O	-1	18589141
5%	O	-1	18589141
pre@@	O	-1	18589141
o@@	O	-1	18589141
per@@	O	-1	18589141
ati@@	O	-1	18589141
vel@@	O	-1	18589141
y,	O	-1	18589141
5.@@	O	-1	18589141
6%	O	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
7@@	O	-1	18589141
,	O	-1	18589141
and	O	-1	18589141
5.@@	O	-1	18589141
6%	O	-1	18589141
on	O	-1	18589141
P@@	O	-1	18589141
O@@	O	-1	18589141
D	O	-1	18589141
14@@	O	-1	18589141
.	O	-1	18589141
N@@	O	-1	18589141
one	O	-1	18589141
of	O	-1	18589141
the	O	-1	18589141
subj@@	O	-1	18589141
ect@@	O	-1	18589141
s/@@	O	-1	18589141
patients	O	-1	18589141
developed	O	-1	18589141
U@@	B-Chemical	D006493	18589141
F@@	I-Chemical	-1	18589141
H	I-Chemical	-1	18589141
-@@	O	-1	18589141
related	O	-1	18589141
H@@	B-Disease	D013921	18589141
I@@	I-Disease	-1	18589141
T	I-Disease	-1	18589141
.	O	-1	18589141
CONCLUSIONS:	O	-1	18589141
In	O	-1	18589141
our	O	-1	18589141
seri@@	O	-1	18589141
es,	O	-1	18589141
the	O	-1	18589141
occur@@	O	-1	18589141
rence	O	-1	18589141
of	O	-1	18589141
H@@	B-Disease	D013921	18589141
I@@	I-Disease	-1	18589141
T	I-Disease	-1	18589141
after	O	-1	18589141
liver	O	-1	18589141
transplant@@	O	-1	18589141
ation	O	-1	18589141
was	O	-1	18589141
un@@	O	-1	18589141
common@@	O	-1	18589141
.	O	-1	18589141

P@@	B-Chemical	D011441	16418614
T@@	I-Chemical	-1	16418614
U	I-Chemical	-1	16418614
-@@	O	-1	16418614
associated	O	-1	16418614
vas@@	B-Disease	D014657	16418614
cul@@	I-Disease	-1	16418614
iti@@	I-Disease	-1	16418614
s	I-Disease	-1	16418614
in	O	-1	16418614
a	O	-1	16418614
gi@@	O	-1	16418614
r@@	O	-1	16418614
l	O	-1	16418614
with	O	-1	16418614
T@@	B-Disease	D014424	16418614
ur@@	I-Disease	-1	16418614
n@@	I-Disease	-1	16418614
er	I-Disease	-1	16418614
S@@	I-Disease	-1	16418614
yn@@	I-Disease	-1	16418614
drom@@	I-Disease	-1	16418614
e	I-Disease	-1	16418614
and	O	-1	16418614
G@@	B-Disease	D006111	16418614
ra@@	I-Disease	-1	16418614
v@@	I-Disease	-1	16418614
es@@	I-Disease	-1	16418614
'	I-Disease	-1	16418614
disease	I-Disease	-1	16418614
.	O	-1	16418614
P@@	O	-1	16418614
al@@	O	-1	16418614
pa@@	O	-1	16418614
ble	O	-1	16418614
pur@@	B-Disease	D011693	16418614
pur@@	I-Disease	-1	16418614
a	I-Disease	-1	16418614
is	O	-1	16418614
a	O	-1	16418614
con@@	O	-1	16418614
cer@@	O	-1	16418614
ning	O	-1	16418614
clinical	O	-1	16418614
find@@	O	-1	16418614
ing	O	-1	16418614
in	O	-1	16418614
pe@@	O	-1	16418614
di@@	O	-1	16418614
atric	O	-1	16418614
patients	O	-1	16418614
and	O	-1	16418614
can	O	-1	16418614
have	O	-1	16418614
man@@	O	-1	16418614
y	O	-1	16418614
ca@@	O	-1	16418614
us@@	O	-1	16418614
es,	O	-1	16418614
including	O	-1	16418614
inf@@	O	-1	16418614
ecti@@	O	-1	16418614
ous	O	-1	16418614
and	O	-1	16418614
auto@@	O	-1	16418614
immun@@	O	-1	16418614
e	O	-1	16418614
pro@@	O	-1	16418614
cess@@	O	-1	16418614
es.	O	-1	16418614
A	O	-1	16418614
r@@	O	-1	16418614
are	O	-1	16418614
ca@@	O	-1	16418614
use@@	O	-1	16418614
,	O	-1	16418614
drug@@	O	-1	16418614
-induced	O	-1	16418614
vas@@	B-Disease	D014657	16418614
cul@@	I-Disease	-1	16418614
iti@@	I-Disease	-1	16418614
s	I-Disease	-1	16418614
,	O	-1	16418614
may	O	-1	16418614
result	O	-1	16418614
from	O	-1	16418614
the	O	-1	16418614
pro@@	O	-1	16418614
duction	O	-1	16418614
of	O	-1	16418614
ant@@	O	-1	16418614
ine@@	O	-1	16418614
ut@@	O	-1	16418614
ro@@	O	-1	16418614
ph@@	O	-1	16418614
il	O	-1	16418614
cyto@@	O	-1	16418614
plas@@	O	-1	16418614
mic	O	-1	16418614
anti@@	O	-1	16418614
bo@@	O	-1	16418614
di@@	O	-1	16418614
es	O	-1	16418614
(A@@	O	-1	16418614
N@@	O	-1	16418614
CA@@	O	-1	16418614
s)	O	-1	16418614
in	O	-1	16418614
response	O	-1	16418614
to	O	-1	16418614
a	O	-1	16418614
medic@@	O	-1	16418614
ation.	O	-1	16418614
We	O	-1	16418614
report	O	-1	16418614
a	O	-1	16418614
gi@@	O	-1	16418614
r@@	O	-1	16418614
l	O	-1	16418614
with	O	-1	16418614
T@@	B-Disease	D014424	16418614
ur@@	I-Disease	-1	16418614
n@@	I-Disease	-1	16418614
er	I-Disease	-1	16418614
syndrome	I-Disease	-1	16418614
and	O	-1	16418614
G@@	B-Disease	D006111	16418614
ra@@	I-Disease	-1	16418614
v@@	I-Disease	-1	16418614
es@@	I-Disease	-1	16418614
'	I-Disease	-1	16418614
disease	I-Disease	-1	16418614
who	O	-1	16418614
presented	O	-1	16418614
with	O	-1	16418614
p@@	O	-1	16418614
al@@	O	-1	16418614
pa@@	O	-1	16418614
ble	O	-1	16418614
pur@@	B-Disease	D011693	16418614
pur@@	I-Disease	-1	16418614
ic	I-Disease	-1	16418614
lesions	I-Disease	-1	16418614
.	O	-1	16418614
The	O	-1	16418614
diagnosis	O	-1	16418614
of	O	-1	16418614
prop@@	B-Chemical	D011441	16418614
yl@@	I-Chemical	-1	16418614
th@@	I-Chemical	-1	16418614
io@@	I-Chemical	-1	16418614
urac@@	I-Chemical	-1	16418614
il	I-Chemical	-1	16418614
(	O	-1	16418614
P@@	B-Chemical	D011441	16418614
T@@	I-Chemical	-1	16418614
U	I-Chemical	-1	16418614
)-@@	O	-1	16418614
associated	O	-1	16418614
vas@@	B-Disease	D014657	16418614
cul@@	I-Disease	-1	16418614
iti@@	I-Disease	-1	16418614
s	I-Disease	-1	16418614
was	O	-1	16418614
m@@	O	-1	16418614
ade	O	-1	16418614
by	O	-1	16418614
observ@@	O	-1	16418614
ation	O	-1	16418614
of	O	-1	16418614
consist@@	O	-1	16418614
ent	O	-1	16418614
clinical	O	-1	16418614
feat@@	O	-1	16418614
ures@@	O	-1	16418614
,	O	-1	16418614
the	O	-1	16418614
det@@	O	-1	16418614
ection	O	-1	16418614
of	O	-1	16418614
elevated	O	-1	16418614
A@@	O	-1	16418614
NA	O	-1	16418614
and	O	-1	16418614
AN@@	O	-1	16418614
C@@	O	-1	16418614
A	O	-1	16418614
in	O	-1	16418614
the	O	-1	16418614
blo@@	O	-1	16418614
o@@	O	-1	16418614
d,	O	-1	16418614
and	O	-1	16418614
the	O	-1	16418614
observed	O	-1	16418614
clinical	O	-1	16418614
resol@@	O	-1	16418614
u@@	O	-1	16418614
tion	O	-1	16418614
of	O	-1	16418614
symptoms	O	-1	16418614
following	O	-1	16418614
withdrawal	O	-1	16418614
of	O	-1	16418614
P@@	B-Chemical	D011441	16418614
T@@	I-Chemical	-1	16418614
U	I-Chemical	-1	16418614
.	O	-1	16418614
S@@	O	-1	16418614
ub@@	O	-1	16418614
sequ@@	O	-1	16418614
ent	O	-1	16418614
treatment	O	-1	16418614
of	O	-1	16418614
per@@	O	-1	16418614
sist@@	O	-1	16418614
ent	O	-1	16418614
hyper@@	B-Disease	D006980	16418614
th@@	I-Disease	-1	16418614
yro@@	I-Disease	-1	16418614
i@@	I-Disease	-1	16418614
dis@@	I-Disease	-1	16418614
m	I-Disease	-1	16418614
with	O	-1	16418614
radi@@	O	-1	16418614
o@@	O	-1	16418614
abl@@	O	-1	16418614
ation	O	-1	16418614
did	O	-1	16418614
not	O	-1	16418614
result	O	-1	16418614
in	O	-1	16418614
an	O	-1	16418614
ex@@	O	-1	16418614
ac@@	O	-1	16418614
er@@	O	-1	16418614
b@@	O	-1	16418614
ation	O	-1	16418614
of	O	-1	16418614
the	O	-1	16418614
vas@@	B-Disease	D014657	16418614
cul@@	I-Disease	-1	16418614
iti@@	I-Disease	-1	16418614
s	I-Disease	-1	16418614
,	O	-1	16418614
a	O	-1	16418614
complication	O	-1	16418614
descri@@	O	-1	16418614
bed	O	-1	16418614
in	O	-1	16418614
prior	O	-1	16418614
case	O	-1	16418614
repor@@	O	-1	16418614
t@@	O	-1	16418614
s.	O	-1	16418614

S@@	B-Chemical	D013390	15893386
uc@@	I-Chemical	-1	15893386
cin@@	I-Chemical	-1	15893386
ylcholine	I-Chemical	-1	15893386
-induced	O	-1	15893386
mas@@	B-Disease	D014313	15893386
se@@	I-Disease	-1	15893386
ter	I-Disease	-1	15893386
musc@@	I-Disease	-1	15893386
le	I-Disease	-1	15893386
rig@@	I-Disease	-1	15893386
idity	I-Disease	-1	15893386
during	O	-1	15893386
b@@	O	-1	15893386
ron@@	O	-1	15893386
ch@@	O	-1	15893386
os@@	O	-1	15893386
co@@	O	-1	15893386
p@@	O	-1	15893386
ic	O	-1	15893386
re@@	O	-1	15893386
mo@@	O	-1	15893386
v@@	O	-1	15893386
al	O	-1	15893386
of	O	-1	15893386
a	O	-1	15893386
trac@@	O	-1	15893386
he@@	O	-1	15893386
al	O	-1	15893386
fo@@	O	-1	15893386
re@@	O	-1	15893386
ig@@	O	-1	15893386
n	O	-1	15893386
bo@@	O	-1	15893386
d@@	O	-1	15893386
y.	O	-1	15893386
M@@	B-Disease	D014313	15893386
as@@	I-Disease	-1	15893386
se@@	I-Disease	-1	15893386
ter	I-Disease	-1	15893386
musc@@	I-Disease	-1	15893386
le	I-Disease	-1	15893386
rig@@	I-Disease	-1	15893386
idity	I-Disease	-1	15893386
during	O	-1	15893386
gener@@	O	-1	15893386
al	O	-1	15893386
anesthe@@	O	-1	15893386
sia	O	-1	15893386
is	O	-1	15893386
considered	O	-1	15893386
an	O	-1	15893386
early	O	-1	15893386
war@@	O	-1	15893386
ning	O	-1	15893386
si@@	O	-1	15893386
g@@	O	-1	15893386
n	O	-1	15893386
of	O	-1	15893386
a	O	-1	15893386
possible	O	-1	15893386
episo@@	O	-1	15893386
de	O	-1	15893386
of	O	-1	15893386
mal@@	B-Disease	D008305	15893386
i@@	I-Disease	-1	15893386
gn@@	I-Disease	-1	15893386
ant	I-Disease	-1	15893386
hyper@@	I-Disease	-1	15893386
ther@@	I-Disease	-1	15893386
mia	I-Disease	-1	15893386
.	O	-1	15893386
The	O	-1	15893386
dec@@	O	-1	15893386
i@@	O	-1	15893386
sion	O	-1	15893386
whether	O	-1	15893386
to	O	-1	15893386
continu@@	O	-1	15893386
e	O	-1	15893386
or	O	-1	15893386
discontinu@@	O	-1	15893386
e	O	-1	15893386
the	O	-1	15893386
proce@@	O	-1	15893386
d@@	O	-1	15893386
ure	O	-1	15893386
depend@@	O	-1	15893386
s	O	-1	15893386
on	O	-1	15893386
the	O	-1	15893386
ur@@	O	-1	15893386
gen@@	O	-1	15893386
c@@	O	-1	15893386
y	O	-1	15893386
of	O	-1	15893386
the	O	-1	15893386
surger@@	O	-1	15893386
y	O	-1	15893386
and	O	-1	15893386
severity	O	-1	15893386
of	O	-1	15893386
mas@@	B-Disease	D014313	15893386
se@@	I-Disease	-1	15893386
ter	I-Disease	-1	15893386
musc@@	I-Disease	-1	15893386
le	I-Disease	-1	15893386
rig@@	I-Disease	-1	15893386
idity	I-Disease	-1	15893386
.	O	-1	15893386
He@@	O	-1	15893386
re,	O	-1	15893386
we	O	-1	15893386
describe	O	-1	15893386
a	O	-1	15893386
case	O	-1	15893386
of	O	-1	15893386
severe	O	-1	15893386
mas@@	B-Disease	D014313	15893386
se@@	I-Disease	-1	15893386
ter	I-Disease	-1	15893386
musc@@	I-Disease	-1	15893386
le	I-Disease	-1	15893386
rig@@	I-Disease	-1	15893386
idity	I-Disease	-1	15893386
(	O	-1	15893386
j@@	B-Disease	D014313	15893386
a@@	I-Disease	-1	15893386
w	I-Disease	-1	15893386
of	I-Disease	-1	15893386
ste@@	I-Disease	-1	15893386
el	I-Disease	-1	15893386
)	O	-1	15893386
after	O	-1	15893386
suc@@	B-Chemical	D013390	15893386
cin@@	I-Chemical	-1	15893386
ylcholine	I-Chemical	-1	15893386
(	O	-1	15893386
S@@	B-Chemical	D013390	15893386
ch	I-Chemical	-1	15893386
)	O	-1	15893386
administration	O	-1	15893386
during	O	-1	15893386
gener@@	O	-1	15893386
al	O	-1	15893386
anesthe@@	O	-1	15893386
tic	O	-1	15893386
man@@	O	-1	15893386
ag@@	O	-1	15893386
ement	O	-1	15893386
for	O	-1	15893386
rig@@	O	-1	15893386
id	O	-1	15893386
b@@	O	-1	15893386
ron@@	O	-1	15893386
ch@@	O	-1	15893386
os@@	O	-1	15893386
co@@	O	-1	15893386
p@@	O	-1	15893386
ic	O	-1	15893386
re@@	O	-1	15893386
mo@@	O	-1	15893386
v@@	O	-1	15893386
al	O	-1	15893386
of	O	-1	15893386
a	O	-1	15893386
trac@@	O	-1	15893386
he@@	O	-1	15893386
al	O	-1	15893386
fo@@	O	-1	15893386
re@@	O	-1	15893386
ig@@	O	-1	15893386
n	O	-1	15893386
bo@@	O	-1	15893386
d@@	O	-1	15893386
y.	O	-1	15893386
An@@	O	-1	15893386
esthe@@	O	-1	15893386
sia	O	-1	15893386
was	O	-1	15893386
continu@@	O	-1	15893386
ed	O	-1	15893386
un@@	O	-1	15893386
event@@	O	-1	15893386
ful@@	O	-1	15893386
ly	O	-1	15893386
with	O	-1	15893386
pro@@	B-Chemical	D015742	15893386
po@@	I-Chemical	-1	15893386
f@@	I-Chemical	-1	15893386
ol	I-Chemical	-1	15893386
infusion	O	-1	15893386
while	O	-1	15893386
all	O	-1	15893386
fac@@	O	-1	15893386
il@@	O	-1	15893386
ities	O	-1	15893386
were	O	-1	15893386
av@@	O	-1	15893386
ail@@	O	-1	15893386
able	O	-1	15893386
to	O	-1	15893386
det@@	O	-1	15893386
ect	O	-1	15893386
and	O	-1	15893386
tre@@	O	-1	15893386
at	O	-1	15893386
mal@@	B-Disease	D008305	15893386
i@@	I-Disease	-1	15893386
gn@@	I-Disease	-1	15893386
ant	I-Disease	-1	15893386
hyper@@	I-Disease	-1	15893386
ther@@	I-Disease	-1	15893386
mia	I-Disease	-1	15893386
.	O	-1	15893386

M@@	O	-1	15814210
in@@	O	-1	15814210
or	O	-1	15814210
neurolog@@	B-Disease	D009422	15814210
ical	I-Disease	-1	15814210
dysfunction	I-Disease	-1	15814210
,	O	-1	15814210
cognitive	O	-1	15814210
develop@@	O	-1	15814210
ment@@	O	-1	15814210
,	O	-1	15814210
and	O	-1	15814210
s@@	O	-1	15814210
om@@	O	-1	15814210
atic	O	-1	15814210
development	O	-1	15814210
at	O	-1	15814210
the	O	-1	15814210
age	O	-1	15814210
of	O	-1	15814210
3	O	-1	15814210
to	O	-1	15814210
7	O	-1	15814210
years	O	-1	15814210
after	O	-1	15814210
de@@	B-Chemical	D003907	15814210
xameth@@	I-Chemical	-1	15814210
as@@	I-Chemical	-1	15814210
one	I-Chemical	-1	15814210
treatment	O	-1	15814210
in	O	-1	15814210
ver@@	O	-1	15814210
y-@@	O	-1	15814210
low	O	-1	15814210
b@@	O	-1	15814210
ir@@	O	-1	15814210
th@@	O	-1	15814210
-@@	O	-1	15814210
weight	O	-1	15814210
inf@@	O	-1	15814210
ant@@	O	-1	15814210
s.	O	-1	15814210
The	O	-1	15814210
ob@@	O	-1	15814210
j@@	O	-1	15814210
ective	O	-1	15814210
of	O	-1	15814210
this	O	-1	15814210
study	O	-1	15814210
was	O	-1	15814210
to	O	-1	15814210
ass@@	O	-1	15814210
ess	O	-1	15814210
min@@	O	-1	15814210
or	O	-1	15814210
neurolog@@	B-Disease	D009422	15814210
ical	I-Disease	-1	15814210
dysfunction	I-Disease	-1	15814210
,	O	-1	15814210
cognitive	O	-1	15814210
develop@@	O	-1	15814210
ment@@	O	-1	15814210
,	O	-1	15814210
and	O	-1	15814210
s@@	O	-1	15814210
om@@	O	-1	15814210
atic	O	-1	15814210
development	O	-1	15814210
after	O	-1	15814210
de@@	B-Chemical	D003907	15814210
xameth@@	I-Chemical	-1	15814210
as@@	I-Chemical	-1	15814210
one	I-Chemical	-1	15814210
therapy	O	-1	15814210
in	O	-1	15814210
ver@@	O	-1	15814210
y-@@	O	-1	15814210
low@@	O	-1	15814210
-@@	O	-1	15814210
b@@	O	-1	15814210
ir@@	O	-1	15814210
th@@	O	-1	15814210
weight	O	-1	15814210
inf@@	O	-1	15814210
ant@@	O	-1	15814210
s.	O	-1	15814210
Th@@	O	-1	15814210
ir@@	O	-1	15814210
ty-@@	O	-1	15814210
three	O	-1	15814210
children	O	-1	15814210
after	O	-1	15814210
de@@	B-Chemical	D003907	15814210
xameth@@	I-Chemical	-1	15814210
as@@	I-Chemical	-1	15814210
one	I-Chemical	-1	15814210
treatment	O	-1	15814210
were	O	-1	15814210
mat@@	O	-1	15814210
ch@@	O	-1	15814210
ed	O	-1	15814210
to	O	-1	15814210
3@@	O	-1	15814210
3	O	-1	15814210
children	O	-1	15814210
without	O	-1	15814210
de@@	B-Chemical	D003907	15814210
xameth@@	I-Chemical	-1	15814210
as@@	I-Chemical	-1	15814210
one	I-Chemical	-1	15814210
treatment.	O	-1	15814210
D@@	O	-1	15814210
at@@	O	-1	15814210
a	O	-1	15814210
were	O	-1	15814210
assessed	O	-1	15814210
at	O	-1	15814210
the	O	-1	15814210
age	O	-1	15814210
of	O	-1	15814210
3-@@	O	-1	15814210
7	O	-1	15814210
year@@	O	-1	15814210
s.	O	-1	15814210
D@@	B-Chemical	D003907	15814210
ex@@	I-Chemical	-1	15814210
ameth@@	I-Chemical	-1	15814210
as@@	I-Chemical	-1	15814210
one	I-Chemical	-1	15814210
was	O	-1	15814210
star@@	O	-1	15814210
ted	O	-1	15814210
between	O	-1	15814210
the	O	-1	15814210
7@@	O	-1	15814210
th	O	-1	15814210
and	O	-1	15814210
the	O	-1	15814210
2@@	O	-1	15814210
8@@	O	-1	15814210
th	O	-1	15814210
day	O	-1	15814210
of	O	-1	15814210
lif@@	O	-1	15814210
e	O	-1	15814210
over	O	-1	15814210
7	O	-1	15814210
days	O	-1	15814210
with	O	-1	15814210
a	O	-1	15814210
total	O	-1	15814210
dose	O	-1	15814210
of	O	-1	15814210
2.@@	O	-1	15814210
3@@	O	-1	15814210
5	O	-1	15814210
mg/k@@	O	-1	15814210
g/@@	O	-1	15814210
da@@	O	-1	15814210
y.	O	-1	15814210
E@@	O	-1	15814210
x@@	O	-1	15814210
cl@@	O	-1	15814210
usion	O	-1	15814210
c@@	O	-1	15814210
rit@@	O	-1	15814210
er@@	O	-1	15814210
ia	O	-1	15814210
were	O	-1	15814210
as@@	B-Disease	D001237	15814210
ph@@	I-Disease	-1	15814210
y@@	I-Disease	-1	15814210
x@@	I-Disease	-1	15814210
ia	I-Disease	-1	15814210
,	O	-1	15814210
mal@@	B-Disease	D000014	15814210
form@@	I-Disease	-1	15814210
ations	I-Disease	-1	15814210
,	O	-1	15814210
major	O	-1	15814210
surg@@	O	-1	15814210
ical	O	-1	15814210
inter@@	O	-1	15814210
ven@@	O	-1	15814210
tion@@	O	-1	15814210
s,	O	-1	15814210
sm@@	O	-1	15814210
all	O	-1	15814210
for	O	-1	15814210
g@@	O	-1	15814210
est@@	O	-1	15814210
ation@@	O	-1	15814210
al	O	-1	15814210
age,	O	-1	15814210
intra@@	O	-1	15814210
ventricular	O	-1	15814210
haem@@	B-Disease	D006470	15814210
or@@	I-Disease	-1	15814210
rh@@	I-Disease	-1	15814210
age	I-Disease	-1	15814210
gra@@	O	-1	15814210
des	O	-1	15814210
I@@	O	-1	15814210
II	O	-1	15814210
and	O	-1	15814210
I@@	O	-1	15814210
V@@	O	-1	15814210
,	O	-1	15814210
peri@@	B-Disease	D007969	15814210
ventricular	I-Disease	-1	15814210
leuk@@	I-Disease	-1	15814210
om@@	I-Disease	-1	15814210
al@@	I-Disease	-1	15814210
ac@@	I-Disease	-1	15814210
ia	I-Disease	-1	15814210
,	O	-1	15814210
and	O	-1	15814210
severe	O	-1	15814210
psych@@	B-Disease	D011596	15814210
om@@	I-Disease	-1	15814210
otor	I-Disease	-1	15814210
ret@@	I-Disease	-1	15814210
ar@@	I-Disease	-1	15814210
d@@	I-Disease	-1	15814210
ation	I-Disease	-1	15814210
.	O	-1	15814210
E@@	O	-1	15814210
ach	O	-1	15814210
ch@@	O	-1	15814210
il@@	O	-1	15814210
d	O	-1	15814210
was	O	-1	15814210
examined	O	-1	15814210
by	O	-1	15814210
a	O	-1	15814210
neuro@@	O	-1	15814210
pe@@	O	-1	15814210
di@@	O	-1	15814210
at@@	O	-1	15814210
r@@	O	-1	15814210
ici@@	O	-1	15814210
an	O	-1	15814210
for	O	-1	15814210
min@@	O	-1	15814210
or	O	-1	15814210
neurolog@@	B-Disease	D009422	15814210
ical	I-Disease	-1	15814210
dysfunc@@	I-Disease	-1	15814210
tions	I-Disease	-1	15814210
and	O	-1	15814210
tested	O	-1	15814210
by	O	-1	15814210
a	O	-1	15814210
psych@@	O	-1	15814210
olog@@	O	-1	15814210
ist	O	-1	15814210
for	O	-1	15814210
cognitive	O	-1	15814210
development	O	-1	15814210
with	O	-1	15814210
a	O	-1	15814210
K@@	O	-1	15814210
au@@	O	-1	15814210
f@@	O	-1	15814210
man	O	-1	15814210
A@@	O	-1	15814210
s@@	O	-1	15814210
s@@	O	-1	15814210
ess@@	O	-1	15814210
ment	O	-1	15814210
B@@	O	-1	15814210
at@@	O	-1	15814210
ter@@	O	-1	15814210
y	O	-1	15814210
for	O	-1	15814210
Ch@@	O	-1	15814210
ild@@	O	-1	15814210
ren	O	-1	15814210
and	O	-1	15814210
a	O	-1	15814210
D@@	O	-1	15814210
ra@@	O	-1	15814210
w@@	O	-1	15814210
-@@	O	-1	15814210
a@@	O	-1	15814210
-@@	O	-1	15814210
M@@	O	-1	15814210
an	O	-1	15814210
T@@	O	-1	15814210
est@@	O	-1	15814210
.	O	-1	15814210
There	O	-1	15814210
were	O	-1	15814210
no	O	-1	15814210
differences	O	-1	15814210
in	O	-1	15814210
de@@	O	-1	15814210
mo@@	O	-1	15814210
graph@@	O	-1	15814210
ic	O	-1	15814210
dat@@	O	-1	15814210
a,	O	-1	15814210
grow@@	O	-1	15814210
th@@	O	-1	15814210
,	O	-1	15814210
and	O	-1	15814210
s@@	O	-1	15814210
oc@@	O	-1	15814210
io@@	O	-1	15814210
-@@	O	-1	15814210
ec@@	O	-1	15814210
on@@	O	-1	15814210
om@@	O	-1	15814210
ic	O	-1	15814210
status	O	-1	15814210
between	O	-1	15814210
the	O	-1	15814210
two	O	-1	15814210
groups.	O	-1	15814210
F@@	O	-1	15814210
ine	O	-1	15814210
motor	O	-1	15814210
s@@	O	-1	15814210
k@@	O	-1	15814210
ill@@	O	-1	15814210
s	O	-1	15814210
and	O	-1	15814210
g@@	O	-1	15814210
ros@@	O	-1	15814210
s	O	-1	15814210
motor	O	-1	15814210
function	O	-1	15814210
were	O	-1	15814210
significantly	O	-1	15814210
bet@@	O	-1	15814210
ter	O	-1	15814210
in	O	-1	15814210
the	O	-1	15814210
control	O	-1	15814210
group	O	-1	15814210
(p@@	O	-1	15814210
<@@	O	-1	15814210
0.0@@	O	-1	15814210
1).	O	-1	15814210
In	O	-1	15814210
the	O	-1	15814210
D@@	O	-1	15814210
ra@@	O	-1	15814210
w@@	O	-1	15814210
-@@	O	-1	15814210
a@@	O	-1	15814210
-@@	O	-1	15814210
M@@	O	-1	15814210
an	O	-1	15814210
T@@	O	-1	15814210
est@@	O	-1	15814210
,	O	-1	15814210
the	O	-1	15814210
control	O	-1	15814210
group	O	-1	15814210
showed	O	-1	15814210
bet@@	O	-1	15814210
ter	O	-1	15814210
results	O	-1	15814210
(p@@	O	-1	15814210
<@@	O	-1	15814210
0.00@@	O	-1	15814210
1).	O	-1	15814210
There	O	-1	15814210
were	O	-1	15814210
no	O	-1	15814210
differences	O	-1	15814210
in	O	-1	15814210
development	O	-1	15814210
of	O	-1	15814210
sp@@	O	-1	15814210
e@@	O	-1	15814210
ech@@	O	-1	15814210
,	O	-1	15814210
s@@	O	-1	15814210
oci@@	O	-1	15814210
al	O	-1	15814210
develop@@	O	-1	15814210
ment@@	O	-1	15814210
,	O	-1	15814210
and	O	-1	15814210
the	O	-1	15814210
K@@	O	-1	15814210
au@@	O	-1	15814210
f@@	O	-1	15814210
man	O	-1	15814210
A@@	O	-1	15814210
s@@	O	-1	15814210
s@@	O	-1	15814210
ess@@	O	-1	15814210
ment	O	-1	15814210
B@@	O	-1	15814210
at@@	O	-1	15814210
ter@@	O	-1	15814210
y	O	-1	15814210
for	O	-1	15814210
Ch@@	O	-1	15814210
ild@@	O	-1	15814210
ren@@	O	-1	15814210
.	O	-1	15814210
After	O	-1	15814210
de@@	B-Chemical	D003907	15814210
xameth@@	I-Chemical	-1	15814210
as@@	I-Chemical	-1	15814210
one	I-Chemical	-1	15814210
treatment,	O	-1	15814210
children	O	-1	15814210
showed	O	-1	15814210
a	O	-1	15814210
higher	O	-1	15814210
rate	O	-1	15814210
of	O	-1	15814210
min@@	O	-1	15814210
or	O	-1	15814210
neurolog@@	B-Disease	D009422	15814210
ical	I-Disease	-1	15814210
dysfunc@@	I-Disease	-1	15814210
tions	I-Disease	-1	15814210
.	O	-1	15814210
Ne@@	O	-1	15814210
uro@@	O	-1	15814210
log@@	O	-1	15814210
ical	O	-1	15814210
development	O	-1	15814210
was	O	-1	15814210
affected	O	-1	15814210
even	O	-1	15814210
without	O	-1	15814210
neurolog@@	O	-1	15814210
ical	O	-1	15814210
diagno@@	O	-1	15814210
sis.	O	-1	15814210
F@@	O	-1	15814210
urther	O	-1	15814210
long-term	O	-1	15814210
follow-up	O	-1	15814210
studies	O	-1	15814210
wil@@	O	-1	15814210
l	O	-1	15814210
be	O	-1	15814210
nec@@	O	-1	15814210
ess@@	O	-1	15814210
ary	O	-1	15814210
to	O	-1	15814210
ful@@	O	-1	15814210
ly	O	-1	15814210
evalu@@	O	-1	15814210
ate	O	-1	15814210
the	O	-1	15814210
im@@	O	-1	15814210
pac@@	O	-1	15814210
t	O	-1	15814210
of	O	-1	15814210
de@@	B-Chemical	D003907	15814210
xameth@@	I-Chemical	-1	15814210
as@@	I-Chemical	-1	15814210
one	I-Chemical	-1	15814210
on	O	-1	15814210
neurolog@@	O	-1	15814210
ical	O	-1	15814210
and	O	-1	15814210
cognitive	O	-1	15814210
develop@@	O	-1	15814210
ment.	O	-1	15814210

F@@	O	-1	11912119
or@@	O	-1	11912119
ce	O	-1	11912119
over@@	O	-1	11912119
flow	O	-1	11912119
and	O	-1	11912119
levo@@	B-Chemical	D007980	11912119
dopa	I-Chemical	-1	11912119
-induced	O	-1	11912119
dyskine@@	B-Disease	D004409	11912119
si@@	I-Disease	-1	11912119
as	I-Disease	-1	11912119
in	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
.	O	-1	11912119
We	O	-1	11912119
assessed	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
co@@	O	-1	11912119
or@@	O	-1	11912119
d@@	O	-1	11912119
in@@	O	-1	11912119
ation	O	-1	11912119
of	O	-1	11912119
the	O	-1	11912119
h@@	O	-1	11912119
and	O	-1	11912119
in	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
and	O	-1	11912119
its	O	-1	11912119
rel@@	O	-1	11912119
ationship	O	-1	11912119
to	O	-1	11912119
motor	O	-1	11912119
complications	O	-1	11912119
of	O	-1	11912119
levo@@	B-Chemical	D007980	11912119
dopa	I-Chemical	-1	11912119
therapy,	O	-1	11912119
partic@@	O	-1	11912119
ul@@	O	-1	11912119
arly	O	-1	11912119
to	O	-1	11912119
levo@@	B-Chemical	D007980	11912119
dopa	I-Chemical	-1	11912119
-induced	O	-1	11912119
dyskine@@	B-Disease	D004409	11912119
si@@	I-Disease	-1	11912119
as	I-Disease	-1	11912119
(	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
).	O	-1	11912119
We	O	-1	11912119
studied	O	-1	11912119
two	O	-1	11912119
groups	O	-1	11912119
of	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
patients	O	-1	11912119
with	O	-1	11912119
(	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
+	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
,	O	-1	11912119
n	O	-1	11912119
=	O	-1	11912119
2@@	O	-1	11912119
3@@	O	-1	11912119
)	O	-1	11912119
and	O	-1	11912119
without	O	-1	11912119
levo@@	B-Chemical	D007980	11912119
dopa	I-Chemical	-1	11912119
-induced	O	-1	11912119
dyskine@@	B-Disease	D004409	11912119
si@@	I-Disease	-1	11912119
as	I-Disease	-1	11912119
(	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
-	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
,	O	-1	11912119
n	O	-1	11912119
=	O	-1	11912119
10@@	O	-1	11912119
),	O	-1	11912119
and	O	-1	11912119
ag@@	O	-1	11912119
e-@@	O	-1	11912119
mat@@	O	-1	11912119
ch@@	O	-1	11912119
ed	O	-1	11912119
healthy	O	-1	11912119
controls.	O	-1	11912119
The	O	-1	11912119
motor	O	-1	11912119
scor@@	O	-1	11912119
e	O	-1	11912119
of	O	-1	11912119
the	O	-1	11912119
U@@	O	-1	11912119
n@@	O	-1	11912119
if@@	O	-1	11912119
ied	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
Di@@	I-Disease	-1	11912119
se@@	I-Disease	-1	11912119
ase	I-Disease	-1	11912119
R@@	O	-1	11912119
ating	O	-1	11912119
S@@	O	-1	11912119
cal@@	O	-1	11912119
e,	O	-1	11912119
a	O	-1	11912119
dyskine@@	B-Disease	D004409	11912119
sia	I-Disease	-1	11912119
scor@@	O	-1	11912119
e	O	-1	11912119
and	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
in	O	-1	11912119
a	O	-1	11912119
g@@	O	-1	11912119
ri@@	O	-1	11912119
p@@	O	-1	11912119
-@@	O	-1	11912119
li@@	O	-1	11912119
ft	O	-1	11912119
par@@	O	-1	11912119
a@@	O	-1	11912119
di@@	O	-1	11912119
g@@	O	-1	11912119
m	O	-1	11912119
were	O	-1	11912119
assessed	O	-1	11912119
O@@	O	-1	11912119
N	O	-1	11912119
and	O	-1	11912119
O@@	O	-1	11912119
F@@	O	-1	11912119
F	O	-1	11912119
levo@@	B-Chemical	D007980	11912119
dopa	I-Chemical	-1	11912119
.	O	-1	11912119
A	O	-1	11912119
path@@	O	-1	11912119
ological	O	-1	11912119
increase	O	-1	11912119
of	O	-1	11912119
for@@	O	-1	11912119
ces	O	-1	11912119
was	O	-1	11912119
seen	O	-1	11912119
in	O	-1	11912119
ON@@	O	-1	11912119
-@@	O	-1	11912119
state	O	-1	11912119
in	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
+	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
on@@	O	-1	11912119
ly.	O	-1	11912119
In	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
+	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
,	O	-1	11912119
the	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
involved	O	-1	11912119
in	O	-1	11912119
press@@	O	-1	11912119
ing	O	-1	11912119
do@@	O	-1	11912119
w@@	O	-1	11912119
n	O	-1	11912119
the	O	-1	11912119
ob@@	O	-1	11912119
j@@	O	-1	11912119
ect	O	-1	11912119
before	O	-1	11912119
lif@@	O	-1	11912119
ting	O	-1	11912119
was	O	-1	11912119
significantly	O	-1	11912119
increased	O	-1	11912119
by	O	-1	11912119
levo@@	B-Chemical	D007980	11912119
dopa	I-Chemical	-1	11912119
(@@	O	-1	11912119
by	O	-1	11912119
6@@	O	-1	11912119
1@@	O	-1	11912119
%,	O	-1	11912119
P	O	-1	11912119
<	O	-1	11912119
0.05@@	O	-1	11912119
).	O	-1	11912119
An	O	-1	11912119
over@@	O	-1	11912119
sho@@	O	-1	11912119
ot@@	O	-1	11912119
ing	O	-1	11912119
of	O	-1	11912119
pe@@	O	-1	11912119
a@@	O	-1	11912119
k	O	-1	11912119
g@@	O	-1	11912119
ri@@	O	-1	11912119
p	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
by	O	-1	11912119
5@@	O	-1	11912119
1@@	O	-1	11912119
%	O	-1	11912119
(P	O	-1	11912119
<	O	-1	11912119
0.05@@	O	-1	11912119
)	O	-1	11912119
and	O	-1	11912119
of	O	-1	11912119
st@@	O	-1	11912119
atic	O	-1	11912119
g@@	O	-1	11912119
ri@@	O	-1	11912119
p	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
by	O	-1	11912119
4@@	O	-1	11912119
5%	O	-1	11912119
(P	O	-1	11912119
<	O	-1	11912119
0.0@@	O	-1	11912119
1)	O	-1	11912119
was	O	-1	11912119
observed	O	-1	11912119
in	O	-1	11912119
the	O	-1	11912119
ON@@	O	-1	11912119
-	O	-1	11912119
compared	O	-1	11912119
with	O	-1	11912119
the	O	-1	11912119
O@@	O	-1	11912119
F@@	O	-1	11912119
F@@	O	-1	11912119
-@@	O	-1	11912119
drug	O	-1	11912119
condi@@	O	-1	11912119
tion.	O	-1	11912119
In	O	-1	11912119
contrast@@	O	-1	11912119
,	O	-1	11912119
no	O	-1	11912119
ex@@	O	-1	11912119
ces@@	O	-1	11912119
sive	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
was	O	-1	11912119
found	O	-1	11912119
in	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
-	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
.	O	-1	11912119
P@@	O	-1	11912119
e@@	O	-1	11912119
a@@	O	-1	11912119
k	O	-1	11912119
g@@	O	-1	11912119
ri@@	O	-1	11912119
p	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
in	O	-1	11912119
ON@@	O	-1	11912119
-@@	O	-1	11912119
state	O	-1	11912119
was	O	-1	11912119
14@@	O	-1	11912119
0%	O	-1	11912119
(P	O	-1	11912119
<	O	-1	11912119
0.05@@	O	-1	11912119
)	O	-1	11912119
higher	O	-1	11912119
in	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
+	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
than	O	-1	11912119
in	O	-1	11912119
Parkinson's	B-Disease	D010300	11912119
disease	I-Disease	-1	11912119
-	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
,	O	-1	11912119
while	O	-1	11912119
st@@	O	-1	11912119
atic	O	-1	11912119
g@@	O	-1	11912119
ri@@	O	-1	11912119
p	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
was	O	-1	11912119
increased	O	-1	11912119
by	O	-1	11912119
13@@	O	-1	11912119
8@@	O	-1	11912119
%	O	-1	11912119
(P	O	-1	11912119
<	O	-1	11912119
0.0@@	O	-1	11912119
1)	O	-1	11912119
between	O	-1	11912119
groups.	O	-1	11912119
S@@	O	-1	11912119
e@@	O	-1	11912119
ver@@	O	-1	11912119
ity	O	-1	11912119
of	O	-1	11912119
pe@@	O	-1	11912119
ak@@	O	-1	11912119
-@@	O	-1	11912119
dose	O	-1	11912119
dyskine@@	B-Disease	D004409	11912119
si@@	I-Disease	-1	11912119
as	I-Disease	-1	11912119
was	O	-1	11912119
st@@	O	-1	11912119
ron@@	O	-1	11912119
g@@	O	-1	11912119
ly	O	-1	11912119
cor@@	O	-1	11912119
related	O	-1	11912119
with	O	-1	11912119
g@@	O	-1	11912119
ri@@	O	-1	11912119
p	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
in	O	-1	11912119
ON@@	O	-1	11912119
-@@	O	-1	11912119
state	O	-1	11912119
(@@	O	-1	11912119
r	O	-1	11912119
=	O	-1	11912119
0.@@	O	-1	11912119
7@@	O	-1	11912119
9	O	-1	11912119
with	O	-1	11912119
pe@@	O	-1	11912119
a@@	O	-1	11912119
k	O	-1	11912119
for@@	O	-1	11912119
ce@@	O	-1	11912119
,	O	-1	11912119
P	O	-1	11912119
<	O	-1	11912119
0.0@@	O	-1	11912119
1).	O	-1	11912119
No	O	-1	11912119
correl@@	O	-1	11912119
ation	O	-1	11912119
was	O	-1	11912119
observed	O	-1	11912119
between	O	-1	11912119
for@@	O	-1	11912119
ces	O	-1	11912119
and	O	-1	11912119
the	O	-1	11912119
motor	O	-1	11912119
scor@@	O	-1	11912119
e	O	-1	11912119
as	O	-1	11912119
well	O	-1	11912119
as	O	-1	11912119
with	O	-1	11912119
the	O	-1	11912119
daily	O	-1	11912119
dose	O	-1	11912119
of	O	-1	11912119
dop@@	O	-1	11912119
aminergic	O	-1	11912119
medic@@	O	-1	11912119
ation.	O	-1	11912119
F@@	O	-1	11912119
or@@	O	-1	11912119
ce	O	-1	11912119
ex@@	O	-1	11912119
cess	O	-1	11912119
was	O	-1	11912119
only	O	-1	11912119
observed	O	-1	11912119
in	O	-1	11912119
patients	O	-1	11912119
with	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
and	O	-1	11912119
motor	O	-1	11912119
f@@	O	-1	11912119
l@@	O	-1	11912119
uc@@	O	-1	11912119
tu@@	O	-1	11912119
ations.	O	-1	11912119
A	O	-1	11912119
clo@@	O	-1	11912119
se	O	-1	11912119
rel@@	O	-1	11912119
ationship	O	-1	11912119
was	O	-1	11912119
seen	O	-1	11912119
between	O	-1	11912119
the	O	-1	11912119
over@@	O	-1	11912119
sho@@	O	-1	11912119
ot@@	O	-1	11912119
ing	O	-1	11912119
of	O	-1	11912119
for@@	O	-1	11912119
ces	O	-1	11912119
and	O	-1	11912119
dyskine@@	B-Disease	D004409	11912119
si@@	I-Disease	-1	11912119
as	I-Disease	-1	11912119
in	O	-1	11912119
the	O	-1	11912119
ON@@	O	-1	11912119
-@@	O	-1	11912119
drug	O	-1	11912119
condi@@	O	-1	11912119
tion.	O	-1	11912119
We	O	-1	11912119
post@@	O	-1	11912119
ul@@	O	-1	11912119
ate	O	-1	11912119
that	O	-1	11912119
both	O	-1	11912119
L@@	B-Disease	D004409	11912119
I@@	I-Disease	-1	11912119
D	I-Disease	-1	11912119
and	O	-1	11912119
g@@	O	-1	11912119
ri@@	O	-1	11912119
p	O	-1	11912119
for@@	O	-1	11912119
ce	O	-1	11912119
ex@@	O	-1	11912119
cess	O	-1	11912119
sh@@	O	-1	11912119
are	O	-1	11912119
common	O	-1	11912119
path@@	O	-1	11912119
oph@@	O	-1	11912119
ysi@@	O	-1	11912119
ological	O	-1	11912119
mechanisms	O	-1	11912119
related	O	-1	11912119
to	O	-1	11912119
motor	O	-1	11912119
f@@	O	-1	11912119
l@@	O	-1	11912119
uc@@	O	-1	11912119
tu@@	O	-1	11912119
ations.	O	-1	11912119

P@@	O	-1	9105126
ost@@	O	-1	9105126
infarction	O	-1	9105126
ventricular	B-Disease	D018658	9105126
se@@	I-Disease	-1	9105126
pt@@	I-Disease	-1	9105126
al	I-Disease	-1	9105126
def@@	I-Disease	-1	9105126
ect	I-Disease	-1	9105126
associated	O	-1	9105126
with	O	-1	9105126
long-term	O	-1	9105126
ster@@	B-Chemical	D013256	9105126
oid	I-Chemical	-1	9105126
therapy.	O	-1	9105126
Two	O	-1	9105126
cases	O	-1	9105126
of	O	-1	9105126
post@@	O	-1	9105126
infarction	O	-1	9105126
ventricular	B-Disease	D018658	9105126
se@@	I-Disease	-1	9105126
pt@@	I-Disease	-1	9105126
al	I-Disease	-1	9105126
ru@@	I-Disease	-1	9105126
pt@@	I-Disease	-1	9105126
ure	I-Disease	-1	9105126
in	O	-1	9105126
patients	O	-1	9105126
on	O	-1	9105126
long-term	O	-1	9105126
ster@@	B-Chemical	D013256	9105126
oid	I-Chemical	-1	9105126
therapy	O	-1	9105126
are	O	-1	9105126
presented	O	-1	9105126
and	O	-1	9105126
the	O	-1	9105126
f@@	O	-1	9105126
av@@	O	-1	9105126
o@@	O	-1	9105126
ur@@	O	-1	9105126
able	O	-1	9105126
outcom@@	O	-1	9105126
e	O	-1	9105126
in	O	-1	9105126
both	O	-1	9105126
cases	O	-1	9105126
descri@@	O	-1	9105126
be@@	O	-1	9105126
d.	O	-1	9105126
A	O	-1	9105126
possible	O	-1	9105126
association	O	-1	9105126
between	O	-1	9105126
ster@@	B-Chemical	D013256	9105126
oid	I-Chemical	-1	9105126
therapy	O	-1	9105126
and	O	-1	9105126
subsequ@@	O	-1	9105126
ent	O	-1	9105126
post@@	O	-1	9105126
infarction	O	-1	9105126
se@@	B-Disease	D018658	9105126
pt@@	I-Disease	-1	9105126
al	I-Disease	-1	9105126
ru@@	I-Disease	-1	9105126
pt@@	I-Disease	-1	9105126
ure	I-Disease	-1	9105126
is	O	-1	9105126
discus@@	O	-1	9105126
sed.	O	-1	9105126

An@@	B-Disease	D000799	8599504
g@@	I-Disease	-1	8599504
io@@	I-Disease	-1	8599504
e@@	I-Disease	-1	8599504
de@@	I-Disease	-1	8599504
ma	I-Disease	-1	8599504
associated	O	-1	8599504
with	O	-1	8599504
dro@@	B-Chemical	D004329	8599504
perid@@	I-Chemical	-1	8599504
ol	I-Chemical	-1	8599504
administr@@	O	-1	8599504
ation.	O	-1	8599504
An@@	B-Disease	D000799	8599504
g@@	I-Disease	-1	8599504
io@@	I-Disease	-1	8599504
e@@	I-Disease	-1	8599504
de@@	I-Disease	-1	8599504
ma	I-Disease	-1	8599504
,	O	-1	8599504
also	O	-1	8599504
known	O	-1	8599504
as	O	-1	8599504
angi@@	B-Disease	D000799	8599504
one@@	I-Disease	-1	8599504
uro@@	I-Disease	-1	8599504
tic	I-Disease	-1	8599504
e@@	I-Disease	-1	8599504
de@@	I-Disease	-1	8599504
ma	I-Disease	-1	8599504
or	O	-1	8599504
Q@@	B-Disease	D000799	8599504
u@@	I-Disease	-1	8599504
inc@@	I-Disease	-1	8599504
ke@@	I-Disease	-1	8599504
's	I-Disease	-1	8599504
disease	I-Disease	-1	8599504
,	O	-1	8599504
is	O	-1	8599504
a	O	-1	8599504
we@@	O	-1	8599504
ll@@	O	-1	8599504
-@@	O	-1	8599504
de@@	O	-1	8599504
m@@	O	-1	8599504
arc@@	O	-1	8599504
at@@	O	-1	8599504
ed,	O	-1	8599504
lo@@	O	-1	8599504
cal@@	O	-1	8599504
ized	O	-1	8599504
e@@	B-Disease	D004487	8599504
de@@	I-Disease	-1	8599504
ma	I-Disease	-1	8599504
invol@@	O	-1	8599504
ving	O	-1	8599504
the	O	-1	8599504
sub@@	O	-1	8599504
c@@	O	-1	8599504
utaneous	O	-1	8599504
tissu@@	O	-1	8599504
es	O	-1	8599504
that	O	-1	8599504
may	O	-1	8599504
cause	O	-1	8599504
up@@	B-Disease	D000402	8599504
per@@	I-Disease	-1	8599504
-@@	I-Disease	-1	8599504
a@@	I-Disease	-1	8599504
ir@@	I-Disease	-1	8599504
w@@	I-Disease	-1	8599504
ay	I-Disease	-1	8599504
ob@@	I-Disease	-1	8599504
struc@@	I-Disease	-1	8599504
tion	I-Disease	-1	8599504
.	O	-1	8599504
We	O	-1	8599504
report	O	-1	8599504
the	O	-1	8599504
case	O	-1	8599504
of	O	-1	8599504
a	O	-1	8599504
previously	O	-1	8599504
healthy	O	-1	8599504
19@@	O	-1	8599504
-@@	O	-1	8599504
year-old	O	-1	8599504
man	O	-1	8599504
with	O	-1	8599504
no	O	-1	8599504
known	O	-1	8599504
drug	B-Disease	D004342	8599504
all@@	I-Disease	-1	8599504
er@@	I-Disease	-1	8599504
gi@@	I-Disease	-1	8599504
es	I-Disease	-1	8599504
in	O	-1	8599504
whom	O	-1	8599504
angio@@	B-Disease	D000799	8599504
e@@	I-Disease	-1	8599504
de@@	I-Disease	-1	8599504
ma	I-Disease	-1	8599504
with	O	-1	8599504
significant	O	-1	8599504
t@@	B-Disease	D014060	8599504
on@@	I-Disease	-1	8599504
gu@@	I-Disease	-1	8599504
e	I-Disease	-1	8599504
s@@	I-Disease	-1	8599504
we@@	I-Disease	-1	8599504
ll@@	I-Disease	-1	8599504
ing	I-Disease	-1	8599504
t@@	B-Disease	D004487	8599504
on@@	I-Disease	-1	8599504
gu@@	I-Disease	-1	8599504
e	I-Disease	-1	8599504
s@@	I-Disease	-1	8599504
we@@	I-Disease	-1	8599504
ll@@	I-Disease	-1	8599504
ing	I-Disease	-1	8599504
and	O	-1	8599504
prot@@	O	-1	8599504
ru@@	O	-1	8599504
sion	O	-1	8599504
developed	O	-1	8599504
within	O	-1	8599504
10	O	-1	8599504
minutes	O	-1	8599504
of	O	-1	8599504
the	O	-1	8599504
administration	O	-1	8599504
of	O	-1	8599504
a	O	-1	8599504
single	O	-1	8599504
IV	O	-1	8599504
dose	O	-1	8599504
of	O	-1	8599504
dro@@	B-Chemical	D004329	8599504
perid@@	I-Chemical	-1	8599504
ol	I-Chemical	-1	8599504
.	O	-1	8599504

Cl@@	B-Chemical	D017291	8546130
ari@@	I-Chemical	-1	8546130
throm@@	I-Chemical	-1	8546130
ycin	I-Chemical	-1	8546130
-@@	O	-1	8546130
associated	O	-1	8546130
visual	B-Disease	D006212	8546130
h@@	I-Disease	-1	8546130
all@@	I-Disease	-1	8546130
uc@@	I-Disease	-1	8546130
in@@	I-Disease	-1	8546130
ations	I-Disease	-1	8546130
in	O	-1	8546130
a	O	-1	8546130
patient	O	-1	8546130
with	O	-1	8546130
chronic	B-Disease	D007676	8546130
renal	I-Disease	-1	8546130
failure	I-Disease	-1	8546130
on	O	-1	8546130
continu@@	O	-1	8546130
ous	O	-1	8546130
am@@	O	-1	8546130
b@@	O	-1	8546130
ul@@	O	-1	8546130
atory	O	-1	8546130
per@@	O	-1	8546130
it@@	O	-1	8546130
one@@	O	-1	8546130
al	O	-1	8546130
dialy@@	O	-1	8546130
sis.	O	-1	8546130
V@@	B-Disease	D006212	8546130
i@@	I-Disease	-1	8546130
sual	I-Disease	-1	8546130
h@@	I-Disease	-1	8546130
all@@	I-Disease	-1	8546130
uc@@	I-Disease	-1	8546130
in@@	I-Disease	-1	8546130
ations	I-Disease	-1	8546130
are	O	-1	8546130
a	O	-1	8546130
r@@	O	-1	8546130
are	O	-1	8546130
ev@@	O	-1	8546130
ent	O	-1	8546130
in	O	-1	8546130
chronic	B-Disease	D007676	8546130
renal	I-Disease	-1	8546130
failure	I-Disease	-1	8546130
and	O	-1	8546130
not	O	-1	8546130
related	O	-1	8546130
to	O	-1	8546130
ure@@	B-Disease	D014511	8546130
mia	I-Disease	-1	8546130
per	O	-1	8546130
se.	O	-1	8546130
U@@	O	-1	8546130
n@@	O	-1	8546130
reported	O	-1	8546130
in	O	-1	8546130
the	O	-1	8546130
literat@@	O	-1	8546130
ure	O	-1	8546130
is	O	-1	8546130
visual	B-Disease	D006212	8546130
h@@	I-Disease	-1	8546130
all@@	I-Disease	-1	8546130
uc@@	I-Disease	-1	8546130
in@@	I-Disease	-1	8546130
ations	I-Disease	-1	8546130
occur@@	O	-1	8546130
r@@	O	-1	8546130
ing	O	-1	8546130
in	O	-1	8546130
association	O	-1	8546130
with	O	-1	8546130
the	O	-1	8546130
new	O	-1	8546130
mac@@	B-Chemical	D018942	8546130
ro@@	I-Chemical	-1	8546130
l@@	I-Chemical	-1	8546130
ide	I-Chemical	-1	8546130
anti@@	O	-1	8546130
bio@@	O	-1	8546130
tic@@	O	-1	8546130
,	O	-1	8546130
cl@@	B-Chemical	D017291	8546130
ari@@	I-Chemical	-1	8546130
throm@@	I-Chemical	-1	8546130
ycin	I-Chemical	-1	8546130
.	O	-1	8546130
We	O	-1	8546130
describe	O	-1	8546130
such	O	-1	8546130
a	O	-1	8546130
case	O	-1	8546130
in	O	-1	8546130
a	O	-1	8546130
patient	O	-1	8546130
with	O	-1	8546130
en@@	B-Disease	D007676	8546130
d-@@	I-Disease	-1	8546130
st@@	I-Disease	-1	8546130
age	I-Disease	-1	8546130
renal	I-Disease	-1	8546130
disease	I-Disease	-1	8546130
(	O	-1	8546130
ES@@	B-Disease	D007676	8546130
R@@	I-Disease	-1	8546130
D	I-Disease	-1	8546130
)	O	-1	8546130
maint@@	O	-1	8546130
ained	O	-1	8546130
on	O	-1	8546130
continu@@	O	-1	8546130
ous	O	-1	8546130
am@@	O	-1	8546130
b@@	O	-1	8546130
ul@@	O	-1	8546130
atory	O	-1	8546130
per@@	O	-1	8546130
it@@	O	-1	8546130
one@@	O	-1	8546130
al	O	-1	8546130
dialy@@	O	-1	8546130
sis	O	-1	8546130
(C@@	O	-1	8546130
A@@	O	-1	8546130
P@@	O	-1	8546130
D@@	O	-1	8546130
).	O	-1	8546130
The	O	-1	8546130
combination	O	-1	8546130
of	O	-1	8546130
a	O	-1	8546130
rel@@	O	-1	8546130
atively	O	-1	8546130
high	O	-1	8546130
dose	O	-1	8546130
of	O	-1	8546130
cl@@	B-Chemical	D017291	8546130
ari@@	I-Chemical	-1	8546130
throm@@	I-Chemical	-1	8546130
ycin	I-Chemical	-1	8546130
in	O	-1	8546130
fac@@	O	-1	8546130
e	O	-1	8546130
of	O	-1	8546130
chronic	B-Disease	D007676	8546130
renal	I-Disease	-1	8546130
failure	I-Disease	-1	8546130
in	O	-1	8546130
a	O	-1	8546130
func@@	O	-1	8546130
tion@@	O	-1	8546130
ally	O	-1	8546130
ane@@	O	-1	8546130
ph@@	O	-1	8546130
ric	O	-1	8546130
patient@@	O	-1	8546130
,	O	-1	8546130
with	O	-1	8546130
underlying	O	-1	8546130
alu@@	B-Chemical	D000535	8546130
min@@	I-Chemical	-1	8546130
um	I-Chemical	-1	8546130
in@@	O	-1	8546130
toxic@@	O	-1	8546130
ation,	O	-1	8546130
may	O	-1	8546130
have	O	-1	8546130
fac@@	O	-1	8546130
il@@	O	-1	8546130
it@@	O	-1	8546130
ated	O	-1	8546130
the	O	-1	8546130
appear@@	O	-1	8546130
ance	O	-1	8546130
of	O	-1	8546130
this	O	-1	8546130
neuro@@	B-Disease	D020258	8546130
toxic	I-Disease	-1	8546130
side	O	-1	8546130
effect@@	O	-1	8546130
.	O	-1	8546130
It	O	-1	8546130
is	O	-1	8546130
important	O	-1	8546130
to	O	-1	8546130
under@@	O	-1	8546130
st@@	O	-1	8546130
and	O	-1	8546130
the	O	-1	8546130
pharmac@@	O	-1	8546130
o@@	O	-1	8546130
kine@@	O	-1	8546130
tics	O	-1	8546130
of	O	-1	8546130
medic@@	O	-1	8546130
ations	O	-1	8546130
in	O	-1	8546130
fac@@	O	-1	8546130
e	O	-1	8546130
of	O	-1	8546130
chronic	B-Disease	D007676	8546130
renal	I-Disease	-1	8546130
failure	I-Disease	-1	8546130
,	O	-1	8546130
the	O	-1	8546130
possib@@	O	-1	8546130
ility	O	-1	8546130
of	O	-1	8546130
drug	O	-1	8546130
inter@@	O	-1	8546130
ac@@	O	-1	8546130
tion@@	O	-1	8546130
s,	O	-1	8546130
and	O	-1	8546130
ho@@	O	-1	8546130
w	O	-1	8546130
these	O	-1	8546130
factors	O	-1	8546130
should	O	-1	8546130
he@@	O	-1	8546130
l@@	O	-1	8546130
p	O	-1	8546130
gu@@	O	-1	8546130
ide	O	-1	8546130
medic@@	O	-1	8546130
ation	O	-1	8546130
therapy	O	-1	8546130
in	O	-1	8546130
the	O	-1	8546130
ES@@	B-Disease	D007676	8546130
R@@	I-Disease	-1	8546130
D	I-Disease	-1	8546130
patient@@	O	-1	8546130
.	O	-1	8546130

Ac@@	O	-1	7724492
ute	O	-1	7724492
renal	B-Disease	D007674	7724492
toxicity	I-Disease	-1	7724492
of	O	-1	7724492
dox@@	B-Chemical	D004317	7724492
orub@@	I-Chemical	-1	7724492
icin	I-Chemical	-1	7724492
(	O	-1	7724492
adriam@@	B-Chemical	D004317	7724492
ycin	I-Chemical	-1	7724492
)-@@	O	-1	7724492
lo@@	O	-1	7724492
ad@@	O	-1	7724492
ed	O	-1	7724492
cy@@	B-Chemical	D003487	7724492
an@@	I-Chemical	-1	7724492
o@@	I-Chemical	-1	7724492
ac@@	I-Chemical	-1	7724492
r@@	I-Chemical	-1	7724492
yl@@	I-Chemical	-1	7724492
ate	I-Chemical	-1	7724492
n@@	O	-1	7724492
an@@	O	-1	7724492
o@@	O	-1	7724492
par@@	O	-1	7724492
ti@@	O	-1	7724492
cl@@	O	-1	7724492
es.	O	-1	7724492
Ac@@	O	-1	7724492
ute	O	-1	7724492
dox@@	B-Chemical	D004317	7724492
orub@@	I-Chemical	-1	7724492
icin	I-Chemical	-1	7724492
-@@	O	-1	7724492
lo@@	O	-1	7724492
ad@@	O	-1	7724492
ed	O	-1	7724492
n@@	O	-1	7724492
an@@	O	-1	7724492
o@@	O	-1	7724492
partic@@	O	-1	7724492
le	O	-1	7724492
(D@@	O	-1	7724492
X@@	O	-1	7724492
N@@	O	-1	7724492
P)	O	-1	7724492
renal	B-Disease	D007674	7724492
toxicity	I-Disease	-1	7724492
was	O	-1	7724492
ex@@	O	-1	7724492
p@@	O	-1	7724492
lo@@	O	-1	7724492
red	O	-1	7724492
in	O	-1	7724492
both	O	-1	7724492
normal	O	-1	7724492
rats	O	-1	7724492
and	O	-1	7724492
rats	O	-1	7724492
with	O	-1	7724492
experimental	O	-1	7724492
glomerul@@	B-Disease	D005921	7724492
one@@	I-Disease	-1	7724492
ph@@	I-Disease	-1	7724492
ritis	I-Disease	-1	7724492
.	O	-1	7724492
In	O	-1	7724492
normal	O	-1	7724492
rats,	O	-1	7724492
2@@	O	-1	7724492
/@@	O	-1	7724492
6	O	-1	7724492
rats	O	-1	7724492
given	O	-1	7724492
free	O	-1	7724492
dox@@	B-Chemical	D004317	7724492
orub@@	I-Chemical	-1	7724492
icin	I-Chemical	-1	7724492
(	O	-1	7724492
D@@	B-Chemical	D004317	7724492
X	I-Chemical	-1	7724492
)	O	-1	7724492
(@@	O	-1	7724492
5	O	-1	7724492
mg/kg)	O	-1	7724492
di@@	O	-1	7724492
ed	O	-1	7724492
within	O	-1	7724492
one	O	-1	7724492
week@@	O	-1	7724492
,	O	-1	7724492
whereas	O	-1	7724492
all	O	-1	7724492
control	O	-1	7724492
animals	O	-1	7724492
and	O	-1	7724492
all	O	-1	7724492
rats	O	-1	7724492
ha@@	O	-1	7724492
ving	O	-1	7724492
received	O	-1	7724492
free	O	-1	7724492
N@@	O	-1	7724492
P	O	-1	7724492
or	O	-1	7724492
D@@	O	-1	7724492
X@@	O	-1	7724492
N@@	O	-1	7724492
P	O	-1	7724492
sur@@	O	-1	7724492
vi@@	O	-1	7724492
ved.	O	-1	7724492
A	O	-1	7724492
3	O	-1	7724492
times	O	-1	7724492
higher	O	-1	7724492
proteinuria	B-Disease	D011507	7724492
appe@@	O	-1	7724492
a@@	O	-1	7724492
red	O	-1	7724492
in	O	-1	7724492
animals	O	-1	7724492
treated	O	-1	7724492
with	O	-1	7724492
D@@	O	-1	7724492
X@@	O	-1	7724492
N@@	O	-1	7724492
P	O	-1	7724492
than	O	-1	7724492
in	O	-1	7724492
those	O	-1	7724492
treated	O	-1	7724492
with	O	-1	7724492
D@@	B-Chemical	D004317	7724492
X	I-Chemical	-1	7724492
.	O	-1	7724492
F@@	O	-1	7724492
ree	O	-1	7724492
N@@	O	-1	7724492
P	O	-1	7724492
did	O	-1	7724492
not	O	-1	7724492
prov@@	O	-1	7724492
o@@	O	-1	7724492
k@@	O	-1	7724492
e	O	-1	7724492
any	O	-1	7724492
proteinuria	B-Disease	D011507	7724492
.	O	-1	7724492
Two	O	-1	7724492
h@@	O	-1	7724492
r	O	-1	7724492
post@@	O	-1	7724492
-@@	O	-1	7724492
injec@@	O	-1	7724492
tion,	O	-1	7724492
D@@	O	-1	7724492
X@@	O	-1	7724492
N@@	O	-1	7724492
P	O	-1	7724492
was	O	-1	7724492
2.@@	O	-1	7724492
7	O	-1	7724492
times	O	-1	7724492
more	O	-1	7724492
concentr@@	O	-1	7724492
ated	O	-1	7724492
in	O	-1	7724492
kidne@@	O	-1	7724492
ys	O	-1	7724492
than	O	-1	7724492
free	O	-1	7724492
D@@	B-Chemical	D004317	7724492
X	I-Chemical	-1	7724492
(p	O	-1	7724492
<	O	-1	7724492
0.0@@	O	-1	7724492
25@@	O	-1	7724492
).	O	-1	7724492
In	O	-1	7724492
rats	O	-1	7724492
with	O	-1	7724492
immun@@	O	-1	7724492
e	O	-1	7724492
experimental	O	-1	7724492
glomerul@@	B-Disease	D005921	7724492
one@@	I-Disease	-1	7724492
ph@@	I-Disease	-1	7724492
ritis	I-Disease	-1	7724492
,	O	-1	7724492
5@@	O	-1	7724492
/@@	O	-1	7724492
6	O	-1	7724492
rats	O	-1	7724492
given	O	-1	7724492
D@@	B-Chemical	D004317	7724492
X	I-Chemical	-1	7724492
di@@	O	-1	7724492
ed	O	-1	7724492
within	O	-1	7724492
7	O	-1	7724492
day@@	O	-1	7724492
s,	O	-1	7724492
in	O	-1	7724492
contr@@	O	-1	7724492
ast	O	-1	7724492
to	O	-1	7724492
animals	O	-1	7724492
treated	O	-1	7724492
by	O	-1	7724492
D@@	O	-1	7724492
X@@	O	-1	7724492
N@@	O	-1	7724492
P@@	O	-1	7724492
,	O	-1	7724492
N@@	O	-1	7724492
P@@	O	-1	7724492
,	O	-1	7724492
or	O	-1	7724492
un@@	O	-1	7724492
treat@@	O	-1	7724492
ed,	O	-1	7724492
which	O	-1	7724492
all	O	-1	7724492
sur@@	O	-1	7724492
vi@@	O	-1	7724492
ved.	O	-1	7724492
Pro@@	B-Disease	D011507	7724492
te@@	I-Disease	-1	7724492
in@@	I-Disease	-1	7724492
uria	I-Disease	-1	7724492
appe@@	O	-1	7724492
a@@	O	-1	7724492
red	O	-1	7724492
in	O	-1	7724492
all	O	-1	7724492
seri@@	O	-1	7724492
es,	O	-1	7724492
but	O	-1	7724492
was	O	-1	7724492
2-@@	O	-1	7724492
5	O	-1	7724492
times	O	-1	7724492
more	O	-1	7724492
int@@	O	-1	7724492
en@@	O	-1	7724492
se	O	-1	7724492
(p	O	-1	7724492
>	O	-1	7724492
0.00@@	O	-1	7724492
1)	O	-1	7724492
and	O	-1	7724492
prolonged	O	-1	7724492
after	O	-1	7724492
dox@@	B-Chemical	D004317	7724492
orub@@	I-Chemical	-1	7724492
icin	I-Chemical	-1	7724492
treatment	O	-1	7724492
(4@@	O	-1	7724492
0@@	O	-1	7724492
0-@@	O	-1	7724492
7@@	O	-1	7724492
00	O	-1	7724492
mg/@@	O	-1	7724492
day@@	O	-1	7724492
),	O	-1	7724492
without	O	-1	7724492
significant	O	-1	7724492
difference	O	-1	7724492
between	O	-1	7724492
D@@	O	-1	7724492
X@@	O	-1	7724492
N@@	O	-1	7724492
P	O	-1	7724492
and	O	-1	7724492
D@@	B-Chemical	D004317	7724492
X	I-Chemical	-1	7724492
.	O	-1	7724492
R@@	O	-1	7724492
at@@	O	-1	7724492
s	O	-1	7724492
treated	O	-1	7724492
by	O	-1	7724492
un@@	O	-1	7724492
lo@@	O	-1	7724492
ad@@	O	-1	7724492
ed	O	-1	7724492
N@@	O	-1	7724492
P	O	-1	7724492
be@@	O	-1	7724492
ha@@	O	-1	7724492
ved	O	-1	7724492
as	O	-1	7724492
controls.	O	-1	7724492
These	O	-1	7724492
results	O	-1	7724492
demon@@	O	-1	7724492
st@@	O	-1	7724492
rate	O	-1	7724492
th@@	O	-1	7724492
at@@	O	-1	7724492
,	O	-1	7724492
in	O	-1	7724492
these	O	-1	7724492
experimental	O	-1	7724492
condi@@	O	-1	7724492
tion@@	O	-1	7724492
s,	O	-1	7724492
D@@	O	-1	7724492
X@@	O	-1	7724492
N@@	O	-1	7724492
P	O	-1	7724492
k@@	O	-1	7724492
ill@@	O	-1	7724492
ed	O	-1	7724492
less	O	-1	7724492
animals	O	-1	7724492
than	O	-1	7724492
free	O	-1	7724492
D@@	B-Chemical	D004317	7724492
X	I-Chemical	-1	7724492
,	O	-1	7724492
des@@	O	-1	7724492
pit@@	O	-1	7724492
e	O	-1	7724492
of	O	-1	7724492
an	O	-1	7724492
enhanced	O	-1	7724492
renal	B-Disease	D007674	7724492
toxicity	I-Disease	-1	7724492
of	O	-1	7724492
the	O	-1	7724492
form@@	O	-1	7724492
er.	O	-1	7724492
B@@	O	-1	7724492
oth	O	-1	7724492
effects	O	-1	7724492
(@@	O	-1	7724492
bet@@	O	-1	7724492
ter	O	-1	7724492
sur@@	O	-1	7724492
viv@@	O	-1	7724492
al	O	-1	7724492
and	O	-1	7724492
nephro@@	B-Disease	D009401	7724492
sis	I-Disease	-1	7724492
)	O	-1	7724492
are	O	-1	7724492
most	O	-1	7724492
prob@@	O	-1	7724492
ably	O	-1	7724492
related	O	-1	7724492
to	O	-1	7724492
an	O	-1	7724492
enhanced	O	-1	7724492
cap@@	O	-1	7724492
t@@	O	-1	7724492
ure	O	-1	7724492
of	O	-1	7724492
D@@	O	-1	7724492
X@@	O	-1	7724492
N@@	O	-1	7724492
P	O	-1	7724492
by	O	-1	7724492
cells	O	-1	7724492
of	O	-1	7724492
the	O	-1	7724492
mon@@	O	-1	7724492
on@@	O	-1	7724492
ucle@@	O	-1	7724492
ar	O	-1	7724492
ph@@	O	-1	7724492
ag@@	O	-1	7724492
ocyte	O	-1	7724492
system@@	O	-1	7724492
,	O	-1	7724492
including	O	-1	7724492
m@@	O	-1	7724492
es@@	O	-1	7724492
ang@@	O	-1	7724492
ial	O	-1	7724492
cell@@	O	-1	7724492
s.	O	-1	7724492

E@@	B-Chemical	D005047	7619765
to@@	I-Chemical	-1	7619765
po@@	I-Chemical	-1	7619765
side	I-Chemical	-1	7619765
-@@	O	-1	7619765
related	O	-1	7619765
myocardial	B-Disease	D009203	7619765
infarction	I-Disease	-1	7619765
.	O	-1	7619765
The	O	-1	7619765
occur@@	O	-1	7619765
rence	O	-1	7619765
of	O	-1	7619765
a	O	-1	7619765
myocardial	B-Disease	D009203	7619765
infarction	I-Disease	-1	7619765
is	O	-1	7619765
reported	O	-1	7619765
after	O	-1	7619765
chemotherapy	O	-1	7619765
containing	O	-1	7619765
e@@	B-Chemical	D005047	7619765
to@@	I-Chemical	-1	7619765
po@@	I-Chemical	-1	7619765
side	I-Chemical	-1	7619765
,	O	-1	7619765
in	O	-1	7619765
a	O	-1	7619765
man	O	-1	7619765
with	O	-1	7619765
no	O	-1	7619765
risk	O	-1	7619765
factors	O	-1	7619765
for	O	-1	7619765
coronary	B-Disease	D003327	7619765
heart	I-Disease	-1	7619765
disease	I-Disease	-1	7619765
.	O	-1	7619765
P@@	O	-1	7619765
os@@	O	-1	7619765
sible	O	-1	7619765
ca@@	O	-1	7619765
us@@	O	-1	7619765
al	O	-1	7619765
mechanisms	O	-1	7619765
are	O	-1	7619765
discus@@	O	-1	7619765
sed.	O	-1	7619765

S@@	O	-1	7416947
ub@@	O	-1	7416947
j@@	O	-1	7416947
ective	O	-1	7416947
assess@@	O	-1	7416947
ment	O	-1	7416947
of	O	-1	7416947
sex@@	B-Disease	D020018	7416947
ual	I-Disease	-1	7416947
dysfunction	I-Disease	-1	7416947
of	O	-1	7416947
patients	O	-1	7416947
on	O	-1	7416947
long-term	O	-1	7416947
administration	O	-1	7416947
of	O	-1	7416947
di@@	B-Chemical	D004077	7416947
g@@	I-Chemical	-1	7416947
ox@@	I-Chemical	-1	7416947
in	I-Chemical	-1	7416947
.	O	-1	7416947
V@@	O	-1	7416947
ari@@	O	-1	7416947
ous	O	-1	7416947
data	O	-1	7416947
suggest	O	-1	7416947
that	O	-1	7416947
male	O	-1	7416947
patients	O	-1	7416947
who	O	-1	7416947
have	O	-1	7416947
received	O	-1	7416947
di@@	B-Chemical	D004077	7416947
g@@	I-Chemical	-1	7416947
ox@@	I-Chemical	-1	7416947
in	I-Chemical	-1	7416947
on	O	-1	7416947
a	O	-1	7416947
long@@	O	-1	7416947
term	O	-1	7416947
b@@	O	-1	7416947
asis	O	-1	7416947
have	O	-1	7416947
increased	O	-1	7416947
levels	O	-1	7416947
of	O	-1	7416947
serum	O	-1	7416947
est@@	B-Chemical	D004967	7416947
ro@@	I-Chemical	-1	7416947
gen	I-Chemical	-1	7416947
and	O	-1	7416947
decreased	O	-1	7416947
levels	O	-1	7416947
of	O	-1	7416947
plasma	O	-1	7416947
test@@	B-Chemical	D013739	7416947
osterone	I-Chemical	-1	7416947
and	O	-1	7416947
lu@@	O	-1	7416947
te@@	O	-1	7416947
in@@	O	-1	7416947
iz@@	O	-1	7416947
ing	O	-1	7416947
h@@	O	-1	7416947
orm@@	O	-1	7416947
one	O	-1	7416947
(@@	O	-1	7416947
L@@	O	-1	7416947
H@@	O	-1	7416947
).	O	-1	7416947
This	O	-1	7416947
study	O	-1	7416947
was	O	-1	7416947
under@@	O	-1	7416947
tak@@	O	-1	7416947
en	O	-1	7416947
to	O	-1	7416947
investigate	O	-1	7416947
the	O	-1	7416947
lin@@	O	-1	7416947
k@@	O	-1	7416947
s	O	-1	7416947
between	O	-1	7416947
the	O	-1	7416947
long-term	O	-1	7416947
administration	O	-1	7416947
of	O	-1	7416947
di@@	B-Chemical	D004077	7416947
g@@	I-Chemical	-1	7416947
ox@@	I-Chemical	-1	7416947
in	I-Chemical	-1	7416947
therapy	O	-1	7416947
and	O	-1	7416947
sex@@	O	-1	7416947
ual	O	-1	7416947
behavi@@	O	-1	7416947
or@@	O	-1	7416947
,	O	-1	7416947
and	O	-1	7416947
the	O	-1	7416947
effect	O	-1	7416947
of	O	-1	7416947
di@@	B-Chemical	D004077	7416947
g@@	I-Chemical	-1	7416947
ox@@	I-Chemical	-1	7416947
in	I-Chemical	-1	7416947
on	O	-1	7416947
plasma	O	-1	7416947
levels	O	-1	7416947
of	O	-1	7416947
est@@	B-Chemical	D004958	7416947
radi@@	I-Chemical	-1	7416947
ol	I-Chemical	-1	7416947
,	O	-1	7416947
test@@	B-Chemical	D013739	7416947
osterone	I-Chemical	-1	7416947
,	O	-1	7416947
and	O	-1	7416947
L@@	O	-1	7416947
H@@	O	-1	7416947
.	O	-1	7416947
The	O	-1	7416947
patients	O	-1	7416947
of	O	-1	7416947
the	O	-1	7416947
study	O	-1	7416947
and	O	-1	7416947
control	O	-1	7416947
group	O	-1	7416947
(@@	O	-1	7416947
without	O	-1	7416947
di@@	B-Chemical	D004077	7416947
g@@	I-Chemical	-1	7416947
ox@@	I-Chemical	-1	7416947
in	I-Chemical	-1	7416947
)	O	-1	7416947
were	O	-1	7416947
of	O	-1	7416947
similar	O	-1	7416947
cardiac	O	-1	7416947
functional	O	-1	7416947
cap@@	O	-1	7416947
ac@@	O	-1	7416947
ity	O	-1	7416947
and	O	-1	7416947
age	O	-1	7416947
(2@@	O	-1	7416947
5-@@	O	-1	7416947
40	O	-1	7416947
year@@	O	-1	7416947
s)	O	-1	7416947
and	O	-1	7416947
were	O	-1	7416947
random@@	O	-1	7416947
ly	O	-1	7416947
sel@@	O	-1	7416947
ected	O	-1	7416947
from	O	-1	7416947
the	O	-1	7416947
r@@	B-Disease	D012214	7416947
he@@	I-Disease	-1	7416947
um@@	I-Disease	-1	7416947
atic	I-Disease	-1	7416947
heart	I-Disease	-1	7416947
disease	I-Disease	-1	7416947
patients.	O	-1	7416947
A	O	-1	7416947
subj@@	O	-1	7416947
ective	O	-1	7416947
assess@@	O	-1	7416947
ment	O	-1	7416947
of	O	-1	7416947
sex@@	O	-1	7416947
ual	O	-1	7416947
behavi@@	O	-1	7416947
or	O	-1	7416947
in	O	-1	7416947
the	O	-1	7416947
study	O	-1	7416947
and	O	-1	7416947
control	O	-1	7416947
groups	O	-1	7416947
was	O	-1	7416947
car@@	O	-1	7416947
ri@@	O	-1	7416947
ed	O	-1	7416947
out@@	O	-1	7416947
,	O	-1	7416947
using	O	-1	7416947
par@@	O	-1	7416947
ame@@	O	-1	7416947
ters	O	-1	7416947
such	O	-1	7416947
as	O	-1	7416947
sex@@	O	-1	7416947
ual	O	-1	7416947
desi@@	O	-1	7416947
re,	O	-1	7416947
sex@@	O	-1	7416947
ual	O	-1	7416947
ex@@	O	-1	7416947
cit@@	O	-1	7416947
em@@	O	-1	7416947
ent@@	O	-1	7416947
,	O	-1	7416947
and	O	-1	7416947
frequency	O	-1	7416947
of	O	-1	7416947
sex@@	O	-1	7416947
ual	O	-1	7416947
rel@@	O	-1	7416947
ations.	O	-1	7416947
P@@	O	-1	7416947
er@@	O	-1	7416947
son@@	O	-1	7416947
al	O	-1	7416947
inter@@	O	-1	7416947
vie@@	O	-1	7416947
w@@	O	-1	7416947
s	O	-1	7416947
and	O	-1	7416947
a	O	-1	7416947
qu@@	O	-1	7416947
es@@	O	-1	7416947
tion@@	O	-1	7416947
na@@	O	-1	7416947
ir@@	O	-1	7416947
e	O	-1	7416947
were	O	-1	7416947
also	O	-1	7416947
used	O	-1	7416947
for	O	-1	7416947
the	O	-1	7416947
evalu@@	O	-1	7416947
ation	O	-1	7416947
of	O	-1	7416947
sex@@	O	-1	7416947
ual	O	-1	7416947
behavi@@	O	-1	7416947
or@@	O	-1	7416947
.	O	-1	7416947
The	O	-1	7416947
findings	O	-1	7416947
suppor@@	O	-1	7416947
t	O	-1	7416947
the	O	-1	7416947
reports	O	-1	7416947
con@@	O	-1	7416947
cer@@	O	-1	7416947
ning	O	-1	7416947
di@@	B-Chemical	D004077	7416947
g@@	I-Chemical	-1	7416947
ox@@	I-Chemical	-1	7416947
in	I-Chemical	-1	7416947
effect	O	-1	7416947
on	O	-1	7416947
plasma	O	-1	7416947
est@@	B-Chemical	D004958	7416947
radi@@	I-Chemical	-1	7416947
ol	I-Chemical	-1	7416947
,	O	-1	7416947
test@@	B-Chemical	D013739	7416947
osterone	I-Chemical	-1	7416947
,	O	-1	7416947
and	O	-1	7416947
L@@	O	-1	7416947
H@@	O	-1	7416947
.	O	-1	7416947
The	O	-1	7416947
differences	O	-1	7416947
in	O	-1	7416947
the	O	-1	7416947
me@@	O	-1	7416947
ans	O	-1	7416947
were	O	-1	7416947
significant@@	O	-1	7416947
.	O	-1	7416947
T@@	O	-1	7416947
est@@	O	-1	7416947
s	O	-1	7416947
used	O	-1	7416947
to	O	-1	7416947
evalu@@	O	-1	7416947
ate	O	-1	7416947
the	O	-1	7416947
changes	O	-1	7416947
in	O	-1	7416947
sex@@	O	-1	7416947
ual	O	-1	7416947
behavi@@	O	-1	7416947
or	O	-1	7416947
showed	O	-1	7416947
a	O	-1	7416947
significant	O	-1	7416947
decrease	B-Disease	D020018	7416947
in	I-Disease	-1	7416947
sex@@	I-Disease	-1	7416947
ual	I-Disease	-1	7416947
desi@@	I-Disease	-1	7416947
r@@	I-Disease	-1	7416947
e	I-Disease	-1	7416947
,	O	-1	7416947
sex@@	O	-1	7416947
ual	O	-1	7416947
ex@@	O	-1	7416947
cit@@	O	-1	7416947
ement	O	-1	7416947
phase	O	-1	7416947
(@@	O	-1	7416947
e@@	O	-1	7416947
rec@@	O	-1	7416947
tion@@	O	-1	7416947
),	O	-1	7416947
and	O	-1	7416947
frequency	O	-1	7416947
of	O	-1	7416947
sex@@	O	-1	7416947
ual	O	-1	7416947
rel@@	O	-1	7416947
ations	O	-1	7416947
in	O	-1	7416947
the	O	-1	7416947
study	O	-1	7416947
group.	O	-1	7416947

F@@	O	-1	7263204
atal	O	-1	7263204
ap@@	B-Disease	D000741	7263204
las@@	I-Disease	-1	7263204
tic	I-Disease	-1	7263204
anemia	I-Disease	-1	7263204
due	O	-1	7263204
to	O	-1	7263204
in@@	B-Chemical	D007213	7263204
do@@	I-Chemical	-1	7263204
meth@@	I-Chemical	-1	7263204
ac@@	I-Chemical	-1	7263204
in	I-Chemical	-1	7263204
-@@	O	-1	7263204
-@@	O	-1	7263204
lymph@@	O	-1	7263204
ocyte	O	-1	7263204
trans@@	O	-1	7263204
formation	O	-1	7263204
tests	O	-1	7263204
in	O	-1	7263204
vit@@	O	-1	7263204
ro@@	O	-1	7263204
.	O	-1	7263204
Although	O	-1	7263204
in@@	B-Chemical	D007213	7263204
do@@	I-Chemical	-1	7263204
meth@@	I-Chemical	-1	7263204
ac@@	I-Chemical	-1	7263204
in	I-Chemical	-1	7263204
has	O	-1	7263204
been	O	-1	7263204
implic@@	O	-1	7263204
ated	O	-1	7263204
as	O	-1	7263204
a	O	-1	7263204
possible	O	-1	7263204
cause	O	-1	7263204
of	O	-1	7263204
ap@@	B-Disease	D000741	7263204
las@@	I-Disease	-1	7263204
tic	I-Disease	-1	7263204
anemia	I-Disease	-1	7263204
on	O	-1	7263204
the	O	-1	7263204
b@@	O	-1	7263204
asis	O	-1	7263204
of	O	-1	7263204
a	O	-1	7263204
fe@@	O	-1	7263204
w	O	-1	7263204
clinical	O	-1	7263204
observ@@	O	-1	7263204
ation@@	O	-1	7263204
s,	O	-1	7263204
its	O	-1	7263204
role	O	-1	7263204
has	O	-1	7263204
not	O	-1	7263204
been	O	-1	7263204
def@@	O	-1	7263204
in@@	O	-1	7263204
it@@	O	-1	7263204
ely	O	-1	7263204
est@@	O	-1	7263204
abl@@	O	-1	7263204
is@@	O	-1	7263204
he@@	O	-1	7263204
d.	O	-1	7263204
A	O	-1	7263204
case	O	-1	7263204
of	O	-1	7263204
f@@	O	-1	7263204
atal	O	-1	7263204
ap@@	B-Disease	D000741	7263204
las@@	I-Disease	-1	7263204
tic	I-Disease	-1	7263204
anemia	I-Disease	-1	7263204
is	O	-1	7263204
descri@@	O	-1	7263204
bed	O	-1	7263204
in	O	-1	7263204
which	O	-1	7263204
no	O	-1	7263204
drugs	O	-1	7263204
other	O	-1	7263204
than	O	-1	7263204
al@@	B-Chemical	D000493	7263204
lop@@	I-Chemical	-1	7263204
ur@@	I-Chemical	-1	7263204
in@@	I-Chemical	-1	7263204
ol	I-Chemical	-1	7263204
and	O	-1	7263204
in@@	B-Chemical	D007213	7263204
do@@	I-Chemical	-1	7263204
meth@@	I-Chemical	-1	7263204
ac@@	I-Chemical	-1	7263204
in	I-Chemical	-1	7263204
were	O	-1	7263204
gi@@	O	-1	7263204
ven@@	O	-1	7263204
.	O	-1	7263204
In@@	B-Chemical	D007213	7263204
do@@	I-Chemical	-1	7263204
meth@@	I-Chemical	-1	7263204
ac@@	I-Chemical	-1	7263204
in	I-Chemical	-1	7263204
was	O	-1	7263204
first	O	-1	7263204
given	O	-1	7263204
four	O	-1	7263204
weeks	O	-1	7263204
prior	O	-1	7263204
to	O	-1	7263204
the	O	-1	7263204
onset	O	-1	7263204
of	O	-1	7263204
symptom@@	O	-1	7263204
s.	O	-1	7263204
A	O	-1	7263204
positive	O	-1	7263204
lymph@@	O	-1	7263204
ocyte	O	-1	7263204
trans@@	O	-1	7263204
formation	O	-1	7263204
test	O	-1	7263204
with	O	-1	7263204
in@@	B-Chemical	D007213	7263204
do@@	I-Chemical	-1	7263204
meth@@	I-Chemical	-1	7263204
ac@@	I-Chemical	-1	7263204
in	I-Chemical	-1	7263204
in	O	-1	7263204
vit@@	O	-1	7263204
r@@	O	-1	7263204
o	O	-1	7263204
further	O	-1	7263204
subst@@	O	-1	7263204
anti@@	O	-1	7263204
ates	O	-1	7263204
the	O	-1	7263204
potential	O	-1	7263204
role	O	-1	7263204
of	O	-1	7263204
this	O	-1	7263204
drug	O	-1	7263204
in	O	-1	7263204
ca@@	O	-1	7263204
using	O	-1	7263204
ap@@	B-Disease	D000741	7263204
las@@	I-Disease	-1	7263204
tic	I-Disease	-1	7263204
anemia	I-Disease	-1	7263204
in	O	-1	7263204
a	O	-1	7263204
sus@@	O	-1	7263204
cep@@	O	-1	7263204
ti@@	O	-1	7263204
ble	O	-1	7263204
patient@@	O	-1	7263204
.	O	-1	7263204
F@@	O	-1	7263204
ort@@	O	-1	7263204
un@@	O	-1	7263204
at@@	O	-1	7263204
el@@	O	-1	7263204
y,	O	-1	7263204
this	O	-1	7263204
se@@	O	-1	7263204
em@@	O	-1	7263204
s	O	-1	7263204
to	O	-1	7263204
be	O	-1	7263204
a	O	-1	7263204
very	O	-1	7263204
r@@	O	-1	7263204
are	O	-1	7263204
complic@@	O	-1	7263204
ation.	O	-1	7263204

P@@	O	-1	7066357
las@@	O	-1	7066357
ma	O	-1	7066357
and	O	-1	7066357
urinary	O	-1	7066357
li@@	O	-1	7066357
pid@@	O	-1	7066357
s	O	-1	7066357
and	O	-1	7066357
li@@	O	-1	7066357
po@@	O	-1	7066357
protein@@	O	-1	7066357
s	O	-1	7066357
during	O	-1	7066357
the	O	-1	7066357
development	O	-1	7066357
of	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
syndrome	I-Disease	-1	7066357
induced	O	-1	7066357
in	O	-1	7066357
the	O	-1	7066357
rat	O	-1	7066357
by	O	-1	7066357
p@@	B-Chemical	D011692	7066357
uro@@	I-Chemical	-1	7066357
m@@	I-Chemical	-1	7066357
ycin	I-Chemical	-1	7066357
amin@@	I-Chemical	-1	7066357
on@@	I-Chemical	-1	7066357
ucle@@	I-Chemical	-1	7066357
o@@	I-Chemical	-1	7066357
side	I-Chemical	-1	7066357
.	O	-1	7066357
This	O	-1	7066357
study	O	-1	7066357
was	O	-1	7066357
under@@	O	-1	7066357
tak@@	O	-1	7066357
en	O	-1	7066357
to	O	-1	7066357
as@@	O	-1	7066357
cer@@	O	-1	7066357
t@@	O	-1	7066357
ain	O	-1	7066357
whether	O	-1	7066357
the	O	-1	7066357
al@@	O	-1	7066357
ter@@	O	-1	7066357
ations	O	-1	7066357
of	O	-1	7066357
plasma	O	-1	7066357
li@@	O	-1	7066357
po@@	O	-1	7066357
protein@@	O	-1	7066357
s	O	-1	7066357
found	O	-1	7066357
in	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
syndrome	I-Disease	-1	7066357
induced	O	-1	7066357
by	O	-1	7066357
p@@	B-Chemical	D011692	7066357
uro@@	I-Chemical	-1	7066357
m@@	I-Chemical	-1	7066357
ycin	I-Chemical	-1	7066357
amin@@	I-Chemical	-1	7066357
on@@	I-Chemical	-1	7066357
ucle@@	I-Chemical	-1	7066357
o@@	I-Chemical	-1	7066357
side	I-Chemical	-1	7066357
were	O	-1	7066357
due	O	-1	7066357
to	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
syndrome	I-Disease	-1	7066357
per	O	-1	7066357
se@@	O	-1	7066357
,	O	-1	7066357
or@@	O	-1	7066357
,	O	-1	7066357
at	O	-1	7066357
le@@	O	-1	7066357
ast	O	-1	7066357
in	O	-1	7066357
part@@	O	-1	7066357
,	O	-1	7066357
to	O	-1	7066357
the	O	-1	7066357
amin@@	B-Chemical	D011692	7066357
on@@	I-Chemical	-1	7066357
ucle@@	I-Chemical	-1	7066357
o@@	I-Chemical	-1	7066357
side	I-Chemical	-1	7066357
.	O	-1	7066357
The	O	-1	7066357
pur@@	O	-1	7066357
p@@	O	-1	7066357
ose	O	-1	7066357
of	O	-1	7066357
the	O	-1	7066357
present	O	-1	7066357
study	O	-1	7066357
was	O	-1	7066357
to	O	-1	7066357
investigate	O	-1	7066357
the	O	-1	7066357
changes	O	-1	7066357
in	O	-1	7066357
plasma	O	-1	7066357
and	O	-1	7066357
urinary	O	-1	7066357
li@@	O	-1	7066357
po@@	O	-1	7066357
protein@@	O	-1	7066357
s	O	-1	7066357
during	O	-1	7066357
the	O	-1	7066357
administration	O	-1	7066357
of	O	-1	7066357
p@@	B-Chemical	D011692	7066357
uro@@	I-Chemical	-1	7066357
m@@	I-Chemical	-1	7066357
ycin	I-Chemical	-1	7066357
amin@@	I-Chemical	-1	7066357
on@@	I-Chemical	-1	7066357
ucle@@	I-Chemical	-1	7066357
o@@	I-Chemical	-1	7066357
side	I-Chemical	-1	7066357
(2@@	O	-1	7066357
0	O	-1	7066357
mg/kg	O	-1	7066357
for	O	-1	7066357
7	O	-1	7066357
da@@	O	-1	7066357
ys@@	O	-1	7066357
)	O	-1	7066357
and	O	-1	7066357
the	O	-1	7066357
subsequ@@	O	-1	7066357
ent	O	-1	7066357
development	O	-1	7066357
of	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
syndrome	I-Disease	-1	7066357
.	O	-1	7066357
S@@	O	-1	7066357
inc@@	O	-1	7066357
e	O	-1	7066357
mas@@	O	-1	7066357
sive	O	-1	7066357
al@@	B-Disease	D000419	7066357
bu@@	I-Disease	-1	7066357
min@@	I-Disease	-1	7066357
uria	I-Disease	-1	7066357
occurred	O	-1	7066357
after	O	-1	7066357
6	O	-1	7066357
days	O	-1	7066357
of	O	-1	7066357
treatment,	O	-1	7066357
the	O	-1	7066357
ti@@	O	-1	7066357
me@@	O	-1	7066357
-@@	O	-1	7066357
course	O	-1	7066357
study	O	-1	7066357
was	O	-1	7066357
divid@@	O	-1	7066357
ed	O	-1	7066357
into	O	-1	7066357
two	O	-1	7066357
st@@	O	-1	7066357
ag@@	O	-1	7066357
es@@	O	-1	7066357
:	O	-1	7066357
pre@@	O	-1	7066357
-	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
st@@	O	-1	7066357
age	O	-1	7066357
(@@	O	-1	7066357
day	O	-1	7066357
1-@@	O	-1	7066357
5@@	O	-1	7066357
)	O	-1	7066357
and	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
st@@	O	-1	7066357
age	O	-1	7066357
(@@	O	-1	7066357
day	O	-1	7066357
6@@	O	-1	7066357
-1@@	O	-1	7066357
1).	O	-1	7066357
In	O	-1	7066357
pre@@	O	-1	7066357
-	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
st@@	O	-1	7066357
age	O	-1	7066357
the	O	-1	7066357
plasma	O	-1	7066357
level	O	-1	7066357
of	O	-1	7066357
f@@	B-Chemical	D005227	7066357
at@@	I-Chemical	-1	7066357
t@@	I-Chemical	-1	7066357
y	I-Chemical	-1	7066357
acid@@	I-Chemical	-1	7066357
s	I-Chemical	-1	7066357
,	O	-1	7066357
tri@@	B-Chemical	D014280	7066357
ac@@	I-Chemical	-1	7066357
yl@@	I-Chemical	-1	7066357
glycer@@	I-Chemical	-1	7066357
ol	I-Chemical	-1	7066357
and	O	-1	7066357
V@@	O	-1	7066357
L@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
decreased	O	-1	7066357
while	O	-1	7066357
that	O	-1	7066357
of	O	-1	7066357
phosph@@	O	-1	7066357
ol@@	O	-1	7066357
ip@@	O	-1	7066357
id@@	O	-1	7066357
,	O	-1	7066357
cholest@@	B-Chemical	D002788	7066357
ery@@	I-Chemical	-1	7066357
l	I-Chemical	-1	7066357
est@@	I-Chemical	-1	7066357
ers	I-Chemical	-1	7066357
and	O	-1	7066357
H@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
remained	O	-1	7066357
con@@	O	-1	7066357
st@@	O	-1	7066357
ant@@	O	-1	7066357
.	O	-1	7066357
P@@	O	-1	7066357
las@@	O	-1	7066357
ma	O	-1	7066357
ap@@	O	-1	7066357
ol@@	O	-1	7066357
i@@	O	-1	7066357
po@@	O	-1	7066357
protein	O	-1	7066357
A@@	O	-1	7066357
-@@	O	-1	7066357
I	O	-1	7066357
ten@@	O	-1	7066357
ded	O	-1	7066357
to	O	-1	7066357
increase	O	-1	7066357
(4@@	O	-1	7066357
0%	O	-1	7066357
increase	O	-1	7066357
at	O	-1	7066357
day	O	-1	7066357
5@@	O	-1	7066357
).	O	-1	7066357
A@@	O	-1	7066357
t	O	-1	7066357
the	O	-1	7066357
be@@	O	-1	7066357
g@@	O	-1	7066357
in@@	O	-1	7066357
ning	O	-1	7066357
of	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
st@@	O	-1	7066357
age	O	-1	7066357
(@@	O	-1	7066357
day	O	-1	7066357
6@@	O	-1	7066357
)	O	-1	7066357
the	O	-1	7066357
concentration	O	-1	7066357
of	O	-1	7066357
plasma	O	-1	7066357
al@@	O	-1	7066357
b@@	O	-1	7066357
um@@	O	-1	7066357
in	O	-1	7066357
dro@@	O	-1	7066357
pp@@	O	-1	7066357
ed	O	-1	7066357
to	O	-1	7066357
a	O	-1	7066357
very	O	-1	7066357
low	O	-1	7066357
level@@	O	-1	7066357
,	O	-1	7066357
while	O	-1	7066357
that	O	-1	7066357
of	O	-1	7066357
ap@@	O	-1	7066357
ol@@	O	-1	7066357
i@@	O	-1	7066357
po@@	O	-1	7066357
protein	O	-1	7066357
A@@	O	-1	7066357
-@@	O	-1	7066357
I	O	-1	7066357
increased	O	-1	7066357
ab@@	O	-1	7066357
ru@@	O	-1	7066357
pt@@	O	-1	7066357
ly	O	-1	7066357
(@@	O	-1	7066357
4-@@	O	-1	7066357
fol@@	O	-1	7066357
d	O	-1	7066357
increas@@	O	-1	7066357
e@@	O	-1	7066357
)	O	-1	7066357
and	O	-1	7066357
continu@@	O	-1	7066357
ed	O	-1	7066357
to	O	-1	7066357
ri@@	O	-1	7066357
se@@	O	-1	7066357
,	O	-1	7066357
although	O	-1	7066357
less	O	-1	7066357
ste@@	O	-1	7066357
e@@	O	-1	7066357
pl@@	O	-1	7066357
y,	O	-1	7066357
in	O	-1	7066357
the	O	-1	7066357
following	O	-1	7066357
days.	O	-1	7066357
The	O	-1	7066357
plasma	O	-1	7066357
concentration	O	-1	7066357
of	O	-1	7066357
H@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
followed	O	-1	7066357
the	O	-1	7066357
same	O	-1	7066357
pat@@	O	-1	7066357
tern@@	O	-1	7066357
.	O	-1	7066357
P@@	O	-1	7066357
las@@	O	-1	7066357
ma	O	-1	7066357
V@@	O	-1	7066357
L@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
and	O	-1	7066357
L@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
increased	O	-1	7066357
at	O	-1	7066357
a	O	-1	7066357
lat@@	O	-1	7066357
er	O	-1	7066357
st@@	O	-1	7066357
age	O	-1	7066357
(@@	O	-1	7066357
day	O	-1	7066357
9@@	O	-1	7066357
).	O	-1	7066357
P@@	O	-1	7066357
las@@	O	-1	7066357
ma	O	-1	7066357
ap@@	O	-1	7066357
ol@@	O	-1	7066357
i@@	O	-1	7066357
po@@	O	-1	7066357
protein	O	-1	7066357
A@@	O	-1	7066357
-@@	O	-1	7066357
I	O	-1	7066357
was	O	-1	7066357
found	O	-1	7066357
not	O	-1	7066357
only	O	-1	7066357
in	O	-1	7066357
H@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
(1@@	O	-1	7066357
.@@	O	-1	7066357
0@@	O	-1	7066357
6@@	O	-1	7066357
3-@@	O	-1	7066357
1.@@	O	-1	7066357
2@@	O	-1	7066357
10	O	-1	7066357
g/@@	O	-1	7066357
ml@@	O	-1	7066357
)	O	-1	7066357
but	O	-1	7066357
also	O	-1	7066357
in	O	-1	7066357
the	O	-1	7066357
L@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
d@@	O	-1	7066357
ensity	O	-1	7066357
cl@@	O	-1	7066357
as@@	O	-1	7066357
s	O	-1	7066357
(1@@	O	-1	7066357
.@@	O	-1	7066357
0@@	O	-1	7066357
2@@	O	-1	7066357
5-@@	O	-1	7066357
1.@@	O	-1	7066357
0@@	O	-1	7066357
50	O	-1	7066357
g/@@	O	-1	7066357
ml@@	O	-1	7066357
).	O	-1	7066357
In	O	-1	7066357
the	O	-1	7066357
pre@@	O	-1	7066357
-	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
st@@	O	-1	7066357
age	O	-1	7066357
li@@	O	-1	7066357
po@@	O	-1	7066357
proteinuria	O	-1	7066357
was	O	-1	7066357
neg@@	O	-1	7066357
li@@	O	-1	7066357
gi@@	O	-1	7066357
ble@@	O	-1	7066357
,	O	-1	7066357
while	O	-1	7066357
in	O	-1	7066357
the	O	-1	7066357
early	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
st@@	O	-1	7066357
age	O	-1	7066357
the	O	-1	7066357
urinary	O	-1	7066357
loss	O	-1	7066357
of	O	-1	7066357
plasma	O	-1	7066357
li@@	O	-1	7066357
po@@	O	-1	7066357
protein@@	O	-1	7066357
s	O	-1	7066357
consist@@	O	-1	7066357
ed	O	-1	7066357
main@@	O	-1	7066357
ly	O	-1	7066357
of	O	-1	7066357
H@@	O	-1	7066357
D@@	O	-1	7066357
L@@	O	-1	7066357
.	O	-1	7066357
These	O	-1	7066357
observ@@	O	-1	7066357
ations	O	-1	7066357
indicate	O	-1	7066357
that	O	-1	7066357
p@@	B-Chemical	D011692	7066357
uro@@	I-Chemical	-1	7066357
m@@	I-Chemical	-1	7066357
ycin	I-Chemical	-1	7066357
amin@@	I-Chemical	-1	7066357
on@@	I-Chemical	-1	7066357
ucle@@	I-Chemical	-1	7066357
o@@	I-Chemical	-1	7066357
side	I-Chemical	-1	7066357
al@@	O	-1	7066357
ters	O	-1	7066357
plasma	O	-1	7066357
li@@	O	-1	7066357
po@@	O	-1	7066357
protein@@	O	-1	7066357
s	O	-1	7066357
by	O	-1	7066357
low@@	O	-1	7066357
ering	O	-1	7066357
V@@	O	-1	7066357
L@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
and	O	-1	7066357
increas@@	O	-1	7066357
ing	O	-1	7066357
H@@	O	-1	7066357
D@@	O	-1	7066357
L@@	O	-1	7066357
.	O	-1	7066357
It	O	-1	7066357
is	O	-1	7066357
likely	O	-1	7066357
that	O	-1	7066357
the	O	-1	7066357
early	O	-1	7066357
and	O	-1	7066357
stri@@	O	-1	7066357
king	O	-1	7066357
increase	O	-1	7066357
of	O	-1	7066357
plasma	O	-1	7066357
H@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
found	O	-1	7066357
in	O	-1	7066357
nephro@@	B-Disease	D009404	7066357
tic	I-Disease	-1	7066357
rats	O	-1	7066357
is	O	-1	7066357
related	O	-1	7066357
to	O	-1	7066357
a	O	-1	7066357
direct	O	-1	7066357
effect	O	-1	7066357
of	O	-1	7066357
the	O	-1	7066357
drug	O	-1	7066357
on	O	-1	7066357
H@@	O	-1	7066357
D@@	O	-1	7066357
L	O	-1	7066357
metabol@@	O	-1	7066357
is@@	O	-1	7066357
m.	O	-1	7066357

C@@	O	-1	7007443
ir@@	O	-1	7007443
cul@@	O	-1	7007443
ating	O	-1	7007443
l@@	O	-1	7007443
ys@@	O	-1	7007443
os@@	O	-1	7007443
om@@	O	-1	7007443
al	O	-1	7007443
enzym@@	O	-1	7007443
es	O	-1	7007443
and	O	-1	7007443
acute	B-Disease	D017114	7007443
hepatic	I-Disease	-1	7007443
necro@@	I-Disease	-1	7007443
sis	I-Disease	-1	7007443
.	O	-1	7007443
The	O	-1	7007443
ac@@	O	-1	7007443
ti@@	O	-1	7007443
vi@@	O	-1	7007443
ties	O	-1	7007443
of	O	-1	7007443
the	O	-1	7007443
l@@	O	-1	7007443
ys@@	O	-1	7007443
os@@	O	-1	7007443
om@@	O	-1	7007443
al	O	-1	7007443
enzym@@	O	-1	7007443
es	O	-1	7007443
acid	O	-1	7007443
and	O	-1	7007443
ne@@	O	-1	7007443
ut@@	O	-1	7007443
ral	O	-1	7007443
prote@@	O	-1	7007443
ase,	O	-1	7007443
N@@	O	-1	7007443
-@@	O	-1	7007443
acet@@	O	-1	7007443
yl@@	O	-1	7007443
g@@	O	-1	7007443
lu@@	O	-1	7007443
co@@	O	-1	7007443
s@@	O	-1	7007443
amin@@	O	-1	7007443
id@@	O	-1	7007443
ase,	O	-1	7007443
and	O	-1	7007443
acid	O	-1	7007443
phosph@@	O	-1	7007443
at@@	O	-1	7007443
ase	O	-1	7007443
were	O	-1	7007443
measured	O	-1	7007443
in	O	-1	7007443
the	O	-1	7007443
serum	O	-1	7007443
of	O	-1	7007443
patients	O	-1	7007443
with	O	-1	7007443
ful@@	B-Disease	D017114	7007443
min@@	I-Disease	-1	7007443
ant	I-Disease	-1	7007443
hepatic	I-Disease	-1	7007443
failure	I-Disease	-1	7007443
.	O	-1	7007443
A@@	O	-1	7007443
ci@@	O	-1	7007443
d	O	-1	7007443
prote@@	O	-1	7007443
ase	O	-1	7007443
(@@	O	-1	7007443
ca@@	O	-1	7007443
the@@	O	-1	7007443
p@@	O	-1	7007443
s@@	O	-1	7007443
in	O	-1	7007443
D)	O	-1	7007443
activity	O	-1	7007443
was	O	-1	7007443
increased	O	-1	7007443
about	O	-1	7007443
ten@@	O	-1	7007443
fol@@	O	-1	7007443
d	O	-1	7007443
in	O	-1	7007443
patients	O	-1	7007443
who	O	-1	7007443
di@@	O	-1	7007443
ed	O	-1	7007443
and	O	-1	7007443
ne@@	O	-1	7007443
arly	O	-1	7007443
fo@@	O	-1	7007443
ur@@	O	-1	7007443
fol@@	O	-1	7007443
d	O	-1	7007443
in	O	-1	7007443
those	O	-1	7007443
who	O	-1	7007443
sur@@	O	-1	7007443
vi@@	O	-1	7007443
ved	O	-1	7007443
ful@@	B-Disease	D017114	7007443
min@@	I-Disease	-1	7007443
ant	I-Disease	-1	7007443
hepatic	I-Disease	-1	7007443
failure	I-Disease	-1	7007443
after	O	-1	7007443
par@@	B-Chemical	D000082	7007443
acet@@	I-Chemical	-1	7007443
am@@	I-Chemical	-1	7007443
ol	I-Chemical	-1	7007443
over@@	B-Disease	D062787	7007443
dose	I-Disease	-1	7007443
,	O	-1	7007443
whereas	O	-1	7007443
ac@@	O	-1	7007443
ti@@	O	-1	7007443
vi@@	O	-1	7007443
ties	O	-1	7007443
were	O	-1	7007443
increased	O	-1	7007443
equ@@	O	-1	7007443
ally	O	-1	7007443
in	O	-1	7007443
patients	O	-1	7007443
with	O	-1	7007443
ful@@	B-Disease	D017114	7007443
min@@	I-Disease	-1	7007443
ant	I-Disease	-1	7007443
hepatic	I-Disease	-1	7007443
failure	I-Disease	-1	7007443
due	O	-1	7007443
to	O	-1	7007443
viral	B-Disease	D006525	7007443
hepatitis	I-Disease	-1	7007443
whether	O	-1	7007443
or	O	-1	7007443
not	O	-1	7007443
they	O	-1	7007443
sur@@	O	-1	7007443
vi@@	O	-1	7007443
ved.	O	-1	7007443
A	O	-1	7007443
correl@@	O	-1	7007443
ation	O	-1	7007443
was	O	-1	7007443
found	O	-1	7007443
between	O	-1	7007443
serum	O	-1	7007443
acid	O	-1	7007443
prote@@	O	-1	7007443
ase	O	-1	7007443
activity	O	-1	7007443
and	O	-1	7007443
pro@@	O	-1	7007443
throm@@	O	-1	7007443
bin	O	-1	7007443
ti@@	O	-1	7007443
me,	O	-1	7007443
and	O	-1	7007443
the	O	-1	7007443
increase	O	-1	7007443
in	O	-1	7007443
ca@@	O	-1	7007443
the@@	O	-1	7007443
p@@	O	-1	7007443
s@@	O	-1	7007443
in	O	-1	7007443
D	O	-1	7007443
activity	O	-1	7007443
was	O	-1	7007443
su@@	O	-1	7007443
st@@	O	-1	7007443
ained	O	-1	7007443
over	O	-1	7007443
several	O	-1	7007443
days	O	-1	7007443
compared	O	-1	7007443
with	O	-1	7007443
as@@	B-Chemical	D001224	7007443
part@@	I-Chemical	-1	7007443
ate	I-Chemical	-1	7007443
amin@@	O	-1	7007443
ot@@	O	-1	7007443
ran@@	O	-1	7007443
s@@	O	-1	7007443
fer@@	O	-1	7007443
ase,	O	-1	7007443
which	O	-1	7007443
showed	O	-1	7007443
a	O	-1	7007443
sh@@	O	-1	7007443
ar@@	O	-1	7007443
p	O	-1	7007443
early	O	-1	7007443
pe@@	O	-1	7007443
a@@	O	-1	7007443
k	O	-1	7007443
and	O	-1	7007443
then	O	-1	7007443
a	O	-1	7007443
f@@	O	-1	7007443
all@@	O	-1	7007443
.	O	-1	7007443
C@@	O	-1	7007443
ir@@	O	-1	7007443
cul@@	O	-1	7007443
ating	O	-1	7007443
l@@	O	-1	7007443
ys@@	O	-1	7007443
os@@	O	-1	7007443
om@@	O	-1	7007443
al	O	-1	7007443
prote@@	O	-1	7007443
as@@	O	-1	7007443
es	O	-1	7007443
can	O	-1	7007443
damage	O	-1	7007443
other	O	-1	7007443
org@@	O	-1	7007443
an@@	O	-1	7007443
s,	O	-1	7007443
and	O	-1	7007443
meas@@	O	-1	7007443
ure@@	O	-1	7007443
ment	O	-1	7007443
of	O	-1	7007443
their	O	-1	7007443
activity	O	-1	7007443
may	O	-1	7007443
the@@	O	-1	7007443
re@@	O	-1	7007443
fore	O	-1	7007443
be	O	-1	7007443
of	O	-1	7007443
ad@@	O	-1	7007443
ded	O	-1	7007443
valu@@	O	-1	7007443
e	O	-1	7007443
in	O	-1	7007443
assess@@	O	-1	7007443
ing	O	-1	7007443
pro@@	O	-1	7007443
g@@	O	-1	7007443
no@@	O	-1	7007443
sis	O	-1	7007443
in	O	-1	7007443
this	O	-1	7007443
condi@@	O	-1	7007443
tion.	O	-1	7007443

T@@	O	-1	3762968
ran@@	O	-1	3762968
s@@	O	-1	3762968
k@@	O	-1	3762968
et@@	O	-1	3762968
ol@@	O	-1	3762968
ase	O	-1	3762968
abnormal@@	O	-1	3762968
ity	O	-1	3762968
in	O	-1	3762968
t@@	B-Chemical	D014042	3762968
ol@@	I-Chemical	-1	3762968
az@@	I-Chemical	-1	3762968
amide	I-Chemical	-1	3762968
-induced	O	-1	3762968
W@@	B-Disease	D014899	3762968
er@@	I-Disease	-1	3762968
n@@	I-Disease	-1	3762968
ic@@	I-Disease	-1	3762968
ke@@	I-Disease	-1	3762968
's	I-Disease	-1	3762968
encephalo@@	I-Disease	-1	3762968
pathy	I-Disease	-1	3762968
.	O	-1	3762968
We	O	-1	3762968
studied	O	-1	3762968
a	O	-1	3762968
thi@@	B-Chemical	D013831	3762968
amine	I-Chemical	-1	3762968
-@@	O	-1	3762968
dependent	O	-1	3762968
enz@@	O	-1	3762968
y@@	O	-1	3762968
me,	O	-1	3762968
trans@@	O	-1	3762968
k@@	O	-1	3762968
et@@	O	-1	3762968
ol@@	O	-1	3762968
ase,	O	-1	3762968
from	O	-1	3762968
fib@@	O	-1	3762968
ro@@	O	-1	3762968
bl@@	O	-1	3762968
ast@@	O	-1	3762968
s	O	-1	3762968
of	O	-1	3762968
a	O	-1	3762968
dia@@	B-Disease	D003920	3762968
be@@	I-Disease	-1	3762968
tic	I-Disease	-1	3762968
patient	O	-1	3762968
who	O	-1	3762968
developed	O	-1	3762968
W@@	B-Disease	D014899	3762968
er@@	I-Disease	-1	3762968
n@@	I-Disease	-1	3762968
ic@@	I-Disease	-1	3762968
ke@@	I-Disease	-1	3762968
's	I-Disease	-1	3762968
encephalo@@	I-Disease	-1	3762968
pathy	I-Disease	-1	3762968
when	O	-1	3762968
treated	O	-1	3762968
with	O	-1	3762968
t@@	B-Chemical	D014042	3762968
ol@@	I-Chemical	-1	3762968
az@@	I-Chemical	-1	3762968
amide	I-Chemical	-1	3762968
,	O	-1	3762968
in	O	-1	3762968
or@@	O	-1	3762968
der	O	-1	3762968
to	O	-1	3762968
del@@	O	-1	3762968
ine@@	O	-1	3762968
ate	O	-1	3762968
if	O	-1	3762968
this	O	-1	3762968
patient	O	-1	3762968
also	O	-1	3762968
had	O	-1	3762968
trans@@	O	-1	3762968
k@@	O	-1	3762968
et@@	O	-1	3762968
ol@@	O	-1	3762968
ase	O	-1	3762968
abnormal@@	O	-1	3762968
ity	O	-1	3762968
[@@	O	-1	3762968
high	O	-1	3762968
K@@	O	-1	3762968
m	O	-1	3762968
for	O	-1	3762968
thi@@	B-Chemical	D013835	3762968
amine	I-Chemical	-1	3762968
py@@	I-Chemical	-1	3762968
ro@@	I-Chemical	-1	3762968
phosph@@	I-Chemical	-1	3762968
ate	I-Chemical	-1	3762968
(	O	-1	3762968
T@@	B-Chemical	D013835	3762968
P@@	I-Chemical	-1	3762968
P	I-Chemical	-1	3762968
)@@	O	-1	3762968
]@@	O	-1	3762968
,	O	-1	3762968
as	O	-1	3762968
previously	O	-1	3762968
reported	O	-1	3762968
in	O	-1	3762968
post@@	O	-1	3762968
alco@@	O	-1	3762968
h@@	O	-1	3762968
olic	O	-1	3762968
W@@	B-Disease	D020915	3762968
er@@	I-Disease	-1	3762968
n@@	I-Disease	-1	3762968
ic@@	I-Disease	-1	3762968
k@@	I-Disease	-1	3762968
e-@@	I-Disease	-1	3762968
K@@	I-Disease	-1	3762968
or@@	I-Disease	-1	3762968
s@@	I-Disease	-1	3762968
ak@@	I-Disease	-1	3762968
of@@	I-Disease	-1	3762968
f	I-Disease	-1	3762968
syndrome	I-Disease	-1	3762968
.	O	-1	3762968
In	O	-1	3762968
addition	O	-1	3762968
to	O	-1	3762968
this	O	-1	3762968
patient@@	O	-1	3762968
,	O	-1	3762968
we	O	-1	3762968
also	O	-1	3762968
studied	O	-1	3762968
this	O	-1	3762968
enzyme	O	-1	3762968
from	O	-1	3762968
three	O	-1	3762968
dia@@	B-Disease	D003920	3762968
be@@	I-Disease	-1	3762968
tic	I-Disease	-1	3762968
k@@	O	-1	3762968
ind@@	O	-1	3762968
re@@	O	-1	3762968
ds	O	-1	3762968
without	O	-1	3762968
any	O	-1	3762968
hist@@	O	-1	3762968
ory	O	-1	3762968
of	O	-1	3762968
W@@	B-Disease	D014899	3762968
er@@	I-Disease	-1	3762968
n@@	I-Disease	-1	3762968
ic@@	I-Disease	-1	3762968
ke@@	I-Disease	-1	3762968
's	I-Disease	-1	3762968
encephalo@@	I-Disease	-1	3762968
pathy	I-Disease	-1	3762968
and	O	-1	3762968
from	O	-1	3762968
four	O	-1	3762968
normal	O	-1	3762968
controls.	O	-1	3762968
We	O	-1	3762968
found	O	-1	3762968
that	O	-1	3762968
the	O	-1	3762968
ab@@	O	-1	3762968
o@@	O	-1	3762968
ve@@	O	-1	3762968
-@@	O	-1	3762968
men@@	O	-1	3762968
tion@@	O	-1	3762968
ed	O	-1	3762968
patient	O	-1	3762968
and	O	-1	3762968
one	O	-1	3762968
of	O	-1	3762968
the	O	-1	3762968
dia@@	B-Disease	D003920	3762968
be@@	I-Disease	-1	3762968
tic	I-Disease	-1	3762968
k@@	O	-1	3762968
ind@@	O	-1	3762968
re@@	O	-1	3762968
ds	O	-1	3762968
with	O	-1	3762968
no	O	-1	3762968
hist@@	O	-1	3762968
ory	O	-1	3762968
of	O	-1	3762968
W@@	B-Disease	D014899	3762968
er@@	I-Disease	-1	3762968
n@@	I-Disease	-1	3762968
ic@@	I-Disease	-1	3762968
ke@@	I-Disease	-1	3762968
's	I-Disease	-1	3762968
encephalo@@	I-Disease	-1	3762968
pathy	I-Disease	-1	3762968
had	O	-1	3762968
ab@@	O	-1	3762968
normal	O	-1	3762968
trans@@	O	-1	3762968
k@@	O	-1	3762968
et@@	O	-1	3762968
ol@@	O	-1	3762968
ase	O	-1	3762968
as	O	-1	3762968
determined	O	-1	3762968
by	O	-1	3762968
its	O	-1	3762968
K@@	O	-1	3762968
m	O	-1	3762968
for	O	-1	3762968
T@@	B-Chemical	D013835	3762968
P@@	I-Chemical	-1	3762968
P	I-Chemical	-1	3762968
.	O	-1	3762968
These	O	-1	3762968
data	O	-1	3762968
suggest	O	-1	3762968
a	O	-1	3762968
simil@@	O	-1	3762968
ar@@	O	-1	3762968
ity	O	-1	3762968
between	O	-1	3762968
post@@	O	-1	3762968
alco@@	O	-1	3762968
h@@	O	-1	3762968
olic	O	-1	3762968
W@@	B-Disease	D020915	3762968
er@@	I-Disease	-1	3762968
n@@	I-Disease	-1	3762968
ic@@	I-Disease	-1	3762968
k@@	I-Disease	-1	3762968
e-@@	I-Disease	-1	3762968
K@@	I-Disease	-1	3762968
or@@	I-Disease	-1	3762968
s@@	I-Disease	-1	3762968
ak@@	I-Disease	-1	3762968
of@@	I-Disease	-1	3762968
f	I-Disease	-1	3762968
syndrome	I-Disease	-1	3762968
and	O	-1	3762968
the	O	-1	3762968
patient	O	-1	3762968
with	O	-1	3762968
t@@	B-Chemical	D014042	3762968
ol@@	I-Chemical	-1	3762968
az@@	I-Chemical	-1	3762968
amide	I-Chemical	-1	3762968
-induced	O	-1	3762968
W@@	B-Disease	D014899	3762968
er@@	I-Disease	-1	3762968
n@@	I-Disease	-1	3762968
ic@@	I-Disease	-1	3762968
ke@@	I-Disease	-1	3762968
's	I-Disease	-1	3762968
encephalo@@	I-Disease	-1	3762968
pathy	I-Disease	-1	3762968
from	O	-1	3762968
the	O	-1	3762968
stand@@	O	-1	3762968
po@@	O	-1	3762968
in@@	O	-1	3762968
t	O	-1	3762968
of	O	-1	3762968
trans@@	O	-1	3762968
k@@	O	-1	3762968
et@@	O	-1	3762968
ol@@	O	-1	3762968
ase	O	-1	3762968
abnormal@@	O	-1	3762968
ity.	O	-1	3762968

M@@	O	-1	3413271
echan@@	O	-1	3413271
is@@	O	-1	3413271
ms	O	-1	3413271
of	O	-1	3413271
myocardial	B-Disease	D017202	3413271
ischem@@	I-Disease	-1	3413271
ia	I-Disease	-1	3413271
induced	O	-1	3413271
by	O	-1	3413271
ep@@	B-Chemical	D004837	3413271
ine@@	I-Chemical	-1	3413271
phrine	I-Chemical	-1	3413271
:	O	-1	3413271
compar@@	O	-1	3413271
ison	O	-1	3413271
with	O	-1	3413271
ex@@	O	-1	3413271
er@@	O	-1	3413271
ci@@	O	-1	3413271
se@@	O	-1	3413271
-induced	O	-1	3413271
ischem@@	B-Disease	D007511	3413271
ia	I-Disease	-1	3413271
.	O	-1	3413271
The	O	-1	3413271
role	O	-1	3413271
of	O	-1	3413271
ep@@	B-Chemical	D004837	3413271
ine@@	I-Chemical	-1	3413271
phrine	I-Chemical	-1	3413271
in	O	-1	3413271
el@@	O	-1	3413271
ic@@	O	-1	3413271
it@@	O	-1	3413271
ing	O	-1	3413271
myocardial	B-Disease	D017202	3413271
ischem@@	I-Disease	-1	3413271
ia	I-Disease	-1	3413271
was	O	-1	3413271
examined	O	-1	3413271
in	O	-1	3413271
patients	O	-1	3413271
with	O	-1	3413271
coronary	B-Disease	D003324	3413271
artery	I-Disease	-1	3413271
disease	I-Disease	-1	3413271
.	O	-1	3413271
O@@	O	-1	3413271
b@@	O	-1	3413271
j@@	O	-1	3413271
ective	O	-1	3413271
signs	O	-1	3413271
of	O	-1	3413271
ischem@@	B-Disease	D007511	3413271
ia	I-Disease	-1	3413271
and	O	-1	3413271
factors	O	-1	3413271
increas@@	O	-1	3413271
ing	O	-1	3413271
myocardial	O	-1	3413271
oxy@@	B-Chemical	D010100	3413271
gen	I-Chemical	-1	3413271
consum@@	O	-1	3413271
ption	O	-1	3413271
were	O	-1	3413271
compared	O	-1	3413271
during	O	-1	3413271
ep@@	B-Chemical	D004837	3413271
ine@@	I-Chemical	-1	3413271
phrine	I-Chemical	-1	3413271
infusion	O	-1	3413271
and	O	-1	3413271
sup@@	O	-1	3413271
ine	O	-1	3413271
b@@	O	-1	3413271
ic@@	O	-1	3413271
yc@@	O	-1	3413271
le	O	-1	3413271
ex@@	O	-1	3413271
er@@	O	-1	3413271
ci@@	O	-1	3413271
se.	O	-1	3413271
B@@	O	-1	3413271
oth	O	-1	3413271
ep@@	B-Chemical	D004837	3413271
ine@@	I-Chemical	-1	3413271
phrine	I-Chemical	-1	3413271
and	O	-1	3413271
ex@@	O	-1	3413271
er@@	O	-1	3413271
cis@@	O	-1	3413271
e	O	-1	3413271
produced	O	-1	3413271
myocardial	B-Disease	D017202	3413271
ischem@@	I-Disease	-1	3413271
ia	I-Disease	-1	3413271
as	O	-1	3413271
ev@@	O	-1	3413271
id@@	O	-1	3413271
enc@@	O	-1	3413271
ed	O	-1	3413271
by	O	-1	3413271
S@@	O	-1	3413271
T	O	-1	3413271
seg@@	O	-1	3413271
ment	O	-1	3413271
de@@	B-Disease	D003866	3413271
pression	I-Disease	-1	3413271
and	O	-1	3413271
ang@@	B-Disease	D000787	3413271
in@@	I-Disease	-1	3413271
a	I-Disease	-1	3413271
.	O	-1	3413271
However,	O	-1	3413271
the	O	-1	3413271
mechanisms	O	-1	3413271
of	O	-1	3413271
myocardial	B-Disease	D017202	3413271
ischem@@	I-Disease	-1	3413271
ia	I-Disease	-1	3413271
induced	O	-1	3413271
by	O	-1	3413271
ep@@	B-Chemical	D004837	3413271
ine@@	I-Chemical	-1	3413271
phrine	I-Chemical	-1	3413271
were	O	-1	3413271
significantly	O	-1	3413271
different	O	-1	3413271
from	O	-1	3413271
those	O	-1	3413271
of	O	-1	3413271
ex@@	O	-1	3413271
er@@	O	-1	3413271
ci@@	O	-1	3413271
se.	O	-1	3413271
E@@	O	-1	3413271
x@@	O	-1	3413271
er@@	O	-1	3413271
ci@@	O	-1	3413271
se@@	O	-1	3413271
-induced	O	-1	3413271
myocardial	B-Disease	D017202	3413271
ischem@@	I-Disease	-1	3413271
ia	I-Disease	-1	3413271
was	O	-1	3413271
mark@@	O	-1	3413271
ed	O	-1	3413271
pre@@	O	-1	3413271
domin@@	O	-1	3413271
ant@@	O	-1	3413271
ly	O	-1	3413271
by	O	-1	3413271
increased	O	-1	3413271
heart	O	-1	3413271
rate	O	-1	3413271
and	O	-1	3413271
rat@@	O	-1	3413271
e-@@	O	-1	3413271
pressure	O	-1	3413271
produc@@	O	-1	3413271
t	O	-1	3413271
with	O	-1	3413271
a	O	-1	3413271
min@@	O	-1	3413271
or	O	-1	3413271
cont@@	O	-1	3413271
ri@@	O	-1	3413271
bu@@	O	-1	3413271
tion	O	-1	3413271
of	O	-1	3413271
en@@	O	-1	3413271
d-@@	O	-1	3413271
di@@	O	-1	3413271
ast@@	O	-1	3413271
olic	O	-1	3413271
vol@@	O	-1	3413271
u@@	O	-1	3413271
me,	O	-1	3413271
while	O	-1	3413271
ep@@	B-Chemical	D004837	3413271
ine@@	I-Chemical	-1	3413271
phrine	I-Chemical	-1	3413271
-induced	O	-1	3413271
ischem@@	B-Disease	D007511	3413271
ia	I-Disease	-1	3413271
was	O	-1	3413271
character@@	O	-1	3413271
ized	O	-1	3413271
by	O	-1	3413271
a	O	-1	3413271
mark@@	O	-1	3413271
ed	O	-1	3413271
increase	O	-1	3413271
in	O	-1	3413271
contrac@@	O	-1	3413271
til@@	O	-1	3413271
ity	O	-1	3413271
and	O	-1	3413271
a	O	-1	3413271
less	O	-1	3413271
p@@	O	-1	3413271
ron@@	O	-1	3413271
oun@@	O	-1	3413271
c@@	O	-1	3413271
ed	O	-1	3413271
increase	O	-1	3413271
in	O	-1	3413271
heart	O	-1	3413271
rate	O	-1	3413271
and	O	-1	3413271
rat@@	O	-1	3413271
e-@@	O	-1	3413271
pressure	O	-1	3413271
produc@@	O	-1	3413271
t.	O	-1	3413271
These	O	-1	3413271
findings	O	-1	3413271
indicate	O	-1	3413271
that	O	-1	3413271
ischem@@	B-Disease	D007511	3413271
ia	I-Disease	-1	3413271
produced	O	-1	3413271
by	O	-1	3413271
ep@@	B-Chemical	D004837	3413271
ine@@	I-Chemical	-1	3413271
phrine	I-Chemical	-1	3413271
,	O	-1	3413271
as	O	-1	3413271
may	O	-1	3413271
occ@@	O	-1	3413271
ur	O	-1	3413271
during	O	-1	3413271
st@@	O	-1	3413271
ates	O	-1	3413271
of	O	-1	3413271
em@@	O	-1	3413271
o@@	O	-1	3413271
tional	O	-1	3413271
dist@@	O	-1	3413271
res@@	O	-1	3413271
s,	O	-1	3413271
has	O	-1	3413271
a	O	-1	3413271
mechanism	O	-1	3413271
dist@@	O	-1	3413271
inc@@	O	-1	3413271
t	O	-1	3413271
from	O	-1	3413271
that	O	-1	3413271
due	O	-1	3413271
to	O	-1	3413271
physi@@	O	-1	3413271
c@@	O	-1	3413271
al	O	-1	3413271
ex@@	O	-1	3413271
er@@	O	-1	3413271
tion.	O	-1	3413271

T@@	O	-1	3088349
ran@@	O	-1	3088349
si@@	O	-1	3088349
ent	O	-1	3088349
contr@@	B-Disease	D009069	3088349
al@@	I-Disease	-1	3088349
ateral	I-Disease	-1	3088349
ro@@	I-Disease	-1	3088349
t@@	I-Disease	-1	3088349
ation	I-Disease	-1	3088349
following	O	-1	3088349
un@@	O	-1	3088349
il@@	O	-1	3088349
ateral	O	-1	3088349
subst@@	B-Disease	-1	3088349
anti@@	I-Disease	-1	3088349
a	I-Disease	-1	3088349
n@@	I-Disease	-1	3088349
ig@@	I-Disease	-1	3088349
r@@	I-Disease	-1	3088349
a	I-Disease	-1	3088349
le@@	I-Disease	-1	3088349
sion	I-Disease	-1	3088349
ref@@	O	-1	3088349
l@@	O	-1	3088349
ects	O	-1	3088349
sus@@	O	-1	3088349
cep@@	O	-1	3088349
ti@@	O	-1	3088349
b@@	O	-1	3088349
ility	O	-1	3088349
of	O	-1	3088349
the	O	-1	3088349
n@@	O	-1	3088349
ig@@	O	-1	3088349
ro@@	O	-1	3088349
stri@@	O	-1	3088349
atal	O	-1	3088349
system	O	-1	3088349
to	O	-1	3088349
ex@@	O	-1	3088349
ha@@	O	-1	3088349
us@@	O	-1	3088349
tion	O	-1	3088349
by	O	-1	3088349
amphetamine	B-Chemical	D000661	3088349
.	O	-1	3088349
F@@	O	-1	3088349
ol@@	O	-1	3088349
low@@	O	-1	3088349
ing	O	-1	3088349
un@@	O	-1	3088349
il@@	O	-1	3088349
ateral	O	-1	3088349
6-@@	B-Chemical	D016627	3088349
O@@	I-Chemical	-1	3088349
H@@	I-Chemical	-1	3088349
D@@	I-Chemical	-1	3088349
A	I-Chemical	-1	3088349
induced	O	-1	3088349
S@@	B-Disease	-1	3088349
N	I-Disease	-1	3088349
le@@	I-Disease	-1	3088349
sion	I-Disease	-1	3088349
,	O	-1	3088349
a	O	-1	3088349
transi@@	O	-1	3088349
ent	O	-1	3088349
period	O	-1	3088349
of	O	-1	3088349
contr@@	B-Disease	D009069	3088349
al@@	I-Disease	-1	3088349
ateral	I-Disease	-1	3088349
ro@@	I-Disease	-1	3088349
t@@	I-Disease	-1	3088349
ation	I-Disease	-1	3088349
has	O	-1	3088349
been	O	-1	3088349
reported	O	-1	3088349
to	O	-1	3088349
pre@@	O	-1	3088349
ce@@	O	-1	3088349
de	O	-1	3088349
the	O	-1	3088349
pre@@	O	-1	3088349
domin@@	O	-1	3088349
ant	O	-1	3088349
ip@@	B-Disease	D009069	3088349
si@@	I-Disease	-1	3088349
lat@@	I-Disease	-1	3088349
eral	I-Disease	-1	3088349
cir@@	I-Disease	-1	3088349
cl@@	I-Disease	-1	3088349
ing	I-Disease	-1	3088349
.	O	-1	3088349
In	O	-1	3088349
or@@	O	-1	3088349
der	O	-1	3088349
to	O	-1	3088349
cl@@	O	-1	3088349
ar@@	O	-1	3088349
if@@	O	-1	3088349
y	O	-1	3088349
the	O	-1	3088349
n@@	O	-1	3088349
at@@	O	-1	3088349
ure	O	-1	3088349
of	O	-1	3088349
this	O	-1	3088349
initial	O	-1	3088349
contr@@	B-Disease	D009069	3088349
al@@	I-Disease	-1	3088349
ateral	I-Disease	-1	3088349
ro@@	I-Disease	-1	3088349
t@@	I-Disease	-1	3088349
ation	I-Disease	-1	3088349
we	O	-1	3088349
examined	O	-1	3088349
the	O	-1	3088349
effect	O	-1	3088349
of	O	-1	3088349
the	O	-1	3088349
duration	O	-1	3088349
of	O	-1	3088349
recovery	O	-1	3088349
period	O	-1	3088349
after	O	-1	3088349
the	O	-1	3088349
le@@	O	-1	3088349
sion,	O	-1	3088349
on	O	-1	3088349
amphetamine	B-Chemical	D000661	3088349
-induced	O	-1	3088349
ro@@	B-Disease	D009069	3088349
t@@	I-Disease	-1	3088349
ation@@	I-Disease	-1	3088349
al	I-Disease	-1	3088349
behavi@@	I-Disease	-1	3088349
or	I-Disease	-1	3088349
.	O	-1	3088349
Th@@	O	-1	3088349
ree	O	-1	3088349
days	O	-1	3088349
pos@@	O	-1	3088349
t	O	-1	3088349
le@@	O	-1	3088349
sion,	O	-1	3088349
most	O	-1	3088349
rats	O	-1	3088349
cir@@	O	-1	3088349
cl@@	O	-1	3088349
ed	O	-1	3088349
pre@@	O	-1	3088349
domin@@	O	-1	3088349
ant@@	O	-1	3088349
ly	O	-1	3088349
contr@@	O	-1	3088349
al@@	O	-1	3088349
at@@	O	-1	3088349
er@@	O	-1	3088349
ally	O	-1	3088349
to	O	-1	3088349
the	O	-1	3088349
le@@	O	-1	3088349
sion.	O	-1	3088349
S@@	O	-1	3088349
uc@@	O	-1	3088349
h	O	-1	3088349
contr@@	B-Disease	D009069	3088349
al@@	I-Disease	-1	3088349
ateral	I-Disease	-1	3088349
ro@@	I-Disease	-1	3088349
t@@	I-Disease	-1	3088349
ation	I-Disease	-1	3088349
may	O	-1	3088349
result	O	-1	3088349
from	O	-1	3088349
either	O	-1	3088349
de@@	O	-1	3088349
gener@@	O	-1	3088349
ation@@	O	-1	3088349
-induced	O	-1	3088349
b@@	O	-1	3088349
re@@	O	-1	3088349
ak@@	O	-1	3088349
do@@	O	-1	3088349
w@@	O	-1	3088349
n	O	-1	3088349
of	O	-1	3088349
the	O	-1	3088349
D@@	O	-1	3088349
A	O	-1	3088349
po@@	O	-1	3088349
ol@@	O	-1	3088349
,	O	-1	3088349
or	O	-1	3088349
le@@	O	-1	3088349
sion@@	O	-1	3088349
-induced	O	-1	3088349
increase	O	-1	3088349
of	O	-1	3088349
D@@	O	-1	3088349
A	O	-1	3088349
t@@	O	-1	3088349
ur@@	O	-1	3088349
no@@	O	-1	3088349
ver	O	-1	3088349
in	O	-1	3088349
the	O	-1	3088349
s@@	O	-1	3088349
pared	O	-1	3088349
neuron@@	O	-1	3088349
s.	O	-1	3088349
A	O	-1	3088349
subst@@	O	-1	3088349
anti@@	O	-1	3088349
al	O	-1	3088349
de@@	O	-1	3088349
g@@	O	-1	3088349
ree	O	-1	3088349
of	O	-1	3088349
contr@@	O	-1	3088349
al@@	O	-1	3088349
ateral	O	-1	3088349
pre@@	O	-1	3088349
fe@@	O	-1	3088349
rence	O	-1	3088349
was	O	-1	3088349
sti@@	O	-1	3088349
ll	O	-1	3088349
ev@@	O	-1	3088349
id@@	O	-1	3088349
ent	O	-1	3088349
when	O	-1	3088349
amphetamine	B-Chemical	D000661	3088349
was	O	-1	3088349
administered	O	-1	3088349
for	O	-1	3088349
the	O	-1	3088349
first	O	-1	3088349
time	O	-1	3088349
24	O	-1	3088349
days	O	-1	3088349
after	O	-1	3088349
le@@	O	-1	3088349
sion@@	O	-1	3088349
ing,	O	-1	3088349
indicating	O	-1	3088349
invol@@	O	-1	3088349
vement	O	-1	3088349
of	O	-1	3088349
s@@	O	-1	3088349
pared	O	-1	3088349
cells	O	-1	3088349
in	O	-1	3088349
the	O	-1	3088349
contr@@	B-Disease	D009069	3088349
al@@	I-Disease	-1	3088349
ateral	I-Disease	-1	3088349
ro@@	I-Disease	-1	3088349
t@@	I-Disease	-1	3088349
ation	I-Disease	-1	3088349
.	O	-1	3088349
However,	O	-1	3088349
reg@@	O	-1	3088349
ar@@	O	-1	3088349
d@@	O	-1	3088349
less	O	-1	3088349
of	O	-1	3088349
the	O	-1	3088349
duration	O	-1	3088349
of	O	-1	3088349
recovery	O	-1	3088349
(@@	O	-1	3088349
and	O	-1	3088349
ir@@	O	-1	3088349
resp@@	O	-1	3088349
ective	O	-1	3088349
of	O	-1	3088349
either	O	-1	3088349
le@@	O	-1	3088349
sion	O	-1	3088349
vol@@	O	-1	3088349
u@@	O	-1	3088349
me,	O	-1	3088349
amphetamine	B-Chemical	D000661	3088349
dose@@	O	-1	3088349
,	O	-1	3088349
or	O	-1	3088349
post@@	O	-1	3088349
-@@	O	-1	3088349
le@@	O	-1	3088349
sion	O	-1	3088349
motor	O	-1	3088349
ex@@	O	-1	3088349
er@@	O	-1	3088349
ci@@	O	-1	3088349
se@@	O	-1	3088349
),	O	-1	3088349
amphetamine	B-Chemical	D000661	3088349
-induced	O	-1	3088349
ro@@	B-Disease	D009069	3088349
t@@	I-Disease	-1	3088349
ation	I-Disease	-1	3088349
ten@@	O	-1	3088349
ded	O	-1	3088349
to	O	-1	3088349
b@@	O	-1	3088349
ec@@	O	-1	3088349
ome	O	-1	3088349
gra@@	O	-1	3088349
du@@	O	-1	3088349
ally	O	-1	3088349
more	O	-1	3088349
ip@@	O	-1	3088349
si@@	O	-1	3088349
lat@@	O	-1	3088349
eral	O	-1	3088349
as	O	-1	3088349
the	O	-1	3088349
observ@@	O	-1	3088349
ation	O	-1	3088349
s@@	O	-1	3088349
es@@	O	-1	3088349
sion	O	-1	3088349
progres@@	O	-1	3088349
se@@	O	-1	3088349
d,	O	-1	3088349
and	O	-1	3088349
all	O	-1	3088349
rats	O	-1	3088349
cir@@	O	-1	3088349
cl@@	O	-1	3088349
ed	O	-1	3088349
ip@@	O	-1	3088349
si@@	O	-1	3088349
lat@@	O	-1	3088349
er@@	O	-1	3088349
ally	O	-1	3088349
to	O	-1	3088349
the	O	-1	3088349
le@@	O	-1	3088349
sion	O	-1	3088349
in	O	-1	3088349
response	O	-1	3088349
to	O	-1	3088349
further	O	-1	3088349
amphetamine	B-Chemical	D000661	3088349
injec@@	O	-1	3088349
tions.	O	-1	3088349
These	O	-1	3088349
findings	O	-1	3088349
suggest	O	-1	3088349
that	O	-1	3088349
amphetamine	B-Chemical	D000661	3088349
has	O	-1	3088349
an	O	-1	3088349
ir@@	O	-1	3088349
reversible	O	-1	3088349
effect	O	-1	3088349
on	O	-1	3088349
the	O	-1	3088349
post@@	O	-1	3088349
-@@	O	-1	3088349
le@@	O	-1	3088349
sion	O	-1	3088349
D@@	O	-1	3088349
A	O	-1	3088349
po@@	O	-1	3088349
ol	O	-1	3088349
cont@@	O	-1	3088349
ri@@	O	-1	3088349
but@@	O	-1	3088349
ing	O	-1	3088349
to	O	-1	3088349
contr@@	B-Disease	D009069	3088349
al@@	I-Disease	-1	3088349
ateral	I-Disease	-1	3088349
ro@@	I-Disease	-1	3088349
t@@	I-Disease	-1	3088349
ation	I-Disease	-1	3088349
.	O	-1	3088349

Th@@	O	-1	3001299
yro@@	O	-1	3001299
id	O	-1	3001299
function	O	-1	3001299
and	O	-1	3001299
ur@@	O	-1	3001299
ine-@@	O	-1	3001299
con@@	O	-1	3001299
c@@	O	-1	3001299
ent@@	O	-1	3001299
rat@@	O	-1	3001299
ing	O	-1	3001299
ability	O	-1	3001299
during	O	-1	3001299
lithium	B-Chemical	D008094	3001299
treatment.	O	-1	3001299
It	O	-1	3001299
has	O	-1	3001299
been	O	-1	3001299
suggested	O	-1	3001299
that	O	-1	3001299
aden@@	O	-1	3001299
yl@@	O	-1	3001299
ate	O	-1	3001299
cy@@	O	-1	3001299
cl@@	O	-1	3001299
ase	O	-1	3001299
inhibition	O	-1	3001299
may	O	-1	3001299
be	O	-1	3001299
important	O	-1	3001299
in	O	-1	3001299
the	O	-1	3001299
development	O	-1	3001299
of	O	-1	3001299
both	O	-1	3001299
nephro@@	B-Disease	D018500	3001299
genic	I-Disease	-1	3001299
dia@@	I-Disease	-1	3001299
bet@@	I-Disease	-1	3001299
es	I-Disease	-1	3001299
in@@	I-Disease	-1	3001299
si@@	I-Disease	-1	3001299
pid@@	I-Disease	-1	3001299
us	I-Disease	-1	3001299
and	O	-1	3001299
hypo@@	B-Disease	D007037	3001299
th@@	I-Disease	-1	3001299
yro@@	I-Disease	-1	3001299
i@@	I-Disease	-1	3001299
dis@@	I-Disease	-1	3001299
m	I-Disease	-1	3001299
during	O	-1	3001299
lithium	B-Chemical	D008094	3001299
treatment.	O	-1	3001299
We	O	-1	3001299
measured	O	-1	3001299
serum	O	-1	3001299
th@@	B-Chemical	D013974	3001299
yro@@	I-Chemical	-1	3001299
x@@	I-Chemical	-1	3001299
ine	I-Chemical	-1	3001299
and	O	-1	3001299
ur@@	O	-1	3001299
ine-@@	O	-1	3001299
con@@	O	-1	3001299
c@@	O	-1	3001299
ent@@	O	-1	3001299
rat@@	O	-1	3001299
ing	O	-1	3001299
ability	O	-1	3001299
(@@	O	-1	3001299
U@@	O	-1	3001299
ma@@	O	-1	3001299
x@@	O	-1	3001299
)	O	-1	3001299
in	O	-1	3001299
response	O	-1	3001299
to	O	-1	3001299
des@@	O	-1	3001299
mo@@	O	-1	3001299
press@@	O	-1	3001299
in	O	-1	3001299
(D@@	O	-1	3001299
D@@	O	-1	3001299
A@@	O	-1	3001299
V@@	O	-1	3001299
P)	O	-1	3001299
in	O	-1	3001299
8@@	O	-1	3001299
5	O	-1	3001299
patients	O	-1	3001299
receiving	O	-1	3001299
lithium	B-Chemical	D008094	3001299
.	O	-1	3001299
H@@	B-Disease	D007037	3001299
y@@	I-Disease	-1	3001299
po@@	I-Disease	-1	3001299
th@@	I-Disease	-1	3001299
yro@@	I-Disease	-1	3001299
i@@	I-Disease	-1	3001299
dis@@	I-Disease	-1	3001299
m	I-Disease	-1	3001299
developed	O	-1	3001299
in	O	-1	3001299
e@@	O	-1	3001299
ight	O	-1	3001299
patients	O	-1	3001299
while	O	-1	3001299
they	O	-1	3001299
were	O	-1	3001299
taking	O	-1	3001299
lithium	B-Chemical	D008094	3001299
.	O	-1	3001299
Im@@	O	-1	3001299
pa@@	O	-1	3001299
ired	O	-1	3001299
U@@	O	-1	3001299
ma@@	O	-1	3001299
x	O	-1	3001299
was	O	-1	3001299
found	O	-1	3001299
in	O	-1	3001299
both	O	-1	3001299
eu@@	O	-1	3001299
th@@	O	-1	3001299
yro@@	O	-1	3001299
id	O	-1	3001299
and	O	-1	3001299
hypo@@	B-Disease	D007037	3001299
th@@	I-Disease	-1	3001299
yro@@	I-Disease	-1	3001299
id	I-Disease	-1	3001299
patients	O	-1	3001299
while	O	-1	3001299
some	O	-1	3001299
hypo@@	B-Disease	D007037	3001299
th@@	I-Disease	-1	3001299
yro@@	I-Disease	-1	3001299
id	I-Disease	-1	3001299
patients	O	-1	3001299
concentr@@	O	-1	3001299
ated	O	-1	3001299
their	O	-1	3001299
urine	O	-1	3001299
we@@	O	-1	3001299
ll@@	O	-1	3001299
.	O	-1	3001299
It	O	-1	3001299
is	O	-1	3001299
concl@@	O	-1	3001299
uded	O	-1	3001299
that	O	-1	3001299
the	O	-1	3001299
domin@@	O	-1	3001299
ant	O	-1	3001299
mechanisms	O	-1	3001299
by	O	-1	3001299
which	O	-1	3001299
lithium	B-Chemical	D008094	3001299
ex@@	O	-1	3001299
er@@	O	-1	3001299
ts	O	-1	3001299
these	O	-1	3001299
two	O	-1	3001299
effects	O	-1	3001299
are	O	-1	3001299
differen@@	O	-1	3001299
t.	O	-1	3001299

S@@	O	-1	2004015
en@@	O	-1	2004015
si@@	O	-1	2004015
tivity	O	-1	2004015
of	O	-1	2004015
erythro@@	O	-1	2004015
id	O	-1	2004015
pro@@	O	-1	2004015
gen@@	O	-1	2004015
it@@	O	-1	2004015
or	O	-1	2004015
co@@	O	-1	2004015
lon@@	O	-1	2004015
i@@	O	-1	2004015
es	O	-1	2004015
to	O	-1	2004015
erythro@@	O	-1	2004015
po@@	O	-1	2004015
i@@	O	-1	2004015
e@@	O	-1	2004015
tin	O	-1	2004015
in	O	-1	2004015
az@@	B-Chemical	D015215	2004015
id@@	I-Chemical	-1	2004015
o@@	I-Chemical	-1	2004015
th@@	I-Chemical	-1	2004015
ym@@	I-Chemical	-1	2004015
idine	I-Chemical	-1	2004015
treated	O	-1	2004015
immuno@@	B-Disease	C565469	2004015
defici@@	I-Disease	-1	2004015
ent	I-Disease	-1	2004015
mice.	O	-1	2004015
The	O	-1	2004015
ana@@	B-Disease	D000740	2004015
emia	I-Disease	-1	2004015
induced	O	-1	2004015
by	O	-1	2004015
3@@	B-Chemical	D015215	2004015
'@@	I-Chemical	-1	2004015
-@@	I-Chemical	-1	2004015
az@@	I-Chemical	-1	2004015
id@@	I-Chemical	-1	2004015
o@@	I-Chemical	-1	2004015
-@@	I-Chemical	-1	2004015
3@@	I-Chemical	-1	2004015
'@@	I-Chemical	-1	2004015
di@@	I-Chemical	-1	2004015
de@@	I-Chemical	-1	2004015
oxy@@	I-Chemical	-1	2004015
th@@	I-Chemical	-1	2004015
ym@@	I-Chemical	-1	2004015
idine	I-Chemical	-1	2004015
(	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
)	O	-1	2004015
is	O	-1	2004015
po@@	O	-1	2004015
or@@	O	-1	2004015
ly	O	-1	2004015
under@@	O	-1	2004015
sto@@	O	-1	2004015
o@@	O	-1	2004015
d.	O	-1	2004015
We	O	-1	2004015
have	O	-1	2004015
used	O	-1	2004015
a	O	-1	2004015
m@@	O	-1	2004015
urine	O	-1	2004015
model	O	-1	2004015
of	O	-1	2004015
A@@	B-Disease	D000163	2004015
I@@	I-Disease	-1	2004015
D@@	I-Disease	-1	2004015
S	I-Disease	-1	2004015
,	O	-1	2004015
inf@@	B-Disease	D007239	2004015
ection	I-Disease	-1	2004015
of	O	-1	2004015
female	O	-1	2004015
C@@	O	-1	2004015
5@@	O	-1	2004015
7@@	O	-1	2004015
B@@	O	-1	2004015
L@@	O	-1	2004015
/@@	O	-1	2004015
6	O	-1	2004015
mice	O	-1	2004015
with	O	-1	2004015
L@@	O	-1	2004015
P@@	O	-1	2004015
-@@	O	-1	2004015
B@@	O	-1	2004015
M@@	O	-1	2004015
5	O	-1	2004015
m@@	O	-1	2004015
urine	O	-1	2004015
leuk@@	B-Disease	D007938	2004015
a@@	I-Disease	-1	2004015
emia	I-Disease	-1	2004015
(@@	O	-1	2004015
M@@	O	-1	2004015
u@@	O	-1	2004015
L@@	O	-1	2004015
V@@	O	-1	2004015
)	O	-1	2004015
vi@@	O	-1	2004015
r@@	O	-1	2004015
us,	O	-1	2004015
to	O	-1	2004015
determine	O	-1	2004015
if	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
-induced	O	-1	2004015
ana@@	B-Disease	D000740	2004015
emia	I-Disease	-1	2004015
is	O	-1	2004015
du@@	O	-1	2004015
e,	O	-1	2004015
in	O	-1	2004015
part@@	O	-1	2004015
,	O	-1	2004015
to	O	-1	2004015
decreased	O	-1	2004015
respon@@	O	-1	2004015
si@@	O	-1	2004015
ven@@	O	-1	2004015
ess	O	-1	2004015
of	O	-1	2004015
erythro@@	O	-1	2004015
po@@	O	-1	2004015
i@@	O	-1	2004015
e@@	O	-1	2004015
tic	O	-1	2004015
pre@@	O	-1	2004015
cur@@	O	-1	2004015
s@@	O	-1	2004015
ors	O	-1	2004015
(B@@	O	-1	2004015
F@@	O	-1	2004015
U@@	O	-1	2004015
-@@	O	-1	2004015
e@@	O	-1	2004015
)	O	-1	2004015
to	O	-1	2004015
erythro@@	O	-1	2004015
po@@	O	-1	2004015
i@@	O	-1	2004015
e@@	O	-1	2004015
tin	O	-1	2004015
(@@	O	-1	2004015
EP@@	O	-1	2004015
O@@	O	-1	2004015
).	O	-1	2004015
M@@	O	-1	2004015
ic@@	O	-1	2004015
e	O	-1	2004015
in	O	-1	2004015
the	O	-1	2004015
early	O	-1	2004015
st@@	O	-1	2004015
age	O	-1	2004015
of	O	-1	2004015
L@@	O	-1	2004015
P@@	O	-1	2004015
-@@	O	-1	2004015
B@@	O	-1	2004015
M@@	O	-1	2004015
5	O	-1	2004015
M@@	O	-1	2004015
u@@	O	-1	2004015
L@@	O	-1	2004015
V	O	-1	2004015
disease	O	-1	2004015
were	O	-1	2004015
given	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
in	O	-1	2004015
their	O	-1	2004015
d@@	O	-1	2004015
r@@	O	-1	2004015
in@@	O	-1	2004015
king	O	-1	2004015
w@@	O	-1	2004015
at@@	O	-1	2004015
er	O	-1	2004015
at	O	-1	2004015
1.@@	O	-1	2004015
0	O	-1	2004015
and	O	-1	2004015
2.@@	O	-1	2004015
5	O	-1	2004015
mg/m@@	O	-1	2004015
l@@	O	-1	2004015
.	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
produced	O	-1	2004015
ana@@	B-Disease	D000740	2004015
emia	I-Disease	-1	2004015
in	O	-1	2004015
both	O	-1	2004015
group@@	O	-1	2004015
s,	O	-1	2004015
in	O	-1	2004015
a	O	-1	2004015
dose-@@	O	-1	2004015
dependent	O	-1	2004015
f@@	O	-1	2004015
as@@	O	-1	2004015
hi@@	O	-1	2004015
on@@	O	-1	2004015
.	O	-1	2004015
D@@	O	-1	2004015
es@@	O	-1	2004015
pit@@	O	-1	2004015
e	O	-1	2004015
the	O	-1	2004015
ana@@	B-Disease	D000740	2004015
emia	I-Disease	-1	2004015
,	O	-1	2004015
the	O	-1	2004015
number	O	-1	2004015
of	O	-1	2004015
s@@	O	-1	2004015
pl@@	O	-1	2004015
en@@	O	-1	2004015
ic	O	-1	2004015
and	O	-1	2004015
b@@	O	-1	2004015
one	O	-1	2004015
m@@	O	-1	2004015
ar@@	O	-1	2004015
ro@@	O	-1	2004015
w	O	-1	2004015
B@@	O	-1	2004015
F@@	O	-1	2004015
U@@	O	-1	2004015
-@@	O	-1	2004015
e	O	-1	2004015
in	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
treated	O	-1	2004015
mice	O	-1	2004015
increased	O	-1	2004015
up	O	-1	2004015
to	O	-1	2004015
fi@@	O	-1	2004015
ve@@	O	-1	2004015
-@@	O	-1	2004015
fol@@	O	-1	2004015
d	O	-1	2004015
over	O	-1	2004015
levels	O	-1	2004015
observed	O	-1	2004015
in	O	-1	2004015
inf@@	O	-1	2004015
ected	O	-1	2004015
un@@	O	-1	2004015
treated	O	-1	2004015
animals	O	-1	2004015
after	O	-1	2004015
15	O	-1	2004015
d	O	-1	2004015
of	O	-1	2004015
treatment.	O	-1	2004015
C@@	O	-1	2004015
ol@@	O	-1	2004015
on@@	O	-1	2004015
y	O	-1	2004015
formation	O	-1	2004015
by	O	-1	2004015
s@@	O	-1	2004015
pl@@	O	-1	2004015
en@@	O	-1	2004015
ic	O	-1	2004015
and	O	-1	2004015
b@@	O	-1	2004015
one	O	-1	2004015
m@@	O	-1	2004015
ar@@	O	-1	2004015
ro@@	O	-1	2004015
w	O	-1	2004015
B@@	O	-1	2004015
F@@	O	-1	2004015
U@@	O	-1	2004015
e	O	-1	2004015
was	O	-1	2004015
stimul@@	O	-1	2004015
ated	O	-1	2004015
at	O	-1	2004015
lower	O	-1	2004015
concentrations	O	-1	2004015
of	O	-1	2004015
EP@@	O	-1	2004015
O	O	-1	2004015
in	O	-1	2004015
mice	O	-1	2004015
receiving	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
for	O	-1	2004015
15	O	-1	2004015
d	O	-1	2004015
than	O	-1	2004015
for	O	-1	2004015
inf@@	O	-1	2004015
ect@@	O	-1	2004015
ed,	O	-1	2004015
un@@	O	-1	2004015
treated	O	-1	2004015
mice.	O	-1	2004015
B@@	O	-1	2004015
y	O	-1	2004015
day	O	-1	2004015
3@@	O	-1	2004015
0@@	O	-1	2004015
,	O	-1	2004015
sensitivity	O	-1	2004015
of	O	-1	2004015
both	O	-1	2004015
s@@	O	-1	2004015
pl@@	O	-1	2004015
en@@	O	-1	2004015
ic	O	-1	2004015
and	O	-1	2004015
b@@	O	-1	2004015
one	O	-1	2004015
m@@	O	-1	2004015
ar@@	O	-1	2004015
ro@@	O	-1	2004015
w	O	-1	2004015
B@@	O	-1	2004015
F@@	O	-1	2004015
U@@	O	-1	2004015
-@@	O	-1	2004015
e	O	-1	2004015
of	O	-1	2004015
treated	O	-1	2004015
animals	O	-1	2004015
retur@@	O	-1	2004015
n@@	O	-1	2004015
ed	O	-1	2004015
to	O	-1	2004015
that	O	-1	2004015
observed	O	-1	2004015
from	O	-1	2004015
cells	O	-1	2004015
of	O	-1	2004015
inf@@	O	-1	2004015
ected	O	-1	2004015
un@@	O	-1	2004015
treated	O	-1	2004015
anim@@	O	-1	2004015
al@@	O	-1	2004015
s.	O	-1	2004015
The	O	-1	2004015
mean	O	-1	2004015
plasma	O	-1	2004015
levels	O	-1	2004015
of	O	-1	2004015
EP@@	O	-1	2004015
O	O	-1	2004015
observed	O	-1	2004015
in	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
treated	O	-1	2004015
mice	O	-1	2004015
were	O	-1	2004015
appro@@	O	-1	2004015
pri@@	O	-1	2004015
ate	O	-1	2004015
for	O	-1	2004015
the	O	-1	2004015
de@@	O	-1	2004015
g@@	O	-1	2004015
ree	O	-1	2004015
of	O	-1	2004015
ana@@	B-Disease	D000740	2004015
emia	I-Disease	-1	2004015
observed	O	-1	2004015
when	O	-1	2004015
compared	O	-1	2004015
with	O	-1	2004015
phenyl@@	B-Chemical	C030299	2004015
hy@@	I-Chemical	-1	2004015
dra@@	I-Chemical	-1	2004015
z@@	I-Chemical	-1	2004015
ine	I-Chemical	-1	2004015
(	O	-1	2004015
P@@	B-Chemical	C030299	2004015
H@@	I-Chemical	-1	2004015
Z	I-Chemical	-1	2004015
)	O	-1	2004015
treated	O	-1	2004015
mice.	O	-1	2004015
The	O	-1	2004015
numb@@	O	-1	2004015
ers	O	-1	2004015
of	O	-1	2004015
B@@	O	-1	2004015
F@@	O	-1	2004015
U@@	O	-1	2004015
-@@	O	-1	2004015
e	O	-1	2004015
and	O	-1	2004015
the	O	-1	2004015
perc@@	O	-1	2004015
ent@@	O	-1	2004015
age	O	-1	2004015
of	O	-1	2004015
b@@	O	-1	2004015
one	O	-1	2004015
m@@	O	-1	2004015
ar@@	O	-1	2004015
ro@@	O	-1	2004015
w	O	-1	2004015
erythro@@	O	-1	2004015
bl@@	O	-1	2004015
ast@@	O	-1	2004015
s	O	-1	2004015
observed	O	-1	2004015
were	O	-1	2004015
compar@@	O	-1	2004015
able	O	-1	2004015
in	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
and	O	-1	2004015
P@@	B-Chemical	C030299	2004015
H@@	I-Chemical	-1	2004015
Z	I-Chemical	-1	2004015
treated	O	-1	2004015
mice	O	-1	2004015
with	O	-1	2004015
similar	O	-1	2004015
de@@	O	-1	2004015
gre@@	O	-1	2004015
es	O	-1	2004015
of	O	-1	2004015
ana@@	B-Disease	D000740	2004015
emia	I-Disease	-1	2004015
.	O	-1	2004015
However,	O	-1	2004015
re@@	B-Disease	D045262	2004015
tic@@	I-Disease	-1	2004015
ulo@@	I-Disease	-1	2004015
cyto@@	I-Disease	-1	2004015
sis	I-Disease	-1	2004015
was	O	-1	2004015
in@@	O	-1	2004015
appro@@	O	-1	2004015
pri@@	O	-1	2004015
ate	O	-1	2004015
for	O	-1	2004015
the	O	-1	2004015
de@@	O	-1	2004015
g@@	O	-1	2004015
ree	O	-1	2004015
of	O	-1	2004015
ana@@	B-Disease	D000740	2004015
emia	I-Disease	-1	2004015
observed	O	-1	2004015
in	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
treated	O	-1	2004015
inf@@	O	-1	2004015
ected	O	-1	2004015
mice.	O	-1	2004015
A@@	B-Chemical	D015215	2004015
Z@@	I-Chemical	-1	2004015
T	I-Chemical	-1	2004015
-induced	O	-1	2004015
peripheral	O	-1	2004015
ana@@	B-Disease	D000740	2004015
emia	I-Disease	-1	2004015
in	O	-1	2004015
the	O	-1	2004015
fac@@	O	-1	2004015
e	O	-1	2004015
of	O	-1	2004015
increased	O	-1	2004015
numb@@	O	-1	2004015
ers	O	-1	2004015
of	O	-1	2004015
B@@	O	-1	2004015
F@@	O	-1	2004015
U@@	O	-1	2004015
-@@	O	-1	2004015
e	O	-1	2004015
and	O	-1	2004015
increased	O	-1	2004015
levels	O	-1	2004015
of	O	-1	2004015
plasma	O	-1	2004015
EP@@	O	-1	2004015
O	O	-1	2004015
suggest	O	-1	2004015
a	O	-1	2004015
le@@	O	-1	2004015
sion	O	-1	2004015
in	O	-1	2004015
ter@@	O	-1	2004015
min@@	O	-1	2004015
al	O	-1	2004015
differen@@	O	-1	2004015
ti@@	O	-1	2004015
ation.	O	-1	2004015

D@@	O	-1	1732442
et@@	O	-1	1732442
ection	O	-1	1732442
of	O	-1	1732442
ab@@	O	-1	1732442
normal	O	-1	1732442
cardiac	O	-1	1732442
adrenergic	O	-1	1732442
neuro@@	O	-1	1732442
n	O	-1	1732442
activity	O	-1	1732442
in	O	-1	1732442
adriam@@	B-Chemical	D004317	1732442
ycin	I-Chemical	-1	1732442
-induced	O	-1	1732442
cardi@@	B-Disease	D009202	1732442
om@@	I-Disease	-1	1732442
yo@@	I-Disease	-1	1732442
pathy	I-Disease	-1	1732442
with	O	-1	1732442
iod@@	B-Chemical	D019797	1732442
ine-@@	I-Chemical	-1	1732442
12@@	I-Chemical	-1	1732442
5-@@	I-Chemical	-1	1732442
met@@	I-Chemical	-1	1732442
a@@	I-Chemical	-1	1732442
io@@	I-Chemical	-1	1732442
do@@	I-Chemical	-1	1732442
b@@	I-Chemical	-1	1732442
enz@@	I-Chemical	-1	1732442
yl@@	I-Chemical	-1	1732442
gu@@	I-Chemical	-1	1732442
an@@	I-Chemical	-1	1732442
idine	I-Chemical	-1	1732442
.	O	-1	1732442
R@@	B-Chemical	D019797	1732442
a@@	I-Chemical	-1	1732442
di@@	I-Chemical	-1	1732442
ol@@	I-Chemical	-1	1732442
a@@	I-Chemical	-1	1732442
be@@	I-Chemical	-1	1732442
l@@	I-Chemical	-1	1732442
ed	I-Chemical	-1	1732442
met@@	I-Chemical	-1	1732442
a@@	I-Chemical	-1	1732442
io@@	I-Chemical	-1	1732442
do@@	I-Chemical	-1	1732442
b@@	I-Chemical	-1	1732442
enz@@	I-Chemical	-1	1732442
yl@@	I-Chemical	-1	1732442
gu@@	I-Chemical	-1	1732442
an@@	I-Chemical	-1	1732442
idine	I-Chemical	-1	1732442
(	O	-1	1732442
M@@	B-Chemical	D019797	1732442
I@@	I-Chemical	-1	1732442
B@@	I-Chemical	-1	1732442
G	I-Chemical	-1	1732442
),	O	-1	1732442
an	O	-1	1732442
an@@	O	-1	1732442
alo@@	O	-1	1732442
g	O	-1	1732442
of	O	-1	1732442
no@@	B-Chemical	D009638	1732442
re@@	I-Chemical	-1	1732442
p@@	I-Chemical	-1	1732442
ine@@	I-Chemical	-1	1732442
phrine	I-Chemical	-1	1732442
(	O	-1	1732442
N@@	B-Chemical	D009638	1732442
E	I-Chemical	-1	1732442
),	O	-1	1732442
ser@@	O	-1	1732442
v@@	O	-1	1732442
es	O	-1	1732442
as	O	-1	1732442
an	O	-1	1732442
in@@	O	-1	1732442
de@@	O	-1	1732442
x	O	-1	1732442
of	O	-1	1732442
adrenergic	O	-1	1732442
neuro@@	O	-1	1732442
n	O	-1	1732442
in@@	O	-1	1732442
te@@	O	-1	1732442
g@@	O	-1	1732442
r@@	O	-1	1732442
ity	O	-1	1732442
and	O	-1	1732442
func@@	O	-1	1732442
tion.	O	-1	1732442
U@@	O	-1	1732442
s@@	O	-1	1732442
ing	O	-1	1732442
a	O	-1	1732442
rat	O	-1	1732442
model	O	-1	1732442
of	O	-1	1732442
adriam@@	B-Chemical	D004317	1732442
ycin	I-Chemical	-1	1732442
-induced	O	-1	1732442
cardi@@	B-Disease	D009202	1732442
om@@	I-Disease	-1	1732442
yo@@	I-Disease	-1	1732442
pathy	I-Disease	-1	1732442
,	O	-1	1732442
we	O	-1	1732442
tested	O	-1	1732442
the	O	-1	1732442
hypo@@	O	-1	1732442
thesis	O	-1	1732442
that	O	-1	1732442
ab@@	O	-1	1732442
normal	O	-1	1732442
cardiac	O	-1	1732442
adrenergic	O	-1	1732442
neuro@@	O	-1	1732442
n	O	-1	1732442
activity	O	-1	1732442
may	O	-1	1732442
appe@@	O	-1	1732442
ar	O	-1	1732442
and	O	-1	1732442
be	O	-1	1732442
ex@@	O	-1	1732442
ac@@	O	-1	1732442
er@@	O	-1	1732442
b@@	O	-1	1732442
ated	O	-1	1732442
dose-@@	O	-1	1732442
depend@@	O	-1	1732442
ently	O	-1	1732442
in	O	-1	1732442
adriam@@	B-Chemical	D004317	1732442
ycin	I-Chemical	-1	1732442
cardi@@	B-Disease	D009202	1732442
om@@	I-Disease	-1	1732442
yo@@	I-Disease	-1	1732442
pathy	I-Disease	-1	1732442
.	O	-1	1732442
The	O	-1	1732442
de@@	O	-1	1732442
g@@	O	-1	1732442
ree	O	-1	1732442
of	O	-1	1732442
vac@@	B-Disease	C536522	1732442
u@@	I-Disease	-1	1732442
ol@@	I-Disease	-1	1732442
ar	I-Disease	-1	1732442
de@@	I-Disease	-1	1732442
generation	I-Disease	-1	1732442
of	I-Disease	-1	1732442
myocardial	I-Disease	-1	1732442
cells	I-Disease	-1	1732442
was	O	-1	1732442
analy@@	O	-1	1732442
zed	O	-1	1732442
in	O	-1	1732442
rel@@	O	-1	1732442
ation	O	-1	1732442
to	O	-1	1732442
the	O	-1	1732442
duration	O	-1	1732442
of	O	-1	1732442
adriam@@	B-Chemical	D004317	1732442
ycin	I-Chemical	-1	1732442
treatment	O	-1	1732442
(@@	O	-1	1732442
2	O	-1	1732442
mg/kg@@	O	-1	1732442
,	O	-1	1732442
on@@	O	-1	1732442
ce	O	-1	1732442
a	O	-1	1732442
week@@	O	-1	1732442
).	O	-1	1732442
There	O	-1	1732442
were	O	-1	1732442
no	O	-1	1732442
abnormal@@	O	-1	1732442
ities	O	-1	1732442
or	O	-1	1732442
only	O	-1	1732442
isol@@	O	-1	1732442
ated	O	-1	1732442
de@@	O	-1	1732442
generation	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
1@@	O	-1	1732442
-	O	-1	1732442
or	O	-1	1732442
2-@@	O	-1	1732442
w@@	O	-1	1732442
k	O	-1	1732442
treatment	O	-1	1732442
group@@	O	-1	1732442
s,	O	-1	1732442
isol@@	O	-1	1732442
ated	O	-1	1732442
or	O	-1	1732442
s@@	O	-1	1732442
cat@@	O	-1	1732442
te@@	O	-1	1732442
red	O	-1	1732442
de@@	O	-1	1732442
generation	O	-1	1732442
in	O	-1	1732442
h@@	O	-1	1732442
al@@	O	-1	1732442
f	O	-1	1732442
of	O	-1	1732442
the	O	-1	1732442
3-@@	O	-1	1732442
w@@	O	-1	1732442
k	O	-1	1732442
group@@	O	-1	1732442
,	O	-1	1732442
frequent	O	-1	1732442
s@@	O	-1	1732442
cat@@	O	-1	1732442
te@@	O	-1	1732442
red	O	-1	1732442
de@@	O	-1	1732442
generation	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
4-@@	O	-1	1732442
w@@	O	-1	1732442
k	O	-1	1732442
group@@	O	-1	1732442
,	O	-1	1732442
s@@	O	-1	1732442
cat@@	O	-1	1732442
te@@	O	-1	1732442
red	O	-1	1732442
or	O	-1	1732442
foc@@	O	-1	1732442
al	O	-1	1732442
de@@	O	-1	1732442
generation	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
5-@@	O	-1	1732442
w@@	O	-1	1732442
k	O	-1	1732442
group@@	O	-1	1732442
,	O	-1	1732442
and	O	-1	1732442
exten@@	O	-1	1732442
sive	O	-1	1732442
de@@	O	-1	1732442
generation	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
8@@	O	-1	1732442
-@@	O	-1	1732442
w@@	O	-1	1732442
k	O	-1	1732442
group.	O	-1	1732442
M@@	O	-1	1732442
y@@	O	-1	1732442
ocardi@@	O	-1	1732442
al	O	-1	1732442
accum@@	O	-1	1732442
ulation	O	-1	1732442
of	O	-1	1732442
[@@	O	-1	1732442
12@@	O	-1	1732442
5@@	O	-1	1732442
I@@	O	-1	1732442
]	O	-1	1732442
M@@	B-Chemical	D019797	1732442
I@@	I-Chemical	-1	1732442
B@@	I-Chemical	-1	1732442
G	I-Chemical	-1	1732442
4	O	-1	1732442
h@@	O	-1	1732442
r	O	-1	1732442
after	O	-1	1732442
intravenous	O	-1	1732442
injection	O	-1	1732442
did	O	-1	1732442
not	O	-1	1732442
diff@@	O	-1	1732442
er	O	-1	1732442
between	O	-1	1732442
the	O	-1	1732442
controls	O	-1	1732442
and	O	-1	1732442
the	O	-1	1732442
groups	O	-1	1732442
treated	O	-1	1732442
3	O	-1	1732442
w@@	O	-1	1732442
k	O	-1	1732442
or	O	-1	1732442
l@@	O	-1	1732442
es@@	O	-1	1732442
s.	O	-1	1732442
However,	O	-1	1732442
the	O	-1	1732442
4-@@	O	-1	1732442
w@@	O	-1	1732442
k	O	-1	1732442
group	O	-1	1732442
had	O	-1	1732442
a	O	-1	1732442
s@@	O	-1	1732442
li@@	O	-1	1732442
gh@@	O	-1	1732442
tly	O	-1	1732442
lower	O	-1	1732442
accum@@	O	-1	1732442
ulation	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
right	O	-1	1732442
ventricular	O	-1	1732442
w@@	O	-1	1732442
all	O	-1	1732442
(@@	O	-1	1732442
8@@	O	-1	1732442
2@@	O	-1	1732442
%	O	-1	1732442
of	O	-1	1732442
the	O	-1	1732442
control@@	O	-1	1732442
)	O	-1	1732442
and	O	-1	1732442
significantly	O	-1	1732442
lower	O	-1	1732442
accum@@	O	-1	1732442
ulation	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
left	O	-1	1732442
ventricular	O	-1	1732442
w@@	O	-1	1732442
all	O	-1	1732442
(@@	O	-1	1732442
about	O	-1	1732442
6@@	O	-1	1732442
6%	O	-1	1732442
of	O	-1	1732442
the	O	-1	1732442
control@@	O	-1	1732442
:	O	-1	1732442
p	O	-1	1732442
less	O	-1	1732442
than	O	-1	1732442
0.05@@	O	-1	1732442
).	O	-1	1732442
In	O	-1	1732442
the	O	-1	1732442
5-@@	O	-1	1732442
w@@	O	-1	1732442
k	O	-1	1732442
group@@	O	-1	1732442
,	O	-1	1732442
M@@	B-Chemical	D019797	1732442
I@@	I-Chemical	-1	1732442
B@@	I-Chemical	-1	1732442
G	I-Chemical	-1	1732442
accum@@	O	-1	1732442
ulation	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
right	O	-1	1732442
and	O	-1	1732442
left	O	-1	1732442
ventricular	O	-1	1732442
w@@	O	-1	1732442
all	O	-1	1732442
was	O	-1	1732442
3@@	O	-1	1732442
5%	O	-1	1732442
and	O	-1	1732442
27@@	O	-1	1732442
%	O	-1	1732442
of	O	-1	1732442
that	O	-1	1732442
in	O	-1	1732442
control@@	O	-1	1732442
s,	O	-1	1732442
respecti@@	O	-1	1732442
vely	O	-1	1732442
(p	O	-1	1732442
less	O	-1	1732442
than	O	-1	1732442
0.00@@	O	-1	1732442
1).	O	-1	1732442
In	O	-1	1732442
the	O	-1	1732442
8@@	O	-1	1732442
-@@	O	-1	1732442
w@@	O	-1	1732442
k	O	-1	1732442
group@@	O	-1	1732442
,	O	-1	1732442
M@@	B-Chemical	D019797	1732442
I@@	I-Chemical	-1	1732442
B@@	I-Chemical	-1	1732442
G	I-Chemical	-1	1732442
accum@@	O	-1	1732442
ulation	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
right	O	-1	1732442
and	O	-1	1732442
left	O	-1	1732442
ventricular	O	-1	1732442
w@@	O	-1	1732442
all	O	-1	1732442
was	O	-1	1732442
18@@	O	-1	1732442
%	O	-1	1732442
and	O	-1	1732442
14@@	O	-1	1732442
%	O	-1	1732442
of	O	-1	1732442
that	O	-1	1732442
in	O	-1	1732442
control@@	O	-1	1732442
s,	O	-1	1732442
respecti@@	O	-1	1732442
vely	O	-1	1732442
(p	O	-1	1732442
less	O	-1	1732442
than	O	-1	1732442
0.00@@	O	-1	1732442
1).	O	-1	1732442
Th@@	O	-1	1732442
us,	O	-1	1732442
M@@	B-Chemical	D019797	1732442
I@@	I-Chemical	-1	1732442
B@@	I-Chemical	-1	1732442
G	I-Chemical	-1	1732442
accum@@	O	-1	1732442
ulation	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
myocardi@@	O	-1	1732442
um	O	-1	1732442
decreased	O	-1	1732442
in	O	-1	1732442
an	O	-1	1732442
adriam@@	B-Chemical	D004317	1732442
ycin	I-Chemical	-1	1732442
dose-@@	O	-1	1732442
dependent	O	-1	1732442
man@@	O	-1	1732442
ner@@	O	-1	1732442
.	O	-1	1732442
The	O	-1	1732442
appear@@	O	-1	1732442
ance	O	-1	1732442
of	O	-1	1732442
impaired	O	-1	1732442
cardiac	O	-1	1732442
adrenergic	O	-1	1732442
neuro@@	O	-1	1732442
n	O	-1	1732442
activity	O	-1	1732442
in	O	-1	1732442
the	O	-1	1732442
presence	O	-1	1732442
of	O	-1	1732442
s@@	O	-1	1732442
li@@	O	-1	1732442
ght	O	-1	1732442
myocardial	B-Disease	D009202	1732442
impair@@	I-Disease	-1	1732442
ment	I-Disease	-1	1732442
(@@	O	-1	1732442
s@@	O	-1	1732442
cat@@	O	-1	1732442
te@@	O	-1	1732442
red	O	-1	1732442
or	O	-1	1732442
foc@@	O	-1	1732442
al	O	-1	1732442
vac@@	B-Disease	C536522	1732442
u@@	I-Disease	-1	1732442
ol@@	I-Disease	-1	1732442
ar	I-Disease	-1	1732442
de@@	I-Disease	-1	1732442
generation	I-Disease	-1	1732442
)	O	-1	1732442
indic@@	O	-1	1732442
ates	O	-1	1732442
that	O	-1	1732442
M@@	B-Chemical	D019797	1732442
I@@	I-Chemical	-1	1732442
B@@	I-Chemical	-1	1732442
G	I-Chemical	-1	1732442
s@@	O	-1	1732442
cin@@	O	-1	1732442
ti@@	O	-1	1732442
graph@@	O	-1	1732442
y	O	-1	1732442
may	O	-1	1732442
be	O	-1	1732442
a	O	-1	1732442
use@@	O	-1	1732442
ful	O	-1	1732442
meth@@	O	-1	1732442
od	O	-1	1732442
for	O	-1	1732442
det@@	O	-1	1732442
ection	O	-1	1732442
of	O	-1	1732442
adriam@@	B-Chemical	D004317	1732442
ycin	I-Chemical	-1	1732442
-induced	O	-1	1732442
cardi@@	B-Disease	D009202	1732442
om@@	I-Disease	-1	1732442
yo@@	I-Disease	-1	1732442
pathy	I-Disease	-1	1732442
.	O	-1	1732442

A@@	B-Disease	D000647	1423339
m@@	I-Disease	-1	1423339
n@@	I-Disease	-1	1423339
es@@	I-Disease	-1	1423339
tic	I-Disease	-1	1423339
syndrome	I-Disease	-1	1423339
associated	O	-1	1423339
with	O	-1	1423339
prop@@	B-Chemical	D011433	1423339
ran@@	I-Chemical	-1	1423339
o@@	I-Chemical	-1	1423339
lol	I-Chemical	-1	1423339
toxicity	B-Disease	D064420	1423339
:	O	-1	1423339
a	O	-1	1423339
case	O	-1	1423339
repor@@	O	-1	1423339
t.	O	-1	1423339
An	O	-1	1423339
el@@	O	-1	1423339
der@@	O	-1	1423339
ly	O	-1	1423339
woman	O	-1	1423339
developed	O	-1	1423339
an	O	-1	1423339
Al@@	B-Disease	D000544	1423339
z@@	I-Disease	-1	1423339
he@@	I-Disease	-1	1423339
im@@	I-Disease	-1	1423339
er	I-Disease	-1	1423339
-@@	O	-1	1423339
like	O	-1	1423339
sub@@	O	-1	1423339
acute	O	-1	1423339
de@@	B-Disease	D003704	1423339
m@@	I-Disease	-1	1423339
enti@@	I-Disease	-1	1423339
a	I-Disease	-1	1423339
as	O	-1	1423339
a	O	-1	1423339
result	O	-1	1423339
of	O	-1	1423339
prop@@	B-Chemical	D011433	1423339
ran@@	I-Chemical	-1	1423339
o@@	I-Chemical	-1	1423339
lol	I-Chemical	-1	1423339
toxicity	B-Disease	D064420	1423339
.	O	-1	1423339
An@@	O	-1	1423339
aly@@	O	-1	1423339
sis	O	-1	1423339
of	O	-1	1423339
the	O	-1	1423339
man@@	O	-1	1423339
if@@	O	-1	1423339
est@@	O	-1	1423339
ations	O	-1	1423339
showed	O	-1	1423339
that	O	-1	1423339
severe	O	-1	1423339
impair@@	O	-1	1423339
ment	O	-1	1423339
of	O	-1	1423339
memory	O	-1	1423339
ac@@	O	-1	1423339
coun@@	O	-1	1423339
ted	O	-1	1423339
for	O	-1	1423339
vi@@	O	-1	1423339
r@@	O	-1	1423339
tu@@	O	-1	1423339
ally	O	-1	1423339
all	O	-1	1423339
of	O	-1	1423339
the	O	-1	1423339
abnormal@@	O	-1	1423339
iti@@	O	-1	1423339
es.	O	-1	1423339
There	O	-1	1423339
is	O	-1	1423339
evidence	O	-1	1423339
that	O	-1	1423339
cerebral	O	-1	1423339
reactions	O	-1	1423339
to	O	-1	1423339
drug	O	-1	1423339
toxicity	B-Disease	D064420	1423339
can	O	-1	1423339
ex@@	O	-1	1423339
hib@@	O	-1	1423339
it	O	-1	1423339
pat@@	O	-1	1423339
tern@@	O	-1	1423339
s	O	-1	1423339
that	O	-1	1423339
suggest	O	-1	1423339
high@@	O	-1	1423339
ly	O	-1	1423339
selective	O	-1	1423339
invol@@	O	-1	1423339
vement	O	-1	1423339
of	O	-1	1423339
functional	O	-1	1423339
sub@@	O	-1	1423339
di@@	O	-1	1423339
vi@@	O	-1	1423339
sions	O	-1	1423339
of	O	-1	1423339
the	O	-1	1423339
bra@@	O	-1	1423339
in.	O	-1	1423339

B@@	O	-1	921394
i@@	O	-1	921394
pha@@	O	-1	921394
sic	O	-1	921394
response	O	-1	921394
of	O	-1	921394
the	O	-1	921394
S@@	O	-1	921394
A	O	-1	921394
no@@	O	-1	921394
de	O	-1	921394
of	O	-1	921394
the	O	-1	921394
do@@	O	-1	921394
g	O	-1	921394
heart	O	-1	921394
in	O	-1	921394
viv@@	O	-1	921394
o	O	-1	921394
to	O	-1	921394
selective	O	-1	921394
administration	O	-1	921394
of	O	-1	921394
k@@	B-Chemical	D007649	921394
et@@	I-Chemical	-1	921394
amine	I-Chemical	-1	921394
.	O	-1	921394
Eff@@	O	-1	921394
ect	O	-1	921394
of	O	-1	921394
k@@	B-Chemical	D007649	921394
et@@	I-Chemical	-1	921394
amine	I-Chemical	-1	921394
on	O	-1	921394
the	O	-1	921394
S@@	O	-1	921394
A	O	-1	921394
no@@	O	-1	921394
de	O	-1	921394
of	O	-1	921394
the	O	-1	921394
do@@	O	-1	921394
g	O	-1	921394
heart	O	-1	921394
was	O	-1	921394
studied	O	-1	921394
in	O	-1	921394
viv@@	O	-1	921394
o	O	-1	921394
using	O	-1	921394
a	O	-1	921394
selective	O	-1	921394
per@@	O	-1	921394
f@@	O	-1	921394
usion	O	-1	921394
t@@	O	-1	921394
ech@@	O	-1	921394
n@@	O	-1	921394
i@@	O	-1	921394
qu@@	O	-1	921394
e	O	-1	921394
of	O	-1	921394
the	O	-1	921394
S@@	O	-1	921394
A	O	-1	921394
no@@	O	-1	921394
de	O	-1	921394
arter@@	O	-1	921394
y.	O	-1	921394
In@@	O	-1	921394
j@@	O	-1	921394
ec@@	O	-1	921394
tions	O	-1	921394
of	O	-1	921394
k@@	B-Chemical	D007649	921394
et@@	I-Chemical	-1	921394
amine	I-Chemical	-1	921394
in	O	-1	921394
doses	O	-1	921394
from	O	-1	921394
100	O	-1	921394
micro@@	O	-1	921394
gra@@	O	-1	921394
m	O	-1	921394
to	O	-1	921394
3	O	-1	921394
mg	O	-1	921394
into	O	-1	921394
the	O	-1	921394
artery	O	-1	921394
produced	O	-1	921394
a	O	-1	921394
de@@	B-Disease	D003866	921394
pression	I-Disease	-1	921394
of	O	-1	921394
the	O	-1	921394
S@@	O	-1	921394
A	O	-1	921394
no@@	O	-1	921394
d@@	O	-1	921394
al	O	-1	921394
activity	O	-1	921394
by	O	-1	921394
a	O	-1	921394
direct	O	-1	921394
ac@@	O	-1	921394
tion.	O	-1	921394
This	O	-1	921394
de@@	B-Disease	D003866	921394
pression	I-Disease	-1	921394
was	O	-1	921394
followed	O	-1	921394
by	O	-1	921394
the	O	-1	921394
su@@	O	-1	921394
d@@	O	-1	921394
de@@	O	-1	921394
n	O	-1	921394
appear@@	O	-1	921394
ance	O	-1	921394
of	O	-1	921394
a	O	-1	921394
stimul@@	O	-1	921394
atory	O	-1	921394
ph@@	O	-1	921394
as@@	O	-1	921394
e.	O	-1	921394
B@@	O	-1	921394
il@@	O	-1	921394
ateral	O	-1	921394
v@@	O	-1	921394
ag@@	O	-1	921394
ot@@	O	-1	921394
om@@	O	-1	921394
y	O	-1	921394
and	O	-1	921394
sym@@	O	-1	921394
path@@	O	-1	921394
ect@@	O	-1	921394
om@@	O	-1	921394
y	O	-1	921394
or	O	-1	921394
prior	O	-1	921394
administration	O	-1	921394
of	O	-1	921394
a	O	-1	921394
g@@	O	-1	921394
ang@@	O	-1	921394
li@@	O	-1	921394
on	O	-1	921394
block@@	O	-1	921394
er	O	-1	921394
fail@@	O	-1	921394
ed	O	-1	921394
to	O	-1	921394
inhib@@	O	-1	921394
it	O	-1	921394
the	O	-1	921394
occur@@	O	-1	921394
rence	O	-1	921394
of	O	-1	921394
the	O	-1	921394
k@@	B-Chemical	D007649	921394
et@@	I-Chemical	-1	921394
amine	I-Chemical	-1	921394
-induced	O	-1	921394
tachycardia	B-Disease	D013610	921394
,	O	-1	921394
while	O	-1	921394
it	O	-1	921394
was	O	-1	921394
complete@@	O	-1	921394
ly	O	-1	921394
abol@@	O	-1	921394
ished	O	-1	921394
in	O	-1	921394
the	O	-1	921394
res@@	O	-1	921394
er@@	O	-1	921394
p@@	O	-1	921394
in@@	O	-1	921394
ized	O	-1	921394
dog@@	O	-1	921394
s	O	-1	921394
or	O	-1	921394
by	O	-1	921394
a	O	-1	921394
prior	O	-1	921394
injection	O	-1	921394
of	O	-1	921394
a	O	-1	921394
beta-@@	O	-1	921394
block@@	O	-1	921394
ing	O	-1	921394
agent	O	-1	921394
into	O	-1	921394
the	O	-1	921394
S@@	O	-1	921394
A	O	-1	921394
no@@	O	-1	921394
de	O	-1	921394
arter@@	O	-1	921394
y.	O	-1	921394
This	O	-1	921394
may	O	-1	921394
indicate	O	-1	921394
that	O	-1	921394
an	O	-1	921394
activation	O	-1	921394
of	O	-1	921394
the	O	-1	921394
peripheral	O	-1	921394
adrenergic	O	-1	921394
mechanism	O	-1	921394
pl@@	O	-1	921394
ays	O	-1	921394
an	O	-1	921394
important	O	-1	921394
role	O	-1	921394
in	O	-1	921394
the	O	-1	921394
induction	O	-1	921394
of	O	-1	921394
the	O	-1	921394
ex@@	O	-1	921394
cit@@	O	-1	921394
atory	O	-1	921394
effect	O	-1	921394
of	O	-1	921394
k@@	B-Chemical	D007649	921394
et@@	I-Chemical	-1	921394
amine	I-Chemical	-1	921394
injected	O	-1	921394
in	O	-1	921394
the	O	-1	921394
S@@	O	-1	921394
A	O	-1	921394
no@@	O	-1	921394
de	O	-1	921394
arter@@	O	-1	921394
y.	O	-1	921394

The	O	-1	871943
use	O	-1	871943
of	O	-1	871943
serum	O	-1	871943
chol@@	O	-1	871943
ine@@	O	-1	871943
ster@@	O	-1	871943
ase	O	-1	871943
in	O	-1	871943
suc@@	B-Chemical	D013390	871943
cin@@	I-Chemical	-1	871943
ylcholine	I-Chemical	-1	871943
ap@@	B-Disease	D001049	871943
no@@	I-Disease	-1	871943
e@@	I-Disease	-1	871943
a	I-Disease	-1	871943
.	O	-1	871943
F@@	O	-1	871943
if@@	O	-1	871943
te@@	O	-1	871943
en	O	-1	871943
patients	O	-1	871943
demon@@	O	-1	871943
strat@@	O	-1	871943
ing	O	-1	871943
un@@	O	-1	871943
ex@@	O	-1	871943
p@@	O	-1	871943
ected	O	-1	871943
prolonged	O	-1	871943
ap@@	B-Disease	D001049	871943
no@@	I-Disease	-1	871943
e@@	I-Disease	-1	871943
a	I-Disease	-1	871943
l@@	O	-1	871943
ast@@	O	-1	871943
ing	O	-1	871943
several	O	-1	871943
hours	O	-1	871943
after	O	-1	871943
suc@@	B-Chemical	D013390	871943
cin@@	I-Chemical	-1	871943
ylcholine	I-Chemical	-1	871943
have	O	-1	871943
been	O	-1	871943
treated	O	-1	871943
by	O	-1	871943
a	O	-1	871943
new	O	-1	871943
pre@@	O	-1	871943
par@@	O	-1	871943
ation	O	-1	871943
of	O	-1	871943
human	O	-1	871943
serum	O	-1	871943
chol@@	O	-1	871943
ine@@	O	-1	871943
ster@@	O	-1	871943
as@@	O	-1	871943
e.	O	-1	871943
A@@	O	-1	871943
de@@	O	-1	871943
qu@@	O	-1	871943
ate	O	-1	871943
spont@@	O	-1	871943
aneous	O	-1	871943
res@@	O	-1	871943
pi@@	O	-1	871943
ration	O	-1	871943
was	O	-1	871943
re@@	O	-1	871943
-@@	O	-1	871943
est@@	O	-1	871943
abl@@	O	-1	871943
ished	O	-1	871943
in	O	-1	871943
an	O	-1	871943
average	O	-1	871943
period	O	-1	871943
of	O	-1	871943
ten	O	-1	871943
minutes	O	-1	871943
after	O	-1	871943
the	O	-1	871943
injec@@	O	-1	871943
tion.	O	-1	871943
In	O	-1	871943
12	O	-1	871943
patients	O	-1	871943
bio@@	O	-1	871943
chemical	O	-1	871943
gene@@	O	-1	871943
tic	O	-1	871943
examin@@	O	-1	871943
ations	O	-1	871943
con@@	O	-1	871943
fir@@	O	-1	871943
m@@	O	-1	871943
ed	O	-1	871943
the	O	-1	871943
presence	O	-1	871943
of	O	-1	871943
an	O	-1	871943
at@@	O	-1	871943
yp@@	O	-1	871943
ical	O	-1	871943
serum	O	-1	871943
chol@@	O	-1	871943
ine@@	O	-1	871943
ster@@	O	-1	871943
as@@	O	-1	871943
e.	O	-1	871943
In	O	-1	871943
three	O	-1	871943
patients	O	-1	871943
n@@	O	-1	871943
one	O	-1	871943
of	O	-1	871943
the	O	-1	871943
us@@	O	-1	871943
ual	O	-1	871943
vari@@	O	-1	871943
ants	O	-1	871943
were	O	-1	871943
f@@	O	-1	871943
oun@@	O	-1	871943
d.	O	-1	871943
It	O	-1	871943
is	O	-1	871943
the@@	O	-1	871943
re@@	O	-1	871943
fore	O	-1	871943
sup@@	O	-1	871943
pos@@	O	-1	871943
ed	O	-1	871943
that	O	-1	871943
other	O	-1	871943
un@@	O	-1	871943
known	O	-1	871943
vari@@	O	-1	871943
ants	O	-1	871943
of	O	-1	871943
serum	O	-1	871943
chol@@	O	-1	871943
ine@@	O	-1	871943
ster@@	O	-1	871943
ase	O	-1	871943
ex@@	O	-1	871943
ist	O	-1	871943
which	O	-1	871943
can@@	O	-1	871943
not	O	-1	871943
hydro@@	O	-1	871943
ly@@	O	-1	871943
ze	O	-1	871943
suc@@	B-Chemical	D013390	871943
cin@@	I-Chemical	-1	871943
ylcholine	I-Chemical	-1	871943
.	O	-1	871943
The	O	-1	871943
use	O	-1	871943
of	O	-1	871943
serum	O	-1	871943
chol@@	O	-1	871943
ine@@	O	-1	871943
ster@@	O	-1	871943
ase	O	-1	871943
in	O	-1	871943
suc@@	B-Chemical	D013390	871943
cin@@	I-Chemical	-1	871943
ylcholine	I-Chemical	-1	871943
ap@@	B-Disease	D001049	871943
no@@	I-Disease	-1	871943
e@@	I-Disease	-1	871943
a	I-Disease	-1	871943
pro@@	O	-1	871943
vid@@	O	-1	871943
ed	O	-1	871943
con@@	O	-1	871943
si@@	O	-1	871943
der@@	O	-1	871943
able	O	-1	871943
re@@	O	-1	871943
li@@	O	-1	871943
e@@	O	-1	871943
f	O	-1	871943
to	O	-1	871943
both	O	-1	871943
patient	O	-1	871943
and	O	-1	871943
anaesthe@@	O	-1	871943
ti@@	O	-1	871943
st@@	O	-1	871943
.	O	-1	871943

O@@	B-Disease	D007024	1355091
r@@	I-Disease	-1	1355091
th@@	I-Disease	-1	1355091
ost@@	I-Disease	-1	1355091
atic	I-Disease	-1	1355091
hypotension	I-Disease	-1	1355091
occur@@	O	-1	1355091
s	O	-1	1355091
following	O	-1	1355091
al@@	O	-1	1355091
ph@@	O	-1	1355091
a	O	-1	1355091
2-@@	O	-1	1355091
adren@@	O	-1	1355091
oc@@	O	-1	1355091
e@@	O	-1	1355091
pt@@	O	-1	1355091
or	O	-1	1355091
block@@	O	-1	1355091
ade	O	-1	1355091
in	O	-1	1355091
chronic	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
-@@	O	-1	1355091
pre@@	O	-1	1355091
treated	O	-1	1355091
con@@	O	-1	1355091
s@@	O	-1	1355091
ci@@	O	-1	1355091
ous	O	-1	1355091
spont@@	O	-1	1355091
ane@@	O	-1	1355091
ously	O	-1	1355091
hypertensive	B-Disease	D006973	1355091
rats.	O	-1	1355091
1@@	O	-1	1355091
.	O	-1	1355091
S@@	O	-1	1355091
t@@	O	-1	1355091
udi@@	O	-1	1355091
es	O	-1	1355091
were	O	-1	1355091
performed	O	-1	1355091
to	O	-1	1355091
evalu@@	O	-1	1355091
ate	O	-1	1355091
whether	O	-1	1355091
chronic	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
treatment	O	-1	1355091
al@@	O	-1	1355091
ters	O	-1	1355091
the	O	-1	1355091
al@@	O	-1	1355091
ph@@	O	-1	1355091
a	O	-1	1355091
2-@@	O	-1	1355091
adren@@	O	-1	1355091
oc@@	O	-1	1355091
e@@	O	-1	1355091
pt@@	O	-1	1355091
or	O	-1	1355091
function	O	-1	1355091
for	O	-1	1355091
or@@	O	-1	1355091
th@@	O	-1	1355091
ost@@	O	-1	1355091
atic	O	-1	1355091
control	O	-1	1355091
of	O	-1	1355091
arterial	O	-1	1355091
blood	O	-1	1355091
pressure	O	-1	1355091
in	O	-1	1355091
con@@	O	-1	1355091
s@@	O	-1	1355091
ci@@	O	-1	1355091
ous	O	-1	1355091
spont@@	O	-1	1355091
ane@@	O	-1	1355091
ously	O	-1	1355091
hypertensive	B-Disease	D006973	1355091
rats	O	-1	1355091
(S@@	O	-1	1355091
H@@	O	-1	1355091
R@@	O	-1	1355091
).	O	-1	1355091
2@@	O	-1	1355091
.	O	-1	1355091
Con@@	O	-1	1355091
s@@	O	-1	1355091
ci@@	O	-1	1355091
ous	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
(@@	O	-1	1355091
male	O	-1	1355091
3@@	O	-1	1355091
0@@	O	-1	1355091
0-@@	O	-1	1355091
3@@	O	-1	1355091
50	O	-1	1355091
g@@	O	-1	1355091
)	O	-1	1355091
were	O	-1	1355091
subj@@	O	-1	1355091
ected	O	-1	1355091
to	O	-1	1355091
9@@	O	-1	1355091
0	O	-1	1355091
de@@	O	-1	1355091
gre@@	O	-1	1355091
es	O	-1	1355091
head@@	O	-1	1355091
-@@	O	-1	1355091
up	O	-1	1355091
til@@	O	-1	1355091
ts	O	-1	1355091
for	O	-1	1355091
60	O	-1	1355091
s	O	-1	1355091
following	O	-1	1355091
acute	O	-1	1355091
administration	O	-1	1355091
of	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
(0.@@	O	-1	1355091
1	O	-1	1355091
mg	O	-1	1355091
kg@@	O	-1	1355091
-1	O	-1	1355091
i.p.@@	O	-1	1355091
)	O	-1	1355091
or	O	-1	1355091
ra@@	B-Chemical	D015016	1355091
u@@	I-Chemical	-1	1355091
w@@	I-Chemical	-1	1355091
ol@@	I-Chemical	-1	1355091
s@@	I-Chemical	-1	1355091
c@@	I-Chemical	-1	1355091
ine	I-Chemical	-1	1355091
(@@	O	-1	1355091
3	O	-1	1355091
mg	O	-1	1355091
kg@@	O	-1	1355091
-1	O	-1	1355091
i.v@@	O	-1	1355091
.@@	O	-1	1355091
).	O	-1	1355091
O@@	B-Disease	D007024	1355091
r@@	I-Disease	-1	1355091
th@@	I-Disease	-1	1355091
ost@@	I-Disease	-1	1355091
atic	I-Disease	-1	1355091
hypotension	I-Disease	-1	1355091
was	O	-1	1355091
determined	O	-1	1355091
by	O	-1	1355091
the	O	-1	1355091
average	O	-1	1355091
decrease	O	-1	1355091
(@@	O	-1	1355091
%)	O	-1	1355091
in	O	-1	1355091
mean	O	-1	1355091
arterial	O	-1	1355091
pressure	O	-1	1355091
(@@	O	-1	1355091
MA@@	O	-1	1355091
P	O	-1	1355091
fem@@	O	-1	1355091
or@@	O	-1	1355091
al@@	O	-1	1355091
)	O	-1	1355091
over	O	-1	1355091
the	O	-1	1355091
6@@	O	-1	1355091
0-@@	O	-1	1355091
s	O	-1	1355091
til@@	O	-1	1355091
t	O	-1	1355091
perio@@	O	-1	1355091
d.	O	-1	1355091
The	O	-1	1355091
bas@@	O	-1	1355091
al	O	-1	1355091
MA@@	O	-1	1355091
P	O	-1	1355091
of	O	-1	1355091
con@@	O	-1	1355091
s@@	O	-1	1355091
ci@@	O	-1	1355091
ous	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
was	O	-1	1355091
reduced	O	-1	1355091
to	O	-1	1355091
a	O	-1	1355091
similar	O	-1	1355091
ext@@	O	-1	1355091
ent	O	-1	1355091
by	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
(-@@	O	-1	1355091
2@@	O	-1	1355091
3@@	O	-1	1355091
%@@	O	-1	1355091
(-@@	O	-1	1355091
)-@@	O	-1	1355091
2@@	O	-1	1355091
6%	O	-1	1355091
MA@@	O	-1	1355091
P)	O	-1	1355091
and	O	-1	1355091
ra@@	B-Chemical	D015016	1355091
u@@	I-Chemical	-1	1355091
w@@	I-Chemical	-1	1355091
ol@@	I-Chemical	-1	1355091
s@@	I-Chemical	-1	1355091
c@@	I-Chemical	-1	1355091
ine	I-Chemical	-1	1355091
(@@	O	-1	1355091
-1@@	O	-1	1355091
6@@	O	-1	1355091
%@@	O	-1	1355091
(-@@	O	-1	1355091
)-@@	O	-1	1355091
3@@	O	-1	1355091
3@@	O	-1	1355091
%	O	-1	1355091
MA@@	O	-1	1355091
P@@	O	-1	1355091
).	O	-1	1355091
However,	O	-1	1355091
the	O	-1	1355091
head@@	O	-1	1355091
-@@	O	-1	1355091
up	O	-1	1355091
til@@	O	-1	1355091
t	O	-1	1355091
induced	O	-1	1355091
or@@	B-Disease	D007024	1355091
th@@	I-Disease	-1	1355091
ost@@	I-Disease	-1	1355091
atic	I-Disease	-1	1355091
hypotension	I-Disease	-1	1355091
in	O	-1	1355091
the	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
treated	O	-1	1355091
with	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
(@@	O	-1	1355091
-1@@	O	-1	1355091
6%	O	-1	1355091
MA@@	O	-1	1355091
P@@	O	-1	1355091
,	O	-1	1355091
n	O	-1	1355091
=	O	-1	1355091
6@@	O	-1	1355091
),	O	-1	1355091
but	O	-1	1355091
not	O	-1	1355091
in	O	-1	1355091
the	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
treated	O	-1	1355091
with	O	-1	1355091
ra@@	B-Chemical	D015016	1355091
u@@	I-Chemical	-1	1355091
w@@	I-Chemical	-1	1355091
ol@@	I-Chemical	-1	1355091
s@@	I-Chemical	-1	1355091
c@@	I-Chemical	-1	1355091
ine	I-Chemical	-1	1355091
(@@	O	-1	1355091
less	O	-1	1355091
than	O	-1	1355091
+@@	O	-1	1355091
2@@	O	-1	1355091
%	O	-1	1355091
MA@@	O	-1	1355091
P@@	O	-1	1355091
,	O	-1	1355091
n	O	-1	1355091
=	O	-1	1355091
6@@	O	-1	1355091
).	O	-1	1355091
3@@	O	-1	1355091
.	O	-1	1355091
Con@@	O	-1	1355091
s@@	O	-1	1355091
ci@@	O	-1	1355091
ous	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
were	O	-1	1355091
treated	O	-1	1355091
for	O	-1	1355091
4	O	-1	1355091
days	O	-1	1355091
with	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
at	O	-1	1355091
2	O	-1	1355091
mg	O	-1	1355091
kg@@	O	-1	1355091
-1	O	-1	1355091
day@@	O	-1	1355091
-1	O	-1	1355091
i.@@	O	-1	1355091
p@@	O	-1	1355091
.	O	-1	1355091
for	O	-1	1355091
chronic	O	-1	1355091
al@@	O	-1	1355091
ph@@	O	-1	1355091
a	O	-1	1355091
1-@@	O	-1	1355091
adren@@	O	-1	1355091
oc@@	O	-1	1355091
e@@	O	-1	1355091
pt@@	O	-1	1355091
or	O	-1	1355091
block@@	O	-1	1355091
ade@@	O	-1	1355091
.	O	-1	1355091
MA@@	O	-1	1355091
P	O	-1	1355091
in	O	-1	1355091
con@@	O	-1	1355091
s@@	O	-1	1355091
ci@@	O	-1	1355091
ous	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
after	O	-1	1355091
chronic	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
treatment	O	-1	1355091
was	O	-1	1355091
14@@	O	-1	1355091
%	O	-1	1355091
lower	O	-1	1355091
than	O	-1	1355091
in	O	-1	1355091
the	O	-1	1355091
un@@	O	-1	1355091
treated	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
(n	O	-1	1355091
=	O	-1	1355091
8@@	O	-1	1355091
).	O	-1	1355091
He@@	O	-1	1355091
ad@@	O	-1	1355091
-@@	O	-1	1355091
up	O	-1	1355091
til@@	O	-1	1355091
ts	O	-1	1355091
in	O	-1	1355091
these	O	-1	1355091
rats	O	-1	1355091
did	O	-1	1355091
not	O	-1	1355091
produce	O	-1	1355091
or@@	B-Disease	D007024	1355091
th@@	I-Disease	-1	1355091
ost@@	I-Disease	-1	1355091
atic	I-Disease	-1	1355091
hypotension	I-Disease	-1	1355091
when	O	-1	1355091
performed	O	-1	1355091
either	O	-1	1355091
prior	O	-1	1355091
to	O	-1	1355091
or	O	-1	1355091
after	O	-1	1355091
acute	O	-1	1355091
dos@@	O	-1	1355091
ing	O	-1	1355091
of	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
(0.@@	O	-1	1355091
1	O	-1	1355091
mg	O	-1	1355091
kg@@	O	-1	1355091
-1	O	-1	1355091
i.p.@@	O	-1	1355091
).	O	-1	1355091
Con@@	O	-1	1355091
ver@@	O	-1	1355091
sel@@	O	-1	1355091
y,	O	-1	1355091
administration	O	-1	1355091
of	O	-1	1355091
ra@@	B-Chemical	D015016	1355091
u@@	I-Chemical	-1	1355091
w@@	I-Chemical	-1	1355091
ol@@	I-Chemical	-1	1355091
s@@	I-Chemical	-1	1355091
c@@	I-Chemical	-1	1355091
ine	I-Chemical	-1	1355091
(@@	O	-1	1355091
3	O	-1	1355091
mg	O	-1	1355091
kg@@	O	-1	1355091
-1	O	-1	1355091
i.v@@	O	-1	1355091
.)	O	-1	1355091
in	O	-1	1355091
chronic	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
treated	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
decreased	O	-1	1355091
the	O	-1	1355091
bas@@	O	-1	1355091
al	O	-1	1355091
MA@@	O	-1	1355091
P	O	-1	1355091
by	O	-1	1355091
1@@	O	-1	1355091
2-@@	O	-1	1355091
3@@	O	-1	1355091
1@@	O	-1	1355091
%	O	-1	1355091
(n	O	-1	1355091
=	O	-1	1355091
4@@	O	-1	1355091
),	O	-1	1355091
and	O	-1	1355091
subsequ@@	O	-1	1355091
ent	O	-1	1355091
til@@	O	-1	1355091
ts	O	-1	1355091
induced	O	-1	1355091
further	O	-1	1355091
dro@@	O	-1	1355091
p@@	O	-1	1355091
s	O	-1	1355091
of	O	-1	1355091
MA@@	O	-1	1355091
P	O	-1	1355091
by	O	-1	1355091
19@@	O	-1	1355091
-@@	O	-1	1355091
2@@	O	-1	1355091
3@@	O	-1	1355091
%	O	-1	1355091
in	O	-1	1355091
these	O	-1	1355091
rats.	O	-1	1355091
4@@	O	-1	1355091
.	O	-1	1355091
The	O	-1	1355091
press@@	O	-1	1355091
or	O	-1	1355091
responses	O	-1	1355091
and	O	-1	1355091
brady@@	B-Disease	D001919	1355091
cardia	I-Disease	-1	1355091
to	O	-1	1355091
the	O	-1	1355091
al@@	O	-1	1355091
ph@@	O	-1	1355091
a	O	-1	1355091
1-@@	O	-1	1355091
agon@@	O	-1	1355091
ist	O	-1	1355091
ci@@	B-Chemical	C014282	1355091
ra@@	I-Chemical	-1	1355091
z@@	I-Chemical	-1	1355091
ol@@	I-Chemical	-1	1355091
ine	I-Chemical	-1	1355091
(0.@@	O	-1	1355091
6	O	-1	1355091
and	O	-1	1355091
2	O	-1	1355091
microgram@@	O	-1	1355091
s	O	-1	1355091
kg@@	O	-1	1355091
-1	O	-1	1355091
i.v@@	O	-1	1355091
.@@	O	-1	1355091
),	O	-1	1355091
the	O	-1	1355091
al@@	O	-1	1355091
ph@@	O	-1	1355091
a	O	-1	1355091
2-@@	O	-1	1355091
agon@@	O	-1	1355091
ist	O	-1	1355091
A@@	B-Chemical	C056299	1355091
b@@	I-Chemical	-1	1355091
b@@	I-Chemical	-1	1355091
ot@@	I-Chemical	-1	1355091
t-@@	I-Chemical	-1	1355091
5@@	I-Chemical	-1	1355091
3@@	I-Chemical	-1	1355091
6@@	I-Chemical	-1	1355091
9@@	I-Chemical	-1	1355091
3	I-Chemical	-1	1355091
(@@	O	-1	1355091
1	O	-1	1355091
and	O	-1	1355091
3	O	-1	1355091
microgram@@	O	-1	1355091
s	O	-1	1355091
kg@@	O	-1	1355091
-1	O	-1	1355091
i.v@@	O	-1	1355091
.@@	O	-1	1355091
),	O	-1	1355091
and	O	-1	1355091
nor@@	B-Chemical	D009638	1355091
adren@@	I-Chemical	-1	1355091
aline	I-Chemical	-1	1355091
(0.@@	O	-1	1355091
1	O	-1	1355091
and	O	-1	1355091
1.@@	O	-1	1355091
0	O	-1	1355091
microgram@@	O	-1	1355091
s	O	-1	1355091
kg@@	O	-1	1355091
-1	O	-1	1355091
i.v@@	O	-1	1355091
.)	O	-1	1355091
were	O	-1	1355091
determined	O	-1	1355091
in	O	-1	1355091
con@@	O	-1	1355091
s@@	O	-1	1355091
ci@@	O	-1	1355091
ous	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
with	O	-1	1355091
and	O	-1	1355091
without	O	-1	1355091
chronic	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
pre@@	O	-1	1355091
treatment.	O	-1	1355091
B@@	O	-1	1355091
oth	O	-1	1355091
the	O	-1	1355091
press@@	O	-1	1355091
or	O	-1	1355091
and	O	-1	1355091
brady@@	B-Disease	D001919	1355091
cardia	I-Disease	-1	1355091
effects	O	-1	1355091
of	O	-1	1355091
ci@@	B-Chemical	C014282	1355091
ra@@	I-Chemical	-1	1355091
z@@	I-Chemical	-1	1355091
ol@@	I-Chemical	-1	1355091
ine	I-Chemical	-1	1355091
were	O	-1	1355091
abol@@	O	-1	1355091
ished	O	-1	1355091
in	O	-1	1355091
chronic	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
treated	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
(n	O	-1	1355091
=	O	-1	1355091
4@@	O	-1	1355091
)	O	-1	1355091
as	O	-1	1355091
compared	O	-1	1355091
to	O	-1	1355091
the	O	-1	1355091
un@@	O	-1	1355091
treated	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
(n	O	-1	1355091
=	O	-1	1355091
4@@	O	-1	1355091
).	O	-1	1355091
O@@	O	-1	1355091
n	O	-1	1355091
the	O	-1	1355091
other	O	-1	1355091
h@@	O	-1	1355091
and@@	O	-1	1355091
,	O	-1	1355091
the	O	-1	1355091
press@@	O	-1	1355091
or	O	-1	1355091
effects	O	-1	1355091
of	O	-1	1355091
A@@	B-Chemical	C056299	1355091
b@@	I-Chemical	-1	1355091
b@@	I-Chemical	-1	1355091
ot@@	I-Chemical	-1	1355091
t-@@	I-Chemical	-1	1355091
5@@	I-Chemical	-1	1355091
3@@	I-Chemical	-1	1355091
6@@	I-Chemical	-1	1355091
9@@	I-Chemical	-1	1355091
3	I-Chemical	-1	1355091
were	O	-1	1355091
similar	O	-1	1355091
in	O	-1	1355091
both	O	-1	1355091
groups	O	-1	1355091
of	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R@@	O	-1	1355091
,	O	-1	1355091
but	O	-1	1355091
the	O	-1	1355091
ac@@	O	-1	1355091
comp@@	O	-1	1355091
an@@	O	-1	1355091
y@@	O	-1	1355091
ing	O	-1	1355091
brady@@	B-Disease	D001919	1355091
cardia	I-Disease	-1	1355091
was	O	-1	1355091
greater	O	-1	1355091
in	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
with	O	-1	1355091
chronic	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
treatment	O	-1	1355091
than	O	-1	1355091
without	O	-1	1355091
such	O	-1	1355091
treatment.	O	-1	1355091
F@@	O	-1	1355091
ur@@	O	-1	1355091
ther@@	O	-1	1355091
mo@@	O	-1	1355091
re,	O	-1	1355091
the	O	-1	1355091
brady@@	B-Disease	D001919	1355091
cardia	I-Disease	-1	1355091
that	O	-1	1355091
ac@@	O	-1	1355091
comp@@	O	-1	1355091
an@@	O	-1	1355091
ied	O	-1	1355091
the	O	-1	1355091
nor@@	B-Chemical	D009638	1355091
adren@@	I-Chemical	-1	1355091
aline	I-Chemical	-1	1355091
-induced	O	-1	1355091
press@@	O	-1	1355091
or	O	-1	1355091
effect	O	-1	1355091
in	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R	O	-1	1355091
was	O	-1	1355091
similar	O	-1	1355091
with	O	-1	1355091
and	O	-1	1355091
without	O	-1	1355091
chronic	O	-1	1355091
praz@@	B-Chemical	D011224	1355091
os@@	I-Chemical	-1	1355091
in	I-Chemical	-1	1355091
treatment	O	-1	1355091
des@@	O	-1	1355091
pit@@	O	-1	1355091
e	O	-1	1355091
a	O	-1	1355091
4@@	O	-1	1355091
7-@@	O	-1	1355091
7@@	O	-1	1355091
1@@	O	-1	1355091
%	O	-1	1355091
reduction	O	-1	1355091
of	O	-1	1355091
the	O	-1	1355091
press@@	O	-1	1355091
or	O	-1	1355091
effect	O	-1	1355091
in	O	-1	1355091
chronic	O	-1	1355091
al@@	O	-1	1355091
ph@@	O	-1	1355091
a	O	-1	1355091
1-@@	O	-1	1355091
receptor	O	-1	1355091
block@@	O	-1	1355091
ed	O	-1	1355091
S@@	O	-1	1355091
H@@	O	-1	1355091
R@@	O	-1	1355091
.@@	O	-1	1355091
(A@@	O	-1	1355091
B@@	O	-1	1355091
S@@	O	-1	1355091
TR@@	O	-1	1355091
AC@@	O	-1	1355091
T	O	-1	1355091
TR@@	O	-1	1355091
UN@@	O	-1	1355091
C@@	O	-1	1355091
AT@@	O	-1	1355091
E@@	O	-1	1355091
D	O	-1	1355091
A@@	O	-1	1355091
T	O	-1	1355091
4@@	O	-1	1355091
00	O	-1	1355091
W@@	O	-1	1355091
O@@	O	-1	1355091
RD@@	O	-1	1355091
S)	O	-1	1355091

C@@	O	-1	8638876
o@@	O	-1	8638876
ex@@	O	-1	8638876
ist@@	O	-1	8638876
ence	O	-1	8638876
of	O	-1	8638876
cerebral	B-Disease	D012851	8638876
venous	I-Disease	-1	8638876
s@@	I-Disease	-1	8638876
in@@	I-Disease	-1	8638876
us	I-Disease	-1	8638876
and	I-Disease	-1	8638876
inter@@	I-Disease	-1	8638876
n@@	I-Disease	-1	8638876
al	I-Disease	-1	8638876
ca@@	I-Disease	-1	8638876
ro@@	I-Disease	-1	8638876
ti@@	I-Disease	-1	8638876
d	I-Disease	-1	8638876
artery	I-Disease	-1	8638876
thrombo@@	I-Disease	-1	8638876
sis	I-Disease	-1	8638876
cerebral	B-Disease	D002341	8638876
venous	I-Disease	-1	8638876
s@@	I-Disease	-1	8638876
in@@	I-Disease	-1	8638876
us	I-Disease	-1	8638876
and	I-Disease	-1	8638876
inter@@	I-Disease	-1	8638876
n@@	I-Disease	-1	8638876
al	I-Disease	-1	8638876
ca@@	I-Disease	-1	8638876
ro@@	I-Disease	-1	8638876
ti@@	I-Disease	-1	8638876
d	I-Disease	-1	8638876
artery	I-Disease	-1	8638876
thrombo@@	I-Disease	-1	8638876
sis	I-Disease	-1	8638876
associated	O	-1	8638876
with	O	-1	8638876
ex@@	O	-1	8638876
o@@	O	-1	8638876
gen@@	O	-1	8638876
ous	O	-1	8638876
se@@	O	-1	8638876
x	O	-1	8638876
h@@	O	-1	8638876
orm@@	O	-1	8638876
on@@	O	-1	8638876
es.	O	-1	8638876
A	O	-1	8638876
case	O	-1	8638876
repor@@	O	-1	8638876
t.	O	-1	8638876
A	O	-1	8638876
for@@	O	-1	8638876
ty-@@	O	-1	8638876
six	O	-1	8638876
year-old	O	-1	8638876
pre@@	O	-1	8638876
men@@	O	-1	8638876
o@@	O	-1	8638876
pa@@	O	-1	8638876
us@@	O	-1	8638876
al	O	-1	8638876
woman	O	-1	8638876
developed	O	-1	8638876
headac@@	B-Disease	D006261	8638876
he	I-Disease	-1	8638876
,	O	-1	8638876
nausea	B-Disease	D009325	8638876
and	O	-1	8638876
v@@	B-Disease	D014839	8638876
om@@	I-Disease	-1	8638876
it@@	I-Disease	-1	8638876
ing	I-Disease	-1	8638876
,	O	-1	8638876
left	O	-1	8638876
he@@	B-Disease	D010291	8638876
mi@@	I-Disease	-1	8638876
pa@@	I-Disease	-1	8638876
re@@	I-Disease	-1	8638876
sis	I-Disease	-1	8638876
and	O	-1	8638876
seizure	B-Disease	D012640	8638876
two	O	-1	8638876
days	O	-1	8638876
after	O	-1	8638876
pa@@	O	-1	8638876
ren@@	O	-1	8638876
ter@@	O	-1	8638876
al	O	-1	8638876
use	O	-1	8638876
of	O	-1	8638876
pro@@	B-Chemical	D011374	8638876
g@@	I-Chemical	-1	8638876
est@@	I-Chemical	-1	8638876
er@@	I-Chemical	-1	8638876
one	I-Chemical	-1	8638876
and	O	-1	8638876
est@@	B-Chemical	D004958	8638876
radi@@	I-Chemical	-1	8638876
ol	I-Chemical	-1	8638876
.	O	-1	8638876
D@@	B-Disease	D003920	8638876
ia@@	I-Disease	-1	8638876
bet@@	I-Disease	-1	8638876
es	I-Disease	-1	8638876
me@@	I-Disease	-1	8638876
ll@@	I-Disease	-1	8638876
it@@	I-Disease	-1	8638876
us	I-Disease	-1	8638876
(	O	-1	8638876
D@@	B-Disease	D003920	8638876
M	I-Disease	-1	8638876
)	O	-1	8638876
was	O	-1	8638876
found	O	-1	8638876
during	O	-1	8638876
ad@@	O	-1	8638876
mis@@	O	-1	8638876
sion.	O	-1	8638876
Com@@	O	-1	8638876
p@@	O	-1	8638876
ut@@	O	-1	8638876
ed	O	-1	8638876
to@@	O	-1	8638876
mo@@	O	-1	8638876
graph@@	O	-1	8638876
y	O	-1	8638876
showed	O	-1	8638876
a	O	-1	8638876
hemorrh@@	B-Disease	D002543	8638876
ag@@	I-Disease	-1	8638876
ic	I-Disease	-1	8638876
infarc@@	I-Disease	-1	8638876
t	I-Disease	-1	8638876
hemorrh@@	B-Disease	D002544	8638876
ag@@	I-Disease	-1	8638876
ic	I-Disease	-1	8638876
infarc@@	I-Disease	-1	8638876
t	I-Disease	-1	8638876
in	O	-1	8638876
the	O	-1	8638876
right	O	-1	8638876
fron@@	O	-1	8638876
t@@	O	-1	8638876
al	O	-1	8638876
lo@@	O	-1	8638876
be	O	-1	8638876
and	O	-1	8638876
increased	O	-1	8638876
d@@	O	-1	8638876
ensity	O	-1	8638876
in	O	-1	8638876
the	O	-1	8638876
su@@	O	-1	8638876
peri@@	O	-1	8638876
or	O	-1	8638876
s@@	O	-1	8638876
ag@@	O	-1	8638876
it@@	O	-1	8638876
t@@	O	-1	8638876
al	O	-1	8638876
s@@	O	-1	8638876
in@@	O	-1	8638876
us	O	-1	8638876
(S@@	O	-1	8638876
S@@	O	-1	8638876
S@@	O	-1	8638876
).	O	-1	8638876
L@@	O	-1	8638876
e@@	O	-1	8638876
ft	O	-1	8638876
ca@@	O	-1	8638876
ro@@	O	-1	8638876
ti@@	O	-1	8638876
d	O	-1	8638876
angio@@	O	-1	8638876
graph@@	O	-1	8638876
y	O	-1	8638876
found	O	-1	8638876
oc@@	B-Disease	D001157	8638876
cl@@	I-Disease	-1	8638876
usion	I-Disease	-1	8638876
of	I-Disease	-1	8638876
the	I-Disease	-1	8638876
left	I-Disease	-1	8638876
inter@@	I-Disease	-1	8638876
n@@	I-Disease	-1	8638876
al	I-Disease	-1	8638876
ca@@	I-Disease	-1	8638876
ro@@	I-Disease	-1	8638876
ti@@	I-Disease	-1	8638876
d	I-Disease	-1	8638876
artery	I-Disease	-1	8638876
(@@	O	-1	8638876
I@@	O	-1	8638876
CA@@	O	-1	8638876
).	O	-1	8638876
R@@	O	-1	8638876
ight	O	-1	8638876
ca@@	O	-1	8638876
ro@@	O	-1	8638876
ti@@	O	-1	8638876
d	O	-1	8638876
angio@@	O	-1	8638876
gram@@	O	-1	8638876
s	O	-1	8638876
fail@@	O	-1	8638876
ed	O	-1	8638876
to	O	-1	8638876
show	O	-1	8638876
the	O	-1	8638876
S@@	O	-1	8638876
S@@	O	-1	8638876
S	O	-1	8638876
and	O	-1	8638876
inf@@	O	-1	8638876
er@@	O	-1	8638876
ior	O	-1	8638876
s@@	O	-1	8638876
ag@@	O	-1	8638876
it@@	O	-1	8638876
t@@	O	-1	8638876
al	O	-1	8638876
s@@	O	-1	8638876
in@@	O	-1	8638876
us,	O	-1	8638876
sugg@@	O	-1	8638876
es@@	O	-1	8638876
tive	O	-1	8638876
of	O	-1	8638876
venous	B-Disease	D012851	8638876
s@@	I-Disease	-1	8638876
in@@	I-Disease	-1	8638876
us	I-Disease	-1	8638876
thrombo@@	I-Disease	-1	8638876
sis	I-Disease	-1	8638876
.	O	-1	8638876
C@@	O	-1	8638876
o@@	O	-1	8638876
ex@@	O	-1	8638876
ist@@	O	-1	8638876
ence	O	-1	8638876
of	O	-1	8638876
the	O	-1	8638876
cerebral	B-Disease	D002544	8638876
artery	I-Disease	-1	8638876
and	I-Disease	-1	8638876
the	I-Disease	-1	8638876
venous	I-Disease	-1	8638876
s@@	I-Disease	-1	8638876
in@@	I-Disease	-1	8638876
us	I-Disease	-1	8638876
oc@@	I-Disease	-1	8638876
cl@@	I-Disease	-1	8638876
usion	I-Disease	-1	8638876
cerebral	B-Disease	-1	8638876
artery	I-Disease	-1	8638876
and	I-Disease	-1	8638876
the	I-Disease	-1	8638876
venous	I-Disease	-1	8638876
s@@	I-Disease	-1	8638876
in@@	I-Disease	-1	8638876
us	I-Disease	-1	8638876
oc@@	I-Disease	-1	8638876
cl@@	I-Disease	-1	8638876
usion	I-Disease	-1	8638876
has	O	-1	8638876
been	O	-1	8638876
descri@@	O	-1	8638876
bed	O	-1	8638876
inf@@	O	-1	8638876
requ@@	O	-1	8638876
ent@@	O	-1	8638876
ly.	O	-1	8638876
In	O	-1	8638876
this	O	-1	8638876
cas@@	O	-1	8638876
e,	O	-1	8638876
the	O	-1	8638876
au@@	O	-1	8638876
th@@	O	-1	8638876
ors	O	-1	8638876
post@@	O	-1	8638876
ul@@	O	-1	8638876
ate	O	-1	8638876
that	O	-1	8638876
the	O	-1	8638876
use	O	-1	8638876
of	O	-1	8638876
est@@	B-Chemical	D004958	8638876
radi@@	I-Chemical	-1	8638876
ol	I-Chemical	-1	8638876
and	O	-1	8638876
pro@@	B-Chemical	D011374	8638876
g@@	I-Chemical	-1	8638876
est@@	I-Chemical	-1	8638876
er@@	I-Chemical	-1	8638876
one	I-Chemical	-1	8638876
and	O	-1	8638876
the	O	-1	8638876
underlying	O	-1	8638876
D@@	B-Disease	D003920	8638876
M	I-Disease	-1	8638876
increased	O	-1	8638876
vascular	O	-1	8638876
thrombo@@	O	-1	8638876
gen@@	O	-1	8638876
ic@@	O	-1	8638876
ity,	O	-1	8638876
which	O	-1	8638876
pro@@	O	-1	8638876
vid@@	O	-1	8638876
ed	O	-1	8638876
a	O	-1	8638876
common	O	-1	8638876
d@@	O	-1	8638876
en@@	O	-1	8638876
o@@	O	-1	8638876
min@@	O	-1	8638876
at@@	O	-1	8638876
or	O	-1	8638876
for	O	-1	8638876
thrombo@@	B-Disease	D002341	8638876
sis	I-Disease	-1	8638876
of	I-Disease	-1	8638876
both	I-Disease	-1	8638876
the	I-Disease	-1	8638876
IC@@	I-Disease	-1	8638876
A	I-Disease	-1	8638876
and	I-Disease	-1	8638876
the	I-Disease	-1	8638876
venous	I-Disease	-1	8638876
s@@	I-Disease	-1	8638876
in@@	I-Disease	-1	8638876
us	I-Disease	-1	8638876
thrombo@@	B-Disease	D012851	8638876
sis	I-Disease	-1	8638876
of	I-Disease	-1	8638876
both	I-Disease	-1	8638876
the	I-Disease	-1	8638876
IC@@	I-Disease	-1	8638876
A	I-Disease	-1	8638876
and	I-Disease	-1	8638876
the	I-Disease	-1	8638876
venous	I-Disease	-1	8638876
s@@	I-Disease	-1	8638876
in@@	I-Disease	-1	8638876
us	I-Disease	-1	8638876
.	O	-1	8638876

Ch@@	B-Chemical	D002738	1628552
loro@@	I-Chemical	-1	1628552
qu@@	I-Chemical	-1	1628552
ine	I-Chemical	-1	1628552
related	O	-1	1628552
complete	O	-1	1628552
heart	B-Disease	D006327	1628552
bloc@@	I-Disease	-1	1628552
k	I-Disease	-1	1628552
with	O	-1	1628552
bl@@	B-Disease	D001766	1628552
ind@@	I-Disease	-1	1628552
ness	I-Disease	-1	1628552
:	O	-1	1628552
case	O	-1	1628552
repor@@	O	-1	1628552
t.	O	-1	1628552
A	O	-1	1628552
27@@	O	-1	1628552
-@@	O	-1	1628552
year	O	-1	1628552
old	O	-1	1628552
Af@@	O	-1	1628552
r@@	O	-1	1628552
ic@@	O	-1	1628552
an	O	-1	1628552
woman	O	-1	1628552
with	O	-1	1628552
hist@@	O	-1	1628552
ory	O	-1	1628552
of	O	-1	1628552
reg@@	O	-1	1628552
ular	O	-1	1628552
ch@@	B-Chemical	D002738	1628552
loro@@	I-Chemical	-1	1628552
qu@@	I-Chemical	-1	1628552
ine	I-Chemical	-1	1628552
ing@@	O	-1	1628552
es@@	O	-1	1628552
tion	O	-1	1628552
presented	O	-1	1628552
with	O	-1	1628552
progressive	O	-1	1628552
deter@@	B-Disease	D015354	1628552
i@@	I-Disease	-1	1628552
or@@	I-Disease	-1	1628552
ation	I-Disease	-1	1628552
of	I-Disease	-1	1628552
vi@@	I-Disease	-1	1628552
sion	I-Disease	-1	1628552
,	O	-1	1628552
e@@	O	-1	1628552
as@@	O	-1	1628552
y	O	-1	1628552
f@@	B-Disease	D005221	1628552
ati@@	I-Disease	-1	1628552
gu@@	I-Disease	-1	1628552
ability	I-Disease	-1	1628552
,	O	-1	1628552
dys@@	B-Disease	D004417	1628552
p@@	I-Disease	-1	1628552
no@@	I-Disease	-1	1628552
e@@	I-Disease	-1	1628552
a	I-Disease	-1	1628552
,	O	-1	1628552
di@@	B-Disease	D004244	1628552
z@@	I-Disease	-1	1628552
z@@	I-Disease	-1	1628552
in@@	I-Disease	-1	1628552
ess	I-Disease	-1	1628552
progres@@	O	-1	1628552
s@@	O	-1	1628552
ing	O	-1	1628552
to	O	-1	1628552
syn@@	B-Disease	D013575	1628552
co@@	I-Disease	-1	1628552
p@@	I-Disease	-1	1628552
al	I-Disease	-1	1628552
at@@	I-Disease	-1	1628552
tac@@	I-Disease	-1	1628552
k@@	I-Disease	-1	1628552
s	I-Disease	-1	1628552
.	O	-1	1628552
O@@	O	-1	1628552
ph@@	O	-1	1628552
thal@@	O	-1	1628552
mo@@	O	-1	1628552
log@@	O	-1	1628552
ical	O	-1	1628552
assess@@	O	-1	1628552
ment	O	-1	1628552
revealed	O	-1	1628552
feat@@	O	-1	1628552
ures	O	-1	1628552
of	O	-1	1628552
ch@@	B-Chemical	D002738	1628552
loro@@	I-Chemical	-1	1628552
qu@@	I-Chemical	-1	1628552
ine	I-Chemical	-1	1628552
ret@@	B-Disease	D012164	1628552
ino@@	I-Disease	-1	1628552
pathy	I-Disease	-1	1628552
,	O	-1	1628552
cardiac	O	-1	1628552
assess@@	O	-1	1628552
ment	O	-1	1628552
revealed	O	-1	1628552
feat@@	O	-1	1628552
ures	O	-1	1628552
of	O	-1	1628552
heart	B-Disease	D006333	1628552
failure	I-Disease	-1	1628552
and	O	-1	1628552
a	O	-1	1628552
complete	O	-1	1628552
heart	B-Disease	D006327	1628552
bloc@@	I-Disease	-1	1628552
k	I-Disease	-1	1628552
with	O	-1	1628552
right	B-Disease	D002037	1628552
b@@	I-Disease	-1	1628552
und@@	I-Disease	-1	1628552
le	I-Disease	-1	1628552
b@@	I-Disease	-1	1628552
ran@@	I-Disease	-1	1628552
ch	I-Disease	-1	1628552
bloc@@	I-Disease	-1	1628552
k	I-Disease	-1	1628552
pat@@	O	-1	1628552
tern@@	O	-1	1628552
.	O	-1	1628552
The	O	-1	1628552
heart	B-Disease	D006327	1628552
bloc@@	I-Disease	-1	1628552
k	I-Disease	-1	1628552
was	O	-1	1628552
treated	O	-1	1628552
by	O	-1	1628552
pac@@	O	-1	1628552
em@@	O	-1	1628552
ak@@	O	-1	1628552
er	O	-1	1628552
in@@	O	-1	1628552
ser@@	O	-1	1628552
tion	O	-1	1628552
and	O	-1	1628552
the	O	-1	1628552
heart	B-Disease	D006333	1628552
failure	I-Disease	-1	1628552
resol@@	O	-1	1628552
ved	O	-1	1628552
spont@@	O	-1	1628552
ane@@	O	-1	1628552
ously	O	-1	1628552
following	O	-1	1628552
ch@@	B-Chemical	D002738	1628552
loro@@	I-Chemical	-1	1628552
qu@@	I-Chemical	-1	1628552
ine	I-Chemical	-1	1628552
discontinu@@	O	-1	1628552
ation.	O	-1	1628552
S@@	O	-1	1628552
he	O	-1	1628552
ho@@	O	-1	1628552
we@@	O	-1	1628552
ver	O	-1	1628552
remain@@	O	-1	1628552
s	O	-1	1628552
bl@@	B-Disease	D001766	1628552
ind	I-Disease	-1	1628552
.	O	-1	1628552

S@@	O	-1	11524350
y@@	O	-1	11524350
st@@	O	-1	11524350
em@@	O	-1	11524350
ic	O	-1	11524350
toxicity	B-Disease	D064420	11524350
and	O	-1	11524350
res@@	O	-1	11524350
us@@	O	-1	11524350
cit@@	O	-1	11524350
ation	O	-1	11524350
in	O	-1	11524350
bupivac@@	B-Chemical	D002045	11524350
aine	I-Chemical	-1	11524350
-@@	O	-1	11524350
,	O	-1	11524350
levo@@	B-Chemical	C476513	11524350
bupivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
-@@	O	-1	11524350
,	O	-1	11524350
or	O	-1	11524350
ro@@	B-Chemical	C037663	11524350
pivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
-@@	O	-1	11524350
inf@@	O	-1	11524350
used	O	-1	11524350
rats.	O	-1	11524350
We	O	-1	11524350
compared	O	-1	11524350
the	O	-1	11524350
systemic	O	-1	11524350
toxicity	B-Disease	D064420	11524350
of	O	-1	11524350
bupivac@@	B-Chemical	D002045	11524350
aine	I-Chemical	-1	11524350
,	O	-1	11524350
levo@@	B-Chemical	C476513	11524350
bupivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
,	O	-1	11524350
and	O	-1	11524350
ro@@	B-Chemical	C037663	11524350
pivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
in	O	-1	11524350
anesthe@@	O	-1	11524350
tiz@@	O	-1	11524350
ed	O	-1	11524350
rats.	O	-1	11524350
We	O	-1	11524350
also	O	-1	11524350
compared	O	-1	11524350
the	O	-1	11524350
ability	O	-1	11524350
to	O	-1	11524350
res@@	O	-1	11524350
us@@	O	-1	11524350
cit@@	O	-1	11524350
ate	O	-1	11524350
rats	O	-1	11524350
after	O	-1	11524350
le@@	O	-1	11524350
th@@	O	-1	11524350
al	O	-1	11524350
doses	O	-1	11524350
of	O	-1	11524350
these	O	-1	11524350
loc@@	O	-1	11524350
al	O	-1	11524350
anesthe@@	O	-1	11524350
tic@@	O	-1	11524350
s.	O	-1	11524350
B@@	B-Chemical	D002045	11524350
u@@	I-Chemical	-1	11524350
pivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
,	O	-1	11524350
levo@@	B-Chemical	C476513	11524350
bupivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
,	O	-1	11524350
or	O	-1	11524350
ro@@	B-Chemical	C037663	11524350
pivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
was	O	-1	11524350
inf@@	O	-1	11524350
used	O	-1	11524350
at	O	-1	11524350
a	O	-1	11524350
rate	O	-1	11524350
of	O	-1	11524350
2	O	-1	11524350
mg@@	O	-1	11524350
.	O	-1	11524350
kg@@	O	-1	11524350
(@@	O	-1	11524350
-1@@	O	-1	11524350
).	O	-1	11524350
min@@	O	-1	11524350
(@@	O	-1	11524350
-1@@	O	-1	11524350
)	O	-1	11524350
while	O	-1	11524350
electro@@	O	-1	11524350
cardio@@	O	-1	11524350
gram@@	O	-1	11524350
,	O	-1	11524350
electro@@	O	-1	11524350
encephalo@@	O	-1	11524350
gram@@	O	-1	11524350
,	O	-1	11524350
and	O	-1	11524350
arterial	O	-1	11524350
pressure	O	-1	11524350
were	O	-1	11524350
continu@@	O	-1	11524350
ously	O	-1	11524350
monit@@	O	-1	11524350
o@@	O	-1	11524350
red.	O	-1	11524350
Whe@@	O	-1	11524350
n	O	-1	11524350
as@@	B-Disease	D006323	11524350
y@@	I-Disease	-1	11524350
st@@	I-Disease	-1	11524350
ole	I-Disease	-1	11524350
was	O	-1	11524350
recor@@	O	-1	11524350
de@@	O	-1	11524350
d,	O	-1	11524350
drug	O	-1	11524350
infusion	O	-1	11524350
was	O	-1	11524350
sto@@	O	-1	11524350
pp@@	O	-1	11524350
ed	O	-1	11524350
and	O	-1	11524350
a	O	-1	11524350
res@@	O	-1	11524350
us@@	O	-1	11524350
cit@@	O	-1	11524350
ation	O	-1	11524350
sequ@@	O	-1	11524350
ence	O	-1	11524350
was	O	-1	11524350
be@@	O	-1	11524350
g@@	O	-1	11524350
un@@	O	-1	11524350
.	O	-1	11524350
E@@	B-Chemical	D004837	11524350
p@@	I-Chemical	-1	11524350
ine@@	I-Chemical	-1	11524350
phrine	I-Chemical	-1	11524350
0.0@@	O	-1	11524350
1	O	-1	11524350
mg/kg	O	-1	11524350
was	O	-1	11524350
administered	O	-1	11524350
at	O	-1	11524350
1-@@	O	-1	11524350
min	O	-1	11524350
interv@@	O	-1	11524350
als	O	-1	11524350
while	O	-1	11524350
ex@@	O	-1	11524350
tern@@	O	-1	11524350
al	O	-1	11524350
cardiac	O	-1	11524350
com@@	O	-1	11524350
pres@@	O	-1	11524350
sions	O	-1	11524350
were	O	-1	11524350
ap@@	O	-1	11524350
pl@@	O	-1	11524350
i@@	O	-1	11524350
ed.	O	-1	11524350
R@@	O	-1	11524350
es@@	O	-1	11524350
us@@	O	-1	11524350
cit@@	O	-1	11524350
ation	O	-1	11524350
was	O	-1	11524350
considered	O	-1	11524350
suc@@	O	-1	11524350
cess@@	O	-1	11524350
ful	O	-1	11524350
when	O	-1	11524350
a	O	-1	11524350
systolic	O	-1	11524350
arterial	O	-1	11524350
pressure	O	-1	11524350
>	O	-1	11524350
or	O	-1	11524350
=@@	O	-1	11524350
100	O	-1	11524350
mm	O	-1	11524350
H@@	O	-1	11524350
g	O	-1	11524350
was	O	-1	11524350
achi@@	O	-1	11524350
ev@@	O	-1	11524350
ed	O	-1	11524350
within	O	-1	11524350
5	O	-1	11524350
min@@	O	-1	11524350
.	O	-1	11524350
The	O	-1	11524350
cum@@	O	-1	11524350
ul@@	O	-1	11524350
ative	O	-1	11524350
doses	O	-1	11524350
of	O	-1	11524350
levo@@	B-Chemical	C476513	11524350
bupivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
and	O	-1	11524350
ro@@	B-Chemical	C037663	11524350
pivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
that	O	-1	11524350
produced	O	-1	11524350
seizures	B-Disease	D012640	11524350
were	O	-1	11524350
similar	O	-1	11524350
and	O	-1	11524350
were	O	-1	11524350
larg@@	O	-1	11524350
er	O	-1	11524350
than	O	-1	11524350
those	O	-1	11524350
of	O	-1	11524350
bupivac@@	B-Chemical	D002045	11524350
aine	I-Chemical	-1	11524350
.	O	-1	11524350
The	O	-1	11524350
cum@@	O	-1	11524350
ul@@	O	-1	11524350
ative	O	-1	11524350
doses	O	-1	11524350
of	O	-1	11524350
levo@@	B-Chemical	C476513	11524350
bupivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
that	O	-1	11524350
produced	O	-1	11524350
dys@@	B-Disease	D001145	11524350
rhyth@@	I-Disease	-1	11524350
mi@@	I-Disease	-1	11524350
as	I-Disease	-1	11524350
and	O	-1	11524350
as@@	B-Disease	D006323	11524350
y@@	I-Disease	-1	11524350
st@@	I-Disease	-1	11524350
ole	I-Disease	-1	11524350
were	O	-1	11524350
sm@@	O	-1	11524350
all@@	O	-1	11524350
er	O	-1	11524350
than	O	-1	11524350
the	O	-1	11524350
cor@@	O	-1	11524350
respon@@	O	-1	11524350
ding	O	-1	11524350
doses	O	-1	11524350
of	O	-1	11524350
ro@@	B-Chemical	C037663	11524350
pivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
,	O	-1	11524350
but	O	-1	11524350
they	O	-1	11524350
were	O	-1	11524350
larg@@	O	-1	11524350
er	O	-1	11524350
than	O	-1	11524350
those	O	-1	11524350
of	O	-1	11524350
bupivac@@	B-Chemical	D002045	11524350
aine	I-Chemical	-1	11524350
.	O	-1	11524350
The	O	-1	11524350
number	O	-1	11524350
of	O	-1	11524350
suc@@	O	-1	11524350
cess@@	O	-1	11524350
ful	O	-1	11524350
res@@	O	-1	11524350
us@@	O	-1	11524350
cit@@	O	-1	11524350
ations	O	-1	11524350
did	O	-1	11524350
not	O	-1	11524350
diff@@	O	-1	11524350
er	O	-1	11524350
among	O	-1	11524350
groups.	O	-1	11524350
However,	O	-1	11524350
a	O	-1	11524350
sm@@	O	-1	11524350
all@@	O	-1	11524350
er	O	-1	11524350
dose	O	-1	11524350
of	O	-1	11524350
ep@@	B-Chemical	D004837	11524350
ine@@	I-Chemical	-1	11524350
phrine	I-Chemical	-1	11524350
was	O	-1	11524350
requ@@	O	-1	11524350
ired	O	-1	11524350
in	O	-1	11524350
the	O	-1	11524350
R@@	B-Chemical	C037663	11524350
o@@	I-Chemical	-1	11524350
pivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
group	O	-1	11524350
than	O	-1	11524350
in	O	-1	11524350
the	O	-1	11524350
other	O	-1	11524350
groups.	O	-1	11524350
We	O	-1	11524350
concl@@	O	-1	11524350
ude	O	-1	11524350
that	O	-1	11524350
the	O	-1	11524350
systemic	O	-1	11524350
toxicity	B-Disease	D064420	11524350
of	O	-1	11524350
levo@@	B-Chemical	C476513	11524350
bupivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
is	O	-1	11524350
inter@@	O	-1	11524350
medi@@	O	-1	11524350
ate	O	-1	11524350
between	O	-1	11524350
that	O	-1	11524350
of	O	-1	11524350
ro@@	B-Chemical	C037663	11524350
pivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
and	O	-1	11524350
bupivac@@	B-Chemical	D002045	11524350
aine	I-Chemical	-1	11524350
when	O	-1	11524350
administered	O	-1	11524350
at	O	-1	11524350
the	O	-1	11524350
same	O	-1	11524350
rate	O	-1	11524350
and	O	-1	11524350
that	O	-1	11524350
ro@@	B-Chemical	C037663	11524350
pivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
-induced	O	-1	11524350
cardiac	B-Disease	D006323	11524350
ar@@	I-Disease	-1	11524350
res@@	I-Disease	-1	11524350
t	I-Disease	-1	11524350
appear@@	O	-1	11524350
s	O	-1	11524350
to	O	-1	11524350
be	O	-1	11524350
more	O	-1	11524350
sus@@	O	-1	11524350
cep@@	O	-1	11524350
ti@@	O	-1	11524350
ble	O	-1	11524350
to	O	-1	11524350
treatment	O	-1	11524350
than	O	-1	11524350
that	O	-1	11524350
induced	O	-1	11524350
by	O	-1	11524350
bupivac@@	B-Chemical	D002045	11524350
aine	I-Chemical	-1	11524350
or	O	-1	11524350
levo@@	B-Chemical	C476513	11524350
bupivac@@	I-Chemical	-1	11524350
aine	I-Chemical	-1	11524350
.	O	-1	11524350

2@@	B-Chemical	C051883	10027919
2-@@	I-Chemical	-1	10027919
ox@@	I-Chemical	-1	10027919
ac@@	I-Chemical	-1	10027919
al@@	I-Chemical	-1	10027919
cit@@	I-Chemical	-1	10027919
ri@@	I-Chemical	-1	10027919
ol	I-Chemical	-1	10027919
sup@@	O	-1	10027919
pres@@	O	-1	10027919
ses	O	-1	10027919
secondary	B-Disease	D006962	10027919
hyper@@	I-Disease	-1	10027919
par@@	I-Disease	-1	10027919
ath@@	I-Disease	-1	10027919
yro@@	I-Disease	-1	10027919
i@@	I-Disease	-1	10027919
dis@@	I-Disease	-1	10027919
m	I-Disease	-1	10027919
without	O	-1	10027919
induc@@	O	-1	10027919
ing	O	-1	10027919
low	B-Disease	D001851	10027919
b@@	I-Disease	-1	10027919
one	I-Disease	-1	10027919
t@@	I-Disease	-1	10027919
ur@@	I-Disease	-1	10027919
no@@	I-Disease	-1	10027919
ver	I-Disease	-1	10027919
in	O	-1	10027919
dog@@	O	-1	10027919
s	O	-1	10027919
with	O	-1	10027919
renal	B-Disease	D051437	10027919
failure	I-Disease	-1	10027919
.	O	-1	10027919
BACKGROUND:	O	-1	10027919
C@@	B-Chemical	D002117	10027919
al@@	I-Chemical	-1	10027919
cit@@	I-Chemical	-1	10027919
ri@@	I-Chemical	-1	10027919
ol	I-Chemical	-1	10027919
therapy	O	-1	10027919
sup@@	O	-1	10027919
pres@@	O	-1	10027919
ses	O	-1	10027919
serum	O	-1	10027919
levels	O	-1	10027919
of	O	-1	10027919
par@@	O	-1	10027919
ath@@	O	-1	10027919
yro@@	O	-1	10027919
id	O	-1	10027919
h@@	O	-1	10027919
orm@@	O	-1	10027919
one	O	-1	10027919
(P@@	O	-1	10027919
T@@	O	-1	10027919
H@@	O	-1	10027919
)	O	-1	10027919
in	O	-1	10027919
patients	O	-1	10027919
with	O	-1	10027919
renal	B-Disease	D051437	10027919
failure	I-Disease	-1	10027919
but	O	-1	10027919
has	O	-1	10027919
several	O	-1	10027919
draw@@	O	-1	10027919
bac@@	O	-1	10027919
k@@	O	-1	10027919
s,	O	-1	10027919
including	O	-1	10027919
hyper@@	B-Disease	D006934	10027919
cal@@	I-Disease	-1	10027919
ce@@	I-Disease	-1	10027919
mia	I-Disease	-1	10027919
and/or	O	-1	10027919
mark@@	O	-1	10027919
ed	O	-1	10027919
sup@@	B-Disease	D001851	10027919
pression	I-Disease	-1	10027919
of	I-Disease	-1	10027919
b@@	I-Disease	-1	10027919
one	I-Disease	-1	10027919
t@@	I-Disease	-1	10027919
ur@@	I-Disease	-1	10027919
no@@	I-Disease	-1	10027919
ver	I-Disease	-1	10027919
,	O	-1	10027919
which	O	-1	10027919
may	O	-1	10027919
le@@	O	-1	10027919
ad	O	-1	10027919
to	O	-1	10027919
ad@@	B-Disease	D001851	10027919
y@@	I-Disease	-1	10027919
nam@@	I-Disease	-1	10027919
ic	I-Disease	-1	10027919
b@@	I-Disease	-1	10027919
one	I-Disease	-1	10027919
disease	I-Disease	-1	10027919
.	O	-1	10027919
A	O	-1	10027919
new	O	-1	10027919
vitamin	B-Chemical	D014807	10027919
D	I-Chemical	-1	10027919
an@@	O	-1	10027919
alo@@	O	-1	10027919
gu@@	O	-1	10027919
e,	O	-1	10027919
2@@	B-Chemical	C051883	10027919
2-@@	I-Chemical	-1	10027919
ox@@	I-Chemical	-1	10027919
ac@@	I-Chemical	-1	10027919
al@@	I-Chemical	-1	10027919
cit@@	I-Chemical	-1	10027919
ri@@	I-Chemical	-1	10027919
ol	I-Chemical	-1	10027919
(	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
),	O	-1	10027919
has	O	-1	10027919
been	O	-1	10027919
shown	O	-1	10027919
to	O	-1	10027919
have	O	-1	10027919
pro@@	O	-1	10027919
mis@@	O	-1	10027919
ing	O	-1	10027919
character@@	O	-1	10027919
is@@	O	-1	10027919
tic@@	O	-1	10027919
s.	O	-1	10027919
This	O	-1	10027919
study	O	-1	10027919
was	O	-1	10027919
under@@	O	-1	10027919
tak@@	O	-1	10027919
en	O	-1	10027919
to	O	-1	10027919
determine	O	-1	10027919
the	O	-1	10027919
effects	O	-1	10027919
of	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
on	O	-1	10027919
serum	O	-1	10027919
P@@	O	-1	10027919
T@@	O	-1	10027919
H	O	-1	10027919
levels	O	-1	10027919
and	O	-1	10027919
b@@	O	-1	10027919
one	O	-1	10027919
t@@	O	-1	10027919
ur@@	O	-1	10027919
no@@	O	-1	10027919
ver	O	-1	10027919
in	O	-1	10027919
st@@	O	-1	10027919
ates	O	-1	10027919
of	O	-1	10027919
normal	O	-1	10027919
or	O	-1	10027919
impaired	B-Disease	D007674	10027919
renal	I-Disease	-1	10027919
function	I-Disease	-1	10027919
.	O	-1	10027919
METHODS:	O	-1	10027919
Si@@	O	-1	10027919
x@@	O	-1	10027919
t@@	O	-1	10027919
y	O	-1	10027919
dog@@	O	-1	10027919
s	O	-1	10027919
were	O	-1	10027919
either	O	-1	10027919
neph@@	O	-1	10027919
rec@@	O	-1	10027919
to@@	O	-1	10027919
m@@	O	-1	10027919
ized	O	-1	10027919
(N@@	O	-1	10027919
x@@	O	-1	10027919
,	O	-1	10027919
N	O	-1	10027919
=	O	-1	10027919
3@@	O	-1	10027919
8@@	O	-1	10027919
)	O	-1	10027919
or	O	-1	10027919
sh@@	O	-1	10027919
am@@	O	-1	10027919
-@@	O	-1	10027919
o@@	O	-1	10027919
per@@	O	-1	10027919
ated	O	-1	10027919
(S@@	O	-1	10027919
h@@	O	-1	10027919
am@@	O	-1	10027919
,	O	-1	10027919
N	O	-1	10027919
=	O	-1	10027919
2@@	O	-1	10027919
2@@	O	-1	10027919
).	O	-1	10027919
The	O	-1	10027919
animals	O	-1	10027919
received	O	-1	10027919
sup@@	O	-1	10027919
ple@@	O	-1	10027919
mental	O	-1	10027919
phosph@@	B-Chemical	D010710	10027919
ate	I-Chemical	-1	10027919
to	O	-1	10027919
enh@@	O	-1	10027919
ance	O	-1	10027919
P@@	O	-1	10027919
T@@	O	-1	10027919
H	O	-1	10027919
secre@@	O	-1	10027919
tion.	O	-1	10027919
F@@	O	-1	10027919
o@@	O	-1	10027919
ur@@	O	-1	10027919
te@@	O	-1	10027919
en	O	-1	10027919
weeks	O	-1	10027919
after	O	-1	10027919
the	O	-1	10027919
star@@	O	-1	10027919
t	O	-1	10027919
of	O	-1	10027919
phosph@@	B-Chemical	D010710	10027919
ate	I-Chemical	-1	10027919
sup@@	O	-1	10027919
ple@@	O	-1	10027919
ment@@	O	-1	10027919
ation,	O	-1	10027919
h@@	O	-1	10027919
al@@	O	-1	10027919
f	O	-1	10027919
of	O	-1	10027919
the	O	-1	10027919
N@@	O	-1	10027919
x	O	-1	10027919
and	O	-1	10027919
S@@	O	-1	10027919
ha@@	O	-1	10027919
m	O	-1	10027919
dog@@	O	-1	10027919
s	O	-1	10027919
received	O	-1	10027919
doses	O	-1	10027919
of	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
(@@	O	-1	10027919
three	O	-1	10027919
times	O	-1	10027919
per	O	-1	10027919
week@@	O	-1	10027919
);	O	-1	10027919
the	O	-1	10027919
other	O	-1	10027919
h@@	O	-1	10027919
al@@	O	-1	10027919
f	O	-1	10027919
were	O	-1	10027919
given	O	-1	10027919
ve@@	O	-1	10027919
h@@	O	-1	10027919
ic@@	O	-1	10027919
le	O	-1	10027919
for	O	-1	10027919
60	O	-1	10027919
week@@	O	-1	10027919
s.	O	-1	10027919
The@@	O	-1	10027919
re@@	O	-1	10027919
af@@	O	-1	10027919
ter@@	O	-1	10027919
,	O	-1	10027919
the	O	-1	10027919
treatment	O	-1	10027919
mod@@	O	-1	10027919
al@@	O	-1	10027919
ities	O	-1	10027919
for	O	-1	10027919
a	O	-1	10027919
sub@@	O	-1	10027919
set	O	-1	10027919
of	O	-1	10027919
animals	O	-1	10027919
were	O	-1	10027919
cros@@	O	-1	10027919
sed	O	-1	10027919
over	O	-1	10027919
for	O	-1	10027919
an	O	-1	10027919
addi@@	O	-1	10027919
tional	O	-1	10027919
e@@	O	-1	10027919
ight	O	-1	10027919
months.	O	-1	10027919
B@@	O	-1	10027919
io@@	O	-1	10027919
chemical	O	-1	10027919
and	O	-1	10027919
h@@	O	-1	10027919
orm@@	O	-1	10027919
on@@	O	-1	10027919
al	O	-1	10027919
indic@@	O	-1	10027919
es	O	-1	10027919
of	O	-1	10027919
calcium	B-Chemical	D002118	10027919
and	O	-1	10027919
b@@	O	-1	10027919
one	O	-1	10027919
metabol@@	O	-1	10027919
ism	O	-1	10027919
were	O	-1	10027919
measured	O	-1	10027919
throu@@	O	-1	10027919
gh@@	O	-1	10027919
out	O	-1	10027919
the	O	-1	10027919
study,	O	-1	10027919
and	O	-1	10027919
b@@	O	-1	10027919
one	O	-1	10027919
biop@@	O	-1	10027919
si@@	O	-1	10027919
es	O	-1	10027919
were	O	-1	10027919
d@@	O	-1	10027919
one	O	-1	10027919
at	O	-1	10027919
basel@@	O	-1	10027919
ine,	O	-1	10027919
60	O	-1	10027919
weeks	O	-1	10027919
after	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
or	O	-1	10027919
ve@@	O	-1	10027919
h@@	O	-1	10027919
ic@@	O	-1	10027919
le	O	-1	10027919
treatment,	O	-1	10027919
and	O	-1	10027919
at	O	-1	10027919
the	O	-1	10027919
end	O	-1	10027919
of	O	-1	10027919
the	O	-1	10027919
cros@@	O	-1	10027919
s@@	O	-1	10027919
over	O	-1	10027919
perio@@	O	-1	10027919
d.	O	-1	10027919
RESULTS:	O	-1	10027919
In	O	-1	10027919
N@@	O	-1	10027919
x	O	-1	10027919
dog@@	O	-1	10027919
s,	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
significantly	O	-1	10027919
decreased	O	-1	10027919
serum	O	-1	10027919
P@@	O	-1	10027919
T@@	O	-1	10027919
H	O	-1	10027919
levels	O	-1	10027919
so@@	O	-1	10027919
on	O	-1	10027919
after	O	-1	10027919
the	O	-1	10027919
induction	O	-1	10027919
of	O	-1	10027919
renal	B-Disease	D051437	10027919
in@@	I-Disease	-1	10027919
suffici@@	I-Disease	-1	10027919
ency	I-Disease	-1	10027919
.	O	-1	10027919
In	O	-1	10027919
long@@	O	-1	10027919
-@@	O	-1	10027919
stand@@	O	-1	10027919
ing	O	-1	10027919
secondary	B-Disease	D006962	10027919
hyper@@	I-Disease	-1	10027919
par@@	I-Disease	-1	10027919
ath@@	I-Disease	-1	10027919
yro@@	I-Disease	-1	10027919
i@@	I-Disease	-1	10027919
dis@@	I-Disease	-1	10027919
m	I-Disease	-1	10027919
,	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
(@@	O	-1	10027919
0.0@@	O	-1	10027919
3	O	-1	10027919
micro@@	O	-1	10027919
g/@@	O	-1	10027919
kg@@	O	-1	10027919
)	O	-1	10027919
st@@	O	-1	10027919
abil@@	O	-1	10027919
ized	O	-1	10027919
serum	O	-1	10027919
P@@	O	-1	10027919
T@@	O	-1	10027919
H	O	-1	10027919
levels	O	-1	10027919
during	O	-1	10027919
the	O	-1	10027919
first	O	-1	10027919
months.	O	-1	10027919
S@@	O	-1	10027919
er@@	O	-1	10027919
um	O	-1	10027919
P@@	O	-1	10027919
T@@	O	-1	10027919
H	O	-1	10027919
levels	O	-1	10027919
ro@@	O	-1	10027919
se	O	-1	10027919
the@@	O	-1	10027919
re@@	O	-1	10027919
af@@	O	-1	10027919
ter@@	O	-1	10027919
,	O	-1	10027919
but	O	-1	10027919
the	O	-1	10027919
ri@@	O	-1	10027919
se	O	-1	10027919
was	O	-1	10027919
less	O	-1	10027919
p@@	O	-1	10027919
ron@@	O	-1	10027919
oun@@	O	-1	10027919
c@@	O	-1	10027919
ed	O	-1	10027919
compared	O	-1	10027919
with	O	-1	10027919
baseline	O	-1	10027919
than	O	-1	10027919
the	O	-1	10027919
ri@@	O	-1	10027919
se	O	-1	10027919
seen	O	-1	10027919
in	O	-1	10027919
N@@	O	-1	10027919
x	O	-1	10027919
control@@	O	-1	10027919
.	O	-1	10027919
These	O	-1	10027919
effects	O	-1	10027919
were	O	-1	10027919
ac@@	O	-1	10027919
comp@@	O	-1	10027919
an@@	O	-1	10027919
ied	O	-1	10027919
by	O	-1	10027919
episo@@	O	-1	10027919
des	O	-1	10027919
of	O	-1	10027919
hyper@@	B-Disease	D006934	10027919
cal@@	I-Disease	-1	10027919
ce@@	I-Disease	-1	10027919
mia	I-Disease	-1	10027919
and	O	-1	10027919
hyper@@	B-Disease	D054559	10027919
phosph@@	I-Disease	-1	10027919
at@@	I-Disease	-1	10027919
emia	I-Disease	-1	10027919
.	O	-1	10027919
In	O	-1	10027919
animals	O	-1	10027919
with	O	-1	10027919
normal	O	-1	10027919
renal	O	-1	10027919
func@@	O	-1	10027919
tion,	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
induced	O	-1	10027919
a	O	-1	10027919
transi@@	O	-1	10027919
ent	O	-1	10027919
decrease	O	-1	10027919
in	O	-1	10027919
serum	O	-1	10027919
P@@	O	-1	10027919
T@@	O	-1	10027919
H	O	-1	10027919
levels	O	-1	10027919
at	O	-1	10027919
a	O	-1	10027919
dose	O	-1	10027919
of	O	-1	10027919
0.@@	O	-1	10027919
1	O	-1	10027919
micro@@	O	-1	10027919
g/@@	O	-1	10027919
kg@@	O	-1	10027919
,	O	-1	10027919
which	O	-1	10027919
was	O	-1	10027919
not	O	-1	10027919
su@@	O	-1	10027919
st@@	O	-1	10027919
ained	O	-1	10027919
with	O	-1	10027919
low@@	O	-1	10027919
ering	O	-1	10027919
of	O	-1	10027919
the	O	-1	10027919
dos@@	O	-1	10027919
es.	O	-1	10027919
In	O	-1	10027919
N@@	O	-1	10027919
x	O	-1	10027919
dog@@	O	-1	10027919
s,	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
reversed	O	-1	10027919
ab@@	O	-1	10027919
normal	O	-1	10027919
b@@	O	-1	10027919
one	O	-1	10027919
form@@	O	-1	10027919
ation,	O	-1	10027919
such	O	-1	10027919
as	O	-1	10027919
wo@@	B-Disease	-1	10027919
ven	I-Disease	-1	10027919
ost@@	I-Disease	-1	10027919
e@@	I-Disease	-1	10027919
oid	I-Disease	-1	10027919
and	O	-1	10027919
fib@@	B-Disease	D005355	10027919
ro@@	I-Disease	-1	10027919
sis	I-Disease	-1	10027919
,	O	-1	10027919
but	O	-1	10027919
did	O	-1	10027919
not	O	-1	10027919
significantly	O	-1	10027919
al@@	O	-1	10027919
ter	O	-1	10027919
the	O	-1	10027919
level	O	-1	10027919
of	O	-1	10027919
b@@	O	-1	10027919
one	O	-1	10027919
t@@	O	-1	10027919
ur@@	O	-1	10027919
no@@	O	-1	10027919
ver@@	O	-1	10027919
.	O	-1	10027919
In	O	-1	10027919
addi@@	O	-1	10027919
tion,	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
improved	O	-1	10027919
min@@	O	-1	10027919
er@@	O	-1	10027919
al@@	O	-1	10027919
ization	O	-1	10027919
l@@	O	-1	10027919
a@@	O	-1	10027919
g	O	-1	10027919
ti@@	O	-1	10027919
me,	O	-1	10027919
(@@	O	-1	10027919
that	O	-1	10027919
is@@	O	-1	10027919
,	O	-1	10027919
the	O	-1	10027919
rate	O	-1	10027919
at	O	-1	10027919
which	O	-1	10027919
ost@@	O	-1	10027919
e@@	O	-1	10027919
oid	O	-1	10027919
min@@	O	-1	10027919
er@@	O	-1	10027919
al@@	O	-1	10027919
iz@@	O	-1	10027919
es@@	O	-1	10027919
)	O	-1	10027919
in	O	-1	10027919
both	O	-1	10027919
N@@	O	-1	10027919
x	O	-1	10027919
and	O	-1	10027919
S@@	O	-1	10027919
ha@@	O	-1	10027919
m	O	-1	10027919
dog@@	O	-1	10027919
s.	O	-1	10027919
CONCLUSIONS:	O	-1	10027919
These	O	-1	10027919
results	O	-1	10027919
indicate	O	-1	10027919
that	O	-1	10027919
even	O	-1	10027919
though	O	-1	10027919
O@@	B-Chemical	C051883	10027919
C@@	I-Chemical	-1	10027919
T	I-Chemical	-1	10027919
does	O	-1	10027919
not	O	-1	10027919
complete@@	O	-1	10027919
ly	O	-1	10027919
prev@@	O	-1	10027919
ent	O	-1	10027919
the	O	-1	10027919
occur@@	O	-1	10027919
rence	O	-1	10027919
of	O	-1	10027919
hyper@@	B-Disease	D006934	10027919
cal@@	I-Disease	-1	10027919
ce@@	I-Disease	-1	10027919
mia	I-Disease	-1	10027919
in	O	-1	10027919
experimental	O	-1	10027919
dog@@	O	-1	10027919
s	O	-1	10027919
with	O	-1	10027919
renal	B-Disease	D051437	10027919
in@@	I-Disease	-1	10027919
suffici@@	I-Disease	-1	10027919
ency	I-Disease	-1	10027919
,	O	-1	10027919
it	O	-1	10027919
may	O	-1	10027919
be	O	-1	10027919
of	O	-1	10027919
use	O	-1	10027919
in	O	-1	10027919
the	O	-1	10027919
man@@	O	-1	10027919
ag@@	O	-1	10027919
ement	O	-1	10027919
of	O	-1	10027919
secondary	B-Disease	D006962	10027919
hyper@@	I-Disease	-1	10027919
par@@	I-Disease	-1	10027919
ath@@	I-Disease	-1	10027919
yro@@	I-Disease	-1	10027919
i@@	I-Disease	-1	10027919
dis@@	I-Disease	-1	10027919
m	I-Disease	-1	10027919
because	O	-1	10027919
it	O	-1	10027919
does	O	-1	10027919
not	O	-1	10027919
induce	O	-1	10027919
low	B-Disease	D001851	10027919
b@@	I-Disease	-1	10027919
one	I-Disease	-1	10027919
t@@	I-Disease	-1	10027919
ur@@	I-Disease	-1	10027919
no@@	I-Disease	-1	10027919
ver	I-Disease	-1	10027919
and@@	O	-1	10027919
,	O	-1	10027919
the@@	O	-1	10027919
refore,	O	-1	10027919
does	O	-1	10027919
not	O	-1	10027919
increase	O	-1	10027919
the	O	-1	10027919
risk	O	-1	10027919
of	O	-1	10027919
ad@@	B-Disease	D001851	10027919
y@@	I-Disease	-1	10027919
nam@@	I-Disease	-1	10027919
ic	I-Disease	-1	10027919
b@@	I-Disease	-1	10027919
one	I-Disease	-1	10027919
disease	I-Disease	-1	10027919
.	O	-1	10027919

C@@	O	-1	8643966
hemo@@	O	-1	8643966
therapy	O	-1	8643966
of	O	-1	8643966
adv@@	O	-1	8643966
anced	O	-1	8643966
ino@@	O	-1	8643966
per@@	O	-1	8643966
able	O	-1	8643966
non-@@	B-Disease	D002289	8643966
sm@@	I-Disease	-1	8643966
all	I-Disease	-1	8643966
cell	I-Disease	-1	8643966
l@@	I-Disease	-1	8643966
un@@	I-Disease	-1	8643966
g	I-Disease	-1	8643966
cancer	I-Disease	-1	8643966
with	O	-1	8643966
paclitax@@	B-Chemical	D017239	8643966
el	I-Chemical	-1	8643966
:	O	-1	8643966
a	O	-1	8643966
phase	O	-1	8643966
II	O	-1	8643966
tri@@	O	-1	8643966
al.	O	-1	8643966
P@@	B-Chemical	D017239	8643966
ac@@	I-Chemical	-1	8643966
litax@@	I-Chemical	-1	8643966
el	I-Chemical	-1	8643966
(	O	-1	8643966
T@@	B-Chemical	D017239	8643966
ax@@	I-Chemical	-1	8643966
ol	I-Chemical	-1	8643966
;	O	-1	8643966
B@@	O	-1	8643966
ri@@	O	-1	8643966
st@@	O	-1	8643966
ol@@	O	-1	8643966
-@@	O	-1	8643966
M@@	O	-1	8643966
y@@	O	-1	8643966
ers	O	-1	8643966
S@@	O	-1	8643966
qu@@	O	-1	8643966
i@@	O	-1	8643966
b@@	O	-1	8643966
b	O	-1	8643966
Com@@	O	-1	8643966
p@@	O	-1	8643966
an@@	O	-1	8643966
y,	O	-1	8643966
P@@	O	-1	8643966
r@@	O	-1	8643966
in@@	O	-1	8643966
ce@@	O	-1	8643966
t@@	O	-1	8643966
on@@	O	-1	8643966
,	O	-1	8643966
N@@	O	-1	8643966
J@@	O	-1	8643966
)	O	-1	8643966
has	O	-1	8643966
demonstrated	O	-1	8643966
significant	O	-1	8643966
ant@@	O	-1	8643966
ine@@	O	-1	8643966
o@@	O	-1	8643966
plas@@	O	-1	8643966
tic	O	-1	8643966
activity	O	-1	8643966
against	O	-1	8643966
different	O	-1	8643966
tumor	B-Disease	D009369	8643966
typ@@	O	-1	8643966
es,	O	-1	8643966
not@@	O	-1	8643966
ably	O	-1	8643966
o@@	B-Disease	D010051	8643966
vari@@	I-Disease	-1	8643966
an	I-Disease	-1	8643966
and	I-Disease	-1	8643966
b@@	I-Disease	-1	8643966
reas@@	I-Disease	-1	8643966
t	I-Disease	-1	8643966
carcin@@	I-Disease	-1	8643966
oma	I-Disease	-1	8643966
o@@	B-Disease	D001943	8643966
vari@@	I-Disease	-1	8643966
an	I-Disease	-1	8643966
and	I-Disease	-1	8643966
b@@	I-Disease	-1	8643966
reas@@	I-Disease	-1	8643966
t	I-Disease	-1	8643966
carcin@@	I-Disease	-1	8643966
oma	I-Disease	-1	8643966
.	O	-1	8643966
Two	O	-1	8643966
phase	O	-1	8643966
II	O	-1	8643966
tri@@	O	-1	8643966
als	O	-1	8643966
of	O	-1	8643966
2@@	O	-1	8643966
4-@@	O	-1	8643966
h@@	O	-1	8643966
our	O	-1	8643966
paclitax@@	B-Chemical	D017239	8643966
el	I-Chemical	-1	8643966
infu@@	O	-1	8643966
sions	O	-1	8643966
in	O	-1	8643966
chemo@@	O	-1	8643966
therap@@	O	-1	8643966
y-@@	O	-1	8643966
na@@	O	-1	8643966
i@@	O	-1	8643966
ve	O	-1	8643966
patients	O	-1	8643966
with	O	-1	8643966
st@@	O	-1	8643966
age	O	-1	8643966
II@@	O	-1	8643966
I@@	O	-1	8643966
B	O	-1	8643966
or	O	-1	8643966
IV	O	-1	8643966
non-@@	B-Disease	D002289	8643966
sm@@	I-Disease	-1	8643966
all	I-Disease	-1	8643966
cell	I-Disease	-1	8643966
l@@	I-Disease	-1	8643966
un@@	I-Disease	-1	8643966
g	I-Disease	-1	8643966
cancer	I-Disease	-1	8643966
(	O	-1	8643966
N@@	B-Disease	D002289	8643966
S@@	I-Disease	-1	8643966
CL@@	I-Disease	-1	8643966
C	I-Disease	-1	8643966
)	O	-1	8643966
reported	O	-1	8643966
response	O	-1	8643966
rat@@	O	-1	8643966
es	O	-1	8643966
of	O	-1	8643966
2@@	O	-1	8643966
1@@	O	-1	8643966
%	O	-1	8643966
and	O	-1	8643966
2@@	O	-1	8643966
4@@	O	-1	8643966
%.	O	-1	8643966
L@@	B-Disease	D007970	8643966
eu@@	I-Disease	-1	8643966
k@@	I-Disease	-1	8643966
o@@	I-Disease	-1	8643966
pen@@	I-Disease	-1	8643966
ia	I-Disease	-1	8643966
was	O	-1	8643966
dose	O	-1	8643966
lim@@	O	-1	8643966
it@@	O	-1	8643966
ing@@	O	-1	8643966
:	O	-1	8643966
as	O	-1	8643966
man@@	O	-1	8643966
y	O	-1	8643966
as	O	-1	8643966
6@@	O	-1	8643966
2.@@	O	-1	8643966
5%	O	-1	8643966
of	O	-1	8643966
patients	O	-1	8643966
experienced	O	-1	8643966
gra@@	O	-1	8643966
de	O	-1	8643966
4	O	-1	8643966
leuk@@	B-Disease	D007970	8643966
o@@	I-Disease	-1	8643966
pen@@	I-Disease	-1	8643966
ia	I-Disease	-1	8643966
.	O	-1	8643966
We	O	-1	8643966
investigated	O	-1	8643966
the	O	-1	8643966
efficacy	O	-1	8643966
and	O	-1	8643966
toxicity	B-Disease	D064420	8643966
of	O	-1	8643966
a	O	-1	8643966
3-@@	O	-1	8643966
h@@	O	-1	8643966
our	O	-1	8643966
paclitax@@	B-Chemical	D017239	8643966
el	I-Chemical	-1	8643966
infusion	O	-1	8643966
in	O	-1	8643966
a	O	-1	8643966
phase	O	-1	8643966
II	O	-1	8643966
trial	O	-1	8643966
in	O	-1	8643966
patients	O	-1	8643966
with	O	-1	8643966
ino@@	O	-1	8643966
per@@	O	-1	8643966
able	O	-1	8643966
st@@	O	-1	8643966
age	O	-1	8643966
II@@	O	-1	8643966
I@@	O	-1	8643966
B	O	-1	8643966
or	O	-1	8643966
IV	O	-1	8643966
N@@	B-Disease	D002289	8643966
S@@	I-Disease	-1	8643966
CL@@	I-Disease	-1	8643966
C	I-Disease	-1	8643966
.	O	-1	8643966
The	O	-1	8643966
5@@	O	-1	8643966
8	O	-1	8643966
patients	O	-1	8643966
treated	O	-1	8643966
(4@@	O	-1	8643966
1	O	-1	8643966
men	O	-1	8643966
and	O	-1	8643966
17	O	-1	8643966
wom@@	O	-1	8643966
en@@	O	-1	8643966
)	O	-1	8643966
had	O	-1	8643966
a	O	-1	8643966
median	O	-1	8643966
age	O	-1	8643966
of	O	-1	8643966
5@@	O	-1	8643966
9	O	-1	8643966
years	O	-1	8643966
(@@	O	-1	8643966
age	O	-1	8643966
rang@@	O	-1	8643966
e,	O	-1	8643966
25	O	-1	8643966
to	O	-1	8643966
7@@	O	-1	8643966
5@@	O	-1	8643966
)	O	-1	8643966
and	O	-1	8643966
a	O	-1	8643966
perform@@	O	-1	8643966
ance	O	-1	8643966
status	O	-1	8643966
of	O	-1	8643966
0	O	-1	8643966
through	O	-1	8643966
2@@	O	-1	8643966
.	O	-1	8643966
M@@	O	-1	8643966
ost	O	-1	8643966
patients	O	-1	8643966
(@@	O	-1	8643966
7@@	O	-1	8643966
2.@@	O	-1	8643966
4@@	O	-1	8643966
%)	O	-1	8643966
had	O	-1	8643966
st@@	O	-1	8643966
age	O	-1	8643966
IV	O	-1	8643966
N@@	B-Disease	D002289	8643966
S@@	I-Disease	-1	8643966
CL@@	I-Disease	-1	8643966
C	I-Disease	-1	8643966
.	O	-1	8643966
P@@	B-Chemical	D017239	8643966
ac@@	I-Chemical	-1	8643966
litax@@	I-Chemical	-1	8643966
el	I-Chemical	-1	8643966
2@@	O	-1	8643966
25	O	-1	8643966
mg/m@@	O	-1	8643966
2	O	-1	8643966
was	O	-1	8643966
inf@@	O	-1	8643966
used	O	-1	8643966
over	O	-1	8643966
3	O	-1	8643966
hours	O	-1	8643966
every	O	-1	8643966
3	O	-1	8643966
weeks	O	-1	8643966
with	O	-1	8643966
standard	O	-1	8643966
pro@@	O	-1	8643966
phyl@@	O	-1	8643966
ac@@	O	-1	8643966
tic	O	-1	8643966
pre@@	O	-1	8643966
medic@@	O	-1	8643966
ation.	O	-1	8643966
Of	O	-1	8643966
50	O	-1	8643966
patients	O	-1	8643966
evalu@@	O	-1	8643966
able	O	-1	8643966
for	O	-1	8643966
respon@@	O	-1	8643966
se@@	O	-1	8643966
,	O	-1	8643966
12	O	-1	8643966
(2@@	O	-1	8643966
4@@	O	-1	8643966
%)	O	-1	8643966
had	O	-1	8643966
partial	O	-1	8643966
re@@	O	-1	8643966
mis@@	O	-1	8643966
sion,	O	-1	8643966
2@@	O	-1	8643966
6	O	-1	8643966
(5@@	O	-1	8643966
2@@	O	-1	8643966
%)	O	-1	8643966
had	O	-1	8643966
no	O	-1	8643966
chang@@	O	-1	8643966
e,	O	-1	8643966
and	O	-1	8643966
12	O	-1	8643966
had	O	-1	8643966
disease	O	-1	8643966
progres@@	O	-1	8643966
sion	O	-1	8643966
(2@@	O	-1	8643966
4@@	O	-1	8643966
%).	O	-1	8643966
H@@	O	-1	8643966
em@@	O	-1	8643966
at@@	O	-1	8643966
ologic	O	-1	8643966
toxic@@	B-Disease	D064420	8643966
ities	I-Disease	-1	8643966
were	O	-1	8643966
mil@@	O	-1	8643966
d@@	O	-1	8643966
:	O	-1	8643966
only	O	-1	8643966
one	O	-1	8643966
patient	O	-1	8643966
(2@@	O	-1	8643966
%)	O	-1	8643966
developed	O	-1	8643966
gra@@	O	-1	8643966
de	O	-1	8643966
3	O	-1	8643966
or	O	-1	8643966
4	O	-1	8643966
ne@@	B-Disease	D009503	8643966
ut@@	I-Disease	-1	8643966
ro@@	I-Disease	-1	8643966
pen@@	I-Disease	-1	8643966
ia	I-Disease	-1	8643966
,	O	-1	8643966
while	O	-1	8643966
2@@	O	-1	8643966
9@@	O	-1	8643966
%	O	-1	8643966
had	O	-1	8643966
gra@@	O	-1	8643966
de	O	-1	8643966
1	O	-1	8643966
or	O	-1	8643966
2@@	O	-1	8643966
.	O	-1	8643966
G@@	O	-1	8643966
ra@@	O	-1	8643966
de	O	-1	8643966
1	O	-1	8643966
or	O	-1	8643966
2	O	-1	8643966
poly@@	B-Disease	D011115	8643966
neuropathy	I-Disease	-1	8643966
affected	O	-1	8643966
5@@	O	-1	8643966
6%	O	-1	8643966
of	O	-1	8643966
patients	O	-1	8643966
while	O	-1	8643966
only	O	-1	8643966
one	O	-1	8643966
(2@@	O	-1	8643966
%)	O	-1	8643966
experienced	O	-1	8643966
severe	O	-1	8643966
poly@@	B-Disease	D011115	8643966
neuropathy	I-Disease	-1	8643966
.	O	-1	8643966
S@@	O	-1	8643966
im@@	O	-1	8643966
il@@	O	-1	8643966
ar@@	O	-1	8643966
ly,	O	-1	8643966
gra@@	O	-1	8643966
de	O	-1	8643966
1	O	-1	8643966
or	O	-1	8643966
2	O	-1	8643966
my@@	B-Disease	D063806	8643966
al@@	I-Disease	-1	8643966
g@@	I-Disease	-1	8643966
ia	I-Disease	-1	8643966
/	O	-1	8643966
arth@@	B-Disease	D018771	8643966
r@@	I-Disease	-1	8643966
al@@	I-Disease	-1	8643966
g@@	I-Disease	-1	8643966
ia	I-Disease	-1	8643966
was	O	-1	8643966
observed	O	-1	8643966
in	O	-1	8643966
6@@	O	-1	8643966
3.@@	O	-1	8643966
2@@	O	-1	8643966
%	O	-1	8643966
of	O	-1	8643966
patients,	O	-1	8643966
but	O	-1	8643966
only	O	-1	8643966
1@@	O	-1	8643966
4.@@	O	-1	8643966
3@@	O	-1	8643966
%	O	-1	8643966
experienced	O	-1	8643966
gra@@	O	-1	8643966
de	O	-1	8643966
3	O	-1	8643966
or	O	-1	8643966
4@@	O	-1	8643966
.	O	-1	8643966
Na@@	B-Disease	D009325	8643966
use@@	I-Disease	-1	8643966
a	I-Disease	-1	8643966
and	O	-1	8643966
v@@	B-Disease	D014839	8643966
om@@	I-Disease	-1	8643966
it@@	I-Disease	-1	8643966
ing	I-Disease	-1	8643966
were	O	-1	8643966
inf@@	O	-1	8643966
requ@@	O	-1	8643966
ent@@	O	-1	8643966
,	O	-1	8643966
with	O	-1	8643966
14@@	O	-1	8643966
%	O	-1	8643966
of	O	-1	8643966
patients	O	-1	8643966
experienc@@	O	-1	8643966
ing	O	-1	8643966
gra@@	O	-1	8643966
de	O	-1	8643966
1	O	-1	8643966
or	O	-1	8643966
2	O	-1	8643966
and	O	-1	8643966
only	O	-1	8643966
2@@	O	-1	8643966
%	O	-1	8643966
experienc@@	O	-1	8643966
ing	O	-1	8643966
gra@@	O	-1	8643966
de	O	-1	8643966
3	O	-1	8643966
or	O	-1	8643966
4@@	O	-1	8643966
.	O	-1	8643966
P@@	B-Chemical	D017239	8643966
ac@@	I-Chemical	-1	8643966
litax@@	I-Chemical	-1	8643966
el	I-Chemical	-1	8643966
is	O	-1	8643966
th@@	O	-1	8643966
us	O	-1	8643966
an	O	-1	8643966
active	O	-1	8643966
single	O	-1	8643966
agent	O	-1	8643966
in	O	-1	8643966
this	O	-1	8643966
patient	O	-1	8643966
po@@	O	-1	8643966
pul@@	O	-1	8643966
ation,	O	-1	8643966
with	O	-1	8643966
a	O	-1	8643966
3-@@	O	-1	8643966
h@@	O	-1	8643966
our	O	-1	8643966
infusion	O	-1	8643966
pro@@	O	-1	8643966
ving	O	-1	8643966
compar@@	O	-1	8643966
ably	O	-1	8643966
effective	O	-1	8643966
to	O	-1	8643966
a	O	-1	8643966
2@@	O	-1	8643966
4-@@	O	-1	8643966
h@@	O	-1	8643966
our	O	-1	8643966
infusion	O	-1	8643966
and	O	-1	8643966
su@@	O	-1	8643966
peri@@	O	-1	8643966
or	O	-1	8643966
in	O	-1	8643966
ter@@	O	-1	8643966
ms	O	-1	8643966
of	O	-1	8643966
the	O	-1	8643966
incidence	O	-1	8643966
of	O	-1	8643966
hemat@@	O	-1	8643966
ologic	O	-1	8643966
and	O	-1	8643966
non@@	O	-1	8643966
hemat@@	O	-1	8643966
ologic	O	-1	8643966
toxicity	B-Disease	D064420	8643966
.	O	-1	8643966
F@@	O	-1	8643966
urther	O	-1	8643966
phase	O	-1	8643966
II	O	-1	8643966
studies	O	-1	8643966
with	O	-1	8643966
paclitax@@	B-Chemical	D017239	8643966
el	I-Chemical	-1	8643966
combined	O	-1	8643966
with	O	-1	8643966
other	O	-1	8643966
drugs	O	-1	8643966
active	O	-1	8643966
against	O	-1	8643966
N@@	B-Disease	D002289	8643966
S@@	I-Disease	-1	8643966
CL@@	I-Disease	-1	8643966
C	I-Disease	-1	8643966
are	O	-1	8643966
indic@@	O	-1	8643966
at@@	O	-1	8643966
ed,	O	-1	8643966
and	O	-1	8643966
phase	O	-1	8643966
I@@	O	-1	8643966
II	O	-1	8643966
studies	O	-1	8643966
compar@@	O	-1	8643966
ing	O	-1	8643966
paclitax@@	B-Chemical	D017239	8643966
el	I-Chemical	-1	8643966
with	O	-1	8643966
standard	O	-1	8643966
chemotherapy	O	-1	8643966
re@@	O	-1	8643966
ma@@	O	-1	8643966
in	O	-1	8643966
to	O	-1	8643966
be	O	-1	8643966
comple@@	O	-1	8643966
ted.	O	-1	8643966

C@@	B-Disease	D002543	6695415
e@@	I-Disease	-1	6695415
rebral	I-Disease	-1	6695415
hemorrh@@	I-Disease	-1	6695415
age	I-Disease	-1	6695415
associated	O	-1	6695415
with	O	-1	6695415
phenyl@@	B-Chemical	D010665	6695415
prop@@	I-Chemical	-1	6695415
an@@	I-Chemical	-1	6695415
ol@@	I-Chemical	-1	6695415
amine	I-Chemical	-1	6695415
in	O	-1	6695415
combination	O	-1	6695415
with	O	-1	6695415
caffe@@	B-Chemical	D002110	6695415
ine	I-Chemical	-1	6695415
.	O	-1	6695415
Ph@@	B-Chemical	D010665	6695415
en@@	I-Chemical	-1	6695415
yl@@	I-Chemical	-1	6695415
prop@@	I-Chemical	-1	6695415
an@@	I-Chemical	-1	6695415
ol@@	I-Chemical	-1	6695415
amine	I-Chemical	-1	6695415
(	O	-1	6695415
P@@	B-Chemical	D010665	6695415
P@@	I-Chemical	-1	6695415
A	I-Chemical	-1	6695415
)	O	-1	6695415
is	O	-1	6695415
a	O	-1	6695415
drug	O	-1	6695415
that	O	-1	6695415
has	O	-1	6695415
been	O	-1	6695415
associated	O	-1	6695415
with	O	-1	6695415
seri@@	O	-1	6695415
ous	O	-1	6695415
side	O	-1	6695415
effects	O	-1	6695415
including	O	-1	6695415
strok@@	B-Disease	D020521	6695415
e	I-Disease	-1	6695415
.	O	-1	6695415
It	O	-1	6695415
is	O	-1	6695415
often	O	-1	6695415
combined	O	-1	6695415
with	O	-1	6695415
caffe@@	B-Chemical	D002110	6695415
ine	I-Chemical	-1	6695415
in	O	-1	6695415
diet	O	-1	6695415
pre@@	O	-1	6695415
par@@	O	-1	6695415
ations	O	-1	6695415
and	O	-1	6695415
"@@	O	-1	6695415
lo@@	O	-1	6695415
o@@	O	-1	6695415
k@@	O	-1	6695415
-@@	O	-1	6695415
al@@	O	-1	6695415
i@@	O	-1	6695415
ke@@	O	-1	6695415
"	O	-1	6695415
p@@	O	-1	6695415
ill@@	O	-1	6695415
s.	O	-1	6695415
In	O	-1	6695415
or@@	O	-1	6695415
der	O	-1	6695415
to	O	-1	6695415
determine	O	-1	6695415
if	O	-1	6695415
P@@	B-Chemical	D010665	6695415
P@@	I-Chemical	-1	6695415
A	I-Chemical	-1	6695415
/	O	-1	6695415
caffe@@	B-Chemical	D002110	6695415
ine	I-Chemical	-1	6695415
can	O	-1	6695415
le@@	O	-1	6695415
ad	O	-1	6695415
to	O	-1	6695415
strok@@	B-Disease	D020521	6695415
e	I-Disease	-1	6695415
in	O	-1	6695415
norm@@	O	-1	6695415
oten@@	O	-1	6695415
sive	O	-1	6695415
and/or	O	-1	6695415
hypertensive	B-Disease	D006973	6695415
rats,	O	-1	6695415
we	O	-1	6695415
administered	O	-1	6695415
the	O	-1	6695415
combination	O	-1	6695415
in	O	-1	6695415
six	O	-1	6695415
times	O	-1	6695415
the	O	-1	6695415
al@@	O	-1	6695415
low@@	O	-1	6695415
ed	O	-1	6695415
human	O	-1	6695415
dose	O	-1	6695415
calc@@	O	-1	6695415
ul@@	O	-1	6695415
ated	O	-1	6695415
on	O	-1	6695415
a	O	-1	6695415
per	O	-1	6695415
weight	O	-1	6695415
b@@	O	-1	6695415
asis	O	-1	6695415
for	O	-1	6695415
the	O	-1	6695415
rats	O	-1	6695415
two	O	-1	6695415
times	O	-1	6695415
per	O	-1	6695415
day	O	-1	6695415
for	O	-1	6695415
five	O	-1	6695415
days.	O	-1	6695415
S@@	B-Disease	D013345	6695415
ub@@	I-Disease	-1	6695415
arac@@	I-Disease	-1	6695415
h@@	I-Disease	-1	6695415
no@@	I-Disease	-1	6695415
id	I-Disease	-1	6695415
and	I-Disease	-1	6695415
cerebral	I-Disease	-1	6695415
hemorrh@@	I-Disease	-1	6695415
age	I-Disease	-1	6695415
S@@	B-Disease	D002543	6695415
ub@@	I-Disease	-1	6695415
arac@@	I-Disease	-1	6695415
h@@	I-Disease	-1	6695415
no@@	I-Disease	-1	6695415
id	I-Disease	-1	6695415
and	I-Disease	-1	6695415
cerebral	I-Disease	-1	6695415
hemorrh@@	I-Disease	-1	6695415
age	I-Disease	-1	6695415
was	O	-1	6695415
not@@	O	-1	6695415
ed	O	-1	6695415
in	O	-1	6695415
18@@	O	-1	6695415
%	O	-1	6695415
of	O	-1	6695415
the	O	-1	6695415
hypertensive	B-Disease	D006973	6695415
rats.	O	-1	6695415
A	O	-1	6695415
single	O	-1	6695415
P@@	B-Chemical	D010665	6695415
P@@	I-Chemical	-1	6695415
A	I-Chemical	-1	6695415
/	O	-1	6695415
caffe@@	B-Chemical	D002110	6695415
ine	I-Chemical	-1	6695415
administration	O	-1	6695415
(@@	O	-1	6695415
same	O	-1	6695415
dose@@	O	-1	6695415
)	O	-1	6695415
le@@	O	-1	6695415
ad	O	-1	6695415
to	O	-1	6695415
acute	O	-1	6695415
hypertension	B-Disease	D006973	6695415
in	O	-1	6695415
both	O	-1	6695415
the	O	-1	6695415
norm@@	O	-1	6695415
oten@@	O	-1	6695415
sive	O	-1	6695415
and	O	-1	6695415
hypertensive	B-Disease	D006973	6695415
anim@@	O	-1	6695415
al@@	O	-1	6695415
s.	O	-1	6695415
These	O	-1	6695415
results	O	-1	6695415
suggest	O	-1	6695415
that	O	-1	6695415
P@@	B-Chemical	D010665	6695415
P@@	I-Chemical	-1	6695415
A	I-Chemical	-1	6695415
/	O	-1	6695415
caffe@@	B-Chemical	D002110	6695415
ine	I-Chemical	-1	6695415
can	O	-1	6695415
le@@	O	-1	6695415
ad	O	-1	6695415
to	O	-1	6695415
cerebral	B-Disease	D002543	6695415
hemorrh@@	I-Disease	-1	6695415
age	I-Disease	-1	6695415
in	O	-1	6695415
previously	O	-1	6695415
hypertensive	B-Disease	D006973	6695415
animals	O	-1	6695415
when	O	-1	6695415
administered	O	-1	6695415
in	O	-1	6695415
greater	O	-1	6695415
than	O	-1	6695415
the	O	-1	6695415
al@@	O	-1	6695415
low@@	O	-1	6695415
ed	O	-1	6695415
dos@@	O	-1	6695415
age.	O	-1	6695415
An	O	-1	6695415
acute	O	-1	6695415
elev@@	O	-1	6695415
ation	O	-1	6695415
in	O	-1	6695415
blood	O	-1	6695415
pressure	O	-1	6695415
may	O	-1	6695415
be	O	-1	6695415
a	O	-1	6695415
cont@@	O	-1	6695415
ri@@	O	-1	6695415
but@@	O	-1	6695415
ing	O	-1	6695415
fact@@	O	-1	6695415
or@@	O	-1	6695415
.	O	-1	6695415

L@@	O	-1	6637851
on@@	O	-1	6637851
g@@	O	-1	6637851
-term	O	-1	6637851
efficacy	O	-1	6637851
and	O	-1	6637851
toxicity	B-Disease	D064420	6637851
of	O	-1	6637851
high-dose	O	-1	6637851
am@@	B-Chemical	D000638	6637851
iodar@@	I-Chemical	-1	6637851
one	I-Chemical	-1	6637851
therapy	O	-1	6637851
for	O	-1	6637851
ventricular	B-Disease	D017180	6637851
tachycardia	I-Disease	-1	6637851
or	O	-1	6637851
ventricular	B-Disease	D014693	6637851
fibrill@@	I-Disease	-1	6637851
ation	I-Disease	-1	6637851
.	O	-1	6637851
A@@	B-Chemical	D000638	6637851
m@@	I-Chemical	-1	6637851
iodar@@	I-Chemical	-1	6637851
one	I-Chemical	-1	6637851
was	O	-1	6637851
administered	O	-1	6637851
to	O	-1	6637851
1@@	O	-1	6637851
5@@	O	-1	6637851
4	O	-1	6637851
patients	O	-1	6637851
who	O	-1	6637851
had	O	-1	6637851
su@@	O	-1	6637851
st@@	O	-1	6637851
a@@	O	-1	6637851
ine@@	O	-1	6637851
d,	O	-1	6637851
symptom@@	O	-1	6637851
atic	O	-1	6637851
ventricular	B-Disease	D017180	6637851
tachycardia	I-Disease	-1	6637851
(	O	-1	6637851
V@@	B-Disease	D017180	6637851
T	I-Disease	-1	6637851
)	O	-1	6637851
(n	O	-1	6637851
=	O	-1	6637851
1@@	O	-1	6637851
18@@	O	-1	6637851
)	O	-1	6637851
or	O	-1	6637851
a	O	-1	6637851
cardiac	B-Disease	D006323	6637851
ar@@	I-Disease	-1	6637851
res@@	I-Disease	-1	6637851
t	I-Disease	-1	6637851
(n	O	-1	6637851
=	O	-1	6637851
3@@	O	-1	6637851
6@@	O	-1	6637851
)	O	-1	6637851
and	O	-1	6637851
who	O	-1	6637851
were	O	-1	6637851
ref@@	O	-1	6637851
rac@@	O	-1	6637851
t@@	O	-1	6637851
ory	O	-1	6637851
to	O	-1	6637851
con@@	O	-1	6637851
ven@@	O	-1	6637851
tional	O	-1	6637851
anti@@	O	-1	6637851
arrhyth@@	O	-1	6637851
mic	O	-1	6637851
drug@@	O	-1	6637851
s.	O	-1	6637851
The	O	-1	6637851
lo@@	O	-1	6637851
ad@@	O	-1	6637851
ing	O	-1	6637851
dose	O	-1	6637851
was	O	-1	6637851
8@@	O	-1	6637851
00	O	-1	6637851
mg/@@	O	-1	6637851
day	O	-1	6637851
for	O	-1	6637851
6	O	-1	6637851
weeks	O	-1	6637851
and	O	-1	6637851
the	O	-1	6637851
maint@@	O	-1	6637851
en@@	O	-1	6637851
ance	O	-1	6637851
dose	O	-1	6637851
was	O	-1	6637851
6@@	O	-1	6637851
00	O	-1	6637851
mg/@@	O	-1	6637851
da@@	O	-1	6637851
y.	O	-1	6637851
Si@@	O	-1	6637851
x@@	O	-1	6637851
ty-@@	O	-1	6637851
n@@	O	-1	6637851
ine	O	-1	6637851
perc@@	O	-1	6637851
ent	O	-1	6637851
of	O	-1	6637851
patients	O	-1	6637851
continu@@	O	-1	6637851
ed	O	-1	6637851
treatment	O	-1	6637851
with	O	-1	6637851
am@@	B-Chemical	D000638	6637851
iodar@@	I-Chemical	-1	6637851
one	I-Chemical	-1	6637851
and	O	-1	6637851
had	O	-1	6637851
no	O	-1	6637851
recur@@	O	-1	6637851
rence	O	-1	6637851
of	O	-1	6637851
symptom@@	O	-1	6637851
atic	O	-1	6637851
V@@	B-Disease	D017180	6637851
T	I-Disease	-1	6637851
or	O	-1	6637851
ventricular	B-Disease	D014693	6637851
fibrill@@	I-Disease	-1	6637851
ation	I-Disease	-1	6637851
(	O	-1	6637851
V@@	B-Disease	D014693	6637851
F	I-Disease	-1	6637851
)	O	-1	6637851
over	O	-1	6637851
a	O	-1	6637851
follow-up	O	-1	6637851
of	O	-1	6637851
6	O	-1	6637851
to	O	-1	6637851
5@@	O	-1	6637851
2	O	-1	6637851
months	O	-1	6637851
(@@	O	-1	6637851
mean	O	-1	6637851
+/-	O	-1	6637851
standard	O	-1	6637851
de@@	O	-1	6637851
vi@@	O	-1	6637851
ation	O	-1	6637851
1@@	O	-1	6637851
4.@@	O	-1	6637851
2	O	-1	6637851
+/-	O	-1	6637851
8.@@	O	-1	6637851
2@@	O	-1	6637851
).	O	-1	6637851
Si@@	O	-1	6637851
x	O	-1	6637851
perc@@	O	-1	6637851
ent	O	-1	6637851
of	O	-1	6637851
the	O	-1	6637851
patients	O	-1	6637851
had	O	-1	6637851
a	O	-1	6637851
non@@	O	-1	6637851
f@@	O	-1	6637851
atal	O	-1	6637851
recur@@	O	-1	6637851
rence	O	-1	6637851
of	O	-1	6637851
V@@	B-Disease	D017180	6637851
T	I-Disease	-1	6637851
and	O	-1	6637851
were	O	-1	6637851
suc@@	O	-1	6637851
cess@@	O	-1	6637851
ful@@	O	-1	6637851
ly	O	-1	6637851
man@@	O	-1	6637851
aged	O	-1	6637851
by	O	-1	6637851
continu@@	O	-1	6637851
ing	O	-1	6637851
am@@	B-Chemical	D000638	6637851
iodar@@	I-Chemical	-1	6637851
one	I-Chemical	-1	6637851
at	O	-1	6637851
a	O	-1	6637851
higher	O	-1	6637851
dose	O	-1	6637851
or	O	-1	6637851
by	O	-1	6637851
the	O	-1	6637851
addition	O	-1	6637851
of	O	-1	6637851
a	O	-1	6637851
con@@	O	-1	6637851
ven@@	O	-1	6637851
tional	O	-1	6637851
anti@@	O	-1	6637851
arrhyth@@	O	-1	6637851
mic	O	-1	6637851
drug.	O	-1	6637851
One	O	-1	6637851
or	O	-1	6637851
more	O	-1	6637851
adverse	O	-1	6637851
drug	O	-1	6637851
reactions	O	-1	6637851
occurred	O	-1	6637851
in	O	-1	6637851
5@@	O	-1	6637851
1@@	O	-1	6637851
%	O	-1	6637851
of	O	-1	6637851
patients.	O	-1	6637851
Ad@@	O	-1	6637851
verse	O	-1	6637851
effects	O	-1	6637851
for@@	O	-1	6637851
c@@	O	-1	6637851
ed	O	-1	6637851
a	O	-1	6637851
reduction	O	-1	6637851
in	O	-1	6637851
the	O	-1	6637851
dose	O	-1	6637851
of	O	-1	6637851
am@@	B-Chemical	D000638	6637851
iodar@@	I-Chemical	-1	6637851
one	I-Chemical	-1	6637851
in	O	-1	6637851
4@@	O	-1	6637851
1@@	O	-1	6637851
%	O	-1	6637851
and	O	-1	6637851
discontinu@@	O	-1	6637851
ation	O	-1	6637851
of	O	-1	6637851
am@@	B-Chemical	D000638	6637851
iodar@@	I-Chemical	-1	6637851
one	I-Chemical	-1	6637851
in	O	-1	6637851
10@@	O	-1	6637851
%	O	-1	6637851
of	O	-1	6637851
patients.	O	-1	6637851
The	O	-1	6637851
most	O	-1	6637851
common	O	-1	6637851
symptom@@	O	-1	6637851
atic	O	-1	6637851
adverse	O	-1	6637851
reactions	O	-1	6637851
were	O	-1	6637851
trem@@	B-Disease	D014202	6637851
or	I-Disease	-1	6637851
or	O	-1	6637851
at@@	B-Disease	D001259	6637851
ax@@	I-Disease	-1	6637851
ia	I-Disease	-1	6637851
(3@@	O	-1	6637851
5@@	O	-1	6637851
%),	O	-1	6637851
nausea	B-Disease	D009325	6637851
and	O	-1	6637851
an@@	B-Disease	D000855	6637851
ore@@	I-Disease	-1	6637851
x@@	I-Disease	-1	6637851
ia	I-Disease	-1	6637851
(@@	O	-1	6637851
8@@	O	-1	6637851
%),	O	-1	6637851
visual	B-Disease	D014786	6637851
halo@@	I-Disease	-1	6637851
s	I-Disease	-1	6637851
or	I-Disease	-1	6637851
bl@@	I-Disease	-1	6637851
ur@@	I-Disease	-1	6637851
r@@	I-Disease	-1	6637851
ing	I-Disease	-1	6637851
(6@@	O	-1	6637851
%),	O	-1	6637851
th@@	B-Disease	D013959	6637851
yro@@	I-Disease	-1	6637851
id	I-Disease	-1	6637851
function	I-Disease	-1	6637851
abnormal@@	I-Disease	-1	6637851
ities	I-Disease	-1	6637851
(6@@	O	-1	6637851
%)	O	-1	6637851
and	O	-1	6637851
pulmonary	B-Disease	-1	6637851
interstitial	I-Disease	-1	6637851
inf@@	I-Disease	-1	6637851
ilt@@	I-Disease	-1	6637851
rat@@	I-Disease	-1	6637851
es	I-Disease	-1	6637851
(5@@	O	-1	6637851
%).	O	-1	6637851
Although	O	-1	6637851
larg@@	O	-1	6637851
e-@@	O	-1	6637851
dose	O	-1	6637851
am@@	B-Chemical	D000638	6637851
iodar@@	I-Chemical	-1	6637851
one	I-Chemical	-1	6637851
is	O	-1	6637851
high@@	O	-1	6637851
ly	O	-1	6637851
effective	O	-1	6637851
in	O	-1	6637851
the	O	-1	6637851
long-term	O	-1	6637851
treatment	O	-1	6637851
of	O	-1	6637851
V@@	B-Disease	D017180	6637851
T	I-Disease	-1	6637851
or	O	-1	6637851
V@@	B-Disease	D014693	6637851
F	I-Disease	-1	6637851
ref@@	O	-1	6637851
rac@@	O	-1	6637851
t@@	O	-1	6637851
ory	O	-1	6637851
to	O	-1	6637851
con@@	O	-1	6637851
ven@@	O	-1	6637851
tional	O	-1	6637851
anti@@	O	-1	6637851
arrhyth@@	O	-1	6637851
mic	O	-1	6637851
drug@@	O	-1	6637851
s,	O	-1	6637851
it	O	-1	6637851
causes	O	-1	6637851
significant	O	-1	6637851
toxicity	B-Disease	D064420	6637851
in	O	-1	6637851
appro@@	O	-1	6637851
xim@@	O	-1	6637851
ately	O	-1	6637851
50@@	O	-1	6637851
%	O	-1	6637851
of	O	-1	6637851
patients.	O	-1	6637851
However,	O	-1	6637851
when	O	-1	6637851
the	O	-1	6637851
dose	O	-1	6637851
is	O	-1	6637851
adjust@@	O	-1	6637851
ed	O	-1	6637851
bas@@	O	-1	6637851
ed	O	-1	6637851
on	O	-1	6637851
clinical	O	-1	6637851
response	O	-1	6637851
or	O	-1	6637851
the	O	-1	6637851
development	O	-1	6637851
of	O	-1	6637851
adverse	O	-1	6637851
effect@@	O	-1	6637851
s,	O	-1	6637851
7@@	O	-1	6637851
5%	O	-1	6637851
of	O	-1	6637851
patients	O	-1	6637851
with	O	-1	6637851
V@@	B-Disease	D017180	6637851
T	I-Disease	-1	6637851
or	O	-1	6637851
V@@	B-Disease	D014693	6637851
F	I-Disease	-1	6637851
can	O	-1	6637851
be	O	-1	6637851
suc@@	O	-1	6637851
cess@@	O	-1	6637851
ful@@	O	-1	6637851
ly	O	-1	6637851
man@@	O	-1	6637851
aged	O	-1	6637851
with	O	-1	6637851
am@@	B-Chemical	D000638	6637851
iodar@@	I-Chemical	-1	6637851
one	I-Chemical	-1	6637851
.	O	-1	6637851

Eff@@	O	-1	8800187
ect	O	-1	8800187
of	O	-1	8800187
calcium	B-Chemical	D002122	8800187
chlor@@	I-Chemical	-1	8800187
ide	I-Chemical	-1	8800187
and	O	-1	8800187
4-@@	B-Chemical	D015761	8800187
amino@@	I-Chemical	-1	8800187
pyri@@	I-Chemical	-1	8800187
d@@	I-Chemical	-1	8800187
ine	I-Chemical	-1	8800187
therapy	O	-1	8800187
on	O	-1	8800187
desi@@	B-Chemical	D003891	8800187
pramine	I-Chemical	-1	8800187
toxicity	B-Disease	D064420	8800187
in	O	-1	8800187
rats.	O	-1	8800187
BACKGROUND:	O	-1	8800187
H@@	B-Disease	D007022	8800187
y@@	I-Disease	-1	8800187
poten@@	I-Disease	-1	8800187
sion	I-Disease	-1	8800187
is	O	-1	8800187
a	O	-1	8800187
major	O	-1	8800187
cont@@	O	-1	8800187
ri@@	O	-1	8800187
but@@	O	-1	8800187
or	O	-1	8800187
to	O	-1	8800187
mor@@	O	-1	8800187
t@@	O	-1	8800187
ality	O	-1	8800187
in	O	-1	8800187
tr@@	O	-1	8800187
ic@@	O	-1	8800187
y@@	O	-1	8800187
cl@@	O	-1	8800187
ic	O	-1	8800187
antidepress@@	O	-1	8800187
ant	O	-1	8800187
over@@	B-Disease	D062787	8800187
dose	I-Disease	-1	8800187
.	O	-1	8800187
Rec@@	O	-1	8800187
ent	O	-1	8800187
data	O	-1	8800187
suggest	O	-1	8800187
that	O	-1	8800187
tr@@	O	-1	8800187
ic@@	O	-1	8800187
y@@	O	-1	8800187
cl@@	O	-1	8800187
ic	O	-1	8800187
antidepress@@	O	-1	8800187
ants	O	-1	8800187
inhib@@	O	-1	8800187
it	O	-1	8800187
calcium	B-Chemical	D002118	8800187
influ@@	O	-1	8800187
x	O	-1	8800187
in	O	-1	8800187
some	O	-1	8800187
tissu@@	O	-1	8800187
es.	O	-1	8800187
This	O	-1	8800187
study	O	-1	8800187
ad@@	O	-1	8800187
d@@	O	-1	8800187
res@@	O	-1	8800187
sed	O	-1	8800187
the	O	-1	8800187
potential	O	-1	8800187
role	O	-1	8800187
of	O	-1	8800187
calcium	B-Chemical	D002118	8800187
channel	O	-1	8800187
block@@	O	-1	8800187
ade	O	-1	8800187
in	O	-1	8800187
tr@@	O	-1	8800187
ic@@	O	-1	8800187
y@@	O	-1	8800187
cl@@	O	-1	8800187
ic	O	-1	8800187
antidepress@@	O	-1	8800187
ant@@	O	-1	8800187
-induced	O	-1	8800187
hypotension	B-Disease	D007022	8800187
.	O	-1	8800187
METHODS:	O	-1	8800187
Two	O	-1	8800187
inter@@	O	-1	8800187
ven@@	O	-1	8800187
tions	O	-1	8800187
were	O	-1	8800187
studied	O	-1	8800187
that	O	-1	8800187
have	O	-1	8800187
been	O	-1	8800187
shown	O	-1	8800187
previously	O	-1	8800187
to	O	-1	8800187
impro@@	O	-1	8800187
ve	O	-1	8800187
blood	O	-1	8800187
pressure	O	-1	8800187
with	O	-1	8800187
calcium	B-Chemical	D002118	8800187
channel	O	-1	8800187
block@@	O	-1	8800187
er	O	-1	8800187
over@@	B-Disease	D062787	8800187
dose	I-Disease	-1	8800187
.	O	-1	8800187
Ca@@	B-Chemical	D002122	8800187
Cl@@	I-Chemical	-1	8800187
2	I-Chemical	-1	8800187
and	O	-1	8800187
4-@@	B-Chemical	D015761	8800187
amino@@	I-Chemical	-1	8800187
pyri@@	I-Chemical	-1	8800187
d@@	I-Chemical	-1	8800187
ine	I-Chemical	-1	8800187
.	O	-1	8800187
An@@	O	-1	8800187
esthe@@	O	-1	8800187
tiz@@	O	-1	8800187
ed	O	-1	8800187
rats	O	-1	8800187
received	O	-1	8800187
the	O	-1	8800187
tr@@	O	-1	8800187
ic@@	O	-1	8800187
y@@	O	-1	8800187
cl@@	O	-1	8800187
ic	O	-1	8800187
antidepress@@	O	-1	8800187
ant	O	-1	8800187
desi@@	B-Chemical	D003891	8800187
pramine	I-Chemical	-1	8800187
I@@	O	-1	8800187
P	O	-1	8800187
to	O	-1	8800187
produce	O	-1	8800187
hypotension	B-Disease	D007022	8800187
,	O	-1	8800187
Q@@	O	-1	8800187
R@@	O	-1	8800187
S	O	-1	8800187
prolong@@	O	-1	8800187
ation,	O	-1	8800187
and	O	-1	8800187
brady@@	B-Disease	D001919	8800187
cardia	I-Disease	-1	8800187
.	O	-1	8800187
F@@	O	-1	8800187
if@@	O	-1	8800187
te@@	O	-1	8800187
en	O	-1	8800187
min	O	-1	8800187
lat@@	O	-1	8800187
er,	O	-1	8800187
animals	O	-1	8800187
received	O	-1	8800187
Ca@@	B-Chemical	D002122	8800187
Cl@@	I-Chemical	-1	8800187
2	I-Chemical	-1	8800187
,	O	-1	8800187
Na@@	B-Chemical	D017693	8800187
H@@	I-Chemical	-1	8800187
CO@@	I-Chemical	-1	8800187
3	I-Chemical	-1	8800187
,	O	-1	8800187
or	O	-1	8800187
sal@@	O	-1	8800187
ine.	O	-1	8800187
In	O	-1	8800187
a	O	-1	8800187
second	O	-1	8800187
experim@@	O	-1	8800187
ent@@	O	-1	8800187
,	O	-1	8800187
rats	O	-1	8800187
received	O	-1	8800187
tr@@	O	-1	8800187
ic@@	O	-1	8800187
y@@	O	-1	8800187
cl@@	O	-1	8800187
ic	O	-1	8800187
antidepress@@	O	-1	8800187
ant	O	-1	8800187
desi@@	B-Chemical	D003891	8800187
pramine	I-Chemical	-1	8800187
I@@	O	-1	8800187
P	O	-1	8800187
followed	O	-1	8800187
in	O	-1	8800187
15	O	-1	8800187
min	O	-1	8800187
by	O	-1	8800187
4-@@	B-Chemical	D015761	8800187
amino@@	I-Chemical	-1	8800187
pyri@@	I-Chemical	-1	8800187
d@@	I-Chemical	-1	8800187
ine	I-Chemical	-1	8800187
or	O	-1	8800187
sal@@	O	-1	8800187
ine.	O	-1	8800187
RESULTS:	O	-1	8800187
Na@@	B-Chemical	D017693	8800187
H@@	I-Chemical	-1	8800187
CO@@	I-Chemical	-1	8800187
3	I-Chemical	-1	8800187
b@@	O	-1	8800187
ri@@	O	-1	8800187
e@@	O	-1	8800187
f@@	O	-1	8800187
ly	O	-1	8800187
(@@	O	-1	8800187
5	O	-1	8800187
min@@	O	-1	8800187
)	O	-1	8800187
reversed	O	-1	8800187
hypotension	B-Disease	D007022	8800187
and	O	-1	8800187
Q@@	O	-1	8800187
R@@	O	-1	8800187
S	O	-1	8800187
prolong@@	O	-1	8800187
ation.	O	-1	8800187
Ca@@	B-Chemical	D002122	8800187
Cl@@	I-Chemical	-1	8800187
2	I-Chemical	-1	8800187
and	O	-1	8800187
4-@@	B-Chemical	D015761	8800187
amino@@	I-Chemical	-1	8800187
pyri@@	I-Chemical	-1	8800187
d@@	I-Chemical	-1	8800187
ine	I-Chemical	-1	8800187
fail@@	O	-1	8800187
ed	O	-1	8800187
to	O	-1	8800187
impro@@	O	-1	8800187
ve	O	-1	8800187
blood	O	-1	8800187
pressu@@	O	-1	8800187
re.	O	-1	8800187
The	O	-1	8800187
incidence	O	-1	8800187
of	O	-1	8800187
ventricular	B-Disease	D001145	8800187
arrhyth@@	I-Disease	-1	8800187
mi@@	I-Disease	-1	8800187
as	I-Disease	-1	8800187
(p	O	-1	8800187
=	O	-1	8800187
0.00@@	O	-1	8800187
4@@	O	-1	8800187
)	O	-1	8800187
and	O	-1	8800187
seizures	B-Disease	D012640	8800187
(p	O	-1	8800187
=	O	-1	8800187
0.0@@	O	-1	8800187
3@@	O	-1	8800187
)	O	-1	8800187
in	O	-1	8800187
the	O	-1	8800187
Ca@@	B-Chemical	D002122	8800187
Cl@@	I-Chemical	-1	8800187
2	I-Chemical	-1	8800187
group	O	-1	8800187
was	O	-1	8800187
higher	O	-1	8800187
than	O	-1	8800187
the	O	-1	8800187
other	O	-1	8800187
groups.	O	-1	8800187
CONCLUSION:	O	-1	8800187
The	O	-1	8800187
administration	O	-1	8800187
of	O	-1	8800187
Ca@@	B-Chemical	D002122	8800187
Cl@@	I-Chemical	-1	8800187
2	I-Chemical	-1	8800187
or	O	-1	8800187
4-@@	B-Chemical	D015761	8800187
amino@@	I-Chemical	-1	8800187
pyri@@	I-Chemical	-1	8800187
d@@	I-Chemical	-1	8800187
ine	I-Chemical	-1	8800187
did	O	-1	8800187
not	O	-1	8800187
re@@	O	-1	8800187
verse	O	-1	8800187
tr@@	O	-1	8800187
ic@@	O	-1	8800187
y@@	O	-1	8800187
cl@@	O	-1	8800187
ic	O	-1	8800187
antidepress@@	O	-1	8800187
ant@@	O	-1	8800187
-induced	O	-1	8800187
hypotension	B-Disease	D007022	8800187
in	O	-1	8800187
rats.	O	-1	8800187
Ca@@	B-Chemical	D002122	8800187
Cl@@	I-Chemical	-1	8800187
2	I-Chemical	-1	8800187
therapy	O	-1	8800187
may	O	-1	8800187
possib@@	O	-1	8800187
ly	O	-1	8800187
wor@@	O	-1	8800187
se@@	O	-1	8800187
n	O	-1	8800187
both	O	-1	8800187
cardiovascular	B-Disease	D002318	8800187
and	I-Disease	-1	8800187
central	I-Disease	-1	8800187
ner@@	I-Disease	-1	8800187
v@@	I-Disease	-1	8800187
ous	I-Disease	-1	8800187
system	I-Disease	-1	8800187
toxicity	I-Disease	-1	8800187
cardiovascular	B-Disease	D002493	8800187
and	I-Disease	-1	8800187
central	I-Disease	-1	8800187
ner@@	I-Disease	-1	8800187
v@@	I-Disease	-1	8800187
ous	I-Disease	-1	8800187
system	I-Disease	-1	8800187
toxicity	I-Disease	-1	8800187
.	O	-1	8800187
These	O	-1	8800187
findings	O	-1	8800187
d@@	O	-1	8800187
o	O	-1	8800187
not	O	-1	8800187
suppor@@	O	-1	8800187
t	O	-1	8800187
a	O	-1	8800187
role	O	-1	8800187
for	O	-1	8800187
calcium	B-Chemical	D002118	8800187
channel	O	-1	8800187
inhibition	O	-1	8800187
in	O	-1	8800187
the	O	-1	8800187
path@@	O	-1	8800187
o@@	O	-1	8800187
genesis	O	-1	8800187
of	O	-1	8800187
tr@@	O	-1	8800187
ic@@	O	-1	8800187
y@@	O	-1	8800187
cl@@	O	-1	8800187
ic	O	-1	8800187
antidepress@@	O	-1	8800187
ant@@	O	-1	8800187
-induced	O	-1	8800187
hypotension	B-Disease	D007022	8800187
.	O	-1	8800187

Ph@@	O	-1	7707116
ase	O	-1	7707116
I	O	-1	7707116
trial	O	-1	7707116
of	O	-1	7707116
1@@	B-Chemical	D015474	7707116
3-@@	I-Chemical	-1	7707116
cis@@	I-Chemical	-1	7707116
-@@	I-Chemical	-1	7707116
ret@@	I-Chemical	-1	7707116
ino@@	I-Chemical	-1	7707116
ic	I-Chemical	-1	7707116
acid	I-Chemical	-1	7707116
in	O	-1	7707116
children	O	-1	7707116
with	O	-1	7707116
neuro@@	B-Disease	D009447	7707116
bl@@	I-Disease	-1	7707116
ast@@	I-Disease	-1	7707116
oma	I-Disease	-1	7707116
following	O	-1	7707116
b@@	O	-1	7707116
one	O	-1	7707116
m@@	O	-1	7707116
ar@@	O	-1	7707116
ro@@	O	-1	7707116
w	O	-1	7707116
transplant@@	O	-1	7707116
ation.	O	-1	7707116
P@@	O	-1	7707116
U@@	O	-1	7707116
R@@	O	-1	7707116
P@@	O	-1	7707116
O@@	O	-1	7707116
S@@	O	-1	7707116
E:	O	-1	7707116
Treat@@	O	-1	7707116
ment	O	-1	7707116
of	O	-1	7707116
neuro@@	B-Disease	D009447	7707116
bl@@	I-Disease	-1	7707116
ast@@	I-Disease	-1	7707116
oma	I-Disease	-1	7707116
cell	O	-1	7707116
lin@@	O	-1	7707116
es	O	-1	7707116
with	O	-1	7707116
1@@	B-Chemical	D015474	7707116
3-@@	I-Chemical	-1	7707116
cis@@	I-Chemical	-1	7707116
-@@	I-Chemical	-1	7707116
ret@@	I-Chemical	-1	7707116
ino@@	I-Chemical	-1	7707116
ic	I-Chemical	-1	7707116
acid	I-Chemical	-1	7707116
(	O	-1	7707116
cis@@	B-Chemical	D015474	7707116
-@@	I-Chemical	-1	7707116
R@@	I-Chemical	-1	7707116
A	I-Chemical	-1	7707116
)	O	-1	7707116
can	O	-1	7707116
cause	O	-1	7707116
su@@	O	-1	7707116
st@@	O	-1	7707116
ained	O	-1	7707116
inhibition	O	-1	7707116
of	O	-1	7707116
pro@@	O	-1	7707116
li@@	O	-1	7707116
fer@@	O	-1	7707116
ation.	O	-1	7707116
S@@	O	-1	7707116
inc@@	O	-1	7707116
e	O	-1	7707116
cis@@	B-Chemical	D015474	7707116
-@@	I-Chemical	-1	7707116
R@@	I-Chemical	-1	7707116
A	I-Chemical	-1	7707116
has	O	-1	7707116
demonstrated	O	-1	7707116
clinical	O	-1	7707116
responses	O	-1	7707116
in	O	-1	7707116
neuro@@	B-Disease	D009447	7707116
bl@@	I-Disease	-1	7707116
ast@@	I-Disease	-1	7707116
oma	I-Disease	-1	7707116
patients,	O	-1	7707116
it	O	-1	7707116
may	O	-1	7707116
be	O	-1	7707116
effective	O	-1	7707116
in	O	-1	7707116
prevent@@	O	-1	7707116
ing	O	-1	7707116
rel@@	O	-1	7707116
ap@@	O	-1	7707116
se	O	-1	7707116
after	O	-1	7707116
cy@@	O	-1	7707116
tot@@	O	-1	7707116
ox@@	O	-1	7707116
ic	O	-1	7707116
therapy.	O	-1	7707116
This	O	-1	7707116
phase	O	-1	7707116
I	O	-1	7707116
trial	O	-1	7707116
was	O	-1	7707116
de@@	O	-1	7707116
signed	O	-1	7707116
to	O	-1	7707116
determine	O	-1	7707116
the	O	-1	7707116
maxim@@	O	-1	7707116
al@@	O	-1	7707116
-@@	O	-1	7707116
toler@@	O	-1	7707116
ated	O	-1	7707116
dos@@	O	-1	7707116
age	O	-1	7707116
(@@	O	-1	7707116
M@@	O	-1	7707116
T@@	O	-1	7707116
D@@	O	-1	7707116
),	O	-1	7707116
toxic@@	B-Disease	D064420	7707116
ities	I-Disease	-1	7707116
,	O	-1	7707116
and	O	-1	7707116
pharmac@@	O	-1	7707116
o@@	O	-1	7707116
kine@@	O	-1	7707116
tics	O	-1	7707116
of	O	-1	7707116
cis@@	B-Chemical	D015474	7707116
-@@	I-Chemical	-1	7707116
R@@	I-Chemical	-1	7707116
A	I-Chemical	-1	7707116
administered	O	-1	7707116
on	O	-1	7707116
an	O	-1	7707116
inter@@	O	-1	7707116
mit@@	O	-1	7707116
t@@	O	-1	7707116
ent	O	-1	7707116
sch@@	O	-1	7707116
ed@@	O	-1	7707116
ul@@	O	-1	7707116
e	O	-1	7707116
in	O	-1	7707116
children	O	-1	7707116
with	O	-1	7707116
neuro@@	B-Disease	D009447	7707116
bl@@	I-Disease	-1	7707116
ast@@	I-Disease	-1	7707116
oma	I-Disease	-1	7707116
following	O	-1	7707116
b@@	O	-1	7707116
one	O	-1	7707116
m@@	O	-1	7707116
ar@@	O	-1	7707116
ro@@	O	-1	7707116
w	O	-1	7707116
transplant@@	O	-1	7707116
ation	O	-1	7707116
(B@@	O	-1	7707116
M@@	O	-1	7707116
T@@	O	-1	7707116
).	O	-1	7707116
PA@@	O	-1	7707116
TI@@	O	-1	7707116
E@@	O	-1	7707116
N@@	O	-1	7707116
T@@	O	-1	7707116
S	O	-1	7707116
AN@@	O	-1	7707116
D	O	-1	7707116
METHODS:	O	-1	7707116
F@@	O	-1	7707116
if@@	O	-1	7707116
ty-@@	O	-1	7707116
one	O	-1	7707116
assess@@	O	-1	7707116
able	O	-1	7707116
patients,	O	-1	7707116
2	O	-1	7707116
to	O	-1	7707116
12	O	-1	7707116
years	O	-1	7707116
of	O	-1	7707116
age,	O	-1	7707116
were	O	-1	7707116
treated	O	-1	7707116
with	O	-1	7707116
oral	O	-1	7707116
cis@@	B-Chemical	D015474	7707116
-@@	I-Chemical	-1	7707116
R@@	I-Chemical	-1	7707116
A	I-Chemical	-1	7707116
administered	O	-1	7707116
in	O	-1	7707116
two	O	-1	7707116
equ@@	O	-1	7707116
ally	O	-1	7707116
divid@@	O	-1	7707116
ed	O	-1	7707116
doses	O	-1	7707116
daily	O	-1	7707116
for	O	-1	7707116
2	O	-1	7707116
week@@	O	-1	7707116
s,	O	-1	7707116
followed	O	-1	7707116
by	O	-1	7707116
a	O	-1	7707116
2-@@	O	-1	7707116
week	O	-1	7707116
res@@	O	-1	7707116
t	O	-1	7707116
perio@@	O	-1	7707116
d,	O	-1	7707116
for	O	-1	7707116
up	O	-1	7707116
to	O	-1	7707116
12	O	-1	7707116
cour@@	O	-1	7707116
s@@	O	-1	7707116
es.	O	-1	7707116
The	O	-1	7707116
dose	O	-1	7707116
was	O	-1	7707116
es@@	O	-1	7707116
cal@@	O	-1	7707116
ated	O	-1	7707116
from	O	-1	7707116
100	O	-1	7707116
to	O	-1	7707116
2@@	O	-1	7707116
00	O	-1	7707116
mg/m@@	O	-1	7707116
2@@	O	-1	7707116
/@@	O	-1	7707116
d	O	-1	7707116
un@@	O	-1	7707116
ti@@	O	-1	7707116
l	O	-1	7707116
dose-@@	O	-1	7707116
lim@@	O	-1	7707116
it@@	O	-1	7707116
ing	O	-1	7707116
toxicity	B-Disease	D064420	7707116
(D@@	O	-1	7707116
LT@@	O	-1	7707116
)	O	-1	7707116
was	O	-1	7707116
obser@@	O	-1	7707116
ved.	O	-1	7707116
A	O	-1	7707116
single	O	-1	7707116
intra@@	O	-1	7707116
patient	O	-1	7707116
dose	O	-1	7707116
es@@	O	-1	7707116
cal@@	O	-1	7707116
ation	O	-1	7707116
was	O	-1	7707116
per@@	O	-1	7707116
mit@@	O	-1	7707116
ted.	O	-1	7707116
RESULTS:	O	-1	7707116
The	O	-1	7707116
M@@	O	-1	7707116
T@@	O	-1	7707116
D	O	-1	7707116
of	O	-1	7707116
cis@@	B-Chemical	D015474	7707116
-@@	I-Chemical	-1	7707116
R@@	I-Chemical	-1	7707116
A	I-Chemical	-1	7707116
was	O	-1	7707116
1@@	O	-1	7707116
60	O	-1	7707116
mg/m@@	O	-1	7707116
2@@	O	-1	7707116
/@@	O	-1	7707116
d.	O	-1	7707116
D@@	O	-1	7707116
o@@	O	-1	7707116
se@@	O	-1	7707116
-@@	O	-1	7707116
lim@@	O	-1	7707116
it@@	O	-1	7707116
ing	O	-1	7707116
toxic@@	B-Disease	D064420	7707116
ities	I-Disease	-1	7707116
in	O	-1	7707116
six	O	-1	7707116
of	O	-1	7707116
n@@	O	-1	7707116
ine	O	-1	7707116
patients	O	-1	7707116
at	O	-1	7707116
2@@	O	-1	7707116
00	O	-1	7707116
mg/m@@	O	-1	7707116
2@@	O	-1	7707116
/@@	O	-1	7707116
d	O	-1	7707116
included	O	-1	7707116
hyper@@	B-Disease	D006934	7707116
cal@@	I-Disease	-1	7707116
ce@@	I-Disease	-1	7707116
mia	I-Disease	-1	7707116
(n	O	-1	7707116
=	O	-1	7707116
3@@	O	-1	7707116
),	O	-1	7707116
r@@	B-Disease	D005076	7707116
as@@	I-Disease	-1	7707116
h	I-Disease	-1	7707116
(n	O	-1	7707116
=	O	-1	7707116
2@@	O	-1	7707116
),	O	-1	7707116
and	O	-1	7707116
anemia	B-Disease	D000740	7707116
/	O	-1	7707116
throm@@	B-Disease	D013921	7707116
b@@	I-Disease	-1	7707116
ocyto@@	I-Disease	-1	7707116
pen@@	I-Disease	-1	7707116
ia	I-Disease	-1	7707116
/	O	-1	7707116
e@@	B-Disease	D014839	7707116
me@@	I-Disease	-1	7707116
sis	I-Disease	-1	7707116
/	O	-1	7707116
r@@	B-Disease	D005076	7707116
as@@	I-Disease	-1	7707116
h	I-Disease	-1	7707116
(n	O	-1	7707116
=	O	-1	7707116
1).	O	-1	7707116
All	O	-1	7707116
toxic@@	B-Disease	D064420	7707116
ities	I-Disease	-1	7707116
resol@@	O	-1	7707116
ved	O	-1	7707116
after	O	-1	7707116
cis@@	B-Chemical	D015474	7707116
-@@	I-Chemical	-1	7707116
R@@	I-Chemical	-1	7707116
A	I-Chemical	-1	7707116
was	O	-1	7707116
discontinu@@	O	-1	7707116
ed.	O	-1	7707116
Th@@	O	-1	7707116
ree	O	-1	7707116
complete	O	-1	7707116
responses	O	-1	7707116
were	O	-1	7707116
observed	O	-1	7707116
in	O	-1	7707116
m@@	O	-1	7707116
ar@@	O	-1	7707116
ro@@	O	-1	7707116
w	O	-1	7707116
met@@	B-Disease	D009362	7707116
ast@@	I-Disease	-1	7707116
as@@	I-Disease	-1	7707116
es	I-Disease	-1	7707116
.	O	-1	7707116
S@@	O	-1	7707116
er@@	O	-1	7707116
um	O	-1	7707116
levels	O	-1	7707116
of	O	-1	7707116
7.@@	O	-1	7707116
4	O	-1	7707116
+/-	O	-1	7707116
3.@@	O	-1	7707116
0	O	-1	7707116
m@@	O	-1	7707116
um@@	O	-1	7707116
ol@@	O	-1	7707116
/@@	O	-1	7707116
L	O	-1	7707116
(@@	O	-1	7707116
pe@@	O	-1	7707116
ak@@	O	-1	7707116
)	O	-1	7707116
and	O	-1	7707116
4.@@	O	-1	7707116
0	O	-1	7707116
+/-	O	-1	7707116
2.@@	O	-1	7707116
8	O	-1	7707116
m@@	O	-1	7707116
um@@	O	-1	7707116
ol@@	O	-1	7707116
/@@	O	-1	7707116
L	O	-1	7707116
(@@	O	-1	7707116
t@@	O	-1	7707116
rou@@	O	-1	7707116
gh@@	O	-1	7707116
)	O	-1	7707116
at	O	-1	7707116
the	O	-1	7707116
M@@	O	-1	7707116
T@@	O	-1	7707116
D	O	-1	7707116
were	O	-1	7707116
maint@@	O	-1	7707116
ained	O	-1	7707116
during	O	-1	7707116
14	O	-1	7707116
days	O	-1	7707116
of	O	-1	7707116
therapy.	O	-1	7707116
The	O	-1	7707116
D@@	O	-1	7707116
L@@	O	-1	7707116
T	O	-1	7707116
cor@@	O	-1	7707116
related	O	-1	7707116
with	O	-1	7707116
serum	O	-1	7707116
levels	O	-1	7707116
>	O	-1	7707116
or	O	-1	7707116
=	O	-1	7707116
10	O	-1	7707116
m@@	O	-1	7707116
um@@	O	-1	7707116
ol@@	O	-1	7707116
/@@	O	-1	7707116
L@@	O	-1	7707116
.	O	-1	7707116
CONCLUSION:	O	-1	7707116
The	O	-1	7707116
M@@	O	-1	7707116
T@@	O	-1	7707116
D	O	-1	7707116
of	O	-1	7707116
cis@@	B-Chemical	D015474	7707116
-@@	I-Chemical	-1	7707116
R@@	I-Chemical	-1	7707116
A	I-Chemical	-1	7707116
given	O	-1	7707116
on	O	-1	7707116
this	O	-1	7707116
inter@@	O	-1	7707116
mit@@	O	-1	7707116
t@@	O	-1	7707116
ent	O	-1	7707116
sch@@	O	-1	7707116
ed@@	O	-1	7707116
ul@@	O	-1	7707116
e	O	-1	7707116
was	O	-1	7707116
1@@	O	-1	7707116
60	O	-1	7707116
mg/m@@	O	-1	7707116
2@@	O	-1	7707116
/@@	O	-1	7707116
d.	O	-1	7707116
S@@	O	-1	7707116
er@@	O	-1	7707116
um	O	-1	7707116
levels	O	-1	7707116
known	O	-1	7707116
to	O	-1	7707116
be	O	-1	7707116
effective	O	-1	7707116
against	O	-1	7707116
neuro@@	B-Disease	D009447	7707116
bl@@	I-Disease	-1	7707116
ast@@	I-Disease	-1	7707116
oma	I-Disease	-1	7707116
in	O	-1	7707116
vit@@	O	-1	7707116
r@@	O	-1	7707116
o	O	-1	7707116
were	O	-1	7707116
achi@@	O	-1	7707116
ev@@	O	-1	7707116
ed	O	-1	7707116
at	O	-1	7707116
this	O	-1	7707116
dose.	O	-1	7707116
The	O	-1	7707116
D@@	O	-1	7707116
L@@	O	-1	7707116
T	O	-1	7707116
included	O	-1	7707116
hyper@@	B-Disease	D006934	7707116
cal@@	I-Disease	-1	7707116
ce@@	I-Disease	-1	7707116
mia	I-Disease	-1	7707116
,	O	-1	7707116
and	O	-1	7707116
may	O	-1	7707116
be	O	-1	7707116
predic@@	O	-1	7707116
ted	O	-1	7707116
by	O	-1	7707116
serum	O	-1	7707116
cis@@	B-Chemical	D015474	7707116
-@@	I-Chemical	-1	7707116
R@@	I-Chemical	-1	7707116
A	I-Chemical	-1	7707116
level@@	O	-1	7707116
s.	O	-1	7707116
M@@	O	-1	7707116
on@@	O	-1	7707116
it@@	O	-1	7707116
or@@	O	-1	7707116
ing	O	-1	7707116
of	O	-1	7707116
serum	O	-1	7707116
calcium	B-Chemical	D002118	7707116
and	O	-1	7707116
cis@@	B-Chemical	D015474	7707116
-@@	I-Chemical	-1	7707116
R@@	I-Chemical	-1	7707116
A	I-Chemical	-1	7707116
levels	O	-1	7707116
is	O	-1	7707116
indic@@	O	-1	7707116
ated	O	-1	7707116
in	O	-1	7707116
f@@	O	-1	7707116
ut@@	O	-1	7707116
ure	O	-1	7707116
tri@@	O	-1	7707116
al@@	O	-1	7707116
s.	O	-1	7707116

Eff@@	O	-1	6892185
ect	O	-1	6892185
of	O	-1	6892185
calcium	B-Chemical	D002122	6892185
chlor@@	I-Chemical	-1	6892185
ide	I-Chemical	-1	6892185
on	O	-1	6892185
g@@	O	-1	6892185
ros@@	O	-1	6892185
s	O	-1	6892185
behavi@@	O	-1	6892185
o@@	O	-1	6892185
ural	O	-1	6892185
changes	O	-1	6892185
produced	O	-1	6892185
by	O	-1	6892185
carb@@	B-Chemical	D002217	6892185
ac@@	I-Chemical	-1	6892185
hol	I-Chemical	-1	6892185
and	O	-1	6892185
es@@	B-Chemical	D010830	6892185
er@@	I-Chemical	-1	6892185
ine	I-Chemical	-1	6892185
in	O	-1	6892185
cat@@	O	-1	6892185
s.	O	-1	6892185
The	O	-1	6892185
effect	O	-1	6892185
of	O	-1	6892185
calcium	B-Chemical	D002122	6892185
chlor@@	I-Chemical	-1	6892185
ide	I-Chemical	-1	6892185
injected	O	-1	6892185
into	O	-1	6892185
the	O	-1	6892185
cerebral	O	-1	6892185
ventric@@	O	-1	6892185
le@@	O	-1	6892185
s	O	-1	6892185
of	O	-1	6892185
group@@	O	-1	6892185
-@@	O	-1	6892185
h@@	O	-1	6892185
ous@@	O	-1	6892185
ed	O	-1	6892185
un@@	O	-1	6892185
anaesthe@@	O	-1	6892185
tiz@@	O	-1	6892185
ed	O	-1	6892185
cat@@	O	-1	6892185
s	O	-1	6892185
up@@	O	-1	6892185
on	O	-1	6892185
v@@	O	-1	6892185
oc@@	O	-1	6892185
al@@	O	-1	6892185
ization	O	-1	6892185
(@@	O	-1	6892185
ra@@	O	-1	6892185
g@@	O	-1	6892185
e,	O	-1	6892185
h@@	O	-1	6892185
is@@	O	-1	6892185
s@@	O	-1	6892185
ing	O	-1	6892185
and	O	-1	6892185
s@@	O	-1	6892185
n@@	O	-1	6892185
ar@@	O	-1	6892185
l@@	O	-1	6892185
ing@@	O	-1	6892185
),	O	-1	6892185
fi@@	O	-1	6892185
gh@@	O	-1	6892185
ting	O	-1	6892185
(@@	O	-1	6892185
at@@	O	-1	6892185
tac@@	O	-1	6892185
k	O	-1	6892185
with	O	-1	6892185
pa@@	O	-1	6892185
w@@	O	-1	6892185
s	O	-1	6892185
and	O	-1	6892185
cl@@	O	-1	6892185
aw@@	O	-1	6892185
s,	O	-1	6892185
def@@	O	-1	6892185
en@@	O	-1	6892185
se	O	-1	6892185
with	O	-1	6892185
pa@@	O	-1	6892185
w@@	O	-1	6892185
s	O	-1	6892185
and	O	-1	6892185
cl@@	O	-1	6892185
aw@@	O	-1	6892185
s	O	-1	6892185
and	O	-1	6892185
b@@	O	-1	6892185
it@@	O	-1	6892185
ing@@	O	-1	6892185
),	O	-1	6892185
my@@	B-Disease	D015878	6892185
d@@	I-Disease	-1	6892185
ri@@	I-Disease	-1	6892185
asis	I-Disease	-1	6892185
,	O	-1	6892185
trem@@	B-Disease	D014202	6892185
or	I-Disease	-1	6892185
and	O	-1	6892185
clon@@	B-Disease	D004830	6892185
ic@@	I-Disease	-1	6892185
-@@	I-Disease	-1	6892185
t@@	I-Disease	-1	6892185
onic	I-Disease	-1	6892185
convul@@	I-Disease	-1	6892185
sions	I-Disease	-1	6892185
produced	O	-1	6892185
by	O	-1	6892185
carb@@	B-Chemical	D002217	6892185
ac@@	I-Chemical	-1	6892185
hol	I-Chemical	-1	6892185
and	O	-1	6892185
es@@	B-Chemical	D010830	6892185
er@@	I-Chemical	-1	6892185
ine	I-Chemical	-1	6892185
injected	O	-1	6892185
simil@@	O	-1	6892185
arly	O	-1	6892185
was	O	-1	6892185
investig@@	O	-1	6892185
ated.	O	-1	6892185
C@@	B-Chemical	D002122	6892185
al@@	I-Chemical	-1	6892185
ci@@	I-Chemical	-1	6892185
um	I-Chemical	-1	6892185
chlor@@	I-Chemical	-1	6892185
ide	I-Chemical	-1	6892185
depress@@	O	-1	6892185
ed	O	-1	6892185
or	O	-1	6892185
al@@	O	-1	6892185
most	O	-1	6892185
complete@@	O	-1	6892185
ly	O	-1	6892185
abol@@	O	-1	6892185
ished	O	-1	6892185
the	O	-1	6892185
v@@	O	-1	6892185
oc@@	O	-1	6892185
al@@	O	-1	6892185
ization	O	-1	6892185
and	O	-1	6892185
fi@@	O	-1	6892185
gh@@	O	-1	6892185
ting	O	-1	6892185
due	O	-1	6892185
to	O	-1	6892185
carb@@	B-Chemical	D002217	6892185
ac@@	I-Chemical	-1	6892185
hol	I-Chemical	-1	6892185
and	O	-1	6892185
es@@	B-Chemical	D010830	6892185
er@@	I-Chemical	-1	6892185
ine	I-Chemical	-1	6892185
.	O	-1	6892185
O@@	O	-1	6892185
n	O	-1	6892185
the	O	-1	6892185
other	O	-1	6892185
h@@	O	-1	6892185
and@@	O	-1	6892185
,	O	-1	6892185
my@@	B-Disease	D015878	6892185
d@@	I-Disease	-1	6892185
ri@@	I-Disease	-1	6892185
asis	I-Disease	-1	6892185
,	O	-1	6892185
trem@@	B-Disease	D014202	6892185
or	I-Disease	-1	6892185
and	O	-1	6892185
clon@@	B-Disease	D004830	6892185
ic@@	I-Disease	-1	6892185
-@@	I-Disease	-1	6892185
t@@	I-Disease	-1	6892185
onic	I-Disease	-1	6892185
convul@@	I-Disease	-1	6892185
sions	I-Disease	-1	6892185
evoked	O	-1	6892185
by	O	-1	6892185
carb@@	B-Chemical	D002217	6892185
ac@@	I-Chemical	-1	6892185
hol	I-Chemical	-1	6892185
and	O	-1	6892185
es@@	B-Chemical	D010830	6892185
er@@	I-Chemical	-1	6892185
ine	I-Chemical	-1	6892185
were	O	-1	6892185
not	O	-1	6892185
significantly	O	-1	6892185
chang@@	O	-1	6892185
ed	O	-1	6892185
by	O	-1	6892185
calcium	B-Chemical	D002122	6892185
chlor@@	I-Chemical	-1	6892185
ide	I-Chemical	-1	6892185
.	O	-1	6892185
It	O	-1	6892185
is	O	-1	6892185
appa@@	O	-1	6892185
rent	O	-1	6892185
that	O	-1	6892185
calcium	B-Chemical	D002122	6892185
chlor@@	I-Chemical	-1	6892185
ide	I-Chemical	-1	6892185
can	O	-1	6892185
"@@	O	-1	6892185
dis@@	O	-1	6892185
s@@	O	-1	6892185
oci@@	O	-1	6892185
ate@@	O	-1	6892185
"	O	-1	6892185
v@@	O	-1	6892185
oc@@	O	-1	6892185
al@@	O	-1	6892185
ization	O	-1	6892185
and	O	-1	6892185
fi@@	O	-1	6892185
gh@@	O	-1	6892185
ting	O	-1	6892185
from	O	-1	6892185
a@@	O	-1	6892185
ut@@	O	-1	6892185
on@@	O	-1	6892185
om@@	O	-1	6892185
ic	O	-1	6892185
and	O	-1	6892185
motor	O	-1	6892185
phen@@	O	-1	6892185
om@@	O	-1	6892185
en@@	O	-1	6892185
a	O	-1	6892185
such	O	-1	6892185
as	O	-1	6892185
my@@	B-Disease	D015878	6892185
d@@	I-Disease	-1	6892185
ri@@	I-Disease	-1	6892185
asis	I-Disease	-1	6892185
,	O	-1	6892185
trem@@	B-Disease	D014202	6892185
or	I-Disease	-1	6892185
and	O	-1	6892185
clon@@	B-Disease	D004830	6892185
ic@@	I-Disease	-1	6892185
-@@	I-Disease	-1	6892185
t@@	I-Disease	-1	6892185
onic	I-Disease	-1	6892185
convul@@	I-Disease	-1	6892185
sions	I-Disease	-1	6892185
caused	O	-1	6892185
by	O	-1	6892185
carb@@	B-Chemical	D002217	6892185
ac@@	I-Chemical	-1	6892185
hol	I-Chemical	-1	6892185
and	O	-1	6892185
es@@	B-Chemical	D010830	6892185
er@@	I-Chemical	-1	6892185
ine	I-Chemical	-1	6892185
.	O	-1	6892185
C@@	B-Chemical	D002122	6892185
al@@	I-Chemical	-1	6892185
ci@@	I-Chemical	-1	6892185
um	I-Chemical	-1	6892185
chlor@@	I-Chemical	-1	6892185
ide	I-Chemical	-1	6892185
inhibited	O	-1	6892185
the	O	-1	6892185
v@@	O	-1	6892185
oc@@	O	-1	6892185
al@@	O	-1	6892185
ization	O	-1	6892185
and	O	-1	6892185
fi@@	O	-1	6892185
gh@@	O	-1	6892185
ting	O	-1	6892185
produced	O	-1	6892185
by	O	-1	6892185
carb@@	B-Chemical	D002217	6892185
ac@@	I-Chemical	-1	6892185
hol	I-Chemical	-1	6892185
and	O	-1	6892185
es@@	B-Chemical	D010830	6892185
er@@	I-Chemical	-1	6892185
ine	I-Chemical	-1	6892185
most	O	-1	6892185
prob@@	O	-1	6892185
ably	O	-1	6892185
by	O	-1	6892185
a	O	-1	6892185
non@@	O	-1	6892185
specific	O	-1	6892185
st@@	O	-1	6892185
abil@@	O	-1	6892185
iz@@	O	-1	6892185
ing	O	-1	6892185
action	O	-1	6892185
on	O	-1	6892185
central	O	-1	6892185
mus@@	O	-1	6892185
car@@	O	-1	6892185
inic	O	-1	6892185
chol@@	O	-1	6892185
in@@	O	-1	6892185
oc@@	O	-1	6892185
ep@@	O	-1	6892185
tive	O	-1	6892185
sit@@	O	-1	6892185
es.	O	-1	6892185
These	O	-1	6892185
results	O	-1	6892185
further	O	-1	6892185
suppor@@	O	-1	6892185
t	O	-1	6892185
the	O	-1	6892185
vie@@	O	-1	6892185
w	O	-1	6892185
that	O	-1	6892185
calcium	B-Chemical	D002118	6892185
i@@	O	-1	6892185
ons	O	-1	6892185
in	O	-1	6892185
ex@@	O	-1	6892185
cess	O	-1	6892185
have	O	-1	6892185
an	O	-1	6892185
atro@@	B-Chemical	D001285	6892185
pine	I-Chemical	-1	6892185
-@@	O	-1	6892185
like	O	-1	6892185
action	O	-1	6892185
also	O	-1	6892185
in	O	-1	6892185
the	O	-1	6892185
central	O	-1	6892185
ner@@	O	-1	6892185
v@@	O	-1	6892185
ous	O	-1	6892185
system@@	O	-1	6892185
.	O	-1	6892185

M@@	O	-1	6216862
ul@@	O	-1	6216862
ti@@	O	-1	6216862
ple	O	-1	6216862
side	O	-1	6216862
effects	O	-1	6216862
of	O	-1	6216862
pen@@	B-Chemical	D010396	6216862
icill@@	I-Chemical	-1	6216862
amine	I-Chemical	-1	6216862
therapy	O	-1	6216862
in	O	-1	6216862
one	O	-1	6216862
patient	O	-1	6216862
with	O	-1	6216862
r@@	B-Disease	D001172	6216862
he@@	I-Disease	-1	6216862
um@@	I-Disease	-1	6216862
at@@	I-Disease	-1	6216862
oid	I-Disease	-1	6216862
arth@@	I-Disease	-1	6216862
ritis	I-Disease	-1	6216862
.	O	-1	6216862
S@@	B-Disease	D005076	6216862
k@@	I-Disease	-1	6216862
in	I-Disease	-1	6216862
r@@	I-Disease	-1	6216862
as@@	I-Disease	-1	6216862
h@@	I-Disease	-1	6216862
es	I-Disease	-1	6216862
,	O	-1	6216862
proteinuria	B-Disease	D011507	6216862
,	O	-1	6216862
systemic	B-Disease	D008180	6216862
lu@@	I-Disease	-1	6216862
p@@	I-Disease	-1	6216862
us	I-Disease	-1	6216862
eryth@@	I-Disease	-1	6216862
em@@	I-Disease	-1	6216862
at@@	I-Disease	-1	6216862
os@@	I-Disease	-1	6216862
us	I-Disease	-1	6216862
,	O	-1	6216862
poly@@	B-Disease	D017285	6216862
my@@	I-Disease	-1	6216862
o@@	I-Disease	-1	6216862
si@@	I-Disease	-1	6216862
tis	I-Disease	-1	6216862
and	O	-1	6216862
my@@	B-Disease	D009157	6216862
as@@	I-Disease	-1	6216862
th@@	I-Disease	-1	6216862
en@@	I-Disease	-1	6216862
ia	I-Disease	-1	6216862
gra@@	I-Disease	-1	6216862
v@@	I-Disease	-1	6216862
is	I-Disease	-1	6216862
have	O	-1	6216862
all	O	-1	6216862
been	O	-1	6216862
recor@@	O	-1	6216862
ded	O	-1	6216862
as	O	-1	6216862
complications	O	-1	6216862
of	O	-1	6216862
pen@@	B-Chemical	D010396	6216862
icill@@	I-Chemical	-1	6216862
amine	I-Chemical	-1	6216862
therapy	O	-1	6216862
in	O	-1	6216862
patients	O	-1	6216862
with	O	-1	6216862
r@@	B-Disease	D001172	6216862
he@@	I-Disease	-1	6216862
um@@	I-Disease	-1	6216862
at@@	I-Disease	-1	6216862
oid	I-Disease	-1	6216862
arth@@	I-Disease	-1	6216862
ritis	I-Disease	-1	6216862
.	O	-1	6216862
A	O	-1	6216862
patient	O	-1	6216862
who	O	-1	6216862
had	O	-1	6216862
developed	O	-1	6216862
all	O	-1	6216862
5	O	-1	6216862
is	O	-1	6216862
no@@	O	-1	6216862
w	O	-1	6216862
descri@@	O	-1	6216862
be@@	O	-1	6216862
d.	O	-1	6216862
The	O	-1	6216862
s@@	B-Disease	D012871	6216862
k@@	I-Disease	-1	6216862
in	I-Disease	-1	6216862
le@@	I-Disease	-1	6216862
sion	I-Disease	-1	6216862
re@@	O	-1	6216862
se@@	O	-1	6216862
m@@	O	-1	6216862
bl@@	O	-1	6216862
ed	O	-1	6216862
el@@	B-Disease	C536202	6216862
ast@@	I-Disease	-1	6216862
o@@	I-Disease	-1	6216862
sis	I-Disease	-1	6216862
per@@	I-Disease	-1	6216862
for@@	I-Disease	-1	6216862
ans	I-Disease	-1	6216862
ser@@	I-Disease	-1	6216862
pi@@	I-Disease	-1	6216862
g@@	I-Disease	-1	6216862
in@@	I-Disease	-1	6216862
os@@	I-Disease	-1	6216862
a	I-Disease	-1	6216862
,	O	-1	6216862
which	O	-1	6216862
has	O	-1	6216862
been	O	-1	6216862
reported	O	-1	6216862
as	O	-1	6216862
a	O	-1	6216862
r@@	O	-1	6216862
are	O	-1	6216862
side	O	-1	6216862
effect	O	-1	6216862
in	O	-1	6216862
patients	O	-1	6216862
with	O	-1	6216862
W@@	B-Disease	D006527	6216862
il@@	I-Disease	-1	6216862
son@@	I-Disease	-1	6216862
's	I-Disease	-1	6216862
disease	I-Disease	-1	6216862
but	O	-1	6216862
not	O	-1	6216862
in	O	-1	6216862
patients	O	-1	6216862
with	O	-1	6216862
r@@	B-Disease	D001172	6216862
he@@	I-Disease	-1	6216862
um@@	I-Disease	-1	6216862
at@@	I-Disease	-1	6216862
oid	I-Disease	-1	6216862
arth@@	I-Disease	-1	6216862
ritis	I-Disease	-1	6216862
treated	O	-1	6216862
with	O	-1	6216862
pen@@	B-Chemical	D010396	6216862
icill@@	I-Chemical	-1	6216862
amine	I-Chemical	-1	6216862
.	O	-1	6216862

E@@	O	-1	2004
l@@	O	-1	2004
ect@@	O	-1	2004
ro@@	O	-1	2004
cardio@@	O	-1	2004
graph@@	O	-1	2004
ic	O	-1	2004
changes	O	-1	2004
and	O	-1	2004
cardiac	B-Disease	D001145	2004
arrhyth@@	I-Disease	-1	2004
mi@@	I-Disease	-1	2004
as	I-Disease	-1	2004
in	O	-1	2004
patients	O	-1	2004
receiving	O	-1	2004
psych@@	O	-1	2004
ot@@	O	-1	2004
ro@@	O	-1	2004
p@@	O	-1	2004
ic	O	-1	2004
drug@@	O	-1	2004
s.	O	-1	2004
E@@	O	-1	2004
ight	O	-1	2004
patients	O	-1	2004
had	O	-1	2004
cardiac	O	-1	2004
man@@	O	-1	2004
if@@	O	-1	2004
est@@	O	-1	2004
ations	O	-1	2004
that	O	-1	2004
were	O	-1	2004
lif@@	O	-1	2004
e-@@	O	-1	2004
th@@	O	-1	2004
reat@@	O	-1	2004
en@@	O	-1	2004
ing	O	-1	2004
in	O	-1	2004
five	O	-1	2004
while	O	-1	2004
taking	O	-1	2004
psych@@	O	-1	2004
ot@@	O	-1	2004
ro@@	O	-1	2004
p@@	O	-1	2004
ic	O	-1	2004
drug@@	O	-1	2004
s,	O	-1	2004
either	O	-1	2004
phen@@	B-Chemical	D010640	2004
o@@	I-Chemical	-1	2004
thi@@	I-Chemical	-1	2004
az@@	I-Chemical	-1	2004
in@@	I-Chemical	-1	2004
es	I-Chemical	-1	2004
or	O	-1	2004
tr@@	O	-1	2004
ic@@	O	-1	2004
y@@	O	-1	2004
cl@@	O	-1	2004
ic	O	-1	2004
antidepress@@	O	-1	2004
ant@@	O	-1	2004
s.	O	-1	2004
Although	O	-1	2004
most	O	-1	2004
patients	O	-1	2004
were	O	-1	2004
receiving	O	-1	2004
several	O	-1	2004
drug@@	O	-1	2004
s,	O	-1	2004
M@@	B-Chemical	D013881	2004
ell@@	I-Chemical	-1	2004
ari@@	I-Chemical	-1	2004
l	I-Chemical	-1	2004
(	O	-1	2004
thi@@	B-Chemical	D013881	2004
or@@	I-Chemical	-1	2004
id@@	I-Chemical	-1	2004
az@@	I-Chemical	-1	2004
ine	I-Chemical	-1	2004
)	O	-1	2004
appe@@	O	-1	2004
a@@	O	-1	2004
red	O	-1	2004
to	O	-1	2004
be	O	-1	2004
respon@@	O	-1	2004
sible	O	-1	2004
for	O	-1	2004
five	O	-1	2004
cases	O	-1	2004
of	O	-1	2004
ventricular	B-Disease	D017180	2004
tachycardia	I-Disease	-1	2004
,	O	-1	2004
one	O	-1	2004
of	O	-1	2004
which	O	-1	2004
was	O	-1	2004
f@@	O	-1	2004
atal	O	-1	2004
in	O	-1	2004
a	O	-1	2004
3@@	O	-1	2004
5	O	-1	2004
year	O	-1	2004
old	O	-1	2004
wom@@	O	-1	2004
an@@	O	-1	2004
.	O	-1	2004
S@@	B-Disease	D013617	2004
up@@	I-Disease	-1	2004
ra@@	I-Disease	-1	2004
ventricular	I-Disease	-1	2004
tachycardia	I-Disease	-1	2004
developed	O	-1	2004
in	O	-1	2004
one	O	-1	2004
patient	O	-1	2004
receiving	O	-1	2004
Th@@	B-Chemical	D002746	2004
or@@	I-Chemical	-1	2004
az@@	I-Chemical	-1	2004
ine	I-Chemical	-1	2004
(	O	-1	2004
chlor@@	B-Chemical	D002746	2004
pro@@	I-Chemical	-1	2004
ma@@	I-Chemical	-1	2004
z@@	I-Chemical	-1	2004
ine	I-Chemical	-1	2004
).	O	-1	2004
A@@	B-Chemical	D009661	2004
v@@	I-Chemical	-1	2004
ent@@	I-Chemical	-1	2004
yl	I-Chemical	-1	2004
(	O	-1	2004
nor@@	B-Chemical	D009661	2004
tri@@	I-Chemical	-1	2004
pt@@	I-Chemical	-1	2004
yl@@	I-Chemical	-1	2004
ine	I-Chemical	-1	2004
)	O	-1	2004
and	O	-1	2004
E@@	B-Chemical	D000639	2004
l@@	I-Chemical	-1	2004
avi@@	I-Chemical	-1	2004
l	I-Chemical	-1	2004
(	O	-1	2004
am@@	B-Chemical	D000639	2004
it@@	I-Chemical	-1	2004
ript@@	I-Chemical	-1	2004
yl@@	I-Chemical	-1	2004
ine	I-Chemical	-1	2004
)	O	-1	2004
each	O	-1	2004
produced	O	-1	2004
left	B-Disease	D002037	2004
b@@	I-Disease	-1	2004
und@@	I-Disease	-1	2004
le	I-Disease	-1	2004
b@@	I-Disease	-1	2004
ran@@	I-Disease	-1	2004
ch	I-Disease	-1	2004
bloc@@	I-Disease	-1	2004
k	I-Disease	-1	2004
in	O	-1	2004
a	O	-1	2004
7@@	O	-1	2004
3	O	-1	2004
year	O	-1	2004
old	O	-1	2004
wom@@	O	-1	2004
an@@	O	-1	2004
.	O	-1	2004
E@@	O	-1	2004
l@@	O	-1	2004
ect@@	O	-1	2004
ro@@	O	-1	2004
cardio@@	O	-1	2004
graph@@	O	-1	2004
ic	O	-1	2004
T	O	-1	2004
and	O	-1	2004
U	O	-1	2004
w@@	O	-1	2004
a@@	O	-1	2004
ve	O	-1	2004
abnormal@@	O	-1	2004
ities	O	-1	2004
were	O	-1	2004
present	O	-1	2004
in	O	-1	2004
most	O	-1	2004
patients.	O	-1	2004
The	O	-1	2004
ventricular	B-Disease	D001145	2004
arrhyth@@	I-Disease	-1	2004
mi@@	I-Disease	-1	2004
as	I-Disease	-1	2004
respon@@	O	-1	2004
ded	O	-1	2004
to	O	-1	2004
intravenous	O	-1	2004
administration	O	-1	2004
of	O	-1	2004
lidocaine	B-Chemical	D008012	2004
and	O	-1	2004
to	O	-1	2004
direct	O	-1	2004
current	O	-1	2004
elect@@	O	-1	2004
ric	O	-1	2004
sh@@	O	-1	2004
oc@@	O	-1	2004
k@@	O	-1	2004
;	O	-1	2004
ventricular	O	-1	2004
pac@@	O	-1	2004
ing	O	-1	2004
was	O	-1	2004
requ@@	O	-1	2004
ired	O	-1	2004
in	O	-1	2004
some	O	-1	2004
in@@	O	-1	2004
st@@	O	-1	2004
anc@@	O	-1	2004
es	O	-1	2004
and	O	-1	2004
intravenous	O	-1	2004
administration	O	-1	2004
of	O	-1	2004
prop@@	B-Chemical	D011433	2004
ran@@	I-Chemical	-1	2004
o@@	I-Chemical	-1	2004
lol	I-Chemical	-1	2004
combined	O	-1	2004
with	O	-1	2004
ventricular	O	-1	2004
pac@@	O	-1	2004
ing	O	-1	2004
in	O	-1	2004
one.	O	-1	2004
The	O	-1	2004
tachy@@	B-Disease	D013610	2004
arrhyth@@	I-Disease	-1	2004
mi@@	I-Disease	-1	2004
as	I-Disease	-1	2004
gener@@	O	-1	2004
ally	O	-1	2004
sub@@	O	-1	2004
si@@	O	-1	2004
ded	O	-1	2004
within	O	-1	2004
4@@	O	-1	2004
8	O	-1	2004
hours	O	-1	2004
after	O	-1	2004
administration	O	-1	2004
of	O	-1	2004
the	O	-1	2004
drugs	O	-1	2004
was	O	-1	2004
sto@@	O	-1	2004
pp@@	O	-1	2004
ed.	O	-1	2004
F@@	O	-1	2004
i@@	O	-1	2004
ve	O	-1	2004
of	O	-1	2004
the	O	-1	2004
e@@	O	-1	2004
ight	O	-1	2004
patients	O	-1	2004
were	O	-1	2004
50	O	-1	2004
years	O	-1	2004
of	O	-1	2004
age	O	-1	2004
or	O	-1	2004
youn@@	O	-1	2004
g@@	O	-1	2004
er@@	O	-1	2004
;	O	-1	2004
only	O	-1	2004
one	O	-1	2004
clear@@	O	-1	2004
ly	O	-1	2004
had	O	-1	2004
ant@@	O	-1	2004
ec@@	O	-1	2004
ed@@	O	-1	2004
ent	O	-1	2004
heart	B-Disease	D006331	2004
disease	I-Disease	-1	2004
.	O	-1	2004
M@@	O	-1	2004
a@@	O	-1	2004
j@@	O	-1	2004
or	O	-1	2004
cardiac	B-Disease	D001145	2004
arrhyth@@	I-Disease	-1	2004
mi@@	I-Disease	-1	2004
as	I-Disease	-1	2004
are	O	-1	2004
a	O	-1	2004
potential	O	-1	2004
ha@@	O	-1	2004
z@@	O	-1	2004
ard	O	-1	2004
in	O	-1	2004
patients	O	-1	2004
without	O	-1	2004
heart	B-Disease	D006331	2004
disease	I-Disease	-1	2004
who	O	-1	2004
are	O	-1	2004
receiving	O	-1	2004
c@@	O	-1	2004
ust@@	O	-1	2004
om@@	O	-1	2004
ary	O	-1	2004
therapeutic	O	-1	2004
doses	O	-1	2004
of	O	-1	2004
psych@@	O	-1	2004
ot@@	O	-1	2004
ro@@	O	-1	2004
p@@	O	-1	2004
ic	O	-1	2004
drug@@	O	-1	2004
s.	O	-1	2004
A	O	-1	2004
pro@@	O	-1	2004
sp@@	O	-1	2004
ective	O	-1	2004
clinical	O	-1	2004
trial	O	-1	2004
is	O	-1	2004
suggested	O	-1	2004
to	O	-1	2004
qu@@	O	-1	2004
anti@@	O	-1	2004
f@@	O	-1	2004
y	O	-1	2004
the	O	-1	2004
risk	O	-1	2004
of	O	-1	2004
cardiac	B-Disease	D005117	2004
complications	I-Disease	-1	2004
to	O	-1	2004
patients	O	-1	2004
receiving	O	-1	2004
phen@@	B-Chemical	D010640	2004
o@@	I-Chemical	-1	2004
thi@@	I-Chemical	-1	2004
az@@	I-Chemical	-1	2004
in@@	I-Chemical	-1	2004
es	I-Chemical	-1	2004
or	O	-1	2004
tr@@	O	-1	2004
ic@@	O	-1	2004
y@@	O	-1	2004
cl@@	O	-1	2004
ic	O	-1	2004
antidepress@@	O	-1	2004
ant	O	-1	2004
drug@@	O	-1	2004
s.	O	-1	2004

S@@	O	-1	6118280
er@@	O	-1	6118280
oton@@	O	-1	6118280
ergic	O	-1	6118280
drug@@	O	-1	6118280
s,	O	-1	6118280
b@@	B-Chemical	D001569	6118280
enz@@	I-Chemical	-1	6118280
odi@@	I-Chemical	-1	6118280
azep@@	I-Chemical	-1	6118280
in@@	I-Chemical	-1	6118280
es	I-Chemical	-1	6118280
and	O	-1	6118280
bac@@	B-Chemical	D001418	6118280
lo@@	I-Chemical	-1	6118280
f@@	I-Chemical	-1	6118280
en	I-Chemical	-1	6118280
bloc@@	O	-1	6118280
k	O	-1	6118280
musc@@	B-Chemical	D009118	6118280
im@@	I-Chemical	-1	6118280
ol	I-Chemical	-1	6118280
-induced	O	-1	6118280
my@@	B-Disease	D009207	6118280
oc@@	I-Disease	-1	6118280
lon@@	I-Disease	-1	6118280
ic	I-Disease	-1	6118280
j@@	I-Disease	-1	6118280
er@@	I-Disease	-1	6118280
k@@	I-Disease	-1	6118280
s	I-Disease	-1	6118280
in	O	-1	6118280
a	O	-1	6118280
stra@@	O	-1	6118280
in	O	-1	6118280
of	O	-1	6118280
mice.	O	-1	6118280
In	O	-1	6118280
male	O	-1	6118280
S@@	O	-1	6118280
w@@	O	-1	6118280
is@@	O	-1	6118280
s	O	-1	6118280
mic@@	O	-1	6118280
e,	O	-1	6118280
musc@@	B-Chemical	D009118	6118280
im@@	I-Chemical	-1	6118280
ol	I-Chemical	-1	6118280
produced	O	-1	6118280
my@@	B-Disease	D009207	6118280
oc@@	I-Disease	-1	6118280
lon@@	I-Disease	-1	6118280
ic	I-Disease	-1	6118280
j@@	I-Disease	-1	6118280
er@@	I-Disease	-1	6118280
k@@	I-Disease	-1	6118280
s	I-Disease	-1	6118280
.	O	-1	6118280
A	O	-1	6118280
3	O	-1	6118280
mg/kg	O	-1	6118280
(@@	O	-1	6118280
i.p.@@	O	-1	6118280
)	O	-1	6118280
dose	O	-1	6118280
induced	O	-1	6118280
this	O	-1	6118280
response	O	-1	6118280
in	O	-1	6118280
all	O	-1	6118280
of	O	-1	6118280
the	O	-1	6118280
mice	O	-1	6118280
tested	O	-1	6118280
and	O	-1	6118280
the	O	-1	6118280
pe@@	O	-1	6118280
a@@	O	-1	6118280
k	O	-1	6118280
response	O	-1	6118280
of	O	-1	6118280
7@@	O	-1	6118280
3	O	-1	6118280
j@@	O	-1	6118280
er@@	O	-1	6118280
k@@	O	-1	6118280
s	O	-1	6118280
per	O	-1	6118280
min	O	-1	6118280
was	O	-1	6118280
observed	O	-1	6118280
between	O	-1	6118280
2@@	O	-1	6118280
7	O	-1	6118280
and	O	-1	6118280
4@@	O	-1	6118280
5	O	-1	6118280
min@@	O	-1	6118280
.	O	-1	6118280
In@@	O	-1	6118280
c@@	O	-1	6118280
reas@@	O	-1	6118280
ing	O	-1	6118280
the	O	-1	6118280
brain	O	-1	6118280
seroton@@	B-Chemical	D012701	6118280
in	I-Chemical	-1	6118280
levels	O	-1	6118280
by	O	-1	6118280
the	O	-1	6118280
administration	O	-1	6118280
of	O	-1	6118280
5-@@	B-Chemical	D006916	6118280
hydrox@@	I-Chemical	-1	6118280
y@@	I-Chemical	-1	6118280
tr@@	I-Chemical	-1	6118280
y@@	I-Chemical	-1	6118280
pto@@	I-Chemical	-1	6118280
ph@@	I-Chemical	-1	6118280
an	I-Chemical	-1	6118280
(@@	O	-1	6118280
80@@	O	-1	6118280
-1@@	O	-1	6118280
60	O	-1	6118280
mg/kg)	O	-1	6118280
in	O	-1	6118280
combination	O	-1	6118280
with	O	-1	6118280
a	O	-1	6118280
peripheral	O	-1	6118280
dec@@	O	-1	6118280
arb@@	O	-1	6118280
ox@@	O	-1	6118280
yl@@	O	-1	6118280
ase	O	-1	6118280
inhibitor	O	-1	6118280
resulted	O	-1	6118280
in	O	-1	6118280
an	O	-1	6118280
inhibition	O	-1	6118280
of	O	-1	6118280
the	O	-1	6118280
musc@@	B-Chemical	D009118	6118280
im@@	I-Chemical	-1	6118280
ol	I-Chemical	-1	6118280
effect@@	O	-1	6118280
.	O	-1	6118280
However,	O	-1	6118280
in	O	-1	6118280
a	O	-1	6118280
similar	O	-1	6118280
experim@@	O	-1	6118280
ent	O	-1	6118280
l@@	B-Chemical	D007980	6118280
-@@	I-Chemical	-1	6118280
dopa	I-Chemical	-1	6118280
(@@	O	-1	6118280
80@@	O	-1	6118280
-1@@	O	-1	6118280
60	O	-1	6118280
mg/kg)	O	-1	6118280
was	O	-1	6118280
without	O	-1	6118280
effect@@	O	-1	6118280
.	O	-1	6118280
In	O	-1	6118280
doses	O	-1	6118280
of	O	-1	6118280
3-@@	O	-1	6118280
10	O	-1	6118280
mg/kg@@	O	-1	6118280
,	O	-1	6118280
the	O	-1	6118280
seroton@@	B-Chemical	D012701	6118280
in	I-Chemical	-1	6118280
receptor	O	-1	6118280
agon@@	O	-1	6118280
ist	O	-1	6118280
M@@	B-Chemical	C014896	6118280
K@@	I-Chemical	-1	6118280
-@@	I-Chemical	-1	6118280
2@@	I-Chemical	-1	6118280
12	I-Chemical	-1	6118280
caused	O	-1	6118280
a	O	-1	6118280
dose-@@	O	-1	6118280
dependent	O	-1	6118280
block@@	O	-1	6118280
ade	O	-1	6118280
of	O	-1	6118280
the	O	-1	6118280
response	O	-1	6118280
of	O	-1	6118280
musc@@	B-Chemical	D009118	6118280
im@@	I-Chemical	-1	6118280
ol	I-Chemical	-1	6118280
.	O	-1	6118280
Of	O	-1	6118280
the	O	-1	6118280
b@@	B-Chemical	D001569	6118280
enz@@	I-Chemical	-1	6118280
odi@@	I-Chemical	-1	6118280
azep@@	I-Chemical	-1	6118280
in@@	I-Chemical	-1	6118280
es	I-Chemical	-1	6118280
,	O	-1	6118280
clon@@	B-Chemical	D002998	6118280
az@@	I-Chemical	-1	6118280
epam	I-Chemical	-1	6118280
(0.@@	O	-1	6118280
1-@@	O	-1	6118280
0.@@	O	-1	6118280
3	O	-1	6118280
mg/kg)	O	-1	6118280
was	O	-1	6118280
found	O	-1	6118280
to	O	-1	6118280
be	O	-1	6118280
several	O	-1	6118280
fol@@	O	-1	6118280
d	O	-1	6118280
more	O	-1	6118280
pot@@	O	-1	6118280
ent	O	-1	6118280
than	O	-1	6118280
di@@	B-Chemical	D003975	6118280
az@@	I-Chemical	-1	6118280
epam	I-Chemical	-1	6118280
(0.@@	O	-1	6118280
3-@@	O	-1	6118280
3	O	-1	6118280
mg/kg)	O	-1	6118280
in	O	-1	6118280
block@@	O	-1	6118280
ing	O	-1	6118280
the	O	-1	6118280
my@@	B-Disease	D009207	6118280
oc@@	I-Disease	-1	6118280
lon@@	I-Disease	-1	6118280
ic	I-Disease	-1	6118280
j@@	I-Disease	-1	6118280
er@@	I-Disease	-1	6118280
k@@	I-Disease	-1	6118280
s	I-Disease	-1	6118280
.	O	-1	6118280
W@@	O	-1	6118280
h@@	O	-1	6118280
ile	O	-1	6118280
(-@@	O	-1	6118280
)@@	O	-1	6118280
-	O	-1	6118280
bac@@	B-Chemical	D001418	6118280
lo@@	I-Chemical	-1	6118280
f@@	I-Chemical	-1	6118280
en	I-Chemical	-1	6118280
(1@@	O	-1	6118280
-@@	O	-1	6118280
3	O	-1	6118280
mg/kg)	O	-1	6118280
pro@@	O	-1	6118280
ved	O	-1	6118280
to	O	-1	6118280
be	O	-1	6118280
an	O	-1	6118280
effective	O	-1	6118280
antagonist	O	-1	6118280
of	O	-1	6118280
musc@@	B-Chemical	D009118	6118280
im@@	I-Chemical	-1	6118280
ol	I-Chemical	-1	6118280
,	O	-1	6118280
its	O	-1	6118280
(@@	O	-1	6118280
+@@	O	-1	6118280
)-@@	O	-1	6118280
is@@	O	-1	6118280
om@@	O	-1	6118280
er	O	-1	6118280
(@@	O	-1	6118280
5-@@	O	-1	6118280
20	O	-1	6118280
mg/kg)	O	-1	6118280
l@@	O	-1	6118280
ac@@	O	-1	6118280
ked	O	-1	6118280
this	O	-1	6118280
pro@@	O	-1	6118280
per@@	O	-1	6118280
t@@	O	-1	6118280
y.	O	-1	6118280
Con@@	O	-1	6118280
si@@	O	-1	6118280
der@@	O	-1	6118280
ing	O	-1	6118280
the	O	-1	6118280
fac@@	O	-1	6118280
t	O	-1	6118280
that	O	-1	6118280
5-@@	B-Chemical	D006916	6118280
H@@	I-Chemical	-1	6118280
T@@	I-Chemical	-1	6118280
P	I-Chemical	-1	6118280
and	O	-1	6118280
the	O	-1	6118280
b@@	B-Chemical	D001569	6118280
enz@@	I-Chemical	-1	6118280
odi@@	I-Chemical	-1	6118280
azep@@	I-Chemical	-1	6118280
in@@	I-Chemical	-1	6118280
es	I-Chemical	-1	6118280
have	O	-1	6118280
been	O	-1	6118280
found	O	-1	6118280
to	O	-1	6118280
be	O	-1	6118280
ben@@	O	-1	6118280
e@@	O	-1	6118280
fic@@	O	-1	6118280
ial	O	-1	6118280
in	O	-1	6118280
the	O	-1	6118280
man@@	O	-1	6118280
ag@@	O	-1	6118280
ement	O	-1	6118280
of	O	-1	6118280
clinical	O	-1	6118280
my@@	B-Disease	D009207	6118280
oc@@	I-Disease	-1	6118280
lon@@	I-Disease	-1	6118280
us	I-Disease	-1	6118280
,	O	-1	6118280
the	O	-1	6118280
musc@@	B-Chemical	D009118	6118280
im@@	I-Chemical	-1	6118280
ol	I-Chemical	-1	6118280
-induced	O	-1	6118280
my@@	B-Disease	D009207	6118280
oc@@	I-Disease	-1	6118280
lon@@	I-Disease	-1	6118280
us	I-Disease	-1	6118280
se@@	O	-1	6118280
em@@	O	-1	6118280
s	O	-1	6118280
to	O	-1	6118280
be	O	-1	6118280
a	O	-1	6118280
s@@	O	-1	6118280
atis@@	O	-1	6118280
fact@@	O	-1	6118280
ory	O	-1	6118280
anim@@	O	-1	6118280
al	O	-1	6118280
model	O	-1	6118280
that	O	-1	6118280
may	O	-1	6118280
pro@@	O	-1	6118280
ve	O	-1	6118280
use@@	O	-1	6118280
ful	O	-1	6118280
for	O	-1	6118280
the	O	-1	6118280
development	O	-1	6118280
of	O	-1	6118280
new	O	-1	6118280
drug	O	-1	6118280
treat@@	O	-1	6118280
ments	O	-1	6118280
for	O	-1	6118280
this	O	-1	6118280
condi@@	O	-1	6118280
tion.	O	-1	6118280
Our	O	-1	6118280
present	O	-1	6118280
study	O	-1	6118280
indic@@	O	-1	6118280
ated	O	-1	6118280
the	O	-1	6118280
possible	O	-1	6118280
valu@@	O	-1	6118280
e	O	-1	6118280
of	O	-1	6118280
M@@	B-Chemical	C014896	6118280
K@@	I-Chemical	-1	6118280
-@@	I-Chemical	-1	6118280
2@@	I-Chemical	-1	6118280
12	I-Chemical	-1	6118280
and	O	-1	6118280
(-@@	O	-1	6118280
)@@	O	-1	6118280
-	O	-1	6118280
bac@@	B-Chemical	D001418	6118280
lo@@	I-Chemical	-1	6118280
f@@	I-Chemical	-1	6118280
en	I-Chemical	-1	6118280
in	O	-1	6118280
the	O	-1	6118280
man@@	O	-1	6118280
ag@@	O	-1	6118280
ement	O	-1	6118280
of	O	-1	6118280
clinical	O	-1	6118280
my@@	B-Disease	D009207	6118280
oc@@	I-Disease	-1	6118280
lon@@	I-Disease	-1	6118280
us	I-Disease	-1	6118280
.	O	-1	6118280

H@@	B-Disease	D006943	3703509
y@@	I-Disease	-1	3703509
per@@	I-Disease	-1	3703509
gly@@	I-Disease	-1	3703509
ce@@	I-Disease	-1	3703509
mic	I-Disease	-1	3703509
acid@@	I-Disease	-1	3703509
o@@	I-Disease	-1	3703509
tic	I-Disease	-1	3703509
com@@	I-Disease	-1	3703509
a	I-Disease	-1	3703509
H@@	B-Disease	D000140	3703509
y@@	I-Disease	-1	3703509
per@@	I-Disease	-1	3703509
gly@@	I-Disease	-1	3703509
ce@@	I-Disease	-1	3703509
mic	I-Disease	-1	3703509
acid@@	I-Disease	-1	3703509
o@@	I-Disease	-1	3703509
tic	I-Disease	-1	3703509
com@@	I-Disease	-1	3703509
a	I-Disease	-1	3703509
H@@	B-Disease	D003128	3703509
y@@	I-Disease	-1	3703509
per@@	I-Disease	-1	3703509
gly@@	I-Disease	-1	3703509
ce@@	I-Disease	-1	3703509
mic	I-Disease	-1	3703509
acid@@	I-Disease	-1	3703509
o@@	I-Disease	-1	3703509
tic	I-Disease	-1	3703509
com@@	I-Disease	-1	3703509
a	I-Disease	-1	3703509
and	O	-1	3703509
death	O	-1	3703509
in	O	-1	3703509
K@@	B-Disease	D007625	3703509
ear@@	I-Disease	-1	3703509
n@@	I-Disease	-1	3703509
s-@@	I-Disease	-1	3703509
S@@	I-Disease	-1	3703509
ay@@	I-Disease	-1	3703509
r@@	I-Disease	-1	3703509
e	I-Disease	-1	3703509
syndrome	I-Disease	-1	3703509
.	O	-1	3703509
This	O	-1	3703509
pap@@	O	-1	3703509
er	O	-1	3703509
pres@@	O	-1	3703509
ents	O	-1	3703509
the	O	-1	3703509
clinical	O	-1	3703509
and	O	-1	3703509
met@@	O	-1	3703509
ab@@	O	-1	3703509
olic	O	-1	3703509
findings	O	-1	3703509
in	O	-1	3703509
two	O	-1	3703509
youn@@	O	-1	3703509
g	O	-1	3703509
bo@@	O	-1	3703509
ys	O	-1	3703509
with	O	-1	3703509
long@@	O	-1	3703509
-@@	O	-1	3703509
stand@@	O	-1	3703509
ing	O	-1	3703509
K@@	B-Disease	D007625	3703509
ear@@	I-Disease	-1	3703509
n@@	I-Disease	-1	3703509
s-@@	I-Disease	-1	3703509
S@@	I-Disease	-1	3703509
ay@@	I-Disease	-1	3703509
r@@	I-Disease	-1	3703509
e	I-Disease	-1	3703509
syndrome	I-Disease	-1	3703509
.	O	-1	3703509
F@@	O	-1	3703509
ol@@	O	-1	3703509
low@@	O	-1	3703509
ing	O	-1	3703509
sh@@	O	-1	3703509
ort	O	-1	3703509
exposure	O	-1	3703509
to	O	-1	3703509
oral	O	-1	3703509
pre@@	B-Chemical	D011241	3703509
d@@	I-Chemical	-1	3703509
n@@	I-Chemical	-1	3703509
is@@	I-Chemical	-1	3703509
one	I-Chemical	-1	3703509
,	O	-1	3703509
both	O	-1	3703509
bo@@	O	-1	3703509
ys	O	-1	3703509
developed	O	-1	3703509
le@@	B-Disease	D053609	3703509
th@@	I-Disease	-1	3703509
arg@@	I-Disease	-1	3703509
y	I-Disease	-1	3703509
,	O	-1	3703509
increas@@	O	-1	3703509
ing	O	-1	3703509
s@@	B-Disease	D006970	3703509
om@@	I-Disease	-1	3703509
n@@	I-Disease	-1	3703509
ol@@	I-Disease	-1	3703509
ence	I-Disease	-1	3703509
,	O	-1	3703509
poly@@	B-Disease	D059606	3703509
di@@	I-Disease	-1	3703509
p@@	I-Disease	-1	3703509
sia	I-Disease	-1	3703509
,	O	-1	3703509
poly@@	B-Disease	D006963	3703509
ph@@	I-Disease	-1	3703509
ag@@	I-Disease	-1	3703509
ia	I-Disease	-1	3703509
,	O	-1	3703509
and	O	-1	3703509
poly@@	B-Disease	D011141	3703509
uria	I-Disease	-1	3703509
.	O	-1	3703509
B@@	O	-1	3703509
oth	O	-1	3703509
presented	O	-1	3703509
in	O	-1	3703509
the	O	-1	3703509
em@@	O	-1	3703509
er@@	O	-1	3703509
gen@@	O	-1	3703509
c@@	O	-1	3703509
y	O	-1	3703509
ro@@	O	-1	3703509
o@@	O	-1	3703509
m	O	-1	3703509
with	O	-1	3703509
pro@@	O	-1	3703509
found	O	-1	3703509
com@@	B-Disease	D003128	3703509
a	I-Disease	-1	3703509
,	O	-1	3703509
hypotension	B-Disease	D007022	3703509
,	O	-1	3703509
severe	O	-1	3703509
hyper@@	B-Disease	D006943	3703509
gly@@	I-Disease	-1	3703509
ce@@	I-Disease	-1	3703509
mia	I-Disease	-1	3703509
,	O	-1	3703509
and	O	-1	3703509
acid@@	B-Disease	D000138	3703509
o@@	I-Disease	-1	3703509
sis	I-Disease	-1	3703509
.	O	-1	3703509
N@@	O	-1	3703509
on@@	O	-1	3703509
ke@@	O	-1	3703509
to@@	O	-1	3703509
tic	O	-1	3703509
l@@	B-Disease	D000140	3703509
ac@@	I-Disease	-1	3703509
tic	I-Disease	-1	3703509
acid@@	I-Disease	-1	3703509
o@@	I-Disease	-1	3703509
sis	I-Disease	-1	3703509
was	O	-1	3703509
present	O	-1	3703509
in	O	-1	3703509
one	O	-1	3703509
and	O	-1	3703509
ke@@	B-Disease	D007662	3703509
to@@	I-Disease	-1	3703509
sis	I-Disease	-1	3703509
without	O	-1	3703509
a	O	-1	3703509
known	O	-1	3703509
serum	O	-1	3703509
l@@	B-Chemical	D019344	3703509
act@@	I-Chemical	-1	3703509
ate	I-Chemical	-1	3703509
level	O	-1	3703509
was	O	-1	3703509
present	O	-1	3703509
in	O	-1	3703509
the	O	-1	3703509
o@@	O	-1	3703509
ther@@	O	-1	3703509
.	O	-1	3703509
R@@	B-Disease	D012131	3703509
es@@	I-Disease	-1	3703509
piratory	I-Disease	-1	3703509
failure	I-Disease	-1	3703509
ra@@	O	-1	3703509
pid@@	O	-1	3703509
ly	O	-1	3703509
en@@	O	-1	3703509
su@@	O	-1	3703509
ed	O	-1	3703509
and	O	-1	3703509
both	O	-1	3703509
patients	O	-1	3703509
ex@@	O	-1	3703509
pi@@	O	-1	3703509
red	O	-1	3703509
in	O	-1	3703509
sp@@	O	-1	3703509
ite	O	-1	3703509
of	O	-1	3703509
eff@@	O	-1	3703509
or@@	O	-1	3703509
ts	O	-1	3703509
at	O	-1	3703509
res@@	O	-1	3703509
us@@	O	-1	3703509
cit@@	O	-1	3703509
ation.	O	-1	3703509
We	O	-1	3703509
be@@	O	-1	3703509
li@@	O	-1	3703509
e@@	O	-1	3703509
ve	O	-1	3703509
these	O	-1	3703509
two	O	-1	3703509
cases	O	-1	3703509
re@@	O	-1	3703509
present	O	-1	3703509
a	O	-1	3703509
ne@@	O	-1	3703509
w@@	O	-1	3703509
ly	O	-1	3703509
descri@@	O	-1	3703509
bed	O	-1	3703509
and	O	-1	3703509
cat@@	O	-1	3703509
ast@@	O	-1	3703509
ro@@	O	-1	3703509
ph@@	O	-1	3703509
ic	O	-1	3703509
metabol@@	B-Disease	-1	3703509
ic@@	I-Disease	-1	3703509
-@@	I-Disease	-1	3703509
en@@	I-Disease	-1	3703509
doc@@	I-Disease	-1	3703509
rine	I-Disease	-1	3703509
failure	I-Disease	-1	3703509
in	O	-1	3703509
the	O	-1	3703509
K@@	B-Disease	D007625	3703509
ear@@	I-Disease	-1	3703509
n@@	I-Disease	-1	3703509
s-@@	I-Disease	-1	3703509
S@@	I-Disease	-1	3703509
ay@@	I-Disease	-1	3703509
r@@	I-Disease	-1	3703509
e	I-Disease	-1	3703509
syndrome	I-Disease	-1	3703509
.	O	-1	3703509

Eff@@	O	-1	20683499
ects	O	-1	20683499
of	O	-1	20683499
active	O	-1	20683499
con@@	O	-1	20683499
sti@@	O	-1	20683499
tu@@	O	-1	20683499
ents	O	-1	20683499
of	O	-1	20683499
C@@	O	-1	20683499
ro@@	O	-1	20683499
c@@	O	-1	20683499
us	O	-1	20683499
s@@	O	-1	20683499
ati@@	O	-1	20683499
v@@	O	-1	20683499
us	O	-1	20683499
L@@	O	-1	20683499
.,	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
c@@	I-Chemical	-1	20683499
in	I-Chemical	-1	20683499
on	O	-1	20683499
st@@	B-Chemical	D013311	20683499
re@@	I-Chemical	-1	20683499
pto@@	I-Chemical	-1	20683499
z@@	I-Chemical	-1	20683499
oc@@	I-Chemical	-1	20683499
in	I-Chemical	-1	20683499
-induced	O	-1	20683499
model	O	-1	20683499
of	O	-1	20683499
s@@	O	-1	20683499
por@@	O	-1	20683499
a@@	O	-1	20683499
di@@	O	-1	20683499
c	O	-1	20683499
Al@@	B-Disease	D000544	20683499
z@@	I-Disease	-1	20683499
he@@	I-Disease	-1	20683499
im@@	I-Disease	-1	20683499
er@@	I-Disease	-1	20683499
's	I-Disease	-1	20683499
disease	I-Disease	-1	20683499
in	O	-1	20683499
male	O	-1	20683499
rats.	O	-1	20683499
BACKGROUND:	O	-1	20683499
The	O	-1	20683499
invol@@	O	-1	20683499
vement	O	-1	20683499
of	O	-1	20683499
w@@	O	-1	20683499
at@@	O	-1	20683499
er@@	O	-1	20683499
-@@	O	-1	20683499
sol@@	O	-1	20683499
ub@@	O	-1	20683499
le	O	-1	20683499
ca@@	B-Chemical	D002338	20683499
ro@@	I-Chemical	-1	20683499
ten@@	I-Chemical	-1	20683499
oid@@	I-Chemical	-1	20683499
s	I-Chemical	-1	20683499
,	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
cin@@	I-Chemical	-1	20683499
s	I-Chemical	-1	20683499
,	O	-1	20683499
as	O	-1	20683499
the	O	-1	20683499
ma@@	O	-1	20683499
in	O	-1	20683499
and	O	-1	20683499
active	O	-1	20683499
comp@@	O	-1	20683499
on@@	O	-1	20683499
ents	O	-1	20683499
of	O	-1	20683499
C@@	O	-1	20683499
ro@@	O	-1	20683499
c@@	O	-1	20683499
us	O	-1	20683499
s@@	O	-1	20683499
ati@@	O	-1	20683499
v@@	O	-1	20683499
us	O	-1	20683499
L@@	O	-1	20683499
.	O	-1	20683499
extrac@@	O	-1	20683499
t	O	-1	20683499
in	O	-1	20683499
lear@@	O	-1	20683499
ning	O	-1	20683499
and	O	-1	20683499
memory	O	-1	20683499
pro@@	O	-1	20683499
ces@@	O	-1	20683499
ses	O	-1	20683499
has	O	-1	20683499
been	O	-1	20683499
pro@@	O	-1	20683499
po@@	O	-1	20683499
sed.	O	-1	20683499
In	O	-1	20683499
the	O	-1	20683499
present	O	-1	20683499
study,	O	-1	20683499
the	O	-1	20683499
effect	O	-1	20683499
of	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
cin@@	I-Chemical	-1	20683499
s	I-Chemical	-1	20683499
on	O	-1	20683499
s@@	O	-1	20683499
por@@	O	-1	20683499
a@@	O	-1	20683499
di@@	O	-1	20683499
c	O	-1	20683499
Al@@	B-Disease	D000544	20683499
z@@	I-Disease	-1	20683499
he@@	I-Disease	-1	20683499
im@@	I-Disease	-1	20683499
er@@	I-Disease	-1	20683499
's	I-Disease	-1	20683499
disease	I-Disease	-1	20683499
induced	O	-1	20683499
by	O	-1	20683499
intrac@@	O	-1	20683499
e@@	O	-1	20683499
reb@@	O	-1	20683499
ro@@	O	-1	20683499
ventricular	O	-1	20683499
(@@	O	-1	20683499
ic@@	O	-1	20683499
v@@	O	-1	20683499
)	O	-1	20683499
st@@	B-Chemical	D013311	20683499
re@@	I-Chemical	-1	20683499
pto@@	I-Chemical	-1	20683499
z@@	I-Chemical	-1	20683499
oc@@	I-Chemical	-1	20683499
in	I-Chemical	-1	20683499
(	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
)	O	-1	20683499
in	O	-1	20683499
male	O	-1	20683499
rats	O	-1	20683499
was	O	-1	20683499
investig@@	O	-1	20683499
ated.	O	-1	20683499
METHODS:	O	-1	20683499
M@@	O	-1	20683499
al@@	O	-1	20683499
e	O	-1	20683499
ad@@	O	-1	20683499
ult	O	-1	20683499
Wistar	O	-1	20683499
rats	O	-1	20683499
(n	O	-1	20683499
=	O	-1	20683499
9@@	O	-1	20683499
0	O	-1	20683499
and	O	-1	20683499
2@@	O	-1	20683499
6@@	O	-1	20683499
0-@@	O	-1	20683499
2@@	O	-1	20683499
9@@	O	-1	20683499
0	O	-1	20683499
g@@	O	-1	20683499
)	O	-1	20683499
were	O	-1	20683499
divid@@	O	-1	20683499
ed	O	-1	20683499
into	O	-1	20683499
1,	O	-1	20683499
control@@	O	-1	20683499
;	O	-1	20683499
2	O	-1	20683499
and	O	-1	20683499
3,	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
cin@@	I-Chemical	-1	20683499
s	I-Chemical	-1	20683499
(1@@	O	-1	20683499
5	O	-1	20683499
and	O	-1	20683499
30	O	-1	20683499
mg/kg@@	O	-1	20683499
);	O	-1	20683499
4@@	O	-1	20683499
,	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
;	O	-1	20683499
5	O	-1	20683499
and	O	-1	20683499
6,	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
+	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
cin@@	I-Chemical	-1	20683499
s	I-Chemical	-1	20683499
(1@@	O	-1	20683499
5	O	-1	20683499
and	O	-1	20683499
30	O	-1	20683499
mg/kg)	O	-1	20683499
groups.	O	-1	20683499
In	O	-1	20683499
Al@@	B-Disease	D000544	20683499
z@@	I-Disease	-1	20683499
he@@	I-Disease	-1	20683499
im@@	I-Disease	-1	20683499
er@@	I-Disease	-1	20683499
's	I-Disease	-1	20683499
disease	I-Disease	-1	20683499
group@@	O	-1	20683499
s,	O	-1	20683499
rats	O	-1	20683499
were	O	-1	20683499
injected	O	-1	20683499
with	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
-@@	O	-1	20683499
ic@@	O	-1	20683499
v	O	-1	20683499
bil@@	O	-1	20683499
at@@	O	-1	20683499
er@@	O	-1	20683499
ally	O	-1	20683499
(@@	O	-1	20683499
3	O	-1	20683499
mg/kg)	O	-1	20683499
in	O	-1	20683499
first	O	-1	20683499
day	O	-1	20683499
and	O	-1	20683499
3	O	-1	20683499
days	O	-1	20683499
lat@@	O	-1	20683499
er,	O	-1	20683499
a	O	-1	20683499
similar	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
-@@	O	-1	20683499
ic@@	O	-1	20683499
v	O	-1	20683499
ap@@	O	-1	20683499
plic@@	O	-1	20683499
ation	O	-1	20683499
was	O	-1	20683499
repe@@	O	-1	20683499
ated.	O	-1	20683499
In	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
+	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
c@@	I-Chemical	-1	20683499
in	I-Chemical	-1	20683499
anim@@	O	-1	20683499
al	O	-1	20683499
group@@	O	-1	20683499
s,	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
c@@	I-Chemical	-1	20683499
in	I-Chemical	-1	20683499
was	O	-1	20683499
ap@@	O	-1	20683499
pl@@	O	-1	20683499
ied	O	-1	20683499
in	O	-1	20683499
doses	O	-1	20683499
of	O	-1	20683499
15	O	-1	20683499
and	O	-1	20683499
30	O	-1	20683499
mg/kg@@	O	-1	20683499
,	O	-1	20683499
i.p.@@	O	-1	20683499
,	O	-1	20683499
one	O	-1	20683499
day	O	-1	20683499
pre-@@	O	-1	20683499
surger@@	O	-1	20683499
y	O	-1	20683499
and	O	-1	20683499
continu@@	O	-1	20683499
ed	O	-1	20683499
for	O	-1	20683499
three	O	-1	20683499
week@@	O	-1	20683499
s.	O	-1	20683499
P@@	O	-1	20683499
res@@	O	-1	20683499
cri@@	O	-1	20683499
ption	O	-1	20683499
of	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
c@@	I-Chemical	-1	20683499
in	I-Chemical	-1	20683499
in	O	-1	20683499
each	O	-1	20683499
dose	O	-1	20683499
was	O	-1	20683499
repe@@	O	-1	20683499
ated	O	-1	20683499
on@@	O	-1	20683499
ce	O	-1	20683499
for	O	-1	20683499
two	O	-1	20683499
days.	O	-1	20683499
However,	O	-1	20683499
the	O	-1	20683499
lear@@	O	-1	20683499
ning	O	-1	20683499
and	O	-1	20683499
memory	O	-1	20683499
perform@@	O	-1	20683499
ance	O	-1	20683499
was	O	-1	20683499
assessed	O	-1	20683499
using	O	-1	20683499
p@@	O	-1	20683499
as@@	O	-1	20683499
sive	O	-1	20683499
avoid@@	O	-1	20683499
ance	O	-1	20683499
par@@	O	-1	20683499
a@@	O	-1	20683499
di@@	O	-1	20683499
g@@	O	-1	20683499
m@@	O	-1	20683499
,	O	-1	20683499
and	O	-1	20683499
for	O	-1	20683499
s@@	O	-1	20683499
pati@@	O	-1	20683499
al	O	-1	20683499
cogn@@	O	-1	20683499
ition	O	-1	20683499
evalu@@	O	-1	20683499
ation,	O	-1	20683499
Y@@	O	-1	20683499
-@@	O	-1	20683499
ma@@	O	-1	20683499
ze	O	-1	20683499
t@@	O	-1	20683499
as@@	O	-1	20683499
k	O	-1	20683499
was	O	-1	20683499
use@@	O	-1	20683499
d.	O	-1	20683499
RESULTS:	O	-1	20683499
It	O	-1	20683499
was	O	-1	20683499
found	O	-1	20683499
out	O	-1	20683499
that	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
c@@	I-Chemical	-1	20683499
in	I-Chemical	-1	20683499
(@@	O	-1	20683499
30	O	-1	20683499
mg/kg@@	O	-1	20683499
)-@@	O	-1	20683499
treated	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
-@@	O	-1	20683499
injected	O	-1	20683499
rats	O	-1	20683499
show	O	-1	20683499
higher	O	-1	20683499
cor@@	O	-1	20683499
rec@@	O	-1	20683499
t	O	-1	20683499
ch@@	O	-1	20683499
o@@	O	-1	20683499
ic@@	O	-1	20683499
es	O	-1	20683499
and	O	-1	20683499
lower	O	-1	20683499
er@@	O	-1	20683499
ro@@	O	-1	20683499
r@@	O	-1	20683499
s	O	-1	20683499
in	O	-1	20683499
Y@@	O	-1	20683499
-@@	O	-1	20683499
ma@@	O	-1	20683499
ze	O	-1	20683499
than	O	-1	20683499
ve@@	O	-1	20683499
h@@	O	-1	20683499
ic@@	O	-1	20683499
le@@	O	-1	20683499
-treated	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
-@@	O	-1	20683499
injected	O	-1	20683499
rats.	O	-1	20683499
In	O	-1	20683499
addi@@	O	-1	20683499
tion,	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
c@@	I-Chemical	-1	20683499
in	I-Chemical	-1	20683499
in	O	-1	20683499
the	O	-1	20683499
men@@	O	-1	20683499
tion@@	O	-1	20683499
ed	O	-1	20683499
dose	O	-1	20683499
could	O	-1	20683499
significantly	O	-1	20683499
attenu@@	O	-1	20683499
ated	O	-1	20683499
lear@@	B-Disease	D007859	20683499
ning	I-Disease	-1	20683499
and	I-Disease	-1	20683499
memory	I-Disease	-1	20683499
impair@@	I-Disease	-1	20683499
ment	I-Disease	-1	20683499
lear@@	B-Disease	D008569	20683499
ning	I-Disease	-1	20683499
and	I-Disease	-1	20683499
memory	I-Disease	-1	20683499
impair@@	I-Disease	-1	20683499
ment	I-Disease	-1	20683499
in	O	-1	20683499
treated	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
-@@	O	-1	20683499
injected	O	-1	20683499
group	O	-1	20683499
in	O	-1	20683499
p@@	O	-1	20683499
as@@	O	-1	20683499
sive	O	-1	20683499
avoid@@	O	-1	20683499
ance	O	-1	20683499
test@@	O	-1	20683499
.	O	-1	20683499
CONCLUSION:	O	-1	20683499
The@@	O	-1	20683499
refore,	O	-1	20683499
these	O	-1	20683499
results	O	-1	20683499
demon@@	O	-1	20683499
st@@	O	-1	20683499
rate	O	-1	20683499
the	O	-1	20683499
eff@@	O	-1	20683499
ec@@	O	-1	20683499
tiv@@	O	-1	20683499
en@@	O	-1	20683499
ess	O	-1	20683499
of	O	-1	20683499
c@@	B-Chemical	C029036	20683499
ro@@	I-Chemical	-1	20683499
c@@	I-Chemical	-1	20683499
in	I-Chemical	-1	20683499
(@@	O	-1	20683499
30	O	-1	20683499
mg/kg)	O	-1	20683499
in	O	-1	20683499
antagon@@	O	-1	20683499
iz@@	O	-1	20683499
ing	O	-1	20683499
the	O	-1	20683499
cognitive	B-Disease	D003072	20683499
defic@@	I-Disease	-1	20683499
its	I-Disease	-1	20683499
caused	O	-1	20683499
by	O	-1	20683499
S@@	B-Chemical	D013311	20683499
T@@	I-Chemical	-1	20683499
Z	I-Chemical	-1	20683499
-@@	O	-1	20683499
ic@@	O	-1	20683499
v	O	-1	20683499
in	O	-1	20683499
rats	O	-1	20683499
and	O	-1	20683499
its	O	-1	20683499
potential	O	-1	20683499
in	O	-1	20683499
the	O	-1	20683499
treatment	O	-1	20683499
of	O	-1	20683499
neuro@@	B-Disease	D019636	20683499
de@@	I-Disease	-1	20683499
gener@@	I-Disease	-1	20683499
ative	I-Disease	-1	20683499
diseas@@	I-Disease	-1	20683499
es	I-Disease	-1	20683499
such	O	-1	20683499
as	O	-1	20683499
Al@@	B-Disease	D000544	20683499
z@@	I-Disease	-1	20683499
he@@	I-Disease	-1	20683499
im@@	I-Disease	-1	20683499
er@@	I-Disease	-1	20683499
's	I-Disease	-1	20683499
disease	I-Disease	-1	20683499
.	O	-1	20683499

R@@	O	-1	20466178
os@@	O	-1	20466178
ace@@	O	-1	20466178
if@@	O	-1	20466178
or@@	O	-1	20466178
m	O	-1	20466178
der@@	B-Disease	D003872	20466178
m@@	I-Disease	-1	20466178
ati@@	I-Disease	-1	20466178
tis	I-Disease	-1	20466178
associated	O	-1	20466178
with	O	-1	20466178
to@@	O	-1	20466178
p@@	O	-1	20466178
ical	O	-1	20466178
tacrolimus	B-Chemical	D016559	20466178
treatment.	O	-1	20466178
We	O	-1	20466178
describe	O	-1	20466178
he@@	O	-1	20466178
re@@	O	-1	20466178
in	O	-1	20466178
3	O	-1	20466178
patients	O	-1	20466178
who	O	-1	20466178
developed	O	-1	20466178
ros@@	B-Disease	D012393	20466178
ace@@	I-Disease	-1	20466178
a	I-Disease	-1	20466178
-@@	O	-1	20466178
like	O	-1	20466178
der@@	B-Disease	D003872	20466178
m@@	I-Disease	-1	20466178
ati@@	I-Disease	-1	20466178
tis	I-Disease	-1	20466178
er@@	B-Disease	D003875	20466178
up@@	I-Disease	-1	20466178
tions	I-Disease	-1	20466178
while	O	-1	20466178
using	O	-1	20466178
0.0@@	O	-1	20466178
3@@	O	-1	20466178
%	O	-1	20466178
or	O	-1	20466178
0.@@	O	-1	20466178
1@@	O	-1	20466178
%	O	-1	20466178
tacrolimus	B-Chemical	D016559	20466178
o@@	O	-1	20466178
int@@	O	-1	20466178
ment	O	-1	20466178
for	O	-1	20466178
fac@@	B-Disease	D005148	20466178
ial	I-Disease	-1	20466178
der@@	I-Disease	-1	20466178
m@@	I-Disease	-1	20466178
ati@@	I-Disease	-1	20466178
tis	I-Disease	-1	20466178
.	O	-1	20466178
S@@	O	-1	20466178
k@@	O	-1	20466178
in	O	-1	20466178
biop@@	O	-1	20466178
sy	O	-1	20466178
spec@@	O	-1	20466178
imen@@	O	-1	20466178
s	O	-1	20466178
showed	O	-1	20466178
te@@	B-Disease	D013684	20466178
l@@	I-Disease	-1	20466178
angi@@	I-Disease	-1	20466178
ect@@	I-Disease	-1	20466178
a@@	I-Disease	-1	20466178
sia	I-Disease	-1	20466178
and	O	-1	20466178
non@@	O	-1	20466178
cas@@	O	-1	20466178
e@@	O	-1	20466178
ating	O	-1	20466178
epi@@	O	-1	20466178
the@@	O	-1	20466178
li@@	O	-1	20466178
oid	O	-1	20466178
gran@@	O	-1	20466178
ulo@@	O	-1	20466178
mat@@	O	-1	20466178
ous	O	-1	20466178
tissue	O	-1	20466178
formation	O	-1	20466178
in	O	-1	20466178
the	O	-1	20466178
pap@@	O	-1	20466178
ill@@	O	-1	20466178
ary	O	-1	20466178
to	O	-1	20466178
m@@	O	-1	20466178
id	O	-1	20466178
der@@	O	-1	20466178
mi@@	O	-1	20466178
s.	O	-1	20466178
C@@	O	-1	20466178
ont@@	O	-1	20466178
in@@	O	-1	20466178
u@@	O	-1	20466178
ous	O	-1	20466178
to@@	O	-1	20466178
p@@	O	-1	20466178
ical	O	-1	20466178
use	O	-1	20466178
of	O	-1	20466178
immuno@@	O	-1	20466178
mod@@	O	-1	20466178
ul@@	O	-1	20466178
at@@	O	-1	20466178
ors	O	-1	20466178
such	O	-1	20466178
as	O	-1	20466178
tacrolimus	B-Chemical	D016559	20466178
or	O	-1	20466178
p@@	B-Chemical	C117268	20466178
im@@	I-Chemical	-1	20466178
ec@@	I-Chemical	-1	20466178
rolimus	I-Chemical	-1	20466178
should	O	-1	20466178
be	O	-1	20466178
reg@@	O	-1	20466178
ar@@	O	-1	20466178
ded	O	-1	20466178
as	O	-1	20466178
a	O	-1	20466178
potential	O	-1	20466178
cause	O	-1	20466178
of	O	-1	20466178
ros@@	O	-1	20466178
ace@@	O	-1	20466178
if@@	O	-1	20466178
or@@	O	-1	20466178
m	O	-1	20466178
der@@	B-Disease	D003872	20466178
m@@	I-Disease	-1	20466178
ati@@	I-Disease	-1	20466178
tis	I-Disease	-1	20466178
,	O	-1	20466178
although	O	-1	20466178
man@@	O	-1	20466178
y	O	-1	20466178
cases	O	-1	20466178
have	O	-1	20466178
not	O	-1	20466178
been	O	-1	20466178
repor@@	O	-1	20466178
ted.	O	-1	20466178

A	O	-1	19944736
novel	O	-1	19944736
anim@@	O	-1	19944736
al	O	-1	19944736
model	O	-1	19944736
to	O	-1	19944736
evalu@@	O	-1	19944736
ate	O	-1	19944736
the	O	-1	19944736
ability	O	-1	19944736
of	O	-1	19944736
a	O	-1	19944736
drug	O	-1	19944736
de@@	O	-1	19944736
li@@	O	-1	19944736
very	O	-1	19944736
system	O	-1	19944736
to	O	-1	19944736
pro@@	O	-1	19944736
m@@	O	-1	19944736
ot@@	O	-1	19944736
e	O	-1	19944736
the	O	-1	19944736
p@@	O	-1	19944736
ass@@	O	-1	19944736
age	O	-1	19944736
through	O	-1	19944736
the	O	-1	19944736
B@@	O	-1	19944736
B@@	O	-1	19944736
B@@	O	-1	19944736
.	O	-1	19944736
The	O	-1	19944736
pur@@	O	-1	19944736
p@@	O	-1	19944736
ose	O	-1	19944736
of	O	-1	19944736
this	O	-1	19944736
investig@@	O	-1	19944736
ation	O	-1	19944736
was	O	-1	19944736
to	O	-1	19944736
expl@@	O	-1	19944736
or@@	O	-1	19944736
e	O	-1	19944736
the	O	-1	19944736
potenti@@	O	-1	19944736
ality	O	-1	19944736
of	O	-1	19944736
a	O	-1	19944736
novel	O	-1	19944736
anim@@	O	-1	19944736
al	O	-1	19944736
model	O	-1	19944736
to	O	-1	19944736
be	O	-1	19944736
used	O	-1	19944736
for	O	-1	19944736
the	O	-1	19944736
in	O	-1	19944736
viv@@	O	-1	19944736
o	O	-1	19944736
evalu@@	O	-1	19944736
ation	O	-1	19944736
of	O	-1	19944736
the	O	-1	19944736
ability	O	-1	19944736
of	O	-1	19944736
a	O	-1	19944736
drug	O	-1	19944736
de@@	O	-1	19944736
li@@	O	-1	19944736
very	O	-1	19944736
system	O	-1	19944736
to	O	-1	19944736
pro@@	O	-1	19944736
m@@	O	-1	19944736
ot@@	O	-1	19944736
e	O	-1	19944736
the	O	-1	19944736
p@@	O	-1	19944736
ass@@	O	-1	19944736
age	O	-1	19944736
through	O	-1	19944736
the	O	-1	19944736
blo@@	O	-1	19944736
o@@	O	-1	19944736
d-@@	O	-1	19944736
brain	O	-1	19944736
bar@@	O	-1	19944736
ri@@	O	-1	19944736
er	O	-1	19944736
(B@@	O	-1	19944736
B@@	O	-1	19944736
B@@	O	-1	19944736
)	O	-1	19944736
and/or	O	-1	19944736
to	O	-1	19944736
impro@@	O	-1	19944736
ve	O	-1	19944736
the	O	-1	19944736
brain	O	-1	19944736
lo@@	O	-1	19944736
cal@@	O	-1	19944736
ization	O	-1	19944736
of	O	-1	19944736
a	O	-1	19944736
bio@@	O	-1	19944736
active	O	-1	19944736
comp@@	O	-1	19944736
oun@@	O	-1	19944736
d.	O	-1	19944736
A	O	-1	19944736
T@@	O	-1	19944736
ween	O	-1	19944736
8@@	O	-1	19944736
0-@@	O	-1	19944736
co@@	O	-1	19944736
ated	O	-1	19944736
poly@@	B-Chemical	-1	19944736
-@@	I-Chemical	-1	19944736
L-@@	I-Chemical	-1	19944736
l@@	I-Chemical	-1	19944736
ac@@	I-Chemical	-1	19944736
ti@@	I-Chemical	-1	19944736
d	I-Chemical	-1	19944736
acid	I-Chemical	-1	19944736
n@@	O	-1	19944736
an@@	O	-1	19944736
o@@	O	-1	19944736
partic@@	O	-1	19944736
le@@	O	-1	19944736
s	O	-1	19944736
was	O	-1	19944736
used	O	-1	19944736
as	O	-1	19944736
a	O	-1	19944736
model	O	-1	19944736
of	O	-1	19944736
co@@	O	-1	19944736
l@@	O	-1	19944736
lo@@	O	-1	19944736
idal	O	-1	19944736
drug	O	-1	19944736
de@@	O	-1	19944736
li@@	O	-1	19944736
very	O	-1	19944736
system@@	O	-1	19944736
,	O	-1	19944736
able	O	-1	19944736
to	O	-1	19944736
t@@	O	-1	19944736
resp@@	O	-1	19944736
as@@	O	-1	19944736
s	O	-1	19944736
the	O	-1	19944736
B@@	O	-1	19944736
B@@	O	-1	19944736
B@@	O	-1	19944736
.	O	-1	19944736
T@@	B-Chemical	D013619	19944736
ac@@	I-Chemical	-1	19944736
rine	I-Chemical	-1	19944736
,	O	-1	19944736
administered	O	-1	19944736
in	O	-1	19944736
L@@	B-Chemical	D018021	19944736
i@@	I-Chemical	-1	19944736
C@@	I-Chemical	-1	19944736
l	I-Chemical	-1	19944736
pre@@	O	-1	19944736
-treated	O	-1	19944736
rats,	O	-1	19944736
induc@@	O	-1	19944736
es	O	-1	19944736
electro@@	O	-1	19944736
cortico@@	O	-1	19944736
graph@@	O	-1	19944736
ic	O	-1	19944736
seizures	B-Disease	D012640	19944736
and	O	-1	19944736
del@@	O	-1	19944736
ayed	O	-1	19944736
hippocamp@@	B-Disease	D001930	19944736
al	I-Disease	-1	19944736
damage	I-Disease	-1	19944736
.	O	-1	19944736
The	O	-1	19944736
toxic	O	-1	19944736
effects	O	-1	19944736
of	O	-1	19944736
tac@@	B-Chemical	D013619	19944736
rine	I-Chemical	-1	19944736
-@@	O	-1	19944736
lo@@	O	-1	19944736
ad@@	O	-1	19944736
ed	O	-1	19944736
poly@@	B-Chemical	-1	19944736
-@@	I-Chemical	-1	19944736
L-@@	I-Chemical	-1	19944736
l@@	I-Chemical	-1	19944736
ac@@	I-Chemical	-1	19944736
ti@@	I-Chemical	-1	19944736
d	I-Chemical	-1	19944736
acid	I-Chemical	-1	19944736
n@@	O	-1	19944736
an@@	O	-1	19944736
o@@	O	-1	19944736
partic@@	O	-1	19944736
le@@	O	-1	19944736
s	O	-1	19944736
(5@@	O	-1	19944736
mg/kg@@	O	-1	19944736
),	O	-1	19944736
a	O	-1	19944736
saline	O	-1	19944736
sol@@	O	-1	19944736
u@@	O	-1	19944736
tion	O	-1	19944736
of	O	-1	19944736
tac@@	B-Chemical	D013619	19944736
rine	I-Chemical	-1	19944736
(5@@	O	-1	19944736
mg/kg)	O	-1	19944736
and	O	-1	19944736
an	O	-1	19944736
em@@	O	-1	19944736
pt@@	O	-1	19944736
y	O	-1	19944736
co@@	O	-1	19944736
l@@	O	-1	19944736
lo@@	O	-1	19944736
idal	O	-1	19944736
n@@	O	-1	19944736
an@@	O	-1	19944736
o@@	O	-1	19944736
partic@@	O	-1	19944736
le	O	-1	19944736
sus@@	O	-1	19944736
pen@@	O	-1	19944736
sion	O	-1	19944736
were	O	-1	19944736
compared	O	-1	19944736
following	O	-1	19944736
i.@@	O	-1	19944736
p@@	O	-1	19944736
.	O	-1	19944736
administration	O	-1	19944736
in	O	-1	19944736
L@@	B-Chemical	D018021	19944736
i@@	I-Chemical	-1	19944736
C@@	I-Chemical	-1	19944736
l	I-Chemical	-1	19944736
-@@	O	-1	19944736
pre@@	O	-1	19944736
-treated	O	-1	19944736
Wistar	O	-1	19944736
rats.	O	-1	19944736
All	O	-1	19944736
the	O	-1	19944736
animals	O	-1	19944736
treated	O	-1	19944736
with	O	-1	19944736
tac@@	B-Chemical	D013619	19944736
rine	I-Chemical	-1	19944736
-@@	O	-1	19944736
lo@@	O	-1	19944736
ad@@	O	-1	19944736
ed	O	-1	19944736
n@@	O	-1	19944736
an@@	O	-1	19944736
o@@	O	-1	19944736
partic@@	O	-1	19944736
le@@	O	-1	19944736
s	O	-1	19944736
showed	O	-1	19944736
an	O	-1	19944736
ear@@	O	-1	19944736
li@@	O	-1	19944736
er	O	-1	19944736
outcom@@	O	-1	19944736
e	O	-1	19944736
of	O	-1	19944736
C@@	O	-1	19944736
N@@	O	-1	19944736
S	O	-1	19944736
adverse	O	-1	19944736
symptom@@	O	-1	19944736
s,	O	-1	19944736
i.@@	O	-1	19944736
e.	O	-1	19944736
epileptic	B-Disease	D004827	19944736
on@@	O	-1	19944736
se@@	O	-1	19944736
t,	O	-1	19944736
with	O	-1	19944736
resp@@	O	-1	19944736
ect	O	-1	19944736
to	O	-1	19944736
those	O	-1	19944736
animals	O	-1	19944736
treated	O	-1	19944736
with	O	-1	19944736
the	O	-1	19944736
free	O	-1	19944736
comp@@	O	-1	19944736
ound	O	-1	19944736
(10	O	-1	19944736
min	O	-1	19944736
vs.	O	-1	19944736
2@@	O	-1	19944736
2	O	-1	19944736
min	O	-1	19944736
respectivel@@	O	-1	19944736
y@@	O	-1	19944736
).	O	-1	19944736
In	O	-1	19944736
addi@@	O	-1	19944736
tion,	O	-1	19944736
tac@@	B-Chemical	D013619	19944736
rine	I-Chemical	-1	19944736
-@@	O	-1	19944736
lo@@	O	-1	19944736
ad@@	O	-1	19944736
ed	O	-1	19944736
n@@	O	-1	19944736
an@@	O	-1	19944736
o@@	O	-1	19944736
partic@@	O	-1	19944736
le@@	O	-1	19944736
s	O	-1	19944736
administration	O	-1	19944736
induced	O	-1	19944736
damage	B-Disease	D001930	19944736
of	I-Disease	-1	19944736
neuron@@	I-Disease	-1	19944736
al	I-Disease	-1	19944736
cells	I-Disease	-1	19944736
in	O	-1	19944736
CA@@	O	-1	19944736
1	O	-1	19944736
fi@@	O	-1	19944736
el@@	O	-1	19944736
d	O	-1	19944736
of	O	-1	19944736
the	O	-1	19944736
hippocamp@@	O	-1	19944736
us	O	-1	19944736
in	O	-1	19944736
all	O	-1	19944736
treated	O	-1	19944736
anim@@	O	-1	19944736
al@@	O	-1	19944736
s,	O	-1	19944736
while	O	-1	19944736
the	O	-1	19944736
saline	O	-1	19944736
sol@@	O	-1	19944736
u@@	O	-1	19944736
tion	O	-1	19944736
of	O	-1	19944736
tac@@	B-Chemical	D013619	19944736
rine	I-Chemical	-1	19944736
only	O	-1	19944736
in	O	-1	19944736
6@@	O	-1	19944736
0%	O	-1	19944736
of	O	-1	19944736
anim@@	O	-1	19944736
al@@	O	-1	19944736
s.	O	-1	19944736
E@@	O	-1	19944736
m@@	O	-1	19944736
pt@@	O	-1	19944736
y	O	-1	19944736
n@@	O	-1	19944736
an@@	O	-1	19944736
o@@	O	-1	19944736
partic@@	O	-1	19944736
le@@	O	-1	19944736
s	O	-1	19944736
pro@@	O	-1	19944736
vid@@	O	-1	19944736
ed	O	-1	19944736
similar	O	-1	19944736
results	O	-1	19944736
to	O	-1	19944736
control	O	-1	19944736
(@@	O	-1	19944736
sal@@	O	-1	19944736
ine-@@	O	-1	19944736
treat@@	O	-1	19944736
ed@@	O	-1	19944736
)	O	-1	19944736
group	O	-1	19944736
of	O	-1	19944736
anim@@	O	-1	19944736
al@@	O	-1	19944736
s.	O	-1	19944736
In	O	-1	19944736
concl@@	O	-1	19944736
u@@	O	-1	19944736
sion,	O	-1	19944736
the	O	-1	19944736
evalu@@	O	-1	19944736
ation	O	-1	19944736
of	O	-1	19944736
ti@@	O	-1	19944736
me@@	O	-1	19944736
-@@	O	-1	19944736
to@@	O	-1	19944736
-@@	O	-1	19944736
onset	O	-1	19944736
of	O	-1	19944736
symptoms	O	-1	19944736
and	O	-1	19944736
the	O	-1	19944736
severity	O	-1	19944736
of	O	-1	19944736
neuro@@	O	-1	19944736
de@@	O	-1	19944736
gener@@	O	-1	19944736
ative	O	-1	19944736
pro@@	O	-1	19944736
ces@@	O	-1	19944736
ses	O	-1	19944736
induced	O	-1	19944736
by	O	-1	19944736
the	O	-1	19944736
tac@@	B-Chemical	D013619	19944736
rine	I-Chemical	-1	19944736
-	O	-1	19944736
lithium	B-Chemical	D008094	19944736
model	O	-1	19944736
of	O	-1	19944736
epilep@@	B-Disease	D004827	19944736
sy	I-Disease	-1	19944736
in	O	-1	19944736
the	O	-1	19944736
rat@@	O	-1	19944736
,	O	-1	19944736
could	O	-1	19944736
be	O	-1	19944736
used	O	-1	19944736
to	O	-1	19944736
evalu@@	O	-1	19944736
ate	O	-1	19944736
pre@@	O	-1	19944736
lim@@	O	-1	19944736
in@@	O	-1	19944736
ari@@	O	-1	19944736
ly	O	-1	19944736
the	O	-1	19944736
cap@@	O	-1	19944736
ability	O	-1	19944736
of	O	-1	19944736
a	O	-1	19944736
drug	O	-1	19944736
de@@	O	-1	19944736
li@@	O	-1	19944736
very	O	-1	19944736
system	O	-1	19944736
to	O	-1	19944736
t@@	O	-1	19944736
resp@@	O	-1	19944736
as@@	O	-1	19944736
s	O	-1	19944736
(@@	O	-1	19944736
or	O	-1	19944736
not@@	O	-1	19944736
)	O	-1	19944736
the	O	-1	19944736
B@@	O	-1	19944736
B@@	O	-1	19944736
B	O	-1	19944736
in	O	-1	19944736
viv@@	O	-1	19944736
o@@	O	-1	19944736
.	O	-1	19944736

The	O	-1	19721134
anti@@	O	-1	19721134
arrhyth@@	O	-1	19721134
mic	O	-1	19721134
effect	O	-1	19721134
and	O	-1	19721134
possible	O	-1	19721134
i@@	O	-1	19721134
onic	O	-1	19721134
mechanisms	O	-1	19721134
of	O	-1	19721134
pilocar@@	B-Chemical	D010862	19721134
pine	I-Chemical	-1	19721134
on	O	-1	19721134
anim@@	O	-1	19721134
al	O	-1	19721134
model@@	O	-1	19721134
s.	O	-1	19721134
This	O	-1	19721134
study	O	-1	19721134
was	O	-1	19721134
de@@	O	-1	19721134
signed	O	-1	19721134
to	O	-1	19721134
evalu@@	O	-1	19721134
ate	O	-1	19721134
the	O	-1	19721134
effects	O	-1	19721134
of	O	-1	19721134
pilocar@@	B-Chemical	D010862	19721134
pine	I-Chemical	-1	19721134
and	O	-1	19721134
expl@@	O	-1	19721134
or@@	O	-1	19721134
e	O	-1	19721134
the	O	-1	19721134
underlying	O	-1	19721134
i@@	O	-1	19721134
onic	O	-1	19721134
mechanis@@	O	-1	19721134
m@@	O	-1	19721134
,	O	-1	19721134
using	O	-1	19721134
both	O	-1	19721134
ac@@	B-Chemical	D000157	19721134
on@@	I-Chemical	-1	19721134
it@@	I-Chemical	-1	19721134
ine	I-Chemical	-1	19721134
-induced	O	-1	19721134
rat	O	-1	19721134
and	O	-1	19721134
ou@@	B-Chemical	D010042	19721134
ab@@	I-Chemical	-1	19721134
ain	I-Chemical	-1	19721134
-induced	O	-1	19721134
gu@@	O	-1	19721134
ine@@	O	-1	19721134
a	O	-1	19721134
pi@@	O	-1	19721134
g	O	-1	19721134
arrhyth@@	B-Disease	D001145	19721134
mia	I-Disease	-1	19721134
model@@	O	-1	19721134
s.	O	-1	19721134
Con@@	O	-1	19721134
foc@@	O	-1	19721134
al	O	-1	19721134
micro@@	O	-1	19721134
sco@@	O	-1	19721134
p@@	O	-1	19721134
y	O	-1	19721134
was	O	-1	19721134
used	O	-1	19721134
to	O	-1	19721134
meas@@	O	-1	19721134
ure	O	-1	19721134
intrac@@	O	-1	19721134
ell@@	O	-1	19721134
ular	O	-1	19721134
f@@	O	-1	19721134
re@@	O	-1	19721134
e@@	O	-1	19721134
-	O	-1	19721134
calcium	B-Chemical	D002118	19721134
concentrations	O	-1	19721134
(@@	O	-1	19721134
[	O	-1	19721134
C@@	B-Chemical	D002118	19721134
a	I-Chemical	-1	19721134
(2@@	O	-1	19721134
+@@	O	-1	19721134
)@@	O	-1	19721134
]@@	O	-1	19721134
(@@	O	-1	19721134
i@@	O	-1	19721134
)@@	O	-1	19721134
)	O	-1	19721134
in	O	-1	19721134
isol@@	O	-1	19721134
ated	O	-1	19721134
my@@	O	-1	19721134
ocy@@	O	-1	19721134
t@@	O	-1	19721134
es.	O	-1	19721134
The	O	-1	19721134
current	O	-1	19721134
data	O	-1	19721134
showed	O	-1	19721134
that	O	-1	19721134
pilocar@@	B-Chemical	D010862	19721134
pine	I-Chemical	-1	19721134
significantly	O	-1	19721134
del@@	O	-1	19721134
ayed	O	-1	19721134
onset	O	-1	19721134
of	O	-1	19721134
arrhyth@@	B-Disease	D001145	19721134
mi@@	I-Disease	-1	19721134
as	I-Disease	-1	19721134
,	O	-1	19721134
decreased	O	-1	19721134
the	O	-1	19721134
time	O	-1	19721134
course	O	-1	19721134
of	O	-1	19721134
ventricular	B-Disease	D017180	19721134
tachycardia	I-Disease	-1	19721134
and	I-Disease	-1	19721134
fibrill@@	I-Disease	-1	19721134
ation	I-Disease	-1	19721134
ventricular	B-Disease	D014693	19721134
tachycardia	I-Disease	-1	19721134
and	I-Disease	-1	19721134
fibrill@@	I-Disease	-1	19721134
ation	I-Disease	-1	19721134
,	O	-1	19721134
reduced	O	-1	19721134
arrhyth@@	B-Disease	D001145	19721134
mia	I-Disease	-1	19721134
sco@@	O	-1	19721134
re,	O	-1	19721134
and	O	-1	19721134
increased	O	-1	19721134
the	O	-1	19721134
sur@@	O	-1	19721134
viv@@	O	-1	19721134
al	O	-1	19721134
time	O	-1	19721134
of	O	-1	19721134
arrhyth@@	B-Disease	D001145	19721134
mic	I-Disease	-1	19721134
rats	O	-1	19721134
and	O	-1	19721134
gu@@	O	-1	19721134
ine@@	O	-1	19721134
a	O	-1	19721134
pi@@	O	-1	19721134
g@@	O	-1	19721134
s.	O	-1	19721134
[	O	-1	19721134
C@@	B-Chemical	D002118	19721134
a	I-Chemical	-1	19721134
(2@@	O	-1	19721134
+@@	O	-1	19721134
)@@	O	-1	19721134
]@@	O	-1	19721134
(@@	O	-1	19721134
i@@	O	-1	19721134
)	O	-1	19721134
over@@	O	-1	19721134
lo@@	O	-1	19721134
ad	O	-1	19721134
induced	O	-1	19721134
by	O	-1	19721134
ac@@	B-Chemical	D000157	19721134
on@@	I-Chemical	-1	19721134
it@@	I-Chemical	-1	19721134
ine	I-Chemical	-1	19721134
or	O	-1	19721134
ou@@	B-Chemical	D010042	19721134
ab@@	I-Chemical	-1	19721134
ain	I-Chemical	-1	19721134
was	O	-1	19721134
reduced	O	-1	19721134
in	O	-1	19721134
isol@@	O	-1	19721134
ated	O	-1	19721134
my@@	O	-1	19721134
ocy@@	O	-1	19721134
tes	O	-1	19721134
pre@@	O	-1	19721134
treated	O	-1	19721134
with	O	-1	19721134
pilocar@@	B-Chemical	D010862	19721134
pine	I-Chemical	-1	19721134
.	O	-1	19721134
M@@	O	-1	19721134
ore@@	O	-1	19721134
o@@	O	-1	19721134
ver,	O	-1	19721134
M@@	O	-1	19721134
(3@@	O	-1	19721134
)-@@	O	-1	19721134
mus@@	O	-1	19721134
car@@	O	-1	19721134
inic	O	-1	19721134
acet@@	B-Chemical	D000109	19721134
ylcholine	I-Chemical	-1	19721134
receptor	O	-1	19721134
(@@	O	-1	19721134
m@@	O	-1	19721134
AC@@	O	-1	19721134
h@@	O	-1	19721134
R@@	O	-1	19721134
)	O	-1	19721134
antagonist	O	-1	19721134
4-@@	B-Chemical	C042375	19721134
D@@	I-Chemical	-1	19721134
AM@@	I-Chemical	-1	19721134
P	I-Chemical	-1	19721134
(	O	-1	19721134
4-@@	B-Chemical	C042375	19721134
di@@	I-Chemical	-1	19721134
phenyl@@	I-Chemical	-1	19721134
ace@@	I-Chemical	-1	19721134
tox@@	I-Chemical	-1	19721134
y-@@	I-Chemical	-1	19721134
N@@	I-Chemical	-1	19721134
-@@	I-Chemical	-1	19721134
methyl@@	I-Chemical	-1	19721134
pi@@	I-Chemical	-1	19721134
perid@@	I-Chemical	-1	19721134
ine-@@	I-Chemical	-1	19721134
meth@@	I-Chemical	-1	19721134
io@@	I-Chemical	-1	19721134
di@@	I-Chemical	-1	19721134
de	I-Chemical	-1	19721134
)	O	-1	19721134
par@@	O	-1	19721134
ti@@	O	-1	19721134
ally	O	-1	19721134
abol@@	O	-1	19721134
ished	O	-1	19721134
the	O	-1	19721134
ben@@	O	-1	19721134
e@@	O	-1	19721134
fic@@	O	-1	19721134
ial	O	-1	19721134
effects	O	-1	19721134
of	O	-1	19721134
pilocar@@	B-Chemical	D010862	19721134
pine	I-Chemical	-1	19721134
.	O	-1	19721134
These	O	-1	19721134
data	O	-1	19721134
suggest	O	-1	19721134
that	O	-1	19721134
pilocar@@	B-Chemical	D010862	19721134
pine	I-Chemical	-1	19721134
produced	O	-1	19721134
anti@@	O	-1	19721134
arrhyth@@	O	-1	19721134
mic	O	-1	19721134
ac@@	O	-1	19721134
tions	O	-1	19721134
on	O	-1	19721134
arrhyth@@	B-Disease	D001145	19721134
mic	I-Disease	-1	19721134
rat	O	-1	19721134
and	O	-1	19721134
gu@@	O	-1	19721134
ine@@	O	-1	19721134
a	O	-1	19721134
pi@@	O	-1	19721134
g	O	-1	19721134
models	O	-1	19721134
induced	O	-1	19721134
by	O	-1	19721134
ac@@	B-Chemical	D000157	19721134
on@@	I-Chemical	-1	19721134
it@@	I-Chemical	-1	19721134
ine	I-Chemical	-1	19721134
or	O	-1	19721134
ou@@	B-Chemical	D010042	19721134
ab@@	I-Chemical	-1	19721134
ain	I-Chemical	-1	19721134
vi@@	O	-1	19721134
a	O	-1	19721134
stimul@@	O	-1	19721134
ating	O	-1	19721134
the	O	-1	19721134
cardiac	O	-1	19721134
M@@	O	-1	19721134
(3@@	O	-1	19721134
)-@@	O	-1	19721134
m@@	O	-1	19721134
AC@@	O	-1	19721134
h@@	O	-1	19721134
R@@	O	-1	19721134
.	O	-1	19721134
The	O	-1	19721134
mechanism	O	-1	19721134
may	O	-1	19721134
be	O	-1	19721134
related	O	-1	19721134
to	O	-1	19721134
the	O	-1	19721134
impro@@	O	-1	19721134
vement	O	-1	19721134
of	O	-1	19721134
C@@	B-Chemical	D002118	19721134
a	I-Chemical	-1	19721134
(2@@	O	-1	19721134
+@@	O	-1	19721134
)	O	-1	19721134
h@@	O	-1	19721134
and@@	O	-1	19721134
l@@	O	-1	19721134
ing.	O	-1	19721134

D@@	B-Chemical	D004221	17786501
is@@	I-Chemical	-1	17786501
ul@@	I-Chemical	-1	17786501
fi@@	I-Chemical	-1	17786501
ra@@	I-Chemical	-1	17786501
m	I-Chemical	-1	17786501
-induced	O	-1	17786501
transi@@	O	-1	17786501
ent	O	-1	17786501
op@@	B-Disease	D009901	17786501
tic	I-Disease	-1	17786501
and	I-Disease	-1	17786501
peripheral	I-Disease	-1	17786501
neuropathy	I-Disease	-1	17786501
op@@	B-Disease	D010523	17786501
tic	I-Disease	-1	17786501
and	I-Disease	-1	17786501
peripheral	I-Disease	-1	17786501
neuropathy	I-Disease	-1	17786501
:	O	-1	17786501
a	O	-1	17786501
case	O	-1	17786501
repor@@	O	-1	17786501
t.	O	-1	17786501
A@@	O	-1	17786501
I@@	O	-1	17786501
M@@	O	-1	17786501
:	O	-1	17786501
To	O	-1	17786501
report	O	-1	17786501
a	O	-1	17786501
case	O	-1	17786501
of	O	-1	17786501
op@@	B-Disease	D009901	17786501
tic	I-Disease	-1	17786501
and	I-Disease	-1	17786501
peripheral	I-Disease	-1	17786501
neuropathy	I-Disease	-1	17786501
op@@	B-Disease	D010523	17786501
tic	I-Disease	-1	17786501
and	I-Disease	-1	17786501
peripheral	I-Disease	-1	17786501
neuropathy	I-Disease	-1	17786501
after	O	-1	17786501
chronic	O	-1	17786501
use	O	-1	17786501
of	O	-1	17786501
dis@@	B-Chemical	D004221	17786501
ul@@	I-Chemical	-1	17786501
fi@@	I-Chemical	-1	17786501
ra@@	I-Chemical	-1	17786501
m	I-Chemical	-1	17786501
for	O	-1	17786501
alco@@	B-Disease	D000437	17786501
hol	I-Disease	-1	17786501
depend@@	I-Disease	-1	17786501
ence	I-Disease	-1	17786501
man@@	O	-1	17786501
ag@@	O	-1	17786501
em@@	O	-1	17786501
ent@@	O	-1	17786501
.	O	-1	17786501
M@@	O	-1	17786501
AT@@	O	-1	17786501
E@@	O	-1	17786501
R@@	O	-1	17786501
I@@	O	-1	17786501
AL@@	O	-1	17786501
S	O	-1	17786501
AN@@	O	-1	17786501
D	O	-1	17786501
METHODS:	O	-1	17786501
A	O	-1	17786501
case	O	-1	17786501
repor@@	O	-1	17786501
t.	O	-1	17786501
RESULTS:	O	-1	17786501
A	O	-1	17786501
5@@	O	-1	17786501
7-@@	O	-1	17786501
year-old	O	-1	17786501
male	O	-1	17786501
presented	O	-1	17786501
with	O	-1	17786501
gra@@	O	-1	17786501
du@@	O	-1	17786501
al	O	-1	17786501
loss	B-Disease	D014786	17786501
of	I-Disease	-1	17786501
vi@@	I-Disease	-1	17786501
sion	I-Disease	-1	17786501
in	O	-1	17786501
both	O	-1	17786501
e@@	O	-1	17786501
y@@	O	-1	17786501
es	O	-1	17786501
with	O	-1	17786501
inter@@	O	-1	17786501
mit@@	O	-1	17786501
t@@	O	-1	17786501
ent	O	-1	17786501
headac@@	B-Disease	D006261	17786501
h@@	I-Disease	-1	17786501
es	I-Disease	-1	17786501
for	O	-1	17786501
2	O	-1	17786501
months.	O	-1	17786501
H@@	O	-1	17786501
e	O	-1	17786501
also	O	-1	17786501
com@@	O	-1	17786501
pl@@	O	-1	17786501
ained	O	-1	17786501
of	O	-1	17786501
par@@	B-Disease	D010292	17786501
a@@	I-Disease	-1	17786501
esthe@@	I-Disease	-1	17786501
sia	I-Disease	-1	17786501
with	O	-1	17786501
numb@@	B-Disease	D006987	17786501
ness	I-Disease	-1	17786501
in	O	-1	17786501
both	O	-1	17786501
fe@@	O	-1	17786501
et@@	O	-1	17786501
.	O	-1	17786501
H@@	O	-1	17786501
is	O	-1	17786501
vi@@	O	-1	17786501
sion	O	-1	17786501
was	O	-1	17786501
6@@	O	-1	17786501
/@@	O	-1	17786501
15	O	-1	17786501
and	O	-1	17786501
2@@	O	-1	17786501
/@@	O	-1	17786501
60	O	-1	17786501
in	O	-1	17786501
the	O	-1	17786501
right	O	-1	17786501
and	O	-1	17786501
left	O	-1	17786501
e@@	O	-1	17786501
y@@	O	-1	17786501
es,	O	-1	17786501
respectively.	O	-1	17786501
F@@	O	-1	17786501
un@@	O	-1	17786501
dos@@	O	-1	17786501
co@@	O	-1	17786501
p@@	O	-1	17786501
y	O	-1	17786501
revealed	O	-1	17786501
bil@@	O	-1	17786501
at@@	O	-1	17786501
er@@	O	-1	17786501
ally	O	-1	17786501
s@@	O	-1	17786501
w@@	O	-1	17786501
ol@@	O	-1	17786501
le@@	O	-1	17786501
n	O	-1	17786501
op@@	O	-1	17786501
tic	O	-1	17786501
nerve	O	-1	17786501
head@@	O	-1	17786501
s.	O	-1	17786501
V@@	O	-1	17786501
i@@	O	-1	17786501
sual	O	-1	17786501
fi@@	O	-1	17786501
el@@	O	-1	17786501
d	O	-1	17786501
test@@	O	-1	17786501
ing	O	-1	17786501
con@@	O	-1	17786501
fir@@	O	-1	17786501
m@@	O	-1	17786501
ed	O	-1	17786501
bil@@	O	-1	17786501
ateral	O	-1	17786501
centr@@	O	-1	17786501
al@@	O	-1	17786501
-@@	O	-1	17786501
ca@@	O	-1	17786501
ec@@	O	-1	17786501
al	O	-1	17786501
sco@@	B-Disease	D012607	17786501
to@@	I-Disease	-1	17786501
mat@@	I-Disease	-1	17786501
a	I-Disease	-1	17786501
.	O	-1	17786501
H@@	O	-1	17786501
e	O	-1	17786501
had	O	-1	17786501
been	O	-1	17786501
taking	O	-1	17786501
dis@@	B-Chemical	D004221	17786501
ul@@	I-Chemical	-1	17786501
fi@@	I-Chemical	-1	17786501
ra@@	I-Chemical	-1	17786501
m	I-Chemical	-1	17786501
for	O	-1	17786501
alco@@	B-Disease	D000437	17786501
hol	I-Disease	-1	17786501
depend@@	I-Disease	-1	17786501
ence	I-Disease	-1	17786501
for	O	-1	17786501
the	O	-1	17786501
pre@@	O	-1	17786501
ce@@	O	-1	17786501
ding	O	-1	17786501
3	O	-1	17786501
year@@	O	-1	17786501
s.	O	-1	17786501
D@@	B-Chemical	D004221	17786501
is@@	I-Chemical	-1	17786501
ul@@	I-Chemical	-1	17786501
fi@@	I-Chemical	-1	17786501
ra@@	I-Chemical	-1	17786501
m	I-Chemical	-1	17786501
discontinu@@	O	-1	17786501
ation	O	-1	17786501
le@@	O	-1	17786501
ad	O	-1	17786501
to	O	-1	17786501
an	O	-1	17786501
immedi@@	O	-1	17786501
ate	O	-1	17786501
symptom@@	O	-1	17786501
atic	O	-1	17786501
impro@@	O	-1	17786501
ve@@	O	-1	17786501
ment.	O	-1	17786501
CONCLUSION:	O	-1	17786501
P@@	O	-1	17786501
hy@@	O	-1	17786501
si@@	O	-1	17786501
ci@@	O	-1	17786501
ans	O	-1	17786501
initi@@	O	-1	17786501
ating	O	-1	17786501
long-term	O	-1	17786501
dis@@	B-Chemical	D004221	17786501
ul@@	I-Chemical	-1	17786501
fi@@	I-Chemical	-1	17786501
ra@@	I-Chemical	-1	17786501
m	I-Chemical	-1	17786501
therapy	O	-1	17786501
should	O	-1	17786501
be	O	-1	17786501
aw@@	O	-1	17786501
are	O	-1	17786501
of	O	-1	17786501
these	O	-1	17786501
adverse	O	-1	17786501
effects.	O	-1	17786501
The@@	O	-1	17786501
y	O	-1	17786501
should	O	-1	17786501
recomm@@	O	-1	17786501
end	O	-1	17786501
an@@	O	-1	17786501
n@@	O	-1	17786501
ual	O	-1	17786501
oph@@	O	-1	17786501
thal@@	O	-1	17786501
mic	O	-1	17786501
revie@@	O	-1	17786501
w@@	O	-1	17786501
s	O	-1	17786501
with	O	-1	17786501
visual	O	-1	17786501
fi@@	O	-1	17786501
el@@	O	-1	17786501
d	O	-1	17786501
test@@	O	-1	17786501
ing.	O	-1	17786501
Patients	O	-1	17786501
should	O	-1	17786501
be	O	-1	17786501
reas@@	O	-1	17786501
su@@	O	-1	17786501
red	O	-1	17786501
with	O	-1	17786501
resp@@	O	-1	17786501
ect	O	-1	17786501
to	O	-1	17786501
the	O	-1	17786501
rever@@	O	-1	17786501
sib@@	O	-1	17786501
ility	O	-1	17786501
of	O	-1	17786501
these	O	-1	17786501
adverse	O	-1	17786501
effects.	O	-1	17786501

S@@	O	-1	16960342
ust@@	O	-1	16960342
ained	O	-1	16960342
clinical	O	-1	16960342
impro@@	O	-1	16960342
vement	O	-1	16960342
of	O	-1	16960342
a	O	-1	16960342
patient	O	-1	16960342
with	O	-1	16960342
dec@@	O	-1	16960342
om@@	O	-1	16960342
pen@@	O	-1	16960342
s@@	O	-1	16960342
ated	O	-1	16960342
hepatitis	B-Disease	D006509	16960342
B	I-Disease	-1	16960342
vi@@	O	-1	16960342
r@@	O	-1	16960342
us@@	O	-1	16960342
-@@	O	-1	16960342
related	O	-1	16960342
cir@@	B-Disease	D005355	16960342
r@@	I-Disease	-1	16960342
ho@@	I-Disease	-1	16960342
sis	I-Disease	-1	16960342
after	O	-1	16960342
treatment	O	-1	16960342
with	O	-1	16960342
lamivud@@	B-Chemical	D019259	16960342
ine	I-Chemical	-1	16960342
mon@@	O	-1	16960342
o@@	O	-1	16960342
therapy.	O	-1	16960342
He@@	B-Disease	D006509	16960342
pati@@	I-Disease	-1	16960342
tis	I-Disease	-1	16960342
B	I-Disease	-1	16960342
vi@@	I-Disease	-1	16960342
ru@@	I-Disease	-1	16960342
s	I-Disease	-1	16960342
(@@	I-Disease	-1	16960342
HB@@	I-Disease	-1	16960342
V@@	I-Disease	-1	16960342
)	I-Disease	-1	16960342
inf@@	I-Disease	-1	16960342
ection	I-Disease	-1	16960342
,	O	-1	16960342
which	O	-1	16960342
causes	O	-1	16960342
liver	B-Disease	D008103	16960342
cir@@	I-Disease	-1	16960342
r@@	I-Disease	-1	16960342
ho@@	I-Disease	-1	16960342
sis	I-Disease	-1	16960342
and	O	-1	16960342
hepat@@	B-Disease	D006528	16960342
oc@@	I-Disease	-1	16960342
ell@@	I-Disease	-1	16960342
ular	I-Disease	-1	16960342
carcin@@	I-Disease	-1	16960342
oma	I-Disease	-1	16960342
,	O	-1	16960342
remain@@	O	-1	16960342
s	O	-1	16960342
a	O	-1	16960342
major	O	-1	16960342
heal@@	O	-1	16960342
th	O	-1	16960342
pro@@	O	-1	16960342
ble@@	O	-1	16960342
m	O	-1	16960342
in	O	-1	16960342
A@@	O	-1	16960342
si@@	O	-1	16960342
an	O	-1	16960342
coun@@	O	-1	16960342
tri@@	O	-1	16960342
es.	O	-1	16960342
Rec@@	O	-1	16960342
ent	O	-1	16960342
development	O	-1	16960342
of	O	-1	16960342
vac@@	O	-1	16960342
c@@	O	-1	16960342
ine	O	-1	16960342
for	O	-1	16960342
pre@@	O	-1	16960342
ven@@	O	-1	16960342
tion	O	-1	16960342
is	O	-1	16960342
reported	O	-1	16960342
to	O	-1	16960342
be	O	-1	16960342
suc@@	O	-1	16960342
cess@@	O	-1	16960342
ful	O	-1	16960342
in	O	-1	16960342
reduc@@	O	-1	16960342
ing	O	-1	16960342
the	O	-1	16960342
size	O	-1	16960342
of	O	-1	16960342
chron@@	O	-1	16960342
ically	O	-1	16960342
inf@@	O	-1	16960342
ected	O	-1	16960342
car@@	O	-1	16960342
ri@@	O	-1	16960342
er@@	O	-1	16960342
s,	O	-1	16960342
although	O	-1	16960342
the	O	-1	16960342
standard	O	-1	16960342
med@@	O	-1	16960342
ical	O	-1	16960342
therap@@	O	-1	16960342
i@@	O	-1	16960342
es	O	-1	16960342
have	O	-1	16960342
not	O	-1	16960342
been	O	-1	16960342
est@@	O	-1	16960342
abl@@	O	-1	16960342
ished	O	-1	16960342
up	O	-1	16960342
to	O	-1	16960342
now@@	O	-1	16960342
.	O	-1	16960342
In	O	-1	16960342
this	O	-1	16960342
repor@@	O	-1	16960342
t,	O	-1	16960342
we	O	-1	16960342
en@@	O	-1	16960342
coun@@	O	-1	16960342
te@@	O	-1	16960342
red	O	-1	16960342
a	O	-1	16960342
patient	O	-1	16960342
with	O	-1	16960342
dec@@	O	-1	16960342
om@@	O	-1	16960342
pen@@	O	-1	16960342
s@@	O	-1	16960342
ated	O	-1	16960342
HB@@	O	-1	16960342
V@@	O	-1	16960342
-@@	O	-1	16960342
related	O	-1	16960342
cir@@	B-Disease	D005355	16960342
r@@	I-Disease	-1	16960342
ho@@	I-Disease	-1	16960342
sis	I-Disease	-1	16960342
who	O	-1	16960342
ex@@	O	-1	16960342
hib@@	O	-1	16960342
ited	O	-1	16960342
the	O	-1	16960342
d@@	O	-1	16960342
ram@@	O	-1	16960342
atic	O	-1	16960342
impro@@	O	-1	16960342
ve@@	O	-1	16960342
ments	O	-1	16960342
after	O	-1	16960342
anti@@	O	-1	16960342
viral	O	-1	16960342
therapy.	O	-1	16960342
The	O	-1	16960342
patient	O	-1	16960342
was	O	-1	16960342
a	O	-1	16960342
50@@	O	-1	16960342
-@@	O	-1	16960342
year-old	O	-1	16960342
wom@@	O	-1	16960342
an@@	O	-1	16960342
.	O	-1	16960342
Pre@@	O	-1	16960342
vi@@	O	-1	16960342
ous	O	-1	16960342
con@@	O	-1	16960342
ven@@	O	-1	16960342
tional	O	-1	16960342
med@@	O	-1	16960342
ical	O	-1	16960342
treat@@	O	-1	16960342
ments	O	-1	16960342
were	O	-1	16960342
not	O	-1	16960342
effective	O	-1	16960342
for	O	-1	16960342
this	O	-1	16960342
patient@@	O	-1	16960342
,	O	-1	16960342
th@@	O	-1	16960342
us	O	-1	16960342
this	O	-1	16960342
patient	O	-1	16960342
had	O	-1	16960342
been	O	-1	16960342
ref@@	O	-1	16960342
er@@	O	-1	16960342
red	O	-1	16960342
to	O	-1	16960342
our	O	-1	16960342
hospit@@	O	-1	16960342
al.	O	-1	16960342
However,	O	-1	16960342
the	O	-1	16960342
administration	O	-1	16960342
of	O	-1	16960342
lamivud@@	B-Chemical	D019259	16960342
ine	I-Chemical	-1	16960342
,	O	-1	16960342
a	O	-1	16960342
re@@	O	-1	16960342
verse	O	-1	16960342
trans@@	O	-1	16960342
cri@@	O	-1	16960342
pt@@	O	-1	16960342
ase	O	-1	16960342
inhibitor@@	O	-1	16960342
,	O	-1	16960342
for	O	-1	16960342
2@@	O	-1	16960342
3	O	-1	16960342
months	O	-1	16960342
d@@	O	-1	16960342
ram@@	O	-1	16960342
ati@@	O	-1	16960342
c@@	O	-1	16960342
ally	O	-1	16960342
improved	O	-1	16960342
h@@	O	-1	16960342
er	O	-1	16960342
liver	O	-1	16960342
sever@@	O	-1	16960342
ity.	O	-1	16960342
D@@	O	-1	16960342
uring	O	-1	16960342
this	O	-1	16960342
perio@@	O	-1	16960342
d,	O	-1	16960342
no	O	-1	16960342
drug	O	-1	16960342
resist@@	O	-1	16960342
ant	O	-1	16960342
mut@@	O	-1	16960342
ant	O	-1	16960342
HBV	O	-1	16960342
em@@	O	-1	16960342
erg@@	O	-1	16960342
ed,	O	-1	16960342
and	O	-1	16960342
the	O	-1	16960342
serum	O	-1	16960342
HB@@	O	-1	16960342
V@@	O	-1	16960342
-@@	O	-1	16960342
D@@	O	-1	16960342
NA	O	-1	16960342
level	O	-1	16960342
was	O	-1	16960342
continu@@	O	-1	16960342
ously	O	-1	16960342
sup@@	O	-1	16960342
pres@@	O	-1	16960342
sed.	O	-1	16960342
These	O	-1	16960342
vi@@	O	-1	16960342
ro@@	O	-1	16960342
log@@	O	-1	16960342
ical	O	-1	16960342
responses	O	-1	16960342
were	O	-1	16960342
also	O	-1	16960342
maint@@	O	-1	16960342
ained	O	-1	16960342
even	O	-1	16960342
after	O	-1	16960342
the	O	-1	16960342
anti@@	O	-1	16960342
viral	O	-1	16960342
therapy	O	-1	16960342
was	O	-1	16960342
discontinu@@	O	-1	16960342
ed.	O	-1	16960342
M@@	O	-1	16960342
ore@@	O	-1	16960342
o@@	O	-1	16960342
ver,	O	-1	16960342
both	O	-1	16960342
hepatitis	B-Chemical	D006514	16960342
B	I-Chemical	-1	16960342
sur@@	I-Chemical	-1	16960342
fac@@	I-Chemical	-1	16960342
e	I-Chemical	-1	16960342
anti@@	I-Chemical	-1	16960342
gen	I-Chemical	-1	16960342
and	I-Chemical	-1	16960342
e	I-Chemical	-1	16960342
anti@@	I-Chemical	-1	16960342
gen	I-Chemical	-1	16960342
hepatitis	B-Chemical	D006513	16960342
B	I-Chemical	-1	16960342
sur@@	I-Chemical	-1	16960342
fac@@	I-Chemical	-1	16960342
e	I-Chemical	-1	16960342
anti@@	I-Chemical	-1	16960342
gen	I-Chemical	-1	16960342
and	I-Chemical	-1	16960342
e	I-Chemical	-1	16960342
anti@@	I-Chemical	-1	16960342
gen	I-Chemical	-1	16960342
were	O	-1	16960342
observed	O	-1	16960342
to	O	-1	16960342
have	O	-1	16960342
dis@@	O	-1	16960342
appe@@	O	-1	16960342
a@@	O	-1	16960342
red	O	-1	16960342
in	O	-1	16960342
this	O	-1	16960342
patient@@	O	-1	16960342
.	O	-1	16960342
The	O	-1	16960342
administration	O	-1	16960342
of	O	-1	16960342
lamivud@@	B-Chemical	D019259	16960342
ine	I-Chemical	-1	16960342
to	O	-1	16960342
patients	O	-1	16960342
with	O	-1	16960342
HB@@	O	-1	16960342
V@@	O	-1	16960342
-@@	O	-1	16960342
related	O	-1	16960342
cir@@	B-Disease	D005355	16960342
r@@	I-Disease	-1	16960342
ho@@	I-Disease	-1	16960342
sis	I-Disease	-1	16960342
,	O	-1	16960342
like	O	-1	16960342
our	O	-1	16960342
present	O	-1	16960342
cas@@	O	-1	16960342
e,	O	-1	16960342
should	O	-1	16960342
be	O	-1	16960342
considered	O	-1	16960342
as	O	-1	16960342
an	O	-1	16960342
initial	O	-1	16960342
med@@	O	-1	16960342
ical	O	-1	16960342
therapeutic	O	-1	16960342
op@@	O	-1	16960342
tion,	O	-1	16960342
es@@	O	-1	16960342
p@@	O	-1	16960342
ec@@	O	-1	16960342
i@@	O	-1	16960342
ally	O	-1	16960342
in	O	-1	16960342
coun@@	O	-1	16960342
tri@@	O	-1	16960342
es	O	-1	16960342
wh@@	O	-1	16960342
ere	O	-1	16960342
liver	O	-1	16960342
transplant@@	O	-1	16960342
ation	O	-1	16960342
is	O	-1	16960342
not	O	-1	16960342
re@@	O	-1	16960342
li@@	O	-1	16960342
ably	O	-1	16960342
av@@	O	-1	16960342
ail@@	O	-1	16960342
able@@	O	-1	16960342
.	O	-1	16960342

D@@	O	-1	11226639
ual	O	-1	11226639
effects	O	-1	11226639
of	O	-1	11226639
me@@	B-Chemical	D008550	11226639
lat@@	I-Chemical	-1	11226639
on@@	I-Chemical	-1	11226639
in	I-Chemical	-1	11226639
on	O	-1	11226639
b@@	B-Chemical	C032232	11226639
arbit@@	I-Chemical	-1	11226639
ur@@	I-Chemical	-1	11226639
ate	I-Chemical	-1	11226639
-induced	O	-1	11226639
n@@	B-Disease	D053608	11226639
ar@@	I-Disease	-1	11226639
co@@	I-Disease	-1	11226639
sis	I-Disease	-1	11226639
in	O	-1	11226639
rats.	O	-1	11226639
M@@	B-Chemical	D008550	11226639
el@@	I-Chemical	-1	11226639
at@@	I-Chemical	-1	11226639
on@@	I-Chemical	-1	11226639
in	I-Chemical	-1	11226639
aff@@	O	-1	11226639
ects	O	-1	11226639
the	O	-1	11226639
cir@@	O	-1	11226639
ca@@	O	-1	11226639
di@@	O	-1	11226639
an	O	-1	11226639
sle@@	O	-1	11226639
ep@@	O	-1	11226639
/@@	O	-1	11226639
w@@	O	-1	11226639
ake	O	-1	11226639
cyc@@	O	-1	11226639
le@@	O	-1	11226639
,	O	-1	11226639
but	O	-1	11226639
it	O	-1	11226639
is	O	-1	11226639
not	O	-1	11226639
c@@	O	-1	11226639
le@@	O	-1	11226639
ar	O	-1	11226639
whether	O	-1	11226639
it	O	-1	11226639
may	O	-1	11226639
influence	O	-1	11226639
drug@@	O	-1	11226639
-induced	O	-1	11226639
n@@	B-Disease	D053608	11226639
ar@@	I-Disease	-1	11226639
co@@	I-Disease	-1	11226639
sis	I-Disease	-1	11226639
.	O	-1	11226639
S@@	B-Chemical	D013874	11226639
odium	I-Chemical	-1	11226639
th@@	I-Chemical	-1	11226639
io@@	I-Chemical	-1	11226639
pen@@	I-Chemical	-1	11226639
th@@	I-Chemical	-1	11226639
al	I-Chemical	-1	11226639
was	O	-1	11226639
administered	O	-1	11226639
intra@@	O	-1	11226639
per@@	O	-1	11226639
it@@	O	-1	11226639
one@@	O	-1	11226639
ally	O	-1	11226639
into	O	-1	11226639
male	O	-1	11226639
rats	O	-1	11226639
pre@@	O	-1	11226639
-treated	O	-1	11226639
with	O	-1	11226639
me@@	B-Chemical	D008550	11226639
lat@@	I-Chemical	-1	11226639
on@@	I-Chemical	-1	11226639
in	I-Chemical	-1	11226639
(@@	O	-1	11226639
0.05@@	O	-1	11226639
,	O	-1	11226639
0.@@	O	-1	11226639
5,	O	-1	11226639
5	O	-1	11226639
and	O	-1	11226639
50	O	-1	11226639
mg/kg@@	O	-1	11226639
).	O	-1	11226639
M@@	B-Chemical	D008550	11226639
el@@	I-Chemical	-1	11226639
at@@	I-Chemical	-1	11226639
on@@	I-Chemical	-1	11226639
in	I-Chemical	-1	11226639
pre-@@	O	-1	11226639
treatment	O	-1	11226639
affected	O	-1	11226639
in	O	-1	11226639
a	O	-1	11226639
du@@	O	-1	11226639
al	O	-1	11226639
man@@	O	-1	11226639
n@@	O	-1	11226639
er	O	-1	11226639
b@@	B-Chemical	C032232	11226639
arbit@@	I-Chemical	-1	11226639
ur@@	I-Chemical	-1	11226639
ate	I-Chemical	-1	11226639
n@@	B-Disease	D053608	11226639
ar@@	I-Disease	-1	11226639
co@@	I-Disease	-1	11226639
sis	I-Disease	-1	11226639
,	O	-1	11226639
however,	O	-1	11226639
no	O	-1	11226639
dose-@@	O	-1	11226639
effect	O	-1	11226639
correl@@	O	-1	11226639
ation	O	-1	11226639
was	O	-1	11226639
f@@	O	-1	11226639
oun@@	O	-1	11226639
d.	O	-1	11226639
In	O	-1	11226639
partic@@	O	-1	11226639
ul@@	O	-1	11226639
ar@@	O	-1	11226639
,	O	-1	11226639
low	O	-1	11226639
doses	O	-1	11226639
reduced	O	-1	11226639
the	O	-1	11226639
lat@@	O	-1	11226639
ency	O	-1	11226639
to	O	-1	11226639
and	O	-1	11226639
prolonged	O	-1	11226639
the	O	-1	11226639
duration	O	-1	11226639
of	O	-1	11226639
b@@	B-Chemical	C032232	11226639
arbit@@	I-Chemical	-1	11226639
ur@@	I-Chemical	-1	11226639
ate	I-Chemical	-1	11226639
n@@	B-Disease	D053608	11226639
ar@@	I-Disease	-1	11226639
co@@	I-Disease	-1	11226639
sis	I-Disease	-1	11226639
.	O	-1	11226639
In	O	-1	11226639
contrast@@	O	-1	11226639
,	O	-1	11226639
the	O	-1	11226639
high@@	O	-1	11226639
est	O	-1	11226639
dose	O	-1	11226639
of	O	-1	11226639
me@@	B-Chemical	D008550	11226639
lat@@	I-Chemical	-1	11226639
on@@	I-Chemical	-1	11226639
in	I-Chemical	-1	11226639
(@@	O	-1	11226639
50	O	-1	11226639
mg/kg)	O	-1	11226639
caused	O	-1	11226639
a	O	-1	11226639
par@@	O	-1	11226639
ad@@	O	-1	11226639
ox@@	O	-1	11226639
ical	O	-1	11226639
increase	O	-1	11226639
in	O	-1	11226639
the	O	-1	11226639
lat@@	O	-1	11226639
ency	O	-1	11226639
and	O	-1	11226639
produced	O	-1	11226639
a	O	-1	11226639
su@@	O	-1	11226639
st@@	O	-1	11226639
ained	O	-1	11226639
reduction	O	-1	11226639
of	O	-1	11226639
the	O	-1	11226639
duration	O	-1	11226639
of	O	-1	11226639
n@@	B-Disease	D053608	11226639
ar@@	I-Disease	-1	11226639
co@@	I-Disease	-1	11226639
sis	I-Disease	-1	11226639
,	O	-1	11226639
and	O	-1	11226639
a	O	-1	11226639
reduction	O	-1	11226639
in	O	-1	11226639
mor@@	O	-1	11226639
t@@	O	-1	11226639
ality	O	-1	11226639
rat@@	O	-1	11226639
e.	O	-1	11226639
M@@	B-Chemical	D008550	11226639
el@@	I-Chemical	-1	11226639
at@@	I-Chemical	-1	11226639
on@@	I-Chemical	-1	11226639
in	I-Chemical	-1	11226639
0.@@	O	-1	11226639
5	O	-1	11226639
and	O	-1	11226639
5	O	-1	11226639
mg/kg	O	-1	11226639
influ@@	O	-1	11226639
enc@@	O	-1	11226639
ed	O	-1	11226639
the	O	-1	11226639
duration	O	-1	11226639
but	O	-1	11226639
not	O	-1	11226639
the	O	-1	11226639
lat@@	O	-1	11226639
ency	O	-1	11226639
of	O	-1	11226639
k@@	B-Chemical	D007649	11226639
et@@	I-Chemical	-1	11226639
amine	I-Chemical	-1	11226639
-	O	-1	11226639
or	O	-1	11226639
di@@	B-Chemical	D003975	11226639
az@@	I-Chemical	-1	11226639
epam	I-Chemical	-1	11226639
-induced	O	-1	11226639
n@@	B-Disease	D053608	11226639
ar@@	I-Disease	-1	11226639
co@@	I-Disease	-1	11226639
sis	I-Disease	-1	11226639
.	O	-1	11226639
Th@@	O	-1	11226639
us,	O	-1	11226639
the	O	-1	11226639
du@@	O	-1	11226639
al	O	-1	11226639
action	O	-1	11226639
of	O	-1	11226639
me@@	B-Chemical	D008550	11226639
lat@@	I-Chemical	-1	11226639
on@@	I-Chemical	-1	11226639
in	I-Chemical	-1	11226639
on	O	-1	11226639
pharmac@@	O	-1	11226639
ological	O	-1	11226639
n@@	B-Disease	D053608	11226639
ar@@	I-Disease	-1	11226639
co@@	I-Disease	-1	11226639
sis	I-Disease	-1	11226639
se@@	O	-1	11226639
em@@	O	-1	11226639
s	O	-1	11226639
to	O	-1	11226639
be	O	-1	11226639
specific	O	-1	11226639
for	O	-1	11226639
the	O	-1	11226639
b@@	B-Chemical	C032232	11226639
arbit@@	I-Chemical	-1	11226639
ur@@	I-Chemical	-1	11226639
ate	I-Chemical	-1	11226639
mechanism	O	-1	11226639
of	O	-1	11226639
ac@@	O	-1	11226639
tion.	O	-1	11226639

Eff@@	O	-1	9228650
ects	O	-1	9228650
of	O	-1	9228650
N@@	B-Chemical	C049860	9228650
I@@	I-Chemical	-1	9228650
K@@	I-Chemical	-1	9228650
-@@	I-Chemical	-1	9228650
2@@	I-Chemical	-1	9228650
4@@	I-Chemical	-1	9228650
7	I-Chemical	-1	9228650
on	O	-1	9228650
chol@@	O	-1	9228650
ine@@	O	-1	9228650
ster@@	O	-1	9228650
ase	O	-1	9228650
and	O	-1	9228650
scopol@@	B-Chemical	D012601	9228650
amine	I-Chemical	-1	9228650
-induced	O	-1	9228650
am@@	B-Disease	D000647	9228650
ne@@	I-Disease	-1	9228650
sia	I-Disease	-1	9228650
.	O	-1	9228650
The	O	-1	9228650
effects	O	-1	9228650
of	O	-1	9228650
N@@	B-Chemical	C049860	9228650
I@@	I-Chemical	-1	9228650
K@@	I-Chemical	-1	9228650
-@@	I-Chemical	-1	9228650
2@@	I-Chemical	-1	9228650
4@@	I-Chemical	-1	9228650
7	I-Chemical	-1	9228650
on	O	-1	9228650
chol@@	O	-1	9228650
ine@@	O	-1	9228650
ster@@	O	-1	9228650
ase,	O	-1	9228650
scopol@@	B-Chemical	D012601	9228650
amine	I-Chemical	-1	9228650
-induced	O	-1	9228650
am@@	B-Disease	D000647	9228650
ne@@	I-Disease	-1	9228650
sia	I-Disease	-1	9228650
and	O	-1	9228650
spont@@	O	-1	9228650
aneous	O	-1	9228650
mo@@	O	-1	9228650
vement	O	-1	9228650
were	O	-1	9228650
examined	O	-1	9228650
and	O	-1	9228650
compared	O	-1	9228650
with	O	-1	9228650
those	O	-1	9228650
of	O	-1	9228650
the	O	-1	9228650
we@@	O	-1	9228650
ll@@	O	-1	9228650
-@@	O	-1	9228650
known	O	-1	9228650
chol@@	O	-1	9228650
ine@@	O	-1	9228650
ster@@	O	-1	9228650
ase	O	-1	9228650
inhibitors	O	-1	9228650
tac@@	B-Chemical	D013619	9228650
rine	I-Chemical	-1	9228650
and	O	-1	9228650
E@@	B-Chemical	C076946	9228650
-@@	I-Chemical	-1	9228650
20@@	I-Chemical	-1	9228650
20	I-Chemical	-1	9228650
.	O	-1	9228650
N@@	B-Chemical	C049860	9228650
I@@	I-Chemical	-1	9228650
K@@	I-Chemical	-1	9228650
-@@	I-Chemical	-1	9228650
2@@	I-Chemical	-1	9228650
4@@	I-Chemical	-1	9228650
7	I-Chemical	-1	9228650
,	O	-1	9228650
tac@@	B-Chemical	D013619	9228650
rine	I-Chemical	-1	9228650
and	O	-1	9228650
E@@	B-Chemical	C076946	9228650
-@@	I-Chemical	-1	9228650
20@@	I-Chemical	-1	9228650
20	I-Chemical	-1	9228650
all	O	-1	9228650
st@@	O	-1	9228650
ron@@	O	-1	9228650
g@@	O	-1	9228650
ly	O	-1	9228650
inhibited	O	-1	9228650
acet@@	O	-1	9228650
ylchol@@	O	-1	9228650
ine@@	O	-1	9228650
ster@@	O	-1	9228650
ase	O	-1	9228650
(@@	O	-1	9228650
AC@@	O	-1	9228650
h@@	O	-1	9228650
E@@	O	-1	9228650
)	O	-1	9228650
in	O	-1	9228650
human	O	-1	9228650
red	O	-1	9228650
blood	O	-1	9228650
cells	O	-1	9228650
(@@	O	-1	9228650
IC@@	O	-1	9228650
50@@	O	-1	9228650
s	O	-1	9228650
=	O	-1	9228650
1.@@	O	-1	9228650
0	O	-1	9228650
x	O	-1	9228650
10@@	O	-1	9228650
(-@@	O	-1	9228650
6@@	O	-1	9228650
),	O	-1	9228650
2.@@	O	-1	9228650
9	O	-1	9228650
x	O	-1	9228650
10@@	O	-1	9228650
(-@@	O	-1	9228650
7@@	O	-1	9228650
)	O	-1	9228650
and	O	-1	9228650
3.@@	O	-1	9228650
7	O	-1	9228650
x	O	-1	9228650
10@@	O	-1	9228650
(-@@	O	-1	9228650
8@@	O	-1	9228650
)	O	-1	9228650
M@@	O	-1	9228650
,	O	-1	9228650
respectivel@@	O	-1	9228650
y@@	O	-1	9228650
).	O	-1	9228650
In	O	-1	9228650
addi@@	O	-1	9228650
tion,	O	-1	9228650
N@@	B-Chemical	C049860	9228650
I@@	I-Chemical	-1	9228650
K@@	I-Chemical	-1	9228650
-@@	I-Chemical	-1	9228650
2@@	I-Chemical	-1	9228650
4@@	I-Chemical	-1	9228650
7	I-Chemical	-1	9228650
and	O	-1	9228650
tac@@	B-Chemical	D013619	9228650
rine	I-Chemical	-1	9228650
,	O	-1	9228650
but	O	-1	9228650
not	O	-1	9228650
E@@	B-Chemical	C076946	9228650
-@@	I-Chemical	-1	9228650
20@@	I-Chemical	-1	9228650
20	I-Chemical	-1	9228650
,	O	-1	9228650
st@@	O	-1	9228650
ron@@	O	-1	9228650
g@@	O	-1	9228650
ly	O	-1	9228650
inhibited	O	-1	9228650
but@@	O	-1	9228650
y@@	O	-1	9228650
r@@	O	-1	9228650
ylchol@@	O	-1	9228650
ine@@	O	-1	9228650
str@@	O	-1	9228650
ase	O	-1	9228650
(B@@	O	-1	9228650
u@@	O	-1	9228650
Ch@@	O	-1	9228650
E@@	O	-1	9228650
)	O	-1	9228650
in	O	-1	9228650
human	O	-1	9228650
ser@@	O	-1	9228650
um@@	O	-1	9228650
.	O	-1	9228650
All	O	-1	9228650
three	O	-1	9228650
drugs	O	-1	9228650
produced	O	-1	9228650
mi@@	O	-1	9228650
x@@	O	-1	9228650
ed	O	-1	9228650
inhibition	O	-1	9228650
of	O	-1	9228650
AC@@	O	-1	9228650
h@@	O	-1	9228650
E	O	-1	9228650
activ@@	O	-1	9228650
ity.	O	-1	9228650
M@@	O	-1	9228650
ore@@	O	-1	9228650
o@@	O	-1	9228650
ver,	O	-1	9228650
the	O	-1	9228650
inhibit@@	O	-1	9228650
ory	O	-1	9228650
effect	O	-1	9228650
of	O	-1	9228650
N@@	B-Chemical	C049860	9228650
I@@	I-Chemical	-1	9228650
K@@	I-Chemical	-1	9228650
-@@	I-Chemical	-1	9228650
2@@	I-Chemical	-1	9228650
4@@	I-Chemical	-1	9228650
7	I-Chemical	-1	9228650
on	O	-1	9228650
AC@@	O	-1	9228650
h@@	O	-1	9228650
E	O	-1	9228650
was	O	-1	9228650
rever@@	O	-1	9228650
sib@@	O	-1	9228650
le@@	O	-1	9228650
.	O	-1	9228650
All	O	-1	9228650
comp@@	O	-1	9228650
oun@@	O	-1	9228650
ds	O	-1	9228650
at	O	-1	9228650
0.@@	O	-1	9228650
1-@@	O	-1	9228650
1	O	-1	9228650
mg/kg	O	-1	9228650
p.@@	O	-1	9228650
o@@	O	-1	9228650
.	O	-1	9228650
significantly	O	-1	9228650
improved	O	-1	9228650
the	O	-1	9228650
am@@	B-Disease	D000647	9228650
ne@@	I-Disease	-1	9228650
sia	I-Disease	-1	9228650
induced	O	-1	9228650
by	O	-1	9228650
scopol@@	B-Chemical	D012601	9228650
amine	I-Chemical	-1	9228650
(0.@@	O	-1	9228650
5	O	-1	9228650
mg/kg	O	-1	9228650
s@@	O	-1	9228650
.@@	O	-1	9228650
c@@	O	-1	9228650
.)	O	-1	9228650
in	O	-1	9228650
rats	O	-1	9228650
perform@@	O	-1	9228650
ing	O	-1	9228650
a	O	-1	9228650
p@@	O	-1	9228650
as@@	O	-1	9228650
sive	O	-1	9228650
avoid@@	O	-1	9228650
ance	O	-1	9228650
t@@	O	-1	9228650
as@@	O	-1	9228650
k@@	O	-1	9228650
.	O	-1	9228650
The	O	-1	9228650
three	O	-1	9228650
comp@@	O	-1	9228650
oun@@	O	-1	9228650
ds	O	-1	9228650
at	O	-1	9228650
1	O	-1	9228650
and	O	-1	9228650
3	O	-1	9228650
mg/kg	O	-1	9228650
p.@@	O	-1	9228650
o@@	O	-1	9228650
.	O	-1	9228650
did	O	-1	9228650
not	O	-1	9228650
significantly	O	-1	9228650
decrease	O	-1	9228650
spont@@	O	-1	9228650
aneous	O	-1	9228650
mo@@	O	-1	9228650
vement	O	-1	9228650
by	O	-1	9228650
rats.	O	-1	9228650
These	O	-1	9228650
findings	O	-1	9228650
suggest	O	-1	9228650
that	O	-1	9228650
N@@	B-Chemical	C049860	9228650
I@@	I-Chemical	-1	9228650
K@@	I-Chemical	-1	9228650
-@@	I-Chemical	-1	9228650
2@@	I-Chemical	-1	9228650
4@@	I-Chemical	-1	9228650
7	I-Chemical	-1	9228650
at	O	-1	9228650
a	O	-1	9228650
low	O	-1	9228650
dose	O	-1	9228650
(0.@@	O	-1	9228650
1-@@	O	-1	9228650
1	O	-1	9228650
mg/kg	O	-1	9228650
p.@@	O	-1	9228650
o@@	O	-1	9228650
.)	O	-1	9228650
impro@@	O	-1	9228650
v@@	O	-1	9228650
es	O	-1	9228650
scopol@@	B-Chemical	D012601	9228650
amine	I-Chemical	-1	9228650
-induced	O	-1	9228650
am@@	B-Disease	D000647	9228650
ne@@	I-Disease	-1	9228650
sia	I-Disease	-1	9228650
but	O	-1	9228650
does	O	-1	9228650
not	O	-1	9228650
aff@@	O	-1	9228650
ect	O	-1	9228650
spont@@	O	-1	9228650
aneous	O	-1	9228650
mo@@	O	-1	9228650
ve@@	O	-1	9228650
ment.	O	-1	9228650
The	O	-1	9228650
findings	O	-1	9228650
suggest	O	-1	9228650
that	O	-1	9228650
N@@	B-Chemical	C049860	9228650
I@@	I-Chemical	-1	9228650
K@@	I-Chemical	-1	9228650
-@@	I-Chemical	-1	9228650
2@@	I-Chemical	-1	9228650
4@@	I-Chemical	-1	9228650
7	I-Chemical	-1	9228650
may	O	-1	9228650
be	O	-1	9228650
a	O	-1	9228650
use@@	O	-1	9228650
ful	O	-1	9228650
drug	O	-1	9228650
for	O	-1	9228650
the	O	-1	9228650
treatment	O	-1	9228650
of	O	-1	9228650
Al@@	B-Disease	D000544	9228650
z@@	I-Disease	-1	9228650
he@@	I-Disease	-1	9228650
im@@	I-Disease	-1	9228650
er@@	I-Disease	-1	9228650
's	I-Disease	-1	9228650
disease	I-Disease	-1	9228650
.	O	-1	9228650

N@@	O	-1	8766220
igh@@	O	-1	8766220
t@@	O	-1	8766220
ma@@	O	-1	8766220
res	O	-1	8766220
and	O	-1	8766220
h@@	B-Disease	D006212	8766220
all@@	I-Disease	-1	8766220
uc@@	I-Disease	-1	8766220
in@@	I-Disease	-1	8766220
ations	I-Disease	-1	8766220
after	O	-1	8766220
long-term	O	-1	8766220
int@@	O	-1	8766220
ake	O	-1	8766220
of	O	-1	8766220
t@@	B-Chemical	D014147	8766220
ram@@	I-Chemical	-1	8766220
ad@@	I-Chemical	-1	8766220
ol	I-Chemical	-1	8766220
combined	O	-1	8766220
with	O	-1	8766220
antidepress@@	O	-1	8766220
ant@@	O	-1	8766220
s.	O	-1	8766220
T@@	B-Chemical	D014147	8766220
ram@@	I-Chemical	-1	8766220
ad@@	I-Chemical	-1	8766220
ol	I-Chemical	-1	8766220
is	O	-1	8766220
a	O	-1	8766220
we@@	O	-1	8766220
a@@	O	-1	8766220
k	O	-1	8766220
o@@	O	-1	8766220
pi@@	O	-1	8766220
oid	O	-1	8766220
with	O	-1	8766220
effects	O	-1	8766220
on	O	-1	8766220
adrenergic	O	-1	8766220
and	O	-1	8766220
seroton@@	O	-1	8766220
ergic	O	-1	8766220
neuro@@	O	-1	8766220
trans@@	O	-1	8766220
mission	O	-1	8766220
that	O	-1	8766220
is	O	-1	8766220
used	O	-1	8766220
to	O	-1	8766220
tre@@	O	-1	8766220
at	O	-1	8766220
cancer	B-Disease	D009369	8766220
pain	B-Disease	D010146	8766220
and	O	-1	8766220
chronic	O	-1	8766220
n@@	O	-1	8766220
on	O	-1	8766220
mal@@	O	-1	8766220
i@@	O	-1	8766220
gn@@	O	-1	8766220
ant	O	-1	8766220
pain	B-Disease	D010146	8766220
.	O	-1	8766220
This	O	-1	8766220
drug	O	-1	8766220
was	O	-1	8766220
initi@@	O	-1	8766220
ated	O	-1	8766220
in	O	-1	8766220
association	O	-1	8766220
with	O	-1	8766220
pa@@	B-Chemical	D017374	8766220
ro@@	I-Chemical	-1	8766220
x@@	I-Chemical	-1	8766220
et@@	I-Chemical	-1	8766220
ine	I-Chemical	-1	8766220
and	O	-1	8766220
dos@@	B-Chemical	D004308	8766220
ul@@	I-Chemical	-1	8766220
ep@@	I-Chemical	-1	8766220
ine	I-Chemical	-1	8766220
hydro@@	I-Chemical	-1	8766220
chlor@@	I-Chemical	-1	8766220
ide	I-Chemical	-1	8766220
in	O	-1	8766220
a	O	-1	8766220
te@@	B-Disease	-1	8766220
tra@@	I-Disease	-1	8766220
pa@@	I-Disease	-1	8766220
re@@	I-Disease	-1	8766220
tic	I-Disease	-1	8766220
patient	O	-1	8766220
with	O	-1	8766220
chronic	B-Disease	D059350	8766220
pain	I-Disease	-1	8766220
.	O	-1	8766220
F@@	O	-1	8766220
if@@	O	-1	8766220
ty-@@	O	-1	8766220
six	O	-1	8766220
days	O	-1	8766220
after	O	-1	8766220
initi@@	O	-1	8766220
ation	O	-1	8766220
of	O	-1	8766220
the	O	-1	8766220
treatment	O	-1	8766220
the	O	-1	8766220
patient	O	-1	8766220
presented	O	-1	8766220
h@@	B-Disease	D006212	8766220
all@@	I-Disease	-1	8766220
uc@@	I-Disease	-1	8766220
in@@	I-Disease	-1	8766220
ations	I-Disease	-1	8766220
that	O	-1	8766220
only	O	-1	8766220
sto@@	O	-1	8766220
pp@@	O	-1	8766220
ed	O	-1	8766220
after	O	-1	8766220
the	O	-1	8766220
withdrawal	O	-1	8766220
of	O	-1	8766220
psycho@@	O	-1	8766220
-@@	O	-1	8766220
active	O	-1	8766220
drugs	O	-1	8766220
and	O	-1	8766220
t@@	B-Chemical	D014147	8766220
ram@@	I-Chemical	-1	8766220
ad@@	I-Chemical	-1	8766220
ol	I-Chemical	-1	8766220
.	O	-1	8766220
The	O	-1	8766220
case	O	-1	8766220
report	O	-1	8766220
qu@@	O	-1	8766220
es@@	O	-1	8766220
tions	O	-1	8766220
the	O	-1	8766220
lon@@	O	-1	8766220
g	O	-1	8766220
term	O	-1	8766220
use	O	-1	8766220
of	O	-1	8766220
pain	B-Disease	D010146	8766220
k@@	O	-1	8766220
ill@@	O	-1	8766220
ers	O	-1	8766220
combined	O	-1	8766220
with	O	-1	8766220
psycho@@	O	-1	8766220
-@@	O	-1	8766220
active	O	-1	8766220
drugs	O	-1	8766220
in	O	-1	8766220
chronic	O	-1	8766220
n@@	O	-1	8766220
on	O	-1	8766220
mal@@	O	-1	8766220
i@@	O	-1	8766220
gn@@	O	-1	8766220
ant	O	-1	8766220
pain	B-Disease	D010146	8766220
,	O	-1	8766220
es@@	O	-1	8766220
p@@	O	-1	8766220
ec@@	O	-1	8766220
i@@	O	-1	8766220
ally	O	-1	8766220
if	O	-1	8766220
pain	B-Disease	D010146	8766220
is	O	-1	8766220
under	O	-1	8766220
control@@	O	-1	8766220
.	O	-1	8766220

A@@	O	-1	8441146
p@@	O	-1	8441146
pa@@	O	-1	8441146
rent	O	-1	8441146
c@@	O	-1	8441146
ure	O	-1	8441146
of	O	-1	8441146
r@@	B-Disease	D001172	8441146
he@@	I-Disease	-1	8441146
um@@	I-Disease	-1	8441146
at@@	I-Disease	-1	8441146
oid	I-Disease	-1	8441146
arth@@	I-Disease	-1	8441146
ritis	I-Disease	-1	8441146
by	O	-1	8441146
b@@	O	-1	8441146
one	O	-1	8441146
m@@	O	-1	8441146
ar@@	O	-1	8441146
ro@@	O	-1	8441146
w	O	-1	8441146
transplant@@	O	-1	8441146
ation.	O	-1	8441146
We	O	-1	8441146
describe	O	-1	8441146
the	O	-1	8441146
induction	O	-1	8441146
of	O	-1	8441146
su@@	O	-1	8441146
st@@	O	-1	8441146
ained	O	-1	8441146
re@@	O	-1	8441146
mis@@	O	-1	8441146
sions	O	-1	8441146
and	O	-1	8441146
possible	O	-1	8441146
c@@	O	-1	8441146
ure	O	-1	8441146
of	O	-1	8441146
severe	O	-1	8441146
ero@@	O	-1	8441146
sive	O	-1	8441146
r@@	B-Disease	D001172	8441146
he@@	I-Disease	-1	8441146
um@@	I-Disease	-1	8441146
at@@	I-Disease	-1	8441146
oid	I-Disease	-1	8441146
arth@@	I-Disease	-1	8441146
ritis	I-Disease	-1	8441146
(	O	-1	8441146
R@@	B-Disease	D001172	8441146
A	I-Disease	-1	8441146
)	O	-1	8441146
by	O	-1	8441146
b@@	O	-1	8441146
one	O	-1	8441146
m@@	O	-1	8441146
ar@@	O	-1	8441146
ro@@	O	-1	8441146
w	O	-1	8441146
transplant@@	O	-1	8441146
ation	O	-1	8441146
(B@@	O	-1	8441146
M@@	O	-1	8441146
T)	O	-1	8441146
in	O	-1	8441146
2	O	-1	8441146
patients.	O	-1	8441146
B@@	O	-1	8441146
M@@	O	-1	8441146
T	O	-1	8441146
was	O	-1	8441146
used	O	-1	8441146
to	O	-1	8441146
tre@@	O	-1	8441146
at	O	-1	8441146
severe	O	-1	8441146
ap@@	B-Disease	D000741	8441146
las@@	I-Disease	-1	8441146
tic	I-Disease	-1	8441146
anemia	I-Disease	-1	8441146
which	O	-1	8441146
was	O	-1	8441146
caused	O	-1	8441146
by	O	-1	8441146
g@@	B-Chemical	D006046	8441146
old	I-Chemical	-1	8441146
in	O	-1	8441146
one	O	-1	8441146
case	O	-1	8441146
and	O	-1	8441146
D-@@	B-Chemical	D010396	8441146
pen@@	I-Chemical	-1	8441146
icill@@	I-Chemical	-1	8441146
amine	I-Chemical	-1	8441146
in	O	-1	8441146
the	O	-1	8441146
o@@	O	-1	8441146
ther@@	O	-1	8441146
.	O	-1	8441146
In	O	-1	8441146
the	O	-1	8441146
8	O	-1	8441146
and	O	-1	8441146
6	O	-1	8441146
years	O	-1	8441146
s@@	O	-1	8441146
inc@@	O	-1	8441146
e	O	-1	8441146
the	O	-1	8441146
transplant@@	O	-1	8441146
s	O	-1	8441146
(@@	O	-1	8441146
re@@	O	-1	8441146
present@@	O	-1	8441146
ing	O	-1	8441146
8	O	-1	8441146
and	O	-1	8441146
4	O	-1	8441146
years	O	-1	8441146
s@@	O	-1	8441146
inc@@	O	-1	8441146
e	O	-1	8441146
cess@@	O	-1	8441146
ation	O	-1	8441146
of	O	-1	8441146
all	O	-1	8441146
immunosup@@	O	-1	8441146
pressive	O	-1	8441146
therapy,	O	-1	8441146
respectivel@@	O	-1	8441146
y@@	O	-1	8441146
),	O	-1	8441146
the	O	-1	8441146
R@@	B-Disease	D001172	8441146
A	I-Disease	-1	8441146
in	O	-1	8441146
each	O	-1	8441146
case	O	-1	8441146
has	O	-1	8441146
been	O	-1	8441146
complete@@	O	-1	8441146
ly	O	-1	8441146
qu@@	O	-1	8441146
i@@	O	-1	8441146
es@@	O	-1	8441146
c@@	O	-1	8441146
ent@@	O	-1	8441146
.	O	-1	8441146
Although	O	-1	8441146
sh@@	O	-1	8441146
ort	O	-1	8441146
term	O	-1	8441146
re@@	O	-1	8441146
mission	O	-1	8441146
of	O	-1	8441146
severe	O	-1	8441146
R@@	B-Disease	D001172	8441146
A	I-Disease	-1	8441146
following	O	-1	8441146
B@@	O	-1	8441146
M@@	O	-1	8441146
T	O	-1	8441146
has	O	-1	8441146
been	O	-1	8441146
repor@@	O	-1	8441146
te@@	O	-1	8441146
d,	O	-1	8441146
these	O	-1	8441146
are	O	-1	8441146
the	O	-1	8441146
first	O	-1	8441146
cases	O	-1	8441146
for	O	-1	8441146
which	O	-1	8441146
prolonged	O	-1	8441146
follow@@	O	-1	8441146
up	O	-1	8441146
has	O	-1	8441146
been	O	-1	8441146
av@@	O	-1	8441146
ail@@	O	-1	8441146
able@@	O	-1	8441146
.	O	-1	8441146
This	O	-1	8441146
experi@@	O	-1	8441146
ence	O	-1	8441146
ra@@	O	-1	8441146
i@@	O	-1	8441146
ses	O	-1	8441146
the	O	-1	8441146
qu@@	O	-1	8441146
es@@	O	-1	8441146
tion	O	-1	8441146
of	O	-1	8441146
the	O	-1	8441146
role	O	-1	8441146
of	O	-1	8441146
B@@	O	-1	8441146
M@@	O	-1	8441146
T	O	-1	8441146
it@@	O	-1	8441146
sel@@	O	-1	8441146
f	O	-1	8441146
as	O	-1	8441146
a	O	-1	8441146
therapeutic	O	-1	8441146
op@@	O	-1	8441146
tion	O	-1	8441146
for	O	-1	8441146
patients	O	-1	8441146
with	O	-1	8441146
un@@	O	-1	8441146
controlled	O	-1	8441146
de@@	O	-1	8441146
struc@@	O	-1	8441146
tive	O	-1	8441146
sy@@	B-Disease	D013585	8441146
no@@	I-Disease	-1	8441146
vi@@	I-Disease	-1	8441146
tis	I-Disease	-1	8441146
.	O	-1	8441146

U@@	O	-1	3653576
r@@	O	-1	3653576
inary	O	-1	3653576
enzym@@	O	-1	3653576
es	O	-1	3653576
and	O	-1	3653576
protein	O	-1	3653576
pat@@	O	-1	3653576
tern@@	O	-1	3653576
s	O	-1	3653576
as	O	-1	3653576
indic@@	O	-1	3653576
at@@	O	-1	3653576
ors	O	-1	3653576
of	O	-1	3653576
injury	B-Disease	D007674	3653576
to	I-Disease	-1	3653576
different	I-Disease	-1	3653576
regi@@	I-Disease	-1	3653576
ons	I-Disease	-1	3653576
of	I-Disease	-1	3653576
the	I-Disease	-1	3653576
kidney	I-Disease	-1	3653576
.	O	-1	3653576
Ac@@	B-Disease	D058186	3653576
ute	I-Disease	-1	3653576
experimental	I-Disease	-1	3653576
models	I-Disease	-1	3653576
of	I-Disease	-1	3653576
renal	I-Disease	-1	3653576
damage	I-Disease	-1	3653576
to	O	-1	3653576
the	O	-1	3653576
pro@@	O	-1	3653576
xim@@	O	-1	3653576
al	O	-1	3653576
tub@@	O	-1	3653576
ul@@	O	-1	3653576
ar@@	O	-1	3653576
,	O	-1	3653576
glomerul@@	O	-1	3653576
ar@@	O	-1	3653576
,	O	-1	3653576
and	O	-1	3653576
pap@@	O	-1	3653576
ill@@	O	-1	3653576
ary	O	-1	3653576
regi@@	O	-1	3653576
ons	O	-1	3653576
of	O	-1	3653576
the	O	-1	3653576
rat	O	-1	3653576
were	O	-1	3653576
produced	O	-1	3653576
by	O	-1	3653576
administration	O	-1	3653576
of	O	-1	3653576
he@@	B-Chemical	C001335	3653576
x@@	I-Chemical	-1	3653576
ac@@	I-Chemical	-1	3653576
h@@	I-Chemical	-1	3653576
loro@@	I-Chemical	-1	3653576
-1@@	I-Chemical	-1	3653576
:@@	I-Chemical	-1	3653576
3-@@	I-Chemical	-1	3653576
but@@	I-Chemical	-1	3653576
a@@	I-Chemical	-1	3653576
di@@	I-Chemical	-1	3653576
ene	I-Chemical	-1	3653576
(	O	-1	3653576
HC@@	B-Chemical	C001335	3653576
B@@	I-Chemical	-1	3653576
D	I-Chemical	-1	3653576
),	O	-1	3653576
p@@	B-Chemical	D011692	3653576
uro@@	I-Chemical	-1	3653576
m@@	I-Chemical	-1	3653576
ycin	I-Chemical	-1	3653576
amin@@	I-Chemical	-1	3653576
on@@	I-Chemical	-1	3653576
ucle@@	I-Chemical	-1	3653576
o@@	I-Chemical	-1	3653576
side	I-Chemical	-1	3653576
(	O	-1	3653576
PA@@	B-Chemical	D011692	3653576
N	I-Chemical	-1	3653576
),	O	-1	3653576
and	O	-1	3653576
2-@@	B-Chemical	C004504	3653576
b@@	I-Chemical	-1	3653576
ro@@	I-Chemical	-1	3653576
mo@@	I-Chemical	-1	3653576
eth@@	I-Chemical	-1	3653576
yl@@	I-Chemical	-1	3653576
amine	I-Chemical	-1	3653576
(	O	-1	3653576
B@@	B-Chemical	C004504	3653576
E@@	I-Chemical	-1	3653576
A	I-Chemical	-1	3653576
),	O	-1	3653576
respectively.	O	-1	3653576
S@@	O	-1	3653576
e@@	O	-1	3653576
ver@@	O	-1	3653576
al	O	-1	3653576
ro@@	O	-1	3653576
ut@@	O	-1	3653576
ine	O	-1	3653576
indic@@	O	-1	3653576
at@@	O	-1	3653576
ors	O	-1	3653576
of	O	-1	3653576
nephro@@	B-Disease	D007674	3653576
toxicity	I-Disease	-1	3653576
,	O	-1	3653576
the	O	-1	3653576
enzym@@	O	-1	3653576
es	O	-1	3653576
al@@	O	-1	3653576
k@@	O	-1	3653576
aline	O	-1	3653576
phosph@@	O	-1	3653576
at@@	O	-1	3653576
ase	O	-1	3653576
and	O	-1	3653576
N@@	O	-1	3653576
-@@	O	-1	3653576
acet@@	O	-1	3653576
yl@@	O	-1	3653576
-@@	O	-1	3653576
beta-@@	O	-1	3653576
g@@	O	-1	3653576
lu@@	O	-1	3653576
co@@	O	-1	3653576
s@@	O	-1	3653576
amin@@	O	-1	3653576
id@@	O	-1	3653576
ase,	O	-1	3653576
and	O	-1	3653576
the	O	-1	3653576
mol@@	O	-1	3653576
ec@@	O	-1	3653576
ular	O	-1	3653576
weight	O	-1	3653576
of	O	-1	3653576
protein	B-Disease	D011507	3653576
ex@@	I-Disease	-1	3653576
cre@@	I-Disease	-1	3653576
tion	I-Disease	-1	3653576
were	O	-1	3653576
determined	O	-1	3653576
on	O	-1	3653576
urine	O	-1	3653576
sam@@	O	-1	3653576
pl@@	O	-1	3653576
es.	O	-1	3653576
T@@	O	-1	3653576
ub@@	O	-1	3653576
ular	O	-1	3653576
damage	O	-1	3653576
produced	O	-1	3653576
by	O	-1	3653576
HC@@	B-Chemical	C001335	3653576
B@@	I-Chemical	-1	3653576
D	I-Chemical	-1	3653576
or	O	-1	3653576
B@@	B-Chemical	C004504	3653576
E@@	I-Chemical	-1	3653576
A	I-Chemical	-1	3653576
was	O	-1	3653576
dis@@	O	-1	3653576
cri@@	O	-1	3653576
min@@	O	-1	3653576
ated	O	-1	3653576
both	O	-1	3653576
qu@@	O	-1	3653576
anti@@	O	-1	3653576
t@@	O	-1	3653576
atively	O	-1	3653576
and	O	-1	3653576
qu@@	O	-1	3653576
al@@	O	-1	3653576
it@@	O	-1	3653576
atively	O	-1	3653576
from	O	-1	3653576
glomerular	B-Disease	D007674	3653576
damage	I-Disease	-1	3653576
produced	O	-1	3653576
by	O	-1	3653576
PA@@	B-Chemical	D011692	3653576
N	I-Chemical	-1	3653576
.	O	-1	3653576
The	O	-1	3653576
lat@@	O	-1	3653576
ter	O	-1	3653576
was	O	-1	3653576
character@@	O	-1	3653576
ized	O	-1	3653576
by	O	-1	3653576
a	O	-1	3653576
p@@	O	-1	3653576
ron@@	O	-1	3653576
oun@@	O	-1	3653576
c@@	O	-1	3653576
ed	O	-1	3653576
increase	O	-1	3653576
in	O	-1	3653576
protein	B-Disease	D011507	3653576
ex@@	I-Disease	-1	3653576
cre@@	I-Disease	-1	3653576
tion	I-Disease	-1	3653576
,	O	-1	3653576
es@@	O	-1	3653576
p@@	O	-1	3653576
ec@@	O	-1	3653576
i@@	O	-1	3653576
ally	O	-1	3653576
protein@@	O	-1	3653576
s	O	-1	3653576
with	O	-1	3653576
mol@@	O	-1	3653576
ec@@	O	-1	3653576
ular	O	-1	3653576
weight	O	-1	3653576
greater	O	-1	3653576
than	O	-1	3653576
4@@	O	-1	3653576
0@@	O	-1	3653576
,@@	O	-1	3653576
0@@	O	-1	3653576
00	O	-1	3653576
D@@	O	-1	3653576
a.	O	-1	3653576
In	O	-1	3653576
contrast@@	O	-1	3653576
,	O	-1	3653576
protein	B-Disease	D011507	3653576
ex@@	I-Disease	-1	3653576
cre@@	I-Disease	-1	3653576
tion	I-Disease	-1	3653576
in	O	-1	3653576
tub@@	O	-1	3653576
ular	O	-1	3653576
damage	O	-1	3653576
was	O	-1	3653576
ra@@	O	-1	3653576
is@@	O	-1	3653576
ed	O	-1	3653576
only	O	-1	3653576
s@@	O	-1	3653576
li@@	O	-1	3653576
gh@@	O	-1	3653576
tly	O	-1	3653576
and	O	-1	3653576
character@@	O	-1	3653576
ized	O	-1	3653576
by	O	-1	3653576
ex@@	B-Disease	D011507	3653576
cre@@	I-Disease	-1	3653576
tion	I-Disease	-1	3653576
of	I-Disease	-1	3653576
protein@@	I-Disease	-1	3653576
s	I-Disease	-1	3653576
of	O	-1	3653576
a	O	-1	3653576
w@@	O	-1	3653576
ide	O	-1	3653576
range	O	-1	3653576
of	O	-1	3653576
mol@@	O	-1	3653576
ec@@	O	-1	3653576
ular	O	-1	3653576
weigh@@	O	-1	3653576
t@@	O	-1	3653576
s.	O	-1	3653576
Pro@@	O	-1	3653576
xim@@	O	-1	3653576
al	O	-1	3653576
tub@@	O	-1	3653576
ular	O	-1	3653576
damage	O	-1	3653576
caused	O	-1	3653576
by	O	-1	3653576
HC@@	B-Chemical	C001335	3653576
B@@	I-Chemical	-1	3653576
D	I-Chemical	-1	3653576
and	O	-1	3653576
pap@@	O	-1	3653576
ill@@	O	-1	3653576
ary	O	-1	3653576
damage	O	-1	3653576
caused	O	-1	3653576
by	O	-1	3653576
B@@	B-Chemical	C004504	3653576
E@@	I-Chemical	-1	3653576
A	I-Chemical	-1	3653576
were	O	-1	3653576
dist@@	O	-1	3653576
ing@@	O	-1	3653576
u@@	O	-1	3653576
ished	O	-1	3653576
both	O	-1	3653576
by	O	-1	3653576
con@@	O	-1	3653576
ven@@	O	-1	3653576
tional	O	-1	3653576
ur@@	O	-1	3653576
in@@	O	-1	3653576
aly@@	O	-1	3653576
sis	O	-1	3653576
(@@	O	-1	3653576
volume	O	-1	3653576
and	O	-1	3653576
specific	O	-1	3653576
gra@@	O	-1	3653576
vit@@	O	-1	3653576
y@@	O	-1	3653576
)	O	-1	3653576
and	O	-1	3653576
by	O	-1	3653576
meas@@	O	-1	3653576
ure@@	O	-1	3653576
ment	O	-1	3653576
of	O	-1	3653576
the	O	-1	3653576
two	O	-1	3653576
urinary	O	-1	3653576
enzym@@	O	-1	3653576
es.	O	-1	3653576
Al@@	O	-1	3653576
k@@	O	-1	3653576
aline	O	-1	3653576
phosph@@	O	-1	3653576
at@@	O	-1	3653576
ase	O	-1	3653576
and	O	-1	3653576
g@@	B-Chemical	D005947	3653576
lu@@	I-Chemical	-1	3653576
co@@	I-Chemical	-1	3653576
se	I-Chemical	-1	3653576
were	O	-1	3653576
mark@@	O	-1	3653576
ed@@	O	-1	3653576
ly	O	-1	3653576
and	O	-1	3653576
transi@@	O	-1	3653576
ently	O	-1	3653576
elevated	O	-1	3653576
in	O	-1	3653576
pro@@	O	-1	3653576
xim@@	O	-1	3653576
al	O	-1	3653576
tub@@	O	-1	3653576
ular	O	-1	3653576
damage	O	-1	3653576
and	O	-1	3653576
N@@	O	-1	3653576
-@@	O	-1	3653576
acet@@	O	-1	3653576
yl@@	O	-1	3653576
-@@	O	-1	3653576
beta-@@	O	-1	3653576
g@@	O	-1	3653576
lu@@	O	-1	3653576
co@@	O	-1	3653576
s@@	O	-1	3653576
amin@@	O	-1	3653576
id@@	O	-1	3653576
ase	O	-1	3653576
showed	O	-1	3653576
a	O	-1	3653576
su@@	O	-1	3653576
st@@	O	-1	3653576
ained	O	-1	3653576
elev@@	O	-1	3653576
ation	O	-1	3653576
in	O	-1	3653576
pap@@	O	-1	3653576
ill@@	O	-1	3653576
ary	O	-1	3653576
dam@@	O	-1	3653576
age.	O	-1	3653576
It	O	-1	3653576
is	O	-1	3653576
concl@@	O	-1	3653576
uded	O	-1	3653576
that	O	-1	3653576
both	O	-1	3653576
selective	O	-1	3653576
urinary	O	-1	3653576
enzym@@	O	-1	3653576
es	O	-1	3653576
and	O	-1	3653576
the	O	-1	3653576
mol@@	O	-1	3653576
ec@@	O	-1	3653576
ular	O	-1	3653576
weight	O	-1	3653576
pat@@	O	-1	3653576
ter@@	O	-1	3653576
n	O	-1	3653576
of	O	-1	3653576
urinary	O	-1	3653576
protein@@	O	-1	3653576
s	O	-1	3653576
can	O	-1	3653576
be	O	-1	3653576
used	O	-1	3653576
to	O	-1	3653576
prov@@	O	-1	3653576
ide	O	-1	3653576
diagnos@@	O	-1	3653576
tic	O	-1	3653576
inf@@	O	-1	3653576
orm@@	O	-1	3653576
ation	O	-1	3653576
about	O	-1	3653576
the	O	-1	3653576
possible	O	-1	3653576
sit@@	O	-1	3653576
e	O	-1	3653576
of	O	-1	3653576
renal	B-Disease	D007674	3653576
damage	I-Disease	-1	3653576
.	O	-1	3653576

Ne@@	B-Disease	D020879	2750819
uro@@	I-Disease	-1	2750819
mus@@	I-Disease	-1	2750819
cular	I-Disease	-1	2750819
block@@	I-Disease	-1	2750819
ade	I-Disease	-1	2750819
with	O	-1	2750819
mag@@	B-Chemical	D008278	2750819
ne@@	I-Chemical	-1	2750819
si@@	I-Chemical	-1	2750819
um	I-Chemical	-1	2750819
sulf@@	I-Chemical	-1	2750819
ate	I-Chemical	-1	2750819
and	O	-1	2750819
n@@	B-Chemical	D009543	2750819
if@@	I-Chemical	-1	2750819
edi@@	I-Chemical	-1	2750819
pine	I-Chemical	-1	2750819
.	O	-1	2750819
A	O	-1	2750819
patient	O	-1	2750819
who	O	-1	2750819
received	O	-1	2750819
to@@	O	-1	2750819
co@@	O	-1	2750819
ly@@	O	-1	2750819
sis	O	-1	2750819
with	O	-1	2750819
n@@	B-Chemical	D009543	2750819
if@@	I-Chemical	-1	2750819
edi@@	I-Chemical	-1	2750819
pine	I-Chemical	-1	2750819
developed	O	-1	2750819
neuro@@	B-Disease	D020879	2750819
mus@@	I-Disease	-1	2750819
cular	I-Disease	-1	2750819
block@@	I-Disease	-1	2750819
ade	I-Disease	-1	2750819
after	O	-1	2750819
5@@	O	-1	2750819
00	O	-1	2750819
mg	O	-1	2750819
of	O	-1	2750819
mag@@	B-Chemical	D008278	2750819
ne@@	I-Chemical	-1	2750819
si@@	I-Chemical	-1	2750819
um	I-Chemical	-1	2750819
sulf@@	I-Chemical	-1	2750819
ate	I-Chemical	-1	2750819
was	O	-1	2750819
administ@@	O	-1	2750819
e@@	O	-1	2750819
red.	O	-1	2750819
This	O	-1	2750819
reaction	O	-1	2750819
demon@@	O	-1	2750819
strat@@	O	-1	2750819
es	O	-1	2750819
that	O	-1	2750819
n@@	B-Chemical	D009543	2750819
if@@	I-Chemical	-1	2750819
edi@@	I-Chemical	-1	2750819
pine	I-Chemical	-1	2750819
can	O	-1	2750819
seri@@	O	-1	2750819
ously	O	-1	2750819
potenti@@	O	-1	2750819
ate	O	-1	2750819
the	O	-1	2750819
toxicity	B-Disease	D064420	2750819
of	O	-1	2750819
mag@@	B-Chemical	D008274	2750819
ne@@	I-Chemical	-1	2750819
si@@	I-Chemical	-1	2750819
um	I-Chemical	-1	2750819
.	O	-1	2750819
C@@	O	-1	2750819
au@@	O	-1	2750819
tion	O	-1	2750819
should	O	-1	2750819
be	O	-1	2750819
ex@@	O	-1	2750819
er@@	O	-1	2750819
cis@@	O	-1	2750819
ed	O	-1	2750819
when	O	-1	2750819
these	O	-1	2750819
two	O	-1	2750819
to@@	O	-1	2750819
co@@	O	-1	2750819
ly@@	O	-1	2750819
tics	O	-1	2750819
are	O	-1	2750819
com@@	O	-1	2750819
b@@	O	-1	2750819
ine@@	O	-1	2750819
d.	O	-1	2750819

I@@	B-Chemical	D007069	1899352
f@@	I-Chemical	-1	1899352
os@@	I-Chemical	-1	1899352
f@@	I-Chemical	-1	1899352
amide	I-Chemical	-1	1899352
continu@@	O	-1	1899352
ous	O	-1	1899352
infusion	O	-1	1899352
without	O	-1	1899352
m@@	B-Chemical	D015080	1899352
es@@	I-Chemical	-1	1899352
n@@	I-Chemical	-1	1899352
a	I-Chemical	-1	1899352
.	O	-1	1899352
A	O	-1	1899352
phase	O	-1	1899352
I	O	-1	1899352
trial	O	-1	1899352
of	O	-1	1899352
a	O	-1	1899352
1@@	O	-1	1899352
4-@@	O	-1	1899352
day	O	-1	1899352
cyc@@	O	-1	1899352
le@@	O	-1	1899352
.	O	-1	1899352
Tw@@	O	-1	1899352
ent@@	O	-1	1899352
y	O	-1	1899352
patients	O	-1	1899352
received	O	-1	1899352
2@@	O	-1	1899352
7	O	-1	1899352
cour@@	O	-1	1899352
ses	O	-1	1899352
of	O	-1	1899352
if@@	B-Chemical	D007069	1899352
os@@	I-Chemical	-1	1899352
f@@	I-Chemical	-1	1899352
amide	I-Chemical	-1	1899352
administered	O	-1	1899352
as	O	-1	1899352
a	O	-1	1899352
2@@	O	-1	1899352
4-@@	O	-1	1899352
h@@	O	-1	1899352
our	O	-1	1899352
continu@@	O	-1	1899352
ous	O	-1	1899352
infusion	O	-1	1899352
for	O	-1	1899352
14	O	-1	1899352
days	O	-1	1899352
without	O	-1	1899352
M@@	B-Chemical	D015080	1899352
es@@	I-Chemical	-1	1899352
n@@	I-Chemical	-1	1899352
a	I-Chemical	-1	1899352
.	O	-1	1899352
The	O	-1	1899352
go@@	O	-1	1899352
al	O	-1	1899352
of	O	-1	1899352
the	O	-1	1899352
study	O	-1	1899352
was	O	-1	1899352
to	O	-1	1899352
de@@	O	-1	1899352
liver	O	-1	1899352
a	O	-1	1899352
dose	O	-1	1899352
rate	O	-1	1899352
and	O	-1	1899352
total	O	-1	1899352
cum@@	O	-1	1899352
ul@@	O	-1	1899352
ative	O	-1	1899352
dose	O	-1	1899352
of	O	-1	1899352
if@@	B-Chemical	D007069	1899352
os@@	I-Chemical	-1	1899352
f@@	I-Chemical	-1	1899352
amide	I-Chemical	-1	1899352
that	O	-1	1899352
wo@@	O	-1	1899352
uld	O	-1	1899352
be	O	-1	1899352
compar@@	O	-1	1899352
able	O	-1	1899352
to	O	-1	1899352
standard	O	-1	1899352
b@@	O	-1	1899352
ol@@	O	-1	1899352
us	O	-1	1899352
or	O	-1	1899352
sh@@	O	-1	1899352
ort@@	O	-1	1899352
-term	O	-1	1899352
infu@@	O	-1	1899352
sions	O	-1	1899352
administered	O	-1	1899352
with	O	-1	1899352
M@@	B-Chemical	D015080	1899352
es@@	I-Chemical	-1	1899352
n@@	I-Chemical	-1	1899352
a	I-Chemical	-1	1899352
.	O	-1	1899352
D@@	O	-1	1899352
ose	O	-1	1899352
es@@	O	-1	1899352
cal@@	O	-1	1899352
ations	O	-1	1899352
proce@@	O	-1	1899352
ed@@	O	-1	1899352
ed	O	-1	1899352
from	O	-1	1899352
2@@	O	-1	1899352
00	O	-1	1899352
to	O	-1	1899352
3@@	O	-1	1899352
0@@	O	-1	1899352
0@@	O	-1	1899352
,	O	-1	1899352
4@@	O	-1	1899352
0@@	O	-1	1899352
0@@	O	-1	1899352
,	O	-1	1899352
4@@	O	-1	1899352
50@@	O	-1	1899352
,	O	-1	1899352
50@@	O	-1	1899352
0@@	O	-1	1899352
,	O	-1	1899352
and	O	-1	1899352
5@@	O	-1	1899352
50	O	-1	1899352
mg/m@@	O	-1	1899352
2@@	O	-1	1899352
/@@	O	-1	1899352
d.	O	-1	1899352
F@@	O	-1	1899352
our	O	-1	1899352
patients	O	-1	1899352
developed	O	-1	1899352
transi@@	O	-1	1899352
ent	O	-1	1899352
micro@@	O	-1	1899352
sco@@	O	-1	1899352
p@@	O	-1	1899352
ic	O	-1	1899352
hemat@@	B-Disease	D006417	1899352
uria	I-Disease	-1	1899352
at	O	-1	1899352
4@@	O	-1	1899352
0@@	O	-1	1899352
0@@	O	-1	1899352
,	O	-1	1899352
4@@	O	-1	1899352
50@@	O	-1	1899352
,	O	-1	1899352
and	O	-1	1899352
5@@	O	-1	1899352
00	O	-1	1899352
mg/m@@	O	-1	1899352
2@@	O	-1	1899352
/@@	O	-1	1899352
d.	O	-1	1899352
There	O	-1	1899352
were	O	-1	1899352
no	O	-1	1899352
in@@	O	-1	1899352
st@@	O	-1	1899352
anc@@	O	-1	1899352
es	O	-1	1899352
of	O	-1	1899352
mac@@	O	-1	1899352
ro@@	O	-1	1899352
sco@@	O	-1	1899352
p@@	O	-1	1899352
ic	O	-1	1899352
hemat@@	B-Disease	D006417	1899352
uria	I-Disease	-1	1899352
.	O	-1	1899352
A@@	O	-1	1899352
t	O	-1	1899352
5@@	O	-1	1899352
50	O	-1	1899352
mg/m@@	O	-1	1899352
2@@	O	-1	1899352
/@@	O	-1	1899352
d,	O	-1	1899352
three	O	-1	1899352
patients	O	-1	1899352
experienced	O	-1	1899352
non@@	O	-1	1899352
uro@@	O	-1	1899352
log@@	O	-1	1899352
ic	O	-1	1899352
toxicity	B-Disease	D064420	1899352
;	O	-1	1899352
conf@@	B-Disease	D003221	1899352
usion	I-Disease	-1	1899352
(1@@	O	-1	1899352
),	O	-1	1899352
nausea	B-Disease	D009325	1899352
(1@@	O	-1	1899352
),	O	-1	1899352
and	O	-1	1899352
G@@	O	-1	1899352
ra@@	O	-1	1899352
de	O	-1	1899352
2	O	-1	1899352
leuk@@	B-Disease	D007970	1899352
o@@	I-Disease	-1	1899352
pen@@	I-Disease	-1	1899352
ia	I-Disease	-1	1899352
(1@@	O	-1	1899352
).	O	-1	1899352
The	O	-1	1899352
recomm@@	O	-1	1899352
en@@	O	-1	1899352
ded	O	-1	1899352
dose	O	-1	1899352
of	O	-1	1899352
5@@	O	-1	1899352
00	O	-1	1899352
mg/m@@	O	-1	1899352
2@@	O	-1	1899352
/@@	O	-1	1899352
d	O	-1	1899352
de@@	O	-1	1899352
li@@	O	-1	1899352
ver@@	O	-1	1899352
s	O	-1	1899352
a	O	-1	1899352
total	O	-1	1899352
dose	O	-1	1899352
of	O	-1	1899352
7	O	-1	1899352
g/@@	O	-1	1899352
m@@	O	-1	1899352
2	O	-1	1899352
per	O	-1	1899352
cyc@@	O	-1	1899352
le@@	O	-1	1899352
,	O	-1	1899352
which	O	-1	1899352
is	O	-1	1899352
compar@@	O	-1	1899352
able	O	-1	1899352
to	O	-1	1899352
that	O	-1	1899352
de@@	O	-1	1899352
li@@	O	-1	1899352
vered	O	-1	1899352
in	O	-1	1899352
clinical	O	-1	1899352
p@@	O	-1	1899352
rac@@	O	-1	1899352
ti@@	O	-1	1899352
ce	O	-1	1899352
for	O	-1	1899352
b@@	O	-1	1899352
ol@@	O	-1	1899352
us	O	-1	1899352
or	O	-1	1899352
sh@@	O	-1	1899352
ort@@	O	-1	1899352
-term	O	-1	1899352
infu@@	O	-1	1899352
sion.	O	-1	1899352
B@@	O	-1	1899352
ecause	O	-1	1899352
fe@@	O	-1	1899352
w	O	-1	1899352
patients	O	-1	1899352
received	O	-1	1899352
multiple	O	-1	1899352
cour@@	O	-1	1899352
ses	O	-1	1899352
over	O	-1	1899352
ti@@	O	-1	1899352
me,	O	-1	1899352
the	O	-1	1899352
cum@@	O	-1	1899352
ul@@	O	-1	1899352
ative	O	-1	1899352
effects	O	-1	1899352
are	O	-1	1899352
in@@	O	-1	1899352
determin@@	O	-1	1899352
ate	O	-1	1899352
in	O	-1	1899352
the	O	-1	1899352
present	O	-1	1899352
tri@@	O	-1	1899352
al.	O	-1	1899352
The	O	-1	1899352
frequency	O	-1	1899352
and	O	-1	1899352
predic@@	O	-1	1899352
t@@	O	-1	1899352
ability	O	-1	1899352
of	O	-1	1899352
hemat@@	B-Disease	D006417	1899352
uria	I-Disease	-1	1899352
are	O	-1	1899352
not	O	-1	1899352
pre@@	O	-1	1899352
ci@@	O	-1	1899352
se@@	O	-1	1899352
,	O	-1	1899352
and	O	-1	1899352
at	O	-1	1899352
le@@	O	-1	1899352
ast	O	-1	1899352
daily	O	-1	1899352
monit@@	O	-1	1899352
or@@	O	-1	1899352
ing	O	-1	1899352
by	O	-1	1899352
urine	O	-1	1899352
H@@	O	-1	1899352
em@@	O	-1	1899352
at@@	O	-1	1899352
est	O	-1	1899352
is	O	-1	1899352
es@@	O	-1	1899352
sen@@	O	-1	1899352
ti@@	O	-1	1899352
al,	O	-1	1899352
ad@@	O	-1	1899352
ding	O	-1	1899352
M@@	B-Chemical	D015080	1899352
es@@	I-Chemical	-1	1899352
n@@	I-Chemical	-1	1899352
a	I-Chemical	-1	1899352
to	O	-1	1899352
the	O	-1	1899352
inf@@	O	-1	1899352
us@@	O	-1	1899352
ate	O	-1	1899352
in	O	-1	1899352
patients	O	-1	1899352
with	O	-1	1899352
per@@	O	-1	1899352
sist@@	O	-1	1899352
ent	O	-1	1899352
hemat@@	B-Disease	D006417	1899352
uria	I-Disease	-1	1899352
.	O	-1	1899352
The	O	-1	1899352
prot@@	O	-1	1899352
rac@@	O	-1	1899352
ted	O	-1	1899352
infusion	O	-1	1899352
sch@@	O	-1	1899352
ed@@	O	-1	1899352
ul@@	O	-1	1899352
e	O	-1	1899352
for	O	-1	1899352
if@@	B-Chemical	D007069	1899352
os@@	I-Chemical	-1	1899352
f@@	I-Chemical	-1	1899352
amide	I-Chemical	-1	1899352
per@@	O	-1	1899352
m@@	O	-1	1899352
its	O	-1	1899352
con@@	O	-1	1899352
ven@@	O	-1	1899352
i@@	O	-1	1899352
ent	O	-1	1899352
out@@	O	-1	1899352
patient	O	-1	1899352
administration	O	-1	1899352
without	O	-1	1899352
M@@	B-Chemical	D015080	1899352
es@@	I-Chemical	-1	1899352
n@@	I-Chemical	-1	1899352
a	I-Chemical	-1	1899352
and	O	-1	1899352
reduc@@	O	-1	1899352
es	O	-1	1899352
the	O	-1	1899352
drug	O	-1	1899352
co@@	O	-1	1899352
st	O	-1	1899352
of	O	-1	1899352
clinical	O	-1	1899352
us@@	O	-1	1899352
age	O	-1	1899352
of	O	-1	1899352
this	O	-1	1899352
agent	O	-1	1899352
by	O	-1	1899352
up	O	-1	1899352
to	O	-1	1899352
8@@	O	-1	1899352
9@@	O	-1	1899352
0	O	-1	1899352
per	O	-1	1899352
cyc@@	O	-1	1899352
le@@	O	-1	1899352
.	O	-1	1899352
Clin@@	O	-1	1899352
ical	O	-1	1899352
activity	O	-1	1899352
was	O	-1	1899352
demonstrated	O	-1	1899352
in	O	-1	1899352
a	O	-1	1899352
single	O	-1	1899352
patient@@	O	-1	1899352
,	O	-1	1899352
but	O	-1	1899352
a	O	-1	1899352
compar@@	O	-1	1899352
ative	O	-1	1899352
trial	O	-1	1899352
of	O	-1	1899352
standard	O	-1	1899352
b@@	O	-1	1899352
ol@@	O	-1	1899352
us	O	-1	1899352
sch@@	O	-1	1899352
ed@@	O	-1	1899352
ul@@	O	-1	1899352
es	O	-1	1899352
with	O	-1	1899352
the	O	-1	1899352
prot@@	O	-1	1899352
rac@@	O	-1	1899352
ted	O	-1	1899352
infusion	O	-1	1899352
sch@@	O	-1	1899352
ed@@	O	-1	1899352
ul@@	O	-1	1899352
e	O	-1	1899352
wil@@	O	-1	1899352
l	O	-1	1899352
be	O	-1	1899352
nec@@	O	-1	1899352
ess@@	O	-1	1899352
ary	O	-1	1899352
to	O	-1	1899352
determine	O	-1	1899352
if	O	-1	1899352
the	O	-1	1899352
clinical	O	-1	1899352
eff@@	O	-1	1899352
ec@@	O	-1	1899352
tiv@@	O	-1	1899352
en@@	O	-1	1899352
ess	O	-1	1899352
of	O	-1	1899352
the	O	-1	1899352
drug	O	-1	1899352
is	O	-1	1899352
maint@@	O	-1	1899352
a@@	O	-1	1899352
ine@@	O	-1	1899352
d.	O	-1	1899352

M@@	B-Disease	D009203	18161408
y@@	I-Disease	-1	18161408
ocardi@@	I-Disease	-1	18161408
al	I-Disease	-1	18161408
infarction	I-Disease	-1	18161408
in	O	-1	18161408
pregn@@	O	-1	18161408
anc@@	O	-1	18161408
y	O	-1	18161408
associated	O	-1	18161408
with	O	-1	18161408
clo@@	B-Chemical	D002996	18161408
mi@@	I-Chemical	-1	18161408
phen@@	I-Chemical	-1	18161408
e	I-Chemical	-1	18161408
cit@@	I-Chemical	-1	18161408
rate	I-Chemical	-1	18161408
for	O	-1	18161408
o@@	O	-1	18161408
v@@	O	-1	18161408
ulation	O	-1	18161408
induc@@	O	-1	18161408
tion@@	O	-1	18161408
:	O	-1	18161408
a	O	-1	18161408
case	O	-1	18161408
repor@@	O	-1	18161408
t.	O	-1	18161408
BACKGROUND:	O	-1	18161408
C@@	B-Chemical	D002996	18161408
lo@@	I-Chemical	-1	18161408
mi@@	I-Chemical	-1	18161408
phen@@	I-Chemical	-1	18161408
e	I-Chemical	-1	18161408
cit@@	I-Chemical	-1	18161408
rate	I-Chemical	-1	18161408
(	O	-1	18161408
C@@	B-Chemical	D002996	18161408
C	I-Chemical	-1	18161408
)	O	-1	18161408
is	O	-1	18161408
common@@	O	-1	18161408
ly	O	-1	18161408
prescri@@	O	-1	18161408
bed	O	-1	18161408
for	O	-1	18161408
o@@	O	-1	18161408
v@@	O	-1	18161408
ulation	O	-1	18161408
induc@@	O	-1	18161408
tion.	O	-1	18161408
It	O	-1	18161408
is	O	-1	18161408
considered	O	-1	18161408
saf@@	O	-1	18161408
e,	O	-1	18161408
with	O	-1	18161408
minim@@	O	-1	18161408
al	O	-1	18161408
side	O	-1	18161408
effects.	O	-1	18161408
Th@@	B-Disease	D013923	18161408
rom@@	I-Disease	-1	18161408
bo@@	I-Disease	-1	18161408
emb@@	I-Disease	-1	18161408
ol@@	I-Disease	-1	18161408
ism	I-Disease	-1	18161408
is	O	-1	18161408
a	O	-1	18161408
r@@	O	-1	18161408
are	O	-1	18161408
but	O	-1	18161408
lif@@	O	-1	18161408
e-@@	O	-1	18161408
th@@	O	-1	18161408
reat@@	O	-1	18161408
en@@	O	-1	18161408
ing	O	-1	18161408
complication	O	-1	18161408
that	O	-1	18161408
has	O	-1	18161408
been	O	-1	18161408
reported	O	-1	18161408
after	O	-1	18161408
o@@	O	-1	18161408
v@@	O	-1	18161408
ulation	O	-1	18161408
induction	O	-1	18161408
with	O	-1	18161408
C@@	B-Chemical	D002996	18161408
C	I-Chemical	-1	18161408
.	O	-1	18161408
S@@	O	-1	18161408
p@@	O	-1	18161408
ont@@	O	-1	18161408
aneous	O	-1	18161408
coronary	B-Disease	D003328	18161408
thrombo@@	I-Disease	-1	18161408
sis	I-Disease	-1	18161408
or	O	-1	18161408
thrombo@@	B-Disease	D013923	18161408
emb@@	I-Disease	-1	18161408
ol@@	I-Disease	-1	18161408
ism	I-Disease	-1	18161408
with	O	-1	18161408
subsequ@@	O	-1	18161408
ent	O	-1	18161408
clo@@	O	-1	18161408
t	O	-1	18161408
ly@@	O	-1	18161408
sis	O	-1	18161408
has	O	-1	18161408
been	O	-1	18161408
suggested	O	-1	18161408
as	O	-1	18161408
one	O	-1	18161408
of	O	-1	18161408
the	O	-1	18161408
most	O	-1	18161408
common	O	-1	18161408
causes	O	-1	18161408
of	O	-1	18161408
myocardial	B-Disease	D009203	18161408
infarction	I-Disease	-1	18161408
(	O	-1	18161408
M@@	B-Disease	D009203	18161408
I	I-Disease	-1	18161408
)	O	-1	18161408
during	O	-1	18161408
pregn@@	O	-1	18161408
anc@@	O	-1	18161408
y,	O	-1	18161408
with	O	-1	18161408
a	O	-1	18161408
subsequ@@	O	-1	18161408
ently	O	-1	18161408
normal	O	-1	18161408
coronary	O	-1	18161408
angio@@	O	-1	18161408
gram@@	O	-1	18161408
.	O	-1	18161408
CA@@	O	-1	18161408
S@@	O	-1	18161408
E:	O	-1	18161408
A	O	-1	18161408
3@@	O	-1	18161408
3-@@	O	-1	18161408
year-old	O	-1	18161408
woman	O	-1	18161408
with	O	-1	18161408
a	O	-1	18161408
5-@@	O	-1	18161408
week	O	-1	18161408
g@@	O	-1	18161408
est@@	O	-1	18161408
ation	O	-1	18161408
had	O	-1	18161408
rec@@	O	-1	18161408
ently	O	-1	18161408
received	O	-1	18161408
C@@	B-Chemical	D002996	18161408
C	I-Chemical	-1	18161408
for	O	-1	18161408
o@@	O	-1	18161408
v@@	O	-1	18161408
ulation	O	-1	18161408
induction	O	-1	18161408
and	O	-1	18161408
presented	O	-1	18161408
with	O	-1	18161408
ch@@	B-Disease	D002637	18161408
est	I-Disease	-1	18161408
pain	I-Disease	-1	18161408
.	O	-1	18161408
An	O	-1	18161408
electro@@	O	-1	18161408
cardio@@	O	-1	18161408
gra@@	O	-1	18161408
m	O	-1	18161408
showed	O	-1	18161408
a	O	-1	18161408
lat@@	O	-1	18161408
eral	O	-1	18161408
and	O	-1	18161408
an@@	O	-1	18161408
ter@@	O	-1	18161408
ior	O	-1	18161408
w@@	O	-1	18161408
all	O	-1	18161408
myocardial	B-Disease	D009203	18161408
infarction	I-Disease	-1	18161408
.	O	-1	18161408
C@@	O	-1	18161408
ardi@@	O	-1	18161408
a@@	O	-1	18161408
c	O	-1	18161408
enzym@@	O	-1	18161408
es	O	-1	18161408
showed	O	-1	18161408
a	O	-1	18161408
pe@@	O	-1	18161408
a@@	O	-1	18161408
k	O	-1	18161408
ri@@	O	-1	18161408
se	O	-1	18161408
in	O	-1	18161408
tro@@	O	-1	18161408
p@@	O	-1	18161408
on@@	O	-1	18161408
in	O	-1	18161408
I	O	-1	18161408
to	O	-1	18161408
9.@@	O	-1	18161408
10	O	-1	18161408
n@@	O	-1	18161408
g/@@	O	-1	18161408
m@@	O	-1	18161408
L@@	O	-1	18161408
.	O	-1	18161408
An	O	-1	18161408
initial	O	-1	18161408
ex@@	O	-1	18161408
er@@	O	-1	18161408
cis@@	O	-1	18161408
e	O	-1	18161408
stres@@	O	-1	18161408
s	O	-1	18161408
test	O	-1	18161408
was	O	-1	18161408
normal@@	O	-1	18161408
.	O	-1	18161408
A@@	O	-1	18161408
t	O	-1	18161408
the	O	-1	18161408
time	O	-1	18161408
of	O	-1	18161408
ad@@	O	-1	18161408
mis@@	O	-1	18161408
sion,	O	-1	18161408
the	O	-1	18161408
patient	O	-1	18161408
was	O	-1	18161408
at	O	-1	18161408
high	O	-1	18161408
risk	O	-1	18161408
of	O	-1	18161408
radi@@	B-Disease	D011832	18161408
ation	I-Disease	-1	18161408
injury	I-Disease	-1	18161408
to	O	-1	18161408
the	O	-1	18161408
f@@	O	-1	18161408
et@@	O	-1	18161408
us,	O	-1	18161408
so	O	-1	18161408
a	O	-1	18161408
coronary	O	-1	18161408
angio@@	O	-1	18161408
gra@@	O	-1	18161408
m	O	-1	18161408
was	O	-1	18161408
post@@	O	-1	18161408
p@@	O	-1	18161408
on@@	O	-1	18161408
ed	O	-1	18161408
un@@	O	-1	18161408
ti@@	O	-1	18161408
l	O	-1	18161408
the	O	-1	18161408
second	O	-1	18161408
tri@@	O	-1	18161408
me@@	O	-1	18161408
ster@@	O	-1	18161408
.	O	-1	18161408
It	O	-1	18161408
showed	O	-1	18161408
normal	O	-1	18161408
coronary	O	-1	18161408
v@@	O	-1	18161408
es@@	O	-1	18161408
sel@@	O	-1	18161408
s.	O	-1	18161408
CONCLUSION:	O	-1	18161408
This	O	-1	18161408
appear@@	O	-1	18161408
s	O	-1	18161408
to	O	-1	18161408
be	O	-1	18161408
the	O	-1	18161408
first	O	-1	18161408
reported	O	-1	18161408
case	O	-1	18161408
doc@@	O	-1	18161408
um@@	O	-1	18161408
ent@@	O	-1	18161408
ing	O	-1	18161408
a	O	-1	18161408
possible	O	-1	18161408
association	O	-1	18161408
between	O	-1	18161408
C@@	B-Chemical	D002996	18161408
C	I-Chemical	-1	18161408
and	O	-1	18161408
myocardial	B-Disease	D009203	18161408
infarction	I-Disease	-1	18161408
.	O	-1	18161408
Th@@	B-Disease	D013927	18161408
rom@@	I-Disease	-1	18161408
bo@@	I-Disease	-1	18161408
sis	I-Disease	-1	18161408
might	O	-1	18161408
be	O	-1	18161408
a	O	-1	18161408
r@@	O	-1	18161408
are	O	-1	18161408
but	O	-1	18161408
ha@@	O	-1	18161408
z@@	O	-1	18161408
ar@@	O	-1	18161408
d@@	O	-1	18161408
ous	O	-1	18161408
complication	O	-1	18161408
of	O	-1	18161408
C@@	B-Chemical	D002996	18161408
C	I-Chemical	-1	18161408
.	O	-1	18161408
G@@	O	-1	18161408
i@@	O	-1	18161408
ven	O	-1	18161408
this	O	-1	18161408
lif@@	O	-1	18161408
e-@@	O	-1	18161408
th@@	O	-1	18161408
reat@@	O	-1	18161408
en@@	O	-1	18161408
ing	O	-1	18161408
complic@@	O	-1	18161408
ation,	O	-1	18161408
appro@@	O	-1	18161408
pri@@	O	-1	18161408
ate	O	-1	18161408
pro@@	O	-1	18161408
phyl@@	O	-1	18161408
ac@@	O	-1	18161408
tic	O	-1	18161408
meas@@	O	-1	18161408
ures	O	-1	18161408
should	O	-1	18161408
be	O	-1	18161408
used	O	-1	18161408
in	O	-1	18161408
high-@@	O	-1	18161408
risk	O	-1	18161408
woman	O	-1	18161408
under@@	O	-1	18161408
go@@	O	-1	18161408
ing	O	-1	18161408
o@@	O	-1	18161408
vari@@	O	-1	18161408
an	O	-1	18161408
stimul@@	O	-1	18161408
ation.	O	-1	18161408

H@@	B-Disease	-1	17574447
ep@@	I-Disease	-1	17574447
at@@	I-Disease	-1	17574447
on@@	I-Disease	-1	17574447
ec@@	I-Disease	-1	17574447
ro@@	I-Disease	-1	17574447
sis	I-Disease	-1	17574447
and	O	-1	17574447
chol@@	B-Disease	D002761	17574447
ang@@	I-Disease	-1	17574447
iti@@	I-Disease	-1	17574447
s	I-Disease	-1	17574447
related	O	-1	17574447
to	O	-1	17574447
long-term	O	-1	17574447
phenobarbit@@	B-Chemical	D010634	17574447
al	I-Chemical	-1	17574447
therap@@	O	-1	17574447
y@@	O	-1	17574447
:	O	-1	17574447
an	O	-1	17574447
auto@@	O	-1	17574447
p@@	O	-1	17574447
sy	O	-1	17574447
report	O	-1	17574447
of	O	-1	17574447
two	O	-1	17574447
patients.	O	-1	17574447
Ph@@	B-Chemical	D010634	17574447
en@@	I-Chemical	-1	17574447
obarbit@@	I-Chemical	-1	17574447
al	I-Chemical	-1	17574447
(	O	-1	17574447
P@@	B-Chemical	D010634	17574447
B	I-Chemical	-1	17574447
)	O	-1	17574447
has	O	-1	17574447
a	O	-1	17574447
re@@	O	-1	17574447
p@@	O	-1	17574447
ut@@	O	-1	17574447
ation	O	-1	17574447
for	O	-1	17574447
saf@@	O	-1	17574447
et@@	O	-1	17574447
y,	O	-1	17574447
and	O	-1	17574447
it	O	-1	17574447
is	O	-1	17574447
common@@	O	-1	17574447
ly	O	-1	17574447
be@@	O	-1	17574447
li@@	O	-1	17574447
ev@@	O	-1	17574447
ed	O	-1	17574447
that	O	-1	17574447
P@@	B-Chemical	D010634	17574447
B	I-Chemical	-1	17574447
-@@	O	-1	17574447
related	O	-1	17574447
increases	O	-1	17574447
in	O	-1	17574447
serum	O	-1	17574447
amin@@	O	-1	17574447
ot@@	O	-1	17574447
ran@@	O	-1	17574447
s@@	O	-1	17574447
fer@@	O	-1	17574447
ase	O	-1	17574447
levels	O	-1	17574447
d@@	O	-1	17574447
o	O	-1	17574447
not	O	-1	17574447
indicate	O	-1	17574447
or	O	-1	17574447
predic@@	O	-1	17574447
t	O	-1	17574447
the	O	-1	17574447
development	O	-1	17574447
of	O	-1	17574447
significant	O	-1	17574447
chronic	O	-1	17574447
liver	B-Disease	D008107	17574447
disease	I-Disease	-1	17574447
.	O	-1	17574447
H@@	O	-1	17574447
ere	O	-1	17574447
we	O	-1	17574447
report	O	-1	17574447
of	O	-1	17574447
two	O	-1	17574447
ad@@	O	-1	17574447
ult	O	-1	17574447
patients	O	-1	17574447
with	O	-1	17574447
a	O	-1	17574447
lon@@	O	-1	17574447
g	O	-1	17574447
hist@@	O	-1	17574447
ory	O	-1	17574447
of	O	-1	17574447
epilep@@	B-Disease	D004827	17574447
sy	I-Disease	-1	17574447
treated	O	-1	17574447
with	O	-1	17574447
P@@	B-Chemical	D010634	17574447
B	I-Chemical	-1	17574447
who	O	-1	17574447
di@@	O	-1	17574447
ed	O	-1	17574447
su@@	O	-1	17574447
d@@	O	-1	17574447
d@@	O	-1	17574447
en@@	O	-1	17574447
ly@@	O	-1	17574447
:	O	-1	17574447
one	O	-1	17574447
as	O	-1	17574447
con@@	O	-1	17574447
sequ@@	O	-1	17574447
ence	O	-1	17574447
of	O	-1	17574447
cardiac	B-Disease	D006323	17574447
ar@@	I-Disease	-1	17574447
res@@	I-Disease	-1	17574447
t	I-Disease	-1	17574447
,	O	-1	17574447
the	O	-1	17574447
other	O	-1	17574447
of	O	-1	17574447
acute	O	-1	17574447
b@@	B-Disease	D001996	17574447
ron@@	I-Disease	-1	17574447
ch@@	I-Disease	-1	17574447
op@@	I-Disease	-1	17574447
ne@@	I-Disease	-1	17574447
um@@	I-Disease	-1	17574447
on@@	I-Disease	-1	17574447
ia	I-Disease	-1	17574447
.	O	-1	17574447
A@@	O	-1	17574447
t	O	-1	17574447
auto@@	O	-1	17574447
psy@@	O	-1	17574447
,	O	-1	17574447
analysis	O	-1	17574447
of	O	-1	17574447
liver	O	-1	17574447
pa@@	O	-1	17574447
ren@@	O	-1	17574447
ch@@	O	-1	17574447
y@@	O	-1	17574447
ma	O	-1	17574447
revealed	O	-1	17574447
r@@	O	-1	17574447
ich	O	-1	17574447
port@@	O	-1	17574447
al	O	-1	17574447
inflam@@	O	-1	17574447
mat@@	O	-1	17574447
ory	O	-1	17574447
inf@@	O	-1	17574447
ilt@@	O	-1	17574447
rat@@	O	-1	17574447
e,	O	-1	17574447
which	O	-1	17574447
consist@@	O	-1	17574447
ed	O	-1	17574447
of	O	-1	17574447
mi@@	O	-1	17574447
x@@	O	-1	17574447
ed	O	-1	17574447
e@@	O	-1	17574447
os@@	O	-1	17574447
in@@	O	-1	17574447
oph@@	O	-1	17574447
il	O	-1	17574447
and	O	-1	17574447
mon@@	O	-1	17574447
ocyte	O	-1	17574447
cell@@	O	-1	17574447
s,	O	-1	17574447
associated	O	-1	17574447
with	O	-1	17574447
several	O	-1	17574447
foc@@	O	-1	17574447
i	O	-1	17574447
of	O	-1	17574447
necro@@	B-Disease	D009336	17574447
sis	I-Disease	-1	17574447
sur@@	O	-1	17574447
ro@@	O	-1	17574447
un@@	O	-1	17574447
ded	O	-1	17574447
by	O	-1	17574447
a	O	-1	17574447
h@@	O	-1	17574447
ard	O	-1	17574447
r@@	O	-1	17574447
ing	O	-1	17574447
of	O	-1	17574447
non-@@	O	-1	17574447
specific	O	-1	17574447
gran@@	O	-1	17574447
ulo@@	O	-1	17574447
mat@@	O	-1	17574447
ous	O	-1	17574447
tissu@@	O	-1	17574447
e.	O	-1	17574447
In@@	O	-1	17574447
f@@	O	-1	17574447
lam@@	O	-1	17574447
mat@@	O	-1	17574447
ory	O	-1	17574447
reactions	O	-1	17574447
of	O	-1	17574447
inter@@	O	-1	17574447
n@@	O	-1	17574447
al	O	-1	17574447
and	O	-1	17574447
ex@@	O	-1	17574447
tern@@	O	-1	17574447
al	O	-1	17574447
hepatic	O	-1	17574447
bil@@	O	-1	17574447
i@@	O	-1	17574447
ary	O	-1	17574447
duc@@	O	-1	17574447
ts	O	-1	17574447
were	O	-1	17574447
also	O	-1	17574447
se@@	O	-1	17574447
en@@	O	-1	17574447
.	O	-1	17574447
Our	O	-1	17574447
findings	O	-1	17574447
il@@	O	-1	17574447
lu@@	O	-1	17574447
st@@	O	-1	17574447
rate	O	-1	17574447
that	O	-1	17574447
P@@	B-Chemical	D010634	17574447
B	I-Chemical	-1	17574447
may	O	-1	17574447
be	O	-1	17574447
associated	O	-1	17574447
with	O	-1	17574447
chronic	O	-1	17574447
liver	B-Disease	D008107	17574447
damage	I-Disease	-1	17574447
,	O	-1	17574447
which	O	-1	17574447
may	O	-1	17574447
le@@	O	-1	17574447
ad	O	-1	17574447
to	O	-1	17574447
more	O	-1	17574447
seri@@	O	-1	17574447
ous	O	-1	17574447
and	O	-1	17574447
de@@	O	-1	17574447
le@@	O	-1	17574447
ter@@	O	-1	17574447
i@@	O	-1	17574447
ous	O	-1	17574447
con@@	O	-1	17574447
sequ@@	O	-1	17574447
enc@@	O	-1	17574447
es.	O	-1	17574447
F@@	O	-1	17574447
or	O	-1	17574447
this	O	-1	17574447
reas@@	O	-1	17574447
on@@	O	-1	17574447
,	O	-1	17574447
each	O	-1	17574447
clin@@	O	-1	17574447
ici@@	O	-1	17574447
an	O	-1	17574447
should	O	-1	17574447
reco@@	O	-1	17574447
gn@@	O	-1	17574447
iz@@	O	-1	17574447
e	O	-1	17574447
this	O	-1	17574447
enti@@	O	-1	17574447
t@@	O	-1	17574447
y	O	-1	17574447
in	O	-1	17574447
the	O	-1	17574447
differen@@	O	-1	17574447
tial	O	-1	17574447
diagnosis	O	-1	17574447
of	O	-1	17574447
P@@	B-Chemical	D010634	17574447
B	I-Chemical	-1	17574447
-@@	O	-1	17574447
related	O	-1	17574447
as@@	O	-1	17574447
ym@@	O	-1	17574447
pto@@	O	-1	17574447
m@@	O	-1	17574447
atic	O	-1	17574447
chronic	B-Disease	D056487	17574447
hepatic	I-Disease	-1	17574447
enzyme	I-Disease	-1	17574447
dysfunction	I-Disease	-1	17574447
.	O	-1	17574447

E@@	B-Chemical	D004977	16710500
th@@	I-Chemical	-1	16710500
am@@	I-Chemical	-1	16710500
bu@@	I-Chemical	-1	16710500
to@@	I-Chemical	-1	16710500
l	I-Chemical	-1	16710500
-@@	O	-1	16710500
associated	O	-1	16710500
op@@	B-Disease	D009901	16710500
tic	I-Disease	-1	16710500
neuropathy	I-Disease	-1	16710500
.	O	-1	16710500
IN@@	O	-1	16710500
T@@	O	-1	16710500
RO@@	O	-1	16710500
D@@	O	-1	16710500
U@@	O	-1	16710500
C@@	O	-1	16710500
T@@	O	-1	16710500
ION@@	O	-1	16710500
:	O	-1	16710500
E@@	B-Chemical	D004977	16710500
th@@	I-Chemical	-1	16710500
am@@	I-Chemical	-1	16710500
bu@@	I-Chemical	-1	16710500
to@@	I-Chemical	-1	16710500
l	I-Chemical	-1	16710500
is	O	-1	16710500
used	O	-1	16710500
in	O	-1	16710500
the	O	-1	16710500
treatment	O	-1	16710500
of	O	-1	16710500
tub@@	B-Disease	D014376	16710500
er@@	I-Disease	-1	16710500
c@@	I-Disease	-1	16710500
ulo@@	I-Disease	-1	16710500
sis	I-Disease	-1	16710500
,	O	-1	16710500
which	O	-1	16710500
is	O	-1	16710500
sti@@	O	-1	16710500
ll	O	-1	16710500
prev@@	O	-1	16710500
al@@	O	-1	16710500
ent	O	-1	16710500
in	O	-1	16710500
S@@	O	-1	16710500
ou@@	O	-1	16710500
the@@	O	-1	16710500
ast	O	-1	16710500
A@@	O	-1	16710500
si@@	O	-1	16710500
a,	O	-1	16710500
and	O	-1	16710500
can	O	-1	16710500
be	O	-1	16710500
associated	O	-1	16710500
with	O	-1	16710500
per@@	O	-1	16710500
man@@	O	-1	16710500
ent	O	-1	16710500
visual	B-Disease	D014786	16710500
loss	I-Disease	-1	16710500
.	O	-1	16710500
We	O	-1	16710500
report	O	-1	16710500
3	O	-1	16710500
cases	O	-1	16710500
which	O	-1	16710500
presented	O	-1	16710500
with	O	-1	16710500
b@@	B-Disease	D006423	16710500
it@@	I-Disease	-1	16710500
em@@	I-Disease	-1	16710500
por@@	I-Disease	-1	16710500
al	I-Disease	-1	16710500
he@@	I-Disease	-1	16710500
mi@@	I-Disease	-1	16710500
an@@	I-Disease	-1	16710500
o@@	I-Disease	-1	16710500
pi@@	I-Disease	-1	16710500
a	I-Disease	-1	16710500
.	O	-1	16710500
CL@@	O	-1	16710500
IN@@	O	-1	16710500
I@@	O	-1	16710500
CA@@	O	-1	16710500
L	O	-1	16710500
P@@	O	-1	16710500
IC@@	O	-1	16710500
T@@	O	-1	16710500
U@@	O	-1	16710500
R@@	O	-1	16710500
E:	O	-1	16710500
Th@@	O	-1	16710500
ree	O	-1	16710500
patients	O	-1	16710500
with	O	-1	16710500
eth@@	B-Chemical	D004977	16710500
am@@	I-Chemical	-1	16710500
bu@@	I-Chemical	-1	16710500
to@@	I-Chemical	-1	16710500
l	I-Chemical	-1	16710500
-@@	O	-1	16710500
associated	O	-1	16710500
toxic	O	-1	16710500
op@@	B-Disease	D009901	16710500
tic	I-Disease	-1	16710500
neuropathy	I-Disease	-1	16710500
are	O	-1	16710500
descri@@	O	-1	16710500
be@@	O	-1	16710500
d.	O	-1	16710500
All	O	-1	16710500
3	O	-1	16710500
patients	O	-1	16710500
had	O	-1	16710500
loss	B-Disease	D014786	16710500
of	I-Disease	-1	16710500
central	I-Disease	-1	16710500
visual	I-Disease	-1	16710500
ac@@	I-Disease	-1	16710500
u@@	I-Disease	-1	16710500
ity,	I-Disease	-1	16710500
co@@	I-Disease	-1	16710500
lo@@	I-Disease	-1	16710500
ur	I-Disease	-1	16710500
vi@@	I-Disease	-1	16710500
sion	I-Disease	-1	16710500
(@@	I-Disease	-1	16710500
I@@	I-Disease	-1	16710500
shi@@	I-Disease	-1	16710500
h@@	I-Disease	-1	16710500
ar@@	I-Disease	-1	16710500
a@@	I-Disease	-1	16710500
)	I-Disease	-1	16710500
and	I-Disease	-1	16710500
visual	I-Disease	-1	16710500
fi@@	I-Disease	-1	16710500
el@@	I-Disease	-1	16710500
d	I-Disease	-1	16710500
.	O	-1	16710500
The	O	-1	16710500
visual	B-Disease	D014786	16710500
fi@@	I-Disease	-1	16710500
el@@	I-Disease	-1	16710500
d	I-Disease	-1	16710500
loss	I-Disease	-1	16710500
had	O	-1	16710500
a	O	-1	16710500
b@@	O	-1	16710500
it@@	O	-1	16710500
em@@	O	-1	16710500
por@@	O	-1	16710500
al	O	-1	16710500
f@@	O	-1	16710500
l@@	O	-1	16710500
av@@	O	-1	16710500
o@@	O	-1	16710500
ur@@	O	-1	16710500
,	O	-1	16710500
suggesting	O	-1	16710500
invol@@	O	-1	16710500
vement	O	-1	16710500
of	O	-1	16710500
the	O	-1	16710500
op@@	O	-1	16710500
tic	O	-1	16710500
ch@@	O	-1	16710500
i@@	O	-1	16710500
as@@	O	-1	16710500
m.	O	-1	16710500
TR@@	O	-1	16710500
E@@	O	-1	16710500
AT@@	O	-1	16710500
M@@	O	-1	16710500
E@@	O	-1	16710500
N@@	O	-1	16710500
T@@	O	-1	16710500
:	O	-1	16710500
D@@	O	-1	16710500
es@@	O	-1	16710500
pit@@	O	-1	16710500
e	O	-1	16710500
sto@@	O	-1	16710500
pp@@	O	-1	16710500
ing	O	-1	16710500
eth@@	B-Chemical	D004977	16710500
am@@	I-Chemical	-1	16710500
bu@@	I-Chemical	-1	16710500
to@@	I-Chemical	-1	16710500
l	I-Chemical	-1	16710500
on	O	-1	16710500
diagno@@	O	-1	16710500
sis,	O	-1	16710500
visual	O	-1	16710500
function	O	-1	16710500
continu@@	O	-1	16710500
ed	O	-1	16710500
to	O	-1	16710500
deter@@	O	-1	16710500
i@@	O	-1	16710500
or@@	O	-1	16710500
ate	O	-1	16710500
for	O	-1	16710500
a	O	-1	16710500
fe@@	O	-1	16710500
w	O	-1	16710500
months.	O	-1	16710500
S@@	O	-1	16710500
ub@@	O	-1	16710500
sequ@@	O	-1	16710500
ent	O	-1	16710500
impro@@	O	-1	16710500
vement	O	-1	16710500
was	O	-1	16710500
mil@@	O	-1	16710500
d	O	-1	16710500
in	O	-1	16710500
2	O	-1	16710500
cas@@	O	-1	16710500
es.	O	-1	16710500
In	O	-1	16710500
the	O	-1	16710500
thir@@	O	-1	16710500
d	O	-1	16710500
cas@@	O	-1	16710500
e,	O	-1	16710500
visual	O	-1	16710500
ac@@	O	-1	16710500
u@@	O	-1	16710500
ity	O	-1	16710500
and	O	-1	16710500
co@@	O	-1	16710500
lo@@	O	-1	16710500
ur	O	-1	16710500
vi@@	O	-1	16710500
sion	O	-1	16710500
normal@@	O	-1	16710500
is@@	O	-1	16710500
ed	O	-1	16710500
but	O	-1	16710500
the	O	-1	16710500
op@@	O	-1	16710500
tic	O	-1	16710500
disc@@	O	-1	16710500
s	O	-1	16710500
were	O	-1	16710500
p@@	O	-1	16710500
al@@	O	-1	16710500
e.	O	-1	16710500
O@@	O	-1	16710500
U@@	O	-1	16710500
T@@	O	-1	16710500
CO@@	O	-1	16710500
M@@	O	-1	16710500
E:	O	-1	16710500
All	O	-1	16710500
3	O	-1	16710500
patients	O	-1	16710500
had	O	-1	16710500
some	O	-1	16710500
per@@	O	-1	16710500
man@@	O	-1	16710500
ent	O	-1	16710500
loss	B-Disease	D014786	16710500
of	I-Disease	-1	16710500
visual	I-Disease	-1	16710500
function	I-Disease	-1	16710500
.	O	-1	16710500
CONCLUSIONS:	O	-1	16710500
E@@	B-Chemical	D004977	16710500
th@@	I-Chemical	-1	16710500
am@@	I-Chemical	-1	16710500
bu@@	I-Chemical	-1	16710500
to@@	I-Chemical	-1	16710500
l	I-Chemical	-1	16710500
us@@	O	-1	16710500
age	O	-1	16710500
is	O	-1	16710500
associated	O	-1	16710500
with	O	-1	16710500
per@@	O	-1	16710500
man@@	O	-1	16710500
ent	O	-1	16710500
visual	B-Disease	D014786	16710500
loss	I-Disease	-1	16710500
and	O	-1	16710500
should	O	-1	16710500
be	O	-1	16710500
avoid@@	O	-1	16710500
ed	O	-1	16710500
if	O	-1	16710500
possible	O	-1	16710500
or	O	-1	16710500
used	O	-1	16710500
with	O	-1	16710500
cau@@	O	-1	16710500
tion	O	-1	16710500
and	O	-1	16710500
pro@@	O	-1	16710500
per	O	-1	16710500
oph@@	O	-1	16710500
thal@@	O	-1	16710500
mo@@	O	-1	16710500
log@@	O	-1	16710500
ical	O	-1	16710500
follow-@@	O	-1	16710500
up@@	O	-1	16710500
.	O	-1	16710500
The	O	-1	16710500
au@@	O	-1	16710500
th@@	O	-1	16710500
or	O	-1	16710500
post@@	O	-1	16710500
ul@@	O	-1	16710500
ates	O	-1	16710500
that	O	-1	16710500
in	O	-1	16710500
cases	O	-1	16710500
of	O	-1	16710500
eth@@	B-Chemical	D004977	16710500
am@@	I-Chemical	-1	16710500
bu@@	I-Chemical	-1	16710500
to@@	I-Chemical	-1	16710500
l	I-Chemical	-1	16710500
associated	O	-1	16710500
ch@@	O	-1	16710500
i@@	O	-1	16710500
as@@	O	-1	16710500
mo@@	O	-1	16710500
pathy,	O	-1	16710500
eth@@	B-Chemical	D004977	16710500
am@@	I-Chemical	-1	16710500
bu@@	I-Chemical	-1	16710500
to@@	I-Chemical	-1	16710500
l	I-Chemical	-1	16710500
may	O	-1	16710500
initi@@	O	-1	16710500
ally	O	-1	16710500
aff@@	O	-1	16710500
ect	O	-1	16710500
the	O	-1	16710500
op@@	O	-1	16710500
tic	O	-1	16710500
ner@@	O	-1	16710500
v@@	O	-1	16710500
es	O	-1	16710500
and	O	-1	16710500
subsequ@@	O	-1	16710500
ently	O	-1	16710500
progres@@	O	-1	16710500
s	O	-1	16710500
to	O	-1	16710500
invol@@	O	-1	16710500
ve	O	-1	16710500
the	O	-1	16710500
op@@	O	-1	16710500
tic	O	-1	16710500
ch@@	O	-1	16710500
i@@	O	-1	16710500
as@@	O	-1	16710500
m.	O	-1	16710500

T@@	O	-1	11694026
oler@@	O	-1	11694026
ability	O	-1	11694026
of	O	-1	11694026
n@@	B-Chemical	C012655	11694026
im@@	I-Chemical	-1	11694026
es@@	I-Chemical	-1	11694026
ul@@	I-Chemical	-1	11694026
ide	I-Chemical	-1	11694026
and	O	-1	11694026
par@@	B-Chemical	D000082	11694026
acet@@	I-Chemical	-1	11694026
am@@	I-Chemical	-1	11694026
ol	I-Chemical	-1	11694026
in	O	-1	11694026
patients	O	-1	11694026
with	O	-1	11694026
N@@	B-Chemical	D000894	11694026
S@@	I-Chemical	-1	11694026
A@@	I-Chemical	-1	11694026
I@@	I-Chemical	-1	11694026
D	I-Chemical	-1	11694026
-induced	O	-1	11694026
ur@@	B-Disease	D014581	11694026
ti@@	I-Disease	-1	11694026
car@@	I-Disease	-1	11694026
ia	I-Disease	-1	11694026
/	O	-1	11694026
angio@@	B-Disease	D000799	11694026
e@@	I-Disease	-1	11694026
de@@	I-Disease	-1	11694026
ma	I-Disease	-1	11694026
.	O	-1	11694026
Pre@@	O	-1	11694026
vi@@	O	-1	11694026
ous	O	-1	11694026
studies	O	-1	11694026
evaluated	O	-1	11694026
the	O	-1	11694026
toler@@	O	-1	11694026
ance	O	-1	11694026
of	O	-1	11694026
n@@	B-Chemical	C012655	11694026
im@@	I-Chemical	-1	11694026
es@@	I-Chemical	-1	11694026
ul@@	I-Chemical	-1	11694026
ide	I-Chemical	-1	11694026
and	O	-1	11694026
par@@	B-Chemical	D000082	11694026
acet@@	I-Chemical	-1	11694026
am@@	I-Chemical	-1	11694026
ol	I-Chemical	-1	11694026
in	O	-1	11694026
subjects	O	-1	11694026
with	O	-1	11694026
c@@	O	-1	11694026
ut@@	O	-1	11694026
ane@@	O	-1	11694026
ou@@	O	-1	11694026
s,	O	-1	11694026
respiratory	O	-1	11694026
and	O	-1	11694026
ana@@	O	-1	11694026
phyl@@	O	-1	11694026
ac@@	O	-1	11694026
to@@	O	-1	11694026
id	O	-1	11694026
reactions	O	-1	11694026
induced	O	-1	11694026
by	O	-1	11694026
non@@	B-Chemical	D000894	11694026
steroid@@	I-Chemical	-1	11694026
al	I-Chemical	-1	11694026
anti@@	I-Chemical	-1	11694026
-@@	I-Chemical	-1	11694026
inflam@@	I-Chemical	-1	11694026
mat@@	I-Chemical	-1	11694026
ory	I-Chemical	-1	11694026
drugs	I-Chemical	-1	11694026
(	O	-1	11694026
N@@	B-Chemical	D000894	11694026
S@@	I-Chemical	-1	11694026
A@@	I-Chemical	-1	11694026
I@@	I-Chemical	-1	11694026
D@@	I-Chemical	-1	11694026
s	I-Chemical	-1	11694026
).	O	-1	11694026
In	O	-1	11694026
this	O	-1	11694026
study	O	-1	11694026
we	O	-1	11694026
investigated	O	-1	11694026
toler@@	O	-1	11694026
ability	O	-1	11694026
and	O	-1	11694026
re@@	O	-1	11694026
li@@	O	-1	11694026
ability	O	-1	11694026
of	O	-1	11694026
n@@	B-Chemical	C012655	11694026
im@@	I-Chemical	-1	11694026
es@@	I-Chemical	-1	11694026
ul@@	I-Chemical	-1	11694026
ide	I-Chemical	-1	11694026
and	O	-1	11694026
par@@	B-Chemical	D000082	11694026
acet@@	I-Chemical	-1	11694026
am@@	I-Chemical	-1	11694026
ol	I-Chemical	-1	11694026
in	O	-1	11694026
a	O	-1	11694026
very	O	-1	11694026
larg@@	O	-1	11694026
e	O	-1	11694026
number	O	-1	11694026
of	O	-1	11694026
patients	O	-1	11694026
with	O	-1	11694026
an	O	-1	11694026
ex@@	O	-1	11694026
cl@@	O	-1	11694026
u@@	O	-1	11694026
sive	O	-1	11694026
we@@	O	-1	11694026
ll@@	O	-1	11694026
-@@	O	-1	11694026
doc@@	O	-1	11694026
um@@	O	-1	11694026
ent@@	O	-1	11694026
ed	O	-1	11694026
hist@@	O	-1	11694026
ory	O	-1	11694026
of	O	-1	11694026
N@@	B-Chemical	D000894	11694026
S@@	I-Chemical	-1	11694026
A@@	I-Chemical	-1	11694026
I@@	I-Chemical	-1	11694026
D	I-Chemical	-1	11694026
-induced	O	-1	11694026
ur@@	B-Disease	D014581	11694026
ti@@	I-Disease	-1	11694026
car@@	I-Disease	-1	11694026
ia	I-Disease	-1	11694026
/	O	-1	11694026
angio@@	B-Disease	D000799	11694026
e@@	I-Disease	-1	11694026
de@@	I-Disease	-1	11694026
ma	I-Disease	-1	11694026
.	O	-1	11694026
F@@	O	-1	11694026
ur@@	O	-1	11694026
ther@@	O	-1	11694026
mo@@	O	-1	11694026
re,	O	-1	11694026
we	O	-1	11694026
evaluated	O	-1	11694026
whether	O	-1	11694026
some	O	-1	11694026
factors	O	-1	11694026
have	O	-1	11694026
the	O	-1	11694026
potential	O	-1	11694026
to	O	-1	11694026
increase	O	-1	11694026
the	O	-1	11694026
risk	O	-1	11694026
of	O	-1	11694026
reaction	O	-1	11694026
to	O	-1	11694026
par@@	B-Chemical	D000082	11694026
acet@@	I-Chemical	-1	11694026
am@@	I-Chemical	-1	11694026
ol	I-Chemical	-1	11694026
and	O	-1	11694026
n@@	B-Chemical	C012655	11694026
im@@	I-Chemical	-1	11694026
es@@	I-Chemical	-1	11694026
ul@@	I-Chemical	-1	11694026
ide	I-Chemical	-1	11694026
.	O	-1	11694026
A	O	-1	11694026
sing@@	O	-1	11694026
le@@	O	-1	11694026
-@@	O	-1	11694026
placebo@@	O	-1	11694026
-@@	O	-1	11694026
controlled	O	-1	11694026
oral	O	-1	11694026
ch@@	O	-1	11694026
all@@	O	-1	11694026
enge	O	-1	11694026
proce@@	O	-1	11694026
d@@	O	-1	11694026
ure	O	-1	11694026
with	O	-1	11694026
n@@	B-Chemical	C012655	11694026
im@@	I-Chemical	-1	11694026
es@@	I-Chemical	-1	11694026
ul@@	I-Chemical	-1	11694026
ide	I-Chemical	-1	11694026
or	O	-1	11694026
par@@	B-Chemical	D000082	11694026
acet@@	I-Chemical	-1	11694026
am@@	I-Chemical	-1	11694026
ol	I-Chemical	-1	11694026
was	O	-1	11694026
ap@@	O	-1	11694026
pl@@	O	-1	11694026
ied	O	-1	11694026
to	O	-1	11694026
8@@	O	-1	11694026
2@@	O	-1	11694026
9	O	-1	11694026
patients	O	-1	11694026
with	O	-1	11694026
a	O	-1	11694026
hist@@	O	-1	11694026
ory	O	-1	11694026
of	O	-1	11694026
N@@	B-Chemical	D000894	11694026
S@@	I-Chemical	-1	11694026
A@@	I-Chemical	-1	11694026
I@@	I-Chemical	-1	11694026
D	I-Chemical	-1	11694026
-induced	O	-1	11694026
ur@@	B-Disease	D014581	11694026
ti@@	I-Disease	-1	11694026
car@@	I-Disease	-1	11694026
ia	I-Disease	-1	11694026
/	O	-1	11694026
angio@@	B-Disease	D000799	11694026
e@@	I-Disease	-1	11694026
de@@	I-Disease	-1	11694026
ma	I-Disease	-1	11694026
.	O	-1	11694026
A	O	-1	11694026
total	O	-1	11694026
of	O	-1	11694026
7@@	O	-1	11694026
5@@	O	-1	11694026
/@@	O	-1	11694026
8@@	O	-1	11694026
2@@	O	-1	11694026
9	O	-1	11694026
(@@	O	-1	11694026
9.@@	O	-1	11694026
4@@	O	-1	11694026
%)	O	-1	11694026
patients	O	-1	11694026
experienced	O	-1	11694026
reactions	O	-1	11694026
to	O	-1	11694026
n@@	B-Chemical	C012655	11694026
im@@	I-Chemical	-1	11694026
es@@	I-Chemical	-1	11694026
ul@@	I-Chemical	-1	11694026
ide	I-Chemical	-1	11694026
or	O	-1	11694026
par@@	B-Chemical	D000082	11694026
acet@@	I-Chemical	-1	11694026
am@@	I-Chemical	-1	11694026
ol	I-Chemical	-1	11694026
.	O	-1	11694026
Of	O	-1	11694026
the	O	-1	11694026
7@@	O	-1	11694026
15	O	-1	11694026
patients	O	-1	11694026
tested	O	-1	11694026
with	O	-1	11694026
n@@	B-Chemical	C012655	11694026
im@@	I-Chemical	-1	11694026
es@@	I-Chemical	-1	11694026
ul@@	I-Chemical	-1	11694026
ide	I-Chemical	-1	11694026
6@@	O	-1	11694026
2	O	-1	11694026
(@@	O	-1	11694026
8.@@	O	-1	11694026
6@@	O	-1	11694026
%)	O	-1	11694026
showed	O	-1	11694026
a	O	-1	11694026
positive	O	-1	11694026
test@@	O	-1	11694026
,	O	-1	11694026
while	O	-1	11694026
of	O	-1	11694026
1@@	O	-1	11694026
14	O	-1	11694026
subjects	O	-1	11694026
sub@@	O	-1	11694026
mit@@	O	-1	11694026
ted	O	-1	11694026
to	O	-1	11694026
the	O	-1	11694026
ch@@	O	-1	11694026
all@@	O	-1	11694026
enge	O	-1	11694026
with	O	-1	11694026
par@@	B-Chemical	D000082	11694026
acet@@	I-Chemical	-1	11694026
am@@	I-Chemical	-1	11694026
ol	I-Chemical	-1	11694026
,	O	-1	11694026
13	O	-1	11694026
(@@	O	-1	11694026
9.@@	O	-1	11694026
6@@	O	-1	11694026
%)	O	-1	11694026
did	O	-1	11694026
not	O	-1	11694026
toler@@	O	-1	11694026
ate	O	-1	11694026
this	O	-1	11694026
drug.	O	-1	11694026
F@@	O	-1	11694026
ur@@	O	-1	11694026
ther@@	O	-1	11694026
mo@@	O	-1	11694026
re,	O	-1	11694026
1@@	O	-1	11694026
8.@@	O	-1	11694026
2@@	O	-1	11694026
8@@	O	-1	11694026
%	O	-1	11694026
of	O	-1	11694026
patients	O	-1	11694026
with	O	-1	11694026
a	O	-1	11694026
hist@@	O	-1	11694026
ory	O	-1	11694026
of	O	-1	11694026
chronic	O	-1	11694026
ur@@	B-Disease	D014581	11694026
ti@@	I-Disease	-1	11694026
car@@	I-Disease	-1	11694026
ia	I-Disease	-1	11694026
and	O	-1	11694026
1@@	O	-1	11694026
1.@@	O	-1	11694026
8@@	O	-1	11694026
%	O	-1	11694026
of	O	-1	11694026
subjects	O	-1	11694026
with	O	-1	11694026
an	O	-1	11694026
hist@@	O	-1	11694026
ory	O	-1	11694026
of	O	-1	11694026
N@@	B-Chemical	D000894	11694026
S@@	I-Chemical	-1	11694026
A@@	I-Chemical	-1	11694026
I@@	I-Chemical	-1	11694026
D	I-Chemical	-1	11694026
-induced	O	-1	11694026
ur@@	B-Disease	D014581	11694026
ti@@	I-Disease	-1	11694026
car@@	I-Disease	-1	11694026
ia	I-Disease	-1	11694026
/	O	-1	11694026
angio@@	B-Disease	D000799	11694026
e@@	I-Disease	-1	11694026
de@@	I-Disease	-1	11694026
ma	I-Disease	-1	11694026
or	O	-1	11694026
angio@@	B-Disease	D000799	11694026
e@@	I-Disease	-1	11694026
de@@	I-Disease	-1	11694026
ma	I-Disease	-1	11694026
alone	O	-1	11694026
(@@	O	-1	11694026
with	O	-1	11694026
or	O	-1	11694026
without	O	-1	11694026
chronic	O	-1	11694026
ur@@	B-Disease	D014581	11694026
ti@@	I-Disease	-1	11694026
car@@	I-Disease	-1	11694026
ia	I-Disease	-1	11694026
)	O	-1	11694026
resulted	O	-1	11694026
to	O	-1	11694026
be	O	-1	11694026
int@@	O	-1	11694026
oler@@	O	-1	11694026
ant	O	-1	11694026
to	O	-1	11694026
al@@	O	-1	11694026
tern@@	O	-1	11694026
ative	O	-1	11694026
drug@@	O	-1	11694026
s.	O	-1	11694026
T@@	O	-1	11694026
ak@@	O	-1	11694026
en	O	-1	11694026
to@@	O	-1	11694026
ge@@	O	-1	11694026
ther@@	O	-1	11694026
,	O	-1	11694026
our	O	-1	11694026
results	O	-1	11694026
con@@	O	-1	11694026
fir@@	O	-1	11694026
m	O	-1	11694026
the	O	-1	11694026
go@@	O	-1	11694026
od	O	-1	11694026
toler@@	O	-1	11694026
ability	O	-1	11694026
of	O	-1	11694026
n@@	B-Chemical	C012655	11694026
im@@	I-Chemical	-1	11694026
es@@	I-Chemical	-1	11694026
ul@@	I-Chemical	-1	11694026
ide	I-Chemical	-1	11694026
and	O	-1	11694026
par@@	B-Chemical	D000082	11694026
acet@@	I-Chemical	-1	11694026
am@@	I-Chemical	-1	11694026
ol	I-Chemical	-1	11694026
in	O	-1	11694026
patients	O	-1	11694026
who	O	-1	11694026
experienced	O	-1	11694026
ur@@	B-Disease	D014581	11694026
ti@@	I-Disease	-1	11694026
car@@	I-Disease	-1	11694026
ia	I-Disease	-1	11694026
/	O	-1	11694026
angio@@	B-Disease	D000799	11694026
e@@	I-Disease	-1	11694026
de@@	I-Disease	-1	11694026
ma	I-Disease	-1	11694026
caused	O	-1	11694026
by	O	-1	11694026
N@@	B-Chemical	D000894	11694026
S@@	I-Chemical	-1	11694026
A@@	I-Chemical	-1	11694026
I@@	I-Chemical	-1	11694026
D@@	I-Chemical	-1	11694026
s	I-Chemical	-1	11694026
.	O	-1	11694026
However,	O	-1	11694026
the	O	-1	11694026
risk	O	-1	11694026
of	O	-1	11694026
reaction	O	-1	11694026
to	O	-1	11694026
these	O	-1	11694026
al@@	O	-1	11694026
tern@@	O	-1	11694026
ative	O	-1	11694026
study	O	-1	11694026
drugs	O	-1	11694026
is	O	-1	11694026
statis@@	O	-1	11694026
tically	O	-1	11694026
increased	O	-1	11694026
by	O	-1	11694026
a	O	-1	11694026
hist@@	O	-1	11694026
ory	O	-1	11694026
of	O	-1	11694026
chronic	O	-1	11694026
ur@@	B-Disease	D014581	11694026
ti@@	I-Disease	-1	11694026
car@@	I-Disease	-1	11694026
ia	I-Disease	-1	11694026
and@@	O	-1	11694026
,	O	-1	11694026
ab@@	O	-1	11694026
o@@	O	-1	11694026
ve	O	-1	11694026
all@@	O	-1	11694026
,	O	-1	11694026
by	O	-1	11694026
a	O	-1	11694026
hist@@	O	-1	11694026
ory	O	-1	11694026
of	O	-1	11694026
N@@	B-Chemical	D000894	11694026
S@@	I-Chemical	-1	11694026
A@@	I-Chemical	-1	11694026
I@@	I-Chemical	-1	11694026
D	I-Chemical	-1	11694026
-induced	O	-1	11694026
angio@@	B-Disease	D000799	11694026
e@@	I-Disease	-1	11694026
de@@	I-Disease	-1	11694026
ma	I-Disease	-1	11694026
.	O	-1	11694026

Eff@@	O	-1	11282081
ects	O	-1	11282081
of	O	-1	11282081
verap@@	B-Chemical	D014700	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
on	O	-1	11282081
atrial	B-Disease	D001281	11282081
fibrill@@	I-Disease	-1	11282081
ation	I-Disease	-1	11282081
and	O	-1	11282081
its	O	-1	11282081
electro@@	O	-1	11282081
physi@@	O	-1	11282081
ological	O	-1	11282081
determin@@	O	-1	11282081
ants	O	-1	11282081
in	O	-1	11282081
dog@@	O	-1	11282081
s.	O	-1	11282081
BACKGROUND:	O	-1	11282081
A@@	B-Disease	D013617	11282081
trial	I-Disease	-1	11282081
tachycardia	I-Disease	-1	11282081
-induced	O	-1	11282081
re@@	O	-1	11282081
model@@	O	-1	11282081
ing	O	-1	11282081
pro@@	O	-1	11282081
m@@	O	-1	11282081
ot@@	O	-1	11282081
es	O	-1	11282081
the	O	-1	11282081
occur@@	O	-1	11282081
rence	O	-1	11282081
and	O	-1	11282081
maint@@	O	-1	11282081
en@@	O	-1	11282081
ance	O	-1	11282081
of	O	-1	11282081
atrial	B-Disease	D001281	11282081
fibrill@@	I-Disease	-1	11282081
ation	I-Disease	-1	11282081
(	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
)	O	-1	11282081
and	O	-1	11282081
decreas@@	O	-1	11282081
es	O	-1	11282081
L-@@	O	-1	11282081
type	O	-1	11282081
C@@	B-Chemical	D002118	11282081
a	I-Chemical	-1	11282081
(2@@	O	-1	11282081
+@@	O	-1	11282081
)	O	-1	11282081
cur@@	O	-1	11282081
ren@@	O	-1	11282081
t.	O	-1	11282081
There	O	-1	11282081
is	O	-1	11282081
also	O	-1	11282081
a	O	-1	11282081
clinical	O	-1	11282081
sugg@@	O	-1	11282081
es@@	O	-1	11282081
tion	O	-1	11282081
that	O	-1	11282081
acute	O	-1	11282081
L-@@	O	-1	11282081
type	O	-1	11282081
C@@	B-Chemical	D002118	11282081
a	I-Chemical	-1	11282081
(2@@	O	-1	11282081
)	O	-1	11282081
channel	O	-1	11282081
block@@	O	-1	11282081
ade	O	-1	11282081
can	O	-1	11282081
pro@@	O	-1	11282081
m@@	O	-1	11282081
ot@@	O	-1	11282081
e	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
,	O	-1	11282081
consist@@	O	-1	11282081
ent	O	-1	11282081
with	O	-1	11282081
an	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
pro@@	O	-1	11282081
m@@	O	-1	11282081
ot@@	O	-1	11282081
ing	O	-1	11282081
effect	O	-1	11282081
of	O	-1	11282081
C@@	B-Chemical	D002118	11282081
a	I-Chemical	-1	11282081
(2@@	O	-1	11282081
+@@	O	-1	11282081
)	O	-1	11282081
channel	O	-1	11282081
inhib@@	O	-1	11282081
i@@	O	-1	11282081
tion.	O	-1	11282081
METHODS:	O	-1	11282081
To	O	-1	11282081
evalu@@	O	-1	11282081
ate	O	-1	11282081
the	O	-1	11282081
potential	O	-1	11282081
mechanisms	O	-1	11282081
of	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
pro@@	O	-1	11282081
mo@@	O	-1	11282081
tion	O	-1	11282081
by	O	-1	11282081
C@@	B-Chemical	D002118	11282081
a	I-Chemical	-1	11282081
(2@@	O	-1	11282081
+@@	O	-1	11282081
)	O	-1	11282081
channel	O	-1	11282081
block@@	O	-1	11282081
er@@	O	-1	11282081
s,	O	-1	11282081
we	O	-1	11282081
administered	O	-1	11282081
verap@@	B-Chemical	D014700	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
to	O	-1	11282081
morphine	B-Chemical	D009020	11282081
-	O	-1	11282081
chlor@@	B-Chemical	D002698	11282081
al@@	I-Chemical	-1	11282081
ose	I-Chemical	-1	11282081
anesthe@@	O	-1	11282081
tiz@@	O	-1	11282081
ed	O	-1	11282081
dog@@	O	-1	11282081
s.	O	-1	11282081
D@@	B-Chemical	D004110	11282081
il@@	I-Chemical	-1	11282081
ti@@	I-Chemical	-1	11282081
az@@	I-Chemical	-1	11282081
em	I-Chemical	-1	11282081
was	O	-1	11282081
used	O	-1	11282081
as	O	-1	11282081
a	O	-1	11282081
compar@@	O	-1	11282081
ison	O	-1	11282081
drug	O	-1	11282081
and	O	-1	11282081
a@@	O	-1	11282081
ut@@	O	-1	11282081
on@@	O	-1	11282081
om@@	O	-1	11282081
ic	O	-1	11282081
block@@	O	-1	11282081
ade	O	-1	11282081
with	O	-1	11282081
atro@@	B-Chemical	D001285	11282081
pine	I-Chemical	-1	11282081
and	O	-1	11282081
n@@	B-Chemical	D009248	11282081
ad@@	I-Chemical	-1	11282081
o@@	I-Chemical	-1	11282081
lol	I-Chemical	-1	11282081
was	O	-1	11282081
ap@@	O	-1	11282081
pl@@	O	-1	11282081
ied	O	-1	11282081
in	O	-1	11282081
some	O	-1	11282081
experim@@	O	-1	11282081
ent@@	O	-1	11282081
s.	O	-1	11282081
E@@	O	-1	11282081
p@@	O	-1	11282081
ic@@	O	-1	11282081
ardi@@	O	-1	11282081
al	O	-1	11282081
m@@	O	-1	11282081
app@@	O	-1	11282081
ing	O	-1	11282081
with	O	-1	11282081
2@@	O	-1	11282081
40	O	-1	11282081
ep@@	O	-1	11282081
ic@@	O	-1	11282081
ardi@@	O	-1	11282081
al	O	-1	11282081
electro@@	O	-1	11282081
des	O	-1	11282081
was	O	-1	11282081
used	O	-1	11282081
to	O	-1	11282081
evalu@@	O	-1	11282081
ate	O	-1	11282081
activation	O	-1	11282081
during	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
.	O	-1	11282081
RESULTS:	O	-1	11282081
V@@	B-Chemical	D014700	11282081
er@@	I-Chemical	-1	11282081
ap@@	I-Chemical	-1	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
caused	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
pro@@	O	-1	11282081
mo@@	O	-1	11282081
tion	O	-1	11282081
in	O	-1	11282081
six	O	-1	11282081
dog@@	O	-1	11282081
s,	O	-1	11282081
increas@@	O	-1	11282081
ing	O	-1	11282081
mean	O	-1	11282081
duration	O	-1	11282081
of	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
induced	O	-1	11282081
by	O	-1	11282081
b@@	O	-1	11282081
ur@@	O	-1	11282081
st	O	-1	11282081
pac@@	O	-1	11282081
ing,	O	-1	11282081
from	O	-1	11282081
8@@	O	-1	11282081
+/-@@	O	-1	11282081
4	O	-1	11282081
s	O	-1	11282081
(@@	O	-1	11282081
me@@	O	-1	11282081
an@@	O	-1	11282081
+/-@@	O	-1	11282081
S@@	O	-1	11282081
.@@	O	-1	11282081
E@@	O	-1	11282081
.)	O	-1	11282081
to	O	-1	11282081
9@@	O	-1	11282081
5@@	O	-1	11282081
+/-@@	O	-1	11282081
3@@	O	-1	11282081
9	O	-1	11282081
s	O	-1	11282081
(P@@	O	-1	11282081
<@@	O	-1	11282081
0.0@@	O	-1	11282081
1	O	-1	11282081
vs.	O	-1	11282081
control@@	O	-1	11282081
)	O	-1	11282081
at	O	-1	11282081
a	O	-1	11282081
lo@@	O	-1	11282081
ad@@	O	-1	11282081
ing	O	-1	11282081
dose	O	-1	11282081
of	O	-1	11282081
0.@@	O	-1	11282081
1	O	-1	11282081
mg/kg	O	-1	11282081
and	O	-1	11282081
2@@	O	-1	11282081
2@@	O	-1	11282081
8@@	O	-1	11282081
+/-@@	O	-1	11282081
10@@	O	-1	11282081
1	O	-1	11282081
s	O	-1	11282081
(P@@	O	-1	11282081
<@@	O	-1	11282081
0.00@@	O	-1	11282081
0@@	O	-1	11282081
5	O	-1	11282081
vs.	O	-1	11282081
control@@	O	-1	11282081
)	O	-1	11282081
at	O	-1	11282081
a	O	-1	11282081
dose	O	-1	11282081
of	O	-1	11282081
0.@@	O	-1	11282081
2	O	-1	11282081
mg/kg@@	O	-1	11282081
.	O	-1	11282081
U@@	O	-1	11282081
n@@	O	-1	11282081
der@@	O	-1	11282081
ly@@	O	-1	11282081
ing	O	-1	11282081
electro@@	O	-1	11282081
physi@@	O	-1	11282081
ological	O	-1	11282081
mechanisms	O	-1	11282081
were	O	-1	11282081
studied	O	-1	11282081
in	O	-1	11282081
det@@	O	-1	11282081
a@@	O	-1	11282081
il	O	-1	11282081
in	O	-1	11282081
five	O	-1	11282081
addi@@	O	-1	11282081
tional	O	-1	11282081
dog@@	O	-1	11282081
s	O	-1	11282081
under	O	-1	11282081
control	O	-1	11282081
condi@@	O	-1	11282081
tions	O	-1	11282081
and	O	-1	11282081
in	O	-1	11282081
the	O	-1	11282081
presence	O	-1	11282081
of	O	-1	11282081
the	O	-1	11282081
higher	O	-1	11282081
dose	O	-1	11282081
of	O	-1	11282081
verap@@	B-Chemical	D014700	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
.	O	-1	11282081
In	O	-1	11282081
these	O	-1	11282081
experim@@	O	-1	11282081
ent@@	O	-1	11282081
s,	O	-1	11282081
verap@@	B-Chemical	D014700	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
sh@@	O	-1	11282081
or@@	O	-1	11282081
ten@@	O	-1	11282081
ed	O	-1	11282081
mean	O	-1	11282081
effective	O	-1	11282081
ref@@	O	-1	11282081
rac@@	O	-1	11282081
t@@	O	-1	11282081
ory	O	-1	11282081
period	O	-1	11282081
(@@	O	-1	11282081
E@@	O	-1	11282081
R@@	O	-1	11282081
P)	O	-1	11282081
from	O	-1	11282081
12@@	O	-1	11282081
2@@	O	-1	11282081
+/-@@	O	-1	11282081
5	O	-1	11282081
to	O	-1	11282081
1@@	O	-1	11282081
14@@	O	-1	11282081
+/-@@	O	-1	11282081
4	O	-1	11282081
ms	O	-1	11282081
(P@@	O	-1	11282081
<@@	O	-1	11282081
0.0@@	O	-1	11282081
2)	O	-1	11282081
at	O	-1	11282081
a	O	-1	11282081
cyc@@	O	-1	11282081
le	O	-1	11282081
l@@	O	-1	11282081
en@@	O	-1	11282081
g@@	O	-1	11282081
th	O	-1	11282081
of	O	-1	11282081
3@@	O	-1	11282081
00	O	-1	11282081
m@@	O	-1	11282081
s,	O	-1	11282081
decreased	O	-1	11282081
E@@	O	-1	11282081
R@@	O	-1	11282081
P	O	-1	11282081
he@@	O	-1	11282081
ter@@	O	-1	11282081
o@@	O	-1	11282081
gene@@	O	-1	11282081
ity	O	-1	11282081
(@@	O	-1	11282081
from	O	-1	11282081
1@@	O	-1	11282081
5@@	O	-1	11282081
+/@@	O	-1	11282081
-1	O	-1	11282081
to	O	-1	11282081
10@@	O	-1	11282081
+/@@	O	-1	11282081
-1@@	O	-1	11282081
%,	O	-1	11282081
P@@	O	-1	11282081
<@@	O	-1	11282081
0.05@@	O	-1	11282081
),	O	-1	11282081
he@@	O	-1	11282081
ter@@	O	-1	11282081
o@@	O	-1	11282081
gene@@	O	-1	11282081
ously	O	-1	11282081
ac@@	O	-1	11282081
ce@@	O	-1	11282081
l@@	O	-1	11282081
er@@	O	-1	11282081
ated	O	-1	11282081
atrial	O	-1	11282081
con@@	O	-1	11282081
duction	O	-1	11282081
and	O	-1	11282081
decreased	O	-1	11282081
the	O	-1	11282081
cyc@@	O	-1	11282081
le	O	-1	11282081
l@@	O	-1	11282081
en@@	O	-1	11282081
g@@	O	-1	11282081
th	O	-1	11282081
of	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
(@@	O	-1	11282081
9@@	O	-1	11282081
4@@	O	-1	11282081
+/-@@	O	-1	11282081
4	O	-1	11282081
to	O	-1	11282081
8@@	O	-1	11282081
4@@	O	-1	11282081
+/-@@	O	-1	11282081
3	O	-1	11282081
m@@	O	-1	11282081
s,	O	-1	11282081
P@@	O	-1	11282081
<@@	O	-1	11282081
0.00@@	O	-1	11282081
5@@	O	-1	11282081
).	O	-1	11282081
D@@	B-Chemical	D004110	11282081
il@@	I-Chemical	-1	11282081
ti@@	I-Chemical	-1	11282081
az@@	I-Chemical	-1	11282081
em	I-Chemical	-1	11282081
did	O	-1	11282081
not	O	-1	11282081
aff@@	O	-1	11282081
ect	O	-1	11282081
E@@	O	-1	11282081
R@@	O	-1	11282081
P@@	O	-1	11282081
,	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
cyc@@	O	-1	11282081
le	O	-1	11282081
l@@	O	-1	11282081
en@@	O	-1	11282081
g@@	O	-1	11282081
th	O	-1	11282081
or	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
dur@@	O	-1	11282081
ation,	O	-1	11282081
but	O	-1	11282081
produced	O	-1	11282081
con@@	O	-1	11282081
duction	O	-1	11282081
ac@@	O	-1	11282081
ce@@	O	-1	11282081
l@@	O	-1	11282081
er@@	O	-1	11282081
ation	O	-1	11282081
similar	O	-1	11282081
to	O	-1	11282081
that	O	-1	11282081
caused	O	-1	11282081
by	O	-1	11282081
verap@@	B-Chemical	D014700	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
(n@@	O	-1	11282081
=@@	O	-1	11282081
5@@	O	-1	11282081
).	O	-1	11282081
In	O	-1	11282081
the	O	-1	11282081
presence	O	-1	11282081
of	O	-1	11282081
a@@	O	-1	11282081
ut@@	O	-1	11282081
on@@	O	-1	11282081
om@@	O	-1	11282081
ic	O	-1	11282081
block@@	O	-1	11282081
ade@@	O	-1	11282081
,	O	-1	11282081
verap@@	B-Chemical	D014700	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
fail@@	O	-1	11282081
ed	O	-1	11282081
to	O	-1	11282081
pro@@	O	-1	11282081
m@@	O	-1	11282081
ot@@	O	-1	11282081
e	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
and	O	-1	11282081
increas@@	O	-1	11282081
ed,	O	-1	11282081
ra@@	O	-1	11282081
ther	O	-1	11282081
than	O	-1	11282081
decreas@@	O	-1	11282081
ing,	O	-1	11282081
ref@@	O	-1	11282081
rac@@	O	-1	11282081
t@@	O	-1	11282081
or@@	O	-1	11282081
in@@	O	-1	11282081
es@@	O	-1	11282081
s.	O	-1	11282081
N@@	O	-1	11282081
either	O	-1	11282081
verap@@	B-Chemical	D014700	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
n@@	O	-1	11282081
or	O	-1	11282081
di@@	B-Chemical	D004110	11282081
l@@	I-Chemical	-1	11282081
ti@@	I-Chemical	-1	11282081
az@@	I-Chemical	-1	11282081
em	I-Chemical	-1	11282081
affected	O	-1	11282081
atrial	O	-1	11282081
con@@	O	-1	11282081
duction	O	-1	11282081
in	O	-1	11282081
the	O	-1	11282081
presence	O	-1	11282081
of	O	-1	11282081
a@@	O	-1	11282081
ut@@	O	-1	11282081
on@@	O	-1	11282081
om@@	O	-1	11282081
ic	O	-1	11282081
block@@	O	-1	11282081
ade@@	O	-1	11282081
.	O	-1	11282081
E@@	O	-1	11282081
p@@	O	-1	11282081
ic@@	O	-1	11282081
ardi@@	O	-1	11282081
al	O	-1	11282081
m@@	O	-1	11282081
app@@	O	-1	11282081
ing	O	-1	11282081
suggested	O	-1	11282081
that	O	-1	11282081
verap@@	B-Chemical	D014700	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
pro@@	O	-1	11282081
m@@	O	-1	11282081
ot@@	O	-1	11282081
ed	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
by	O	-1	11282081
increas@@	O	-1	11282081
ing	O	-1	11282081
the	O	-1	11282081
number	O	-1	11282081
of	O	-1	11282081
sim@@	O	-1	11282081
ult@@	O	-1	11282081
aneous	O	-1	11282081
w@@	O	-1	11282081
a@@	O	-1	11282081
ve@@	O	-1	11282081
fron@@	O	-1	11282081
ts	O	-1	11282081
ref@@	O	-1	11282081
l@@	O	-1	11282081
ected	O	-1	11282081
by	O	-1	11282081
se@@	O	-1	11282081
par@@	O	-1	11282081
ate	O	-1	11282081
z@@	O	-1	11282081
on@@	O	-1	11282081
es	O	-1	11282081
of	O	-1	11282081
re@@	O	-1	11282081
activation	O	-1	11282081
in	O	-1	11282081
each	O	-1	11282081
cyc@@	O	-1	11282081
le@@	O	-1	11282081
.	O	-1	11282081
CONCLUSIONS:	O	-1	11282081
V@@	B-Chemical	D014700	11282081
er@@	I-Chemical	-1	11282081
ap@@	I-Chemical	-1	11282081
ami@@	I-Chemical	-1	11282081
l	I-Chemical	-1	11282081
pro@@	O	-1	11282081
m@@	O	-1	11282081
ot@@	O	-1	11282081
es	O	-1	11282081
A@@	B-Disease	D001281	11282081
F	I-Disease	-1	11282081
in	O	-1	11282081
normal	O	-1	11282081
dog@@	O	-1	11282081
s	O	-1	11282081
by	O	-1	11282081
pro@@	O	-1	11282081
m@@	O	-1	11282081
ot@@	O	-1	11282081
ing	O	-1	11282081
multiple	O	-1	11282081
cir@@	O	-1	11282081
c@@	O	-1	11282081
u@@	O	-1	11282081
it	O	-1	11282081
re@@	O	-1	11282081
entr@@	O	-1	11282081
y,	O	-1	11282081
an	O	-1	11282081
effect	O	-1	11282081
dependent	O	-1	11282081
on	O	-1	11282081
int@@	O	-1	11282081
ac@@	O	-1	11282081
t	O	-1	11282081
a@@	O	-1	11282081
ut@@	O	-1	11282081
on@@	O	-1	11282081
om@@	O	-1	11282081
ic	O	-1	11282081
t@@	O	-1	11282081
one	O	-1	11282081
and	O	-1	11282081
not	O	-1	11282081
s@@	O	-1	11282081
ha@@	O	-1	11282081
red	O	-1	11282081
by	O	-1	11282081
di@@	B-Chemical	D004110	11282081
l@@	I-Chemical	-1	11282081
ti@@	I-Chemical	-1	11282081
az@@	I-Chemical	-1	11282081
em	I-Chemical	-1	11282081
.	O	-1	11282081

H@@	B-Disease	D007022	10074612
y@@	I-Disease	-1	10074612
poten@@	I-Disease	-1	10074612
sion	I-Disease	-1	10074612
,	O	-1	10074612
brady@@	B-Disease	D001919	10074612
cardia	I-Disease	-1	10074612
,	O	-1	10074612
and	O	-1	10074612
as@@	B-Disease	D006323	10074612
y@@	I-Disease	-1	10074612
st@@	I-Disease	-1	10074612
ole	I-Disease	-1	10074612
after	O	-1	10074612
high-dose	O	-1	10074612
intravenous	O	-1	10074612
methyl@@	B-Chemical	D008775	10074612
pre@@	I-Chemical	-1	10074612
d@@	I-Chemical	-1	10074612
n@@	I-Chemical	-1	10074612
isol@@	I-Chemical	-1	10074612
one	I-Chemical	-1	10074612
in	O	-1	10074612
a	O	-1	10074612
monit@@	O	-1	10074612
o@@	O	-1	10074612
red	O	-1	10074612
patient@@	O	-1	10074612
.	O	-1	10074612
We	O	-1	10074612
report	O	-1	10074612
a	O	-1	10074612
case	O	-1	10074612
of	O	-1	10074612
hypotension	B-Disease	D007022	10074612
,	O	-1	10074612
brady@@	B-Disease	D001919	10074612
cardia	I-Disease	-1	10074612
,	O	-1	10074612
and	O	-1	10074612
as@@	B-Disease	D006323	10074612
y@@	I-Disease	-1	10074612
st@@	I-Disease	-1	10074612
ole	I-Disease	-1	10074612
after	O	-1	10074612
intravenous	O	-1	10074612
administration	O	-1	10074612
of	O	-1	10074612
high-dose	O	-1	10074612
methyl@@	B-Chemical	D008775	10074612
pre@@	I-Chemical	-1	10074612
d@@	I-Chemical	-1	10074612
n@@	I-Chemical	-1	10074612
isol@@	I-Chemical	-1	10074612
one	I-Chemical	-1	10074612
in	O	-1	10074612
a	O	-1	10074612
7@@	O	-1	10074612
3-@@	O	-1	10074612
year-old	O	-1	10074612
patient	O	-1	10074612
who	O	-1	10074612
under@@	O	-1	10074612
w@@	O	-1	10074612
ent	O	-1	10074612
electro@@	O	-1	10074612
cardio@@	O	-1	10074612
graph@@	O	-1	10074612
ic	O	-1	10074612
(@@	O	-1	10074612
EC@@	O	-1	10074612
G@@	O	-1	10074612
)	O	-1	10074612
monit@@	O	-1	10074612
or@@	O	-1	10074612
ing	O	-1	10074612
throu@@	O	-1	10074612
gh@@	O	-1	10074612
out	O	-1	10074612
the	O	-1	10074612
episo@@	O	-1	10074612
de@@	O	-1	10074612
.	O	-1	10074612
There	O	-1	10074612
was	O	-1	10074612
a	O	-1	10074612
hist@@	O	-1	10074612
ory	O	-1	10074612
of	O	-1	10074612
ischem@@	B-Disease	D007511	10074612
ic	I-Disease	-1	10074612
cardiac	B-Disease	D006331	10074612
disease	I-Disease	-1	10074612
9	O	-1	10074612
years	O	-1	10074612
ear@@	O	-1	10074612
li@@	O	-1	10074612
er.	O	-1	10074612
The	O	-1	10074612
patient	O	-1	10074612
was	O	-1	10074612
ad@@	O	-1	10074612
mit@@	O	-1	10074612
ted	O	-1	10074612
with	O	-1	10074612
a	O	-1	10074612
pul@@	B-Disease	C538458	10074612
mon@@	I-Disease	-1	10074612
ar@@	I-Disease	-1	10074612
y-@@	I-Disease	-1	10074612
renal	I-Disease	-1	10074612
syndrome	I-Disease	-1	10074612
with	O	-1	10074612
hemo@@	B-Disease	D006469	10074612
pt@@	I-Disease	-1	10074612
y@@	I-Disease	-1	10074612
sis	I-Disease	-1	10074612
,	O	-1	10074612
ra@@	O	-1	10074612
pid@@	O	-1	10074612
ly	O	-1	10074612
progressive	O	-1	10074612
renal	B-Disease	D051437	10074612
failure	I-Disease	-1	10074612
,	O	-1	10074612
and	O	-1	10074612
hypo@@	B-Disease	D000860	10074612
x@@	I-Disease	-1	10074612
emia	I-Disease	-1	10074612
that	O	-1	10074612
requ@@	O	-1	10074612
ired	O	-1	10074612
mechan@@	O	-1	10074612
ical	O	-1	10074612
ven@@	O	-1	10074612
til@@	O	-1	10074612
ation	O	-1	10074612
in	O	-1	10074612
the	O	-1	10074612
int@@	O	-1	10074612
en@@	O	-1	10074612
sive	O	-1	10074612
car@@	O	-1	10074612
e	O	-1	10074612
un@@	O	-1	10074612
it@@	O	-1	10074612
.	O	-1	10074612
After	O	-1	10074612
receiving	O	-1	10074612
adv@@	O	-1	10074612
anced	O	-1	10074612
cardio@@	O	-1	10074612
pulmonary	O	-1	10074612
res@@	O	-1	10074612
us@@	O	-1	10074612
cit@@	O	-1	10074612
ation,	O	-1	10074612
the	O	-1	10074612
patient	O	-1	10074612
reco@@	O	-1	10074612
vered	O	-1	10074612
cardiac	O	-1	10074612
rhyth@@	O	-1	10074612
m.	O	-1	10074612
The	O	-1	10074612
EC@@	O	-1	10074612
G	O	-1	10074612
showed	O	-1	10074612
a	O	-1	10074612
j@@	O	-1	10074612
unc@@	O	-1	10074612
tional	O	-1	10074612
rhyth@@	O	-1	10074612
m	O	-1	10074612
without	O	-1	10074612
ventricular	B-Disease	D001145	10074612
arrhyth@@	I-Disease	-1	10074612
mia	I-Disease	-1	10074612
.	O	-1	10074612
This	O	-1	10074612
study	O	-1	10074612
revie@@	O	-1	10074612
w@@	O	-1	10074612
s	O	-1	10074612
the	O	-1	10074612
current	O	-1	10074612
pro@@	O	-1	10074612
pos@@	O	-1	10074612
ed	O	-1	10074612
mechanisms	O	-1	10074612
of	O	-1	10074612
su@@	B-Disease	D003645	10074612
d@@	I-Disease	-1	10074612
de@@	I-Disease	-1	10074612
n	I-Disease	-1	10074612
death	I-Disease	-1	10074612
after	O	-1	10074612
a	O	-1	10074612
high	O	-1	10074612
dose	O	-1	10074612
of	O	-1	10074612
intravenous	O	-1	10074612
methyl@@	B-Chemical	D008775	10074612
pre@@	I-Chemical	-1	10074612
d@@	I-Chemical	-1	10074612
n@@	I-Chemical	-1	10074612
isol@@	I-Chemical	-1	10074612
one	I-Chemical	-1	10074612
(	O	-1	10074612
I@@	B-Chemical	D008775	10074612
V@@	I-Chemical	-1	10074612
M@@	I-Chemical	-1	10074612
P	I-Chemical	-1	10074612
).	O	-1	10074612
These	O	-1	10074612
mechanisms	O	-1	10074612
are	O	-1	10074612
not	O	-1	10074612
well	O	-1	10074612
under@@	O	-1	10074612
sto@@	O	-1	10074612
od	O	-1	10074612
b@@	O	-1	10074612
ec@@	O	-1	10074612
a@@	O	-1	10074612
use@@	O	-1	10074612
,	O	-1	10074612
in	O	-1	10074612
most	O	-1	10074612
cas@@	O	-1	10074612
es,	O	-1	10074612
the	O	-1	10074612
patients	O	-1	10074612
were	O	-1	10074612
not	O	-1	10074612
monit@@	O	-1	10074612
o@@	O	-1	10074612
red	O	-1	10074612
at	O	-1	10074612
the	O	-1	10074612
mo@@	O	-1	10074612
ment	O	-1	10074612
of	O	-1	10074612
the	O	-1	10074612
event@@	O	-1	10074612
.	O	-1	10074612
R@@	O	-1	10074612
ap@@	O	-1	10074612
id	O	-1	10074612
infusion	O	-1	10074612
and	O	-1	10074612
underlying	O	-1	10074612
cardiac	B-Disease	D006331	10074612
disease	I-Disease	-1	10074612
were	O	-1	10074612
important	O	-1	10074612
risk	O	-1	10074612
factors	O	-1	10074612
in	O	-1	10074612
the	O	-1	10074612
case	O	-1	10074612
reported	O	-1	10074612
he@@	O	-1	10074612
re,	O	-1	10074612
and	O	-1	10074612
the	O	-1	10074612
au@@	O	-1	10074612
th@@	O	-1	10074612
ors	O	-1	10074612
dis@@	O	-1	10074612
coun@@	O	-1	10074612
t	O	-1	10074612
ventricular	B-Disease	D001145	10074612
arrhyth@@	I-Disease	-1	10074612
mia	I-Disease	-1	10074612
as	O	-1	10074612
the	O	-1	10074612
ma@@	O	-1	10074612
in	O	-1	10074612
mechanis@@	O	-1	10074612
m.	O	-1	10074612

L@@	O	-1	9209318
if@@	O	-1	9209318
e@@	O	-1	9209318
time	O	-1	9209318
treatment	O	-1	9209318
of	O	-1	9209318
mice	O	-1	9209318
with	O	-1	9209318
az@@	B-Chemical	D015215	9209318
id@@	I-Chemical	-1	9209318
o@@	I-Chemical	-1	9209318
th@@	I-Chemical	-1	9209318
ym@@	I-Chemical	-1	9209318
idine	I-Chemical	-1	9209318
(	O	-1	9209318
A@@	B-Chemical	D015215	9209318
Z@@	I-Chemical	-1	9209318
T	I-Chemical	-1	9209318
)	O	-1	9209318
produc@@	O	-1	9209318
es	O	-1	9209318
my@@	B-Disease	D009190	9209318
e@@	I-Disease	-1	9209318
lo@@	I-Disease	-1	9209318
dys@@	I-Disease	-1	9209318
pl@@	I-Disease	-1	9209318
a@@	I-Disease	-1	9209318
sia	I-Disease	-1	9209318
.	O	-1	9209318
A@@	B-Chemical	D015215	9209318
Z@@	I-Chemical	-1	9209318
T	I-Chemical	-1	9209318
has	O	-1	9209318
induced	O	-1	9209318
a	O	-1	9209318
mac@@	B-Disease	D000748	9209318
ro@@	I-Disease	-1	9209318
cy@@	I-Disease	-1	9209318
tic	I-Disease	-1	9209318
anemia	I-Disease	-1	9209318
in	O	-1	9209318
A@@	B-Disease	D000163	9209318
I@@	I-Disease	-1	9209318
D@@	I-Disease	-1	9209318
S	I-Disease	-1	9209318
patients	O	-1	9209318
on	O	-1	9209318
lon@@	O	-1	9209318
g	O	-1	9209318
term	O	-1	9209318
A@@	B-Chemical	D015215	9209318
Z@@	I-Chemical	-1	9209318
T	I-Chemical	-1	9209318
therapy.	O	-1	9209318
It	O	-1	9209318
is	O	-1	9209318
gener@@	O	-1	9209318
ally	O	-1	9209318
as@@	O	-1	9209318
sum@@	O	-1	9209318
ed	O	-1	9209318
that	O	-1	9209318
D@@	O	-1	9209318
NA	O	-1	9209318
el@@	O	-1	9209318
on@@	O	-1	9209318
g@@	O	-1	9209318
ation	O	-1	9209318
is	O	-1	9209318
sto@@	O	-1	9209318
pp@@	O	-1	9209318
ed	O	-1	9209318
by	O	-1	9209318
the	O	-1	9209318
in@@	O	-1	9209318
ser@@	O	-1	9209318
tion	O	-1	9209318
of	O	-1	9209318
A@@	B-Chemical	D015215	9209318
Z@@	I-Chemical	-1	9209318
T	I-Chemical	-1	9209318
into	O	-1	9209318
the	O	-1	9209318
ch@@	O	-1	9209318
ain	O	-1	9209318
in	O	-1	9209318
pl@@	O	-1	9209318
ac@@	O	-1	9209318
e	O	-1	9209318
of	O	-1	9209318
th@@	B-Chemical	D013936	9209318
ym@@	I-Chemical	-1	9209318
idine	I-Chemical	-1	9209318
th@@	O	-1	9209318
us	O	-1	9209318
prevent@@	O	-1	9209318
ing	O	-1	9209318
the	O	-1	9209318
phosph@@	B-Chemical	D010710	9209318
ate	I-Chemical	-1	9209318
hydrox@@	O	-1	9209318
yl	O	-1	9209318
lin@@	O	-1	9209318
k@@	O	-1	9209318
ages	O	-1	9209318
and	O	-1	9209318
the@@	O	-1	9209318
re@@	O	-1	9209318
fore	O	-1	9209318
sup@@	O	-1	9209318
pres@@	O	-1	9209318
ses	O	-1	9209318
hemo@@	O	-1	9209318
po@@	O	-1	9209318
i@@	O	-1	9209318
e@@	O	-1	9209318
tic	O	-1	9209318
pro@@	O	-1	9209318
gen@@	O	-1	9209318
it@@	O	-1	9209318
or	O	-1	9209318
cell	O	-1	9209318
pro@@	O	-1	9209318
li@@	O	-1	9209318
fer@@	O	-1	9209318
ation	O	-1	9209318
in	O	-1	9209318
an	O	-1	9209318
early	O	-1	9209318
st@@	O	-1	9209318
age	O	-1	9209318
of	O	-1	9209318
differen@@	O	-1	9209318
ti@@	O	-1	9209318
ation.	O	-1	9209318
C@@	O	-1	9209318
BA@@	O	-1	9209318
/@@	O	-1	9209318
C@@	O	-1	9209318
a	O	-1	9209318
male	O	-1	9209318
mice	O	-1	9209318
star@@	O	-1	9209318
ted	O	-1	9209318
on	O	-1	9209318
A@@	B-Chemical	D015215	9209318
Z@@	I-Chemical	-1	9209318
T	I-Chemical	-1	9209318
0.@@	O	-1	9209318
7@@	O	-1	9209318
5	O	-1	9209318
mg/m@@	O	-1	9209318
l	O	-1	9209318
H@@	O	-1	9209318
2@@	O	-1	9209318
O	O	-1	9209318
at	O	-1	9209318
8@@	O	-1	9209318
4	O	-1	9209318
days	O	-1	9209318
of	O	-1	9209318
age	O	-1	9209318
and	O	-1	9209318
k@@	O	-1	9209318
ep@@	O	-1	9209318
t	O	-1	9209318
on	O	-1	9209318
it	O	-1	9209318
for	O	-1	9209318
6@@	O	-1	9209318
8@@	O	-1	9209318
7	O	-1	9209318
days	O	-1	9209318
when	O	-1	9209318
dos@@	O	-1	9209318
age	O	-1	9209318
reduced	O	-1	9209318
to	O	-1	9209318
0.@@	O	-1	9209318
5	O	-1	9209318
mg/m@@	O	-1	9209318
l	O	-1	9209318
H@@	O	-1	9209318
2@@	O	-1	9209318
O	O	-1	9209318
for	O	-1	9209318
a	O	-1	9209318
group@@	O	-1	9209318
,	O	-1	9209318
an@@	O	-1	9209318
other	O	-1	9209318
group	O	-1	9209318
re@@	O	-1	9209318
mo@@	O	-1	9209318
ved	O	-1	9209318
from	O	-1	9209318
A@@	B-Chemical	D015215	9209318
Z@@	I-Chemical	-1	9209318
T	I-Chemical	-1	9209318
to	O	-1	9209318
se@@	O	-1	9209318
e	O	-1	9209318
reco@@	O	-1	9209318
ver@@	O	-1	9209318
y,	O	-1	9209318
and	O	-1	9209318
thir@@	O	-1	9209318
d	O	-1	9209318
group	O	-1	9209318
remained	O	-1	9209318
on	O	-1	9209318
0.@@	O	-1	9209318
7@@	O	-1	9209318
5	O	-1	9209318
mg@@	O	-1	9209318
.	O	-1	9209318
A@@	O	-1	9209318
t	O	-1	9209318
6@@	O	-1	9209318
8@@	O	-1	9209318
7	O	-1	9209318
days	O	-1	9209318
mice	O	-1	9209318
that	O	-1	9209318
had	O	-1	9209318
been	O	-1	9209318
on	O	-1	9209318
0.@@	O	-1	9209318
7@@	O	-1	9209318
5	O	-1	9209318
mg	O	-1	9209318
had	O	-1	9209318
average	O	-1	9209318
platele@@	O	-1	9209318
t	O	-1	9209318
coun@@	O	-1	9209318
ts	O	-1	9209318
of	O	-1	9209318
2.@@	O	-1	9209318
5	O	-1	9209318
x	O	-1	9209318
10@@	O	-1	9209318
(6@@	O	-1	9209318
).	O	-1	9209318
H@@	O	-1	9209318
ist@@	O	-1	9209318
ological	O	-1	9209318
examin@@	O	-1	9209318
ation	O	-1	9209318
on	O	-1	9209318
9	O	-1	9209318
of	O	-1	9209318
10	O	-1	9209318
mice	O	-1	9209318
with	O	-1	9209318
such	O	-1	9209318
throm@@	B-Disease	D013921	9209318
b@@	I-Disease	-1	9209318
ocyto@@	I-Disease	-1	9209318
pen@@	I-Disease	-1	9209318
ia	I-Disease	-1	9209318
showed	O	-1	9209318
changes	O	-1	9209318
com@@	O	-1	9209318
pati@@	O	-1	9209318
ble	O	-1	9209318
with	O	-1	9209318
my@@	B-Disease	D009190	9209318
e@@	I-Disease	-1	9209318
lo@@	I-Disease	-1	9209318
dys@@	I-Disease	-1	9209318
plas@@	I-Disease	-1	9209318
tic	I-Disease	-1	9209318
syndrome	I-Disease	-1	9209318
(	O	-1	9209318
MD@@	B-Disease	D009190	9209318
S	I-Disease	-1	9209318
).	O	-1	9209318
A	O	-1	9209318
vari@@	O	-1	9209318
ety	O	-1	9209318
of	O	-1	9209318
hist@@	O	-1	9209318
ological	O	-1	9209318
pat@@	O	-1	9209318
tern@@	O	-1	9209318
s	O	-1	9209318
was	O	-1	9209318
obser@@	O	-1	9209318
ved.	O	-1	9209318
There	O	-1	9209318
were	O	-1	9209318
two	O	-1	9209318
cases	O	-1	9209318
of	O	-1	9209318
hy@@	O	-1	9209318
p@@	O	-1	9209318
oc@@	O	-1	9209318
ell@@	O	-1	9209318
ular	O	-1	9209318
my@@	B-Disease	D009190	9209318
e@@	I-Disease	-1	9209318
lo@@	I-Disease	-1	9209318
dys@@	I-Disease	-1	9209318
pl@@	I-Disease	-1	9209318
a@@	I-Disease	-1	9209318
sia	I-Disease	-1	9209318
,	O	-1	9209318
two	O	-1	9209318
cases	O	-1	9209318
of	O	-1	9209318
hyper@@	O	-1	9209318
seg@@	O	-1	9209318
ment@@	O	-1	9209318
ed	O	-1	9209318
my@@	B-Disease	D009190	9209318
e@@	I-Disease	-1	9209318
lo@@	I-Disease	-1	9209318
dys@@	I-Disease	-1	9209318
plas@@	I-Disease	-1	9209318
tic	I-Disease	-1	9209318
gran@@	O	-1	9209318
ulo@@	O	-1	9209318
cyto@@	O	-1	9209318
sis,	O	-1	9209318
two	O	-1	9209318
cases	O	-1	9209318
of	O	-1	9209318
hyper@@	O	-1	9209318
cell@@	O	-1	9209318
ular	O	-1	9209318
m@@	O	-1	9209318
ar@@	O	-1	9209318
ro@@	O	-1	9209318
w	O	-1	9209318
with	O	-1	9209318
ab@@	O	-1	9209318
normal	O	-1	9209318
me@@	O	-1	9209318
g@@	O	-1	9209318
ak@@	O	-1	9209318
ar@@	O	-1	9209318
y@@	O	-1	9209318
ocy@@	O	-1	9209318
tes	O	-1	9209318
with	O	-1	9209318
b@@	O	-1	9209318
iz@@	O	-1	9209318
ar@@	O	-1	9209318
r@@	O	-1	9209318
e	O	-1	9209318
nucle@@	O	-1	9209318
i@@	O	-1	9209318
,	O	-1	9209318
one	O	-1	9209318
case	O	-1	9209318
of	O	-1	9209318
me@@	O	-1	9209318
g@@	O	-1	9209318
ak@@	O	-1	9209318
ar@@	O	-1	9209318
y@@	O	-1	9209318
ocy@@	O	-1	9209318
tic	O	-1	9209318
my@@	O	-1	9209318
e@@	O	-1	9209318
lo@@	O	-1	9209318
sis	O	-1	9209318
associated	O	-1	9209318
with	O	-1	9209318
a	O	-1	9209318
hyper@@	B-Disease	D001855	9209318
plas@@	I-Disease	-1	9209318
tic	I-Disease	-1	9209318
m@@	I-Disease	-1	9209318
ar@@	I-Disease	-1	9209318
ro@@	I-Disease	-1	9209318
w	I-Disease	-1	9209318
,	O	-1	9209318
dys@@	B-Disease	D009190	9209318
my@@	I-Disease	-1	9209318
e@@	I-Disease	-1	9209318
lo@@	I-Disease	-1	9209318
po@@	I-Disease	-1	9209318
i@@	I-Disease	-1	9209318
e@@	I-Disease	-1	9209318
sis	I-Disease	-1	9209318
and	O	-1	9209318
a	O	-1	9209318
hy@@	B-Disease	D001855	9209318
p@@	I-Disease	-1	9209318
oc@@	I-Disease	-1	9209318
ell@@	I-Disease	-1	9209318
ular	I-Disease	-1	9209318
m@@	I-Disease	-1	9209318
ar@@	I-Disease	-1	9209318
ro@@	I-Disease	-1	9209318
w	I-Disease	-1	9209318
and	O	-1	9209318
two	O	-1	9209318
cases	O	-1	9209318
of	O	-1	9209318
my@@	B-Disease	D009190	9209318
e@@	I-Disease	-1	9209318
lo@@	I-Disease	-1	9209318
dys@@	I-Disease	-1	9209318
pl@@	I-Disease	-1	9209318
a@@	I-Disease	-1	9209318
sia	I-Disease	-1	9209318
with	O	-1	9209318
dy@@	B-Disease	-1	9209318
ser@@	I-Disease	-1	9209318
y@@	I-Disease	-1	9209318
th@@	I-Disease	-1	9209318
ro@@	I-Disease	-1	9209318
po@@	I-Disease	-1	9209318
i@@	I-Disease	-1	9209318
e@@	I-Disease	-1	9209318
sis	I-Disease	-1	9209318
,	O	-1	9209318
hemo@@	B-Disease	D006486	9209318
si@@	I-Disease	-1	9209318
der@@	I-Disease	-1	9209318
o@@	I-Disease	-1	9209318
sis	I-Disease	-1	9209318
and	O	-1	9209318
a	O	-1	9209318
hy@@	B-Disease	D001855	9209318
p@@	I-Disease	-1	9209318
oc@@	I-Disease	-1	9209318
ell@@	I-Disease	-1	9209318
ular	I-Disease	-1	9209318
m@@	I-Disease	-1	9209318
ar@@	I-Disease	-1	9209318
ro@@	I-Disease	-1	9209318
w	I-Disease	-1	9209318
.	O	-1	9209318
A@@	O	-1	9209318
bo@@	O	-1	9209318
ve	O	-1	9209318
men@@	O	-1	9209318
tion@@	O	-1	9209318
ed	O	-1	9209318
A@@	B-Chemical	D015215	9209318
Z@@	I-Chemical	-1	9209318
T	I-Chemical	-1	9209318
inc@@	O	-1	9209318
or@@	O	-1	9209318
por@@	O	-1	9209318
ation	O	-1	9209318
may	O	-1	9209318
have	O	-1	9209318
induced	O	-1	9209318
an	O	-1	9209318
ine@@	O	-1	9209318
ff@@	O	-1	9209318
ective	O	-1	9209318
hemo@@	O	-1	9209318
po@@	O	-1	9209318
i@@	O	-1	9209318
e@@	O	-1	9209318
sis	O	-1	9209318
in	O	-1	9209318
the	O	-1	9209318
pri@@	O	-1	9209318
mi@@	O	-1	9209318
tive	O	-1	9209318
hemo@@	O	-1	9209318
po@@	O	-1	9209318
i@@	O	-1	9209318
e@@	O	-1	9209318
tic	O	-1	9209318
pro@@	O	-1	9209318
gen@@	O	-1	9209318
it@@	O	-1	9209318
or	O	-1	9209318
cell@@	O	-1	9209318
s,	O	-1	9209318
which	O	-1	9209318
is	O	-1	9209318
known	O	-1	9209318
to	O	-1	9209318
be	O	-1	9209318
seen	O	-1	9209318
common@@	O	-1	9209318
ly	O	-1	9209318
in	O	-1	9209318
the	O	-1	9209318
my@@	B-Disease	D009190	9209318
e@@	I-Disease	-1	9209318
lo@@	I-Disease	-1	9209318
dys@@	I-Disease	-1	9209318
plas@@	I-Disease	-1	9209318
tic	I-Disease	-1	9209318
syndrome	I-Disease	-1	9209318
.	O	-1	9209318

In@@	O	-1	8742498
flu@@	O	-1	8742498
ence	O	-1	8742498
of	O	-1	8742498
diet	O	-1	8742498
free	O	-1	8742498
of	O	-1	8742498
N@@	B-Chemical	D009243	8742498
A@@	I-Chemical	-1	8742498
D	I-Chemical	-1	8742498
-@@	O	-1	8742498
pre@@	O	-1	8742498
cur@@	O	-1	8742498
s@@	O	-1	8742498
ors	O	-1	8742498
on	O	-1	8742498
acet@@	B-Chemical	D000082	8742498
aminoph@@	I-Chemical	-1	8742498
en	I-Chemical	-1	8742498
hepat@@	B-Disease	D056486	8742498
otoxicity	I-Disease	-1	8742498
in	O	-1	8742498
mice.	O	-1	8742498
Rec@@	O	-1	8742498
ent@@	O	-1	8742498
ly,	O	-1	8742498
we	O	-1	8742498
demonstrated	O	-1	8742498
the	O	-1	8742498
hepat@@	O	-1	8742498
o@@	O	-1	8742498
protective	O	-1	8742498
effects	O	-1	8742498
of	O	-1	8742498
nicot@@	B-Chemical	D009536	8742498
inic	I-Chemical	-1	8742498
acid	I-Chemical	-1	8742498
amide	I-Chemical	-1	8742498
,	O	-1	8742498
a	O	-1	8742498
selective	O	-1	8742498
inhibitor	O	-1	8742498
of	O	-1	8742498
poly@@	B-Chemical	D011064	8742498
(A@@	I-Chemical	-1	8742498
D@@	I-Chemical	-1	8742498
P@@	I-Chemical	-1	8742498
-@@	I-Chemical	-1	8742498
ri@@	I-Chemical	-1	8742498
bo@@	I-Chemical	-1	8742498
se@@	I-Chemical	-1	8742498
)	I-Chemical	-1	8742498
poly@@	O	-1	8742498
mer@@	O	-1	8742498
ase	O	-1	8742498
(@@	O	-1	8742498
PA@@	O	-1	8742498
R@@	O	-1	8742498
P@@	O	-1	8742498
;	O	-1	8742498
E@@	O	-1	8742498
C	O	-1	8742498
2.@@	O	-1	8742498
4.@@	O	-1	8742498
2.@@	O	-1	8742498
3@@	O	-1	8742498
0@@	O	-1	8742498
)	O	-1	8742498
on	O	-1	8742498
mice	O	-1	8742498
suff@@	O	-1	8742498
ering	O	-1	8742498
from	O	-1	8742498
acet@@	B-Chemical	D000082	8742498
aminoph@@	I-Chemical	-1	8742498
en	I-Chemical	-1	8742498
(	O	-1	8742498
A@@	B-Chemical	D000082	8742498
A@@	I-Chemical	-1	8742498
P	I-Chemical	-1	8742498
)@@	O	-1	8742498
-	O	-1	8742498
hepatitis	B-Disease	D056486	8742498
,	O	-1	8742498
suggesting	O	-1	8742498
that	O	-1	8742498
the	O	-1	8742498
A@@	B-Chemical	D000082	8742498
A@@	I-Chemical	-1	8742498
P	I-Chemical	-1	8742498
-induced	O	-1	8742498
liver	B-Disease	D056486	8742498
injury	I-Disease	-1	8742498
invol@@	O	-1	8742498
v@@	O	-1	8742498
es	O	-1	8742498
a	O	-1	8742498
st@@	O	-1	8742498
ep	O	-1	8742498
which	O	-1	8742498
depend@@	O	-1	8742498
s	O	-1	8742498
on	O	-1	8742498
aden@@	O	-1	8742498
or@@	O	-1	8742498
i@@	O	-1	8742498
b@@	O	-1	8742498
os@@	O	-1	8742498
yl@@	O	-1	8742498
ation.	O	-1	8742498
The	O	-1	8742498
present	O	-1	8742498
study	O	-1	8742498
investig@@	O	-1	8742498
ates	O	-1	8742498
the	O	-1	8742498
effects	O	-1	8742498
of	O	-1	8742498
a	O	-1	8742498
diet	O	-1	8742498
free	O	-1	8742498
of	O	-1	8742498
pre@@	O	-1	8742498
cur@@	O	-1	8742498
s@@	O	-1	8742498
ors	O	-1	8742498
of	O	-1	8742498
N@@	B-Chemical	D009243	8742498
A@@	I-Chemical	-1	8742498
D	I-Chemical	-1	8742498
,	O	-1	8742498
the	O	-1	8742498
subst@@	O	-1	8742498
rate	O	-1	8742498
on	O	-1	8742498
which	O	-1	8742498
PA@@	O	-1	8742498
R@@	O	-1	8742498
P	O	-1	8742498
act@@	O	-1	8742498
s,	O	-1	8742498
in	O	-1	8742498
female	O	-1	8742498
N@@	O	-1	8742498
MR@@	O	-1	8742498
I	O	-1	8742498
mice	O	-1	8742498
with	O	-1	8742498
A@@	B-Chemical	D000082	8742498
A@@	I-Chemical	-1	8742498
P	I-Chemical	-1	8742498
hepatitis	B-Disease	D056486	8742498
and	O	-1	8742498
evalu@@	O	-1	8742498
ates	O	-1	8742498
the	O	-1	8742498
influence	O	-1	8742498
of	O	-1	8742498
sim@@	O	-1	8742498
ult@@	O	-1	8742498
aneous	O	-1	8742498
eth@@	B-Chemical	D000431	8742498
an@@	I-Chemical	-1	8742498
ol	I-Chemical	-1	8742498
consum@@	O	-1	8742498
ption	O	-1	8742498
in	O	-1	8742498
these	O	-1	8742498
anim@@	O	-1	8742498
al@@	O	-1	8742498
s.	O	-1	8742498
L@@	B-Disease	D056486	8742498
i@@	I-Disease	-1	8742498
ver	I-Disease	-1	8742498
injur@@	I-Disease	-1	8742498
i@@	I-Disease	-1	8742498
es	I-Disease	-1	8742498
were	O	-1	8742498
qu@@	O	-1	8742498
anti@@	O	-1	8742498
fied	O	-1	8742498
as	O	-1	8742498
serum	O	-1	8742498
ac@@	O	-1	8742498
ti@@	O	-1	8742498
vi@@	O	-1	8742498
ties	O	-1	8742498
of	O	-1	8742498
glutamate	B-Chemical	D018698	8742498
-	O	-1	8742498
ox@@	B-Chemical	D062907	8742498
alo@@	I-Chemical	-1	8742498
acet@@	I-Chemical	-1	8742498
ate	I-Chemical	-1	8742498
trans@@	O	-1	8742498
amin@@	O	-1	8742498
ase	O	-1	8742498
(@@	O	-1	8742498
G@@	O	-1	8742498
O@@	O	-1	8742498
T)	O	-1	8742498
and	O	-1	8742498
glutamate	B-Chemical	D018698	8742498
-	O	-1	8742498
py@@	B-Chemical	D019289	8742498
ru@@	I-Chemical	-1	8742498
v@@	I-Chemical	-1	8742498
ate	I-Chemical	-1	8742498
trans@@	O	-1	8742498
amin@@	O	-1	8742498
ase	O	-1	8742498
(@@	O	-1	8742498
G@@	O	-1	8742498
P@@	O	-1	8742498
T@@	O	-1	8742498
).	O	-1	8742498
W@@	O	-1	8742498
h@@	O	-1	8742498
ile	O	-1	8742498
A@@	B-Chemical	D000082	8742498
A@@	I-Chemical	-1	8742498
P	I-Chemical	-1	8742498
caused	O	-1	8742498
a	O	-1	8742498
1@@	O	-1	8742498
17@@	O	-1	8742498
-@@	O	-1	8742498
fol@@	O	-1	8742498
d	O	-1	8742498
elev@@	O	-1	8742498
ation	O	-1	8742498
of	O	-1	8742498
serum	O	-1	8742498
trans@@	O	-1	8742498
amin@@	O	-1	8742498
ase	O	-1	8742498
ac@@	O	-1	8742498
ti@@	O	-1	8742498
vi@@	O	-1	8742498
ties	O	-1	8742498
in	O	-1	8742498
mice	O	-1	8742498
k@@	O	-1	8742498
ep@@	O	-1	8742498
t	O	-1	8742498
on	O	-1	8742498
a	O	-1	8742498
standard	O	-1	8742498
labor@@	O	-1	8742498
atory	O	-1	8742498
di@@	O	-1	8742498
et@@	O	-1	8742498
,	O	-1	8742498
which	O	-1	8742498
was	O	-1	8742498
significantly	O	-1	8742498
ex@@	O	-1	8742498
ac@@	O	-1	8742498
er@@	O	-1	8742498
b@@	O	-1	8742498
ated	O	-1	8742498
by	O	-1	8742498
eth@@	B-Chemical	D000431	8742498
an@@	I-Chemical	-1	8742498
ol	I-Chemical	-1	8742498
and	O	-1	8742498
inhibited	O	-1	8742498
by	O	-1	8742498
nicot@@	B-Chemical	D009536	8742498
inic	I-Chemical	-1	8742498
acid	I-Chemical	-1	8742498
amide	I-Chemical	-1	8742498
(	O	-1	8742498
N@@	B-Chemical	D009536	8742498
A@@	I-Chemical	-1	8742498
A	I-Chemical	-1	8742498
),	O	-1	8742498
adverse	O	-1	8742498
effects	O	-1	8742498
were	O	-1	8742498
not@@	O	-1	8742498
ed	O	-1	8742498
in	O	-1	8742498
animals	O	-1	8742498
f@@	O	-1	8742498
ed	O	-1	8742498
a	O	-1	8742498
diet	O	-1	8742498
free	O	-1	8742498
of	O	-1	8742498
pre@@	O	-1	8742498
cur@@	O	-1	8742498
s@@	O	-1	8742498
ors	O	-1	8742498
of	O	-1	8742498
N@@	B-Chemical	D009243	8742498
A@@	I-Chemical	-1	8742498
D	I-Chemical	-1	8742498
.	O	-1	8742498
In	O	-1	8742498
these	O	-1	8742498
anim@@	O	-1	8742498
al@@	O	-1	8742498
s,	O	-1	8742498
only	O	-1	8742498
min@@	O	-1	8742498
or	O	-1	8742498
increases	O	-1	8742498
of	O	-1	8742498
serum	O	-1	8742498
trans@@	O	-1	8742498
amin@@	O	-1	8742498
ase	O	-1	8742498
ac@@	O	-1	8742498
ti@@	O	-1	8742498
vi@@	O	-1	8742498
ties	O	-1	8742498
were	O	-1	8742498
measured	O	-1	8742498
in	O	-1	8742498
the	O	-1	8742498
presence	O	-1	8742498
of	O	-1	8742498
A@@	B-Chemical	D000082	8742498
A@@	I-Chemical	-1	8742498
P	I-Chemical	-1	8742498
,	O	-1	8742498
and	O	-1	8742498
un@@	O	-1	8742498
like	O	-1	8742498
the	O	-1	8742498
ex@@	O	-1	8742498
ac@@	O	-1	8742498
er@@	O	-1	8742498
b@@	O	-1	8742498
ation	O	-1	8742498
caused	O	-1	8742498
by	O	-1	8742498
eth@@	B-Chemical	D000431	8742498
an@@	I-Chemical	-1	8742498
ol	I-Chemical	-1	8742498
in	O	-1	8742498
mice	O	-1	8742498
on	O	-1	8742498
a	O	-1	8742498
standard	O	-1	8742498
di@@	O	-1	8742498
et@@	O	-1	8742498
,	O	-1	8742498
the	O	-1	8742498
liver	B-Disease	D056486	8742498
damage	I-Disease	-1	8742498
was	O	-1	8742498
inhibited	O	-1	8742498
by	O	-1	8742498
50@@	O	-1	8742498
%	O	-1	8742498
by	O	-1	8742498
eth@@	B-Chemical	D000431	8742498
an@@	I-Chemical	-1	8742498
ol	I-Chemical	-1	8742498
.	O	-1	8742498
A	O	-1	8742498
further	O	-1	8742498
6@@	O	-1	8742498
4@@	O	-1	8742498
%	O	-1	8742498
reduction	O	-1	8742498
of	O	-1	8742498
hepatitis	B-Disease	D056486	8742498
was	O	-1	8742498
obser@@	O	-1	8742498
ve@@	O	-1	8742498
d,	O	-1	8742498
when	O	-1	8742498
N@@	B-Chemical	D009536	8742498
A@@	I-Chemical	-1	8742498
A	I-Chemical	-1	8742498
was	O	-1	8742498
given	O	-1	8742498
to	O	-1	8742498
eth@@	B-Chemical	D000431	8742498
an@@	I-Chemical	-1	8742498
ol	I-Chemical	-1	8742498
/	O	-1	8742498
A@@	B-Chemical	D000082	8742498
A@@	I-Chemical	-1	8742498
P	I-Chemical	-1	8742498
-@@	O	-1	8742498
mice.	O	-1	8742498
Our	O	-1	8742498
results	O	-1	8742498
prov@@	O	-1	8742498
ide	O	-1	8742498
evidence	O	-1	8742498
that	O	-1	8742498
the	O	-1	8742498
A@@	B-Chemical	D000082	8742498
A@@	I-Chemical	-1	8742498
P	I-Chemical	-1	8742498
-induced	O	-1	8742498
hepatitis	B-Disease	D056486	8742498
and	O	-1	8742498
its	O	-1	8742498
ex@@	O	-1	8742498
ac@@	O	-1	8742498
er@@	O	-1	8742498
b@@	O	-1	8742498
ation	O	-1	8742498
by	O	-1	8742498
eth@@	B-Chemical	D000431	8742498
an@@	I-Chemical	-1	8742498
ol	I-Chemical	-1	8742498
can	O	-1	8742498
either	O	-1	8742498
be	O	-1	8742498
reduced	O	-1	8742498
by	O	-1	8742498
en@@	O	-1	8742498
d-@@	O	-1	8742498
produc@@	O	-1	8742498
t	O	-1	8742498
inhibition	O	-1	8742498
of	O	-1	8742498
PA@@	O	-1	8742498
R@@	O	-1	8742498
P	O	-1	8742498
by	O	-1	8742498
N@@	B-Chemical	D009536	8742498
A@@	I-Chemical	-1	8742498
A	I-Chemical	-1	8742498
or	O	-1	8742498
by	O	-1	8742498
di@@	O	-1	8742498
et@@	O	-1	8742498
ary	O	-1	8742498
deple@@	O	-1	8742498
tion	O	-1	8742498
of	O	-1	8742498
the	O	-1	8742498
enz@@	O	-1	8742498
y@@	O	-1	8742498
me@@	O	-1	8742498
's	O	-1	8742498
subst@@	O	-1	8742498
rate	O	-1	8742498
N@@	B-Chemical	D009243	8742498
A@@	I-Chemical	-1	8742498
D	I-Chemical	-1	8742498
.	O	-1	8742498
We	O	-1	8742498
se@@	O	-1	8742498
e	O	-1	8742498
the	O	-1	8742498
ma@@	O	-1	8742498
in	O	-1	8742498
ap@@	O	-1	8742498
plic@@	O	-1	8742498
ation	O	-1	8742498
of	O	-1	8742498
N@@	B-Chemical	D009536	8742498
A@@	I-Chemical	-1	8742498
A	I-Chemical	-1	8742498
as	O	-1	8742498
for	O	-1	8742498
the	O	-1	8742498
combin@@	O	-1	8742498
ation@@	O	-1	8742498
al	O	-1	8742498
use	O	-1	8742498
in	O	-1	8742498
ph@@	O	-1	8742498
ar@@	O	-1	8742498
m@@	O	-1	8742498
ace@@	O	-1	8742498
u@@	O	-1	8742498
tical	O	-1	8742498
pre@@	O	-1	8742498
par@@	O	-1	8742498
ations	O	-1	8742498
of	O	-1	8742498
acet@@	B-Chemical	D000082	8742498
aminoph@@	I-Chemical	-1	8742498
en	I-Chemical	-1	8742498
in	O	-1	8742498
or@@	O	-1	8742498
der	O	-1	8742498
to	O	-1	8742498
av@@	O	-1	8742498
oid	O	-1	8742498
hepatic	B-Disease	D056486	8742498
damage	I-Disease	-1	8742498
in	O	-1	8742498
patients	O	-1	8742498
treated	O	-1	8742498
with	O	-1	8742498
this	O	-1	8742498
wi@@	O	-1	8742498
de@@	O	-1	8742498
ly	O	-1	8742498
used	O	-1	8742498
analge@@	O	-1	8742498
si@@	O	-1	8742498
c@@	O	-1	8742498
.	O	-1	8742498

An@@	O	-1	2435991
ti@@	O	-1	2435991
arrhyth@@	O	-1	2435991
mic	O	-1	2435991
plasma	O	-1	2435991
concentrations	O	-1	2435991
of	O	-1	2435991
ci@@	B-Chemical	C032151	2435991
b@@	I-Chemical	-1	2435991
enz@@	I-Chemical	-1	2435991
ol@@	I-Chemical	-1	2435991
ine	I-Chemical	-1	2435991
on	O	-1	2435991
can@@	O	-1	2435991
ine	O	-1	2435991
ventricular	B-Disease	D001145	2435991
arrhyth@@	I-Disease	-1	2435991
mi@@	I-Disease	-1	2435991
as	I-Disease	-1	2435991
.	O	-1	2435991
U@@	O	-1	2435991
s@@	O	-1	2435991
ing	O	-1	2435991
tw@@	O	-1	2435991
o@@	O	-1	2435991
-@@	O	-1	2435991
st@@	O	-1	2435991
age	O	-1	2435991
coronary	O	-1	2435991
li@@	O	-1	2435991
g@@	O	-1	2435991
ation@@	O	-1	2435991
-@@	O	-1	2435991
,	O	-1	2435991
di@@	B-Chemical	D004071	2435991
g@@	I-Chemical	-1	2435991
it@@	I-Chemical	-1	2435991
al@@	I-Chemical	-1	2435991
is	I-Chemical	-1	2435991
-@@	O	-1	2435991
,	O	-1	2435991
and	O	-1	2435991
adren@@	B-Chemical	D004837	2435991
aline	I-Chemical	-1	2435991
-induced	O	-1	2435991
can@@	O	-1	2435991
ine	O	-1	2435991
ventricular	B-Disease	D001145	2435991
arrhyth@@	I-Disease	-1	2435991
mi@@	I-Disease	-1	2435991
as	I-Disease	-1	2435991
,	O	-1	2435991
anti@@	O	-1	2435991
arrhyth@@	O	-1	2435991
mic	O	-1	2435991
effects	O	-1	2435991
of	O	-1	2435991
ci@@	B-Chemical	C032151	2435991
b@@	I-Chemical	-1	2435991
enz@@	I-Chemical	-1	2435991
ol@@	I-Chemical	-1	2435991
ine	I-Chemical	-1	2435991
were	O	-1	2435991
examined	O	-1	2435991
and	O	-1	2435991
the	O	-1	2435991
minim@@	O	-1	2435991
um	O	-1	2435991
effective	O	-1	2435991
plasma	O	-1	2435991
concentration	O	-1	2435991
for	O	-1	2435991
each	O	-1	2435991
arrhyth@@	B-Disease	D001145	2435991
mia	I-Disease	-1	2435991
model	O	-1	2435991
was	O	-1	2435991
deter@@	O	-1	2435991
m@@	O	-1	2435991
ine@@	O	-1	2435991
d.	O	-1	2435991
C@@	B-Chemical	C032151	2435991
i@@	I-Chemical	-1	2435991
b@@	I-Chemical	-1	2435991
enz@@	I-Chemical	-1	2435991
ol@@	I-Chemical	-1	2435991
ine	I-Chemical	-1	2435991
sup@@	O	-1	2435991
press@@	O	-1	2435991
ed	O	-1	2435991
all	O	-1	2435991
the	O	-1	2435991
arrhyth@@	B-Disease	D001145	2435991
mi@@	I-Disease	-1	2435991
as	I-Disease	-1	2435991
,	O	-1	2435991
and	O	-1	2435991
the	O	-1	2435991
minim@@	O	-1	2435991
um	O	-1	2435991
effective	O	-1	2435991
plasma	O	-1	2435991
concentrations	O	-1	2435991
for	O	-1	2435991
arrhyth@@	B-Disease	D001145	2435991
mi@@	I-Disease	-1	2435991
as	I-Disease	-1	2435991
induced	O	-1	2435991
by	O	-1	2435991
2@@	O	-1	2435991
4-@@	O	-1	2435991
h	O	-1	2435991
coronary	O	-1	2435991
li@@	O	-1	2435991
g@@	O	-1	2435991
ation,	O	-1	2435991
4@@	O	-1	2435991
8@@	O	-1	2435991
-@@	O	-1	2435991
h	O	-1	2435991
coronary	O	-1	2435991
li@@	O	-1	2435991
g@@	O	-1	2435991
ation,	O	-1	2435991
di@@	B-Chemical	D004071	2435991
g@@	I-Chemical	-1	2435991
it@@	I-Chemical	-1	2435991
al@@	I-Chemical	-1	2435991
is	I-Chemical	-1	2435991
,	O	-1	2435991
and	O	-1	2435991
adren@@	B-Chemical	D004837	2435991
aline	I-Chemical	-1	2435991
were	O	-1	2435991
1.@@	O	-1	2435991
9	O	-1	2435991
+/-	O	-1	2435991
0.@@	O	-1	2435991
9	O	-1	2435991
(@@	O	-1	2435991
by	O	-1	2435991
8	O	-1	2435991
mg/kg	O	-1	2435991
i.v@@	O	-1	2435991
.@@	O	-1	2435991
),	O	-1	2435991
1.@@	O	-1	2435991
6	O	-1	2435991
+/-	O	-1	2435991
0.@@	O	-1	2435991
5	O	-1	2435991
(@@	O	-1	2435991
by	O	-1	2435991
8	O	-1	2435991
mg/kg	O	-1	2435991
i.v@@	O	-1	2435991
.@@	O	-1	2435991
),	O	-1	2435991
0.@@	O	-1	2435991
6	O	-1	2435991
+/-	O	-1	2435991
0.@@	O	-1	2435991
2	O	-1	2435991
(@@	O	-1	2435991
by	O	-1	2435991
2	O	-1	2435991
mg/kg	O	-1	2435991
i.v@@	O	-1	2435991
.@@	O	-1	2435991
),	O	-1	2435991
and	O	-1	2435991
3.@@	O	-1	2435991
5	O	-1	2435991
+/-	O	-1	2435991
1.@@	O	-1	2435991
3	O	-1	2435991
(@@	O	-1	2435991
by	O	-1	2435991
5	O	-1	2435991
mg/kg	O	-1	2435991
i.v@@	O	-1	2435991
.)	O	-1	2435991
microgram@@	O	-1	2435991
s/@@	O	-1	2435991
ml@@	O	-1	2435991
,	O	-1	2435991
respecti@@	O	-1	2435991
vely	O	-1	2435991
(@@	O	-1	2435991
mean	O	-1	2435991
+/-	O	-1	2435991
S@@	O	-1	2435991
D@@	O	-1	2435991
M@@	O	-1	2435991
,	O	-1	2435991
n	O	-1	2435991
=	O	-1	2435991
6-@@	O	-1	2435991
7@@	O	-1	2435991
).	O	-1	2435991
The	O	-1	2435991
concentration	O	-1	2435991
for	O	-1	2435991
adren@@	B-Chemical	D004837	2435991
aline	I-Chemical	-1	2435991
-induced	O	-1	2435991
arrhyth@@	B-Disease	D001145	2435991
mia	I-Disease	-1	2435991
was	O	-1	2435991
significantly	O	-1	2435991
higher	O	-1	2435991
than	O	-1	2435991
those	O	-1	2435991
for	O	-1	2435991
the	O	-1	2435991
other	O	-1	2435991
typ@@	O	-1	2435991
es	O	-1	2435991
of	O	-1	2435991
arrhyth@@	B-Disease	D001145	2435991
mi@@	I-Disease	-1	2435991
as	I-Disease	-1	2435991
.	O	-1	2435991
This	O	-1	2435991
pharmac@@	O	-1	2435991
ological	O	-1	2435991
prof@@	O	-1	2435991
ile	O	-1	2435991
is	O	-1	2435991
similar	O	-1	2435991
to	O	-1	2435991
those	O	-1	2435991
of	O	-1	2435991
me@@	B-Chemical	D008801	2435991
xi@@	I-Chemical	-1	2435991
le@@	I-Chemical	-1	2435991
t@@	I-Chemical	-1	2435991
ine	I-Chemical	-1	2435991
and	O	-1	2435991
t@@	B-Chemical	D016677	2435991
oc@@	I-Chemical	-1	2435991
ain@@	I-Chemical	-1	2435991
ide	I-Chemical	-1	2435991
,	O	-1	2435991
and	O	-1	2435991
all	O	-1	2435991
three	O	-1	2435991
drugs	O	-1	2435991
have	O	-1	2435991
central	O	-1	2435991
ner@@	O	-1	2435991
v@@	O	-1	2435991
ous	O	-1	2435991
system	O	-1	2435991
(C@@	O	-1	2435991
N@@	O	-1	2435991
S)	O	-1	2435991
stimul@@	O	-1	2435991
ant	O	-1	2435991
ac@@	O	-1	2435991
tion.	O	-1	2435991
B@@	O	-1	2435991
ecause	O	-1	2435991
ci@@	B-Chemical	C032151	2435991
b@@	I-Chemical	-1	2435991
enz@@	I-Chemical	-1	2435991
ol@@	I-Chemical	-1	2435991
ine	I-Chemical	-1	2435991
had	O	-1	2435991
only	O	-1	2435991
we@@	O	-1	2435991
a@@	O	-1	2435991
k	O	-1	2435991
hypoten@@	B-Disease	D007022	2435991
sive	I-Disease	-1	2435991
and	O	-1	2435991
s@@	O	-1	2435991
in@@	O	-1	2435991
us	O	-1	2435991
no@@	O	-1	2435991
de	O	-1	2435991
de@@	B-Disease	D003866	2435991
pressive	I-Disease	-1	2435991
effects	O	-1	2435991
and	O	-1	2435991
was	O	-1	2435991
found	O	-1	2435991
to	O	-1	2435991
be	O	-1	2435991
or@@	O	-1	2435991
ally	O	-1	2435991
active	O	-1	2435991
when	O	-1	2435991
given	O	-1	2435991
to	O	-1	2435991
coronary	O	-1	2435991
li@@	O	-1	2435991
g@@	O	-1	2435991
ation	O	-1	2435991
arrhyth@@	B-Disease	D001145	2435991
mia	I-Disease	-1	2435991
dog@@	O	-1	2435991
s,	O	-1	2435991
its	O	-1	2435991
clinical	O	-1	2435991
use@@	O	-1	2435991
ful@@	O	-1	2435991
ness	O	-1	2435991
is	O	-1	2435991
ex@@	O	-1	2435991
p@@	O	-1	2435991
ect@@	O	-1	2435991
ed.	O	-1	2435991

Im@@	O	-1	950631
mun@@	O	-1	950631
o@@	O	-1	950631
path@@	O	-1	950631
ology	O	-1	950631
of	O	-1	950631
pen@@	B-Chemical	D010396	950631
icill@@	I-Chemical	-1	950631
amine	I-Chemical	-1	950631
-induced	O	-1	950631
glomerular	B-Disease	D007674	950631
disease	I-Disease	-1	950631
.	O	-1	950631
F@@	O	-1	950631
our	O	-1	950631
patients	O	-1	950631
with	O	-1	950631
r@@	B-Disease	D001172	950631
he@@	I-Disease	-1	950631
um@@	I-Disease	-1	950631
at@@	I-Disease	-1	950631
oid	I-Disease	-1	950631
arth@@	I-Disease	-1	950631
ritis	I-Disease	-1	950631
developed	O	-1	950631
he@@	O	-1	950631
av@@	O	-1	950631
y	O	-1	950631
proteinuria	B-Disease	D011507	950631
after	O	-1	950631
five	O	-1	950631
to	O	-1	950631
12	O	-1	950631
months	O	-1	950631
of	O	-1	950631
treatment	O	-1	950631
with	O	-1	950631
D-@@	B-Chemical	D010396	950631
pen@@	I-Chemical	-1	950631
icill@@	I-Chemical	-1	950631
amine	I-Chemical	-1	950631
.	O	-1	950631
L@@	O	-1	950631
ight	O	-1	950631
micro@@	O	-1	950631
sco@@	O	-1	950631
p@@	O	-1	950631
y	O	-1	950631
of	O	-1	950631
renal	O	-1	950631
biop@@	O	-1	950631
sy	O	-1	950631
sam@@	O	-1	950631
ple@@	O	-1	950631
s	O	-1	950631
showed	O	-1	950631
minim@@	O	-1	950631
al	O	-1	950631
glomerular	O	-1	950631
cap@@	O	-1	950631
ill@@	O	-1	950631
ary	O	-1	950631
w@@	O	-1	950631
all	O	-1	950631
th@@	O	-1	950631
ic@@	O	-1	950631
k@@	O	-1	950631
en@@	O	-1	950631
ing	O	-1	950631
and	O	-1	950631
m@@	O	-1	950631
es@@	O	-1	950631
ang@@	O	-1	950631
ial	O	-1	950631
mat@@	O	-1	950631
ri@@	O	-1	950631
x	O	-1	950631
increas@@	O	-1	950631
e,	O	-1	950631
or	O	-1	950631
no	O	-1	950631
de@@	O	-1	950631
part@@	O	-1	950631
ure	O	-1	950631
from	O	-1	950631
normal@@	O	-1	950631
.	O	-1	950631
E@@	O	-1	950631
l@@	O	-1	950631
ect@@	O	-1	950631
ro@@	O	-1	950631
n	O	-1	950631
micro@@	O	-1	950631
sco@@	O	-1	950631
p@@	O	-1	950631
y,	O	-1	950631
however,	O	-1	950631
revealed	O	-1	950631
su@@	O	-1	950631
be@@	O	-1	950631
pi@@	O	-1	950631
thelial	O	-1	950631
elect@@	O	-1	950631
ron@@	O	-1	950631
-@@	O	-1	950631
d@@	O	-1	950631
en@@	O	-1	950631
se	O	-1	950631
de@@	O	-1	950631
pos@@	O	-1	950631
it@@	O	-1	950631
s,	O	-1	950631
f@@	O	-1	950631
usion	O	-1	950631
of	O	-1	950631
epi@@	O	-1	950631
thelial	O	-1	950631
cell	O	-1	950631
fo@@	O	-1	950631
o@@	O	-1	950631
t	O	-1	950631
pro@@	O	-1	950631
cess@@	O	-1	950631
es,	O	-1	950631
and	O	-1	950631
evidence	O	-1	950631
of	O	-1	950631
m@@	O	-1	950631
es@@	O	-1	950631
ang@@	O	-1	950631
ial	O	-1	950631
cell	O	-1	950631
hyper@@	O	-1	950631
activ@@	O	-1	950631
ity.	O	-1	950631
Im@@	O	-1	950631
mun@@	O	-1	950631
o@@	O	-1	950631
fluo@@	O	-1	950631
res@@	O	-1	950631
c@@	O	-1	950631
ence	O	-1	950631
micro@@	O	-1	950631
sco@@	O	-1	950631
p@@	O	-1	950631
y	O	-1	950631
demonstrated	O	-1	950631
gran@@	O	-1	950631
ular	O	-1	950631
cap@@	O	-1	950631
ill@@	O	-1	950631
ary	O	-1	950631
w@@	O	-1	950631
all	O	-1	950631
de@@	O	-1	950631
pos@@	O	-1	950631
its	O	-1	950631
of	O	-1	950631
I@@	O	-1	950631
g@@	O	-1	950631
G	O	-1	950631
and	O	-1	950631
C@@	O	-1	950631
3@@	O	-1	950631
.	O	-1	950631
The	O	-1	950631
findings	O	-1	950631
were	O	-1	950631
similar	O	-1	950631
to	O	-1	950631
those	O	-1	950631
in	O	-1	950631
early	O	-1	950631
membran@@	B-Disease	D015433	950631
ous	I-Disease	-1	950631
glomerul@@	I-Disease	-1	950631
one@@	I-Disease	-1	950631
ph@@	I-Disease	-1	950631
ritis	I-Disease	-1	950631
,	O	-1	950631
differences	O	-1	950631
being	O	-1	950631
observed	O	-1	950631
ho@@	O	-1	950631
we@@	O	-1	950631
ver	O	-1	950631
in	O	-1	950631
the	O	-1	950631
results	O	-1	950631
of	O	-1	950631
st@@	O	-1	950631
aining	O	-1	950631
for	O	-1	950631
the	O	-1	950631
ear@@	O	-1	950631
l@@	O	-1	950631
y-@@	O	-1	950631
act@@	O	-1	950631
ing	O	-1	950631
comple@@	O	-1	950631
ment	O	-1	950631
comp@@	O	-1	950631
on@@	O	-1	950631
ents	O	-1	950631
C@@	O	-1	950631
1@@	O	-1	950631
q	O	-1	950631
and	O	-1	950631
C@@	O	-1	950631
4@@	O	-1	950631
.	O	-1	950631
It	O	-1	950631
is	O	-1	950631
t@@	O	-1	950631
ent@@	O	-1	950631
atively	O	-1	950631
concl@@	O	-1	950631
uded	O	-1	950631
that	O	-1	950631
comple@@	O	-1	950631
ment	O	-1	950631
was	O	-1	950631
activ@@	O	-1	950631
ated	O	-1	950631
by	O	-1	950631
the	O	-1	950631
cl@@	O	-1	950631
assi@@	O	-1	950631
c@@	O	-1	950631
al	O	-1	950631
path@@	O	-1	950631
w@@	O	-1	950631
a@@	O	-1	950631
y.	O	-1	950631

V@@	B-Disease	D014693	663266
entr@@	I-Disease	-1	663266
ic@@	I-Disease	-1	663266
ular	I-Disease	-1	663266
fibrill@@	I-Disease	-1	663266
ation	I-Disease	-1	663266
from	O	-1	663266
di@@	B-Chemical	D003973	663266
atri@@	I-Chemical	-1	663266
z@@	I-Chemical	-1	663266
o@@	I-Chemical	-1	663266
ate	I-Chemical	-1	663266
with	O	-1	663266
and	O	-1	663266
without	O	-1	663266
ch@@	O	-1	663266
el@@	O	-1	663266
ating	O	-1	663266
agent@@	O	-1	663266
s.	O	-1	663266
The	O	-1	663266
toxicity	B-Disease	D064420	663266
of	O	-1	663266
R@@	B-Chemical	C027278	663266
en@@	I-Chemical	-1	663266
o@@	I-Chemical	-1	663266
gra@@	I-Chemical	-1	663266
f@@	I-Chemical	-1	663266
in	I-Chemical	-1	663266
7@@	I-Chemical	-1	663266
6%	I-Chemical	-1	663266
was	O	-1	663266
compared	O	-1	663266
with	O	-1	663266
that	O	-1	663266
of	O	-1	663266
H@@	B-Chemical	C027278	663266
y@@	I-Chemical	-1	663266
pa@@	I-Chemical	-1	663266
qu@@	I-Chemical	-1	663266
e	I-Chemical	-1	663266
7@@	I-Chemical	-1	663266
6%	I-Chemical	-1	663266
by	O	-1	663266
selective	O	-1	663266
injection	O	-1	663266
of	O	-1	663266
each	O	-1	663266
into	O	-1	663266
the	O	-1	663266
right	O	-1	663266
coronary	O	-1	663266
artery	O	-1	663266
of	O	-1	663266
dog@@	O	-1	663266
s.	O	-1	663266
R@@	B-Chemical	D003974	663266
en@@	I-Chemical	-1	663266
o@@	I-Chemical	-1	663266
gra@@	I-Chemical	-1	663266
f@@	I-Chemical	-1	663266
in	I-Chemical	-1	663266
cont@@	O	-1	663266
ain@@	O	-1	663266
s	O	-1	663266
the	O	-1	663266
ch@@	O	-1	663266
el@@	O	-1	663266
ating	O	-1	663266
agents	O	-1	663266
sodium	B-Chemical	C102006	663266
cit@@	I-Chemical	-1	663266
rate	I-Chemical	-1	663266
and	O	-1	663266
dis@@	B-Chemical	D004492	663266
odium	I-Chemical	-1	663266
e@@	I-Chemical	-1	663266
det@@	I-Chemical	-1	663266
ate	I-Chemical	-1	663266
,	O	-1	663266
while	O	-1	663266
H@@	B-Chemical	D003973	663266
y@@	I-Chemical	-1	663266
pa@@	I-Chemical	-1	663266
qu@@	I-Chemical	-1	663266
e	I-Chemical	-1	663266
cont@@	O	-1	663266
ain@@	O	-1	663266
s	O	-1	663266
calcium	B-Chemical	D004492	663266
dis@@	I-Chemical	-1	663266
odium	I-Chemical	-1	663266
e@@	I-Chemical	-1	663266
det@@	I-Chemical	-1	663266
ate	I-Chemical	-1	663266
and	O	-1	663266
no	O	-1	663266
sodium	B-Chemical	C102006	663266
cit@@	I-Chemical	-1	663266
rate	I-Chemical	-1	663266
.	O	-1	663266
V@@	B-Disease	D014693	663266
entr@@	I-Disease	-1	663266
ic@@	I-Disease	-1	663266
ular	I-Disease	-1	663266
fibrill@@	I-Disease	-1	663266
ation	I-Disease	-1	663266
occurred	O	-1	663266
significantly	O	-1	663266
more	O	-1	663266
often	O	-1	663266
with	O	-1	663266
R@@	B-Chemical	D003974	663266
en@@	I-Chemical	-1	663266
o@@	I-Chemical	-1	663266
gra@@	I-Chemical	-1	663266
f@@	I-Chemical	-1	663266
in	I-Chemical	-1	663266
,	O	-1	663266
suggesting	O	-1	663266
that	O	-1	663266
ch@@	O	-1	663266
el@@	O	-1	663266
ating	O	-1	663266
agents	O	-1	663266
cont@@	O	-1	663266
rib@@	O	-1	663266
ute	O	-1	663266
to	O	-1	663266
toxicity	B-Disease	D064420	663266
in	O	-1	663266
coronary	O	-1	663266
angio@@	O	-1	663266
graph@@	O	-1	663266
y.	O	-1	663266

R@@	O	-1	19319147
ap@@	O	-1	19319147
id	O	-1	19319147
rever@@	O	-1	19319147
s@@	O	-1	19319147
al	O	-1	19319147
of	O	-1	19319147
anti@@	O	-1	19319147
co@@	O	-1	19319147
ag@@	O	-1	19319147
ulation	O	-1	19319147
reduc@@	O	-1	19319147
es	O	-1	19319147
hemorrh@@	B-Disease	D006470	19319147
age	I-Disease	-1	19319147
volume	O	-1	19319147
in	O	-1	19319147
a	O	-1	19319147
mouse	O	-1	19319147
model	O	-1	19319147
of	O	-1	19319147
war@@	B-Chemical	D014859	19319147
farin	I-Chemical	-1	19319147
-@@	O	-1	19319147
associated	O	-1	19319147
intrac@@	B-Disease	D002543	19319147
e@@	I-Disease	-1	19319147
rebral	I-Disease	-1	19319147
hemorrh@@	I-Disease	-1	19319147
age	I-Disease	-1	19319147
.	O	-1	19319147
W@@	B-Chemical	D014859	19319147
ar@@	I-Chemical	-1	19319147
farin	I-Chemical	-1	19319147
-@@	O	-1	19319147
associated	O	-1	19319147
intrac@@	B-Disease	D002543	19319147
e@@	I-Disease	-1	19319147
rebral	I-Disease	-1	19319147
hemorrh@@	I-Disease	-1	19319147
age	I-Disease	-1	19319147
(@@	O	-1	19319147
W@@	O	-1	19319147
-	O	-1	19319147
IC@@	B-Disease	D002543	19319147
H	I-Disease	-1	19319147
)	O	-1	19319147
is	O	-1	19319147
a	O	-1	19319147
severe	O	-1	19319147
type	O	-1	19319147
of	O	-1	19319147
strok@@	B-Disease	D020521	19319147
e	I-Disease	-1	19319147
.	O	-1	19319147
There	O	-1	19319147
is	O	-1	19319147
no	O	-1	19319147
con@@	O	-1	19319147
sen@@	O	-1	19319147
su@@	O	-1	19319147
s	O	-1	19319147
on	O	-1	19319147
the	O	-1	19319147
op@@	O	-1	19319147
tim@@	O	-1	19319147
al	O	-1	19319147
treatment	O	-1	19319147
for	O	-1	19319147
W@@	O	-1	19319147
-	O	-1	19319147
IC@@	B-Disease	D002543	19319147
H	I-Disease	-1	19319147
.	O	-1	19319147
U@@	O	-1	19319147
s@@	O	-1	19319147
ing	O	-1	19319147
a	O	-1	19319147
mouse	O	-1	19319147
model@@	O	-1	19319147
,	O	-1	19319147
we	O	-1	19319147
tested	O	-1	19319147
whether	O	-1	19319147
the	O	-1	19319147
ra@@	O	-1	19319147
pid	O	-1	19319147
rever@@	O	-1	19319147
s@@	O	-1	19319147
al	O	-1	19319147
of	O	-1	19319147
anti@@	O	-1	19319147
co@@	O	-1	19319147
ag@@	O	-1	19319147
ulation	O	-1	19319147
using	O	-1	19319147
human	O	-1	19319147
pro@@	B-Chemical	C025667	19319147
throm@@	I-Chemical	-1	19319147
bin	I-Chemical	-1	19319147
comple@@	I-Chemical	-1	19319147
x	I-Chemical	-1	19319147
con@@	I-Chemical	-1	19319147
c@@	I-Chemical	-1	19319147
ent@@	I-Chemical	-1	19319147
rate	I-Chemical	-1	19319147
(	O	-1	19319147
P@@	B-Chemical	C025667	19319147
C@@	I-Chemical	-1	19319147
C	I-Chemical	-1	19319147
)	O	-1	19319147
can	O	-1	19319147
re@@	O	-1	19319147
duce	O	-1	19319147
hemorrh@@	O	-1	19319147
ag@@	O	-1	19319147
ic	O	-1	19319147
blood	O	-1	19319147
vol@@	O	-1	19319147
u@@	O	-1	19319147
me.	O	-1	19319147
M@@	O	-1	19319147
al@@	O	-1	19319147
e	O	-1	19319147
C@@	O	-1	19319147
D@@	O	-1	19319147
-1	O	-1	19319147
mice	O	-1	19319147
were	O	-1	19319147
treated	O	-1	19319147
with	O	-1	19319147
war@@	B-Chemical	D014859	19319147
farin	I-Chemical	-1	19319147
(@@	O	-1	19319147
2	O	-1	19319147
mg/kg	O	-1	19319147
over	O	-1	19319147
24	O	-1	19319147
h@@	O	-1	19319147
),	O	-1	19319147
result@@	O	-1	19319147
ing	O	-1	19319147
in	O	-1	19319147
a	O	-1	19319147
mean	O	-1	19319147
(@@	O	-1	19319147
+/-@@	O	-1	19319147
s@@	O	-1	19319147
.@@	O	-1	19319147
d@@	O	-1	19319147
.)	O	-1	19319147
In@@	O	-1	19319147
tern@@	O	-1	19319147
ation@@	O	-1	19319147
al	O	-1	19319147
N@@	O	-1	19319147
orm@@	O	-1	19319147
al@@	O	-1	19319147
ized	O	-1	19319147
R@@	O	-1	19319147
ati@@	O	-1	19319147
o	O	-1	19319147
of	O	-1	19319147
3.@@	O	-1	19319147
5@@	O	-1	19319147
+/-@@	O	-1	19319147
0.@@	O	-1	19319147
9@@	O	-1	19319147
.	O	-1	19319147
F@@	O	-1	19319147
ir@@	O	-1	19319147
st@@	O	-1	19319147
,	O	-1	19319147
we	O	-1	19319147
showed	O	-1	19319147
that	O	-1	19319147
an	O	-1	19319147
intravenous	O	-1	19319147
administration	O	-1	19319147
of	O	-1	19319147
human	O	-1	19319147
P@@	B-Chemical	C025667	19319147
C@@	I-Chemical	-1	19319147
C	I-Chemical	-1	19319147
ra@@	O	-1	19319147
pid@@	O	-1	19319147
ly	O	-1	19319147
reversed	O	-1	19319147
anti@@	O	-1	19319147
co@@	O	-1	19319147
ag@@	O	-1	19319147
ulation	O	-1	19319147
in	O	-1	19319147
mice.	O	-1	19319147
S@@	O	-1	19319147
ec@@	O	-1	19319147
on@@	O	-1	19319147
d,	O	-1	19319147
a	O	-1	19319147
ste@@	O	-1	19319147
re@@	O	-1	19319147
ot@@	O	-1	19319147
ac@@	O	-1	19319147
tic	O	-1	19319147
injection	O	-1	19319147
of	O	-1	19319147
coll@@	O	-1	19319147
ag@@	O	-1	19319147
en@@	O	-1	19319147
ase	O	-1	19319147
was	O	-1	19319147
administered	O	-1	19319147
to	O	-1	19319147
induce	O	-1	19319147
hemorrh@@	B-Disease	D006470	19319147
age	I-Disease	-1	19319147
in	O	-1	19319147
the	O	-1	19319147
right	O	-1	19319147
striat@@	O	-1	19319147
um@@	O	-1	19319147
.	O	-1	19319147
F@@	O	-1	19319147
or@@	O	-1	19319147
ty-@@	O	-1	19319147
five	O	-1	19319147
minutes	O	-1	19319147
lat@@	O	-1	19319147
er,	O	-1	19319147
the	O	-1	19319147
animals	O	-1	19319147
were	O	-1	19319147
random@@	O	-1	19319147
ly	O	-1	19319147
treated	O	-1	19319147
with	O	-1	19319147
P@@	B-Chemical	C025667	19319147
C@@	I-Chemical	-1	19319147
C	I-Chemical	-1	19319147
(@@	O	-1	19319147
100	O	-1	19319147
U@@	O	-1	19319147
/@@	O	-1	19319147
kg@@	O	-1	19319147
)	O	-1	19319147
or	O	-1	19319147
saline	O	-1	19319147
i.v@@	O	-1	19319147
.	O	-1	19319147
(n@@	O	-1	19319147
=@@	O	-1	19319147
12	O	-1	19319147
per	O	-1	19319147
group@@	O	-1	19319147
).	O	-1	19319147
Tw@@	O	-1	19319147
ent@@	O	-1	19319147
y-@@	O	-1	19319147
four	O	-1	19319147
hours	O	-1	19319147
after	O	-1	19319147
hemorrh@@	B-Disease	D006470	19319147
age	I-Disease	-1	19319147
induc@@	O	-1	19319147
tion,	O	-1	19319147
hemorrh@@	O	-1	19319147
ag@@	O	-1	19319147
ic	O	-1	19319147
blood	O	-1	19319147
volume	O	-1	19319147
was	O	-1	19319147
qu@@	O	-1	19319147
anti@@	O	-1	19319147
fied	O	-1	19319147
using	O	-1	19319147
a	O	-1	19319147
ph@@	O	-1	19319147
ot@@	O	-1	19319147
o@@	O	-1	19319147
me@@	O	-1	19319147
tri@@	O	-1	19319147
c	O	-1	19319147
hemo@@	O	-1	19319147
globin	O	-1	19319147
ass@@	O	-1	19319147
a@@	O	-1	19319147
y.	O	-1	19319147
The	O	-1	19319147
mean	O	-1	19319147
hemorrh@@	O	-1	19319147
ag@@	O	-1	19319147
ic	O	-1	19319147
blood	O	-1	19319147
volume	O	-1	19319147
was	O	-1	19319147
reduced	O	-1	19319147
in	O	-1	19319147
P@@	B-Chemical	C025667	19319147
C@@	I-Chemical	-1	19319147
C	I-Chemical	-1	19319147
-treated	O	-1	19319147
animals	O	-1	19319147
(@@	O	-1	19319147
6.@@	O	-1	19319147
5@@	O	-1	19319147
+/-@@	O	-1	19319147
3.@@	O	-1	19319147
1	O	-1	19319147
micro@@	O	-1	19319147
L@@	O	-1	19319147
)	O	-1	19319147
compared	O	-1	19319147
with	O	-1	19319147
saline	O	-1	19319147
controls	O	-1	19319147
(1@@	O	-1	19319147
5.@@	O	-1	19319147
3@@	O	-1	19319147
+/@@	O	-1	19319147
-1@@	O	-1	19319147
1.@@	O	-1	19319147
2	O	-1	19319147
micro@@	O	-1	19319147
L@@	O	-1	19319147
,	O	-1	19319147
P@@	O	-1	19319147
=@@	O	-1	19319147
0.0@@	O	-1	19319147
1@@	O	-1	19319147
5@@	O	-1	19319147
).	O	-1	19319147
In	O	-1	19319147
the	O	-1	19319147
saline	O	-1	19319147
group@@	O	-1	19319147
,	O	-1	19319147
4@@	O	-1	19319147
5%	O	-1	19319147
of	O	-1	19319147
the	O	-1	19319147
mice	O	-1	19319147
developed	O	-1	19319147
larg@@	O	-1	19319147
e	O	-1	19319147
hemat@@	B-Disease	D006406	19319147
om@@	I-Disease	-1	19319147
as	I-Disease	-1	19319147
(@@	O	-1	19319147
i.@@	O	-1	19319147
e@@	O	-1	19319147
.,	O	-1	19319147
>@@	O	-1	19319147
15	O	-1	19319147
micro@@	O	-1	19319147
L@@	O	-1	19319147
).	O	-1	19319147
In	O	-1	19319147
contrast@@	O	-1	19319147
,	O	-1	19319147
such	O	-1	19319147
exten@@	O	-1	19319147
sive	O	-1	19319147
lesions	O	-1	19319147
were	O	-1	19319147
ne@@	O	-1	19319147
ver	O	-1	19319147
found	O	-1	19319147
in	O	-1	19319147
the	O	-1	19319147
P@@	B-Chemical	C025667	19319147
C@@	I-Chemical	-1	19319147
C	I-Chemical	-1	19319147
group.	O	-1	19319147
We	O	-1	19319147
prov@@	O	-1	19319147
ide	O	-1	19319147
experimental	O	-1	19319147
data	O	-1	19319147
suggesting	O	-1	19319147
P@@	B-Chemical	C025667	19319147
C@@	I-Chemical	-1	19319147
C	I-Chemical	-1	19319147
to	O	-1	19319147
be	O	-1	19319147
an	O	-1	19319147
effective	O	-1	19319147
acute	O	-1	19319147
treatment	O	-1	19319147
for	O	-1	19319147
W@@	O	-1	19319147
-	O	-1	19319147
IC@@	B-Disease	D002543	19319147
H	I-Disease	-1	19319147
in	O	-1	19319147
ter@@	O	-1	19319147
ms	O	-1	19319147
of	O	-1	19319147
reduc@@	O	-1	19319147
ing	O	-1	19319147
hemorrh@@	O	-1	19319147
ag@@	O	-1	19319147
ic	O	-1	19319147
blood	O	-1	19319147
vol@@	O	-1	19319147
u@@	O	-1	19319147
me.	O	-1	19319147
F@@	O	-1	19319147
ut@@	O	-1	19319147
ure	O	-1	19319147
studies	O	-1	19319147
are	O	-1	19319147
ne@@	O	-1	19319147
ed@@	O	-1	19319147
ed	O	-1	19319147
to	O	-1	19319147
ass@@	O	-1	19319147
ess	O	-1	19319147
the	O	-1	19319147
therapeutic	O	-1	19319147
potential	O	-1	19319147
em@@	O	-1	19319147
erg@@	O	-1	19319147
ing	O	-1	19319147
from	O	-1	19319147
our	O	-1	19319147
find@@	O	-1	19319147
ing	O	-1	19319147
for	O	-1	19319147
human	O	-1	19319147
W@@	O	-1	19319147
-	O	-1	19319147
IC@@	B-Disease	D002543	19319147
H	I-Disease	-1	19319147
.	O	-1	19319147

Im@@	O	-1	16634859
pac@@	O	-1	16634859
t	O	-1	16634859
of	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
exposure	O	-1	16634859
after	O	-1	16634859
pregn@@	O	-1	16634859
anc@@	O	-1	16634859
y	O	-1	16634859
reco@@	O	-1	16634859
gn@@	O	-1	16634859
ition	O	-1	16634859
on	O	-1	16634859
ult@@	O	-1	16634859
r@@	O	-1	16634859
as@@	O	-1	16634859
on@@	O	-1	16634859
ograph@@	O	-1	16634859
ic	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
growth	O	-1	16634859
meas@@	O	-1	16634859
ures@@	O	-1	16634859
.	O	-1	16634859
BACKGROUND:	O	-1	16634859
M@@	O	-1	16634859
or@@	O	-1	16634859
e	O	-1	16634859
than	O	-1	16634859
3	O	-1	16634859
dec@@	O	-1	16634859
a@@	O	-1	16634859
des	O	-1	16634859
after	O	-1	16634859
J@@	O	-1	16634859
on@@	O	-1	16634859
es	O	-1	16634859
and	O	-1	16634859
S@@	O	-1	16634859
mit@@	O	-1	16634859
h	O	-1	16634859
(1@@	O	-1	16634859
9@@	O	-1	16634859
7@@	O	-1	16634859
3@@	O	-1	16634859
)	O	-1	16634859
reported	O	-1	16634859
on	O	-1	16634859
the	O	-1	16634859
de@@	O	-1	16634859
vast@@	O	-1	16634859
ation	O	-1	16634859
caused	O	-1	16634859
by	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
exposure	O	-1	16634859
on	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
develop@@	O	-1	16634859
ment@@	O	-1	16634859
,	O	-1	16634859
the	O	-1	16634859
rat@@	O	-1	16634859
es	O	-1	16634859
of	O	-1	16634859
he@@	O	-1	16634859
av@@	O	-1	16634859
y	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
king	O	-1	16634859
during	O	-1	16634859
pregn@@	O	-1	16634859
anc@@	O	-1	16634859
y	O	-1	16634859
re@@	O	-1	16634859
ma@@	O	-1	16634859
in	O	-1	16634859
rel@@	O	-1	16634859
atively	O	-1	16634859
un@@	O	-1	16634859
chang@@	O	-1	16634859
ed.	O	-1	16634859
E@@	O	-1	16634859
arly	O	-1	16634859
identi@@	O	-1	16634859
fic@@	O	-1	16634859
ation	O	-1	16634859
of	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
exposure	O	-1	16634859
and	O	-1	16634859
mat@@	O	-1	16634859
er@@	O	-1	16634859
n@@	O	-1	16634859
al	O	-1	16634859
ab@@	O	-1	16634859
st@@	O	-1	16634859
in@@	O	-1	16634859
ence	O	-1	16634859
l@@	O	-1	16634859
ed	O	-1	16634859
to	O	-1	16634859
bet@@	O	-1	16634859
ter	O	-1	16634859
inf@@	O	-1	16634859
ant	O	-1	16634859
outcom@@	O	-1	16634859
es.	O	-1	16634859
This	O	-1	16634859
study	O	-1	16634859
examined	O	-1	16634859
the	O	-1	16634859
u@@	O	-1	16634859
til@@	O	-1	16634859
ity	O	-1	16634859
of	O	-1	16634859
bio@@	O	-1	16634859
met@@	O	-1	16634859
r@@	O	-1	16634859
y	O	-1	16634859
for	O	-1	16634859
det@@	O	-1	16634859
ect@@	O	-1	16634859
ing	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
-@@	O	-1	16634859
related	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
growth	B-Disease	D006130	16634859
impair@@	I-Disease	-1	16634859
ment	I-Disease	-1	16634859
.	O	-1	16634859
METHODS:	O	-1	16634859
We	O	-1	16634859
obtained	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
ult@@	O	-1	16634859
r@@	O	-1	16634859
as@@	O	-1	16634859
ound	O	-1	16634859
meas@@	O	-1	16634859
ures	O	-1	16634859
from	O	-1	16634859
ro@@	O	-1	16634859
ut@@	O	-1	16634859
ine	O	-1	16634859
ult@@	O	-1	16634859
r@@	O	-1	16634859
as@@	O	-1	16634859
ound	O	-1	16634859
examin@@	O	-1	16634859
ations	O	-1	16634859
for	O	-1	16634859
1@@	O	-1	16634859
6@@	O	-1	16634859
7	O	-1	16634859
pregn@@	O	-1	16634859
ant	O	-1	16634859
ha@@	O	-1	16634859
z@@	O	-1	16634859
ar@@	O	-1	16634859
d@@	O	-1	16634859
ous	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
k@@	O	-1	16634859
ers	O	-1	16634859
who	O	-1	16634859
were	O	-1	16634859
en@@	O	-1	16634859
ro@@	O	-1	16634859
lled	O	-1	16634859
in	O	-1	16634859
a	O	-1	16634859
b@@	O	-1	16634859
ri@@	O	-1	16634859
e@@	O	-1	16634859
f	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
inter@@	O	-1	16634859
ven@@	O	-1	16634859
tion	O	-1	16634859
study.	O	-1	16634859
The	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
meas@@	O	-1	16634859
ures	O	-1	16634859
for	O	-1	16634859
women	O	-1	16634859
who	O	-1	16634859
qu@@	O	-1	16634859
it	O	-1	16634859
after	O	-1	16634859
lear@@	O	-1	16634859
ning	O	-1	16634859
of	O	-1	16634859
their	O	-1	16634859
pregn@@	O	-1	16634859
an@@	O	-1	16634859
ci@@	O	-1	16634859
es	O	-1	16634859
were	O	-1	16634859
compared	O	-1	16634859
with	O	-1	16634859
meas@@	O	-1	16634859
ures	O	-1	16634859
for	O	-1	16634859
women	O	-1	16634859
who	O	-1	16634859
continu@@	O	-1	16634859
ed	O	-1	16634859
some	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
king	O	-1	16634859
throu@@	O	-1	16634859
gh@@	O	-1	16634859
out	O	-1	16634859
the	O	-1	16634859
course	O	-1	16634859
of	O	-1	16634859
their	O	-1	16634859
pregn@@	O	-1	16634859
an@@	O	-1	16634859
ci@@	O	-1	16634859
es.	O	-1	16634859
B@@	O	-1	16634859
ecause	O	-1	16634859
int@@	O	-1	16634859
ensity	O	-1	16634859
of	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
consum@@	O	-1	16634859
ption	O	-1	16634859
is	O	-1	16634859
associated	O	-1	16634859
with	O	-1	16634859
po@@	O	-1	16634859
ore@@	O	-1	16634859
r	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
outcom@@	O	-1	16634859
es,	O	-1	16634859
se@@	O	-1	16634859
par@@	O	-1	16634859
ate	O	-1	16634859
analy@@	O	-1	16634859
ses	O	-1	16634859
were	O	-1	16634859
con@@	O	-1	16634859
duc@@	O	-1	16634859
ted	O	-1	16634859
for	O	-1	16634859
the	O	-1	16634859
he@@	O	-1	16634859
av@@	O	-1	16634859
y	O	-1	16634859
(@@	O	-1	16634859
average	O	-1	16634859
of	O	-1	16634859
>@@	O	-1	16634859
or@@	O	-1	16634859
=@@	O	-1	16634859
5	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
k@@	O	-1	16634859
s	O	-1	16634859
per	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
king	O	-1	16634859
day@@	O	-1	16634859
)	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
con@@	O	-1	16634859
su@@	O	-1	16634859
mer@@	O	-1	16634859
s.	O	-1	16634859
F@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
meas@@	O	-1	16634859
ures	O	-1	16634859
from	O	-1	16634859
the	O	-1	16634859
he@@	O	-1	16634859
av@@	O	-1	16634859
y-@@	O	-1	16634859
exposed	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
u@@	O	-1	16634859
ses	O	-1	16634859
were	O	-1	16634859
also	O	-1	16634859
compared	O	-1	16634859
with	O	-1	16634859
meas@@	O	-1	16634859
ures	O	-1	16634859
from	O	-1	16634859
a	O	-1	16634859
non@@	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
king	O	-1	16634859
group	O	-1	16634859
that	O	-1	16634859
was	O	-1	16634859
re@@	O	-1	16634859
present@@	O	-1	16634859
ative	O	-1	16634859
of	O	-1	16634859
normal@@	O	-1	16634859
,	O	-1	16634859
un@@	O	-1	16634859
complic@@	O	-1	16634859
ated	O	-1	16634859
pregn@@	O	-1	16634859
an@@	O	-1	16634859
ci@@	O	-1	16634859
es	O	-1	16634859
from	O	-1	16634859
our	O	-1	16634859
clin@@	O	-1	16634859
ic@@	O	-1	16634859
s.	O	-1	16634859
An@@	O	-1	16634859
aly@@	O	-1	16634859
ses	O	-1	16634859
of	O	-1	16634859
co@@	O	-1	16634859
vari@@	O	-1	16634859
ance	O	-1	16634859
were	O	-1	16634859
used	O	-1	16634859
to	O	-1	16634859
determine	O	-1	16634859
whether	O	-1	16634859
there	O	-1	16634859
were	O	-1	16634859
differences	O	-1	16634859
between	O	-1	16634859
groups	O	-1	16634859
after	O	-1	16634859
contro@@	O	-1	16634859
ll@@	O	-1	16634859
ing	O	-1	16634859
for	O	-1	16634859
influ@@	O	-1	16634859
enc@@	O	-1	16634859
es	O	-1	16634859
of	O	-1	16634859
g@@	O	-1	16634859
est@@	O	-1	16634859
ation@@	O	-1	16634859
al	O	-1	16634859
age	O	-1	16634859
and	O	-1	16634859
drug	B-Disease	D019966	16634859
ab@@	I-Disease	-1	16634859
use	I-Disease	-1	16634859
.	O	-1	16634859
RESULTS:	O	-1	16634859
N@@	O	-1	16634859
early	O	-1	16634859
h@@	O	-1	16634859
al@@	O	-1	16634859
f	O	-1	16634859
of	O	-1	16634859
the	O	-1	16634859
pregn@@	O	-1	16634859
ant	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
k@@	O	-1	16634859
ers	O	-1	16634859
ab@@	O	-1	16634859
st@@	O	-1	16634859
ained	O	-1	16634859
after	O	-1	16634859
lear@@	O	-1	16634859
ning	O	-1	16634859
of	O	-1	16634859
their	O	-1	16634859
pregn@@	O	-1	16634859
an@@	O	-1	16634859
ci@@	O	-1	16634859
es.	O	-1	16634859
Whe@@	O	-1	16634859
n	O	-1	16634859
women	O	-1	16634859
repor@@	O	-1	16634859
te@@	O	-1	16634859
d@@	O	-1	16634859
ly	O	-1	16634859
qu@@	O	-1	16634859
it	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
king	O	-1	16634859
early	O	-1	16634859
in	O	-1	16634859
their	O	-1	16634859
pregn@@	O	-1	16634859
an@@	O	-1	16634859
ci@@	O	-1	16634859
es,	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
growth	O	-1	16634859
meas@@	O	-1	16634859
ures	O	-1	16634859
were	O	-1	16634859
not	O	-1	16634859
significantly	O	-1	16634859
different	O	-1	16634859
from	O	-1	16634859
a	O	-1	16634859
non@@	O	-1	16634859
-	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
-@@	O	-1	16634859
exposed	O	-1	16634859
group@@	O	-1	16634859
,	O	-1	16634859
reg@@	O	-1	16634859
ar@@	O	-1	16634859
d@@	O	-1	16634859
less	O	-1	16634859
of	O	-1	16634859
prior	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
king	O	-1	16634859
pat@@	O	-1	16634859
tern@@	O	-1	16634859
s.	O	-1	16634859
An@@	O	-1	16634859
y	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
consum@@	O	-1	16634859
ption	O	-1	16634859
post@@	O	-1	16634859
pregn@@	O	-1	16634859
anc@@	O	-1	16634859
y	O	-1	16634859
reco@@	O	-1	16634859
gn@@	O	-1	16634859
ition	O	-1	16634859
among	O	-1	16634859
the	O	-1	16634859
he@@	O	-1	16634859
av@@	O	-1	16634859
y	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
k@@	O	-1	16634859
ers	O	-1	16634859
resulted	O	-1	16634859
in	O	-1	16634859
reduced	B-Disease	D006130	16634859
ce@@	I-Disease	-1	16634859
re@@	I-Disease	-1	16634859
bell@@	I-Disease	-1	16634859
ar	I-Disease	-1	16634859
growth	I-Disease	-1	16634859
as	O	-1	16634859
well	O	-1	16634859
as	O	-1	16634859
decreased	B-Disease	D006130	16634859
c@@	I-Disease	-1	16634859
ranial	I-Disease	-1	16634859
to	I-Disease	-1	16634859
body	I-Disease	-1	16634859
growth	I-Disease	-1	16634859
in	O	-1	16634859
compar@@	O	-1	16634859
ison	O	-1	16634859
with	O	-1	16634859
women	O	-1	16634859
who	O	-1	16634859
either	O	-1	16634859
qu@@	O	-1	16634859
it	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
king	O	-1	16634859
or	O	-1	16634859
who	O	-1	16634859
were	O	-1	16634859
non@@	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
k@@	O	-1	16634859
ers.	O	-1	16634859
A@@	B-Chemical	D000661	16634859
m@@	I-Chemical	-1	16634859
ph@@	I-Chemical	-1	16634859
et@@	I-Chemical	-1	16634859
amine	I-Chemical	-1	16634859
ab@@	O	-1	16634859
use	O	-1	16634859
was	O	-1	16634859
predic@@	O	-1	16634859
tive	O	-1	16634859
of	O	-1	16634859
larg@@	O	-1	16634859
er	O	-1	16634859
c@@	O	-1	16634859
ranial	O	-1	16634859
to	O	-1	16634859
body	O	-1	16634859
growth	O	-1	16634859
rati@@	O	-1	16634859
o@@	O	-1	16634859
s.	O	-1	16634859
CONCLUSIONS:	O	-1	16634859
Al@@	O	-1	16634859
ter@@	O	-1	16634859
ations	O	-1	16634859
in	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
bio@@	O	-1	16634859
me@@	O	-1	16634859
tri@@	O	-1	16634859
c	O	-1	16634859
meas@@	O	-1	16634859
ure@@	O	-1	16634859
ments	O	-1	16634859
were	O	-1	16634859
observed	O	-1	16634859
among	O	-1	16634859
the	O	-1	16634859
he@@	O	-1	16634859
av@@	O	-1	16634859
y	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
k@@	O	-1	16634859
ers	O	-1	16634859
only	O	-1	16634859
when	O	-1	16634859
they	O	-1	16634859
continu@@	O	-1	16634859
ed	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
king	O	-1	16634859
after	O	-1	16634859
b@@	O	-1	16634859
ec@@	O	-1	16634859
om@@	O	-1	16634859
ing	O	-1	16634859
aw@@	O	-1	16634859
are	O	-1	16634859
of	O	-1	16634859
their	O	-1	16634859
pregn@@	O	-1	16634859
an@@	O	-1	16634859
ci@@	O	-1	16634859
es.	O	-1	16634859
Although	O	-1	16634859
the	O	-1	16634859
re@@	O	-1	16634859
li@@	O	-1	16634859
ance	O	-1	16634859
on	O	-1	16634859
sel@@	O	-1	16634859
f@@	O	-1	16634859
-@@	O	-1	16634859
reported	O	-1	16634859
d@@	O	-1	16634859
r@@	O	-1	16634859
in@@	O	-1	16634859
king	O	-1	16634859
is	O	-1	16634859
a	O	-1	16634859
lim@@	O	-1	16634859
it@@	O	-1	16634859
ation	O	-1	16634859
in	O	-1	16634859
this	O	-1	16634859
study,	O	-1	16634859
these	O	-1	16634859
findings	O	-1	16634859
suppor@@	O	-1	16634859
t	O	-1	16634859
the	O	-1	16634859
ben@@	O	-1	16634859
e@@	O	-1	16634859
f@@	O	-1	16634859
its	O	-1	16634859
of	O	-1	16634859
early	O	-1	16634859
ab@@	O	-1	16634859
st@@	O	-1	16634859
in@@	O	-1	16634859
ence	O	-1	16634859
and	O	-1	16634859
the	O	-1	16634859
potential	O	-1	16634859
for	O	-1	16634859
ult@@	O	-1	16634859
r@@	O	-1	16634859
as@@	O	-1	16634859
ound	O	-1	16634859
examin@@	O	-1	16634859
ations	O	-1	16634859
in	O	-1	16634859
the	O	-1	16634859
det@@	O	-1	16634859
ection	O	-1	16634859
of	O	-1	16634859
f@@	O	-1	16634859
et@@	O	-1	16634859
al	O	-1	16634859
alco@@	B-Chemical	D000431	16634859
hol	I-Chemical	-1	16634859
effects.	O	-1	16634859

U@@	O	-1	16471092
r@@	O	-1	16471092
inary	O	-1	16471092
symptoms	O	-1	16471092
and	O	-1	16471092
qu@@	O	-1	16471092
ality	O	-1	16471092
of	O	-1	16471092
lif@@	O	-1	16471092
e	O	-1	16471092
changes	O	-1	16471092
in	O	-1	16471092
Th@@	O	-1	16471092
a@@	O	-1	16471092
i	O	-1	16471092
women	O	-1	16471092
with	O	-1	16471092
over@@	B-Disease	D053201	16471092
active	I-Disease	-1	16471092
bladder	I-Disease	-1	16471092
after	O	-1	16471092
t@@	B-Chemical	C099041	16471092
ol@@	I-Chemical	-1	16471092
ter@@	I-Chemical	-1	16471092
o@@	I-Chemical	-1	16471092
d@@	I-Chemical	-1	16471092
ine	I-Chemical	-1	16471092
treatment.	O	-1	16471092
OBJECTIV@@	O	-1	16471092
E@@	O	-1	16471092
S:	O	-1	16471092
To	O	-1	16471092
study	O	-1	16471092
the	O	-1	16471092
urinary	O	-1	16471092
symptoms	O	-1	16471092
and	O	-1	16471092
qu@@	O	-1	16471092
ality	O	-1	16471092
of	O	-1	16471092
lif@@	O	-1	16471092
e	O	-1	16471092
changes	O	-1	16471092
in	O	-1	16471092
Th@@	O	-1	16471092
a@@	O	-1	16471092
i	O	-1	16471092
women	O	-1	16471092
with	O	-1	16471092
over@@	B-Disease	D053201	16471092
active	I-Disease	-1	16471092
bladder	I-Disease	-1	16471092
(	O	-1	16471092
O@@	B-Disease	D053201	16471092
A@@	I-Disease	-1	16471092
B	I-Disease	-1	16471092
)	O	-1	16471092
after	O	-1	16471092
t@@	B-Chemical	C099041	16471092
ol@@	I-Chemical	-1	16471092
ter@@	I-Chemical	-1	16471092
o@@	I-Chemical	-1	16471092
d@@	I-Chemical	-1	16471092
ine	I-Chemical	-1	16471092
treatment.	O	-1	16471092
M@@	O	-1	16471092
AT@@	O	-1	16471092
E@@	O	-1	16471092
R@@	O	-1	16471092
I@@	O	-1	16471092
A@@	O	-1	16471092
L	O	-1	16471092
AN@@	O	-1	16471092
D	O	-1	16471092
METHOD@@	O	-1	16471092
:	O	-1	16471092
Th@@	O	-1	16471092
ir@@	O	-1	16471092
t@@	O	-1	16471092
y	O	-1	16471092
women	O	-1	16471092
(@@	O	-1	16471092
aged	O	-1	16471092
3@@	O	-1	16471092
0-@@	O	-1	16471092
7@@	O	-1	16471092
7	O	-1	16471092
year@@	O	-1	16471092
s)	O	-1	16471092
diagnos@@	O	-1	16471092
ed	O	-1	16471092
as	O	-1	16471092
ha@@	O	-1	16471092
ving	O	-1	16471092
O@@	B-Disease	D053201	16471092
A@@	I-Disease	-1	16471092
B	I-Disease	-1	16471092
at	O	-1	16471092
the	O	-1	16471092
G@@	O	-1	16471092
y@@	O	-1	16471092
nec@@	O	-1	16471092
ology	O	-1	16471092
Clin@@	O	-1	16471092
ic@@	O	-1	16471092
,	O	-1	16471092
K@@	O	-1	16471092
ing	O	-1	16471092
Ch@@	O	-1	16471092
ul@@	O	-1	16471092
al@@	O	-1	16471092
on@@	O	-1	16471092
g@@	O	-1	16471092
k@@	O	-1	16471092
or@@	O	-1	16471092
n	O	-1	16471092
M@@	O	-1	16471092
em@@	O	-1	16471092
or@@	O	-1	16471092
ial	O	-1	16471092
H@@	O	-1	16471092
ospit@@	O	-1	16471092
al	O	-1	16471092
from	O	-1	16471092
J@@	O	-1	16471092
an@@	O	-1	16471092
u@@	O	-1	16471092
ary	O	-1	16471092
to	O	-1	16471092
A@@	O	-1	16471092
pri@@	O	-1	16471092
l	O	-1	16471092
20@@	O	-1	16471092
0@@	O	-1	16471092
4	O	-1	16471092
were	O	-1	16471092
included	O	-1	16471092
in	O	-1	16471092
the	O	-1	16471092
present	O	-1	16471092
study.	O	-1	16471092
T@@	B-Chemical	C099041	16471092
ol@@	I-Chemical	-1	16471092
ter@@	I-Chemical	-1	16471092
o@@	I-Chemical	-1	16471092
d@@	I-Chemical	-1	16471092
ine	I-Chemical	-1	16471092
2	O	-1	16471092
mg@@	O	-1	16471092
,	O	-1	16471092
tw@@	O	-1	16471092
ic@@	O	-1	16471092
e	O	-1	16471092
daily	O	-1	16471092
was	O	-1	16471092
gi@@	O	-1	16471092
ven@@	O	-1	16471092
.	O	-1	16471092
After	O	-1	16471092
8	O	-1	16471092
weeks	O	-1	16471092
treatment,	O	-1	16471092
changes	O	-1	16471092
in	O	-1	16471092
mic@@	O	-1	16471092
t@@	O	-1	16471092
ur@@	O	-1	16471092
ition	O	-1	16471092
di@@	O	-1	16471092
ary	O	-1	16471092
vari@@	O	-1	16471092
able@@	O	-1	16471092
s	O	-1	16471092
and	O	-1	16471092
toler@@	O	-1	16471092
ability	O	-1	16471092
were	O	-1	16471092
deter@@	O	-1	16471092
m@@	O	-1	16471092
ine@@	O	-1	16471092
d.	O	-1	16471092
S@@	O	-1	16471092
h@@	O	-1	16471092
ort	O	-1	16471092
form	O	-1	16471092
3@@	O	-1	16471092
6	O	-1	16471092
(S@@	O	-1	16471092
F@@	O	-1	16471092
3@@	O	-1	16471092
6@@	O	-1	16471092
)	O	-1	16471092
qu@@	O	-1	16471092
es@@	O	-1	16471092
tion@@	O	-1	16471092
a@@	O	-1	16471092
i@@	O	-1	16471092
res	O	-1	16471092
(@@	O	-1	16471092
Th@@	O	-1	16471092
a@@	O	-1	16471092
i	O	-1	16471092
ver@@	O	-1	16471092
sion@@	O	-1	16471092
)	O	-1	16471092
were	O	-1	16471092
given	O	-1	16471092
before	O	-1	16471092
and	O	-1	16471092
after	O	-1	16471092
8	O	-1	16471092
weeks	O	-1	16471092
of	O	-1	16471092
treatment.	O	-1	16471092
RESULTS:	O	-1	16471092
A@@	O	-1	16471092
t	O	-1	16471092
8	O	-1	16471092
week@@	O	-1	16471092
s,	O	-1	16471092
all	O	-1	16471092
mic@@	O	-1	16471092
t@@	O	-1	16471092
ur@@	O	-1	16471092
ition	O	-1	16471092
per	O	-1	16471092
day	O	-1	16471092
decreased	O	-1	16471092
from	O	-1	16471092
1@@	O	-1	16471092
6@@	O	-1	16471092
.	O	-1	16471092
7	O	-1	16471092
+/-	O	-1	16471092
5@@	O	-1	16471092
.	O	-1	16471092
3	O	-1	16471092
to	O	-1	16471092
6@@	O	-1	16471092
.	O	-1	16471092
7	O	-1	16471092
+/-	O	-1	16471092
2.@@	O	-1	16471092
4	O	-1	16471092
times	O	-1	16471092
per	O	-1	16471092
da@@	O	-1	16471092
y.	O	-1	16471092
The	O	-1	16471092
number	O	-1	16471092
of	O	-1	16471092
n@@	B-Disease	D053158	16471092
oc@@	I-Disease	-1	16471092
t@@	I-Disease	-1	16471092
uria	I-Disease	-1	16471092
episo@@	O	-1	16471092
des	O	-1	16471092
decreased	O	-1	16471092
from	O	-1	16471092
5.@@	O	-1	16471092
4	O	-1	16471092
+/-	O	-1	16471092
4.@@	O	-1	16471092
2	O	-1	16471092
to	O	-1	16471092
1.@@	O	-1	16471092
1	O	-1	16471092
+/-	O	-1	16471092
1.@@	O	-1	16471092
0	O	-1	16471092
times	O	-1	16471092
per	O	-1	16471092
n@@	O	-1	16471092
igh@@	O	-1	16471092
t.	O	-1	16471092
The	O	-1	16471092
most	O	-1	16471092
common	O	-1	16471092
side	O	-1	16471092
effect	O	-1	16471092
was	O	-1	16471092
d@@	B-Disease	D014987	16471092
r@@	I-Disease	-1	16471092
y	I-Disease	-1	16471092
mon@@	I-Disease	-1	16471092
th	I-Disease	-1	16471092
in	O	-1	16471092
5	O	-1	16471092
cases	O	-1	16471092
(1@@	O	-1	16471092
6.@@	O	-1	16471092
7@@	O	-1	16471092
%)	O	-1	16471092
with	O	-1	16471092
2	O	-1	16471092
cases	O	-1	16471092
repor@@	O	-1	16471092
ting	O	-1	16471092
a	O	-1	16471092
moder@@	O	-1	16471092
ate	O	-1	16471092
de@@	O	-1	16471092
g@@	O	-1	16471092
ree	O	-1	16471092
and	O	-1	16471092
1	O	-1	16471092
case	O	-1	16471092
with	O	-1	16471092
severe	O	-1	16471092
de@@	O	-1	16471092
gre@@	O	-1	16471092
e.	O	-1	16471092
On@@	O	-1	16471092
ly	O	-1	16471092
one	O	-1	16471092
case	O	-1	16471092
(@@	O	-1	16471092
3.@@	O	-1	16471092
3@@	O	-1	16471092
%)	O	-1	16471092
with@@	O	-1	16471092
d@@	O	-1	16471092
re@@	O	-1	16471092
w	O	-1	16471092
from	O	-1	16471092
the	O	-1	16471092
present	O	-1	16471092
study	O	-1	16471092
due	O	-1	16471092
to	O	-1	16471092
a	O	-1	16471092
severe	O	-1	16471092
d@@	B-Disease	D014987	16471092
r@@	I-Disease	-1	16471092
y	I-Disease	-1	16471092
mou@@	I-Disease	-1	16471092
th	I-Disease	-1	16471092
.	O	-1	16471092
The	O	-1	16471092
S@@	O	-1	16471092
F@@	O	-1	16471092
-@@	O	-1	16471092
3@@	O	-1	16471092
6	O	-1	16471092
sco@@	O	-1	16471092
res	O	-1	16471092
chang@@	O	-1	16471092
ed	O	-1	16471092
significantly	O	-1	16471092
in	O	-1	16471092
the	O	-1	16471092
do@@	O	-1	16471092
main@@	O	-1	16471092
s	O	-1	16471092
of	O	-1	16471092
physi@@	O	-1	16471092
c@@	O	-1	16471092
al	O	-1	16471092
func@@	O	-1	16471092
tion@@	O	-1	16471092
ing,	O	-1	16471092
role	O	-1	16471092
function	O	-1	16471092
em@@	O	-1	16471092
o@@	O	-1	16471092
tion@@	O	-1	16471092
al,	O	-1	16471092
s@@	O	-1	16471092
oci@@	O	-1	16471092
al	O	-1	16471092
function	O	-1	16471092
and	O	-1	16471092
mental	O	-1	16471092
he@@	O	-1	16471092
ath@@	O	-1	16471092
.	O	-1	16471092
CONCLUSION:	O	-1	16471092
T@@	B-Chemical	C099041	16471092
ol@@	I-Chemical	-1	16471092
ter@@	I-Chemical	-1	16471092
o@@	I-Chemical	-1	16471092
d@@	I-Chemical	-1	16471092
ine	I-Chemical	-1	16471092
was	O	-1	16471092
well	O	-1	16471092
toler@@	O	-1	16471092
ated	O	-1	16471092
and	O	-1	16471092
its	O	-1	16471092
effects	O	-1	16471092
improved	O	-1	16471092
the	O	-1	16471092
qu@@	O	-1	16471092
ality	O	-1	16471092
of	O	-1	16471092
lif@@	O	-1	16471092
e	O	-1	16471092
in	O	-1	16471092
Th@@	O	-1	16471092
a@@	O	-1	16471092
i	O	-1	16471092
women	O	-1	16471092
with	O	-1	16471092
O@@	B-Disease	D053201	16471092
A@@	I-Disease	-1	16471092
B	I-Disease	-1	16471092
.	O	-1	16471092

A@@	O	-1	16174948
b@@	O	-1	16174948
s@@	O	-1	16174948
ence	O	-1	16174948
of	O	-1	16174948
acute	O	-1	16174948
cerebral	O	-1	16174948
vas@@	O	-1	16174948
o@@	O	-1	16174948
con@@	O	-1	16174948
stric@@	O	-1	16174948
tion	O	-1	16174948
after	O	-1	16174948
cocaine	B-Chemical	D003042	16174948
-@@	O	-1	16174948
associated	O	-1	16174948
sub@@	B-Disease	D013345	16174948
arac@@	I-Disease	-1	16174948
h@@	I-Disease	-1	16174948
no@@	I-Disease	-1	16174948
id	I-Disease	-1	16174948
hemorrh@@	I-Disease	-1	16174948
age	I-Disease	-1	16174948
.	O	-1	16174948
IN@@	O	-1	16174948
T@@	O	-1	16174948
RO@@	O	-1	16174948
D@@	O	-1	16174948
U@@	O	-1	16174948
C@@	O	-1	16174948
T@@	O	-1	16174948
ION@@	O	-1	16174948
:	O	-1	16174948
C@@	B-Chemical	D003042	16174948
oc@@	I-Chemical	-1	16174948
aine	I-Chemical	-1	16174948
use	O	-1	16174948
has	O	-1	16174948
been	O	-1	16174948
associated	O	-1	16174948
with	O	-1	16174948
neuro@@	B-Disease	D013901	16174948
vascular	I-Disease	-1	16174948
complications	I-Disease	-1	16174948
,	O	-1	16174948
including	O	-1	16174948
arterial	O	-1	16174948
vas@@	O	-1	16174948
o@@	O	-1	16174948
con@@	O	-1	16174948
stric@@	O	-1	16174948
tion	O	-1	16174948
and	O	-1	16174948
vas@@	B-Disease	D014657	16174948
cul@@	I-Disease	-1	16174948
iti@@	I-Disease	-1	16174948
s	I-Disease	-1	16174948
.	O	-1	16174948
However,	O	-1	16174948
there	O	-1	16174948
are	O	-1	16174948
fe@@	O	-1	16174948
w	O	-1	16174948
studies	O	-1	16174948
of	O	-1	16174948
angio@@	O	-1	16174948
graph@@	O	-1	16174948
ic	O	-1	16174948
effects	O	-1	16174948
of	O	-1	16174948
cocaine	B-Chemical	D003042	16174948
on	O	-1	16174948
human	O	-1	16174948
cerebral	O	-1	16174948
arter@@	O	-1	16174948
i@@	O	-1	16174948
es.	O	-1	16174948
In@@	O	-1	16174948
formation	O	-1	16174948
on	O	-1	16174948
these	O	-1	16174948
effects	O	-1	16174948
could	O	-1	16174948
be	O	-1	16174948
obtained	O	-1	16174948
from	O	-1	16174948
angio@@	O	-1	16174948
gram@@	O	-1	16174948
s	O	-1	16174948
of	O	-1	16174948
patients	O	-1	16174948
with	O	-1	16174948
cocaine	B-Chemical	D003042	16174948
-@@	O	-1	16174948
associated	O	-1	16174948
sub@@	B-Disease	D013345	16174948
arac@@	I-Disease	-1	16174948
h@@	I-Disease	-1	16174948
no@@	I-Disease	-1	16174948
id	I-Disease	-1	16174948
hemorrh@@	I-Disease	-1	16174948
age	I-Disease	-1	16174948
(	O	-1	16174948
S@@	B-Disease	D013345	16174948
A@@	I-Disease	-1	16174948
H	I-Disease	-1	16174948
)	O	-1	16174948
who	O	-1	16174948
under@@	O	-1	16174948
w@@	O	-1	16174948
ent	O	-1	16174948
angio@@	O	-1	16174948
graph@@	O	-1	16174948
y	O	-1	16174948
sh@@	O	-1	16174948
ort@@	O	-1	16174948
ly	O	-1	16174948
after	O	-1	16174948
cocaine	B-Chemical	D003042	16174948
use.	O	-1	16174948
METHODS:	O	-1	16174948
We	O	-1	16174948
s@@	O	-1	16174948
cre@@	O	-1	16174948
en@@	O	-1	16174948
ed	O	-1	16174948
patients	O	-1	16174948
with	O	-1	16174948
S@@	B-Disease	D013345	16174948
A@@	I-Disease	-1	16174948
H	I-Disease	-1	16174948
ret@@	O	-1	16174948
ro@@	O	-1	16174948
sp@@	O	-1	16174948
ectively	O	-1	16174948
and	O	-1	16174948
identi@@	O	-1	16174948
fied	O	-1	16174948
those	O	-1	16174948
with	O	-1	16174948
positive	O	-1	16174948
urine	O	-1	16174948
toxic@@	O	-1	16174948
ology	O	-1	16174948
for	O	-1	16174948
cocaine	B-Chemical	D003042	16174948
or	O	-1	16174948
its	O	-1	16174948
metabol@@	O	-1	16174948
it@@	O	-1	16174948
es.	O	-1	16174948
Q@@	O	-1	16174948
u@@	O	-1	16174948
anti@@	O	-1	16174948
t@@	O	-1	16174948
ative	O	-1	16174948
arterial	O	-1	16174948
di@@	O	-1	16174948
ame@@	O	-1	16174948
ter	O	-1	16174948
meas@@	O	-1	16174948
ure@@	O	-1	16174948
ments	O	-1	16174948
from	O	-1	16174948
angio@@	O	-1	16174948
gram@@	O	-1	16174948
s	O	-1	16174948
of	O	-1	16174948
these	O	-1	16174948
patients	O	-1	16174948
were	O	-1	16174948
compared	O	-1	16174948
to	O	-1	16174948
meas@@	O	-1	16174948
ure@@	O	-1	16174948
ments	O	-1	16174948
from	O	-1	16174948
control	O	-1	16174948
patients	O	-1	16174948
with	O	-1	16174948
S@@	B-Disease	D013345	16174948
A@@	I-Disease	-1	16174948
H	I-Disease	-1	16174948
who	O	-1	16174948
were	O	-1	16174948
mat@@	O	-1	16174948
ch@@	O	-1	16174948
ed	O	-1	16174948
for	O	-1	16174948
factors	O	-1	16174948
known	O	-1	16174948
to	O	-1	16174948
influence	O	-1	16174948
arterial	O	-1	16174948
di@@	O	-1	16174948
ame@@	O	-1	16174948
ter@@	O	-1	16174948
.	O	-1	16174948
Q@@	O	-1	16174948
u@@	O	-1	16174948
al@@	O	-1	16174948
it@@	O	-1	16174948
ative	O	-1	16174948
compar@@	O	-1	16174948
is@@	O	-1	16174948
ons	O	-1	16174948
of	O	-1	16174948
sm@@	O	-1	16174948
all	O	-1	16174948
artery	O	-1	16174948
changes	O	-1	16174948
also	O	-1	16174948
were	O	-1	16174948
ma@@	O	-1	16174948
de@@	O	-1	16174948
.	O	-1	16174948
RESULTS:	O	-1	16174948
Th@@	O	-1	16174948
ir@@	O	-1	16174948
te@@	O	-1	16174948
en	O	-1	16174948
patients	O	-1	16174948
with	O	-1	16174948
positive	O	-1	16174948
cocaine	B-Chemical	D003042	16174948
toxic@@	O	-1	16174948
ology	O	-1	16174948
were	O	-1	16174948
compared	O	-1	16174948
to	O	-1	16174948
2@@	O	-1	16174948
6	O	-1	16174948
controls.	O	-1	16174948
There	O	-1	16174948
were	O	-1	16174948
no	O	-1	16174948
significant	O	-1	16174948
differences	O	-1	16174948
between	O	-1	16174948
groups	O	-1	16174948
in	O	-1	16174948
the	O	-1	16174948
mean	O	-1	16174948
di@@	O	-1	16174948
ame@@	O	-1	16174948
ters	O	-1	16174948
of	O	-1	16174948
the	O	-1	16174948
intra@@	O	-1	16174948
dur@@	O	-1	16174948
al	O	-1	16174948
inter@@	O	-1	16174948
n@@	O	-1	16174948
al	O	-1	16174948
ca@@	O	-1	16174948
ro@@	O	-1	16174948
ti@@	O	-1	16174948
d,	O	-1	16174948
s@@	O	-1	16174948
phen@@	O	-1	16174948
oid@@	O	-1	16174948
al	O	-1	16174948
seg@@	O	-1	16174948
ment	O	-1	16174948
of	O	-1	16174948
the	O	-1	16174948
mid@@	O	-1	16174948
d@@	O	-1	16174948
le	O	-1	16174948
ce@@	O	-1	16174948
reb@@	O	-1	16174948
r@@	O	-1	16174948
al,	O	-1	16174948
pre@@	O	-1	16174948
com@@	O	-1	16174948
mun@@	O	-1	16174948
ic@@	O	-1	16174948
ating	O	-1	16174948
seg@@	O	-1	16174948
ment	O	-1	16174948
of	O	-1	16174948
the	O	-1	16174948
an@@	O	-1	16174948
ter@@	O	-1	16174948
ior	O	-1	16174948
ce@@	O	-1	16174948
reb@@	O	-1	16174948
r@@	O	-1	16174948
al,	O	-1	16174948
or	O	-1	16174948
b@@	O	-1	16174948
a@@	O	-1	16174948
si@@	O	-1	16174948
l@@	O	-1	16174948
ar	O	-1	16174948
arter@@	O	-1	16174948
i@@	O	-1	16174948
es	O	-1	16174948
(p	O	-1	16174948
greater	O	-1	16174948
than	O	-1	16174948
0.0@@	O	-1	16174948
5	O	-1	16174948
for	O	-1	16174948
all	O	-1	16174948
compar@@	O	-1	16174948
is@@	O	-1	16174948
on@@	O	-1	16174948
s,	O	-1	16174948
un@@	O	-1	16174948
pa@@	O	-1	16174948
ired	O	-1	16174948
t-@@	O	-1	16174948
test@@	O	-1	16174948
s@@	O	-1	16174948
).	O	-1	16174948
There	O	-1	16174948
also	O	-1	16174948
were	O	-1	16174948
no	O	-1	16174948
significant	O	-1	16174948
differences	O	-1	16174948
between	O	-1	16174948
groups	O	-1	16174948
when	O	-1	16174948
ex@@	O	-1	16174948
press@@	O	-1	16174948
ing	O	-1	16174948
di@@	O	-1	16174948
ame@@	O	-1	16174948
ters	O	-1	16174948
as	O	-1	16174948
the	O	-1	16174948
su@@	O	-1	16174948
m	O	-1	16174948
of	O	-1	16174948
the	O	-1	16174948
pre@@	O	-1	16174948
com@@	O	-1	16174948
mun@@	O	-1	16174948
ic@@	O	-1	16174948
ating	O	-1	16174948
seg@@	O	-1	16174948
ment	O	-1	16174948
of	O	-1	16174948
the	O	-1	16174948
an@@	O	-1	16174948
ter@@	O	-1	16174948
ior	O	-1	16174948
cerebral	O	-1	16174948
+	O	-1	16174948
s@@	O	-1	16174948
phen@@	O	-1	16174948
oid@@	O	-1	16174948
al	O	-1	16174948
seg@@	O	-1	16174948
ment	O	-1	16174948
of	O	-1	16174948
the	O	-1	16174948
mid@@	O	-1	16174948
d@@	O	-1	16174948
le	O	-1	16174948
cerebral	O	-1	16174948
+	O	-1	16174948
sup@@	O	-1	16174948
rac@@	O	-1	16174948
lin@@	O	-1	16174948
oid	O	-1	16174948
inter@@	O	-1	16174948
n@@	O	-1	16174948
al	O	-1	16174948
ca@@	O	-1	16174948
ro@@	O	-1	16174948
ti@@	O	-1	16174948
d	O	-1	16174948
artery	O	-1	16174948
+	O	-1	16174948
b@@	O	-1	16174948
a@@	O	-1	16174948
si@@	O	-1	16174948
l@@	O	-1	16174948
ar	O	-1	16174948
artery	O	-1	16174948
divid@@	O	-1	16174948
ed	O	-1	16174948
by	O	-1	16174948
the	O	-1	16174948
di@@	O	-1	16174948
ame@@	O	-1	16174948
ter	O	-1	16174948
of	O	-1	16174948
the	O	-1	16174948
p@@	O	-1	16174948
et@@	O	-1	16174948
rou@@	O	-1	16174948
s	O	-1	16174948
inter@@	O	-1	16174948
n@@	O	-1	16174948
al	O	-1	16174948
ca@@	O	-1	16174948
ro@@	O	-1	16174948
ti@@	O	-1	16174948
d	O	-1	16174948
artery	O	-1	16174948
(p	O	-1	16174948
greater	O	-1	16174948
than	O	-1	16174948
0.05@@	O	-1	16174948
,	O	-1	16174948
un@@	O	-1	16174948
pa@@	O	-1	16174948
ired	O	-1	16174948
t-@@	O	-1	16174948
test@@	O	-1	16174948
s@@	O	-1	16174948
).	O	-1	16174948
Q@@	O	-1	16174948
u@@	O	-1	16174948
al@@	O	-1	16174948
it@@	O	-1	16174948
ative	O	-1	16174948
assess@@	O	-1	16174948
ments	O	-1	16174948
showed	O	-1	16174948
two	O	-1	16174948
arterial	O	-1	16174948
ir@@	O	-1	16174948
reg@@	O	-1	16174948
ul@@	O	-1	16174948
ar@@	O	-1	16174948
ities	O	-1	16174948
in	O	-1	16174948
the	O	-1	16174948
dist@@	O	-1	16174948
al	O	-1	16174948
vas@@	O	-1	16174948
cul@@	O	-1	16174948
at@@	O	-1	16174948
ure	O	-1	16174948
in	O	-1	16174948
each	O	-1	16174948
group.	O	-1	16174948
CONCLUSION:	O	-1	16174948
No	O	-1	16174948
qu@@	O	-1	16174948
anti@@	O	-1	16174948
t@@	O	-1	16174948
ative	O	-1	16174948
evidence	O	-1	16174948
for	O	-1	16174948
n@@	O	-1	16174948
ar@@	O	-1	16174948
row@@	O	-1	16174948
ing	O	-1	16174948
of	O	-1	16174948
larg@@	O	-1	16174948
e	O	-1	16174948
cerebral	O	-1	16174948
arter@@	O	-1	16174948
i@@	O	-1	16174948
es	O	-1	16174948
or	O	-1	16174948
qu@@	O	-1	16174948
al@@	O	-1	16174948
it@@	O	-1	16174948
ative	O	-1	16174948
angio@@	O	-1	16174948
graph@@	O	-1	16174948
ic	O	-1	16174948
evidence	O	-1	16174948
for	O	-1	16174948
dist@@	O	-1	16174948
al	O	-1	16174948
n@@	O	-1	16174948
ar@@	O	-1	16174948
row@@	O	-1	16174948
ing	O	-1	16174948
or	O	-1	16174948
vas@@	B-Disease	D014657	16174948
cul@@	I-Disease	-1	16174948
iti@@	I-Disease	-1	16174948
s	I-Disease	-1	16174948
could	O	-1	16174948
be	O	-1	16174948
found	O	-1	16174948
in	O	-1	16174948
patients	O	-1	16174948
who	O	-1	16174948
under@@	O	-1	16174948
w@@	O	-1	16174948
ent	O	-1	16174948
angio@@	O	-1	16174948
graph@@	O	-1	16174948
y	O	-1	16174948
after	O	-1	16174948
aneurys@@	B-Disease	D017542	16174948
m@@	I-Disease	-1	16174948
al	I-Disease	-1	16174948
S@@	B-Disease	D013345	16174948
A@@	I-Disease	-1	16174948
H	I-Disease	-1	16174948
associated	O	-1	16174948
with	O	-1	16174948
cocaine	B-Chemical	D003042	16174948
use.	O	-1	16174948

A@@	B-Disease	D001281	15042318
trial	I-Disease	-1	15042318
fibrill@@	I-Disease	-1	15042318
ation	I-Disease	-1	15042318
following	O	-1	15042318
chemotherapy	O	-1	15042318
for	O	-1	15042318
st@@	O	-1	15042318
age	O	-1	15042318
II@@	O	-1	15042318
I@@	O	-1	15042318
E	O	-1	15042318
diff@@	O	-1	15042318
use	O	-1	15042318
larg@@	O	-1	15042318
e	O	-1	15042318
B@@	O	-1	15042318
-@@	O	-1	15042318
cell	O	-1	15042318
gast@@	B-Disease	C535648	15042318
ric	I-Disease	-1	15042318
lymph@@	I-Disease	-1	15042318
oma	I-Disease	-1	15042318
in	O	-1	15042318
a	O	-1	15042318
patient	O	-1	15042318
with	O	-1	15042318
my@@	B-Disease	D009223	15042318
oton@@	I-Disease	-1	15042318
ic	I-Disease	-1	15042318
dy@@	I-Disease	-1	15042318
stro@@	I-Disease	-1	15042318
ph@@	I-Disease	-1	15042318
y	I-Disease	-1	15042318
(	O	-1	15042318
S@@	B-Disease	D009223	15042318
te@@	I-Disease	-1	15042318
in@@	I-Disease	-1	15042318
er@@	I-Disease	-1	15042318
t@@	I-Disease	-1	15042318
's	I-Disease	-1	15042318
disease	I-Disease	-1	15042318
).	O	-1	15042318
The	O	-1	15042318
au@@	O	-1	15042318
th@@	O	-1	15042318
ors	O	-1	15042318
describe	O	-1	15042318
the	O	-1	15042318
un@@	O	-1	15042318
us@@	O	-1	15042318
ual	O	-1	15042318
association	O	-1	15042318
between	O	-1	15042318
diff@@	O	-1	15042318
use	O	-1	15042318
B@@	O	-1	15042318
-@@	O	-1	15042318
cell	O	-1	15042318
gast@@	B-Disease	C535648	15042318
ric	I-Disease	-1	15042318
lymph@@	I-Disease	-1	15042318
oma	I-Disease	-1	15042318
and	O	-1	15042318
my@@	B-Disease	D009223	15042318
oton@@	I-Disease	-1	15042318
ic	I-Disease	-1	15042318
dy@@	I-Disease	-1	15042318
stro@@	I-Disease	-1	15042318
ph@@	I-Disease	-1	15042318
y	I-Disease	-1	15042318
,	O	-1	15042318
the	O	-1	15042318
most	O	-1	15042318
common	O	-1	15042318
form	O	-1	15042318
of	O	-1	15042318
ad@@	O	-1	15042318
ult	O	-1	15042318
mus@@	B-Disease	D009136	15042318
cular	I-Disease	-1	15042318
dy@@	I-Disease	-1	15042318
stro@@	I-Disease	-1	15042318
ph@@	I-Disease	-1	15042318
y	I-Disease	-1	15042318
,	O	-1	15042318
and	O	-1	15042318
su@@	O	-1	15042318
d@@	O	-1	15042318
de@@	O	-1	15042318
n	O	-1	15042318
atrial	B-Disease	D001281	15042318
fibrill@@	I-Disease	-1	15042318
ation	I-Disease	-1	15042318
following	O	-1	15042318
one	O	-1	15042318
cyc@@	O	-1	15042318
le	O	-1	15042318
of	O	-1	15042318
dox@@	B-Chemical	D004317	15042318
orub@@	I-Chemical	-1	15042318
icin	I-Chemical	-1	15042318
-@@	O	-1	15042318
bas@@	O	-1	15042318
ed	O	-1	15042318
chemotherapy	O	-1	15042318
in	O	-1	15042318
the	O	-1	15042318
same	O	-1	15042318
patient@@	O	-1	15042318
.	O	-1	15042318
A@@	B-Disease	D001281	15042318
trial	I-Disease	-1	15042318
fibrill@@	I-Disease	-1	15042318
ation	I-Disease	-1	15042318
or	O	-1	15042318
other	O	-1	15042318
cardiac	B-Disease	D001145	15042318
arrhyth@@	I-Disease	-1	15042318
mi@@	I-Disease	-1	15042318
as	I-Disease	-1	15042318
are	O	-1	15042318
un@@	O	-1	15042318
us@@	O	-1	15042318
ual	O	-1	15042318
complications	O	-1	15042318
in	O	-1	15042318
patients	O	-1	15042318
treated	O	-1	15042318
with	O	-1	15042318
chemo@@	O	-1	15042318
therapy.	O	-1	15042318
The	O	-1	15042318
cardiac	B-Disease	D066126	15042318
toxicity	I-Disease	-1	15042318
int@@	O	-1	15042318
r@@	O	-1	15042318
in@@	O	-1	15042318
si@@	O	-1	15042318
c@@	O	-1	15042318
ally	O	-1	15042318
associated	O	-1	15042318
with	O	-1	15042318
the	O	-1	15042318
ag@@	O	-1	15042318
gres@@	O	-1	15042318
sive	O	-1	15042318
chemotherapy	O	-1	15042318
em@@	O	-1	15042318
p@@	O	-1	15042318
lo@@	O	-1	15042318
y@@	O	-1	15042318
ed	O	-1	15042318
could	O	-1	15042318
function	O	-1	15042318
as	O	-1	15042318
a	O	-1	15042318
tri@@	O	-1	15042318
g@@	O	-1	15042318
g@@	O	-1	15042318
ering	O	-1	15042318
factor	O	-1	15042318
for	O	-1	15042318
the	O	-1	15042318
arrhyth@@	B-Disease	D001145	15042318
mia	I-Disease	-1	15042318
in	O	-1	15042318
the	O	-1	15042318
pre@@	O	-1	15042318
dis@@	O	-1	15042318
pos@@	O	-1	15042318
ed	O	-1	15042318
myocardi@@	O	-1	15042318
um	O	-1	15042318
of	O	-1	15042318
this	O	-1	15042318
patient@@	O	-1	15042318
.	O	-1	15042318

A	O	-1	12448656
phase	O	-1	12448656
II	O	-1	12448656
study	O	-1	12448656
of	O	-1	12448656
thal@@	B-Chemical	D013792	12448656
id@@	I-Chemical	-1	12448656
om@@	I-Chemical	-1	12448656
ide	I-Chemical	-1	12448656
in	O	-1	12448656
adv@@	O	-1	12448656
anced	O	-1	12448656
met@@	O	-1	12448656
ast@@	O	-1	12448656
atic	O	-1	12448656
renal	B-Disease	D002292	12448656
cell	I-Disease	-1	12448656
carcin@@	I-Disease	-1	12448656
oma	I-Disease	-1	12448656
.	O	-1	12448656
OBJECTIV@@	O	-1	12448656
E@@	O	-1	12448656
S:	O	-1	12448656
To	O	-1	12448656
evalu@@	O	-1	12448656
ate	O	-1	12448656
the	O	-1	12448656
toxicity	B-Disease	D064420	12448656
and	O	-1	12448656
activity	O	-1	12448656
of	O	-1	12448656
thal@@	B-Chemical	D013792	12448656
id@@	I-Chemical	-1	12448656
om@@	I-Chemical	-1	12448656
ide	I-Chemical	-1	12448656
in	O	-1	12448656
patients	O	-1	12448656
with	O	-1	12448656
adv@@	O	-1	12448656
anced	O	-1	12448656
met@@	O	-1	12448656
ast@@	O	-1	12448656
atic	O	-1	12448656
renal	B-Disease	D002292	12448656
cell	I-Disease	-1	12448656
cancer	I-Disease	-1	12448656
and	O	-1	12448656
to	O	-1	12448656
meas@@	O	-1	12448656
ure	O	-1	12448656
changes	O	-1	12448656
of	O	-1	12448656
one	O	-1	12448656
angio@@	O	-1	12448656
genic	O	-1	12448656
fact@@	O	-1	12448656
or@@	O	-1	12448656
,	O	-1	12448656
vascular	O	-1	12448656
endothelial	O	-1	12448656
growth	O	-1	12448656
factor	O	-1	12448656
(V@@	O	-1	12448656
E@@	O	-1	12448656
GF@@	O	-1	12448656
)@@	O	-1	12448656
1@@	O	-1	12448656
6@@	O	-1	12448656
5,	O	-1	12448656
with	O	-1	12448656
therapy.	O	-1	12448656
PA@@	O	-1	12448656
TI@@	O	-1	12448656
E@@	O	-1	12448656
N@@	O	-1	12448656
T@@	O	-1	12448656
S	O	-1	12448656
AN@@	O	-1	12448656
D	O	-1	12448656
METHODS:	O	-1	12448656
2@@	O	-1	12448656
9	O	-1	12448656
patients	O	-1	12448656
were	O	-1	12448656
en@@	O	-1	12448656
ro@@	O	-1	12448656
lled	O	-1	12448656
on	O	-1	12448656
a	O	-1	12448656
study	O	-1	12448656
of	O	-1	12448656
thal@@	B-Chemical	D013792	12448656
id@@	I-Chemical	-1	12448656
om@@	I-Chemical	-1	12448656
ide	I-Chemical	-1	12448656
using	O	-1	12448656
an	O	-1	12448656
intra@@	O	-1	12448656
-@@	O	-1	12448656
patient	O	-1	12448656
dose	O	-1	12448656
es@@	O	-1	12448656
cal@@	O	-1	12448656
ation	O	-1	12448656
sch@@	O	-1	12448656
ed@@	O	-1	12448656
ul@@	O	-1	12448656
e.	O	-1	12448656
Patients	O	-1	12448656
be@@	O	-1	12448656
g@@	O	-1	12448656
an	O	-1	12448656
thal@@	B-Chemical	D013792	12448656
id@@	I-Chemical	-1	12448656
om@@	I-Chemical	-1	12448656
ide	I-Chemical	-1	12448656
at	O	-1	12448656
4@@	O	-1	12448656
00	O	-1	12448656
mg/@@	O	-1	12448656
d	O	-1	12448656
and	O	-1	12448656
es@@	O	-1	12448656
cal@@	O	-1	12448656
ated	O	-1	12448656
as	O	-1	12448656
toler@@	O	-1	12448656
ated	O	-1	12448656
to	O	-1	12448656
12@@	O	-1	12448656
00	O	-1	12448656
mg/@@	O	-1	12448656
d	O	-1	12448656
by	O	-1	12448656
day	O	-1	12448656
5@@	O	-1	12448656
4@@	O	-1	12448656
.	O	-1	12448656
F@@	O	-1	12448656
if@@	O	-1	12448656
ty-@@	O	-1	12448656
n@@	O	-1	12448656
ine	O	-1	12448656
per	O	-1	12448656
c@@	O	-1	12448656
ent	O	-1	12448656
of	O	-1	12448656
patients	O	-1	12448656
had	O	-1	12448656
had	O	-1	12448656
previ@@	O	-1	12448656
ous	O	-1	12448656
therapy	O	-1	12448656
with	O	-1	12448656
I@@	O	-1	12448656
L-@@	O	-1	12448656
2	O	-1	12448656
and	O	-1	12448656
5@@	O	-1	12448656
2@@	O	-1	12448656
%	O	-1	12448656
were	O	-1	12448656
perform@@	O	-1	12448656
ance	O	-1	12448656
status	O	-1	12448656
2	O	-1	12448656
or	O	-1	12448656
3@@	O	-1	12448656
.	O	-1	12448656
S@@	O	-1	12448656
y@@	O	-1	12448656
st@@	O	-1	12448656
em@@	O	-1	12448656
ic	O	-1	12448656
plasma	O	-1	12448656
V@@	O	-1	12448656
E@@	O	-1	12448656
GF@@	O	-1	12448656
1@@	O	-1	12448656
6@@	O	-1	12448656
5	O	-1	12448656
levels	O	-1	12448656
were	O	-1	12448656
measured	O	-1	12448656
by	O	-1	12448656
du@@	O	-1	12448656
al	O	-1	12448656
mon@@	O	-1	12448656
oc@@	O	-1	12448656
lon@@	O	-1	12448656
al	O	-1	12448656
E@@	O	-1	12448656
L@@	O	-1	12448656
I@@	O	-1	12448656
S@@	O	-1	12448656
A	O	-1	12448656
in	O	-1	12448656
8	O	-1	12448656
patients.	O	-1	12448656
RESULTS:	O	-1	12448656
24	O	-1	12448656
patients	O	-1	12448656
were	O	-1	12448656
evalu@@	O	-1	12448656
able	O	-1	12448656
for	O	-1	12448656
response	O	-1	12448656
with	O	-1	12448656
one	O	-1	12448656
partial	O	-1	12448656
response	O	-1	12448656
of	O	-1	12448656
11	O	-1	12448656
months	O	-1	12448656
duration	O	-1	12448656
of	O	-1	12448656
a	O	-1	12448656
patient	O	-1	12448656
with	O	-1	12448656
hepatic	O	-1	12448656
and	O	-1	12448656
pulmonary	O	-1	12448656
met@@	B-Disease	D009362	12448656
ast@@	I-Disease	-1	12448656
as@@	I-Disease	-1	12448656
es	I-Disease	-1	12448656
(4@@	O	-1	12448656
%),	O	-1	12448656
one	O	-1	12448656
min@@	O	-1	12448656
or	O	-1	12448656
respon@@	O	-1	12448656
se@@	O	-1	12448656
,	O	-1	12448656
and	O	-1	12448656
2	O	-1	12448656
patients	O	-1	12448656
st@@	O	-1	12448656
able	O	-1	12448656
for	O	-1	12448656
over	O	-1	12448656
6	O	-1	12448656
months.	O	-1	12448656
S@@	B-Disease	D006970	12448656
om@@	I-Disease	-1	12448656
n@@	I-Disease	-1	12448656
ol@@	I-Disease	-1	12448656
ence	I-Disease	-1	12448656
and	O	-1	12448656
con@@	B-Disease	D003248	12448656
sti@@	I-Disease	-1	12448656
p@@	I-Disease	-1	12448656
ation	I-Disease	-1	12448656
were	O	-1	12448656
pro@@	O	-1	12448656
min@@	O	-1	12448656
ent	O	-1	12448656
toxic@@	B-Disease	D064420	12448656
ities	I-Disease	-1	12448656
and	O	-1	12448656
most	O	-1	12448656
patients	O	-1	12448656
could	O	-1	12448656
not	O	-1	12448656
toler@@	O	-1	12448656
ate	O	-1	12448656
the	O	-1	12448656
12@@	O	-1	12448656
00	O	-1	12448656
mg/@@	O	-1	12448656
day	O	-1	12448656
dose	O	-1	12448656
level@@	O	-1	12448656
.	O	-1	12448656
S@@	O	-1	12448656
y@@	O	-1	12448656
st@@	O	-1	12448656
em@@	O	-1	12448656
ic	O	-1	12448656
plasma	O	-1	12448656
V@@	O	-1	12448656
E@@	O	-1	12448656
GF@@	O	-1	12448656
1@@	O	-1	12448656
6@@	O	-1	12448656
5	O	-1	12448656
levels	O	-1	12448656
did	O	-1	12448656
not	O	-1	12448656
change	O	-1	12448656
with	O	-1	12448656
therapy.	O	-1	12448656
CONCLUSION:	O	-1	12448656
These	O	-1	12448656
results	O	-1	12448656
are	O	-1	12448656
consist@@	O	-1	12448656
ent	O	-1	12448656
with	O	-1	12448656
a	O	-1	12448656
low	O	-1	12448656
level	O	-1	12448656
of	O	-1	12448656
activity	O	-1	12448656
of	O	-1	12448656
thal@@	B-Chemical	D013792	12448656
id@@	I-Chemical	-1	12448656
om@@	I-Chemical	-1	12448656
ide	I-Chemical	-1	12448656
in	O	-1	12448656
renal	B-Disease	D002292	12448656
cell	I-Disease	-1	12448656
carcin@@	I-Disease	-1	12448656
oma	I-Disease	-1	12448656
.	O	-1	12448656
Ad@@	O	-1	12448656
minist@@	O	-1	12448656
ration	O	-1	12448656
of	O	-1	12448656
doses	O	-1	12448656
over	O	-1	12448656
8@@	O	-1	12448656
00	O	-1	12448656
mg/@@	O	-1	12448656
day	O	-1	12448656
was	O	-1	12448656
diff@@	O	-1	12448656
ic@@	O	-1	12448656
ult	O	-1	12448656
to	O	-1	12448656
achi@@	O	-1	12448656
e@@	O	-1	12448656
ve	O	-1	12448656
in	O	-1	12448656
this	O	-1	12448656
patient	O	-1	12448656
po@@	O	-1	12448656
pul@@	O	-1	12448656
ation,	O	-1	12448656
ho@@	O	-1	12448656
we@@	O	-1	12448656
ver	O	-1	12448656
lower	O	-1	12448656
doses	O	-1	12448656
were	O	-1	12448656
p@@	O	-1	12448656
rac@@	O	-1	12448656
tic@@	O	-1	12448656
al.	O	-1	12448656
The	O	-1	12448656
dose-@@	O	-1	12448656
response	O	-1	12448656
rel@@	O	-1	12448656
ation@@	O	-1	12448656
shi@@	O	-1	12448656
p@@	O	-1	12448656
,	O	-1	12448656
if	O	-1	12448656
an@@	O	-1	12448656
y,	O	-1	12448656
of	O	-1	12448656
thal@@	B-Chemical	D013792	12448656
id@@	I-Chemical	-1	12448656
om@@	I-Chemical	-1	12448656
ide	I-Chemical	-1	12448656
for	O	-1	12448656
renal	B-Disease	D002292	12448656
cell	I-Disease	-1	12448656
carcin@@	I-Disease	-1	12448656
oma	I-Disease	-1	12448656
is	O	-1	12448656
unc@@	O	-1	12448656
lear@@	O	-1	12448656
.	O	-1	12448656

The	O	-1	12231232
striat@@	O	-1	12231232
um	O	-1	12231232
as	O	-1	12231232
a	O	-1	12231232
t@@	O	-1	12231232
arg@@	O	-1	12231232
et	O	-1	12231232
for	O	-1	12231232
anti@@	O	-1	12231232
-@@	O	-1	12231232
rig@@	O	-1	12231232
or	O	-1	12231232
effects	O	-1	12231232
of	O	-1	12231232
an	O	-1	12231232
antagonist	O	-1	12231232
of	O	-1	12231232
m@@	O	-1	12231232
G@@	O	-1	12231232
lu@@	O	-1	12231232
R@@	O	-1	12231232
1,	O	-1	12231232
but	O	-1	12231232
not	O	-1	12231232
an	O	-1	12231232
agon@@	O	-1	12231232
ist	O	-1	12231232
of	O	-1	12231232
group	O	-1	12231232
II	O	-1	12231232
met@@	O	-1	12231232
ab@@	O	-1	12231232
ot@@	O	-1	12231232
ro@@	O	-1	12231232
p@@	O	-1	12231232
ic	O	-1	12231232
glutamate	B-Chemical	D018698	12231232
receptor@@	O	-1	12231232
s.	O	-1	12231232
The	O	-1	12231232
a@@	O	-1	12231232
im	O	-1	12231232
of	O	-1	12231232
the	O	-1	12231232
present	O	-1	12231232
study	O	-1	12231232
was	O	-1	12231232
to	O	-1	12231232
f@@	O	-1	12231232
ind	O	-1	12231232
out	O	-1	12231232
whether	O	-1	12231232
the	O	-1	12231232
met@@	O	-1	12231232
ab@@	O	-1	12231232
ot@@	O	-1	12231232
ro@@	O	-1	12231232
p@@	O	-1	12231232
ic	O	-1	12231232
receptor	O	-1	12231232
1	O	-1	12231232
(@@	O	-1	12231232
m@@	O	-1	12231232
G@@	O	-1	12231232
lu@@	O	-1	12231232
R@@	O	-1	12231232
1)	O	-1	12231232
and	O	-1	12231232
group	O	-1	12231232
II	O	-1	12231232
m@@	O	-1	12231232
G@@	O	-1	12231232
lu@@	O	-1	12231232
R@@	O	-1	12231232
s,	O	-1	12231232
lo@@	O	-1	12231232
cal@@	O	-1	12231232
ized	O	-1	12231232
in	O	-1	12231232
the	O	-1	12231232
striat@@	O	-1	12231232
um,	O	-1	12231232
are	O	-1	12231232
involved	O	-1	12231232
in	O	-1	12231232
anti@@	O	-1	12231232
par@@	O	-1	12231232
k@@	O	-1	12231232
inson@@	O	-1	12231232
i@@	O	-1	12231232
an@@	O	-1	12231232
-@@	O	-1	12231232
like	O	-1	12231232
effects	O	-1	12231232
in	O	-1	12231232
rats.	O	-1	12231232
H@@	B-Chemical	D006220	12231232
alo@@	I-Chemical	-1	12231232
perid@@	I-Chemical	-1	12231232
ol	I-Chemical	-1	12231232
(@@	O	-1	12231232
1	O	-1	12231232
mg/kg	O	-1	12231232
ip@@	O	-1	12231232
)	O	-1	12231232
induced	O	-1	12231232
par@@	B-Disease	D010300	12231232
k@@	I-Disease	-1	12231232
inson@@	I-Disease	-1	12231232
i@@	I-Disease	-1	12231232
an	I-Disease	-1	12231232
-@@	O	-1	12231232
like	O	-1	12231232
musc@@	B-Disease	D009127	12231232
le	I-Disease	-1	12231232
rig@@	I-Disease	-1	12231232
idity	I-Disease	-1	12231232
,	O	-1	12231232
measured	O	-1	12231232
as	O	-1	12231232
an	O	-1	12231232
increased	O	-1	12231232
resist@@	O	-1	12231232
ance	O	-1	12231232
of	O	-1	12231232
a	O	-1	12231232
rat@@	O	-1	12231232
's	O	-1	12231232
h@@	O	-1	12231232
ind	O	-1	12231232
fo@@	O	-1	12231232
o@@	O	-1	12231232
t	O	-1	12231232
to	O	-1	12231232
p@@	O	-1	12231232
as@@	O	-1	12231232
sive	O	-1	12231232
f@@	O	-1	12231232
le@@	O	-1	12231232
xi@@	O	-1	12231232
on	O	-1	12231232
and	O	-1	12231232
exten@@	O	-1	12231232
sion	O	-1	12231232
at	O	-1	12231232
the	O	-1	12231232
an@@	O	-1	12231232
k@@	O	-1	12231232
le	O	-1	12231232
j@@	O	-1	12231232
o@@	O	-1	12231232
int@@	O	-1	12231232
.	O	-1	12231232
(@@	B-Chemical	C095756	12231232
R@@	I-Chemical	-1	12231232
S@@	I-Chemical	-1	12231232
)@@	I-Chemical	-1	12231232
-1@@	I-Chemical	-1	12231232
-@@	I-Chemical	-1	12231232
amino@@	I-Chemical	-1	12231232
ind@@	I-Chemical	-1	12231232
an@@	I-Chemical	-1	12231232
-1@@	I-Chemical	-1	12231232
,@@	I-Chemical	-1	12231232
5-@@	I-Chemical	-1	12231232
dic@@	I-Chemical	-1	12231232
arb@@	I-Chemical	-1	12231232
ox@@	I-Chemical	-1	12231232
yl@@	I-Chemical	-1	12231232
ic	I-Chemical	-1	12231232
acid	I-Chemical	-1	12231232
(	O	-1	12231232
A@@	B-Chemical	C095756	12231232
I@@	I-Chemical	-1	12231232
D@@	I-Chemical	-1	12231232
A	I-Chemical	-1	12231232
;	O	-1	12231232
0.@@	O	-1	12231232
5-@@	O	-1	12231232
15	O	-1	12231232
micro@@	O	-1	12231232
g/@@	O	-1	12231232
0.@@	O	-1	12231232
5	O	-1	12231232
micro@@	O	-1	12231232
l@@	O	-1	12231232
),	O	-1	12231232
a	O	-1	12231232
pot@@	O	-1	12231232
ent	O	-1	12231232
and	O	-1	12231232
selective	O	-1	12231232
m@@	O	-1	12231232
G@@	O	-1	12231232
lu@@	O	-1	12231232
R@@	O	-1	12231232
1	O	-1	12231232
antagonist@@	O	-1	12231232
,	O	-1	12231232
or	O	-1	12231232
(2@@	B-Chemical	C097299	12231232
R@@	I-Chemical	-1	12231232
,@@	I-Chemical	-1	12231232
4@@	I-Chemical	-1	12231232
R@@	I-Chemical	-1	12231232
)-@@	I-Chemical	-1	12231232
4-@@	I-Chemical	-1	12231232
amino@@	I-Chemical	-1	12231232
py@@	I-Chemical	-1	12231232
r@@	I-Chemical	-1	12231232
ro@@	I-Chemical	-1	12231232
l@@	I-Chemical	-1	12231232
id@@	I-Chemical	-1	12231232
ine-@@	I-Chemical	-1	12231232
2@@	I-Chemical	-1	12231232
,@@	I-Chemical	-1	12231232
4-@@	I-Chemical	-1	12231232
dic@@	I-Chemical	-1	12231232
arb@@	I-Chemical	-1	12231232
ox@@	I-Chemical	-1	12231232
yl@@	I-Chemical	-1	12231232
ate	I-Chemical	-1	12231232
(	O	-1	12231232
2@@	B-Chemical	C097299	12231232
R@@	I-Chemical	-1	12231232
,@@	I-Chemical	-1	12231232
4@@	I-Chemical	-1	12231232
R@@	I-Chemical	-1	12231232
-@@	I-Chemical	-1	12231232
A@@	I-Chemical	-1	12231232
P@@	I-Chemical	-1	12231232
D@@	I-Chemical	-1	12231232
C	I-Chemical	-1	12231232
;	O	-1	12231232
7.@@	O	-1	12231232
5-@@	O	-1	12231232
15	O	-1	12231232
micro@@	O	-1	12231232
g/@@	O	-1	12231232
0.@@	O	-1	12231232
5	O	-1	12231232
micro@@	O	-1	12231232
l@@	O	-1	12231232
),	O	-1	12231232
a	O	-1	12231232
selective	O	-1	12231232
group	O	-1	12231232
II	O	-1	12231232
agon@@	O	-1	12231232
ist@@	O	-1	12231232
,	O	-1	12231232
was	O	-1	12231232
injected	O	-1	12231232
bil@@	O	-1	12231232
at@@	O	-1	12231232
er@@	O	-1	12231232
ally	O	-1	12231232
into	O	-1	12231232
the	O	-1	12231232
striat@@	O	-1	12231232
um	O	-1	12231232
of	O	-1	12231232
haloperidol	B-Chemical	D006220	12231232
-treated	O	-1	12231232
anim@@	O	-1	12231232
al@@	O	-1	12231232
s.	O	-1	12231232
A@@	B-Chemical	C095756	12231232
I@@	I-Chemical	-1	12231232
D@@	I-Chemical	-1	12231232
A	I-Chemical	-1	12231232
in	O	-1	12231232
doses	O	-1	12231232
of	O	-1	12231232
7.@@	O	-1	12231232
5-@@	O	-1	12231232
15	O	-1	12231232
micro@@	O	-1	12231232
g/@@	O	-1	12231232
0.@@	O	-1	12231232
5	O	-1	12231232
micro@@	O	-1	12231232
l	O	-1	12231232
di@@	O	-1	12231232
min@@	O	-1	12231232
ished	O	-1	12231232
the	O	-1	12231232
haloperidol	B-Chemical	D006220	12231232
-induced	O	-1	12231232
musc@@	B-Disease	D009127	12231232
le	I-Disease	-1	12231232
rig@@	I-Disease	-1	12231232
idity	I-Disease	-1	12231232
.	O	-1	12231232
In	O	-1	12231232
contrast@@	O	-1	12231232
,	O	-1	12231232
2@@	B-Chemical	C097299	12231232
R@@	I-Chemical	-1	12231232
,@@	I-Chemical	-1	12231232
4@@	I-Chemical	-1	12231232
R@@	I-Chemical	-1	12231232
-@@	I-Chemical	-1	12231232
A@@	I-Chemical	-1	12231232
P@@	I-Chemical	-1	12231232
D@@	I-Chemical	-1	12231232
C	I-Chemical	-1	12231232
injec@@	O	-1	12231232
tions	O	-1	12231232
were	O	-1	12231232
ine@@	O	-1	12231232
ff@@	O	-1	12231232
ecti@@	O	-1	12231232
ve.	O	-1	12231232
The	O	-1	12231232
present	O	-1	12231232
results	O	-1	12231232
may	O	-1	12231232
suggest	O	-1	12231232
that	O	-1	12231232
the	O	-1	12231232
block@@	O	-1	12231232
ade	O	-1	12231232
of	O	-1	12231232
stri@@	O	-1	12231232
atal	O	-1	12231232
m@@	O	-1	12231232
G@@	O	-1	12231232
lu@@	O	-1	12231232
R@@	O	-1	12231232
1,	O	-1	12231232
but	O	-1	12231232
not	O	-1	12231232
the	O	-1	12231232
stimulation	O	-1	12231232
of	O	-1	12231232
group	O	-1	12231232
II	O	-1	12231232
m@@	O	-1	12231232
G@@	O	-1	12231232
lu@@	O	-1	12231232
R@@	O	-1	12231232
s,	O	-1	12231232
may	O	-1	12231232
ame@@	O	-1	12231232
li@@	O	-1	12231232
or@@	O	-1	12231232
ate	O	-1	12231232
par@@	B-Disease	D010300	12231232
k@@	I-Disease	-1	12231232
inson@@	I-Disease	-1	12231232
i@@	I-Disease	-1	12231232
an	I-Disease	-1	12231232
musc@@	B-Disease	D009127	12231232
le	I-Disease	-1	12231232
rig@@	I-Disease	-1	12231232
idity	I-Disease	-1	12231232
.	O	-1	12231232

Ac@@	O	-1	11847945
ute	O	-1	11847945
cholest@@	B-Disease	D002779	11847945
atic	I-Disease	-1	11847945
hepatitis	I-Disease	-1	11847945
cholest@@	B-Disease	D056486	11847945
atic	I-Disease	-1	11847945
hepatitis	I-Disease	-1	11847945
after	O	-1	11847945
exposure	O	-1	11847945
to	O	-1	11847945
iso@@	B-Chemical	D007530	11847945
f@@	I-Chemical	-1	11847945
lur@@	I-Chemical	-1	11847945
ane	I-Chemical	-1	11847945
.	O	-1	11847945
OBJECTIVE:	O	-1	11847945
To	O	-1	11847945
report	O	-1	11847945
a	O	-1	11847945
case	O	-1	11847945
of	O	-1	11847945
acute	O	-1	11847945
cholest@@	B-Disease	D002779	11847945
atic	I-Disease	-1	11847945
hepatitis	I-Disease	-1	11847945
cholest@@	B-Disease	D056486	11847945
atic	I-Disease	-1	11847945
hepatitis	I-Disease	-1	11847945
following	O	-1	11847945
exposure	O	-1	11847945
to	O	-1	11847945
the	O	-1	11847945
in@@	O	-1	11847945
h@@	O	-1	11847945
al@@	O	-1	11847945
ation@@	O	-1	11847945
al	O	-1	11847945
anesthe@@	O	-1	11847945
tic	O	-1	11847945
iso@@	B-Chemical	D007530	11847945
f@@	I-Chemical	-1	11847945
lur@@	I-Chemical	-1	11847945
ane	I-Chemical	-1	11847945
.	O	-1	11847945
CA@@	O	-1	11847945
S@@	O	-1	11847945
E	O	-1	11847945
S@@	O	-1	11847945
U@@	O	-1	11847945
M@@	O	-1	11847945
MA@@	O	-1	11847945
R@@	O	-1	11847945
Y@@	O	-1	11847945
:	O	-1	11847945
A	O	-1	11847945
7@@	O	-1	11847945
0-@@	O	-1	11847945
year-old	O	-1	11847945
healthy	O	-1	11847945
woman	O	-1	11847945
from	O	-1	11847945
I@@	O	-1	11847945
ra@@	O	-1	11847945
q	O	-1	11847945
developed	O	-1	11847945
acute	O	-1	11847945
cholest@@	B-Disease	D002779	11847945
atic	I-Disease	-1	11847945
hepatitis	I-Disease	-1	11847945
cholest@@	B-Disease	D056486	11847945
atic	I-Disease	-1	11847945
hepatitis	I-Disease	-1	11847945
3	O	-1	11847945
weeks	O	-1	11847945
following	O	-1	11847945
re@@	O	-1	11847945
pa@@	O	-1	11847945
ir	O	-1	11847945
of	O	-1	11847945
the	O	-1	11847945
right	O	-1	11847945
ro@@	O	-1	11847945
t@@	O	-1	11847945
at@@	O	-1	11847945
or	O	-1	11847945
c@@	O	-1	11847945
u@@	O	-1	11847945
f@@	O	-1	11847945
f	O	-1	11847945
under	O	-1	11847945
gener@@	O	-1	11847945
al	O	-1	11847945
anesthe@@	O	-1	11847945
sia.	O	-1	11847945
There	O	-1	11847945
was	O	-1	11847945
no	O	-1	11847945
evidence	O	-1	11847945
for	O	-1	11847945
vi@@	O	-1	11847945
r@@	O	-1	11847945
al,	O	-1	11847945
auto@@	O	-1	11847945
immun@@	O	-1	11847945
e,	O	-1	11847945
or	O	-1	11847945
met@@	O	-1	11847945
ab@@	O	-1	11847945
olic	O	-1	11847945
causes	O	-1	11847945
of	O	-1	11847945
hepatitis	B-Disease	D056486	11847945
.	O	-1	11847945
No	O	-1	11847945
other	O	-1	11847945
medic@@	O	-1	11847945
ations	O	-1	11847945
were	O	-1	11847945
involved	O	-1	11847945
ex@@	O	-1	11847945
cep@@	O	-1	11847945
t	O	-1	11847945
for	O	-1	11847945
di@@	B-Chemical	D004177	11847945
py@@	I-Chemical	-1	11847945
r@@	I-Chemical	-1	11847945
one	I-Chemical	-1	11847945
for	O	-1	11847945
analge@@	B-Disease	D000699	11847945
sia	I-Disease	-1	11847945
.	O	-1	11847945
The	O	-1	11847945
al@@	B-Chemical	D000409	11847945
an@@	I-Chemical	-1	11847945
ine	I-Chemical	-1	11847945
amin@@	O	-1	11847945
ot@@	O	-1	11847945
ran@@	O	-1	11847945
s@@	O	-1	11847945
fer@@	O	-1	11847945
ase	O	-1	11847945
was	O	-1	11847945
elevated	O	-1	11847945
to	O	-1	11847945
a	O	-1	11847945
pe@@	O	-1	11847945
a@@	O	-1	11847945
k	O	-1	11847945
concentration	O	-1	11847945
of	O	-1	11847945
1@@	O	-1	11847945
5@@	O	-1	11847945
3@@	O	-1	11847945
3	O	-1	11847945
U@@	O	-1	11847945
/@@	O	-1	11847945
L	O	-1	11847945
and	O	-1	11847945
the	O	-1	11847945
serum	O	-1	11847945
bil@@	B-Chemical	D001663	11847945
i@@	I-Chemical	-1	11847945
ru@@	I-Chemical	-1	11847945
bin	I-Chemical	-1	11847945
reac@@	O	-1	11847945
h@@	O	-1	11847945
ed	O	-1	11847945
a	O	-1	11847945
pe@@	O	-1	11847945
a@@	O	-1	11847945
k	O	-1	11847945
of	O	-1	11847945
1@@	O	-1	11847945
7.@@	O	-1	11847945
0	O	-1	11847945
mg/d@@	O	-1	11847945
L@@	O	-1	11847945
.	O	-1	11847945
There	O	-1	11847945
was	O	-1	11847945
s@@	O	-1	11847945
low	O	-1	11847945
impro@@	O	-1	11847945
vement	O	-1	11847945
over	O	-1	11847945
4	O	-1	11847945
months.	O	-1	11847945
Ac@@	O	-1	11847945
c@@	O	-1	11847945
id@@	O	-1	11847945
ental	O	-1	11847945
re@@	O	-1	11847945
exposure	O	-1	11847945
by	O	-1	11847945
the	O	-1	11847945
patient	O	-1	11847945
to	O	-1	11847945
di@@	B-Chemical	D004177	11847945
py@@	I-Chemical	-1	11847945
r@@	I-Chemical	-1	11847945
one	I-Chemical	-1	11847945
was	O	-1	11847945
un@@	O	-1	11847945
event@@	O	-1	11847945
ful@@	O	-1	11847945
.	O	-1	11847945
D@@	O	-1	11847945
I@@	O	-1	11847945
S@@	O	-1	11847945
C@@	O	-1	11847945
US@@	O	-1	11847945
S@@	O	-1	11847945
ION@@	O	-1	11847945
:	O	-1	11847945
The	O	-1	11847945
clinical	O	-1	11847945
and	O	-1	11847945
hist@@	O	-1	11847945
ologic	O	-1	11847945
p@@	O	-1	11847945
ic@@	O	-1	11847945
t@@	O	-1	11847945
ure	O	-1	11847945
of	O	-1	11847945
this	O	-1	11847945
case	O	-1	11847945
re@@	O	-1	11847945
se@@	O	-1	11847945
m@@	O	-1	11847945
ble@@	O	-1	11847945
s	O	-1	11847945
halo@@	B-Disease	C562477	11847945
th@@	I-Disease	-1	11847945
ane	I-Disease	-1	11847945
hepatitis	I-Disease	-1	11847945
,	O	-1	11847945
which	O	-1	11847945
has	O	-1	11847945
a	O	-1	11847945
significant	O	-1	11847945
mor@@	O	-1	11847945
t@@	O	-1	11847945
ality	O	-1	11847945
rat@@	O	-1	11847945
e.	O	-1	11847945
CONCLUSIONS:	O	-1	11847945
I@@	B-Chemical	D007530	11847945
s@@	I-Chemical	-1	11847945
of@@	I-Chemical	-1	11847945
lur@@	I-Chemical	-1	11847945
ane	I-Chemical	-1	11847945
,	O	-1	11847945
a	O	-1	11847945
common	O	-1	11847945
anesthe@@	O	-1	11847945
tic	O	-1	11847945
agent@@	O	-1	11847945
,	O	-1	11847945
can	O	-1	11847945
cause	O	-1	11847945
severe	O	-1	11847945
cholest@@	B-Disease	D002779	11847945
atic	I-Disease	-1	11847945
hepatitis	I-Disease	-1	11847945
cholest@@	B-Disease	D056486	11847945
atic	I-Disease	-1	11847945
hepatitis	I-Disease	-1	11847945
.	O	-1	11847945

C@@	O	-1	11284996
al@@	O	-1	11284996
cit@@	O	-1	11284996
on@@	O	-1	11284996
in	O	-1	11284996
gen@@	O	-1	11284996
e-@@	O	-1	11284996
related	O	-1	11284996
p@@	O	-1	11284996
ep@@	O	-1	11284996
ti@@	O	-1	11284996
de	O	-1	11284996
levels	O	-1	11284996
during	O	-1	11284996
nit@@	B-Chemical	D009569	11284996
ric	I-Chemical	-1	11284996
ox@@	I-Chemical	-1	11284996
ide	I-Chemical	-1	11284996
-induced	O	-1	11284996
headac@@	B-Disease	D006261	11284996
he	I-Disease	-1	11284996
in	O	-1	11284996
patients	O	-1	11284996
with	O	-1	11284996
chronic	O	-1	11284996
ten@@	B-Disease	D018781	11284996
sion@@	I-Disease	-1	11284996
-@@	I-Disease	-1	11284996
type	I-Disease	-1	11284996
headac@@	I-Disease	-1	11284996
he	I-Disease	-1	11284996
.	O	-1	11284996
It	O	-1	11284996
has	O	-1	11284996
been	O	-1	11284996
pro@@	O	-1	11284996
pos@@	O	-1	11284996
ed	O	-1	11284996
that	O	-1	11284996
nit@@	B-Chemical	D009569	11284996
ric	I-Chemical	-1	11284996
ox@@	I-Chemical	-1	11284996
ide	I-Chemical	-1	11284996
(	O	-1	11284996
N@@	B-Chemical	D009569	11284996
O	I-Chemical	-1	11284996
)	O	-1	11284996
induced	O	-1	11284996
headac@@	B-Disease	D006261	11284996
he	I-Disease	-1	11284996
in	O	-1	11284996
prim@@	B-Disease	D051270	11284996
ary	I-Disease	-1	11284996
headac@@	I-Disease	-1	11284996
h@@	I-Disease	-1	11284996
es	I-Disease	-1	11284996
may	O	-1	11284996
be	O	-1	11284996
associated	O	-1	11284996
with	O	-1	11284996
release	O	-1	11284996
of	O	-1	11284996
calc@@	O	-1	11284996
it@@	O	-1	11284996
on@@	O	-1	11284996
in	O	-1	11284996
gen@@	O	-1	11284996
e-@@	O	-1	11284996
related	O	-1	11284996
p@@	O	-1	11284996
ep@@	O	-1	11284996
ti@@	O	-1	11284996
de	O	-1	11284996
(C@@	O	-1	11284996
G@@	O	-1	11284996
R@@	O	-1	11284996
P@@	O	-1	11284996
).	O	-1	11284996
In	O	-1	11284996
the	O	-1	11284996
present	O	-1	11284996
study	O	-1	11284996
we	O	-1	11284996
a@@	O	-1	11284996
im@@	O	-1	11284996
ed	O	-1	11284996
to	O	-1	11284996
investigate	O	-1	11284996
plasma	O	-1	11284996
levels	O	-1	11284996
of	O	-1	11284996
C@@	O	-1	11284996
G@@	O	-1	11284996
R@@	O	-1	11284996
P	O	-1	11284996
during	O	-1	11284996
headac@@	B-Disease	D006261	11284996
he	I-Disease	-1	11284996
induced	O	-1	11284996
by	O	-1	11284996
the	O	-1	11284996
N@@	B-Chemical	D009569	11284996
O	I-Chemical	-1	11284996
d@@	O	-1	11284996
on@@	O	-1	11284996
or	O	-1	11284996
glyc@@	B-Chemical	D005996	11284996
ery@@	I-Chemical	-1	11284996
l	I-Chemical	-1	11284996
tr@@	I-Chemical	-1	11284996
in@@	I-Chemical	-1	11284996
it@@	I-Chemical	-1	11284996
rate	I-Chemical	-1	11284996
(	O	-1	11284996
G@@	B-Chemical	D005996	11284996
T@@	I-Chemical	-1	11284996
N	I-Chemical	-1	11284996
)	O	-1	11284996
in	O	-1	11284996
16	O	-1	11284996
patients	O	-1	11284996
with	O	-1	11284996
chronic	O	-1	11284996
ten@@	B-Disease	D018781	11284996
sion@@	I-Disease	-1	11284996
-@@	I-Disease	-1	11284996
type	I-Disease	-1	11284996
headac@@	I-Disease	-1	11284996
he	I-Disease	-1	11284996
and	O	-1	11284996
16	O	-1	11284996
healthy	O	-1	11284996
controls.	O	-1	11284996
The	O	-1	11284996
subjects	O	-1	11284996
were	O	-1	11284996
random@@	O	-1	11284996
ly	O	-1	11284996
al@@	O	-1	11284996
loc@@	O	-1	11284996
ated	O	-1	11284996
to	O	-1	11284996
recei@@	O	-1	11284996
ve	O	-1	11284996
0.@@	O	-1	11284996
5	O	-1	11284996
micro@@	O	-1	11284996
g/@@	O	-1	11284996
k@@	O	-1	11284996
g/@@	O	-1	11284996
min	O	-1	11284996
G@@	B-Chemical	D005996	11284996
T@@	I-Chemical	-1	11284996
N	I-Chemical	-1	11284996
or	O	-1	11284996
placebo	O	-1	11284996
over	O	-1	11284996
20	O	-1	11284996
min	O	-1	11284996
on	O	-1	11284996
two	O	-1	11284996
headac@@	B-Disease	D006261	11284996
he	I-Disease	-1	11284996
-@@	O	-1	11284996
free	O	-1	11284996
days.	O	-1	11284996
B@@	O	-1	11284996
lo@@	O	-1	11284996
od	O	-1	11284996
sam@@	O	-1	11284996
ple@@	O	-1	11284996
s	O	-1	11284996
were	O	-1	11284996
coll@@	O	-1	11284996
ected	O	-1	11284996
at	O	-1	11284996
basel@@	O	-1	11284996
ine,	O	-1	11284996
10@@	O	-1	11284996
,	O	-1	11284996
20	O	-1	11284996
and	O	-1	11284996
60	O	-1	11284996
min	O	-1	11284996
after	O	-1	11284996
star@@	O	-1	11284996
t	O	-1	11284996
of	O	-1	11284996
infu@@	O	-1	11284996
sion.	O	-1	11284996
B@@	O	-1	11284996
oth	O	-1	11284996
patients	O	-1	11284996
and	O	-1	11284996
controls	O	-1	11284996
developed	O	-1	11284996
significantly	O	-1	11284996
st@@	O	-1	11284996
ron@@	O	-1	11284996
g@@	O	-1	11284996
er	O	-1	11284996
immedi@@	O	-1	11284996
ate	O	-1	11284996
headac@@	B-Disease	D006261	11284996
he	I-Disease	-1	11284996
on	O	-1	11284996
the	O	-1	11284996
G@@	B-Chemical	D005996	11284996
T@@	I-Chemical	-1	11284996
N	I-Chemical	-1	11284996
day	O	-1	11284996
than	O	-1	11284996
on	O	-1	11284996
the	O	-1	11284996
placebo	O	-1	11284996
day	O	-1	11284996
and	O	-1	11284996
the	O	-1	11284996
headac@@	B-Disease	D006261	11284996
he	I-Disease	-1	11284996
was	O	-1	11284996
significantly	O	-1	11284996
more	O	-1	11284996
p@@	O	-1	11284996
ron@@	O	-1	11284996
oun@@	O	-1	11284996
c@@	O	-1	11284996
ed	O	-1	11284996
in	O	-1	11284996
patients	O	-1	11284996
than	O	-1	11284996
in	O	-1	11284996
controls.	O	-1	11284996
There	O	-1	11284996
was	O	-1	11284996
no	O	-1	11284996
difference	O	-1	11284996
between	O	-1	11284996
the	O	-1	11284996
a@@	O	-1	11284996
re@@	O	-1	11284996
a	O	-1	11284996
under	O	-1	11284996
the	O	-1	11284996
C@@	O	-1	11284996
G@@	O	-1	11284996
R@@	O	-1	11284996
P	O	-1	11284996
cur@@	O	-1	11284996
ve	O	-1	11284996
(A@@	O	-1	11284996
U@@	O	-1	11284996
C@@	O	-1	11284996
C@@	O	-1	11284996
G@@	O	-1	11284996
R@@	O	-1	11284996
P)	O	-1	11284996
on	O	-1	11284996
G@@	B-Chemical	D005996	11284996
T@@	I-Chemical	-1	11284996
N	I-Chemical	-1	11284996
vs.	O	-1	11284996
placebo	O	-1	11284996
day	O	-1	11284996
in	O	-1	11284996
either	O	-1	11284996
patients	O	-1	11284996
(P@@	O	-1	11284996
=@@	O	-1	11284996
0.@@	O	-1	11284996
6@@	O	-1	11284996
5@@	O	-1	11284996
)	O	-1	11284996
or	O	-1	11284996
controls	O	-1	11284996
(P@@	O	-1	11284996
=@@	O	-1	11284996
0.@@	O	-1	11284996
4@@	O	-1	11284996
8@@	O	-1	11284996
).	O	-1	11284996
The	O	-1	11284996
A@@	O	-1	11284996
U@@	O	-1	11284996
C@@	O	-1	11284996
C@@	O	-1	11284996
G@@	O	-1	11284996
R@@	O	-1	11284996
P	O	-1	11284996
recor@@	O	-1	11284996
ded	O	-1	11284996
on	O	-1	11284996
the	O	-1	11284996
G@@	B-Chemical	D005996	11284996
T@@	I-Chemical	-1	11284996
N	I-Chemical	-1	11284996
day	O	-1	11284996
did	O	-1	11284996
not	O	-1	11284996
diff@@	O	-1	11284996
er	O	-1	11284996
between	O	-1	11284996
patients	O	-1	11284996
and	O	-1	11284996
controls	O	-1	11284996
(P@@	O	-1	11284996
=@@	O	-1	11284996
0.@@	O	-1	11284996
3@@	O	-1	11284996
6@@	O	-1	11284996
).	O	-1	11284996
B@@	O	-1	11284996
oth	O	-1	11284996
in	O	-1	11284996
patients	O	-1	11284996
and	O	-1	11284996
control@@	O	-1	11284996
s,	O	-1	11284996
C@@	O	-1	11284996
G@@	O	-1	11284996
R@@	O	-1	11284996
P	O	-1	11284996
levels	O	-1	11284996
chang@@	O	-1	11284996
ed	O	-1	11284996
significantly	O	-1	11284996
over	O	-1	11284996
ti@@	O	-1	11284996
me,	O	-1	11284996
on	O	-1	11284996
both	O	-1	11284996
the	O	-1	11284996
G@@	B-Chemical	D005996	11284996
T@@	I-Chemical	-1	11284996
N	I-Chemical	-1	11284996
and	O	-1	11284996
placebo	O	-1	11284996
days	O	-1	11284996
(P	O	-1	11284996
<	O	-1	11284996
0.05@@	O	-1	11284996
).	O	-1	11284996
The	O	-1	11284996
present	O	-1	11284996
study	O	-1	11284996
indic@@	O	-1	11284996
ates	O	-1	11284996
that	O	-1	11284996
N@@	B-Chemical	D009569	11284996
O	I-Chemical	-1	11284996
-induced	O	-1	11284996
immedi@@	O	-1	11284996
ate	O	-1	11284996
headac@@	B-Disease	D006261	11284996
he	I-Disease	-1	11284996
is	O	-1	11284996
not	O	-1	11284996
associated	O	-1	11284996
with	O	-1	11284996
release	O	-1	11284996
of	O	-1	11284996
C@@	O	-1	11284996
G@@	O	-1	11284996
R@@	O	-1	11284996
P@@	O	-1	11284996
.	O	-1	11284996

M@@	B-Disease	D017202	11078231
y@@	I-Disease	-1	11078231
ocardi@@	I-Disease	-1	11078231
al	I-Disease	-1	11078231
ischem@@	I-Disease	-1	11078231
ia	I-Disease	-1	11078231
due	O	-1	11078231
to	O	-1	11078231
coronary	B-Disease	D003329	11078231
artery	I-Disease	-1	11078231
sp@@	I-Disease	-1	11078231
as@@	I-Disease	-1	11078231
m	I-Disease	-1	11078231
during	O	-1	11078231
do@@	B-Chemical	D004280	11078231
but@@	I-Chemical	-1	11078231
amine	I-Chemical	-1	11078231
stres@@	O	-1	11078231
s	O	-1	11078231
echocardiograph@@	O	-1	11078231
y.	O	-1	11078231
D@@	B-Chemical	D004280	11078231
ob@@	I-Chemical	-1	11078231
ut@@	I-Chemical	-1	11078231
amine	I-Chemical	-1	11078231
stres@@	O	-1	11078231
s	O	-1	11078231
echocardiograph@@	O	-1	11078231
y	O	-1	11078231
(D@@	O	-1	11078231
S@@	O	-1	11078231
E@@	O	-1	11078231
)	O	-1	11078231
is	O	-1	11078231
a	O	-1	11078231
use@@	O	-1	11078231
ful	O	-1	11078231
and	O	-1	11078231
saf@@	O	-1	11078231
e	O	-1	11078231
prov@@	O	-1	11078231
oc@@	O	-1	11078231
ation	O	-1	11078231
test	O	-1	11078231
for	O	-1	11078231
myocardial	B-Disease	D017202	11078231
ischem@@	I-Disease	-1	11078231
ia	I-Disease	-1	11078231
.	O	-1	11078231
U@@	O	-1	11078231
n@@	O	-1	11078231
ti@@	O	-1	11078231
l	O	-1	11078231
now@@	O	-1	11078231
,	O	-1	11078231
the	O	-1	11078231
test	O	-1	11078231
has	O	-1	11078231
been	O	-1	11078231
foc@@	O	-1	11078231
used	O	-1	11078231
only	O	-1	11078231
on	O	-1	11078231
the	O	-1	11078231
org@@	O	-1	11078231
anic	O	-1	11078231
le@@	O	-1	11078231
sion	O	-1	11078231
in	O	-1	11078231
the	O	-1	11078231
coronary	O	-1	11078231
arter@@	O	-1	11078231
y,	O	-1	11078231
and	O	-1	11078231
positive	O	-1	11078231
D@@	O	-1	11078231
S@@	O	-1	11078231
E	O	-1	11078231
has	O	-1	11078231
indic@@	O	-1	11078231
ated	O	-1	11078231
the	O	-1	11078231
presence	O	-1	11078231
of	O	-1	11078231
significant	O	-1	11078231
fi@@	O	-1	11078231
x@@	O	-1	11078231
ed	O	-1	11078231
coronary	B-Disease	D023921	11078231
artery	I-Disease	-1	11078231
st@@	I-Disease	-1	11078231
en@@	I-Disease	-1	11078231
o@@	I-Disease	-1	11078231
sis	I-Disease	-1	11078231
.	O	-1	11078231
The	O	-1	11078231
a@@	O	-1	11078231
im	O	-1	11078231
of	O	-1	11078231
the	O	-1	11078231
present	O	-1	11078231
study	O	-1	11078231
is	O	-1	11078231
to	O	-1	11078231
ex@@	O	-1	11078231
amine	O	-1	11078231
whether	O	-1	11078231
myocardial	B-Disease	D017202	11078231
ischem@@	I-Disease	-1	11078231
ia	I-Disease	-1	11078231
due	O	-1	11078231
to	O	-1	11078231
coronary	B-Disease	D003329	11078231
sp@@	I-Disease	-1	11078231
as@@	I-Disease	-1	11078231
m	I-Disease	-1	11078231
is	O	-1	11078231
induced	O	-1	11078231
by	O	-1	11078231
do@@	B-Chemical	D004280	11078231
but@@	I-Chemical	-1	11078231
amine	I-Chemical	-1	11078231
.	O	-1	11078231
We	O	-1	11078231
performed	O	-1	11078231
D@@	O	-1	11078231
S@@	O	-1	11078231
E	O	-1	11078231
on	O	-1	11078231
5@@	O	-1	11078231
1	O	-1	11078231
patients	O	-1	11078231
with	O	-1	11078231
coronary	B-Disease	D000788	11078231
sp@@	I-Disease	-1	11078231
as@@	I-Disease	-1	11078231
tic	I-Disease	-1	11078231
ang@@	I-Disease	-1	11078231
in@@	I-Disease	-1	11078231
a	I-Disease	-1	11078231
but	O	-1	11078231
without	O	-1	11078231
significant	O	-1	11078231
fi@@	O	-1	11078231
x@@	O	-1	11078231
ed	O	-1	11078231
coronary	B-Disease	D023921	11078231
artery	I-Disease	-1	11078231
st@@	I-Disease	-1	11078231
en@@	I-Disease	-1	11078231
o@@	I-Disease	-1	11078231
sis	I-Disease	-1	11078231
.	O	-1	11078231
All	O	-1	11078231
patients	O	-1	11078231
had	O	-1	11078231
ang@@	B-Disease	D000787	11078231
inal	I-Disease	-1	11078231
at@@	O	-1	11078231
tac@@	O	-1	11078231
k@@	O	-1	11078231
s	O	-1	11078231
at	O	-1	11078231
res@@	O	-1	11078231
t	O	-1	11078231
with	O	-1	11078231
S@@	O	-1	11078231
T	O	-1	11078231
elev@@	O	-1	11078231
ation	O	-1	11078231
on	O	-1	11078231
the	O	-1	11078231
electro@@	O	-1	11078231
cardio@@	O	-1	11078231
gra@@	O	-1	11078231
m	O	-1	11078231
(	O	-1	11078231
vari@@	B-Disease	D000788	11078231
ant	I-Disease	-1	11078231
ang@@	I-Disease	-1	11078231
in@@	I-Disease	-1	11078231
a	I-Disease	-1	11078231
).	O	-1	11078231
C@@	O	-1	11078231
or@@	O	-1	11078231
onary	O	-1	11078231
sp@@	O	-1	11078231
as@@	O	-1	11078231
m	O	-1	11078231
was	O	-1	11078231
induced	O	-1	11078231
by	O	-1	11078231
intrac@@	O	-1	11078231
or@@	O	-1	11078231
onary	O	-1	11078231
injection	O	-1	11078231
of	O	-1	11078231
acet@@	B-Chemical	D000109	11078231
ylcholine	I-Chemical	-1	11078231
,	O	-1	11078231
and	O	-1	11078231
no	O	-1	11078231
fi@@	O	-1	11078231
x@@	O	-1	11078231
ed	O	-1	11078231
coronary	B-Disease	D023921	11078231
artery	I-Disease	-1	11078231
st@@	I-Disease	-1	11078231
en@@	I-Disease	-1	11078231
o@@	I-Disease	-1	11078231
sis	I-Disease	-1	11078231
was	O	-1	11078231
doc@@	O	-1	11078231
um@@	O	-1	11078231
ent@@	O	-1	11078231
ed	O	-1	11078231
on	O	-1	11078231
angio@@	O	-1	11078231
gram@@	O	-1	11078231
s	O	-1	11078231
in	O	-1	11078231
all	O	-1	11078231
patients.	O	-1	11078231
D@@	O	-1	11078231
S@@	O	-1	11078231
E	O	-1	11078231
was	O	-1	11078231
performed	O	-1	11078231
with	O	-1	11078231
intravenous	O	-1	11078231
do@@	B-Chemical	D004280	11078231
but@@	I-Chemical	-1	11078231
amine	I-Chemical	-1	11078231
infusion	O	-1	11078231
with	O	-1	11078231
an	O	-1	11078231
inc@@	O	-1	11078231
re@@	O	-1	11078231
mental	O	-1	11078231
doses	O	-1	11078231
of	O	-1	11078231
5,	O	-1	11078231
10@@	O	-1	11078231
,	O	-1	11078231
20@@	O	-1	11078231
,	O	-1	11078231
3@@	O	-1	11078231
0@@	O	-1	11078231
,	O	-1	11078231
and	O	-1	11078231
40	O	-1	11078231
micro@@	O	-1	11078231
g/@@	O	-1	11078231
k@@	O	-1	11078231
g/@@	O	-1	11078231
min	O	-1	11078231
every	O	-1	11078231
5	O	-1	11078231
minut@@	O	-1	11078231
es.	O	-1	11078231
Of	O	-1	11078231
the	O	-1	11078231
5@@	O	-1	11078231
1	O	-1	11078231
patients,	O	-1	11078231
7	O	-1	11078231
patients	O	-1	11078231
showed	O	-1	11078231
as@@	O	-1	11078231
yn@@	O	-1	11078231
erg@@	O	-1	11078231
y	O	-1	11078231
with	O	-1	11078231
S@@	O	-1	11078231
T	O	-1	11078231
elev@@	O	-1	11078231
ation.	O	-1	11078231
All	O	-1	11078231
7	O	-1	11078231
patients	O	-1	11078231
(1@@	O	-1	11078231
3.@@	O	-1	11078231
7@@	O	-1	11078231
%)	O	-1	11078231
had	O	-1	11078231
ch@@	B-Disease	D002637	11078231
est	I-Disease	-1	11078231
pain	I-Disease	-1	11078231
during	O	-1	11078231
as@@	O	-1	11078231
yn@@	O	-1	11078231
erg@@	O	-1	11078231
y,	O	-1	11078231
and	O	-1	11078231
both	O	-1	11078231
ch@@	B-Disease	D002637	11078231
est	I-Disease	-1	11078231
pain	I-Disease	-1	11078231
and	O	-1	11078231
electro@@	O	-1	11078231
cardio@@	O	-1	11078231
graph@@	O	-1	11078231
ic	O	-1	11078231
changes	O	-1	11078231
were	O	-1	11078231
pre@@	O	-1	11078231
ce@@	O	-1	11078231
ded	O	-1	11078231
by	O	-1	11078231
as@@	O	-1	11078231
yn@@	O	-1	11078231
erg@@	O	-1	11078231
y.	O	-1	11078231
These	O	-1	11078231
findings	O	-1	11078231
indicate	O	-1	11078231
that	O	-1	11078231
do@@	B-Chemical	D004280	11078231
but@@	I-Chemical	-1	11078231
amine	I-Chemical	-1	11078231
can	O	-1	11078231
prov@@	O	-1	11078231
o@@	O	-1	11078231
k@@	O	-1	11078231
e	O	-1	11078231
coronary	B-Disease	D003329	11078231
sp@@	I-Disease	-1	11078231
as@@	I-Disease	-1	11078231
m	I-Disease	-1	11078231
in	O	-1	11078231
some	O	-1	11078231
patients	O	-1	11078231
with	O	-1	11078231
coronary	B-Disease	D000788	11078231
sp@@	I-Disease	-1	11078231
as@@	I-Disease	-1	11078231
tic	I-Disease	-1	11078231
ang@@	I-Disease	-1	11078231
in@@	I-Disease	-1	11078231
a	I-Disease	-1	11078231
.	O	-1	11078231
Whe@@	O	-1	11078231
n	O	-1	11078231
D@@	O	-1	11078231
S@@	O	-1	11078231
E	O	-1	11078231
is	O	-1	11078231
performed	O	-1	11078231
to	O	-1	11078231
evalu@@	O	-1	11078231
ate	O	-1	11078231
coronary	B-Disease	D003324	11078231
artery	I-Disease	-1	11078231
disease	I-Disease	-1	11078231
,	O	-1	11078231
not	O	-1	11078231
only	O	-1	11078231
fi@@	O	-1	11078231
x@@	O	-1	11078231
ed	O	-1	11078231
coronary	B-Disease	D023921	11078231
st@@	I-Disease	-1	11078231
en@@	I-Disease	-1	11078231
o@@	I-Disease	-1	11078231
sis	I-Disease	-1	11078231
,	O	-1	11078231
but	O	-1	11078231
also	O	-1	11078231
coronary	B-Disease	D003329	11078231
sp@@	I-Disease	-1	11078231
as@@	I-Disease	-1	11078231
m	I-Disease	-1	11078231
should	O	-1	11078231
be	O	-1	11078231
considered	O	-1	11078231
as	O	-1	11078231
a	O	-1	11078231
genesis	O	-1	11078231
of	O	-1	11078231
as@@	O	-1	11078231
yn@@	O	-1	11078231
erg@@	O	-1	11078231
y.	O	-1	11078231

N@@	B-Chemical	D009569	10523326
it@@	I-Chemical	-1	10523326
ric	I-Chemical	-1	10523326
ox@@	I-Chemical	-1	10523326
ide	I-Chemical	-1	10523326
syn@@	O	-1	10523326
th@@	O	-1	10523326
ase	O	-1	10523326
expression	O	-1	10523326
in	O	-1	10523326
the	O	-1	10523326
course	O	-1	10523326
of	O	-1	10523326
le@@	B-Chemical	D007854	10523326
ad	I-Chemical	-1	10523326
-induced	O	-1	10523326
hypertension	B-Disease	D006973	10523326
.	O	-1	10523326
We	O	-1	10523326
rec@@	O	-1	10523326
ently	O	-1	10523326
showed	O	-1	10523326
elevated	O	-1	10523326
reac@@	O	-1	10523326
tive	O	-1	10523326
oxy@@	B-Chemical	D010100	10523326
gen	I-Chemical	-1	10523326
spec@@	O	-1	10523326
i@@	O	-1	10523326
es	O	-1	10523326
(@@	O	-1	10523326
RO@@	O	-1	10523326
S@@	O	-1	10523326
),	O	-1	10523326
reduced	O	-1	10523326
urinary	O	-1	10523326
ex@@	O	-1	10523326
cre@@	O	-1	10523326
tion	O	-1	10523326
of	O	-1	10523326
N@@	B-Chemical	D009569	10523326
O	I-Chemical	-1	10523326
metabol@@	O	-1	10523326
it@@	O	-1	10523326
es	O	-1	10523326
(N@@	O	-1	10523326
O@@	O	-1	10523326
x@@	O	-1	10523326
),	O	-1	10523326
and	O	-1	10523326
increased	O	-1	10523326
N@@	B-Chemical	D009569	10523326
O	I-Chemical	-1	10523326
sequ@@	O	-1	10523326
est@@	O	-1	10523326
ration	O	-1	10523326
as	O	-1	10523326
nitro@@	B-Chemical	C002744	10523326
ty@@	I-Chemical	-1	10523326
ros@@	I-Chemical	-1	10523326
ine	I-Chemical	-1	10523326
in	O	-1	10523326
various	O	-1	10523326
tissu@@	O	-1	10523326
es	O	-1	10523326
in	O	-1	10523326
rats	O	-1	10523326
with	O	-1	10523326
le@@	B-Chemical	D007854	10523326
ad	I-Chemical	-1	10523326
-induced	O	-1	10523326
hypertension	B-Disease	D006973	10523326
.	O	-1	10523326
This	O	-1	10523326
study	O	-1	10523326
was	O	-1	10523326
de@@	O	-1	10523326
signed	O	-1	10523326
to	O	-1	10523326
disc@@	O	-1	10523326
er@@	O	-1	10523326
n	O	-1	10523326
whether	O	-1	10523326
the	O	-1	10523326
reduction	O	-1	10523326
in	O	-1	10523326
urinary	O	-1	10523326
NO@@	O	-1	10523326
x	O	-1	10523326
in	O	-1	10523326
le@@	B-Chemical	D007854	10523326
ad	I-Chemical	-1	10523326
-induced	O	-1	10523326
hypertension	B-Disease	D006973	10523326
is@@	O	-1	10523326
,	O	-1	10523326
in	O	-1	10523326
part@@	O	-1	10523326
,	O	-1	10523326
due	O	-1	10523326
to	O	-1	10523326
depress@@	O	-1	10523326
ed	O	-1	10523326
N@@	B-Chemical	D009569	10523326
O	I-Chemical	-1	10523326
syn@@	O	-1	10523326
th@@	O	-1	10523326
ase	O	-1	10523326
(N@@	O	-1	10523326
O@@	O	-1	10523326
S)	O	-1	10523326
ex@@	O	-1	10523326
pres@@	O	-1	10523326
sion.	O	-1	10523326
M@@	O	-1	10523326
al@@	O	-1	10523326
e	O	-1	10523326
S@@	O	-1	10523326
pra@@	O	-1	10523326
gu@@	O	-1	10523326
e-@@	O	-1	10523326
D@@	O	-1	10523326
aw@@	O	-1	10523326
le@@	O	-1	10523326
y	O	-1	10523326
rats	O	-1	10523326
were	O	-1	10523326
random@@	O	-1	10523326
ly	O	-1	10523326
as@@	O	-1	10523326
signed	O	-1	10523326
to	O	-1	10523326
a	O	-1	10523326
le@@	B-Chemical	D007854	10523326
ad	I-Chemical	-1	10523326
-treated	O	-1	10523326
group	O	-1	10523326
(@@	O	-1	10523326
given	O	-1	10523326
le@@	B-Chemical	C008261	10523326
ad	I-Chemical	-1	10523326
acet@@	I-Chemical	-1	10523326
ate	I-Chemical	-1	10523326
,	O	-1	10523326
100	O	-1	10523326
pp@@	O	-1	10523326
m@@	O	-1	10523326
,	O	-1	10523326
in	O	-1	10523326
d@@	O	-1	10523326
r@@	O	-1	10523326
in@@	O	-1	10523326
king	O	-1	10523326
w@@	O	-1	10523326
at@@	O	-1	10523326
er	O	-1	10523326
and	O	-1	10523326
reg@@	O	-1	10523326
ular	O	-1	10523326
rat	O	-1	10523326
ch@@	O	-1	10523326
o@@	O	-1	10523326
w@@	O	-1	10523326
),	O	-1	10523326
a	O	-1	10523326
group	O	-1	10523326
given	O	-1	10523326
le@@	B-Chemical	D007854	10523326
ad	I-Chemical	-1	10523326
and	O	-1	10523326
vitamin	B-Chemical	D014810	10523326
E	I-Chemical	-1	10523326
-@@	O	-1	10523326
for@@	O	-1	10523326
ti@@	O	-1	10523326
fied	O	-1	10523326
ch@@	O	-1	10523326
o@@	O	-1	10523326
w@@	O	-1	10523326
,	O	-1	10523326
or	O	-1	10523326
a	O	-1	10523326
normal	O	-1	10523326
control	O	-1	10523326
group	O	-1	10523326
given	O	-1	10523326
either	O	-1	10523326
reg@@	O	-1	10523326
ular	O	-1	10523326
fo@@	O	-1	10523326
od	O	-1	10523326
and	O	-1	10523326
w@@	O	-1	10523326
at@@	O	-1	10523326
er	O	-1	10523326
or	O	-1	10523326
vitamin	B-Chemical	D014810	10523326
E	I-Chemical	-1	10523326
-@@	O	-1	10523326
for@@	O	-1	10523326
ti@@	O	-1	10523326
fied	O	-1	10523326
fo@@	O	-1	10523326
od	O	-1	10523326
for	O	-1	10523326
12	O	-1	10523326
week@@	O	-1	10523326
s.	O	-1	10523326
T@@	O	-1	10523326
a@@	O	-1	10523326
il	O	-1	10523326
blood	O	-1	10523326
pressu@@	O	-1	10523326
re,	O	-1	10523326
urinary	O	-1	10523326
NO@@	O	-1	10523326
x	O	-1	10523326
ex@@	O	-1	10523326
cre@@	O	-1	10523326
tion,	O	-1	10523326
plasma	O	-1	10523326
mal@@	B-Chemical	D008315	10523326
on@@	I-Chemical	-1	10523326
di@@	I-Chemical	-1	10523326
al@@	I-Chemical	-1	10523326
de@@	I-Chemical	-1	10523326
hy@@	I-Chemical	-1	10523326
de	I-Chemical	-1	10523326
(	O	-1	10523326
MD@@	B-Chemical	D008315	10523326
A	I-Chemical	-1	10523326
),	O	-1	10523326
and	O	-1	10523326
endothelial	O	-1	10523326
and	O	-1	10523326
induc@@	O	-1	10523326
i@@	O	-1	10523326
ble	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
(@@	O	-1	10523326
e@@	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
and	O	-1	10523326
i@@	O	-1	10523326
NO@@	O	-1	10523326
S)	O	-1	10523326
is@@	O	-1	10523326
ot@@	O	-1	10523326
yp@@	O	-1	10523326
es	O	-1	10523326
in	O	-1	10523326
the	O	-1	10523326
a@@	O	-1	10523326
ort@@	O	-1	10523326
a	O	-1	10523326
and	O	-1	10523326
kidney	O	-1	10523326
were	O	-1	10523326
meas@@	O	-1	10523326
ure@@	O	-1	10523326
d.	O	-1	10523326
The	O	-1	10523326
le@@	B-Chemical	D007854	10523326
ad	I-Chemical	-1	10523326
-treated	O	-1	10523326
group	O	-1	10523326
ex@@	O	-1	10523326
hib@@	O	-1	10523326
ited	O	-1	10523326
a	O	-1	10523326
ri@@	O	-1	10523326
se	O	-1	10523326
in	O	-1	10523326
blood	O	-1	10523326
pressure	O	-1	10523326
and	O	-1	10523326
plasma	O	-1	10523326
MD@@	B-Chemical	D008315	10523326
A	I-Chemical	-1	10523326
concentr@@	O	-1	10523326
ation,	O	-1	10523326
a	O	-1	10523326
f@@	O	-1	10523326
all	O	-1	10523326
in	O	-1	10523326
urinary	O	-1	10523326
NO@@	O	-1	10523326
x	O	-1	10523326
ex@@	O	-1	10523326
cre@@	O	-1	10523326
tion,	O	-1	10523326
and	O	-1	10523326
a	O	-1	10523326
par@@	O	-1	10523326
ad@@	O	-1	10523326
ox@@	O	-1	10523326
ical	O	-1	10523326
ri@@	O	-1	10523326
se	O	-1	10523326
in	O	-1	10523326
vascular	O	-1	10523326
and	O	-1	10523326
renal	O	-1	10523326
tissue	O	-1	10523326
e@@	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
and	O	-1	10523326
i@@	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
ex@@	O	-1	10523326
pres@@	O	-1	10523326
sion.	O	-1	10523326
V@@	B-Chemical	D014810	10523326
it@@	I-Chemical	-1	10523326
amin	I-Chemical	-1	10523326
E	I-Chemical	-1	10523326
sup@@	O	-1	10523326
ple@@	O	-1	10523326
ment@@	O	-1	10523326
ation	O	-1	10523326
ame@@	O	-1	10523326
li@@	O	-1	10523326
or@@	O	-1	10523326
ated	O	-1	10523326
hypertension	B-Disease	D006973	10523326
,	O	-1	10523326
lo@@	O	-1	10523326
we@@	O	-1	10523326
red	O	-1	10523326
plasma	O	-1	10523326
MD@@	B-Chemical	D008315	10523326
A	I-Chemical	-1	10523326
concentr@@	O	-1	10523326
ation,	O	-1	10523326
and	O	-1	10523326
ra@@	O	-1	10523326
is@@	O	-1	10523326
ed	O	-1	10523326
urinary	O	-1	10523326
NO@@	O	-1	10523326
x	O	-1	10523326
ex@@	O	-1	10523326
cre@@	O	-1	10523326
tion	O	-1	10523326
while	O	-1	10523326
significantly	O	-1	10523326
low@@	O	-1	10523326
ering	O	-1	10523326
vas@@	O	-1	10523326
cul@@	O	-1	10523326
ar@@	O	-1	10523326
,	O	-1	10523326
but	O	-1	10523326
not	O	-1	10523326
ren@@	O	-1	10523326
al,	O	-1	10523326
tissue	O	-1	10523326
e@@	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
and	O	-1	10523326
i@@	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
ex@@	O	-1	10523326
pres@@	O	-1	10523326
sion.	O	-1	10523326
V@@	B-Chemical	D014810	10523326
it@@	I-Chemical	-1	10523326
amin	I-Chemical	-1	10523326
E	I-Chemical	-1	10523326
sup@@	O	-1	10523326
ple@@	O	-1	10523326
ment@@	O	-1	10523326
ation	O	-1	10523326
had	O	-1	10523326
no	O	-1	10523326
effect	O	-1	10523326
on	O	-1	10523326
either	O	-1	10523326
blood	O	-1	10523326
pressu@@	O	-1	10523326
re,	O	-1	10523326
plasma	O	-1	10523326
MD@@	B-Chemical	D008315	10523326
A	I-Chemical	-1	10523326
,	O	-1	10523326
or	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
expression	O	-1	10523326
in	O	-1	10523326
the	O	-1	10523326
control	O	-1	10523326
group.	O	-1	10523326
The	O	-1	10523326
study	O	-1	10523326
also	O	-1	10523326
revealed	O	-1	10523326
significant	O	-1	10523326
inhibition	O	-1	10523326
of	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
enzym@@	O	-1	10523326
atic	O	-1	10523326
activity	O	-1	10523326
by	O	-1	10523326
le@@	B-Chemical	D007854	10523326
ad	I-Chemical	-1	10523326
in	O	-1	10523326
cell@@	O	-1	10523326
-@@	O	-1	10523326
free	O	-1	10523326
pre@@	O	-1	10523326
par@@	O	-1	10523326
ations.	O	-1	10523326
In	O	-1	10523326
concl@@	O	-1	10523326
u@@	O	-1	10523326
sion,	O	-1	10523326
le@@	B-Chemical	D007854	10523326
ad	I-Chemical	-1	10523326
-induced	O	-1	10523326
hypertension	B-Disease	D006973	10523326
in	O	-1	10523326
this	O	-1	10523326
model	O	-1	10523326
was	O	-1	10523326
associated	O	-1	10523326
with	O	-1	10523326
a	O	-1	10523326
com@@	O	-1	10523326
pen@@	O	-1	10523326
s@@	O	-1	10523326
atory	O	-1	10523326
u@@	O	-1	10523326
pre@@	O	-1	10523326
g@@	O	-1	10523326
ulation	O	-1	10523326
of	O	-1	10523326
renal	O	-1	10523326
and	O	-1	10523326
vascular	O	-1	10523326
e@@	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
and	O	-1	10523326
i@@	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
ex@@	O	-1	10523326
pres@@	O	-1	10523326
sion.	O	-1	10523326
This	O	-1	10523326
is@@	O	-1	10523326
,	O	-1	10523326
in	O	-1	10523326
part@@	O	-1	10523326
,	O	-1	10523326
due	O	-1	10523326
to	O	-1	10523326
RO@@	O	-1	10523326
S@@	O	-1	10523326
-@@	O	-1	10523326
mediated	O	-1	10523326
N@@	B-Chemical	D009569	10523326
O	I-Chemical	-1	10523326
in@@	O	-1	10523326
activ@@	O	-1	10523326
ation,	O	-1	10523326
le@@	B-Chemical	D007854	10523326
ad	I-Chemical	-1	10523326
-@@	O	-1	10523326
associated	O	-1	10523326
inhibition	O	-1	10523326
of	O	-1	10523326
NO@@	O	-1	10523326
S	O	-1	10523326
activ@@	O	-1	10523326
ity,	O	-1	10523326
and	O	-1	10523326
per@@	O	-1	10523326
h@@	O	-1	10523326
ap@@	O	-1	10523326
s	O	-1	10523326
stimul@@	O	-1	10523326
atory	O	-1	10523326
ac@@	O	-1	10523326
tions	O	-1	10523326
of	O	-1	10523326
increased	O	-1	10523326
s@@	O	-1	10523326
he@@	O	-1	10523326
ar	O	-1	10523326
stres@@	O	-1	10523326
s	O	-1	10523326
associated	O	-1	10523326
with	O	-1	10523326
hypertension	B-Disease	D006973	10523326
.	O	-1	10523326

R@@	O	-1	9867728
is@@	O	-1	9867728
k	O	-1	9867728
for	O	-1	9867728
val@@	B-Disease	D006349	9867728
v@@	I-Disease	-1	9867728
ular	I-Disease	-1	9867728
heart	I-Disease	-1	9867728
disease	I-Disease	-1	9867728
among	O	-1	9867728
users	O	-1	9867728
of	O	-1	9867728
f@@	B-Chemical	D005277	9867728
en@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
lur@@	I-Chemical	-1	9867728
amine	I-Chemical	-1	9867728
and	O	-1	9867728
de@@	B-Chemical	D020372	9867728
x@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
en@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
lur@@	I-Chemical	-1	9867728
amine	I-Chemical	-1	9867728
who	O	-1	9867728
under@@	O	-1	9867728
w@@	O	-1	9867728
ent	O	-1	9867728
echocardiograph@@	O	-1	9867728
y	O	-1	9867728
before	O	-1	9867728
use	O	-1	9867728
of	O	-1	9867728
medic@@	O	-1	9867728
ation.	O	-1	9867728
BACKGROUND:	O	-1	9867728
B@@	O	-1	9867728
ecause	O	-1	9867728
un@@	O	-1	9867728
controlled	O	-1	9867728
echocardiograph@@	O	-1	9867728
ic	O	-1	9867728
sur@@	O	-1	9867728
ve@@	O	-1	9867728
ys	O	-1	9867728
suggested	O	-1	9867728
that	O	-1	9867728
up	O	-1	9867728
to	O	-1	9867728
3@@	O	-1	9867728
0%	O	-1	9867728
to	O	-1	9867728
3@@	O	-1	9867728
8@@	O	-1	9867728
%	O	-1	9867728
of	O	-1	9867728
users	O	-1	9867728
of	O	-1	9867728
f@@	B-Chemical	D005277	9867728
en@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
lur@@	I-Chemical	-1	9867728
amine	I-Chemical	-1	9867728
and	O	-1	9867728
de@@	B-Chemical	D020372	9867728
x@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
en@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
lur@@	I-Chemical	-1	9867728
amine	I-Chemical	-1	9867728
had	O	-1	9867728
val@@	B-Disease	D006349	9867728
v@@	I-Disease	-1	9867728
ular	I-Disease	-1	9867728
disease	I-Disease	-1	9867728
,	O	-1	9867728
these	O	-1	9867728
drugs	O	-1	9867728
were	O	-1	9867728
withdraw@@	O	-1	9867728
n	O	-1	9867728
from	O	-1	9867728
the	O	-1	9867728
mark@@	O	-1	9867728
et@@	O	-1	9867728
.	O	-1	9867728
OBJECTIVE:	O	-1	9867728
To	O	-1	9867728
determine	O	-1	9867728
the	O	-1	9867728
risk	O	-1	9867728
for	O	-1	9867728
new	O	-1	9867728
or	O	-1	9867728
wor@@	O	-1	9867728
sen@@	O	-1	9867728
ing	O	-1	9867728
val@@	B-Disease	D006349	9867728
v@@	I-Disease	-1	9867728
ular	I-Disease	-1	9867728
abnormal@@	I-Disease	-1	9867728
ities	I-Disease	-1	9867728
among	O	-1	9867728
users	O	-1	9867728
of	O	-1	9867728
f@@	B-Chemical	D005277	9867728
en@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
lur@@	I-Chemical	-1	9867728
amine	I-Chemical	-1	9867728
or	O	-1	9867728
de@@	B-Chemical	D020372	9867728
x@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
en@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
lur@@	I-Chemical	-1	9867728
amine	I-Chemical	-1	9867728
who	O	-1	9867728
under@@	O	-1	9867728
w@@	O	-1	9867728
ent	O	-1	9867728
echocardiograph@@	O	-1	9867728
y	O	-1	9867728
before	O	-1	9867728
they	O	-1	9867728
be@@	O	-1	9867728
g@@	O	-1	9867728
an	O	-1	9867728
to	O	-1	9867728
tak@@	O	-1	9867728
e	O	-1	9867728
these	O	-1	9867728
medic@@	O	-1	9867728
ations.	O	-1	9867728
D@@	O	-1	9867728
ES@@	O	-1	9867728
I@@	O	-1	9867728
G@@	O	-1	9867728
N@@	O	-1	9867728
:	O	-1	9867728
C@@	O	-1	9867728
o@@	O	-1	9867728
h@@	O	-1	9867728
ort	O	-1	9867728
study.	O	-1	9867728
S@@	O	-1	9867728
ET@@	O	-1	9867728
TI@@	O	-1	9867728
N@@	O	-1	9867728
G@@	O	-1	9867728
:	O	-1	9867728
A@@	O	-1	9867728
ca@@	O	-1	9867728
de@@	O	-1	9867728
mic	O	-1	9867728
prim@@	O	-1	9867728
ary	O	-1	9867728
car@@	O	-1	9867728
e	O	-1	9867728
p@@	O	-1	9867728
rac@@	O	-1	9867728
tic@@	O	-1	9867728
es.	O	-1	9867728
PA@@	O	-1	9867728
TI@@	O	-1	9867728
E@@	O	-1	9867728
N@@	O	-1	9867728
T@@	O	-1	9867728
S:	O	-1	9867728
4@@	O	-1	9867728
6	O	-1	9867728
patients	O	-1	9867728
who	O	-1	9867728
used	O	-1	9867728
f@@	B-Chemical	D005277	9867728
en@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
lur@@	I-Chemical	-1	9867728
amine	I-Chemical	-1	9867728
or	O	-1	9867728
de@@	B-Chemical	D020372	9867728
x@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
en@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
lur@@	I-Chemical	-1	9867728
amine	I-Chemical	-1	9867728
for	O	-1	9867728
14	O	-1	9867728
days	O	-1	9867728
or	O	-1	9867728
more	O	-1	9867728
and	O	-1	9867728
had	O	-1	9867728
ech@@	O	-1	9867728
ocardi@@	O	-1	9867728
o@@	O	-1	9867728
gram@@	O	-1	9867728
s	O	-1	9867728
obtained	O	-1	9867728
before	O	-1	9867728
therapy.	O	-1	9867728
M@@	O	-1	9867728
E@@	O	-1	9867728
A@@	O	-1	9867728
S@@	O	-1	9867728
U@@	O	-1	9867728
R@@	O	-1	9867728
E@@	O	-1	9867728
M@@	O	-1	9867728
E@@	O	-1	9867728
N@@	O	-1	9867728
T@@	O	-1	9867728
S:	O	-1	9867728
F@@	O	-1	9867728
ol@@	O	-1	9867728
low@@	O	-1	9867728
-@@	O	-1	9867728
up	O	-1	9867728
echocardiograph@@	O	-1	9867728
y.	O	-1	9867728
The	O	-1	9867728
prim@@	O	-1	9867728
ary	O	-1	9867728
outcom@@	O	-1	9867728
e	O	-1	9867728
was	O	-1	9867728
new	O	-1	9867728
or	O	-1	9867728
wor@@	O	-1	9867728
sen@@	O	-1	9867728
ing	O	-1	9867728
val@@	B-Disease	D006349	9867728
v@@	I-Disease	-1	9867728
ulo@@	I-Disease	-1	9867728
pathy	I-Disease	-1	9867728
,	O	-1	9867728
def@@	O	-1	9867728
in@@	O	-1	9867728
ed	O	-1	9867728
as	O	-1	9867728
progres@@	O	-1	9867728
sion	O	-1	9867728
of	O	-1	9867728
either	O	-1	9867728
a@@	B-Disease	D001022	9867728
or@@	I-Disease	-1	9867728
tic	I-Disease	-1	9867728
or	I-Disease	-1	9867728
mit@@	I-Disease	-1	9867728
ral	I-Disease	-1	9867728
reg@@	I-Disease	-1	9867728
ur@@	I-Disease	-1	9867728
g@@	I-Disease	-1	9867728
it@@	I-Disease	-1	9867728
ation	I-Disease	-1	9867728
a@@	B-Disease	D008944	9867728
or@@	I-Disease	-1	9867728
tic	I-Disease	-1	9867728
or	I-Disease	-1	9867728
mit@@	I-Disease	-1	9867728
ral	I-Disease	-1	9867728
reg@@	I-Disease	-1	9867728
ur@@	I-Disease	-1	9867728
g@@	I-Disease	-1	9867728
it@@	I-Disease	-1	9867728
ation	I-Disease	-1	9867728
by	O	-1	9867728
at	O	-1	9867728
le@@	O	-1	9867728
ast	O	-1	9867728
one	O	-1	9867728
de@@	O	-1	9867728
g@@	O	-1	9867728
ree	O	-1	9867728
of	O	-1	9867728
severity	O	-1	9867728
and	O	-1	9867728
disease	O	-1	9867728
that	O	-1	9867728
me@@	O	-1	9867728
t	O	-1	9867728
U@@	O	-1	9867728
.@@	O	-1	9867728
S@@	O	-1	9867728
.	O	-1	9867728
F@@	O	-1	9867728
o@@	O	-1	9867728
od	O	-1	9867728
and	O	-1	9867728
D@@	O	-1	9867728
ru@@	O	-1	9867728
g	O	-1	9867728
Ad@@	O	-1	9867728
minist@@	O	-1	9867728
ration	O	-1	9867728
c@@	O	-1	9867728
rit@@	O	-1	9867728
er@@	O	-1	9867728
ia	O	-1	9867728
(@@	O	-1	9867728
at	O	-1	9867728
le@@	O	-1	9867728
ast	O	-1	9867728
mil@@	O	-1	9867728
d	O	-1	9867728
a@@	B-Disease	D001022	9867728
or@@	I-Disease	-1	9867728
tic	I-Disease	-1	9867728
reg@@	I-Disease	-1	9867728
ur@@	I-Disease	-1	9867728
g@@	I-Disease	-1	9867728
it@@	I-Disease	-1	9867728
ation	I-Disease	-1	9867728
or	O	-1	9867728
moder@@	O	-1	9867728
ate	O	-1	9867728
mit@@	B-Disease	D008944	9867728
ral	I-Disease	-1	9867728
reg@@	I-Disease	-1	9867728
ur@@	I-Disease	-1	9867728
g@@	I-Disease	-1	9867728
it@@	I-Disease	-1	9867728
ation	I-Disease	-1	9867728
).	O	-1	9867728
RESULTS:	O	-1	9867728
Two	O	-1	9867728
patients	O	-1	9867728
(@@	O	-1	9867728
4.@@	O	-1	9867728
3@@	O	-1	9867728
%	O	-1	9867728
[@@	O	-1	9867728
95%	O	-1	9867728
CI@@	O	-1	9867728
,	O	-1	9867728
0.@@	O	-1	9867728
6%	O	-1	9867728
to	O	-1	9867728
1@@	O	-1	9867728
4.@@	O	-1	9867728
8@@	O	-1	9867728
%@@	O	-1	9867728
]@@	O	-1	9867728
)	O	-1	9867728
receiving	O	-1	9867728
f@@	B-Chemical	D005277	9867728
en@@	I-Chemical	-1	9867728
f@@	I-Chemical	-1	9867728
lur@@	I-Chemical	-1	9867728
amine	I-Chemical	-1	9867728
-	O	-1	9867728
ph@@	B-Chemical	D010645	9867728
ent@@	I-Chemical	-1	9867728
er@@	I-Chemical	-1	9867728
mine	I-Chemical	-1	9867728
developed	O	-1	9867728
val@@	B-Disease	D006349	9867728
v@@	I-Disease	-1	9867728
ular	I-Disease	-1	9867728
heart	I-Disease	-1	9867728
disease	I-Disease	-1	9867728
.	O	-1	9867728
One	O	-1	9867728
had	O	-1	9867728
baseline	O	-1	9867728
b@@	B-Disease	C562388	9867728
ic@@	I-Disease	-1	9867728
us@@	I-Disease	-1	9867728
pid	I-Disease	-1	9867728
a@@	I-Disease	-1	9867728
or@@	I-Disease	-1	9867728
tic	I-Disease	-1	9867728
val@@	I-Disease	-1	9867728
ve	I-Disease	-1	9867728
and	O	-1	9867728
mil@@	O	-1	9867728
d	O	-1	9867728
a@@	B-Disease	D001022	9867728
or@@	I-Disease	-1	9867728
tic	I-Disease	-1	9867728
reg@@	I-Disease	-1	9867728
ur@@	I-Disease	-1	9867728
g@@	I-Disease	-1	9867728
it@@	I-Disease	-1	9867728
ation	I-Disease	-1	9867728
that	O	-1	9867728
progres@@	O	-1	9867728
sed	O	-1	9867728
to	O	-1	9867728
moder@@	O	-1	9867728
ate	O	-1	9867728
reg@@	O	-1	9867728
ur@@	O	-1	9867728
g@@	O	-1	9867728
it@@	O	-1	9867728
ation.	O	-1	9867728
The	O	-1	9867728
second	O	-1	9867728
patient	O	-1	9867728
developed	O	-1	9867728
new	O	-1	9867728
moder@@	O	-1	9867728
ate	O	-1	9867728
a@@	B-Disease	D001022	9867728
or@@	I-Disease	-1	9867728
tic	I-Disease	-1	9867728
in@@	I-Disease	-1	9867728
suffici@@	I-Disease	-1	9867728
ency	I-Disease	-1	9867728
.	O	-1	9867728
CONCLUSION:	O	-1	9867728
U@@	O	-1	9867728
ser@@	O	-1	9867728
s	O	-1	9867728
of	O	-1	9867728
diet	O	-1	9867728
medic@@	O	-1	9867728
ations	O	-1	9867728
are	O	-1	9867728
at	O	-1	9867728
risk	O	-1	9867728
for	O	-1	9867728
val@@	B-Disease	D006349	9867728
v@@	I-Disease	-1	9867728
ular	I-Disease	-1	9867728
heart	I-Disease	-1	9867728
disease	I-Disease	-1	9867728
.	O	-1	9867728
However,	O	-1	9867728
the	O	-1	9867728
incidence	O	-1	9867728
may	O	-1	9867728
be	O	-1	9867728
lower	O	-1	9867728
than	O	-1	9867728
that	O	-1	9867728
reported	O	-1	9867728
previ@@	O	-1	9867728
ous@@	O	-1	9867728
ly.	O	-1	9867728

C@@	B-Chemical	D016190	9636837
ar@@	I-Chemical	-1	9636837
bo@@	I-Chemical	-1	9636837
pl@@	I-Chemical	-1	9636837
atin	I-Chemical	-1	9636837
toxic	O	-1	9636837
effects	O	-1	9636837
on	O	-1	9636837
the	O	-1	9636837
peripheral	O	-1	9636837
ner@@	O	-1	9636837
v@@	O	-1	9636837
ous	O	-1	9636837
system	O	-1	9636837
of	O	-1	9636837
the	O	-1	9636837
rat@@	O	-1	9636837
.	O	-1	9636837
BACKGROUND:	O	-1	9636837
The	O	-1	9636837
most	O	-1	9636837
stri@@	O	-1	9636837
king	O	-1	9636837
of	O	-1	9636837
car@@	B-Chemical	D016190	9636837
bo@@	I-Chemical	-1	9636837
pl@@	I-Chemical	-1	9636837
atin	I-Chemical	-1	9636837
's	O	-1	9636837
adv@@	O	-1	9636837
ant@@	O	-1	9636837
ages	O	-1	9636837
(	O	-1	9636837
C@@	B-Chemical	D016190	9636837
B@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
C@@	I-Chemical	-1	9636837
A	I-Chemical	-1	9636837
)	O	-1	9636837
over	O	-1	9636837
cisplatin	B-Chemical	D002945	9636837
(	O	-1	9636837
C@@	B-Chemical	D002945	9636837
D@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
P	I-Chemical	-1	9636837
)	O	-1	9636837
is	O	-1	9636837
its	O	-1	9636837
mark@@	O	-1	9636837
ed@@	O	-1	9636837
ly	O	-1	9636837
reduced	O	-1	9636837
rate	O	-1	9636837
of	O	-1	9636837
neuro@@	B-Disease	D020258	9636837
toxic	I-Disease	-1	9636837
effects.	O	-1	9636837
However,	O	-1	9636837
the	O	-1	9636837
use	O	-1	9636837
of	O	-1	9636837
C@@	B-Chemical	D016190	9636837
B@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
C@@	I-Chemical	-1	9636837
A	I-Chemical	-1	9636837
high@@	O	-1	9636837
er@@	O	-1	9636837
-@@	O	-1	9636837
int@@	O	-1	9636837
ensity	O	-1	9636837
sch@@	O	-1	9636837
ed@@	O	-1	9636837
ul@@	O	-1	9636837
es	O	-1	9636837
and	O	-1	9636837
the	O	-1	9636837
association	O	-1	9636837
with	O	-1	9636837
other	O	-1	9636837
neuro@@	B-Disease	D020258	9636837
toxic	I-Disease	-1	9636837
drugs	O	-1	9636837
in	O	-1	9636837
poly@@	O	-1	9636837
chemotherapy	O	-1	9636837
may	O	-1	9636837
cause	O	-1	9636837
some	O	-1	9636837
con@@	O	-1	9636837
cer@@	O	-1	9636837
n	O	-1	9636837
about	O	-1	9636837
its	O	-1	9636837
safety	O	-1	9636837
with	O	-1	9636837
resp@@	O	-1	9636837
ect	O	-1	9636837
to	O	-1	9636837
peripheral	B-Disease	D010523	9636837
ner@@	I-Disease	-1	9636837
v@@	I-Disease	-1	9636837
ous	I-Disease	-1	9636837
system	I-Disease	-1	9636837
damage	I-Disease	-1	9636837
.	O	-1	9636837
M@@	O	-1	9636837
AT@@	O	-1	9636837
E@@	O	-1	9636837
R@@	O	-1	9636837
I@@	O	-1	9636837
AL@@	O	-1	9636837
S	O	-1	9636837
AN@@	O	-1	9636837
D	O	-1	9636837
METHODS:	O	-1	9636837
Two	O	-1	9636837
different	O	-1	9636837
sch@@	O	-1	9636837
ed@@	O	-1	9636837
ul@@	O	-1	9636837
es	O	-1	9636837
of	O	-1	9636837
C@@	B-Chemical	D016190	9636837
B@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
C@@	I-Chemical	-1	9636837
A	I-Chemical	-1	9636837
administration	O	-1	9636837
(10	O	-1	9636837
mg/kg	O	-1	9636837
and	O	-1	9636837
15	O	-1	9636837
mg/kg	O	-1	9636837
i.@@	O	-1	9636837
p@@	O	-1	9636837
.	O	-1	9636837
tw@@	O	-1	9636837
ic@@	O	-1	9636837
e	O	-1	9636837
a	O	-1	9636837
week	O	-1	9636837
for	O	-1	9636837
n@@	O	-1	9636837
ine	O	-1	9636837
tim@@	O	-1	9636837
es@@	O	-1	9636837
)	O	-1	9636837
were	O	-1	9636837
evaluated	O	-1	9636837
in	O	-1	9636837
Wistar	O	-1	9636837
rats.	O	-1	9636837
Ne@@	B-Disease	D020258	9636837
uro@@	I-Disease	-1	9636837
toxicity	I-Disease	-1	9636837
was	O	-1	9636837
assessed	O	-1	9636837
for	O	-1	9636837
behavioral	O	-1	9636837
(@@	O	-1	9636837
t@@	O	-1	9636837
ail@@	O	-1	9636837
-@@	O	-1	9636837
f@@	O	-1	9636837
l@@	O	-1	9636837
ic@@	O	-1	9636837
k	O	-1	9636837
test@@	O	-1	9636837
),	O	-1	9636837
neuro@@	O	-1	9636837
physi@@	O	-1	9636837
ological	O	-1	9636837
(@@	O	-1	9636837
nerve	O	-1	9636837
con@@	O	-1	9636837
duction	O	-1	9636837
ve@@	O	-1	9636837
loc@@	O	-1	9636837
ity	O	-1	9636837
in	O	-1	9636837
the	O	-1	9636837
t@@	O	-1	9636837
a@@	O	-1	9636837
il	O	-1	9636837
ner@@	O	-1	9636837
ve@@	O	-1	9636837
),	O	-1	9636837
morph@@	O	-1	9636837
olog@@	O	-1	9636837
ic@@	O	-1	9636837
al,	O	-1	9636837
morph@@	O	-1	9636837
o@@	O	-1	9636837
met@@	O	-1	9636837
r@@	O	-1	9636837
ical	O	-1	9636837
and	O	-1	9636837
analy@@	O	-1	9636837
tical	O	-1	9636837
effects.	O	-1	9636837
RESULTS:	O	-1	9636837
C@@	B-Chemical	D016190	9636837
B@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
C@@	I-Chemical	-1	9636837
A	I-Chemical	-1	9636837
administration	O	-1	9636837
induced	O	-1	9636837
dose-@@	O	-1	9636837
dependent	O	-1	9636837
peripheral	B-Disease	D010523	9636837
neuro@@	I-Disease	-1	9636837
toxicity	I-Disease	-1	9636837
.	O	-1	9636837
P@@	B-Disease	D010146	9636837
ain	I-Disease	-1	9636837
per@@	O	-1	9636837
ce@@	O	-1	9636837
ption	O	-1	9636837
and	O	-1	9636837
nerve	O	-1	9636837
con@@	O	-1	9636837
duction	O	-1	9636837
ve@@	O	-1	9636837
loc@@	O	-1	9636837
ity	O	-1	9636837
in	O	-1	9636837
the	O	-1	9636837
t@@	O	-1	9636837
a@@	O	-1	9636837
il	O	-1	9636837
were	O	-1	9636837
significantly	O	-1	9636837
impa@@	O	-1	9636837
i@@	O	-1	9636837
re@@	O	-1	9636837
d,	O	-1	9636837
partic@@	O	-1	9636837
ul@@	O	-1	9636837
arly	O	-1	9636837
after	O	-1	9636837
the	O	-1	9636837
high-dose	O	-1	9636837
treatment.	O	-1	9636837
The	O	-1	9636837
d@@	O	-1	9636837
or@@	O	-1	9636837
s@@	O	-1	9636837
al	O	-1	9636837
ro@@	O	-1	9636837
o@@	O	-1	9636837
t	O	-1	9636837
g@@	O	-1	9636837
ang@@	O	-1	9636837
li@@	O	-1	9636837
a	O	-1	9636837
sens@@	O	-1	9636837
ory	O	-1	9636837
neuron@@	O	-1	9636837
s	O	-1	9636837
and@@	O	-1	9636837
,	O	-1	9636837
to	O	-1	9636837
a	O	-1	9636837
l@@	O	-1	9636837
ess@@	O	-1	9636837
er	O	-1	9636837
ext@@	O	-1	9636837
ent@@	O	-1	9636837
,	O	-1	9636837
s@@	O	-1	9636837
ate@@	O	-1	9636837
ll@@	O	-1	9636837
ite	O	-1	9636837
cells	O	-1	9636837
showed	O	-1	9636837
the	O	-1	9636837
same	O	-1	9636837
changes	O	-1	9636837
as	O	-1	9636837
those	O	-1	9636837
induced	O	-1	9636837
by	O	-1	9636837
C@@	B-Chemical	D002945	9636837
D@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
P	I-Chemical	-1	9636837
,	O	-1	9636837
main@@	O	-1	9636837
ly	O	-1	9636837
aff@@	O	-1	9636837
ect@@	O	-1	9636837
ing	O	-1	9636837
the	O	-1	9636837
nucle@@	O	-1	9636837
us	O	-1	9636837
and	O	-1	9636837
nucle@@	O	-1	9636837
ol@@	O	-1	9636837
us	O	-1	9636837
of	O	-1	9636837
g@@	O	-1	9636837
ang@@	O	-1	9636837
li@@	O	-1	9636837
onic	O	-1	9636837
sens@@	O	-1	9636837
ory	O	-1	9636837
neuron@@	O	-1	9636837
s.	O	-1	9636837
M@@	O	-1	9636837
ore@@	O	-1	9636837
o@@	O	-1	9636837
ver,	O	-1	9636837
significant	O	-1	9636837
amoun@@	O	-1	9636837
ts	O	-1	9636837
of	O	-1	9636837
pl@@	B-Chemical	D010984	9636837
at@@	I-Chemical	-1	9636837
in@@	I-Chemical	-1	9636837
um	I-Chemical	-1	9636837
were	O	-1	9636837
det@@	O	-1	9636837
ected	O	-1	9636837
in	O	-1	9636837
the	O	-1	9636837
d@@	O	-1	9636837
or@@	O	-1	9636837
s@@	O	-1	9636837
al	O	-1	9636837
ro@@	O	-1	9636837
o@@	O	-1	9636837
t	O	-1	9636837
g@@	O	-1	9636837
ang@@	O	-1	9636837
li@@	O	-1	9636837
a	O	-1	9636837
and	O	-1	9636837
kidney	O	-1	9636837
after	O	-1	9636837
C@@	B-Chemical	D016190	9636837
B@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
C@@	I-Chemical	-1	9636837
A	I-Chemical	-1	9636837
treatment.	O	-1	9636837
CONCLUSIONS:	O	-1	9636837
C@@	B-Chemical	D016190	9636837
B@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
C@@	I-Chemical	-1	9636837
A	I-Chemical	-1	9636837
is	O	-1	9636837
neuro@@	B-Disease	D020258	9636837
toxic	I-Disease	-1	9636837
in	O	-1	9636837
our	O	-1	9636837
model@@	O	-1	9636837
,	O	-1	9636837
and	O	-1	9636837
the	O	-1	9636837
type	O	-1	9636837
of	O	-1	9636837
path@@	O	-1	9636837
ological	O	-1	9636837
changes	O	-1	9636837
it	O	-1	9636837
induc@@	O	-1	9636837
es	O	-1	9636837
are	O	-1	9636837
so	O	-1	9636837
clo@@	O	-1	9636837
se@@	O	-1	9636837
ly	O	-1	9636837
similar	O	-1	9636837
to	O	-1	9636837
those	O	-1	9636837
caused	O	-1	9636837
by	O	-1	9636837
C@@	B-Chemical	D002945	9636837
D@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
P	I-Chemical	-1	9636837
that	O	-1	9636837
it	O	-1	9636837
is	O	-1	9636837
prob@@	O	-1	9636837
able	O	-1	9636837
that	O	-1	9636837
neuro@@	B-Disease	D020258	9636837
toxicity	I-Disease	-1	9636837
is	O	-1	9636837
induced	O	-1	9636837
in	O	-1	9636837
the	O	-1	9636837
two	O	-1	9636837
drugs	O	-1	9636837
by	O	-1	9636837
the	O	-1	9636837
same	O	-1	9636837
mechanis@@	O	-1	9636837
m.	O	-1	9636837
This	O	-1	9636837
model	O	-1	9636837
can	O	-1	9636837
be	O	-1	9636837
used	O	-1	9636837
alone	O	-1	9636837
or	O	-1	9636837
in	O	-1	9636837
combination	O	-1	9636837
with	O	-1	9636837
other	O	-1	9636837
drugs	O	-1	9636837
to	O	-1	9636837
expl@@	O	-1	9636837
or@@	O	-1	9636837
e	O	-1	9636837
the	O	-1	9636837
effect	O	-1	9636837
of	O	-1	9636837
C@@	B-Chemical	D016190	9636837
B@@	I-Chemical	-1	9636837
D@@	I-Chemical	-1	9636837
C@@	I-Chemical	-1	9636837
A	I-Chemical	-1	9636837
on	O	-1	9636837
the	O	-1	9636837
peripheral	O	-1	9636837
ner@@	O	-1	9636837
v@@	O	-1	9636837
ous	O	-1	9636837
system@@	O	-1	9636837
.	O	-1	9636837

I@@	O	-1	9579567
atro@@	O	-1	9579567
genic	O	-1	9579567
ris@@	O	-1	9579567
k@@	O	-1	9579567
s	O	-1	9579567
of	O	-1	9579567
endo@@	B-Disease	D016889	9579567
me@@	I-Disease	-1	9579567
trial	I-Disease	-1	9579567
carcin@@	I-Disease	-1	9579567
oma	I-Disease	-1	9579567
after	O	-1	9579567
treatment	O	-1	9579567
for	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
in	O	-1	9579567
a	O	-1	9579567
larg@@	O	-1	9579567
e	O	-1	9579567
F@@	O	-1	9579567
ren@@	O	-1	9579567
ch	O	-1	9579567
cas@@	O	-1	9579567
e-@@	O	-1	9579567
control	O	-1	9579567
study.	O	-1	9579567
F	O	-1	9579567
d	O	-1	9579567
ration	O	-1	9579567
N@@	O	-1	9579567
ation@@	O	-1	9579567
al@@	O	-1	9579567
e	O	-1	9579567
des	O	-1	9579567
C@@	O	-1	9579567
ent@@	O	-1	9579567
res	O	-1	9579567
de	O	-1	9579567
L@@	O	-1	9579567
ut@@	O	-1	9579567
te	O	-1	9579567
C@@	O	-1	9579567
ont@@	O	-1	9579567
r@@	O	-1	9579567
e	O	-1	9579567
le	O	-1	9579567
C@@	O	-1	9579567
anc@@	O	-1	9579567
er	O	-1	9579567
(@@	O	-1	9579567
F@@	O	-1	9579567
N@@	O	-1	9579567
CL@@	O	-1	9579567
C@@	O	-1	9579567
C@@	O	-1	9579567
).	O	-1	9579567
S@@	O	-1	9579567
inc@@	O	-1	9579567
e	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
is	O	-1	9579567
wi@@	O	-1	9579567
de@@	O	-1	9579567
ly	O	-1	9579567
used	O	-1	9579567
in	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
treatment	O	-1	9579567
and	O	-1	9579567
has	O	-1	9579567
been	O	-1	9579567
pro@@	O	-1	9579567
pos@@	O	-1	9579567
ed	O	-1	9579567
for	O	-1	9579567
the	O	-1	9579567
pre@@	O	-1	9579567
ven@@	O	-1	9579567
tion	O	-1	9579567
of	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
,	O	-1	9579567
its	O	-1	9579567
endo@@	O	-1	9579567
me@@	O	-1	9579567
trial	O	-1	9579567
i@@	O	-1	9579567
atro@@	O	-1	9579567
genic	O	-1	9579567
effects	O	-1	9579567
mus@@	O	-1	9579567
t	O	-1	9579567
be	O	-1	9579567
ca@@	O	-1	9579567
ref@@	O	-1	9579567
ul@@	O	-1	9579567
ly	O	-1	9579567
ex@@	O	-1	9579567
am@@	O	-1	9579567
ine@@	O	-1	9579567
d.	O	-1	9579567
We	O	-1	9579567
have	O	-1	9579567
investigated	O	-1	9579567
the	O	-1	9579567
association	O	-1	9579567
between	O	-1	9579567
endo@@	B-Disease	D016889	9579567
me@@	I-Disease	-1	9579567
trial	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
and	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
use	O	-1	9579567
or	O	-1	9579567
other	O	-1	9579567
treat@@	O	-1	9579567
ments	O	-1	9579567
in	O	-1	9579567
women	O	-1	9579567
treated	O	-1	9579567
for	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
in	O	-1	9579567
a	O	-1	9579567
cas@@	O	-1	9579567
e-@@	O	-1	9579567
control	O	-1	9579567
study.	O	-1	9579567
C@@	O	-1	9579567
as@@	O	-1	9579567
es	O	-1	9579567
of	O	-1	9579567
endo@@	B-Disease	D016889	9579567
me@@	I-Disease	-1	9579567
trial	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
diagnos@@	O	-1	9579567
ed	O	-1	9579567
after	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
(n	O	-1	9579567
=	O	-1	9579567
13@@	O	-1	9579567
5@@	O	-1	9579567
)	O	-1	9579567
and	O	-1	9579567
4@@	O	-1	9579567
6@@	O	-1	9579567
7	O	-1	9579567
controls	O	-1	9579567
mat@@	O	-1	9579567
ch@@	O	-1	9579567
ed	O	-1	9579567
for	O	-1	9579567
age,	O	-1	9579567
year	O	-1	9579567
of	O	-1	9579567
diagnosis	O	-1	9579567
of	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
and	O	-1	9579567
hospit@@	O	-1	9579567
al	O	-1	9579567
and	O	-1	9579567
sur@@	O	-1	9579567
viv@@	O	-1	9579567
al	O	-1	9579567
time	O	-1	9579567
with	O	-1	9579567
an	O	-1	9579567
int@@	O	-1	9579567
ac@@	O	-1	9579567
t	O	-1	9579567
u@@	O	-1	9579567
ter@@	O	-1	9579567
us	O	-1	9579567
were	O	-1	9579567
inc@@	O	-1	9579567
lu@@	O	-1	9579567
de@@	O	-1	9579567
d.	O	-1	9579567
W@@	O	-1	9579567
o@@	O	-1	9579567
men	O	-1	9579567
who	O	-1	9579567
had	O	-1	9579567
received	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
were	O	-1	9579567
significantly	O	-1	9579567
more	O	-1	9579567
likely	O	-1	9579567
to	O	-1	9579567
have	O	-1	9579567
endo@@	B-Disease	D016889	9579567
me@@	I-Disease	-1	9579567
trial	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
diagnos@@	O	-1	9579567
ed	O	-1	9579567
than	O	-1	9579567
those	O	-1	9579567
who	O	-1	9579567
had	O	-1	9579567
not	O	-1	9579567
(@@	O	-1	9579567
c@@	O	-1	9579567
r@@	O	-1	9579567
ude	O	-1	9579567
rel@@	O	-1	9579567
ative	O	-1	9579567
risk	O	-1	9579567
=	O	-1	9579567
4.@@	O	-1	9579567
9@@	O	-1	9579567
,	O	-1	9579567
p	O	-1	9579567
=	O	-1	9579567
0.00@@	O	-1	9579567
0@@	O	-1	9579567
1).	O	-1	9579567
U@@	O	-1	9579567
n@@	O	-1	9579567
i@@	O	-1	9579567
vari@@	O	-1	9579567
ate	O	-1	9579567
and	O	-1	9579567
adjust@@	O	-1	9579567
ed	O	-1	9579567
analy@@	O	-1	9579567
ses	O	-1	9579567
showed	O	-1	9579567
that	O	-1	9579567
the	O	-1	9579567
risk	O	-1	9579567
increased	O	-1	9579567
with	O	-1	9579567
the	O	-1	9579567
l@@	O	-1	9579567
en@@	O	-1	9579567
g@@	O	-1	9579567
th	O	-1	9579567
of	O	-1	9579567
treatment	O	-1	9579567
(p	O	-1	9579567
=	O	-1	9579567
0.00@@	O	-1	9579567
0@@	O	-1	9579567
1)	O	-1	9579567
or	O	-1	9579567
the	O	-1	9579567
cum@@	O	-1	9579567
ul@@	O	-1	9579567
ative	O	-1	9579567
dose	O	-1	9579567
of	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
received	O	-1	9579567
(p	O	-1	9579567
=	O	-1	9579567
0.00@@	O	-1	9579567
0@@	O	-1	9579567
1),	O	-1	9579567
ir@@	O	-1	9579567
resp@@	O	-1	9579567
ective	O	-1	9579567
of	O	-1	9579567
the	O	-1	9579567
daily	O	-1	9579567
dose.	O	-1	9579567
W@@	O	-1	9579567
o@@	O	-1	9579567
men	O	-1	9579567
who	O	-1	9579567
had	O	-1	9579567
under@@	O	-1	9579567
g@@	O	-1	9579567
one	O	-1	9579567
p@@	O	-1	9579567
el@@	O	-1	9579567
v@@	O	-1	9579567
ic	O	-1	9579567
radi@@	O	-1	9579567
o@@	O	-1	9579567
therapy	O	-1	9579567
also	O	-1	9579567
had	O	-1	9579567
a	O	-1	9579567
higher	O	-1	9579567
risk	O	-1	9579567
(@@	O	-1	9579567
c@@	O	-1	9579567
r@@	O	-1	9579567
ude	O	-1	9579567
rel@@	O	-1	9579567
ative	O	-1	9579567
risk	O	-1	9579567
=	O	-1	9579567
7.@@	O	-1	9579567
8@@	O	-1	9579567
,	O	-1	9579567
p	O	-1	9579567
=	O	-1	9579567
0.00@@	O	-1	9579567
0@@	O	-1	9579567
1).	O	-1	9579567
After	O	-1	9579567
adjust@@	O	-1	9579567
ing	O	-1	9579567
for	O	-1	9579567
conf@@	O	-1	9579567
oun@@	O	-1	9579567
ding	O	-1	9579567
fact@@	O	-1	9579567
or@@	O	-1	9579567
s,	O	-1	9579567
the	O	-1	9579567
risk	O	-1	9579567
was	O	-1	9579567
higher	O	-1	9579567
for	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
users	O	-1	9579567
(p	O	-1	9579567
=	O	-1	9579567
0.00@@	O	-1	9579567
12@@	O	-1	9579567
),	O	-1	9579567
treatment	O	-1	9579567
for	O	-1	9579567
more	O	-1	9579567
than	O	-1	9579567
3	O	-1	9579567
years	O	-1	9579567
(@@	O	-1	9579567
all	O	-1	9579567
p	O	-1	9579567
<	O	-1	9579567
0.0@@	O	-1	9579567
3@@	O	-1	9579567
)	O	-1	9579567
and	O	-1	9579567
p@@	O	-1	9579567
el@@	O	-1	9579567
v@@	O	-1	9579567
ic	O	-1	9579567
radi@@	O	-1	9579567
o@@	O	-1	9579567
therapy	O	-1	9579567
(p	O	-1	9579567
=	O	-1	9579567
0.0@@	O	-1	9579567
12@@	O	-1	9579567
).	O	-1	9579567
W@@	O	-1	9579567
o@@	O	-1	9579567
men	O	-1	9579567
who	O	-1	9579567
had	O	-1	9579567
endo@@	B-Disease	D016889	9579567
me@@	I-Disease	-1	9579567
trial	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
and	O	-1	9579567
had	O	-1	9579567
received	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
had	O	-1	9579567
more	O	-1	9579567
adv@@	B-Disease	D020178	9579567
anced	I-Disease	-1	9579567
disease	I-Disease	-1	9579567
and	O	-1	9579567
po@@	O	-1	9579567
ore@@	O	-1	9579567
r	O	-1	9579567
pro@@	O	-1	9579567
g@@	O	-1	9579567
no@@	O	-1	9579567
sis	O	-1	9579567
than	O	-1	9579567
those	O	-1	9579567
with	O	-1	9579567
endo@@	B-Disease	D016889	9579567
me@@	I-Disease	-1	9579567
trial	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
who	O	-1	9579567
had	O	-1	9579567
not	O	-1	9579567
received	O	-1	9579567
this	O	-1	9579567
treatment.	O	-1	9579567
Our	O	-1	9579567
results	O	-1	9579567
suggest	O	-1	9579567
a	O	-1	9579567
ca@@	O	-1	9579567
us@@	O	-1	9579567
al	O	-1	9579567
role	O	-1	9579567
of	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
in	O	-1	9579567
endo@@	B-Disease	D016889	9579567
me@@	I-Disease	-1	9579567
trial	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
,	O	-1	9579567
partic@@	O	-1	9579567
ul@@	O	-1	9579567
arly	O	-1	9579567
when	O	-1	9579567
used	O	-1	9579567
as	O	-1	9579567
cur@@	O	-1	9579567
ren@@	O	-1	9579567
tly	O	-1	9579567
pro@@	O	-1	9579567
pos@@	O	-1	9579567
ed	O	-1	9579567
for	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
pre@@	O	-1	9579567
ven@@	O	-1	9579567
tion.	O	-1	9579567
P@@	O	-1	9579567
el@@	O	-1	9579567
v@@	O	-1	9579567
ic	O	-1	9579567
radi@@	O	-1	9579567
o@@	O	-1	9579567
therapy	O	-1	9579567
may	O	-1	9579567
be	O	-1	9579567
an	O	-1	9579567
addi@@	O	-1	9579567
tional	O	-1	9579567
i@@	O	-1	9579567
atro@@	O	-1	9579567
genic	O	-1	9579567
factor	O	-1	9579567
for	O	-1	9579567
women	O	-1	9579567
with	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
.	O	-1	9579567
E@@	B-Disease	D016889	9579567
n@@	I-Disease	-1	9579567
do@@	I-Disease	-1	9579567
me@@	I-Disease	-1	9579567
trial	I-Disease	-1	9579567
canc@@	I-Disease	-1	9579567
ers	I-Disease	-1	9579567
diagnos@@	O	-1	9579567
ed	O	-1	9579567
in	O	-1	9579567
women	O	-1	9579567
treated	O	-1	9579567
with	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
have	O	-1	9579567
po@@	O	-1	9579567
ore@@	O	-1	9579567
r	O	-1	9579567
pro@@	O	-1	9579567
g@@	O	-1	9579567
no@@	O	-1	9579567
sis.	O	-1	9579567
W@@	O	-1	9579567
o@@	O	-1	9579567
men	O	-1	9579567
who	O	-1	9579567
recei@@	O	-1	9579567
ve	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
for	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
should	O	-1	9579567
be	O	-1	9579567
o@@	O	-1	9579567
ffe@@	O	-1	9579567
red	O	-1	9579567
g@@	O	-1	9579567
y@@	O	-1	9579567
na@@	O	-1	9579567
ec@@	O	-1	9579567
ological	O	-1	9579567
sur@@	O	-1	9579567
ve@@	O	-1	9579567
ill@@	O	-1	9579567
ance	O	-1	9579567
during	O	-1	9579567
and	O	-1	9579567
after	O	-1	9579567
treatment.	O	-1	9579567
A	O	-1	9579567
long-term	O	-1	9579567
evalu@@	O	-1	9579567
ation	O	-1	9579567
of	O	-1	9579567
the	O	-1	9579567
ris@@	O	-1	9579567
k@@	O	-1	9579567
-@@	O	-1	9579567
ben@@	O	-1	9579567
e@@	O	-1	9579567
fi@@	O	-1	9579567
t	O	-1	9579567
rati@@	O	-1	9579567
o	O	-1	9579567
of	O	-1	9579567
t@@	B-Chemical	D013629	9579567
am@@	I-Chemical	-1	9579567
oxif@@	I-Chemical	-1	9579567
en	I-Chemical	-1	9579567
as	O	-1	9579567
a	O	-1	9579567
pre@@	O	-1	9579567
ven@@	O	-1	9579567
tive	O	-1	9579567
treatment	O	-1	9579567
for	O	-1	9579567
b@@	B-Disease	D001943	9579567
reas@@	I-Disease	-1	9579567
t	I-Disease	-1	9579567
cancer	I-Disease	-1	9579567
is	O	-1	9579567
clear@@	O	-1	9579567
ly	O	-1	9579567
war@@	O	-1	9579567
ran@@	O	-1	9579567
ted.	O	-1	9579567

G@@	B-Disease	C537296	9205462
ran@@	I-Disease	-1	9205462
u@@	I-Disease	-1	9205462
los@@	I-Disease	-1	9205462
a	I-Disease	-1	9205462
cell	I-Disease	-1	9205462
tumor	I-Disease	-1	9205462
of	I-Disease	-1	9205462
the	I-Disease	-1	9205462
o@@	I-Disease	-1	9205462
v@@	I-Disease	-1	9205462
ary	I-Disease	-1	9205462
associated	O	-1	9205462
with	O	-1	9205462
ant@@	O	-1	9205462
ec@@	O	-1	9205462
ed@@	O	-1	9205462
ent	O	-1	9205462
t@@	B-Chemical	D013629	9205462
am@@	I-Chemical	-1	9205462
oxif@@	I-Chemical	-1	9205462
en	I-Chemical	-1	9205462
use.	O	-1	9205462
BACKGROUND:	O	-1	9205462
In@@	O	-1	9205462
c@@	O	-1	9205462
reas@@	O	-1	9205462
ed	O	-1	9205462
atten@@	O	-1	9205462
tion	O	-1	9205462
has	O	-1	9205462
been	O	-1	9205462
foc@@	O	-1	9205462
used	O	-1	9205462
rec@@	O	-1	9205462
ently	O	-1	9205462
on	O	-1	9205462
the	O	-1	9205462
est@@	O	-1	9205462
ro@@	O	-1	9205462
genic	O	-1	9205462
effects	O	-1	9205462
of	O	-1	9205462
t@@	B-Chemical	D013629	9205462
am@@	I-Chemical	-1	9205462
oxif@@	I-Chemical	-1	9205462
en	I-Chemical	-1	9205462
.	O	-1	9205462
Re@@	O	-1	9205462
vie@@	O	-1	9205462
w	O	-1	9205462
of	O	-1	9205462
the	O	-1	9205462
literat@@	O	-1	9205462
ure	O	-1	9205462
reve@@	O	-1	9205462
als	O	-1	9205462
an	O	-1	9205462
association	O	-1	9205462
between	O	-1	9205462
t@@	B-Chemical	D013629	9205462
am@@	I-Chemical	-1	9205462
oxif@@	I-Chemical	-1	9205462
en	I-Chemical	-1	9205462
use	O	-1	9205462
and	O	-1	9205462
g@@	O	-1	9205462
y@@	O	-1	9205462
nec@@	O	-1	9205462
ologic	O	-1	9205462
tu@@	B-Disease	D009369	9205462
mor@@	I-Disease	-1	9205462
s	I-Disease	-1	9205462
.	O	-1	9205462
CA@@	O	-1	9205462
S@@	O	-1	9205462
E:	O	-1	9205462
A	O	-1	9205462
5@@	O	-1	9205462
2-@@	O	-1	9205462
year-old	O	-1	9205462
post@@	O	-1	9205462
men@@	O	-1	9205462
o@@	O	-1	9205462
pa@@	O	-1	9205462
us@@	O	-1	9205462
al	O	-1	9205462
woman	O	-1	9205462
was	O	-1	9205462
treated	O	-1	9205462
with	O	-1	9205462
t@@	B-Chemical	D013629	9205462
am@@	I-Chemical	-1	9205462
oxif@@	I-Chemical	-1	9205462
en	I-Chemical	-1	9205462
for	O	-1	9205462
st@@	O	-1	9205462
age	O	-1	9205462
II	O	-1	9205462
est@@	B-Chemical	D004967	9205462
ro@@	I-Chemical	-1	9205462
gen	I-Chemical	-1	9205462
receptor@@	O	-1	9205462
-@@	O	-1	9205462
positive	O	-1	9205462
b@@	B-Disease	D001943	9205462
reas@@	I-Disease	-1	9205462
t	I-Disease	-1	9205462
carcin@@	I-Disease	-1	9205462
oma	I-Disease	-1	9205462
.	O	-1	9205462
H@@	O	-1	9205462
er	O	-1	9205462
as@@	B-Chemical	D001224	9205462
part@@	I-Chemical	-1	9205462
ate	I-Chemical	-1	9205462
trans@@	O	-1	9205462
amin@@	O	-1	9205462
ase	O	-1	9205462
and	O	-1	9205462
al@@	B-Chemical	D000409	9205462
an@@	I-Chemical	-1	9205462
ine	I-Chemical	-1	9205462
trans@@	O	-1	9205462
amin@@	O	-1	9205462
ase	O	-1	9205462
levels	O	-1	9205462
increase	O	-1	9205462
mark@@	O	-1	9205462
ed@@	O	-1	9205462
ly	O	-1	9205462
after	O	-1	9205462
6	O	-1	9205462
months	O	-1	9205462
of	O	-1	9205462
t@@	B-Chemical	D013629	9205462
am@@	I-Chemical	-1	9205462
oxif@@	I-Chemical	-1	9205462
en	I-Chemical	-1	9205462
use.	O	-1	9205462
After	O	-1	9205462
an	O	-1	9205462
addi@@	O	-1	9205462
tional	O	-1	9205462
17	O	-1	9205462
months	O	-1	9205462
of	O	-1	9205462
elevated	O	-1	9205462
serum	O	-1	9205462
trans@@	O	-1	9205462
amin@@	O	-1	9205462
as@@	O	-1	9205462
es,	O	-1	9205462
the	O	-1	9205462
patient	O	-1	9205462
was	O	-1	9205462
found	O	-1	9205462
to	O	-1	9205462
have	O	-1	9205462
a	O	-1	9205462
st@@	O	-1	9205462
age	O	-1	9205462
I@@	O	-1	9205462
c	O	-1	9205462
gran@@	B-Disease	C537296	9205462
u@@	I-Disease	-1	9205462
los@@	I-Disease	-1	9205462
a	I-Disease	-1	9205462
cell	I-Disease	-1	9205462
tumor	I-Disease	-1	9205462
of	I-Disease	-1	9205462
the	I-Disease	-1	9205462
o@@	I-Disease	-1	9205462
v@@	I-Disease	-1	9205462
ary	I-Disease	-1	9205462
.	O	-1	9205462
CONCLUSION:	O	-1	9205462
Patients	O	-1	9205462
with	O	-1	9205462
t@@	B-Chemical	D013629	9205462
am@@	I-Chemical	-1	9205462
oxif@@	I-Chemical	-1	9205462
en	I-Chemical	-1	9205462
-induced	O	-1	9205462
liver	B-Disease	D017093	9205462
dysfunction	I-Disease	-1	9205462
may	O	-1	9205462
be	O	-1	9205462
at	O	-1	9205462
increased	O	-1	9205462
risk	O	-1	9205462
for	O	-1	9205462
gran@@	B-Disease	D006106	9205462
u@@	I-Disease	-1	9205462
los@@	I-Disease	-1	9205462
a	I-Disease	-1	9205462
cell	I-Disease	-1	9205462
tu@@	I-Disease	-1	9205462
mor@@	I-Disease	-1	9205462
s	I-Disease	-1	9205462
because	O	-1	9205462
of	O	-1	9205462
al@@	O	-1	9205462
ter@@	O	-1	9205462
ations	O	-1	9205462
in	O	-1	9205462
t@@	B-Chemical	D013629	9205462
am@@	I-Chemical	-1	9205462
oxif@@	I-Chemical	-1	9205462
en	I-Chemical	-1	9205462
metabol@@	O	-1	9205462
is@@	O	-1	9205462
m.	O	-1	9205462

A	O	-1	9098464
m@@	O	-1	9098464
urine	O	-1	9098464
model	O	-1	9098464
of	O	-1	9098464
aden@@	B-Disease	D062788	9098464
om@@	I-Disease	-1	9098464
yo@@	I-Disease	-1	9098464
sis	I-Disease	-1	9098464
:	O	-1	9098464
the	O	-1	9098464
effects	O	-1	9098464
of	O	-1	9098464
hyper@@	B-Disease	D006966	9098464
prol@@	I-Disease	-1	9098464
act@@	I-Disease	-1	9098464
ine@@	I-Disease	-1	9098464
mia	I-Disease	-1	9098464
induced	O	-1	9098464
by	O	-1	9098464
flu@@	B-Chemical	D005473	9098464
ox@@	I-Chemical	-1	9098464
et@@	I-Chemical	-1	9098464
ine	I-Chemical	-1	9098464
hydro@@	I-Chemical	-1	9098464
chlor@@	I-Chemical	-1	9098464
ide	I-Chemical	-1	9098464
,	O	-1	9098464
a	O	-1	9098464
selective	O	-1	9098464
seroton@@	B-Chemical	D012701	9098464
in	I-Chemical	-1	9098464
re@@	O	-1	9098464
u@@	O	-1	9098464
pt@@	O	-1	9098464
ake	O	-1	9098464
inhibitor@@	O	-1	9098464
,	O	-1	9098464
on	O	-1	9098464
aden@@	B-Disease	D062788	9098464
om@@	I-Disease	-1	9098464
yo@@	I-Disease	-1	9098464
sis	I-Disease	-1	9098464
induction	O	-1	9098464
in	O	-1	9098464
Wistar	O	-1	9098464
al@@	O	-1	9098464
bin@@	O	-1	9098464
o	O	-1	9098464
rats.	O	-1	9098464
OBJECTIVE:	O	-1	9098464
The	O	-1	9098464
a@@	O	-1	9098464
im	O	-1	9098464
of	O	-1	9098464
this	O	-1	9098464
study	O	-1	9098464
was	O	-1	9098464
to	O	-1	9098464
investigate	O	-1	9098464
whether	O	-1	9098464
flu@@	B-Chemical	D005473	9098464
ox@@	I-Chemical	-1	9098464
et@@	I-Chemical	-1	9098464
ine	I-Chemical	-1	9098464
given	O	-1	9098464
to	O	-1	9098464
ca@@	O	-1	9098464
strated	O	-1	9098464
and	O	-1	9098464
non@@	O	-1	9098464
ca@@	O	-1	9098464
strated	O	-1	9098464
rats	O	-1	9098464
caused	O	-1	9098464
hyper@@	B-Disease	D006966	9098464
prol@@	I-Disease	-1	9098464
act@@	I-Disease	-1	9098464
ine@@	I-Disease	-1	9098464
mia	I-Disease	-1	9098464
and	O	-1	9098464
its	O	-1	9098464
effects	O	-1	9098464
with	O	-1	9098464
resp@@	O	-1	9098464
ect	O	-1	9098464
to	O	-1	9098464
aden@@	B-Disease	D062788	9098464
om@@	I-Disease	-1	9098464
yo@@	I-Disease	-1	9098464
sis	I-Disease	-1	9098464
.	O	-1	9098464
D@@	O	-1	9098464
ES@@	O	-1	9098464
I@@	O	-1	9098464
G@@	O	-1	9098464
N@@	O	-1	9098464
:	O	-1	9098464
F@@	B-Chemical	D005473	9098464
lu@@	I-Chemical	-1	9098464
ox@@	I-Chemical	-1	9098464
et@@	I-Chemical	-1	9098464
ine	I-Chemical	-1	9098464
,	O	-1	9098464
a	O	-1	9098464
seroton@@	B-Chemical	D012701	9098464
in	I-Chemical	-1	9098464
re@@	O	-1	9098464
u@@	O	-1	9098464
pt@@	O	-1	9098464
ake	O	-1	9098464
inhibitor@@	O	-1	9098464
,	O	-1	9098464
was	O	-1	9098464
given	O	-1	9098464
to	O	-1	9098464
Wistar	O	-1	9098464
Al@@	O	-1	9098464
bin@@	O	-1	9098464
o	O	-1	9098464
rats	O	-1	9098464
for	O	-1	9098464
9@@	O	-1	9098464
8	O	-1	9098464
days	O	-1	9098464
to	O	-1	9098464
produce	O	-1	9098464
hyper@@	B-Disease	D006966	9098464
prol@@	I-Disease	-1	9098464
act@@	I-Disease	-1	9098464
ine@@	I-Disease	-1	9098464
mia	I-Disease	-1	9098464
.	O	-1	9098464
The	O	-1	9098464
drug	O	-1	9098464
was	O	-1	9098464
given	O	-1	9098464
to	O	-1	9098464
two	O	-1	9098464
groups	O	-1	9098464
consist@@	O	-1	9098464
ing	O	-1	9098464
of	O	-1	9098464
ca@@	O	-1	9098464
strated	O	-1	9098464
and	O	-1	9098464
non@@	O	-1	9098464
ca@@	O	-1	9098464
strated	O	-1	9098464
rats	O	-1	9098464
and	O	-1	9098464
compared	O	-1	9098464
to	O	-1	9098464
two	O	-1	9098464
groups	O	-1	9098464
of	O	-1	9098464
ca@@	O	-1	9098464
strated	O	-1	9098464
and	O	-1	9098464
non@@	O	-1	9098464
ca@@	O	-1	9098464
strated	O	-1	9098464
controls.	O	-1	9098464
Pro@@	O	-1	9098464
l@@	O	-1	9098464
actin	O	-1	9098464
levels	O	-1	9098464
were	O	-1	9098464
measured	O	-1	9098464
and	O	-1	9098464
the	O	-1	9098464
u@@	O	-1	9098464
ter@@	O	-1	9098464
i	O	-1	9098464
of	O	-1	9098464
the	O	-1	9098464
rats	O	-1	9098464
were	O	-1	9098464
re@@	O	-1	9098464
mo@@	O	-1	9098464
ved	O	-1	9098464
for	O	-1	9098464
histo@@	O	-1	9098464
path@@	O	-1	9098464
ological	O	-1	9098464
analysis	O	-1	9098464
at	O	-1	9098464
the	O	-1	9098464
end	O	-1	9098464
of	O	-1	9098464
9@@	O	-1	9098464
8	O	-1	9098464
days.	O	-1	9098464
S@@	O	-1	9098464
ET@@	O	-1	9098464
TI@@	O	-1	9098464
N@@	O	-1	9098464
G@@	O	-1	9098464
:	O	-1	9098464
M@@	O	-1	9098464
ar@@	O	-1	9098464
m@@	O	-1	9098464
ar@@	O	-1	9098464
a	O	-1	9098464
U@@	O	-1	9098464
n@@	O	-1	9098464
i@@	O	-1	9098464
ver@@	O	-1	9098464
s@@	O	-1	9098464
ity	O	-1	9098464
S@@	O	-1	9098464
ch@@	O	-1	9098464
o@@	O	-1	9098464
ol	O	-1	9098464
of	O	-1	9098464
M@@	O	-1	9098464
ed@@	O	-1	9098464
ic@@	O	-1	9098464
ine,	O	-1	9098464
De@@	O	-1	9098464
part@@	O	-1	9098464
ment	O	-1	9098464
of	O	-1	9098464
H@@	O	-1	9098464
ist@@	O	-1	9098464
ology	O	-1	9098464
and	O	-1	9098464
E@@	O	-1	9098464
mb@@	O	-1	9098464
r@@	O	-1	9098464
y@@	O	-1	9098464
olog@@	O	-1	9098464
y,	O	-1	9098464
Z@@	O	-1	9098464
e@@	O	-1	9098464
y@@	O	-1	9098464
ne@@	O	-1	9098464
p	O	-1	9098464
K@@	O	-1	9098464
ami@@	O	-1	9098464
l	O	-1	9098464
W@@	O	-1	9098464
o@@	O	-1	9098464
men	O	-1	9098464
and	O	-1	9098464
Ch@@	O	-1	9098464
ild@@	O	-1	9098464
ren@@	O	-1	9098464
's	O	-1	9098464
H@@	O	-1	9098464
ospit@@	O	-1	9098464
al.	O	-1	9098464
MA@@	O	-1	9098464
I@@	O	-1	9098464
N	O	-1	9098464
O@@	O	-1	9098464
U@@	O	-1	9098464
T@@	O	-1	9098464
CO@@	O	-1	9098464
M@@	O	-1	9098464
E	O	-1	9098464
M@@	O	-1	9098464
E@@	O	-1	9098464
A@@	O	-1	9098464
S@@	O	-1	9098464
U@@	O	-1	9098464
R@@	O	-1	9098464
E@@	O	-1	9098464
S:	O	-1	9098464
S@@	O	-1	9098464
er@@	O	-1	9098464
um	O	-1	9098464
prolactin	O	-1	9098464
level@@	O	-1	9098464
s,	O	-1	9098464
u@@	O	-1	9098464
ter@@	O	-1	9098464
ine	O	-1	9098464
histo@@	O	-1	9098464
path@@	O	-1	9098464
olog@@	O	-1	9098464
y.	O	-1	9098464
RESULTS:	O	-1	9098464
The	O	-1	9098464
prolactin	O	-1	9098464
levels	O	-1	9098464
of	O	-1	9098464
ca@@	O	-1	9098464
strated	O	-1	9098464
and	O	-1	9098464
non@@	O	-1	9098464
ca@@	O	-1	9098464
strated	O	-1	9098464
groups	O	-1	9098464
treated	O	-1	9098464
with	O	-1	9098464
flu@@	B-Chemical	D005473	9098464
ox@@	I-Chemical	-1	9098464
et@@	I-Chemical	-1	9098464
ine	I-Chemical	-1	9098464
were	O	-1	9098464
statis@@	O	-1	9098464
tically	O	-1	9098464
significantly	O	-1	9098464
higher	O	-1	9098464
when	O	-1	9098464
compared	O	-1	9098464
to	O	-1	9098464
their	O	-1	9098464
resp@@	O	-1	9098464
ective	O	-1	9098464
control	O	-1	9098464
groups.	O	-1	9098464
H@@	O	-1	9098464
ist@@	O	-1	9098464
ological	O	-1	9098464
studies	O	-1	9098464
revealed	O	-1	9098464
11	O	-1	9098464
cases	O	-1	9098464
of	O	-1	9098464
aden@@	B-Disease	D062788	9098464
om@@	I-Disease	-1	9098464
yo@@	I-Disease	-1	9098464
sis	I-Disease	-1	9098464
,	O	-1	9098464
all	O	-1	9098464
within	O	-1	9098464
the	O	-1	9098464
non@@	O	-1	9098464
ca@@	O	-1	9098464
strated	O	-1	9098464
group	O	-1	9098464
receiving	O	-1	9098464
flu@@	B-Chemical	D005473	9098464
ox@@	I-Chemical	-1	9098464
et@@	I-Chemical	-1	9098464
ine	I-Chemical	-1	9098464
.	O	-1	9098464
CONCLUSION:	O	-1	9098464
It	O	-1	9098464
was	O	-1	9098464
suggested	O	-1	9098464
that	O	-1	9098464
high	O	-1	9098464
serum	O	-1	9098464
prolactin	O	-1	9098464
levels	O	-1	9098464
cause	O	-1	9098464
de@@	O	-1	9098464
generation	O	-1	9098464
of	O	-1	9098464
my@@	O	-1	9098464
o@@	O	-1	9098464
me@@	O	-1	9098464
trial	O	-1	9098464
cells	O	-1	9098464
in	O	-1	9098464
the	O	-1	9098464
presence	O	-1	9098464
of	O	-1	9098464
o@@	O	-1	9098464
vari@@	O	-1	9098464
an	O	-1	9098464
steroid@@	B-Chemical	D013256	9098464
s	I-Chemical	-1	9098464
that	O	-1	9098464
results	O	-1	9098464
in	O	-1	9098464
a	O	-1	9098464
my@@	O	-1	9098464
o@@	O	-1	9098464
me@@	O	-1	9098464
trial	O	-1	9098464
inv@@	O	-1	9098464
a@@	O	-1	9098464
sion	O	-1	9098464
by	O	-1	9098464
endo@@	O	-1	9098464
me@@	O	-1	9098464
trial	O	-1	9098464
stro@@	O	-1	9098464
ma.	O	-1	9098464
This	O	-1	9098464
inv@@	O	-1	9098464
a@@	O	-1	9098464
sion	O	-1	9098464
event@@	O	-1	9098464
ually	O	-1	9098464
progres@@	O	-1	9098464
ses	O	-1	9098464
to	O	-1	9098464
aden@@	B-Disease	D062788	9098464
om@@	I-Disease	-1	9098464
yo@@	I-Disease	-1	9098464
sis	I-Disease	-1	9098464
.	O	-1	9098464

Eff@@	O	-1	8424298
ects	O	-1	8424298
of	O	-1	8424298
de@@	O	-1	8424298
li@@	O	-1	8424298
b@@	O	-1	8424298
er@@	O	-1	8424298
ate	O	-1	8424298
hypotension	B-Disease	D007022	8424298
induced	O	-1	8424298
by	O	-1	8424298
l@@	B-Chemical	D007741	8424298
a@@	I-Chemical	-1	8424298
bet@@	I-Chemical	-1	8424298
al@@	I-Chemical	-1	8424298
ol	I-Chemical	-1	8424298
with	O	-1	8424298
iso@@	B-Chemical	D007530	8424298
f@@	I-Chemical	-1	8424298
lur@@	I-Chemical	-1	8424298
ane	I-Chemical	-1	8424298
on	O	-1	8424298
neuro@@	O	-1	8424298
psych@@	O	-1	8424298
ological	O	-1	8424298
func@@	O	-1	8424298
tion.	O	-1	8424298
The	O	-1	8424298
effect	O	-1	8424298
of	O	-1	8424298
de@@	O	-1	8424298
li@@	O	-1	8424298
b@@	O	-1	8424298
er@@	O	-1	8424298
ate	O	-1	8424298
hypotension	B-Disease	D007022	8424298
on	O	-1	8424298
brain	O	-1	8424298
function	O	-1	8424298
measured	O	-1	8424298
by	O	-1	8424298
neuro@@	O	-1	8424298
psych@@	O	-1	8424298
ological	O	-1	8424298
tests	O	-1	8424298
was	O	-1	8424298
studied	O	-1	8424298
in	O	-1	8424298
4@@	O	-1	8424298
1	O	-1	8424298
ad@@	O	-1	8424298
ult	O	-1	8424298
patients.	O	-1	8424298
Tw@@	O	-1	8424298
ent@@	O	-1	8424298
y-@@	O	-1	8424298
four	O	-1	8424298
patients	O	-1	8424298
were	O	-1	8424298
anaesthe@@	O	-1	8424298
tiz@@	O	-1	8424298
ed	O	-1	8424298
for	O	-1	8424298
mid@@	O	-1	8424298
d@@	O	-1	8424298
le@@	O	-1	8424298
-@@	O	-1	8424298
e@@	O	-1	8424298
ar	O	-1	8424298
surger@@	O	-1	8424298
y	O	-1	8424298
with	O	-1	8424298
de@@	O	-1	8424298
li@@	O	-1	8424298
b@@	O	-1	8424298
er@@	O	-1	8424298
ate	O	-1	8424298
hypotension	B-Disease	D007022	8424298
induced	O	-1	8424298
by	O	-1	8424298
l@@	B-Chemical	D007741	8424298
a@@	I-Chemical	-1	8424298
bet@@	I-Chemical	-1	8424298
al@@	I-Chemical	-1	8424298
ol	I-Chemical	-1	8424298
with	O	-1	8424298
iso@@	B-Chemical	D007530	8424298
f@@	I-Chemical	-1	8424298
lur@@	I-Chemical	-1	8424298
ane	I-Chemical	-1	8424298
(	O	-1	8424298
hypoten@@	B-Disease	D007022	8424298
sive	I-Disease	-1	8424298
group@@	O	-1	8424298
).	O	-1	8424298
S@@	O	-1	8424298
event@@	O	-1	8424298
e@@	O	-1	8424298
en	O	-1	8424298
patients	O	-1	8424298
without	O	-1	8424298
hypotension	B-Disease	D007022	8424298
ser@@	O	-1	8424298
ved	O	-1	8424298
as	O	-1	8424298
a	O	-1	8424298
control	O	-1	8424298
group.	O	-1	8424298
The	O	-1	8424298
mean	O	-1	8424298
arterial	O	-1	8424298
pressure	O	-1	8424298
was	O	-1	8424298
7@@	O	-1	8424298
7	O	-1	8424298
+/-	O	-1	8424298
2	O	-1	8424298
mm@@	O	-1	8424298
H@@	O	-1	8424298
g	O	-1	8424298
(1@@	O	-1	8424298
0.@@	O	-1	8424298
3	O	-1	8424298
+/-	O	-1	8424298
0.@@	O	-1	8424298
3	O	-1	8424298
k@@	O	-1	8424298
P@@	O	-1	8424298
a@@	O	-1	8424298
)	O	-1	8424298
before	O	-1	8424298
hypotension	B-Disease	D007022	8424298
and	O	-1	8424298
50	O	-1	8424298
+/-	O	-1	8424298
0	O	-1	8424298
mm@@	O	-1	8424298
H@@	O	-1	8424298
g	O	-1	8424298
(@@	O	-1	8424298
6.@@	O	-1	8424298
7	O	-1	8424298
+/-	O	-1	8424298
0.@@	O	-1	8424298
0	O	-1	8424298
k@@	O	-1	8424298
P@@	O	-1	8424298
a@@	O	-1	8424298
)	O	-1	8424298
during	O	-1	8424298
hypotension	B-Disease	D007022	8424298
in	O	-1	8424298
the	O	-1	8424298
hypoten@@	B-Disease	D007022	8424298
sive	I-Disease	-1	8424298
group@@	O	-1	8424298
,	O	-1	8424298
and	O	-1	8424298
8@@	O	-1	8424298
6	O	-1	8424298
+/-	O	-1	8424298
2	O	-1	8424298
mm@@	O	-1	8424298
H@@	O	-1	8424298
g	O	-1	8424298
(1@@	O	-1	8424298
1.@@	O	-1	8424298
5	O	-1	8424298
+/-	O	-1	8424298
0.@@	O	-1	8424298
3	O	-1	8424298
k@@	O	-1	8424298
P@@	O	-1	8424298
a@@	O	-1	8424298
)	O	-1	8424298
during	O	-1	8424298
anaesthe@@	O	-1	8424298
sia	O	-1	8424298
in	O	-1	8424298
the	O	-1	8424298
control	O	-1	8424298
group.	O	-1	8424298
The	O	-1	8424298
following	O	-1	8424298
psych@@	O	-1	8424298
ological	O	-1	8424298
tests	O	-1	8424298
were	O	-1	8424298
per@@	O	-1	8424298
for@@	O	-1	8424298
med@@	O	-1	8424298
:	O	-1	8424298
four	O	-1	8424298
sub@@	O	-1	8424298
tests	O	-1	8424298
of	O	-1	8424298
the	O	-1	8424298
W@@	O	-1	8424298
ech@@	O	-1	8424298
s@@	O	-1	8424298
l@@	O	-1	8424298
er	O	-1	8424298
Ad@@	O	-1	8424298
ult	O	-1	8424298
In@@	O	-1	8424298
te@@	O	-1	8424298
l@@	O	-1	8424298
li@@	O	-1	8424298
gen@@	O	-1	8424298
ce	O	-1	8424298
S@@	O	-1	8424298
cal@@	O	-1	8424298
e	O	-1	8424298
(@@	O	-1	8424298
simil@@	O	-1	8424298
ar@@	O	-1	8424298
iti@@	O	-1	8424298
es,	O	-1	8424298
di@@	O	-1	8424298
gi@@	O	-1	8424298
t	O	-1	8424298
sp@@	O	-1	8424298
an@@	O	-1	8424298
,	O	-1	8424298
v@@	O	-1	8424298
oc@@	O	-1	8424298
ab@@	O	-1	8424298
ul@@	O	-1	8424298
ary	O	-1	8424298
and	O	-1	8424298
di@@	O	-1	8424298
gi@@	O	-1	8424298
t	O	-1	8424298
sym@@	O	-1	8424298
b@@	O	-1	8424298
ol@@	O	-1	8424298
),	O	-1	8424298
T@@	O	-1	8424298
ra@@	O	-1	8424298
il@@	O	-1	8424298
-@@	O	-1	8424298
M@@	O	-1	8424298
ak@@	O	-1	8424298
ing	O	-1	8424298
tests	O	-1	8424298
A	O	-1	8424298
and	O	-1	8424298
B@@	O	-1	8424298
,	O	-1	8424298
Z@@	O	-1	8424298
un@@	O	-1	8424298
g	O	-1	8424298
tests	O	-1	8424298
(@@	O	-1	8424298
sel@@	O	-1	8424298
f@@	O	-1	8424298
-@@	O	-1	8424298
rat@@	O	-1	8424298
ing	O	-1	8424298
an@@	B-Disease	D001008	8424298
xi@@	I-Disease	-1	8424298
ety	I-Disease	-1	8424298
s@@	O	-1	8424298
cal@@	O	-1	8424298
e	O	-1	8424298
and	O	-1	8424298
sel@@	O	-1	8424298
f@@	O	-1	8424298
-@@	O	-1	8424298
rat@@	O	-1	8424298
ing	O	-1	8424298
de@@	B-Disease	D003866	8424298
pression	I-Disease	-1	8424298
s@@	O	-1	8424298
cal@@	O	-1	8424298
e@@	O	-1	8424298
)	O	-1	8424298
and	O	-1	8424298
tw@@	O	-1	8424298
o@@	O	-1	8424298
-@@	O	-1	8424298
par@@	O	-1	8424298
t	O	-1	8424298
memory	O	-1	8424298
test	O	-1	8424298
b@@	O	-1	8424298
at@@	O	-1	8424298
ter@@	O	-1	8424298
y	O	-1	8424298
with	O	-1	8424298
immedi@@	O	-1	8424298
ate	O	-1	8424298
and	O	-1	8424298
del@@	O	-1	8424298
ayed	O	-1	8424298
rec@@	O	-1	8424298
all@@	O	-1	8424298
.	O	-1	8424298
The	O	-1	8424298
tests	O	-1	8424298
were	O	-1	8424298
performed	O	-1	8424298
pre@@	O	-1	8424298
o@@	O	-1	8424298
per@@	O	-1	8424298
atively	O	-1	8424298
and	O	-1	8424298
2	O	-1	8424298
days	O	-1	8424298
posto@@	O	-1	8424298
per@@	O	-1	8424298
ati@@	O	-1	8424298
vel@@	O	-1	8424298
y.	O	-1	8424298
There	O	-1	8424298
were	O	-1	8424298
no	O	-1	8424298
statis@@	O	-1	8424298
tically	O	-1	8424298
significant	O	-1	8424298
differences	O	-1	8424298
between	O	-1	8424298
the	O	-1	8424298
groups	O	-1	8424298
in	O	-1	8424298
any	O	-1	8424298
of	O	-1	8424298
the	O	-1	8424298
tests	O	-1	8424298
in	O	-1	8424298
the	O	-1	8424298
changes	O	-1	8424298
from	O	-1	8424298
pre@@	O	-1	8424298
o@@	O	-1	8424298
perative	O	-1	8424298
valu@@	O	-1	8424298
e	O	-1	8424298
to	O	-1	8424298
postoperative	O	-1	8424298
valu@@	O	-1	8424298
e.	O	-1	8424298
The	O	-1	8424298
results	O	-1	8424298
indicate	O	-1	8424298
that	O	-1	8424298
hypotension	B-Disease	D007022	8424298
induced	O	-1	8424298
by	O	-1	8424298
l@@	B-Chemical	D007741	8424298
a@@	I-Chemical	-1	8424298
bet@@	I-Chemical	-1	8424298
al@@	I-Chemical	-1	8424298
ol	I-Chemical	-1	8424298
with	O	-1	8424298
iso@@	B-Chemical	D007530	8424298
f@@	I-Chemical	-1	8424298
lur@@	I-Chemical	-1	8424298
ane	I-Chemical	-1	8424298
has	O	-1	8424298
no	O	-1	8424298
significant	O	-1	8424298
h@@	O	-1	8424298
ar@@	O	-1	8424298
m@@	O	-1	8424298
ful	O	-1	8424298
effects	O	-1	8424298
on	O	-1	8424298
mental	O	-1	8424298
func@@	O	-1	8424298
tions	O	-1	8424298
compared	O	-1	8424298
to	O	-1	8424298
norm@@	O	-1	8424298
oten@@	O	-1	8424298
sive	O	-1	8424298
anaesthe@@	O	-1	8424298
sia.	O	-1	8424298

A@@	O	-1	7880714
ud@@	O	-1	7880714
it@@	O	-1	7880714
ory	O	-1	7880714
dist@@	O	-1	7880714
urb@@	O	-1	7880714
ance	O	-1	7880714
associated	O	-1	7880714
with	O	-1	7880714
inter@@	O	-1	7880714
s@@	O	-1	7880714
cal@@	O	-1	7880714
ene	O	-1	7880714
b@@	O	-1	7880714
rac@@	O	-1	7880714
hi@@	O	-1	7880714
al	O	-1	7880714
ple@@	O	-1	7880714
x@@	O	-1	7880714
us	O	-1	7880714
block@@	O	-1	7880714
.	O	-1	7880714
We	O	-1	7880714
performed	O	-1	7880714
an	O	-1	7880714
a@@	O	-1	7880714
udi@@	O	-1	7880714
o@@	O	-1	7880714
me@@	O	-1	7880714
tri@@	O	-1	7880714
c	O	-1	7880714
study	O	-1	7880714
in	O	-1	7880714
20	O	-1	7880714
patients	O	-1	7880714
who	O	-1	7880714
under@@	O	-1	7880714
w@@	O	-1	7880714
ent	O	-1	7880714
surger@@	O	-1	7880714
y	O	-1	7880714
of	O	-1	7880714
the	O	-1	7880714
sho@@	O	-1	7880714
ul@@	O	-1	7880714
der	O	-1	7880714
regi@@	O	-1	7880714
on	O	-1	7880714
under	O	-1	7880714
an	O	-1	7880714
inter@@	O	-1	7880714
s@@	O	-1	7880714
cal@@	O	-1	7880714
ene	O	-1	7880714
b@@	O	-1	7880714
rac@@	O	-1	7880714
hi@@	O	-1	7880714
al	O	-1	7880714
ple@@	O	-1	7880714
x@@	O	-1	7880714
us	O	-1	7880714
bloc@@	O	-1	7880714
k	O	-1	7880714
(@@	O	-1	7880714
I@@	O	-1	7880714
B@@	O	-1	7880714
P@@	O	-1	7880714
B@@	O	-1	7880714
).	O	-1	7880714
B@@	B-Chemical	D002045	7880714
u@@	I-Chemical	-1	7880714
pivac@@	I-Chemical	-1	7880714
aine	I-Chemical	-1	7880714
0.@@	O	-1	7880714
7@@	O	-1	7880714
5%	O	-1	7880714
with	O	-1	7880714
adren@@	B-Chemical	D004837	7880714
aline	I-Chemical	-1	7880714
was	O	-1	7880714
given	O	-1	7880714
followed	O	-1	7880714
by	O	-1	7880714
a	O	-1	7880714
2@@	O	-1	7880714
4-@@	O	-1	7880714
h@@	O	-1	7880714
r	O	-1	7880714
continu@@	O	-1	7880714
ous	O	-1	7880714
infusion	O	-1	7880714
of	O	-1	7880714
0.@@	O	-1	7880714
2@@	O	-1	7880714
5%	O	-1	7880714
bupivac@@	B-Chemical	D002045	7880714
aine	I-Chemical	-1	7880714
.	O	-1	7880714
Th@@	O	-1	7880714
ree	O	-1	7880714
a@@	O	-1	7880714
udi@@	O	-1	7880714
o@@	O	-1	7880714
me@@	O	-1	7880714
tri@@	O	-1	7880714
c	O	-1	7880714
th@@	O	-1	7880714
res@@	O	-1	7880714
h@@	O	-1	7880714
old	O	-1	7880714
meas@@	O	-1	7880714
ure@@	O	-1	7880714
ments	O	-1	7880714
(0.@@	O	-1	7880714
2@@	O	-1	7880714
5-@@	O	-1	7880714
1@@	O	-1	7880714
8	O	-1	7880714
k@@	O	-1	7880714
H@@	O	-1	7880714
z@@	O	-1	7880714
)	O	-1	7880714
were	O	-1	7880714
ma@@	O	-1	7880714
de@@	O	-1	7880714
:	O	-1	7880714
the	O	-1	7880714
first	O	-1	7880714
before	O	-1	7880714
I@@	O	-1	7880714
B@@	O	-1	7880714
P@@	O	-1	7880714
B@@	O	-1	7880714
,	O	-1	7880714
the	O	-1	7880714
second	O	-1	7880714
2-@@	O	-1	7880714
6	O	-1	7880714
h	O	-1	7880714
after	O	-1	7880714
surger@@	O	-1	7880714
y	O	-1	7880714
and	O	-1	7880714
the	O	-1	7880714
thir@@	O	-1	7880714
d	O	-1	7880714
on	O	-1	7880714
the	O	-1	7880714
first	O	-1	7880714
day	O	-1	7880714
after	O	-1	7880714
o@@	O	-1	7880714
per@@	O	-1	7880714
ation.	O	-1	7880714
In	O	-1	7880714
four	O	-1	7880714
patients	O	-1	7880714
hearing	B-Disease	D034381	7880714
impair@@	I-Disease	-1	7880714
ment	I-Disease	-1	7880714
on	O	-1	7880714
the	O	-1	7880714
side	O	-1	7880714
of	O	-1	7880714
the	O	-1	7880714
bloc@@	O	-1	7880714
k	O	-1	7880714
was	O	-1	7880714
demonstrated	O	-1	7880714
after	O	-1	7880714
o@@	O	-1	7880714
per@@	O	-1	7880714
ation,	O	-1	7880714
in	O	-1	7880714
three	O	-1	7880714
meas@@	O	-1	7880714
ure@@	O	-1	7880714
ments	O	-1	7880714
on	O	-1	7880714
the	O	-1	7880714
day	O	-1	7880714
of	O	-1	7880714
surger@@	O	-1	7880714
y	O	-1	7880714
and	O	-1	7880714
in	O	-1	7880714
one	O	-1	7880714
on	O	-1	7880714
the	O	-1	7880714
following	O	-1	7880714
da@@	O	-1	7880714
y.	O	-1	7880714
The	O	-1	7880714
frequ@@	O	-1	7880714
en@@	O	-1	7880714
ci@@	O	-1	7880714
es	O	-1	7880714
at	O	-1	7880714
which	O	-1	7880714
the	O	-1	7880714
impair@@	O	-1	7880714
ment	O	-1	7880714
occurred	O	-1	7880714
vari@@	O	-1	7880714
ed	O	-1	7880714
between	O	-1	7880714
patient@@	O	-1	7880714
s;	O	-1	7880714
in	O	-1	7880714
one	O	-1	7880714
only	O	-1	7880714
low	O	-1	7880714
frequ@@	O	-1	7880714
en@@	O	-1	7880714
ci@@	O	-1	7880714
es	O	-1	7880714
(0.@@	O	-1	7880714
2@@	O	-1	7880714
5-@@	O	-1	7880714
0.@@	O	-1	7880714
5	O	-1	7880714
k@@	O	-1	7880714
H@@	O	-1	7880714
z@@	O	-1	7880714
)	O	-1	7880714
were	O	-1	7880714
invol@@	O	-1	7880714
ved.	O	-1	7880714
The	O	-1	7880714
maxim@@	O	-1	7880714
um	O	-1	7880714
change	O	-1	7880714
in	O	-1	7880714
th@@	O	-1	7880714
res@@	O	-1	7880714
h@@	O	-1	7880714
old	O	-1	7880714
was	O	-1	7880714
3@@	O	-1	7880714
5	O	-1	7880714
d@@	O	-1	7880714
B	O	-1	7880714
at	O	-1	7880714
6	O	-1	7880714
k@@	O	-1	7880714
H@@	O	-1	7880714
z	O	-1	7880714
measured	O	-1	7880714
at	O	-1	7880714
the	O	-1	7880714
end	O	-1	7880714
of	O	-1	7880714
the	O	-1	7880714
continu@@	O	-1	7880714
ous	O	-1	7880714
infusion	O	-1	7880714
of	O	-1	7880714
bupivac@@	B-Chemical	D002045	7880714
aine	I-Chemical	-1	7880714
.	O	-1	7880714
This	O	-1	7880714
patient	O	-1	7880714
had	O	-1	7880714
hearing	O	-1	7880714
th@@	O	-1	7880714
res@@	O	-1	7880714
h@@	O	-1	7880714
old	O	-1	7880714
changes	O	-1	7880714
(1@@	O	-1	7880714
5-@@	O	-1	7880714
20	O	-1	7880714
d@@	O	-1	7880714
B@@	O	-1	7880714
)	O	-1	7880714
at	O	-1	7880714
6-@@	O	-1	7880714
10	O	-1	7880714
k@@	O	-1	7880714
H@@	O	-1	7880714
z	O	-1	7880714
on	O	-1	7880714
the	O	-1	7880714
op@@	O	-1	7880714
pos@@	O	-1	7880714
ite	O	-1	7880714
side	O	-1	7880714
al@@	O	-1	7880714
so@@	O	-1	7880714
.	O	-1	7880714
I@@	O	-1	7880714
B@@	O	-1	7880714
P@@	O	-1	7880714
B	O	-1	7880714
may	O	-1	7880714
cause	O	-1	7880714
transi@@	O	-1	7880714
ent	O	-1	7880714
a@@	B-Disease	D006311	7880714
ud@@	I-Disease	-1	7880714
it@@	I-Disease	-1	7880714
ory	I-Disease	-1	7880714
dysfunction	I-Disease	-1	7880714
in	O	-1	7880714
the	O	-1	7880714
ip@@	O	-1	7880714
si@@	O	-1	7880714
lat@@	O	-1	7880714
eral	O	-1	7880714
ear@@	O	-1	7880714
,	O	-1	7880714
possib@@	O	-1	7880714
ly	O	-1	7880714
vi@@	O	-1	7880714
a	O	-1	7880714
an	O	-1	7880714
effect	O	-1	7880714
on	O	-1	7880714
sym@@	O	-1	7880714
pa@@	O	-1	7880714
thetic	O	-1	7880714
in@@	O	-1	7880714
ner@@	O	-1	7880714
v@@	O	-1	7880714
ation.	O	-1	7880714

M@@	B-Chemical	D008874	7102237
id@@	I-Chemical	-1	7102237
azol@@	I-Chemical	-1	7102237
am	I-Chemical	-1	7102237
compared	O	-1	7102237
with	O	-1	7102237
th@@	B-Chemical	D013874	7102237
io@@	I-Chemical	-1	7102237
pent@@	I-Chemical	-1	7102237
one	I-Chemical	-1	7102237
as	O	-1	7102237
an	O	-1	7102237
induction	O	-1	7102237
agent@@	O	-1	7102237
.	O	-1	7102237
In	O	-1	7102237
patients	O	-1	7102237
pre@@	O	-1	7102237
medic@@	O	-1	7102237
ated	O	-1	7102237
with	O	-1	7102237
scopol@@	B-Chemical	D012601	7102237
amine	I-Chemical	-1	7102237
+	O	-1	7102237
morphine	B-Chemical	D009020	7102237
(@@	O	-1	7102237
+@@	O	-1	7102237
5	O	-1	7102237
mg	O	-1	7102237
nit@@	B-Chemical	D009567	7102237
ra@@	I-Chemical	-1	7102237
z@@	I-Chemical	-1	7102237
epam	I-Chemical	-1	7102237
the	O	-1	7102237
ev@@	O	-1	7102237
en@@	O	-1	7102237
ing	O	-1	7102237
before	O	-1	7102237
surg@@	O	-1	7102237
ery@@	O	-1	7102237
),	O	-1	7102237
the	O	-1	7102237
sle@@	O	-1	7102237
ep@@	O	-1	7102237
-@@	O	-1	7102237
induc@@	O	-1	7102237
ing	O	-1	7102237
effect	O	-1	7102237
of	O	-1	7102237
mid@@	B-Chemical	D008874	7102237
azol@@	I-Chemical	-1	7102237
am	I-Chemical	-1	7102237
0.@@	O	-1	7102237
15	O	-1	7102237
mg/kg	O	-1	7102237
i.v@@	O	-1	7102237
.	O	-1	7102237
was	O	-1	7102237
clear@@	O	-1	7102237
ly	O	-1	7102237
s@@	O	-1	7102237
lower	O	-1	7102237
in	O	-1	7102237
onset	O	-1	7102237
than	O	-1	7102237
that	O	-1	7102237
of	O	-1	7102237
th@@	B-Chemical	D013874	7102237
io@@	I-Chemical	-1	7102237
pent@@	I-Chemical	-1	7102237
one	I-Chemical	-1	7102237
4.@@	O	-1	7102237
6@@	O	-1	7102237
7	O	-1	7102237
mg/kg	O	-1	7102237
i.v@@	O	-1	7102237
.	O	-1	7102237
S@@	O	-1	7102237
o@@	O	-1	7102237
me@@	O	-1	7102237
wh@@	O	-1	7102237
at	O	-1	7102237
fe@@	O	-1	7102237
w@@	O	-1	7102237
er	O	-1	7102237
cardiovascular	O	-1	7102237
and	O	-1	7102237
loc@@	O	-1	7102237
al	O	-1	7102237
sequ@@	O	-1	7102237
el@@	O	-1	7102237
a@@	O	-1	7102237
e	O	-1	7102237
were	O	-1	7102237
found	O	-1	7102237
in	O	-1	7102237
the	O	-1	7102237
mid@@	B-Chemical	D008874	7102237
azol@@	I-Chemical	-1	7102237
am	I-Chemical	-1	7102237
group@@	O	-1	7102237
,	O	-1	7102237
but@@	O	-1	7102237
,	O	-1	7102237
although	O	-1	7102237
ap@@	B-Disease	D001049	7102237
no@@	I-Disease	-1	7102237
e@@	I-Disease	-1	7102237
a	I-Disease	-1	7102237
occurred	O	-1	7102237
less	O	-1	7102237
often	O	-1	7102237
in	O	-1	7102237
the	O	-1	7102237
mid@@	B-Chemical	D008874	7102237
azol@@	I-Chemical	-1	7102237
am	I-Chemical	-1	7102237
group	O	-1	7102237
it	O	-1	7102237
l@@	O	-1	7102237
ast@@	O	-1	7102237
ed	O	-1	7102237
long@@	O	-1	7102237
er.	O	-1	7102237
O@@	O	-1	7102237
n	O	-1	7102237
the	O	-1	7102237
wh@@	O	-1	7102237
ol@@	O	-1	7102237
e,	O	-1	7102237
the	O	-1	7102237
differences	O	-1	7102237
between	O	-1	7102237
mid@@	B-Chemical	D008874	7102237
azol@@	I-Chemical	-1	7102237
am	I-Chemical	-1	7102237
and	O	-1	7102237
th@@	B-Chemical	D013874	7102237
io@@	I-Chemical	-1	7102237
pent@@	I-Chemical	-1	7102237
one	I-Chemical	-1	7102237
had	O	-1	7102237
no	O	-1	7102237
appa@@	O	-1	7102237
rent	O	-1	7102237
clinical	O	-1	7102237
con@@	O	-1	7102237
sequ@@	O	-1	7102237
enc@@	O	-1	7102237
es.	O	-1	7102237
M@@	B-Chemical	D008874	7102237
id@@	I-Chemical	-1	7102237
azol@@	I-Chemical	-1	7102237
am	I-Chemical	-1	7102237
is	O	-1	7102237
a	O	-1	7102237
new	O	-1	7102237
al@@	O	-1	7102237
tern@@	O	-1	7102237
ative	O	-1	7102237
agent	O	-1	7102237
for	O	-1	7102237
induction	O	-1	7102237
in	O	-1	7102237
combination	O	-1	7102237
anaesthe@@	O	-1	7102237
sia.	O	-1	7102237

C@@	B-Disease	D066126	6769133
ardi@@	I-Disease	-1	6769133
ot@@	I-Disease	-1	6769133
ox@@	I-Disease	-1	6769133
ic	I-Disease	-1	6769133
and	O	-1	6769133
possible	O	-1	6769133
leuk@@	O	-1	6769133
em@@	O	-1	6769133
o@@	O	-1	6769133
genic	O	-1	6769133
effects	O	-1	6769133
of	O	-1	6769133
adriam@@	B-Chemical	D004317	6769133
ycin	I-Chemical	-1	6769133
in	O	-1	6769133
non@@	O	-1	6769133
human	O	-1	6769133
pri@@	O	-1	6769133
mat@@	O	-1	6769133
es.	O	-1	6769133
10	O	-1	6769133
mon@@	O	-1	6769133
ke@@	O	-1	6769133
ys	O	-1	6769133
(@@	O	-1	6769133
mac@@	O	-1	6769133
a@@	O	-1	6769133
qu@@	O	-1	6769133
es@@	O	-1	6769133
)	O	-1	6769133
received	O	-1	6769133
adriam@@	B-Chemical	D004317	6769133
ycin	I-Chemical	-1	6769133
by	O	-1	6769133
month@@	O	-1	6769133
ly	O	-1	6769133
intravenous	O	-1	6769133
injec@@	O	-1	6769133
tions	O	-1	6769133
at	O	-1	6769133
12	O	-1	6769133
mg/m@@	O	-1	6769133
2	O	-1	6769133
(@@	O	-1	6769133
1	O	-1	6769133
mg/kg@@	O	-1	6769133
).	O	-1	6769133
8	O	-1	6769133
of	O	-1	6769133
the	O	-1	6769133
10	O	-1	6769133
mon@@	O	-1	6769133
ke@@	O	-1	6769133
ys	O	-1	6769133
developed	O	-1	6769133
con@@	B-Disease	D006333	6769133
g@@	I-Disease	-1	6769133
es@@	I-Disease	-1	6769133
tive	I-Disease	-1	6769133
heart	I-Disease	-1	6769133
failure	I-Disease	-1	6769133
at	O	-1	6769133
an	O	-1	6769133
average	O	-1	6769133
cum@@	O	-1	6769133
ul@@	O	-1	6769133
ative	O	-1	6769133
adriam@@	B-Chemical	D004317	6769133
ycin	I-Chemical	-1	6769133
dose	O	-1	6769133
(3@@	O	-1	6769133
10	O	-1	6769133
mg/m@@	O	-1	6769133
2)	O	-1	6769133
well	O	-1	6769133
be@@	O	-1	6769133
low	O	-1	6769133
that	O	-1	6769133
considered	O	-1	6769133
the	O	-1	6769133
saf@@	O	-1	6769133
e	O	-1	6769133
up@@	O	-1	6769133
per	O	-1	6769133
lim@@	O	-1	6769133
it	O	-1	6769133
(5@@	O	-1	6769133
50	O	-1	6769133
mg/m@@	O	-1	6769133
2)	O	-1	6769133
in	O	-1	6769133
man@@	O	-1	6769133
.	O	-1	6769133
H@@	O	-1	6769133
ist@@	O	-1	6769133
olog@@	O	-1	6769133
ic@@	O	-1	6769133
ally,	O	-1	6769133
the	O	-1	6769133
myocardial	B-Disease	D001768	6769133
lesions	I-Disease	-1	6769133
re@@	O	-1	6769133
se@@	O	-1	6769133
m@@	O	-1	6769133
bl@@	O	-1	6769133
ed	O	-1	6769133
those	O	-1	6769133
found	O	-1	6769133
in	O	-1	6769133
human	O	-1	6769133
an@@	B-Chemical	D018943	6769133
th@@	I-Chemical	-1	6769133
rac@@	I-Chemical	-1	6769133
y@@	I-Chemical	-1	6769133
cl@@	I-Chemical	-1	6769133
ine	I-Chemical	-1	6769133
-induced	O	-1	6769133
cardi@@	B-Disease	D009202	6769133
om@@	I-Disease	-1	6769133
yo@@	I-Disease	-1	6769133
pathy	I-Disease	-1	6769133
.	O	-1	6769133
1	O	-1	6769133
of	O	-1	6769133
the	O	-1	6769133
10	O	-1	6769133
mon@@	O	-1	6769133
ke@@	O	-1	6769133
ys	O	-1	6769133
developed	O	-1	6769133
acute	B-Disease	D015470	6769133
my@@	I-Disease	-1	6769133
e@@	I-Disease	-1	6769133
lo@@	I-Disease	-1	6769133
bl@@	I-Disease	-1	6769133
as@@	I-Disease	-1	6769133
tic	I-Disease	-1	6769133
leuk@@	I-Disease	-1	6769133
emia	I-Disease	-1	6769133
after	O	-1	6769133
receiving	O	-1	6769133
3@@	O	-1	6769133
24	O	-1	6769133
mg/m@@	O	-1	6769133
2	O	-1	6769133
of	O	-1	6769133
adriam@@	B-Chemical	D004317	6769133
ycin	I-Chemical	-1	6769133
;	O	-1	6769133
the	O	-1	6769133
10@@	O	-1	6769133
th	O	-1	6769133
mon@@	O	-1	6769133
ke@@	O	-1	6769133
y	O	-1	6769133
is	O	-1	6769133
al@@	O	-1	6769133
i@@	O	-1	6769133
ve	O	-1	6769133
and	O	-1	6769133
well	O	-1	6769133
2@@	O	-1	6769133
6	O	-1	6769133
months	O	-1	6769133
after	O	-1	6769133
the	O	-1	6769133
las@@	O	-1	6769133
t	O	-1	6769133
dose	O	-1	6769133
of	O	-1	6769133
drug.	O	-1	6769133
Our	O	-1	6769133
results	O	-1	6769133
suggest	O	-1	6769133
that	O	-1	6769133
adriam@@	B-Chemical	D004317	6769133
ycin	I-Chemical	-1	6769133
is	O	-1	6769133
a	O	-1	6769133
more	O	-1	6769133
pot@@	O	-1	6769133
ent	O	-1	6769133
cardi@@	O	-1	6769133
ot@@	O	-1	6769133
ox@@	O	-1	6769133
in	O	-1	6769133
in	O	-1	6769133
mon@@	O	-1	6769133
ke@@	O	-1	6769133
ys	O	-1	6769133
than	O	-1	6769133
in	O	-1	6769133
man@@	O	-1	6769133
,	O	-1	6769133
and	O	-1	6769133
that	O	-1	6769133
leuk@@	B-Disease	D007938	6769133
emia	I-Disease	-1	6769133
may	O	-1	6769133
be	O	-1	6769133
a	O	-1	6769133
con@@	O	-1	6769133
sequ@@	O	-1	6769133
ence	O	-1	6769133
of	O	-1	6769133
prolonged	O	-1	6769133
treatment	O	-1	6769133
with	O	-1	6769133
this	O	-1	6769133
drug.	O	-1	6769133

D@@	B-Chemical	D004317	6292680
ox@@	I-Chemical	-1	6292680
orub@@	I-Chemical	-1	6292680
icin	I-Chemical	-1	6292680
cardi@@	B-Disease	D009202	6292680
om@@	I-Disease	-1	6292680
yo@@	I-Disease	-1	6292680
pathy	I-Disease	-1	6292680
in	O	-1	6292680
children	O	-1	6292680
with	O	-1	6292680
le@@	O	-1	6292680
f@@	O	-1	6292680
t-@@	O	-1	6292680
si@@	O	-1	6292680
ded	O	-1	6292680
W@@	B-Disease	D009396	6292680
il@@	I-Disease	-1	6292680
ms	I-Disease	-1	6292680
tumor	I-Disease	-1	6292680
.	O	-1	6292680
Two	O	-1	6292680
children	O	-1	6292680
with	O	-1	6292680
W@@	B-Disease	D009396	6292680
il@@	I-Disease	-1	6292680
ms	I-Disease	-1	6292680
tumor	I-Disease	-1	6292680
of	O	-1	6292680
the	O	-1	6292680
left	O	-1	6292680
kidney	O	-1	6292680
experienced	O	-1	6292680
severe	O	-1	6292680
an@@	B-Chemical	D018943	6292680
th@@	I-Chemical	-1	6292680
rac@@	I-Chemical	-1	6292680
y@@	I-Chemical	-1	6292680
cl@@	I-Chemical	-1	6292680
ine	I-Chemical	-1	6292680
cardi@@	B-Disease	D009202	6292680
om@@	I-Disease	-1	6292680
yo@@	I-Disease	-1	6292680
pathy	I-Disease	-1	6292680
after	O	-1	6292680
ir@@	O	-1	6292680
radi@@	O	-1	6292680
ation	O	-1	6292680
to	O	-1	6292680
the	O	-1	6292680
tumor	B-Disease	D009369	6292680
bed	O	-1	6292680
and	O	-1	6292680
con@@	O	-1	6292680
ven@@	O	-1	6292680
tional	O	-1	6292680
dos@@	O	-1	6292680
age	O	-1	6292680
of	O	-1	6292680
dox@@	B-Chemical	D004317	6292680
orub@@	I-Chemical	-1	6292680
icin	I-Chemical	-1	6292680
.	O	-1	6292680
The	O	-1	6292680
cardi@@	B-Disease	D009202	6292680
om@@	I-Disease	-1	6292680
yo@@	I-Disease	-1	6292680
pathy	I-Disease	-1	6292680
is	O	-1	6292680
at@@	O	-1	6292680
tri@@	O	-1	6292680
but@@	O	-1	6292680
ed	O	-1	6292680
1)	O	-1	6292680
to	O	-1	6292680
the	O	-1	6292680
fac@@	O	-1	6292680
t	O	-1	6292680
that	O	-1	6292680
radi@@	O	-1	6292680
ation	O	-1	6292680
fi@@	O	-1	6292680
el@@	O	-1	6292680
ds	O	-1	6292680
for	O	-1	6292680
left	O	-1	6292680
W@@	B-Disease	D009396	6292680
il@@	I-Disease	-1	6292680
ms	I-Disease	-1	6292680
tumor	I-Disease	-1	6292680
includ@@	O	-1	6292680
e	O	-1	6292680
the	O	-1	6292680
lower	O	-1	6292680
por@@	O	-1	6292680
tion	O	-1	6292680
of	O	-1	6292680
the	O	-1	6292680
heart	O	-1	6292680
and	O	-1	6292680
2)	O	-1	6292680
to	O	-1	6292680
the	O	-1	6292680
inter@@	O	-1	6292680
action	O	-1	6292680
of	O	-1	6292680
dox@@	B-Chemical	D004317	6292680
orub@@	I-Chemical	-1	6292680
icin	I-Chemical	-1	6292680
and	O	-1	6292680
ir@@	O	-1	6292680
radi@@	O	-1	6292680
ation	O	-1	6292680
on	O	-1	6292680
cardiac	O	-1	6292680
musc@@	O	-1	6292680
le@@	O	-1	6292680
.	O	-1	6292680
It	O	-1	6292680
is	O	-1	6292680
recomm@@	O	-1	6292680
en@@	O	-1	6292680
ded	O	-1	6292680
that	O	-1	6292680
dox@@	B-Chemical	D004317	6292680
orub@@	I-Chemical	-1	6292680
icin	I-Chemical	-1	6292680
dos@@	O	-1	6292680
age	O	-1	6292680
be	O	-1	6292680
sh@@	O	-1	6292680
ar@@	O	-1	6292680
p@@	O	-1	6292680
ly	O	-1	6292680
re@@	O	-1	6292680
stric@@	O	-1	6292680
ted	O	-1	6292680
in	O	-1	6292680
children	O	-1	6292680
with	O	-1	6292680
W@@	B-Disease	D009396	6292680
il@@	I-Disease	-1	6292680
ms	I-Disease	-1	6292680
tumor	I-Disease	-1	6292680
of	O	-1	6292680
the	O	-1	6292680
left	O	-1	6292680
kidney	O	-1	6292680
who	O	-1	6292680
recei@@	O	-1	6292680
ve	O	-1	6292680
postoperative	O	-1	6292680
ir@@	O	-1	6292680
radi@@	O	-1	6292680
ation.	O	-1	6292680

Pro@@	O	-1	3969369
mo@@	O	-1	3969369
tional	O	-1	3969369
effects	O	-1	3969369
of	O	-1	3969369
test@@	B-Chemical	D013739	3969369
osterone	I-Chemical	-1	3969369
and	O	-1	3969369
di@@	O	-1	3969369
et@@	O	-1	3969369
ary	O	-1	3969369
f@@	O	-1	3969369
at	O	-1	3969369
on	O	-1	3969369
pro@@	O	-1	3969369
state	O	-1	3969369
carcino@@	B-Disease	D063646	3969369
genesis	I-Disease	-1	3969369
in	O	-1	3969369
gene@@	O	-1	3969369
tically	O	-1	3969369
sus@@	O	-1	3969369
cep@@	O	-1	3969369
ti@@	O	-1	3969369
ble	O	-1	3969369
rats.	O	-1	3969369
G@@	O	-1	3969369
er@@	O	-1	3969369
m@@	O	-1	3969369
free	O	-1	3969369
(@@	O	-1	3969369
GF@@	O	-1	3969369
)	O	-1	3969369
L@@	O	-1	3969369
ob@@	O	-1	3969369
un@@	O	-1	3969369
d	O	-1	3969369
stra@@	O	-1	3969369
in	O	-1	3969369
Wistar	O	-1	3969369
(@@	O	-1	3969369
L@@	O	-1	3969369
W@@	O	-1	3969369
)	O	-1	3969369
rats,	O	-1	3969369
f@@	O	-1	3969369
ed	O	-1	3969369
ve@@	O	-1	3969369
g@@	O	-1	3969369
et@@	O	-1	3969369
able	O	-1	3969369
diet	O	-1	3969369
L-@@	O	-1	3969369
4@@	O	-1	3969369
8@@	O	-1	3969369
5,	O	-1	3969369
have	O	-1	3969369
developed	O	-1	3969369
pro@@	B-Disease	D011471	3969369
state	I-Disease	-1	3969369
aden@@	I-Disease	-1	3969369
oc@@	I-Disease	-1	3969369
arc@@	I-Disease	-1	3969369
in@@	I-Disease	-1	3969369
om@@	I-Disease	-1	3969369
as	I-Disease	-1	3969369
spont@@	O	-1	3969369
ane@@	O	-1	3969369
ously	O	-1	3969369
(@@	O	-1	3969369
10@@	O	-1	3969369
%	O	-1	3969369
inc@@	O	-1	3969369
id@@	O	-1	3969369
ence@@	O	-1	3969369
)	O	-1	3969369
at	O	-1	3969369
average	O	-1	3969369
age	O	-1	3969369
3@@	O	-1	3969369
4	O	-1	3969369
months.	O	-1	3969369
Con@@	O	-1	3969369
ven@@	O	-1	3969369
tional	O	-1	3969369
L@@	O	-1	3969369
W	O	-1	3969369
rats,	O	-1	3969369
im@@	O	-1	3969369
pl@@	O	-1	3969369
ant@@	O	-1	3969369
ed	O	-1	3969369
with	O	-1	3969369
test@@	B-Chemical	D013739	3969369
osterone	I-Chemical	-1	3969369
at	O	-1	3969369
age	O	-1	3969369
4	O	-1	3969369
month@@	O	-1	3969369
s,	O	-1	3969369
developed	O	-1	3969369
a	O	-1	3969369
higher	O	-1	3969369
incidence	O	-1	3969369
of	O	-1	3969369
pro@@	B-Disease	D011471	3969369
state	I-Disease	-1	3969369
cancer	I-Disease	-1	3969369
after	O	-1	3969369
an	O	-1	3969369
average	O	-1	3969369
interv@@	O	-1	3969369
al	O	-1	3969369
of	O	-1	3969369
14	O	-1	3969369
month@@	O	-1	3969369
s:	O	-1	3969369
2@@	O	-1	3969369
4@@	O	-1	3969369
%	O	-1	3969369
had	O	-1	3969369
developed	O	-1	3969369
g@@	O	-1	3969369
ros@@	O	-1	3969369
s	O	-1	3969369
tu@@	B-Disease	D009369	3969369
mor@@	I-Disease	-1	3969369
s	I-Disease	-1	3969369
,	O	-1	3969369
and	O	-1	3969369
4@@	O	-1	3969369
0%	O	-1	3969369
when	O	-1	3969369
it	O	-1	3969369
included	O	-1	3969369
micro@@	O	-1	3969369
sco@@	O	-1	3969369
p@@	O	-1	3969369
ic	O	-1	3969369
tu@@	B-Disease	D009369	3969369
mor@@	I-Disease	-1	3969369
s	I-Disease	-1	3969369
.	O	-1	3969369
P@@	O	-1	3969369
rel@@	O	-1	3969369
im@@	O	-1	3969369
inary	O	-1	3969369
results	O	-1	3969369
indicate	O	-1	3969369
that	O	-1	3969369
test@@	B-Chemical	D013739	3969369
osterone	I-Chemical	-1	3969369
-treated	O	-1	3969369
L@@	O	-1	3969369
W	O	-1	3969369
rats	O	-1	3969369
that	O	-1	3969369
were	O	-1	3969369
f@@	O	-1	3969369
ed	O	-1	3969369
the	O	-1	3969369
same	O	-1	3969369
di@@	O	-1	3969369
et@@	O	-1	3969369
,	O	-1	3969369
which	O	-1	3969369
was	O	-1	3969369
sup@@	O	-1	3969369
ple@@	O	-1	3969369
ment@@	O	-1	3969369
ed	O	-1	3969369
with	O	-1	3969369
cor@@	O	-1	3969369
n	O	-1	3969369
o@@	O	-1	3969369
il	O	-1	3969369
up	O	-1	3969369
to	O	-1	3969369
20@@	O	-1	3969369
%	O	-1	3969369
f@@	O	-1	3969369
at@@	O	-1	3969369
,	O	-1	3969369
developed	O	-1	3969369
pro@@	B-Disease	D011471	3969369
state	I-Disease	-1	3969369
cancer	I-Disease	-1	3969369
after	O	-1	3969369
interv@@	O	-1	3969369
als	O	-1	3969369
of	O	-1	3969369
6@@	O	-1	3969369
-1@@	O	-1	3969369
2	O	-1	3969369
months.	O	-1	3969369
A@@	O	-1	3969369
g@@	O	-1	3969369
ed	O	-1	3969369
G@@	O	-1	3969369
F	O	-1	3969369
S@@	O	-1	3969369
pra@@	O	-1	3969369
gu@@	O	-1	3969369
e-@@	O	-1	3969369
D@@	O	-1	3969369
aw@@	O	-1	3969369
le@@	O	-1	3969369
y	O	-1	3969369
(S@@	O	-1	3969369
D)	O	-1	3969369
rats	O	-1	3969369
have	O	-1	3969369
not	O	-1	3969369
developed	O	-1	3969369
pro@@	B-Disease	D011471	3969369
state	I-Disease	-1	3969369
cancer	I-Disease	-1	3969369
spont@@	O	-1	3969369
ane@@	O	-1	3969369
ous@@	O	-1	3969369
ly.	O	-1	3969369
Con@@	O	-1	3969369
ven@@	O	-1	3969369
tional	O	-1	3969369
S@@	O	-1	3969369
D	O	-1	3969369
rats	O	-1	3969369
f@@	O	-1	3969369
ed	O	-1	3969369
diet	O	-1	3969369
L-@@	O	-1	3969369
4@@	O	-1	3969369
8@@	O	-1	3969369
5	O	-1	3969369
and	O	-1	3969369
treated	O	-1	3969369
with	O	-1	3969369
test@@	B-Chemical	D013739	3969369
osterone	I-Chemical	-1	3969369
developed	O	-1	3969369
only	O	-1	3969369
pro@@	B-Disease	D011472	3969369
st@@	I-Disease	-1	3969369
ati@@	I-Disease	-1	3969369
tis	I-Disease	-1	3969369
.	O	-1	3969369
E@@	O	-1	3969369
x@@	O	-1	3969369
per@@	O	-1	3969369
im@@	O	-1	3969369
ental	O	-1	3969369
de@@	O	-1	3969369
signs	O	-1	3969369
should	O	-1	3969369
con@@	O	-1	3969369
si@@	O	-1	3969369
der	O	-1	3969369
gene@@	O	-1	3969369
tic	O	-1	3969369
sus@@	O	-1	3969369
cep@@	O	-1	3969369
ti@@	O	-1	3969369
b@@	O	-1	3969369
ility	O	-1	3969369
as	O	-1	3969369
a	O	-1	3969369
b@@	O	-1	3969369
a@@	O	-1	3969369
sic	O	-1	3969369
pre@@	O	-1	3969369
requ@@	O	-1	3969369
is@@	O	-1	3969369
ite	O	-1	3969369
for	O	-1	3969369
studies	O	-1	3969369
on	O	-1	3969369
experimental	O	-1	3969369
pro@@	B-Disease	D011471	3969369
state	I-Disease	-1	3969369
cancer	I-Disease	-1	3969369
.	O	-1	3969369

M@@	B-Chemical	D016685	3108839
it@@	I-Chemical	-1	3108839
om@@	I-Chemical	-1	3108839
ycin	I-Chemical	-1	3108839
C	I-Chemical	-1	3108839
associated	O	-1	3108839
hemolytic	B-Disease	D006463	3108839
ure@@	I-Disease	-1	3108839
mic	I-Disease	-1	3108839
syndrome	I-Disease	-1	3108839
.	O	-1	3108839
M@@	B-Chemical	D016685	3108839
it@@	I-Chemical	-1	3108839
om@@	I-Chemical	-1	3108839
ycin	I-Chemical	-1	3108839
C	I-Chemical	-1	3108839
associated	O	-1	3108839
H@@	B-Disease	D006463	3108839
em@@	I-Disease	-1	3108839
oly@@	I-Disease	-1	3108839
tic	I-Disease	-1	3108839
U@@	I-Disease	-1	3108839
re@@	I-Disease	-1	3108839
mic	I-Disease	-1	3108839
S@@	I-Disease	-1	3108839
yn@@	I-Disease	-1	3108839
drom@@	I-Disease	-1	3108839
e	I-Disease	-1	3108839
(	O	-1	3108839
H@@	B-Disease	D006463	3108839
U@@	I-Disease	-1	3108839
S	I-Disease	-1	3108839
)	O	-1	3108839
is	O	-1	3108839
a	O	-1	3108839
potenti@@	O	-1	3108839
ally	O	-1	3108839
f@@	O	-1	3108839
atal	O	-1	3108839
but	O	-1	3108839
un@@	O	-1	3108839
common	O	-1	3108839
condi@@	O	-1	3108839
tion	O	-1	3108839
that	O	-1	3108839
is	O	-1	3108839
not	O	-1	3108839
y@@	O	-1	3108839
et	O	-1	3108839
wi@@	O	-1	3108839
de@@	O	-1	3108839
ly	O	-1	3108839
reco@@	O	-1	3108839
gn@@	O	-1	3108839
i@@	O	-1	3108839
sed.	O	-1	3108839
It	O	-1	3108839
consist@@	O	-1	3108839
s	O	-1	3108839
of	O	-1	3108839
microangio@@	O	-1	3108839
path@@	O	-1	3108839
ic	O	-1	3108839
hemolytic	B-Disease	D000743	3108839
anemia	I-Disease	-1	3108839
,	O	-1	3108839
throm@@	B-Disease	D013921	3108839
b@@	I-Disease	-1	3108839
ocyto@@	I-Disease	-1	3108839
pen@@	I-Disease	-1	3108839
ia	I-Disease	-1	3108839
and	O	-1	3108839
progressive	O	-1	3108839
renal	B-Disease	D051437	3108839
failure	I-Disease	-1	3108839
associated	O	-1	3108839
with	O	-1	3108839
mit@@	B-Chemical	D016685	3108839
om@@	I-Chemical	-1	3108839
ycin	I-Chemical	-1	3108839
C	I-Chemical	-1	3108839
treatment	O	-1	3108839
and	O	-1	3108839
aff@@	O	-1	3108839
ects	O	-1	3108839
about	O	-1	3108839
10@@	O	-1	3108839
%	O	-1	3108839
of	O	-1	3108839
patients	O	-1	3108839
treated	O	-1	3108839
with	O	-1	3108839
this	O	-1	3108839
agent@@	O	-1	3108839
.	O	-1	3108839
The	O	-1	3108839
renal	B-Disease	D051437	3108839
failure	I-Disease	-1	3108839
us@@	O	-1	3108839
ually	O	-1	3108839
develop@@	O	-1	3108839
s	O	-1	3108839
about	O	-1	3108839
8@@	O	-1	3108839
-@@	O	-1	3108839
10	O	-1	3108839
m@@	O	-1	3108839
th	O	-1	3108839
after	O	-1	3108839
star@@	O	-1	3108839
t	O	-1	3108839
of	O	-1	3108839
mit@@	B-Chemical	D016685	3108839
om@@	I-Chemical	-1	3108839
ycin	I-Chemical	-1	3108839
C	I-Chemical	-1	3108839
treatment	O	-1	3108839
and	O	-1	3108839
the	O	-1	3108839
mor@@	O	-1	3108839
t@@	O	-1	3108839
ality	O	-1	3108839
is	O	-1	3108839
appro@@	O	-1	3108839
xim@@	O	-1	3108839
ately	O	-1	3108839
6@@	O	-1	3108839
0%	O	-1	3108839
from	O	-1	3108839
renal	B-Disease	D051437	3108839
failure	I-Disease	-1	3108839
or	O	-1	3108839
pulmonary	B-Disease	D011654	3108839
e@@	I-Disease	-1	3108839
de@@	I-Disease	-1	3108839
ma	I-Disease	-1	3108839
.	O	-1	3108839
R@@	B-Disease	D051437	3108839
en@@	I-Disease	-1	3108839
al	I-Disease	-1	3108839
lesions	I-Disease	-1	3108839
are	O	-1	3108839
similar	O	-1	3108839
to	O	-1	3108839
those	O	-1	3108839
seen	O	-1	3108839
in	O	-1	3108839
i@@	O	-1	3108839
di@@	O	-1	3108839
o@@	O	-1	3108839
path@@	O	-1	3108839
ic	O	-1	3108839
H@@	B-Disease	D006463	3108839
U@@	I-Disease	-1	3108839
S	I-Disease	-1	3108839
and	O	-1	3108839
includ@@	O	-1	3108839
e	O	-1	3108839
arter@@	O	-1	3108839
i@@	O	-1	3108839
ol@@	O	-1	3108839
ar	O	-1	3108839
fib@@	O	-1	3108839
rin	O	-1	3108839
throm@@	B-Disease	D013927	3108839
b@@	I-Disease	-1	3108839
i	I-Disease	-1	3108839
,	O	-1	3108839
ex@@	O	-1	3108839
p@@	O	-1	3108839
and@@	O	-1	3108839
ed	O	-1	3108839
sub@@	O	-1	3108839
endothelial	O	-1	3108839
z@@	O	-1	3108839
on@@	O	-1	3108839
es	O	-1	3108839
in	O	-1	3108839
glomerular	O	-1	3108839
cap@@	O	-1	3108839
ill@@	O	-1	3108839
ary	O	-1	3108839
w@@	O	-1	3108839
all@@	O	-1	3108839
s,	O	-1	3108839
ischem@@	B-Disease	D007511	3108839
ic	I-Disease	-1	3108839
w@@	O	-1	3108839
r@@	O	-1	3108839
in@@	O	-1	3108839
k@@	O	-1	3108839
l@@	O	-1	3108839
ing	O	-1	3108839
of	O	-1	3108839
glomerular	O	-1	3108839
bas@@	O	-1	3108839
ement	O	-1	3108839
membran@@	O	-1	3108839
es	O	-1	3108839
and	O	-1	3108839
m@@	O	-1	3108839
es@@	O	-1	3108839
angi@@	O	-1	3108839
oly@@	O	-1	3108839
sis.	O	-1	3108839
The	O	-1	3108839
mechanism	O	-1	3108839
of	O	-1	3108839
action	O	-1	3108839
is	O	-1	3108839
post@@	O	-1	3108839
ul@@	O	-1	3108839
ated	O	-1	3108839
as	O	-1	3108839
mit@@	B-Chemical	D016685	3108839
om@@	I-Chemical	-1	3108839
ycin	I-Chemical	-1	3108839
C	I-Chemical	-1	3108839
-induced	O	-1	3108839
endothelial	O	-1	3108839
cell	O	-1	3108839
dam@@	O	-1	3108839
age.	O	-1	3108839
We	O	-1	3108839
describe	O	-1	3108839
the	O	-1	3108839
clinical	O	-1	3108839
course	O	-1	3108839
and	O	-1	3108839
path@@	O	-1	3108839
ological	O	-1	3108839
findings	O	-1	3108839
in	O	-1	3108839
a	O	-1	3108839
6@@	O	-1	3108839
5	O	-1	3108839
y@@	O	-1	3108839
r@@	O	-1	3108839
-old	O	-1	3108839
man	O	-1	3108839
with	O	-1	3108839
gast@@	B-Disease	D013274	3108839
ric	I-Disease	-1	3108839
aden@@	I-Disease	-1	3108839
oc@@	I-Disease	-1	3108839
arc@@	I-Disease	-1	3108839
in@@	I-Disease	-1	3108839
oma	I-Disease	-1	3108839
who	O	-1	3108839
developed	O	-1	3108839
renal	B-Disease	D051437	3108839
failure	I-Disease	-1	3108839
and	O	-1	3108839
throm@@	B-Disease	D013921	3108839
b@@	I-Disease	-1	3108839
ocyto@@	I-Disease	-1	3108839
pen@@	I-Disease	-1	3108839
ia	I-Disease	-1	3108839
while	O	-1	3108839
on	O	-1	3108839
treatment	O	-1	3108839
with	O	-1	3108839
mit@@	B-Chemical	D016685	3108839
om@@	I-Chemical	-1	3108839
ycin	I-Chemical	-1	3108839
C	I-Chemical	-1	3108839
and	O	-1	3108839
di@@	O	-1	3108839
ed	O	-1	3108839
in	O	-1	3108839
pulmonary	B-Disease	D011654	3108839
e@@	I-Disease	-1	3108839
de@@	I-Disease	-1	3108839
ma	I-Disease	-1	3108839
.	O	-1	3108839

C@@	O	-1	2466960
ont@@	O	-1	2466960
in@@	O	-1	2466960
u@@	O	-1	2466960
ous	O	-1	2466960
am@@	O	-1	2466960
b@@	O	-1	2466960
ul@@	O	-1	2466960
atory	O	-1	2466960
EC@@	O	-1	2466960
G	O	-1	2466960
monit@@	O	-1	2466960
or@@	O	-1	2466960
ing	O	-1	2466960
during	O	-1	2466960
fluoro@@	B-Chemical	D005472	2466960
urac@@	I-Chemical	-1	2466960
il	I-Chemical	-1	2466960
therap@@	O	-1	2466960
y@@	O	-1	2466960
:	O	-1	2466960
a	O	-1	2466960
pro@@	O	-1	2466960
sp@@	O	-1	2466960
ective	O	-1	2466960
study.	O	-1	2466960
Although	O	-1	2466960
there	O	-1	2466960
have	O	-1	2466960
been	O	-1	2466960
an@@	O	-1	2466960
ec@@	O	-1	2466960
d@@	O	-1	2466960
ot@@	O	-1	2466960
al	O	-1	2466960
reports	O	-1	2466960
of	O	-1	2466960
cardiac	B-Disease	D066126	2466960
toxicity	I-Disease	-1	2466960
associated	O	-1	2466960
with	O	-1	2466960
fluoro@@	B-Chemical	D005472	2466960
urac@@	I-Chemical	-1	2466960
il	I-Chemical	-1	2466960
(	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
)	O	-1	2466960
therapy,	O	-1	2466960
this	O	-1	2466960
phen@@	O	-1	2466960
om@@	O	-1	2466960
en@@	O	-1	2466960
on	O	-1	2466960
has	O	-1	2466960
not	O	-1	2466960
been	O	-1	2466960
studied	O	-1	2466960
in	O	-1	2466960
a	O	-1	2466960
system@@	O	-1	2466960
atic	O	-1	2466960
f@@	O	-1	2466960
as@@	O	-1	2466960
hi@@	O	-1	2466960
on@@	O	-1	2466960
.	O	-1	2466960
We	O	-1	2466960
pro@@	O	-1	2466960
sp@@	O	-1	2466960
ectively	O	-1	2466960
performed	O	-1	2466960
continu@@	O	-1	2466960
ous	O	-1	2466960
am@@	O	-1	2466960
b@@	O	-1	2466960
ul@@	O	-1	2466960
atory	O	-1	2466960
EC@@	O	-1	2466960
G	O	-1	2466960
monit@@	O	-1	2466960
or@@	O	-1	2466960
ing	O	-1	2466960
on	O	-1	2466960
25	O	-1	2466960
patients	O	-1	2466960
under@@	O	-1	2466960
go@@	O	-1	2466960
ing	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
infusion	O	-1	2466960
for	O	-1	2466960
treatment	O	-1	2466960
of	O	-1	2466960
sol@@	O	-1	2466960
id	O	-1	2466960
tu@@	B-Disease	D009369	2466960
mor@@	I-Disease	-1	2466960
s	I-Disease	-1	2466960
in	O	-1	2466960
or@@	O	-1	2466960
der	O	-1	2466960
to	O	-1	2466960
ass@@	O	-1	2466960
ess	O	-1	2466960
the	O	-1	2466960
incidence	O	-1	2466960
of	O	-1	2466960
ischem@@	B-Disease	D007511	2466960
ic	I-Disease	-1	2466960
S@@	O	-1	2466960
T	O	-1	2466960
chang@@	O	-1	2466960
es.	O	-1	2466960
Patients	O	-1	2466960
were	O	-1	2466960
monit@@	O	-1	2466960
o@@	O	-1	2466960
red	O	-1	2466960
for	O	-1	2466960
2@@	O	-1	2466960
3	O	-1	2466960
+/-	O	-1	2466960
4	O	-1	2466960
hours	O	-1	2466960
before	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
infu@@	O	-1	2466960
sion,	O	-1	2466960
and	O	-1	2466960
9@@	O	-1	2466960
8	O	-1	2466960
+/-	O	-1	2466960
9	O	-1	2466960
hours	O	-1	2466960
during	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
infu@@	O	-1	2466960
sion.	O	-1	2466960
An@@	B-Disease	D000787	2466960
g@@	I-Disease	-1	2466960
inal	I-Disease	-1	2466960
episo@@	O	-1	2466960
des	O	-1	2466960
were	O	-1	2466960
ra@@	O	-1	2466960
re@@	O	-1	2466960
:	O	-1	2466960
only	O	-1	2466960
one	O	-1	2466960
patient	O	-1	2466960
had	O	-1	2466960
ang@@	B-Disease	D000787	2466960
in@@	I-Disease	-1	2466960
a	I-Disease	-1	2466960
(@@	O	-1	2466960
during	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
infu@@	O	-1	2466960
sion@@	O	-1	2466960
).	O	-1	2466960
However,	O	-1	2466960
as@@	O	-1	2466960
ym@@	O	-1	2466960
pto@@	O	-1	2466960
m@@	O	-1	2466960
atic	O	-1	2466960
S@@	O	-1	2466960
T	O	-1	2466960
changes	O	-1	2466960
(@@	O	-1	2466960
greater	O	-1	2466960
than	O	-1	2466960
or	O	-1	2466960
equ@@	O	-1	2466960
al	O	-1	2466960
to	O	-1	2466960
1	O	-1	2466960
mm	O	-1	2466960
S@@	O	-1	2466960
T	O	-1	2466960
de@@	O	-1	2466960
vi@@	O	-1	2466960
ation@@	O	-1	2466960
)	O	-1	2466960
were	O	-1	2466960
common@@	O	-1	2466960
:	O	-1	2466960
six	O	-1	2466960
of	O	-1	2466960
25	O	-1	2466960
patients	O	-1	2466960
(2@@	O	-1	2466960
4@@	O	-1	2466960
%)	O	-1	2466960
had	O	-1	2466960
S@@	O	-1	2466960
T	O	-1	2466960
changes	O	-1	2466960
before	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
infusion	O	-1	2466960
v	O	-1	2466960
17	O	-1	2466960
(6@@	O	-1	2466960
8@@	O	-1	2466960
%)	O	-1	2466960
during	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
infusion	O	-1	2466960
(P	O	-1	2466960
less	O	-1	2466960
than	O	-1	2466960
.@@	O	-1	2466960
0@@	O	-1	2466960
0@@	O	-1	2466960
2@@	O	-1	2466960
).	O	-1	2466960
The	O	-1	2466960
incidence	O	-1	2466960
of	O	-1	2466960
ischem@@	B-Disease	D007511	2466960
ic	I-Disease	-1	2466960
episo@@	O	-1	2466960
des	O	-1	2466960
per	O	-1	2466960
patient	O	-1	2466960
per	O	-1	2466960
h@@	O	-1	2466960
our	O	-1	2466960
was	O	-1	2466960
0.0@@	O	-1	2466960
5	O	-1	2466960
+/-	O	-1	2466960
0.0@@	O	-1	2466960
2	O	-1	2466960
prior	O	-1	2466960
to	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
infusion	O	-1	2466960
v	O	-1	2466960
0.@@	O	-1	2466960
13	O	-1	2466960
+/-	O	-1	2466960
0.0@@	O	-1	2466960
3	O	-1	2466960
during	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
infusion	O	-1	2466960
(P	O	-1	2466960
less	O	-1	2466960
than	O	-1	2466960
.@@	O	-1	2466960
0@@	O	-1	2466960
0@@	O	-1	2466960
1@@	O	-1	2466960
);	O	-1	2466960
the	O	-1	2466960
duration	O	-1	2466960
of	O	-1	2466960
EC@@	O	-1	2466960
G	O	-1	2466960
changes	O	-1	2466960
was	O	-1	2466960
0.@@	O	-1	2466960
6	O	-1	2466960
+/-	O	-1	2466960
0.@@	O	-1	2466960
3	O	-1	2466960
minutes	O	-1	2466960
per	O	-1	2466960
patient	O	-1	2466960
per	O	-1	2466960
h@@	O	-1	2466960
our	O	-1	2466960
before	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
v	O	-1	2466960
1.@@	O	-1	2466960
9	O	-1	2466960
+/-	O	-1	2466960
0.@@	O	-1	2466960
5	O	-1	2466960
minutes	O	-1	2466960
per	O	-1	2466960
patient	O	-1	2466960
per	O	-1	2466960
h@@	O	-1	2466960
our	O	-1	2466960
during	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
(P	O	-1	2466960
less	O	-1	2466960
than	O	-1	2466960
.@@	O	-1	2466960
0@@	O	-1	2466960
1).	O	-1	2466960
EC@@	O	-1	2466960
G	O	-1	2466960
changes	O	-1	2466960
were	O	-1	2466960
more	O	-1	2466960
common	O	-1	2466960
among	O	-1	2466960
patients	O	-1	2466960
with	O	-1	2466960
known	O	-1	2466960
coronary	B-Disease	D003324	2466960
artery	I-Disease	-1	2466960
disease	I-Disease	-1	2466960
.	O	-1	2466960
There	O	-1	2466960
were	O	-1	2466960
two	O	-1	2466960
cases	O	-1	2466960
of	O	-1	2466960
su@@	B-Disease	D003645	2466960
d@@	I-Disease	-1	2466960
de@@	I-Disease	-1	2466960
n	I-Disease	-1	2466960
death	I-Disease	-1	2466960
,	O	-1	2466960
both	O	-1	2466960
of	O	-1	2466960
which	O	-1	2466960
occurred	O	-1	2466960
at	O	-1	2466960
the	O	-1	2466960
end	O	-1	2466960
of	O	-1	2466960
the	O	-1	2466960
chemotherapy	O	-1	2466960
cour@@	O	-1	2466960
se.	O	-1	2466960
We	O	-1	2466960
concl@@	O	-1	2466960
ude	O	-1	2466960
that	O	-1	2466960
5-@@	B-Chemical	D005472	2466960
F@@	I-Chemical	-1	2466960
U	I-Chemical	-1	2466960
infusion	O	-1	2466960
is	O	-1	2466960
associated	O	-1	2466960
with	O	-1	2466960
a	O	-1	2466960
significant	O	-1	2466960
increase	O	-1	2466960
in	O	-1	2466960
si@@	O	-1	2466960
l@@	O	-1	2466960
ent	O	-1	2466960
S@@	O	-1	2466960
T	O	-1	2466960
seg@@	O	-1	2466960
ment	O	-1	2466960
de@@	O	-1	2466960
vi@@	O	-1	2466960
ation	O	-1	2466960
sugg@@	O	-1	2466960
es@@	O	-1	2466960
tive	O	-1	2466960
of	O	-1	2466960
ischem@@	B-Disease	D007511	2466960
ia	I-Disease	-1	2466960
,	O	-1	2466960
partic@@	O	-1	2466960
ul@@	O	-1	2466960
arly	O	-1	2466960
among	O	-1	2466960
patients	O	-1	2466960
with	O	-1	2466960
coronary	B-Disease	D003324	2466960
artery	I-Disease	-1	2466960
disease	I-Disease	-1	2466960
.	O	-1	2466960
The	O	-1	2466960
mechanism	O	-1	2466960
and	O	-1	2466960
clinical	O	-1	2466960
signific@@	O	-1	2466960
ance	O	-1	2466960
of	O	-1	2466960
these	O	-1	2466960
EC@@	O	-1	2466960
G	O	-1	2466960
changes	O	-1	2466960
re@@	O	-1	2466960
ma@@	O	-1	2466960
in	O	-1	2466960
to	O	-1	2466960
be	O	-1	2466960
deter@@	O	-1	2466960
m@@	O	-1	2466960
ine@@	O	-1	2466960
d.	O	-1	2466960

L@@	O	-1	2320800
eth@@	O	-1	2320800
al	O	-1	2320800
an@@	B-Disease	D001002	2320800
uria	I-Disease	-1	2320800
complic@@	O	-1	2320800
ating	O	-1	2320800
high	O	-1	2320800
dose	O	-1	2320800
if@@	B-Chemical	D007069	2320800
os@@	I-Chemical	-1	2320800
f@@	I-Chemical	-1	2320800
amide	I-Chemical	-1	2320800
chemotherapy	O	-1	2320800
in	O	-1	2320800
a	O	-1	2320800
b@@	B-Disease	D001943	2320800
reas@@	I-Disease	-1	2320800
t	I-Disease	-1	2320800
cancer	I-Disease	-1	2320800
patient	O	-1	2320800
with	O	-1	2320800
an	O	-1	2320800
impaired	B-Disease	D007674	2320800
renal	I-Disease	-1	2320800
function	I-Disease	-1	2320800
.	O	-1	2320800
A	O	-1	2320800
si@@	O	-1	2320800
x@@	O	-1	2320800
ty-@@	O	-1	2320800
year-old	O	-1	2320800
woman	O	-1	2320800
with	O	-1	2320800
adv@@	O	-1	2320800
anced	O	-1	2320800
b@@	B-Disease	D001943	2320800
reas@@	I-Disease	-1	2320800
t	I-Disease	-1	2320800
cancer	I-Disease	-1	2320800
,	O	-1	2320800
previously	O	-1	2320800
treated	O	-1	2320800
with	O	-1	2320800
cisplatin	B-Chemical	D002945	2320800
,	O	-1	2320800
developed	O	-1	2320800
an	O	-1	2320800
ir@@	O	-1	2320800
reversible	O	-1	2320800
le@@	O	-1	2320800
th@@	O	-1	2320800
al	O	-1	2320800
renal	B-Disease	D051437	2320800
failure	I-Disease	-1	2320800
with	O	-1	2320800
an@@	B-Disease	D001002	2320800
uria	I-Disease	-1	2320800
,	O	-1	2320800
the	O	-1	2320800
day	O	-1	2320800
after	O	-1	2320800
5	O	-1	2320800
g/@@	O	-1	2320800
m@@	O	-1	2320800
2	O	-1	2320800
b@@	O	-1	2320800
ol@@	O	-1	2320800
us	O	-1	2320800
if@@	B-Chemical	D007069	2320800
os@@	I-Chemical	-1	2320800
f@@	I-Chemical	-1	2320800
amide	I-Chemical	-1	2320800
.	O	-1	2320800
P@@	B-Disease	D007674	2320800
ost@@	I-Disease	-1	2320800
renal	I-Disease	-1	2320800
failure	I-Disease	-1	2320800
was	O	-1	2320800
ex@@	O	-1	2320800
cl@@	O	-1	2320800
uded	O	-1	2320800
by	O	-1	2320800
ec@@	O	-1	2320800
ho@@	O	-1	2320800
graph@@	O	-1	2320800
y.	O	-1	2320800
A	O	-1	2320800
pre@@	O	-1	2320800
renal	O	-1	2320800
comp@@	O	-1	2320800
on@@	O	-1	2320800
ent	O	-1	2320800
could	O	-1	2320800
have	O	-1	2320800
cont@@	O	-1	2320800
ri@@	O	-1	2320800
but@@	O	-1	2320800
ed	O	-1	2320800
to	O	-1	2320800
renal	B-Disease	D051437	2320800
failure	I-Disease	-1	2320800
because	O	-1	2320800
of	O	-1	2320800
a	O	-1	2320800
transi@@	O	-1	2320800
ent	O	-1	2320800
hypotension	B-Disease	D007022	2320800
,	O	-1	2320800
due	O	-1	2320800
to	O	-1	2320800
an	O	-1	2320800
increas@@	O	-1	2320800
ing	O	-1	2320800
as@@	O	-1	2320800
ci@@	O	-1	2320800
tis,	O	-1	2320800
occur@@	O	-1	2320800
r@@	O	-1	2320800
ing	O	-1	2320800
j@@	O	-1	2320800
us@@	O	-1	2320800
t	O	-1	2320800
before	O	-1	2320800
an@@	B-Disease	D001002	2320800
uria	I-Disease	-1	2320800
.	O	-1	2320800
However,	O	-1	2320800
cor@@	O	-1	2320800
rec@@	O	-1	2320800
tion	O	-1	2320800
of	O	-1	2320800
the	O	-1	2320800
hemo@@	O	-1	2320800
dynam@@	O	-1	2320800
ic	O	-1	2320800
par@@	O	-1	2320800
ame@@	O	-1	2320800
ters	O	-1	2320800
did	O	-1	2320800
not	O	-1	2320800
impro@@	O	-1	2320800
ve	O	-1	2320800
renal	O	-1	2320800
func@@	O	-1	2320800
tion.	O	-1	2320800
I@@	B-Chemical	D007069	2320800
f@@	I-Chemical	-1	2320800
os@@	I-Chemical	-1	2320800
f@@	I-Chemical	-1	2320800
amide	I-Chemical	-1	2320800
is	O	-1	2320800
a	O	-1	2320800
known	O	-1	2320800
nephro@@	B-Disease	D007674	2320800
toxic	I-Disease	-1	2320800
drug	O	-1	2320800
with	O	-1	2320800
demonstrated	O	-1	2320800
tu@@	B-Disease	D007674	2320800
bu@@	I-Disease	-1	2320800
lo@@	I-Disease	-1	2320800
path@@	I-Disease	-1	2320800
i@@	I-Disease	-1	2320800
es	I-Disease	-1	2320800
.	O	-1	2320800
We	O	-1	2320800
st@@	O	-1	2320800
ron@@	O	-1	2320800
g@@	O	-1	2320800
ly	O	-1	2320800
sus@@	O	-1	2320800
p@@	O	-1	2320800
ect	O	-1	2320800
that	O	-1	2320800
this	O	-1	2320800
le@@	O	-1	2320800
th@@	O	-1	2320800
al	O	-1	2320800
an@@	B-Disease	D001002	2320800
uria	I-Disease	-1	2320800
was	O	-1	2320800
main@@	O	-1	2320800
ly	O	-1	2320800
due	O	-1	2320800
to	O	-1	2320800
if@@	B-Chemical	D007069	2320800
os@@	I-Chemical	-1	2320800
f@@	I-Chemical	-1	2320800
amide	I-Chemical	-1	2320800
,	O	-1	2320800
occur@@	O	-1	2320800
r@@	O	-1	2320800
ing	O	-1	2320800
in	O	-1	2320800
a	O	-1	2320800
patient	O	-1	2320800
ha@@	O	-1	2320800
ving	O	-1	2320800
received	O	-1	2320800
previ@@	O	-1	2320800
ous	O	-1	2320800
cisplatin	B-Chemical	D002945	2320800
chemotherapy	O	-1	2320800
and	O	-1	2320800
with	O	-1	2320800
po@@	O	-1	2320800
or	O	-1	2320800
kidney	O	-1	2320800
per@@	O	-1	2320800
f@@	O	-1	2320800
usion	O	-1	2320800
due	O	-1	2320800
to	O	-1	2320800
transi@@	O	-1	2320800
ent	O	-1	2320800
hypotension	B-Disease	D007022	2320800
.	O	-1	2320800
We	O	-1	2320800
recomm@@	O	-1	2320800
end	O	-1	2320800
ca@@	O	-1	2320800
ref@@	O	-1	2320800
u@@	O	-1	2320800
l	O	-1	2320800
use	O	-1	2320800
of	O	-1	2320800
if@@	B-Chemical	D007069	2320800
os@@	I-Chemical	-1	2320800
f@@	I-Chemical	-1	2320800
amide	I-Chemical	-1	2320800
in	O	-1	2320800
patients	O	-1	2320800
pre@@	O	-1	2320800
treated	O	-1	2320800
with	O	-1	2320800
nephro@@	B-Disease	D007674	2320800
toxic	I-Disease	-1	2320800
chemotherapy	O	-1	2320800
and	O	-1	2320800
in@@	O	-1	2320800
ade@@	O	-1	2320800
qu@@	O	-1	2320800
ate	O	-1	2320800
renal	O	-1	2320800
per@@	O	-1	2320800
fu@@	O	-1	2320800
sion.	O	-1	2320800

C@@	O	-1	2220369
entr@@	O	-1	2220369
al	O	-1	2220369
ve@@	B-Disease	D020246	2220369
in	I-Disease	-1	2220369
thrombo@@	I-Disease	-1	2220369
sis	I-Disease	-1	2220369
and	O	-1	2220369
to@@	O	-1	2220369
p@@	O	-1	2220369
ical	O	-1	2220369
di@@	B-Chemical	C015173	2220369
pi@@	I-Chemical	-1	2220369
v@@	I-Chemical	-1	2220369
aly@@	I-Chemical	-1	2220369
l	I-Chemical	-1	2220369
ep@@	I-Chemical	-1	2220369
ine@@	I-Chemical	-1	2220369
phrine	I-Chemical	-1	2220369
.	O	-1	2220369
A	O	-1	2220369
report	O	-1	2220369
is	O	-1	2220369
given	O	-1	2220369
on	O	-1	2220369
an	O	-1	2220369
8@@	O	-1	2220369
3-@@	O	-1	2220369
year-old	O	-1	2220369
female	O	-1	2220369
who	O	-1	2220369
ac@@	O	-1	2220369
qu@@	O	-1	2220369
ired	O	-1	2220369
central	O	-1	2220369
ve@@	B-Disease	D020246	2220369
in	I-Disease	-1	2220369
thrombo@@	I-Disease	-1	2220369
sis	I-Disease	-1	2220369
in	O	-1	2220369
h@@	O	-1	2220369
er	O	-1	2220369
se@@	O	-1	2220369
e@@	O	-1	2220369
ing	O	-1	2220369
e@@	O	-1	2220369
y@@	O	-1	2220369
e	O	-1	2220369
one	O	-1	2220369
day	O	-1	2220369
after	O	-1	2220369
ha@@	O	-1	2220369
ving	O	-1	2220369
star@@	O	-1	2220369
ted	O	-1	2220369
to@@	O	-1	2220369
p@@	O	-1	2220369
ical	O	-1	2220369
medic@@	O	-1	2220369
ation	O	-1	2220369
with	O	-1	2220369
di@@	B-Chemical	C015173	2220369
pi@@	I-Chemical	-1	2220369
v@@	I-Chemical	-1	2220369
aly@@	I-Chemical	-1	2220369
l	I-Chemical	-1	2220369
ep@@	I-Chemical	-1	2220369
ine@@	I-Chemical	-1	2220369
phrine	I-Chemical	-1	2220369
for	O	-1	2220369
adv@@	O	-1	2220369
anced	O	-1	2220369
gl@@	B-Disease	D005901	2220369
au@@	I-Disease	-1	2220369
com@@	I-Disease	-1	2220369
a	I-Disease	-1	2220369
dis@@	O	-1	2220369
co@@	O	-1	2220369
vered	O	-1	2220369
in	O	-1	2220369
the	O	-1	2220369
other	O	-1	2220369
e@@	O	-1	2220369
y@@	O	-1	2220369
e.	O	-1	2220369
F@@	O	-1	2220369
rom	O	-1	2220369
present	O	-1	2220369
know@@	O	-1	2220369
le@@	O	-1	2220369
d@@	O	-1	2220369
ge	O	-1	2220369
about	O	-1	2220369
the	O	-1	2220369
effects	O	-1	2220369
of	O	-1	2220369
adrenergic	O	-1	2220369
e@@	O	-1	2220369
y@@	O	-1	2220369
e	O	-1	2220369
dro@@	O	-1	2220369
p@@	O	-1	2220369
s	O	-1	2220369
on	O	-1	2220369
oc@@	O	-1	2220369
ular	O	-1	2220369
blood	O	-1	2220369
cir@@	O	-1	2220369
cul@@	O	-1	2220369
ation,	O	-1	2220369
it	O	-1	2220369
is	O	-1	2220369
diff@@	O	-1	2220369
ic@@	O	-1	2220369
ult	O	-1	2220369
to	O	-1	2220369
suggest	O	-1	2220369
an	O	-1	2220369
association	O	-1	2220369
between	O	-1	2220369
the	O	-1	2220369
two	O	-1	2220369
event@@	O	-1	2220369
s,	O	-1	2220369
which	O	-1	2220369
may	O	-1	2220369
be	O	-1	2220369
co@@	O	-1	2220369
inc@@	O	-1	2220369
id@@	O	-1	2220369
ental	O	-1	2220369
on@@	O	-1	2220369
ly.	O	-1	2220369

A@@	O	-1	326460
me@@	O	-1	326460
li@@	O	-1	326460
or@@	O	-1	326460
ation	O	-1	326460
of	O	-1	326460
ben@@	B-Chemical	D001539	326460
dro@@	I-Chemical	-1	326460
flu@@	I-Chemical	-1	326460
az@@	I-Chemical	-1	326460
ide	I-Chemical	-1	326460
-induced	O	-1	326460
hypo@@	B-Disease	D007008	326460
k@@	I-Disease	-1	326460
al@@	I-Disease	-1	326460
emia	I-Disease	-1	326460
by	O	-1	326460
ti@@	B-Chemical	D013999	326460
mo@@	I-Chemical	-1	326460
lol	I-Chemical	-1	326460
.	O	-1	326460
The	O	-1	326460
bet@@	O	-1	326460
a	O	-1	326460
adrenergic	O	-1	326460
block@@	O	-1	326460
ing	O	-1	326460
drug@@	O	-1	326460
,	O	-1	326460
ti@@	B-Chemical	D013999	326460
mo@@	I-Chemical	-1	326460
lol	I-Chemical	-1	326460
,	O	-1	326460
ten@@	O	-1	326460
ded	O	-1	326460
to	O	-1	326460
cor@@	O	-1	326460
rec@@	O	-1	326460
t	O	-1	326460
the	O	-1	326460
hypo@@	B-Disease	D007008	326460
k@@	I-Disease	-1	326460
al@@	I-Disease	-1	326460
emia	I-Disease	-1	326460
of	O	-1	326460
sh@@	O	-1	326460
ort@@	O	-1	326460
-term	O	-1	326460
ben@@	B-Chemical	D001539	326460
dro@@	I-Chemical	-1	326460
flu@@	I-Chemical	-1	326460
az@@	I-Chemical	-1	326460
ide	I-Chemical	-1	326460
treatment	O	-1	326460
in	O	-1	326460
6	O	-1	326460
healthy	O	-1	326460
male	O	-1	326460
subjects	O	-1	326460
and	O	-1	326460
although	O	-1	326460
the	O	-1	326460
effect	O	-1	326460
was	O	-1	326460
sm@@	O	-1	326460
all	O	-1	326460
it	O	-1	326460
was	O	-1	326460
significant@@	O	-1	326460
.	O	-1	326460
T@@	B-Chemical	D013999	326460
im@@	I-Chemical	-1	326460
o@@	I-Chemical	-1	326460
lol	I-Chemical	-1	326460
also	O	-1	326460
reduced	O	-1	326460
the	O	-1	326460
ri@@	O	-1	326460
se	O	-1	326460
in	O	-1	326460
plasma	O	-1	326460
al@@	B-Chemical	D000450	326460
do@@	I-Chemical	-1	326460
sterone	I-Chemical	-1	326460
and	O	-1	326460
urine	O	-1	326460
pot@@	B-Chemical	D011188	326460
assi@@	I-Chemical	-1	326460
um	I-Chemical	-1	326460
ex@@	O	-1	326460
cre@@	O	-1	326460
tion	O	-1	326460
following	O	-1	326460
ben@@	B-Chemical	D001539	326460
dro@@	I-Chemical	-1	326460
flu@@	I-Chemical	-1	326460
az@@	I-Chemical	-1	326460
ide	I-Chemical	-1	326460
and	O	-1	326460
increased	O	-1	326460
the	O	-1	326460
urine	O	-1	326460
sodium	B-Chemical	D012964	326460
/	O	-1	326460
pot@@	B-Chemical	D011188	326460
assi@@	I-Chemical	-1	326460
um	I-Chemical	-1	326460
rati@@	O	-1	326460
o@@	O	-1	326460
.	O	-1	326460
There	O	-1	326460
was	O	-1	326460
no	O	-1	326460
evidence	O	-1	326460
of	O	-1	326460
a	O	-1	326460
shi@@	O	-1	326460
ft	O	-1	326460
of	O	-1	326460
pot@@	B-Chemical	D011188	326460
assi@@	I-Chemical	-1	326460
um	I-Chemical	-1	326460
from	O	-1	326460
the	O	-1	326460
intrac@@	O	-1	326460
ell@@	O	-1	326460
ular	O	-1	326460
to	O	-1	326460
the	O	-1	326460
extrac@@	O	-1	326460
ell@@	O	-1	326460
ular	O	-1	326460
sp@@	O	-1	326460
ac@@	O	-1	326460
e.	O	-1	326460

A	O	-1	20331935
cros@@	O	-1	20331935
s-@@	O	-1	20331935
sec@@	O	-1	20331935
tional	O	-1	20331935
evalu@@	O	-1	20331935
ation	O	-1	20331935
of	O	-1	20331935
the	O	-1	20331935
effect	O	-1	20331935
of	O	-1	20331935
ris@@	B-Chemical	D018967	20331935
perid@@	I-Chemical	-1	20331935
one	I-Chemical	-1	20331935
and	O	-1	20331935
selective	O	-1	20331935
seroton@@	B-Chemical	D012701	20331935
in	I-Chemical	-1	20331935
re@@	O	-1	20331935
u@@	O	-1	20331935
pt@@	O	-1	20331935
ake	O	-1	20331935
inhibitors	O	-1	20331935
on	O	-1	20331935
b@@	O	-1	20331935
one	O	-1	20331935
min@@	O	-1	20331935
eral	O	-1	20331935
d@@	O	-1	20331935
ensity	O	-1	20331935
in	O	-1	20331935
bo@@	O	-1	20331935
y@@	O	-1	20331935
s.	O	-1	20331935
OBJECTIVE:	O	-1	20331935
The	O	-1	20331935
a@@	O	-1	20331935
im	O	-1	20331935
of	O	-1	20331935
the	O	-1	20331935
present	O	-1	20331935
study	O	-1	20331935
was	O	-1	20331935
to	O	-1	20331935
investigate	O	-1	20331935
the	O	-1	20331935
effect	O	-1	20331935
of	O	-1	20331935
ris@@	B-Chemical	D018967	20331935
perid@@	I-Chemical	-1	20331935
one	I-Chemical	-1	20331935
-induced	O	-1	20331935
hyper@@	B-Disease	D006966	20331935
prol@@	I-Disease	-1	20331935
act@@	I-Disease	-1	20331935
ine@@	I-Disease	-1	20331935
mia	I-Disease	-1	20331935
on	O	-1	20331935
tra@@	O	-1	20331935
b@@	O	-1	20331935
ec@@	O	-1	20331935
ular	O	-1	20331935
b@@	O	-1	20331935
one	O	-1	20331935
min@@	O	-1	20331935
eral	O	-1	20331935
d@@	O	-1	20331935
ensity	O	-1	20331935
(B@@	O	-1	20331935
MD@@	O	-1	20331935
)	O	-1	20331935
in	O	-1	20331935
children	O	-1	20331935
and	O	-1	20331935
ad@@	O	-1	20331935
ol@@	O	-1	20331935
es@@	O	-1	20331935
c@@	O	-1	20331935
ent@@	O	-1	20331935
s.	O	-1	20331935
METHOD@@	O	-1	20331935
:	O	-1	20331935
M@@	O	-1	20331935
ed@@	O	-1	20331935
ically	O	-1	20331935
healthy	O	-1	20331935
7@@	O	-1	20331935
-	O	-1	20331935
to	O	-1	20331935
17@@	O	-1	20331935
-@@	O	-1	20331935
year-old	O	-1	20331935
mal@@	O	-1	20331935
es	O	-1	20331935
chron@@	O	-1	20331935
ically	O	-1	20331935
treat@@	O	-1	20331935
ed,	O	-1	20331935
in	O	-1	20331935
a	O	-1	20331935
n@@	O	-1	20331935
at@@	O	-1	20331935
ur@@	O	-1	20331935
al@@	O	-1	20331935
istic	O	-1	20331935
se@@	O	-1	20331935
t@@	O	-1	20331935
t@@	O	-1	20331935
ing,	O	-1	20331935
with	O	-1	20331935
ris@@	B-Chemical	D018967	20331935
perid@@	I-Chemical	-1	20331935
one	I-Chemical	-1	20331935
were	O	-1	20331935
rec@@	O	-1	20331935
ru@@	O	-1	20331935
ited	O	-1	20331935
for	O	-1	20331935
this	O	-1	20331935
cros@@	O	-1	20331935
s-@@	O	-1	20331935
sec@@	O	-1	20331935
tional	O	-1	20331935
study	O	-1	20331935
through	O	-1	20331935
ch@@	O	-1	20331935
il@@	O	-1	20331935
d	O	-1	20331935
psych@@	O	-1	20331935
i@@	O	-1	20331935
at@@	O	-1	20331935
r@@	O	-1	20331935
y	O	-1	20331935
out@@	O	-1	20331935
patient	O	-1	20331935
clin@@	O	-1	20331935
ic@@	O	-1	20331935
s	O	-1	20331935
between	O	-1	20331935
N@@	O	-1	20331935
o@@	O	-1	20331935
ve@@	O	-1	20331935
mb@@	O	-1	20331935
er	O	-1	20331935
20@@	O	-1	20331935
0@@	O	-1	20331935
5	O	-1	20331935
and	O	-1	20331935
J@@	O	-1	20331935
un@@	O	-1	20331935
e	O	-1	20331935
20@@	O	-1	20331935
0@@	O	-1	20331935
7@@	O	-1	20331935
.	O	-1	20331935
An@@	O	-1	20331935
th@@	O	-1	20331935
ro@@	O	-1	20331935
po@@	O	-1	20331935
me@@	O	-1	20331935
tri@@	O	-1	20331935
c	O	-1	20331935
meas@@	O	-1	20331935
ure@@	O	-1	20331935
ments	O	-1	20331935
and	O	-1	20331935
labor@@	O	-1	20331935
atory	O	-1	20331935
test@@	O	-1	20331935
ing	O	-1	20331935
were	O	-1	20331935
con@@	O	-1	20331935
duc@@	O	-1	20331935
ted.	O	-1	20331935
The	O	-1	20331935
clinical	O	-1	20331935
diagno@@	O	-1	20331935
ses	O	-1	20331935
were	O	-1	20331935
bas@@	O	-1	20331935
ed	O	-1	20331935
on	O	-1	20331935
ch@@	O	-1	20331935
ar@@	O	-1	20331935
t	O	-1	20331935
revie@@	O	-1	20331935
w@@	O	-1	20331935
,	O	-1	20331935
and	O	-1	20331935
develop@@	O	-1	20331935
mental	O	-1	20331935
and	O	-1	20331935
treatment	O	-1	20331935
hist@@	O	-1	20331935
ory	O	-1	20331935
was	O	-1	20331935
obtained	O	-1	20331935
from	O	-1	20331935
the	O	-1	20331935
med@@	O	-1	20331935
ical	O	-1	20331935
recor@@	O	-1	20331935
d.	O	-1	20331935
V@@	O	-1	20331935
ol@@	O	-1	20331935
u@@	O	-1	20331935
me@@	O	-1	20331935
tri@@	O	-1	20331935
c	O	-1	20331935
B@@	O	-1	20331935
M@@	O	-1	20331935
D	O	-1	20331935
of	O	-1	20331935
the	O	-1	20331935
ult@@	O	-1	20331935
radi@@	O	-1	20331935
st@@	O	-1	20331935
al	O	-1	20331935
radi@@	O	-1	20331935
us	O	-1	20331935
was	O	-1	20331935
measured	O	-1	20331935
using	O	-1	20331935
peripheral	O	-1	20331935
qu@@	O	-1	20331935
anti@@	O	-1	20331935
t@@	O	-1	20331935
ative	O	-1	20331935
comp@@	O	-1	20331935
ut@@	O	-1	20331935
ed	O	-1	20331935
to@@	O	-1	20331935
mo@@	O	-1	20331935
graph@@	O	-1	20331935
y,	O	-1	20331935
and	O	-1	20331935
a@@	O	-1	20331935
re@@	O	-1	20331935
al	O	-1	20331935
B@@	O	-1	20331935
M@@	O	-1	20331935
D	O	-1	20331935
of	O	-1	20331935
the	O	-1	20331935
l@@	O	-1	20331935
umb@@	O	-1	20331935
ar	O	-1	20331935
sp@@	O	-1	20331935
ine	O	-1	20331935
was	O	-1	20331935
estim@@	O	-1	20331935
ated	O	-1	20331935
using	O	-1	20331935
du@@	O	-1	20331935
al@@	O	-1	20331935
-@@	O	-1	20331935
en@@	O	-1	20331935
erg@@	O	-1	20331935
y	O	-1	20331935
x@@	O	-1	20331935
-@@	O	-1	20331935
ra@@	O	-1	20331935
y	O	-1	20331935
abs@@	O	-1	20331935
or@@	O	-1	20331935
p@@	O	-1	20331935
ti@@	O	-1	20331935
o@@	O	-1	20331935
met@@	O	-1	20331935
r@@	O	-1	20331935
y.	O	-1	20331935
RESULTS:	O	-1	20331935
H@@	B-Disease	D006966	20331935
y@@	I-Disease	-1	20331935
per@@	I-Disease	-1	20331935
prol@@	I-Disease	-1	20331935
act@@	I-Disease	-1	20331935
ine@@	I-Disease	-1	20331935
mia	I-Disease	-1	20331935
was	O	-1	20331935
present	O	-1	20331935
in	O	-1	20331935
4@@	O	-1	20331935
9@@	O	-1	20331935
%	O	-1	20331935
of	O	-1	20331935
8@@	O	-1	20331935
3	O	-1	20331935
bo@@	O	-1	20331935
ys	O	-1	20331935
(n	O	-1	20331935
=	O	-1	20331935
4@@	O	-1	20331935
1)	O	-1	20331935
treated	O	-1	20331935
with	O	-1	20331935
ris@@	B-Chemical	D018967	20331935
perid@@	I-Chemical	-1	20331935
one	I-Chemical	-1	20331935
for	O	-1	20331935
a	O	-1	20331935
mean	O	-1	20331935
of	O	-1	20331935
2.@@	O	-1	20331935
9	O	-1	20331935
year@@	O	-1	20331935
s.	O	-1	20331935
S@@	O	-1	20331935
er@@	O	-1	20331935
um	O	-1	20331935
test@@	B-Chemical	D013739	20331935
osterone	I-Chemical	-1	20331935
concentration	O	-1	20331935
increased	O	-1	20331935
with	O	-1	20331935
p@@	O	-1	20331935
ub@@	O	-1	20331935
er@@	O	-1	20331935
t@@	O	-1	20331935
al	O	-1	20331935
status	O	-1	20331935
but	O	-1	20331935
was	O	-1	20331935
not	O	-1	20331935
affected	O	-1	20331935
by	O	-1	20331935
hyper@@	B-Disease	D006966	20331935
prol@@	I-Disease	-1	20331935
act@@	I-Disease	-1	20331935
ine@@	I-Disease	-1	20331935
mia	I-Disease	-1	20331935
.	O	-1	20331935
A@@	O	-1	20331935
s	O	-1	20331935
ex@@	O	-1	20331935
p@@	O	-1	20331935
ect@@	O	-1	20331935
ed,	O	-1	20331935
b@@	O	-1	20331935
one	O	-1	20331935
min@@	O	-1	20331935
eral	O	-1	20331935
cont@@	O	-1	20331935
ent	O	-1	20331935
and	O	-1	20331935
B@@	O	-1	20331935
M@@	O	-1	20331935
D	O	-1	20331935
increased	O	-1	20331935
with	O	-1	20331935
sex@@	O	-1	20331935
ual	O	-1	20331935
mat@@	O	-1	20331935
ur@@	O	-1	20331935
ity.	O	-1	20331935
After	O	-1	20331935
adjust@@	O	-1	20331935
ing	O	-1	20331935
for	O	-1	20331935
the	O	-1	20331935
st@@	O	-1	20331935
age	O	-1	20331935
of	O	-1	20331935
sex@@	O	-1	20331935
ual	O	-1	20331935
development	O	-1	20331935
and	O	-1	20331935
he@@	O	-1	20331935
ight	O	-1	20331935
and	O	-1	20331935
B@@	O	-1	20331935
M@@	O	-1	20331935
I	O	-1	20331935
z	O	-1	20331935
sco@@	O	-1	20331935
res@@	O	-1	20331935
,	O	-1	20331935
serum	O	-1	20331935
prolactin	O	-1	20331935
was	O	-1	20331935
neg@@	O	-1	20331935
atively	O	-1	20331935
associated	O	-1	20331935
with	O	-1	20331935
tra@@	O	-1	20331935
b@@	O	-1	20331935
ec@@	O	-1	20331935
ular	O	-1	20331935
vol@@	O	-1	20331935
u@@	O	-1	20331935
me@@	O	-1	20331935
tri@@	O	-1	20331935
c	O	-1	20331935
B@@	O	-1	20331935
M@@	O	-1	20331935
D	O	-1	20331935
at	O	-1	20331935
the	O	-1	20331935
ult@@	O	-1	20331935
radi@@	O	-1	20331935
st@@	O	-1	20331935
al	O	-1	20331935
radi@@	O	-1	20331935
us	O	-1	20331935
(P	O	-1	20331935
<	O	-1	20331935
.@@	O	-1	20331935
0@@	O	-1	20331935
3@@	O	-1	20331935
).	O	-1	20331935
C@@	O	-1	20331935
ont@@	O	-1	20331935
ro@@	O	-1	20331935
ll@@	O	-1	20331935
ing	O	-1	20331935
for	O	-1	20331935
re@@	O	-1	20331935
lev@@	O	-1	20331935
ant	O	-1	20331935
co@@	O	-1	20331935
vari@@	O	-1	20331935
at@@	O	-1	20331935
es,	O	-1	20331935
we	O	-1	20331935
also	O	-1	20331935
found	O	-1	20331935
treatment	O	-1	20331935
with	O	-1	20331935
selective	O	-1	20331935
seroton@@	B-Chemical	D012701	20331935
in	I-Chemical	-1	20331935
re@@	O	-1	20331935
u@@	O	-1	20331935
pt@@	O	-1	20331935
ake	O	-1	20331935
inhibitors	O	-1	20331935
(S@@	O	-1	20331935
SR@@	O	-1	20331935
I@@	O	-1	20331935
s)	O	-1	20331935
to	O	-1	20331935
be	O	-1	20331935
associated	O	-1	20331935
with	O	-1	20331935
lower	O	-1	20331935
tra@@	O	-1	20331935
b@@	O	-1	20331935
ec@@	O	-1	20331935
ular	O	-1	20331935
B@@	O	-1	20331935
M@@	O	-1	20331935
D	O	-1	20331935
at	O	-1	20331935
the	O	-1	20331935
radi@@	O	-1	20331935
us	O	-1	20331935
(P	O	-1	20331935
=	O	-1	20331935
.@@	O	-1	20331935
0@@	O	-1	20331935
3@@	O	-1	20331935
)	O	-1	20331935
and	O	-1	20331935
B@@	O	-1	20331935
M@@	O	-1	20331935
D	O	-1	20331935
z	O	-1	20331935
scor@@	O	-1	20331935
e	O	-1	20331935
at	O	-1	20331935
the	O	-1	20331935
l@@	O	-1	20331935
umb@@	O	-1	20331935
ar	O	-1	20331935
sp@@	O	-1	20331935
ine	O	-1	20331935
(P	O	-1	20331935
<	O	-1	20331935
.@@	O	-1	20331935
0@@	O	-1	20331935
5@@	O	-1	20331935
).	O	-1	20331935
These	O	-1	20331935
findings	O	-1	20331935
b@@	O	-1	20331935
ec@@	O	-1	20331935
am@@	O	-1	20331935
e	O	-1	20331935
more	O	-1	20331935
mark@@	O	-1	20331935
ed	O	-1	20331935
when	O	-1	20331935
the	O	-1	20331935
analysis	O	-1	20331935
was	O	-1	20331935
re@@	O	-1	20331935
stric@@	O	-1	20331935
ted	O	-1	20331935
to	O	-1	20331935
non-@@	O	-1	20331935
H@@	O	-1	20331935
is@@	O	-1	20331935
p@@	O	-1	20331935
anic	O	-1	20331935
wh@@	O	-1	20331935
ite	O	-1	20331935
patients.	O	-1	20331935
Of	O	-1	20331935
13	O	-1	20331935
doc@@	O	-1	20331935
um@@	O	-1	20331935
ent@@	O	-1	20331935
ed	O	-1	20331935
frac@@	B-Disease	D050723	20331935
t@@	I-Disease	-1	20331935
ures	I-Disease	-1	20331935
,	O	-1	20331935
3	O	-1	20331935
occurred	O	-1	20331935
after	O	-1	20331935
ris@@	B-Chemical	D018967	20331935
perid@@	I-Chemical	-1	20331935
one	I-Chemical	-1	20331935
and	O	-1	20331935
S@@	O	-1	20331935
SR@@	O	-1	20331935
I@@	O	-1	20331935
s	O	-1	20331935
were	O	-1	20331935
star@@	O	-1	20331935
te@@	O	-1	20331935
d,	O	-1	20331935
and	O	-1	20331935
n@@	O	-1	20331935
one	O	-1	20331935
occurred	O	-1	20331935
in	O	-1	20331935
patients	O	-1	20331935
with	O	-1	20331935
hyper@@	B-Disease	D006966	20331935
prol@@	I-Disease	-1	20331935
act@@	I-Disease	-1	20331935
ine@@	I-Disease	-1	20331935
mia	I-Disease	-1	20331935
.	O	-1	20331935
CONCLUSIONS:	O	-1	20331935
This	O	-1	20331935
is	O	-1	20331935
the	O	-1	20331935
first	O	-1	20331935
study	O	-1	20331935
to	O	-1	20331935
lin@@	O	-1	20331935
k	O	-1	20331935
ris@@	B-Chemical	D018967	20331935
perid@@	I-Chemical	-1	20331935
one	I-Chemical	-1	20331935
-induced	O	-1	20331935
hyper@@	B-Disease	D006966	20331935
prol@@	I-Disease	-1	20331935
act@@	I-Disease	-1	20331935
ine@@	I-Disease	-1	20331935
mia	I-Disease	-1	20331935
and	O	-1	20331935
S@@	O	-1	20331935
SR@@	O	-1	20331935
I	O	-1	20331935
treatment	O	-1	20331935
to	O	-1	20331935
lower	O	-1	20331935
B@@	O	-1	20331935
M@@	O	-1	20331935
D	O	-1	20331935
in	O	-1	20331935
children	O	-1	20331935
and	O	-1	20331935
ad@@	O	-1	20331935
ol@@	O	-1	20331935
es@@	O	-1	20331935
c@@	O	-1	20331935
ent@@	O	-1	20331935
s.	O	-1	20331935
F@@	O	-1	20331935
ut@@	O	-1	20331935
ure	O	-1	20331935
re@@	O	-1	20331935
se@@	O	-1	20331935
arc@@	O	-1	20331935
h	O	-1	20331935
should	O	-1	20331935
evalu@@	O	-1	20331935
ate	O	-1	20331935
the	O	-1	20331935
long@@	O	-1	20331935
it@@	O	-1	20331935
ud@@	O	-1	20331935
inal	O	-1	20331935
course	O	-1	20331935
of	O	-1	20331935
this	O	-1	20331935
adverse	O	-1	20331935
ev@@	O	-1	20331935
ent	O	-1	20331935
to	O	-1	20331935
determine	O	-1	20331935
its	O	-1	20331935
tempor@@	O	-1	20331935
al	O	-1	20331935
st@@	O	-1	20331935
ability	O	-1	20331935
and	O	-1	20331935
whether	O	-1	20331935
a	O	-1	20331935
higher	O	-1	20331935
frac@@	O	-1	20331935
t@@	O	-1	20331935
ure	O	-1	20331935
rate	O	-1	20331935
en@@	O	-1	20331935
su@@	O	-1	20331935
es.	O	-1	20331935

S@@	B-Disease	D012640	19707748
e@@	I-Disease	-1	19707748
iz@@	I-Disease	-1	19707748
ures	I-Disease	-1	19707748
associated	O	-1	19707748
with	O	-1	19707748
lev@@	B-Chemical	D064704	19707748
of@@	I-Chemical	-1	19707748
lo@@	I-Chemical	-1	19707748
x@@	I-Chemical	-1	19707748
ac@@	I-Chemical	-1	19707748
in	I-Chemical	-1	19707748
:	O	-1	19707748
case	O	-1	19707748
present@@	O	-1	19707748
ation	O	-1	19707748
and	O	-1	19707748
literat@@	O	-1	19707748
ure	O	-1	19707748
revie@@	O	-1	19707748
w@@	O	-1	19707748
.	O	-1	19707748
P@@	O	-1	19707748
U@@	O	-1	19707748
R@@	O	-1	19707748
P@@	O	-1	19707748
O@@	O	-1	19707748
S@@	O	-1	19707748
E:	O	-1	19707748
We	O	-1	19707748
present	O	-1	19707748
a	O	-1	19707748
case	O	-1	19707748
of	O	-1	19707748
a	O	-1	19707748
patient	O	-1	19707748
who	O	-1	19707748
developed	O	-1	19707748
seizures	B-Disease	D012640	19707748
sh@@	O	-1	19707748
ort@@	O	-1	19707748
ly	O	-1	19707748
after	O	-1	19707748
initi@@	O	-1	19707748
ating	O	-1	19707748
treatment	O	-1	19707748
with	O	-1	19707748
lev@@	B-Chemical	D064704	19707748
of@@	I-Chemical	-1	19707748
lo@@	I-Chemical	-1	19707748
x@@	I-Chemical	-1	19707748
ac@@	I-Chemical	-1	19707748
in	I-Chemical	-1	19707748
and	O	-1	19707748
to	O	-1	19707748
discus@@	O	-1	19707748
s	O	-1	19707748
the	O	-1	19707748
potential	O	-1	19707748
drug@@	O	-1	19707748
-@@	O	-1	19707748
drug	O	-1	19707748
inter@@	O	-1	19707748
ac@@	O	-1	19707748
tions	O	-1	19707748
related	O	-1	19707748
to	O	-1	19707748
the	O	-1	19707748
inhibition	O	-1	19707748
of	O	-1	19707748
cyto@@	O	-1	19707748
ch@@	O	-1	19707748
rom@@	O	-1	19707748
e	O	-1	19707748
P@@	O	-1	19707748
4@@	O	-1	19707748
50	O	-1	19707748
(C@@	O	-1	19707748
Y@@	O	-1	19707748
P)	O	-1	19707748
1@@	O	-1	19707748
A@@	O	-1	19707748
2	O	-1	19707748
in	O	-1	19707748
this	O	-1	19707748
cas@@	O	-1	19707748
e,	O	-1	19707748
as	O	-1	19707748
well	O	-1	19707748
as	O	-1	19707748
in	O	-1	19707748
other	O	-1	19707748
cas@@	O	-1	19707748
es,	O	-1	19707748
of	O	-1	19707748
lev@@	B-Chemical	D064704	19707748
of@@	I-Chemical	-1	19707748
lo@@	I-Chemical	-1	19707748
x@@	I-Chemical	-1	19707748
ac@@	I-Chemical	-1	19707748
in	I-Chemical	-1	19707748
-induced	O	-1	19707748
seizures	B-Disease	D012640	19707748
.	O	-1	19707748
METHODS:	O	-1	19707748
S@@	O	-1	19707748
e@@	O	-1	19707748
ver@@	O	-1	19707748
al	O	-1	19707748
bio@@	O	-1	19707748
med@@	O	-1	19707748
ical	O	-1	19707748
dat@@	O	-1	19707748
ab@@	O	-1	19707748
as@@	O	-1	19707748
es	O	-1	19707748
were	O	-1	19707748
se@@	O	-1	19707748
ar@@	O	-1	19707748
ch@@	O	-1	19707748
ed	O	-1	19707748
including	O	-1	19707748
M@@	O	-1	19707748
E@@	O	-1	19707748
D@@	O	-1	19707748
L@@	O	-1	19707748
IN@@	O	-1	19707748
E@@	O	-1	19707748
,	O	-1	19707748
C@@	O	-1	19707748
och@@	O	-1	19707748
ran@@	O	-1	19707748
e	O	-1	19707748
and	O	-1	19707748
O@@	O	-1	19707748
vid@@	O	-1	19707748
.	O	-1	19707748
The	O	-1	19707748
ma@@	O	-1	19707748
in	O	-1	19707748
se@@	O	-1	19707748
arc@@	O	-1	19707748
h	O	-1	19707748
ter@@	O	-1	19707748
ms	O	-1	19707748
u@@	O	-1	19707748
ti@@	O	-1	19707748
li@@	O	-1	19707748
zed	O	-1	19707748
were	O	-1	19707748
case	O	-1	19707748
report	O	-1	19707748
and	O	-1	19707748
lev@@	B-Chemical	D064704	19707748
of@@	I-Chemical	-1	19707748
lo@@	I-Chemical	-1	19707748
x@@	I-Chemical	-1	19707748
ac@@	I-Chemical	-1	19707748
in	I-Chemical	-1	19707748
.	O	-1	19707748
The	O	-1	19707748
se@@	O	-1	19707748
arc@@	O	-1	19707748
h	O	-1	19707748
was	O	-1	19707748
lim@@	O	-1	19707748
ited	O	-1	19707748
to	O	-1	19707748
studies	O	-1	19707748
pu@@	O	-1	19707748
bl@@	O	-1	19707748
ished	O	-1	19707748
in	O	-1	19707748
E@@	O	-1	19707748
n@@	O	-1	19707748
gl@@	O	-1	19707748
ish@@	O	-1	19707748
.	O	-1	19707748
RESULTS:	O	-1	19707748
Si@@	O	-1	19707748
x	O	-1	19707748
cases	O	-1	19707748
of	O	-1	19707748
lev@@	B-Chemical	D064704	19707748
of@@	I-Chemical	-1	19707748
lo@@	I-Chemical	-1	19707748
x@@	I-Chemical	-1	19707748
ac@@	I-Chemical	-1	19707748
in	I-Chemical	-1	19707748
-induced	O	-1	19707748
seizures	B-Disease	D012640	19707748
have	O	-1	19707748
been	O	-1	19707748
reported	O	-1	19707748
in	O	-1	19707748
the	O	-1	19707748
literat@@	O	-1	19707748
ure.	O	-1	19707748
D@@	O	-1	19707748
ru@@	O	-1	19707748
g@@	O	-1	19707748
-@@	O	-1	19707748
drug	O	-1	19707748
inter@@	O	-1	19707748
ac@@	O	-1	19707748
tions	O	-1	19707748
related	O	-1	19707748
to	O	-1	19707748
the	O	-1	19707748
inhibition	O	-1	19707748
of	O	-1	19707748
C@@	O	-1	19707748
Y@@	O	-1	19707748
P@@	O	-1	19707748
1@@	O	-1	19707748
A@@	O	-1	19707748
2	O	-1	19707748
by	O	-1	19707748
lev@@	B-Chemical	D064704	19707748
of@@	I-Chemical	-1	19707748
lo@@	I-Chemical	-1	19707748
x@@	I-Chemical	-1	19707748
ac@@	I-Chemical	-1	19707748
in	I-Chemical	-1	19707748
are	O	-1	19707748
likely	O	-1	19707748
involved	O	-1	19707748
in	O	-1	19707748
the	O	-1	19707748
clinical	O	-1	19707748
outcom@@	O	-1	19707748
e	O	-1	19707748
of	O	-1	19707748
these	O	-1	19707748
cas@@	O	-1	19707748
es.	O	-1	19707748
CONCLUSIONS:	O	-1	19707748
Clin@@	O	-1	19707748
ici@@	O	-1	19707748
ans	O	-1	19707748
are	O	-1	19707748
ex@@	O	-1	19707748
h@@	O	-1	19707748
or@@	O	-1	19707748
ted	O	-1	19707748
to	O	-1	19707748
pa@@	O	-1	19707748
y	O	-1	19707748
clo@@	O	-1	19707748
se	O	-1	19707748
atten@@	O	-1	19707748
tion	O	-1	19707748
when	O	-1	19707748
initi@@	O	-1	19707748
ating	O	-1	19707748
lev@@	B-Chemical	D064704	19707748
of@@	I-Chemical	-1	19707748
lo@@	I-Chemical	-1	19707748
x@@	I-Chemical	-1	19707748
ac@@	I-Chemical	-1	19707748
in	I-Chemical	-1	19707748
therapy	O	-1	19707748
in	O	-1	19707748
patients	O	-1	19707748
taking	O	-1	19707748
medic@@	O	-1	19707748
ations	O	-1	19707748
with	O	-1	19707748
epile@@	O	-1	19707748
pto@@	O	-1	19707748
genic	O	-1	19707748
pro@@	O	-1	19707748
per@@	O	-1	19707748
ties	O	-1	19707748
that	O	-1	19707748
are	O	-1	19707748
C@@	O	-1	19707748
Y@@	O	-1	19707748
P@@	O	-1	19707748
1@@	O	-1	19707748
A@@	O	-1	19707748
2	O	-1	19707748
sub@@	O	-1	19707748
strat@@	O	-1	19707748
es.	O	-1	19707748

M@@	O	-1	19692487
ic@@	O	-1	19692487
e	O	-1	19692487
l@@	O	-1	19692487
ac@@	O	-1	19692487
king	O	-1	19692487
m@@	O	-1	19692487
PG@@	O	-1	19692487
ES@@	O	-1	19692487
-1	O	-1	19692487
are	O	-1	19692487
resist@@	O	-1	19692487
ant	O	-1	19692487
to	O	-1	19692487
lithium	B-Chemical	D008094	19692487
-induced	O	-1	19692487
poly@@	B-Disease	D011141	19692487
uria	I-Disease	-1	19692487
.	O	-1	19692487
C@@	O	-1	19692487
yc@@	O	-1	19692487
lo@@	O	-1	19692487
oxy@@	O	-1	19692487
gen@@	O	-1	19692487
as@@	O	-1	19692487
e-@@	O	-1	19692487
2	O	-1	19692487
activity	O	-1	19692487
is	O	-1	19692487
requ@@	O	-1	19692487
ired	O	-1	19692487
for	O	-1	19692487
the	O	-1	19692487
development	O	-1	19692487
of	O	-1	19692487
lithium	B-Chemical	D008094	19692487
-induced	O	-1	19692487
poly@@	B-Disease	D011141	19692487
uria	I-Disease	-1	19692487
.	O	-1	19692487
However,	O	-1	19692487
the	O	-1	19692487
invol@@	O	-1	19692487
vement	O	-1	19692487
of	O	-1	19692487
a	O	-1	19692487
spec@@	O	-1	19692487
ific@@	O	-1	19692487
,	O	-1	19692487
ter@@	O	-1	19692487
min@@	O	-1	19692487
al	O	-1	19692487
pro@@	B-Chemical	D011453	19692487
st@@	I-Chemical	-1	19692487
ag@@	I-Chemical	-1	19692487
l@@	I-Chemical	-1	19692487
and@@	I-Chemical	-1	19692487
in	I-Chemical	-1	19692487
(	O	-1	19692487
P@@	B-Chemical	D011453	19692487
G	I-Chemical	-1	19692487
)	O	-1	19692487
is@@	O	-1	19692487
om@@	O	-1	19692487
er@@	O	-1	19692487
ase	O	-1	19692487
has	O	-1	19692487
not	O	-1	19692487
been	O	-1	19692487
evalu@@	O	-1	19692487
ated.	O	-1	19692487
The	O	-1	19692487
present	O	-1	19692487
study	O	-1	19692487
was	O	-1	19692487
under@@	O	-1	19692487
tak@@	O	-1	19692487
en	O	-1	19692487
to	O	-1	19692487
ass@@	O	-1	19692487
ess	O	-1	19692487
lithium	B-Chemical	D008094	19692487
-induced	O	-1	19692487
poly@@	B-Disease	D011141	19692487
uria	I-Disease	-1	19692487
in	O	-1	19692487
mice	O	-1	19692487
defici@@	O	-1	19692487
ent	O	-1	19692487
in	O	-1	19692487
micro@@	O	-1	19692487
s@@	O	-1	19692487
om@@	O	-1	19692487
al	O	-1	19692487
pro@@	B-Chemical	D011458	19692487
st@@	I-Chemical	-1	19692487
ag@@	I-Chemical	-1	19692487
l@@	I-Chemical	-1	19692487
and@@	I-Chemical	-1	19692487
in	I-Chemical	-1	19692487
E	I-Chemical	-1	19692487
syn@@	O	-1	19692487
th@@	O	-1	19692487
as@@	O	-1	19692487
e-@@	O	-1	19692487
1	O	-1	19692487
(@@	O	-1	19692487
m@@	O	-1	19692487
PG@@	O	-1	19692487
ES@@	O	-1	19692487
-1@@	O	-1	19692487
).	O	-1	19692487
A	O	-1	19692487
2-@@	O	-1	19692487
w@@	O	-1	19692487
k	O	-1	19692487
administration	O	-1	19692487
of	O	-1	19692487
L@@	B-Chemical	D018021	19692487
i@@	I-Chemical	-1	19692487
C@@	I-Chemical	-1	19692487
l	I-Chemical	-1	19692487
(@@	O	-1	19692487
4	O	-1	19692487
m@@	O	-1	19692487
mol@@	O	-1	19692487
.@@	O	-1	19692487
kg@@	O	-1	19692487
(@@	O	-1	19692487
-1@@	O	-1	19692487
)@@	O	-1	19692487
.@@	O	-1	19692487
day@@	O	-1	19692487
(@@	O	-1	19692487
-1@@	O	-1	19692487
)	O	-1	19692487
ip@@	O	-1	19692487
)	O	-1	19692487
in	O	-1	19692487
m@@	O	-1	19692487
PG@@	O	-1	19692487
ES@@	O	-1	19692487
-1	O	-1	19692487
+/@@	O	-1	19692487
+	O	-1	19692487
mice	O	-1	19692487
l@@	O	-1	19692487
ed	O	-1	19692487
to	O	-1	19692487
a	O	-1	19692487
mark@@	O	-1	19692487
ed	O	-1	19692487
poly@@	B-Disease	D011141	19692487
uria	I-Disease	-1	19692487
with	O	-1	19692487
hy@@	O	-1	19692487
pos@@	O	-1	19692487
mo@@	O	-1	19692487
tic	O	-1	19692487
ur@@	O	-1	19692487
ine.	O	-1	19692487
This	O	-1	19692487
was	O	-1	19692487
associated	O	-1	19692487
with	O	-1	19692487
elevated	O	-1	19692487
renal	O	-1	19692487
m@@	O	-1	19692487
PG@@	O	-1	19692487
ES@@	O	-1	19692487
-1	O	-1	19692487
protein	O	-1	19692487
expression	O	-1	19692487
and	O	-1	19692487
increased	O	-1	19692487
urine	O	-1	19692487
PG@@	B-Chemical	D015232	19692487
E@@	I-Chemical	-1	19692487
(2@@	I-Chemical	-1	19692487
)	I-Chemical	-1	19692487
ex@@	O	-1	19692487
cre@@	O	-1	19692487
tion.	O	-1	19692487
In	O	-1	19692487
contrast@@	O	-1	19692487
,	O	-1	19692487
m@@	O	-1	19692487
PG@@	O	-1	19692487
ES@@	O	-1	19692487
-1	O	-1	19692487
-@@	O	-1	19692487
/@@	O	-1	19692487
-	O	-1	19692487
mice	O	-1	19692487
were	O	-1	19692487
larg@@	O	-1	19692487
ely	O	-1	19692487
resist@@	O	-1	19692487
ant	O	-1	19692487
to	O	-1	19692487
lithium	B-Chemical	D008094	19692487
-induced	O	-1	19692487
poly@@	B-Disease	D011141	19692487
uria	I-Disease	-1	19692487
and	O	-1	19692487
a	O	-1	19692487
urine	O	-1	19692487
con@@	O	-1	19692487
c@@	O	-1	19692487
ent@@	O	-1	19692487
rat@@	O	-1	19692487
ing	O	-1	19692487
def@@	O	-1	19692487
ect@@	O	-1	19692487
,	O	-1	19692487
ac@@	O	-1	19692487
comp@@	O	-1	19692487
an@@	O	-1	19692487
ied	O	-1	19692487
by	O	-1	19692487
ne@@	O	-1	19692487
arly	O	-1	19692487
complete	O	-1	19692487
block@@	O	-1	19692487
ade	O	-1	19692487
of	O	-1	19692487
high	O	-1	19692487
urine	O	-1	19692487
PG@@	B-Chemical	D015232	19692487
E@@	I-Chemical	-1	19692487
(2@@	I-Chemical	-1	19692487
)	I-Chemical	-1	19692487
and	O	-1	19692487
c@@	O	-1	19692487
AM@@	O	-1	19692487
P	O	-1	19692487
out@@	O	-1	19692487
p@@	O	-1	19692487
ut@@	O	-1	19692487
.	O	-1	19692487
Im@@	O	-1	19692487
mun@@	O	-1	19692487
ob@@	O	-1	19692487
lo@@	O	-1	19692487
t@@	O	-1	19692487
t@@	O	-1	19692487
ing,	O	-1	19692487
immuno@@	O	-1	19692487
histo@@	O	-1	19692487
chem@@	O	-1	19692487
ist@@	O	-1	19692487
r@@	O	-1	19692487
y,	O	-1	19692487
and	O	-1	19692487
qu@@	O	-1	19692487
anti@@	O	-1	19692487
t@@	O	-1	19692487
ative	O	-1	19692487
(@@	O	-1	19692487
q@@	O	-1	19692487
)	O	-1	19692487
R@@	O	-1	19692487
T@@	O	-1	19692487
-@@	O	-1	19692487
P@@	O	-1	19692487
C@@	O	-1	19692487
R	O	-1	19692487
consist@@	O	-1	19692487
ently	O	-1	19692487
det@@	O	-1	19692487
ected	O	-1	19692487
a	O	-1	19692487
significant	O	-1	19692487
decrease	O	-1	19692487
in	O	-1	19692487
a@@	O	-1	19692487
qu@@	O	-1	19692487
ap@@	O	-1	19692487
or@@	O	-1	19692487
in-@@	O	-1	19692487
2	O	-1	19692487
(A@@	O	-1	19692487
Q@@	O	-1	19692487
P@@	O	-1	19692487
2)	O	-1	19692487
protein	O	-1	19692487
expression	O	-1	19692487
in	O	-1	19692487
both	O	-1	19692487
the	O	-1	19692487
renal	O	-1	19692487
cor@@	O	-1	19692487
te@@	O	-1	19692487
x	O	-1	19692487
and	O	-1	19692487
med@@	O	-1	19692487
ul@@	O	-1	19692487
l@@	O	-1	19692487
a	O	-1	19692487
of	O	-1	19692487
lithium	B-Chemical	D008094	19692487
-treated	O	-1	19692487
+/@@	O	-1	19692487
+	O	-1	19692487
mice.	O	-1	19692487
This	O	-1	19692487
decrease	O	-1	19692487
was	O	-1	19692487
significantly	O	-1	19692487
attenu@@	O	-1	19692487
ated	O	-1	19692487
in	O	-1	19692487
the	O	-1	19692487
-@@	O	-1	19692487
/@@	O	-1	19692487
-	O	-1	19692487
mice.	O	-1	19692487
q@@	O	-1	19692487
R@@	O	-1	19692487
T@@	O	-1	19692487
-@@	O	-1	19692487
P@@	O	-1	19692487
C@@	O	-1	19692487
R	O	-1	19692487
det@@	O	-1	19692487
ected	O	-1	19692487
similar	O	-1	19692487
pat@@	O	-1	19692487
tern@@	O	-1	19692487
s	O	-1	19692487
of	O	-1	19692487
changes	O	-1	19692487
in	O	-1	19692487
A@@	O	-1	19692487
Q@@	O	-1	19692487
P@@	O	-1	19692487
2	O	-1	19692487
mRNA	O	-1	19692487
in	O	-1	19692487
the	O	-1	19692487
med@@	O	-1	19692487
ul@@	O	-1	19692487
l@@	O	-1	19692487
a	O	-1	19692487
but	O	-1	19692487
not	O	-1	19692487
in	O	-1	19692487
the	O	-1	19692487
cor@@	O	-1	19692487
t@@	O	-1	19692487
ex@@	O	-1	19692487
.	O	-1	19692487
S@@	O	-1	19692487
im@@	O	-1	19692487
il@@	O	-1	19692487
ar@@	O	-1	19692487
ly,	O	-1	19692487
the	O	-1	19692487
total	O	-1	19692487
protein	O	-1	19692487
ab@@	O	-1	19692487
und@@	O	-1	19692487
ance	O	-1	19692487
of	O	-1	19692487
the	O	-1	19692487
N@@	B-Chemical	D012964	19692487
a	I-Chemical	-1	19692487
-	O	-1	19692487
K	B-Chemical	D011188	19692487
-@@	O	-1	19692487
2	O	-1	19692487
C@@	B-Chemical	D002713	19692487
l	I-Chemical	-1	19692487
co@@	O	-1	19692487
trans@@	O	-1	19692487
por@@	O	-1	19692487
ter	O	-1	19692487
(N@@	O	-1	19692487
K@@	O	-1	19692487
C@@	O	-1	19692487
C@@	O	-1	19692487
2)	O	-1	19692487
in	O	-1	19692487
the	O	-1	19692487
med@@	O	-1	19692487
ul@@	O	-1	19692487
l@@	O	-1	19692487
a	O	-1	19692487
but	O	-1	19692487
not	O	-1	19692487
in	O	-1	19692487
the	O	-1	19692487
cor@@	O	-1	19692487
te@@	O	-1	19692487
x	O	-1	19692487
of	O	-1	19692487
the	O	-1	19692487
+/@@	O	-1	19692487
+	O	-1	19692487
mice	O	-1	19692487
was	O	-1	19692487
significantly	O	-1	19692487
reduced	O	-1	19692487
by	O	-1	19692487
lithium	B-Chemical	D008094	19692487
treatment.	O	-1	19692487
In	O	-1	19692487
contrast@@	O	-1	19692487
,	O	-1	19692487
the	O	-1	19692487
do@@	O	-1	19692487
w@@	O	-1	19692487
reg@@	O	-1	19692487
ulation	O	-1	19692487
of	O	-1	19692487
renal	O	-1	19692487
med@@	O	-1	19692487
ul@@	O	-1	19692487
l@@	O	-1	19692487
ary	O	-1	19692487
N@@	O	-1	19692487
K@@	O	-1	19692487
C@@	O	-1	19692487
C@@	O	-1	19692487
2	O	-1	19692487
expression	O	-1	19692487
was	O	-1	19692487
significantly	O	-1	19692487
attenu@@	O	-1	19692487
ated	O	-1	19692487
in	O	-1	19692487
the	O	-1	19692487
-@@	O	-1	19692487
/@@	O	-1	19692487
-	O	-1	19692487
mice.	O	-1	19692487
We	O	-1	19692487
concl@@	O	-1	19692487
ude	O	-1	19692487
that	O	-1	19692487
m@@	O	-1	19692487
PG@@	O	-1	19692487
ES@@	O	-1	19692487
-1@@	O	-1	19692487
-@@	O	-1	19692487
der@@	O	-1	19692487
i@@	O	-1	19692487
ved	O	-1	19692487
PG@@	B-Chemical	D015232	19692487
E@@	I-Chemical	-1	19692487
(2@@	I-Chemical	-1	19692487
)	I-Chemical	-1	19692487
medi@@	O	-1	19692487
ates	O	-1	19692487
lithium	B-Chemical	D008094	19692487
-induced	O	-1	19692487
poly@@	B-Disease	D011141	19692487
uria	I-Disease	-1	19692487
likely	O	-1	19692487
vi@@	O	-1	19692487
a	O	-1	19692487
inhibition	O	-1	19692487
of	O	-1	19692487
A@@	O	-1	19692487
Q@@	O	-1	19692487
P@@	O	-1	19692487
2	O	-1	19692487
and	O	-1	19692487
N@@	O	-1	19692487
K@@	O	-1	19692487
C@@	O	-1	19692487
C@@	O	-1	19692487
2	O	-1	19692487
ex@@	O	-1	19692487
pres@@	O	-1	19692487
sion.	O	-1	19692487

I@@	O	-1	19289093
d@@	O	-1	19289093
enti@@	O	-1	19289093
fic@@	O	-1	19289093
ation	O	-1	19289093
of	O	-1	19289093
a	O	-1	19289093
sim@@	O	-1	19289093
ple	O	-1	19289093
and	O	-1	19289093
sensitive	O	-1	19289093
micro@@	O	-1	19289093
pl@@	O	-1	19289093
ate	O	-1	19289093
meth@@	O	-1	19289093
od	O	-1	19289093
for	O	-1	19289093
the	O	-1	19289093
det@@	O	-1	19289093
ection	O	-1	19289093
of	O	-1	19289093
over@@	O	-1	19289093
sulf@@	O	-1	19289093
ated	O	-1	19289093
ch@@	B-Chemical	D002809	19289093
on@@	I-Chemical	-1	19289093
dro@@	I-Chemical	-1	19289093
iti@@	I-Chemical	-1	19289093
n	I-Chemical	-1	19289093
sulf@@	I-Chemical	-1	19289093
ate	I-Chemical	-1	19289093
in	O	-1	19289093
hepar@@	B-Chemical	D006493	19289093
in	I-Chemical	-1	19289093
produc@@	O	-1	19289093
t@@	O	-1	19289093
s.	O	-1	19289093
He@@	B-Chemical	D006493	19289093
par@@	I-Chemical	-1	19289093
in	I-Chemical	-1	19289093
is	O	-1	19289093
a	O	-1	19289093
common@@	O	-1	19289093
ly	O	-1	19289093
im@@	O	-1	19289093
ple@@	O	-1	19289093
ment@@	O	-1	19289093
ed	O	-1	19289093
anti@@	O	-1	19289093
co@@	O	-1	19289093
ag@@	O	-1	19289093
ul@@	O	-1	19289093
ant	O	-1	19289093
used	O	-1	19289093
to	O	-1	19289093
tre@@	O	-1	19289093
at	O	-1	19289093
cri@@	O	-1	19289093
tically	O	-1	19289093
il@@	O	-1	19289093
l	O	-1	19289093
patients.	O	-1	19289093
Rec@@	O	-1	19289093
ent@@	O	-1	19289093
ly,	O	-1	19289093
a	O	-1	19289093
number	O	-1	19289093
of	O	-1	19289093
com@@	O	-1	19289093
mer@@	O	-1	19289093
ci@@	O	-1	19289093
al	O	-1	19289093
lo@@	O	-1	19289093
ts	O	-1	19289093
of	O	-1	19289093
hepar@@	B-Chemical	D006493	19289093
in	I-Chemical	-1	19289093
produc@@	O	-1	19289093
ts	O	-1	19289093
were	O	-1	19289093
found	O	-1	19289093
to	O	-1	19289093
be	O	-1	19289093
cont@@	O	-1	19289093
amin@@	O	-1	19289093
ated	O	-1	19289093
with	O	-1	19289093
an	O	-1	19289093
over@@	O	-1	19289093
sulf@@	O	-1	19289093
ated	O	-1	19289093
ch@@	B-Chemical	D002809	19289093
on@@	I-Chemical	-1	19289093
dro@@	I-Chemical	-1	19289093
iti@@	I-Chemical	-1	19289093
n	I-Chemical	-1	19289093
sulf@@	I-Chemical	-1	19289093
ate	I-Chemical	-1	19289093
(@@	O	-1	19289093
O@@	O	-1	19289093
S@@	O	-1	19289093
C@@	O	-1	19289093
S)	O	-1	19289093
der@@	O	-1	19289093
i@@	O	-1	19289093
v@@	O	-1	19289093
ative	O	-1	19289093
that	O	-1	19289093
could	O	-1	19289093
el@@	O	-1	19289093
ic@@	O	-1	19289093
it	O	-1	19289093
a	O	-1	19289093
hypoten@@	B-Disease	D007022	19289093
sive	I-Disease	-1	19289093
response	O	-1	19289093
in	O	-1	19289093
pi@@	O	-1	19289093
g@@	O	-1	19289093
s	O	-1	19289093
following	O	-1	19289093
a	O	-1	19289093
single	O	-1	19289093
high-dose	O	-1	19289093
infu@@	O	-1	19289093
sion.	O	-1	19289093
U@@	O	-1	19289093
s@@	O	-1	19289093
ing	O	-1	19289093
both	O	-1	19289093
cont@@	O	-1	19289093
amin@@	O	-1	19289093
ated	O	-1	19289093
hepar@@	B-Chemical	D006493	19289093
in	I-Chemical	-1	19289093
produc@@	O	-1	19289093
ts	O	-1	19289093
and	O	-1	19289093
the	O	-1	19289093
syn@@	O	-1	19289093
the@@	O	-1	19289093
tically	O	-1	19289093
produced	O	-1	19289093
der@@	O	-1	19289093
i@@	O	-1	19289093
v@@	O	-1	19289093
ati@@	O	-1	19289093
ve,	O	-1	19289093
we	O	-1	19289093
showed	O	-1	19289093
that	O	-1	19289093
the	O	-1	19289093
O@@	O	-1	19289093
S@@	O	-1	19289093
C@@	O	-1	19289093
S	O	-1	19289093
produc@@	O	-1	19289093
es	O	-1	19289093
dose-@@	O	-1	19289093
dependent	O	-1	19289093
hypotension	B-Disease	D007022	19289093
in	O	-1	19289093
pi@@	O	-1	19289093
g@@	O	-1	19289093
s.	O	-1	19289093
The	O	-1	19289093
no	O	-1	19289093
observed	O	-1	19289093
effect	O	-1	19289093
level	O	-1	19289093
(N@@	O	-1	19289093
O@@	O	-1	19289093
E@@	O	-1	19289093
L@@	O	-1	19289093
)	O	-1	19289093
for	O	-1	19289093
this	O	-1	19289093
cont@@	O	-1	19289093
amin@@	O	-1	19289093
ant	O	-1	19289093
appear@@	O	-1	19289093
s	O	-1	19289093
to	O	-1	19289093
be	O	-1	19289093
appro@@	O	-1	19289093
xim@@	O	-1	19289093
ately	O	-1	19289093
1@@	O	-1	19289093
mg/kg@@	O	-1	19289093
,	O	-1	19289093
cor@@	O	-1	19289093
respon@@	O	-1	19289093
ding	O	-1	19289093
to	O	-1	19289093
a	O	-1	19289093
cont@@	O	-1	19289093
amin@@	O	-1	19289093
ation	O	-1	19289093
level	O	-1	19289093
of	O	-1	19289093
appro@@	O	-1	19289093
xim@@	O	-1	19289093
ately	O	-1	19289093
3@@	O	-1	19289093
%.	O	-1	19289093
We	O	-1	19289093
also	O	-1	19289093
demonstrated	O	-1	19289093
that	O	-1	19289093
O@@	O	-1	19289093
S@@	O	-1	19289093
C@@	O	-1	19289093
S	O	-1	19289093
can	O	-1	19289093
be	O	-1	19289093
identi@@	O	-1	19289093
fied	O	-1	19289093
in	O	-1	19289093
hepar@@	B-Chemical	D006493	19289093
in	I-Chemical	-1	19289093
produc@@	O	-1	19289093
ts	O	-1	19289093
using	O	-1	19289093
a	O	-1	19289093
sim@@	O	-1	19289093
ple@@	O	-1	19289093
,	O	-1	19289093
in@@	O	-1	19289093
ex@@	O	-1	19289093
pen@@	O	-1	19289093
si@@	O	-1	19289093
ve,	O	-1	19289093
com@@	O	-1	19289093
mer@@	O	-1	19289093
ci@@	O	-1	19289093
ally	O	-1	19289093
av@@	O	-1	19289093
ail@@	O	-1	19289093
able	O	-1	19289093
hepar@@	B-Chemical	D006493	19289093
in	I-Chemical	-1	19289093
enzyme	O	-1	19289093
immuno@@	O	-1	19289093
ass@@	O	-1	19289093
ay	O	-1	19289093
(@@	O	-1	19289093
E@@	O	-1	19289093
I@@	O	-1	19289093
A@@	O	-1	19289093
)	O	-1	19289093
k@@	O	-1	19289093
it	O	-1	19289093
that	O	-1	19289093
has	O	-1	19289093
a	O	-1	19289093
lim@@	O	-1	19289093
it	O	-1	19289093
of	O	-1	19289093
det@@	O	-1	19289093
ection	O	-1	19289093
of	O	-1	19289093
appro@@	O	-1	19289093
xim@@	O	-1	19289093
ately	O	-1	19289093
0.@@	O	-1	19289093
1@@	O	-1	19289093
%,	O	-1	19289093
well	O	-1	19289093
be@@	O	-1	19289093
low	O	-1	19289093
the	O	-1	19289093
NO@@	O	-1	19289093
E@@	O	-1	19289093
L@@	O	-1	19289093
.	O	-1	19289093
This	O	-1	19289093
k@@	O	-1	19289093
it	O	-1	19289093
may	O	-1	19289093
prov@@	O	-1	19289093
ide	O	-1	19289093
a	O	-1	19289093
use@@	O	-1	19289093
ful	O	-1	19289093
meth@@	O	-1	19289093
od	O	-1	19289093
to	O	-1	19289093
test	O	-1	19289093
hepar@@	B-Chemical	D006493	19289093
in	I-Chemical	-1	19289093
produc@@	O	-1	19289093
ts	O	-1	19289093
for	O	-1	19289093
cont@@	O	-1	19289093
amin@@	O	-1	19289093
ation	O	-1	19289093
with	O	-1	19289093
over@@	O	-1	19289093
sulf@@	O	-1	19289093
ated	O	-1	19289093
G@@	O	-1	19289093
A@@	O	-1	19289093
G	O	-1	19289093
der@@	O	-1	19289093
i@@	O	-1	19289093
v@@	O	-1	19289093
ati@@	O	-1	19289093
v@@	O	-1	19289093
es.	O	-1	19289093

D@@	B-Chemical	D004317	18627295
ox@@	I-Chemical	-1	18627295
orub@@	I-Chemical	-1	18627295
icin	I-Chemical	-1	18627295
cardi@@	B-Disease	D009202	18627295
om@@	I-Disease	-1	18627295
yo@@	I-Disease	-1	18627295
pathy	I-Disease	-1	18627295
-induced	O	-1	18627295
inflam@@	B-Disease	D007249	18627295
m@@	I-Disease	-1	18627295
ation	I-Disease	-1	18627295
and	O	-1	18627295
apo@@	O	-1	18627295
pto@@	O	-1	18627295
sis	O	-1	18627295
are	O	-1	18627295
attenu@@	O	-1	18627295
ated	O	-1	18627295
by	O	-1	18627295
gen@@	O	-1	18627295
e	O	-1	18627295
de@@	O	-1	18627295
le@@	O	-1	18627295
tion	O	-1	18627295
of	O	-1	18627295
the	O	-1	18627295
kin@@	O	-1	18627295
in	O	-1	18627295
B@@	O	-1	18627295
1	O	-1	18627295
receptor@@	O	-1	18627295
.	O	-1	18627295
Clin@@	O	-1	18627295
ical	O	-1	18627295
use	O	-1	18627295
of	O	-1	18627295
the	O	-1	18627295
an@@	B-Chemical	D018943	18627295
th@@	I-Chemical	-1	18627295
rac@@	I-Chemical	-1	18627295
y@@	I-Chemical	-1	18627295
cl@@	I-Chemical	-1	18627295
ine	I-Chemical	-1	18627295
dox@@	B-Chemical	D004317	18627295
orub@@	I-Chemical	-1	18627295
icin	I-Chemical	-1	18627295
(	O	-1	18627295
DO@@	B-Chemical	D004317	18627295
X	I-Chemical	-1	18627295
)	O	-1	18627295
is	O	-1	18627295
lim@@	O	-1	18627295
ited	O	-1	18627295
by	O	-1	18627295
its	O	-1	18627295
cardi@@	B-Disease	D066126	18627295
ot@@	I-Disease	-1	18627295
ox@@	I-Disease	-1	18627295
ic	I-Disease	-1	18627295
effect@@	O	-1	18627295
s,	O	-1	18627295
which	O	-1	18627295
are	O	-1	18627295
at@@	O	-1	18627295
tri@@	O	-1	18627295
but@@	O	-1	18627295
ed	O	-1	18627295
to	O	-1	18627295
the	O	-1	18627295
induction	O	-1	18627295
of	O	-1	18627295
apo@@	O	-1	18627295
pto@@	O	-1	18627295
sis.	O	-1	18627295
To	O	-1	18627295
el@@	O	-1	18627295
uc@@	O	-1	18627295
id@@	O	-1	18627295
ate	O	-1	18627295
the	O	-1	18627295
possible	O	-1	18627295
role	O	-1	18627295
of	O	-1	18627295
the	O	-1	18627295
kin@@	O	-1	18627295
in	O	-1	18627295
B@@	O	-1	18627295
1	O	-1	18627295
receptor	O	-1	18627295
(B@@	O	-1	18627295
1@@	O	-1	18627295
R@@	O	-1	18627295
)	O	-1	18627295
during	O	-1	18627295
the	O	-1	18627295
development	O	-1	18627295
of	O	-1	18627295
DO@@	B-Chemical	D004317	18627295
X	I-Chemical	-1	18627295
cardi@@	B-Disease	D009202	18627295
om@@	I-Disease	-1	18627295
yo@@	I-Disease	-1	18627295
pathy	I-Disease	-1	18627295
,	O	-1	18627295
we	O	-1	18627295
studied	O	-1	18627295
B@@	O	-1	18627295
1@@	O	-1	18627295
R	O	-1	18627295
k@@	O	-1	18627295
n@@	O	-1	18627295
oc@@	O	-1	18627295
k@@	O	-1	18627295
out	O	-1	18627295
mice	O	-1	18627295
(B@@	O	-1	18627295
1@@	O	-1	18627295
R@@	O	-1	18627295
(-@@	O	-1	18627295
/@@	O	-1	18627295
-@@	O	-1	18627295
)@@	O	-1	18627295
)	O	-1	18627295
by	O	-1	18627295
investig@@	O	-1	18627295
ating	O	-1	18627295
cardiac	O	-1	18627295
inflam@@	B-Disease	D007249	18627295
m@@	I-Disease	-1	18627295
ation	I-Disease	-1	18627295
and	O	-1	18627295
apo@@	O	-1	18627295
pto@@	O	-1	18627295
sis	O	-1	18627295
after	O	-1	18627295
induction	O	-1	18627295
of	O	-1	18627295
DO@@	B-Chemical	D004317	18627295
X	I-Chemical	-1	18627295
-induced	O	-1	18627295
cardi@@	B-Disease	D009202	18627295
om@@	I-Disease	-1	18627295
yo@@	I-Disease	-1	18627295
pathy	I-Disease	-1	18627295
.	O	-1	18627295
DO@@	B-Chemical	D004317	18627295
X	I-Chemical	-1	18627295
control	O	-1	18627295
mice	O	-1	18627295
showed	O	-1	18627295
cardiac	B-Disease	D006331	18627295
dysfunction	I-Disease	-1	18627295
measured	O	-1	18627295
by	O	-1	18627295
pressu@@	O	-1	18627295
re@@	O	-1	18627295
-@@	O	-1	18627295
volume	O	-1	18627295
lo@@	O	-1	18627295
op@@	O	-1	18627295
s	O	-1	18627295
in	O	-1	18627295
viv@@	O	-1	18627295
o@@	O	-1	18627295
.	O	-1	18627295
This	O	-1	18627295
was	O	-1	18627295
associated	O	-1	18627295
with	O	-1	18627295
a	O	-1	18627295
reduced	O	-1	18627295
activation	O	-1	18627295
state	O	-1	18627295
of	O	-1	18627295
A@@	O	-1	18627295
K@@	O	-1	18627295
T@@	O	-1	18627295
,	O	-1	18627295
as	O	-1	18627295
well	O	-1	18627295
as	O	-1	18627295
an	O	-1	18627295
increased	O	-1	18627295
b@@	O	-1	18627295
ax@@	O	-1	18627295
/@@	O	-1	18627295
b@@	O	-1	18627295
cl@@	O	-1	18627295
2	O	-1	18627295
rati@@	O	-1	18627295
o	O	-1	18627295
in	O	-1	18627295
W@@	O	-1	18627295
est@@	O	-1	18627295
er@@	O	-1	18627295
n	O	-1	18627295
blo@@	O	-1	18627295
t@@	O	-1	18627295
s,	O	-1	18627295
indicating	O	-1	18627295
cardiac	B-Disease	D006331	18627295
apo@@	I-Disease	-1	18627295
pto@@	I-Disease	-1	18627295
sis	I-Disease	-1	18627295
.	O	-1	18627295
F@@	O	-1	18627295
ur@@	O	-1	18627295
ther@@	O	-1	18627295
mo@@	O	-1	18627295
re,	O	-1	18627295
mRNA	O	-1	18627295
levels	O	-1	18627295
of	O	-1	18627295
the	O	-1	18627295
pro@@	O	-1	18627295
inflam@@	O	-1	18627295
mat@@	O	-1	18627295
ory	O	-1	18627295
cyto@@	O	-1	18627295
k@@	O	-1	18627295
ine	O	-1	18627295
inter@@	O	-1	18627295
leuk@@	O	-1	18627295
in	O	-1	18627295
6	O	-1	18627295
were	O	-1	18627295
increased	O	-1	18627295
in	O	-1	18627295
the	O	-1	18627295
cardiac	O	-1	18627295
tissu@@	O	-1	18627295
e.	O	-1	18627295
In	O	-1	18627295
DO@@	B-Chemical	D004317	18627295
X	I-Chemical	-1	18627295
B@@	O	-1	18627295
1@@	O	-1	18627295
R@@	O	-1	18627295
(-@@	O	-1	18627295
/@@	O	-1	18627295
-@@	O	-1	18627295
)	O	-1	18627295
mic@@	O	-1	18627295
e,	O	-1	18627295
cardiac	B-Disease	D006331	18627295
dysfunction	I-Disease	-1	18627295
was	O	-1	18627295
improved	O	-1	18627295
compared	O	-1	18627295
to	O	-1	18627295
DO@@	B-Chemical	D004317	18627295
X	I-Chemical	-1	18627295
control	O	-1	18627295
mic@@	O	-1	18627295
e,	O	-1	18627295
which	O	-1	18627295
was	O	-1	18627295
associated	O	-1	18627295
with	O	-1	18627295
normal@@	O	-1	18627295
ization	O	-1	18627295
of	O	-1	18627295
the	O	-1	18627295
b@@	O	-1	18627295
ax@@	O	-1	18627295
/@@	O	-1	18627295
b@@	O	-1	18627295
cl@@	O	-1	18627295
-@@	O	-1	18627295
2	O	-1	18627295
rati@@	O	-1	18627295
o	O	-1	18627295
and	O	-1	18627295
inter@@	O	-1	18627295
leuk@@	O	-1	18627295
in	O	-1	18627295
6,	O	-1	18627295
as	O	-1	18627295
well	O	-1	18627295
as	O	-1	18627295
A@@	O	-1	18627295
K@@	O	-1	18627295
T	O	-1	18627295
activation	O	-1	18627295
stat@@	O	-1	18627295
e.	O	-1	18627295
These	O	-1	18627295
findings	O	-1	18627295
suggest	O	-1	18627295
that	O	-1	18627295
B@@	O	-1	18627295
1@@	O	-1	18627295
R	O	-1	18627295
is	O	-1	18627295
de@@	O	-1	18627295
tri@@	O	-1	18627295
mental	O	-1	18627295
in	O	-1	18627295
DO@@	B-Chemical	D004317	18627295
X	I-Chemical	-1	18627295
cardi@@	B-Disease	D009202	18627295
om@@	I-Disease	-1	18627295
yo@@	I-Disease	-1	18627295
pathy	I-Disease	-1	18627295
in	O	-1	18627295
that	O	-1	18627295
it	O	-1	18627295
medi@@	O	-1	18627295
ates	O	-1	18627295
the	O	-1	18627295
inflam@@	O	-1	18627295
mat@@	O	-1	18627295
ory	O	-1	18627295
response	O	-1	18627295
and	O	-1	18627295
apo@@	O	-1	18627295
pto@@	O	-1	18627295
sis.	O	-1	18627295
These	O	-1	18627295
in@@	O	-1	18627295
si@@	O	-1	18627295
gh@@	O	-1	18627295
ts	O	-1	18627295
might	O	-1	18627295
have	O	-1	18627295
use@@	O	-1	18627295
ful	O	-1	18627295
implic@@	O	-1	18627295
ations	O	-1	18627295
for	O	-1	18627295
f@@	O	-1	18627295
ut@@	O	-1	18627295
ure	O	-1	18627295
studies	O	-1	18627295
u@@	O	-1	18627295
ti@@	O	-1	18627295
li@@	O	-1	18627295
z@@	O	-1	18627295
ing	O	-1	18627295
B@@	O	-1	18627295
1@@	O	-1	18627295
R	O	-1	18627295
antagonist@@	O	-1	18627295
s	O	-1	18627295
for	O	-1	18627295
treatment	O	-1	18627295
of	O	-1	18627295
human	O	-1	18627295
DO@@	B-Chemical	D004317	18627295
X	I-Chemical	-1	18627295
cardi@@	B-Disease	D009202	18627295
om@@	I-Disease	-1	18627295
yo@@	I-Disease	-1	18627295
pathy	I-Disease	-1	18627295
.	O	-1	18627295

H@@	B-Disease	D056486	18405372
ep@@	I-Disease	-1	18405372
at@@	I-Disease	-1	18405372
otoxicity	I-Disease	-1	18405372
associated	O	-1	18405372
with	O	-1	18405372
sulf@@	B-Chemical	D012460	18405372
as@@	I-Chemical	-1	18405372
al@@	I-Chemical	-1	18405372
az@@	I-Chemical	-1	18405372
ine	I-Chemical	-1	18405372
in	O	-1	18405372
inflam@@	O	-1	18405372
mat@@	O	-1	18405372
ory	O	-1	18405372
arth@@	B-Disease	D001168	18405372
ritis	I-Disease	-1	18405372
:	O	-1	18405372
A	O	-1	18405372
case	O	-1	18405372
seri@@	O	-1	18405372
es	O	-1	18405372
from	O	-1	18405372
a	O	-1	18405372
loc@@	O	-1	18405372
al	O	-1	18405372
sur@@	O	-1	18405372
ve@@	O	-1	18405372
ill@@	O	-1	18405372
ance	O	-1	18405372
of	O	-1	18405372
seri@@	O	-1	18405372
ous	O	-1	18405372
adverse	O	-1	18405372
event@@	O	-1	18405372
s.	O	-1	18405372
BACKGROUND:	O	-1	18405372
S@@	O	-1	18405372
p@@	O	-1	18405372
ont@@	O	-1	18405372
aneous	O	-1	18405372
repor@@	O	-1	18405372
ting	O	-1	18405372
system@@	O	-1	18405372
s	O	-1	18405372
for	O	-1	18405372
adverse	O	-1	18405372
drug	O	-1	18405372
reactions	O	-1	18405372
(A@@	O	-1	18405372
D@@	O	-1	18405372
R@@	O	-1	18405372
s)	O	-1	18405372
are	O	-1	18405372
h@@	O	-1	18405372
and@@	O	-1	18405372
ic@@	O	-1	18405372
app@@	O	-1	18405372
ed	O	-1	18405372
by	O	-1	18405372
under@@	O	-1	18405372
-@@	O	-1	18405372
repor@@	O	-1	18405372
ting	O	-1	18405372
and	O	-1	18405372
lim@@	O	-1	18405372
ited	O	-1	18405372
det@@	O	-1	18405372
a@@	O	-1	18405372
il	O	-1	18405372
on	O	-1	18405372
individ@@	O	-1	18405372
ual	O	-1	18405372
cas@@	O	-1	18405372
es.	O	-1	18405372
We	O	-1	18405372
report	O	-1	18405372
an	O	-1	18405372
investig@@	O	-1	18405372
ation	O	-1	18405372
from	O	-1	18405372
a	O	-1	18405372
loc@@	O	-1	18405372
al	O	-1	18405372
sur@@	O	-1	18405372
ve@@	O	-1	18405372
ill@@	O	-1	18405372
ance	O	-1	18405372
for	O	-1	18405372
seri@@	O	-1	18405372
ous	O	-1	18405372
adverse	O	-1	18405372
drug	O	-1	18405372
reactions	O	-1	18405372
associated	O	-1	18405372
with	O	-1	18405372
disease	O	-1	18405372
mo@@	O	-1	18405372
di@@	O	-1	18405372
f@@	O	-1	18405372
y@@	O	-1	18405372
ing	O	-1	18405372
anti@@	O	-1	18405372
-@@	O	-1	18405372
r@@	O	-1	18405372
he@@	O	-1	18405372
um@@	O	-1	18405372
atic	O	-1	18405372
drugs	O	-1	18405372
that	O	-1	18405372
was	O	-1	18405372
tri@@	O	-1	18405372
g@@	O	-1	18405372
ge@@	O	-1	18405372
red	O	-1	18405372
by	O	-1	18405372
the	O	-1	18405372
occur@@	O	-1	18405372
rence	O	-1	18405372
of	O	-1	18405372
liver	B-Disease	D017093	18405372
failure	I-Disease	-1	18405372
in	O	-1	18405372
two	O	-1	18405372
of	O	-1	18405372
our	O	-1	18405372
patients.	O	-1	18405372
METHODS:	O	-1	18405372
S@@	O	-1	18405372
er@@	O	-1	18405372
i@@	O	-1	18405372
ous	O	-1	18405372
AD@@	O	-1	18405372
R	O	-1	18405372
reports	O	-1	18405372
have	O	-1	18405372
been	O	-1	18405372
sol@@	O	-1	18405372
ic@@	O	-1	18405372
ited	O	-1	18405372
from	O	-1	18405372
loc@@	O	-1	18405372
al	O	-1	18405372
clin@@	O	-1	18405372
ici@@	O	-1	18405372
ans	O	-1	18405372
by	O	-1	18405372
reg@@	O	-1	18405372
ular	O	-1	18405372
post@@	O	-1	18405372
car@@	O	-1	18405372
ds	O	-1	18405372
over	O	-1	18405372
the	O	-1	18405372
p@@	O	-1	18405372
ast	O	-1	18405372
seven	O	-1	18405372
year@@	O	-1	18405372
s.	O	-1	18405372
Pati@@	O	-1	18405372
ent@@	O	-1	18405372
s@@	O	-1	18405372
'@@	O	-1	18405372
,	O	-1	18405372
who	O	-1	18405372
had	O	-1	18405372
hepat@@	B-Disease	D056486	18405372
otoxicity	I-Disease	-1	18405372
on	O	-1	18405372
sulf@@	B-Chemical	D012460	18405372
as@@	I-Chemical	-1	18405372
al@@	I-Chemical	-1	18405372
az@@	I-Chemical	-1	18405372
ine	I-Chemical	-1	18405372
and	O	-1	18405372
me@@	O	-1	18405372
t	O	-1	18405372
a	O	-1	18405372
def@@	O	-1	18405372
in@@	O	-1	18405372
ition	O	-1	18405372
of	O	-1	18405372
a	O	-1	18405372
seri@@	O	-1	18405372
ous	O	-1	18405372
AD@@	O	-1	18405372
R@@	O	-1	18405372
,	O	-1	18405372
were	O	-1	18405372
identi@@	O	-1	18405372
fi@@	O	-1	18405372
ed.	O	-1	18405372
Two	O	-1	18405372
clin@@	O	-1	18405372
ici@@	O	-1	18405372
ans	O	-1	18405372
revie@@	O	-1	18405372
w@@	O	-1	18405372
ed	O	-1	18405372
struct@@	O	-1	18405372
ured	O	-1	18405372
case	O	-1	18405372
reports	O	-1	18405372
and	O	-1	18405372
assessed	O	-1	18405372
ca@@	O	-1	18405372
us@@	O	-1	18405372
ality	O	-1	18405372
by	O	-1	18405372
con@@	O	-1	18405372
sen@@	O	-1	18405372
su@@	O	-1	18405372
s	O	-1	18405372
and	O	-1	18405372
by	O	-1	18405372
using	O	-1	18405372
a	O	-1	18405372
ca@@	O	-1	18405372
us@@	O	-1	18405372
ality	O	-1	18405372
assess@@	O	-1	18405372
ment	O	-1	18405372
in@@	O	-1	18405372
st@@	O	-1	18405372
ru@@	O	-1	18405372
ment.	O	-1	18405372
The	O	-1	18405372
likely	O	-1	18405372
frequency	O	-1	18405372
of	O	-1	18405372
hepat@@	B-Disease	D056486	18405372
otoxicity	I-Disease	-1	18405372
with	O	-1	18405372
sulf@@	B-Chemical	D012460	18405372
as@@	I-Chemical	-1	18405372
al@@	I-Chemical	-1	18405372
az@@	I-Chemical	-1	18405372
ine	I-Chemical	-1	18405372
was	O	-1	18405372
estim@@	O	-1	18405372
ated	O	-1	18405372
by	O	-1	18405372
ma@@	O	-1	18405372
king	O	-1	18405372
a	O	-1	18405372
seri@@	O	-1	18405372
es	O	-1	18405372
of	O	-1	18405372
con@@	O	-1	18405372
ser@@	O	-1	18405372
v@@	O	-1	18405372
ative	O	-1	18405372
as@@	O	-1	18405372
sum@@	O	-1	18405372
p@@	O	-1	18405372
tions.	O	-1	18405372
RESULTS:	O	-1	18405372
T@@	O	-1	18405372
en	O	-1	18405372
cases	O	-1	18405372
were	O	-1	18405372
identi@@	O	-1	18405372
fi@@	O	-1	18405372
ed@@	O	-1	18405372
:	O	-1	18405372
e@@	O	-1	18405372
ight	O	-1	18405372
occurred	O	-1	18405372
during	O	-1	18405372
sur@@	O	-1	18405372
ve@@	O	-1	18405372
ill@@	O	-1	18405372
ance@@	O	-1	18405372
.	O	-1	18405372
E@@	O	-1	18405372
ight	O	-1	18405372
patients	O	-1	18405372
were	O	-1	18405372
hospit@@	O	-1	18405372
al@@	O	-1	18405372
i@@	O	-1	18405372
se@@	O	-1	18405372
d,	O	-1	18405372
two	O	-1	18405372
in	O	-1	18405372
hepatic	B-Disease	D017093	18405372
failure	I-Disease	-1	18405372
-	O	-1	18405372
one	O	-1	18405372
di@@	O	-1	18405372
ed	O	-1	18405372
after	O	-1	18405372
a	O	-1	18405372
liver	O	-1	18405372
transplant@@	O	-1	18405372
.	O	-1	18405372
All	O	-1	18405372
but	O	-1	18405372
one	O	-1	18405372
ev@@	O	-1	18405372
ent	O	-1	18405372
occurred	O	-1	18405372
within	O	-1	18405372
6	O	-1	18405372
weeks	O	-1	18405372
of	O	-1	18405372
treatment.	O	-1	18405372
S@@	O	-1	18405372
even	O	-1	18405372
patients	O	-1	18405372
had	O	-1	18405372
a	O	-1	18405372
s@@	B-Disease	D005076	18405372
k@@	I-Disease	-1	18405372
in	I-Disease	-1	18405372
r@@	I-Disease	-1	18405372
as@@	I-Disease	-1	18405372
h	I-Disease	-1	18405372
,	O	-1	18405372
three	O	-1	18405372
e@@	B-Disease	D004802	18405372
os@@	I-Disease	-1	18405372
in@@	I-Disease	-1	18405372
oph@@	I-Disease	-1	18405372
il@@	I-Disease	-1	18405372
ia	I-Disease	-1	18405372
and	O	-1	18405372
one	O	-1	18405372
interstitial	B-Disease	D009395	18405372
neph@@	I-Disease	-1	18405372
ritis	I-Disease	-1	18405372
.	O	-1	18405372
F@@	O	-1	18405372
i@@	O	-1	18405372
ve	O	-1	18405372
patients	O	-1	18405372
were	O	-1	18405372
of	O	-1	18405372
B@@	O	-1	18405372
l@@	O	-1	18405372
ac@@	O	-1	18405372
k	O	-1	18405372
B@@	O	-1	18405372
ri@@	O	-1	18405372
tis@@	O	-1	18405372
h	O	-1	18405372
of	O	-1	18405372
Af@@	O	-1	18405372
r@@	O	-1	18405372
ic@@	O	-1	18405372
an	O	-1	18405372
or	O	-1	18405372
C@@	O	-1	18405372
ari@@	O	-1	18405372
b@@	O	-1	18405372
be@@	O	-1	18405372
an	O	-1	18405372
des@@	O	-1	18405372
c@@	O	-1	18405372
ent@@	O	-1	18405372
.	O	-1	18405372
L@@	O	-1	18405372
i@@	O	-1	18405372
ver	O	-1	18405372
enzym@@	O	-1	18405372
es	O	-1	18405372
showed	O	-1	18405372
a	O	-1	18405372
hepat@@	O	-1	18405372
oc@@	O	-1	18405372
ell@@	O	-1	18405372
ular	O	-1	18405372
pat@@	O	-1	18405372
ter@@	O	-1	18405372
n	O	-1	18405372
in	O	-1	18405372
four	O	-1	18405372
cases	O	-1	18405372
and	O	-1	18405372
a	O	-1	18405372
mi@@	O	-1	18405372
x@@	O	-1	18405372
ed	O	-1	18405372
pat@@	O	-1	18405372
ter@@	O	-1	18405372
n	O	-1	18405372
in	O	-1	18405372
si@@	O	-1	18405372
x@@	O	-1	18405372
.	O	-1	18405372
D@@	O	-1	18405372
ru@@	O	-1	18405372
g@@	O	-1	18405372
-@@	O	-1	18405372
related	O	-1	18405372
hepat@@	B-Disease	D056486	18405372
otoxicity	I-Disease	-1	18405372
was	O	-1	18405372
j@@	O	-1	18405372
ud@@	O	-1	18405372
g@@	O	-1	18405372
ed	O	-1	18405372
prob@@	O	-1	18405372
able	O	-1	18405372
or	O	-1	18405372
high@@	O	-1	18405372
ly	O	-1	18405372
prob@@	O	-1	18405372
able	O	-1	18405372
in	O	-1	18405372
8	O	-1	18405372
patients.	O	-1	18405372
The	O	-1	18405372
likely	O	-1	18405372
frequency	O	-1	18405372
of	O	-1	18405372
seri@@	O	-1	18405372
ous	O	-1	18405372
hepat@@	B-Disease	D056486	18405372
otoxicity	I-Disease	-1	18405372
with	O	-1	18405372
sulf@@	B-Chemical	D012460	18405372
as@@	I-Chemical	-1	18405372
al@@	I-Chemical	-1	18405372
az@@	I-Chemical	-1	18405372
ine	I-Chemical	-1	18405372
was	O	-1	18405372
estim@@	O	-1	18405372
ated	O	-1	18405372
at	O	-1	18405372
0.@@	O	-1	18405372
4@@	O	-1	18405372
%	O	-1	18405372
of	O	-1	18405372
treated	O	-1	18405372
patients.	O	-1	18405372
CONCLUSION:	O	-1	18405372
S@@	O	-1	18405372
er@@	O	-1	18405372
i@@	O	-1	18405372
ous	O	-1	18405372
hepat@@	B-Disease	D056486	18405372
otoxicity	I-Disease	-1	18405372
associated	O	-1	18405372
with	O	-1	18405372
sulf@@	B-Chemical	D012460	18405372
as@@	I-Chemical	-1	18405372
al@@	I-Chemical	-1	18405372
az@@	I-Chemical	-1	18405372
ine	I-Chemical	-1	18405372
appear@@	O	-1	18405372
s	O	-1	18405372
to	O	-1	18405372
be	O	-1	18405372
under@@	O	-1	18405372
-@@	O	-1	18405372
ap@@	O	-1	18405372
pre@@	O	-1	18405372
ci@@	O	-1	18405372
ated	O	-1	18405372
and	O	-1	18405372
int@@	O	-1	18405372
en@@	O	-1	18405372
sive	O	-1	18405372
monit@@	O	-1	18405372
or@@	O	-1	18405372
ing	O	-1	18405372
and	O	-1	18405372
vi@@	O	-1	18405372
g@@	O	-1	18405372
il@@	O	-1	18405372
ance	O	-1	18405372
in	O	-1	18405372
the	O	-1	18405372
first	O	-1	18405372
6	O	-1	18405372
weeks	O	-1	18405372
of	O	-1	18405372
treatment	O	-1	18405372
is	O	-1	18405372
es@@	O	-1	18405372
p@@	O	-1	18405372
ec@@	O	-1	18405372
i@@	O	-1	18405372
ally	O	-1	18405372
import@@	O	-1	18405372
ant@@	O	-1	18405372
.	O	-1	18405372

An	O	-1	18356633
evalu@@	O	-1	18356633
ation	O	-1	18356633
of	O	-1	18356633
ami@@	B-Chemical	D000583	18356633
k@@	I-Chemical	-1	18356633
ac@@	I-Chemical	-1	18356633
in	I-Chemical	-1	18356633
nephro@@	B-Disease	D007674	18356633
toxicity	I-Disease	-1	18356633
in	O	-1	18356633
the	O	-1	18356633
hemat@@	O	-1	18356633
olog@@	O	-1	18356633
y@@	O	-1	18356633
/@@	O	-1	18356633
on@@	O	-1	18356633
co@@	O	-1	18356633
log@@	O	-1	18356633
y	O	-1	18356633
po@@	O	-1	18356633
pul@@	O	-1	18356633
ation.	O	-1	18356633
A@@	B-Chemical	D000583	18356633
mi@@	I-Chemical	-1	18356633
k@@	I-Chemical	-1	18356633
ac@@	I-Chemical	-1	18356633
in	I-Chemical	-1	18356633
is	O	-1	18356633
an	O	-1	18356633
amino@@	B-Chemical	D000617	18356633
gly@@	I-Chemical	-1	18356633
co@@	I-Chemical	-1	18356633
side	I-Chemical	-1	18356633
common@@	O	-1	18356633
ly	O	-1	18356633
used	O	-1	18356633
to	O	-1	18356633
prov@@	O	-1	18356633
ide	O	-1	18356633
em@@	O	-1	18356633
pi@@	O	-1	18356633
r@@	O	-1	18356633
ical	O	-1	18356633
dou@@	O	-1	18356633
ble	O	-1	18356633
gram@@	O	-1	18356633
-@@	O	-1	18356633
negative	O	-1	18356633
treatment	O	-1	18356633
for	O	-1	18356633
fe@@	B-Disease	D009503	18356633
b@@	I-Disease	-1	18356633
ri@@	I-Disease	-1	18356633
le	I-Disease	-1	18356633
ne@@	I-Disease	-1	18356633
ut@@	I-Disease	-1	18356633
ro@@	I-Disease	-1	18356633
pen@@	I-Disease	-1	18356633
ia	I-Disease	-1	18356633
and	O	-1	18356633
other	O	-1	18356633
sus@@	O	-1	18356633
p@@	O	-1	18356633
ected	O	-1	18356633
inf@@	B-Disease	D007239	18356633
ec@@	I-Disease	-1	18356633
tions	I-Disease	-1	18356633
.	O	-1	18356633
S@@	O	-1	18356633
t@@	O	-1	18356633
rat@@	O	-1	18356633
e@@	O	-1	18356633
gi@@	O	-1	18356633
es	O	-1	18356633
of	O	-1	18356633
exten@@	O	-1	18356633
de@@	O	-1	18356633
d-@@	O	-1	18356633
interv@@	O	-1	18356633
al	O	-1	18356633
and	O	-1	18356633
con@@	O	-1	18356633
ven@@	O	-1	18356633
tional	O	-1	18356633
dos@@	O	-1	18356633
ing	O	-1	18356633
have	O	-1	18356633
been	O	-1	18356633
u@@	O	-1	18356633
ti@@	O	-1	18356633
li@@	O	-1	18356633
zed	O	-1	18356633
exten@@	O	-1	18356633
si@@	O	-1	18356633
vely	O	-1	18356633
in	O	-1	18356633
the	O	-1	18356633
gener@@	O	-1	18356633
al	O	-1	18356633
med@@	O	-1	18356633
ical	O	-1	18356633
po@@	O	-1	18356633
pul@@	O	-1	18356633
ation@@	O	-1	18356633
;	O	-1	18356633
however,	O	-1	18356633
data	O	-1	18356633
are	O	-1	18356633
l@@	O	-1	18356633
ac@@	O	-1	18356633
king	O	-1	18356633
to	O	-1	18356633
suppor@@	O	-1	18356633
t	O	-1	18356633
a	O	-1	18356633
dos@@	O	-1	18356633
ing	O	-1	18356633
strat@@	O	-1	18356633
e@@	O	-1	18356633
g@@	O	-1	18356633
y	O	-1	18356633
in	O	-1	18356633
the	O	-1	18356633
hemat@@	O	-1	18356633
olog@@	O	-1	18356633
y@@	O	-1	18356633
/@@	O	-1	18356633
on@@	O	-1	18356633
co@@	O	-1	18356633
log@@	O	-1	18356633
y	O	-1	18356633
po@@	O	-1	18356633
pul@@	O	-1	18356633
ation.	O	-1	18356633
To	O	-1	18356633
evalu@@	O	-1	18356633
ate	O	-1	18356633
ami@@	B-Chemical	D000583	18356633
k@@	I-Chemical	-1	18356633
ac@@	I-Chemical	-1	18356633
in	I-Chemical	-1	18356633
-@@	O	-1	18356633
associated	O	-1	18356633
nephro@@	B-Disease	D007674	18356633
toxicity	I-Disease	-1	18356633
in	O	-1	18356633
an	O	-1	18356633
ad@@	O	-1	18356633
ult	O	-1	18356633
hemat@@	O	-1	18356633
olog@@	O	-1	18356633
y@@	O	-1	18356633
/@@	O	-1	18356633
on@@	O	-1	18356633
co@@	O	-1	18356633
log@@	O	-1	18356633
y	O	-1	18356633
po@@	O	-1	18356633
pul@@	O	-1	18356633
ation,	O	-1	18356633
a	O	-1	18356633
pro@@	O	-1	18356633
sp@@	O	-1	18356633
ecti@@	O	-1	18356633
ve,	O	-1	18356633
random@@	O	-1	18356633
iz@@	O	-1	18356633
ed,	O	-1	18356633
o@@	O	-1	18356633
pen@@	O	-1	18356633
-@@	O	-1	18356633
l@@	O	-1	18356633
a@@	O	-1	18356633
be@@	O	-1	18356633
l	O	-1	18356633
trial	O	-1	18356633
was	O	-1	18356633
con@@	O	-1	18356633
duc@@	O	-1	18356633
ted	O	-1	18356633
at	O	-1	18356633
a	O	-1	18356633
un@@	O	-1	18356633
i@@	O	-1	18356633
ver@@	O	-1	18356633
sit@@	O	-1	18356633
y-@@	O	-1	18356633
aff@@	O	-1	18356633
il@@	O	-1	18356633
i@@	O	-1	18356633
ated	O	-1	18356633
med@@	O	-1	18356633
ical	O	-1	18356633
c@@	O	-1	18356633
ent@@	O	-1	18356633
er.	O	-1	18356633
F@@	O	-1	18356633
ort@@	O	-1	18356633
y	O	-1	18356633
patients	O	-1	18356633
with	O	-1	18356633
a	O	-1	18356633
diagnosis	O	-1	18356633
consist@@	O	-1	18356633
ent	O	-1	18356633
with	O	-1	18356633
a	O	-1	18356633
hemat@@	B-Disease	D006402	18356633
olog@@	I-Disease	-1	18356633
ic@@	I-Disease	-1	18356633
/@@	I-Disease	-1	18356633
on@@	I-Disease	-1	18356633
co@@	I-Disease	-1	18356633
log@@	I-Disease	-1	18356633
ic	I-Disease	-1	18356633
disor@@	I-Disease	-1	18356633
der	I-Disease	-1	18356633
hemat@@	B-Disease	D009369	18356633
olog@@	I-Disease	-1	18356633
ic@@	I-Disease	-1	18356633
/@@	I-Disease	-1	18356633
on@@	I-Disease	-1	18356633
co@@	I-Disease	-1	18356633
log@@	I-Disease	-1	18356633
ic	I-Disease	-1	18356633
disor@@	I-Disease	-1	18356633
der	I-Disease	-1	18356633
that	O	-1	18356633
requ@@	O	-1	18356633
ired	O	-1	18356633
treatment	O	-1	18356633
with	O	-1	18356633
an	O	-1	18356633
amino@@	B-Chemical	D000617	18356633
gly@@	I-Chemical	-1	18356633
co@@	I-Chemical	-1	18356633
side	I-Chemical	-1	18356633
were	O	-1	18356633
randomized	O	-1	18356633
to	O	-1	18356633
either	O	-1	18356633
con@@	O	-1	18356633
ven@@	O	-1	18356633
tional	O	-1	18356633
or	O	-1	18356633
exten@@	O	-1	18356633
de@@	O	-1	18356633
d-@@	O	-1	18356633
interv@@	O	-1	18356633
al	O	-1	18356633
ami@@	B-Chemical	D000583	18356633
k@@	I-Chemical	-1	18356633
ac@@	I-Chemical	-1	18356633
in	I-Chemical	-1	18356633
.	O	-1	18356633
The	O	-1	18356633
occur@@	O	-1	18356633
rence	O	-1	18356633
of	O	-1	18356633
nephro@@	B-Disease	D007674	18356633
toxicity	I-Disease	-1	18356633
by	O	-1	18356633
me@@	O	-1	18356633
ans	O	-1	18356633
of	O	-1	18356633
an	O	-1	18356633
increase	O	-1	18356633
in	O	-1	18356633
serum	O	-1	18356633
creatinine	B-Chemical	D003404	18356633
and	O	-1	18356633
evalu@@	O	-1	18356633
ation	O	-1	18356633
of	O	-1	18356633
efficacy	O	-1	18356633
vi@@	O	-1	18356633
a	O	-1	18356633
ami@@	B-Chemical	D000583	18356633
k@@	I-Chemical	-1	18356633
ac@@	I-Chemical	-1	18356633
in	I-Chemical	-1	18356633
serum	O	-1	18356633
concentrations	O	-1	18356633
with	O	-1	18356633
resp@@	O	-1	18356633
ective	O	-1	18356633
path@@	O	-1	18356633
o@@	O	-1	18356633
gen@@	O	-1	18356633
s	O	-1	18356633
were	O	-1	18356633
ass@@	O	-1	18356633
es@@	O	-1	18356633
sed.	O	-1	18356633
The	O	-1	18356633
occur@@	O	-1	18356633
rence	O	-1	18356633
of	O	-1	18356633
nephro@@	B-Disease	D007674	18356633
toxicity	I-Disease	-1	18356633
was	O	-1	18356633
similar	O	-1	18356633
between	O	-1	18356633
the	O	-1	18356633
con@@	O	-1	18356633
ven@@	O	-1	18356633
tional	O	-1	18356633
and	O	-1	18356633
exten@@	O	-1	18356633
de@@	O	-1	18356633
d-@@	O	-1	18356633
interv@@	O	-1	18356633
al	O	-1	18356633
group@@	O	-1	18356633
s,	O	-1	18356633
at	O	-1	18356633
10@@	O	-1	18356633
%	O	-1	18356633
and	O	-1	18356633
5@@	O	-1	18356633
%,	O	-1	18356633
respecti@@	O	-1	18356633
vely	O	-1	18356633
(P	O	-1	18356633
=	O	-1	18356633
1.@@	O	-1	18356633
0@@	O	-1	18356633
0@@	O	-1	18356633
).	O	-1	18356633
Si@@	O	-1	18356633
x	O	-1	18356633
patients	O	-1	18356633
in	O	-1	18356633
the	O	-1	18356633
con@@	O	-1	18356633
ven@@	O	-1	18356633
tional	O	-1	18356633
group	O	-1	18356633
had	O	-1	18356633
a	O	-1	18356633
positive	O	-1	18356633
c@@	O	-1	18356633
ult@@	O	-1	18356633
ure,	O	-1	18356633
compared	O	-1	18356633
with	O	-1	18356633
n@@	O	-1	18356633
one	O	-1	18356633
in	O	-1	18356633
the	O	-1	18356633
exten@@	O	-1	18356633
de@@	O	-1	18356633
d-@@	O	-1	18356633
interv@@	O	-1	18356633
al	O	-1	18356633
group	O	-1	18356633
(P	O	-1	18356633
=	O	-1	18356633
0.00@@	O	-1	18356633
2@@	O	-1	18356633
).	O	-1	18356633
The	O	-1	18356633
occur@@	O	-1	18356633
rence	O	-1	18356633
of	O	-1	18356633
nephro@@	B-Disease	D007674	18356633
toxicity	I-Disease	-1	18356633
was	O	-1	18356633
similar	O	-1	18356633
between	O	-1	18356633
the	O	-1	18356633
two	O	-1	18356633
dos@@	O	-1	18356633
ing	O	-1	18356633
regimen@@	O	-1	18356633
s,	O	-1	18356633
but	O	-1	18356633
the	O	-1	18356633
di@@	O	-1	18356633
stri@@	O	-1	18356633
bu@@	O	-1	18356633
tion	O	-1	18356633
of	O	-1	18356633
risk	O	-1	18356633
factors	O	-1	18356633
was	O	-1	18356633
vari@@	O	-1	18356633
able	O	-1	18356633
between	O	-1	18356633
the	O	-1	18356633
two	O	-1	18356633
groups.	O	-1	18356633
Eff@@	O	-1	18356633
icac@@	O	-1	18356633
y	O	-1	18356633
could	O	-1	18356633
not	O	-1	18356633
be	O	-1	18356633
ass@@	O	-1	18356633
es@@	O	-1	18356633
sed.	O	-1	18356633

M@@	O	-1	16574713
em@@	O	-1	16574713
ory	O	-1	16574713
function	O	-1	16574713
and	O	-1	16574713
seroton@@	B-Chemical	D012701	16574713
in	I-Chemical	-1	16574713
trans@@	O	-1	16574713
por@@	O	-1	16574713
ter	O	-1	16574713
pro@@	O	-1	16574713
m@@	O	-1	16574713
ot@@	O	-1	16574713
er	O	-1	16574713
gen@@	O	-1	16574713
e	O	-1	16574713
poly@@	O	-1	16574713
morph@@	O	-1	16574713
ism	O	-1	16574713
in	O	-1	16574713
ec@@	B-Chemical	D018817	16574713
st@@	I-Chemical	-1	16574713
as@@	I-Chemical	-1	16574713
y	I-Chemical	-1	16574713
(	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
)	O	-1	16574713
us@@	O	-1	16574713
ers.	O	-1	16574713
Although	O	-1	16574713
3@@	B-Chemical	D018817	16574713
,@@	I-Chemical	-1	16574713
4-@@	I-Chemical	-1	16574713
methyl@@	I-Chemical	-1	16574713
en@@	I-Chemical	-1	16574713
edi@@	I-Chemical	-1	16574713
oxy@@	I-Chemical	-1	16574713
meth@@	I-Chemical	-1	16574713
amphetamine	I-Chemical	-1	16574713
(	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
or	O	-1	16574713
ec@@	B-Chemical	D018817	16574713
st@@	I-Chemical	-1	16574713
as@@	I-Chemical	-1	16574713
y	I-Chemical	-1	16574713
)	O	-1	16574713
has	O	-1	16574713
been	O	-1	16574713
shown	O	-1	16574713
to	O	-1	16574713
damage	O	-1	16574713
brain	O	-1	16574713
seroton@@	B-Chemical	D012701	16574713
in	I-Chemical	-1	16574713
(	O	-1	16574713
5-@@	B-Chemical	D012701	16574713
H@@	I-Chemical	-1	16574713
T	I-Chemical	-1	16574713
)	O	-1	16574713
neuron@@	O	-1	16574713
s	O	-1	16574713
in	O	-1	16574713
animals	O	-1	16574713
and	O	-1	16574713
possib@@	O	-1	16574713
ly	O	-1	16574713
hum@@	O	-1	16574713
an@@	O	-1	16574713
s,	O	-1	16574713
lit@@	O	-1	16574713
t@@	O	-1	16574713
le	O	-1	16574713
is	O	-1	16574713
known	O	-1	16574713
about	O	-1	16574713
the	O	-1	16574713
long-term	O	-1	16574713
con@@	O	-1	16574713
sequ@@	O	-1	16574713
enc@@	O	-1	16574713
es	O	-1	16574713
of	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
-induced	O	-1	16574713
5-@@	B-Chemical	D012701	16574713
H@@	I-Chemical	-1	16574713
T	I-Chemical	-1	16574713
neuro@@	B-Disease	D020258	16574713
toxic	I-Disease	-1	16574713
lesions	I-Disease	-1	16574713
on	O	-1	16574713
func@@	O	-1	16574713
tions	O	-1	16574713
in	O	-1	16574713
which	O	-1	16574713
5-@@	B-Chemical	D012701	16574713
H@@	I-Chemical	-1	16574713
T	I-Chemical	-1	16574713
is	O	-1	16574713
invol@@	O	-1	16574713
ve@@	O	-1	16574713
d,	O	-1	16574713
such	O	-1	16574713
as	O	-1	16574713
cognitive	O	-1	16574713
func@@	O	-1	16574713
tion.	O	-1	16574713
B@@	O	-1	16574713
ecause	O	-1	16574713
5-@@	B-Chemical	D012701	16574713
H@@	I-Chemical	-1	16574713
T	I-Chemical	-1	16574713
trans@@	O	-1	16574713
por@@	O	-1	16574713
ters	O	-1	16574713
pl@@	O	-1	16574713
ay	O	-1	16574713
a	O	-1	16574713
ke@@	O	-1	16574713
y	O	-1	16574713
e@@	O	-1	16574713
le@@	O	-1	16574713
ment	O	-1	16574713
in	O	-1	16574713
the	O	-1	16574713
reg@@	O	-1	16574713
ulation	O	-1	16574713
of	O	-1	16574713
syn@@	O	-1	16574713
ap@@	O	-1	16574713
tic	O	-1	16574713
5-@@	B-Chemical	D012701	16574713
H@@	I-Chemical	-1	16574713
T	I-Chemical	-1	16574713
trans@@	O	-1	16574713
mission	O	-1	16574713
it	O	-1	16574713
may	O	-1	16574713
be	O	-1	16574713
important	O	-1	16574713
to	O	-1	16574713
control	O	-1	16574713
for	O	-1	16574713
the	O	-1	16574713
potential	O	-1	16574713
co@@	O	-1	16574713
vari@@	O	-1	16574713
ance	O	-1	16574713
effect	O	-1	16574713
of	O	-1	16574713
a	O	-1	16574713
poly@@	O	-1	16574713
morph@@	O	-1	16574713
ism	O	-1	16574713
in	O	-1	16574713
the	O	-1	16574713
5-@@	B-Chemical	D012701	16574713
H@@	I-Chemical	-1	16574713
T	I-Chemical	-1	16574713
trans@@	O	-1	16574713
por@@	O	-1	16574713
ter	O	-1	16574713
pro@@	O	-1	16574713
m@@	O	-1	16574713
ot@@	O	-1	16574713
er	O	-1	16574713
gen@@	O	-1	16574713
e	O	-1	16574713
regi@@	O	-1	16574713
on	O	-1	16574713
(@@	O	-1	16574713
5-@@	O	-1	16574713
H@@	O	-1	16574713
T@@	O	-1	16574713
T@@	O	-1	16574713
L@@	O	-1	16574713
P@@	O	-1	16574713
R@@	O	-1	16574713
)	O	-1	16574713
when	O	-1	16574713
stud@@	O	-1	16574713
y@@	O	-1	16574713
ing	O	-1	16574713
the	O	-1	16574713
effects	O	-1	16574713
of	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
as	O	-1	16574713
well	O	-1	16574713
as	O	-1	16574713
cognitive	O	-1	16574713
func@@	O	-1	16574713
tion@@	O	-1	16574713
ing.	O	-1	16574713
The	O	-1	16574713
a@@	O	-1	16574713
im	O	-1	16574713
of	O	-1	16574713
the	O	-1	16574713
study	O	-1	16574713
was	O	-1	16574713
to	O	-1	16574713
investigate	O	-1	16574713
the	O	-1	16574713
effects	O	-1	16574713
of	O	-1	16574713
moder@@	O	-1	16574713
ate	O	-1	16574713
and	O	-1	16574713
he@@	O	-1	16574713
av@@	O	-1	16574713
y	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
use	O	-1	16574713
on	O	-1	16574713
cognitive	O	-1	16574713
func@@	O	-1	16574713
tion,	O	-1	16574713
as	O	-1	16574713
well	O	-1	16574713
as	O	-1	16574713
the	O	-1	16574713
effects	O	-1	16574713
of	O	-1	16574713
long-term	O	-1	16574713
ab@@	O	-1	16574713
st@@	O	-1	16574713
en@@	O	-1	16574713
tion	O	-1	16574713
from	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
,	O	-1	16574713
in	O	-1	16574713
subjects	O	-1	16574713
gen@@	O	-1	16574713
ot@@	O	-1	16574713
yp@@	O	-1	16574713
ed	O	-1	16574713
for	O	-1	16574713
5-@@	O	-1	16574713
H@@	O	-1	16574713
T@@	O	-1	16574713
T@@	O	-1	16574713
L@@	O	-1	16574713
P@@	O	-1	16574713
R@@	O	-1	16574713
.	O	-1	16574713
A	O	-1	16574713
second	O	-1	16574713
a@@	O	-1	16574713
im	O	-1	16574713
of	O	-1	16574713
the	O	-1	16574713
study	O	-1	16574713
was	O	-1	16574713
to	O	-1	16574713
determine	O	-1	16574713
whether	O	-1	16574713
these	O	-1	16574713
effects	O	-1	16574713
diff@@	O	-1	16574713
er	O	-1	16574713
for	O	-1	16574713
femal@@	O	-1	16574713
es	O	-1	16574713
and	O	-1	16574713
mal@@	O	-1	16574713
es.	O	-1	16574713
F@@	O	-1	16574713
if@@	O	-1	16574713
te@@	O	-1	16574713
en	O	-1	16574713
moder@@	O	-1	16574713
ate	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
users	O	-1	16574713
(@@	O	-1	16574713
<@@	O	-1	16574713
5@@	O	-1	16574713
5	O	-1	16574713
li@@	O	-1	16574713
fe@@	O	-1	16574713
time	O	-1	16574713
t@@	O	-1	16574713
able@@	O	-1	16574713
t@@	O	-1	16574713
s),	O	-1	16574713
2@@	O	-1	16574713
2	O	-1	16574713
he@@	O	-1	16574713
av@@	O	-1	16574713
y	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
+	O	-1	16574713
users	O	-1	16574713
(@@	O	-1	16574713
>@@	O	-1	16574713
5@@	O	-1	16574713
5	O	-1	16574713
li@@	O	-1	16574713
fe@@	O	-1	16574713
time	O	-1	16574713
t@@	O	-1	16574713
able@@	O	-1	16574713
t@@	O	-1	16574713
s),	O	-1	16574713
16	O	-1	16574713
ex@@	O	-1	16574713
-	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
+	O	-1	16574713
users	O	-1	16574713
(@@	O	-1	16574713
las@@	O	-1	16574713
t	O	-1	16574713
t@@	O	-1	16574713
able@@	O	-1	16574713
t	O	-1	16574713
>	O	-1	16574713
1	O	-1	16574713
year	O	-1	16574713
ag@@	O	-1	16574713
o@@	O	-1	16574713
)	O	-1	16574713
and	O	-1	16574713
13	O	-1	16574713
controls	O	-1	16574713
were	O	-1	16574713
compared	O	-1	16574713
on	O	-1	16574713
a	O	-1	16574713
b@@	O	-1	16574713
at@@	O	-1	16574713
ter@@	O	-1	16574713
y	O	-1	16574713
of	O	-1	16574713
neuro@@	O	-1	16574713
psych@@	O	-1	16574713
ological	O	-1	16574713
test@@	O	-1	16574713
s.	O	-1	16574713
D@@	O	-1	16574713
NA	O	-1	16574713
from	O	-1	16574713
peripheral	O	-1	16574713
nucle@@	O	-1	16574713
ar	O	-1	16574713
blood	O	-1	16574713
cells	O	-1	16574713
was	O	-1	16574713
gen@@	O	-1	16574713
ot@@	O	-1	16574713
yp@@	O	-1	16574713
ed	O	-1	16574713
for	O	-1	16574713
5-@@	O	-1	16574713
H@@	O	-1	16574713
T@@	O	-1	16574713
T@@	O	-1	16574713
L@@	O	-1	16574713
P@@	O	-1	16574713
R	O	-1	16574713
using	O	-1	16574713
standard	O	-1	16574713
poly@@	O	-1	16574713
mer@@	O	-1	16574713
ase	O	-1	16574713
ch@@	O	-1	16574713
ain	O	-1	16574713
reaction	O	-1	16574713
meth@@	O	-1	16574713
o@@	O	-1	16574713
d@@	O	-1	16574713
s@@	O	-1	16574713
.@@	O	-1	16574713
A	O	-1	16574713
significant	O	-1	16574713
group	O	-1	16574713
effect	O	-1	16574713
was	O	-1	16574713
observed	O	-1	16574713
only	O	-1	16574713
on	O	-1	16574713
memory	O	-1	16574713
function	O	-1	16574713
t@@	O	-1	16574713
as@@	O	-1	16574713
k@@	O	-1	16574713
s	O	-1	16574713
(p	O	-1	16574713
=	O	-1	16574713
0.0@@	O	-1	16574713
4@@	O	-1	16574713
)	O	-1	16574713
but	O	-1	16574713
not	O	-1	16574713
on	O	-1	16574713
reaction	O	-1	16574713
times	O	-1	16574713
(p	O	-1	16574713
=	O	-1	16574713
0.@@	O	-1	16574713
6@@	O	-1	16574713
1)	O	-1	16574713
or	O	-1	16574713
atten@@	O	-1	16574713
tion@@	O	-1	16574713
/@@	O	-1	16574713
ex@@	O	-1	16574713
ec@@	O	-1	16574713
utive	O	-1	16574713
func@@	O	-1	16574713
tion@@	O	-1	16574713
ing	O	-1	16574713
(p	O	-1	16574713
=	O	-1	16574713
0.@@	O	-1	16574713
5@@	O	-1	16574713
9@@	O	-1	16574713
).	O	-1	16574713
He@@	O	-1	16574713
av@@	O	-1	16574713
y	O	-1	16574713
and	O	-1	16574713
ex@@	O	-1	16574713
-	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
+	O	-1	16574713
users	O	-1	16574713
performed	O	-1	16574713
significantly	O	-1	16574713
po@@	O	-1	16574713
ore@@	O	-1	16574713
r	O	-1	16574713
on	O	-1	16574713
memory	O	-1	16574713
t@@	O	-1	16574713
as@@	O	-1	16574713
k@@	O	-1	16574713
s	O	-1	16574713
than	O	-1	16574713
controls.	O	-1	16574713
In	O	-1	16574713
contrast@@	O	-1	16574713
,	O	-1	16574713
no	O	-1	16574713
evidence	O	-1	16574713
of	O	-1	16574713
memory	B-Disease	D008569	16574713
impair@@	I-Disease	-1	16574713
ment	I-Disease	-1	16574713
was	O	-1	16574713
observed	O	-1	16574713
in	O	-1	16574713
moder@@	O	-1	16574713
ate	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
us@@	O	-1	16574713
ers.	O	-1	16574713
No	O	-1	16574713
significant	O	-1	16574713
effect	O	-1	16574713
of	O	-1	16574713
5-@@	O	-1	16574713
H@@	O	-1	16574713
T@@	O	-1	16574713
T@@	O	-1	16574713
L@@	O	-1	16574713
P@@	O	-1	16574713
R	O	-1	16574713
or	O	-1	16574713
gen@@	O	-1	16574713
der	O	-1	16574713
was	O	-1	16574713
obser@@	O	-1	16574713
ved.	O	-1	16574713
W@@	O	-1	16574713
h@@	O	-1	16574713
ile	O	-1	16574713
the	O	-1	16574713
use	O	-1	16574713
of	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
in	O	-1	16574713
qu@@	O	-1	16574713
anti@@	O	-1	16574713
ties	O	-1	16574713
that	O	-1	16574713
may	O	-1	16574713
be	O	-1	16574713
considered	O	-1	16574713
"@@	O	-1	16574713
moder@@	O	-1	16574713
ate@@	O	-1	16574713
"	O	-1	16574713
is	O	-1	16574713
not	O	-1	16574713
associated	O	-1	16574713
with	O	-1	16574713
impaired	B-Disease	D008569	16574713
memory	I-Disease	-1	16574713
func@@	I-Disease	-1	16574713
tion@@	I-Disease	-1	16574713
ing	I-Disease	-1	16574713
,	O	-1	16574713
he@@	O	-1	16574713
av@@	O	-1	16574713
y	O	-1	16574713
use	O	-1	16574713
of	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
use	O	-1	16574713
may	O	-1	16574713
le@@	O	-1	16574713
ad	O	-1	16574713
to	O	-1	16574713
lon@@	O	-1	16574713
g	O	-1	16574713
l@@	O	-1	16574713
ast@@	O	-1	16574713
ing	O	-1	16574713
memory	B-Disease	D008569	16574713
impair@@	I-Disease	-1	16574713
ments	I-Disease	-1	16574713
.	O	-1	16574713
No	O	-1	16574713
effect	O	-1	16574713
of	O	-1	16574713
5-@@	O	-1	16574713
H@@	O	-1	16574713
T@@	O	-1	16574713
T@@	O	-1	16574713
L@@	O	-1	16574713
P@@	O	-1	16574713
R	O	-1	16574713
or	O	-1	16574713
gen@@	O	-1	16574713
der	O	-1	16574713
on	O	-1	16574713
memory	O	-1	16574713
function	O	-1	16574713
or	O	-1	16574713
MD@@	B-Chemical	D018817	16574713
M@@	I-Chemical	-1	16574713
A	I-Chemical	-1	16574713
use	O	-1	16574713
was	O	-1	16574713
obser@@	O	-1	16574713
ved.	O	-1	16574713

A@@	O	-1	15638391
g@@	O	-1	15638391
ing	O	-1	15638391
pro@@	O	-1	15638391
cess	O	-1	15638391
of	O	-1	15638391
epi@@	O	-1	15638391
thelial	O	-1	15638391
cells	O	-1	15638391
of	O	-1	15638391
the	O	-1	15638391
rat	O	-1	15638391
pro@@	O	-1	15638391
state	O	-1	15638391
lat@@	O	-1	15638391
eral	O	-1	15638391
lo@@	O	-1	15638391
be	O	-1	15638391
in	O	-1	15638391
experimental	O	-1	15638391
hyper@@	B-Disease	D006966	15638391
prol@@	I-Disease	-1	15638391
act@@	I-Disease	-1	15638391
ine@@	I-Disease	-1	15638391
mia	I-Disease	-1	15638391
induced	O	-1	15638391
by	O	-1	15638391
haloperidol	B-Chemical	D006220	15638391
.	O	-1	15638391
The	O	-1	15638391
a@@	O	-1	15638391
im	O	-1	15638391
of	O	-1	15638391
the	O	-1	15638391
study	O	-1	15638391
was	O	-1	15638391
to	O	-1	15638391
ex@@	O	-1	15638391
amine	O	-1	15638391
the	O	-1	15638391
influence	O	-1	15638391
of	O	-1	15638391
hyper@@	B-Disease	D006966	15638391
prol@@	I-Disease	-1	15638391
act@@	I-Disease	-1	15638391
ine@@	I-Disease	-1	15638391
mia	I-Disease	-1	15638391
,	O	-1	15638391
induced	O	-1	15638391
by	O	-1	15638391
haloperidol	B-Chemical	D006220	15638391
(	O	-1	15638391
H@@	B-Chemical	D006220	15638391
A@@	I-Chemical	-1	15638391
L	I-Chemical	-1	15638391
)	O	-1	15638391
on	O	-1	15638391
age	O	-1	15638391
related	O	-1	15638391
morph@@	O	-1	15638391
ology	O	-1	15638391
and	O	-1	15638391
function	O	-1	15638391
changes	O	-1	15638391
of	O	-1	15638391
epi@@	O	-1	15638391
thelial	O	-1	15638391
cells	O	-1	15638391
in	O	-1	15638391
rat	O	-1	15638391
pro@@	O	-1	15638391
state	O	-1	15638391
lat@@	O	-1	15638391
eral	O	-1	15638391
lo@@	O	-1	15638391
be@@	O	-1	15638391
.	O	-1	15638391
The	O	-1	15638391
study	O	-1	15638391
was	O	-1	15638391
performed	O	-1	15638391
on	O	-1	15638391
sex@@	O	-1	15638391
ually	O	-1	15638391
mat@@	O	-1	15638391
ure	O	-1	15638391
male	O	-1	15638391
rats.	O	-1	15638391
S@@	O	-1	15638391
er@@	O	-1	15638391
um	O	-1	15638391
concentrations	O	-1	15638391
of	O	-1	15638391
prolactin	O	-1	15638391
(	O	-1	15638391
P@@	B-Chemical	D011388	15638391
R@@	I-Chemical	-1	15638391
L	I-Chemical	-1	15638391
)	O	-1	15638391
and	O	-1	15638391
test@@	B-Chemical	D013739	15638391
osterone	I-Chemical	-1	15638391
(	O	-1	15638391
T	B-Chemical	D013739	15638391
)	O	-1	15638391
were	O	-1	15638391
meas@@	O	-1	15638391
ure@@	O	-1	15638391
d.	O	-1	15638391
T@@	O	-1	15638391
is@@	O	-1	15638391
su@@	O	-1	15638391
e	O	-1	15638391
sec@@	O	-1	15638391
tions	O	-1	15638391
were	O	-1	15638391
evaluated	O	-1	15638391
with	O	-1	15638391
li@@	O	-1	15638391
ght	O	-1	15638391
and	O	-1	15638391
electro@@	O	-1	15638391
n	O	-1	15638391
micro@@	O	-1	15638391
sco@@	O	-1	15638391
p@@	O	-1	15638391
y.	O	-1	15638391
Im@@	O	-1	15638391
mun@@	O	-1	15638391
o@@	O	-1	15638391
histo@@	O	-1	15638391
chemical	O	-1	15638391
reactions	O	-1	15638391
for	O	-1	15638391
An@@	O	-1	15638391
ti@@	O	-1	15638391
-@@	O	-1	15638391
Pro@@	O	-1	15638391
li@@	O	-1	15638391
fer@@	O	-1	15638391
ating	O	-1	15638391
C@@	O	-1	15638391
el@@	O	-1	15638391
l	O	-1	15638391
N@@	O	-1	15638391
ucle@@	O	-1	15638391
ar	O	-1	15638391
An@@	O	-1	15638391
tig@@	O	-1	15638391
en	O	-1	15638391
(P@@	O	-1	15638391
C@@	O	-1	15638391
N@@	O	-1	15638391
A@@	O	-1	15638391
)	O	-1	15638391
were	O	-1	15638391
per@@	O	-1	15638391
for@@	O	-1	15638391
me@@	O	-1	15638391
d.	O	-1	15638391
In	O	-1	15638391
rats	O	-1	15638391
of	O	-1	15638391
the	O	-1	15638391
experimental	O	-1	15638391
group@@	O	-1	15638391
,	O	-1	15638391
the	O	-1	15638391
mean	O	-1	15638391
concentration	O	-1	15638391
of@@	O	-1	15638391
:	O	-1	15638391
P@@	B-Chemical	D011388	15638391
R@@	I-Chemical	-1	15638391
L	I-Chemical	-1	15638391
was	O	-1	15638391
more	O	-1	15638391
than	O	-1	15638391
tw@@	O	-1	15638391
ic@@	O	-1	15638391
e	O	-1	15638391
high@@	O	-1	15638391
er,	O	-1	15638391
whereas	O	-1	15638391
T	B-Chemical	D013739	15638391
concentration	O	-1	15638391
was	O	-1	15638391
al@@	O	-1	15638391
most	O	-1	15638391
tw@@	O	-1	15638391
ic@@	O	-1	15638391
e	O	-1	15638391
lower	O	-1	15638391
than	O	-1	15638391
that	O	-1	15638391
in	O	-1	15638391
the	O	-1	15638391
control	O	-1	15638391
group.	O	-1	15638391
L@@	O	-1	15638391
ight	O	-1	15638391
micro@@	O	-1	15638391
sco@@	O	-1	15638391
p@@	O	-1	15638391
y	O	-1	15638391
vi@@	O	-1	15638391
su@@	O	-1	15638391
al@@	O	-1	15638391
ized	O	-1	15638391
the	O	-1	15638391
follow@@	O	-1	15638391
ing@@	O	-1	15638391
:	O	-1	15638391
hyper@@	B-Disease	D006984	15638391
tro@@	I-Disease	-1	15638391
ph@@	I-Disease	-1	15638391
y	I-Disease	-1	15638391
and	O	-1	15638391
epi@@	O	-1	15638391
the@@	O	-1	15638391
li@@	O	-1	15638391
um	O	-1	15638391
hyper@@	B-Disease	D006965	15638391
pl@@	I-Disease	-1	15638391
a@@	I-Disease	-1	15638391
sia	I-Disease	-1	15638391
of	O	-1	15638391
the	O	-1	15638391
gl@@	O	-1	15638391
and@@	O	-1	15638391
ular	O	-1	15638391
duc@@	O	-1	15638391
t@@	O	-1	15638391
s,	O	-1	15638391
associated	O	-1	15638391
with	O	-1	15638391
increased	O	-1	15638391
P@@	O	-1	15638391
C@@	O	-1	15638391
NA	O	-1	15638391
ex@@	O	-1	15638391
pres@@	O	-1	15638391
sion.	O	-1	15638391
E@@	O	-1	15638391
l@@	O	-1	15638391
ect@@	O	-1	15638391
ro@@	O	-1	15638391
n	O	-1	15638391
micro@@	O	-1	15638391
sco@@	O	-1	15638391
p@@	O	-1	15638391
y	O	-1	15638391
revealed	O	-1	15638391
changes	O	-1	15638391
in	O	-1	15638391
co@@	O	-1	15638391
l@@	O	-1	15638391
um@@	O	-1	15638391
n@@	O	-1	15638391
ar	O	-1	15638391
epi@@	O	-1	15638391
thelial	O	-1	15638391
cell@@	O	-1	15638391
s,	O	-1	15638391
con@@	O	-1	15638391
cer@@	O	-1	15638391
ning	O	-1	15638391
org@@	O	-1	15638391
ane@@	O	-1	15638391
ll@@	O	-1	15638391
es,	O	-1	15638391
en@@	O	-1	15638391
g@@	O	-1	15638391
aged	O	-1	15638391
in	O	-1	15638391
protein	O	-1	15638391
syn@@	O	-1	15638391
thesis	O	-1	15638391
and	O	-1	15638391
secre@@	O	-1	15638391
tion.	O	-1	15638391

D@@	O	-1	15531665
o@@	O	-1	15531665
es	O	-1	15531665
sup@@	O	-1	15531665
ple@@	O	-1	15531665
mental	O	-1	15531665
vitamin	B-Chemical	D001205	15531665
C	I-Chemical	-1	15531665
increase	O	-1	15531665
cardiovascular	B-Disease	D002318	15531665
disease	I-Disease	-1	15531665
risk	O	-1	15531665
in	O	-1	15531665
women	O	-1	15531665
with	O	-1	15531665
dia@@	B-Disease	D003920	15531665
bet@@	I-Disease	-1	15531665
es	I-Disease	-1	15531665
?	O	-1	15531665
BACKGROUND:	O	-1	15531665
V@@	B-Chemical	D001205	15531665
it@@	I-Chemical	-1	15531665
amin	I-Chemical	-1	15531665
C	I-Chemical	-1	15531665
act@@	O	-1	15531665
s	O	-1	15531665
as	O	-1	15531665
a	O	-1	15531665
pot@@	O	-1	15531665
ent	O	-1	15531665
anti@@	O	-1	15531665
oxid@@	O	-1	15531665
ant@@	O	-1	15531665
;	O	-1	15531665
however,	O	-1	15531665
it	O	-1	15531665
can	O	-1	15531665
also	O	-1	15531665
be	O	-1	15531665
a	O	-1	15531665
pro@@	O	-1	15531665
oxid@@	O	-1	15531665
ant	O	-1	15531665
and	O	-1	15531665
glyc@@	O	-1	15531665
ate	O	-1	15531665
protein	O	-1	15531665
under	O	-1	15531665
cer@@	O	-1	15531665
t@@	O	-1	15531665
ain	O	-1	15531665
cir@@	O	-1	15531665
cum@@	O	-1	15531665
st@@	O	-1	15531665
anc@@	O	-1	15531665
es	O	-1	15531665
in	O	-1	15531665
vit@@	O	-1	15531665
ro@@	O	-1	15531665
.	O	-1	15531665
These	O	-1	15531665
observ@@	O	-1	15531665
ations	O	-1	15531665
l@@	O	-1	15531665
ed	O	-1	15531665
us	O	-1	15531665
to	O	-1	15531665
hypo@@	O	-1	15531665
the@@	O	-1	15531665
size	O	-1	15531665
that	O	-1	15531665
a	O	-1	15531665
high	O	-1	15531665
int@@	O	-1	15531665
ake	O	-1	15531665
of	O	-1	15531665
vitamin	B-Chemical	D001205	15531665
C	I-Chemical	-1	15531665
in	O	-1	15531665
dia@@	B-Disease	D003920	15531665
be@@	I-Disease	-1	15531665
tic	I-Disease	-1	15531665
per@@	O	-1	15531665
son@@	O	-1	15531665
s	O	-1	15531665
might	O	-1	15531665
pro@@	O	-1	15531665
m@@	O	-1	15531665
ot@@	O	-1	15531665
e	O	-1	15531665
a@@	B-Disease	D050197	15531665
therosclero@@	I-Disease	-1	15531665
sis	I-Disease	-1	15531665
.	O	-1	15531665
OBJECTIVE:	O	-1	15531665
The	O	-1	15531665
ob@@	O	-1	15531665
j@@	O	-1	15531665
ective	O	-1	15531665
was	O	-1	15531665
to	O	-1	15531665
ex@@	O	-1	15531665
amine	O	-1	15531665
the	O	-1	15531665
rel@@	O	-1	15531665
ation	O	-1	15531665
between	O	-1	15531665
vitamin	B-Chemical	D001205	15531665
C	I-Chemical	-1	15531665
int@@	O	-1	15531665
ake	O	-1	15531665
and	O	-1	15531665
mor@@	O	-1	15531665
t@@	O	-1	15531665
ality	O	-1	15531665
from	O	-1	15531665
cardiovascular	B-Disease	D002318	15531665
disease	I-Disease	-1	15531665
.	O	-1	15531665
D@@	O	-1	15531665
ES@@	O	-1	15531665
I@@	O	-1	15531665
G@@	O	-1	15531665
N@@	O	-1	15531665
:	O	-1	15531665
We	O	-1	15531665
studied	O	-1	15531665
the	O	-1	15531665
rel@@	O	-1	15531665
ation	O	-1	15531665
between	O	-1	15531665
vitamin	B-Chemical	D001205	15531665
C	I-Chemical	-1	15531665
int@@	O	-1	15531665
ake	O	-1	15531665
and	O	-1	15531665
mor@@	O	-1	15531665
t@@	O	-1	15531665
ality	O	-1	15531665
from	O	-1	15531665
total	O	-1	15531665
cardiovascular	B-Disease	D002318	15531665
disease	I-Disease	-1	15531665
(n	O	-1	15531665
=	O	-1	15531665
2@@	O	-1	15531665
8@@	O	-1	15531665
1),	O	-1	15531665
coronary	B-Disease	D003324	15531665
artery	I-Disease	-1	15531665
disease	I-Disease	-1	15531665
(n	O	-1	15531665
=	O	-1	15531665
17@@	O	-1	15531665
5@@	O	-1	15531665
),	O	-1	15531665
and	O	-1	15531665
strok@@	B-Disease	D020521	15531665
e	I-Disease	-1	15531665
(n	O	-1	15531665
=	O	-1	15531665
5@@	O	-1	15531665
7@@	O	-1	15531665
)	O	-1	15531665
in	O	-1	15531665
19@@	O	-1	15531665
2@@	O	-1	15531665
3	O	-1	15531665
post@@	O	-1	15531665
men@@	O	-1	15531665
o@@	O	-1	15531665
pa@@	O	-1	15531665
us@@	O	-1	15531665
al	O	-1	15531665
women	O	-1	15531665
who	O	-1	15531665
reported	O	-1	15531665
being	O	-1	15531665
dia@@	B-Disease	D003920	15531665
be@@	I-Disease	-1	15531665
tic	I-Disease	-1	15531665
at	O	-1	15531665
basel@@	O	-1	15531665
ine.	O	-1	15531665
Di@@	O	-1	15531665
et	O	-1	15531665
was	O	-1	15531665
assessed	O	-1	15531665
with	O	-1	15531665
a	O	-1	15531665
fo@@	O	-1	15531665
o@@	O	-1	15531665
d-@@	O	-1	15531665
frequency	O	-1	15531665
qu@@	O	-1	15531665
es@@	O	-1	15531665
tion@@	O	-1	15531665
na@@	O	-1	15531665
ir@@	O	-1	15531665
e	O	-1	15531665
at	O	-1	15531665
basel@@	O	-1	15531665
ine,	O	-1	15531665
and	O	-1	15531665
subjects	O	-1	15531665
initi@@	O	-1	15531665
ally	O	-1	15531665
free	O	-1	15531665
of	O	-1	15531665
coronary	B-Disease	D003324	15531665
artery	I-Disease	-1	15531665
disease	I-Disease	-1	15531665
were	O	-1	15531665
pro@@	O	-1	15531665
sp@@	O	-1	15531665
ectively	O	-1	15531665
followed	O	-1	15531665
for	O	-1	15531665
15	O	-1	15531665
y.	O	-1	15531665
RESULTS:	O	-1	15531665
After	O	-1	15531665
adjust@@	O	-1	15531665
ment	O	-1	15531665
for	O	-1	15531665
cardiovascular	B-Disease	D002318	15531665
disease	I-Disease	-1	15531665
risk	O	-1	15531665
fact@@	O	-1	15531665
or@@	O	-1	15531665
s,	O	-1	15531665
type	O	-1	15531665
of	O	-1	15531665
dia@@	B-Disease	D003920	15531665
bet@@	I-Disease	-1	15531665
es	I-Disease	-1	15531665
medic@@	O	-1	15531665
ation	O	-1	15531665
use@@	O	-1	15531665
d,	O	-1	15531665
duration	O	-1	15531665
of	O	-1	15531665
dia@@	B-Disease	D003920	15531665
bet@@	I-Disease	-1	15531665
es	I-Disease	-1	15531665
,	O	-1	15531665
and	O	-1	15531665
int@@	O	-1	15531665
ak@@	O	-1	15531665
es	O	-1	15531665
of	O	-1	15531665
fol@@	B-Chemical	D005492	15531665
ate	I-Chemical	-1	15531665
,	O	-1	15531665
vitamin	B-Chemical	D014810	15531665
E	I-Chemical	-1	15531665
,	O	-1	15531665
and	O	-1	15531665
beta-@@	B-Chemical	D019207	15531665
ca@@	I-Chemical	-1	15531665
ro@@	I-Chemical	-1	15531665
ten@@	I-Chemical	-1	15531665
e	I-Chemical	-1	15531665
,	O	-1	15531665
the	O	-1	15531665
adjust@@	O	-1	15531665
ed	O	-1	15531665
rel@@	O	-1	15531665
ative	O	-1	15531665
ris@@	O	-1	15531665
k@@	O	-1	15531665
s	O	-1	15531665
of	O	-1	15531665
total	O	-1	15531665
cardiovascular	B-Disease	D002318	15531665
disease	I-Disease	-1	15531665
mor@@	O	-1	15531665
t@@	O	-1	15531665
ality	O	-1	15531665
were	O	-1	15531665
1.@@	O	-1	15531665
0@@	O	-1	15531665
,	O	-1	15531665
0.@@	O	-1	15531665
9@@	O	-1	15531665
7@@	O	-1	15531665
,	O	-1	15531665
1.@@	O	-1	15531665
1@@	O	-1	15531665
1,	O	-1	15531665
1.@@	O	-1	15531665
4@@	O	-1	15531665
7@@	O	-1	15531665
,	O	-1	15531665
and	O	-1	15531665
1.@@	O	-1	15531665
8@@	O	-1	15531665
4	O	-1	15531665
(P	O	-1	15531665
for	O	-1	15531665
tre@@	O	-1	15531665
n@@	O	-1	15531665
d	O	-1	15531665
<	O	-1	15531665
0.0@@	O	-1	15531665
1)	O	-1	15531665
ac@@	O	-1	15531665
ros@@	O	-1	15531665
s	O	-1	15531665
qu@@	O	-1	15531665
in@@	O	-1	15531665
ti@@	O	-1	15531665
le@@	O	-1	15531665
s	O	-1	15531665
of	O	-1	15531665
total	O	-1	15531665
vitamin	B-Chemical	D001205	15531665
C	I-Chemical	-1	15531665
int@@	O	-1	15531665
ake	O	-1	15531665
from	O	-1	15531665
fo@@	O	-1	15531665
od	O	-1	15531665
and	O	-1	15531665
sup@@	O	-1	15531665
ple@@	O	-1	15531665
ment@@	O	-1	15531665
s.	O	-1	15531665
Ad@@	O	-1	15531665
j@@	O	-1	15531665
ust@@	O	-1	15531665
ed	O	-1	15531665
rel@@	O	-1	15531665
ative	O	-1	15531665
ris@@	O	-1	15531665
k@@	O	-1	15531665
s	O	-1	15531665
of	O	-1	15531665
coronary	B-Disease	D003324	15531665
artery	I-Disease	-1	15531665
disease	I-Disease	-1	15531665
were	O	-1	15531665
1.@@	O	-1	15531665
0@@	O	-1	15531665
,	O	-1	15531665
0.@@	O	-1	15531665
8@@	O	-1	15531665
1,	O	-1	15531665
0.@@	O	-1	15531665
9@@	O	-1	15531665
9@@	O	-1	15531665
,	O	-1	15531665
1.@@	O	-1	15531665
2@@	O	-1	15531665
6,	O	-1	15531665
and	O	-1	15531665
1.@@	O	-1	15531665
9@@	O	-1	15531665
1	O	-1	15531665
(P	O	-1	15531665
for	O	-1	15531665
tre@@	O	-1	15531665
n@@	O	-1	15531665
d	O	-1	15531665
=	O	-1	15531665
0.0@@	O	-1	15531665
1)	O	-1	15531665
and	O	-1	15531665
of	O	-1	15531665
strok@@	B-Disease	D020521	15531665
e	I-Disease	-1	15531665
were	O	-1	15531665
1.@@	O	-1	15531665
0@@	O	-1	15531665
,	O	-1	15531665
0.@@	O	-1	15531665
5@@	O	-1	15531665
2,	O	-1	15531665
1.@@	O	-1	15531665
2@@	O	-1	15531665
3,	O	-1	15531665
2.@@	O	-1	15531665
2@@	O	-1	15531665
2,	O	-1	15531665
and	O	-1	15531665
2.@@	O	-1	15531665
5@@	O	-1	15531665
7	O	-1	15531665
(P	O	-1	15531665
for	O	-1	15531665
tre@@	O	-1	15531665
n@@	O	-1	15531665
d	O	-1	15531665
<	O	-1	15531665
0.0@@	O	-1	15531665
1).	O	-1	15531665
Whe@@	O	-1	15531665
n	O	-1	15531665
di@@	O	-1	15531665
et@@	O	-1	15531665
ary	O	-1	15531665
and	O	-1	15531665
sup@@	O	-1	15531665
ple@@	O	-1	15531665
mental	O	-1	15531665
vitamin	B-Chemical	D001205	15531665
C	I-Chemical	-1	15531665
were	O	-1	15531665
analy@@	O	-1	15531665
zed	O	-1	15531665
se@@	O	-1	15531665
par@@	O	-1	15531665
at@@	O	-1	15531665
el@@	O	-1	15531665
y,	O	-1	15531665
only	O	-1	15531665
sup@@	O	-1	15531665
ple@@	O	-1	15531665
mental	O	-1	15531665
vitamin	B-Chemical	D001205	15531665
C	I-Chemical	-1	15531665
showed	O	-1	15531665
a	O	-1	15531665
positive	O	-1	15531665
association	O	-1	15531665
with	O	-1	15531665
mor@@	O	-1	15531665
t@@	O	-1	15531665
ality	O	-1	15531665
en@@	O	-1	15531665
d@@	O	-1	15531665
po@@	O	-1	15531665
int@@	O	-1	15531665
s.	O	-1	15531665
V@@	B-Chemical	D001205	15531665
it@@	I-Chemical	-1	15531665
amin	I-Chemical	-1	15531665
C	I-Chemical	-1	15531665
int@@	O	-1	15531665
ake	O	-1	15531665
was	O	-1	15531665
un@@	O	-1	15531665
related	O	-1	15531665
to	O	-1	15531665
mor@@	O	-1	15531665
t@@	O	-1	15531665
ality	O	-1	15531665
from	O	-1	15531665
cardiovascular	B-Disease	D002318	15531665
disease	I-Disease	-1	15531665
in	O	-1	15531665
the	O	-1	15531665
non@@	O	-1	15531665
dia@@	O	-1	15531665
be@@	O	-1	15531665
tic	O	-1	15531665
subjects	O	-1	15531665
at	O	-1	15531665
basel@@	O	-1	15531665
ine.	O	-1	15531665
CONCLUSION:	O	-1	15531665
A	O	-1	15531665
high	O	-1	15531665
vitamin	B-Chemical	D001205	15531665
C	I-Chemical	-1	15531665
int@@	O	-1	15531665
ake	O	-1	15531665
from	O	-1	15531665
sup@@	O	-1	15531665
ple@@	O	-1	15531665
ments	O	-1	15531665
is	O	-1	15531665
associated	O	-1	15531665
with	O	-1	15531665
an	O	-1	15531665
increased	O	-1	15531665
risk	O	-1	15531665
of	O	-1	15531665
cardiovascular	B-Disease	D002318	15531665
disease	I-Disease	-1	15531665
mor@@	O	-1	15531665
t@@	O	-1	15531665
ality	O	-1	15531665
in	O	-1	15531665
post@@	O	-1	15531665
men@@	O	-1	15531665
o@@	O	-1	15531665
pa@@	O	-1	15531665
us@@	O	-1	15531665
al	O	-1	15531665
women	O	-1	15531665
with	O	-1	15531665
dia@@	B-Disease	D003920	15531665
bet@@	I-Disease	-1	15531665
es	I-Disease	-1	15531665
.	O	-1	15531665

A@@	O	-1	12851669
b@@	O	-1	12851669
sol@@	O	-1	12851669
ute	O	-1	12851669
and	O	-1	12851669
at@@	O	-1	12851669
tri@@	O	-1	12851669
but@@	O	-1	12851669
able	O	-1	12851669
risk	O	-1	12851669
of	O	-1	12851669
venous	B-Disease	D054556	12851669
thrombo@@	I-Disease	-1	12851669
emb@@	I-Disease	-1	12851669
ol@@	I-Disease	-1	12851669
ism	I-Disease	-1	12851669
in	O	-1	12851669
women	O	-1	12851669
on	O	-1	12851669
combined	O	-1	12851669
cy@@	B-Chemical	D017373	12851669
pro@@	I-Chemical	-1	12851669
ter@@	I-Chemical	-1	12851669
one	I-Chemical	-1	12851669
acet@@	I-Chemical	-1	12851669
ate	I-Chemical	-1	12851669
and	O	-1	12851669
eth@@	B-Chemical	D004997	12851669
in@@	I-Chemical	-1	12851669
y@@	I-Chemical	-1	12851669
le@@	I-Chemical	-1	12851669
st@@	I-Chemical	-1	12851669
radi@@	I-Chemical	-1	12851669
ol	I-Chemical	-1	12851669
.	O	-1	12851669
OBJECTIVE:	O	-1	12851669
To	O	-1	12851669
achi@@	O	-1	12851669
e@@	O	-1	12851669
ve	O	-1	12851669
abs@@	O	-1	12851669
ol@@	O	-1	12851669
ute	O	-1	12851669
risk	O	-1	12851669
estim@@	O	-1	12851669
ates	O	-1	12851669
of	O	-1	12851669
venous	B-Disease	D054556	12851669
thrombo@@	I-Disease	-1	12851669
emb@@	I-Disease	-1	12851669
ol@@	I-Disease	-1	12851669
ism	I-Disease	-1	12851669
(	O	-1	12851669
V@@	B-Disease	D054556	12851669
T@@	I-Disease	-1	12851669
E	I-Disease	-1	12851669
)	O	-1	12851669
among	O	-1	12851669
women	O	-1	12851669
on	O	-1	12851669
cy@@	B-Chemical	D017373	12851669
pro@@	I-Chemical	-1	12851669
ter@@	I-Chemical	-1	12851669
one	I-Chemical	-1	12851669
acet@@	I-Chemical	-1	12851669
ate	I-Chemical	-1	12851669
plus	O	-1	12851669
eth@@	B-Chemical	D004997	12851669
in@@	I-Chemical	-1	12851669
y@@	I-Chemical	-1	12851669
le@@	I-Chemical	-1	12851669
st@@	I-Chemical	-1	12851669
radi@@	I-Chemical	-1	12851669
ol	I-Chemical	-1	12851669
(	O	-1	12851669
C@@	B-Chemical	D017373	12851669
P@@	I-Chemical	-1	12851669
A	I-Chemical	-1	12851669
/	O	-1	12851669
E@@	B-Chemical	D004997	12851669
E	I-Chemical	-1	12851669
),	O	-1	12851669
and	O	-1	12851669
among	O	-1	12851669
women	O	-1	12851669
on	O	-1	12851669
combined	B-Chemical	D003277	12851669
oral	I-Chemical	-1	12851669
contrac@@	I-Chemical	-1	12851669
ep@@	I-Chemical	-1	12851669
tiv@@	I-Chemical	-1	12851669
es	I-Chemical	-1	12851669
(	O	-1	12851669
CO@@	B-Chemical	D003277	12851669
C@@	I-Chemical	-1	12851669
s	I-Chemical	-1	12851669
).	O	-1	12851669
METHODS:	O	-1	12851669
F@@	O	-1	12851669
rom	O	-1	12851669
the	O	-1	12851669
D@@	O	-1	12851669
an@@	O	-1	12851669
is@@	O	-1	12851669
h	O	-1	12851669
N@@	O	-1	12851669
ation@@	O	-1	12851669
al	O	-1	12851669
Re@@	O	-1	12851669
g@@	O	-1	12851669
ist@@	O	-1	12851669
er	O	-1	12851669
of	O	-1	12851669
Patients	O	-1	12851669
(N@@	O	-1	12851669
R@@	O	-1	12851669
P@@	O	-1	12851669
),	O	-1	12851669
19@@	O	-1	12851669
9@@	O	-1	12851669
6	O	-1	12851669
to	O	-1	12851669
19@@	O	-1	12851669
9@@	O	-1	12851669
8@@	O	-1	12851669
,	O	-1	12851669
the	O	-1	12851669
recor@@	O	-1	12851669
ds	O	-1	12851669
of	O	-1	12851669
1.@@	O	-1	12851669
1	O	-1	12851669
mil@@	O	-1	12851669
li@@	O	-1	12851669
on	O	-1	12851669
D@@	O	-1	12851669
an@@	O	-1	12851669
is@@	O	-1	12851669
h	O	-1	12851669
wom@@	O	-1	12851669
en@@	O	-1	12851669
,	O	-1	12851669
ages	O	-1	12851669
15	O	-1	12851669
to	O	-1	12851669
4@@	O	-1	12851669
4	O	-1	12851669
year@@	O	-1	12851669
s,	O	-1	12851669
were	O	-1	12851669
se@@	O	-1	12851669
ar@@	O	-1	12851669
ch@@	O	-1	12851669
ed	O	-1	12851669
for	O	-1	12851669
evidence	O	-1	12851669
of	O	-1	12851669
V@@	B-Disease	D054556	12851669
T@@	I-Disease	-1	12851669
E	I-Disease	-1	12851669
.	O	-1	12851669
CO@@	B-Chemical	D003277	12851669
C	I-Chemical	-1	12851669
use	O	-1	12851669
was	O	-1	12851669
as@@	O	-1	12851669
cer@@	O	-1	12851669
t@@	O	-1	12851669
ained	O	-1	12851669
through	O	-1	12851669
ma@@	O	-1	12851669
il@@	O	-1	12851669
ed	O	-1	12851669
qu@@	O	-1	12851669
es@@	O	-1	12851669
tion@@	O	-1	12851669
na@@	O	-1	12851669
i@@	O	-1	12851669
res@@	O	-1	12851669
.	O	-1	12851669
S@@	O	-1	12851669
al@@	O	-1	12851669
es	O	-1	12851669
statis@@	O	-1	12851669
tics	O	-1	12851669
of	O	-1	12851669
CO@@	B-Chemical	D003277	12851669
C@@	I-Chemical	-1	12851669
s	I-Chemical	-1	12851669
and	O	-1	12851669
C@@	B-Chemical	D017373	12851669
P@@	I-Chemical	-1	12851669
A	I-Chemical	-1	12851669
/	O	-1	12851669
E@@	B-Chemical	D004997	12851669
E	I-Chemical	-1	12851669
were	O	-1	12851669
pro@@	O	-1	12851669
vid@@	O	-1	12851669
ed	O	-1	12851669
through	O	-1	12851669
D@@	O	-1	12851669
an@@	O	-1	12851669
is@@	O	-1	12851669
h	O	-1	12851669
D@@	O	-1	12851669
ru@@	O	-1	12851669
g	O	-1	12851669
S@@	O	-1	12851669
t@@	O	-1	12851669
atis@@	O	-1	12851669
tic@@	O	-1	12851669
s.	O	-1	12851669
RESULTS:	O	-1	12851669
D@@	O	-1	12851669
uring	O	-1	12851669
the	O	-1	12851669
time	O	-1	12851669
f@@	O	-1	12851669
ram@@	O	-1	12851669
e	O	-1	12851669
of	O	-1	12851669
the	O	-1	12851669
study,	O	-1	12851669
3@@	O	-1	12851669
30	O	-1	12851669
women	O	-1	12851669
were	O	-1	12851669
found	O	-1	12851669
to	O	-1	12851669
have	O	-1	12851669
had	O	-1	12851669
V@@	B-Disease	D054556	12851669
T@@	I-Disease	-1	12851669
E	I-Disease	-1	12851669
while	O	-1	12851669
on	O	-1	12851669
CO@@	B-Chemical	D003277	12851669
C@@	I-Chemical	-1	12851669
s	I-Chemical	-1	12851669
.	O	-1	12851669
Of	O	-1	12851669
these	O	-1	12851669
wom@@	O	-1	12851669
en@@	O	-1	12851669
,	O	-1	12851669
6@@	O	-1	12851669
7	O	-1	12851669
were	O	-1	12851669
on	O	-1	12851669
lev@@	B-Chemical	D016912	12851669
on@@	I-Chemical	-1	12851669
org@@	I-Chemical	-1	12851669
est@@	I-Chemical	-1	12851669
re@@	I-Chemical	-1	12851669
l	I-Chemical	-1	12851669
-@@	O	-1	12851669
containing	O	-1	12851669
CO@@	B-Chemical	D003277	12851669
C@@	I-Chemical	-1	12851669
s	I-Chemical	-1	12851669
.	O	-1	12851669
E@@	O	-1	12851669
le@@	O	-1	12851669
ven	O	-1	12851669
were	O	-1	12851669
on	O	-1	12851669
C@@	B-Chemical	D017373	12851669
P@@	I-Chemical	-1	12851669
A	I-Chemical	-1	12851669
/	O	-1	12851669
E@@	B-Chemical	D004997	12851669
E	I-Chemical	-1	12851669
.	O	-1	12851669
The	O	-1	12851669
cor@@	O	-1	12851669
respon@@	O	-1	12851669
ding	O	-1	12851669
abs@@	O	-1	12851669
ol@@	O	-1	12851669
ute	O	-1	12851669
risk	O	-1	12851669
of	O	-1	12851669
V@@	B-Disease	D054556	12851669
T@@	I-Disease	-1	12851669
E	I-Disease	-1	12851669
was	O	-1	12851669
3.@@	O	-1	12851669
4	O	-1	12851669
(@@	O	-1	12851669
rang@@	O	-1	12851669
e,	O	-1	12851669
3.@@	O	-1	12851669
1-@@	O	-1	12851669
3.@@	O	-1	12851669
8@@	O	-1	12851669
)	O	-1	12851669
per	O	-1	12851669
10	O	-1	12851669
0@@	O	-1	12851669
00	O	-1	12851669
women	O	-1	12851669
years	O	-1	12851669
among	O	-1	12851669
the	O	-1	12851669
women	O	-1	12851669
on	O	-1	12851669
CO@@	B-Chemical	D003277	12851669
C@@	I-Chemical	-1	12851669
s	I-Chemical	-1	12851669
,	O	-1	12851669
4.@@	O	-1	12851669
2	O	-1	12851669
(@@	O	-1	12851669
rang@@	O	-1	12851669
e,	O	-1	12851669
3.@@	O	-1	12851669
2-@@	O	-1	12851669
5.@@	O	-1	12851669
2)	O	-1	12851669
per	O	-1	12851669
10	O	-1	12851669
0@@	O	-1	12851669
00	O	-1	12851669
women	O	-1	12851669
years	O	-1	12851669
among	O	-1	12851669
women	O	-1	12851669
on	O	-1	12851669
lev@@	B-Chemical	D016912	12851669
on@@	I-Chemical	-1	12851669
org@@	I-Chemical	-1	12851669
est@@	I-Chemical	-1	12851669
re@@	I-Chemical	-1	12851669
l	I-Chemical	-1	12851669
-@@	O	-1	12851669
containing	O	-1	12851669
CO@@	B-Chemical	D003277	12851669
C@@	I-Chemical	-1	12851669
s	I-Chemical	-1	12851669
,	O	-1	12851669
and	O	-1	12851669
3.@@	O	-1	12851669
1	O	-1	12851669
(@@	O	-1	12851669
rang@@	O	-1	12851669
e,	O	-1	12851669
1.@@	O	-1	12851669
3-@@	O	-1	12851669
4.@@	O	-1	12851669
9@@	O	-1	12851669
)	O	-1	12851669
per	O	-1	12851669
10	O	-1	12851669
0@@	O	-1	12851669
00	O	-1	12851669
women	O	-1	12851669
years	O	-1	12851669
among	O	-1	12851669
the	O	-1	12851669
women	O	-1	12851669
on	O	-1	12851669
C@@	B-Chemical	D017373	12851669
P@@	I-Chemical	-1	12851669
A	I-Chemical	-1	12851669
/	O	-1	12851669
E@@	B-Chemical	D004997	12851669
E	I-Chemical	-1	12851669
.	O	-1	12851669
CONCLUSION:	O	-1	12851669
Our	O	-1	12851669
results	O	-1	12851669
suggest	O	-1	12851669
the	O	-1	12851669
abs@@	O	-1	12851669
ol@@	O	-1	12851669
ute	O	-1	12851669
risk	O	-1	12851669
of	O	-1	12851669
V@@	B-Disease	D054556	12851669
T@@	I-Disease	-1	12851669
E	I-Disease	-1	12851669
among	O	-1	12851669
D@@	O	-1	12851669
an@@	O	-1	12851669
is@@	O	-1	12851669
h	O	-1	12851669
women	O	-1	12851669
on	O	-1	12851669
CO@@	B-Chemical	D003277	12851669
C@@	I-Chemical	-1	12851669
s	I-Chemical	-1	12851669
is	O	-1	12851669
similar	O	-1	12851669
to	O	-1	12851669
that	O	-1	12851669
among	O	-1	12851669
women	O	-1	12851669
taking	O	-1	12851669
C@@	B-Chemical	D017373	12851669
P@@	I-Chemical	-1	12851669
A	I-Chemical	-1	12851669
/	O	-1	12851669
E@@	B-Chemical	D004997	12851669
E	I-Chemical	-1	12851669
.	O	-1	12851669

Eff@@	O	-1	12842176
ect	O	-1	12842176
of	O	-1	12842176
l@@	B-Chemical	D001556	12842176
ind@@	I-Chemical	-1	12842176
ane	I-Chemical	-1	12842176
on	O	-1	12842176
hepatic	O	-1	12842176
and	O	-1	12842176
brain	O	-1	12842176
cyto@@	O	-1	12842176
ch@@	O	-1	12842176
rom@@	O	-1	12842176
e	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50@@	O	-1	12842176
s	O	-1	12842176
and	O	-1	12842176
influence	O	-1	12842176
of	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
mod@@	O	-1	12842176
ulation	O	-1	12842176
in	O	-1	12842176
l@@	B-Chemical	D001556	12842176
ind@@	I-Chemical	-1	12842176
ane	I-Chemical	-1	12842176
induced	O	-1	12842176
neuro@@	B-Disease	D020258	12842176
toxicity	I-Disease	-1	12842176
.	O	-1	12842176
O@@	O	-1	12842176
ral	O	-1	12842176
administration	O	-1	12842176
of	O	-1	12842176
l@@	B-Chemical	D001556	12842176
ind@@	I-Chemical	-1	12842176
ane	I-Chemical	-1	12842176
(2@@	O	-1	12842176
.@@	O	-1	12842176
5,	O	-1	12842176
5,	O	-1	12842176
10	O	-1	12842176
and	O	-1	12842176
15	O	-1	12842176
mg/kg@@	O	-1	12842176
,	O	-1	12842176
body	O	-1	12842176
weigh@@	O	-1	12842176
t@@	O	-1	12842176
)	O	-1	12842176
for	O	-1	12842176
5	O	-1	12842176
days	O	-1	12842176
was	O	-1	12842176
found	O	-1	12842176
to	O	-1	12842176
produce	O	-1	12842176
a	O	-1	12842176
dose-@@	O	-1	12842176
dependent	O	-1	12842176
increase	O	-1	12842176
in	O	-1	12842176
the	O	-1	12842176
activity	O	-1	12842176
of	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
dependent	O	-1	12842176
7-@@	O	-1	12842176
eth@@	O	-1	12842176
oxy@@	O	-1	12842176
res@@	O	-1	12842176
or@@	O	-1	12842176
u@@	O	-1	12842176
f@@	O	-1	12842176
in-@@	O	-1	12842176
O@@	O	-1	12842176
-@@	O	-1	12842176
de@@	O	-1	12842176
eth@@	O	-1	12842176
yl@@	O	-1	12842176
ase	O	-1	12842176
(@@	O	-1	12842176
E@@	O	-1	12842176
RO@@	O	-1	12842176
D@@	O	-1	12842176
),	O	-1	12842176
7-@@	O	-1	12842176
pent@@	O	-1	12842176
oxy@@	O	-1	12842176
res@@	O	-1	12842176
or@@	O	-1	12842176
u@@	O	-1	12842176
f@@	O	-1	12842176
in-@@	O	-1	12842176
O@@	O	-1	12842176
-@@	O	-1	12842176
de@@	O	-1	12842176
al@@	O	-1	12842176
k@@	O	-1	12842176
yl@@	O	-1	12842176
ase	O	-1	12842176
(P@@	O	-1	12842176
RO@@	O	-1	12842176
D)	O	-1	12842176
and	O	-1	12842176
N@@	B-Chemical	D004128	12842176
-@@	I-Chemical	-1	12842176
nit@@	I-Chemical	-1	12842176
ros@@	I-Chemical	-1	12842176
odi@@	I-Chemical	-1	12842176
methyl@@	I-Chemical	-1	12842176
amine	I-Chemical	-1	12842176
de@@	O	-1	12842176
methyl@@	O	-1	12842176
ase	O	-1	12842176
(	O	-1	12842176
N@@	B-Chemical	D004128	12842176
D@@	I-Chemical	-1	12842176
M@@	I-Chemical	-1	12842176
A	I-Chemical	-1	12842176
-@@	O	-1	12842176
d@@	O	-1	12842176
)	O	-1	12842176
in	O	-1	12842176
rat	O	-1	12842176
brain	O	-1	12842176
and	O	-1	12842176
li@@	O	-1	12842176
ver@@	O	-1	12842176
.	O	-1	12842176
A	O	-1	12842176
significant	O	-1	12842176
increase	O	-1	12842176
in	O	-1	12842176
the	O	-1	12842176
hepatic	O	-1	12842176
and	O	-1	12842176
brain	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
mon@@	O	-1	12842176
o@@	O	-1	12842176
oxy@@	O	-1	12842176
gen@@	O	-1	12842176
as@@	O	-1	12842176
es	O	-1	12842176
was	O	-1	12842176
also	O	-1	12842176
observed	O	-1	12842176
when	O	-1	12842176
the	O	-1	12842176
duration	O	-1	12842176
of	O	-1	12842176
exposure	O	-1	12842176
of	O	-1	12842176
low	O	-1	12842176
dose	O	-1	12842176
(2@@	O	-1	12842176
.@@	O	-1	12842176
5	O	-1	12842176
mg/kg)	O	-1	12842176
of	O	-1	12842176
l@@	B-Chemical	D001556	12842176
ind@@	I-Chemical	-1	12842176
ane	I-Chemical	-1	12842176
was	O	-1	12842176
increased	O	-1	12842176
from	O	-1	12842176
5	O	-1	12842176
days	O	-1	12842176
to	O	-1	12842176
15	O	-1	12842176
or	O	-1	12842176
21	O	-1	12842176
days.	O	-1	12842176
A@@	O	-1	12842176
s	O	-1	12842176
observed	O	-1	12842176
with	O	-1	12842176
different	O	-1	12842176
dos@@	O	-1	12842176
es,	O	-1	12842176
the	O	-1	12842176
mag@@	O	-1	12842176
nit@@	O	-1	12842176
ude	O	-1	12842176
of	O	-1	12842176
induction	O	-1	12842176
in	O	-1	12842176
the	O	-1	12842176
activity	O	-1	12842176
of	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
mon@@	O	-1	12842176
o@@	O	-1	12842176
oxy@@	O	-1	12842176
gen@@	O	-1	12842176
as@@	O	-1	12842176
es	O	-1	12842176
was	O	-1	12842176
several	O	-1	12842176
fol@@	O	-1	12842176
d	O	-1	12842176
higher	O	-1	12842176
in	O	-1	12842176
liver	O	-1	12842176
micro@@	O	-1	12842176
s@@	O	-1	12842176
om@@	O	-1	12842176
es	O	-1	12842176
when	O	-1	12842176
compared	O	-1	12842176
with	O	-1	12842176
the	O	-1	12842176
bra@@	O	-1	12842176
in.	O	-1	12842176
W@@	O	-1	12842176
est@@	O	-1	12842176
er@@	O	-1	12842176
n	O	-1	12842176
blo@@	O	-1	12842176
t@@	O	-1	12842176
ting	O	-1	12842176
studies	O	-1	12842176
have	O	-1	12842176
indic@@	O	-1	12842176
ated	O	-1	12842176
that	O	-1	12842176
the	O	-1	12842176
increase	O	-1	12842176
in	O	-1	12842176
the	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
enzym@@	O	-1	12842176
es	O	-1	12842176
could	O	-1	12842176
be	O	-1	12842176
due	O	-1	12842176
to	O	-1	12842176
the	O	-1	12842176
increase	O	-1	12842176
in	O	-1	12842176
the	O	-1	12842176
expression	O	-1	12842176
of	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
1@@	O	-1	12842176
A@@	O	-1	12842176
1@@	O	-1	12842176
/@@	O	-1	12842176
1@@	O	-1	12842176
A@@	O	-1	12842176
2,	O	-1	12842176
2@@	O	-1	12842176
B@@	O	-1	12842176
1@@	O	-1	12842176
/@@	O	-1	12842176
2@@	O	-1	12842176
B@@	O	-1	12842176
2	O	-1	12842176
and	O	-1	12842176
2@@	O	-1	12842176
E@@	O	-1	12842176
1	O	-1	12842176
iso@@	O	-1	12842176
enzym@@	O	-1	12842176
es.	O	-1	12842176
In	O	-1	12842176
vit@@	O	-1	12842176
r@@	O	-1	12842176
o	O	-1	12842176
studies	O	-1	12842176
using	O	-1	12842176
org@@	O	-1	12842176
anic	O	-1	12842176
inhibitors	O	-1	12842176
specific	O	-1	12842176
for	O	-1	12842176
individ@@	O	-1	12842176
ual	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
iso@@	O	-1	12842176
enzym@@	O	-1	12842176
es	O	-1	12842176
and	O	-1	12842176
anti@@	O	-1	12842176
body	O	-1	12842176
inhibition	O	-1	12842176
experim@@	O	-1	12842176
ents	O	-1	12842176
have	O	-1	12842176
further	O	-1	12842176
demonstrated	O	-1	12842176
that	O	-1	12842176
the	O	-1	12842176
increase	O	-1	12842176
in	O	-1	12842176
the	O	-1	12842176
activity	O	-1	12842176
of	O	-1	12842176
P@@	O	-1	12842176
RO@@	O	-1	12842176
D@@	O	-1	12842176
,	O	-1	12842176
E@@	O	-1	12842176
RO@@	O	-1	12842176
D	O	-1	12842176
and	O	-1	12842176
N@@	B-Chemical	D004128	12842176
D@@	I-Chemical	-1	12842176
M@@	I-Chemical	-1	12842176
A	I-Chemical	-1	12842176
-@@	O	-1	12842176
d	O	-1	12842176
are	O	-1	12842176
due	O	-1	12842176
to	O	-1	12842176
the	O	-1	12842176
increase	O	-1	12842176
in	O	-1	12842176
the	O	-1	12842176
levels	O	-1	12842176
of	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
2@@	O	-1	12842176
B@@	O	-1	12842176
1@@	O	-1	12842176
/@@	O	-1	12842176
2@@	O	-1	12842176
B@@	O	-1	12842176
2,	O	-1	12842176
1@@	O	-1	12842176
A@@	O	-1	12842176
1@@	O	-1	12842176
/@@	O	-1	12842176
1@@	O	-1	12842176
A@@	O	-1	12842176
2	O	-1	12842176
and	O	-1	12842176
2@@	O	-1	12842176
E@@	O	-1	12842176
1	O	-1	12842176
iso@@	O	-1	12842176
enzym@@	O	-1	12842176
es,	O	-1	12842176
respectively.	O	-1	12842176
In@@	O	-1	12842176
duction	O	-1	12842176
studies	O	-1	12842176
have	O	-1	12842176
further	O	-1	12842176
shown	O	-1	12842176
that	O	-1	12842176
while	O	-1	12842176
pretreatment	O	-1	12842176
of	O	-1	12842176
3-@@	B-Chemical	D008748	12842176
methyl@@	I-Chemical	-1	12842176
chol@@	I-Chemical	-1	12842176
an@@	I-Chemical	-1	12842176
th@@	I-Chemical	-1	12842176
ren@@	I-Chemical	-1	12842176
e	I-Chemical	-1	12842176
(	O	-1	12842176
M@@	B-Chemical	D008748	12842176
C	I-Chemical	-1	12842176
),	O	-1	12842176
an	O	-1	12842176
induc@@	O	-1	12842176
er	O	-1	12842176
of	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50@@	O	-1	12842176
1@@	O	-1	12842176
A@@	O	-1	12842176
1@@	O	-1	12842176
/@@	O	-1	12842176
1@@	O	-1	12842176
A@@	O	-1	12842176
2,	O	-1	12842176
did	O	-1	12842176
not	O	-1	12842176
produce	O	-1	12842176
any	O	-1	12842176
significant	O	-1	12842176
effect	O	-1	12842176
in	O	-1	12842176
the	O	-1	12842176
incidence	O	-1	12842176
of	O	-1	12842176
l@@	B-Chemical	D001556	12842176
ind@@	I-Chemical	-1	12842176
ane	I-Chemical	-1	12842176
induced	O	-1	12842176
convul@@	B-Disease	D012640	12842176
sions	I-Disease	-1	12842176
,	O	-1	12842176
pretreatment	O	-1	12842176
with	O	-1	12842176
phenobarbit@@	B-Chemical	D010634	12842176
al	I-Chemical	-1	12842176
(P@@	O	-1	12842176
B@@	O	-1	12842176
),	O	-1	12842176
an	O	-1	12842176
induc@@	O	-1	12842176
er	O	-1	12842176
of	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
2@@	O	-1	12842176
B@@	O	-1	12842176
1@@	O	-1	12842176
/@@	O	-1	12842176
2@@	O	-1	12842176
B@@	O	-1	12842176
2	O	-1	12842176
or	O	-1	12842176
eth@@	B-Chemical	D000431	12842176
an@@	I-Chemical	-1	12842176
ol	I-Chemical	-1	12842176
,	O	-1	12842176
an	O	-1	12842176
induc@@	O	-1	12842176
er	O	-1	12842176
of	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
2@@	O	-1	12842176
E@@	O	-1	12842176
1	O	-1	12842176
cat@@	O	-1	12842176
al@@	O	-1	12842176
ys@@	O	-1	12842176
ed	O	-1	12842176
reac@@	O	-1	12842176
tion@@	O	-1	12842176
s,	O	-1	12842176
significantly	O	-1	12842176
increased	O	-1	12842176
the	O	-1	12842176
incidence	O	-1	12842176
of	O	-1	12842176
l@@	B-Chemical	D001556	12842176
ind@@	I-Chemical	-1	12842176
ane	I-Chemical	-1	12842176
induced	O	-1	12842176
convul@@	B-Disease	D012640	12842176
sions	I-Disease	-1	12842176
.	O	-1	12842176
S@@	O	-1	12842176
im@@	O	-1	12842176
il@@	O	-1	12842176
ar@@	O	-1	12842176
ly,	O	-1	12842176
when	O	-1	12842176
the	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50@@	O	-1	12842176
-@@	O	-1	12842176
mediated	O	-1	12842176
metabol@@	O	-1	12842176
ism	O	-1	12842176
of	O	-1	12842176
l@@	B-Chemical	D001556	12842176
ind@@	I-Chemical	-1	12842176
ane	I-Chemical	-1	12842176
was	O	-1	12842176
block@@	O	-1	12842176
ed	O	-1	12842176
by	O	-1	12842176
co@@	B-Chemical	C018021	12842176
b@@	I-Chemical	-1	12842176
al@@	I-Chemical	-1	12842176
t	I-Chemical	-1	12842176
chlor@@	I-Chemical	-1	12842176
ide	I-Chemical	-1	12842176
incidence	O	-1	12842176
of	O	-1	12842176
convul@@	B-Disease	D012640	12842176
sions	I-Disease	-1	12842176
was	O	-1	12842176
increased	O	-1	12842176
in	O	-1	12842176
animals	O	-1	12842176
treated	O	-1	12842176
with	O	-1	12842176
l@@	B-Chemical	D001556	12842176
ind@@	I-Chemical	-1	12842176
ane	I-Chemical	-1	12842176
indicating	O	-1	12842176
that	O	-1	12842176
l@@	B-Chemical	D001556	12842176
ind@@	I-Chemical	-1	12842176
ane	I-Chemical	-1	12842176
per	O	-1	12842176
se	O	-1	12842176
or	O	-1	12842176
its	O	-1	12842176
metabol@@	O	-1	12842176
it@@	O	-1	12842176
es	O	-1	12842176
form@@	O	-1	12842176
ed	O	-1	12842176
by	O	-1	12842176
P@@	O	-1	12842176
B	O	-1	12842176
or	O	-1	12842176
eth@@	B-Chemical	D000431	12842176
an@@	I-Chemical	-1	12842176
ol	I-Chemical	-1	12842176
induc@@	O	-1	12842176
i@@	O	-1	12842176
ble	O	-1	12842176
P@@	O	-1	12842176
4@@	O	-1	12842176
50	O	-1	12842176
iso@@	O	-1	12842176
enzym@@	O	-1	12842176
es	O	-1	12842176
are	O	-1	12842176
involved	O	-1	12842176
in	O	-1	12842176
its	O	-1	12842176
neuro@@	O	-1	12842176
behavioral	O	-1	12842176
toxicity	B-Disease	D064420	12842176
.	O	-1	12842176

S@@	B-Disease	D012640	12745515
e@@	I-Disease	-1	12745515
iz@@	I-Disease	-1	12745515
ure	I-Disease	-1	12745515
associated	O	-1	12745515
with	O	-1	12745515
sleep	B-Disease	D012892	12745515
de@@	I-Disease	-1	12745515
pri@@	I-Disease	-1	12745515
v@@	I-Disease	-1	12745515
ation	I-Disease	-1	12745515
and	O	-1	12745515
su@@	O	-1	12745515
st@@	O	-1	12745515
a@@	O	-1	12745515
ine@@	O	-1	12745515
d-@@	O	-1	12745515
release	O	-1	12745515
bu@@	B-Chemical	D016642	12745515
pro@@	I-Chemical	-1	12745515
pi@@	I-Chemical	-1	12745515
on	I-Chemical	-1	12745515
.	O	-1	12745515
This	O	-1	12745515
case	O	-1	12745515
report	O	-1	12745515
descri@@	O	-1	12745515
b@@	O	-1	12745515
es	O	-1	12745515
a	O	-1	12745515
gener@@	O	-1	12745515
al@@	O	-1	12745515
ized	O	-1	12745515
seizure	B-Disease	D012640	12745515
associated	O	-1	12745515
with	O	-1	12745515
su@@	O	-1	12745515
st@@	O	-1	12745515
a@@	O	-1	12745515
ine@@	O	-1	12745515
d-@@	O	-1	12745515
release	O	-1	12745515
bu@@	B-Chemical	D016642	12745515
pro@@	I-Chemical	-1	12745515
pi@@	I-Chemical	-1	12745515
on	I-Chemical	-1	12745515
use	O	-1	12745515
and	O	-1	12745515
sleep	B-Disease	D012892	12745515
de@@	I-Disease	-1	12745515
pri@@	I-Disease	-1	12745515
v@@	I-Disease	-1	12745515
ation	I-Disease	-1	12745515
.	O	-1	12745515
The	O	-1	12745515
subj@@	O	-1	12745515
ect@@	O	-1	12745515
,	O	-1	12745515
a	O	-1	12745515
3@@	O	-1	12745515
1-@@	O	-1	12745515
year-old	O	-1	12745515
female	O	-1	12745515
smo@@	O	-1	12745515
k@@	O	-1	12745515
er,	O	-1	12745515
was	O	-1	12745515
partic@@	O	-1	12745515
ip@@	O	-1	12745515
ating	O	-1	12745515
in	O	-1	12745515
a	O	-1	12745515
clinical	O	-1	12745515
trial	O	-1	12745515
evalu@@	O	-1	12745515
ating	O	-1	12745515
an	O	-1	12745515
investig@@	O	-1	12745515
ation@@	O	-1	12745515
al	O	-1	12745515
medic@@	O	-1	12745515
ation	O	-1	12745515
for	O	-1	12745515
smo@@	O	-1	12745515
king	O	-1	12745515
cess@@	O	-1	12745515
ation	O	-1	12745515
that	O	-1	12745515
used	O	-1	12745515
su@@	O	-1	12745515
st@@	O	-1	12745515
a@@	O	-1	12745515
ine@@	O	-1	12745515
d-@@	O	-1	12745515
release	O	-1	12745515
bu@@	B-Chemical	D016642	12745515
pro@@	I-Chemical	-1	12745515
pi@@	I-Chemical	-1	12745515
on	I-Chemical	-1	12745515
as	O	-1	12745515
an	O	-1	12745515
active	O	-1	12745515
control@@	O	-1	12745515
.	O	-1	12745515
After	O	-1	12745515
5	O	-1	12745515
weeks	O	-1	12745515
of	O	-1	12745515
bu@@	B-Chemical	D016642	12745515
pro@@	I-Chemical	-1	12745515
pi@@	I-Chemical	-1	12745515
on	I-Chemical	-1	12745515
use@@	O	-1	12745515
,	O	-1	12745515
the	O	-1	12745515
subj@@	O	-1	12745515
ect	O	-1	12745515
experienced	O	-1	12745515
a	O	-1	12745515
gener@@	O	-1	12745515
al@@	O	-1	12745515
ized	O	-1	12745515
t@@	O	-1	12745515
onic	O	-1	12745515
clon@@	O	-1	12745515
ic	O	-1	12745515
seizure	B-Disease	D012640	12745515
after	O	-1	12745515
st@@	O	-1	12745515
ay@@	O	-1	12745515
ing	O	-1	12745515
up	O	-1	12745515
ne@@	O	-1	12745515
arly	O	-1	12745515
all	O	-1	12745515
n@@	O	-1	12745515
ight	O	-1	12745515
pac@@	O	-1	12745515
king	O	-1	12745515
and	O	-1	12745515
mo@@	O	-1	12745515
ving	O	-1	12745515
to	O	-1	12745515
a	O	-1	12745515
new	O	-1	12745515
re@@	O	-1	12745515
si@@	O	-1	12745515
d@@	O	-1	12745515
ence@@	O	-1	12745515
.	O	-1	12745515
The	O	-1	12745515
patient	O	-1	12745515
had	O	-1	12745515
no	O	-1	12745515
other	O	-1	12745515
risk	O	-1	12745515
factors	O	-1	12745515
for	O	-1	12745515
seizures	B-Disease	D012640	12745515
.	O	-1	12745515
We	O	-1	12745515
suggest	O	-1	12745515
that	O	-1	12745515
sleep	B-Disease	D012892	12745515
de@@	I-Disease	-1	12745515
pri@@	I-Disease	-1	12745515
v@@	I-Disease	-1	12745515
ation	I-Disease	-1	12745515
may	O	-1	12745515
ad@@	O	-1	12745515
d	O	-1	12745515
to	O	-1	12745515
the	O	-1	12745515
risk	O	-1	12745515
of	O	-1	12745515
bu@@	B-Chemical	D016642	12745515
pro@@	I-Chemical	-1	12745515
pi@@	I-Chemical	-1	12745515
on	I-Chemical	-1	12745515
-@@	O	-1	12745515
associated	O	-1	12745515
seizures	B-Disease	D012640	12745515
.	O	-1	12745515

Ne@@	B-Disease	D007674	12571256
ph@@	I-Disease	-1	12571256
ro@@	I-Disease	-1	12571256
toxic	I-Disease	-1	12571256
effects	O	-1	12571256
in	O	-1	12571256
high-@@	O	-1	12571256
risk	O	-1	12571256
patients	O	-1	12571256
under@@	O	-1	12571256
go@@	O	-1	12571256
ing	O	-1	12571256
angio@@	O	-1	12571256
graph@@	O	-1	12571256
y.	O	-1	12571256
BACKGROUND:	O	-1	12571256
The	O	-1	12571256
use	O	-1	12571256
of	O	-1	12571256
iod@@	O	-1	12571256
in@@	O	-1	12571256
ated	O	-1	12571256
contr@@	O	-1	12571256
ast	O	-1	12571256
medi@@	O	-1	12571256
um	O	-1	12571256
can	O	-1	12571256
result	O	-1	12571256
in	O	-1	12571256
nephro@@	B-Disease	D007674	12571256
pathy	I-Disease	-1	12571256
.	O	-1	12571256
Whe@@	O	-1	12571256
ther	O	-1	12571256
iso@@	O	-1	12571256
-@@	O	-1	12571256
os@@	O	-1	12571256
mol@@	O	-1	12571256
ar	O	-1	12571256
contr@@	O	-1	12571256
ast	O	-1	12571256
medi@@	O	-1	12571256
um	O	-1	12571256
is	O	-1	12571256
less	O	-1	12571256
nephro@@	B-Disease	D007674	12571256
toxic	I-Disease	-1	12571256
than	O	-1	12571256
low@@	O	-1	12571256
-@@	O	-1	12571256
os@@	O	-1	12571256
mol@@	O	-1	12571256
ar	O	-1	12571256
contr@@	O	-1	12571256
ast	O	-1	12571256
medi@@	O	-1	12571256
um	O	-1	12571256
in	O	-1	12571256
high-@@	O	-1	12571256
risk	O	-1	12571256
patients	O	-1	12571256
is	O	-1	12571256
unc@@	O	-1	12571256
er@@	O	-1	12571256
t@@	O	-1	12571256
ain@@	O	-1	12571256
.	O	-1	12571256
METHODS:	O	-1	12571256
We	O	-1	12571256
con@@	O	-1	12571256
duc@@	O	-1	12571256
ted	O	-1	12571256
a	O	-1	12571256
random@@	O	-1	12571256
iz@@	O	-1	12571256
ed,	O	-1	12571256
double-bl@@	O	-1	12571256
ind@@	O	-1	12571256
,	O	-1	12571256
pro@@	O	-1	12571256
sp@@	O	-1	12571256
ecti@@	O	-1	12571256
ve,	O	-1	12571256
mul@@	O	-1	12571256
tic@@	O	-1	12571256
ent@@	O	-1	12571256
er	O	-1	12571256
study	O	-1	12571256
compar@@	O	-1	12571256
ing	O	-1	12571256
the	O	-1	12571256
nephro@@	B-Disease	D007674	12571256
toxic	I-Disease	-1	12571256
effects	O	-1	12571256
of	O	-1	12571256
an	O	-1	12571256
iso@@	O	-1	12571256
-@@	O	-1	12571256
os@@	O	-1	12571256
mol@@	O	-1	12571256
ar@@	O	-1	12571256
,	O	-1	12571256
di@@	O	-1	12571256
mer@@	O	-1	12571256
ic@@	O	-1	12571256
,	O	-1	12571256
non@@	O	-1	12571256
i@@	O	-1	12571256
onic	O	-1	12571256
contr@@	O	-1	12571256
ast	O	-1	12571256
medi@@	O	-1	12571256
um,	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
,	O	-1	12571256
with	O	-1	12571256
those	O	-1	12571256
of	O	-1	12571256
a	O	-1	12571256
low@@	O	-1	12571256
-@@	O	-1	12571256
os@@	O	-1	12571256
mol@@	O	-1	12571256
ar@@	O	-1	12571256
,	O	-1	12571256
non@@	O	-1	12571256
i@@	O	-1	12571256
on@@	O	-1	12571256
ic@@	O	-1	12571256
,	O	-1	12571256
mon@@	O	-1	12571256
om@@	O	-1	12571256
er@@	O	-1	12571256
ic	O	-1	12571256
contr@@	O	-1	12571256
ast	O	-1	12571256
medi@@	O	-1	12571256
um,	O	-1	12571256
io@@	B-Chemical	D007472	12571256
he@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
.	O	-1	12571256
The	O	-1	12571256
study	O	-1	12571256
involved	O	-1	12571256
12@@	O	-1	12571256
9	O	-1	12571256
patients	O	-1	12571256
with	O	-1	12571256
dia@@	B-Disease	D003920	12571256
bet@@	I-Disease	-1	12571256
es	I-Disease	-1	12571256
with	O	-1	12571256
serum	O	-1	12571256
creatinine	B-Chemical	D003404	12571256
concentrations	O	-1	12571256
of	O	-1	12571256
1.@@	O	-1	12571256
5	O	-1	12571256
to	O	-1	12571256
3.@@	O	-1	12571256
5	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
who	O	-1	12571256
under@@	O	-1	12571256
w@@	O	-1	12571256
ent	O	-1	12571256
coronary	O	-1	12571256
or	O	-1	12571256
a@@	O	-1	12571256
or@@	O	-1	12571256
to@@	O	-1	12571256
fem@@	O	-1	12571256
oral	O	-1	12571256
angio@@	O	-1	12571256
graph@@	O	-1	12571256
y.	O	-1	12571256
The	O	-1	12571256
prim@@	O	-1	12571256
ary	O	-1	12571256
end	O	-1	12571256
po@@	O	-1	12571256
in@@	O	-1	12571256
t	O	-1	12571256
was	O	-1	12571256
the	O	-1	12571256
pe@@	O	-1	12571256
a@@	O	-1	12571256
k	O	-1	12571256
increase	O	-1	12571256
from	O	-1	12571256
b@@	O	-1	12571256
ase	O	-1	12571256
line	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
creatinine	B-Chemical	D003404	12571256
concentration	O	-1	12571256
during	O	-1	12571256
the	O	-1	12571256
three	O	-1	12571256
days	O	-1	12571256
after	O	-1	12571256
angio@@	O	-1	12571256
graph@@	O	-1	12571256
y.	O	-1	12571256
O@@	O	-1	12571256
ther	O	-1	12571256
end	O	-1	12571256
po@@	O	-1	12571256
int@@	O	-1	12571256
s	O	-1	12571256
were	O	-1	12571256
an	O	-1	12571256
increase	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
creatinine	B-Chemical	D003404	12571256
concentration	O	-1	12571256
of	O	-1	12571256
0.@@	O	-1	12571256
5	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
or	O	-1	12571256
mo@@	O	-1	12571256
re,	O	-1	12571256
an	O	-1	12571256
increase	O	-1	12571256
of	O	-1	12571256
1.@@	O	-1	12571256
0	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
or	O	-1	12571256
mo@@	O	-1	12571256
re,	O	-1	12571256
and	O	-1	12571256
a	O	-1	12571256
change	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
creatinine	B-Chemical	D003404	12571256
concentration	O	-1	12571256
from	O	-1	12571256
day	O	-1	12571256
0	O	-1	12571256
to	O	-1	12571256
day	O	-1	12571256
7@@	O	-1	12571256
.	O	-1	12571256
RESULTS:	O	-1	12571256
The	O	-1	12571256
creatinine	B-Chemical	D003404	12571256
concentration	O	-1	12571256
increased	O	-1	12571256
significantly	O	-1	12571256
less	O	-1	12571256
in	O	-1	12571256
patients	O	-1	12571256
who	O	-1	12571256
received	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
.	O	-1	12571256
F@@	O	-1	12571256
rom	O	-1	12571256
day	O	-1	12571256
0	O	-1	12571256
to	O	-1	12571256
day	O	-1	12571256
3,	O	-1	12571256
the	O	-1	12571256
mean	O	-1	12571256
pe@@	O	-1	12571256
a@@	O	-1	12571256
k	O	-1	12571256
increase	O	-1	12571256
in	O	-1	12571256
creatinine	B-Chemical	D003404	12571256
was	O	-1	12571256
0.@@	O	-1	12571256
13	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group	O	-1	12571256
and	O	-1	12571256
0.@@	O	-1	12571256
5@@	O	-1	12571256
5	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	D007472	12571256
he@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group	O	-1	12571256
(P@@	O	-1	12571256
=@@	O	-1	12571256
0.00@@	O	-1	12571256
1@@	O	-1	12571256
;	O	-1	12571256
the	O	-1	12571256
increase	O	-1	12571256
with	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
min@@	O	-1	12571256
us	O	-1	12571256
the	O	-1	12571256
increase	O	-1	12571256
with	O	-1	12571256
io@@	B-Chemical	D007472	12571256
he@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
,	O	-1	12571256
-@@	O	-1	12571256
0.@@	O	-1	12571256
4@@	O	-1	12571256
2	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
[@@	O	-1	12571256
9@@	O	-1	12571256
5	O	-1	12571256
perc@@	O	-1	12571256
ent	O	-1	12571256
conf@@	O	-1	12571256
idence	O	-1	12571256
inter@@	O	-1	12571256
val@@	O	-1	12571256
,	O	-1	12571256
-@@	O	-1	12571256
0.@@	O	-1	12571256
7@@	O	-1	12571256
3	O	-1	12571256
to	O	-1	12571256
-@@	O	-1	12571256
0.@@	O	-1	12571256
2@@	O	-1	12571256
2@@	O	-1	12571256
]@@	O	-1	12571256
).	O	-1	12571256
Two	O	-1	12571256
of	O	-1	12571256
the	O	-1	12571256
6@@	O	-1	12571256
4	O	-1	12571256
patients	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group	O	-1	12571256
(@@	O	-1	12571256
3	O	-1	12571256
perc@@	O	-1	12571256
ent@@	O	-1	12571256
)	O	-1	12571256
had	O	-1	12571256
an	O	-1	12571256
increase	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
creatinine	B-Chemical	D003404	12571256
concentration	O	-1	12571256
of	O	-1	12571256
0.@@	O	-1	12571256
5	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
or	O	-1	12571256
mo@@	O	-1	12571256
re,	O	-1	12571256
as	O	-1	12571256
compared	O	-1	12571256
with	O	-1	12571256
17	O	-1	12571256
of	O	-1	12571256
the	O	-1	12571256
6@@	O	-1	12571256
5	O	-1	12571256
patients	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	D007472	12571256
he@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group	O	-1	12571256
(2@@	O	-1	12571256
6	O	-1	12571256
perc@@	O	-1	12571256
ent@@	O	-1	12571256
)	O	-1	12571256
(P@@	O	-1	12571256
=@@	O	-1	12571256
0.00@@	O	-1	12571256
2@@	O	-1	12571256
;	O	-1	12571256
o@@	O	-1	12571256
d@@	O	-1	12571256
ds	O	-1	12571256
rati@@	O	-1	12571256
o	O	-1	12571256
for	O	-1	12571256
such	O	-1	12571256
an	O	-1	12571256
increase	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group@@	O	-1	12571256
,	O	-1	12571256
0.0@@	O	-1	12571256
9	O	-1	12571256
[@@	O	-1	12571256
9@@	O	-1	12571256
5	O	-1	12571256
perc@@	O	-1	12571256
ent	O	-1	12571256
conf@@	O	-1	12571256
idence	O	-1	12571256
inter@@	O	-1	12571256
val@@	O	-1	12571256
,	O	-1	12571256
0.0@@	O	-1	12571256
2	O	-1	12571256
to	O	-1	12571256
0.@@	O	-1	12571256
4@@	O	-1	12571256
1@@	O	-1	12571256
]@@	O	-1	12571256
).	O	-1	12571256
No	O	-1	12571256
patient	O	-1	12571256
receiving	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
had	O	-1	12571256
an	O	-1	12571256
increase	O	-1	12571256
of	O	-1	12571256
1.@@	O	-1	12571256
0	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
or	O	-1	12571256
mo@@	O	-1	12571256
re,	O	-1	12571256
but	O	-1	12571256
10	O	-1	12571256
patients	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	D007472	12571256
he@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group	O	-1	12571256
(1@@	O	-1	12571256
5	O	-1	12571256
perc@@	O	-1	12571256
ent@@	O	-1	12571256
)	O	-1	12571256
di@@	O	-1	12571256
d.	O	-1	12571256
The	O	-1	12571256
mean	O	-1	12571256
change	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
creatinine	B-Chemical	D003404	12571256
concentration	O	-1	12571256
from	O	-1	12571256
day	O	-1	12571256
0	O	-1	12571256
to	O	-1	12571256
day	O	-1	12571256
7	O	-1	12571256
was	O	-1	12571256
0.0@@	O	-1	12571256
7	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group	O	-1	12571256
and	O	-1	12571256
0.@@	O	-1	12571256
24	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	D007472	12571256
he@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group	O	-1	12571256
(P@@	O	-1	12571256
=@@	O	-1	12571256
0.00@@	O	-1	12571256
3@@	O	-1	12571256
;	O	-1	12571256
valu@@	O	-1	12571256
e	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group	O	-1	12571256
min@@	O	-1	12571256
us	O	-1	12571256
the	O	-1	12571256
valu@@	O	-1	12571256
e	O	-1	12571256
in	O	-1	12571256
the	O	-1	12571256
io@@	B-Chemical	D007472	12571256
he@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
group@@	O	-1	12571256
,	O	-1	12571256
-@@	O	-1	12571256
0.@@	O	-1	12571256
17	O	-1	12571256
mg	O	-1	12571256
per	O	-1	12571256
dec@@	O	-1	12571256
il@@	O	-1	12571256
it@@	O	-1	12571256
er	O	-1	12571256
[@@	O	-1	12571256
9@@	O	-1	12571256
5	O	-1	12571256
perc@@	O	-1	12571256
ent	O	-1	12571256
conf@@	O	-1	12571256
idence	O	-1	12571256
inter@@	O	-1	12571256
val@@	O	-1	12571256
,	O	-1	12571256
-@@	O	-1	12571256
0.@@	O	-1	12571256
3@@	O	-1	12571256
4	O	-1	12571256
to	O	-1	12571256
-@@	O	-1	12571256
0.0@@	O	-1	12571256
7@@	O	-1	12571256
]@@	O	-1	12571256
).	O	-1	12571256
CONCLUSIONS:	O	-1	12571256
Ne@@	B-Disease	D007674	12571256
ph@@	I-Disease	-1	12571256
ro@@	I-Disease	-1	12571256
pathy	I-Disease	-1	12571256
induced	O	-1	12571256
by	O	-1	12571256
contr@@	O	-1	12571256
ast	O	-1	12571256
medi@@	O	-1	12571256
um	O	-1	12571256
may	O	-1	12571256
be	O	-1	12571256
less	O	-1	12571256
likely	O	-1	12571256
to	O	-1	12571256
deve@@	O	-1	12571256
lo@@	O	-1	12571256
p	O	-1	12571256
in	O	-1	12571256
high-@@	O	-1	12571256
risk	O	-1	12571256
patients	O	-1	12571256
when	O	-1	12571256
io@@	B-Chemical	C044834	12571256
di@@	I-Chemical	-1	12571256
x@@	I-Chemical	-1	12571256
an@@	I-Chemical	-1	12571256
ol	I-Chemical	-1	12571256
is	O	-1	12571256
used	O	-1	12571256
ra@@	O	-1	12571256
ther	O	-1	12571256
than	O	-1	12571256
a	O	-1	12571256
low@@	O	-1	12571256
-@@	O	-1	12571256
os@@	O	-1	12571256
mol@@	O	-1	12571256
ar@@	O	-1	12571256
,	O	-1	12571256
non@@	O	-1	12571256
i@@	O	-1	12571256
onic	O	-1	12571256
contr@@	O	-1	12571256
ast	O	-1	12571256
medi@@	O	-1	12571256
um@@	O	-1	12571256
.	O	-1	12571256

E@@	O	-1	9514561
x@@	O	-1	9514561
per@@	O	-1	9514561
im@@	O	-1	9514561
ental	O	-1	9514561
c@@	O	-1	9514561
ranial	O	-1	9514561
pain	B-Disease	D010146	9514561
el@@	O	-1	9514561
ic@@	O	-1	9514561
ited	O	-1	9514561
by	O	-1	9514561
cap@@	B-Chemical	D002211	9514561
sa@@	I-Chemical	-1	9514561
icin	I-Chemical	-1	9514561
:	O	-1	9514561
a	O	-1	9514561
P@@	O	-1	9514561
E@@	O	-1	9514561
T	O	-1	9514561
study.	O	-1	9514561
U@@	O	-1	9514561
s@@	O	-1	9514561
ing	O	-1	9514561
a	O	-1	9514561
pos@@	O	-1	9514561
it@@	O	-1	9514561
ro@@	O	-1	9514561
n	O	-1	9514561
em@@	O	-1	9514561
is@@	O	-1	9514561
sion	O	-1	9514561
to@@	O	-1	9514561
mo@@	O	-1	9514561
graph@@	O	-1	9514561
y	O	-1	9514561
(P@@	O	-1	9514561
ET@@	O	-1	9514561
)	O	-1	9514561
study	O	-1	9514561
it	O	-1	9514561
was	O	-1	9514561
shown	O	-1	9514561
rec@@	O	-1	9514561
ently	O	-1	9514561
that	O	-1	9514561
in	O	-1	9514561
migra@@	B-Disease	D008881	9514561
ine	I-Disease	-1	9514561
without	O	-1	9514561
a@@	O	-1	9514561
ur@@	O	-1	9514561
a	O	-1	9514561
cer@@	O	-1	9514561
t@@	O	-1	9514561
ain	O	-1	9514561
a@@	O	-1	9514561
reas	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
brain	O	-1	9514561
st@@	O	-1	9514561
em	O	-1	9514561
were	O	-1	9514561
activ@@	O	-1	9514561
ated	O	-1	9514561
during	O	-1	9514561
the	O	-1	9514561
headac@@	B-Disease	D006261	9514561
he	I-Disease	-1	9514561
stat@@	O	-1	9514561
e,	O	-1	9514561
but	O	-1	9514561
not	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
headac@@	B-Disease	D006261	9514561
he	I-Disease	-1	9514561
free	O	-1	9514561
inter@@	O	-1	9514561
val@@	O	-1	9514561
.	O	-1	9514561
It	O	-1	9514561
was	O	-1	9514561
suggested	O	-1	9514561
that	O	-1	9514561
this	O	-1	9514561
brain	O	-1	9514561
st@@	O	-1	9514561
em	O	-1	9514561
activation	O	-1	9514561
is	O	-1	9514561
in@@	O	-1	9514561
he@@	O	-1	9514561
rent	O	-1	9514561
to	O	-1	9514561
the	O	-1	9514561
migra@@	B-Disease	D008881	9514561
ine	I-Disease	-1	9514561
at@@	O	-1	9514561
tac@@	O	-1	9514561
k	O	-1	9514561
it@@	O	-1	9514561
sel@@	O	-1	9514561
f	O	-1	9514561
and	O	-1	9514561
re@@	O	-1	9514561
pres@@	O	-1	9514561
ents	O	-1	9514561
the	O	-1	9514561
so	O	-1	9514561
c@@	O	-1	9514561
all@@	O	-1	9514561
ed	O	-1	9514561
'	O	-1	9514561
migra@@	B-Disease	D008881	9514561
ine	I-Disease	-1	9514561
gener@@	O	-1	9514561
at@@	O	-1	9514561
or@@	O	-1	9514561
'@@	O	-1	9514561
.	O	-1	9514561
To	O	-1	9514561
test	O	-1	9514561
this	O	-1	9514561
hypo@@	O	-1	9514561
thesis	O	-1	9514561
we	O	-1	9514561
performed	O	-1	9514561
an	O	-1	9514561
experimental	O	-1	9514561
pain	B-Disease	D010146	9514561
study	O	-1	9514561
in	O	-1	9514561
seven	O	-1	9514561
healthy	O	-1	9514561
vol@@	O	-1	9514561
un@@	O	-1	9514561
te@@	O	-1	9514561
er@@	O	-1	9514561
s,	O	-1	9514561
using	O	-1	9514561
the	O	-1	9514561
same	O	-1	9514561
posi@@	O	-1	9514561
tion@@	O	-1	9514561
ing	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
P@@	O	-1	9514561
E@@	O	-1	9514561
T	O	-1	9514561
s@@	O	-1	9514561
can@@	O	-1	9514561
n@@	O	-1	9514561
er	O	-1	9514561
as	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
migra@@	B-Disease	D008881	9514561
ine	I-Disease	-1	9514561
patients.	O	-1	9514561
A	O	-1	9514561
sm@@	O	-1	9514561
all	O	-1	9514561
amoun@@	O	-1	9514561
t	O	-1	9514561
of	O	-1	9514561
cap@@	B-Chemical	D002211	9514561
sa@@	I-Chemical	-1	9514561
icin	I-Chemical	-1	9514561
was	O	-1	9514561
administered	O	-1	9514561
sub@@	O	-1	9514561
c@@	O	-1	9514561
ut@@	O	-1	9514561
ane@@	O	-1	9514561
ously	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
right	O	-1	9514561
fo@@	O	-1	9514561
re@@	O	-1	9514561
he@@	O	-1	9514561
ad	O	-1	9514561
to	O	-1	9514561
evo@@	O	-1	9514561
k@@	O	-1	9514561
e	O	-1	9514561
a	O	-1	9514561
b@@	O	-1	9514561
ur@@	O	-1	9514561
ning	O	-1	9514561
pa@@	B-Disease	D010146	9514561
infu@@	I-Disease	-1	9514561
l	I-Disease	-1	9514561
sens@@	O	-1	9514561
ation	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
first	O	-1	9514561
di@@	O	-1	9514561
vi@@	O	-1	9514561
sion	O	-1	9514561
of	O	-1	9514561
the	O	-1	9514561
tri@@	O	-1	9514561
g@@	O	-1	9514561
em@@	O	-1	9514561
inal	O	-1	9514561
ner@@	O	-1	9514561
ve.	O	-1	9514561
In@@	O	-1	9514561
c@@	O	-1	9514561
reas@@	O	-1	9514561
es	O	-1	9514561
of	O	-1	9514561
regi@@	O	-1	9514561
on@@	O	-1	9514561
al	O	-1	9514561
cerebral	O	-1	9514561
blood	O	-1	9514561
flow	O	-1	9514561
(@@	O	-1	9514561
r@@	O	-1	9514561
C@@	O	-1	9514561
B@@	O	-1	9514561
F@@	O	-1	9514561
)	O	-1	9514561
were	O	-1	9514561
found	O	-1	9514561
bil@@	O	-1	9514561
at@@	O	-1	9514561
er@@	O	-1	9514561
ally	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
in@@	O	-1	9514561
sul@@	O	-1	9514561
a,	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
an@@	O	-1	9514561
ter@@	O	-1	9514561
ior	O	-1	9514561
c@@	O	-1	9514561
ing@@	O	-1	9514561
ul@@	O	-1	9514561
ate	O	-1	9514561
cor@@	O	-1	9514561
t@@	O	-1	9514561
ex@@	O	-1	9514561
,	O	-1	9514561
the	O	-1	9514561
ca@@	O	-1	9514561
ver@@	O	-1	9514561
n@@	O	-1	9514561
ous	O	-1	9514561
s@@	O	-1	9514561
in@@	O	-1	9514561
us	O	-1	9514561
and	O	-1	9514561
the	O	-1	9514561
ce@@	O	-1	9514561
re@@	O	-1	9514561
bell@@	O	-1	9514561
um@@	O	-1	9514561
.	O	-1	9514561
U@@	O	-1	9514561
s@@	O	-1	9514561
ing	O	-1	9514561
the	O	-1	9514561
same	O	-1	9514561
ste@@	O	-1	9514561
re@@	O	-1	9514561
ot@@	O	-1	9514561
ac@@	O	-1	9514561
tic	O	-1	9514561
sp@@	O	-1	9514561
ac@@	O	-1	9514561
e	O	-1	9514561
lim@@	O	-1	9514561
its	O	-1	9514561
as	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
ab@@	O	-1	9514561
o@@	O	-1	9514561
ve	O	-1	9514561
men@@	O	-1	9514561
tion@@	O	-1	9514561
ed	O	-1	9514561
migra@@	B-Disease	D008881	9514561
ine	I-Disease	-1	9514561
study	O	-1	9514561
no	O	-1	9514561
brain	O	-1	9514561
st@@	O	-1	9514561
em	O	-1	9514561
activation	O	-1	9514561
was	O	-1	9514561
found	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
acute	O	-1	9514561
pain	B-Disease	D010146	9514561
state	O	-1	9514561
compared	O	-1	9514561
to	O	-1	9514561
the	O	-1	9514561
pain	B-Disease	D010146	9514561
free	O	-1	9514561
stat@@	O	-1	9514561
e.	O	-1	9514561
The	O	-1	9514561
increase	O	-1	9514561
of	O	-1	9514561
activation	O	-1	9514561
in	O	-1	9514561
the	O	-1	9514561
regi@@	O	-1	9514561
on	O	-1	9514561
of	O	-1	9514561
the	O	-1	9514561
ca@@	O	-1	9514561
ver@@	O	-1	9514561
n@@	O	-1	9514561
ous	O	-1	9514561
s@@	O	-1	9514561
in@@	O	-1	9514561
us	O	-1	9514561
however,	O	-1	9514561
suggests	O	-1	9514561
that	O	-1	9514561
this	O	-1	9514561
struct@@	O	-1	9514561
ure	O	-1	9514561
is	O	-1	9514561
more	O	-1	9514561
likely	O	-1	9514561
to	O	-1	9514561
be	O	-1	9514561
involved	O	-1	9514561
in	O	-1	9514561
tri@@	O	-1	9514561
g@@	O	-1	9514561
em@@	O	-1	9514561
inal	O	-1	9514561
trans@@	O	-1	9514561
mit@@	O	-1	9514561
ted	O	-1	9514561
pain	B-Disease	D010146	9514561
as	O	-1	9514561
suc@@	O	-1	9514561
h@@	O	-1	9514561
,	O	-1	9514561
ra@@	O	-1	9514561
ther	O	-1	9514561
than	O	-1	9514561
in	O	-1	9514561
a	O	-1	9514561
specific	O	-1	9514561
type	O	-1	9514561
of	O	-1	9514561
headac@@	B-Disease	D006261	9514561
he	I-Disease	-1	9514561
as	O	-1	9514561
was	O	-1	9514561
suggested	O	-1	9514561
for	O	-1	9514561
cl@@	B-Disease	D003027	9514561
ust@@	I-Disease	-1	9514561
er	I-Disease	-1	9514561
headac@@	I-Disease	-1	9514561
he	I-Disease	-1	9514561
.	O	-1	9514561

Ne@@	B-Disease	D009459	9165568
uro@@	I-Disease	-1	9165568
le@@	I-Disease	-1	9165568
p@@	I-Disease	-1	9165568
tic	I-Disease	-1	9165568
mal@@	I-Disease	-1	9165568
i@@	I-Disease	-1	9165568
gn@@	I-Disease	-1	9165568
ant	I-Disease	-1	9165568
syndrome	I-Disease	-1	9165568
with	O	-1	9165568
ris@@	B-Chemical	D018967	9165568
perid@@	I-Chemical	-1	9165568
one	I-Chemical	-1	9165568
.	O	-1	9165568
Ne@@	B-Disease	D009459	9165568
uro@@	I-Disease	-1	9165568
le@@	I-Disease	-1	9165568
p@@	I-Disease	-1	9165568
tic	I-Disease	-1	9165568
mal@@	I-Disease	-1	9165568
i@@	I-Disease	-1	9165568
gn@@	I-Disease	-1	9165568
ant	I-Disease	-1	9165568
syndrome	I-Disease	-1	9165568
is	O	-1	9165568
thou@@	O	-1	9165568
ght	O	-1	9165568
to	O	-1	9165568
be	O	-1	9165568
a	O	-1	9165568
result	O	-1	9165568
of	O	-1	9165568
dopamine	B-Chemical	D004298	9165568
D2	O	-1	9165568
receptor	O	-1	9165568
block@@	O	-1	9165568
ade	O	-1	9165568
in	O	-1	9165568
the	O	-1	9165568
striat@@	O	-1	9165568
um	O	-1	9165568
of	O	-1	9165568
the	O	-1	9165568
bas@@	O	-1	9165568
al	O	-1	9165568
g@@	O	-1	9165568
ang@@	O	-1	9165568
li@@	O	-1	9165568
a.	O	-1	9165568
R@@	B-Chemical	D018967	9165568
is@@	I-Chemical	-1	9165568
perid@@	I-Chemical	-1	9165568
one	I-Chemical	-1	9165568
,	O	-1	9165568
a	O	-1	9165568
b@@	B-Chemical	C441200	9165568
enz@@	I-Chemical	-1	9165568
is@@	I-Chemical	-1	9165568
ox@@	I-Chemical	-1	9165568
azole	I-Chemical	-1	9165568
der@@	O	-1	9165568
i@@	O	-1	9165568
v@@	O	-1	9165568
ative	O	-1	9165568
anti@@	O	-1	9165568
psycho@@	O	-1	9165568
tic@@	O	-1	9165568
,	O	-1	9165568
has	O	-1	9165568
high	O	-1	9165568
seroton@@	B-Chemical	D012701	9165568
in	I-Chemical	-1	9165568
5-@@	O	-1	9165568
H@@	O	-1	9165568
T@@	O	-1	9165568
2	O	-1	9165568
receptor	O	-1	9165568
block@@	O	-1	9165568
ade	O	-1	9165568
and	O	-1	9165568
dose-@@	O	-1	9165568
related	O	-1	9165568
D2	O	-1	9165568
receptor	O	-1	9165568
block@@	O	-1	9165568
ade@@	O	-1	9165568
.	O	-1	9165568
The	O	-1	9165568
high	O	-1	9165568
rati@@	O	-1	9165568
o	O	-1	9165568
is	O	-1	9165568
be@@	O	-1	9165568
li@@	O	-1	9165568
ev@@	O	-1	9165568
ed	O	-1	9165568
to	O	-1	9165568
im@@	O	-1	9165568
par@@	O	-1	9165568
t	O	-1	9165568
the	O	-1	9165568
low	O	-1	9165568
frequency	O	-1	9165568
of	O	-1	9165568
ext@@	B-Disease	D001480	9165568
ra@@	I-Disease	-1	9165568
py@@	I-Disease	-1	9165568
ram@@	I-Disease	-1	9165568
idal	I-Disease	-1	9165568
symptoms	I-Disease	-1	9165568
with	O	-1	9165568
ris@@	B-Chemical	D018967	9165568
perid@@	I-Chemical	-1	9165568
one	I-Chemical	-1	9165568
at	O	-1	9165568
low	O	-1	9165568
dos@@	O	-1	9165568
ag@@	O	-1	9165568
es.	O	-1	9165568
W@@	O	-1	9165568
it@@	O	-1	9165568
h	O	-1	9165568
this	O	-1	9165568
low	O	-1	9165568
frequency	O	-1	9165568
of	O	-1	9165568
ext@@	B-Disease	D001480	9165568
ra@@	I-Disease	-1	9165568
py@@	I-Disease	-1	9165568
ram@@	I-Disease	-1	9165568
idal	I-Disease	-1	9165568
symptoms	I-Disease	-1	9165568
,	O	-1	9165568
it	O	-1	9165568
was	O	-1	9165568
thou@@	O	-1	9165568
ght	O	-1	9165568
the	O	-1	9165568
frequency	O	-1	9165568
of	O	-1	9165568
neuro@@	B-Disease	D009459	9165568
le@@	I-Disease	-1	9165568
p@@	I-Disease	-1	9165568
tic	I-Disease	-1	9165568
mal@@	I-Disease	-1	9165568
i@@	I-Disease	-1	9165568
gn@@	I-Disease	-1	9165568
ant	I-Disease	-1	9165568
syndrome	I-Disease	-1	9165568
might	O	-1	9165568
also	O	-1	9165568
be	O	-1	9165568
lo@@	O	-1	9165568
we@@	O	-1	9165568
red.	O	-1	9165568
A	O	-1	9165568
7@@	O	-1	9165568
3-@@	O	-1	9165568
year-old	O	-1	9165568
woman	O	-1	9165568
developed	O	-1	9165568
neuro@@	B-Disease	D009459	9165568
le@@	I-Disease	-1	9165568
p@@	I-Disease	-1	9165568
tic	I-Disease	-1	9165568
mal@@	I-Disease	-1	9165568
i@@	I-Disease	-1	9165568
gn@@	I-Disease	-1	9165568
ant	I-Disease	-1	9165568
syndrome	I-Disease	-1	9165568
after	O	-1	9165568
mon@@	O	-1	9165568
o@@	O	-1	9165568
therapy	O	-1	9165568
with	O	-1	9165568
ris@@	B-Chemical	D018967	9165568
perid@@	I-Chemical	-1	9165568
one	I-Chemical	-1	9165568
.	O	-1	9165568
The	O	-1	9165568
syndrome	O	-1	9165568
reversed	O	-1	9165568
after	O	-1	9165568
discontinu@@	O	-1	9165568
ing	O	-1	9165568
ris@@	B-Chemical	D018967	9165568
perid@@	I-Chemical	-1	9165568
one	I-Chemical	-1	9165568
and	O	-1	9165568
star@@	O	-1	9165568
ting	O	-1	9165568
treatment	O	-1	9165568
with	O	-1	9165568
d@@	B-Chemical	D003620	9165568
ant@@	I-Chemical	-1	9165568
ro@@	I-Chemical	-1	9165568
l@@	I-Chemical	-1	9165568
ene	I-Chemical	-1	9165568
and	O	-1	9165568
brom@@	B-Chemical	D001971	9165568
oc@@	I-Chemical	-1	9165568
ript@@	I-Chemical	-1	9165568
ine	I-Chemical	-1	9165568
.	O	-1	9165568
It	O	-1	9165568
appear@@	O	-1	9165568
s	O	-1	9165568
that	O	-1	9165568
the	O	-1	9165568
prot@@	O	-1	9165568
ection	O	-1	9165568
from	O	-1	9165568
ext@@	O	-1	9165568
ra@@	O	-1	9165568
py@@	O	-1	9165568
ram@@	O	-1	9165568
idal	O	-1	9165568
side	O	-1	9165568
effects	O	-1	9165568
observed	O	-1	9165568
with	O	-1	9165568
ris@@	B-Chemical	D018967	9165568
perid@@	I-Chemical	-1	9165568
one	I-Chemical	-1	9165568
does	O	-1	9165568
not	O	-1	9165568
ens@@	O	-1	9165568
ure	O	-1	9165568
prot@@	O	-1	9165568
ection	O	-1	9165568
from	O	-1	9165568
neuro@@	B-Disease	D009459	9165568
le@@	I-Disease	-1	9165568
p@@	I-Disease	-1	9165568
tic	I-Disease	-1	9165568
mal@@	I-Disease	-1	9165568
i@@	I-Disease	-1	9165568
gn@@	I-Disease	-1	9165568
ant	I-Disease	-1	9165568
syndrome	I-Disease	-1	9165568
.	O	-1	9165568

He@@	O	-1	9154656
pati@@	O	-1	9154656
c	O	-1	9154656
and	O	-1	9154656
ext@@	O	-1	9154656
ra@@	O	-1	9154656
hepatic	O	-1	9154656
angiotens@@	O	-1	9154656
ino@@	O	-1	9154656
gen	O	-1	9154656
gen@@	O	-1	9154656
e	O	-1	9154656
expression	O	-1	9154656
in	O	-1	9154656
rats	O	-1	9154656
with	O	-1	9154656
acute	O	-1	9154656
nephro@@	B-Disease	D009404	9154656
tic	I-Disease	-1	9154656
syndrome	I-Disease	-1	9154656
.	O	-1	9154656
P@@	O	-1	9154656
las@@	O	-1	9154656
ma	O	-1	9154656
concentration	O	-1	9154656
and	O	-1	9154656
urine	O	-1	9154656
ex@@	O	-1	9154656
cre@@	O	-1	9154656
tion	O	-1	9154656
of	O	-1	9154656
the	O	-1	9154656
ren@@	O	-1	9154656
in@@	O	-1	9154656
-	O	-1	9154656
angiotens@@	B-Chemical	D000809	9154656
in	I-Chemical	-1	9154656
system	O	-1	9154656
protein@@	O	-1	9154656
s	O	-1	9154656
are	O	-1	9154656
al@@	O	-1	9154656
te@@	O	-1	9154656
red	O	-1	9154656
in	O	-1	9154656
rats	O	-1	9154656
with	O	-1	9154656
nephro@@	B-Disease	D009404	9154656
tic	I-Disease	-1	9154656
syndrome	I-Disease	-1	9154656
(	O	-1	9154656
N@@	B-Disease	D009404	9154656
S	I-Disease	-1	9154656
).	O	-1	9154656
In	O	-1	9154656
this	O	-1	9154656
wor@@	O	-1	9154656
k	O	-1	9154656
the	O	-1	9154656
m@@	O	-1	9154656
es@@	O	-1	9154656
sen@@	O	-1	9154656
g@@	O	-1	9154656
er	O	-1	9154656
rib@@	O	-1	9154656
on@@	O	-1	9154656
ucle@@	O	-1	9154656
ic	O	-1	9154656
acid	O	-1	9154656
(@@	O	-1	9154656
mR@@	O	-1	9154656
N@@	O	-1	9154656
A@@	O	-1	9154656
)	O	-1	9154656
levels	O	-1	9154656
of	O	-1	9154656
angiotens@@	O	-1	9154656
ino@@	O	-1	9154656
gen	O	-1	9154656
(A@@	O	-1	9154656
o@@	O	-1	9154656
)	O	-1	9154656
were	O	-1	9154656
analy@@	O	-1	9154656
zed	O	-1	9154656
with	O	-1	9154656
the	O	-1	9154656
s@@	O	-1	9154656
lo@@	O	-1	9154656
t-@@	O	-1	9154656
blo@@	O	-1	9154656
t	O	-1	9154656
hy@@	O	-1	9154656
b@@	O	-1	9154656
ri@@	O	-1	9154656
di@@	O	-1	9154656
z@@	O	-1	9154656
ation	O	-1	9154656
t@@	O	-1	9154656
ech@@	O	-1	9154656
n@@	O	-1	9154656
i@@	O	-1	9154656
qu@@	O	-1	9154656
e	O	-1	9154656
in	O	-1	9154656
liver	O	-1	9154656
and	O	-1	9154656
other	O	-1	9154656
ext@@	O	-1	9154656
ra@@	O	-1	9154656
hepatic	O	-1	9154656
tissu@@	O	-1	9154656
es@@	O	-1	9154656
:	O	-1	9154656
kidne@@	O	-1	9154656
y,	O	-1	9154656
hear@@	O	-1	9154656
t,	O	-1	9154656
bra@@	O	-1	9154656
in,	O	-1	9154656
and	O	-1	9154656
ad@@	O	-1	9154656
renal	O	-1	9154656
gl@@	O	-1	9154656
and	O	-1	9154656
from	O	-1	9154656
control@@	O	-1	9154656
,	O	-1	9154656
nephro@@	B-Disease	D009404	9154656
tic	I-Disease	-1	9154656
,	O	-1	9154656
and	O	-1	9154656
pa@@	O	-1	9154656
ir@@	O	-1	9154656
-@@	O	-1	9154656
f@@	O	-1	9154656
ed	O	-1	9154656
(P@@	O	-1	9154656
F@@	O	-1	9154656
)	O	-1	9154656
rats.	O	-1	9154656
N@@	B-Disease	D009404	9154656
S	I-Disease	-1	9154656
was	O	-1	9154656
induced	O	-1	9154656
by	O	-1	9154656
a	O	-1	9154656
single	O	-1	9154656
injection	O	-1	9154656
of	O	-1	9154656
p@@	B-Chemical	D011692	9154656
uro@@	I-Chemical	-1	9154656
m@@	I-Chemical	-1	9154656
ycin	I-Chemical	-1	9154656
amino@@	I-Chemical	-1	9154656
-@@	I-Chemical	-1	9154656
nucle@@	I-Chemical	-1	9154656
o@@	I-Chemical	-1	9154656
side	I-Chemical	-1	9154656
(	O	-1	9154656
PA@@	B-Chemical	D011692	9154656
N	I-Chemical	-1	9154656
).	O	-1	9154656
Although	O	-1	9154656
a	O	-1	9154656
gre@@	O	-1	9154656
at	O	-1	9154656
urinary	O	-1	9154656
ex@@	O	-1	9154656
cre@@	O	-1	9154656
tion	O	-1	9154656
and	O	-1	9154656
h@@	O	-1	9154656
al@@	O	-1	9154656
f@@	O	-1	9154656
-@@	O	-1	9154656
normal	O	-1	9154656
plasma	O	-1	9154656
levels	O	-1	9154656
of	O	-1	9154656
A@@	O	-1	9154656
o	O	-1	9154656
were	O	-1	9154656
observed	O	-1	9154656
on	O	-1	9154656
day	O	-1	9154656
6	O	-1	9154656
after	O	-1	9154656
PA@@	B-Chemical	D011692	9154656
N	I-Chemical	-1	9154656
injec@@	O	-1	9154656
tion,	O	-1	9154656
when	O	-1	9154656
N@@	B-Disease	D009404	9154656
S	I-Disease	-1	9154656
was	O	-1	9154656
clear@@	O	-1	9154656
ly	O	-1	9154656
est@@	O	-1	9154656
abl@@	O	-1	9154656
is@@	O	-1	9154656
he@@	O	-1	9154656
d,	O	-1	9154656
hepatic	O	-1	9154656
A@@	O	-1	9154656
o	O	-1	9154656
mRNA	O	-1	9154656
levels	O	-1	9154656
did	O	-1	9154656
not	O	-1	9154656
chang@@	O	-1	9154656
e.	O	-1	9154656
F@@	O	-1	9154656
ur@@	O	-1	9154656
ther@@	O	-1	9154656
mo@@	O	-1	9154656
re,	O	-1	9154656
the	O	-1	9154656
A@@	O	-1	9154656
o	O	-1	9154656
mRNA	O	-1	9154656
levels	O	-1	9154656
did	O	-1	9154656
not	O	-1	9154656
change	O	-1	9154656
in	O	-1	9154656
any	O	-1	9154656
of	O	-1	9154656
the	O	-1	9154656
ext@@	O	-1	9154656
ra@@	O	-1	9154656
hepatic	O	-1	9154656
tissu@@	O	-1	9154656
es	O	-1	9154656
studied	O	-1	9154656
on	O	-1	9154656
day	O	-1	9154656
6,	O	-1	9154656
n@@	O	-1	9154656
or	O	-1	9154656
did	O	-1	9154656
its	O	-1	9154656
hepatic	O	-1	9154656
levels	O	-1	9154656
at	O	-1	9154656
days	O	-1	9154656
1,	O	-1	9154656
3,	O	-1	9154656
5,	O	-1	9154656
or	O	-1	9154656
7	O	-1	9154656
after	O	-1	9154656
PA@@	B-Chemical	D011692	9154656
N	I-Chemical	-1	9154656
injec@@	O	-1	9154656
tion.	O	-1	9154656
These	O	-1	9154656
data	O	-1	9154656
suggest	O	-1	9154656
that	O	-1	9154656
the	O	-1	9154656
hepatic	O	-1	9154656
and	O	-1	9154656
ext@@	O	-1	9154656
ra@@	O	-1	9154656
hepatic	O	-1	9154656
A@@	O	-1	9154656
o	O	-1	9154656
mRNA	O	-1	9154656
levels	O	-1	9154656
are	O	-1	9154656
un@@	O	-1	9154656
al@@	O	-1	9154656
te@@	O	-1	9154656
red	O	-1	9154656
during	O	-1	9154656
the	O	-1	9154656
development	O	-1	9154656
of	O	-1	9154656
the	O	-1	9154656
acute	O	-1	9154656
N@@	B-Disease	D009404	9154656
S	I-Disease	-1	9154656
induced	O	-1	9154656
by	O	-1	9154656
PA@@	B-Chemical	D011692	9154656
N	I-Chemical	-1	9154656
.	O	-1	9154656

C@@	B-Chemical	D003520	8911359
yc@@	I-Chemical	-1	8911359
lo@@	I-Chemical	-1	8911359
phosph@@	I-Chemical	-1	8911359
amide	I-Chemical	-1	8911359
associated	O	-1	8911359
bladder	B-Disease	D001749	8911359
cancer	I-Disease	-1	8911359
-@@	O	-1	8911359
-@@	O	-1	8911359
a	O	-1	8911359
high@@	O	-1	8911359
ly	O	-1	8911359
ag@@	O	-1	8911359
gres@@	O	-1	8911359
sive	O	-1	8911359
diseas@@	O	-1	8911359
e@@	O	-1	8911359
:	O	-1	8911359
analysis	O	-1	8911359
of	O	-1	8911359
12	O	-1	8911359
cas@@	O	-1	8911359
es.	O	-1	8911359
P@@	O	-1	8911359
U@@	O	-1	8911359
R@@	O	-1	8911359
P@@	O	-1	8911359
O@@	O	-1	8911359
S@@	O	-1	8911359
E:	O	-1	8911359
We	O	-1	8911359
g@@	O	-1	8911359
ained	O	-1	8911359
know@@	O	-1	8911359
le@@	O	-1	8911359
d@@	O	-1	8911359
ge	O	-1	8911359
of	O	-1	8911359
the	O	-1	8911359
e@@	O	-1	8911359
ti@@	O	-1	8911359
olog@@	O	-1	8911359
y,	O	-1	8911359
treatment	O	-1	8911359
and	O	-1	8911359
pre@@	O	-1	8911359
ven@@	O	-1	8911359
tion	O	-1	8911359
of	O	-1	8911359
cyclophosph@@	B-Chemical	D003520	8911359
amide	I-Chemical	-1	8911359
associated	O	-1	8911359
uro@@	B-Disease	D014523	8911359
thelial	I-Disease	-1	8911359
cancer	I-Disease	-1	8911359
.	O	-1	8911359
M@@	O	-1	8911359
AT@@	O	-1	8911359
E@@	O	-1	8911359
R@@	O	-1	8911359
I@@	O	-1	8911359
AL@@	O	-1	8911359
S	O	-1	8911359
AN@@	O	-1	8911359
D	O	-1	8911359
METHODS:	O	-1	8911359
The	O	-1	8911359
med@@	O	-1	8911359
ical	O	-1	8911359
recor@@	O	-1	8911359
ds	O	-1	8911359
of	O	-1	8911359
6	O	-1	8911359
men	O	-1	8911359
and	O	-1	8911359
6	O	-1	8911359
women	O	-1	8911359
(@@	O	-1	8911359
mean	O	-1	8911359
age	O	-1	8911359
5@@	O	-1	8911359
5	O	-1	8911359
year@@	O	-1	8911359
s)	O	-1	8911359
with	O	-1	8911359
cyclophosph@@	B-Chemical	D003520	8911359
amide	I-Chemical	-1	8911359
associated	O	-1	8911359
bladder	B-Disease	D001749	8911359
cancer	I-Disease	-1	8911359
were	O	-1	8911359
revie@@	O	-1	8911359
we@@	O	-1	8911359
d.	O	-1	8911359
RESULTS:	O	-1	8911359
All	O	-1	8911359
tu@@	B-Disease	D009369	8911359
mor@@	I-Disease	-1	8911359
s	I-Disease	-1	8911359
were	O	-1	8911359
gra@@	O	-1	8911359
de	O	-1	8911359
3	O	-1	8911359
or	O	-1	8911359
4	O	-1	8911359
transi@@	O	-1	8911359
tional	O	-1	8911359
cell	O	-1	8911359
carcin@@	B-Disease	D002277	8911359
oma	I-Disease	-1	8911359
.	O	-1	8911359
Of	O	-1	8911359
the	O	-1	8911359
5	O	-1	8911359
patients	O	-1	8911359
initi@@	O	-1	8911359
ally	O	-1	8911359
treated	O	-1	8911359
with	O	-1	8911359
en@@	O	-1	8911359
dos@@	O	-1	8911359
co@@	O	-1	8911359
p@@	O	-1	8911359
ic	O	-1	8911359
res@@	O	-1	8911359
ection	O	-1	8911359
alone	O	-1	8911359
only	O	-1	8911359
1	O	-1	8911359
is	O	-1	8911359
al@@	O	-1	8911359
i@@	O	-1	8911359
ve	O	-1	8911359
without	O	-1	8911359
disease.	O	-1	8911359
Of	O	-1	8911359
the	O	-1	8911359
6	O	-1	8911359
patients	O	-1	8911359
who	O	-1	8911359
under@@	O	-1	8911359
w@@	O	-1	8911359
ent	O	-1	8911359
early	O	-1	8911359
cy@@	O	-1	8911359
st@@	O	-1	8911359
ect@@	O	-1	8911359
om@@	O	-1	8911359
y	O	-1	8911359
4	O	-1	8911359
were	O	-1	8911359
al@@	O	-1	8911359
i@@	O	-1	8911359
ve	O	-1	8911359
at	O	-1	8911359
24	O	-1	8911359
to	O	-1	8911359
1@@	O	-1	8911359
11	O	-1	8911359
months.	O	-1	8911359
The	O	-1	8911359
remain@@	O	-1	8911359
ing	O	-1	8911359
patient	O	-1	8911359
with	O	-1	8911359
exten@@	O	-1	8911359
sive	O	-1	8911359
cancer	B-Disease	D009369	8911359
under@@	O	-1	8911359
w@@	O	-1	8911359
ent	O	-1	8911359
partial	O	-1	8911359
cy@@	O	-1	8911359
st@@	O	-1	8911359
ect@@	O	-1	8911359
om@@	O	-1	8911359
y	O	-1	8911359
for	O	-1	8911359
p@@	O	-1	8911359
al@@	O	-1	8911359
li@@	O	-1	8911359
ation	O	-1	8911359
and	O	-1	8911359
di@@	O	-1	8911359
ed	O	-1	8911359
3	O	-1	8911359
months	O	-1	8911359
lat@@	O	-1	8911359
er.	O	-1	8911359
CONCLUSIONS:	O	-1	8911359
C@@	B-Chemical	D003520	8911359
yc@@	I-Chemical	-1	8911359
lo@@	I-Chemical	-1	8911359
phosph@@	I-Chemical	-1	8911359
amide	I-Chemical	-1	8911359
associated	O	-1	8911359
bladder	B-Disease	D001749	8911359
tumor	I-Disease	-1	8911359
is	O	-1	8911359
an	O	-1	8911359
ag@@	O	-1	8911359
gres@@	O	-1	8911359
sive	O	-1	8911359
disease.	O	-1	8911359
However,	O	-1	8911359
long-term	O	-1	8911359
sur@@	O	-1	8911359
viv@@	O	-1	8911359
al	O	-1	8911359
is	O	-1	8911359
possible	O	-1	8911359
when	O	-1	8911359
ra@@	O	-1	8911359
d@@	O	-1	8911359
ical	O	-1	8911359
cy@@	O	-1	8911359
st@@	O	-1	8911359
ect@@	O	-1	8911359
om@@	O	-1	8911359
y	O	-1	8911359
is	O	-1	8911359
performed	O	-1	8911359
for	O	-1	8911359
bladder	B-Disease	D001749	8911359
tu@@	I-Disease	-1	8911359
mor@@	I-Disease	-1	8911359
s	I-Disease	-1	8911359
with	O	-1	8911359
any	O	-1	8911359
si@@	O	-1	8911359
g@@	O	-1	8911359
n	O	-1	8911359
of	O	-1	8911359
inv@@	O	-1	8911359
a@@	O	-1	8911359
sion	O	-1	8911359
and	O	-1	8911359
for	O	-1	8911359
recur@@	O	-1	8911359
rent	O	-1	8911359
high	O	-1	8911359
gra@@	O	-1	8911359
de	O	-1	8911359
diseas@@	O	-1	8911359
e,	O	-1	8911359
even	O	-1	8911359
when	O	-1	8911359
non@@	O	-1	8911359
inv@@	O	-1	8911359
a@@	O	-1	8911359
si@@	O	-1	8911359
ve.	O	-1	8911359

L@@	B-Disease	D001416	8686832
e@@	I-Disease	-1	8686832
g	I-Disease	-1	8686832
and	I-Disease	-1	8686832
bac@@	I-Disease	-1	8686832
k	I-Disease	-1	8686832
pain	I-Disease	-1	8686832
after	O	-1	8686832
spinal	O	-1	8686832
anaesthe@@	O	-1	8686832
sia	O	-1	8686832
invol@@	O	-1	8686832
ving	O	-1	8686832
hyper@@	O	-1	8686832
bar@@	O	-1	8686832
ic	O	-1	8686832
5%	O	-1	8686832
li@@	B-Chemical	D008012	8686832
gn@@	I-Chemical	-1	8686832
oc@@	I-Chemical	-1	8686832
aine	I-Chemical	-1	8686832
.	O	-1	8686832
F@@	O	-1	8686832
if@@	O	-1	8686832
ty-@@	O	-1	8686832
four	O	-1	8686832
patients,	O	-1	8686832
aged	O	-1	8686832
27@@	O	-1	8686832
-@@	O	-1	8686832
9@@	O	-1	8686832
0	O	-1	8686832
year@@	O	-1	8686832
s,	O	-1	8686832
who	O	-1	8686832
were	O	-1	8686832
given	O	-1	8686832
li@@	B-Chemical	D008012	8686832
gn@@	I-Chemical	-1	8686832
oc@@	I-Chemical	-1	8686832
aine	I-Chemical	-1	8686832
5%	O	-1	8686832
in	O	-1	8686832
6.@@	O	-1	8686832
8@@	O	-1	8686832
%	O	-1	8686832
g@@	B-Chemical	D005947	8686832
lu@@	I-Chemical	-1	8686832
co@@	I-Chemical	-1	8686832
se	I-Chemical	-1	8686832
sol@@	O	-1	8686832
u@@	O	-1	8686832
tion	O	-1	8686832
for	O	-1	8686832
spinal	O	-1	8686832
anaesthe@@	O	-1	8686832
sia	O	-1	8686832
were	O	-1	8686832
studi@@	O	-1	8686832
ed.	O	-1	8686832
Th@@	O	-1	8686832
ir@@	O	-1	8686832
te@@	O	-1	8686832
en	O	-1	8686832
of	O	-1	8686832
these	O	-1	8686832
patients	O	-1	8686832
experienced	O	-1	8686832
pain	B-Disease	D001416	8686832
in	I-Disease	-1	8686832
the	I-Disease	-1	8686832
le@@	I-Disease	-1	8686832
g@@	I-Disease	-1	8686832
s	I-Disease	-1	8686832
and/or	I-Disease	-1	8686832
bac@@	I-Disease	-1	8686832
k	I-Disease	-1	8686832
after	O	-1	8686832
recovery	O	-1	8686832
from	O	-1	8686832
anaesthe@@	O	-1	8686832
sia.	O	-1	8686832
The	O	-1	8686832
patients	O	-1	8686832
affected	O	-1	8686832
were	O	-1	8686832
youn@@	O	-1	8686832
g@@	O	-1	8686832
er	O	-1	8686832
(p	O	-1	8686832
<	O	-1	8686832
0.05@@	O	-1	8686832
)	O	-1	8686832
and	O	-1	8686832
the	O	-1	8686832
sit@@	O	-1	8686832
e	O	-1	8686832
of	O	-1	8686832
the	O	-1	8686832
dur@@	O	-1	8686832
al	O	-1	8686832
p@@	O	-1	8686832
unc@@	O	-1	8686832
t@@	O	-1	8686832
ure	O	-1	8686832
was	O	-1	8686832
higher	O	-1	8686832
(p	O	-1	8686832
<	O	-1	8686832
0.0@@	O	-1	8686832
1)	O	-1	8686832
than	O	-1	8686832
those	O	-1	8686832
individ@@	O	-1	8686832
u@@	O	-1	8686832
als	O	-1	8686832
without	O	-1	8686832
pain	B-Disease	D010146	8686832
.	O	-1	8686832
F@@	O	-1	8686832
i@@	O	-1	8686832
ve	O	-1	8686832
of	O	-1	8686832
the	O	-1	8686832
13	O	-1	8686832
patients	O	-1	8686832
(3@@	O	-1	8686832
8@@	O	-1	8686832
%)	O	-1	8686832
with	O	-1	8686832
pain	B-Disease	D010146	8686832
and	O	-1	8686832
seven	O	-1	8686832
of	O	-1	8686832
the	O	-1	8686832
4@@	O	-1	8686832
1	O	-1	8686832
patients	O	-1	8686832
(1@@	O	-1	8686832
7@@	O	-1	8686832
%)	O	-1	8686832
without	O	-1	8686832
pain	B-Disease	D010146	8686832
ad@@	O	-1	8686832
mit@@	O	-1	8686832
ted	O	-1	8686832
to	O	-1	8686832
a	O	-1	8686832
high	O	-1	8686832
alco@@	B-Chemical	D000431	8686832
hol	I-Chemical	-1	8686832
int@@	O	-1	8686832
ak@@	O	-1	8686832
e,	O	-1	8686832
which	O	-1	8686832
might	O	-1	8686832
be	O	-1	8686832
a	O	-1	8686832
cont@@	O	-1	8686832
ri@@	O	-1	8686832
but@@	O	-1	8686832
ing	O	-1	8686832
fact@@	O	-1	8686832
or@@	O	-1	8686832
.	O	-1	8686832
L@@	B-Disease	D001416	8686832
e@@	I-Disease	-1	8686832
g	I-Disease	-1	8686832
and/or	I-Disease	-1	8686832
bac@@	I-Disease	-1	8686832
k	I-Disease	-1	8686832
pain	I-Disease	-1	8686832
is	O	-1	8686832
associated	O	-1	8686832
with	O	-1	8686832
the	O	-1	8686832
intra@@	O	-1	8686832
th@@	O	-1	8686832
ec@@	O	-1	8686832
al	O	-1	8686832
use	O	-1	8686832
of	O	-1	8686832
hyper@@	O	-1	8686832
bar@@	O	-1	8686832
ic	O	-1	8686832
5%	O	-1	8686832
li@@	B-Chemical	D008012	8686832
gn@@	I-Chemical	-1	8686832
oc@@	I-Chemical	-1	8686832
aine	I-Chemical	-1	8686832
.	O	-1	8686832

Ac@@	O	-1	8607407
ute	O	-1	8607407
blood	O	-1	8607407
pressure	O	-1	8607407
elev@@	O	-1	8607407
ations	O	-1	8607407
with	O	-1	8607407
caffe@@	B-Chemical	D002110	8607407
ine	I-Chemical	-1	8607407
in	O	-1	8607407
men	O	-1	8607407
with	O	-1	8607407
b@@	O	-1	8607407
or@@	O	-1	8607407
der@@	O	-1	8607407
line	O	-1	8607407
systemic	O	-1	8607407
hypertension	B-Disease	D006973	8607407
.	O	-1	8607407
Whe@@	O	-1	8607407
ther	O	-1	8607407
the	O	-1	8607407
vas@@	O	-1	8607407
o@@	O	-1	8607407
con@@	O	-1	8607407
stric@@	O	-1	8607407
tive	O	-1	8607407
ac@@	O	-1	8607407
tions	O	-1	8607407
of	O	-1	8607407
caffe@@	B-Chemical	D002110	8607407
ine	I-Chemical	-1	8607407
are	O	-1	8607407
enhanced	O	-1	8607407
in	O	-1	8607407
hypertensive	B-Disease	D006973	8607407
per@@	O	-1	8607407
son@@	O	-1	8607407
s	O	-1	8607407
has	O	-1	8607407
not	O	-1	8607407
been	O	-1	8607407
demon@@	O	-1	8607407
strat@@	O	-1	8607407
ed.	O	-1	8607407
Th@@	O	-1	8607407
us,	O	-1	8607407
caffe@@	B-Chemical	D002110	8607407
ine	I-Chemical	-1	8607407
(@@	O	-1	8607407
3.@@	O	-1	8607407
3	O	-1	8607407
mg/kg)	O	-1	8607407
versus	O	-1	8607407
placebo	O	-1	8607407
was	O	-1	8607407
tested	O	-1	8607407
in	O	-1	8607407
4@@	O	-1	8607407
8	O	-1	8607407
healthy	O	-1	8607407
men	O	-1	8607407
(@@	O	-1	8607407
aged	O	-1	8607407
20	O	-1	8607407
to	O	-1	8607407
3@@	O	-1	8607407
5	O	-1	8607407
year@@	O	-1	8607407
s)	O	-1	8607407
sel@@	O	-1	8607407
ected	O	-1	8607407
after	O	-1	8607407
s@@	O	-1	8607407
cre@@	O	-1	8607407
en@@	O	-1	8607407
ing	O	-1	8607407
on	O	-1	8607407
2	O	-1	8607407
se@@	O	-1	8607407
par@@	O	-1	8607407
ate	O	-1	8607407
oc@@	O	-1	8607407
ca@@	O	-1	8607407
sion@@	O	-1	8607407
s.	O	-1	8607407
B@@	O	-1	8607407
or@@	O	-1	8607407
der@@	O	-1	8607407
line	O	-1	8607407
hypertensive	B-Disease	D006973	8607407
men	O	-1	8607407
(n	O	-1	8607407
=	O	-1	8607407
2@@	O	-1	8607407
4@@	O	-1	8607407
)	O	-1	8607407
were	O	-1	8607407
sel@@	O	-1	8607407
ected	O	-1	8607407
with	O	-1	8607407
s@@	O	-1	8607407
cre@@	O	-1	8607407
en@@	O	-1	8607407
ing	O	-1	8607407
systolic	O	-1	8607407
blood	O	-1	8607407
pressure	O	-1	8607407
(B@@	O	-1	8607407
P)	O	-1	8607407
of	O	-1	8607407
1@@	O	-1	8607407
40	O	-1	8607407
to	O	-1	8607407
1@@	O	-1	8607407
60	O	-1	8607407
mm	O	-1	8607407
H@@	O	-1	8607407
g	O	-1	8607407
and/or	O	-1	8607407
di@@	O	-1	8607407
ast@@	O	-1	8607407
olic	O	-1	8607407
B@@	O	-1	8607407
P	O	-1	8607407
9@@	O	-1	8607407
0	O	-1	8607407
to	O	-1	8607407
9@@	O	-1	8607407
9	O	-1	8607407
mm	O	-1	8607407
H@@	O	-1	8607407
g@@	O	-1	8607407
.	O	-1	8607407
L@@	O	-1	8607407
o@@	O	-1	8607407
w@@	O	-1	8607407
-@@	O	-1	8607407
risk	O	-1	8607407
controls	O	-1	8607407
(n	O	-1	8607407
=	O	-1	8607407
2@@	O	-1	8607407
4@@	O	-1	8607407
)	O	-1	8607407
reported	O	-1	8607407
no	O	-1	8607407
pa@@	O	-1	8607407
ren@@	O	-1	8607407
t@@	O	-1	8607407
al	O	-1	8607407
hist@@	O	-1	8607407
ory	O	-1	8607407
of	O	-1	8607407
hypertension	B-Disease	D006973	8607407
and	O	-1	8607407
had	O	-1	8607407
s@@	O	-1	8607407
cre@@	O	-1	8607407
en@@	O	-1	8607407
ing	O	-1	8607407
B@@	O	-1	8607407
P	O	-1	8607407
<	O	-1	8607407
13@@	O	-1	8607407
0@@	O	-1	8607407
/@@	O	-1	8607407
8@@	O	-1	8607407
5	O	-1	8607407
mm	O	-1	8607407
H@@	O	-1	8607407
g@@	O	-1	8607407
.	O	-1	8607407
P@@	O	-1	8607407
ar@@	O	-1	8607407
tic@@	O	-1	8607407
ip@@	O	-1	8607407
ants	O	-1	8607407
were	O	-1	8607407
then	O	-1	8607407
tested	O	-1	8607407
on	O	-1	8607407
2	O	-1	8607407
oc@@	O	-1	8607407
ca@@	O	-1	8607407
sions	O	-1	8607407
after	O	-1	8607407
1@@	O	-1	8607407
2-@@	O	-1	8607407
h@@	O	-1	8607407
our	O	-1	8607407
ab@@	O	-1	8607407
st@@	O	-1	8607407
in@@	O	-1	8607407
ence	O	-1	8607407
from	O	-1	8607407
caffe@@	B-Chemical	D002110	8607407
ine	I-Chemical	-1	8607407
in	O	-1	8607407
each	O	-1	8607407
of	O	-1	8607407
2	O	-1	8607407
pro@@	O	-1	8607407
to@@	O	-1	8607407
co@@	O	-1	8607407
l@@	O	-1	8607407
s;	O	-1	8607407
this	O	-1	8607407
requ@@	O	-1	8607407
ired	O	-1	8607407
a	O	-1	8607407
total	O	-1	8607407
of	O	-1	8607407
4	O	-1	8607407
labor@@	O	-1	8607407
atory	O	-1	8607407
v@@	O	-1	8607407
is@@	O	-1	8607407
it@@	O	-1	8607407
s.	O	-1	8607407
Ca@@	B-Chemical	D002110	8607407
ffe@@	I-Chemical	-1	8607407
ine	I-Chemical	-1	8607407
-induced	O	-1	8607407
changes	O	-1	8607407
in	O	-1	8607407
di@@	O	-1	8607407
ast@@	O	-1	8607407
olic	O	-1	8607407
B@@	O	-1	8607407
P	O	-1	8607407
were	O	-1	8607407
2	O	-1	8607407
to	O	-1	8607407
3	O	-1	8607407
times	O	-1	8607407
larg@@	O	-1	8607407
er	O	-1	8607407
in	O	-1	8607407
b@@	O	-1	8607407
or@@	O	-1	8607407
der@@	O	-1	8607407
line	O	-1	8607407
subjects	O	-1	8607407
than	O	-1	8607407
in	O	-1	8607407
controls	O	-1	8607407
(@@	O	-1	8607407
+@@	O	-1	8607407
8.@@	O	-1	8607407
4	O	-1	8607407
v@@	O	-1	8607407
s	O	-1	8607407
+@@	O	-1	8607407
3.@@	O	-1	8607407
8	O	-1	8607407
mm	O	-1	8607407
H@@	O	-1	8607407
g@@	O	-1	8607407
,	O	-1	8607407
p	O	-1	8607407
<	O	-1	8607407
0.00@@	O	-1	8607407
0@@	O	-1	8607407
1),	O	-1	8607407
and	O	-1	8607407
were	O	-1	8607407
at@@	O	-1	8607407
tri@@	O	-1	8607407
but@@	O	-1	8607407
able	O	-1	8607407
to	O	-1	8607407
larg@@	O	-1	8607407
er	O	-1	8607407
changes	O	-1	8607407
in	O	-1	8607407
im@@	O	-1	8607407
p@@	O	-1	8607407
ed@@	O	-1	8607407
ance@@	O	-1	8607407
-@@	O	-1	8607407
der@@	O	-1	8607407
i@@	O	-1	8607407
ved	O	-1	8607407
meas@@	O	-1	8607407
ures	O	-1	8607407
of	O	-1	8607407
systemic	O	-1	8607407
vascular	O	-1	8607407
resist@@	O	-1	8607407
ance	O	-1	8607407
(@@	O	-1	8607407
+@@	O	-1	8607407
13@@	O	-1	8607407
5	O	-1	8607407
v@@	O	-1	8607407
s	O	-1	8607407
+@@	O	-1	8607407
4@@	O	-1	8607407
5	O	-1	8607407
dy@@	O	-1	8607407
n@@	O	-1	8607407
es@@	O	-1	8607407
.@@	O	-1	8607407
s@@	O	-1	8607407
.@@	O	-1	8607407
c@@	O	-1	8607407
m@@	O	-1	8607407
-@@	O	-1	8607407
5,	O	-1	8607407
p	O	-1	8607407
<	O	-1	8607407
0.00@@	O	-1	8607407
4@@	O	-1	8607407
).	O	-1	8607407
These	O	-1	8607407
findings	O	-1	8607407
were	O	-1	8607407
consist@@	O	-1	8607407
ent	O	-1	8607407
and	O	-1	8607407
reac@@	O	-1	8607407
h@@	O	-1	8607407
ed	O	-1	8607407
signific@@	O	-1	8607407
ance	O	-1	8607407
in	O	-1	8607407
both	O	-1	8607407
pro@@	O	-1	8607407
to@@	O	-1	8607407
co@@	O	-1	8607407
l@@	O	-1	8607407
s.	O	-1	8607407
The	O	-1	8607407
perc@@	O	-1	8607407
ent@@	O	-1	8607407
age	O	-1	8607407
of	O	-1	8607407
b@@	O	-1	8607407
or@@	O	-1	8607407
der@@	O	-1	8607407
line	O	-1	8607407
subjects	O	-1	8607407
in	O	-1	8607407
whom	O	-1	8607407
di@@	O	-1	8607407
ast@@	O	-1	8607407
olic	O	-1	8607407
B@@	O	-1	8607407
P	O	-1	8607407
changes	O	-1	8607407
ex@@	O	-1	8607407
ce@@	O	-1	8607407
ed@@	O	-1	8607407
ed	O	-1	8607407
the	O	-1	8607407
median	O	-1	8607407
control	O	-1	8607407
response	O	-1	8607407
was	O	-1	8607407
9@@	O	-1	8607407
6@@	O	-1	8607407
%.	O	-1	8607407
Con@@	O	-1	8607407
sequ@@	O	-1	8607407
ent@@	O	-1	8607407
ly,	O	-1	8607407
whereas	O	-1	8607407
all	O	-1	8607407
partic@@	O	-1	8607407
ip@@	O	-1	8607407
ants	O	-1	8607407
ex@@	O	-1	8607407
hib@@	O	-1	8607407
ited	O	-1	8607407
norm@@	O	-1	8607407
oten@@	O	-1	8607407
sive	O	-1	8607407
levels	O	-1	8607407
during	O	-1	8607407
the	O	-1	8607407
rest@@	O	-1	8607407
ing	O	-1	8607407
pre@@	O	-1	8607407
drug	O	-1	8607407
basel@@	O	-1	8607407
ine,	O	-1	8607407
3@@	O	-1	8607407
3@@	O	-1	8607407
%	O	-1	8607407
of	O	-1	8607407
b@@	O	-1	8607407
or@@	O	-1	8607407
der@@	O	-1	8607407
line	O	-1	8607407
subjects	O	-1	8607407
achi@@	O	-1	8607407
ev@@	O	-1	8607407
ed	O	-1	8607407
hypertensive	B-Disease	D006973	8607407
B@@	O	-1	8607407
P	O	-1	8607407
levels	O	-1	8607407
after	O	-1	8607407
caffe@@	B-Chemical	D002110	8607407
ine	I-Chemical	-1	8607407
ing@@	O	-1	8607407
es@@	O	-1	8607407
tion.	O	-1	8607407
Th@@	O	-1	8607407
us,	O	-1	8607407
in	O	-1	8607407
b@@	O	-1	8607407
or@@	O	-1	8607407
der@@	O	-1	8607407
line	O	-1	8607407
hypertensive	B-Disease	D006973	8607407
men@@	O	-1	8607407
,	O	-1	8607407
ex@@	O	-1	8607407
ag@@	O	-1	8607407
g@@	O	-1	8607407
er@@	O	-1	8607407
ated	O	-1	8607407
responses	O	-1	8607407
to	O	-1	8607407
caffe@@	B-Chemical	D002110	8607407
ine	I-Chemical	-1	8607407
we@@	O	-1	8607407
re@@	O	-1	8607407
:	O	-1	8607407
selective	O	-1	8607407
for	O	-1	8607407
di@@	O	-1	8607407
ast@@	O	-1	8607407
olic	O	-1	8607407
B@@	O	-1	8607407
P@@	O	-1	8607407
,	O	-1	8607407
consist@@	O	-1	8607407
ent	O	-1	8607407
with	O	-1	8607407
greater	O	-1	8607407
vas@@	O	-1	8607407
o@@	O	-1	8607407
con@@	O	-1	8607407
stric@@	O	-1	8607407
tion,	O	-1	8607407
re@@	O	-1	8607407
plic@@	O	-1	8607407
ated	O	-1	8607407
in	O	-1	8607407
2	O	-1	8607407
pro@@	O	-1	8607407
to@@	O	-1	8607407
co@@	O	-1	8607407
l@@	O	-1	8607407
s,	O	-1	8607407
and	O	-1	8607407
re@@	O	-1	8607407
present@@	O	-1	8607407
ative	O	-1	8607407
of	O	-1	8607407
ne@@	O	-1	8607407
arly	O	-1	8607407
all	O	-1	8607407
b@@	O	-1	8607407
or@@	O	-1	8607407
der@@	O	-1	8607407
line	O	-1	8607407
hyperten@@	B-Disease	D006973	8607407
si@@	I-Disease	-1	8607407
v@@	I-Disease	-1	8607407
es	I-Disease	-1	8607407
.	O	-1	8607407
We	O	-1	8607407
sus@@	O	-1	8607407
p@@	O	-1	8607407
ect	O	-1	8607407
that	O	-1	8607407
the	O	-1	8607407
potential	O	-1	8607407
for	O	-1	8607407
caffe@@	B-Chemical	D002110	8607407
ine	I-Chemical	-1	8607407
to	O	-1	8607407
st@@	O	-1	8607407
abil@@	O	-1	8607407
iz@@	O	-1	8607407
e	O	-1	8607407
high	O	-1	8607407
resist@@	O	-1	8607407
ance	O	-1	8607407
st@@	O	-1	8607407
ates	O	-1	8607407
in	O	-1	8607407
sus@@	O	-1	8607407
cep@@	O	-1	8607407
ti@@	O	-1	8607407
ble	O	-1	8607407
per@@	O	-1	8607407
son@@	O	-1	8607407
s	O	-1	8607407
suggests	O	-1	8607407
that	O	-1	8607407
its	O	-1	8607407
use	O	-1	8607407
may	O	-1	8607407
fac@@	O	-1	8607407
il@@	O	-1	8607407
it@@	O	-1	8607407
ate	O	-1	8607407
their	O	-1	8607407
disease	O	-1	8607407
progres@@	O	-1	8607407
sion,	O	-1	8607407
as	O	-1	8607407
well	O	-1	8607407
as	O	-1	8607407
h@@	O	-1	8607407
ind@@	O	-1	8607407
er	O	-1	8607407
ac@@	O	-1	8607407
cur@@	O	-1	8607407
ate	O	-1	8607407
diagnosis	O	-1	8607407
and	O	-1	8607407
treatment.	O	-1	8607407

H@@	B-Disease	D006212	8111719
all@@	I-Disease	-1	8111719
uc@@	I-Disease	-1	8111719
in@@	I-Disease	-1	8111719
ations	I-Disease	-1	8111719
and	O	-1	8111719
if@@	B-Chemical	D007069	8111719
os@@	I-Chemical	-1	8111719
f@@	I-Chemical	-1	8111719
amide	I-Chemical	-1	8111719
-induced	O	-1	8111719
neuro@@	B-Disease	D020258	8111719
toxicity	I-Disease	-1	8111719
.	O	-1	8111719
BACKGROUND:	O	-1	8111719
H@@	B-Disease	D006212	8111719
all@@	I-Disease	-1	8111719
uc@@	I-Disease	-1	8111719
in@@	I-Disease	-1	8111719
ations	I-Disease	-1	8111719
as	O	-1	8111719
a	O	-1	8111719
sympto@@	O	-1	8111719
m	O	-1	8111719
of	O	-1	8111719
central	O	-1	8111719
neuro@@	B-Disease	D020258	8111719
toxicity	I-Disease	-1	8111719
are	O	-1	8111719
a	O	-1	8111719
known	O	-1	8111719
but	O	-1	8111719
po@@	O	-1	8111719
or@@	O	-1	8111719
ly	O	-1	8111719
descri@@	O	-1	8111719
bed	O	-1	8111719
side	O	-1	8111719
effect	O	-1	8111719
of	O	-1	8111719
if@@	B-Chemical	D007069	8111719
os@@	I-Chemical	-1	8111719
f@@	I-Chemical	-1	8111719
amide	I-Chemical	-1	8111719
.	O	-1	8111719
M@@	O	-1	8111719
ost	O	-1	8111719
cases	O	-1	8111719
of	O	-1	8111719
if@@	B-Chemical	D007069	8111719
os@@	I-Chemical	-1	8111719
f@@	I-Chemical	-1	8111719
amide	I-Chemical	-1	8111719
-induced	O	-1	8111719
h@@	B-Disease	D006212	8111719
all@@	I-Disease	-1	8111719
uc@@	I-Disease	-1	8111719
in@@	I-Disease	-1	8111719
ations	I-Disease	-1	8111719
have	O	-1	8111719
been	O	-1	8111719
reported	O	-1	8111719
with	O	-1	8111719
other	O	-1	8111719
mental	O	-1	8111719
status	O	-1	8111719
chang@@	O	-1	8111719
es.	O	-1	8111719
METHODS:	O	-1	8111719
The	O	-1	8111719
au@@	O	-1	8111719
th@@	O	-1	8111719
ors	O	-1	8111719
inter@@	O	-1	8111719
vie@@	O	-1	8111719
w@@	O	-1	8111719
ed	O	-1	8111719
six	O	-1	8111719
per@@	O	-1	8111719
son@@	O	-1	8111719
s	O	-1	8111719
with	O	-1	8111719
if@@	B-Chemical	D007069	8111719
os@@	I-Chemical	-1	8111719
f@@	I-Chemical	-1	8111719
amide	I-Chemical	-1	8111719
-induced	O	-1	8111719
h@@	B-Disease	D006212	8111719
all@@	I-Disease	-1	8111719
uc@@	I-Disease	-1	8111719
in@@	I-Disease	-1	8111719
ations	I-Disease	-1	8111719
in	O	-1	8111719
the	O	-1	8111719
presence	O	-1	8111719
of	O	-1	8111719
a	O	-1	8111719
c@@	O	-1	8111719
le@@	O	-1	8111719
ar	O	-1	8111719
sens@@	O	-1	8111719
or@@	O	-1	8111719
i@@	O	-1	8111719
um@@	O	-1	8111719
.	O	-1	8111719
All	O	-1	8111719
patients	O	-1	8111719
were	O	-1	8111719
receiving	O	-1	8111719
high-dose	O	-1	8111719
if@@	B-Chemical	D007069	8111719
os@@	I-Chemical	-1	8111719
f@@	I-Chemical	-1	8111719
amide	I-Chemical	-1	8111719
as	O	-1	8111719
par@@	O	-1	8111719
t	O	-1	8111719
of	O	-1	8111719
their	O	-1	8111719
b@@	O	-1	8111719
one	O	-1	8111719
m@@	O	-1	8111719
ar@@	O	-1	8111719
ro@@	O	-1	8111719
w	O	-1	8111719
transplant	O	-1	8111719
proce@@	O	-1	8111719
d@@	O	-1	8111719
ure.	O	-1	8111719
RESULTS:	O	-1	8111719
H@@	B-Disease	D006212	8111719
all@@	I-Disease	-1	8111719
uc@@	I-Disease	-1	8111719
in@@	I-Disease	-1	8111719
ations	I-Disease	-1	8111719
occurred	O	-1	8111719
only	O	-1	8111719
when	O	-1	8111719
the	O	-1	8111719
patient@@	O	-1	8111719
's	O	-1	8111719
e@@	O	-1	8111719
y@@	O	-1	8111719
es	O	-1	8111719
were	O	-1	8111719
c@@	O	-1	8111719
los@@	O	-1	8111719
ed	O	-1	8111719
and@@	O	-1	8111719
,	O	-1	8111719
in	O	-1	8111719
all	O	-1	8111719
but	O	-1	8111719
one	O	-1	8111719
cas@@	O	-1	8111719
e,	O	-1	8111719
were	O	-1	8111719
reported	O	-1	8111719
as	O	-1	8111719
dist@@	O	-1	8111719
urb@@	O	-1	8111719
ing	O	-1	8111719
or	O	-1	8111719
f@@	O	-1	8111719
ri@@	O	-1	8111719
gh@@	O	-1	8111719
ten@@	O	-1	8111719
ing.	O	-1	8111719
U@@	O	-1	8111719
n@@	O	-1	8111719
der@@	O	-1	8111719
repor@@	O	-1	8111719
ting	O	-1	8111719
of	O	-1	8111719
these	O	-1	8111719
h@@	B-Disease	D006212	8111719
all@@	I-Disease	-1	8111719
uc@@	I-Disease	-1	8111719
in@@	I-Disease	-1	8111719
ations	I-Disease	-1	8111719
by	O	-1	8111719
patients	O	-1	8111719
is	O	-1	8111719
lik@@	O	-1	8111719
el@@	O	-1	8111719
y.	O	-1	8111719
CONCLUSIONS:	O	-1	8111719
H@@	B-Disease	D006212	8111719
all@@	I-Disease	-1	8111719
uc@@	I-Disease	-1	8111719
in@@	I-Disease	-1	8111719
ations	I-Disease	-1	8111719
may	O	-1	8111719
be	O	-1	8111719
the	O	-1	8111719
sol@@	O	-1	8111719
e	O	-1	8111719
or	O	-1	8111719
first	O	-1	8111719
man@@	O	-1	8111719
if@@	O	-1	8111719
est@@	O	-1	8111719
ation	O	-1	8111719
of	O	-1	8111719
neuro@@	B-Disease	D020258	8111719
toxicity	I-Disease	-1	8111719
.	O	-1	8111719
The	O	-1	8111719
incidence	O	-1	8111719
may	O	-1	8111719
be	O	-1	8111719
dose	O	-1	8111719
and	O	-1	8111719
infu@@	O	-1	8111719
sion@@	O	-1	8111719
-@@	O	-1	8111719
time	O	-1	8111719
rel@@	O	-1	8111719
ated.	O	-1	8111719
The	O	-1	8111719
clin@@	O	-1	8111719
ici@@	O	-1	8111719
an	O	-1	8111719
should	O	-1	8111719
be	O	-1	8111719
al@@	O	-1	8111719
er@@	O	-1	8111719
ted	O	-1	8111719
for	O	-1	8111719
possible	O	-1	8111719
if@@	B-Chemical	D007069	8111719
os@@	I-Chemical	-1	8111719
f@@	I-Chemical	-1	8111719
amide	I-Chemical	-1	8111719
-induced	O	-1	8111719
h@@	B-Disease	D006212	8111719
all@@	I-Disease	-1	8111719
uc@@	I-Disease	-1	8111719
in@@	I-Disease	-1	8111719
ations	I-Disease	-1	8111719
,	O	-1	8111719
which	O	-1	8111719
may	O	-1	8111719
occ@@	O	-1	8111719
ur	O	-1	8111719
without	O	-1	8111719
other	O	-1	8111719
signs	O	-1	8111719
of	O	-1	8111719
neuro@@	B-Disease	D020258	8111719
toxicity	I-Disease	-1	8111719
.	O	-1	8111719
"@@	O	-1	8111719
E@@	O	-1	8111719
y@@	O	-1	8111719
es@@	O	-1	8111719
-@@	O	-1	8111719
clo@@	O	-1	8111719
sed@@	O	-1	8111719
"	O	-1	8111719
h@@	B-Disease	D006212	8111719
all@@	I-Disease	-1	8111719
uc@@	I-Disease	-1	8111719
in@@	I-Disease	-1	8111719
atory	I-Disease	-1	8111719
experienc@@	O	-1	8111719
es	O	-1	8111719
appe@@	O	-1	8111719
ar	O	-1	8111719
to	O	-1	8111719
be	O	-1	8111719
an	O	-1	8111719
un@@	O	-1	8111719
us@@	O	-1	8111719
ual	O	-1	8111719
feat@@	O	-1	8111719
ure	O	-1	8111719
of	O	-1	8111719
this	O	-1	8111719
present@@	O	-1	8111719
ation.	O	-1	8111719
Patients	O	-1	8111719
an@@	O	-1	8111719
xi@@	O	-1	8111719
ous	O	-1	8111719
about	O	-1	8111719
this	O	-1	8111719
experi@@	O	-1	8111719
ence	O	-1	8111719
respon@@	O	-1	8111719
d	O	-1	8111719
well	O	-1	8111719
to	O	-1	8111719
suppor@@	O	-1	8111719
t	O	-1	8111719
and	O	-1	8111719
e@@	O	-1	8111719
duc@@	O	-1	8111719
ation	O	-1	8111719
about	O	-1	8111719
this	O	-1	8111719
occur@@	O	-1	8111719
ren@@	O	-1	8111719
ce@@	O	-1	8111719
.	O	-1	8111719
O@@	O	-1	8111719
p@@	O	-1	8111719
tim@@	O	-1	8111719
al	O	-1	8111719
pharmac@@	O	-1	8111719
ologic	O	-1	8111719
man@@	O	-1	8111719
ag@@	O	-1	8111719
ement	O	-1	8111719
of	O	-1	8111719
dist@@	O	-1	8111719
ur@@	O	-1	8111719
bed	O	-1	8111719
patients	O	-1	8111719
is	O	-1	8111719
unc@@	O	-1	8111719
lear@@	O	-1	8111719
.	O	-1	8111719
I@@	O	-1	8111719
f	O	-1	8111719
ag@@	B-Disease	D011595	8111719
it@@	I-Disease	-1	8111719
ation	I-Disease	-1	8111719
b@@	O	-1	8111719
ec@@	O	-1	8111719
om@@	O	-1	8111719
es	O	-1	8111719
mark@@	O	-1	8111719
ed,	O	-1	8111719
high-@@	O	-1	8111719
poten@@	O	-1	8111719
c@@	O	-1	8111719
y	O	-1	8111719
neuro@@	O	-1	8111719
le@@	O	-1	8111719
p@@	O	-1	8111719
tics	O	-1	8111719
(@@	O	-1	8111719
i.@@	O	-1	8111719
e@@	O	-1	8111719
.,	O	-1	8111719
haloperidol	B-Chemical	D006220	8111719
)	O	-1	8111719
may	O	-1	8111719
be	O	-1	8111719
eff@@	O	-1	8111719
ecti@@	O	-1	8111719
ve.	O	-1	8111719

Ch@@	B-Chemical	D002747	7059267
lor@@	I-Chemical	-1	7059267
prop@@	I-Chemical	-1	7059267
amide	I-Chemical	-1	7059267
-induced	O	-1	7059267
op@@	B-Disease	D009901	7059267
tic	I-Disease	-1	7059267
neuropathy	I-Disease	-1	7059267
.	O	-1	7059267
A	O	-1	7059267
6@@	O	-1	7059267
5-@@	O	-1	7059267
year-old	O	-1	7059267
woman	O	-1	7059267
with	O	-1	7059267
ad@@	B-Disease	D003924	7059267
ult@@	I-Disease	-1	7059267
-@@	I-Disease	-1	7059267
onset	I-Disease	-1	7059267
dia@@	I-Disease	-1	7059267
bet@@	I-Disease	-1	7059267
es	I-Disease	-1	7059267
treated	O	-1	7059267
with	O	-1	7059267
chlor@@	B-Chemical	D002747	7059267
prop@@	I-Chemical	-1	7059267
amide	I-Chemical	-1	7059267
(	O	-1	7059267
Di@@	B-Chemical	D002747	7059267
ab@@	I-Chemical	-1	7059267
en@@	I-Chemical	-1	7059267
ese	I-Chemical	-1	7059267
)	O	-1	7059267
had	O	-1	7059267
a	O	-1	7059267
toxic	B-Disease	D009901	7059267
op@@	I-Disease	-1	7059267
tic	I-Disease	-1	7059267
neuropathy	I-Disease	-1	7059267
that	O	-1	7059267
resol@@	O	-1	7059267
ved	O	-1	7059267
with	O	-1	7059267
discontinu@@	O	-1	7059267
ation	O	-1	7059267
of	O	-1	7059267
chlor@@	B-Chemical	D002747	7059267
prop@@	I-Chemical	-1	7059267
amide	I-Chemical	-1	7059267
therapy.	O	-1	7059267
V@@	B-Disease	D014786	7059267
i@@	I-Disease	-1	7059267
sual	I-Disease	-1	7059267
loss	I-Disease	-1	7059267
occur@@	O	-1	7059267
s	O	-1	7059267
in	O	-1	7059267
dia@@	B-Disease	D003920	7059267
be@@	I-Disease	-1	7059267
tics	I-Disease	-1	7059267
for	O	-1	7059267
a	O	-1	7059267
vari@@	O	-1	7059267
ety	O	-1	7059267
of	O	-1	7059267
reas@@	O	-1	7059267
on@@	O	-1	7059267
s,	O	-1	7059267
and	O	-1	7059267
ac@@	O	-1	7059267
cur@@	O	-1	7059267
ate	O	-1	7059267
diagnosis	O	-1	7059267
is	O	-1	7059267
nec@@	O	-1	7059267
ess@@	O	-1	7059267
ary	O	-1	7059267
to	O	-1	7059267
insti@@	O	-1	7059267
t@@	O	-1	7059267
ute	O	-1	7059267
appro@@	O	-1	7059267
pri@@	O	-1	7059267
ate	O	-1	7059267
therapy.	O	-1	7059267
The	O	-1	7059267
possib@@	O	-1	7059267
ility	O	-1	7059267
of	O	-1	7059267
a	O	-1	7059267
drug@@	O	-1	7059267
-induced	O	-1	7059267
op@@	B-Disease	D009901	7059267
tic	I-Disease	-1	7059267
neuropathy	I-Disease	-1	7059267
should	O	-1	7059267
be	O	-1	7059267
considered	O	-1	7059267
in	O	-1	7059267
the	O	-1	7059267
differen@@	O	-1	7059267
tial	O	-1	7059267
diagnosis	O	-1	7059267
of	O	-1	7059267
visual	B-Disease	D014786	7059267
loss	I-Disease	-1	7059267
in	O	-1	7059267
dia@@	B-Disease	D003920	7059267
be@@	I-Disease	-1	7059267
tics	I-Disease	-1	7059267
.	O	-1	7059267

L@@	B-Chemical	D007980	6381653
evo@@	I-Chemical	-1	6381653
dopa	I-Chemical	-1	6381653
-induced	O	-1	6381653
dyskine@@	B-Disease	D004409	6381653
sia	I-Disease	-1	6381653
and	O	-1	6381653
thal@@	O	-1	6381653
am@@	O	-1	6381653
ot@@	O	-1	6381653
om@@	O	-1	6381653
y.	O	-1	6381653
L@@	B-Chemical	D007980	6381653
evo@@	I-Chemical	-1	6381653
dopa	I-Chemical	-1	6381653
-induced	O	-1	6381653
dyskine@@	B-Disease	D004409	6381653
sia	I-Disease	-1	6381653
of	O	-1	6381653
the	O	-1	6381653
lim@@	O	-1	6381653
b@@	O	-1	6381653
s	O	-1	6381653
in	O	-1	6381653
thir@@	O	-1	6381653
te@@	O	-1	6381653
en	O	-1	6381653
cases	O	-1	6381653
of	O	-1	6381653
Parkinson@@	B-Disease	D010302	6381653
ism	I-Disease	-1	6381653
,	O	-1	6381653
which	O	-1	6381653
was	O	-1	6381653
ch@@	O	-1	6381653
ore@@	O	-1	6381653
ic@@	O	-1	6381653
,	O	-1	6381653
b@@	O	-1	6381653
all@@	O	-1	6381653
istic	O	-1	6381653
or	O	-1	6381653
dy@@	B-Disease	D020821	6381653
st@@	I-Disease	-1	6381653
onic	I-Disease	-1	6381653
in	O	-1	6381653
typ@@	O	-1	6381653
e,	O	-1	6381653
was	O	-1	6381653
al@@	O	-1	6381653
le@@	O	-1	6381653
vi@@	O	-1	6381653
ated	O	-1	6381653
al@@	O	-1	6381653
most	O	-1	6381653
complete@@	O	-1	6381653
ly	O	-1	6381653
by	O	-1	6381653
ste@@	O	-1	6381653
re@@	O	-1	6381653
ot@@	O	-1	6381653
ax@@	O	-1	6381653
ic	O	-1	6381653
surger@@	O	-1	6381653
y	O	-1	6381653
using	O	-1	6381653
a	O	-1	6381653
micro@@	O	-1	6381653
electro@@	O	-1	6381653
de	O	-1	6381653
t@@	O	-1	6381653
ech@@	O	-1	6381653
n@@	O	-1	6381653
i@@	O	-1	6381653
qu@@	O	-1	6381653
e	O	-1	6381653
for	O	-1	6381653
the	O	-1	6381653
ventr@@	O	-1	6381653
al@@	O	-1	6381653
is	O	-1	6381653
or@@	O	-1	6381653
al@@	O	-1	6381653
is	O	-1	6381653
an@@	O	-1	6381653
ter@@	O	-1	6381653
ior	O	-1	6381653
and	O	-1	6381653
po@@	O	-1	6381653
ster@@	O	-1	6381653
ior	O	-1	6381653
nucle@@	O	-1	6381653
i	O	-1	6381653
of	O	-1	6381653
the	O	-1	6381653
thal@@	O	-1	6381653
am@@	O	-1	6381653
us,	O	-1	6381653
but	O	-1	6381653
m@@	O	-1	6381653
uc@@	O	-1	6381653
h	O	-1	6381653
less	O	-1	6381653
by	O	-1	6381653
the	O	-1	6381653
ventr@@	O	-1	6381653
al@@	O	-1	6381653
is	O	-1	6381653
inter@@	O	-1	6381653
medi@@	O	-1	6381653
us	O	-1	6381653
nucle@@	O	-1	6381653
us.	O	-1	6381653
C@@	O	-1	6381653
ont@@	O	-1	6381653
ro@@	O	-1	6381653
l	O	-1	6381653
of	O	-1	6381653
levo@@	B-Chemical	D007980	6381653
dopa	I-Chemical	-1	6381653
-induced	O	-1	6381653
dyskine@@	B-Disease	D004409	6381653
si@@	I-Disease	-1	6381653
as	I-Disease	-1	6381653
by	O	-1	6381653
thal@@	B-Disease	D013786	6381653
am@@	I-Disease	-1	6381653
ic	I-Disease	-1	6381653
lesions	I-Disease	-1	6381653
in	O	-1	6381653
the	O	-1	6381653
course	O	-1	6381653
of	O	-1	6381653
ro@@	O	-1	6381653
ut@@	O	-1	6381653
ine	O	-1	6381653
treatment	O	-1	6381653
of	O	-1	6381653
Parkinson@@	B-Disease	D010302	6381653
ism	I-Disease	-1	6381653
is	O	-1	6381653
discus@@	O	-1	6381653
sed.	O	-1	6381653

F@@	O	-1	3950060
act@@	O	-1	3950060
ors	O	-1	3950060
associated	O	-1	3950060
with	O	-1	3950060
nephro@@	B-Disease	D007674	3950060
toxicity	I-Disease	-1	3950060
and	O	-1	3950060
clinical	O	-1	3950060
outcom@@	O	-1	3950060
e	O	-1	3950060
in	O	-1	3950060
patients	O	-1	3950060
receiving	O	-1	3950060
ami@@	B-Chemical	D000583	3950060
k@@	I-Chemical	-1	3950060
ac@@	I-Chemical	-1	3950060
in	I-Chemical	-1	3950060
.	O	-1	3950060
D@@	O	-1	3950060
at@@	O	-1	3950060
a	O	-1	3950060
from	O	-1	3950060
60	O	-1	3950060
patients	O	-1	3950060
treated	O	-1	3950060
with	O	-1	3950060
ami@@	B-Chemical	D000583	3950060
k@@	I-Chemical	-1	3950060
ac@@	I-Chemical	-1	3950060
in	I-Chemical	-1	3950060
were	O	-1	3950060
analy@@	O	-1	3950060
zed	O	-1	3950060
for	O	-1	3950060
factors	O	-1	3950060
associated	O	-1	3950060
with	O	-1	3950060
nephro@@	B-Disease	D007674	3950060
toxicity	I-Disease	-1	3950060
.	O	-1	3950060
In	O	-1	3950060
4@@	O	-1	3950060
2	O	-1	3950060
of	O	-1	3950060
these	O	-1	3950060
patients,	O	-1	3950060
data	O	-1	3950060
were	O	-1	3950060
examined	O	-1	3950060
for	O	-1	3950060
factors	O	-1	3950060
associated	O	-1	3950060
with	O	-1	3950060
clinical	O	-1	3950060
out@@	O	-1	3950060
co@@	O	-1	3950060
me.	O	-1	3950060
V@@	O	-1	3950060
ari@@	O	-1	3950060
able@@	O	-1	3950060
s	O	-1	3950060
evaluated	O	-1	3950060
included	O	-1	3950060
patient	O	-1	3950060
weigh@@	O	-1	3950060
t,	O	-1	3950060
age,	O	-1	3950060
sex@@	O	-1	3950060
,	O	-1	3950060
serum	O	-1	3950060
creatinine	B-Chemical	D003404	3950060
level@@	O	-1	3950060
,	O	-1	3950060
creatinine	B-Chemical	D003404	3950060
clear@@	O	-1	3950060
ance@@	O	-1	3950060
,	O	-1	3950060
duration	O	-1	3950060
of	O	-1	3950060
therapy,	O	-1	3950060
total	O	-1	3950060
dose@@	O	-1	3950060
,	O	-1	3950060
mean	O	-1	3950060
daily	O	-1	3950060
dose@@	O	-1	3950060
,	O	-1	3950060
org@@	O	-1	3950060
an@@	O	-1	3950060
ism	O	-1	3950060
minim@@	O	-1	3950060
um	O	-1	3950060
inhibit@@	O	-1	3950060
ory	O	-1	3950060
concentration	O	-1	3950060
(@@	O	-1	3950060
M@@	O	-1	3950060
IC@@	O	-1	3950060
),	O	-1	3950060
mean	O	-1	3950060
pe@@	O	-1	3950060
a@@	O	-1	3950060
k	O	-1	3950060
level@@	O	-1	3950060
s,	O	-1	3950060
mean	O	-1	3950060
t@@	O	-1	3950060
rou@@	O	-1	3950060
gh	O	-1	3950060
level@@	O	-1	3950060
s,	O	-1	3950060
mean	O	-1	3950060
a@@	O	-1	3950060
re@@	O	-1	3950060
a	O	-1	3950060
under	O	-1	3950060
the	O	-1	3950060
serum	O	-1	3950060
concentr@@	O	-1	3950060
ation@@	O	-1	3950060
-@@	O	-1	3950060
time	O	-1	3950060
cur@@	O	-1	3950060
ve	O	-1	3950060
(A@@	O	-1	3950060
U@@	O	-1	3950060
C@@	O	-1	3950060
),	O	-1	3950060
total	O	-1	3950060
A@@	O	-1	3950060
U@@	O	-1	3950060
C@@	O	-1	3950060
,	O	-1	3950060
mean	O	-1	3950060
A@@	O	-1	3950060
U@@	O	-1	3950060
C	O	-1	3950060
greater	O	-1	3950060
than	O	-1	3950060
M@@	O	-1	3950060
IC@@	O	-1	3950060
,	O	-1	3950060
total	O	-1	3950060
A@@	O	-1	3950060
U@@	O	-1	3950060
C	O	-1	3950060
greater	O	-1	3950060
than	O	-1	3950060
M@@	O	-1	3950060
IC@@	O	-1	3950060
,	O	-1	3950060
mean	O	-1	3950060
S@@	O	-1	3950060
ch@@	O	-1	3950060
um@@	O	-1	3950060
ac@@	O	-1	3950060
h@@	O	-1	3950060
er@@	O	-1	3950060
's	O	-1	3950060
int@@	O	-1	3950060
ensity	O	-1	3950060
factor	O	-1	3950060
(@@	O	-1	3950060
I@@	O	-1	3950060
F@@	O	-1	3950060
),	O	-1	3950060
total	O	-1	3950060
I@@	O	-1	3950060
F@@	O	-1	3950060
,	O	-1	3950060
In	O	-1	3950060
(@@	O	-1	3950060
mean	O	-1	3950060
maxim@@	O	-1	3950060
um	O	-1	3950060
concentration	O	-1	3950060
[@@	O	-1	3950060
C@@	O	-1	3950060
ma@@	O	-1	3950060
x@@	O	-1	3950060
]@@	O	-1	3950060
/@@	O	-1	3950060
M@@	O	-1	3950060
IC@@	O	-1	3950060
).	O	-1	3950060
M@@	O	-1	3950060
o@@	O	-1	3950060
del@@	O	-1	3950060
-@@	O	-1	3950060
dependent	O	-1	3950060
pharmac@@	O	-1	3950060
o@@	O	-1	3950060
kine@@	O	-1	3950060
tic	O	-1	3950060
par@@	O	-1	3950060
ame@@	O	-1	3950060
ters	O	-1	3950060
were	O	-1	3950060
calc@@	O	-1	3950060
ul@@	O	-1	3950060
ated	O	-1	3950060
by	O	-1	3950060
comp@@	O	-1	3950060
u@@	O	-1	3950060
ter	O	-1	3950060
bas@@	O	-1	3950060
ed	O	-1	3950060
on	O	-1	3950060
a	O	-1	3950060
on@@	O	-1	3950060
e-@@	O	-1	3950060
compar@@	O	-1	3950060
t@@	O	-1	3950060
ment	O	-1	3950060
model@@	O	-1	3950060
.	O	-1	3950060
Whe@@	O	-1	3950060
n	O	-1	3950060
the	O	-1	3950060
par@@	O	-1	3950060
ame@@	O	-1	3950060
ters	O	-1	3950060
were	O	-1	3950060
examined	O	-1	3950060
individ@@	O	-1	3950060
u@@	O	-1	3950060
ally,	O	-1	3950060
duration	O	-1	3950060
of	O	-1	3950060
therapy	O	-1	3950060
and	O	-1	3950060
total	O	-1	3950060
A@@	O	-1	3950060
U@@	O	-1	3950060
C	O	-1	3950060
cor@@	O	-1	3950060
related	O	-1	3950060
significantly	O	-1	3950060
(P	O	-1	3950060
less	O	-1	3950060
than	O	-1	3950060
.@@	O	-1	3950060
0@@	O	-1	3950060
5@@	O	-1	3950060
)	O	-1	3950060
with	O	-1	3950060
nephro@@	B-Disease	D007674	3950060
toxicity	I-Disease	-1	3950060
.	O	-1	3950060
In	O	-1	3950060
contrast@@	O	-1	3950060
,	O	-1	3950060
a	O	-1	3950060
st@@	O	-1	3950060
ep@@	O	-1	3950060
w@@	O	-1	3950060
is@@	O	-1	3950060
e	O	-1	3950060
dis@@	O	-1	3950060
cri@@	O	-1	3950060
min@@	O	-1	3950060
ant	O	-1	3950060
function	O	-1	3950060
analysis	O	-1	3950060
identi@@	O	-1	3950060
fied	O	-1	3950060
only	O	-1	3950060
duration	O	-1	3950060
of	O	-1	3950060
therapy	O	-1	3950060
(P	O	-1	3950060
less	O	-1	3950060
than	O	-1	3950060
.@@	O	-1	3950060
0@@	O	-1	3950060
0@@	O	-1	3950060
1)	O	-1	3950060
as	O	-1	3950060
an	O	-1	3950060
important	O	-1	3950060
fact@@	O	-1	3950060
or@@	O	-1	3950060
.	O	-1	3950060
B@@	O	-1	3950060
as@@	O	-1	3950060
ed	O	-1	3950060
on	O	-1	3950060
this	O	-1	3950060
model	O	-1	3950060
and	O	-1	3950060
on	O	-1	3950060
B@@	O	-1	3950060
ay@@	O	-1	3950060
es@@	O	-1	3950060
'	O	-1	3950060
the@@	O	-1	3950060
ore@@	O	-1	3950060
m@@	O	-1	3950060
,	O	-1	3950060
the	O	-1	3950060
predic@@	O	-1	3950060
tive	O	-1	3950060
ac@@	O	-1	3950060
cur@@	O	-1	3950060
ac@@	O	-1	3950060
y	O	-1	3950060
of	O	-1	3950060
identi@@	O	-1	3950060
f@@	O	-1	3950060
y@@	O	-1	3950060
ing	O	-1	3950060
"	O	-1	3950060
nephro@@	B-Disease	D007674	3950060
toxic	I-Disease	-1	3950060
"	O	-1	3950060
patients	O	-1	3950060
increased	O	-1	3950060
from	O	-1	3950060
0.@@	O	-1	3950060
17	O	-1	3950060
to	O	-1	3950060
0.@@	O	-1	3950060
3@@	O	-1	3950060
9@@	O	-1	3950060
.	O	-1	3950060
Whe@@	O	-1	3950060
n	O	-1	3950060
examined	O	-1	3950060
individ@@	O	-1	3950060
u@@	O	-1	3950060
ally,	O	-1	3950060
mean	O	-1	3950060
I@@	O	-1	3950060
F@@	O	-1	3950060
,	O	-1	3950060
M@@	O	-1	3950060
IC@@	O	-1	3950060
,	O	-1	3950060
total	O	-1	3950060
dose@@	O	-1	3950060
,	O	-1	3950060
mean	O	-1	3950060
daily	O	-1	3950060
dose@@	O	-1	3950060
,	O	-1	3950060
and	O	-1	3950060
l@@	O	-1	3950060
n	O	-1	3950060
(@@	O	-1	3950060
mean	O	-1	3950060
C@@	O	-1	3950060
ma@@	O	-1	3950060
x@@	O	-1	3950060
/@@	O	-1	3950060
M@@	O	-1	3950060
IC@@	O	-1	3950060
)	O	-1	3950060
cor@@	O	-1	3950060
related	O	-1	3950060
significantly	O	-1	3950060
(P	O	-1	3950060
less	O	-1	3950060
than	O	-1	3950060
.@@	O	-1	3950060
0@@	O	-1	3950060
5@@	O	-1	3950060
)	O	-1	3950060
with	O	-1	3950060
c@@	O	-1	3950060
ure.	O	-1	3950060
In	O	-1	3950060
contrast@@	O	-1	3950060
,	O	-1	3950060
a	O	-1	3950060
sim@@	O	-1	3950060
ult@@	O	-1	3950060
aneous	O	-1	3950060
mul@@	O	-1	3950060
tiv@@	O	-1	3950060
ari@@	O	-1	3950060
able	O	-1	3950060
analysis	O	-1	3950060
identi@@	O	-1	3950060
fied	O	-1	3950060
I@@	O	-1	3950060
F@@	O	-1	3950060
,	O	-1	3950060
M@@	O	-1	3950060
IC@@	O	-1	3950060
,	O	-1	3950060
and	O	-1	3950060
total	O	-1	3950060
dose	O	-1	3950060
ac@@	O	-1	3950060
cor@@	O	-1	3950060
ding	O	-1	3950060
to	O	-1	3950060
one	O	-1	3950060
model	O	-1	3950060
and	O	-1	3950060
l@@	O	-1	3950060
n	O	-1	3950060
(@@	O	-1	3950060
mean	O	-1	3950060
C@@	O	-1	3950060
ma@@	O	-1	3950060
x@@	O	-1	3950060
/@@	O	-1	3950060
M@@	O	-1	3950060
IC@@	O	-1	3950060
)	O	-1	3950060
ac@@	O	-1	3950060
cor@@	O	-1	3950060
ding	O	-1	3950060
to	O	-1	3950060
a	O	-1	3950060
second	O	-1	3950060
statis@@	O	-1	3950060
tical	O	-1	3950060
model	O	-1	3950060
of	O	-1	3950060
par@@	O	-1	3950060
ame@@	O	-1	3950060
ters	O	-1	3950060
sel@@	O	-1	3950060
ected	O	-1	3950060
to	O	-1	3950060
have	O	-1	3950060
the	O	-1	3950060
great@@	O	-1	3950060
est	O	-1	3950060
pro@@	O	-1	3950060
sp@@	O	-1	3950060
ective	O	-1	3950060
valu@@	O	-1	3950060
e.	O	-1	3950060
B@@	O	-1	3950060
as@@	O	-1	3950060
ed	O	-1	3950060
on	O	-1	3950060
B@@	O	-1	3950060
ay@@	O	-1	3950060
es@@	O	-1	3950060
'	O	-1	3950060
the@@	O	-1	3950060
ore@@	O	-1	3950060
m	O	-1	3950060
and	O	-1	3950060
the	O	-1	3950060
first	O	-1	3950060
model@@	O	-1	3950060
,	O	-1	3950060
the	O	-1	3950060
predic@@	O	-1	3950060
tive	O	-1	3950060
ac@@	O	-1	3950060
cur@@	O	-1	3950060
ac@@	O	-1	3950060
y	O	-1	3950060
of	O	-1	3950060
identi@@	O	-1	3950060
f@@	O	-1	3950060
y@@	O	-1	3950060
ing	O	-1	3950060
patients	O	-1	3950060
not	O	-1	3950060
c@@	O	-1	3950060
ured	O	-1	3950060
increased	O	-1	3950060
from	O	-1	3950060
0.@@	O	-1	3950060
1@@	O	-1	3950060
9	O	-1	3950060
to	O	-1	3950060
0.@@	O	-1	3950060
8@@	O	-1	3950060
3@@	O	-1	3950060
.	O	-1	3950060
F@@	O	-1	3950060
or	O	-1	3950060
the	O	-1	3950060
second	O	-1	3950060
model@@	O	-1	3950060
,	O	-1	3950060
the	O	-1	3950060
predic@@	O	-1	3950060
tive	O	-1	3950060
ac@@	O	-1	3950060
cur@@	O	-1	3950060
ac@@	O	-1	3950060
y	O	-1	3950060
increased	O	-1	3950060
from	O	-1	3950060
0.@@	O	-1	3950060
1@@	O	-1	3950060
9	O	-1	3950060
to	O	-1	3950060
0.@@	O	-1	3950060
5@@	O	-1	3950060
0.@@	O	-1	3950060
(A@@	O	-1	3950060
B@@	O	-1	3950060
S@@	O	-1	3950060
TR@@	O	-1	3950060
AC@@	O	-1	3950060
T	O	-1	3950060
TR@@	O	-1	3950060
UN@@	O	-1	3950060
C@@	O	-1	3950060
AT@@	O	-1	3950060
E@@	O	-1	3950060
D	O	-1	3950060
A@@	O	-1	3950060
T	O	-1	3950060
2@@	O	-1	3950060
50	O	-1	3950060
W@@	O	-1	3950060
O@@	O	-1	3950060
RD@@	O	-1	3950060
S)	O	-1	3950060

C@@	O	-1	3311455
ardi@@	O	-1	3311455
a@@	O	-1	3311455
c	O	-1	3311455
transplant@@	O	-1	3311455
ation@@	O	-1	3311455
:	O	-1	3311455
improved	O	-1	3311455
qu@@	O	-1	3311455
ality	O	-1	3311455
of	O	-1	3311455
sur@@	O	-1	3311455
viv@@	O	-1	3311455
al	O	-1	3311455
with	O	-1	3311455
a	O	-1	3311455
mo@@	O	-1	3311455
di@@	O	-1	3311455
fied	O	-1	3311455
immunosup@@	O	-1	3311455
pressive	O	-1	3311455
pro@@	O	-1	3311455
to@@	O	-1	3311455
co@@	O	-1	3311455
l@@	O	-1	3311455
.	O	-1	3311455
The	O	-1	3311455
effects	O	-1	3311455
on	O	-1	3311455
renal	O	-1	3311455
function	O	-1	3311455
on	O	-1	3311455
two	O	-1	3311455
different	O	-1	3311455
immunosup@@	O	-1	3311455
pressive	O	-1	3311455
pro@@	O	-1	3311455
to@@	O	-1	3311455
co@@	O	-1	3311455
l@@	O	-1	3311455
s	O	-1	3311455
were	O	-1	3311455
evaluated	O	-1	3311455
ret@@	O	-1	3311455
ro@@	O	-1	3311455
sp@@	O	-1	3311455
ectively	O	-1	3311455
in	O	-1	3311455
two	O	-1	3311455
subsequ@@	O	-1	3311455
ent	O	-1	3311455
groups	O	-1	3311455
of	O	-1	3311455
heart	O	-1	3311455
transplant	O	-1	3311455
re@@	O	-1	3311455
ci@@	O	-1	3311455
pi@@	O	-1	3311455
ent@@	O	-1	3311455
s.	O	-1	3311455
In	O	-1	3311455
group	O	-1	3311455
I@@	O	-1	3311455
,	O	-1	3311455
cyclospor@@	B-Chemical	D016572	3311455
ine	I-Chemical	-1	3311455
was	O	-1	3311455
given	O	-1	3311455
before	O	-1	3311455
the	O	-1	3311455
proce@@	O	-1	3311455
d@@	O	-1	3311455
ure	O	-1	3311455
at	O	-1	3311455
a	O	-1	3311455
lo@@	O	-1	3311455
ad@@	O	-1	3311455
ing	O	-1	3311455
dose	O	-1	3311455
of	O	-1	3311455
1@@	O	-1	3311455
7.@@	O	-1	3311455
5	O	-1	3311455
mg/kg	O	-1	3311455
and	O	-1	3311455
then	O	-1	3311455
continu@@	O	-1	3311455
ed	O	-1	3311455
after	O	-1	3311455
the	O	-1	3311455
proce@@	O	-1	3311455
d@@	O	-1	3311455
ure	O	-1	3311455
to	O	-1	3311455
ke@@	O	-1	3311455
ep	O	-1	3311455
a	O	-1	3311455
wh@@	O	-1	3311455
ole	O	-1	3311455
blood	O	-1	3311455
level	O	-1	3311455
about	O	-1	3311455
10@@	O	-1	3311455
00	O	-1	3311455
n@@	O	-1	3311455
g/@@	O	-1	3311455
ml@@	O	-1	3311455
.	O	-1	3311455
In	O	-1	3311455
group	O	-1	3311455
II@@	O	-1	3311455
,	O	-1	3311455
cyclospor@@	B-Chemical	D016572	3311455
ine	I-Chemical	-1	3311455
was	O	-1	3311455
star@@	O	-1	3311455
ted	O	-1	3311455
only	O	-1	3311455
after	O	-1	3311455
the	O	-1	3311455
proce@@	O	-1	3311455
d@@	O	-1	3311455
ure	O	-1	3311455
at	O	-1	3311455
a	O	-1	3311455
lower	O	-1	3311455
dos@@	O	-1	3311455
age	O	-1	3311455
and	O	-1	3311455
was	O	-1	3311455
comple@@	O	-1	3311455
ment@@	O	-1	3311455
ed	O	-1	3311455
by	O	-1	3311455
az@@	B-Chemical	D001379	3311455
ath@@	I-Chemical	-1	3311455
io@@	I-Chemical	-1	3311455
p@@	I-Chemical	-1	3311455
rine	I-Chemical	-1	3311455
,	O	-1	3311455
which	O	-1	3311455
was	O	-1	3311455
used	O	-1	3311455
for	O	-1	3311455
the	O	-1	3311455
first	O	-1	3311455
postoperative	O	-1	3311455
week@@	O	-1	3311455
.	O	-1	3311455
Group	O	-1	3311455
II	O	-1	3311455
showed	O	-1	3311455
a	O	-1	3311455
bet@@	O	-1	3311455
ter	O	-1	3311455
perio@@	O	-1	3311455
perative	O	-1	3311455
renal	O	-1	3311455
function	O	-1	3311455
as	O	-1	3311455
determined	O	-1	3311455
by	O	-1	3311455
serum	O	-1	3311455
blood	O	-1	3311455
ure@@	B-Chemical	D001806	3311455
a	I-Chemical	-1	3311455
nitro@@	I-Chemical	-1	3311455
gen	I-Chemical	-1	3311455
and	O	-1	3311455
serum	O	-1	3311455
creatinine	B-Chemical	D003404	3311455
level@@	O	-1	3311455
s.	O	-1	3311455
Group	O	-1	3311455
II	O	-1	3311455
also	O	-1	3311455
showed	O	-1	3311455
a	O	-1	3311455
significant	O	-1	3311455
decrease	O	-1	3311455
of	O	-1	3311455
chronic	O	-1	3311455
nephro@@	B-Disease	D007674	3311455
toxicity	I-Disease	-1	3311455
secondary	O	-1	3311455
to	O	-1	3311455
long-term	O	-1	3311455
therapy	O	-1	3311455
with	O	-1	3311455
cyclospor@@	B-Chemical	D016572	3311455
ine	I-Chemical	-1	3311455
.	O	-1	3311455
D@@	O	-1	3311455
es@@	O	-1	3311455
pit@@	O	-1	3311455
e	O	-1	3311455
this	O	-1	3311455
impro@@	O	-1	3311455
vement	O	-1	3311455
in	O	-1	3311455
l@@	O	-1	3311455
ate	O	-1	3311455
renal	O	-1	3311455
func@@	O	-1	3311455
tion,	O	-1	3311455
group	O	-1	3311455
II	O	-1	3311455
sti@@	O	-1	3311455
ll	O	-1	3311455
show@@	O	-1	3311455
s	O	-1	3311455
a	O	-1	3311455
s@@	O	-1	3311455
low	O	-1	3311455
ri@@	O	-1	3311455
se	O	-1	3311455
in	O	-1	3311455
serum	O	-1	3311455
creatinine	B-Chemical	D003404	3311455
.	O	-1	3311455
We	O	-1	3311455
th@@	O	-1	3311455
in@@	O	-1	3311455
k	O	-1	3311455
that	O	-1	3311455
even	O	-1	3311455
these	O	-1	3311455
lower	O	-1	3311455
dos@@	O	-1	3311455
ages	O	-1	3311455
of	O	-1	3311455
cyclospor@@	B-Chemical	D016572	3311455
ine	I-Chemical	-1	3311455
can	O	-1	3311455
cause	O	-1	3311455
chronic	O	-1	3311455
nephro@@	B-Disease	D007674	3311455
toxicity	I-Disease	-1	3311455
and	O	-1	3311455
that	O	-1	3311455
further	O	-1	3311455
mo@@	O	-1	3311455
di@@	O	-1	3311455
fic@@	O	-1	3311455
ation	O	-1	3311455
of	O	-1	3311455
the	O	-1	3311455
immunosup@@	O	-1	3311455
pressive	O	-1	3311455
regi@@	O	-1	3311455
men	O	-1	3311455
is	O	-1	3311455
requ@@	O	-1	3311455
ired	O	-1	3311455
to	O	-1	3311455
complete@@	O	-1	3311455
ly	O	-1	3311455
abol@@	O	-1	3311455
is@@	O	-1	3311455
h	O	-1	3311455
this	O	-1	3311455
toxic	O	-1	3311455
side	O	-1	3311455
effect@@	O	-1	3311455
.	O	-1	3311455

Re@@	O	-1	2051906
ver@@	O	-1	2051906
sible	O	-1	2051906
cholest@@	B-Disease	D002779	2051906
asis	I-Disease	-1	2051906
with	O	-1	2051906
b@@	B-Disease	D002779	2051906
ile	I-Disease	-1	2051906
duc@@	I-Disease	-1	2051906
t	I-Disease	-1	2051906
injury	I-Disease	-1	2051906
following	O	-1	2051906
az@@	B-Chemical	D001379	2051906
ath@@	I-Chemical	-1	2051906
io@@	I-Chemical	-1	2051906
p@@	I-Chemical	-1	2051906
rine	I-Chemical	-1	2051906
therapy.	O	-1	2051906
A	O	-1	2051906
case	O	-1	2051906
repor@@	O	-1	2051906
t.	O	-1	2051906
A	O	-1	2051906
6@@	O	-1	2051906
7-@@	O	-1	2051906
year-old	O	-1	2051906
patient@@	O	-1	2051906
,	O	-1	2051906
with	O	-1	2051906
prim@@	O	-1	2051906
ary	O	-1	2051906
poly@@	B-Disease	D017285	2051906
my@@	I-Disease	-1	2051906
o@@	I-Disease	-1	2051906
si@@	I-Disease	-1	2051906
tis	I-Disease	-1	2051906
and	O	-1	2051906
without	O	-1	2051906
previ@@	O	-1	2051906
ous	O	-1	2051906
evidence	O	-1	2051906
of	O	-1	2051906
liver	B-Disease	D008107	2051906
disease	I-Disease	-1	2051906
,	O	-1	2051906
developed	O	-1	2051906
clinical	O	-1	2051906
and	O	-1	2051906
bio@@	O	-1	2051906
chemical	O	-1	2051906
feat@@	O	-1	2051906
ures	O	-1	2051906
of	O	-1	2051906
severe	O	-1	2051906
cholest@@	B-Disease	D002779	2051906
asis	I-Disease	-1	2051906
3	O	-1	2051906
months	O	-1	2051906
after	O	-1	2051906
initi@@	O	-1	2051906
ation	O	-1	2051906
of	O	-1	2051906
az@@	B-Chemical	D001379	2051906
ath@@	I-Chemical	-1	2051906
io@@	I-Chemical	-1	2051906
p@@	I-Chemical	-1	2051906
rine	I-Chemical	-1	2051906
therapy.	O	-1	2051906
L@@	O	-1	2051906
i@@	O	-1	2051906
ver	O	-1	2051906
biop@@	O	-1	2051906
sy	O	-1	2051906
showed	O	-1	2051906
cholest@@	B-Disease	D002779	2051906
asis	I-Disease	-1	2051906
with	O	-1	2051906
both	O	-1	2051906
cyto@@	O	-1	2051906
log@@	O	-1	2051906
ical	O	-1	2051906
and	O	-1	2051906
ar@@	O	-1	2051906
ch@@	O	-1	2051906
it@@	O	-1	2051906
ect@@	O	-1	2051906
ural	O	-1	2051906
al@@	O	-1	2051906
ter@@	O	-1	2051906
ations	O	-1	2051906
of	O	-1	2051906
inter@@	O	-1	2051906
lo@@	O	-1	2051906
b@@	O	-1	2051906
ular	O	-1	2051906
b@@	O	-1	2051906
ile	O	-1	2051906
duc@@	O	-1	2051906
t@@	O	-1	2051906
s.	O	-1	2051906
A@@	B-Chemical	D001379	2051906
z@@	I-Chemical	-1	2051906
ath@@	I-Chemical	-1	2051906
io@@	I-Chemical	-1	2051906
p@@	I-Chemical	-1	2051906
rine	I-Chemical	-1	2051906
withdrawal	O	-1	2051906
resulted	O	-1	2051906
after	O	-1	2051906
7	O	-1	2051906
weeks	O	-1	2051906
in	O	-1	2051906
the	O	-1	2051906
resol@@	O	-1	2051906
u@@	O	-1	2051906
tion	O	-1	2051906
of	O	-1	2051906
clinical	O	-1	2051906
and	O	-1	2051906
bio@@	O	-1	2051906
chemical	O	-1	2051906
abnormal@@	O	-1	2051906
iti@@	O	-1	2051906
es.	O	-1	2051906
It	O	-1	2051906
is	O	-1	2051906
be@@	O	-1	2051906
li@@	O	-1	2051906
ev@@	O	-1	2051906
ed	O	-1	2051906
that	O	-1	2051906
this	O	-1	2051906
is	O	-1	2051906
the	O	-1	2051906
first	O	-1	2051906
reported	O	-1	2051906
case	O	-1	2051906
of	O	-1	2051906
reversible	O	-1	2051906
az@@	B-Chemical	D001379	2051906
ath@@	I-Chemical	-1	2051906
io@@	I-Chemical	-1	2051906
p@@	I-Chemical	-1	2051906
rine	I-Chemical	-1	2051906
-induced	O	-1	2051906
cholest@@	B-Disease	D002779	2051906
asis	I-Disease	-1	2051906
associated	O	-1	2051906
with	O	-1	2051906
hist@@	O	-1	2051906
ological	O	-1	2051906
evidence	O	-1	2051906
of	O	-1	2051906
b@@	B-Disease	D002779	2051906
ile	I-Disease	-1	2051906
duc@@	I-Disease	-1	2051906
t	I-Disease	-1	2051906
injury	I-Disease	-1	2051906
.	O	-1	2051906

R@@	O	-1	2021202
en@@	O	-1	2021202
al	O	-1	2021202
function	O	-1	2021202
and	O	-1	2021202
hemo@@	O	-1	2021202
dynam@@	O	-1	2021202
ic@@	O	-1	2021202
s	O	-1	2021202
during	O	-1	2021202
prolonged	O	-1	2021202
iso@@	B-Chemical	D007530	2021202
f@@	I-Chemical	-1	2021202
lur@@	I-Chemical	-1	2021202
ane	I-Chemical	-1	2021202
-induced	O	-1	2021202
hypotension	B-Disease	D007022	2021202
in	O	-1	2021202
hum@@	O	-1	2021202
an@@	O	-1	2021202
s.	O	-1	2021202
The	O	-1	2021202
effect	O	-1	2021202
of	O	-1	2021202
iso@@	B-Chemical	D007530	2021202
f@@	I-Chemical	-1	2021202
lur@@	I-Chemical	-1	2021202
ane	I-Chemical	-1	2021202
-induced	O	-1	2021202
hypotension	B-Disease	D007022	2021202
on	O	-1	2021202
glomerular	O	-1	2021202
function	O	-1	2021202
and	O	-1	2021202
renal	O	-1	2021202
blood	O	-1	2021202
flow	O	-1	2021202
was	O	-1	2021202
investigated	O	-1	2021202
in	O	-1	2021202
20	O	-1	2021202
human	O	-1	2021202
subj@@	O	-1	2021202
ect@@	O	-1	2021202
s.	O	-1	2021202
G@@	O	-1	2021202
lo@@	O	-1	2021202
mer@@	O	-1	2021202
ular	O	-1	2021202
f@@	O	-1	2021202
iltration	O	-1	2021202
rate	O	-1	2021202
(@@	O	-1	2021202
GF@@	O	-1	2021202
R@@	O	-1	2021202
)	O	-1	2021202
and	O	-1	2021202
effective	O	-1	2021202
renal	O	-1	2021202
plasma	O	-1	2021202
flow	O	-1	2021202
(@@	O	-1	2021202
E@@	O	-1	2021202
R@@	O	-1	2021202
P@@	O	-1	2021202
F@@	O	-1	2021202
)	O	-1	2021202
were	O	-1	2021202
measured	O	-1	2021202
by	O	-1	2021202
in@@	O	-1	2021202
ul@@	O	-1	2021202
in	O	-1	2021202
and	O	-1	2021202
par@@	B-Chemical	D010130	2021202
a@@	I-Chemical	-1	2021202
-@@	I-Chemical	-1	2021202
amino@@	I-Chemical	-1	2021202
hi@@	I-Chemical	-1	2021202
pp@@	I-Chemical	-1	2021202
ur@@	I-Chemical	-1	2021202
ate	I-Chemical	-1	2021202
(	O	-1	2021202
PA@@	B-Chemical	D010130	2021202
H	I-Chemical	-1	2021202
)	O	-1	2021202
clear@@	O	-1	2021202
ance@@	O	-1	2021202
,	O	-1	2021202
respectively.	O	-1	2021202
An@@	O	-1	2021202
esthe@@	O	-1	2021202
sia	O	-1	2021202
was	O	-1	2021202
maint@@	O	-1	2021202
ained	O	-1	2021202
with	O	-1	2021202
f@@	B-Chemical	D005283	2021202
entan@@	I-Chemical	-1	2021202
yl	I-Chemical	-1	2021202
,	O	-1	2021202
nit@@	B-Chemical	D009609	2021202
rou@@	I-Chemical	-1	2021202
s	I-Chemical	-1	2021202
ox@@	I-Chemical	-1	2021202
ide	I-Chemical	-1	2021202
,	O	-1	2021202
oxy@@	B-Chemical	D010100	2021202
gen	I-Chemical	-1	2021202
,	O	-1	2021202
and	O	-1	2021202
iso@@	B-Chemical	D007530	2021202
f@@	I-Chemical	-1	2021202
lur@@	I-Chemical	-1	2021202
ane	I-Chemical	-1	2021202
.	O	-1	2021202
H@@	B-Disease	D007022	2021202
y@@	I-Disease	-1	2021202
poten@@	I-Disease	-1	2021202
sion	I-Disease	-1	2021202
was	O	-1	2021202
induced	O	-1	2021202
for	O	-1	2021202
2@@	O	-1	2021202
3@@	O	-1	2021202
6.@@	O	-1	2021202
9	O	-1	2021202
+/-	O	-1	2021202
1@@	O	-1	2021202
5.@@	O	-1	2021202
1	O	-1	2021202
min	O	-1	2021202
by	O	-1	2021202
increas@@	O	-1	2021202
ing	O	-1	2021202
the	O	-1	2021202
iso@@	B-Chemical	D007530	2021202
f@@	I-Chemical	-1	2021202
lur@@	I-Chemical	-1	2021202
ane	I-Chemical	-1	2021202
in@@	O	-1	2021202
s@@	O	-1	2021202
pi@@	O	-1	2021202
red	O	-1	2021202
concentration	O	-1	2021202
to	O	-1	2021202
maint@@	O	-1	2021202
ain	O	-1	2021202
a	O	-1	2021202
mean	O	-1	2021202
arterial	O	-1	2021202
pressure	O	-1	2021202
of	O	-1	2021202
5@@	O	-1	2021202
9.@@	O	-1	2021202
8	O	-1	2021202
+/-	O	-1	2021202
0.@@	O	-1	2021202
4	O	-1	2021202
mm@@	O	-1	2021202
H@@	O	-1	2021202
g@@	O	-1	2021202
.	O	-1	2021202
GF@@	O	-1	2021202
R	O	-1	2021202
and	O	-1	2021202
E@@	O	-1	2021202
R@@	O	-1	2021202
P@@	O	-1	2021202
F	O	-1	2021202
decreased	O	-1	2021202
with	O	-1	2021202
the	O	-1	2021202
induction	O	-1	2021202
of	O	-1	2021202
anesthe@@	O	-1	2021202
sia	O	-1	2021202
but	O	-1	2021202
not	O	-1	2021202
significantly	O	-1	2021202
more	O	-1	2021202
during	O	-1	2021202
hypotension	B-Disease	D007022	2021202
.	O	-1	2021202
P@@	O	-1	2021202
o@@	O	-1	2021202
sto@@	O	-1	2021202
per@@	O	-1	2021202
ati@@	O	-1	2021202
vel@@	O	-1	2021202
y,	O	-1	2021202
E@@	O	-1	2021202
R@@	O	-1	2021202
P@@	O	-1	2021202
F	O	-1	2021202
retur@@	O	-1	2021202
n@@	O	-1	2021202
ed	O	-1	2021202
to	O	-1	2021202
pre@@	O	-1	2021202
o@@	O	-1	2021202
perative	O	-1	2021202
valu@@	O	-1	2021202
es,	O	-1	2021202
whereas	O	-1	2021202
GF@@	O	-1	2021202
R	O	-1	2021202
was	O	-1	2021202
higher	O	-1	2021202
than	O	-1	2021202
pre@@	O	-1	2021202
o@@	O	-1	2021202
perative	O	-1	2021202
valu@@	O	-1	2021202
es.	O	-1	2021202
R@@	O	-1	2021202
en@@	O	-1	2021202
al	O	-1	2021202
vascular	O	-1	2021202
resist@@	O	-1	2021202
ance	O	-1	2021202
increased	O	-1	2021202
during	O	-1	2021202
anesthe@@	O	-1	2021202
sia	O	-1	2021202
but	O	-1	2021202
decreased	O	-1	2021202
when	O	-1	2021202
hypotension	B-Disease	D007022	2021202
was	O	-1	2021202
induc@@	O	-1	2021202
ed,	O	-1	2021202
al@@	O	-1	2021202
low@@	O	-1	2021202
ing	O	-1	2021202
the	O	-1	2021202
maint@@	O	-1	2021202
en@@	O	-1	2021202
ance	O	-1	2021202
of	O	-1	2021202
renal	O	-1	2021202
blood	O	-1	2021202
f@@	O	-1	2021202
low@@	O	-1	2021202
.	O	-1	2021202
We	O	-1	2021202
concl@@	O	-1	2021202
ude	O	-1	2021202
that	O	-1	2021202
renal	O	-1	2021202
com@@	O	-1	2021202
pen@@	O	-1	2021202
s@@	O	-1	2021202
atory	O	-1	2021202
mechanisms	O	-1	2021202
are	O	-1	2021202
pres@@	O	-1	2021202
er@@	O	-1	2021202
ved	O	-1	2021202
during	O	-1	2021202
iso@@	B-Chemical	D007530	2021202
f@@	I-Chemical	-1	2021202
lur@@	I-Chemical	-1	2021202
ane	I-Chemical	-1	2021202
-induced	O	-1	2021202
hypotension	B-Disease	D007022	2021202
and	O	-1	2021202
that	O	-1	2021202
renal	O	-1	2021202
function	O	-1	2021202
and	O	-1	2021202
hemo@@	O	-1	2021202
dynam@@	O	-1	2021202
ic@@	O	-1	2021202
s	O	-1	2021202
qu@@	O	-1	2021202
ic@@	O	-1	2021202
k@@	O	-1	2021202
ly	O	-1	2021202
retur@@	O	-1	2021202
n	O	-1	2021202
to	O	-1	2021202
normal	O	-1	2021202
when	O	-1	2021202
norm@@	O	-1	2021202
oten@@	O	-1	2021202
sion	O	-1	2021202
is	O	-1	2021202
res@@	O	-1	2021202
u@@	O	-1	2021202
me@@	O	-1	2021202
d.	O	-1	2021202

De@@	B-Chemical	D003647	1848636
b@@	I-Chemical	-1	1848636
ris@@	I-Chemical	-1	1848636
o@@	I-Chemical	-1	1848636
qu@@	I-Chemical	-1	1848636
ine	I-Chemical	-1	1848636
phen@@	O	-1	1848636
ot@@	O	-1	1848636
yp@@	O	-1	1848636
e	O	-1	1848636
and	O	-1	1848636
the	O	-1	1848636
pharmac@@	O	-1	1848636
o@@	O	-1	1848636
kine@@	O	-1	1848636
tics	O	-1	1848636
and	O	-1	1848636
beta-@@	O	-1	1848636
2	O	-1	1848636
receptor	O	-1	1848636
pharmac@@	O	-1	1848636
o@@	O	-1	1848636
dynam@@	O	-1	1848636
ic@@	O	-1	1848636
s	O	-1	1848636
of	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
and	O	-1	1848636
its	O	-1	1848636
en@@	O	-1	1848636
anti@@	O	-1	1848636
om@@	O	-1	1848636
ers.	O	-1	1848636
The	O	-1	1848636
metabol@@	O	-1	1848636
ism	O	-1	1848636
of	O	-1	1848636
the	O	-1	1848636
cardio@@	O	-1	1848636
selective	O	-1	1848636
beta-@@	O	-1	1848636
block@@	O	-1	1848636
er	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
is	O	-1	1848636
under	O	-1	1848636
gene@@	O	-1	1848636
tic	O	-1	1848636
control	O	-1	1848636
of	O	-1	1848636
the	O	-1	1848636
de@@	B-Chemical	D003647	1848636
b@@	I-Chemical	-1	1848636
ris@@	I-Chemical	-1	1848636
o@@	I-Chemical	-1	1848636
qu@@	I-Chemical	-1	1848636
ine	I-Chemical	-1	1848636
/	O	-1	1848636
s@@	B-Chemical	D013034	1848636
par@@	I-Chemical	-1	1848636
te@@	I-Chemical	-1	1848636
ine	I-Chemical	-1	1848636
typ@@	O	-1	1848636
e.	O	-1	1848636
The	O	-1	1848636
two	O	-1	1848636
met@@	O	-1	1848636
ab@@	O	-1	1848636
olic	O	-1	1848636
phen@@	O	-1	1848636
ot@@	O	-1	1848636
yp@@	O	-1	1848636
es,	O	-1	1848636
exten@@	O	-1	1848636
sive	O	-1	1848636
(@@	O	-1	1848636
E@@	O	-1	1848636
M@@	O	-1	1848636
)	O	-1	1848636
and	O	-1	1848636
po@@	O	-1	1848636
or	O	-1	1848636
metabol@@	O	-1	1848636
iz@@	O	-1	1848636
ers	O	-1	1848636
(P@@	O	-1	1848636
M@@	O	-1	1848636
),	O	-1	1848636
show	O	-1	1848636
different	O	-1	1848636
ste@@	O	-1	1848636
re@@	O	-1	1848636
o@@	O	-1	1848636
selective	O	-1	1848636
metabol@@	O	-1	1848636
is@@	O	-1	1848636
m@@	O	-1	1848636
,	O	-1	1848636
result@@	O	-1	1848636
ing	O	-1	1848636
in	O	-1	1848636
appa@@	O	-1	1848636
ren@@	O	-1	1848636
tly	O	-1	1848636
higher	O	-1	1848636
beta-@@	O	-1	1848636
1	O	-1	1848636
adren@@	O	-1	1848636
oc@@	O	-1	1848636
e@@	O	-1	1848636
pt@@	O	-1	1848636
or	O	-1	1848636
antagon@@	O	-1	1848636
istic	O	-1	1848636
poten@@	O	-1	1848636
c@@	O	-1	1848636
y	O	-1	1848636
of	O	-1	1848636
rac@@	O	-1	1848636
em@@	O	-1	1848636
ic	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
in	O	-1	1848636
E@@	O	-1	1848636
M@@	O	-1	1848636
s.	O	-1	1848636
We	O	-1	1848636
investigated	O	-1	1848636
if	O	-1	1848636
the	O	-1	1848636
lat@@	O	-1	1848636
ter	O	-1	1848636
also	O	-1	1848636
ap@@	O	-1	1848636
pl@@	O	-1	1848636
i@@	O	-1	1848636
es	O	-1	1848636
to	O	-1	1848636
the	O	-1	1848636
beta-@@	O	-1	1848636
2	O	-1	1848636
adren@@	O	-1	1848636
oc@@	O	-1	1848636
e@@	O	-1	1848636
pt@@	O	-1	1848636
or	O	-1	1848636
antagon@@	O	-1	1848636
ism	O	-1	1848636
by	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
.	O	-1	1848636
The	O	-1	1848636
drug	O	-1	1848636
effect	O	-1	1848636
studied	O	-1	1848636
was	O	-1	1848636
the	O	-1	1848636
antagon@@	O	-1	1848636
ism	O	-1	1848636
by	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
of	O	-1	1848636
ter@@	B-Chemical	D013726	1848636
but@@	I-Chemical	-1	1848636
aline	I-Chemical	-1	1848636
-induced	O	-1	1848636
hypo@@	B-Disease	D007008	1848636
k@@	I-Disease	-1	1848636
al@@	I-Disease	-1	1848636
emia	I-Disease	-1	1848636
.	O	-1	1848636
B@@	O	-1	1848636
y	O	-1	1848636
using	O	-1	1848636
pharmac@@	O	-1	1848636
o@@	O	-1	1848636
kine@@	O	-1	1848636
tic	O	-1	1848636
pharmac@@	O	-1	1848636
o@@	O	-1	1848636
dynam@@	O	-1	1848636
ic	O	-1	1848636
model@@	O	-1	1848636
ing	O	-1	1848636
the	O	-1	1848636
pharmac@@	O	-1	1848636
o@@	O	-1	1848636
dynam@@	O	-1	1848636
ic@@	O	-1	1848636
s	O	-1	1848636
of	O	-1	1848636
rac@@	O	-1	1848636
em@@	O	-1	1848636
ic	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
and	O	-1	1848636
the	O	-1	1848636
active	O	-1	1848636
S@@	O	-1	1848636
-@@	O	-1	1848636
is@@	O	-1	1848636
om@@	O	-1	1848636
er,	O	-1	1848636
were	O	-1	1848636
qu@@	O	-1	1848636
anti@@	O	-1	1848636
t@@	O	-1	1848636
ated	O	-1	1848636
in	O	-1	1848636
E@@	O	-1	1848636
M@@	O	-1	1848636
s	O	-1	1848636
and	O	-1	1848636
P@@	O	-1	1848636
M@@	O	-1	1848636
s	O	-1	1848636
in	O	-1	1848636
ter@@	O	-1	1848636
ms	O	-1	1848636
of	O	-1	1848636
IC@@	O	-1	1848636
50	O	-1	1848636
valu@@	O	-1	1848636
es,	O	-1	1848636
re@@	O	-1	1848636
present@@	O	-1	1848636
ing	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
plasma	O	-1	1848636
concentrations	O	-1	1848636
result@@	O	-1	1848636
ing	O	-1	1848636
in	O	-1	1848636
h@@	O	-1	1848636
al@@	O	-1	1848636
f@@	O	-1	1848636
-@@	O	-1	1848636
maxim@@	O	-1	1848636
um	O	-1	1848636
receptor	O	-1	1848636
occ@@	O	-1	1848636
up@@	O	-1	1848636
anc@@	O	-1	1848636
y.	O	-1	1848636
Si@@	O	-1	1848636
x	O	-1	1848636
E@@	O	-1	1848636
M@@	O	-1	1848636
s	O	-1	1848636
received	O	-1	1848636
0.@@	O	-1	1848636
5	O	-1	1848636
mg	O	-1	1848636
of	O	-1	1848636
ter@@	B-Chemical	D013726	1848636
but@@	I-Chemical	-1	1848636
aline	I-Chemical	-1	1848636
s@@	O	-1	1848636
.@@	O	-1	1848636
c@@	O	-1	1848636
.	O	-1	1848636
on	O	-1	1848636
two	O	-1	1848636
different	O	-1	1848636
oc@@	O	-1	1848636
ca@@	O	-1	1848636
sion@@	O	-1	1848636
s:	O	-1	1848636
1)	O	-1	1848636
1	O	-1	1848636
h@@	O	-1	1848636
r	O	-1	1848636
after	O	-1	1848636
administration	O	-1	1848636
of	O	-1	1848636
a	O	-1	1848636
placebo	O	-1	1848636
and	O	-1	1848636
2)	O	-1	1848636
1	O	-1	1848636
h@@	O	-1	1848636
r	O	-1	1848636
after	O	-1	1848636
1@@	O	-1	1848636
50	O	-1	1848636
mg	O	-1	1848636
of	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
p.@@	O	-1	1848636
o@@	O	-1	1848636
.	O	-1	1848636
F@@	O	-1	1848636
i@@	O	-1	1848636
ve	O	-1	1848636
P@@	O	-1	1848636
M@@	O	-1	1848636
s	O	-1	1848636
were	O	-1	1848636
studied	O	-1	1848636
ac@@	O	-1	1848636
cor@@	O	-1	1848636
ding	O	-1	1848636
to	O	-1	1848636
the	O	-1	1848636
same	O	-1	1848636
pro@@	O	-1	1848636
to@@	O	-1	1848636
co@@	O	-1	1848636
l@@	O	-1	1848636
,	O	-1	1848636
ex@@	O	-1	1848636
cep@@	O	-1	1848636
t	O	-1	1848636
for	O	-1	1848636
a	O	-1	1848636
higher	O	-1	1848636
ter@@	B-Chemical	D013726	1848636
but@@	I-Chemical	-1	1848636
aline	I-Chemical	-1	1848636
dose	O	-1	1848636
(0.@@	O	-1	1848636
7@@	O	-1	1848636
5	O	-1	1848636
mg@@	O	-1	1848636
)	O	-1	1848636
on	O	-1	1848636
day	O	-1	1848636
2@@	O	-1	1848636
.	O	-1	1848636
B@@	O	-1	1848636
lo@@	O	-1	1848636
od	O	-1	1848636
sam@@	O	-1	1848636
ple@@	O	-1	1848636
s	O	-1	1848636
for	O	-1	1848636
the	O	-1	1848636
analysis	O	-1	1848636
of	O	-1	1848636
plasma	O	-1	1848636
pot@@	B-Chemical	D011188	1848636
assi@@	I-Chemical	-1	1848636
um	I-Chemical	-1	1848636
,	O	-1	1848636
ter@@	B-Chemical	D013726	1848636
but@@	I-Chemical	-1	1848636
aline	I-Chemical	-1	1848636
,	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
(@@	O	-1	1848636
rac@@	O	-1	1848636
em@@	O	-1	1848636
ic@@	O	-1	1848636
,	O	-1	1848636
R@@	O	-1	1848636
-	O	-1	1848636
and	O	-1	1848636
S@@	O	-1	1848636
-@@	O	-1	1848636
is@@	O	-1	1848636
om@@	O	-1	1848636
er@@	O	-1	1848636
),	O	-1	1848636
and	O	-1	1848636
alpha-@@	B-Chemical	C029504	1848636
hydrox@@	I-Chemical	-1	1848636
y@@	I-Chemical	-1	1848636
me@@	I-Chemical	-1	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
concentrations	O	-1	1848636
were	O	-1	1848636
tak@@	O	-1	1848636
en	O	-1	1848636
at	O	-1	1848636
reg@@	O	-1	1848636
ular	O	-1	1848636
time	O	-1	1848636
inter@@	O	-1	1848636
val@@	O	-1	1848636
s,	O	-1	1848636
during	O	-1	1848636
8	O	-1	1848636
h@@	O	-1	1848636
r	O	-1	1848636
after	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
.	O	-1	1848636
In	O	-1	1848636
P@@	O	-1	1848636
M@@	O	-1	1848636
s,	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
increased	O	-1	1848636
the	O	-1	1848636
ter@@	B-Chemical	D013726	1848636
but@@	I-Chemical	-1	1848636
aline	I-Chemical	-1	1848636
a@@	O	-1	1848636
re@@	O	-1	1848636
a	O	-1	1848636
under	O	-1	1848636
the	O	-1	1848636
plasma	O	-1	1848636
concentration	O	-1	1848636
vs.	O	-1	1848636
time	O	-1	1848636
cur@@	O	-1	1848636
ve	O	-1	1848636
(@@	O	-1	1848636
+@@	O	-1	1848636
6@@	O	-1	1848636
7@@	O	-1	1848636
%).	O	-1	1848636
H@@	O	-1	1848636
igh@@	O	-1	1848636
er	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
/	O	-1	1848636
alpha-@@	B-Chemical	C029504	1848636
hydrox@@	I-Chemical	-1	1848636
y@@	I-Chemical	-1	1848636
me@@	I-Chemical	-1	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
rati@@	O	-1	1848636
o@@	O	-1	1848636
s	O	-1	1848636
in	O	-1	1848636
P@@	O	-1	1848636
M@@	O	-1	1848636
s	O	-1	1848636
were	O	-1	1848636
predic@@	O	-1	1848636
tive	O	-1	1848636
for	O	-1	1848636
higher	O	-1	1848636
R@@	O	-1	1848636
-@@	O	-1	1848636
/@@	O	-1	1848636
S@@	O	-1	1848636
-@@	O	-1	1848636
is@@	O	-1	1848636
om@@	O	-1	1848636
er	O	-1	1848636
rati@@	O	-1	1848636
o@@	O	-1	1848636
s	O	-1	1848636
of	O	-1	1848636
un@@	O	-1	1848636
chang@@	O	-1	1848636
ed	O	-1	1848636
drug.	O	-1	1848636
There	O	-1	1848636
was	O	-1	1848636
a	O	-1	1848636
difference	O	-1	1848636
in	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
poten@@	O	-1	1848636
c@@	O	-1	1848636
y	O	-1	1848636
with	O	-1	1848636
higher	O	-1	1848636
rac@@	O	-1	1848636
em@@	O	-1	1848636
ic	O	-1	1848636
me@@	B-Chemical	D008790	1848636
to@@	I-Chemical	-1	1848636
pro@@	I-Chemical	-1	1848636
lol	I-Chemical	-1	1848636
IC@@	O	-1	1848636
50	O	-1	1848636
values	O	-1	1848636
in	O	-1	1848636
P@@	O	-1	1848636
M@@	O	-1	1848636
s	O	-1	1848636
(@@	O	-1	1848636
7@@	O	-1	1848636
2	O	-1	1848636
+/-	O	-1	1848636
7	O	-1	1848636
n@@	O	-1	1848636
g@@	O	-1	1848636
.@@	O	-1	1848636
ml@@	O	-1	1848636
-1@@	O	-1	1848636
)	O	-1	1848636
than	O	-1	1848636
E@@	O	-1	1848636
M@@	O	-1	1848636
s	O	-1	1848636
(4@@	O	-1	1848636
2	O	-1	1848636
+/-	O	-1	1848636
8	O	-1	1848636
n@@	O	-1	1848636
g@@	O	-1	1848636
.@@	O	-1	1848636
ml@@	O	-1	1848636
-1@@	O	-1	1848636
,	O	-1	1848636
P	O	-1	1848636
less	O	-1	1848636
than	O	-1	1848636
.@@	O	-1	1848636
0@@	O	-1	1848636
0@@	O	-1	1848636
1@@	O	-1	1848636
)@@	O	-1	1848636
.@@	O	-1	1848636
(A@@	O	-1	1848636
B@@	O	-1	1848636
S@@	O	-1	1848636
TR@@	O	-1	1848636
AC@@	O	-1	1848636
T	O	-1	1848636
TR@@	O	-1	1848636
UN@@	O	-1	1848636
C@@	O	-1	1848636
AT@@	O	-1	1848636
E@@	O	-1	1848636
D	O	-1	1848636
A@@	O	-1	1848636
T	O	-1	1848636
2@@	O	-1	1848636
50	O	-1	1848636
W@@	O	-1	1848636
O@@	O	-1	1848636
RD@@	O	-1	1848636
S)	O	-1	1848636

C@@	B-Chemical	D015313	1445986
e@@	I-Chemical	-1	1445986
f@@	I-Chemical	-1	1445986
ot@@	I-Chemical	-1	1445986
et@@	I-Chemical	-1	1445986
an	I-Chemical	-1	1445986
-induced	O	-1	1445986
immun@@	O	-1	1445986
e	O	-1	1445986
hemolytic	B-Disease	D000743	1445986
anemia	I-Disease	-1	1445986
.	O	-1	1445986
Im@@	O	-1	1445986
mun@@	O	-1	1445986
e	O	-1	1445986
hemolytic	B-Disease	D000743	1445986
anemia	I-Disease	-1	1445986
due	O	-1	1445986
to	O	-1	1445986
a	O	-1	1445986
drug@@	O	-1	1445986
-@@	O	-1	1445986
ad@@	O	-1	1445986
s@@	O	-1	1445986
or@@	O	-1	1445986
ption	O	-1	1445986
mechanism	O	-1	1445986
has	O	-1	1445986
been	O	-1	1445986
descri@@	O	-1	1445986
bed	O	-1	1445986
prim@@	O	-1	1445986
ari@@	O	-1	1445986
ly	O	-1	1445986
in	O	-1	1445986
patients	O	-1	1445986
receiving	O	-1	1445986
pen@@	B-Chemical	D010406	1445986
icill@@	I-Chemical	-1	1445986
ins	I-Chemical	-1	1445986
and	O	-1	1445986
fir@@	O	-1	1445986
st@@	O	-1	1445986
-@@	O	-1	1445986
generation	O	-1	1445986
ce@@	B-Chemical	D002511	1445986
ph@@	I-Chemical	-1	1445986
al@@	I-Chemical	-1	1445986
os@@	I-Chemical	-1	1445986
por@@	I-Chemical	-1	1445986
ins	I-Chemical	-1	1445986
.	O	-1	1445986
We	O	-1	1445986
describe	O	-1	1445986
a	O	-1	1445986
patient	O	-1	1445986
who	O	-1	1445986
developed	O	-1	1445986
anemia	B-Disease	D000740	1445986
while	O	-1	1445986
receiving	O	-1	1445986
intravenous	O	-1	1445986
ce@@	B-Chemical	D015313	1445986
f@@	I-Chemical	-1	1445986
ot@@	I-Chemical	-1	1445986
et@@	I-Chemical	-1	1445986
an	I-Chemical	-1	1445986
.	O	-1	1445986
C@@	B-Chemical	D015313	1445986
e@@	I-Chemical	-1	1445986
f@@	I-Chemical	-1	1445986
ot@@	I-Chemical	-1	1445986
et@@	I-Chemical	-1	1445986
an	I-Chemical	-1	1445986
-@@	O	-1	1445986
dependent	O	-1	1445986
anti@@	O	-1	1445986
bo@@	O	-1	1445986
di@@	O	-1	1445986
es	O	-1	1445986
were	O	-1	1445986
det@@	O	-1	1445986
ected	O	-1	1445986
in	O	-1	1445986
the	O	-1	1445986
patient@@	O	-1	1445986
's	O	-1	1445986
serum	O	-1	1445986
and	O	-1	1445986
in	O	-1	1445986
an	O	-1	1445986
el@@	O	-1	1445986
u@@	O	-1	1445986
ate	O	-1	1445986
pre@@	O	-1	1445986
pared	O	-1	1445986
from	O	-1	1445986
h@@	O	-1	1445986
is	O	-1	1445986
red	O	-1	1445986
blood	O	-1	1445986
cell@@	O	-1	1445986
s.	O	-1	1445986
The	O	-1	1445986
el@@	O	-1	1445986
u@@	O	-1	1445986
ate	O	-1	1445986
also	O	-1	1445986
reac@@	O	-1	1445986
ted	O	-1	1445986
we@@	O	-1	1445986
ak@@	O	-1	1445986
ly	O	-1	1445986
with	O	-1	1445986
red	O	-1	1445986
blood	O	-1	1445986
cells	O	-1	1445986
in	O	-1	1445986
the	O	-1	1445986
absence	O	-1	1445986
of	O	-1	1445986
ce@@	B-Chemical	D015313	1445986
f@@	I-Chemical	-1	1445986
ot@@	I-Chemical	-1	1445986
et@@	I-Chemical	-1	1445986
an	I-Chemical	-1	1445986
,	O	-1	1445986
suggesting	O	-1	1445986
the	O	-1	1445986
concomit@@	O	-1	1445986
ant	O	-1	1445986
formation	O	-1	1445986
of	O	-1	1445986
war@@	O	-1	1445986
m@@	O	-1	1445986
-@@	O	-1	1445986
reac@@	O	-1	1445986
tive	O	-1	1445986
auto@@	O	-1	1445986
anti@@	O	-1	1445986
bo@@	O	-1	1445986
di@@	O	-1	1445986
es.	O	-1	1445986
These	O	-1	1445986
observ@@	O	-1	1445986
ation@@	O	-1	1445986
s,	O	-1	1445986
in	O	-1	1445986
con@@	O	-1	1445986
j@@	O	-1	1445986
unc@@	O	-1	1445986
tion	O	-1	1445986
with	O	-1	1445986
clinical	O	-1	1445986
and	O	-1	1445986
labor@@	O	-1	1445986
atory	O	-1	1445986
evidence	O	-1	1445986
of	O	-1	1445986
ext@@	O	-1	1445986
ra@@	O	-1	1445986
vascular	O	-1	1445986
hemoly@@	B-Disease	D006461	1445986
sis	I-Disease	-1	1445986
,	O	-1	1445986
are	O	-1	1445986
consist@@	O	-1	1445986
ent	O	-1	1445986
with	O	-1	1445986
drug@@	O	-1	1445986
-induced	O	-1	1445986
hemolytic	B-Disease	D000743	1445986
anemia	I-Disease	-1	1445986
,	O	-1	1445986
possib@@	O	-1	1445986
ly	O	-1	1445986
invol@@	O	-1	1445986
ving	O	-1	1445986
both	O	-1	1445986
drug@@	O	-1	1445986
-@@	O	-1	1445986
ad@@	O	-1	1445986
s@@	O	-1	1445986
or@@	O	-1	1445986
ption	O	-1	1445986
and	O	-1	1445986
auto@@	O	-1	1445986
anti@@	O	-1	1445986
body	O	-1	1445986
formation	O	-1	1445986
mechanis@@	O	-1	1445986
m@@	O	-1	1445986
s.	O	-1	1445986
This	O	-1	1445986
case	O	-1	1445986
em@@	O	-1	1445986
pha@@	O	-1	1445986
si@@	O	-1	1445986
z@@	O	-1	1445986
es	O	-1	1445986
the	O	-1	1445986
need	O	-1	1445986
for	O	-1	1445986
increased	O	-1	1445986
aw@@	O	-1	1445986
a@@	O	-1	1445986
ren@@	O	-1	1445986
ess	O	-1	1445986
of	O	-1	1445986
hemolytic	O	-1	1445986
reactions	O	-1	1445986
to	O	-1	1445986
all	O	-1	1445986
ce@@	B-Chemical	D002511	1445986
ph@@	I-Chemical	-1	1445986
al@@	I-Chemical	-1	1445986
os@@	I-Chemical	-1	1445986
por@@	I-Chemical	-1	1445986
ins	I-Chemical	-1	1445986
.	O	-1	1445986

Ac@@	B-Disease	D058186	982002
ute	I-Disease	-1	982002
renal	I-Disease	-1	982002
failure	I-Disease	-1	982002
subsequ@@	O	-1	982002
ent	O	-1	982002
to	O	-1	982002
the	O	-1	982002
administration	O	-1	982002
of	O	-1	982002
ri@@	B-Chemical	D012293	982002
f@@	I-Chemical	-1	982002
amp@@	I-Chemical	-1	982002
icin	I-Chemical	-1	982002
.	O	-1	982002
A	O	-1	982002
follow-up	O	-1	982002
study	O	-1	982002
of	O	-1	982002
cases	O	-1	982002
reported	O	-1	982002
ear@@	O	-1	982002
li@@	O	-1	982002
er.	O	-1	982002
A	O	-1	982002
clinical	O	-1	982002
present@@	O	-1	982002
ation	O	-1	982002
is	O	-1	982002
m@@	O	-1	982002
ade	O	-1	982002
of	O	-1	982002
a	O	-1	982002
2-@@	O	-1	982002
3	O	-1	982002
year	O	-1	982002
follow-up	O	-1	982002
of	O	-1	982002
six	O	-1	982002
cases	O	-1	982002
of	O	-1	982002
acute	B-Disease	D058186	982002
renal	I-Disease	-1	982002
failure	I-Disease	-1	982002
that	O	-1	982002
have	O	-1	982002
been	O	-1	982002
reported	O	-1	982002
ear@@	O	-1	982002
li@@	O	-1	982002
er.	O	-1	982002
The	O	-1	982002
patients	O	-1	982002
had	O	-1	982002
developed	O	-1	982002
transi@@	O	-1	982002
ent	O	-1	982002
renal	B-Disease	D051437	982002
failure	I-Disease	-1	982002
after	O	-1	982002
the	O	-1	982002
inter@@	O	-1	982002
mit@@	O	-1	982002
t@@	O	-1	982002
ent	O	-1	982002
administration	O	-1	982002
of	O	-1	982002
ri@@	B-Chemical	D012293	982002
f@@	I-Chemical	-1	982002
amp@@	I-Chemical	-1	982002
icin	I-Chemical	-1	982002
.	O	-1	982002
The	O	-1	982002
st@@	O	-1	982002
age	O	-1	982002
of	O	-1	982002
ol@@	O	-1	982002
ig@@	O	-1	982002
-	O	-1	982002
an@@	B-Disease	D001002	982002
uria	I-Disease	-1	982002
l@@	O	-1	982002
ast@@	O	-1	982002
ed	O	-1	982002
for	O	-1	982002
1-@@	O	-1	982002
3	O	-1	982002
week@@	O	-1	982002
s,	O	-1	982002
and	O	-1	982002
five	O	-1	982002
of	O	-1	982002
the	O	-1	982002
patients	O	-1	982002
were	O	-1	982002
treated	O	-1	982002
by	O	-1	982002
hemo@@	O	-1	982002
dialy@@	O	-1	982002
sis.	O	-1	982002
Two	O	-1	982002
of	O	-1	982002
the	O	-1	982002
patients	O	-1	982002
di@@	O	-1	982002
ed	O	-1	982002
due	O	-1	982002
to	O	-1	982002
un@@	O	-1	982002
related	O	-1	982002
causes	O	-1	982002
during	O	-1	982002
the	O	-1	982002
follow-up	O	-1	982002
perio@@	O	-1	982002
d.	O	-1	982002
The	O	-1	982002
four	O	-1	982002
patients	O	-1	982002
re@@	O	-1	982002
-@@	O	-1	982002
examined	O	-1	982002
were	O	-1	982002
clin@@	O	-1	982002
ically	O	-1	982002
c@@	O	-1	982002
ure@@	O	-1	982002
d.	O	-1	982002
P@@	O	-1	982002
ath@@	O	-1	982002
ologic	O	-1	982002
findings	O	-1	982002
by	O	-1	982002
li@@	O	-1	982002
ght	O	-1	982002
micro@@	O	-1	982002
sco@@	O	-1	982002
p@@	O	-1	982002
y	O	-1	982002
and	O	-1	982002
immuno@@	O	-1	982002
fluo@@	O	-1	982002
res@@	O	-1	982002
c@@	O	-1	982002
ence	O	-1	982002
at	O	-1	982002
biop@@	O	-1	982002
sy	O	-1	982002
were	O	-1	982002
s@@	O	-1	982002
car@@	O	-1	982002
ce@@	O	-1	982002
.	O	-1	982002
N@@	O	-1	982002
o@@	O	-1	982002
th@@	O	-1	982002
ing	O	-1	982002
ab@@	O	-1	982002
normal	O	-1	982002
was	O	-1	982002
seen	O	-1	982002
by	O	-1	982002
electro@@	O	-1	982002
n	O	-1	982002
micro@@	O	-1	982002
sco@@	O	-1	982002
p@@	O	-1	982002
y	O	-1	982002
in	O	-1	982002
two	O	-1	982002
of	O	-1	982002
the	O	-1	982002
cases	O	-1	982002
studi@@	O	-1	982002
ed.	O	-1	982002
R@@	O	-1	982002
en@@	O	-1	982002
al	O	-1	982002
function	O	-1	982002
was	O	-1	982002
normal@@	O	-1	982002
.	O	-1	982002
In	O	-1	982002
three	O	-1	982002
cases	O	-1	982002
the	O	-1	982002
ex@@	O	-1	982002
cre@@	O	-1	982002
tion	O	-1	982002
at	O	-1	982002
13@@	O	-1	982002
1@@	O	-1	982002
I@@	O	-1	982002
-@@	O	-1	982002
hi@@	O	-1	982002
pp@@	O	-1	982002
ur@@	O	-1	982002
an	O	-1	982002
ren@@	O	-1	982002
ograph@@	O	-1	982002
y	O	-1	982002
was	O	-1	982002
s@@	O	-1	982002
li@@	O	-1	982002
gh@@	O	-1	982002
tly	O	-1	982002
s@@	O	-1	982002
lo@@	O	-1	982002
we@@	O	-1	982002
d.	O	-1	982002
Although	O	-1	982002
in	O	-1	982002
the	O	-1	982002
acute	O	-1	982002
st@@	O	-1	982002
age	O	-1	982002
the	O	-1	982002
renal	B-Disease	D007674	982002
lesions	I-Disease	-1	982002
hist@@	O	-1	982002
olog@@	O	-1	982002
ically	O	-1	982002
appe@@	O	-1	982002
a@@	O	-1	982002
red	O	-1	982002
toxic@@	O	-1	982002
,	O	-1	982002
evidence	O	-1	982002
sugg@@	O	-1	982002
es@@	O	-1	982002
tive	O	-1	982002
of	O	-1	982002
an	O	-1	982002
immun@@	O	-1	982002
ological	O	-1	982002
mechanism	O	-1	982002
can@@	O	-1	982002
not	O	-1	982002
be	O	-1	982002
ex@@	O	-1	982002
cl@@	O	-1	982002
u@@	O	-1	982002
de@@	O	-1	982002
d.	O	-1	982002

T@@	B-Disease	D006509	343678
yp@@	I-Disease	-1	343678
e	I-Disease	-1	343678
B	I-Disease	-1	343678
hepatitis	I-Disease	-1	343678
after	O	-1	343678
ne@@	O	-1	343678
ed@@	O	-1	343678
le@@	O	-1	343678
-@@	O	-1	343678
s@@	O	-1	343678
tic@@	O	-1	343678
k	O	-1	343678
expos@@	O	-1	343678
ure@@	O	-1	343678
:	O	-1	343678
pre@@	O	-1	343678
ven@@	O	-1	343678
tion	O	-1	343678
with	O	-1	343678
hepatitis	B-Disease	D006509	343678
B	I-Disease	-1	343678
immun@@	O	-1	343678
e	O	-1	343678
glo@@	O	-1	343678
b@@	O	-1	343678
ul@@	O	-1	343678
in.	O	-1	343678
F@@	O	-1	343678
inal	O	-1	343678
report	O	-1	343678
of	O	-1	343678
the	O	-1	343678
V@@	O	-1	343678
e@@	O	-1	343678
ter@@	O	-1	343678
ans	O	-1	343678
Ad@@	O	-1	343678
minist@@	O	-1	343678
ration	O	-1	343678
C@@	O	-1	343678
o@@	O	-1	343678
o@@	O	-1	343678
perative	O	-1	343678
S@@	O	-1	343678
t@@	O	-1	343678
ud@@	O	-1	343678
y.	O	-1	343678
He@@	B-Disease	D006509	343678
pati@@	I-Disease	-1	343678
tis	I-Disease	-1	343678
B	I-Disease	-1	343678
immun@@	O	-1	343678
e	O	-1	343678
glo@@	O	-1	343678
b@@	O	-1	343678
ul@@	O	-1	343678
in	O	-1	343678
(@@	O	-1	343678
HB@@	O	-1	343678
I@@	O	-1	343678
G@@	O	-1	343678
)	O	-1	343678
and	O	-1	343678
immun@@	O	-1	343678
e	O	-1	343678
serum	O	-1	343678
glo@@	O	-1	343678
b@@	O	-1	343678
ul@@	O	-1	343678
in	O	-1	343678
(@@	O	-1	343678
I@@	O	-1	343678
S@@	O	-1	343678
G@@	O	-1	343678
)	O	-1	343678
were	O	-1	343678
examined	O	-1	343678
in	O	-1	343678
a	O	-1	343678
random@@	O	-1	343678
iz@@	O	-1	343678
ed,	O	-1	343678
double-bl@@	O	-1	343678
ind	O	-1	343678
trial	O	-1	343678
to	O	-1	343678
ass@@	O	-1	343678
ess	O	-1	343678
their	O	-1	343678
rel@@	O	-1	343678
ative	O	-1	343678
efficac@@	O	-1	343678
i@@	O	-1	343678
es	O	-1	343678
in	O	-1	343678
prevent@@	O	-1	343678
ing	O	-1	343678
type	B-Disease	D006509	343678
B	I-Disease	-1	343678
hepatitis	I-Disease	-1	343678
after	O	-1	343678
ne@@	O	-1	343678
ed@@	O	-1	343678
le@@	O	-1	343678
-@@	O	-1	343678
s@@	O	-1	343678
tic@@	O	-1	343678
k	O	-1	343678
exposure	O	-1	343678
to	O	-1	343678
hepatitis	B-Chemical	D006514	343678
B	I-Chemical	-1	343678
sur@@	I-Chemical	-1	343678
fac@@	I-Chemical	-1	343678
e	I-Chemical	-1	343678
anti@@	I-Chemical	-1	343678
gen	I-Chemical	-1	343678
(	O	-1	343678
HB@@	B-Chemical	D006514	343678
s@@	I-Chemical	-1	343678
A@@	I-Chemical	-1	343678
G	I-Chemical	-1	343678
)-@@	O	-1	343678
positive	O	-1	343678
d@@	O	-1	343678
on@@	O	-1	343678
or@@	O	-1	343678
s.	O	-1	343678
Clin@@	O	-1	343678
ical	O	-1	343678
hepatitis	B-Disease	D056486	343678
developed	O	-1	343678
in	O	-1	343678
1.@@	O	-1	343678
4@@	O	-1	343678
%	O	-1	343678
of	O	-1	343678
HB@@	O	-1	343678
I@@	O	-1	343678
G	O	-1	343678
and	O	-1	343678
in	O	-1	343678
5.@@	O	-1	343678
9@@	O	-1	343678
%	O	-1	343678
of	O	-1	343678
I@@	O	-1	343678
S@@	O	-1	343678
G	O	-1	343678
re@@	O	-1	343678
ci@@	O	-1	343678
pi@@	O	-1	343678
ents	O	-1	343678
(P	O	-1	343678
=	O	-1	343678
0.0@@	O	-1	343678
1@@	O	-1	343678
6@@	O	-1	343678
),	O	-1	343678
and	O	-1	343678
ser@@	O	-1	343678
o@@	O	-1	343678
conver@@	O	-1	343678
sion	O	-1	343678
(@@	O	-1	343678
anti@@	O	-1	343678
-@@	O	-1	343678
HB@@	O	-1	343678
s)	O	-1	343678
occurred	O	-1	343678
in	O	-1	343678
5.@@	O	-1	343678
6%	O	-1	343678
and	O	-1	343678
2@@	O	-1	343678
0.@@	O	-1	343678
7@@	O	-1	343678
%	O	-1	343678
of	O	-1	343678
the@@	O	-1	343678
m	O	-1	343678
respecti@@	O	-1	343678
vely	O	-1	343678
(P	O	-1	343678
less	O	-1	343678
than	O	-1	343678
0.00@@	O	-1	343678
1).	O	-1	343678
M@@	O	-1	343678
il@@	O	-1	343678
d	O	-1	343678
and	O	-1	343678
transi@@	O	-1	343678
ent	O	-1	343678
side@@	O	-1	343678
-@@	O	-1	343678
effects	O	-1	343678
were	O	-1	343678
not@@	O	-1	343678
ed	O	-1	343678
in	O	-1	343678
3.@@	O	-1	343678
0%	O	-1	343678
of	O	-1	343678
I@@	O	-1	343678
S@@	O	-1	343678
G	O	-1	343678
and	O	-1	343678
in	O	-1	343678
3.@@	O	-1	343678
2@@	O	-1	343678
%	O	-1	343678
of	O	-1	343678
HB@@	O	-1	343678
I@@	O	-1	343678
G	O	-1	343678
re@@	O	-1	343678
ci@@	O	-1	343678
pi@@	O	-1	343678
ent@@	O	-1	343678
s.	O	-1	343678
A@@	O	-1	343678
v@@	O	-1	343678
ail@@	O	-1	343678
able	O	-1	343678
d@@	O	-1	343678
on@@	O	-1	343678
or	O	-1	343678
ser@@	O	-1	343678
a	O	-1	343678
were	O	-1	343678
examined	O	-1	343678
for	O	-1	343678
D@@	O	-1	343678
NA	O	-1	343678
poly@@	O	-1	343678
mer@@	O	-1	343678
ase	O	-1	343678
(D@@	O	-1	343678
N@@	O	-1	343678
A@@	O	-1	343678
P)	O	-1	343678
and	O	-1	343678
e	O	-1	343678
anti@@	O	-1	343678
gen	O	-1	343678
and	O	-1	343678
anti@@	O	-1	343678
body	O	-1	343678
(	O	-1	343678
HB@@	B-Chemical	D006513	343678
e@@	I-Chemical	-1	343678
A@@	I-Chemical	-1	343678
g	I-Chemical	-1	343678
;	O	-1	343678
anti@@	O	-1	343678
-@@	O	-1	343678
HB@@	O	-1	343678
E@@	O	-1	343678
).	O	-1	343678
B@@	O	-1	343678
oth	O	-1	343678
D@@	O	-1	343678
N@@	O	-1	343678
A@@	O	-1	343678
P	O	-1	343678
and	O	-1	343678
HB@@	B-Chemical	D006513	343678
e@@	I-Chemical	-1	343678
A@@	I-Chemical	-1	343678
g	I-Chemical	-1	343678
showed	O	-1	343678
a	O	-1	343678
high@@	O	-1	343678
ly	O	-1	343678
statis@@	O	-1	343678
tically	O	-1	343678
significant	O	-1	343678
correl@@	O	-1	343678
ation	O	-1	343678
with	O	-1	343678
the	O	-1	343678
inf@@	O	-1	343678
ec@@	O	-1	343678
tivity	O	-1	343678
of	O	-1	343678
HB@@	B-Chemical	D006514	343678
s@@	I-Chemical	-1	343678
A@@	I-Chemical	-1	343678
g	I-Chemical	-1	343678
-@@	O	-1	343678
positive	O	-1	343678
d@@	O	-1	343678
on@@	O	-1	343678
or@@	O	-1	343678
s.	O	-1	343678
He@@	B-Disease	D006509	343678
pati@@	I-Disease	-1	343678
tis	I-Disease	-1	343678
B	I-Disease	-1	343678
immun@@	O	-1	343678
e	O	-1	343678
glo@@	O	-1	343678
b@@	O	-1	343678
ul@@	O	-1	343678
in	O	-1	343678
remained	O	-1	343678
significantly	O	-1	343678
su@@	O	-1	343678
peri@@	O	-1	343678
or	O	-1	343678
to	O	-1	343678
I@@	O	-1	343678
S@@	O	-1	343678
G	O	-1	343678
in	O	-1	343678
prevent@@	O	-1	343678
ing	O	-1	343678
type	B-Disease	D006509	343678
B	I-Disease	-1	343678
hepatitis	I-Disease	-1	343678
even	O	-1	343678
when	O	-1	343678
the	O	-1	343678
analysis	O	-1	343678
was	O	-1	343678
conf@@	O	-1	343678
in@@	O	-1	343678
ed	O	-1	343678
to	O	-1	343678
these	O	-1	343678
two	O	-1	343678
high-@@	O	-1	343678
risk	O	-1	343678
sub@@	O	-1	343678
groups.	O	-1	343678
The	O	-1	343678
efficacy	O	-1	343678
of	O	-1	343678
I@@	O	-1	343678
S@@	O	-1	343678
G	O	-1	343678
in	O	-1	343678
prevent@@	O	-1	343678
ing	O	-1	343678
type	B-Disease	D006509	343678
B	I-Disease	-1	343678
hepatitis	I-Disease	-1	343678
can@@	O	-1	343678
not	O	-1	343678
be	O	-1	343678
as@@	O	-1	343678
cer@@	O	-1	343678
t@@	O	-1	343678
ained	O	-1	343678
because	O	-1	343678
a	O	-1	343678
t@@	O	-1	343678
ru@@	O	-1	343678
e	O	-1	343678
placebo	O	-1	343678
group	O	-1	343678
was	O	-1	343678
not	O	-1	343678
inc@@	O	-1	343678
lu@@	O	-1	343678
de@@	O	-1	343678
d.	O	-1	343678

S@@	B-Disease	D020230	8888541
er@@	I-Disease	-1	8888541
oton@@	I-Disease	-1	8888541
in	I-Disease	-1	8888541
syndrome	I-Disease	-1	8888541
from	O	-1	8888541
ven@@	B-Chemical	C047426	8888541
l@@	I-Chemical	-1	8888541
af@@	I-Chemical	-1	8888541
ax@@	I-Chemical	-1	8888541
ine	I-Chemical	-1	8888541
-	O	-1	8888541
tran@@	B-Chemical	D014191	8888541
yl@@	I-Chemical	-1	8888541
cy@@	I-Chemical	-1	8888541
pro@@	I-Chemical	-1	8888541
mine	I-Chemical	-1	8888541
inter@@	O	-1	8888541
ac@@	O	-1	8888541
tion.	O	-1	8888541
E@@	O	-1	8888541
x@@	O	-1	8888541
ces@@	O	-1	8888541
sive	O	-1	8888541
stimulation	O	-1	8888541
of	O	-1	8888541
seroton@@	B-Chemical	D012701	8888541
in	I-Chemical	-1	8888541
5@@	O	-1	8888541
H@@	O	-1	8888541
T@@	O	-1	8888541
1@@	O	-1	8888541
A	O	-1	8888541
receptors	O	-1	8888541
causes	O	-1	8888541
a	O	-1	8888541
syndrome	O	-1	8888541
of	O	-1	8888541
seroton@@	B-Chemical	D012701	8888541
in	I-Chemical	-1	8888541
ex@@	O	-1	8888541
cess	O	-1	8888541
that	O	-1	8888541
consist@@	O	-1	8888541
s	O	-1	8888541
of	O	-1	8888541
shi@@	O	-1	8888541
ver@@	O	-1	8888541
ing,	O	-1	8888541
musc@@	B-Disease	D009127	8888541
le	I-Disease	-1	8888541
rig@@	I-Disease	-1	8888541
idity	I-Disease	-1	8888541
,	O	-1	8888541
sal@@	B-Disease	D012798	8888541
i@@	I-Disease	-1	8888541
v@@	I-Disease	-1	8888541
ation	I-Disease	-1	8888541
,	O	-1	8888541
conf@@	B-Disease	D003221	8888541
usion	I-Disease	-1	8888541
,	O	-1	8888541
ag@@	B-Disease	D011595	8888541
it@@	I-Disease	-1	8888541
ation	I-Disease	-1	8888541
and	O	-1	8888541
hyper@@	B-Disease	D005334	8888541
ther@@	I-Disease	-1	8888541
mia	I-Disease	-1	8888541
.	O	-1	8888541
The	O	-1	8888541
most	O	-1	8888541
common	O	-1	8888541
cause	O	-1	8888541
of	O	-1	8888541
this	O	-1	8888541
syndrome	O	-1	8888541
is	O	-1	8888541
an	O	-1	8888541
inter@@	O	-1	8888541
action	O	-1	8888541
between	O	-1	8888541
a	O	-1	8888541
mon@@	O	-1	8888541
o@@	O	-1	8888541
amine	O	-1	8888541
oxid@@	O	-1	8888541
ase	O	-1	8888541
inhibitor	O	-1	8888541
(@@	O	-1	8888541
MA@@	O	-1	8888541
O@@	O	-1	8888541
I@@	O	-1	8888541
)	O	-1	8888541
and	O	-1	8888541
a	O	-1	8888541
specific	O	-1	8888541
seroton@@	B-Chemical	D012701	8888541
in	I-Chemical	-1	8888541
re@@	O	-1	8888541
u@@	O	-1	8888541
pt@@	O	-1	8888541
ake	O	-1	8888541
inhibitor@@	O	-1	8888541
.	O	-1	8888541
V@@	B-Chemical	C047426	8888541
en@@	I-Chemical	-1	8888541
l@@	I-Chemical	-1	8888541
af@@	I-Chemical	-1	8888541
ax@@	I-Chemical	-1	8888541
ine	I-Chemical	-1	8888541
is	O	-1	8888541
a	O	-1	8888541
new	O	-1	8888541
antidepress@@	O	-1	8888541
ant	O	-1	8888541
agent	O	-1	8888541
that	O	-1	8888541
inhibit@@	O	-1	8888541
s	O	-1	8888541
the	O	-1	8888541
re@@	O	-1	8888541
u@@	O	-1	8888541
pt@@	O	-1	8888541
ake	O	-1	8888541
of	O	-1	8888541
seroton@@	B-Chemical	D012701	8888541
in	I-Chemical	-1	8888541
and	O	-1	8888541
no@@	B-Chemical	D009638	8888541
re@@	I-Chemical	-1	8888541
p@@	I-Chemical	-1	8888541
ine@@	I-Chemical	-1	8888541
phrine	I-Chemical	-1	8888541
.	O	-1	8888541
We	O	-1	8888541
report	O	-1	8888541
a	O	-1	8888541
ven@@	B-Chemical	C047426	8888541
l@@	I-Chemical	-1	8888541
af@@	I-Chemical	-1	8888541
ax@@	I-Chemical	-1	8888541
ine	I-Chemical	-1	8888541
-@@	O	-1	8888541
MA@@	O	-1	8888541
O@@	O	-1	8888541
I	O	-1	8888541
inter@@	O	-1	8888541
action	O	-1	8888541
that	O	-1	8888541
resulted	O	-1	8888541
in	O	-1	8888541
the	O	-1	8888541
seroton@@	B-Disease	D020230	8888541
in	I-Disease	-1	8888541
syndrome	I-Disease	-1	8888541
in	O	-1	8888541
a	O	-1	8888541
2@@	O	-1	8888541
3-@@	O	-1	8888541
y@@	O	-1	8888541
-old	O	-1	8888541
male	O	-1	8888541
who	O	-1	8888541
was	O	-1	8888541
taking	O	-1	8888541
tran@@	B-Chemical	D014191	8888541
yl@@	I-Chemical	-1	8888541
cy@@	I-Chemical	-1	8888541
pro@@	I-Chemical	-1	8888541
mine	I-Chemical	-1	8888541
for	O	-1	8888541
de@@	B-Disease	D003866	8888541
pression	I-Disease	-1	8888541
.	O	-1	8888541
H@@	O	-1	8888541
e	O	-1	8888541
had	O	-1	8888541
been	O	-1	8888541
well	O	-1	8888541
un@@	O	-1	8888541
ti@@	O	-1	8888541
l	O	-1	8888541
the	O	-1	8888541
mor@@	O	-1	8888541
ning	O	-1	8888541
of	O	-1	8888541
present@@	O	-1	8888541
ation	O	-1	8888541
when	O	-1	8888541
he	O	-1	8888541
to@@	O	-1	8888541
o@@	O	-1	8888541
k	O	-1	8888541
1@@	O	-1	8888541
/@@	O	-1	8888541
2	O	-1	8888541
t@@	O	-1	8888541
a@@	O	-1	8888541
b	O	-1	8888541
of	O	-1	8888541
ven@@	B-Chemical	C047426	8888541
l@@	I-Chemical	-1	8888541
af@@	I-Chemical	-1	8888541
ax@@	I-Chemical	-1	8888541
ine	I-Chemical	-1	8888541
.	O	-1	8888541
W@@	O	-1	8888541
i@@	O	-1	8888541
th@@	O	-1	8888541
in	O	-1	8888541
2	O	-1	8888541
h	O	-1	8888541
he	O	-1	8888541
b@@	O	-1	8888541
ec@@	O	-1	8888541
am@@	O	-1	8888541
e	O	-1	8888541
conf@@	O	-1	8888541
used	O	-1	8888541
with	O	-1	8888541
j@@	O	-1	8888541
er@@	O	-1	8888541
king	O	-1	8888541
mo@@	O	-1	8888541
ve@@	O	-1	8888541
ments	O	-1	8888541
of	O	-1	8888541
h@@	O	-1	8888541
is	O	-1	8888541
ex@@	O	-1	8888541
trem@@	O	-1	8888541
iti@@	O	-1	8888541
es,	O	-1	8888541
tre@@	B-Disease	D014202	8888541
mor@@	I-Disease	-1	8888541
s	I-Disease	-1	8888541
and	O	-1	8888541
rig@@	B-Disease	D009127	8888541
idity	I-Disease	-1	8888541
.	O	-1	8888541
H@@	O	-1	8888541
e	O	-1	8888541
was	O	-1	8888541
b@@	O	-1	8888541
rou@@	O	-1	8888541
ght	O	-1	8888541
direc@@	O	-1	8888541
tly	O	-1	8888541
to	O	-1	8888541
a	O	-1	8888541
hospit@@	O	-1	8888541
al	O	-1	8888541
wh@@	O	-1	8888541
ere	O	-1	8888541
he	O	-1	8888541
was	O	-1	8888541
found	O	-1	8888541
to	O	-1	8888541
be	O	-1	8888541
ag@@	O	-1	8888541
it@@	O	-1	8888541
ated	O	-1	8888541
and	O	-1	8888541
conf@@	O	-1	8888541
used	O	-1	8888541
with	O	-1	8888541
shi@@	O	-1	8888541
ver@@	O	-1	8888541
ing,	O	-1	8888541
my@@	B-Disease	D009207	8888541
oc@@	I-Disease	-1	8888541
lon@@	I-Disease	-1	8888541
ic	I-Disease	-1	8888541
j@@	I-Disease	-1	8888541
er@@	I-Disease	-1	8888541
k@@	I-Disease	-1	8888541
s	I-Disease	-1	8888541
,	O	-1	8888541
rig@@	B-Disease	D009127	8888541
idity	I-Disease	-1	8888541
,	O	-1	8888541
sal@@	B-Disease	D012798	8888541
i@@	I-Disease	-1	8888541
v@@	I-Disease	-1	8888541
ation	I-Disease	-1	8888541
and	O	-1	8888541
dia@@	O	-1	8888541
ph@@	O	-1	8888541
ore@@	O	-1	8888541
sis.	O	-1	8888541
H@@	O	-1	8888541
is	O	-1	8888541
p@@	O	-1	8888541
up@@	O	-1	8888541
il@@	O	-1	8888541
s	O	-1	8888541
were	O	-1	8888541
7	O	-1	8888541
mm	O	-1	8888541
and	O	-1	8888541
s@@	O	-1	8888541
lu@@	O	-1	8888541
g@@	O	-1	8888541
g@@	O	-1	8888541
ish@@	O	-1	8888541
ly	O	-1	8888541
reac@@	O	-1	8888541
tive	O	-1	8888541
to	O	-1	8888541
li@@	O	-1	8888541
gh@@	O	-1	8888541
t.	O	-1	8888541
V@@	O	-1	8888541
it@@	O	-1	8888541
al	O	-1	8888541
signs	O	-1	8888541
we@@	O	-1	8888541
re@@	O	-1	8888541
:	O	-1	8888541
blood	O	-1	8888541
pressure	O	-1	8888541
1@@	O	-1	8888541
20@@	O	-1	8888541
/@@	O	-1	8888541
6@@	O	-1	8888541
7	O	-1	8888541
mm	O	-1	8888541
H@@	O	-1	8888541
g@@	O	-1	8888541
,	O	-1	8888541
heart	O	-1	8888541
rate	O	-1	8888541
12@@	O	-1	8888541
7@@	O	-1	8888541
/@@	O	-1	8888541
min@@	O	-1	8888541
,	O	-1	8888541
respiratory	O	-1	8888541
rate	O	-1	8888541
2@@	O	-1	8888541
8@@	O	-1	8888541
/@@	O	-1	8888541
min@@	O	-1	8888541
,	O	-1	8888541
and	O	-1	8888541
tem@@	O	-1	8888541
per@@	O	-1	8888541
at@@	O	-1	8888541
ure	O	-1	8888541
9@@	O	-1	8888541
7	O	-1	8888541
F@@	O	-1	8888541
.	O	-1	8888541
After	O	-1	8888541
18@@	O	-1	8888541
0	O	-1	8888541
mg	O	-1	8888541
of	O	-1	8888541
di@@	B-Chemical	D003975	8888541
az@@	I-Chemical	-1	8888541
epam	I-Chemical	-1	8888541
i.v@@	O	-1	8888541
.	O	-1	8888541
he	O	-1	8888541
remained	O	-1	8888541
trem@@	O	-1	8888541
ulo@@	O	-1	8888541
us	O	-1	8888541
with	O	-1	8888541
musc@@	B-Disease	D009127	8888541
le	I-Disease	-1	8888541
rig@@	I-Disease	-1	8888541
idity	I-Disease	-1	8888541
and	O	-1	8888541
cl@@	O	-1	8888541
en@@	O	-1	8888541
ch@@	O	-1	8888541
ed	O	-1	8888541
j@@	O	-1	8888541
aw@@	O	-1	8888541
s.	O	-1	8888541
H@@	O	-1	8888541
e	O	-1	8888541
was	O	-1	8888541
int@@	O	-1	8888541
ub@@	O	-1	8888541
ated	O	-1	8888541
for	O	-1	8888541
a@@	O	-1	8888541
ir@@	O	-1	8888541
w@@	O	-1	8888541
ay	O	-1	8888541
prot@@	O	-1	8888541
ection	O	-1	8888541
and	O	-1	8888541
because	O	-1	8888541
of	O	-1	8888541
hypo@@	B-Disease	D007040	8888541
ven@@	I-Disease	-1	8888541
til@@	I-Disease	-1	8888541
ation	I-Disease	-1	8888541
,	O	-1	8888541
and	O	-1	8888541
was	O	-1	8888541
par@@	B-Disease	D010243	8888541
aly@@	I-Disease	-1	8888541
zed	I-Disease	-1	8888541
to	O	-1	8888541
control	O	-1	8888541
musc@@	B-Disease	D009127	8888541
le	I-Disease	-1	8888541
rig@@	I-Disease	-1	8888541
idity	I-Disease	-1	8888541
.	O	-1	8888541
H@@	O	-1	8888541
is	O	-1	8888541
subsequ@@	O	-1	8888541
ent	O	-1	8888541
course	O	-1	8888541
was	O	-1	8888541
re@@	O	-1	8888541
mark@@	O	-1	8888541
able	O	-1	8888541
for	O	-1	8888541
non-@@	O	-1	8888541
immun@@	O	-1	8888541
e	O	-1	8888541
throm@@	B-Disease	D013921	8888541
b@@	I-Disease	-1	8888541
ocyto@@	I-Disease	-1	8888541
pen@@	I-Disease	-1	8888541
ia	I-Disease	-1	8888541
which	O	-1	8888541
resol@@	O	-1	8888541
ved.	O	-1	8888541
The	O	-1	8888541
patient@@	O	-1	8888541
's	O	-1	8888541
maxim@@	O	-1	8888541
al	O	-1	8888541
tem@@	O	-1	8888541
per@@	O	-1	8888541
at@@	O	-1	8888541
ure	O	-1	8888541
was	O	-1	8888541
10@@	O	-1	8888541
1.@@	O	-1	8888541
2	O	-1	8888541
F	O	-1	8888541
and	O	-1	8888541
h@@	O	-1	8888541
is	O	-1	8888541
C@@	O	-1	8888541
P@@	O	-1	8888541
K	O	-1	8888541
remained	O	-1	8888541
<	O	-1	8888541
5@@	O	-1	8888541
00	O	-1	8888541
un@@	O	-1	8888541
it@@	O	-1	8888541
s/@@	O	-1	8888541
L	O	-1	8888541
with	O	-1	8888541
no	O	-1	8888541
other	O	-1	8888541
evidence	O	-1	8888541
of	O	-1	8888541
rh@@	B-Disease	D012206	8888541
ab@@	I-Disease	-1	8888541
do@@	I-Disease	-1	8888541
my@@	I-Disease	-1	8888541
oly@@	I-Disease	-1	8888541
sis	I-Disease	-1	8888541
.	O	-1	8888541
H@@	O	-1	8888541
is	O	-1	8888541
mental	O	-1	8888541
status	O	-1	8888541
normal@@	O	-1	8888541
ized	O	-1	8888541
and	O	-1	8888541
he	O	-1	8888541
was	O	-1	8888541
trans@@	O	-1	8888541
fer@@	O	-1	8888541
red	O	-1	8888541
to	O	-1	8888541
a	O	-1	8888541
psych@@	O	-1	8888541
i@@	O	-1	8888541
at@@	O	-1	8888541
r@@	O	-1	8888541
y	O	-1	8888541
war@@	O	-1	8888541
d.	O	-1	8888541
This	O	-1	8888541
patient	O	-1	8888541
sur@@	O	-1	8888541
vi@@	O	-1	8888541
ved	O	-1	8888541
without	O	-1	8888541
sequ@@	O	-1	8888541
el@@	O	-1	8888541
a@@	O	-1	8888541
e	O	-1	8888541
due	O	-1	8888541
to	O	-1	8888541
the	O	-1	8888541
ag@@	O	-1	8888541
gres@@	O	-1	8888541
sive	O	-1	8888541
sed@@	O	-1	8888541
ation	O	-1	8888541
and	O	-1	8888541
neuro@@	O	-1	8888541
mus@@	O	-1	8888541
cular	O	-1	8888541
par@@	B-Disease	D010243	8888541
aly@@	I-Disease	-1	8888541
sis	I-Disease	-1	8888541
.	O	-1	8888541

Eff@@	O	-1	8106150
ect	O	-1	8106150
of	O	-1	8106150
non@@	O	-1	8106150
dop@@	O	-1	8106150
aminergic	O	-1	8106150
drugs	O	-1	8106150
on	O	-1	8106150
L-@@	B-Chemical	D007980	8106150
dopa	I-Chemical	-1	8106150
-induced	O	-1	8106150
dyskine@@	B-Disease	D004409	8106150
si@@	I-Disease	-1	8106150
as	I-Disease	-1	8106150
in	O	-1	8106150
MP@@	B-Chemical	D015632	8106150
T@@	I-Chemical	-1	8106150
P	I-Chemical	-1	8106150
-treated	O	-1	8106150
mon@@	O	-1	8106150
ke@@	O	-1	8106150
y@@	O	-1	8106150
s.	O	-1	8106150
A	O	-1	8106150
group	O	-1	8106150
of	O	-1	8106150
four	O	-1	8106150
mon@@	O	-1	8106150
ke@@	O	-1	8106150
ys	O	-1	8106150
was	O	-1	8106150
ren@@	O	-1	8106150
de@@	O	-1	8106150
red	O	-1	8106150
par@@	B-Disease	D020734	8106150
k@@	I-Disease	-1	8106150
inson@@	I-Disease	-1	8106150
i@@	I-Disease	-1	8106150
an	I-Disease	-1	8106150
with	O	-1	8106150
the	O	-1	8106150
tox@@	O	-1	8106150
in	O	-1	8106150
MP@@	B-Chemical	D015632	8106150
T@@	I-Chemical	-1	8106150
P	I-Chemical	-1	8106150
.	O	-1	8106150
The@@	O	-1	8106150
y	O	-1	8106150
were	O	-1	8106150
then	O	-1	8106150
treated	O	-1	8106150
chron@@	O	-1	8106150
ically	O	-1	8106150
with	O	-1	8106150
L-@@	B-Chemical	C005177	8106150
DO@@	I-Chemical	-1	8106150
PA@@	I-Chemical	-1	8106150
/@@	I-Chemical	-1	8106150
ben@@	I-Chemical	-1	8106150
ser@@	I-Chemical	-1	8106150
az@@	I-Chemical	-1	8106150
ide	I-Chemical	-1	8106150
50@@	O	-1	8106150
/@@	O	-1	8106150
1@@	O	-1	8106150
2.@@	O	-1	8106150
5	O	-1	8106150
mg/kg	O	-1	8106150
given	O	-1	8106150
or@@	O	-1	8106150
ally	O	-1	8106150
daily	O	-1	8106150
for	O	-1	8106150
2	O	-1	8106150
months.	O	-1	8106150
This	O	-1	8106150
dose	O	-1	8106150
produced	O	-1	8106150
a	O	-1	8106150
stri@@	O	-1	8106150
king	O	-1	8106150
anti@@	O	-1	8106150
par@@	O	-1	8106150
k@@	O	-1	8106150
inson@@	O	-1	8106150
i@@	O	-1	8106150
an	O	-1	8106150
effect@@	O	-1	8106150
,	O	-1	8106150
but	O	-1	8106150
all	O	-1	8106150
animals	O	-1	8106150
man@@	O	-1	8106150
if@@	O	-1	8106150
est@@	O	-1	8106150
ed	O	-1	8106150
dyskine@@	B-Disease	D004409	8106150
sia	I-Disease	-1	8106150
.	O	-1	8106150
A	O	-1	8106150
seri@@	O	-1	8106150
es	O	-1	8106150
of	O	-1	8106150
agents	O	-1	8106150
act@@	O	-1	8106150
ing	O	-1	8106150
prim@@	O	-1	8106150
ari@@	O	-1	8106150
ly	O	-1	8106150
on	O	-1	8106150
neuro@@	O	-1	8106150
trans@@	O	-1	8106150
mit@@	O	-1	8106150
ters	O	-1	8106150
other	O	-1	8106150
than	O	-1	8106150
dopamine	B-Chemical	D004298	8106150
were	O	-1	8106150
then	O	-1	8106150
tested	O	-1	8106150
in	O	-1	8106150
combination	O	-1	8106150
with	O	-1	8106150
L-@@	B-Chemical	D007980	8106150
DO@@	I-Chemical	-1	8106150
P@@	I-Chemical	-1	8106150
A	I-Chemical	-1	8106150
to	O	-1	8106150
se@@	O	-1	8106150
e	O	-1	8106150
if	O	-1	8106150
the	O	-1	8106150
dyskine@@	B-Disease	D004409	8106150
tic	I-Disease	-1	8106150
mo@@	O	-1	8106150
ve@@	O	-1	8106150
ments	O	-1	8106150
wo@@	O	-1	8106150
uld	O	-1	8106150
be	O	-1	8106150
mo@@	O	-1	8106150
di@@	O	-1	8106150
fi@@	O	-1	8106150
ed.	O	-1	8106150
S@@	O	-1	8106150
e@@	O	-1	8106150
ver@@	O	-1	8106150
al	O	-1	8106150
drug@@	O	-1	8106150
s,	O	-1	8106150
including	O	-1	8106150
clonidine	B-Chemical	D003000	8106150
,	O	-1	8106150
ph@@	B-Chemical	D010830	8106150
ys@@	I-Chemical	-1	8106150
os@@	I-Chemical	-1	8106150
tig@@	I-Chemical	-1	8106150
mine	I-Chemical	-1	8106150
,	O	-1	8106150
meth@@	B-Chemical	D008784	8106150
y@@	I-Chemical	-1	8106150
ser@@	I-Chemical	-1	8106150
g@@	I-Chemical	-1	8106150
ide	I-Chemical	-1	8106150
,	O	-1	8106150
5-@@	B-Chemical	-1	8106150
MD@@	I-Chemical	-1	8106150
O@@	I-Chemical	-1	8106150
T	I-Chemical	-1	8106150
,	O	-1	8106150
prop@@	B-Chemical	D011433	8106150
ran@@	I-Chemical	-1	8106150
o@@	I-Chemical	-1	8106150
lol	I-Chemical	-1	8106150
,	O	-1	8106150
and	O	-1	8106150
M@@	B-Chemical	D016291	8106150
K@@	I-Chemical	-1	8106150
-@@	I-Chemical	-1	8106150
80@@	I-Chemical	-1	8106150
1	I-Chemical	-1	8106150
,	O	-1	8106150
mark@@	O	-1	8106150
ed@@	O	-1	8106150
ly	O	-1	8106150
reduced	O	-1	8106150
the	O	-1	8106150
dyskine@@	B-Disease	D004409	8106150
tic	I-Disease	-1	8106150
mo@@	O	-1	8106150
ve@@	O	-1	8106150
ments	O	-1	8106150
but	O	-1	8106150
at	O	-1	8106150
the	O	-1	8106150
co@@	O	-1	8106150
st	O	-1	8106150
of	O	-1	8106150
a	O	-1	8106150
retur@@	O	-1	8106150
n	O	-1	8106150
of	O	-1	8106150
par@@	B-Disease	D020734	8106150
k@@	I-Disease	-1	8106150
inson@@	I-Disease	-1	8106150
i@@	I-Disease	-1	8106150
an	I-Disease	-1	8106150
sympto@@	O	-1	8106150
mat@@	O	-1	8106150
olog@@	O	-1	8106150
y.	O	-1	8106150
However,	O	-1	8106150
yo@@	B-Chemical	D015016	8106150
h@@	I-Chemical	-1	8106150
im@@	I-Chemical	-1	8106150
b@@	I-Chemical	-1	8106150
ine	I-Chemical	-1	8106150
and	O	-1	8106150
me@@	B-Chemical	D008614	8106150
perid@@	I-Chemical	-1	8106150
ine	I-Chemical	-1	8106150
reduced	O	-1	8106150
pre@@	O	-1	8106150
domin@@	O	-1	8106150
ant@@	O	-1	8106150
ly	O	-1	8106150
the	O	-1	8106150
dyskine@@	B-Disease	D004409	8106150
tic	I-Disease	-1	8106150
mo@@	O	-1	8106150
ve@@	O	-1	8106150
ment@@	O	-1	8106150
s.	O	-1	8106150
B@@	B-Chemical	D001418	8106150
ac@@	I-Chemical	-1	8106150
lo@@	I-Chemical	-1	8106150
f@@	I-Chemical	-1	8106150
en	I-Chemical	-1	8106150
was	O	-1	8106150
also	O	-1	8106150
use@@	O	-1	8106150
ful	O	-1	8106150
in	O	-1	8106150
one	O	-1	8106150
mon@@	O	-1	8106150
ke@@	O	-1	8106150
y	O	-1	8106150
against	O	-1	8106150
a	O	-1	8106150
more	O	-1	8106150
dy@@	B-Disease	D020821	8106150
st@@	I-Disease	-1	8106150
onic	I-Disease	-1	8106150
form	O	-1	8106150
of	O	-1	8106150
dyskine@@	B-Disease	D004409	8106150
sia	I-Disease	-1	8106150
.	O	-1	8106150
A@@	B-Chemical	D001285	8106150
tro@@	I-Chemical	-1	8106150
pine	I-Chemical	-1	8106150
conver@@	O	-1	8106150
ted	O	-1	8106150
the	O	-1	8106150
dy@@	B-Disease	D020821	8106150
st@@	I-Disease	-1	8106150
onic	I-Disease	-1	8106150
mo@@	O	-1	8106150
ve@@	O	-1	8106150
ments	O	-1	8106150
into	O	-1	8106150
ch@@	B-Disease	D002819	8106150
ore@@	I-Disease	-1	8106150
a	I-Disease	-1	8106150
.	O	-1	8106150

C@@	B-Chemical	D008130	21418164
C@@	I-Chemical	-1	21418164
N@@	I-Chemical	-1	21418164
U	I-Chemical	-1	21418164
(	O	-1	21418164
lo@@	B-Chemical	D008130	21418164
m@@	I-Chemical	-1	21418164
ust@@	I-Chemical	-1	21418164
ine	I-Chemical	-1	21418164
)	O	-1	21418164
toxicity	B-Disease	D064420	21418164
in	O	-1	21418164
dog@@	O	-1	21418164
s:	O	-1	21418164
a	O	-1	21418164
ret@@	O	-1	21418164
ro@@	O	-1	21418164
sp@@	O	-1	21418164
ective	O	-1	21418164
study	O	-1	21418164
(2@@	O	-1	21418164
0@@	O	-1	21418164
0@@	O	-1	21418164
2-@@	O	-1	21418164
0@@	O	-1	21418164
7@@	O	-1	21418164
).	O	-1	21418164
OBJECTIVE:	O	-1	21418164
To	O	-1	21418164
describe	O	-1	21418164
the	O	-1	21418164
incidence	O	-1	21418164
of	O	-1	21418164
haem@@	B-Disease	D006402	21418164
at@@	I-Disease	-1	21418164
olog@@	I-Disease	-1	21418164
ic@@	I-Disease	-1	21418164
al,	I-Disease	-1	21418164
ren@@	I-Disease	-1	21418164
al,	I-Disease	-1	21418164
hepatic	I-Disease	-1	21418164
and	I-Disease	-1	21418164
gast@@	I-Disease	-1	21418164
ro@@	I-Disease	-1	21418164
in@@	I-Disease	-1	21418164
test@@	I-Disease	-1	21418164
inal	I-Disease	-1	21418164
toxic@@	I-Disease	-1	21418164
ities	I-Disease	-1	21418164
haem@@	B-Disease	D007674	21418164
at@@	I-Disease	-1	21418164
olog@@	I-Disease	-1	21418164
ic@@	I-Disease	-1	21418164
al,	I-Disease	-1	21418164
ren@@	I-Disease	-1	21418164
al,	I-Disease	-1	21418164
hepatic	I-Disease	-1	21418164
and	I-Disease	-1	21418164
gast@@	I-Disease	-1	21418164
ro@@	I-Disease	-1	21418164
in@@	I-Disease	-1	21418164
test@@	I-Disease	-1	21418164
inal	I-Disease	-1	21418164
toxic@@	I-Disease	-1	21418164
ities	I-Disease	-1	21418164
haem@@	B-Disease	D056486	21418164
at@@	I-Disease	-1	21418164
olog@@	I-Disease	-1	21418164
ic@@	I-Disease	-1	21418164
al,	I-Disease	-1	21418164
ren@@	I-Disease	-1	21418164
al,	I-Disease	-1	21418164
hepatic	I-Disease	-1	21418164
and	I-Disease	-1	21418164
gast@@	I-Disease	-1	21418164
ro@@	I-Disease	-1	21418164
in@@	I-Disease	-1	21418164
test@@	I-Disease	-1	21418164
inal	I-Disease	-1	21418164
toxic@@	I-Disease	-1	21418164
ities	I-Disease	-1	21418164
haem@@	B-Disease	D005767	21418164
at@@	I-Disease	-1	21418164
olog@@	I-Disease	-1	21418164
ic@@	I-Disease	-1	21418164
al,	I-Disease	-1	21418164
ren@@	I-Disease	-1	21418164
al,	I-Disease	-1	21418164
hepatic	I-Disease	-1	21418164
and	I-Disease	-1	21418164
gast@@	I-Disease	-1	21418164
ro@@	I-Disease	-1	21418164
in@@	I-Disease	-1	21418164
test@@	I-Disease	-1	21418164
inal	I-Disease	-1	21418164
toxic@@	I-Disease	-1	21418164
ities	I-Disease	-1	21418164
in	O	-1	21418164
tu@@	O	-1	21418164
mo@@	O	-1	21418164
ur@@	O	-1	21418164
-@@	O	-1	21418164
be@@	O	-1	21418164
ar@@	O	-1	21418164
ing	O	-1	21418164
dog@@	O	-1	21418164
s	O	-1	21418164
receiving	O	-1	21418164
1-@@	B-Chemical	D008130	21418164
(2@@	I-Chemical	-1	21418164
-@@	I-Chemical	-1	21418164
ch@@	I-Chemical	-1	21418164
loro@@	I-Chemical	-1	21418164
eth@@	I-Chemical	-1	21418164
yl@@	I-Chemical	-1	21418164
)-@@	I-Chemical	-1	21418164
3-@@	I-Chemical	-1	21418164
cyclo@@	I-Chemical	-1	21418164
he@@	I-Chemical	-1	21418164
x@@	I-Chemical	-1	21418164
yl@@	I-Chemical	-1	21418164
-1@@	I-Chemical	-1	21418164
-@@	I-Chemical	-1	21418164
nit@@	I-Chemical	-1	21418164
ros@@	I-Chemical	-1	21418164
ou@@	I-Chemical	-1	21418164
re@@	I-Chemical	-1	21418164
a	I-Chemical	-1	21418164
(	O	-1	21418164
C@@	B-Chemical	D008130	21418164
C@@	I-Chemical	-1	21418164
N@@	I-Chemical	-1	21418164
U	I-Chemical	-1	21418164
).	O	-1	21418164
D@@	O	-1	21418164
ES@@	O	-1	21418164
I@@	O	-1	21418164
G@@	O	-1	21418164
N@@	O	-1	21418164
:	O	-1	21418164
The	O	-1	21418164
med@@	O	-1	21418164
ical	O	-1	21418164
recor@@	O	-1	21418164
ds	O	-1	21418164
of	O	-1	21418164
20@@	O	-1	21418164
6	O	-1	21418164
dog@@	O	-1	21418164
s	O	-1	21418164
that	O	-1	21418164
were	O	-1	21418164
treated	O	-1	21418164
with	O	-1	21418164
C@@	B-Chemical	D008130	21418164
C@@	I-Chemical	-1	21418164
N@@	I-Chemical	-1	21418164
U	I-Chemical	-1	21418164
at	O	-1	21418164
the	O	-1	21418164
M@@	O	-1	21418164
el@@	O	-1	21418164
bo@@	O	-1	21418164
ur@@	O	-1	21418164
n@@	O	-1	21418164
e	O	-1	21418164
V@@	O	-1	21418164
e@@	O	-1	21418164
ter@@	O	-1	21418164
inary	O	-1	21418164
S@@	O	-1	21418164
p@@	O	-1	21418164
ec@@	O	-1	21418164
i@@	O	-1	21418164
al@@	O	-1	21418164
ist	O	-1	21418164
C@@	O	-1	21418164
entr@@	O	-1	21418164
e	O	-1	21418164
between	O	-1	21418164
F@@	O	-1	21418164
e@@	O	-1	21418164
b@@	O	-1	21418164
ru@@	O	-1	21418164
ary	O	-1	21418164
20@@	O	-1	21418164
0@@	O	-1	21418164
2	O	-1	21418164
and	O	-1	21418164
D@@	O	-1	21418164
ec@@	O	-1	21418164
emb@@	O	-1	21418164
er	O	-1	21418164
20@@	O	-1	21418164
0@@	O	-1	21418164
7	O	-1	21418164
were	O	-1	21418164
ret@@	O	-1	21418164
ro@@	O	-1	21418164
sp@@	O	-1	21418164
ectively	O	-1	21418164
evalu@@	O	-1	21418164
ated.	O	-1	21418164
RESULTS:	O	-1	21418164
Of	O	-1	21418164
the	O	-1	21418164
20@@	O	-1	21418164
6	O	-1	21418164
dog@@	O	-1	21418164
s	O	-1	21418164
treated	O	-1	21418164
with	O	-1	21418164
C@@	B-Chemical	D008130	21418164
C@@	I-Chemical	-1	21418164
N@@	I-Chemical	-1	21418164
U	I-Chemical	-1	21418164
,	O	-1	21418164
18@@	O	-1	21418164
5	O	-1	21418164
me@@	O	-1	21418164
t	O	-1	21418164
the	O	-1	21418164
inc@@	O	-1	21418164
lu@@	O	-1	21418164
sion	O	-1	21418164
c@@	O	-1	21418164
rit@@	O	-1	21418164
er@@	O	-1	21418164
ia	O	-1	21418164
for	O	-1	21418164
at	O	-1	21418164
le@@	O	-1	21418164
ast	O	-1	21418164
one	O	-1	21418164
cl@@	O	-1	21418164
as@@	O	-1	21418164
s	O	-1	21418164
of	O	-1	21418164
toxicity	B-Disease	D064420	21418164
.	O	-1	21418164
C@@	B-Chemical	D008130	21418164
C@@	I-Chemical	-1	21418164
N@@	I-Chemical	-1	21418164
U	I-Chemical	-1	21418164
was	O	-1	21418164
used	O	-1	21418164
most	O	-1	21418164
common@@	O	-1	21418164
ly	O	-1	21418164
in	O	-1	21418164
the	O	-1	21418164
treatment	O	-1	21418164
of	O	-1	21418164
lymph@@	B-Disease	D008223	21418164
oma	I-Disease	-1	21418164
,	O	-1	21418164
m@@	B-Disease	D034801	21418164
ast	I-Disease	-1	21418164
cell	I-Disease	-1	21418164
tum@@	I-Disease	-1	21418164
our	I-Disease	-1	21418164
,	O	-1	21418164
brain	B-Disease	D001932	21418164
tum@@	I-Disease	-1	21418164
our	I-Disease	-1	21418164
,	O	-1	21418164
h@@	B-Disease	D015620	21418164
is@@	I-Disease	-1	21418164
ti@@	I-Disease	-1	21418164
ocy@@	I-Disease	-1	21418164
tic	I-Disease	-1	21418164
tu@@	I-Disease	-1	21418164
mo@@	I-Disease	-1	21418164
ur@@	I-Disease	-1	21418164
s	I-Disease	-1	21418164
and	O	-1	21418164
epi@@	B-Disease	D008223	21418164
the@@	I-Disease	-1	21418164
li@@	I-Disease	-1	21418164
ot@@	I-Disease	-1	21418164
ro@@	I-Disease	-1	21418164
p@@	I-Disease	-1	21418164
ic	I-Disease	-1	21418164
lymph@@	I-Disease	-1	21418164
oma	I-Disease	-1	21418164
.	O	-1	21418164
Th@@	O	-1	21418164
rou@@	O	-1	21418164
gh@@	O	-1	21418164
out	O	-1	21418164
treatment,	O	-1	21418164
5@@	O	-1	21418164
6.@@	O	-1	21418164
9@@	O	-1	21418164
%	O	-1	21418164
of	O	-1	21418164
dog@@	O	-1	21418164
s	O	-1	21418164
experienced	O	-1	21418164
ne@@	B-Disease	D009503	21418164
ut@@	I-Disease	-1	21418164
ro@@	I-Disease	-1	21418164
pen@@	I-Disease	-1	21418164
ia	I-Disease	-1	21418164
,	O	-1	21418164
3@@	O	-1	21418164
4.@@	O	-1	21418164
2@@	O	-1	21418164
%	O	-1	21418164
experienced	O	-1	21418164
ana@@	B-Disease	D000740	21418164
emia	I-Disease	-1	21418164
and	O	-1	21418164
1@@	O	-1	21418164
4.@@	O	-1	21418164
2@@	O	-1	21418164
%	O	-1	21418164
experienced	O	-1	21418164
throm@@	B-Disease	D013921	21418164
b@@	I-Disease	-1	21418164
ocyto@@	I-Disease	-1	21418164
pen@@	I-Disease	-1	21418164
ia	I-Disease	-1	21418164
.	O	-1	21418164
G@@	B-Disease	D005767	21418164
ast@@	I-Disease	-1	21418164
ro@@	I-Disease	-1	21418164
in@@	I-Disease	-1	21418164
test@@	I-Disease	-1	21418164
inal	I-Disease	-1	21418164
toxic@@	I-Disease	-1	21418164
o@@	I-Disease	-1	21418164
sis	I-Disease	-1	21418164
was	O	-1	21418164
det@@	O	-1	21418164
ected	O	-1	21418164
in	O	-1	21418164
3@@	O	-1	21418164
7.@@	O	-1	21418164
8@@	O	-1	21418164
%	O	-1	21418164
of	O	-1	21418164
dog@@	O	-1	21418164
s,	O	-1	21418164
the	O	-1	21418164
most	O	-1	21418164
common	O	-1	21418164
si@@	O	-1	21418164
g@@	O	-1	21418164
n	O	-1	21418164
of	O	-1	21418164
which	O	-1	21418164
was	O	-1	21418164
v@@	B-Disease	D014839	21418164
om@@	I-Disease	-1	21418164
it@@	I-Disease	-1	21418164
ing	I-Disease	-1	21418164
(2@@	O	-1	21418164
4.@@	O	-1	21418164
3@@	O	-1	21418164
%).	O	-1	21418164
P@@	O	-1	21418164
oten@@	O	-1	21418164
tial	O	-1	21418164
renal	O	-1	21418164
toxicity	B-Disease	D064420	21418164
and	O	-1	21418164
elevated	O	-1	21418164
al@@	B-Chemical	D000409	21418164
an@@	I-Chemical	-1	21418164
ine	I-Chemical	-1	21418164
trans@@	O	-1	21418164
amin@@	O	-1	21418164
ase	O	-1	21418164
(A@@	O	-1	21418164
LT@@	O	-1	21418164
)	O	-1	21418164
concentration	O	-1	21418164
were	O	-1	21418164
reported	O	-1	21418164
in	O	-1	21418164
1@@	O	-1	21418164
2.@@	O	-1	21418164
2@@	O	-1	21418164
%	O	-1	21418164
and	O	-1	21418164
4@@	O	-1	21418164
8.@@	O	-1	21418164
8@@	O	-1	21418164
%	O	-1	21418164
of	O	-1	21418164
dog@@	O	-1	21418164
s,	O	-1	21418164
respectively.	O	-1	21418164
The	O	-1	21418164
incidence	O	-1	21418164
of	O	-1	21418164
hepatic	B-Disease	D017093	21418164
failure	I-Disease	-1	21418164
was	O	-1	21418164
1.@@	O	-1	21418164
2@@	O	-1	21418164
%.	O	-1	21418164
CONCLUSIONS:	O	-1	21418164
C@@	B-Chemical	D008130	21418164
C@@	I-Chemical	-1	21418164
N@@	I-Chemical	-1	21418164
U	I-Chemical	-1	21418164
-@@	O	-1	21418164
associated	O	-1	21418164
toxicity	B-Disease	D064420	21418164
in	O	-1	21418164
dog@@	O	-1	21418164
s	O	-1	21418164
is	O	-1	21418164
common@@	O	-1	21418164
,	O	-1	21418164
but	O	-1	21418164
is	O	-1	21418164
us@@	O	-1	21418164
ually	O	-1	21418164
not	O	-1	21418164
lif@@	O	-1	21418164
e	O	-1	21418164
th@@	O	-1	21418164
reat@@	O	-1	21418164
en@@	O	-1	21418164
ing.	O	-1	21418164

Ne@@	O	-1	9121607
uro@@	O	-1	9121607
active	O	-1	9121607
steroid@@	B-Chemical	D013256	9121607
s	I-Chemical	-1	9121607
prot@@	O	-1	9121607
ect	O	-1	9121607
against	O	-1	9121607
pilocar@@	B-Chemical	D010862	9121607
pine	I-Chemical	-1	9121607
-	O	-1	9121607
and	O	-1	9121607
k@@	B-Chemical	D007608	9121607
ain@@	I-Chemical	-1	9121607
ic	I-Chemical	-1	9121607
acid	I-Chemical	-1	9121607
-induced	O	-1	9121607
lim@@	O	-1	9121607
b@@	O	-1	9121607
ic	O	-1	9121607
seizures	B-Disease	D012640	9121607
and	O	-1	9121607
status	B-Disease	D013226	9121607
epilep@@	I-Disease	-1	9121607
tic@@	I-Disease	-1	9121607
us	I-Disease	-1	9121607
in	O	-1	9121607
mice.	O	-1	9121607
S@@	O	-1	9121607
e@@	O	-1	9121607
ver@@	O	-1	9121607
al	O	-1	9121607
struct@@	O	-1	9121607
ur@@	O	-1	9121607
ally	O	-1	9121607
related	O	-1	9121607
metabol@@	O	-1	9121607
it@@	O	-1	9121607
es	O	-1	9121607
of	O	-1	9121607
pro@@	B-Chemical	D011374	9121607
g@@	I-Chemical	-1	9121607
est@@	I-Chemical	-1	9121607
er@@	I-Chemical	-1	9121607
one	I-Chemical	-1	9121607
(	O	-1	9121607
3	B-Chemical	D011374	9121607
alpha-@@	I-Chemical	-1	9121607
hydrox@@	I-Chemical	-1	9121607
y	I-Chemical	-1	9121607
pregn@@	I-Chemical	-1	9121607
an@@	I-Chemical	-1	9121607
e-@@	I-Chemical	-1	9121607
20@@	I-Chemical	-1	9121607
-@@	I-Chemical	-1	9121607
on@@	I-Chemical	-1	9121607
es	I-Chemical	-1	9121607
)	O	-1	9121607
and	O	-1	9121607
de@@	B-Chemical	D003900	9121607
oxy@@	I-Chemical	-1	9121607
cortico@@	I-Chemical	-1	9121607
sterone	I-Chemical	-1	9121607
(	O	-1	9121607
3	B-Chemical	D003900	9121607
alpha-@@	I-Chemical	-1	9121607
hydrox@@	I-Chemical	-1	9121607
y	I-Chemical	-1	9121607
pregn@@	I-Chemical	-1	9121607
an@@	I-Chemical	-1	9121607
e-@@	I-Chemical	-1	9121607
2@@	I-Chemical	-1	9121607
1-@@	I-Chemical	-1	9121607
di@@	I-Chemical	-1	9121607
ol@@	I-Chemical	-1	9121607
-@@	I-Chemical	-1	9121607
20@@	I-Chemical	-1	9121607
-@@	I-Chemical	-1	9121607
on@@	I-Chemical	-1	9121607
es	I-Chemical	-1	9121607
)	O	-1	9121607
and	O	-1	9121607
their	O	-1	9121607
3	O	-1	9121607
beta-@@	O	-1	9121607
ep@@	O	-1	9121607
im@@	O	-1	9121607
ers	O	-1	9121607
were	O	-1	9121607
evaluated	O	-1	9121607
for	O	-1	9121607
protective	O	-1	9121607
activity	O	-1	9121607
against	O	-1	9121607
pilocar@@	B-Chemical	D010862	9121607
pine	I-Chemical	-1	9121607
-@@	O	-1	9121607
,	O	-1	9121607
k@@	B-Chemical	D007608	9121607
ain@@	I-Chemical	-1	9121607
ic	I-Chemical	-1	9121607
acid	I-Chemical	-1	9121607
-	O	-1	9121607
and	O	-1	9121607
N@@	B-Chemical	D016202	9121607
-@@	I-Chemical	-1	9121607
methyl@@	I-Chemical	-1	9121607
-@@	I-Chemical	-1	9121607
D-@@	I-Chemical	-1	9121607
as@@	I-Chemical	-1	9121607
part@@	I-Chemical	-1	9121607
ate	I-Chemical	-1	9121607
(	O	-1	9121607
N@@	B-Chemical	D016202	9121607
MD@@	I-Chemical	-1	9121607
A	I-Chemical	-1	9121607
)@@	O	-1	9121607
-induced	O	-1	9121607
seizures	B-Disease	D012640	9121607
in	O	-1	9121607
mice.	O	-1	9121607
S@@	B-Chemical	D013256	9121607
ter@@	I-Chemical	-1	9121607
oid@@	I-Chemical	-1	9121607
s	I-Chemical	-1	9121607
with	O	-1	9121607
the	O	-1	9121607
3-@@	O	-1	9121607
hydrox@@	O	-1	9121607
y	O	-1	9121607
group	O	-1	9121607
in	O	-1	9121607
the	O	-1	9121607
alpha-@@	O	-1	9121607
posi@@	O	-1	9121607
tion	O	-1	9121607
and	O	-1	9121607
5-@@	O	-1	9121607
H	O	-1	9121607
in	O	-1	9121607
the	O	-1	9121607
alpha@@	O	-1	9121607
-	O	-1	9121607
or	O	-1	9121607
beta-@@	O	-1	9121607
con@@	O	-1	9121607
fi@@	O	-1	9121607
g@@	O	-1	9121607
ur@@	O	-1	9121607
ations	O	-1	9121607
were	O	-1	9121607
high@@	O	-1	9121607
ly	O	-1	9121607
effective	O	-1	9121607
in	O	-1	9121607
prot@@	O	-1	9121607
ect@@	O	-1	9121607
ing	O	-1	9121607
against	O	-1	9121607
pilocar@@	B-Chemical	D010862	9121607
pine	I-Chemical	-1	9121607
(4@@	O	-1	9121607
16	O	-1	9121607
mg/kg@@	O	-1	9121607
,	O	-1	9121607
s@@	O	-1	9121607
.@@	O	-1	9121607
c@@	O	-1	9121607
.@@	O	-1	9121607
)@@	O	-1	9121607
-induced	O	-1	9121607
lim@@	O	-1	9121607
b@@	O	-1	9121607
ic	O	-1	9121607
motor	O	-1	9121607
seizures	B-Disease	D012640	9121607
and	O	-1	9121607
status	B-Disease	D013226	9121607
epilep@@	I-Disease	-1	9121607
tic@@	I-Disease	-1	9121607
us	I-Disease	-1	9121607
(@@	O	-1	9121607
E@@	O	-1	9121607
D@@	O	-1	9121607
50	O	-1	9121607
valu@@	O	-1	9121607
es,	O	-1	9121607
7.@@	O	-1	9121607
0@@	O	-1	9121607
-1@@	O	-1	9121607
8.@@	O	-1	9121607
7	O	-1	9121607
mg/kg@@	O	-1	9121607
,	O	-1	9121607
i.p.@@	O	-1	9121607
).	O	-1	9121607
The	O	-1	9121607
cor@@	O	-1	9121607
respon@@	O	-1	9121607
ding	O	-1	9121607
ep@@	O	-1	9121607
im@@	O	-1	9121607
ers	O	-1	9121607
with	O	-1	9121607
the	O	-1	9121607
3-@@	O	-1	9121607
hydrox@@	O	-1	9121607
y	O	-1	9121607
group	O	-1	9121607
in	O	-1	9121607
the	O	-1	9121607
beta-@@	O	-1	9121607
posi@@	O	-1	9121607
tion	O	-1	9121607
were	O	-1	9121607
also	O	-1	9121607
effective	O	-1	9121607
but	O	-1	9121607
less	O	-1	9121607
pot@@	O	-1	9121607
ent	O	-1	9121607
(@@	O	-1	9121607
E@@	O	-1	9121607
D@@	O	-1	9121607
50	O	-1	9121607
valu@@	O	-1	9121607
es,	O	-1	9121607
3@@	O	-1	9121607
3.@@	O	-1	9121607
8@@	O	-1	9121607
-@@	O	-1	9121607
6@@	O	-1	9121607
3.@@	O	-1	9121607
5,	O	-1	9121607
i.p.@@	O	-1	9121607
).	O	-1	9121607
Although	O	-1	9121607
the	O	-1	9121607
neuro@@	O	-1	9121607
active	O	-1	9121607
steroid@@	B-Chemical	D013256	9121607
s	I-Chemical	-1	9121607
were	O	-1	9121607
con@@	O	-1	9121607
si@@	O	-1	9121607
der@@	O	-1	9121607
ably	O	-1	9121607
less	O	-1	9121607
pot@@	O	-1	9121607
ent	O	-1	9121607
than	O	-1	9121607
the	O	-1	9121607
b@@	B-Chemical	D001569	9121607
enz@@	I-Chemical	-1	9121607
odi@@	I-Chemical	-1	9121607
azepine	I-Chemical	-1	9121607
clon@@	B-Chemical	D002998	9121607
az@@	I-Chemical	-1	9121607
epam	I-Chemical	-1	9121607
in	O	-1	9121607
prot@@	O	-1	9121607
ect@@	O	-1	9121607
ing	O	-1	9121607
against	O	-1	9121607
pilocar@@	B-Chemical	D010862	9121607
pine	I-Chemical	-1	9121607
seizures	B-Disease	D012640	9121607
,	O	-1	9121607
steroid@@	B-Chemical	D013256	9121607
s	I-Chemical	-1	9121607
with	O	-1	9121607
the	O	-1	9121607
5	O	-1	9121607
alpha@@	O	-1	9121607
,@@	O	-1	9121607
3	O	-1	9121607
alpha-@@	O	-1	9121607
con@@	O	-1	9121607
fi@@	O	-1	9121607
g@@	O	-1	9121607
ur@@	O	-1	9121607
ation	O	-1	9121607
had	O	-1	9121607
compar@@	O	-1	9121607
able	O	-1	9121607
or	O	-1	9121607
higher	O	-1	9121607
protective	O	-1	9121607
in@@	O	-1	9121607
de@@	O	-1	9121607
x	O	-1	9121607
values	O	-1	9121607
(T@@	O	-1	9121607
D@@	O	-1	9121607
50	O	-1	9121607
for	O	-1	9121607
motor	O	-1	9121607
impair@@	O	-1	9121607
ment	O	-1	9121607
divid@@	O	-1	9121607
ed	O	-1	9121607
by	O	-1	9121607
E@@	O	-1	9121607
D@@	O	-1	9121607
50	O	-1	9121607
for	O	-1	9121607
seizure	B-Disease	D012640	9121607
prot@@	O	-1	9121607
ec@@	O	-1	9121607
tion@@	O	-1	9121607
)	O	-1	9121607
than	O	-1	9121607
clon@@	B-Chemical	D002998	9121607
az@@	I-Chemical	-1	9121607
epam	I-Chemical	-1	9121607
,	O	-1	9121607
indicating	O	-1	9121607
that	O	-1	9121607
some	O	-1	9121607
neuro@@	O	-1	9121607
active	O	-1	9121607
steroid@@	B-Chemical	D013256	9121607
s	I-Chemical	-1	9121607
may	O	-1	9121607
have	O	-1	9121607
lower	O	-1	9121607
rel@@	O	-1	9121607
ative	O	-1	9121607
toxicity	B-Disease	D064420	9121607
.	O	-1	9121607
S@@	B-Chemical	D013256	9121607
ter@@	I-Chemical	-1	9121607
oid@@	I-Chemical	-1	9121607
s	I-Chemical	-1	9121607
with	O	-1	9121607
the	O	-1	9121607
5	O	-1	9121607
alpha@@	O	-1	9121607
,@@	O	-1	9121607
3	O	-1	9121607
alpha@@	O	-1	9121607
-	O	-1	9121607
or	O	-1	9121607
5	O	-1	9121607
beta@@	O	-1	9121607
,@@	O	-1	9121607
3	O	-1	9121607
alpha-@@	O	-1	9121607
con@@	O	-1	9121607
fi@@	O	-1	9121607
g@@	O	-1	9121607
ur@@	O	-1	9121607
ations	O	-1	9121607
also	O	-1	9121607
produced	O	-1	9121607
a	O	-1	9121607
dose-@@	O	-1	9121607
dependent	O	-1	9121607
del@@	O	-1	9121607
ay	O	-1	9121607
in	O	-1	9121607
the	O	-1	9121607
onset	O	-1	9121607
of	O	-1	9121607
lim@@	O	-1	9121607
b@@	O	-1	9121607
ic	O	-1	9121607
seizures	B-Disease	D012640	9121607
induced	O	-1	9121607
by	O	-1	9121607
k@@	B-Chemical	D007608	9121607
ain@@	I-Chemical	-1	9121607
ic	I-Chemical	-1	9121607
acid	I-Chemical	-1	9121607
(3@@	O	-1	9121607
2	O	-1	9121607
mg/kg@@	O	-1	9121607
,	O	-1	9121607
s@@	O	-1	9121607
.@@	O	-1	9121607
c@@	O	-1	9121607
.@@	O	-1	9121607
),	O	-1	9121607
but	O	-1	9121607
did	O	-1	9121607
not	O	-1	9121607
complete@@	O	-1	9121607
ly	O	-1	9121607
prot@@	O	-1	9121607
ect	O	-1	9121607
against	O	-1	9121607
the	O	-1	9121607
seizures	B-Disease	D012640	9121607
.	O	-1	9121607
However,	O	-1	9121607
when	O	-1	9121607
a	O	-1	9121607
second	O	-1	9121607
dose	O	-1	9121607
of	O	-1	9121607
the	O	-1	9121607
ster@@	B-Chemical	D013256	9121607
oid	I-Chemical	-1	9121607
was	O	-1	9121607
administered	O	-1	9121607
1	O	-1	9121607
h@@	O	-1	9121607
r	O	-1	9121607
after	O	-1	9121607
the	O	-1	9121607
first	O	-1	9121607
dose@@	O	-1	9121607
,	O	-1	9121607
complete	O	-1	9121607
prot@@	O	-1	9121607
ection	O	-1	9121607
from	O	-1	9121607
the	O	-1	9121607
k@@	B-Chemical	D007608	9121607
ain@@	I-Chemical	-1	9121607
ic	I-Chemical	-1	9121607
acid	I-Chemical	-1	9121607
-induced	O	-1	9121607
lim@@	O	-1	9121607
b@@	O	-1	9121607
ic	O	-1	9121607
seizures	B-Disease	D012640	9121607
and	O	-1	9121607
status	B-Disease	D013226	9121607
epilep@@	I-Disease	-1	9121607
tic@@	I-Disease	-1	9121607
us	I-Disease	-1	9121607
was	O	-1	9121607
obt@@	O	-1	9121607
a@@	O	-1	9121607
ine@@	O	-1	9121607
d.	O	-1	9121607
The	O	-1	9121607
steroid@@	B-Chemical	D013256	9121607
s	I-Chemical	-1	9121607
also	O	-1	9121607
caused	O	-1	9121607
a	O	-1	9121607
dose-@@	O	-1	9121607
dependent	O	-1	9121607
del@@	O	-1	9121607
ay	O	-1	9121607
in	O	-1	9121607
N@@	B-Chemical	D016202	9121607
MD@@	I-Chemical	-1	9121607
A	I-Chemical	-1	9121607
(2@@	O	-1	9121607
5@@	O	-1	9121607
7	O	-1	9121607
mg/kg@@	O	-1	9121607
,	O	-1	9121607
s@@	O	-1	9121607
.@@	O	-1	9121607
c@@	O	-1	9121607
.@@	O	-1	9121607
)@@	O	-1	9121607
-induced	O	-1	9121607
le@@	O	-1	9121607
thal@@	O	-1	9121607
ity,	O	-1	9121607
but	O	-1	9121607
did	O	-1	9121607
not	O	-1	9121607
complete@@	O	-1	9121607
ly	O	-1	9121607
prot@@	O	-1	9121607
ect	O	-1	9121607
against	O	-1	9121607
N@@	B-Chemical	D016202	9121607
MD@@	I-Chemical	-1	9121607
A	I-Chemical	-1	9121607
seizures	B-Disease	D012640	9121607
or	O	-1	9121607
le@@	O	-1	9121607
thal@@	O	-1	9121607
ity.	O	-1	9121607
We	O	-1	9121607
concl@@	O	-1	9121607
ude	O	-1	9121607
that	O	-1	9121607
neuro@@	O	-1	9121607
active	O	-1	9121607
steroid@@	B-Chemical	D013256	9121607
s	I-Chemical	-1	9121607
are	O	-1	9121607
high@@	O	-1	9121607
ly	O	-1	9121607
effective	O	-1	9121607
in	O	-1	9121607
prot@@	O	-1	9121607
ect@@	O	-1	9121607
ing	O	-1	9121607
against	O	-1	9121607
pilocar@@	B-Chemical	D010862	9121607
pine	I-Chemical	-1	9121607
-	O	-1	9121607
and	O	-1	9121607
k@@	B-Chemical	D007608	9121607
ain@@	I-Chemical	-1	9121607
ic	I-Chemical	-1	9121607
acid	I-Chemical	-1	9121607
-induced	O	-1	9121607
seizures	B-Disease	D012640	9121607
and	O	-1	9121607
status	B-Disease	D013226	9121607
epilep@@	I-Disease	-1	9121607
tic@@	I-Disease	-1	9121607
us	I-Disease	-1	9121607
in	O	-1	9121607
mic@@	O	-1	9121607
e,	O	-1	9121607
and	O	-1	9121607
may	O	-1	9121607
be	O	-1	9121607
of	O	-1	9121607
u@@	O	-1	9121607
til@@	O	-1	9121607
ity	O	-1	9121607
in	O	-1	9121607
the	O	-1	9121607
treatment	O	-1	9121607
of	O	-1	9121607
some	O	-1	9121607
form@@	O	-1	9121607
s	O	-1	9121607
of	O	-1	9121607
status	B-Disease	D013226	9121607
epilep@@	I-Disease	-1	9121607
tic@@	I-Disease	-1	9121607
us	I-Disease	-1	9121607
in	O	-1	9121607
hum@@	O	-1	9121607
an@@	O	-1	9121607
s.	O	-1	9121607

The	O	-1	7905523
safety	O	-1	7905523
and	O	-1	7905523
efficacy	O	-1	7905523
of	O	-1	7905523
combination	O	-1	7905523
N@@	B-Chemical	C059896	7905523
-@@	I-Chemical	-1	7905523
but@@	I-Chemical	-1	7905523
yl@@	I-Chemical	-1	7905523
-@@	I-Chemical	-1	7905523
de@@	I-Chemical	-1	7905523
oxy@@	I-Chemical	-1	7905523
no@@	I-Chemical	-1	7905523
j@@	I-Chemical	-1	7905523
i@@	I-Chemical	-1	7905523
ri@@	I-Chemical	-1	7905523
m@@	I-Chemical	-1	7905523
ycin	I-Chemical	-1	7905523
(	O	-1	7905523
S@@	B-Chemical	C059896	7905523
C@@	I-Chemical	-1	7905523
-@@	I-Chemical	-1	7905523
4@@	I-Chemical	-1	7905523
8@@	I-Chemical	-1	7905523
3@@	I-Chemical	-1	7905523
3@@	I-Chemical	-1	7905523
4	I-Chemical	-1	7905523
)	O	-1	7905523
and	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
in	O	-1	7905523
patients	O	-1	7905523
with	O	-1	7905523
H@@	B-Disease	D015658	7905523
I@@	I-Disease	-1	7905523
V@@	I-Disease	-1	7905523
-1	I-Disease	-1	7905523
inf@@	I-Disease	-1	7905523
ection	I-Disease	-1	7905523
and	O	-1	7905523
20@@	O	-1	7905523
0-@@	O	-1	7905523
5@@	O	-1	7905523
00	O	-1	7905523
C@@	O	-1	7905523
D@@	O	-1	7905523
4	O	-1	7905523
cell@@	O	-1	7905523
s/@@	O	-1	7905523
mm@@	O	-1	7905523
3@@	O	-1	7905523
.	O	-1	7905523
We	O	-1	7905523
con@@	O	-1	7905523
duc@@	O	-1	7905523
ted	O	-1	7905523
a	O	-1	7905523
double-bl@@	O	-1	7905523
ind@@	O	-1	7905523
,	O	-1	7905523
randomized	O	-1	7905523
phase	O	-1	7905523
II	O	-1	7905523
study	O	-1	7905523
to	O	-1	7905523
evalu@@	O	-1	7905523
ate	O	-1	7905523
the	O	-1	7905523
safety	O	-1	7905523
and	O	-1	7905523
activity	O	-1	7905523
of	O	-1	7905523
combination	O	-1	7905523
therapy	O	-1	7905523
with	O	-1	7905523
N@@	B-Chemical	C059896	7905523
-@@	I-Chemical	-1	7905523
but@@	I-Chemical	-1	7905523
yl@@	I-Chemical	-1	7905523
-@@	I-Chemical	-1	7905523
de@@	I-Chemical	-1	7905523
oxy@@	I-Chemical	-1	7905523
no@@	I-Chemical	-1	7905523
j@@	I-Chemical	-1	7905523
i@@	I-Chemical	-1	7905523
ri@@	I-Chemical	-1	7905523
m@@	I-Chemical	-1	7905523
ycin	I-Chemical	-1	7905523
(	O	-1	7905523
S@@	B-Chemical	C059896	7905523
C@@	I-Chemical	-1	7905523
-@@	I-Chemical	-1	7905523
4@@	I-Chemical	-1	7905523
8@@	I-Chemical	-1	7905523
3@@	I-Chemical	-1	7905523
3@@	I-Chemical	-1	7905523
4	I-Chemical	-1	7905523
)	O	-1	7905523
(@@	O	-1	7905523
an	O	-1	7905523
alpha-@@	O	-1	7905523
g@@	O	-1	7905523
lu@@	O	-1	7905523
co@@	O	-1	7905523
si@@	O	-1	7905523
d@@	O	-1	7905523
ase	O	-1	7905523
I	O	-1	7905523
inhibitor@@	O	-1	7905523
)	O	-1	7905523
and	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
versus	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
al@@	O	-1	7905523
one.	O	-1	7905523
Patients	O	-1	7905523
with	O	-1	7905523
2@@	O	-1	7905523
00	O	-1	7905523
to	O	-1	7905523
5@@	O	-1	7905523
00	O	-1	7905523
C@@	O	-1	7905523
D@@	O	-1	7905523
4	O	-1	7905523
cell@@	O	-1	7905523
s/@@	O	-1	7905523
mm@@	O	-1	7905523
3	O	-1	7905523
who	O	-1	7905523
toler@@	O	-1	7905523
ated	O	-1	7905523
<	O	-1	7905523
or	O	-1	7905523
=	O	-1	7905523
12	O	-1	7905523
weeks	O	-1	7905523
of	O	-1	7905523
prior	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
therapy	O	-1	7905523
received	O	-1	7905523
S@@	B-Chemical	C059896	7905523
C@@	I-Chemical	-1	7905523
-@@	I-Chemical	-1	7905523
4@@	I-Chemical	-1	7905523
8@@	I-Chemical	-1	7905523
3@@	I-Chemical	-1	7905523
3@@	I-Chemical	-1	7905523
4	I-Chemical	-1	7905523
(@@	O	-1	7905523
10@@	O	-1	7905523
00	O	-1	7905523
mg	O	-1	7905523
every	O	-1	7905523
8	O	-1	7905523
h@@	O	-1	7905523
)	O	-1	7905523
and	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
(@@	O	-1	7905523
100	O	-1	7905523
mg	O	-1	7905523
every	O	-1	7905523
8	O	-1	7905523
h@@	O	-1	7905523
)	O	-1	7905523
or	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
and	O	-1	7905523
placebo@@	O	-1	7905523
.	O	-1	7905523
Si@@	O	-1	7905523
x@@	O	-1	7905523
t@@	O	-1	7905523
y	O	-1	7905523
patients	O	-1	7905523
received	O	-1	7905523
combination	O	-1	7905523
therapy	O	-1	7905523
and	O	-1	7905523
5@@	O	-1	7905523
8@@	O	-1	7905523
,	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
and	O	-1	7905523
placebo@@	O	-1	7905523
.	O	-1	7905523
Tw@@	O	-1	7905523
ent@@	O	-1	7905523
y-@@	O	-1	7905523
three	O	-1	7905523
patients	O	-1	7905523
(3@@	O	-1	7905523
8@@	O	-1	7905523
%)	O	-1	7905523
and	O	-1	7905523
15	O	-1	7905523
(2@@	O	-1	7905523
6@@	O	-1	7905523
%),	O	-1	7905523
in	O	-1	7905523
the	O	-1	7905523
combination	O	-1	7905523
and	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
group@@	O	-1	7905523
s,	O	-1	7905523
respectivel@@	O	-1	7905523
y,	O	-1	7905523
discontinu@@	O	-1	7905523
ed	O	-1	7905523
therapy	O	-1	7905523
(p	O	-1	7905523
=	O	-1	7905523
0.@@	O	-1	7905523
1@@	O	-1	7905523
5@@	O	-1	7905523
).	O	-1	7905523
The	O	-1	7905523
mean	O	-1	7905523
S@@	B-Chemical	C059896	7905523
C@@	I-Chemical	-1	7905523
-@@	I-Chemical	-1	7905523
4@@	I-Chemical	-1	7905523
8@@	I-Chemical	-1	7905523
3@@	I-Chemical	-1	7905523
3@@	I-Chemical	-1	7905523
4	I-Chemical	-1	7905523
ste@@	O	-1	7905523
ad@@	O	-1	7905523
y-@@	O	-1	7905523
state	O	-1	7905523
t@@	O	-1	7905523
rou@@	O	-1	7905523
gh	O	-1	7905523
level	O	-1	7905523
(@@	O	-1	7905523
4.@@	O	-1	7905523
0@@	O	-1	7905523
4	O	-1	7905523
+/-	O	-1	7905523
0.@@	O	-1	7905523
9@@	O	-1	7905523
9	O	-1	7905523
microgram@@	O	-1	7905523
s/@@	O	-1	7905523
ml@@	O	-1	7905523
)	O	-1	7905523
was	O	-1	7905523
be@@	O	-1	7905523
low	O	-1	7905523
the	O	-1	7905523
in	O	-1	7905523
vit@@	O	-1	7905523
r@@	O	-1	7905523
o	O	-1	7905523
inhibit@@	O	-1	7905523
ory	O	-1	7905523
concentration	O	-1	7905523
for	O	-1	7905523
human	O	-1	7905523
immuno@@	B-Disease	D007153	7905523
defici@@	I-Disease	-1	7905523
ency	I-Disease	-1	7905523
vi@@	O	-1	7905523
ru@@	O	-1	7905523
s	O	-1	7905523
(@@	O	-1	7905523
H@@	O	-1	7905523
I@@	O	-1	7905523
V@@	O	-1	7905523
).	O	-1	7905523
The	O	-1	7905523
mean	O	-1	7905523
increase	O	-1	7905523
in	O	-1	7905523
C@@	O	-1	7905523
D@@	O	-1	7905523
4	O	-1	7905523
cells	O	-1	7905523
at	O	-1	7905523
week	O	-1	7905523
4	O	-1	7905523
was	O	-1	7905523
7@@	O	-1	7905523
3.@@	O	-1	7905523
8	O	-1	7905523
cell@@	O	-1	7905523
s/@@	O	-1	7905523
mm@@	O	-1	7905523
3	O	-1	7905523
and	O	-1	7905523
5@@	O	-1	7905523
2.@@	O	-1	7905523
4	O	-1	7905523
cell@@	O	-1	7905523
s/@@	O	-1	7905523
mm@@	O	-1	7905523
3	O	-1	7905523
for	O	-1	7905523
the	O	-1	7905523
combination	O	-1	7905523
and	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
group@@	O	-1	7905523
s,	O	-1	7905523
respecti@@	O	-1	7905523
vely	O	-1	7905523
(p	O	-1	7905523
>	O	-1	7905523
0.@@	O	-1	7905523
3@@	O	-1	7905523
6@@	O	-1	7905523
).	O	-1	7905523
F@@	O	-1	7905523
or	O	-1	7905523
patients	O	-1	7905523
with	O	-1	7905523
prior	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
therapy,	O	-1	7905523
the	O	-1	7905523
mean	O	-1	7905523
change	O	-1	7905523
in	O	-1	7905523
C@@	O	-1	7905523
D@@	O	-1	7905523
4	O	-1	7905523
cells	O	-1	7905523
in	O	-1	7905523
the	O	-1	7905523
combination	O	-1	7905523
and	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
groups	O	-1	7905523
was	O	-1	7905523
6@@	O	-1	7905523
3.@@	O	-1	7905523
7	O	-1	7905523
cell@@	O	-1	7905523
s/@@	O	-1	7905523
mm@@	O	-1	7905523
3	O	-1	7905523
and	O	-1	7905523
4.@@	O	-1	7905523
9	O	-1	7905523
cell@@	O	-1	7905523
s/@@	O	-1	7905523
mm@@	O	-1	7905523
3	O	-1	7905523
at	O	-1	7905523
week	O	-1	7905523
8	O	-1	7905523
and	O	-1	7905523
6.@@	O	-1	7905523
8	O	-1	7905523
cell@@	O	-1	7905523
s/@@	O	-1	7905523
mm@@	O	-1	7905523
3	O	-1	7905523
and	O	-1	7905523
-@@	O	-1	7905523
4@@	O	-1	7905523
5.@@	O	-1	7905523
1	O	-1	7905523
cell@@	O	-1	7905523
s/@@	O	-1	7905523
mm@@	O	-1	7905523
3	O	-1	7905523
at	O	-1	7905523
week	O	-1	7905523
1@@	O	-1	7905523
6,	O	-1	7905523
respectively.	O	-1	7905523
The	O	-1	7905523
number	O	-1	7905523
of	O	-1	7905523
patients	O	-1	7905523
with	O	-1	7905523
sup@@	O	-1	7905523
pression	O	-1	7905523
of	O	-1	7905523
H@@	O	-1	7905523
IV	O	-1	7905523
p@@	O	-1	7905523
24	O	-1	7905523
anti@@	O	-1	7905523
gen@@	O	-1	7905523
emia	O	-1	7905523
in	O	-1	7905523
the	O	-1	7905523
combination	O	-1	7905523
and	O	-1	7905523
z@@	B-Chemical	D015215	7905523
id@@	I-Chemical	-1	7905523
o@@	I-Chemical	-1	7905523
vud@@	I-Chemical	-1	7905523
ine	I-Chemical	-1	7905523
groups	O	-1	7905523
was	O	-1	7905523
six	O	-1	7905523
(4@@	O	-1	7905523
0@@	O	-1	7905523
%)	O	-1	7905523
and	O	-1	7905523
two	O	-1	7905523
(1@@	O	-1	7905523
1@@	O	-1	7905523
%)	O	-1	7905523
at	O	-1	7905523
week	O	-1	7905523
4	O	-1	7905523
(p	O	-1	7905523
=	O	-1	7905523
0.@@	O	-1	7905523
10@@	O	-1	7905523
)	O	-1	7905523
and	O	-1	7905523
five	O	-1	7905523
(4@@	O	-1	7905523
5@@	O	-1	7905523
%)	O	-1	7905523
and	O	-1	7905523
two	O	-1	7905523
(1@@	O	-1	7905523
4@@	O	-1	7905523
%)	O	-1	7905523
at	O	-1	7905523
week	O	-1	7905523
24	O	-1	7905523
(p	O	-1	7905523
=	O	-1	7905523
0.0@@	O	-1	7905523
8@@	O	-1	7905523
),	O	-1	7905523
respectively.	O	-1	7905523
Di@@	B-Disease	D003967	7905523
ar@@	I-Disease	-1	7905523
r@@	I-Disease	-1	7905523
he@@	I-Disease	-1	7905523
a	I-Disease	-1	7905523
,	O	-1	7905523
f@@	B-Disease	D005414	7905523
lat@@	I-Disease	-1	7905523
ul@@	I-Disease	-1	7905523
ence	I-Disease	-1	7905523
,	O	-1	7905523
ab@@	B-Disease	D015746	7905523
domin@@	I-Disease	-1	7905523
al	I-Disease	-1	7905523
pain	I-Disease	-1	7905523
,	O	-1	7905523
and	O	-1	7905523
weight	B-Disease	D015431	7905523
loss	I-Disease	-1	7905523
were	O	-1	7905523
common	O	-1	7905523
for	O	-1	7905523
combination	O	-1	7905523
re@@	O	-1	7905523
ci@@	O	-1	7905523
pi@@	O	-1	7905523
ent@@	O	-1	7905523
s@@	O	-1	7905523
.@@	O	-1	7905523
(A@@	O	-1	7905523
B@@	O	-1	7905523
S@@	O	-1	7905523
TR@@	O	-1	7905523
AC@@	O	-1	7905523
T	O	-1	7905523
TR@@	O	-1	7905523
UN@@	O	-1	7905523
C@@	O	-1	7905523
AT@@	O	-1	7905523
E@@	O	-1	7905523
D	O	-1	7905523
A@@	O	-1	7905523
T	O	-1	7905523
2@@	O	-1	7905523
50	O	-1	7905523
W@@	O	-1	7905523
O@@	O	-1	7905523
RD@@	O	-1	7905523
S)	O	-1	7905523

Rec@@	O	-1	3431591
ent	O	-1	3431591
pre@@	O	-1	3431591
clinical	O	-1	3431591
and	O	-1	3431591
clinical	O	-1	3431591
studies	O	-1	3431591
with	O	-1	3431591
the	O	-1	3431591
th@@	O	-1	3431591
ym@@	O	-1	3431591
id@@	O	-1	3431591
yl@@	O	-1	3431591
ate	O	-1	3431591
syn@@	O	-1	3431591
th@@	O	-1	3431591
ase	O	-1	3431591
inhibitor	O	-1	3431591
N@@	B-Chemical	C031662	3431591
10-@@	I-Chemical	-1	3431591
pro@@	I-Chemical	-1	3431591
par@@	I-Chemical	-1	3431591
g@@	I-Chemical	-1	3431591
yl@@	I-Chemical	-1	3431591
-@@	I-Chemical	-1	3431591
5@@	I-Chemical	-1	3431591
,@@	I-Chemical	-1	3431591
8@@	I-Chemical	-1	3431591
-@@	I-Chemical	-1	3431591
di@@	I-Chemical	-1	3431591
de@@	I-Chemical	-1	3431591
az@@	I-Chemical	-1	3431591
af@@	I-Chemical	-1	3431591
olic	I-Chemical	-1	3431591
acid	I-Chemical	-1	3431591
(	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
).	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
,	O	-1	3431591
N@@	B-Chemical	C031662	3431591
10-@@	I-Chemical	-1	3431591
pro@@	I-Chemical	-1	3431591
par@@	I-Chemical	-1	3431591
g@@	I-Chemical	-1	3431591
yl@@	I-Chemical	-1	3431591
-@@	I-Chemical	-1	3431591
5@@	I-Chemical	-1	3431591
,@@	I-Chemical	-1	3431591
8@@	I-Chemical	-1	3431591
-@@	I-Chemical	-1	3431591
di@@	I-Chemical	-1	3431591
de@@	I-Chemical	-1	3431591
az@@	I-Chemical	-1	3431591
af@@	I-Chemical	-1	3431591
olic	I-Chemical	-1	3431591
acid	I-Chemical	-1	3431591
,	O	-1	3431591
is	O	-1	3431591
a	O	-1	3431591
ti@@	O	-1	3431591
gh@@	O	-1	3431591
t-@@	O	-1	3431591
b@@	O	-1	3431591
ind@@	O	-1	3431591
ing	O	-1	3431591
inhibitor	O	-1	3431591
of	O	-1	3431591
th@@	O	-1	3431591
ym@@	O	-1	3431591
id@@	O	-1	3431591
yl@@	O	-1	3431591
ate	O	-1	3431591
syn@@	O	-1	3431591
th@@	O	-1	3431591
ase	O	-1	3431591
(T@@	O	-1	3431591
S)	O	-1	3431591
wh@@	O	-1	3431591
ose	O	-1	3431591
cy@@	B-Disease	D064420	3431591
tot@@	I-Disease	-1	3431591
oxic@@	I-Disease	-1	3431591
ity	I-Disease	-1	3431591
is	O	-1	3431591
mediated	O	-1	3431591
sol@@	O	-1	3431591
ely	O	-1	3431591
through	O	-1	3431591
the	O	-1	3431591
inhibition	O	-1	3431591
of	O	-1	3431591
this	O	-1	3431591
enz@@	O	-1	3431591
y@@	O	-1	3431591
me.	O	-1	3431591
Rec@@	O	-1	3431591
ent	O	-1	3431591
pre@@	O	-1	3431591
clinical	O	-1	3431591
studies	O	-1	3431591
have	O	-1	3431591
foc@@	O	-1	3431591
used	O	-1	3431591
on	O	-1	3431591
the	O	-1	3431591
intrac@@	O	-1	3431591
ell@@	O	-1	3431591
ular	O	-1	3431591
formation	O	-1	3431591
of	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
poly@@	O	-1	3431591
glutam@@	O	-1	3431591
at@@	O	-1	3431591
es.	O	-1	3431591
F@@	O	-1	3431591
ol@@	O	-1	3431591
low@@	O	-1	3431591
ing	O	-1	3431591
a	O	-1	3431591
1@@	O	-1	3431591
2-@@	O	-1	3431591
h@@	O	-1	3431591
our	O	-1	3431591
exposure	O	-1	3431591
of	O	-1	3431591
L@@	O	-1	3431591
12@@	O	-1	3431591
10	O	-1	3431591
cells	O	-1	3431591
to	O	-1	3431591
50	O	-1	3431591
micro@@	O	-1	3431591
M	O	-1	3431591
[@@	O	-1	3431591
3@@	O	-1	3431591
H@@	O	-1	3431591
]	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
,	O	-1	3431591
3@@	O	-1	3431591
0%	O	-1	3431591
of	O	-1	3431591
the	O	-1	3431591
extrac@@	O	-1	3431591
t@@	O	-1	3431591
able	O	-1	3431591
radi@@	O	-1	3431591
o@@	O	-1	3431591
activity	O	-1	3431591
could	O	-1	3431591
be	O	-1	3431591
ac@@	O	-1	3431591
coun@@	O	-1	3431591
ted	O	-1	3431591
for	O	-1	3431591
as	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
te@@	O	-1	3431591
tra@@	O	-1	3431591
-	O	-1	3431591
and	O	-1	3431591
pent@@	O	-1	3431591
ag@@	O	-1	3431591
l@@	O	-1	3431591
ut@@	O	-1	3431591
am@@	O	-1	3431591
ate,	O	-1	3431591
as	O	-1	3431591
determined	O	-1	3431591
by	O	-1	3431591
high-@@	O	-1	3431591
pressure	O	-1	3431591
li@@	O	-1	3431591
qu@@	O	-1	3431591
id	O	-1	3431591
ch@@	O	-1	3431591
rom@@	O	-1	3431591
at@@	O	-1	3431591
ograph@@	O	-1	3431591
y	O	-1	3431591
(@@	O	-1	3431591
H@@	O	-1	3431591
P@@	O	-1	3431591
L@@	O	-1	3431591
C@@	O	-1	3431591
)	O	-1	3431591
an@@	O	-1	3431591
al@@	O	-1	3431591
ys@@	O	-1	3431591
es.	O	-1	3431591
A@@	O	-1	3431591
s	O	-1	3431591
inhibitors	O	-1	3431591
of	O	-1	3431591
isol@@	O	-1	3431591
ated	O	-1	3431591
L@@	O	-1	3431591
12@@	O	-1	3431591
10	O	-1	3431591
T@@	O	-1	3431591
S@@	O	-1	3431591
,	O	-1	3431591
C@@	O	-1	3431591
B	O	-1	3431591
3@@	O	-1	3431591
7@@	O	-1	3431591
17	O	-1	3431591
di@@	O	-1	3431591
-@@	O	-1	3431591
,	O	-1	3431591
tri@@	O	-1	3431591
-@@	O	-1	3431591
,	O	-1	3431591
te@@	O	-1	3431591
tra@@	O	-1	3431591
-	O	-1	3431591
and	O	-1	3431591
pent@@	O	-1	3431591
ag@@	O	-1	3431591
l@@	O	-1	3431591
ut@@	O	-1	3431591
am@@	O	-1	3431591
ate	O	-1	3431591
are	O	-1	3431591
2@@	O	-1	3431591
6-@@	O	-1	3431591
,	O	-1	3431591
8@@	O	-1	3431591
7-@@	O	-1	3431591
,	O	-1	3431591
1@@	O	-1	3431591
19@@	O	-1	3431591
-	O	-1	3431591
and	O	-1	3431591
1@@	O	-1	3431591
1@@	O	-1	3431591
4-@@	O	-1	3431591
fol@@	O	-1	3431591
d	O	-1	3431591
more	O	-1	3431591
pot@@	O	-1	3431591
ent	O	-1	3431591
than	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
,	O	-1	3431591
respectivel@@	O	-1	3431591
y,	O	-1	3431591
and	O	-1	3431591
their	O	-1	3431591
formation	O	-1	3431591
ma@@	O	-1	3431591
y,	O	-1	3431591
the@@	O	-1	3431591
refore,	O	-1	3431591
be	O	-1	3431591
an	O	-1	3431591
important	O	-1	3431591
determin@@	O	-1	3431591
ant	O	-1	3431591
of	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
cy@@	B-Disease	D064420	3431591
tot@@	I-Disease	-1	3431591
oxic@@	I-Disease	-1	3431591
ity	I-Disease	-1	3431591
.	O	-1	3431591
In	O	-1	3431591
early	O	-1	3431591
clinical	O	-1	3431591
studies	O	-1	3431591
with	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
,	O	-1	3431591
activity	O	-1	3431591
has	O	-1	3431591
been	O	-1	3431591
seen	O	-1	3431591
in	O	-1	3431591
b@@	B-Disease	D001943	3431591
reas@@	I-Disease	-1	3431591
t	I-Disease	-1	3431591
cancer	I-Disease	-1	3431591
,	O	-1	3431591
o@@	B-Disease	D010051	3431591
vari@@	I-Disease	-1	3431591
an	I-Disease	-1	3431591
cancer	I-Disease	-1	3431591
,	O	-1	3431591
hepat@@	B-Disease	D006528	3431591
oma	I-Disease	-1	3431591
,	O	-1	3431591
and	O	-1	3431591
m@@	B-Disease	D008654	3431591
es@@	I-Disease	-1	3431591
o@@	I-Disease	-1	3431591
the@@	I-Disease	-1	3431591
li@@	I-Disease	-1	3431591
oma	I-Disease	-1	3431591
.	O	-1	3431591
T@@	B-Disease	D064420	3431591
oxic@@	I-Disease	-1	3431591
ities	I-Disease	-1	3431591
included	O	-1	3431591
hepat@@	B-Disease	D056486	3431591
otoxicity	I-Disease	-1	3431591
,	O	-1	3431591
mal@@	B-Disease	D005221	3431591
a@@	I-Disease	-1	3431591
is@@	I-Disease	-1	3431591
e	I-Disease	-1	3431591
,	O	-1	3431591
and	O	-1	3431591
dose-@@	O	-1	3431591
lim@@	O	-1	3431591
it@@	O	-1	3431591
ing	O	-1	3431591
nephro@@	B-Disease	D007674	3431591
toxicity	I-Disease	-1	3431591
.	O	-1	3431591
This	O	-1	3431591
lat@@	O	-1	3431591
ter	O	-1	3431591
effect	O	-1	3431591
is	O	-1	3431591
thou@@	O	-1	3431591
ght	O	-1	3431591
to	O	-1	3431591
be	O	-1	3431591
due	O	-1	3431591
to	O	-1	3431591
drug	O	-1	3431591
pre@@	O	-1	3431591
ci@@	O	-1	3431591
pit@@	O	-1	3431591
ation	O	-1	3431591
within	O	-1	3431591
the	O	-1	3431591
renal	O	-1	3431591
tub@@	O	-1	3431591
ul@@	O	-1	3431591
e	O	-1	3431591
as	O	-1	3431591
a	O	-1	3431591
result	O	-1	3431591
of	O	-1	3431591
the	O	-1	3431591
po@@	O	-1	3431591
or	O	-1	3431591
sol@@	O	-1	3431591
ub@@	O	-1	3431591
ility	O	-1	3431591
of	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
under	O	-1	3431591
ac@@	O	-1	3431591
i@@	O	-1	3431591
di@@	O	-1	3431591
c	O	-1	3431591
condi@@	O	-1	3431591
tions.	O	-1	3431591
In	O	-1	3431591
an	O	-1	3431591
at@@	O	-1	3431591
tem@@	O	-1	3431591
p@@	O	-1	3431591
t	O	-1	3431591
to	O	-1	3431591
over@@	O	-1	3431591
com@@	O	-1	3431591
e	O	-1	3431591
this	O	-1	3431591
pro@@	O	-1	3431591
ble@@	O	-1	3431591
m@@	O	-1	3431591
,	O	-1	3431591
a	O	-1	3431591
clinical	O	-1	3431591
trial	O	-1	3431591
of	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
administered	O	-1	3431591
with	O	-1	3431591
al@@	O	-1	3431591
k@@	O	-1	3431591
aline	O	-1	3431591
di@@	O	-1	3431591
ure@@	O	-1	3431591
sis	O	-1	3431591
is	O	-1	3431591
under	O	-1	3431591
w@@	O	-1	3431591
a@@	O	-1	3431591
y.	O	-1	3431591
P@@	O	-1	3431591
rel@@	O	-1	3431591
im@@	O	-1	3431591
inary	O	-1	3431591
results	O	-1	3431591
at	O	-1	3431591
4@@	O	-1	3431591
00	O	-1	3431591
and	O	-1	3431591
5@@	O	-1	3431591
00	O	-1	3431591
mg/m@@	O	-1	3431591
2	O	-1	3431591
suggest	O	-1	3431591
that	O	-1	3431591
a	O	-1	3431591
reduction	O	-1	3431591
in	O	-1	3431591
nephro@@	B-Disease	D007674	3431591
toxicity	I-Disease	-1	3431591
may	O	-1	3431591
have	O	-1	3431591
been	O	-1	3431591
achi@@	O	-1	3431591
ev@@	O	-1	3431591
ed	O	-1	3431591
with	O	-1	3431591
only	O	-1	3431591
1	O	-1	3431591
in@@	O	-1	3431591
st@@	O	-1	3431591
ance	O	-1	3431591
of	O	-1	3431591
renal	B-Disease	D007674	3431591
toxicity	I-Disease	-1	3431591
in	O	-1	3431591
10	O	-1	3431591
patients.	O	-1	3431591
H@@	B-Disease	D056486	3431591
ep@@	I-Disease	-1	3431591
at@@	I-Disease	-1	3431591
otoxicity	I-Disease	-1	3431591
and	O	-1	3431591
mal@@	B-Disease	D005221	3431591
a@@	I-Disease	-1	3431591
is@@	I-Disease	-1	3431591
e	I-Disease	-1	3431591
are	O	-1	3431591
ag@@	O	-1	3431591
ain	O	-1	3431591
the	O	-1	3431591
most	O	-1	3431591
frequent	O	-1	3431591
side	O	-1	3431591
effects.	O	-1	3431591
E@@	O	-1	3431591
v@@	O	-1	3431591
idence	O	-1	3431591
of	O	-1	3431591
anti@@	O	-1	3431591
tumor	O	-1	3431591
activity	O	-1	3431591
has	O	-1	3431591
been	O	-1	3431591
seen	O	-1	3431591
in	O	-1	3431591
3	O	-1	3431591
patients.	O	-1	3431591
Ph@@	O	-1	3431591
armac@@	O	-1	3431591
o@@	O	-1	3431591
kine@@	O	-1	3431591
tic	O	-1	3431591
investig@@	O	-1	3431591
ations	O	-1	3431591
have	O	-1	3431591
shown	O	-1	3431591
that	O	-1	3431591
al@@	O	-1	3431591
k@@	O	-1	3431591
aline	O	-1	3431591
di@@	O	-1	3431591
ure@@	O	-1	3431591
sis	O	-1	3431591
does	O	-1	3431591
not	O	-1	3431591
al@@	O	-1	3431591
ter	O	-1	3431591
C@@	B-Chemical	C031662	3431591
B	I-Chemical	-1	3431591
3@@	I-Chemical	-1	3431591
7@@	I-Chemical	-1	3431591
17	I-Chemical	-1	3431591
plasma	O	-1	3431591
levels	O	-1	3431591
or	O	-1	3431591
urinary	O	-1	3431591
ex@@	O	-1	3431591
cre@@	O	-1	3431591
tion	O	-1	3431591
and	O	-1	3431591
that	O	-1	3431591
s@@	O	-1	3431591
atis@@	O	-1	3431591
fact@@	O	-1	3431591
ory	O	-1	3431591
urinary	O	-1	3431591
al@@	O	-1	3431591
k@@	O	-1	3431591
al@@	O	-1	3431591
in@@	O	-1	3431591
ization	O	-1	3431591
can	O	-1	3431591
be	O	-1	3431591
re@@	O	-1	3431591
a@@	O	-1	3431591
di@@	O	-1	3431591
ly	O	-1	3431591
achi@@	O	-1	3431591
e@@	O	-1	3431591
ved.	O	-1	3431591

E@@	B-Chemical	C084820	33969
th@@	I-Chemical	-1	33969
o@@	I-Chemical	-1	33969
pro@@	I-Chemical	-1	33969
pa@@	I-Chemical	-1	33969
z@@	I-Chemical	-1	33969
ine	I-Chemical	-1	33969
and	O	-1	33969
b@@	B-Chemical	D001590	33969
enz@@	I-Chemical	-1	33969
tro@@	I-Chemical	-1	33969
pine	I-Chemical	-1	33969
in	O	-1	33969
neuro@@	O	-1	33969
le@@	O	-1	33969
p@@	O	-1	33969
tic@@	O	-1	33969
-induced	O	-1	33969
par@@	B-Disease	D010302	33969
k@@	I-Disease	-1	33969
inson@@	I-Disease	-1	33969
ism	I-Disease	-1	33969
.	O	-1	33969
In	O	-1	33969
a	O	-1	33969
1@@	O	-1	33969
2-@@	O	-1	33969
week	O	-1	33969
controlled	O	-1	33969
study	O	-1	33969
eth@@	B-Chemical	C084820	33969
o@@	I-Chemical	-1	33969
pro@@	I-Chemical	-1	33969
pa@@	I-Chemical	-1	33969
z@@	I-Chemical	-1	33969
ine	I-Chemical	-1	33969
was	O	-1	33969
compared	O	-1	33969
to	O	-1	33969
b@@	B-Chemical	D001590	33969
enz@@	I-Chemical	-1	33969
tro@@	I-Chemical	-1	33969
pine	I-Chemical	-1	33969
in	O	-1	33969
the	O	-1	33969
treatment	O	-1	33969
of	O	-1	33969
par@@	B-Disease	D010302	33969
k@@	I-Disease	-1	33969
inson@@	I-Disease	-1	33969
ism	I-Disease	-1	33969
induced	O	-1	33969
by	O	-1	33969
flu@@	B-Chemical	C017610	33969
phen@@	I-Chemical	-1	33969
az@@	I-Chemical	-1	33969
ine	I-Chemical	-1	33969
en@@	I-Chemical	-1	33969
an@@	I-Chemical	-1	33969
th@@	I-Chemical	-1	33969
ate	I-Chemical	-1	33969
in	O	-1	33969
60	O	-1	33969
sch@@	B-Disease	D012559	33969
iz@@	I-Disease	-1	33969
oph@@	I-Disease	-1	33969
ren@@	I-Disease	-1	33969
ic	I-Disease	-1	33969
out@@	O	-1	33969
patients.	O	-1	33969
E@@	B-Chemical	C084820	33969
th@@	I-Chemical	-1	33969
o@@	I-Chemical	-1	33969
pro@@	I-Chemical	-1	33969
pa@@	I-Chemical	-1	33969
z@@	I-Chemical	-1	33969
ine	I-Chemical	-1	33969
and	O	-1	33969
b@@	B-Chemical	D001590	33969
enz@@	I-Chemical	-1	33969
tro@@	I-Chemical	-1	33969
pine	I-Chemical	-1	33969
were	O	-1	33969
found	O	-1	33969
to	O	-1	33969
be	O	-1	33969
equ@@	O	-1	33969
ally	O	-1	33969
effective	O	-1	33969
in	O	-1	33969
contro@@	O	-1	33969
ll@@	O	-1	33969
ing	O	-1	33969
par@@	B-Disease	D010302	33969
k@@	I-Disease	-1	33969
inson@@	I-Disease	-1	33969
i@@	I-Disease	-1	33969
an	I-Disease	-1	33969
symptoms	I-Disease	-1	33969
and	O	-1	33969
were	O	-1	33969
as	O	-1	33969
efficac@@	O	-1	33969
i@@	O	-1	33969
ous	O	-1	33969
as	O	-1	33969
pro@@	B-Chemical	D011352	33969
cy@@	I-Chemical	-1	33969
cl@@	I-Chemical	-1	33969
idine	I-Chemical	-1	33969
,	O	-1	33969
their	O	-1	33969
previ@@	O	-1	33969
ous	O	-1	33969
anti@@	O	-1	33969
par@@	O	-1	33969
k@@	O	-1	33969
inson@@	O	-1	33969
i@@	O	-1	33969
an	O	-1	33969
drug.	O	-1	33969
However,	O	-1	33969
b@@	B-Chemical	D001590	33969
enz@@	I-Chemical	-1	33969
tro@@	I-Chemical	-1	33969
pine	I-Chemical	-1	33969
treated	O	-1	33969
patients	O	-1	33969
had	O	-1	33969
a	O	-1	33969
significant	O	-1	33969
increase	O	-1	33969
in	O	-1	33969
t@@	B-Disease	D004409	33969
ardi@@	I-Disease	-1	33969
ve	I-Disease	-1	33969
dyskine@@	I-Disease	-1	33969
sia	I-Disease	-1	33969
compared	O	-1	33969
to	O	-1	33969
their	O	-1	33969
condi@@	O	-1	33969
tion	O	-1	33969
during	O	-1	33969
pro@@	B-Chemical	D011352	33969
cy@@	I-Chemical	-1	33969
cl@@	I-Chemical	-1	33969
ind@@	I-Chemical	-1	33969
ine	I-Chemical	-1	33969
treatment,	O	-1	33969
and	O	-1	33969
significantly	O	-1	33969
more	O	-1	33969
an@@	B-Disease	D001008	33969
xi@@	I-Disease	-1	33969
ety	I-Disease	-1	33969
and	O	-1	33969
de@@	B-Disease	D003866	33969
pression	I-Disease	-1	33969
than	O	-1	33969
eth@@	B-Chemical	C084820	33969
o@@	I-Chemical	-1	33969
pro@@	I-Chemical	-1	33969
pa@@	I-Chemical	-1	33969
z@@	I-Chemical	-1	33969
ine	I-Chemical	-1	33969
treated	O	-1	33969
patients.	O	-1	33969
This	O	-1	33969
suggests	O	-1	33969
that	O	-1	33969
b@@	B-Chemical	D001590	33969
enz@@	I-Chemical	-1	33969
tro@@	I-Chemical	-1	33969
pine	I-Chemical	-1	33969
is	O	-1	33969
not	O	-1	33969
the	O	-1	33969
anti@@	O	-1	33969
cholinergic	O	-1	33969
drug	O	-1	33969
of	O	-1	33969
ch@@	O	-1	33969
o@@	O	-1	33969
ic@@	O	-1	33969
e	O	-1	33969
in	O	-1	33969
the	O	-1	33969
treatment	O	-1	33969
of	O	-1	33969
neuro@@	O	-1	33969
le@@	O	-1	33969
p@@	O	-1	33969
tic@@	O	-1	33969
-induced	O	-1	33969
par@@	B-Disease	D010302	33969
k@@	I-Disease	-1	33969
inson@@	I-Disease	-1	33969
i@@	I-Disease	-1	33969
an	I-Disease	-1	33969
symptoms	I-Disease	-1	33969
,	O	-1	33969
because	O	-1	33969
of	O	-1	33969
its	O	-1	33969
more	O	-1	33969
toxic	O	-1	33969
central	O	-1	33969
and	O	-1	33969
peripheral	O	-1	33969
atro@@	O	-1	33969
p@@	O	-1	33969
inic	O	-1	33969
effect@@	O	-1	33969
.	O	-1	33969

Eff@@	O	-1	16844102
ect	O	-1	16844102
of	O	-1	16844102
alpha-@@	B-Chemical	D024502	16844102
to@@	I-Chemical	-1	16844102
co@@	I-Chemical	-1	16844102
ph@@	I-Chemical	-1	16844102
er@@	I-Chemical	-1	16844102
ol	I-Chemical	-1	16844102
and	O	-1	16844102
def@@	B-Chemical	D003676	16844102
er@@	I-Chemical	-1	16844102
ox@@	I-Chemical	-1	16844102
amine	I-Chemical	-1	16844102
on	O	-1	16844102
meth@@	B-Chemical	D008694	16844102
amphetamine	I-Chemical	-1	16844102
-induced	O	-1	16844102
neuro@@	B-Disease	D020258	16844102
toxicity	I-Disease	-1	16844102
.	O	-1	16844102
M@@	B-Chemical	D008694	16844102
eth@@	I-Chemical	-1	16844102
amphetamine	I-Chemical	-1	16844102
(	O	-1	16844102
M@@	B-Chemical	D008694	16844102
A	I-Chemical	-1	16844102
)@@	O	-1	16844102
-induced	O	-1	16844102
dop@@	O	-1	16844102
aminergic	O	-1	16844102
neuro@@	B-Disease	D020258	16844102
toxicity	I-Disease	-1	16844102
is	O	-1	16844102
be@@	O	-1	16844102
li@@	O	-1	16844102
ev@@	O	-1	16844102
ed	O	-1	16844102
to	O	-1	16844102
be	O	-1	16844102
associated	O	-1	16844102
with	O	-1	16844102
the	O	-1	16844102
increased	O	-1	16844102
formation	O	-1	16844102
of	O	-1	16844102
free	O	-1	16844102
ra@@	O	-1	16844102
dic@@	O	-1	16844102
al@@	O	-1	16844102
s.	O	-1	16844102
This	O	-1	16844102
study	O	-1	16844102
examined	O	-1	16844102
the	O	-1	16844102
effect	O	-1	16844102
of	O	-1	16844102
alpha-@@	B-Chemical	D024502	16844102
to@@	I-Chemical	-1	16844102
co@@	I-Chemical	-1	16844102
ph@@	I-Chemical	-1	16844102
er@@	I-Chemical	-1	16844102
ol	I-Chemical	-1	16844102
(	O	-1	16844102
alpha-@@	B-Chemical	D024502	16844102
T@@	I-Chemical	-1	16844102
C	I-Chemical	-1	16844102
),	O	-1	16844102
a	O	-1	16844102
s@@	O	-1	16844102
ca@@	O	-1	16844102
ven@@	O	-1	16844102
g@@	O	-1	16844102
er	O	-1	16844102
of	O	-1	16844102
reac@@	O	-1	16844102
tive	O	-1	16844102
oxy@@	B-Chemical	D010100	16844102
gen	I-Chemical	-1	16844102
spec@@	O	-1	16844102
i@@	O	-1	16844102
es,	O	-1	16844102
and	O	-1	16844102
def@@	B-Chemical	D003676	16844102
er@@	I-Chemical	-1	16844102
ox@@	I-Chemical	-1	16844102
amine	I-Chemical	-1	16844102
(	O	-1	16844102
DF@@	B-Chemical	D003676	16844102
O	I-Chemical	-1	16844102
),	O	-1	16844102
an	O	-1	16844102
i@@	B-Chemical	D007501	16844102
ro@@	I-Chemical	-1	16844102
n	I-Chemical	-1	16844102
ch@@	O	-1	16844102
el@@	O	-1	16844102
at@@	O	-1	16844102
or@@	O	-1	16844102
,	O	-1	16844102
on	O	-1	16844102
the	O	-1	16844102
M@@	B-Chemical	D008694	16844102
A	I-Chemical	-1	16844102
-induced	O	-1	16844102
neuro@@	B-Disease	D020258	16844102
toxicity	I-Disease	-1	16844102
.	O	-1	16844102
M@@	O	-1	16844102
al@@	O	-1	16844102
e	O	-1	16844102
rats	O	-1	16844102
were	O	-1	16844102
treated	O	-1	16844102
with	O	-1	16844102
M@@	B-Chemical	D008694	16844102
A	I-Chemical	-1	16844102
(10	O	-1	16844102
mg/kg@@	O	-1	16844102
,	O	-1	16844102
every	O	-1	16844102
2	O	-1	16844102
h	O	-1	16844102
for	O	-1	16844102
four	O	-1	16844102
injec@@	O	-1	16844102
tion@@	O	-1	16844102
s@@	O	-1	16844102
).	O	-1	16844102
The	O	-1	16844102
rat	O	-1	16844102
received	O	-1	16844102
either	O	-1	16844102
alpha-@@	B-Chemical	D024502	16844102
T@@	I-Chemical	-1	16844102
C	I-Chemical	-1	16844102
(2@@	O	-1	16844102
0	O	-1	16844102
mg/kg)	O	-1	16844102
intra@@	O	-1	16844102
per@@	O	-1	16844102
it@@	O	-1	16844102
one@@	O	-1	16844102
ally	O	-1	16844102
for	O	-1	16844102
3	O	-1	16844102
days	O	-1	16844102
and	O	-1	16844102
30	O	-1	16844102
min	O	-1	16844102
prior	O	-1	16844102
to	O	-1	16844102
M@@	B-Chemical	D008694	16844102
A	I-Chemical	-1	16844102
administration	O	-1	16844102
or	O	-1	16844102
DF@@	B-Chemical	D003676	16844102
O	I-Chemical	-1	16844102
(@@	O	-1	16844102
50	O	-1	16844102
mg/kg)	O	-1	16844102
sub@@	O	-1	16844102
c@@	O	-1	16844102
ut@@	O	-1	16844102
ane@@	O	-1	16844102
ously	O	-1	16844102
30	O	-1	16844102
min	O	-1	16844102
before	O	-1	16844102
M@@	B-Chemical	D008694	16844102
A	I-Chemical	-1	16844102
administr@@	O	-1	16844102
ation.	O	-1	16844102
The	O	-1	16844102
concentrations	O	-1	16844102
of	O	-1	16844102
dopamine	B-Chemical	D004298	16844102
(	O	-1	16844102
D@@	B-Chemical	D004298	16844102
A	I-Chemical	-1	16844102
),	O	-1	16844102
seroton@@	B-Chemical	D012701	16844102
in	I-Chemical	-1	16844102
and	O	-1	16844102
their	O	-1	16844102
metabol@@	O	-1	16844102
it@@	O	-1	16844102
es	O	-1	16844102
decreased	O	-1	16844102
significantly	O	-1	16844102
after	O	-1	16844102
M@@	B-Chemical	D008694	16844102
A	I-Chemical	-1	16844102
administr@@	O	-1	16844102
ation,	O	-1	16844102
which	O	-1	16844102
was	O	-1	16844102
inhibited	O	-1	16844102
by	O	-1	16844102
the	O	-1	16844102
alpha-@@	B-Chemical	D024502	16844102
T@@	I-Chemical	-1	16844102
C	I-Chemical	-1	16844102
and	O	-1	16844102
DF@@	B-Chemical	D003676	16844102
O	I-Chemical	-1	16844102
pre@@	O	-1	16844102
treatment.	O	-1	16844102
alpha-@@	B-Chemical	D024502	16844102
T@@	I-Chemical	-1	16844102
C	I-Chemical	-1	16844102
and	O	-1	16844102
DF@@	B-Chemical	D003676	16844102
O	I-Chemical	-1	16844102
attenu@@	O	-1	16844102
ated	O	-1	16844102
the	O	-1	16844102
M@@	B-Chemical	D008694	16844102
A	I-Chemical	-1	16844102
-induced	O	-1	16844102
hyper@@	B-Disease	D005334	16844102
ther@@	I-Disease	-1	16844102
mia	I-Disease	-1	16844102
as	O	-1	16844102
well	O	-1	16844102
as	O	-1	16844102
the	O	-1	16844102
al@@	O	-1	16844102
ter@@	O	-1	16844102
ations	O	-1	16844102
in	O	-1	16844102
the	O	-1	16844102
locomotor	O	-1	16844102
activ@@	O	-1	16844102
ity.	O	-1	16844102
The	O	-1	16844102
level	O	-1	16844102
of	O	-1	16844102
li@@	O	-1	16844102
pid	O	-1	16844102
per@@	O	-1	16844102
oxid@@	O	-1	16844102
ation	O	-1	16844102
was	O	-1	16844102
higher	O	-1	16844102
and	O	-1	16844102
the	O	-1	16844102
reduced	O	-1	16844102
glut@@	B-Chemical	D005978	16844102
athi@@	I-Chemical	-1	16844102
one	I-Chemical	-1	16844102
concentration	O	-1	16844102
was	O	-1	16844102
lower	O	-1	16844102
in	O	-1	16844102
the	O	-1	16844102
M@@	B-Chemical	D008694	16844102
A	I-Chemical	-1	16844102
-treated	O	-1	16844102
rats.	O	-1	16844102
These	O	-1	16844102
changes	O	-1	16844102
were	O	-1	16844102
significantly	O	-1	16844102
attenu@@	O	-1	16844102
ated	O	-1	16844102
by	O	-1	16844102
alpha-@@	B-Chemical	D024502	16844102
T@@	I-Chemical	-1	16844102
C	I-Chemical	-1	16844102
and	O	-1	16844102
DF@@	B-Chemical	D003676	16844102
O	I-Chemical	-1	16844102
.	O	-1	16844102
This	O	-1	16844102
suggests	O	-1	16844102
that	O	-1	16844102
alpha-@@	B-Chemical	D024502	16844102
T@@	I-Chemical	-1	16844102
C	I-Chemical	-1	16844102
and	O	-1	16844102
DF@@	B-Chemical	D003676	16844102
O	I-Chemical	-1	16844102
ame@@	O	-1	16844102
li@@	O	-1	16844102
or@@	O	-1	16844102
ate	O	-1	16844102
the	O	-1	16844102
M@@	B-Chemical	D008694	16844102
A	I-Chemical	-1	16844102
-induced	O	-1	16844102
neuron@@	B-Disease	D009422	16844102
al	I-Disease	-1	16844102
damage	I-Disease	-1	16844102
by	O	-1	16844102
decreas@@	O	-1	16844102
ing	O	-1	16844102
the	O	-1	16844102
level	O	-1	16844102
of	O	-1	16844102
oxid@@	O	-1	16844102
ative	O	-1	16844102
stres@@	O	-1	16844102
s.	O	-1	16844102

U@@	O	-1	14633084
se	O	-1	14633084
of	O	-1	14633084
de@@	B-Chemical	D003907	14633084
xameth@@	I-Chemical	-1	14633084
as@@	I-Chemical	-1	14633084
one	I-Chemical	-1	14633084
with	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
for	O	-1	14633084
the	O	-1	14633084
pre@@	O	-1	14633084
ven@@	O	-1	14633084
tion	O	-1	14633084
of	O	-1	14633084
if@@	B-Chemical	D007069	14633084
os@@	I-Chemical	-1	14633084
f@@	I-Chemical	-1	14633084
amide	I-Chemical	-1	14633084
-induced	O	-1	14633084
hemorrh@@	B-Disease	D006470	14633084
ag@@	I-Disease	-1	14633084
ic	I-Disease	-1	14633084
cys@@	I-Disease	-1	14633084
ti@@	I-Disease	-1	14633084
tis	I-Disease	-1	14633084
hemorrh@@	B-Disease	D003556	14633084
ag@@	I-Disease	-1	14633084
ic	I-Disease	-1	14633084
cys@@	I-Disease	-1	14633084
ti@@	I-Disease	-1	14633084
tis	I-Disease	-1	14633084
.	O	-1	14633084
A@@	O	-1	14633084
I@@	O	-1	14633084
M@@	O	-1	14633084
:	O	-1	14633084
H@@	B-Disease	D006470	14633084
em@@	I-Disease	-1	14633084
or@@	I-Disease	-1	14633084
rh@@	I-Disease	-1	14633084
ag@@	I-Disease	-1	14633084
ic	I-Disease	-1	14633084
cys@@	I-Disease	-1	14633084
ti@@	I-Disease	-1	14633084
tis	I-Disease	-1	14633084
H@@	B-Disease	D003556	14633084
em@@	I-Disease	-1	14633084
or@@	I-Disease	-1	14633084
rh@@	I-Disease	-1	14633084
ag@@	I-Disease	-1	14633084
ic	I-Disease	-1	14633084
cys@@	I-Disease	-1	14633084
ti@@	I-Disease	-1	14633084
tis	I-Disease	-1	14633084
(	O	-1	14633084
H@@	B-Disease	D006470	14633084
C	I-Disease	-1	14633084
H@@	B-Disease	D003556	14633084
C	I-Disease	-1	14633084
)	O	-1	14633084
is	O	-1	14633084
a	O	-1	14633084
lim@@	O	-1	14633084
it@@	O	-1	14633084
ing	O	-1	14633084
side@@	O	-1	14633084
-@@	O	-1	14633084
effect	O	-1	14633084
of	O	-1	14633084
chemotherapy	O	-1	14633084
with	O	-1	14633084
if@@	B-Chemical	D007069	14633084
os@@	I-Chemical	-1	14633084
f@@	I-Chemical	-1	14633084
amide	I-Chemical	-1	14633084
(	O	-1	14633084
I@@	B-Chemical	D007069	14633084
F@@	I-Chemical	-1	14633084
S	I-Chemical	-1	14633084
).	O	-1	14633084
In	O	-1	14633084
the	O	-1	14633084
study	O	-1	14633084
presented	O	-1	14633084
he@@	O	-1	14633084
re,	O	-1	14633084
we	O	-1	14633084
investigated	O	-1	14633084
the	O	-1	14633084
use	O	-1	14633084
of	O	-1	14633084
de@@	B-Chemical	D003907	14633084
xameth@@	I-Chemical	-1	14633084
as@@	I-Chemical	-1	14633084
one	I-Chemical	-1	14633084
in	O	-1	14633084
combination	O	-1	14633084
with	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
for	O	-1	14633084
the	O	-1	14633084
pre@@	O	-1	14633084
ven@@	O	-1	14633084
tion	O	-1	14633084
of	O	-1	14633084
I@@	B-Chemical	D007069	14633084
F@@	I-Chemical	-1	14633084
S	I-Chemical	-1	14633084
-induced	O	-1	14633084
H@@	B-Disease	D006470	14633084
C	I-Disease	-1	14633084
H@@	B-Disease	D003556	14633084
C	I-Disease	-1	14633084
.	O	-1	14633084
METHODS:	O	-1	14633084
M@@	O	-1	14633084
al@@	O	-1	14633084
e	O	-1	14633084
Wistar	O	-1	14633084
rats	O	-1	14633084
(1@@	O	-1	14633084
50@@	O	-1	14633084
-@@	O	-1	14633084
2@@	O	-1	14633084
00	O	-1	14633084
g@@	O	-1	14633084
;	O	-1	14633084
6	O	-1	14633084
rats	O	-1	14633084
per	O	-1	14633084
group@@	O	-1	14633084
)	O	-1	14633084
were	O	-1	14633084
treated	O	-1	14633084
with	O	-1	14633084
saline	O	-1	14633084
or	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
5	O	-1	14633084
min	O	-1	14633084
(@@	O	-1	14633084
i.p.@@	O	-1	14633084
)	O	-1	14633084
before	O	-1	14633084
and	O	-1	14633084
2	O	-1	14633084
and	O	-1	14633084
6	O	-1	14633084
h	O	-1	14633084
after	O	-1	14633084
(@@	O	-1	14633084
v@@	O	-1	14633084
.@@	O	-1	14633084
o@@	O	-1	14633084
.)	O	-1	14633084
administration	O	-1	14633084
of	O	-1	14633084
I@@	B-Chemical	D007069	14633084
F@@	I-Chemical	-1	14633084
S	I-Chemical	-1	14633084
.	O	-1	14633084
O@@	O	-1	14633084
ne@@	O	-1	14633084
,	O	-1	14633084
two	O	-1	14633084
or	O	-1	14633084
three	O	-1	14633084
doses	O	-1	14633084
of	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
were	O	-1	14633084
re@@	O	-1	14633084
pl@@	O	-1	14633084
ac@@	O	-1	14633084
ed	O	-1	14633084
with	O	-1	14633084
de@@	B-Chemical	D003907	14633084
xameth@@	I-Chemical	-1	14633084
as@@	I-Chemical	-1	14633084
one	I-Chemical	-1	14633084
alone	O	-1	14633084
or	O	-1	14633084
with	O	-1	14633084
de@@	B-Chemical	D003907	14633084
xameth@@	I-Chemical	-1	14633084
as@@	I-Chemical	-1	14633084
one	I-Chemical	-1	14633084
plus	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
.	O	-1	14633084
C@@	B-Disease	D003556	14633084
ys@@	I-Disease	-1	14633084
ti@@	I-Disease	-1	14633084
tis	I-Disease	-1	14633084
was	O	-1	14633084
evaluated	O	-1	14633084
24	O	-1	14633084
h	O	-1	14633084
after	O	-1	14633084
its	O	-1	14633084
induction	O	-1	14633084
by	O	-1	14633084
the	O	-1	14633084
changes	O	-1	14633084
in	O	-1	14633084
bladder	O	-1	14633084
we@@	O	-1	14633084
t	O	-1	14633084
weight	O	-1	14633084
and	O	-1	14633084
by	O	-1	14633084
mac@@	O	-1	14633084
ro@@	O	-1	14633084
sco@@	O	-1	14633084
p@@	O	-1	14633084
ic	O	-1	14633084
and	O	-1	14633084
micro@@	O	-1	14633084
sco@@	O	-1	14633084
p@@	O	-1	14633084
ic	O	-1	14633084
analy@@	O	-1	14633084
sis.	O	-1	14633084
RESULTS:	O	-1	14633084
The	O	-1	14633084
re@@	O	-1	14633084
pl@@	O	-1	14633084
ac@@	O	-1	14633084
ement	O	-1	14633084
of	O	-1	14633084
the	O	-1	14633084
las@@	O	-1	14633084
t	O	-1	14633084
dose	O	-1	14633084
or	O	-1	14633084
the	O	-1	14633084
las@@	O	-1	14633084
t	O	-1	14633084
two	O	-1	14633084
doses	O	-1	14633084
of	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
with	O	-1	14633084
de@@	B-Chemical	D003907	14633084
xameth@@	I-Chemical	-1	14633084
as@@	I-Chemical	-1	14633084
one	I-Chemical	-1	14633084
reduced	O	-1	14633084
the	O	-1	14633084
increase	O	-1	14633084
in	O	-1	14633084
bladder	O	-1	14633084
we@@	O	-1	14633084
t	O	-1	14633084
weight	O	-1	14633084
induced	O	-1	14633084
by	O	-1	14633084
I@@	B-Chemical	D007069	14633084
F@@	I-Chemical	-1	14633084
S	I-Chemical	-1	14633084
by	O	-1	14633084
8@@	O	-1	14633084
4.@@	O	-1	14633084
7@@	O	-1	14633084
9@@	O	-1	14633084
%	O	-1	14633084
and	O	-1	14633084
8@@	O	-1	14633084
9.@@	O	-1	14633084
13@@	O	-1	14633084
%,	O	-1	14633084
respectively.	O	-1	14633084
In	O	-1	14633084
addi@@	O	-1	14633084
tion,	O	-1	14633084
it	O	-1	14633084
al@@	O	-1	14633084
most	O	-1	14633084
abol@@	O	-1	14633084
ished	O	-1	14633084
the	O	-1	14633084
mac@@	O	-1	14633084
ro@@	O	-1	14633084
sco@@	O	-1	14633084
p@@	O	-1	14633084
ic	O	-1	14633084
and	O	-1	14633084
micro@@	O	-1	14633084
sco@@	O	-1	14633084
p@@	O	-1	14633084
ic	O	-1	14633084
al@@	O	-1	14633084
ter@@	O	-1	14633084
ations	O	-1	14633084
induced	O	-1	14633084
by	O	-1	14633084
I@@	B-Chemical	D007069	14633084
F@@	I-Chemical	-1	14633084
S	I-Chemical	-1	14633084
.	O	-1	14633084
M@@	O	-1	14633084
ore@@	O	-1	14633084
o@@	O	-1	14633084
ver,	O	-1	14633084
the	O	-1	14633084
addition	O	-1	14633084
of	O	-1	14633084
de@@	B-Chemical	D003907	14633084
xameth@@	I-Chemical	-1	14633084
as@@	I-Chemical	-1	14633084
one	I-Chemical	-1	14633084
to	O	-1	14633084
the	O	-1	14633084
las@@	O	-1	14633084
t	O	-1	14633084
two	O	-1	14633084
doses	O	-1	14633084
of	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
was	O	-1	14633084
more	O	-1	14633084
eff@@	O	-1	14633084
ici@@	O	-1	14633084
ent	O	-1	14633084
than	O	-1	14633084
three	O	-1	14633084
doses	O	-1	14633084
of	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
alone	O	-1	14633084
when	O	-1	14633084
evaluated	O	-1	14633084
micro@@	O	-1	14633084
sco@@	O	-1	14633084
p@@	O	-1	14633084
ic@@	O	-1	14633084
all@@	O	-1	14633084
y.	O	-1	14633084
CONCLUSION:	O	-1	14633084
D@@	B-Chemical	D003907	14633084
ex@@	I-Chemical	-1	14633084
ameth@@	I-Chemical	-1	14633084
as@@	I-Chemical	-1	14633084
one	I-Chemical	-1	14633084
in	O	-1	14633084
combination	O	-1	14633084
with	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
was	O	-1	14633084
eff@@	O	-1	14633084
ici@@	O	-1	14633084
ent	O	-1	14633084
in	O	-1	14633084
block@@	O	-1	14633084
ing	O	-1	14633084
I@@	B-Chemical	D007069	14633084
F@@	I-Chemical	-1	14633084
S	I-Chemical	-1	14633084
-induced	O	-1	14633084
H@@	B-Disease	D006470	14633084
C	I-Disease	-1	14633084
H@@	B-Disease	D003556	14633084
C	I-Disease	-1	14633084
.	O	-1	14633084
However,	O	-1	14633084
the	O	-1	14633084
re@@	O	-1	14633084
pl@@	O	-1	14633084
ac@@	O	-1	14633084
ement	O	-1	14633084
of	O	-1	14633084
las@@	O	-1	14633084
t	O	-1	14633084
two	O	-1	14633084
doses	O	-1	14633084
of	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
with	O	-1	14633084
saline	O	-1	14633084
or	O	-1	14633084
all	O	-1	14633084
of	O	-1	14633084
the	O	-1	14633084
m@@	B-Chemical	D015080	14633084
es@@	I-Chemical	-1	14633084
n@@	I-Chemical	-1	14633084
a	I-Chemical	-1	14633084
doses	O	-1	14633084
with	O	-1	14633084
de@@	B-Chemical	D003907	14633084
xameth@@	I-Chemical	-1	14633084
as@@	I-Chemical	-1	14633084
one	I-Chemical	-1	14633084
did	O	-1	14633084
not	O	-1	14633084
prev@@	O	-1	14633084
ent	O	-1	14633084
H@@	B-Disease	D006470	14633084
C	I-Disease	-1	14633084
H@@	B-Disease	D003556	14633084
C	I-Disease	-1	14633084
.	O	-1	14633084

B@@	O	-1	11999899
e@@	O	-1	11999899
havi@@	O	-1	11999899
oral	O	-1	11999899
effects	O	-1	11999899
of	O	-1	11999899
M@@	B-Chemical	D016291	11999899
K@@	I-Chemical	-1	11999899
-@@	I-Chemical	-1	11999899
80@@	I-Chemical	-1	11999899
1	I-Chemical	-1	11999899
on	O	-1	11999899
res@@	B-Chemical	D012110	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
-treated	O	-1	11999899
mice.	O	-1	11999899
The	O	-1	11999899
effects	O	-1	11999899
of	O	-1	11999899
di@@	B-Chemical	D016291	11999899
z@@	I-Chemical	-1	11999899
oc@@	I-Chemical	-1	11999899
il@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
(	O	-1	11999899
M@@	B-Chemical	D016291	11999899
K@@	I-Chemical	-1	11999899
-@@	I-Chemical	-1	11999899
80@@	I-Chemical	-1	11999899
1	I-Chemical	-1	11999899
),	O	-1	11999899
a	O	-1	11999899
non@@	O	-1	11999899
comp@@	O	-1	11999899
e@@	O	-1	11999899
ti@@	O	-1	11999899
tive	O	-1	11999899
N@@	B-Chemical	D016202	11999899
-@@	I-Chemical	-1	11999899
methyl@@	I-Chemical	-1	11999899
-@@	I-Chemical	-1	11999899
D-@@	I-Chemical	-1	11999899
as@@	I-Chemical	-1	11999899
part@@	I-Chemical	-1	11999899
ate	I-Chemical	-1	11999899
(	O	-1	11999899
N@@	B-Chemical	D016202	11999899
MD@@	I-Chemical	-1	11999899
A	I-Chemical	-1	11999899
)	O	-1	11999899
receptor	O	-1	11999899
antagonist@@	O	-1	11999899
,	O	-1	11999899
were	O	-1	11999899
studied	O	-1	11999899
on	O	-1	11999899
dopamine	B-Chemical	D004298	11999899
-@@	O	-1	11999899
related	O	-1	11999899
behavi@@	O	-1	11999899
ors	O	-1	11999899
induced	O	-1	11999899
by	O	-1	11999899
res@@	B-Chemical	D012110	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
treatment@@	O	-1	11999899
s.	O	-1	11999899
This	O	-1	11999899
study	O	-1	11999899
foc@@	O	-1	11999899
u@@	O	-1	11999899
ses	O	-1	11999899
on	O	-1	11999899
behavioral	O	-1	11999899
syndrom@@	O	-1	11999899
es	O	-1	11999899
that	O	-1	11999899
may	O	-1	11999899
used	O	-1	11999899
as	O	-1	11999899
models	O	-1	11999899
for	O	-1	11999899
Parkinson's	B-Disease	D010300	11999899
disease	I-Disease	-1	11999899
,	O	-1	11999899
or	O	-1	11999899
t@@	B-Disease	D004409	11999899
ardi@@	I-Disease	-1	11999899
ve	I-Disease	-1	11999899
dyskine@@	I-Disease	-1	11999899
sia	I-Disease	-1	11999899
,	O	-1	11999899
and	O	-1	11999899
its	O	-1	11999899
response	O	-1	11999899
after	O	-1	11999899
glutam@@	O	-1	11999899
at@@	O	-1	11999899
ergic	O	-1	11999899
block@@	O	-1	11999899
age.	O	-1	11999899
R@@	B-Chemical	D012110	11999899
es@@	I-Chemical	-1	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
(@@	O	-1	11999899
1	O	-1	11999899
mg/kg@@	O	-1	11999899
),	O	-1	11999899
administered	O	-1	11999899
on@@	O	-1	11999899
ce	O	-1	11999899
every	O	-1	11999899
other	O	-1	11999899
day	O	-1	11999899
for	O	-1	11999899
4	O	-1	11999899
day@@	O	-1	11999899
s,	O	-1	11999899
produced	O	-1	11999899
increases	O	-1	11999899
in	O	-1	11999899
o@@	B-Disease	D009069	11999899
ro@@	I-Disease	-1	11999899
fac@@	I-Disease	-1	11999899
ial	I-Disease	-1	11999899
dyskine@@	I-Disease	-1	11999899
sia	I-Disease	-1	11999899
,	O	-1	11999899
t@@	O	-1	11999899
on@@	O	-1	11999899
gu@@	O	-1	11999899
e	O	-1	11999899
prot@@	O	-1	11999899
ru@@	O	-1	11999899
sion	O	-1	11999899
and	O	-1	11999899
vac@@	O	-1	11999899
u@@	O	-1	11999899
ous	O	-1	11999899
ch@@	O	-1	11999899
e@@	O	-1	11999899
w@@	O	-1	11999899
ing	O	-1	11999899
in	O	-1	11999899
mic@@	O	-1	11999899
e,	O	-1	11999899
which	O	-1	11999899
are	O	-1	11999899
signs	O	-1	11999899
indic@@	O	-1	11999899
ative	O	-1	11999899
of	O	-1	11999899
t@@	B-Disease	D004409	11999899
ardi@@	I-Disease	-1	11999899
ve	I-Disease	-1	11999899
dyskine@@	I-Disease	-1	11999899
sia	I-Disease	-1	11999899
.	O	-1	11999899
R@@	B-Chemical	D012110	11999899
es@@	I-Chemical	-1	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
also	O	-1	11999899
produced	O	-1	11999899
trem@@	B-Disease	D014202	11999899
or	I-Disease	-1	11999899
and	O	-1	11999899
cat@@	B-Disease	D002375	11999899
al@@	I-Disease	-1	11999899
ep@@	I-Disease	-1	11999899
sy	I-Disease	-1	11999899
,	O	-1	11999899
which	O	-1	11999899
are	O	-1	11999899
signs	O	-1	11999899
sugg@@	O	-1	11999899
es@@	O	-1	11999899
tive	O	-1	11999899
of	O	-1	11999899
Parkinson's	B-Disease	D010300	11999899
disease	I-Disease	-1	11999899
.	O	-1	11999899
M@@	B-Chemical	D016291	11999899
K@@	I-Chemical	-1	11999899
-@@	I-Chemical	-1	11999899
80@@	I-Chemical	-1	11999899
1	I-Chemical	-1	11999899
(0.@@	O	-1	11999899
1	O	-1	11999899
mg/kg@@	O	-1	11999899
),	O	-1	11999899
administered	O	-1	11999899
30	O	-1	11999899
min	O	-1	11999899
before	O	-1	11999899
the	O	-1	11999899
observ@@	O	-1	11999899
ation	O	-1	11999899
test@@	O	-1	11999899
,	O	-1	11999899
prevent@@	O	-1	11999899
ed	O	-1	11999899
the	O	-1	11999899
vac@@	O	-1	11999899
u@@	O	-1	11999899
ous	O	-1	11999899
ch@@	O	-1	11999899
e@@	O	-1	11999899
w@@	O	-1	11999899
ing	O	-1	11999899
mo@@	O	-1	11999899
ve@@	O	-1	11999899
ment@@	O	-1	11999899
s,	O	-1	11999899
t@@	O	-1	11999899
on@@	O	-1	11999899
gu@@	O	-1	11999899
e	O	-1	11999899
prot@@	O	-1	11999899
ru@@	O	-1	11999899
sions	O	-1	11999899
and	O	-1	11999899
cat@@	B-Disease	D002375	11999899
al@@	I-Disease	-1	11999899
ep@@	I-Disease	-1	11999899
sy	I-Disease	-1	11999899
induced	O	-1	11999899
by	O	-1	11999899
res@@	B-Chemical	D012110	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
.	O	-1	11999899
However,	O	-1	11999899
M@@	B-Chemical	D016291	11999899
K@@	I-Chemical	-1	11999899
-@@	I-Chemical	-1	11999899
80@@	I-Chemical	-1	11999899
1	I-Chemical	-1	11999899
injection	O	-1	11999899
produced	O	-1	11999899
a	O	-1	11999899
significant	O	-1	11999899
increase	O	-1	11999899
of	O	-1	11999899
trem@@	B-Disease	D014202	11999899
or	I-Disease	-1	11999899
in	O	-1	11999899
res@@	B-Chemical	D012110	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
-treated	O	-1	11999899
mice.	O	-1	11999899
R@@	B-Chemical	D012110	11999899
es@@	I-Chemical	-1	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
(@@	O	-1	11999899
1	O	-1	11999899
mg/kg@@	O	-1	11999899
),	O	-1	11999899
administered	O	-1	11999899
9@@	O	-1	11999899
0	O	-1	11999899
min	O	-1	11999899
before	O	-1	11999899
the	O	-1	11999899
test	O	-1	11999899
and	O	-1	11999899
followed	O	-1	11999899
by	O	-1	11999899
apo@@	B-Chemical	D001058	11999899
mo@@	I-Chemical	-1	11999899
ph@@	I-Chemical	-1	11999899
ine	I-Chemical	-1	11999899
injection	O	-1	11999899
(0.@@	O	-1	11999899
1	O	-1	11999899
mg/kg)	O	-1	11999899
5	O	-1	11999899
min	O	-1	11999899
before	O	-1	11999899
the	O	-1	11999899
test@@	O	-1	11999899
,	O	-1	11999899
did	O	-1	11999899
not	O	-1	11999899
produce	O	-1	11999899
oral	B-Disease	D009069	11999899
dyskine@@	I-Disease	-1	11999899
sia	I-Disease	-1	11999899
in	O	-1	11999899
mice.	O	-1	11999899
O@@	O	-1	11999899
n	O	-1	11999899
the	O	-1	11999899
other	O	-1	11999899
h@@	O	-1	11999899
and@@	O	-1	11999899
,	O	-1	11999899
res@@	B-Chemical	D012110	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
induced	O	-1	11999899
increases	O	-1	11999899
in	O	-1	11999899
trem@@	B-Disease	D014202	11999899
or	I-Disease	-1	11999899
and	O	-1	11999899
cat@@	B-Disease	D002375	11999899
al@@	I-Disease	-1	11999899
ep@@	I-Disease	-1	11999899
sy	I-Disease	-1	11999899
compared	O	-1	11999899
to	O	-1	11999899
control	O	-1	11999899
mice.	O	-1	11999899
M@@	B-Chemical	D016291	11999899
K@@	I-Chemical	-1	11999899
-@@	I-Chemical	-1	11999899
80@@	I-Chemical	-1	11999899
1	I-Chemical	-1	11999899
(0.@@	O	-1	11999899
1	O	-1	11999899
mg/kg)	O	-1	11999899
administration	O	-1	11999899
attenu@@	O	-1	11999899
ated	O	-1	11999899
the	O	-1	11999899
cat@@	B-Disease	D002375	11999899
al@@	I-Disease	-1	11999899
ep@@	I-Disease	-1	11999899
sy	I-Disease	-1	11999899
and	O	-1	11999899
trem@@	B-Disease	D014202	11999899
or	I-Disease	-1	11999899
induced	O	-1	11999899
by	O	-1	11999899
res@@	B-Chemical	D012110	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
.	O	-1	11999899
Pre@@	O	-1	11999899
treatment	O	-1	11999899
with	O	-1	11999899
res@@	B-Chemical	D012110	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
(@@	O	-1	11999899
1	O	-1	11999899
mg/kg)	O	-1	11999899
24	O	-1	11999899
h	O	-1	11999899
before	O	-1	11999899
the	O	-1	11999899
observ@@	O	-1	11999899
ation	O	-1	11999899
test	O	-1	11999899
produced	O	-1	11999899
increases	O	-1	11999899
in	O	-1	11999899
vac@@	O	-1	11999899
u@@	O	-1	11999899
ous	O	-1	11999899
ch@@	O	-1	11999899
e@@	O	-1	11999899
w@@	O	-1	11999899
ing	O	-1	11999899
mo@@	O	-1	11999899
ve@@	O	-1	11999899
ments	O	-1	11999899
and	O	-1	11999899
t@@	O	-1	11999899
on@@	O	-1	11999899
gu@@	O	-1	11999899
e	O	-1	11999899
prot@@	O	-1	11999899
ru@@	O	-1	11999899
sion,	O	-1	11999899
as	O	-1	11999899
well	O	-1	11999899
as	O	-1	11999899
increases	O	-1	11999899
in	O	-1	11999899
trem@@	B-Disease	D014202	11999899
or	I-Disease	-1	11999899
and	O	-1	11999899
cat@@	B-Disease	D002375	11999899
al@@	I-Disease	-1	11999899
ep@@	I-Disease	-1	11999899
sy	I-Disease	-1	11999899
,	O	-1	11999899
whereas	O	-1	11999899
M@@	B-Chemical	D016291	11999899
K@@	I-Chemical	-1	11999899
-@@	I-Chemical	-1	11999899
80@@	I-Chemical	-1	11999899
1	I-Chemical	-1	11999899
(0.@@	O	-1	11999899
1	O	-1	11999899
mg/kg)	O	-1	11999899
injection	O	-1	11999899
9@@	O	-1	11999899
0	O	-1	11999899
min	O	-1	11999899
before	O	-1	11999899
the	O	-1	11999899
test	O	-1	11999899
reversed	O	-1	11999899
the	O	-1	11999899
effects	O	-1	11999899
of	O	-1	11999899
res@@	B-Chemical	D012110	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
.	O	-1	11999899
These	O	-1	11999899
results	O	-1	11999899
show	O	-1	11999899
that	O	-1	11999899
res@@	B-Chemical	D012110	11999899
er@@	I-Chemical	-1	11999899
pine	I-Chemical	-1	11999899
produc@@	O	-1	11999899
es	O	-1	11999899
different	O	-1	11999899
and	O	-1	11999899
ab@@	B-Disease	D004409	11999899
normal	I-Disease	-1	11999899
mo@@	I-Disease	-1	11999899
ve@@	I-Disease	-1	11999899
ments	I-Disease	-1	11999899
,	O	-1	11999899
which	O	-1	11999899
are	O	-1	11999899
related	O	-1	11999899
to	O	-1	11999899
dose	O	-1	11999899
and	O	-1	11999899
sch@@	O	-1	11999899
ed@@	O	-1	11999899
ul@@	O	-1	11999899
e	O	-1	11999899
em@@	O	-1	11999899
p@@	O	-1	11999899
lo@@	O	-1	11999899
y@@	O	-1	11999899
ed	O	-1	11999899
and	O	-1	11999899
can	O	-1	11999899
be	O	-1	11999899
considered	O	-1	11999899
as	O	-1	11999899
par@@	B-Disease	D010300	11999899
k@@	I-Disease	-1	11999899
inson@@	I-Disease	-1	11999899
i@@	I-Disease	-1	11999899
an	I-Disease	-1	11999899
-@@	O	-1	11999899
like	O	-1	11999899
and	O	-1	11999899
t@@	B-Disease	D004409	11999899
ardi@@	I-Disease	-1	11999899
ve	I-Disease	-1	11999899
d@@	I-Disease	-1	11999899
sy@@	I-Disease	-1	11999899
kine@@	I-Disease	-1	11999899
sia	I-Disease	-1	11999899
sign@@	O	-1	11999899
s.	O	-1	11999899
The	O	-1	11999899
glutam@@	O	-1	11999899
at@@	O	-1	11999899
ergic	O	-1	11999899
block@@	O	-1	11999899
age	O	-1	11999899
produced	O	-1	11999899
by	O	-1	11999899
N@@	B-Chemical	D016202	11999899
MD@@	I-Chemical	-1	11999899
A	I-Chemical	-1	11999899
can	O	-1	11999899
rest@@	O	-1	11999899
or@@	O	-1	11999899
e	O	-1	11999899
these	O	-1	11999899
sign@@	O	-1	11999899
s,	O	-1	11999899
such	O	-1	11999899
as	O	-1	11999899
vac@@	O	-1	11999899
u@@	O	-1	11999899
ous	O	-1	11999899
ch@@	O	-1	11999899
e@@	O	-1	11999899
w@@	O	-1	11999899
ing	O	-1	11999899
mo@@	O	-1	11999899
ve@@	O	-1	11999899
ment@@	O	-1	11999899
s,	O	-1	11999899
t@@	O	-1	11999899
on@@	O	-1	11999899
gu@@	O	-1	11999899
e	O	-1	11999899
prot@@	O	-1	11999899
ru@@	O	-1	11999899
sion@@	O	-1	11999899
s,	O	-1	11999899
cat@@	B-Disease	D002375	11999899
al@@	I-Disease	-1	11999899
ep@@	I-Disease	-1	11999899
sy	I-Disease	-1	11999899
and	O	-1	11999899
trem@@	B-Disease	D014202	11999899
or	I-Disease	-1	11999899
ac@@	O	-1	11999899
cor@@	O	-1	11999899
ding	O	-1	11999899
to	O	-1	11999899
the	O	-1	11999899
em@@	O	-1	11999899
p@@	O	-1	11999899
lo@@	O	-1	11999899
y@@	O	-1	11999899
ed	O	-1	11999899
model@@	O	-1	11999899
.	O	-1	11999899

Eff@@	O	-1	9431903
ect	O	-1	9431903
of	O	-1	9431903
glyc@@	B-Chemical	D005996	9431903
ery@@	I-Chemical	-1	9431903
l	I-Chemical	-1	9431903
tr@@	I-Chemical	-1	9431903
in@@	I-Chemical	-1	9431903
it@@	I-Chemical	-1	9431903
rate	I-Chemical	-1	9431903
on	O	-1	9431903
the	O	-1	9431903
s@@	B-Disease	D046628	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
sp@@	I-Disease	-1	9431903
as@@	I-Disease	-1	9431903
m	I-Disease	-1	9431903
s@@	B-Disease	D013035	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
sp@@	I-Disease	-1	9431903
as@@	I-Disease	-1	9431903
m	I-Disease	-1	9431903
evoked	O	-1	9431903
by	O	-1	9431903
pro@@	B-Chemical	D009388	9431903
s@@	I-Chemical	-1	9431903
tig@@	I-Chemical	-1	9431903
mine	I-Chemical	-1	9431903
-	O	-1	9431903
morphine	B-Chemical	D009020	9431903
administr@@	O	-1	9431903
ation.	O	-1	9431903
OBJECTIVE:	O	-1	9431903
In	O	-1	9431903
this	O	-1	9431903
study	O	-1	9431903
the	O	-1	9431903
effect	O	-1	9431903
of	O	-1	9431903
glyc@@	B-Chemical	D005996	9431903
ery@@	I-Chemical	-1	9431903
l	I-Chemical	-1	9431903
tr@@	I-Chemical	-1	9431903
in@@	I-Chemical	-1	9431903
it@@	I-Chemical	-1	9431903
rate	I-Chemical	-1	9431903
on	O	-1	9431903
the	O	-1	9431903
pro@@	B-Chemical	D009388	9431903
s@@	I-Chemical	-1	9431903
tig@@	I-Chemical	-1	9431903
mine	I-Chemical	-1	9431903
-	O	-1	9431903
morphine	B-Chemical	D009020	9431903
-induced	O	-1	9431903
s@@	B-Disease	D046628	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
sp@@	I-Disease	-1	9431903
as@@	I-Disease	-1	9431903
m	I-Disease	-1	9431903
s@@	B-Disease	D013035	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
sp@@	I-Disease	-1	9431903
as@@	I-Disease	-1	9431903
m	I-Disease	-1	9431903
was	O	-1	9431903
evaluated	O	-1	9431903
in	O	-1	9431903
n@@	O	-1	9431903
ine	O	-1	9431903
female	O	-1	9431903
patients	O	-1	9431903
with	O	-1	9431903
s@@	B-Disease	D046628	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
dyskine@@	I-Disease	-1	9431903
sia	I-Disease	-1	9431903
.	O	-1	9431903
METHOD@@	O	-1	9431903
:	O	-1	9431903
S@@	B-Disease	D046628	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
sp@@	I-Disease	-1	9431903
as@@	I-Disease	-1	9431903
m	I-Disease	-1	9431903
S@@	B-Disease	D013035	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
sp@@	I-Disease	-1	9431903
as@@	I-Disease	-1	9431903
m	I-Disease	-1	9431903
was	O	-1	9431903
induced	O	-1	9431903
by	O	-1	9431903
pro@@	B-Chemical	D009388	9431903
s@@	I-Chemical	-1	9431903
tig@@	I-Chemical	-1	9431903
mine	I-Chemical	-1	9431903
-	O	-1	9431903
morphine	B-Chemical	D009020	9431903
administration	O	-1	9431903
(0.@@	O	-1	9431903
5	O	-1	9431903
mg	O	-1	9431903
pro@@	B-Chemical	D009388	9431903
s@@	I-Chemical	-1	9431903
tig@@	I-Chemical	-1	9431903
mine	I-Chemical	-1	9431903
int@@	O	-1	9431903
ram@@	O	-1	9431903
us@@	O	-1	9431903
cul@@	O	-1	9431903
arly	O	-1	9431903
and	O	-1	9431903
10	O	-1	9431903
mg	O	-1	9431903
morphine	B-Chemical	D009020	9431903
sub@@	O	-1	9431903
c@@	O	-1	9431903
ut@@	O	-1	9431903
ane@@	O	-1	9431903
ous@@	O	-1	9431903
ly@@	O	-1	9431903
)	O	-1	9431903
and	O	-1	9431903
vi@@	O	-1	9431903
su@@	O	-1	9431903
al@@	O	-1	9431903
ized	O	-1	9431903
by	O	-1	9431903
qu@@	O	-1	9431903
anti@@	O	-1	9431903
t@@	O	-1	9431903
ative	O	-1	9431903
hepat@@	O	-1	9431903
ob@@	O	-1	9431903
il@@	O	-1	9431903
i@@	O	-1	9431903
ary	O	-1	9431903
s@@	O	-1	9431903
cin@@	O	-1	9431903
ti@@	O	-1	9431903
graph@@	O	-1	9431903
y.	O	-1	9431903
The	O	-1	9431903
enti@@	O	-1	9431903
r@@	O	-1	9431903
e	O	-1	9431903
proce@@	O	-1	9431903
d@@	O	-1	9431903
ure	O	-1	9431903
was	O	-1	9431903
repe@@	O	-1	9431903
ated	O	-1	9431903
during	O	-1	9431903
glyc@@	B-Chemical	D005996	9431903
ery@@	I-Chemical	-1	9431903
l	I-Chemical	-1	9431903
tr@@	I-Chemical	-1	9431903
in@@	I-Chemical	-1	9431903
it@@	I-Chemical	-1	9431903
rate	I-Chemical	-1	9431903
infusion	O	-1	9431903
(	O	-1	9431903
N@@	B-Chemical	D005996	9431903
it@@	I-Chemical	-1	9431903
ro@@	I-Chemical	-1	9431903
l@@	I-Chemical	-1	9431903
ing@@	I-Chemical	-1	9431903
ual	I-Chemical	-1	9431903
1	O	-1	9431903
micro@@	O	-1	9431903
g/@@	O	-1	9431903
k@@	O	-1	9431903
g/@@	O	-1	9431903
min	O	-1	9431903
for	O	-1	9431903
1@@	O	-1	9431903
20	O	-1	9431903
min@@	O	-1	9431903
).	O	-1	9431903
RESULTS:	O	-1	9431903
P@@	B-Chemical	D009388	9431903
ros@@	I-Chemical	-1	9431903
tig@@	I-Chemical	-1	9431903
mine	I-Chemical	-1	9431903
-	O	-1	9431903
morphine	B-Chemical	D009020	9431903
prov@@	O	-1	9431903
oc@@	O	-1	9431903
ation	O	-1	9431903
caused	O	-1	9431903
significant	O	-1	9431903
increases	O	-1	9431903
in	O	-1	9431903
the	O	-1	9431903
time	O	-1	9431903
to	O	-1	9431903
pe@@	O	-1	9431903
a@@	O	-1	9431903
k	O	-1	9431903
activity	O	-1	9431903
(T@@	O	-1	9431903
ma@@	O	-1	9431903
x@@	O	-1	9431903
)	O	-1	9431903
over	O	-1	9431903
the	O	-1	9431903
hepatic	O	-1	9431903
h@@	O	-1	9431903
il@@	O	-1	9431903
um	O	-1	9431903
(@@	O	-1	9431903
H@@	O	-1	9431903
H@@	O	-1	9431903
:	O	-1	9431903
3@@	O	-1	9431903
4.@@	O	-1	9431903
3@@	O	-1	9431903
3	O	-1	9431903
+/-	O	-1	9431903
5.@@	O	-1	9431903
0@@	O	-1	9431903
5	O	-1	9431903
vs.	O	-1	9431903
2@@	O	-1	9431903
2.@@	O	-1	9431903
7@@	O	-1	9431903
7	O	-1	9431903
+/-	O	-1	9431903
3.@@	O	-1	9431903
2@@	O	-1	9431903
6@@	O	-1	9431903
)	O	-1	9431903
and	O	-1	9431903
the	O	-1	9431903
common	O	-1	9431903
b@@	O	-1	9431903
ile	O	-1	9431903
duc@@	O	-1	9431903
t	O	-1	9431903
(C@@	O	-1	9431903
B@@	O	-1	9431903
D@@	O	-1	9431903
:	O	-1	9431903
6@@	O	-1	9431903
0.@@	O	-1	9431903
4@@	O	-1	9431903
4	O	-1	9431903
+/-	O	-1	9431903
5.@@	O	-1	9431903
9@@	O	-1	9431903
9	O	-1	9431903
vs.	O	-1	9431903
4@@	O	-1	9431903
0.@@	O	-1	9431903
0	O	-1	9431903
+/-	O	-1	9431903
2.@@	O	-1	9431903
8@@	O	-1	9431903
8@@	O	-1	9431903
)	O	-1	9431903
and	O	-1	9431903
in	O	-1	9431903
the	O	-1	9431903
h@@	O	-1	9431903
al@@	O	-1	9431903
f@@	O	-1	9431903
-@@	O	-1	9431903
time	O	-1	9431903
of	O	-1	9431903
ex@@	O	-1	9431903
cre@@	O	-1	9431903
tion	O	-1	9431903
(T@@	O	-1	9431903
1@@	O	-1	9431903
/@@	O	-1	9431903
2)	O	-1	9431903
over	O	-1	9431903
the	O	-1	9431903
liver	O	-1	9431903
pa@@	O	-1	9431903
ren@@	O	-1	9431903
ch@@	O	-1	9431903
y@@	O	-1	9431903
ma	O	-1	9431903
(@@	O	-1	9431903
L@@	O	-1	9431903
P@@	O	-1	9431903
:	O	-1	9431903
12@@	O	-1	9431903
0.0@@	O	-1	9431903
4	O	-1	9431903
+/-	O	-1	9431903
1@@	O	-1	9431903
6.@@	O	-1	9431903
0@@	O	-1	9431903
1	O	-1	9431903
vs.	O	-1	9431903
2@@	O	-1	9431903
7.@@	O	-1	9431903
3@@	O	-1	9431903
7	O	-1	9431903
+/-	O	-1	9431903
2.@@	O	-1	9431903
19@@	O	-1	9431903
),	O	-1	9431903
H@@	O	-1	9431903
H	O	-1	9431903
(1@@	O	-1	9431903
1@@	O	-1	9431903
7.@@	O	-1	9431903
6@@	O	-1	9431903
1	O	-1	9431903
+/-	O	-1	9431903
1@@	O	-1	9431903
4.@@	O	-1	9431903
7@@	O	-1	9431903
1	O	-1	9431903
vs.	O	-1	9431903
3@@	O	-1	9431903
1.@@	O	-1	9431903
8@@	O	-1	9431903
5	O	-1	9431903
+/-	O	-1	9431903
3.@@	O	-1	9431903
9@@	O	-1	9431903
9@@	O	-1	9431903
)	O	-1	9431903
and	O	-1	9431903
C@@	O	-1	9431903
B@@	O	-1	9431903
D	O	-1	9431903
(1@@	O	-1	9431903
5@@	O	-1	9431903
8.@@	O	-1	9431903
11	O	-1	9431903
+/-	O	-1	9431903
9.@@	O	-1	9431903
1@@	O	-1	9431903
8	O	-1	9431903
vs.	O	-1	9431903
4@@	O	-1	9431903
0.@@	O	-1	9431903
1	O	-1	9431903
+/-	O	-1	9431903
6.@@	O	-1	9431903
2@@	O	-1	9431903
4@@	O	-1	9431903
),	O	-1	9431903
indicating	O	-1	9431903
a	O	-1	9431903
complete	O	-1	9431903
sp@@	B-Disease	D013035	9431903
as@@	I-Disease	-1	9431903
m	I-Disease	-1	9431903
at	O	-1	9431903
the	O	-1	9431903
level	O	-1	9431903
of	O	-1	9431903
the	O	-1	9431903
s@@	O	-1	9431903
ph@@	O	-1	9431903
inc@@	O	-1	9431903
ter	O	-1	9431903
of	O	-1	9431903
O@@	O	-1	9431903
d@@	O	-1	9431903
di@@	O	-1	9431903
.	O	-1	9431903
G@@	B-Chemical	D005996	9431903
l@@	I-Chemical	-1	9431903
yc@@	I-Chemical	-1	9431903
ery@@	I-Chemical	-1	9431903
l	I-Chemical	-1	9431903
tr@@	I-Chemical	-1	9431903
in@@	I-Chemical	-1	9431903
it@@	I-Chemical	-1	9431903
rate	I-Chemical	-1	9431903
infusion	O	-1	9431903
complete@@	O	-1	9431903
ly	O	-1	9431903
normal@@	O	-1	9431903
ized	O	-1	9431903
the	O	-1	9431903
pro@@	B-Chemical	D009388	9431903
s@@	I-Chemical	-1	9431903
tig@@	I-Chemical	-1	9431903
mine	I-Chemical	-1	9431903
-	O	-1	9431903
morphine	B-Chemical	D009020	9431903
-induced	O	-1	9431903
al@@	O	-1	9431903
ter@@	O	-1	9431903
ations	O	-1	9431903
in	O	-1	9431903
these	O	-1	9431903
qu@@	O	-1	9431903
anti@@	O	-1	9431903
t@@	O	-1	9431903
ative	O	-1	9431903
par@@	O	-1	9431903
ame@@	O	-1	9431903
ters	O	-1	9431903
(T@@	O	-1	9431903
ma@@	O	-1	9431903
X	O	-1	9431903
over	O	-1	9431903
the	O	-1	9431903
L@@	O	-1	9431903
P@@	O	-1	9431903
:	O	-1	9431903
1@@	O	-1	9431903
1.@@	O	-1	9431903
3@@	O	-1	9431903
3	O	-1	9431903
+/-	O	-1	9431903
1.@@	O	-1	9431903
13@@	O	-1	9431903
;	O	-1	9431903
over	O	-1	9431903
the	O	-1	9431903
H@@	O	-1	9431903
H@@	O	-1	9431903
:	O	-1	9431903
1@@	O	-1	9431903
8.@@	O	-1	9431903
8@@	O	-1	9431903
8	O	-1	9431903
+/-	O	-1	9431903
1.@@	O	-1	9431903
4@@	O	-1	9431903
8@@	O	-1	9431903
;	O	-1	9431903
and	O	-1	9431903
over	O	-1	9431903
the	O	-1	9431903
C@@	O	-1	9431903
B@@	O	-1	9431903
D@@	O	-1	9431903
:	O	-1	9431903
3@@	O	-1	9431903
6.@@	O	-1	9431903
2@@	O	-1	9431903
2	O	-1	9431903
+/-	O	-1	9431903
1.@@	O	-1	9431903
9@@	O	-1	9431903
2@@	O	-1	9431903
;	O	-1	9431903
and	O	-1	9431903
T@@	O	-1	9431903
1@@	O	-1	9431903
/@@	O	-1	9431903
2	O	-1	9431903
over	O	-1	9431903
the	O	-1	9431903
L@@	O	-1	9431903
P@@	O	-1	9431903
:	O	-1	9431903
2@@	O	-1	9431903
8.@@	O	-1	9431903
21	O	-1	9431903
+/-	O	-1	9431903
1.@@	O	-1	9431903
8@@	O	-1	9431903
3@@	O	-1	9431903
;	O	-1	9431903
over	O	-1	9431903
the	O	-1	9431903
H@@	O	-1	9431903
H@@	O	-1	9431903
:	O	-1	9431903
3@@	O	-1	9431903
3.@@	O	-1	9431903
4@@	O	-1	9431903
2	O	-1	9431903
+/-	O	-1	9431903
3.@@	O	-1	9431903
10@@	O	-1	9431903
;	O	-1	9431903
and	O	-1	9431903
over	O	-1	9431903
the	O	-1	9431903
C@@	O	-1	9431903
B@@	O	-1	9431903
D@@	O	-1	9431903
:	O	-1	9431903
4@@	O	-1	9431903
1.@@	O	-1	9431903
6@@	O	-1	9431903
6	O	-1	9431903
+/-	O	-1	9431903
6.@@	O	-1	9431903
3@@	O	-1	9431903
3@@	O	-1	9431903
),	O	-1	9431903
suggesting	O	-1	9431903
an	O	-1	9431903
effective	O	-1	9431903
s@@	O	-1	9431903
ph@@	O	-1	9431903
inc@@	O	-1	9431903
ter@@	O	-1	9431903
-@@	O	-1	9431903
rel@@	O	-1	9431903
ax@@	O	-1	9431903
ing	O	-1	9431903
effect	O	-1	9431903
of	O	-1	9431903
glyc@@	B-Chemical	D005996	9431903
ery@@	I-Chemical	-1	9431903
l	I-Chemical	-1	9431903
tr@@	I-Chemical	-1	9431903
in@@	I-Chemical	-1	9431903
it@@	I-Chemical	-1	9431903
rate	I-Chemical	-1	9431903
.	O	-1	9431903
CONCLUSION:	O	-1	9431903
These	O	-1	9431903
results	O	-1	9431903
prov@@	O	-1	9431903
ide	O	-1	9431903
the	O	-1	9431903
first	O	-1	9431903
evidence	O	-1	9431903
of	O	-1	9431903
the	O	-1	9431903
eff@@	O	-1	9431903
ec@@	O	-1	9431903
tiv@@	O	-1	9431903
en@@	O	-1	9431903
ess	O	-1	9431903
of	O	-1	9431903
glyc@@	B-Chemical	D005996	9431903
ery@@	I-Chemical	-1	9431903
l	I-Chemical	-1	9431903
tr@@	I-Chemical	-1	9431903
in@@	I-Chemical	-1	9431903
it@@	I-Chemical	-1	9431903
rate	I-Chemical	-1	9431903
on	O	-1	9431903
the	O	-1	9431903
morphine	B-Chemical	D009020	9431903
-induced	O	-1	9431903
s@@	B-Disease	D046628	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
sp@@	I-Disease	-1	9431903
as@@	I-Disease	-1	9431903
m	I-Disease	-1	9431903
s@@	B-Disease	D013035	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
sp@@	I-Disease	-1	9431903
as@@	I-Disease	-1	9431903
m	I-Disease	-1	9431903
in	O	-1	9431903
hum@@	O	-1	9431903
an@@	O	-1	9431903
s.	O	-1	9431903
S@@	O	-1	9431903
inc@@	O	-1	9431903
e	O	-1	9431903
glyc@@	B-Chemical	D005996	9431903
ery@@	I-Chemical	-1	9431903
l	I-Chemical	-1	9431903
tr@@	I-Chemical	-1	9431903
in@@	I-Chemical	-1	9431903
it@@	I-Chemical	-1	9431903
rate	I-Chemical	-1	9431903
is	O	-1	9431903
able	O	-1	9431903
to	O	-1	9431903
over@@	O	-1	9431903
com@@	O	-1	9431903
e	O	-1	9431903
even	O	-1	9431903
the	O	-1	9431903
d@@	O	-1	9431903
r@@	O	-1	9431903
as@@	O	-1	9431903
tic	O	-1	9431903
effect	O	-1	9431903
of	O	-1	9431903
morphine	B-Chemical	D009020	9431903
,	O	-1	9431903
it	O	-1	9431903
might	O	-1	9431903
be	O	-1	9431903
of	O	-1	9431903
re@@	O	-1	9431903
lev@@	O	-1	9431903
ance	O	-1	9431903
in	O	-1	9431903
the	O	-1	9431903
treatment	O	-1	9431903
of	O	-1	9431903
s@@	B-Disease	D046628	9431903
ph@@	I-Disease	-1	9431903
inc@@	I-Disease	-1	9431903
ter	I-Disease	-1	9431903
of	I-Disease	-1	9431903
O@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
d@@	I-Disease	-1	9431903
i	I-Disease	-1	9431903
dyskine@@	I-Disease	-1	9431903
sia	I-Disease	-1	9431903
.	O	-1	9431903

Eff@@	O	-1	8665051
ects	O	-1	8665051
of	O	-1	8665051
acute	O	-1	8665051
ster@@	B-Chemical	D013256	8665051
oid	I-Chemical	-1	8665051
administration	O	-1	8665051
on	O	-1	8665051
ven@@	O	-1	8665051
ti@@	O	-1	8665051
lat@@	O	-1	8665051
ory	O	-1	8665051
and	O	-1	8665051
peripheral	O	-1	8665051
musc@@	O	-1	8665051
le@@	O	-1	8665051
s	O	-1	8665051
in	O	-1	8665051
rats.	O	-1	8665051
O@@	O	-1	8665051
c@@	O	-1	8665051
ca@@	O	-1	8665051
sion@@	O	-1	8665051
al	O	-1	8665051
case	O	-1	8665051
reports	O	-1	8665051
have	O	-1	8665051
shown	O	-1	8665051
that	O	-1	8665051
acute	O	-1	8665051
my@@	B-Disease	D009135	8665051
o@@	I-Disease	-1	8665051
pathy	I-Disease	-1	8665051
may	O	-1	8665051
occ@@	O	-1	8665051
ur	O	-1	8665051
in	O	-1	8665051
patients	O	-1	8665051
treated	O	-1	8665051
with	O	-1	8665051
mas@@	O	-1	8665051
sive	O	-1	8665051
doses	O	-1	8665051
of	O	-1	8665051
cortico@@	B-Chemical	D000305	8665051
steroid@@	I-Chemical	-1	8665051
s	I-Chemical	-1	8665051
.	O	-1	8665051
The	O	-1	8665051
mechanism	O	-1	8665051
of	O	-1	8665051
this	O	-1	8665051
my@@	B-Disease	D009135	8665051
o@@	I-Disease	-1	8665051
pathy	I-Disease	-1	8665051
is	O	-1	8665051
po@@	O	-1	8665051
or@@	O	-1	8665051
ly	O	-1	8665051
under@@	O	-1	8665051
sto@@	O	-1	8665051
o@@	O	-1	8665051
d.	O	-1	8665051
The@@	O	-1	8665051
refore,	O	-1	8665051
60	O	-1	8665051
male	O	-1	8665051
rats	O	-1	8665051
were	O	-1	8665051
random@@	O	-1	8665051
ly	O	-1	8665051
as@@	O	-1	8665051
signed	O	-1	8665051
to	O	-1	8665051
recei@@	O	-1	8665051
ve	O	-1	8665051
daily	O	-1	8665051
injection	O	-1	8665051
of	O	-1	8665051
saline	O	-1	8665051
(C@@	O	-1	8665051
),	O	-1	8665051
methyl@@	B-Chemical	D008775	8665051
pre@@	I-Chemical	-1	8665051
d@@	I-Chemical	-1	8665051
n@@	I-Chemical	-1	8665051
isol@@	I-Chemical	-1	8665051
one	I-Chemical	-1	8665051
(	O	-1	8665051
M	B-Chemical	D008775	8665051
),	O	-1	8665051
or	O	-1	8665051
tri@@	B-Chemical	D014221	8665051
am@@	I-Chemical	-1	8665051
cin@@	I-Chemical	-1	8665051
ol@@	I-Chemical	-1	8665051
one	I-Chemical	-1	8665051
(	O	-1	8665051
T	B-Chemical	D014221	8665051
)	O	-1	8665051
8@@	O	-1	8665051
0	O	-1	8665051
mg/k@@	O	-1	8665051
g/@@	O	-1	8665051
d	O	-1	8665051
for	O	-1	8665051
5	O	-1	8665051
d.	O	-1	8665051
N@@	O	-1	8665051
ut@@	O	-1	8665051
ri@@	O	-1	8665051
tional	O	-1	8665051
int@@	O	-1	8665051
ak@@	O	-1	8665051
e,	O	-1	8665051
measured	O	-1	8665051
daily	O	-1	8665051
in	O	-1	8665051
15	O	-1	8665051
anim@@	O	-1	8665051
al@@	O	-1	8665051
s,	O	-1	8665051
showed	O	-1	8665051
a	O	-1	8665051
significant	O	-1	8665051
reduction	B-Disease	D000855	8665051
of	I-Disease	-1	8665051
fo@@	I-Disease	-1	8665051
od	I-Disease	-1	8665051
int@@	I-Disease	-1	8665051
ake	I-Disease	-1	8665051
in	O	-1	8665051
the	O	-1	8665051
ster@@	B-Chemical	D013256	8665051
oid	I-Chemical	-1	8665051
-treated	O	-1	8665051
groups	O	-1	8665051
(-@@	O	-1	8665051
50	O	-1	8665051
and	O	-1	8665051
-@@	O	-1	8665051
7@@	O	-1	8665051
9@@	O	-1	8665051
%	O	-1	8665051
in	O	-1	8665051
M	B-Chemical	D008775	8665051
and	O	-1	8665051
T	B-Chemical	D014221	8665051
,	O	-1	8665051
respectivel@@	O	-1	8665051
y@@	O	-1	8665051
).	O	-1	8665051
This	O	-1	8665051
was	O	-1	8665051
associated	O	-1	8665051
with	O	-1	8665051
a	O	-1	8665051
similar	O	-1	8665051
loss	B-Disease	D015431	8665051
in	I-Disease	-1	8665051
body	I-Disease	-1	8665051
weight	I-Disease	-1	8665051
.	O	-1	8665051
In	O	-1	8665051
the	O	-1	8665051
4@@	O	-1	8665051
5	O	-1	8665051
remain@@	O	-1	8665051
ing	O	-1	8665051
anim@@	O	-1	8665051
al@@	O	-1	8665051
s,	O	-1	8665051
dia@@	O	-1	8665051
ph@@	O	-1	8665051
ra@@	O	-1	8665051
g@@	O	-1	8665051
m	O	-1	8665051
contrac@@	O	-1	8665051
til@@	O	-1	8665051
ity	O	-1	8665051
and	O	-1	8665051
histo@@	O	-1	8665051
path@@	O	-1	8665051
ologic	O	-1	8665051
feat@@	O	-1	8665051
ures	O	-1	8665051
of	O	-1	8665051
several	O	-1	8665051
musc@@	O	-1	8665051
le@@	O	-1	8665051
s	O	-1	8665051
were	O	-1	8665051
studi@@	O	-1	8665051
ed.	O	-1	8665051
W@@	O	-1	8665051
e@@	O	-1	8665051
igh@@	O	-1	8665051
ts	O	-1	8665051
of	O	-1	8665051
respiratory	O	-1	8665051
and	O	-1	8665051
peripheral	O	-1	8665051
musc@@	O	-1	8665051
le@@	O	-1	8665051
s	O	-1	8665051
were	O	-1	8665051
simil@@	O	-1	8665051
arly	O	-1	8665051
decreased	O	-1	8665051
after	O	-1	8665051
ster@@	B-Chemical	D013256	8665051
oid	I-Chemical	-1	8665051
treatment.	O	-1	8665051
M@@	O	-1	8665051
ax@@	O	-1	8665051
im@@	O	-1	8665051
al	O	-1	8665051
t@@	O	-1	8665051
witch@@	O	-1	8665051
es	O	-1	8665051
of	O	-1	8665051
the	O	-1	8665051
dia@@	O	-1	8665051
ph@@	O	-1	8665051
ra@@	O	-1	8665051
g@@	O	-1	8665051
m	O	-1	8665051
were	O	-1	8665051
lower	O	-1	8665051
in	O	-1	8665051
the	O	-1	8665051
C	O	-1	8665051
group	O	-1	8665051
(6@@	O	-1	8665051
5@@	O	-1	8665051
3	O	-1	8665051
+/-	O	-1	8665051
17@@	O	-1	8665051
4	O	-1	8665051
g/@@	O	-1	8665051
c@@	O	-1	8665051
m@@	O	-1	8665051
(2@@	O	-1	8665051
)@@	O	-1	8665051
)	O	-1	8665051
than	O	-1	8665051
in	O	-1	8665051
the	O	-1	8665051
M	B-Chemical	D008775	8665051
group	O	-1	8665051
(@@	O	-1	8665051
8@@	O	-1	8665051
3@@	O	-1	8665051
7	O	-1	8665051
+/-	O	-1	8665051
17@@	O	-1	8665051
1	O	-1	8665051
g/@@	O	-1	8665051
c@@	O	-1	8665051
m@@	O	-1	8665051
(2@@	O	-1	8665051
);	O	-1	8665051
p	O	-1	8665051
<	O	-1	8665051
0.05@@	O	-1	8665051
)	O	-1	8665051
and	O	-1	8665051
the	O	-1	8665051
T	B-Chemical	D014221	8665051
group	O	-1	8665051
(@@	O	-1	8665051
7@@	O	-1	8665051
6@@	O	-1	8665051
5	O	-1	8665051
+/-	O	-1	8665051
14@@	O	-1	8665051
5	O	-1	8665051
g/@@	O	-1	8665051
c@@	O	-1	8665051
m@@	O	-1	8665051
(2@@	O	-1	8665051
),	O	-1	8665051
N@@	O	-1	8665051
S@@	O	-1	8665051
).	O	-1	8665051
H@@	O	-1	8665051
al@@	O	-1	8665051
f@@	O	-1	8665051
-@@	O	-1	8665051
rel@@	O	-1	8665051
ax@@	O	-1	8665051
ation	O	-1	8665051
time	O	-1	8665051
was	O	-1	8665051
prolonged	O	-1	8665051
in	O	-1	8665051
both	O	-1	8665051
ster@@	B-Chemical	D013256	8665051
oid	I-Chemical	-1	8665051
group@@	O	-1	8665051
s,	O	-1	8665051
and	O	-1	8665051
time	O	-1	8665051
to	O	-1	8665051
pe@@	O	-1	8665051
a@@	O	-1	8665051
k	O	-1	8665051
ten@@	O	-1	8665051
sion	O	-1	8665051
was	O	-1	8665051
long@@	O	-1	8665051
er	O	-1	8665051
with	O	-1	8665051
M	B-Chemical	D008775	8665051
,	O	-1	8665051
whereas	O	-1	8665051
te@@	B-Disease	D013746	8665051
t@@	I-Disease	-1	8665051
anic	I-Disease	-1	8665051
ten@@	O	-1	8665051
sions	O	-1	8665051
were	O	-1	8665051
simil@@	O	-1	8665051
ar@@	O	-1	8665051
.	O	-1	8665051
S@@	B-Chemical	D013256	8665051
ter@@	I-Chemical	-1	8665051
oid	I-Chemical	-1	8665051
treatment	O	-1	8665051
also	O	-1	8665051
induced	O	-1	8665051
a	O	-1	8665051
le@@	O	-1	8665051
f@@	O	-1	8665051
tw@@	O	-1	8665051
ard	O	-1	8665051
shi@@	O	-1	8665051
ft	O	-1	8665051
of	O	-1	8665051
the	O	-1	8665051
for@@	O	-1	8665051
ce@@	O	-1	8665051
-@@	O	-1	8665051
frequency	O	-1	8665051
cur@@	O	-1	8665051
ve	O	-1	8665051
at	O	-1	8665051
25	O	-1	8665051
and	O	-1	8665051
50	O	-1	8665051
H@@	O	-1	8665051
z	O	-1	8665051
when	O	-1	8665051
compared	O	-1	8665051
with	O	-1	8665051
saline	O	-1	8665051
treatment	O	-1	8665051
(p	O	-1	8665051
<	O	-1	8665051
0.05@@	O	-1	8665051
).	O	-1	8665051
AT@@	O	-1	8665051
P@@	O	-1	8665051
ase	O	-1	8665051
st@@	O	-1	8665051
aining	O	-1	8665051
of	O	-1	8665051
the	O	-1	8665051
dia@@	O	-1	8665051
ph@@	O	-1	8665051
ra@@	O	-1	8665051
g@@	O	-1	8665051
m@@	O	-1	8665051
,	O	-1	8665051
s@@	O	-1	8665051
cal@@	O	-1	8665051
en@@	O	-1	8665051
us	O	-1	8665051
medi@@	O	-1	8665051
us,	O	-1	8665051
and	O	-1	8665051
gast@@	O	-1	8665051
ro@@	O	-1	8665051
c@@	O	-1	8665051
ne@@	O	-1	8665051
mi@@	O	-1	8665051
us	O	-1	8665051
showed	O	-1	8665051
type	O	-1	8665051
II@@	O	-1	8665051
b	O	-1	8665051
fib@@	O	-1	8665051
er	O	-1	8665051
atro@@	B-Disease	D009133	8665051
ph@@	I-Disease	-1	8665051
y	I-Disease	-1	8665051
in	O	-1	8665051
the	O	-1	8665051
ster@@	B-Chemical	D013256	8665051
oid	I-Chemical	-1	8665051
groups	O	-1	8665051
and	O	-1	8665051
also	O	-1	8665051
dia@@	O	-1	8665051
ph@@	O	-1	8665051
ra@@	O	-1	8665051
g@@	O	-1	8665051
m@@	O	-1	8665051
atic	O	-1	8665051
type	O	-1	8665051
II@@	O	-1	8665051
a	O	-1	8665051
atro@@	B-Disease	D009133	8665051
ph@@	I-Disease	-1	8665051
y	I-Disease	-1	8665051
with	O	-1	8665051
T	B-Chemical	D014221	8665051
,	O	-1	8665051
whereas	O	-1	8665051
hist@@	O	-1	8665051
ologic	O	-1	8665051
examin@@	O	-1	8665051
ations	O	-1	8665051
revealed	O	-1	8665051
a	O	-1	8665051
normal	O	-1	8665051
mus@@	O	-1	8665051
cular	O	-1	8665051
pat@@	O	-1	8665051
ter@@	O	-1	8665051
n	O	-1	8665051
with	O	-1	8665051
absence	O	-1	8665051
of	O	-1	8665051
necro@@	B-Disease	D009336	8665051
sis	I-Disease	-1	8665051
.	O	-1	8665051
F@@	O	-1	8665051
in@@	O	-1	8665051
ally,	O	-1	8665051
a	O	-1	8665051
pa@@	O	-1	8665051
ir@@	O	-1	8665051
-@@	O	-1	8665051
f@@	O	-1	8665051
ed	O	-1	8665051
(P@@	O	-1	8665051
F@@	O	-1	8665051
)	O	-1	8665051
study,	O	-1	8665051
performed	O	-1	8665051
in	O	-1	8665051
1@@	O	-1	8665051
8	O	-1	8665051
rats	O	-1	8665051
(C@@	O	-1	8665051
,	O	-1	8665051
T	B-Chemical	D014221	8665051
,	O	-1	8665051
and	O	-1	8665051
P@@	O	-1	8665051
F@@	O	-1	8665051
),	O	-1	8665051
showed	O	-1	8665051
that	O	-1	8665051
musc@@	B-Disease	D009133	8665051
le	I-Disease	-1	8665051
atro@@	I-Disease	-1	8665051
ph@@	I-Disease	-1	8665051
y	I-Disease	-1	8665051
was	O	-1	8665051
con@@	O	-1	8665051
si@@	O	-1	8665051
der@@	O	-1	8665051
ably	O	-1	8665051
less	O	-1	8665051
p@@	O	-1	8665051
ron@@	O	-1	8665051
oun@@	O	-1	8665051
c@@	O	-1	8665051
ed	O	-1	8665051
in	O	-1	8665051
P@@	O	-1	8665051
F	O	-1	8665051
animals	O	-1	8665051
than	O	-1	8665051
in	O	-1	8665051
T	B-Chemical	D014221	8665051
-treated	O	-1	8665051
anim@@	O	-1	8665051
al@@	O	-1	8665051
s.	O	-1	8665051
We	O	-1	8665051
concl@@	O	-1	8665051
ude	O	-1	8665051
that	O	-1	8665051
(1@@	O	-1	8665051
)	O	-1	8665051
sh@@	O	-1	8665051
ort@@	O	-1	8665051
-term	O	-1	8665051
treatment	O	-1	8665051
with	O	-1	8665051
mas@@	O	-1	8665051
sive	O	-1	8665051
doses	O	-1	8665051
of	O	-1	8665051
steroid@@	B-Chemical	D013256	8665051
s	I-Chemical	-1	8665051
induced	O	-1	8665051
severe	O	-1	8665051
respiratory	O	-1	8665051
and	O	-1	8665051
lim@@	O	-1	8665051
b	O	-1	8665051
musc@@	O	-1	8665051
le	O	-1	8665051
w@@	O	-1	8665051
ast@@	O	-1	8665051
ing@@	O	-1	8665051
;	O	-1	8665051
(2@@	O	-1	8665051
)	O	-1	8665051
both	O	-1	8665051
typ@@	O	-1	8665051
es	O	-1	8665051
of	O	-1	8665051
steroid@@	B-Chemical	D013256	8665051
s	I-Chemical	-1	8665051
induced	O	-1	8665051
pre@@	O	-1	8665051
domin@@	O	-1	8665051
ant@@	O	-1	8665051
ly	O	-1	8665051
type	O	-1	8665051
II@@	O	-1	8665051
b	O	-1	8665051
atro@@	B-Disease	D001284	8665051
ph@@	I-Disease	-1	8665051
y	I-Disease	-1	8665051
,	O	-1	8665051
result@@	O	-1	8665051
ing	O	-1	8665051
in	O	-1	8665051
the	O	-1	8665051
ex@@	O	-1	8665051
p@@	O	-1	8665051
ected	O	-1	8665051
al@@	O	-1	8665051
ter@@	O	-1	8665051
ations	O	-1	8665051
in	O	-1	8665051
dia@@	O	-1	8665051
ph@@	O	-1	8665051
ra@@	O	-1	8665051
g@@	O	-1	8665051
m	O	-1	8665051
contrac@@	O	-1	8665051
ti@@	O	-1	8665051
le	O	-1	8665051
pro@@	O	-1	8665051
per@@	O	-1	8665051
ti@@	O	-1	8665051
es@@	O	-1	8665051
;	O	-1	8665051
(3@@	O	-1	8665051
)	O	-1	8665051
ne@@	O	-1	8665051
ither	O	-1	8665051
ster@@	B-Chemical	D013256	8665051
oid	I-Chemical	-1	8665051
caused	O	-1	8665051
musc@@	O	-1	8665051
le	O	-1	8665051
necro@@	B-Disease	D009336	8665051
sis	I-Disease	-1	8665051
;	O	-1	8665051
(4@@	O	-1	8665051
)	O	-1	8665051
type	O	-1	8665051
II@@	O	-1	8665051
b	O	-1	8665051
atro@@	B-Disease	D009133	8665051
ph@@	I-Disease	-1	8665051
y	I-Disease	-1	8665051
was	O	-1	8665051
not	O	-1	8665051
caused	O	-1	8665051
by	O	-1	8665051
acute	O	-1	8665051
n@@	O	-1	8665051
ut@@	O	-1	8665051
ri@@	O	-1	8665051
tional	O	-1	8665051
de@@	O	-1	8665051
pri@@	O	-1	8665051
v@@	O	-1	8665051
ation	O	-1	8665051
al@@	O	-1	8665051
one.	O	-1	8665051

Re@@	O	-1	7785794
frac@@	O	-1	7785794
t@@	O	-1	7785794
ory	O	-1	7785794
cardio@@	B-Disease	D012770	7785794
genic	I-Disease	-1	7785794
sh@@	I-Disease	-1	7785794
oc@@	I-Disease	-1	7785794
k	I-Disease	-1	7785794
and	O	-1	7785794
complete	O	-1	7785794
heart	B-Disease	D006327	7785794
bloc@@	I-Disease	-1	7785794
k	I-Disease	-1	7785794
after	O	-1	7785794
verap@@	B-Chemical	D014700	7785794
ami@@	I-Chemical	-1	7785794
l	I-Chemical	-1	7785794
S@@	O	-1	7785794
R	O	-1	7785794
and	O	-1	7785794
me@@	B-Chemical	D008790	7785794
to@@	I-Chemical	-1	7785794
pro@@	I-Chemical	-1	7785794
lol	I-Chemical	-1	7785794
treatment.	O	-1	7785794
A	O	-1	7785794
case	O	-1	7785794
repor@@	O	-1	7785794
t.	O	-1	7785794
A	O	-1	7785794
sev@@	O	-1	7785794
ent@@	O	-1	7785794
y-@@	O	-1	7785794
e@@	O	-1	7785794
igh@@	O	-1	7785794
t-@@	O	-1	7785794
year-old	O	-1	7785794
woman	O	-1	7785794
presented	O	-1	7785794
with	O	-1	7785794
complete	O	-1	7785794
heart	B-Disease	D006327	7785794
bloc@@	I-Disease	-1	7785794
k	I-Disease	-1	7785794
and	O	-1	7785794
ref@@	O	-1	7785794
rac@@	O	-1	7785794
t@@	O	-1	7785794
ory	O	-1	7785794
hypotension	B-Disease	D007022	7785794
two	O	-1	7785794
days	O	-1	7785794
after	O	-1	7785794
a	O	-1	7785794
therapeutic	O	-1	7785794
dose	O	-1	7785794
of	O	-1	7785794
su@@	O	-1	7785794
st@@	O	-1	7785794
a@@	O	-1	7785794
ine@@	O	-1	7785794
d-@@	O	-1	7785794
release	O	-1	7785794
verap@@	B-Chemical	D014700	7785794
ami@@	I-Chemical	-1	7785794
l	I-Chemical	-1	7785794
with	O	-1	7785794
concomit@@	O	-1	7785794
ant	O	-1	7785794
use	O	-1	7785794
of	O	-1	7785794
me@@	B-Chemical	D008790	7785794
to@@	I-Chemical	-1	7785794
pro@@	I-Chemical	-1	7785794
lol	I-Chemical	-1	7785794
.	O	-1	7785794
The	O	-1	7785794
patient	O	-1	7785794
continu@@	O	-1	7785794
ed	O	-1	7785794
to	O	-1	7785794
re@@	O	-1	7785794
ma@@	O	-1	7785794
in	O	-1	7785794
hypoten@@	B-Disease	D007022	7785794
sive	I-Disease	-1	7785794
with	O	-1	7785794
complete	O	-1	7785794
heart	B-Disease	D006327	7785794
bloc@@	I-Disease	-1	7785794
k	I-Disease	-1	7785794
,	O	-1	7785794
even	O	-1	7785794
with	O	-1	7785794
multiple	O	-1	7785794
u@@	O	-1	7785794
ses	O	-1	7785794
of	O	-1	7785794
intravenous	O	-1	7785794
atro@@	B-Chemical	D001285	7785794
pine	I-Chemical	-1	7785794
as	O	-1	7785794
well	O	-1	7785794
as	O	-1	7785794
high	O	-1	7785794
doses	O	-1	7785794
of	O	-1	7785794
press@@	O	-1	7785794
or	O	-1	7785794
agents	O	-1	7785794
such	O	-1	7785794
as	O	-1	7785794
dopamine	B-Chemical	D004298	7785794
and	O	-1	7785794
do@@	B-Chemical	D004280	7785794
but@@	I-Chemical	-1	7785794
amine	I-Chemical	-1	7785794
.	O	-1	7785794
However,	O	-1	7785794
sh@@	O	-1	7785794
ort@@	O	-1	7785794
ly	O	-1	7785794
after	O	-1	7785794
the	O	-1	7785794
use	O	-1	7785794
of	O	-1	7785794
intravenous	O	-1	7785794
calcium	B-Chemical	D002122	7785794
chlor@@	I-Chemical	-1	7785794
ide	I-Chemical	-1	7785794
,	O	-1	7785794
the	O	-1	7785794
ref@@	O	-1	7785794
rac@@	O	-1	7785794
t@@	O	-1	7785794
ory	O	-1	7785794
hypotension	B-Disease	D007022	7785794
and	O	-1	7785794
complete	O	-1	7785794
heart	B-Disease	D006327	7785794
bloc@@	I-Disease	-1	7785794
k	I-Disease	-1	7785794
resol@@	O	-1	7785794
ved.	O	-1	7785794

A	O	-1	8958188
phase	O	-1	8958188
I	O	-1	8958188
clinical	O	-1	8958188
study	O	-1	8958188
of	O	-1	8958188
the	O	-1	8958188
anti@@	B-Chemical	D000983	8958188
pur@@	I-Chemical	-1	8958188
ine	I-Chemical	-1	8958188
anti@@	O	-1	8958188
fol@@	O	-1	8958188
ate	O	-1	8958188
lo@@	B-Chemical	C045894	8958188
me@@	I-Chemical	-1	8958188
tre@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ol	I-Chemical	-1	8958188
(	O	-1	8958188
D@@	B-Chemical	C045894	8958188
D@@	I-Chemical	-1	8958188
AT@@	I-Chemical	-1	8958188
H@@	I-Chemical	-1	8958188
F	I-Chemical	-1	8958188
)	O	-1	8958188
given	O	-1	8958188
with	O	-1	8958188
oral	O	-1	8958188
fol@@	B-Chemical	D005492	8958188
ic	I-Chemical	-1	8958188
acid	I-Chemical	-1	8958188
.	O	-1	8958188
L@@	B-Chemical	C045894	8958188
o@@	I-Chemical	-1	8958188
me@@	I-Chemical	-1	8958188
tre@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ol	I-Chemical	-1	8958188
is	O	-1	8958188
an	O	-1	8958188
anti@@	O	-1	8958188
fol@@	O	-1	8958188
ate	O	-1	8958188
which	O	-1	8958188
inhibit@@	O	-1	8958188
s	O	-1	8958188
glyc@@	B-Chemical	C402896	8958188
in@@	I-Chemical	-1	8958188
amide	I-Chemical	-1	8958188
rib@@	I-Chemical	-1	8958188
on@@	I-Chemical	-1	8958188
ucle@@	I-Chemical	-1	8958188
o@@	I-Chemical	-1	8958188
ti@@	I-Chemical	-1	8958188
de	I-Chemical	-1	8958188
form@@	O	-1	8958188
yl@@	O	-1	8958188
trans@@	O	-1	8958188
fer@@	O	-1	8958188
ase	O	-1	8958188
(@@	O	-1	8958188
G@@	O	-1	8958188
A@@	O	-1	8958188
R@@	O	-1	8958188
F@@	O	-1	8958188
T@@	O	-1	8958188
),	O	-1	8958188
an	O	-1	8958188
enzyme	O	-1	8958188
es@@	O	-1	8958188
sen@@	O	-1	8958188
tial	O	-1	8958188
for	O	-1	8958188
de	O	-1	8958188
no@@	O	-1	8958188
v@@	O	-1	8958188
o	O	-1	8958188
pur@@	B-Chemical	D011687	8958188
ine	I-Chemical	-1	8958188
syn@@	O	-1	8958188
the@@	O	-1	8958188
sis.	O	-1	8958188
E@@	O	-1	8958188
x@@	O	-1	8958188
ten@@	O	-1	8958188
sive	O	-1	8958188
experimental	O	-1	8958188
and	O	-1	8958188
lim@@	O	-1	8958188
ited	O	-1	8958188
clinical	O	-1	8958188
data	O	-1	8958188
have	O	-1	8958188
shown	O	-1	8958188
that	O	-1	8958188
lo@@	B-Chemical	C045894	8958188
me@@	I-Chemical	-1	8958188
tre@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ol	I-Chemical	-1	8958188
has	O	-1	8958188
activity	O	-1	8958188
against	O	-1	8958188
tu@@	B-Disease	D009369	8958188
mo@@	I-Disease	-1	8958188
ur@@	I-Disease	-1	8958188
s	I-Disease	-1	8958188
which	O	-1	8958188
are	O	-1	8958188
ref@@	O	-1	8958188
rac@@	O	-1	8958188
t@@	O	-1	8958188
ory	O	-1	8958188
to	O	-1	8958188
other	O	-1	8958188
drug@@	O	-1	8958188
s,	O	-1	8958188
not@@	O	-1	8958188
ably	O	-1	8958188
meth@@	B-Chemical	D008727	8958188
ot@@	I-Chemical	-1	8958188
re@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ate	I-Chemical	-1	8958188
.	O	-1	8958188
However,	O	-1	8958188
the	O	-1	8958188
initial	O	-1	8958188
clinical	O	-1	8958188
development	O	-1	8958188
of	O	-1	8958188
lo@@	B-Chemical	C045894	8958188
me@@	I-Chemical	-1	8958188
tre@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ol	I-Chemical	-1	8958188
was	O	-1	8958188
cur@@	O	-1	8958188
t@@	O	-1	8958188
ail@@	O	-1	8958188
ed	O	-1	8958188
because	O	-1	8958188
of	O	-1	8958188
severe	O	-1	8958188
and	O	-1	8958188
cum@@	O	-1	8958188
ul@@	O	-1	8958188
ative	O	-1	8958188
anti@@	O	-1	8958188
pro@@	O	-1	8958188
li@@	O	-1	8958188
fer@@	O	-1	8958188
ative	O	-1	8958188
toxic@@	B-Disease	D064420	8958188
ities	I-Disease	-1	8958188
.	O	-1	8958188
Pre@@	O	-1	8958188
clinical	O	-1	8958188
m@@	O	-1	8958188
urine	O	-1	8958188
studies	O	-1	8958188
demonstrated	O	-1	8958188
that	O	-1	8958188
the	O	-1	8958188
toxicity	B-Disease	D064420	8958188
of	O	-1	8958188
lo@@	B-Chemical	C045894	8958188
me@@	I-Chemical	-1	8958188
tre@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ol	I-Chemical	-1	8958188
can	O	-1	8958188
be	O	-1	8958188
prevent@@	O	-1	8958188
ed	O	-1	8958188
by	O	-1	8958188
low	O	-1	8958188
dose	O	-1	8958188
fol@@	B-Chemical	D005492	8958188
ic	I-Chemical	-1	8958188
acid	I-Chemical	-1	8958188
administr@@	O	-1	8958188
ation,	O	-1	8958188
i.@@	O	-1	8958188
e.	O	-1	8958188
for	O	-1	8958188
7	O	-1	8958188
days	O	-1	8958188
prior	O	-1	8958188
to	O	-1	8958188
and	O	-1	8958188
7	O	-1	8958188
days	O	-1	8958188
following	O	-1	8958188
a	O	-1	8958188
single	O	-1	8958188
b@@	O	-1	8958188
ol@@	O	-1	8958188
us	O	-1	8958188
dose.	O	-1	8958188
This	O	-1	8958188
observ@@	O	-1	8958188
ation	O	-1	8958188
pro@@	O	-1	8958188
m@@	O	-1	8958188
pt@@	O	-1	8958188
ed	O	-1	8958188
a	O	-1	8958188
Ph@@	O	-1	8958188
ase	O	-1	8958188
I	O	-1	8958188
clinical	O	-1	8958188
study	O	-1	8958188
of	O	-1	8958188
lo@@	B-Chemical	C045894	8958188
me@@	I-Chemical	-1	8958188
tre@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ol	I-Chemical	-1	8958188
given	O	-1	8958188
with	O	-1	8958188
fol@@	B-Chemical	D005492	8958188
ic	I-Chemical	-1	8958188
acid	I-Chemical	-1	8958188
sup@@	O	-1	8958188
ple@@	O	-1	8958188
ment@@	O	-1	8958188
ation	O	-1	8958188
which	O	-1	8958188
has	O	-1	8958188
con@@	O	-1	8958188
fir@@	O	-1	8958188
m@@	O	-1	8958188
ed	O	-1	8958188
that	O	-1	8958188
the	O	-1	8958188
toxicity	B-Disease	D064420	8958188
of	O	-1	8958188
lo@@	B-Chemical	C045894	8958188
me@@	I-Chemical	-1	8958188
tre@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ol	I-Chemical	-1	8958188
can	O	-1	8958188
be	O	-1	8958188
mark@@	O	-1	8958188
ed@@	O	-1	8958188
ly	O	-1	8958188
reduced	O	-1	8958188
by	O	-1	8958188
fol@@	B-Chemical	D005492	8958188
ic	I-Chemical	-1	8958188
acid	I-Chemical	-1	8958188
sup@@	O	-1	8958188
ple@@	O	-1	8958188
ment@@	O	-1	8958188
ation.	O	-1	8958188
Th@@	B-Disease	D013921	8958188
rom@@	I-Disease	-1	8958188
b@@	I-Disease	-1	8958188
ocyto@@	I-Disease	-1	8958188
pen@@	I-Disease	-1	8958188
ia	I-Disease	-1	8958188
and	O	-1	8958188
m@@	B-Disease	D052016	8958188
u@@	I-Disease	-1	8958188
co@@	I-Disease	-1	8958188
si@@	I-Disease	-1	8958188
tis	I-Disease	-1	8958188
were	O	-1	8958188
the	O	-1	8958188
major	O	-1	8958188
toxic@@	B-Disease	D064420	8958188
ities	I-Disease	-1	8958188
.	O	-1	8958188
There	O	-1	8958188
was	O	-1	8958188
no	O	-1	8958188
c@@	O	-1	8958188
le@@	O	-1	8958188
ar	O	-1	8958188
rel@@	O	-1	8958188
ationship	O	-1	8958188
between	O	-1	8958188
clinical	O	-1	8958188
toxicity	B-Disease	D064420	8958188
and	O	-1	8958188
the	O	-1	8958188
ext@@	O	-1	8958188
ent	O	-1	8958188
of	O	-1	8958188
plasma	O	-1	8958188
fol@@	B-Chemical	D005492	8958188
ate	I-Chemical	-1	8958188
elev@@	O	-1	8958188
ation.	O	-1	8958188
A@@	O	-1	8958188
s@@	O	-1	8958188
s@@	O	-1	8958188
oci@@	O	-1	8958188
ated	O	-1	8958188
studies	O	-1	8958188
demonstrated	O	-1	8958188
that	O	-1	8958188
lo@@	B-Chemical	C045894	8958188
me@@	I-Chemical	-1	8958188
tre@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ol	I-Chemical	-1	8958188
plasma	O	-1	8958188
pharmac@@	O	-1	8958188
o@@	O	-1	8958188
kine@@	O	-1	8958188
tics	O	-1	8958188
were	O	-1	8958188
not	O	-1	8958188
al@@	O	-1	8958188
te@@	O	-1	8958188
red	O	-1	8958188
by	O	-1	8958188
fol@@	B-Chemical	D005492	8958188
ic	I-Chemical	-1	8958188
acid	I-Chemical	-1	8958188
administration	O	-1	8958188
indicating	O	-1	8958188
that	O	-1	8958188
sup@@	O	-1	8958188
ple@@	O	-1	8958188
ment@@	O	-1	8958188
ation	O	-1	8958188
is	O	-1	8958188
un@@	O	-1	8958188
likely	O	-1	8958188
to	O	-1	8958188
re@@	O	-1	8958188
duce	O	-1	8958188
toxicity	B-Disease	D064420	8958188
by	O	-1	8958188
enh@@	O	-1	8958188
anc@@	O	-1	8958188
ing	O	-1	8958188
lo@@	B-Chemical	C045894	8958188
me@@	I-Chemical	-1	8958188
tre@@	I-Chemical	-1	8958188
x@@	I-Chemical	-1	8958188
ol	I-Chemical	-1	8958188
plasma	O	-1	8958188
clear@@	O	-1	8958188
ance@@	O	-1	8958188
.	O	-1	8958188
The	O	-1	8958188
wor@@	O	-1	8958188
k	O	-1	8958188
descri@@	O	-1	8958188
bed	O	-1	8958188
in	O	-1	8958188
this	O	-1	8958188
report	O	-1	8958188
has	O	-1	8958188
identi@@	O	-1	8958188
fied	O	-1	8958188
for	O	-1	8958188
the	O	-1	8958188
first	O	-1	8958188
time	O	-1	8958188
a	O	-1	8958188
clin@@	O	-1	8958188
ically	O	-1	8958188
ac@@	O	-1	8958188
ce@@	O	-1	8958188
pt@@	O	-1	8958188
able	O	-1	8958188
sch@@	O	-1	8958188
ed@@	O	-1	8958188
ul@@	O	-1	8958188
e	O	-1	8958188
for	O	-1	8958188
the	O	-1	8958188
administration	O	-1	8958188
of	O	-1	8958188
a	O	-1	8958188
G@@	O	-1	8958188
A@@	O	-1	8958188
R@@	O	-1	8958188
F@@	O	-1	8958188
T	O	-1	8958188
inhibitor@@	O	-1	8958188
.	O	-1	8958188
This	O	-1	8958188
inf@@	O	-1	8958188
orm@@	O	-1	8958188
ation	O	-1	8958188
wil@@	O	-1	8958188
l	O	-1	8958188
fac@@	O	-1	8958188
il@@	O	-1	8958188
it@@	O	-1	8958188
ate	O	-1	8958188
the	O	-1	8958188
f@@	O	-1	8958188
ut@@	O	-1	8958188
ure	O	-1	8958188
evalu@@	O	-1	8958188
ation	O	-1	8958188
of	O	-1	8958188
this	O	-1	8958188
cl@@	O	-1	8958188
as@@	O	-1	8958188
s	O	-1	8958188
of	O	-1	8958188
comp@@	O	-1	8958188
oun@@	O	-1	8958188
ds	O	-1	8958188
in	O	-1	8958188
cancer	B-Disease	D009369	8958188
therapy.	O	-1	8958188

In@@	O	-1	2557556
vol@@	O	-1	2557556
vement	O	-1	2557556
of	O	-1	2557556
the	O	-1	2557556
m@@	O	-1	2557556
u@@	O	-1	2557556
-@@	O	-1	2557556
o@@	O	-1	2557556
pi@@	O	-1	2557556
ate	O	-1	2557556
receptor	O	-1	2557556
in	O	-1	2557556
peripheral	O	-1	2557556
analge@@	B-Disease	D000699	2557556
sia	I-Disease	-1	2557556
.	O	-1	2557556
The	O	-1	2557556
intra@@	O	-1	2557556
der@@	O	-1	2557556
m@@	O	-1	2557556
al	O	-1	2557556
injection	O	-1	2557556
of	O	-1	2557556
m@@	O	-1	2557556
u	O	-1	2557556
(	O	-1	2557556
morphine	B-Chemical	D009020	2557556
,	O	-1	2557556
T@@	B-Chemical	D020875	2557556
y@@	I-Chemical	-1	2557556
r@@	I-Chemical	-1	2557556
-@@	I-Chemical	-1	2557556
D-@@	I-Chemical	-1	2557556
Al@@	I-Chemical	-1	2557556
a@@	I-Chemical	-1	2557556
-@@	I-Chemical	-1	2557556
G@@	I-Chemical	-1	2557556
l@@	I-Chemical	-1	2557556
y-@@	I-Chemical	-1	2557556
N@@	I-Chemical	-1	2557556
M@@	I-Chemical	-1	2557556
e-@@	I-Chemical	-1	2557556
P@@	I-Chemical	-1	2557556
he@@	I-Chemical	-1	2557556
-@@	I-Chemical	-1	2557556
G@@	I-Chemical	-1	2557556
l@@	I-Chemical	-1	2557556
y-@@	I-Chemical	-1	2557556
ol	I-Chemical	-1	2557556
and	O	-1	2557556
morph@@	B-Chemical	C028889	2557556
icep@@	I-Chemical	-1	2557556
tin	I-Chemical	-1	2557556
),	O	-1	2557556
k@@	O	-1	2557556
app@@	O	-1	2557556
a	O	-1	2557556
(	O	-1	2557556
trans@@	B-Chemical	D019900	2557556
-@@	I-Chemical	-1	2557556
3@@	I-Chemical	-1	2557556
,@@	I-Chemical	-1	2557556
4-@@	I-Chemical	-1	2557556
dic@@	I-Chemical	-1	2557556
h@@	I-Chemical	-1	2557556
loro@@	I-Chemical	-1	2557556
-@@	I-Chemical	-1	2557556
N@@	I-Chemical	-1	2557556
-@@	I-Chemical	-1	2557556
methyl@@	I-Chemical	-1	2557556
-@@	I-Chemical	-1	2557556
N@@	I-Chemical	-1	2557556
[@@	I-Chemical	-1	2557556
2-@@	I-Chemical	-1	2557556
(1@@	I-Chemical	-1	2557556
-@@	I-Chemical	-1	2557556
py@@	I-Chemical	-1	2557556
r@@	I-Chemical	-1	2557556
ro@@	I-Chemical	-1	2557556
l@@	I-Chemical	-1	2557556
id@@	I-Chemical	-1	2557556
in@@	I-Chemical	-1	2557556
yl@@	I-Chemical	-1	2557556
)	I-Chemical	-1	2557556
cyclo@@	I-Chemical	-1	2557556
he@@	I-Chemical	-1	2557556
x@@	I-Chemical	-1	2557556
yl@@	I-Chemical	-1	2557556
]@@	I-Chemical	-1	2557556
b@@	I-Chemical	-1	2557556
enz@@	I-Chemical	-1	2557556
en@@	I-Chemical	-1	2557556
e@@	I-Chemical	-1	2557556
act@@	I-Chemical	-1	2557556
em@@	I-Chemical	-1	2557556
ide	I-Chemical	-1	2557556
)	O	-1	2557556
and	O	-1	2557556
del@@	O	-1	2557556
t@@	O	-1	2557556
a	O	-1	2557556
(	O	-1	2557556
[@@	B-Chemical	D020881	2557556
D-@@	I-Chemical	-1	2557556
P@@	I-Chemical	-1	2557556
en@@	I-Chemical	-1	2557556
2.@@	I-Chemical	-1	2557556
5@@	I-Chemical	-1	2557556
]@@	I-Chemical	-1	2557556
-@@	I-Chemical	-1	2557556
en@@	I-Chemical	-1	2557556
ke@@	I-Chemical	-1	2557556
ph@@	I-Chemical	-1	2557556
al@@	I-Chemical	-1	2557556
in	I-Chemical	-1	2557556
and	O	-1	2557556
[@@	B-Chemical	C034318	2557556
D-@@	I-Chemical	-1	2557556
S@@	I-Chemical	-1	2557556
er@@	I-Chemical	-1	2557556
2@@	I-Chemical	-1	2557556
]@@	I-Chemical	-1	2557556
-@@	I-Chemical	-1	2557556
[@@	I-Chemical	-1	2557556
L@@	I-Chemical	-1	2557556
eu@@	I-Chemical	-1	2557556
]@@	I-Chemical	-1	2557556
en@@	I-Chemical	-1	2557556
ke@@	I-Chemical	-1	2557556
ph@@	I-Chemical	-1	2557556
al@@	I-Chemical	-1	2557556
in-@@	I-Chemical	-1	2557556
Th@@	I-Chemical	-1	2557556
r	I-Chemical	-1	2557556
)	O	-1	2557556
selective	O	-1	2557556
o@@	O	-1	2557556
pi@@	O	-1	2557556
oid@@	O	-1	2557556
-@@	O	-1	2557556
agon@@	O	-1	2557556
ist@@	O	-1	2557556
s,	O	-1	2557556
by	O	-1	2557556
th@@	O	-1	2557556
em@@	O	-1	2557556
sel@@	O	-1	2557556
v@@	O	-1	2557556
es,	O	-1	2557556
did	O	-1	2557556
not	O	-1	2557556
significantly	O	-1	2557556
aff@@	O	-1	2557556
ect	O	-1	2557556
the	O	-1	2557556
mechan@@	O	-1	2557556
ical	O	-1	2557556
n@@	O	-1	2557556
ocicep@@	O	-1	2557556
tive	O	-1	2557556
th@@	O	-1	2557556
res@@	O	-1	2557556
h@@	O	-1	2557556
old	O	-1	2557556
in	O	-1	2557556
the	O	-1	2557556
h@@	O	-1	2557556
ind@@	O	-1	2557556
pa@@	O	-1	2557556
w	O	-1	2557556
of	O	-1	2557556
the	O	-1	2557556
rat@@	O	-1	2557556
.	O	-1	2557556
In@@	O	-1	2557556
tra@@	O	-1	2557556
der@@	O	-1	2557556
m@@	O	-1	2557556
al	O	-1	2557556
injection	O	-1	2557556
of	O	-1	2557556
m@@	O	-1	2557556
u@@	O	-1	2557556
,	O	-1	2557556
but	O	-1	2557556
not	O	-1	2557556
del@@	O	-1	2557556
t@@	O	-1	2557556
a	O	-1	2557556
or	O	-1	2557556
k@@	O	-1	2557556
app@@	O	-1	2557556
a	O	-1	2557556
o@@	O	-1	2557556
pi@@	O	-1	2557556
oid@@	O	-1	2557556
-@@	O	-1	2557556
agon@@	O	-1	2557556
ist@@	O	-1	2557556
s,	O	-1	2557556
however,	O	-1	2557556
produced	O	-1	2557556
dose-@@	O	-1	2557556
dependent	O	-1	2557556
inhibition	O	-1	2557556
of	O	-1	2557556
pro@@	B-Chemical	D015232	2557556
st@@	I-Chemical	-1	2557556
ag@@	I-Chemical	-1	2557556
l@@	I-Chemical	-1	2557556
and@@	I-Chemical	-1	2557556
in	I-Chemical	-1	2557556
E@@	I-Chemical	-1	2557556
2	I-Chemical	-1	2557556
-induced	O	-1	2557556
hyperalge@@	B-Disease	D006930	2557556
sia	I-Disease	-1	2557556
.	O	-1	2557556
The	O	-1	2557556
analge@@	O	-1	2557556
sic	O	-1	2557556
effect	O	-1	2557556
of	O	-1	2557556
the	O	-1	2557556
m@@	O	-1	2557556
u@@	O	-1	2557556
-@@	O	-1	2557556
agon@@	O	-1	2557556
ist	O	-1	2557556
morphine	B-Chemical	D009020	2557556
was	O	-1	2557556
dose-@@	O	-1	2557556
depend@@	O	-1	2557556
ently	O	-1	2557556
antagon@@	O	-1	2557556
ized	O	-1	2557556
by	O	-1	2557556
n@@	B-Chemical	D009270	2557556
al@@	I-Chemical	-1	2557556
ox@@	I-Chemical	-1	2557556
one	I-Chemical	-1	2557556
and	O	-1	2557556
prevent@@	O	-1	2557556
ed	O	-1	2557556
by	O	-1	2557556
co-@@	O	-1	2557556
injection	O	-1	2557556
of	O	-1	2557556
per@@	O	-1	2557556
t@@	O	-1	2557556
us@@	O	-1	2557556
sis	O	-1	2557556
tox@@	O	-1	2557556
in.	O	-1	2557556
M@@	B-Chemical	D009020	2557556
or@@	I-Chemical	-1	2557556
ph@@	I-Chemical	-1	2557556
ine	I-Chemical	-1	2557556
did	O	-1	2557556
not@@	O	-1	2557556
,	O	-1	2557556
however,	O	-1	2557556
al@@	O	-1	2557556
ter	O	-1	2557556
the	O	-1	2557556
hyperalge@@	B-Disease	D006930	2557556
sia	I-Disease	-1	2557556
induced	O	-1	2557556
by	O	-1	2557556
8@@	B-Chemical	D015124	2557556
-@@	I-Chemical	-1	2557556
brom@@	I-Chemical	-1	2557556
o	I-Chemical	-1	2557556
cy@@	I-Chemical	-1	2557556
cl@@	I-Chemical	-1	2557556
ic	I-Chemical	-1	2557556
aden@@	I-Chemical	-1	2557556
os@@	I-Chemical	-1	2557556
ine	I-Chemical	-1	2557556
mon@@	I-Chemical	-1	2557556
oph@@	I-Chemical	-1	2557556
osph@@	I-Chemical	-1	2557556
ate	I-Chemical	-1	2557556
.	O	-1	2557556
We	O	-1	2557556
concl@@	O	-1	2557556
ude	O	-1	2557556
that	O	-1	2557556
the	O	-1	2557556
analge@@	O	-1	2557556
sic	O	-1	2557556
action	O	-1	2557556
of	O	-1	2557556
o@@	O	-1	2557556
pi@@	O	-1	2557556
oid@@	O	-1	2557556
s	O	-1	2557556
on	O	-1	2557556
the	O	-1	2557556
peripheral	O	-1	2557556
ter@@	O	-1	2557556
min@@	O	-1	2557556
als	O	-1	2557556
of	O	-1	2557556
prim@@	O	-1	2557556
ary	O	-1	2557556
a@@	O	-1	2557556
fferen@@	O	-1	2557556
ts	O	-1	2557556
is	O	-1	2557556
vi@@	O	-1	2557556
a	O	-1	2557556
a	O	-1	2557556
b@@	O	-1	2557556
ind@@	O	-1	2557556
ing	O	-1	2557556
sit@@	O	-1	2557556
e	O	-1	2557556
with	O	-1	2557556
character@@	O	-1	2557556
is@@	O	-1	2557556
tics	O	-1	2557556
of	O	-1	2557556
the	O	-1	2557556
m@@	O	-1	2557556
u@@	O	-1	2557556
-@@	O	-1	2557556
o@@	O	-1	2557556
pi@@	O	-1	2557556
oid	O	-1	2557556
receptor	O	-1	2557556
and	O	-1	2557556
that	O	-1	2557556
this	O	-1	2557556
action	O	-1	2557556
is	O	-1	2557556
mediated	O	-1	2557556
by	O	-1	2557556
inhibition	O	-1	2557556
of	O	-1	2557556
the	O	-1	2557556
cy@@	B-Chemical	D000242	2557556
cl@@	I-Chemical	-1	2557556
ic	I-Chemical	-1	2557556
aden@@	I-Chemical	-1	2557556
os@@	I-Chemical	-1	2557556
ine	I-Chemical	-1	2557556
mon@@	I-Chemical	-1	2557556
oph@@	I-Chemical	-1	2557556
osph@@	I-Chemical	-1	2557556
ate	I-Chemical	-1	2557556
second	O	-1	2557556
m@@	O	-1	2557556
es@@	O	-1	2557556
sen@@	O	-1	2557556
g@@	O	-1	2557556
er	O	-1	2557556
system@@	O	-1	2557556
.	O	-1	2557556

A@@	O	-1	15580403
de@@	O	-1	15580403
qu@@	O	-1	15580403
ate	O	-1	15580403
tim@@	O	-1	15580403
ing	O	-1	15580403
of	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
reduction	O	-1	15580403
in	O	-1	15580403
patients	O	-1	15580403
with	O	-1	15580403
hemoly@@	B-Disease	D006461	15580403
sis	I-Disease	-1	15580403
during	O	-1	15580403
combination	O	-1	15580403
therapy	O	-1	15580403
of	O	-1	15580403
inter@@	B-Chemical	D007372	15580403
fer@@	I-Chemical	-1	15580403
on	I-Chemical	-1	15580403
and	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
for	O	-1	15580403
chronic	B-Disease	D019698	15580403
hepatitis	I-Disease	-1	15580403
C	I-Disease	-1	15580403
.	O	-1	15580403
BACKGROUND:	O	-1	15580403
H@@	B-Disease	D000743	15580403
em@@	I-Disease	-1	15580403
oly@@	I-Disease	-1	15580403
tic	I-Disease	-1	15580403
anemia	I-Disease	-1	15580403
is	O	-1	15580403
one	O	-1	15580403
of	O	-1	15580403
the	O	-1	15580403
major	O	-1	15580403
adverse	O	-1	15580403
events	O	-1	15580403
of	O	-1	15580403
the	O	-1	15580403
combination	O	-1	15580403
therapy	O	-1	15580403
of	O	-1	15580403
inter@@	B-Chemical	D007372	15580403
fer@@	I-Chemical	-1	15580403
on	I-Chemical	-1	15580403
and	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
.	O	-1	15580403
B@@	O	-1	15580403
ecause	O	-1	15580403
of	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
-@@	O	-1	15580403
related	O	-1	15580403
hemolytic	B-Disease	D000743	15580403
anemia	I-Disease	-1	15580403
,	O	-1	15580403
dose	O	-1	15580403
reduction	O	-1	15580403
is	O	-1	15580403
a	O	-1	15580403
common	O	-1	15580403
ev@@	O	-1	15580403
ent	O	-1	15580403
in	O	-1	15580403
this	O	-1	15580403
therapy.	O	-1	15580403
In	O	-1	15580403
this	O	-1	15580403
clinical	O	-1	15580403
ret@@	O	-1	15580403
ro@@	O	-1	15580403
sp@@	O	-1	15580403
ective	O	-1	15580403
co@@	O	-1	15580403
h@@	O	-1	15580403
ort	O	-1	15580403
study	O	-1	15580403
we	O	-1	15580403
have	O	-1	15580403
examined	O	-1	15580403
the	O	-1	15580403
su@@	O	-1	15580403
it@@	O	-1	15580403
able	O	-1	15580403
tim@@	O	-1	15580403
ing	O	-1	15580403
of	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
reduction	O	-1	15580403
in	O	-1	15580403
patients	O	-1	15580403
with	O	-1	15580403
hemoly@@	B-Disease	D006461	15580403
sis	I-Disease	-1	15580403
during	O	-1	15580403
combination	O	-1	15580403
therapy.	O	-1	15580403
METHODS:	O	-1	15580403
Th@@	O	-1	15580403
ir@@	O	-1	15580403
ty-@@	O	-1	15580403
seven	O	-1	15580403
of	O	-1	15580403
1@@	O	-1	15580403
60	O	-1	15580403
patients	O	-1	15580403
who	O	-1	15580403
had	O	-1	15580403
HC@@	O	-1	15580403
V@@	O	-1	15580403
-@@	O	-1	15580403
gen@@	O	-1	15580403
ot@@	O	-1	15580403
yp@@	O	-1	15580403
e	O	-1	15580403
1@@	O	-1	15580403
b@@	O	-1	15580403
,	O	-1	15580403
had	O	-1	15580403
high	O	-1	15580403
vi@@	O	-1	15580403
ru@@	O	-1	15580403
s	O	-1	15580403
lo@@	O	-1	15580403
ad@@	O	-1	15580403
,	O	-1	15580403
and	O	-1	15580403
received	O	-1	15580403
2@@	O	-1	15580403
4-@@	O	-1	15580403
week	O	-1	15580403
combination	O	-1	15580403
therapy	O	-1	15580403
developed	O	-1	15580403
anemia	B-Disease	D000740	15580403
with	O	-1	15580403
hemo@@	O	-1	15580403
globin	O	-1	15580403
level	O	-1	15580403
<@@	O	-1	15580403
10	O	-1	15580403
g/@@	O	-1	15580403
d@@	O	-1	15580403
l	O	-1	15580403
or	O	-1	15580403
anemia	B-Disease	D000740	15580403
-@@	O	-1	15580403
related	O	-1	15580403
signs	O	-1	15580403
during	O	-1	15580403
therapy.	O	-1	15580403
After	O	-1	15580403
th@@	O	-1	15580403
at@@	O	-1	15580403
,	O	-1	15580403
these	O	-1	15580403
3@@	O	-1	15580403
7	O	-1	15580403
patients	O	-1	15580403
were	O	-1	15580403
reduced	O	-1	15580403
one	O	-1	15580403
t@@	O	-1	15580403
able@@	O	-1	15580403
t	O	-1	15580403
of	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
(2@@	O	-1	15580403
00	O	-1	15580403
mg@@	O	-1	15580403
)	O	-1	15580403
per	O	-1	15580403
da@@	O	-1	15580403
y.	O	-1	15580403
After	O	-1	15580403
reduction	O	-1	15580403
of	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
,	O	-1	15580403
2@@	O	-1	15580403
7	O	-1	15580403
of	O	-1	15580403
3@@	O	-1	15580403
7	O	-1	15580403
patients	O	-1	15580403
could	O	-1	15580403
continu@@	O	-1	15580403
e	O	-1	15580403
combination	O	-1	15580403
therapy	O	-1	15580403
for	O	-1	15580403
a	O	-1	15580403
total	O	-1	15580403
of	O	-1	15580403
24	O	-1	15580403
weeks	O	-1	15580403
(@@	O	-1	15580403
group	O	-1	15580403
A@@	O	-1	15580403
).	O	-1	15580403
However,	O	-1	15580403
10	O	-1	15580403
of	O	-1	15580403
3@@	O	-1	15580403
7	O	-1	15580403
patients	O	-1	15580403
with	O	-1	15580403
reduction	O	-1	15580403
of	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
could	O	-1	15580403
not	O	-1	15580403
continu@@	O	-1	15580403
e	O	-1	15580403
combination	O	-1	15580403
therapy	O	-1	15580403
because	O	-1	15580403
their	O	-1	15580403
<@@	O	-1	15580403
8.@@	O	-1	15580403
5	O	-1	15580403
g/@@	O	-1	15580403
d@@	O	-1	15580403
l	O	-1	15580403
hemo@@	O	-1	15580403
globin	O	-1	15580403
values	O	-1	15580403
decreased	O	-1	15580403
to	O	-1	15580403
or	O	-1	15580403
anemia	B-Disease	D000740	15580403
-@@	O	-1	15580403
related	O	-1	15580403
severe	O	-1	15580403
side	O	-1	15580403
effects	O	-1	15580403
occurred	O	-1	15580403
(@@	O	-1	15580403
group	O	-1	15580403
B@@	O	-1	15580403
).	O	-1	15580403
We	O	-1	15580403
assessed	O	-1	15580403
the	O	-1	15580403
f@@	O	-1	15580403
inal	O	-1	15580403
efficacy	O	-1	15580403
and	O	-1	15580403
safety	O	-1	15580403
after	O	-1	15580403
reduction	O	-1	15580403
of	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
in	O	-1	15580403
groups	O	-1	15580403
A	O	-1	15580403
and	O	-1	15580403
B@@	O	-1	15580403
.	O	-1	15580403
RESULTS:	O	-1	15580403
A	O	-1	15580403
su@@	O	-1	15580403
st@@	O	-1	15580403
ained	O	-1	15580403
vi@@	O	-1	15580403
ro@@	O	-1	15580403
log@@	O	-1	15580403
ical	O	-1	15580403
response	O	-1	15580403
(S@@	O	-1	15580403
V@@	O	-1	15580403
R@@	O	-1	15580403
)	O	-1	15580403
was	O	-1	15580403
2@@	O	-1	15580403
9.@@	O	-1	15580403
6%	O	-1	15580403
(@@	O	-1	15580403
8@@	O	-1	15580403
/@@	O	-1	15580403
27@@	O	-1	15580403
)	O	-1	15580403
in	O	-1	15580403
group	O	-1	15580403
A	O	-1	15580403
and	O	-1	15580403
10@@	O	-1	15580403
%	O	-1	15580403
(1@@	O	-1	15580403
/@@	O	-1	15580403
10@@	O	-1	15580403
)	O	-1	15580403
in	O	-1	15580403
group	O	-1	15580403
B@@	O	-1	15580403
,	O	-1	15580403
respectively.	O	-1	15580403
A	O	-1	15580403
3@@	O	-1	15580403
4.@@	O	-1	15580403
4@@	O	-1	15580403
%	O	-1	15580403
(1@@	O	-1	15580403
2@@	O	-1	15580403
/@@	O	-1	15580403
27@@	O	-1	15580403
)	O	-1	15580403
of	O	-1	15580403
S@@	O	-1	15580403
V@@	O	-1	15580403
R	O	-1	15580403
+	O	-1	15580403
bio@@	O	-1	15580403
log@@	O	-1	15580403
ical	O	-1	15580403
response	O	-1	15580403
in	O	-1	15580403
group	O	-1	15580403
A	O	-1	15580403
was	O	-1	15580403
higher	O	-1	15580403
than	O	-1	15580403
10@@	O	-1	15580403
%	O	-1	15580403
(1@@	O	-1	15580403
/@@	O	-1	15580403
10@@	O	-1	15580403
)	O	-1	15580403
in	O	-1	15580403
group	O	-1	15580403
B	O	-1	15580403
(	O	-1	15580403
P	O	-1	15580403
=	O	-1	15580403
0.05@@	O	-1	15580403
1),	O	-1	15580403
with	O	-1	15580403
s@@	O	-1	15580403
li@@	O	-1	15580403
ght	O	-1	15580403
signific@@	O	-1	15580403
ance@@	O	-1	15580403
.	O	-1	15580403
W@@	O	-1	15580403
it@@	O	-1	15580403
h	O	-1	15580403
resp@@	O	-1	15580403
ect	O	-1	15580403
to	O	-1	15580403
hemo@@	O	-1	15580403
globin	O	-1	15580403
level	O	-1	15580403
at	O	-1	15580403
the	O	-1	15580403
time	O	-1	15580403
of	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
reduc@@	O	-1	15580403
tion,	O	-1	15580403
a	O	-1	15580403
rate	O	-1	15580403
of	O	-1	15580403
continu@@	O	-1	15580403
ation	O	-1	15580403
of	O	-1	15580403
therapy	O	-1	15580403
in	O	-1	15580403
patients	O	-1	15580403
with	O	-1	15580403
>	O	-1	15580403
or	O	-1	15580403
=@@	O	-1	15580403
10	O	-1	15580403
g/@@	O	-1	15580403
d@@	O	-1	15580403
l	O	-1	15580403
hemo@@	O	-1	15580403
globin	O	-1	15580403
was	O	-1	15580403
higher	O	-1	15580403
than	O	-1	15580403
that	O	-1	15580403
in	O	-1	15580403
patients	O	-1	15580403
with	O	-1	15580403
<@@	O	-1	15580403
10	O	-1	15580403
g/@@	O	-1	15580403
d@@	O	-1	15580403
l	O	-1	15580403
(	O	-1	15580403
P	O	-1	15580403
=	O	-1	15580403
0.0@@	O	-1	15580403
3@@	O	-1	15580403
6@@	O	-1	15580403
).	O	-1	15580403
CONCLUSIONS:	O	-1	15580403
Re@@	O	-1	15580403
duction	O	-1	15580403
of	O	-1	15580403
rib@@	B-Chemical	D012254	15580403
avi@@	I-Chemical	-1	15580403
rin	I-Chemical	-1	15580403
at	O	-1	15580403
hemo@@	O	-1	15580403
globin	O	-1	15580403
level	O	-1	15580403
>	O	-1	15580403
or	O	-1	15580403
=@@	O	-1	15580403
10	O	-1	15580403
g/@@	O	-1	15580403
d@@	O	-1	15580403
l	O	-1	15580403
is	O	-1	15580403
su@@	O	-1	15580403
it@@	O	-1	15580403
able	O	-1	15580403
in	O	-1	15580403
ter@@	O	-1	15580403
ms	O	-1	15580403
of	O	-1	15580403
efficacy	O	-1	15580403
and	O	-1	15580403
side	O	-1	15580403
effects.	O	-1	15580403

In@@	O	-1	15075188
c@@	O	-1	15075188
reas@@	O	-1	15075188
ed	O	-1	15075188
expression	O	-1	15075188
and	O	-1	15075188
ap@@	O	-1	15075188
ical	O	-1	15075188
t@@	O	-1	15075188
arg@@	O	-1	15075188
et@@	O	-1	15075188
ing	O	-1	15075188
of	O	-1	15075188
renal	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C	O	-1	15075188
sub@@	O	-1	15075188
un@@	O	-1	15075188
its	O	-1	15075188
in	O	-1	15075188
p@@	B-Chemical	D011692	15075188
uro@@	I-Chemical	-1	15075188
m@@	I-Chemical	-1	15075188
ycin	I-Chemical	-1	15075188
amin@@	I-Chemical	-1	15075188
on@@	I-Chemical	-1	15075188
ucle@@	I-Chemical	-1	15075188
o@@	I-Chemical	-1	15075188
side	I-Chemical	-1	15075188
-induced	O	-1	15075188
nephro@@	B-Disease	D009404	15075188
tic	I-Disease	-1	15075188
syndrome	I-Disease	-1	15075188
in	O	-1	15075188
rats.	O	-1	15075188
Ne@@	B-Disease	D009404	15075188
ph@@	I-Disease	-1	15075188
ro@@	I-Disease	-1	15075188
tic	I-Disease	-1	15075188
syndrome	I-Disease	-1	15075188
is	O	-1	15075188
often	O	-1	15075188
ac@@	O	-1	15075188
comp@@	O	-1	15075188
an@@	O	-1	15075188
ied	O	-1	15075188
by	O	-1	15075188
sodium	B-Chemical	D012964	15075188
re@@	O	-1	15075188
ten@@	O	-1	15075188
tion	O	-1	15075188
and	O	-1	15075188
gener@@	O	-1	15075188
al@@	O	-1	15075188
ized	O	-1	15075188
e@@	B-Disease	D004487	15075188
de@@	I-Disease	-1	15075188
ma	I-Disease	-1	15075188
.	O	-1	15075188
However,	O	-1	15075188
the	O	-1	15075188
mol@@	O	-1	15075188
ec@@	O	-1	15075188
ular	O	-1	15075188
b@@	O	-1	15075188
asis	O	-1	15075188
for	O	-1	15075188
the	O	-1	15075188
decreased	O	-1	15075188
renal	O	-1	15075188
sodium	B-Chemical	D012964	15075188
ex@@	O	-1	15075188
cre@@	O	-1	15075188
tion	O	-1	15075188
remain@@	O	-1	15075188
s	O	-1	15075188
un@@	O	-1	15075188
def@@	O	-1	15075188
ine@@	O	-1	15075188
d.	O	-1	15075188
We	O	-1	15075188
hypo@@	O	-1	15075188
the@@	O	-1	15075188
si@@	O	-1	15075188
zed	O	-1	15075188
that	O	-1	15075188
epi@@	O	-1	15075188
thelial	O	-1	15075188
N@@	B-Chemical	D012964	15075188
a	I-Chemical	-1	15075188
channel	O	-1	15075188
(@@	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C@@	O	-1	15075188
)	O	-1	15075188
sub@@	O	-1	15075188
un@@	O	-1	15075188
it	O	-1	15075188
dys@@	O	-1	15075188
reg@@	O	-1	15075188
ulation	O	-1	15075188
may	O	-1	15075188
be	O	-1	15075188
respon@@	O	-1	15075188
sible	O	-1	15075188
for	O	-1	15075188
the	O	-1	15075188
increased	O	-1	15075188
sodium	B-Chemical	D012964	15075188
re@@	O	-1	15075188
ten@@	O	-1	15075188
tion.	O	-1	15075188
An	O	-1	15075188
experimental	O	-1	15075188
group	O	-1	15075188
of	O	-1	15075188
rats	O	-1	15075188
was	O	-1	15075188
treated	O	-1	15075188
with	O	-1	15075188
p@@	B-Chemical	D011692	15075188
uro@@	I-Chemical	-1	15075188
m@@	I-Chemical	-1	15075188
ycin	I-Chemical	-1	15075188
amin@@	I-Chemical	-1	15075188
on@@	I-Chemical	-1	15075188
ucle@@	I-Chemical	-1	15075188
o@@	I-Chemical	-1	15075188
side	I-Chemical	-1	15075188
(	O	-1	15075188
PA@@	B-Chemical	D011692	15075188
N	I-Chemical	-1	15075188
;	O	-1	15075188
18@@	O	-1	15075188
0	O	-1	15075188
mg/kg	O	-1	15075188
i@@	O	-1	15075188
v@@	O	-1	15075188
),	O	-1	15075188
whereas	O	-1	15075188
the	O	-1	15075188
control	O	-1	15075188
group	O	-1	15075188
received	O	-1	15075188
only	O	-1	15075188
ve@@	O	-1	15075188
h@@	O	-1	15075188
ic@@	O	-1	15075188
le@@	O	-1	15075188
.	O	-1	15075188
After	O	-1	15075188
7	O	-1	15075188
day@@	O	-1	15075188
s,	O	-1	15075188
PA@@	B-Chemical	D011692	15075188
N	I-Chemical	-1	15075188
treatment	O	-1	15075188
induced	O	-1	15075188
significant	O	-1	15075188
proteinuria	B-Disease	D011507	15075188
,	O	-1	15075188
hypo@@	B-Disease	D034141	15075188
al@@	I-Disease	-1	15075188
b@@	I-Disease	-1	15075188
um@@	I-Disease	-1	15075188
ine@@	I-Disease	-1	15075188
mia	I-Disease	-1	15075188
,	O	-1	15075188
decreased	O	-1	15075188
urinary	O	-1	15075188
sodium	B-Chemical	D012964	15075188
ex@@	O	-1	15075188
cre@@	O	-1	15075188
tion,	O	-1	15075188
and	O	-1	15075188
exten@@	O	-1	15075188
sive	O	-1	15075188
as@@	B-Disease	D001201	15075188
cit@@	I-Disease	-1	15075188
es	I-Disease	-1	15075188
.	O	-1	15075188
The	O	-1	15075188
protein	O	-1	15075188
ab@@	O	-1	15075188
und@@	O	-1	15075188
ance	O	-1	15075188
of	O	-1	15075188
alpha-@@	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C	O	-1	15075188
and	O	-1	15075188
beta-@@	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C	O	-1	15075188
was	O	-1	15075188
increased	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
in@@	O	-1	15075188
n@@	O	-1	15075188
er	O	-1	15075188
stri@@	O	-1	15075188
p@@	O	-1	15075188
e	O	-1	15075188
of	O	-1	15075188
the	O	-1	15075188
ou@@	O	-1	15075188
ter	O	-1	15075188
med@@	O	-1	15075188
ul@@	O	-1	15075188
l@@	O	-1	15075188
a	O	-1	15075188
(@@	O	-1	15075188
I@@	O	-1	15075188
S@@	O	-1	15075188
O@@	O	-1	15075188
M@@	O	-1	15075188
)	O	-1	15075188
and	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
in@@	O	-1	15075188
n@@	O	-1	15075188
er	O	-1	15075188
med@@	O	-1	15075188
ul@@	O	-1	15075188
l@@	O	-1	15075188
a	O	-1	15075188
(@@	O	-1	15075188
I@@	O	-1	15075188
M@@	O	-1	15075188
)	O	-1	15075188
but	O	-1	15075188
was	O	-1	15075188
not	O	-1	15075188
al@@	O	-1	15075188
te@@	O	-1	15075188
red	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
cor@@	O	-1	15075188
t@@	O	-1	15075188
ex@@	O	-1	15075188
.	O	-1	15075188
gamma@@	O	-1	15075188
-@@	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C	O	-1	15075188
ab@@	O	-1	15075188
und@@	O	-1	15075188
ance	O	-1	15075188
was	O	-1	15075188
increased	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
cor@@	O	-1	15075188
t@@	O	-1	15075188
ex@@	O	-1	15075188
,	O	-1	15075188
I@@	O	-1	15075188
S@@	O	-1	15075188
O@@	O	-1	15075188
M@@	O	-1	15075188
,	O	-1	15075188
and	O	-1	15075188
I@@	O	-1	15075188
M@@	O	-1	15075188
.	O	-1	15075188
Im@@	O	-1	15075188
mun@@	O	-1	15075188
o@@	O	-1	15075188
per@@	O	-1	15075188
oxid@@	O	-1	15075188
ase	O	-1	15075188
b@@	O	-1	15075188
ri@@	O	-1	15075188
gh@@	O	-1	15075188
t@@	O	-1	15075188
fi@@	O	-1	15075188
el@@	O	-1	15075188
d@@	O	-1	15075188
-	O	-1	15075188
and	O	-1	15075188
las@@	O	-1	15075188
er@@	O	-1	15075188
-@@	O	-1	15075188
s@@	O	-1	15075188
can@@	O	-1	15075188
ning	O	-1	15075188
conf@@	O	-1	15075188
oc@@	O	-1	15075188
al	O	-1	15075188
fluo@@	O	-1	15075188
res@@	O	-1	15075188
c@@	O	-1	15075188
ence	O	-1	15075188
micro@@	O	-1	15075188
sco@@	O	-1	15075188
p@@	O	-1	15075188
y	O	-1	15075188
demonstrated	O	-1	15075188
increased	O	-1	15075188
t@@	O	-1	15075188
arg@@	O	-1	15075188
et@@	O	-1	15075188
ing	O	-1	15075188
of	O	-1	15075188
alpha-@@	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C@@	O	-1	15075188
,	O	-1	15075188
beta-@@	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C@@	O	-1	15075188
,	O	-1	15075188
and	O	-1	15075188
gamma@@	O	-1	15075188
-@@	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C	O	-1	15075188
sub@@	O	-1	15075188
un@@	O	-1	15075188
its	O	-1	15075188
to	O	-1	15075188
the	O	-1	15075188
ap@@	O	-1	15075188
ical	O	-1	15075188
plasma	O	-1	15075188
membran@@	O	-1	15075188
e	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
dist@@	O	-1	15075188
al	O	-1	15075188
con@@	O	-1	15075188
vol@@	O	-1	15075188
ut@@	O	-1	15075188
ed	O	-1	15075188
tub@@	O	-1	15075188
ul@@	O	-1	15075188
e	O	-1	15075188
(D@@	O	-1	15075188
C@@	O	-1	15075188
T@@	O	-1	15075188
2@@	O	-1	15075188
),	O	-1	15075188
con@@	O	-1	15075188
n@@	O	-1	15075188
ect@@	O	-1	15075188
ing	O	-1	15075188
tub@@	O	-1	15075188
ul@@	O	-1	15075188
e,	O	-1	15075188
and	O	-1	15075188
cor@@	O	-1	15075188
tical	O	-1	15075188
and	O	-1	15075188
med@@	O	-1	15075188
ul@@	O	-1	15075188
l@@	O	-1	15075188
ary	O	-1	15075188
coll@@	O	-1	15075188
ect@@	O	-1	15075188
ing	O	-1	15075188
duc@@	O	-1	15075188
t	O	-1	15075188
seg@@	O	-1	15075188
ment@@	O	-1	15075188
s.	O	-1	15075188
Im@@	O	-1	15075188
mun@@	O	-1	15075188
o@@	O	-1	15075188
electro@@	O	-1	15075188
n	O	-1	15075188
micro@@	O	-1	15075188
sco@@	O	-1	15075188
p@@	O	-1	15075188
y	O	-1	15075188
further	O	-1	15075188
revealed	O	-1	15075188
an	O	-1	15075188
increased	O	-1	15075188
l@@	O	-1	15075188
a@@	O	-1	15075188
be@@	O	-1	15075188
l@@	O	-1	15075188
ing	O	-1	15075188
of	O	-1	15075188
alpha-@@	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
ap@@	O	-1	15075188
ical	O	-1	15075188
plasma	O	-1	15075188
membran@@	O	-1	15075188
e	O	-1	15075188
of	O	-1	15075188
cor@@	O	-1	15075188
tical	O	-1	15075188
coll@@	O	-1	15075188
ect@@	O	-1	15075188
ing	O	-1	15075188
duc@@	O	-1	15075188
t	O	-1	15075188
pr@@	O	-1	15075188
inc@@	O	-1	15075188
ip@@	O	-1	15075188
al	O	-1	15075188
cells	O	-1	15075188
of	O	-1	15075188
PA@@	B-Chemical	D011692	15075188
N	I-Chemical	-1	15075188
-treated	O	-1	15075188
rats,	O	-1	15075188
indicating	O	-1	15075188
enhanced	O	-1	15075188
ap@@	O	-1	15075188
ical	O	-1	15075188
t@@	O	-1	15075188
arg@@	O	-1	15075188
et@@	O	-1	15075188
ing	O	-1	15075188
of	O	-1	15075188
alpha-@@	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C	O	-1	15075188
sub@@	O	-1	15075188
un@@	O	-1	15075188
it@@	O	-1	15075188
s.	O	-1	15075188
In	O	-1	15075188
contrast@@	O	-1	15075188
,	O	-1	15075188
the	O	-1	15075188
protein	O	-1	15075188
ab@@	O	-1	15075188
und@@	O	-1	15075188
anc@@	O	-1	15075188
es	O	-1	15075188
of	O	-1	15075188
N@@	B-Chemical	D012964	15075188
a	I-Chemical	-1	15075188
(@@	O	-1	15075188
+@@	O	-1	15075188
)@@	O	-1	15075188
/	O	-1	15075188
H	B-Chemical	D006859	15075188
(@@	O	-1	15075188
+@@	O	-1	15075188
)	O	-1	15075188
ex@@	O	-1	15075188
chang@@	O	-1	15075188
er	O	-1	15075188
type	O	-1	15075188
3	O	-1	15075188
(N@@	O	-1	15075188
H@@	O	-1	15075188
E@@	O	-1	15075188
3@@	O	-1	15075188
),	O	-1	15075188
N@@	B-Chemical	D012964	15075188
a	I-Chemical	-1	15075188
(@@	O	-1	15075188
+@@	O	-1	15075188
)@@	O	-1	15075188
-	O	-1	15075188
K	B-Chemical	D011188	15075188
(@@	O	-1	15075188
+@@	O	-1	15075188
)-@@	O	-1	15075188
2	O	-1	15075188
C@@	B-Chemical	D002713	15075188
l	I-Chemical	-1	15075188
(-@@	O	-1	15075188
)	O	-1	15075188
co@@	O	-1	15075188
trans@@	O	-1	15075188
por@@	O	-1	15075188
ter	O	-1	15075188
(B@@	O	-1	15075188
S@@	O	-1	15075188
C@@	O	-1	15075188
-1@@	O	-1	15075188
),	O	-1	15075188
and	O	-1	15075188
thi@@	B-Chemical	D049971	15075188
az@@	I-Chemical	-1	15075188
ide	I-Chemical	-1	15075188
-@@	O	-1	15075188
sensitive	O	-1	15075188
N@@	B-Chemical	D012964	15075188
a	I-Chemical	-1	15075188
(@@	O	-1	15075188
+@@	O	-1	15075188
)@@	O	-1	15075188
-	O	-1	15075188
C@@	B-Chemical	D002713	15075188
l	I-Chemical	-1	15075188
(-@@	O	-1	15075188
)	O	-1	15075188
co@@	O	-1	15075188
trans@@	O	-1	15075188
por@@	O	-1	15075188
ter	O	-1	15075188
(T@@	O	-1	15075188
S@@	O	-1	15075188
C@@	O	-1	15075188
)	O	-1	15075188
were	O	-1	15075188
decreas@@	O	-1	15075188
ed.	O	-1	15075188
M@@	O	-1	15075188
ore@@	O	-1	15075188
o@@	O	-1	15075188
ver,	O	-1	15075188
the	O	-1	15075188
ab@@	O	-1	15075188
und@@	O	-1	15075188
ance	O	-1	15075188
of	O	-1	15075188
the	O	-1	15075188
alpha@@	O	-1	15075188
(1@@	O	-1	15075188
)-@@	O	-1	15075188
sub@@	O	-1	15075188
un@@	O	-1	15075188
it	O	-1	15075188
of	O	-1	15075188
the	O	-1	15075188
N@@	B-Chemical	D012964	15075188
a	I-Chemical	-1	15075188
-	O	-1	15075188
K	B-Chemical	D011188	15075188
-@@	O	-1	15075188
AT@@	O	-1	15075188
P@@	O	-1	15075188
ase	O	-1	15075188
was	O	-1	15075188
decreased	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
cor@@	O	-1	15075188
te@@	O	-1	15075188
x	O	-1	15075188
and	O	-1	15075188
I@@	O	-1	15075188
S@@	O	-1	15075188
O@@	O	-1	15075188
M@@	O	-1	15075188
,	O	-1	15075188
but	O	-1	15075188
it	O	-1	15075188
remained	O	-1	15075188
un@@	O	-1	15075188
chang@@	O	-1	15075188
ed	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
I@@	O	-1	15075188
M@@	O	-1	15075188
.	O	-1	15075188
In	O	-1	15075188
concl@@	O	-1	15075188
u@@	O	-1	15075188
sion,	O	-1	15075188
the	O	-1	15075188
increased	O	-1	15075188
or	O	-1	15075188
su@@	O	-1	15075188
st@@	O	-1	15075188
ained	O	-1	15075188
expression	O	-1	15075188
of	O	-1	15075188
E@@	O	-1	15075188
Na@@	O	-1	15075188
C	O	-1	15075188
sub@@	O	-1	15075188
un@@	O	-1	15075188
its	O	-1	15075188
combined	O	-1	15075188
with	O	-1	15075188
increased	O	-1	15075188
ap@@	O	-1	15075188
ical	O	-1	15075188
t@@	O	-1	15075188
arg@@	O	-1	15075188
et@@	O	-1	15075188
ing	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
D@@	O	-1	15075188
C@@	O	-1	15075188
T@@	O	-1	15075188
2,	O	-1	15075188
con@@	O	-1	15075188
n@@	O	-1	15075188
ect@@	O	-1	15075188
ing	O	-1	15075188
tub@@	O	-1	15075188
ul@@	O	-1	15075188
e,	O	-1	15075188
and	O	-1	15075188
coll@@	O	-1	15075188
ect@@	O	-1	15075188
ing	O	-1	15075188
duc@@	O	-1	15075188
t	O	-1	15075188
are	O	-1	15075188
likely	O	-1	15075188
to	O	-1	15075188
pl@@	O	-1	15075188
ay	O	-1	15075188
a	O	-1	15075188
role	O	-1	15075188
in	O	-1	15075188
the	O	-1	15075188
sodium	B-Chemical	D012964	15075188
re@@	O	-1	15075188
ten@@	O	-1	15075188
tion	O	-1	15075188
associated	O	-1	15075188
with	O	-1	15075188
PA@@	B-Chemical	D011692	15075188
N	I-Chemical	-1	15075188
-induced	O	-1	15075188
nephro@@	B-Disease	D009404	15075188
tic	I-Disease	-1	15075188
syndrome	I-Disease	-1	15075188
.	O	-1	15075188
The	O	-1	15075188
decreased	O	-1	15075188
ab@@	O	-1	15075188
und@@	O	-1	15075188
ance	O	-1	15075188
of	O	-1	15075188
N@@	O	-1	15075188
H@@	O	-1	15075188
E@@	O	-1	15075188
3,	O	-1	15075188
B@@	O	-1	15075188
S@@	O	-1	15075188
C@@	O	-1	15075188
-1@@	O	-1	15075188
,	O	-1	15075188
T@@	O	-1	15075188
S@@	O	-1	15075188
C@@	O	-1	15075188
,	O	-1	15075188
and	O	-1	15075188
N@@	B-Chemical	D012964	15075188
a	I-Chemical	-1	15075188
-	O	-1	15075188
K	B-Chemical	D011188	15075188
-@@	O	-1	15075188
AT@@	O	-1	15075188
P@@	O	-1	15075188
ase	O	-1	15075188
may	O	-1	15075188
pl@@	O	-1	15075188
ay	O	-1	15075188
a	O	-1	15075188
com@@	O	-1	15075188
pen@@	O	-1	15075188
s@@	O	-1	15075188
atory	O	-1	15075188
role	O	-1	15075188
to	O	-1	15075188
pro@@	O	-1	15075188
m@@	O	-1	15075188
ot@@	O	-1	15075188
e	O	-1	15075188
sodium	B-Chemical	D012964	15075188
ex@@	O	-1	15075188
cre@@	O	-1	15075188
tion.	O	-1	15075188

D@@	O	-1	14745746
o@@	O	-1	14745746
es	O	-1	14745746
h@@	O	-1	14745746
orm@@	O	-1	14745746
one	O	-1	14745746
therapy	O	-1	14745746
for	O	-1	14745746
the	O	-1	14745746
treatment	O	-1	14745746
of	O	-1	14745746
b@@	B-Disease	D001943	14745746
reas@@	I-Disease	-1	14745746
t	I-Disease	-1	14745746
cancer	I-Disease	-1	14745746
have	O	-1	14745746
a	O	-1	14745746
de@@	B-Disease	D008569	14745746
tri@@	I-Disease	-1	14745746
mental	I-Disease	-1	14745746
effect	I-Disease	-1	14745746
on	I-Disease	-1	14745746
memory	I-Disease	-1	14745746
and	I-Disease	-1	14745746
cogn@@	I-Disease	-1	14745746
ition	I-Disease	-1	14745746
de@@	B-Disease	D003072	14745746
tri@@	I-Disease	-1	14745746
mental	I-Disease	-1	14745746
effect	I-Disease	-1	14745746
on	I-Disease	-1	14745746
memory	I-Disease	-1	14745746
and	I-Disease	-1	14745746
cogn@@	I-Disease	-1	14745746
ition	I-Disease	-1	14745746
?	O	-1	14745746
A	O	-1	14745746
pilo@@	O	-1	14745746
t	O	-1	14745746
study.	O	-1	14745746
This	O	-1	14745746
pilo@@	O	-1	14745746
t	O	-1	14745746
study	O	-1	14745746
examin@@	O	-1	14745746
es	O	-1	14745746
whether	O	-1	14745746
h@@	O	-1	14745746
orm@@	O	-1	14745746
one	O	-1	14745746
therapy	O	-1	14745746
for	O	-1	14745746
b@@	B-Disease	D001943	14745746
reas@@	I-Disease	-1	14745746
t	I-Disease	-1	14745746
cancer	I-Disease	-1	14745746
aff@@	O	-1	14745746
ects	O	-1	14745746
cogn@@	O	-1	14745746
i@@	O	-1	14745746
tion.	O	-1	14745746
Patients	O	-1	14745746
partic@@	O	-1	14745746
ip@@	O	-1	14745746
ating	O	-1	14745746
in	O	-1	14745746
a	O	-1	14745746
random@@	O	-1	14745746
is@@	O	-1	14745746
ed	O	-1	14745746
trial	O	-1	14745746
of	O	-1	14745746
an@@	B-Chemical	C090450	14745746
ast@@	I-Chemical	-1	14745746
ro@@	I-Chemical	-1	14745746
z@@	I-Chemical	-1	14745746
ole	I-Chemical	-1	14745746
,	O	-1	14745746
t@@	B-Chemical	D013629	14745746
am@@	I-Chemical	-1	14745746
oxif@@	I-Chemical	-1	14745746
en	I-Chemical	-1	14745746
alone	O	-1	14745746
or	O	-1	14745746
combined	O	-1	14745746
(A@@	O	-1	14745746
T@@	O	-1	14745746
AC@@	O	-1	14745746
)	O	-1	14745746
(n@@	O	-1	14745746
=@@	O	-1	14745746
9@@	O	-1	14745746
4@@	O	-1	14745746
)	O	-1	14745746
and	O	-1	14745746
a	O	-1	14745746
group	O	-1	14745746
of	O	-1	14745746
women	O	-1	14745746
without	O	-1	14745746
b@@	B-Disease	D001943	14745746
reas@@	I-Disease	-1	14745746
t	I-Disease	-1	14745746
cancer	I-Disease	-1	14745746
(n@@	O	-1	14745746
=@@	O	-1	14745746
3@@	O	-1	14745746
5@@	O	-1	14745746
)	O	-1	14745746
comple@@	O	-1	14745746
ted	O	-1	14745746
a	O	-1	14745746
b@@	O	-1	14745746
at@@	O	-1	14745746
ter@@	O	-1	14745746
y	O	-1	14745746
of	O	-1	14745746
neuro@@	O	-1	14745746
psych@@	O	-1	14745746
ological	O	-1	14745746
meas@@	O	-1	14745746
ures@@	O	-1	14745746
.	O	-1	14745746
Com@@	O	-1	14745746
pared	O	-1	14745746
with	O	-1	14745746
the	O	-1	14745746
control	O	-1	14745746
group@@	O	-1	14745746
,	O	-1	14745746
the	O	-1	14745746
patients	O	-1	14745746
were	O	-1	14745746
impaired	O	-1	14745746
on	O	-1	14745746
a	O	-1	14745746
pro@@	O	-1	14745746
cess@@	O	-1	14745746
ing	O	-1	14745746
sp@@	O	-1	14745746
e@@	O	-1	14745746
ed	O	-1	14745746
t@@	O	-1	14745746
as@@	O	-1	14745746
k	O	-1	14745746
(p@@	O	-1	14745746
=@@	O	-1	14745746
0.0@@	O	-1	14745746
3@@	O	-1	14745746
2)	O	-1	14745746
and	O	-1	14745746
on	O	-1	14745746
a	O	-1	14745746
meas@@	O	-1	14745746
ure	O	-1	14745746
of	O	-1	14745746
immedi@@	O	-1	14745746
ate	O	-1	14745746
ver@@	O	-1	14745746
b@@	O	-1	14745746
al	O	-1	14745746
memory	O	-1	14745746
(p@@	O	-1	14745746
=@@	O	-1	14745746
0.0@@	O	-1	14745746
2@@	O	-1	14745746
6@@	O	-1	14745746
)	O	-1	14745746
after	O	-1	14745746
contro@@	O	-1	14745746
ll@@	O	-1	14745746
ing	O	-1	14745746
for	O	-1	14745746
the	O	-1	14745746
use	O	-1	14745746
of	O	-1	14745746
h@@	O	-1	14745746
orm@@	O	-1	14745746
one	O	-1	14745746
re@@	O	-1	14745746
pl@@	O	-1	14745746
ac@@	O	-1	14745746
ement	O	-1	14745746
therapy	O	-1	14745746
in	O	-1	14745746
both	O	-1	14745746
groups.	O	-1	14745746
Pati@@	O	-1	14745746
ent	O	-1	14745746
group	O	-1	14745746
perform@@	O	-1	14745746
ance	O	-1	14745746
was	O	-1	14745746
not	O	-1	14745746
significantly	O	-1	14745746
related	O	-1	14745746
to	O	-1	14745746
l@@	O	-1	14745746
en@@	O	-1	14745746
g@@	O	-1	14745746
th	O	-1	14745746
of	O	-1	14745746
treatment	O	-1	14745746
or	O	-1	14745746
meas@@	O	-1	14745746
ures	O	-1	14745746
of	O	-1	14745746
psych@@	O	-1	14745746
ological	O	-1	14745746
mor@@	O	-1	14745746
b@@	O	-1	14745746
id@@	O	-1	14745746
ity.	O	-1	14745746
The	O	-1	14745746
results	O	-1	14745746
showed	O	-1	14745746
specific	O	-1	14745746
impair@@	O	-1	14745746
ments	O	-1	14745746
in	O	-1	14745746
pro@@	O	-1	14745746
cess@@	O	-1	14745746
ing	O	-1	14745746
sp@@	O	-1	14745746
e@@	O	-1	14745746
ed	O	-1	14745746
and	O	-1	14745746
ver@@	O	-1	14745746
b@@	O	-1	14745746
al	O	-1	14745746
memory	O	-1	14745746
in	O	-1	14745746
women	O	-1	14745746
receiving	O	-1	14745746
h@@	O	-1	14745746
orm@@	O	-1	14745746
on@@	O	-1	14745746
al	O	-1	14745746
therapy	O	-1	14745746
for	O	-1	14745746
the	O	-1	14745746
treatment	O	-1	14745746
of	O	-1	14745746
b@@	B-Disease	D001943	14745746
reas@@	I-Disease	-1	14745746
t	I-Disease	-1	14745746
cancer	I-Disease	-1	14745746
.	O	-1	14745746
V@@	O	-1	14745746
er@@	O	-1	14745746
b@@	O	-1	14745746
al	O	-1	14745746
memory	O	-1	14745746
may	O	-1	14745746
be	O	-1	14745746
es@@	O	-1	14745746
p@@	O	-1	14745746
ec@@	O	-1	14745746
i@@	O	-1	14745746
ally	O	-1	14745746
sensitive	O	-1	14745746
to	O	-1	14745746
changes	O	-1	14745746
in	O	-1	14745746
o@@	B-Chemical	D004967	14745746
est@@	I-Chemical	-1	14745746
ro@@	I-Chemical	-1	14745746
gen	I-Chemical	-1	14745746
level@@	O	-1	14745746
s,	O	-1	14745746
a	O	-1	14745746
find@@	O	-1	14745746
ing	O	-1	14745746
common@@	O	-1	14745746
ly	O	-1	14745746
reported	O	-1	14745746
in	O	-1	14745746
studies	O	-1	14745746
of	O	-1	14745746
h@@	O	-1	14745746
orm@@	O	-1	14745746
one	O	-1	14745746
re@@	O	-1	14745746
pl@@	O	-1	14745746
ac@@	O	-1	14745746
ement	O	-1	14745746
therapy	O	-1	14745746
in	O	-1	14745746
healthy	O	-1	14745746
wom@@	O	-1	14745746
en@@	O	-1	14745746
.	O	-1	14745746
In	O	-1	14745746
vie@@	O	-1	14745746
w	O	-1	14745746
of	O	-1	14745746
the	O	-1	14745746
increased	O	-1	14745746
use	O	-1	14745746
of	O	-1	14745746
h@@	O	-1	14745746
orm@@	O	-1	14745746
one	O	-1	14745746
therap@@	O	-1	14745746
i@@	O	-1	14745746
es	O	-1	14745746
in	O	-1	14745746
an	O	-1	14745746
adj@@	O	-1	14745746
u@@	O	-1	14745746
v@@	O	-1	14745746
ant	O	-1	14745746
and	O	-1	14745746
prevent@@	O	-1	14745746
ative	O	-1	14745746
se@@	O	-1	14745746
t@@	O	-1	14745746
ting	O	-1	14745746
their	O	-1	14745746
im@@	O	-1	14745746
pac@@	O	-1	14745746
t	O	-1	14745746
on	O	-1	14745746
cognitive	O	-1	14745746
func@@	O	-1	14745746
tion@@	O	-1	14745746
ing	O	-1	14745746
should	O	-1	14745746
be	O	-1	14745746
investigated	O	-1	14745746
more	O	-1	14745746
th@@	O	-1	14745746
o@@	O	-1	14745746
rou@@	O	-1	14745746
gh@@	O	-1	14745746
ly.	O	-1	14745746

A@@	O	-1	11208990
s@@	O	-1	11208990
s@@	O	-1	11208990
oci@@	O	-1	11208990
ation	O	-1	11208990
of	O	-1	11208990
nit@@	B-Chemical	D009569	11208990
ric	I-Chemical	-1	11208990
ox@@	I-Chemical	-1	11208990
ide	I-Chemical	-1	11208990
pro@@	O	-1	11208990
duction	O	-1	11208990
and	O	-1	11208990
apo@@	O	-1	11208990
pto@@	O	-1	11208990
sis	O	-1	11208990
in	O	-1	11208990
a	O	-1	11208990
model	O	-1	11208990
of	O	-1	11208990
experimental	O	-1	11208990
nephro@@	B-Disease	D007674	11208990
pathy	I-Disease	-1	11208990
.	O	-1	11208990
BACKGROUND:	O	-1	11208990
In	O	-1	11208990
rec@@	O	-1	11208990
ent	O	-1	11208990
studies	O	-1	11208990
increased	O	-1	11208990
amoun@@	O	-1	11208990
ts	O	-1	11208990
of	O	-1	11208990
nit@@	B-Chemical	D009569	11208990
ric	I-Chemical	-1	11208990
ox@@	I-Chemical	-1	11208990
ide	I-Chemical	-1	11208990
(	O	-1	11208990
N@@	B-Chemical	D009569	11208990
O	I-Chemical	-1	11208990
)	O	-1	11208990
and	O	-1	11208990
apo@@	O	-1	11208990
pto@@	O	-1	11208990
sis	O	-1	11208990
have	O	-1	11208990
been	O	-1	11208990
implic@@	O	-1	11208990
ated	O	-1	11208990
in	O	-1	11208990
various	O	-1	11208990
path@@	O	-1	11208990
ological	O	-1	11208990
condi@@	O	-1	11208990
tions	O	-1	11208990
in	O	-1	11208990
the	O	-1	11208990
kidne@@	O	-1	11208990
y.	O	-1	11208990
We	O	-1	11208990
have	O	-1	11208990
studied	O	-1	11208990
the	O	-1	11208990
role	O	-1	11208990
of	O	-1	11208990
N@@	B-Chemical	D009569	11208990
O	I-Chemical	-1	11208990
and	O	-1	11208990
its	O	-1	11208990
association	O	-1	11208990
with	O	-1	11208990
apo@@	O	-1	11208990
pto@@	O	-1	11208990
sis	O	-1	11208990
in	O	-1	11208990
an	O	-1	11208990
experimental	O	-1	11208990
model	O	-1	11208990
of	O	-1	11208990
nephro@@	B-Disease	D009404	11208990
tic	I-Disease	-1	11208990
syndrome	I-Disease	-1	11208990
induced	O	-1	11208990
by	O	-1	11208990
a	O	-1	11208990
single	O	-1	11208990
injection	O	-1	11208990
of	O	-1	11208990
adriam@@	B-Chemical	D004317	11208990
ycin	I-Chemical	-1	11208990
(	O	-1	11208990
AD@@	B-Chemical	D004317	11208990
R	I-Chemical	-1	11208990
).	O	-1	11208990
METHODS:	O	-1	11208990
The	O	-1	11208990
al@@	O	-1	11208990
ter@@	O	-1	11208990
ation	O	-1	11208990
in	O	-1	11208990
the	O	-1	11208990
N@@	B-Chemical	D009569	11208990
O	I-Chemical	-1	11208990
path@@	O	-1	11208990
w@@	O	-1	11208990
ay	O	-1	11208990
was	O	-1	11208990
assessed	O	-1	11208990
by	O	-1	11208990
meas@@	O	-1	11208990
uring	O	-1	11208990
nit@@	B-Chemical	D009573	11208990
rit@@	I-Chemical	-1	11208990
e	I-Chemical	-1	11208990
levels	O	-1	11208990
in	O	-1	11208990
ser@@	O	-1	11208990
um@@	O	-1	11208990
/@@	O	-1	11208990
urine	O	-1	11208990
and	O	-1	11208990
by	O	-1	11208990
evalu@@	O	-1	11208990
ating	O	-1	11208990
the	O	-1	11208990
changes	O	-1	11208990
in	O	-1	11208990
vascular	O	-1	11208990
re@@	O	-1	11208990
activity	O	-1	11208990
of	O	-1	11208990
the	O	-1	11208990
isol@@	O	-1	11208990
ated	O	-1	11208990
per@@	O	-1	11208990
f@@	O	-1	11208990
used	O	-1	11208990
rat	O	-1	11208990
kidney	O	-1	11208990
(@@	O	-1	11208990
I@@	O	-1	11208990
P@@	O	-1	11208990
R@@	O	-1	11208990
K@@	O	-1	11208990
)	O	-1	11208990
system@@	O	-1	11208990
.	O	-1	11208990
R@@	O	-1	11208990
at@@	O	-1	11208990
s	O	-1	11208990
were	O	-1	11208990
str@@	O	-1	11208990
ati@@	O	-1	11208990
fied	O	-1	11208990
into	O	-1	11208990
control	O	-1	11208990
groups	O	-1	11208990
and	O	-1	11208990
AD@@	B-Chemical	D004317	11208990
R	I-Chemical	-1	11208990
-induced	O	-1	11208990
nephro@@	B-Disease	D007674	11208990
pathy	I-Disease	-1	11208990
groups.	O	-1	11208990
These	O	-1	11208990
two	O	-1	11208990
groups	O	-1	11208990
were	O	-1	11208990
then	O	-1	11208990
divid@@	O	-1	11208990
ed	O	-1	11208990
in@@	O	-1	11208990
to@@	O	-1	11208990
:	O	-1	11208990
group	O	-1	11208990
1,	O	-1	11208990
animals	O	-1	11208990
receiving	O	-1	11208990
sal@@	O	-1	11208990
ine@@	O	-1	11208990
;	O	-1	11208990
and	O	-1	11208990
group	O	-1	11208990
2,	O	-1	11208990
animals	O	-1	11208990
receiving	O	-1	11208990
amino@@	B-Chemical	C004479	11208990
gu@@	I-Chemical	-1	11208990
an@@	I-Chemical	-1	11208990
idine	I-Chemical	-1	11208990
(	O	-1	11208990
A@@	B-Chemical	C004479	11208990
G	I-Chemical	-1	11208990
)	O	-1	11208990
which	O	-1	11208990
is	O	-1	11208990
a	O	-1	11208990
specific	O	-1	11208990
inhibitor	O	-1	11208990
of	O	-1	11208990
induc@@	O	-1	11208990
i@@	O	-1	11208990
ble@@	O	-1	11208990
-	O	-1	11208990
N@@	B-Chemical	D009569	11208990
O	I-Chemical	-1	11208990
syn@@	O	-1	11208990
th@@	O	-1	11208990
as@@	O	-1	11208990
e.	O	-1	11208990
O@@	O	-1	11208990
n	O	-1	11208990
day	O	-1	11208990
2@@	O	-1	11208990
1,	O	-1	11208990
rats	O	-1	11208990
were	O	-1	11208990
s@@	O	-1	11208990
ac@@	O	-1	11208990
ri@@	O	-1	11208990
fic@@	O	-1	11208990
ed	O	-1	11208990
after	O	-1	11208990
obt@@	O	-1	11208990
aining	O	-1	11208990
mat@@	O	-1	11208990
er@@	O	-1	11208990
ial	O	-1	11208990
for	O	-1	11208990
bio@@	O	-1	11208990
chemical	O	-1	11208990
analy@@	O	-1	11208990
sis.	O	-1	11208990
RESULTS:	O	-1	11208990
H@@	O	-1	11208990
ist@@	O	-1	11208990
o@@	O	-1	11208990
path@@	O	-1	11208990
ological	O	-1	11208990
examin@@	O	-1	11208990
ation	O	-1	11208990
of	O	-1	11208990
the	O	-1	11208990
kidne@@	O	-1	11208990
ys	O	-1	11208990
of	O	-1	11208990
rats	O	-1	11208990
treated	O	-1	11208990
with	O	-1	11208990
AD@@	B-Chemical	D004317	11208990
R	I-Chemical	-1	11208990
revealed	O	-1	11208990
foc@@	O	-1	11208990
al	O	-1	11208990
a@@	O	-1	11208990
reas	O	-1	11208990
of	O	-1	11208990
m@@	B-Disease	C537346	11208990
es@@	I-Disease	-1	11208990
ang@@	I-Disease	-1	11208990
ial	I-Disease	-1	11208990
pro@@	I-Disease	-1	11208990
li@@	I-Disease	-1	11208990
fer@@	I-Disease	-1	11208990
ation	I-Disease	-1	11208990
and	O	-1	11208990
mil@@	O	-1	11208990
d	O	-1	11208990
tu@@	B-Disease	D009395	11208990
bu@@	I-Disease	-1	11208990
lo@@	I-Disease	-1	11208990
interstitial	I-Disease	-1	11208990
inflam@@	I-Disease	-1	11208990
m@@	I-Disease	-1	11208990
ation	I-Disease	-1	11208990
.	O	-1	11208990
The@@	O	-1	11208990
y	O	-1	11208990
also	O	-1	11208990
had	O	-1	11208990
significantly	O	-1	11208990
higher	O	-1	11208990
levels	O	-1	11208990
of	O	-1	11208990
proteinuria	B-Disease	D011507	11208990
compared	O	-1	11208990
with	O	-1	11208990
control	O	-1	11208990
and	O	-1	11208990
treatment	O	-1	11208990
groups	O	-1	11208990
(P	O	-1	11208990
<	O	-1	11208990
0.05@@	O	-1	11208990
).	O	-1	11208990
U@@	O	-1	11208990
rine	O	-1	11208990
nit@@	B-Chemical	D009573	11208990
rit@@	I-Chemical	-1	11208990
e	I-Chemical	-1	11208990
levels	O	-1	11208990
were	O	-1	11208990
significantly	O	-1	11208990
increased	O	-1	11208990
in	O	-1	11208990
the	O	-1	11208990
AD@@	B-Chemical	D004317	11208990
R	I-Chemical	-1	11208990
-	O	-1	11208990
nephro@@	B-Disease	D007674	11208990
pathy	I-Disease	-1	11208990
group	O	-1	11208990
(P	O	-1	11208990
<	O	-1	11208990
0.05@@	O	-1	11208990
).	O	-1	11208990
In	O	-1	11208990
the	O	-1	11208990
I@@	O	-1	11208990
P@@	O	-1	11208990
R@@	O	-1	11208990
K	O	-1	11208990
pheny@@	B-Chemical	D010656	11208990
le@@	I-Chemical	-1	11208990
phrine	I-Chemical	-1	11208990
and	O	-1	11208990
acet@@	B-Chemical	D000109	11208990
ylcholine	I-Chemical	-1	11208990
related	O	-1	11208990
responses	O	-1	11208990
were	O	-1	11208990
significantly	O	-1	11208990
impaired	O	-1	11208990
in	O	-1	11208990
the	O	-1	11208990
AD@@	B-Chemical	D004317	11208990
R	I-Chemical	-1	11208990
-	O	-1	11208990
nephro@@	B-Disease	D007674	11208990
pathy	I-Disease	-1	11208990
group.	O	-1	11208990
A@@	O	-1	11208990
po@@	O	-1	11208990
pto@@	O	-1	11208990
sis	O	-1	11208990
was	O	-1	11208990
not	O	-1	11208990
det@@	O	-1	11208990
ected	O	-1	11208990
in	O	-1	11208990
controls.	O	-1	11208990
However,	O	-1	11208990
in	O	-1	11208990
the	O	-1	11208990
AD@@	B-Chemical	D004317	11208990
R	I-Chemical	-1	11208990
-	O	-1	11208990
nephro@@	B-Disease	D007674	11208990
pathy	I-Disease	-1	11208990
group@@	O	-1	11208990
,	O	-1	11208990
n@@	O	-1	11208990
um@@	O	-1	11208990
er@@	O	-1	11208990
ous	O	-1	11208990
apo@@	O	-1	11208990
pto@@	O	-1	11208990
tic	O	-1	11208990
cells	O	-1	11208990
were	O	-1	11208990
identi@@	O	-1	11208990
fied	O	-1	11208990
in	O	-1	11208990
the	O	-1	11208990
tu@@	O	-1	11208990
bu@@	O	-1	11208990
lo@@	O	-1	11208990
interstitial	O	-1	11208990
a@@	O	-1	11208990
reas@@	O	-1	11208990
.	O	-1	11208990
D@@	O	-1	11208990
ou@@	O	-1	11208990
ble	O	-1	11208990
st@@	O	-1	11208990
aining	O	-1	11208990
revealed	O	-1	11208990
n@@	O	-1	11208990
um@@	O	-1	11208990
er@@	O	-1	11208990
ous	O	-1	11208990
interstitial	O	-1	11208990
apo@@	O	-1	11208990
pto@@	O	-1	11208990
tic	O	-1	11208990
cells	O	-1	11208990
to	O	-1	11208990
st@@	O	-1	11208990
ain	O	-1	11208990
for	O	-1	11208990
E@@	O	-1	11208990
D@@	O	-1	11208990
1,	O	-1	11208990
a	O	-1	11208990
mark@@	O	-1	11208990
er	O	-1	11208990
for	O	-1	11208990
mon@@	O	-1	11208990
ocy@@	O	-1	11208990
t@@	O	-1	11208990
es@@	O	-1	11208990
/@@	O	-1	11208990
mac@@	O	-1	11208990
ro@@	O	-1	11208990
ph@@	O	-1	11208990
ag@@	O	-1	11208990
es.	O	-1	11208990
Treat@@	O	-1	11208990
ment	O	-1	11208990
with	O	-1	11208990
A@@	B-Chemical	C004479	11208990
G	I-Chemical	-1	11208990
prevent@@	O	-1	11208990
ed	O	-1	11208990
the	O	-1	11208990
impair@@	O	-1	11208990
ment	O	-1	11208990
of	O	-1	11208990
renal	O	-1	11208990
vascular	O	-1	11208990
bed	O	-1	11208990
responses	O	-1	11208990
and	O	-1	11208990
reduced	O	-1	11208990
both	O	-1	11208990
urine	O	-1	11208990
nit@@	B-Chemical	D009573	11208990
rit@@	I-Chemical	-1	11208990
e	I-Chemical	-1	11208990
levels	O	-1	11208990
and	O	-1	11208990
apo@@	O	-1	11208990
pto@@	O	-1	11208990
sis	O	-1	11208990
to	O	-1	11208990
control	O	-1	11208990
level@@	O	-1	11208990
s.	O	-1	11208990
CONCLUSION:	O	-1	11208990
We	O	-1	11208990
suggest	O	-1	11208990
that	O	-1	11208990
inter@@	O	-1	11208990
ac@@	O	-1	11208990
tions	O	-1	11208990
between	O	-1	11208990
N@@	B-Chemical	D009569	11208990
O	I-Chemical	-1	11208990
and	O	-1	11208990
apo@@	O	-1	11208990
pto@@	O	-1	11208990
sis	O	-1	11208990
are	O	-1	11208990
important	O	-1	11208990
in	O	-1	11208990
the	O	-1	11208990
path@@	O	-1	11208990
o@@	O	-1	11208990
genesis	O	-1	11208990
of	O	-1	11208990
the	O	-1	11208990
AD@@	B-Chemical	D004317	11208990
R	I-Chemical	-1	11208990
-induced	O	-1	11208990
nephro@@	B-Disease	D009401	11208990
sis	I-Disease	-1	11208990
.	O	-1	11208990

The	O	-1	9201797
attenu@@	O	-1	9201797
ating	O	-1	9201797
effect	O	-1	9201797
of	O	-1	9201797
car@@	B-Chemical	D002354	9201797
te@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
hydro@@	I-Chemical	-1	9201797
chlor@@	I-Chemical	-1	9201797
ide	I-Chemical	-1	9201797
,	O	-1	9201797
a	O	-1	9201797
beta-@@	O	-1	9201797
adren@@	O	-1	9201797
oc@@	O	-1	9201797
e@@	O	-1	9201797
pt@@	O	-1	9201797
or	O	-1	9201797
antagonist@@	O	-1	9201797
,	O	-1	9201797
on	O	-1	9201797
neuro@@	O	-1	9201797
le@@	O	-1	9201797
p@@	O	-1	9201797
tic@@	O	-1	9201797
-induced	O	-1	9201797
cat@@	B-Disease	D002375	9201797
al@@	I-Disease	-1	9201797
ep@@	I-Disease	-1	9201797
sy	I-Disease	-1	9201797
in	O	-1	9201797
rats.	O	-1	9201797
It	O	-1	9201797
is	O	-1	9201797
known	O	-1	9201797
that	O	-1	9201797
beta-@@	O	-1	9201797
adren@@	O	-1	9201797
oc@@	O	-1	9201797
e@@	O	-1	9201797
pt@@	O	-1	9201797
or	O	-1	9201797
antagonist@@	O	-1	9201797
s	O	-1	9201797
are	O	-1	9201797
effective	O	-1	9201797
in	O	-1	9201797
the	O	-1	9201797
treatment	O	-1	9201797
of	O	-1	9201797
ak@@	B-Disease	D017109	9201797
athi@@	I-Disease	-1	9201797
sia	I-Disease	-1	9201797
,	O	-1	9201797
one	O	-1	9201797
of	O	-1	9201797
the	O	-1	9201797
ext@@	O	-1	9201797
ra@@	O	-1	9201797
py@@	O	-1	9201797
ram@@	O	-1	9201797
idal	O	-1	9201797
side	O	-1	9201797
effects	O	-1	9201797
that	O	-1	9201797
occ@@	O	-1	9201797
ur	O	-1	9201797
during	O	-1	9201797
neuro@@	O	-1	9201797
le@@	O	-1	9201797
p@@	O	-1	9201797
tic	O	-1	9201797
treatment.	O	-1	9201797
Ne@@	O	-1	9201797
uro@@	O	-1	9201797
le@@	O	-1	9201797
p@@	O	-1	9201797
tic@@	O	-1	9201797
-induced	O	-1	9201797
cat@@	B-Disease	D002375	9201797
al@@	I-Disease	-1	9201797
ep@@	I-Disease	-1	9201797
sy	I-Disease	-1	9201797
,	O	-1	9201797
a	O	-1	9201797
model	O	-1	9201797
of	O	-1	9201797
neuro@@	O	-1	9201797
le@@	O	-1	9201797
p@@	O	-1	9201797
tic@@	O	-1	9201797
-induced	O	-1	9201797
ext@@	O	-1	9201797
ra@@	O	-1	9201797
py@@	O	-1	9201797
ram@@	O	-1	9201797
idal	O	-1	9201797
side	O	-1	9201797
effect@@	O	-1	9201797
s,	O	-1	9201797
was	O	-1	9201797
considered	O	-1	9201797
su@@	O	-1	9201797
it@@	O	-1	9201797
able	O	-1	9201797
as	O	-1	9201797
a	O	-1	9201797
model	O	-1	9201797
for	O	-1	9201797
predic@@	O	-1	9201797
ting	O	-1	9201797
neuro@@	O	-1	9201797
le@@	O	-1	9201797
p@@	O	-1	9201797
tic@@	O	-1	9201797
-induced	O	-1	9201797
ak@@	B-Disease	D017109	9201797
athi@@	I-Disease	-1	9201797
sia	I-Disease	-1	9201797
in	O	-1	9201797
hum@@	O	-1	9201797
an@@	O	-1	9201797
s,	O	-1	9201797
although	O	-1	9201797
neuro@@	O	-1	9201797
le@@	O	-1	9201797
p@@	O	-1	9201797
tic@@	O	-1	9201797
-induced	O	-1	9201797
cat@@	B-Disease	D002375	9201797
al@@	I-Disease	-1	9201797
ep@@	I-Disease	-1	9201797
sy	I-Disease	-1	9201797
was	O	-1	9201797
not	O	-1	9201797
considered	O	-1	9201797
a	O	-1	9201797
specific	O	-1	9201797
test	O	-1	9201797
for	O	-1	9201797
neuro@@	O	-1	9201797
le@@	O	-1	9201797
p@@	O	-1	9201797
tic@@	O	-1	9201797
-induced	O	-1	9201797
ak@@	B-Disease	D017109	9201797
athi@@	I-Disease	-1	9201797
sia	I-Disease	-1	9201797
.	O	-1	9201797
The@@	O	-1	9201797
refore,	O	-1	9201797
the	O	-1	9201797
effects	O	-1	9201797
of	O	-1	9201797
car@@	B-Chemical	D002354	9201797
te@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
,	O	-1	9201797
a	O	-1	9201797
beta-@@	O	-1	9201797
adren@@	O	-1	9201797
oc@@	O	-1	9201797
e@@	O	-1	9201797
pt@@	O	-1	9201797
or	O	-1	9201797
antagonist@@	O	-1	9201797
,	O	-1	9201797
on	O	-1	9201797
haloperidol	B-Chemical	D006220	9201797
-induced	O	-1	9201797
cat@@	B-Disease	D002375	9201797
al@@	I-Disease	-1	9201797
ep@@	I-Disease	-1	9201797
sy	I-Disease	-1	9201797
in	O	-1	9201797
rats	O	-1	9201797
were	O	-1	9201797
behavi@@	O	-1	9201797
or@@	O	-1	9201797
ally	O	-1	9201797
studied	O	-1	9201797
and	O	-1	9201797
compared	O	-1	9201797
with	O	-1	9201797
those	O	-1	9201797
of	O	-1	9201797
prop@@	B-Chemical	D011433	9201797
ran@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
and	O	-1	9201797
b@@	B-Chemical	D001712	9201797
i@@	I-Chemical	-1	9201797
peri@@	I-Chemical	-1	9201797
de@@	I-Chemical	-1	9201797
n	I-Chemical	-1	9201797
,	O	-1	9201797
a	O	-1	9201797
mus@@	O	-1	9201797
car@@	O	-1	9201797
inic	O	-1	9201797
receptor	O	-1	9201797
antagonist@@	O	-1	9201797
.	O	-1	9201797
C@@	B-Chemical	D002354	9201797
ar@@	I-Chemical	-1	9201797
te@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
,	O	-1	9201797
as	O	-1	9201797
well	O	-1	9201797
as	O	-1	9201797
prop@@	B-Chemical	D011433	9201797
ran@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
and	O	-1	9201797
b@@	B-Chemical	D001712	9201797
i@@	I-Chemical	-1	9201797
peri@@	I-Chemical	-1	9201797
de@@	I-Chemical	-1	9201797
n	I-Chemical	-1	9201797
,	O	-1	9201797
inhibited	O	-1	9201797
the	O	-1	9201797
haloperidol	B-Chemical	D006220	9201797
-induced	O	-1	9201797
cat@@	B-Disease	D002375	9201797
al@@	I-Disease	-1	9201797
ep@@	I-Disease	-1	9201797
sy	I-Disease	-1	9201797
.	O	-1	9201797
The	O	-1	9201797
inhibit@@	O	-1	9201797
ory	O	-1	9201797
effect	O	-1	9201797
of	O	-1	9201797
car@@	B-Chemical	D002354	9201797
te@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
was	O	-1	9201797
al@@	O	-1	9201797
most	O	-1	9201797
compar@@	O	-1	9201797
able	O	-1	9201797
to	O	-1	9201797
that	O	-1	9201797
of	O	-1	9201797
prop@@	B-Chemical	D011433	9201797
ran@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
,	O	-1	9201797
but	O	-1	9201797
was	O	-1	9201797
we@@	O	-1	9201797
ak@@	O	-1	9201797
er	O	-1	9201797
than	O	-1	9201797
that	O	-1	9201797
of	O	-1	9201797
b@@	B-Chemical	D001712	9201797
i@@	I-Chemical	-1	9201797
peri@@	I-Chemical	-1	9201797
de@@	I-Chemical	-1	9201797
n	I-Chemical	-1	9201797
.	O	-1	9201797
C@@	B-Chemical	D002354	9201797
ar@@	I-Chemical	-1	9201797
te@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
did	O	-1	9201797
not	O	-1	9201797
evo@@	O	-1	9201797
k@@	O	-1	9201797
e	O	-1	9201797
post@@	O	-1	9201797
syn@@	O	-1	9201797
ap@@	O	-1	9201797
tic	O	-1	9201797
dopamine	B-Chemical	D004298	9201797
receptor@@	O	-1	9201797
-@@	O	-1	9201797
stimul@@	O	-1	9201797
ating	O	-1	9201797
behavioral	O	-1	9201797
signs	O	-1	9201797
such	O	-1	9201797
as	O	-1	9201797
ste@@	O	-1	9201797
re@@	O	-1	9201797
ot@@	O	-1	9201797
yp@@	O	-1	9201797
y	O	-1	9201797
and	O	-1	9201797
hyper@@	B-Disease	D009069	9201797
locom@@	I-Disease	-1	9201797
o@@	I-Disease	-1	9201797
tion	I-Disease	-1	9201797
in	O	-1	9201797
rats.	O	-1	9201797
C@@	B-Chemical	D002354	9201797
ar@@	I-Chemical	-1	9201797
te@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
did	O	-1	9201797
not	O	-1	9201797
antagon@@	O	-1	9201797
iz@@	O	-1	9201797
e	O	-1	9201797
the	O	-1	9201797
inhibit@@	O	-1	9201797
ory	O	-1	9201797
effects	O	-1	9201797
of	O	-1	9201797
haloperidol	B-Chemical	D006220	9201797
on	O	-1	9201797
apo@@	B-Chemical	D001058	9201797
morphine	I-Chemical	-1	9201797
-induced	O	-1	9201797
ste@@	O	-1	9201797
re@@	O	-1	9201797
ot@@	O	-1	9201797
yp@@	O	-1	9201797
y	O	-1	9201797
and	O	-1	9201797
locomotor	O	-1	9201797
activity	O	-1	9201797
in	O	-1	9201797
rats.	O	-1	9201797
In	O	-1	9201797
addi@@	O	-1	9201797
tion,	O	-1	9201797
car@@	B-Chemical	D002354	9201797
te@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
did	O	-1	9201797
not	O	-1	9201797
evo@@	O	-1	9201797
k@@	O	-1	9201797
e	O	-1	9201797
5-@@	O	-1	9201797
H@@	O	-1	9201797
T@@	O	-1	9201797
1@@	O	-1	9201797
A	O	-1	9201797
receptor@@	O	-1	9201797
-@@	O	-1	9201797
stimul@@	O	-1	9201797
ating	O	-1	9201797
behavioral	O	-1	9201797
signs	O	-1	9201797
such	O	-1	9201797
as	O	-1	9201797
f@@	O	-1	9201797
l@@	O	-1	9201797
at	O	-1	9201797
body	O	-1	9201797
post@@	O	-1	9201797
ure	O	-1	9201797
and	O	-1	9201797
fo@@	O	-1	9201797
re@@	O	-1	9201797
pa@@	O	-1	9201797
w	O	-1	9201797
tre@@	O	-1	9201797
ad@@	O	-1	9201797
ing	O	-1	9201797
and	O	-1	9201797
did	O	-1	9201797
not	O	-1	9201797
inhib@@	O	-1	9201797
it	O	-1	9201797
5-@@	B-Chemical	D006916	9201797
hydrox@@	I-Chemical	-1	9201797
y@@	I-Chemical	-1	9201797
tr@@	I-Chemical	-1	9201797
y@@	I-Chemical	-1	9201797
pto@@	I-Chemical	-1	9201797
ph@@	I-Chemical	-1	9201797
an	I-Chemical	-1	9201797
-induced	O	-1	9201797
he@@	O	-1	9201797
ad	O	-1	9201797
t@@	O	-1	9201797
wit@@	O	-1	9201797
ch	O	-1	9201797
in	O	-1	9201797
rats.	O	-1	9201797
F@@	O	-1	9201797
in@@	O	-1	9201797
ally,	O	-1	9201797
car@@	B-Chemical	D002354	9201797
te@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
did	O	-1	9201797
not	O	-1	9201797
inhib@@	O	-1	9201797
it	O	-1	9201797
ph@@	B-Chemical	D010830	9201797
ys@@	I-Chemical	-1	9201797
os@@	I-Chemical	-1	9201797
tig@@	I-Chemical	-1	9201797
mine	I-Chemical	-1	9201797
-induced	O	-1	9201797
le@@	O	-1	9201797
thal@@	O	-1	9201797
ity	O	-1	9201797
in	O	-1	9201797
rats.	O	-1	9201797
These	O	-1	9201797
results	O	-1	9201797
st@@	O	-1	9201797
ron@@	O	-1	9201797
g@@	O	-1	9201797
ly	O	-1	9201797
suggest	O	-1	9201797
that	O	-1	9201797
car@@	B-Chemical	D002354	9201797
te@@	I-Chemical	-1	9201797
o@@	I-Chemical	-1	9201797
lol	I-Chemical	-1	9201797
impro@@	O	-1	9201797
v@@	O	-1	9201797
es	O	-1	9201797
haloperidol	B-Chemical	D006220	9201797
-induced	O	-1	9201797
cat@@	B-Disease	D002375	9201797
al@@	I-Disease	-1	9201797
ep@@	I-Disease	-1	9201797
sy	I-Disease	-1	9201797
vi@@	O	-1	9201797
a	O	-1	9201797
its	O	-1	9201797
beta-@@	O	-1	9201797
adren@@	O	-1	9201797
oc@@	O	-1	9201797
e@@	O	-1	9201797
pt@@	O	-1	9201797
or	O	-1	9201797
antagon@@	O	-1	9201797
istic	O	-1	9201797
activity	O	-1	9201797
and	O	-1	9201797
is	O	-1	9201797
ex@@	O	-1	9201797
p@@	O	-1	9201797
ected	O	-1	9201797
to	O	-1	9201797
be	O	-1	9201797
effective	O	-1	9201797
in	O	-1	9201797
the	O	-1	9201797
treatment	O	-1	9201797
of	O	-1	9201797
ak@@	B-Disease	D017109	9201797
athi@@	I-Disease	-1	9201797
sia	I-Disease	-1	9201797
without	O	-1	9201797
attenu@@	O	-1	9201797
ating	O	-1	9201797
neuro@@	O	-1	9201797
le@@	O	-1	9201797
p@@	O	-1	9201797
tic@@	O	-1	9201797
-induced	O	-1	9201797
anti@@	O	-1	9201797
psycho@@	O	-1	9201797
tic	O	-1	9201797
effects	O	-1	9201797
due	O	-1	9201797
to	O	-1	9201797
its	O	-1	9201797
post@@	O	-1	9201797
syn@@	O	-1	9201797
ap@@	O	-1	9201797
tic	O	-1	9201797
dopamine	B-Chemical	D004298	9201797
receptor	O	-1	9201797
antagon@@	O	-1	9201797
istic	O	-1	9201797
activ@@	O	-1	9201797
ity.	O	-1	9201797

P@@	B-Chemical	D010396	8267029
en@@	I-Chemical	-1	8267029
icill@@	I-Chemical	-1	8267029
amine	I-Chemical	-1	8267029
-induced	O	-1	8267029
ra@@	O	-1	8267029
pid@@	O	-1	8267029
ly	O	-1	8267029
progressive	O	-1	8267029
glomerul@@	B-Disease	D005921	8267029
one@@	I-Disease	-1	8267029
ph@@	I-Disease	-1	8267029
ritis	I-Disease	-1	8267029
in	O	-1	8267029
a	O	-1	8267029
patient	O	-1	8267029
with	O	-1	8267029
r@@	B-Disease	D001172	8267029
he@@	I-Disease	-1	8267029
um@@	I-Disease	-1	8267029
at@@	I-Disease	-1	8267029
oid	I-Disease	-1	8267029
arth@@	I-Disease	-1	8267029
ritis	I-Disease	-1	8267029
.	O	-1	8267029
A	O	-1	8267029
6@@	O	-1	8267029
7-@@	O	-1	8267029
year-old	O	-1	8267029
woman	O	-1	8267029
with	O	-1	8267029
r@@	B-Disease	D001172	8267029
he@@	I-Disease	-1	8267029
um@@	I-Disease	-1	8267029
at@@	I-Disease	-1	8267029
oid	I-Disease	-1	8267029
arth@@	I-Disease	-1	8267029
ritis	I-Disease	-1	8267029
presented	O	-1	8267029
ra@@	O	-1	8267029
pid@@	O	-1	8267029
ly	O	-1	8267029
progressive	O	-1	8267029
glomerul@@	B-Disease	D005921	8267029
one@@	I-Disease	-1	8267029
ph@@	I-Disease	-1	8267029
ritis	I-Disease	-1	8267029
(	O	-1	8267029
R@@	B-Disease	D005921	8267029
PG@@	I-Disease	-1	8267029
N	I-Disease	-1	8267029
)	O	-1	8267029
after	O	-1	8267029
5	O	-1	8267029
months	O	-1	8267029
of	O	-1	8267029
D-@@	B-Chemical	D010396	8267029
pen@@	I-Chemical	-1	8267029
icill@@	I-Chemical	-1	8267029
amine	I-Chemical	-1	8267029
(2@@	O	-1	8267029
50	O	-1	8267029
mg/@@	O	-1	8267029
day@@	O	-1	8267029
)	O	-1	8267029
treatment.	O	-1	8267029
L@@	O	-1	8267029
ight	O	-1	8267029
micro@@	O	-1	8267029
sco@@	O	-1	8267029
p@@	O	-1	8267029
y	O	-1	8267029
study	O	-1	8267029
showed	O	-1	8267029
severe	O	-1	8267029
glomerul@@	B-Disease	D005921	8267029
one@@	I-Disease	-1	8267029
ph@@	I-Disease	-1	8267029
ritis	I-Disease	-1	8267029
with	O	-1	8267029
c@@	O	-1	8267029
res@@	O	-1	8267029
c@@	O	-1	8267029
ent	O	-1	8267029
formation	O	-1	8267029
in	O	-1	8267029
6@@	O	-1	8267029
0%	O	-1	8267029
of	O	-1	8267029
the	O	-1	8267029
glomerul@@	O	-1	8267029
i	O	-1	8267029
and	O	-1	8267029
inf@@	O	-1	8267029
iltration	O	-1	8267029
of	O	-1	8267029
inflam@@	O	-1	8267029
mat@@	O	-1	8267029
ory	O	-1	8267029
cells	O	-1	8267029
in	O	-1	8267029
the	O	-1	8267029
w@@	O	-1	8267029
all	O	-1	8267029
of	O	-1	8267029
an	O	-1	8267029
arter@@	O	-1	8267029
i@@	O	-1	8267029
ol@@	O	-1	8267029
e.	O	-1	8267029
Im@@	O	-1	8267029
mun@@	O	-1	8267029
o@@	O	-1	8267029
fluo@@	O	-1	8267029
res@@	O	-1	8267029
c@@	O	-1	8267029
ence	O	-1	8267029
revealed	O	-1	8267029
s@@	O	-1	8267029
c@@	O	-1	8267029
ant@@	O	-1	8267029
y	O	-1	8267029
gran@@	O	-1	8267029
ular	O	-1	8267029
I@@	O	-1	8267029
g@@	O	-1	8267029
G@@	O	-1	8267029
,	O	-1	8267029
I@@	O	-1	8267029
g@@	O	-1	8267029
A	O	-1	8267029
and	O	-1	8267029
C@@	O	-1	8267029
3	O	-1	8267029
de@@	O	-1	8267029
pos@@	O	-1	8267029
its	O	-1	8267029
al@@	O	-1	8267029
ong	O	-1	8267029
the	O	-1	8267029
cap@@	O	-1	8267029
ill@@	O	-1	8267029
ary	O	-1	8267029
w@@	O	-1	8267029
all@@	O	-1	8267029
s	O	-1	8267029
and	O	-1	8267029
m@@	O	-1	8267029
es@@	O	-1	8267029
angi@@	O	-1	8267029
um@@	O	-1	8267029
.	O	-1	8267029
The	O	-1	8267029
patient	O	-1	8267029
was	O	-1	8267029
treated	O	-1	8267029
with	O	-1	8267029
ster@@	B-Chemical	D013256	8267029
oid	I-Chemical	-1	8267029
pul@@	O	-1	8267029
se@@	O	-1	8267029
,	O	-1	8267029
plas@@	O	-1	8267029
ma@@	O	-1	8267029
ph@@	O	-1	8267029
e@@	O	-1	8267029
re@@	O	-1	8267029
sis,	O	-1	8267029
cyclophosph@@	B-Chemical	D003520	8267029
amide	I-Chemical	-1	8267029
and	O	-1	8267029
anti@@	B-Chemical	D010975	8267029
platele@@	I-Chemical	-1	8267029
t	I-Chemical	-1	8267029
agents	I-Chemical	-1	8267029
.	O	-1	8267029
A	O	-1	8267029
complete	O	-1	8267029
recovery	O	-1	8267029
of	O	-1	8267029
renal	O	-1	8267029
function	O	-1	8267029
was	O	-1	8267029
achi@@	O	-1	8267029
ev@@	O	-1	8267029
ed	O	-1	8267029
in	O	-1	8267029
a	O	-1	8267029
fe@@	O	-1	8267029
w	O	-1	8267029
week@@	O	-1	8267029
s.	O	-1	8267029
This	O	-1	8267029
new	O	-1	8267029
case	O	-1	8267029
of	O	-1	8267029
R@@	B-Disease	D005921	8267029
PG@@	I-Disease	-1	8267029
N	I-Disease	-1	8267029
in	O	-1	8267029
the	O	-1	8267029
course	O	-1	8267029
of	O	-1	8267029
D-@@	B-Chemical	D010396	8267029
pen@@	I-Chemical	-1	8267029
icill@@	I-Chemical	-1	8267029
amine	I-Chemical	-1	8267029
treatment	O	-1	8267029
em@@	O	-1	8267029
pha@@	O	-1	8267029
si@@	O	-1	8267029
z@@	O	-1	8267029
es	O	-1	8267029
the	O	-1	8267029
need	O	-1	8267029
for	O	-1	8267029
frequent	O	-1	8267029
monit@@	O	-1	8267029
or@@	O	-1	8267029
ing	O	-1	8267029
of	O	-1	8267029
renal	O	-1	8267029
function	O	-1	8267029
and	O	-1	8267029
evalu@@	O	-1	8267029
ation	O	-1	8267029
of	O	-1	8267029
urinary	O	-1	8267029
se@@	O	-1	8267029
di@@	O	-1	8267029
ment	O	-1	8267029
and	O	-1	8267029
proteinuria	B-Disease	D011507	8267029
in	O	-1	8267029
these	O	-1	8267029
patients.	O	-1	8267029
The	O	-1	8267029
pro@@	O	-1	8267029
m@@	O	-1	8267029
p@@	O	-1	8267029
t	O	-1	8267029
discontinu@@	O	-1	8267029
ation	O	-1	8267029
of	O	-1	8267029
D-@@	B-Chemical	D010396	8267029
pen@@	I-Chemical	-1	8267029
icill@@	I-Chemical	-1	8267029
amine	I-Chemical	-1	8267029
and	O	-1	8267029
vi@@	O	-1	8267029
go@@	O	-1	8267029
rou@@	O	-1	8267029
s	O	-1	8267029
treatment	O	-1	8267029
meas@@	O	-1	8267029
ures	O	-1	8267029
could	O	-1	8267029
al@@	O	-1	8267029
low	O	-1	8267029
for	O	-1	8267029
a	O	-1	8267029
go@@	O	-1	8267029
od	O	-1	8267029
pro@@	O	-1	8267029
g@@	O	-1	8267029
no@@	O	-1	8267029
sis	O	-1	8267029
as	O	-1	8267029
in	O	-1	8267029
this	O	-1	8267029
cas@@	O	-1	8267029
e.	O	-1	8267029

N@@	O	-1	2528969
at@@	O	-1	2528969
ure,	O	-1	2528969
time	O	-1	2528969
course	O	-1	2528969
and	O	-1	2528969
dose	O	-1	2528969
depend@@	O	-1	2528969
ence	O	-1	2528969
of	O	-1	2528969
z@@	B-Chemical	D015215	2528969
id@@	I-Chemical	-1	2528969
o@@	I-Chemical	-1	2528969
vud@@	I-Chemical	-1	2528969
ine	I-Chemical	-1	2528969
-@@	O	-1	2528969
related	O	-1	2528969
side	O	-1	2528969
effect@@	O	-1	2528969
s:	O	-1	2528969
results	O	-1	2528969
from	O	-1	2528969
the	O	-1	2528969
M@@	O	-1	2528969
ul@@	O	-1	2528969
tic@@	O	-1	2528969
ent@@	O	-1	2528969
er	O	-1	2528969
C@@	O	-1	2528969
ana@@	O	-1	2528969
di@@	O	-1	2528969
an	O	-1	2528969
A@@	B-Chemical	D015215	2528969
z@@	I-Chemical	-1	2528969
id@@	I-Chemical	-1	2528969
o@@	I-Chemical	-1	2528969
th@@	I-Chemical	-1	2528969
ym@@	I-Chemical	-1	2528969
idine	I-Chemical	-1	2528969
T@@	O	-1	2528969
ri@@	O	-1	2528969
al.	O	-1	2528969
To	O	-1	2528969
character@@	O	-1	2528969
iz@@	O	-1	2528969
e	O	-1	2528969
the	O	-1	2528969
n@@	O	-1	2528969
at@@	O	-1	2528969
ure,	O	-1	2528969
time	O	-1	2528969
course	O	-1	2528969
and	O	-1	2528969
dose	O	-1	2528969
depend@@	O	-1	2528969
ency	O	-1	2528969
of	O	-1	2528969
z@@	B-Chemical	D015215	2528969
id@@	I-Chemical	-1	2528969
o@@	I-Chemical	-1	2528969
vud@@	I-Chemical	-1	2528969
ine	I-Chemical	-1	2528969
-@@	O	-1	2528969
related	O	-1	2528969
side	O	-1	2528969
effect@@	O	-1	2528969
s,	O	-1	2528969
we	O	-1	2528969
under@@	O	-1	2528969
to@@	O	-1	2528969
o@@	O	-1	2528969
k	O	-1	2528969
a	O	-1	2528969
mul@@	O	-1	2528969
tic@@	O	-1	2528969
ent@@	O	-1	2528969
er,	O	-1	2528969
pro@@	O	-1	2528969
sp@@	O	-1	2528969
ecti@@	O	-1	2528969
ve,	O	-1	2528969
dose-@@	O	-1	2528969
range	O	-1	2528969
find@@	O	-1	2528969
ing	O	-1	2528969
study.	O	-1	2528969
Our	O	-1	2528969
study	O	-1	2528969
group	O	-1	2528969
consist@@	O	-1	2528969
ed	O	-1	2528969
of	O	-1	2528969
7@@	O	-1	2528969
4	O	-1	2528969
H@@	O	-1	2528969
I@@	O	-1	2528969
V@@	O	-1	2528969
-@@	O	-1	2528969
positive	O	-1	2528969
ho@@	O	-1	2528969
mo@@	O	-1	2528969
sex@@	O	-1	2528969
ual	O	-1	2528969
men	O	-1	2528969
be@@	O	-1	2528969
long@@	O	-1	2528969
ing	O	-1	2528969
to	O	-1	2528969
groups	O	-1	2528969
II	O	-1	2528969
B@@	O	-1	2528969
,	O	-1	2528969
I@@	O	-1	2528969
II	O	-1	2528969
and	O	-1	2528969
IV	O	-1	2528969
C@@	O	-1	2528969
2	O	-1	2528969
from	O	-1	2528969
the	O	-1	2528969
C@@	O	-1	2528969
ent@@	O	-1	2528969
ers	O	-1	2528969
for	O	-1	2528969
Di@@	O	-1	2528969
se@@	O	-1	2528969
ase	O	-1	2528969
C@@	O	-1	2528969
ont@@	O	-1	2528969
ro@@	O	-1	2528969
l	O	-1	2528969
(C@@	O	-1	2528969
D@@	O	-1	2528969
C@@	O	-1	2528969
)	O	-1	2528969
cl@@	O	-1	2528969
assi@@	O	-1	2528969
fic@@	O	-1	2528969
ation	O	-1	2528969
of	O	-1	2528969
H@@	B-Disease	D015658	2528969
IV	I-Disease	-1	2528969
disease	I-Disease	-1	2528969
.	O	-1	2528969
F@@	O	-1	2528969
ol@@	O	-1	2528969
low@@	O	-1	2528969
ing	O	-1	2528969
a	O	-1	2528969
3-@@	O	-1	2528969
week	O	-1	2528969
observ@@	O	-1	2528969
ation	O	-1	2528969
perio@@	O	-1	2528969
d,	O	-1	2528969
vol@@	O	-1	2528969
un@@	O	-1	2528969
te@@	O	-1	2528969
ers	O	-1	2528969
were	O	-1	2528969
treated	O	-1	2528969
with	O	-1	2528969
z@@	B-Chemical	D015215	2528969
id@@	I-Chemical	-1	2528969
o@@	I-Chemical	-1	2528969
vud@@	I-Chemical	-1	2528969
ine	I-Chemical	-1	2528969
6@@	O	-1	2528969
00	O	-1	2528969
mg/@@	O	-1	2528969
day	O	-1	2528969
for	O	-1	2528969
1@@	O	-1	2528969
8	O	-1	2528969
week@@	O	-1	2528969
s,	O	-1	2528969
9@@	O	-1	2528969
00	O	-1	2528969
mg/@@	O	-1	2528969
day	O	-1	2528969
for	O	-1	2528969
9	O	-1	2528969
weeks	O	-1	2528969
and	O	-1	2528969
12@@	O	-1	2528969
00	O	-1	2528969
mg/@@	O	-1	2528969
day	O	-1	2528969
for	O	-1	2528969
9	O	-1	2528969
week@@	O	-1	2528969
s,	O	-1	2528969
followed	O	-1	2528969
by	O	-1	2528969
a	O	-1	2528969
w@@	O	-1	2528969
as@@	O	-1	2528969
h@@	O	-1	2528969
out	O	-1	2528969
period	O	-1	2528969
of	O	-1	2528969
6	O	-1	2528969
weeks	O	-1	2528969
after	O	-1	2528969
which	O	-1	2528969
they	O	-1	2528969
were	O	-1	2528969
re@@	O	-1	2528969
-@@	O	-1	2528969
star@@	O	-1	2528969
ted	O	-1	2528969
on	O	-1	2528969
12@@	O	-1	2528969
00	O	-1	2528969
mg/@@	O	-1	2528969
day	O	-1	2528969
or	O	-1	2528969
the	O	-1	2528969
high@@	O	-1	2528969
est	O	-1	2528969
toler@@	O	-1	2528969
ated	O	-1	2528969
dose	O	-1	2528969
at	O	-1	2528969
8@@	O	-1	2528969
-@@	O	-1	2528969
hour@@	O	-1	2528969
ly	O	-1	2528969
inter@@	O	-1	2528969
val@@	O	-1	2528969
s.	O	-1	2528969
S@@	O	-1	2528969
ub@@	O	-1	2528969
j@@	O	-1	2528969
ects	O	-1	2528969
were	O	-1	2528969
random@@	O	-1	2528969
ly	O	-1	2528969
as@@	O	-1	2528969
signed	O	-1	2528969
to	O	-1	2528969
4-@@	O	-1	2528969
hour@@	O	-1	2528969
ly	O	-1	2528969
or	O	-1	2528969
8@@	O	-1	2528969
-@@	O	-1	2528969
hour@@	O	-1	2528969
ly	O	-1	2528969
regimen@@	O	-1	2528969
s	O	-1	2528969
within	O	-1	2528969
C@@	O	-1	2528969
D@@	O	-1	2528969
C	O	-1	2528969
groups	O	-1	2528969
while	O	-1	2528969
taking	O	-1	2528969
6@@	O	-1	2528969
00	O	-1	2528969
and	O	-1	2528969
12@@	O	-1	2528969
00	O	-1	2528969
mg/@@	O	-1	2528969
da@@	O	-1	2528969
y.	O	-1	2528969
Clin@@	O	-1	2528969
ical	O	-1	2528969
and	O	-1	2528969
labor@@	O	-1	2528969
atory	O	-1	2528969
evalu@@	O	-1	2528969
ations	O	-1	2528969
were	O	-1	2528969
performed	O	-1	2528969
at	O	-1	2528969
3-@@	O	-1	2528969
week	O	-1	2528969
inter@@	O	-1	2528969
val@@	O	-1	2528969
s.	O	-1	2528969
S@@	O	-1	2528969
ym@@	O	-1	2528969
pto@@	O	-1	2528969
m@@	O	-1	2528969
atic	O	-1	2528969
adverse	O	-1	2528969
effects	O	-1	2528969
were	O	-1	2528969
present	O	-1	2528969
in	O	-1	2528969
9@@	O	-1	2528969
6%	O	-1	2528969
of	O	-1	2528969
subj@@	O	-1	2528969
ect@@	O	-1	2528969
s,	O	-1	2528969
most	O	-1	2528969
common@@	O	-1	2528969
ly	O	-1	2528969
nausea	B-Disease	D009325	2528969
(6@@	O	-1	2528969
4@@	O	-1	2528969
%),	O	-1	2528969
f@@	B-Disease	D005221	2528969
ati@@	I-Disease	-1	2528969
gu@@	I-Disease	-1	2528969
e	I-Disease	-1	2528969
(5@@	O	-1	2528969
5@@	O	-1	2528969
%)	O	-1	2528969
and	O	-1	2528969
headac@@	B-Disease	D006261	2528969
he	I-Disease	-1	2528969
(4@@	O	-1	2528969
9@@	O	-1	2528969
%).	O	-1	2528969
These	O	-1	2528969
were	O	-1	2528969
gener@@	O	-1	2528969
ally	O	-1	2528969
sel@@	O	-1	2528969
f@@	O	-1	2528969
-@@	O	-1	2528969
lim@@	O	-1	2528969
it@@	O	-1	2528969
ed,	O	-1	2528969
re@@	O	-1	2528969
appear@@	O	-1	2528969
ing	O	-1	2528969
b@@	O	-1	2528969
ri@@	O	-1	2528969
e@@	O	-1	2528969
f@@	O	-1	2528969
ly	O	-1	2528969
at	O	-1	2528969
each	O	-1	2528969
dose	O	-1	2528969
inc@@	O	-1	2528969
re@@	O	-1	2528969
ment.	O	-1	2528969
A	O	-1	2528969
decrease	O	-1	2528969
in	O	-1	2528969
hemo@@	O	-1	2528969
globin	O	-1	2528969
occurred	O	-1	2528969
sh@@	O	-1	2528969
ort@@	O	-1	2528969
ly	O	-1	2528969
after	O	-1	2528969
initi@@	O	-1	2528969
ation	O	-1	2528969
of	O	-1	2528969
therapy.	O	-1	2528969
This	O	-1	2528969
was	O	-1	2528969
not	O	-1	2528969
dose	O	-1	2528969
dependent	O	-1	2528969
and	O	-1	2528969
reversed	O	-1	2528969
ra@@	O	-1	2528969
pid@@	O	-1	2528969
ly	O	-1	2528969
up@@	O	-1	2528969
on	O	-1	2528969
discontinu@@	O	-1	2528969
ation	O	-1	2528969
of	O	-1	2528969
treatment.	O	-1	2528969
A	O	-1	2528969
red	O	-1	2528969
blood	O	-1	2528969
cell	O	-1	2528969
coun@@	O	-1	2528969
t	O	-1	2528969
decreas@@	O	-1	2528969
e,	O	-1	2528969
a	O	-1	2528969
mean	O	-1	2528969
cell	O	-1	2528969
volume	O	-1	2528969
increase	O	-1	2528969
and	O	-1	2528969
a	O	-1	2528969
gran@@	O	-1	2528969
ulo@@	O	-1	2528969
cy@@	O	-1	2528969
te	O	-1	2528969
coun@@	O	-1	2528969
t	O	-1	2528969
decrease	O	-1	2528969
developed	O	-1	2528969
early	O	-1	2528969
in	O	-1	2528969
a	O	-1	2528969
dose-@@	O	-1	2528969
in@@	O	-1	2528969
dependent	O	-1	2528969
f@@	O	-1	2528969
as@@	O	-1	2528969
hi@@	O	-1	2528969
on@@	O	-1	2528969
,	O	-1	2528969
rever@@	O	-1	2528969
ting	O	-1	2528969
at	O	-1	2528969
le@@	O	-1	2528969
ast	O	-1	2528969
par@@	O	-1	2528969
ti@@	O	-1	2528969
ally	O	-1	2528969
during	O	-1	2528969
the	O	-1	2528969
w@@	O	-1	2528969
as@@	O	-1	2528969
h@@	O	-1	2528969
out	O	-1	2528969
ph@@	O	-1	2528969
as@@	O	-1	2528969
e.	O	-1	2528969
The	O	-1	2528969
decrease	O	-1	2528969
in	O	-1	2528969
re@@	O	-1	2528969
tic@@	O	-1	2528969
ulo@@	O	-1	2528969
cy@@	O	-1	2528969
te	O	-1	2528969
coun@@	O	-1	2528969
t	O	-1	2528969
was	O	-1	2528969
dose	O	-1	2528969
related	O	-1	2528969
between	O	-1	2528969
6@@	O	-1	2528969
00	O	-1	2528969
and	O	-1	2528969
9@@	O	-1	2528969
00	O	-1	2528969
mg/@@	O	-1	2528969
day	O	-1	2528969
with	O	-1	2528969
no	O	-1	2528969
further	O	-1	2528969
change	O	-1	2528969
when	O	-1	2528969
the	O	-1	2528969
dose	O	-1	2528969
was	O	-1	2528969
es@@	O	-1	2528969
cal@@	O	-1	2528969
ated	O	-1	2528969
to	O	-1	2528969
12@@	O	-1	2528969
00	O	-1	2528969
mg/@@	O	-1	2528969
da@@	O	-1	2528969
y.	O	-1	2528969
B@@	O	-1	2528969
one	O	-1	2528969
m@@	O	-1	2528969
ar@@	O	-1	2528969
ro@@	O	-1	2528969
w	O	-1	2528969
changes	O	-1	2528969
occurred	O	-1	2528969
ra@@	O	-1	2528969
pid@@	O	-1	2528969
ly	O	-1	2528969
as	O	-1	2528969
demonstrated	O	-1	2528969
by	O	-1	2528969
me@@	B-Disease	-1	2528969
g@@	I-Disease	-1	2528969
al@@	I-Disease	-1	2528969
ob@@	I-Disease	-1	2528969
l@@	I-Disease	-1	2528969
ast@@	I-Disease	-1	2528969
o@@	I-Disease	-1	2528969
sis	I-Disease	-1	2528969
in	O	-1	2528969
95%	O	-1	2528969
of	O	-1	2528969
6@@	O	-1	2528969
5	O	-1	2528969
spec@@	O	-1	2528969
imen@@	O	-1	2528969
s	O	-1	2528969
at	O	-1	2528969
week	O	-1	2528969
1@@	O	-1	2528969
8.@@	O	-1	2528969
(A@@	O	-1	2528969
B@@	O	-1	2528969
S@@	O	-1	2528969
TR@@	O	-1	2528969
AC@@	O	-1	2528969
T	O	-1	2528969
TR@@	O	-1	2528969
UN@@	O	-1	2528969
C@@	O	-1	2528969
AT@@	O	-1	2528969
E@@	O	-1	2528969
D	O	-1	2528969
A@@	O	-1	2528969
T	O	-1	2528969
2@@	O	-1	2528969
50	O	-1	2528969
W@@	O	-1	2528969
O@@	O	-1	2528969
RD@@	O	-1	2528969
S)	O	-1	2528969

B@@	B-Disease	D009901	384871
il@@	I-Disease	-1	384871
ateral	I-Disease	-1	384871
op@@	I-Disease	-1	384871
tic	I-Disease	-1	384871
neuropathy	I-Disease	-1	384871
due	O	-1	384871
to	O	-1	384871
combined	O	-1	384871
eth@@	B-Chemical	D004977	384871
am@@	I-Chemical	-1	384871
bu@@	I-Chemical	-1	384871
to@@	I-Chemical	-1	384871
l	I-Chemical	-1	384871
and	O	-1	384871
is@@	B-Chemical	D007538	384871
oni@@	I-Chemical	-1	384871
az@@	I-Chemical	-1	384871
id	I-Chemical	-1	384871
treatment.	O	-1	384871
The	O	-1	384871
case	O	-1	384871
of	O	-1	384871
a	O	-1	384871
4@@	O	-1	384871
0-@@	O	-1	384871
year-old	O	-1	384871
patient	O	-1	384871
who	O	-1	384871
under@@	O	-1	384871
w@@	O	-1	384871
ent	O	-1	384871
an	O	-1	384871
un@@	O	-1	384871
suc@@	O	-1	384871
cess@@	O	-1	384871
ful	O	-1	384871
c@@	O	-1	384871
ad@@	O	-1	384871
a@@	O	-1	384871
ver	O	-1	384871
kidney	O	-1	384871
transplant@@	O	-1	384871
ation	O	-1	384871
and	O	-1	384871
was	O	-1	384871
treated	O	-1	384871
with	O	-1	384871
eth@@	B-Chemical	D004977	384871
am@@	I-Chemical	-1	384871
bu@@	I-Chemical	-1	384871
to@@	I-Chemical	-1	384871
l	I-Chemical	-1	384871
and	O	-1	384871
is@@	B-Chemical	D007538	384871
oni@@	I-Chemical	-1	384871
az@@	I-Chemical	-1	384871
id	I-Chemical	-1	384871
is	O	-1	384871
repor@@	O	-1	384871
ted.	O	-1	384871
A	O	-1	384871
bil@@	B-Disease	D009901	384871
ateral	I-Disease	-1	384871
ret@@	I-Disease	-1	384871
ro@@	I-Disease	-1	384871
b@@	I-Disease	-1	384871
ul@@	I-Disease	-1	384871
b@@	I-Disease	-1	384871
ar	I-Disease	-1	384871
neuropathy	I-Disease	-1	384871
with	O	-1	384871
an	O	-1	384871
un@@	O	-1	384871
us@@	O	-1	384871
ual	O	-1	384871
central	O	-1	384871
b@@	O	-1	384871
it@@	O	-1	384871
em@@	O	-1	384871
por@@	O	-1	384871
al	O	-1	384871
he@@	O	-1	384871
mi@@	O	-1	384871
an@@	O	-1	384871
op@@	O	-1	384871
ic	O	-1	384871
sco@@	B-Disease	D012607	384871
to@@	I-Disease	-1	384871
ma	I-Disease	-1	384871
was	O	-1	384871
f@@	O	-1	384871
oun@@	O	-1	384871
d.	O	-1	384871
E@@	B-Chemical	D004977	384871
th@@	I-Chemical	-1	384871
am@@	I-Chemical	-1	384871
bu@@	I-Chemical	-1	384871
to@@	I-Chemical	-1	384871
l	I-Chemical	-1	384871
was	O	-1	384871
sto@@	O	-1	384871
pp@@	O	-1	384871
ed	O	-1	384871
and	O	-1	384871
only	O	-1	384871
sm@@	O	-1	384871
all	O	-1	384871
impro@@	O	-1	384871
vement	O	-1	384871
of	O	-1	384871
the	O	-1	384871
visual	O	-1	384871
ac@@	O	-1	384871
u@@	O	-1	384871
ity	O	-1	384871
fol@@	O	-1	384871
lo@@	O	-1	384871
we@@	O	-1	384871
d.	O	-1	384871
I@@	B-Chemical	D007538	384871
son@@	I-Chemical	-1	384871
i@@	I-Chemical	-1	384871
az@@	I-Chemical	-1	384871
id	I-Chemical	-1	384871
was	O	-1	384871
discontinu@@	O	-1	384871
ed	O	-1	384871
lat@@	O	-1	384871
er,	O	-1	384871
followed	O	-1	384871
by	O	-1	384871
a	O	-1	384871
d@@	O	-1	384871
ram@@	O	-1	384871
atic	O	-1	384871
impro@@	O	-1	384871
vement	O	-1	384871
in	O	-1	384871
the	O	-1	384871
visual	O	-1	384871
ac@@	O	-1	384871
u@@	O	-1	384871
ity.	O	-1	384871
The	O	-1	384871
ha@@	O	-1	384871
z@@	O	-1	384871
ar@@	O	-1	384871
ds	O	-1	384871
of	O	-1	384871
op@@	O	-1	384871
tic	O	-1	384871
nerve	O	-1	384871
toxicity	B-Disease	D064420	384871
due	O	-1	384871
to	O	-1	384871
eth@@	B-Chemical	D004977	384871
am@@	I-Chemical	-1	384871
bu@@	I-Chemical	-1	384871
to@@	I-Chemical	-1	384871
l	I-Chemical	-1	384871
are	O	-1	384871
know@@	O	-1	384871
n@@	O	-1	384871
.	O	-1	384871
We	O	-1	384871
em@@	O	-1	384871
pha@@	O	-1	384871
size	O	-1	384871
the	O	-1	384871
potential	O	-1	384871
d@@	O	-1	384871
ang@@	O	-1	384871
er	O	-1	384871
in	O	-1	384871
the	O	-1	384871
use	O	-1	384871
of	O	-1	384871
eth@@	B-Chemical	D004977	384871
am@@	I-Chemical	-1	384871
bu@@	I-Chemical	-1	384871
to@@	I-Chemical	-1	384871
l	I-Chemical	-1	384871
and	O	-1	384871
is@@	B-Chemical	D007538	384871
oni@@	I-Chemical	-1	384871
az@@	I-Chemical	-1	384871
id	I-Chemical	-1	384871
.	O	-1	384871

Pro@@	O	-1	133615
g@@	O	-1	133615
est@@	O	-1	133615
ation@@	O	-1	133615
al	O	-1	133615
agents	O	-1	133615
and	O	-1	133615
blood	B-Disease	D001778	133615
co@@	I-Disease	-1	133615
ag@@	I-Disease	-1	133615
ulation	I-Disease	-1	133615
.	O	-1	133615
V@@	O	-1	133615
II@@	O	-1	133615
.	O	-1	133615
Th@@	B-Disease	D013923	133615
rom@@	I-Disease	-1	133615
bo@@	I-Disease	-1	133615
emb@@	I-Disease	-1	133615
olic	I-Disease	-1	133615
and	O	-1	133615
other	O	-1	133615
complications	O	-1	133615
of	O	-1	133615
oral	B-Chemical	D003276	133615
contrac@@	I-Chemical	-1	133615
ep@@	I-Chemical	-1	133615
tive	I-Chemical	-1	133615
therapy	O	-1	133615
in	O	-1	133615
rel@@	O	-1	133615
ationship	O	-1	133615
to	O	-1	133615
pretreatment	O	-1	133615
levels	O	-1	133615
of	O	-1	133615
blood	B-Disease	D001778	133615
co@@	I-Disease	-1	133615
ag@@	I-Disease	-1	133615
ulation	I-Disease	-1	133615
fact@@	O	-1	133615
or@@	O	-1	133615
s:	O	-1	133615
su@@	O	-1	133615
mm@@	O	-1	133615
ary	O	-1	133615
report	O	-1	133615
of	O	-1	133615
a	O	-1	133615
ten@@	O	-1	133615
-@@	O	-1	133615
year	O	-1	133615
study.	O	-1	133615
D@@	O	-1	133615
uring	O	-1	133615
a	O	-1	133615
ten@@	O	-1	133615
-@@	O	-1	133615
year	O	-1	133615
perio@@	O	-1	133615
d,	O	-1	133615
34@@	O	-1	133615
8	O	-1	133615
women	O	-1	133615
were	O	-1	133615
studied	O	-1	133615
for	O	-1	133615
a	O	-1	133615
total	O	-1	133615
of	O	-1	133615
5@@	O	-1	133615
,@@	O	-1	133615
8@@	O	-1	133615
7@@	O	-1	133615
7	O	-1	133615
patient	O	-1	133615
months	O	-1	133615
in	O	-1	133615
four	O	-1	133615
se@@	O	-1	133615
par@@	O	-1	133615
ate	O	-1	133615
studies	O	-1	133615
rel@@	O	-1	133615
ating	O	-1	133615
oral	B-Chemical	D003276	133615
contrac@@	I-Chemical	-1	133615
ep@@	I-Chemical	-1	133615
tiv@@	I-Chemical	-1	133615
es	I-Chemical	-1	133615
to	O	-1	133615
changes	O	-1	133615
in	O	-1	133615
hemat@@	O	-1	133615
ologic	O	-1	133615
par@@	O	-1	133615
ame@@	O	-1	133615
ter@@	O	-1	133615
s.	O	-1	133615
Si@@	O	-1	133615
gn@@	O	-1	133615
ific@@	O	-1	133615
ant	O	-1	133615
increases	O	-1	133615
in	O	-1	133615
cer@@	O	-1	133615
t@@	O	-1	133615
ain	O	-1	133615
factors	O	-1	133615
of	O	-1	133615
the	O	-1	133615
blood	B-Disease	D001778	133615
co@@	I-Disease	-1	133615
ag@@	I-Disease	-1	133615
ulation	I-Disease	-1	133615
and	O	-1	133615
fib@@	O	-1	133615
r@@	O	-1	133615
in@@	O	-1	133615
ol@@	O	-1	133615
ys@@	O	-1	133615
in	O	-1	133615
system@@	O	-1	133615
s	O	-1	133615
(@@	O	-1	133615
factors	O	-1	133615
I@@	O	-1	133615
,@@	O	-1	133615
II@@	O	-1	133615
,@@	O	-1	133615
V@@	O	-1	133615
II@@	O	-1	133615
,@@	O	-1	133615
V@@	O	-1	133615
II@@	O	-1	133615
I@@	O	-1	133615
,@@	O	-1	133615
I@@	O	-1	133615
X@@	O	-1	133615
,	O	-1	133615
and	O	-1	133615
X	O	-1	133615
and	O	-1	133615
plas@@	O	-1	133615
min@@	O	-1	133615
o@@	O	-1	133615
gen@@	O	-1	133615
)	O	-1	133615
were	O	-1	133615
observed	O	-1	133615
in	O	-1	133615
the	O	-1	133615
treated	O	-1	133615
groups.	O	-1	133615
S@@	O	-1	133615
ev@@	O	-1	133615
ere	O	-1	133615
complications	O	-1	133615
developed	O	-1	133615
in	O	-1	133615
four	O	-1	133615
patients.	O	-1	133615
All	O	-1	133615
four	O	-1	133615
had	O	-1	133615
an	O	-1	133615
ab@@	O	-1	133615
normal	O	-1	133615
blood	B-Disease	D001778	133615
co@@	I-Disease	-1	133615
ag@@	I-Disease	-1	133615
ulation	I-Disease	-1	133615
pro@@	O	-1	133615
fi@@	O	-1	133615
le@@	O	-1	133615
,	O	-1	133615
suggesting	O	-1	133615
"	O	-1	133615
hyper@@	B-Disease	D019851	133615
co@@	I-Disease	-1	133615
ag@@	I-Disease	-1	133615
ul@@	I-Disease	-1	133615
ability	I-Disease	-1	133615
"	O	-1	133615
before	O	-1	133615
initi@@	O	-1	133615
ation	O	-1	133615
of	O	-1	133615
therapy.	O	-1	133615
S@@	O	-1	133615
ome	O	-1	133615
of	O	-1	133615
these	O	-1	133615
findings	O	-1	133615
re@@	O	-1	133615
presented	O	-1	133615
the	O	-1	133615
most	O	-1	133615
ex@@	O	-1	133615
trem@@	O	-1	133615
e	O	-1	133615
abnormal@@	O	-1	133615
ities	O	-1	133615
seen	O	-1	133615
in	O	-1	133615
the	O	-1	133615
enti@@	O	-1	133615
r@@	O	-1	133615
e	O	-1	133615
group	O	-1	133615
of	O	-1	133615
patient@@	O	-1	133615
s;	O	-1	133615
some	O	-1	133615
increased	O	-1	133615
further	O	-1	133615
during	O	-1	133615
therapy.	O	-1	133615
One	O	-1	133615
of	O	-1	133615
these	O	-1	133615
patients	O	-1	133615
developed	O	-1	133615
a	O	-1	133615
myocardial	B-Disease	D009203	133615
infarction	I-Disease	-1	133615
before	O	-1	133615
receiving	O	-1	133615
any	O	-1	133615
medic@@	O	-1	133615
ation,	O	-1	133615
sh@@	O	-1	133615
ort@@	O	-1	133615
ly	O	-1	133615
after	O	-1	133615
the	O	-1	133615
bas@@	O	-1	133615
e-@@	O	-1	133615
line	O	-1	133615
values	O	-1	133615
were	O	-1	133615
obt@@	O	-1	133615
a@@	O	-1	133615
ine@@	O	-1	133615
d.	O	-1	133615
One	O	-1	133615
patient	O	-1	133615
developed	O	-1	133615
ret@@	B-Disease	D012164	133615
ino@@	I-Disease	-1	133615
pathy	I-Disease	-1	133615
1@@	O	-1	133615
9	O	-1	133615
months	O	-1	133615
after	O	-1	133615
sh@@	O	-1	133615
e	O	-1	133615
be@@	O	-1	133615
g@@	O	-1	133615
an	O	-1	133615
therapy,	O	-1	133615
and	O	-1	133615
an@@	O	-1	133615
other	O	-1	133615
developed	O	-1	133615
thrombo@@	B-Disease	D013924	133615
ph@@	I-Disease	-1	133615
le@@	I-Disease	-1	133615
b@@	I-Disease	-1	133615
iti@@	I-Disease	-1	133615
s	I-Disease	-1	133615
after	O	-1	133615
2@@	O	-1	133615
7	O	-1	133615
months	O	-1	133615
of	O	-1	133615
therapy.	O	-1	133615
The	O	-1	133615
fo@@	O	-1	133615
ur@@	O	-1	133615
th	O	-1	133615
patient	O	-1	133615
developed	O	-1	133615
thrombo@@	B-Disease	D013924	133615
ph@@	I-Disease	-1	133615
le@@	I-Disease	-1	133615
b@@	I-Disease	-1	133615
iti@@	I-Disease	-1	133615
s	I-Disease	-1	133615
14	O	-1	133615
days	O	-1	133615
after	O	-1	133615
initi@@	O	-1	133615
ation	O	-1	133615
of	O	-1	133615
contrac@@	O	-1	133615
ep@@	O	-1	133615
tive	O	-1	133615
therapy.	O	-1	133615
All	O	-1	133615
four	O	-1	133615
patients	O	-1	133615
were	O	-1	133615
of	O	-1	133615
the	O	-1	133615
A	O	-1	133615
or	O	-1	133615
A@@	O	-1	133615
B	O	-1	133615
blood	O	-1	133615
group.	O	-1	133615
Pre@@	O	-1	133615
vi@@	O	-1	133615
ous	O	-1	133615
studies	O	-1	133615
suggested	O	-1	133615
the	O	-1	133615
possib@@	O	-1	133615
l@@	O	-1	133615
ility	O	-1	133615
of	O	-1	133615
increased	O	-1	133615
pro@@	O	-1	133615
pen@@	O	-1	133615
s@@	O	-1	133615
ity	O	-1	133615
for	O	-1	133615
thrombo@@	B-Disease	D013923	133615
emb@@	I-Disease	-1	133615
olic	I-Disease	-1	133615
episo@@	I-Disease	-1	133615
des	I-Disease	-1	133615
in	O	-1	133615
patients	O	-1	133615
pos@@	O	-1	133615
s@@	O	-1	133615
ess@@	O	-1	133615
ing	O	-1	133615
the	O	-1	133615
A	O	-1	133615
anti@@	O	-1	133615
gen@@	O	-1	133615
.	O	-1	133615
It	O	-1	133615
appear@@	O	-1	133615
s	O	-1	133615
from	O	-1	133615
these	O	-1	133615
data	O	-1	133615
that	O	-1	133615
hemat@@	O	-1	133615
ologic	O	-1	133615
wor@@	O	-1	133615
k@@	O	-1	133615
-@@	O	-1	133615
up@@	O	-1	133615
s	O	-1	133615
may	O	-1	133615
be	O	-1	133615
use@@	O	-1	133615
ful	O	-1	133615
in	O	-1	133615
women	O	-1	133615
who	O	-1	133615
are	O	-1	133615
about	O	-1	133615
to	O	-1	133615
star@@	O	-1	133615
t	O	-1	133615
long-term	O	-1	133615
oral	B-Chemical	D003276	133615
contrac@@	I-Chemical	-1	133615
ep@@	I-Chemical	-1	133615
tive	I-Chemical	-1	133615
therapy.	O	-1	133615

C@@	B-Disease	D006323	17263743
ardi@@	I-Disease	-1	17263743
a@@	I-Disease	-1	17263743
c	I-Disease	-1	17263743
ar@@	I-Disease	-1	17263743
res@@	I-Disease	-1	17263743
t	I-Disease	-1	17263743
in	O	-1	17263743
a	O	-1	17263743
ch@@	O	-1	17263743
il@@	O	-1	17263743
d	O	-1	17263743
with	O	-1	17263743
cerebral	B-Disease	D002547	17263743
p@@	I-Disease	-1	17263743
al@@	I-Disease	-1	17263743
sy	I-Disease	-1	17263743
under@@	O	-1	17263743
go@@	O	-1	17263743
ing	O	-1	17263743
sev@@	B-Chemical	C009250	17263743
of@@	I-Chemical	-1	17263743
lur@@	I-Chemical	-1	17263743
ane	I-Chemical	-1	17263743
induction	O	-1	17263743
of	O	-1	17263743
anesthe@@	O	-1	17263743
sia	O	-1	17263743
after	O	-1	17263743
pre@@	O	-1	17263743
o@@	O	-1	17263743
perative	O	-1	17263743
clonidine	B-Chemical	D003000	17263743
.	O	-1	17263743
C@@	B-Chemical	D003000	17263743
lon@@	I-Chemical	-1	17263743
idine	I-Chemical	-1	17263743
is	O	-1	17263743
a	O	-1	17263743
frequ@@	O	-1	17263743
ently	O	-1	17263743
administered	O	-1	17263743
alpha@@	O	-1	17263743
2-@@	O	-1	17263743
adrenergic	O	-1	17263743
agon@@	O	-1	17263743
ist	O	-1	17263743
which	O	-1	17263743
can	O	-1	17263743
decrease	O	-1	17263743
heart	O	-1	17263743
rate	O	-1	17263743
and	O	-1	17263743
blood	O	-1	17263743
pressu@@	O	-1	17263743
re.	O	-1	17263743
We	O	-1	17263743
present	O	-1	17263743
a	O	-1	17263743
case	O	-1	17263743
of	O	-1	17263743
a	O	-1	17263743
5-@@	O	-1	17263743
year-old	O	-1	17263743
ch@@	O	-1	17263743
il@@	O	-1	17263743
d	O	-1	17263743
with	O	-1	17263743
cerebral	B-Disease	D002547	17263743
p@@	I-Disease	-1	17263743
al@@	I-Disease	-1	17263743
sy	I-Disease	-1	17263743
and	O	-1	17263743
seizure	B-Disease	D004827	17263743
disor@@	I-Disease	-1	17263743
der	I-Disease	-1	17263743
,	O	-1	17263743
receiving	O	-1	17263743
clonidine	B-Chemical	D003000	17263743
for	O	-1	17263743
rest@@	B-Disease	D011595	17263743
l@@	I-Disease	-1	17263743
ess@@	I-Disease	-1	17263743
ness	I-Disease	-1	17263743
,	O	-1	17263743
who	O	-1	17263743
presented	O	-1	17263743
for	O	-1	17263743
pl@@	O	-1	17263743
ac@@	O	-1	17263743
ement	O	-1	17263743
of	O	-1	17263743
a	O	-1	17263743
bac@@	B-Chemical	D001418	17263743
lo@@	I-Chemical	-1	17263743
f@@	I-Chemical	-1	17263743
en	I-Chemical	-1	17263743
p@@	O	-1	17263743
um@@	O	-1	17263743
p@@	O	-1	17263743
.	O	-1	17263743
W@@	O	-1	17263743
i@@	O	-1	17263743
th@@	O	-1	17263743
out	O	-1	17263743
the	O	-1	17263743
know@@	O	-1	17263743
le@@	O	-1	17263743
d@@	O	-1	17263743
ge	O	-1	17263743
of	O	-1	17263743
the	O	-1	17263743
med@@	O	-1	17263743
ical	O	-1	17263743
per@@	O	-1	17263743
son@@	O	-1	17263743
ne@@	O	-1	17263743
l@@	O	-1	17263743
,	O	-1	17263743
the	O	-1	17263743
patient@@	O	-1	17263743
's	O	-1	17263743
mo@@	O	-1	17263743
ther	O	-1	17263743
administered	O	-1	17263743
three	O	-1	17263743
doses	O	-1	17263743
of	O	-1	17263743
clonidine	B-Chemical	D003000	17263743
during	O	-1	17263743
the	O	-1	17263743
ev@@	O	-1	17263743
en@@	O	-1	17263743
ing	O	-1	17263743
before	O	-1	17263743
and	O	-1	17263743
mor@@	O	-1	17263743
ning	O	-1	17263743
of	O	-1	17263743
surger@@	O	-1	17263743
y	O	-1	17263743
to	O	-1	17263743
re@@	O	-1	17263743
duce	O	-1	17263743
an@@	B-Disease	D001008	17263743
xi@@	I-Disease	-1	17263743
ety	I-Disease	-1	17263743
.	O	-1	17263743
D@@	O	-1	17263743
uring	O	-1	17263743
induction	O	-1	17263743
of	O	-1	17263743
anesthe@@	O	-1	17263743
si@@	O	-1	17263743
a,	O	-1	17263743
the	O	-1	17263743
patient	O	-1	17263743
developed	O	-1	17263743
brady@@	B-Disease	D001919	17263743
cardia	I-Disease	-1	17263743
and	O	-1	17263743
hypotension	B-Disease	D007022	17263743
requ@@	O	-1	17263743
ir@@	O	-1	17263743
ing	O	-1	17263743
cardiac	O	-1	17263743
res@@	O	-1	17263743
us@@	O	-1	17263743
cit@@	O	-1	17263743
ation.	O	-1	17263743
There	O	-1	17263743
are	O	-1	17263743
no	O	-1	17263743
previ@@	O	-1	17263743
ous	O	-1	17263743
reports	O	-1	17263743
of	O	-1	17263743
clonidine	B-Chemical	D003000	17263743
-@@	O	-1	17263743
associated	O	-1	17263743
cardiac	B-Disease	D006323	17263743
ar@@	I-Disease	-1	17263743
res@@	I-Disease	-1	17263743
t	I-Disease	-1	17263743
in	O	-1	17263743
a	O	-1	17263743
ch@@	O	-1	17263743
il@@	O	-1	17263743
d	O	-1	17263743
under@@	O	-1	17263743
go@@	O	-1	17263743
ing	O	-1	17263743
induction	O	-1	17263743
of	O	-1	17263743
anesthe@@	O	-1	17263743
sia.	O	-1	17263743

Eff@@	O	-1	17241657
ects	O	-1	17241657
of	O	-1	17241657
U@@	B-Chemical	C519696	17241657
M@@	I-Chemical	-1	17241657
B@@	I-Chemical	-1	17241657
24	I-Chemical	-1	17241657
and	O	-1	17241657
(@@	O	-1	17241657
+/-@@	O	-1	17241657
)@@	O	-1	17241657
-	O	-1	17241657
S@@	B-Chemical	C107044	17241657
M	I-Chemical	-1	17241657
21	I-Chemical	-1	17241657
,	O	-1	17241657
p@@	O	-1	17241657
ut@@	O	-1	17241657
ative	O	-1	17241657
si@@	O	-1	17241657
g@@	O	-1	17241657
ma@@	O	-1	17241657
2-@@	O	-1	17241657
pre@@	O	-1	17241657
fer@@	O	-1	17241657
r@@	O	-1	17241657
ing	O	-1	17241657
antagonist@@	O	-1	17241657
s,	O	-1	17241657
on	O	-1	17241657
behavioral	O	-1	17241657
toxic	O	-1	17241657
and	O	-1	17241657
stimul@@	O	-1	17241657
ant	O	-1	17241657
effects	O	-1	17241657
of	O	-1	17241657
cocaine	B-Chemical	D003042	17241657
in	O	-1	17241657
mice.	O	-1	17241657
E@@	O	-1	17241657
ar@@	O	-1	17241657
li@@	O	-1	17241657
er	O	-1	17241657
studies	O	-1	17241657
have	O	-1	17241657
demonstrated	O	-1	17241657
that	O	-1	17241657
antagon@@	O	-1	17241657
ism	O	-1	17241657
of	O	-1	17241657
si@@	O	-1	17241657
g@@	O	-1	17241657
ma@@	O	-1	17241657
1	O	-1	17241657
receptors	O	-1	17241657
attenu@@	O	-1	17241657
ates	O	-1	17241657
the	O	-1	17241657
convul@@	B-Disease	D012640	17241657
sive	I-Disease	-1	17241657
,	O	-1	17241657
le@@	O	-1	17241657
thal@@	O	-1	17241657
,	O	-1	17241657
locomotor	O	-1	17241657
stimul@@	O	-1	17241657
atory	O	-1	17241657
and	O	-1	17241657
re@@	O	-1	17241657
war@@	O	-1	17241657
ding	O	-1	17241657
ac@@	O	-1	17241657
tions	O	-1	17241657
of	O	-1	17241657
cocaine	B-Chemical	D003042	17241657
in	O	-1	17241657
mice.	O	-1	17241657
In	O	-1	17241657
contrast@@	O	-1	17241657
,	O	-1	17241657
the	O	-1	17241657
cont@@	O	-1	17241657
ri@@	O	-1	17241657
bu@@	O	-1	17241657
tion	O	-1	17241657
of	O	-1	17241657
si@@	O	-1	17241657
g@@	O	-1	17241657
ma@@	O	-1	17241657
2	O	-1	17241657
receptors	O	-1	17241657
is	O	-1	17241657
unc@@	O	-1	17241657
le@@	O	-1	17241657
ar	O	-1	17241657
because	O	-1	17241657
experimental	O	-1	17241657
to@@	O	-1	17241657
ol@@	O	-1	17241657
s	O	-1	17241657
to	O	-1	17241657
sel@@	O	-1	17241657
ectively	O	-1	17241657
t@@	O	-1	17241657
arg@@	O	-1	17241657
et	O	-1	17241657
this	O	-1	17241657
sub@@	O	-1	17241657
type	O	-1	17241657
are	O	-1	17241657
un@@	O	-1	17241657
av@@	O	-1	17241657
ail@@	O	-1	17241657
able@@	O	-1	17241657
.	O	-1	17241657
To	O	-1	17241657
be@@	O	-1	17241657
g@@	O	-1	17241657
in	O	-1	17241657
ad@@	O	-1	17241657
d@@	O	-1	17241657
res@@	O	-1	17241657
s@@	O	-1	17241657
ing	O	-1	17241657
this	O	-1	17241657
ne@@	O	-1	17241657
ed,	O	-1	17241657
we	O	-1	17241657
character@@	O	-1	17241657
ized	O	-1	17241657
U@@	B-Chemical	C519696	17241657
M@@	I-Chemical	-1	17241657
B@@	I-Chemical	-1	17241657
24	I-Chemical	-1	17241657
(	O	-1	17241657
1-@@	B-Chemical	C519696	17241657
(2@@	I-Chemical	-1	17241657
-@@	I-Chemical	-1	17241657
phen@@	I-Chemical	-1	17241657
eth@@	I-Chemical	-1	17241657
yl@@	I-Chemical	-1	17241657
)-@@	I-Chemical	-1	17241657
4-@@	I-Chemical	-1	17241657
(2@@	I-Chemical	-1	17241657
-@@	I-Chemical	-1	17241657
pyri@@	I-Chemical	-1	17241657
d@@	I-Chemical	-1	17241657
yl@@	I-Chemical	-1	17241657
)-@@	I-Chemical	-1	17241657
pi@@	I-Chemical	-1	17241657
per@@	I-Chemical	-1	17241657
az@@	I-Chemical	-1	17241657
ine	I-Chemical	-1	17241657
)	O	-1	17241657
and	O	-1	17241657
(@@	O	-1	17241657
+/-@@	O	-1	17241657
)@@	O	-1	17241657
-	O	-1	17241657
S@@	B-Chemical	C107044	17241657
M	I-Chemical	-1	17241657
21	I-Chemical	-1	17241657
(	O	-1	17241657
3@@	B-Chemical	C107044	17241657
alpha-@@	I-Chemical	-1	17241657
tro@@	I-Chemical	-1	17241657
p@@	I-Chemical	-1	17241657
an@@	I-Chemical	-1	17241657
yl@@	I-Chemical	-1	17241657
-@@	I-Chemical	-1	17241657
2-@@	I-Chemical	-1	17241657
(@@	I-Chemical	-1	17241657
4-@@	I-Chemical	-1	17241657
ch@@	I-Chemical	-1	17241657
o@@	I-Chemical	-1	17241657
ro@@	I-Chemical	-1	17241657
phen@@	I-Chemical	-1	17241657
oxy@@	I-Chemical	-1	17241657
)@@	I-Chemical	-1	17241657
but@@	I-Chemical	-1	17241657
y@@	I-Chemical	-1	17241657
rate	I-Chemical	-1	17241657
)	O	-1	17241657
in	O	-1	17241657
receptor	O	-1	17241657
b@@	O	-1	17241657
ind@@	O	-1	17241657
ing	O	-1	17241657
and	O	-1	17241657
behavioral	O	-1	17241657
studi@@	O	-1	17241657
es.	O	-1	17241657
Rec@@	O	-1	17241657
e@@	O	-1	17241657
pt@@	O	-1	17241657
or	O	-1	17241657
b@@	O	-1	17241657
ind@@	O	-1	17241657
ing	O	-1	17241657
studies	O	-1	17241657
con@@	O	-1	17241657
fir@@	O	-1	17241657
m@@	O	-1	17241657
ed	O	-1	17241657
that	O	-1	17241657
U@@	B-Chemical	C519696	17241657
M@@	I-Chemical	-1	17241657
B@@	I-Chemical	-1	17241657
24	I-Chemical	-1	17241657
and	O	-1	17241657
(@@	O	-1	17241657
+/-@@	O	-1	17241657
)@@	O	-1	17241657
-	O	-1	17241657
S@@	B-Chemical	C107044	17241657
M	I-Chemical	-1	17241657
21	I-Chemical	-1	17241657
dis@@	O	-1	17241657
pl@@	O	-1	17241657
ay	O	-1	17241657
pre@@	O	-1	17241657
fe@@	O	-1	17241657
ren@@	O	-1	17241657
tial	O	-1	17241657
aff@@	O	-1	17241657
in@@	O	-1	17241657
ity	O	-1	17241657
for	O	-1	17241657
si@@	O	-1	17241657
g@@	O	-1	17241657
ma@@	O	-1	17241657
2	O	-1	17241657
over	O	-1	17241657
si@@	O	-1	17241657
g@@	O	-1	17241657
ma@@	O	-1	17241657
1	O	-1	17241657
receptor@@	O	-1	17241657
s.	O	-1	17241657
In	O	-1	17241657
behavioral	O	-1	17241657
studi@@	O	-1	17241657
es,	O	-1	17241657
pretreatment	O	-1	17241657
of	O	-1	17241657
S@@	O	-1	17241657
w@@	O	-1	17241657
is@@	O	-1	17241657
s	O	-1	17241657
W@@	O	-1	17241657
e@@	O	-1	17241657
b@@	O	-1	17241657
st@@	O	-1	17241657
er	O	-1	17241657
mice	O	-1	17241657
with	O	-1	17241657
U@@	B-Chemical	C519696	17241657
M@@	I-Chemical	-1	17241657
B@@	I-Chemical	-1	17241657
24	I-Chemical	-1	17241657
or	O	-1	17241657
(@@	O	-1	17241657
+/-@@	O	-1	17241657
)@@	O	-1	17241657
-	O	-1	17241657
S@@	B-Chemical	C107044	17241657
M	I-Chemical	-1	17241657
21	I-Chemical	-1	17241657
significantly	O	-1	17241657
attenu@@	O	-1	17241657
ated	O	-1	17241657
cocaine	B-Chemical	D003042	17241657
-induced	O	-1	17241657
convul@@	B-Disease	D012640	17241657
sions	I-Disease	-1	17241657
and	O	-1	17241657
locomotor	O	-1	17241657
activ@@	O	-1	17241657
ity,	O	-1	17241657
but	O	-1	17241657
not	O	-1	17241657
le@@	O	-1	17241657
thal@@	O	-1	17241657
ity.	O	-1	17241657
Whe@@	O	-1	17241657
n	O	-1	17241657
administered	O	-1	17241657
al@@	O	-1	17241657
one,	O	-1	17241657
(@@	O	-1	17241657
+/-@@	O	-1	17241657
)@@	O	-1	17241657
-	O	-1	17241657
S@@	B-Chemical	C107044	17241657
M	I-Chemical	-1	17241657
21	I-Chemical	-1	17241657
produced	O	-1	17241657
no	O	-1	17241657
significant	O	-1	17241657
effects	O	-1	17241657
compared	O	-1	17241657
to	O	-1	17241657
control	O	-1	17241657
injec@@	O	-1	17241657
tions	O	-1	17241657
of	O	-1	17241657
sal@@	O	-1	17241657
ine,	O	-1	17241657
but	O	-1	17241657
U@@	B-Chemical	C519696	17241657
M@@	I-Chemical	-1	17241657
B@@	I-Chemical	-1	17241657
24	I-Chemical	-1	17241657
had	O	-1	17241657
locomotor	O	-1	17241657
depress@@	O	-1	17241657
ant	O	-1	17241657
ac@@	O	-1	17241657
tions.	O	-1	17241657
T@@	O	-1	17241657
o@@	O	-1	17241657
ge@@	O	-1	17241657
ther@@	O	-1	17241657
,	O	-1	17241657
the	O	-1	17241657
data	O	-1	17241657
suggest	O	-1	17241657
that	O	-1	17241657
si@@	O	-1	17241657
g@@	O	-1	17241657
ma@@	O	-1	17241657
2	O	-1	17241657
receptor	O	-1	17241657
antagonist@@	O	-1	17241657
s	O	-1	17241657
have	O	-1	17241657
the	O	-1	17241657
potential	O	-1	17241657
to	O	-1	17241657
attenu@@	O	-1	17241657
ate	O	-1	17241657
some	O	-1	17241657
of	O	-1	17241657
the	O	-1	17241657
behavioral	O	-1	17241657
effects	O	-1	17241657
of	O	-1	17241657
cocaine	B-Chemical	D003042	17241657
,	O	-1	17241657
and	O	-1	17241657
further	O	-1	17241657
development	O	-1	17241657
of	O	-1	17241657
more	O	-1	17241657
sel@@	O	-1	17241657
ecti@@	O	-1	17241657
ve,	O	-1	17241657
high	O	-1	17241657
aff@@	O	-1	17241657
in@@	O	-1	17241657
ity	O	-1	17241657
li@@	O	-1	17241657
g@@	O	-1	17241657
and@@	O	-1	17241657
s	O	-1	17241657
are	O	-1	17241657
war@@	O	-1	17241657
ran@@	O	-1	17241657
ted.	O	-1	17241657

M@@	B-Chemical	D008713	14982270
eth@@	I-Chemical	-1	14982270
im@@	I-Chemical	-1	14982270
azole	I-Chemical	-1	14982270
-induced	O	-1	14982270
cholest@@	B-Disease	D041781	14982270
atic	I-Disease	-1	14982270
j@@	I-Disease	-1	14982270
a@@	I-Disease	-1	14982270
un@@	I-Disease	-1	14982270
dic@@	I-Disease	-1	14982270
e	I-Disease	-1	14982270
.	O	-1	14982270
M@@	B-Chemical	D008713	14982270
eth@@	I-Chemical	-1	14982270
im@@	I-Chemical	-1	14982270
azole	I-Chemical	-1	14982270
is	O	-1	14982270
a	O	-1	14982270
wi@@	O	-1	14982270
de@@	O	-1	14982270
ly	O	-1	14982270
used	O	-1	14982270
and	O	-1	14982270
gener@@	O	-1	14982270
ally	O	-1	14982270
we@@	O	-1	14982270
ll@@	O	-1	14982270
-@@	O	-1	14982270
toler@@	O	-1	14982270
ated	O	-1	14982270
anti@@	O	-1	14982270
th@@	O	-1	14982270
yro@@	O	-1	14982270
id	O	-1	14982270
agent@@	O	-1	14982270
.	O	-1	14982270
A	O	-1	14982270
4@@	O	-1	14982270
3-@@	O	-1	14982270
year-old	O	-1	14982270
woman	O	-1	14982270
had	O	-1	14982270
severe	O	-1	14982270
j@@	B-Disease	D007565	14982270
a@@	I-Disease	-1	14982270
un@@	I-Disease	-1	14982270
dic@@	I-Disease	-1	14982270
e	I-Disease	-1	14982270
and	O	-1	14982270
it@@	B-Disease	D011537	14982270
ch@@	I-Disease	-1	14982270
ing	I-Disease	-1	14982270
1	O	-1	14982270
mon@@	O	-1	14982270
th	O	-1	14982270
after	O	-1	14982270
receiving	O	-1	14982270
meth@@	B-Chemical	D008713	14982270
im@@	I-Chemical	-1	14982270
azole	I-Chemical	-1	14982270
(10	O	-1	14982270
mg	O	-1	14982270
tid@@	O	-1	14982270
)	O	-1	14982270
and	O	-1	14982270
prop@@	B-Chemical	D011433	14982270
ran@@	I-Chemical	-1	14982270
o@@	I-Chemical	-1	14982270
lol	I-Chemical	-1	14982270
(2@@	O	-1	14982270
0	O	-1	14982270
mg	O	-1	14982270
tid@@	O	-1	14982270
)	O	-1	14982270
for	O	-1	14982270
treatment	O	-1	14982270
of	O	-1	14982270
hyper@@	B-Disease	D006980	14982270
th@@	I-Disease	-1	14982270
yro@@	I-Disease	-1	14982270
i@@	I-Disease	-1	14982270
dis@@	I-Disease	-1	14982270
m	I-Disease	-1	14982270
.	O	-1	14982270
The	O	-1	14982270
patient	O	-1	14982270
continu@@	O	-1	14982270
ed	O	-1	14982270
treatment	O	-1	14982270
for	O	-1	14982270
an@@	O	-1	14982270
other	O	-1	14982270
4	O	-1	14982270
days	O	-1	14982270
after	O	-1	14982270
the	O	-1	14982270
appear@@	O	-1	14982270
ance	O	-1	14982270
of	O	-1	14982270
j@@	B-Disease	D007565	14982270
a@@	I-Disease	-1	14982270
un@@	I-Disease	-1	14982270
dic@@	I-Disease	-1	14982270
e	I-Disease	-1	14982270
un@@	O	-1	14982270
ti@@	O	-1	14982270
l	O	-1	14982270
sh@@	O	-1	14982270
e	O	-1	14982270
f@@	O	-1	14982270
in@@	O	-1	14982270
ished	O	-1	14982270
both	O	-1	14982270
medic@@	O	-1	14982270
ations.	O	-1	14982270
Whe@@	O	-1	14982270
n	O	-1	14982270
seen	O	-1	14982270
at	O	-1	14982270
the	O	-1	14982270
em@@	O	-1	14982270
er@@	O	-1	14982270
gen@@	O	-1	14982270
c@@	O	-1	14982270
y	O	-1	14982270
de@@	O	-1	14982270
part@@	O	-1	14982270
ment	O	-1	14982270
2	O	-1	14982270
weeks	O	-1	14982270
lat@@	O	-1	14982270
er,	O	-1	14982270
sh@@	O	-1	14982270
e	O	-1	14982270
sti@@	O	-1	14982270
ll	O	-1	14982270
had	O	-1	14982270
severe	O	-1	14982270
ic@@	B-Disease	D007565	14982270
ter@@	I-Disease	-1	14982270
us	I-Disease	-1	14982270
,	O	-1	14982270
pr@@	B-Disease	D011537	14982270
ur@@	I-Disease	-1	14982270
it@@	I-Disease	-1	14982270
us	I-Disease	-1	14982270
,	O	-1	14982270
and	O	-1	14982270
hyper@@	B-Disease	D006932	14982270
bil@@	I-Disease	-1	14982270
i@@	I-Disease	-1	14982270
ru@@	I-Disease	-1	14982270
b@@	I-Disease	-1	14982270
ine@@	I-Disease	-1	14982270
mia	I-Disease	-1	14982270
,	O	-1	14982270
form@@	O	-1	14982270
ed	O	-1	14982270
main@@	O	-1	14982270
ly	O	-1	14982270
of	O	-1	14982270
the	O	-1	14982270
con@@	O	-1	14982270
j@@	O	-1	14982270
u@@	O	-1	14982270
g@@	O	-1	14982270
ated	O	-1	14982270
frac@@	O	-1	14982270
tion.	O	-1	14982270
M@@	B-Chemical	D008713	14982270
eth@@	I-Chemical	-1	14982270
im@@	I-Chemical	-1	14982270
azole	I-Chemical	-1	14982270
-induced	O	-1	14982270
cholest@@	B-Disease	D002779	14982270
asis	I-Disease	-1	14982270
was	O	-1	14982270
diagno@@	O	-1	14982270
se@@	O	-1	14982270
d,	O	-1	14982270
and	O	-1	14982270
prop@@	B-Chemical	D011433	14982270
ran@@	I-Chemical	-1	14982270
o@@	I-Chemical	-1	14982270
lol	I-Chemical	-1	14982270
therapy	O	-1	14982270
was	O	-1	14982270
res@@	O	-1	14982270
u@@	O	-1	14982270
me@@	O	-1	14982270
d.	O	-1	14982270
O@@	O	-1	14982270
ver	O	-1	14982270
the	O	-1	14982270
following	O	-1	14982270
9	O	-1	14982270
day@@	O	-1	14982270
s,	O	-1	14982270
the	O	-1	14982270
symptoms	O	-1	14982270
improved	O	-1	14982270
and	O	-1	14982270
plasma	O	-1	14982270
bil@@	B-Chemical	D001663	14982270
i@@	I-Chemical	-1	14982270
ru@@	I-Chemical	-1	14982270
bin	I-Chemical	-1	14982270
levels	O	-1	14982270
were	O	-1	14982270
normal	O	-1	14982270
after	O	-1	14982270
12	O	-1	14982270
weeks	O	-1	14982270
without	O	-1	14982270
meth@@	B-Chemical	D008713	14982270
im@@	I-Chemical	-1	14982270
azole	I-Chemical	-1	14982270
.	O	-1	14982270
In	O	-1	14982270
r@@	O	-1	14982270
are	O	-1	14982270
cases	O	-1	14982270
within	O	-1	14982270
the	O	-1	14982270
first	O	-1	14982270
fe@@	O	-1	14982270
w	O	-1	14982270
weeks	O	-1	14982270
of	O	-1	14982270
therapy,	O	-1	14982270
this	O	-1	14982270
drug	O	-1	14982270
can	O	-1	14982270
cause	O	-1	14982270
severe	O	-1	14982270
and	O	-1	14982270
reversible	O	-1	14982270
cholest@@	B-Disease	D041781	14982270
atic	I-Disease	-1	14982270
j@@	I-Disease	-1	14982270
a@@	I-Disease	-1	14982270
un@@	I-Disease	-1	14982270
dic@@	I-Disease	-1	14982270
e	I-Disease	-1	14982270
.	O	-1	14982270
P@@	O	-1	14982270
hy@@	O	-1	14982270
si@@	O	-1	14982270
ci@@	O	-1	14982270
ans	O	-1	14982270
and	O	-1	14982270
patients	O	-1	14982270
should	O	-1	14982270
be	O	-1	14982270
aw@@	O	-1	14982270
are	O	-1	14982270
of	O	-1	14982270
this	O	-1	14982270
adverse	O	-1	14982270
effect	O	-1	14982270
so	O	-1	14982270
th@@	O	-1	14982270
at@@	O	-1	14982270
,	O	-1	14982270
up@@	O	-1	14982270
on	O	-1	14982270
occur@@	O	-1	14982270
ren@@	O	-1	14982270
ce@@	O	-1	14982270
,	O	-1	14982270
they	O	-1	14982270
can	O	-1	14982270
discontinu@@	O	-1	14982270
e	O	-1	14982270
meth@@	B-Chemical	D008713	14982270
im@@	I-Chemical	-1	14982270
azole	I-Chemical	-1	14982270
therapy	O	-1	14982270
and	O	-1	14982270
av@@	O	-1	14982270
oid	O	-1	14982270
un@@	O	-1	14982270
nec@@	O	-1	14982270
ess@@	O	-1	14982270
ary	O	-1	14982270
inv@@	O	-1	14982270
a@@	O	-1	14982270
sive	O	-1	14982270
proce@@	O	-1	14982270
du@@	O	-1	14982270
res@@	O	-1	14982270
.	O	-1	14982270

C@@	B-Chemical	D002939	12911170
i@@	I-Chemical	-1	12911170
prof@@	I-Chemical	-1	12911170
lo@@	I-Chemical	-1	12911170
x@@	I-Chemical	-1	12911170
ac@@	I-Chemical	-1	12911170
in	I-Chemical	-1	12911170
-induced	O	-1	12911170
acute	O	-1	12911170
interstitial	B-Disease	D009395	12911170
neph@@	I-Disease	-1	12911170
ritis	I-Disease	-1	12911170
and	O	-1	12911170
auto@@	B-Disease	D000744	12911170
immun@@	I-Disease	-1	12911170
e	I-Disease	-1	12911170
hemolytic	I-Disease	-1	12911170
anemia	I-Disease	-1	12911170
.	O	-1	12911170
C@@	B-Chemical	D002939	12911170
i@@	I-Chemical	-1	12911170
prof@@	I-Chemical	-1	12911170
lo@@	I-Chemical	-1	12911170
x@@	I-Chemical	-1	12911170
ac@@	I-Chemical	-1	12911170
in	I-Chemical	-1	12911170
has	O	-1	12911170
been	O	-1	12911170
associated	O	-1	12911170
with	O	-1	12911170
several	O	-1	12911170
side	O	-1	12911170
effects	O	-1	12911170
including	O	-1	12911170
interstitial	B-Disease	D009395	12911170
neph@@	I-Disease	-1	12911170
ritis	I-Disease	-1	12911170
and	O	-1	12911170
hemolytic	B-Disease	D000743	12911170
anemia	I-Disease	-1	12911170
.	O	-1	12911170
The	O	-1	12911170
combination	O	-1	12911170
of	O	-1	12911170
both	O	-1	12911170
side	O	-1	12911170
effects	O	-1	12911170
is	O	-1	12911170
ex@@	O	-1	12911170
tre@@	O	-1	12911170
me@@	O	-1	12911170
ly	O	-1	12911170
ra@@	O	-1	12911170
re.	O	-1	12911170
In	O	-1	12911170
this	O	-1	12911170
repor@@	O	-1	12911170
t,	O	-1	12911170
we	O	-1	12911170
describe	O	-1	12911170
a	O	-1	12911170
case	O	-1	12911170
of	O	-1	12911170
ci@@	B-Chemical	D002939	12911170
prof@@	I-Chemical	-1	12911170
lo@@	I-Chemical	-1	12911170
x@@	I-Chemical	-1	12911170
ac@@	I-Chemical	-1	12911170
in	I-Chemical	-1	12911170
-induced	O	-1	12911170
interstitial	B-Disease	D009395	12911170
neph@@	I-Disease	-1	12911170
ritis	I-Disease	-1	12911170
and	O	-1	12911170
auto@@	B-Disease	D000744	12911170
immun@@	I-Disease	-1	12911170
e	I-Disease	-1	12911170
hemolytic	I-Disease	-1	12911170
anemia	I-Disease	-1	12911170
.	O	-1	12911170
H@@	B-Disease	D000743	12911170
em@@	I-Disease	-1	12911170
oly@@	I-Disease	-1	12911170
tic	I-Disease	-1	12911170
anemia	I-Disease	-1	12911170
improved	O	-1	12911170
after	O	-1	12911170
sto@@	O	-1	12911170
pp@@	O	-1	12911170
ing	O	-1	12911170
the	O	-1	12911170
drug	O	-1	12911170
and	O	-1	12911170
initi@@	O	-1	12911170
ation	O	-1	12911170
of	O	-1	12911170
ster@@	B-Chemical	D013256	12911170
oid	I-Chemical	-1	12911170
therapy.	O	-1	12911170
U@@	O	-1	12911170
n@@	O	-1	12911170
for@@	O	-1	12911170
t@@	O	-1	12911170
un@@	O	-1	12911170
at@@	O	-1	12911170
el@@	O	-1	12911170
y,	O	-1	12911170
acute	O	-1	12911170
interstitial	B-Disease	D009395	12911170
neph@@	I-Disease	-1	12911170
ritis	I-Disease	-1	12911170
was	O	-1	12911170
ir@@	O	-1	12911170
reversible	O	-1	12911170
and	O	-1	12911170
the	O	-1	12911170
patient	O	-1	12911170
developed	O	-1	12911170
en@@	B-Disease	D007676	12911170
d-@@	I-Disease	-1	12911170
st@@	I-Disease	-1	12911170
age	I-Disease	-1	12911170
renal	I-Disease	-1	12911170
disease	I-Disease	-1	12911170
.	O	-1	12911170

Con@@	O	-1	11195262
tri@@	O	-1	11195262
bu@@	O	-1	11195262
tion	O	-1	11195262
of	O	-1	11195262
sodium	B-Chemical	D014635	11195262
valpro@@	I-Chemical	-1	11195262
ate	I-Chemical	-1	11195262
to	O	-1	11195262
the	O	-1	11195262
syndrome	B-Disease	D007177	11195262
of	I-Disease	-1	11195262
in@@	I-Disease	-1	11195262
appro@@	I-Disease	-1	11195262
pri@@	I-Disease	-1	11195262
ate	I-Disease	-1	11195262
secre@@	I-Disease	-1	11195262
tion	I-Disease	-1	11195262
of	I-Disease	-1	11195262
anti@@	I-Disease	-1	11195262
di@@	I-Disease	-1	11195262
ure@@	I-Disease	-1	11195262
tic	I-Disease	-1	11195262
h@@	I-Disease	-1	11195262
orm@@	I-Disease	-1	11195262
one	I-Disease	-1	11195262
.	O	-1	11195262
We	O	-1	11195262
report	O	-1	11195262
the	O	-1	11195262
case	O	-1	11195262
of	O	-1	11195262
a	O	-1	11195262
6@@	O	-1	11195262
2-@@	O	-1	11195262
year-old	O	-1	11195262
man	O	-1	11195262
who	O	-1	11195262
was	O	-1	11195262
administered	O	-1	11195262
sodium	B-Chemical	D014635	11195262
valpro@@	I-Chemical	-1	11195262
ate	I-Chemical	-1	11195262
(	O	-1	11195262
V@@	B-Chemical	D014635	11195262
P@@	I-Chemical	-1	11195262
A	I-Chemical	-1	11195262
)	O	-1	11195262
and	O	-1	11195262
who	O	-1	11195262
subsequ@@	O	-1	11195262
ently	O	-1	11195262
developed	O	-1	11195262
the	O	-1	11195262
syndrome	B-Disease	D007177	11195262
of	I-Disease	-1	11195262
in@@	I-Disease	-1	11195262
appro@@	I-Disease	-1	11195262
pri@@	I-Disease	-1	11195262
ate	I-Disease	-1	11195262
secre@@	I-Disease	-1	11195262
tion	I-Disease	-1	11195262
of	I-Disease	-1	11195262
anti@@	I-Disease	-1	11195262
di@@	I-Disease	-1	11195262
ure@@	I-Disease	-1	11195262
tic	I-Disease	-1	11195262
h@@	I-Disease	-1	11195262
orm@@	I-Disease	-1	11195262
one	I-Disease	-1	11195262
(	O	-1	11195262
S@@	B-Disease	D007177	11195262
I@@	I-Disease	-1	11195262
AD@@	I-Disease	-1	11195262
H	I-Disease	-1	11195262
).	O	-1	11195262
H@@	O	-1	11195262
e	O	-1	11195262
had	O	-1	11195262
been	O	-1	11195262
taking	O	-1	11195262
V@@	B-Chemical	D014635	11195262
P@@	I-Chemical	-1	11195262
A	I-Chemical	-1	11195262
for	O	-1	11195262
treatment	O	-1	11195262
of	O	-1	11195262
i@@	O	-1	11195262
di@@	O	-1	11195262
o@@	O	-1	11195262
path@@	O	-1	11195262
ic	O	-1	11195262
gener@@	O	-1	11195262
al@@	O	-1	11195262
ized	O	-1	11195262
t@@	B-Disease	D004830	11195262
on@@	I-Disease	-1	11195262
ic@@	I-Disease	-1	11195262
-@@	I-Disease	-1	11195262
clon@@	I-Disease	-1	11195262
ic	I-Disease	-1	11195262
convul@@	I-Disease	-1	11195262
sions	I-Disease	-1	11195262
s@@	O	-1	11195262
inc@@	O	-1	11195262
e	O	-1	11195262
he	O	-1	11195262
was	O	-1	11195262
5@@	O	-1	11195262
6	O	-1	11195262
years	O	-1	11195262
ol@@	O	-1	11195262
d.	O	-1	11195262
After	O	-1	11195262
sub@@	O	-1	11195262
sti@@	O	-1	11195262
t@@	O	-1	11195262
ut@@	O	-1	11195262
ing	O	-1	11195262
V@@	B-Chemical	D014635	11195262
P@@	I-Chemical	-1	11195262
A	I-Chemical	-1	11195262
with	O	-1	11195262
z@@	B-Chemical	C022189	11195262
on@@	I-Chemical	-1	11195262
is@@	I-Chemical	-1	11195262
amide	I-Chemical	-1	11195262
,	O	-1	11195262
the	O	-1	11195262
serum	O	-1	11195262
sodium	B-Chemical	D012964	11195262
level	O	-1	11195262
retur@@	O	-1	11195262
n@@	O	-1	11195262
ed	O	-1	11195262
to	O	-1	11195262
normal@@	O	-1	11195262
.	O	-1	11195262
We	O	-1	11195262
con@@	O	-1	11195262
si@@	O	-1	11195262
der	O	-1	11195262
this	O	-1	11195262
episo@@	O	-1	11195262
de	O	-1	11195262
of	O	-1	11195262
S@@	B-Disease	D007177	11195262
I@@	I-Disease	-1	11195262
AD@@	I-Disease	-1	11195262
H	I-Disease	-1	11195262
to	O	-1	11195262
be	O	-1	11195262
the	O	-1	11195262
result	O	-1	11195262
of	O	-1	11195262
a	O	-1	11195262
combination	O	-1	11195262
of	O	-1	11195262
factors	O	-1	11195262
including	O	-1	11195262
a	O	-1	11195262
we@@	B-Disease	D002493	11195262
ak@@	I-Disease	-1	11195262
ness	I-Disease	-1	11195262
of	I-Disease	-1	11195262
the	I-Disease	-1	11195262
central	I-Disease	-1	11195262
ner@@	I-Disease	-1	11195262
v@@	I-Disease	-1	11195262
ous	I-Disease	-1	11195262
system	I-Disease	-1	11195262
and	O	-1	11195262
the	O	-1	11195262
long-term	O	-1	11195262
administration	O	-1	11195262
of	O	-1	11195262
V@@	B-Chemical	D014635	11195262
P@@	I-Chemical	-1	11195262
A	I-Chemical	-1	11195262
.	O	-1	11195262

V@@	B-Chemical	D014667	10728962
as@@	I-Chemical	-1	10728962
o@@	I-Chemical	-1	10728962
press@@	I-Chemical	-1	10728962
in	I-Chemical	-1	10728962
in	O	-1	10728962
the	O	-1	10728962
treatment	O	-1	10728962
of	O	-1	10728962
mil@@	B-Chemical	D020105	10728962
r@@	I-Chemical	-1	10728962
in@@	I-Chemical	-1	10728962
one	I-Chemical	-1	10728962
-induced	O	-1	10728962
hypotension	B-Disease	D007022	10728962
in	O	-1	10728962
severe	O	-1	10728962
heart	B-Disease	D006333	10728962
failure	I-Disease	-1	10728962
.	O	-1	10728962
The	O	-1	10728962
use	O	-1	10728962
of	O	-1	10728962
phosph@@	O	-1	10728962
odi@@	O	-1	10728962
est@@	O	-1	10728962
er@@	O	-1	10728962
ase	O	-1	10728962
inhibitors	O	-1	10728962
such	O	-1	10728962
as	O	-1	10728962
mil@@	B-Chemical	D020105	10728962
r@@	I-Chemical	-1	10728962
in@@	I-Chemical	-1	10728962
one	I-Chemical	-1	10728962
in	O	-1	10728962
the	O	-1	10728962
treatment	O	-1	10728962
of	O	-1	10728962
severe	O	-1	10728962
heart	B-Disease	D006333	10728962
failure	I-Disease	-1	10728962
is	O	-1	10728962
frequ@@	O	-1	10728962
ently	O	-1	10728962
re@@	O	-1	10728962
stric@@	O	-1	10728962
ted	O	-1	10728962
because	O	-1	10728962
they	O	-1	10728962
cause	O	-1	10728962
vas@@	O	-1	10728962
odi@@	O	-1	10728962
l@@	O	-1	10728962
ation	O	-1	10728962
and	O	-1	10728962
hypotension	B-Disease	D007022	10728962
.	O	-1	10728962
In	O	-1	10728962
patients	O	-1	10728962
with	O	-1	10728962
dec@@	O	-1	10728962
om@@	O	-1	10728962
pen@@	O	-1	10728962
s@@	O	-1	10728962
ated	O	-1	10728962
heart	B-Disease	D006333	10728962
failure	I-Disease	-1	10728962
with	O	-1	10728962
hypotension	B-Disease	D007022	10728962
after	O	-1	10728962
treatment	O	-1	10728962
with	O	-1	10728962
mil@@	B-Chemical	D020105	10728962
r@@	I-Chemical	-1	10728962
in@@	I-Chemical	-1	10728962
one	I-Chemical	-1	10728962
,	O	-1	10728962
low	O	-1	10728962
doses	O	-1	10728962
of	O	-1	10728962
vas@@	B-Chemical	D014667	10728962
o@@	I-Chemical	-1	10728962
press@@	I-Chemical	-1	10728962
in	I-Chemical	-1	10728962
re@@	O	-1	10728962
sto@@	O	-1	10728962
red	O	-1	10728962
blood	O	-1	10728962
pressure	O	-1	10728962
without	O	-1	10728962
inhibit@@	O	-1	10728962
ing	O	-1	10728962
the	O	-1	10728962
in@@	O	-1	10728962
ot@@	O	-1	10728962
ro@@	O	-1	10728962
p@@	O	-1	10728962
ic	O	-1	10728962
effect	O	-1	10728962
of	O	-1	10728962
mil@@	B-Chemical	D020105	10728962
r@@	I-Chemical	-1	10728962
in@@	I-Chemical	-1	10728962
one	I-Chemical	-1	10728962
.	O	-1	10728962

H@@	O	-1	7647582
alo@@	O	-1	7647582
gen@@	O	-1	7647582
ated	O	-1	7647582
anesthe@@	O	-1	7647582
tics	O	-1	7647582
form	O	-1	7647582
liver	O	-1	7647582
ad@@	O	-1	7647582
duc@@	O	-1	7647582
ts	O	-1	7647582
and	O	-1	7647582
anti@@	O	-1	7647582
gen@@	O	-1	7647582
s	O	-1	7647582
that	O	-1	7647582
cros@@	O	-1	7647582
s-@@	O	-1	7647582
reac@@	O	-1	7647582
t	O	-1	7647582
with	O	-1	7647582
halo@@	B-Chemical	D006221	7647582
th@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
-induced	O	-1	7647582
anti@@	O	-1	7647582
bo@@	O	-1	7647582
di@@	O	-1	7647582
es.	O	-1	7647582
Two	O	-1	7647582
halo@@	O	-1	7647582
gen@@	O	-1	7647582
ated	O	-1	7647582
anesthe@@	O	-1	7647582
tic@@	O	-1	7647582
s,	O	-1	7647582
en@@	B-Chemical	D004737	7647582
f@@	I-Chemical	-1	7647582
lur@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
and	O	-1	7647582
iso@@	B-Chemical	D007530	7647582
f@@	I-Chemical	-1	7647582
lur@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
,	O	-1	7647582
have	O	-1	7647582
been	O	-1	7647582
associated	O	-1	7647582
with	O	-1	7647582
an	O	-1	7647582
all@@	O	-1	7647582
erg@@	O	-1	7647582
ic@@	O	-1	7647582
-@@	O	-1	7647582
type	O	-1	7647582
hepatic	B-Disease	D056486	7647582
injury	I-Disease	-1	7647582
both	O	-1	7647582
alone	O	-1	7647582
and	O	-1	7647582
following	O	-1	7647582
previ@@	O	-1	7647582
ous	O	-1	7647582
exposure	O	-1	7647582
to	O	-1	7647582
halo@@	B-Chemical	D006221	7647582
th@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
.	O	-1	7647582
H@@	B-Chemical	D006221	7647582
alo@@	I-Chemical	-1	7647582
th@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
hepatitis	B-Disease	D056486	7647582
appear@@	O	-1	7647582
s	O	-1	7647582
to	O	-1	7647582
invol@@	O	-1	7647582
ve	O	-1	7647582
an	O	-1	7647582
ab@@	O	-1	7647582
er@@	O	-1	7647582
ran@@	O	-1	7647582
t	O	-1	7647582
immun@@	O	-1	7647582
e	O	-1	7647582
respon@@	O	-1	7647582
se.	O	-1	7647582
An	O	-1	7647582
anti@@	O	-1	7647582
body	O	-1	7647582
response	O	-1	7647582
to	O	-1	7647582
a	O	-1	7647582
protein@@	O	-1	7647582
-@@	O	-1	7647582
b@@	O	-1	7647582
ound	O	-1	7647582
b@@	O	-1	7647582
i@@	O	-1	7647582
ot@@	O	-1	7647582
ran@@	O	-1	7647582
s@@	O	-1	7647582
formation	O	-1	7647582
produc@@	O	-1	7647582
t	O	-1	7647582
(	O	-1	7647582
tri@@	B-Chemical	D014269	7647582
fluoro@@	I-Chemical	-1	7647582
acet@@	I-Chemical	-1	7647582
yl	I-Chemical	-1	7647582
ad@@	O	-1	7647582
duc@@	O	-1	7647582
t@@	O	-1	7647582
)	O	-1	7647582
has	O	-1	7647582
been	O	-1	7647582
det@@	O	-1	7647582
ected	O	-1	7647582
on	O	-1	7647582
halo@@	B-Chemical	D006221	7647582
th@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
hepatitis	B-Disease	D056486	7647582
patients.	O	-1	7647582
This	O	-1	7647582
study	O	-1	7647582
was	O	-1	7647582
performed	O	-1	7647582
to	O	-1	7647582
determine	O	-1	7647582
cros@@	O	-1	7647582
s-@@	O	-1	7647582
re@@	O	-1	7647582
activity	O	-1	7647582
between	O	-1	7647582
en@@	B-Chemical	D004737	7647582
f@@	I-Chemical	-1	7647582
lur@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
and	O	-1	7647582
iso@@	B-Chemical	D007530	7647582
f@@	I-Chemical	-1	7647582
lur@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
with	O	-1	7647582
the	O	-1	7647582
hyper@@	B-Disease	D004342	7647582
sensitivity	I-Disease	-1	7647582
induced	O	-1	7647582
by	O	-1	7647582
halo@@	B-Chemical	D006221	7647582
th@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
.	O	-1	7647582
The	O	-1	7647582
sub@@	O	-1	7647582
cell@@	O	-1	7647582
ular	O	-1	7647582
and	O	-1	7647582
lo@@	O	-1	7647582
b@@	O	-1	7647582
ular	O	-1	7647582
pro@@	O	-1	7647582
duction	O	-1	7647582
of	O	-1	7647582
hepatic	O	-1	7647582
ne@@	O	-1	7647582
o@@	O	-1	7647582
anti@@	O	-1	7647582
gen@@	O	-1	7647582
s	O	-1	7647582
reco@@	O	-1	7647582
gn@@	O	-1	7647582
ized	O	-1	7647582
by	O	-1	7647582
halo@@	B-Chemical	D006221	7647582
th@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
-induced	O	-1	7647582
anti@@	O	-1	7647582
bo@@	O	-1	7647582
di@@	O	-1	7647582
es	O	-1	7647582
following	O	-1	7647582
en@@	B-Chemical	D004737	7647582
f@@	I-Chemical	-1	7647582
lur@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
and	O	-1	7647582
iso@@	B-Chemical	D007530	7647582
f@@	I-Chemical	-1	7647582
lur@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
,	O	-1	7647582
and	O	-1	7647582
the	O	-1	7647582
bio@@	O	-1	7647582
chemical	O	-1	7647582
n@@	O	-1	7647582
at@@	O	-1	7647582
ure	O	-1	7647582
of	O	-1	7647582
these	O	-1	7647582
ne@@	O	-1	7647582
o@@	O	-1	7647582
anti@@	O	-1	7647582
gen@@	O	-1	7647582
s	O	-1	7647582
was	O	-1	7647582
investigated	O	-1	7647582
in	O	-1	7647582
two	O	-1	7647582
anim@@	O	-1	7647582
al	O	-1	7647582
model@@	O	-1	7647582
s.	O	-1	7647582
E@@	B-Chemical	D004737	7647582
n@@	I-Chemical	-1	7647582
f@@	I-Chemical	-1	7647582
lur@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
administration	O	-1	7647582
resulted	O	-1	7647582
in	O	-1	7647582
ne@@	O	-1	7647582
o@@	O	-1	7647582
anti@@	O	-1	7647582
gen@@	O	-1	7647582
s	O	-1	7647582
det@@	O	-1	7647582
ected	O	-1	7647582
in	O	-1	7647582
both	O	-1	7647582
the	O	-1	7647582
micro@@	O	-1	7647582
s@@	O	-1	7647582
om@@	O	-1	7647582
al	O	-1	7647582
and	O	-1	7647582
cy@@	O	-1	7647582
t@@	O	-1	7647582
os@@	O	-1	7647582
olic	O	-1	7647582
frac@@	O	-1	7647582
tion	O	-1	7647582
of	O	-1	7647582
liver	O	-1	7647582
ho@@	O	-1	7647582
mo@@	O	-1	7647582
gen@@	O	-1	7647582
ates	O	-1	7647582
and	O	-1	7647582
in	O	-1	7647582
the	O	-1	7647582
c@@	O	-1	7647582
ent@@	O	-1	7647582
ri@@	O	-1	7647582
lo@@	O	-1	7647582
b@@	O	-1	7647582
ular	O	-1	7647582
regi@@	O	-1	7647582
on	O	-1	7647582
of	O	-1	7647582
the	O	-1	7647582
li@@	O	-1	7647582
ver@@	O	-1	7647582
.	O	-1	7647582
In	O	-1	7647582
the	O	-1	7647582
same	O	-1	7647582
li@@	O	-1	7647582
ver,	O	-1	7647582
bio@@	O	-1	7647582
chemical	O	-1	7647582
analysis	O	-1	7647582
det@@	O	-1	7647582
ected	O	-1	7647582
flu@@	O	-1	7647582
or@@	O	-1	7647582
in@@	O	-1	7647582
ated	O	-1	7647582
liver	O	-1	7647582
ad@@	O	-1	7647582
duc@@	O	-1	7647582
ts	O	-1	7647582
that	O	-1	7647582
were	O	-1	7647582
up	O	-1	7647582
to	O	-1	7647582
20@@	O	-1	7647582
-@@	O	-1	7647582
fol@@	O	-1	7647582
d	O	-1	7647582
greater	O	-1	7647582
in	O	-1	7647582
gu@@	O	-1	7647582
ine@@	O	-1	7647582
a	O	-1	7647582
pi@@	O	-1	7647582
g@@	O	-1	7647582
s	O	-1	7647582
than	O	-1	7647582
in	O	-1	7647582
rats.	O	-1	7647582
This	O	-1	7647582
suppor@@	O	-1	7647582
ts	O	-1	7647582
and	O	-1	7647582
exten@@	O	-1	7647582
ds	O	-1	7647582
previ@@	O	-1	7647582
ous	O	-1	7647582
evidence	O	-1	7647582
for	O	-1	7647582
a	O	-1	7647582
mechanism	O	-1	7647582
by	O	-1	7647582
which	O	-1	7647582
en@@	B-Chemical	D004737	7647582
f@@	I-Chemical	-1	7647582
lur@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
and/or	O	-1	7647582
iso@@	B-Chemical	D007530	7647582
f@@	I-Chemical	-1	7647582
lur@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
could	O	-1	7647582
produce	O	-1	7647582
a	O	-1	7647582
hyper@@	B-Disease	D004342	7647582
sensitivity	I-Disease	-1	7647582
condi@@	O	-1	7647582
tion	O	-1	7647582
similar	O	-1	7647582
to	O	-1	7647582
that	O	-1	7647582
of	O	-1	7647582
halo@@	B-Chemical	D006221	7647582
th@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
hepatitis	B-Disease	D056486	7647582
either	O	-1	7647582
alone	O	-1	7647582
or	O	-1	7647582
subsequ@@	O	-1	7647582
ent	O	-1	7647582
to	O	-1	7647582
halo@@	B-Chemical	D006221	7647582
th@@	I-Chemical	-1	7647582
ane	I-Chemical	-1	7647582
administr@@	O	-1	7647582
ation.	O	-1	7647582
The	O	-1	7647582
gu@@	O	-1	7647582
ine@@	O	-1	7647582
a	O	-1	7647582
pi@@	O	-1	7647582
g	O	-1	7647582
wo@@	O	-1	7647582
uld	O	-1	7647582
appe@@	O	-1	7647582
ar	O	-1	7647582
to	O	-1	7647582
be	O	-1	7647582
a	O	-1	7647582
use@@	O	-1	7647582
ful	O	-1	7647582
model	O	-1	7647582
for	O	-1	7647582
further	O	-1	7647582
investig@@	O	-1	7647582
ations	O	-1	7647582
of	O	-1	7647582
the	O	-1	7647582
immun@@	O	-1	7647582
ological	O	-1	7647582
response	O	-1	7647582
to	O	-1	7647582
these	O	-1	7647582
anti@@	O	-1	7647582
gen@@	O	-1	7647582
s.	O	-1	7647582

In@@	O	-1	4090988
duction	O	-1	4090988
by	O	-1	4090988
par@@	B-Chemical	D000082	4090988
acet@@	I-Chemical	-1	4090988
am@@	I-Chemical	-1	4090988
ol	I-Chemical	-1	4090988
of	O	-1	4090988
bladder	B-Disease	D001749	4090988
and	I-Disease	-1	4090988
liver	I-Disease	-1	4090988
tu@@	I-Disease	-1	4090988
mo@@	I-Disease	-1	4090988
ur@@	I-Disease	-1	4090988
s	I-Disease	-1	4090988
bladder	B-Disease	D008113	4090988
and	I-Disease	-1	4090988
liver	I-Disease	-1	4090988
tu@@	I-Disease	-1	4090988
mo@@	I-Disease	-1	4090988
ur@@	I-Disease	-1	4090988
s	I-Disease	-1	4090988
in	O	-1	4090988
the	O	-1	4090988
rat@@	O	-1	4090988
.	O	-1	4090988
Eff@@	O	-1	4090988
ects	O	-1	4090988
on	O	-1	4090988
hepat@@	O	-1	4090988
ocyte	O	-1	4090988
f@@	O	-1	4090988
ine	O	-1	4090988
struct@@	O	-1	4090988
ure.	O	-1	4090988
Grou@@	O	-1	4090988
p@@	O	-1	4090988
s	O	-1	4090988
of	O	-1	4090988
male	O	-1	4090988
and	O	-1	4090988
female	O	-1	4090988
in@@	O	-1	4090988
b@@	O	-1	4090988
red	O	-1	4090988
L@@	O	-1	4090988
e@@	O	-1	4090988
ed@@	O	-1	4090988
s	O	-1	4090988
stra@@	O	-1	4090988
in	O	-1	4090988
rats	O	-1	4090988
were	O	-1	4090988
f@@	O	-1	4090988
ed	O	-1	4090988
di@@	O	-1	4090988
et@@	O	-1	4090988
s	O	-1	4090988
containing	O	-1	4090988
either	O	-1	4090988
0.@@	O	-1	4090988
5%	O	-1	4090988
or	O	-1	4090988
1.@@	O	-1	4090988
0%	O	-1	4090988
par@@	B-Chemical	D000082	4090988
acet@@	I-Chemical	-1	4090988
am@@	I-Chemical	-1	4090988
ol	I-Chemical	-1	4090988
by	O	-1	4090988
weight	O	-1	4090988
for	O	-1	4090988
up	O	-1	4090988
to	O	-1	4090988
1@@	O	-1	4090988
8	O	-1	4090988
months.	O	-1	4090988
A@@	O	-1	4090988
t	O	-1	4090988
the	O	-1	4090988
1.@@	O	-1	4090988
0%	O	-1	4090988
dos@@	O	-1	4090988
age	O	-1	4090988
level@@	O	-1	4090988
,	O	-1	4090988
20@@	O	-1	4090988
%	O	-1	4090988
of	O	-1	4090988
rats	O	-1	4090988
of	O	-1	4090988
both	O	-1	4090988
sex@@	O	-1	4090988
es	O	-1	4090988
developed	O	-1	4090988
ne@@	O	-1	4090988
o@@	O	-1	4090988
plas@@	O	-1	4090988
tic	O	-1	4090988
no@@	O	-1	4090988
d@@	O	-1	4090988
ul@@	O	-1	4090988
es	O	-1	4090988
of	O	-1	4090988
the	O	-1	4090988
li@@	O	-1	4090988
ver,	O	-1	4090988
a	O	-1	4090988
statis@@	O	-1	4090988
tically	O	-1	4090988
significant	O	-1	4090988
inc@@	O	-1	4090988
id@@	O	-1	4090988
ence@@	O	-1	4090988
.	O	-1	4090988
These	O	-1	4090988
rats	O	-1	4090988
also	O	-1	4090988
showed	O	-1	4090988
g@@	O	-1	4090988
ros@@	O	-1	4090988
s	O	-1	4090988
en@@	O	-1	4090988
larg@@	O	-1	4090988
ement	O	-1	4090988
of	O	-1	4090988
their	O	-1	4090988
li@@	O	-1	4090988
ver@@	O	-1	4090988
s	O	-1	4090988
and	O	-1	4090988
an	O	-1	4090988
increase	O	-1	4090988
in	O	-1	4090988
foc@@	O	-1	4090988
i	O	-1	4090988
of	O	-1	4090988
cell@@	O	-1	4090988
ular	O	-1	4090988
al@@	O	-1	4090988
ter@@	O	-1	4090988
ation,	O	-1	4090988
the	O	-1	4090988
lat@@	O	-1	4090988
ter	O	-1	4090988
also	O	-1	4090988
being	O	-1	4090988
observed	O	-1	4090988
in	O	-1	4090988
the	O	-1	4090988
low	O	-1	4090988
dos@@	O	-1	4090988
age	O	-1	4090988
male	O	-1	4090988
rats.	O	-1	4090988
P@@	B-Disease	D010212	4090988
ap@@	I-Disease	-1	4090988
il@@	I-Disease	-1	4090988
lo@@	I-Disease	-1	4090988
m@@	I-Disease	-1	4090988
as	I-Disease	-1	4090988
of	O	-1	4090988
the	O	-1	4090988
transi@@	O	-1	4090988
tional	O	-1	4090988
epi@@	O	-1	4090988
the@@	O	-1	4090988
li@@	O	-1	4090988
um	O	-1	4090988
of	O	-1	4090988
the	O	-1	4090988
bladder	O	-1	4090988
developed	O	-1	4090988
in	O	-1	4090988
all	O	-1	4090988
par@@	B-Chemical	D000082	4090988
acet@@	I-Chemical	-1	4090988
am@@	I-Chemical	-1	4090988
ol	I-Chemical	-1	4090988
-treated	O	-1	4090988
group@@	O	-1	4090988
s,	O	-1	4090988
and	O	-1	4090988
three	O	-1	4090988
rats	O	-1	4090988
b@@	O	-1	4090988
or@@	O	-1	4090988
e	O	-1	4090988
bladder	B-Disease	D001749	4090988
carcin@@	I-Disease	-1	4090988
om@@	I-Disease	-1	4090988
as	I-Disease	-1	4090988
.	O	-1	4090988
However,	O	-1	4090988
significant	O	-1	4090988
y@@	O	-1	4090988
i@@	O	-1	4090988
el@@	O	-1	4090988
ds	O	-1	4090988
of	O	-1	4090988
bladder	B-Disease	D001749	4090988
tu@@	I-Disease	-1	4090988
mo@@	I-Disease	-1	4090988
ur@@	I-Disease	-1	4090988
s	I-Disease	-1	4090988
were	O	-1	4090988
only	O	-1	4090988
obtained	O	-1	4090988
from	O	-1	4090988
low	O	-1	4090988
dos@@	O	-1	4090988
age	O	-1	4090988
femal@@	O	-1	4090988
es	O	-1	4090988
and	O	-1	4090988
high	O	-1	4090988
dos@@	O	-1	4090988
age	O	-1	4090988
mal@@	O	-1	4090988
es.	O	-1	4090988
Ad@@	O	-1	4090988
di@@	O	-1	4090988
tion@@	O	-1	4090988
ally,	O	-1	4090988
20	O	-1	4090988
to	O	-1	4090988
2@@	O	-1	4090988
5%	O	-1	4090988
of	O	-1	4090988
par@@	B-Chemical	D000082	4090988
acet@@	I-Chemical	-1	4090988
am@@	I-Chemical	-1	4090988
ol	I-Chemical	-1	4090988
-treated	O	-1	4090988
rats	O	-1	4090988
developed	O	-1	4090988
hyper@@	B-Disease	D006965	4090988
pl@@	I-Disease	-1	4090988
a@@	I-Disease	-1	4090988
sia	I-Disease	-1	4090988
of	O	-1	4090988
the	O	-1	4090988
bladder	O	-1	4090988
epi@@	O	-1	4090988
the@@	O	-1	4090988
li@@	O	-1	4090988
um,	O	-1	4090988
which	O	-1	4090988
was	O	-1	4090988
not	O	-1	4090988
co@@	O	-1	4090988
inc@@	O	-1	4090988
id@@	O	-1	4090988
ent	O	-1	4090988
with	O	-1	4090988
the	O	-1	4090988
presence	O	-1	4090988
of	O	-1	4090988
bladder	B-Disease	D001744	4090988
calc@@	I-Disease	-1	4090988
ul@@	I-Disease	-1	4090988
i	I-Disease	-1	4090988
.	O	-1	4090988
A	O	-1	4090988
low	O	-1	4090988
y@@	O	-1	4090988
i@@	O	-1	4090988
el@@	O	-1	4090988
d	O	-1	4090988
of	O	-1	4090988
tu@@	B-Disease	D009369	4090988
mo@@	I-Disease	-1	4090988
ur@@	I-Disease	-1	4090988
s	I-Disease	-1	4090988
at	O	-1	4090988
various	O	-1	4090988
other	O	-1	4090988
sit@@	O	-1	4090988
es	O	-1	4090988
also	O	-1	4090988
a@@	O	-1	4090988
ro@@	O	-1	4090988
se	O	-1	4090988
following	O	-1	4090988
par@@	B-Chemical	D000082	4090988
acet@@	I-Chemical	-1	4090988
am@@	I-Chemical	-1	4090988
ol	I-Chemical	-1	4090988
fe@@	O	-1	4090988
ed@@	O	-1	4090988
ing.	O	-1	4090988
An	O	-1	4090988
electro@@	O	-1	4090988
n	O	-1	4090988
micro@@	O	-1	4090988
sco@@	O	-1	4090988
p@@	O	-1	4090988
e	O	-1	4090988
study	O	-1	4090988
of	O	-1	4090988
the	O	-1	4090988
li@@	O	-1	4090988
ver@@	O	-1	4090988
s	O	-1	4090988
of	O	-1	4090988
par@@	B-Chemical	D000082	4090988
acet@@	I-Chemical	-1	4090988
am@@	I-Chemical	-1	4090988
ol	I-Chemical	-1	4090988
-treated	O	-1	4090988
rats	O	-1	4090988
revealed	O	-1	4090988
ult@@	O	-1	4090988
ra@@	O	-1	4090988
struct@@	O	-1	4090988
ural	O	-1	4090988
changes	O	-1	4090988
in	O	-1	4090988
the	O	-1	4090988
hepat@@	O	-1	4090988
ocy@@	O	-1	4090988
tes	O	-1	4090988
that	O	-1	4090988
re@@	O	-1	4090988
se@@	O	-1	4090988
mb@@	O	-1	4090988
le	O	-1	4090988
those	O	-1	4090988
that	O	-1	4090988
result	O	-1	4090988
from	O	-1	4090988
exposure	O	-1	4090988
to	O	-1	4090988
a	O	-1	4090988
vari@@	O	-1	4090988
ety	O	-1	4090988
of	O	-1	4090988
known	O	-1	4090988
hepat@@	B-Disease	D008113	4090988
oc@@	I-Disease	-1	4090988
arc@@	I-Disease	-1	4090988
ino@@	I-Disease	-1	4090988
gen@@	I-Disease	-1	4090988
s	I-Disease	-1	4090988
.	O	-1	4090988

R@@	O	-1	4038130
at	O	-1	4038130
ext@@	O	-1	4038130
ra@@	O	-1	4038130
oc@@	O	-1	4038130
ular	O	-1	4038130
musc@@	O	-1	4038130
le	O	-1	4038130
re@@	O	-1	4038130
gener@@	O	-1	4038130
ation.	O	-1	4038130
Re@@	O	-1	4038130
pa@@	O	-1	4038130
ir	O	-1	4038130
of	O	-1	4038130
loc@@	O	-1	4038130
al	O	-1	4038130
anesthe@@	O	-1	4038130
tic@@	O	-1	4038130
-induced	O	-1	4038130
dam@@	O	-1	4038130
age.	O	-1	4038130
L@@	O	-1	4038130
oc@@	O	-1	4038130
al	O	-1	4038130
anesthe@@	O	-1	4038130
tics	O	-1	4038130
that	O	-1	4038130
are	O	-1	4038130
common@@	O	-1	4038130
ly	O	-1	4038130
used	O	-1	4038130
in	O	-1	4038130
oph@@	O	-1	4038130
thal@@	O	-1	4038130
mic	O	-1	4038130
surger@@	O	-1	4038130
y	O	-1	4038130
(0.@@	O	-1	4038130
7@@	O	-1	4038130
5%	O	-1	4038130
bupivac@@	B-Chemical	D002045	4038130
aine	I-Chemical	-1	4038130
hydro@@	I-Chemical	-1	4038130
chlor@@	I-Chemical	-1	4038130
ide	I-Chemical	-1	4038130
,	O	-1	4038130
2.@@	O	-1	4038130
0%	O	-1	4038130
me@@	B-Chemical	D008619	4038130
pivac@@	I-Chemical	-1	4038130
aine	I-Chemical	-1	4038130
hydro@@	I-Chemical	-1	4038130
chlor@@	I-Chemical	-1	4038130
ide	I-Chemical	-1	4038130
,	O	-1	4038130
and	O	-1	4038130
2.@@	O	-1	4038130
0%	O	-1	4038130
lidocaine	B-Chemical	D008012	4038130
hydro@@	I-Chemical	-1	4038130
chlor@@	I-Chemical	-1	4038130
ide	I-Chemical	-1	4038130
plus	O	-1	4038130
1@@	O	-1	4038130
:@@	O	-1	4038130
10@@	O	-1	4038130
0@@	O	-1	4038130
,@@	O	-1	4038130
0@@	O	-1	4038130
00	O	-1	4038130
ep@@	B-Chemical	D004837	4038130
ine@@	I-Chemical	-1	4038130
phrine	I-Chemical	-1	4038130
)	O	-1	4038130
were	O	-1	4038130
injected	O	-1	4038130
into	O	-1	4038130
the	O	-1	4038130
ret@@	O	-1	4038130
ro@@	O	-1	4038130
b@@	O	-1	4038130
ul@@	O	-1	4038130
b@@	O	-1	4038130
ar	O	-1	4038130
a@@	O	-1	4038130
re@@	O	-1	4038130
a	O	-1	4038130
of	O	-1	4038130
rat	O	-1	4038130
e@@	O	-1	4038130
y@@	O	-1	4038130
es.	O	-1	4038130
C@@	O	-1	4038130
ont@@	O	-1	4038130
ro@@	O	-1	4038130
l@@	O	-1	4038130
s	O	-1	4038130
were	O	-1	4038130
injected	O	-1	4038130
with	O	-1	4038130
physi@@	O	-1	4038130
ological	O	-1	4038130
sal@@	O	-1	4038130
ine.	O	-1	4038130
All	O	-1	4038130
three	O	-1	4038130
anesthe@@	O	-1	4038130
tics	O	-1	4038130
produced	O	-1	4038130
mas@@	O	-1	4038130
sive	O	-1	4038130
de@@	O	-1	4038130
generation	O	-1	4038130
of	O	-1	4038130
the	O	-1	4038130
ext@@	O	-1	4038130
ra@@	O	-1	4038130
oc@@	O	-1	4038130
ular	O	-1	4038130
mus@@	O	-1	4038130
cl@@	O	-1	4038130
es.	O	-1	4038130
M@@	B-Disease	D009135	4038130
us@@	I-Disease	-1	4038130
c@@	I-Disease	-1	4038130
le	I-Disease	-1	4038130
de@@	I-Disease	-1	4038130
generation	I-Disease	-1	4038130
is	O	-1	4038130
followed	O	-1	4038130
by	O	-1	4038130
re@@	O	-1	4038130
generation	O	-1	4038130
of	O	-1	4038130
the	O	-1	4038130
dam@@	O	-1	4038130
aged	O	-1	4038130
musc@@	O	-1	4038130
le	O	-1	4038130
fib@@	O	-1	4038130
ers.	O	-1	4038130
In	O	-1	4038130
addition	O	-1	4038130
to	O	-1	4038130
musc@@	B-Disease	D009135	4038130
le	I-Disease	-1	4038130
damage	I-Disease	-1	4038130
,	O	-1	4038130
severe	O	-1	4038130
damage	O	-1	4038130
was	O	-1	4038130
also	O	-1	4038130
seen	O	-1	4038130
in	O	-1	4038130
h@@	O	-1	4038130
ar@@	O	-1	4038130
der@@	O	-1	4038130
i@@	O	-1	4038130
an	O	-1	4038130
gl@@	O	-1	4038130
and@@	O	-1	4038130
s,	O	-1	4038130
es@@	O	-1	4038130
p@@	O	-1	4038130
ec@@	O	-1	4038130
i@@	O	-1	4038130
ally	O	-1	4038130
after	O	-1	4038130
exposure	O	-1	4038130
to	O	-1	4038130
me@@	B-Chemical	D008619	4038130
pivac@@	I-Chemical	-1	4038130
aine	I-Chemical	-1	4038130
and	O	-1	4038130
lidocaine	B-Chemical	D008012	4038130
plus	O	-1	4038130
ep@@	B-Chemical	D004837	4038130
ine@@	I-Chemical	-1	4038130
phrine	I-Chemical	-1	4038130
.	O	-1	4038130
W@@	O	-1	4038130
it@@	O	-1	4038130
h	O	-1	4038130
these	O	-1	4038130
findings	O	-1	4038130
in	O	-1	4038130
rats,	O	-1	4038130
it	O	-1	4038130
is	O	-1	4038130
hypo@@	O	-1	4038130
the@@	O	-1	4038130
si@@	O	-1	4038130
zed	O	-1	4038130
that	O	-1	4038130
the	O	-1	4038130
tempor@@	O	-1	4038130
ary	O	-1	4038130
di@@	B-Disease	D004172	4038130
p@@	I-Disease	-1	4038130
lo@@	I-Disease	-1	4038130
pi@@	I-Disease	-1	4038130
a	I-Disease	-1	4038130
so@@	O	-1	4038130
me@@	O	-1	4038130
times	O	-1	4038130
seen	O	-1	4038130
in	O	-1	4038130
patients	O	-1	4038130
after	O	-1	4038130
oph@@	O	-1	4038130
thal@@	O	-1	4038130
mic	O	-1	4038130
surger@@	O	-1	4038130
y	O	-1	4038130
might	O	-1	4038130
be	O	-1	4038130
due	O	-1	4038130
to	O	-1	4038130
anesthe@@	O	-1	4038130
tic@@	O	-1	4038130
-induced	O	-1	4038130
damage	O	-1	4038130
to	O	-1	4038130
the	O	-1	4038130
ext@@	O	-1	4038130
ra@@	O	-1	4038130
oc@@	O	-1	4038130
ular	O	-1	4038130
mus@@	O	-1	4038130
cl@@	O	-1	4038130
es.	O	-1	4038130

Re@@	O	-1	2907585
ver@@	O	-1	2907585
s@@	O	-1	2907585
al	O	-1	2907585
of	O	-1	2907585
neuro@@	O	-1	2907585
le@@	O	-1	2907585
p@@	O	-1	2907585
tic@@	O	-1	2907585
-induced	O	-1	2907585
cat@@	B-Disease	D002375	2907585
al@@	I-Disease	-1	2907585
ep@@	I-Disease	-1	2907585
sy	I-Disease	-1	2907585
by	O	-1	2907585
novel	O	-1	2907585
ar@@	B-Chemical	-1	2907585
yl@@	I-Chemical	-1	2907585
-@@	I-Chemical	-1	2907585
pi@@	I-Chemical	-1	2907585
per@@	I-Chemical	-1	2907585
az@@	I-Chemical	-1	2907585
ine	I-Chemical	-1	2907585
an@@	O	-1	2907585
xi@@	O	-1	2907585
oly@@	O	-1	2907585
tic	O	-1	2907585
drug@@	O	-1	2907585
s.	O	-1	2907585
The	O	-1	2907585
novel	O	-1	2907585
an@@	O	-1	2907585
xi@@	O	-1	2907585
oly@@	O	-1	2907585
tic	O	-1	2907585
drug@@	O	-1	2907585
,	O	-1	2907585
b@@	B-Chemical	D002065	2907585
us@@	I-Chemical	-1	2907585
pi@@	I-Chemical	-1	2907585
r@@	I-Chemical	-1	2907585
one	I-Chemical	-1	2907585
,	O	-1	2907585
rever@@	O	-1	2907585
ses	O	-1	2907585
cat@@	B-Disease	D002375	2907585
al@@	I-Disease	-1	2907585
ep@@	I-Disease	-1	2907585
sy	I-Disease	-1	2907585
induced	O	-1	2907585
by	O	-1	2907585
haloperidol	B-Chemical	D006220	2907585
.	O	-1	2907585
A	O	-1	2907585
seri@@	O	-1	2907585
es	O	-1	2907585
of	O	-1	2907585
ar@@	B-Chemical	-1	2907585
yl@@	I-Chemical	-1	2907585
-@@	I-Chemical	-1	2907585
pi@@	I-Chemical	-1	2907585
per@@	I-Chemical	-1	2907585
az@@	I-Chemical	-1	2907585
ine	I-Chemical	-1	2907585
an@@	O	-1	2907585
alo@@	O	-1	2907585
gu@@	O	-1	2907585
es	O	-1	2907585
of	O	-1	2907585
b@@	B-Chemical	D002065	2907585
us@@	I-Chemical	-1	2907585
pi@@	I-Chemical	-1	2907585
r@@	I-Chemical	-1	2907585
one	I-Chemical	-1	2907585
and	O	-1	2907585
other	O	-1	2907585
5-@@	B-Chemical	D058825	2907585
hydrox@@	I-Chemical	-1	2907585
y@@	I-Chemical	-1	2907585
tr@@	I-Chemical	-1	2907585
y@@	I-Chemical	-1	2907585
pt@@	I-Chemical	-1	2907585
aminergic	I-Chemical	-1	2907585
agon@@	I-Chemical	-1	2907585
ist@@	I-Chemical	-1	2907585
s	I-Chemical	-1	2907585
were	O	-1	2907585
tested	O	-1	2907585
for	O	-1	2907585
their	O	-1	2907585
ability	O	-1	2907585
to	O	-1	2907585
re@@	O	-1	2907585
verse	O	-1	2907585
haloperidol	B-Chemical	D006220	2907585
induced	O	-1	2907585
cat@@	B-Disease	D002375	2907585
al@@	I-Disease	-1	2907585
ep@@	I-Disease	-1	2907585
sy	I-Disease	-1	2907585
.	O	-1	2907585
Th@@	O	-1	2907585
ose	O	-1	2907585
drugs	O	-1	2907585
with	O	-1	2907585
st@@	O	-1	2907585
ron@@	O	-1	2907585
g	O	-1	2907585
aff@@	O	-1	2907585
in@@	O	-1	2907585
ity	O	-1	2907585
for	O	-1	2907585
5-@@	B-Chemical	D012701	2907585
hydrox@@	I-Chemical	-1	2907585
y@@	I-Chemical	-1	2907585
tr@@	I-Chemical	-1	2907585
y@@	I-Chemical	-1	2907585
pt@@	I-Chemical	-1	2907585
amine	I-Chemical	-1	2907585
1@@	O	-1	2907585
a	O	-1	2907585
receptors	O	-1	2907585
were	O	-1	2907585
able	O	-1	2907585
to	O	-1	2907585
re@@	O	-1	2907585
verse	O	-1	2907585
cat@@	B-Disease	D002375	2907585
al@@	I-Disease	-1	2907585
ep@@	I-Disease	-1	2907585
sy	I-Disease	-1	2907585
.	O	-1	2907585
D@@	O	-1	2907585
ru@@	O	-1	2907585
g@@	O	-1	2907585
s	O	-1	2907585
with	O	-1	2907585
aff@@	O	-1	2907585
in@@	O	-1	2907585
ity	O	-1	2907585
for	O	-1	2907585
other	O	-1	2907585
5-@@	B-Chemical	D012701	2907585
H@@	I-Chemical	-1	2907585
T	I-Chemical	-1	2907585
receptors	O	-1	2907585
or	O	-1	2907585
we@@	O	-1	2907585
a@@	O	-1	2907585
k	O	-1	2907585
aff@@	O	-1	2907585
in@@	O	-1	2907585
ity	O	-1	2907585
were	O	-1	2907585
ine@@	O	-1	2907585
ff@@	O	-1	2907585
ecti@@	O	-1	2907585
ve.	O	-1	2907585
However,	O	-1	2907585
inhibition	O	-1	2907585
of	O	-1	2907585
post@@	O	-1	2907585
syn@@	O	-1	2907585
ap@@	O	-1	2907585
tic	O	-1	2907585
5-@@	B-Chemical	D012701	2907585
H@@	I-Chemical	-1	2907585
T	I-Chemical	-1	2907585
receptors	O	-1	2907585
ne@@	O	-1	2907585
ither	O	-1	2907585
inhibited	O	-1	2907585
n@@	O	-1	2907585
or	O	-1	2907585
potenti@@	O	-1	2907585
ated	O	-1	2907585
rever@@	O	-1	2907585
s@@	O	-1	2907585
al	O	-1	2907585
of	O	-1	2907585
cat@@	B-Disease	D002375	2907585
al@@	I-Disease	-1	2907585
ep@@	I-Disease	-1	2907585
sy	I-Disease	-1	2907585
and	O	-1	2907585
le@@	O	-1	2907585
av@@	O	-1	2907585
es	O	-1	2907585
op@@	O	-1	2907585
en	O	-1	2907585
the	O	-1	2907585
qu@@	O	-1	2907585
es@@	O	-1	2907585
tion	O	-1	2907585
as	O	-1	2907585
to	O	-1	2907585
the	O	-1	2907585
sit@@	O	-1	2907585
e	O	-1	2907585
or	O	-1	2907585
mechanism	O	-1	2907585
for	O	-1	2907585
this	O	-1	2907585
effect@@	O	-1	2907585
.	O	-1	2907585

Di@@	B-Chemical	D003975	2894433
az@@	I-Chemical	-1	2894433
epam	I-Chemical	-1	2894433
fac@@	O	-1	2894433
il@@	O	-1	2894433
it@@	O	-1	2894433
ates	O	-1	2894433
ref@@	O	-1	2894433
le@@	O	-1	2894433
x	O	-1	2894433
brady@@	B-Disease	D001919	2894433
cardia	I-Disease	-1	2894433
in	O	-1	2894433
con@@	O	-1	2894433
s@@	O	-1	2894433
ci@@	O	-1	2894433
ous	O	-1	2894433
rats.	O	-1	2894433
The	O	-1	2894433
effects	O	-1	2894433
of	O	-1	2894433
di@@	B-Chemical	D003975	2894433
az@@	I-Chemical	-1	2894433
epam	I-Chemical	-1	2894433
on	O	-1	2894433
cardiovascular	O	-1	2894433
function	O	-1	2894433
were	O	-1	2894433
assessed	O	-1	2894433
in	O	-1	2894433
con@@	O	-1	2894433
s@@	O	-1	2894433
ci@@	O	-1	2894433
ous	O	-1	2894433
rats.	O	-1	2894433
In@@	O	-1	2894433
tra@@	O	-1	2894433
venous	O	-1	2894433
administration	O	-1	2894433
of	O	-1	2894433
di@@	B-Chemical	D003975	2894433
az@@	I-Chemical	-1	2894433
epam	I-Chemical	-1	2894433
(1@@	O	-1	2894433
-@@	O	-1	2894433
30	O	-1	2894433
mg	O	-1	2894433
kg@@	O	-1	2894433
-1@@	O	-1	2894433
)	O	-1	2894433
produced	O	-1	2894433
a	O	-1	2894433
dose-@@	O	-1	2894433
dependent	O	-1	2894433
decrease	O	-1	2894433
in	O	-1	2894433
both	O	-1	2894433
the	O	-1	2894433
mean	O	-1	2894433
arterial	O	-1	2894433
pressure	O	-1	2894433
and	O	-1	2894433
the	O	-1	2894433
heart	O	-1	2894433
rat@@	O	-1	2894433
e.	O	-1	2894433
Al@@	O	-1	2894433
so@@	O	-1	2894433
,	O	-1	2894433
ref@@	O	-1	2894433
le@@	O	-1	2894433
x	O	-1	2894433
brady@@	B-Disease	D001919	2894433
cardia	I-Disease	-1	2894433
was	O	-1	2894433
produced	O	-1	2894433
in	O	-1	2894433
rats	O	-1	2894433
by	O	-1	2894433
intravenous	O	-1	2894433
infusion	O	-1	2894433
of	O	-1	2894433
adren@@	B-Chemical	D004837	2894433
aline	I-Chemical	-1	2894433
(1@@	O	-1	2894433
.@@	O	-1	2894433
2@@	O	-1	2894433
5-@@	O	-1	2894433
2.@@	O	-1	2894433
5	O	-1	2894433
microgram@@	O	-1	2894433
s	O	-1	2894433
kg@@	O	-1	2894433
-1@@	O	-1	2894433
).	O	-1	2894433
In@@	O	-1	2894433
tra@@	O	-1	2894433
venous	O	-1	2894433
pretreatment	O	-1	2894433
of	O	-1	2894433
the	O	-1	2894433
rats	O	-1	2894433
with	O	-1	2894433
di@@	B-Chemical	D003975	2894433
az@@	I-Chemical	-1	2894433
epam	I-Chemical	-1	2894433
,	O	-1	2894433
although	O	-1	2894433
ca@@	O	-1	2894433
using	O	-1	2894433
no	O	-1	2894433
change	O	-1	2894433
in	O	-1	2894433
the	O	-1	2894433
adren@@	B-Chemical	D004837	2894433
aline	I-Chemical	-1	2894433
-induced	O	-1	2894433
press@@	O	-1	2894433
or	O	-1	2894433
effect@@	O	-1	2894433
,	O	-1	2894433
did	O	-1	2894433
enh@@	O	-1	2894433
ance	O	-1	2894433
the	O	-1	2894433
adren@@	B-Chemical	D004837	2894433
aline	I-Chemical	-1	2894433
-induced	O	-1	2894433
ref@@	O	-1	2894433
le@@	O	-1	2894433
x	O	-1	2894433
brady@@	B-Disease	D001919	2894433
cardia	I-Disease	-1	2894433
.	O	-1	2894433
However,	O	-1	2894433
the	O	-1	2894433
di@@	B-Chemical	D003975	2894433
az@@	I-Chemical	-1	2894433
epam	I-Chemical	-1	2894433
enh@@	O	-1	2894433
ance@@	O	-1	2894433
ment	O	-1	2894433
of	O	-1	2894433
adren@@	B-Chemical	D004837	2894433
aline	I-Chemical	-1	2894433
-induced	O	-1	2894433
ref@@	O	-1	2894433
le@@	O	-1	2894433
x	O	-1	2894433
brady@@	B-Disease	D001919	2894433
cardia	I-Disease	-1	2894433
was	O	-1	2894433
antagon@@	O	-1	2894433
ized	O	-1	2894433
by	O	-1	2894433
pretreatment	O	-1	2894433
of	O	-1	2894433
rats	O	-1	2894433
with	O	-1	2894433
an	O	-1	2894433
intravenous	O	-1	2894433
dose	O	-1	2894433
of	O	-1	2894433
p@@	B-Chemical	D010852	2894433
ic@@	I-Chemical	-1	2894433
ro@@	I-Chemical	-1	2894433
tox@@	I-Chemical	-1	2894433
in	I-Chemical	-1	2894433
(@@	O	-1	2894433
an	O	-1	2894433
agent	O	-1	2894433
block@@	O	-1	2894433
s	O	-1	2894433
chlor@@	B-Chemical	D002712	2894433
ide	I-Chemical	-1	2894433
channe@@	O	-1	2894433
l@@	O	-1	2894433
s	O	-1	2894433
by	O	-1	2894433
b@@	O	-1	2894433
ind@@	O	-1	2894433
ing	O	-1	2894433
to	O	-1	2894433
sit@@	O	-1	2894433
es	O	-1	2894433
associated	O	-1	2894433
with	O	-1	2894433
the	O	-1	2894433
b@@	B-Chemical	D001569	2894433
enz@@	I-Chemical	-1	2894433
odi@@	I-Chemical	-1	2894433
azepine	I-Chemical	-1	2894433
-	O	-1	2894433
G@@	B-Chemical	D005680	2894433
A@@	I-Chemical	-1	2894433
B@@	I-Chemical	-1	2894433
A	I-Chemical	-1	2894433
-	O	-1	2894433
chlor@@	B-Chemical	D002712	2894433
ide	I-Chemical	-1	2894433
channel	O	-1	2894433
mac@@	O	-1	2894433
rom@@	O	-1	2894433
ol@@	O	-1	2894433
ec@@	O	-1	2894433
ular	O	-1	2894433
comple@@	O	-1	2894433
x@@	O	-1	2894433
).	O	-1	2894433
The	O	-1	2894433
data	O	-1	2894433
indicate	O	-1	2894433
that	O	-1	2894433
di@@	B-Chemical	D003975	2894433
az@@	I-Chemical	-1	2894433
epam	I-Chemical	-1	2894433
act@@	O	-1	2894433
s	O	-1	2894433
through	O	-1	2894433
the	O	-1	2894433
b@@	B-Chemical	D001569	2894433
enz@@	I-Chemical	-1	2894433
odi@@	I-Chemical	-1	2894433
azepine	I-Chemical	-1	2894433
-	O	-1	2894433
G@@	B-Chemical	D005680	2894433
A@@	I-Chemical	-1	2894433
B@@	I-Chemical	-1	2894433
A	I-Chemical	-1	2894433
-	O	-1	2894433
chlor@@	B-Chemical	D002712	2894433
ide	I-Chemical	-1	2894433
channel	O	-1	2894433
mac@@	O	-1	2894433
rom@@	O	-1	2894433
ol@@	O	-1	2894433
ec@@	O	-1	2894433
ular	O	-1	2894433
comple@@	O	-1	2894433
x	O	-1	2894433
within	O	-1	2894433
the	O	-1	2894433
central	O	-1	2894433
ner@@	O	-1	2894433
v@@	O	-1	2894433
ous	O	-1	2894433
system	O	-1	2894433
to	O	-1	2894433
fac@@	O	-1	2894433
il@@	O	-1	2894433
it@@	O	-1	2894433
ate	O	-1	2894433
ref@@	O	-1	2894433
le@@	O	-1	2894433
x	O	-1	2894433
brady@@	B-Disease	D001919	2894433
cardia	I-Disease	-1	2894433
mediated	O	-1	2894433
through	O	-1	2894433
b@@	O	-1	2894433
a@@	O	-1	2894433
ro@@	O	-1	2894433
receptor	O	-1	2894433
ref@@	O	-1	2894433
le@@	O	-1	2894433
x@@	O	-1	2894433
es	O	-1	2894433
in	O	-1	2894433
response	O	-1	2894433
to	O	-1	2894433
an	O	-1	2894433
acute	O	-1	2894433
increase	O	-1	2894433
in	O	-1	2894433
arterial	O	-1	2894433
pressu@@	O	-1	2894433
re.	O	-1	2894433

Ch@@	O	-1	2790457
ron@@	O	-1	2790457
ic	O	-1	2790457
carbamazepine	B-Chemical	D002220	2790457
inhibit@@	O	-1	2790457
s	O	-1	2790457
the	O	-1	2790457
development	O	-1	2790457
of	O	-1	2790457
loc@@	O	-1	2790457
al	O	-1	2790457
anesthe@@	O	-1	2790457
tic	O	-1	2790457
seizures	B-Disease	D012640	2790457
k@@	O	-1	2790457
ind@@	O	-1	2790457
l@@	O	-1	2790457
ed	O	-1	2790457
by	O	-1	2790457
cocaine	B-Chemical	D003042	2790457
and	O	-1	2790457
lidocaine	B-Chemical	D008012	2790457
.	O	-1	2790457
The	O	-1	2790457
effects	O	-1	2790457
of	O	-1	2790457
carbamazepine	B-Chemical	D002220	2790457
(	O	-1	2790457
C@@	B-Chemical	D002220	2790457
B@@	I-Chemical	-1	2790457
Z	I-Chemical	-1	2790457
)	O	-1	2790457
treatment	O	-1	2790457
on	O	-1	2790457
loc@@	O	-1	2790457
al	O	-1	2790457
anesthe@@	O	-1	2790457
tic@@	O	-1	2790457
-@@	O	-1	2790457
k@@	O	-1	2790457
ind@@	O	-1	2790457
l@@	O	-1	2790457
ed	O	-1	2790457
seizures	B-Disease	D012640	2790457
and	O	-1	2790457
le@@	O	-1	2790457
thal@@	O	-1	2790457
ity	O	-1	2790457
were	O	-1	2790457
evaluated	O	-1	2790457
in	O	-1	2790457
different	O	-1	2790457
st@@	O	-1	2790457
ages	O	-1	2790457
of	O	-1	2790457
the	O	-1	2790457
k@@	O	-1	2790457
ind@@	O	-1	2790457
l@@	O	-1	2790457
ing	O	-1	2790457
pro@@	O	-1	2790457
cess	O	-1	2790457
and	O	-1	2790457
under	O	-1	2790457
different	O	-1	2790457
meth@@	O	-1	2790457
o@@	O	-1	2790457
ds	O	-1	2790457
of	O	-1	2790457
C@@	B-Chemical	D002220	2790457
B@@	I-Chemical	-1	2790457
Z	I-Chemical	-1	2790457
administr@@	O	-1	2790457
ation.	O	-1	2790457
Ch@@	O	-1	2790457
ron@@	O	-1	2790457
ic	O	-1	2790457
oral	O	-1	2790457
C@@	B-Chemical	D002220	2790457
B@@	I-Chemical	-1	2790457
Z	I-Chemical	-1	2790457
inhibited	O	-1	2790457
the	O	-1	2790457
development	O	-1	2790457
of	O	-1	2790457
both	O	-1	2790457
lidocaine	B-Chemical	D008012	2790457
-	O	-1	2790457
and	O	-1	2790457
cocaine	B-Chemical	D003042	2790457
-induced	O	-1	2790457
seizures	B-Disease	D012640	2790457
,	O	-1	2790457
but	O	-1	2790457
had	O	-1	2790457
lit@@	O	-1	2790457
t@@	O	-1	2790457
le	O	-1	2790457
effect	O	-1	2790457
on	O	-1	2790457
the	O	-1	2790457
ful@@	O	-1	2790457
ly	O	-1	2790457
developed	O	-1	2790457
loc@@	O	-1	2790457
al	O	-1	2790457
anesthe@@	O	-1	2790457
tic	O	-1	2790457
seizures	B-Disease	D012640	2790457
.	O	-1	2790457
Ch@@	O	-1	2790457
ron@@	O	-1	2790457
ic	O	-1	2790457
C@@	B-Chemical	D002220	2790457
B@@	I-Chemical	-1	2790457
Z	I-Chemical	-1	2790457
also	O	-1	2790457
decreased	O	-1	2790457
the	O	-1	2790457
incidence	O	-1	2790457
of	O	-1	2790457
seizure	B-Disease	D012640	2790457
-@@	O	-1	2790457
related	O	-1	2790457
mor@@	O	-1	2790457
t@@	O	-1	2790457
ality	O	-1	2790457
in	O	-1	2790457
the	O	-1	2790457
cocaine	B-Chemical	D003042	2790457
-@@	O	-1	2790457
injected	O	-1	2790457
rats.	O	-1	2790457
Ac@@	O	-1	2790457
ute	O	-1	2790457
C@@	B-Chemical	D002220	2790457
B@@	I-Chemical	-1	2790457
Z	I-Chemical	-1	2790457
over	O	-1	2790457
a	O	-1	2790457
range	O	-1	2790457
of	O	-1	2790457
doses	O	-1	2790457
(1@@	O	-1	2790457
5-@@	O	-1	2790457
50	O	-1	2790457
mg/kg)	O	-1	2790457
had	O	-1	2790457
no	O	-1	2790457
effect	O	-1	2790457
on	O	-1	2790457
comple@@	O	-1	2790457
ted	O	-1	2790457
lidocaine	B-Chemical	D008012	2790457
-@@	O	-1	2790457
k@@	O	-1	2790457
ind@@	O	-1	2790457
l@@	O	-1	2790457
ed	O	-1	2790457
or	O	-1	2790457
acute	O	-1	2790457
cocaine	B-Chemical	D003042	2790457
-induced	O	-1	2790457
seizures	B-Disease	D012640	2790457
.	O	-1	2790457
R@@	O	-1	2790457
ep@@	O	-1	2790457
e@@	O	-1	2790457
ated	O	-1	2790457
i.@@	O	-1	2790457
p@@	O	-1	2790457
.	O	-1	2790457
injection	O	-1	2790457
of	O	-1	2790457
C@@	B-Chemical	D002220	2790457
B@@	I-Chemical	-1	2790457
Z	I-Chemical	-1	2790457
(1@@	O	-1	2790457
5	O	-1	2790457
mg/kg)	O	-1	2790457
also	O	-1	2790457
was	O	-1	2790457
without	O	-1	2790457
effect	O	-1	2790457
on	O	-1	2790457
the	O	-1	2790457
development	O	-1	2790457
of	O	-1	2790457
lidocaine	B-Chemical	D008012	2790457
-	O	-1	2790457
or	O	-1	2790457
cocaine	B-Chemical	D003042	2790457
-@@	O	-1	2790457
k@@	O	-1	2790457
ind@@	O	-1	2790457
l@@	O	-1	2790457
ed	O	-1	2790457
seizures	B-Disease	D012640	2790457
.	O	-1	2790457
The	O	-1	2790457
differen@@	O	-1	2790457
tial	O	-1	2790457
effects	O	-1	2790457
of	O	-1	2790457
C@@	B-Chemical	D002220	2790457
B@@	I-Chemical	-1	2790457
Z	I-Chemical	-1	2790457
depend@@	O	-1	2790457
ing	O	-1	2790457
up@@	O	-1	2790457
on	O	-1	2790457
st@@	O	-1	2790457
age	O	-1	2790457
of	O	-1	2790457
seizure	B-Disease	D012640	2790457
development	O	-1	2790457
suggest	O	-1	2790457
that	O	-1	2790457
dist@@	O	-1	2790457
inc@@	O	-1	2790457
t	O	-1	2790457
mechanisms	O	-1	2790457
under@@	O	-1	2790457
li@@	O	-1	2790457
e	O	-1	2790457
the	O	-1	2790457
development	O	-1	2790457
versus	O	-1	2790457
maint@@	O	-1	2790457
en@@	O	-1	2790457
ance	O	-1	2790457
of	O	-1	2790457
loc@@	O	-1	2790457
al	O	-1	2790457
anesthe@@	O	-1	2790457
tic@@	O	-1	2790457
-@@	O	-1	2790457
k@@	O	-1	2790457
ind@@	O	-1	2790457
l@@	O	-1	2790457
ed	O	-1	2790457
seizures	B-Disease	D012640	2790457
.	O	-1	2790457
The	O	-1	2790457
eff@@	O	-1	2790457
ec@@	O	-1	2790457
tiv@@	O	-1	2790457
en@@	O	-1	2790457
ess	O	-1	2790457
of	O	-1	2790457
chronic	O	-1	2790457
but	O	-1	2790457
not	O	-1	2790457
repe@@	O	-1	2790457
at@@	O	-1	2790457
ed,	O	-1	2790457
inter@@	O	-1	2790457
mit@@	O	-1	2790457
t@@	O	-1	2790457
ent	O	-1	2790457
injec@@	O	-1	2790457
tions	O	-1	2790457
of	O	-1	2790457
C@@	B-Chemical	D002220	2790457
B@@	I-Chemical	-1	2790457
Z	I-Chemical	-1	2790457
suggests	O	-1	2790457
that	O	-1	2790457
different	O	-1	2790457
bio@@	O	-1	2790457
chemical	O	-1	2790457
con@@	O	-1	2790457
sequ@@	O	-1	2790457
enc@@	O	-1	2790457
es	O	-1	2790457
result	O	-1	2790457
from	O	-1	2790457
the	O	-1	2790457
different	O	-1	2790457
treatment	O	-1	2790457
regimen@@	O	-1	2790457
s.	O	-1	2790457
The	O	-1	2790457
possible	O	-1	2790457
u@@	O	-1	2790457
til@@	O	-1	2790457
ity	O	-1	2790457
of	O	-1	2790457
chronic	O	-1	2790457
C@@	B-Chemical	D002220	2790457
B@@	I-Chemical	-1	2790457
Z	I-Chemical	-1	2790457
in	O	-1	2790457
prevent@@	O	-1	2790457
ing	O	-1	2790457
the	O	-1	2790457
development	O	-1	2790457
of	O	-1	2790457
toxic	O	-1	2790457
side	O	-1	2790457
effects	O	-1	2790457
in	O	-1	2790457
human	O	-1	2790457
cocaine	B-Chemical	D003042	2790457
users	O	-1	2790457
is	O	-1	2790457
suggested	O	-1	2790457
by	O	-1	2790457
these	O	-1	2790457
dat@@	O	-1	2790457
a,	O	-1	2790457
but	O	-1	2790457
remain@@	O	-1	2790457
s	O	-1	2790457
to	O	-1	2790457
be	O	-1	2790457
direc@@	O	-1	2790457
tly	O	-1	2790457
evalu@@	O	-1	2790457
ated.	O	-1	2790457

D-@@	B-Chemical	D010396	2334179
pen@@	I-Chemical	-1	2334179
icill@@	I-Chemical	-1	2334179
amine	I-Chemical	-1	2334179
in	O	-1	2334179
the	O	-1	2334179
treatment	O	-1	2334179
of	O	-1	2334179
lo@@	B-Disease	D012594	2334179
cal@@	I-Disease	-1	2334179
ized	I-Disease	-1	2334179
s@@	I-Disease	-1	2334179
clero@@	I-Disease	-1	2334179
der@@	I-Disease	-1	2334179
ma	I-Disease	-1	2334179
.	O	-1	2334179
L@@	B-Disease	D012594	2334179
oc@@	I-Disease	-1	2334179
al@@	I-Disease	-1	2334179
ized	I-Disease	-1	2334179
s@@	I-Disease	-1	2334179
clero@@	I-Disease	-1	2334179
der@@	I-Disease	-1	2334179
ma	I-Disease	-1	2334179
has	O	-1	2334179
no	O	-1	2334179
reco@@	O	-1	2334179
gn@@	O	-1	2334179
ized	O	-1	2334179
inter@@	O	-1	2334179
n@@	O	-1	2334179
al	O	-1	2334179
org@@	O	-1	2334179
an	O	-1	2334179
invol@@	O	-1	2334179
vement	O	-1	2334179
but	O	-1	2334179
may	O	-1	2334179
be	O	-1	2334179
dis@@	O	-1	2334179
fi@@	O	-1	2334179
g@@	O	-1	2334179
uring	O	-1	2334179
and	O	-1	2334179
dis@@	O	-1	2334179
abl@@	O	-1	2334179
ing	O	-1	2334179
when	O	-1	2334179
the	O	-1	2334179
c@@	O	-1	2334179
utaneous	O	-1	2334179
lesions	O	-1	2334179
are	O	-1	2334179
exten@@	O	-1	2334179
sive	O	-1	2334179
or	O	-1	2334179
aff@@	O	-1	2334179
ect	O	-1	2334179
child@@	O	-1	2334179
ren@@	O	-1	2334179
.	O	-1	2334179
There	O	-1	2334179
is	O	-1	2334179
no	O	-1	2334179
ac@@	O	-1	2334179
ce@@	O	-1	2334179
pt@@	O	-1	2334179
ed	O	-1	2334179
or	O	-1	2334179
pro@@	O	-1	2334179
ven	O	-1	2334179
treatment	O	-1	2334179
for	O	-1	2334179
lo@@	B-Disease	D012594	2334179
cal@@	I-Disease	-1	2334179
ized	I-Disease	-1	2334179
s@@	I-Disease	-1	2334179
clero@@	I-Disease	-1	2334179
der@@	I-Disease	-1	2334179
ma	I-Disease	-1	2334179
.	O	-1	2334179
C@@	O	-1	2334179
ase	O	-1	2334179
reports	O	-1	2334179
of	O	-1	2334179
11	O	-1	2334179
patients	O	-1	2334179
with	O	-1	2334179
se@@	O	-1	2334179
ve@@	O	-1	2334179
re,	O	-1	2334179
exten@@	O	-1	2334179
sive	O	-1	2334179
lo@@	B-Disease	D012594	2334179
cal@@	I-Disease	-1	2334179
ized	I-Disease	-1	2334179
s@@	I-Disease	-1	2334179
clero@@	I-Disease	-1	2334179
der@@	I-Disease	-1	2334179
ma	I-Disease	-1	2334179
who	O	-1	2334179
were	O	-1	2334179
treated	O	-1	2334179
with	O	-1	2334179
D-@@	B-Chemical	D010396	2334179
pen@@	I-Chemical	-1	2334179
icill@@	I-Chemical	-1	2334179
amine	I-Chemical	-1	2334179
are	O	-1	2334179
su@@	O	-1	2334179
mm@@	O	-1	2334179
ar@@	O	-1	2334179
ized	O	-1	2334179
in	O	-1	2334179
this	O	-1	2334179
ar@@	O	-1	2334179
tic@@	O	-1	2334179
le@@	O	-1	2334179
.	O	-1	2334179
This	O	-1	2334179
drug	O	-1	2334179
was	O	-1	2334179
j@@	O	-1	2334179
ud@@	O	-1	2334179
g@@	O	-1	2334179
ed	O	-1	2334179
to	O	-1	2334179
have	O	-1	2334179
a	O	-1	2334179
f@@	O	-1	2334179
av@@	O	-1	2334179
or@@	O	-1	2334179
able	O	-1	2334179
effect	O	-1	2334179
on	O	-1	2334179
the	O	-1	2334179
disease	O	-1	2334179
course	O	-1	2334179
in	O	-1	2334179
7	O	-1	2334179
(6@@	O	-1	2334179
4@@	O	-1	2334179
%)	O	-1	2334179
of	O	-1	2334179
11	O	-1	2334179
patients.	O	-1	2334179
Im@@	O	-1	2334179
pro@@	O	-1	2334179
vement	O	-1	2334179
be@@	O	-1	2334179
g@@	O	-1	2334179
an	O	-1	2334179
within	O	-1	2334179
3	O	-1	2334179
to	O	-1	2334179
6	O	-1	2334179
months	O	-1	2334179
and	O	-1	2334179
consist@@	O	-1	2334179
ed	O	-1	2334179
of	O	-1	2334179
cess@@	O	-1	2334179
ation	O	-1	2334179
of	O	-1	2334179
active	O	-1	2334179
c@@	O	-1	2334179
utaneous	O	-1	2334179
lesions	O	-1	2334179
in	O	-1	2334179
all	O	-1	2334179
7	O	-1	2334179
patients,	O	-1	2334179
s@@	O	-1	2334179
k@@	O	-1	2334179
in	O	-1	2334179
s@@	O	-1	2334179
of@@	O	-1	2334179
ten@@	O	-1	2334179
ing	O	-1	2334179
in	O	-1	2334179
5,	O	-1	2334179
and	O	-1	2334179
more	O	-1	2334179
normal	O	-1	2334179
growth	O	-1	2334179
of	O	-1	2334179
the	O	-1	2334179
affected	O	-1	2334179
lim@@	O	-1	2334179
b	O	-1	2334179
in	O	-1	2334179
2	O	-1	2334179
of	O	-1	2334179
3	O	-1	2334179
child@@	O	-1	2334179
ren@@	O	-1	2334179
.	O	-1	2334179
J@@	O	-1	2334179
o@@	O	-1	2334179
in@@	O	-1	2334179
t	O	-1	2334179
sti@@	O	-1	2334179
ff@@	O	-1	2334179
ness	O	-1	2334179
and	O	-1	2334179
contrac@@	B-Disease	D003286	2334179
t@@	I-Disease	-1	2334179
ures	I-Disease	-1	2334179
also	O	-1	2334179
impro@@	O	-1	2334179
ved.	O	-1	2334179
The	O	-1	2334179
dose	O	-1	2334179
of	O	-1	2334179
D-@@	B-Chemical	D010396	2334179
pen@@	I-Chemical	-1	2334179
icill@@	I-Chemical	-1	2334179
amine	I-Chemical	-1	2334179
associated	O	-1	2334179
with	O	-1	2334179
a	O	-1	2334179
f@@	O	-1	2334179
av@@	O	-1	2334179
or@@	O	-1	2334179
able	O	-1	2334179
response	O	-1	2334179
was	O	-1	2334179
as	O	-1	2334179
low	O	-1	2334179
as	O	-1	2334179
2	O	-1	2334179
to	O	-1	2334179
5	O	-1	2334179
mg/kg	O	-1	2334179
per	O	-1	2334179
day	O	-1	2334179
given	O	-1	2334179
over	O	-1	2334179
a	O	-1	2334179
period	O	-1	2334179
rang@@	O	-1	2334179
ing	O	-1	2334179
from	O	-1	2334179
15	O	-1	2334179
to	O	-1	2334179
5@@	O	-1	2334179
3	O	-1	2334179
months.	O	-1	2334179
D-@@	B-Chemical	D010396	2334179
P@@	I-Chemical	-1	2334179
en@@	I-Chemical	-1	2334179
icill@@	I-Chemical	-1	2334179
amine	I-Chemical	-1	2334179
caused	O	-1	2334179
nephro@@	B-Disease	D009404	2334179
tic	I-Disease	-1	2334179
syndrome	I-Disease	-1	2334179
in	O	-1	2334179
1	O	-1	2334179
patient	O	-1	2334179
and	O	-1	2334179
mil@@	O	-1	2334179
der	O	-1	2334179
reversible	O	-1	2334179
proteinuria	B-Disease	D011507	2334179
in	O	-1	2334179
3	O	-1	2334179
other	O	-1	2334179
patient@@	O	-1	2334179
s;	O	-1	2334179
n@@	O	-1	2334179
one	O	-1	2334179
developed	O	-1	2334179
renal	B-Disease	D051437	2334179
in@@	I-Disease	-1	2334179
suffici@@	I-Disease	-1	2334179
ency	I-Disease	-1	2334179
.	O	-1	2334179
These	O	-1	2334179
data	O	-1	2334179
suggest	O	-1	2334179
that	O	-1	2334179
D-@@	B-Chemical	D010396	2334179
pen@@	I-Chemical	-1	2334179
icill@@	I-Chemical	-1	2334179
amine	I-Chemical	-1	2334179
may	O	-1	2334179
be	O	-1	2334179
effective	O	-1	2334179
in	O	-1	2334179
severe	O	-1	2334179
cases	O	-1	2334179
of	O	-1	2334179
lo@@	B-Disease	D012594	2334179
cal@@	I-Disease	-1	2334179
ized	I-Disease	-1	2334179
s@@	I-Disease	-1	2334179
clero@@	I-Disease	-1	2334179
der@@	I-Disease	-1	2334179
ma	I-Disease	-1	2334179
.	O	-1	2334179

P@@	O	-1	1969772
res@@	O	-1	1969772
er@@	O	-1	1969772
v@@	O	-1	1969772
ation	O	-1	1969772
of	O	-1	1969772
renal	O	-1	1969772
blood	O	-1	1969772
flow	O	-1	1969772
during	O	-1	1969772
hypotension	B-Disease	D007022	1969772
induced	O	-1	1969772
with	O	-1	1969772
f@@	B-Chemical	D018818	1969772
en@@	I-Chemical	-1	1969772
ol@@	I-Chemical	-1	1969772
do@@	I-Chemical	-1	1969772
pa@@	I-Chemical	-1	1969772
m	I-Chemical	-1	1969772
in	O	-1	1969772
dog@@	O	-1	1969772
s.	O	-1	1969772
The	O	-1	1969772
int@@	O	-1	1969772
ro@@	O	-1	1969772
duction	O	-1	1969772
of	O	-1	1969772
drugs	O	-1	1969772
that	O	-1	1969772
could	O	-1	1969772
induce	O	-1	1969772
hypotension	B-Disease	D007022	1969772
with	O	-1	1969772
different	O	-1	1969772
pharmac@@	O	-1	1969772
ological	O	-1	1969772
ac@@	O	-1	1969772
tions	O	-1	1969772
wo@@	O	-1	1969772
uld	O	-1	1969772
be	O	-1	1969772
adv@@	O	-1	1969772
ant@@	O	-1	1969772
ag@@	O	-1	1969772
e@@	O	-1	1969772
ous	O	-1	1969772
because	O	-1	1969772
side	O	-1	1969772
effects	O	-1	1969772
un@@	O	-1	1969772
i@@	O	-1	1969772
qu@@	O	-1	1969772
e	O	-1	1969772
to	O	-1	1969772
a	O	-1	1969772
specific	O	-1	1969772
drug	O	-1	1969772
could	O	-1	1969772
be	O	-1	1969772
minim@@	O	-1	1969772
ized	O	-1	1969772
by	O	-1	1969772
sel@@	O	-1	1969772
ect@@	O	-1	1969772
ing	O	-1	1969772
appro@@	O	-1	1969772
pri@@	O	-1	1969772
ate	O	-1	1969772
therapy.	O	-1	1969772
S@@	O	-1	1969772
p@@	O	-1	1969772
ec@@	O	-1	1969772
if@@	O	-1	1969772
ic	O	-1	1969772
dopamine	B-Chemical	D004298	1969772
-1@@	O	-1	1969772
,	O	-1	1969772
(	O	-1	1969772
D@@	B-Chemical	D004298	1969772
A	I-Chemical	-1	1969772
1)	O	-1	1969772
and	O	-1	1969772
dopamine	B-Chemical	D004298	1969772
-@@	O	-1	1969772
2	O	-1	1969772
(	O	-1	1969772
D@@	B-Chemical	D004298	1969772
A	I-Chemical	-1	1969772
2)	O	-1	1969772
receptor	O	-1	1969772
agon@@	O	-1	1969772
ist@@	O	-1	1969772
s	O	-1	1969772
are	O	-1	1969772
no@@	O	-1	1969772
w	O	-1	1969772
under	O	-1	1969772
clinical	O	-1	1969772
investig@@	O	-1	1969772
ation.	O	-1	1969772
F@@	B-Chemical	D018818	1969772
en@@	I-Chemical	-1	1969772
ol@@	I-Chemical	-1	1969772
do@@	I-Chemical	-1	1969772
pa@@	I-Chemical	-1	1969772
m	I-Chemical	-1	1969772
m@@	I-Chemical	-1	1969772
es@@	I-Chemical	-1	1969772
yl@@	I-Chemical	-1	1969772
ate	I-Chemical	-1	1969772
is	O	-1	1969772
a	O	-1	1969772
specific	O	-1	1969772
D@@	O	-1	1969772
A@@	O	-1	1969772
1	O	-1	1969772
receptor	O	-1	1969772
agon@@	O	-1	1969772
ist	O	-1	1969772
that	O	-1	1969772
low@@	O	-1	1969772
ers	O	-1	1969772
blood	O	-1	1969772
pressure	O	-1	1969772
by	O	-1	1969772
vas@@	O	-1	1969772
odi@@	O	-1	1969772
lat@@	O	-1	1969772
ation.	O	-1	1969772
The	O	-1	1969772
hypo@@	O	-1	1969772
thesis	O	-1	1969772
that	O	-1	1969772
f@@	B-Chemical	D018818	1969772
en@@	I-Chemical	-1	1969772
ol@@	I-Chemical	-1	1969772
do@@	I-Chemical	-1	1969772
pa@@	I-Chemical	-1	1969772
m	I-Chemical	-1	1969772
could	O	-1	1969772
be	O	-1	1969772
used	O	-1	1969772
to	O	-1	1969772
induce	O	-1	1969772
hypotension	B-Disease	D007022	1969772
and	O	-1	1969772
pres@@	O	-1	1969772
er@@	O	-1	1969772
ve	O	-1	1969772
blood	O	-1	1969772
flow	O	-1	1969772
to	O	-1	1969772
the	O	-1	1969772
kidney	O	-1	1969772
was	O	-1	1969772
test@@	O	-1	1969772
ed.	O	-1	1969772
S@@	O	-1	1969772
y@@	O	-1	1969772
st@@	O	-1	1969772
em@@	O	-1	1969772
ic	O	-1	1969772
a@@	O	-1	1969772
or@@	O	-1	1969772
tic	O	-1	1969772
blood	O	-1	1969772
pressure	O	-1	1969772
and	O	-1	1969772
renal	O	-1	1969772
blood	O	-1	1969772
flow	O	-1	1969772
were	O	-1	1969772
measured	O	-1	1969772
continu@@	O	-1	1969772
ously	O	-1	1969772
with	O	-1	1969772
a	O	-1	1969772
ca@@	O	-1	1969772
ro@@	O	-1	1969772
ti@@	O	-1	1969772
d	O	-1	1969772
arterial	O	-1	1969772
ca@@	O	-1	1969772
the@@	O	-1	1969772
ter	O	-1	1969772
and	O	-1	1969772
an	O	-1	1969772
elect@@	O	-1	1969772
rom@@	O	-1	1969772
ag@@	O	-1	1969772
ne@@	O	-1	1969772
tic	O	-1	1969772
flow	O	-1	1969772
pro@@	O	-1	1969772
be	O	-1	1969772
respectivel@@	O	-1	1969772
y,	O	-1	1969772
in	O	-1	1969772
or@@	O	-1	1969772
der	O	-1	1969772
to	O	-1	1969772
compar@@	O	-1	1969772
e	O	-1	1969772
the	O	-1	1969772
cardiovascular	O	-1	1969772
and	O	-1	1969772
renal	O	-1	1969772
vascular	O	-1	1969772
effects	O	-1	1969772
of	O	-1	1969772
f@@	B-Chemical	D018818	1969772
en@@	I-Chemical	-1	1969772
ol@@	I-Chemical	-1	1969772
do@@	I-Chemical	-1	1969772
pa@@	I-Chemical	-1	1969772
m	I-Chemical	-1	1969772
and	O	-1	1969772
sodium	B-Chemical	D012964	1969772
nitro@@	B-Chemical	D009599	1969772
pr@@	I-Chemical	-1	1969772
us@@	I-Chemical	-1	1969772
side	I-Chemical	-1	1969772
in	O	-1	1969772
ten	O	-1	1969772
dog@@	O	-1	1969772
s	O	-1	1969772
under	O	-1	1969772
halo@@	B-Chemical	D006221	1969772
th@@	I-Chemical	-1	1969772
ane	I-Chemical	-1	1969772
gener@@	O	-1	1969772
al	O	-1	1969772
anaesthe@@	O	-1	1969772
sia.	O	-1	1969772
M@@	O	-1	1969772
e@@	O	-1	1969772
an	O	-1	1969772
arterial	O	-1	1969772
pressure	O	-1	1969772
was	O	-1	1969772
decreased	O	-1	1969772
30	O	-1	1969772
+/-	O	-1	1969772
8	O	-1	1969772
per	O	-1	1969772
c@@	O	-1	1969772
ent	O	-1	1969772
from	O	-1	1969772
control	O	-1	1969772
with	O	-1	1969772
infusion	O	-1	1969772
of	O	-1	1969772
f@@	B-Chemical	D018818	1969772
en@@	I-Chemical	-1	1969772
ol@@	I-Chemical	-1	1969772
do@@	I-Chemical	-1	1969772
pa@@	I-Chemical	-1	1969772
m	I-Chemical	-1	1969772
(@@	O	-1	1969772
3.@@	O	-1	1969772
4	O	-1	1969772
+/-	O	-1	1969772
2.@@	O	-1	1969772
0	O	-1	1969772
microgram@@	O	-1	1969772
s@@	O	-1	1969772
.@@	O	-1	1969772
kg@@	O	-1	1969772
-@@	O	-1	1969772
1.@@	O	-1	1969772
min@@	O	-1	1969772
-1@@	O	-1	1969772
)	O	-1	1969772
and	O	-1	1969772
3@@	O	-1	1969772
4	O	-1	1969772
+/-	O	-1	1969772
4	O	-1	1969772
per	O	-1	1969772
c@@	O	-1	1969772
ent	O	-1	1969772
with	O	-1	1969772
infusion	O	-1	1969772
of	O	-1	1969772
sodium	B-Chemical	D012964	1969772
nitro@@	B-Chemical	D009599	1969772
pr@@	I-Chemical	-1	1969772
us@@	I-Chemical	-1	1969772
side	I-Chemical	-1	1969772
(@@	O	-1	1969772
5.@@	O	-1	1969772
9	O	-1	1969772
microgram@@	O	-1	1969772
s@@	O	-1	1969772
.@@	O	-1	1969772
kg@@	O	-1	1969772
-@@	O	-1	1969772
1.@@	O	-1	1969772
min@@	O	-1	1969772
-1@@	O	-1	1969772
)	O	-1	1969772
(N@@	O	-1	1969772
S@@	O	-1	1969772
).	O	-1	1969772
R@@	O	-1	1969772
en@@	O	-1	1969772
al	O	-1	1969772
blood	O	-1	1969772
flow	O	-1	1969772
(@@	O	-1	1969772
R@@	O	-1	1969772
B@@	O	-1	1969772
F@@	O	-1	1969772
)	O	-1	1969772
increased	O	-1	1969772
during	O	-1	1969772
f@@	B-Chemical	D018818	1969772
en@@	I-Chemical	-1	1969772
ol@@	I-Chemical	-1	1969772
do@@	I-Chemical	-1	1969772
pa@@	I-Chemical	-1	1969772
m	I-Chemical	-1	1969772
-induced	O	-1	1969772
hypotension	B-Disease	D007022	1969772
11	O	-1	1969772
+/-	O	-1	1969772
7	O	-1	1969772
per	O	-1	1969772
c@@	O	-1	1969772
ent	O	-1	1969772
and	O	-1	1969772
decreased	O	-1	1969772
21	O	-1	1969772
+/-	O	-1	1969772
8	O	-1	1969772
per	O	-1	1969772
c@@	O	-1	1969772
ent	O	-1	1969772
during	O	-1	1969772
sodium	B-Chemical	D012964	1969772
nitro@@	B-Chemical	D009599	1969772
pr@@	I-Chemical	-1	1969772
us@@	I-Chemical	-1	1969772
side	I-Chemical	-1	1969772
-induced	O	-1	1969772
hypotension	B-Disease	D007022	1969772
(P	O	-1	1969772
less	O	-1	1969772
than	O	-1	1969772
0.0@@	O	-1	1969772
1).	O	-1	1969772
S@@	O	-1	1969772
odium	O	-1	1969772
nitro@@	B-Chemical	D009599	1969772
pr@@	I-Chemical	-1	1969772
us@@	I-Chemical	-1	1969772
side	I-Chemical	-1	1969772
is	O	-1	1969772
a	O	-1	1969772
non-@@	O	-1	1969772
selective	O	-1	1969772
arter@@	O	-1	1969772
i@@	O	-1	1969772
ol@@	O	-1	1969772
ar	O	-1	1969772
and	O	-1	1969772
venous	O	-1	1969772
vas@@	O	-1	1969772
odi@@	O	-1	1969772
lat@@	O	-1	1969772
or	O	-1	1969772
that	O	-1	1969772
can	O	-1	1969772
produce	O	-1	1969772
re@@	O	-1	1969772
di@@	O	-1	1969772
stri@@	O	-1	1969772
bu@@	O	-1	1969772
tion	O	-1	1969772
of	O	-1	1969772
blood	O	-1	1969772
flow	O	-1	1969772
aw@@	O	-1	1969772
ay	O	-1	1969772
from	O	-1	1969772
the	O	-1	1969772
kidney	O	-1	1969772
during	O	-1	1969772
induced	O	-1	1969772
hypotension	B-Disease	D007022	1969772
.	O	-1	1969772
F@@	O	-1	1969772
en@@	O	-1	1969772
ol@@	O	-1	1969772
do@@	O	-1	1969772
pa@@	O	-1	1969772
m	O	-1	1969772
is	O	-1	1969772
a	O	-1	1969772
selective	O	-1	1969772
dopamine	B-Chemical	D004298	1969772
-1	O	-1	1969772
(D@@	O	-1	1969772
A@@	O	-1	1969772
1)	O	-1	1969772
receptor	O	-1	1969772
agon@@	O	-1	1969772
ist	O	-1	1969772
that	O	-1	1969772
causes	O	-1	1969772
vas@@	O	-1	1969772
odi@@	O	-1	1969772
lat@@	O	-1	1969772
ation	O	-1	1969772
to	O	-1	1969772
the	O	-1	1969772
kidney	O	-1	1969772
and	O	-1	1969772
other	O	-1	1969772
org@@	O	-1	1969772
ans	O	-1	1969772
with	O	-1	1969772
D@@	O	-1	1969772
A@@	O	-1	1969772
1	O	-1	1969772
receptors	O	-1	1969772
and	O	-1	1969772
pres@@	O	-1	1969772
er@@	O	-1	1969772
v@@	O	-1	1969772
es	O	-1	1969772
blood	O	-1	1969772
flow	O	-1	1969772
to	O	-1	1969772
the	O	-1	1969772
kidney	O	-1	1969772
during	O	-1	1969772
induced	O	-1	1969772
hypotension	B-Disease	D007022	1969772
.	O	-1	1969772

An@@	O	-1	1700207
ti@@	O	-1	1700207
arrhyth@@	O	-1	1700207
mic	O	-1	1700207
effects	O	-1	1700207
of	O	-1	1700207
op@@	O	-1	1700207
tical	O	-1	1700207
is@@	O	-1	1700207
om@@	O	-1	1700207
ers	O	-1	1700207
of	O	-1	1700207
ci@@	B-Chemical	C032151	1700207
b@@	I-Chemical	-1	1700207
enz@@	I-Chemical	-1	1700207
ol@@	I-Chemical	-1	1700207
ine	I-Chemical	-1	1700207
on	O	-1	1700207
can@@	O	-1	1700207
ine	O	-1	1700207
ventricular	B-Disease	D001145	1700207
arrhyth@@	I-Disease	-1	1700207
mi@@	I-Disease	-1	1700207
as	I-Disease	-1	1700207
.	O	-1	1700207
An@@	O	-1	1700207
ti@@	O	-1	1700207
arrhyth@@	O	-1	1700207
mic	O	-1	1700207
effects	O	-1	1700207
of	O	-1	1700207
(@@	O	-1	1700207
+@@	O	-1	1700207
)@@	O	-1	1700207
-	O	-1	1700207
ci@@	B-Chemical	C032151	1700207
b@@	I-Chemical	-1	1700207
enz@@	I-Chemical	-1	1700207
ol@@	I-Chemical	-1	1700207
ine	I-Chemical	-1	1700207
and	O	-1	1700207
(-@@	O	-1	1700207
)@@	O	-1	1700207
-	O	-1	1700207
ci@@	B-Chemical	C032151	1700207
b@@	I-Chemical	-1	1700207
enz@@	I-Chemical	-1	1700207
ol@@	I-Chemical	-1	1700207
ine	I-Chemical	-1	1700207
were	O	-1	1700207
examined	O	-1	1700207
using	O	-1	1700207
two	O	-1	1700207
can@@	O	-1	1700207
ine	O	-1	1700207
ventricular	B-Disease	D001145	1700207
arrhyth@@	I-Disease	-1	1700207
mia	I-Disease	-1	1700207
model@@	O	-1	1700207
s.	O	-1	1700207
D@@	B-Chemical	D004070	1700207
ig@@	I-Chemical	-1	1700207
it@@	I-Chemical	-1	1700207
al@@	I-Chemical	-1	1700207
is	I-Chemical	-1	1700207
arrhyth@@	B-Disease	D001145	1700207
mia	I-Disease	-1	1700207
,	O	-1	1700207
which	O	-1	1700207
is	O	-1	1700207
sup@@	O	-1	1700207
press@@	O	-1	1700207
ed	O	-1	1700207
by	O	-1	1700207
N@@	B-Chemical	D012964	1700207
a	I-Chemical	-1	1700207
channel	O	-1	1700207
block@@	O	-1	1700207
er@@	O	-1	1700207
s,	O	-1	1700207
was	O	-1	1700207
induced	O	-1	1700207
by	O	-1	1700207
inter@@	O	-1	1700207
mit@@	O	-1	1700207
t@@	O	-1	1700207
ent	O	-1	1700207
intravenous	O	-1	1700207
(@@	O	-1	1700207
i.v@@	O	-1	1700207
.)	O	-1	1700207
injection	O	-1	1700207
of	O	-1	1700207
ou@@	B-Chemical	D010042	1700207
ab@@	I-Chemical	-1	1700207
ain	I-Chemical	-1	1700207
in	O	-1	1700207
pent@@	B-Chemical	D010424	1700207
obarbit@@	I-Chemical	-1	1700207
al	I-Chemical	-1	1700207
-@@	O	-1	1700207
anesthe@@	O	-1	1700207
tiz@@	O	-1	1700207
ed	O	-1	1700207
dog@@	O	-1	1700207
s.	O	-1	1700207
Ad@@	B-Disease	D001145	1700207
ren@@	I-Disease	-1	1700207
aline	I-Disease	-1	1700207
arrhyth@@	I-Disease	-1	1700207
mia	I-Disease	-1	1700207
,	O	-1	1700207
which	O	-1	1700207
is	O	-1	1700207
sup@@	O	-1	1700207
press@@	O	-1	1700207
ed	O	-1	1700207
by	O	-1	1700207
C@@	B-Chemical	D002118	1700207
a	I-Chemical	-1	1700207
channel	O	-1	1700207
block@@	O	-1	1700207
er@@	O	-1	1700207
s,	O	-1	1700207
was	O	-1	1700207
induced	O	-1	1700207
by	O	-1	1700207
adren@@	B-Chemical	D004837	1700207
aline	I-Chemical	-1	1700207
infusion	O	-1	1700207
in	O	-1	1700207
halo@@	B-Chemical	D006221	1700207
th@@	I-Chemical	-1	1700207
ane	I-Chemical	-1	1700207
-@@	O	-1	1700207
anesthe@@	O	-1	1700207
tiz@@	O	-1	1700207
ed	O	-1	1700207
dog@@	O	-1	1700207
s.	O	-1	1700207
T@@	O	-1	1700207
en	O	-1	1700207
and	O	-1	1700207
5	O	-1	1700207
mg/kg	O	-1	1700207
i.v@@	O	-1	1700207
.	O	-1	1700207
(@@	O	-1	1700207
+@@	O	-1	1700207
)@@	O	-1	1700207
-	O	-1	1700207
ci@@	B-Chemical	C032151	1700207
b@@	I-Chemical	-1	1700207
enz@@	I-Chemical	-1	1700207
ol@@	I-Chemical	-1	1700207
ine	I-Chemical	-1	1700207
sup@@	O	-1	1700207
press@@	O	-1	1700207
ed	O	-1	1700207
di@@	B-Chemical	D004070	1700207
g@@	I-Chemical	-1	1700207
it@@	I-Chemical	-1	1700207
al@@	I-Chemical	-1	1700207
is	I-Chemical	-1	1700207
-	O	-1	1700207
and	O	-1	1700207
adren@@	B-Chemical	D004837	1700207
aline	I-Chemical	-1	1700207
-induced	O	-1	1700207
arrhyth@@	B-Disease	D001145	1700207
mi@@	I-Disease	-1	1700207
as	I-Disease	-1	1700207
,	O	-1	1700207
respectively.	O	-1	1700207
The	O	-1	1700207
minim@@	O	-1	1700207
um	O	-1	1700207
effective	O	-1	1700207
plasma	O	-1	1700207
concentrations	O	-1	1700207
of	O	-1	1700207
(@@	O	-1	1700207
+@@	O	-1	1700207
)@@	O	-1	1700207
-	O	-1	1700207
ci@@	B-Chemical	C032151	1700207
b@@	I-Chemical	-1	1700207
enz@@	I-Chemical	-1	1700207
ol@@	I-Chemical	-1	1700207
ine	I-Chemical	-1	1700207
for	O	-1	1700207
di@@	B-Chemical	D004070	1700207
g@@	I-Chemical	-1	1700207
it@@	I-Chemical	-1	1700207
al@@	I-Chemical	-1	1700207
is	I-Chemical	-1	1700207
-	O	-1	1700207
and	O	-1	1700207
adren@@	B-Chemical	D004837	1700207
aline	I-Chemical	-1	1700207
-induced	O	-1	1700207
arrhyth@@	B-Disease	D001145	1700207
mi@@	I-Disease	-1	1700207
as	I-Disease	-1	1700207
were	O	-1	1700207
1.@@	O	-1	1700207
4	O	-1	1700207
+/-	O	-1	1700207
0.@@	O	-1	1700207
4	O	-1	1700207
and	O	-1	1700207
2.@@	O	-1	1700207
0	O	-1	1700207
+/-	O	-1	1700207
0.@@	O	-1	1700207
6	O	-1	1700207
microgram@@	O	-1	1700207
s/@@	O	-1	1700207
ml@@	O	-1	1700207
,	O	-1	1700207
respecti@@	O	-1	1700207
vely	O	-1	1700207
(@@	O	-1	1700207
mean	O	-1	1700207
+/-	O	-1	1700207
S@@	O	-1	1700207
D@@	O	-1	1700207
,	O	-1	1700207
n	O	-1	1700207
=	O	-1	1700207
6@@	O	-1	1700207
).	O	-1	1700207
A	O	-1	1700207
lower	O	-1	1700207
dose	O	-1	1700207
of	O	-1	1700207
1	O	-1	1700207
mg/kg	O	-1	1700207
i.v@@	O	-1	1700207
.	O	-1	1700207
of	O	-1	1700207
(-@@	O	-1	1700207
)@@	O	-1	1700207
-	O	-1	1700207
ci@@	B-Chemical	C032151	1700207
b@@	I-Chemical	-1	1700207
enz@@	I-Chemical	-1	1700207
ol@@	I-Chemical	-1	1700207
ine	I-Chemical	-1	1700207
sup@@	O	-1	1700207
press@@	O	-1	1700207
ed	O	-1	1700207
the	O	-1	1700207
di@@	B-Chemical	D004070	1700207
g@@	I-Chemical	-1	1700207
it@@	I-Chemical	-1	1700207
al@@	I-Chemical	-1	1700207
is	I-Chemical	-1	1700207
-induced	O	-1	1700207
arrhyth@@	B-Disease	D001145	1700207
mia	I-Disease	-1	1700207
,	O	-1	1700207
whereas	O	-1	1700207
5	O	-1	1700207
mg/kg	O	-1	1700207
i.v@@	O	-1	1700207
.	O	-1	1700207
was	O	-1	1700207
ne@@	O	-1	1700207
ed@@	O	-1	1700207
ed	O	-1	1700207
to	O	-1	1700207
sup@@	O	-1	1700207
pres@@	O	-1	1700207
s	O	-1	1700207
adren@@	B-Chemical	D004837	1700207
aline	I-Chemical	-1	1700207
-induced	O	-1	1700207
arrhyth@@	B-Disease	D001145	1700207
mi@@	I-Disease	-1	1700207
as	I-Disease	-1	1700207
.	O	-1	1700207
The	O	-1	1700207
minim@@	O	-1	1700207
um	O	-1	1700207
effective	O	-1	1700207
plasma	O	-1	1700207
concentrations	O	-1	1700207
of	O	-1	1700207
(-@@	O	-1	1700207
)@@	O	-1	1700207
-	O	-1	1700207
ci@@	B-Chemical	C032151	1700207
b@@	I-Chemical	-1	1700207
enz@@	I-Chemical	-1	1700207
ol@@	I-Chemical	-1	1700207
ine	I-Chemical	-1	1700207
for	O	-1	1700207
di@@	B-Chemical	D004070	1700207
g@@	I-Chemical	-1	1700207
it@@	I-Chemical	-1	1700207
al@@	I-Chemical	-1	1700207
is	I-Chemical	-1	1700207
-	O	-1	1700207
and	O	-1	1700207
adren@@	B-Chemical	D004837	1700207
aline	I-Chemical	-1	1700207
-induced	O	-1	1700207
arrhyth@@	B-Disease	D001145	1700207
mia	I-Disease	-1	1700207
were	O	-1	1700207
0.0@@	O	-1	1700207
6	O	-1	1700207
+/-	O	-1	1700207
0.0@@	O	-1	1700207
4	O	-1	1700207
and	O	-1	1700207
0.@@	O	-1	1700207
7	O	-1	1700207
+/-	O	-1	1700207
0.@@	O	-1	1700207
1	O	-1	1700207
microgram@@	O	-1	1700207
s/@@	O	-1	1700207
ml@@	O	-1	1700207
,	O	-1	1700207
respecti@@	O	-1	1700207
vely	O	-1	1700207
(@@	O	-1	1700207
mean	O	-1	1700207
+/-	O	-1	1700207
S@@	O	-1	1700207
D@@	O	-1	1700207
,	O	-1	1700207
n	O	-1	1700207
=	O	-1	1700207
6@@	O	-1	1700207
).	O	-1	1700207
The	O	-1	1700207
st@@	O	-1	1700207
ron@@	O	-1	1700207
g@@	O	-1	1700207
er	O	-1	1700207
anti@@	O	-1	1700207
arrhyth@@	O	-1	1700207
mic	O	-1	1700207
effect	O	-1	1700207
of	O	-1	1700207
(-@@	O	-1	1700207
)@@	O	-1	1700207
-	O	-1	1700207
ci@@	B-Chemical	C032151	1700207
b@@	I-Chemical	-1	1700207
enz@@	I-Chemical	-1	1700207
ol@@	I-Chemical	-1	1700207
ine	I-Chemical	-1	1700207
indic@@	O	-1	1700207
ates	O	-1	1700207
that	O	-1	1700207
(-@@	O	-1	1700207
)-@@	O	-1	1700207
is@@	O	-1	1700207
om@@	O	-1	1700207
er	O	-1	1700207
may	O	-1	1700207
have	O	-1	1700207
an	O	-1	1700207
effect	O	-1	1700207
ne@@	O	-1	1700207
arly	O	-1	1700207
5-@@	O	-1	1700207
20	O	-1	1700207
times	O	-1	1700207
st@@	O	-1	1700207
ron@@	O	-1	1700207
g@@	O	-1	1700207
er	O	-1	1700207
in	O	-1	1700207
sup@@	O	-1	1700207
press@@	O	-1	1700207
ing	O	-1	1700207
N@@	B-Chemical	D012964	1700207
a	I-Chemical	-1	1700207
channe@@	O	-1	1700207
l@@	O	-1	1700207
s,	O	-1	1700207
but	O	-1	1700207
effects	O	-1	1700207
of	O	-1	1700207
both	O	-1	1700207
drugs	O	-1	1700207
on	O	-1	1700207
C@@	B-Chemical	D002118	1700207
a	I-Chemical	-1	1700207
channe@@	O	-1	1700207
l@@	O	-1	1700207
s	O	-1	1700207
may	O	-1	1700207
be	O	-1	1700207
al@@	O	-1	1700207
most	O	-1	1700207
equ@@	O	-1	1700207
ip@@	O	-1	1700207
ot@@	O	-1	1700207
ent@@	O	-1	1700207
.	O	-1	1700207

Eff@@	O	-1	19761039
ect	O	-1	19761039
of	O	-1	19761039
H@@	B-Chemical	D010936	19761039
i@@	I-Chemical	-1	19761039
b@@	I-Chemical	-1	19761039
is@@	I-Chemical	-1	19761039
c@@	I-Chemical	-1	19761039
us	I-Chemical	-1	19761039
ros@@	I-Chemical	-1	19761039
a	I-Chemical	-1	19761039
s@@	I-Chemical	-1	19761039
in@@	I-Chemical	-1	19761039
en@@	I-Chemical	-1	19761039
sis	I-Chemical	-1	19761039
on	O	-1	19761039
res@@	B-Chemical	D012110	19761039
er@@	I-Chemical	-1	19761039
pine	I-Chemical	-1	19761039
-induced	O	-1	19761039
neuro@@	O	-1	19761039
behavioral	O	-1	19761039
and	O	-1	19761039
bio@@	O	-1	19761039
chemical	O	-1	19761039
al@@	O	-1	19761039
ter@@	O	-1	19761039
ations	O	-1	19761039
in	O	-1	19761039
rats.	O	-1	19761039
Eff@@	O	-1	19761039
ect	O	-1	19761039
of	O	-1	19761039
meth@@	O	-1	19761039
an@@	O	-1	19761039
olic	O	-1	19761039
extrac@@	O	-1	19761039
t	O	-1	19761039
of	O	-1	19761039
H@@	B-Chemical	D010936	19761039
i@@	I-Chemical	-1	19761039
b@@	I-Chemical	-1	19761039
is@@	I-Chemical	-1	19761039
c@@	I-Chemical	-1	19761039
us	I-Chemical	-1	19761039
ros@@	I-Chemical	-1	19761039
a	I-Chemical	-1	19761039
s@@	I-Chemical	-1	19761039
in@@	I-Chemical	-1	19761039
en@@	I-Chemical	-1	19761039
sis	I-Chemical	-1	19761039
(@@	O	-1	19761039
10@@	O	-1	19761039
0-@@	O	-1	19761039
3@@	O	-1	19761039
00	O	-1	19761039
mg/kg)	O	-1	19761039
was	O	-1	19761039
studied	O	-1	19761039
on	O	-1	19761039
res@@	B-Chemical	D012110	19761039
er@@	I-Chemical	-1	19761039
pine	I-Chemical	-1	19761039
-induced	O	-1	19761039
o@@	O	-1	19761039
ro@@	O	-1	19761039
fac@@	O	-1	19761039
ial	O	-1	19761039
dyskine@@	B-Disease	D004409	19761039
sia	I-Disease	-1	19761039
and	O	-1	19761039
neuro@@	O	-1	19761039
chemical	O	-1	19761039
al@@	O	-1	19761039
ter@@	O	-1	19761039
ations.	O	-1	19761039
The	O	-1	19761039
rats	O	-1	19761039
were	O	-1	19761039
treated	O	-1	19761039
with	O	-1	19761039
intra@@	O	-1	19761039
per@@	O	-1	19761039
it@@	O	-1	19761039
one@@	O	-1	19761039
al	O	-1	19761039
res@@	B-Chemical	D012110	19761039
er@@	I-Chemical	-1	19761039
pine	I-Chemical	-1	19761039
(@@	O	-1	19761039
1	O	-1	19761039
mg/kg@@	O	-1	19761039
,	O	-1	19761039
ip@@	O	-1	19761039
)	O	-1	19761039
for	O	-1	19761039
3	O	-1	19761039
days	O	-1	19761039
every	O	-1	19761039
other	O	-1	19761039
da@@	O	-1	19761039
y.	O	-1	19761039
O@@	O	-1	19761039
n	O	-1	19761039
day	O	-1	19761039
5,	O	-1	19761039
vac@@	O	-1	19761039
u@@	O	-1	19761039
ous	O	-1	19761039
ch@@	O	-1	19761039
e@@	O	-1	19761039
w@@	O	-1	19761039
ing	O	-1	19761039
mo@@	O	-1	19761039
ve@@	O	-1	19761039
ments	O	-1	19761039
and	O	-1	19761039
t@@	O	-1	19761039
on@@	O	-1	19761039
gu@@	O	-1	19761039
e	O	-1	19761039
prot@@	O	-1	19761039
ru@@	O	-1	19761039
sions	O	-1	19761039
were	O	-1	19761039
coun@@	O	-1	19761039
ted	O	-1	19761039
for	O	-1	19761039
5	O	-1	19761039
min@@	O	-1	19761039
.	O	-1	19761039
R@@	B-Chemical	D012110	19761039
es@@	I-Chemical	-1	19761039
er@@	I-Chemical	-1	19761039
pine	I-Chemical	-1	19761039
treated	O	-1	19761039
rats	O	-1	19761039
significantly	O	-1	19761039
developed	O	-1	19761039
vac@@	O	-1	19761039
u@@	O	-1	19761039
ous	O	-1	19761039
ch@@	O	-1	19761039
e@@	O	-1	19761039
w@@	O	-1	19761039
ing	O	-1	19761039
mo@@	O	-1	19761039
ve@@	O	-1	19761039
ments	O	-1	19761039
and	O	-1	19761039
t@@	O	-1	19761039
on@@	O	-1	19761039
gu@@	O	-1	19761039
e	O	-1	19761039
prot@@	O	-1	19761039
ru@@	O	-1	19761039
sions	O	-1	19761039
however,	O	-1	19761039
co@@	O	-1	19761039
administration	O	-1	19761039
of	O	-1	19761039
H@@	B-Chemical	D010936	19761039
i@@	I-Chemical	-1	19761039
b@@	I-Chemical	-1	19761039
is@@	I-Chemical	-1	19761039
c@@	I-Chemical	-1	19761039
us	I-Chemical	-1	19761039
ros@@	I-Chemical	-1	19761039
a	I-Chemical	-1	19761039
s@@	I-Chemical	-1	19761039
in@@	I-Chemical	-1	19761039
en@@	I-Chemical	-1	19761039
sis	I-Chemical	-1	19761039
ro@@	O	-1	19761039
ot@@	O	-1	19761039
s	O	-1	19761039
extrac@@	O	-1	19761039
t	O	-1	19761039
(@@	O	-1	19761039
10@@	O	-1	19761039
0@@	O	-1	19761039
,	O	-1	19761039
2@@	O	-1	19761039
00	O	-1	19761039
and	O	-1	19761039
3@@	O	-1	19761039
00	O	-1	19761039
mg/kg@@	O	-1	19761039
,	O	-1	19761039
per	O	-1	19761039
or@@	O	-1	19761039
all@@	O	-1	19761039
y@@	O	-1	19761039
)	O	-1	19761039
attenu@@	O	-1	19761039
ated	O	-1	19761039
the	O	-1	19761039
effects.	O	-1	19761039
B@@	O	-1	19761039
io@@	O	-1	19761039
chemical	O	-1	19761039
analysis	O	-1	19761039
of	O	-1	19761039
brain	O	-1	19761039
revealed	O	-1	19761039
that	O	-1	19761039
the	O	-1	19761039
res@@	B-Chemical	D012110	19761039
er@@	I-Chemical	-1	19761039
pine	I-Chemical	-1	19761039
treatment	O	-1	19761039
significantly	O	-1	19761039
increased	O	-1	19761039
li@@	O	-1	19761039
pid	O	-1	19761039
per@@	O	-1	19761039
oxid@@	O	-1	19761039
ation	O	-1	19761039
and	O	-1	19761039
decreased	O	-1	19761039
levels	O	-1	19761039
of	O	-1	19761039
su@@	B-Chemical	D013481	19761039
per@@	I-Chemical	-1	19761039
ox@@	I-Chemical	-1	19761039
ide	I-Chemical	-1	19761039
dis@@	O	-1	19761039
mut@@	O	-1	19761039
ase	O	-1	19761039
(S@@	O	-1	19761039
O@@	O	-1	19761039
D@@	O	-1	19761039
),	O	-1	19761039
cat@@	O	-1	19761039
al@@	O	-1	19761039
ase	O	-1	19761039
(C@@	O	-1	19761039
AT@@	O	-1	19761039
)	O	-1	19761039
and	O	-1	19761039
glut@@	B-Chemical	D005978	19761039
athi@@	I-Chemical	-1	19761039
one	I-Chemical	-1	19761039
reduc@@	O	-1	19761039
t@@	O	-1	19761039
ase	O	-1	19761039
(@@	O	-1	19761039
G@@	O	-1	19761039
S@@	O	-1	19761039
H@@	O	-1	19761039
),	O	-1	19761039
an	O	-1	19761039
in@@	O	-1	19761039
de@@	O	-1	19761039
x	O	-1	19761039
of	O	-1	19761039
oxid@@	O	-1	19761039
ative	O	-1	19761039
stres@@	O	-1	19761039
s	O	-1	19761039
pro@@	O	-1	19761039
ces@@	O	-1	19761039
s.	O	-1	19761039
C@@	O	-1	19761039
o@@	O	-1	19761039
administration	O	-1	19761039
of	O	-1	19761039
extrac@@	O	-1	19761039
t	O	-1	19761039
significantly	O	-1	19761039
reduced	O	-1	19761039
the	O	-1	19761039
li@@	O	-1	19761039
pid	O	-1	19761039
per@@	O	-1	19761039
oxid@@	O	-1	19761039
ation	O	-1	19761039
and	O	-1	19761039
reversed	O	-1	19761039
the	O	-1	19761039
decrease	O	-1	19761039
in	O	-1	19761039
brain	O	-1	19761039
S@@	O	-1	19761039
O@@	O	-1	19761039
D@@	O	-1	19761039
,	O	-1	19761039
CA@@	O	-1	19761039
T	O	-1	19761039
and	O	-1	19761039
G@@	O	-1	19761039
S@@	O	-1	19761039
H	O	-1	19761039
level@@	O	-1	19761039
s.	O	-1	19761039
The	O	-1	19761039
results	O	-1	19761039
of	O	-1	19761039
the	O	-1	19761039
present	O	-1	19761039
study	O	-1	19761039
suggested	O	-1	19761039
that	O	-1	19761039
H@@	B-Chemical	D010936	19761039
i@@	I-Chemical	-1	19761039
b@@	I-Chemical	-1	19761039
is@@	I-Chemical	-1	19761039
c@@	I-Chemical	-1	19761039
us	I-Chemical	-1	19761039
ros@@	I-Chemical	-1	19761039
a	I-Chemical	-1	19761039
s@@	I-Chemical	-1	19761039
in@@	I-Chemical	-1	19761039
en@@	I-Chemical	-1	19761039
sis	I-Chemical	-1	19761039
had	O	-1	19761039
a	O	-1	19761039
protective	O	-1	19761039
role	O	-1	19761039
against	O	-1	19761039
res@@	B-Chemical	D012110	19761039
er@@	I-Chemical	-1	19761039
pine	I-Chemical	-1	19761039
-induced	O	-1	19761039
o@@	O	-1	19761039
ro@@	O	-1	19761039
fac@@	O	-1	19761039
ial	O	-1	19761039
dyskine@@	B-Disease	D004409	19761039
sia	I-Disease	-1	19761039
and	O	-1	19761039
oxid@@	O	-1	19761039
ative	O	-1	19761039
stres@@	O	-1	19761039
s.	O	-1	19761039

Com@@	O	-1	11704023
par@@	O	-1	11704023
ison	O	-1	11704023
of	O	-1	11704023
a@@	O	-1	11704023
qu@@	O	-1	11704023
e@@	O	-1	11704023
ous	O	-1	11704023
and	O	-1	11704023
ge@@	O	-1	11704023
ll@@	O	-1	11704023
an	O	-1	11704023
oph@@	O	-1	11704023
thal@@	O	-1	11704023
mic	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
with	O	-1	11704023
placebo	O	-1	11704023
on	O	-1	11704023
the	O	-1	11704023
2@@	O	-1	11704023
4-@@	O	-1	11704023
h@@	O	-1	11704023
our	O	-1	11704023
heart	O	-1	11704023
rate	O	-1	11704023
response	O	-1	11704023
in	O	-1	11704023
patients	O	-1	11704023
on	O	-1	11704023
treatment	O	-1	11704023
for	O	-1	11704023
gl@@	B-Disease	D005901	11704023
au@@	I-Disease	-1	11704023
com@@	I-Disease	-1	11704023
a	I-Disease	-1	11704023
.	O	-1	11704023
P@@	O	-1	11704023
U@@	O	-1	11704023
R@@	O	-1	11704023
P@@	O	-1	11704023
O@@	O	-1	11704023
S@@	O	-1	11704023
E:	O	-1	11704023
T@@	O	-1	11704023
op@@	O	-1	11704023
ical	O	-1	11704023
beta-@@	O	-1	11704023
block@@	O	-1	11704023
er	O	-1	11704023
treatment	O	-1	11704023
is	O	-1	11704023
ro@@	O	-1	11704023
ut@@	O	-1	11704023
ine	O	-1	11704023
therapy	O	-1	11704023
in	O	-1	11704023
the	O	-1	11704023
man@@	O	-1	11704023
ag@@	O	-1	11704023
ement	O	-1	11704023
of	O	-1	11704023
patients	O	-1	11704023
with	O	-1	11704023
gl@@	B-Disease	D005901	11704023
au@@	I-Disease	-1	11704023
com@@	I-Disease	-1	11704023
a	I-Disease	-1	11704023
.	O	-1	11704023
Th@@	O	-1	11704023
er@@	O	-1	11704023
ap@@	O	-1	11704023
y	O	-1	11704023
results	O	-1	11704023
in	O	-1	11704023
systemic	O	-1	11704023
abs@@	O	-1	11704023
or@@	O	-1	11704023
p@@	O	-1	11704023
tion,	O	-1	11704023
however,	O	-1	11704023
the	O	-1	11704023
de@@	O	-1	11704023
g@@	O	-1	11704023
ree	O	-1	11704023
of	O	-1	11704023
reduction	O	-1	11704023
of	O	-1	11704023
rest@@	O	-1	11704023
ing	O	-1	11704023
and	O	-1	11704023
pe@@	O	-1	11704023
a@@	O	-1	11704023
k	O	-1	11704023
heart	O	-1	11704023
rate	O	-1	11704023
has	O	-1	11704023
not	O	-1	11704023
been	O	-1	11704023
qu@@	O	-1	11704023
anti@@	O	-1	11704023
fi@@	O	-1	11704023
ed.	O	-1	11704023
D@@	O	-1	11704023
ES@@	O	-1	11704023
I@@	O	-1	11704023
G@@	O	-1	11704023
N@@	O	-1	11704023
:	O	-1	11704023
This	O	-1	11704023
trial	O	-1	11704023
evaluated	O	-1	11704023
the	O	-1	11704023
effect	O	-1	11704023
of	O	-1	11704023
placebo@@	O	-1	11704023
,	O	-1	11704023
0.@@	O	-1	11704023
5%	O	-1	11704023
a@@	O	-1	11704023
qu@@	O	-1	11704023
e@@	O	-1	11704023
ous	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
(	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
sol@@	O	-1	11704023
u@@	O	-1	11704023
tion@@	O	-1	11704023
)	O	-1	11704023
and	O	-1	11704023
a	O	-1	11704023
0.@@	O	-1	11704023
5%	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
sus@@	O	-1	11704023
pen@@	O	-1	11704023
sion	O	-1	11704023
that	O	-1	11704023
form@@	O	-1	11704023
s	O	-1	11704023
a	O	-1	11704023
ge@@	O	-1	11704023
l	O	-1	11704023
on	O	-1	11704023
ap@@	O	-1	11704023
plic@@	O	-1	11704023
ation	O	-1	11704023
to	O	-1	11704023
the	O	-1	11704023
con@@	O	-1	11704023
j@@	O	-1	11704023
unc@@	O	-1	11704023
tiv@@	O	-1	11704023
a	O	-1	11704023
(	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
ge@@	O	-1	11704023
ll@@	O	-1	11704023
an@@	O	-1	11704023
)	O	-1	11704023
on	O	-1	11704023
the	O	-1	11704023
2@@	O	-1	11704023
4-@@	O	-1	11704023
h@@	O	-1	11704023
our	O	-1	11704023
heart	O	-1	11704023
rate	O	-1	11704023
in	O	-1	11704023
patients	O	-1	11704023
cur@@	O	-1	11704023
ren@@	O	-1	11704023
tly	O	-1	11704023
being	O	-1	11704023
treated	O	-1	11704023
for	O	-1	11704023
gl@@	B-Disease	D005901	11704023
au@@	I-Disease	-1	11704023
com@@	I-Disease	-1	11704023
a	I-Disease	-1	11704023
to	O	-1	11704023
qu@@	O	-1	11704023
anti@@	O	-1	11704023
f@@	O	-1	11704023
y	O	-1	11704023
the	O	-1	11704023
reduction	O	-1	11704023
in	O	-1	11704023
mean	O	-1	11704023
heart	O	-1	11704023
rat@@	O	-1	11704023
e.	O	-1	11704023
METHODS:	O	-1	11704023
F@@	O	-1	11704023
or@@	O	-1	11704023
ty-@@	O	-1	11704023
three	O	-1	11704023
Ca@@	O	-1	11704023
uc@@	O	-1	11704023
a@@	O	-1	11704023
si@@	O	-1	11704023
an	O	-1	11704023
patients	O	-1	11704023
with	O	-1	11704023
prim@@	O	-1	11704023
ary	O	-1	11704023
o@@	B-Disease	D005902	11704023
pen@@	I-Disease	-1	11704023
-@@	I-Disease	-1	11704023
ang@@	I-Disease	-1	11704023
le	I-Disease	-1	11704023
gl@@	I-Disease	-1	11704023
au@@	I-Disease	-1	11704023
com@@	I-Disease	-1	11704023
a	I-Disease	-1	11704023
or	O	-1	11704023
oc@@	B-Disease	D009798	11704023
ular	I-Disease	-1	11704023
hypertension	I-Disease	-1	11704023
with	O	-1	11704023
a	O	-1	11704023
mean	O	-1	11704023
(@@	O	-1	11704023
+/-@@	O	-1	11704023
S@@	O	-1	11704023
D)	O	-1	11704023
age	O	-1	11704023
of	O	-1	11704023
6@@	O	-1	11704023
3	O	-1	11704023
(@@	O	-1	11704023
+/-@@	O	-1	11704023
8@@	O	-1	11704023
)	O	-1	11704023
years	O	-1	11704023
were	O	-1	11704023
randomized	O	-1	11704023
and	O	-1	11704023
cros@@	O	-1	11704023
sed	O	-1	11704023
over	O	-1	11704023
in	O	-1	11704023
a	O	-1	11704023
double-@@	O	-1	11704023
mas@@	O	-1	11704023
ked	O	-1	11704023
man@@	O	-1	11704023
n@@	O	-1	11704023
er	O	-1	11704023
to	O	-1	11704023
14	O	-1	11704023
days	O	-1	11704023
of	O	-1	11704023
treatment	O	-1	11704023
with	O	-1	11704023
placebo	O	-1	11704023
(@@	O	-1	11704023
mor@@	O	-1	11704023
ning	O	-1	11704023
and	O	-1	11704023
ev@@	O	-1	11704023
en@@	O	-1	11704023
ing	O	-1	11704023
in	O	-1	11704023
both	O	-1	11704023
e@@	O	-1	11704023
y@@	O	-1	11704023
es@@	O	-1	11704023
),	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
sol@@	O	-1	11704023
u@@	O	-1	11704023
tion	O	-1	11704023
(@@	O	-1	11704023
mor@@	O	-1	11704023
ning	O	-1	11704023
and	O	-1	11704023
ev@@	O	-1	11704023
en@@	O	-1	11704023
ing	O	-1	11704023
in	O	-1	11704023
both	O	-1	11704023
e@@	O	-1	11704023
y@@	O	-1	11704023
es@@	O	-1	11704023
),	O	-1	11704023
or	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
ge@@	O	-1	11704023
ll@@	O	-1	11704023
an	O	-1	11704023
(@@	O	-1	11704023
mor@@	O	-1	11704023
ning	O	-1	11704023
in	O	-1	11704023
both	O	-1	11704023
e@@	O	-1	11704023
y@@	O	-1	11704023
es	O	-1	11704023
with	O	-1	11704023
placebo	O	-1	11704023
in	O	-1	11704023
the	O	-1	11704023
ev@@	O	-1	11704023
en@@	O	-1	11704023
ing@@	O	-1	11704023
).	O	-1	11704023
O@@	O	-1	11704023
n	O	-1	11704023
the	O	-1	11704023
13@@	O	-1	11704023
th	O	-1	11704023
day	O	-1	11704023
of	O	-1	11704023
each	O	-1	11704023
perio@@	O	-1	11704023
d,	O	-1	11704023
heart	O	-1	11704023
rate	O	-1	11704023
was	O	-1	11704023
recor@@	O	-1	11704023
ded	O	-1	11704023
continu@@	O	-1	11704023
ously	O	-1	11704023
during	O	-1	11704023
a	O	-1	11704023
typ@@	O	-1	11704023
ic@@	O	-1	11704023
al,	O	-1	11704023
am@@	O	-1	11704023
b@@	O	-1	11704023
ul@@	O	-1	11704023
ant	O	-1	11704023
2@@	O	-1	11704023
4-@@	O	-1	11704023
h@@	O	-1	11704023
our	O	-1	11704023
perio@@	O	-1	11704023
d.	O	-1	11704023
RESULTS:	O	-1	11704023
B@@	O	-1	11704023
oth	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
sol@@	O	-1	11704023
u@@	O	-1	11704023
tion	O	-1	11704023
and	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
ge@@	O	-1	11704023
ll@@	O	-1	11704023
an	O	-1	11704023
reduced	O	-1	11704023
the	O	-1	11704023
mean	O	-1	11704023
2@@	O	-1	11704023
4-@@	O	-1	11704023
h@@	O	-1	11704023
our	O	-1	11704023
heart	O	-1	11704023
rate	O	-1	11704023
compared	O	-1	11704023
with	O	-1	11704023
placebo	O	-1	11704023
(P	O	-1	11704023
<	O	-1	11704023
or	O	-1	11704023
=	O	-1	11704023
.@@	O	-1	11704023
0@@	O	-1	11704023
0@@	O	-1	11704023
1),	O	-1	11704023
and	O	-1	11704023
this	O	-1	11704023
reduction	O	-1	11704023
was	O	-1	11704023
most	O	-1	11704023
p@@	O	-1	11704023
ron@@	O	-1	11704023
oun@@	O	-1	11704023
c@@	O	-1	11704023
ed	O	-1	11704023
during	O	-1	11704023
the	O	-1	11704023
day@@	O	-1	11704023
time	O	-1	11704023
(-@@	O	-1	11704023
7.@@	O	-1	11704023
5%	O	-1	11704023
change	O	-1	11704023
in	O	-1	11704023
mean	O	-1	11704023
heart	O	-1	11704023
rat@@	O	-1	11704023
e,	O	-1	11704023
-@@	O	-1	11704023
5.@@	O	-1	11704023
7	O	-1	11704023
be@@	O	-1	11704023
at@@	O	-1	11704023
s/@@	O	-1	11704023
min@@	O	-1	11704023
).	O	-1	11704023
T@@	B-Chemical	D013999	11704023
im@@	I-Chemical	-1	11704023
o@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
ge@@	O	-1	11704023
ll@@	O	-1	11704023
an	O	-1	11704023
showed	O	-1	11704023
a	O	-1	11704023
n@@	O	-1	11704023
um@@	O	-1	11704023
er@@	O	-1	11704023
ically	O	-1	11704023
but	O	-1	11704023
not	O	-1	11704023
significantly	O	-1	11704023
sm@@	O	-1	11704023
all@@	O	-1	11704023
er	O	-1	11704023
reduction	O	-1	11704023
in	O	-1	11704023
2@@	O	-1	11704023
4-@@	O	-1	11704023
h@@	O	-1	11704023
our	O	-1	11704023
heart	O	-1	11704023
rat@@	O	-1	11704023
e,	O	-1	11704023
compared	O	-1	11704023
with	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
sol@@	O	-1	11704023
u@@	O	-1	11704023
tion.	O	-1	11704023
D@@	O	-1	11704023
uring	O	-1	11704023
the	O	-1	11704023
n@@	O	-1	11704023
igh@@	O	-1	11704023
t,	O	-1	11704023
the	O	-1	11704023
mean	O	-1	11704023
1@@	O	-1	11704023
2-@@	O	-1	11704023
h@@	O	-1	11704023
our	O	-1	11704023
heart	O	-1	11704023
rate	O	-1	11704023
on	O	-1	11704023
placebo	O	-1	11704023
and	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
ge@@	O	-1	11704023
ll@@	O	-1	11704023
an	O	-1	11704023
were	O	-1	11704023
both	O	-1	11704023
significantly	O	-1	11704023
less	O	-1	11704023
than	O	-1	11704023
on	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
sol@@	O	-1	11704023
u@@	O	-1	11704023
tion@@	O	-1	11704023
;	O	-1	11704023
the	O	-1	11704023
difference	O	-1	11704023
between	O	-1	11704023
sol@@	O	-1	11704023
u@@	O	-1	11704023
tion	O	-1	11704023
and	O	-1	11704023
ge@@	O	-1	11704023
ll@@	O	-1	11704023
an	O	-1	11704023
treat@@	O	-1	11704023
ments	O	-1	11704023
was	O	-1	11704023
statis@@	O	-1	11704023
tically	O	-1	11704023
significant	O	-1	11704023
(P	O	-1	11704023
=	O	-1	11704023
.@@	O	-1	11704023
0@@	O	-1	11704023
1).	O	-1	11704023
CONCLUSIONS:	O	-1	11704023
B@@	O	-1	11704023
oth	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
sol@@	O	-1	11704023
u@@	O	-1	11704023
tion	O	-1	11704023
and	O	-1	11704023
ti@@	B-Chemical	D013999	11704023
mo@@	I-Chemical	-1	11704023
lol	I-Chemical	-1	11704023
ge@@	O	-1	11704023
ll@@	O	-1	11704023
an	O	-1	11704023
decrease	O	-1	11704023
the	O	-1	11704023
mean	O	-1	11704023
2@@	O	-1	11704023
4-@@	O	-1	11704023
h@@	O	-1	11704023
our	O	-1	11704023
heart	O	-1	11704023
rate	O	-1	11704023
compared	O	-1	11704023
with	O	-1	11704023
placebo@@	O	-1	11704023
.	O	-1	11704023
This	O	-1	11704023
response	O	-1	11704023
was	O	-1	11704023
most	O	-1	11704023
p@@	O	-1	11704023
ron@@	O	-1	11704023
oun@@	O	-1	11704023
c@@	O	-1	11704023
ed	O	-1	11704023
during	O	-1	11704023
the	O	-1	11704023
active	O	-1	11704023
day@@	O	-1	11704023
time	O	-1	11704023
perio@@	O	-1	11704023
d.	O	-1	11704023
These	O	-1	11704023
data	O	-1	11704023
qu@@	O	-1	11704023
anti@@	O	-1	11704023
f@@	O	-1	11704023
y	O	-1	11704023
the	O	-1	11704023
mod@@	O	-1	11704023
est	O	-1	11704023
brady@@	B-Disease	D001919	11704023
cardia	I-Disease	-1	11704023
associated	O	-1	11704023
with	O	-1	11704023
oph@@	O	-1	11704023
thal@@	O	-1	11704023
mic	O	-1	11704023
beta-@@	O	-1	11704023
block@@	O	-1	11704023
er	O	-1	11704023
therapy	O	-1	11704023
in	O	-1	11704023
a	O	-1	11704023
typ@@	O	-1	11704023
ical	O	-1	11704023
patient	O	-1	11704023
po@@	O	-1	11704023
p@@	O	-1	11704023
ulation	O	-1	11704023
on	O	-1	11704023
therapy	O	-1	11704023
for	O	-1	11704023
gl@@	B-Disease	D005901	11704023
au@@	I-Disease	-1	11704023
com@@	I-Disease	-1	11704023
a	I-Disease	-1	11704023
.	O	-1	11704023
Although	O	-1	11704023
ex@@	O	-1	11704023
er@@	O	-1	11704023
cis@@	O	-1	11704023
e	O	-1	11704023
perform@@	O	-1	11704023
ance	O	-1	11704023
was	O	-1	11704023
not	O	-1	11704023
assessed	O	-1	11704023
in	O	-1	11704023
this	O	-1	11704023
tri@@	O	-1	11704023
al,	O	-1	11704023
reduc@@	O	-1	11704023
tions	O	-1	11704023
of	O	-1	11704023
this	O	-1	11704023
mag@@	O	-1	11704023
nit@@	O	-1	11704023
ude	O	-1	11704023
should	O	-1	11704023
not	O	-1	11704023
have	O	-1	11704023
subst@@	O	-1	11704023
anti@@	O	-1	11704023
al	O	-1	11704023
clinical	O	-1	11704023
con@@	O	-1	11704023
sequ@@	O	-1	11704023
enc@@	O	-1	11704023
es.	O	-1	11704023

5	B-Chemical	D005472	19300240
f@@	I-Chemical	-1	19300240
lo@@	I-Chemical	-1	19300240
uro@@	I-Chemical	-1	19300240
urac@@	I-Chemical	-1	19300240
il	I-Chemical	-1	19300240
-induced	O	-1	19300240
ap@@	B-Disease	D054549	19300240
ical	I-Disease	-1	19300240
b@@	I-Disease	-1	19300240
al@@	I-Disease	-1	19300240
lo@@	I-Disease	-1	19300240
on@@	I-Disease	-1	19300240
ing	I-Disease	-1	19300240
syndrome	I-Disease	-1	19300240
:	O	-1	19300240
a	O	-1	19300240
case	O	-1	19300240
repor@@	O	-1	19300240
t.	O	-1	19300240
The	O	-1	19300240
ap@@	B-Disease	D054549	19300240
ical	I-Disease	-1	19300240
b@@	I-Disease	-1	19300240
al@@	I-Disease	-1	19300240
lo@@	I-Disease	-1	19300240
on@@	I-Disease	-1	19300240
ing	I-Disease	-1	19300240
syndrome	I-Disease	-1	19300240
(	O	-1	19300240
A@@	B-Disease	D054549	19300240
B@@	I-Disease	-1	19300240
S	I-Disease	-1	19300240
)	O	-1	19300240
is	O	-1	19300240
a	O	-1	19300240
rec@@	O	-1	19300240
ently	O	-1	19300240
descri@@	O	-1	19300240
bed	O	-1	19300240
stres@@	O	-1	19300240
s-@@	O	-1	19300240
mediated	O	-1	19300240
acute	B-Disease	D006331	19300240
cardiac	I-Disease	-1	19300240
syndrome	I-Disease	-1	19300240
character@@	O	-1	19300240
ized	O	-1	19300240
by	O	-1	19300240
transi@@	O	-1	19300240
ent	O	-1	19300240
w@@	O	-1	19300240
all@@	O	-1	19300240
-@@	O	-1	19300240
mo@@	O	-1	19300240
tion	O	-1	19300240
abnormal@@	O	-1	19300240
ities	O	-1	19300240
invol@@	O	-1	19300240
ving	O	-1	19300240
the	O	-1	19300240
ap@@	O	-1	19300240
e@@	O	-1	19300240
x	O	-1	19300240
and	O	-1	19300240
mid@@	O	-1	19300240
ventric@@	O	-1	19300240
le	O	-1	19300240
with	O	-1	19300240
hyper@@	B-Disease	D006948	19300240
kine@@	I-Disease	-1	19300240
sis	I-Disease	-1	19300240
of	O	-1	19300240
the	O	-1	19300240
bas@@	O	-1	19300240
al	O	-1	19300240
left	O	-1	19300240
ventricular	O	-1	19300240
(@@	O	-1	19300240
L@@	O	-1	19300240
V@@	O	-1	19300240
)	O	-1	19300240
seg@@	O	-1	19300240
ments	O	-1	19300240
without	O	-1	19300240
ob@@	O	-1	19300240
struc@@	O	-1	19300240
tive	O	-1	19300240
ep@@	B-Disease	D003327	19300240
ic@@	I-Disease	-1	19300240
ardi@@	I-Disease	-1	19300240
al	I-Disease	-1	19300240
coronary	I-Disease	-1	19300240
disease	I-Disease	-1	19300240
.	O	-1	19300240
C@@	B-Disease	D066126	19300240
ardi@@	I-Disease	-1	19300240
otoxicity	I-Disease	-1	19300240
is	O	-1	19300240
not	O	-1	19300240
an	O	-1	19300240
un@@	O	-1	19300240
common	O	-1	19300240
adverse	O	-1	19300240
effect	O	-1	19300240
of	O	-1	19300240
chemo@@	O	-1	19300240
therapeutic	O	-1	19300240
agent@@	O	-1	19300240
s.	O	-1	19300240
However,	O	-1	19300240
there	O	-1	19300240
are	O	-1	19300240
no	O	-1	19300240
reports	O	-1	19300240
of	O	-1	19300240
A@@	B-Disease	D054549	19300240
B@@	I-Disease	-1	19300240
S	I-Disease	-1	19300240
secondary	O	-1	19300240
to	O	-1	19300240
chemo@@	O	-1	19300240
therapeutic	O	-1	19300240
agent@@	O	-1	19300240
s.	O	-1	19300240
We	O	-1	19300240
describe	O	-1	19300240
the	O	-1	19300240
case	O	-1	19300240
of	O	-1	19300240
a	O	-1	19300240
woman	O	-1	19300240
who	O	-1	19300240
developed	O	-1	19300240
the	O	-1	19300240
syndrome	O	-1	19300240
after	O	-1	19300240
chemotherapy	O	-1	19300240
for	O	-1	19300240
met@@	O	-1	19300240
ast@@	O	-1	19300240
atic	O	-1	19300240
cancer	B-Disease	D009369	19300240
.	O	-1	19300240
A	O	-1	19300240
7@@	O	-1	19300240
9@@	O	-1	19300240
-@@	O	-1	19300240
year-old	O	-1	19300240
woman	O	-1	19300240
presented	O	-1	19300240
with	O	-1	19300240
typ@@	O	-1	19300240
ical	O	-1	19300240
ischem@@	B-Disease	D007511	19300240
ic	I-Disease	-1	19300240
ch@@	B-Disease	D002637	19300240
est	I-Disease	-1	19300240
pain	I-Disease	-1	19300240
,	O	-1	19300240
elevated	O	-1	19300240
cardiac	O	-1	19300240
enzym@@	O	-1	19300240
es	O	-1	19300240
with	O	-1	19300240
significant	O	-1	19300240
S@@	O	-1	19300240
T@@	O	-1	19300240
-@@	O	-1	19300240
seg@@	O	-1	19300240
ment	O	-1	19300240
abnormal@@	O	-1	19300240
ities	O	-1	19300240
on	O	-1	19300240
h@@	O	-1	19300240
er	O	-1	19300240
electro@@	O	-1	19300240
cardio@@	O	-1	19300240
gram@@	O	-1	19300240
.	O	-1	19300240
S@@	O	-1	19300240
he	O	-1	19300240
under@@	O	-1	19300240
w@@	O	-1	19300240
ent	O	-1	19300240
rec@@	O	-1	19300240
ent	O	-1	19300240
chemotherapy	O	-1	19300240
with	O	-1	19300240
fluoro@@	B-Chemical	D005472	19300240
urac@@	I-Chemical	-1	19300240
il	I-Chemical	-1	19300240
for	O	-1	19300240
met@@	O	-1	19300240
ast@@	O	-1	19300240
atic	O	-1	19300240
co@@	B-Disease	D015179	19300240
lo@@	I-Disease	-1	19300240
rec@@	I-Disease	-1	19300240
t@@	I-Disease	-1	19300240
al	I-Disease	-1	19300240
cancer	I-Disease	-1	19300240
.	O	-1	19300240
E@@	O	-1	19300240
ch@@	O	-1	19300240
ocardiograph@@	O	-1	19300240
y	O	-1	19300240
revealed	O	-1	19300240
a	O	-1	19300240
w@@	O	-1	19300240
all@@	O	-1	19300240
-@@	O	-1	19300240
mo@@	O	-1	19300240
tion	O	-1	19300240
abnormal@@	O	-1	19300240
ity	O	-1	19300240
invol@@	O	-1	19300240
ving	O	-1	19300240
the	O	-1	19300240
ap@@	O	-1	19300240
ical	O	-1	19300240
and	O	-1	19300240
peri@@	O	-1	19300240
ap@@	O	-1	19300240
ical	O	-1	19300240
seg@@	O	-1	19300240
ments	O	-1	19300240
which	O	-1	19300240
appe@@	O	-1	19300240
a@@	O	-1	19300240
red	O	-1	19300240
ak@@	B-Disease	D018476	19300240
ine@@	I-Disease	-1	19300240
tic	I-Disease	-1	19300240
.	O	-1	19300240
C@@	O	-1	19300240
or@@	O	-1	19300240
onary	O	-1	19300240
angio@@	O	-1	19300240
graph@@	O	-1	19300240
y	O	-1	19300240
revealed	O	-1	19300240
no	O	-1	19300240
ob@@	O	-1	19300240
struc@@	O	-1	19300240
tive	O	-1	19300240
coronary	O	-1	19300240
le@@	O	-1	19300240
sion@@	O	-1	19300240
s.	O	-1	19300240
The	O	-1	19300240
patient	O	-1	19300240
was	O	-1	19300240
st@@	O	-1	19300240
abil@@	O	-1	19300240
ized	O	-1	19300240
with	O	-1	19300240
med@@	O	-1	19300240
ical	O	-1	19300240
therapy.	O	-1	19300240
F@@	O	-1	19300240
our	O	-1	19300240
weeks	O	-1	19300240
lat@@	O	-1	19300240
er	O	-1	19300240
sh@@	O	-1	19300240
e	O	-1	19300240
remained	O	-1	19300240
complete@@	O	-1	19300240
ly	O	-1	19300240
as@@	O	-1	19300240
ym@@	O	-1	19300240
pto@@	O	-1	19300240
m@@	O	-1	19300240
ati@@	O	-1	19300240
c@@	O	-1	19300240
.	O	-1	19300240
E@@	O	-1	19300240
ch@@	O	-1	19300240
ocardi@@	O	-1	19300240
o@@	O	-1	19300240
gra@@	O	-1	19300240
m	O	-1	19300240
revealed	O	-1	19300240
a	O	-1	19300240
normal	O	-1	19300240
e@@	O	-1	19300240
j@@	O	-1	19300240
ection	O	-1	19300240
frac@@	O	-1	19300240
tion	O	-1	19300240
and	O	-1	19300240
a	O	-1	19300240
resol@@	O	-1	19300240
u@@	O	-1	19300240
tion	O	-1	19300240
of	O	-1	19300240
the	O	-1	19300240
ap@@	O	-1	19300240
ical	O	-1	19300240
ak@@	B-Disease	D018476	19300240
ine@@	I-Disease	-1	19300240
sis	I-Disease	-1	19300240
.	O	-1	19300240
P@@	O	-1	19300240
ath@@	O	-1	19300240
o@@	O	-1	19300240
gene@@	O	-1	19300240
tic	O	-1	19300240
mechanisms	O	-1	19300240
of	O	-1	19300240
cardiac	B-Disease	D005117	19300240
complications	I-Disease	-1	19300240
in	O	-1	19300240
cancer	B-Disease	D009369	19300240
patients	O	-1	19300240
under@@	O	-1	19300240
go@@	O	-1	19300240
ing	O	-1	19300240
chemotherapy	O	-1	19300240
includ@@	O	-1	19300240
e	O	-1	19300240
coronary	B-Disease	D003329	19300240
vas@@	I-Disease	-1	19300240
os@@	I-Disease	-1	19300240
p@@	I-Disease	-1	19300240
as@@	I-Disease	-1	19300240
m	I-Disease	-1	19300240
,	O	-1	19300240
endothelial	O	-1	19300240
damage	O	-1	19300240
and	O	-1	19300240
con@@	O	-1	19300240
sequ@@	O	-1	19300240
ent	O	-1	19300240
throm@@	B-Disease	D013927	19300240
bu@@	I-Disease	-1	19300240
s	I-Disease	-1	19300240
form@@	O	-1	19300240
ation.	O	-1	19300240
In	O	-1	19300240
our	O	-1	19300240
patient@@	O	-1	19300240
,	O	-1	19300240
both	O	-1	19300240
sup@@	O	-1	19300240
ra@@	O	-1	19300240
physi@@	O	-1	19300240
ologic	O	-1	19300240
levels	O	-1	19300240
of	O	-1	19300240
plasma	O	-1	19300240
cat@@	B-Chemical	D002395	19300240
ech@@	I-Chemical	-1	19300240
ol@@	I-Chemical	-1	19300240
amin@@	I-Chemical	-1	19300240
es	I-Chemical	-1	19300240
and	O	-1	19300240
stres@@	O	-1	19300240
s	O	-1	19300240
related	O	-1	19300240
neuro@@	O	-1	19300240
p@@	O	-1	19300240
ep@@	O	-1	19300240
ti@@	O	-1	19300240
des	O	-1	19300240
caused	O	-1	19300240
by	O	-1	19300240
cancer	B-Disease	D009369	19300240
diagnosis	O	-1	19300240
as	O	-1	19300240
well	O	-1	19300240
as	O	-1	19300240
chemotherapy	O	-1	19300240
may	O	-1	19300240
have	O	-1	19300240
cont@@	O	-1	19300240
ri@@	O	-1	19300240
but@@	O	-1	19300240
ed	O	-1	19300240
the	O	-1	19300240
development	O	-1	19300240
of	O	-1	19300240
A@@	B-Disease	D054549	19300240
B@@	I-Disease	-1	19300240
S	I-Disease	-1	19300240
.	O	-1	19300240

Re@@	O	-1	18006530
duction	O	-1	18006530
of	O	-1	18006530
pain	B-Disease	D010146	18006530
during	O	-1	18006530
induction	O	-1	18006530
with	O	-1	18006530
t@@	O	-1	18006530
arg@@	O	-1	18006530
et@@	O	-1	18006530
-@@	O	-1	18006530
controlled	O	-1	18006530
pro@@	B-Chemical	D015742	18006530
po@@	I-Chemical	-1	18006530
f@@	I-Chemical	-1	18006530
ol	I-Chemical	-1	18006530
and	O	-1	18006530
re@@	B-Chemical	C071741	18006530
m@@	I-Chemical	-1	18006530
if@@	I-Chemical	-1	18006530
entan@@	I-Chemical	-1	18006530
il	I-Chemical	-1	18006530
.	O	-1	18006530
BACKGROUND:	O	-1	18006530
P@@	B-Disease	D010146	18006530
ain	I-Disease	-1	18006530
on	O	-1	18006530
injection	O	-1	18006530
of	O	-1	18006530
pro@@	B-Chemical	D015742	18006530
po@@	I-Chemical	-1	18006530
f@@	I-Chemical	-1	18006530
ol	I-Chemical	-1	18006530
is	O	-1	18006530
un@@	O	-1	18006530
ple@@	O	-1	18006530
as@@	O	-1	18006530
ant@@	O	-1	18006530
.	O	-1	18006530
We	O	-1	18006530
hypo@@	O	-1	18006530
the@@	O	-1	18006530
si@@	O	-1	18006530
zed	O	-1	18006530
that	O	-1	18006530
pro@@	B-Chemical	D015742	18006530
po@@	I-Chemical	-1	18006530
f@@	I-Chemical	-1	18006530
ol	I-Chemical	-1	18006530
infusion	O	-1	18006530
pain	B-Disease	D010146	18006530
might	O	-1	18006530
be	O	-1	18006530
prevent@@	O	-1	18006530
ed	O	-1	18006530
by	O	-1	18006530
inf@@	O	-1	18006530
using	O	-1	18006530
re@@	B-Chemical	C071741	18006530
m@@	I-Chemical	-1	18006530
if@@	I-Chemical	-1	18006530
entan@@	I-Chemical	-1	18006530
il	I-Chemical	-1	18006530
before	O	-1	18006530
star@@	O	-1	18006530
ting	O	-1	18006530
the	O	-1	18006530
pro@@	B-Chemical	D015742	18006530
po@@	I-Chemical	-1	18006530
f@@	I-Chemical	-1	18006530
ol	I-Chemical	-1	18006530
infusion	O	-1	18006530
in	O	-1	18006530
a	O	-1	18006530
clinical	O	-1	18006530
se@@	O	-1	18006530
t@@	O	-1	18006530
ting	O	-1	18006530
wh@@	O	-1	18006530
ere	O	-1	18006530
t@@	O	-1	18006530
arg@@	O	-1	18006530
et@@	O	-1	18006530
-@@	O	-1	18006530
controlled	O	-1	18006530
infu@@	O	-1	18006530
sions	O	-1	18006530
(T@@	O	-1	18006530
CI@@	O	-1	18006530
)	O	-1	18006530
of	O	-1	18006530
both	O	-1	18006530
drugs	O	-1	18006530
were	O	-1	18006530
use@@	O	-1	18006530
d.	O	-1	18006530
A	O	-1	18006530
pro@@	O	-1	18006530
sp@@	O	-1	18006530
ecti@@	O	-1	18006530
ve,	O	-1	18006530
random@@	O	-1	18006530
iz@@	O	-1	18006530
ed,	O	-1	18006530
double-bl@@	O	-1	18006530
ind@@	O	-1	18006530
,	O	-1	18006530
placebo@@	O	-1	18006530
-@@	O	-1	18006530
controlled	O	-1	18006530
trial	O	-1	18006530
was	O	-1	18006530
performed	O	-1	18006530
to	O	-1	18006530
determine	O	-1	18006530
the	O	-1	18006530
effect@@	O	-1	18006530
-@@	O	-1	18006530
sit@@	O	-1	18006530
e	O	-1	18006530
concentration	O	-1	18006530
(C@@	O	-1	18006530
e@@	O	-1	18006530
)	O	-1	18006530
of	O	-1	18006530
re@@	B-Chemical	C071741	18006530
m@@	I-Chemical	-1	18006530
if@@	I-Chemical	-1	18006530
entan@@	I-Chemical	-1	18006530
il	I-Chemical	-1	18006530
to	O	-1	18006530
prev@@	O	-1	18006530
ent	O	-1	18006530
the	O	-1	18006530
pain	B-Disease	D010146	18006530
without	O	-1	18006530
produc@@	O	-1	18006530
ing	O	-1	18006530
complic@@	O	-1	18006530
ations.	O	-1	18006530
METHODS:	O	-1	18006530
A	O	-1	18006530
total	O	-1	18006530
of	O	-1	18006530
12@@	O	-1	18006530
8	O	-1	18006530
patients	O	-1	18006530
under@@	O	-1	18006530
go@@	O	-1	18006530
ing	O	-1	18006530
gener@@	O	-1	18006530
al	O	-1	18006530
surger@@	O	-1	18006530
y	O	-1	18006530
were	O	-1	18006530
random@@	O	-1	18006530
ly	O	-1	18006530
al@@	O	-1	18006530
loc@@	O	-1	18006530
ated	O	-1	18006530
to	O	-1	18006530
recei@@	O	-1	18006530
ve	O	-1	18006530
normal	O	-1	18006530
saline	O	-1	18006530
(@@	O	-1	18006530
control@@	O	-1	18006530
)	O	-1	18006530
or	O	-1	18006530
re@@	B-Chemical	C071741	18006530
m@@	I-Chemical	-1	18006530
if@@	I-Chemical	-1	18006530
entan@@	I-Chemical	-1	18006530
il	I-Chemical	-1	18006530
to	O	-1	18006530
a	O	-1	18006530
t@@	O	-1	18006530
arg@@	O	-1	18006530
et	O	-1	18006530
C@@	O	-1	18006530
e	O	-1	18006530
of	O	-1	18006530
2	O	-1	18006530
n@@	O	-1	18006530
g	O	-1	18006530
ml@@	O	-1	18006530
(@@	O	-1	18006530
-1@@	O	-1	18006530
)	O	-1	18006530
(@@	O	-1	18006530
R@@	O	-1	18006530
2@@	O	-1	18006530
),	O	-1	18006530
4	O	-1	18006530
n@@	O	-1	18006530
g	O	-1	18006530
ml@@	O	-1	18006530
(@@	O	-1	18006530
-1@@	O	-1	18006530
)	O	-1	18006530
(@@	O	-1	18006530
R@@	O	-1	18006530
4@@	O	-1	18006530
),	O	-1	18006530
or	O	-1	18006530
6	O	-1	18006530
n@@	O	-1	18006530
g	O	-1	18006530
ml@@	O	-1	18006530
(@@	O	-1	18006530
-1@@	O	-1	18006530
)	O	-1	18006530
(@@	O	-1	18006530
R@@	O	-1	18006530
6@@	O	-1	18006530
)	O	-1	18006530
administered	O	-1	18006530
vi@@	O	-1	18006530
a	O	-1	18006530
T@@	O	-1	18006530
CI@@	O	-1	18006530
.	O	-1	18006530
After	O	-1	18006530
the	O	-1	18006530
t@@	O	-1	18006530
arg@@	O	-1	18006530
et	O	-1	18006530
C@@	O	-1	18006530
e	O	-1	18006530
was	O	-1	18006530
achi@@	O	-1	18006530
e@@	O	-1	18006530
ve@@	O	-1	18006530
d,	O	-1	18006530
the	O	-1	18006530
infusion	O	-1	18006530
of	O	-1	18006530
pro@@	B-Chemical	D015742	18006530
po@@	I-Chemical	-1	18006530
f@@	I-Chemical	-1	18006530
ol	I-Chemical	-1	18006530
was	O	-1	18006530
star@@	O	-1	18006530
ted.	O	-1	18006530
R@@	B-Chemical	C071741	18006530
em@@	I-Chemical	-1	18006530
if@@	I-Chemical	-1	18006530
entan@@	I-Chemical	-1	18006530
il	I-Chemical	-1	18006530
-@@	O	-1	18006530
related	O	-1	18006530
complications	O	-1	18006530
were	O	-1	18006530
assessed	O	-1	18006530
during	O	-1	18006530
the	O	-1	18006530
re@@	B-Chemical	C071741	18006530
m@@	I-Chemical	-1	18006530
if@@	I-Chemical	-1	18006530
entan@@	I-Chemical	-1	18006530
il	I-Chemical	-1	18006530
infu@@	O	-1	18006530
sion,	O	-1	18006530
and	O	-1	18006530
pain	B-Disease	D010146	18006530
caused	O	-1	18006530
by	O	-1	18006530
pro@@	B-Chemical	D015742	18006530
po@@	I-Chemical	-1	18006530
f@@	I-Chemical	-1	18006530
ol	I-Chemical	-1	18006530
was	O	-1	18006530
evaluated	O	-1	18006530
using	O	-1	18006530
a	O	-1	18006530
fo@@	O	-1	18006530
ur@@	O	-1	18006530
-@@	O	-1	18006530
po@@	O	-1	18006530
in@@	O	-1	18006530
t	O	-1	18006530
s@@	O	-1	18006530
cal@@	O	-1	18006530
e	O	-1	18006530
during	O	-1	18006530
the	O	-1	18006530
pro@@	B-Chemical	D015742	18006530
po@@	I-Chemical	-1	18006530
f@@	I-Chemical	-1	18006530
ol	I-Chemical	-1	18006530
infu@@	O	-1	18006530
sion.	O	-1	18006530
RESULTS:	O	-1	18006530
The	O	-1	18006530
incidence	O	-1	18006530
of	O	-1	18006530
pain	B-Disease	D010146	18006530
was	O	-1	18006530
significantly	O	-1	18006530
lower	O	-1	18006530
in	O	-1	18006530
Grou@@	O	-1	18006530
p@@	O	-1	18006530
s	O	-1	18006530
R@@	O	-1	18006530
4	O	-1	18006530
and	O	-1	18006530
R@@	O	-1	18006530
6	O	-1	18006530
than	O	-1	18006530
in	O	-1	18006530
the	O	-1	18006530
control	O	-1	18006530
and	O	-1	18006530
R@@	O	-1	18006530
2	O	-1	18006530
groups	O	-1	18006530
(1@@	O	-1	18006530
2@@	O	-1	18006530
/@@	O	-1	18006530
3@@	O	-1	18006530
2	O	-1	18006530
and	O	-1	18006530
6@@	O	-1	18006530
/@@	O	-1	18006530
3@@	O	-1	18006530
1	O	-1	18006530
v@@	O	-1	18006530
s	O	-1	18006530
2@@	O	-1	18006530
6@@	O	-1	18006530
/@@	O	-1	18006530
3@@	O	-1	18006530
1	O	-1	18006530
and	O	-1	18006530
25@@	O	-1	18006530
/@@	O	-1	18006530
3@@	O	-1	18006530
2,	O	-1	18006530
respectivel@@	O	-1	18006530
y,	O	-1	18006530
P@@	O	-1	18006530
<@@	O	-1	18006530
0.00@@	O	-1	18006530
1).	O	-1	18006530
P@@	B-Disease	D010146	18006530
ain	I-Disease	-1	18006530
was	O	-1	18006530
less	O	-1	18006530
severe	O	-1	18006530
in	O	-1	18006530
Grou@@	O	-1	18006530
p@@	O	-1	18006530
s	O	-1	18006530
R@@	O	-1	18006530
4	O	-1	18006530
and	O	-1	18006530
R@@	O	-1	18006530
6	O	-1	18006530
than	O	-1	18006530
in	O	-1	18006530
the	O	-1	18006530
control	O	-1	18006530
and	O	-1	18006530
R@@	O	-1	18006530
2	O	-1	18006530
groups	O	-1	18006530
(P@@	O	-1	18006530
<@@	O	-1	18006530
0.00@@	O	-1	18006530
1).	O	-1	18006530
However,	O	-1	18006530
both	O	-1	18006530
incidence	O	-1	18006530
and	O	-1	18006530
severity	O	-1	18006530
of	O	-1	18006530
pain	B-Disease	D010146	18006530
were	O	-1	18006530
not	O	-1	18006530
different	O	-1	18006530
between	O	-1	18006530
Grou@@	O	-1	18006530
p@@	O	-1	18006530
s	O	-1	18006530
R@@	O	-1	18006530
4	O	-1	18006530
and	O	-1	18006530
R@@	O	-1	18006530
6@@	O	-1	18006530
.	O	-1	18006530
No	O	-1	18006530
significant	O	-1	18006530
complications	O	-1	18006530
were	O	-1	18006530
observed	O	-1	18006530
during	O	-1	18006530
the	O	-1	18006530
study.	O	-1	18006530
CONCLUSIONS:	O	-1	18006530
D@@	O	-1	18006530
uring	O	-1	18006530
induction	O	-1	18006530
of	O	-1	18006530
anaesthe@@	O	-1	18006530
sia	O	-1	18006530
with	O	-1	18006530
T@@	O	-1	18006530
C@@	O	-1	18006530
I	O	-1	18006530
of	O	-1	18006530
pro@@	B-Chemical	D015742	18006530
po@@	I-Chemical	-1	18006530
f@@	I-Chemical	-1	18006530
ol	I-Chemical	-1	18006530
and	O	-1	18006530
re@@	B-Chemical	C071741	18006530
m@@	I-Chemical	-1	18006530
if@@	I-Chemical	-1	18006530
entan@@	I-Chemical	-1	18006530
il	I-Chemical	-1	18006530
,	O	-1	18006530
a	O	-1	18006530
significant	O	-1	18006530
reduction	O	-1	18006530
in	O	-1	18006530
pro@@	B-Chemical	D015742	18006530
po@@	I-Chemical	-1	18006530
f@@	I-Chemical	-1	18006530
ol	I-Chemical	-1	18006530
infusion	O	-1	18006530
pain	B-Disease	D010146	18006530
was	O	-1	18006530
achi@@	O	-1	18006530
ev@@	O	-1	18006530
ed	O	-1	18006530
without	O	-1	18006530
significant	O	-1	18006530
complications	O	-1	18006530
by	O	-1	18006530
prior	O	-1	18006530
administration	O	-1	18006530
of	O	-1	18006530
re@@	B-Chemical	C071741	18006530
m@@	I-Chemical	-1	18006530
if@@	I-Chemical	-1	18006530
entan@@	I-Chemical	-1	18006530
il	I-Chemical	-1	18006530
at	O	-1	18006530
a	O	-1	18006530
t@@	O	-1	18006530
arg@@	O	-1	18006530
et	O	-1	18006530
C@@	O	-1	18006530
e	O	-1	18006530
of	O	-1	18006530
4	O	-1	18006530
n@@	O	-1	18006530
g	O	-1	18006530
ml@@	O	-1	18006530
(@@	O	-1	18006530
-1@@	O	-1	18006530
).	O	-1	18006530

P@@	O	-1	17702969
ren@@	O	-1	17702969
atal	O	-1	17702969
exposure	O	-1	17702969
to	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
induc@@	O	-1	17702969
es	O	-1	17702969
f@@	B-Disease	D005315	17702969
et@@	I-Disease	-1	17702969
al	I-Disease	-1	17702969
pulmonary	I-Disease	-1	17702969
hypertension	I-Disease	-1	17702969
f@@	B-Disease	D006976	17702969
et@@	I-Disease	-1	17702969
al	I-Disease	-1	17702969
pulmonary	I-Disease	-1	17702969
hypertension	I-Disease	-1	17702969
in	O	-1	17702969
the	O	-1	17702969
rat@@	O	-1	17702969
.	O	-1	17702969
R@@	O	-1	17702969
AT@@	O	-1	17702969
ION@@	O	-1	17702969
AL@@	O	-1	17702969
E:	O	-1	17702969
F@@	B-Chemical	D005473	17702969
lu@@	I-Chemical	-1	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
is	O	-1	17702969
a	O	-1	17702969
selective	O	-1	17702969
seroton@@	B-Chemical	D012701	17702969
in	I-Chemical	-1	17702969
re@@	O	-1	17702969
u@@	O	-1	17702969
pt@@	O	-1	17702969
ake	O	-1	17702969
inhibitor	O	-1	17702969
antidepress@@	O	-1	17702969
ant	O	-1	17702969
wi@@	O	-1	17702969
de@@	O	-1	17702969
ly	O	-1	17702969
used	O	-1	17702969
by	O	-1	17702969
pregn@@	O	-1	17702969
ant	O	-1	17702969
wom@@	O	-1	17702969
en@@	O	-1	17702969
.	O	-1	17702969
E@@	O	-1	17702969
pi@@	O	-1	17702969
de@@	O	-1	17702969
m@@	O	-1	17702969
io@@	O	-1	17702969
log@@	O	-1	17702969
ical	O	-1	17702969
data	O	-1	17702969
suggest	O	-1	17702969
that	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
exposure	O	-1	17702969
p@@	O	-1	17702969
ren@@	O	-1	17702969
at@@	O	-1	17702969
ally	O	-1	17702969
increases	O	-1	17702969
the	O	-1	17702969
prev@@	O	-1	17702969
al@@	O	-1	17702969
ence	O	-1	17702969
of	O	-1	17702969
per@@	O	-1	17702969
sist@@	O	-1	17702969
ent	O	-1	17702969
pulmonary	B-Disease	D006976	17702969
hypertension	I-Disease	-1	17702969
syndrome	I-Disease	-1	17702969
of	O	-1	17702969
the	O	-1	17702969
ne@@	O	-1	17702969
w@@	O	-1	17702969
b@@	O	-1	17702969
or@@	O	-1	17702969
n@@	O	-1	17702969
.	O	-1	17702969
The	O	-1	17702969
mechanism	O	-1	17702969
respon@@	O	-1	17702969
sible	O	-1	17702969
for	O	-1	17702969
this	O	-1	17702969
effect	O	-1	17702969
is	O	-1	17702969
unc@@	O	-1	17702969
le@@	O	-1	17702969
ar	O	-1	17702969
and	O	-1	17702969
par@@	O	-1	17702969
ad@@	O	-1	17702969
oxic@@	O	-1	17702969
al,	O	-1	17702969
con@@	O	-1	17702969
si@@	O	-1	17702969
der@@	O	-1	17702969
ing	O	-1	17702969
the	O	-1	17702969
current	O	-1	17702969
evidence	O	-1	17702969
of	O	-1	17702969
a	O	-1	17702969
pulmonary	B-Disease	D006976	17702969
hypertension	I-Disease	-1	17702969
protective	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
effect	O	-1	17702969
in	O	-1	17702969
ad@@	O	-1	17702969
ult	O	-1	17702969
ro@@	O	-1	17702969
d@@	O	-1	17702969
ent@@	O	-1	17702969
s.	O	-1	17702969
OBJECTIV@@	O	-1	17702969
E@@	O	-1	17702969
S:	O	-1	17702969
To	O	-1	17702969
evalu@@	O	-1	17702969
ate	O	-1	17702969
the	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
effect	O	-1	17702969
on	O	-1	17702969
f@@	O	-1	17702969
et@@	O	-1	17702969
al	O	-1	17702969
rat	O	-1	17702969
pulmonary	O	-1	17702969
vascular	O	-1	17702969
smo@@	O	-1	17702969
oth	O	-1	17702969
musc@@	O	-1	17702969
le	O	-1	17702969
mechan@@	O	-1	17702969
ical	O	-1	17702969
pro@@	O	-1	17702969
per@@	O	-1	17702969
ties	O	-1	17702969
and	O	-1	17702969
cell	O	-1	17702969
pro@@	O	-1	17702969
li@@	O	-1	17702969
fer@@	O	-1	17702969
ation	O	-1	17702969
rat@@	O	-1	17702969
e.	O	-1	17702969
METHODS:	O	-1	17702969
Pre@@	O	-1	17702969
gn@@	O	-1	17702969
ant	O	-1	17702969
rats	O	-1	17702969
were	O	-1	17702969
treated	O	-1	17702969
with	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
(10	O	-1	17702969
mg/kg)	O	-1	17702969
from	O	-1	17702969
D@@	O	-1	17702969
ay	O	-1	17702969
11	O	-1	17702969
through	O	-1	17702969
D@@	O	-1	17702969
ay	O	-1	17702969
21	O	-1	17702969
of	O	-1	17702969
g@@	O	-1	17702969
est@@	O	-1	17702969
ation.	O	-1	17702969
M@@	O	-1	17702969
E@@	O	-1	17702969
A@@	O	-1	17702969
S@@	O	-1	17702969
U@@	O	-1	17702969
R@@	O	-1	17702969
E@@	O	-1	17702969
M@@	O	-1	17702969
E@@	O	-1	17702969
N@@	O	-1	17702969
T@@	O	-1	17702969
S	O	-1	17702969
AN@@	O	-1	17702969
D	O	-1	17702969
MA@@	O	-1	17702969
I@@	O	-1	17702969
N	O	-1	17702969
RESULTS:	O	-1	17702969
F@@	O	-1	17702969
et@@	O	-1	17702969
u@@	O	-1	17702969
ses	O	-1	17702969
were	O	-1	17702969
de@@	O	-1	17702969
li@@	O	-1	17702969
vered	O	-1	17702969
by	O	-1	17702969
ces@@	O	-1	17702969
a@@	O	-1	17702969
re@@	O	-1	17702969
an	O	-1	17702969
sec@@	O	-1	17702969
tion.	O	-1	17702969
A@@	O	-1	17702969
s	O	-1	17702969
compared	O	-1	17702969
with	O	-1	17702969
control@@	O	-1	17702969
s,	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
exposure	O	-1	17702969
resulted	O	-1	17702969
in	O	-1	17702969
f@@	B-Disease	D005315	17702969
et@@	I-Disease	-1	17702969
al	I-Disease	-1	17702969
pulmonary	I-Disease	-1	17702969
hypertension	I-Disease	-1	17702969
f@@	B-Disease	D006976	17702969
et@@	I-Disease	-1	17702969
al	I-Disease	-1	17702969
pulmonary	I-Disease	-1	17702969
hypertension	I-Disease	-1	17702969
as	O	-1	17702969
ev@@	O	-1	17702969
id@@	O	-1	17702969
enc@@	O	-1	17702969
ed	O	-1	17702969
by	O	-1	17702969
an	O	-1	17702969
increase	O	-1	17702969
in	O	-1	17702969
the	O	-1	17702969
weight	O	-1	17702969
rati@@	O	-1	17702969
o	O	-1	17702969
of	O	-1	17702969
the	O	-1	17702969
right	O	-1	17702969
ventric@@	O	-1	17702969
le	O	-1	17702969
to	O	-1	17702969
the	O	-1	17702969
left	O	-1	17702969
ventric@@	O	-1	17702969
le	O	-1	17702969
plus	O	-1	17702969
se@@	O	-1	17702969
pt@@	O	-1	17702969
um	O	-1	17702969
(P	O	-1	17702969
=	O	-1	17702969
0.0@@	O	-1	17702969
2)	O	-1	17702969
and	O	-1	17702969
by	O	-1	17702969
an	O	-1	17702969
increase	O	-1	17702969
in	O	-1	17702969
pulmonary	O	-1	17702969
arterial	O	-1	17702969
medi@@	O	-1	17702969
al	O	-1	17702969
th@@	O	-1	17702969
ic@@	O	-1	17702969
k@@	O	-1	17702969
ness	O	-1	17702969
(P	O	-1	17702969
<	O	-1	17702969
0.0@@	O	-1	17702969
1).	O	-1	17702969
P@@	O	-1	17702969
ost@@	O	-1	17702969
n@@	O	-1	17702969
atal	O	-1	17702969
mor@@	O	-1	17702969
t@@	O	-1	17702969
ality	O	-1	17702969
was	O	-1	17702969
increased	O	-1	17702969
among	O	-1	17702969
experimental	O	-1	17702969
anim@@	O	-1	17702969
al@@	O	-1	17702969
s,	O	-1	17702969
and	O	-1	17702969
arterial	O	-1	17702969
oxy@@	B-Chemical	D010100	17702969
gen	I-Chemical	-1	17702969
s@@	O	-1	17702969
at@@	O	-1	17702969
ur@@	O	-1	17702969
ation	O	-1	17702969
was	O	-1	17702969
9@@	O	-1	17702969
6	O	-1	17702969
+/-	O	-1	17702969
1@@	O	-1	17702969
%	O	-1	17702969
in	O	-1	17702969
1-@@	O	-1	17702969
day@@	O	-1	17702969
-old	O	-1	17702969
control	O	-1	17702969
animals	O	-1	17702969
and	O	-1	17702969
significantly	O	-1	17702969
lower	O	-1	17702969
(P	O	-1	17702969
<	O	-1	17702969
0.0@@	O	-1	17702969
1)	O	-1	17702969
in	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
-@@	O	-1	17702969
exposed	O	-1	17702969
p@@	O	-1	17702969
up@@	O	-1	17702969
s	O	-1	17702969
(@@	O	-1	17702969
7@@	O	-1	17702969
9	O	-1	17702969
+/-	O	-1	17702969
2@@	O	-1	17702969
%).	O	-1	17702969
In	O	-1	17702969
vit@@	O	-1	17702969
ro@@	O	-1	17702969
,	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
induced	O	-1	17702969
pulmonary	O	-1	17702969
arterial	O	-1	17702969
musc@@	O	-1	17702969
le	O	-1	17702969
contrac@@	O	-1	17702969
tion	O	-1	17702969
in	O	-1	17702969
f@@	O	-1	17702969
et@@	O	-1	17702969
al,	O	-1	17702969
but	O	-1	17702969
not	O	-1	17702969
ad@@	O	-1	17702969
ult@@	O	-1	17702969
,	O	-1	17702969
animals	O	-1	17702969
(P	O	-1	17702969
<	O	-1	17702969
0.0@@	O	-1	17702969
1)	O	-1	17702969
and	O	-1	17702969
reduced	O	-1	17702969
seroton@@	B-Chemical	D012701	17702969
in	I-Chemical	-1	17702969
-induced	O	-1	17702969
contrac@@	O	-1	17702969
tion	O	-1	17702969
at	O	-1	17702969
both	O	-1	17702969
ages	O	-1	17702969
(P	O	-1	17702969
<	O	-1	17702969
0.0@@	O	-1	17702969
1).	O	-1	17702969
After	O	-1	17702969
in	O	-1	17702969
u@@	O	-1	17702969
ter@@	O	-1	17702969
o	O	-1	17702969
exposure	O	-1	17702969
to	O	-1	17702969
a	O	-1	17702969
low	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
concentration	O	-1	17702969
the	O	-1	17702969
pulmonary	O	-1	17702969
arterial	O	-1	17702969
smo@@	O	-1	17702969
oth	O	-1	17702969
musc@@	O	-1	17702969
le	O	-1	17702969
cell	O	-1	17702969
pro@@	O	-1	17702969
li@@	O	-1	17702969
fer@@	O	-1	17702969
ation	O	-1	17702969
rate	O	-1	17702969
was	O	-1	17702969
significantly	O	-1	17702969
increased	O	-1	17702969
in	O	-1	17702969
f@@	O	-1	17702969
et@@	O	-1	17702969
al,	O	-1	17702969
but	O	-1	17702969
not	O	-1	17702969
ad@@	O	-1	17702969
ult@@	O	-1	17702969
,	O	-1	17702969
cells	O	-1	17702969
(P	O	-1	17702969
<	O	-1	17702969
0.0@@	O	-1	17702969
1).	O	-1	17702969
CONCLUSIONS:	O	-1	17702969
In	O	-1	17702969
contr@@	O	-1	17702969
ast	O	-1	17702969
to	O	-1	17702969
the	O	-1	17702969
ad@@	O	-1	17702969
ult@@	O	-1	17702969
,	O	-1	17702969
flu@@	B-Chemical	D005473	17702969
ox@@	I-Chemical	-1	17702969
et@@	I-Chemical	-1	17702969
ine	I-Chemical	-1	17702969
exposure	O	-1	17702969
in	O	-1	17702969
u@@	O	-1	17702969
ter@@	O	-1	17702969
o	O	-1	17702969
induc@@	O	-1	17702969
es	O	-1	17702969
pulmonary	B-Disease	D006976	17702969
hypertension	I-Disease	-1	17702969
in	O	-1	17702969
the	O	-1	17702969
f@@	O	-1	17702969
et@@	O	-1	17702969
al	O	-1	17702969
rat	O	-1	17702969
as	O	-1	17702969
a	O	-1	17702969
result	O	-1	17702969
of	O	-1	17702969
a	O	-1	17702969
develop@@	O	-1	17702969
ment@@	O	-1	17702969
ally	O	-1	17702969
reg@@	O	-1	17702969
ul@@	O	-1	17702969
ated	O	-1	17702969
increase	O	-1	17702969
in	O	-1	17702969
pulmonary	O	-1	17702969
vascular	O	-1	17702969
smo@@	O	-1	17702969
oth	O	-1	17702969
musc@@	O	-1	17702969
le	O	-1	17702969
pro@@	O	-1	17702969
li@@	O	-1	17702969
fer@@	O	-1	17702969
ation.	O	-1	17702969

S@@	B-Disease	D013575	17344330
yn@@	I-Disease	-1	17344330
co@@	I-Disease	-1	17344330
p@@	I-Disease	-1	17344330
e	I-Disease	-1	17344330
and	O	-1	17344330
Q@@	B-Disease	D008133	17344330
T	I-Disease	-1	17344330
prolong@@	I-Disease	-1	17344330
ation	I-Disease	-1	17344330
among	O	-1	17344330
patients	O	-1	17344330
treated	O	-1	17344330
with	O	-1	17344330
meth@@	B-Chemical	D008691	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
for	O	-1	17344330
h@@	B-Chemical	D003932	17344330
ero@@	I-Chemical	-1	17344330
in	I-Chemical	-1	17344330
depend@@	O	-1	17344330
ence	O	-1	17344330
in	O	-1	17344330
the	O	-1	17344330
c@@	O	-1	17344330
ity	O	-1	17344330
of	O	-1	17344330
C@@	O	-1	17344330
o@@	O	-1	17344330
pen@@	O	-1	17344330
h@@	O	-1	17344330
ag@@	O	-1	17344330
en@@	O	-1	17344330
.	O	-1	17344330
BACKGROUND:	O	-1	17344330
M@@	B-Chemical	D008691	17344330
eth@@	I-Chemical	-1	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
is	O	-1	17344330
prescri@@	O	-1	17344330
bed	O	-1	17344330
to	O	-1	17344330
h@@	B-Chemical	D003932	17344330
ero@@	I-Chemical	-1	17344330
in	I-Chemical	-1	17344330
ad@@	O	-1	17344330
dic@@	O	-1	17344330
ts	O	-1	17344330
to	O	-1	17344330
decrease	O	-1	17344330
ill@@	O	-1	17344330
ic@@	O	-1	17344330
it	O	-1	17344330
o@@	O	-1	17344330
pi@@	O	-1	17344330
oid	O	-1	17344330
use.	O	-1	17344330
Pro@@	O	-1	17344330
long@@	O	-1	17344330
ation	O	-1	17344330
of	O	-1	17344330
the	O	-1	17344330
Q@@	O	-1	17344330
T	O	-1	17344330
interv@@	O	-1	17344330
al	O	-1	17344330
in	O	-1	17344330
the	O	-1	17344330
EC@@	O	-1	17344330
G	O	-1	17344330
of	O	-1	17344330
patients	O	-1	17344330
with	O	-1	17344330
t@@	B-Disease	D016171	17344330
or@@	I-Disease	-1	17344330
s@@	I-Disease	-1	17344330
ade	I-Disease	-1	17344330
de	I-Disease	-1	17344330
po@@	I-Disease	-1	17344330
int@@	I-Disease	-1	17344330
es	I-Disease	-1	17344330
(	O	-1	17344330
T@@	B-Disease	D016171	17344330
d@@	I-Disease	-1	17344330
P	I-Disease	-1	17344330
)	O	-1	17344330
has	O	-1	17344330
been	O	-1	17344330
reported	O	-1	17344330
in	O	-1	17344330
meth@@	B-Chemical	D008691	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
us@@	O	-1	17344330
ers.	O	-1	17344330
A@@	O	-1	17344330
s	O	-1	17344330
h@@	B-Chemical	D003932	17344330
ero@@	I-Chemical	-1	17344330
in	I-Chemical	-1	17344330
ad@@	O	-1	17344330
dic@@	O	-1	17344330
ts	O	-1	17344330
so@@	O	-1	17344330
me@@	O	-1	17344330
times	O	-1	17344330
f@@	O	-1	17344330
ain@@	O	-1	17344330
t	O	-1	17344330
while	O	-1	17344330
using	O	-1	17344330
ill@@	O	-1	17344330
ic@@	O	-1	17344330
it	O	-1	17344330
drug@@	O	-1	17344330
s,	O	-1	17344330
doc@@	O	-1	17344330
t@@	O	-1	17344330
ors	O	-1	17344330
might	O	-1	17344330
at@@	O	-1	17344330
tri@@	O	-1	17344330
b@@	O	-1	17344330
ute	O	-1	17344330
to@@	O	-1	17344330
o	O	-1	17344330
man@@	O	-1	17344330
y	O	-1	17344330
episo@@	O	-1	17344330
des	O	-1	17344330
of	O	-1	17344330
syn@@	B-Disease	D013575	17344330
co@@	I-Disease	-1	17344330
p@@	I-Disease	-1	17344330
e	I-Disease	-1	17344330
to	O	-1	17344330
ill@@	O	-1	17344330
ic@@	O	-1	17344330
it	O	-1	17344330
drug	O	-1	17344330
use	O	-1	17344330
and	O	-1	17344330
the@@	O	-1	17344330
re@@	O	-1	17344330
by	O	-1	17344330
un@@	O	-1	17344330
de@@	O	-1	17344330
res@@	O	-1	17344330
tim@@	O	-1	17344330
ate	O	-1	17344330
the	O	-1	17344330
incidence	O	-1	17344330
of	O	-1	17344330
T@@	B-Disease	D016171	17344330
d@@	I-Disease	-1	17344330
P	I-Disease	-1	17344330
in	O	-1	17344330
this	O	-1	17344330
spec@@	O	-1	17344330
ial	O	-1	17344330
po@@	O	-1	17344330
pul@@	O	-1	17344330
ation,	O	-1	17344330
and	O	-1	17344330
the	O	-1	17344330
high	O	-1	17344330
mor@@	O	-1	17344330
t@@	O	-1	17344330
ality	O	-1	17344330
in	O	-1	17344330
this	O	-1	17344330
po@@	O	-1	17344330
p@@	O	-1	17344330
ulation	O	-1	17344330
ma@@	O	-1	17344330
y,	O	-1	17344330
in	O	-1	17344330
part@@	O	-1	17344330
,	O	-1	17344330
be	O	-1	17344330
caused	O	-1	17344330
by	O	-1	17344330
the	O	-1	17344330
pro@@	O	-1	17344330
arrhyth@@	O	-1	17344330
mic	O	-1	17344330
effect	O	-1	17344330
of	O	-1	17344330
meth@@	B-Chemical	D008691	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
.	O	-1	17344330
METHODS:	O	-1	17344330
In	O	-1	17344330
this	O	-1	17344330
cros@@	O	-1	17344330
s-@@	O	-1	17344330
sec@@	O	-1	17344330
tional	O	-1	17344330
study	O	-1	17344330
inter@@	O	-1	17344330
vie@@	O	-1	17344330
w@@	O	-1	17344330
,	O	-1	17344330
EC@@	O	-1	17344330
G@@	O	-1	17344330
s	O	-1	17344330
and	O	-1	17344330
blood	O	-1	17344330
sam@@	O	-1	17344330
ple@@	O	-1	17344330
s	O	-1	17344330
were	O	-1	17344330
coll@@	O	-1	17344330
ected	O	-1	17344330
in	O	-1	17344330
a	O	-1	17344330
po@@	O	-1	17344330
p@@	O	-1	17344330
ulation	O	-1	17344330
of	O	-1	17344330
ad@@	O	-1	17344330
ult	O	-1	17344330
h@@	B-Chemical	D003932	17344330
ero@@	I-Chemical	-1	17344330
in	I-Chemical	-1	17344330
ad@@	O	-1	17344330
dic@@	O	-1	17344330
ts	O	-1	17344330
treated	O	-1	17344330
with	O	-1	17344330
meth@@	B-Chemical	D008691	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
or	O	-1	17344330
bu@@	B-Chemical	D002047	17344330
p@@	I-Chemical	-1	17344330
ren@@	I-Chemical	-1	17344330
or@@	I-Chemical	-1	17344330
ph@@	I-Chemical	-1	17344330
ine	I-Chemical	-1	17344330
on	O	-1	17344330
a	O	-1	17344330
daily	O	-1	17344330
b@@	O	-1	17344330
a@@	O	-1	17344330
sis.	O	-1	17344330
Of	O	-1	17344330
the	O	-1	17344330
patients	O	-1	17344330
at	O	-1	17344330
the	O	-1	17344330
D@@	O	-1	17344330
ru@@	O	-1	17344330
g	O	-1	17344330
Ad@@	O	-1	17344330
dic@@	O	-1	17344330
tion	O	-1	17344330
S@@	O	-1	17344330
er@@	O	-1	17344330
v@@	O	-1	17344330
ic@@	O	-1	17344330
e	O	-1	17344330
in	O	-1	17344330
the	O	-1	17344330
mun@@	O	-1	17344330
ici@@	O	-1	17344330
p@@	O	-1	17344330
al	O	-1	17344330
of	O	-1	17344330
C@@	O	-1	17344330
o@@	O	-1	17344330
pen@@	O	-1	17344330
h@@	O	-1	17344330
ag@@	O	-1	17344330
en@@	O	-1	17344330
,	O	-1	17344330
4@@	O	-1	17344330
50	O	-1	17344330
(@@	O	-1	17344330
appro@@	O	-1	17344330
xim@@	O	-1	17344330
ately	O	-1	17344330
5@@	O	-1	17344330
2@@	O	-1	17344330
%)	O	-1	17344330
were	O	-1	17344330
inc@@	O	-1	17344330
lu@@	O	-1	17344330
de@@	O	-1	17344330
d.	O	-1	17344330
The	O	-1	17344330
Q@@	O	-1	17344330
T	O	-1	17344330
interv@@	O	-1	17344330
al	O	-1	17344330
was	O	-1	17344330
estim@@	O	-1	17344330
ated	O	-1	17344330
from	O	-1	17344330
12	O	-1	17344330
le@@	O	-1	17344330
ad	O	-1	17344330
EC@@	O	-1	17344330
G@@	O	-1	17344330
s.	O	-1	17344330
All	O	-1	17344330
partic@@	O	-1	17344330
ip@@	O	-1	17344330
ants	O	-1	17344330
were	O	-1	17344330
inter@@	O	-1	17344330
vie@@	O	-1	17344330
w@@	O	-1	17344330
ed	O	-1	17344330
about	O	-1	17344330
any	O	-1	17344330
experi@@	O	-1	17344330
ence	O	-1	17344330
of	O	-1	17344330
syn@@	B-Disease	D013575	17344330
co@@	I-Disease	-1	17344330
p@@	I-Disease	-1	17344330
e	I-Disease	-1	17344330
.	O	-1	17344330
The	O	-1	17344330
association	O	-1	17344330
between	O	-1	17344330
o@@	O	-1	17344330
pi@@	O	-1	17344330
oid	O	-1	17344330
dose	O	-1	17344330
and	O	-1	17344330
Q@@	O	-1	17344330
T@@	O	-1	17344330
,	O	-1	17344330
and	O	-1	17344330
meth@@	B-Chemical	D008691	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
dose	O	-1	17344330
and	O	-1	17344330
repor@@	O	-1	17344330
ting	O	-1	17344330
of	O	-1	17344330
syn@@	B-Disease	D013575	17344330
co@@	I-Disease	-1	17344330
p@@	I-Disease	-1	17344330
e	I-Disease	-1	17344330
was	O	-1	17344330
assessed	O	-1	17344330
using	O	-1	17344330
mul@@	O	-1	17344330
tiv@@	O	-1	17344330
ari@@	O	-1	17344330
ate	O	-1	17344330
l@@	O	-1	17344330
ine@@	O	-1	17344330
ar	O	-1	17344330
reg@@	O	-1	17344330
res@@	O	-1	17344330
sion	O	-1	17344330
and	O	-1	17344330
log@@	O	-1	17344330
istic	O	-1	17344330
reg@@	O	-1	17344330
res@@	O	-1	17344330
sion,	O	-1	17344330
respectively.	O	-1	17344330
RESULTS:	O	-1	17344330
M@@	B-Chemical	D008691	17344330
eth@@	I-Chemical	-1	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
dose	O	-1	17344330
was	O	-1	17344330
associated	O	-1	17344330
with	O	-1	17344330
long@@	O	-1	17344330
er	O	-1	17344330
Q@@	O	-1	17344330
T	O	-1	17344330
interv@@	O	-1	17344330
al	O	-1	17344330
of	O	-1	17344330
0.@@	O	-1	17344330
1@@	O	-1	17344330
40	O	-1	17344330
m@@	O	-1	17344330
s/@@	O	-1	17344330
mg	O	-1	17344330
(p	O	-1	17344330
=	O	-1	17344330
0.00@@	O	-1	17344330
2@@	O	-1	17344330
).	O	-1	17344330
No	O	-1	17344330
association	O	-1	17344330
between	O	-1	17344330
bu@@	B-Chemical	D002047	17344330
p@@	I-Chemical	-1	17344330
ren@@	I-Chemical	-1	17344330
or@@	I-Chemical	-1	17344330
ph@@	I-Chemical	-1	17344330
ine	I-Chemical	-1	17344330
and	O	-1	17344330
Q@@	O	-1	17344330
T@@	O	-1	17344330
c	O	-1	17344330
was	O	-1	17344330
f@@	O	-1	17344330
oun@@	O	-1	17344330
d.	O	-1	17344330
A@@	O	-1	17344330
mon@@	O	-1	17344330
g	O	-1	17344330
the	O	-1	17344330
subjects	O	-1	17344330
treated	O	-1	17344330
with	O	-1	17344330
meth@@	B-Chemical	D008691	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
,	O	-1	17344330
2@@	O	-1	17344330
8@@	O	-1	17344330
%	O	-1	17344330
men	O	-1	17344330
and	O	-1	17344330
3@@	O	-1	17344330
2@@	O	-1	17344330
%	O	-1	17344330
women	O	-1	17344330
had	O	-1	17344330
prolonged	B-Disease	D008133	17344330
Q@@	I-Disease	-1	17344330
T@@	I-Disease	-1	17344330
c	I-Disease	-1	17344330
interv@@	I-Disease	-1	17344330
al	I-Disease	-1	17344330
.	O	-1	17344330
N@@	O	-1	17344330
one	O	-1	17344330
of	O	-1	17344330
the	O	-1	17344330
subjects	O	-1	17344330
treated	O	-1	17344330
with	O	-1	17344330
bu@@	B-Chemical	D002047	17344330
p@@	I-Chemical	-1	17344330
ren@@	I-Chemical	-1	17344330
or@@	I-Chemical	-1	17344330
ph@@	I-Chemical	-1	17344330
ine	I-Chemical	-1	17344330
had	O	-1	17344330
Q@@	O	-1	17344330
T@@	O	-1	17344330
c	O	-1	17344330
interv@@	O	-1	17344330
al	O	-1	17344330
>@@	O	-1	17344330
0.@@	O	-1	17344330
4@@	O	-1	17344330
40	O	-1	17344330
s@@	O	-1	17344330
(@@	O	-1	17344330
(1@@	O	-1	17344330
/@@	O	-1	17344330
2@@	O	-1	17344330
)@@	O	-1	17344330
).	O	-1	17344330
A	O	-1	17344330
50	O	-1	17344330
mg	O	-1	17344330
higher	O	-1	17344330
meth@@	B-Chemical	D008691	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
dose	O	-1	17344330
was	O	-1	17344330
associated	O	-1	17344330
with	O	-1	17344330
a	O	-1	17344330
1.@@	O	-1	17344330
2	O	-1	17344330
(@@	O	-1	17344330
95%	O	-1	17344330
C@@	O	-1	17344330
I	O	-1	17344330
1.@@	O	-1	17344330
1	O	-1	17344330
to	O	-1	17344330
1.@@	O	-1	17344330
4@@	O	-1	17344330
)	O	-1	17344330
times	O	-1	17344330
higher	O	-1	17344330
o@@	O	-1	17344330
d@@	O	-1	17344330
ds	O	-1	17344330
for	O	-1	17344330
syn@@	B-Disease	D013575	17344330
co@@	I-Disease	-1	17344330
p@@	I-Disease	-1	17344330
e	I-Disease	-1	17344330
.	O	-1	17344330
CONCLUSIONS:	O	-1	17344330
M@@	B-Chemical	D008691	17344330
eth@@	I-Chemical	-1	17344330
ad@@	I-Chemical	-1	17344330
one	I-Chemical	-1	17344330
is	O	-1	17344330
associated	O	-1	17344330
with	O	-1	17344330
Q@@	B-Disease	D008133	17344330
T	I-Disease	-1	17344330
prolong@@	I-Disease	-1	17344330
ation	I-Disease	-1	17344330
and	O	-1	17344330
higher	O	-1	17344330
repor@@	O	-1	17344330
ting	O	-1	17344330
of	O	-1	17344330
syn@@	B-Disease	D013575	17344330
co@@	I-Disease	-1	17344330
p@@	I-Disease	-1	17344330
e	I-Disease	-1	17344330
in	O	-1	17344330
a	O	-1	17344330
po@@	O	-1	17344330
p@@	O	-1	17344330
ulation	O	-1	17344330
of	O	-1	17344330
h@@	B-Chemical	D003932	17344330
ero@@	I-Chemical	-1	17344330
in	I-Chemical	-1	17344330
ad@@	O	-1	17344330
dic@@	O	-1	17344330
t@@	O	-1	17344330
s.	O	-1	17344330

P@@	B-Disease	D010523	16826348
er@@	I-Disease	-1	16826348
i@@	I-Disease	-1	16826348
pheral	I-Disease	-1	16826348
neuropathy	I-Disease	-1	16826348
caused	O	-1	16826348
by	O	-1	16826348
high-dose	O	-1	16826348
cy@@	B-Chemical	D003561	16826348
t@@	I-Chemical	-1	16826348
os@@	I-Chemical	-1	16826348
ine	I-Chemical	-1	16826348
ar@@	I-Chemical	-1	16826348
ab@@	I-Chemical	-1	16826348
ino@@	I-Chemical	-1	16826348
side	I-Chemical	-1	16826348
treatment	O	-1	16826348
in	O	-1	16826348
a	O	-1	16826348
patient	O	-1	16826348
with	O	-1	16826348
acute	B-Disease	D015470	16826348
my@@	I-Disease	-1	16826348
e@@	I-Disease	-1	16826348
lo@@	I-Disease	-1	16826348
id	I-Disease	-1	16826348
leuk@@	I-Disease	-1	16826348
emia	I-Disease	-1	16826348
.	O	-1	16826348
The	O	-1	16826348
central	O	-1	16826348
ner@@	O	-1	16826348
v@@	O	-1	16826348
ous	O	-1	16826348
system	O	-1	16826348
toxicity	B-Disease	D064420	16826348
of	O	-1	16826348
high-dose	O	-1	16826348
cy@@	B-Chemical	D003561	16826348
t@@	I-Chemical	-1	16826348
os@@	I-Chemical	-1	16826348
ine	I-Chemical	-1	16826348
ar@@	I-Chemical	-1	16826348
ab@@	I-Chemical	-1	16826348
ino@@	I-Chemical	-1	16826348
side	I-Chemical	-1	16826348
is	O	-1	16826348
well	O	-1	16826348
reco@@	O	-1	16826348
gn@@	O	-1	16826348
iz@@	O	-1	16826348
ed,	O	-1	16826348
but	O	-1	16826348
the	O	-1	16826348
toxicity	B-Disease	D064420	16826348
of	O	-1	16826348
cy@@	B-Chemical	D003561	16826348
t@@	I-Chemical	-1	16826348
os@@	I-Chemical	-1	16826348
ine	I-Chemical	-1	16826348
ar@@	I-Chemical	-1	16826348
ab@@	I-Chemical	-1	16826348
ino@@	I-Chemical	-1	16826348
side	I-Chemical	-1	16826348
in	O	-1	16826348
the	O	-1	16826348
peripheral	O	-1	16826348
ner@@	O	-1	16826348
v@@	O	-1	16826348
ous	O	-1	16826348
system	O	-1	16826348
has	O	-1	16826348
been	O	-1	16826348
inf@@	O	-1	16826348
requ@@	O	-1	16826348
ently	O	-1	16826348
repor@@	O	-1	16826348
ted.	O	-1	16826348
A	O	-1	16826348
4@@	O	-1	16826348
9@@	O	-1	16826348
-@@	O	-1	16826348
year-old	O	-1	16826348
J@@	O	-1	16826348
ap@@	O	-1	16826348
an@@	O	-1	16826348
ese	O	-1	16826348
man	O	-1	16826348
was	O	-1	16826348
diagnos@@	O	-1	16826348
ed	O	-1	16826348
with	O	-1	16826348
acute	B-Disease	D015470	16826348
my@@	I-Disease	-1	16826348
e@@	I-Disease	-1	16826348
lo@@	I-Disease	-1	16826348
id	I-Disease	-1	16826348
leuk@@	I-Disease	-1	16826348
emia	I-Disease	-1	16826348
.	O	-1	16826348
After	O	-1	16826348
he	O	-1	16826348
achi@@	O	-1	16826348
ev@@	O	-1	16826348
ed	O	-1	16826348
complete	O	-1	16826348
re@@	O	-1	16826348
mis@@	O	-1	16826348
sion,	O	-1	16826348
he	O	-1	16826348
received	O	-1	16826348
high-dose	O	-1	16826348
cy@@	B-Chemical	D003561	16826348
t@@	I-Chemical	-1	16826348
os@@	I-Chemical	-1	16826348
ine	I-Chemical	-1	16826348
ar@@	I-Chemical	-1	16826348
ab@@	I-Chemical	-1	16826348
ino@@	I-Chemical	-1	16826348
side	I-Chemical	-1	16826348
treatment	O	-1	16826348
(@@	O	-1	16826348
2	O	-1	16826348
g/@@	O	-1	16826348
m@@	O	-1	16826348
2	O	-1	16826348
tw@@	O	-1	16826348
ic@@	O	-1	16826348
e	O	-1	16826348
a	O	-1	16826348
day	O	-1	16826348
for	O	-1	16826348
5	O	-1	16826348
da@@	O	-1	16826348
ys@@	O	-1	16826348
;	O	-1	16826348
tot@@	O	-1	16826348
al,	O	-1	16826348
20	O	-1	16826348
g/@@	O	-1	16826348
m@@	O	-1	16826348
2)	O	-1	16826348
as	O	-1	16826348
con@@	O	-1	16826348
sol@@	O	-1	16826348
id@@	O	-1	16826348
ation	O	-1	16826348
therapy.	O	-1	16826348
The	O	-1	16826348
first	O	-1	16826348
course	O	-1	16826348
of	O	-1	16826348
high-dose	O	-1	16826348
cy@@	B-Chemical	D003561	16826348
t@@	I-Chemical	-1	16826348
os@@	I-Chemical	-1	16826348
ine	I-Chemical	-1	16826348
ar@@	I-Chemical	-1	16826348
ab@@	I-Chemical	-1	16826348
ino@@	I-Chemical	-1	16826348
side	I-Chemical	-1	16826348
resulted	O	-1	16826348
in	O	-1	16826348
no	O	-1	16826348
un@@	O	-1	16826348
us@@	O	-1	16826348
ual	O	-1	16826348
symptom@@	O	-1	16826348
s,	O	-1	16826348
but	O	-1	16826348
on	O	-1	16826348
day	O	-1	16826348
21	O	-1	16826348
of	O	-1	16826348
the	O	-1	16826348
second	O	-1	16826348
course	O	-1	16826348
of	O	-1	16826348
treatment,	O	-1	16826348
the	O	-1	16826348
patient	O	-1	16826348
com@@	O	-1	16826348
pl@@	O	-1	16826348
ained	O	-1	16826348
of	O	-1	16826348
numb@@	B-Disease	D006987	16826348
ness	I-Disease	-1	16826348
in	O	-1	16826348
h@@	O	-1	16826348
is	O	-1	16826348
right	O	-1	16826348
fo@@	O	-1	16826348
ot@@	O	-1	16826348
.	O	-1	16826348
E@@	O	-1	16826348
l@@	O	-1	16826348
ect@@	O	-1	16826348
rom@@	O	-1	16826348
yo@@	O	-1	16826348
gra@@	O	-1	16826348
m	O	-1	16826348
and	O	-1	16826348
ner@@	O	-1	16826348
ve@@	O	-1	16826348
-@@	O	-1	16826348
con@@	O	-1	16826348
duction	O	-1	16826348
studies	O	-1	16826348
showed	O	-1	16826348
peripheral	B-Disease	D010523	16826348
neuropathy	I-Disease	-1	16826348
in	O	-1	16826348
both	O	-1	16826348
per@@	O	-1	16826348
one@@	O	-1	16826348
al	O	-1	16826348
ner@@	O	-1	16826348
v@@	O	-1	16826348
es.	O	-1	16826348
This	O	-1	16826348
neuropathy	B-Disease	D009422	16826348
was	O	-1	16826348
gra@@	O	-1	16826348
du@@	O	-1	16826348
ally	O	-1	16826348
resol@@	O	-1	16826348
v@@	O	-1	16826348
ing@@	O	-1	16826348
;	O	-1	16826348
however,	O	-1	16826348
after	O	-1	16826348
the	O	-1	16826348
patient	O	-1	16826348
received	O	-1	16826348
al@@	O	-1	16826348
log@@	O	-1	16826348
en@@	O	-1	16826348
e@@	O	-1	16826348
ic	O	-1	16826348
b@@	O	-1	16826348
one	O	-1	16826348
m@@	O	-1	16826348
ar@@	O	-1	16826348
ro@@	O	-1	16826348
w	O	-1	16826348
transplant@@	O	-1	16826348
ation,	O	-1	16826348
the	O	-1	16826348
symptoms	O	-1	16826348
wor@@	O	-1	16826348
sen@@	O	-1	16826348
ed,	O	-1	16826348
with	O	-1	16826348
the	O	-1	16826348
development	O	-1	16826348
of	O	-1	16826348
gra@@	B-Disease	D006086	16826348
f@@	I-Disease	-1	16826348
t-@@	I-Disease	-1	16826348
ver@@	I-Disease	-1	16826348
sus@@	I-Disease	-1	16826348
-@@	I-Disease	-1	16826348
h@@	I-Disease	-1	16826348
ost	I-Disease	-1	16826348
disease	I-Disease	-1	16826348
,	O	-1	16826348
and	O	-1	16826348
the	O	-1	16826348
symptoms	O	-1	16826348
subsequ@@	O	-1	16826348
ently	O	-1	16826348
respon@@	O	-1	16826348
ded	O	-1	16826348
to	O	-1	16826348
methyl@@	B-Chemical	D008775	16826348
pre@@	I-Chemical	-1	16826348
d@@	I-Chemical	-1	16826348
n@@	I-Chemical	-1	16826348
isol@@	I-Chemical	-1	16826348
one	I-Chemical	-1	16826348
.	O	-1	16826348
Although	O	-1	16826348
the	O	-1	16826348
mechanisms	O	-1	16826348
of	O	-1	16826348
peripheral	B-Disease	D010523	16826348
neuropathy	I-Disease	-1	16826348
are	O	-1	16826348
sti@@	O	-1	16826348
ll	O	-1	16826348
unc@@	O	-1	16826348
lear@@	O	-1	16826348
,	O	-1	16826348
high-dose	O	-1	16826348
cy@@	B-Chemical	D003561	16826348
t@@	I-Chemical	-1	16826348
os@@	I-Chemical	-1	16826348
ine	I-Chemical	-1	16826348
ar@@	I-Chemical	-1	16826348
ab@@	I-Chemical	-1	16826348
ino@@	I-Chemical	-1	16826348
side	I-Chemical	-1	16826348
is	O	-1	16826348
a	O	-1	16826348
therapy	O	-1	16826348
that	O	-1	16826348
is	O	-1	16826348
potenti@@	O	-1	16826348
ally	O	-1	16826348
toxic	O	-1	16826348
to	O	-1	16826348
the	O	-1	16826348
peripheral	O	-1	16826348
ner@@	O	-1	16826348
v@@	O	-1	16826348
ous	O	-1	16826348
system@@	O	-1	16826348
,	O	-1	16826348
and	O	-1	16826348
auto@@	O	-1	16826348
/@@	O	-1	16826348
al@@	O	-1	16826348
lo@@	O	-1	16826348
immun@@	O	-1	16826348
ity	O	-1	16826348
may	O	-1	16826348
pl@@	O	-1	16826348
ay	O	-1	16826348
an	O	-1	16826348
important	O	-1	16826348
role	O	-1	16826348
in	O	-1	16826348
these	O	-1	16826348
mechanis@@	O	-1	16826348
m@@	O	-1	16826348
s.	O	-1	16826348

A@@	B-Chemical	C065179	16820346
t@@	I-Chemical	-1	16820346
or@@	I-Chemical	-1	16820346
vastatin	I-Chemical	-1	16820346
prevent@@	O	-1	16820346
ed	O	-1	16820346
and	O	-1	16820346
reversed	O	-1	16820346
de@@	B-Chemical	D003907	16820346
xameth@@	I-Chemical	-1	16820346
as@@	I-Chemical	-1	16820346
one	I-Chemical	-1	16820346
-induced	O	-1	16820346
hypertension	B-Disease	D006973	16820346
in	O	-1	16820346
the	O	-1	16820346
rat@@	O	-1	16820346
.	O	-1	16820346
To	O	-1	16820346
ass@@	O	-1	16820346
ess	O	-1	16820346
the	O	-1	16820346
anti@@	O	-1	16820346
oxid@@	O	-1	16820346
ant	O	-1	16820346
effects	O	-1	16820346
of	O	-1	16820346
at@@	B-Chemical	C065179	16820346
or@@	I-Chemical	-1	16820346
vastatin	I-Chemical	-1	16820346
(	O	-1	16820346
at@@	B-Chemical	C065179	16820346
or@@	I-Chemical	-1	16820346
v@@	I-Chemical	-1	16820346
a	I-Chemical	-1	16820346
)	O	-1	16820346
on	O	-1	16820346
de@@	B-Chemical	D003907	16820346
xameth@@	I-Chemical	-1	16820346
as@@	I-Chemical	-1	16820346
one	I-Chemical	-1	16820346
(	O	-1	16820346
de@@	B-Chemical	D003907	16820346
x	I-Chemical	-1	16820346
)@@	O	-1	16820346
-induced	O	-1	16820346
hypertension	B-Disease	D006973	16820346
,	O	-1	16820346
60	O	-1	16820346
male	O	-1	16820346
S@@	O	-1	16820346
pra@@	O	-1	16820346
gu@@	O	-1	16820346
e-@@	O	-1	16820346
D@@	O	-1	16820346
aw@@	O	-1	16820346
le@@	O	-1	16820346
y	O	-1	16820346
rats	O	-1	16820346
were	O	-1	16820346
treated	O	-1	16820346
with	O	-1	16820346
at@@	B-Chemical	C065179	16820346
or@@	I-Chemical	-1	16820346
v@@	I-Chemical	-1	16820346
a	I-Chemical	-1	16820346
30	O	-1	16820346
mg/k@@	O	-1	16820346
g/@@	O	-1	16820346
day	O	-1	16820346
or	O	-1	16820346
t@@	O	-1	16820346
a@@	O	-1	16820346
p	O	-1	16820346
w@@	O	-1	16820346
at@@	O	-1	16820346
er	O	-1	16820346
for	O	-1	16820346
15	O	-1	16820346
days.	O	-1	16820346
De@@	B-Chemical	D003907	16820346
x	I-Chemical	-1	16820346
increased	O	-1	16820346
systolic	O	-1	16820346
blood	O	-1	16820346
pressure	O	-1	16820346
(S@@	O	-1	16820346
B@@	O	-1	16820346
P)	O	-1	16820346
from	O	-1	16820346
10@@	O	-1	16820346
9	O	-1	16820346
+/-	O	-1	16820346
1.@@	O	-1	16820346
8	O	-1	16820346
to	O	-1	16820346
13@@	O	-1	16820346
5	O	-1	16820346
+/-	O	-1	16820346
0.@@	O	-1	16820346
6	O	-1	16820346
mm@@	O	-1	16820346
H@@	O	-1	16820346
g	O	-1	16820346
and	O	-1	16820346
plasma	O	-1	16820346
su@@	B-Chemical	D013481	16820346
per@@	I-Chemical	-1	16820346
ox@@	I-Chemical	-1	16820346
ide	I-Chemical	-1	16820346
(5@@	O	-1	16820346
7@@	O	-1	16820346
11	O	-1	16820346
+/-	O	-1	16820346
2@@	O	-1	16820346
8@@	O	-1	16820346
4.@@	O	-1	16820346
9	O	-1	16820346
sal@@	O	-1	16820346
ine,	O	-1	16820346
7@@	O	-1	16820346
9@@	O	-1	16820346
3@@	O	-1	16820346
1	O	-1	16820346
+/-	O	-1	16820346
3@@	O	-1	16820346
9@@	O	-1	16820346
2.@@	O	-1	16820346
8	O	-1	16820346
U@@	O	-1	16820346
/@@	O	-1	16820346
m@@	O	-1	16820346
l	O	-1	16820346
de@@	B-Chemical	D003907	16820346
x	I-Chemical	-1	16820346
,	O	-1	16820346
P	O	-1	16820346
<	O	-1	16820346
0.00@@	O	-1	16820346
1).	O	-1	16820346
In	O	-1	16820346
this	O	-1	16820346
pre@@	O	-1	16820346
ven@@	O	-1	16820346
tion	O	-1	16820346
study,	O	-1	16820346
S@@	O	-1	16820346
B@@	O	-1	16820346
P	O	-1	16820346
in	O	-1	16820346
the	O	-1	16820346
at@@	B-Chemical	C065179	16820346
or@@	I-Chemical	-1	16820346
v@@	I-Chemical	-1	16820346
a	I-Chemical	-1	16820346
+	O	-1	16820346
de@@	B-Chemical	D003907	16820346
x	I-Chemical	-1	16820346
group	O	-1	16820346
was	O	-1	16820346
increased	O	-1	16820346
from	O	-1	16820346
1@@	O	-1	16820346
15	O	-1	16820346
+/-	O	-1	16820346
0.@@	O	-1	16820346
4	O	-1	16820346
to	O	-1	16820346
1@@	O	-1	16820346
24	O	-1	16820346
+/-	O	-1	16820346
1.@@	O	-1	16820346
5	O	-1	16820346
mm@@	O	-1	16820346
H@@	O	-1	16820346
g@@	O	-1	16820346
,	O	-1	16820346
but	O	-1	16820346
this	O	-1	16820346
was	O	-1	16820346
significantly	O	-1	16820346
lower	O	-1	16820346
than	O	-1	16820346
in	O	-1	16820346
the	O	-1	16820346
de@@	B-Chemical	D003907	16820346
x	I-Chemical	-1	16820346
-@@	O	-1	16820346
only	O	-1	16820346
group	O	-1	16820346
(P@@	O	-1	16820346
'	O	-1	16820346
<	O	-1	16820346
0.05@@	O	-1	16820346
).	O	-1	16820346
A@@	B-Chemical	C065179	16820346
t@@	I-Chemical	-1	16820346
or@@	I-Chemical	-1	16820346
v@@	I-Chemical	-1	16820346
a	I-Chemical	-1	16820346
reversed	O	-1	16820346
de@@	B-Chemical	D003907	16820346
x	I-Chemical	-1	16820346
-induced	O	-1	16820346
hypertension	B-Disease	D006973	16820346
(1@@	O	-1	16820346
2@@	O	-1	16820346
9	O	-1	16820346
+/-	O	-1	16820346
0.@@	O	-1	16820346
6	O	-1	16820346
mm@@	O	-1	16820346
H@@	O	-1	16820346
g@@	O	-1	16820346
,	O	-1	16820346
vs.	O	-1	16820346
13@@	O	-1	16820346
5	O	-1	16820346
+/-	O	-1	16820346
0.@@	O	-1	16820346
6	O	-1	16820346
mm@@	O	-1	16820346
H@@	O	-1	16820346
g	O	-1	16820346
P@@	O	-1	16820346
'	O	-1	16820346
<	O	-1	16820346
0.05@@	O	-1	16820346
)	O	-1	16820346
and	O	-1	16820346
decreased	O	-1	16820346
plasma	O	-1	16820346
su@@	B-Chemical	D013481	16820346
per@@	I-Chemical	-1	16820346
ox@@	I-Chemical	-1	16820346
ide	I-Chemical	-1	16820346
(@@	O	-1	16820346
7@@	O	-1	16820346
9@@	O	-1	16820346
3@@	O	-1	16820346
1	O	-1	16820346
+/-	O	-1	16820346
3@@	O	-1	16820346
9@@	O	-1	16820346
2.@@	O	-1	16820346
8	O	-1	16820346
de@@	B-Chemical	D003907	16820346
x	I-Chemical	-1	16820346
,	O	-1	16820346
1@@	O	-1	16820346
18@@	O	-1	16820346
7	O	-1	16820346
+/-	O	-1	16820346
4@@	O	-1	16820346
4@@	O	-1	16820346
1.@@	O	-1	16820346
2	O	-1	16820346
at@@	B-Chemical	C065179	16820346
or@@	I-Chemical	-1	16820346
v@@	I-Chemical	-1	16820346
a	I-Chemical	-1	16820346
+	O	-1	16820346
de@@	B-Chemical	D003907	16820346
x	I-Chemical	-1	16820346
,	O	-1	16820346
P	O	-1	16820346
<	O	-1	16820346
0.00@@	O	-1	16820346
0@@	O	-1	16820346
1).	O	-1	16820346
P@@	O	-1	16820346
las@@	O	-1	16820346
ma	O	-1	16820346
nit@@	B-Chemical	D009566	16820346
rate	I-Chemical	-1	16820346
/	O	-1	16820346
nit@@	B-Chemical	D009573	16820346
rit@@	I-Chemical	-1	16820346
e	I-Chemical	-1	16820346
(N@@	O	-1	16820346
O@@	O	-1	16820346
x@@	O	-1	16820346
)	O	-1	16820346
was	O	-1	16820346
decreased	O	-1	16820346
in	O	-1	16820346
de@@	B-Chemical	D003907	16820346
x	I-Chemical	-1	16820346
-treated	O	-1	16820346
rats	O	-1	16820346
compared	O	-1	16820346
to	O	-1	16820346
sal@@	O	-1	16820346
ine-@@	O	-1	16820346
treated	O	-1	16820346
rats	O	-1	16820346
(1@@	O	-1	16820346
1.@@	O	-1	16820346
2	O	-1	16820346
+/-	O	-1	16820346
1.@@	O	-1	16820346
0@@	O	-1	16820346
8	O	-1	16820346
mic@@	O	-1	16820346
rom@@	O	-1	16820346
,	O	-1	16820346
1@@	O	-1	16820346
5.@@	O	-1	16820346
3	O	-1	16820346
+/-	O	-1	16820346
1.@@	O	-1	16820346
17	O	-1	16820346
mic@@	O	-1	16820346
rom@@	O	-1	16820346
,	O	-1	16820346
respectivel@@	O	-1	16820346
y,	O	-1	16820346
P	O	-1	16820346
<	O	-1	16820346
0.05@@	O	-1	16820346
).	O	-1	16820346
A@@	B-Chemical	C065179	16820346
t@@	I-Chemical	-1	16820346
or@@	I-Chemical	-1	16820346
v@@	I-Chemical	-1	16820346
a	I-Chemical	-1	16820346
affected	O	-1	16820346
ne@@	O	-1	16820346
ither	O	-1	16820346
plasma	O	-1	16820346
NO@@	O	-1	16820346
x	O	-1	16820346
n@@	O	-1	16820346
or	O	-1	16820346
th@@	O	-1	16820346
ym@@	O	-1	16820346
us	O	-1	16820346
weigh@@	O	-1	16820346
t.	O	-1	16820346
Th@@	O	-1	16820346
us,	O	-1	16820346
at@@	B-Chemical	C065179	16820346
or@@	I-Chemical	-1	16820346
vastatin	I-Chemical	-1	16820346
prevent@@	O	-1	16820346
ed	O	-1	16820346
and	O	-1	16820346
reversed	O	-1	16820346
de@@	B-Chemical	D003907	16820346
xameth@@	I-Chemical	-1	16820346
as@@	I-Chemical	-1	16820346
one	I-Chemical	-1	16820346
-induced	O	-1	16820346
hypertension	B-Disease	D006973	16820346
in	O	-1	16820346
the	O	-1	16820346
rat@@	O	-1	16820346
.	O	-1	16820346

Two	O	-1	15974569
pro@@	O	-1	15974569
drugs	O	-1	15974569
of	O	-1	15974569
pot@@	O	-1	15974569
ent	O	-1	15974569
and	O	-1	15974569
selective	O	-1	15974569
G@@	O	-1	15974569
lu@@	O	-1	15974569
R@@	O	-1	15974569
5	O	-1	15974569
k@@	B-Chemical	D007608	15974569
ain@@	I-Chemical	-1	15974569
ate	I-Chemical	-1	15974569
receptor	O	-1	15974569
antagonist@@	O	-1	15974569
s	O	-1	15974569
activ@@	O	-1	15974569
es	O	-1	15974569
in	O	-1	15974569
three	O	-1	15974569
anim@@	O	-1	15974569
al	O	-1	15974569
models	O	-1	15974569
of	O	-1	15974569
pain	B-Disease	D010146	15974569
.	O	-1	15974569
A@@	O	-1	15974569
min@@	O	-1	15974569
o	O	-1	15974569
acid@@	O	-1	15974569
s	O	-1	15974569
5	O	-1	15974569
and	O	-1	15974569
7@@	O	-1	15974569
,	O	-1	15974569
two	O	-1	15974569
pot@@	O	-1	15974569
ent	O	-1	15974569
and	O	-1	15974569
selective	O	-1	15974569
comp@@	O	-1	15974569
e@@	O	-1	15974569
ti@@	O	-1	15974569
tive	O	-1	15974569
G@@	O	-1	15974569
lu@@	O	-1	15974569
R@@	O	-1	15974569
5	O	-1	15974569
K@@	B-Chemical	D007608	15974569
A	I-Chemical	-1	15974569
receptor	O	-1	15974569
antagonist@@	O	-1	15974569
s,	O	-1	15974569
ex@@	O	-1	15974569
hib@@	O	-1	15974569
ited	O	-1	15974569
high	O	-1	15974569
G@@	O	-1	15974569
lu@@	O	-1	15974569
R@@	O	-1	15974569
5	O	-1	15974569
receptor	O	-1	15974569
aff@@	O	-1	15974569
in@@	O	-1	15974569
ity	O	-1	15974569
over	O	-1	15974569
other	O	-1	15974569
glutamate	B-Chemical	D018698	15974569
receptor@@	O	-1	15974569
s.	O	-1	15974569
The@@	O	-1	15974569
ir	O	-1	15974569
est@@	O	-1	15974569
er	O	-1	15974569
pro@@	O	-1	15974569
drugs	O	-1	15974569
6	O	-1	15974569
and	O	-1	15974569
8	O	-1	15974569
were	O	-1	15974569
or@@	O	-1	15974569
ally	O	-1	15974569
active	O	-1	15974569
in	O	-1	15974569
three	O	-1	15974569
models	O	-1	15974569
of	O	-1	15974569
pain	B-Disease	D010146	15974569
:	O	-1	15974569
rever@@	O	-1	15974569
s@@	O	-1	15974569
al	O	-1	15974569
of	O	-1	15974569
form@@	B-Chemical	D005557	15974569
al@@	I-Chemical	-1	15974569
in	I-Chemical	-1	15974569
-induced	O	-1	15974569
pa@@	O	-1	15974569
w	O	-1	15974569
l@@	O	-1	15974569
ic@@	O	-1	15974569
k@@	O	-1	15974569
ing,	O	-1	15974569
car@@	B-Chemical	D002351	15974569
ra@@	I-Chemical	-1	15974569
ge@@	I-Chemical	-1	15974569
en@@	I-Chemical	-1	15974569
an	I-Chemical	-1	15974569
-induced	O	-1	15974569
ther@@	B-Disease	D006930	15974569
m@@	I-Disease	-1	15974569
al	I-Disease	-1	15974569
hyperalge@@	I-Disease	-1	15974569
sia	I-Disease	-1	15974569
,	O	-1	15974569
and	O	-1	15974569
cap@@	B-Chemical	D002211	15974569
sa@@	I-Chemical	-1	15974569
icin	I-Chemical	-1	15974569
-induced	O	-1	15974569
mechan@@	B-Disease	D006930	15974569
ical	I-Disease	-1	15974569
hyperalge@@	I-Disease	-1	15974569
sia	I-Disease	-1	15974569
.	O	-1	15974569

Si@@	B-Chemical	D020123	11583940
rolimus	I-Chemical	-1	11583940
and	O	-1	11583940
my@@	B-Chemical	C063008	11583940
co@@	I-Chemical	-1	11583940
phen@@	I-Chemical	-1	11583940
ol@@	I-Chemical	-1	11583940
ate	I-Chemical	-1	11583940
mo@@	I-Chemical	-1	11583940
fe@@	I-Chemical	-1	11583940
ti@@	I-Chemical	-1	11583940
l	I-Chemical	-1	11583940
for	O	-1	11583940
calc@@	O	-1	11583940
ine@@	O	-1	11583940
ur@@	O	-1	11583940
in-@@	O	-1	11583940
free	O	-1	11583940
immunosup@@	O	-1	11583940
pression	O	-1	11583940
in	O	-1	11583940
renal	O	-1	11583940
transplant	O	-1	11583940
re@@	O	-1	11583940
ci@@	O	-1	11583940
pi@@	O	-1	11583940
ent@@	O	-1	11583940
s.	O	-1	11583940
C@@	O	-1	11583940
al@@	O	-1	11583940
c@@	O	-1	11583940
ine@@	O	-1	11583940
ur@@	O	-1	11583940
in	O	-1	11583940
inhibitor@@	O	-1	11583940
s,	O	-1	11583940
such	O	-1	11583940
as	O	-1	11583940
cyclospor@@	B-Chemical	D016572	11583940
ine	I-Chemical	-1	11583940
and	O	-1	11583940
tacrolimus	B-Chemical	D016559	11583940
,	O	-1	11583940
have	O	-1	11583940
been	O	-1	11583940
av@@	O	-1	11583940
ail@@	O	-1	11583940
able	O	-1	11583940
for	O	-1	11583940
al@@	O	-1	11583940
most	O	-1	11583940
20	O	-1	11583940
year@@	O	-1	11583940
s.	O	-1	11583940
Although	O	-1	11583940
these	O	-1	11583940
drugs	O	-1	11583940
are	O	-1	11583940
high@@	O	-1	11583940
ly	O	-1	11583940
effective	O	-1	11583940
and	O	-1	11583940
re@@	O	-1	11583940
present	O	-1	11583940
the	O	-1	11583940
main@@	O	-1	11583940
st@@	O	-1	11583940
ay	O	-1	11583940
of	O	-1	11583940
transplant	O	-1	11583940
immunosup@@	O	-1	11583940
pres@@	O	-1	11583940
sion,	O	-1	11583940
they	O	-1	11583940
are	O	-1	11583940
associated	O	-1	11583940
with	O	-1	11583940
acute	O	-1	11583940
and	O	-1	11583940
chronic	O	-1	11583940
nephro@@	B-Disease	D007674	11583940
toxicity	I-Disease	-1	11583940
.	O	-1	11583940
Ac@@	O	-1	11583940
ute	O	-1	11583940
nephro@@	B-Disease	D007674	11583940
toxicity	I-Disease	-1	11583940
,	O	-1	11583940
which	O	-1	11583940
occur@@	O	-1	11583940
s	O	-1	11583940
in	O	-1	11583940
the	O	-1	11583940
early	O	-1	11583940
period	O	-1	11583940
after	O	-1	11583940
transplant@@	O	-1	11583940
ation,	O	-1	11583940
lead@@	O	-1	11583940
s	O	-1	11583940
to	O	-1	11583940
a	O	-1	11583940
higher	O	-1	11583940
rate	O	-1	11583940
of	O	-1	11583940
dialy@@	O	-1	11583940
sis,	O	-1	11583940
and	O	-1	11583940
chronic	O	-1	11583940
nephro@@	B-Disease	D007674	11583940
toxicity	I-Disease	-1	11583940
may	O	-1	11583940
event@@	O	-1	11583940
ually	O	-1	11583940
result	O	-1	11583940
in	O	-1	11583940
gra@@	O	-1	11583940
ft	O	-1	11583940
los@@	O	-1	11583940
s.	O	-1	11583940
Ac@@	O	-1	11583940
ute	O	-1	11583940
and	O	-1	11583940
chronic	O	-1	11583940
nephro@@	B-Disease	D007674	11583940
toxicity	I-Disease	-1	11583940
is	O	-1	11583940
b@@	O	-1	11583940
ec@@	O	-1	11583940
om@@	O	-1	11583940
ing	O	-1	11583940
more	O	-1	11583940
common	O	-1	11583940
as	O	-1	11583940
the	O	-1	11583940
use	O	-1	11583940
of	O	-1	11583940
m@@	O	-1	11583940
arg@@	O	-1	11583940
inal	O	-1	11583940
kidne@@	O	-1	11583940
ys	O	-1	11583940
for	O	-1	11583940
transplant@@	O	-1	11583940
ation	O	-1	11583940
increas@@	O	-1	11583940
es.	O	-1	11583940
Two	O	-1	11583940
rec@@	O	-1	11583940
ently	O	-1	11583940
av@@	O	-1	11583940
ail@@	O	-1	11583940
able	O	-1	11583940
immunosup@@	O	-1	11583940
pressive	O	-1	11583940
agent@@	O	-1	11583940
s,	O	-1	11583940
my@@	B-Chemical	C063008	11583940
co@@	I-Chemical	-1	11583940
phen@@	I-Chemical	-1	11583940
ol@@	I-Chemical	-1	11583940
ate	I-Chemical	-1	11583940
mo@@	I-Chemical	-1	11583940
fe@@	I-Chemical	-1	11583940
ti@@	I-Chemical	-1	11583940
l	I-Chemical	-1	11583940
and	O	-1	11583940
sirolimus	B-Chemical	D020123	11583940
(	O	-1	11583940
ra@@	B-Chemical	D020123	11583940
p@@	I-Chemical	-1	11583940
am@@	I-Chemical	-1	11583940
ycin	I-Chemical	-1	11583940
),	O	-1	11583940
have	O	-1	11583940
no	O	-1	11583940
nephro@@	B-Disease	D007674	11583940
toxicity	I-Disease	-1	11583940
.	O	-1	11583940
The	O	-1	11583940
use	O	-1	11583940
of	O	-1	11583940
these	O	-1	11583940
drugs	O	-1	11583940
in	O	-1	11583940
combination	O	-1	11583940
with	O	-1	11583940
other	O	-1	11583940
agents	O	-1	11583940
has	O	-1	11583940
l@@	O	-1	11583940
ed	O	-1	11583940
to	O	-1	11583940
the	O	-1	11583940
development	O	-1	11583940
of	O	-1	11583940
new	O	-1	11583940
par@@	O	-1	11583940
a@@	O	-1	11583940
di@@	O	-1	11583940
g@@	O	-1	11583940
ms	O	-1	11583940
of	O	-1	11583940
immunosup@@	O	-1	11583940
pressive	O	-1	11583940
therapy.	O	-1	11583940
This	O	-1	11583940
pap@@	O	-1	11583940
er	O	-1	11583940
revie@@	O	-1	11583940
w@@	O	-1	11583940
s	O	-1	11583940
the	O	-1	11583940
results	O	-1	11583940
of	O	-1	11583940
clinical	O	-1	11583940
tri@@	O	-1	11583940
als	O	-1	11583940
that	O	-1	11583940
have	O	-1	11583940
investigated	O	-1	11583940
these	O	-1	11583940
new	O	-1	11583940
appro@@	O	-1	11583940
ac@@	O	-1	11583940
h@@	O	-1	11583940
es	O	-1	11583940
to	O	-1	11583940
immunosup@@	O	-1	11583940
pression	O	-1	11583940
in	O	-1	11583940
renal	O	-1	11583940
transplant	O	-1	11583940
re@@	O	-1	11583940
ci@@	O	-1	11583940
pi@@	O	-1	11583940
ent@@	O	-1	11583940
s.	O	-1	11583940

E@@	O	-1	11245434
r@@	O	-1	11245434
y@@	O	-1	11245434
th@@	O	-1	11245434
ro@@	O	-1	11245434
po@@	O	-1	11245434
i@@	O	-1	11245434
e@@	O	-1	11245434
tin	O	-1	11245434
re@@	O	-1	11245434
sto@@	O	-1	11245434
res	O	-1	11245434
the	O	-1	11245434
anemia	B-Disease	D000740	11245434
-induced	O	-1	11245434
reduction	O	-1	11245434
in	O	-1	11245434
cyclophosph@@	B-Chemical	D003520	11245434
amide	I-Chemical	-1	11245434
cy@@	B-Disease	D064420	11245434
tot@@	I-Disease	-1	11245434
oxic@@	I-Disease	-1	11245434
ity	I-Disease	-1	11245434
in	O	-1	11245434
rat	O	-1	11245434
tu@@	B-Disease	D009369	11245434
mor@@	I-Disease	-1	11245434
s	I-Disease	-1	11245434
.	O	-1	11245434
The	O	-1	11245434
a@@	O	-1	11245434
im	O	-1	11245434
of	O	-1	11245434
this	O	-1	11245434
study	O	-1	11245434
was	O	-1	11245434
to	O	-1	11245434
ex@@	O	-1	11245434
amine	O	-1	11245434
the	O	-1	11245434
im@@	O	-1	11245434
pac@@	O	-1	11245434
t	O	-1	11245434
of	O	-1	11245434
anemia	B-Disease	D000740	11245434
pre@@	O	-1	11245434
ven@@	O	-1	11245434
tion	O	-1	11245434
by	O	-1	11245434
re@@	O	-1	11245434
combin@@	O	-1	11245434
ant	O	-1	11245434
human	O	-1	11245434
erythro@@	O	-1	11245434
po@@	O	-1	11245434
i@@	O	-1	11245434
e@@	O	-1	11245434
tin	O	-1	11245434
(@@	O	-1	11245434
r@@	O	-1	11245434
H@@	O	-1	11245434
u@@	O	-1	11245434
EP@@	O	-1	11245434
O@@	O	-1	11245434
)	O	-1	11245434
treatment	O	-1	11245434
on	O	-1	11245434
the	O	-1	11245434
cy@@	B-Disease	D064420	11245434
tot@@	I-Disease	-1	11245434
oxic@@	I-Disease	-1	11245434
ity	I-Disease	-1	11245434
of	O	-1	11245434
cyclophosph@@	B-Chemical	D003520	11245434
amide	I-Chemical	-1	11245434
in	O	-1	11245434
sol@@	O	-1	11245434
id	O	-1	11245434
experimental	O	-1	11245434
tu@@	B-Disease	D009369	11245434
mor@@	I-Disease	-1	11245434
s	I-Disease	-1	11245434
.	O	-1	11245434
A@@	B-Disease	D000740	11245434
ne@@	I-Disease	-1	11245434
mia	I-Disease	-1	11245434
was	O	-1	11245434
induced	O	-1	11245434
using	O	-1	11245434
a	O	-1	11245434
single	O	-1	11245434
dose	O	-1	11245434
of	O	-1	11245434
car@@	B-Chemical	D016190	11245434
bo@@	I-Chemical	-1	11245434
pl@@	I-Chemical	-1	11245434
atin	I-Chemical	-1	11245434
(@@	O	-1	11245434
50	O	-1	11245434
mg/kg	O	-1	11245434
i.v@@	O	-1	11245434
.)	O	-1	11245434
result@@	O	-1	11245434
ing	O	-1	11245434
in	O	-1	11245434
a	O	-1	11245434
long@@	O	-1	11245434
-@@	O	-1	11245434
l@@	O	-1	11245434
ast@@	O	-1	11245434
ing	O	-1	11245434
reduction	O	-1	11245434
(3@@	O	-1	11245434
0@@	O	-1	11245434
%)	O	-1	11245434
of	O	-1	11245434
the	O	-1	11245434
hemo@@	O	-1	11245434
globin	O	-1	11245434
concentr@@	O	-1	11245434
ation.	O	-1	11245434
In	O	-1	11245434
a	O	-1	11245434
second	O	-1	11245434
group@@	O	-1	11245434
,	O	-1	11245434
the	O	-1	11245434
development	O	-1	11245434
of	O	-1	11245434
anemia	B-Disease	D000740	11245434
was	O	-1	11245434
prevent@@	O	-1	11245434
ed	O	-1	11245434
by	O	-1	11245434
r@@	O	-1	11245434
H@@	O	-1	11245434
u@@	O	-1	11245434
EP@@	O	-1	11245434
O	O	-1	11245434
(@@	O	-1	11245434
10@@	O	-1	11245434
00	O	-1	11245434
I@@	O	-1	11245434
U@@	O	-1	11245434
/@@	O	-1	11245434
kg@@	O	-1	11245434
)	O	-1	11245434
administered	O	-1	11245434
s@@	O	-1	11245434
.@@	O	-1	11245434
c@@	O	-1	11245434
.	O	-1	11245434
three	O	-1	11245434
tim@@	O	-1	11245434
es@@	O	-1	11245434
/@@	O	-1	11245434
week	O	-1	11245434
star@@	O	-1	11245434
ting	O	-1	11245434
7	O	-1	11245434
days	O	-1	11245434
before	O	-1	11245434
car@@	B-Chemical	D016190	11245434
bo@@	I-Chemical	-1	11245434
pl@@	I-Chemical	-1	11245434
atin	I-Chemical	-1	11245434
ap@@	O	-1	11245434
plic@@	O	-1	11245434
ation.	O	-1	11245434
F@@	O	-1	11245434
our	O	-1	11245434
days	O	-1	11245434
after	O	-1	11245434
car@@	B-Chemical	D016190	11245434
bo@@	I-Chemical	-1	11245434
pl@@	I-Chemical	-1	11245434
atin	I-Chemical	-1	11245434
treatment,	O	-1	11245434
tu@@	B-Disease	D009369	11245434
mor@@	I-Disease	-1	11245434
s	I-Disease	-1	11245434
(D@@	O	-1	11245434
S@@	O	-1	11245434
-	O	-1	11245434
s@@	B-Disease	D012509	11245434
ar@@	I-Disease	-1	11245434
com@@	I-Disease	-1	11245434
a	I-Disease	-1	11245434
of	O	-1	11245434
the	O	-1	11245434
rat@@	O	-1	11245434
)	O	-1	11245434
were	O	-1	11245434
im@@	O	-1	11245434
pl@@	O	-1	11245434
ant@@	O	-1	11245434
ed	O	-1	11245434
s@@	O	-1	11245434
.@@	O	-1	11245434
c@@	O	-1	11245434
.	O	-1	11245434
on@@	O	-1	11245434
to	O	-1	11245434
the	O	-1	11245434
h@@	O	-1	11245434
ind	O	-1	11245434
fo@@	O	-1	11245434
od	O	-1	11245434
d@@	O	-1	11245434
or@@	O	-1	11245434
su@@	O	-1	11245434
m.	O	-1	11245434
N@@	O	-1	11245434
either	O	-1	11245434
car@@	B-Chemical	D016190	11245434
bo@@	I-Chemical	-1	11245434
pl@@	I-Chemical	-1	11245434
atin	I-Chemical	-1	11245434
n@@	O	-1	11245434
or	O	-1	11245434
r@@	O	-1	11245434
H@@	O	-1	11245434
u@@	O	-1	11245434
EP@@	O	-1	11245434
O	O	-1	11245434
treatment	O	-1	11245434
influ@@	O	-1	11245434
enc@@	O	-1	11245434
ed	O	-1	11245434
tumor	B-Disease	D009369	11245434
growth	O	-1	11245434
rate	O	-1	11245434
per	O	-1	11245434
se.	O	-1	11245434
Whe@@	O	-1	11245434
n	O	-1	11245434
tu@@	B-Disease	D009369	11245434
mor@@	I-Disease	-1	11245434
s	I-Disease	-1	11245434
were	O	-1	11245434
treated	O	-1	11245434
with	O	-1	11245434
a	O	-1	11245434
single	O	-1	11245434
dose	O	-1	11245434
of	O	-1	11245434
cyclophosph@@	B-Chemical	D003520	11245434
amide	I-Chemical	-1	11245434
(@@	O	-1	11245434
60	O	-1	11245434
mg/kg	O	-1	11245434
i.p.@@	O	-1	11245434
)	O	-1	11245434
5	O	-1	11245434
days	O	-1	11245434
after	O	-1	11245434
im@@	O	-1	11245434
pl@@	O	-1	11245434
ant@@	O	-1	11245434
ation,	O	-1	11245434
a	O	-1	11245434
growth	O	-1	11245434
del@@	O	-1	11245434
ay	O	-1	11245434
with	O	-1	11245434
a	O	-1	11245434
subsequ@@	O	-1	11245434
ent	O	-1	11245434
reg@@	O	-1	11245434
row@@	O	-1	11245434
th	O	-1	11245434
of	O	-1	11245434
the	O	-1	11245434
tu@@	B-Disease	D009369	11245434
mor@@	I-Disease	-1	11245434
s	I-Disease	-1	11245434
was	O	-1	11245434
obser@@	O	-1	11245434
ved.	O	-1	11245434
In	O	-1	11245434
the	O	-1	11245434
anemia	B-Disease	D000740	11245434
group@@	O	-1	11245434
,	O	-1	11245434
the	O	-1	11245434
growth	O	-1	11245434
del@@	O	-1	11245434
ay	O	-1	11245434
was	O	-1	11245434
significantly	O	-1	11245434
sh@@	O	-1	11245434
or@@	O	-1	11245434
ter	O	-1	11245434
compared	O	-1	11245434
with	O	-1	11245434
non@@	O	-1	11245434
an@@	O	-1	11245434
em@@	O	-1	11245434
ic	O	-1	11245434
controls	O	-1	11245434
(1@@	O	-1	11245434
3.@@	O	-1	11245434
3	O	-1	11245434
days	O	-1	11245434
versus	O	-1	11245434
8.@@	O	-1	11245434
6	O	-1	11245434
da@@	O	-1	11245434
ys@@	O	-1	11245434
).	O	-1	11245434
In	O	-1	11245434
the	O	-1	11245434
group	O	-1	11245434
wh@@	O	-1	11245434
ere	O	-1	11245434
anemia	B-Disease	D000740	11245434
was	O	-1	11245434
prevent@@	O	-1	11245434
ed	O	-1	11245434
by	O	-1	11245434
r@@	O	-1	11245434
H@@	O	-1	11245434
u@@	O	-1	11245434
EP@@	O	-1	11245434
O	O	-1	11245434
treatment,	O	-1	11245434
growth	O	-1	11245434
del@@	O	-1	11245434
ay	O	-1	11245434
was	O	-1	11245434
compar@@	O	-1	11245434
able	O	-1	11245434
with	O	-1	11245434
that	O	-1	11245434
of	O	-1	11245434
non@@	O	-1	11245434
an@@	O	-1	11245434
em@@	O	-1	11245434
ic	O	-1	11245434
controls	O	-1	11245434
(1@@	O	-1	11245434
3.@@	O	-1	11245434
3	O	-1	11245434
da@@	O	-1	11245434
ys@@	O	-1	11245434
).	O	-1	11245434
These	O	-1	11245434
results	O	-1	11245434
suggest	O	-1	11245434
that	O	-1	11245434
chemo@@	O	-1	11245434
therap@@	O	-1	11245434
y@@	O	-1	11245434
-induced	O	-1	11245434
anemia	B-Disease	D000740	11245434
reduc@@	O	-1	11245434
es	O	-1	11245434
cy@@	B-Disease	D064420	11245434
tot@@	I-Disease	-1	11245434
oxic@@	I-Disease	-1	11245434
ity	I-Disease	-1	11245434
of	O	-1	11245434
cyclophosph@@	B-Chemical	D003520	11245434
amide	I-Chemical	-1	11245434
in	O	-1	11245434
tu@@	B-Disease	D009369	11245434
mor@@	I-Disease	-1	11245434
s	I-Disease	-1	11245434
,	O	-1	11245434
whereas	O	-1	11245434
cor@@	O	-1	11245434
rec@@	O	-1	11245434
tion	O	-1	11245434
of	O	-1	11245434
anemia	B-Disease	D000740	11245434
by	O	-1	11245434
r@@	O	-1	11245434
H@@	O	-1	11245434
u@@	O	-1	11245434
EP@@	O	-1	11245434
O	O	-1	11245434
treatment	O	-1	11245434
(@@	O	-1	11245434
e@@	O	-1	11245434
po@@	O	-1	11245434
e@@	O	-1	11245434
tin	O	-1	11245434
alpha@@	O	-1	11245434
)	O	-1	11245434
increases	O	-1	11245434
the	O	-1	11245434
sensi@@	O	-1	11245434
tiv@@	O	-1	11245434
ity,	O	-1	11245434
prob@@	O	-1	11245434
ably	O	-1	11245434
as	O	-1	11245434
a	O	-1	11245434
result	O	-1	11245434
of	O	-1	11245434
an	O	-1	11245434
improved	O	-1	11245434
oxy@@	B-Chemical	D010100	11245434
gen	I-Chemical	-1	11245434
sup@@	O	-1	11245434
p@@	O	-1	11245434
ly	O	-1	11245434
to	O	-1	11245434
tumor	B-Disease	D009369	11245434
tissu@@	O	-1	11245434
e.	O	-1	11245434

The	O	-1	11243580
role	O	-1	11243580
of	O	-1	11243580
nit@@	O	-1	11243580
re@@	O	-1	11243580
r@@	O	-1	11243580
g@@	O	-1	11243580
ic	O	-1	11243580
system	O	-1	11243580
in	O	-1	11243580
lidocaine	B-Chemical	D008012	11243580
-induced	O	-1	11243580
convul@@	B-Disease	D012640	11243580
sion	I-Disease	-1	11243580
in	O	-1	11243580
the	O	-1	11243580
mou@@	O	-1	11243580
se.	O	-1	11243580
The	O	-1	11243580
effects	O	-1	11243580
of	O	-1	11243580
N@@	B-Chemical	D019331	11243580
-@@	I-Chemical	-1	11243580
nitro@@	I-Chemical	-1	11243580
-@@	I-Chemical	-1	11243580
L-@@	I-Chemical	-1	11243580
arg@@	I-Chemical	-1	11243580
in@@	I-Chemical	-1	11243580
ine-@@	I-Chemical	-1	11243580
meth@@	I-Chemical	-1	11243580
yl	I-Chemical	-1	11243580
est@@	I-Chemical	-1	11243580
er	I-Chemical	-1	11243580
(	O	-1	11243580
L-@@	B-Chemical	D019331	11243580
N@@	I-Chemical	-1	11243580
AM@@	I-Chemical	-1	11243580
E	I-Chemical	-1	11243580
)	O	-1	11243580
a	O	-1	11243580
nit@@	B-Chemical	D009569	11243580
ric	I-Chemical	-1	11243580
ox@@	I-Chemical	-1	11243580
ide	I-Chemical	-1	11243580
(	O	-1	11243580
N@@	B-Chemical	D009569	11243580
O	I-Chemical	-1	11243580
)	O	-1	11243580
syn@@	O	-1	11243580
th@@	O	-1	11243580
ase	O	-1	11243580
inhibitor	O	-1	11243580
and	O	-1	11243580
L-@@	B-Chemical	D001120	11243580
arg@@	I-Chemical	-1	11243580
inine	I-Chemical	-1	11243580
,	O	-1	11243580
a	O	-1	11243580
N@@	B-Chemical	D009569	11243580
O	I-Chemical	-1	11243580
pre@@	O	-1	11243580
cur@@	O	-1	11243580
s@@	O	-1	11243580
or@@	O	-1	11243580
,	O	-1	11243580
were	O	-1	11243580
investigated	O	-1	11243580
on	O	-1	11243580
lidocaine	B-Chemical	D008012	11243580
-induced	O	-1	11243580
convul@@	B-Disease	D012640	11243580
sions	I-Disease	-1	11243580
.	O	-1	11243580
In	O	-1	11243580
the	O	-1	11243580
first	O	-1	11243580
experim@@	O	-1	11243580
ent@@	O	-1	11243580
,	O	-1	11243580
four	O	-1	11243580
groups	O	-1	11243580
of	O	-1	11243580
mice	O	-1	11243580
received	O	-1	11243580
physi@@	O	-1	11243580
ological	O	-1	11243580
saline	O	-1	11243580
(0.@@	O	-1	11243580
9@@	O	-1	11243580
%),	O	-1	11243580
L-@@	B-Chemical	D001120	11243580
arg@@	I-Chemical	-1	11243580
inine	I-Chemical	-1	11243580
(3@@	O	-1	11243580
00	O	-1	11243580
mg/kg@@	O	-1	11243580
,	O	-1	11243580
i.p.@@	O	-1	11243580
),	O	-1	11243580
L-@@	B-Chemical	D019331	11243580
N@@	I-Chemical	-1	11243580
AM@@	I-Chemical	-1	11243580
E	I-Chemical	-1	11243580
(@@	O	-1	11243580
100	O	-1	11243580
mg/kg@@	O	-1	11243580
,	O	-1	11243580
i.p.@@	O	-1	11243580
)	O	-1	11243580
and	O	-1	11243580
di@@	B-Chemical	D003975	11243580
az@@	I-Chemical	-1	11243580
epam	I-Chemical	-1	11243580
(@@	O	-1	11243580
2	O	-1	11243580
mg/kg@@	O	-1	11243580
),	O	-1	11243580
respectively.	O	-1	11243580
Th@@	O	-1	11243580
ir@@	O	-1	11243580
t@@	O	-1	11243580
y	O	-1	11243580
minutes	O	-1	11243580
after	O	-1	11243580
these	O	-1	11243580
injec@@	O	-1	11243580
tion@@	O	-1	11243580
s,	O	-1	11243580
all	O	-1	11243580
mice	O	-1	11243580
received	O	-1	11243580
lidocaine	B-Chemical	D008012	11243580
(@@	O	-1	11243580
50	O	-1	11243580
mg/kg@@	O	-1	11243580
,	O	-1	11243580
i.p.@@	O	-1	11243580
).	O	-1	11243580
In	O	-1	11243580
the	O	-1	11243580
second	O	-1	11243580
experim@@	O	-1	11243580
ent@@	O	-1	11243580
,	O	-1	11243580
four	O	-1	11243580
groups	O	-1	11243580
of	O	-1	11243580
mice	O	-1	11243580
received	O	-1	11243580
similar	O	-1	11243580
treatment	O	-1	11243580
in	O	-1	11243580
the	O	-1	11243580
first	O	-1	11243580
experim@@	O	-1	11243580
ent@@	O	-1	11243580
,	O	-1	11243580
and	O	-1	11243580
30	O	-1	11243580
min	O	-1	11243580
after	O	-1	11243580
these	O	-1	11243580
injec@@	O	-1	11243580
tion@@	O	-1	11243580
s,	O	-1	11243580
all	O	-1	11243580
mice	O	-1	11243580
received	O	-1	11243580
a	O	-1	11243580
higher	O	-1	11243580
dose	O	-1	11243580
of	O	-1	11243580
lidocaine	B-Chemical	D008012	11243580
(@@	O	-1	11243580
8@@	O	-1	11243580
0	O	-1	11243580
mg/kg@@	O	-1	11243580
).	O	-1	11243580
L-@@	B-Chemical	D019331	11243580
N@@	I-Chemical	-1	11243580
AM@@	I-Chemical	-1	11243580
E	I-Chemical	-1	11243580
(@@	O	-1	11243580
100	O	-1	11243580
mg/kg@@	O	-1	11243580
,	O	-1	11243580
i.p.@@	O	-1	11243580
)	O	-1	11243580
and	O	-1	11243580
di@@	B-Chemical	D003975	11243580
az@@	I-Chemical	-1	11243580
epam	I-Chemical	-1	11243580
(@@	O	-1	11243580
2	O	-1	11243580
mg/kg)	O	-1	11243580
significantly	O	-1	11243580
decreased	O	-1	11243580
the	O	-1	11243580
incidence	O	-1	11243580
of	O	-1	11243580
lidocaine	B-Chemical	D008012	11243580
(@@	O	-1	11243580
50	O	-1	11243580
mg/kg@@	O	-1	11243580
)@@	O	-1	11243580
-induced	O	-1	11243580
convul@@	B-Disease	D012640	11243580
sions	I-Disease	-1	11243580
.	O	-1	11243580
In	O	-1	11243580
contrast@@	O	-1	11243580
,	O	-1	11243580
the	O	-1	11243580
L-@@	B-Chemical	D001120	11243580
arg@@	I-Chemical	-1	11243580
inine	I-Chemical	-1	11243580
treatment	O	-1	11243580
increased	O	-1	11243580
the	O	-1	11243580
incidence	O	-1	11243580
of	O	-1	11243580
lidocaine	B-Chemical	D008012	11243580
(@@	O	-1	11243580
8@@	O	-1	11243580
0	O	-1	11243580
mg/kg@@	O	-1	11243580
,	O	-1	11243580
i.p.@@	O	-1	11243580
)@@	O	-1	11243580
-induced	O	-1	11243580
convul@@	B-Disease	D012640	11243580
sions	I-Disease	-1	11243580
significant@@	O	-1	11243580
ly.	O	-1	11243580
These	O	-1	11243580
results	O	-1	11243580
may	O	-1	11243580
suggest	O	-1	11243580
that	O	-1	11243580
N@@	B-Chemical	D009569	11243580
O	I-Chemical	-1	11243580
is	O	-1	11243580
a	O	-1	11243580
pro@@	O	-1	11243580
convul@@	O	-1	11243580
s@@	O	-1	11243580
ant	O	-1	11243580
medi@@	O	-1	11243580
at@@	O	-1	11243580
or	O	-1	11243580
in	O	-1	11243580
lidocaine	B-Chemical	D008012	11243580
-induced	O	-1	11243580
convul@@	B-Disease	D012640	11243580
sions	I-Disease	-1	11243580
.	O	-1	11243580

Eff@@	O	-1	11079278
ect	O	-1	11079278
of	O	-1	11079278
intravenous	O	-1	11079278
me@@	B-Chemical	D008790	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
or	O	-1	11079278
intravenous	O	-1	11079278
me@@	B-Chemical	D008790	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
plus	O	-1	11079278
gl@@	O	-1	11079278
uc@@	O	-1	11079278
ag@@	O	-1	11079278
on	O	-1	11079278
on	O	-1	11079278
do@@	B-Chemical	D004280	11079278
but@@	I-Chemical	-1	11079278
amine	I-Chemical	-1	11079278
-induced	O	-1	11079278
myocardial	B-Disease	D017202	11079278
ischem@@	I-Disease	-1	11079278
ia	I-Disease	-1	11079278
.	O	-1	11079278
S@@	O	-1	11079278
T@@	O	-1	11079278
U@@	O	-1	11079278
D@@	O	-1	11079278
Y	O	-1	11079278
OBJECTIVE:	O	-1	11079278
To	O	-1	11079278
determine	O	-1	11079278
the	O	-1	11079278
effect	O	-1	11079278
of	O	-1	11079278
me@@	B-Chemical	D008790	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
on	O	-1	11079278
do@@	B-Chemical	D004280	11079278
but@@	I-Chemical	-1	11079278
amine	I-Chemical	-1	11079278
stres@@	O	-1	11079278
s	O	-1	11079278
test@@	O	-1	11079278
ing	O	-1	11079278
with	O	-1	11079278
t@@	B-Chemical	D017256	11079278
ech@@	I-Chemical	-1	11079278
ne@@	I-Chemical	-1	11079278
ti@@	I-Chemical	-1	11079278
um@@	I-Chemical	-1	11079278
-@@	I-Chemical	-1	11079278
9@@	I-Chemical	-1	11079278
9@@	I-Chemical	-1	11079278
m	I-Chemical	-1	11079278
se@@	I-Chemical	-1	11079278
st@@	I-Chemical	-1	11079278
ami@@	I-Chemical	-1	11079278
b@@	I-Chemical	-1	11079278
i	I-Chemical	-1	11079278
sing@@	O	-1	11079278
le@@	O	-1	11079278
-@@	O	-1	11079278
ph@@	O	-1	11079278
ot@@	O	-1	11079278
on	O	-1	11079278
em@@	O	-1	11079278
is@@	O	-1	11079278
sion	O	-1	11079278
comp@@	O	-1	11079278
ut@@	O	-1	11079278
ed	O	-1	11079278
to@@	O	-1	11079278
mo@@	O	-1	11079278
graph@@	O	-1	11079278
y	O	-1	11079278
imaging	O	-1	11079278
and	O	-1	11079278
S@@	O	-1	11079278
T@@	O	-1	11079278
-@@	O	-1	11079278
seg@@	O	-1	11079278
ment	O	-1	11079278
monit@@	O	-1	11079278
or@@	O	-1	11079278
ing,	O	-1	11079278
and	O	-1	11079278
to	O	-1	11079278
ass@@	O	-1	11079278
ess	O	-1	11079278
the	O	-1	11079278
im@@	O	-1	11079278
pac@@	O	-1	11079278
t	O	-1	11079278
of	O	-1	11079278
intravenous	O	-1	11079278
gl@@	O	-1	11079278
uc@@	O	-1	11079278
ag@@	O	-1	11079278
on	O	-1	11079278
on	O	-1	11079278
me@@	B-Chemical	D008790	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
's	O	-1	11079278
effects.	O	-1	11079278
D@@	O	-1	11079278
ES@@	O	-1	11079278
I@@	O	-1	11079278
G@@	O	-1	11079278
N@@	O	-1	11079278
:	O	-1	11079278
R@@	O	-1	11079278
an@@	O	-1	11079278
dom@@	O	-1	11079278
iz@@	O	-1	11079278
ed,	O	-1	11079278
double-bl@@	O	-1	11079278
ind@@	O	-1	11079278
,	O	-1	11079278
placebo@@	O	-1	11079278
-@@	O	-1	11079278
controlled	O	-1	11079278
tri@@	O	-1	11079278
al.	O	-1	11079278
S@@	O	-1	11079278
ET@@	O	-1	11079278
TI@@	O	-1	11079278
N@@	O	-1	11079278
G@@	O	-1	11079278
:	O	-1	11079278
Com@@	O	-1	11079278
mun@@	O	-1	11079278
ity	O	-1	11079278
hospit@@	O	-1	11079278
al.	O	-1	11079278
PA@@	O	-1	11079278
TI@@	O	-1	11079278
E@@	O	-1	11079278
N@@	O	-1	11079278
T@@	O	-1	11079278
S:	O	-1	11079278
Tw@@	O	-1	11079278
ent@@	O	-1	11079278
y-@@	O	-1	11079278
two	O	-1	11079278
patients	O	-1	11079278
with	O	-1	11079278
known	O	-1	11079278
reversible	O	-1	11079278
per@@	O	-1	11079278
f@@	O	-1	11079278
usion	O	-1	11079278
def@@	O	-1	11079278
ect@@	O	-1	11079278
s.	O	-1	11079278
IN@@	O	-1	11079278
TE@@	O	-1	11079278
R@@	O	-1	11079278
V@@	O	-1	11079278
E@@	O	-1	11079278
N@@	O	-1	11079278
T@@	O	-1	11079278
ION@@	O	-1	11079278
:	O	-1	11079278
Patients	O	-1	11079278
under@@	O	-1	11079278
w@@	O	-1	11079278
ent	O	-1	11079278
do@@	B-Chemical	D004280	11079278
but@@	I-Chemical	-1	11079278
amine	I-Chemical	-1	11079278
stres@@	O	-1	11079278
s	O	-1	11079278
tests	O	-1	11079278
per	O	-1	11079278
standard	O	-1	11079278
pro@@	O	-1	11079278
to@@	O	-1	11079278
co@@	O	-1	11079278
l@@	O	-1	11079278
.	O	-1	11079278
B@@	O	-1	11079278
e@@	O	-1	11079278
fore	O	-1	11079278
do@@	B-Chemical	D004280	11079278
but@@	I-Chemical	-1	11079278
amine	I-Chemical	-1	11079278
was	O	-1	11079278
be@@	O	-1	11079278
g@@	O	-1	11079278
un@@	O	-1	11079278
,	O	-1	11079278
no	O	-1	11079278
therapy	O	-1	11079278
was	O	-1	11079278
given	O	-1	11079278
during	O	-1	11079278
the	O	-1	11079278
first	O	-1	11079278
v@@	O	-1	11079278
is@@	O	-1	11079278
it@@	O	-1	11079278
,	O	-1	11079278
and	O	-1	11079278
patients	O	-1	11079278
were	O	-1	11079278
randomized	O	-1	11079278
on	O	-1	11079278
subsequ@@	O	-1	11079278
ent	O	-1	11079278
v@@	O	-1	11079278
is@@	O	-1	11079278
its	O	-1	11079278
to	O	-1	11079278
recei@@	O	-1	11079278
ve	O	-1	11079278
me@@	B-Chemical	D008790	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
or	O	-1	11079278
me@@	B-Chemical	D008790	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
plus	O	-1	11079278
gl@@	O	-1	11079278
uc@@	O	-1	11079278
ag@@	O	-1	11079278
on	O	-1	11079278
1	O	-1	11079278
mg@@	O	-1	11079278
.	O	-1	11079278
M@@	B-Chemical	D008790	11079278
e@@	I-Chemical	-1	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
was	O	-1	11079278
dos@@	O	-1	11079278
ed	O	-1	11079278
to	O	-1	11079278
achi@@	O	-1	11079278
e@@	O	-1	11079278
ve	O	-1	11079278
a	O	-1	11079278
rest@@	O	-1	11079278
ing	O	-1	11079278
pre@@	B-Chemical	-1	11079278
do@@	I-Chemical	-1	11079278
but@@	I-Chemical	-1	11079278
amine	I-Chemical	-1	11079278
heart	O	-1	11079278
rate	O	-1	11079278
be@@	O	-1	11079278
low	O	-1	11079278
6@@	O	-1	11079278
5	O	-1	11079278
be@@	O	-1	11079278
at@@	O	-1	11079278
s/@@	O	-1	11079278
min@@	O	-1	11079278
ute	O	-1	11079278
or	O	-1	11079278
a	O	-1	11079278
total	O	-1	11079278
intravenous	O	-1	11079278
dose	O	-1	11079278
of	O	-1	11079278
20	O	-1	11079278
mg@@	O	-1	11079278
.	O	-1	11079278
M@@	O	-1	11079278
E@@	O	-1	11079278
A@@	O	-1	11079278
S@@	O	-1	11079278
U@@	O	-1	11079278
R@@	O	-1	11079278
E@@	O	-1	11079278
M@@	O	-1	11079278
E@@	O	-1	11079278
N@@	O	-1	11079278
T@@	O	-1	11079278
S	O	-1	11079278
AN@@	O	-1	11079278
D	O	-1	11079278
MA@@	O	-1	11079278
I@@	O	-1	11079278
N	O	-1	11079278
RESULTS:	O	-1	11079278
M@@	B-Chemical	D008790	11079278
e@@	I-Chemical	-1	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
reduced	O	-1	11079278
maxim@@	O	-1	11079278
um	O	-1	11079278
heart	O	-1	11079278
rate	O	-1	11079278
3@@	O	-1	11079278
1@@	O	-1	11079278
%,	O	-1	11079278
su@@	O	-1	11079278
mm@@	O	-1	11079278
ed	O	-1	11079278
stres@@	O	-1	11079278
s	O	-1	11079278
sco@@	O	-1	11079278
res	O	-1	11079278
2@@	O	-1	11079278
9@@	O	-1	11079278
%,	O	-1	11079278
and	O	-1	11079278
su@@	O	-1	11079278
mm@@	O	-1	11079278
ed	O	-1	11079278
difference	O	-1	11079278
sco@@	O	-1	11079278
res	O	-1	11079278
4@@	O	-1	11079278
3@@	O	-1	11079278
%	O	-1	11079278
versus	O	-1	11079278
control@@	O	-1	11079278
.	O	-1	11079278
M@@	B-Chemical	D008790	11079278
e@@	I-Chemical	-1	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
plus	O	-1	11079278
gl@@	O	-1	11079278
uc@@	O	-1	11079278
ag@@	O	-1	11079278
on	O	-1	11079278
also	O	-1	11079278
reduced	O	-1	11079278
the	O	-1	11079278
maxim@@	O	-1	11079278
um	O	-1	11079278
heart	O	-1	11079278
rate	O	-1	11079278
2@@	O	-1	11079278
9@@	O	-1	11079278
%	O	-1	11079278
versus	O	-1	11079278
control@@	O	-1	11079278
.	O	-1	11079278
S@@	O	-1	11079278
um@@	O	-1	11079278
m@@	O	-1	11079278
ed	O	-1	11079278
stres@@	O	-1	11079278
s	O	-1	11079278
and	O	-1	11079278
su@@	O	-1	11079278
mm@@	O	-1	11079278
ed	O	-1	11079278
difference	O	-1	11079278
sco@@	O	-1	11079278
res	O	-1	11079278
were	O	-1	11079278
not	O	-1	11079278
significantly	O	-1	11079278
reduc@@	O	-1	11079278
ed,	O	-1	11079278
although	O	-1	11079278
they	O	-1	11079278
were	O	-1	11079278
18@@	O	-1	11079278
%	O	-1	11079278
and	O	-1	11079278
3@@	O	-1	11079278
0%	O	-1	11079278
low@@	O	-1	11079278
er,	O	-1	11079278
respectivel@@	O	-1	11079278
y,	O	-1	11079278
than	O	-1	11079278
control@@	O	-1	11079278
.	O	-1	11079278
No	O	-1	11079278
significant	O	-1	11079278
differences	O	-1	11079278
were	O	-1	11079278
found	O	-1	11079278
in	O	-1	11079278
any	O	-1	11079278
par@@	O	-1	11079278
ame@@	O	-1	11079278
ter	O	-1	11079278
between	O	-1	11079278
me@@	B-Chemical	D008790	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
and	O	-1	11079278
me@@	B-Chemical	D008790	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
-@@	O	-1	11079278
gl@@	O	-1	11079278
uc@@	O	-1	11079278
agon@@	O	-1	11079278
.	O	-1	11079278
CONCLUSION:	O	-1	11079278
D@@	O	-1	11079278
uring	O	-1	11079278
do@@	B-Chemical	D004280	11079278
but@@	I-Chemical	-1	11079278
amine	I-Chemical	-1	11079278
stres@@	O	-1	11079278
s	O	-1	11079278
test@@	O	-1	11079278
ing,	O	-1	11079278
me@@	B-Chemical	D008790	11079278
to@@	I-Chemical	-1	11079278
pro@@	I-Chemical	-1	11079278
lol	I-Chemical	-1	11079278
attenu@@	O	-1	11079278
ates	O	-1	11079278
or	O	-1	11079278
el@@	O	-1	11079278
im@@	O	-1	11079278
in@@	O	-1	11079278
ates	O	-1	11079278
evidence	O	-1	11079278
of	O	-1	11079278
myocardial	B-Disease	D017202	11079278
ischem@@	I-Disease	-1	11079278
ia	I-Disease	-1	11079278
.	O	-1	11079278
G@@	O	-1	11079278
l@@	O	-1	11079278
uc@@	O	-1	11079278
ag@@	O	-1	11079278
on	O	-1	11079278
1	O	-1	11079278
mg@@	O	-1	11079278
,	O	-1	11079278
although	O	-1	11079278
so@@	O	-1	11079278
me@@	O	-1	11079278
wh@@	O	-1	11079278
at	O	-1	11079278
eff@@	O	-1	11079278
ecti@@	O	-1	11079278
ve,	O	-1	11079278
does	O	-1	11079278
not	O	-1	11079278
cor@@	O	-1	11079278
rec@@	O	-1	11079278
t	O	-1	11079278
this	O	-1	11079278
effect	O	-1	11079278
to	O	-1	11079278
the	O	-1	11079278
ext@@	O	-1	11079278
ent	O	-1	11079278
that	O	-1	11079278
it	O	-1	11079278
can	O	-1	11079278
be	O	-1	11079278
administered	O	-1	11079278
clin@@	O	-1	11079278
ic@@	O	-1	11079278
all@@	O	-1	11079278
y.	O	-1	11079278

Pre@@	B-Chemical	D011239	10910842
d@@	I-Chemical	-1	10910842
n@@	I-Chemical	-1	10910842
isol@@	I-Chemical	-1	10910842
one	I-Chemical	-1	10910842
-induced	O	-1	10910842
musc@@	B-Disease	D018908	10910842
le	I-Disease	-1	10910842
dysfunction	I-Disease	-1	10910842
is	O	-1	10910842
caused	O	-1	10910842
more	O	-1	10910842
by	O	-1	10910842
atro@@	B-Disease	D001284	10910842
ph@@	I-Disease	-1	10910842
y	I-Disease	-1	10910842
than	O	-1	10910842
by	O	-1	10910842
al@@	O	-1	10910842
te@@	O	-1	10910842
red	O	-1	10910842
acet@@	B-Chemical	D000109	10910842
ylcholine	I-Chemical	-1	10910842
receptor	O	-1	10910842
ex@@	O	-1	10910842
pres@@	O	-1	10910842
sion.	O	-1	10910842
L@@	O	-1	10910842
arg@@	O	-1	10910842
e	O	-1	10910842
doses	O	-1	10910842
of	O	-1	10910842
g@@	O	-1	10910842
lu@@	O	-1	10910842
co@@	O	-1	10910842
cortico@@	O	-1	10910842
id@@	O	-1	10910842
s	O	-1	10910842
can	O	-1	10910842
al@@	O	-1	10910842
ter	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
physi@@	O	-1	10910842
ology	O	-1	10910842
and	O	-1	10910842
sus@@	O	-1	10910842
cep@@	O	-1	10910842
ti@@	O	-1	10910842
b@@	O	-1	10910842
ility	O	-1	10910842
to	O	-1	10910842
neuro@@	O	-1	10910842
mus@@	O	-1	10910842
cular	O	-1	10910842
block@@	O	-1	10910842
ing	O	-1	10910842
drugs	O	-1	10910842
by	O	-1	10910842
mechanisms	O	-1	10910842
not	O	-1	10910842
clear@@	O	-1	10910842
ly	O	-1	10910842
under@@	O	-1	10910842
sto@@	O	-1	10910842
o@@	O	-1	10910842
d.	O	-1	10910842
We	O	-1	10910842
investigated	O	-1	10910842
the	O	-1	10910842
effects	O	-1	10910842
of	O	-1	10910842
moder@@	O	-1	10910842
ate	O	-1	10910842
and	O	-1	10910842
larg@@	O	-1	10910842
e	O	-1	10910842
doses	O	-1	10910842
of	O	-1	10910842
pre@@	B-Chemical	D011239	10910842
d@@	I-Chemical	-1	10910842
n@@	I-Chemical	-1	10910842
isol@@	I-Chemical	-1	10910842
one	I-Chemical	-1	10910842
on	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
function	O	-1	10910842
and	O	-1	10910842
pharmac@@	O	-1	10910842
olog@@	O	-1	10910842
y,	O	-1	10910842
and	O	-1	10910842
their	O	-1	10910842
rel@@	O	-1	10910842
ationship	O	-1	10910842
to	O	-1	10910842
changes	O	-1	10910842
in	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
size	O	-1	10910842
and	O	-1	10910842
acet@@	B-Chemical	D000109	10910842
ylcholine	I-Chemical	-1	10910842
receptor	O	-1	10910842
(@@	O	-1	10910842
AC@@	O	-1	10910842
h@@	O	-1	10910842
R@@	O	-1	10910842
)	O	-1	10910842
ex@@	O	-1	10910842
pres@@	O	-1	10910842
sion.	O	-1	10910842
W@@	O	-1	10910842
it@@	O	-1	10910842
h	O	-1	10910842
insti@@	O	-1	10910842
tu@@	O	-1	10910842
tional	O	-1	10910842
appro@@	O	-1	10910842
val@@	O	-1	10910842
,	O	-1	10910842
3@@	O	-1	10910842
5	O	-1	10910842
S@@	O	-1	10910842
pra@@	O	-1	10910842
gu@@	O	-1	10910842
e-@@	O	-1	10910842
D@@	O	-1	10910842
aw@@	O	-1	10910842
le@@	O	-1	10910842
y	O	-1	10910842
rats	O	-1	10910842
were	O	-1	10910842
random@@	O	-1	10910842
ly	O	-1	10910842
al@@	O	-1	10910842
loc@@	O	-1	10910842
ated	O	-1	10910842
to	O	-1	10910842
recei@@	O	-1	10910842
ve	O	-1	10910842
daily	O	-1	10910842
sub@@	O	-1	10910842
c@@	O	-1	10910842
utaneous	O	-1	10910842
doses	O	-1	10910842
of	O	-1	10910842
10	O	-1	10910842
mg/kg	O	-1	10910842
pre@@	B-Chemical	D011239	10910842
d@@	I-Chemical	-1	10910842
n@@	I-Chemical	-1	10910842
isol@@	I-Chemical	-1	10910842
one	I-Chemical	-1	10910842
(P@@	O	-1	10910842
10	O	-1	10910842
group@@	O	-1	10910842
),	O	-1	10910842
100	O	-1	10910842
mg/kg	O	-1	10910842
pre@@	B-Chemical	D011239	10910842
d@@	I-Chemical	-1	10910842
n@@	I-Chemical	-1	10910842
isol@@	I-Chemical	-1	10910842
one	I-Chemical	-1	10910842
(P@@	O	-1	10910842
100	O	-1	10910842
group@@	O	-1	10910842
),	O	-1	10910842
or	O	-1	10910842
an	O	-1	10910842
equ@@	O	-1	10910842
al	O	-1	10910842
volume	O	-1	10910842
of	O	-1	10910842
saline	O	-1	10910842
(@@	O	-1	10910842
S	O	-1	10910842
group@@	O	-1	10910842
)	O	-1	10910842
for	O	-1	10910842
7	O	-1	10910842
days.	O	-1	10910842
A	O	-1	10910842
fo@@	O	-1	10910842
ur@@	O	-1	10910842
th	O	-1	10910842
group	O	-1	10910842
of	O	-1	10910842
rats	O	-1	10910842
was	O	-1	10910842
pa@@	O	-1	10910842
ir	O	-1	10910842
f@@	O	-1	10910842
ed	O	-1	10910842
(@@	O	-1	10910842
fo@@	O	-1	10910842
od	O	-1	10910842
re@@	O	-1	10910842
stric@@	O	-1	10910842
te@@	O	-1	10910842
d@@	O	-1	10910842
)	O	-1	10910842
with	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
100	O	-1	10910842
rats	O	-1	10910842
for	O	-1	10910842
7	O	-1	10910842
days	O	-1	10910842
(@@	O	-1	10910842
F@@	O	-1	10910842
R	O	-1	10910842
group@@	O	-1	10910842
).	O	-1	10910842
O@@	O	-1	10910842
n	O	-1	10910842
D@@	O	-1	10910842
ay	O	-1	10910842
8@@	O	-1	10910842
,	O	-1	10910842
the	O	-1	10910842
ner@@	O	-1	10910842
ve@@	O	-1	10910842
-@@	O	-1	10910842
evoked	O	-1	10910842
pe@@	O	-1	10910842
a@@	O	-1	10910842
k	O	-1	10910842
t@@	O	-1	10910842
wit@@	O	-1	10910842
ch	O	-1	10910842
ten@@	O	-1	10910842
sion@@	O	-1	10910842
s,	O	-1	10910842
te@@	B-Disease	D013746	10910842
t@@	I-Disease	-1	10910842
anic	I-Disease	-1	10910842
ten@@	O	-1	10910842
sion@@	O	-1	10910842
s,	O	-1	10910842
and	O	-1	10910842
f@@	O	-1	10910842
ati@@	O	-1	10910842
g@@	O	-1	10910842
abil@@	O	-1	10910842
ity,	O	-1	10910842
and	O	-1	10910842
the	O	-1	10910842
dose-@@	O	-1	10910842
response	O	-1	10910842
cur@@	O	-1	10910842
v@@	O	-1	10910842
es	O	-1	10910842
of	O	-1	10910842
d-@@	B-Chemical	D014403	10910842
tub@@	I-Chemical	-1	10910842
oc@@	I-Chemical	-1	10910842
ur@@	I-Chemical	-1	10910842
ar@@	I-Chemical	-1	10910842
ine	I-Chemical	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
ti@@	O	-1	10910842
b@@	O	-1	10910842
i@@	O	-1	10910842
al@@	O	-1	10910842
is	O	-1	10910842
c@@	O	-1	10910842
ran@@	O	-1	10910842
i@@	O	-1	10910842
al@@	O	-1	10910842
is	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
were	O	-1	10910842
measured	O	-1	10910842
in	O	-1	10910842
viv@@	O	-1	10910842
o	O	-1	10910842
and	O	-1	10910842
related	O	-1	10910842
to	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
mas@@	O	-1	10910842
s	O	-1	10910842
or	O	-1	10910842
expression	O	-1	10910842
of	O	-1	10910842
AC@@	O	-1	10910842
h@@	O	-1	10910842
R@@	O	-1	10910842
s.	O	-1	10910842
R@@	O	-1	10910842
ate	O	-1	10910842
of	O	-1	10910842
body	O	-1	10910842
weight	O	-1	10910842
g@@	O	-1	10910842
ain	O	-1	10910842
was	O	-1	10910842
depress@@	O	-1	10910842
ed	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
10@@	O	-1	10910842
0@@	O	-1	10910842
,	O	-1	10910842
F@@	O	-1	10910842
R@@	O	-1	10910842
,	O	-1	10910842
and	O	-1	10910842
P@@	O	-1	10910842
10	O	-1	10910842
groups	O	-1	10910842
compared	O	-1	10910842
with	O	-1	10910842
the	O	-1	10910842
S	O	-1	10910842
group.	O	-1	10910842
T@@	O	-1	10910842
i@@	O	-1	10910842
b@@	O	-1	10910842
i@@	O	-1	10910842
al@@	O	-1	10910842
is	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
mas@@	O	-1	10910842
s	O	-1	10910842
was	O	-1	10910842
sm@@	O	-1	10910842
all@@	O	-1	10910842
er	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
100	O	-1	10910842
group	O	-1	10910842
than	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
10	O	-1	10910842
or	O	-1	10910842
S	O	-1	10910842
groups.	O	-1	10910842
The	O	-1	10910842
evoked	O	-1	10910842
pe@@	O	-1	10910842
a@@	O	-1	10910842
k	O	-1	10910842
t@@	O	-1	10910842
wit@@	O	-1	10910842
ch	O	-1	10910842
and	O	-1	10910842
te@@	B-Disease	D013746	10910842
t@@	I-Disease	-1	10910842
anic	I-Disease	-1	10910842
ten@@	O	-1	10910842
sions	O	-1	10910842
were	O	-1	10910842
less	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
100	O	-1	10910842
group	O	-1	10910842
than	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
10	O	-1	10910842
or	O	-1	10910842
S	O	-1	10910842
group@@	O	-1	10910842
s,	O	-1	10910842
however,	O	-1	10910842
ten@@	O	-1	10910842
sion	O	-1	10910842
per	O	-1	10910842
mil@@	O	-1	10910842
li@@	O	-1	10910842
gra@@	O	-1	10910842
m	O	-1	10910842
of	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
mas@@	O	-1	10910842
s	O	-1	10910842
was	O	-1	10910842
greater	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
100	O	-1	10910842
group	O	-1	10910842
than	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
S	O	-1	10910842
group.	O	-1	10910842
The	O	-1	10910842
50@@	O	-1	10910842
%	O	-1	10910842
effective	O	-1	10910842
dose	O	-1	10910842
of	O	-1	10910842
d-@@	B-Chemical	D014403	10910842
tub@@	I-Chemical	-1	10910842
oc@@	I-Chemical	-1	10910842
ur@@	I-Chemical	-1	10910842
ar@@	I-Chemical	-1	10910842
ine	I-Chemical	-1	10910842
(@@	O	-1	10910842
micro@@	O	-1	10910842
g/@@	O	-1	10910842
kg@@	O	-1	10910842
)	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
ti@@	O	-1	10910842
b@@	O	-1	10910842
i@@	O	-1	10910842
al@@	O	-1	10910842
is	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
was	O	-1	10910842
sm@@	O	-1	10910842
all@@	O	-1	10910842
er	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
10	O	-1	10910842
(3@@	O	-1	10910842
3.@@	O	-1	10910842
6	O	-1	10910842
+/-	O	-1	10910842
5.@@	O	-1	10910842
4@@	O	-1	10910842
)	O	-1	10910842
than	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
S	O	-1	10910842
(6@@	O	-1	10910842
1.@@	O	-1	10910842
9	O	-1	10910842
+/-	O	-1	10910842
5.@@	O	-1	10910842
0@@	O	-1	10910842
)	O	-1	10910842
or	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
100	O	-1	10910842
(@@	O	-1	10910842
7@@	O	-1	10910842
1.@@	O	-1	10910842
3	O	-1	10910842
+/-	O	-1	10910842
9.@@	O	-1	10910842
6@@	O	-1	10910842
)	O	-1	10910842
groups.	O	-1	10910842
AC@@	O	-1	10910842
h@@	O	-1	10910842
R	O	-1	10910842
expression	O	-1	10910842
was	O	-1	10910842
less	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
P@@	O	-1	10910842
10	O	-1	10910842
group	O	-1	10910842
than	O	-1	10910842
in	O	-1	10910842
the	O	-1	10910842
S	O	-1	10910842
group.	O	-1	10910842
The	O	-1	10910842
evoked	O	-1	10910842
ten@@	O	-1	10910842
sions	O	-1	10910842
cor@@	O	-1	10910842
related	O	-1	10910842
with	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
mas@@	O	-1	10910842
s	O	-1	10910842
(@@	O	-1	10910842
r@@	O	-1	10910842
(2@@	O	-1	10910842
)	O	-1	10910842
=	O	-1	10910842
0.@@	O	-1	10910842
3@@	O	-1	10910842
2,	O	-1	10910842
P	O	-1	10910842
<	O	-1	10910842
0.00@@	O	-1	10910842
1),	O	-1	10910842
however,	O	-1	10910842
not	O	-1	10910842
with	O	-1	10910842
expression	O	-1	10910842
of	O	-1	10910842
AC@@	O	-1	10910842
h@@	O	-1	10910842
R@@	O	-1	10910842
.	O	-1	10910842
The	O	-1	10910842
50@@	O	-1	10910842
%	O	-1	10910842
effective	O	-1	10910842
dose	O	-1	10910842
of	O	-1	10910842
d-@@	B-Chemical	D014403	10910842
tub@@	I-Chemical	-1	10910842
oc@@	I-Chemical	-1	10910842
ur@@	I-Chemical	-1	10910842
ar@@	I-Chemical	-1	10910842
ine	I-Chemical	-1	10910842
did	O	-1	10910842
not	O	-1	10910842
correl@@	O	-1	10910842
ate	O	-1	10910842
with	O	-1	10910842
musc@@	O	-1	10910842
le	O	-1	10910842
mas@@	O	-1	10910842
s	O	-1	10910842
or	O	-1	10910842
AC@@	O	-1	10910842
h@@	O	-1	10910842
R	O	-1	10910842
ex@@	O	-1	10910842
pres@@	O	-1	10910842
sion.	O	-1	10910842
Our	O	-1	10910842
results	O	-1	10910842
suggest	O	-1	10910842
that	O	-1	10910842
the	O	-1	10910842
neuro@@	B-Disease	D009468	10910842
mus@@	I-Disease	-1	10910842
cular	I-Disease	-1	10910842
dysfunction	I-Disease	-1	10910842
after	O	-1	10910842
pre@@	B-Chemical	D011239	10910842
d@@	I-Chemical	-1	10910842
n@@	I-Chemical	-1	10910842
isol@@	I-Chemical	-1	10910842
one	I-Chemical	-1	10910842
is	O	-1	10910842
dose-@@	O	-1	10910842
depend@@	O	-1	10910842
ent@@	O	-1	10910842
,	O	-1	10910842
and	O	-1	10910842
der@@	O	-1	10910842
i@@	O	-1	10910842
v@@	O	-1	10910842
es	O	-1	10910842
prim@@	O	-1	10910842
ari@@	O	-1	10910842
ly	O	-1	10910842
from	O	-1	10910842
musc@@	B-Disease	D009133	10910842
le	I-Disease	-1	10910842
atro@@	I-Disease	-1	10910842
ph@@	I-Disease	-1	10910842
y	I-Disease	-1	10910842
and	O	-1	10910842
der@@	O	-1	10910842
i@@	O	-1	10910842
v@@	O	-1	10910842
es	O	-1	10910842
less	O	-1	10910842
so	O	-1	10910842
from	O	-1	10910842
changes	O	-1	10910842
in	O	-1	10910842
AC@@	O	-1	10910842
h@@	O	-1	10910842
R	O	-1	10910842
ex@@	O	-1	10910842
pres@@	O	-1	10910842
sion.	O	-1	10910842
I@@	O	-1	10910842
MP@@	O	-1	10910842
L@@	O	-1	10910842
IC@@	O	-1	10910842
AT@@	O	-1	10910842
ION@@	O	-1	10910842
S:	O	-1	10910842
The	O	-1	10910842
mechanisms	O	-1	10910842
by	O	-1	10910842
which	O	-1	10910842
chronic	O	-1	10910842
g@@	O	-1	10910842
lu@@	O	-1	10910842
co@@	O	-1	10910842
cortico@@	O	-1	10910842
id	O	-1	10910842
therapy	O	-1	10910842
al@@	O	-1	10910842
ters	O	-1	10910842
neuro@@	O	-1	10910842
mus@@	O	-1	10910842
cular	O	-1	10910842
physi@@	O	-1	10910842
ology	O	-1	10910842
and	O	-1	10910842
pharmac@@	O	-1	10910842
ology	O	-1	10910842
are	O	-1	10910842
unc@@	O	-1	10910842
lear@@	O	-1	10910842
.	O	-1	10910842
We	O	-1	10910842
suggest	O	-1	10910842
that	O	-1	10910842
the	O	-1	10910842
observed	O	-1	10910842
effects	O	-1	10910842
are	O	-1	10910842
dose-@@	O	-1	10910842
dependent	O	-1	10910842
and	O	-1	10910842
der@@	O	-1	10910842
i@@	O	-1	10910842
ve	O	-1	10910842
prim@@	O	-1	10910842
ari@@	O	-1	10910842
ly	O	-1	10910842
from	O	-1	10910842
musc@@	B-Disease	D009133	10910842
le	I-Disease	-1	10910842
atro@@	I-Disease	-1	10910842
ph@@	I-Disease	-1	10910842
y	I-Disease	-1	10910842
and	O	-1	10910842
der@@	O	-1	10910842
i@@	O	-1	10910842
ve	O	-1	10910842
less	O	-1	10910842
from	O	-1	10910842
changes	O	-1	10910842
in	O	-1	10910842
acet@@	B-Chemical	D000109	10910842
ylcholine	I-Chemical	-1	10910842
receptor	O	-1	10910842
ex@@	O	-1	10910842
pres@@	O	-1	10910842
sion.	O	-1	10910842

R@@	O	-1	10533019
ap@@	O	-1	10533019
id	O	-1	10533019
rever@@	O	-1	10533019
s@@	O	-1	10533019
al	O	-1	10533019
of	O	-1	10533019
lif@@	O	-1	10533019
e-@@	O	-1	10533019
th@@	O	-1	10533019
reat@@	O	-1	10533019
en@@	O	-1	10533019
ing	O	-1	10533019
di@@	B-Chemical	D004110	10533019
l@@	I-Chemical	-1	10533019
ti@@	I-Chemical	-1	10533019
az@@	I-Chemical	-1	10533019
em	I-Chemical	-1	10533019
-induced	O	-1	10533019
te@@	B-Disease	D013746	10533019
t@@	I-Disease	-1	10533019
any	I-Disease	-1	10533019
with	O	-1	10533019
calcium	B-Chemical	D002122	10533019
chlor@@	I-Chemical	-1	10533019
ide	I-Chemical	-1	10533019
.	O	-1	10533019
We	O	-1	10533019
describe	O	-1	10533019
a	O	-1	10533019
patient	O	-1	10533019
who	O	-1	10533019
developed	O	-1	10533019
te@@	B-Disease	D013746	10533019
t@@	I-Disease	-1	10533019
any	I-Disease	-1	10533019
with	O	-1	10533019
su@@	O	-1	10533019
d@@	O	-1	10533019
de@@	O	-1	10533019
n	O	-1	10533019
respiratory	B-Disease	D012131	10533019
ar@@	I-Disease	-1	10533019
res@@	I-Disease	-1	10533019
t	I-Disease	-1	10533019
after	O	-1	10533019
the	O	-1	10533019
infusion	O	-1	10533019
of	O	-1	10533019
intravenous	O	-1	10533019
di@@	B-Chemical	D004110	10533019
l@@	I-Chemical	-1	10533019
ti@@	I-Chemical	-1	10533019
az@@	I-Chemical	-1	10533019
em	I-Chemical	-1	10533019
.	O	-1	10533019
The	O	-1	10533019
administration	O	-1	10533019
of	O	-1	10533019
calcium	B-Chemical	D002122	10533019
chlor@@	I-Chemical	-1	10533019
ide	I-Chemical	-1	10533019
ra@@	O	-1	10533019
pid@@	O	-1	10533019
ly	O	-1	10533019
resol@@	O	-1	10533019
ved	O	-1	10533019
the	O	-1	10533019
patient@@	O	-1	10533019
's	O	-1	10533019
te@@	B-Disease	D013746	10533019
t@@	I-Disease	-1	10533019
any	I-Disease	-1	10533019
with	O	-1	10533019
pro@@	O	-1	10533019
m@@	O	-1	10533019
p@@	O	-1	10533019
t	O	-1	10533019
recovery	O	-1	10533019
of	O	-1	10533019
respiratory	O	-1	10533019
func@@	O	-1	10533019
tion,	O	-1	10533019
aver@@	O	-1	10533019
ting	O	-1	10533019
the	O	-1	10533019
need	O	-1	10533019
for	O	-1	10533019
more	O	-1	10533019
ag@@	O	-1	10533019
gres@@	O	-1	10533019
sive	O	-1	10533019
a@@	O	-1	10533019
ir@@	O	-1	10533019
w@@	O	-1	10533019
ay	O	-1	10533019
man@@	O	-1	10533019
ag@@	O	-1	10533019
ement	O	-1	10533019
and	O	-1	10533019
ven@@	O	-1	10533019
ti@@	O	-1	10533019
lat@@	O	-1	10533019
ory	O	-1	10533019
sup@@	O	-1	10533019
port@@	O	-1	10533019
.	O	-1	10533019
The	O	-1	10533019
em@@	O	-1	10533019
er@@	O	-1	10533019
gen@@	O	-1	10533019
c@@	O	-1	10533019
y	O	-1	10533019
physi@@	O	-1	10533019
ci@@	O	-1	10533019
an	O	-1	10533019
should	O	-1	10533019
be	O	-1	10533019
aw@@	O	-1	10533019
are	O	-1	10533019
that	O	-1	10533019
lif@@	O	-1	10533019
e-@@	O	-1	10533019
th@@	O	-1	10533019
reat@@	O	-1	10533019
en@@	O	-1	10533019
ing	O	-1	10533019
te@@	B-Disease	D013746	10533019
t@@	I-Disease	-1	10533019
any	I-Disease	-1	10533019
may	O	-1	10533019
ac@@	O	-1	10533019
comp@@	O	-1	10533019
any	O	-1	10533019
the	O	-1	10533019
administration	O	-1	10533019
of	O	-1	10533019
intravenous	O	-1	10533019
di@@	B-Chemical	D004110	10533019
l@@	I-Chemical	-1	10533019
ti@@	I-Chemical	-1	10533019
az@@	I-Chemical	-1	10533019
em	I-Chemical	-1	10533019
and	O	-1	10533019
that	O	-1	10533019
calcium	B-Chemical	D002122	10533019
chlor@@	I-Chemical	-1	10533019
ide	I-Chemical	-1	10533019
may	O	-1	10533019
be	O	-1	10533019
a	O	-1	10533019
ra@@	O	-1	10533019
pid	O	-1	10533019
and	O	-1	10533019
effective	O	-1	10533019
re@@	O	-1	10533019
med@@	O	-1	10533019
y.	O	-1	10533019

Eff@@	O	-1	10414674
ects	O	-1	10414674
of	O	-1	10414674
non@@	O	-1	10414674
steroid@@	O	-1	10414674
al	O	-1	10414674
anti@@	O	-1	10414674
-@@	O	-1	10414674
inflam@@	O	-1	10414674
mat@@	O	-1	10414674
ory	O	-1	10414674
drugs	O	-1	10414674
on	O	-1	10414674
hemo@@	O	-1	10414674
st@@	O	-1	10414674
asis	O	-1	10414674
in	O	-1	10414674
patients	O	-1	10414674
with	O	-1	10414674
aneurys@@	B-Disease	D013345	10414674
m@@	I-Disease	-1	10414674
al	I-Disease	-1	10414674
sub@@	I-Disease	-1	10414674
arac@@	I-Disease	-1	10414674
h@@	I-Disease	-1	10414674
no@@	I-Disease	-1	10414674
id	I-Disease	-1	10414674
hemorrh@@	I-Disease	-1	10414674
age	I-Disease	-1	10414674
.	O	-1	10414674
P@@	O	-1	10414674
lat@@	O	-1	10414674
e@@	O	-1	10414674
le@@	O	-1	10414674
t	O	-1	10414674
function	O	-1	10414674
is	O	-1	10414674
impaired	O	-1	10414674
by	O	-1	10414674
non@@	O	-1	10414674
steroid@@	O	-1	10414674
al	O	-1	10414674
anti@@	O	-1	10414674
-@@	O	-1	10414674
inflam@@	O	-1	10414674
mat@@	O	-1	10414674
ory	O	-1	10414674
drugs	O	-1	10414674
(N@@	O	-1	10414674
S@@	O	-1	10414674
A@@	O	-1	10414674
I@@	O	-1	10414674
D@@	O	-1	10414674
s)	O	-1	10414674
with	O	-1	10414674
pro@@	O	-1	10414674
min@@	O	-1	10414674
ent	O	-1	10414674
anti@@	O	-1	10414674
-@@	O	-1	10414674
inflam@@	O	-1	10414674
mat@@	O	-1	10414674
ory	O	-1	10414674
pro@@	O	-1	10414674
per@@	O	-1	10414674
ti@@	O	-1	10414674
es.	O	-1	10414674
The@@	O	-1	10414674
ir	O	-1	10414674
safety	O	-1	10414674
in	O	-1	10414674
patients	O	-1	10414674
under@@	O	-1	10414674
go@@	O	-1	10414674
ing	O	-1	10414674
intrac@@	O	-1	10414674
ranial	O	-1	10414674
surger@@	O	-1	10414674
y	O	-1	10414674
is	O	-1	10414674
under	O	-1	10414674
de@@	O	-1	10414674
b@@	O	-1	10414674
at@@	O	-1	10414674
e.	O	-1	10414674
Patients	O	-1	10414674
with	O	-1	10414674
aneurys@@	B-Disease	D013345	10414674
m@@	I-Disease	-1	10414674
al	I-Disease	-1	10414674
sub@@	I-Disease	-1	10414674
arac@@	I-Disease	-1	10414674
h@@	I-Disease	-1	10414674
no@@	I-Disease	-1	10414674
id	I-Disease	-1	10414674
hemorrh@@	I-Disease	-1	10414674
age	I-Disease	-1	10414674
(	O	-1	10414674
S@@	B-Disease	D013345	10414674
A@@	I-Disease	-1	10414674
H	I-Disease	-1	10414674
)	O	-1	10414674
were	O	-1	10414674
randomized	O	-1	10414674
to	O	-1	10414674
recei@@	O	-1	10414674
ve	O	-1	10414674
either	O	-1	10414674
ke@@	B-Chemical	D007660	10414674
to@@	I-Chemical	-1	10414674
prof@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
,	O	-1	10414674
100	O	-1	10414674
mg@@	O	-1	10414674
,	O	-1	10414674
three	O	-1	10414674
times	O	-1	10414674
a	O	-1	10414674
day	O	-1	10414674
(	O	-1	10414674
ke@@	B-Chemical	D007660	10414674
to@@	I-Chemical	-1	10414674
prof@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
group@@	O	-1	10414674
,	O	-1	10414674
n	O	-1	10414674
=	O	-1	10414674
9@@	O	-1	10414674
)	O	-1	10414674
or	O	-1	10414674
a	O	-1	10414674
we@@	O	-1	10414674
a@@	O	-1	10414674
k	O	-1	10414674
N@@	O	-1	10414674
S@@	O	-1	10414674
A@@	O	-1	10414674
I@@	O	-1	10414674
D@@	O	-1	10414674
,	O	-1	10414674
acet@@	B-Chemical	D000082	10414674
aminoph@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
,	O	-1	10414674
1	O	-1	10414674
g@@	O	-1	10414674
,	O	-1	10414674
three	O	-1	10414674
times	O	-1	10414674
a	O	-1	10414674
day	O	-1	10414674
(	O	-1	10414674
acet@@	B-Chemical	D000082	10414674
aminoph@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
group@@	O	-1	10414674
,	O	-1	10414674
n	O	-1	10414674
=	O	-1	10414674
9@@	O	-1	10414674
)	O	-1	10414674
star@@	O	-1	10414674
ting	O	-1	10414674
immedi@@	O	-1	10414674
ately	O	-1	10414674
after	O	-1	10414674
the	O	-1	10414674
diagnosis	O	-1	10414674
of	O	-1	10414674
aneurys@@	B-Disease	D017542	10414674
m@@	I-Disease	-1	10414674
al	I-Disease	-1	10414674
S@@	B-Disease	D013345	10414674
A@@	I-Disease	-1	10414674
H	I-Disease	-1	10414674
.	O	-1	10414674
Treat@@	O	-1	10414674
ment	O	-1	10414674
was	O	-1	10414674
continu@@	O	-1	10414674
ed	O	-1	10414674
for	O	-1	10414674
3	O	-1	10414674
days	O	-1	10414674
posto@@	O	-1	10414674
per@@	O	-1	10414674
ati@@	O	-1	10414674
vel@@	O	-1	10414674
y.	O	-1	10414674
T@@	O	-1	10414674
est	O	-1	10414674
blood	O	-1	10414674
sam@@	O	-1	10414674
ple@@	O	-1	10414674
s	O	-1	10414674
were	O	-1	10414674
tak@@	O	-1	10414674
en	O	-1	10414674
before	O	-1	10414674
treatment	O	-1	10414674
and	O	-1	10414674
surger@@	O	-1	10414674
y	O	-1	10414674
as	O	-1	10414674
well	O	-1	10414674
as	O	-1	10414674
on	O	-1	10414674
the	O	-1	10414674
fir@@	O	-1	10414674
st@@	O	-1	10414674
,	O	-1	10414674
thir@@	O	-1	10414674
d,	O	-1	10414674
and	O	-1	10414674
f@@	O	-1	10414674
if@@	O	-1	10414674
th	O	-1	10414674
postoperative	O	-1	10414674
mor@@	O	-1	10414674
n@@	O	-1	10414674
ing@@	O	-1	10414674
s.	O	-1	10414674
M@@	O	-1	10414674
ax@@	O	-1	10414674
im@@	O	-1	10414674
al	O	-1	10414674
platele@@	B-Disease	D001791	10414674
t	I-Disease	-1	10414674
ag@@	I-Disease	-1	10414674
g@@	I-Disease	-1	10414674
reg@@	I-Disease	-1	10414674
ation	I-Disease	-1	10414674
induced	O	-1	10414674
by	O	-1	10414674
6	O	-1	10414674
micro@@	O	-1	10414674
M	O	-1	10414674
of	O	-1	10414674
aden@@	B-Chemical	D000244	10414674
os@@	I-Chemical	-1	10414674
ine	I-Chemical	-1	10414674
di@@	I-Chemical	-1	10414674
phosph@@	I-Chemical	-1	10414674
ate	I-Chemical	-1	10414674
decreased	O	-1	10414674
after	O	-1	10414674
administration	O	-1	10414674
of	O	-1	10414674
ke@@	B-Chemical	D007660	10414674
to@@	I-Chemical	-1	10414674
prof@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
.	O	-1	10414674
A@@	O	-1	10414674
g@@	O	-1	10414674
g@@	O	-1	10414674
reg@@	O	-1	10414674
ation	O	-1	10414674
was	O	-1	10414674
lower	O	-1	10414674
(P	O	-1	10414674
<	O	-1	10414674
.@@	O	-1	10414674
0@@	O	-1	10414674
5@@	O	-1	10414674
)	O	-1	10414674
in	O	-1	10414674
the	O	-1	10414674
ke@@	B-Chemical	D007660	10414674
to@@	I-Chemical	-1	10414674
prof@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
group	O	-1	10414674
than	O	-1	10414674
in	O	-1	10414674
the	O	-1	10414674
acet@@	B-Chemical	D000082	10414674
aminoph@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
group	O	-1	10414674
j@@	O	-1	10414674
us@@	O	-1	10414674
t	O	-1	10414674
before	O	-1	10414674
surger@@	O	-1	10414674
y	O	-1	10414674
and	O	-1	10414674
on	O	-1	10414674
the	O	-1	10414674
thir@@	O	-1	10414674
d	O	-1	10414674
postoperative	O	-1	10414674
da@@	O	-1	10414674
y.	O	-1	10414674
In	O	-1	10414674
contrast@@	O	-1	10414674
,	O	-1	10414674
maxim@@	O	-1	10414674
al	O	-1	10414674
platele@@	B-Disease	D001791	10414674
t	I-Disease	-1	10414674
ag@@	I-Disease	-1	10414674
g@@	I-Disease	-1	10414674
reg@@	I-Disease	-1	10414674
ation	I-Disease	-1	10414674
increased	O	-1	10414674
in	O	-1	10414674
the	O	-1	10414674
acet@@	B-Chemical	D000082	10414674
aminoph@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
group	O	-1	10414674
on	O	-1	10414674
the	O	-1	10414674
thir@@	O	-1	10414674
d	O	-1	10414674
postoperative	O	-1	10414674
day	O	-1	10414674
as	O	-1	10414674
compared	O	-1	10414674
with	O	-1	10414674
the	O	-1	10414674
pretreatment	O	-1	10414674
platele@@	B-Disease	D001791	10414674
t	I-Disease	-1	10414674
ag@@	I-Disease	-1	10414674
g@@	I-Disease	-1	10414674
reg@@	I-Disease	-1	10414674
ation	I-Disease	-1	10414674
results	O	-1	10414674
(P	O	-1	10414674
<	O	-1	10414674
.@@	O	-1	10414674
0@@	O	-1	10414674
5@@	O	-1	10414674
).	O	-1	10414674
One	O	-1	10414674
patient	O	-1	10414674
in	O	-1	10414674
the	O	-1	10414674
ke@@	B-Chemical	D007660	10414674
to@@	I-Chemical	-1	10414674
prof@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
group	O	-1	10414674
developed	O	-1	10414674
a	O	-1	10414674
postoperative	O	-1	10414674
intrac@@	O	-1	10414674
ranial	O	-1	10414674
hemat@@	B-Disease	D006406	10414674
oma	I-Disease	-1	10414674
.	O	-1	10414674
C@@	O	-1	10414674
o@@	O	-1	10414674
ag@@	O	-1	10414674
ulation	O	-1	10414674
(@@	O	-1	10414674
pro@@	O	-1	10414674
throm@@	O	-1	10414674
bin	O	-1	10414674
time	O	-1	10414674
[@@	O	-1	10414674
P@@	O	-1	10414674
T@@	O	-1	10414674
]@@	O	-1	10414674
,	O	-1	10414674
activ@@	O	-1	10414674
ated	O	-1	10414674
partial	O	-1	10414674
thrombo@@	O	-1	10414674
plas@@	O	-1	10414674
tin	O	-1	10414674
time	O	-1	10414674
[@@	O	-1	10414674
A@@	O	-1	10414674
P@@	O	-1	10414674
P@@	O	-1	10414674
T@@	O	-1	10414674
]@@	O	-1	10414674
,	O	-1	10414674
fib@@	O	-1	10414674
r@@	O	-1	10414674
ino@@	O	-1	10414674
gen	O	-1	10414674
concentr@@	O	-1	10414674
ation,	O	-1	10414674
and	O	-1	10414674
anti@@	O	-1	10414674
throm@@	O	-1	10414674
bin	O	-1	10414674
I@@	O	-1	10414674
II	O	-1	10414674
[@@	O	-1	10414674
A@@	O	-1	10414674
T	O	-1	10414674
II@@	O	-1	10414674
I@@	O	-1	10414674
]@@	O	-1	10414674
)	O	-1	10414674
was	O	-1	10414674
compar@@	O	-1	10414674
able	O	-1	10414674
between	O	-1	10414674
the	O	-1	10414674
two	O	-1	10414674
groups.	O	-1	10414674
K@@	B-Chemical	D007660	10414674
e@@	I-Chemical	-1	10414674
to@@	I-Chemical	-1	10414674
prof@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
but	O	-1	10414674
not	O	-1	10414674
acet@@	B-Chemical	D000082	10414674
aminoph@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
impaired	O	-1	10414674
platele@@	O	-1	10414674
t	O	-1	10414674
function	O	-1	10414674
in	O	-1	10414674
patients	O	-1	10414674
with	O	-1	10414674
S@@	B-Disease	D013345	10414674
A@@	I-Disease	-1	10414674
H	I-Disease	-1	10414674
.	O	-1	10414674
I@@	O	-1	10414674
f	O	-1	10414674
ke@@	B-Chemical	D007660	10414674
to@@	I-Chemical	-1	10414674
prof@@	I-Chemical	-1	10414674
en	I-Chemical	-1	10414674
is	O	-1	10414674
used	O	-1	10414674
before	O	-1	10414674
surger@@	O	-1	10414674
y	O	-1	10414674
on	O	-1	10414674
cerebral	O	-1	10414674
artery	B-Disease	D002532	10414674
aneurys@@	I-Disease	-1	10414674
ms	I-Disease	-1	10414674
,	O	-1	10414674
it	O	-1	10414674
may	O	-1	10414674
p@@	O	-1	10414674
ose	O	-1	10414674
an	O	-1	10414674
addi@@	O	-1	10414674
tional	O	-1	10414674
risk	O	-1	10414674
factor	O	-1	10414674
for	O	-1	10414674
hemorrh@@	B-Disease	D006470	10414674
age	I-Disease	-1	10414674
.	O	-1	10414674

V@@	O	-1	9523850
alu@@	O	-1	9523850
e	O	-1	9523850
of	O	-1	9523850
methyl@@	B-Chemical	D008775	9523850
pre@@	I-Chemical	-1	9523850
d@@	I-Chemical	-1	9523850
n@@	I-Chemical	-1	9523850
isol@@	I-Chemical	-1	9523850
one	I-Chemical	-1	9523850
in	O	-1	9523850
pre@@	O	-1	9523850
ven@@	O	-1	9523850
tion	O	-1	9523850
of	O	-1	9523850
the	O	-1	9523850
arth@@	B-Disease	D018771	9523850
r@@	I-Disease	-1	9523850
al@@	I-Disease	-1	9523850
g@@	I-Disease	-1	9523850
ia	I-Disease	-1	9523850
-	O	-1	9523850
my@@	B-Disease	D063806	9523850
al@@	I-Disease	-1	9523850
g@@	I-Disease	-1	9523850
ia	I-Disease	-1	9523850
syndrome	O	-1	9523850
associated	O	-1	9523850
with	O	-1	9523850
the	O	-1	9523850
total	O	-1	9523850
dose	O	-1	9523850
infusion	O	-1	9523850
of	O	-1	9523850
i@@	B-Chemical	D007505	9523850
ro@@	I-Chemical	-1	9523850
n	I-Chemical	-1	9523850
de@@	I-Chemical	-1	9523850
x@@	I-Chemical	-1	9523850
tra@@	I-Chemical	-1	9523850
n	I-Chemical	-1	9523850
:	O	-1	9523850
a	O	-1	9523850
dou@@	O	-1	9523850
ble	O	-1	9523850
bl@@	O	-1	9523850
ind	O	-1	9523850
randomized	O	-1	9523850
tri@@	O	-1	9523850
al.	O	-1	9523850
The	O	-1	9523850
safety	O	-1	9523850
and	O	-1	9523850
efficacy	O	-1	9523850
of	O	-1	9523850
total	O	-1	9523850
dose	O	-1	9523850
infusion	O	-1	9523850
(T@@	O	-1	9523850
D@@	O	-1	9523850
I@@	O	-1	9523850
)	O	-1	9523850
of	O	-1	9523850
i@@	B-Chemical	D007505	9523850
ro@@	I-Chemical	-1	9523850
n	I-Chemical	-1	9523850
de@@	I-Chemical	-1	9523850
x@@	I-Chemical	-1	9523850
tra@@	I-Chemical	-1	9523850
n	I-Chemical	-1	9523850
has	O	-1	9523850
been	O	-1	9523850
well	O	-1	9523850
doc@@	O	-1	9523850
um@@	O	-1	9523850
ent@@	O	-1	9523850
ed.	O	-1	9523850
In	O	-1	9523850
4@@	O	-1	9523850
0%	O	-1	9523850
of	O	-1	9523850
treated	O	-1	9523850
patients,	O	-1	9523850
an	O	-1	9523850
arth@@	B-Disease	D018771	9523850
r@@	I-Disease	-1	9523850
al@@	I-Disease	-1	9523850
g@@	I-Disease	-1	9523850
ia	I-Disease	-1	9523850
-	O	-1	9523850
my@@	B-Disease	D063806	9523850
al@@	I-Disease	-1	9523850
g@@	I-Disease	-1	9523850
ia	I-Disease	-1	9523850
syndrome	O	-1	9523850
develop@@	O	-1	9523850
s.	O	-1	9523850
The	O	-1	9523850
pur@@	O	-1	9523850
p@@	O	-1	9523850
ose	O	-1	9523850
of	O	-1	9523850
this	O	-1	9523850
random@@	O	-1	9523850
iz@@	O	-1	9523850
ed,	O	-1	9523850
double-bl@@	O	-1	9523850
ind@@	O	-1	9523850
,	O	-1	9523850
pro@@	O	-1	9523850
sp@@	O	-1	9523850
ective	O	-1	9523850
study	O	-1	9523850
was	O	-1	9523850
to	O	-1	9523850
investigate	O	-1	9523850
whether	O	-1	9523850
intravenous	O	-1	9523850
(@@	O	-1	9523850
i.v@@	O	-1	9523850
.)	O	-1	9523850
administration	O	-1	9523850
of	O	-1	9523850
methyl@@	B-Chemical	D008775	9523850
pre@@	I-Chemical	-1	9523850
d@@	I-Chemical	-1	9523850
n@@	I-Chemical	-1	9523850
isol@@	I-Chemical	-1	9523850
one	I-Chemical	-1	9523850
(	O	-1	9523850
M@@	B-Chemical	D008775	9523850
P	I-Chemical	-1	9523850
)	O	-1	9523850
prev@@	O	-1	9523850
ents	O	-1	9523850
this	O	-1	9523850
complic@@	O	-1	9523850
ation.	O	-1	9523850
Si@@	O	-1	9523850
x@@	O	-1	9523850
ty-@@	O	-1	9523850
five	O	-1	9523850
patients,	O	-1	9523850
3@@	O	-1	9523850
4	O	-1	9523850
women	O	-1	9523850
and	O	-1	9523850
3@@	O	-1	9523850
1	O	-1	9523850
men@@	O	-1	9523850
,	O	-1	9523850
ages	O	-1	9523850
3@@	O	-1	9523850
6	O	-1	9523850
to	O	-1	9523850
8@@	O	-1	9523850
0	O	-1	9523850
year@@	O	-1	9523850
s,	O	-1	9523850
received	O	-1	9523850
either	O	-1	9523850
normal	O	-1	9523850
saline	O	-1	9523850
before	O	-1	9523850
and	O	-1	9523850
after	O	-1	9523850
T@@	O	-1	9523850
D@@	O	-1	9523850
I	O	-1	9523850
(@@	O	-1	9523850
group	O	-1	9523850
1),	O	-1	9523850
12@@	O	-1	9523850
5	O	-1	9523850
mg	O	-1	9523850
i.v@@	O	-1	9523850
.	O	-1	9523850
M@@	B-Chemical	D008775	9523850
P	I-Chemical	-1	9523850
before	O	-1	9523850
and	O	-1	9523850
saline	O	-1	9523850
after	O	-1	9523850
T@@	O	-1	9523850
D@@	O	-1	9523850
I	O	-1	9523850
(@@	O	-1	9523850
group	O	-1	9523850
2@@	O	-1	9523850
),	O	-1	9523850
or	O	-1	9523850
12@@	O	-1	9523850
5	O	-1	9523850
mg	O	-1	9523850
i.v@@	O	-1	9523850
.	O	-1	9523850
M@@	B-Chemical	D008775	9523850
P	I-Chemical	-1	9523850
before	O	-1	9523850
and	O	-1	9523850
after	O	-1	9523850
T@@	O	-1	9523850
D@@	O	-1	9523850
I	O	-1	9523850
(@@	O	-1	9523850
group	O	-1	9523850
3@@	O	-1	9523850
).	O	-1	9523850
Patients	O	-1	9523850
were	O	-1	9523850
observed	O	-1	9523850
for	O	-1	9523850
7@@	O	-1	9523850
2	O	-1	9523850
hours	O	-1	9523850
and	O	-1	9523850
reactions	O	-1	9523850
were	O	-1	9523850
recor@@	O	-1	9523850
ded	O	-1	9523850
and	O	-1	9523850
gra@@	O	-1	9523850
ded	O	-1	9523850
ac@@	O	-1	9523850
cor@@	O	-1	9523850
ding	O	-1	9523850
to	O	-1	9523850
sever@@	O	-1	9523850
ity.	O	-1	9523850
F@@	O	-1	9523850
if@@	O	-1	9523850
ty-@@	O	-1	9523850
e@@	O	-1	9523850
ight	O	-1	9523850
perc@@	O	-1	9523850
ent	O	-1	9523850
of	O	-1	9523850
group	O	-1	9523850
1	O	-1	9523850
patients,	O	-1	9523850
3@@	O	-1	9523850
3@@	O	-1	9523850
%	O	-1	9523850
of	O	-1	9523850
group	O	-1	9523850
2,	O	-1	9523850
and	O	-1	9523850
2@@	O	-1	9523850
6%	O	-1	9523850
of	O	-1	9523850
group	O	-1	9523850
3	O	-1	9523850
had	O	-1	9523850
reactions	O	-1	9523850
to	O	-1	9523850
T@@	O	-1	9523850
D@@	O	-1	9523850
I@@	O	-1	9523850
.	O	-1	9523850
The	O	-1	9523850
severity	O	-1	9523850
of	O	-1	9523850
reactions	O	-1	9523850
(@@	O	-1	9523850
minim@@	O	-1	9523850
al,	O	-1	9523850
mil@@	O	-1	9523850
d,	O	-1	9523850
and	O	-1	9523850
moder@@	O	-1	9523850
ate,	O	-1	9523850
respectivel@@	O	-1	9523850
y@@	O	-1	9523850
)	O	-1	9523850
was	O	-1	9523850
as	O	-1	9523850
follow@@	O	-1	9523850
s:	O	-1	9523850
group	O	-1	9523850
1-@@	O	-1	9523850
-@@	O	-1	9523850
6,	O	-1	9523850
6,	O	-1	9523850
and	O	-1	9523850
2@@	O	-1	9523850
;	O	-1	9523850
group	O	-1	9523850
2-@@	O	-1	9523850
-1@@	O	-1	9523850
,	O	-1	9523850
5,	O	-1	9523850
and	O	-1	9523850
0@@	O	-1	9523850
;	O	-1	9523850
group	O	-1	9523850
3-@@	O	-1	9523850
-@@	O	-1	9523850
5,	O	-1	9523850
1,	O	-1	9523850
and	O	-1	9523850
0@@	O	-1	9523850
.	O	-1	9523850
D@@	O	-1	9523850
at@@	O	-1	9523850
a	O	-1	9523850
were	O	-1	9523850
analy@@	O	-1	9523850
zed	O	-1	9523850
by	O	-1	9523850
the	O	-1	9523850
tw@@	O	-1	9523850
o@@	O	-1	9523850
-@@	O	-1	9523850
si@@	O	-1	9523850
ded	O	-1	9523850
F@@	O	-1	9523850
ish@@	O	-1	9523850
er@@	O	-1	9523850
's	O	-1	9523850
ex@@	O	-1	9523850
ac@@	O	-1	9523850
t	O	-1	9523850
test	O	-1	9523850
using	O	-1	9523850
95%	O	-1	9523850
conf@@	O	-1	9523850
idence	O	-1	9523850
interv@@	O	-1	9523850
als	O	-1	9523850
with	O	-1	9523850
the	O	-1	9523850
appro@@	O	-1	9523850
xim@@	O	-1	9523850
ation	O	-1	9523850
of	O	-1	9523850
W@@	O	-1	9523850
o@@	O	-1	9523850
ol@@	O	-1	9523850
f@@	O	-1	9523850
.	O	-1	9523850
These	O	-1	9523850
data	O	-1	9523850
demon@@	O	-1	9523850
st@@	O	-1	9523850
rate	O	-1	9523850
that	O	-1	9523850
administration	O	-1	9523850
of	O	-1	9523850
M@@	B-Chemical	D008775	9523850
P	I-Chemical	-1	9523850
before	O	-1	9523850
and	O	-1	9523850
after	O	-1	9523850
T@@	O	-1	9523850
D@@	O	-1	9523850
I	O	-1	9523850
reduc@@	O	-1	9523850
es	O	-1	9523850
the	O	-1	9523850
frequency	O	-1	9523850
and	O	-1	9523850
severity	O	-1	9523850
of	O	-1	9523850
the	O	-1	9523850
arth@@	B-Disease	D018771	9523850
r@@	I-Disease	-1	9523850
al@@	I-Disease	-1	9523850
g@@	I-Disease	-1	9523850
ia	I-Disease	-1	9523850
-	O	-1	9523850
my@@	B-Disease	D063806	9523850
al@@	I-Disease	-1	9523850
g@@	I-Disease	-1	9523850
ia	I-Disease	-1	9523850
syndro@@	O	-1	9523850
me.	O	-1	9523850
We	O	-1	9523850
concl@@	O	-1	9523850
ude	O	-1	9523850
that	O	-1	9523850
12@@	O	-1	9523850
5	O	-1	9523850
mg	O	-1	9523850
i.v@@	O	-1	9523850
.	O	-1	9523850
M@@	B-Chemical	D008775	9523850
P	I-Chemical	-1	9523850
should	O	-1	9523850
be	O	-1	9523850
given	O	-1	9523850
ro@@	O	-1	9523850
ut@@	O	-1	9523850
ine@@	O	-1	9523850
ly	O	-1	9523850
before	O	-1	9523850
and	O	-1	9523850
after	O	-1	9523850
T@@	O	-1	9523850
D@@	O	-1	9523850
I	O	-1	9523850
of	O	-1	9523850
i@@	B-Chemical	D007505	9523850
ro@@	I-Chemical	-1	9523850
n	I-Chemical	-1	9523850
de@@	I-Chemical	-1	9523850
x@@	I-Chemical	-1	9523850
tra@@	I-Chemical	-1	9523850
n	I-Chemical	-1	9523850
.	O	-1	9523850

L@@	O	-1	8384253
on@@	O	-1	8384253
g@@	O	-1	8384253
-term	O	-1	8384253
effects	O	-1	8384253
of	O	-1	8384253
v@@	B-Chemical	D014750	8384253
inc@@	I-Chemical	-1	8384253
ri@@	I-Chemical	-1	8384253
st@@	I-Chemical	-1	8384253
ine	I-Chemical	-1	8384253
on	O	-1	8384253
the	O	-1	8384253
peripheral	O	-1	8384253
ner@@	O	-1	8384253
v@@	O	-1	8384253
ous	O	-1	8384253
system@@	O	-1	8384253
.	O	-1	8384253
F@@	O	-1	8384253
ort@@	O	-1	8384253
y	O	-1	8384253
patients	O	-1	8384253
with	O	-1	8384253
N@@	B-Disease	D008228	8384253
on@@	I-Disease	-1	8384253
-@@	I-Disease	-1	8384253
Ho@@	I-Disease	-1	8384253
d@@	I-Disease	-1	8384253
g@@	I-Disease	-1	8384253
kin@@	I-Disease	-1	8384253
's	I-Disease	-1	8384253
L@@	I-Disease	-1	8384253
ym@@	I-Disease	-1	8384253
ph@@	I-Disease	-1	8384253
oma	I-Disease	-1	8384253
treated	O	-1	8384253
with	O	-1	8384253
v@@	B-Chemical	D014750	8384253
inc@@	I-Chemical	-1	8384253
ri@@	I-Chemical	-1	8384253
st@@	I-Chemical	-1	8384253
ine	I-Chemical	-1	8384253
between	O	-1	8384253
19@@	O	-1	8384253
8@@	O	-1	8384253
4	O	-1	8384253
and	O	-1	8384253
19@@	O	-1	8384253
9@@	O	-1	8384253
0	O	-1	8384253
(@@	O	-1	8384253
cum@@	O	-1	8384253
ul@@	O	-1	8384253
ative	O	-1	8384253
dose	O	-1	8384253
12	O	-1	8384253
mg	O	-1	8384253
in	O	-1	8384253
18@@	O	-1	8384253
-@@	O	-1	8384253
24	O	-1	8384253
week@@	O	-1	8384253
s)	O	-1	8384253
were	O	-1	8384253
investigated	O	-1	8384253
in	O	-1	8384253
or@@	O	-1	8384253
der	O	-1	8384253
to	O	-1	8384253
evalu@@	O	-1	8384253
ate	O	-1	8384253
the	O	-1	8384253
lon@@	O	-1	8384253
g	O	-1	8384253
term	O	-1	8384253
effects	O	-1	8384253
of	O	-1	8384253
v@@	B-Chemical	D014750	8384253
inc@@	I-Chemical	-1	8384253
ri@@	I-Chemical	-1	8384253
st@@	I-Chemical	-1	8384253
ine	I-Chemical	-1	8384253
on	O	-1	8384253
the	O	-1	8384253
peripheral	O	-1	8384253
ner@@	O	-1	8384253
v@@	O	-1	8384253
ous	O	-1	8384253
system@@	O	-1	8384253
.	O	-1	8384253
The	O	-1	8384253
patients	O	-1	8384253
were	O	-1	8384253
inter@@	O	-1	8384253
vie@@	O	-1	8384253
w@@	O	-1	8384253
ed	O	-1	8384253
with	O	-1	8384253
em@@	O	-1	8384253
pha@@	O	-1	8384253
sis	O	-1	8384253
on	O	-1	8384253
neuro@@	B-Disease	D012678	8384253
path@@	I-Disease	-1	8384253
ic	I-Disease	-1	8384253
symptoms	I-Disease	-1	8384253
.	O	-1	8384253
P@@	O	-1	8384253
hy@@	O	-1	8384253
si@@	O	-1	8384253
c@@	O	-1	8384253
al	O	-1	8384253
and	O	-1	8384253
qu@@	O	-1	8384253
anti@@	O	-1	8384253
t@@	O	-1	8384253
ative	O	-1	8384253
sens@@	O	-1	8384253
ory	O	-1	8384253
examin@@	O	-1	8384253
ation	O	-1	8384253
with	O	-1	8384253
determin@@	O	-1	8384253
ation	O	-1	8384253
of	O	-1	8384253
vi@@	O	-1	8384253
b@@	O	-1	8384253
ratory	O	-1	8384253
per@@	O	-1	8384253
ce@@	O	-1	8384253
ption	O	-1	8384253
and	O	-1	8384253
ther@@	O	-1	8384253
m@@	O	-1	8384253
al	O	-1	8384253
dis@@	O	-1	8384253
cri@@	O	-1	8384253
min@@	O	-1	8384253
ation	O	-1	8384253
th@@	O	-1	8384253
res@@	O	-1	8384253
h@@	O	-1	8384253
ol@@	O	-1	8384253
ds	O	-1	8384253
were	O	-1	8384253
per@@	O	-1	8384253
for@@	O	-1	8384253
me@@	O	-1	8384253
d,	O	-1	8384253
four	O	-1	8384253
to	O	-1	8384253
7@@	O	-1	8384253
7	O	-1	8384253
months	O	-1	8384253
(@@	O	-1	8384253
median	O	-1	8384253
3@@	O	-1	8384253
4	O	-1	8384253
month@@	O	-1	8384253
s)	O	-1	8384253
after	O	-1	8384253
v@@	B-Chemical	D014750	8384253
inc@@	I-Chemical	-1	8384253
ri@@	I-Chemical	-1	8384253
st@@	I-Chemical	-1	8384253
ine	I-Chemical	-1	8384253
treatment.	O	-1	8384253
Tw@@	O	-1	8384253
ent@@	O	-1	8384253
y-@@	O	-1	8384253
seven	O	-1	8384253
patients	O	-1	8384253
reported	O	-1	8384253
neuro@@	B-Disease	D012678	8384253
path@@	I-Disease	-1	8384253
ic	I-Disease	-1	8384253
symptoms	I-Disease	-1	8384253
.	O	-1	8384253
In	O	-1	8384253
13	O	-1	8384253
of	O	-1	8384253
these	O	-1	8384253
2@@	O	-1	8384253
7	O	-1	8384253
patients	O	-1	8384253
symptoms	O	-1	8384253
were	O	-1	8384253
sti@@	O	-1	8384253
ll	O	-1	8384253
present	O	-1	8384253
at	O	-1	8384253
the	O	-1	8384253
time	O	-1	8384253
of	O	-1	8384253
examin@@	O	-1	8384253
ation.	O	-1	8384253
In	O	-1	8384253
these	O	-1	8384253
patients	O	-1	8384253
sens@@	O	-1	8384253
ory	O	-1	8384253
signs	O	-1	8384253
and	O	-1	8384253
symptoms	O	-1	8384253
pre@@	O	-1	8384253
domin@@	O	-1	8384253
ated.	O	-1	8384253
In	O	-1	8384253
the	O	-1	8384253
other	O	-1	8384253
14	O	-1	8384253
patients	O	-1	8384253
symptoms	O	-1	8384253
had	O	-1	8384253
been	O	-1	8384253
present	O	-1	8384253
in	O	-1	8384253
the	O	-1	8384253
pa@@	O	-1	8384253
st@@	O	-1	8384253
.	O	-1	8384253
S@@	O	-1	8384253
ym@@	O	-1	8384253
pto@@	O	-1	8384253
ms	O	-1	8384253
per@@	O	-1	8384253
sist@@	O	-1	8384253
ed	O	-1	8384253
maxim@@	O	-1	8384253
ally	O	-1	8384253
40	O	-1	8384253
months	O	-1	8384253
s@@	O	-1	8384253
inc@@	O	-1	8384253
e	O	-1	8384253
cess@@	O	-1	8384253
ation	O	-1	8384253
of	O	-1	8384253
therapy.	O	-1	8384253
There	O	-1	8384253
was	O	-1	8384253
no	O	-1	8384253
age	O	-1	8384253
difference	O	-1	8384253
between	O	-1	8384253
patients	O	-1	8384253
with	O	-1	8384253
and	O	-1	8384253
without	O	-1	8384253
com@@	O	-1	8384253
pl@@	O	-1	8384253
a@@	O	-1	8384253
int@@	O	-1	8384253
s	O	-1	8384253
at	O	-1	8384253
the	O	-1	8384253
time	O	-1	8384253
of	O	-1	8384253
examin@@	O	-1	8384253
ation.	O	-1	8384253
N@@	O	-1	8384253
orm@@	O	-1	8384253
al	O	-1	8384253
ref@@	O	-1	8384253
le@@	O	-1	8384253
x@@	O	-1	8384253
es	O	-1	8384253
were	O	-1	8384253
found	O	-1	8384253
in	O	-1	8384253
two	O	-1	8384253
thir@@	O	-1	8384253
d	O	-1	8384253
of	O	-1	8384253
patients.	O	-1	8384253
Ne@@	O	-1	8384253
uro@@	O	-1	8384253
path@@	O	-1	8384253
ic	O	-1	8384253
com@@	O	-1	8384253
pl@@	O	-1	8384253
a@@	O	-1	8384253
int@@	O	-1	8384253
s	O	-1	8384253
were	O	-1	8384253
not	O	-1	8384253
very	O	-1	8384253
t@@	O	-1	8384253
rou@@	O	-1	8384253
bl@@	O	-1	8384253
es@@	O	-1	8384253
ome	O	-1	8384253
on	O	-1	8384253
the	O	-1	8384253
lon@@	O	-1	8384253
g	O	-1	8384253
ter@@	O	-1	8384253
m.	O	-1	8384253
It	O	-1	8384253
is	O	-1	8384253
concl@@	O	-1	8384253
uded	O	-1	8384253
that	O	-1	8384253
with	O	-1	8384253
the	O	-1	8384253
ab@@	O	-1	8384253
o@@	O	-1	8384253
ve	O	-1	8384253
men@@	O	-1	8384253
tion@@	O	-1	8384253
ed	O	-1	8384253
v@@	B-Chemical	D014750	8384253
inc@@	I-Chemical	-1	8384253
ri@@	I-Chemical	-1	8384253
st@@	I-Chemical	-1	8384253
ine	I-Chemical	-1	8384253
dose	O	-1	8384253
sch@@	O	-1	8384253
ed@@	O	-1	8384253
ul@@	O	-1	8384253
e	O	-1	8384253
signs	O	-1	8384253
and	O	-1	8384253
symptoms	O	-1	8384253
of	O	-1	8384253
v@@	B-Chemical	D014750	8384253
inc@@	I-Chemical	-1	8384253
ri@@	I-Chemical	-1	8384253
st@@	I-Chemical	-1	8384253
ine	I-Chemical	-1	8384253
neuropathy	B-Disease	D009422	8384253
are	O	-1	8384253
reversible	O	-1	8384253
for	O	-1	8384253
a	O	-1	8384253
gre@@	O	-1	8384253
at	O	-1	8384253
de@@	O	-1	8384253
al	O	-1	8384253
and	O	-1	8384253
pro@@	O	-1	8384253
g@@	O	-1	8384253
no@@	O	-1	8384253
sis	O	-1	8384253
is	O	-1	8384253
f@@	O	-1	8384253
a@@	O	-1	8384253
ir@@	O	-1	8384253
ly	O	-1	8384253
go@@	O	-1	8384253
o@@	O	-1	8384253
d.	O	-1	8384253

A	O	-1	8268147
case	O	-1	8268147
of	O	-1	8268147
poly@@	B-Disease	D017285	8268147
my@@	I-Disease	-1	8268147
o@@	I-Disease	-1	8268147
si@@	I-Disease	-1	8268147
tis	I-Disease	-1	8268147
in	O	-1	8268147
a	O	-1	8268147
patient	O	-1	8268147
with	O	-1	8268147
prim@@	B-Disease	D008105	8268147
ary	I-Disease	-1	8268147
bil@@	I-Disease	-1	8268147
i@@	I-Disease	-1	8268147
ary	I-Disease	-1	8268147
cir@@	I-Disease	-1	8268147
r@@	I-Disease	-1	8268147
ho@@	I-Disease	-1	8268147
sis	I-Disease	-1	8268147
treated	O	-1	8268147
with	O	-1	8268147
D-@@	B-Chemical	D010396	8268147
pen@@	I-Chemical	-1	8268147
icill@@	I-Chemical	-1	8268147
amine	I-Chemical	-1	8268147
.	O	-1	8268147
Although	O	-1	8268147
D-@@	B-Chemical	D010396	8268147
pen@@	I-Chemical	-1	8268147
icill@@	I-Chemical	-1	8268147
amine	I-Chemical	-1	8268147
has	O	-1	8268147
been	O	-1	8268147
used	O	-1	8268147
for	O	-1	8268147
man@@	O	-1	8268147
y	O	-1	8268147
r@@	B-Disease	D012216	8268147
he@@	I-Disease	-1	8268147
um@@	I-Disease	-1	8268147
at@@	I-Disease	-1	8268147
ologic	I-Disease	-1	8268147
diseas@@	I-Disease	-1	8268147
es	I-Disease	-1	8268147
,	O	-1	8268147
toxicity	B-Disease	D064420	8268147
lim@@	O	-1	8268147
its	O	-1	8268147
its	O	-1	8268147
use@@	O	-1	8268147
ful@@	O	-1	8268147
ness	O	-1	8268147
in	O	-1	8268147
man@@	O	-1	8268147
y	O	-1	8268147
patients.	O	-1	8268147
P@@	B-Disease	D017285	8268147
oly@@	I-Disease	-1	8268147
my@@	I-Disease	-1	8268147
o@@	I-Disease	-1	8268147
si@@	I-Disease	-1	8268147
tis	I-Disease	-1	8268147
/	O	-1	8268147
der@@	B-Disease	D003882	8268147
mat@@	I-Disease	-1	8268147
om@@	I-Disease	-1	8268147
yo@@	I-Disease	-1	8268147
si@@	I-Disease	-1	8268147
tis	I-Disease	-1	8268147
can	O	-1	8268147
deve@@	O	-1	8268147
lo@@	O	-1	8268147
p	O	-1	8268147
as	O	-1	8268147
one	O	-1	8268147
of	O	-1	8268147
the	O	-1	8268147
auto@@	O	-1	8268147
immun@@	O	-1	8268147
e	O	-1	8268147
complications	O	-1	8268147
of	O	-1	8268147
D-@@	B-Chemical	D010396	8268147
pen@@	I-Chemical	-1	8268147
icill@@	I-Chemical	-1	8268147
amine	I-Chemical	-1	8268147
treatment,	O	-1	8268147
but	O	-1	8268147
its	O	-1	8268147
ex@@	O	-1	8268147
ac@@	O	-1	8268147
t	O	-1	8268147
path@@	O	-1	8268147
o@@	O	-1	8268147
genesis	O	-1	8268147
remain@@	O	-1	8268147
s	O	-1	8268147
unc@@	O	-1	8268147
lear@@	O	-1	8268147
.	O	-1	8268147
We	O	-1	8268147
report	O	-1	8268147
a	O	-1	8268147
patient	O	-1	8268147
with	O	-1	8268147
prim@@	B-Disease	D008105	8268147
ary	I-Disease	-1	8268147
bil@@	I-Disease	-1	8268147
i@@	I-Disease	-1	8268147
ary	I-Disease	-1	8268147
cir@@	I-Disease	-1	8268147
r@@	I-Disease	-1	8268147
ho@@	I-Disease	-1	8268147
sis	I-Disease	-1	8268147
,	O	-1	8268147
who	O	-1	8268147
developed	O	-1	8268147
poly@@	B-Disease	D017285	8268147
my@@	I-Disease	-1	8268147
o@@	I-Disease	-1	8268147
si@@	I-Disease	-1	8268147
tis	I-Disease	-1	8268147
while	O	-1	8268147
receiving	O	-1	8268147
D-@@	B-Chemical	D010396	8268147
pen@@	I-Chemical	-1	8268147
icill@@	I-Chemical	-1	8268147
amine	I-Chemical	-1	8268147
therapy.	O	-1	8268147
We	O	-1	8268147
descri@@	O	-1	8268147
bed	O	-1	8268147
the	O	-1	8268147
spec@@	O	-1	8268147
ial	O	-1	8268147
clinical	O	-1	8268147
course	O	-1	8268147
of	O	-1	8268147
the	O	-1	8268147
patient@@	O	-1	8268147
.	O	-1	8268147
Patients	O	-1	8268147
receiving	O	-1	8268147
D-@@	B-Chemical	D010396	8268147
pen@@	I-Chemical	-1	8268147
icill@@	I-Chemical	-1	8268147
amine	I-Chemical	-1	8268147
therapy	O	-1	8268147
should	O	-1	8268147
be	O	-1	8268147
followed	O	-1	8268147
ca@@	O	-1	8268147
ref@@	O	-1	8268147
ul@@	O	-1	8268147
ly	O	-1	8268147
for	O	-1	8268147
the	O	-1	8268147
development	O	-1	8268147
of	O	-1	8268147
auto@@	O	-1	8268147
immun@@	O	-1	8268147
e	O	-1	8268147
complications	O	-1	8268147
like	O	-1	8268147
poly@@	B-Disease	D017285	8268147
my@@	I-Disease	-1	8268147
o@@	I-Disease	-1	8268147
si@@	I-Disease	-1	8268147
tis	I-Disease	-1	8268147
/	O	-1	8268147
der@@	B-Disease	D003882	8268147
mat@@	I-Disease	-1	8268147
om@@	I-Disease	-1	8268147
yo@@	I-Disease	-1	8268147
si@@	I-Disease	-1	8268147
tis	I-Disease	-1	8268147
.	O	-1	8268147

Ph@@	O	-1	8251368
ot@@	O	-1	8251368
odi@@	O	-1	8251368
stri@@	O	-1	8251368
but@@	O	-1	8251368
ed	O	-1	8251368
n@@	B-Chemical	D009543	8251368
if@@	I-Chemical	-1	8251368
edi@@	I-Chemical	-1	8251368
pine	I-Chemical	-1	8251368
-induced	O	-1	8251368
fac@@	O	-1	8251368
ial	O	-1	8251368
te@@	B-Disease	D013684	8251368
l@@	I-Disease	-1	8251368
angi@@	I-Disease	-1	8251368
ect@@	I-Disease	-1	8251368
a@@	I-Disease	-1	8251368
sia	I-Disease	-1	8251368
.	O	-1	8251368
F@@	O	-1	8251368
i@@	O	-1	8251368
ve	O	-1	8251368
months	O	-1	8251368
after	O	-1	8251368
star@@	O	-1	8251368
ting	O	-1	8251368
n@@	B-Chemical	D009543	8251368
if@@	I-Chemical	-1	8251368
edi@@	I-Chemical	-1	8251368
pine	I-Chemical	-1	8251368
(	O	-1	8251368
Ad@@	B-Chemical	D009543	8251368
al@@	I-Chemical	-1	8251368
at	I-Chemical	-1	8251368
),	O	-1	8251368
two	O	-1	8251368
patients	O	-1	8251368
developed	O	-1	8251368
ph@@	O	-1	8251368
ot@@	O	-1	8251368
odi@@	O	-1	8251368
stri@@	O	-1	8251368
but@@	O	-1	8251368
ed	O	-1	8251368
fac@@	O	-1	8251368
ial	O	-1	8251368
te@@	B-Disease	D013684	8251368
l@@	I-Disease	-1	8251368
angi@@	I-Disease	-1	8251368
ect@@	I-Disease	-1	8251368
a@@	I-Disease	-1	8251368
sia	I-Disease	-1	8251368
,	O	-1	8251368
which	O	-1	8251368
b@@	O	-1	8251368
ec@@	O	-1	8251368
am@@	O	-1	8251368
e	O	-1	8251368
more	O	-1	8251368
no@@	O	-1	8251368
ti@@	O	-1	8251368
ce@@	O	-1	8251368
able	O	-1	8251368
with	O	-1	8251368
ti@@	O	-1	8251368
me.	O	-1	8251368
N@@	O	-1	8251368
either	O	-1	8251368
patient	O	-1	8251368
com@@	O	-1	8251368
pl@@	O	-1	8251368
ained	O	-1	8251368
of	O	-1	8251368
ph@@	O	-1	8251368
ot@@	O	-1	8251368
os@@	O	-1	8251368
en@@	O	-1	8251368
si@@	O	-1	8251368
tivity	O	-1	8251368
or	O	-1	8251368
f@@	B-Disease	D005483	8251368
l@@	I-Disease	-1	8251368
us@@	I-Disease	-1	8251368
h@@	I-Disease	-1	8251368
ing	I-Disease	-1	8251368
.	O	-1	8251368
B@@	O	-1	8251368
oth	O	-1	8251368
patients	O	-1	8251368
reported	O	-1	8251368
a	O	-1	8251368
significant	O	-1	8251368
co@@	O	-1	8251368
s@@	O	-1	8251368
me@@	O	-1	8251368
tic	O	-1	8251368
impro@@	O	-1	8251368
vement	O	-1	8251368
after	O	-1	8251368
discontinu@@	O	-1	8251368
ing	O	-1	8251368
the	O	-1	8251368
drug.	O	-1	8251368
One	O	-1	8251368
comm@@	O	-1	8251368
enc@@	O	-1	8251368
ed	O	-1	8251368
the	O	-1	8251368
clo@@	O	-1	8251368
se@@	O	-1	8251368
ly	O	-1	8251368
related	O	-1	8251368
drug	O	-1	8251368
am@@	B-Chemical	D017311	8251368
lo@@	I-Chemical	-1	8251368
di@@	I-Chemical	-1	8251368
pine	I-Chemical	-1	8251368
3	O	-1	8251368
years	O	-1	8251368
lat@@	O	-1	8251368
er,	O	-1	8251368
with	O	-1	8251368
recur@@	O	-1	8251368
rence	O	-1	8251368
of	O	-1	8251368
te@@	B-Disease	D013684	8251368
l@@	I-Disease	-1	8251368
angi@@	I-Disease	-1	8251368
ect@@	I-Disease	-1	8251368
a@@	I-Disease	-1	8251368
sia	I-Disease	-1	8251368
.	O	-1	8251368
The	O	-1	8251368
ph@@	O	-1	8251368
ot@@	O	-1	8251368
odi@@	O	-1	8251368
stri@@	O	-1	8251368
bu@@	O	-1	8251368
tion	O	-1	8251368
of	O	-1	8251368
the	O	-1	8251368
te@@	B-Disease	D013684	8251368
l@@	I-Disease	-1	8251368
angi@@	I-Disease	-1	8251368
ect@@	I-Disease	-1	8251368
a@@	I-Disease	-1	8251368
sia	I-Disease	-1	8251368
suggests	O	-1	8251368
a	O	-1	8251368
significant	O	-1	8251368
dru@@	O	-1	8251368
g/@@	O	-1	8251368
li@@	O	-1	8251368
ght	O	-1	8251368
inter@@	O	-1	8251368
ac@@	O	-1	8251368
tion.	O	-1	8251368

Ne@@	B-Disease	D007674	7542793
ph@@	I-Disease	-1	7542793
ro@@	I-Disease	-1	7542793
toxicity	I-Disease	-1	7542793
of	O	-1	7542793
cyclospor@@	B-Chemical	D016572	7542793
in	I-Chemical	-1	7542793
A	I-Chemical	-1	7542793
and	O	-1	7542793
FK50@@	B-Chemical	D016559	7542793
6	I-Chemical	-1	7542793
:	O	-1	7542793
inhibition	O	-1	7542793
of	O	-1	7542793
calc@@	O	-1	7542793
ine@@	O	-1	7542793
ur@@	O	-1	7542793
in	O	-1	7542793
phosph@@	O	-1	7542793
at@@	O	-1	7542793
as@@	O	-1	7542793
e.	O	-1	7542793
C@@	B-Chemical	D016572	7542793
yc@@	I-Chemical	-1	7542793
lospor@@	I-Chemical	-1	7542793
in	I-Chemical	-1	7542793
A	I-Chemical	-1	7542793
(	O	-1	7542793
C@@	B-Chemical	D016572	7542793
s@@	I-Chemical	-1	7542793
A	I-Chemical	-1	7542793
;	O	-1	7542793
50	O	-1	7542793
mg/kg)	O	-1	7542793
and	O	-1	7542793
F@@	B-Chemical	D016559	7542793
u@@	I-Chemical	-1	7542793
j@@	I-Chemical	-1	7542793
im@@	I-Chemical	-1	7542793
yc@@	I-Chemical	-1	7542793
ine	I-Chemical	-1	7542793
(	O	-1	7542793
FK50@@	B-Chemical	D016559	7542793
6	I-Chemical	-1	7542793
;	O	-1	7542793
5	O	-1	7542793
mg/kg@@	O	-1	7542793
),	O	-1	7542793
but	O	-1	7542793
not	O	-1	7542793
the	O	-1	7542793
related	O	-1	7542793
mac@@	B-Chemical	D018942	7542793
ro@@	I-Chemical	-1	7542793
l@@	I-Chemical	-1	7542793
ide	I-Chemical	-1	7542793
immunosup@@	O	-1	7542793
press@@	O	-1	7542793
ant	O	-1	7542793
ra@@	B-Chemical	D020123	7542793
p@@	I-Chemical	-1	7542793
am@@	I-Chemical	-1	7542793
ycin	I-Chemical	-1	7542793
(@@	O	-1	7542793
5	O	-1	7542793
mg/kg@@	O	-1	7542793
),	O	-1	7542793
caused	O	-1	7542793
a	O	-1	7542793
reduction	O	-1	7542793
of	O	-1	7542793
glomerular	O	-1	7542793
f@@	O	-1	7542793
iltration	O	-1	7542793
rat@@	O	-1	7542793
e,	O	-1	7542793
de@@	O	-1	7542793
gener@@	O	-1	7542793
ative	O	-1	7542793
changes	O	-1	7542793
of	O	-1	7542793
pro@@	O	-1	7542793
xim@@	O	-1	7542793
al	O	-1	7542793
tub@@	O	-1	7542793
ular	O	-1	7542793
epi@@	O	-1	7542793
the@@	O	-1	7542793
li@@	O	-1	7542793
um,	O	-1	7542793
and	O	-1	7542793
hyper@@	B-Disease	D006984	7542793
tro@@	I-Disease	-1	7542793
ph@@	I-Disease	-1	7542793
y	I-Disease	-1	7542793
of	O	-1	7542793
the	O	-1	7542793
j@@	O	-1	7542793
u@@	O	-1	7542793
x@@	O	-1	7542793
t@@	O	-1	7542793
ag@@	O	-1	7542793
lo@@	O	-1	7542793
mer@@	O	-1	7542793
ular	O	-1	7542793
ap@@	O	-1	7542793
par@@	O	-1	7542793
at@@	O	-1	7542793
us	O	-1	7542793
in	O	-1	7542793
male	O	-1	7542793
Wistar	O	-1	7542793
rats	O	-1	7542793
when	O	-1	7542793
given	O	-1	7542793
for	O	-1	7542793
10	O	-1	7542793
days.	O	-1	7542793
The	O	-1	7542793
mol@@	O	-1	7542793
ec@@	O	-1	7542793
ular	O	-1	7542793
mechanisms	O	-1	7542793
of	O	-1	7542793
C@@	B-Chemical	D016572	7542793
s@@	I-Chemical	-1	7542793
A	I-Chemical	-1	7542793
and	O	-1	7542793
FK50@@	B-Chemical	D016559	7542793
6	I-Chemical	-1	7542793
toxicity	B-Disease	D064420	7542793
were	O	-1	7542793
investig@@	O	-1	7542793
ated.	O	-1	7542793
C@@	O	-1	7542793
yc@@	O	-1	7542793
lo@@	O	-1	7542793
ph@@	O	-1	7542793
il@@	O	-1	7542793
in	O	-1	7542793
A	O	-1	7542793
and	O	-1	7542793
FK50@@	B-Chemical	D016559	7542793
6	I-Chemical	-1	7542793
-@@	O	-1	7542793
b@@	O	-1	7542793
ind@@	O	-1	7542793
ing	O	-1	7542793
protein@@	O	-1	7542793
,	O	-1	7542793
the	O	-1	7542793
ma@@	O	-1	7542793
in	O	-1	7542793
intrac@@	O	-1	7542793
y@@	O	-1	7542793
to@@	O	-1	7542793
plas@@	O	-1	7542793
mic	O	-1	7542793
receptors	O	-1	7542793
for	O	-1	7542793
C@@	B-Chemical	D016572	7542793
s@@	I-Chemical	-1	7542793
A	I-Chemical	-1	7542793
and	O	-1	7542793
FK50@@	B-Chemical	D016559	7542793
6	I-Chemical	-1	7542793
,	O	-1	7542793
respectivel@@	O	-1	7542793
y,	O	-1	7542793
were	O	-1	7542793
each	O	-1	7542793
det@@	O	-1	7542793
ected	O	-1	7542793
in	O	-1	7542793
renal	O	-1	7542793
tissue	O	-1	7542793
extrac@@	O	-1	7542793
t.	O	-1	7542793
In	O	-1	7542793
the	O	-1	7542793
kidne@@	O	-1	7542793
y,	O	-1	7542793
high	O	-1	7542793
levels	O	-1	7542793
of	O	-1	7542793
immuno@@	O	-1	7542793
reac@@	O	-1	7542793
tive	O	-1	7542793
and	O	-1	7542793
enzym@@	O	-1	7542793
ati@@	O	-1	7542793
c@@	O	-1	7542793
ally	O	-1	7542793
active	O	-1	7542793
calc@@	O	-1	7542793
ine@@	O	-1	7542793
ur@@	O	-1	7542793
in	O	-1	7542793
were	O	-1	7542793
found	O	-1	7542793
which	O	-1	7542793
were	O	-1	7542793
inhibited	O	-1	7542793
by	O	-1	7542793
the	O	-1	7542793
immunosup@@	O	-1	7542793
press@@	O	-1	7542793
ants	O	-1	7542793
C@@	B-Chemical	D016572	7542793
s@@	I-Chemical	-1	7542793
A	I-Chemical	-1	7542793
and	O	-1	7542793
FK50@@	B-Chemical	D016559	7542793
6	I-Chemical	-1	7542793
,	O	-1	7542793
but	O	-1	7542793
not	O	-1	7542793
by	O	-1	7542793
ra@@	B-Chemical	D020123	7542793
p@@	I-Chemical	-1	7542793
am@@	I-Chemical	-1	7542793
ycin	I-Chemical	-1	7542793
.	O	-1	7542793
F@@	O	-1	7542793
in@@	O	-1	7542793
ally,	O	-1	7542793
specific	O	-1	7542793
immun@@	O	-1	7542793
oph@@	O	-1	7542793
il@@	O	-1	7542793
in-@@	O	-1	7542793
drug@@	O	-1	7542793
-@@	O	-1	7542793
calc@@	O	-1	7542793
ine@@	O	-1	7542793
ur@@	O	-1	7542793
in	O	-1	7542793
comple@@	O	-1	7542793
x@@	O	-1	7542793
es	O	-1	7542793
form@@	O	-1	7542793
ed	O	-1	7542793
only	O	-1	7542793
in	O	-1	7542793
the	O	-1	7542793
presence	O	-1	7542793
of	O	-1	7542793
C@@	B-Chemical	D016572	7542793
s@@	I-Chemical	-1	7542793
A	I-Chemical	-1	7542793
and	O	-1	7542793
FK50@@	B-Chemical	D016559	7542793
6	I-Chemical	-1	7542793
,	O	-1	7542793
but	O	-1	7542793
not	O	-1	7542793
ra@@	B-Chemical	D020123	7542793
p@@	I-Chemical	-1	7542793
am@@	I-Chemical	-1	7542793
ycin	I-Chemical	-1	7542793
.	O	-1	7542793
These	O	-1	7542793
results	O	-1	7542793
suggest	O	-1	7542793
that	O	-1	7542793
the	O	-1	7542793
nephro@@	B-Disease	D007674	7542793
toxic	I-Disease	-1	7542793
effects	O	-1	7542793
of	O	-1	7542793
C@@	B-Chemical	D016572	7542793
s@@	I-Chemical	-1	7542793
A	I-Chemical	-1	7542793
and	O	-1	7542793
FK50@@	B-Chemical	D016559	7542793
6	I-Chemical	-1	7542793
is	O	-1	7542793
likely	O	-1	7542793
mediated	O	-1	7542793
through	O	-1	7542793
b@@	O	-1	7542793
ind@@	O	-1	7542793
ing	O	-1	7542793
to	O	-1	7542793
renal	O	-1	7542793
immun@@	O	-1	7542793
oph@@	O	-1	7542793
il@@	O	-1	7542793
in	O	-1	7542793
and	O	-1	7542793
inhibit@@	O	-1	7542793
ing	O	-1	7542793
calc@@	O	-1	7542793
ine@@	O	-1	7542793
ur@@	O	-1	7542793
in	O	-1	7542793
phosph@@	O	-1	7542793
at@@	O	-1	7542793
as@@	O	-1	7542793
e.	O	-1	7542793

M@@	O	-1	7337133
as@@	O	-1	7337133
sive	O	-1	7337133
cerebral	B-Disease	D001929	7337133
e@@	I-Disease	-1	7337133
de@@	I-Disease	-1	7337133
ma	I-Disease	-1	7337133
associated	O	-1	7337133
with	O	-1	7337133
ful@@	O	-1	7337133
min@@	O	-1	7337133
ant	O	-1	7337133
hepatic	B-Disease	D017093	7337133
failure	I-Disease	-1	7337133
in	O	-1	7337133
acet@@	B-Chemical	D000082	7337133
aminoph@@	I-Chemical	-1	7337133
en	I-Chemical	-1	7337133
over@@	B-Disease	D062787	7337133
dose	I-Disease	-1	7337133
:	O	-1	7337133
possible	O	-1	7337133
role	O	-1	7337133
of	O	-1	7337133
c@@	O	-1	7337133
ranial	O	-1	7337133
dec@@	O	-1	7337133
om@@	O	-1	7337133
pres@@	O	-1	7337133
sion.	O	-1	7337133
C@@	B-Disease	D001929	7337133
e@@	I-Disease	-1	7337133
rebral	I-Disease	-1	7337133
e@@	I-Disease	-1	7337133
de@@	I-Disease	-1	7337133
ma	I-Disease	-1	7337133
may	O	-1	7337133
complic@@	O	-1	7337133
ate	O	-1	7337133
the	O	-1	7337133
course	O	-1	7337133
of	O	-1	7337133
ful@@	B-Disease	D017093	7337133
min@@	I-Disease	-1	7337133
ant	I-Disease	-1	7337133
hepatic	I-Disease	-1	7337133
failure	I-Disease	-1	7337133
.	O	-1	7337133
R@@	O	-1	7337133
es@@	O	-1	7337133
p@@	O	-1	7337133
on@@	O	-1	7337133
se	O	-1	7337133
to	O	-1	7337133
con@@	O	-1	7337133
ven@@	O	-1	7337133
tional	O	-1	7337133
therapy	O	-1	7337133
has	O	-1	7337133
been	O	-1	7337133
dis@@	O	-1	7337133
ap@@	O	-1	7337133
po@@	O	-1	7337133
int@@	O	-1	7337133
ing.	O	-1	7337133
We	O	-1	7337133
present	O	-1	7337133
a	O	-1	7337133
patient	O	-1	7337133
with	O	-1	7337133
f@@	O	-1	7337133
atal	O	-1	7337133
acet@@	B-Chemical	D000082	7337133
aminoph@@	I-Chemical	-1	7337133
en	I-Chemical	-1	7337133
-induced	O	-1	7337133
ful@@	B-Disease	D017093	7337133
min@@	I-Disease	-1	7337133
ant	I-Disease	-1	7337133
hepatic	I-Disease	-1	7337133
failure	I-Disease	-1	7337133
,	O	-1	7337133
with	O	-1	7337133
signs	O	-1	7337133
and	O	-1	7337133
symptoms	O	-1	7337133
of	O	-1	7337133
cerebral	B-Disease	D001929	7337133
e@@	I-Disease	-1	7337133
de@@	I-Disease	-1	7337133
ma	I-Disease	-1	7337133
,	O	-1	7337133
un@@	O	-1	7337133
respon@@	O	-1	7337133
sive	O	-1	7337133
to	O	-1	7337133
con@@	O	-1	7337133
ven@@	O	-1	7337133
tional	O	-1	7337133
med@@	O	-1	7337133
ical	O	-1	7337133
therapy.	O	-1	7337133
C@@	O	-1	7337133
ranial	O	-1	7337133
dec@@	O	-1	7337133
om@@	O	-1	7337133
pression	O	-1	7337133
was	O	-1	7337133
car@@	O	-1	7337133
ri@@	O	-1	7337133
ed	O	-1	7337133
out@@	O	-1	7337133
.	O	-1	7337133
A	O	-1	7337133
j@@	O	-1	7337133
us@@	O	-1	7337133
ti@@	O	-1	7337133
fic@@	O	-1	7337133
ation	O	-1	7337133
of	O	-1	7337133
the	O	-1	7337133
need	O	-1	7337133
for	O	-1	7337133
further	O	-1	7337133
evalu@@	O	-1	7337133
ation	O	-1	7337133
of	O	-1	7337133
c@@	O	-1	7337133
ranial	O	-1	7337133
dec@@	O	-1	7337133
om@@	O	-1	7337133
pression	O	-1	7337133
in	O	-1	7337133
such	O	-1	7337133
patients	O	-1	7337133
is	O	-1	7337133
present@@	O	-1	7337133
ed.	O	-1	7337133

G@@	B-Chemical	D005839	4069770
ent@@	I-Chemical	-1	4069770
am@@	I-Chemical	-1	4069770
icin	I-Chemical	-1	4069770
nephro@@	B-Disease	D007674	4069770
pathy	I-Disease	-1	4069770
in	O	-1	4069770
a	O	-1	4069770
ne@@	O	-1	4069770
on@@	O	-1	4069770
at@@	O	-1	4069770
e.	O	-1	4069770
The	O	-1	4069770
clinical	O	-1	4069770
and	O	-1	4069770
auto@@	O	-1	4069770
p@@	O	-1	4069770
sy	O	-1	4069770
findings	O	-1	4069770
in	O	-1	4069770
a	O	-1	4069770
pre@@	O	-1	4069770
mat@@	O	-1	4069770
ure	O	-1	4069770
b@@	O	-1	4069770
a@@	O	-1	4069770
by	O	-1	4069770
who	O	-1	4069770
di@@	O	-1	4069770
ed	O	-1	4069770
of	O	-1	4069770
acute	B-Disease	D058186	4069770
renal	I-Disease	-1	4069770
failure	I-Disease	-1	4069770
after	O	-1	4069770
therapy	O	-1	4069770
with	O	-1	4069770
g@@	B-Chemical	D005839	4069770
ent@@	I-Chemical	-1	4069770
am@@	I-Chemical	-1	4069770
icin	I-Chemical	-1	4069770
(@@	O	-1	4069770
5	O	-1	4069770
mg/k@@	O	-1	4069770
g/@@	O	-1	4069770
day@@	O	-1	4069770
)	O	-1	4069770
and	O	-1	4069770
pen@@	B-Chemical	D010406	4069770
icill@@	I-Chemical	-1	4069770
in	I-Chemical	-1	4069770
are	O	-1	4069770
present@@	O	-1	4069770
ed.	O	-1	4069770
The	O	-1	4069770
serum	O	-1	4069770
g@@	B-Chemical	D005839	4069770
ent@@	I-Chemical	-1	4069770
am@@	I-Chemical	-1	4069770
icin	I-Chemical	-1	4069770
concentration	O	-1	4069770
had	O	-1	4069770
reac@@	O	-1	4069770
h@@	O	-1	4069770
ed	O	-1	4069770
toxic	O	-1	4069770
levels	O	-1	4069770
when	O	-1	4069770
an@@	B-Disease	D001002	4069770
uria	I-Disease	-1	4069770
develop@@	O	-1	4069770
ed.	O	-1	4069770
N@@	O	-1	4069770
um@@	O	-1	4069770
er@@	O	-1	4069770
ous	O	-1	4069770
perio@@	B-Chemical	D010504	4069770
di@@	I-Chemical	-1	4069770
c	I-Chemical	-1	4069770
acid	I-Chemical	-1	4069770
S@@	O	-1	4069770
ch@@	O	-1	4069770
if@@	O	-1	4069770
f	O	-1	4069770
(@@	O	-1	4069770
PA@@	O	-1	4069770
S)	O	-1	4069770
posi@@	O	-1	4069770
ti@@	O	-1	4069770
ve,	O	-1	4069770
di@@	O	-1	4069770
ast@@	O	-1	4069770
ase	O	-1	4069770
resist@@	O	-1	4069770
ant	O	-1	4069770
cyto@@	O	-1	4069770
plas@@	O	-1	4069770
mic	O	-1	4069770
inc@@	O	-1	4069770
lu@@	O	-1	4069770
sion	O	-1	4069770
bo@@	O	-1	4069770
di@@	O	-1	4069770
es	O	-1	4069770
which	O	-1	4069770
appe@@	O	-1	4069770
a@@	O	-1	4069770
red	O	-1	4069770
as	O	-1	4069770
my@@	O	-1	4069770
el@@	O	-1	4069770
in	O	-1	4069770
fi@@	O	-1	4069770
g@@	O	-1	4069770
ures	O	-1	4069770
in	O	-1	4069770
cyto@@	O	-1	4069770
se@@	O	-1	4069770
gres@@	O	-1	4069770
om@@	O	-1	4069770
es	O	-1	4069770
under	O	-1	4069770
the	O	-1	4069770
electro@@	O	-1	4069770
n	O	-1	4069770
micro@@	O	-1	4069770
sco@@	O	-1	4069770
p@@	O	-1	4069770
e	O	-1	4069770
were	O	-1	4069770
identi@@	O	-1	4069770
fied	O	-1	4069770
in	O	-1	4069770
the	O	-1	4069770
pro@@	O	-1	4069770
xim@@	O	-1	4069770
al	O	-1	4069770
con@@	O	-1	4069770
vol@@	O	-1	4069770
ut@@	O	-1	4069770
ed	O	-1	4069770
tub@@	O	-1	4069770
ul@@	O	-1	4069770
es.	O	-1	4069770
The	O	-1	4069770
path@@	O	-1	4069770
ological	O	-1	4069770
changes	O	-1	4069770
induced	O	-1	4069770
by	O	-1	4069770
g@@	B-Chemical	D005839	4069770
ent@@	I-Chemical	-1	4069770
am@@	I-Chemical	-1	4069770
icin	I-Chemical	-1	4069770
in	O	-1	4069770
the	O	-1	4069770
human	O	-1	4069770
ne@@	O	-1	4069770
on@@	O	-1	4069770
atal	O	-1	4069770
kidne@@	O	-1	4069770
ys	O	-1	4069770
have	O	-1	4069770
not	O	-1	4069770
been	O	-1	4069770
previously	O	-1	4069770
repor@@	O	-1	4069770
ted.	O	-1	4069770

An@@	O	-1	3780814
ti@@	O	-1	3780814
-	O	-1	3780814
carcino@@	B-Disease	D063646	3780814
genic	I-Disease	-1	3780814
action	O	-1	3780814
of	O	-1	3780814
phenobarbit@@	B-Chemical	D010634	3780814
al	I-Chemical	-1	3780814
given	O	-1	3780814
sim@@	O	-1	3780814
ult@@	O	-1	3780814
ane@@	O	-1	3780814
ously	O	-1	3780814
with	O	-1	3780814
di@@	B-Chemical	D004052	3780814
eth@@	I-Chemical	-1	3780814
yl@@	I-Chemical	-1	3780814
nit@@	I-Chemical	-1	3780814
ros@@	I-Chemical	-1	3780814
amine	I-Chemical	-1	3780814
in	O	-1	3780814
the	O	-1	3780814
rat@@	O	-1	3780814
.	O	-1	3780814
The	O	-1	3780814
present	O	-1	3780814
wor@@	O	-1	3780814
k	O	-1	3780814
has	O	-1	3780814
been	O	-1	3780814
pl@@	O	-1	3780814
an@@	O	-1	3780814
n@@	O	-1	3780814
ed	O	-1	3780814
in	O	-1	3780814
or@@	O	-1	3780814
der	O	-1	3780814
to	O	-1	3780814
el@@	O	-1	3780814
uc@@	O	-1	3780814
id@@	O	-1	3780814
ate	O	-1	3780814
the	O	-1	3780814
effect	O	-1	3780814
of	O	-1	3780814
phenobarbit@@	B-Chemical	D010634	3780814
al	I-Chemical	-1	3780814
(	O	-1	3780814
P@@	B-Chemical	D010634	3780814
B	I-Chemical	-1	3780814
:	O	-1	3780814
15	O	-1	3780814
mg	O	-1	3780814
per	O	-1	3780814
rat	O	-1	3780814
of	O	-1	3780814
ing@@	O	-1	3780814
est@@	O	-1	3780814
ed	O	-1	3780814
dose@@	O	-1	3780814
)	O	-1	3780814
on	O	-1	3780814
carcino@@	B-Disease	D063646	3780814
genesis	I-Disease	-1	3780814
when	O	-1	3780814
it	O	-1	3780814
is	O	-1	3780814
administered	O	-1	3780814
sim@@	O	-1	3780814
ult@@	O	-1	3780814
ane@@	O	-1	3780814
ously	O	-1	3780814
with	O	-1	3780814
di@@	B-Chemical	D004052	3780814
eth@@	I-Chemical	-1	3780814
yl@@	I-Chemical	-1	3780814
nit@@	I-Chemical	-1	3780814
ros@@	I-Chemical	-1	3780814
amine	I-Chemical	-1	3780814
(	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
:	O	-1	3780814
10	O	-1	3780814
mg/k@@	O	-1	3780814
g/@@	O	-1	3780814
day@@	O	-1	3780814
).	O	-1	3780814
Wistar	O	-1	3780814
rats	O	-1	3780814
(1@@	O	-1	3780814
8@@	O	-1	3780814
0	O	-1	3780814
g@@	O	-1	3780814
)	O	-1	3780814
were	O	-1	3780814
treated	O	-1	3780814
by	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
alone	O	-1	3780814
or	O	-1	3780814
by	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
+	O	-1	3780814
P@@	B-Chemical	D010634	3780814
B	I-Chemical	-1	3780814
during	O	-1	3780814
2,	O	-1	3780814
4	O	-1	3780814
and	O	-1	3780814
6	O	-1	3780814
weeks	O	-1	3780814
ac@@	O	-1	3780814
cor@@	O	-1	3780814
ding	O	-1	3780814
to	O	-1	3780814
our	O	-1	3780814
sch@@	O	-1	3780814
ed@@	O	-1	3780814
ul@@	O	-1	3780814
e	O	-1	3780814
for	O	-1	3780814
hepat@@	B-Disease	D063646	3780814
oc@@	I-Disease	-1	3780814
arc@@	I-Disease	-1	3780814
ino@@	I-Disease	-1	3780814
genesis	I-Disease	-1	3780814
.	O	-1	3780814
After	O	-1	3780814
the	O	-1	3780814
end	O	-1	3780814
of	O	-1	3780814
the	O	-1	3780814
treatment,	O	-1	3780814
the	O	-1	3780814
number	O	-1	3780814
and	O	-1	3780814
the	O	-1	3780814
size	O	-1	3780814
of	O	-1	3780814
induced	O	-1	3780814
PA@@	O	-1	3780814
S	O	-1	3780814
positive	O	-1	3780814
pre@@	B-Disease	D011230	3780814
ne@@	I-Disease	-1	3780814
o@@	I-Disease	-1	3780814
plas@@	I-Disease	-1	3780814
tic	I-Disease	-1	3780814
foc@@	I-Disease	-1	3780814
i	I-Disease	-1	3780814
was	O	-1	3780814
significantly	O	-1	3780814
reduced	O	-1	3780814
when	O	-1	3780814
P@@	B-Chemical	D010634	3780814
B	I-Chemical	-1	3780814
was	O	-1	3780814
given	O	-1	3780814
sim@@	O	-1	3780814
ult@@	O	-1	3780814
ane@@	O	-1	3780814
ously	O	-1	3780814
with	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
for	O	-1	3780814
4	O	-1	3780814
and	O	-1	3780814
6	O	-1	3780814
week@@	O	-1	3780814
s.	O	-1	3780814
The	O	-1	3780814
mit@@	O	-1	3780814
o@@	O	-1	3780814
tic	O	-1	3780814
inhibition	O	-1	3780814
and	O	-1	3780814
the	O	-1	3780814
pro@@	O	-1	3780814
duction	O	-1	3780814
of	O	-1	3780814
mic@@	O	-1	3780814
ron@@	O	-1	3780814
ucle@@	O	-1	3780814
i	O	-1	3780814
norm@@	O	-1	3780814
ally	O	-1	3780814
observed	O	-1	3780814
after	O	-1	3780814
partial	O	-1	3780814
hepat@@	O	-1	3780814
ect@@	O	-1	3780814
om@@	O	-1	3780814
y	O	-1	3780814
in	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
treated	O	-1	3780814
rats	O	-1	3780814
were	O	-1	3780814
also	O	-1	3780814
significantly	O	-1	3780814
decreased	O	-1	3780814
in	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
+	O	-1	3780814
P@@	B-Chemical	D010634	3780814
B	I-Chemical	-1	3780814
treated	O	-1	3780814
rats.	O	-1	3780814
Whe@@	O	-1	3780814
n	O	-1	3780814
the	O	-1	3780814
treatment	O	-1	3780814
las@@	O	-1	3780814
t	O	-1	3780814
only	O	-1	3780814
2	O	-1	3780814
week@@	O	-1	3780814
s,	O	-1	3780814
the	O	-1	3780814
presence	O	-1	3780814
of	O	-1	3780814
P@@	B-Chemical	D010634	3780814
B	I-Chemical	-1	3780814
did	O	-1	3780814
not	O	-1	3780814
change	O	-1	3780814
significantly	O	-1	3780814
the	O	-1	3780814
las@@	O	-1	3780814
t	O	-1	3780814
par@@	O	-1	3780814
ame@@	O	-1	3780814
ter@@	O	-1	3780814
s.	O	-1	3780814
In	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
+	O	-1	3780814
P@@	B-Chemical	D010634	3780814
B	I-Chemical	-1	3780814
treated	O	-1	3780814
rats,	O	-1	3780814
the	O	-1	3780814
sur@@	O	-1	3780814
viv@@	O	-1	3780814
al	O	-1	3780814
was	O	-1	3780814
prolonged	O	-1	3780814
and	O	-1	3780814
the	O	-1	3780814
tumor	B-Disease	D009369	3780814
incidence	O	-1	3780814
decreased	O	-1	3780814
as	O	-1	3780814
compared	O	-1	3780814
with	O	-1	3780814
the	O	-1	3780814
results	O	-1	3780814
obtained	O	-1	3780814
by	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
al@@	O	-1	3780814
one.	O	-1	3780814
It	O	-1	3780814
is	O	-1	3780814
concl@@	O	-1	3780814
uded	O	-1	3780814
that	O	-1	3780814
P@@	B-Chemical	D010634	3780814
B	I-Chemical	-1	3780814
,	O	-1	3780814
which	O	-1	3780814
pro@@	O	-1	3780814
m@@	O	-1	3780814
ot@@	O	-1	3780814
es	O	-1	3780814
carcino@@	B-Disease	D063646	3780814
genesis	I-Disease	-1	3780814
when	O	-1	3780814
administered	O	-1	3780814
after	O	-1	3780814
the	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
treatment,	O	-1	3780814
reduc@@	O	-1	3780814
es	O	-1	3780814
the	O	-1	3780814
carcino@@	O	-1	3780814
gen	O	-1	3780814
effect	O	-1	3780814
when	O	-1	3780814
given	O	-1	3780814
sim@@	O	-1	3780814
ult@@	O	-1	3780814
ane@@	O	-1	3780814
ously	O	-1	3780814
with	O	-1	3780814
D@@	B-Chemical	D004052	3780814
E@@	I-Chemical	-1	3780814
N	I-Chemical	-1	3780814
.	O	-1	3780814
This	O	-1	3780814
'@@	O	-1	3780814
anti@@	O	-1	3780814
-@@	O	-1	3780814
carcino@@	O	-1	3780814
gen@@	O	-1	3780814
'	O	-1	3780814
effect	O	-1	3780814
act@@	O	-1	3780814
s	O	-1	3780814
on	O	-1	3780814
the	O	-1	3780814
initi@@	O	-1	3780814
ation	O	-1	3780814
as	O	-1	3780814
well	O	-1	3780814
as	O	-1	3780814
on	O	-1	3780814
the	O	-1	3780814
pro@@	O	-1	3780814
mo@@	O	-1	3780814
tion	O	-1	3780814
of	O	-1	3780814
the	O	-1	3780814
pre@@	B-Disease	D011230	3780814
canc@@	I-Disease	-1	3780814
er@@	I-Disease	-1	3780814
ous	I-Disease	-1	3780814
lesions	I-Disease	-1	3780814
.	O	-1	3780814
B@@	O	-1	3780814
io@@	O	-1	3780814
chemical	O	-1	3780814
investig@@	O	-1	3780814
ations	O	-1	3780814
are	O	-1	3780814
in	O	-1	3780814
progres@@	O	-1	3780814
s	O	-1	3780814
to	O	-1	3780814
obt@@	O	-1	3780814
ain	O	-1	3780814
more	O	-1	3780814
inf@@	O	-1	3780814
orm@@	O	-1	3780814
ation	O	-1	3780814
about	O	-1	3780814
this	O	-1	3780814
'@@	O	-1	3780814
par@@	O	-1	3780814
ad@@	O	-1	3780814
oxic@@	O	-1	3780814
al@@	O	-1	3780814
'	O	-1	3780814
P@@	B-Chemical	D010634	3780814
B	I-Chemical	-1	3780814
effect@@	O	-1	3780814
.	O	-1	3780814

P@@	O	-1	3780697
ost@@	O	-1	3780697
-@@	O	-1	3780697
o@@	O	-1	3780697
perative	O	-1	3780697
rig@@	B-Disease	D009127	3780697
idity	I-Disease	-1	3780697
after	O	-1	3780697
f@@	B-Chemical	D005283	3780697
entan@@	I-Chemical	-1	3780697
yl	I-Chemical	-1	3780697
administr@@	O	-1	3780697
ation.	O	-1	3780697
A	O	-1	3780697
case	O	-1	3780697
of	O	-1	3780697
th@@	O	-1	3780697
or@@	O	-1	3780697
ac@@	O	-1	3780697
o@@	O	-1	3780697
-@@	O	-1	3780697
ab@@	O	-1	3780697
domin@@	O	-1	3780697
al	O	-1	3780697
rig@@	B-Disease	D009127	3780697
idity	I-Disease	-1	3780697
lead@@	O	-1	3780697
ing	O	-1	3780697
to	O	-1	3780697
respiratory	B-Disease	D012131	3780697
failure	I-Disease	-1	3780697
is	O	-1	3780697
descri@@	O	-1	3780697
bed	O	-1	3780697
in	O	-1	3780697
the	O	-1	3780697
post@@	O	-1	3780697
-@@	O	-1	3780697
o@@	O	-1	3780697
perative	O	-1	3780697
period	O	-1	3780697
in	O	-1	3780697
an	O	-1	3780697
el@@	O	-1	3780697
der@@	O	-1	3780697
ly	O	-1	3780697
patient	O	-1	3780697
who	O	-1	3780697
received	O	-1	3780697
a	O	-1	3780697
moder@@	O	-1	3780697
ate	O	-1	3780697
dose	O	-1	3780697
of	O	-1	3780697
f@@	B-Chemical	D005283	3780697
entan@@	I-Chemical	-1	3780697
yl	I-Chemical	-1	3780697
.	O	-1	3780697
This	O	-1	3780697
was	O	-1	3780697
suc@@	O	-1	3780697
cess@@	O	-1	3780697
ful@@	O	-1	3780697
ly	O	-1	3780697
reversed	O	-1	3780697
by	O	-1	3780697
n@@	B-Chemical	D009270	3780697
al@@	I-Chemical	-1	3780697
ox@@	I-Chemical	-1	3780697
one	I-Chemical	-1	3780697
.	O	-1	3780697
The	O	-1	3780697
mechanisms	O	-1	3780697
possib@@	O	-1	3780697
ly	O	-1	3780697
implic@@	O	-1	3780697
ated	O	-1	3780697
in	O	-1	3780697
this	O	-1	3780697
ac@@	O	-1	3780697
c@@	O	-1	3780697
id@@	O	-1	3780697
ent	O	-1	3780697
are	O	-1	3780697
discus@@	O	-1	3780697
sed.	O	-1	3780697

P@@	O	-1	3686155
ost@@	O	-1	3686155
part@@	O	-1	3686155
um	O	-1	3686155
psycho@@	B-Disease	D011605	3686155
sis	I-Disease	-1	3686155
induced	O	-1	3686155
by	O	-1	3686155
brom@@	B-Chemical	D001971	3686155
oc@@	I-Chemical	-1	3686155
ript@@	I-Chemical	-1	3686155
ine	I-Chemical	-1	3686155
.	O	-1	3686155
Two	O	-1	3686155
multi@@	O	-1	3686155
gra@@	O	-1	3686155
vid@@	O	-1	3686155
a	O	-1	3686155
patients	O	-1	3686155
with	O	-1	3686155
no	O	-1	3686155
prior	O	-1	3686155
psych@@	B-Disease	D001523	3686155
i@@	I-Disease	-1	3686155
atric	I-Disease	-1	3686155
hist@@	O	-1	3686155
ory	O	-1	3686155
were	O	-1	3686155
seen	O	-1	3686155
with	O	-1	3686155
post@@	O	-1	3686155
part@@	O	-1	3686155
um	O	-1	3686155
psycho@@	B-Disease	D011605	3686155
sis	I-Disease	-1	3686155
,	O	-1	3686155
ha@@	O	-1	3686155
ving	O	-1	3686155
received	O	-1	3686155
brom@@	B-Chemical	D001971	3686155
oc@@	I-Chemical	-1	3686155
ript@@	I-Chemical	-1	3686155
ine	I-Chemical	-1	3686155
for	O	-1	3686155
inhibition	B-Disease	D007775	3686155
of	I-Disease	-1	3686155
l@@	I-Disease	-1	3686155
act@@	I-Disease	-1	3686155
ation	I-Disease	-1	3686155
.	O	-1	3686155
B@@	B-Chemical	D001971	3686155
rom@@	I-Chemical	-1	3686155
oc@@	I-Chemical	-1	3686155
ript@@	I-Chemical	-1	3686155
ine	I-Chemical	-1	3686155
given	O	-1	3686155
in	O	-1	3686155
high	O	-1	3686155
doses	O	-1	3686155
has	O	-1	3686155
been	O	-1	3686155
associated	O	-1	3686155
with	O	-1	3686155
psycho@@	B-Disease	D011605	3686155
sis	I-Disease	-1	3686155
in	O	-1	3686155
patients	O	-1	3686155
receiving	O	-1	3686155
the	O	-1	3686155
drug	O	-1	3686155
for	O	-1	3686155
Parkinson's	B-Disease	D010300	3686155
disease	I-Disease	-1	3686155
.	O	-1	3686155
These	O	-1	3686155
cases	O	-1	3686155
demon@@	O	-1	3686155
st@@	O	-1	3686155
rate	O	-1	3686155
that	O	-1	3686155
brom@@	B-Chemical	D001971	3686155
oc@@	I-Chemical	-1	3686155
ript@@	I-Chemical	-1	3686155
ine	I-Chemical	-1	3686155
may	O	-1	3686155
cause	O	-1	3686155
psycho@@	B-Disease	D011605	3686155
sis	I-Disease	-1	3686155
even	O	-1	3686155
when	O	-1	3686155
given	O	-1	3686155
in	O	-1	3686155
low	O	-1	3686155
dos@@	O	-1	3686155
es.	O	-1	3686155

A	O	-1	3137399
pro@@	O	-1	3137399
sp@@	O	-1	3137399
ective	O	-1	3137399
study	O	-1	3137399
on	O	-1	3137399
the	O	-1	3137399
dose	O	-1	3137399
depend@@	O	-1	3137399
ency	O	-1	3137399
of	O	-1	3137399
cardi@@	B-Disease	D066126	3137399
otoxicity	I-Disease	-1	3137399
induced	O	-1	3137399
by	O	-1	3137399
mit@@	B-Chemical	D016685	3137399
om@@	I-Chemical	-1	3137399
ycin	I-Chemical	-1	3137399
C	I-Chemical	-1	3137399
.	O	-1	3137399
S@@	O	-1	3137399
inc@@	O	-1	3137399
e	O	-1	3137399
19@@	O	-1	3137399
7@@	O	-1	3137399
5	O	-1	3137399
mit@@	B-Chemical	D016685	3137399
om@@	I-Chemical	-1	3137399
ycin	I-Chemical	-1	3137399
C	I-Chemical	-1	3137399
(	O	-1	3137399
M@@	B-Chemical	D016685	3137399
M@@	I-Chemical	-1	3137399
C	I-Chemical	-1	3137399
)	O	-1	3137399
has	O	-1	3137399
been	O	-1	3137399
suggested	O	-1	3137399
to	O	-1	3137399
be	O	-1	3137399
cardi@@	B-Disease	D066126	3137399
ot@@	I-Disease	-1	3137399
ox@@	I-Disease	-1	3137399
ic	I-Disease	-1	3137399
,	O	-1	3137399
es@@	O	-1	3137399
p@@	O	-1	3137399
ec@@	O	-1	3137399
i@@	O	-1	3137399
ally	O	-1	3137399
when	O	-1	3137399
combined	O	-1	3137399
with	O	-1	3137399
or	O	-1	3137399
given	O	-1	3137399
following	O	-1	3137399
dox@@	B-Chemical	D004317	3137399
orub@@	I-Chemical	-1	3137399
icin	I-Chemical	-1	3137399
.	O	-1	3137399
D@@	O	-1	3137399
at@@	O	-1	3137399
a	O	-1	3137399
on	O	-1	3137399
dose	O	-1	3137399
depend@@	O	-1	3137399
ency	O	-1	3137399
or	O	-1	3137399
incidence	O	-1	3137399
con@@	O	-1	3137399
cer@@	O	-1	3137399
ning	O	-1	3137399
this	O	-1	3137399
side	O	-1	3137399
effect	O	-1	3137399
were	O	-1	3137399
not	O	-1	3137399
know@@	O	-1	3137399
n@@	O	-1	3137399
.	O	-1	3137399
We	O	-1	3137399
have	O	-1	3137399
initi@@	O	-1	3137399
ated	O	-1	3137399
a	O	-1	3137399
pro@@	O	-1	3137399
sp@@	O	-1	3137399
ective	O	-1	3137399
study	O	-1	3137399
to	O	-1	3137399
obt@@	O	-1	3137399
ain	O	-1	3137399
some	O	-1	3137399
more	O	-1	3137399
data	O	-1	3137399
on	O	-1	3137399
these	O	-1	3137399
subj@@	O	-1	3137399
ect@@	O	-1	3137399
s.	O	-1	3137399
F@@	O	-1	3137399
or@@	O	-1	3137399
ty-@@	O	-1	3137399
four	O	-1	3137399
M@@	B-Chemical	D016685	3137399
M@@	I-Chemical	-1	3137399
C	I-Chemical	-1	3137399
-treated	O	-1	3137399
patients	O	-1	3137399
were	O	-1	3137399
studi@@	O	-1	3137399
ed,	O	-1	3137399
3@@	O	-1	3137399
7	O	-1	3137399
of	O	-1	3137399
the@@	O	-1	3137399
m	O	-1	3137399
could	O	-1	3137399
be	O	-1	3137399
evalu@@	O	-1	3137399
ated.	O	-1	3137399
All	O	-1	3137399
patients	O	-1	3137399
were	O	-1	3137399
studied	O	-1	3137399
by	O	-1	3137399
repe@@	O	-1	3137399
ated	O	-1	3137399
physi@@	O	-1	3137399
c@@	O	-1	3137399
al	O	-1	3137399
examin@@	O	-1	3137399
ation@@	O	-1	3137399
s,	O	-1	3137399
ch@@	O	-1	3137399
est	O	-1	3137399
X@@	O	-1	3137399
-@@	O	-1	3137399
ra@@	O	-1	3137399
y@@	O	-1	3137399
s,	O	-1	3137399
electro@@	O	-1	3137399
-	O	-1	3137399
and	O	-1	3137399
echocardiograph@@	O	-1	3137399
y	O	-1	3137399
and	O	-1	3137399
radi@@	O	-1	3137399
on@@	O	-1	3137399
uc@@	O	-1	3137399
l@@	O	-1	3137399
ide	O	-1	3137399
left	O	-1	3137399
ventricular	O	-1	3137399
e@@	O	-1	3137399
j@@	O	-1	3137399
ection	O	-1	3137399
frac@@	O	-1	3137399
tion	O	-1	3137399
(@@	O	-1	3137399
E@@	O	-1	3137399
F@@	O	-1	3137399
)	O	-1	3137399
determin@@	O	-1	3137399
ations.	O	-1	3137399
The	O	-1	3137399
results	O	-1	3137399
were	O	-1	3137399
evaluated	O	-1	3137399
per	O	-1	3137399
cum@@	O	-1	3137399
ul@@	O	-1	3137399
ative	O	-1	3137399
dose	O	-1	3137399
level@@	O	-1	3137399
.	O	-1	3137399
One	O	-1	3137399
of	O	-1	3137399
the	O	-1	3137399
patients	O	-1	3137399
developed	O	-1	3137399
cardiac	B-Disease	D006333	3137399
failure	I-Disease	-1	3137399
after	O	-1	3137399
30	O	-1	3137399
mg	O	-1	3137399
m@@	O	-1	3137399
-@@	O	-1	3137399
2	O	-1	3137399
M@@	B-Chemical	D016685	3137399
M@@	I-Chemical	-1	3137399
C	I-Chemical	-1	3137399
and	O	-1	3137399
only	O	-1	3137399
1@@	O	-1	3137399
50	O	-1	3137399
mg	O	-1	3137399
m@@	O	-1	3137399
-@@	O	-1	3137399
2	O	-1	3137399
dox@@	B-Chemical	D004317	3137399
orub@@	I-Chemical	-1	3137399
icin	I-Chemical	-1	3137399
.	O	-1	3137399
The	O	-1	3137399
cardiac	B-Disease	D006333	3137399
failure	I-Disease	-1	3137399
was	O	-1	3137399
predic@@	O	-1	3137399
ted	O	-1	3137399
by	O	-1	3137399
a	O	-1	3137399
dro@@	O	-1	3137399
p	O	-1	3137399
in	O	-1	3137399
E@@	O	-1	3137399
F	O	-1	3137399
determined	O	-1	3137399
during	O	-1	3137399
a	O	-1	3137399
co@@	O	-1	3137399
l@@	O	-1	3137399
d	O	-1	3137399
press@@	O	-1	3137399
or	O	-1	3137399
test@@	O	-1	3137399
.	O	-1	3137399
N@@	O	-1	3137399
one	O	-1	3137399
of	O	-1	3137399
the	O	-1	3137399
other	O	-1	3137399
patients	O	-1	3137399
developed	O	-1	3137399
clinical	O	-1	3137399
cardi@@	B-Disease	D066126	3137399
otoxicity	I-Disease	-1	3137399
,	O	-1	3137399
n@@	O	-1	3137399
or	O	-1	3137399
did	O	-1	3137399
the	O	-1	3137399
studied	O	-1	3137399
par@@	O	-1	3137399
ame@@	O	-1	3137399
ters	O	-1	3137399
chang@@	O	-1	3137399
e.	O	-1	3137399
The	O	-1	3137399
literat@@	O	-1	3137399
ure	O	-1	3137399
on	O	-1	3137399
this	O	-1	3137399
subj@@	O	-1	3137399
ect	O	-1	3137399
was	O	-1	3137399
also	O	-1	3137399
revie@@	O	-1	3137399
we@@	O	-1	3137399
d.	O	-1	3137399
B@@	O	-1	3137399
as@@	O	-1	3137399
ed	O	-1	3137399
on	O	-1	3137399
the	O	-1	3137399
combined	O	-1	3137399
data	O	-1	3137399
from	O	-1	3137399
the	O	-1	3137399
present	O	-1	3137399
study	O	-1	3137399
and	O	-1	3137399
the	O	-1	3137399
literat@@	O	-1	3137399
ure,	O	-1	3137399
we	O	-1	3137399
suggest	O	-1	3137399
that	O	-1	3137399
M@@	B-Chemical	D016685	3137399
M@@	I-Chemical	-1	3137399
C	I-Chemical	-1	3137399
-@@	O	-1	3137399
related	O	-1	3137399
cardi@@	B-Disease	D066126	3137399
otoxicity	I-Disease	-1	3137399
is	O	-1	3137399
dose	O	-1	3137399
depend@@	O	-1	3137399
ent@@	O	-1	3137399
,	O	-1	3137399
occur@@	O	-1	3137399
r@@	O	-1	3137399
ing	O	-1	3137399
at	O	-1	3137399
cum@@	O	-1	3137399
ul@@	O	-1	3137399
ative	O	-1	3137399
dose	O	-1	3137399
levels	O	-1	3137399
of	O	-1	3137399
30	O	-1	3137399
mg	O	-1	3137399
m@@	O	-1	3137399
-@@	O	-1	3137399
2	O	-1	3137399
or	O	-1	3137399
mo@@	O	-1	3137399
re,	O	-1	3137399
main@@	O	-1	3137399
ly	O	-1	3137399
in	O	-1	3137399
patients	O	-1	3137399
also	O	-1	3137399
(@@	O	-1	3137399
previously	O	-1	3137399
or	O	-1	3137399
sim@@	O	-1	3137399
ult@@	O	-1	3137399
ane@@	O	-1	3137399
ous@@	O	-1	3137399
ly@@	O	-1	3137399
)	O	-1	3137399
treated	O	-1	3137399
with	O	-1	3137399
dox@@	B-Chemical	D004317	3137399
orub@@	I-Chemical	-1	3137399
icin	I-Chemical	-1	3137399
.	O	-1	3137399
The	O	-1	3137399
incidence	O	-1	3137399
is	O	-1	3137399
likely	O	-1	3137399
to	O	-1	3137399
be	O	-1	3137399
less	O	-1	3137399
than	O	-1	3137399
10@@	O	-1	3137399
%	O	-1	3137399
even	O	-1	3137399
for	O	-1	3137399
this	O	-1	3137399
risk	O	-1	3137399
group.	O	-1	3137399

Ph@@	B-Chemical	D010695	2709684
lor@@	I-Chemical	-1	2709684
iz@@	I-Chemical	-1	2709684
in	I-Chemical	-1	2709684
-induced	O	-1	2709684
gly@@	B-Disease	D006029	2709684
co@@	I-Disease	-1	2709684
sur@@	I-Disease	-1	2709684
ia	I-Disease	-1	2709684
does	O	-1	2709684
not	O	-1	2709684
prev@@	O	-1	2709684
ent	O	-1	2709684
g@@	B-Chemical	D005839	2709684
ent@@	I-Chemical	-1	2709684
am@@	I-Chemical	-1	2709684
icin	I-Chemical	-1	2709684
nephro@@	B-Disease	D007674	2709684
toxicity	I-Disease	-1	2709684
in	O	-1	2709684
rats.	O	-1	2709684
B@@	O	-1	2709684
ecause	O	-1	2709684
rats	O	-1	2709684
with	O	-1	2709684
st@@	B-Chemical	D013311	2709684
re@@	I-Chemical	-1	2709684
pto@@	I-Chemical	-1	2709684
z@@	I-Chemical	-1	2709684
ot@@	I-Chemical	-1	2709684
oc@@	I-Chemical	-1	2709684
in	I-Chemical	-1	2709684
-induced	O	-1	2709684
dia@@	B-Disease	D003920	2709684
bet@@	I-Disease	-1	2709684
es	I-Disease	-1	2709684
me@@	I-Disease	-1	2709684
ll@@	I-Disease	-1	2709684
it@@	I-Disease	-1	2709684
us	I-Disease	-1	2709684
(	O	-1	2709684
D@@	B-Disease	D003920	2709684
M	I-Disease	-1	2709684
)	O	-1	2709684
have	O	-1	2709684
a	O	-1	2709684
high	O	-1	2709684
sol@@	O	-1	2709684
ute	O	-1	2709684
di@@	O	-1	2709684
ure@@	O	-1	2709684
sis	O	-1	2709684
(	O	-1	2709684
gly@@	B-Disease	D006029	2709684
co@@	I-Disease	-1	2709684
sur@@	I-Disease	-1	2709684
ia	I-Disease	-1	2709684
of	O	-1	2709684
10	O	-1	2709684
to	O	-1	2709684
12	O	-1	2709684
g/@@	O	-1	2709684
day@@	O	-1	2709684
),	O	-1	2709684
we	O	-1	2709684
have	O	-1	2709684
suggested	O	-1	2709684
that	O	-1	2709684
this	O	-1	2709684
may	O	-1	2709684
in	O	-1	2709684
par@@	O	-1	2709684
t	O	-1	2709684
be	O	-1	2709684
respon@@	O	-1	2709684
sible	O	-1	2709684
for	O	-1	2709684
their	O	-1	2709684
resist@@	O	-1	2709684
ance	O	-1	2709684
to	O	-1	2709684
g@@	B-Chemical	D005839	2709684
ent@@	I-Chemical	-1	2709684
am@@	I-Chemical	-1	2709684
icin	I-Chemical	-1	2709684
-induced	O	-1	2709684
acute	B-Disease	D058186	2709684
renal	I-Disease	-1	2709684
failure	I-Disease	-1	2709684
(	O	-1	2709684
A@@	B-Disease	D058186	2709684
R@@	I-Disease	-1	2709684
F	I-Disease	-1	2709684
).	O	-1	2709684
The	O	-1	2709684
prot@@	O	-1	2709684
ection	O	-1	2709684
from	O	-1	2709684
g@@	B-Chemical	D005839	2709684
ent@@	I-Chemical	-1	2709684
am@@	I-Chemical	-1	2709684
icin	I-Chemical	-1	2709684
nephro@@	B-Disease	D007674	2709684
toxicity	I-Disease	-1	2709684
was	O	-1	2709684
studied	O	-1	2709684
in	O	-1	2709684
non@@	O	-1	2709684
-	O	-1	2709684
dia@@	B-Disease	D003920	2709684
be@@	I-Disease	-1	2709684
tic	I-Disease	-1	2709684
rats	O	-1	2709684
with	O	-1	2709684
chronic	O	-1	2709684
sol@@	O	-1	2709684
ute	O	-1	2709684
di@@	O	-1	2709684
ure@@	O	-1	2709684
sis	O	-1	2709684
induced	O	-1	2709684
by	O	-1	2709684
block@@	O	-1	2709684
age	O	-1	2709684
of	O	-1	2709684
tub@@	O	-1	2709684
ular	O	-1	2709684
g@@	B-Chemical	D005947	2709684
lu@@	I-Chemical	-1	2709684
co@@	I-Chemical	-1	2709684
se	I-Chemical	-1	2709684
re@@	O	-1	2709684
abs@@	O	-1	2709684
or@@	O	-1	2709684
ption	O	-1	2709684
with	O	-1	2709684
ph@@	B-Chemical	D010695	2709684
lor@@	I-Chemical	-1	2709684
iz@@	I-Chemical	-1	2709684
in	I-Chemical	-1	2709684
(	O	-1	2709684
P	B-Chemical	D010695	2709684
).	O	-1	2709684
D@@	B-Disease	D003920	2709684
M	I-Disease	-1	2709684
rats	O	-1	2709684
with	O	-1	2709684
mil@@	O	-1	2709684
d	O	-1	2709684
gly@@	B-Disease	D006029	2709684
co@@	I-Disease	-1	2709684
sur@@	I-Disease	-1	2709684
ia	I-Disease	-1	2709684
(@@	O	-1	2709684
similar	O	-1	2709684
in	O	-1	2709684
de@@	O	-1	2709684
g@@	O	-1	2709684
ree	O	-1	2709684
to	O	-1	2709684
that	O	-1	2709684
of	O	-1	2709684
the	O	-1	2709684
P	B-Chemical	D010695	2709684
treated	O	-1	2709684
anim@@	O	-1	2709684
al@@	O	-1	2709684
s)	O	-1	2709684
were	O	-1	2709684
also	O	-1	2709684
studi@@	O	-1	2709684
ed.	O	-1	2709684
U@@	O	-1	2709684
n@@	O	-1	2709684
anesthe@@	O	-1	2709684
tiz@@	O	-1	2709684
ed	O	-1	2709684
ad@@	O	-1	2709684
ult	O	-1	2709684
femal@@	O	-1	2709684
e,	O	-1	2709684
S@@	O	-1	2709684
pra@@	O	-1	2709684
gu@@	O	-1	2709684
e-@@	O	-1	2709684
D@@	O	-1	2709684
aw@@	O	-1	2709684
le@@	O	-1	2709684
y	O	-1	2709684
rats	O	-1	2709684
were	O	-1	2709684
divid@@	O	-1	2709684
ed	O	-1	2709684
in	O	-1	2709684
four	O	-1	2709684
groups	O	-1	2709684
and	O	-1	2709684
studied	O	-1	2709684
for	O	-1	2709684
15	O	-1	2709684
days.	O	-1	2709684
Group	O	-1	2709684
1	O	-1	2709684
(	O	-1	2709684
P	B-Chemical	D010695	2709684
al@@	O	-1	2709684
one@@	O	-1	2709684
)	O	-1	2709684
received	O	-1	2709684
P	B-Chemical	D010695	2709684
,	O	-1	2709684
3@@	O	-1	2709684
60	O	-1	2709684
mg/@@	O	-1	2709684
da@@	O	-1	2709684
y,	O	-1	2709684
for	O	-1	2709684
15	O	-1	2709684
da@@	O	-1	2709684
ys@@	O	-1	2709684
;	O	-1	2709684
Group	O	-1	2709684
II	O	-1	2709684
(	O	-1	2709684
P	B-Chemical	D010695	2709684
+	O	-1	2709684
g@@	B-Chemical	D005839	2709684
ent@@	I-Chemical	-1	2709684
am@@	I-Chemical	-1	2709684
icin	I-Chemical	-1	2709684
);	O	-1	2709684
Group	O	-1	2709684
I@@	O	-1	2709684
II	O	-1	2709684
(	O	-1	2709684
g@@	B-Chemical	D005839	2709684
ent@@	I-Chemical	-1	2709684
am@@	I-Chemical	-1	2709684
icin	I-Chemical	-1	2709684
al@@	O	-1	2709684
one@@	O	-1	2709684
)	O	-1	2709684
and	O	-1	2709684
Group	O	-1	2709684
IV	O	-1	2709684
(@@	O	-1	2709684
mil@@	O	-1	2709684
d	O	-1	2709684
D@@	B-Disease	D003920	2709684
M	I-Disease	-1	2709684
+	O	-1	2709684
g@@	B-Chemical	D005839	2709684
ent@@	I-Chemical	-1	2709684
am@@	I-Chemical	-1	2709684
icin	I-Chemical	-1	2709684
).	O	-1	2709684
Ne@@	B-Disease	D007674	2709684
ph@@	I-Disease	-1	2709684
ro@@	I-Disease	-1	2709684
toxic	I-Disease	-1	2709684
doses	O	-1	2709684
(@@	O	-1	2709684
40	O	-1	2709684
mg/kg	O	-1	2709684
body	O	-1	2709684
w@@	O	-1	2709684
t@@	O	-1	2709684
/@@	O	-1	2709684
day@@	O	-1	2709684
)	O	-1	2709684
of	O	-1	2709684
g@@	B-Chemical	D005839	2709684
ent@@	I-Chemical	-1	2709684
am@@	I-Chemical	-1	2709684
icin	I-Chemical	-1	2709684
were	O	-1	2709684
injected	O	-1	2709684
during	O	-1	2709684
the	O	-1	2709684
las@@	O	-1	2709684
t	O	-1	2709684
n@@	O	-1	2709684
ine	O	-1	2709684
days	O	-1	2709684
of	O	-1	2709684
study	O	-1	2709684
to	O	-1	2709684
the	O	-1	2709684
animals	O	-1	2709684
of	O	-1	2709684
groups	O	-1	2709684
II	O	-1	2709684
to	O	-1	2709684
I@@	O	-1	2709684
V@@	O	-1	2709684
.	O	-1	2709684
In	O	-1	2709684
Group	O	-1	2709684
I@@	O	-1	2709684
,	O	-1	2709684
P	B-Chemical	D010695	2709684
induced	O	-1	2709684
a	O	-1	2709684
moder@@	O	-1	2709684
ate	O	-1	2709684
and	O	-1	2709684
st@@	O	-1	2709684
able	O	-1	2709684
gly@@	B-Disease	D006029	2709684
co@@	I-Disease	-1	2709684
sur@@	I-Disease	-1	2709684
ia	I-Disease	-1	2709684
(@@	O	-1	2709684
3.@@	O	-1	2709684
9	O	-1	2709684
+/-	O	-1	2709684
0.@@	O	-1	2709684
1	O	-1	2709684
g/@@	O	-1	2709684
da@@	O	-1	2709684
y,	O	-1	2709684
S@@	O	-1	2709684
E@@	O	-1	2709684
),	O	-1	2709684
and	O	-1	2709684
no	O	-1	2709684
functional	O	-1	2709684
or	O	-1	2709684
morph@@	O	-1	2709684
ologic	O	-1	2709684
evidence	O	-1	2709684
of	O	-1	2709684
renal	B-Disease	D007674	2709684
dysfunction	I-Disease	-1	2709684
(@@	O	-1	2709684
baseline	O	-1	2709684
C@@	O	-1	2709684
C@@	O	-1	2709684
r	O	-1	2709684
2.@@	O	-1	2709684
1	O	-1	2709684
+/-	O	-1	2709684
0.@@	O	-1	2709684
1	O	-1	2709684
ml@@	O	-1	2709684
/@@	O	-1	2709684
min@@	O	-1	2709684
,	O	-1	2709684
un@@	O	-1	2709684
det@@	O	-1	2709684
ect@@	O	-1	2709684
able	O	-1	2709684
l@@	O	-1	2709684
ys@@	O	-1	2709684
o@@	O	-1	2709684
z@@	O	-1	2709684
ym@@	O	-1	2709684
ur@@	O	-1	2709684
ia@@	O	-1	2709684
)	O	-1	2709684
or	O	-1	2709684
damage	O	-1	2709684
(	O	-1	2709684
tub@@	B-Disease	D009956	2709684
ular	I-Disease	-1	2709684
necro@@	I-Disease	-1	2709684
sis	I-Disease	-1	2709684
scor@@	O	-1	2709684
e	O	-1	2709684
[@@	O	-1	2709684
maxim@@	O	-1	2709684
um	O	-1	2709684
4@@	O	-1	2709684
]@@	O	-1	2709684
,	O	-1	2709684
z@@	O	-1	2709684
ero@@	O	-1	2709684
).	O	-1	2709684
In	O	-1	2709684
Group	O	-1	2709684
II@@	O	-1	2709684
,	O	-1	2709684
P	B-Chemical	D010695	2709684
did	O	-1	2709684
not	O	-1	2709684
prev@@	O	-1	2709684
ent	O	-1	2709684
g@@	B-Chemical	D005839	2709684
ent@@	I-Chemical	-1	2709684
am@@	I-Chemical	-1	2709684
icin	I-Chemical	-1	2709684
-	O	-1	2709684
A@@	B-Disease	D058186	2709684
R@@	I-Disease	-1	2709684
F	I-Disease	-1	2709684
(@@	O	-1	2709684
maxim@@	O	-1	2709684
al	O	-1	2709684
decrease	O	-1	2709684
in	O	-1	2709684
C@@	O	-1	2709684
C@@	O	-1	2709684
r	O	-1	2709684
at	O	-1	2709684
day	O	-1	2709684
9.@@	O	-1	2709684
8@@	O	-1	2709684
9@@	O	-1	2709684
%,	O	-1	2709684
P	B-Chemical	D010695	2709684
less	O	-1	2709684
than	O	-1	2709684
0.00@@	O	-1	2709684
1@@	O	-1	2709684
;	O	-1	2709684
pe@@	O	-1	2709684
a@@	O	-1	2709684
k	O	-1	2709684
l@@	O	-1	2709684
ys@@	O	-1	2709684
o@@	O	-1	2709684
z@@	O	-1	2709684
ym@@	O	-1	2709684
ur@@	O	-1	2709684
ia,	O	-1	2709684
18@@	O	-1	2709684
6@@	O	-1	2709684
3	O	-1	2709684
+/-	O	-1	2709684
3@@	O	-1	2709684
21	O	-1	2709684
microgram@@	O	-1	2709684
s/@@	O	-1	2709684
day@@	O	-1	2709684
;	O	-1	2709684
and	O	-1	2709684
tub@@	B-Disease	D009956	2709684
ular	I-Disease	-1	2709684
necro@@	I-Disease	-1	2709684
sis	I-Disease	-1	2709684
sco@@	O	-1	2709684
re,	O	-1	2709684
3.@@	O	-1	2709684
9	O	-1	2709684
+/-	O	-1	2709684
0.@@	O	-1	2709684
1).	O	-1	2709684
These	O	-1	2709684
values	O	-1	2709684
were	O	-1	2709684
not	O	-1	2709684
different	O	-1	2709684
from	O	-1	2709684
those	O	-1	2709684
of	O	-1	2709684
Group	O	-1	2709684
II@@	O	-1	2709684
I@@	O	-1	2709684
:	O	-1	2709684
maxim@@	O	-1	2709684
al	O	-1	2709684
decrease	O	-1	2709684
in	O	-1	2709684
C@@	O	-1	2709684
C@@	O	-1	2709684
r	O	-1	2709684
7@@	O	-1	2709684
3@@	O	-1	2709684
%	O	-1	2709684
(	O	-1	2709684
P	B-Chemical	D010695	2709684
less	O	-1	2709684
than	O	-1	2709684
0.00@@	O	-1	2709684
1@@	O	-1	2709684
);	O	-1	2709684
l@@	O	-1	2709684
ys@@	O	-1	2709684
o@@	O	-1	2709684
z@@	O	-1	2709684
ym@@	O	-1	2709684
ur@@	O	-1	2709684
ia,	O	-1	2709684
2@@	O	-1	2709684
14@@	O	-1	2709684
7	O	-1	2709684
+/-	O	-1	2709684
7@@	O	-1	2709684
0@@	O	-1	2709684
1	O	-1	2709684
microgram@@	O	-1	2709684
s/@@	O	-1	2709684
day@@	O	-1	2709684
;	O	-1	2709684
tub@@	B-Disease	D009956	2709684
ular	I-Disease	-1	2709684
necro@@	I-Disease	-1	2709684
sis	I-Disease	-1	2709684
sco@@	O	-1	2709684
re,	O	-1	2709684
3.@@	O	-1	2709684
8	O	-1	2709684
+/-	O	-1	2709684
0.@@	O	-1	2709684
1.@@	O	-1	2709684
(A@@	O	-1	2709684
B@@	O	-1	2709684
S@@	O	-1	2709684
TR@@	O	-1	2709684
AC@@	O	-1	2709684
T	O	-1	2709684
TR@@	O	-1	2709684
UN@@	O	-1	2709684
C@@	O	-1	2709684
AT@@	O	-1	2709684
E@@	O	-1	2709684
D	O	-1	2709684
A@@	O	-1	2709684
T	O	-1	2709684
2@@	O	-1	2709684
50	O	-1	2709684
W@@	O	-1	2709684
O@@	O	-1	2709684
RD@@	O	-1	2709684
S)	O	-1	2709684

T@@	B-Chemical	D063325	458486
i@@	I-Chemical	-1	458486
apri@@	I-Chemical	-1	458486
de	I-Chemical	-1	458486
in	O	-1	458486
levo@@	B-Chemical	D007980	458486
dopa	I-Chemical	-1	458486
-induced	O	-1	458486
invol@@	B-Disease	D004409	458486
un@@	I-Disease	-1	458486
t@@	I-Disease	-1	458486
ary	I-Disease	-1	458486
mo@@	I-Disease	-1	458486
ve@@	I-Disease	-1	458486
ments	I-Disease	-1	458486
.	O	-1	458486
T@@	B-Chemical	D063325	458486
i@@	I-Chemical	-1	458486
apri@@	I-Chemical	-1	458486
de	I-Chemical	-1	458486
,	O	-1	458486
a	O	-1	458486
sub@@	O	-1	458486
sti@@	O	-1	458486
t@@	O	-1	458486
ut@@	O	-1	458486
ed	O	-1	458486
b@@	B-Chemical	C037689	458486
enz@@	I-Chemical	-1	458486
amide	I-Chemical	-1	458486
der@@	O	-1	458486
i@@	O	-1	458486
v@@	O	-1	458486
ative	O	-1	458486
clo@@	O	-1	458486
se@@	O	-1	458486
ly	O	-1	458486
related	O	-1	458486
to	O	-1	458486
met@@	B-Chemical	D008787	458486
oc@@	I-Chemical	-1	458486
lop@@	I-Chemical	-1	458486
ram@@	I-Chemical	-1	458486
ide	I-Chemical	-1	458486
,	O	-1	458486
reduced	O	-1	458486
levo@@	B-Chemical	D007980	458486
dopa	I-Chemical	-1	458486
-induced	O	-1	458486
pe@@	O	-1	458486
a@@	O	-1	458486
k	O	-1	458486
dose	O	-1	458486
invol@@	B-Disease	D004409	458486
un@@	I-Disease	-1	458486
t@@	I-Disease	-1	458486
ary	I-Disease	-1	458486
mo@@	I-Disease	-1	458486
ve@@	I-Disease	-1	458486
ments	I-Disease	-1	458486
in	O	-1	458486
16	O	-1	458486
patients	O	-1	458486
with	O	-1	458486
i@@	B-Disease	D010300	458486
di@@	I-Disease	-1	458486
o@@	I-Disease	-1	458486
path@@	I-Disease	-1	458486
ic	I-Disease	-1	458486
Parkinson's	I-Disease	-1	458486
disease	I-Disease	-1	458486
.	O	-1	458486
However,	O	-1	458486
an	O	-1	458486
un@@	O	-1	458486
ac@@	O	-1	458486
ce@@	O	-1	458486
pt@@	O	-1	458486
able	O	-1	458486
increase	O	-1	458486
in	O	-1	458486
dis@@	O	-1	458486
ability	O	-1	458486
from	O	-1	458486
Parkinson@@	B-Disease	D010300	458486
ism	I-Disease	-1	458486
with	O	-1	458486
ag@@	O	-1	458486
gra@@	O	-1	458486
v@@	O	-1	458486
ation	O	-1	458486
of	O	-1	458486
en@@	O	-1	458486
d-@@	O	-1	458486
of@@	O	-1	458486
-@@	O	-1	458486
dose	O	-1	458486
ak@@	B-Disease	D004409	458486
ine@@	I-Disease	-1	458486
sia	I-Disease	-1	458486
l@@	O	-1	458486
ed	O	-1	458486
to	O	-1	458486
its	O	-1	458486
cess@@	O	-1	458486
ation	O	-1	458486
in	O	-1	458486
14	O	-1	458486
patients.	O	-1	458486
T@@	B-Chemical	D063325	458486
i@@	I-Chemical	-1	458486
apri@@	I-Chemical	-1	458486
de	I-Chemical	-1	458486
had	O	-1	458486
no	O	-1	458486
effect	O	-1	458486
on	O	-1	458486
levo@@	B-Chemical	D007980	458486
dopa	I-Chemical	-1	458486
-induced	O	-1	458486
early	O	-1	458486
mor@@	O	-1	458486
ning	O	-1	458486
of	O	-1	458486
"@@	O	-1	458486
o@@	O	-1	458486
ff@@	O	-1	458486
-@@	O	-1	458486
perio@@	O	-1	458486
d@@	O	-1	458486
"	O	-1	458486
seg@@	O	-1	458486
mental	O	-1	458486
dy@@	B-Disease	D004421	458486
ston@@	I-Disease	-1	458486
ia	I-Disease	-1	458486
.	O	-1	458486
These	O	-1	458486
results	O	-1	458486
f@@	O	-1	458486
a@@	O	-1	458486
il	O	-1	458486
to	O	-1	458486
suppor@@	O	-1	458486
t	O	-1	458486
the	O	-1	458486
no@@	O	-1	458486
tion	O	-1	458486
that	O	-1	458486
levo@@	B-Chemical	D007980	458486
dopa	I-Chemical	-1	458486
-induced	O	-1	458486
dyskine@@	B-Disease	D004409	458486
si@@	I-Disease	-1	458486
as	I-Disease	-1	458486
are	O	-1	458486
caused	O	-1	458486
by	O	-1	458486
over@@	O	-1	458486
stimulation	O	-1	458486
of	O	-1	458486
a	O	-1	458486
se@@	O	-1	458486
par@@	O	-1	458486
ate	O	-1	458486
group	O	-1	458486
of	O	-1	458486
dopamine	B-Chemical	D004298	458486
receptor@@	O	-1	458486
s.	O	-1	458486

Eff@@	O	-1	21294084
ects	O	-1	21294084
of	O	-1	21294084
the	O	-1	21294084
hippocamp@@	O	-1	21294084
al	O	-1	21294084
de@@	O	-1	21294084
ep	O	-1	21294084
brain	O	-1	21294084
stimulation	O	-1	21294084
on	O	-1	21294084
cor@@	O	-1	21294084
tical	O	-1	21294084
epileptic	B-Disease	D004827	21294084
dis@@	O	-1	21294084
ch@@	O	-1	21294084
arg@@	O	-1	21294084
es	O	-1	21294084
in	O	-1	21294084
pen@@	B-Chemical	D010406	21294084
icill@@	I-Chemical	-1	21294084
in	I-Chemical	-1	21294084
-	O	-1	21294084
induced	O	-1	21294084
epilep@@	B-Disease	D004827	21294084
sy	I-Disease	-1	21294084
model	O	-1	21294084
in	O	-1	21294084
rats.	O	-1	21294084
A@@	O	-1	21294084
I@@	O	-1	21294084
M@@	O	-1	21294084
:	O	-1	21294084
E@@	O	-1	21294084
x@@	O	-1	21294084
per@@	O	-1	21294084
im@@	O	-1	21294084
ental	O	-1	21294084
and	O	-1	21294084
clinical	O	-1	21294084
studies	O	-1	21294084
have	O	-1	21294084
revealed	O	-1	21294084
that	O	-1	21294084
hippocamp@@	O	-1	21294084
al	O	-1	21294084
D@@	O	-1	21294084
B@@	O	-1	21294084
S	O	-1	21294084
can	O	-1	21294084
control	O	-1	21294084
epileptic	B-Disease	D004827	21294084
activ@@	O	-1	21294084
ity,	O	-1	21294084
but	O	-1	21294084
the	O	-1	21294084
mechanism	O	-1	21294084
of	O	-1	21294084
action	O	-1	21294084
is	O	-1	21294084
ob@@	O	-1	21294084
s@@	O	-1	21294084
c@@	O	-1	21294084
ure	O	-1	21294084
and	O	-1	21294084
op@@	O	-1	21294084
tim@@	O	-1	21294084
al	O	-1	21294084
stimulation	O	-1	21294084
par@@	O	-1	21294084
ame@@	O	-1	21294084
ters	O	-1	21294084
are	O	-1	21294084
not	O	-1	21294084
clear@@	O	-1	21294084
ly	O	-1	21294084
def@@	O	-1	21294084
ine@@	O	-1	21294084
d.	O	-1	21294084
The	O	-1	21294084
a@@	O	-1	21294084
im	O	-1	21294084
was	O	-1	21294084
to	O	-1	21294084
evalu@@	O	-1	21294084
ate	O	-1	21294084
the	O	-1	21294084
effects	O	-1	21294084
of	O	-1	21294084
high	O	-1	21294084
frequency	O	-1	21294084
hippocamp@@	O	-1	21294084
al	O	-1	21294084
stimulation	O	-1	21294084
on	O	-1	21294084
cor@@	O	-1	21294084
tical	O	-1	21294084
epileptic	B-Disease	D004827	21294084
activity	O	-1	21294084
in	O	-1	21294084
pen@@	B-Chemical	D010406	21294084
icill@@	I-Chemical	-1	21294084
in	I-Chemical	-1	21294084
-induced	O	-1	21294084
epilep@@	B-Disease	D004827	21294084
sy	I-Disease	-1	21294084
model@@	O	-1	21294084
.	O	-1	21294084
M@@	O	-1	21294084
AT@@	O	-1	21294084
E@@	O	-1	21294084
R@@	O	-1	21294084
I@@	O	-1	21294084
A@@	O	-1	21294084
L	O	-1	21294084
AN@@	O	-1	21294084
D	O	-1	21294084
METHODS:	O	-1	21294084
Tw@@	O	-1	21294084
ent@@	O	-1	21294084
y-@@	O	-1	21294084
five	O	-1	21294084
S@@	O	-1	21294084
pra@@	O	-1	21294084
gu@@	O	-1	21294084
e-@@	O	-1	21294084
D@@	O	-1	21294084
aw@@	O	-1	21294084
le@@	O	-1	21294084
y	O	-1	21294084
rats	O	-1	21294084
were	O	-1	21294084
im@@	O	-1	21294084
pl@@	O	-1	21294084
ant@@	O	-1	21294084
ed	O	-1	21294084
D@@	O	-1	21294084
B@@	O	-1	21294084
S	O	-1	21294084
electro@@	O	-1	21294084
d@@	O	-1	21294084
es.	O	-1	21294084
In	O	-1	21294084
group@@	O	-1	21294084
-1	O	-1	21294084
(n@@	O	-1	21294084
=@@	O	-1	21294084
10@@	O	-1	21294084
)	O	-1	21294084
hippocamp@@	O	-1	21294084
al	O	-1	21294084
D@@	O	-1	21294084
B@@	O	-1	21294084
S	O	-1	21294084
was	O	-1	21294084
of@@	O	-1	21294084
f	O	-1	21294084
and	O	-1	21294084
in	O	-1	21294084
the	O	-1	21294084
group@@	O	-1	21294084
-@@	O	-1	21294084
2	O	-1	21294084
(n@@	O	-1	21294084
=@@	O	-1	21294084
10@@	O	-1	21294084
)	O	-1	21294084
hippocamp@@	O	-1	21294084
al	O	-1	21294084
D@@	O	-1	21294084
B@@	O	-1	21294084
S	O	-1	21294084
was	O	-1	21294084
on	O	-1	21294084
(1@@	O	-1	21294084
8@@	O	-1	21294084
5	O	-1	21294084
H@@	O	-1	21294084
z@@	O	-1	21294084
,	O	-1	21294084
0.@@	O	-1	21294084
5@@	O	-1	21294084
V@@	O	-1	21294084
,	O	-1	21294084
1@@	O	-1	21294084
V@@	O	-1	21294084
,	O	-1	21294084
2@@	O	-1	21294084
V@@	O	-1	21294084
,	O	-1	21294084
and	O	-1	21294084
5@@	O	-1	21294084
V	O	-1	21294084
for	O	-1	21294084
60	O	-1	21294084
sec@@	O	-1	21294084
)	O	-1	21294084
following	O	-1	21294084
pen@@	B-Chemical	D010400	21294084
icill@@	I-Chemical	-1	21294084
in	I-Chemical	-1	21294084
G	I-Chemical	-1	21294084
injection	O	-1	21294084
intrac@@	O	-1	21294084
or@@	O	-1	21294084
tic@@	O	-1	21294084
all@@	O	-1	21294084
y.	O	-1	21294084
In	O	-1	21294084
the	O	-1	21294084
control	O	-1	21294084
group	O	-1	21294084
hippocamp@@	O	-1	21294084
al	O	-1	21294084
D@@	O	-1	21294084
B@@	O	-1	21294084
S	O	-1	21294084
was	O	-1	21294084
on	O	-1	21294084
following	O	-1	21294084
8	O	-1	21294084
l	O	-1	21294084
saline	O	-1	21294084
injection	O	-1	21294084
intrac@@	O	-1	21294084
or@@	O	-1	21294084
tic@@	O	-1	21294084
all@@	O	-1	21294084
y.	O	-1	21294084
E@@	O	-1	21294084
E@@	O	-1	21294084
G	O	-1	21294084
recor@@	O	-1	21294084
d@@	O	-1	21294084
ings	O	-1	21294084
were	O	-1	21294084
obtained	O	-1	21294084
before	O	-1	21294084
and	O	-1	21294084
15	O	-1	21294084
minutes	O	-1	21294084
following	O	-1	21294084
pen@@	B-Chemical	D010400	21294084
icill@@	I-Chemical	-1	21294084
in-@@	I-Chemical	-1	21294084
G	I-Chemical	-1	21294084
injec@@	O	-1	21294084
tion,	O	-1	21294084
and	O	-1	21294084
at	O	-1	21294084
10@@	O	-1	21294084
th	O	-1	21294084
minutes	O	-1	21294084
following	O	-1	21294084
each	O	-1	21294084
stimul@@	O	-1	21294084
us	O	-1	21294084
for	O	-1	21294084
analysis	O	-1	21294084
in	O	-1	21294084
ter@@	O	-1	21294084
ms	O	-1	21294084
of	O	-1	21294084
frequ@@	O	-1	21294084
enc@@	O	-1	21294084
y,	O	-1	21294084
am@@	O	-1	21294084
pl@@	O	-1	21294084
it@@	O	-1	21294084
u@@	O	-1	21294084
de@@	O	-1	21294084
,	O	-1	21294084
and	O	-1	21294084
po@@	O	-1	21294084
w@@	O	-1	21294084
er	O	-1	21294084
sp@@	O	-1	21294084
ect@@	O	-1	21294084
ru@@	O	-1	21294084
m.	O	-1	21294084
RESULTS:	O	-1	21294084
H@@	O	-1	21294084
i@@	O	-1	21294084
gh	O	-1	21294084
frequency	O	-1	21294084
hippocamp@@	O	-1	21294084
al	O	-1	21294084
D@@	O	-1	21294084
B@@	O	-1	21294084
S	O	-1	21294084
sup@@	O	-1	21294084
press@@	O	-1	21294084
ed	O	-1	21294084
the	O	-1	21294084
acute	O	-1	21294084
pen@@	B-Chemical	D010406	21294084
icill@@	I-Chemical	-1	21294084
in	I-Chemical	-1	21294084
-induced	O	-1	21294084
cor@@	O	-1	21294084
tical	O	-1	21294084
epileptic	B-Disease	D004827	21294084
activity	O	-1	21294084
in@@	O	-1	21294084
dependent	O	-1	21294084
from	O	-1	21294084
stimul@@	O	-1	21294084
us	O	-1	21294084
int@@	O	-1	21294084
ens@@	O	-1	21294084
ity.	O	-1	21294084
In	O	-1	21294084
the	O	-1	21294084
control	O	-1	21294084
group@@	O	-1	21294084
,	O	-1	21294084
hippocamp@@	O	-1	21294084
al	O	-1	21294084
stimulation	O	-1	21294084
alone	O	-1	21294084
le@@	O	-1	21294084
ad	O	-1	21294084
only	O	-1	21294084
to	O	-1	21294084
diff@@	O	-1	21294084
use	O	-1	21294084
s@@	O	-1	21294084
low@@	O	-1	21294084
ing	O	-1	21294084
of	O	-1	21294084
cerebral	O	-1	21294084
bio@@	O	-1	21294084
elect@@	O	-1	21294084
r@@	O	-1	21294084
ical	O	-1	21294084
activity	O	-1	21294084
at	O	-1	21294084
5@@	O	-1	21294084
V	O	-1	21294084
stimul@@	O	-1	21294084
ation.	O	-1	21294084
CONCLUSION:	O	-1	21294084
Our	O	-1	21294084
results	O	-1	21294084
revealed	O	-1	21294084
that	O	-1	21294084
continu@@	O	-1	21294084
ous	O	-1	21294084
high	O	-1	21294084
frequency	O	-1	21294084
stimulation	O	-1	21294084
of	O	-1	21294084
the	O	-1	21294084
hippocamp@@	O	-1	21294084
us	O	-1	21294084
sup@@	O	-1	21294084
press@@	O	-1	21294084
ed	O	-1	21294084
acute	O	-1	21294084
cor@@	O	-1	21294084
tical	O	-1	21294084
epileptic	B-Disease	D004827	21294084
activity	O	-1	21294084
eff@@	O	-1	21294084
ectively	O	-1	21294084
without	O	-1	21294084
ca@@	O	-1	21294084
using	O	-1	21294084
secondary	O	-1	21294084
epileptic	B-Disease	D004827	21294084
dis@@	O	-1	21294084
ch@@	O	-1	21294084
arg@@	O	-1	21294084
es.	O	-1	21294084
These	O	-1	21294084
results	O	-1	21294084
are	O	-1	21294084
important	O	-1	21294084
in	O	-1	21294084
ter@@	O	-1	21294084
ms	O	-1	21294084
of	O	-1	21294084
def@@	O	-1	21294084
in@@	O	-1	21294084
ing	O	-1	21294084
the	O	-1	21294084
op@@	O	-1	21294084
tim@@	O	-1	21294084
al	O	-1	21294084
par@@	O	-1	21294084
ame@@	O	-1	21294084
ters	O	-1	21294084
of	O	-1	21294084
hippocamp@@	O	-1	21294084
al	O	-1	21294084
D@@	O	-1	21294084
B@@	O	-1	21294084
S	O	-1	21294084
in	O	-1	21294084
patients	O	-1	21294084
with	O	-1	21294084
epilep@@	B-Disease	D004827	21294084
sy	I-Disease	-1	21294084
.	O	-1	21294084

Ne@@	O	-1	20727411
ural	O	-1	20727411
correl@@	O	-1	20727411
ates	O	-1	20727411
of	O	-1	20727411
S@@	B-Chemical	-1	20727411
-@@	I-Chemical	-1	20727411
k@@	I-Chemical	-1	20727411
et@@	I-Chemical	-1	20727411
amine	I-Chemical	-1	20727411
induced	O	-1	20727411
psycho@@	B-Disease	D011605	20727411
sis	I-Disease	-1	20727411
during	O	-1	20727411
over@@	O	-1	20727411
t	O	-1	20727411
continu@@	O	-1	20727411
ous	O	-1	20727411
ver@@	O	-1	20727411
b@@	O	-1	20727411
al	O	-1	20727411
flu@@	O	-1	20727411
enc@@	O	-1	20727411
y.	O	-1	20727411
The	O	-1	20727411
glutam@@	O	-1	20727411
at@@	O	-1	20727411
ergic	O	-1	20727411
N@@	B-Chemical	D016202	20727411
-@@	I-Chemical	-1	20727411
methyl@@	I-Chemical	-1	20727411
-@@	I-Chemical	-1	20727411
D-@@	I-Chemical	-1	20727411
as@@	I-Chemical	-1	20727411
part@@	I-Chemical	-1	20727411
ate	I-Chemical	-1	20727411
(	O	-1	20727411
N@@	B-Chemical	D016202	20727411
MD@@	I-Chemical	-1	20727411
A	I-Chemical	-1	20727411
)	O	-1	20727411
receptor	O	-1	20727411
has	O	-1	20727411
been	O	-1	20727411
implic@@	O	-1	20727411
ated	O	-1	20727411
in	O	-1	20727411
the	O	-1	20727411
path@@	O	-1	20727411
oph@@	O	-1	20727411
ysi@@	O	-1	20727411
ology	O	-1	20727411
of	O	-1	20727411
sch@@	B-Disease	D012559	20727411
iz@@	I-Disease	-1	20727411
oph@@	I-Disease	-1	20727411
ren@@	I-Disease	-1	20727411
ia	I-Disease	-1	20727411
.	O	-1	20727411
Ad@@	O	-1	20727411
minist@@	O	-1	20727411
ered	O	-1	20727411
to	O	-1	20727411
healthy	O	-1	20727411
vol@@	O	-1	20727411
un@@	O	-1	20727411
te@@	O	-1	20727411
er@@	O	-1	20727411
s,	O	-1	20727411
a	O	-1	20727411
sub@@	O	-1	20727411
anesthe@@	O	-1	20727411
tic	O	-1	20727411
dose	O	-1	20727411
of	O	-1	20727411
the	O	-1	20727411
non-@@	O	-1	20727411
comp@@	O	-1	20727411
e@@	O	-1	20727411
ti@@	O	-1	20727411
tive	O	-1	20727411
N@@	B-Chemical	D016202	20727411
MD@@	I-Chemical	-1	20727411
A	I-Chemical	-1	20727411
receptor	O	-1	20727411
antagonist	O	-1	20727411
k@@	B-Chemical	D007649	20727411
et@@	I-Chemical	-1	20727411
amine	I-Chemical	-1	20727411
lead@@	O	-1	20727411
s	O	-1	20727411
to	O	-1	20727411
psycho@@	O	-1	20727411
path@@	O	-1	20727411
ological	O	-1	20727411
symptoms	O	-1	20727411
similar	O	-1	20727411
to	O	-1	20727411
those	O	-1	20727411
observed	O	-1	20727411
in	O	-1	20727411
sch@@	B-Disease	D012559	20727411
iz@@	I-Disease	-1	20727411
oph@@	I-Disease	-1	20727411
ren@@	I-Disease	-1	20727411
ia	I-Disease	-1	20727411
.	O	-1	20727411
In	O	-1	20727411
patients	O	-1	20727411
with	O	-1	20727411
sch@@	B-Disease	D012559	20727411
iz@@	I-Disease	-1	20727411
oph@@	I-Disease	-1	20727411
ren@@	I-Disease	-1	20727411
ia	I-Disease	-1	20727411
,	O	-1	20727411
k@@	B-Chemical	D007649	20727411
et@@	I-Chemical	-1	20727411
amine	I-Chemical	-1	20727411
ex@@	O	-1	20727411
ac@@	O	-1	20727411
er@@	O	-1	20727411
b@@	O	-1	20727411
ates	O	-1	20727411
the	O	-1	20727411
cor@@	O	-1	20727411
e	O	-1	20727411
symptoms	O	-1	20727411
of	O	-1	20727411
ill@@	O	-1	20727411
n@@	O	-1	20727411
es@@	O	-1	20727411
s,	O	-1	20727411
sup@@	O	-1	20727411
port@@	O	-1	20727411
ing	O	-1	20727411
the	O	-1	20727411
hypo@@	O	-1	20727411
thesis	O	-1	20727411
of	O	-1	20727411
a	O	-1	20727411
glutam@@	B-Disease	D018754	20727411
at@@	I-Disease	-1	20727411
ergic	I-Disease	-1	20727411
dysfunction	I-Disease	-1	20727411
.	O	-1	20727411
In	O	-1	20727411
a	O	-1	20727411
coun@@	O	-1	20727411
ter@@	O	-1	20727411
b@@	O	-1	20727411
al@@	O	-1	20727411
ance@@	O	-1	20727411
d,	O	-1	20727411
placebo@@	O	-1	20727411
-@@	O	-1	20727411
control@@	O	-1	20727411
le@@	O	-1	20727411
d,	O	-1	20727411
double-bl@@	O	-1	20727411
ind	O	-1	20727411
study	O	-1	20727411
de@@	O	-1	20727411
sign@@	O	-1	20727411
,	O	-1	20727411
healthy	O	-1	20727411
subjects	O	-1	20727411
were	O	-1	20727411
administered	O	-1	20727411
a	O	-1	20727411
continu@@	O	-1	20727411
ous	O	-1	20727411
sub@@	O	-1	20727411
anesthe@@	O	-1	20727411
tic	O	-1	20727411
S@@	B-Chemical	-1	20727411
-@@	I-Chemical	-1	20727411
k@@	I-Chemical	-1	20727411
et@@	I-Chemical	-1	20727411
amine	I-Chemical	-1	20727411
infusion	O	-1	20727411
while	O	-1	20727411
differences	O	-1	20727411
in	O	-1	20727411
B@@	O	-1	20727411
O@@	O	-1	20727411
L@@	O	-1	20727411
D	O	-1	20727411
responses	O	-1	20727411
measured	O	-1	20727411
with	O	-1	20727411
f@@	O	-1	20727411
MR@@	O	-1	20727411
I	O	-1	20727411
were	O	-1	20727411
det@@	O	-1	20727411
ect@@	O	-1	20727411
ed.	O	-1	20727411
D@@	O	-1	20727411
uring	O	-1	20727411
the	O	-1	20727411
s@@	O	-1	20727411
can@@	O	-1	20727411
ning	O	-1	20727411
perio@@	O	-1	20727411
d,	O	-1	20727411
subjects	O	-1	20727411
performed	O	-1	20727411
continu@@	O	-1	20727411
ous	O	-1	20727411
over@@	O	-1	20727411
t	O	-1	20727411
ver@@	O	-1	20727411
b@@	O	-1	20727411
al	O	-1	20727411
flu@@	O	-1	20727411
ency	O	-1	20727411
t@@	O	-1	20727411
as@@	O	-1	20727411
k@@	O	-1	20727411
s	O	-1	20727411
(@@	O	-1	20727411
ph@@	O	-1	20727411
on@@	O	-1	20727411
olog@@	O	-1	20727411
ic@@	O	-1	20727411
al,	O	-1	20727411
le@@	O	-1	20727411
x@@	O	-1	20727411
ical	O	-1	20727411
and	O	-1	20727411
se@@	O	-1	20727411
m@@	O	-1	20727411
anti@@	O	-1	20727411
c@@	O	-1	20727411
).	O	-1	20727411
K@@	B-Chemical	D007649	20727411
et@@	I-Chemical	-1	20727411
amine	I-Chemical	-1	20727411
-induced	O	-1	20727411
psycho@@	O	-1	20727411
path@@	O	-1	20727411
ological	O	-1	20727411
symptoms	O	-1	20727411
were	O	-1	20727411
assessed	O	-1	20727411
with	O	-1	20727411
the	O	-1	20727411
P@@	O	-1	20727411
o@@	O	-1	20727411
si@@	O	-1	20727411
tive	O	-1	20727411
and	O	-1	20727411
Ne@@	O	-1	20727411
g@@	O	-1	20727411
ative	O	-1	20727411
S@@	O	-1	20727411
yn@@	O	-1	20727411
drom@@	O	-1	20727411
e	O	-1	20727411
S@@	O	-1	20727411
cal@@	O	-1	20727411
e	O	-1	20727411
(@@	O	-1	20727411
PA@@	O	-1	20727411
N@@	O	-1	20727411
S@@	O	-1	20727411
S@@	O	-1	20727411
).	O	-1	20727411
K@@	B-Chemical	D007649	20727411
et@@	I-Chemical	-1	20727411
amine	I-Chemical	-1	20727411
el@@	O	-1	20727411
ic@@	O	-1	20727411
ited	O	-1	20727411
psycho@@	B-Disease	D011605	20727411
sis	I-Disease	-1	20727411
like	O	-1	20727411
psycho@@	O	-1	20727411
path@@	O	-1	20727411
olog@@	O	-1	20727411
y.	O	-1	20727411
P@@	O	-1	20727411
ost@@	O	-1	20727411
-@@	O	-1	20727411
ho@@	O	-1	20727411
c	O	-1	20727411
t-@@	O	-1	20727411
tests	O	-1	20727411
revealed	O	-1	20727411
significant	O	-1	20727411
differences	O	-1	20727411
between	O	-1	20727411
placebo	O	-1	20727411
and	O	-1	20727411
k@@	B-Chemical	D007649	20727411
et@@	I-Chemical	-1	20727411
amine	I-Chemical	-1	20727411
for	O	-1	20727411
the	O	-1	20727411
amoun@@	O	-1	20727411
ts	O	-1	20727411
of	O	-1	20727411
wor@@	O	-1	20727411
ds	O	-1	20727411
gener@@	O	-1	20727411
ated	O	-1	20727411
during	O	-1	20727411
le@@	O	-1	20727411
x@@	O	-1	20727411
ical	O	-1	20727411
and	O	-1	20727411
se@@	O	-1	20727411
man@@	O	-1	20727411
tic	O	-1	20727411
ver@@	O	-1	20727411
b@@	O	-1	20727411
al	O	-1	20727411
flu@@	O	-1	20727411
enc@@	O	-1	20727411
y,	O	-1	20727411
while	O	-1	20727411
the	O	-1	20727411
ph@@	O	-1	20727411
on@@	O	-1	20727411
ological	O	-1	20727411
do@@	O	-1	20727411
ma@@	O	-1	20727411
in	O	-1	20727411
remained	O	-1	20727411
un@@	O	-1	20727411
aff@@	O	-1	20727411
ect@@	O	-1	20727411
ed.	O	-1	20727411
K@@	B-Chemical	D007649	20727411
et@@	I-Chemical	-1	20727411
amine	I-Chemical	-1	20727411
l@@	O	-1	20727411
ed	O	-1	20727411
to	O	-1	20727411
enhanced	O	-1	20727411
cor@@	O	-1	20727411
tical	O	-1	20727411
activ@@	O	-1	20727411
ations	O	-1	20727411
in	O	-1	20727411
sup@@	O	-1	20727411
ram@@	O	-1	20727411
arg@@	O	-1	20727411
inal	O	-1	20727411
and	O	-1	20727411
fron@@	O	-1	20727411
t@@	O	-1	20727411
al	O	-1	20727411
brain	O	-1	20727411
regi@@	O	-1	20727411
ons	O	-1	20727411
for	O	-1	20727411
ph@@	O	-1	20727411
on@@	O	-1	20727411
ological	O	-1	20727411
and	O	-1	20727411
le@@	O	-1	20727411
x@@	O	-1	20727411
ical	O	-1	20727411
ver@@	O	-1	20727411
b@@	O	-1	20727411
al	O	-1	20727411
flu@@	O	-1	20727411
enc@@	O	-1	20727411
y,	O	-1	20727411
but	O	-1	20727411
not	O	-1	20727411
for	O	-1	20727411
se@@	O	-1	20727411
man@@	O	-1	20727411
tic	O	-1	20727411
ver@@	O	-1	20727411
b@@	O	-1	20727411
al	O	-1	20727411
flu@@	O	-1	20727411
enc@@	O	-1	20727411
y.	O	-1	20727411
K@@	B-Chemical	D007649	20727411
et@@	I-Chemical	-1	20727411
amine	I-Chemical	-1	20727411
induc@@	O	-1	20727411
es	O	-1	20727411
activation	O	-1	20727411
changes	O	-1	20727411
in	O	-1	20727411
healthy	O	-1	20727411
subjects	O	-1	20727411
similar	O	-1	20727411
to	O	-1	20727411
those	O	-1	20727411
observed	O	-1	20727411
in	O	-1	20727411
patients	O	-1	20727411
with	O	-1	20727411
sch@@	B-Disease	D012559	20727411
iz@@	I-Disease	-1	20727411
oph@@	I-Disease	-1	20727411
ren@@	I-Disease	-1	20727411
ia	I-Disease	-1	20727411
,	O	-1	20727411
partic@@	O	-1	20727411
ul@@	O	-1	20727411
arly	O	-1	20727411
in	O	-1	20727411
fron@@	O	-1	20727411
t@@	O	-1	20727411
al	O	-1	20727411
and	O	-1	20727411
tempor@@	O	-1	20727411
al	O	-1	20727411
brain	O	-1	20727411
regi@@	O	-1	20727411
on@@	O	-1	20727411
s.	O	-1	20727411
Our	O	-1	20727411
results	O	-1	20727411
prov@@	O	-1	20727411
ide	O	-1	20727411
further	O	-1	20727411
suppor@@	O	-1	20727411
t	O	-1	20727411
for	O	-1	20727411
the	O	-1	20727411
hypo@@	O	-1	20727411
thesis	O	-1	20727411
of	O	-1	20727411
an	O	-1	20727411
N@@	B-Chemical	D016202	20727411
MD@@	I-Chemical	-1	20727411
A	I-Chemical	-1	20727411
receptor	O	-1	20727411
dysfunction	O	-1	20727411
in	O	-1	20727411
the	O	-1	20727411
path@@	O	-1	20727411
oph@@	O	-1	20727411
ysi@@	O	-1	20727411
ology	O	-1	20727411
of	O	-1	20727411
sch@@	B-Disease	D012559	20727411
iz@@	I-Disease	-1	20727411
oph@@	I-Disease	-1	20727411
ren@@	I-Disease	-1	20727411
ia	I-Disease	-1	20727411
.	O	-1	20727411

D@@	B-Chemical	D004298	20533999
op@@	I-Chemical	-1	20533999
amine	I-Chemical	-1	20533999
is	O	-1	20533999
not	O	-1	20533999
es@@	O	-1	20533999
sen@@	O	-1	20533999
tial	O	-1	20533999
for	O	-1	20533999
the	O	-1	20533999
development	O	-1	20533999
of	O	-1	20533999
meth@@	B-Chemical	D008694	20533999
amphetamine	I-Chemical	-1	20533999
-induced	O	-1	20533999
neuro@@	B-Disease	D020258	20533999
toxicity	I-Disease	-1	20533999
.	O	-1	20533999
It	O	-1	20533999
is	O	-1	20533999
wi@@	O	-1	20533999
de@@	O	-1	20533999
ly	O	-1	20533999
be@@	O	-1	20533999
li@@	O	-1	20533999
ev@@	O	-1	20533999
ed	O	-1	20533999
that	O	-1	20533999
dopamine	B-Chemical	D004298	20533999
(	O	-1	20533999
D@@	B-Chemical	D004298	20533999
A	I-Chemical	-1	20533999
)	O	-1	20533999
medi@@	O	-1	20533999
ates	O	-1	20533999
meth@@	B-Chemical	D008694	20533999
amphetamine	I-Chemical	-1	20533999
(	O	-1	20533999
MET@@	B-Chemical	D008694	20533999
H	I-Chemical	-1	20533999
)@@	O	-1	20533999
-induced	O	-1	20533999
toxicity	B-Disease	D064420	20533999
to	O	-1	20533999
brain	O	-1	20533999
dop@@	O	-1	20533999
aminergic	O	-1	20533999
neuron@@	O	-1	20533999
s,	O	-1	20533999
because	O	-1	20533999
drugs	O	-1	20533999
that	O	-1	20533999
inter@@	O	-1	20533999
f@@	O	-1	20533999
ere	O	-1	20533999
with	O	-1	20533999
D@@	B-Chemical	D004298	20533999
A	I-Chemical	-1	20533999
neuro@@	O	-1	20533999
trans@@	O	-1	20533999
mission	O	-1	20533999
decrease	O	-1	20533999
toxicity	B-Disease	D064420	20533999
,	O	-1	20533999
whereas	O	-1	20533999
drugs	O	-1	20533999
that	O	-1	20533999
increase	O	-1	20533999
D@@	B-Chemical	D004298	20533999
A	I-Chemical	-1	20533999
neuro@@	O	-1	20533999
trans@@	O	-1	20533999
mission	O	-1	20533999
enh@@	O	-1	20533999
ance	O	-1	20533999
toxicity	B-Disease	D064420	20533999
.	O	-1	20533999
However,	O	-1	20533999
tem@@	O	-1	20533999
per@@	O	-1	20533999
at@@	O	-1	20533999
ure	O	-1	20533999
effects	O	-1	20533999
of	O	-1	20533999
drugs	O	-1	20533999
that	O	-1	20533999
have	O	-1	20533999
been	O	-1	20533999
used	O	-1	20533999
to	O	-1	20533999
man@@	O	-1	20533999
ip@@	O	-1	20533999
ul@@	O	-1	20533999
ate	O	-1	20533999
brain	O	-1	20533999
D@@	B-Chemical	D004298	20533999
A	I-Chemical	-1	20533999
neuro@@	O	-1	20533999
trans@@	O	-1	20533999
mission	O	-1	20533999
con@@	O	-1	20533999
found	O	-1	20533999
inter@@	O	-1	20533999
pre@@	O	-1	20533999
t@@	O	-1	20533999
ation	O	-1	20533999
of	O	-1	20533999
the	O	-1	20533999
dat@@	O	-1	20533999
a.	O	-1	20533999
H@@	O	-1	20533999
ere	O	-1	20533999
we	O	-1	20533999
show	O	-1	20533999
that	O	-1	20533999
the	O	-1	20533999
rec@@	O	-1	20533999
ently	O	-1	20533999
reported	O	-1	20533999
ability	O	-1	20533999
of	O	-1	20533999
L-@@	B-Chemical	D007980	20533999
di@@	I-Chemical	-1	20533999
hydrox@@	I-Chemical	-1	20533999
y@@	I-Chemical	-1	20533999
phenyl@@	I-Chemical	-1	20533999
al@@	I-Chemical	-1	20533999
an@@	I-Chemical	-1	20533999
ine	I-Chemical	-1	20533999
to	O	-1	20533999
re@@	O	-1	20533999
verse	O	-1	20533999
the	O	-1	20533999
protective	O	-1	20533999
effect	O	-1	20533999
of	O	-1	20533999
alpha-@@	B-Chemical	D019805	20533999
methyl@@	I-Chemical	-1	20533999
-@@	I-Chemical	-1	20533999
par@@	I-Chemical	-1	20533999
a@@	I-Chemical	-1	20533999
-@@	I-Chemical	-1	20533999
ty@@	I-Chemical	-1	20533999
ros@@	I-Chemical	-1	20533999
ine	I-Chemical	-1	20533999
on	O	-1	20533999
MET@@	B-Chemical	D008694	20533999
H	I-Chemical	-1	20533999
-induced	O	-1	20533999
D@@	B-Chemical	D004298	20533999
A	I-Chemical	-1	20533999
neuro@@	B-Disease	D020258	20533999
toxicity	I-Disease	-1	20533999
is	O	-1	20533999
also	O	-1	20533999
conf@@	O	-1	20533999
oun@@	O	-1	20533999
ded	O	-1	20533999
by	O	-1	20533999
drug	O	-1	20533999
effects	O	-1	20533999
on	O	-1	20533999
body	O	-1	20533999
tem@@	O	-1	20533999
per@@	O	-1	20533999
at@@	O	-1	20533999
ure.	O	-1	20533999
F@@	O	-1	20533999
ur@@	O	-1	20533999
ther@@	O	-1	20533999
,	O	-1	20533999
we	O	-1	20533999
show	O	-1	20533999
that	O	-1	20533999
mice	O	-1	20533999
gene@@	O	-1	20533999
tically	O	-1	20533999
en@@	O	-1	20533999
g@@	O	-1	20533999
ine@@	O	-1	20533999
ered	O	-1	20533999
to	O	-1	20533999
be	O	-1	20533999
defici@@	O	-1	20533999
ent	O	-1	20533999
in	O	-1	20533999
brain	O	-1	20533999
D@@	B-Chemical	D004298	20533999
A	I-Chemical	-1	20533999
deve@@	O	-1	20533999
lo@@	O	-1	20533999
p	O	-1	20533999
MET@@	B-Chemical	D008694	20533999
H	I-Chemical	-1	20533999
neuro@@	B-Disease	D020258	20533999
toxicity	I-Disease	-1	20533999
,	O	-1	20533999
as	O	-1	20533999
lon@@	O	-1	20533999
g	O	-1	20533999
as	O	-1	20533999
the	O	-1	20533999
ther@@	O	-1	20533999
mic	O	-1	20533999
effects	O	-1	20533999
of	O	-1	20533999
MET@@	B-Chemical	D008694	20533999
H	I-Chemical	-1	20533999
are	O	-1	20533999
pres@@	O	-1	20533999
er@@	O	-1	20533999
ved.	O	-1	20533999
In	O	-1	20533999
addi@@	O	-1	20533999
tion,	O	-1	20533999
we	O	-1	20533999
demon@@	O	-1	20533999
st@@	O	-1	20533999
rate	O	-1	20533999
that	O	-1	20533999
mice	O	-1	20533999
gene@@	O	-1	20533999
tically	O	-1	20533999
en@@	O	-1	20533999
g@@	O	-1	20533999
ine@@	O	-1	20533999
ered	O	-1	20533999
to	O	-1	20533999
have	O	-1	20533999
un@@	O	-1	20533999
il@@	O	-1	20533999
ateral	O	-1	20533999
brain	O	-1	20533999
D@@	B-Chemical	D004298	20533999
A	I-Chemical	-1	20533999
defic@@	O	-1	20533999
its	O	-1	20533999
deve@@	O	-1	20533999
lo@@	O	-1	20533999
p	O	-1	20533999
MET@@	B-Chemical	D008694	20533999
H	I-Chemical	-1	20533999
-induced	O	-1	20533999
dop@@	B-Disease	D009461	20533999
aminergic	I-Disease	-1	20533999
defic@@	I-Disease	-1	20533999
its	I-Disease	-1	20533999
that	O	-1	20533999
are	O	-1	20533999
of	O	-1	20533999
compar@@	O	-1	20533999
able	O	-1	20533999
mag@@	O	-1	20533999
nit@@	O	-1	20533999
ude	O	-1	20533999
on	O	-1	20533999
both	O	-1	20533999
side@@	O	-1	20533999
s	O	-1	20533999
of	O	-1	20533999
the	O	-1	20533999
bra@@	O	-1	20533999
in.	O	-1	20533999
T@@	O	-1	20533999
ak@@	O	-1	20533999
en	O	-1	20533999
to@@	O	-1	20533999
ge@@	O	-1	20533999
ther@@	O	-1	20533999
,	O	-1	20533999
these	O	-1	20533999
findings	O	-1	20533999
demon@@	O	-1	20533999
st@@	O	-1	20533999
rate	O	-1	20533999
that	O	-1	20533999
D@@	B-Chemical	D004298	20533999
A	I-Chemical	-1	20533999
is	O	-1	20533999
not	O	-1	20533999
es@@	O	-1	20533999
sen@@	O	-1	20533999
tial	O	-1	20533999
for	O	-1	20533999
the	O	-1	20533999
development	O	-1	20533999
of	O	-1	20533999
MET@@	B-Chemical	D008694	20533999
H	I-Chemical	-1	20533999
-induced	O	-1	20533999
dop@@	O	-1	20533999
aminergic	O	-1	20533999
neuro@@	B-Disease	D020258	20533999
toxicity	I-Disease	-1	20533999
and	O	-1	20533999
suggest	O	-1	20533999
that	O	-1	20533999
mechanisms	O	-1	20533999
in@@	O	-1	20533999
dependent	O	-1	20533999
of	O	-1	20533999
D@@	B-Chemical	D004298	20533999
A	I-Chemical	-1	20533999
war@@	O	-1	20533999
ran@@	O	-1	20533999
t	O	-1	20533999
more	O	-1	20533999
int@@	O	-1	20533999
en@@	O	-1	20533999
se	O	-1	20533999
investig@@	O	-1	20533999
ation.	O	-1	20533999

B@@	B-Disease	-1	20304337
ra@@	I-Disease	-1	20304337
in@@	I-Disease	-1	20304337
st@@	I-Disease	-1	20304337
em	I-Disease	-1	20304337
dys@@	I-Disease	-1	20304337
genesis	I-Disease	-1	20304337
in	O	-1	20304337
an	O	-1	20304337
inf@@	O	-1	20304337
ant	O	-1	20304337
p@@	O	-1	20304337
ren@@	O	-1	20304337
at@@	O	-1	20304337
ally	O	-1	20304337
exposed	O	-1	20304337
to	O	-1	20304337
cocaine	B-Chemical	D003042	20304337
.	O	-1	20304337
M@@	O	-1	20304337
any	O	-1	20304337
au@@	O	-1	20304337
th@@	O	-1	20304337
ors	O	-1	20304337
descri@@	O	-1	20304337
bed	O	-1	20304337
the	O	-1	20304337
effects	O	-1	20304337
on	O	-1	20304337
the	O	-1	20304337
f@@	O	-1	20304337
et@@	O	-1	20304337
us	O	-1	20304337
of	O	-1	20304337
mat@@	O	-1	20304337
er@@	O	-1	20304337
n@@	O	-1	20304337
al	O	-1	20304337
cocaine	B-Disease	D019970	20304337
ab@@	I-Disease	-1	20304337
use	I-Disease	-1	20304337
during	O	-1	20304337
pregn@@	O	-1	20304337
anc@@	O	-1	20304337
y.	O	-1	20304337
V@@	O	-1	20304337
as@@	O	-1	20304337
o@@	O	-1	20304337
con@@	O	-1	20304337
stric@@	O	-1	20304337
tion	O	-1	20304337
appear@@	O	-1	20304337
s	O	-1	20304337
to	O	-1	20304337
be	O	-1	20304337
the	O	-1	20304337
common	O	-1	20304337
mechanism	O	-1	20304337
of	O	-1	20304337
action	O	-1	20304337
lead@@	O	-1	20304337
ing	O	-1	20304337
to	O	-1	20304337
a	O	-1	20304337
w@@	O	-1	20304337
ide	O	-1	20304337
range	O	-1	20304337
of	O	-1	20304337
f@@	B-Disease	D005315	20304337
et@@	I-Disease	-1	20304337
al	I-Disease	-1	20304337
an@@	I-Disease	-1	20304337
om@@	I-Disease	-1	20304337
al@@	I-Disease	-1	20304337
i@@	I-Disease	-1	20304337
es	I-Disease	-1	20304337
.	O	-1	20304337
We	O	-1	20304337
report	O	-1	20304337
on	O	-1	20304337
an	O	-1	20304337
inf@@	O	-1	20304337
ant	O	-1	20304337
with	O	-1	20304337
multiple	B-Disease	D003389	20304337
c@@	I-Disease	-1	20304337
ran@@	I-Disease	-1	20304337
i@@	I-Disease	-1	20304337
al@@	I-Disease	-1	20304337
-@@	I-Disease	-1	20304337
nerve	I-Disease	-1	20304337
invol@@	I-Disease	-1	20304337
vement	I-Disease	-1	20304337
at@@	O	-1	20304337
tri@@	O	-1	20304337
but@@	O	-1	20304337
able	O	-1	20304337
to	O	-1	20304337
bra@@	B-Disease	-1	20304337
in@@	I-Disease	-1	20304337
st@@	I-Disease	-1	20304337
em	I-Disease	-1	20304337
dys@@	I-Disease	-1	20304337
genesis	I-Disease	-1	20304337
,	O	-1	20304337
b@@	O	-1	20304337
or@@	O	-1	20304337
n	O	-1	20304337
to	O	-1	20304337
a	O	-1	20304337
coca@@	B-Disease	D019970	20304337
ine-@@	I-Disease	-1	20304337
ad@@	I-Disease	-1	20304337
dic@@	I-Disease	-1	20304337
ted	I-Disease	-1	20304337
mo@@	O	-1	20304337
ther@@	O	-1	20304337
.	O	-1	20304337

The	O	-1	20103708
protective	O	-1	20103708
role	O	-1	20103708
of	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
in	O	-1	20103708
st@@	B-Chemical	D013311	20103708
re@@	I-Chemical	-1	20103708
pto@@	I-Chemical	-1	20103708
z@@	I-Chemical	-1	20103708
ot@@	I-Chemical	-1	20103708
oc@@	I-Chemical	-1	20103708
in	I-Chemical	-1	20103708
-induced	O	-1	20103708
dia@@	B-Disease	D003928	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
.	O	-1	20103708
OBJECTIVE:	O	-1	20103708
D@@	B-Disease	D003928	20103708
ia@@	I-Disease	-1	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
is	O	-1	20103708
one	O	-1	20103708
of	O	-1	20103708
the	O	-1	20103708
major	O	-1	20103708
causes	O	-1	20103708
of	O	-1	20103708
renal	B-Disease	D051437	20103708
failure	I-Disease	-1	20103708
,	O	-1	20103708
which	O	-1	20103708
is	O	-1	20103708
ac@@	O	-1	20103708
comp@@	O	-1	20103708
an@@	O	-1	20103708
ied	O	-1	20103708
by	O	-1	20103708
the	O	-1	20103708
pro@@	O	-1	20103708
duction	O	-1	20103708
of	O	-1	20103708
reac@@	O	-1	20103708
tive	O	-1	20103708
oxy@@	B-Chemical	D010100	20103708
gen	I-Chemical	-1	20103708
spec@@	O	-1	20103708
i@@	O	-1	20103708
es	O	-1	20103708
(@@	O	-1	20103708
RO@@	O	-1	20103708
S@@	O	-1	20103708
).	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
is	O	-1	20103708
the	O	-1	20103708
prim@@	O	-1	20103708
ary	O	-1	20103708
trans@@	O	-1	20103708
cri@@	O	-1	20103708
ption	O	-1	20103708
factor	O	-1	20103708
that	O	-1	20103708
controls	O	-1	20103708
the	O	-1	20103708
anti@@	O	-1	20103708
oxid@@	O	-1	20103708
ant	O	-1	20103708
response	O	-1	20103708
es@@	O	-1	20103708
sen@@	O	-1	20103708
tial	O	-1	20103708
for	O	-1	20103708
maint@@	O	-1	20103708
aining	O	-1	20103708
cell@@	O	-1	20103708
ular	O	-1	20103708
re@@	O	-1	20103708
do@@	O	-1	20103708
x	O	-1	20103708
ho@@	O	-1	20103708
me@@	O	-1	20103708
ost@@	O	-1	20103708
a@@	O	-1	20103708
sis.	O	-1	20103708
He@@	O	-1	20103708
re,	O	-1	20103708
we	O	-1	20103708
report	O	-1	20103708
our	O	-1	20103708
findings	O	-1	20103708
demon@@	O	-1	20103708
strat@@	O	-1	20103708
ing	O	-1	20103708
a	O	-1	20103708
protective	O	-1	20103708
role	O	-1	20103708
of	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
against	O	-1	20103708
dia@@	B-Disease	D003928	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
.	O	-1	20103708
RES@@	O	-1	20103708
E@@	O	-1	20103708
A@@	O	-1	20103708
R@@	O	-1	20103708
C@@	O	-1	20103708
H	O	-1	20103708
D@@	O	-1	20103708
ES@@	O	-1	20103708
I@@	O	-1	20103708
G@@	O	-1	20103708
N	O	-1	20103708
AN@@	O	-1	20103708
D	O	-1	20103708
METHODS:	O	-1	20103708
We	O	-1	20103708
expl@@	O	-1	20103708
or@@	O	-1	20103708
e	O	-1	20103708
the	O	-1	20103708
protective	O	-1	20103708
role	O	-1	20103708
of	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
against	O	-1	20103708
dia@@	B-Disease	D003928	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
using	O	-1	20103708
human	O	-1	20103708
kidney	O	-1	20103708
biop@@	O	-1	20103708
sy	O	-1	20103708
tissu@@	O	-1	20103708
es	O	-1	20103708
from	O	-1	20103708
dia@@	B-Disease	D003928	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
patients,	O	-1	20103708
a	O	-1	20103708
st@@	B-Chemical	D013311	20103708
re@@	I-Chemical	-1	20103708
pto@@	I-Chemical	-1	20103708
z@@	I-Chemical	-1	20103708
ot@@	I-Chemical	-1	20103708
oc@@	I-Chemical	-1	20103708
in	I-Chemical	-1	20103708
-induced	O	-1	20103708
dia@@	B-Disease	D003928	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
model	O	-1	20103708
in	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2@@	O	-1	20103708
(-@@	O	-1	20103708
/@@	O	-1	20103708
-@@	O	-1	20103708
)	O	-1	20103708
mic@@	O	-1	20103708
e,	O	-1	20103708
and	O	-1	20103708
c@@	O	-1	20103708
ult@@	O	-1	20103708
ured	O	-1	20103708
human	O	-1	20103708
m@@	O	-1	20103708
es@@	O	-1	20103708
ang@@	O	-1	20103708
ial	O	-1	20103708
cell@@	O	-1	20103708
s.	O	-1	20103708
RESULTS:	O	-1	20103708
The	O	-1	20103708
glomerul@@	O	-1	20103708
i	O	-1	20103708
of	O	-1	20103708
human	O	-1	20103708
dia@@	B-Disease	D003928	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
patients	O	-1	20103708
were	O	-1	20103708
under	O	-1	20103708
oxid@@	O	-1	20103708
ative	O	-1	20103708
stres@@	O	-1	20103708
s	O	-1	20103708
and	O	-1	20103708
had	O	-1	20103708
elevated	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
level@@	O	-1	20103708
s.	O	-1	20103708
In	O	-1	20103708
the	O	-1	20103708
anim@@	O	-1	20103708
al	O	-1	20103708
study,	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
was	O	-1	20103708
demonstrated	O	-1	20103708
to	O	-1	20103708
be	O	-1	20103708
c@@	O	-1	20103708
r@@	O	-1	20103708
uc@@	O	-1	20103708
ial	O	-1	20103708
in	O	-1	20103708
ame@@	O	-1	20103708
li@@	O	-1	20103708
or@@	O	-1	20103708
ating	O	-1	20103708
st@@	B-Chemical	D013311	20103708
re@@	I-Chemical	-1	20103708
pto@@	I-Chemical	-1	20103708
z@@	I-Chemical	-1	20103708
ot@@	I-Chemical	-1	20103708
oc@@	I-Chemical	-1	20103708
in	I-Chemical	-1	20103708
-induced	O	-1	20103708
renal	B-Disease	D058186	20103708
damage	I-Disease	-1	20103708
.	O	-1	20103708
This	O	-1	20103708
is	O	-1	20103708
ev@@	O	-1	20103708
id@@	O	-1	20103708
ent	O	-1	20103708
by	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2@@	O	-1	20103708
(-@@	O	-1	20103708
/@@	O	-1	20103708
-@@	O	-1	20103708
)	O	-1	20103708
mice	O	-1	20103708
ha@@	O	-1	20103708
ving	O	-1	20103708
higher	O	-1	20103708
RO@@	O	-1	20103708
S	O	-1	20103708
pro@@	O	-1	20103708
duction	O	-1	20103708
and	O	-1	20103708
suff@@	O	-1	20103708
ering	O	-1	20103708
from	O	-1	20103708
greater	O	-1	20103708
oxid@@	O	-1	20103708
ative	O	-1	20103708
D@@	O	-1	20103708
NA	O	-1	20103708
damage	O	-1	20103708
and	O	-1	20103708
renal	B-Disease	D058186	20103708
injury	I-Disease	-1	20103708
compared	O	-1	20103708
with	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2@@	O	-1	20103708
(@@	O	-1	20103708
+/@@	O	-1	20103708
+@@	O	-1	20103708
)	O	-1	20103708
mice.	O	-1	20103708
M@@	O	-1	20103708
echan@@	O	-1	20103708
istic	O	-1	20103708
studies	O	-1	20103708
in	O	-1	20103708
both	O	-1	20103708
in	O	-1	20103708
viv@@	O	-1	20103708
o	O	-1	20103708
and	O	-1	20103708
in	O	-1	20103708
vit@@	O	-1	20103708
r@@	O	-1	20103708
o	O	-1	20103708
system@@	O	-1	20103708
s	O	-1	20103708
showed	O	-1	20103708
that	O	-1	20103708
the	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2-@@	O	-1	20103708
mediated	O	-1	20103708
prot@@	O	-1	20103708
ection	O	-1	20103708
against	O	-1	20103708
dia@@	B-Disease	D003928	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
is@@	O	-1	20103708
,	O	-1	20103708
at	O	-1	20103708
le@@	O	-1	20103708
ast@@	O	-1	20103708
,	O	-1	20103708
par@@	O	-1	20103708
ti@@	O	-1	20103708
ally	O	-1	20103708
through	O	-1	20103708
inhibition	O	-1	20103708
of	O	-1	20103708
trans@@	O	-1	20103708
form@@	O	-1	20103708
ing	O	-1	20103708
growth	O	-1	20103708
fact@@	O	-1	20103708
or@@	O	-1	20103708
-@@	O	-1	20103708
beta@@	O	-1	20103708
1	O	-1	20103708
(T@@	O	-1	20103708
GF@@	O	-1	20103708
-@@	O	-1	20103708
beta@@	O	-1	20103708
1)	O	-1	20103708
and	O	-1	20103708
reduction	O	-1	20103708
of	O	-1	20103708
extrac@@	O	-1	20103708
ell@@	O	-1	20103708
ular	O	-1	20103708
mat@@	O	-1	20103708
ri@@	O	-1	20103708
x	O	-1	20103708
produc@@	O	-1	20103708
tion.	O	-1	20103708
In	O	-1	20103708
human	O	-1	20103708
renal	O	-1	20103708
m@@	O	-1	20103708
es@@	O	-1	20103708
ang@@	O	-1	20103708
ial	O	-1	20103708
cell@@	O	-1	20103708
s,	O	-1	20103708
high	O	-1	20103708
g@@	B-Chemical	D005947	20103708
lu@@	I-Chemical	-1	20103708
co@@	I-Chemical	-1	20103708
se	I-Chemical	-1	20103708
induced	O	-1	20103708
RO@@	O	-1	20103708
S	O	-1	20103708
pro@@	O	-1	20103708
duction	O	-1	20103708
and	O	-1	20103708
activ@@	O	-1	20103708
ated	O	-1	20103708
expression	O	-1	20103708
of	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
and	O	-1	20103708
its	O	-1	20103708
do@@	O	-1	20103708
w@@	O	-1	20103708
n@@	O	-1	20103708
st@@	O	-1	20103708
re@@	O	-1	20103708
am	O	-1	20103708
gen@@	O	-1	20103708
es.	O	-1	20103708
F@@	O	-1	20103708
ur@@	O	-1	20103708
ther@@	O	-1	20103708
mo@@	O	-1	20103708
re,	O	-1	20103708
activation	O	-1	20103708
or	O	-1	20103708
o@@	O	-1	20103708
ve@@	O	-1	20103708
re@@	O	-1	20103708
x@@	O	-1	20103708
pression	O	-1	20103708
of	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
inhibited	O	-1	20103708
the	O	-1	20103708
pro@@	O	-1	20103708
m@@	O	-1	20103708
ot@@	O	-1	20103708
er	O	-1	20103708
activity	O	-1	20103708
of	O	-1	20103708
T@@	O	-1	20103708
GF@@	O	-1	20103708
-@@	O	-1	20103708
beta@@	O	-1	20103708
1	O	-1	20103708
in	O	-1	20103708
a	O	-1	20103708
dose-@@	O	-1	20103708
dependent	O	-1	20103708
man@@	O	-1	20103708
ner@@	O	-1	20103708
,	O	-1	20103708
whereas	O	-1	20103708
k@@	O	-1	20103708
n@@	O	-1	20103708
oc@@	O	-1	20103708
k@@	O	-1	20103708
do@@	O	-1	20103708
w@@	O	-1	20103708
n	O	-1	20103708
of	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
by	O	-1	20103708
si@@	O	-1	20103708
R@@	O	-1	20103708
NA	O	-1	20103708
enhanced	O	-1	20103708
T@@	O	-1	20103708
GF@@	O	-1	20103708
-@@	O	-1	20103708
beta@@	O	-1	20103708
1	O	-1	20103708
trans@@	O	-1	20103708
cri@@	O	-1	20103708
ption	O	-1	20103708
and	O	-1	20103708
fib@@	O	-1	20103708
ron@@	O	-1	20103708
ecti@@	O	-1	20103708
n	O	-1	20103708
produc@@	O	-1	20103708
tion.	O	-1	20103708
CONCLUSIONS:	O	-1	20103708
This	O	-1	20103708
wor@@	O	-1	20103708
k	O	-1	20103708
clear@@	O	-1	20103708
ly	O	-1	20103708
indic@@	O	-1	20103708
ates	O	-1	20103708
a	O	-1	20103708
protective	O	-1	20103708
role	O	-1	20103708
of	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
in	O	-1	20103708
dia@@	B-Disease	D003928	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
,	O	-1	20103708
suggesting	O	-1	20103708
that	O	-1	20103708
di@@	O	-1	20103708
et@@	O	-1	20103708
ary	O	-1	20103708
or	O	-1	20103708
therapeutic	O	-1	20103708
activation	O	-1	20103708
of	O	-1	20103708
N@@	O	-1	20103708
r@@	O	-1	20103708
f@@	O	-1	20103708
2	O	-1	20103708
could	O	-1	20103708
be	O	-1	20103708
used	O	-1	20103708
as	O	-1	20103708
a	O	-1	20103708
strat@@	O	-1	20103708
e@@	O	-1	20103708
g@@	O	-1	20103708
y	O	-1	20103708
to	O	-1	20103708
prev@@	O	-1	20103708
ent	O	-1	20103708
or	O	-1	20103708
s@@	O	-1	20103708
low	O	-1	20103708
do@@	O	-1	20103708
w@@	O	-1	20103708
n	O	-1	20103708
the	O	-1	20103708
progres@@	O	-1	20103708
sion	O	-1	20103708
of	O	-1	20103708
dia@@	B-Disease	D003928	20103708
be@@	I-Disease	-1	20103708
tic	I-Disease	-1	20103708
nephro@@	I-Disease	-1	20103708
pathy	I-Disease	-1	20103708
.	O	-1	20103708

H@@	O	-1	19996135
igh@@	O	-1	19996135
-@@	O	-1	19996135
dose	O	-1	19996135
tran@@	B-Chemical	D014148	19996135
ex@@	I-Chemical	-1	19996135
am@@	I-Chemical	-1	19996135
ic	I-Chemical	-1	19996135
A@@	I-Chemical	-1	19996135
ci@@	I-Chemical	-1	19996135
d	I-Chemical	-1	19996135
is	O	-1	19996135
associated	O	-1	19996135
with	O	-1	19996135
non@@	O	-1	19996135
ischem@@	O	-1	19996135
ic	O	-1	19996135
clinical	O	-1	19996135
seizures	B-Disease	D012640	19996135
in	O	-1	19996135
cardiac	O	-1	19996135
surg@@	O	-1	19996135
ical	O	-1	19996135
patients.	O	-1	19996135
BACKGROUND:	O	-1	19996135
In	O	-1	19996135
2	O	-1	19996135
se@@	O	-1	19996135
par@@	O	-1	19996135
ate	O	-1	19996135
c@@	O	-1	19996135
ent@@	O	-1	19996135
er@@	O	-1	19996135
s,	O	-1	19996135
we	O	-1	19996135
observed	O	-1	19996135
a	O	-1	19996135
not@@	O	-1	19996135
able	O	-1	19996135
increase	O	-1	19996135
in	O	-1	19996135
the	O	-1	19996135
incidence	O	-1	19996135
of	O	-1	19996135
postoperative	O	-1	19996135
convul@@	B-Disease	D012640	19996135
sive	I-Disease	-1	19996135
seizures	B-Disease	D012640	19996135
from	O	-1	19996135
1.@@	O	-1	19996135
3@@	O	-1	19996135
%	O	-1	19996135
to	O	-1	19996135
3.@@	O	-1	19996135
8@@	O	-1	19996135
%	O	-1	19996135
in	O	-1	19996135
patients	O	-1	19996135
ha@@	O	-1	19996135
ving	O	-1	19996135
under@@	O	-1	19996135
g@@	O	-1	19996135
one	O	-1	19996135
major	O	-1	19996135
cardiac	O	-1	19996135
surg@@	O	-1	19996135
ical	O	-1	19996135
proce@@	O	-1	19996135
du@@	O	-1	19996135
res@@	O	-1	19996135
.	O	-1	19996135
These	O	-1	19996135
events	O	-1	19996135
were	O	-1	19996135
tempor@@	O	-1	19996135
ally	O	-1	19996135
co@@	O	-1	19996135
inc@@	O	-1	19996135
id@@	O	-1	19996135
ent	O	-1	19996135
with	O	-1	19996135
the	O	-1	19996135
initial	O	-1	19996135
use	O	-1	19996135
of	O	-1	19996135
high-dose	O	-1	19996135
tran@@	B-Chemical	D014148	19996135
ex@@	I-Chemical	-1	19996135
am@@	I-Chemical	-1	19996135
ic	I-Chemical	-1	19996135
acid	I-Chemical	-1	19996135
(	O	-1	19996135
T@@	B-Chemical	D014148	19996135
X@@	I-Chemical	-1	19996135
A	I-Chemical	-1	19996135
)	O	-1	19996135
therapy	O	-1	19996135
after	O	-1	19996135
withdrawal	O	-1	19996135
of	O	-1	19996135
a@@	O	-1	19996135
prot@@	O	-1	19996135
in@@	O	-1	19996135
in	O	-1	19996135
from	O	-1	19996135
gener@@	O	-1	19996135
al	O	-1	19996135
clinical	O	-1	19996135
us@@	O	-1	19996135
age.	O	-1	19996135
The	O	-1	19996135
pur@@	O	-1	19996135
p@@	O	-1	19996135
ose	O	-1	19996135
of	O	-1	19996135
this	O	-1	19996135
revie@@	O	-1	19996135
w	O	-1	19996135
was	O	-1	19996135
to	O	-1	19996135
per@@	O	-1	19996135
form	O	-1	19996135
a	O	-1	19996135
ret@@	O	-1	19996135
ro@@	O	-1	19996135
sp@@	O	-1	19996135
ective	O	-1	19996135
analysis	O	-1	19996135
to	O	-1	19996135
ex@@	O	-1	19996135
amine	O	-1	19996135
whether	O	-1	19996135
there	O	-1	19996135
was	O	-1	19996135
a	O	-1	19996135
rel@@	O	-1	19996135
ation	O	-1	19996135
between	O	-1	19996135
T@@	B-Chemical	D014148	19996135
X@@	I-Chemical	-1	19996135
A	I-Chemical	-1	19996135
us@@	O	-1	19996135
age	O	-1	19996135
and	O	-1	19996135
seizures	B-Disease	D012640	19996135
after	O	-1	19996135
cardiac	O	-1	19996135
surger@@	O	-1	19996135
y.	O	-1	19996135
METHODS:	O	-1	19996135
An	O	-1	19996135
in-@@	O	-1	19996135
de@@	O	-1	19996135
pt@@	O	-1	19996135
h	O	-1	19996135
ch@@	O	-1	19996135
ar@@	O	-1	19996135
t	O	-1	19996135
revie@@	O	-1	19996135
w	O	-1	19996135
was	O	-1	19996135
under@@	O	-1	19996135
tak@@	O	-1	19996135
en	O	-1	19996135
in	O	-1	19996135
all	O	-1	19996135
24	O	-1	19996135
patients	O	-1	19996135
who	O	-1	19996135
developed	O	-1	19996135
perio@@	O	-1	19996135
perative	O	-1	19996135
seizures	B-Disease	D012640	19996135
.	O	-1	19996135
E@@	O	-1	19996135
l@@	O	-1	19996135
ect@@	O	-1	19996135
ro@@	O	-1	19996135
encephalo@@	O	-1	19996135
graph@@	O	-1	19996135
ic	O	-1	19996135
activity	O	-1	19996135
was	O	-1	19996135
recor@@	O	-1	19996135
ded	O	-1	19996135
in	O	-1	19996135
11	O	-1	19996135
of	O	-1	19996135
these	O	-1	19996135
patients,	O	-1	19996135
and	O	-1	19996135
all	O	-1	19996135
patients	O	-1	19996135
had	O	-1	19996135
a	O	-1	19996135
form@@	O	-1	19996135
al	O	-1	19996135
neurolog@@	O	-1	19996135
ical	O	-1	19996135
evalu@@	O	-1	19996135
ation	O	-1	19996135
and	O	-1	19996135
brain	O	-1	19996135
imaging	O	-1	19996135
studi@@	O	-1	19996135
es.	O	-1	19996135
RESULTS:	O	-1	19996135
Tw@@	O	-1	19996135
ent@@	O	-1	19996135
y-@@	O	-1	19996135
one	O	-1	19996135
of	O	-1	19996135
the	O	-1	19996135
24	O	-1	19996135
patients	O	-1	19996135
did	O	-1	19996135
not	O	-1	19996135
have	O	-1	19996135
evidence	O	-1	19996135
of	O	-1	19996135
new	O	-1	19996135
cerebral	B-Disease	D001930	19996135
ischem@@	I-Disease	-1	19996135
ic	I-Disease	-1	19996135
injury	I-Disease	-1	19996135
,	O	-1	19996135
but	O	-1	19996135
seizures	B-Disease	D012640	19996135
were	O	-1	19996135
likely	O	-1	19996135
due	O	-1	19996135
to	O	-1	19996135
ischem@@	B-Disease	D001930	19996135
ic	I-Disease	-1	19996135
brain	I-Disease	-1	19996135
injury	I-Disease	-1	19996135
in	O	-1	19996135
3	O	-1	19996135
patients.	O	-1	19996135
All	O	-1	19996135
patients	O	-1	19996135
with	O	-1	19996135
seizures	B-Disease	D012640	19996135
did	O	-1	19996135
not	O	-1	19996135
have	O	-1	19996135
per@@	O	-1	19996135
man@@	O	-1	19996135
ent	O	-1	19996135
neurolog@@	B-Disease	D009422	19996135
ical	I-Disease	-1	19996135
abnormal@@	I-Disease	-1	19996135
ities	I-Disease	-1	19996135
.	O	-1	19996135
All	O	-1	19996135
24	O	-1	19996135
patients	O	-1	19996135
with	O	-1	19996135
seizures	B-Disease	D012640	19996135
received	O	-1	19996135
high	O	-1	19996135
doses	O	-1	19996135
of	O	-1	19996135
T@@	B-Chemical	D014148	19996135
X@@	I-Chemical	-1	19996135
A	I-Chemical	-1	19996135
intra@@	O	-1	19996135
o@@	O	-1	19996135
per@@	O	-1	19996135
atively	O	-1	19996135
rang@@	O	-1	19996135
ing	O	-1	19996135
from	O	-1	19996135
6@@	O	-1	19996135
1	O	-1	19996135
to	O	-1	19996135
25@@	O	-1	19996135
9	O	-1	19996135
mg/kg@@	O	-1	19996135
,	O	-1	19996135
had	O	-1	19996135
a	O	-1	19996135
mean	O	-1	19996135
age	O	-1	19996135
of	O	-1	19996135
6@@	O	-1	19996135
9.@@	O	-1	19996135
9	O	-1	19996135
year@@	O	-1	19996135
s,	O	-1	19996135
and	O	-1	19996135
21	O	-1	19996135
of	O	-1	19996135
24	O	-1	19996135
had	O	-1	19996135
under@@	O	-1	19996135
g@@	O	-1	19996135
one	O	-1	19996135
op@@	O	-1	19996135
en	O	-1	19996135
ch@@	O	-1	19996135
am@@	O	-1	19996135
b@@	O	-1	19996135
er	O	-1	19996135
ra@@	O	-1	19996135
ther	O	-1	19996135
than	O	-1	19996135
coronary	O	-1	19996135
b@@	O	-1	19996135
yp@@	O	-1	19996135
as@@	O	-1	19996135
s	O	-1	19996135
proce@@	O	-1	19996135
du@@	O	-1	19996135
res@@	O	-1	19996135
.	O	-1	19996135
All	O	-1	19996135
but	O	-1	19996135
one	O	-1	19996135
patient	O	-1	19996135
were	O	-1	19996135
man@@	O	-1	19996135
aged	O	-1	19996135
using	O	-1	19996135
cardio@@	O	-1	19996135
pulmonary	O	-1	19996135
b@@	O	-1	19996135
yp@@	O	-1	19996135
as@@	O	-1	19996135
s.	O	-1	19996135
No	O	-1	19996135
evidence	O	-1	19996135
of	O	-1	19996135
brain	B-Disease	D002546	19996135
ischem@@	I-Disease	-1	19996135
ic	I-Disease	-1	19996135
,	O	-1	19996135
metabol@@	O	-1	19996135
ic@@	O	-1	19996135
,	O	-1	19996135
or	O	-1	19996135
hyper@@	B-Disease	D005334	19996135
ther@@	I-Disease	-1	19996135
mia	I-Disease	-1	19996135
-induced	O	-1	19996135
causes	O	-1	19996135
for	O	-1	19996135
their	O	-1	19996135
seizures	B-Disease	D012640	19996135
was	O	-1	19996135
appa@@	O	-1	19996135
ren@@	O	-1	19996135
t.	O	-1	19996135
CONCLUSION:	O	-1	19996135
Our	O	-1	19996135
results	O	-1	19996135
suggest	O	-1	19996135
that	O	-1	19996135
use	O	-1	19996135
of	O	-1	19996135
high-dose	O	-1	19996135
T@@	B-Chemical	D014148	19996135
X@@	I-Chemical	-1	19996135
A	I-Chemical	-1	19996135
in	O	-1	19996135
ol@@	O	-1	19996135
der	O	-1	19996135
patients	O	-1	19996135
in	O	-1	19996135
con@@	O	-1	19996135
j@@	O	-1	19996135
unc@@	O	-1	19996135
tion	O	-1	19996135
with	O	-1	19996135
cardio@@	O	-1	19996135
pulmonary	O	-1	19996135
b@@	O	-1	19996135
yp@@	O	-1	19996135
as@@	O	-1	19996135
s	O	-1	19996135
and	O	-1	19996135
o@@	O	-1	19996135
pen@@	O	-1	19996135
-@@	O	-1	19996135
ch@@	O	-1	19996135
am@@	O	-1	19996135
b@@	O	-1	19996135
er	O	-1	19996135
cardiac	O	-1	19996135
surger@@	O	-1	19996135
y	O	-1	19996135
is	O	-1	19996135
associated	O	-1	19996135
with	O	-1	19996135
clinical	O	-1	19996135
seizures	B-Disease	D012640	19996135
in	O	-1	19996135
sus@@	O	-1	19996135
cep@@	O	-1	19996135
ti@@	O	-1	19996135
ble	O	-1	19996135
patients.	O	-1	19996135

Rec@@	O	-1	19674115
ur@@	O	-1	19674115
rent	O	-1	19674115
dys@@	B-Disease	D000857	19674115
os@@	I-Disease	-1	19674115
mia	I-Disease	-1	19674115
induced	O	-1	19674115
by	O	-1	19674115
py@@	B-Chemical	D011718	19674115
ra@@	I-Chemical	-1	19674115
z@@	I-Chemical	-1	19674115
in@@	I-Chemical	-1	19674115
amide	I-Chemical	-1	19674115
.	O	-1	19674115
P@@	B-Chemical	D011718	19674115
y@@	I-Chemical	-1	19674115
ra@@	I-Chemical	-1	19674115
z@@	I-Chemical	-1	19674115
in@@	I-Chemical	-1	19674115
amide	I-Chemical	-1	19674115
can	O	-1	19674115
have	O	-1	19674115
adverse	O	-1	19674115
effects	O	-1	19674115
such	O	-1	19674115
as	O	-1	19674115
hepatic	B-Disease	D056486	19674115
toxicity	I-Disease	-1	19674115
,	O	-1	19674115
hyper@@	B-Disease	D033461	19674115
ur@@	I-Disease	-1	19674115
ic@@	I-Disease	-1	19674115
emia	I-Disease	-1	19674115
or	O	-1	19674115
di@@	O	-1	19674115
g@@	O	-1	19674115
es@@	O	-1	19674115
tive	O	-1	19674115
disorder@@	O	-1	19674115
s.	O	-1	19674115
In	O	-1	19674115
r@@	O	-1	19674115
are	O	-1	19674115
cas@@	O	-1	19674115
es,	O	-1	19674115
al@@	O	-1	19674115
ter@@	O	-1	19674115
ations	O	-1	19674115
in	O	-1	19674115
t@@	O	-1	19674115
ast@@	O	-1	19674115
e	O	-1	19674115
and	O	-1	19674115
s@@	O	-1	19674115
me@@	O	-1	19674115
ll	O	-1	19674115
function	O	-1	19674115
have	O	-1	19674115
been	O	-1	19674115
reported	O	-1	19674115
for	O	-1	19674115
py@@	B-Chemical	D011718	19674115
ra@@	I-Chemical	-1	19674115
z@@	I-Chemical	-1	19674115
in@@	I-Chemical	-1	19674115
amide	I-Chemical	-1	19674115
when	O	-1	19674115
combined	O	-1	19674115
with	O	-1	19674115
other	O	-1	19674115
drug@@	O	-1	19674115
s.	O	-1	19674115
We	O	-1	19674115
report	O	-1	19674115
a	O	-1	19674115
case	O	-1	19674115
of	O	-1	19674115
reversible	O	-1	19674115
ol@@	B-Disease	D000857	19674115
fact@@	I-Disease	-1	19674115
ory	I-Disease	-1	19674115
disor@@	I-Disease	-1	19674115
der	I-Disease	-1	19674115
related	O	-1	19674115
to	O	-1	19674115
py@@	B-Chemical	D011718	19674115
ra@@	I-Chemical	-1	19674115
z@@	I-Chemical	-1	19674115
in@@	I-Chemical	-1	19674115
amide	I-Chemical	-1	19674115
in	O	-1	19674115
a	O	-1	19674115
wom@@	O	-1	19674115
an@@	O	-1	19674115
,	O	-1	19674115
with	O	-1	19674115
a	O	-1	19674115
positive	O	-1	19674115
re@@	O	-1	19674115
ch@@	O	-1	19674115
all@@	O	-1	19674115
en@@	O	-1	19674115
g@@	O	-1	19674115
e.	O	-1	19674115
The	O	-1	19674115
patient	O	-1	19674115
presented	O	-1	19674115
every	O	-1	19674115
day	O	-1	19674115
a	O	-1	19674115
sens@@	O	-1	19674115
ation	O	-1	19674115
of	O	-1	19674115
s@@	O	-1	19674115
me@@	O	-1	19674115
ll@@	O	-1	19674115
ing	O	-1	19674115
so@@	O	-1	19674115
meth@@	O	-1	19674115
ing	O	-1	19674115
b@@	O	-1	19674115
ur@@	O	-1	19674115
ning	O	-1	19674115
15	O	-1	19674115
min	O	-1	19674115
after	O	-1	19674115
drug	O	-1	19674115
int@@	O	-1	19674115
ak@@	O	-1	19674115
e.	O	-1	19674115
D@@	B-Disease	D000857	19674115
ys@@	I-Disease	-1	19674115
os@@	I-Disease	-1	19674115
mia	I-Disease	-1	19674115
dis@@	O	-1	19674115
appe@@	O	-1	19674115
a@@	O	-1	19674115
red	O	-1	19674115
complete@@	O	-1	19674115
ly	O	-1	19674115
after	O	-1	19674115
py@@	B-Chemical	D011718	19674115
ra@@	I-Chemical	-1	19674115
z@@	I-Chemical	-1	19674115
in@@	I-Chemical	-1	19674115
amide	I-Chemical	-1	19674115
withdrawal	O	-1	19674115
and	O	-1	19674115
recur@@	O	-1	19674115
red	O	-1	19674115
after	O	-1	19674115
its	O	-1	19674115
re@@	O	-1	19674115
ch@@	O	-1	19674115
all@@	O	-1	19674115
en@@	O	-1	19674115
g@@	O	-1	19674115
e.	O	-1	19674115
The	O	-1	19674115
case	O	-1	19674115
was	O	-1	19674115
reported	O	-1	19674115
to	O	-1	19674115
the	O	-1	19674115
T@@	O	-1	19674115
un@@	O	-1	19674115
i@@	O	-1	19674115
si@@	O	-1	19674115
an	O	-1	19674115
C@@	O	-1	19674115
entr@@	O	-1	19674115
e	O	-1	19674115
of	O	-1	19674115
Ph@@	O	-1	19674115
armac@@	O	-1	19674115
o@@	O	-1	19674115
vi@@	O	-1	19674115
g@@	O	-1	19674115
il@@	O	-1	19674115
ance@@	O	-1	19674115
.	O	-1	19674115

L@@	O	-1	19139001
on@@	O	-1	19139001
g@@	O	-1	19139001
it@@	O	-1	19139001
ud@@	O	-1	19139001
inal	O	-1	19139001
assess@@	O	-1	19139001
ment	O	-1	19139001
of	O	-1	19139001
a@@	O	-1	19139001
ir	O	-1	19139001
con@@	O	-1	19139001
duction	O	-1	19139001
a@@	O	-1	19139001
udi@@	O	-1	19139001
o@@	O	-1	19139001
gram@@	O	-1	19139001
s	O	-1	19139001
in	O	-1	19139001
a	O	-1	19139001
phase	O	-1	19139001
I@@	O	-1	19139001
II	O	-1	19139001
clinical	O	-1	19139001
trial	O	-1	19139001
of	O	-1	19139001
di@@	B-Chemical	D000518	19139001
fluoro@@	I-Chemical	-1	19139001
methyl@@	I-Chemical	-1	19139001
or@@	I-Chemical	-1	19139001
n@@	I-Chemical	-1	19139001
i@@	I-Chemical	-1	19139001
th@@	I-Chemical	-1	19139001
ine	I-Chemical	-1	19139001
and	O	-1	19139001
sul@@	B-Chemical	D013467	19139001
in@@	I-Chemical	-1	19139001
da@@	I-Chemical	-1	19139001
c	I-Chemical	-1	19139001
for	O	-1	19139001
pre@@	O	-1	19139001
ven@@	O	-1	19139001
tion	O	-1	19139001
of	O	-1	19139001
s@@	O	-1	19139001
por@@	O	-1	19139001
a@@	O	-1	19139001
di@@	O	-1	19139001
c	O	-1	19139001
co@@	B-Disease	D015179	19139001
lo@@	I-Disease	-1	19139001
rec@@	I-Disease	-1	19139001
t@@	I-Disease	-1	19139001
al	I-Disease	-1	19139001
aden@@	I-Disease	-1	19139001
om@@	I-Disease	-1	19139001
as	I-Disease	-1	19139001
.	O	-1	19139001
A	O	-1	19139001
phase	O	-1	19139001
I@@	O	-1	19139001
II	O	-1	19139001
clinical	O	-1	19139001
trial	O	-1	19139001
assessed	O	-1	19139001
the	O	-1	19139001
recur@@	O	-1	19139001
rence	O	-1	19139001
of	O	-1	19139001
aden@@	B-Disease	D018256	19139001
om@@	I-Disease	-1	19139001
at@@	I-Disease	-1	19139001
ous	I-Disease	-1	19139001
poly@@	I-Disease	-1	19139001
p@@	I-Disease	-1	19139001
s	I-Disease	-1	19139001
after	O	-1	19139001
treatment	O	-1	19139001
for	O	-1	19139001
3@@	O	-1	19139001
6	O	-1	19139001
months	O	-1	19139001
with	O	-1	19139001
di@@	B-Chemical	D000518	19139001
fluoro@@	I-Chemical	-1	19139001
methyl@@	I-Chemical	-1	19139001
or@@	I-Chemical	-1	19139001
n@@	I-Chemical	-1	19139001
i@@	I-Chemical	-1	19139001
th@@	I-Chemical	-1	19139001
ine	I-Chemical	-1	19139001
(	O	-1	19139001
DF@@	B-Chemical	D000518	19139001
M@@	I-Chemical	-1	19139001
O	I-Chemical	-1	19139001
)	O	-1	19139001
plus	O	-1	19139001
sul@@	B-Chemical	D013467	19139001
in@@	I-Chemical	-1	19139001
da@@	I-Chemical	-1	19139001
c	I-Chemical	-1	19139001
or	O	-1	19139001
mat@@	O	-1	19139001
ch@@	O	-1	19139001
ed	O	-1	19139001
placebo@@	O	-1	19139001
s.	O	-1	19139001
T@@	O	-1	19139001
em@@	O	-1	19139001
por@@	O	-1	19139001
ary	O	-1	19139001
hearing	B-Disease	D034381	19139001
loss	I-Disease	-1	19139001
is	O	-1	19139001
a	O	-1	19139001
known	O	-1	19139001
toxicity	B-Disease	D064420	19139001
of	O	-1	19139001
treatment	O	-1	19139001
with	O	-1	19139001
DF@@	B-Chemical	D000518	19139001
M@@	I-Chemical	-1	19139001
O	I-Chemical	-1	19139001
,	O	-1	19139001
th@@	O	-1	19139001
us	O	-1	19139001
a	O	-1	19139001
com@@	O	-1	19139001
pre@@	O	-1	19139001
h@@	O	-1	19139001
en@@	O	-1	19139001
sive	O	-1	19139001
appro@@	O	-1	19139001
ach	O	-1	19139001
was	O	-1	19139001
developed	O	-1	19139001
to	O	-1	19139001
analy@@	O	-1	19139001
ze	O	-1	19139001
ser@@	O	-1	19139001
ial	O	-1	19139001
a@@	O	-1	19139001
ir	O	-1	19139001
con@@	O	-1	19139001
duction	O	-1	19139001
a@@	O	-1	19139001
udi@@	O	-1	19139001
o@@	O	-1	19139001
gram@@	O	-1	19139001
s.	O	-1	19139001
The	O	-1	19139001
gener@@	O	-1	19139001
al@@	O	-1	19139001
ized	O	-1	19139001
estim@@	O	-1	19139001
ating	O	-1	19139001
equ@@	O	-1	19139001
ation	O	-1	19139001
meth@@	O	-1	19139001
od	O	-1	19139001
estim@@	O	-1	19139001
ated	O	-1	19139001
the	O	-1	19139001
mean	O	-1	19139001
difference	O	-1	19139001
between	O	-1	19139001
treatment	O	-1	19139001
ar@@	O	-1	19139001
ms	O	-1	19139001
with	O	-1	19139001
reg@@	O	-1	19139001
ard	O	-1	19139001
to	O	-1	19139001
change	O	-1	19139001
in	O	-1	19139001
a@@	O	-1	19139001
ir	O	-1	19139001
con@@	O	-1	19139001
duction	O	-1	19139001
p@@	O	-1	19139001
ure	O	-1	19139001
t@@	O	-1	19139001
one	O	-1	19139001
th@@	O	-1	19139001
res@@	O	-1	19139001
h@@	O	-1	19139001
ol@@	O	-1	19139001
ds	O	-1	19139001
while	O	-1	19139001
ac@@	O	-1	19139001
coun@@	O	-1	19139001
ting	O	-1	19139001
for	O	-1	19139001
with@@	O	-1	19139001
in-@@	O	-1	19139001
subj@@	O	-1	19139001
ect	O	-1	19139001
correl@@	O	-1	19139001
ation	O	-1	19139001
due	O	-1	19139001
to	O	-1	19139001
repe@@	O	-1	19139001
ated	O	-1	19139001
meas@@	O	-1	19139001
ure@@	O	-1	19139001
ments	O	-1	19139001
at	O	-1	19139001
frequ@@	O	-1	19139001
en@@	O	-1	19139001
ci@@	O	-1	19139001
es.	O	-1	19139001
B@@	O	-1	19139001
as@@	O	-1	19139001
ed	O	-1	19139001
on	O	-1	19139001
2@@	O	-1	19139001
9@@	O	-1	19139001
0	O	-1	19139001
subj@@	O	-1	19139001
ect@@	O	-1	19139001
s,	O	-1	19139001
there	O	-1	19139001
was	O	-1	19139001
an	O	-1	19139001
average	O	-1	19139001
difference	O	-1	19139001
of	O	-1	19139001
0.@@	O	-1	19139001
50	O	-1	19139001
d@@	O	-1	19139001
B	O	-1	19139001
between	O	-1	19139001
subjects	O	-1	19139001
treated	O	-1	19139001
with	O	-1	19139001
DF@@	B-Chemical	D000518	19139001
M@@	I-Chemical	-1	19139001
O	I-Chemical	-1	19139001
plus	O	-1	19139001
sul@@	B-Chemical	D013467	19139001
in@@	I-Chemical	-1	19139001
da@@	I-Chemical	-1	19139001
c	I-Chemical	-1	19139001
compared	O	-1	19139001
with	O	-1	19139001
those	O	-1	19139001
treated	O	-1	19139001
with	O	-1	19139001
placebo	O	-1	19139001
(@@	O	-1	19139001
95%	O	-1	19139001
conf@@	O	-1	19139001
idence	O	-1	19139001
inter@@	O	-1	19139001
val@@	O	-1	19139001
,	O	-1	19139001
-@@	O	-1	19139001
0.@@	O	-1	19139001
6@@	O	-1	19139001
4	O	-1	19139001
to	O	-1	19139001
1.@@	O	-1	19139001
6@@	O	-1	19139001
3	O	-1	19139001
d@@	O	-1	19139001
B@@	O	-1	19139001
;	O	-1	19139001
P	O	-1	19139001
=	O	-1	19139001
0.@@	O	-1	19139001
3@@	O	-1	19139001
9@@	O	-1	19139001
),	O	-1	19139001
adjust@@	O	-1	19139001
ed	O	-1	19139001
for	O	-1	19139001
baseline	O	-1	19139001
valu@@	O	-1	19139001
es,	O	-1	19139001
age,	O	-1	19139001
and	O	-1	19139001
frequ@@	O	-1	19139001
en@@	O	-1	19139001
ci@@	O	-1	19139001
es.	O	-1	19139001
In	O	-1	19139001
the	O	-1	19139001
normal	O	-1	19139001
sp@@	O	-1	19139001
e@@	O	-1	19139001
ec@@	O	-1	19139001
h	O	-1	19139001
range	O	-1	19139001
of	O	-1	19139001
5@@	O	-1	19139001
00	O	-1	19139001
to	O	-1	19139001
3@@	O	-1	19139001
,@@	O	-1	19139001
0@@	O	-1	19139001
00	O	-1	19139001
H@@	O	-1	19139001
z@@	O	-1	19139001
,	O	-1	19139001
an	O	-1	19139001
estim@@	O	-1	19139001
ated	O	-1	19139001
difference	O	-1	19139001
of	O	-1	19139001
0.@@	O	-1	19139001
9@@	O	-1	19139001
9	O	-1	19139001
d@@	O	-1	19139001
B	O	-1	19139001
(-@@	O	-1	19139001
0.@@	O	-1	19139001
17	O	-1	19139001
to	O	-1	19139001
2.@@	O	-1	19139001
14	O	-1	19139001
d@@	O	-1	19139001
B@@	O	-1	19139001
;	O	-1	19139001
P	O	-1	19139001
=	O	-1	19139001
0.0@@	O	-1	19139001
9@@	O	-1	19139001
)	O	-1	19139001
was	O	-1	19139001
det@@	O	-1	19139001
ect@@	O	-1	19139001
ed.	O	-1	19139001
D@@	O	-1	19139001
ose	O	-1	19139001
int@@	O	-1	19139001
ensity	O	-1	19139001
did	O	-1	19139001
not	O	-1	19139001
ad@@	O	-1	19139001
d	O	-1	19139001
inf@@	O	-1	19139001
orm@@	O	-1	19139001
ation	O	-1	19139001
to	O	-1	19139001
model@@	O	-1	19139001
s.	O	-1	19139001
There	O	-1	19139001
were	O	-1	19139001
14	O	-1	19139001
of	O	-1	19139001
1@@	O	-1	19139001
5@@	O	-1	19139001
1	O	-1	19139001
(@@	O	-1	19139001
9.@@	O	-1	19139001
3@@	O	-1	19139001
%)	O	-1	19139001
in	O	-1	19139001
the	O	-1	19139001
DF@@	B-Chemical	D000518	19139001
M@@	I-Chemical	-1	19139001
O	I-Chemical	-1	19139001
plus	O	-1	19139001
sul@@	B-Chemical	D013467	19139001
in@@	I-Chemical	-1	19139001
da@@	I-Chemical	-1	19139001
c	I-Chemical	-1	19139001
group	O	-1	19139001
and	O	-1	19139001
4	O	-1	19139001
of	O	-1	19139001
13@@	O	-1	19139001
9	O	-1	19139001
(2@@	O	-1	19139001
.@@	O	-1	19139001
9@@	O	-1	19139001
%)	O	-1	19139001
in	O	-1	19139001
the	O	-1	19139001
placebo	O	-1	19139001
group	O	-1	19139001
who	O	-1	19139001
experienced	O	-1	19139001
at	O	-1	19139001
le@@	O	-1	19139001
ast	O	-1	19139001
15	O	-1	19139001
d@@	O	-1	19139001
B	O	-1	19139001
hearing	O	-1	19139001
reduction	O	-1	19139001
from	O	-1	19139001
baseline	O	-1	19139001
in	O	-1	19139001
2	O	-1	19139001
or	O	-1	19139001
more	O	-1	19139001
con@@	O	-1	19139001
sec@@	O	-1	19139001
utive	O	-1	19139001
frequ@@	O	-1	19139001
en@@	O	-1	19139001
ci@@	O	-1	19139001
es	O	-1	19139001
ac@@	O	-1	19139001
ros@@	O	-1	19139001
s	O	-1	19139001
the	O	-1	19139001
enti@@	O	-1	19139001
r@@	O	-1	19139001
e	O	-1	19139001
range	O	-1	19139001
tested	O	-1	19139001
(P	O	-1	19139001
=	O	-1	19139001
0.0@@	O	-1	19139001
2@@	O	-1	19139001
).	O	-1	19139001
F@@	O	-1	19139001
ol@@	O	-1	19139001
low@@	O	-1	19139001
-@@	O	-1	19139001
up	O	-1	19139001
a@@	O	-1	19139001
ir	O	-1	19139001
con@@	O	-1	19139001
duction	O	-1	19139001
d@@	O	-1	19139001
one	O	-1	19139001
at	O	-1	19139001
le@@	O	-1	19139001
ast	O	-1	19139001
6	O	-1	19139001
months	O	-1	19139001
after	O	-1	19139001
end	O	-1	19139001
of	O	-1	19139001
treatment	O	-1	19139001
showed	O	-1	19139001
an	O	-1	19139001
adjust@@	O	-1	19139001
ed	O	-1	19139001
mean	O	-1	19139001
difference	O	-1	19139001
in	O	-1	19139001
hearing	O	-1	19139001
th@@	O	-1	19139001
res@@	O	-1	19139001
h@@	O	-1	19139001
ol@@	O	-1	19139001
ds	O	-1	19139001
of	O	-1	19139001
1.@@	O	-1	19139001
0@@	O	-1	19139001
8	O	-1	19139001
d@@	O	-1	19139001
B	O	-1	19139001
(-@@	O	-1	19139001
0.@@	O	-1	19139001
8@@	O	-1	19139001
1	O	-1	19139001
to	O	-1	19139001
2.@@	O	-1	19139001
9@@	O	-1	19139001
6	O	-1	19139001
d@@	O	-1	19139001
B@@	O	-1	19139001
;	O	-1	19139001
P	O	-1	19139001
=	O	-1	19139001
0.@@	O	-1	19139001
2@@	O	-1	19139001
6@@	O	-1	19139001
)	O	-1	19139001
between	O	-1	19139001
treatment	O	-1	19139001
ar@@	O	-1	19139001
m@@	O	-1	19139001
s.	O	-1	19139001
There	O	-1	19139001
was	O	-1	19139001
no	O	-1	19139001
significant	O	-1	19139001
difference	O	-1	19139001
in	O	-1	19139001
the	O	-1	19139001
pro@@	O	-1	19139001
por@@	O	-1	19139001
tion	O	-1	19139001
of	O	-1	19139001
subjects	O	-1	19139001
in	O	-1	19139001
the	O	-1	19139001
DF@@	B-Chemical	D000518	19139001
M@@	I-Chemical	-1	19139001
O	I-Chemical	-1	19139001
plus	O	-1	19139001
sul@@	B-Chemical	D013467	19139001
in@@	I-Chemical	-1	19139001
da@@	I-Chemical	-1	19139001
c	I-Chemical	-1	19139001
group	O	-1	19139001
who	O	-1	19139001
experienced	O	-1	19139001
clin@@	O	-1	19139001
ically	O	-1	19139001
significant	O	-1	19139001
hearing	B-Disease	D034381	19139001
loss	I-Disease	-1	19139001
compared	O	-1	19139001
with	O	-1	19139001
the	O	-1	19139001
placebo	O	-1	19139001
group.	O	-1	19139001
The	O	-1	19139001
estim@@	O	-1	19139001
ated	O	-1	19139001
at@@	O	-1	19139001
tri@@	O	-1	19139001
but@@	O	-1	19139001
able	O	-1	19139001
risk	O	-1	19139001
of	O	-1	19139001
ot@@	B-Disease	D006311	19139001
otoxicity	I-Disease	-1	19139001
from	O	-1	19139001
exposure	O	-1	19139001
to	O	-1	19139001
the	O	-1	19139001
drug	O	-1	19139001
is	O	-1	19139001
8.@@	O	-1	19139001
4@@	O	-1	19139001
%	O	-1	19139001
(@@	O	-1	19139001
95%	O	-1	19139001
conf@@	O	-1	19139001
idence	O	-1	19139001
inter@@	O	-1	19139001
val@@	O	-1	19139001
,	O	-1	19139001
-@@	O	-1	19139001
2.@@	O	-1	19139001
0%	O	-1	19139001
to	O	-1	19139001
1@@	O	-1	19139001
8.@@	O	-1	19139001
8@@	O	-1	19139001
%@@	O	-1	19139001
;	O	-1	19139001
P	O	-1	19139001
=	O	-1	19139001
0.@@	O	-1	19139001
12@@	O	-1	19139001
).	O	-1	19139001
There	O	-1	19139001
is	O	-1	19139001
a	O	-1	19139001
<@@	O	-1	19139001
2	O	-1	19139001
d@@	O	-1	19139001
B	O	-1	19139001
difference	O	-1	19139001
in	O	-1	19139001
mean	O	-1	19139001
th@@	O	-1	19139001
res@@	O	-1	19139001
h@@	O	-1	19139001
old	O	-1	19139001
for	O	-1	19139001
patients	O	-1	19139001
treated	O	-1	19139001
with	O	-1	19139001
DF@@	B-Chemical	D000518	19139001
M@@	I-Chemical	-1	19139001
O	I-Chemical	-1	19139001
plus	O	-1	19139001
sul@@	B-Chemical	D013467	19139001
in@@	I-Chemical	-1	19139001
da@@	I-Chemical	-1	19139001
c	I-Chemical	-1	19139001
compared	O	-1	19139001
with	O	-1	19139001
those	O	-1	19139001
treated	O	-1	19139001
with	O	-1	19139001
placebo@@	O	-1	19139001
.	O	-1	19139001

In@@	O	-1	18239197
c@@	O	-1	18239197
reas@@	O	-1	18239197
ed	O	-1	18239197
mental	B-Disease	D003072	18239197
s@@	I-Disease	-1	18239197
low@@	I-Disease	-1	18239197
ing	I-Disease	-1	18239197
associated	O	-1	18239197
with	O	-1	18239197
the	O	-1	18239197
A@@	O	-1	18239197
P@@	O	-1	18239197
O@@	O	-1	18239197
E	O	-1	18239197
ep@@	O	-1	18239197
si@@	O	-1	18239197
lon@@	O	-1	18239197
4	O	-1	18239197
al@@	O	-1	18239197
le@@	O	-1	18239197
le	O	-1	18239197
after	O	-1	18239197
tri@@	B-Chemical	D014282	18239197
he@@	I-Chemical	-1	18239197
x@@	I-Chemical	-1	18239197
y@@	I-Chemical	-1	18239197
phen@@	I-Chemical	-1	18239197
id@@	I-Chemical	-1	18239197
yl	I-Chemical	-1	18239197
oral	O	-1	18239197
anti@@	O	-1	18239197
cholinergic	O	-1	18239197
ch@@	O	-1	18239197
all@@	O	-1	18239197
enge	O	-1	18239197
in	O	-1	18239197
healthy	O	-1	18239197
el@@	O	-1	18239197
der@@	O	-1	18239197
ly.	O	-1	18239197
OBJECTIV@@	O	-1	18239197
E@@	O	-1	18239197
S:	O	-1	18239197
The	O	-1	18239197
ob@@	O	-1	18239197
j@@	O	-1	18239197
ec@@	O	-1	18239197
tiv@@	O	-1	18239197
es	O	-1	18239197
of	O	-1	18239197
this	O	-1	18239197
study	O	-1	18239197
were	O	-1	18239197
to	O	-1	18239197
ex@@	O	-1	18239197
amine	O	-1	18239197
the	O	-1	18239197
rel@@	O	-1	18239197
ationship	O	-1	18239197
between	O	-1	18239197
A@@	O	-1	18239197
P@@	O	-1	18239197
O@@	O	-1	18239197
E	O	-1	18239197
ep@@	O	-1	18239197
si@@	O	-1	18239197
lon@@	O	-1	18239197
4	O	-1	18239197
and	O	-1	18239197
subj@@	O	-1	18239197
ective	O	-1	18239197
effects	O	-1	18239197
of	O	-1	18239197
tri@@	B-Chemical	D014282	18239197
he@@	I-Chemical	-1	18239197
x@@	I-Chemical	-1	18239197
y@@	I-Chemical	-1	18239197
phen@@	I-Chemical	-1	18239197
id@@	I-Chemical	-1	18239197
yl	I-Chemical	-1	18239197
on	O	-1	18239197
meas@@	O	-1	18239197
ures	O	-1	18239197
ref@@	O	-1	18239197
l@@	O	-1	18239197
ect@@	O	-1	18239197
ing	O	-1	18239197
sed@@	O	-1	18239197
ation	O	-1	18239197
and	O	-1	18239197
conf@@	B-Disease	D003221	18239197
usion	I-Disease	-1	18239197
and	O	-1	18239197
to	O	-1	18239197
investigate	O	-1	18239197
the	O	-1	18239197
rel@@	O	-1	18239197
ationship	O	-1	18239197
between	O	-1	18239197
tri@@	B-Chemical	D014282	18239197
he@@	I-Chemical	-1	18239197
x@@	I-Chemical	-1	18239197
y@@	I-Chemical	-1	18239197
phen@@	I-Chemical	-1	18239197
id@@	I-Chemical	-1	18239197
yl	I-Chemical	-1	18239197
-induced	O	-1	18239197
subj@@	O	-1	18239197
ective	O	-1	18239197
effects	O	-1	18239197
and	O	-1	18239197
ob@@	O	-1	18239197
j@@	O	-1	18239197
ective	O	-1	18239197
memory	O	-1	18239197
perform@@	O	-1	18239197
ance@@	O	-1	18239197
.	O	-1	18239197
METHODS:	O	-1	18239197
This	O	-1	18239197
study	O	-1	18239197
comp@@	O	-1	18239197
ris@@	O	-1	18239197
ed	O	-1	18239197
24	O	-1	18239197
cogn@@	O	-1	18239197
iti@@	O	-1	18239197
vely	O	-1	18239197
int@@	O	-1	18239197
act@@	O	-1	18239197
,	O	-1	18239197
heal@@	O	-1	18239197
th	O	-1	18239197
el@@	O	-1	18239197
der@@	O	-1	18239197
ly	O	-1	18239197
ad@@	O	-1	18239197
ult@@	O	-1	18239197
s	O	-1	18239197
(1@@	O	-1	18239197
2	O	-1	18239197
A@@	O	-1	18239197
P@@	O	-1	18239197
O@@	O	-1	18239197
E	O	-1	18239197
ep@@	O	-1	18239197
si@@	O	-1	18239197
lon@@	O	-1	18239197
4	O	-1	18239197
car@@	O	-1	18239197
ri@@	O	-1	18239197
er@@	O	-1	18239197
s)	O	-1	18239197
at	O	-1	18239197
an	O	-1	18239197
out@@	O	-1	18239197
patient	O	-1	18239197
g@@	O	-1	18239197
er@@	O	-1	18239197
i@@	O	-1	18239197
atric	O	-1	18239197
psych@@	O	-1	18239197
i@@	O	-1	18239197
at@@	O	-1	18239197
r@@	O	-1	18239197
y	O	-1	18239197
re@@	O	-1	18239197
se@@	O	-1	18239197
arc@@	O	-1	18239197
h	O	-1	18239197
clin@@	O	-1	18239197
ic@@	O	-1	18239197
.	O	-1	18239197
This	O	-1	18239197
was	O	-1	18239197
a	O	-1	18239197
random@@	O	-1	18239197
iz@@	O	-1	18239197
ed,	O	-1	18239197
dou@@	O	-1	18239197
ble	O	-1	18239197
bl@@	O	-1	18239197
ind@@	O	-1	18239197
,	O	-1	18239197
placebo@@	O	-1	18239197
-@@	O	-1	18239197
control@@	O	-1	18239197
le@@	O	-1	18239197
d,	O	-1	18239197
th@@	O	-1	18239197
re@@	O	-1	18239197
e-@@	O	-1	18239197
w@@	O	-1	18239197
a@@	O	-1	18239197
y,	O	-1	18239197
cros@@	O	-1	18239197
s@@	O	-1	18239197
over	O	-1	18239197
experimental	O	-1	18239197
de@@	O	-1	18239197
sign@@	O	-1	18239197
.	O	-1	18239197
All	O	-1	18239197
partic@@	O	-1	18239197
ip@@	O	-1	18239197
ants	O	-1	18239197
received	O	-1	18239197
1.@@	O	-1	18239197
0	O	-1	18239197
mg	O	-1	18239197
or	O	-1	18239197
2.@@	O	-1	18239197
0	O	-1	18239197
mg	O	-1	18239197
tri@@	B-Chemical	D014282	18239197
he@@	I-Chemical	-1	18239197
x@@	I-Chemical	-1	18239197
y@@	I-Chemical	-1	18239197
phen@@	I-Chemical	-1	18239197
id@@	I-Chemical	-1	18239197
yl	I-Chemical	-1	18239197
or	O	-1	18239197
placebo	O	-1	18239197
administered	O	-1	18239197
in	O	-1	18239197
coun@@	O	-1	18239197
ter@@	O	-1	18239197
b@@	O	-1	18239197
al@@	O	-1	18239197
anced	O	-1	18239197
sequ@@	O	-1	18239197
enc@@	O	-1	18239197
es	O	-1	18239197
over	O	-1	18239197
a	O	-1	18239197
period	O	-1	18239197
of	O	-1	18239197
three	O	-1	18239197
con@@	O	-1	18239197
sec@@	O	-1	18239197
utive	O	-1	18239197
week@@	O	-1	18239197
s.	O	-1	18239197
B@@	O	-1	18239197
on@@	O	-1	18239197
d	O	-1	18239197
and	O	-1	18239197
L@@	O	-1	18239197
ad@@	O	-1	18239197
er@@	O	-1	18239197
's	O	-1	18239197
visual	O	-1	18239197
an@@	O	-1	18239197
alo@@	O	-1	18239197
g	O	-1	18239197
s@@	O	-1	18239197
cal@@	O	-1	18239197
es	O	-1	18239197
and	O	-1	18239197
al@@	O	-1	18239197
tern@@	O	-1	18239197
ate	O	-1	18239197
ver@@	O	-1	18239197
sions	O	-1	18239197
of	O	-1	18239197
the	O	-1	18239197
B@@	O	-1	18239197
us@@	O	-1	18239197
ch@@	O	-1	18239197
k@@	O	-1	18239197
e	O	-1	18239197
S@@	O	-1	18239197
el@@	O	-1	18239197
ective	O	-1	18239197
R@@	O	-1	18239197
em@@	O	-1	18239197
ind@@	O	-1	18239197
ing	O	-1	18239197
T@@	O	-1	18239197
est	O	-1	18239197
were	O	-1	18239197
administered	O	-1	18239197
in	O	-1	18239197
a	O	-1	18239197
repe@@	O	-1	18239197
ated	O	-1	18239197
meas@@	O	-1	18239197
ures	O	-1	18239197
desi@@	O	-1	18239197
g@@	O	-1	18239197
n	O	-1	18239197
at	O	-1	18239197
basel@@	O	-1	18239197
ine,	O	-1	18239197
1,	O	-1	18239197
2.@@	O	-1	18239197
5,	O	-1	18239197
and	O	-1	18239197
5	O	-1	18239197
hours	O	-1	18239197
post@@	O	-1	18239197
drug	O	-1	18239197
administr@@	O	-1	18239197
ation.	O	-1	18239197
RESULTS:	O	-1	18239197
A	O	-1	18239197
2.@@	O	-1	18239197
0-@@	O	-1	18239197
mg	O	-1	18239197
oral	O	-1	18239197
dose	O	-1	18239197
of	O	-1	18239197
tri@@	B-Chemical	D014282	18239197
he@@	I-Chemical	-1	18239197
x@@	I-Chemical	-1	18239197
y@@	I-Chemical	-1	18239197
phen@@	I-Chemical	-1	18239197
id@@	I-Chemical	-1	18239197
yl	I-Chemical	-1	18239197
resulted	O	-1	18239197
in	O	-1	18239197
increased	O	-1	18239197
subj@@	O	-1	18239197
ective	O	-1	18239197
rat@@	O	-1	18239197
ings	O	-1	18239197
of	O	-1	18239197
mental	B-Disease	D003072	18239197
s@@	I-Disease	-1	18239197
low@@	I-Disease	-1	18239197
ness	I-Disease	-1	18239197
in	O	-1	18239197
car@@	O	-1	18239197
ri@@	O	-1	18239197
ers	O	-1	18239197
of	O	-1	18239197
the	O	-1	18239197
A@@	O	-1	18239197
P@@	O	-1	18239197
O@@	O	-1	18239197
E	O	-1	18239197
ep@@	O	-1	18239197
si@@	O	-1	18239197
lon@@	O	-1	18239197
4	O	-1	18239197
al@@	O	-1	18239197
le@@	O	-1	18239197
le	O	-1	18239197
on@@	O	-1	18239197
ly.	O	-1	18239197
D@@	O	-1	18239197
ru@@	O	-1	18239197
g	O	-1	18239197
effects	O	-1	18239197
as	O	-1	18239197
determined	O	-1	18239197
by	O	-1	18239197
difference	O	-1	18239197
sco@@	O	-1	18239197
res	O	-1	18239197
between	O	-1	18239197
2.@@	O	-1	18239197
0	O	-1	18239197
mg	O	-1	18239197
tri@@	B-Chemical	D014282	18239197
he@@	I-Chemical	-1	18239197
x@@	I-Chemical	-1	18239197
y@@	I-Chemical	-1	18239197
phen@@	I-Chemical	-1	18239197
id@@	I-Chemical	-1	18239197
yl	I-Chemical	-1	18239197
and	O	-1	18239197
placebo	O	-1	18239197
on	O	-1	18239197
rat@@	O	-1	18239197
ings	O	-1	18239197
of	O	-1	18239197
mental	B-Disease	D003072	18239197
s@@	I-Disease	-1	18239197
low@@	I-Disease	-1	18239197
ness	I-Disease	-1	18239197
significantly	O	-1	18239197
cor@@	O	-1	18239197
related	O	-1	18239197
with	O	-1	18239197
total	O	-1	18239197
and	O	-1	18239197
del@@	O	-1	18239197
ayed	O	-1	18239197
rec@@	O	-1	18239197
all	O	-1	18239197
on	O	-1	18239197
the	O	-1	18239197
B@@	O	-1	18239197
us@@	O	-1	18239197
ch@@	O	-1	18239197
k@@	O	-1	18239197
e	O	-1	18239197
S@@	O	-1	18239197
el@@	O	-1	18239197
ective	O	-1	18239197
R@@	O	-1	18239197
em@@	O	-1	18239197
ind@@	O	-1	18239197
ing	O	-1	18239197
T@@	O	-1	18239197
est	O	-1	18239197
in	O	-1	18239197
car@@	O	-1	18239197
ri@@	O	-1	18239197
ers	O	-1	18239197
of	O	-1	18239197
the	O	-1	18239197
A@@	O	-1	18239197
P@@	O	-1	18239197
O@@	O	-1	18239197
E	O	-1	18239197
ep@@	O	-1	18239197
si@@	O	-1	18239197
lon@@	O	-1	18239197
4	O	-1	18239197
al@@	O	-1	18239197
le@@	O	-1	18239197
le	O	-1	18239197
on@@	O	-1	18239197
ly.	O	-1	18239197
However,	O	-1	18239197
no	O	-1	18239197
significant	O	-1	18239197
effects	O	-1	18239197
were	O	-1	18239197
found	O	-1	18239197
with	O	-1	18239197
other	O	-1	18239197
visual	O	-1	18239197
an@@	O	-1	18239197
alo@@	O	-1	18239197
g	O	-1	18239197
s@@	O	-1	18239197
cal@@	O	-1	18239197
es	O	-1	18239197
ref@@	O	-1	18239197
l@@	O	-1	18239197
ect@@	O	-1	18239197
ing	O	-1	18239197
subj@@	O	-1	18239197
ective	O	-1	18239197
sed@@	O	-1	18239197
ation	O	-1	18239197
and	O	-1	18239197
clear@@	O	-1	18239197
-@@	O	-1	18239197
he@@	O	-1	18239197
ade@@	O	-1	18239197
d@@	O	-1	18239197
n@@	O	-1	18239197
es@@	O	-1	18239197
s.	O	-1	18239197
CONCLUSION:	O	-1	18239197
The	O	-1	18239197
ep@@	O	-1	18239197
si@@	O	-1	18239197
lon@@	O	-1	18239197
4	O	-1	18239197
al@@	O	-1	18239197
le@@	O	-1	18239197
le	O	-1	18239197
in	O	-1	18239197
healthy	O	-1	18239197
el@@	O	-1	18239197
der@@	O	-1	18239197
ly	O	-1	18239197
was	O	-1	18239197
associated	O	-1	18239197
with	O	-1	18239197
increased	O	-1	18239197
subj@@	O	-1	18239197
ective	O	-1	18239197
mental	B-Disease	D003072	18239197
s@@	I-Disease	-1	18239197
low@@	I-Disease	-1	18239197
ing	I-Disease	-1	18239197
after	O	-1	18239197
tri@@	B-Chemical	D014282	18239197
he@@	I-Chemical	-1	18239197
x@@	I-Chemical	-1	18239197
y@@	I-Chemical	-1	18239197
phen@@	I-Chemical	-1	18239197
id@@	I-Chemical	-1	18239197
yl	I-Chemical	-1	18239197
anti@@	O	-1	18239197
cholinergic	O	-1	18239197
ch@@	O	-1	18239197
all@@	O	-1	18239197
en@@	O	-1	18239197
g@@	O	-1	18239197
e.	O	-1	18239197

B@@	O	-1	17194457
e@@	O	-1	17194457
havi@@	O	-1	17194457
oral	O	-1	17194457
effects	O	-1	17194457
of	O	-1	17194457
p@@	O	-1	17194457
ub@@	O	-1	17194457
er@@	O	-1	17194457
t@@	O	-1	17194457
al	O	-1	17194457
an@@	O	-1	17194457
ab@@	O	-1	17194457
olic	O	-1	17194457
and@@	O	-1	17194457
ro@@	O	-1	17194457
genic	O	-1	17194457
ster@@	B-Chemical	D013256	17194457
oid	I-Chemical	-1	17194457
exposure	O	-1	17194457
in	O	-1	17194457
male	O	-1	17194457
rats	O	-1	17194457
with	O	-1	17194457
low	O	-1	17194457
seroton@@	B-Chemical	D012701	17194457
in	I-Chemical	-1	17194457
.	O	-1	17194457
The	O	-1	17194457
go@@	O	-1	17194457
al	O	-1	17194457
of	O	-1	17194457
this	O	-1	17194457
study	O	-1	17194457
was	O	-1	17194457
to	O	-1	17194457
ass@@	O	-1	17194457
ess	O	-1	17194457
the	O	-1	17194457
inter@@	O	-1	17194457
active	O	-1	17194457
effects	O	-1	17194457
of	O	-1	17194457
chronic	O	-1	17194457
an@@	O	-1	17194457
ab@@	O	-1	17194457
olic	O	-1	17194457
and@@	O	-1	17194457
ro@@	O	-1	17194457
genic	O	-1	17194457
ster@@	B-Chemical	D013256	17194457
oid	I-Chemical	-1	17194457
(A@@	O	-1	17194457
A@@	O	-1	17194457
S)	O	-1	17194457
exposure	O	-1	17194457
and	O	-1	17194457
brain	O	-1	17194457
seroton@@	B-Chemical	D012701	17194457
in	I-Chemical	-1	17194457
(	O	-1	17194457
5-@@	B-Chemical	D012701	17194457
hydrox@@	I-Chemical	-1	17194457
y@@	I-Chemical	-1	17194457
tr@@	I-Chemical	-1	17194457
y@@	I-Chemical	-1	17194457
pt@@	I-Chemical	-1	17194457
amine	I-Chemical	-1	17194457
,	O	-1	17194457
5-@@	B-Chemical	D012701	17194457
H@@	I-Chemical	-1	17194457
T	I-Chemical	-1	17194457
)	O	-1	17194457
deple@@	O	-1	17194457
tion	O	-1	17194457
on	O	-1	17194457
behavi@@	O	-1	17194457
or	O	-1	17194457
of	O	-1	17194457
p@@	O	-1	17194457
ub@@	O	-1	17194457
er@@	O	-1	17194457
t@@	O	-1	17194457
al	O	-1	17194457
male	O	-1	17194457
rats.	O	-1	17194457
S@@	B-Chemical	D012701	17194457
er@@	I-Chemical	-1	17194457
oton@@	I-Chemical	-1	17194457
in	I-Chemical	-1	17194457
was	O	-1	17194457
deple@@	O	-1	17194457
ted	O	-1	17194457
be@@	O	-1	17194457
g@@	O	-1	17194457
in@@	O	-1	17194457
ning	O	-1	17194457
on	O	-1	17194457
post@@	O	-1	17194457
n@@	O	-1	17194457
atal	O	-1	17194457
day	O	-1	17194457
2@@	O	-1	17194457
6	O	-1	17194457
with	O	-1	17194457
par@@	B-Chemical	-1	17194457
ac@@	I-Chemical	-1	17194457
h@@	I-Chemical	-1	17194457
loro@@	I-Chemical	-1	17194457
phenyl@@	I-Chemical	-1	17194457
al@@	I-Chemical	-1	17194457
an@@	I-Chemical	-1	17194457
ine	I-Chemical	-1	17194457
(	O	-1	17194457
P@@	B-Chemical	-1	17194457
C@@	I-Chemical	-1	17194457
P@@	I-Chemical	-1	17194457
A	I-Chemical	-1	17194457
100	O	-1	17194457
mg/kg@@	O	-1	17194457
,	O	-1	17194457
every	O	-1	17194457
other	O	-1	17194457
day@@	O	-1	17194457
);	O	-1	17194457
controls	O	-1	17194457
received	O	-1	17194457
sal@@	O	-1	17194457
ine.	O	-1	17194457
A@@	O	-1	17194457
t	O	-1	17194457
p@@	O	-1	17194457
ub@@	O	-1	17194457
er@@	O	-1	17194457
t@@	O	-1	17194457
y	O	-1	17194457
(P@@	O	-1	17194457
4@@	O	-1	17194457
0@@	O	-1	17194457
),	O	-1	17194457
h@@	O	-1	17194457
al@@	O	-1	17194457
f	O	-1	17194457
the	O	-1	17194457
P@@	B-Chemical	-1	17194457
C@@	I-Chemical	-1	17194457
P@@	I-Chemical	-1	17194457
A	I-Chemical	-1	17194457
-treated	O	-1	17194457
rats	O	-1	17194457
and	O	-1	17194457
h@@	O	-1	17194457
al@@	O	-1	17194457
f	O	-1	17194457
the	O	-1	17194457
sal@@	O	-1	17194457
ine-@@	O	-1	17194457
treated	O	-1	17194457
rats	O	-1	17194457
be@@	O	-1	17194457
g@@	O	-1	17194457
an	O	-1	17194457
treatment	O	-1	17194457
with	O	-1	17194457
test@@	B-Chemical	D013739	17194457
osterone	I-Chemical	-1	17194457
(	O	-1	17194457
T	B-Chemical	D013739	17194457
,	O	-1	17194457
5	O	-1	17194457
mg/kg@@	O	-1	17194457
,	O	-1	17194457
5	O	-1	17194457
da@@	O	-1	17194457
ys@@	O	-1	17194457
/@@	O	-1	17194457
week@@	O	-1	17194457
).	O	-1	17194457
B@@	O	-1	17194457
e@@	O	-1	17194457
havi@@	O	-1	17194457
oral	O	-1	17194457
meas@@	O	-1	17194457
ures	O	-1	17194457
included	O	-1	17194457
locom@@	O	-1	17194457
o@@	O	-1	17194457
tion,	O	-1	17194457
ir@@	B-Disease	D001523	17194457
rit@@	I-Disease	-1	17194457
ability	I-Disease	-1	17194457
,	O	-1	17194457
co@@	O	-1	17194457
pul@@	O	-1	17194457
ation,	O	-1	17194457
part@@	O	-1	17194457
n@@	O	-1	17194457
er	O	-1	17194457
pre@@	O	-1	17194457
fe@@	O	-1	17194457
ren@@	O	-1	17194457
ce@@	O	-1	17194457
,	O	-1	17194457
and	O	-1	17194457
ag@@	B-Disease	D001523	17194457
gres@@	I-Disease	-1	17194457
sion	I-Disease	-1	17194457
.	O	-1	17194457
An@@	O	-1	17194457
im@@	O	-1	17194457
als	O	-1	17194457
were	O	-1	17194457
tested	O	-1	17194457
for	O	-1	17194457
ag@@	B-Disease	D001523	17194457
gres@@	I-Disease	-1	17194457
sion	I-Disease	-1	17194457
in	O	-1	17194457
their	O	-1	17194457
ho@@	O	-1	17194457
m@@	O	-1	17194457
e	O	-1	17194457
c@@	O	-1	17194457
age,	O	-1	17194457
both	O	-1	17194457
with	O	-1	17194457
and	O	-1	17194457
without	O	-1	17194457
physi@@	O	-1	17194457
c@@	O	-1	17194457
al	O	-1	17194457
prov@@	O	-1	17194457
oc@@	O	-1	17194457
ation	O	-1	17194457
(@@	O	-1	17194457
mil@@	O	-1	17194457
d	O	-1	17194457
t@@	O	-1	17194457
a@@	O	-1	17194457
il	O	-1	17194457
p@@	O	-1	17194457
in@@	O	-1	17194457
ch@@	O	-1	17194457
).	O	-1	17194457
B@@	O	-1	17194457
ra@@	O	-1	17194457
in	O	-1	17194457
levels	O	-1	17194457
of	O	-1	17194457
5-@@	B-Chemical	D012701	17194457
H@@	I-Chemical	-1	17194457
T	I-Chemical	-1	17194457
and	O	-1	17194457
its	O	-1	17194457
metabol@@	O	-1	17194457
it@@	O	-1	17194457
e,	O	-1	17194457
5-@@	B-Chemical	D006897	17194457
hydrox@@	I-Chemical	-1	17194457
y@@	I-Chemical	-1	17194457
ind@@	I-Chemical	-1	17194457
ol@@	I-Chemical	-1	17194457
e@@	I-Chemical	-1	17194457
ace@@	I-Chemical	-1	17194457
tic	I-Chemical	-1	17194457
acid	I-Chemical	-1	17194457
(	O	-1	17194457
5-@@	B-Chemical	D006897	17194457
H@@	I-Chemical	-1	17194457
I@@	I-Chemical	-1	17194457
A@@	I-Chemical	-1	17194457
A	I-Chemical	-1	17194457
),	O	-1	17194457
were	O	-1	17194457
determined	O	-1	17194457
using	O	-1	17194457
H@@	O	-1	17194457
P@@	O	-1	17194457
L@@	O	-1	17194457
C@@	O	-1	17194457
.	O	-1	17194457
P@@	B-Chemical	-1	17194457
C@@	I-Chemical	-1	17194457
P@@	I-Chemical	-1	17194457
A	I-Chemical	-1	17194457
significantly	O	-1	17194457
and	O	-1	17194457
subst@@	O	-1	17194457
anti@@	O	-1	17194457
ally	O	-1	17194457
deple@@	O	-1	17194457
ted	O	-1	17194457
5-@@	B-Chemical	D012701	17194457
H@@	I-Chemical	-1	17194457
T	I-Chemical	-1	17194457
and	O	-1	17194457
5-@@	B-Chemical	D006897	17194457
H@@	I-Chemical	-1	17194457
I@@	I-Chemical	-1	17194457
A@@	I-Chemical	-1	17194457
A	I-Chemical	-1	17194457
in	O	-1	17194457
all	O	-1	17194457
brain	O	-1	17194457
regi@@	O	-1	17194457
ons	O	-1	17194457
ex@@	O	-1	17194457
am@@	O	-1	17194457
ine@@	O	-1	17194457
d.	O	-1	17194457
Ch@@	O	-1	17194457
ron@@	O	-1	17194457
ic	O	-1	17194457
T	B-Chemical	D013739	17194457
treatment	O	-1	17194457
significantly	O	-1	17194457
decreased	O	-1	17194457
5-@@	B-Chemical	D012701	17194457
H@@	I-Chemical	-1	17194457
T	I-Chemical	-1	17194457
and	O	-1	17194457
5-@@	B-Chemical	D006897	17194457
H@@	I-Chemical	-1	17194457
I@@	I-Chemical	-1	17194457
A@@	I-Chemical	-1	17194457
A	I-Chemical	-1	17194457
in	O	-1	17194457
cer@@	O	-1	17194457
t@@	O	-1	17194457
ain	O	-1	17194457
brain	O	-1	17194457
a@@	O	-1	17194457
reas@@	O	-1	17194457
,	O	-1	17194457
but	O	-1	17194457
to	O	-1	17194457
a	O	-1	17194457
m@@	O	-1	17194457
uc@@	O	-1	17194457
h	O	-1	17194457
l@@	O	-1	17194457
ess@@	O	-1	17194457
er	O	-1	17194457
ext@@	O	-1	17194457
ent	O	-1	17194457
than	O	-1	17194457
P@@	B-Chemical	-1	17194457
C@@	I-Chemical	-1	17194457
P@@	I-Chemical	-1	17194457
A	I-Chemical	-1	17194457
.	O	-1	17194457
Ch@@	O	-1	17194457
ron@@	O	-1	17194457
ic	O	-1	17194457
exposure	O	-1	17194457
to	O	-1	17194457
P@@	B-Chemical	-1	17194457
C@@	I-Chemical	-1	17194457
P@@	I-Chemical	-1	17194457
A	I-Chemical	-1	17194457
alone	O	-1	17194457
significantly	O	-1	17194457
decreased	O	-1	17194457
locomotor	O	-1	17194457
activity	O	-1	17194457
and	O	-1	17194457
increased	O	-1	17194457
ir@@	B-Disease	D001523	17194457
rit@@	I-Disease	-1	17194457
ability	I-Disease	-1	17194457
but	O	-1	17194457
had	O	-1	17194457
no	O	-1	17194457
effect	O	-1	17194457
on	O	-1	17194457
sex@@	O	-1	17194457
ual	O	-1	17194457
behavi@@	O	-1	17194457
or@@	O	-1	17194457
,	O	-1	17194457
part@@	O	-1	17194457
n@@	O	-1	17194457
er	O	-1	17194457
pre@@	O	-1	17194457
fe@@	O	-1	17194457
ren@@	O	-1	17194457
ce@@	O	-1	17194457
,	O	-1	17194457
or	O	-1	17194457
ag@@	B-Disease	D001523	17194457
gres@@	I-Disease	-1	17194457
sion	I-Disease	-1	17194457
.	O	-1	17194457
T	B-Chemical	D013739	17194457
alone	O	-1	17194457
had	O	-1	17194457
no	O	-1	17194457
effect	O	-1	17194457
on	O	-1	17194457
locom@@	O	-1	17194457
o@@	O	-1	17194457
tion,	O	-1	17194457
ir@@	B-Disease	D001523	17194457
rit@@	I-Disease	-1	17194457
ability	I-Disease	-1	17194457
,	O	-1	17194457
or	O	-1	17194457
sex@@	O	-1	17194457
ual	O	-1	17194457
behavi@@	O	-1	17194457
or	O	-1	17194457
but	O	-1	17194457
increased	O	-1	17194457
part@@	O	-1	17194457
n@@	O	-1	17194457
er	O	-1	17194457
pre@@	O	-1	17194457
fe@@	O	-1	17194457
rence	O	-1	17194457
and	O	-1	17194457
ag@@	B-Disease	D001523	17194457
gres@@	I-Disease	-1	17194457
sion	I-Disease	-1	17194457
.	O	-1	17194457
The	O	-1	17194457
most	O	-1	17194457
stri@@	O	-1	17194457
king	O	-1	17194457
effect	O	-1	17194457
of	O	-1	17194457
combin@@	O	-1	17194457
ing	O	-1	17194457
T	B-Chemical	D013739	17194457
+	O	-1	17194457
P@@	B-Chemical	-1	17194457
C@@	I-Chemical	-1	17194457
P@@	I-Chemical	-1	17194457
A	I-Chemical	-1	17194457
was	O	-1	17194457
a	O	-1	17194457
significant	O	-1	17194457
increase	O	-1	17194457
in	O	-1	17194457
at@@	O	-1	17194457
tac@@	O	-1	17194457
k	O	-1	17194457
frequency	O	-1	17194457
as	O	-1	17194457
well	O	-1	17194457
as	O	-1	17194457
a	O	-1	17194457
significant	O	-1	17194457
decrease	O	-1	17194457
in	O	-1	17194457
the	O	-1	17194457
lat@@	O	-1	17194457
ency	O	-1	17194457
to	O	-1	17194457
at@@	O	-1	17194457
tac@@	O	-1	17194457
k@@	O	-1	17194457
,	O	-1	17194457
partic@@	O	-1	17194457
ul@@	O	-1	17194457
arly	O	-1	17194457
following	O	-1	17194457
physi@@	O	-1	17194457
c@@	O	-1	17194457
al	O	-1	17194457
prov@@	O	-1	17194457
oc@@	O	-1	17194457
ation.	O	-1	17194457
B@@	O	-1	17194457
as@@	O	-1	17194457
ed	O	-1	17194457
on	O	-1	17194457
these	O	-1	17194457
dat@@	O	-1	17194457
a,	O	-1	17194457
it	O	-1	17194457
can	O	-1	17194457
be	O	-1	17194457
spec@@	O	-1	17194457
ul@@	O	-1	17194457
ated	O	-1	17194457
that	O	-1	17194457
p@@	O	-1	17194457
ub@@	O	-1	17194457
er@@	O	-1	17194457
t@@	O	-1	17194457
al	O	-1	17194457
A@@	O	-1	17194457
A@@	O	-1	17194457
S	O	-1	17194457
users	O	-1	17194457
with	O	-1	17194457
low	O	-1	17194457
central	O	-1	17194457
5-@@	B-Chemical	D012701	17194457
H@@	I-Chemical	-1	17194457
T	I-Chemical	-1	17194457
may	O	-1	17194457
be	O	-1	17194457
es@@	O	-1	17194457
p@@	O	-1	17194457
ec@@	O	-1	17194457
i@@	O	-1	17194457
ally	O	-1	17194457
pr@@	O	-1	17194457
one	O	-1	17194457
to	O	-1	17194457
ex@@	O	-1	17194457
hib@@	O	-1	17194457
it	O	-1	17194457
ag@@	B-Disease	D001523	17194457
gres@@	I-Disease	-1	17194457
sive	I-Disease	-1	17194457
behavi@@	I-Disease	-1	17194457
or	I-Disease	-1	17194457
.	O	-1	17194457

In@@	O	-1	16132524
trac@@	O	-1	16132524
av@@	O	-1	16132524
it@@	O	-1	16132524
ary	O	-1	16132524
chemotherapy	O	-1	16132524
(	O	-1	16132524
paclitax@@	B-Chemical	D017239	16132524
el	I-Chemical	-1	16132524
/	O	-1	16132524
car@@	B-Chemical	D016190	16132524
bo@@	I-Chemical	-1	16132524
pl@@	I-Chemical	-1	16132524
atin	I-Chemical	-1	16132524
li@@	O	-1	16132524
qu@@	O	-1	16132524
id	O	-1	16132524
c@@	O	-1	16132524
r@@	O	-1	16132524
y@@	O	-1	16132524
st@@	O	-1	16132524
all@@	O	-1	16132524
ine	O	-1	16132524
c@@	O	-1	16132524
ub@@	O	-1	16132524
ic	O	-1	16132524
ph@@	O	-1	16132524
as@@	O	-1	16132524
es@@	O	-1	16132524
)	O	-1	16132524
for	O	-1	16132524
recur@@	O	-1	16132524
rent	O	-1	16132524
g@@	B-Disease	D005909	16132524
li@@	I-Disease	-1	16132524
ob@@	I-Disease	-1	16132524
l@@	I-Disease	-1	16132524
ast@@	I-Disease	-1	16132524
oma	I-Disease	-1	16132524
-@@	O	-1	16132524
-	O	-1	16132524
clinical	O	-1	16132524
observ@@	O	-1	16132524
ations.	O	-1	16132524
H@@	O	-1	16132524
um@@	O	-1	16132524
an	O	-1	16132524
mal@@	O	-1	16132524
i@@	O	-1	16132524
gn@@	O	-1	16132524
ant	O	-1	16132524
brain	B-Disease	D001932	16132524
tu@@	I-Disease	-1	16132524
mor@@	I-Disease	-1	16132524
s	I-Disease	-1	16132524
have	O	-1	16132524
a	O	-1	16132524
po@@	O	-1	16132524
or	O	-1	16132524
pro@@	O	-1	16132524
g@@	O	-1	16132524
no@@	O	-1	16132524
sis	O	-1	16132524
in	O	-1	16132524
sp@@	O	-1	16132524
ite	O	-1	16132524
of	O	-1	16132524
surger@@	O	-1	16132524
y	O	-1	16132524
and	O	-1	16132524
radi@@	O	-1	16132524
ation	O	-1	16132524
therapy.	O	-1	16132524
C@@	O	-1	16132524
ub@@	O	-1	16132524
ic	O	-1	16132524
ph@@	O	-1	16132524
as@@	O	-1	16132524
es	O	-1	16132524
con@@	O	-1	16132524
si@@	O	-1	16132524
st	O	-1	16132524
of	O	-1	16132524
cur@@	O	-1	16132524
ved	O	-1	16132524
bio@@	O	-1	16132524
continu@@	O	-1	16132524
ous	O	-1	16132524
li@@	O	-1	16132524
pid	O	-1	16132524
bil@@	O	-1	16132524
ay@@	O	-1	16132524
er@@	O	-1	16132524
s,	O	-1	16132524
se@@	O	-1	16132524
par@@	O	-1	16132524
ating	O	-1	16132524
two	O	-1	16132524
con@@	O	-1	16132524
g@@	O	-1	16132524
ru@@	O	-1	16132524
ent	O	-1	16132524
ne@@	O	-1	16132524
tw@@	O	-1	16132524
or@@	O	-1	16132524
k@@	O	-1	16132524
s	O	-1	16132524
of	O	-1	16132524
w@@	O	-1	16132524
at@@	O	-1	16132524
er	O	-1	16132524
channe@@	O	-1	16132524
l@@	O	-1	16132524
s.	O	-1	16132524
U@@	O	-1	16132524
sed	O	-1	16132524
as	O	-1	16132524
a	O	-1	16132524
h@@	O	-1	16132524
ost	O	-1	16132524
for	O	-1	16132524
cy@@	O	-1	16132524
tot@@	O	-1	16132524
ox@@	O	-1	16132524
ic	O	-1	16132524
drug@@	O	-1	16132524
s,	O	-1	16132524
the	O	-1	16132524
g@@	O	-1	16132524
el@@	O	-1	16132524
-@@	O	-1	16132524
like	O	-1	16132524
mat@@	O	-1	16132524
ri@@	O	-1	16132524
x	O	-1	16132524
can	O	-1	16132524
e@@	O	-1	16132524
a@@	O	-1	16132524
si@@	O	-1	16132524
ly	O	-1	16132524
be	O	-1	16132524
ap@@	O	-1	16132524
pl@@	O	-1	16132524
ied	O	-1	16132524
to	O	-1	16132524
the	O	-1	16132524
w@@	O	-1	16132524
all@@	O	-1	16132524
s	O	-1	16132524
of	O	-1	16132524
a	O	-1	16132524
surg@@	O	-1	16132524
ical	O	-1	16132524
res@@	O	-1	16132524
ection	O	-1	16132524
ca@@	O	-1	16132524
v@@	O	-1	16132524
ity.	O	-1	16132524
F@@	O	-1	16132524
or	O	-1	16132524
human	O	-1	16132524
g@@	B-Disease	D005909	16132524
li@@	I-Disease	-1	16132524
ob@@	I-Disease	-1	16132524
l@@	I-Disease	-1	16132524
ast@@	I-Disease	-1	16132524
oma	I-Disease	-1	16132524
recur@@	O	-1	16132524
ren@@	O	-1	16132524
c@@	O	-1	16132524
es,	O	-1	16132524
the	O	-1	16132524
fe@@	O	-1	16132524
a@@	O	-1	16132524
sib@@	O	-1	16132524
il@@	O	-1	16132524
ity,	O	-1	16132524
saf@@	O	-1	16132524
et@@	O	-1	16132524
y,	O	-1	16132524
and	O	-1	16132524
sh@@	O	-1	16132524
ort@@	O	-1	16132524
-term	O	-1	16132524
effects	O	-1	16132524
of	O	-1	16132524
a	O	-1	16132524
surg@@	O	-1	16132524
ical	O	-1	16132524
intrac@@	O	-1	16132524
av@@	O	-1	16132524
it@@	O	-1	16132524
ary	O	-1	16132524
ap@@	O	-1	16132524
plic@@	O	-1	16132524
ation	O	-1	16132524
of	O	-1	16132524
paclitax@@	B-Chemical	D017239	16132524
el	I-Chemical	-1	16132524
and	O	-1	16132524
car@@	B-Chemical	D016190	16132524
bo@@	I-Chemical	-1	16132524
pl@@	I-Chemical	-1	16132524
atin	I-Chemical	-1	16132524
enc@@	O	-1	16132524
ap@@	O	-1	16132524
sul@@	O	-1	16132524
ated	O	-1	16132524
by	O	-1	16132524
li@@	O	-1	16132524
qu@@	O	-1	16132524
id	O	-1	16132524
c@@	O	-1	16132524
r@@	O	-1	16132524
y@@	O	-1	16132524
st@@	O	-1	16132524
all@@	O	-1	16132524
ine	O	-1	16132524
c@@	O	-1	16132524
ub@@	O	-1	16132524
ic	O	-1	16132524
ph@@	O	-1	16132524
as@@	O	-1	16132524
es	O	-1	16132524
are	O	-1	16132524
examined	O	-1	16132524
in	O	-1	16132524
a	O	-1	16132524
pilo@@	O	-1	16132524
t	O	-1	16132524
study.	O	-1	16132524
A	O	-1	16132524
total	O	-1	16132524
of	O	-1	16132524
12	O	-1	16132524
patients	O	-1	16132524
with	O	-1	16132524
a	O	-1	16132524
recur@@	O	-1	16132524
rence	O	-1	16132524
of	O	-1	16132524
a	O	-1	16132524
g@@	B-Disease	D005909	16132524
li@@	I-Disease	-1	16132524
ob@@	I-Disease	-1	16132524
l@@	I-Disease	-1	16132524
ast@@	I-Disease	-1	16132524
oma	I-Disease	-1	16132524
multi@@	O	-1	16132524
form@@	O	-1	16132524
e	O	-1	16132524
under@@	O	-1	16132524
w@@	O	-1	16132524
ent	O	-1	16132524
re@@	O	-1	16132524
-@@	O	-1	16132524
res@@	O	-1	16132524
ection	O	-1	16132524
and	O	-1	16132524
received	O	-1	16132524
an	O	-1	16132524
intrac@@	O	-1	16132524
av@@	O	-1	16132524
it@@	O	-1	16132524
ary	O	-1	16132524
ap@@	O	-1	16132524
plic@@	O	-1	16132524
ation	O	-1	16132524
of	O	-1	16132524
paclitax@@	B-Chemical	D017239	16132524
el	I-Chemical	-1	16132524
and	O	-1	16132524
car@@	B-Chemical	D016190	16132524
bo@@	I-Chemical	-1	16132524
pl@@	I-Chemical	-1	16132524
atin	I-Chemical	-1	16132524
c@@	O	-1	16132524
ub@@	O	-1	16132524
ic	O	-1	16132524
ph@@	O	-1	16132524
as@@	O	-1	16132524
es	O	-1	16132524
in	O	-1	16132524
different	O	-1	16132524
dos@@	O	-1	16132524
ag@@	O	-1	16132524
es.	O	-1	16132524
Si@@	O	-1	16132524
x	O	-1	16132524
of	O	-1	16132524
the	O	-1	16132524
patients	O	-1	16132524
received	O	-1	16132524
more	O	-1	16132524
than	O	-1	16132524
15	O	-1	16132524
mg	O	-1	16132524
paclitax@@	B-Chemical	D017239	16132524
el	I-Chemical	-1	16132524
and	O	-1	16132524
su@@	O	-1	16132524
ffe@@	O	-1	16132524
red	O	-1	16132524
from	O	-1	16132524
moder@@	O	-1	16132524
ate	O	-1	16132524
to	O	-1	16132524
severe	O	-1	16132524
brain	B-Disease	D001929	16132524
e@@	I-Disease	-1	16132524
de@@	I-Disease	-1	16132524
ma	I-Disease	-1	16132524
,	O	-1	16132524
while	O	-1	16132524
the	O	-1	16132524
remain@@	O	-1	16132524
ing	O	-1	16132524
patients	O	-1	16132524
received	O	-1	16132524
only	O	-1	16132524
a	O	-1	16132524
total	O	-1	16132524
of	O	-1	16132524
15	O	-1	16132524
mg	O	-1	16132524
paclitax@@	B-Chemical	D017239	16132524
el	I-Chemical	-1	16132524
.	O	-1	16132524
In	O	-1	16132524
the	O	-1	16132524
lat@@	O	-1	16132524
ter	O	-1	16132524
group@@	O	-1	16132524
,	O	-1	16132524
brain	B-Disease	D001929	16132524
e@@	I-Disease	-1	16132524
de@@	I-Disease	-1	16132524
ma	I-Disease	-1	16132524
was	O	-1	16132524
mark@@	O	-1	16132524
ed@@	O	-1	16132524
ly	O	-1	16132524
reduced	O	-1	16132524
and	O	-1	16132524
de@@	O	-1	16132524
al@@	O	-1	16132524
t	O	-1	16132524
medic@@	O	-1	16132524
all@@	O	-1	16132524
y.	O	-1	16132524
In@@	O	-1	16132524
trac@@	O	-1	16132524
av@@	O	-1	16132524
it@@	O	-1	16132524
ary	O	-1	16132524
chemotherapy	O	-1	16132524
in	O	-1	16132524
recur@@	O	-1	16132524
rent	O	-1	16132524
g@@	B-Disease	D005909	16132524
li@@	I-Disease	-1	16132524
ob@@	I-Disease	-1	16132524
l@@	I-Disease	-1	16132524
ast@@	I-Disease	-1	16132524
oma	I-Disease	-1	16132524
using	O	-1	16132524
c@@	O	-1	16132524
ub@@	O	-1	16132524
ic	O	-1	16132524
ph@@	O	-1	16132524
as@@	O	-1	16132524
es	O	-1	16132524
is	O	-1	16132524
fe@@	O	-1	16132524
a@@	O	-1	16132524
sible	O	-1	16132524
and	O	-1	16132524
saf@@	O	-1	16132524
e,	O	-1	16132524
y@@	O	-1	16132524
et	O	-1	16132524
the	O	-1	16132524
clinical	O	-1	16132524
ben@@	O	-1	16132524
e@@	O	-1	16132524
fi@@	O	-1	16132524
t	O	-1	16132524
remain@@	O	-1	16132524
s	O	-1	16132524
to	O	-1	16132524
be	O	-1	16132524
examined	O	-1	16132524
in	O	-1	16132524
a	O	-1	16132524
clinical	O	-1	16132524
phase	O	-1	16132524
II	O	-1	16132524
study.	O	-1	16132524

M@@	B-Chemical	D008774	12907924
eth@@	I-Chemical	-1	12907924
yl@@	I-Chemical	-1	12907924
phen@@	I-Chemical	-1	12907924
id@@	I-Chemical	-1	12907924
ate	I-Chemical	-1	12907924
-induced	O	-1	12907924
ob@@	B-Disease	D009771	12907924
s@@	I-Disease	-1	12907924
es@@	I-Disease	-1	12907924
si@@	I-Disease	-1	12907924
ve@@	I-Disease	-1	12907924
-@@	I-Disease	-1	12907924
comp@@	I-Disease	-1	12907924
ul@@	I-Disease	-1	12907924
sive	I-Disease	-1	12907924
symptoms	I-Disease	-1	12907924
in	O	-1	12907924
an	O	-1	12907924
el@@	O	-1	12907924
der@@	O	-1	12907924
ly	O	-1	12907924
man@@	O	-1	12907924
.	O	-1	12907924
An	O	-1	12907924
8@@	O	-1	12907924
2-@@	O	-1	12907924
year-old	O	-1	12907924
man	O	-1	12907924
with	O	-1	12907924
treatment@@	B-Disease	D061218	12907924
-@@	I-Disease	-1	12907924
resist@@	I-Disease	-1	12907924
ant	I-Disease	-1	12907924
de@@	I-Disease	-1	12907924
pression	I-Disease	-1	12907924
and	O	-1	12907924
early	O	-1	12907924
Al@@	B-Disease	D000544	12907924
z@@	I-Disease	-1	12907924
he@@	I-Disease	-1	12907924
im@@	I-Disease	-1	12907924
er@@	I-Disease	-1	12907924
's	I-Disease	-1	12907924
disease	I-Disease	-1	12907924
was	O	-1	12907924
star@@	O	-1	12907924
ted	O	-1	12907924
on	O	-1	12907924
methyl@@	B-Chemical	D008774	12907924
phen@@	I-Chemical	-1	12907924
id@@	I-Chemical	-1	12907924
ate	I-Chemical	-1	12907924
.	O	-1	12907924
Si@@	O	-1	12907924
gn@@	O	-1	12907924
ific@@	O	-1	12907924
ant	O	-1	12907924
ob@@	B-Disease	D009771	12907924
s@@	I-Disease	-1	12907924
es@@	I-Disease	-1	12907924
si@@	I-Disease	-1	12907924
ve@@	I-Disease	-1	12907924
-@@	I-Disease	-1	12907924
comp@@	I-Disease	-1	12907924
ul@@	I-Disease	-1	12907924
sive	I-Disease	-1	12907924
behavi@@	I-Disease	-1	12907924
or	I-Disease	-1	12907924
en@@	O	-1	12907924
su@@	O	-1	12907924
ed	O	-1	12907924
but	O	-1	12907924
di@@	O	-1	12907924
min@@	O	-1	12907924
ished	O	-1	12907924
over	O	-1	12907924
several	O	-1	12907924
weeks	O	-1	12907924
when	O	-1	12907924
methyl@@	B-Chemical	D008774	12907924
phen@@	I-Chemical	-1	12907924
id@@	I-Chemical	-1	12907924
ate	I-Chemical	-1	12907924
was	O	-1	12907924
re@@	O	-1	12907924
pl@@	O	-1	12907924
ac@@	O	-1	12907924
ed	O	-1	12907924
by	O	-1	12907924
flu@@	B-Chemical	D016666	12907924
v@@	I-Chemical	-1	12907924
ox@@	I-Chemical	-1	12907924
amine	I-Chemical	-1	12907924
.	O	-1	12907924
The	O	-1	12907924
patient	O	-1	12907924
had	O	-1	12907924
no	O	-1	12907924
prior	O	-1	12907924
psych@@	B-Disease	D001523	12907924
i@@	I-Disease	-1	12907924
atric	I-Disease	-1	12907924
hist@@	O	-1	12907924
or@@	O	-1	12907924
y,	O	-1	12907924
but	O	-1	12907924
he	O	-1	12907924
had	O	-1	12907924
a	O	-1	12907924
sist@@	O	-1	12907924
er	O	-1	12907924
with	O	-1	12907924
ob@@	B-Disease	D009771	12907924
s@@	I-Disease	-1	12907924
es@@	I-Disease	-1	12907924
si@@	I-Disease	-1	12907924
ve@@	I-Disease	-1	12907924
-@@	I-Disease	-1	12907924
comp@@	I-Disease	-1	12907924
ul@@	I-Disease	-1	12907924
sive	I-Disease	-1	12907924
disor@@	I-Disease	-1	12907924
der	I-Disease	-1	12907924
.	O	-1	12907924
It	O	-1	12907924
appear@@	O	-1	12907924
s	O	-1	12907924
that	O	-1	12907924
methyl@@	B-Chemical	D008774	12907924
phen@@	I-Chemical	-1	12907924
id@@	I-Chemical	-1	12907924
ate	I-Chemical	-1	12907924
pre@@	O	-1	12907924
ci@@	O	-1	12907924
pit@@	O	-1	12907924
ated	O	-1	12907924
the	O	-1	12907924
patient@@	O	-1	12907924
's	O	-1	12907924
path@@	O	-1	12907924
ological	O	-1	12907924
behavi@@	O	-1	12907924
or@@	O	-1	12907924
.	O	-1	12907924

C@@	B-Disease	D006323	12139551
ardi@@	I-Disease	-1	12139551
a@@	I-Disease	-1	12139551
c	I-Disease	-1	12139551
ar@@	I-Disease	-1	12139551
res@@	I-Disease	-1	12139551
t	I-Disease	-1	12139551
after	O	-1	12139551
intravenous	O	-1	12139551
met@@	B-Chemical	D008787	12139551
oc@@	I-Chemical	-1	12139551
lop@@	I-Chemical	-1	12139551
ram@@	I-Chemical	-1	12139551
ide	I-Chemical	-1	12139551
-	O	-1	12139551
a	O	-1	12139551
case	O	-1	12139551
of	O	-1	12139551
five	O	-1	12139551
repe@@	O	-1	12139551
ated	O	-1	12139551
injec@@	O	-1	12139551
tions	O	-1	12139551
of	O	-1	12139551
met@@	B-Chemical	D008787	12139551
oc@@	I-Chemical	-1	12139551
lop@@	I-Chemical	-1	12139551
ram@@	I-Chemical	-1	12139551
ide	I-Chemical	-1	12139551
ca@@	O	-1	12139551
using	O	-1	12139551
five	O	-1	12139551
episo@@	O	-1	12139551
des	O	-1	12139551
of	O	-1	12139551
cardiac	B-Disease	D006323	12139551
ar@@	I-Disease	-1	12139551
res@@	I-Disease	-1	12139551
t	I-Disease	-1	12139551
.	O	-1	12139551
We	O	-1	12139551
describe	O	-1	12139551
a	O	-1	12139551
patient	O	-1	12139551
wh@@	O	-1	12139551
ere	O	-1	12139551
intravenous	O	-1	12139551
injection	O	-1	12139551
of	O	-1	12139551
met@@	B-Chemical	D008787	12139551
oc@@	I-Chemical	-1	12139551
lop@@	I-Chemical	-1	12139551
ram@@	I-Chemical	-1	12139551
ide	I-Chemical	-1	12139551
was	O	-1	12139551
immedi@@	O	-1	12139551
ately	O	-1	12139551
followed	O	-1	12139551
by	O	-1	12139551
as@@	B-Disease	D006323	12139551
y@@	I-Disease	-1	12139551
st@@	I-Disease	-1	12139551
ole	I-Disease	-1	12139551
repe@@	O	-1	12139551
ated@@	O	-1	12139551
ly.	O	-1	12139551
The	O	-1	12139551
patient	O	-1	12139551
received	O	-1	12139551
met@@	B-Chemical	D008787	12139551
oc@@	I-Chemical	-1	12139551
lop@@	I-Chemical	-1	12139551
ram@@	I-Chemical	-1	12139551
ide	I-Chemical	-1	12139551
10	O	-1	12139551
mg	O	-1	12139551
i.v@@	O	-1	12139551
.	O	-1	12139551
five	O	-1	12139551
times	O	-1	12139551
during	O	-1	12139551
4@@	O	-1	12139551
8	O	-1	12139551
h@@	O	-1	12139551
.	O	-1	12139551
After	O	-1	12139551
inter@@	O	-1	12139551
vie@@	O	-1	12139551
w@@	O	-1	12139551
ing	O	-1	12139551
the	O	-1	12139551
atten@@	O	-1	12139551
ding	O	-1	12139551
n@@	O	-1	12139551
ur@@	O	-1	12139551
ses	O	-1	12139551
and	O	-1	12139551
revie@@	O	-1	12139551
w@@	O	-1	12139551
ing	O	-1	12139551
the	O	-1	12139551
w@@	O	-1	12139551
rit@@	O	-1	12139551
ten	O	-1	12139551
doc@@	O	-1	12139551
um@@	O	-1	12139551
ent@@	O	-1	12139551
ation,	O	-1	12139551
it	O	-1	12139551
is	O	-1	12139551
c@@	O	-1	12139551
le@@	O	-1	12139551
ar	O	-1	12139551
that	O	-1	12139551
every	O	-1	12139551
administration	O	-1	12139551
of	O	-1	12139551
met@@	B-Chemical	D008787	12139551
oc@@	I-Chemical	-1	12139551
lop@@	I-Chemical	-1	12139551
ram@@	I-Chemical	-1	12139551
ide	I-Chemical	-1	12139551
was	O	-1	12139551
immedi@@	O	-1	12139551
ately	O	-1	12139551
(@@	O	-1	12139551
within	O	-1	12139551
s)	O	-1	12139551
followed	O	-1	12139551
by	O	-1	12139551
as@@	B-Disease	D006323	12139551
y@@	I-Disease	-1	12139551
st@@	I-Disease	-1	12139551
ole	I-Disease	-1	12139551
.	O	-1	12139551
The	O	-1	12139551
as@@	B-Disease	D006323	12139551
y@@	I-Disease	-1	12139551
st@@	I-Disease	-1	12139551
ole	I-Disease	-1	12139551
l@@	O	-1	12139551
ast@@	O	-1	12139551
ed	O	-1	12139551
1@@	O	-1	12139551
5-@@	O	-1	12139551
30	O	-1	12139551
s	O	-1	12139551
on	O	-1	12139551
four	O	-1	12139551
oc@@	O	-1	12139551
ca@@	O	-1	12139551
sion@@	O	-1	12139551
s,	O	-1	12139551
on	O	-1	12139551
one	O	-1	12139551
oc@@	O	-1	12139551
ca@@	O	-1	12139551
sion	O	-1	12139551
it	O	-1	12139551
l@@	O	-1	12139551
ast@@	O	-1	12139551
ed	O	-1	12139551
2	O	-1	12139551
min@@	O	-1	12139551
.	O	-1	12139551
The	O	-1	12139551
patient	O	-1	12139551
received	O	-1	12139551
atro@@	B-Chemical	D001285	12139551
pine	I-Chemical	-1	12139551
0.@@	O	-1	12139551
5-@@	O	-1	12139551
1	O	-1	12139551
mg	O	-1	12139551
and	O	-1	12139551
ch@@	O	-1	12139551
est	O	-1	12139551
com@@	O	-1	12139551
pres@@	O	-1	12139551
sion@@	O	-1	12139551
s,	O	-1	12139551
before	O	-1	12139551
s@@	O	-1	12139551
in@@	O	-1	12139551
us	O	-1	12139551
rhyth@@	O	-1	12139551
m	O	-1	12139551
ag@@	O	-1	12139551
ain	O	-1	12139551
to@@	O	-1	12139551
o@@	O	-1	12139551
k	O	-1	12139551
over@@	O	-1	12139551
.	O	-1	12139551
We	O	-1	12139551
inter@@	O	-1	12139551
pre@@	O	-1	12139551
t	O	-1	12139551
this	O	-1	12139551
as	O	-1	12139551
episo@@	O	-1	12139551
des	O	-1	12139551
of	O	-1	12139551
cardiac	B-Disease	D006323	12139551
ar@@	I-Disease	-1	12139551
res@@	I-Disease	-1	12139551
t	I-Disease	-1	12139551
caused	O	-1	12139551
by	O	-1	12139551
met@@	B-Chemical	D008787	12139551
oc@@	I-Chemical	-1	12139551
lop@@	I-Chemical	-1	12139551
ram@@	I-Chemical	-1	12139551
ide	I-Chemical	-1	12139551
.	O	-1	12139551
The	O	-1	12139551
ra@@	O	-1	12139551
pid	O	-1	12139551
injection	O	-1	12139551
vi@@	O	-1	12139551
a	O	-1	12139551
the	O	-1	12139551
central	O	-1	12139551
venous	O	-1	12139551
ro@@	O	-1	12139551
ute	O	-1	12139551
and	O	-1	12139551
the	O	-1	12139551
concomit@@	O	-1	12139551
ant	O	-1	12139551
t@@	O	-1	12139551
a@@	O	-1	12139551
per@@	O	-1	12139551
ing	O	-1	12139551
of	O	-1	12139551
dopamine	B-Chemical	D004298	12139551
infusion	O	-1	12139551
might	O	-1	12139551
have	O	-1	12139551
cont@@	O	-1	12139551
ri@@	O	-1	12139551
but@@	O	-1	12139551
ed	O	-1	12139551
in	O	-1	12139551
pre@@	O	-1	12139551
ci@@	O	-1	12139551
pit@@	O	-1	12139551
ating	O	-1	12139551
the	O	-1	12139551
adverse	O	-1	12139551
drug	O	-1	12139551
reac@@	O	-1	12139551
tion.	O	-1	12139551

S@@	O	-1	10411803
ev@@	O	-1	10411803
ere	O	-1	10411803
immun@@	O	-1	10411803
e	O	-1	10411803
hemolytic	B-Disease	D000743	10411803
anemia	I-Disease	-1	10411803
associated	O	-1	10411803
with	O	-1	10411803
pro@@	O	-1	10411803
phyl@@	O	-1	10411803
ac@@	O	-1	10411803
tic	O	-1	10411803
use	O	-1	10411803
of	O	-1	10411803
ce@@	B-Chemical	D015313	10411803
f@@	I-Chemical	-1	10411803
ot@@	I-Chemical	-1	10411803
et@@	I-Chemical	-1	10411803
an	I-Chemical	-1	10411803
in	O	-1	10411803
ob@@	O	-1	10411803
st@@	O	-1	10411803
et@@	O	-1	10411803
ric	O	-1	10411803
and	O	-1	10411803
g@@	O	-1	10411803
y@@	O	-1	10411803
nec@@	O	-1	10411803
ologic	O	-1	10411803
proce@@	O	-1	10411803
du@@	O	-1	10411803
res@@	O	-1	10411803
.	O	-1	10411803
S@@	O	-1	10411803
ec@@	O	-1	10411803
ond@@	O	-1	10411803
-	O	-1	10411803
and	O	-1	10411803
thir@@	O	-1	10411803
d-@@	O	-1	10411803
generation	O	-1	10411803
ce@@	B-Chemical	D002511	10411803
ph@@	I-Chemical	-1	10411803
al@@	I-Chemical	-1	10411803
os@@	I-Chemical	-1	10411803
por@@	I-Chemical	-1	10411803
ins	I-Chemical	-1	10411803
,	O	-1	10411803
es@@	O	-1	10411803
p@@	O	-1	10411803
ec@@	O	-1	10411803
i@@	O	-1	10411803
ally	O	-1	10411803
ce@@	B-Chemical	D015313	10411803
f@@	I-Chemical	-1	10411803
ot@@	I-Chemical	-1	10411803
et@@	I-Chemical	-1	10411803
an	I-Chemical	-1	10411803
,	O	-1	10411803
are	O	-1	10411803
increas@@	O	-1	10411803
ing@@	O	-1	10411803
ly	O	-1	10411803
associated	O	-1	10411803
with	O	-1	10411803
se@@	O	-1	10411803
ve@@	O	-1	10411803
re,	O	-1	10411803
so@@	O	-1	10411803
me@@	O	-1	10411803
times	O	-1	10411803
f@@	O	-1	10411803
atal	O	-1	10411803
immun@@	O	-1	10411803
e	O	-1	10411803
hemolytic	B-Disease	D000743	10411803
anemia	I-Disease	-1	10411803
.	O	-1	10411803
We	O	-1	10411803
no@@	O	-1	10411803
tic@@	O	-1	10411803
ed	O	-1	10411803
that	O	-1	10411803
10	O	-1	10411803
of	O	-1	10411803
our	O	-1	10411803
3@@	O	-1	10411803
5	O	-1	10411803
cases	O	-1	10411803
of	O	-1	10411803
ce@@	B-Chemical	D015313	10411803
f@@	I-Chemical	-1	10411803
ot@@	I-Chemical	-1	10411803
et@@	I-Chemical	-1	10411803
an	I-Chemical	-1	10411803
-induced	O	-1	10411803
hemolytic	B-Disease	D000743	10411803
an@@	I-Disease	-1	10411803
em@@	I-Disease	-1	10411803
i@@	I-Disease	-1	10411803
as	I-Disease	-1	10411803
were	O	-1	10411803
in	O	-1	10411803
patients	O	-1	10411803
who	O	-1	10411803
had	O	-1	10411803
received	O	-1	10411803
ce@@	B-Chemical	D015313	10411803
f@@	I-Chemical	-1	10411803
ot@@	I-Chemical	-1	10411803
et@@	I-Chemical	-1	10411803
an	I-Chemical	-1	10411803
pro@@	O	-1	10411803
phyl@@	O	-1	10411803
ac@@	O	-1	10411803
tically	O	-1	10411803
for	O	-1	10411803
ob@@	O	-1	10411803
st@@	O	-1	10411803
et@@	O	-1	10411803
ric	O	-1	10411803
and	O	-1	10411803
g@@	O	-1	10411803
y@@	O	-1	10411803
nec@@	O	-1	10411803
ologic	O	-1	10411803
proce@@	O	-1	10411803
du@@	O	-1	10411803
res@@	O	-1	10411803
.	O	-1	10411803
E@@	O	-1	10411803
ight	O	-1	10411803
of	O	-1	10411803
these	O	-1	10411803
cases	O	-1	10411803
of	O	-1	10411803
severe	O	-1	10411803
immun@@	O	-1	10411803
e	O	-1	10411803
hemolytic	B-Disease	D000743	10411803
anemia	I-Disease	-1	10411803
are	O	-1	10411803
descri@@	O	-1	10411803
be@@	O	-1	10411803
d.	O	-1	10411803

Ca@@	B-Disease	D011128	10225068
ud@@	I-Disease	-1	10225068
a	I-Disease	-1	10225068
equ@@	I-Disease	-1	10225068
in@@	I-Disease	-1	10225068
a	I-Disease	-1	10225068
syndrome	I-Disease	-1	10225068
after	O	-1	10225068
spinal	O	-1	10225068
anaesthe@@	O	-1	10225068
sia	O	-1	10225068
with	O	-1	10225068
hyper@@	O	-1	10225068
bar@@	O	-1	10225068
ic	O	-1	10225068
5%	O	-1	10225068
li@@	B-Chemical	D008012	10225068
gn@@	I-Chemical	-1	10225068
oc@@	I-Chemical	-1	10225068
aine	I-Chemical	-1	10225068
:	O	-1	10225068
a	O	-1	10225068
revie@@	O	-1	10225068
w	O	-1	10225068
of	O	-1	10225068
six	O	-1	10225068
cases	O	-1	10225068
of	O	-1	10225068
ca@@	B-Disease	D011128	10225068
ud@@	I-Disease	-1	10225068
a	I-Disease	-1	10225068
equ@@	I-Disease	-1	10225068
in@@	I-Disease	-1	10225068
a	I-Disease	-1	10225068
syndrome	I-Disease	-1	10225068
reported	O	-1	10225068
to	O	-1	10225068
the	O	-1	10225068
S@@	O	-1	10225068
we@@	O	-1	10225068
dis@@	O	-1	10225068
h	O	-1	10225068
Ph@@	O	-1	10225068
ar@@	O	-1	10225068
m@@	O	-1	10225068
ace@@	O	-1	10225068
u@@	O	-1	10225068
tical	O	-1	10225068
In@@	O	-1	10225068
sur@@	O	-1	10225068
ance	O	-1	10225068
19@@	O	-1	10225068
9@@	O	-1	10225068
3@@	O	-1	10225068
-1@@	O	-1	10225068
9@@	O	-1	10225068
9@@	O	-1	10225068
7@@	O	-1	10225068
.	O	-1	10225068
Si@@	O	-1	10225068
x	O	-1	10225068
cases	O	-1	10225068
of	O	-1	10225068
ca@@	B-Disease	D011128	10225068
ud@@	I-Disease	-1	10225068
a	I-Disease	-1	10225068
equ@@	I-Disease	-1	10225068
in@@	I-Disease	-1	10225068
a	I-Disease	-1	10225068
syndrome	I-Disease	-1	10225068
with	O	-1	10225068
v@@	O	-1	10225068
ar@@	O	-1	10225068
y@@	O	-1	10225068
ing	O	-1	10225068
severity	O	-1	10225068
were	O	-1	10225068
reported	O	-1	10225068
to	O	-1	10225068
the	O	-1	10225068
S@@	O	-1	10225068
we@@	O	-1	10225068
dis@@	O	-1	10225068
h	O	-1	10225068
Ph@@	O	-1	10225068
ar@@	O	-1	10225068
m@@	O	-1	10225068
ace@@	O	-1	10225068
u@@	O	-1	10225068
tical	O	-1	10225068
In@@	O	-1	10225068
sur@@	O	-1	10225068
ance	O	-1	10225068
during	O	-1	10225068
the	O	-1	10225068
period	O	-1	10225068
19@@	O	-1	10225068
9@@	O	-1	10225068
3@@	O	-1	10225068
-1@@	O	-1	10225068
9@@	O	-1	10225068
9@@	O	-1	10225068
7@@	O	-1	10225068
.	O	-1	10225068
All	O	-1	10225068
were	O	-1	10225068
associated	O	-1	10225068
with	O	-1	10225068
spinal	O	-1	10225068
anaesthe@@	O	-1	10225068
sia	O	-1	10225068
using	O	-1	10225068
hyper@@	O	-1	10225068
bar@@	O	-1	10225068
ic	O	-1	10225068
5%	O	-1	10225068
li@@	B-Chemical	D008012	10225068
gn@@	I-Chemical	-1	10225068
oc@@	I-Chemical	-1	10225068
aine	I-Chemical	-1	10225068
.	O	-1	10225068
F@@	O	-1	10225068
i@@	O	-1	10225068
ve	O	-1	10225068
cases	O	-1	10225068
had	O	-1	10225068
sing@@	O	-1	10225068
le@@	O	-1	10225068
-@@	O	-1	10225068
sho@@	O	-1	10225068
t	O	-1	10225068
spinal	O	-1	10225068
anaesthe@@	O	-1	10225068
sia	O	-1	10225068
and	O	-1	10225068
one	O	-1	10225068
had	O	-1	10225068
a	O	-1	10225068
repe@@	O	-1	10225068
at	O	-1	10225068
spinal	O	-1	10225068
anaesthe@@	O	-1	10225068
tic	O	-1	10225068
due	O	-1	10225068
to	O	-1	10225068
in@@	O	-1	10225068
ade@@	O	-1	10225068
qu@@	O	-1	10225068
ate	O	-1	10225068
block@@	O	-1	10225068
.	O	-1	10225068
The	O	-1	10225068
dose	O	-1	10225068
of	O	-1	10225068
hyper@@	O	-1	10225068
bar@@	O	-1	10225068
ic	O	-1	10225068
5%	O	-1	10225068
li@@	B-Chemical	D008012	10225068
gn@@	I-Chemical	-1	10225068
oc@@	I-Chemical	-1	10225068
aine	I-Chemical	-1	10225068
administered	O	-1	10225068
rang@@	O	-1	10225068
ed	O	-1	10225068
from	O	-1	10225068
60	O	-1	10225068
to	O	-1	10225068
1@@	O	-1	10225068
20	O	-1	10225068
mg@@	O	-1	10225068
.	O	-1	10225068
Th@@	O	-1	10225068
ree	O	-1	10225068
of	O	-1	10225068
the	O	-1	10225068
cases	O	-1	10225068
were	O	-1	10225068
most	O	-1	10225068
likely	O	-1	10225068
caused	O	-1	10225068
by	O	-1	10225068
direct	O	-1	10225068
neuro@@	B-Disease	D020258	10225068
toxicity	I-Disease	-1	10225068
of	O	-1	10225068
hyper@@	O	-1	10225068
bar@@	O	-1	10225068
ic	O	-1	10225068
5%	O	-1	10225068
li@@	B-Chemical	D008012	10225068
gn@@	I-Chemical	-1	10225068
oc@@	I-Chemical	-1	10225068
aine	I-Chemical	-1	10225068
.	O	-1	10225068
In	O	-1	10225068
the	O	-1	10225068
other	O	-1	10225068
3	O	-1	10225068
cas@@	O	-1	10225068
es,	O	-1	10225068
direct	O	-1	10225068
neuro@@	B-Disease	D020258	10225068
toxicity	I-Disease	-1	10225068
was	O	-1	10225068
also	O	-1	10225068
prob@@	O	-1	10225068
able@@	O	-1	10225068
,	O	-1	10225068
but	O	-1	10225068
un@@	O	-1	10225068
for@@	O	-1	10225068
t@@	O	-1	10225068
un@@	O	-1	10225068
ately	O	-1	10225068
radi@@	O	-1	10225068
ological	O	-1	10225068
investig@@	O	-1	10225068
ations	O	-1	10225068
were	O	-1	10225068
not	O	-1	10225068
d@@	O	-1	10225068
one	O	-1	10225068
to	O	-1	10225068
def@@	O	-1	10225068
in@@	O	-1	10225068
it@@	O	-1	10225068
ely	O	-1	10225068
ex@@	O	-1	10225068
cl@@	O	-1	10225068
ude	O	-1	10225068
a	O	-1	10225068
com@@	O	-1	10225068
pressive	O	-1	10225068
a@@	O	-1	10225068
e@@	O	-1	10225068
ti@@	O	-1	10225068
olog@@	O	-1	10225068
y.	O	-1	10225068
All	O	-1	10225068
cases	O	-1	10225068
su@@	O	-1	10225068
st@@	O	-1	10225068
ained	O	-1	10225068
per@@	O	-1	10225068
man@@	O	-1	10225068
ent	O	-1	10225068
neurolog@@	B-Disease	D009461	10225068
ical	I-Disease	-1	10225068
defic@@	I-Disease	-1	10225068
its	I-Disease	-1	10225068
.	O	-1	10225068
We	O	-1	10225068
recomm@@	O	-1	10225068
end	O	-1	10225068
that	O	-1	10225068
hyper@@	O	-1	10225068
bar@@	O	-1	10225068
ic	O	-1	10225068
li@@	B-Chemical	D008012	10225068
gn@@	I-Chemical	-1	10225068
oc@@	I-Chemical	-1	10225068
aine	I-Chemical	-1	10225068
should	O	-1	10225068
be	O	-1	10225068
administered	O	-1	10225068
in	O	-1	10225068
concentrations	O	-1	10225068
not	O	-1	10225068
greater	O	-1	10225068
than	O	-1	10225068
2@@	O	-1	10225068
%	O	-1	10225068
and	O	-1	10225068
at	O	-1	10225068
a	O	-1	10225068
total	O	-1	10225068
dose	O	-1	10225068
pre@@	O	-1	10225068
fer@@	O	-1	10225068
ably	O	-1	10225068
not	O	-1	10225068
ex@@	O	-1	10225068
ce@@	O	-1	10225068
ed@@	O	-1	10225068
ing	O	-1	10225068
60	O	-1	10225068
mg@@	O	-1	10225068
.	O	-1	10225068

C@@	O	-1	9549528
or@@	O	-1	9549528
tical	O	-1	9549528
motor	O	-1	9549528
over@@	O	-1	9549528
activation	O	-1	9549528
in	O	-1	9549528
par@@	B-Disease	D020734	9549528
k@@	I-Disease	-1	9549528
inson@@	I-Disease	-1	9549528
i@@	I-Disease	-1	9549528
an	I-Disease	-1	9549528
patients	O	-1	9549528
with	O	-1	9549528
L-@@	B-Chemical	D007980	9549528
dopa	I-Chemical	-1	9549528
-induced	O	-1	9549528
pe@@	O	-1	9549528
ak@@	O	-1	9549528
-@@	O	-1	9549528
dose	O	-1	9549528
dyskine@@	B-Disease	D004409	9549528
sia	I-Disease	-1	9549528
.	O	-1	9549528
We	O	-1	9549528
have	O	-1	9549528
studied	O	-1	9549528
the	O	-1	9549528
regi@@	O	-1	9549528
on@@	O	-1	9549528
al	O	-1	9549528
cerebral	O	-1	9549528
blood	O	-1	9549528
flow	O	-1	9549528
(@@	O	-1	9549528
r@@	O	-1	9549528
C@@	O	-1	9549528
B@@	O	-1	9549528
F@@	O	-1	9549528
)	O	-1	9549528
changes	O	-1	9549528
induced	O	-1	9549528
by	O	-1	9549528
the	O	-1	9549528
ex@@	O	-1	9549528
ec@@	O	-1	9549528
u@@	O	-1	9549528
tion	O	-1	9549528
of	O	-1	9549528
a	O	-1	9549528
f@@	O	-1	9549528
ing@@	O	-1	9549528
er@@	O	-1	9549528
-@@	O	-1	9549528
to@@	O	-1	9549528
-@@	O	-1	9549528
th@@	O	-1	9549528
um@@	O	-1	9549528
b	O	-1	9549528
op@@	O	-1	9549528
posi@@	O	-1	9549528
tion	O	-1	9549528
motor	O	-1	9549528
t@@	O	-1	9549528
as@@	O	-1	9549528
k	O	-1	9549528
in	O	-1	9549528
the	O	-1	9549528
sup@@	O	-1	9549528
ple@@	O	-1	9549528
ment@@	O	-1	9549528
ary	O	-1	9549528
and	O	-1	9549528
prim@@	O	-1	9549528
ary	O	-1	9549528
motor	O	-1	9549528
cor@@	O	-1	9549528
te@@	O	-1	9549528
x	O	-1	9549528
of	O	-1	9549528
two	O	-1	9549528
groups	O	-1	9549528
of	O	-1	9549528
par@@	B-Disease	D020734	9549528
k@@	I-Disease	-1	9549528
inson@@	I-Disease	-1	9549528
i@@	I-Disease	-1	9549528
an	I-Disease	-1	9549528
patients	O	-1	9549528
on	O	-1	9549528
L-@@	B-Chemical	D007980	9549528
dopa	I-Chemical	-1	9549528
medic@@	O	-1	9549528
ation,	O	-1	9549528
the	O	-1	9549528
first	O	-1	9549528
one	O	-1	9549528
without	O	-1	9549528
L-@@	B-Chemical	D007980	9549528
dopa	I-Chemical	-1	9549528
induced	O	-1	9549528
dyskine@@	B-Disease	D004409	9549528
sia	I-Disease	-1	9549528
(n	O	-1	9549528
=	O	-1	9549528
2@@	O	-1	9549528
3@@	O	-1	9549528
)	O	-1	9549528
and	O	-1	9549528
the	O	-1	9549528
other	O	-1	9549528
with	O	-1	9549528
moder@@	O	-1	9549528
ate	O	-1	9549528
pe@@	O	-1	9549528
ak@@	O	-1	9549528
-@@	O	-1	9549528
dose	O	-1	9549528
dyskine@@	B-Disease	D004409	9549528
sia	I-Disease	-1	9549528
(n	O	-1	9549528
=	O	-1	9549528
1@@	O	-1	9549528
5@@	O	-1	9549528
),	O	-1	9549528
and	O	-1	9549528
of	O	-1	9549528
a	O	-1	9549528
group	O	-1	9549528
of	O	-1	9549528
14	O	-1	9549528
normal	O	-1	9549528
subj@@	O	-1	9549528
ect@@	O	-1	9549528
s.	O	-1	9549528
S@@	O	-1	9549528
ing@@	O	-1	9549528
le	O	-1	9549528
ph@@	O	-1	9549528
ot@@	O	-1	9549528
on	O	-1	9549528
em@@	O	-1	9549528
is@@	O	-1	9549528
sion	O	-1	9549528
to@@	O	-1	9549528
mo@@	O	-1	9549528
graph@@	O	-1	9549528
y	O	-1	9549528
with	O	-1	9549528
i.v@@	O	-1	9549528
.	O	-1	9549528
13@@	O	-1	9549528
3@@	O	-1	9549528
X@@	O	-1	9549528
e	O	-1	9549528
was	O	-1	9549528
used	O	-1	9549528
to	O	-1	9549528
meas@@	O	-1	9549528
ure	O	-1	9549528
the	O	-1	9549528
r@@	O	-1	9549528
C@@	O	-1	9549528
B@@	O	-1	9549528
F	O	-1	9549528
chang@@	O	-1	9549528
es.	O	-1	9549528
The	O	-1	9549528
dyskine@@	B-Disease	D004409	9549528
tic	I-Disease	-1	9549528
par@@	B-Disease	D020734	9549528
k@@	I-Disease	-1	9549528
inson@@	I-Disease	-1	9549528
i@@	I-Disease	-1	9549528
an	I-Disease	-1	9549528
patients	O	-1	9549528
ex@@	O	-1	9549528
hib@@	O	-1	9549528
ited	O	-1	9549528
a	O	-1	9549528
pat@@	O	-1	9549528
ter@@	O	-1	9549528
n	O	-1	9549528
of	O	-1	9549528
response	O	-1	9549528
which	O	-1	9549528
was	O	-1	9549528
mark@@	O	-1	9549528
ed@@	O	-1	9549528
ly	O	-1	9549528
different	O	-1	9549528
from	O	-1	9549528
those	O	-1	9549528
of	O	-1	9549528
the	O	-1	9549528
normal	O	-1	9549528
subjects	O	-1	9549528
and	O	-1	9549528
non@@	O	-1	9549528
-	O	-1	9549528
dyskine@@	B-Disease	D004409	9549528
tic	I-Disease	-1	9549528
par@@	B-Disease	D020734	9549528
k@@	I-Disease	-1	9549528
inson@@	I-Disease	-1	9549528
i@@	I-Disease	-1	9549528
an	I-Disease	-1	9549528
patients,	O	-1	9549528
with	O	-1	9549528
a	O	-1	9549528
significant	O	-1	9549528
over@@	O	-1	9549528
activation	O	-1	9549528
in	O	-1	9549528
the	O	-1	9549528
sup@@	O	-1	9549528
ple@@	O	-1	9549528
ment@@	O	-1	9549528
ary	O	-1	9549528
motor	O	-1	9549528
a@@	O	-1	9549528
re@@	O	-1	9549528
a	O	-1	9549528
and	O	-1	9549528
the	O	-1	9549528
ip@@	O	-1	9549528
si@@	O	-1	9549528
-	O	-1	9549528
and	O	-1	9549528
contr@@	O	-1	9549528
al@@	O	-1	9549528
ateral	O	-1	9549528
prim@@	O	-1	9549528
ary	O	-1	9549528
motor	O	-1	9549528
a@@	O	-1	9549528
reas@@	O	-1	9549528
.	O	-1	9549528
These	O	-1	9549528
results	O	-1	9549528
are	O	-1	9549528
com@@	O	-1	9549528
pati@@	O	-1	9549528
ble	O	-1	9549528
with	O	-1	9549528
the	O	-1	9549528
hypo@@	O	-1	9549528
thesis	O	-1	9549528
that	O	-1	9549528
an	O	-1	9549528
hyper@@	B-Disease	D006948	9549528
kine@@	I-Disease	-1	9549528
tic	I-Disease	-1	9549528
ab@@	B-Disease	D004409	9549528
normal	I-Disease	-1	9549528
invol@@	I-Disease	-1	9549528
un@@	I-Disease	-1	9549528
t@@	I-Disease	-1	9549528
ary	I-Disease	-1	9549528
mo@@	I-Disease	-1	9549528
vement	I-Disease	-1	9549528
,	O	-1	9549528
like	O	-1	9549528
L-@@	B-Chemical	D007980	9549528
dopa	I-Chemical	-1	9549528
-induced	O	-1	9549528
pe@@	O	-1	9549528
a@@	O	-1	9549528
k	O	-1	9549528
dose	O	-1	9549528
dyskine@@	B-Disease	D004409	9549528
sia	I-Disease	-1	9549528
,	O	-1	9549528
is	O	-1	9549528
due	O	-1	9549528
to	O	-1	9549528
a	O	-1	9549528
dis@@	O	-1	9549528
inhibition	O	-1	9549528
of	O	-1	9549528
the	O	-1	9549528
prim@@	O	-1	9549528
ary	O	-1	9549528
and	O	-1	9549528
associated	O	-1	9549528
motor	O	-1	9549528
cor@@	O	-1	9549528
te@@	O	-1	9549528
x	O	-1	9549528
secondary	O	-1	9549528
to	O	-1	9549528
an	O	-1	9549528
ex@@	O	-1	9549528
ces@@	O	-1	9549528
sive	O	-1	9549528
out@@	O	-1	9549528
flow	O	-1	9549528
of	O	-1	9549528
the	O	-1	9549528
p@@	O	-1	9549528
all@@	O	-1	9549528
id@@	O	-1	9549528
o@@	O	-1	9549528
thal@@	O	-1	9549528
am@@	O	-1	9549528
oc@@	O	-1	9549528
or@@	O	-1	9549528
tical	O	-1	9549528
motor	O	-1	9549528
lo@@	O	-1	9549528
op@@	O	-1	9549528
.	O	-1	9549528

D@@	B-Chemical	D003907	7843916
ex@@	I-Chemical	-1	7843916
ameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
-induced	O	-1	7843916
oc@@	B-Disease	D009798	7843916
ular	I-Disease	-1	7843916
hypertension	I-Disease	-1	7843916
in	O	-1	7843916
per@@	O	-1	7843916
fu@@	O	-1	7843916
sion@@	O	-1	7843916
-@@	O	-1	7843916
c@@	O	-1	7843916
ult@@	O	-1	7843916
ured	O	-1	7843916
human	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es.	O	-1	7843916
P@@	O	-1	7843916
U@@	O	-1	7843916
R@@	O	-1	7843916
P@@	O	-1	7843916
O@@	O	-1	7843916
S@@	O	-1	7843916
E:	O	-1	7843916
G@@	O	-1	7843916
lu@@	O	-1	7843916
co@@	O	-1	7843916
cortico@@	O	-1	7843916
id	O	-1	7843916
administration	O	-1	7843916
can	O	-1	7843916
le@@	O	-1	7843916
ad	O	-1	7843916
to	O	-1	7843916
the	O	-1	7843916
development	O	-1	7843916
of	O	-1	7843916
oc@@	B-Disease	D009798	7843916
ular	I-Disease	-1	7843916
hypertension	I-Disease	-1	7843916
and	O	-1	7843916
cortico@@	B-Disease	D005901	7843916
ster@@	I-Disease	-1	7843916
oid	I-Disease	-1	7843916
gl@@	I-Disease	-1	7843916
au@@	I-Disease	-1	7843916
com@@	I-Disease	-1	7843916
a	I-Disease	-1	7843916
in	O	-1	7843916
a	O	-1	7843916
sub@@	O	-1	7843916
set	O	-1	7843916
of	O	-1	7843916
the	O	-1	7843916
po@@	O	-1	7843916
p@@	O	-1	7843916
ulation	O	-1	7843916
through	O	-1	7843916
a	O	-1	7843916
decrease	O	-1	7843916
in	O	-1	7843916
the	O	-1	7843916
a@@	O	-1	7843916
qu@@	O	-1	7843916
e@@	O	-1	7843916
ous	O	-1	7843916
hum@@	O	-1	7843916
or	O	-1	7843916
out@@	O	-1	7843916
flow	O	-1	7843916
fac@@	O	-1	7843916
il@@	O	-1	7843916
ity.	O	-1	7843916
The	O	-1	7843916
pur@@	O	-1	7843916
p@@	O	-1	7843916
ose	O	-1	7843916
of	O	-1	7843916
this	O	-1	7843916
study	O	-1	7843916
was	O	-1	7843916
to	O	-1	7843916
determine	O	-1	7843916
whether	O	-1	7843916
g@@	O	-1	7843916
lu@@	O	-1	7843916
co@@	O	-1	7843916
cortico@@	O	-1	7843916
id	O	-1	7843916
treatment	O	-1	7843916
can	O	-1	7843916
direc@@	O	-1	7843916
tly	O	-1	7843916
aff@@	O	-1	7843916
ect	O	-1	7843916
the	O	-1	7843916
out@@	O	-1	7843916
flow	O	-1	7843916
fac@@	O	-1	7843916
ility	O	-1	7843916
of	O	-1	7843916
isol@@	O	-1	7843916
at@@	O	-1	7843916
ed,	O	-1	7843916
per@@	O	-1	7843916
fu@@	O	-1	7843916
sion@@	O	-1	7843916
-@@	O	-1	7843916
c@@	O	-1	7843916
ult@@	O	-1	7843916
ured	O	-1	7843916
human	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es.	O	-1	7843916
METHODS:	O	-1	7843916
The	O	-1	7843916
an@@	O	-1	7843916
ter@@	O	-1	7843916
ior	O	-1	7843916
seg@@	O	-1	7843916
ments	O	-1	7843916
of	O	-1	7843916
human	O	-1	7843916
d@@	O	-1	7843916
on@@	O	-1	7843916
or	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es	O	-1	7843916
from	O	-1	7843916
regi@@	O	-1	7843916
on@@	O	-1	7843916
al	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
e	O	-1	7843916
b@@	O	-1	7843916
an@@	O	-1	7843916
k@@	O	-1	7843916
s	O	-1	7843916
were	O	-1	7843916
pl@@	O	-1	7843916
ac@@	O	-1	7843916
ed	O	-1	7843916
in	O	-1	7843916
a	O	-1	7843916
con@@	O	-1	7843916
st@@	O	-1	7843916
ant	O	-1	7843916
f@@	O	-1	7843916
low@@	O	-1	7843916
,	O	-1	7843916
vari@@	O	-1	7843916
able	O	-1	7843916
pressure	O	-1	7843916
per@@	O	-1	7843916
f@@	O	-1	7843916
usion	O	-1	7843916
c@@	O	-1	7843916
ult@@	O	-1	7843916
ure	O	-1	7843916
system@@	O	-1	7843916
.	O	-1	7843916
P@@	O	-1	7843916
a@@	O	-1	7843916
ired	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es	O	-1	7843916
were	O	-1	7843916
per@@	O	-1	7843916
f@@	O	-1	7843916
used	O	-1	7843916
in	O	-1	7843916
ser@@	O	-1	7843916
um@@	O	-1	7843916
-@@	O	-1	7843916
free	O	-1	7843916
medi@@	O	-1	7843916
a	O	-1	7843916
with	O	-1	7843916
or	O	-1	7843916
without	O	-1	7843916
10@@	O	-1	7843916
(-@@	O	-1	7843916
7@@	O	-1	7843916
)	O	-1	7843916
M	O	-1	7843916
de@@	B-Chemical	D003907	7843916
xameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
for	O	-1	7843916
12	O	-1	7843916
days.	O	-1	7843916
In@@	O	-1	7843916
tra@@	O	-1	7843916
oc@@	O	-1	7843916
ular	O	-1	7843916
pressure	O	-1	7843916
was	O	-1	7843916
monit@@	O	-1	7843916
o@@	O	-1	7843916
red	O	-1	7843916
da@@	O	-1	7843916
il@@	O	-1	7843916
y.	O	-1	7843916
After	O	-1	7843916
inc@@	O	-1	7843916
ub@@	O	-1	7843916
ation,	O	-1	7843916
the	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es	O	-1	7843916
were	O	-1	7843916
morph@@	O	-1	7843916
olog@@	O	-1	7843916
ically	O	-1	7843916
character@@	O	-1	7843916
ized	O	-1	7843916
by	O	-1	7843916
li@@	O	-1	7843916
ght	O	-1	7843916
micro@@	O	-1	7843916
sco@@	O	-1	7843916
p@@	O	-1	7843916
y,	O	-1	7843916
trans@@	O	-1	7843916
mission	O	-1	7843916
and	O	-1	7843916
s@@	O	-1	7843916
can@@	O	-1	7843916
ning	O	-1	7843916
electro@@	O	-1	7843916
n	O	-1	7843916
micro@@	O	-1	7843916
sco@@	O	-1	7843916
p@@	O	-1	7843916
y,	O	-1	7843916
and	O	-1	7843916
s@@	O	-1	7843916
can@@	O	-1	7843916
ning	O	-1	7843916
las@@	O	-1	7843916
er	O	-1	7843916
conf@@	O	-1	7843916
oc@@	O	-1	7843916
al	O	-1	7843916
micro@@	O	-1	7843916
sco@@	O	-1	7843916
p@@	O	-1	7843916
y.	O	-1	7843916
RESULTS:	O	-1	7843916
A	O	-1	7843916
significant	O	-1	7843916
increase	O	-1	7843916
in	O	-1	7843916
intra@@	O	-1	7843916
oc@@	O	-1	7843916
ular	O	-1	7843916
pressure	O	-1	7843916
developed	O	-1	7843916
in	O	-1	7843916
13	O	-1	7843916
of	O	-1	7843916
the	O	-1	7843916
4@@	O	-1	7843916
4	O	-1	7843916
pa@@	O	-1	7843916
ir@@	O	-1	7843916
s	O	-1	7843916
of	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es	O	-1	7843916
per@@	O	-1	7843916
f@@	O	-1	7843916
used	O	-1	7843916
with	O	-1	7843916
de@@	B-Chemical	D003907	7843916
xameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
with	O	-1	7843916
an	O	-1	7843916
average	O	-1	7843916
pressure	O	-1	7843916
ri@@	O	-1	7843916
se	O	-1	7843916
of	O	-1	7843916
1@@	O	-1	7843916
7.@@	O	-1	7843916
5	O	-1	7843916
+/-	O	-1	7843916
3.@@	O	-1	7843916
8	O	-1	7843916
mm	O	-1	7843916
H@@	O	-1	7843916
g	O	-1	7843916
after	O	-1	7843916
12	O	-1	7843916
days	O	-1	7843916
of	O	-1	7843916
de@@	B-Chemical	D003907	7843916
xameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
expos@@	O	-1	7843916
ure.	O	-1	7843916
The	O	-1	7843916
contr@@	O	-1	7843916
al@@	O	-1	7843916
ateral	O	-1	7843916
control	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es,	O	-1	7843916
which	O	-1	7843916
did	O	-1	7843916
not	O	-1	7843916
recei@@	O	-1	7843916
ve	O	-1	7843916
de@@	B-Chemical	D003907	7843916
xameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
,	O	-1	7843916
maint@@	O	-1	7843916
ained	O	-1	7843916
a	O	-1	7843916
st@@	O	-1	7843916
able	O	-1	7843916
intra@@	O	-1	7843916
oc@@	O	-1	7843916
ular	O	-1	7843916
pressure	O	-1	7843916
during	O	-1	7843916
the	O	-1	7843916
same	O	-1	7843916
perio@@	O	-1	7843916
d.	O	-1	7843916
The	O	-1	7843916
out@@	O	-1	7843916
flow	O	-1	7843916
path@@	O	-1	7843916
w@@	O	-1	7843916
ay	O	-1	7843916
of	O	-1	7843916
the	O	-1	7843916
un@@	O	-1	7843916
treated	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es	O	-1	7843916
appe@@	O	-1	7843916
a@@	O	-1	7843916
red	O	-1	7843916
morph@@	O	-1	7843916
olog@@	O	-1	7843916
ically	O	-1	7843916
normal@@	O	-1	7843916
.	O	-1	7843916
In	O	-1	7843916
contrast@@	O	-1	7843916
,	O	-1	7843916
the	O	-1	7843916
de@@	B-Chemical	D003907	7843916
xameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
-treated	O	-1	7843916
hypertensive	B-Disease	D009798	7843916
e@@	I-Disease	-1	7843916
y@@	I-Disease	-1	7843916
es	I-Disease	-1	7843916
had	O	-1	7843916
th@@	O	-1	7843916
ic@@	O	-1	7843916
k@@	O	-1	7843916
en@@	O	-1	7843916
ed	O	-1	7843916
tra@@	O	-1	7843916
b@@	O	-1	7843916
ec@@	O	-1	7843916
ular	O	-1	7843916
be@@	O	-1	7843916
am@@	O	-1	7843916
s,	O	-1	7843916
decreased	O	-1	7843916
inter@@	O	-1	7843916
tra@@	O	-1	7843916
b@@	O	-1	7843916
ec@@	O	-1	7843916
ular	O	-1	7843916
sp@@	O	-1	7843916
ac@@	O	-1	7843916
es,	O	-1	7843916
th@@	O	-1	7843916
ic@@	O	-1	7843916
k@@	O	-1	7843916
en@@	O	-1	7843916
ed	O	-1	7843916
j@@	O	-1	7843916
u@@	O	-1	7843916
x@@	O	-1	7843916
tac@@	O	-1	7843916
an@@	O	-1	7843916
al@@	O	-1	7843916
ic@@	O	-1	7843916
ular	O	-1	7843916
tissu@@	O	-1	7843916
e,	O	-1	7843916
activ@@	O	-1	7843916
ated	O	-1	7843916
tra@@	O	-1	7843916
b@@	O	-1	7843916
ec@@	O	-1	7843916
ular	O	-1	7843916
m@@	O	-1	7843916
es@@	O	-1	7843916
h@@	O	-1	7843916
wor@@	O	-1	7843916
k	O	-1	7843916
cell@@	O	-1	7843916
s,	O	-1	7843916
and	O	-1	7843916
increased	O	-1	7843916
amoun@@	O	-1	7843916
ts	O	-1	7843916
of	O	-1	7843916
am@@	O	-1	7843916
or@@	O	-1	7843916
ph@@	O	-1	7843916
o@@	O	-1	7843916
gran@@	O	-1	7843916
ular	O	-1	7843916
extrac@@	O	-1	7843916
ell@@	O	-1	7843916
ular	O	-1	7843916
mat@@	O	-1	7843916
er@@	O	-1	7843916
i@@	O	-1	7843916
al,	O	-1	7843916
es@@	O	-1	7843916
p@@	O	-1	7843916
ec@@	O	-1	7843916
i@@	O	-1	7843916
ally	O	-1	7843916
in	O	-1	7843916
the	O	-1	7843916
j@@	O	-1	7843916
u@@	O	-1	7843916
x@@	O	-1	7843916
tac@@	O	-1	7843916
an@@	O	-1	7843916
al@@	O	-1	7843916
ic@@	O	-1	7843916
ular	O	-1	7843916
tissue	O	-1	7843916
and	O	-1	7843916
ben@@	O	-1	7843916
e@@	O	-1	7843916
ath	O	-1	7843916
the	O	-1	7843916
endothelial	O	-1	7843916
lin@@	O	-1	7843916
ing	O	-1	7843916
of	O	-1	7843916
the	O	-1	7843916
can@@	O	-1	7843916
al	O	-1	7843916
of	O	-1	7843916
S@@	O	-1	7843916
ch@@	O	-1	7843916
le@@	O	-1	7843916
mm@@	O	-1	7843916
.	O	-1	7843916
The	O	-1	7843916
de@@	B-Chemical	D003907	7843916
xameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
-treated	O	-1	7843916
non@@	O	-1	7843916
respon@@	O	-1	7843916
der	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es	O	-1	7843916
appe@@	O	-1	7843916
a@@	O	-1	7843916
red	O	-1	7843916
to	O	-1	7843916
be	O	-1	7843916
morph@@	O	-1	7843916
olog@@	O	-1	7843916
ically	O	-1	7843916
similar	O	-1	7843916
to	O	-1	7843916
the	O	-1	7843916
un@@	O	-1	7843916
treated	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es,	O	-1	7843916
although	O	-1	7843916
several	O	-1	7843916
sub@@	O	-1	7843916
t@@	O	-1	7843916
le	O	-1	7843916
de@@	B-Chemical	D003907	7843916
xameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
-induced	O	-1	7843916
morph@@	O	-1	7843916
ologic	O	-1	7843916
changes	O	-1	7843916
were	O	-1	7843916
ev@@	O	-1	7843916
id@@	O	-1	7843916
ent@@	O	-1	7843916
.	O	-1	7843916
CONCLUSION:	O	-1	7843916
D@@	B-Chemical	D003907	7843916
ex@@	I-Chemical	-1	7843916
ameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
treatment	O	-1	7843916
of	O	-1	7843916
isol@@	O	-1	7843916
at@@	O	-1	7843916
ed,	O	-1	7843916
per@@	O	-1	7843916
fu@@	O	-1	7843916
sion@@	O	-1	7843916
-@@	O	-1	7843916
c@@	O	-1	7843916
ult@@	O	-1	7843916
ured	O	-1	7843916
human	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es	O	-1	7843916
l@@	O	-1	7843916
ed	O	-1	7843916
to	O	-1	7843916
the	O	-1	7843916
generation	O	-1	7843916
of	O	-1	7843916
oc@@	B-Disease	D009798	7843916
ular	I-Disease	-1	7843916
hypertension	I-Disease	-1	7843916
in	O	-1	7843916
appro@@	O	-1	7843916
xim@@	O	-1	7843916
ately	O	-1	7843916
3@@	O	-1	7843916
0%	O	-1	7843916
of	O	-1	7843916
the	O	-1	7843916
de@@	B-Chemical	D003907	7843916
xameth@@	I-Chemical	-1	7843916
as@@	I-Chemical	-1	7843916
one	I-Chemical	-1	7843916
-treated	O	-1	7843916
e@@	O	-1	7843916
y@@	O	-1	7843916
es.	O	-1	7843916
S@@	B-Chemical	D013256	7843916
ter@@	I-Chemical	-1	7843916
oid	I-Chemical	-1	7843916
treatment	O	-1	7843916
resulted	O	-1	7843916
in	O	-1	7843916
morph@@	O	-1	7843916
ologic	O	-1	7843916
changes	O	-1	7843916
in	O	-1	7843916
the	O	-1	7843916
tra@@	O	-1	7843916
b@@	O	-1	7843916
ec@@	O	-1	7843916
ular	O	-1	7843916
m@@	O	-1	7843916
es@@	O	-1	7843916
h@@	O	-1	7843916
wor@@	O	-1	7843916
k	O	-1	7843916
similar	O	-1	7843916
to	O	-1	7843916
those	O	-1	7843916
reported	O	-1	7843916
for	O	-1	7843916
cortico@@	B-Disease	D005901	7843916
ster@@	I-Disease	-1	7843916
oid	I-Disease	-1	7843916
gl@@	I-Disease	-1	7843916
au@@	I-Disease	-1	7843916
com@@	I-Disease	-1	7843916
a	I-Disease	-1	7843916
and	O	-1	7843916
op@@	B-Disease	D005902	7843916
en	I-Disease	-1	7843916
ang@@	I-Disease	-1	7843916
le	I-Disease	-1	7843916
gl@@	I-Disease	-1	7843916
au@@	I-Disease	-1	7843916
com@@	I-Disease	-1	7843916
a	I-Disease	-1	7843916
.	O	-1	7843916
This	O	-1	7843916
system	O	-1	7843916
may	O	-1	7843916
prov@@	O	-1	7843916
ide	O	-1	7843916
an	O	-1	7843916
acute	O	-1	7843916
model	O	-1	7843916
in	O	-1	7843916
which	O	-1	7843916
to	O	-1	7843916
study	O	-1	7843916
the	O	-1	7843916
path@@	O	-1	7843916
o@@	O	-1	7843916
genic	O	-1	7843916
mechanisms	O	-1	7843916
involved	O	-1	7843916
in	O	-1	7843916
ster@@	B-Disease	D005901	7843916
oid	I-Disease	-1	7843916
gl@@	I-Disease	-1	7843916
au@@	I-Disease	-1	7843916
com@@	I-Disease	-1	7843916
a	I-Disease	-1	7843916
and	O	-1	7843916
prim@@	B-Disease	D005902	7843916
ary	I-Disease	-1	7843916
op@@	I-Disease	-1	7843916
en	I-Disease	-1	7843916
ang@@	I-Disease	-1	7843916
le	I-Disease	-1	7843916
gl@@	I-Disease	-1	7843916
au@@	I-Disease	-1	7843916
com@@	I-Disease	-1	7843916
a	I-Disease	-1	7843916
.	O	-1	7843916

C@@	B-Disease	D003072	7803371
o@@	I-Disease	-1	7803371
gn@@	I-Disease	-1	7803371
itive	I-Disease	-1	7803371
deter@@	I-Disease	-1	7803371
i@@	I-Disease	-1	7803371
or@@	I-Disease	-1	7803371
ation	I-Disease	-1	7803371
from	O	-1	7803371
long-term	O	-1	7803371
ab@@	O	-1	7803371
use	O	-1	7803371
of	O	-1	7803371
de@@	B-Chemical	D003915	7803371
x@@	I-Chemical	-1	7803371
tro@@	I-Chemical	-1	7803371
meth@@	I-Chemical	-1	7803371
or@@	I-Chemical	-1	7803371
ph@@	I-Chemical	-1	7803371
an	I-Chemical	-1	7803371
:	O	-1	7803371
a	O	-1	7803371
case	O	-1	7803371
repor@@	O	-1	7803371
t.	O	-1	7803371
D@@	B-Chemical	D003915	7803371
ext@@	I-Chemical	-1	7803371
ro@@	I-Chemical	-1	7803371
meth@@	I-Chemical	-1	7803371
or@@	I-Chemical	-1	7803371
ph@@	I-Chemical	-1	7803371
an	I-Chemical	-1	7803371
(	O	-1	7803371
D@@	B-Chemical	D003915	7803371
M	I-Chemical	-1	7803371
),	O	-1	7803371
the	O	-1	7803371
de@@	O	-1	7803371
x@@	O	-1	7803371
tro@@	O	-1	7803371
ro@@	O	-1	7803371
t@@	O	-1	7803371
atory	O	-1	7803371
is@@	O	-1	7803371
om@@	O	-1	7803371
er	O	-1	7803371
of	O	-1	7803371
3-@@	B-Chemical	D007981	7803371
hydrox@@	I-Chemical	-1	7803371
y-@@	I-Chemical	-1	7803371
N@@	I-Chemical	-1	7803371
-@@	I-Chemical	-1	7803371
methyl@@	I-Chemical	-1	7803371
morph@@	I-Chemical	-1	7803371
in@@	I-Chemical	-1	7803371
an	I-Chemical	-1	7803371
,	O	-1	7803371
is	O	-1	7803371
the	O	-1	7803371
ma@@	O	-1	7803371
in	O	-1	7803371
ing@@	O	-1	7803371
re@@	O	-1	7803371
di@@	O	-1	7803371
ent	O	-1	7803371
in	O	-1	7803371
a	O	-1	7803371
number	O	-1	7803371
of	O	-1	7803371
wi@@	O	-1	7803371
de@@	O	-1	7803371
ly	O	-1	7803371
av@@	O	-1	7803371
ail@@	O	-1	7803371
able@@	O	-1	7803371
,	O	-1	7803371
over@@	O	-1	7803371
-@@	O	-1	7803371
the@@	O	-1	7803371
-@@	O	-1	7803371
coun@@	O	-1	7803371
ter	O	-1	7803371
anti@@	O	-1	7803371
t@@	O	-1	7803371
us@@	O	-1	7803371
si@@	O	-1	7803371
v@@	O	-1	7803371
es.	O	-1	7803371
In@@	O	-1	7803371
iti@@	O	-1	7803371
al	O	-1	7803371
studies	O	-1	7803371
(B@@	O	-1	7803371
or@@	O	-1	7803371
n@@	O	-1	7803371
ste@@	O	-1	7803371
in	O	-1	7803371
19@@	O	-1	7803371
6@@	O	-1	7803371
8@@	O	-1	7803371
)	O	-1	7803371
showed	O	-1	7803371
that	O	-1	7803371
it	O	-1	7803371
pos@@	O	-1	7803371
s@@	O	-1	7803371
ess@@	O	-1	7803371
ed	O	-1	7803371
no	O	-1	7803371
respiratory	O	-1	7803371
sup@@	O	-1	7803371
press@@	O	-1	7803371
ant	O	-1	7803371
effects	O	-1	7803371
and	O	-1	7803371
no	O	-1	7803371
ad@@	O	-1	7803371
dic@@	O	-1	7803371
tion	O	-1	7803371
li@@	O	-1	7803371
abil@@	O	-1	7803371
ity.	O	-1	7803371
S@@	O	-1	7803371
ub@@	O	-1	7803371
sequ@@	O	-1	7803371
ent@@	O	-1	7803371
ly,	O	-1	7803371
however,	O	-1	7803371
several	O	-1	7803371
ar@@	O	-1	7803371
tic@@	O	-1	7803371
le@@	O	-1	7803371
s	O	-1	7803371
repor@@	O	-1	7803371
ting	O	-1	7803371
ab@@	O	-1	7803371
use	O	-1	7803371
of	O	-1	7803371
this	O	-1	7803371
drug	O	-1	7803371
have	O	-1	7803371
appe@@	O	-1	7803371
a@@	O	-1	7803371
red	O	-1	7803371
in	O	-1	7803371
the	O	-1	7803371
literat@@	O	-1	7803371
ure.	O	-1	7803371
The	O	-1	7803371
drug	O	-1	7803371
is	O	-1	7803371
known	O	-1	7803371
to	O	-1	7803371
cause	O	-1	7803371
a	O	-1	7803371
vari@@	O	-1	7803371
ety	O	-1	7803371
of	O	-1	7803371
acute	O	-1	7803371
toxic	O	-1	7803371
effect@@	O	-1	7803371
s,	O	-1	7803371
rang@@	O	-1	7803371
ing	O	-1	7803371
from	O	-1	7803371
nausea	B-Disease	D009325	7803371
,	O	-1	7803371
rest@@	B-Disease	D011595	7803371
l@@	I-Disease	-1	7803371
ess@@	I-Disease	-1	7803371
ness	I-Disease	-1	7803371
,	O	-1	7803371
in@@	B-Disease	D007319	7803371
s@@	I-Disease	-1	7803371
om@@	I-Disease	-1	7803371
n@@	I-Disease	-1	7803371
ia	I-Disease	-1	7803371
,	O	-1	7803371
at@@	B-Disease	D001259	7803371
ax@@	I-Disease	-1	7803371
ia	I-Disease	-1	7803371
,	O	-1	7803371
s@@	O	-1	7803371
lur@@	O	-1	7803371
red	O	-1	7803371
sp@@	O	-1	7803371
e@@	O	-1	7803371
ec@@	O	-1	7803371
h	O	-1	7803371
and	O	-1	7803371
n@@	B-Disease	C564088	7803371
y@@	I-Disease	-1	7803371
st@@	I-Disease	-1	7803371
ag@@	I-Disease	-1	7803371
m@@	I-Disease	-1	7803371
us	I-Disease	-1	7803371
to	O	-1	7803371
mo@@	O	-1	7803371
od	O	-1	7803371
chang@@	O	-1	7803371
es,	O	-1	7803371
per@@	O	-1	7803371
ce@@	O	-1	7803371
pt@@	O	-1	7803371
ual	O	-1	7803371
al@@	O	-1	7803371
ter@@	O	-1	7803371
ation@@	O	-1	7803371
s,	O	-1	7803371
in@@	O	-1	7803371
atten@@	O	-1	7803371
tion,	O	-1	7803371
disor@@	O	-1	7803371
i@@	O	-1	7803371
ent@@	O	-1	7803371
ation	O	-1	7803371
and	O	-1	7803371
ag@@	B-Disease	D001523	7803371
gres@@	I-Disease	-1	7803371
sive	I-Disease	-1	7803371
behavi@@	I-Disease	-1	7803371
or	I-Disease	-1	7803371
(@@	O	-1	7803371
R@@	O	-1	7803371
am@@	O	-1	7803371
m@@	O	-1	7803371
er	O	-1	7803371
et	O	-1	7803371
al	O	-1	7803371
19@@	O	-1	7803371
8@@	O	-1	7803371
8@@	O	-1	7803371
;	O	-1	7803371
K@@	O	-1	7803371
at@@	O	-1	7803371
on@@	O	-1	7803371
a	O	-1	7803371
and	O	-1	7803371
W@@	O	-1	7803371
at@@	O	-1	7803371
s@@	O	-1	7803371
on	O	-1	7803371
19@@	O	-1	7803371
8@@	O	-1	7803371
6@@	O	-1	7803371
;	O	-1	7803371
I@@	O	-1	7803371
s@@	O	-1	7803371
be@@	O	-1	7803371
ll	O	-1	7803371
and	O	-1	7803371
F@@	O	-1	7803371
r@@	O	-1	7803371
as@@	O	-1	7803371
er	O	-1	7803371
19@@	O	-1	7803371
5@@	O	-1	7803371
3@@	O	-1	7803371
;	O	-1	7803371
D@@	O	-1	7803371
ev@@	O	-1	7803371
l@@	O	-1	7803371
in	O	-1	7803371
et	O	-1	7803371
al	O	-1	7803371
19@@	O	-1	7803371
8@@	O	-1	7803371
5@@	O	-1	7803371
;	O	-1	7803371
M@@	O	-1	7803371
c@@	O	-1	7803371
C@@	O	-1	7803371
arth@@	O	-1	7803371
y	O	-1	7803371
19@@	O	-1	7803371
7@@	O	-1	7803371
1@@	O	-1	7803371
;	O	-1	7803371
D@@	O	-1	7803371
o@@	O	-1	7803371
d@@	O	-1	7803371
ds	O	-1	7803371
and	O	-1	7803371
R@@	O	-1	7803371
ev@@	O	-1	7803371
a@@	O	-1	7803371
i	O	-1	7803371
19@@	O	-1	7803371
6@@	O	-1	7803371
7@@	O	-1	7803371
;	O	-1	7803371
De@@	O	-1	7803371
g@@	O	-1	7803371
k@@	O	-1	7803371
wit@@	O	-1	7803371
z	O	-1	7803371
19@@	O	-1	7803371
6@@	O	-1	7803371
4@@	O	-1	7803371
;	O	-1	7803371
H@@	O	-1	7803371
il@@	O	-1	7803371
de@@	O	-1	7803371
b@@	O	-1	7803371
r@@	O	-1	7803371
and	O	-1	7803371
et	O	-1	7803371
al	O	-1	7803371
19@@	O	-1	7803371
8@@	O	-1	7803371
9@@	O	-1	7803371
).	O	-1	7803371
There	O	-1	7803371
have	O	-1	7803371
also	O	-1	7803371
been	O	-1	7803371
two	O	-1	7803371
reported	O	-1	7803371
f@@	O	-1	7803371
at@@	O	-1	7803371
al@@	O	-1	7803371
ities	O	-1	7803371
from	O	-1	7803371
D@@	B-Chemical	D003915	7803371
M	I-Chemical	-1	7803371
over@@	O	-1	7803371
doses	O	-1	7803371
(@@	O	-1	7803371
F@@	O	-1	7803371
le@@	O	-1	7803371
m@@	O	-1	7803371
ing	O	-1	7803371
19@@	O	-1	7803371
8@@	O	-1	7803371
6@@	O	-1	7803371
).	O	-1	7803371
However,	O	-1	7803371
there	O	-1	7803371
are	O	-1	7803371
no	O	-1	7803371
reports	O	-1	7803371
descri@@	O	-1	7803371
b@@	O	-1	7803371
ing	O	-1	7803371
the	O	-1	7803371
effects	O	-1	7803371
of	O	-1	7803371
chronic	O	-1	7803371
ab@@	O	-1	7803371
use.	O	-1	7803371
This	O	-1	7803371
report	O	-1	7803371
descri@@	O	-1	7803371
b@@	O	-1	7803371
es	O	-1	7803371
a	O	-1	7803371
case	O	-1	7803371
of	O	-1	7803371
cognitive	B-Disease	D003072	7803371
deter@@	I-Disease	-1	7803371
i@@	I-Disease	-1	7803371
or@@	I-Disease	-1	7803371
ation	I-Disease	-1	7803371
result@@	O	-1	7803371
ing	O	-1	7803371
from	O	-1	7803371
prolonged	O	-1	7803371
use	O	-1	7803371
of	O	-1	7803371
D@@	B-Chemical	D003915	7803371
M	I-Chemical	-1	7803371
.	O	-1	7803371

L@@	O	-1	7437994
on@@	O	-1	7437994
g@@	O	-1	7437994
-term	O	-1	7437994
lithium	B-Chemical	D008094	7437994
treatment	O	-1	7437994
and	O	-1	7437994
the	O	-1	7437994
kidne@@	O	-1	7437994
y.	O	-1	7437994
In@@	O	-1	7437994
ter@@	O	-1	7437994
im	O	-1	7437994
report	O	-1	7437994
on	O	-1	7437994
f@@	O	-1	7437994
if@@	O	-1	7437994
t@@	O	-1	7437994
y	O	-1	7437994
patients.	O	-1	7437994
This	O	-1	7437994
is	O	-1	7437994
a	O	-1	7437994
report	O	-1	7437994
on	O	-1	7437994
the	O	-1	7437994
first	O	-1	7437994
par@@	O	-1	7437994
t	O	-1	7437994
of	O	-1	7437994
our	O	-1	7437994
study	O	-1	7437994
of	O	-1	7437994
the	O	-1	7437994
effects	O	-1	7437994
of	O	-1	7437994
long-term	O	-1	7437994
lithium	B-Chemical	D008094	7437994
treatment	O	-1	7437994
on	O	-1	7437994
the	O	-1	7437994
kidne@@	O	-1	7437994
y.	O	-1	7437994
C@@	B-Chemical	D003404	7437994
reat@@	I-Chemical	-1	7437994
inine	I-Chemical	-1	7437994
clear@@	O	-1	7437994
ance@@	O	-1	7437994
,	O	-1	7437994
maxim@@	O	-1	7437994
um	O	-1	7437994
urinary	O	-1	7437994
os@@	O	-1	7437994
mol@@	O	-1	7437994
ality	O	-1	7437994
and	O	-1	7437994
24	O	-1	7437994
h@@	O	-1	7437994
our	O	-1	7437994
urine	O	-1	7437994
volume	O	-1	7437994
have	O	-1	7437994
been	O	-1	7437994
tested	O	-1	7437994
in	O	-1	7437994
50	O	-1	7437994
aff@@	O	-1	7437994
ectively	O	-1	7437994
il@@	O	-1	7437994
l	O	-1	7437994
patients	O	-1	7437994
who	O	-1	7437994
have	O	-1	7437994
been	O	-1	7437994
on	O	-1	7437994
long-term	O	-1	7437994
lithium	B-Chemical	D008094	7437994
for	O	-1	7437994
more	O	-1	7437994
than	O	-1	7437994
one	O	-1	7437994
year@@	O	-1	7437994
.	O	-1	7437994
These	O	-1	7437994
findings	O	-1	7437994
have	O	-1	7437994
been	O	-1	7437994
compared	O	-1	7437994
with	O	-1	7437994
norm@@	O	-1	7437994
s	O	-1	7437994
and	O	-1	7437994
with	O	-1	7437994
values	O	-1	7437994
of	O	-1	7437994
the	O	-1	7437994
same	O	-1	7437994
tests	O	-1	7437994
from	O	-1	7437994
s@@	O	-1	7437994
cre@@	O	-1	7437994
en@@	O	-1	7437994
ing	O	-1	7437994
prior	O	-1	7437994
to	O	-1	7437994
lithium	B-Chemical	D008094	7437994
,	O	-1	7437994
av@@	O	-1	7437994
ail@@	O	-1	7437994
able	O	-1	7437994
for	O	-1	7437994
most	O	-1	7437994
of	O	-1	7437994
our	O	-1	7437994
patients.	O	-1	7437994
No	O	-1	7437994
evidence	O	-1	7437994
was	O	-1	7437994
found	O	-1	7437994
for	O	-1	7437994
any	O	-1	7437994
reduction	O	-1	7437994
of	O	-1	7437994
glomerular	O	-1	7437994
f@@	O	-1	7437994
iltration	O	-1	7437994
during	O	-1	7437994
lithium	B-Chemical	D008094	7437994
treatment.	O	-1	7437994
L@@	O	-1	7437994
o@@	O	-1	7437994
w	O	-1	7437994
clear@@	O	-1	7437994
ance	O	-1	7437994
values	O	-1	7437994
found	O	-1	7437994
in	O	-1	7437994
several	O	-1	7437994
patients	O	-1	7437994
could	O	-1	7437994
be	O	-1	7437994
ac@@	O	-1	7437994
coun@@	O	-1	7437994
ted	O	-1	7437994
for	O	-1	7437994
by	O	-1	7437994
their	O	-1	7437994
age	O	-1	7437994
and	O	-1	7437994
their	O	-1	7437994
pre@@	O	-1	7437994
-	O	-1	7437994
lithium	B-Chemical	D008094	7437994
valu@@	O	-1	7437994
es.	O	-1	7437994
U@@	O	-1	7437994
r@@	O	-1	7437994
inary	O	-1	7437994
concentration	O	-1	7437994
def@@	O	-1	7437994
ect	O	-1	7437994
appe@@	O	-1	7437994
a@@	O	-1	7437994
red	O	-1	7437994
frequent	O	-1	7437994
but	O	-1	7437994
the	O	-1	7437994
ext@@	O	-1	7437994
ent	O	-1	7437994
of	O	-1	7437994
the	O	-1	7437994
impair@@	O	-1	7437994
ment	O	-1	7437994
is	O	-1	7437994
diff@@	O	-1	7437994
ic@@	O	-1	7437994
ult	O	-1	7437994
to	O	-1	7437994
ass@@	O	-1	7437994
ess	O	-1	7437994
because	O	-1	7437994
of	O	-1	7437994
the	O	-1	7437994
unc@@	O	-1	7437994
er@@	O	-1	7437994
t@@	O	-1	7437994
a@@	O	-1	7437994
int@@	O	-1	7437994
y	O	-1	7437994
about	O	-1	7437994
the	O	-1	7437994
norm@@	O	-1	7437994
s	O	-1	7437994
ap@@	O	-1	7437994
plic@@	O	-1	7437994
able	O	-1	7437994
to	O	-1	7437994
this	O	-1	7437994
group	O	-1	7437994
of	O	-1	7437994
patients.	O	-1	7437994
The	O	-1	7437994
concentration	O	-1	7437994
def@@	O	-1	7437994
ect	O	-1	7437994
appe@@	O	-1	7437994
a@@	O	-1	7437994
red	O	-1	7437994
rever@@	O	-1	7437994
sib@@	O	-1	7437994
le@@	O	-1	7437994
,	O	-1	7437994
at	O	-1	7437994
le@@	O	-1	7437994
ast	O	-1	7437994
in	O	-1	7437994
part@@	O	-1	7437994
.	O	-1	7437994
P@@	B-Disease	D011141	7437994
oly@@	I-Disease	-1	7437994
uria	I-Disease	-1	7437994
ab@@	O	-1	7437994
o@@	O	-1	7437994
ve	O	-1	7437994
3	O	-1	7437994
lit@@	O	-1	7437994
res@@	O	-1	7437994
/@@	O	-1	7437994
24	O	-1	7437994
hours	O	-1	7437994
was	O	-1	7437994
found	O	-1	7437994
in	O	-1	7437994
10@@	O	-1	7437994
%	O	-1	7437994
of	O	-1	7437994
patients.	O	-1	7437994
An	O	-1	7437994
at@@	O	-1	7437994
tem@@	O	-1	7437994
p@@	O	-1	7437994
t	O	-1	7437994
is	O	-1	7437994
m@@	O	-1	7437994
ade	O	-1	7437994
to	O	-1	7437994
dra@@	O	-1	7437994
w	O	-1	7437994
p@@	O	-1	7437994
rac@@	O	-1	7437994
tical	O	-1	7437994
concl@@	O	-1	7437994
u@@	O	-1	7437994
sions	O	-1	7437994
from	O	-1	7437994
the	O	-1	7437994
pre@@	O	-1	7437994
lim@@	O	-1	7437994
inary	O	-1	7437994
find@@	O	-1	7437994
ing@@	O	-1	7437994
s.	O	-1	7437994

Com@@	O	-1	6496797
ple@@	O	-1	6496797
te	O	-1	6496797
heart	B-Disease	D006327	6496797
bloc@@	I-Disease	-1	6496797
k	I-Disease	-1	6496797
following	O	-1	6496797
a	O	-1	6496797
single	O	-1	6496797
dose	O	-1	6496797
of	O	-1	6496797
tra@@	B-Chemical	D014196	6496797
z@@	I-Chemical	-1	6496797
o@@	I-Chemical	-1	6496797
d@@	I-Chemical	-1	6496797
one	I-Chemical	-1	6496797
.	O	-1	6496797
F@@	O	-1	6496797
ort@@	O	-1	6496797
y	O	-1	6496797
minutes	O	-1	6496797
after	O	-1	6496797
receiving	O	-1	6496797
a	O	-1	6496797
single	O	-1	6496797
star@@	O	-1	6496797
ting	O	-1	6496797
dose	O	-1	6496797
of	O	-1	6496797
tra@@	B-Chemical	D014196	6496797
z@@	I-Chemical	-1	6496797
o@@	I-Chemical	-1	6496797
d@@	I-Chemical	-1	6496797
one	I-Chemical	-1	6496797
,	O	-1	6496797
a	O	-1	6496797
patient	O	-1	6496797
developed	O	-1	6496797
complete	O	-1	6496797
heart	B-Disease	D006327	6496797
bloc@@	I-Disease	-1	6496797
k	I-Disease	-1	6496797
.	O	-1	6496797
The	O	-1	6496797
case	O	-1	6496797
il@@	O	-1	6496797
lu@@	O	-1	6496797
strat@@	O	-1	6496797
es	O	-1	6496797
th@@	O	-1	6496797
at@@	O	-1	6496797
,	O	-1	6496797
des@@	O	-1	6496797
pit@@	O	-1	6496797
e	O	-1	6496797
the	O	-1	6496797
results	O	-1	6496797
of	O	-1	6496797
ear@@	O	-1	6496797
li@@	O	-1	6496797
er	O	-1	6496797
studi@@	O	-1	6496797
es,	O	-1	6496797
tra@@	B-Chemical	D014196	6496797
z@@	I-Chemical	-1	6496797
o@@	I-Chemical	-1	6496797
d@@	I-Chemical	-1	6496797
one	I-Chemical	-1	6496797
's	O	-1	6496797
effect	O	-1	6496797
on	O	-1	6496797
cardiac	O	-1	6496797
con@@	O	-1	6496797
duction	O	-1	6496797
may	O	-1	6496797
be	O	-1	6496797
severe	O	-1	6496797
in	O	-1	6496797
individ@@	O	-1	6496797
u@@	O	-1	6496797
als	O	-1	6496797
at	O	-1	6496797
risk	O	-1	6496797
for	O	-1	6496797
con@@	O	-1	6496797
duction	O	-1	6496797
del@@	O	-1	6496797
a@@	O	-1	6496797
y.	O	-1	6496797

Q@@	B-Chemical	C033457	3411101
u@@	I-Chemical	-1	3411101
in@@	I-Chemical	-1	3411101
idine	I-Chemical	-1	3411101
pheny@@	I-Chemical	-1	3411101
le@@	I-Chemical	-1	3411101
th@@	I-Chemical	-1	3411101
yl@@	I-Chemical	-1	3411101
b@@	I-Chemical	-1	3411101
arbit@@	I-Chemical	-1	3411101
ur@@	I-Chemical	-1	3411101
ate	I-Chemical	-1	3411101
-induced	O	-1	3411101
ful@@	O	-1	3411101
min@@	O	-1	3411101
ant	O	-1	3411101
hepatitis	B-Disease	D056486	3411101
in	O	-1	3411101
a	O	-1	3411101
pregn@@	O	-1	3411101
ant	O	-1	3411101
wom@@	O	-1	3411101
an@@	O	-1	3411101
.	O	-1	3411101
A	O	-1	3411101
case	O	-1	3411101
repor@@	O	-1	3411101
t.	O	-1	3411101
We	O	-1	3411101
report	O	-1	3411101
the	O	-1	3411101
case	O	-1	3411101
of	O	-1	3411101
a	O	-1	3411101
19@@	O	-1	3411101
-@@	O	-1	3411101
year-old	O	-1	3411101
L@@	O	-1	3411101
a@@	O	-1	3411101
o@@	O	-1	3411101
ti@@	O	-1	3411101
an	O	-1	3411101
patient	O	-1	3411101
affected	O	-1	3411101
by	O	-1	3411101
ful@@	O	-1	3411101
min@@	O	-1	3411101
ant	O	-1	3411101
hepatitis	B-Disease	D056486	3411101
during	O	-1	3411101
the	O	-1	3411101
thir@@	O	-1	3411101
d	O	-1	3411101
tri@@	O	-1	3411101
me@@	O	-1	3411101
st@@	O	-1	3411101
er	O	-1	3411101
of	O	-1	3411101
h@@	O	-1	3411101
er	O	-1	3411101
pregn@@	O	-1	3411101
anc@@	O	-1	3411101
y	O	-1	3411101
after	O	-1	3411101
a	O	-1	3411101
1-@@	O	-1	3411101
mon@@	O	-1	3411101
th	O	-1	3411101
administration	O	-1	3411101
of	O	-1	3411101
qu@@	B-Chemical	C033457	3411101
in@@	I-Chemical	-1	3411101
idine	I-Chemical	-1	3411101
pheny@@	I-Chemical	-1	3411101
le@@	I-Chemical	-1	3411101
th@@	I-Chemical	-1	3411101
yl@@	I-Chemical	-1	3411101
b@@	I-Chemical	-1	3411101
arbit@@	I-Chemical	-1	3411101
ur@@	I-Chemical	-1	3411101
ate	I-Chemical	-1	3411101
.	O	-1	3411101
After	O	-1	3411101
de@@	O	-1	3411101
li@@	O	-1	3411101
ver@@	O	-1	3411101
y,	O	-1	3411101
the	O	-1	3411101
patient	O	-1	3411101
under@@	O	-1	3411101
w@@	O	-1	3411101
ent	O	-1	3411101
or@@	O	-1	3411101
th@@	O	-1	3411101
ot@@	O	-1	3411101
op@@	O	-1	3411101
ic	O	-1	3411101
liver	O	-1	3411101
transplant@@	O	-1	3411101
ation.	O	-1	3411101
The	O	-1	3411101
patient	O	-1	3411101
was	O	-1	3411101
in	O	-1	3411101
go@@	O	-1	3411101
od	O	-1	3411101
condi@@	O	-1	3411101
tion	O	-1	3411101
16	O	-1	3411101
months	O	-1	3411101
after	O	-1	3411101
liver	O	-1	3411101
transplant@@	O	-1	3411101
ation.	O	-1	3411101
Q@@	B-Chemical	D011802	3411101
u@@	I-Chemical	-1	3411101
in@@	I-Chemical	-1	3411101
idine	I-Chemical	-1	3411101
it@@	O	-1	3411101
sel@@	O	-1	3411101
f	O	-1	3411101
or	O	-1	3411101
pheny@@	B-Chemical	C033457	3411101
le@@	I-Chemical	-1	3411101
th@@	I-Chemical	-1	3411101
yl@@	I-Chemical	-1	3411101
b@@	I-Chemical	-1	3411101
arbit@@	I-Chemical	-1	3411101
ur@@	I-Chemical	-1	3411101
ate	I-Chemical	-1	3411101
may	O	-1	3411101
be	O	-1	3411101
respon@@	O	-1	3411101
sible	O	-1	3411101
for	O	-1	3411101
ful@@	O	-1	3411101
min@@	O	-1	3411101
ant	O	-1	3411101
hepatitis	B-Disease	D056486	3411101
in	O	-1	3411101
this	O	-1	3411101
patient@@	O	-1	3411101
.	O	-1	3411101

The	O	-1	2598570
epi@@	O	-1	2598570
de@@	O	-1	2598570
m@@	O	-1	2598570
io@@	O	-1	2598570
log@@	O	-1	2598570
y	O	-1	2598570
of	O	-1	2598570
the	O	-1	2598570
acute	O	-1	2598570
f@@	B-Disease	D021501	2598570
l@@	I-Disease	-1	2598570
an@@	I-Disease	-1	2598570
k	I-Disease	-1	2598570
pain	I-Disease	-1	2598570
syndrome	O	-1	2598570
from	O	-1	2598570
su@@	B-Chemical	D013496	2598570
prof@@	I-Chemical	-1	2598570
en	I-Chemical	-1	2598570
.	O	-1	2598570
S@@	B-Chemical	D013496	2598570
u@@	I-Chemical	-1	2598570
prof@@	I-Chemical	-1	2598570
en	I-Chemical	-1	2598570
,	O	-1	2598570
a	O	-1	2598570
new	O	-1	2598570
non@@	O	-1	2598570
steroid@@	O	-1	2598570
al	O	-1	2598570
anti@@	O	-1	2598570
-@@	O	-1	2598570
inflam@@	O	-1	2598570
mat@@	O	-1	2598570
ory	O	-1	2598570
drug@@	O	-1	2598570
,	O	-1	2598570
was	O	-1	2598570
mark@@	O	-1	2598570
et@@	O	-1	2598570
ed	O	-1	2598570
in	O	-1	2598570
early	O	-1	2598570
19@@	O	-1	2598570
8@@	O	-1	2598570
6	O	-1	2598570
as	O	-1	2598570
an	O	-1	2598570
analge@@	O	-1	2598570
sic	O	-1	2598570
agent@@	O	-1	2598570
.	O	-1	2598570
U@@	O	-1	2598570
n@@	O	-1	2598570
ti@@	O	-1	2598570
l	O	-1	2598570
physi@@	O	-1	2598570
ci@@	O	-1	2598570
ans	O	-1	2598570
be@@	O	-1	2598570
g@@	O	-1	2598570
an	O	-1	2598570
repor@@	O	-1	2598570
ting	O	-1	2598570
an	O	-1	2598570
un@@	O	-1	2598570
us@@	O	-1	2598570
ual	O	-1	2598570
acute	O	-1	2598570
f@@	B-Disease	D021501	2598570
l@@	I-Disease	-1	2598570
an@@	I-Disease	-1	2598570
k	I-Disease	-1	2598570
pain	I-Disease	-1	2598570
syndrome	O	-1	2598570
to	O	-1	2598570
the	O	-1	2598570
spont@@	O	-1	2598570
aneous	O	-1	2598570
repor@@	O	-1	2598570
ting	O	-1	2598570
system@@	O	-1	2598570
,	O	-1	2598570
7@@	O	-1	2598570
0@@	O	-1	2598570
0@@	O	-1	2598570
,@@	O	-1	2598570
0@@	O	-1	2598570
00	O	-1	2598570
per@@	O	-1	2598570
son@@	O	-1	2598570
s	O	-1	2598570
used	O	-1	2598570
the	O	-1	2598570
drug	O	-1	2598570
in	O	-1	2598570
the	O	-1	2598570
U@@	O	-1	2598570
nit@@	O	-1	2598570
ed	O	-1	2598570
S@@	O	-1	2598570
t@@	O	-1	2598570
at@@	O	-1	2598570
es.	O	-1	2598570
Th@@	O	-1	2598570
rou@@	O	-1	2598570
gh	O	-1	2598570
A@@	O	-1	2598570
u@@	O	-1	2598570
g@@	O	-1	2598570
us@@	O	-1	2598570
t	O	-1	2598570
19@@	O	-1	2598570
8@@	O	-1	2598570
6,	O	-1	2598570
a	O	-1	2598570
total	O	-1	2598570
of	O	-1	2598570
1@@	O	-1	2598570
6@@	O	-1	2598570
3	O	-1	2598570
cases	O	-1	2598570
of	O	-1	2598570
this	O	-1	2598570
syndrome	O	-1	2598570
were	O	-1	2598570
repor@@	O	-1	2598570
ted.	O	-1	2598570
To	O	-1	2598570
el@@	O	-1	2598570
uc@@	O	-1	2598570
id@@	O	-1	2598570
ate	O	-1	2598570
the	O	-1	2598570
epi@@	O	-1	2598570
de@@	O	-1	2598570
m@@	O	-1	2598570
io@@	O	-1	2598570
log@@	O	-1	2598570
y	O	-1	2598570
of	O	-1	2598570
the	O	-1	2598570
syndro@@	O	-1	2598570
me,	O	-1	2598570
a	O	-1	2598570
cas@@	O	-1	2598570
e-@@	O	-1	2598570
control	O	-1	2598570
study	O	-1	2598570
was	O	-1	2598570
per@@	O	-1	2598570
for@@	O	-1	2598570
me@@	O	-1	2598570
d,	O	-1	2598570
compar@@	O	-1	2598570
ing	O	-1	2598570
6@@	O	-1	2598570
2	O	-1	2598570
of	O	-1	2598570
the	O	-1	2598570
case	O	-1	2598570
patients	O	-1	2598570
who	O	-1	2598570
had	O	-1	2598570
been	O	-1	2598570
reported	O	-1	2598570
to	O	-1	2598570
the	O	-1	2598570
spont@@	O	-1	2598570
aneous	O	-1	2598570
repor@@	O	-1	2598570
ting	O	-1	2598570
system	O	-1	2598570
to	O	-1	2598570
18@@	O	-1	2598570
5	O	-1	2598570
su@@	B-Chemical	D013496	2598570
prof@@	I-Chemical	-1	2598570
en	I-Chemical	-1	2598570
-@@	O	-1	2598570
exposed	O	-1	2598570
control	O	-1	2598570
subjects	O	-1	2598570
who	O	-1	2598570
did	O	-1	2598570
not	O	-1	2598570
have	O	-1	2598570
the	O	-1	2598570
syndro@@	O	-1	2598570
me.	O	-1	2598570
C@@	O	-1	2598570
ase	O	-1	2598570
patients	O	-1	2598570
were	O	-1	2598570
more	O	-1	2598570
likely	O	-1	2598570
to	O	-1	2598570
be	O	-1	2598570
men	O	-1	2598570
(@@	O	-1	2598570
o@@	O	-1	2598570
d@@	O	-1	2598570
ds	O	-1	2598570
rati@@	O	-1	2598570
o@@	O	-1	2598570
,	O	-1	2598570
3.@@	O	-1	2598570
8@@	O	-1	2598570
;	O	-1	2598570
95%	O	-1	2598570
conf@@	O	-1	2598570
idence	O	-1	2598570
inter@@	O	-1	2598570
val@@	O	-1	2598570
,	O	-1	2598570
1.@@	O	-1	2598570
2-@@	O	-1	2598570
1@@	O	-1	2598570
2.@@	O	-1	2598570
1),	O	-1	2598570
suff@@	O	-1	2598570
er	O	-1	2598570
from	O	-1	2598570
ha@@	B-Disease	D006255	2598570
y	I-Disease	-1	2598570
f@@	I-Disease	-1	2598570
ev@@	I-Disease	-1	2598570
er	I-Disease	-1	2598570
and	O	-1	2598570
as@@	B-Disease	D001249	2598570
th@@	I-Disease	-1	2598570
ma	I-Disease	-1	2598570
(@@	O	-1	2598570
o@@	O	-1	2598570
d@@	O	-1	2598570
ds	O	-1	2598570
rati@@	O	-1	2598570
o@@	O	-1	2598570
,	O	-1	2598570
3.@@	O	-1	2598570
4@@	O	-1	2598570
;	O	-1	2598570
95%	O	-1	2598570
conf@@	O	-1	2598570
idence	O	-1	2598570
inter@@	O	-1	2598570
val@@	O	-1	2598570
,	O	-1	2598570
1.@@	O	-1	2598570
0@@	O	-1	2598570
-1@@	O	-1	2598570
1.@@	O	-1	2598570
9@@	O	-1	2598570
);	O	-1	2598570
to	O	-1	2598570
partic@@	O	-1	2598570
ip@@	O	-1	2598570
ate	O	-1	2598570
in	O	-1	2598570
reg@@	O	-1	2598570
ular	O	-1	2598570
ex@@	O	-1	2598570
er@@	O	-1	2598570
cis@@	O	-1	2598570
e	O	-1	2598570
(@@	O	-1	2598570
o@@	O	-1	2598570
d@@	O	-1	2598570
ds	O	-1	2598570
rati@@	O	-1	2598570
o@@	O	-1	2598570
,	O	-1	2598570
5.@@	O	-1	2598570
9@@	O	-1	2598570
;	O	-1	2598570
95%	O	-1	2598570
conf@@	O	-1	2598570
idence	O	-1	2598570
inter@@	O	-1	2598570
val@@	O	-1	2598570
,	O	-1	2598570
1.@@	O	-1	2598570
1-@@	O	-1	2598570
3@@	O	-1	2598570
0.@@	O	-1	2598570
7@@	O	-1	2598570
),	O	-1	2598570
es@@	O	-1	2598570
p@@	O	-1	2598570
ec@@	O	-1	2598570
i@@	O	-1	2598570
ally	O	-1	2598570
in	O	-1	2598570
the	O	-1	2598570
use	O	-1	2598570
of	O	-1	2598570
Na@@	O	-1	2598570
u@@	O	-1	2598570
til@@	O	-1	2598570
us	O	-1	2598570
equ@@	O	-1	2598570
ip@@	O	-1	2598570
ment	O	-1	2598570
(p	O	-1	2598570
=	O	-1	2598570
0.0@@	O	-1	2598570
2@@	O	-1	2598570
);	O	-1	2598570
and	O	-1	2598570
to	O	-1	2598570
use	O	-1	2598570
alco@@	B-Chemical	D000431	2598570
hol	I-Chemical	-1	2598570
(@@	O	-1	2598570
o@@	O	-1	2598570
d@@	O	-1	2598570
ds	O	-1	2598570
rati@@	O	-1	2598570
o@@	O	-1	2598570
,	O	-1	2598570
4.@@	O	-1	2598570
4@@	O	-1	2598570
;	O	-1	2598570
95%	O	-1	2598570
conf@@	O	-1	2598570
idence	O	-1	2598570
inter@@	O	-1	2598570
val@@	O	-1	2598570
,	O	-1	2598570
1.@@	O	-1	2598570
1@@	O	-1	2598570
-1@@	O	-1	2598570
7.@@	O	-1	2598570
5@@	O	-1	2598570
).	O	-1	2598570
P@@	O	-1	2598570
os@@	O	-1	2598570
sible	O	-1	2598570
risk	O	-1	2598570
factors	O	-1	2598570
included	O	-1	2598570
youn@@	O	-1	2598570
g	O	-1	2598570
age,	O	-1	2598570
con@@	O	-1	2598570
current	O	-1	2598570
use	O	-1	2598570
of	O	-1	2598570
other	O	-1	2598570
analge@@	O	-1	2598570
sic	O	-1	2598570
agents	O	-1	2598570
(@@	O	-1	2598570
es@@	O	-1	2598570
p@@	O	-1	2598570
ec@@	O	-1	2598570
i@@	O	-1	2598570
ally	O	-1	2598570
i@@	B-Chemical	D007052	2598570
bu@@	I-Chemical	-1	2598570
prof@@	I-Chemical	-1	2598570
en	I-Chemical	-1	2598570
),	O	-1	2598570
pre@@	O	-1	2598570
ex@@	O	-1	2598570
ist@@	O	-1	2598570
ing	O	-1	2598570
renal	B-Disease	D007674	2598570
disease	I-Disease	-1	2598570
,	O	-1	2598570
a	O	-1	2598570
hist@@	O	-1	2598570
ory	O	-1	2598570
of	O	-1	2598570
kidney	B-Disease	D007669	2598570
ston@@	I-Disease	-1	2598570
es	I-Disease	-1	2598570
,	O	-1	2598570
a	O	-1	2598570
hist@@	O	-1	2598570
ory	O	-1	2598570
of	O	-1	2598570
g@@	B-Disease	D006073	2598570
out	I-Disease	-1	2598570
,	O	-1	2598570
a	O	-1	2598570
rec@@	O	-1	2598570
ent	O	-1	2598570
increase	O	-1	2598570
in	O	-1	2598570
activ@@	O	-1	2598570
ity,	O	-1	2598570
a	O	-1	2598570
rec@@	O	-1	2598570
ent	O	-1	2598570
increase	O	-1	2598570
in	O	-1	2598570
su@@	O	-1	2598570
n	O	-1	2598570
expos@@	O	-1	2598570
ure,	O	-1	2598570
and	O	-1	2598570
re@@	O	-1	2598570
si@@	O	-1	2598570
d@@	O	-1	2598570
ence	O	-1	2598570
in	O	-1	2598570
the	O	-1	2598570
S@@	O	-1	2598570
un@@	O	-1	2598570
be@@	O	-1	2598570
l@@	O	-1	2598570
t.	O	-1	2598570
These	O	-1	2598570
were	O	-1	2598570
findings	O	-1	2598570
that	O	-1	2598570
were	O	-1	2598570
sugg@@	O	-1	2598570
es@@	O	-1	2598570
tive	O	-1	2598570
but	O	-1	2598570
did	O	-1	2598570
not	O	-1	2598570
reac@@	O	-1	2598570
h	O	-1	2598570
con@@	O	-1	2598570
ven@@	O	-1	2598570
tional	O	-1	2598570
statis@@	O	-1	2598570
tical	O	-1	2598570
signific@@	O	-1	2598570
ance@@	O	-1	2598570
.	O	-1	2598570
These	O	-1	2598570
findings	O	-1	2598570
are	O	-1	2598570
consist@@	O	-1	2598570
ent	O	-1	2598570
with	O	-1	2598570
the	O	-1	2598570
post@@	O	-1	2598570
ul@@	O	-1	2598570
ated	O	-1	2598570
mechanism	O	-1	2598570
for	O	-1	2598570
this	O	-1	2598570
un@@	O	-1	2598570
us@@	O	-1	2598570
ual	O	-1	2598570
syndro@@	O	-1	2598570
me@@	O	-1	2598570
:	O	-1	2598570
acute	O	-1	2598570
diff@@	O	-1	2598570
use	O	-1	2598570
c@@	O	-1	2598570
r@@	O	-1	2598570
y@@	O	-1	2598570
st@@	O	-1	2598570
al@@	O	-1	2598570
li@@	O	-1	2598570
z@@	O	-1	2598570
ation	O	-1	2598570
of	O	-1	2598570
ur@@	B-Chemical	D014527	2598570
ic	I-Chemical	-1	2598570
acid	I-Chemical	-1	2598570
in	O	-1	2598570
renal	O	-1	2598570
tub@@	O	-1	2598570
ul@@	O	-1	2598570
es.	O	-1	2598570

H@@	B-Disease	D006463	1415380
em@@	I-Disease	-1	1415380
oly@@	I-Disease	-1	1415380
tic@@	I-Disease	-1	1415380
-@@	I-Disease	-1	1415380
ure@@	I-Disease	-1	1415380
mic	I-Disease	-1	1415380
syndrome	I-Disease	-1	1415380
associated	O	-1	1415380
with	O	-1	1415380
ing@@	O	-1	1415380
es@@	O	-1	1415380
tion	O	-1	1415380
of	O	-1	1415380
qu@@	B-Chemical	D011803	1415380
inine	I-Chemical	-1	1415380
.	O	-1	1415380
H@@	B-Disease	D006463	1415380
em@@	I-Disease	-1	1415380
oly@@	I-Disease	-1	1415380
tic@@	I-Disease	-1	1415380
-@@	I-Disease	-1	1415380
ure@@	I-Disease	-1	1415380
mic	I-Disease	-1	1415380
syndrome	I-Disease	-1	1415380
following	O	-1	1415380
qu@@	B-Chemical	D011803	1415380
inine	I-Chemical	-1	1415380
ing@@	O	-1	1415380
es@@	O	-1	1415380
tion	O	-1	1415380
is	O	-1	1415380
a	O	-1	1415380
ne@@	O	-1	1415380
w@@	O	-1	1415380
ly	O	-1	1415380
descri@@	O	-1	1415380
bed	O	-1	1415380
phen@@	O	-1	1415380
om@@	O	-1	1415380
en@@	O	-1	1415380
on@@	O	-1	1415380
,	O	-1	1415380
with	O	-1	1415380
j@@	O	-1	1415380
us@@	O	-1	1415380
t	O	-1	1415380
two	O	-1	1415380
previ@@	O	-1	1415380
ous	O	-1	1415380
descri@@	O	-1	1415380
p@@	O	-1	1415380
tions	O	-1	1415380
of	O	-1	1415380
4	O	-1	1415380
cases	O	-1	1415380
in	O	-1	1415380
the	O	-1	1415380
literat@@	O	-1	1415380
ure.	O	-1	1415380
We	O	-1	1415380
describe	O	-1	1415380
a	O	-1	1415380
5@@	O	-1	1415380
th	O	-1	1415380
cas@@	O	-1	1415380
e.	O	-1	1415380
The	O	-1	1415380
reaction	O	-1	1415380
may	O	-1	1415380
be	O	-1	1415380
mediated	O	-1	1415380
by	O	-1	1415380
the	O	-1	1415380
presence	O	-1	1415380
of	O	-1	1415380
anti@@	O	-1	1415380
bo@@	O	-1	1415380
di@@	O	-1	1415380
es	O	-1	1415380
reac@@	O	-1	1415380
tive	O	-1	1415380
against	O	-1	1415380
platele@@	O	-1	1415380
ts	O	-1	1415380
in	O	-1	1415380
the	O	-1	1415380
presence	O	-1	1415380
of	O	-1	1415380
qu@@	B-Chemical	D011803	1415380
inine	I-Chemical	-1	1415380
.	O	-1	1415380
Treat@@	O	-1	1415380
ment	O	-1	1415380
has	O	-1	1415380
included	O	-1	1415380
use	O	-1	1415380
of	O	-1	1415380
plasma	O	-1	1415380
ex@@	O	-1	1415380
chang@@	O	-1	1415380
e,	O	-1	1415380
pre@@	B-Chemical	D011241	1415380
d@@	I-Chemical	-1	1415380
n@@	I-Chemical	-1	1415380
is@@	I-Chemical	-1	1415380
one	I-Chemical	-1	1415380
,	O	-1	1415380
as@@	B-Chemical	D001241	1415380
pi@@	I-Chemical	-1	1415380
rin	I-Chemical	-1	1415380
,	O	-1	1415380
and	O	-1	1415380
di@@	B-Chemical	D004176	1415380
pyri@@	I-Chemical	-1	1415380
dam@@	I-Chemical	-1	1415380
ole	I-Chemical	-1	1415380
.	O	-1	1415380
The	O	-1	1415380
patients	O	-1	1415380
have	O	-1	1415380
all	O	-1	1415380
reg@@	O	-1	1415380
ained	O	-1	1415380
some	O	-1	1415380
de@@	O	-1	1415380
g@@	O	-1	1415380
ree	O	-1	1415380
of	O	-1	1415380
renal	O	-1	1415380
func@@	O	-1	1415380
tion.	O	-1	1415380
However,	O	-1	1415380
it	O	-1	1415380
is	O	-1	1415380
unc@@	O	-1	1415380
le@@	O	-1	1415380
ar	O	-1	1415380
whether	O	-1	1415380
pharmac@@	O	-1	1415380
ological	O	-1	1415380
treatment	O	-1	1415380
or	O	-1	1415380
spont@@	O	-1	1415380
aneous	O	-1	1415380
resol@@	O	-1	1415380
u@@	O	-1	1415380
tion	O	-1	1415380
is	O	-1	1415380
respon@@	O	-1	1415380
sible	O	-1	1415380
for	O	-1	1415380
the	O	-1	1415380
impro@@	O	-1	1415380
ve@@	O	-1	1415380
ment.	O	-1	1415380
Q@@	B-Chemical	D011803	1415380
u@@	I-Chemical	-1	1415380
inine	I-Chemical	-1	1415380
-@@	O	-1	1415380
associated	O	-1	1415380
hemoly@@	B-Disease	D006463	1415380
tic@@	I-Disease	-1	1415380
-@@	I-Disease	-1	1415380
ure@@	I-Disease	-1	1415380
mic	I-Disease	-1	1415380
syndrome	I-Disease	-1	1415380
prob@@	O	-1	1415380
ably	O	-1	1415380
occur@@	O	-1	1415380
s	O	-1	1415380
more	O	-1	1415380
often	O	-1	1415380
than	O	-1	1415380
is	O	-1	1415380
reco@@	O	-1	1415380
gn@@	O	-1	1415380
iz@@	O	-1	1415380
ed.	O	-1	1415380
It	O	-1	1415380
is	O	-1	1415380
important	O	-1	1415380
to	O	-1	1415380
reco@@	O	-1	1415380
gn@@	O	-1	1415380
iz@@	O	-1	1415380
e	O	-1	1415380
this	O	-1	1415380
reaction	O	-1	1415380
when	O	-1	1415380
it	O	-1	1415380
occur@@	O	-1	1415380
s	O	-1	1415380
and	O	-1	1415380
to	O	-1	1415380
av@@	O	-1	1415380
oid	O	-1	1415380
further	O	-1	1415380
qu@@	B-Chemical	D011803	1415380
inine	I-Chemical	-1	1415380
expos@@	O	-1	1415380
ure,	O	-1	1415380
s@@	O	-1	1415380
inc@@	O	-1	1415380
e	O	-1	1415380
the	O	-1	1415380
reaction	O	-1	1415380
se@@	O	-1	1415380
em@@	O	-1	1415380
s	O	-1	1415380
to	O	-1	1415380
be	O	-1	1415380
recur@@	O	-1	1415380
ren@@	O	-1	1415380
t.	O	-1	1415380

P@@	O	-1	1255900
ye@@	O	-1	1255900
lo@@	O	-1	1255900
ure@@	O	-1	1255900
ter@@	O	-1	1255900
al	O	-1	1255900
f@@	O	-1	1255900
ill@@	O	-1	1255900
ing	O	-1	1255900
def@@	O	-1	1255900
ects	O	-1	1255900
associated	O	-1	1255900
with	O	-1	1255900
systemic	O	-1	1255900
anti@@	O	-1	1255900
co@@	O	-1	1255900
ag@@	O	-1	1255900
ul@@	O	-1	1255900
ation@@	O	-1	1255900
:	O	-1	1255900
a	O	-1	1255900
case	O	-1	1255900
repor@@	O	-1	1255900
t.	O	-1	1255900
The	O	-1	1255900
e@@	O	-1	1255900
ti@@	O	-1	1255900
ology	O	-1	1255900
of	O	-1	1255900
py@@	B-Disease	D011702	1255900
e@@	I-Disease	-1	1255900
lo@@	I-Disease	-1	1255900
ure@@	I-Disease	-1	1255900
ter@@	I-Disease	-1	1255900
iti@@	I-Disease	-1	1255900
s	I-Disease	-1	1255900
cys@@	I-Disease	-1	1255900
tic@@	I-Disease	-1	1255900
a	I-Disease	-1	1255900
has	O	-1	1255900
lon@@	O	-1	1255900
g	O	-1	1255900
been	O	-1	1255900
at@@	O	-1	1255900
tri@@	O	-1	1255900
but@@	O	-1	1255900
ed	O	-1	1255900
to	O	-1	1255900
chronic	O	-1	1255900
inf@@	B-Disease	D007239	1255900
ection	I-Disease	-1	1255900
and	O	-1	1255900
inflam@@	B-Disease	D007249	1255900
m@@	I-Disease	-1	1255900
ation	I-Disease	-1	1255900
.	O	-1	1255900
A	O	-1	1255900
case	O	-1	1255900
is	O	-1	1255900
presented	O	-1	1255900
that	O	-1	1255900
is	O	-1	1255900
un@@	O	-1	1255900
i@@	O	-1	1255900
qu@@	O	-1	1255900
e	O	-1	1255900
in	O	-1	1255900
that	O	-1	1255900
the	O	-1	1255900
acute	O	-1	1255900
onset	O	-1	1255900
and	O	-1	1255900
the	O	-1	1255900
ra@@	O	-1	1255900
pid	O	-1	1255900
resol@@	O	-1	1255900
u@@	O	-1	1255900
tion	O	-1	1255900
of	O	-1	1255900
py@@	O	-1	1255900
e@@	O	-1	1255900
lo@@	O	-1	1255900
ure@@	O	-1	1255900
ter@@	O	-1	1255900
al	O	-1	1255900
f@@	O	-1	1255900
ill@@	O	-1	1255900
ing	O	-1	1255900
def@@	O	-1	1255900
ects	O	-1	1255900
in	O	-1	1255900
this	O	-1	1255900
patient	O	-1	1255900
were	O	-1	1255900
doc@@	O	-1	1255900
um@@	O	-1	1255900
ent@@	O	-1	1255900
ed	O	-1	1255900
by	O	-1	1255900
radi@@	O	-1	1255900
ograph@@	O	-1	1255900
y.	O	-1	1255900
There	O	-1	1255900
is	O	-1	1255900
no	O	-1	1255900
evidence	O	-1	1255900
of	O	-1	1255900
ant@@	O	-1	1255900
ec@@	O	-1	1255900
ed@@	O	-1	1255900
ent	O	-1	1255900
or	O	-1	1255900
con@@	O	-1	1255900
current	O	-1	1255900
inf@@	B-Disease	D007239	1255900
ection	I-Disease	-1	1255900
in	O	-1	1255900
this	O	-1	1255900
patient@@	O	-1	1255900
.	O	-1	1255900
The	O	-1	1255900
disease	O	-1	1255900
occurred	O	-1	1255900
subsequ@@	O	-1	1255900
ent	O	-1	1255900
to	O	-1	1255900
the	O	-1	1255900
initi@@	O	-1	1255900
ation	O	-1	1255900
of	O	-1	1255900
hepar@@	B-Chemical	D006493	1255900
in	I-Chemical	-1	1255900
therapy	O	-1	1255900
for	O	-1	1255900
sus@@	O	-1	1255900
p@@	O	-1	1255900
ected	O	-1	1255900
p@@	O	-1	1255900
el@@	O	-1	1255900
v@@	O	-1	1255900
ic	O	-1	1255900
thrombo@@	B-Disease	D013924	1255900
ph@@	I-Disease	-1	1255900
le@@	I-Disease	-1	1255900
b@@	I-Disease	-1	1255900
iti@@	I-Disease	-1	1255900
s	I-Disease	-1	1255900
and	O	-1	1255900
c@@	O	-1	1255900
le@@	O	-1	1255900
a@@	O	-1	1255900
red	O	-1	1255900
ra@@	O	-1	1255900
pid@@	O	-1	1255900
ly	O	-1	1255900
subsequ@@	O	-1	1255900
ent	O	-1	1255900
to	O	-1	1255900
its	O	-1	1255900
discontinu@@	O	-1	1255900
ation.	O	-1	1255900
The	O	-1	1255900
rate	O	-1	1255900
of	O	-1	1255900
resol@@	O	-1	1255900
u@@	O	-1	1255900
tion	O	-1	1255900
of	O	-1	1255900
the	O	-1	1255900
radi@@	O	-1	1255900
ograph@@	O	-1	1255900
ic	O	-1	1255900
findings	O	-1	1255900
may	O	-1	1255900
be	O	-1	1255900
he@@	O	-1	1255900
l@@	O	-1	1255900
p@@	O	-1	1255900
ful	O	-1	1255900
in	O	-1	1255900
dist@@	O	-1	1255900
ing@@	O	-1	1255900
u@@	O	-1	1255900
ish@@	O	-1	1255900
ing	O	-1	1255900
between	O	-1	1255900
t@@	O	-1	1255900
ru@@	O	-1	1255900
e	O	-1	1255900
py@@	B-Disease	D011702	1255900
e@@	I-Disease	-1	1255900
lo@@	I-Disease	-1	1255900
ure@@	I-Disease	-1	1255900
ter@@	I-Disease	-1	1255900
iti@@	I-Disease	-1	1255900
s	I-Disease	-1	1255900
cys@@	I-Disease	-1	1255900
tic@@	I-Disease	-1	1255900
a	I-Disease	-1	1255900
and	O	-1	1255900
sub@@	B-Disease	D006470	1255900
m@@	I-Disease	-1	1255900
u@@	I-Disease	-1	1255900
co@@	I-Disease	-1	1255900
s@@	I-Disease	-1	1255900
al	I-Disease	-1	1255900
hemorrh@@	I-Disease	-1	1255900
age	I-Disease	-1	1255900
.	O	-1	1255900

Ch@@	O	-1	85485
ang@@	O	-1	85485
es	O	-1	85485
in	O	-1	85485
per@@	O	-1	85485
ox@@	O	-1	85485
is@@	O	-1	85485
om@@	O	-1	85485
es	O	-1	85485
in	O	-1	85485
pre@@	O	-1	85485
ne@@	O	-1	85485
o@@	O	-1	85485
plas@@	O	-1	85485
tic	O	-1	85485
liver	O	-1	85485
and	O	-1	85485
hepat@@	B-Disease	D006528	85485
oma	I-Disease	-1	85485
of	O	-1	85485
mice	O	-1	85485
induced	O	-1	85485
by	O	-1	85485
alpha-@@	B-Chemical	D001556	85485
b@@	I-Chemical	-1	85485
enz@@	I-Chemical	-1	85485
ene	I-Chemical	-1	85485
he@@	I-Chemical	-1	85485
x@@	I-Chemical	-1	85485
ac@@	I-Chemical	-1	85485
h@@	I-Chemical	-1	85485
lor@@	I-Chemical	-1	85485
ide	I-Chemical	-1	85485
.	O	-1	85485
P@@	O	-1	85485
er@@	O	-1	85485
ox@@	O	-1	85485
is@@	O	-1	85485
om@@	O	-1	85485
es	O	-1	85485
in	O	-1	85485
hepat@@	B-Disease	D006528	85485
om@@	I-Disease	-1	85485
as	I-Disease	-1	85485
and	O	-1	85485
hyper@@	O	-1	85485
plas@@	O	-1	85485
tic	O	-1	85485
pre@@	O	-1	85485
ne@@	O	-1	85485
o@@	O	-1	85485
plas@@	O	-1	85485
tic	O	-1	85485
liver	B-Disease	D017093	85485
lesions	I-Disease	-1	85485
induced	O	-1	85485
in	O	-1	85485
mice	O	-1	85485
by	O	-1	85485
5@@	O	-1	85485
00	O	-1	85485
pp@@	O	-1	85485
m	O	-1	85485
alpha-@@	B-Chemical	D001556	85485
b@@	I-Chemical	-1	85485
enz@@	I-Chemical	-1	85485
ene	I-Chemical	-1	85485
he@@	I-Chemical	-1	85485
x@@	I-Chemical	-1	85485
ac@@	I-Chemical	-1	85485
h@@	I-Chemical	-1	85485
lor@@	I-Chemical	-1	85485
ide	I-Chemical	-1	85485
were	O	-1	85485
examined	O	-1	85485
histo@@	O	-1	85485
chem@@	O	-1	85485
ically	O	-1	85485
and	O	-1	85485
electro@@	O	-1	85485
n	O	-1	85485
micro@@	O	-1	85485
sco@@	O	-1	85485
p@@	O	-1	85485
ic@@	O	-1	85485
all@@	O	-1	85485
y.	O	-1	85485
Although	O	-1	85485
most	O	-1	85485
of	O	-1	85485
the	O	-1	85485
hepat@@	B-Disease	D006528	85485
om@@	I-Disease	-1	85485
as	I-Disease	-1	85485
were	O	-1	85485
we@@	O	-1	85485
ll@@	O	-1	85485
-@@	O	-1	85485
differen@@	O	-1	85485
ti@@	O	-1	85485
ated	O	-1	85485
tu@@	B-Disease	D009369	85485
mor@@	I-Disease	-1	85485
s	I-Disease	-1	85485
and	O	-1	85485
cont@@	O	-1	85485
ained	O	-1	85485
a	O	-1	85485
con@@	O	-1	85485
si@@	O	-1	85485
der@@	O	-1	85485
able	O	-1	85485
number	O	-1	85485
of	O	-1	85485
per@@	O	-1	85485
ox@@	O	-1	85485
is@@	O	-1	85485
om@@	O	-1	85485
es,	O	-1	85485
the	O	-1	85485
tumor	B-Disease	D009369	85485
cells	O	-1	85485
did	O	-1	85485
not	O	-1	85485
respon@@	O	-1	85485
d	O	-1	85485
to	O	-1	85485
eth@@	B-Chemical	C012282	85485
yl@@	I-Chemical	-1	85485
-@@	I-Chemical	-1	85485
alpha-@@	I-Chemical	-1	85485
p@@	I-Chemical	-1	85485
-@@	I-Chemical	-1	85485
ch@@	I-Chemical	-1	85485
loro@@	I-Chemical	-1	85485
phen@@	I-Chemical	-1	85485
oxy@@	I-Chemical	-1	85485
is@@	I-Chemical	-1	85485
ob@@	I-Chemical	-1	85485
ut@@	I-Chemical	-1	85485
y@@	I-Chemical	-1	85485
rate	I-Chemical	-1	85485
with	O	-1	85485
pro@@	O	-1	85485
li@@	O	-1	85485
fer@@	O	-1	85485
ation	O	-1	85485
of	O	-1	85485
per@@	O	-1	85485
ox@@	O	-1	85485
is@@	O	-1	85485
om@@	O	-1	85485
es.	O	-1	85485
A@@	O	-1	85485
t	O	-1	85485
the	O	-1	85485
1@@	O	-1	85485
6@@	O	-1	85485
th	O	-1	85485
week	O	-1	85485
of	O	-1	85485
carcino@@	O	-1	85485
gen	O	-1	85485
fe@@	O	-1	85485
ed@@	O	-1	85485
ing,	O	-1	85485
hyper@@	O	-1	85485
plas@@	O	-1	85485
tic	O	-1	85485
no@@	O	-1	85485
d@@	O	-1	85485
ul@@	O	-1	85485
es	O	-1	85485
appe@@	O	-1	85485
a@@	O	-1	85485
red	O	-1	85485
and	O	-1	85485
adv@@	O	-1	85485
anced	O	-1	85485
to	O	-1	85485
further	O	-1	85485
st@@	O	-1	85485
ag@@	O	-1	85485
es.	O	-1	85485
A	O	-1	85485
maj@@	O	-1	85485
or@@	O	-1	85485
ity	O	-1	85485
of	O	-1	85485
the	O	-1	85485
no@@	O	-1	85485
d@@	O	-1	85485
ul@@	O	-1	85485
es	O	-1	85485
showed	O	-1	85485
a	O	-1	85485
con@@	O	-1	85485
si@@	O	-1	85485
der@@	O	-1	85485
able	O	-1	85485
number	O	-1	85485
of	O	-1	85485
per@@	O	-1	85485
ox@@	O	-1	85485
is@@	O	-1	85485
om@@	O	-1	85485
es	O	-1	85485
and	O	-1	85485
the	O	-1	85485
induc@@	O	-1	85485
tive	O	-1	85485
pro@@	O	-1	85485
li@@	O	-1	85485
fer@@	O	-1	85485
ation	O	-1	85485
of	O	-1	85485
per@@	O	-1	85485
ox@@	O	-1	85485
is@@	O	-1	85485
om@@	O	-1	85485
es.	O	-1	85485
W@@	O	-1	85485
i@@	O	-1	85485
th@@	O	-1	85485
in	O	-1	85485
the	O	-1	85485
no@@	O	-1	85485
d@@	O	-1	85485
ul@@	O	-1	85485
es,	O	-1	85485
foc@@	O	-1	85485
i	O	-1	85485
of	O	-1	85485
pro@@	O	-1	85485
li@@	O	-1	85485
fer@@	O	-1	85485
ation	O	-1	85485
of	O	-1	85485
the	O	-1	85485
cells	O	-1	85485
that	O	-1	85485
showed	O	-1	85485
no	O	-1	85485
induc@@	O	-1	85485
i@@	O	-1	85485
b@@	O	-1	85485
ility	O	-1	85485
of	O	-1	85485
pro@@	O	-1	85485
li@@	O	-1	85485
fer@@	O	-1	85485
ation	O	-1	85485
of	O	-1	85485
per@@	O	-1	85485
ox@@	O	-1	85485
is@@	O	-1	85485
om@@	O	-1	85485
es	O	-1	85485
appe@@	O	-1	85485
a@@	O	-1	85485
red.	O	-1	85485
These	O	-1	85485
cells	O	-1	85485
pro@@	O	-1	85485
li@@	O	-1	85485
fer@@	O	-1	85485
ated	O	-1	85485
f@@	O	-1	85485
ur@@	O	-1	85485
ther@@	O	-1	85485
,	O	-1	85485
re@@	O	-1	85485
pl@@	O	-1	85485
ac@@	O	-1	85485
ing	O	-1	85485
the	O	-1	85485
most	O	-1	85485
par@@	O	-1	85485
t	O	-1	85485
of	O	-1	85485
the	O	-1	85485
no@@	O	-1	85485
d@@	O	-1	85485
ul@@	O	-1	85485
es,	O	-1	85485
and	O	-1	85485
with	O	-1	85485
this	O	-1	85485
pro@@	O	-1	85485
cess	O	-1	85485
hepat@@	B-Disease	D006528	85485
om@@	I-Disease	-1	85485
as	I-Disease	-1	85485
appe@@	O	-1	85485
a@@	O	-1	85485
red	O	-1	85485
to	O	-1	85485
have	O	-1	85485
been	O	-1	85485
for@@	O	-1	85485
me@@	O	-1	85485
d.	O	-1	85485
No	O	-1	85485
ab@@	O	-1	85485
normal	O	-1	85485
mat@@	O	-1	85485
r@@	O	-1	85485
ical	O	-1	85485
inc@@	O	-1	85485
lu@@	O	-1	85485
sions	O	-1	85485
of	O	-1	85485
per@@	O	-1	85485
ox@@	O	-1	85485
is@@	O	-1	85485
om@@	O	-1	85485
es	O	-1	85485
were	O	-1	85485
form@@	O	-1	85485
ed	O	-1	85485
in	O	-1	85485
the	O	-1	85485
cells	O	-1	85485
of	O	-1	85485
hyper@@	O	-1	85485
plas@@	O	-1	85485
tic	O	-1	85485
no@@	O	-1	85485
d@@	O	-1	85485
ul@@	O	-1	85485
es	O	-1	85485
by	O	-1	85485
eth@@	B-Chemical	C012282	85485
yl@@	I-Chemical	-1	85485
-@@	I-Chemical	-1	85485
alpha-@@	I-Chemical	-1	85485
p@@	I-Chemical	-1	85485
-@@	I-Chemical	-1	85485
ch@@	I-Chemical	-1	85485
loro@@	I-Chemical	-1	85485
phen@@	I-Chemical	-1	85485
oxy@@	I-Chemical	-1	85485
is@@	I-Chemical	-1	85485
ob@@	I-Chemical	-1	85485
ut@@	I-Chemical	-1	85485
y@@	I-Chemical	-1	85485
rate	I-Chemical	-1	85485
un@@	O	-1	85485
like	O	-1	85485
in	O	-1	85485
the	O	-1	85485
case	O	-1	85485
of	O	-1	85485
rats.	O	-1	85485

Q@@	B-Chemical	D011802	48362
u@@	I-Chemical	-1	48362
in@@	I-Chemical	-1	48362
idine	I-Chemical	-1	48362
hepatitis	B-Disease	D056486	48362
.	O	-1	48362
L@@	O	-1	48362
on@@	O	-1	48362
g@@	O	-1	48362
-term	O	-1	48362
administration	O	-1	48362
of	O	-1	48362
qu@@	B-Chemical	D011802	48362
in@@	I-Chemical	-1	48362
idine	I-Chemical	-1	48362
was	O	-1	48362
associated	O	-1	48362
with	O	-1	48362
per@@	O	-1	48362
sist@@	O	-1	48362
ent	O	-1	48362
elev@@	O	-1	48362
ation	O	-1	48362
of	O	-1	48362
serum	O	-1	48362
concentrations	O	-1	48362
of	O	-1	48362
S@@	O	-1	48362
G@@	O	-1	48362
O@@	O	-1	48362
T@@	O	-1	48362
,	O	-1	48362
l@@	B-Chemical	D019344	48362
ac@@	I-Chemical	-1	48362
tic	I-Chemical	-1	48362
acid	I-Chemical	-1	48362
de@@	O	-1	48362
hydro@@	O	-1	48362
gen@@	O	-1	48362
ase,	O	-1	48362
and	O	-1	48362
al@@	O	-1	48362
k@@	O	-1	48362
aline	O	-1	48362
phosph@@	O	-1	48362
at@@	O	-1	48362
as@@	O	-1	48362
e.	O	-1	48362
L@@	O	-1	48362
i@@	O	-1	48362
ver	O	-1	48362
biop@@	O	-1	48362
sy	O	-1	48362
showed	O	-1	48362
active	O	-1	48362
hepatitis	B-Disease	D056486	48362
.	O	-1	48362
D@@	O	-1	48362
is@@	O	-1	48362
continu@@	O	-1	48362
ance	O	-1	48362
of	O	-1	48362
qu@@	B-Chemical	D011802	48362
in@@	I-Chemical	-1	48362
idine	I-Chemical	-1	48362
therapy	O	-1	48362
l@@	O	-1	48362
ed	O	-1	48362
to	O	-1	48362
normal@@	O	-1	48362
ization	O	-1	48362
of	O	-1	48362
liver	O	-1	48362
function	O	-1	48362
test@@	O	-1	48362
s.	O	-1	48362
A	O	-1	48362
ch@@	O	-1	48362
all@@	O	-1	48362
enge	O	-1	48362
dose	O	-1	48362
of	O	-1	48362
qu@@	B-Chemical	D011802	48362
in@@	I-Chemical	-1	48362
idine	I-Chemical	-1	48362
caused	O	-1	48362
clinical	O	-1	48362
symptoms	O	-1	48362
and	O	-1	48362
ab@@	O	-1	48362
ru@@	O	-1	48362
p@@	O	-1	48362
t	O	-1	48362
elev@@	O	-1	48362
ation	O	-1	48362
of	O	-1	48362
S@@	O	-1	48362
G@@	O	-1	48362
O@@	O	-1	48362
T@@	O	-1	48362
,	O	-1	48362
al@@	O	-1	48362
k@@	O	-1	48362
aline	O	-1	48362
phosph@@	O	-1	48362
at@@	O	-1	48362
ase,	O	-1	48362
and	O	-1	48362
l@@	B-Chemical	D019344	48362
ac@@	I-Chemical	-1	48362
tic	I-Chemical	-1	48362
acid	I-Chemical	-1	48362
de@@	O	-1	48362
hydro@@	O	-1	48362
gen@@	O	-1	48362
ase	O	-1	48362
valu@@	O	-1	48362
es.	O	-1	48362
We	O	-1	48362
concl@@	O	-1	48362
uded	O	-1	48362
that	O	-1	48362
this	O	-1	48362
patient	O	-1	48362
had	O	-1	48362
qu@@	B-Chemical	D011802	48362
in@@	I-Chemical	-1	48362
idine	I-Chemical	-1	48362
hepat@@	B-Disease	D056486	48362
otoxicity	I-Disease	-1	48362
and	O	-1	48362
be@@	O	-1	48362
li@@	O	-1	48362
e@@	O	-1	48362
ve	O	-1	48362
that	O	-1	48362
this	O	-1	48362
is	O	-1	48362
the	O	-1	48362
first	O	-1	48362
case	O	-1	48362
reported	O	-1	48362
with	O	-1	48362
liver	O	-1	48362
biop@@	O	-1	48362
sy	O	-1	48362
doc@@	O	-1	48362
um@@	O	-1	48362
ent@@	O	-1	48362
ation.	O	-1	48362
This	O	-1	48362
report	O	-1	48362
also	O	-1	48362
suggests	O	-1	48362
th@@	O	-1	48362
at@@	O	-1	48362
,	O	-1	48362
even	O	-1	48362
after	O	-1	48362
long-term	O	-1	48362
administr@@	O	-1	48362
ation,	O	-1	48362
the	O	-1	48362
hepatic	B-Disease	D056486	48362
toxicity	I-Disease	-1	48362
is	O	-1	48362
rever@@	O	-1	48362
sib@@	O	-1	48362
le@@	O	-1	48362
.	O	-1	48362

Ch@@	B-Chemical	C013440	9067481
ol@@	I-Chemical	-1	9067481
est@@	I-Chemical	-1	9067481
ery@@	I-Chemical	-1	9067481
l	I-Chemical	-1	9067481
he@@	I-Chemical	-1	9067481
mis@@	I-Chemical	-1	9067481
uc@@	I-Chemical	-1	9067481
cin@@	I-Chemical	-1	9067481
ate	I-Chemical	-1	9067481
treatment	O	-1	9067481
prot@@	O	-1	9067481
ects	O	-1	9067481
ro@@	O	-1	9067481
d@@	O	-1	9067481
ents	O	-1	9067481
from	O	-1	9067481
the	O	-1	9067481
toxic	O	-1	9067481
effects	O	-1	9067481
of	O	-1	9067481
acet@@	B-Chemical	D000082	9067481
aminoph@@	I-Chemical	-1	9067481
en	I-Chemical	-1	9067481
,	O	-1	9067481
adriam@@	B-Chemical	D004317	9067481
ycin	I-Chemical	-1	9067481
,	O	-1	9067481
carb@@	B-Chemical	D002251	9067481
on	I-Chemical	-1	9067481
te@@	I-Chemical	-1	9067481
trac@@	I-Chemical	-1	9067481
h@@	I-Chemical	-1	9067481
lor@@	I-Chemical	-1	9067481
ide	I-Chemical	-1	9067481
,	O	-1	9067481
ch@@	B-Chemical	D002725	9067481
loro@@	I-Chemical	-1	9067481
form	I-Chemical	-1	9067481
and	O	-1	9067481
g@@	B-Chemical	D005688	9067481
al@@	I-Chemical	-1	9067481
act@@	I-Chemical	-1	9067481
os@@	I-Chemical	-1	9067481
amine	I-Chemical	-1	9067481
.	O	-1	9067481
In	O	-1	9067481
addition	O	-1	9067481
to	O	-1	9067481
its	O	-1	9067481
use	O	-1	9067481
as	O	-1	9067481
a	O	-1	9067481
st@@	O	-1	9067481
abil@@	O	-1	9067481
iz@@	O	-1	9067481
er@@	O	-1	9067481
/@@	O	-1	9067481
ri@@	O	-1	9067481
gi@@	O	-1	9067481
di@@	O	-1	9067481
fi@@	O	-1	9067481
er	O	-1	9067481
of	O	-1	9067481
membran@@	O	-1	9067481
es,	O	-1	9067481
cholest@@	B-Chemical	C013440	9067481
ery@@	I-Chemical	-1	9067481
l	I-Chemical	-1	9067481
he@@	I-Chemical	-1	9067481
mis@@	I-Chemical	-1	9067481
uc@@	I-Chemical	-1	9067481
cin@@	I-Chemical	-1	9067481
ate	I-Chemical	-1	9067481
,	O	-1	9067481
tri@@	B-Chemical	-1	9067481
s	I-Chemical	-1	9067481
sal@@	I-Chemical	-1	9067481
t	I-Chemical	-1	9067481
(	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
)	O	-1	9067481
administration	O	-1	9067481
has	O	-1	9067481
also	O	-1	9067481
been	O	-1	9067481
shown	O	-1	9067481
to	O	-1	9067481
prot@@	O	-1	9067481
ect	O	-1	9067481
rats	O	-1	9067481
from	O	-1	9067481
the	O	-1	9067481
hepat@@	B-Disease	D056486	9067481
ot@@	I-Disease	-1	9067481
ox@@	I-Disease	-1	9067481
ic	I-Disease	-1	9067481
effects	O	-1	9067481
of	O	-1	9067481
carb@@	B-Chemical	D002251	9067481
on	I-Chemical	-1	9067481
te@@	I-Chemical	-1	9067481
trac@@	I-Chemical	-1	9067481
h@@	I-Chemical	-1	9067481
lor@@	I-Chemical	-1	9067481
ide	I-Chemical	-1	9067481
(	O	-1	9067481
C@@	B-Chemical	D002251	9067481
Cl@@	I-Chemical	-1	9067481
4	I-Chemical	-1	9067481
).	O	-1	9067481
To	O	-1	9067481
further	O	-1	9067481
our	O	-1	9067481
under@@	O	-1	9067481
stand@@	O	-1	9067481
ing	O	-1	9067481
of	O	-1	9067481
the	O	-1	9067481
mechanism	O	-1	9067481
of	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
cyto@@	O	-1	9067481
prot@@	O	-1	9067481
ec@@	O	-1	9067481
tion,	O	-1	9067481
we	O	-1	9067481
examined	O	-1	9067481
in	O	-1	9067481
rats	O	-1	9067481
and	O	-1	9067481
mice	O	-1	9067481
the	O	-1	9067481
protective	O	-1	9067481
abil@@	O	-1	9067481
ities	O	-1	9067481
of	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
and	O	-1	9067481
the	O	-1	9067481
non-@@	O	-1	9067481
hydro@@	O	-1	9067481
ly@@	O	-1	9067481
z@@	O	-1	9067481
able	O	-1	9067481
e@@	O	-1	9067481
ther	O	-1	9067481
form	O	-1	9067481
of	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
,	O	-1	9067481
gamma@@	B-Chemical	C103872	9067481
-@@	I-Chemical	-1	9067481
cholest@@	I-Chemical	-1	9067481
ery@@	I-Chemical	-1	9067481
lo@@	I-Chemical	-1	9067481
x@@	I-Chemical	-1	9067481
y@@	I-Chemical	-1	9067481
but@@	I-Chemical	-1	9067481
y@@	I-Chemical	-1	9067481
ric	I-Chemical	-1	9067481
acid	I-Chemical	-1	9067481
,	O	-1	9067481
tri@@	B-Chemical	-1	9067481
s	I-Chemical	-1	9067481
sal@@	I-Chemical	-1	9067481
t	I-Chemical	-1	9067481
(	O	-1	9067481
C@@	B-Chemical	-1	9067481
S@@	I-Chemical	-1	9067481
E	I-Chemical	-1	9067481
)	O	-1	9067481
against	O	-1	9067481
acet@@	B-Chemical	D000082	9067481
aminoph@@	I-Chemical	-1	9067481
en	I-Chemical	-1	9067481
-@@	O	-1	9067481
,	O	-1	9067481
adriam@@	B-Chemical	D004317	9067481
ycin	I-Chemical	-1	9067481
-@@	O	-1	9067481
,	O	-1	9067481
carb@@	B-Chemical	D002251	9067481
on	I-Chemical	-1	9067481
te@@	I-Chemical	-1	9067481
trac@@	I-Chemical	-1	9067481
h@@	I-Chemical	-1	9067481
lor@@	I-Chemical	-1	9067481
ide	I-Chemical	-1	9067481
-@@	O	-1	9067481
,	O	-1	9067481
ch@@	B-Chemical	D002725	9067481
loro@@	I-Chemical	-1	9067481
form	I-Chemical	-1	9067481
-	O	-1	9067481
and	O	-1	9067481
g@@	B-Chemical	D005688	9067481
al@@	I-Chemical	-1	9067481
act@@	I-Chemical	-1	9067481
os@@	I-Chemical	-1	9067481
amine	I-Chemical	-1	9067481
-induced	O	-1	9067481
toxicity	B-Disease	D064420	9067481
.	O	-1	9067481
The	O	-1	9067481
results	O	-1	9067481
of	O	-1	9067481
these	O	-1	9067481
studies	O	-1	9067481
demonstrated	O	-1	9067481
that	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
-@@	O	-1	9067481
mediated	O	-1	9067481
prot@@	O	-1	9067481
ection	O	-1	9067481
is	O	-1	9067481
not	O	-1	9067481
selective	O	-1	9067481
for	O	-1	9067481
a	O	-1	9067481
partic@@	O	-1	9067481
ular	O	-1	9067481
spec@@	O	-1	9067481
i@@	O	-1	9067481
es,	O	-1	9067481
org@@	O	-1	9067481
an	O	-1	9067481
system	O	-1	9067481
or	O	-1	9067481
toxic	O	-1	9067481
chem@@	O	-1	9067481
ic@@	O	-1	9067481
al.	O	-1	9067481
A	O	-1	9067481
2@@	O	-1	9067481
4-@@	O	-1	9067481
h	O	-1	9067481
pretreatment	O	-1	9067481
of	O	-1	9067481
both	O	-1	9067481
rats	O	-1	9067481
and	O	-1	9067481
mice	O	-1	9067481
with	O	-1	9067481
a	O	-1	9067481
single	O	-1	9067481
dose	O	-1	9067481
of	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
(@@	O	-1	9067481
10@@	O	-1	9067481
0@@	O	-1	9067481
mg/kg@@	O	-1	9067481
,	O	-1	9067481
i.p.@@	O	-1	9067481
),	O	-1	9067481
resulted	O	-1	9067481
in	O	-1	9067481
significant	O	-1	9067481
prot@@	O	-1	9067481
ection	O	-1	9067481
against	O	-1	9067481
the	O	-1	9067481
hepat@@	B-Disease	D056486	9067481
ot@@	I-Disease	-1	9067481
ox@@	I-Disease	-1	9067481
ic	I-Disease	-1	9067481
effects	O	-1	9067481
of	O	-1	9067481
C@@	B-Chemical	D002251	9067481
Cl@@	I-Chemical	-1	9067481
4	I-Chemical	-1	9067481
,	O	-1	9067481
C@@	B-Chemical	D002725	9067481
HC@@	I-Chemical	-1	9067481
l@@	I-Chemical	-1	9067481
3	I-Chemical	-1	9067481
,	O	-1	9067481
acet@@	B-Chemical	D000082	9067481
aminoph@@	I-Chemical	-1	9067481
en	I-Chemical	-1	9067481
and	O	-1	9067481
g@@	B-Chemical	D005688	9067481
al@@	I-Chemical	-1	9067481
act@@	I-Chemical	-1	9067481
os@@	I-Chemical	-1	9067481
amine	I-Chemical	-1	9067481
and	O	-1	9067481
against	O	-1	9067481
the	O	-1	9067481
le@@	O	-1	9067481
th@@	O	-1	9067481
al	O	-1	9067481
(@@	O	-1	9067481
and	O	-1	9067481
pres@@	O	-1	9067481
um@@	O	-1	9067481
ably	O	-1	9067481
cardi@@	B-Disease	D066126	9067481
ot@@	I-Disease	-1	9067481
ox@@	I-Disease	-1	9067481
ic	I-Disease	-1	9067481
)	O	-1	9067481
effect	O	-1	9067481
of	O	-1	9067481
adriam@@	B-Chemical	D004317	9067481
ycin	I-Chemical	-1	9067481
administr@@	O	-1	9067481
ation.	O	-1	9067481
M@@	O	-1	9067481
ax@@	O	-1	9067481
im@@	O	-1	9067481
al	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
-@@	O	-1	9067481
mediated	O	-1	9067481
prot@@	O	-1	9067481
ection	O	-1	9067481
was	O	-1	9067481
observed	O	-1	9067481
in	O	-1	9067481
experimental	O	-1	9067481
animals	O	-1	9067481
pre@@	O	-1	9067481
treated	O	-1	9067481
24	O	-1	9067481
h	O	-1	9067481
prior	O	-1	9067481
to	O	-1	9067481
the	O	-1	9067481
toxic	O	-1	9067481
in@@	O	-1	9067481
s@@	O	-1	9067481
ult@@	O	-1	9067481
.	O	-1	9067481
These	O	-1	9067481
data	O	-1	9067481
suggest	O	-1	9067481
that	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
inter@@	O	-1	9067481
ven@@	O	-1	9067481
es	O	-1	9067481
in	O	-1	9067481
a	O	-1	9067481
cri@@	O	-1	9067481
tical	O	-1	9067481
cell@@	O	-1	9067481
ular	O	-1	9067481
ev@@	O	-1	9067481
ent	O	-1	9067481
that	O	-1	9067481
is	O	-1	9067481
an	O	-1	9067481
important	O	-1	9067481
common	O	-1	9067481
path@@	O	-1	9067481
w@@	O	-1	9067481
ay	O	-1	9067481
to	O	-1	9067481
toxic	O	-1	9067481
cell	O	-1	9067481
de@@	O	-1	9067481
ath@@	O	-1	9067481
.	O	-1	9067481
The	O	-1	9067481
mechanism	O	-1	9067481
of	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
prot@@	O	-1	9067481
ection	O	-1	9067481
does	O	-1	9067481
not	O	-1	9067481
appe@@	O	-1	9067481
ar	O	-1	9067481
to	O	-1	9067481
be	O	-1	9067481
dependent	O	-1	9067481
on	O	-1	9067481
the	O	-1	9067481
inhibition	O	-1	9067481
of	O	-1	9067481
chemical	O	-1	9067481
bio@@	O	-1	9067481
activation	O	-1	9067481
to	O	-1	9067481
a	O	-1	9067481
toxic	O	-1	9067481
reac@@	O	-1	9067481
tive	O	-1	9067481
inter@@	O	-1	9067481
medi@@	O	-1	9067481
ate	O	-1	9067481
(@@	O	-1	9067481
in	O	-1	9067481
li@@	O	-1	9067481
ght	O	-1	9067481
of	O	-1	9067481
the	O	-1	9067481
prot@@	O	-1	9067481
ection	O	-1	9067481
observed	O	-1	9067481
against	O	-1	9067481
g@@	B-Chemical	D005688	9067481
al@@	I-Chemical	-1	9067481
act@@	I-Chemical	-1	9067481
os@@	I-Chemical	-1	9067481
amine	I-Chemical	-1	9067481
hepat@@	B-Disease	D056486	9067481
otoxicity	I-Disease	-1	9067481
).	O	-1	9067481
However,	O	-1	9067481
bas@@	O	-1	9067481
ed	O	-1	9067481
on	O	-1	9067481
the	O	-1	9067481
data	O	-1	9067481
present@@	O	-1	9067481
ed,	O	-1	9067481
we	O	-1	9067481
can	O	-1	9067481
not	O	-1	9067481
ex@@	O	-1	9067481
cl@@	O	-1	9067481
ude	O	-1	9067481
the	O	-1	9067481
possib@@	O	-1	9067481
ility	O	-1	9067481
that	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
administration	O	-1	9067481
inhibit@@	O	-1	9067481
s	O	-1	9067481
chemical	O	-1	9067481
bio@@	O	-1	9067481
activ@@	O	-1	9067481
ation.	O	-1	9067481
Our	O	-1	9067481
findings	O	-1	9067481
d@@	O	-1	9067481
o	O	-1	9067481
suggest	O	-1	9067481
that	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
-@@	O	-1	9067481
mediated	O	-1	9067481
prot@@	O	-1	9067481
ection	O	-1	9067481
is	O	-1	9067481
dependent	O	-1	9067481
on	O	-1	9067481
the	O	-1	9067481
action	O	-1	9067481
of	O	-1	9067481
the	O	-1	9067481
int@@	O	-1	9067481
ac@@	O	-1	9067481
t	O	-1	9067481
an@@	O	-1	9067481
i@@	O	-1	9067481
onic	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
mol@@	O	-1	9067481
ec@@	O	-1	9067481
ul@@	O	-1	9067481
e	O	-1	9067481
(@@	O	-1	9067481
non-@@	O	-1	9067481
hydro@@	O	-1	9067481
ly@@	O	-1	9067481
z@@	O	-1	9067481
able	O	-1	9067481
C@@	B-Chemical	-1	9067481
S@@	I-Chemical	-1	9067481
E	I-Chemical	-1	9067481
was	O	-1	9067481
as	O	-1	9067481
protective	O	-1	9067481
as	O	-1	9067481
C@@	B-Chemical	-1	9067481
S	I-Chemical	-1	9067481
),	O	-1	9067481
wh@@	O	-1	9067481
ose	O	-1	9067481
mechanism	O	-1	9067481
has	O	-1	9067481
y@@	O	-1	9067481
et	O	-1	9067481
to	O	-1	9067481
be	O	-1	9067481
def@@	O	-1	9067481
ine@@	O	-1	9067481
d.	O	-1	9067481

D@@	O	-1	19274460
S@@	O	-1	19274460
M@@	O	-1	19274460
M	O	-1	19274460
X@@	O	-1	19274460
I	O	-1	19274460
stud@@	O	-1	19274460
y@@	O	-1	19274460
:	O	-1	19274460
dose	O	-1	19274460
def@@	O	-1	19274460
in@@	O	-1	19274460
ition	O	-1	19274460
for	O	-1	19274460
intravenous	O	-1	19274460
cyclophosph@@	B-Chemical	D003520	19274460
amide	I-Chemical	-1	19274460
in	O	-1	19274460
combination	O	-1	19274460
with	O	-1	19274460
b@@	B-Chemical	C400082	19274460
or@@	I-Chemical	-1	19274460
te@@	I-Chemical	-1	19274460
z@@	I-Chemical	-1	19274460
om@@	I-Chemical	-1	19274460
i@@	I-Chemical	-1	19274460
b	I-Chemical	-1	19274460
/	O	-1	19274460
de@@	B-Chemical	D003907	19274460
xameth@@	I-Chemical	-1	19274460
as@@	I-Chemical	-1	19274460
one	I-Chemical	-1	19274460
for	O	-1	19274460
re@@	O	-1	19274460
mission	O	-1	19274460
induction	O	-1	19274460
in	O	-1	19274460
patients	O	-1	19274460
with	O	-1	19274460
ne@@	O	-1	19274460
w@@	O	-1	19274460
ly	O	-1	19274460
diagnos@@	O	-1	19274460
ed	O	-1	19274460
my@@	B-Disease	D009101	19274460
e@@	I-Disease	-1	19274460
lo@@	I-Disease	-1	19274460
ma	I-Disease	-1	19274460
.	O	-1	19274460
A	O	-1	19274460
clinical	O	-1	19274460
trial	O	-1	19274460
was	O	-1	19274460
initi@@	O	-1	19274460
ated	O	-1	19274460
to	O	-1	19274460
evalu@@	O	-1	19274460
ate	O	-1	19274460
the	O	-1	19274460
recomm@@	O	-1	19274460
en@@	O	-1	19274460
ded	O	-1	19274460
dose	O	-1	19274460
of	O	-1	19274460
cyclophosph@@	B-Chemical	D003520	19274460
amide	I-Chemical	-1	19274460
in	O	-1	19274460
combination	O	-1	19274460
with	O	-1	19274460
b@@	B-Chemical	C400082	19274460
or@@	I-Chemical	-1	19274460
te@@	I-Chemical	-1	19274460
z@@	I-Chemical	-1	19274460
om@@	I-Chemical	-1	19274460
i@@	I-Chemical	-1	19274460
b	I-Chemical	-1	19274460
and	O	-1	19274460
de@@	B-Chemical	D003907	19274460
xameth@@	I-Chemical	-1	19274460
as@@	I-Chemical	-1	19274460
one	I-Chemical	-1	19274460
as	O	-1	19274460
induction	O	-1	19274460
treatment	O	-1	19274460
before	O	-1	19274460
st@@	O	-1	19274460
em	O	-1	19274460
cell	O	-1	19274460
transplant@@	O	-1	19274460
ation	O	-1	19274460
for	O	-1	19274460
youn@@	O	-1	19274460
g@@	O	-1	19274460
er	O	-1	19274460
patients	O	-1	19274460
with	O	-1	19274460
ne@@	O	-1	19274460
w@@	O	-1	19274460
ly	O	-1	19274460
diagnos@@	O	-1	19274460
ed	O	-1	19274460
multiple	B-Disease	D009101	19274460
my@@	I-Disease	-1	19274460
e@@	I-Disease	-1	19274460
lo@@	I-Disease	-1	19274460
ma	I-Disease	-1	19274460
(	O	-1	19274460
M@@	B-Disease	D009101	19274460
M	I-Disease	-1	19274460
).	O	-1	19274460
Th@@	O	-1	19274460
ir@@	O	-1	19274460
t@@	O	-1	19274460
y	O	-1	19274460
patients	O	-1	19274460
were	O	-1	19274460
treated	O	-1	19274460
with	O	-1	19274460
three	O	-1	19274460
2@@	O	-1	19274460
1-@@	O	-1	19274460
day	O	-1	19274460
cyc@@	O	-1	19274460
le@@	O	-1	19274460
s	O	-1	19274460
of	O	-1	19274460
b@@	B-Chemical	C400082	19274460
or@@	I-Chemical	-1	19274460
te@@	I-Chemical	-1	19274460
z@@	I-Chemical	-1	19274460
om@@	I-Chemical	-1	19274460
i@@	I-Chemical	-1	19274460
b	I-Chemical	-1	19274460
1.@@	O	-1	19274460
3	O	-1	19274460
mg/m@@	O	-1	19274460
(2@@	O	-1	19274460
)	O	-1	19274460
on	O	-1	19274460
days	O	-1	19274460
1,	O	-1	19274460
4@@	O	-1	19274460
,	O	-1	19274460
8@@	O	-1	19274460
,	O	-1	19274460
and	O	-1	19274460
11	O	-1	19274460
plus	O	-1	19274460
de@@	B-Chemical	D003907	19274460
xameth@@	I-Chemical	-1	19274460
as@@	I-Chemical	-1	19274460
one	I-Chemical	-1	19274460
40	O	-1	19274460
mg	O	-1	19274460
on	O	-1	19274460
the	O	-1	19274460
day	O	-1	19274460
of	O	-1	19274460
b@@	B-Chemical	C400082	19274460
or@@	I-Chemical	-1	19274460
te@@	I-Chemical	-1	19274460
z@@	I-Chemical	-1	19274460
om@@	I-Chemical	-1	19274460
i@@	I-Chemical	-1	19274460
b	I-Chemical	-1	19274460
injection	O	-1	19274460
and	O	-1	19274460
the	O	-1	19274460
day	O	-1	19274460
after	O	-1	19274460
plus	O	-1	19274460
cyclophosph@@	B-Chemical	D003520	19274460
amide	I-Chemical	-1	19274460
at	O	-1	19274460
9@@	O	-1	19274460
0@@	O	-1	19274460
0@@	O	-1	19274460
,	O	-1	19274460
1@@	O	-1	19274460
,@@	O	-1	19274460
20@@	O	-1	19274460
0@@	O	-1	19274460
,	O	-1	19274460
or	O	-1	19274460
1@@	O	-1	19274460
,@@	O	-1	19274460
5@@	O	-1	19274460
00	O	-1	19274460
mg/m@@	O	-1	19274460
(2@@	O	-1	19274460
)	O	-1	19274460
on	O	-1	19274460
day	O	-1	19274460
1@@	O	-1	19274460
.	O	-1	19274460
The	O	-1	19274460
maxim@@	O	-1	19274460
um	O	-1	19274460
toler@@	O	-1	19274460
ated	O	-1	19274460
dose	O	-1	19274460
of	O	-1	19274460
cyclophosph@@	B-Chemical	D003520	19274460
amide	I-Chemical	-1	19274460
was	O	-1	19274460
def@@	O	-1	19274460
in@@	O	-1	19274460
ed	O	-1	19274460
as	O	-1	19274460
9@@	O	-1	19274460
00	O	-1	19274460
mg/m@@	O	-1	19274460
(2@@	O	-1	19274460
).	O	-1	19274460
A@@	O	-1	19274460
t	O	-1	19274460
this	O	-1	19274460
dose	O	-1	19274460
level@@	O	-1	19274460
,	O	-1	19274460
9@@	O	-1	19274460
2@@	O	-1	19274460
%	O	-1	19274460
of	O	-1	19274460
patients	O	-1	19274460
achi@@	O	-1	19274460
ev@@	O	-1	19274460
ed	O	-1	19274460
at	O	-1	19274460
le@@	O	-1	19274460
ast	O	-1	19274460
a	O	-1	19274460
partial	O	-1	19274460
respon@@	O	-1	19274460
se.	O	-1	19274460
The	O	-1	19274460
over@@	O	-1	19274460
all	O	-1	19274460
response	O	-1	19274460
rate	O	-1	19274460
[@@	O	-1	19274460
complete	O	-1	19274460
response	O	-1	19274460
(C@@	O	-1	19274460
R@@	O	-1	19274460
)	O	-1	19274460
plus	O	-1	19274460
partial	O	-1	19274460
response	O	-1	19274460
(P@@	O	-1	19274460
R@@	O	-1	19274460
)@@	O	-1	19274460
]	O	-1	19274460
ac@@	O	-1	19274460
ros@@	O	-1	19274460
s	O	-1	19274460
all	O	-1	19274460
dose	O	-1	19274460
levels	O	-1	19274460
was	O	-1	19274460
7@@	O	-1	19274460
7@@	O	-1	19274460
%,	O	-1	19274460
with	O	-1	19274460
a	O	-1	19274460
10@@	O	-1	19274460
%	O	-1	19274460
C@@	O	-1	19274460
R	O	-1	19274460
rat@@	O	-1	19274460
e.	O	-1	19274460
No	O	-1	19274460
patient	O	-1	19274460
experienced	O	-1	19274460
progressive	O	-1	19274460
disease.	O	-1	19274460
The	O	-1	19274460
most	O	-1	19274460
frequent	O	-1	19274460
adverse	O	-1	19274460
events	O	-1	19274460
were	O	-1	19274460
hemat@@	B-Disease	D006402	19274460
ological	I-Disease	-1	19274460
and	I-Disease	-1	19274460
gast@@	I-Disease	-1	19274460
ro@@	I-Disease	-1	19274460
in@@	I-Disease	-1	19274460
test@@	I-Disease	-1	19274460
inal	I-Disease	-1	19274460
toxic@@	I-Disease	-1	19274460
ities	I-Disease	-1	19274460
hemat@@	B-Disease	D005767	19274460
ological	I-Disease	-1	19274460
and	I-Disease	-1	19274460
gast@@	I-Disease	-1	19274460
ro@@	I-Disease	-1	19274460
in@@	I-Disease	-1	19274460
test@@	I-Disease	-1	19274460
inal	I-Disease	-1	19274460
toxic@@	I-Disease	-1	19274460
ities	I-Disease	-1	19274460
as	O	-1	19274460
well	O	-1	19274460
as	O	-1	19274460
neuropathy	B-Disease	D009422	19274460
.	O	-1	19274460
The	O	-1	19274460
results	O	-1	19274460
suggest	O	-1	19274460
that	O	-1	19274460
b@@	B-Chemical	C400082	19274460
or@@	I-Chemical	-1	19274460
te@@	I-Chemical	-1	19274460
z@@	I-Chemical	-1	19274460
om@@	I-Chemical	-1	19274460
i@@	I-Chemical	-1	19274460
b	I-Chemical	-1	19274460
in	O	-1	19274460
combination	O	-1	19274460
with	O	-1	19274460
cyclophosph@@	B-Chemical	D003520	19274460
amide	I-Chemical	-1	19274460
at	O	-1	19274460
9@@	O	-1	19274460
00	O	-1	19274460
mg/m@@	O	-1	19274460
(2@@	O	-1	19274460
)	O	-1	19274460
and	O	-1	19274460
de@@	B-Chemical	D003907	19274460
xameth@@	I-Chemical	-1	19274460
as@@	I-Chemical	-1	19274460
one	I-Chemical	-1	19274460
is	O	-1	19274460
an	O	-1	19274460
effective	O	-1	19274460
induction	O	-1	19274460
treatment	O	-1	19274460
for	O	-1	19274460
patients	O	-1	19274460
with	O	-1	19274460
ne@@	O	-1	19274460
w@@	O	-1	19274460
ly	O	-1	19274460
diagnos@@	O	-1	19274460
ed	O	-1	19274460
M@@	B-Disease	D009101	19274460
M	I-Disease	-1	19274460
that	O	-1	19274460
war@@	O	-1	19274460
ran@@	O	-1	19274460
ts	O	-1	19274460
further	O	-1	19274460
investig@@	O	-1	19274460
ation.	O	-1	19274460

R@@	O	-1	18201582
es@@	O	-1	18201582
ult@@	O	-1	18201582
s	O	-1	18201582
of	O	-1	18201582
a	O	-1	18201582
compar@@	O	-1	18201582
ati@@	O	-1	18201582
ve,	O	-1	18201582
phase	O	-1	18201582
II@@	O	-1	18201582
I@@	O	-1	18201582
,	O	-1	18201582
1@@	O	-1	18201582
2-@@	O	-1	18201582
week@@	O	-1	18201582
,	O	-1	18201582
mul@@	O	-1	18201582
tic@@	O	-1	18201582
ent@@	O	-1	18201582
er,	O	-1	18201582
pro@@	O	-1	18201582
sp@@	O	-1	18201582
ecti@@	O	-1	18201582
ve,	O	-1	18201582
random@@	O	-1	18201582
iz@@	O	-1	18201582
ed,	O	-1	18201582
double-bl@@	O	-1	18201582
ind	O	-1	18201582
assess@@	O	-1	18201582
ment	O	-1	18201582
of	O	-1	18201582
the	O	-1	18201582
efficacy	O	-1	18201582
and	O	-1	18201582
toler@@	O	-1	18201582
ability	O	-1	18201582
of	O	-1	18201582
a	O	-1	18201582
fi@@	O	-1	18201582
x@@	O	-1	18201582
ed@@	O	-1	18201582
-@@	O	-1	18201582
dose	O	-1	18201582
combination	O	-1	18201582
of	O	-1	18201582
te@@	B-Chemical	C084178	18201582
l@@	I-Chemical	-1	18201582
mis@@	I-Chemical	-1	18201582
ar@@	I-Chemical	-1	18201582
t@@	I-Chemical	-1	18201582
an	I-Chemical	-1	18201582
and	O	-1	18201582
am@@	B-Chemical	D017311	18201582
lo@@	I-Chemical	-1	18201582
di@@	I-Chemical	-1	18201582
pine	I-Chemical	-1	18201582
versus	O	-1	18201582
am@@	B-Chemical	D017311	18201582
lo@@	I-Chemical	-1	18201582
di@@	I-Chemical	-1	18201582
pine	I-Chemical	-1	18201582
mon@@	O	-1	18201582
o@@	O	-1	18201582
therapy	O	-1	18201582
in	O	-1	18201582
In@@	O	-1	18201582
di@@	O	-1	18201582
an	O	-1	18201582
ad@@	O	-1	18201582
ult@@	O	-1	18201582
s	O	-1	18201582
with	O	-1	18201582
st@@	O	-1	18201582
age	O	-1	18201582
II	O	-1	18201582
hypertension	B-Disease	D006973	18201582
.	O	-1	18201582
OBJECTIVE:	O	-1	18201582
The	O	-1	18201582
a@@	O	-1	18201582
im	O	-1	18201582
of	O	-1	18201582
this	O	-1	18201582
study	O	-1	18201582
was	O	-1	18201582
to	O	-1	18201582
evalu@@	O	-1	18201582
ate	O	-1	18201582
the	O	-1	18201582
efficacy	O	-1	18201582
and	O	-1	18201582
toler@@	O	-1	18201582
ability	O	-1	18201582
of	O	-1	18201582
a	O	-1	18201582
new	O	-1	18201582
fi@@	O	-1	18201582
x@@	O	-1	18201582
ed@@	O	-1	18201582
-@@	O	-1	18201582
dose	O	-1	18201582
combination	O	-1	18201582
(@@	O	-1	18201582
F@@	O	-1	18201582
D@@	O	-1	18201582
C@@	O	-1	18201582
)	O	-1	18201582
of	O	-1	18201582
te@@	B-Chemical	C084178	18201582
l@@	I-Chemical	-1	18201582
mis@@	I-Chemical	-1	18201582
ar@@	I-Chemical	-1	18201582
t@@	I-Chemical	-1	18201582
an	I-Chemical	-1	18201582
40	O	-1	18201582
mg	O	-1	18201582
+	O	-1	18201582
am@@	B-Chemical	D017311	18201582
lo@@	I-Chemical	-1	18201582
di@@	I-Chemical	-1	18201582
pine	I-Chemical	-1	18201582
5	O	-1	18201582
mg	O	-1	18201582
(T@@	O	-1	18201582
+@@	O	-1	18201582
A@@	O	-1	18201582
)	O	-1	18201582
compared	O	-1	18201582
with	O	-1	18201582
am@@	B-Chemical	D017311	18201582
lo@@	I-Chemical	-1	18201582
di@@	I-Chemical	-1	18201582
pine	I-Chemical	-1	18201582
5-@@	O	-1	18201582
mg	O	-1	18201582
mon@@	O	-1	18201582
o@@	O	-1	18201582
therapy	O	-1	18201582
(A@@	O	-1	18201582
)	O	-1	18201582
in	O	-1	18201582
ad@@	O	-1	18201582
ult	O	-1	18201582
In@@	O	-1	18201582
di@@	O	-1	18201582
an	O	-1	18201582
patients	O	-1	18201582
with	O	-1	18201582
st@@	O	-1	18201582
age	O	-1	18201582
II	O	-1	18201582
hypertension	B-Disease	D006973	18201582
.	O	-1	18201582
METHODS:	O	-1	18201582
This	O	-1	18201582
compar@@	O	-1	18201582
ati@@	O	-1	18201582
ve,	O	-1	18201582
Ph@@	O	-1	18201582
ase	O	-1	18201582
II@@	O	-1	18201582
I@@	O	-1	18201582
,	O	-1	18201582
1@@	O	-1	18201582
2-@@	O	-1	18201582
week@@	O	-1	18201582
,	O	-1	18201582
mul@@	O	-1	18201582
tic@@	O	-1	18201582
ent@@	O	-1	18201582
er,	O	-1	18201582
pro@@	O	-1	18201582
sp@@	O	-1	18201582
ecti@@	O	-1	18201582
ve,	O	-1	18201582
random@@	O	-1	18201582
iz@@	O	-1	18201582
ed,	O	-1	18201582
double-bl@@	O	-1	18201582
ind	O	-1	18201582
study	O	-1	18201582
was	O	-1	18201582
con@@	O	-1	18201582
duc@@	O	-1	18201582
ted	O	-1	18201582
in	O	-1	18201582
In@@	O	-1	18201582
di@@	O	-1	18201582
an	O	-1	18201582
patients	O	-1	18201582
aged	O	-1	18201582
1@@	O	-1	18201582
8	O	-1	18201582
to	O	-1	18201582
6@@	O	-1	18201582
5	O	-1	18201582
years	O	-1	18201582
with	O	-1	18201582
est@@	O	-1	18201582
abl@@	O	-1	18201582
ished	O	-1	18201582
st@@	O	-1	18201582
age	O	-1	18201582
II	O	-1	18201582
hypertension	B-Disease	D006973	18201582
.	O	-1	18201582
Patients	O	-1	18201582
were	O	-1	18201582
treated	O	-1	18201582
with	O	-1	18201582
oral	O	-1	18201582
F@@	O	-1	18201582
D@@	O	-1	18201582
C	O	-1	18201582
of	O	-1	18201582
T@@	O	-1	18201582
+@@	O	-1	18201582
A	O	-1	18201582
or	O	-1	18201582
A	O	-1	18201582
Q@@	O	-1	18201582
D	O	-1	18201582
before	O	-1	18201582
b@@	O	-1	18201582
re@@	O	-1	18201582
ak@@	O	-1	18201582
f@@	O	-1	18201582
ast	O	-1	18201582
for	O	-1	18201582
12	O	-1	18201582
week@@	O	-1	18201582
s;	O	-1	18201582
blood	O	-1	18201582
pressure	O	-1	18201582
(B@@	O	-1	18201582
P)	O	-1	18201582
and	O	-1	18201582
heart	O	-1	18201582
rate	O	-1	18201582
were	O	-1	18201582
measured	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
sit@@	O	-1	18201582
ting	O	-1	18201582
posi@@	O	-1	18201582
tion.	O	-1	18201582
P@@	O	-1	18201582
ri@@	O	-1	18201582
m@@	O	-1	18201582
ary	O	-1	18201582
efficacy	O	-1	18201582
end	O	-1	18201582
po@@	O	-1	18201582
int@@	O	-1	18201582
s	O	-1	18201582
were	O	-1	18201582
reduction	O	-1	18201582
in	O	-1	18201582
clinical	O	-1	18201582
systolic	O	-1	18201582
B@@	O	-1	18201582
P	O	-1	18201582
(S@@	O	-1	18201582
B@@	O	-1	18201582
P@@	O	-1	18201582
)@@	O	-1	18201582
/	O	-1	18201582
di@@	O	-1	18201582
ast@@	O	-1	18201582
olic	O	-1	18201582
B@@	O	-1	18201582
P	O	-1	18201582
(D@@	O	-1	18201582
B@@	O	-1	18201582
P)	O	-1	18201582
from	O	-1	18201582
baseline	O	-1	18201582
to	O	-1	18201582
study	O	-1	18201582
end	O	-1	18201582
and	O	-1	18201582
number	O	-1	18201582
of	O	-1	18201582
respon@@	O	-1	18201582
der@@	O	-1	18201582
s	O	-1	18201582
(@@	O	-1	18201582
i@@	O	-1	18201582
e,	O	-1	18201582
patients	O	-1	18201582
who	O	-1	18201582
achi@@	O	-1	18201582
ev@@	O	-1	18201582
ed	O	-1	18201582
t@@	O	-1	18201582
arg@@	O	-1	18201582
et	O	-1	18201582
S@@	O	-1	18201582
B@@	O	-1	18201582
P@@	O	-1	18201582
/	O	-1	18201582
D@@	O	-1	18201582
B@@	O	-1	18201582
P	O	-1	18201582
<@@	O	-1	18201582
13@@	O	-1	18201582
0@@	O	-1	18201582
/@@	O	-1	18201582
<@@	O	-1	18201582
8@@	O	-1	18201582
0	O	-1	18201582
mm	O	-1	18201582
H@@	O	-1	18201582
g@@	O	-1	18201582
)	O	-1	18201582
at	O	-1	18201582
end	O	-1	18201582
of	O	-1	18201582
study.	O	-1	18201582
T@@	O	-1	18201582
oler@@	O	-1	18201582
ability	O	-1	18201582
was	O	-1	18201582
assessed	O	-1	18201582
by	O	-1	18201582
treatment@@	O	-1	18201582
-@@	O	-1	18201582
em@@	O	-1	18201582
erg@@	O	-1	18201582
ent	O	-1	18201582
adverse	O	-1	18201582
event@@	O	-1	18201582
s,	O	-1	18201582
identi@@	O	-1	18201582
fied	O	-1	18201582
using	O	-1	18201582
physi@@	O	-1	18201582
c@@	O	-1	18201582
al	O	-1	18201582
examin@@	O	-1	18201582
ation,	O	-1	18201582
labor@@	O	-1	18201582
atory	O	-1	18201582
analy@@	O	-1	18201582
sis,	O	-1	18201582
and	O	-1	18201582
electro@@	O	-1	18201582
cardio@@	O	-1	18201582
graph@@	O	-1	18201582
y.	O	-1	18201582
RESULTS:	O	-1	18201582
A	O	-1	18201582
total	O	-1	18201582
of	O	-1	18201582
2@@	O	-1	18201582
10	O	-1	18201582
patients	O	-1	18201582
were	O	-1	18201582
en@@	O	-1	18201582
ro@@	O	-1	18201582
lled	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
stud@@	O	-1	18201582
y@@	O	-1	18201582
;	O	-1	18201582
20@@	O	-1	18201582
3	O	-1	18201582
patients	O	-1	18201582
(1@@	O	-1	18201582
4@@	O	-1	18201582
3	O	-1	18201582
men@@	O	-1	18201582
,	O	-1	18201582
60	O	-1	18201582
wom@@	O	-1	18201582
en@@	O	-1	18201582
)	O	-1	18201582
comple@@	O	-1	18201582
ted	O	-1	18201582
the	O	-1	18201582
study	O	-1	18201582
while	O	-1	18201582
7	O	-1	18201582
were	O	-1	18201582
lo@@	O	-1	18201582
st	O	-1	18201582
to	O	-1	18201582
follow-up	O	-1	18201582
(@@	O	-1	18201582
4	O	-1	18201582
patients	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
T@@	O	-1	18201582
+@@	O	-1	18201582
A	O	-1	18201582
group	O	-1	18201582
and	O	-1	18201582
3	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
A	O	-1	18201582
group@@	O	-1	18201582
)	O	-1	18201582
and	O	-1	18201582
considered	O	-1	18201582
with@@	O	-1	18201582
-@@	O	-1	18201582
draw@@	O	-1	18201582
n@@	O	-1	18201582
.	O	-1	18201582
A@@	O	-1	18201582
t	O	-1	18201582
study	O	-1	18201582
en@@	O	-1	18201582
d,	O	-1	18201582
statis@@	O	-1	18201582
tically	O	-1	18201582
significant	O	-1	18201582
perc@@	O	-1	18201582
ent@@	O	-1	18201582
age	O	-1	18201582
reduc@@	O	-1	18201582
tions	O	-1	18201582
from	O	-1	18201582
baseline	O	-1	18201582
within	O	-1	18201582
groups	O	-1	18201582
and	O	-1	18201582
between	O	-1	18201582
groups	O	-1	18201582
were	O	-1	18201582
observed	O	-1	18201582
in	O	-1	18201582
S@@	O	-1	18201582
B@@	O	-1	18201582
P	O	-1	18201582
(T@@	O	-1	18201582
+@@	O	-1	18201582
A	O	-1	18201582
[@@	O	-1	18201582
-@@	O	-1	18201582
2@@	O	-1	18201582
7.@@	O	-1	18201582
4@@	O	-1	18201582
%@@	O	-1	18201582
]@@	O	-1	18201582
;	O	-1	18201582
A	O	-1	18201582
[@@	O	-1	18201582
-1@@	O	-1	18201582
6.@@	O	-1	18201582
6@@	O	-1	18201582
%@@	O	-1	18201582
]@@	O	-1	18201582
)	O	-1	18201582
and	O	-1	18201582
D@@	O	-1	18201582
B@@	O	-1	18201582
P	O	-1	18201582
(T@@	O	-1	18201582
+@@	O	-1	18201582
A	O	-1	18201582
[@@	O	-1	18201582
-@@	O	-1	18201582
2@@	O	-1	18201582
0.@@	O	-1	18201582
1@@	O	-1	18201582
%@@	O	-1	18201582
]@@	O	-1	18201582
;	O	-1	18201582
A	O	-1	18201582
[@@	O	-1	18201582
-1@@	O	-1	18201582
3.@@	O	-1	18201582
3@@	O	-1	18201582
%@@	O	-1	18201582
]@@	O	-1	18201582
)	O	-1	18201582
(@@	O	-1	18201582
all@@	O	-1	18201582
,	O	-1	18201582
P	O	-1	18201582
<	O	-1	18201582
0.05@@	O	-1	18201582
).	O	-1	18201582
R@@	O	-1	18201582
es@@	O	-1	18201582
p@@	O	-1	18201582
on@@	O	-1	18201582
se	O	-1	18201582
rat@@	O	-1	18201582
es	O	-1	18201582
were	O	-1	18201582
8@@	O	-1	18201582
7.@@	O	-1	18201582
3@@	O	-1	18201582
%	O	-1	18201582
(@@	O	-1	18201582
8@@	O	-1	18201582
9@@	O	-1	18201582
/@@	O	-1	18201582
10@@	O	-1	18201582
2)	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
T@@	O	-1	18201582
+@@	O	-1	18201582
A	O	-1	18201582
group	O	-1	18201582
and	O	-1	18201582
6@@	O	-1	18201582
9.@@	O	-1	18201582
3@@	O	-1	18201582
%	O	-1	18201582
(@@	O	-1	18201582
7@@	O	-1	18201582
0@@	O	-1	18201582
/@@	O	-1	18201582
10@@	O	-1	18201582
1)	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
A	O	-1	18201582
group	O	-1	18201582
(P	O	-1	18201582
<	O	-1	18201582
0.05@@	O	-1	18201582
).	O	-1	18201582
The	O	-1	18201582
prev@@	O	-1	18201582
al@@	O	-1	18201582
enc@@	O	-1	18201582
es	O	-1	18201582
of	O	-1	18201582
adverse	O	-1	18201582
events	O	-1	18201582
were	O	-1	18201582
not	O	-1	18201582
significantly	O	-1	18201582
different	O	-1	18201582
between	O	-1	18201582
the	O	-1	18201582
2	O	-1	18201582
treatment	O	-1	18201582
groups	O	-1	18201582
(T@@	O	-1	18201582
+@@	O	-1	18201582
A@@	O	-1	18201582
,	O	-1	18201582
1@@	O	-1	18201582
6.@@	O	-1	18201582
0%	O	-1	18201582
[@@	O	-1	18201582
17@@	O	-1	18201582
/@@	O	-1	18201582
10@@	O	-1	18201582
6@@	O	-1	18201582
]@@	O	-1	18201582
;	O	-1	18201582
A@@	O	-1	18201582
,	O	-1	18201582
1@@	O	-1	18201582
5.@@	O	-1	18201582
4@@	O	-1	18201582
%	O	-1	18201582
[@@	O	-1	18201582
1@@	O	-1	18201582
6@@	O	-1	18201582
/@@	O	-1	18201582
10@@	O	-1	18201582
4@@	O	-1	18201582
]@@	O	-1	18201582
).	O	-1	18201582
P@@	O	-1	18201582
er@@	O	-1	18201582
i@@	O	-1	18201582
pheral	O	-1	18201582
e@@	B-Disease	D004487	18201582
de@@	I-Disease	-1	18201582
ma	I-Disease	-1	18201582
was	O	-1	18201582
reported	O	-1	18201582
in	O	-1	18201582
8.@@	O	-1	18201582
5%	O	-1	18201582
patients	O	-1	18201582
(@@	O	-1	18201582
9@@	O	-1	18201582
/@@	O	-1	18201582
10@@	O	-1	18201582
6@@	O	-1	18201582
)	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
T@@	O	-1	18201582
+@@	O	-1	18201582
A	O	-1	18201582
group	O	-1	18201582
compared	O	-1	18201582
with	O	-1	18201582
1@@	O	-1	18201582
3.@@	O	-1	18201582
5%	O	-1	18201582
(1@@	O	-1	18201582
4@@	O	-1	18201582
/@@	O	-1	18201582
10@@	O	-1	18201582
4@@	O	-1	18201582
)	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
A	O	-1	18201582
group@@	O	-1	18201582
,	O	-1	18201582
and	O	-1	18201582
co@@	B-Disease	D003371	18201582
u@@	I-Disease	-1	18201582
gh	I-Disease	-1	18201582
was	O	-1	18201582
reported	O	-1	18201582
in	O	-1	18201582
3.@@	O	-1	18201582
8@@	O	-1	18201582
%	O	-1	18201582
patients	O	-1	18201582
(4@@	O	-1	18201582
/@@	O	-1	18201582
10@@	O	-1	18201582
6@@	O	-1	18201582
)	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
T@@	O	-1	18201582
+@@	O	-1	18201582
A	O	-1	18201582
group	O	-1	18201582
and	O	-1	18201582
1.@@	O	-1	18201582
0%	O	-1	18201582
(1@@	O	-1	18201582
/@@	O	-1	18201582
10@@	O	-1	18201582
4@@	O	-1	18201582
)	O	-1	18201582
patients	O	-1	18201582
in	O	-1	18201582
the	O	-1	18201582
A	O	-1	18201582
group@@	O	-1	18201582
;	O	-1	18201582
these	O	-1	18201582
differences	O	-1	18201582
did	O	-1	18201582
not	O	-1	18201582
reac@@	O	-1	18201582
h	O	-1	18201582
statis@@	O	-1	18201582
tical	O	-1	18201582
signific@@	O	-1	18201582
ance@@	O	-1	18201582
.	O	-1	18201582
The	O	-1	18201582
inc@@	O	-1	18201582
id@@	O	-1	18201582
enc@@	O	-1	18201582
es	O	-1	18201582
of	O	-1	18201582
headac@@	B-Disease	D006261	18201582
he	I-Disease	-1	18201582
,	O	-1	18201582
di@@	B-Disease	D004244	18201582
z@@	I-Disease	-1	18201582
z@@	I-Disease	-1	18201582
in@@	I-Disease	-1	18201582
ess	I-Disease	-1	18201582
,	O	-1	18201582
and	O	-1	18201582
di@@	B-Disease	D003967	18201582
ar@@	I-Disease	-1	18201582
r@@	I-Disease	-1	18201582
he@@	I-Disease	-1	18201582
a	I-Disease	-1	18201582
were	O	-1	18201582
similar	O	-1	18201582
between	O	-1	18201582
the	O	-1	18201582
2	O	-1	18201582
groups.	O	-1	18201582
CONCLUSIONS:	O	-1	18201582
A@@	O	-1	18201582
mon@@	O	-1	18201582
g	O	-1	18201582
these	O	-1	18201582
In@@	O	-1	18201582
di@@	O	-1	18201582
an	O	-1	18201582
patients	O	-1	18201582
with	O	-1	18201582
st@@	O	-1	18201582
age	O	-1	18201582
II	O	-1	18201582
hypertension	B-Disease	D006973	18201582
,	O	-1	18201582
the	O	-1	18201582
F@@	O	-1	18201582
D@@	O	-1	18201582
C	O	-1	18201582
of	O	-1	18201582
T@@	O	-1	18201582
+@@	O	-1	18201582
A	O	-1	18201582
was	O	-1	18201582
found	O	-1	18201582
to	O	-1	18201582
be	O	-1	18201582
significantly	O	-1	18201582
more	O	-1	18201582
eff@@	O	-1	18201582
ecti@@	O	-1	18201582
ve,	O	-1	18201582
with	O	-1	18201582
reg@@	O	-1	18201582
ard	O	-1	18201582
to	O	-1	18201582
B@@	O	-1	18201582
P	O	-1	18201582
reduc@@	O	-1	18201582
tion@@	O	-1	18201582
s,	O	-1	18201582
than	O	-1	18201582
A@@	O	-1	18201582
,	O	-1	18201582
and	O	-1	18201582
both	O	-1	18201582
treat@@	O	-1	18201582
ments	O	-1	18201582
were	O	-1	18201582
well	O	-1	18201582
toler@@	O	-1	18201582
ated.	O	-1	18201582

C@@	B-Disease	D018366	11337188
utaneous	I-Disease	-1	11337188
leu@@	I-Disease	-1	11337188
co@@	I-Disease	-1	11337188
cy@@	I-Disease	-1	11337188
t@@	I-Disease	-1	11337188
oc@@	I-Disease	-1	11337188
las@@	I-Disease	-1	11337188
tic	I-Disease	-1	11337188
vas@@	I-Disease	-1	11337188
cul@@	I-Disease	-1	11337188
iti@@	I-Disease	-1	11337188
s	I-Disease	-1	11337188
associated	O	-1	11337188
with	O	-1	11337188
ox@@	B-Chemical	D010068	11337188
ac@@	I-Chemical	-1	11337188
ill@@	I-Chemical	-1	11337188
in	I-Chemical	-1	11337188
.	O	-1	11337188
A	O	-1	11337188
6@@	O	-1	11337188
7-@@	O	-1	11337188
year-old	O	-1	11337188
man	O	-1	11337188
who	O	-1	11337188
was	O	-1	11337188
treated	O	-1	11337188
with	O	-1	11337188
ox@@	B-Chemical	D010068	11337188
ac@@	I-Chemical	-1	11337188
ill@@	I-Chemical	-1	11337188
in	I-Chemical	-1	11337188
for	O	-1	11337188
one	O	-1	11337188
week	O	-1	11337188
because	O	-1	11337188
of	O	-1	11337188
S@@	B-Disease	D013203	11337188
t@@	I-Disease	-1	11337188
a@@	I-Disease	-1	11337188
ph@@	I-Disease	-1	11337188
y@@	I-Disease	-1	11337188
lo@@	I-Disease	-1	11337188
co@@	I-Disease	-1	11337188
c@@	I-Disease	-1	11337188
c@@	I-Disease	-1	11337188
us	I-Disease	-1	11337188
a@@	I-Disease	-1	11337188
ure@@	I-Disease	-1	11337188
us	I-Disease	-1	11337188
bac@@	I-Disease	-1	11337188
te@@	I-Disease	-1	11337188
re@@	I-Disease	-1	11337188
mia	I-Disease	-1	11337188
S@@	B-Disease	D016470	11337188
t@@	I-Disease	-1	11337188
a@@	I-Disease	-1	11337188
ph@@	I-Disease	-1	11337188
y@@	I-Disease	-1	11337188
lo@@	I-Disease	-1	11337188
co@@	I-Disease	-1	11337188
c@@	I-Disease	-1	11337188
c@@	I-Disease	-1	11337188
us	I-Disease	-1	11337188
a@@	I-Disease	-1	11337188
ure@@	I-Disease	-1	11337188
us	I-Disease	-1	11337188
bac@@	I-Disease	-1	11337188
te@@	I-Disease	-1	11337188
re@@	I-Disease	-1	11337188
mia	I-Disease	-1	11337188
,	O	-1	11337188
developed	O	-1	11337188
renal	B-Disease	D051437	11337188
failure	I-Disease	-1	11337188
and	O	-1	11337188
diff@@	O	-1	11337188
use@@	O	-1	11337188
,	O	-1	11337188
sym@@	O	-1	11337188
met@@	O	-1	11337188
r@@	O	-1	11337188
ic@@	O	-1	11337188
,	O	-1	11337188
p@@	O	-1	11337188
al@@	O	-1	11337188
pa@@	O	-1	11337188
ble	O	-1	11337188
pur@@	B-Disease	D011693	11337188
pur@@	I-Disease	-1	11337188
ic	I-Disease	-1	11337188
lesions	I-Disease	-1	11337188
on	O	-1	11337188
h@@	O	-1	11337188
is	O	-1	11337188
fe@@	O	-1	11337188
et@@	O	-1	11337188
.	O	-1	11337188
N@@	B-Disease	D009336	11337188
ec@@	I-Disease	-1	11337188
ro@@	I-Disease	-1	11337188
tic	I-Disease	-1	11337188
b@@	I-Disease	-1	11337188
li@@	I-Disease	-1	11337188
ster@@	I-Disease	-1	11337188
s	I-Disease	-1	11337188
N@@	B-Disease	D001768	11337188
ec@@	I-Disease	-1	11337188
ro@@	I-Disease	-1	11337188
tic	I-Disease	-1	11337188
b@@	I-Disease	-1	11337188
li@@	I-Disease	-1	11337188
ster@@	I-Disease	-1	11337188
s	I-Disease	-1	11337188
were	O	-1	11337188
not@@	O	-1	11337188
ed	O	-1	11337188
on	O	-1	11337188
h@@	O	-1	11337188
is	O	-1	11337188
f@@	O	-1	11337188
ing@@	O	-1	11337188
ers.	O	-1	11337188
S@@	O	-1	11337188
k@@	O	-1	11337188
in	O	-1	11337188
biop@@	O	-1	11337188
si@@	O	-1	11337188
es	O	-1	11337188
showed	O	-1	11337188
findings	O	-1	11337188
diagnos@@	O	-1	11337188
tic	O	-1	11337188
of	O	-1	11337188
leu@@	B-Disease	D018366	11337188
co@@	I-Disease	-1	11337188
cy@@	I-Disease	-1	11337188
t@@	I-Disease	-1	11337188
oc@@	I-Disease	-1	11337188
las@@	I-Disease	-1	11337188
tic	I-Disease	-1	11337188
vas@@	I-Disease	-1	11337188
cul@@	I-Disease	-1	11337188
iti@@	I-Disease	-1	11337188
s	I-Disease	-1	11337188
.	O	-1	11337188
O@@	B-Chemical	D010068	11337188
x@@	I-Chemical	-1	11337188
ac@@	I-Chemical	-1	11337188
ill@@	I-Chemical	-1	11337188
in	I-Chemical	-1	11337188
was	O	-1	11337188
discontinu@@	O	-1	11337188
ed	O	-1	11337188
and	O	-1	11337188
patient	O	-1	11337188
was	O	-1	11337188
treated	O	-1	11337188
with	O	-1	11337188
cortico@@	B-Chemical	D000305	11337188
steroid@@	I-Chemical	-1	11337188
s	I-Chemical	-1	11337188
.	O	-1	11337188
The	O	-1	11337188
r@@	B-Disease	D005076	11337188
as@@	I-Disease	-1	11337188
h	I-Disease	-1	11337188
dis@@	O	-1	11337188
appe@@	O	-1	11337188
a@@	O	-1	11337188
red	O	-1	11337188
after	O	-1	11337188
three	O	-1	11337188
weeks	O	-1	11337188
and	O	-1	11337188
renal	O	-1	11337188
function	O	-1	11337188
retur@@	O	-1	11337188
n@@	O	-1	11337188
ed	O	-1	11337188
to	O	-1	11337188
normal@@	O	-1	11337188
.	O	-1	11337188
L@@	B-Disease	D018366	11337188
eu@@	I-Disease	-1	11337188
co@@	I-Disease	-1	11337188
cy@@	I-Disease	-1	11337188
t@@	I-Disease	-1	11337188
oc@@	I-Disease	-1	11337188
las@@	I-Disease	-1	11337188
tic	I-Disease	-1	11337188
vas@@	I-Disease	-1	11337188
cul@@	I-Disease	-1	11337188
iti@@	I-Disease	-1	11337188
s	I-Disease	-1	11337188
pres@@	O	-1	11337188
ents	O	-1	11337188
as	O	-1	11337188
p@@	O	-1	11337188
al@@	O	-1	11337188
pa@@	O	-1	11337188
ble	O	-1	11337188
pur@@	B-Disease	D011693	11337188
pur@@	I-Disease	-1	11337188
a	I-Disease	-1	11337188
of	O	-1	11337188
the	O	-1	11337188
lower	O	-1	11337188
ex@@	O	-1	11337188
trem@@	O	-1	11337188
ities	O	-1	11337188
often	O	-1	11337188
ac@@	O	-1	11337188
comp@@	O	-1	11337188
an@@	O	-1	11337188
ied	O	-1	11337188
by	O	-1	11337188
ab@@	B-Disease	D015746	11337188
domin@@	I-Disease	-1	11337188
al	I-Disease	-1	11337188
pain	I-Disease	-1	11337188
,	O	-1	11337188
arth@@	B-Disease	D018771	11337188
r@@	I-Disease	-1	11337188
al@@	I-Disease	-1	11337188
g@@	I-Disease	-1	11337188
ia	I-Disease	-1	11337188
,	O	-1	11337188
and	O	-1	11337188
renal	B-Disease	D007674	11337188
invol@@	I-Disease	-1	11337188
vement	I-Disease	-1	11337188
.	O	-1	11337188
E@@	O	-1	11337188
ti@@	O	-1	11337188
ologic	O	-1	11337188
factors	O	-1	11337188
or	O	-1	11337188
associated	O	-1	11337188
disorder@@	O	-1	11337188
s	O	-1	11337188
includ@@	O	-1	11337188
e	O	-1	11337188
inf@@	B-Disease	D007239	11337188
ec@@	I-Disease	-1	11337188
tions	I-Disease	-1	11337188
,	O	-1	11337188
medic@@	O	-1	11337188
ation@@	O	-1	11337188
s,	O	-1	11337188
coll@@	B-Disease	D003095	11337188
ag@@	I-Disease	-1	11337188
en	I-Disease	-1	11337188
vascular	I-Disease	-1	11337188
disease	I-Disease	-1	11337188
and	O	-1	11337188
ne@@	B-Disease	D009369	11337188
o@@	I-Disease	-1	11337188
pl@@	I-Disease	-1	11337188
a@@	I-Disease	-1	11337188
sia	I-Disease	-1	11337188
.	O	-1	11337188
However,	O	-1	11337188
in	O	-1	11337188
h@@	O	-1	11337188
al@@	O	-1	11337188
f	O	-1	11337188
of	O	-1	11337188
the	O	-1	11337188
cases	O	-1	11337188
no	O	-1	11337188
e@@	O	-1	11337188
ti@@	O	-1	11337188
ologic	O	-1	11337188
factor	O	-1	11337188
is	O	-1	11337188
identi@@	O	-1	11337188
fi@@	O	-1	11337188
ed.	O	-1	11337188
U@@	O	-1	11337188
su@@	O	-1	11337188
ally	O	-1	11337188
it	O	-1	11337188
is	O	-1	11337188
a	O	-1	11337188
sel@@	O	-1	11337188
f@@	O	-1	11337188
-@@	O	-1	11337188
lim@@	O	-1	11337188
ited	O	-1	11337188
disorder@@	O	-1	11337188
,	O	-1	11337188
but	O	-1	11337188
cortico@@	B-Chemical	D000305	11337188
ster@@	I-Chemical	-1	11337188
oid	I-Chemical	-1	11337188
therapy	O	-1	11337188
may	O	-1	11337188
be	O	-1	11337188
ne@@	O	-1	11337188
ed@@	O	-1	11337188
ed	O	-1	11337188
in	O	-1	11337188
lif@@	O	-1	11337188
e-@@	O	-1	11337188
th@@	O	-1	11337188
reat@@	O	-1	11337188
en@@	O	-1	11337188
ing	O	-1	11337188
cases	O	-1	11337188
s@@	O	-1	11337188
inc@@	O	-1	11337188
e	O	-1	11337188
early	O	-1	11337188
treatment	O	-1	11337188
with	O	-1	11337188
cortico@@	B-Chemical	D000305	11337188
steroid@@	I-Chemical	-1	11337188
s	I-Chemical	-1	11337188
in	O	-1	11337188
severe	O	-1	11337188
cases	O	-1	11337188
can	O	-1	11337188
prev@@	O	-1	11337188
ent	O	-1	11337188
complic@@	O	-1	11337188
ations.	O	-1	11337188
O@@	B-Chemical	D010068	11337188
x@@	I-Chemical	-1	11337188
ac@@	I-Chemical	-1	11337188
ill@@	I-Chemical	-1	11337188
in	I-Chemical	-1	11337188
should	O	-1	11337188
be	O	-1	11337188
included	O	-1	11337188
among	O	-1	11337188
the	O	-1	11337188
drugs	O	-1	11337188
that	O	-1	11337188
can	O	-1	11337188
cause	O	-1	11337188
leu@@	B-Disease	D018366	11337188
co@@	I-Disease	-1	11337188
cy@@	I-Disease	-1	11337188
t@@	I-Disease	-1	11337188
oc@@	I-Disease	-1	11337188
las@@	I-Disease	-1	11337188
tic	I-Disease	-1	11337188
vas@@	I-Disease	-1	11337188
cul@@	I-Disease	-1	11337188
iti@@	I-Disease	-1	11337188
s	I-Disease	-1	11337188
.	O	-1	11337188

N@@	B-Chemical	C024224	6308526
al@@	I-Chemical	-1	6308526
ox@@	I-Chemical	-1	6308526
az@@	I-Chemical	-1	6308526
one	I-Chemical	-1	6308526
pretreatment	O	-1	6308526
mo@@	O	-1	6308526
di@@	O	-1	6308526
fi@@	O	-1	6308526
es	O	-1	6308526
cardio@@	O	-1	6308526
res@@	O	-1	6308526
pi@@	O	-1	6308526
rat@@	O	-1	6308526
or@@	O	-1	6308526
y,	O	-1	6308526
tem@@	O	-1	6308526
per@@	O	-1	6308526
at@@	O	-1	6308526
ure,	O	-1	6308526
and	O	-1	6308526
behavioral	O	-1	6308526
effects	O	-1	6308526
of	O	-1	6308526
morphine	B-Chemical	D009020	6308526
.	O	-1	6308526
B@@	O	-1	6308526
e@@	O	-1	6308526
havi@@	O	-1	6308526
oral	O	-1	6308526
and	O	-1	6308526
cardio@@	O	-1	6308526
respiratory	O	-1	6308526
responses	O	-1	6308526
to	O	-1	6308526
a	O	-1	6308526
le@@	O	-1	6308526
th@@	O	-1	6308526
al	O	-1	6308526
dose	O	-1	6308526
of	O	-1	6308526
morphine	B-Chemical	D009020	6308526
were	O	-1	6308526
evaluated	O	-1	6308526
in	O	-1	6308526
rats	O	-1	6308526
pre@@	O	-1	6308526
treated	O	-1	6308526
with	O	-1	6308526
saline	O	-1	6308526
or	O	-1	6308526
n@@	B-Chemical	C024224	6308526
al@@	I-Chemical	-1	6308526
ox@@	I-Chemical	-1	6308526
az@@	I-Chemical	-1	6308526
one	I-Chemical	-1	6308526
,	O	-1	6308526
an	O	-1	6308526
antagonist	O	-1	6308526
of	O	-1	6308526
high-@@	O	-1	6308526
aff@@	O	-1	6308526
in@@	O	-1	6308526
ity	O	-1	6308526
m@@	O	-1	6308526
u	O	-1	6308526
1	O	-1	6308526
o@@	O	-1	6308526
pi@@	O	-1	6308526
oid	O	-1	6308526
receptor@@	O	-1	6308526
s.	O	-1	6308526
Pre@@	O	-1	6308526
treatment	O	-1	6308526
with	O	-1	6308526
n@@	B-Chemical	C024224	6308526
al@@	I-Chemical	-1	6308526
ox@@	I-Chemical	-1	6308526
az@@	I-Chemical	-1	6308526
one	I-Chemical	-1	6308526
significantly	O	-1	6308526
block@@	O	-1	6308526
ed	O	-1	6308526
morphine	B-Chemical	D009020	6308526
analge@@	B-Disease	D000699	6308526
sia	I-Disease	-1	6308526
,	O	-1	6308526
cat@@	B-Disease	D002375	6308526
al@@	I-Disease	-1	6308526
ep@@	I-Disease	-1	6308526
sy	I-Disease	-1	6308526
and	O	-1	6308526
hypo@@	B-Disease	D007035	6308526
ther@@	I-Disease	-1	6308526
mia	I-Disease	-1	6308526
at	O	-1	6308526
a	O	-1	6308526
dose	O	-1	6308526
which	O	-1	6308526
complete@@	O	-1	6308526
ly	O	-1	6308526
el@@	O	-1	6308526
im@@	O	-1	6308526
in@@	O	-1	6308526
ated	O	-1	6308526
high-@@	O	-1	6308526
aff@@	O	-1	6308526
in@@	O	-1	6308526
ity	O	-1	6308526
b@@	O	-1	6308526
ind@@	O	-1	6308526
ing	O	-1	6308526
in	O	-1	6308526
brain	O	-1	6308526
membran@@	O	-1	6308526
es.	O	-1	6308526
M@@	O	-1	6308526
ore@@	O	-1	6308526
o@@	O	-1	6308526
ver,	O	-1	6308526
n@@	B-Chemical	C024224	6308526
al@@	I-Chemical	-1	6308526
ox@@	I-Chemical	-1	6308526
az@@	I-Chemical	-1	6308526
one	I-Chemical	-1	6308526
significantly	O	-1	6308526
attenu@@	O	-1	6308526
ated	O	-1	6308526
the	O	-1	6308526
morphine	B-Chemical	D009020	6308526
-induced	O	-1	6308526
hypotension	B-Disease	D007022	6308526
and	O	-1	6308526
respiratory	B-Disease	D012131	6308526
de@@	I-Disease	-1	6308526
pression	I-Disease	-1	6308526
,	O	-1	6308526
whereas	O	-1	6308526
morphine	B-Chemical	D009020	6308526
-induced	O	-1	6308526
brady@@	B-Disease	D001919	6308526
cardia	I-Disease	-1	6308526
was	O	-1	6308526
less	O	-1	6308526
aff@@	O	-1	6308526
ect@@	O	-1	6308526
ed.	O	-1	6308526
R@@	O	-1	6308526
es@@	O	-1	6308526
ult@@	O	-1	6308526
s	O	-1	6308526
indicate	O	-1	6308526
that	O	-1	6308526
sub@@	O	-1	6308526
po@@	O	-1	6308526
pul@@	O	-1	6308526
ations	O	-1	6308526
of	O	-1	6308526
m@@	O	-1	6308526
u	O	-1	6308526
receptors	O	-1	6308526
may	O	-1	6308526
medi@@	O	-1	6308526
ate	O	-1	6308526
selective	O	-1	6308526
behavioral	O	-1	6308526
and	O	-1	6308526
cardio@@	O	-1	6308526
respiratory	O	-1	6308526
responses	O	-1	6308526
to	O	-1	6308526
morphine	B-Chemical	D009020	6308526
.	O	-1	6308526

D@@	B-Chemical	D064730	15897593
ex@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
prot@@	O	-1	15897593
ects	O	-1	15897593
against	O	-1	15897593
my@@	B-Disease	D001855	15897593
e@@	I-Disease	-1	15897593
lo@@	I-Disease	-1	15897593
sup@@	I-Disease	-1	15897593
pression	I-Disease	-1	15897593
from	O	-1	15897593
the	O	-1	15897593
D@@	O	-1	15897593
NA	O	-1	15897593
c@@	O	-1	15897593
le@@	O	-1	15897593
av@@	O	-1	15897593
ag@@	O	-1	15897593
e-@@	O	-1	15897593
enh@@	O	-1	15897593
anc@@	O	-1	15897593
ing	O	-1	15897593
drugs	O	-1	15897593
e@@	B-Chemical	D005047	15897593
to@@	I-Chemical	-1	15897593
po@@	I-Chemical	-1	15897593
side	I-Chemical	-1	15897593
and	O	-1	15897593
da@@	B-Chemical	D003630	15897593
un@@	I-Chemical	-1	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
but	O	-1	15897593
not	O	-1	15897593
dox@@	B-Chemical	D004317	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
.	O	-1	15897593
P@@	O	-1	15897593
U@@	O	-1	15897593
R@@	O	-1	15897593
P@@	O	-1	15897593
O@@	O	-1	15897593
S@@	O	-1	15897593
E:	O	-1	15897593
The	O	-1	15897593
an@@	B-Chemical	D018943	15897593
th@@	I-Chemical	-1	15897593
rac@@	I-Chemical	-1	15897593
y@@	I-Chemical	-1	15897593
clin@@	I-Chemical	-1	15897593
es	I-Chemical	-1	15897593
da@@	B-Chemical	D003630	15897593
un@@	I-Chemical	-1	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
and	O	-1	15897593
dox@@	B-Chemical	D004317	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
and	O	-1	15897593
the	O	-1	15897593
epi@@	B-Chemical	D011034	15897593
po@@	I-Chemical	-1	15897593
do@@	I-Chemical	-1	15897593
phyl@@	I-Chemical	-1	15897593
lo@@	I-Chemical	-1	15897593
tox@@	I-Chemical	-1	15897593
in	I-Chemical	-1	15897593
e@@	B-Chemical	D005047	15897593
to@@	I-Chemical	-1	15897593
po@@	I-Chemical	-1	15897593
side	I-Chemical	-1	15897593
are	O	-1	15897593
pot@@	O	-1	15897593
ent	O	-1	15897593
D@@	O	-1	15897593
NA	O	-1	15897593
c@@	O	-1	15897593
le@@	O	-1	15897593
av@@	O	-1	15897593
ag@@	O	-1	15897593
e-@@	O	-1	15897593
enh@@	O	-1	15897593
anc@@	O	-1	15897593
ing	O	-1	15897593
drugs	O	-1	15897593
that	O	-1	15897593
are	O	-1	15897593
wi@@	O	-1	15897593
de@@	O	-1	15897593
ly	O	-1	15897593
used	O	-1	15897593
in	O	-1	15897593
clinical	O	-1	15897593
on@@	O	-1	15897593
co@@	O	-1	15897593
log@@	O	-1	15897593
y@@	O	-1	15897593
;	O	-1	15897593
however,	O	-1	15897593
my@@	B-Disease	D001855	15897593
e@@	I-Disease	-1	15897593
lo@@	I-Disease	-1	15897593
sup@@	I-Disease	-1	15897593
pression	I-Disease	-1	15897593
and	O	-1	15897593
cardiac	B-Disease	D066126	15897593
toxicity	I-Disease	-1	15897593
lim@@	O	-1	15897593
it	O	-1	15897593
their	O	-1	15897593
use.	O	-1	15897593
D@@	B-Chemical	D064730	15897593
ex@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
(	O	-1	15897593
I@@	B-Chemical	D064730	15897593
CR@@	I-Chemical	-1	15897593
F@@	I-Chemical	-1	15897593
-1@@	I-Chemical	-1	15897593
8@@	I-Chemical	-1	15897593
7	I-Chemical	-1	15897593
)	O	-1	15897593
is	O	-1	15897593
recomm@@	O	-1	15897593
en@@	O	-1	15897593
ded	O	-1	15897593
for	O	-1	15897593
prot@@	O	-1	15897593
ection	O	-1	15897593
against	O	-1	15897593
an@@	B-Chemical	D018943	15897593
th@@	I-Chemical	-1	15897593
rac@@	I-Chemical	-1	15897593
y@@	I-Chemical	-1	15897593
cl@@	I-Chemical	-1	15897593
ine	I-Chemical	-1	15897593
-induced	O	-1	15897593
cardi@@	B-Disease	D066126	15897593
otoxicity	I-Disease	-1	15897593
.	O	-1	15897593
E@@	O	-1	15897593
X@@	O	-1	15897593
P@@	O	-1	15897593
E@@	O	-1	15897593
R@@	O	-1	15897593
I@@	O	-1	15897593
M@@	O	-1	15897593
E@@	O	-1	15897593
N@@	O	-1	15897593
TA@@	O	-1	15897593
L	O	-1	15897593
D@@	O	-1	15897593
ES@@	O	-1	15897593
I@@	O	-1	15897593
G@@	O	-1	15897593
N@@	O	-1	15897593
:	O	-1	15897593
B@@	O	-1	15897593
ecause	O	-1	15897593
of	O	-1	15897593
their	O	-1	15897593
w@@	O	-1	15897593
id@@	O	-1	15897593
es@@	O	-1	15897593
pre@@	O	-1	15897593
ad	O	-1	15897593
use@@	O	-1	15897593
,	O	-1	15897593
the	O	-1	15897593
hemat@@	B-Disease	D006402	15897593
ologic	I-Disease	-1	15897593
toxicity	I-Disease	-1	15897593
following	O	-1	15897593
co@@	O	-1	15897593
administration	O	-1	15897593
of	O	-1	15897593
de@@	B-Chemical	D064730	15897593
x@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
and	O	-1	15897593
these	O	-1	15897593
three	O	-1	15897593
struct@@	O	-1	15897593
ur@@	O	-1	15897593
ally	O	-1	15897593
different	O	-1	15897593
D@@	O	-1	15897593
NA	O	-1	15897593
c@@	O	-1	15897593
le@@	O	-1	15897593
av@@	O	-1	15897593
age	O	-1	15897593
enh@@	O	-1	15897593
anc@@	O	-1	15897593
ers	O	-1	15897593
was	O	-1	15897593
investig@@	O	-1	15897593
ated@@	O	-1	15897593
:	O	-1	15897593
S@@	O	-1	15897593
en@@	O	-1	15897593
si@@	O	-1	15897593
tivity	O	-1	15897593
of	O	-1	15897593
human	O	-1	15897593
and	O	-1	15897593
m@@	O	-1	15897593
urine	O	-1	15897593
blood	O	-1	15897593
pro@@	O	-1	15897593
gen@@	O	-1	15897593
it@@	O	-1	15897593
or	O	-1	15897593
cells	O	-1	15897593
to	O	-1	15897593
e@@	B-Chemical	D005047	15897593
to@@	I-Chemical	-1	15897593
po@@	I-Chemical	-1	15897593
side	I-Chemical	-1	15897593
,	O	-1	15897593
da@@	B-Chemical	D003630	15897593
un@@	I-Chemical	-1	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
,	O	-1	15897593
and	O	-1	15897593
dox@@	B-Chemical	D004317	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
+/-	O	-1	15897593
de@@	B-Chemical	D064730	15897593
x@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
was	O	-1	15897593
determined	O	-1	15897593
in	O	-1	15897593
gran@@	O	-1	15897593
ulo@@	O	-1	15897593
cy@@	O	-1	15897593
te@@	O	-1	15897593
-@@	O	-1	15897593
mac@@	O	-1	15897593
ro@@	O	-1	15897593
ph@@	O	-1	15897593
age	O	-1	15897593
co@@	O	-1	15897593
lon@@	O	-1	15897593
y	O	-1	15897593
form@@	O	-1	15897593
ing	O	-1	15897593
ass@@	O	-1	15897593
ay@@	O	-1	15897593
s.	O	-1	15897593
L@@	O	-1	15897593
i@@	O	-1	15897593
ke@@	O	-1	15897593
wi@@	O	-1	15897593
se@@	O	-1	15897593
,	O	-1	15897593
in	O	-1	15897593
viv@@	O	-1	15897593
o@@	O	-1	15897593
,	O	-1	15897593
B@@	O	-1	15897593
6@@	O	-1	15897593
D@@	O	-1	15897593
2@@	O	-1	15897593
F@@	O	-1	15897593
1	O	-1	15897593
mice	O	-1	15897593
were	O	-1	15897593
treated	O	-1	15897593
with	O	-1	15897593
e@@	B-Chemical	D005047	15897593
to@@	I-Chemical	-1	15897593
po@@	I-Chemical	-1	15897593
side	I-Chemical	-1	15897593
,	O	-1	15897593
da@@	B-Chemical	D003630	15897593
un@@	I-Chemical	-1	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
,	O	-1	15897593
and	O	-1	15897593
dox@@	B-Chemical	D004317	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
,	O	-1	15897593
with	O	-1	15897593
or	O	-1	15897593
without	O	-1	15897593
de@@	B-Chemical	D064730	15897593
x@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
over	O	-1	15897593
a	O	-1	15897593
w@@	O	-1	15897593
ide	O	-1	15897593
range	O	-1	15897593
of	O	-1	15897593
dos@@	O	-1	15897593
es@@	O	-1	15897593
:	O	-1	15897593
post@@	O	-1	15897593
treatment,	O	-1	15897593
a	O	-1	15897593
ful@@	O	-1	15897593
l	O	-1	15897593
hemat@@	O	-1	15897593
ologic	O	-1	15897593
evalu@@	O	-1	15897593
ation	O	-1	15897593
was	O	-1	15897593
d@@	O	-1	15897593
one.	O	-1	15897593
RESULTS:	O	-1	15897593
N@@	O	-1	15897593
on@@	O	-1	15897593
toxic	O	-1	15897593
doses	O	-1	15897593
of	O	-1	15897593
de@@	B-Chemical	D064730	15897593
x@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
reduced	O	-1	15897593
my@@	B-Disease	D001855	15897593
e@@	I-Disease	-1	15897593
lo@@	I-Disease	-1	15897593
sup@@	I-Disease	-1	15897593
pression	I-Disease	-1	15897593
and	O	-1	15897593
weight	B-Disease	D015431	15897593
loss	I-Disease	-1	15897593
from	O	-1	15897593
da@@	B-Chemical	D003630	15897593
un@@	I-Chemical	-1	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
and	O	-1	15897593
e@@	B-Chemical	D005047	15897593
to@@	I-Chemical	-1	15897593
po@@	I-Chemical	-1	15897593
side	I-Chemical	-1	15897593
in	O	-1	15897593
mice	O	-1	15897593
and	O	-1	15897593
antagon@@	O	-1	15897593
ized	O	-1	15897593
their	O	-1	15897593
anti@@	O	-1	15897593
pro@@	O	-1	15897593
li@@	O	-1	15897593
fer@@	O	-1	15897593
ative	O	-1	15897593
effects	O	-1	15897593
in	O	-1	15897593
the	O	-1	15897593
co@@	O	-1	15897593
lon@@	O	-1	15897593
y	O	-1	15897593
ass@@	O	-1	15897593
ay@@	O	-1	15897593
;	O	-1	15897593
however,	O	-1	15897593
de@@	B-Chemical	D064730	15897593
x@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
ne@@	O	-1	15897593
ither	O	-1	15897593
reduced	O	-1	15897593
my@@	B-Disease	D001855	15897593
e@@	I-Disease	-1	15897593
lo@@	I-Disease	-1	15897593
sup@@	I-Disease	-1	15897593
pression	I-Disease	-1	15897593
,	O	-1	15897593
weight	B-Disease	D015431	15897593
loss	I-Disease	-1	15897593
,	O	-1	15897593
n@@	O	-1	15897593
or	O	-1	15897593
the	O	-1	15897593
in	O	-1	15897593
vit@@	O	-1	15897593
r@@	O	-1	15897593
o	O	-1	15897593
cy@@	B-Disease	D064420	15897593
tot@@	I-Disease	-1	15897593
oxic@@	I-Disease	-1	15897593
ity	I-Disease	-1	15897593
from	O	-1	15897593
dox@@	B-Chemical	D004317	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
.	O	-1	15897593
CONCLUSION:	O	-1	15897593
Although	O	-1	15897593
our	O	-1	15897593
findings	O	-1	15897593
suppor@@	O	-1	15897593
t	O	-1	15897593
the	O	-1	15897593
observ@@	O	-1	15897593
ation	O	-1	15897593
that	O	-1	15897593
de@@	B-Chemical	D064730	15897593
x@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
reduc@@	O	-1	15897593
es	O	-1	15897593
ne@@	O	-1	15897593
ither	O	-1	15897593
hemat@@	O	-1	15897593
ologic	O	-1	15897593
activity	O	-1	15897593
n@@	O	-1	15897593
or	O	-1	15897593
anti@@	O	-1	15897593
tumor	O	-1	15897593
activity	O	-1	15897593
from	O	-1	15897593
dox@@	B-Chemical	D004317	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
clin@@	O	-1	15897593
ic@@	O	-1	15897593
ally,	O	-1	15897593
the	O	-1	15897593
pot@@	O	-1	15897593
ent	O	-1	15897593
antagon@@	O	-1	15897593
ism	O	-1	15897593
of	O	-1	15897593
da@@	B-Chemical	D003630	15897593
un@@	I-Chemical	-1	15897593
orub@@	I-Chemical	-1	15897593
icin	I-Chemical	-1	15897593
activity	O	-1	15897593
ra@@	O	-1	15897593
i@@	O	-1	15897593
ses	O	-1	15897593
con@@	O	-1	15897593
cer@@	O	-1	15897593
n@@	O	-1	15897593
;	O	-1	15897593
a	O	-1	15897593
possible	O	-1	15897593
inter@@	O	-1	15897593
fe@@	O	-1	15897593
rence	O	-1	15897593
with	O	-1	15897593
anti@@	O	-1	15897593
cancer	O	-1	15897593
efficacy	O	-1	15897593
cer@@	O	-1	15897593
t@@	O	-1	15897593
ain@@	O	-1	15897593
ly	O	-1	15897593
wo@@	O	-1	15897593
uld	O	-1	15897593
c@@	O	-1	15897593
all	O	-1	15897593
for	O	-1	15897593
re@@	O	-1	15897593
ne@@	O	-1	15897593
w@@	O	-1	15897593
ed	O	-1	15897593
atten@@	O	-1	15897593
tion.	O	-1	15897593
Our	O	-1	15897593
data	O	-1	15897593
also	O	-1	15897593
suggest	O	-1	15897593
that	O	-1	15897593
significant	O	-1	15897593
e@@	B-Chemical	D005047	15897593
to@@	I-Chemical	-1	15897593
po@@	I-Chemical	-1	15897593
side	I-Chemical	-1	15897593
dose	O	-1	15897593
es@@	O	-1	15897593
cal@@	O	-1	15897593
ation	O	-1	15897593
is	O	-1	15897593
per@@	O	-1	15897593
h@@	O	-1	15897593
ap@@	O	-1	15897593
s	O	-1	15897593
possible	O	-1	15897593
by	O	-1	15897593
the	O	-1	15897593
use	O	-1	15897593
of	O	-1	15897593
de@@	B-Chemical	D064730	15897593
x@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
.	O	-1	15897593
Clin@@	O	-1	15897593
ical	O	-1	15897593
tri@@	O	-1	15897593
als	O	-1	15897593
in	O	-1	15897593
patients	O	-1	15897593
with	O	-1	15897593
brain	O	-1	15897593
met@@	B-Disease	D009362	15897593
ast@@	I-Disease	-1	15897593
as@@	I-Disease	-1	15897593
es	I-Disease	-1	15897593
combin@@	O	-1	15897593
ing	O	-1	15897593
de@@	B-Chemical	D064730	15897593
x@@	I-Chemical	-1	15897593
ra@@	I-Chemical	-1	15897593
z@@	I-Chemical	-1	15897593
ox@@	I-Chemical	-1	15897593
ane	I-Chemical	-1	15897593
and	O	-1	15897593
high	O	-1	15897593
doses	O	-1	15897593
of	O	-1	15897593
e@@	B-Chemical	D005047	15897593
to@@	I-Chemical	-1	15897593
po@@	I-Chemical	-1	15897593
side	I-Chemical	-1	15897593
is	O	-1	15897593
on@@	O	-1	15897593
go@@	O	-1	15897593
ing	O	-1	15897593
with	O	-1	15897593
the	O	-1	15897593
a@@	O	-1	15897593
im	O	-1	15897593
of	O	-1	15897593
impro@@	O	-1	15897593
ving	O	-1	15897593
efficacy	O	-1	15897593
without	O	-1	15897593
ag@@	O	-1	15897593
gra@@	O	-1	15897593
v@@	O	-1	15897593
ating	O	-1	15897593
hemat@@	B-Disease	D006402	15897593
ologic	I-Disease	-1	15897593
toxicity	I-Disease	-1	15897593
.	O	-1	15897593
I@@	O	-1	15897593
f	O	-1	15897593
suc@@	O	-1	15897593
cess@@	O	-1	15897593
ful@@	O	-1	15897593
,	O	-1	15897593
this	O	-1	15897593
re@@	O	-1	15897593
pres@@	O	-1	15897593
ents	O	-1	15897593
an	O	-1	15897593
ex@@	O	-1	15897593
cit@@	O	-1	15897593
ing	O	-1	15897593
mechanism	O	-1	15897593
for	O	-1	15897593
pharmac@@	O	-1	15897593
ologic	O	-1	15897593
reg@@	O	-1	15897593
ulation	O	-1	15897593
of	O	-1	15897593
side	O	-1	15897593
effects	O	-1	15897593
from	O	-1	15897593
cy@@	O	-1	15897593
tot@@	O	-1	15897593
ox@@	O	-1	15897593
ic	O	-1	15897593
chemo@@	O	-1	15897593
therapy.	O	-1	15897593

Eff@@	O	-1	6817363
ects	O	-1	6817363
of	O	-1	6817363
the	O	-1	6817363
novel	O	-1	6817363
comp@@	O	-1	6817363
ound	O	-1	6817363
an@@	B-Chemical	C036466	6817363
i@@	I-Chemical	-1	6817363
rac@@	I-Chemical	-1	6817363
et@@	I-Chemical	-1	6817363
am	I-Chemical	-1	6817363
(	O	-1	6817363
R@@	B-Chemical	C036466	6817363
o	I-Chemical	-1	6817363
1@@	I-Chemical	-1	6817363
3-@@	I-Chemical	-1	6817363
50@@	I-Chemical	-1	6817363
5@@	I-Chemical	-1	6817363
7	I-Chemical	-1	6817363
)	O	-1	6817363
up@@	O	-1	6817363
on	O	-1	6817363
impaired	B-Disease	D007859	6817363
lear@@	I-Disease	-1	6817363
ning	I-Disease	-1	6817363
and	I-Disease	-1	6817363
memory	I-Disease	-1	6817363
impaired	B-Disease	D008569	6817363
lear@@	I-Disease	-1	6817363
ning	I-Disease	-1	6817363
and	I-Disease	-1	6817363
memory	I-Disease	-1	6817363
in	O	-1	6817363
ro@@	O	-1	6817363
d@@	O	-1	6817363
ent@@	O	-1	6817363
s.	O	-1	6817363
The	O	-1	6817363
effect	O	-1	6817363
of	O	-1	6817363
an@@	B-Chemical	C036466	6817363
i@@	I-Chemical	-1	6817363
rac@@	I-Chemical	-1	6817363
et@@	I-Chemical	-1	6817363
am	I-Chemical	-1	6817363
(	O	-1	6817363
R@@	B-Chemical	C036466	6817363
o	I-Chemical	-1	6817363
1@@	I-Chemical	-1	6817363
3-@@	I-Chemical	-1	6817363
50@@	I-Chemical	-1	6817363
5@@	I-Chemical	-1	6817363
7	I-Chemical	-1	6817363
,	O	-1	6817363
1-@@	B-Chemical	C036466	6817363
an@@	I-Chemical	-1	6817363
iso@@	I-Chemical	-1	6817363
yl@@	I-Chemical	-1	6817363
-@@	I-Chemical	-1	6817363
2-@@	I-Chemical	-1	6817363
py@@	I-Chemical	-1	6817363
r@@	I-Chemical	-1	6817363
ro@@	I-Chemical	-1	6817363
l@@	I-Chemical	-1	6817363
id@@	I-Chemical	-1	6817363
in@@	I-Chemical	-1	6817363
one	I-Chemical	-1	6817363
)	O	-1	6817363
was	O	-1	6817363
studied	O	-1	6817363
on	O	-1	6817363
various	O	-1	6817363
form@@	O	-1	6817363
s	O	-1	6817363
of	O	-1	6817363
experim@@	O	-1	6817363
ent@@	O	-1	6817363
ally	O	-1	6817363
impaired	B-Disease	D003072	6817363
cognitive	I-Disease	-1	6817363
func@@	I-Disease	-1	6817363
tions	I-Disease	-1	6817363
(@@	O	-1	6817363
lear@@	O	-1	6817363
ning	O	-1	6817363
and	O	-1	6817363
memor@@	O	-1	6817363
y@@	O	-1	6817363
)	O	-1	6817363
in	O	-1	6817363
ro@@	O	-1	6817363
d@@	O	-1	6817363
ents	O	-1	6817363
and	O	-1	6817363
produced	O	-1	6817363
the	O	-1	6817363
following	O	-1	6817363
effect@@	O	-1	6817363
s:	O	-1	6817363
(1@@	O	-1	6817363
)	O	-1	6817363
al@@	O	-1	6817363
most	O	-1	6817363
complete	O	-1	6817363
pre@@	O	-1	6817363
ven@@	O	-1	6817363
tion	O	-1	6817363
of	O	-1	6817363
the	O	-1	6817363
inc@@	O	-1	6817363
ap@@	O	-1	6817363
ac@@	O	-1	6817363
ity	O	-1	6817363
to	O	-1	6817363
lear@@	O	-1	6817363
n	O	-1	6817363
a	O	-1	6817363
disc@@	O	-1	6817363
ret@@	O	-1	6817363
e	O	-1	6817363
es@@	O	-1	6817363
cap@@	O	-1	6817363
e	O	-1	6817363
response	O	-1	6817363
in	O	-1	6817363
rats	O	-1	6817363
exposed	O	-1	6817363
to	O	-1	6817363
sub@@	O	-1	6817363
le@@	O	-1	6817363
th@@	O	-1	6817363
al	O	-1	6817363
hyper@@	B-Disease	D006935	6817363
cap@@	I-Disease	-1	6817363
n@@	I-Disease	-1	6817363
ia	I-Disease	-1	6817363
immedi@@	O	-1	6817363
ately	O	-1	6817363
before	O	-1	6817363
the	O	-1	6817363
ac@@	O	-1	6817363
qu@@	O	-1	6817363
i@@	O	-1	6817363
si@@	O	-1	6817363
tion	O	-1	6817363
s@@	O	-1	6817363
es@@	O	-1	6817363
sion@@	O	-1	6817363
;	O	-1	6817363
(2@@	O	-1	6817363
)	O	-1	6817363
partial	O	-1	6817363
(@@	O	-1	6817363
rat@@	O	-1	6817363
s)	O	-1	6817363
or	O	-1	6817363
complete	O	-1	6817363
(@@	O	-1	6817363
mic@@	O	-1	6817363
e@@	O	-1	6817363
)	O	-1	6817363
pre@@	O	-1	6817363
ven@@	O	-1	6817363
tion	O	-1	6817363
of	O	-1	6817363
the	O	-1	6817363
scopol@@	B-Chemical	D012601	6817363
amine	I-Chemical	-1	6817363
-induced	O	-1	6817363
sh@@	O	-1	6817363
ort@@	O	-1	6817363
-term	O	-1	6817363
am@@	B-Disease	D000647	6817363
ne@@	I-Disease	-1	6817363
sia	I-Disease	-1	6817363
for	O	-1	6817363
a	O	-1	6817363
p@@	O	-1	6817363
as@@	O	-1	6817363
sive	O	-1	6817363
avoid@@	O	-1	6817363
ance	O	-1	6817363
t@@	O	-1	6817363
as@@	O	-1	6817363
k@@	O	-1	6817363
;	O	-1	6817363
(3@@	O	-1	6817363
)	O	-1	6817363
complete	O	-1	6817363
prot@@	O	-1	6817363
ection	O	-1	6817363
against	O	-1	6817363
am@@	B-Disease	D000647	6817363
ne@@	I-Disease	-1	6817363
sia	I-Disease	-1	6817363
for	O	-1	6817363
a	O	-1	6817363
p@@	O	-1	6817363
as@@	O	-1	6817363
sive	O	-1	6817363
avoid@@	O	-1	6817363
ance	O	-1	6817363
t@@	O	-1	6817363
as@@	O	-1	6817363
k	O	-1	6817363
in	O	-1	6817363
rats	O	-1	6817363
sub@@	O	-1	6817363
mit@@	O	-1	6817363
ted	O	-1	6817363
to	O	-1	6817363
electro@@	O	-1	6817363
convul@@	O	-1	6817363
sive	O	-1	6817363
sh@@	O	-1	6817363
oc@@	O	-1	6817363
k	O	-1	6817363
immedi@@	O	-1	6817363
ately	O	-1	6817363
after	O	-1	6817363
avoid@@	O	-1	6817363
ance	O	-1	6817363
ac@@	O	-1	6817363
qu@@	O	-1	6817363
i@@	O	-1	6817363
si@@	O	-1	6817363
tion@@	O	-1	6817363
;	O	-1	6817363
(4@@	O	-1	6817363
)	O	-1	6817363
pre@@	O	-1	6817363
ven@@	O	-1	6817363
tion	O	-1	6817363
of	O	-1	6817363
the	O	-1	6817363
long-term	O	-1	6817363
re@@	O	-1	6817363
ten@@	O	-1	6817363
tion@@	O	-1	6817363
-	O	-1	6817363
or	O	-1	6817363
re@@	O	-1	6817363
tri@@	O	-1	6817363
ev@@	O	-1	6817363
al@@	O	-1	6817363
-@@	O	-1	6817363
defic@@	O	-1	6817363
it	O	-1	6817363
for	O	-1	6817363
a	O	-1	6817363
p@@	O	-1	6817363
as@@	O	-1	6817363
sive	O	-1	6817363
avoid@@	O	-1	6817363
ance	O	-1	6817363
t@@	O	-1	6817363
as@@	O	-1	6817363
k	O	-1	6817363
induced	O	-1	6817363
in	O	-1	6817363
rats	O	-1	6817363
and	O	-1	6817363
mice	O	-1	6817363
by	O	-1	6817363
chlor@@	B-Chemical	D002701	6817363
am@@	I-Chemical	-1	6817363
phen@@	I-Chemical	-1	6817363
ic@@	I-Chemical	-1	6817363
ol	I-Chemical	-1	6817363
or	O	-1	6817363
cyclo@@	B-Chemical	D003513	6817363
he@@	I-Chemical	-1	6817363
xim@@	I-Chemical	-1	6817363
ide	I-Chemical	-1	6817363
administered	O	-1	6817363
immedi@@	O	-1	6817363
ately	O	-1	6817363
after	O	-1	6817363
ac@@	O	-1	6817363
qu@@	O	-1	6817363
i@@	O	-1	6817363
si@@	O	-1	6817363
tion@@	O	-1	6817363
;	O	-1	6817363
(5@@	O	-1	6817363
)	O	-1	6817363
rever@@	O	-1	6817363
sal@@	O	-1	6817363
,	O	-1	6817363
when	O	-1	6817363
administered	O	-1	6817363
as	O	-1	6817363
l@@	O	-1	6817363
ate	O	-1	6817363
as	O	-1	6817363
1	O	-1	6817363
h	O	-1	6817363
before	O	-1	6817363
the	O	-1	6817363
re@@	O	-1	6817363
ten@@	O	-1	6817363
tion	O	-1	6817363
test@@	O	-1	6817363
,	O	-1	6817363
of	O	-1	6817363
the	O	-1	6817363
defic@@	O	-1	6817363
it	O	-1	6817363
in	O	-1	6817363
re@@	O	-1	6817363
ten@@	O	-1	6817363
tion	O	-1	6817363
or	O	-1	6817363
re@@	O	-1	6817363
tri@@	O	-1	6817363
ev@@	O	-1	6817363
al	O	-1	6817363
of	O	-1	6817363
a	O	-1	6817363
p@@	O	-1	6817363
as@@	O	-1	6817363
sive	O	-1	6817363
avoid@@	O	-1	6817363
ance	O	-1	6817363
t@@	O	-1	6817363
as@@	O	-1	6817363
k	O	-1	6817363
induced	O	-1	6817363
by	O	-1	6817363
cyclo@@	B-Chemical	D003513	6817363
he@@	I-Chemical	-1	6817363
xim@@	I-Chemical	-1	6817363
ide	I-Chemical	-1	6817363
injected	O	-1	6817363
2	O	-1	6817363
days	O	-1	6817363
previ@@	O	-1	6817363
ous@@	O	-1	6817363
ly@@	O	-1	6817363
;	O	-1	6817363
(6@@	O	-1	6817363
)	O	-1	6817363
pre@@	O	-1	6817363
ven@@	O	-1	6817363
tion	O	-1	6817363
of	O	-1	6817363
the	O	-1	6817363
defic@@	O	-1	6817363
it	O	-1	6817363
in	O	-1	6817363
the	O	-1	6817363
re@@	O	-1	6817363
tri@@	O	-1	6817363
ev@@	O	-1	6817363
al	O	-1	6817363
of	O	-1	6817363
an	O	-1	6817363
active	O	-1	6817363
avoid@@	O	-1	6817363
ance	O	-1	6817363
t@@	O	-1	6817363
as@@	O	-1	6817363
k	O	-1	6817363
induced	O	-1	6817363
in	O	-1	6817363
mice	O	-1	6817363
by	O	-1	6817363
sub@@	O	-1	6817363
convul@@	O	-1	6817363
s@@	O	-1	6817363
ant	O	-1	6817363
electro@@	O	-1	6817363
sh@@	O	-1	6817363
oc@@	O	-1	6817363
k	O	-1	6817363
or	O	-1	6817363
hyper@@	B-Disease	D006935	6817363
cap@@	I-Disease	-1	6817363
n@@	I-Disease	-1	6817363
ia	I-Disease	-1	6817363
ap@@	O	-1	6817363
pl@@	O	-1	6817363
ied	O	-1	6817363
immedi@@	O	-1	6817363
ately	O	-1	6817363
before	O	-1	6817363
re@@	O	-1	6817363
tri@@	O	-1	6817363
ev@@	O	-1	6817363
al	O	-1	6817363
test@@	O	-1	6817363
ing	O	-1	6817363
(2@@	O	-1	6817363
4	O	-1	6817363
h	O	-1	6817363
after	O	-1	6817363
ac@@	O	-1	6817363
qu@@	O	-1	6817363
i@@	O	-1	6817363
si@@	O	-1	6817363
tion@@	O	-1	6817363
).	O	-1	6817363
These	O	-1	6817363
impro@@	O	-1	6817363
ve@@	O	-1	6817363
ments	O	-1	6817363
or	O	-1	6817363
normal@@	O	-1	6817363
iz@@	O	-1	6817363
ations	O	-1	6817363
of	O	-1	6817363
impaired	B-Disease	D003072	6817363
cognitive	I-Disease	-1	6817363
func@@	I-Disease	-1	6817363
tions	I-Disease	-1	6817363
were	O	-1	6817363
seen	O	-1	6817363
at	O	-1	6817363
oral	O	-1	6817363
an@@	B-Chemical	C036466	6817363
i@@	I-Chemical	-1	6817363
rac@@	I-Chemical	-1	6817363
et@@	I-Chemical	-1	6817363
am	I-Chemical	-1	6817363
doses	O	-1	6817363
of	O	-1	6817363
10-@@	O	-1	6817363
100	O	-1	6817363
mg/kg@@	O	-1	6817363
.	O	-1	6817363
G@@	O	-1	6817363
en@@	O	-1	6817363
er@@	O	-1	6817363
ally,	O	-1	6817363
the	O	-1	6817363
dose-@@	O	-1	6817363
response	O	-1	6817363
cur@@	O	-1	6817363
v@@	O	-1	6817363
es	O	-1	6817363
were	O	-1	6817363
bell@@	O	-1	6817363
-@@	O	-1	6817363
sh@@	O	-1	6817363
ap@@	O	-1	6817363
ed.	O	-1	6817363
The	O	-1	6817363
mechanisms	O	-1	6817363
underlying	O	-1	6817363
the	O	-1	6817363
activity	O	-1	6817363
of	O	-1	6817363
an@@	B-Chemical	C036466	6817363
i@@	I-Chemical	-1	6817363
rac@@	I-Chemical	-1	6817363
et@@	I-Chemical	-1	6817363
am	I-Chemical	-1	6817363
and	O	-1	6817363
its	O	-1	6817363
'@@	O	-1	6817363
therapeutic	O	-1	6817363
w@@	O	-1	6817363
in@@	O	-1	6817363
do@@	O	-1	6817363
w@@	O	-1	6817363
'	O	-1	6817363
are	O	-1	6817363
un@@	O	-1	6817363
know@@	O	-1	6817363
n@@	O	-1	6817363
.	O	-1	6817363
P@@	B-Chemical	D010889	6817363
i@@	I-Chemical	-1	6817363
rac@@	I-Chemical	-1	6817363
et@@	I-Chemical	-1	6817363
am	I-Chemical	-1	6817363
,	O	-1	6817363
an@@	O	-1	6817363
other	O	-1	6817363
py@@	B-Chemical	D011760	6817363
r@@	I-Chemical	-1	6817363
ro@@	I-Chemical	-1	6817363
l@@	I-Chemical	-1	6817363
id@@	I-Chemical	-1	6817363
in@@	I-Chemical	-1	6817363
one	I-Chemical	-1	6817363
der@@	O	-1	6817363
i@@	O	-1	6817363
v@@	O	-1	6817363
ative	O	-1	6817363
was	O	-1	6817363
used	O	-1	6817363
for	O	-1	6817363
compar@@	O	-1	6817363
is@@	O	-1	6817363
on@@	O	-1	6817363
.	O	-1	6817363
It	O	-1	6817363
was	O	-1	6817363
active	O	-1	6817363
only	O	-1	6817363
in	O	-1	6817363
six	O	-1	6817363
of	O	-1	6817363
n@@	O	-1	6817363
ine	O	-1	6817363
tests	O	-1	6817363
and	O	-1	6817363
had	O	-1	6817363
about	O	-1	6817363
on@@	O	-1	6817363
e-@@	O	-1	6817363
t@@	O	-1	6817363
ent@@	O	-1	6817363
h	O	-1	6817363
the	O	-1	6817363
poten@@	O	-1	6817363
c@@	O	-1	6817363
y	O	-1	6817363
of	O	-1	6817363
an@@	B-Chemical	C036466	6817363
i@@	I-Chemical	-1	6817363
rac@@	I-Chemical	-1	6817363
et@@	I-Chemical	-1	6817363
am	I-Chemical	-1	6817363
.	O	-1	6817363
The	O	-1	6817363
results	O	-1	6817363
indicate	O	-1	6817363
that	O	-1	6817363
an@@	B-Chemical	C036466	6817363
i@@	I-Chemical	-1	6817363
rac@@	I-Chemical	-1	6817363
et@@	I-Chemical	-1	6817363
am	I-Chemical	-1	6817363
impro@@	O	-1	6817363
v@@	O	-1	6817363
es	O	-1	6817363
cognitive	O	-1	6817363
func@@	O	-1	6817363
tions	O	-1	6817363
which	O	-1	6817363
are	O	-1	6817363
impaired	O	-1	6817363
by	O	-1	6817363
different	O	-1	6817363
proce@@	O	-1	6817363
d@@	O	-1	6817363
ure	O	-1	6817363
and	O	-1	6817363
in	O	-1	6817363
different	O	-1	6817363
ph@@	O	-1	6817363
as@@	O	-1	6817363
es	O	-1	6817363
of	O	-1	6817363
the	O	-1	6817363
lear@@	O	-1	6817363
ning	O	-1	6817363
and	O	-1	6817363
memory	O	-1	6817363
pro@@	O	-1	6817363
ces@@	O	-1	6817363
s.	O	-1	6817363

N@@	B-Chemical	D009538	11900788
icot@@	I-Chemical	-1	11900788
ine	I-Chemical	-1	11900788
potenti@@	O	-1	11900788
ation	O	-1	11900788
of	O	-1	11900788
morphine	B-Chemical	D009020	11900788
-induced	O	-1	11900788
cat@@	B-Disease	D002375	11900788
al@@	I-Disease	-1	11900788
ep@@	I-Disease	-1	11900788
sy	I-Disease	-1	11900788
in	O	-1	11900788
mice.	O	-1	11900788
In	O	-1	11900788
the	O	-1	11900788
present	O	-1	11900788
study,	O	-1	11900788
effects	O	-1	11900788
of	O	-1	11900788
nicotine	B-Chemical	D009538	11900788
on	O	-1	11900788
cat@@	B-Disease	D002375	11900788
al@@	I-Disease	-1	11900788
ep@@	I-Disease	-1	11900788
sy	I-Disease	-1	11900788
induced	O	-1	11900788
by	O	-1	11900788
morphine	B-Chemical	D009020	11900788
in	O	-1	11900788
mice	O	-1	11900788
have	O	-1	11900788
been	O	-1	11900788
investig@@	O	-1	11900788
ated.	O	-1	11900788
M@@	B-Chemical	D009020	11900788
or@@	I-Chemical	-1	11900788
ph@@	I-Chemical	-1	11900788
ine	I-Chemical	-1	11900788
but	O	-1	11900788
not	O	-1	11900788
nicotine	B-Chemical	D009538	11900788
induced	O	-1	11900788
a	O	-1	11900788
dose-@@	O	-1	11900788
dependent	O	-1	11900788
cat@@	B-Disease	D002375	11900788
al@@	I-Disease	-1	11900788
ep@@	I-Disease	-1	11900788
sy	I-Disease	-1	11900788
.	O	-1	11900788
The	O	-1	11900788
response	O	-1	11900788
of	O	-1	11900788
morphine	B-Chemical	D009020	11900788
was	O	-1	11900788
potenti@@	O	-1	11900788
ated	O	-1	11900788
by	O	-1	11900788
nicotine	B-Chemical	D009538	11900788
.	O	-1	11900788
In@@	O	-1	11900788
tra@@	O	-1	11900788
per@@	O	-1	11900788
it@@	O	-1	11900788
one@@	O	-1	11900788
al	O	-1	11900788
administration	O	-1	11900788
of	O	-1	11900788
atro@@	B-Chemical	D001285	11900788
pine	I-Chemical	-1	11900788
,	O	-1	11900788
n@@	B-Chemical	D009270	11900788
al@@	I-Chemical	-1	11900788
ox@@	I-Chemical	-1	11900788
one	I-Chemical	-1	11900788
,	O	-1	11900788
m@@	B-Chemical	D008464	11900788
ec@@	I-Chemical	-1	11900788
am@@	I-Chemical	-1	11900788
yl@@	I-Chemical	-1	11900788
amine	I-Chemical	-1	11900788
,	O	-1	11900788
and	O	-1	11900788
he@@	B-Chemical	D018738	11900788
xameth@@	I-Chemical	-1	11900788
oni@@	I-Chemical	-1	11900788
um	I-Chemical	-1	11900788
to	O	-1	11900788
mice	O	-1	11900788
reduced	O	-1	11900788
cat@@	B-Disease	D002375	11900788
al@@	I-Disease	-1	11900788
ep@@	I-Disease	-1	11900788
sy	I-Disease	-1	11900788
induced	O	-1	11900788
by	O	-1	11900788
a	O	-1	11900788
combination	O	-1	11900788
of	O	-1	11900788
morphine	B-Chemical	D009020	11900788
with	O	-1	11900788
nicotine	B-Chemical	D009538	11900788
.	O	-1	11900788
In@@	O	-1	11900788
trac@@	O	-1	11900788
e@@	O	-1	11900788
reb@@	O	-1	11900788
ro@@	O	-1	11900788
ventricular	O	-1	11900788
injection	O	-1	11900788
of	O	-1	11900788
atro@@	B-Chemical	D001285	11900788
pine	I-Chemical	-1	11900788
,	O	-1	11900788
he@@	B-Chemical	D018738	11900788
xameth@@	I-Chemical	-1	11900788
oni@@	I-Chemical	-1	11900788
um	I-Chemical	-1	11900788
,	O	-1	11900788
and	O	-1	11900788
n@@	B-Chemical	D009270	11900788
al@@	I-Chemical	-1	11900788
ox@@	I-Chemical	-1	11900788
one	I-Chemical	-1	11900788
also	O	-1	11900788
decreased	O	-1	11900788
cat@@	B-Disease	D002375	11900788
al@@	I-Disease	-1	11900788
ep@@	I-Disease	-1	11900788
sy	I-Disease	-1	11900788
induced	O	-1	11900788
by	O	-1	11900788
morphine	B-Chemical	D009020	11900788
plus	O	-1	11900788
nicotine	B-Chemical	D009538	11900788
.	O	-1	11900788
In@@	O	-1	11900788
tra@@	O	-1	11900788
per@@	O	-1	11900788
it@@	O	-1	11900788
one@@	O	-1	11900788
al	O	-1	11900788
administration	O	-1	11900788
of	O	-1	11900788
atro@@	B-Chemical	D001285	11900788
pine	I-Chemical	-1	11900788
,	O	-1	11900788
but	O	-1	11900788
not	O	-1	11900788
intra@@	O	-1	11900788
per@@	O	-1	11900788
it@@	O	-1	11900788
one@@	O	-1	11900788
al	O	-1	11900788
or	O	-1	11900788
intrac@@	O	-1	11900788
e@@	O	-1	11900788
reb@@	O	-1	11900788
ro@@	O	-1	11900788
ventricular	O	-1	11900788
injection	O	-1	11900788
of	O	-1	11900788
he@@	B-Chemical	D018738	11900788
xameth@@	I-Chemical	-1	11900788
oni@@	I-Chemical	-1	11900788
um	I-Chemical	-1	11900788
,	O	-1	11900788
decreased	O	-1	11900788
the	O	-1	11900788
effect	O	-1	11900788
of	O	-1	11900788
a	O	-1	11900788
single	O	-1	11900788
dose	O	-1	11900788
of	O	-1	11900788
morphine	B-Chemical	D009020	11900788
.	O	-1	11900788
It	O	-1	11900788
was	O	-1	11900788
concl@@	O	-1	11900788
uded	O	-1	11900788
that	O	-1	11900788
morphine	B-Chemical	D009020	11900788
cat@@	B-Disease	D002375	11900788
al@@	I-Disease	-1	11900788
ep@@	I-Disease	-1	11900788
sy	I-Disease	-1	11900788
can	O	-1	11900788
be	O	-1	11900788
el@@	O	-1	11900788
ic@@	O	-1	11900788
ited	O	-1	11900788
by	O	-1	11900788
o@@	O	-1	11900788
pi@@	O	-1	11900788
oid	O	-1	11900788
and	O	-1	11900788
cholinergic	O	-1	11900788
receptor@@	O	-1	11900788
s,	O	-1	11900788
and	O	-1	11900788
the	O	-1	11900788
potenti@@	O	-1	11900788
ation	O	-1	11900788
of	O	-1	11900788
morphine	B-Chemical	D009020	11900788
induced	O	-1	11900788
by	O	-1	11900788
nicotine	B-Chemical	D009538	11900788
may	O	-1	11900788
also	O	-1	11900788
be	O	-1	11900788
mediated	O	-1	11900788
through	O	-1	11900788
cholinergic	O	-1	11900788
receptor	O	-1	11900788
mechanis@@	O	-1	11900788
m@@	O	-1	11900788
s.	O	-1	11900788

Re@@	O	-1	11230490
duced	O	-1	11230490
cardi@@	B-Disease	D066126	11230490
otoxicity	I-Disease	-1	11230490
and	O	-1	11230490
pres@@	O	-1	11230490
er@@	O	-1	11230490
ved	O	-1	11230490
anti@@	O	-1	11230490
tumor	O	-1	11230490
efficacy	O	-1	11230490
of	O	-1	11230490
li@@	O	-1	11230490
pos@@	O	-1	11230490
o@@	O	-1	11230490
me@@	O	-1	11230490
-@@	O	-1	11230490
enc@@	O	-1	11230490
ap@@	O	-1	11230490
sul@@	O	-1	11230490
ated	O	-1	11230490
dox@@	B-Chemical	D004317	11230490
orub@@	I-Chemical	-1	11230490
icin	I-Chemical	-1	11230490
and	O	-1	11230490
cyclophosph@@	B-Chemical	D003520	11230490
amide	I-Chemical	-1	11230490
compared	O	-1	11230490
with	O	-1	11230490
con@@	O	-1	11230490
ven@@	O	-1	11230490
tional	O	-1	11230490
dox@@	B-Chemical	D004317	11230490
orub@@	I-Chemical	-1	11230490
icin	I-Chemical	-1	11230490
and	O	-1	11230490
cyclophosph@@	B-Chemical	D003520	11230490
amide	I-Chemical	-1	11230490
in	O	-1	11230490
a	O	-1	11230490
random@@	O	-1	11230490
iz@@	O	-1	11230490
ed,	O	-1	11230490
mul@@	O	-1	11230490
tic@@	O	-1	11230490
ent@@	O	-1	11230490
er	O	-1	11230490
trial	O	-1	11230490
of	O	-1	11230490
met@@	O	-1	11230490
ast@@	O	-1	11230490
atic	O	-1	11230490
b@@	B-Disease	D001943	11230490
reas@@	I-Disease	-1	11230490
t	I-Disease	-1	11230490
cancer	I-Disease	-1	11230490
.	O	-1	11230490
P@@	O	-1	11230490
U@@	O	-1	11230490
R@@	O	-1	11230490
P@@	O	-1	11230490
O@@	O	-1	11230490
S@@	O	-1	11230490
E:	O	-1	11230490
To	O	-1	11230490
determine	O	-1	11230490
whether	O	-1	11230490
M@@	B-Chemical	D004317	11230490
y@@	I-Chemical	-1	11230490
oc@@	I-Chemical	-1	11230490
et	I-Chemical	-1	11230490
(@@	O	-1	11230490
li@@	O	-1	11230490
pos@@	O	-1	11230490
o@@	O	-1	11230490
me@@	O	-1	11230490
-@@	O	-1	11230490
enc@@	O	-1	11230490
ap@@	O	-1	11230490
sul@@	O	-1	11230490
ated	O	-1	11230490
dox@@	B-Chemical	D004317	11230490
orub@@	I-Chemical	-1	11230490
icin	I-Chemical	-1	11230490
;	O	-1	11230490
The	O	-1	11230490
L@@	O	-1	11230490
i@@	O	-1	11230490
pos@@	O	-1	11230490
ome	O	-1	11230490
Com@@	O	-1	11230490
p@@	O	-1	11230490
an@@	O	-1	11230490
y,	O	-1	11230490
E@@	O	-1	11230490
l@@	O	-1	11230490
an	O	-1	11230490
C@@	O	-1	11230490
or@@	O	-1	11230490
por@@	O	-1	11230490
ation,	O	-1	11230490
P@@	O	-1	11230490
r@@	O	-1	11230490
in@@	O	-1	11230490
ce@@	O	-1	11230490
t@@	O	-1	11230490
on@@	O	-1	11230490
,	O	-1	11230490
N@@	O	-1	11230490
J@@	O	-1	11230490
)	O	-1	11230490
in	O	-1	11230490
combination	O	-1	11230490
with	O	-1	11230490
cyclophosph@@	B-Chemical	D003520	11230490
amide	I-Chemical	-1	11230490
significantly	O	-1	11230490
reduc@@	O	-1	11230490
es	O	-1	11230490
dox@@	B-Chemical	D004317	11230490
orub@@	I-Chemical	-1	11230490
icin	I-Chemical	-1	11230490
cardi@@	B-Disease	D066126	11230490
otoxicity	I-Disease	-1	11230490
while	O	-1	11230490
pro@@	O	-1	11230490
vid@@	O	-1	11230490
ing	O	-1	11230490
compar@@	O	-1	11230490
able	O	-1	11230490
anti@@	O	-1	11230490
tumor	O	-1	11230490
efficacy	O	-1	11230490
in	O	-1	11230490
fir@@	O	-1	11230490
st@@	O	-1	11230490
-@@	O	-1	11230490
line	O	-1	11230490
treatment	O	-1	11230490
of	O	-1	11230490
met@@	O	-1	11230490
ast@@	O	-1	11230490
atic	O	-1	11230490
b@@	B-Disease	D001943	11230490
reas@@	I-Disease	-1	11230490
t	I-Disease	-1	11230490
cancer	I-Disease	-1	11230490
(	O	-1	11230490
M@@	B-Disease	D001943	11230490
B@@	I-Disease	-1	11230490
C	I-Disease	-1	11230490
).	O	-1	11230490
PA@@	O	-1	11230490
TI@@	O	-1	11230490
E@@	O	-1	11230490
N@@	O	-1	11230490
T@@	O	-1	11230490
S	O	-1	11230490
AN@@	O	-1	11230490
D	O	-1	11230490
METHODS:	O	-1	11230490
Two	O	-1	11230490
h@@	O	-1	11230490
und@@	O	-1	11230490
red	O	-1	11230490
n@@	O	-1	11230490
ine@@	O	-1	11230490
ty-@@	O	-1	11230490
seven	O	-1	11230490
patients	O	-1	11230490
with	O	-1	11230490
M@@	B-Disease	D001943	11230490
B@@	I-Disease	-1	11230490
C	I-Disease	-1	11230490
and	O	-1	11230490
no	O	-1	11230490
prior	O	-1	11230490
chemotherapy	O	-1	11230490
for	O	-1	11230490
met@@	O	-1	11230490
ast@@	O	-1	11230490
atic	O	-1	11230490
disease	O	-1	11230490
were	O	-1	11230490
randomized	O	-1	11230490
to	O	-1	11230490
recei@@	O	-1	11230490
ve	O	-1	11230490
either	O	-1	11230490
60	O	-1	11230490
mg/m@@	O	-1	11230490
(2@@	O	-1	11230490
)	O	-1	11230490
of	O	-1	11230490
M@@	B-Chemical	D004317	11230490
y@@	I-Chemical	-1	11230490
oc@@	I-Chemical	-1	11230490
et	I-Chemical	-1	11230490
(@@	O	-1	11230490
M@@	O	-1	11230490
)	O	-1	11230490
or	O	-1	11230490
con@@	O	-1	11230490
ven@@	O	-1	11230490
tional	O	-1	11230490
dox@@	B-Chemical	D004317	11230490
orub@@	I-Chemical	-1	11230490
icin	I-Chemical	-1	11230490
(A@@	O	-1	11230490
),	O	-1	11230490
in	O	-1	11230490
combination	O	-1	11230490
with	O	-1	11230490
6@@	O	-1	11230490
00	O	-1	11230490
mg/m@@	O	-1	11230490
(2@@	O	-1	11230490
)	O	-1	11230490
of	O	-1	11230490
cyclophosph@@	B-Chemical	D003520	11230490
amide	I-Chemical	-1	11230490
(C@@	O	-1	11230490
),	O	-1	11230490
every	O	-1	11230490
3	O	-1	11230490
weeks	O	-1	11230490
un@@	O	-1	11230490
ti@@	O	-1	11230490
l	O	-1	11230490
disease	O	-1	11230490
progres@@	O	-1	11230490
sion	O	-1	11230490
or	O	-1	11230490
un@@	O	-1	11230490
ac@@	O	-1	11230490
ce@@	O	-1	11230490
pt@@	O	-1	11230490
able	O	-1	11230490
toxicity	B-Disease	D064420	11230490
.	O	-1	11230490
C@@	B-Disease	D066126	11230490
ardi@@	I-Disease	-1	11230490
otoxicity	I-Disease	-1	11230490
was	O	-1	11230490
def@@	O	-1	11230490
in@@	O	-1	11230490
ed	O	-1	11230490
by	O	-1	11230490
reduc@@	O	-1	11230490
tions	O	-1	11230490
in	O	-1	11230490
le@@	O	-1	11230490
f@@	O	-1	11230490
t-@@	O	-1	11230490
ventricular	O	-1	11230490
e@@	O	-1	11230490
j@@	O	-1	11230490
ection	O	-1	11230490
frac@@	O	-1	11230490
tion,	O	-1	11230490
assessed	O	-1	11230490
by	O	-1	11230490
ser@@	O	-1	11230490
ial	O	-1	11230490
mul@@	O	-1	11230490
tig@@	O	-1	11230490
ated	O	-1	11230490
radi@@	O	-1	11230490
on@@	O	-1	11230490
uc@@	O	-1	11230490
l@@	O	-1	11230490
ide	O	-1	11230490
angio@@	O	-1	11230490
graph@@	O	-1	11230490
y	O	-1	11230490
s@@	O	-1	11230490
can@@	O	-1	11230490
s,	O	-1	11230490
or	O	-1	11230490
con@@	B-Disease	D006333	11230490
g@@	I-Disease	-1	11230490
es@@	I-Disease	-1	11230490
tive	I-Disease	-1	11230490
heart	I-Disease	-1	11230490
failure	I-Disease	-1	11230490
(	O	-1	11230490
C@@	B-Disease	D006333	11230490
H@@	I-Disease	-1	11230490
F	I-Disease	-1	11230490
).	O	-1	11230490
An@@	O	-1	11230490
ti@@	O	-1	11230490
tumor	O	-1	11230490
efficacy	O	-1	11230490
was	O	-1	11230490
assessed	O	-1	11230490
by	O	-1	11230490
ob@@	O	-1	11230490
j@@	O	-1	11230490
ective	O	-1	11230490
tumor	B-Disease	D009369	11230490
response	O	-1	11230490
rat@@	O	-1	11230490
es	O	-1	11230490
(@@	O	-1	11230490
W@@	O	-1	11230490
or@@	O	-1	11230490
l@@	O	-1	11230490
d	O	-1	11230490
He@@	O	-1	11230490
al@@	O	-1	11230490
th	O	-1	11230490
O@@	O	-1	11230490
r@@	O	-1	11230490
g@@	O	-1	11230490
an@@	O	-1	11230490
ization	O	-1	11230490
c@@	O	-1	11230490
rit@@	O	-1	11230490
er@@	O	-1	11230490
ia@@	O	-1	11230490
),	O	-1	11230490
time	O	-1	11230490
to	O	-1	11230490
progres@@	O	-1	11230490
sion,	O	-1	11230490
and	O	-1	11230490
sur@@	O	-1	11230490
vi@@	O	-1	11230490
val@@	O	-1	11230490
.	O	-1	11230490
RESULTS:	O	-1	11230490
Si@@	O	-1	11230490
x	O	-1	11230490
perc@@	O	-1	11230490
ent	O	-1	11230490
of	O	-1	11230490
M@@	O	-1	11230490
C	O	-1	11230490
patients	O	-1	11230490
versus	O	-1	11230490
2@@	O	-1	11230490
1@@	O	-1	11230490
%	O	-1	11230490
(@@	O	-1	11230490
including	O	-1	11230490
five	O	-1	11230490
cases	O	-1	11230490
of	O	-1	11230490
C@@	B-Disease	D006333	11230490
H@@	I-Disease	-1	11230490
F	I-Disease	-1	11230490
)	O	-1	11230490
of	O	-1	11230490
A@@	O	-1	11230490
C	O	-1	11230490
patients	O	-1	11230490
developed	O	-1	11230490
cardi@@	B-Disease	D066126	11230490
otoxicity	I-Disease	-1	11230490
(P	O	-1	11230490
=@@	O	-1	11230490
.@@	O	-1	11230490
0@@	O	-1	11230490
0@@	O	-1	11230490
0@@	O	-1	11230490
2@@	O	-1	11230490
).	O	-1	11230490
M@@	O	-1	11230490
edi@@	O	-1	11230490
an	O	-1	11230490
cum@@	O	-1	11230490
ul@@	O	-1	11230490
ative	O	-1	11230490
dox@@	B-Chemical	D004317	11230490
orub@@	I-Chemical	-1	11230490
icin	I-Chemical	-1	11230490
dose	O	-1	11230490
at	O	-1	11230490
onset	O	-1	11230490
was	O	-1	11230490
more	O	-1	11230490
than	O	-1	11230490
2@@	O	-1	11230490
,@@	O	-1	11230490
2@@	O	-1	11230490
20	O	-1	11230490
mg/m@@	O	-1	11230490
(2@@	O	-1	11230490
)	O	-1	11230490
for	O	-1	11230490
M@@	O	-1	11230490
C	O	-1	11230490
versus	O	-1	11230490
4@@	O	-1	11230490
8@@	O	-1	11230490
0	O	-1	11230490
mg/m@@	O	-1	11230490
(2@@	O	-1	11230490
)	O	-1	11230490
for	O	-1	11230490
A@@	O	-1	11230490
C	O	-1	11230490
(P	O	-1	11230490
=@@	O	-1	11230490
.@@	O	-1	11230490
0@@	O	-1	11230490
0@@	O	-1	11230490
0@@	O	-1	11230490
1,	O	-1	11230490
ha@@	O	-1	11230490
z@@	O	-1	11230490
ard	O	-1	11230490
rati@@	O	-1	11230490
o@@	O	-1	11230490
,	O	-1	11230490
5.@@	O	-1	11230490
0@@	O	-1	11230490
4@@	O	-1	11230490
).	O	-1	11230490
M@@	O	-1	11230490
C	O	-1	11230490
patients	O	-1	11230490
also	O	-1	11230490
experienced	O	-1	11230490
less	O	-1	11230490
gra@@	O	-1	11230490
de	O	-1	11230490
4	O	-1	11230490
ne@@	B-Disease	D009503	11230490
ut@@	I-Disease	-1	11230490
ro@@	I-Disease	-1	11230490
pen@@	I-Disease	-1	11230490
ia	I-Disease	-1	11230490
.	O	-1	11230490
An@@	O	-1	11230490
ti@@	O	-1	11230490
tumor	O	-1	11230490
efficacy	O	-1	11230490
of	O	-1	11230490
M@@	O	-1	11230490
C	O	-1	11230490
versus	O	-1	11230490
A@@	O	-1	11230490
C	O	-1	11230490
was	O	-1	11230490
compar@@	O	-1	11230490
able@@	O	-1	11230490
:	O	-1	11230490
ob@@	O	-1	11230490
j@@	O	-1	11230490
ective	O	-1	11230490
response	O	-1	11230490
rat@@	O	-1	11230490
es,	O	-1	11230490
4@@	O	-1	11230490
3@@	O	-1	11230490
%	O	-1	11230490
versus	O	-1	11230490
4@@	O	-1	11230490
3@@	O	-1	11230490
%@@	O	-1	11230490
;	O	-1	11230490
median	O	-1	11230490
time	O	-1	11230490
to	O	-1	11230490
progres@@	O	-1	11230490
sion,	O	-1	11230490
5.@@	O	-1	11230490
1@@	O	-1	11230490
%	O	-1	11230490
versus	O	-1	11230490
5.@@	O	-1	11230490
5	O	-1	11230490
month@@	O	-1	11230490
s;	O	-1	11230490
median	O	-1	11230490
time	O	-1	11230490
to	O	-1	11230490
treatment	O	-1	11230490
fail@@	O	-1	11230490
ure,	O	-1	11230490
4.@@	O	-1	11230490
6	O	-1	11230490
versus	O	-1	11230490
4.@@	O	-1	11230490
4	O	-1	11230490
month@@	O	-1	11230490
s;	O	-1	11230490
and	O	-1	11230490
median	O	-1	11230490
sur@@	O	-1	11230490
vi@@	O	-1	11230490
val@@	O	-1	11230490
,	O	-1	11230490
1@@	O	-1	11230490
9	O	-1	11230490
versus	O	-1	11230490
16	O	-1	11230490
months.	O	-1	11230490
CONCLUSION:	O	-1	11230490
M@@	B-Chemical	D004317	11230490
y@@	I-Chemical	-1	11230490
oc@@	I-Chemical	-1	11230490
et	I-Chemical	-1	11230490
impro@@	O	-1	11230490
v@@	O	-1	11230490
es	O	-1	11230490
the	O	-1	11230490
therapeutic	O	-1	11230490
in@@	O	-1	11230490
de@@	O	-1	11230490
x	O	-1	11230490
of	O	-1	11230490
dox@@	B-Chemical	D004317	11230490
orub@@	I-Chemical	-1	11230490
icin	I-Chemical	-1	11230490
by	O	-1	11230490
significantly	O	-1	11230490
reduc@@	O	-1	11230490
ing	O	-1	11230490
cardi@@	B-Disease	D066126	11230490
otoxicity	I-Disease	-1	11230490
and	O	-1	11230490
gra@@	O	-1	11230490
de	O	-1	11230490
4	O	-1	11230490
ne@@	B-Disease	D009503	11230490
ut@@	I-Disease	-1	11230490
ro@@	I-Disease	-1	11230490
pen@@	I-Disease	-1	11230490
ia	I-Disease	-1	11230490
and	O	-1	11230490
pro@@	O	-1	11230490
vi@@	O	-1	11230490
des	O	-1	11230490
compar@@	O	-1	11230490
able	O	-1	11230490
anti@@	O	-1	11230490
tumor	O	-1	11230490
efficac@@	O	-1	11230490
y,	O	-1	11230490
when	O	-1	11230490
used	O	-1	11230490
in	O	-1	11230490
combination	O	-1	11230490
with	O	-1	11230490
cyclophosph@@	B-Chemical	D003520	11230490
amide	I-Chemical	-1	11230490
as	O	-1	11230490
fir@@	O	-1	11230490
st@@	O	-1	11230490
-@@	O	-1	11230490
line	O	-1	11230490
therapy	O	-1	11230490
for	O	-1	11230490
M@@	B-Disease	D001943	11230490
B@@	I-Disease	-1	11230490
C	I-Disease	-1	11230490
.	O	-1	11230490

Pro@@	O	-1	2594614
t@@	O	-1	2594614
ective	O	-1	2594614
effect	O	-1	2594614
of	O	-1	2594614
a	O	-1	2594614
specific	O	-1	2594614
platele@@	O	-1	2594614
t-@@	O	-1	2594614
activ@@	O	-1	2594614
ating	O	-1	2594614
factor	O	-1	2594614
antagonist@@	O	-1	2594614
,	O	-1	2594614
B@@	B-Chemical	C045856	2594614
N	I-Chemical	-1	2594614
5@@	I-Chemical	-1	2594614
20@@	I-Chemical	-1	2594614
21	I-Chemical	-1	2594614
,	O	-1	2594614
on	O	-1	2594614
bupivac@@	B-Chemical	D002045	2594614
aine	I-Chemical	-1	2594614
-induced	O	-1	2594614
cardiovascular	B-Disease	D002318	2594614
impair@@	I-Disease	-1	2594614
ments	I-Disease	-1	2594614
in	O	-1	2594614
rats.	O	-1	2594614
Ad@@	O	-1	2594614
minist@@	O	-1	2594614
ration	O	-1	2594614
of	O	-1	2594614
the	O	-1	2594614
loc@@	O	-1	2594614
al	O	-1	2594614
anaesthe@@	O	-1	2594614
tic	O	-1	2594614
bupivac@@	B-Chemical	D002045	2594614
aine	I-Chemical	-1	2594614
(1@@	O	-1	2594614
.@@	O	-1	2594614
5	O	-1	2594614
or	O	-1	2594614
2	O	-1	2594614
mg/kg@@	O	-1	2594614
,	O	-1	2594614
i.v@@	O	-1	2594614
.)	O	-1	2594614
to	O	-1	2594614
rats	O	-1	2594614
el@@	O	-1	2594614
ic@@	O	-1	2594614
ited	O	-1	2594614
a	O	-1	2594614
mark@@	O	-1	2594614
ed	O	-1	2594614
decrease	B-Disease	D007022	2594614
of	I-Disease	-1	2594614
mean	I-Disease	-1	2594614
arterial	I-Disease	-1	2594614
blood	I-Disease	-1	2594614
pressure	I-Disease	-1	2594614
(@@	I-Disease	-1	2594614
M@@	I-Disease	-1	2594614
B@@	I-Disease	-1	2594614
P)	I-Disease	-1	2594614
and	I-Disease	-1	2594614
heart	I-Disease	-1	2594614
rate	I-Disease	-1	2594614
(@@	I-Disease	-1	2594614
H@@	I-Disease	-1	2594614
R@@	I-Disease	-1	2594614
)	I-Disease	-1	2594614
decrease	B-Disease	D001919	2594614
of	I-Disease	-1	2594614
mean	I-Disease	-1	2594614
arterial	I-Disease	-1	2594614
blood	I-Disease	-1	2594614
pressure	I-Disease	-1	2594614
(@@	I-Disease	-1	2594614
M@@	I-Disease	-1	2594614
B@@	I-Disease	-1	2594614
P)	I-Disease	-1	2594614
and	I-Disease	-1	2594614
heart	I-Disease	-1	2594614
rate	I-Disease	-1	2594614
(@@	I-Disease	-1	2594614
H@@	I-Disease	-1	2594614
R@@	I-Disease	-1	2594614
)	I-Disease	-1	2594614
lead@@	O	-1	2594614
ing	O	-1	2594614
to	O	-1	2594614
death	O	-1	2594614
(@@	O	-1	2594614
in	O	-1	2594614
6@@	O	-1	2594614
7@@	O	-1	2594614
%	O	-1	2594614
or	O	-1	2594614
9@@	O	-1	2594614
0%	O	-1	2594614
of	O	-1	2594614
animals	O	-1	2594614
respectivel@@	O	-1	2594614
y@@	O	-1	2594614
).	O	-1	2594614
In@@	O	-1	2594614
tra@@	O	-1	2594614
venous	O	-1	2594614
injection	O	-1	2594614
of	O	-1	2594614
the	O	-1	2594614
specific	O	-1	2594614
platele@@	O	-1	2594614
t-@@	O	-1	2594614
activ@@	O	-1	2594614
ating	O	-1	2594614
factor	O	-1	2594614
(@@	O	-1	2594614
PA@@	O	-1	2594614
F@@	O	-1	2594614
)	O	-1	2594614
antagonist	O	-1	2594614
B@@	B-Chemical	C045856	2594614
N	I-Chemical	-1	2594614
5@@	I-Chemical	-1	2594614
20@@	I-Chemical	-1	2594614
21	I-Chemical	-1	2594614
(10	O	-1	2594614
mg/kg@@	O	-1	2594614
),	O	-1	2594614
30	O	-1	2594614
min	O	-1	2594614
before	O	-1	2594614
bupivac@@	B-Chemical	D002045	2594614
aine	I-Chemical	-1	2594614
administration	O	-1	2594614
(@@	O	-1	2594614
2	O	-1	2594614
mg/kg	O	-1	2594614
i.v@@	O	-1	2594614
.)	O	-1	2594614
sup@@	O	-1	2594614
press@@	O	-1	2594614
ed	O	-1	2594614
both	O	-1	2594614
the	O	-1	2594614
decrease	B-Disease	D007022	2594614
of	I-Disease	-1	2594614
M@@	I-Disease	-1	2594614
B@@	I-Disease	-1	2594614
P	I-Disease	-1	2594614
and	I-Disease	-1	2594614
H@@	I-Disease	-1	2594614
R	I-Disease	-1	2594614
decrease	B-Disease	D001919	2594614
of	I-Disease	-1	2594614
M@@	I-Disease	-1	2594614
B@@	I-Disease	-1	2594614
P	I-Disease	-1	2594614
and	I-Disease	-1	2594614
H@@	I-Disease	-1	2594614
R	I-Disease	-1	2594614
.	O	-1	2594614
In	O	-1	2594614
contrast@@	O	-1	2594614
,	O	-1	2594614
doses	O	-1	2594614
of	O	-1	2594614
1	O	-1	2594614
mg/kg	O	-1	2594614
B@@	B-Chemical	C045856	2594614
N	I-Chemical	-1	2594614
5@@	I-Chemical	-1	2594614
20@@	I-Chemical	-1	2594614
21	I-Chemical	-1	2594614
given	O	-1	2594614
30	O	-1	2594614
min	O	-1	2594614
before	O	-1	2594614
or	O	-1	2594614
10	O	-1	2594614
mg/kg	O	-1	2594614
administered	O	-1	2594614
5	O	-1	2594614
min	O	-1	2594614
before	O	-1	2594614
i.v@@	O	-1	2594614
.	O	-1	2594614
injection	O	-1	2594614
of	O	-1	2594614
bupivac@@	B-Chemical	D002045	2594614
aine	I-Chemical	-1	2594614
were	O	-1	2594614
ine@@	O	-1	2594614
ff@@	O	-1	2594614
ecti@@	O	-1	2594614
ve.	O	-1	2594614
Whe@@	O	-1	2594614
n	O	-1	2594614
B@@	B-Chemical	C045856	2594614
N	I-Chemical	-1	2594614
5@@	I-Chemical	-1	2594614
20@@	I-Chemical	-1	2594614
21	I-Chemical	-1	2594614
(2@@	O	-1	2594614
0	O	-1	2594614
mg/kg	O	-1	2594614
i.v@@	O	-1	2594614
.)	O	-1	2594614
was	O	-1	2594614
injected	O	-1	2594614
immedi@@	O	-1	2594614
ately	O	-1	2594614
after	O	-1	2594614
bupivac@@	B-Chemical	D002045	2594614
aine	I-Chemical	-1	2594614
(@@	O	-1	2594614
2	O	-1	2594614
mg/kg@@	O	-1	2594614
),	O	-1	2594614
a	O	-1	2594614
partial	O	-1	2594614
rever@@	O	-1	2594614
sion	O	-1	2594614
of	O	-1	2594614
the	O	-1	2594614
decrease	B-Disease	D007022	2594614
of	I-Disease	-1	2594614
M@@	I-Disease	-1	2594614
B@@	I-Disease	-1	2594614
P	I-Disease	-1	2594614
and	I-Disease	-1	2594614
H@@	I-Disease	-1	2594614
R	I-Disease	-1	2594614
decrease	B-Disease	D001919	2594614
of	I-Disease	-1	2594614
M@@	I-Disease	-1	2594614
B@@	I-Disease	-1	2594614
P	I-Disease	-1	2594614
and	I-Disease	-1	2594614
H@@	I-Disease	-1	2594614
R	I-Disease	-1	2594614
was	O	-1	2594614
obser@@	O	-1	2594614
ve@@	O	-1	2594614
d,	O	-1	2594614
whereas	O	-1	2594614
the	O	-1	2594614
dose	O	-1	2594614
of	O	-1	2594614
10	O	-1	2594614
mg/kg	O	-1	2594614
was	O	-1	2594614
ine@@	O	-1	2594614
ff@@	O	-1	2594614
ecti@@	O	-1	2594614
ve.	O	-1	2594614
A	O	-1	2594614
partial	O	-1	2594614
recovery	O	-1	2594614
of	O	-1	2594614
bupivac@@	B-Chemical	D002045	2594614
aine	I-Chemical	-1	2594614
-induced	O	-1	2594614
EC@@	O	-1	2594614
G	O	-1	2594614
al@@	O	-1	2594614
ter@@	O	-1	2594614
ations	O	-1	2594614
was	O	-1	2594614
observed	O	-1	2594614
after	O	-1	2594614
pretreatment	O	-1	2594614
of	O	-1	2594614
the	O	-1	2594614
rats	O	-1	2594614
with	O	-1	2594614
B@@	B-Chemical	C045856	2594614
N	I-Chemical	-1	2594614
5@@	I-Chemical	-1	2594614
20@@	I-Chemical	-1	2594614
21	I-Chemical	-1	2594614
.	O	-1	2594614
S@@	O	-1	2594614
inc@@	O	-1	2594614
e	O	-1	2594614
the	O	-1	2594614
administration	O	-1	2594614
of	O	-1	2594614
B@@	B-Chemical	C045856	2594614
N	I-Chemical	-1	2594614
5@@	I-Chemical	-1	2594614
20@@	I-Chemical	-1	2594614
21	I-Chemical	-1	2594614
,	O	-1	2594614
at	O	-1	2594614
all	O	-1	2594614
doses	O	-1	2594614
studi@@	O	-1	2594614
ed,	O	-1	2594614
did	O	-1	2594614
not	O	-1	2594614
al@@	O	-1	2594614
ter	O	-1	2594614
M@@	O	-1	2594614
B@@	O	-1	2594614
P	O	-1	2594614
and	O	-1	2594614
H@@	O	-1	2594614
R	O	-1	2594614
at	O	-1	2594614
the	O	-1	2594614
doses	O	-1	2594614
use@@	O	-1	2594614
d,	O	-1	2594614
the	O	-1	2594614
b@@	O	-1	2594614
ul@@	O	-1	2594614
k	O	-1	2594614
of	O	-1	2594614
these	O	-1	2594614
results	O	-1	2594614
clear@@	O	-1	2594614
ly	O	-1	2594614
demon@@	O	-1	2594614
st@@	O	-1	2594614
rate	O	-1	2594614
a	O	-1	2594614
protective	O	-1	2594614
action	O	-1	2594614
of	O	-1	2594614
B@@	B-Chemical	C045856	2594614
N	I-Chemical	-1	2594614
5@@	I-Chemical	-1	2594614
20@@	I-Chemical	-1	2594614
21	I-Chemical	-1	2594614
,	O	-1	2594614
a	O	-1	2594614
specific	O	-1	2594614
antagonist	O	-1	2594614
of	O	-1	2594614
PA@@	O	-1	2594614
F@@	O	-1	2594614
,	O	-1	2594614
against	O	-1	2594614
bupivac@@	B-Chemical	D002045	2594614
aine	I-Chemical	-1	2594614
-induced	O	-1	2594614
cardiovascular	B-Disease	D002318	2594614
toxicity	I-Disease	-1	2594614
.	O	-1	2594614
Th@@	O	-1	2594614
us,	O	-1	2594614
consist@@	O	-1	2594614
ent	O	-1	2594614
with	O	-1	2594614
its	O	-1	2594614
direct	O	-1	2594614
effect	O	-1	2594614
on	O	-1	2594614
hear@@	O	-1	2594614
t,	O	-1	2594614
PA@@	O	-1	2594614
F	O	-1	2594614
appear@@	O	-1	2594614
s	O	-1	2594614
to	O	-1	2594614
be	O	-1	2594614
implic@@	O	-1	2594614
ated	O	-1	2594614
in	O	-1	2594614
bupivac@@	B-Chemical	D002045	2594614
aine	I-Chemical	-1	2594614
-induced	O	-1	2594614
cardiovascular	B-Disease	D018376	2594614
al@@	I-Disease	-1	2594614
ter@@	I-Disease	-1	2594614
ations	I-Disease	-1	2594614
.	O	-1	2594614

B@@	B-Chemical	C034753	2257294
enz@@	I-Chemical	-1	2257294
yl@@	I-Chemical	-1	2257294
ac@@	I-Chemical	-1	2257294
yc@@	I-Chemical	-1	2257294
lo@@	I-Chemical	-1	2257294
ur@@	I-Chemical	-1	2257294
idine	I-Chemical	-1	2257294
rever@@	O	-1	2257294
ses	O	-1	2257294
az@@	B-Chemical	D015215	2257294
id@@	I-Chemical	-1	2257294
o@@	I-Chemical	-1	2257294
th@@	I-Chemical	-1	2257294
ym@@	I-Chemical	-1	2257294
idine	I-Chemical	-1	2257294
-induced	O	-1	2257294
m@@	B-Disease	D001855	2257294
ar@@	I-Disease	-1	2257294
ro@@	I-Disease	-1	2257294
w	I-Disease	-1	2257294
sup@@	I-Disease	-1	2257294
pression	I-Disease	-1	2257294
without	O	-1	2257294
impair@@	O	-1	2257294
ment	O	-1	2257294
of	O	-1	2257294
anti@@	O	-1	2257294
-@@	O	-1	2257294
human	O	-1	2257294
immuno@@	B-Disease	D007153	2257294
defici@@	I-Disease	-1	2257294
ency	I-Disease	-1	2257294
vi@@	O	-1	2257294
ru@@	O	-1	2257294
s	O	-1	2257294
activ@@	O	-1	2257294
ity.	O	-1	2257294
In@@	O	-1	2257294
c@@	O	-1	2257294
reas@@	O	-1	2257294
ed	O	-1	2257294
extrac@@	O	-1	2257294
ell@@	O	-1	2257294
ular	O	-1	2257294
concentrations	O	-1	2257294
of	O	-1	2257294
ur@@	B-Chemical	D014529	2257294
idine	I-Chemical	-1	2257294
(	O	-1	2257294
U@@	B-Chemical	D014529	2257294
r@@	I-Chemical	-1	2257294
d	I-Chemical	-1	2257294
)	O	-1	2257294
have	O	-1	2257294
been	O	-1	2257294
reported	O	-1	2257294
to	O	-1	2257294
reduc@@	O	-1	2257294
e,	O	-1	2257294
in	O	-1	2257294
vit@@	O	-1	2257294
ro@@	O	-1	2257294
,	O	-1	2257294
az@@	B-Chemical	D015215	2257294
id@@	I-Chemical	-1	2257294
o@@	I-Chemical	-1	2257294
th@@	I-Chemical	-1	2257294
ym@@	I-Chemical	-1	2257294
idine	I-Chemical	-1	2257294
(	O	-1	2257294
A@@	B-Chemical	D015215	2257294
Z@@	I-Chemical	-1	2257294
T	I-Chemical	-1	2257294
)@@	O	-1	2257294
-induced	O	-1	2257294
inhibition	O	-1	2257294
of	O	-1	2257294
human	O	-1	2257294
gran@@	O	-1	2257294
ulo@@	O	-1	2257294
cy@@	O	-1	2257294
te@@	O	-1	2257294
-@@	O	-1	2257294
mac@@	O	-1	2257294
ro@@	O	-1	2257294
ph@@	O	-1	2257294
age	O	-1	2257294
pro@@	O	-1	2257294
gen@@	O	-1	2257294
it@@	O	-1	2257294
or	O	-1	2257294
cells	O	-1	2257294
without	O	-1	2257294
impair@@	O	-1	2257294
ment	O	-1	2257294
of	O	-1	2257294
its	O	-1	2257294
anti@@	O	-1	2257294
human	O	-1	2257294
immuno@@	B-Disease	D007153	2257294
defici@@	I-Disease	-1	2257294
ency	I-Disease	-1	2257294
vi@@	O	-1	2257294
ru@@	O	-1	2257294
s	O	-1	2257294
(@@	O	-1	2257294
H@@	O	-1	2257294
I@@	O	-1	2257294
V@@	O	-1	2257294
)	O	-1	2257294
activ@@	O	-1	2257294
ity.	O	-1	2257294
B@@	O	-1	2257294
ecause	O	-1	2257294
of	O	-1	2257294
the	O	-1	2257294
clinical	O	-1	2257294
toxic@@	B-Disease	D064420	2257294
ities	I-Disease	-1	2257294
associated	O	-1	2257294
with	O	-1	2257294
chronic	O	-1	2257294
U@@	B-Chemical	D014529	2257294
r@@	I-Chemical	-1	2257294
d	I-Chemical	-1	2257294
administr@@	O	-1	2257294
ation,	O	-1	2257294
the	O	-1	2257294
ability	O	-1	2257294
of	O	-1	2257294
b@@	B-Chemical	C034753	2257294
enz@@	I-Chemical	-1	2257294
yl@@	I-Chemical	-1	2257294
ac@@	I-Chemical	-1	2257294
yc@@	I-Chemical	-1	2257294
lo@@	I-Chemical	-1	2257294
ur@@	I-Chemical	-1	2257294
idine	I-Chemical	-1	2257294
(	O	-1	2257294
BA@@	B-Chemical	C034753	2257294
U	I-Chemical	-1	2257294
)	O	-1	2257294
to	O	-1	2257294
effect@@	O	-1	2257294
,	O	-1	2257294
in	O	-1	2257294
viv@@	O	-1	2257294
o@@	O	-1	2257294
,	O	-1	2257294
A@@	B-Chemical	D015215	2257294
Z@@	I-Chemical	-1	2257294
T	I-Chemical	-1	2257294
-induced	O	-1	2257294
anemia	B-Disease	D000740	2257294
and	O	-1	2257294
leuk@@	B-Disease	D007970	2257294
o@@	I-Disease	-1	2257294
pen@@	I-Disease	-1	2257294
ia	I-Disease	-1	2257294
was	O	-1	2257294
ass@@	O	-1	2257294
es@@	O	-1	2257294
sed.	O	-1	2257294
This	O	-1	2257294
agent	O	-1	2257294
inhibit@@	O	-1	2257294
s	O	-1	2257294
U@@	B-Chemical	D014529	2257294
r@@	I-Chemical	-1	2257294
d	I-Chemical	-1	2257294
cat@@	O	-1	2257294
abol@@	O	-1	2257294
ism	O	-1	2257294
and@@	O	-1	2257294
,	O	-1	2257294
in	O	-1	2257294
viv@@	O	-1	2257294
o@@	O	-1	2257294
,	O	-1	2257294
increases	O	-1	2257294
the	O	-1	2257294
plasma	O	-1	2257294
concentration	O	-1	2257294
of	O	-1	2257294
U@@	B-Chemical	D014529	2257294
r@@	I-Chemical	-1	2257294
d	I-Chemical	-1	2257294
in	O	-1	2257294
a	O	-1	2257294
dose-@@	O	-1	2257294
dependent	O	-1	2257294
man@@	O	-1	2257294
ner@@	O	-1	2257294
,	O	-1	2257294
without	O	-1	2257294
U@@	B-Chemical	D014529	2257294
r@@	I-Chemical	-1	2257294
d	I-Chemical	-1	2257294
-@@	O	-1	2257294
related	O	-1	2257294
toxicity	B-Disease	D064420	2257294
.	O	-1	2257294
In	O	-1	2257294
mice	O	-1	2257294
ren@@	O	-1	2257294
de@@	O	-1	2257294
red	O	-1	2257294
an@@	B-Disease	D000740	2257294
em@@	I-Disease	-1	2257294
ic	I-Disease	-1	2257294
and	O	-1	2257294
leuk@@	B-Disease	D007970	2257294
o@@	I-Disease	-1	2257294
pen@@	I-Disease	-1	2257294
ic	I-Disease	-1	2257294
by	O	-1	2257294
the	O	-1	2257294
administration	O	-1	2257294
of	O	-1	2257294
A@@	B-Chemical	D015215	2257294
Z@@	I-Chemical	-1	2257294
T	I-Chemical	-1	2257294
for	O	-1	2257294
2@@	O	-1	2257294
8	O	-1	2257294
days	O	-1	2257294
in	O	-1	2257294
d@@	O	-1	2257294
r@@	O	-1	2257294
in@@	O	-1	2257294
king	O	-1	2257294
w@@	O	-1	2257294
at@@	O	-1	2257294
er	O	-1	2257294
(1@@	O	-1	2257294
.@@	O	-1	2257294
5	O	-1	2257294
mg/m@@	O	-1	2257294
L@@	O	-1	2257294
),	O	-1	2257294
the	O	-1	2257294
continu@@	O	-1	2257294
ed	O	-1	2257294
administration	O	-1	2257294
of	O	-1	2257294
A@@	B-Chemical	D015215	2257294
Z@@	I-Chemical	-1	2257294
T	I-Chemical	-1	2257294
plus	O	-1	2257294
daily	O	-1	2257294
BA@@	B-Chemical	C034753	2257294
U	I-Chemical	-1	2257294
(3@@	O	-1	2257294
00	O	-1	2257294
mg/kg@@	O	-1	2257294
,	O	-1	2257294
or@@	O	-1	2257294
all@@	O	-1	2257294
y@@	O	-1	2257294
)	O	-1	2257294
par@@	O	-1	2257294
ti@@	O	-1	2257294
ally	O	-1	2257294
reversed	O	-1	2257294
A@@	B-Chemical	D015215	2257294
Z@@	I-Chemical	-1	2257294
T	I-Chemical	-1	2257294
-induced	O	-1	2257294
anemia	B-Disease	D000740	2257294
and	O	-1	2257294
leuk@@	B-Disease	D007970	2257294
o@@	I-Disease	-1	2257294
pen@@	I-Disease	-1	2257294
ia	I-Disease	-1	2257294
(P	O	-1	2257294
less	O	-1	2257294
than	O	-1	2257294
.@@	O	-1	2257294
0@@	O	-1	2257294
5@@	O	-1	2257294
),	O	-1	2257294
increased	O	-1	2257294
peripheral	O	-1	2257294
re@@	O	-1	2257294
tic@@	O	-1	2257294
ulo@@	O	-1	2257294
cy@@	O	-1	2257294
tes	O	-1	2257294
(@@	O	-1	2257294
to	O	-1	2257294
4.@@	O	-1	2257294
9@@	O	-1	2257294
%,	O	-1	2257294
P	O	-1	2257294
less	O	-1	2257294
than	O	-1	2257294
.@@	O	-1	2257294
0@@	O	-1	2257294
1),	O	-1	2257294
increased	O	-1	2257294
cell@@	O	-1	2257294
ul@@	O	-1	2257294
ar@@	O	-1	2257294
ity	O	-1	2257294
in	O	-1	2257294
the	O	-1	2257294
m@@	O	-1	2257294
ar@@	O	-1	2257294
row@@	O	-1	2257294
,	O	-1	2257294
and	O	-1	2257294
improved	O	-1	2257294
me@@	B-Disease	-1	2257294
g@@	I-Disease	-1	2257294
al@@	I-Disease	-1	2257294
ob@@	I-Disease	-1	2257294
l@@	I-Disease	-1	2257294
ast@@	I-Disease	-1	2257294
o@@	I-Disease	-1	2257294
sis	I-Disease	-1	2257294
.	O	-1	2257294
Whe@@	O	-1	2257294
n	O	-1	2257294
co@@	O	-1	2257294
administered	O	-1	2257294
with	O	-1	2257294
A@@	B-Chemical	D015215	2257294
Z@@	I-Chemical	-1	2257294
T	I-Chemical	-1	2257294
from	O	-1	2257294
the	O	-1	2257294
onset	O	-1	2257294
of	O	-1	2257294
drug	O	-1	2257294
administr@@	O	-1	2257294
ation,	O	-1	2257294
BA@@	B-Chemical	C034753	2257294
U	I-Chemical	-1	2257294
reduced	O	-1	2257294
A@@	B-Chemical	D015215	2257294
Z@@	I-Chemical	-1	2257294
T	I-Chemical	-1	2257294
-induced	O	-1	2257294
m@@	B-Disease	D001855	2257294
ar@@	I-Disease	-1	2257294
ro@@	I-Disease	-1	2257294
w	I-Disease	-1	2257294
toxicity	I-Disease	-1	2257294
.	O	-1	2257294
In	O	-1	2257294
vit@@	O	-1	2257294
ro@@	O	-1	2257294
,	O	-1	2257294
at	O	-1	2257294
a	O	-1	2257294
concentration	O	-1	2257294
of	O	-1	2257294
100	O	-1	2257294
m@@	O	-1	2257294
um@@	O	-1	2257294
ol@@	O	-1	2257294
/@@	O	-1	2257294
L@@	O	-1	2257294
,	O	-1	2257294
BA@@	B-Chemical	C034753	2257294
U	I-Chemical	-1	2257294
pos@@	O	-1	2257294
s@@	O	-1	2257294
es@@	O	-1	2257294
ses	O	-1	2257294
minim@@	O	-1	2257294
al	O	-1	2257294
anti@@	O	-1	2257294
-H@@	O	-1	2257294
IV	O	-1	2257294
activity	O	-1	2257294
and	O	-1	2257294
has	O	-1	2257294
no	O	-1	2257294
effect	O	-1	2257294
on	O	-1	2257294
the	O	-1	2257294
ability	O	-1	2257294
of	O	-1	2257294
A@@	B-Chemical	D015215	2257294
Z@@	I-Chemical	-1	2257294
T	I-Chemical	-1	2257294
to	O	-1	2257294
re@@	O	-1	2257294
verse	O	-1	2257294
the	O	-1	2257294
H@@	O	-1	2257294
I@@	O	-1	2257294
V@@	O	-1	2257294
-induced	O	-1	2257294
cyto@@	O	-1	2257294
path@@	O	-1	2257294
ic	O	-1	2257294
effect	O	-1	2257294
in	O	-1	2257294
M@@	O	-1	2257294
T@@	O	-1	2257294
4	O	-1	2257294
cell@@	O	-1	2257294
s.	O	-1	2257294
The	O	-1	2257294
clinical	O	-1	2257294
and	O	-1	2257294
bio@@	O	-1	2257294
chemical	O	-1	2257294
implic@@	O	-1	2257294
ations	O	-1	2257294
of	O	-1	2257294
these	O	-1	2257294
findings	O	-1	2257294
are	O	-1	2257294
discus@@	O	-1	2257294
sed.	O	-1	2257294

C@@	B-Chemical	D003520	10840460
yc@@	I-Chemical	-1	10840460
lo@@	I-Chemical	-1	10840460
phosph@@	I-Chemical	-1	10840460
amide	I-Chemical	-1	10840460
-induced	O	-1	10840460
cys@@	B-Disease	D003556	10840460
ti@@	I-Disease	-1	10840460
tis	I-Disease	-1	10840460
in	O	-1	10840460
f@@	O	-1	10840460
re@@	O	-1	10840460
el@@	O	-1	10840460
y-@@	O	-1	10840460
mo@@	O	-1	10840460
ving	O	-1	10840460
con@@	O	-1	10840460
s@@	O	-1	10840460
ci@@	O	-1	10840460
ous	O	-1	10840460
rat@@	O	-1	10840460
s:	O	-1	10840460
behavioral	O	-1	10840460
appro@@	O	-1	10840460
ach	O	-1	10840460
to	O	-1	10840460
a	O	-1	10840460
new	O	-1	10840460
model	O	-1	10840460
of	O	-1	10840460
v@@	B-Disease	D059265	10840460
is@@	I-Disease	-1	10840460
c@@	I-Disease	-1	10840460
eral	I-Disease	-1	10840460
pain	I-Disease	-1	10840460
.	O	-1	10840460
P@@	O	-1	10840460
U@@	O	-1	10840460
R@@	O	-1	10840460
P@@	O	-1	10840460
O@@	O	-1	10840460
S@@	O	-1	10840460
E:	O	-1	10840460
To	O	-1	10840460
deve@@	O	-1	10840460
lo@@	O	-1	10840460
p	O	-1	10840460
a	O	-1	10840460
model	O	-1	10840460
of	O	-1	10840460
v@@	B-Disease	D059265	10840460
is@@	I-Disease	-1	10840460
c@@	I-Disease	-1	10840460
eral	I-Disease	-1	10840460
pain	I-Disease	-1	10840460
in	O	-1	10840460
rats	O	-1	10840460
using	O	-1	10840460
a	O	-1	10840460
behavioral	O	-1	10840460
appro@@	O	-1	10840460
ac@@	O	-1	10840460
h@@	O	-1	10840460
.	O	-1	10840460
C@@	B-Chemical	D003520	10840460
yc@@	I-Chemical	-1	10840460
lo@@	I-Chemical	-1	10840460
phosph@@	I-Chemical	-1	10840460
amide	I-Chemical	-1	10840460
(	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
),	O	-1	10840460
an	O	-1	10840460
anti@@	O	-1	10840460
tu@@	O	-1	10840460
mor@@	O	-1	10840460
al	O	-1	10840460
agent	O	-1	10840460
known	O	-1	10840460
to	O	-1	10840460
produce	O	-1	10840460
toxic	O	-1	10840460
effects	O	-1	10840460
on	O	-1	10840460
the	O	-1	10840460
bladder	O	-1	10840460
w@@	O	-1	10840460
all	O	-1	10840460
through	O	-1	10840460
its	O	-1	10840460
ma@@	O	-1	10840460
in	O	-1	10840460
toxic	O	-1	10840460
metabol@@	O	-1	10840460
ite	O	-1	10840460
ac@@	B-Chemical	D000171	10840460
ro@@	I-Chemical	-1	10840460
le@@	I-Chemical	-1	10840460
in	I-Chemical	-1	10840460
,	O	-1	10840460
was	O	-1	10840460
used	O	-1	10840460
to	O	-1	10840460
induce	O	-1	10840460
cys@@	B-Disease	D003556	10840460
ti@@	I-Disease	-1	10840460
tis	I-Disease	-1	10840460
.	O	-1	10840460
M@@	O	-1	10840460
AT@@	O	-1	10840460
E@@	O	-1	10840460
R@@	O	-1	10840460
I@@	O	-1	10840460
AL@@	O	-1	10840460
S	O	-1	10840460
AN@@	O	-1	10840460
D	O	-1	10840460
METHODS:	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
was	O	-1	10840460
administered	O	-1	10840460
at	O	-1	10840460
doses	O	-1	10840460
of	O	-1	10840460
50@@	O	-1	10840460
,	O	-1	10840460
100	O	-1	10840460
and	O	-1	10840460
2@@	O	-1	10840460
00	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
i.@@	O	-1	10840460
p@@	O	-1	10840460
.	O	-1	10840460
to	O	-1	10840460
male	O	-1	10840460
rats,	O	-1	10840460
and	O	-1	10840460
their	O	-1	10840460
behavi@@	O	-1	10840460
or	O	-1	10840460
observed	O	-1	10840460
and	O	-1	10840460
sco@@	O	-1	10840460
red.	O	-1	10840460
The	O	-1	10840460
effects	O	-1	10840460
of	O	-1	10840460
morphine	B-Chemical	D009020	10840460
(0.@@	O	-1	10840460
5	O	-1	10840460
to	O	-1	10840460
4	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
i.v@@	O	-1	10840460
.)	O	-1	10840460
on	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
-induced	O	-1	10840460
behavioral	O	-1	10840460
mo@@	O	-1	10840460
di@@	O	-1	10840460
fic@@	O	-1	10840460
ations	O	-1	10840460
were	O	-1	10840460
tested	O	-1	10840460
administered	O	-1	10840460
alone	O	-1	10840460
and	O	-1	10840460
after	O	-1	10840460
n@@	B-Chemical	D009270	10840460
al@@	I-Chemical	-1	10840460
ox@@	I-Chemical	-1	10840460
one	I-Chemical	-1	10840460
(@@	O	-1	10840460
1	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
s@@	O	-1	10840460
.@@	O	-1	10840460
c@@	O	-1	10840460
.@@	O	-1	10840460
).	O	-1	10840460
In	O	-1	10840460
addi@@	O	-1	10840460
tion,	O	-1	10840460
9@@	O	-1	10840460
0	O	-1	10840460
minutes	O	-1	10840460
after	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
injec@@	O	-1	10840460
tion,	O	-1	10840460
that	O	-1	10840460
is@@	O	-1	10840460
,	O	-1	10840460
at	O	-1	10840460
the	O	-1	10840460
time	O	-1	10840460
of	O	-1	10840460
administration	O	-1	10840460
of	O	-1	10840460
morphine	B-Chemical	D009020	10840460
,	O	-1	10840460
the	O	-1	10840460
bladder	O	-1	10840460
was	O	-1	10840460
re@@	O	-1	10840460
mo@@	O	-1	10840460
ved	O	-1	10840460
in	O	-1	10840460
some	O	-1	10840460
rats	O	-1	10840460
for	O	-1	10840460
hist@@	O	-1	10840460
ological	O	-1	10840460
examin@@	O	-1	10840460
ation.	O	-1	10840460
F@@	O	-1	10840460
in@@	O	-1	10840460
ally,	O	-1	10840460
to	O	-1	10840460
show	O	-1	10840460
that	O	-1	10840460
the	O	-1	10840460
bladder	O	-1	10840460
is	O	-1	10840460
es@@	O	-1	10840460
sen@@	O	-1	10840460
tial	O	-1	10840460
for	O	-1	10840460
the	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
-induced	O	-1	10840460
behavioral	O	-1	10840460
mo@@	O	-1	10840460
di@@	O	-1	10840460
fic@@	O	-1	10840460
ation@@	O	-1	10840460
s,	O	-1	10840460
female	O	-1	10840460
rats	O	-1	10840460
also	O	-1	10840460
received	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
at	O	-1	10840460
doses	O	-1	10840460
of	O	-1	10840460
2@@	O	-1	10840460
00	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
i.@@	O	-1	10840460
p@@	O	-1	10840460
.	O	-1	10840460
and	O	-1	10840460
of	O	-1	10840460
20	O	-1	10840460
mg@@	O	-1	10840460
.	O	-1	10840460
by	O	-1	10840460
the	O	-1	10840460
intra@@	O	-1	10840460
ve@@	O	-1	10840460
si@@	O	-1	10840460
c@@	O	-1	10840460
al	O	-1	10840460
rou@@	O	-1	10840460
te@@	O	-1	10840460
,	O	-1	10840460
and	O	-1	10840460
ac@@	B-Chemical	D000171	10840460
ro@@	I-Chemical	-1	10840460
le@@	I-Chemical	-1	10840460
in	I-Chemical	-1	10840460
at	O	-1	10840460
doses	O	-1	10840460
of	O	-1	10840460
0.@@	O	-1	10840460
5	O	-1	10840460
mg@@	O	-1	10840460
.	O	-1	10840460
by	O	-1	10840460
the	O	-1	10840460
intra@@	O	-1	10840460
ve@@	O	-1	10840460
si@@	O	-1	10840460
c@@	O	-1	10840460
al	O	-1	10840460
ro@@	O	-1	10840460
ute	O	-1	10840460
and	O	-1	10840460
of	O	-1	10840460
5	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
i.v@@	O	-1	10840460
.	O	-1	10840460
RESULTS:	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
dose-@@	O	-1	10840460
rel@@	O	-1	10840460
ated@@	O	-1	10840460
ly	O	-1	10840460
induced	O	-1	10840460
mark@@	O	-1	10840460
ed	O	-1	10840460
behavioral	O	-1	10840460
mo@@	O	-1	10840460
di@@	O	-1	10840460
fic@@	O	-1	10840460
ations	O	-1	10840460
in	O	-1	10840460
male	O	-1	10840460
rat@@	O	-1	10840460
s:	O	-1	10840460
b@@	O	-1	10840460
re@@	O	-1	10840460
ath@@	O	-1	10840460
ing	O	-1	10840460
rate	O	-1	10840460
decreas@@	O	-1	10840460
e,	O	-1	10840460
c@@	O	-1	10840460
los@@	O	-1	10840460
ing	O	-1	10840460
of	O	-1	10840460
the	O	-1	10840460
e@@	O	-1	10840460
y@@	O	-1	10840460
es	O	-1	10840460
and	O	-1	10840460
occur@@	O	-1	10840460
rence	O	-1	10840460
of	O	-1	10840460
specific	O	-1	10840460
post@@	O	-1	10840460
ures@@	O	-1	10840460
.	O	-1	10840460
M@@	B-Chemical	D009020	10840460
or@@	I-Chemical	-1	10840460
ph@@	I-Chemical	-1	10840460
ine	I-Chemical	-1	10840460
dose-@@	O	-1	10840460
depend@@	O	-1	10840460
ently	O	-1	10840460
reversed	O	-1	10840460
these	O	-1	10840460
behavioral	B-Disease	D001523	10840460
disorder@@	I-Disease	-1	10840460
s	I-Disease	-1	10840460
.	O	-1	10840460
A	O	-1	10840460
dose	O	-1	10840460
of	O	-1	10840460
0.@@	O	-1	10840460
5	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
produced	O	-1	10840460
a	O	-1	10840460
reduction	O	-1	10840460
of	O	-1	10840460
al@@	O	-1	10840460
most	O	-1	10840460
50@@	O	-1	10840460
%	O	-1	10840460
of	O	-1	10840460
the	O	-1	10840460
behavioral	O	-1	10840460
scor@@	O	-1	10840460
e	O	-1	10840460
induced	O	-1	10840460
by	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
2@@	O	-1	10840460
00	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
This	O	-1	10840460
effect	O	-1	10840460
was	O	-1	10840460
complete@@	O	-1	10840460
ly	O	-1	10840460
prevent@@	O	-1	10840460
ed	O	-1	10840460
by	O	-1	10840460
pretreatment	O	-1	10840460
with	O	-1	10840460
n@@	B-Chemical	D009270	10840460
al@@	I-Chemical	-1	10840460
ox@@	I-Chemical	-1	10840460
one	I-Chemical	-1	10840460
.	O	-1	10840460
A@@	O	-1	10840460
t	O	-1	10840460
the	O	-1	10840460
time	O	-1	10840460
of	O	-1	10840460
administration	O	-1	10840460
of	O	-1	10840460
morphine	B-Chemical	D009020	10840460
,	O	-1	10840460
hist@@	O	-1	10840460
ological	O	-1	10840460
mo@@	O	-1	10840460
di@@	O	-1	10840460
fic@@	O	-1	10840460
ations	O	-1	10840460
of	O	-1	10840460
the	O	-1	10840460
bladder	O	-1	10840460
w@@	O	-1	10840460
all@@	O	-1	10840460
,	O	-1	10840460
such	O	-1	10840460
as	O	-1	10840460
ch@@	O	-1	10840460
or@@	O	-1	10840460
i@@	O	-1	10840460
onic	O	-1	10840460
and	O	-1	10840460
musc@@	O	-1	10840460
le	O	-1	10840460
l@@	O	-1	10840460
ay@@	O	-1	10840460
er	O	-1	10840460
e@@	B-Disease	D004487	10840460
de@@	I-Disease	-1	10840460
ma	I-Disease	-1	10840460
,	O	-1	10840460
were	O	-1	10840460
obser@@	O	-1	10840460
ved.	O	-1	10840460
In	O	-1	10840460
female	O	-1	10840460
rats,	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
2@@	O	-1	10840460
00	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
i.@@	O	-1	10840460
p@@	O	-1	10840460
.	O	-1	10840460
produced	O	-1	10840460
the	O	-1	10840460
same	O	-1	10840460
mark@@	O	-1	10840460
ed	O	-1	10840460
behavioral	O	-1	10840460
mo@@	O	-1	10840460
di@@	O	-1	10840460
fic@@	O	-1	10840460
ations	O	-1	10840460
as	O	-1	10840460
those	O	-1	10840460
observed	O	-1	10840460
in	O	-1	10840460
male	O	-1	10840460
rats.	O	-1	10840460
Ad@@	O	-1	10840460
minist@@	O	-1	10840460
ered	O	-1	10840460
at	O	-1	10840460
the	O	-1	10840460
dose	O	-1	10840460
of	O	-1	10840460
20	O	-1	10840460
mg@@	O	-1	10840460
.	O	-1	10840460
intra@@	O	-1	10840460
ve@@	O	-1	10840460
si@@	O	-1	10840460
c@@	O	-1	10840460
ally,	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
did	O	-1	10840460
not	O	-1	10840460
produce	O	-1	10840460
any	O	-1	10840460
behavioral	O	-1	10840460
effect@@	O	-1	10840460
s,	O	-1	10840460
whereas	O	-1	10840460
ac@@	B-Chemical	D000171	10840460
ro@@	I-Chemical	-1	10840460
le@@	I-Chemical	-1	10840460
in	I-Chemical	-1	10840460
at	O	-1	10840460
0.@@	O	-1	10840460
5	O	-1	10840460
mg@@	O	-1	10840460
.	O	-1	10840460
intra@@	O	-1	10840460
ve@@	O	-1	10840460
si@@	O	-1	10840460
c@@	O	-1	10840460
ally	O	-1	10840460
induced	O	-1	10840460
behavioral	O	-1	10840460
mo@@	O	-1	10840460
di@@	O	-1	10840460
fic@@	O	-1	10840460
ations	O	-1	10840460
id@@	O	-1	10840460
en@@	O	-1	10840460
tical	O	-1	10840460
to	O	-1	10840460
those	O	-1	10840460
under	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
2@@	O	-1	10840460
00	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
i.p.@@	O	-1	10840460
,	O	-1	10840460
with	O	-1	10840460
the	O	-1	10840460
same	O	-1	10840460
maxim@@	O	-1	10840460
al	O	-1	10840460
level@@	O	-1	10840460
s.	O	-1	10840460
Con@@	O	-1	10840460
ver@@	O	-1	10840460
sel@@	O	-1	10840460
y,	O	-1	10840460
ac@@	B-Chemical	D000171	10840460
ro@@	I-Chemical	-1	10840460
le@@	I-Chemical	-1	10840460
in	I-Chemical	-1	10840460
5	O	-1	10840460
mg@@	O	-1	10840460
.@@	O	-1	10840460
/@@	O	-1	10840460
kg@@	O	-1	10840460
.	O	-1	10840460
i.v@@	O	-1	10840460
.	O	-1	10840460
did	O	-1	10840460
not	O	-1	10840460
produce	O	-1	10840460
any	O	-1	10840460
behavioral	O	-1	10840460
effects	O	-1	10840460
at	O	-1	10840460
all@@	O	-1	10840460
.	O	-1	10840460
CONCLUSIONS:	O	-1	10840460
O@@	O	-1	10840460
ver@@	O	-1	10840460
all@@	O	-1	10840460
,	O	-1	10840460
these	O	-1	10840460
results	O	-1	10840460
indicate	O	-1	10840460
that	O	-1	10840460
this	O	-1	10840460
experimental	O	-1	10840460
model	O	-1	10840460
of	O	-1	10840460
C@@	B-Chemical	D003520	10840460
P	I-Chemical	-1	10840460
-induced	O	-1	10840460
cys@@	B-Disease	D003556	10840460
ti@@	I-Disease	-1	10840460
tis	I-Disease	-1	10840460
may	O	-1	10840460
be	O	-1	10840460
an	O	-1	10840460
in@@	O	-1	10840460
te@@	O	-1	10840460
rest@@	O	-1	10840460
ing	O	-1	10840460
new	O	-1	10840460
behavioral	O	-1	10840460
model	O	-1	10840460
of	O	-1	10840460
inflam@@	O	-1	10840460
mat@@	O	-1	10840460
ory	O	-1	10840460
v@@	B-Disease	D059265	10840460
is@@	I-Disease	-1	10840460
c@@	I-Disease	-1	10840460
eral	I-Disease	-1	10840460
pain	I-Disease	-1	10840460
,	O	-1	10840460
al@@	O	-1	10840460
low@@	O	-1	10840460
ing	O	-1	10840460
a	O	-1	10840460
bet@@	O	-1	10840460
ter	O	-1	10840460
under@@	O	-1	10840460
stand@@	O	-1	10840460
ing	O	-1	10840460
of	O	-1	10840460
these	O	-1	10840460
pa@@	B-Disease	D010146	10840460
infu@@	I-Disease	-1	10840460
l	I-Disease	-1	10840460
syndrom@@	I-Disease	-1	10840460
es	I-Disease	-1	10840460
and	O	-1	10840460
th@@	O	-1	10840460
us	O	-1	10840460
a	O	-1	10840460
bet@@	O	-1	10840460
ter	O	-1	10840460
therapeutic	O	-1	10840460
appro@@	O	-1	10840460
ach	O	-1	10840460
to	O	-1	10840460
th@@	O	-1	10840460
em@@	O	-1	10840460
.	O	-1	10840460

H@@	B-Disease	D006930	8278214
y@@	I-Disease	-1	8278214
per@@	I-Disease	-1	8278214
alge@@	I-Disease	-1	8278214
sia	I-Disease	-1	8278214
and	O	-1	8278214
my@@	B-Disease	D009207	8278214
oc@@	I-Disease	-1	8278214
lon@@	I-Disease	-1	8278214
us	I-Disease	-1	8278214
in	O	-1	8278214
ter@@	O	-1	8278214
min@@	O	-1	8278214
al	O	-1	8278214
cancer	B-Disease	D009369	8278214
patients	O	-1	8278214
treated	O	-1	8278214
with	O	-1	8278214
continu@@	O	-1	8278214
ous	O	-1	8278214
intravenous	O	-1	8278214
morphine	B-Chemical	D009020	8278214
.	O	-1	8278214
E@@	O	-1	8278214
ight	O	-1	8278214
cancer	B-Disease	D009369	8278214
patients	O	-1	8278214
in	O	-1	8278214
the	O	-1	8278214
ter@@	O	-1	8278214
min@@	O	-1	8278214
al	O	-1	8278214
st@@	O	-1	8278214
ages	O	-1	8278214
of	O	-1	8278214
the	O	-1	8278214
disease	O	-1	8278214
treated	O	-1	8278214
with	O	-1	8278214
high	O	-1	8278214
doses	O	-1	8278214
of	O	-1	8278214
intravenous	O	-1	8278214
morphine	B-Chemical	D009020	8278214
developed	O	-1	8278214
hyperalge@@	B-Disease	D006930	8278214
sia	I-Disease	-1	8278214
.	O	-1	8278214
All	O	-1	8278214
cases	O	-1	8278214
were	O	-1	8278214
ret@@	O	-1	8278214
ro@@	O	-1	8278214
sp@@	O	-1	8278214
ectively	O	-1	8278214
sam@@	O	-1	8278214
pl@@	O	-1	8278214
ed	O	-1	8278214
from	O	-1	8278214
three	O	-1	8278214
different	O	-1	8278214
hospit@@	O	-1	8278214
als	O	-1	8278214
in	O	-1	8278214
C@@	O	-1	8278214
o@@	O	-1	8278214
pen@@	O	-1	8278214
h@@	O	-1	8278214
ag@@	O	-1	8278214
en@@	O	-1	8278214
.	O	-1	8278214
F@@	O	-1	8278214
i@@	O	-1	8278214
ve	O	-1	8278214
patients	O	-1	8278214
developed	O	-1	8278214
un@@	O	-1	8278214
i@@	O	-1	8278214
ver@@	O	-1	8278214
s@@	O	-1	8278214
al	O	-1	8278214
hyperalge@@	B-Disease	D006930	8278214
sia	I-Disease	-1	8278214
and	O	-1	8278214
hy@@	B-Disease	D006941	8278214
pe@@	I-Disease	-1	8278214
res@@	I-Disease	-1	8278214
the@@	I-Disease	-1	8278214
sia	I-Disease	-1	8278214
which	O	-1	8278214
in	O	-1	8278214
2	O	-1	8278214
cases	O	-1	8278214
were	O	-1	8278214
ac@@	O	-1	8278214
comp@@	O	-1	8278214
an@@	O	-1	8278214
ied	O	-1	8278214
by	O	-1	8278214
my@@	B-Disease	D009207	8278214
oc@@	I-Disease	-1	8278214
lon@@	I-Disease	-1	8278214
us	I-Disease	-1	8278214
.	O	-1	8278214
In	O	-1	8278214
3	O	-1	8278214
patients	O	-1	8278214
a	O	-1	8278214
pre-@@	O	-1	8278214
ex@@	O	-1	8278214
ist@@	O	-1	8278214
ing	O	-1	8278214
ne@@	B-Disease	D009437	8278214
ur@@	I-Disease	-1	8278214
al@@	I-Disease	-1	8278214
g@@	I-Disease	-1	8278214
ia	I-Disease	-1	8278214
increased	O	-1	8278214
to	O	-1	8278214
ex@@	O	-1	8278214
c@@	O	-1	8278214
r@@	O	-1	8278214
uc@@	O	-1	8278214
i@@	O	-1	8278214
ating	O	-1	8278214
int@@	O	-1	8278214
ensity	O	-1	8278214
and	O	-1	8278214
in	O	-1	8278214
2	O	-1	8278214
of	O	-1	8278214
these	O	-1	8278214
cases	O	-1	8278214
my@@	B-Disease	D009207	8278214
oc@@	I-Disease	-1	8278214
lon@@	I-Disease	-1	8278214
us	I-Disease	-1	8278214
occurred	O	-1	8278214
sim@@	O	-1	8278214
ult@@	O	-1	8278214
ane@@	O	-1	8278214
ous@@	O	-1	8278214
ly.	O	-1	8278214
Although	O	-1	8278214
only	O	-1	8278214
fe@@	O	-1	8278214
w	O	-1	8278214
clinical	O	-1	8278214
descri@@	O	-1	8278214
p@@	O	-1	8278214
tions	O	-1	8278214
of	O	-1	8278214
the	O	-1	8278214
rel@@	O	-1	8278214
ationship	O	-1	8278214
between	O	-1	8278214
hyperalge@@	B-Disease	D006930	8278214
sia	I-Disease	-1	8278214
/	O	-1	8278214
my@@	B-Disease	D009207	8278214
oc@@	I-Disease	-1	8278214
lon@@	I-Disease	-1	8278214
us	I-Disease	-1	8278214
and	O	-1	8278214
high	O	-1	8278214
doses	O	-1	8278214
of	O	-1	8278214
morphine	B-Chemical	D009020	8278214
are	O	-1	8278214
av@@	O	-1	8278214
ail@@	O	-1	8278214
able@@	O	-1	8278214
,	O	-1	8278214
experimental	O	-1	8278214
suppor@@	O	-1	8278214
t	O	-1	8278214
from	O	-1	8278214
anim@@	O	-1	8278214
al	O	-1	8278214
studies	O	-1	8278214
indic@@	O	-1	8278214
ates	O	-1	8278214
that	O	-1	8278214
morphine	B-Chemical	D009020	8278214
,	O	-1	8278214
or	O	-1	8278214
its	O	-1	8278214
metabol@@	O	-1	8278214
it@@	O	-1	8278214
es,	O	-1	8278214
pl@@	O	-1	8278214
ays	O	-1	8278214
a	O	-1	8278214
ca@@	O	-1	8278214
us@@	O	-1	8278214
ative	O	-1	8278214
role	O	-1	8278214
for	O	-1	8278214
the	O	-1	8278214
observed	O	-1	8278214
behavi@@	O	-1	8278214
o@@	O	-1	8278214
ural	O	-1	8278214
syndro@@	O	-1	8278214
me.	O	-1	8278214
The	O	-1	8278214
possible	O	-1	8278214
mechanisms	O	-1	8278214
are	O	-1	8278214
discus@@	O	-1	8278214
sed	O	-1	8278214
and	O	-1	8278214
treatment	O	-1	8278214
pro@@	O	-1	8278214
pos@@	O	-1	8278214
als	O	-1	8278214
given	O	-1	8278214
suggesting	O	-1	8278214
the	O	-1	8278214
use	O	-1	8278214
of	O	-1	8278214
more	O	-1	8278214
efficac@@	O	-1	8278214
i@@	O	-1	8278214
ous	O	-1	8278214
o@@	O	-1	8278214
pi@@	O	-1	8278214
oid@@	O	-1	8278214
s	O	-1	8278214
with	O	-1	8278214
less	O	-1	8278214
ex@@	O	-1	8278214
cit@@	O	-1	8278214
atory	O	-1	8278214
poten@@	O	-1	8278214
c@@	O	-1	8278214
y	O	-1	8278214
in	O	-1	8278214
these	O	-1	8278214
sit@@	O	-1	8278214
u@@	O	-1	8278214
ations.	O	-1	8278214

A	O	-1	3934126
pro@@	O	-1	3934126
sp@@	O	-1	3934126
ective	O	-1	3934126
study	O	-1	3934126
of	O	-1	3934126
adverse	O	-1	3934126
reactions	O	-1	3934126
associated	O	-1	3934126
with	O	-1	3934126
v@@	B-Chemical	D014640	3934126
an@@	I-Chemical	-1	3934126
com@@	I-Chemical	-1	3934126
ycin	I-Chemical	-1	3934126
therapy.	O	-1	3934126
A	O	-1	3934126
pro@@	O	-1	3934126
sp@@	O	-1	3934126
ective	O	-1	3934126
evalu@@	O	-1	3934126
ation	O	-1	3934126
of	O	-1	3934126
the	O	-1	3934126
efficacy	O	-1	3934126
and	O	-1	3934126
safety	O	-1	3934126
of	O	-1	3934126
v@@	B-Chemical	D014640	3934126
an@@	I-Chemical	-1	3934126
com@@	I-Chemical	-1	3934126
ycin	I-Chemical	-1	3934126
was	O	-1	3934126
con@@	O	-1	3934126
duc@@	O	-1	3934126
ted	O	-1	3934126
in	O	-1	3934126
5@@	O	-1	3934126
4	O	-1	3934126
con@@	O	-1	3934126
sec@@	O	-1	3934126
utive	O	-1	3934126
patients	O	-1	3934126
over	O	-1	3934126
a	O	-1	3934126
1@@	O	-1	3934126
6-@@	O	-1	3934126
mon@@	O	-1	3934126
th	O	-1	3934126
perio@@	O	-1	3934126
d.	O	-1	3934126
V@@	B-Chemical	D014640	3934126
an@@	I-Chemical	-1	3934126
com@@	I-Chemical	-1	3934126
ycin	I-Chemical	-1	3934126
was	O	-1	3934126
cur@@	O	-1	3934126
ative	O	-1	3934126
in	O	-1	3934126
95%	O	-1	3934126
of	O	-1	3934126
4@@	O	-1	3934126
3	O	-1	3934126
patients	O	-1	3934126
with	O	-1	3934126
pro@@	O	-1	3934126
ven	O	-1	3934126
inf@@	B-Disease	D007239	3934126
ection	I-Disease	-1	3934126
.	O	-1	3934126
D@@	O	-1	3934126
ru@@	O	-1	3934126
g@@	O	-1	3934126
s	O	-1	3934126
were	O	-1	3934126
ce@@	O	-1	3934126
as@@	O	-1	3934126
ed	O	-1	3934126
in	O	-1	3934126
six	O	-1	3934126
patients	O	-1	3934126
because	O	-1	3934126
of	O	-1	3934126
adverse	O	-1	3934126
reac@@	O	-1	3934126
tion@@	O	-1	3934126
s;	O	-1	3934126
in	O	-1	3934126
three	O	-1	3934126
of	O	-1	3934126
these	O	-1	3934126
v@@	B-Chemical	D014640	3934126
an@@	I-Chemical	-1	3934126
com@@	I-Chemical	-1	3934126
ycin	I-Chemical	-1	3934126
was	O	-1	3934126
considered	O	-1	3934126
the	O	-1	3934126
likely	O	-1	3934126
ca@@	O	-1	3934126
use.	O	-1	3934126
Re@@	O	-1	3934126
ac@@	O	-1	3934126
tions	O	-1	3934126
included	O	-1	3934126
thrombo@@	B-Disease	D013924	3934126
ph@@	I-Disease	-1	3934126
le@@	I-Disease	-1	3934126
b@@	I-Disease	-1	3934126
iti@@	I-Disease	-1	3934126
s	I-Disease	-1	3934126
(2@@	O	-1	3934126
0	O	-1	3934126
of	O	-1	3934126
5@@	O	-1	3934126
4	O	-1	3934126
patient@@	O	-1	3934126
s),	O	-1	3934126
r@@	B-Disease	D005076	3934126
as@@	I-Disease	-1	3934126
h	I-Disease	-1	3934126
(@@	O	-1	3934126
4	O	-1	3934126
of	O	-1	3934126
5@@	O	-1	3934126
4@@	O	-1	3934126
),	O	-1	3934126
nephro@@	B-Disease	D007674	3934126
toxicity	I-Disease	-1	3934126
(@@	O	-1	3934126
4	O	-1	3934126
of	O	-1	3934126
50@@	O	-1	3934126
),	O	-1	3934126
proteinuria	B-Disease	D011507	3934126
(@@	O	-1	3934126
1	O	-1	3934126
of	O	-1	3934126
50@@	O	-1	3934126
)	O	-1	3934126
and	O	-1	3934126
ot@@	B-Disease	D006311	3934126
otoxicity	I-Disease	-1	3934126
(@@	O	-1	3934126
1	O	-1	3934126
of	O	-1	3934126
11	O	-1	3934126
patients	O	-1	3934126
tested	O	-1	3934126
by	O	-1	3934126
a@@	O	-1	3934126
udi@@	O	-1	3934126
o@@	O	-1	3934126
met@@	O	-1	3934126
r@@	O	-1	3934126
y@@	O	-1	3934126
).	O	-1	3934126
Th@@	B-Disease	D013924	3934126
rom@@	I-Disease	-1	3934126
bo@@	I-Disease	-1	3934126
ph@@	I-Disease	-1	3934126
le@@	I-Disease	-1	3934126
b@@	I-Disease	-1	3934126
iti@@	I-Disease	-1	3934126
s	I-Disease	-1	3934126
occurred	O	-1	3934126
only	O	-1	3934126
with	O	-1	3934126
infusion	O	-1	3934126
through	O	-1	3934126
peripheral	O	-1	3934126
can@@	O	-1	3934126
n@@	O	-1	3934126
ul@@	O	-1	3934126
a@@	O	-1	3934126
e@@	O	-1	3934126
;	O	-1	3934126
nephro@@	B-Disease	D007674	3934126
toxicity	I-Disease	-1	3934126
and	O	-1	3934126
ot@@	B-Disease	D006311	3934126
otoxicity	I-Disease	-1	3934126
were	O	-1	3934126
conf@@	O	-1	3934126
in@@	O	-1	3934126
ed	O	-1	3934126
to	O	-1	3934126
patients	O	-1	3934126
receiving	O	-1	3934126
an	O	-1	3934126
amino@@	B-Chemical	D000617	3934126
gly@@	I-Chemical	-1	3934126
co@@	I-Chemical	-1	3934126
side	I-Chemical	-1	3934126
plus	O	-1	3934126
v@@	B-Chemical	D014640	3934126
an@@	I-Chemical	-1	3934126
com@@	I-Chemical	-1	3934126
ycin	I-Chemical	-1	3934126
.	O	-1	3934126
We	O	-1	3934126
concl@@	O	-1	3934126
ude	O	-1	3934126
that	O	-1	3934126
v@@	B-Chemical	D014640	3934126
an@@	I-Chemical	-1	3934126
com@@	I-Chemical	-1	3934126
ycin	I-Chemical	-1	3934126
,	O	-1	3934126
administered	O	-1	3934126
appro@@	O	-1	3934126
pri@@	O	-1	3934126
at@@	O	-1	3934126
el@@	O	-1	3934126
y,	O	-1	3934126
con@@	O	-1	3934126
sti@@	O	-1	3934126
t@@	O	-1	3934126
ut@@	O	-1	3934126
es	O	-1	3934126
saf@@	O	-1	3934126
e,	O	-1	3934126
effective	O	-1	3934126
therapy	O	-1	3934126
for	O	-1	3934126
inf@@	B-Disease	D007239	3934126
ec@@	I-Disease	-1	3934126
tions	I-Disease	-1	3934126
caused	O	-1	3934126
by	O	-1	3934126
sus@@	O	-1	3934126
cep@@	O	-1	3934126
ti@@	O	-1	3934126
ble	O	-1	3934126
bac@@	O	-1	3934126
ter@@	O	-1	3934126
ia.	O	-1	3934126

B@@	O	-1	1687392
loc@@	O	-1	1687392
k@@	O	-1	1687392
ade	O	-1	1687392
of	O	-1	1687392
both	O	-1	1687392
D@@	O	-1	1687392
-1	O	-1	1687392
and	O	-1	1687392
D-@@	O	-1	1687392
2	O	-1	1687392
dopamine	B-Chemical	D004298	1687392
receptors	O	-1	1687392
may	O	-1	1687392
induce	O	-1	1687392
cat@@	B-Disease	D002375	1687392
al@@	I-Disease	-1	1687392
ep@@	I-Disease	-1	1687392
sy	I-Disease	-1	1687392
in	O	-1	1687392
mice.	O	-1	1687392
1@@	O	-1	1687392
.	O	-1	1687392
The	O	-1	1687392
cat@@	B-Disease	D002375	1687392
al@@	I-Disease	-1	1687392
ep@@	I-Disease	-1	1687392
sy	I-Disease	-1	1687392
induced	O	-1	1687392
by	O	-1	1687392
dopamine	B-Chemical	D004298	1687392
antagonist@@	O	-1	1687392
s	O	-1	1687392
has	O	-1	1687392
been	O	-1	1687392
tested	O	-1	1687392
and	O	-1	1687392
the	O	-1	1687392
possible	O	-1	1687392
dopamine	B-Chemical	D004298	1687392
sub@@	O	-1	1687392
typ@@	O	-1	1687392
es	O	-1	1687392
involved	O	-1	1687392
in	O	-1	1687392
cat@@	B-Disease	D002375	1687392
al@@	I-Disease	-1	1687392
ep@@	I-Disease	-1	1687392
sy	I-Disease	-1	1687392
was	O	-1	1687392
deter@@	O	-1	1687392
m@@	O	-1	1687392
ine@@	O	-1	1687392
d.	O	-1	1687392
2@@	O	-1	1687392
.	O	-1	1687392
D@@	B-Chemical	D004298	1687392
op@@	I-Chemical	-1	1687392
amine	I-Chemical	-1	1687392
antagonist	O	-1	1687392
flu@@	B-Chemical	D005476	1687392
phen@@	I-Chemical	-1	1687392
az@@	I-Chemical	-1	1687392
ine	I-Chemical	-1	1687392
,	O	-1	1687392
D@@	O	-1	1687392
-1	O	-1	1687392
antagonist	O	-1	1687392
S@@	B-Chemical	C534628	1687392
C@@	I-Chemical	-1	1687392
H	I-Chemical	-1	1687392
2@@	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
9@@	I-Chemical	-1	1687392
0	I-Chemical	-1	1687392
or	O	-1	1687392
D-@@	O	-1	1687392
2	O	-1	1687392
antagonist	O	-1	1687392
sul@@	B-Chemical	D013469	1687392
pi@@	I-Chemical	-1	1687392
ri@@	I-Chemical	-1	1687392
de	I-Chemical	-1	1687392
induced	O	-1	1687392
cat@@	B-Disease	D002375	1687392
al@@	I-Disease	-1	1687392
ep@@	I-Disease	-1	1687392
sy	I-Disease	-1	1687392
.	O	-1	1687392
The	O	-1	1687392
effect	O	-1	1687392
of	O	-1	1687392
flu@@	B-Chemical	D005476	1687392
phen@@	I-Chemical	-1	1687392
az@@	I-Chemical	-1	1687392
ine	I-Chemical	-1	1687392
and	O	-1	1687392
sul@@	B-Chemical	D013469	1687392
pi@@	I-Chemical	-1	1687392
ri@@	I-Chemical	-1	1687392
de	I-Chemical	-1	1687392
was	O	-1	1687392
dose-@@	O	-1	1687392
depend@@	O	-1	1687392
ent@@	O	-1	1687392
.	O	-1	1687392
Com@@	O	-1	1687392
bin@@	O	-1	1687392
ation	O	-1	1687392
of	O	-1	1687392
S@@	B-Chemical	C534628	1687392
C@@	I-Chemical	-1	1687392
H	I-Chemical	-1	1687392
2@@	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
9@@	I-Chemical	-1	1687392
0	I-Chemical	-1	1687392
with	O	-1	1687392
sul@@	B-Chemical	D013469	1687392
pi@@	I-Chemical	-1	1687392
ri@@	I-Chemical	-1	1687392
de	I-Chemical	-1	1687392
did	O	-1	1687392
not	O	-1	1687392
induce	O	-1	1687392
cat@@	B-Disease	D002375	1687392
al@@	I-Disease	-1	1687392
ep@@	I-Disease	-1	1687392
sy	I-Disease	-1	1687392
potenti@@	O	-1	1687392
ation.	O	-1	1687392
3@@	O	-1	1687392
.	O	-1	1687392
D@@	O	-1	1687392
-1	O	-1	1687392
agon@@	O	-1	1687392
ist	O	-1	1687392
S@@	B-Chemical	D015647	1687392
K@@	I-Chemical	-1	1687392
F	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
8@@	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
9@@	I-Chemical	-1	1687392
3	I-Chemical	-1	1687392
or	O	-1	1687392
D-@@	O	-1	1687392
2	O	-1	1687392
agon@@	O	-1	1687392
ist	O	-1	1687392
qu@@	B-Chemical	D019257	1687392
in@@	I-Chemical	-1	1687392
pi@@	I-Chemical	-1	1687392
role	I-Chemical	-1	1687392
decreased	O	-1	1687392
the	O	-1	1687392
cat@@	B-Disease	D002375	1687392
al@@	I-Disease	-1	1687392
ep@@	I-Disease	-1	1687392
sy	I-Disease	-1	1687392
induced	O	-1	1687392
by	O	-1	1687392
flu@@	B-Chemical	D005476	1687392
phen@@	I-Chemical	-1	1687392
az@@	I-Chemical	-1	1687392
ine	I-Chemical	-1	1687392
,	O	-1	1687392
S@@	B-Chemical	C534628	1687392
C@@	I-Chemical	-1	1687392
H	I-Chemical	-1	1687392
2@@	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
9@@	I-Chemical	-1	1687392
0	I-Chemical	-1	1687392
or	O	-1	1687392
sul@@	B-Chemical	D013469	1687392
pi@@	I-Chemical	-1	1687392
ri@@	I-Chemical	-1	1687392
de	I-Chemical	-1	1687392
.	O	-1	1687392
4@@	O	-1	1687392
.	O	-1	1687392
Com@@	O	-1	1687392
bin@@	O	-1	1687392
ation	O	-1	1687392
of	O	-1	1687392
S@@	B-Chemical	D015647	1687392
K@@	I-Chemical	-1	1687392
F	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
8@@	I-Chemical	-1	1687392
3@@	I-Chemical	-1	1687392
9@@	I-Chemical	-1	1687392
3	I-Chemical	-1	1687392
with	O	-1	1687392
qu@@	B-Chemical	D019257	1687392
in@@	I-Chemical	-1	1687392
pi@@	I-Chemical	-1	1687392
role	I-Chemical	-1	1687392
did	O	-1	1687392
not	O	-1	1687392
cause	O	-1	1687392
potenti@@	O	-1	1687392
ated	O	-1	1687392
inhibit@@	O	-1	1687392
ory	O	-1	1687392
effect	O	-1	1687392
on	O	-1	1687392
cat@@	B-Disease	D002375	1687392
al@@	I-Disease	-1	1687392
ep@@	I-Disease	-1	1687392
sy	I-Disease	-1	1687392
induced	O	-1	1687392
by	O	-1	1687392
dopamine	B-Chemical	D004298	1687392
antagonist@@	O	-1	1687392
s.	O	-1	1687392
5@@	O	-1	1687392
.	O	-1	1687392
The	O	-1	1687392
data	O	-1	1687392
may	O	-1	1687392
indicate	O	-1	1687392
that	O	-1	1687392
although	O	-1	1687392
D-@@	O	-1	1687392
2	O	-1	1687392
receptor	O	-1	1687392
block@@	O	-1	1687392
ade	O	-1	1687392
is	O	-1	1687392
involved	O	-1	1687392
in	O	-1	1687392
cat@@	B-Disease	D002375	1687392
al@@	I-Disease	-1	1687392
ep@@	I-Disease	-1	1687392
sy	I-Disease	-1	1687392
,	O	-1	1687392
the	O	-1	1687392
D@@	O	-1	1687392
-1	O	-1	1687392
receptor	O	-1	1687392
may	O	-1	1687392
pl@@	O	-1	1687392
an	O	-1	1687392
a	O	-1	1687392
ro@@	O	-1	1687392
le@@	O	-1	1687392
.	O	-1	1687392

D@@	B-Chemical	D003911	19719056
ext@@	I-Chemical	-1	19719056
ra@@	I-Chemical	-1	19719056
n	I-Chemical	-1	19719056
-	O	-1	19719056
e@@	B-Chemical	D017308	19719056
to@@	I-Chemical	-1	19719056
d@@	I-Chemical	-1	19719056
ol@@	I-Chemical	-1	19719056
a@@	I-Chemical	-1	19719056
c	I-Chemical	-1	19719056
con@@	O	-1	19719056
j@@	O	-1	19719056
u@@	O	-1	19719056
g@@	O	-1	19719056
at@@	O	-1	19719056
es@@	O	-1	19719056
:	O	-1	19719056
syn@@	O	-1	19719056
the@@	O	-1	19719056
sis,	O	-1	19719056
in	O	-1	19719056
vit@@	O	-1	19719056
r@@	O	-1	19719056
o	O	-1	19719056
and	O	-1	19719056
in	O	-1	19719056
viv@@	O	-1	19719056
o	O	-1	19719056
evalu@@	O	-1	19719056
ation.	O	-1	19719056
E@@	B-Chemical	D017308	19719056
to@@	I-Chemical	-1	19719056
d@@	I-Chemical	-1	19719056
ol@@	I-Chemical	-1	19719056
a@@	I-Chemical	-1	19719056
c	I-Chemical	-1	19719056
(	O	-1	19719056
E	B-Chemical	D017308	19719056
),	O	-1	19719056
is	O	-1	19719056
a	O	-1	19719056
non-@@	O	-1	19719056
n@@	O	-1	19719056
ar@@	O	-1	19719056
co@@	O	-1	19719056
tic	O	-1	19719056
analge@@	O	-1	19719056
sic	O	-1	19719056
and	O	-1	19719056
anti@@	O	-1	19719056
inflam@@	O	-1	19719056
mat@@	O	-1	19719056
ory	O	-1	19719056
drug.	O	-1	19719056
A	O	-1	19719056
bio@@	O	-1	19719056
de@@	O	-1	19719056
gra@@	O	-1	19719056
d@@	O	-1	19719056
able	O	-1	19719056
poly@@	O	-1	19719056
m@@	O	-1	19719056
er	O	-1	19719056
de@@	B-Chemical	D003911	19719056
x@@	I-Chemical	-1	19719056
tra@@	I-Chemical	-1	19719056
n	I-Chemical	-1	19719056
has	O	-1	19719056
been	O	-1	19719056
u@@	O	-1	19719056
ti@@	O	-1	19719056
li@@	O	-1	19719056
zed	O	-1	19719056
as	O	-1	19719056
a	O	-1	19719056
car@@	O	-1	19719056
ri@@	O	-1	19719056
er	O	-1	19719056
for	O	-1	19719056
syn@@	O	-1	19719056
thesis	O	-1	19719056
of	O	-1	19719056
e@@	B-Chemical	D017308	19719056
to@@	I-Chemical	-1	19719056
d@@	I-Chemical	-1	19719056
ol@@	I-Chemical	-1	19719056
a@@	I-Chemical	-1	19719056
c	I-Chemical	-1	19719056
-	O	-1	19719056
de@@	B-Chemical	D003911	19719056
x@@	I-Chemical	-1	19719056
tra@@	I-Chemical	-1	19719056
n	I-Chemical	-1	19719056
con@@	O	-1	19719056
j@@	O	-1	19719056
u@@	O	-1	19719056
g@@	O	-1	19719056
ates	O	-1	19719056
(@@	O	-1	19719056
E@@	O	-1	19719056
D)	O	-1	19719056
to	O	-1	19719056
impro@@	O	-1	19719056
ve	O	-1	19719056
its	O	-1	19719056
a@@	O	-1	19719056
qu@@	O	-1	19719056
e@@	O	-1	19719056
ous	O	-1	19719056
sol@@	O	-1	19719056
ub@@	O	-1	19719056
ility	O	-1	19719056
and	O	-1	19719056
re@@	O	-1	19719056
duce	O	-1	19719056
gast@@	O	-1	19719056
ro@@	O	-1	19719056
in@@	O	-1	19719056
test@@	O	-1	19719056
inal	O	-1	19719056
side	O	-1	19719056
effects.	O	-1	19719056
An	O	-1	19719056
activ@@	O	-1	19719056
ated	O	-1	19719056
mo@@	O	-1	19719056
i@@	O	-1	19719056
et@@	O	-1	19719056
y,	O	-1	19719056
i.@@	O	-1	19719056
e.	O	-1	19719056
N@@	B-Chemical	-1	19719056
-@@	I-Chemical	-1	19719056
ac@@	I-Chemical	-1	19719056
yl@@	I-Chemical	-1	19719056
im@@	I-Chemical	-1	19719056
id@@	I-Chemical	-1	19719056
azole	I-Chemical	-1	19719056
der@@	O	-1	19719056
i@@	O	-1	19719056
v@@	O	-1	19719056
ative	O	-1	19719056
of	O	-1	19719056
e@@	B-Chemical	D017308	19719056
to@@	I-Chemical	-1	19719056
d@@	I-Chemical	-1	19719056
ol@@	I-Chemical	-1	19719056
a@@	I-Chemical	-1	19719056
c	I-Chemical	-1	19719056
(	O	-1	19719056
E@@	B-Chemical	-1	19719056
A@@	I-Chemical	-1	19719056
I	I-Chemical	-1	19719056
),	O	-1	19719056
was	O	-1	19719056
con@@	O	-1	19719056
d@@	O	-1	19719056
en@@	O	-1	19719056
sed	O	-1	19719056
with	O	-1	19719056
the	O	-1	19719056
pol@@	O	-1	19719056
ys@@	O	-1	19719056
ac@@	O	-1	19719056
ch@@	O	-1	19719056
ar@@	O	-1	19719056
ide	O	-1	19719056
poly@@	O	-1	19719056
m@@	O	-1	19719056
er	O	-1	19719056
de@@	B-Chemical	D003911	19719056
x@@	I-Chemical	-1	19719056
tra@@	I-Chemical	-1	19719056
n	I-Chemical	-1	19719056
of	O	-1	19719056
different	O	-1	19719056
mol@@	O	-1	19719056
ec@@	O	-1	19719056
ular	O	-1	19719056
weigh@@	O	-1	19719056
ts	O	-1	19719056
(4@@	O	-1	19719056
0@@	O	-1	19719056
0@@	O	-1	19719056
0@@	O	-1	19719056
0@@	O	-1	19719056
,	O	-1	19719056
6@@	O	-1	19719056
0@@	O	-1	19719056
0@@	O	-1	19719056
0@@	O	-1	19719056
0@@	O	-1	19719056
,	O	-1	19719056
1@@	O	-1	19719056
10@@	O	-1	19719056
0@@	O	-1	19719056
00	O	-1	19719056
and	O	-1	19719056
20@@	O	-1	19719056
0@@	O	-1	19719056
0@@	O	-1	19719056
0@@	O	-1	19719056
0@@	O	-1	19719056
).	O	-1	19719056
I@@	O	-1	19719056
R	O	-1	19719056
sp@@	O	-1	19719056
ect@@	O	-1	19719056
ral	O	-1	19719056
data	O	-1	19719056
con@@	O	-1	19719056
fir@@	O	-1	19719056
m@@	O	-1	19719056
ed	O	-1	19719056
formation	O	-1	19719056
of	O	-1	19719056
est@@	O	-1	19719056
er	O	-1	19719056
b@@	O	-1	19719056
on@@	O	-1	19719056
ding	O	-1	19719056
in	O	-1	19719056
the	O	-1	19719056
con@@	O	-1	19719056
j@@	O	-1	19719056
u@@	O	-1	19719056
g@@	O	-1	19719056
at@@	O	-1	19719056
es.	O	-1	19719056
E@@	B-Chemical	D017308	19719056
to@@	I-Chemical	-1	19719056
d@@	I-Chemical	-1	19719056
ol@@	I-Chemical	-1	19719056
a@@	I-Chemical	-1	19719056
c	I-Chemical	-1	19719056
cont@@	O	-1	19719056
ents	O	-1	19719056
were	O	-1	19719056
evaluated	O	-1	19719056
by	O	-1	19719056
U@@	O	-1	19719056
V@@	O	-1	19719056
-@@	O	-1	19719056
sp@@	O	-1	19719056
ect@@	O	-1	19719056
ro@@	O	-1	19719056
ph@@	O	-1	19719056
ot@@	O	-1	19719056
o@@	O	-1	19719056
me@@	O	-1	19719056
tri@@	O	-1	19719056
c	O	-1	19719056
analy@@	O	-1	19719056
sis.	O	-1	19719056
The	O	-1	19719056
mol@@	O	-1	19719056
ec@@	O	-1	19719056
ular	O	-1	19719056
weigh@@	O	-1	19719056
ts	O	-1	19719056
were	O	-1	19719056
determined	O	-1	19719056
by	O	-1	19719056
meas@@	O	-1	19719056
uring	O	-1	19719056
v@@	O	-1	19719056
is@@	O	-1	19719056
co@@	O	-1	19719056
s@@	O	-1	19719056
ity	O	-1	19719056
using	O	-1	19719056
the	O	-1	19719056
M@@	O	-1	19719056
ark@@	O	-1	19719056
-@@	O	-1	19719056
Ho@@	O	-1	19719056
w@@	O	-1	19719056
in@@	O	-1	19719056
k@@	O	-1	19719056
-@@	O	-1	19719056
S@@	O	-1	19719056
ak@@	O	-1	19719056
ur@@	O	-1	19719056
ad@@	O	-1	19719056
a	O	-1	19719056
equ@@	O	-1	19719056
ation.	O	-1	19719056
In	O	-1	19719056
vit@@	O	-1	19719056
r@@	O	-1	19719056
o	O	-1	19719056
hydro@@	O	-1	19719056
ly@@	O	-1	19719056
sis	O	-1	19719056
of	O	-1	19719056
E@@	O	-1	19719056
D	O	-1	19719056
was	O	-1	19719056
d@@	O	-1	19719056
one	O	-1	19719056
in	O	-1	19719056
a@@	O	-1	19719056
qu@@	O	-1	19719056
e@@	O	-1	19719056
ous	O	-1	19719056
bu@@	O	-1	19719056
ff@@	O	-1	19719056
ers	O	-1	19719056
(p@@	O	-1	19719056
H	O	-1	19719056
1.@@	O	-1	19719056
2,	O	-1	19719056
7.@@	O	-1	19719056
4@@	O	-1	19719056
,	O	-1	19719056
9@@	O	-1	19719056
)	O	-1	19719056
and	O	-1	19719056
in	O	-1	19719056
8@@	O	-1	19719056
0%	O	-1	19719056
(@@	O	-1	19719056
v@@	O	-1	19719056
/@@	O	-1	19719056
v@@	O	-1	19719056
)	O	-1	19719056
human	O	-1	19719056
plasma	O	-1	19719056
(p@@	O	-1	19719056
H	O	-1	19719056
7.@@	O	-1	19719056
4@@	O	-1	19719056
).	O	-1	19719056
A@@	O	-1	19719056
t	O	-1	19719056
p@@	O	-1	19719056
H	O	-1	19719056
9@@	O	-1	19719056
,	O	-1	19719056
a	O	-1	19719056
higher	O	-1	19719056
rate	O	-1	19719056
of	O	-1	19719056
e@@	B-Chemical	D017308	19719056
to@@	I-Chemical	-1	19719056
d@@	I-Chemical	-1	19719056
ol@@	I-Chemical	-1	19719056
a@@	I-Chemical	-1	19719056
c	I-Chemical	-1	19719056
release	O	-1	19719056
from	O	-1	19719056
E@@	O	-1	19719056
D	O	-1	19719056
was	O	-1	19719056
observed	O	-1	19719056
as	O	-1	19719056
compared	O	-1	19719056
to	O	-1	19719056
a@@	O	-1	19719056
qu@@	O	-1	19719056
e@@	O	-1	19719056
ous	O	-1	19719056
bu@@	O	-1	19719056
ff@@	O	-1	19719056
er	O	-1	19719056
of	O	-1	19719056
p@@	O	-1	19719056
H	O	-1	19719056
7.@@	O	-1	19719056
4	O	-1	19719056
and	O	-1	19719056
8@@	O	-1	19719056
0%	O	-1	19719056
human	O	-1	19719056
plasma	O	-1	19719056
(p@@	O	-1	19719056
H	O	-1	19719056
7.@@	O	-1	19719056
4@@	O	-1	19719056
),	O	-1	19719056
following	O	-1	19719056
fir@@	O	-1	19719056
st@@	O	-1	19719056
-@@	O	-1	19719056
or@@	O	-1	19719056
der	O	-1	19719056
kine@@	O	-1	19719056
tic@@	O	-1	19719056
s.	O	-1	19719056
In	O	-1	19719056
viv@@	O	-1	19719056
o	O	-1	19719056
investig@@	O	-1	19719056
ations	O	-1	19719056
were	O	-1	19719056
performed	O	-1	19719056
in	O	-1	19719056
anim@@	O	-1	19719056
al@@	O	-1	19719056
s.	O	-1	19719056
Ac@@	O	-1	19719056
ute	O	-1	19719056
analge@@	O	-1	19719056
sic	O	-1	19719056
and	O	-1	19719056
anti@@	O	-1	19719056
inflam@@	O	-1	19719056
mat@@	O	-1	19719056
ory	O	-1	19719056
ac@@	O	-1	19719056
ti@@	O	-1	19719056
vi@@	O	-1	19719056
ties	O	-1	19719056
were	O	-1	19719056
as@@	O	-1	19719056
cer@@	O	-1	19719056
t@@	O	-1	19719056
ained	O	-1	19719056
using	O	-1	19719056
ace@@	B-Chemical	D019342	19719056
tic	I-Chemical	-1	19719056
acid	I-Chemical	-1	19719056
induced	O	-1	19719056
w@@	B-Disease	D010146	19719056
ri@@	I-Disease	-1	19719056
th@@	I-Disease	-1	19719056
ing	I-Disease	-1	19719056
model	O	-1	19719056
(@@	O	-1	19719056
mic@@	O	-1	19719056
e@@	O	-1	19719056
)	O	-1	19719056
and	O	-1	19719056
car@@	B-Chemical	D002351	19719056
ra@@	I-Chemical	-1	19719056
ge@@	I-Chemical	-1	19719056
en@@	I-Chemical	-1	19719056
an	I-Chemical	-1	19719056
-induced	O	-1	19719056
rat	O	-1	19719056
pa@@	O	-1	19719056
w	O	-1	19719056
e@@	B-Disease	D004487	19719056
de@@	I-Disease	-1	19719056
ma	I-Disease	-1	19719056
model@@	O	-1	19719056
,	O	-1	19719056
respectively.	O	-1	19719056
In	O	-1	19719056
compar@@	O	-1	19719056
ison	O	-1	19719056
to	O	-1	19719056
control@@	O	-1	19719056
,	O	-1	19719056
E	B-Chemical	D017308	19719056
and	O	-1	19719056
E@@	O	-1	19719056
D@@	O	-1	19719056
1-@@	O	-1	19719056
E@@	O	-1	19719056
D@@	O	-1	19719056
4	O	-1	19719056
showed	O	-1	19719056
high@@	O	-1	19719056
ly	O	-1	19719056
significant	O	-1	19719056
analge@@	O	-1	19719056
sic	O	-1	19719056
and	O	-1	19719056
anti@@	O	-1	19719056
inflam@@	O	-1	19719056
mat@@	O	-1	19719056
ory	O	-1	19719056
ac@@	O	-1	19719056
ti@@	O	-1	19719056
vi@@	O	-1	19719056
ties	O	-1	19719056
(p	O	-1	19719056
<@@	O	-1	19719056
0.00@@	O	-1	19719056
1).	O	-1	19719056
B@@	O	-1	19719056
io@@	O	-1	19719056
log@@	O	-1	19719056
ical	O	-1	19719056
evalu@@	O	-1	19719056
ation	O	-1	19719056
suggested	O	-1	19719056
that	O	-1	19719056
con@@	O	-1	19719056
j@@	O	-1	19719056
u@@	O	-1	19719056
g@@	O	-1	19719056
ates	O	-1	19719056
(@@	O	-1	19719056
E@@	O	-1	19719056
D@@	O	-1	19719056
1-@@	O	-1	19719056
E@@	O	-1	19719056
D@@	O	-1	19719056
4@@	O	-1	19719056
)	O	-1	19719056
ret@@	O	-1	19719056
ained	O	-1	19719056
compar@@	O	-1	19719056
able	O	-1	19719056
analge@@	O	-1	19719056
sic	O	-1	19719056
and	O	-1	19719056
anti@@	O	-1	19719056
inflam@@	O	-1	19719056
mat@@	O	-1	19719056
ory	O	-1	19719056
ac@@	O	-1	19719056
ti@@	O	-1	19719056
vi@@	O	-1	19719056
ties	O	-1	19719056
with	O	-1	19719056
re@@	O	-1	19719056
mark@@	O	-1	19719056
ably	O	-1	19719056
reduced	O	-1	19719056
ul@@	O	-1	19719056
c@@	O	-1	19719056
ero@@	O	-1	19719056
gen@@	O	-1	19719056
ic@@	O	-1	19719056
ity	O	-1	19719056
as	O	-1	19719056
compared	O	-1	19719056
to	O	-1	19719056
their	O	-1	19719056
pa@@	O	-1	19719056
rent	O	-1	19719056
drug@@	O	-1	19719056
-@@	O	-1	19719056
-	O	-1	19719056
e@@	B-Chemical	D017308	19719056
to@@	I-Chemical	-1	19719056
d@@	I-Chemical	-1	19719056
ol@@	I-Chemical	-1	19719056
a@@	I-Chemical	-1	19719056
c	I-Chemical	-1	19719056
.	O	-1	19719056

H@@	B-Disease	D004342	15266362
y@@	I-Disease	-1	15266362
per@@	I-Disease	-1	15266362
sensitivity	I-Disease	-1	15266362
myocardi@@	B-Disease	D009205	15266362
tis	I-Disease	-1	15266362
complic@@	O	-1	15266362
ating	O	-1	15266362
hyper@@	B-Disease	D002312	15266362
tro@@	I-Disease	-1	15266362
ph@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
cardi@@	I-Disease	-1	15266362
om@@	I-Disease	-1	15266362
yo@@	I-Disease	-1	15266362
pathy	I-Disease	-1	15266362
hear@@	O	-1	15266362
t.	O	-1	15266362
The	O	-1	15266362
present	O	-1	15266362
report	O	-1	15266362
descri@@	O	-1	15266362
b@@	O	-1	15266362
es	O	-1	15266362
a	O	-1	15266362
case	O	-1	15266362
of	O	-1	15266362
e@@	B-Disease	D004802	15266362
os@@	I-Disease	-1	15266362
in@@	I-Disease	-1	15266362
oph@@	I-Disease	-1	15266362
il@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
myocardi@@	I-Disease	-1	15266362
tis	I-Disease	-1	15266362
e@@	B-Disease	D009205	15266362
os@@	I-Disease	-1	15266362
in@@	I-Disease	-1	15266362
oph@@	I-Disease	-1	15266362
il@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
myocardi@@	I-Disease	-1	15266362
tis	I-Disease	-1	15266362
complic@@	O	-1	15266362
ating	O	-1	15266362
hyper@@	B-Disease	D002312	15266362
tro@@	I-Disease	-1	15266362
ph@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
cardi@@	I-Disease	-1	15266362
om@@	I-Disease	-1	15266362
yo@@	I-Disease	-1	15266362
pathy	I-Disease	-1	15266362
.	O	-1	15266362
The	O	-1	15266362
4@@	O	-1	15266362
7-@@	O	-1	15266362
year-old	O	-1	15266362
female	O	-1	15266362
patient@@	O	-1	15266362
,	O	-1	15266362
known	O	-1	15266362
to	O	-1	15266362
have	O	-1	15266362
hyper@@	B-Disease	D002312	15266362
tro@@	I-Disease	-1	15266362
ph@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
cardi@@	I-Disease	-1	15266362
om@@	I-Disease	-1	15266362
yo@@	I-Disease	-1	15266362
pathy	I-Disease	-1	15266362
,	O	-1	15266362
was	O	-1	15266362
ad@@	O	-1	15266362
mit@@	O	-1	15266362
ted	O	-1	15266362
with	O	-1	15266362
b@@	B-Disease	D018754	15266362
i@@	I-Disease	-1	15266362
ventricular	I-Disease	-1	15266362
failure	I-Disease	-1	15266362
and	O	-1	15266362
man@@	O	-1	15266362
aged	O	-1	15266362
ag@@	O	-1	15266362
gres@@	O	-1	15266362
si@@	O	-1	15266362
vely	O	-1	15266362
with	O	-1	15266362
do@@	B-Chemical	D004280	15266362
but@@	I-Chemical	-1	15266362
amine	I-Chemical	-1	15266362
infusion	O	-1	15266362
and	O	-1	15266362
other	O	-1	15266362
drugs	O	-1	15266362
while	O	-1	15266362
being	O	-1	15266362
assessed	O	-1	15266362
for	O	-1	15266362
heart	O	-1	15266362
transplant@@	O	-1	15266362
ation.	O	-1	15266362
O@@	O	-1	15266362
n	O	-1	15266362
trans@@	O	-1	15266362
th@@	O	-1	15266362
or@@	O	-1	15266362
ac@@	O	-1	15266362
ic	O	-1	15266362
ech@@	O	-1	15266362
ocardi@@	O	-1	15266362
o@@	O	-1	15266362
gram@@	O	-1	15266362
,	O	-1	15266362
sh@@	O	-1	15266362
e	O	-1	15266362
had	O	-1	15266362
moder@@	O	-1	15266362
ate	O	-1	15266362
left	B-Disease	D018487	15266362
ventricular	I-Disease	-1	15266362
dysfunction	I-Disease	-1	15266362
with	O	-1	15266362
regi@@	O	-1	15266362
on@@	O	-1	15266362
al	O	-1	15266362
vari@@	O	-1	15266362
ability	O	-1	15266362
and	O	-1	15266362
moder@@	O	-1	15266362
ate	O	-1	15266362
mit@@	B-Disease	D008944	15266362
ral	I-Disease	-1	15266362
reg@@	I-Disease	-1	15266362
ur@@	I-Disease	-1	15266362
g@@	I-Disease	-1	15266362
it@@	I-Disease	-1	15266362
ation	I-Disease	-1	15266362
.	O	-1	15266362
The	O	-1	15266362
re@@	O	-1	15266362
ci@@	O	-1	15266362
pi@@	O	-1	15266362
ent@@	O	-1	15266362
's	O	-1	15266362
heart	O	-1	15266362
showed	O	-1	15266362
the	O	-1	15266362
feat@@	O	-1	15266362
ures	O	-1	15266362
of	O	-1	15266362
ap@@	O	-1	15266362
ical	O	-1	15266362
hyper@@	B-Disease	D002312	15266362
tro@@	I-Disease	-1	15266362
ph@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
cardi@@	I-Disease	-1	15266362
om@@	I-Disease	-1	15266362
yo@@	I-Disease	-1	15266362
pathy	I-Disease	-1	15266362
and	O	-1	15266362
myocardi@@	B-Disease	D009205	15266362
tis	I-Disease	-1	15266362
with	O	-1	15266362
ab@@	O	-1	15266362
und@@	O	-1	15266362
ant	O	-1	15266362
e@@	O	-1	15266362
os@@	O	-1	15266362
in@@	O	-1	15266362
oph@@	O	-1	15266362
il@@	O	-1	15266362
s.	O	-1	15266362
M@@	B-Disease	D009205	15266362
y@@	I-Disease	-1	15266362
ocardi@@	I-Disease	-1	15266362
tis	I-Disease	-1	15266362
is	O	-1	15266362
r@@	O	-1	15266362
are	O	-1	15266362
and	O	-1	15266362
e@@	B-Disease	D004802	15266362
os@@	I-Disease	-1	15266362
in@@	I-Disease	-1	15266362
oph@@	I-Disease	-1	15266362
il@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
myocardi@@	I-Disease	-1	15266362
tis	I-Disease	-1	15266362
e@@	B-Disease	D009205	15266362
os@@	I-Disease	-1	15266362
in@@	I-Disease	-1	15266362
oph@@	I-Disease	-1	15266362
il@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
myocardi@@	I-Disease	-1	15266362
tis	I-Disease	-1	15266362
is	O	-1	15266362
ra@@	O	-1	15266362
re@@	O	-1	15266362
r@@	O	-1	15266362
.	O	-1	15266362
It	O	-1	15266362
is	O	-1	15266362
likely	O	-1	15266362
that	O	-1	15266362
the	O	-1	15266362
hyper@@	B-Disease	D004342	15266362
sensitivity	I-Disease	-1	15266362
(	O	-1	15266362
e@@	B-Disease	D004802	15266362
os@@	I-Disease	-1	15266362
in@@	I-Disease	-1	15266362
oph@@	I-Disease	-1	15266362
il@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
)	O	-1	15266362
myocardi@@	B-Disease	D009205	15266362
tis	I-Disease	-1	15266362
was	O	-1	15266362
related	O	-1	15266362
to	O	-1	15266362
do@@	B-Chemical	D004280	15266362
but@@	I-Chemical	-1	15266362
amine	I-Chemical	-1	15266362
infusion	O	-1	15266362
therapy.	O	-1	15266362
E@@	B-Disease	D004802	15266362
os@@	I-Disease	-1	15266362
in@@	I-Disease	-1	15266362
oph@@	I-Disease	-1	15266362
il@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
myocardi@@	I-Disease	-1	15266362
tis	I-Disease	-1	15266362
E@@	B-Disease	D009205	15266362
os@@	I-Disease	-1	15266362
in@@	I-Disease	-1	15266362
oph@@	I-Disease	-1	15266362
il@@	I-Disease	-1	15266362
ic	I-Disease	-1	15266362
myocardi@@	I-Disease	-1	15266362
tis	I-Disease	-1	15266362
has	O	-1	15266362
been	O	-1	15266362
reported	O	-1	15266362
with	O	-1	15266362
an	O	-1	15266362
incidence	O	-1	15266362
of	O	-1	15266362
2.@@	O	-1	15266362
4@@	O	-1	15266362
%	O	-1	15266362
to	O	-1	15266362
7.@@	O	-1	15266362
2@@	O	-1	15266362
%	O	-1	15266362
in	O	-1	15266362
expl@@	O	-1	15266362
ant@@	O	-1	15266362
ed	O	-1	15266362
hear@@	O	-1	15266362
ts	O	-1	15266362
and	O	-1	15266362
may	O	-1	15266362
be	O	-1	15266362
related	O	-1	15266362
to	O	-1	15266362
multi@@	O	-1	15266362
drug	O	-1	15266362
therapy.	O	-1	15266362

A@@	B-Chemical	D014212	14648024
ll@@	I-Chemical	-1	14648024
-	I-Chemical	-1	14648024
trans@@	I-Chemical	-1	14648024
-@@	I-Chemical	-1	14648024
ret@@	I-Chemical	-1	14648024
ino@@	I-Chemical	-1	14648024
ic	I-Chemical	-1	14648024
acid	I-Chemical	-1	14648024
-induced	O	-1	14648024
eryth@@	B-Disease	D004893	14648024
em@@	I-Disease	-1	14648024
a	I-Disease	-1	14648024
no@@	I-Disease	-1	14648024
dos@@	I-Disease	-1	14648024
um	I-Disease	-1	14648024
in	O	-1	14648024
patients	O	-1	14648024
with	O	-1	14648024
acute	B-Disease	D015473	14648024
pro@@	I-Disease	-1	14648024
my@@	I-Disease	-1	14648024
e@@	I-Disease	-1	14648024
lo@@	I-Disease	-1	14648024
cy@@	I-Disease	-1	14648024
tic	I-Disease	-1	14648024
leuk@@	I-Disease	-1	14648024
emia	I-Disease	-1	14648024
.	O	-1	14648024
E@@	B-Disease	D004893	14648024
r@@	I-Disease	-1	14648024
y@@	I-Disease	-1	14648024
th@@	I-Disease	-1	14648024
em@@	I-Disease	-1	14648024
a	I-Disease	-1	14648024
no@@	I-Disease	-1	14648024
dos@@	I-Disease	-1	14648024
um	I-Disease	-1	14648024
associated	O	-1	14648024
with	O	-1	14648024
all@@	B-Chemical	D014212	14648024
-	I-Chemical	-1	14648024
trans@@	I-Chemical	-1	14648024
-@@	I-Chemical	-1	14648024
ret@@	I-Chemical	-1	14648024
ino@@	I-Chemical	-1	14648024
ic	I-Chemical	-1	14648024
acid	I-Chemical	-1	14648024
(	O	-1	14648024
AT@@	B-Chemical	D014212	14648024
R@@	I-Chemical	-1	14648024
A	I-Chemical	-1	14648024
)	O	-1	14648024
for	O	-1	14648024
acute	B-Disease	D015473	14648024
pro@@	I-Disease	-1	14648024
my@@	I-Disease	-1	14648024
e@@	I-Disease	-1	14648024
lo@@	I-Disease	-1	14648024
cy@@	I-Disease	-1	14648024
tic	I-Disease	-1	14648024
leuk@@	I-Disease	-1	14648024
emia	I-Disease	-1	14648024
(	O	-1	14648024
A@@	B-Disease	D015473	14648024
P@@	I-Disease	-1	14648024
L	I-Disease	-1	14648024
)	O	-1	14648024
is	O	-1	14648024
very	O	-1	14648024
ra@@	O	-1	14648024
re.	O	-1	14648024
We	O	-1	14648024
describe	O	-1	14648024
four	O	-1	14648024
patients	O	-1	14648024
with	O	-1	14648024
cl@@	O	-1	14648024
as@@	O	-1	14648024
sic	O	-1	14648024
A@@	B-Disease	D015473	14648024
P@@	I-Disease	-1	14648024
L	I-Disease	-1	14648024
who	O	-1	14648024
developed	O	-1	14648024
eryth@@	B-Disease	D004893	14648024
em@@	I-Disease	-1	14648024
a	I-Disease	-1	14648024
no@@	I-Disease	-1	14648024
dos@@	I-Disease	-1	14648024
um	I-Disease	-1	14648024
during	O	-1	14648024
AT@@	B-Chemical	D014212	14648024
R@@	I-Chemical	-1	14648024
A	I-Chemical	-1	14648024
therapy.	O	-1	14648024
F@@	B-Disease	D005334	14648024
ev@@	I-Disease	-1	14648024
er	I-Disease	-1	14648024
and	O	-1	14648024
subsequ@@	O	-1	14648024
ent	O	-1	14648024
multiple	O	-1	14648024
pa@@	B-Disease	D010146	14648024
infu@@	I-Disease	-1	14648024
l	I-Disease	-1	14648024
eryth@@	B-Disease	D004893	14648024
em@@	I-Disease	-1	14648024
at@@	I-Disease	-1	14648024
ous	I-Disease	-1	14648024
no@@	I-Disease	-1	14648024
d@@	I-Disease	-1	14648024
ul@@	I-Disease	-1	14648024
es	I-Disease	-1	14648024
over	O	-1	14648024
ex@@	O	-1	14648024
trem@@	O	-1	14648024
ities	O	-1	14648024
developed	O	-1	14648024
on	O	-1	14648024
D@@	O	-1	14648024
1@@	O	-1	14648024
1,	O	-1	14648024
D@@	O	-1	14648024
1@@	O	-1	14648024
6,	O	-1	14648024
D@@	O	-1	14648024
17@@	O	-1	14648024
,	O	-1	14648024
and	O	-1	14648024
D@@	O	-1	14648024
19@@	O	-1	14648024
,	O	-1	14648024
respectivel@@	O	-1	14648024
y,	O	-1	14648024
after	O	-1	14648024
AT@@	B-Chemical	D014212	14648024
R@@	I-Chemical	-1	14648024
A	I-Chemical	-1	14648024
therapy.	O	-1	14648024
The	O	-1	14648024
s@@	O	-1	14648024
k@@	O	-1	14648024
in	O	-1	14648024
biop@@	O	-1	14648024
sy	O	-1	14648024
tak@@	O	-1	14648024
en	O	-1	14648024
from	O	-1	14648024
each	O	-1	14648024
patient	O	-1	14648024
was	O	-1	14648024
consist@@	O	-1	14648024
ent	O	-1	14648024
with	O	-1	14648024
eryth@@	B-Disease	D004893	14648024
em@@	I-Disease	-1	14648024
a	I-Disease	-1	14648024
no@@	I-Disease	-1	14648024
dos@@	I-Disease	-1	14648024
um	I-Disease	-1	14648024
.	O	-1	14648024
All	O	-1	14648024
patients	O	-1	14648024
received	O	-1	14648024
sh@@	O	-1	14648024
ort	O	-1	14648024
course	O	-1	14648024
of	O	-1	14648024
steroid@@	B-Chemical	D013256	14648024
s	I-Chemical	-1	14648024
.	O	-1	14648024
F@@	B-Disease	D005334	14648024
ev@@	I-Disease	-1	14648024
er	I-Disease	-1	14648024
sub@@	O	-1	14648024
si@@	O	-1	14648024
ded	O	-1	14648024
ra@@	O	-1	14648024
pid@@	O	-1	14648024
ly	O	-1	14648024
and	O	-1	14648024
the	O	-1	14648024
s@@	O	-1	14648024
k@@	O	-1	14648024
in	O	-1	14648024
lesions	O	-1	14648024
reg@@	O	-1	14648024
res@@	O	-1	14648024
sed	O	-1	14648024
complete@@	O	-1	14648024
ly.	O	-1	14648024
All	O	-1	14648024
patients	O	-1	14648024
achi@@	O	-1	14648024
ev@@	O	-1	14648024
ed	O	-1	14648024
complete	O	-1	14648024
re@@	O	-1	14648024
mission	O	-1	14648024
without	O	-1	14648024
withdrawal	O	-1	14648024
of	O	-1	14648024
AT@@	B-Chemical	D014212	14648024
R@@	I-Chemical	-1	14648024
A	I-Chemical	-1	14648024
.	O	-1	14648024
AT@@	B-Chemical	D014212	14648024
R@@	I-Chemical	-1	14648024
A	I-Chemical	-1	14648024
se@@	O	-1	14648024
em@@	O	-1	14648024
ed	O	-1	14648024
to	O	-1	14648024
be	O	-1	14648024
the	O	-1	14648024
most	O	-1	14648024
possible	O	-1	14648024
e@@	O	-1	14648024
ti@@	O	-1	14648024
ology	O	-1	14648024
of	O	-1	14648024
eryth@@	B-Disease	D004893	14648024
em@@	I-Disease	-1	14648024
a	I-Disease	-1	14648024
no@@	I-Disease	-1	14648024
dos@@	I-Disease	-1	14648024
um	I-Disease	-1	14648024
in	O	-1	14648024
our	O	-1	14648024
patients.	O	-1	14648024
S@@	O	-1	14648024
h@@	O	-1	14648024
ort@@	O	-1	14648024
-term	O	-1	14648024
use	O	-1	14648024
of	O	-1	14648024
ster@@	B-Chemical	D013256	14648024
oid	I-Chemical	-1	14648024
is	O	-1	14648024
very	O	-1	14648024
effective	O	-1	14648024
in	O	-1	14648024
AT@@	B-Chemical	D014212	14648024
R@@	I-Chemical	-1	14648024
A	I-Chemical	-1	14648024
-induced	O	-1	14648024
eryth@@	B-Disease	D004893	14648024
em@@	I-Disease	-1	14648024
a	I-Disease	-1	14648024
no@@	I-Disease	-1	14648024
dos@@	I-Disease	-1	14648024
um	I-Disease	-1	14648024
.	O	-1	14648024

D@@	O	-1	11827497
el@@	O	-1	11827497
ay@@	O	-1	11827497
ed@@	O	-1	11827497
-@@	O	-1	11827497
onset	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
-induced	O	-1	11827497
throm@@	B-Disease	D013921	11827497
b@@	I-Disease	-1	11827497
ocyto@@	I-Disease	-1	11827497
pen@@	I-Disease	-1	11827497
ia	I-Disease	-1	11827497
.	O	-1	11827497
BACKGROUND:	O	-1	11827497
He@@	B-Chemical	D006493	11827497
par@@	I-Chemical	-1	11827497
in	I-Chemical	-1	11827497
-induced	O	-1	11827497
throm@@	B-Disease	D013921	11827497
b@@	I-Disease	-1	11827497
ocyto@@	I-Disease	-1	11827497
pen@@	I-Disease	-1	11827497
ia	I-Disease	-1	11827497
pres@@	O	-1	11827497
ents	O	-1	11827497
5	O	-1	11827497
to	O	-1	11827497
12	O	-1	11827497
days	O	-1	11827497
after	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
expos@@	O	-1	11827497
ure,	O	-1	11827497
with	O	-1	11827497
or	O	-1	11827497
without	O	-1	11827497
arterial	B-Disease	D001157	11827497
or	I-Disease	-1	11827497
venous	I-Disease	-1	11827497
thrombo@@	I-Disease	-1	11827497
emb@@	I-Disease	-1	11827497
ol@@	I-Disease	-1	11827497
i	I-Disease	-1	11827497
arterial	B-Disease	D054556	11827497
or	I-Disease	-1	11827497
venous	I-Disease	-1	11827497
thrombo@@	I-Disease	-1	11827497
emb@@	I-Disease	-1	11827497
ol@@	I-Disease	-1	11827497
i	I-Disease	-1	11827497
.	O	-1	11827497
D@@	O	-1	11827497
el@@	O	-1	11827497
ayed	O	-1	11827497
reco@@	O	-1	11827497
gn@@	O	-1	11827497
ition	O	-1	11827497
and	O	-1	11827497
treatment	O	-1	11827497
of	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
-induced	O	-1	11827497
throm@@	B-Disease	D013921	11827497
b@@	I-Disease	-1	11827497
ocyto@@	I-Disease	-1	11827497
pen@@	I-Disease	-1	11827497
ia	I-Disease	-1	11827497
cont@@	O	-1	11827497
rib@@	O	-1	11827497
ute	O	-1	11827497
to	O	-1	11827497
po@@	O	-1	11827497
or	O	-1	11827497
patient	O	-1	11827497
outcom@@	O	-1	11827497
es.	O	-1	11827497
OBJECTIVE:	O	-1	11827497
To	O	-1	11827497
describe	O	-1	11827497
and	O	-1	11827497
increase	O	-1	11827497
aw@@	O	-1	11827497
a@@	O	-1	11827497
ren@@	O	-1	11827497
ess	O	-1	11827497
of	O	-1	11827497
a	O	-1	11827497
clinical	O	-1	11827497
s@@	O	-1	11827497
c@@	O	-1	11827497
en@@	O	-1	11827497
ari@@	O	-1	11827497
o	O	-1	11827497
in	O	-1	11827497
which	O	-1	11827497
the	O	-1	11827497
onset	O	-1	11827497
or	O	-1	11827497
man@@	O	-1	11827497
if@@	O	-1	11827497
est@@	O	-1	11827497
ations	O	-1	11827497
of	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
-induced	O	-1	11827497
throm@@	B-Disease	D013921	11827497
b@@	I-Disease	-1	11827497
ocyto@@	I-Disease	-1	11827497
pen@@	I-Disease	-1	11827497
ia	I-Disease	-1	11827497
are	O	-1	11827497
del@@	O	-1	11827497
ay@@	O	-1	11827497
ed.	O	-1	11827497
D@@	O	-1	11827497
ES@@	O	-1	11827497
I@@	O	-1	11827497
G@@	O	-1	11827497
N@@	O	-1	11827497
:	O	-1	11827497
R@@	O	-1	11827497
et@@	O	-1	11827497
ro@@	O	-1	11827497
sp@@	O	-1	11827497
ective	O	-1	11827497
case	O	-1	11827497
seri@@	O	-1	11827497
es.	O	-1	11827497
S@@	O	-1	11827497
ET@@	O	-1	11827497
TI@@	O	-1	11827497
N@@	O	-1	11827497
G@@	O	-1	11827497
:	O	-1	11827497
Th@@	O	-1	11827497
ree	O	-1	11827497
larg@@	O	-1	11827497
e	O	-1	11827497
urb@@	O	-1	11827497
an	O	-1	11827497
hospit@@	O	-1	11827497
als	O	-1	11827497
(@@	O	-1	11827497
with	O	-1	11827497
active	O	-1	11827497
cardiovascular	O	-1	11827497
surger@@	O	-1	11827497
y	O	-1	11827497
pro@@	O	-1	11827497
gram@@	O	-1	11827497
s@@	O	-1	11827497
).	O	-1	11827497
PA@@	O	-1	11827497
TI@@	O	-1	11827497
E@@	O	-1	11827497
N@@	O	-1	11827497
T@@	O	-1	11827497
S:	O	-1	11827497
14	O	-1	11827497
patients	O	-1	11827497
seen	O	-1	11827497
over	O	-1	11827497
a	O	-1	11827497
3-@@	O	-1	11827497
year	O	-1	11827497
period	O	-1	11827497
in	O	-1	11827497
whom	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
-induced	O	-1	11827497
throm@@	B-Disease	D013921	11827497
b@@	I-Disease	-1	11827497
ocyto@@	I-Disease	-1	11827497
pen@@	I-Disease	-1	11827497
ia	I-Disease	-1	11827497
b@@	O	-1	11827497
ec@@	O	-1	11827497
am@@	O	-1	11827497
e	O	-1	11827497
appa@@	O	-1	11827497
rent	O	-1	11827497
on	O	-1	11827497
del@@	O	-1	11827497
ayed	O	-1	11827497
present@@	O	-1	11827497
ation	O	-1	11827497
with	O	-1	11827497
thrombo@@	B-Disease	D013923	11827497
emb@@	I-Disease	-1	11827497
olic	I-Disease	-1	11827497
complic@@	O	-1	11827497
ations.	O	-1	11827497
M@@	O	-1	11827497
E@@	O	-1	11827497
A@@	O	-1	11827497
S@@	O	-1	11827497
U@@	O	-1	11827497
R@@	O	-1	11827497
E@@	O	-1	11827497
M@@	O	-1	11827497
E@@	O	-1	11827497
N@@	O	-1	11827497
T@@	O	-1	11827497
S:	O	-1	11827497
P@@	O	-1	11827497
lat@@	O	-1	11827497
e@@	O	-1	11827497
le@@	O	-1	11827497
t	O	-1	11827497
coun@@	O	-1	11827497
t@@	O	-1	11827497
s,	O	-1	11827497
onset	O	-1	11827497
of	O	-1	11827497
ob@@	O	-1	11827497
j@@	O	-1	11827497
ectively	O	-1	11827497
determined	O	-1	11827497
thrombo@@	B-Disease	D013923	11827497
emb@@	I-Disease	-1	11827497
ol@@	I-Disease	-1	11827497
ism	I-Disease	-1	11827497
,	O	-1	11827497
results	O	-1	11827497
of	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
-induced	O	-1	11827497
platele@@	O	-1	11827497
t	O	-1	11827497
factor	O	-1	11827497
4	O	-1	11827497
anti@@	O	-1	11827497
body	O	-1	11827497
test@@	O	-1	11827497
s,	O	-1	11827497
and	O	-1	11827497
outcom@@	O	-1	11827497
es.	O	-1	11827497
RESULTS:	O	-1	11827497
Patients	O	-1	11827497
w@@	O	-1	11827497
ent	O	-1	11827497
ho@@	O	-1	11827497
m@@	O	-1	11827497
e	O	-1	11827497
after	O	-1	11827497
hospit@@	O	-1	11827497
al@@	O	-1	11827497
iz@@	O	-1	11827497
ations	O	-1	11827497
that	O	-1	11827497
had	O	-1	11827497
included	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
expos@@	O	-1	11827497
ure@@	O	-1	11827497
-@@	O	-1	11827497
-@@	O	-1	11827497
in	O	-1	11827497
most	O	-1	11827497
cas@@	O	-1	11827497
es,	O	-1	11827497
with	O	-1	11827497
no	O	-1	11827497
throm@@	B-Disease	D013921	11827497
b@@	I-Disease	-1	11827497
ocyto@@	I-Disease	-1	11827497
pen@@	I-Disease	-1	11827497
ia	I-Disease	-1	11827497
reco@@	O	-1	11827497
gn@@	O	-1	11827497
iz@@	O	-1	11827497
ed@@	O	-1	11827497
-@@	O	-1	11827497
-@@	O	-1	11827497
only	O	-1	11827497
to	O	-1	11827497
retur@@	O	-1	11827497
n	O	-1	11827497
to	O	-1	11827497
the	O	-1	11827497
hospit@@	O	-1	11827497
al	O	-1	11827497
(@@	O	-1	11827497
medi@@	O	-1	11827497
an@@	O	-1	11827497
,	O	-1	11827497
day	O	-1	11827497
14@@	O	-1	11827497
)	O	-1	11827497
with	O	-1	11827497
thrombo@@	B-Disease	D013923	11827497
emb@@	I-Disease	-1	11827497
olic	I-Disease	-1	11827497
complic@@	O	-1	11827497
ations.	O	-1	11827497
Th@@	B-Disease	D013923	11827497
rom@@	I-Disease	-1	11827497
bo@@	I-Disease	-1	11827497
emb@@	I-Disease	-1	11827497
ol@@	I-Disease	-1	11827497
i	I-Disease	-1	11827497
were	O	-1	11827497
venous	O	-1	11827497
(1@@	O	-1	11827497
2	O	-1	11827497
patients,	O	-1	11827497
7	O	-1	11827497
with	O	-1	11827497
pulmonary	B-Disease	D011655	11827497
emb@@	I-Disease	-1	11827497
ol@@	I-Disease	-1	11827497
i	I-Disease	-1	11827497
)	O	-1	11827497
or	O	-1	11827497
arterial	O	-1	11827497
(@@	O	-1	11827497
4	O	-1	11827497
patient@@	O	-1	11827497
s)	O	-1	11827497
or	O	-1	11827497
bo@@	O	-1	11827497
th@@	O	-1	11827497
.	O	-1	11827497
P@@	O	-1	11827497
lat@@	O	-1	11827497
e@@	O	-1	11827497
le@@	O	-1	11827497
t	O	-1	11827497
coun@@	O	-1	11827497
ts	O	-1	11827497
were	O	-1	11827497
mil@@	O	-1	11827497
d@@	O	-1	11827497
ly	O	-1	11827497
decreased	O	-1	11827497
in	O	-1	11827497
all	O	-1	11827497
but	O	-1	11827497
2	O	-1	11827497
patients	O	-1	11827497
on	O	-1	11827497
second	O	-1	11827497
present@@	O	-1	11827497
ation.	O	-1	11827497
O@@	O	-1	11827497
n	O	-1	11827497
re@@	O	-1	11827497
ad@@	O	-1	11827497
mis@@	O	-1	11827497
sion,	O	-1	11827497
11	O	-1	11827497
patients	O	-1	11827497
received	O	-1	11827497
therapeutic	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
,	O	-1	11827497
which	O	-1	11827497
wor@@	O	-1	11827497
sen@@	O	-1	11827497
ed	O	-1	11827497
the	O	-1	11827497
patient@@	O	-1	11827497
s@@	O	-1	11827497
'	O	-1	11827497
clinical	O	-1	11827497
condi@@	O	-1	11827497
tion	O	-1	11827497
and@@	O	-1	11827497
,	O	-1	11827497
in	O	-1	11827497
all	O	-1	11827497
11	O	-1	11827497
cas@@	O	-1	11827497
es,	O	-1	11827497
decreased	O	-1	11827497
the	O	-1	11827497
platele@@	O	-1	11827497
t	O	-1	11827497
coun@@	O	-1	11827497
t	O	-1	11827497
(@@	O	-1	11827497
mean	O	-1	11827497
at	O	-1	11827497
re@@	O	-1	11827497
ad@@	O	-1	11827497
mis@@	O	-1	11827497
sion,	O	-1	11827497
14@@	O	-1	11827497
3	O	-1	11827497
x	O	-1	11827497
10@@	O	-1	11827497
(@@	O	-1	11827497
9@@	O	-1	11827497
)	O	-1	11827497
cell@@	O	-1	11827497
s/@@	O	-1	11827497
L@@	O	-1	11827497
;	O	-1	11827497
mean	O	-1	11827497
na@@	O	-1	11827497
di@@	O	-1	11827497
r	O	-1	11827497
after	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
re@@	O	-1	11827497
-@@	O	-1	11827497
expos@@	O	-1	11827497
ure,	O	-1	11827497
3@@	O	-1	11827497
9	O	-1	11827497
x	O	-1	11827497
10@@	O	-1	11827497
(@@	O	-1	11827497
9@@	O	-1	11827497
)	O	-1	11827497
cell@@	O	-1	11827497
s/@@	O	-1	11827497
L@@	O	-1	11827497
).	O	-1	11827497
R@@	O	-1	11827497
es@@	O	-1	11827497
ult@@	O	-1	11827497
s	O	-1	11827497
of	O	-1	11827497
ser@@	O	-1	11827497
ologic	O	-1	11827497
tests	O	-1	11827497
for	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
-induced	O	-1	11827497
anti@@	O	-1	11827497
bo@@	O	-1	11827497
di@@	O	-1	11827497
es	O	-1	11827497
were	O	-1	11827497
positive	O	-1	11827497
in	O	-1	11827497
all	O	-1	11827497
patients.	O	-1	11827497
S@@	O	-1	11827497
ub@@	O	-1	11827497
sequ@@	O	-1	11827497
ent	O	-1	11827497
treat@@	O	-1	11827497
ments	O	-1	11827497
included	O	-1	11827497
al@@	O	-1	11827497
tern@@	O	-1	11827497
ative	O	-1	11827497
anti@@	O	-1	11827497
co@@	O	-1	11827497
ag@@	O	-1	11827497
ul@@	O	-1	11827497
ants	O	-1	11827497
(1@@	O	-1	11827497
1	O	-1	11827497
patient@@	O	-1	11827497
s),	O	-1	11827497
throm@@	O	-1	11827497
b@@	O	-1	11827497
oly@@	O	-1	11827497
tic	O	-1	11827497
drugs	O	-1	11827497
(@@	O	-1	11827497
3	O	-1	11827497
patient@@	O	-1	11827497
s),	O	-1	11827497
inf@@	O	-1	11827497
er@@	O	-1	11827497
ior	O	-1	11827497
ven@@	O	-1	11827497
a	O	-1	11827497
ca@@	O	-1	11827497
v@@	O	-1	11827497
a	O	-1	11827497
f@@	O	-1	11827497
il@@	O	-1	11827497
ters	O	-1	11827497
(@@	O	-1	11827497
3	O	-1	11827497
patient@@	O	-1	11827497
s)	O	-1	11827497
and@@	O	-1	11827497
,	O	-1	11827497
event@@	O	-1	11827497
u@@	O	-1	11827497
ally,	O	-1	11827497
war@@	B-Chemical	D014859	11827497
farin	I-Chemical	-1	11827497
(1@@	O	-1	11827497
1	O	-1	11827497
patient@@	O	-1	11827497
s@@	O	-1	11827497
).	O	-1	11827497
Th@@	O	-1	11827497
ree	O	-1	11827497
patients	O	-1	11827497
di@@	O	-1	11827497
ed.	O	-1	11827497
CONCLUSIONS:	O	-1	11827497
D@@	O	-1	11827497
el@@	O	-1	11827497
ay@@	O	-1	11827497
ed@@	O	-1	11827497
-@@	O	-1	11827497
onset	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
-induced	O	-1	11827497
throm@@	B-Disease	D013921	11827497
b@@	I-Disease	-1	11827497
ocyto@@	I-Disease	-1	11827497
pen@@	I-Disease	-1	11827497
ia	I-Disease	-1	11827497
is	O	-1	11827497
increas@@	O	-1	11827497
ing@@	O	-1	11827497
ly	O	-1	11827497
being	O	-1	11827497
reco@@	O	-1	11827497
gn@@	O	-1	11827497
iz@@	O	-1	11827497
ed.	O	-1	11827497
To	O	-1	11827497
av@@	O	-1	11827497
oid	O	-1	11827497
dis@@	O	-1	11827497
ast@@	O	-1	11827497
rou@@	O	-1	11827497
s	O	-1	11827497
outcom@@	O	-1	11827497
es,	O	-1	11827497
physi@@	O	-1	11827497
ci@@	O	-1	11827497
ans	O	-1	11827497
mus@@	O	-1	11827497
t	O	-1	11827497
con@@	O	-1	11827497
si@@	O	-1	11827497
der	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
-induced	O	-1	11827497
throm@@	B-Disease	D013921	11827497
b@@	I-Disease	-1	11827497
ocyto@@	I-Disease	-1	11827497
pen@@	I-Disease	-1	11827497
ia	I-Disease	-1	11827497
wh@@	O	-1	11827497
en@@	O	-1	11827497
ev@@	O	-1	11827497
er	O	-1	11827497
a	O	-1	11827497
rec@@	O	-1	11827497
ently	O	-1	11827497
hospit@@	O	-1	11827497
al@@	O	-1	11827497
ized	O	-1	11827497
patient	O	-1	11827497
retur@@	O	-1	11827497
n@@	O	-1	11827497
s	O	-1	11827497
with	O	-1	11827497
thrombo@@	B-Disease	D013923	11827497
emb@@	I-Disease	-1	11827497
ol@@	I-Disease	-1	11827497
ism	I-Disease	-1	11827497
;	O	-1	11827497
therapy	O	-1	11827497
with	O	-1	11827497
al@@	O	-1	11827497
tern@@	O	-1	11827497
ative	O	-1	11827497
anti@@	O	-1	11827497
co@@	O	-1	11827497
ag@@	O	-1	11827497
ul@@	O	-1	11827497
ant@@	O	-1	11827497
s,	O	-1	11827497
not	O	-1	11827497
hepar@@	B-Chemical	D006493	11827497
in	I-Chemical	-1	11827497
,	O	-1	11827497
should	O	-1	11827497
be	O	-1	11827497
initi@@	O	-1	11827497
ated.	O	-1	11827497

V@@	B-Chemical	C081489	8841157
al@@	I-Chemical	-1	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
,	O	-1	8841157
a	O	-1	8841157
new	O	-1	8841157
angiotens@@	B-Chemical	D000804	8841157
in	I-Chemical	-1	8841157
II	I-Chemical	-1	8841157
antagonist	O	-1	8841157
for	O	-1	8841157
the	O	-1	8841157
treatment	O	-1	8841157
of	O	-1	8841157
es@@	O	-1	8841157
sen@@	O	-1	8841157
tial	O	-1	8841157
hypertension	B-Disease	D006973	8841157
:	O	-1	8841157
a	O	-1	8841157
compar@@	O	-1	8841157
ative	O	-1	8841157
study	O	-1	8841157
of	O	-1	8841157
the	O	-1	8841157
efficacy	O	-1	8841157
and	O	-1	8841157
safety	O	-1	8841157
against	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
.	O	-1	8841157
OBJECTIVE:	O	-1	8841157
To	O	-1	8841157
compar@@	O	-1	8841157
e	O	-1	8841157
the	O	-1	8841157
anti@@	O	-1	8841157
hypertensive	O	-1	8841157
efficacy	O	-1	8841157
of	O	-1	8841157
a	O	-1	8841157
new	O	-1	8841157
angiotens@@	B-Chemical	D000804	8841157
in	I-Chemical	-1	8841157
II	I-Chemical	-1	8841157
antagonist@@	O	-1	8841157
,	O	-1	8841157
val@@	B-Chemical	C081489	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
,	O	-1	8841157
with	O	-1	8841157
a	O	-1	8841157
ref@@	O	-1	8841157
e@@	O	-1	8841157
rence	O	-1	8841157
therapy,	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
.	O	-1	8841157
METHODS:	O	-1	8841157
One	O	-1	8841157
h@@	O	-1	8841157
und@@	O	-1	8841157
red	O	-1	8841157
si@@	O	-1	8841157
x@@	O	-1	8841157
ty-@@	O	-1	8841157
e@@	O	-1	8841157
ight	O	-1	8841157
ad@@	O	-1	8841157
ult	O	-1	8841157
out@@	O	-1	8841157
patients	O	-1	8841157
with	O	-1	8841157
mil@@	O	-1	8841157
d	O	-1	8841157
to	O	-1	8841157
moder@@	O	-1	8841157
ate	O	-1	8841157
hypertension	B-Disease	D006973	8841157
were	O	-1	8841157
random@@	O	-1	8841157
ly	O	-1	8841157
al@@	O	-1	8841157
loc@@	O	-1	8841157
ated	O	-1	8841157
in	O	-1	8841157
double-bl@@	O	-1	8841157
ind	O	-1	8841157
f@@	O	-1	8841157
as@@	O	-1	8841157
hi@@	O	-1	8841157
on	O	-1	8841157
and	O	-1	8841157
equ@@	O	-1	8841157
al	O	-1	8841157
number	O	-1	8841157
to	O	-1	8841157
recei@@	O	-1	8841157
ve	O	-1	8841157
8@@	O	-1	8841157
0	O	-1	8841157
mg	O	-1	8841157
val@@	B-Chemical	C081489	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
or	O	-1	8841157
5	O	-1	8841157
mg	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
for	O	-1	8841157
12	O	-1	8841157
week@@	O	-1	8841157
s.	O	-1	8841157
After	O	-1	8841157
8	O	-1	8841157
weeks	O	-1	8841157
of	O	-1	8841157
therapy,	O	-1	8841157
in	O	-1	8841157
patients	O	-1	8841157
wh@@	O	-1	8841157
ose	O	-1	8841157
blood	O	-1	8841157
pressure	O	-1	8841157
remained	O	-1	8841157
un@@	O	-1	8841157
control@@	O	-1	8841157
le@@	O	-1	8841157
d,	O	-1	8841157
5	O	-1	8841157
mg	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
was	O	-1	8841157
ad@@	O	-1	8841157
ded	O	-1	8841157
to	O	-1	8841157
the	O	-1	8841157
initial	O	-1	8841157
therapy.	O	-1	8841157
Patients	O	-1	8841157
were	O	-1	8841157
assessed	O	-1	8841157
at	O	-1	8841157
4@@	O	-1	8841157
,	O	-1	8841157
8@@	O	-1	8841157
,	O	-1	8841157
and	O	-1	8841157
12	O	-1	8841157
week@@	O	-1	8841157
s.	O	-1	8841157
The	O	-1	8841157
prim@@	O	-1	8841157
ary	O	-1	8841157
efficacy	O	-1	8841157
vari@@	O	-1	8841157
able	O	-1	8841157
was	O	-1	8841157
change	O	-1	8841157
from	O	-1	8841157
baseline	O	-1	8841157
in	O	-1	8841157
mean	O	-1	8841157
sit@@	O	-1	8841157
ting	O	-1	8841157
di@@	O	-1	8841157
ast@@	O	-1	8841157
olic	O	-1	8841157
blood	O	-1	8841157
pressure	O	-1	8841157
at	O	-1	8841157
8	O	-1	8841157
week@@	O	-1	8841157
s.	O	-1	8841157
S@@	O	-1	8841157
ec@@	O	-1	8841157
ond@@	O	-1	8841157
ary	O	-1	8841157
vari@@	O	-1	8841157
able@@	O	-1	8841157
s	O	-1	8841157
included	O	-1	8841157
change	O	-1	8841157
in	O	-1	8841157
sit@@	O	-1	8841157
ting	O	-1	8841157
systolic	O	-1	8841157
blood	O	-1	8841157
pressure	O	-1	8841157
and	O	-1	8841157
respon@@	O	-1	8841157
der	O	-1	8841157
rat@@	O	-1	8841157
es.	O	-1	8841157
RESULTS:	O	-1	8841157
B@@	O	-1	8841157
oth	O	-1	8841157
val@@	B-Chemical	C081489	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
and	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
were	O	-1	8841157
effective	O	-1	8841157
at	O	-1	8841157
low@@	O	-1	8841157
ering	O	-1	8841157
blood	O	-1	8841157
pressure	O	-1	8841157
at	O	-1	8841157
4@@	O	-1	8841157
,	O	-1	8841157
8@@	O	-1	8841157
,	O	-1	8841157
and	O	-1	8841157
12	O	-1	8841157
week@@	O	-1	8841157
s.	O	-1	8841157
S@@	O	-1	8841157
im@@	O	-1	8841157
il@@	O	-1	8841157
ar	O	-1	8841157
decreas@@	O	-1	8841157
es	O	-1	8841157
were	O	-1	8841157
observed	O	-1	8841157
in	O	-1	8841157
both	O	-1	8841157
group@@	O	-1	8841157
s,	O	-1	8841157
with	O	-1	8841157
no	O	-1	8841157
statis@@	O	-1	8841157
tically	O	-1	8841157
significant	O	-1	8841157
differences	O	-1	8841157
between	O	-1	8841157
the	O	-1	8841157
groups	O	-1	8841157
for	O	-1	8841157
any	O	-1	8841157
vari@@	O	-1	8841157
able	O	-1	8841157
analy@@	O	-1	8841157
z@@	O	-1	8841157
ed.	O	-1	8841157
F@@	O	-1	8841157
or	O	-1	8841157
the	O	-1	8841157
prim@@	O	-1	8841157
ary	O	-1	8841157
vari@@	O	-1	8841157
able	O	-1	8841157
the	O	-1	8841157
difference	O	-1	8841157
was	O	-1	8841157
0.@@	O	-1	8841157
5	O	-1	8841157
mm	O	-1	8841157
H@@	O	-1	8841157
g	O	-1	8841157
in	O	-1	8841157
f@@	O	-1	8841157
av@@	O	-1	8841157
or	O	-1	8841157
of	O	-1	8841157
val@@	B-Chemical	C081489	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
(p	O	-1	8841157
=	O	-1	8841157
0.@@	O	-1	8841157
6@@	O	-1	8841157
8@@	O	-1	8841157
;	O	-1	8841157
95%	O	-1	8841157
conf@@	O	-1	8841157
idence	O	-1	8841157
inter@@	O	-1	8841157
val@@	O	-1	8841157
,	O	-1	8841157
-@@	O	-1	8841157
2.@@	O	-1	8841157
7	O	-1	8841157
to	O	-1	8841157
1.@@	O	-1	8841157
7@@	O	-1	8841157
).	O	-1	8841157
R@@	O	-1	8841157
es@@	O	-1	8841157
p@@	O	-1	8841157
on@@	O	-1	8841157
der	O	-1	8841157
rat@@	O	-1	8841157
es	O	-1	8841157
at	O	-1	8841157
8	O	-1	8841157
weeks	O	-1	8841157
were	O	-1	8841157
6@@	O	-1	8841157
6.@@	O	-1	8841157
7@@	O	-1	8841157
%	O	-1	8841157
for	O	-1	8841157
val@@	B-Chemical	C081489	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
and	O	-1	8841157
6@@	O	-1	8841157
0.@@	O	-1	8841157
2@@	O	-1	8841157
%	O	-1	8841157
for	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
(p	O	-1	8841157
=	O	-1	8841157
0.@@	O	-1	8841157
3@@	O	-1	8841157
9@@	O	-1	8841157
).	O	-1	8841157
B@@	O	-1	8841157
oth	O	-1	8841157
treat@@	O	-1	8841157
ments	O	-1	8841157
were	O	-1	8841157
well	O	-1	8841157
toler@@	O	-1	8841157
ated.	O	-1	8841157
The	O	-1	8841157
incidence	O	-1	8841157
of	O	-1	8841157
drug@@	O	-1	8841157
-@@	O	-1	8841157
related	O	-1	8841157
dependent	O	-1	8841157
e@@	B-Disease	D004487	8841157
de@@	I-Disease	-1	8841157
ma	I-Disease	-1	8841157
was	O	-1	8841157
so@@	O	-1	8841157
me@@	O	-1	8841157
wh@@	O	-1	8841157
at	O	-1	8841157
higher	O	-1	8841157
in	O	-1	8841157
the	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
group@@	O	-1	8841157
,	O	-1	8841157
partic@@	O	-1	8841157
ul@@	O	-1	8841157
arly	O	-1	8841157
at	O	-1	8841157
a	O	-1	8841157
dose	O	-1	8841157
of	O	-1	8841157
10	O	-1	8841157
mg	O	-1	8841157
per	O	-1	8841157
day	O	-1	8841157
(2@@	O	-1	8841157
.@@	O	-1	8841157
4@@	O	-1	8841157
%	O	-1	8841157
for	O	-1	8841157
8@@	O	-1	8841157
0	O	-1	8841157
mg	O	-1	8841157
val@@	B-Chemical	C081489	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
;	O	-1	8841157
3.@@	O	-1	8841157
6%	O	-1	8841157
for	O	-1	8841157
5	O	-1	8841157
mg	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
;	O	-1	8841157
0%	O	-1	8841157
for	O	-1	8841157
val@@	B-Chemical	C081489	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
plus	O	-1	8841157
5	O	-1	8841157
mg	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
;	O	-1	8841157
1@@	O	-1	8841157
4.@@	O	-1	8841157
3@@	O	-1	8841157
%	O	-1	8841157
for	O	-1	8841157
10	O	-1	8841157
mg	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
).	O	-1	8841157
CONCLUSIONS:	O	-1	8841157
The	O	-1	8841157
data	O	-1	8841157
show	O	-1	8841157
that	O	-1	8841157
val@@	B-Chemical	C081489	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
is	O	-1	8841157
at	O	-1	8841157
le@@	O	-1	8841157
ast	O	-1	8841157
as	O	-1	8841157
effective	O	-1	8841157
as	O	-1	8841157
am@@	B-Chemical	D017311	8841157
lo@@	I-Chemical	-1	8841157
di@@	I-Chemical	-1	8841157
pine	I-Chemical	-1	8841157
in	O	-1	8841157
the	O	-1	8841157
treatment	O	-1	8841157
of	O	-1	8841157
mil@@	O	-1	8841157
d	O	-1	8841157
to	O	-1	8841157
moder@@	O	-1	8841157
ate	O	-1	8841157
hypertension	B-Disease	D006973	8841157
.	O	-1	8841157
The	O	-1	8841157
results	O	-1	8841157
also	O	-1	8841157
show	O	-1	8841157
val@@	B-Chemical	C081489	8841157
s@@	I-Chemical	-1	8841157
ar@@	I-Chemical	-1	8841157
t@@	I-Chemical	-1	8841157
an	I-Chemical	-1	8841157
to	O	-1	8841157
be	O	-1	8841157
well	O	-1	8841157
toler@@	O	-1	8841157
ated	O	-1	8841157
and	O	-1	8841157
suggest	O	-1	8841157
that	O	-1	8841157
it	O	-1	8841157
is	O	-1	8841157
not	O	-1	8841157
associated	O	-1	8841157
with	O	-1	8841157
side	O	-1	8841157
effects	O	-1	8841157
character@@	O	-1	8841157
istic	O	-1	8841157
of	O	-1	8841157
this	O	-1	8841157
compar@@	O	-1	8841157
at@@	O	-1	8841157
or	O	-1	8841157
cl@@	O	-1	8841157
as@@	O	-1	8841157
s,	O	-1	8841157
di@@	B-Chemical	C038806	8841157
hydro@@	I-Chemical	-1	8841157
pyri@@	I-Chemical	-1	8841157
d@@	I-Chemical	-1	8841157
ine	I-Chemical	-1	8841157
calcium	B-Chemical	D002118	8841157
antagonist@@	O	-1	8841157
s.	O	-1	8841157

K@@	B-Chemical	C081198	8045270
F@@	I-Chemical	-1	8045270
17@@	I-Chemical	-1	8045270
8@@	I-Chemical	-1	8045270
3@@	I-Chemical	-1	8045270
7	I-Chemical	-1	8045270
:	O	-1	8045270
a	O	-1	8045270
novel	O	-1	8045270
selective	O	-1	8045270
aden@@	B-Chemical	D000241	8045270
os@@	I-Chemical	-1	8045270
ine	I-Chemical	-1	8045270
A@@	O	-1	8045270
2@@	O	-1	8045270
A	O	-1	8045270
receptor	O	-1	8045270
antagonist	O	-1	8045270
with	O	-1	8045270
anti@@	O	-1	8045270
cat@@	O	-1	8045270
al@@	O	-1	8045270
ep@@	O	-1	8045270
tic	O	-1	8045270
activ@@	O	-1	8045270
ity.	O	-1	8045270
K@@	B-Chemical	C081198	8045270
F@@	I-Chemical	-1	8045270
17@@	I-Chemical	-1	8045270
8@@	I-Chemical	-1	8045270
3@@	I-Chemical	-1	8045270
7	I-Chemical	-1	8045270
is	O	-1	8045270
a	O	-1	8045270
novel	O	-1	8045270
selective	O	-1	8045270
aden@@	B-Chemical	D000241	8045270
os@@	I-Chemical	-1	8045270
ine	I-Chemical	-1	8045270
A@@	O	-1	8045270
2@@	O	-1	8045270
A	O	-1	8045270
receptor	O	-1	8045270
antagonist@@	O	-1	8045270
.	O	-1	8045270
O@@	O	-1	8045270
ral	O	-1	8045270
administration	O	-1	8045270
of	O	-1	8045270
K@@	B-Chemical	C081198	8045270
F@@	I-Chemical	-1	8045270
17@@	I-Chemical	-1	8045270
8@@	I-Chemical	-1	8045270
3@@	I-Chemical	-1	8045270
7	I-Chemical	-1	8045270
(2@@	O	-1	8045270
.@@	O	-1	8045270
5,	O	-1	8045270
1@@	O	-1	8045270
0.@@	O	-1	8045270
0	O	-1	8045270
and	O	-1	8045270
3@@	O	-1	8045270
0.@@	O	-1	8045270
0	O	-1	8045270
mg/kg)	O	-1	8045270
significantly	O	-1	8045270
ame@@	O	-1	8045270
li@@	O	-1	8045270
or@@	O	-1	8045270
ated	O	-1	8045270
the	O	-1	8045270
cat@@	B-Disease	D002375	8045270
al@@	I-Disease	-1	8045270
ep@@	I-Disease	-1	8045270
tic	I-Disease	-1	8045270
responses	O	-1	8045270
induced	O	-1	8045270
by	O	-1	8045270
intrac@@	O	-1	8045270
e@@	O	-1	8045270
reb@@	O	-1	8045270
ro@@	O	-1	8045270
ventricular	O	-1	8045270
administration	O	-1	8045270
of	O	-1	8045270
an	O	-1	8045270
aden@@	B-Chemical	D000241	8045270
os@@	I-Chemical	-1	8045270
ine	I-Chemical	-1	8045270
A@@	O	-1	8045270
2@@	O	-1	8045270
A	O	-1	8045270
receptor	O	-1	8045270
agon@@	O	-1	8045270
ist@@	O	-1	8045270
,	O	-1	8045270
C@@	B-Chemical	C061282	8045270
G@@	I-Chemical	-1	8045270
S	I-Chemical	-1	8045270
2@@	I-Chemical	-1	8045270
1@@	I-Chemical	-1	8045270
6@@	I-Chemical	-1	8045270
8@@	I-Chemical	-1	8045270
0	I-Chemical	-1	8045270
(10	O	-1	8045270
microgram@@	O	-1	8045270
s),	O	-1	8045270
in	O	-1	8045270
a	O	-1	8045270
dose-@@	O	-1	8045270
dependent	O	-1	8045270
man@@	O	-1	8045270
ner@@	O	-1	8045270
.	O	-1	8045270
K@@	B-Chemical	C081198	8045270
F@@	I-Chemical	-1	8045270
17@@	I-Chemical	-1	8045270
8@@	I-Chemical	-1	8045270
3@@	I-Chemical	-1	8045270
7	I-Chemical	-1	8045270
also	O	-1	8045270
reduced	O	-1	8045270
the	O	-1	8045270
cat@@	B-Disease	D002375	8045270
al@@	I-Disease	-1	8045270
ep@@	I-Disease	-1	8045270
sy	I-Disease	-1	8045270
induced	O	-1	8045270
by	O	-1	8045270
haloperidol	B-Chemical	D006220	8045270
(@@	O	-1	8045270
1	O	-1	8045270
mg/kg	O	-1	8045270
i.p.@@	O	-1	8045270
)	O	-1	8045270
and	O	-1	8045270
by	O	-1	8045270
res@@	B-Chemical	D012110	8045270
er@@	I-Chemical	-1	8045270
pine	I-Chemical	-1	8045270
(@@	O	-1	8045270
5	O	-1	8045270
mg/kg	O	-1	8045270
i.p.@@	O	-1	8045270
).	O	-1	8045270
These	O	-1	8045270
anti@@	O	-1	8045270
cat@@	O	-1	8045270
al@@	O	-1	8045270
ep@@	O	-1	8045270
tic	O	-1	8045270
effects	O	-1	8045270
were	O	-1	8045270
ex@@	O	-1	8045270
hib@@	O	-1	8045270
ited	O	-1	8045270
dose	O	-1	8045270
depend@@	O	-1	8045270
ently	O	-1	8045270
at	O	-1	8045270
doses	O	-1	8045270
from	O	-1	8045270
0.@@	O	-1	8045270
6@@	O	-1	8045270
25	O	-1	8045270
and	O	-1	8045270
2.@@	O	-1	8045270
5	O	-1	8045270
mg/kg	O	-1	8045270
p.@@	O	-1	8045270
o@@	O	-1	8045270
.,	O	-1	8045270
respectively.	O	-1	8045270
M@@	O	-1	8045270
ore@@	O	-1	8045270
o@@	O	-1	8045270
ver,	O	-1	8045270
K@@	B-Chemical	C081198	8045270
F@@	I-Chemical	-1	8045270
17@@	I-Chemical	-1	8045270
8@@	I-Chemical	-1	8045270
3@@	I-Chemical	-1	8045270
7	I-Chemical	-1	8045270
(0.@@	O	-1	8045270
6@@	O	-1	8045270
25	O	-1	8045270
mg/kg	O	-1	8045270
p.@@	O	-1	8045270
o@@	O	-1	8045270
.)	O	-1	8045270
potenti@@	O	-1	8045270
ated	O	-1	8045270
the	O	-1	8045270
anti@@	O	-1	8045270
cat@@	O	-1	8045270
al@@	O	-1	8045270
ep@@	O	-1	8045270
tic	O	-1	8045270
effects	O	-1	8045270
of	O	-1	8045270
a	O	-1	8045270
sub@@	O	-1	8045270
th@@	O	-1	8045270
res@@	O	-1	8045270
h@@	O	-1	8045270
old	O	-1	8045270
dose	O	-1	8045270
of	O	-1	8045270
L-@@	B-Chemical	D007980	8045270
3@@	I-Chemical	-1	8045270
,@@	I-Chemical	-1	8045270
4-@@	I-Chemical	-1	8045270
di@@	I-Chemical	-1	8045270
hydrox@@	I-Chemical	-1	8045270
y@@	I-Chemical	-1	8045270
phenyl@@	I-Chemical	-1	8045270
al@@	I-Chemical	-1	8045270
an@@	I-Chemical	-1	8045270
ine	I-Chemical	-1	8045270
(	O	-1	8045270
L-@@	B-Chemical	D007980	8045270
DO@@	I-Chemical	-1	8045270
P@@	I-Chemical	-1	8045270
A	I-Chemical	-1	8045270
;	O	-1	8045270
25	O	-1	8045270
mg/kg	O	-1	8045270
i.p.@@	O	-1	8045270
)	O	-1	8045270
plus	O	-1	8045270
ben@@	B-Chemical	D001545	8045270
ser@@	I-Chemical	-1	8045270
az@@	I-Chemical	-1	8045270
ide	I-Chemical	-1	8045270
(@@	O	-1	8045270
6.@@	O	-1	8045270
25	O	-1	8045270
mg/kg	O	-1	8045270
i.p.@@	O	-1	8045270
).	O	-1	8045270
These	O	-1	8045270
results	O	-1	8045270
suggested	O	-1	8045270
that	O	-1	8045270
K@@	B-Chemical	C081198	8045270
F@@	I-Chemical	-1	8045270
17@@	I-Chemical	-1	8045270
8@@	I-Chemical	-1	8045270
3@@	I-Chemical	-1	8045270
7	I-Chemical	-1	8045270
is	O	-1	8045270
a	O	-1	8045270
centr@@	O	-1	8045270
ally	O	-1	8045270
active	O	-1	8045270
aden@@	B-Chemical	D000241	8045270
os@@	I-Chemical	-1	8045270
ine	I-Chemical	-1	8045270
A@@	O	-1	8045270
2@@	O	-1	8045270
A	O	-1	8045270
receptor	O	-1	8045270
antagonist	O	-1	8045270
and	O	-1	8045270
that	O	-1	8045270
the	O	-1	8045270
dop@@	O	-1	8045270
aminergic	O	-1	8045270
function	O	-1	8045270
of	O	-1	8045270
the	O	-1	8045270
n@@	O	-1	8045270
ig@@	O	-1	8045270
ro@@	O	-1	8045270
stri@@	O	-1	8045270
atal	O	-1	8045270
path@@	O	-1	8045270
w@@	O	-1	8045270
ay	O	-1	8045270
is	O	-1	8045270
potenti@@	O	-1	8045270
ated	O	-1	8045270
by	O	-1	8045270
aden@@	B-Chemical	D000241	8045270
os@@	I-Chemical	-1	8045270
ine	I-Chemical	-1	8045270
A@@	O	-1	8045270
2@@	O	-1	8045270
A	O	-1	8045270
receptor	O	-1	8045270
antagonist@@	O	-1	8045270
s.	O	-1	8045270
F@@	O	-1	8045270
ur@@	O	-1	8045270
ther@@	O	-1	8045270
mo@@	O	-1	8045270
re,	O	-1	8045270
K@@	B-Chemical	C081198	8045270
F@@	I-Chemical	-1	8045270
17@@	I-Chemical	-1	8045270
8@@	I-Chemical	-1	8045270
3@@	I-Chemical	-1	8045270
7	I-Chemical	-1	8045270
may	O	-1	8045270
be	O	-1	8045270
a	O	-1	8045270
use@@	O	-1	8045270
ful	O	-1	8045270
drug	O	-1	8045270
in	O	-1	8045270
the	O	-1	8045270
treatment	O	-1	8045270
of	O	-1	8045270
par@@	B-Disease	D010302	8045270
k@@	I-Disease	-1	8045270
inson@@	I-Disease	-1	8045270
ism	I-Disease	-1	8045270
.	O	-1	8045270

S@@	O	-1	2576810
ome	O	-1	2576810
central	O	-1	2576810
effects	O	-1	2576810
of	O	-1	2576810
repe@@	O	-1	2576810
ated	O	-1	2576810
treatment	O	-1	2576810
with	O	-1	2576810
flu@@	B-Chemical	D016666	2576810
v@@	I-Chemical	-1	2576810
ox@@	I-Chemical	-1	2576810
amine	I-Chemical	-1	2576810
.	O	-1	2576810
We	O	-1	2576810
investigated	O	-1	2576810
the	O	-1	2576810
effect	O	-1	2576810
of	O	-1	2576810
repe@@	O	-1	2576810
ated	O	-1	2576810
treatment	O	-1	2576810
with	O	-1	2576810
flu@@	B-Chemical	D016666	2576810
v@@	I-Chemical	-1	2576810
ox@@	I-Chemical	-1	2576810
amine	I-Chemical	-1	2576810
,	O	-1	2576810
a	O	-1	2576810
selective	O	-1	2576810
seroton@@	B-Chemical	D012701	2576810
in	I-Chemical	-1	2576810
u@@	O	-1	2576810
pt@@	O	-1	2576810
ake	O	-1	2576810
inhibitor@@	O	-1	2576810
,	O	-1	2576810
on	O	-1	2576810
behavioral	O	-1	2576810
effects	O	-1	2576810
of	O	-1	2576810
dop@@	O	-1	2576810
amin@@	O	-1	2576810
om@@	O	-1	2576810
i@@	O	-1	2576810
me@@	O	-1	2576810
tics	O	-1	2576810
and	O	-1	2576810
meth@@	B-Chemical	D008729	2576810
ox@@	I-Chemical	-1	2576810
amine	I-Chemical	-1	2576810
and	O	-1	2576810
on	O	-1	2576810
the	O	-1	2576810
anim@@	O	-1	2576810
al	O	-1	2576810
behavi@@	O	-1	2576810
or	O	-1	2576810
in	O	-1	2576810
the	O	-1	2576810
"@@	O	-1	2576810
behavioral	O	-1	2576810
des@@	O	-1	2576810
pa@@	O	-1	2576810
ir@@	O	-1	2576810
"	O	-1	2576810
test@@	O	-1	2576810
.	O	-1	2576810
A	O	-1	2576810
repe@@	O	-1	2576810
ated	O	-1	2576810
treatment	O	-1	2576810
with	O	-1	2576810
flu@@	B-Chemical	D016666	2576810
v@@	I-Chemical	-1	2576810
ox@@	I-Chemical	-1	2576810
amine	I-Chemical	-1	2576810
(@@	O	-1	2576810
tw@@	O	-1	2576810
ic@@	O	-1	2576810
e	O	-1	2576810
daily	O	-1	2576810
for	O	-1	2576810
14	O	-1	2576810
da@@	O	-1	2576810
ys@@	O	-1	2576810
)	O	-1	2576810
potenti@@	O	-1	2576810
ated	O	-1	2576810
in	O	-1	2576810
mice	O	-1	2576810
and	O	-1	2576810
in	O	-1	2576810
rats	O	-1	2576810
(@@	O	-1	2576810
we@@	O	-1	2576810
ak@@	O	-1	2576810
er@@	O	-1	2576810
)	O	-1	2576810
the	O	-1	2576810
amphetamine	B-Chemical	D000661	2576810
-induced	O	-1	2576810
hyperactivity	B-Disease	D006948	2576810
.	O	-1	2576810
The	O	-1	2576810
hyperactivity	B-Disease	D006948	2576810
induced	O	-1	2576810
by	O	-1	2576810
no@@	B-Chemical	D009627	2576810
m@@	I-Chemical	-1	2576810
if@@	I-Chemical	-1	2576810
ens@@	I-Chemical	-1	2576810
ine	I-Chemical	-1	2576810
in	O	-1	2576810
mice	O	-1	2576810
remained	O	-1	2576810
un@@	O	-1	2576810
affected	O	-1	2576810
by	O	-1	2576810
flu@@	B-Chemical	D016666	2576810
v@@	I-Chemical	-1	2576810
ox@@	I-Chemical	-1	2576810
amine	I-Chemical	-1	2576810
.	O	-1	2576810
The	O	-1	2576810
stimulation	O	-1	2576810
of	O	-1	2576810
locomotor	O	-1	2576810
activity	O	-1	2576810
by	O	-1	2576810
intrac@@	O	-1	2576810
e@@	O	-1	2576810
reb@@	O	-1	2576810
ro@@	O	-1	2576810
ventric@@	O	-1	2576810
ul@@	O	-1	2576810
arly	O	-1	2576810
administered	O	-1	2576810
meth@@	B-Chemical	D008729	2576810
ox@@	I-Chemical	-1	2576810
amine	I-Chemical	-1	2576810
was	O	-1	2576810
not	O	-1	2576810
affected	O	-1	2576810
by	O	-1	2576810
repe@@	O	-1	2576810
ated	O	-1	2576810
treatment	O	-1	2576810
with	O	-1	2576810
flu@@	B-Chemical	D016666	2576810
v@@	I-Chemical	-1	2576810
ox@@	I-Chemical	-1	2576810
amine	I-Chemical	-1	2576810
.	O	-1	2576810
G@@	O	-1	2576810
i@@	O	-1	2576810
ven	O	-1	2576810
three	O	-1	2576810
times	O	-1	2576810
flu@@	B-Chemical	D016666	2576810
v@@	I-Chemical	-1	2576810
ox@@	I-Chemical	-1	2576810
amine	I-Chemical	-1	2576810
had	O	-1	2576810
no	O	-1	2576810
effect	O	-1	2576810
on	O	-1	2576810
the	O	-1	2576810
im@@	O	-1	2576810
mo@@	O	-1	2576810
bil@@	O	-1	2576810
ization	O	-1	2576810
time	O	-1	2576810
in	O	-1	2576810
the	O	-1	2576810
"@@	O	-1	2576810
behavioral	O	-1	2576810
des@@	O	-1	2576810
pa@@	O	-1	2576810
ir@@	O	-1	2576810
"	O	-1	2576810
test	O	-1	2576810
in	O	-1	2576810
rats.	O	-1	2576810
The	O	-1	2576810
results	O	-1	2576810
indicate	O	-1	2576810
that	O	-1	2576810
flu@@	B-Chemical	D016666	2576810
v@@	I-Chemical	-1	2576810
ox@@	I-Chemical	-1	2576810
amine	I-Chemical	-1	2576810
given	O	-1	2576810
repe@@	O	-1	2576810
ated@@	O	-1	2576810
ly	O	-1	2576810
act@@	O	-1	2576810
s	O	-1	2576810
differen@@	O	-1	2576810
tly	O	-1	2576810
than	O	-1	2576810
cit@@	B-Chemical	D015283	2576810
alo@@	I-Chemical	-1	2576810
pra@@	I-Chemical	-1	2576810
m	I-Chemical	-1	2576810
,	O	-1	2576810
an@@	O	-1	2576810
other	O	-1	2576810
selective	O	-1	2576810
seroton@@	B-Chemical	D012701	2576810
in	I-Chemical	-1	2576810
u@@	O	-1	2576810
pt@@	O	-1	2576810
ake	O	-1	2576810
inhibitor@@	O	-1	2576810
,	O	-1	2576810
and	O	-1	2576810
diff@@	O	-1	2576810
ers	O	-1	2576810
also	O	-1	2576810
from	O	-1	2576810
other	O	-1	2576810
antidepress@@	O	-1	2576810
ant	O	-1	2576810
drug@@	O	-1	2576810
s.	O	-1	2576810

S@@	O	-1	20635749
ev@@	O	-1	20635749
ere	O	-1	20635749
con@@	B-Disease	D006333	20635749
g@@	I-Disease	-1	20635749
es@@	I-Disease	-1	20635749
tive	I-Disease	-1	20635749
heart	I-Disease	-1	20635749
failure	I-Disease	-1	20635749
patient	O	-1	20635749
on	O	-1	20635749
am@@	B-Chemical	D000638	20635749
iodar@@	I-Chemical	-1	20635749
one	I-Chemical	-1	20635749
present@@	O	-1	20635749
ing	O	-1	20635749
with	O	-1	20635749
my@@	B-Disease	D009230	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
mic	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
my@@	B-Disease	D003128	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
mic	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
:	O	-1	20635749
a	O	-1	20635749
case	O	-1	20635749
repor@@	O	-1	20635749
t.	O	-1	20635749
This	O	-1	20635749
is	O	-1	20635749
a	O	-1	20635749
case	O	-1	20635749
report	O	-1	20635749
of	O	-1	20635749
my@@	B-Disease	D009230	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
ma	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
my@@	B-Disease	D003128	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
ma	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
secondary	O	-1	20635749
to	O	-1	20635749
am@@	B-Chemical	D000638	20635749
iodar@@	I-Chemical	-1	20635749
one	I-Chemical	-1	20635749
-induced	O	-1	20635749
hypo@@	B-Disease	D007037	20635749
th@@	I-Disease	-1	20635749
yro@@	I-Disease	-1	20635749
i@@	I-Disease	-1	20635749
dis@@	I-Disease	-1	20635749
m	I-Disease	-1	20635749
in	O	-1	20635749
a	O	-1	20635749
patient	O	-1	20635749
with	O	-1	20635749
severe	O	-1	20635749
con@@	B-Disease	D006333	20635749
g@@	I-Disease	-1	20635749
es@@	I-Disease	-1	20635749
tive	I-Disease	-1	20635749
heart	I-Disease	-1	20635749
failure	I-Disease	-1	20635749
(	O	-1	20635749
C@@	B-Disease	D006333	20635749
H@@	I-Disease	-1	20635749
F	I-Disease	-1	20635749
).	O	-1	20635749
To	O	-1	20635749
our	O	-1	20635749
know@@	O	-1	20635749
le@@	O	-1	20635749
d@@	O	-1	20635749
ge	O	-1	20635749
and	O	-1	20635749
after	O	-1	20635749
revie@@	O	-1	20635749
w@@	O	-1	20635749
ing	O	-1	20635749
the	O	-1	20635749
literat@@	O	-1	20635749
ure	O	-1	20635749
there	O	-1	20635749
is	O	-1	20635749
one	O	-1	20635749
case	O	-1	20635749
report	O	-1	20635749
of	O	-1	20635749
my@@	B-Disease	D009230	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
ma	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
my@@	B-Disease	D003128	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
ma	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
during	O	-1	20635749
lon@@	O	-1	20635749
g	O	-1	20635749
term	O	-1	20635749
am@@	B-Chemical	D000638	20635749
iodar@@	I-Chemical	-1	20635749
one	I-Chemical	-1	20635749
therapy.	O	-1	20635749
M@@	B-Disease	D009230	20635749
y@@	I-Disease	-1	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
ma	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
M@@	B-Disease	D003128	20635749
y@@	I-Disease	-1	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
ma	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
is	O	-1	20635749
a	O	-1	20635749
lif@@	O	-1	20635749
e	O	-1	20635749
th@@	O	-1	20635749
reat@@	O	-1	20635749
en@@	O	-1	20635749
ing	O	-1	20635749
condi@@	O	-1	20635749
tion	O	-1	20635749
that	O	-1	20635749
car@@	O	-1	20635749
ri@@	O	-1	20635749
es	O	-1	20635749
a	O	-1	20635749
mor@@	O	-1	20635749
t@@	O	-1	20635749
ality	O	-1	20635749
reac@@	O	-1	20635749
h@@	O	-1	20635749
ing	O	-1	20635749
as	O	-1	20635749
high	O	-1	20635749
as	O	-1	20635749
20@@	O	-1	20635749
%	O	-1	20635749
with	O	-1	20635749
treatment.	O	-1	20635749
The	O	-1	20635749
condi@@	O	-1	20635749
tion	O	-1	20635749
is	O	-1	20635749
treated	O	-1	20635749
with	O	-1	20635749
intravenous	O	-1	20635749
th@@	B-Chemical	D013974	20635749
yro@@	I-Chemical	-1	20635749
x@@	I-Chemical	-1	20635749
ine	I-Chemical	-1	20635749
(	O	-1	20635749
T@@	B-Chemical	D013974	20635749
4	I-Chemical	-1	20635749
)	O	-1	20635749
or	O	-1	20635749
intravenous	O	-1	20635749
tri@@	B-Chemical	D014284	20635749
-@@	I-Chemical	-1	20635749
io@@	I-Chemical	-1	20635749
do@@	I-Chemical	-1	20635749
-@@	I-Chemical	-1	20635749
th@@	I-Chemical	-1	20635749
y@@	I-Chemical	-1	20635749
ron@@	I-Chemical	-1	20635749
ine	I-Chemical	-1	20635749
(	O	-1	20635749
T@@	B-Chemical	D014284	20635749
3	I-Chemical	-1	20635749
).	O	-1	20635749
Patients	O	-1	20635749
with	O	-1	20635749
C@@	B-Disease	D006333	20635749
H@@	I-Disease	-1	20635749
F	I-Disease	-1	20635749
on	O	-1	20635749
am@@	B-Chemical	D000638	20635749
iodar@@	I-Chemical	-1	20635749
one	I-Chemical	-1	20635749
may	O	-1	20635749
suff@@	O	-1	20635749
er	O	-1	20635749
seri@@	O	-1	20635749
ous	O	-1	20635749
mor@@	O	-1	20635749
b@@	O	-1	20635749
idity	O	-1	20635749
and	O	-1	20635749
mor@@	O	-1	20635749
t@@	O	-1	20635749
ality	O	-1	20635749
from	O	-1	20635749
hypo@@	B-Disease	D007037	20635749
th@@	I-Disease	-1	20635749
yro@@	I-Disease	-1	20635749
i@@	I-Disease	-1	20635749
dis@@	I-Disease	-1	20635749
m	I-Disease	-1	20635749
,	O	-1	20635749
and	O	-1	20635749
th@@	O	-1	20635749
us	O	-1	20635749
may	O	-1	20635749
des@@	O	-1	20635749
er@@	O	-1	20635749
ve	O	-1	20635749
c@@	O	-1	20635749
los@@	O	-1	20635749
er	O	-1	20635749
fol@@	O	-1	20635749
low	O	-1	20635749
up	O	-1	20635749
for	O	-1	20635749
th@@	O	-1	20635749
yro@@	O	-1	20635749
id	O	-1	20635749
stimul@@	O	-1	20635749
ating	O	-1	20635749
h@@	O	-1	20635749
orm@@	O	-1	20635749
one	O	-1	20635749
(T@@	O	-1	20635749
S@@	O	-1	20635749
H@@	O	-1	20635749
)	O	-1	20635749
level@@	O	-1	20635749
s.	O	-1	20635749
This	O	-1	20635749
case	O	-1	20635749
report	O	-1	20635749
car@@	O	-1	20635749
ri@@	O	-1	20635749
es	O	-1	20635749
an	O	-1	20635749
important	O	-1	20635749
clinical	O	-1	20635749
ap@@	O	-1	20635749
plic@@	O	-1	20635749
ation	O	-1	20635749
given	O	-1	20635749
the	O	-1	20635749
frequent	O	-1	20635749
us@@	O	-1	20635749
age	O	-1	20635749
of	O	-1	20635749
am@@	B-Chemical	D000638	20635749
iodar@@	I-Chemical	-1	20635749
one	I-Chemical	-1	20635749
among	O	-1	20635749
C@@	B-Disease	D006333	20635749
H@@	I-Disease	-1	20635749
F	I-Disease	-1	20635749
patients.	O	-1	20635749
The	O	-1	20635749
my@@	O	-1	20635749
ri@@	O	-1	20635749
ad	O	-1	20635749
clinical	O	-1	20635749
present@@	O	-1	20635749
ation	O	-1	20635749
of	O	-1	20635749
my@@	B-Disease	D009230	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
ma	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
my@@	B-Disease	D003128	20635749
x@@	I-Disease	-1	20635749
e@@	I-Disease	-1	20635749
de@@	I-Disease	-1	20635749
ma	I-Disease	-1	20635749
com@@	I-Disease	-1	20635749
a	I-Disease	-1	20635749
and	O	-1	20635749
its	O	-1	20635749
seri@@	O	-1	20635749
ous	O	-1	20635749
mor@@	O	-1	20635749
b@@	O	-1	20635749
idity	O	-1	20635749
and	O	-1	20635749
mor@@	O	-1	20635749
t@@	O	-1	20635749
ality	O	-1	20635749
stres@@	O	-1	20635749
ses	O	-1	20635749
the	O	-1	20635749
need	O	-1	20635749
to	O	-1	20635749
sus@@	O	-1	20635749
p@@	O	-1	20635749
ect	O	-1	20635749
this	O	-1	20635749
clinical	O	-1	20635749
syndrome	O	-1	20635749
among	O	-1	20635749
C@@	B-Disease	D006333	20635749
H@@	I-Disease	-1	20635749
F	I-Disease	-1	20635749
patients	O	-1	20635749
present@@	O	-1	20635749
ing	O	-1	20635749
with	O	-1	20635749
hypotension	B-Disease	D007022	20635749
,	O	-1	20635749
we@@	B-Disease	D018908	20635749
ak@@	I-Disease	-1	20635749
ness	I-Disease	-1	20635749
or	O	-1	20635749
other	O	-1	20635749
un@@	O	-1	20635749
expl@@	O	-1	20635749
ained	O	-1	20635749
symptom@@	O	-1	20635749
s.	O	-1	20635749

F@@	O	-1	20394767
ear@@	O	-1	20394767
-@@	O	-1	20394767
potenti@@	O	-1	20394767
ated	O	-1	20394767
star@@	B-Disease	D012021	20394767
t@@	I-Disease	-1	20394767
le	I-Disease	-1	20394767
,	O	-1	20394767
but	O	-1	20394767
not	O	-1	20394767
li@@	O	-1	20394767
gh@@	O	-1	20394767
t-@@	O	-1	20394767
enhanced	O	-1	20394767
star@@	B-Disease	D012021	20394767
t@@	I-Disease	-1	20394767
le	I-Disease	-1	20394767
,	O	-1	20394767
is	O	-1	20394767
enhanced	O	-1	20394767
by	O	-1	20394767
an@@	O	-1	20394767
x@@	O	-1	20394767
io@@	O	-1	20394767
genic	O	-1	20394767
drug@@	O	-1	20394767
s.	O	-1	20394767
R@@	O	-1	20394767
AT@@	O	-1	20394767
ION@@	O	-1	20394767
AL@@	O	-1	20394767
E	O	-1	20394767
AN@@	O	-1	20394767
D	O	-1	20394767
OBJECTIV@@	O	-1	20394767
E@@	O	-1	20394767
S:	O	-1	20394767
The	O	-1	20394767
li@@	O	-1	20394767
gh@@	O	-1	20394767
t-@@	O	-1	20394767
enhanced	O	-1	20394767
star@@	B-Disease	D012021	20394767
t@@	I-Disease	-1	20394767
le	I-Disease	-1	20394767
par@@	O	-1	20394767
a@@	O	-1	20394767
di@@	O	-1	20394767
g@@	O	-1	20394767
m	O	-1	20394767
(@@	O	-1	20394767
L@@	O	-1	20394767
ES@@	O	-1	20394767
)	O	-1	20394767
is	O	-1	20394767
suggested	O	-1	20394767
to	O	-1	20394767
model	O	-1	20394767
an@@	B-Disease	D001008	20394767
xi@@	I-Disease	-1	20394767
ety	I-Disease	-1	20394767
,	O	-1	20394767
because	O	-1	20394767
of	O	-1	20394767
the	O	-1	20394767
non-@@	O	-1	20394767
specific	O	-1	20394767
c@@	O	-1	20394767
u@@	O	-1	20394767
e	O	-1	20394767
and	O	-1	20394767
the	O	-1	20394767
long-term	O	-1	20394767
effect@@	O	-1	20394767
.	O	-1	20394767
In	O	-1	20394767
contrast@@	O	-1	20394767
,	O	-1	20394767
the	O	-1	20394767
f@@	O	-1	20394767
ear@@	O	-1	20394767
-@@	O	-1	20394767
potenti@@	O	-1	20394767
ated	O	-1	20394767
star@@	B-Disease	D012021	20394767
t@@	I-Disease	-1	20394767
le	I-Disease	-1	20394767
(@@	O	-1	20394767
F@@	O	-1	20394767
P@@	O	-1	20394767
S)	O	-1	20394767
is	O	-1	20394767
suggested	O	-1	20394767
to	O	-1	20394767
model	O	-1	20394767
condi@@	O	-1	20394767
tion@@	O	-1	20394767
ed	O	-1	20394767
f@@	O	-1	20394767
ear@@	O	-1	20394767
.	O	-1	20394767
However,	O	-1	20394767
the	O	-1	20394767
pharmac@@	O	-1	20394767
ological	O	-1	20394767
pro@@	O	-1	20394767
fi@@	O	-1	20394767
le@@	O	-1	20394767
s	O	-1	20394767
of	O	-1	20394767
these	O	-1	20394767
two	O	-1	20394767
par@@	O	-1	20394767
a@@	O	-1	20394767
di@@	O	-1	20394767
g@@	O	-1	20394767
ms	O	-1	20394767
are	O	-1	20394767
very	O	-1	20394767
simil@@	O	-1	20394767
ar@@	O	-1	20394767
.	O	-1	20394767
The	O	-1	20394767
present	O	-1	20394767
study	O	-1	20394767
investigated	O	-1	20394767
the	O	-1	20394767
effects	O	-1	20394767
of	O	-1	20394767
p@@	O	-1	20394767
ut@@	O	-1	20394767
ative	O	-1	20394767
an@@	O	-1	20394767
x@@	O	-1	20394767
io@@	O	-1	20394767
genic	O	-1	20394767
drugs	O	-1	20394767
on	O	-1	20394767
L@@	O	-1	20394767
E@@	O	-1	20394767
S	O	-1	20394767
and	O	-1	20394767
F@@	O	-1	20394767
P@@	O	-1	20394767
S	O	-1	20394767
and	O	-1	20394767
a@@	O	-1	20394767
im@@	O	-1	20394767
ed	O	-1	20394767
at	O	-1	20394767
determin@@	O	-1	20394767
ing	O	-1	20394767
the	O	-1	20394767
sensitivity	O	-1	20394767
of	O	-1	20394767
L@@	O	-1	20394767
E@@	O	-1	20394767
S	O	-1	20394767
for	O	-1	20394767
an@@	O	-1	20394767
x@@	O	-1	20394767
io@@	O	-1	20394767
genic	O	-1	20394767
drugs	O	-1	20394767
and	O	-1	20394767
to	O	-1	20394767
potenti@@	O	-1	20394767
ally	O	-1	20394767
show@@	O	-1	20394767
ing	O	-1	20394767
a	O	-1	20394767
pharmac@@	O	-1	20394767
ological	O	-1	20394767
differen@@	O	-1	20394767
ti@@	O	-1	20394767
ation	O	-1	20394767
between	O	-1	20394767
these	O	-1	20394767
two	O	-1	20394767
par@@	O	-1	20394767
a@@	O	-1	20394767
di@@	O	-1	20394767
g@@	O	-1	20394767
m@@	O	-1	20394767
s.	O	-1	20394767
METHODS:	O	-1	20394767
M@@	O	-1	20394767
al@@	O	-1	20394767
e	O	-1	20394767
Wistar	O	-1	20394767
rats	O	-1	20394767
received	O	-1	20394767
each	O	-1	20394767
dose	O	-1	20394767
of	O	-1	20394767
the	O	-1	20394767
alpha@@	O	-1	20394767
(2@@	O	-1	20394767
)-@@	O	-1	20394767
adren@@	O	-1	20394767
oc@@	O	-1	20394767
e@@	O	-1	20394767
pt@@	O	-1	20394767
or	O	-1	20394767
antagonist	O	-1	20394767
yo@@	B-Chemical	D015016	20394767
h@@	I-Chemical	-1	20394767
im@@	I-Chemical	-1	20394767
b@@	I-Chemical	-1	20394767
ine	I-Chemical	-1	20394767
(0.@@	O	-1	20394767
2@@	O	-1	20394767
5-@@	O	-1	20394767
1.@@	O	-1	20394767
0@@	O	-1	20394767
mg/kg@@	O	-1	20394767
),	O	-1	20394767
the	O	-1	20394767
5-@@	B-Chemical	D012701	20394767
H@@	I-Chemical	-1	20394767
T	I-Chemical	-1	20394767
(2@@	O	-1	20394767
C@@	O	-1	20394767
)	O	-1	20394767
receptor	O	-1	20394767
agon@@	O	-1	20394767
ist	O	-1	20394767
m@@	B-Chemical	C015068	20394767
-@@	I-Chemical	-1	20394767
ch@@	I-Chemical	-1	20394767
loro@@	I-Chemical	-1	20394767
phenyl@@	I-Chemical	-1	20394767
pi@@	I-Chemical	-1	20394767
per@@	I-Chemical	-1	20394767
az@@	I-Chemical	-1	20394767
ine	I-Chemical	-1	20394767
(	O	-1	20394767
m@@	B-Chemical	C015068	20394767
C@@	I-Chemical	-1	20394767
P@@	I-Chemical	-1	20394767
P	I-Chemical	-1	20394767
,	O	-1	20394767
0.@@	O	-1	20394767
5-@@	O	-1	20394767
2.@@	O	-1	20394767
0@@	O	-1	20394767
mg/kg)	O	-1	20394767
or	O	-1	20394767
the	O	-1	20394767
G@@	B-Chemical	D005680	20394767
A@@	I-Chemical	-1	20394767
B@@	I-Chemical	-1	20394767
A	I-Chemical	-1	20394767
(A@@	O	-1	20394767
)	O	-1	20394767
in@@	O	-1	20394767
verse	O	-1	20394767
receptor	O	-1	20394767
agon@@	O	-1	20394767
ist	O	-1	20394767
pent@@	B-Chemical	D010433	20394767
yl@@	I-Chemical	-1	20394767
en@@	I-Chemical	-1	20394767
e@@	I-Chemical	-1	20394767
te@@	I-Chemical	-1	20394767
tra@@	I-Chemical	-1	20394767
z@@	I-Chemical	-1	20394767
ole	I-Chemical	-1	20394767
(	O	-1	20394767
P@@	B-Chemical	D010433	20394767
T@@	I-Chemical	-1	20394767
Z	I-Chemical	-1	20394767
,	O	-1	20394767
3-@@	O	-1	20394767
3@@	O	-1	20394767
0@@	O	-1	20394767
mg/kg)	O	-1	20394767
and	O	-1	20394767
were	O	-1	20394767
subsequ@@	O	-1	20394767
ently	O	-1	20394767
tested	O	-1	20394767
in	O	-1	20394767
either	O	-1	20394767
L@@	O	-1	20394767
E@@	O	-1	20394767
S	O	-1	20394767
or	O	-1	20394767
F@@	O	-1	20394767
P@@	O	-1	20394767
S@@	O	-1	20394767
.	O	-1	20394767
RESULTS:	O	-1	20394767
N@@	O	-1	20394767
one	O	-1	20394767
of	O	-1	20394767
the	O	-1	20394767
drugs	O	-1	20394767
enhanced	O	-1	20394767
L@@	O	-1	20394767
ES@@	O	-1	20394767
,	O	-1	20394767
whereas	O	-1	20394767
m@@	B-Chemical	C015068	20394767
C@@	I-Chemical	-1	20394767
P@@	I-Chemical	-1	20394767
P	I-Chemical	-1	20394767
increased	O	-1	20394767
perc@@	O	-1	20394767
ent@@	O	-1	20394767
age	O	-1	20394767
F@@	O	-1	20394767
P@@	O	-1	20394767
S	O	-1	20394767
and	O	-1	20394767
yo@@	B-Chemical	D015016	20394767
h@@	I-Chemical	-1	20394767
im@@	I-Chemical	-1	20394767
b@@	I-Chemical	-1	20394767
ine	I-Chemical	-1	20394767
increased	O	-1	20394767
abs@@	O	-1	20394767
ol@@	O	-1	20394767
ute	O	-1	20394767
F@@	O	-1	20394767
P@@	O	-1	20394767
S	O	-1	20394767
valu@@	O	-1	20394767
es.	O	-1	20394767
F@@	O	-1	20394767
ur@@	O	-1	20394767
ther@@	O	-1	20394767
mo@@	O	-1	20394767
re,	O	-1	20394767
yo@@	B-Chemical	D015016	20394767
h@@	I-Chemical	-1	20394767
im@@	I-Chemical	-1	20394767
b@@	I-Chemical	-1	20394767
ine	I-Chemical	-1	20394767
increased	O	-1	20394767
baseline	O	-1	20394767
star@@	B-Disease	D012021	20394767
t@@	I-Disease	-1	20394767
le	I-Disease	-1	20394767
am@@	O	-1	20394767
pl@@	O	-1	20394767
it@@	O	-1	20394767
ude	O	-1	20394767
in	O	-1	20394767
the	O	-1	20394767
L@@	O	-1	20394767
ES@@	O	-1	20394767
,	O	-1	20394767
while	O	-1	20394767
m@@	B-Chemical	C015068	20394767
C@@	I-Chemical	-1	20394767
P@@	I-Chemical	-1	20394767
P	I-Chemical	-1	20394767
sup@@	O	-1	20394767
press@@	O	-1	20394767
ed	O	-1	20394767
baseline	O	-1	20394767
star@@	B-Disease	D012021	20394767
t@@	I-Disease	-1	20394767
le	I-Disease	-1	20394767
in	O	-1	20394767
both	O	-1	20394767
the	O	-1	20394767
L@@	O	-1	20394767
E@@	O	-1	20394767
S	O	-1	20394767
and	O	-1	20394767
F@@	O	-1	20394767
P@@	O	-1	20394767
S	O	-1	20394767
and	O	-1	20394767
P@@	B-Chemical	D010433	20394767
T@@	I-Chemical	-1	20394767
Z	I-Chemical	-1	20394767
sup@@	O	-1	20394767
press@@	O	-1	20394767
ed	O	-1	20394767
baseline	O	-1	20394767
star@@	B-Disease	D012021	20394767
t@@	I-Disease	-1	20394767
le	I-Disease	-1	20394767
in	O	-1	20394767
the	O	-1	20394767
F@@	O	-1	20394767
P@@	O	-1	20394767
S@@	O	-1	20394767
.	O	-1	20394767
CONCLUSIONS:	O	-1	20394767
In	O	-1	20394767
contr@@	O	-1	20394767
ast	O	-1	20394767
to	O	-1	20394767
findings	O	-1	20394767
in	O	-1	20394767
the	O	-1	20394767
F@@	O	-1	20394767
P@@	O	-1	20394767
S	O	-1	20394767
par@@	O	-1	20394767
a@@	O	-1	20394767
di@@	O	-1	20394767
g@@	O	-1	20394767
m@@	O	-1	20394767
,	O	-1	20394767
n@@	O	-1	20394767
one	O	-1	20394767
of	O	-1	20394767
the	O	-1	20394767
drugs	O	-1	20394767
were	O	-1	20394767
able	O	-1	20394767
to	O	-1	20394767
ex@@	O	-1	20394767
ac@@	O	-1	20394767
er@@	O	-1	20394767
b@@	O	-1	20394767
ate	O	-1	20394767
the	O	-1	20394767
L@@	O	-1	20394767
E@@	O	-1	20394767
S	O	-1	20394767
respon@@	O	-1	20394767
se.	O	-1	20394767
Th@@	O	-1	20394767
us,	O	-1	20394767
a	O	-1	20394767
c@@	O	-1	20394767
le@@	O	-1	20394767
ar	O	-1	20394767
pharmac@@	O	-1	20394767
ological	O	-1	20394767
differen@@	O	-1	20394767
ti@@	O	-1	20394767
ation	O	-1	20394767
was	O	-1	20394767
found	O	-1	20394767
between	O	-1	20394767
L@@	O	-1	20394767
E@@	O	-1	20394767
S	O	-1	20394767
and	O	-1	20394767
F@@	O	-1	20394767
P@@	O	-1	20394767
S@@	O	-1	20394767
.	O	-1	20394767

Pro@@	O	-1	19203554
te@@	O	-1	19203554
in@@	O	-1	19203554
ase	O	-1	19203554
3-@@	O	-1	19203554
ant@@	O	-1	19203554
ine@@	O	-1	19203554
ut@@	O	-1	19203554
ro@@	O	-1	19203554
ph@@	O	-1	19203554
il	O	-1	19203554
cyto@@	O	-1	19203554
plas@@	O	-1	19203554
mic	O	-1	19203554
anti@@	O	-1	19203554
bo@@	O	-1	19203554
dy@@	O	-1	19203554
-@@	O	-1	19203554
(P@@	O	-1	19203554
R@@	O	-1	19203554
3-@@	O	-1	19203554
AN@@	O	-1	19203554
CA@@	O	-1	19203554
)	O	-1	19203554
positive	O	-1	19203554
necro@@	O	-1	19203554
tiz@@	O	-1	19203554
ing	O	-1	19203554
glomerul@@	B-Disease	D005921	19203554
one@@	I-Disease	-1	19203554
ph@@	I-Disease	-1	19203554
ritis	I-Disease	-1	19203554
after	O	-1	19203554
re@@	O	-1	19203554
star@@	O	-1	19203554
ting	O	-1	19203554
sul@@	B-Chemical	D012460	19203554
ph@@	I-Chemical	-1	19203554
as@@	I-Chemical	-1	19203554
al@@	I-Chemical	-1	19203554
az@@	I-Chemical	-1	19203554
ine	I-Chemical	-1	19203554
treatment.	O	-1	19203554
A	O	-1	19203554
5@@	O	-1	19203554
9@@	O	-1	19203554
-@@	O	-1	19203554
year-old	O	-1	19203554
woman	O	-1	19203554
with	O	-1	19203554
ul@@	B-Disease	D003093	19203554
cer@@	I-Disease	-1	19203554
ative	I-Disease	-1	19203554
co@@	I-Disease	-1	19203554
li@@	I-Disease	-1	19203554
tis	I-Disease	-1	19203554
developed	O	-1	19203554
red	B-Disease	D005128	19203554
e@@	I-Disease	-1	19203554
y@@	I-Disease	-1	19203554
es	I-Disease	-1	19203554
,	O	-1	19203554
ple@@	B-Disease	D010996	19203554
ural	I-Disease	-1	19203554
eff@@	I-Disease	-1	19203554
usion	I-Disease	-1	19203554
,	O	-1	19203554
e@@	B-Disease	D004802	19203554
os@@	I-Disease	-1	19203554
in@@	I-Disease	-1	19203554
oph@@	I-Disease	-1	19203554
il@@	I-Disease	-1	19203554
ia	I-Disease	-1	19203554
and	O	-1	19203554
urinary	B-Disease	D001745	19203554
abnormal@@	I-Disease	-1	19203554
ities	I-Disease	-1	19203554
after	O	-1	19203554
re@@	O	-1	19203554
star@@	O	-1	19203554
ting	O	-1	19203554
of	O	-1	19203554
sul@@	B-Chemical	D012460	19203554
ph@@	I-Chemical	-1	19203554
as@@	I-Chemical	-1	19203554
al@@	I-Chemical	-1	19203554
az@@	I-Chemical	-1	19203554
ine	I-Chemical	-1	19203554
treatment.	O	-1	19203554
L@@	O	-1	19203554
ight	O	-1	19203554
micro@@	O	-1	19203554
sco@@	O	-1	19203554
p@@	O	-1	19203554
y	O	-1	19203554
of	O	-1	19203554
a	O	-1	19203554
kidney	O	-1	19203554
biop@@	O	-1	19203554
sy	O	-1	19203554
revealed	O	-1	19203554
seg@@	B-Disease	D005923	19203554
mental	I-Disease	-1	19203554
necro@@	I-Disease	-1	19203554
tiz@@	I-Disease	-1	19203554
ing	I-Disease	-1	19203554
glomerul@@	I-Disease	-1	19203554
one@@	I-Disease	-1	19203554
ph@@	I-Disease	-1	19203554
ritis	I-Disease	-1	19203554
without	O	-1	19203554
de@@	O	-1	19203554
posi@@	O	-1	19203554
tion	O	-1	19203554
of	O	-1	19203554
immuno@@	O	-1	19203554
glo@@	O	-1	19203554
b@@	O	-1	19203554
ul@@	O	-1	19203554
in	O	-1	19203554
or	O	-1	19203554
comple@@	O	-1	19203554
ment.	O	-1	19203554
Pro@@	O	-1	19203554
te@@	O	-1	19203554
in@@	O	-1	19203554
ase	O	-1	19203554
3-@@	O	-1	19203554
ant@@	O	-1	19203554
ine@@	O	-1	19203554
ut@@	O	-1	19203554
ro@@	O	-1	19203554
ph@@	O	-1	19203554
il	O	-1	19203554
cyto@@	O	-1	19203554
plas@@	O	-1	19203554
mic	O	-1	19203554
anti@@	O	-1	19203554
body	O	-1	19203554
(P@@	O	-1	19203554
R@@	O	-1	19203554
3-@@	O	-1	19203554
AN@@	O	-1	19203554
CA@@	O	-1	19203554
)	O	-1	19203554
ti@@	O	-1	19203554
ter	O	-1	19203554
was	O	-1	19203554
elevated	O	-1	19203554
at	O	-1	19203554
18@@	O	-1	19203554
3	O	-1	19203554
E@@	O	-1	19203554
L@@	O	-1	19203554
I@@	O	-1	19203554
S@@	O	-1	19203554
A	O	-1	19203554
un@@	O	-1	19203554
its	O	-1	19203554
(@@	O	-1	19203554
E@@	O	-1	19203554
U@@	O	-1	19203554
)	O	-1	19203554
in	O	-1	19203554
ser@@	O	-1	19203554
a	O	-1	19203554
(@@	O	-1	19203554
normal	O	-1	19203554
range	O	-1	19203554
less	O	-1	19203554
than	O	-1	19203554
10	O	-1	19203554
E@@	O	-1	19203554
U@@	O	-1	19203554
),	O	-1	19203554
my@@	O	-1	19203554
e@@	O	-1	19203554
lo@@	O	-1	19203554
per@@	O	-1	19203554
oxid@@	O	-1	19203554
as@@	O	-1	19203554
e-@@	O	-1	19203554
AN@@	O	-1	19203554
C@@	O	-1	19203554
A	O	-1	19203554
was	O	-1	19203554
neg@@	O	-1	19203554
ati@@	O	-1	19203554
ve.	O	-1	19203554
P@@	O	-1	19203554
R@@	O	-1	19203554
3-@@	O	-1	19203554
AN@@	O	-1	19203554
C@@	O	-1	19203554
A	O	-1	19203554
ti@@	O	-1	19203554
ter	O	-1	19203554
was	O	-1	19203554
2@@	O	-1	19203554
50	O	-1	19203554
and	O	-1	19203554
1@@	O	-1	19203554
,@@	O	-1	19203554
0@@	O	-1	19203554
7@@	O	-1	19203554
0	O	-1	19203554
E@@	O	-1	19203554
U	O	-1	19203554
in	O	-1	19203554
ple@@	B-Disease	D010996	19203554
ural	I-Disease	-1	19203554
eff@@	I-Disease	-1	19203554
u@@	I-Disease	-1	19203554
sions	I-Disease	-1	19203554
on	O	-1	19203554
right	O	-1	19203554
and	O	-1	19203554
left	O	-1	19203554
side@@	O	-1	19203554
,	O	-1	19203554
respectively.	O	-1	19203554
Although	O	-1	19203554
cess@@	O	-1	19203554
ation	O	-1	19203554
of	O	-1	19203554
sul@@	B-Chemical	D012460	19203554
ph@@	I-Chemical	-1	19203554
as@@	I-Chemical	-1	19203554
al@@	I-Chemical	-1	19203554
az@@	I-Chemical	-1	19203554
ine	I-Chemical	-1	19203554
treatment	O	-1	19203554
resulted	O	-1	19203554
in	O	-1	19203554
impro@@	O	-1	19203554
ve@@	O	-1	19203554
ments	O	-1	19203554
in	O	-1	19203554
f@@	B-Disease	D005334	19203554
ev@@	I-Disease	-1	19203554
er	I-Disease	-1	19203554
,	O	-1	19203554
red	B-Disease	D005128	19203554
e@@	I-Disease	-1	19203554
y@@	I-Disease	-1	19203554
es	I-Disease	-1	19203554
,	O	-1	19203554
ch@@	B-Disease	D002637	19203554
est	I-Disease	-1	19203554
pain	I-Disease	-1	19203554
,	O	-1	19203554
ti@@	O	-1	19203554
ter	O	-1	19203554
of	O	-1	19203554
C@@	O	-1	19203554
-@@	O	-1	19203554
reac@@	O	-1	19203554
tive	O	-1	19203554
protein	O	-1	19203554
and	O	-1	19203554
volume	O	-1	19203554
of	O	-1	19203554
the	O	-1	19203554
ple@@	B-Disease	D010996	19203554
ural	I-Disease	-1	19203554
eff@@	I-Disease	-1	19203554
u@@	I-Disease	-1	19203554
sions	I-Disease	-1	19203554
,	O	-1	19203554
we	O	-1	19203554
initi@@	O	-1	19203554
ated	O	-1	19203554
ster@@	B-Chemical	D013256	19203554
oid	I-Chemical	-1	19203554
therapy,	O	-1	19203554
because	O	-1	19203554
P@@	O	-1	19203554
R@@	O	-1	19203554
3-@@	O	-1	19203554
AN@@	O	-1	19203554
C@@	O	-1	19203554
A	O	-1	19203554
ti@@	O	-1	19203554
ter	O	-1	19203554
ro@@	O	-1	19203554
se	O	-1	19203554
to	O	-1	19203554
3@@	O	-1	19203554
20	O	-1	19203554
E@@	O	-1	19203554
U@@	O	-1	19203554
,	O	-1	19203554
e@@	O	-1	19203554
os@@	O	-1	19203554
in@@	O	-1	19203554
oph@@	O	-1	19203554
il	O	-1	19203554
coun@@	O	-1	19203554
t	O	-1	19203554
increased	O	-1	19203554
to	O	-1	19203554
1@@	O	-1	19203554
,@@	O	-1	19203554
100	O	-1	19203554
cell@@	O	-1	19203554
s/@@	O	-1	19203554
micro@@	O	-1	19203554
l@@	O	-1	19203554
,	O	-1	19203554
and	O	-1	19203554
the	O	-1	19203554
ple@@	B-Disease	D010996	19203554
ural	I-Disease	-1	19203554
eff@@	I-Disease	-1	19203554
usion	I-Disease	-1	19203554
re@@	O	-1	19203554
ma@@	O	-1	19203554
ine@@	O	-1	19203554
d.	O	-1	19203554
One	O	-1	19203554
mon@@	O	-1	19203554
th	O	-1	19203554
after	O	-1	19203554
ster@@	B-Chemical	D013256	19203554
oid	I-Chemical	-1	19203554
therapy,	O	-1	19203554
the	O	-1	19203554
ple@@	B-Disease	D010996	19203554
ural	I-Disease	-1	19203554
eff@@	I-Disease	-1	19203554
usion	I-Disease	-1	19203554
dis@@	O	-1	19203554
appe@@	O	-1	19203554
a@@	O	-1	19203554
re@@	O	-1	19203554
d,	O	-1	19203554
and	O	-1	19203554
P@@	O	-1	19203554
R@@	O	-1	19203554
3-@@	O	-1	19203554
AN@@	O	-1	19203554
C@@	O	-1	19203554
A	O	-1	19203554
ti@@	O	-1	19203554
ter	O	-1	19203554
normal@@	O	-1	19203554
ized	O	-1	19203554
3	O	-1	19203554
months	O	-1	19203554
lat@@	O	-1	19203554
er.	O	-1	19203554
This	O	-1	19203554
case	O	-1	19203554
suggests	O	-1	19203554
that	O	-1	19203554
sul@@	B-Chemical	D012460	19203554
ph@@	I-Chemical	-1	19203554
as@@	I-Chemical	-1	19203554
al@@	I-Chemical	-1	19203554
az@@	I-Chemical	-1	19203554
ine	I-Chemical	-1	19203554
can	O	-1	19203554
induce	O	-1	19203554
P@@	O	-1	19203554
R@@	O	-1	19203554
3-@@	O	-1	19203554
AN@@	O	-1	19203554
CA@@	O	-1	19203554
-@@	O	-1	19203554
positive	O	-1	19203554
necro@@	O	-1	19203554
tiz@@	O	-1	19203554
ing	O	-1	19203554
glomerul@@	B-Disease	D005921	19203554
one@@	I-Disease	-1	19203554
ph@@	I-Disease	-1	19203554
ritis	I-Disease	-1	19203554
.	O	-1	19203554

I@@	O	-1	17049862
s	O	-1	17049862
pheny@@	B-Chemical	D010672	17049862
to@@	I-Chemical	-1	17049862
in	I-Chemical	-1	17049862
administration	O	-1	17049862
saf@@	O	-1	17049862
e	O	-1	17049862
in	O	-1	17049862
a	O	-1	17049862
hypo@@	B-Disease	D007035	17049862
ther@@	I-Disease	-1	17049862
mic	I-Disease	-1	17049862
child@@	O	-1	17049862
?	O	-1	17049862
A	O	-1	17049862
male	O	-1	17049862
ne@@	O	-1	17049862
on@@	O	-1	17049862
ate	O	-1	17049862
with	O	-1	17049862
a	O	-1	17049862
C@@	B-Disease	D001139	17049862
hi@@	I-Disease	-1	17049862
ar@@	I-Disease	-1	17049862
i	I-Disease	-1	17049862
mal@@	I-Disease	-1	17049862
formation	I-Disease	-1	17049862
and	O	-1	17049862
a	O	-1	17049862
le@@	O	-1	17049862
ak@@	O	-1	17049862
ing	O	-1	17049862
my@@	O	-1	17049862
e@@	O	-1	17049862
lo@@	O	-1	17049862
men@@	O	-1	17049862
ing@@	O	-1	17049862
o@@	O	-1	17049862
co@@	O	-1	17049862
e@@	O	-1	17049862
le	O	-1	17049862
under@@	O	-1	17049862
w@@	O	-1	17049862
ent	O	-1	17049862
ventric@@	O	-1	17049862
ulo@@	O	-1	17049862
per@@	O	-1	17049862
it@@	O	-1	17049862
one@@	O	-1	17049862
al	O	-1	17049862
sh@@	O	-1	17049862
un@@	O	-1	17049862
t	O	-1	17049862
in@@	O	-1	17049862
ser@@	O	-1	17049862
tion	O	-1	17049862
followed	O	-1	17049862
by	O	-1	17049862
re@@	O	-1	17049862
pa@@	O	-1	17049862
ir	O	-1	17049862
of	O	-1	17049862
my@@	O	-1	17049862
e@@	O	-1	17049862
lo@@	O	-1	17049862
men@@	O	-1	17049862
ing@@	O	-1	17049862
o@@	O	-1	17049862
co@@	O	-1	17049862
e@@	O	-1	17049862
le@@	O	-1	17049862
.	O	-1	17049862
D@@	O	-1	17049862
uring	O	-1	17049862
anaesthe@@	O	-1	17049862
sia	O	-1	17049862
and	O	-1	17049862
surger@@	O	-1	17049862
y,	O	-1	17049862
he	O	-1	17049862
in@@	O	-1	17049862
ad@@	O	-1	17049862
ver@@	O	-1	17049862
t@@	O	-1	17049862
ently	O	-1	17049862
b@@	O	-1	17049862
ec@@	O	-1	17049862
am@@	O	-1	17049862
e	O	-1	17049862
moder@@	O	-1	17049862
ately	O	-1	17049862
hypo@@	B-Disease	D007035	17049862
ther@@	I-Disease	-1	17049862
mic	I-Disease	-1	17049862
.	O	-1	17049862
In@@	O	-1	17049862
tra@@	O	-1	17049862
venous	O	-1	17049862
pheny@@	B-Chemical	D010672	17049862
to@@	I-Chemical	-1	17049862
in	I-Chemical	-1	17049862
was	O	-1	17049862
administered	O	-1	17049862
during	O	-1	17049862
the	O	-1	17049862
lat@@	O	-1	17049862
er	O	-1	17049862
par@@	O	-1	17049862
t	O	-1	17049862
of	O	-1	17049862
the	O	-1	17049862
surger@@	O	-1	17049862
y	O	-1	17049862
for	O	-1	17049862
seizure	B-Disease	D012640	17049862
pro@@	O	-1	17049862
phyl@@	O	-1	17049862
ax@@	O	-1	17049862
i@@	O	-1	17049862
s.	O	-1	17049862
F@@	O	-1	17049862
ol@@	O	-1	17049862
low@@	O	-1	17049862
ing	O	-1	17049862
pheny@@	B-Chemical	D010672	17049862
to@@	I-Chemical	-1	17049862
in	I-Chemical	-1	17049862
administr@@	O	-1	17049862
ation,	O	-1	17049862
the	O	-1	17049862
patient	O	-1	17049862
developed	O	-1	17049862
acute	O	-1	17049862
severe	O	-1	17049862
brady@@	B-Disease	D001919	17049862
cardia	I-Disease	-1	17049862
,	O	-1	17049862
ref@@	O	-1	17049862
rac@@	O	-1	17049862
t@@	O	-1	17049862
ory	O	-1	17049862
to	O	-1	17049862
atro@@	B-Chemical	D001285	17049862
pine	I-Chemical	-1	17049862
and	O	-1	17049862
adren@@	B-Chemical	D004837	17049862
aline	I-Chemical	-1	17049862
.	O	-1	17049862
The	O	-1	17049862
cardiac	O	-1	17049862
depress@@	O	-1	17049862
ant	O	-1	17049862
ac@@	O	-1	17049862
tions	O	-1	17049862
of	O	-1	17049862
pheny@@	B-Chemical	D010672	17049862
to@@	I-Chemical	-1	17049862
in	I-Chemical	-1	17049862
and	O	-1	17049862
hypo@@	B-Disease	D007035	17049862
ther@@	I-Disease	-1	17049862
mia	I-Disease	-1	17049862
can	O	-1	17049862
be	O	-1	17049862
addi@@	O	-1	17049862
ti@@	O	-1	17049862
ve.	O	-1	17049862
Ad@@	O	-1	17049862
minist@@	O	-1	17049862
ration	O	-1	17049862
of	O	-1	17049862
pheny@@	B-Chemical	D010672	17049862
to@@	I-Chemical	-1	17049862
in	I-Chemical	-1	17049862
in	O	-1	17049862
the	O	-1	17049862
presence	O	-1	17049862
of	O	-1	17049862
hypo@@	B-Disease	D007035	17049862
ther@@	I-Disease	-1	17049862
mia	I-Disease	-1	17049862
may	O	-1	17049862
le@@	O	-1	17049862
ad	O	-1	17049862
to	O	-1	17049862
an	O	-1	17049862
adverse	O	-1	17049862
cardiac	O	-1	17049862
ev@@	O	-1	17049862
ent	O	-1	17049862
in	O	-1	17049862
child@@	O	-1	17049862
ren@@	O	-1	17049862
.	O	-1	17049862
A@@	O	-1	17049862
s	O	-1	17049862
pheny@@	B-Chemical	D010672	17049862
to@@	I-Chemical	-1	17049862
in	I-Chemical	-1	17049862
is	O	-1	17049862
a	O	-1	17049862
common@@	O	-1	17049862
ly	O	-1	17049862
used	O	-1	17049862
drug@@	O	-1	17049862
,	O	-1	17049862
clin@@	O	-1	17049862
ici@@	O	-1	17049862
ans	O	-1	17049862
need	O	-1	17049862
to	O	-1	17049862
be	O	-1	17049862
aw@@	O	-1	17049862
are	O	-1	17049862
of	O	-1	17049862
this	O	-1	17049862
inter@@	O	-1	17049862
ac@@	O	-1	17049862
tion.	O	-1	17049862

A@@	B-Chemical	C012052	16225977
mis@@	I-Chemical	-1	16225977
ul@@	I-Chemical	-1	16225977
pri@@	I-Chemical	-1	16225977
de	I-Chemical	-1	16225977
related	O	-1	16225977
tic@@	B-Disease	D013981	16225977
-@@	I-Disease	-1	16225977
like	I-Disease	-1	16225977
symptoms	I-Disease	-1	16225977
in	O	-1	16225977
an	O	-1	16225977
ad@@	O	-1	16225977
ol@@	O	-1	16225977
es@@	O	-1	16225977
c@@	O	-1	16225977
ent	O	-1	16225977
sch@@	B-Disease	D012559	16225977
iz@@	I-Disease	-1	16225977
oph@@	I-Disease	-1	16225977
ren@@	I-Disease	-1	16225977
ic	I-Disease	-1	16225977
.	O	-1	16225977
T@@	B-Disease	D013981	16225977
ic	I-Disease	-1	16225977
disorder@@	I-Disease	-1	16225977
s	I-Disease	-1	16225977
can	O	-1	16225977
be	O	-1	16225977
eff@@	O	-1	16225977
ectively	O	-1	16225977
treated	O	-1	16225977
by	O	-1	16225977
at@@	O	-1	16225977
yp@@	O	-1	16225977
ical	O	-1	16225977
anti@@	O	-1	16225977
psycho@@	O	-1	16225977
tics	O	-1	16225977
such	O	-1	16225977
as	O	-1	16225977
ris@@	B-Chemical	D018967	16225977
perid@@	I-Chemical	-1	16225977
one	I-Chemical	-1	16225977
,	O	-1	16225977
ol@@	B-Chemical	C076029	16225977
an@@	I-Chemical	-1	16225977
z@@	I-Chemical	-1	16225977
apine	I-Chemical	-1	16225977
and	O	-1	16225977
z@@	B-Chemical	C092292	16225977
ip@@	I-Chemical	-1	16225977
ra@@	I-Chemical	-1	16225977
si@@	I-Chemical	-1	16225977
d@@	I-Chemical	-1	16225977
one	I-Chemical	-1	16225977
.	O	-1	16225977
However,	O	-1	16225977
there	O	-1	16225977
are	O	-1	16225977
two	O	-1	16225977
case	O	-1	16225977
reports	O	-1	16225977
that	O	-1	16225977
show	O	-1	16225977
tic@@	B-Disease	D013981	16225977
-@@	I-Disease	-1	16225977
like	I-Disease	-1	16225977
symptoms	I-Disease	-1	16225977
,	O	-1	16225977
including	O	-1	16225977
motor	O	-1	16225977
and	O	-1	16225977
ph@@	O	-1	16225977
onic	O	-1	16225977
vari@@	O	-1	16225977
ant@@	O	-1	16225977
s,	O	-1	16225977
occur@@	O	-1	16225977
r@@	O	-1	16225977
ing	O	-1	16225977
during	O	-1	16225977
treatment	O	-1	16225977
with	O	-1	16225977
qu@@	B-Chemical	C069541	16225977
e@@	I-Chemical	-1	16225977
ti@@	I-Chemical	-1	16225977
apine	I-Chemical	-1	16225977
or	O	-1	16225977
cloz@@	B-Chemical	D003024	16225977
apine	I-Chemical	-1	16225977
.	O	-1	16225977
We	O	-1	16225977
present	O	-1	16225977
a	O	-1	16225977
1@@	O	-1	16225977
5-@@	O	-1	16225977
year-old	O	-1	16225977
gi@@	O	-1	16225977
r@@	O	-1	16225977
l	O	-1	16225977
sch@@	B-Disease	D012559	16225977
iz@@	I-Disease	-1	16225977
oph@@	I-Disease	-1	16225977
ren@@	I-Disease	-1	16225977
ic	I-Disease	-1	16225977
who	O	-1	16225977
developed	O	-1	16225977
frequent	O	-1	16225977
invol@@	B-Disease	D020820	16225977
un@@	I-Disease	-1	16225977
t@@	I-Disease	-1	16225977
ary	I-Disease	-1	16225977
e@@	I-Disease	-1	16225977
y@@	I-Disease	-1	16225977
e-@@	I-Disease	-1	16225977
bl@@	I-Disease	-1	16225977
in@@	I-Disease	-1	16225977
king	I-Disease	-1	16225977
mo@@	I-Disease	-1	16225977
ve@@	I-Disease	-1	16225977
ments	I-Disease	-1	16225977
after	O	-1	16225977
5	O	-1	16225977
months	O	-1	16225977
of	O	-1	16225977
am@@	B-Chemical	C012052	16225977
is@@	I-Chemical	-1	16225977
ul@@	I-Chemical	-1	16225977
pri@@	I-Chemical	-1	16225977
de	I-Chemical	-1	16225977
treatment	O	-1	16225977
(@@	O	-1	16225977
10@@	O	-1	16225977
00	O	-1	16225977
mg	O	-1	16225977
per	O	-1	16225977
day@@	O	-1	16225977
).	O	-1	16225977
The	O	-1	16225977
tic@@	B-Disease	D013981	16225977
-@@	I-Disease	-1	16225977
like	I-Disease	-1	16225977
symptoms	I-Disease	-1	16225977
resol@@	O	-1	16225977
ved	O	-1	16225977
complete@@	O	-1	16225977
ly	O	-1	16225977
after	O	-1	16225977
we	O	-1	16225977
reduced	O	-1	16225977
the	O	-1	16225977
dose	O	-1	16225977
of	O	-1	16225977
am@@	B-Chemical	C012052	16225977
is@@	I-Chemical	-1	16225977
ul@@	I-Chemical	-1	16225977
pri@@	I-Chemical	-1	16225977
de	I-Chemical	-1	16225977
do@@	O	-1	16225977
w@@	O	-1	16225977
n	O	-1	16225977
to	O	-1	16225977
8@@	O	-1	16225977
00	O	-1	16225977
mg	O	-1	16225977
per	O	-1	16225977
da@@	O	-1	16225977
y.	O	-1	16225977
However,	O	-1	16225977
h@@	O	-1	16225977
er	O	-1	16225977
psycho@@	B-Disease	D011605	16225977
sis	I-Disease	-1	16225977
recur@@	O	-1	16225977
red	O	-1	16225977
after	O	-1	16225977
the	O	-1	16225977
dose	O	-1	16225977
reduc@@	O	-1	16225977
tion.	O	-1	16225977
We	O	-1	16225977
then	O	-1	16225977
pl@@	O	-1	16225977
ac@@	O	-1	16225977
ed	O	-1	16225977
h@@	O	-1	16225977
er	O	-1	16225977
on	O	-1	16225977
an	O	-1	16225977
addi@@	O	-1	16225977
tional	O	-1	16225977
100	O	-1	16225977
mg	O	-1	16225977
per	O	-1	16225977
day	O	-1	16225977
of	O	-1	16225977
qu@@	B-Chemical	C069541	16225977
e@@	I-Chemical	-1	16225977
ti@@	I-Chemical	-1	16225977
apine	I-Chemical	-1	16225977
.	O	-1	16225977
S@@	O	-1	16225977
he	O	-1	16225977
has	O	-1	16225977
been	O	-1	16225977
in	O	-1	16225977
complete	O	-1	16225977
re@@	O	-1	16225977
mission	O	-1	16225977
under	O	-1	16225977
the	O	-1	16225977
combined	O	-1	16225977
medic@@	O	-1	16225977
ations	O	-1	16225977
for	O	-1	16225977
more	O	-1	16225977
than	O	-1	16225977
one	O	-1	16225977
year	O	-1	16225977
and	O	-1	16225977
maint@@	O	-1	16225977
ain@@	O	-1	16225977
s	O	-1	16225977
a	O	-1	16225977
f@@	O	-1	16225977
a@@	O	-1	16225977
ir	O	-1	16225977
role	O	-1	16225977
func@@	O	-1	16225977
tion.	O	-1	16225977
No	O	-1	16225977
more	O	-1	16225977
tic@@	B-Disease	D013981	16225977
-@@	I-Disease	-1	16225977
like	I-Disease	-1	16225977
symptoms	I-Disease	-1	16225977
or	O	-1	16225977
other	O	-1	16225977
side	O	-1	16225977
effects	O	-1	16225977
have	O	-1	16225977
been	O	-1	16225977
repor@@	O	-1	16225977
ted.	O	-1	16225977
T@@	O	-1	16225977
o@@	O	-1	16225977
ge@@	O	-1	16225977
ther	O	-1	16225977
with	O	-1	16225977
previously	O	-1	16225977
reported	O	-1	16225977
cas@@	O	-1	16225977
es,	O	-1	16225977
our	O	-1	16225977
patient	O	-1	16225977
suggests	O	-1	16225977
that	O	-1	16225977
tic@@	B-Disease	D013981	16225977
-@@	I-Disease	-1	16225977
like	I-Disease	-1	16225977
symptoms	I-Disease	-1	16225977
might	O	-1	16225977
occ@@	O	-1	16225977
ur	O	-1	16225977
in	O	-1	16225977
cer@@	O	-1	16225977
t@@	O	-1	16225977
ain	O	-1	16225977
vul@@	O	-1	16225977
ner@@	O	-1	16225977
able	O	-1	16225977
individ@@	O	-1	16225977
u@@	O	-1	16225977
als	O	-1	16225977
during	O	-1	16225977
treatment	O	-1	16225977
with	O	-1	16225977
at@@	O	-1	16225977
yp@@	O	-1	16225977
ical	O	-1	16225977
anti@@	O	-1	16225977
psycho@@	O	-1	16225977
tics	O	-1	16225977
such	O	-1	16225977
as	O	-1	16225977
qu@@	B-Chemical	C069541	16225977
e@@	I-Chemical	-1	16225977
ti@@	I-Chemical	-1	16225977
apine	I-Chemical	-1	16225977
,	O	-1	16225977
cloz@@	B-Chemical	D003024	16225977
apine	I-Chemical	-1	16225977
,	O	-1	16225977
or	O	-1	16225977
am@@	B-Chemical	C012052	16225977
is@@	I-Chemical	-1	16225977
ul@@	I-Chemical	-1	16225977
pri@@	I-Chemical	-1	16225977
de	I-Chemical	-1	16225977
.	O	-1	16225977

Com@@	O	-1	12852481
par@@	O	-1	12852481
ison	O	-1	12852481
of	O	-1	12852481
develop@@	O	-1	12852481
mental	O	-1	12852481
toxic@@	O	-1	12852481
ology	O	-1	12852481
of	O	-1	12852481
as@@	B-Chemical	D001241	12852481
pi@@	I-Chemical	-1	12852481
rin	I-Chemical	-1	12852481
(	O	-1	12852481
acet@@	B-Chemical	D001241	12852481
yl@@	I-Chemical	-1	12852481
sal@@	I-Chemical	-1	12852481
ic@@	I-Chemical	-1	12852481
yl@@	I-Chemical	-1	12852481
ic	I-Chemical	-1	12852481
acid	I-Chemical	-1	12852481
)	O	-1	12852481
in	O	-1	12852481
rats	O	-1	12852481
using	O	-1	12852481
sel@@	O	-1	12852481
ected	O	-1	12852481
dos@@	O	-1	12852481
ing	O	-1	12852481
par@@	O	-1	12852481
a@@	O	-1	12852481
di@@	O	-1	12852481
g@@	O	-1	12852481
m@@	O	-1	12852481
s.	O	-1	12852481
BACKGROUND:	O	-1	12852481
An@@	O	-1	12852481
aly@@	O	-1	12852481
sis	O	-1	12852481
of	O	-1	12852481
the	O	-1	12852481
literat@@	O	-1	12852481
ure	O	-1	12852481
for	O	-1	12852481
non@@	O	-1	12852481
steroid@@	O	-1	12852481
al	O	-1	12852481
anti@@	O	-1	12852481
-@@	O	-1	12852481
inflam@@	O	-1	12852481
mat@@	O	-1	12852481
ory	O	-1	12852481
drugs	O	-1	12852481
(N@@	O	-1	12852481
S@@	O	-1	12852481
A@@	O	-1	12852481
I@@	O	-1	12852481
D@@	O	-1	12852481
s)	O	-1	12852481
suggests	O	-1	12852481
that	O	-1	12852481
a	O	-1	12852481
low	O	-1	12852481
incidence	O	-1	12852481
of	O	-1	12852481
develop@@	B-Disease	D000014	12852481
mental	I-Disease	-1	12852481
an@@	I-Disease	-1	12852481
om@@	I-Disease	-1	12852481
al@@	I-Disease	-1	12852481
i@@	I-Disease	-1	12852481
es	I-Disease	-1	12852481
occur@@	O	-1	12852481
s	O	-1	12852481
in	O	-1	12852481
rats	O	-1	12852481
given	O	-1	12852481
N@@	O	-1	12852481
S@@	O	-1	12852481
A@@	O	-1	12852481
I@@	O	-1	12852481
D@@	O	-1	12852481
s	O	-1	12852481
on	O	-1	12852481
specific	O	-1	12852481
days	O	-1	12852481
during	O	-1	12852481
org@@	O	-1	12852481
an@@	O	-1	12852481
o@@	O	-1	12852481
gene@@	O	-1	12852481
sis.	O	-1	12852481
A@@	B-Chemical	D001241	12852481
s@@	I-Chemical	-1	12852481
pi@@	I-Chemical	-1	12852481
rin	I-Chemical	-1	12852481
(	O	-1	12852481
acet@@	B-Chemical	D001241	12852481
yl@@	I-Chemical	-1	12852481
sal@@	I-Chemical	-1	12852481
ic@@	I-Chemical	-1	12852481
yl@@	I-Chemical	-1	12852481
ic	I-Chemical	-1	12852481
acid	I-Chemical	-1	12852481
[	O	-1	12852481
A@@	B-Chemical	D001241	12852481
S@@	I-Chemical	-1	12852481
A	I-Chemical	-1	12852481
]@@	O	-1	12852481
),	O	-1	12852481
an	O	-1	12852481
ir@@	O	-1	12852481
reversible	O	-1	12852481
cyclo@@	O	-1	12852481
oxy@@	O	-1	12852481
gen@@	O	-1	12852481
ase	O	-1	12852481
1	O	-1	12852481
and	O	-1	12852481
2	O	-1	12852481
inhibitor@@	O	-1	12852481
,	O	-1	12852481
induc@@	O	-1	12852481
es	O	-1	12852481
develop@@	B-Disease	D000014	12852481
mental	I-Disease	-1	12852481
an@@	I-Disease	-1	12852481
om@@	I-Disease	-1	12852481
al@@	I-Disease	-1	12852481
i@@	I-Disease	-1	12852481
es	I-Disease	-1	12852481
when	O	-1	12852481
administered	O	-1	12852481
to	O	-1	12852481
Wistar	O	-1	12852481
rats	O	-1	12852481
on	O	-1	12852481
g@@	O	-1	12852481
est@@	O	-1	12852481
ation@@	O	-1	12852481
al	O	-1	12852481
day	O	-1	12852481
(@@	O	-1	12852481
G@@	O	-1	12852481
D)	O	-1	12852481
9@@	O	-1	12852481
,	O	-1	12852481
10@@	O	-1	12852481
,	O	-1	12852481
or	O	-1	12852481
11	O	-1	12852481
(@@	O	-1	12852481
K@@	O	-1	12852481
im@@	O	-1	12852481
me@@	O	-1	12852481
l	O	-1	12852481
CA@@	O	-1	12852481
,	O	-1	12852481
W@@	O	-1	12852481
il@@	O	-1	12852481
s@@	O	-1	12852481
on	O	-1	12852481
J@@	O	-1	12852481
G@@	O	-1	12852481
,	O	-1	12852481
S@@	O	-1	12852481
ch@@	O	-1	12852481
um@@	O	-1	12852481
ac@@	O	-1	12852481
h@@	O	-1	12852481
er	O	-1	12852481
H@@	O	-1	12852481
J@@	O	-1	12852481
.	O	-1	12852481
T@@	O	-1	12852481
er@@	O	-1	12852481
at@@	O	-1	12852481
ology	O	-1	12852481
4@@	O	-1	12852481
:@@	O	-1	12852481
1@@	O	-1	12852481
5-@@	O	-1	12852481
2@@	O	-1	12852481
4@@	O	-1	12852481
,	O	-1	12852481
19@@	O	-1	12852481
7@@	O	-1	12852481
1).	O	-1	12852481
There	O	-1	12852481
are	O	-1	12852481
no	O	-1	12852481
pu@@	O	-1	12852481
bl@@	O	-1	12852481
ished	O	-1	12852481
A@@	B-Chemical	D001241	12852481
S@@	I-Chemical	-1	12852481
A	I-Chemical	-1	12852481
studies	O	-1	12852481
using	O	-1	12852481
the	O	-1	12852481
multiple	O	-1	12852481
dos@@	O	-1	12852481
ing	O	-1	12852481
par@@	O	-1	12852481
a@@	O	-1	12852481
di@@	O	-1	12852481
g@@	O	-1	12852481
m	O	-1	12852481
of	O	-1	12852481
G@@	O	-1	12852481
D@@	O	-1	12852481
s	O	-1	12852481
6	O	-1	12852481
to	O	-1	12852481
17@@	O	-1	12852481
.	O	-1	12852481
O@@	O	-1	12852481
b@@	O	-1	12852481
j@@	O	-1	12852481
ec@@	O	-1	12852481
tiv@@	O	-1	12852481
es	O	-1	12852481
of	O	-1	12852481
the	O	-1	12852481
current	O	-1	12852481
study	O	-1	12852481
were	O	-1	12852481
to	O	-1	12852481
compar@@	O	-1	12852481
e	O	-1	12852481
results	O	-1	12852481
between	O	-1	12852481
S@@	O	-1	12852481
pra@@	O	-1	12852481
gu@@	O	-1	12852481
e-@@	O	-1	12852481
D@@	O	-1	12852481
aw@@	O	-1	12852481
le@@	O	-1	12852481
y	O	-1	12852481
(S@@	O	-1	12852481
D)	O	-1	12852481
and	O	-1	12852481
Wistar	O	-1	12852481
stra@@	O	-1	12852481
ins	O	-1	12852481
when	O	-1	12852481
A@@	B-Chemical	D001241	12852481
S@@	I-Chemical	-1	12852481
A	I-Chemical	-1	12852481
is	O	-1	12852481
administered	O	-1	12852481
on	O	-1	12852481
G@@	O	-1	12852481
D	O	-1	12852481
9@@	O	-1	12852481
,	O	-1	12852481
10@@	O	-1	12852481
,	O	-1	12852481
or	O	-1	12852481
1@@	O	-1	12852481
1@@	O	-1	12852481
;	O	-1	12852481
to	O	-1	12852481
compar@@	O	-1	12852481
e	O	-1	12852481
the	O	-1	12852481
mal@@	O	-1	12852481
formation	O	-1	12852481
pat@@	O	-1	12852481
tern@@	O	-1	12852481
s	O	-1	12852481
following	O	-1	12852481
single	O	-1	12852481
and	O	-1	12852481
multiple	O	-1	12852481
dos@@	O	-1	12852481
ings	O	-1	12852481
during	O	-1	12852481
org@@	O	-1	12852481
an@@	O	-1	12852481
o@@	O	-1	12852481
genesis	O	-1	12852481
in	O	-1	12852481
S@@	O	-1	12852481
D	O	-1	12852481
rat@@	O	-1	12852481
s;	O	-1	12852481
and	O	-1	12852481
to	O	-1	12852481
test	O	-1	12852481
the	O	-1	12852481
hypo@@	O	-1	12852481
thesis	O	-1	12852481
that	O	-1	12852481
mat@@	O	-1	12852481
er@@	O	-1	12852481
n@@	O	-1	12852481
al	O	-1	12852481
gast@@	B-Disease	D005767	12852481
ro@@	I-Disease	-1	12852481
in@@	I-Disease	-1	12852481
test@@	I-Disease	-1	12852481
inal	I-Disease	-1	12852481
toxicity	I-Disease	-1	12852481
conf@@	O	-1	12852481
oun@@	O	-1	12852481
ds	O	-1	12852481
the	O	-1	12852481
det@@	O	-1	12852481
ection	O	-1	12852481
of	O	-1	12852481
low	O	-1	12852481
incidence	O	-1	12852481
mal@@	B-Disease	D000014	12852481
form@@	I-Disease	-1	12852481
ations	I-Disease	-1	12852481
with	O	-1	12852481
A@@	B-Chemical	D001241	12852481
S@@	I-Chemical	-1	12852481
A	I-Chemical	-1	12852481
when	O	-1	12852481
a	O	-1	12852481
multiple	O	-1	12852481
dos@@	O	-1	12852481
ing	O	-1	12852481
par@@	O	-1	12852481
a@@	O	-1	12852481
di@@	O	-1	12852481
g@@	O	-1	12852481
m	O	-1	12852481
is	O	-1	12852481
use@@	O	-1	12852481
d.	O	-1	12852481
METHODS:	O	-1	12852481
A@@	B-Chemical	D001241	12852481
S@@	I-Chemical	-1	12852481
A	I-Chemical	-1	12852481
was	O	-1	12852481
administered	O	-1	12852481
as	O	-1	12852481
a	O	-1	12852481
single	O	-1	12852481
dose	O	-1	12852481
on	O	-1	12852481
G@@	O	-1	12852481
D	O	-1	12852481
9	O	-1	12852481
(@@	O	-1	12852481
0@@	O	-1	12852481
,	O	-1	12852481
2@@	O	-1	12852481
50@@	O	-1	12852481
,	O	-1	12852481
50@@	O	-1	12852481
0@@	O	-1	12852481
,	O	-1	12852481
or	O	-1	12852481
6@@	O	-1	12852481
25	O	-1	12852481
mg/kg@@	O	-1	12852481
),	O	-1	12852481
10	O	-1	12852481
(@@	O	-1	12852481
0@@	O	-1	12852481
,	O	-1	12852481
50@@	O	-1	12852481
0@@	O	-1	12852481
,	O	-1	12852481
6@@	O	-1	12852481
2@@	O	-1	12852481
5,	O	-1	12852481
or	O	-1	12852481
7@@	O	-1	12852481
50	O	-1	12852481
mg/kg@@	O	-1	12852481
),	O	-1	12852481
or	O	-1	12852481
11	O	-1	12852481
(@@	O	-1	12852481
0@@	O	-1	12852481
,	O	-1	12852481
50@@	O	-1	12852481
0@@	O	-1	12852481
,	O	-1	12852481
7@@	O	-1	12852481
50@@	O	-1	12852481
,	O	-1	12852481
or	O	-1	12852481
10@@	O	-1	12852481
00	O	-1	12852481
mg/kg)	O	-1	12852481
and	O	-1	12852481
from	O	-1	12852481
G@@	O	-1	12852481
D	O	-1	12852481
6	O	-1	12852481
to	O	-1	12852481
G@@	O	-1	12852481
D	O	-1	12852481
17	O	-1	12852481
(@@	O	-1	12852481
0@@	O	-1	12852481
,	O	-1	12852481
50@@	O	-1	12852481
,	O	-1	12852481
12@@	O	-1	12852481
5,	O	-1	12852481
or	O	-1	12852481
2@@	O	-1	12852481
50	O	-1	12852481
mg/kg	O	-1	12852481
a	O	-1	12852481
day@@	O	-1	12852481
)	O	-1	12852481
in	O	-1	12852481
the	O	-1	12852481
multiple	O	-1	12852481
dose	O	-1	12852481
study	O	-1	12852481
to	O	-1	12852481
S@@	O	-1	12852481
D	O	-1	12852481
rats.	O	-1	12852481
An@@	O	-1	12852481
im@@	O	-1	12852481
als	O	-1	12852481
were	O	-1	12852481
k@@	O	-1	12852481
ill@@	O	-1	12852481
ed	O	-1	12852481
on	O	-1	12852481
G@@	O	-1	12852481
D	O	-1	12852481
2@@	O	-1	12852481
1,	O	-1	12852481
and	O	-1	12852481
f@@	O	-1	12852481
et@@	O	-1	12852481
u@@	O	-1	12852481
ses	O	-1	12852481
were	O	-1	12852481
examined	O	-1	12852481
v@@	O	-1	12852481
is@@	O	-1	12852481
cer@@	O	-1	12852481
all@@	O	-1	12852481
y.	O	-1	12852481
RESULTS:	O	-1	12852481
The	O	-1	12852481
literat@@	O	-1	12852481
ure	O	-1	12852481
evalu@@	O	-1	12852481
ation	O	-1	12852481
suggested	O	-1	12852481
that	O	-1	12852481
N@@	O	-1	12852481
S@@	O	-1	12852481
A@@	O	-1	12852481
I@@	O	-1	12852481
D@@	O	-1	12852481
s	O	-1	12852481
induce	O	-1	12852481
ventricular	B-Disease	D006345	12852481
se@@	I-Disease	-1	12852481
pt@@	I-Disease	-1	12852481
al	I-Disease	-1	12852481
def@@	I-Disease	-1	12852481
ects	I-Disease	-1	12852481
(	O	-1	12852481
V@@	B-Disease	D006345	12852481
S@@	I-Disease	-1	12852481
D@@	I-Disease	-1	12852481
s	I-Disease	-1	12852481
)	O	-1	12852481
and	O	-1	12852481
mid@@	B-Disease	D009436	12852481
line	I-Disease	-1	12852481
def@@	I-Disease	-1	12852481
ects	I-Disease	-1	12852481
(	O	-1	12852481
MD@@	B-Disease	D009436	12852481
s	I-Disease	-1	12852481
)	O	-1	12852481
in	O	-1	12852481
rats	O	-1	12852481
and	O	-1	12852481
dia@@	B-Disease	D065630	12852481
ph@@	I-Disease	-1	12852481
ra@@	I-Disease	-1	12852481
g@@	I-Disease	-1	12852481
m@@	I-Disease	-1	12852481
atic	I-Disease	-1	12852481
h@@	I-Disease	-1	12852481
er@@	I-Disease	-1	12852481
n@@	I-Disease	-1	12852481
ia	I-Disease	-1	12852481
(	O	-1	12852481
D@@	B-Disease	D065630	12852481
H	I-Disease	-1	12852481
),	O	-1	12852481
MD@@	B-Disease	D009436	12852481
s	I-Disease	-1	12852481
,	O	-1	12852481
and	O	-1	12852481
V@@	B-Disease	D006345	12852481
S@@	I-Disease	-1	12852481
D@@	I-Disease	-1	12852481
s	I-Disease	-1	12852481
in	O	-1	12852481
ra@@	O	-1	12852481
b@@	O	-1	12852481
b@@	O	-1	12852481
its	O	-1	12852481
(C@@	O	-1	12852481
o@@	O	-1	12852481
o@@	O	-1	12852481
k	O	-1	12852481
J@@	O	-1	12852481
C	O	-1	12852481
et	O	-1	12852481
al@@	O	-1	12852481
.,	O	-1	12852481
20@@	O	-1	12852481
0@@	O	-1	12852481
3@@	O	-1	12852481
);	O	-1	12852481
h@@	O	-1	12852481
ence@@	O	-1	12852481
,	O	-1	12852481
the	O	-1	12852481
present	O	-1	12852481
study	O	-1	12852481
foc@@	O	-1	12852481
used	O	-1	12852481
on	O	-1	12852481
these	O	-1	12852481
mal@@	B-Disease	D000014	12852481
form@@	I-Disease	-1	12852481
ations	I-Disease	-1	12852481
,	O	-1	12852481
even	O	-1	12852481
though	O	-1	12852481
A@@	B-Chemical	D001241	12852481
S@@	I-Chemical	-1	12852481
A	I-Chemical	-1	12852481
induc@@	O	-1	12852481
es	O	-1	12852481
several	O	-1	12852481
other	O	-1	12852481
low@@	O	-1	12852481
-@@	O	-1	12852481
incidence	O	-1	12852481
mal@@	B-Disease	D000014	12852481
form@@	I-Disease	-1	12852481
ations	I-Disease	-1	12852481
.	O	-1	12852481
In	O	-1	12852481
single	O	-1	12852481
dose	O	-1	12852481
studi@@	O	-1	12852481
es,	O	-1	12852481
D@@	B-Disease	D065630	12852481
H	I-Disease	-1	12852481
,	O	-1	12852481
M@@	B-Disease	D009436	12852481
D	I-Disease	-1	12852481
,	O	-1	12852481
and	O	-1	12852481
V@@	B-Disease	D006345	12852481
S@@	I-Disease	-1	12852481
D	I-Disease	-1	12852481
were	O	-1	12852481
induced	O	-1	12852481
on	O	-1	12852481
G@@	O	-1	12852481
D@@	O	-1	12852481
s	O	-1	12852481
9	O	-1	12852481
and	O	-1	12852481
10@@	O	-1	12852481
.	O	-1	12852481
V@@	B-Disease	D006345	12852481
S@@	I-Disease	-1	12852481
D	I-Disease	-1	12852481
also	O	-1	12852481
was	O	-1	12852481
not@@	O	-1	12852481
ed	O	-1	12852481
following	O	-1	12852481
treatment	O	-1	12852481
on	O	-1	12852481
G@@	O	-1	12852481
D	O	-1	12852481
1@@	O	-1	12852481
1@@	O	-1	12852481
.	O	-1	12852481
In	O	-1	12852481
contrast@@	O	-1	12852481
,	O	-1	12852481
D@@	B-Disease	D065630	12852481
H	I-Disease	-1	12852481
and	O	-1	12852481
M@@	B-Disease	D009436	12852481
D	I-Disease	-1	12852481
were	O	-1	12852481
not@@	O	-1	12852481
ed	O	-1	12852481
in	O	-1	12852481
the	O	-1	12852481
multiple	O	-1	12852481
dose	O	-1	12852481
study	O	-1	12852481
desi@@	O	-1	12852481
g@@	O	-1	12852481
n	O	-1	12852481
only	O	-1	12852481
in	O	-1	12852481
the	O	-1	12852481
high-dose	O	-1	12852481
group@@	O	-1	12852481
,	O	-1	12852481
and	O	-1	12852481
V@@	B-Disease	D006345	12852481
S@@	I-Disease	-1	12852481
D	I-Disease	-1	12852481
was	O	-1	12852481
not@@	O	-1	12852481
ed	O	-1	12852481
ac@@	O	-1	12852481
ros@@	O	-1	12852481
s	O	-1	12852481
all	O	-1	12852481
dose	O	-1	12852481
groups.	O	-1	12852481
CONCLUSIONS:	O	-1	12852481
H@@	O	-1	12852481
i@@	O	-1	12852481
gh	O	-1	12852481
con@@	O	-1	12852481
cor@@	O	-1	12852481
d@@	O	-1	12852481
ance	O	-1	12852481
in	O	-1	12852481
major	O	-1	12852481
develop@@	B-Disease	D000014	12852481
mental	I-Disease	-1	12852481
an@@	I-Disease	-1	12852481
om@@	I-Disease	-1	12852481
al@@	I-Disease	-1	12852481
i@@	I-Disease	-1	12852481
es	I-Disease	-1	12852481
between	O	-1	12852481
Wistar	O	-1	12852481
and	O	-1	12852481
S@@	O	-1	12852481
D	O	-1	12852481
rats	O	-1	12852481
were	O	-1	12852481
not@@	O	-1	12852481
ed	O	-1	12852481
with	O	-1	12852481
the	O	-1	12852481
ex@@	O	-1	12852481
ce@@	O	-1	12852481
ption	O	-1	12852481
of	O	-1	12852481
V@@	B-Disease	D006345	12852481
S@@	I-Disease	-1	12852481
D	I-Disease	-1	12852481
in	O	-1	12852481
the	O	-1	12852481
S@@	O	-1	12852481
D	O	-1	12852481
rats	O	-1	12852481
and	O	-1	12852481
hydro@@	B-Disease	D006849	12852481
ce@@	I-Disease	-1	12852481
ph@@	I-Disease	-1	12852481
al@@	I-Disease	-1	12852481
us	I-Disease	-1	12852481
in	O	-1	12852481
the	O	-1	12852481
Wistar	O	-1	12852481
rats.	O	-1	12852481
V@@	O	-1	12852481
ari@@	O	-1	12852481
ations	O	-1	12852481
and	O	-1	12852481
mal@@	B-Disease	D000014	12852481
form@@	I-Disease	-1	12852481
ations	I-Disease	-1	12852481
were	O	-1	12852481
similar	O	-1	12852481
when	O	-1	12852481
A@@	B-Chemical	D001241	12852481
S@@	I-Chemical	-1	12852481
A	I-Chemical	-1	12852481
was	O	-1	12852481
administered	O	-1	12852481
as	O	-1	12852481
a	O	-1	12852481
single	O	-1	12852481
dose	O	-1	12852481
or	O	-1	12852481
during	O	-1	12852481
the	O	-1	12852481
period	O	-1	12852481
of	O	-1	12852481
org@@	O	-1	12852481
an@@	O	-1	12852481
o@@	O	-1	12852481
genesis	O	-1	12852481
(@@	O	-1	12852481
G@@	O	-1	12852481
D@@	O	-1	12852481
s	O	-1	12852481
6	O	-1	12852481
to	O	-1	12852481
17@@	O	-1	12852481
).	O	-1	12852481
It	O	-1	12852481
was	O	-1	12852481
also	O	-1	12852481
ev@@	O	-1	12852481
id@@	O	-1	12852481
ent	O	-1	12852481
th@@	O	-1	12852481
at@@	O	-1	12852481
,	O	-1	12852481
by	O	-1	12852481
ti@@	O	-1	12852481
t@@	O	-1	12852481
rat@@	O	-1	12852481
ing	O	-1	12852481
the	O	-1	12852481
dose	O	-1	12852481
to	O	-1	12852481
achi@@	O	-1	12852481
e@@	O	-1	12852481
ve	O	-1	12852481
a	O	-1	12852481
maxim@@	O	-1	12852481
um	O	-1	12852481
toler@@	O	-1	12852481
ated	O	-1	12852481
dose@@	O	-1	12852481
,	O	-1	12852481
mal@@	B-Disease	D000014	12852481
form@@	I-Disease	-1	12852481
ations	I-Disease	-1	12852481
that	O	-1	12852481
norm@@	O	-1	12852481
ally	O	-1	12852481
occ@@	O	-1	12852481
ur	O	-1	12852481
at	O	-1	12852481
low	O	-1	12852481
inc@@	O	-1	12852481
id@@	O	-1	12852481
ence@@	O	-1	12852481
,	O	-1	12852481
as	O	-1	12852481
reported	O	-1	12852481
from	O	-1	12852481
previ@@	O	-1	12852481
ous	O	-1	12852481
single	O	-1	12852481
dose	O	-1	12852481
studi@@	O	-1	12852481
es,	O	-1	12852481
could	O	-1	12852481
also	O	-1	12852481
be	O	-1	12852481
induced	O	-1	12852481
with	O	-1	12852481
A@@	B-Chemical	D001241	12852481
S@@	I-Chemical	-1	12852481
A	I-Chemical	-1	12852481
given	O	-1	12852481
at	O	-1	12852481
multiple	O	-1	12852481
dos@@	O	-1	12852481
es.	O	-1	12852481

T@@	B-Disease	D016171	11858397
or@@	I-Disease	-1	11858397
s@@	I-Disease	-1	11858397
ade	I-Disease	-1	11858397
de	I-Disease	-1	11858397
po@@	I-Disease	-1	11858397
int@@	I-Disease	-1	11858397
es	I-Disease	-1	11858397
induced	O	-1	11858397
by	O	-1	11858397
met@@	B-Chemical	D008787	11858397
oc@@	I-Chemical	-1	11858397
lop@@	I-Chemical	-1	11858397
ram@@	I-Chemical	-1	11858397
ide	I-Chemical	-1	11858397
in	O	-1	11858397
an	O	-1	11858397
el@@	O	-1	11858397
der@@	O	-1	11858397
ly	O	-1	11858397
woman	O	-1	11858397
with	O	-1	11858397
pre@@	O	-1	11858397
ex@@	O	-1	11858397
ist@@	O	-1	11858397
ing	O	-1	11858397
complete	O	-1	11858397
left	B-Disease	D002037	11858397
b@@	I-Disease	-1	11858397
und@@	I-Disease	-1	11858397
le	I-Disease	-1	11858397
b@@	I-Disease	-1	11858397
ran@@	I-Disease	-1	11858397
ch	I-Disease	-1	11858397
bloc@@	I-Disease	-1	11858397
k	I-Disease	-1	11858397
.	O	-1	11858397
There	O	-1	11858397
is	O	-1	11858397
a	O	-1	11858397
grow@@	O	-1	11858397
ing	O	-1	11858397
l@@	O	-1	11858397
ist	O	-1	11858397
of	O	-1	11858397
drugs	O	-1	11858397
implic@@	O	-1	11858397
ated	O	-1	11858397
in	O	-1	11858397
ac@@	O	-1	11858397
qu@@	O	-1	11858397
ired	O	-1	11858397
lon@@	B-Disease	D008133	11858397
g	I-Disease	-1	11858397
Q@@	I-Disease	-1	11858397
T	I-Disease	-1	11858397
syndrome	I-Disease	-1	11858397
and	O	-1	11858397
t@@	B-Disease	D016171	11858397
or@@	I-Disease	-1	11858397
s@@	I-Disease	-1	11858397
ade	I-Disease	-1	11858397
de	I-Disease	-1	11858397
po@@	I-Disease	-1	11858397
int@@	I-Disease	-1	11858397
es	I-Disease	-1	11858397
.	O	-1	11858397
However,	O	-1	11858397
the	O	-1	11858397
t@@	O	-1	11858397
or@@	O	-1	11858397
s@@	O	-1	11858397
ad@@	O	-1	11858397
o@@	O	-1	11858397
genic	O	-1	11858397
potential	O	-1	11858397
of	O	-1	11858397
met@@	B-Chemical	D008787	11858397
oc@@	I-Chemical	-1	11858397
lop@@	I-Chemical	-1	11858397
ram@@	I-Chemical	-1	11858397
ide	I-Chemical	-1	11858397
,	O	-1	11858397
a	O	-1	11858397
common@@	O	-1	11858397
ly	O	-1	11858397
used	O	-1	11858397
anti@@	O	-1	11858397
e@@	O	-1	11858397
me@@	O	-1	11858397
tic	O	-1	11858397
and	O	-1	11858397
pro@@	O	-1	11858397
kine@@	O	-1	11858397
tic	O	-1	11858397
drug@@	O	-1	11858397
,	O	-1	11858397
has	O	-1	11858397
not	O	-1	11858397
been	O	-1	11858397
reported	O	-1	11858397
in	O	-1	11858397
the	O	-1	11858397
literat@@	O	-1	11858397
ure,	O	-1	11858397
des@@	O	-1	11858397
pit@@	O	-1	11858397
e	O	-1	11858397
its	O	-1	11858397
chemical	O	-1	11858397
simil@@	O	-1	11858397
ar@@	O	-1	11858397
ity	O	-1	11858397
to	O	-1	11858397
pro@@	B-Chemical	D011342	11858397
ca@@	I-Chemical	-1	11858397
in@@	I-Chemical	-1	11858397
amide	I-Chemical	-1	11858397
.	O	-1	11858397
We	O	-1	11858397
report	O	-1	11858397
on	O	-1	11858397
a	O	-1	11858397
9@@	O	-1	11858397
2-@@	O	-1	11858397
year-old	O	-1	11858397
woman	O	-1	11858397
with	O	-1	11858397
pre@@	O	-1	11858397
ex@@	O	-1	11858397
ist@@	O	-1	11858397
ing	O	-1	11858397
complete	O	-1	11858397
left	B-Disease	D002037	11858397
b@@	I-Disease	-1	11858397
und@@	I-Disease	-1	11858397
le	I-Disease	-1	11858397
b@@	I-Disease	-1	11858397
ran@@	I-Disease	-1	11858397
ch	I-Disease	-1	11858397
bloc@@	I-Disease	-1	11858397
k	I-Disease	-1	11858397
who	O	-1	11858397
developed	O	-1	11858397
t@@	B-Disease	D016171	11858397
or@@	I-Disease	-1	11858397
s@@	I-Disease	-1	11858397
ade	I-Disease	-1	11858397
de	I-Disease	-1	11858397
po@@	I-Disease	-1	11858397
int@@	I-Disease	-1	11858397
es	I-Disease	-1	11858397
after	O	-1	11858397
intravenous	O	-1	11858397
and	O	-1	11858397
oral	O	-1	11858397
administration	O	-1	11858397
of	O	-1	11858397
met@@	B-Chemical	D008787	11858397
oc@@	I-Chemical	-1	11858397
lop@@	I-Chemical	-1	11858397
ram@@	I-Chemical	-1	11858397
ide	I-Chemical	-1	11858397
.	O	-1	11858397
This	O	-1	11858397
patient	O	-1	11858397
also	O	-1	11858397
developed	O	-1	11858397
t@@	B-Disease	D016171	11858397
or@@	I-Disease	-1	11858397
s@@	I-Disease	-1	11858397
ade	I-Disease	-1	11858397
de	I-Disease	-1	11858397
po@@	I-Disease	-1	11858397
int@@	I-Disease	-1	11858397
es	I-Disease	-1	11858397
when	O	-1	11858397
cis@@	B-Chemical	D020117	11858397
apri@@	I-Chemical	-1	11858397
de	I-Chemical	-1	11858397
and	O	-1	11858397
ery@@	B-Chemical	D004917	11858397
throm@@	I-Chemical	-1	11858397
ycin	I-Chemical	-1	11858397
were	O	-1	11858397
given	O	-1	11858397
sim@@	O	-1	11858397
ult@@	O	-1	11858397
ane@@	O	-1	11858397
ous@@	O	-1	11858397
ly.	O	-1	11858397
These	O	-1	11858397
two	O	-1	11858397
episo@@	O	-1	11858397
des	O	-1	11858397
were	O	-1	11858397
sup@@	O	-1	11858397
press@@	O	-1	11858397
ed	O	-1	11858397
suc@@	O	-1	11858397
cess@@	O	-1	11858397
ful@@	O	-1	11858397
ly	O	-1	11858397
after	O	-1	11858397
discontinu@@	O	-1	11858397
ing	O	-1	11858397
the	O	-1	11858397
o@@	O	-1	11858397
ff@@	O	-1	11858397
en@@	O	-1	11858397
ding	O	-1	11858397
drugs	O	-1	11858397
and	O	-1	11858397
administ@@	O	-1	11858397
ering	O	-1	11858397
cl@@	O	-1	11858397
as@@	O	-1	11858397
s	O	-1	11858397
I@@	O	-1	11858397
B	O	-1	11858397
drug@@	O	-1	11858397
s.	O	-1	11858397
This	O	-1	11858397
is	O	-1	11858397
the	O	-1	11858397
first	O	-1	11858397
doc@@	O	-1	11858397
um@@	O	-1	11858397
ent@@	O	-1	11858397
ation	O	-1	11858397
that	O	-1	11858397
met@@	B-Chemical	D008787	11858397
oc@@	I-Chemical	-1	11858397
lop@@	I-Chemical	-1	11858397
ram@@	I-Chemical	-1	11858397
ide	I-Chemical	-1	11858397
prov@@	O	-1	11858397
o@@	O	-1	11858397
k@@	O	-1	11858397
es	O	-1	11858397
t@@	B-Disease	D016171	11858397
or@@	I-Disease	-1	11858397
s@@	I-Disease	-1	11858397
ade	I-Disease	-1	11858397
de	I-Disease	-1	11858397
po@@	I-Disease	-1	11858397
int@@	I-Disease	-1	11858397
es	I-Disease	-1	11858397
clin@@	O	-1	11858397
ic@@	O	-1	11858397
all@@	O	-1	11858397
y.	O	-1	11858397
M@@	B-Chemical	D008787	11858397
et@@	I-Chemical	-1	11858397
oc@@	I-Chemical	-1	11858397
lop@@	I-Chemical	-1	11858397
ram@@	I-Chemical	-1	11858397
ide	I-Chemical	-1	11858397
should	O	-1	11858397
be	O	-1	11858397
used	O	-1	11858397
cau@@	O	-1	11858397
ti@@	O	-1	11858397
ously	O	-1	11858397
in	O	-1	11858397
patients	O	-1	11858397
with	O	-1	11858397
a	O	-1	11858397
risk	O	-1	11858397
of	O	-1	11858397
t@@	B-Disease	D016171	11858397
or@@	I-Disease	-1	11858397
s@@	I-Disease	-1	11858397
ade	I-Disease	-1	11858397
de	I-Disease	-1	11858397
po@@	I-Disease	-1	11858397
int@@	I-Disease	-1	11858397
es	I-Disease	-1	11858397
.	O	-1	11858397

A@@	B-Chemical	D001058	11009181
po@@	I-Chemical	-1	11009181
morphine	I-Chemical	-1	11009181
:	O	-1	11009181
an	O	-1	11009181
under@@	O	-1	11009181
u@@	O	-1	11009181
ti@@	O	-1	11009181
li@@	O	-1	11009181
zed	O	-1	11009181
therapy	O	-1	11009181
for	O	-1	11009181
Parkinson's	B-Disease	D010300	11009181
disease	I-Disease	-1	11009181
.	O	-1	11009181
A@@	B-Chemical	D001058	11009181
po@@	I-Chemical	-1	11009181
morphine	I-Chemical	-1	11009181
was	O	-1	11009181
the	O	-1	11009181
first	O	-1	11009181
dop@@	O	-1	11009181
aminergic	O	-1	11009181
drug	O	-1	11009181
ev@@	O	-1	11009181
er	O	-1	11009181
used	O	-1	11009181
to	O	-1	11009181
tre@@	O	-1	11009181
at	O	-1	11009181
symptoms	O	-1	11009181
of	O	-1	11009181
Parkinson's	B-Disease	D010300	11009181
disease	I-Disease	-1	11009181
.	O	-1	11009181
W@@	O	-1	11009181
h@@	O	-1	11009181
ile	O	-1	11009181
po@@	O	-1	11009181
w@@	O	-1	11009181
er@@	O	-1	11009181
ful	O	-1	11009181
anti@@	O	-1	11009181
par@@	O	-1	11009181
k@@	O	-1	11009181
inson@@	O	-1	11009181
i@@	O	-1	11009181
an	O	-1	11009181
effects	O	-1	11009181
had	O	-1	11009181
been	O	-1	11009181
observed	O	-1	11009181
as	O	-1	11009181
early	O	-1	11009181
as	O	-1	11009181
19@@	O	-1	11009181
5@@	O	-1	11009181
1,	O	-1	11009181
the	O	-1	11009181
potential	O	-1	11009181
of	O	-1	11009181
treat@@	O	-1	11009181
ing	O	-1	11009181
f@@	O	-1	11009181
l@@	O	-1	11009181
uc@@	O	-1	11009181
tu@@	O	-1	11009181
ating	O	-1	11009181
Parkinson's	B-Disease	D010300	11009181
disease	I-Disease	-1	11009181
by	O	-1	11009181
sub@@	O	-1	11009181
c@@	O	-1	11009181
utaneous	O	-1	11009181
administration	O	-1	11009181
of	O	-1	11009181
apo@@	B-Chemical	D001058	11009181
morphine	I-Chemical	-1	11009181
has	O	-1	11009181
only	O	-1	11009181
rec@@	O	-1	11009181
ently	O	-1	11009181
b@@	O	-1	11009181
ec@@	O	-1	11009181
ome	O	-1	11009181
the	O	-1	11009181
subj@@	O	-1	11009181
ect	O	-1	11009181
of	O	-1	11009181
system@@	O	-1	11009181
atic	O	-1	11009181
study.	O	-1	11009181
A	O	-1	11009181
number	O	-1	11009181
of	O	-1	11009181
sm@@	O	-1	11009181
all	O	-1	11009181
s@@	O	-1	11009181
cal@@	O	-1	11009181
e	O	-1	11009181
clinical	O	-1	11009181
tri@@	O	-1	11009181
als	O	-1	11009181
have	O	-1	11009181
un@@	O	-1	11009181
equ@@	O	-1	11009181
i@@	O	-1	11009181
v@@	O	-1	11009181
oc@@	O	-1	11009181
ally	O	-1	11009181
shown	O	-1	11009181
that	O	-1	11009181
inter@@	O	-1	11009181
mit@@	O	-1	11009181
t@@	O	-1	11009181
ent	O	-1	11009181
sub@@	O	-1	11009181
c@@	O	-1	11009181
utaneous	O	-1	11009181
apo@@	B-Chemical	D001058	11009181
morphine	I-Chemical	-1	11009181
injec@@	O	-1	11009181
tions	O	-1	11009181
produce	O	-1	11009181
anti@@	O	-1	11009181
par@@	O	-1	11009181
k@@	O	-1	11009181
inson@@	O	-1	11009181
i@@	O	-1	11009181
an	O	-1	11009181
ben@@	O	-1	11009181
e@@	O	-1	11009181
fi@@	O	-1	11009181
t	O	-1	11009181
clo@@	O	-1	11009181
se	O	-1	11009181
if	O	-1	11009181
not	O	-1	11009181
id@@	O	-1	11009181
en@@	O	-1	11009181
tical	O	-1	11009181
to	O	-1	11009181
that	O	-1	11009181
seen	O	-1	11009181
with	O	-1	11009181
levo@@	B-Chemical	D007980	11009181
dopa	I-Chemical	-1	11009181
and	O	-1	11009181
that	O	-1	11009181
apo@@	B-Chemical	D001058	11009181
morphine	I-Chemical	-1	11009181
res@@	O	-1	11009181
c@@	O	-1	11009181
u@@	O	-1	11009181
e	O	-1	11009181
injec@@	O	-1	11009181
tions	O	-1	11009181
can	O	-1	11009181
re@@	O	-1	11009181
li@@	O	-1	11009181
ably	O	-1	11009181
rever@@	O	-1	11009181
t	O	-1	11009181
o@@	O	-1	11009181
ff@@	O	-1	11009181
-@@	O	-1	11009181
perio@@	O	-1	11009181
ds	O	-1	11009181
even	O	-1	11009181
in	O	-1	11009181
patients	O	-1	11009181
with	O	-1	11009181
comple@@	O	-1	11009181
x	O	-1	11009181
on@@	O	-1	11009181
-@@	O	-1	11009181
of@@	O	-1	11009181
f	O	-1	11009181
motor	O	-1	11009181
s@@	O	-1	11009181
w@@	O	-1	11009181
ing@@	O	-1	11009181
s.	O	-1	11009181
C@@	O	-1	11009181
ont@@	O	-1	11009181
in@@	O	-1	11009181
u@@	O	-1	11009181
ous	O	-1	11009181
sub@@	O	-1	11009181
c@@	O	-1	11009181
utaneous	O	-1	11009181
apo@@	B-Chemical	D001058	11009181
morphine	I-Chemical	-1	11009181
infu@@	O	-1	11009181
sions	O	-1	11009181
can	O	-1	11009181
re@@	O	-1	11009181
duce	O	-1	11009181
daily	O	-1	11009181
o@@	O	-1	11009181
ff@@	O	-1	11009181
-@@	O	-1	11009181
time	O	-1	11009181
by	O	-1	11009181
more	O	-1	11009181
than	O	-1	11009181
50@@	O	-1	11009181
%	O	-1	11009181
in	O	-1	11009181
this	O	-1	11009181
group	O	-1	11009181
of	O	-1	11009181
patients,	O	-1	11009181
which	O	-1	11009181
appear@@	O	-1	11009181
s	O	-1	11009181
to	O	-1	11009181
be	O	-1	11009181
a	O	-1	11009181
st@@	O	-1	11009181
ron@@	O	-1	11009181
g@@	O	-1	11009181
er	O	-1	11009181
effect	O	-1	11009181
than	O	-1	11009181
that	O	-1	11009181
gener@@	O	-1	11009181
ally	O	-1	11009181
seen	O	-1	11009181
with	O	-1	11009181
ad@@	O	-1	11009181
d-@@	O	-1	11009181
on	O	-1	11009181
therapy	O	-1	11009181
with	O	-1	11009181
oral	O	-1	11009181
dopamine	B-Chemical	D004298	11009181
agon@@	O	-1	11009181
ist@@	O	-1	11009181
s	O	-1	11009181
or	O	-1	11009181
CO@@	O	-1	11009181
M@@	O	-1	11009181
T	O	-1	11009181
inhibitor@@	O	-1	11009181
s.	O	-1	11009181
E@@	O	-1	11009181
x@@	O	-1	11009181
ten@@	O	-1	11009181
ded	O	-1	11009181
follow-up	O	-1	11009181
studies	O	-1	11009181
of	O	-1	11009181
up	O	-1	11009181
to	O	-1	11009181
8	O	-1	11009181
years	O	-1	11009181
have	O	-1	11009181
demonstrated	O	-1	11009181
long-term	O	-1	11009181
per@@	O	-1	11009181
sist@@	O	-1	11009181
ence	O	-1	11009181
of	O	-1	11009181
apo@@	B-Chemical	D001058	11009181
morphine	I-Chemical	-1	11009181
efficac@@	O	-1	11009181
y.	O	-1	11009181
In	O	-1	11009181
addi@@	O	-1	11009181
tion,	O	-1	11009181
there	O	-1	11009181
is	O	-1	11009181
con@@	O	-1	11009181
v@@	O	-1	11009181
inc@@	O	-1	11009181
ing	O	-1	11009181
clinical	O	-1	11009181
evidence	O	-1	11009181
that	O	-1	11009181
mon@@	O	-1	11009181
o@@	O	-1	11009181
therapy	O	-1	11009181
with	O	-1	11009181
continu@@	O	-1	11009181
ous	O	-1	11009181
sub@@	O	-1	11009181
c@@	O	-1	11009181
utaneous	O	-1	11009181
apo@@	B-Chemical	D001058	11009181
morphine	I-Chemical	-1	11009181
infu@@	O	-1	11009181
sions	O	-1	11009181
is	O	-1	11009181
associated	O	-1	11009181
with	O	-1	11009181
mark@@	O	-1	11009181
ed	O	-1	11009181
reduc@@	O	-1	11009181
tions	O	-1	11009181
of	O	-1	11009181
pre@@	O	-1	11009181
ex@@	O	-1	11009181
ist@@	O	-1	11009181
ing	O	-1	11009181
levo@@	B-Chemical	D007980	11009181
dopa	I-Chemical	-1	11009181
-induced	O	-1	11009181
dyskine@@	B-Disease	D004409	11009181
si@@	I-Disease	-1	11009181
as	I-Disease	-1	11009181
.	O	-1	11009181
The	O	-1	11009181
ma@@	O	-1	11009181
in	O	-1	11009181
side	O	-1	11009181
effects	O	-1	11009181
of	O	-1	11009181
sub@@	O	-1	11009181
c@@	O	-1	11009181
utaneous	O	-1	11009181
apo@@	B-Chemical	D001058	11009181
morphine	I-Chemical	-1	11009181
treatment	O	-1	11009181
are	O	-1	11009181
related	O	-1	11009181
to	O	-1	11009181
c@@	O	-1	11009181
utaneous	O	-1	11009181
toler@@	O	-1	11009181
ability	O	-1	11009181
pro@@	O	-1	11009181
ble@@	O	-1	11009181
m@@	O	-1	11009181
s,	O	-1	11009181
whereas	O	-1	11009181
sed@@	O	-1	11009181
ation	O	-1	11009181
and	O	-1	11009181
psych@@	B-Disease	D001523	11009181
i@@	I-Disease	-1	11009181
atric	I-Disease	-1	11009181
complications	O	-1	11009181
pl@@	O	-1	11009181
ay	O	-1	11009181
a	O	-1	11009181
l@@	O	-1	11009181
ess@@	O	-1	11009181
er	O	-1	11009181
ro@@	O	-1	11009181
le@@	O	-1	11009181
.	O	-1	11009181
G@@	O	-1	11009181
i@@	O	-1	11009181
ven	O	-1	11009181
the	O	-1	11009181
mark@@	O	-1	11009181
ed	O	-1	11009181
de@@	O	-1	11009181
g@@	O	-1	11009181
ree	O	-1	11009181
of	O	-1	11009181
efficacy	O	-1	11009181
of	O	-1	11009181
sub@@	O	-1	11009181
c@@	O	-1	11009181
utaneous	O	-1	11009181
apo@@	B-Chemical	D001058	11009181
morphine	I-Chemical	-1	11009181
treatment	O	-1	11009181
in	O	-1	11009181
f@@	O	-1	11009181
l@@	O	-1	11009181
uc@@	O	-1	11009181
tu@@	O	-1	11009181
ating	O	-1	11009181
Parkinson's	B-Disease	D010300	11009181
disease	I-Disease	-1	11009181
,	O	-1	11009181
this	O	-1	11009181
appro@@	O	-1	11009181
ach	O	-1	11009181
se@@	O	-1	11009181
em@@	O	-1	11009181
s	O	-1	11009181
to	O	-1	11009181
des@@	O	-1	11009181
er@@	O	-1	11009181
ve	O	-1	11009181
more	O	-1	11009181
w@@	O	-1	11009181
id@@	O	-1	11009181
es@@	O	-1	11009181
pre@@	O	-1	11009181
ad	O	-1	11009181
clinical	O	-1	11009181
use.	O	-1	11009181

F@@	O	-1	8988571
atal	O	-1	8988571
ex@@	O	-1	8988571
c@@	O	-1	8988571
ited	O	-1	8988571
de@@	B-Disease	D003693	8988571
li@@	I-Disease	-1	8988571
ri@@	I-Disease	-1	8988571
um	I-Disease	-1	8988571
following	O	-1	8988571
cocaine	B-Chemical	D003042	8988571
use@@	O	-1	8988571
:	O	-1	8988571
epi@@	O	-1	8988571
de@@	O	-1	8988571
m@@	O	-1	8988571
io@@	O	-1	8988571
log@@	O	-1	8988571
ic	O	-1	8988571
findings	O	-1	8988571
prov@@	O	-1	8988571
ide	O	-1	8988571
new	O	-1	8988571
evidence	O	-1	8988571
for	O	-1	8988571
mechanisms	O	-1	8988571
of	O	-1	8988571
cocaine	B-Chemical	D003042	8988571
toxicity	B-Disease	D064420	8988571
.	O	-1	8988571
We	O	-1	8988571
describe	O	-1	8988571
an	O	-1	8988571
out@@	O	-1	8988571
b@@	O	-1	8988571
re@@	O	-1	8988571
a@@	O	-1	8988571
k	O	-1	8988571
of	O	-1	8988571
de@@	O	-1	8988571
ath@@	O	-1	8988571
s	O	-1	8988571
from	O	-1	8988571
cocaine	B-Chemical	D003042	8988571
-induced	O	-1	8988571
ex@@	O	-1	8988571
c@@	O	-1	8988571
ited	O	-1	8988571
de@@	B-Disease	D003693	8988571
li@@	I-Disease	-1	8988571
ri@@	I-Disease	-1	8988571
um	I-Disease	-1	8988571
(	O	-1	8988571
E@@	B-Disease	D003693	8988571
D@@	I-Disease	-1	8988571
D@@	I-Disease	-1	8988571
s	I-Disease	-1	8988571
)	O	-1	8988571
in	O	-1	8988571
D@@	O	-1	8988571
ade	O	-1	8988571
C@@	O	-1	8988571
oun@@	O	-1	8988571
t@@	O	-1	8988571
y,	O	-1	8988571
F@@	O	-1	8988571
lor@@	O	-1	8988571
id@@	O	-1	8988571
a	O	-1	8988571
between	O	-1	8988571
19@@	O	-1	8988571
7@@	O	-1	8988571
9	O	-1	8988571
and	O	-1	8988571
19@@	O	-1	8988571
9@@	O	-1	8988571
0@@	O	-1	8988571
.	O	-1	8988571
F@@	O	-1	8988571
rom	O	-1	8988571
a	O	-1	8988571
reg@@	O	-1	8988571
ist@@	O	-1	8988571
r@@	O	-1	8988571
y	O	-1	8988571
of	O	-1	8988571
all	O	-1	8988571
cocaine	B-Chemical	D003042	8988571
-@@	O	-1	8988571
related	O	-1	8988571
de@@	O	-1	8988571
ath@@	O	-1	8988571
s	O	-1	8988571
in	O	-1	8988571
D@@	O	-1	8988571
ade	O	-1	8988571
C@@	O	-1	8988571
oun@@	O	-1	8988571
t@@	O	-1	8988571
y,	O	-1	8988571
F@@	O	-1	8988571
lor@@	O	-1	8988571
id@@	O	-1	8988571
a,	O	-1	8988571
from	O	-1	8988571
19@@	O	-1	8988571
6@@	O	-1	8988571
9@@	O	-1	8988571
-1@@	O	-1	8988571
9@@	O	-1	8988571
9@@	O	-1	8988571
0@@	O	-1	8988571
,	O	-1	8988571
5@@	O	-1	8988571
8	O	-1	8988571
E@@	B-Disease	D003693	8988571
D@@	I-Disease	-1	8988571
D@@	I-Disease	-1	8988571
s	I-Disease	-1	8988571
were	O	-1	8988571
compared	O	-1	8988571
with	O	-1	8988571
12@@	O	-1	8988571
5	O	-1	8988571
v@@	O	-1	8988571
ic@@	O	-1	8988571
tim@@	O	-1	8988571
s	O	-1	8988571
of	O	-1	8988571
ac@@	O	-1	8988571
c@@	O	-1	8988571
id@@	O	-1	8988571
ental	O	-1	8988571
cocaine	B-Chemical	D003042	8988571
over@@	B-Disease	D062787	8988571
dose	I-Disease	-1	8988571
without	O	-1	8988571
ex@@	O	-1	8988571
c@@	O	-1	8988571
ited	O	-1	8988571
de@@	B-Disease	D003693	8988571
li@@	I-Disease	-1	8988571
ri@@	I-Disease	-1	8988571
um	I-Disease	-1	8988571
.	O	-1	8988571
Com@@	O	-1	8988571
pared	O	-1	8988571
with	O	-1	8988571
control@@	O	-1	8988571
s,	O	-1	8988571
E@@	B-Disease	D003693	8988571
D@@	I-Disease	-1	8988571
D@@	I-Disease	-1	8988571
s	I-Disease	-1	8988571
were	O	-1	8988571
more	O	-1	8988571
frequ@@	O	-1	8988571
ently	O	-1	8988571
bl@@	O	-1	8988571
ac@@	O	-1	8988571
k@@	O	-1	8988571
,	O	-1	8988571
mal@@	O	-1	8988571
e,	O	-1	8988571
and	O	-1	8988571
youn@@	O	-1	8988571
g@@	O	-1	8988571
er.	O	-1	8988571
The@@	O	-1	8988571
y	O	-1	8988571
were	O	-1	8988571
less	O	-1	8988571
likely	O	-1	8988571
to	O	-1	8988571
have	O	-1	8988571
a	O	-1	8988571
low	O	-1	8988571
body	O	-1	8988571
mas@@	O	-1	8988571
s	O	-1	8988571
in@@	O	-1	8988571
de@@	O	-1	8988571
x@@	O	-1	8988571
,	O	-1	8988571
and	O	-1	8988571
more	O	-1	8988571
likely	O	-1	8988571
to	O	-1	8988571
have	O	-1	8988571
di@@	O	-1	8988571
ed	O	-1	8988571
in	O	-1	8988571
pol@@	O	-1	8988571
ic@@	O	-1	8988571
e	O	-1	8988571
c@@	O	-1	8988571
u@@	O	-1	8988571
sto@@	O	-1	8988571
d@@	O	-1	8988571
y,	O	-1	8988571
to	O	-1	8988571
have	O	-1	8988571
received	O	-1	8988571
med@@	O	-1	8988571
ical	O	-1	8988571
treatment	O	-1	8988571
immedi@@	O	-1	8988571
ately	O	-1	8988571
before	O	-1	8988571
de@@	O	-1	8988571
ath@@	O	-1	8988571
,	O	-1	8988571
to	O	-1	8988571
have	O	-1	8988571
sur@@	O	-1	8988571
vi@@	O	-1	8988571
ved	O	-1	8988571
for	O	-1	8988571
a	O	-1	8988571
long@@	O	-1	8988571
er	O	-1	8988571
perio@@	O	-1	8988571
d,	O	-1	8988571
to	O	-1	8988571
have	O	-1	8988571
developed	O	-1	8988571
hyper@@	B-Disease	D005334	8988571
ther@@	I-Disease	-1	8988571
mia	I-Disease	-1	8988571
,	O	-1	8988571
and	O	-1	8988571
to	O	-1	8988571
have	O	-1	8988571
di@@	O	-1	8988571
ed	O	-1	8988571
in	O	-1	8988571
su@@	O	-1	8988571
mm@@	O	-1	8988571
er	O	-1	8988571
months.	O	-1	8988571
E@@	B-Disease	D003693	8988571
D@@	I-Disease	-1	8988571
D@@	I-Disease	-1	8988571
s	I-Disease	-1	8988571
had	O	-1	8988571
concentrations	O	-1	8988571
of	O	-1	8988571
cocaine	B-Chemical	D003042	8988571
and	O	-1	8988571
b@@	B-Chemical	C005618	8988571
enz@@	I-Chemical	-1	8988571
o@@	I-Chemical	-1	8988571
yl@@	I-Chemical	-1	8988571
ec@@	I-Chemical	-1	8988571
g@@	I-Chemical	-1	8988571
on@@	I-Chemical	-1	8988571
ine	I-Chemical	-1	8988571
in	O	-1	8988571
auto@@	O	-1	8988571
p@@	O	-1	8988571
sy	O	-1	8988571
blood	O	-1	8988571
that	O	-1	8988571
were	O	-1	8988571
similar	O	-1	8988571
to	O	-1	8988571
those	O	-1	8988571
for	O	-1	8988571
controls.	O	-1	8988571
The	O	-1	8988571
epi@@	O	-1	8988571
de@@	O	-1	8988571
m@@	O	-1	8988571
io@@	O	-1	8988571
log@@	O	-1	8988571
ic	O	-1	8988571
findings	O	-1	8988571
are	O	-1	8988571
most	O	-1	8988571
consist@@	O	-1	8988571
ent	O	-1	8988571
with	O	-1	8988571
the	O	-1	8988571
hypo@@	O	-1	8988571
thesis	O	-1	8988571
that	O	-1	8988571
chronic	O	-1	8988571
cocaine	B-Chemical	D003042	8988571
use	O	-1	8988571
dis@@	O	-1	8988571
ru@@	O	-1	8988571
pt@@	O	-1	8988571
s	O	-1	8988571
dop@@	O	-1	8988571
aminergic	O	-1	8988571
function	O	-1	8988571
and@@	O	-1	8988571
,	O	-1	8988571
when	O	-1	8988571
co@@	O	-1	8988571
u@@	O	-1	8988571
pl@@	O	-1	8988571
ed	O	-1	8988571
with	O	-1	8988571
rec@@	O	-1	8988571
ent	O	-1	8988571
cocaine	B-Chemical	D003042	8988571
use@@	O	-1	8988571
,	O	-1	8988571
may	O	-1	8988571
pre@@	O	-1	8988571
ci@@	O	-1	8988571
pit@@	O	-1	8988571
ate	O	-1	8988571
ag@@	B-Disease	D011595	8988571
it@@	I-Disease	-1	8988571
ation	I-Disease	-1	8988571
,	O	-1	8988571
de@@	B-Disease	D003693	8988571
li@@	I-Disease	-1	8988571
ri@@	I-Disease	-1	8988571
um	I-Disease	-1	8988571
,	O	-1	8988571
ab@@	O	-1	8988571
er@@	O	-1	8988571
ran@@	O	-1	8988571
t	O	-1	8988571
ther@@	O	-1	8988571
mo@@	O	-1	8988571
reg@@	O	-1	8988571
ul@@	O	-1	8988571
ation,	O	-1	8988571
rh@@	B-Disease	D012206	8988571
ab@@	I-Disease	-1	8988571
do@@	I-Disease	-1	8988571
my@@	I-Disease	-1	8988571
oly@@	I-Disease	-1	8988571
sis	I-Disease	-1	8988571
,	O	-1	8988571
and	O	-1	8988571
su@@	B-Disease	D003645	8988571
d@@	I-Disease	-1	8988571
de@@	I-Disease	-1	8988571
n	I-Disease	-1	8988571
death	I-Disease	-1	8988571
.	O	-1	8988571

He@@	B-Chemical	D006493	6615052
par@@	I-Chemical	-1	6615052
in	I-Chemical	-1	6615052
-induced	O	-1	6615052
throm@@	B-Disease	D013921	6615052
b@@	I-Disease	-1	6615052
ocyto@@	I-Disease	-1	6615052
pen@@	I-Disease	-1	6615052
ia	I-Disease	-1	6615052
,	O	-1	6615052
thrombo@@	B-Disease	D013927	6615052
sis	I-Disease	-1	6615052
,	O	-1	6615052
and	O	-1	6615052
hemorrh@@	B-Disease	D006470	6615052
age	I-Disease	-1	6615052
.	O	-1	6615052
Si@@	O	-1	6615052
x@@	O	-1	6615052
ty-@@	O	-1	6615052
two	O	-1	6615052
patients	O	-1	6615052
with	O	-1	6615052
a	O	-1	6615052
hepar@@	B-Chemical	D006493	6615052
in	I-Chemical	-1	6615052
-induced	O	-1	6615052
throm@@	B-Disease	D013921	6615052
b@@	I-Disease	-1	6615052
ocyto@@	I-Disease	-1	6615052
pen@@	I-Disease	-1	6615052
ia	I-Disease	-1	6615052
are	O	-1	6615052
repor@@	O	-1	6615052
ted.	O	-1	6615052
Clin@@	O	-1	6615052
ical	O	-1	6615052
man@@	O	-1	6615052
if@@	O	-1	6615052
est@@	O	-1	6615052
ations	O	-1	6615052
of	O	-1	6615052
this	O	-1	6615052
disor@@	O	-1	6615052
der	O	-1	6615052
includ@@	O	-1	6615052
e	O	-1	6615052
hemorrh@@	B-Disease	D006470	6615052
age	I-Disease	-1	6615052
or@@	O	-1	6615052
,	O	-1	6615052
more	O	-1	6615052
frequ@@	O	-1	6615052
ent@@	O	-1	6615052
ly,	O	-1	6615052
thrombo@@	B-Disease	D013923	6615052
emb@@	I-Disease	-1	6615052
olic	I-Disease	-1	6615052
events	O	-1	6615052
in	O	-1	6615052
patients	O	-1	6615052
receiving	O	-1	6615052
hepar@@	B-Chemical	D006493	6615052
in	I-Chemical	-1	6615052
.	O	-1	6615052
L@@	O	-1	6615052
abor@@	O	-1	6615052
atory	O	-1	6615052
test@@	O	-1	6615052
ing	O	-1	6615052
has	O	-1	6615052
revealed	O	-1	6615052
a	B-Disease	D001791	6615052
f@@	I-Disease	-1	6615052
all@@	I-Disease	-1	6615052
ing	I-Disease	-1	6615052
platele@@	I-Disease	-1	6615052
t	I-Disease	-1	6615052
coun@@	I-Disease	-1	6615052
t	I-Disease	-1	6615052
,	O	-1	6615052
increased	O	-1	6615052
resist@@	O	-1	6615052
ance	O	-1	6615052
to	O	-1	6615052
hepar@@	B-Chemical	D006493	6615052
in	I-Chemical	-1	6615052
,	O	-1	6615052
and	O	-1	6615052
ag@@	O	-1	6615052
g@@	O	-1	6615052
reg@@	O	-1	6615052
ation	O	-1	6615052
of	O	-1	6615052
platele@@	O	-1	6615052
ts	O	-1	6615052
by	O	-1	6615052
the	O	-1	6615052
patient@@	O	-1	6615052
's	O	-1	6615052
plasma	O	-1	6615052
when	O	-1	6615052
hepar@@	B-Chemical	D006493	6615052
in	I-Chemical	-1	6615052
is	O	-1	6615052
ad@@	O	-1	6615052
de@@	O	-1	6615052
d.	O	-1	6615052
Im@@	O	-1	6615052
mun@@	O	-1	6615052
ologic	O	-1	6615052
test@@	O	-1	6615052
ing	O	-1	6615052
has	O	-1	6615052
demonstrated	O	-1	6615052
the	O	-1	6615052
presence	O	-1	6615052
of	O	-1	6615052
a	O	-1	6615052
hepar@@	B-Chemical	D006493	6615052
in	I-Chemical	-1	6615052
-@@	O	-1	6615052
dependent	O	-1	6615052
platele@@	O	-1	6615052
t	O	-1	6615052
membran@@	O	-1	6615052
e	O	-1	6615052
anti@@	O	-1	6615052
bo@@	O	-1	6615052
d@@	O	-1	6615052
y.	O	-1	6615052
The	O	-1	6615052
20	O	-1	6615052
de@@	O	-1	6615052
ath@@	O	-1	6615052
s,	O	-1	6615052
5@@	O	-1	6615052
2	O	-1	6615052
hemorrh@@	B-Disease	D006470	6615052
ag@@	I-Disease	-1	6615052
ic	I-Disease	-1	6615052
and	I-Disease	-1	6615052
thrombo@@	I-Disease	-1	6615052
emb@@	I-Disease	-1	6615052
olic	I-Disease	-1	6615052
complications	I-Disease	-1	6615052
hemorrh@@	B-Disease	D013923	6615052
ag@@	I-Disease	-1	6615052
ic	I-Disease	-1	6615052
and	I-Disease	-1	6615052
thrombo@@	I-Disease	-1	6615052
emb@@	I-Disease	-1	6615052
olic	I-Disease	-1	6615052
complications	I-Disease	-1	6615052
,	O	-1	6615052
and	O	-1	6615052
21	O	-1	6615052
surg@@	O	-1	6615052
ical	O	-1	6615052
proce@@	O	-1	6615052
d@@	O	-1	6615052
ures	O	-1	6615052
to	O	-1	6615052
man@@	O	-1	6615052
age	O	-1	6615052
the	O	-1	6615052
complications	O	-1	6615052
con@@	O	-1	6615052
fir@@	O	-1	6615052
m	O	-1	6615052
the	O	-1	6615052
seri@@	O	-1	6615052
ous@@	O	-1	6615052
ness	O	-1	6615052
of	O	-1	6615052
the	O	-1	6615052
disorder@@	O	-1	6615052
.	O	-1	6615052
S@@	O	-1	6615052
p@@	O	-1	6615052
ec@@	O	-1	6615052
if@@	O	-1	6615052
ic	O	-1	6615052
risk	O	-1	6615052
factors	O	-1	6615052
have	O	-1	6615052
not	O	-1	6615052
been	O	-1	6615052
identi@@	O	-1	6615052
fi@@	O	-1	6615052
ed@@	O	-1	6615052
;	O	-1	6615052
the@@	O	-1	6615052
refore,	O	-1	6615052
all	O	-1	6615052
patients	O	-1	6615052
receiving	O	-1	6615052
hepar@@	B-Chemical	D006493	6615052
in	I-Chemical	-1	6615052
should	O	-1	6615052
be	O	-1	6615052
monit@@	O	-1	6615052
o@@	O	-1	6615052
red.	O	-1	6615052
I@@	O	-1	6615052
f	O	-1	6615052
the	O	-1	6615052
platele@@	O	-1	6615052
t	O	-1	6615052
coun@@	O	-1	6615052
t	O	-1	6615052
f@@	O	-1	6615052
all@@	O	-1	6615052
s	O	-1	6615052
to	O	-1	6615052
less	O	-1	6615052
than	O	-1	6615052
10@@	O	-1	6615052
0@@	O	-1	6615052
,@@	O	-1	6615052
0@@	O	-1	6615052
0@@	O	-1	6615052
0@@	O	-1	6615052
/@@	O	-1	6615052
mm@@	O	-1	6615052
3,	O	-1	6615052
while	O	-1	6615052
the	O	-1	6615052
patient	O	-1	6615052
is	O	-1	6615052
receiving	O	-1	6615052
hepar@@	B-Chemical	D006493	6615052
in	I-Chemical	-1	6615052
,	O	-1	6615052
platele@@	B-Disease	D001791	6615052
t	I-Disease	-1	6615052
ag@@	I-Disease	-1	6615052
g@@	I-Disease	-1	6615052
reg@@	I-Disease	-1	6615052
ation	I-Disease	-1	6615052
test@@	O	-1	6615052
ing,	O	-1	6615052
using	O	-1	6615052
the	O	-1	6615052
patient@@	O	-1	6615052
's	O	-1	6615052
plas@@	O	-1	6615052
ma@@	O	-1	6615052
,	O	-1	6615052
is	O	-1	6615052
indic@@	O	-1	6615052
ated.	O	-1	6615052
M@@	O	-1	6615052
an@@	O	-1	6615052
ag@@	O	-1	6615052
ement	O	-1	6615052
consist@@	O	-1	6615052
s	O	-1	6615052
of	O	-1	6615052
cess@@	O	-1	6615052
ation	O	-1	6615052
of	O	-1	6615052
hepar@@	B-Chemical	D006493	6615052
in	I-Chemical	-1	6615052
,	O	-1	6615052
platele@@	O	-1	6615052
t	O	-1	6615052
anti@@	O	-1	6615052
-@@	O	-1	6615052
ag@@	O	-1	6615052
g@@	O	-1	6615052
reg@@	O	-1	6615052
ating	O	-1	6615052
agent@@	O	-1	6615052
s,	O	-1	6615052
and	O	-1	6615052
al@@	O	-1	6615052
tern@@	O	-1	6615052
ate	O	-1	6615052
form@@	O	-1	6615052
s	O	-1	6615052
of	O	-1	6615052
anti@@	O	-1	6615052
co@@	O	-1	6615052
ag@@	O	-1	6615052
ulation	O	-1	6615052
when	O	-1	6615052
indic@@	O	-1	6615052
ated.	O	-1	6615052

C@@	B-Disease	D066126	3952818
ardi@@	I-Disease	-1	3952818
a@@	I-Disease	-1	3952818
c	I-Disease	-1	3952818
toxicity	I-Disease	-1	3952818
of	O	-1	3952818
5-@@	B-Chemical	D005472	3952818
fluoro@@	I-Chemical	-1	3952818
urac@@	I-Chemical	-1	3952818
il	I-Chemical	-1	3952818
.	O	-1	3952818
Re@@	O	-1	3952818
por@@	O	-1	3952818
t	O	-1	3952818
of	O	-1	3952818
a	O	-1	3952818
case	O	-1	3952818
of	O	-1	3952818
spont@@	O	-1	3952818
aneous	O	-1	3952818
ang@@	B-Disease	D000787	3952818
in@@	I-Disease	-1	3952818
a	I-Disease	-1	3952818
.	O	-1	3952818
We	O	-1	3952818
report	O	-1	3952818
a	O	-1	3952818
case	O	-1	3952818
of	O	-1	3952818
a	O	-1	3952818
patient	O	-1	3952818
with	O	-1	3952818
co@@	B-Disease	D003110	3952818
l@@	I-Disease	-1	3952818
on	I-Disease	-1	3952818
carcin@@	I-Disease	-1	3952818
oma	I-Disease	-1	3952818
and	O	-1	3952818
liver	O	-1	3952818
met@@	B-Disease	D009362	3952818
ast@@	I-Disease	-1	3952818
asis	I-Disease	-1	3952818
who	O	-1	3952818
presented	O	-1	3952818
ch@@	B-Disease	D002637	3952818
est	I-Disease	-1	3952818
pain	I-Disease	-1	3952818
after	O	-1	3952818
5-@@	B-Chemical	D005472	3952818
fluoro@@	I-Chemical	-1	3952818
urac@@	I-Chemical	-1	3952818
il	I-Chemical	-1	3952818
(	O	-1	3952818
5-@@	B-Chemical	D005472	3952818
F@@	I-Chemical	-1	3952818
U	I-Chemical	-1	3952818
)	O	-1	3952818
administr@@	O	-1	3952818
ation.	O	-1	3952818
Clin@@	O	-1	3952818
ical	O	-1	3952818
electro@@	O	-1	3952818
cardio@@	O	-1	3952818
graph@@	O	-1	3952818
ic	O	-1	3952818
ev@@	O	-1	3952818
ol@@	O	-1	3952818
u@@	O	-1	3952818
tion	O	-1	3952818
was	O	-1	3952818
similar	O	-1	3952818
to	O	-1	3952818
that	O	-1	3952818
observed	O	-1	3952818
in	O	-1	3952818
P@@	B-Disease	D000788	3952818
r@@	I-Disease	-1	3952818
in@@	I-Disease	-1	3952818
z@@	I-Disease	-1	3952818
met@@	I-Disease	-1	3952818
al@@	I-Disease	-1	3952818
's	I-Disease	-1	3952818
ang@@	I-Disease	-1	3952818
in@@	I-Disease	-1	3952818
a	I-Disease	-1	3952818
,	O	-1	3952818
and	O	-1	3952818
ch@@	B-Disease	D002637	3952818
est	I-Disease	-1	3952818
pain	I-Disease	-1	3952818
pro@@	O	-1	3952818
m@@	O	-1	3952818
pt@@	O	-1	3952818
ly	O	-1	3952818
resol@@	O	-1	3952818
ved	O	-1	3952818
with	O	-1	3952818
n@@	B-Chemical	D009543	3952818
if@@	I-Chemical	-1	3952818
edi@@	I-Chemical	-1	3952818
pine	I-Chemical	-1	3952818
.	O	-1	3952818
These	O	-1	3952818
data	O	-1	3952818
suggest	O	-1	3952818
that	O	-1	3952818
coronary	B-Disease	D003329	3952818
sp@@	I-Disease	-1	3952818
as@@	I-Disease	-1	3952818
m	I-Disease	-1	3952818
may	O	-1	3952818
be	O	-1	3952818
the	O	-1	3952818
cause	O	-1	3952818
of	O	-1	3952818
cardi@@	B-Disease	D066126	3952818
otoxicity	I-Disease	-1	3952818
due	O	-1	3952818
to	O	-1	3952818
5-@@	B-Chemical	D005472	3952818
F@@	I-Chemical	-1	3952818
U	I-Chemical	-1	3952818
,	O	-1	3952818
and	O	-1	3952818
that	O	-1	3952818
calcium	B-Chemical	D002118	3952818
antagonist@@	O	-1	3952818
s	O	-1	3952818
may	O	-1	3952818
prob@@	O	-1	3952818
ably	O	-1	3952818
be	O	-1	3952818
used	O	-1	3952818
in	O	-1	3952818
the	O	-1	3952818
pre@@	O	-1	3952818
ven@@	O	-1	3952818
tion	O	-1	3952818
or	O	-1	3952818
treatment	O	-1	3952818
of	O	-1	3952818
5-@@	B-Chemical	D005472	3952818
F@@	I-Chemical	-1	3952818
U	I-Chemical	-1	3952818
cardi@@	B-Disease	D066126	3952818
otoxicity	I-Disease	-1	3952818
.	O	-1	3952818

T@@	B-Disease	D064420	3084782
oxic@@	I-Disease	-1	3084782
ity	I-Disease	-1	3084782
due	O	-1	3084782
to	O	-1	3084782
re@@	O	-1	3084782
mission	O	-1	3084782
induc@@	O	-1	3084782
ing	O	-1	3084782
drugs	O	-1	3084782
in	O	-1	3084782
r@@	B-Disease	D001172	3084782
he@@	I-Disease	-1	3084782
um@@	I-Disease	-1	3084782
at@@	I-Disease	-1	3084782
oid	I-Disease	-1	3084782
arth@@	I-Disease	-1	3084782
ritis	I-Disease	-1	3084782
.	O	-1	3084782
A@@	O	-1	3084782
s@@	O	-1	3084782
s@@	O	-1	3084782
oci@@	O	-1	3084782
ation	O	-1	3084782
with	O	-1	3084782
H@@	O	-1	3084782
L@@	O	-1	3084782
A@@	O	-1	3084782
-@@	O	-1	3084782
B@@	O	-1	3084782
3@@	O	-1	3084782
5	O	-1	3084782
and	O	-1	3084782
C@@	O	-1	3084782
w@@	O	-1	3084782
4	O	-1	3084782
anti@@	O	-1	3084782
gen@@	O	-1	3084782
s.	O	-1	3084782
Tw@@	O	-1	3084782
ent@@	O	-1	3084782
y-@@	O	-1	3084782
five	O	-1	3084782
patients	O	-1	3084782
with	O	-1	3084782
r@@	B-Disease	D001172	3084782
he@@	I-Disease	-1	3084782
um@@	I-Disease	-1	3084782
at@@	I-Disease	-1	3084782
oid	I-Disease	-1	3084782
arth@@	I-Disease	-1	3084782
ritis	I-Disease	-1	3084782
(	O	-1	3084782
R@@	B-Disease	D001172	3084782
A	I-Disease	-1	3084782
)	O	-1	3084782
who	O	-1	3084782
developed	O	-1	3084782
toxicity	B-Disease	D064420	3084782
while	O	-1	3084782
taking	O	-1	3084782
re@@	O	-1	3084782
mission	O	-1	3084782
induc@@	O	-1	3084782
ing	O	-1	3084782
drugs	O	-1	3084782
and	O	-1	3084782
30	O	-1	3084782
without	O	-1	3084782
toxicity	B-Disease	D064420	3084782
were	O	-1	3084782
studied	O	-1	3084782
for	O	-1	3084782
possible	O	-1	3084782
associ@@	O	-1	3084782
ations	O	-1	3084782
with	O	-1	3084782
cl@@	O	-1	3084782
as@@	O	-1	3084782
s	O	-1	3084782
I	O	-1	3084782
and	O	-1	3084782
II	O	-1	3084782
H@@	O	-1	3084782
L@@	O	-1	3084782
A	O	-1	3084782
anti@@	O	-1	3084782
gen@@	O	-1	3084782
s.	O	-1	3084782
A	O	-1	3084782
st@@	O	-1	3084782
ron@@	O	-1	3084782
g	O	-1	3084782
association	O	-1	3084782
has	O	-1	3084782
been	O	-1	3084782
found	O	-1	3084782
between	O	-1	3084782
neph@@	B-Disease	D009393	3084782
ritis	I-Disease	-1	3084782
and	O	-1	3084782
der@@	B-Disease	D003872	3084782
m@@	I-Disease	-1	3084782
ati@@	I-Disease	-1	3084782
tis	I-Disease	-1	3084782
due	O	-1	3084782
to	O	-1	3084782
T@@	B-Chemical	D008625	3084782
io@@	I-Chemical	-1	3084782
p@@	I-Chemical	-1	3084782
ron@@	I-Chemical	-1	3084782
in	I-Chemical	-1	3084782
(@@	O	-1	3084782
a	O	-1	3084782
D-@@	B-Chemical	D010396	3084782
P@@	I-Chemical	-1	3084782
en@@	I-Chemical	-1	3084782
icill@@	I-Chemical	-1	3084782
amine	I-Chemical	-1	3084782
like	O	-1	3084782
comp@@	O	-1	3084782
oun@@	O	-1	3084782
d@@	O	-1	3084782
)	O	-1	3084782
and	O	-1	3084782
cl@@	O	-1	3084782
as@@	O	-1	3084782
s	O	-1	3084782
I	O	-1	3084782
anti@@	O	-1	3084782
gen@@	O	-1	3084782
s	O	-1	3084782
B@@	O	-1	3084782
3@@	O	-1	3084782
5-@@	O	-1	3084782
C@@	O	-1	3084782
w@@	O	-1	3084782
4@@	O	-1	3084782
,	O	-1	3084782
and	O	-1	3084782
between	O	-1	3084782
der@@	B-Disease	D003872	3084782
m@@	I-Disease	-1	3084782
ati@@	I-Disease	-1	3084782
tis	I-Disease	-1	3084782
due	O	-1	3084782
to	O	-1	3084782
g@@	B-Chemical	D006046	3084782
old	I-Chemical	-1	3084782
thi@@	B-Chemical	-1	3084782
os@@	I-Chemical	-1	3084782
ul@@	I-Chemical	-1	3084782
ph@@	I-Chemical	-1	3084782
ate	I-Chemical	-1	3084782
and	O	-1	3084782
B@@	O	-1	3084782
3@@	O	-1	3084782
5@@	O	-1	3084782
.	O	-1	3084782
Com@@	O	-1	3084782
pared	O	-1	3084782
to	O	-1	3084782
healthy	O	-1	3084782
controls	O	-1	3084782
a	O	-1	3084782
lower	O	-1	3084782
D@@	O	-1	3084782
R@@	O	-1	3084782
5	O	-1	3084782
frequency	O	-1	3084782
was	O	-1	3084782
observed	O	-1	3084782
in	O	-1	3084782
patients	O	-1	3084782
with	O	-1	3084782
R@@	B-Disease	D001172	3084782
A	I-Disease	-1	3084782
ex@@	O	-1	3084782
cep@@	O	-1	3084782
t	O	-1	3084782
for	O	-1	3084782
the	O	-1	3084782
T@@	B-Chemical	D008625	3084782
io@@	I-Chemical	-1	3084782
p@@	I-Chemical	-1	3084782
ron@@	I-Chemical	-1	3084782
in	I-Chemical	-1	3084782
related	O	-1	3084782
neph@@	B-Disease	D009393	3084782
ritis	I-Disease	-1	3084782
group.	O	-1	3084782

T@@	O	-1	430165
ran@@	O	-1	430165
si@@	O	-1	430165
ent	O	-1	430165
he@@	B-Disease	D010291	430165
mi@@	I-Disease	-1	430165
pa@@	I-Disease	-1	430165
re@@	I-Disease	-1	430165
sis	I-Disease	-1	430165
:	O	-1	430165
a	O	-1	430165
r@@	O	-1	430165
are	O	-1	430165
man@@	O	-1	430165
if@@	O	-1	430165
est@@	O	-1	430165
ation	O	-1	430165
of	O	-1	430165
di@@	B-Chemical	D010672	430165
phenyl@@	I-Chemical	-1	430165
hy@@	I-Chemical	-1	430165
d@@	I-Chemical	-1	430165
an@@	I-Chemical	-1	430165
to@@	I-Chemical	-1	430165
in	I-Chemical	-1	430165
toxicity	B-Disease	D064420	430165
.	O	-1	430165
Re@@	O	-1	430165
por@@	O	-1	430165
t	O	-1	430165
of	O	-1	430165
two	O	-1	430165
cas@@	O	-1	430165
es.	O	-1	430165
A@@	O	-1	430165
mon@@	O	-1	430165
g	O	-1	430165
the	O	-1	430165
common	O	-1	430165
side	O	-1	430165
effects	O	-1	430165
of	O	-1	430165
di@@	B-Chemical	D010672	430165
phenyl@@	I-Chemical	-1	430165
hy@@	I-Chemical	-1	430165
d@@	I-Chemical	-1	430165
an@@	I-Chemical	-1	430165
to@@	I-Chemical	-1	430165
in	I-Chemical	-1	430165
(	O	-1	430165
D@@	B-Chemical	D010672	430165
P@@	I-Chemical	-1	430165
H	I-Chemical	-1	430165
)	O	-1	430165
over@@	B-Disease	D062787	430165
dose	I-Disease	-1	430165
,	O	-1	430165
the	O	-1	430165
most	O	-1	430165
frequ@@	O	-1	430165
ently	O	-1	430165
en@@	O	-1	430165
coun@@	O	-1	430165
te@@	O	-1	430165
red	O	-1	430165
neurolog@@	O	-1	430165
ical	O	-1	430165
signs	O	-1	430165
are	O	-1	430165
those	O	-1	430165
of	O	-1	430165
ce@@	B-Disease	D002526	430165
re@@	I-Disease	-1	430165
bell@@	I-Disease	-1	430165
ar	I-Disease	-1	430165
dysfunction	I-Disease	-1	430165
.	O	-1	430165
V@@	O	-1	430165
er@@	O	-1	430165
y	O	-1	430165
ra@@	O	-1	430165
rel@@	O	-1	430165
y,	O	-1	430165
the	O	-1	430165
toxic	O	-1	430165
neurolog@@	O	-1	430165
ical	O	-1	430165
man@@	O	-1	430165
if@@	O	-1	430165
est@@	O	-1	430165
ations	O	-1	430165
of	O	-1	430165
this	O	-1	430165
drug	O	-1	430165
are	O	-1	430165
of	O	-1	430165
cerebral	O	-1	430165
or@@	O	-1	430165
ig@@	O	-1	430165
in.	O	-1	430165
Two	O	-1	430165
patients	O	-1	430165
are	O	-1	430165
presented	O	-1	430165
who	O	-1	430165
su@@	O	-1	430165
ffe@@	O	-1	430165
red	O	-1	430165
progressive	O	-1	430165
he@@	B-Disease	D010291	430165
mi@@	I-Disease	-1	430165
pa@@	I-Disease	-1	430165
re@@	I-Disease	-1	430165
sis	I-Disease	-1	430165
due	O	-1	430165
to	O	-1	430165
D@@	B-Chemical	D010672	430165
P@@	I-Chemical	-1	430165
H	I-Chemical	-1	430165
over@@	B-Disease	D062787	430165
dose	I-Disease	-1	430165
.	O	-1	430165
B@@	O	-1	430165
oth	O	-1	430165
had	O	-1	430165
brain	O	-1	430165
surger@@	O	-1	430165
y	O	-1	430165
before	O	-1	430165
D@@	B-Chemical	D010672	430165
P@@	I-Chemical	-1	430165
H	I-Chemical	-1	430165
treatment.	O	-1	430165
It	O	-1	430165
is	O	-1	430165
as@@	O	-1	430165
sum@@	O	-1	430165
ed	O	-1	430165
that	O	-1	430165
patients	O	-1	430165
with	O	-1	430165
some	O	-1	430165
cerebral	B-Disease	D001927	430165
damage	I-Disease	-1	430165
are	O	-1	430165
li@@	O	-1	430165
able	O	-1	430165
to	O	-1	430165
man@@	O	-1	430165
if@@	O	-1	430165
est	O	-1	430165
D@@	B-Chemical	D010672	430165
P@@	I-Chemical	-1	430165
H	I-Chemical	-1	430165
toxicity	B-Disease	D064420	430165
as	O	-1	430165
foc@@	O	-1	430165
al	O	-1	430165
neurolog@@	O	-1	430165
ical	O	-1	430165
sign@@	O	-1	430165
s.	O	-1	430165

N@@	O	-1	16600756
er@@	O	-1	16600756
ve	O	-1	16600756
growth	O	-1	16600756
factor	O	-1	16600756
and	O	-1	16600756
pro@@	B-Chemical	D011453	16600756
st@@	I-Chemical	-1	16600756
ag@@	I-Chemical	-1	16600756
l@@	I-Chemical	-1	16600756
and@@	I-Chemical	-1	16600756
ins	I-Chemical	-1	16600756
in	O	-1	16600756
the	O	-1	16600756
urine	O	-1	16600756
of	O	-1	16600756
female	O	-1	16600756
patients	O	-1	16600756
with	O	-1	16600756
over@@	B-Disease	D053201	16600756
active	I-Disease	-1	16600756
bladder	I-Disease	-1	16600756
.	O	-1	16600756
P@@	O	-1	16600756
U@@	O	-1	16600756
R@@	O	-1	16600756
P@@	O	-1	16600756
O@@	O	-1	16600756
S@@	O	-1	16600756
E:	O	-1	16600756
N@@	O	-1	16600756
G@@	O	-1	16600756
F	O	-1	16600756
and	O	-1	16600756
PG@@	B-Chemical	D011453	16600756
s	I-Chemical	-1	16600756
in	O	-1	16600756
the	O	-1	16600756
bladder	O	-1	16600756
can	O	-1	16600756
be	O	-1	16600756
affected	O	-1	16600756
by	O	-1	16600756
path@@	O	-1	16600756
ological	O	-1	16600756
changes	O	-1	16600756
in	O	-1	16600756
the	O	-1	16600756
bladder	O	-1	16600756
and	O	-1	16600756
these	O	-1	16600756
changes	O	-1	16600756
can	O	-1	16600756
be	O	-1	16600756
det@@	O	-1	16600756
ected	O	-1	16600756
in	O	-1	16600756
ur@@	O	-1	16600756
ine.	O	-1	16600756
We	O	-1	16600756
investigated	O	-1	16600756
changes	O	-1	16600756
in	O	-1	16600756
urinary	O	-1	16600756
N@@	O	-1	16600756
G@@	O	-1	16600756
F	O	-1	16600756
and	O	-1	16600756
PG@@	B-Chemical	D011453	16600756
s	I-Chemical	-1	16600756
in	O	-1	16600756
women	O	-1	16600756
with	O	-1	16600756
O@@	B-Disease	D053201	16600756
A@@	I-Disease	-1	16600756
B	I-Disease	-1	16600756
.	O	-1	16600756
M@@	O	-1	16600756
AT@@	O	-1	16600756
E@@	O	-1	16600756
R@@	O	-1	16600756
I@@	O	-1	16600756
AL@@	O	-1	16600756
S	O	-1	16600756
AN@@	O	-1	16600756
D	O	-1	16600756
METHODS:	O	-1	16600756
The	O	-1	16600756
study	O	-1	16600756
groups	O	-1	16600756
included	O	-1	16600756
6@@	O	-1	16600756
5	O	-1	16600756
women	O	-1	16600756
with	O	-1	16600756
O@@	B-Disease	D053201	16600756
A@@	I-Disease	-1	16600756
B	I-Disease	-1	16600756
and	O	-1	16600756
20	O	-1	16600756
without	O	-1	16600756
bladder	O	-1	16600756
symptoms	O	-1	16600756
who	O	-1	16600756
ser@@	O	-1	16600756
ved	O	-1	16600756
as	O	-1	16600756
controls.	O	-1	16600756
E@@	O	-1	16600756
valu@@	O	-1	16600756
ation	O	-1	16600756
included	O	-1	16600756
patient	O	-1	16600756
hist@@	O	-1	16600756
or@@	O	-1	16600756
y,	O	-1	16600756
ur@@	O	-1	16600756
in@@	O	-1	16600756
aly@@	O	-1	16600756
sis,	O	-1	16600756
a	O	-1	16600756
v@@	O	-1	16600756
oid@@	O	-1	16600756
ing	O	-1	16600756
di@@	O	-1	16600756
ary	O	-1	16600756
and	O	-1	16600756
uro@@	O	-1	16600756
dynam@@	O	-1	16600756
ic	O	-1	16600756
studi@@	O	-1	16600756
es.	O	-1	16600756
U@@	O	-1	16600756
rine	O	-1	16600756
sam@@	O	-1	16600756
ple@@	O	-1	16600756
s	O	-1	16600756
were	O	-1	16600756
coll@@	O	-1	16600756
ect@@	O	-1	16600756
ed.	O	-1	16600756
N@@	O	-1	16600756
GF@@	O	-1	16600756
,	O	-1	16600756
PG@@	B-Chemical	D015232	16600756
E@@	I-Chemical	-1	16600756
2	I-Chemical	-1	16600756
,	O	-1	16600756
PG@@	B-Chemical	D015237	16600756
F@@	I-Chemical	-1	16600756
2@@	I-Chemical	-1	16600756
al@@	I-Chemical	-1	16600756
ph@@	I-Chemical	-1	16600756
a	I-Chemical	-1	16600756
and	O	-1	16600756
PG@@	B-Chemical	D011464	16600756
I@@	I-Chemical	-1	16600756
2	I-Chemical	-1	16600756
were	O	-1	16600756
measured	O	-1	16600756
using	O	-1	16600756
enz@@	O	-1	16600756
y@@	O	-1	16600756
me@@	O	-1	16600756
-@@	O	-1	16600756
lin@@	O	-1	16600756
ked	O	-1	16600756
immun@@	O	-1	16600756
os@@	O	-1	16600756
or@@	O	-1	16600756
b@@	O	-1	16600756
ent	O	-1	16600756
ass@@	O	-1	16600756
ay	O	-1	16600756
and	O	-1	16600756
compared	O	-1	16600756
between	O	-1	16600756
the	O	-1	16600756
groups.	O	-1	16600756
In	O	-1	16600756
addi@@	O	-1	16600756
tion,	O	-1	16600756
correl@@	O	-1	16600756
ations	O	-1	16600756
between	O	-1	16600756
urinary	O	-1	16600756
N@@	O	-1	16600756
G@@	O	-1	16600756
F	O	-1	16600756
and	O	-1	16600756
P@@	B-Chemical	D011453	16600756
G	I-Chemical	-1	16600756
,	O	-1	16600756
and	O	-1	16600756
uro@@	O	-1	16600756
dynam@@	O	-1	16600756
ic	O	-1	16600756
par@@	O	-1	16600756
ame@@	O	-1	16600756
ters	O	-1	16600756
in	O	-1	16600756
patients	O	-1	16600756
with	O	-1	16600756
O@@	B-Disease	D053201	16600756
A@@	I-Disease	-1	16600756
B	I-Disease	-1	16600756
were	O	-1	16600756
ex@@	O	-1	16600756
am@@	O	-1	16600756
ine@@	O	-1	16600756
d.	O	-1	16600756
RESULTS:	O	-1	16600756
U@@	O	-1	16600756
r@@	O	-1	16600756
inary	O	-1	16600756
N@@	O	-1	16600756
GF@@	O	-1	16600756
,	O	-1	16600756
PG@@	B-Chemical	D015232	16600756
E@@	I-Chemical	-1	16600756
2	I-Chemical	-1	16600756
and	O	-1	16600756
PG@@	B-Chemical	D015237	16600756
F@@	I-Chemical	-1	16600756
2@@	I-Chemical	-1	16600756
al@@	I-Chemical	-1	16600756
ph@@	I-Chemical	-1	16600756
a	I-Chemical	-1	16600756
were	O	-1	16600756
significantly	O	-1	16600756
increased	O	-1	16600756
in	O	-1	16600756
patients	O	-1	16600756
with	O	-1	16600756
O@@	B-Disease	D053201	16600756
A@@	I-Disease	-1	16600756
B	I-Disease	-1	16600756
compared	O	-1	16600756
with	O	-1	16600756
controls	O	-1	16600756
(p	O	-1	16600756
<@@	O	-1	16600756
0.05@@	O	-1	16600756
).	O	-1	16600756
However,	O	-1	16600756
urinary	O	-1	16600756
PG@@	B-Chemical	D011464	16600756
I@@	I-Chemical	-1	16600756
2	I-Chemical	-1	16600756
was	O	-1	16600756
not	O	-1	16600756
different	O	-1	16600756
between	O	-1	16600756
controls	O	-1	16600756
and	O	-1	16600756
patients	O	-1	16600756
with	O	-1	16600756
O@@	B-Disease	D053201	16600756
A@@	I-Disease	-1	16600756
B	I-Disease	-1	16600756
.	O	-1	16600756
In	O	-1	16600756
patients	O	-1	16600756
with	O	-1	16600756
O@@	B-Disease	D053201	16600756
A@@	I-Disease	-1	16600756
B	I-Disease	-1	16600756
urinary	O	-1	16600756
PG@@	B-Chemical	D015232	16600756
E@@	I-Chemical	-1	16600756
2	I-Chemical	-1	16600756
posi@@	O	-1	16600756
ti@@	O	-1	16600756
vely	O	-1	16600756
cor@@	O	-1	16600756
related	O	-1	16600756
with	O	-1	16600756
volume	O	-1	16600756
at	O	-1	16600756
first	O	-1	16600756
desi@@	O	-1	16600756
r@@	O	-1	16600756
e	O	-1	16600756
to	O	-1	16600756
v@@	O	-1	16600756
oid	O	-1	16600756
and	O	-1	16600756
maxim@@	O	-1	16600756
um	O	-1	16600756
cy@@	O	-1	16600756
sto@@	O	-1	16600756
me@@	O	-1	16600756
tri@@	O	-1	16600756
c	O	-1	16600756
cap@@	O	-1	16600756
ac@@	O	-1	16600756
ity	O	-1	16600756
(p	O	-1	16600756
<@@	O	-1	16600756
0.05@@	O	-1	16600756
).	O	-1	16600756
U@@	O	-1	16600756
r@@	O	-1	16600756
inary	O	-1	16600756
N@@	O	-1	16600756
GF@@	O	-1	16600756
,	O	-1	16600756
PG@@	B-Chemical	D015237	16600756
F@@	I-Chemical	-1	16600756
2@@	I-Chemical	-1	16600756
al@@	I-Chemical	-1	16600756
ph@@	I-Chemical	-1	16600756
a	I-Chemical	-1	16600756
and	O	-1	16600756
PG@@	B-Chemical	D011464	16600756
I@@	I-Chemical	-1	16600756
2	I-Chemical	-1	16600756
did	O	-1	16600756
not	O	-1	16600756
correl@@	O	-1	16600756
ate	O	-1	16600756
with	O	-1	16600756
uro@@	O	-1	16600756
dynam@@	O	-1	16600756
ic	O	-1	16600756
par@@	O	-1	16600756
ame@@	O	-1	16600756
ters	O	-1	16600756
in	O	-1	16600756
patients	O	-1	16600756
with	O	-1	16600756
O@@	B-Disease	D053201	16600756
A@@	I-Disease	-1	16600756
B	I-Disease	-1	16600756
.	O	-1	16600756
CONCLUSIONS:	O	-1	16600756
N@@	O	-1	16600756
G@@	O	-1	16600756
F	O	-1	16600756
and	O	-1	16600756
PG@@	B-Chemical	D011453	16600756
s	I-Chemical	-1	16600756
have	O	-1	16600756
important	O	-1	16600756
ro@@	O	-1	16600756
le@@	O	-1	16600756
s	O	-1	16600756
in	O	-1	16600756
the	O	-1	16600756
development	O	-1	16600756
of	O	-1	16600756
O@@	B-Disease	D053201	16600756
A@@	I-Disease	-1	16600756
B	I-Disease	-1	16600756
symptoms	O	-1	16600756
in	O	-1	16600756
female	O	-1	16600756
patients.	O	-1	16600756
U@@	O	-1	16600756
r@@	O	-1	16600756
inary	O	-1	16600756
levels	O	-1	16600756
of	O	-1	16600756
these	O	-1	16600756
factors	O	-1	16600756
may	O	-1	16600756
be	O	-1	16600756
used	O	-1	16600756
as	O	-1	16600756
mark@@	O	-1	16600756
ers	O	-1	16600756
to	O	-1	16600756
evalu@@	O	-1	16600756
ate	O	-1	16600756
O@@	B-Disease	D053201	16600756
A@@	I-Disease	-1	16600756
B	I-Disease	-1	16600756
symptom@@	O	-1	16600756
s.	O	-1	16600756

Ac@@	O	-1	15686794
ute	O	-1	15686794
low	B-Disease	D017116	15686794
bac@@	I-Disease	-1	15686794
k	I-Disease	-1	15686794
pain	I-Disease	-1	15686794
during	O	-1	15686794
intravenous	O	-1	15686794
administration	O	-1	15686794
of	O	-1	15686794
am@@	B-Chemical	D000638	15686794
iodar@@	I-Chemical	-1	15686794
one	I-Chemical	-1	15686794
:	O	-1	15686794
a	O	-1	15686794
report	O	-1	15686794
of	O	-1	15686794
two	O	-1	15686794
cas@@	O	-1	15686794
es.	O	-1	15686794
A@@	B-Chemical	D000638	15686794
m@@	I-Chemical	-1	15686794
iodar@@	I-Chemical	-1	15686794
one	I-Chemical	-1	15686794
re@@	O	-1	15686794
pres@@	O	-1	15686794
ents	O	-1	15686794
an	O	-1	15686794
effective	O	-1	15686794
anti@@	O	-1	15686794
arrhyth@@	O	-1	15686794
mic	O	-1	15686794
drug	O	-1	15686794
for	O	-1	15686794
cardio@@	O	-1	15686794
ver@@	O	-1	15686794
sion	O	-1	15686794
of	O	-1	15686794
rec@@	O	-1	15686794
ent@@	O	-1	15686794
-@@	O	-1	15686794
onset	O	-1	15686794
atrial	B-Disease	D001281	15686794
fibrill@@	I-Disease	-1	15686794
ation	I-Disease	-1	15686794
(	O	-1	15686794
A@@	B-Disease	D001281	15686794
F	I-Disease	-1	15686794
)	O	-1	15686794
and	O	-1	15686794
maint@@	O	-1	15686794
en@@	O	-1	15686794
ance	O	-1	15686794
of	O	-1	15686794
s@@	O	-1	15686794
in@@	O	-1	15686794
us	O	-1	15686794
rhyth@@	O	-1	15686794
m.	O	-1	15686794
We	O	-1	15686794
b@@	O	-1	15686794
ri@@	O	-1	15686794
e@@	O	-1	15686794
f@@	O	-1	15686794
ly	O	-1	15686794
describe	O	-1	15686794
two	O	-1	15686794
patients	O	-1	15686794
suff@@	O	-1	15686794
ering	O	-1	15686794
from	O	-1	15686794
rec@@	O	-1	15686794
ent@@	O	-1	15686794
-@@	O	-1	15686794
onset	O	-1	15686794
atrial	B-Disease	D001281	15686794
fibrill@@	I-Disease	-1	15686794
ation	I-Disease	-1	15686794
,	O	-1	15686794
who	O	-1	15686794
experienced	O	-1	15686794
an	O	-1	15686794
acute	O	-1	15686794
de@@	O	-1	15686794
vast@@	O	-1	15686794
ating	O	-1	15686794
low	B-Disease	D017116	15686794
bac@@	I-Disease	-1	15686794
k	I-Disease	-1	15686794
pain	I-Disease	-1	15686794
a	O	-1	15686794
fe@@	O	-1	15686794
w	O	-1	15686794
minutes	O	-1	15686794
after	O	-1	15686794
initi@@	O	-1	15686794
ation	O	-1	15686794
of	O	-1	15686794
intravenous	O	-1	15686794
am@@	B-Chemical	D000638	15686794
iodar@@	I-Chemical	-1	15686794
one	I-Chemical	-1	15686794
lo@@	O	-1	15686794
ad@@	O	-1	15686794
ing.	O	-1	15686794
N@@	O	-1	15686794
ot@@	O	-1	15686794
ab@@	O	-1	15686794
ly,	O	-1	15686794
this	O	-1	15686794
side	O	-1	15686794
effect	O	-1	15686794
has	O	-1	15686794
not	O	-1	15686794
been	O	-1	15686794
ev@@	O	-1	15686794
er	O	-1	15686794
reported	O	-1	15686794
in	O	-1	15686794
the	O	-1	15686794
med@@	O	-1	15686794
ical	O	-1	15686794
literat@@	O	-1	15686794
ure.	O	-1	15686794
Clin@@	O	-1	15686794
ici@@	O	-1	15686794
ans	O	-1	15686794
should	O	-1	15686794
be	O	-1	15686794
aw@@	O	-1	15686794
are	O	-1	15686794
of	O	-1	15686794
this	O	-1	15686794
reaction	O	-1	15686794
s@@	O	-1	15686794
inc@@	O	-1	15686794
e	O	-1	15686794
pro@@	O	-1	15686794
m@@	O	-1	15686794
p@@	O	-1	15686794
t	O	-1	15686794
ter@@	O	-1	15686794
min@@	O	-1	15686794
ation	O	-1	15686794
of	O	-1	15686794
pa@@	O	-1	15686794
ren@@	O	-1	15686794
ter@@	O	-1	15686794
al	O	-1	15686794
administration	O	-1	15686794
lead@@	O	-1	15686794
s	O	-1	15686794
to	O	-1	15686794
complete	O	-1	15686794
resol@@	O	-1	15686794
u@@	O	-1	15686794
tion.	O	-1	15686794

P@@	B-Disease	D010149	12760988
o@@	I-Disease	-1	12760988
sto@@	I-Disease	-1	12760988
perative	I-Disease	-1	12760988
my@@	I-Disease	-1	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
after	O	-1	12760988
suc@@	B-Chemical	D013390	12760988
cin@@	I-Chemical	-1	12760988
ylcholine	I-Chemical	-1	12760988
:	O	-1	12760988
no	O	-1	12760988
evidence	O	-1	12760988
for	O	-1	12760988
an	O	-1	12760988
inflam@@	O	-1	12760988
mat@@	O	-1	12760988
ory	O	-1	12760988
or@@	O	-1	12760988
ig@@	O	-1	12760988
in.	O	-1	12760988
A	O	-1	12760988
common	O	-1	12760988
side	O	-1	12760988
effect	O	-1	12760988
associated	O	-1	12760988
with	O	-1	12760988
suc@@	B-Chemical	D013390	12760988
cin@@	I-Chemical	-1	12760988
ylcholine	I-Chemical	-1	12760988
is	O	-1	12760988
postoperative	B-Disease	D010149	12760988
my@@	I-Disease	-1	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
.	O	-1	12760988
The	O	-1	12760988
path@@	O	-1	12760988
o@@	O	-1	12760988
genesis	O	-1	12760988
of	O	-1	12760988
this	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
is	O	-1	12760988
sti@@	O	-1	12760988
ll	O	-1	12760988
unc@@	O	-1	12760988
lear@@	O	-1	12760988
;	O	-1	12760988
inflam@@	B-Disease	D007249	12760988
m@@	I-Disease	-1	12760988
ation	I-Disease	-1	12760988
has	O	-1	12760988
been	O	-1	12760988
suggested	O	-1	12760988
but	O	-1	12760988
without	O	-1	12760988
con@@	O	-1	12760988
v@@	O	-1	12760988
inc@@	O	-1	12760988
ing	O	-1	12760988
ev@@	O	-1	12760988
id@@	O	-1	12760988
ence@@	O	-1	12760988
.	O	-1	12760988
We	O	-1	12760988
de@@	O	-1	12760988
signed	O	-1	12760988
the	O	-1	12760988
present	O	-1	12760988
study	O	-1	12760988
to	O	-1	12760988
investigate	O	-1	12760988
whether	O	-1	12760988
an	O	-1	12760988
inflam@@	O	-1	12760988
mat@@	O	-1	12760988
ory	O	-1	12760988
reaction	O	-1	12760988
cont@@	O	-1	12760988
ri@@	O	-1	12760988
but@@	O	-1	12760988
es	O	-1	12760988
to	O	-1	12760988
this	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
.	O	-1	12760988
The	O	-1	12760988
incidence	O	-1	12760988
and	O	-1	12760988
severity	O	-1	12760988
of	O	-1	12760988
suc@@	B-Chemical	D013390	12760988
cin@@	I-Chemical	-1	12760988
ylcholine	I-Chemical	-1	12760988
-@@	O	-1	12760988
associated	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
was	O	-1	12760988
determined	O	-1	12760988
in	O	-1	12760988
6@@	O	-1	12760988
4	O	-1	12760988
patients	O	-1	12760988
pre@@	O	-1	12760988
treated	O	-1	12760988
with	O	-1	12760988
saline	O	-1	12760988
or	O	-1	12760988
de@@	B-Chemical	D003907	12760988
xameth@@	I-Chemical	-1	12760988
as@@	I-Chemical	-1	12760988
one	I-Chemical	-1	12760988
before	O	-1	12760988
suc@@	B-Chemical	D013390	12760988
cin@@	I-Chemical	-1	12760988
ylcholine	I-Chemical	-1	12760988
(n	O	-1	12760988
=	O	-1	12760988
3@@	O	-1	12760988
2	O	-1	12760988
for	O	-1	12760988
e@@	O	-1	12760988
ac@@	O	-1	12760988
h@@	O	-1	12760988
).	O	-1	12760988
In@@	O	-1	12760988
c@@	O	-1	12760988
idence	O	-1	12760988
and	O	-1	12760988
severity	O	-1	12760988
of	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
did	O	-1	12760988
not	O	-1	12760988
diff@@	O	-1	12760988
er	O	-1	12760988
significantly	O	-1	12760988
between	O	-1	12760988
the	O	-1	12760988
two	O	-1	12760988
group@@	O	-1	12760988
s:	O	-1	12760988
15	O	-1	12760988
patients	O	-1	12760988
in	O	-1	12760988
the	O	-1	12760988
de@@	B-Chemical	D003907	12760988
xameth@@	I-Chemical	-1	12760988
as@@	I-Chemical	-1	12760988
one	I-Chemical	-1	12760988
group	O	-1	12760988
com@@	O	-1	12760988
pl@@	O	-1	12760988
ained	O	-1	12760988
of	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
compared	O	-1	12760988
with	O	-1	12760988
1@@	O	-1	12760988
8	O	-1	12760988
patients	O	-1	12760988
in	O	-1	12760988
the	O	-1	12760988
saline	O	-1	12760988
group@@	O	-1	12760988
,	O	-1	12760988
and	O	-1	12760988
severe	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
was	O	-1	12760988
reported	O	-1	12760988
by	O	-1	12760988
five	O	-1	12760988
patients	O	-1	12760988
and	O	-1	12760988
three	O	-1	12760988
patients,	O	-1	12760988
respecti@@	O	-1	12760988
vely	O	-1	12760988
(@@	O	-1	12760988
not	O	-1	12760988
significant@@	O	-1	12760988
).	O	-1	12760988
A@@	O	-1	12760988
t	O	-1	12760988
4@@	O	-1	12760988
8	O	-1	12760988
h	O	-1	12760988
after	O	-1	12760988
surger@@	O	-1	12760988
y,	O	-1	12760988
12	O	-1	12760988
patients	O	-1	12760988
in	O	-1	12760988
both	O	-1	12760988
groups	O	-1	12760988
sti@@	O	-1	12760988
ll	O	-1	12760988
su@@	O	-1	12760988
ffe@@	O	-1	12760988
red	O	-1	12760988
from	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
(@@	O	-1	12760988
not	O	-1	12760988
significant@@	O	-1	12760988
).	O	-1	12760988
In	O	-1	12760988
addi@@	O	-1	12760988
tion,	O	-1	12760988
inter@@	O	-1	12760988
leuk@@	O	-1	12760988
in-@@	O	-1	12760988
6	O	-1	12760988
(@@	O	-1	12760988
I@@	O	-1	12760988
L-@@	O	-1	12760988
6@@	O	-1	12760988
)	O	-1	12760988
as	O	-1	12760988
an	O	-1	12760988
early	O	-1	12760988
mark@@	O	-1	12760988
er	O	-1	12760988
of	O	-1	12760988
inflam@@	B-Disease	D007249	12760988
m@@	I-Disease	-1	12760988
ation	I-Disease	-1	12760988
was	O	-1	12760988
assessed	O	-1	12760988
in	O	-1	12760988
a	O	-1	12760988
sub@@	O	-1	12760988
group	O	-1	12760988
of	O	-1	12760988
10	O	-1	12760988
patients	O	-1	12760988
pre@@	O	-1	12760988
treated	O	-1	12760988
with	O	-1	12760988
sal@@	O	-1	12760988
ine.	O	-1	12760988
We	O	-1	12760988
found	O	-1	12760988
an	O	-1	12760988
increase	O	-1	12760988
of	O	-1	12760988
I@@	O	-1	12760988
L-@@	O	-1	12760988
6	O	-1	12760988
for	O	-1	12760988
only	O	-1	12760988
three	O	-1	12760988
patients,	O	-1	12760988
but	O	-1	12760988
only	O	-1	12760988
one	O	-1	12760988
patient	O	-1	12760988
reported	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
;	O	-1	12760988
no	O	-1	12760988
rel@@	O	-1	12760988
ationship	O	-1	12760988
between	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
and	O	-1	12760988
the	O	-1	12760988
increase	O	-1	12760988
of	O	-1	12760988
I@@	O	-1	12760988
L-@@	O	-1	12760988
6	O	-1	12760988
was	O	-1	12760988
f@@	O	-1	12760988
oun@@	O	-1	12760988
d.	O	-1	12760988
In	O	-1	12760988
concl@@	O	-1	12760988
u@@	O	-1	12760988
sion,	O	-1	12760988
there	O	-1	12760988
is	O	-1	12760988
no	O	-1	12760988
evidence	O	-1	12760988
for	O	-1	12760988
an	O	-1	12760988
inflam@@	O	-1	12760988
mat@@	O	-1	12760988
ory	O	-1	12760988
or@@	O	-1	12760988
ig@@	O	-1	12760988
in	O	-1	12760988
of	O	-1	12760988
suc@@	B-Chemical	D013390	12760988
cin@@	I-Chemical	-1	12760988
ylcholine	I-Chemical	-1	12760988
-@@	O	-1	12760988
associated	O	-1	12760988
my@@	B-Disease	D063806	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
.	O	-1	12760988
I@@	O	-1	12760988
MP@@	O	-1	12760988
L@@	O	-1	12760988
IC@@	O	-1	12760988
AT@@	O	-1	12760988
ION@@	O	-1	12760988
S:	O	-1	12760988
Ad@@	O	-1	12760988
minist@@	O	-1	12760988
ration	O	-1	12760988
of	O	-1	12760988
de@@	B-Chemical	D003907	12760988
xameth@@	I-Chemical	-1	12760988
as@@	I-Chemical	-1	12760988
one	I-Chemical	-1	12760988
before	O	-1	12760988
suc@@	B-Chemical	D013390	12760988
cin@@	I-Chemical	-1	12760988
ylcholine	I-Chemical	-1	12760988
was	O	-1	12760988
not	O	-1	12760988
effective	O	-1	12760988
in	O	-1	12760988
decreas@@	O	-1	12760988
ing	O	-1	12760988
the	O	-1	12760988
incidence	O	-1	12760988
or	O	-1	12760988
the	O	-1	12760988
severity	O	-1	12760988
of	O	-1	12760988
suc@@	B-Chemical	D013390	12760988
cin@@	I-Chemical	-1	12760988
ylcholine	I-Chemical	-1	12760988
-induced	O	-1	12760988
postoperative	B-Disease	D010149	12760988
my@@	I-Disease	-1	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
.	O	-1	12760988
F@@	O	-1	12760988
ur@@	O	-1	12760988
ther@@	O	-1	12760988
mo@@	O	-1	12760988
re,	O	-1	12760988
there	O	-1	12760988
was	O	-1	12760988
no	O	-1	12760988
significant	O	-1	12760988
rel@@	O	-1	12760988
ationship	O	-1	12760988
between	O	-1	12760988
postoperative	B-Disease	D010149	12760988
my@@	I-Disease	-1	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
and	O	-1	12760988
time	O	-1	12760988
course	O	-1	12760988
of	O	-1	12760988
inter@@	O	-1	12760988
leuk@@	O	-1	12760988
in-@@	O	-1	12760988
6	O	-1	12760988
concentr@@	O	-1	12760988
ation@@	O	-1	12760988
s,	O	-1	12760988
a	O	-1	12760988
mark@@	O	-1	12760988
er	O	-1	12760988
of	O	-1	12760988
inflam@@	B-Disease	D007249	12760988
m@@	I-Disease	-1	12760988
ation	I-Disease	-1	12760988
.	O	-1	12760988
Pre@@	O	-1	12760988
treatment	O	-1	12760988
with	O	-1	12760988
de@@	B-Chemical	D003907	12760988
xameth@@	I-Chemical	-1	12760988
as@@	I-Chemical	-1	12760988
one	I-Chemical	-1	12760988
is	O	-1	12760988
not	O	-1	12760988
j@@	O	-1	12760988
us@@	O	-1	12760988
ti@@	O	-1	12760988
fied	O	-1	12760988
to	O	-1	12760988
prev@@	O	-1	12760988
ent	O	-1	12760988
postoperative	B-Disease	D010149	12760988
my@@	I-Disease	-1	12760988
al@@	I-Disease	-1	12760988
g@@	I-Disease	-1	12760988
ia	I-Disease	-1	12760988
after	O	-1	12760988
suc@@	B-Chemical	D013390	12760988
cin@@	I-Chemical	-1	12760988
ylcholine	I-Chemical	-1	12760988
.	O	-1	12760988

L@@	B-Chemical	D007980	12691807
evo@@	I-Chemical	-1	12691807
dopa	I-Chemical	-1	12691807
-induced	O	-1	12691807
o@@	O	-1	12691807
rom@@	O	-1	12691807
an@@	O	-1	12691807
di@@	O	-1	12691807
b@@	O	-1	12691807
ular	O	-1	12691807
dy@@	B-Disease	D004421	12691807
ston@@	I-Disease	-1	12691807
ia	I-Disease	-1	12691807
in	O	-1	12691807
progressive	B-Disease	D013494	12691807
sup@@	I-Disease	-1	12691807
ran@@	I-Disease	-1	12691807
ucle@@	I-Disease	-1	12691807
ar	I-Disease	-1	12691807
p@@	I-Disease	-1	12691807
al@@	I-Disease	-1	12691807
sy	I-Disease	-1	12691807
.	O	-1	12691807
L@@	B-Chemical	D007980	12691807
evo@@	I-Chemical	-1	12691807
dopa	I-Chemical	-1	12691807
-induced	O	-1	12691807
dyskine@@	B-Disease	D004409	12691807
si@@	I-Disease	-1	12691807
as	I-Disease	-1	12691807
have	O	-1	12691807
been	O	-1	12691807
reported	O	-1	12691807
in	O	-1	12691807
Parkinson's	B-Disease	D010300	12691807
disease	I-Disease	-1	12691807
and	O	-1	12691807
multiple	B-Disease	D019578	12691807
system	I-Disease	-1	12691807
atro@@	I-Disease	-1	12691807
ph@@	I-Disease	-1	12691807
y	I-Disease	-1	12691807
.	O	-1	12691807
C@@	O	-1	12691807
ranial	O	-1	12691807
dy@@	B-Disease	D004421	12691807
st@@	I-Disease	-1	12691807
oni@@	I-Disease	-1	12691807
as	I-Disease	-1	12691807
are	O	-1	12691807
r@@	O	-1	12691807
are	O	-1	12691807
in	O	-1	12691807
patients	O	-1	12691807
with	O	-1	12691807
progressive	B-Disease	D013494	12691807
sup@@	I-Disease	-1	12691807
ran@@	I-Disease	-1	12691807
ucle@@	I-Disease	-1	12691807
ar	I-Disease	-1	12691807
p@@	I-Disease	-1	12691807
al@@	I-Disease	-1	12691807
sy	I-Disease	-1	12691807
(	O	-1	12691807
P@@	B-Disease	D013494	12691807
S@@	I-Disease	-1	12691807
P	I-Disease	-1	12691807
).	O	-1	12691807
In	O	-1	12691807
this	O	-1	12691807
report	O	-1	12691807
we	O	-1	12691807
describe	O	-1	12691807
an	O	-1	12691807
un@@	O	-1	12691807
us@@	O	-1	12691807
ual	O	-1	12691807
case	O	-1	12691807
of	O	-1	12691807
reversible	O	-1	12691807
levo@@	B-Chemical	D007980	12691807
dopa	I-Chemical	-1	12691807
-induced	O	-1	12691807
O@@	B-Disease	D008538	12691807
rom@@	I-Disease	-1	12691807
an@@	I-Disease	-1	12691807
di@@	I-Disease	-1	12691807
b@@	I-Disease	-1	12691807
ular	I-Disease	-1	12691807
dy@@	I-Disease	-1	12691807
ston@@	I-Disease	-1	12691807
ia	I-Disease	-1	12691807
(	O	-1	12691807
O@@	B-Disease	D008538	12691807
M@@	I-Disease	-1	12691807
D	I-Disease	-1	12691807
)	O	-1	12691807
in	O	-1	12691807
a	O	-1	12691807
P@@	B-Disease	D013494	12691807
S@@	I-Disease	-1	12691807
P	I-Disease	-1	12691807
patient	O	-1	12691807
to	O	-1	12691807
high@@	O	-1	12691807
li@@	O	-1	12691807
ght	O	-1	12691807
the	O	-1	12691807
import@@	O	-1	12691807
ance	O	-1	12691807
of	O	-1	12691807
reco@@	O	-1	12691807
gn@@	O	-1	12691807
iz@@	O	-1	12691807
ing	O	-1	12691807
this	O	-1	12691807
drug	O	-1	12691807
related	O	-1	12691807
complication	O	-1	12691807
in	O	-1	12691807
the	O	-1	12691807
man@@	O	-1	12691807
ag@@	O	-1	12691807
ement	O	-1	12691807
of	O	-1	12691807
P@@	B-Disease	D013494	12691807
S@@	I-Disease	-1	12691807
P	I-Disease	-1	12691807
,	O	-1	12691807
and	O	-1	12691807
discus@@	O	-1	12691807
s	O	-1	12691807
the	O	-1	12691807
possible	O	-1	12691807
underlying	O	-1	12691807
path@@	O	-1	12691807
oph@@	O	-1	12691807
ysi@@	O	-1	12691807
olog@@	O	-1	12691807
y.	O	-1	12691807

Pro@@	O	-1	12600698
t@@	O	-1	12600698
ective	O	-1	12600698
effect	O	-1	12600698
of	O	-1	12600698
ed@@	B-Chemical	C005435	12600698
ar@@	I-Chemical	-1	12600698
av@@	I-Chemical	-1	12600698
one	I-Chemical	-1	12600698
against	O	-1	12600698
st@@	B-Chemical	D013307	12600698
re@@	I-Chemical	-1	12600698
pto@@	I-Chemical	-1	12600698
m@@	I-Chemical	-1	12600698
ycin	I-Chemical	-1	12600698
-induced	O	-1	12600698
v@@	B-Disease	D015837	12600698
es@@	I-Disease	-1	12600698
ti@@	I-Disease	-1	12600698
bu@@	I-Disease	-1	12600698
lo@@	I-Disease	-1	12600698
toxicity	I-Disease	-1	12600698
in	O	-1	12600698
the	O	-1	12600698
gu@@	O	-1	12600698
ine@@	O	-1	12600698
a	O	-1	12600698
pi@@	O	-1	12600698
g@@	O	-1	12600698
.	O	-1	12600698
This	O	-1	12600698
study	O	-1	12600698
investigated	O	-1	12600698
al@@	O	-1	12600698
le@@	O	-1	12600698
vi@@	O	-1	12600698
ation	O	-1	12600698
of	O	-1	12600698
st@@	B-Chemical	D013307	12600698
re@@	I-Chemical	-1	12600698
pto@@	I-Chemical	-1	12600698
m@@	I-Chemical	-1	12600698
ycin	I-Chemical	-1	12600698
-induced	O	-1	12600698
v@@	B-Disease	D015837	12600698
es@@	I-Disease	-1	12600698
ti@@	I-Disease	-1	12600698
bu@@	I-Disease	-1	12600698
lo@@	I-Disease	-1	12600698
toxicity	I-Disease	-1	12600698
by	O	-1	12600698
ed@@	B-Chemical	C005435	12600698
ar@@	I-Chemical	-1	12600698
av@@	I-Chemical	-1	12600698
one	I-Chemical	-1	12600698
in	O	-1	12600698
gu@@	O	-1	12600698
ine@@	O	-1	12600698
a	O	-1	12600698
pi@@	O	-1	12600698
g@@	O	-1	12600698
s.	O	-1	12600698
E@@	B-Chemical	C005435	12600698
d@@	I-Chemical	-1	12600698
ar@@	I-Chemical	-1	12600698
av@@	I-Chemical	-1	12600698
one	I-Chemical	-1	12600698
,	O	-1	12600698
a	O	-1	12600698
free	O	-1	12600698
ra@@	O	-1	12600698
d@@	O	-1	12600698
ical	O	-1	12600698
s@@	O	-1	12600698
ca@@	O	-1	12600698
ven@@	O	-1	12600698
g@@	O	-1	12600698
er,	O	-1	12600698
has	O	-1	12600698
pot@@	O	-1	12600698
ent	O	-1	12600698
free	O	-1	12600698
ra@@	O	-1	12600698
d@@	O	-1	12600698
ical	O	-1	12600698
qu@@	O	-1	12600698
en@@	O	-1	12600698
ch@@	O	-1	12600698
ing	O	-1	12600698
action	O	-1	12600698
and	O	-1	12600698
is	O	-1	12600698
used	O	-1	12600698
in	O	-1	12600698
clinical	O	-1	12600698
p@@	O	-1	12600698
rac@@	O	-1	12600698
ti@@	O	-1	12600698
ce	O	-1	12600698
to	O	-1	12600698
tre@@	O	-1	12600698
at	O	-1	12600698
cerebral	B-Disease	D002544	12600698
infarction	I-Disease	-1	12600698
.	O	-1	12600698
S@@	B-Chemical	D013307	12600698
tre@@	I-Chemical	-1	12600698
pto@@	I-Chemical	-1	12600698
m@@	I-Chemical	-1	12600698
ycin	I-Chemical	-1	12600698
was	O	-1	12600698
administered	O	-1	12600698
to	O	-1	12600698
the	O	-1	12600698
in@@	O	-1	12600698
n@@	O	-1	12600698
er	O	-1	12600698
e@@	O	-1	12600698
ar	O	-1	12600698
by	O	-1	12600698
os@@	O	-1	12600698
mo@@	O	-1	12600698
tic	O	-1	12600698
p@@	O	-1	12600698
um@@	O	-1	12600698
p	O	-1	12600698
for	O	-1	12600698
24	O	-1	12600698
h@@	O	-1	12600698
,	O	-1	12600698
and	O	-1	12600698
ed@@	B-Chemical	C005435	12600698
ar@@	I-Chemical	-1	12600698
av@@	I-Chemical	-1	12600698
one	I-Chemical	-1	12600698
(n@@	O	-1	12600698
=@@	O	-1	12600698
8@@	O	-1	12600698
)	O	-1	12600698
or	O	-1	12600698
saline	O	-1	12600698
(n@@	O	-1	12600698
=@@	O	-1	12600698
6@@	O	-1	12600698
)	O	-1	12600698
was	O	-1	12600698
intra@@	O	-1	12600698
per@@	O	-1	12600698
it@@	O	-1	12600698
one@@	O	-1	12600698
ally	O	-1	12600698
injected	O	-1	12600698
on@@	O	-1	12600698
ce	O	-1	12600698
a	O	-1	12600698
day	O	-1	12600698
for	O	-1	12600698
7	O	-1	12600698
days.	O	-1	12600698
We	O	-1	12600698
observed	O	-1	12600698
h@@	O	-1	12600698
or@@	O	-1	12600698
iz@@	O	-1	12600698
ont@@	O	-1	12600698
al	O	-1	12600698
v@@	O	-1	12600698
es@@	O	-1	12600698
ti@@	O	-1	12600698
bu@@	O	-1	12600698
lo@@	O	-1	12600698
-@@	O	-1	12600698
oc@@	O	-1	12600698
ular	O	-1	12600698
ref@@	O	-1	12600698
le@@	O	-1	12600698
x	O	-1	12600698
as	O	-1	12600698
a	O	-1	12600698
mark@@	O	-1	12600698
er	O	-1	12600698
of	O	-1	12600698
postoperative	O	-1	12600698
v@@	O	-1	12600698
es@@	O	-1	12600698
ti@@	O	-1	12600698
b@@	O	-1	12600698
ular	O	-1	12600698
func@@	O	-1	12600698
tion.	O	-1	12600698
An@@	O	-1	12600698
im@@	O	-1	12600698
als	O	-1	12600698
injected	O	-1	12600698
with	O	-1	12600698
saline	O	-1	12600698
showed	O	-1	12600698
statis@@	O	-1	12600698
tically	O	-1	12600698
sm@@	O	-1	12600698
all@@	O	-1	12600698
er	O	-1	12600698
g@@	O	-1	12600698
ain@@	O	-1	12600698
s	O	-1	12600698
than	O	-1	12600698
those	O	-1	12600698
injected	O	-1	12600698
with	O	-1	12600698
ed@@	B-Chemical	C005435	12600698
ar@@	I-Chemical	-1	12600698
av@@	I-Chemical	-1	12600698
one	I-Chemical	-1	12600698
.	O	-1	12600698
These	O	-1	12600698
results	O	-1	12600698
suggest	O	-1	12600698
that	O	-1	12600698
ed@@	B-Chemical	C005435	12600698
ar@@	I-Chemical	-1	12600698
av@@	I-Chemical	-1	12600698
one	I-Chemical	-1	12600698
sup@@	O	-1	12600698
pres@@	O	-1	12600698
ses	O	-1	12600698
st@@	B-Chemical	D013307	12600698
re@@	I-Chemical	-1	12600698
pto@@	I-Chemical	-1	12600698
m@@	I-Chemical	-1	12600698
ycin	I-Chemical	-1	12600698
-induced	O	-1	12600698
v@@	B-Disease	D015837	12600698
es@@	I-Disease	-1	12600698
ti@@	I-Disease	-1	12600698
bu@@	I-Disease	-1	12600698
lo@@	I-Disease	-1	12600698
toxicity	I-Disease	-1	12600698
.	O	-1	12600698

K@@	B-Chemical	D007649	12091028
et@@	I-Chemical	-1	12091028
amine	I-Chemical	-1	12091028
in	O	-1	12091028
war@@	O	-1	12091028
/@@	O	-1	12091028
tro@@	O	-1	12091028
p@@	O	-1	12091028
ical	O	-1	12091028
surger@@	O	-1	12091028
y	O	-1	12091028
(@@	O	-1	12091028
a	O	-1	12091028
f@@	O	-1	12091028
inal	O	-1	12091028
tri@@	O	-1	12091028
b@@	O	-1	12091028
ute	O	-1	12091028
to	O	-1	12091028
the	O	-1	12091028
rac@@	O	-1	12091028
em@@	O	-1	12091028
ic	O	-1	12091028
mi@@	O	-1	12091028
x@@	O	-1	12091028
t@@	O	-1	12091028
ure@@	O	-1	12091028
).	O	-1	12091028
A	O	-1	12091028
t@@	O	-1	12091028
ech@@	O	-1	12091028
n@@	O	-1	12091028
i@@	O	-1	12091028
qu@@	O	-1	12091028
e	O	-1	12091028
of	O	-1	12091028
continu@@	O	-1	12091028
ous	O	-1	12091028
intravenous	O	-1	12091028
anaesthe@@	O	-1	12091028
sia	O	-1	12091028
with	O	-1	12091028
k@@	B-Chemical	D007649	12091028
et@@	I-Chemical	-1	12091028
amine	I-Chemical	-1	12091028
was	O	-1	12091028
used	O	-1	12091028
suc@@	O	-1	12091028
cess@@	O	-1	12091028
ful@@	O	-1	12091028
ly	O	-1	12091028
during	O	-1	12091028
the	O	-1	12091028
S@@	O	-1	12091028
om@@	O	-1	12091028
al@@	O	-1	12091028
ia	O	-1	12091028
ci@@	O	-1	12091028
vi@@	O	-1	12091028
l	O	-1	12091028
w@@	O	-1	12091028
ar	O	-1	12091028
in	O	-1	12091028
19@@	O	-1	12091028
9@@	O	-1	12091028
4	O	-1	12091028
and	O	-1	12091028
in	O	-1	12091028
nor@@	O	-1	12091028
th	O	-1	12091028
U@@	O	-1	12091028
g@@	O	-1	12091028
and@@	O	-1	12091028
a	O	-1	12091028
in	O	-1	12091028
19@@	O	-1	12091028
9@@	O	-1	12091028
9	O	-1	12091028
for	O	-1	12091028
6@@	O	-1	12091028
4	O	-1	12091028
o@@	O	-1	12091028
per@@	O	-1	12091028
ations	O	-1	12091028
in	O	-1	12091028
6@@	O	-1	12091028
2	O	-1	12091028
patients,	O	-1	12091028
aged	O	-1	12091028
from	O	-1	12091028
6	O	-1	12091028
weeks	O	-1	12091028
to	O	-1	12091028
7@@	O	-1	12091028
0	O	-1	12091028
year@@	O	-1	12091028
s,	O	-1	12091028
under@@	O	-1	12091028
go@@	O	-1	12091028
ing	O	-1	12091028
lim@@	O	-1	12091028
b	O	-1	12091028
and	O	-1	12091028
ab@@	O	-1	12091028
domin@@	O	-1	12091028
al	O	-1	12091028
surger@@	O	-1	12091028
y	O	-1	12091028
including	O	-1	12091028
ca@@	O	-1	12091028
es@@	O	-1	12091028
ari@@	O	-1	12091028
an	O	-1	12091028
sec@@	O	-1	12091028
tions	O	-1	12091028
and	O	-1	12091028
inter@@	O	-1	12091028
ven@@	O	-1	12091028
tions	O	-1	12091028
in	O	-1	12091028
ne@@	O	-1	12091028
on@@	O	-1	12091028
at@@	O	-1	12091028
es.	O	-1	12091028
O@@	O	-1	12091028
per@@	O	-1	12091028
ations	O	-1	12091028
l@@	O	-1	12091028
ast@@	O	-1	12091028
ing	O	-1	12091028
up	O	-1	12091028
to	O	-1	12091028
2@@	O	-1	12091028
h	O	-1	12091028
could	O	-1	12091028
be	O	-1	12091028
performed	O	-1	12091028
in	O	-1	12091028
the	O	-1	12091028
absence	O	-1	12091028
of	O	-1	12091028
s@@	O	-1	12091028
oph@@	O	-1	12091028
is@@	O	-1	12091028
tic@@	O	-1	12091028
ated	O	-1	12091028
equ@@	O	-1	12091028
ip@@	O	-1	12091028
ment	O	-1	12091028
such	O	-1	12091028
as	O	-1	12091028
pul@@	O	-1	12091028
se	O	-1	12091028
ox@@	O	-1	12091028
i@@	O	-1	12091028
me@@	O	-1	12091028
ters	O	-1	12091028
or	O	-1	12091028
ven@@	O	-1	12091028
ti@@	O	-1	12091028
lat@@	O	-1	12091028
ors	O	-1	12091028
in	O	-1	12091028
patients	O	-1	12091028
on	O	-1	12091028
spont@@	O	-1	12091028
aneous	O	-1	12091028
ven@@	O	-1	12091028
til@@	O	-1	12091028
ation	O	-1	12091028
b@@	O	-1	12091028
re@@	O	-1	12091028
ath@@	O	-1	12091028
ing	O	-1	12091028
a@@	O	-1	12091028
ir@@	O	-1	12091028
/	O	-1	12091028
oxy@@	B-Chemical	D010100	12091028
gen	I-Chemical	-1	12091028
on@@	O	-1	12091028
ly.	O	-1	12091028
After	O	-1	12091028
pre@@	O	-1	12091028
medic@@	O	-1	12091028
ation	O	-1	12091028
with	O	-1	12091028
di@@	B-Chemical	D003975	12091028
az@@	I-Chemical	-1	12091028
epam	I-Chemical	-1	12091028
,	O	-1	12091028
gly@@	B-Chemical	D006024	12091028
co@@	I-Chemical	-1	12091028
py@@	I-Chemical	-1	12091028
r@@	I-Chemical	-1	12091028
ro@@	I-Chemical	-1	12091028
l@@	I-Chemical	-1	12091028
ate	I-Chemical	-1	12091028
and	O	-1	12091028
loc@@	O	-1	12091028
al	O	-1	12091028
anaesthe@@	O	-1	12091028
si@@	O	-1	12091028
a,	O	-1	12091028
and	O	-1	12091028
induction	O	-1	12091028
with	O	-1	12091028
standard	O	-1	12091028
doses	O	-1	12091028
of	O	-1	12091028
k@@	B-Chemical	D007649	12091028
et@@	I-Chemical	-1	12091028
amine	I-Chemical	-1	12091028
,	O	-1	12091028
a	O	-1	12091028
maint@@	O	-1	12091028
en@@	O	-1	12091028
ance	O	-1	12091028
dose	O	-1	12091028
of	O	-1	12091028
10-@@	O	-1	12091028
20	O	-1	12091028
micro@@	O	-1	12091028
g/@@	O	-1	12091028
k@@	O	-1	12091028
g/@@	O	-1	12091028
min	O	-1	12091028
of	O	-1	12091028
k@@	B-Chemical	D007649	12091028
et@@	I-Chemical	-1	12091028
amine	I-Chemical	-1	12091028
pro@@	O	-1	12091028
ved	O	-1	12091028
saf@@	O	-1	12091028
e	O	-1	12091028
and	O	-1	12091028
eff@@	O	-1	12091028
ecti@@	O	-1	12091028
ve.	O	-1	12091028
E@@	O	-1	12091028
m@@	O	-1	12091028
pha@@	O	-1	12091028
sis	O	-1	12091028
was	O	-1	12091028
pl@@	O	-1	12091028
ac@@	O	-1	12091028
ed	O	-1	12091028
on	O	-1	12091028
be@@	O	-1	12091028
d@@	O	-1	12091028
side	O	-1	12091028
clinical	O	-1	12091028
monit@@	O	-1	12091028
or@@	O	-1	12091028
ing,	O	-1	12091028
rel@@	O	-1	12091028
y@@	O	-1	12091028
ing	O	-1	12091028
he@@	O	-1	12091028
avi@@	O	-1	12091028
ly	O	-1	12091028
on	O	-1	12091028
the	O	-1	12091028
heart	O	-1	12091028
rat@@	O	-1	12091028
e.	O	-1	12091028
Di@@	B-Chemical	D003975	12091028
az@@	I-Chemical	-1	12091028
epam	I-Chemical	-1	12091028
,	O	-1	12091028
un@@	O	-1	12091028
less	O	-1	12091028
contra@@	O	-1	12091028
indic@@	O	-1	12091028
ated	O	-1	12091028
or	O	-1	12091028
ris@@	O	-1	12091028
k@@	O	-1	12091028
y,	O	-1	12091028
remain@@	O	-1	12091028
s	O	-1	12091028
the	O	-1	12091028
only	O	-1	12091028
nec@@	O	-1	12091028
ess@@	O	-1	12091028
ary	O	-1	12091028
comple@@	O	-1	12091028
ment@@	O	-1	12091028
ary	O	-1	12091028
drug	O	-1	12091028
to	O	-1	12091028
k@@	B-Chemical	D007649	12091028
et@@	I-Chemical	-1	12091028
amine	I-Chemical	-1	12091028
as	O	-1	12091028
it	O	-1	12091028
bu@@	O	-1	12091028
ff@@	O	-1	12091028
ers	O	-1	12091028
its	O	-1	12091028
cardiovascular	O	-1	12091028
response	O	-1	12091028
and	O	-1	12091028
decreas@@	O	-1	12091028
es	O	-1	12091028
the	O	-1	12091028
duration	O	-1	12091028
and	O	-1	12091028
int@@	O	-1	12091028
ensity	O	-1	12091028
of	O	-1	12091028
o@@	O	-1	12091028
perative	O	-1	12091028
and	O	-1	12091028
postoperative	O	-1	12091028
h@@	B-Disease	D006212	12091028
all@@	I-Disease	-1	12091028
uc@@	I-Disease	-1	12091028
in@@	I-Disease	-1	12091028
ations	I-Disease	-1	12091028
.	O	-1	12091028
L@@	O	-1	12091028
oc@@	O	-1	12091028
al	O	-1	12091028
anaesthe@@	O	-1	12091028
tic	O	-1	12091028
block@@	O	-1	12091028
s	O	-1	12091028
were	O	-1	12091028
use@@	O	-1	12091028
ful	O	-1	12091028
in	O	-1	12091028
decreas@@	O	-1	12091028
ing	O	-1	12091028
the	O	-1	12091028
requ@@	O	-1	12091028
i@@	O	-1	12091028
re@@	O	-1	12091028
ment	O	-1	12091028
for	O	-1	12091028
postoperative	O	-1	12091028
analge@@	B-Disease	D000699	12091028
sia	I-Disease	-1	12091028
.	O	-1	12091028
An	O	-1	12091028
anti@@	O	-1	12091028
si@@	O	-1	12091028
alo@@	O	-1	12091028
gu@@	O	-1	12091028
e	O	-1	12091028
was	O	-1	12091028
us@@	O	-1	12091028
ually	O	-1	12091028
un@@	O	-1	12091028
nec@@	O	-1	12091028
ess@@	O	-1	12091028
ary	O	-1	12091028
in	O	-1	12091028
o@@	O	-1	12091028
per@@	O	-1	12091028
ations	O	-1	12091028
l@@	O	-1	12091028
ast@@	O	-1	12091028
ing	O	-1	12091028
up	O	-1	12091028
to	O	-1	12091028
2	O	-1	12091028
h@@	O	-1	12091028
,	O	-1	12091028
gly@@	B-Chemical	D006024	12091028
co@@	I-Chemical	-1	12091028
py@@	I-Chemical	-1	12091028
r@@	I-Chemical	-1	12091028
ro@@	I-Chemical	-1	12091028
l@@	I-Chemical	-1	12091028
ate	I-Chemical	-1	12091028
being	O	-1	12091028
the	O	-1	12091028
b@@	O	-1	12091028
est	O	-1	12091028
ch@@	O	-1	12091028
o@@	O	-1	12091028
ic@@	O	-1	12091028
e	O	-1	12091028
for	O	-1	12091028
its	O	-1	12091028
low@@	O	-1	12091028
est	O	-1	12091028
psych@@	O	-1	12091028
ot@@	O	-1	12091028
ro@@	O	-1	12091028
p@@	O	-1	12091028
ic	O	-1	12091028
and	O	-1	12091028
chron@@	O	-1	12091028
ot@@	O	-1	12091028
ro@@	O	-1	12091028
p@@	O	-1	12091028
ic	O	-1	12091028
effect@@	O	-1	12091028
s,	O	-1	12091028
es@@	O	-1	12091028
p@@	O	-1	12091028
ec@@	O	-1	12091028
i@@	O	-1	12091028
ally	O	-1	12091028
in	O	-1	12091028
a	O	-1	12091028
ho@@	O	-1	12091028
t	O	-1	12091028
cl@@	O	-1	12091028
im@@	O	-1	12091028
at@@	O	-1	12091028
e.	O	-1	12091028
E@@	O	-1	12091028
x@@	O	-1	12091028
peri@@	O	-1	12091028
ence	O	-1	12091028
in	O	-1	12091028
war@@	O	-1	12091028
/@@	O	-1	12091028
tro@@	O	-1	12091028
p@@	O	-1	12091028
ical	O	-1	12091028
se@@	O	-1	12091028
t@@	O	-1	12091028
t@@	O	-1	12091028
ings	O	-1	12091028
suggests	O	-1	12091028
this	O	-1	12091028
t@@	O	-1	12091028
ech@@	O	-1	12091028
n@@	O	-1	12091028
i@@	O	-1	12091028
qu@@	O	-1	12091028
e	O	-1	12091028
could	O	-1	12091028
be	O	-1	12091028
use@@	O	-1	12091028
ful	O	-1	12091028
in	O	-1	12091028
ci@@	O	-1	12091028
v@@	O	-1	12091028
il@@	O	-1	12091028
i@@	O	-1	12091028
an	O	-1	12091028
cont@@	O	-1	12091028
ex@@	O	-1	12091028
ts	O	-1	12091028
such	O	-1	12091028
as	O	-1	12091028
out@@	O	-1	12091028
do@@	O	-1	12091028
or	O	-1	12091028
lif@@	O	-1	12091028
e-@@	O	-1	12091028
sa@@	O	-1	12091028
ving	O	-1	12091028
em@@	O	-1	12091028
er@@	O	-1	12091028
gen@@	O	-1	12091028
c@@	O	-1	12091028
y	O	-1	12091028
surger@@	O	-1	12091028
y	O	-1	12091028
or	O	-1	12091028
in	O	-1	12091028
mas@@	O	-1	12091028
s	O	-1	12091028
cas@@	O	-1	12091028
u@@	O	-1	12091028
al@@	O	-1	12091028
ties	O	-1	12091028
whe@@	O	-1	12091028
re,	O	-1	12091028
e@@	O	-1	12091028
.@@	O	-1	12091028
g@@	O	-1	12091028
.	O	-1	12091028
amp@@	O	-1	12091028
ut@@	O	-1	12091028
ation	O	-1	12091028
and	O	-1	12091028
ra@@	O	-1	12091028
pid	O	-1	12091028
ext@@	O	-1	12091028
r@@	O	-1	12091028
ic@@	O	-1	12091028
ation	O	-1	12091028
were	O	-1	12091028
requ@@	O	-1	12091028
i@@	O	-1	12091028
red.	O	-1	12091028

S@@	B-Chemical	D013256	11860495
ter@@	I-Chemical	-1	11860495
oid	I-Chemical	-1	11860495
struct@@	O	-1	11860495
ure	O	-1	11860495
and	O	-1	11860495
pharmac@@	O	-1	11860495
ological	O	-1	11860495
pro@@	O	-1	11860495
per@@	O	-1	11860495
ties	O	-1	11860495
determine	O	-1	11860495
the	O	-1	11860495
anti@@	O	-1	11860495
-	O	-1	11860495
am@@	B-Disease	D000647	11860495
ne@@	I-Disease	-1	11860495
sic	I-Disease	-1	11860495
effects	O	-1	11860495
of	O	-1	11860495
pregn@@	B-Chemical	C018370	11860495
en@@	I-Chemical	-1	11860495
ol@@	I-Chemical	-1	11860495
one	I-Chemical	-1	11860495
sul@@	I-Chemical	-1	11860495
ph@@	I-Chemical	-1	11860495
ate	I-Chemical	-1	11860495
in	O	-1	11860495
the	O	-1	11860495
p@@	O	-1	11860495
as@@	O	-1	11860495
sive	O	-1	11860495
avoid@@	O	-1	11860495
ance	O	-1	11860495
t@@	O	-1	11860495
as@@	O	-1	11860495
k	O	-1	11860495
in	O	-1	11860495
rats.	O	-1	11860495
Pre@@	B-Chemical	C018370	11860495
gn@@	I-Chemical	-1	11860495
en@@	I-Chemical	-1	11860495
ol@@	I-Chemical	-1	11860495
one	I-Chemical	-1	11860495
sul@@	I-Chemical	-1	11860495
ph@@	I-Chemical	-1	11860495
ate	I-Chemical	-1	11860495
(	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
)	O	-1	11860495
has	O	-1	11860495
gener@@	O	-1	11860495
ated	O	-1	11860495
in@@	O	-1	11860495
te@@	O	-1	11860495
res@@	O	-1	11860495
t	O	-1	11860495
as	O	-1	11860495
one	O	-1	11860495
of	O	-1	11860495
the	O	-1	11860495
most	O	-1	11860495
pot@@	O	-1	11860495
ent	O	-1	11860495
memor@@	O	-1	11860495
y-@@	O	-1	11860495
enh@@	O	-1	11860495
anc@@	O	-1	11860495
ing	O	-1	11860495
neuro@@	O	-1	11860495
steroid@@	O	-1	11860495
s	O	-1	11860495
to	O	-1	11860495
be	O	-1	11860495
examined	O	-1	11860495
in	O	-1	11860495
ro@@	O	-1	11860495
d@@	O	-1	11860495
ent	O	-1	11860495
lear@@	O	-1	11860495
ning	O	-1	11860495
studi@@	O	-1	11860495
es,	O	-1	11860495
with	O	-1	11860495
partic@@	O	-1	11860495
ular	O	-1	11860495
import@@	O	-1	11860495
ance	O	-1	11860495
in	O	-1	11860495
the	O	-1	11860495
ag@@	O	-1	11860495
e@@	O	-1	11860495
ing	O	-1	11860495
pro@@	O	-1	11860495
ces@@	O	-1	11860495
s.	O	-1	11860495
The	O	-1	11860495
mechanism	O	-1	11860495
by	O	-1	11860495
which	O	-1	11860495
this	O	-1	11860495
endo@@	O	-1	11860495
gen@@	O	-1	11860495
ous	O	-1	11860495
ster@@	B-Chemical	D013256	11860495
oid	I-Chemical	-1	11860495
enh@@	O	-1	11860495
anc@@	O	-1	11860495
es	O	-1	11860495
memory	O	-1	11860495
formation	O	-1	11860495
is	O	-1	11860495
hypo@@	O	-1	11860495
the@@	O	-1	11860495
si@@	O	-1	11860495
zed	O	-1	11860495
to	O	-1	11860495
invol@@	O	-1	11860495
ve	O	-1	11860495
ac@@	O	-1	11860495
tions	O	-1	11860495
on	O	-1	11860495
glutam@@	O	-1	11860495
at@@	O	-1	11860495
ergic	O	-1	11860495
and	O	-1	11860495
G@@	O	-1	11860495
A@@	O	-1	11860495
BA@@	O	-1	11860495
ergic	O	-1	11860495
system@@	O	-1	11860495
s.	O	-1	11860495
This	O	-1	11860495
hypo@@	O	-1	11860495
thesis	O	-1	11860495
st@@	O	-1	11860495
em@@	O	-1	11860495
s	O	-1	11860495
from	O	-1	11860495
findings	O	-1	11860495
that	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
is	O	-1	11860495
a	O	-1	11860495
pot@@	O	-1	11860495
ent	O	-1	11860495
positive	O	-1	11860495
mod@@	O	-1	11860495
ul@@	O	-1	11860495
at@@	O	-1	11860495
or	O	-1	11860495
of	O	-1	11860495
N@@	B-Chemical	D016202	11860495
-@@	I-Chemical	-1	11860495
methyl@@	I-Chemical	-1	11860495
-@@	I-Chemical	-1	11860495
d-@@	I-Chemical	-1	11860495
as@@	I-Chemical	-1	11860495
part@@	I-Chemical	-1	11860495
ate	I-Chemical	-1	11860495
receptors	O	-1	11860495
(N@@	O	-1	11860495
MD@@	O	-1	11860495
A@@	O	-1	11860495
R@@	O	-1	11860495
s)	O	-1	11860495
and	O	-1	11860495
a	O	-1	11860495
negative	O	-1	11860495
mod@@	O	-1	11860495
ul@@	O	-1	11860495
at@@	O	-1	11860495
or	O	-1	11860495
of	O	-1	11860495
gamma@@	B-Chemical	D005680	11860495
-@@	I-Chemical	-1	11860495
amin@@	I-Chemical	-1	11860495
ob@@	I-Chemical	-1	11860495
ut@@	I-Chemical	-1	11860495
y@@	I-Chemical	-1	11860495
ric	I-Chemical	-1	11860495
acid	I-Chemical	-1	11860495
(A@@	O	-1	11860495
)	O	-1	11860495
receptors	O	-1	11860495
(	O	-1	11860495
G@@	B-Chemical	D005680	11860495
A@@	I-Chemical	-1	11860495
B@@	I-Chemical	-1	11860495
A	I-Chemical	-1	11860495
(A@@	O	-1	11860495
)@@	O	-1	11860495
R@@	O	-1	11860495
s@@	O	-1	11860495
).	O	-1	11860495
M@@	O	-1	11860495
ore@@	O	-1	11860495
o@@	O	-1	11860495
ver,	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
is	O	-1	11860495
able	O	-1	11860495
to	O	-1	11860495
re@@	O	-1	11860495
verse	O	-1	11860495
the	O	-1	11860495
am@@	B-Disease	D000647	11860495
ne@@	I-Disease	-1	11860495
sic	I-Disease	-1	11860495
-@@	O	-1	11860495
like	O	-1	11860495
effects	O	-1	11860495
of	O	-1	11860495
N@@	O	-1	11860495
MD@@	O	-1	11860495
A@@	O	-1	11860495
R	O	-1	11860495
and	O	-1	11860495
G@@	B-Chemical	D005680	11860495
A@@	I-Chemical	-1	11860495
B@@	I-Chemical	-1	11860495
A	I-Chemical	-1	11860495
(A@@	O	-1	11860495
)@@	O	-1	11860495
R	O	-1	11860495
li@@	O	-1	11860495
g@@	O	-1	11860495
and@@	O	-1	11860495
s.	O	-1	11860495
To	O	-1	11860495
investigate	O	-1	11860495
this	O	-1	11860495
hypo@@	O	-1	11860495
the@@	O	-1	11860495
sis,	O	-1	11860495
the	O	-1	11860495
present	O	-1	11860495
study	O	-1	11860495
in	O	-1	11860495
rats	O	-1	11860495
examined	O	-1	11860495
the	O	-1	11860495
memor@@	O	-1	11860495
y-@@	O	-1	11860495
al@@	O	-1	11860495
ter@@	O	-1	11860495
ing	O	-1	11860495
abil@@	O	-1	11860495
ities	O	-1	11860495
of	O	-1	11860495
struct@@	O	-1	11860495
ural	O	-1	11860495
an@@	O	-1	11860495
alo@@	O	-1	11860495
g@@	O	-1	11860495
s	O	-1	11860495
of	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
,	O	-1	11860495
which	O	-1	11860495
diff@@	O	-1	11860495
er	O	-1	11860495
in	O	-1	11860495
their	O	-1	11860495
mod@@	O	-1	11860495
ulation	O	-1	11860495
of	O	-1	11860495
N@@	O	-1	11860495
MD@@	O	-1	11860495
A@@	O	-1	11860495
R	O	-1	11860495
and/or	O	-1	11860495
G@@	B-Chemical	D005680	11860495
A@@	I-Chemical	-1	11860495
B@@	I-Chemical	-1	11860495
A	I-Chemical	-1	11860495
(A@@	O	-1	11860495
)@@	O	-1	11860495
R	O	-1	11860495
func@@	O	-1	11860495
tion.	O	-1	11860495
The	O	-1	11860495
an@@	O	-1	11860495
alo@@	O	-1	11860495
g@@	O	-1	11860495
s	O	-1	11860495
tested	O	-1	11860495
we@@	O	-1	11860495
re@@	O	-1	11860495
:	O	-1	11860495
1@@	B-Chemical	-1	11860495
1-@@	I-Chemical	-1	11860495
ke@@	I-Chemical	-1	11860495
to@@	I-Chemical	-1	11860495
pregn@@	I-Chemical	-1	11860495
en@@	I-Chemical	-1	11860495
ol@@	I-Chemical	-1	11860495
one	I-Chemical	-1	11860495
sul@@	I-Chemical	-1	11860495
ph@@	I-Chemical	-1	11860495
ate	I-Chemical	-1	11860495
(@@	O	-1	11860495
an	O	-1	11860495
agent	O	-1	11860495
that	O	-1	11860495
is	O	-1	11860495
in@@	O	-1	11860495
active	O	-1	11860495
at	O	-1	11860495
G@@	B-Chemical	D005680	11860495
A@@	I-Chemical	-1	11860495
B@@	I-Chemical	-1	11860495
A	I-Chemical	-1	11860495
(A@@	O	-1	11860495
)@@	O	-1	11860495
R@@	O	-1	11860495
s	O	-1	11860495
and	O	-1	11860495
N@@	O	-1	11860495
MD@@	O	-1	11860495
A@@	O	-1	11860495
R@@	O	-1	11860495
s),	O	-1	11860495
epi@@	B-Chemical	C018370	11860495
pregn@@	I-Chemical	-1	11860495
an@@	I-Chemical	-1	11860495
ol@@	I-Chemical	-1	11860495
one	I-Chemical	-1	11860495
(@@	I-Chemical	-1	11860495
[@@	I-Chemical	-1	11860495
3@@	I-Chemical	-1	11860495
beta-@@	I-Chemical	-1	11860495
hydrox@@	I-Chemical	-1	11860495
y-@@	I-Chemical	-1	11860495
5@@	I-Chemical	-1	11860495
beta-@@	I-Chemical	-1	11860495
pregn@@	I-Chemical	-1	11860495
an@@	I-Chemical	-1	11860495
-@@	I-Chemical	-1	11860495
20@@	I-Chemical	-1	11860495
-@@	I-Chemical	-1	11860495
one@@	I-Chemical	-1	11860495
]	I-Chemical	-1	11860495
sul@@	I-Chemical	-1	11860495
ph@@	I-Chemical	-1	11860495
ate	I-Chemical	-1	11860495
,	O	-1	11860495
an	O	-1	11860495
inhibitor	O	-1	11860495
of	O	-1	11860495
both	O	-1	11860495
G@@	B-Chemical	D005680	11860495
A@@	I-Chemical	-1	11860495
B@@	I-Chemical	-1	11860495
A	I-Chemical	-1	11860495
(A@@	O	-1	11860495
)@@	O	-1	11860495
R@@	O	-1	11860495
s	O	-1	11860495
and	O	-1	11860495
N@@	O	-1	11860495
MD@@	O	-1	11860495
A@@	O	-1	11860495
R@@	O	-1	11860495
s),	O	-1	11860495
and	O	-1	11860495
a	O	-1	11860495
ne@@	O	-1	11860495
w@@	O	-1	11860495
ly	O	-1	11860495
syn@@	O	-1	11860495
the@@	O	-1	11860495
si@@	O	-1	11860495
zed	O	-1	11860495
(-@@	O	-1	11860495
)	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
en@@	O	-1	11860495
anti@@	O	-1	11860495
om@@	O	-1	11860495
er	O	-1	11860495
(@@	O	-1	11860495
which	O	-1	11860495
is	O	-1	11860495
id@@	O	-1	11860495
en@@	O	-1	11860495
tical	O	-1	11860495
to	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
in	O	-1	11860495
effects	O	-1	11860495
on	O	-1	11860495
G@@	B-Chemical	D005680	11860495
A@@	I-Chemical	-1	11860495
B@@	I-Chemical	-1	11860495
A	I-Chemical	-1	11860495
(A@@	O	-1	11860495
)@@	O	-1	11860495
R@@	O	-1	11860495
s	O	-1	11860495
and	O	-1	11860495
N@@	O	-1	11860495
MD@@	O	-1	11860495
A@@	O	-1	11860495
R@@	O	-1	11860495
s@@	O	-1	11860495
).	O	-1	11860495
The	O	-1	11860495
memor@@	O	-1	11860495
y-@@	O	-1	11860495
enh@@	O	-1	11860495
anc@@	O	-1	11860495
ing	O	-1	11860495
effects	O	-1	11860495
of	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
and	O	-1	11860495
its	O	-1	11860495
an@@	O	-1	11860495
alo@@	O	-1	11860495
g@@	O	-1	11860495
s	O	-1	11860495
were	O	-1	11860495
tested	O	-1	11860495
in	O	-1	11860495
the	O	-1	11860495
p@@	O	-1	11860495
as@@	O	-1	11860495
sive	O	-1	11860495
avoid@@	O	-1	11860495
ance	O	-1	11860495
t@@	O	-1	11860495
as@@	O	-1	11860495
k	O	-1	11860495
using	O	-1	11860495
the	O	-1	11860495
model	O	-1	11860495
of	O	-1	11860495
scopol@@	B-Chemical	D012601	11860495
amine	I-Chemical	-1	11860495
-induced	O	-1	11860495
am@@	B-Disease	D000647	11860495
ne@@	I-Disease	-1	11860495
sia	I-Disease	-1	11860495
.	O	-1	11860495
B@@	O	-1	11860495
oth	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
and	O	-1	11860495
its	O	-1	11860495
(-@@	O	-1	11860495
)	O	-1	11860495
en@@	O	-1	11860495
anti@@	O	-1	11860495
om@@	O	-1	11860495
er	O	-1	11860495
block@@	O	-1	11860495
ed	O	-1	11860495
the	O	-1	11860495
effects	O	-1	11860495
of	O	-1	11860495
scopol@@	B-Chemical	D012601	11860495
amine	I-Chemical	-1	11860495
.	O	-1	11860495
The	O	-1	11860495
results	O	-1	11860495
show	O	-1	11860495
th@@	O	-1	11860495
at@@	O	-1	11860495
,	O	-1	11860495
un@@	O	-1	11860495
like	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
,	O	-1	11860495
1@@	B-Chemical	-1	11860495
1-@@	I-Chemical	-1	11860495
ke@@	I-Chemical	-1	11860495
to@@	I-Chemical	-1	11860495
pregn@@	I-Chemical	-1	11860495
en@@	I-Chemical	-1	11860495
ol@@	I-Chemical	-1	11860495
one	I-Chemical	-1	11860495
sul@@	I-Chemical	-1	11860495
ph@@	I-Chemical	-1	11860495
ate	I-Chemical	-1	11860495
and	O	-1	11860495
epi@@	B-Chemical	C018370	11860495
pregn@@	I-Chemical	-1	11860495
an@@	I-Chemical	-1	11860495
ol@@	I-Chemical	-1	11860495
one	I-Chemical	-1	11860495
sul@@	I-Chemical	-1	11860495
ph@@	I-Chemical	-1	11860495
ate	I-Chemical	-1	11860495
fail@@	O	-1	11860495
ed	O	-1	11860495
to	O	-1	11860495
bloc@@	O	-1	11860495
k	O	-1	11860495
the	O	-1	11860495
effect	O	-1	11860495
of	O	-1	11860495
scopol@@	B-Chemical	D012601	11860495
amine	I-Chemical	-1	11860495
,	O	-1	11860495
suggesting	O	-1	11860495
that	O	-1	11860495
al@@	O	-1	11860495
ter@@	O	-1	11860495
ing	O	-1	11860495
the	O	-1	11860495
mod@@	O	-1	11860495
ulation	O	-1	11860495
of	O	-1	11860495
N@@	B-Chemical	D016202	11860495
MD@@	I-Chemical	-1	11860495
A	I-Chemical	-1	11860495
receptors	O	-1	11860495
di@@	O	-1	11860495
min@@	O	-1	11860495
ish@@	O	-1	11860495
es	O	-1	11860495
the	O	-1	11860495
memor@@	O	-1	11860495
y-@@	O	-1	11860495
enh@@	O	-1	11860495
anc@@	O	-1	11860495
ing	O	-1	11860495
effects	O	-1	11860495
of	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
.	O	-1	11860495
M@@	O	-1	11860495
ore@@	O	-1	11860495
o@@	O	-1	11860495
ver,	O	-1	11860495
en@@	O	-1	11860495
anti@@	O	-1	11860495
o@@	O	-1	11860495
sel@@	O	-1	11860495
ec@@	O	-1	11860495
tivity	O	-1	11860495
was	O	-1	11860495
demonstrated	O	-1	11860495
by	O	-1	11860495
the	O	-1	11860495
ability	O	-1	11860495
of	O	-1	11860495
n@@	O	-1	11860495
at@@	O	-1	11860495
ural	O	-1	11860495
P@@	B-Chemical	C018370	11860495
R@@	I-Chemical	-1	11860495
E@@	I-Chemical	-1	11860495
G@@	I-Chemical	-1	11860495
S	I-Chemical	-1	11860495
to	O	-1	11860495
be	O	-1	11860495
an	O	-1	11860495
or@@	O	-1	11860495
der	O	-1	11860495
of	O	-1	11860495
mag@@	O	-1	11860495
nit@@	O	-1	11860495
ude	O	-1	11860495
more	O	-1	11860495
effective	O	-1	11860495
than	O	-1	11860495
its	O	-1	11860495
syn@@	O	-1	11860495
thetic	O	-1	11860495
en@@	O	-1	11860495
anti@@	O	-1	11860495
om@@	O	-1	11860495
er	O	-1	11860495
in	O	-1	11860495
rever@@	O	-1	11860495
s@@	O	-1	11860495
ing	O	-1	11860495
scopol@@	B-Chemical	D012601	11860495
amine	I-Chemical	-1	11860495
-induced	O	-1	11860495
am@@	B-Disease	D000647	11860495
ne@@	I-Disease	-1	11860495
sia	I-Disease	-1	11860495
.	O	-1	11860495
These	O	-1	11860495
results	O	-1	11860495
identi@@	O	-1	11860495
f@@	O	-1	11860495
y	O	-1	11860495
a	O	-1	11860495
novel	O	-1	11860495
neuro@@	O	-1	11860495
pharmac@@	O	-1	11860495
ological	O	-1	11860495
sit@@	O	-1	11860495
e	O	-1	11860495
for	O	-1	11860495
the	O	-1	11860495
mod@@	O	-1	11860495
ulation	O	-1	11860495
of	O	-1	11860495
memory	O	-1	11860495
pro@@	O	-1	11860495
ces@@	O	-1	11860495
ses	O	-1	11860495
by	O	-1	11860495
neuro@@	O	-1	11860495
active	O	-1	11860495
steroid@@	B-Chemical	D013256	11860495
s	I-Chemical	-1	11860495
.	O	-1	11860495

P@@	O	-1	11752998
rel@@	O	-1	11752998
im@@	O	-1	11752998
inary	O	-1	11752998
efficacy	O	-1	11752998
assess@@	O	-1	11752998
ment	O	-1	11752998
of	O	-1	11752998
intra@@	O	-1	11752998
th@@	O	-1	11752998
ec@@	O	-1	11752998
al	O	-1	11752998
injection	O	-1	11752998
of	O	-1	11752998
an	O	-1	11752998
A@@	O	-1	11752998
mer@@	O	-1	11752998
ic@@	O	-1	11752998
an	O	-1	11752998
form@@	O	-1	11752998
ulation	O	-1	11752998
of	O	-1	11752998
aden@@	B-Chemical	D000241	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
in	O	-1	11752998
hum@@	O	-1	11752998
an@@	O	-1	11752998
s.	O	-1	11752998
BACKGROUND:	O	-1	11752998
Pre@@	O	-1	11752998
clinical	O	-1	11752998
studies	O	-1	11752998
of	O	-1	11752998
intra@@	O	-1	11752998
th@@	O	-1	11752998
ec@@	O	-1	11752998
al	O	-1	11752998
aden@@	B-Chemical	D000241	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
suggest	O	-1	11752998
it	O	-1	11752998
may	O	-1	11752998
be	O	-1	11752998
effective	O	-1	11752998
in	O	-1	11752998
the	O	-1	11752998
treatment	O	-1	11752998
of	O	-1	11752998
acute	B-Disease	D059787	11752998
and	I-Disease	-1	11752998
chronic	I-Disease	-1	11752998
pain	I-Disease	-1	11752998
acute	B-Disease	D059350	11752998
and	I-Disease	-1	11752998
chronic	I-Disease	-1	11752998
pain	I-Disease	-1	11752998
in	O	-1	11752998
hum@@	O	-1	11752998
an@@	O	-1	11752998
s,	O	-1	11752998
and	O	-1	11752998
pre@@	O	-1	11752998
lim@@	O	-1	11752998
inary	O	-1	11752998
studies	O	-1	11752998
in	O	-1	11752998
vol@@	O	-1	11752998
un@@	O	-1	11752998
te@@	O	-1	11752998
ers	O	-1	11752998
and	O	-1	11752998
patients	O	-1	11752998
with	O	-1	11752998
a	O	-1	11752998
S@@	O	-1	11752998
we@@	O	-1	11752998
dis@@	O	-1	11752998
h	O	-1	11752998
form@@	O	-1	11752998
ulation	O	-1	11752998
of	O	-1	11752998
aden@@	B-Chemical	D000241	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
suggests	O	-1	11752998
it	O	-1	11752998
may	O	-1	11752998
be	O	-1	11752998
effective	O	-1	11752998
in	O	-1	11752998
hyper@@	B-Disease	D004342	11752998
sensitivity	I-Disease	-1	11752998
st@@	O	-1	11752998
ates	O	-1	11752998
but	O	-1	11752998
not	O	-1	11752998
with	O	-1	11752998
acute	O	-1	11752998
no@@	O	-1	11752998
xi@@	O	-1	11752998
ous	O	-1	11752998
stimul@@	O	-1	11752998
ation.	O	-1	11752998
The	O	-1	11752998
pur@@	O	-1	11752998
p@@	O	-1	11752998
ose	O	-1	11752998
of	O	-1	11752998
this	O	-1	11752998
study	O	-1	11752998
was	O	-1	11752998
to	O	-1	11752998
s@@	O	-1	11752998
cre@@	O	-1	11752998
en	O	-1	11752998
for	O	-1	11752998
efficacy	O	-1	11752998
of	O	-1	11752998
a	O	-1	11752998
different	O	-1	11752998
form@@	O	-1	11752998
ulation	O	-1	11752998
of	O	-1	11752998
aden@@	B-Chemical	D000241	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
mark@@	O	-1	11752998
et@@	O	-1	11752998
ed	O	-1	11752998
in	O	-1	11752998
the	O	-1	11752998
US@@	O	-1	11752998
,	O	-1	11752998
using	O	-1	11752998
both	O	-1	11752998
acute	O	-1	11752998
no@@	O	-1	11752998
xi@@	O	-1	11752998
ous	O	-1	11752998
stimulation	O	-1	11752998
and	O	-1	11752998
cap@@	B-Chemical	D002211	11752998
sa@@	I-Chemical	-1	11752998
icin	I-Chemical	-1	11752998
-@@	O	-1	11752998
evoked	O	-1	11752998
mechan@@	O	-1	11752998
ical	O	-1	11752998
hyper@@	B-Disease	D004342	11752998
sensitivity	I-Disease	-1	11752998
.	O	-1	11752998
METHODS:	O	-1	11752998
F@@	O	-1	11752998
ol@@	O	-1	11752998
low@@	O	-1	11752998
ing	O	-1	11752998
F@@	O	-1	11752998
o@@	O	-1	11752998
od	O	-1	11752998
and	O	-1	11752998
D@@	O	-1	11752998
ru@@	O	-1	11752998
g	O	-1	11752998
Ad@@	O	-1	11752998
minist@@	O	-1	11752998
ration	O	-1	11752998
and	O	-1	11752998
insti@@	O	-1	11752998
tu@@	O	-1	11752998
tional	O	-1	11752998
revie@@	O	-1	11752998
w	O	-1	11752998
bo@@	O	-1	11752998
ard	O	-1	11752998
appro@@	O	-1	11752998
v@@	O	-1	11752998
al	O	-1	11752998
and	O	-1	11752998
w@@	O	-1	11752998
rit@@	O	-1	11752998
ten	O	-1	11752998
inf@@	O	-1	11752998
orm@@	O	-1	11752998
ed	O	-1	11752998
con@@	O	-1	11752998
s@@	O	-1	11752998
ent@@	O	-1	11752998
,	O	-1	11752998
6@@	O	-1	11752998
5	O	-1	11752998
vol@@	O	-1	11752998
un@@	O	-1	11752998
te@@	O	-1	11752998
ers	O	-1	11752998
were	O	-1	11752998
studied	O	-1	11752998
in	O	-1	11752998
two	O	-1	11752998
tri@@	O	-1	11752998
al@@	O	-1	11752998
s:	O	-1	11752998
an	O	-1	11752998
o@@	O	-1	11752998
pen@@	O	-1	11752998
-@@	O	-1	11752998
l@@	O	-1	11752998
a@@	O	-1	11752998
be@@	O	-1	11752998
l@@	O	-1	11752998
,	O	-1	11752998
dose-@@	O	-1	11752998
es@@	O	-1	11752998
cal@@	O	-1	11752998
ating	O	-1	11752998
trial	O	-1	11752998
with	O	-1	11752998
intra@@	O	-1	11752998
th@@	O	-1	11752998
ec@@	O	-1	11752998
al	O	-1	11752998
aden@@	B-Chemical	D000241	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
doses	O	-1	11752998
of	O	-1	11752998
0.@@	O	-1	11752998
2@@	O	-1	11752998
5-@@	O	-1	11752998
2.@@	O	-1	11752998
0	O	-1	11752998
mg	O	-1	11752998
and	O	-1	11752998
a	O	-1	11752998
double-bl@@	O	-1	11752998
ind@@	O	-1	11752998
,	O	-1	11752998
placebo@@	O	-1	11752998
-@@	O	-1	11752998
controlled	O	-1	11752998
trial	O	-1	11752998
of	O	-1	11752998
aden@@	B-Chemical	D000241	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
,	O	-1	11752998
2	O	-1	11752998
mg@@	O	-1	11752998
.	O	-1	11752998
C@@	O	-1	11752998
e@@	O	-1	11752998
reb@@	O	-1	11752998
ro@@	O	-1	11752998
spinal	O	-1	11752998
flu@@	O	-1	11752998
id	O	-1	11752998
was	O	-1	11752998
obtained	O	-1	11752998
for	O	-1	11752998
pharmac@@	O	-1	11752998
o@@	O	-1	11752998
kine@@	O	-1	11752998
tic	O	-1	11752998
analy@@	O	-1	11752998
sis,	O	-1	11752998
and	O	-1	11752998
pain	B-Disease	D010146	11752998
rat@@	O	-1	11752998
ings	O	-1	11752998
in	O	-1	11752998
response	O	-1	11752998
to	O	-1	11752998
acute	O	-1	11752998
he@@	O	-1	11752998
at	O	-1	11752998
stimul@@	O	-1	11752998
i	O	-1	11752998
and	O	-1	11752998
a@@	O	-1	11752998
reas	O	-1	11752998
of	O	-1	11752998
mechan@@	B-Disease	D006930	11752998
ical	I-Disease	-1	11752998
hyperalge@@	I-Disease	-1	11752998
sia	I-Disease	-1	11752998
and	O	-1	11752998
al@@	B-Disease	D006930	11752998
lo@@	I-Disease	-1	11752998
dy@@	I-Disease	-1	11752998
n@@	I-Disease	-1	11752998
ia	I-Disease	-1	11752998
after	O	-1	11752998
intra@@	O	-1	11752998
der@@	O	-1	11752998
m@@	O	-1	11752998
al	O	-1	11752998
cap@@	B-Chemical	D002211	11752998
sa@@	I-Chemical	-1	11752998
icin	I-Chemical	-1	11752998
injection	O	-1	11752998
were	O	-1	11752998
deter@@	O	-1	11752998
m@@	O	-1	11752998
ine@@	O	-1	11752998
d.	O	-1	11752998
RESULTS:	O	-1	11752998
Ad@@	B-Chemical	D000241	11752998
en@@	I-Chemical	-1	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
produced	O	-1	11752998
no	O	-1	11752998
effect	O	-1	11752998
on	O	-1	11752998
pain	B-Disease	D010146	11752998
report	O	-1	11752998
to	O	-1	11752998
acute	O	-1	11752998
no@@	O	-1	11752998
xi@@	O	-1	11752998
ous	O	-1	11752998
ther@@	O	-1	11752998
m@@	O	-1	11752998
al	O	-1	11752998
or	O	-1	11752998
chemical	O	-1	11752998
stimulation	O	-1	11752998
but	O	-1	11752998
reduced	O	-1	11752998
mechan@@	B-Disease	D006930	11752998
ical	I-Disease	-1	11752998
hyperalge@@	I-Disease	-1	11752998
sia	I-Disease	-1	11752998
and	O	-1	11752998
al@@	B-Disease	D006930	11752998
lo@@	I-Disease	-1	11752998
dy@@	I-Disease	-1	11752998
n@@	I-Disease	-1	11752998
ia	I-Disease	-1	11752998
from	O	-1	11752998
intra@@	O	-1	11752998
der@@	O	-1	11752998
m@@	O	-1	11752998
al	O	-1	11752998
cap@@	B-Chemical	D002211	11752998
sa@@	I-Chemical	-1	11752998
icin	I-Chemical	-1	11752998
injection	O	-1	11752998
for	O	-1	11752998
at	O	-1	11752998
le@@	O	-1	11752998
ast	O	-1	11752998
24	O	-1	11752998
h@@	O	-1	11752998
.	O	-1	11752998
In	O	-1	11752998
contrast@@	O	-1	11752998
,	O	-1	11752998
re@@	O	-1	11752998
si@@	O	-1	11752998
d@@	O	-1	11752998
ence	O	-1	11752998
time	O	-1	11752998
of	O	-1	11752998
aden@@	B-Chemical	D000241	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
in	O	-1	11752998
ce@@	O	-1	11752998
reb@@	O	-1	11752998
ro@@	O	-1	11752998
spinal	O	-1	11752998
flu@@	O	-1	11752998
id	O	-1	11752998
was	O	-1	11752998
sh@@	O	-1	11752998
ort	O	-1	11752998
(@@	O	-1	11752998
<	O	-1	11752998
4	O	-1	11752998
h@@	O	-1	11752998
).	O	-1	11752998
CONCLUSIONS:	O	-1	11752998
These	O	-1	11752998
results	O	-1	11752998
show	O	-1	11752998
selective	O	-1	11752998
inhibition	O	-1	11752998
by	O	-1	11752998
intra@@	O	-1	11752998
th@@	O	-1	11752998
ec@@	O	-1	11752998
al	O	-1	11752998
aden@@	B-Chemical	D000241	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
of	O	-1	11752998
hyper@@	B-Disease	D004342	11752998
sensitivity	I-Disease	-1	11752998
,	O	-1	11752998
pres@@	O	-1	11752998
um@@	O	-1	11752998
ed	O	-1	11752998
to	O	-1	11752998
ref@@	O	-1	11752998
l@@	O	-1	11752998
ect	O	-1	11752998
central	O	-1	11752998
sensi@@	O	-1	11752998
tiz@@	O	-1	11752998
ation	O	-1	11752998
in	O	-1	11752998
hum@@	O	-1	11752998
ans	O	-1	11752998
after	O	-1	11752998
peripheral	O	-1	11752998
cap@@	B-Chemical	D002211	11752998
sa@@	I-Chemical	-1	11752998
icin	I-Chemical	-1	11752998
injec@@	O	-1	11752998
tion.	O	-1	11752998
The	O	-1	11752998
long@@	O	-1	11752998
-@@	O	-1	11752998
l@@	O	-1	11752998
ast@@	O	-1	11752998
ing	O	-1	11752998
effect	O	-1	11752998
is	O	-1	11752998
consist@@	O	-1	11752998
ent	O	-1	11752998
with	O	-1	11752998
that	O	-1	11752998
observed	O	-1	11752998
in	O	-1	11752998
pre@@	O	-1	11752998
lim@@	O	-1	11752998
inary	O	-1	11752998
reports	O	-1	11752998
of	O	-1	11752998
patients	O	-1	11752998
with	O	-1	11752998
chronic	O	-1	11752998
neuro@@	B-Disease	D009437	11752998
path@@	I-Disease	-1	11752998
ic	I-Disease	-1	11752998
pain	I-Disease	-1	11752998
and	O	-1	11752998
is	O	-1	11752998
not	O	-1	11752998
due	O	-1	11752998
to	O	-1	11752998
prolonged	O	-1	11752998
re@@	O	-1	11752998
si@@	O	-1	11752998
d@@	O	-1	11752998
ence	O	-1	11752998
of	O	-1	11752998
aden@@	B-Chemical	D000241	11752998
os@@	I-Chemical	-1	11752998
ine	I-Chemical	-1	11752998
in	O	-1	11752998
ce@@	O	-1	11752998
reb@@	O	-1	11752998
ro@@	O	-1	11752998
spinal	O	-1	11752998
flu@@	O	-1	11752998
id@@	O	-1	11752998
.	O	-1	11752998

Eff@@	O	-1	10354657
ect	O	-1	10354657
of	O	-1	10354657
lithium	B-Chemical	D008094	10354657
maint@@	O	-1	10354657
en@@	O	-1	10354657
ance	O	-1	10354657
therapy	O	-1	10354657
on	O	-1	10354657
th@@	O	-1	10354657
yro@@	O	-1	10354657
id	O	-1	10354657
and	O	-1	10354657
par@@	O	-1	10354657
ath@@	O	-1	10354657
yro@@	O	-1	10354657
id	O	-1	10354657
func@@	O	-1	10354657
tion.	O	-1	10354657
OBJECTIV@@	O	-1	10354657
E@@	O	-1	10354657
S:	O	-1	10354657
To	O	-1	10354657
ass@@	O	-1	10354657
ess	O	-1	10354657
changes	O	-1	10354657
induced	O	-1	10354657
by	O	-1	10354657
lithium	B-Chemical	D008094	10354657
maint@@	O	-1	10354657
en@@	O	-1	10354657
ance	O	-1	10354657
therapy	O	-1	10354657
on	O	-1	10354657
the	O	-1	10354657
incidence	O	-1	10354657
of	O	-1	10354657
th@@	O	-1	10354657
yro@@	O	-1	10354657
id@@	O	-1	10354657
,	O	-1	10354657
par@@	O	-1	10354657
ath@@	O	-1	10354657
yro@@	O	-1	10354657
id	O	-1	10354657
and	O	-1	10354657
i@@	O	-1	10354657
on	O	-1	10354657
al@@	O	-1	10354657
ter@@	O	-1	10354657
ations.	O	-1	10354657
These	O	-1	10354657
were	O	-1	10354657
evaluated	O	-1	10354657
with	O	-1	10354657
resp@@	O	-1	10354657
ect	O	-1	10354657
to	O	-1	10354657
the	O	-1	10354657
duration	O	-1	10354657
of	O	-1	10354657
lithium	B-Chemical	D008094	10354657
therapy,	O	-1	10354657
age,	O	-1	10354657
sex@@	O	-1	10354657
,	O	-1	10354657
and	O	-1	10354657
f@@	O	-1	10354657
ami@@	O	-1	10354657
ly	O	-1	10354657
hist@@	O	-1	10354657
ory	O	-1	10354657
(@@	O	-1	10354657
whether	O	-1	10354657
or	O	-1	10354657
not	O	-1	10354657
the	O	-1	10354657
patient	O	-1	10354657
had	O	-1	10354657
a	O	-1	10354657
fir@@	O	-1	10354657
st@@	O	-1	10354657
-@@	O	-1	10354657
de@@	O	-1	10354657
g@@	O	-1	10354657
ree	O	-1	10354657
rel@@	O	-1	10354657
ative	O	-1	10354657
with	O	-1	10354657
th@@	B-Disease	D013959	10354657
yro@@	I-Disease	-1	10354657
id	I-Disease	-1	10354657
disease	I-Disease	-1	10354657
).	O	-1	10354657
D@@	O	-1	10354657
ES@@	O	-1	10354657
I@@	O	-1	10354657
G@@	O	-1	10354657
N@@	O	-1	10354657
:	O	-1	10354657
Pro@@	O	-1	10354657
sp@@	O	-1	10354657
ective	O	-1	10354657
study.	O	-1	10354657
S@@	O	-1	10354657
ET@@	O	-1	10354657
TI@@	O	-1	10354657
N@@	O	-1	10354657
G@@	O	-1	10354657
:	O	-1	10354657
A@@	O	-1	10354657
ff@@	O	-1	10354657
ective	O	-1	10354657
D@@	O	-1	10354657
is@@	O	-1	10354657
or@@	O	-1	10354657
der@@	O	-1	10354657
s	O	-1	10354657
Clin@@	O	-1	10354657
ic	O	-1	10354657
at	O	-1	10354657
S@@	O	-1	10354657
t.	O	-1	10354657
M@@	O	-1	10354657
ar@@	O	-1	10354657
y@@	O	-1	10354657
's	O	-1	10354657
H@@	O	-1	10354657
ospit@@	O	-1	10354657
al,	O	-1	10354657
M@@	O	-1	10354657
on@@	O	-1	10354657
tre@@	O	-1	10354657
al.	O	-1	10354657
PA@@	O	-1	10354657
TI@@	O	-1	10354657
E@@	O	-1	10354657
N@@	O	-1	10354657
T@@	O	-1	10354657
S:	O	-1	10354657
One	O	-1	10354657
h@@	O	-1	10354657
und@@	O	-1	10354657
red	O	-1	10354657
and	O	-1	10354657
one	O	-1	10354657
patients	O	-1	10354657
(2@@	O	-1	10354657
8	O	-1	10354657
men	O	-1	10354657
and	O	-1	10354657
7@@	O	-1	10354657
3	O	-1	10354657
wom@@	O	-1	10354657
en@@	O	-1	10354657
)	O	-1	10354657
with	O	-1	10354657
b@@	B-Disease	D001714	10354657
ip@@	I-Disease	-1	10354657
ol@@	I-Disease	-1	10354657
ar	I-Disease	-1	10354657
disor@@	I-Disease	-1	10354657
der	I-Disease	-1	10354657
receiving	O	-1	10354657
lithium	B-Chemical	D008094	10354657
maint@@	O	-1	10354657
en@@	O	-1	10354657
ance	O	-1	10354657
therapy	O	-1	10354657
rang@@	O	-1	10354657
ing	O	-1	10354657
from	O	-1	10354657
1	O	-1	10354657
year@@	O	-1	10354657
's	O	-1	10354657
to	O	-1	10354657
3@@	O	-1	10354657
2	O	-1	10354657
year@@	O	-1	10354657
s@@	O	-1	10354657
'	O	-1	10354657
dur@@	O	-1	10354657
ation.	O	-1	10354657
The	O	-1	10354657
control	O	-1	10354657
group	O	-1	10354657
consist@@	O	-1	10354657
ed	O	-1	10354657
of	O	-1	10354657
8@@	O	-1	10354657
2	O	-1	10354657
patients	O	-1	10354657
with	O	-1	10354657
no	O	-1	10354657
psych@@	B-Disease	D001523	10354657
i@@	I-Disease	-1	10354657
atric	I-Disease	-1	10354657
or	O	-1	10354657
en@@	O	-1	10354657
doc@@	O	-1	10354657
r@@	O	-1	10354657
in@@	O	-1	10354657
ological	O	-1	10354657
diagno@@	O	-1	10354657
ses	O	-1	10354657
from	O	-1	10354657
the	O	-1	10354657
hospit@@	O	-1	10354657
al@@	O	-1	10354657
's	O	-1	10354657
out@@	O	-1	10354657
-@@	O	-1	10354657
patient	O	-1	10354657
clin@@	O	-1	10354657
ic@@	O	-1	10354657
s.	O	-1	10354657
O@@	O	-1	10354657
U@@	O	-1	10354657
T@@	O	-1	10354657
CO@@	O	-1	10354657
M@@	O	-1	10354657
E	O	-1	10354657
M@@	O	-1	10354657
E@@	O	-1	10354657
A@@	O	-1	10354657
S@@	O	-1	10354657
U@@	O	-1	10354657
R@@	O	-1	10354657
E@@	O	-1	10354657
S:	O	-1	10354657
L@@	O	-1	10354657
abor@@	O	-1	10354657
atory	O	-1	10354657
analy@@	O	-1	10354657
ses	O	-1	10354657
of	O	-1	10354657
calcium	B-Chemical	D002118	10354657
,	O	-1	10354657
mag@@	B-Chemical	D008274	10354657
ne@@	I-Chemical	-1	10354657
si@@	I-Chemical	-1	10354657
um	I-Chemical	-1	10354657
and	O	-1	10354657
th@@	O	-1	10354657
yro@@	O	-1	10354657
id@@	O	-1	10354657
-@@	O	-1	10354657
stimul@@	O	-1	10354657
ating	O	-1	10354657
h@@	O	-1	10354657
orm@@	O	-1	10354657
one	O	-1	10354657
levels	O	-1	10354657
performed	O	-1	10354657
before	O	-1	10354657
be@@	O	-1	10354657
g@@	O	-1	10354657
in@@	O	-1	10354657
ning	O	-1	10354657
lithium	B-Chemical	D008094	10354657
therapy	O	-1	10354657
and	O	-1	10354657
at	O	-1	10354657
b@@	O	-1	10354657
i@@	O	-1	10354657
an@@	O	-1	10354657
n@@	O	-1	10354657
ual	O	-1	10354657
follow-@@	O	-1	10354657
up@@	O	-1	10354657
.	O	-1	10354657
RESULTS:	O	-1	10354657
H@@	B-Disease	D007037	10354657
y@@	I-Disease	-1	10354657
po@@	I-Disease	-1	10354657
th@@	I-Disease	-1	10354657
yro@@	I-Disease	-1	10354657
i@@	I-Disease	-1	10354657
dis@@	I-Disease	-1	10354657
m	I-Disease	-1	10354657
developed	O	-1	10354657
in	O	-1	10354657
40	O	-1	10354657
patients,	O	-1	10354657
ex@@	O	-1	10354657
cl@@	O	-1	10354657
ud@@	O	-1	10354657
ing	O	-1	10354657
8	O	-1	10354657
patients	O	-1	10354657
who	O	-1	10354657
were	O	-1	10354657
hypo@@	B-Disease	D007037	10354657
th@@	I-Disease	-1	10354657
yro@@	I-Disease	-1	10354657
id	I-Disease	-1	10354657
at	O	-1	10354657
basel@@	O	-1	10354657
ine.	O	-1	10354657
All	O	-1	10354657
patients	O	-1	10354657
ha@@	O	-1	10354657
ving	O	-1	10354657
fir@@	O	-1	10354657
st@@	O	-1	10354657
-@@	O	-1	10354657
de@@	O	-1	10354657
g@@	O	-1	10354657
ree	O	-1	10354657
rel@@	O	-1	10354657
ati@@	O	-1	10354657
v@@	O	-1	10354657
es	O	-1	10354657
affected	O	-1	10354657
by	O	-1	10354657
th@@	B-Disease	D013959	10354657
yro@@	I-Disease	-1	10354657
id	I-Disease	-1	10354657
ill@@	I-Disease	-1	10354657
ness	I-Disease	-1	10354657
had	O	-1	10354657
ac@@	O	-1	10354657
ce@@	O	-1	10354657
l@@	O	-1	10354657
er@@	O	-1	10354657
ated	O	-1	10354657
onset	O	-1	10354657
of	O	-1	10354657
hypo@@	B-Disease	D007037	10354657
th@@	I-Disease	-1	10354657
yro@@	I-Disease	-1	10354657
i@@	I-Disease	-1	10354657
dis@@	I-Disease	-1	10354657
m	I-Disease	-1	10354657
(@@	O	-1	10354657
3.@@	O	-1	10354657
7	O	-1	10354657
years	O	-1	10354657
after	O	-1	10354657
onset	O	-1	10354657
of	O	-1	10354657
lithium	B-Chemical	D008094	10354657
therap@@	O	-1	10354657
y@@	O	-1	10354657
)	O	-1	10354657
compared	O	-1	10354657
with	O	-1	10354657
patients	O	-1	10354657
without	O	-1	10354657
a	O	-1	10354657
f@@	O	-1	10354657
ami@@	O	-1	10354657
ly	O	-1	10354657
hist@@	O	-1	10354657
ory	O	-1	10354657
(@@	O	-1	10354657
8.@@	O	-1	10354657
6	O	-1	10354657
years	O	-1	10354657
after	O	-1	10354657
onset	O	-1	10354657
of	O	-1	10354657
lithium	B-Chemical	D008094	10354657
therap@@	O	-1	10354657
y@@	O	-1	10354657
).	O	-1	10354657
W@@	O	-1	10354657
o@@	O	-1	10354657
men	O	-1	10354657
over	O	-1	10354657
60	O	-1	10354657
years	O	-1	10354657
of	O	-1	10354657
age	O	-1	10354657
were	O	-1	10354657
more	O	-1	10354657
often	O	-1	10354657
affected	O	-1	10354657
by	O	-1	10354657
hypo@@	B-Disease	D007037	10354657
th@@	I-Disease	-1	10354657
yro@@	I-Disease	-1	10354657
i@@	I-Disease	-1	10354657
dis@@	I-Disease	-1	10354657
m	I-Disease	-1	10354657
than	O	-1	10354657
women	O	-1	10354657
under	O	-1	10354657
60	O	-1	10354657
years	O	-1	10354657
of	O	-1	10354657
age	O	-1	10354657
(3@@	O	-1	10354657
4.@@	O	-1	10354657
6%	O	-1	10354657
versus	O	-1	10354657
3@@	O	-1	10354657
1.@@	O	-1	10354657
9@@	O	-1	10354657
%).	O	-1	10354657
M@@	B-Chemical	D008274	10354657
ag@@	I-Chemical	-1	10354657
ne@@	I-Chemical	-1	10354657
si@@	I-Chemical	-1	10354657
um	I-Chemical	-1	10354657
levels	O	-1	10354657
in	O	-1	10354657
patients	O	-1	10354657
on	O	-1	10354657
lithium	B-Chemical	D008094	10354657
treatment	O	-1	10354657
were	O	-1	10354657
un@@	O	-1	10354657
chang@@	O	-1	10354657
ed	O	-1	10354657
from	O	-1	10354657
baseline	O	-1	10354657
level@@	O	-1	10354657
s.	O	-1	10354657
After	O	-1	10354657
lithium	B-Chemical	D008094	10354657
treatment,	O	-1	10354657
calcium	B-Chemical	D002118	10354657
levels	O	-1	10354657
were	O	-1	10354657
higher	O	-1	10354657
than	O	-1	10354657
either	O	-1	10354657
baseline	O	-1	10354657
levels	O	-1	10354657
or	O	-1	10354657
control	O	-1	10354657
level@@	O	-1	10354657
s.	O	-1	10354657
Th@@	O	-1	10354657
us,	O	-1	10354657
lithium	B-Chemical	D008094	10354657
treatment	O	-1	10354657
coun@@	O	-1	10354657
ter@@	O	-1	10354657
ac@@	O	-1	10354657
ted	O	-1	10354657
the	O	-1	10354657
decrease	O	-1	10354657
in	O	-1	10354657
plasma	O	-1	10354657
calcium	B-Chemical	D002118	10354657
levels	O	-1	10354657
associated	O	-1	10354657
with	O	-1	10354657
ag@@	O	-1	10354657
ing.	O	-1	10354657
CONCLUSIONS:	O	-1	10354657
F@@	O	-1	10354657
am@@	O	-1	10354657
il@@	O	-1	10354657
ial	O	-1	10354657
th@@	B-Disease	D013959	10354657
yro@@	I-Disease	-1	10354657
id	I-Disease	-1	10354657
ill@@	I-Disease	-1	10354657
ness	I-Disease	-1	10354657
is	O	-1	10354657
a	O	-1	10354657
risk	O	-1	10354657
factor	O	-1	10354657
for	O	-1	10354657
hypo@@	B-Disease	D007037	10354657
th@@	I-Disease	-1	10354657
yro@@	I-Disease	-1	10354657
i@@	I-Disease	-1	10354657
dis@@	I-Disease	-1	10354657
m	I-Disease	-1	10354657
and	O	-1	10354657
hyper@@	B-Disease	D006934	10354657
cal@@	I-Disease	-1	10354657
ce@@	I-Disease	-1	10354657
mia	I-Disease	-1	10354657
during	O	-1	10354657
lithium	B-Chemical	D008094	10354657
therapy.	O	-1	10354657

S@@	O	-1	10328196
y@@	O	-1	10328196
st@@	O	-1	10328196
em@@	O	-1	10328196
ic	O	-1	10328196
toxicity	B-Disease	D064420	10328196
following	O	-1	10328196
administration	O	-1	10328196
of	O	-1	10328196
sirolimus	B-Chemical	D020123	10328196
(@@	O	-1	10328196
form@@	O	-1	10328196
er@@	O	-1	10328196
ly	O	-1	10328196
ra@@	B-Chemical	D020123	10328196
p@@	I-Chemical	-1	10328196
am@@	I-Chemical	-1	10328196
ycin	I-Chemical	-1	10328196
)	O	-1	10328196
for	O	-1	10328196
p@@	B-Disease	D011565	10328196
s@@	I-Disease	-1	10328196
or@@	I-Disease	-1	10328196
ia@@	I-Disease	-1	10328196
sis	I-Disease	-1	10328196
:	O	-1	10328196
association	O	-1	10328196
of	O	-1	10328196
cap@@	B-Disease	D019559	10328196
ill@@	I-Disease	-1	10328196
ary	I-Disease	-1	10328196
le@@	I-Disease	-1	10328196
a@@	I-Disease	-1	10328196
k	I-Disease	-1	10328196
syndrome	I-Disease	-1	10328196
with	O	-1	10328196
apo@@	O	-1	10328196
pto@@	O	-1	10328196
sis	O	-1	10328196
of	O	-1	10328196
le@@	O	-1	10328196
sion@@	O	-1	10328196
al	O	-1	10328196
lymph@@	O	-1	10328196
ocy@@	O	-1	10328196
t@@	O	-1	10328196
es.	O	-1	10328196
BACKGROUND:	O	-1	10328196
Si@@	B-Chemical	D020123	10328196
rolimus	I-Chemical	-1	10328196
(@@	O	-1	10328196
form@@	O	-1	10328196
er@@	O	-1	10328196
ly	O	-1	10328196
ra@@	B-Chemical	D020123	10328196
p@@	I-Chemical	-1	10328196
am@@	I-Chemical	-1	10328196
ycin	I-Chemical	-1	10328196
)	O	-1	10328196
is	O	-1	10328196
an	O	-1	10328196
immunosup@@	O	-1	10328196
pressive	O	-1	10328196
agent	O	-1	10328196
that	O	-1	10328196
inter@@	O	-1	10328196
fe@@	O	-1	10328196
res	O	-1	10328196
with	O	-1	10328196
T@@	O	-1	10328196
-@@	O	-1	10328196
cell	O	-1	10328196
activ@@	O	-1	10328196
ation.	O	-1	10328196
After	O	-1	10328196
2	O	-1	10328196
individ@@	O	-1	10328196
u@@	O	-1	10328196
als	O	-1	10328196
with	O	-1	10328196
p@@	B-Disease	D011565	10328196
s@@	I-Disease	-1	10328196
or@@	I-Disease	-1	10328196
ia@@	I-Disease	-1	10328196
sis	I-Disease	-1	10328196
developed	O	-1	10328196
a	O	-1	10328196
cap@@	B-Disease	D019559	10328196
ill@@	I-Disease	-1	10328196
ary	I-Disease	-1	10328196
le@@	I-Disease	-1	10328196
a@@	I-Disease	-1	10328196
k	I-Disease	-1	10328196
syndrome	I-Disease	-1	10328196
following	O	-1	10328196
treatment	O	-1	10328196
with	O	-1	10328196
oral	O	-1	10328196
sirolimus	B-Chemical	D020123	10328196
le@@	O	-1	10328196
sion@@	O	-1	10328196
al	O	-1	10328196
s@@	O	-1	10328196
k@@	O	-1	10328196
in	O	-1	10328196
cells	O	-1	10328196
and	O	-1	10328196
activ@@	O	-1	10328196
ated	O	-1	10328196
peripheral	O	-1	10328196
blood	O	-1	10328196
cells	O	-1	10328196
were	O	-1	10328196
analy@@	O	-1	10328196
zed	O	-1	10328196
for	O	-1	10328196
induction	O	-1	10328196
of	O	-1	10328196
apo@@	O	-1	10328196
pto@@	O	-1	10328196
sis.	O	-1	10328196
OB@@	O	-1	10328196
S@@	O	-1	10328196
E@@	O	-1	10328196
R@@	O	-1	10328196
V@@	O	-1	10328196
AT@@	O	-1	10328196
ION@@	O	-1	10328196
S:	O	-1	10328196
A	O	-1	10328196
k@@	O	-1	10328196
er@@	O	-1	10328196
at@@	O	-1	10328196
ome	O	-1	10328196
s@@	O	-1	10328196
k@@	O	-1	10328196
in	O	-1	10328196
spec@@	O	-1	10328196
i@@	O	-1	10328196
men	O	-1	10328196
from	O	-1	10328196
1	O	-1	10328196
patient	O	-1	10328196
with	O	-1	10328196
sirolimus	B-Chemical	D020123	10328196
-induced	O	-1	10328196
cap@@	B-Disease	D019559	10328196
ill@@	I-Disease	-1	10328196
ary	I-Disease	-1	10328196
le@@	I-Disease	-1	10328196
a@@	I-Disease	-1	10328196
k	I-Disease	-1	10328196
syndrome	I-Disease	-1	10328196
had	O	-1	10328196
a	O	-1	10328196
2.@@	O	-1	10328196
3-@@	O	-1	10328196
fol@@	O	-1	10328196
d	O	-1	10328196
increase	O	-1	10328196
in	O	-1	10328196
perc@@	O	-1	10328196
ent@@	O	-1	10328196
age	O	-1	10328196
of	O	-1	10328196
apo@@	O	-1	10328196
pto@@	O	-1	10328196
tic	O	-1	10328196
cells	O	-1	10328196
(@@	O	-1	10328196
to	O	-1	10328196
4@@	O	-1	10328196
8@@	O	-1	10328196
%)	O	-1	10328196
compared	O	-1	10328196
with	O	-1	10328196
an	O	-1	10328196
un@@	O	-1	10328196
affected	O	-1	10328196
sirolimus	B-Chemical	D020123	10328196
-treated	O	-1	10328196
patient	O	-1	10328196
with	O	-1	10328196
p@@	B-Disease	D011565	10328196
s@@	I-Disease	-1	10328196
or@@	I-Disease	-1	10328196
ia@@	I-Disease	-1	10328196
sis	I-Disease	-1	10328196
(2@@	O	-1	10328196
1@@	O	-1	10328196
%).	O	-1	10328196
Ac@@	O	-1	10328196
tiv@@	O	-1	10328196
ated	O	-1	10328196
peripheral	O	-1	10328196
blood	O	-1	10328196
T	O	-1	10328196
cells	O	-1	10328196
from	O	-1	10328196
patients	O	-1	10328196
with	O	-1	10328196
p@@	B-Disease	D011565	10328196
s@@	I-Disease	-1	10328196
or@@	I-Disease	-1	10328196
ia@@	I-Disease	-1	10328196
sis	I-Disease	-1	10328196
ten@@	O	-1	10328196
ded	O	-1	10328196
to	O	-1	10328196
ex@@	O	-1	10328196
hib@@	O	-1	10328196
it	O	-1	10328196
greater	O	-1	10328196
spont@@	O	-1	10328196
aneous	O	-1	10328196
or	O	-1	10328196
de@@	B-Chemical	D003907	10328196
xameth@@	I-Chemical	-1	10328196
as@@	I-Chemical	-1	10328196
one	I-Chemical	-1	10328196
-induced	O	-1	10328196
apo@@	O	-1	10328196
pto@@	O	-1	10328196
sis	O	-1	10328196
than	O	-1	10328196
did	O	-1	10328196
normal	O	-1	10328196
T	O	-1	10328196
cell@@	O	-1	10328196
s,	O	-1	10328196
partic@@	O	-1	10328196
ul@@	O	-1	10328196
arly	O	-1	10328196
in	O	-1	10328196
the	O	-1	10328196
presence	O	-1	10328196
of	O	-1	10328196
sirolimus	B-Chemical	D020123	10328196
.	O	-1	10328196
CONCLUSIONS:	O	-1	10328196
S@@	O	-1	10328196
ev@@	O	-1	10328196
ere	O	-1	10328196
adverse	O	-1	10328196
effects	O	-1	10328196
of	O	-1	10328196
sirolimus	B-Chemical	D020123	10328196
includ@@	O	-1	10328196
e	O	-1	10328196
f@@	B-Disease	D005334	10328196
ev@@	I-Disease	-1	10328196
er	I-Disease	-1	10328196
,	O	-1	10328196
anemia	B-Disease	D000740	10328196
,	O	-1	10328196
and	O	-1	10328196
cap@@	B-Disease	D019559	10328196
ill@@	I-Disease	-1	10328196
ary	I-Disease	-1	10328196
le@@	I-Disease	-1	10328196
a@@	I-Disease	-1	10328196
k	I-Disease	-1	10328196
syndrome	I-Disease	-1	10328196
.	O	-1	10328196
These	O	-1	10328196
symptoms	O	-1	10328196
may	O	-1	10328196
be	O	-1	10328196
the	O	-1	10328196
result	O	-1	10328196
of	O	-1	10328196
drug@@	O	-1	10328196
-induced	O	-1	10328196
apo@@	O	-1	10328196
pto@@	O	-1	10328196
sis	O	-1	10328196
of	O	-1	10328196
le@@	O	-1	10328196
sion@@	O	-1	10328196
al	O	-1	10328196
leuk@@	O	-1	10328196
ocy@@	O	-1	10328196
t@@	O	-1	10328196
es,	O	-1	10328196
es@@	O	-1	10328196
p@@	O	-1	10328196
ec@@	O	-1	10328196
i@@	O	-1	10328196
ally	O	-1	10328196
activ@@	O	-1	10328196
ated	O	-1	10328196
T	O	-1	10328196
lymph@@	O	-1	10328196
ocy@@	O	-1	10328196
t@@	O	-1	10328196
es,	O	-1	10328196
and	O	-1	10328196
possib@@	O	-1	10328196
ly	O	-1	10328196
release	O	-1	10328196
of	O	-1	10328196
inflam@@	O	-1	10328196
mat@@	O	-1	10328196
ory	O	-1	10328196
medi@@	O	-1	10328196
at@@	O	-1	10328196
or@@	O	-1	10328196
s.	O	-1	10328196
B@@	O	-1	10328196
ecause	O	-1	10328196
patients	O	-1	10328196
with	O	-1	10328196
severe	O	-1	10328196
p@@	B-Disease	D011565	10328196
s@@	I-Disease	-1	10328196
or@@	I-Disease	-1	10328196
ia@@	I-Disease	-1	10328196
sis	I-Disease	-1	10328196
may	O	-1	10328196
deve@@	O	-1	10328196
lo@@	O	-1	10328196
p	O	-1	10328196
cap@@	B-Disease	D019559	10328196
ill@@	I-Disease	-1	10328196
ary	I-Disease	-1	10328196
le@@	I-Disease	-1	10328196
a@@	I-Disease	-1	10328196
k	I-Disease	-1	10328196
from	O	-1	10328196
various	O	-1	10328196
systemic	O	-1	10328196
therap@@	O	-1	10328196
i@@	O	-1	10328196
es,	O	-1	10328196
clinical	O	-1	10328196
monit@@	O	-1	10328196
or@@	O	-1	10328196
ing	O	-1	10328196
is	O	-1	10328196
adv@@	O	-1	10328196
is@@	O	-1	10328196
able	O	-1	10328196
for	O	-1	10328196
patients	O	-1	10328196
with	O	-1	10328196
inflam@@	B-Disease	D007249	10328196
mat@@	I-Disease	-1	10328196
ory	I-Disease	-1	10328196
diseas@@	I-Disease	-1	10328196
es	I-Disease	-1	10328196
who	O	-1	10328196
are	O	-1	10328196
treated	O	-1	10328196
with	O	-1	10328196
immun@@	O	-1	10328196
e	O	-1	10328196
mod@@	O	-1	10328196
ul@@	O	-1	10328196
at@@	O	-1	10328196
or@@	O	-1	10328196
s.	O	-1	10328196

Con@@	O	-1	9630698
tri@@	O	-1	9630698
bu@@	O	-1	9630698
tion	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
glyc@@	B-Chemical	D005998	9630698
ine	I-Chemical	-1	9630698
sit@@	O	-1	9630698
e	O	-1	9630698
of	O	-1	9630698
N@@	B-Chemical	D016202	9630698
MD@@	I-Chemical	-1	9630698
A	I-Chemical	-1	9630698
receptors	O	-1	9630698
in	O	-1	9630698
ro@@	O	-1	9630698
str@@	O	-1	9630698
al	O	-1	9630698
and	O	-1	9630698
inter@@	O	-1	9630698
medi@@	O	-1	9630698
at@@	O	-1	9630698
e-@@	O	-1	9630698
ca@@	O	-1	9630698
ud@@	O	-1	9630698
al	O	-1	9630698
par@@	O	-1	9630698
ts	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
striat@@	O	-1	9630698
um	O	-1	9630698
to	O	-1	9630698
the	O	-1	9630698
reg@@	O	-1	9630698
ulation	O	-1	9630698
of	O	-1	9630698
musc@@	O	-1	9630698
le	O	-1	9630698
t@@	O	-1	9630698
one	O	-1	9630698
in	O	-1	9630698
rats.	O	-1	9630698
The	O	-1	9630698
a@@	O	-1	9630698
im	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
present	O	-1	9630698
study	O	-1	9630698
was	O	-1	9630698
to	O	-1	9630698
ass@@	O	-1	9630698
ess	O	-1	9630698
the	O	-1	9630698
cont@@	O	-1	9630698
ri@@	O	-1	9630698
bu@@	O	-1	9630698
tion	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
glyc@@	B-Chemical	D005998	9630698
ine	I-Chemical	-1	9630698
sit@@	O	-1	9630698
e	O	-1	9630698
of	O	-1	9630698
N@@	B-Chemical	D016202	9630698
MD@@	I-Chemical	-1	9630698
A	I-Chemical	-1	9630698
receptors	O	-1	9630698
in	O	-1	9630698
the	O	-1	9630698
striat@@	O	-1	9630698
um	O	-1	9630698
to	O	-1	9630698
the	O	-1	9630698
reg@@	O	-1	9630698
ulation	O	-1	9630698
of	O	-1	9630698
musc@@	O	-1	9630698
le	O	-1	9630698
t@@	O	-1	9630698
one.	O	-1	9630698
M@@	O	-1	9630698
us@@	O	-1	9630698
c@@	O	-1	9630698
le	O	-1	9630698
t@@	O	-1	9630698
one	O	-1	9630698
was	O	-1	9630698
examined	O	-1	9630698
using	O	-1	9630698
a	O	-1	9630698
combined	O	-1	9630698
mechan@@	O	-1	9630698
o@@	O	-1	9630698
and	O	-1	9630698
elect@@	O	-1	9630698
rom@@	O	-1	9630698
y@@	O	-1	9630698
ograph@@	O	-1	9630698
ic	O	-1	9630698
meth@@	O	-1	9630698
o@@	O	-1	9630698
d,	O	-1	9630698
which	O	-1	9630698
measured	O	-1	9630698
sim@@	O	-1	9630698
ult@@	O	-1	9630698
ane@@	O	-1	9630698
ously	O	-1	9630698
the	O	-1	9630698
musc@@	O	-1	9630698
le	O	-1	9630698
resist@@	O	-1	9630698
ance	O	-1	9630698
(@@	O	-1	9630698
M@@	O	-1	9630698
M@@	O	-1	9630698
G@@	O	-1	9630698
)	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
rat@@	O	-1	9630698
's	O	-1	9630698
h@@	O	-1	9630698
ind	O	-1	9630698
fo@@	O	-1	9630698
o@@	O	-1	9630698
t	O	-1	9630698
to	O	-1	9630698
p@@	O	-1	9630698
as@@	O	-1	9630698
sive	O	-1	9630698
exten@@	O	-1	9630698
sion	O	-1	9630698
and	O	-1	9630698
f@@	O	-1	9630698
le@@	O	-1	9630698
xi@@	O	-1	9630698
on	O	-1	9630698
in	O	-1	9630698
the	O	-1	9630698
an@@	O	-1	9630698
k@@	O	-1	9630698
le	O	-1	9630698
j@@	O	-1	9630698
o@@	O	-1	9630698
in@@	O	-1	9630698
t	O	-1	9630698
and	O	-1	9630698
the	O	-1	9630698
elect@@	O	-1	9630698
rom@@	O	-1	9630698
y@@	O	-1	9630698
ograph@@	O	-1	9630698
ic	O	-1	9630698
activity	O	-1	9630698
(@@	O	-1	9630698
E@@	O	-1	9630698
M@@	O	-1	9630698
G@@	O	-1	9630698
)	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
antagon@@	O	-1	9630698
istic	O	-1	9630698
musc@@	O	-1	9630698
le@@	O	-1	9630698
s	O	-1	9630698
of	O	-1	9630698
that	O	-1	9630698
j@@	O	-1	9630698
o@@	O	-1	9630698
int@@	O	-1	9630698
:	O	-1	9630698
gast@@	O	-1	9630698
ro@@	O	-1	9630698
c@@	O	-1	9630698
ne@@	O	-1	9630698
mi@@	O	-1	9630698
us	O	-1	9630698
and	O	-1	9630698
ti@@	O	-1	9630698
b@@	O	-1	9630698
i@@	O	-1	9630698
al@@	O	-1	9630698
is	O	-1	9630698
an@@	O	-1	9630698
ter@@	O	-1	9630698
i@@	O	-1	9630698
or@@	O	-1	9630698
.	O	-1	9630698
M@@	B-Disease	D009127	9630698
us@@	I-Disease	-1	9630698
c@@	I-Disease	-1	9630698
le	I-Disease	-1	9630698
rig@@	I-Disease	-1	9630698
idity	I-Disease	-1	9630698
was	O	-1	9630698
induced	O	-1	9630698
by	O	-1	9630698
haloperidol	B-Chemical	D006220	9630698
(2@@	O	-1	9630698
.@@	O	-1	9630698
5	O	-1	9630698
mg/kg	O	-1	9630698
i.p.@@	O	-1	9630698
).	O	-1	9630698
5@@	B-Chemical	C066192	9630698
,@@	I-Chemical	-1	9630698
7-@@	I-Chemical	-1	9630698
dic@@	I-Chemical	-1	9630698
h@@	I-Chemical	-1	9630698
loro@@	I-Chemical	-1	9630698
k@@	I-Chemical	-1	9630698
yn@@	I-Chemical	-1	9630698
u@@	I-Chemical	-1	9630698
ren@@	I-Chemical	-1	9630698
ic	I-Chemical	-1	9630698
acid	I-Chemical	-1	9630698
(	O	-1	9630698
5@@	B-Chemical	C066192	9630698
,@@	I-Chemical	-1	9630698
7-@@	I-Chemical	-1	9630698
D@@	I-Chemical	-1	9630698
C@@	I-Chemical	-1	9630698
K@@	I-Chemical	-1	9630698
A	I-Chemical	-1	9630698
),	O	-1	9630698
a	O	-1	9630698
selective	O	-1	9630698
glyc@@	B-Chemical	D005998	9630698
ine	I-Chemical	-1	9630698
sit@@	O	-1	9630698
e	O	-1	9630698
antagonist@@	O	-1	9630698
,	O	-1	9630698
injected	O	-1	9630698
in	O	-1	9630698
doses	O	-1	9630698
of	O	-1	9630698
2.@@	O	-1	9630698
5	O	-1	9630698
and	O	-1	9630698
4.@@	O	-1	9630698
5	O	-1	9630698
micro@@	O	-1	9630698
g/@@	O	-1	9630698
0.@@	O	-1	9630698
5	O	-1	9630698
micro@@	O	-1	9630698
l	O	-1	9630698
bil@@	O	-1	9630698
at@@	O	-1	9630698
er@@	O	-1	9630698
ally,	O	-1	9630698
into	O	-1	9630698
the	O	-1	9630698
ro@@	O	-1	9630698
str@@	O	-1	9630698
al	O	-1	9630698
regi@@	O	-1	9630698
on	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
striat@@	O	-1	9630698
um,	O	-1	9630698
decreased	O	-1	9630698
both	O	-1	9630698
the	O	-1	9630698
haloperidol	B-Chemical	D006220	9630698
-induced	O	-1	9630698
musc@@	B-Disease	D009127	9630698
le	I-Disease	-1	9630698
rig@@	I-Disease	-1	9630698
idity	I-Disease	-1	9630698
(@@	O	-1	9630698
M@@	O	-1	9630698
M@@	O	-1	9630698
G@@	O	-1	9630698
)	O	-1	9630698
and	O	-1	9630698
the	O	-1	9630698
enhanced	O	-1	9630698
elect@@	O	-1	9630698
rom@@	O	-1	9630698
y@@	O	-1	9630698
ograph@@	O	-1	9630698
ic	O	-1	9630698
activity	O	-1	9630698
(@@	O	-1	9630698
E@@	O	-1	9630698
M@@	O	-1	9630698
G@@	O	-1	9630698
).	O	-1	9630698
5@@	B-Chemical	C066192	9630698
,@@	I-Chemical	-1	9630698
7-@@	I-Chemical	-1	9630698
D@@	I-Chemical	-1	9630698
C@@	I-Chemical	-1	9630698
K@@	I-Chemical	-1	9630698
A	I-Chemical	-1	9630698
injected	O	-1	9630698
bil@@	O	-1	9630698
at@@	O	-1	9630698
er@@	O	-1	9630698
ally	O	-1	9630698
in	O	-1	9630698
a	O	-1	9630698
dose	O	-1	9630698
of	O	-1	9630698
4.@@	O	-1	9630698
5	O	-1	9630698
micro@@	O	-1	9630698
g/@@	O	-1	9630698
0.@@	O	-1	9630698
5	O	-1	9630698
micro@@	O	-1	9630698
l	O	-1	9630698
into	O	-1	9630698
the	O	-1	9630698
inter@@	O	-1	9630698
medi@@	O	-1	9630698
at@@	O	-1	9630698
e-@@	O	-1	9630698
ca@@	O	-1	9630698
ud@@	O	-1	9630698
al	O	-1	9630698
regi@@	O	-1	9630698
on	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
striat@@	O	-1	9630698
um	O	-1	9630698
of	O	-1	9630698
rats	O	-1	9630698
not	O	-1	9630698
pre@@	O	-1	9630698
treated	O	-1	9630698
with	O	-1	9630698
haloperidol	B-Chemical	D006220	9630698
had	O	-1	9630698
no	O	-1	9630698
effect	O	-1	9630698
on	O	-1	9630698
the	O	-1	9630698
musc@@	O	-1	9630698
le	O	-1	9630698
t@@	O	-1	9630698
one.	O	-1	9630698
The	O	-1	9630698
present	O	-1	9630698
results	O	-1	9630698
suggest	O	-1	9630698
that	O	-1	9630698
block@@	O	-1	9630698
ade	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
glyc@@	B-Chemical	D005998	9630698
ine	I-Chemical	-1	9630698
sit@@	O	-1	9630698
e	O	-1	9630698
of	O	-1	9630698
N@@	B-Chemical	D016202	9630698
MD@@	I-Chemical	-1	9630698
A	I-Chemical	-1	9630698
receptors	O	-1	9630698
in	O	-1	9630698
the	O	-1	9630698
ro@@	O	-1	9630698
str@@	O	-1	9630698
al	O	-1	9630698
par@@	O	-1	9630698
t	O	-1	9630698
of	O	-1	9630698
the	O	-1	9630698
striat@@	O	-1	9630698
um	O	-1	9630698
may	O	-1	9630698
be	O	-1	9630698
main@@	O	-1	9630698
ly	O	-1	9630698
respon@@	O	-1	9630698
sible	O	-1	9630698
for	O	-1	9630698
the	O	-1	9630698
anti@@	O	-1	9630698
par@@	O	-1	9630698
k@@	O	-1	9630698
inson@@	O	-1	9630698
i@@	O	-1	9630698
an	O	-1	9630698
action	O	-1	9630698
of	O	-1	9630698
this	O	-1	9630698
drug.	O	-1	9630698

Eff@@	O	-1	8480959
icac@@	O	-1	8480959
y	O	-1	8480959
and	O	-1	8480959
toler@@	O	-1	8480959
ability	O	-1	8480959
of	O	-1	8480959
lo@@	B-Chemical	D008148	8480959
vastatin	I-Chemical	-1	8480959
in	O	-1	8480959
3@@	O	-1	8480959
3@@	O	-1	8480959
9@@	O	-1	8480959
0	O	-1	8480959
women	O	-1	8480959
with	O	-1	8480959
moder@@	O	-1	8480959
ate	O	-1	8480959
hyper@@	B-Disease	D006937	8480959
cholester@@	I-Disease	-1	8480959
ol@@	I-Disease	-1	8480959
emia	I-Disease	-1	8480959
.	O	-1	8480959
OBJECTIVE:	O	-1	8480959
To	O	-1	8480959
evalu@@	O	-1	8480959
ate	O	-1	8480959
the	O	-1	8480959
efficacy	O	-1	8480959
and	O	-1	8480959
safety	O	-1	8480959
of	O	-1	8480959
lo@@	B-Chemical	D008148	8480959
vastatin	I-Chemical	-1	8480959
in	O	-1	8480959
women	O	-1	8480959
with	O	-1	8480959
moder@@	O	-1	8480959
ate	O	-1	8480959
hyper@@	B-Disease	D006937	8480959
cholester@@	I-Disease	-1	8480959
ol@@	I-Disease	-1	8480959
emia	I-Disease	-1	8480959
.	O	-1	8480959
D@@	O	-1	8480959
ES@@	O	-1	8480959
I@@	O	-1	8480959
G@@	O	-1	8480959
N@@	O	-1	8480959
:	O	-1	8480959
The	O	-1	8480959
E@@	O	-1	8480959
x@@	O	-1	8480959
p@@	O	-1	8480959
and@@	O	-1	8480959
ed	O	-1	8480959
Clin@@	O	-1	8480959
ical	O	-1	8480959
E@@	O	-1	8480959
valu@@	O	-1	8480959
ation	O	-1	8480959
of	O	-1	8480959
L@@	B-Chemical	D008148	8480959
o@@	I-Chemical	-1	8480959
vastatin	I-Chemical	-1	8480959
(@@	O	-1	8480959
E@@	O	-1	8480959
X@@	O	-1	8480959
C@@	O	-1	8480959
E@@	O	-1	8480959
L@@	O	-1	8480959
)	O	-1	8480959
S@@	O	-1	8480959
t@@	O	-1	8480959
ud@@	O	-1	8480959
y,	O	-1	8480959
a	O	-1	8480959
mul@@	O	-1	8480959
tic@@	O	-1	8480959
ent@@	O	-1	8480959
er,	O	-1	8480959
double-bl@@	O	-1	8480959
ind@@	O	-1	8480959
,	O	-1	8480959
di@@	O	-1	8480959
et@@	O	-1	8480959
-	O	-1	8480959
and	O	-1	8480959
placebo@@	O	-1	8480959
-@@	O	-1	8480959
controlled	O	-1	8480959
tri@@	O	-1	8480959
al,	O	-1	8480959
in	O	-1	8480959
which	O	-1	8480959
partic@@	O	-1	8480959
ip@@	O	-1	8480959
ants	O	-1	8480959
were	O	-1	8480959
random@@	O	-1	8480959
ly	O	-1	8480959
as@@	O	-1	8480959
signed	O	-1	8480959
to	O	-1	8480959
recei@@	O	-1	8480959
ve	O	-1	8480959
placebo	O	-1	8480959
or	O	-1	8480959
lo@@	B-Chemical	D008148	8480959
vastatin	I-Chemical	-1	8480959
at	O	-1	8480959
doses	O	-1	8480959
of	O	-1	8480959
20	O	-1	8480959
or	O	-1	8480959
40	O	-1	8480959
mg	O	-1	8480959
on@@	O	-1	8480959
ce	O	-1	8480959
da@@	O	-1	8480959
il@@	O	-1	8480959
y,	O	-1	8480959
or	O	-1	8480959
20	O	-1	8480959
or	O	-1	8480959
40	O	-1	8480959
mg	O	-1	8480959
tw@@	O	-1	8480959
ic@@	O	-1	8480959
e	O	-1	8480959
daily	O	-1	8480959
for	O	-1	8480959
4@@	O	-1	8480959
8	O	-1	8480959
week@@	O	-1	8480959
s.	O	-1	8480959
S@@	O	-1	8480959
ET@@	O	-1	8480959
TI@@	O	-1	8480959
N@@	O	-1	8480959
G@@	O	-1	8480959
:	O	-1	8480959
A@@	O	-1	8480959
mb@@	O	-1	8480959
ul@@	O	-1	8480959
atory	O	-1	8480959
patients	O	-1	8480959
rec@@	O	-1	8480959
ru@@	O	-1	8480959
ited	O	-1	8480959
by	O	-1	8480959
3@@	O	-1	8480959
6@@	O	-1	8480959
2	O	-1	8480959
partic@@	O	-1	8480959
ip@@	O	-1	8480959
ating	O	-1	8480959
c@@	O	-1	8480959
ent@@	O	-1	8480959
ers	O	-1	8480959
throu@@	O	-1	8480959
gh@@	O	-1	8480959
out	O	-1	8480959
the	O	-1	8480959
U@@	O	-1	8480959
nit@@	O	-1	8480959
ed	O	-1	8480959
S@@	O	-1	8480959
t@@	O	-1	8480959
at@@	O	-1	8480959
es.	O	-1	8480959
PA@@	O	-1	8480959
TI@@	O	-1	8480959
E@@	O	-1	8480959
N@@	O	-1	8480959
T@@	O	-1	8480959
S:	O	-1	8480959
W@@	O	-1	8480959
o@@	O	-1	8480959
men	O	-1	8480959
(n	O	-1	8480959
=	O	-1	8480959
3@@	O	-1	8480959
3@@	O	-1	8480959
9@@	O	-1	8480959
0@@	O	-1	8480959
)	O	-1	8480959
from	O	-1	8480959
the	O	-1	8480959
total	O	-1	8480959
co@@	O	-1	8480959
h@@	O	-1	8480959
ort	O	-1	8480959
of	O	-1	8480959
8@@	O	-1	8480959
2@@	O	-1	8480959
4@@	O	-1	8480959
5	O	-1	8480959
vol@@	O	-1	8480959
un@@	O	-1	8480959
te@@	O	-1	8480959
ers.	O	-1	8480959
M@@	O	-1	8480959
E@@	O	-1	8480959
A@@	O	-1	8480959
S@@	O	-1	8480959
U@@	O	-1	8480959
R@@	O	-1	8480959
E@@	O	-1	8480959
M@@	O	-1	8480959
E@@	O	-1	8480959
N@@	O	-1	8480959
T@@	O	-1	8480959
S:	O	-1	8480959
P@@	O	-1	8480959
las@@	O	-1	8480959
ma	O	-1	8480959
tot@@	O	-1	8480959
al,	O	-1	8480959
low@@	O	-1	8480959
-@@	O	-1	8480959
d@@	O	-1	8480959
ensity	O	-1	8480959
li@@	O	-1	8480959
po@@	O	-1	8480959
protein	O	-1	8480959
(@@	O	-1	8480959
L@@	O	-1	8480959
D@@	O	-1	8480959
L@@	O	-1	8480959
),	O	-1	8480959
and	O	-1	8480959
high-@@	O	-1	8480959
d@@	O	-1	8480959
ensity	O	-1	8480959
li@@	O	-1	8480959
po@@	O	-1	8480959
protein	O	-1	8480959
(@@	O	-1	8480959
H@@	O	-1	8480959
D@@	O	-1	8480959
L@@	O	-1	8480959
)	O	-1	8480959
cholester@@	B-Chemical	D002784	8480959
ol	I-Chemical	-1	8480959
,	O	-1	8480959
and	O	-1	8480959
tri@@	B-Chemical	D014280	8480959
glycer@@	I-Chemical	-1	8480959
i@@	I-Chemical	-1	8480959
des	I-Chemical	-1	8480959
;	O	-1	8480959
and	O	-1	8480959
labor@@	O	-1	8480959
atory	O	-1	8480959
and	O	-1	8480959
clinical	O	-1	8480959
evidence	O	-1	8480959
of	O	-1	8480959
adverse	O	-1	8480959
events	O	-1	8480959
monit@@	O	-1	8480959
o@@	O	-1	8480959
red	O	-1	8480959
perio@@	O	-1	8480959
dic@@	O	-1	8480959
ally	O	-1	8480959
throu@@	O	-1	8480959
gh@@	O	-1	8480959
out	O	-1	8480959
the	O	-1	8480959
study.	O	-1	8480959
RESULTS:	O	-1	8480959
A@@	O	-1	8480959
mon@@	O	-1	8480959
g	O	-1	8480959
wom@@	O	-1	8480959
en@@	O	-1	8480959
,	O	-1	8480959
lo@@	B-Chemical	D008148	8480959
vastatin	I-Chemical	-1	8480959
(2@@	O	-1	8480959
0	O	-1	8480959
to	O	-1	8480959
8@@	O	-1	8480959
0	O	-1	8480959
mg/d@@	O	-1	8480959
)	O	-1	8480959
produced	O	-1	8480959
su@@	O	-1	8480959
st@@	O	-1	8480959
ained	O	-1	8480959
(1@@	O	-1	8480959
2@@	O	-1	8480959
-	O	-1	8480959
to	O	-1	8480959
4@@	O	-1	8480959
8@@	O	-1	8480959
-@@	O	-1	8480959
week@@	O	-1	8480959
),	O	-1	8480959
dose-@@	O	-1	8480959
related	O	-1	8480959
changes	O	-1	8480959
(P	O	-1	8480959
<	O	-1	8480959
0.00@@	O	-1	8480959
1@@	O	-1	8480959
)@@	O	-1	8480959
:	O	-1	8480959
decreas@@	O	-1	8480959
es	O	-1	8480959
in	O	-1	8480959
L@@	O	-1	8480959
D@@	O	-1	8480959
L	O	-1	8480959
cholester@@	B-Chemical	D002784	8480959
ol	I-Chemical	-1	8480959
(2@@	O	-1	8480959
4@@	O	-1	8480959
%	O	-1	8480959
to	O	-1	8480959
4@@	O	-1	8480959
0@@	O	-1	8480959
%)	O	-1	8480959
and	O	-1	8480959
tri@@	B-Chemical	D014280	8480959
glycer@@	I-Chemical	-1	8480959
i@@	I-Chemical	-1	8480959
des	I-Chemical	-1	8480959
(@@	O	-1	8480959
9@@	O	-1	8480959
%	O	-1	8480959
to	O	-1	8480959
18@@	O	-1	8480959
%),	O	-1	8480959
and	O	-1	8480959
increases	O	-1	8480959
in	O	-1	8480959
H@@	O	-1	8480959
D@@	O	-1	8480959
L	O	-1	8480959
cholester@@	B-Chemical	D002784	8480959
ol	I-Chemical	-1	8480959
(@@	O	-1	8480959
6.@@	O	-1	8480959
7@@	O	-1	8480959
%	O	-1	8480959
to	O	-1	8480959
8.@@	O	-1	8480959
6@@	O	-1	8480959
%).	O	-1	8480959
D@@	O	-1	8480959
ep@@	O	-1	8480959
en@@	O	-1	8480959
ding	O	-1	8480959
on	O	-1	8480959
the	O	-1	8480959
dose@@	O	-1	8480959
,	O	-1	8480959
from	O	-1	8480959
8@@	O	-1	8480959
2@@	O	-1	8480959
%	O	-1	8480959
to	O	-1	8480959
95%	O	-1	8480959
of	O	-1	8480959
lo@@	B-Chemical	D008148	8480959
vastatin	I-Chemical	-1	8480959
-treated	O	-1	8480959
women	O	-1	8480959
achi@@	O	-1	8480959
ev@@	O	-1	8480959
ed	O	-1	8480959
the	O	-1	8480959
N@@	O	-1	8480959
ation@@	O	-1	8480959
al	O	-1	8480959
Ch@@	B-Chemical	D002784	8480959
ol@@	I-Chemical	-1	8480959
est@@	I-Chemical	-1	8480959
er@@	I-Chemical	-1	8480959
ol	I-Chemical	-1	8480959
E@@	O	-1	8480959
duc@@	O	-1	8480959
ation	O	-1	8480959
Pro@@	O	-1	8480959
gra@@	O	-1	8480959
m	O	-1	8480959
go@@	O	-1	8480959
al	O	-1	8480959
of	O	-1	8480959
L@@	O	-1	8480959
D@@	O	-1	8480959
L	O	-1	8480959
cholester@@	B-Chemical	D002784	8480959
ol	I-Chemical	-1	8480959
levels	O	-1	8480959
less	O	-1	8480959
than	O	-1	8480959
4.@@	O	-1	8480959
14	O	-1	8480959
m@@	O	-1	8480959
mol@@	O	-1	8480959
/@@	O	-1	8480959
L	O	-1	8480959
(1@@	O	-1	8480959
60	O	-1	8480959
mg/d@@	O	-1	8480959
L@@	O	-1	8480959
),	O	-1	8480959
and	O	-1	8480959
4@@	O	-1	8480959
0%	O	-1	8480959
to	O	-1	8480959
8@@	O	-1	8480959
7@@	O	-1	8480959
%	O	-1	8480959
achi@@	O	-1	8480959
ev@@	O	-1	8480959
ed	O	-1	8480959
the	O	-1	8480959
go@@	O	-1	8480959
al	O	-1	8480959
of	O	-1	8480959
3.@@	O	-1	8480959
3@@	O	-1	8480959
6	O	-1	8480959
m@@	O	-1	8480959
mol@@	O	-1	8480959
/@@	O	-1	8480959
L	O	-1	8480959
(1@@	O	-1	8480959
30	O	-1	8480959
mg/d@@	O	-1	8480959
L@@	O	-1	8480959
).	O	-1	8480959
S@@	O	-1	8480959
uc@@	O	-1	8480959
ces@@	O	-1	8480959
sive	O	-1	8480959
trans@@	O	-1	8480959
amin@@	O	-1	8480959
ase	O	-1	8480959
elev@@	O	-1	8480959
ations	O	-1	8480959
greater	O	-1	8480959
than	O	-1	8480959
three	O	-1	8480959
times	O	-1	8480959
the	O	-1	8480959
up@@	O	-1	8480959
per	O	-1	8480959
lim@@	O	-1	8480959
it	O	-1	8480959
of	O	-1	8480959
normal	O	-1	8480959
occurred	O	-1	8480959
in	O	-1	8480959
0.@@	O	-1	8480959
1@@	O	-1	8480959
%	O	-1	8480959
of	O	-1	8480959
women	O	-1	8480959
and	O	-1	8480959
were	O	-1	8480959
dose	O	-1	8480959
dependent	O	-1	8480959
ab@@	O	-1	8480959
o@@	O	-1	8480959
ve	O	-1	8480959
the	O	-1	8480959
20@@	O	-1	8480959
-@@	O	-1	8480959
mg	O	-1	8480959
dose.	O	-1	8480959
M@@	B-Disease	D009135	8480959
yo@@	I-Disease	-1	8480959
pathy	I-Disease	-1	8480959
,	O	-1	8480959
def@@	O	-1	8480959
in@@	O	-1	8480959
ed	O	-1	8480959
as	O	-1	8480959
musc@@	O	-1	8480959
le	O	-1	8480959
symptoms	O	-1	8480959
with	O	-1	8480959
creat@@	B-Chemical	D003401	8480959
ine	I-Chemical	-1	8480959
kin@@	O	-1	8480959
ase	O	-1	8480959
elev@@	O	-1	8480959
ations	O	-1	8480959
greater	O	-1	8480959
than	O	-1	8480959
10	O	-1	8480959
times	O	-1	8480959
the	O	-1	8480959
up@@	O	-1	8480959
per	O	-1	8480959
lim@@	O	-1	8480959
it	O	-1	8480959
of	O	-1	8480959
normal@@	O	-1	8480959
,	O	-1	8480959
was	O	-1	8480959
r@@	O	-1	8480959
are	O	-1	8480959
and	O	-1	8480959
associated	O	-1	8480959
with	O	-1	8480959
the	O	-1	8480959
high@@	O	-1	8480959
est	O	-1	8480959
recomm@@	O	-1	8480959
en@@	O	-1	8480959
ded	O	-1	8480959
daily	O	-1	8480959
dose	O	-1	8480959
of	O	-1	8480959
lo@@	B-Chemical	D008148	8480959
vastatin	I-Chemical	-1	8480959
(@@	O	-1	8480959
8@@	O	-1	8480959
0	O	-1	8480959
mg@@	O	-1	8480959
).	O	-1	8480959
E@@	O	-1	8480959
stro@@	O	-1	8480959
gen@@	O	-1	8480959
-@@	O	-1	8480959
re@@	O	-1	8480959
pl@@	O	-1	8480959
ac@@	O	-1	8480959
ement	O	-1	8480959
therapy	O	-1	8480959
appe@@	O	-1	8480959
a@@	O	-1	8480959
red	O	-1	8480959
to	O	-1	8480959
have	O	-1	8480959
no	O	-1	8480959
effect	O	-1	8480959
on	O	-1	8480959
either	O	-1	8480959
the	O	-1	8480959
efficacy	O	-1	8480959
or	O	-1	8480959
safety	O	-1	8480959
prof@@	O	-1	8480959
ile	O	-1	8480959
of	O	-1	8480959
lo@@	B-Chemical	D008148	8480959
vastatin	I-Chemical	-1	8480959
.	O	-1	8480959
CONCLUSION:	O	-1	8480959
L@@	B-Chemical	D008148	8480959
o@@	I-Chemical	-1	8480959
vastatin	I-Chemical	-1	8480959
is	O	-1	8480959
high@@	O	-1	8480959
ly	O	-1	8480959
effective	O	-1	8480959
and	O	-1	8480959
gener@@	O	-1	8480959
ally	O	-1	8480959
well	O	-1	8480959
toler@@	O	-1	8480959
ated	O	-1	8480959
as	O	-1	8480959
therapy	O	-1	8480959
for	O	-1	8480959
prim@@	O	-1	8480959
ary	O	-1	8480959
hyper@@	B-Disease	D006937	8480959
cholester@@	I-Disease	-1	8480959
ol@@	I-Disease	-1	8480959
emia	I-Disease	-1	8480959
in	O	-1	8480959
wom@@	O	-1	8480959
en@@	O	-1	8480959
.	O	-1	8480959

R@@	B-Disease	D012892	7197363
E@@	I-Disease	-1	7197363
M	I-Disease	-1	7197363
sleep	I-Disease	-1	7197363
de@@	I-Disease	-1	7197363
pri@@	I-Disease	-1	7197363
v@@	I-Disease	-1	7197363
ation	I-Disease	-1	7197363
changes	O	-1	7197363
behavioral	O	-1	7197363
response	O	-1	7197363
to	O	-1	7197363
cat@@	O	-1	7197363
ech@@	O	-1	7197363
ol@@	O	-1	7197363
aminergic	O	-1	7197363
and	O	-1	7197363
seroton@@	O	-1	7197363
ergic	O	-1	7197363
receptor	O	-1	7197363
activation	O	-1	7197363
in	O	-1	7197363
rats.	O	-1	7197363
The	O	-1	7197363
effects	O	-1	7197363
of	O	-1	7197363
R@@	B-Disease	D012892	7197363
E@@	I-Disease	-1	7197363
M	I-Disease	-1	7197363
sleep	I-Disease	-1	7197363
de@@	I-Disease	-1	7197363
pri@@	I-Disease	-1	7197363
v@@	I-Disease	-1	7197363
ation	I-Disease	-1	7197363
(	O	-1	7197363
R@@	B-Disease	D012892	7197363
E@@	I-Disease	-1	7197363
M@@	I-Disease	-1	7197363
D	I-Disease	-1	7197363
)	O	-1	7197363
on	O	-1	7197363
apo@@	B-Chemical	D001058	7197363
morphine	I-Chemical	-1	7197363
-induced	O	-1	7197363
ag@@	B-Disease	D001523	7197363
gres@@	I-Disease	-1	7197363
si@@	I-Disease	-1	7197363
ven@@	I-Disease	-1	7197363
ess	I-Disease	-1	7197363
and	O	-1	7197363
qu@@	B-Chemical	D011814	7197363
i@@	I-Chemical	-1	7197363
pa@@	I-Chemical	-1	7197363
z@@	I-Chemical	-1	7197363
ine	I-Chemical	-1	7197363
-induced	O	-1	7197363
he@@	B-Disease	D009069	7197363
ad	I-Disease	-1	7197363
t@@	I-Disease	-1	7197363
witch@@	I-Disease	-1	7197363
es	I-Disease	-1	7197363
in	O	-1	7197363
rats	O	-1	7197363
were	O	-1	7197363
deter@@	O	-1	7197363
m@@	O	-1	7197363
ine@@	O	-1	7197363
d.	O	-1	7197363
F@@	O	-1	7197363
or@@	O	-1	7197363
ty-@@	O	-1	7197363
e@@	O	-1	7197363
ight	O	-1	7197363
h@@	O	-1	7197363
r	O	-1	7197363
of	O	-1	7197363
R@@	B-Disease	D012892	7197363
E@@	I-Disease	-1	7197363
M@@	I-Disease	-1	7197363
D	I-Disease	-1	7197363
increased	O	-1	7197363
apo@@	B-Chemical	D001058	7197363
morphine	I-Chemical	-1	7197363
-induced	O	-1	7197363
ag@@	B-Disease	D001523	7197363
gres@@	I-Disease	-1	7197363
si@@	I-Disease	-1	7197363
ven@@	I-Disease	-1	7197363
ess	I-Disease	-1	7197363
,	O	-1	7197363
and	O	-1	7197363
reduced	O	-1	7197363
(@@	O	-1	7197363
immedi@@	O	-1	7197363
ately	O	-1	7197363
after	O	-1	7197363
comple@@	O	-1	7197363
ting	O	-1	7197363
of	O	-1	7197363
R@@	B-Disease	D012892	7197363
E@@	I-Disease	-1	7197363
M@@	I-Disease	-1	7197363
D	I-Disease	-1	7197363
)	O	-1	7197363
or	O	-1	7197363
increased	O	-1	7197363
(@@	O	-1	7197363
9@@	O	-1	7197363
6	O	-1	7197363
h@@	O	-1	7197363
r	O	-1	7197363
after	O	-1	7197363
comple@@	O	-1	7197363
ting	O	-1	7197363
of	O	-1	7197363
R@@	B-Disease	D012892	7197363
E@@	I-Disease	-1	7197363
M@@	I-Disease	-1	7197363
D	I-Disease	-1	7197363
)	O	-1	7197363
qu@@	B-Chemical	D011814	7197363
i@@	I-Chemical	-1	7197363
pa@@	I-Chemical	-1	7197363
z@@	I-Chemical	-1	7197363
ine	I-Chemical	-1	7197363
-induced	O	-1	7197363
he@@	B-Disease	D009069	7197363
ad	I-Disease	-1	7197363
t@@	I-Disease	-1	7197363
witch@@	I-Disease	-1	7197363
es	I-Disease	-1	7197363
.	O	-1	7197363
R@@	O	-1	7197363
es@@	O	-1	7197363
ult@@	O	-1	7197363
s	O	-1	7197363
are	O	-1	7197363
discus@@	O	-1	7197363
sed	O	-1	7197363
in	O	-1	7197363
ter@@	O	-1	7197363
ms	O	-1	7197363
of	O	-1	7197363
simil@@	O	-1	7197363
ar@@	O	-1	7197363
ity	O	-1	7197363
to	O	-1	7197363
pharmac@@	O	-1	7197363
ological	O	-1	7197363
effects	O	-1	7197363
of	O	-1	7197363
other	O	-1	7197363
anti@@	O	-1	7197363
de@@	O	-1	7197363
pressive	O	-1	7197363
treatment@@	O	-1	7197363
s.	O	-1	7197363

E@@	O	-1	7161250
x@@	O	-1	7161250
tra@@	O	-1	7161250
py@@	O	-1	7161250
ram@@	O	-1	7161250
idal	O	-1	7161250
side	O	-1	7161250
effects	O	-1	7161250
and	O	-1	7161250
oral	O	-1	7161250
haloperidol	B-Chemical	D006220	7161250
:	O	-1	7161250
an	O	-1	7161250
analysis	O	-1	7161250
of	O	-1	7161250
expl@@	O	-1	7161250
an@@	O	-1	7161250
atory	O	-1	7161250
patient	O	-1	7161250
and	O	-1	7161250
treatment	O	-1	7161250
character@@	O	-1	7161250
is@@	O	-1	7161250
tic@@	O	-1	7161250
s.	O	-1	7161250
The	O	-1	7161250
incidence	O	-1	7161250
of	O	-1	7161250
ext@@	O	-1	7161250
ra@@	O	-1	7161250
py@@	O	-1	7161250
ram@@	O	-1	7161250
idal	O	-1	7161250
side	O	-1	7161250
effects	O	-1	7161250
(@@	O	-1	7161250
EP@@	O	-1	7161250
S)	O	-1	7161250
was	O	-1	7161250
evaluated	O	-1	7161250
in	O	-1	7161250
9@@	O	-1	7161250
8	O	-1	7161250
patients	O	-1	7161250
treated	O	-1	7161250
with	O	-1	7161250
haloperidol	B-Chemical	D006220	7161250
.	O	-1	7161250
The	O	-1	7161250
incidence	O	-1	7161250
of	O	-1	7161250
par@@	B-Disease	D010302	7161250
k@@	I-Disease	-1	7161250
inson@@	I-Disease	-1	7161250
ism	I-Disease	-1	7161250
was	O	-1	7161250
higher	O	-1	7161250
at	O	-1	7161250
higher	O	-1	7161250
doses	O	-1	7161250
of	O	-1	7161250
haloperidol	B-Chemical	D006220	7161250
and	O	-1	7161250
in	O	-1	7161250
youn@@	O	-1	7161250
g@@	O	-1	7161250
er	O	-1	7161250
patients.	O	-1	7161250
Pro@@	O	-1	7161250
phyl@@	O	-1	7161250
ac@@	O	-1	7161250
tic	O	-1	7161250
anti@@	O	-1	7161250
par@@	O	-1	7161250
k@@	O	-1	7161250
inson@@	O	-1	7161250
i@@	O	-1	7161250
an	O	-1	7161250
medic@@	O	-1	7161250
ation	O	-1	7161250
was	O	-1	7161250
effective	O	-1	7161250
in	O	-1	7161250
youn@@	O	-1	7161250
g@@	O	-1	7161250
er	O	-1	7161250
but	O	-1	7161250
not	O	-1	7161250
in	O	-1	7161250
ol@@	O	-1	7161250
der	O	-1	7161250
patients.	O	-1	7161250
However,	O	-1	7161250
these	O	-1	7161250
medic@@	O	-1	7161250
ations	O	-1	7161250
were	O	-1	7161250
more	O	-1	7161250
effective	O	-1	7161250
in	O	-1	7161250
both	O	-1	7161250
youn@@	O	-1	7161250
g	O	-1	7161250
and	O	-1	7161250
old	O	-1	7161250
patients	O	-1	7161250
when	O	-1	7161250
given	O	-1	7161250
after	O	-1	7161250
par@@	B-Disease	D010302	7161250
k@@	I-Disease	-1	7161250
inson@@	I-Disease	-1	7161250
ism	I-Disease	-1	7161250
develop@@	O	-1	7161250
ed.	O	-1	7161250
A@@	B-Disease	D017109	7161250
k@@	I-Disease	-1	7161250
athi@@	I-Disease	-1	7161250
sia	I-Disease	-1	7161250
was	O	-1	7161250
controlled	O	-1	7161250
by	O	-1	7161250
the	O	-1	7161250
b@@	B-Chemical	D001569	7161250
enz@@	I-Chemical	-1	7161250
odi@@	I-Chemical	-1	7161250
azepine	I-Chemical	-1	7161250
lor@@	B-Chemical	D008140	7161250
az@@	I-Chemical	-1	7161250
epam	I-Chemical	-1	7161250
in	O	-1	7161250
14	O	-1	7161250
out	O	-1	7161250
of	O	-1	7161250
16	O	-1	7161250
patients,	O	-1	7161250
while	O	-1	7161250
pro@@	O	-1	7161250
phyl@@	O	-1	7161250
ac@@	O	-1	7161250
tic	O	-1	7161250
anti@@	O	-1	7161250
par@@	O	-1	7161250
k@@	O	-1	7161250
inson@@	O	-1	7161250
i@@	O	-1	7161250
ans	O	-1	7161250
were	O	-1	7161250
ine@@	O	-1	7161250
ff@@	O	-1	7161250
ecti@@	O	-1	7161250
ve.	O	-1	7161250
The	O	-1	7161250
present	O	-1	7161250
study	O	-1	7161250
po@@	O	-1	7161250
int@@	O	-1	7161250
s	O	-1	7161250
to	O	-1	7161250
patient	O	-1	7161250
character@@	O	-1	7161250
is@@	O	-1	7161250
tics	O	-1	7161250
that	O	-1	7161250
may	O	-1	7161250
be	O	-1	7161250
of	O	-1	7161250
signific@@	O	-1	7161250
ance	O	-1	7161250
in	O	-1	7161250
the	O	-1	7161250
development	O	-1	7161250
of	O	-1	7161250
EP@@	O	-1	7161250
S	O	-1	7161250
due	O	-1	7161250
to	O	-1	7161250
haloperidol	B-Chemical	D006220	7161250
.	O	-1	7161250

He@@	B-Disease	D006504	7053705
pati@@	I-Disease	-1	7053705
c	I-Disease	-1	7053705
ven@@	I-Disease	-1	7053705
o@@	I-Disease	-1	7053705
-@@	I-Disease	-1	7053705
oc@@	I-Disease	-1	7053705
cl@@	I-Disease	-1	7053705
u@@	I-Disease	-1	7053705
sive	I-Disease	-1	7053705
disease	I-Disease	-1	7053705
caused	O	-1	7053705
by	O	-1	7053705
6-@@	B-Chemical	D013866	7053705
th@@	I-Chemical	-1	7053705
io@@	I-Chemical	-1	7053705
gu@@	I-Chemical	-1	7053705
an@@	I-Chemical	-1	7053705
ine	I-Chemical	-1	7053705
.	O	-1	7053705
Clin@@	O	-1	7053705
ically	O	-1	7053705
reversible	O	-1	7053705
ven@@	B-Disease	D006504	7053705
o@@	I-Disease	-1	7053705
-@@	I-Disease	-1	7053705
oc@@	I-Disease	-1	7053705
cl@@	I-Disease	-1	7053705
u@@	I-Disease	-1	7053705
sive	I-Disease	-1	7053705
disease	I-Disease	-1	7053705
of	I-Disease	-1	7053705
the	I-Disease	-1	7053705
liver	I-Disease	-1	7053705
developed	O	-1	7053705
in	O	-1	7053705
a	O	-1	7053705
2@@	O	-1	7053705
3-@@	O	-1	7053705
year-old	O	-1	7053705
man	O	-1	7053705
with	O	-1	7053705
acute	B-Disease	D054198	7053705
lymph@@	I-Disease	-1	7053705
ocy@@	I-Disease	-1	7053705
tic	I-Disease	-1	7053705
leuk@@	I-Disease	-1	7053705
emia	I-Disease	-1	7053705
after	O	-1	7053705
10	O	-1	7053705
months	O	-1	7053705
of	O	-1	7053705
maint@@	O	-1	7053705
en@@	O	-1	7053705
ance	O	-1	7053705
therapy	O	-1	7053705
with	O	-1	7053705
6-@@	B-Chemical	D013866	7053705
th@@	I-Chemical	-1	7053705
io@@	I-Chemical	-1	7053705
gu@@	I-Chemical	-1	7053705
an@@	I-Chemical	-1	7053705
ine	I-Chemical	-1	7053705
.	O	-1	7053705
S@@	O	-1	7053705
er@@	O	-1	7053705
ial	O	-1	7053705
liver	O	-1	7053705
biop@@	O	-1	7053705
si@@	O	-1	7053705
es	O	-1	7053705
showed	O	-1	7053705
the	O	-1	7053705
development	O	-1	7053705
and	O	-1	7053705
resol@@	O	-1	7053705
u@@	O	-1	7053705
tion	O	-1	7053705
of	O	-1	7053705
int@@	O	-1	7053705
en@@	O	-1	7053705
se	O	-1	7053705
s@@	O	-1	7053705
in@@	O	-1	7053705
us@@	O	-1	7053705
oid@@	O	-1	7053705
al	O	-1	7053705
en@@	O	-1	7053705
g@@	O	-1	7053705
org@@	O	-1	7053705
em@@	O	-1	7053705
ent@@	O	-1	7053705
.	O	-1	7053705
Although	O	-1	7053705
this	O	-1	7053705
disease	O	-1	7053705
was	O	-1	7053705
clin@@	O	-1	7053705
ically	O	-1	7053705
rever@@	O	-1	7053705
sib@@	O	-1	7053705
le@@	O	-1	7053705
,	O	-1	7053705
some	O	-1	7053705
sub@@	O	-1	7053705
in@@	O	-1	7053705
tim@@	O	-1	7053705
al	O	-1	7053705
fib@@	B-Disease	D005355	7053705
ro@@	I-Disease	-1	7053705
sis	I-Disease	-1	7053705
about	O	-1	7053705
the	O	-1	7053705
ter@@	O	-1	7053705
min@@	O	-1	7053705
al	O	-1	7053705
hepatic	O	-1	7053705
ve@@	O	-1	7053705
ins	O	-1	7053705
per@@	O	-1	7053705
sist@@	O	-1	7053705
ed.	O	-1	7053705
This	O	-1	7053705
case	O	-1	7053705
presented	O	-1	7053705
a	O	-1	7053705
un@@	O	-1	7053705
i@@	O	-1	7053705
qu@@	O	-1	7053705
e	O	-1	7053705
op@@	O	-1	7053705
port@@	O	-1	7053705
un@@	O	-1	7053705
ity	O	-1	7053705
to	O	-1	7053705
obser@@	O	-1	7053705
ve	O	-1	7053705
the	O	-1	7053705
hist@@	O	-1	7053705
ologic	O	-1	7053705
feat@@	O	-1	7053705
ures	O	-1	7053705
of	O	-1	7053705
clin@@	O	-1	7053705
ically	O	-1	7053705
reversible	O	-1	7053705
hepatic	B-Disease	D006504	7053705
ven@@	I-Disease	-1	7053705
o@@	I-Disease	-1	7053705
-@@	I-Disease	-1	7053705
oc@@	I-Disease	-1	7053705
cl@@	I-Disease	-1	7053705
u@@	I-Disease	-1	7053705
sive	I-Disease	-1	7053705
disease	I-Disease	-1	7053705
over	O	-1	7053705
ti@@	O	-1	7053705
me,	O	-1	7053705
and	O	-1	7053705
may	O	-1	7053705
be	O	-1	7053705
the	O	-1	7053705
first	O	-1	7053705
case	O	-1	7053705
of	O	-1	7053705
ven@@	O	-1	7053705
o@@	O	-1	7053705
-@@	O	-1	7053705
oc@@	O	-1	7053705
cl@@	O	-1	7053705
u@@	O	-1	7053705
sive	O	-1	7053705
related	O	-1	7053705
sol@@	O	-1	7053705
ely	O	-1	7053705
to	O	-1	7053705
6-@@	B-Chemical	D013866	7053705
th@@	I-Chemical	-1	7053705
io@@	I-Chemical	-1	7053705
gu@@	I-Chemical	-1	7053705
an@@	I-Chemical	-1	7053705
ine	I-Chemical	-1	7053705
.	O	-1	7053705

Treat@@	O	-1	6402369
ment	O	-1	6402369
of	O	-1	6402369
if@@	B-Chemical	D007069	6402369
os@@	I-Chemical	-1	6402369
f@@	I-Chemical	-1	6402369
amide	I-Chemical	-1	6402369
-induced	O	-1	6402369
uro@@	B-Disease	D001745	6402369
thelial	I-Disease	-1	6402369
toxicity	I-Disease	-1	6402369
by	O	-1	6402369
oral	O	-1	6402369
administration	O	-1	6402369
of	O	-1	6402369
sodium	B-Chemical	D015080	6402369
2-@@	I-Chemical	-1	6402369
mer@@	I-Chemical	-1	6402369
cap@@	I-Chemical	-1	6402369
to@@	I-Chemical	-1	6402369
eth@@	I-Chemical	-1	6402369
ane	I-Chemical	-1	6402369
sul@@	I-Chemical	-1	6402369
ph@@	I-Chemical	-1	6402369
on@@	I-Chemical	-1	6402369
ate	I-Chemical	-1	6402369
(	O	-1	6402369
M@@	B-Chemical	D015080	6402369
ES@@	I-Chemical	-1	6402369
NA	I-Chemical	-1	6402369
)	O	-1	6402369
to	O	-1	6402369
patients	O	-1	6402369
with	O	-1	6402369
ino@@	O	-1	6402369
per@@	O	-1	6402369
able	O	-1	6402369
l@@	B-Disease	D008175	6402369
un@@	I-Disease	-1	6402369
g	I-Disease	-1	6402369
cancer	I-Disease	-1	6402369
.	O	-1	6402369
The	O	-1	6402369
protective	O	-1	6402369
effect	O	-1	6402369
of	O	-1	6402369
oral	O	-1	6402369
administration	O	-1	6402369
of	O	-1	6402369
the	O	-1	6402369
th@@	B-Chemical	D013438	6402369
io@@	I-Chemical	-1	6402369
l	I-Chemical	-1	6402369
comp@@	O	-1	6402369
ound	O	-1	6402369
sodium	B-Chemical	D015080	6402369
2-@@	I-Chemical	-1	6402369
mer@@	I-Chemical	-1	6402369
cap@@	I-Chemical	-1	6402369
to@@	I-Chemical	-1	6402369
eth@@	I-Chemical	-1	6402369
ane	I-Chemical	-1	6402369
sul@@	I-Chemical	-1	6402369
ph@@	I-Chemical	-1	6402369
on@@	I-Chemical	-1	6402369
ate	I-Chemical	-1	6402369
(	O	-1	6402369
M@@	B-Chemical	D015080	6402369
ES@@	I-Chemical	-1	6402369
NA	I-Chemical	-1	6402369
)	O	-1	6402369
against	O	-1	6402369
uro@@	B-Disease	D001745	6402369
thelial	I-Disease	-1	6402369
toxicity	I-Disease	-1	6402369
induced	O	-1	6402369
by	O	-1	6402369
if@@	B-Chemical	D007069	6402369
os@@	I-Chemical	-1	6402369
f@@	I-Chemical	-1	6402369
amide	I-Chemical	-1	6402369
(	O	-1	6402369
I@@	B-Chemical	D007069	6402369
F	I-Chemical	-1	6402369
)	O	-1	6402369
was	O	-1	6402369
tested	O	-1	6402369
in	O	-1	6402369
a	O	-1	6402369
group	O	-1	6402369
of	O	-1	6402369
4@@	O	-1	6402369
5	O	-1	6402369
patients	O	-1	6402369
with	O	-1	6402369
ino@@	O	-1	6402369
per@@	O	-1	6402369
able	O	-1	6402369
l@@	B-Disease	D008175	6402369
un@@	I-Disease	-1	6402369
g	I-Disease	-1	6402369
cancer	I-Disease	-1	6402369
under	O	-1	6402369
treatment	O	-1	6402369
with	O	-1	6402369
I@@	B-Chemical	D007069	6402369
F	I-Chemical	-1	6402369
(2@@	O	-1	6402369
2@@	O	-1	6402369
50	O	-1	6402369
mg/m@@	O	-1	6402369
2	O	-1	6402369
on	O	-1	6402369
days	O	-1	6402369
2-@@	O	-1	6402369
5@@	O	-1	6402369
)	O	-1	6402369
as	O	-1	6402369
par@@	O	-1	6402369
t	O	-1	6402369
of	O	-1	6402369
a	O	-1	6402369
poly@@	O	-1	6402369
chemotherapy	O	-1	6402369
regi@@	O	-1	6402369
men	O	-1	6402369
repe@@	O	-1	6402369
ated	O	-1	6402369
in	O	-1	6402369
a	O	-1	6402369
4-@@	O	-1	6402369
week	O	-1	6402369
cyc@@	O	-1	6402369
le@@	O	-1	6402369
.	O	-1	6402369
M@@	B-Chemical	D015080	6402369
ES@@	I-Chemical	-1	6402369
NA	I-Chemical	-1	6402369
was	O	-1	6402369
given	O	-1	6402369
or@@	O	-1	6402369
ally	O	-1	6402369
on	O	-1	6402369
the	O	-1	6402369
days	O	-1	6402369
of	O	-1	6402369
treatment	O	-1	6402369
with	O	-1	6402369
I@@	B-Chemical	D007069	6402369
F	I-Chemical	-1	6402369
in	O	-1	6402369
3	O	-1	6402369
doses	O	-1	6402369
of	O	-1	6402369
8@@	O	-1	6402369
40	O	-1	6402369
mg/m@@	O	-1	6402369
2,	O	-1	6402369
each	O	-1	6402369
administered	O	-1	6402369
at	O	-1	6402369
0	O	-1	6402369
h@@	O	-1	6402369
r	O	-1	6402369
(@@	O	-1	6402369
=	O	-1	6402369
injection	O	-1	6402369
of	O	-1	6402369
I@@	B-Chemical	D007069	6402369
F	I-Chemical	-1	6402369
),	O	-1	6402369
4	O	-1	6402369
h@@	O	-1	6402369
r	O	-1	6402369
and	O	-1	6402369
8	O	-1	6402369
h@@	O	-1	6402369
r	O	-1	6402369
p.@@	O	-1	6402369
i@@	O	-1	6402369
.	O	-1	6402369
O@@	O	-1	6402369
u@@	O	-1	6402369
t	O	-1	6402369
of	O	-1	6402369
a	O	-1	6402369
total	O	-1	6402369
of	O	-1	6402369
8@@	O	-1	6402369
8	O	-1	6402369
cour@@	O	-1	6402369
ses	O	-1	6402369
of	O	-1	6402369
this	O	-1	6402369
treatment	O	-1	6402369
we	O	-1	6402369
observed	O	-1	6402369
10	O	-1	6402369
episo@@	O	-1	6402369
des	O	-1	6402369
of	O	-1	6402369
as@@	O	-1	6402369
ym@@	O	-1	6402369
pto@@	O	-1	6402369
m@@	O	-1	6402369
atic	O	-1	6402369
micro@@	O	-1	6402369
sco@@	O	-1	6402369
p@@	O	-1	6402369
ic	O	-1	6402369
haem@@	B-Disease	D006417	6402369
at@@	I-Disease	-1	6402369
uria	I-Disease	-1	6402369
and	O	-1	6402369
no	O	-1	6402369
episo@@	O	-1	6402369
des	O	-1	6402369
of	O	-1	6402369
g@@	O	-1	6402369
ros@@	O	-1	6402369
s	O	-1	6402369
haem@@	B-Disease	D006417	6402369
at@@	I-Disease	-1	6402369
uria	I-Disease	-1	6402369
.	O	-1	6402369
In	O	-1	6402369
this	O	-1	6402369
group	O	-1	6402369
of	O	-1	6402369
4@@	O	-1	6402369
5	O	-1	6402369
patients	O	-1	6402369
under	O	-1	6402369
prot@@	O	-1	6402369
ection	O	-1	6402369
with	O	-1	6402369
M@@	B-Chemical	D015080	6402369
ES@@	I-Chemical	-1	6402369
NA	I-Chemical	-1	6402369
there	O	-1	6402369
were	O	-1	6402369
5	O	-1	6402369
complete	O	-1	6402369
re@@	O	-1	6402369
mis@@	O	-1	6402369
sions	O	-1	6402369
and	O	-1	6402369
9	O	-1	6402369
partial	O	-1	6402369
re@@	O	-1	6402369
mis@@	O	-1	6402369
sions	O	-1	6402369
(@@	O	-1	6402369
total	O	-1	6402369
3@@	O	-1	6402369
1@@	O	-1	6402369
%).	O	-1	6402369
A	O	-1	6402369
further	O	-1	6402369
group	O	-1	6402369
of	O	-1	6402369
25	O	-1	6402369
patients	O	-1	6402369
under	O	-1	6402369
poly@@	O	-1	6402369
chemotherapy	O	-1	6402369
with	O	-1	6402369
I@@	B-Chemical	D007069	6402369
F	I-Chemical	-1	6402369
were	O	-1	6402369
treated	O	-1	6402369
by	O	-1	6402369
con@@	O	-1	6402369
ven@@	O	-1	6402369
tional	O	-1	6402369
pro@@	O	-1	6402369
phyl@@	O	-1	6402369
ac@@	O	-1	6402369
tic	O	-1	6402369
meas@@	O	-1	6402369
ures	O	-1	6402369
(@@	O	-1	6402369
ra@@	O	-1	6402369
is@@	O	-1	6402369
ed	O	-1	6402369
flu@@	O	-1	6402369
id	O	-1	6402369
int@@	O	-1	6402369
ake	O	-1	6402369
and	O	-1	6402369
for@@	O	-1	6402369
c@@	O	-1	6402369
ed	O	-1	6402369
di@@	O	-1	6402369
ure@@	O	-1	6402369
si@@	O	-1	6402369
s@@	O	-1	6402369
).	O	-1	6402369
In	O	-1	6402369
this	O	-1	6402369
group	O	-1	6402369
there	O	-1	6402369
were	O	-1	6402369
1	O	-1	6402369
complete	O	-1	6402369
and	O	-1	6402369
5	O	-1	6402369
partial	O	-1	6402369
re@@	O	-1	6402369
mis@@	O	-1	6402369
sions	O	-1	6402369
(@@	O	-1	6402369
total	O	-1	6402369
2@@	O	-1	6402369
4@@	O	-1	6402369
%),	O	-1	6402369
but	O	-1	6402369
ne@@	O	-1	6402369
arly	O	-1	6402369
all	O	-1	6402369
patients	O	-1	6402369
developed	O	-1	6402369
either	O	-1	6402369
g@@	O	-1	6402369
ros@@	O	-1	6402369
s	O	-1	6402369
haem@@	B-Disease	D006417	6402369
at@@	I-Disease	-1	6402369
uria	I-Disease	-1	6402369
and/or	O	-1	6402369
symptoms	O	-1	6402369
of	O	-1	6402369
bladder	B-Disease	D001745	6402369
ir@@	I-Disease	-1	6402369
rit@@	I-Disease	-1	6402369
ation	I-Disease	-1	6402369
(	O	-1	6402369
cys@@	B-Disease	D003556	6402369
ti@@	I-Disease	-1	6402369
tis	I-Disease	-1	6402369
and	O	-1	6402369
pol@@	B-Disease	D014555	6402369
l@@	I-Disease	-1	6402369
ak@@	I-Disease	-1	6402369
is@@	I-Disease	-1	6402369
uria	I-Disease	-1	6402369
).	O	-1	6402369
There	O	-1	6402369
were	O	-1	6402369
no	O	-1	6402369
ap@@	O	-1	6402369
pre@@	O	-1	6402369
ci@@	O	-1	6402369
able	O	-1	6402369
differences	O	-1	6402369
between	O	-1	6402369
the	O	-1	6402369
M@@	B-Chemical	D015080	6402369
ES@@	I-Chemical	-1	6402369
NA	I-Chemical	-1	6402369
seri@@	O	-1	6402369
es	O	-1	6402369
and	O	-1	6402369
the	O	-1	6402369
con@@	O	-1	6402369
ven@@	O	-1	6402369
tional	O	-1	6402369
pro@@	O	-1	6402369
phyl@@	O	-1	6402369
ax@@	O	-1	6402369
is	O	-1	6402369
seri@@	O	-1	6402369
es	O	-1	6402369
with	O	-1	6402369
resp@@	O	-1	6402369
ect	O	-1	6402369
to	O	-1	6402369
either	O	-1	6402369
haem@@	O	-1	6402369
at@@	O	-1	6402369
ological	O	-1	6402369
or	O	-1	6402369
systemic	O	-1	6402369
toxicity	B-Disease	D064420	6402369
of	O	-1	6402369
the	O	-1	6402369
cyto@@	O	-1	6402369
st@@	O	-1	6402369
atic	O	-1	6402369
treatment.	O	-1	6402369
Our	O	-1	6402369
results	O	-1	6402369
suppor@@	O	-1	6402369
t	O	-1	6402369
the	O	-1	6402369
vie@@	O	-1	6402369
w	O	-1	6402369
that	O	-1	6402369
M@@	B-Chemical	D015080	6402369
ES@@	I-Chemical	-1	6402369
NA	I-Chemical	-1	6402369
,	O	-1	6402369
given	O	-1	6402369
or@@	O	-1	6402369
ally	O	-1	6402369
in	O	-1	6402369
con@@	O	-1	6402369
j@@	O	-1	6402369
unc@@	O	-1	6402369
tion	O	-1	6402369
with	O	-1	6402369
combined	O	-1	6402369
cyto@@	O	-1	6402369
st@@	O	-1	6402369
atic	O	-1	6402369
regimen@@	O	-1	6402369
s	O	-1	6402369
which	O	-1	6402369
includ@@	O	-1	6402369
e	O	-1	6402369
I@@	B-Chemical	D007069	6402369
F	I-Chemical	-1	6402369
,	O	-1	6402369
sim@@	O	-1	6402369
pl@@	O	-1	6402369
if@@	O	-1	6402369
i@@	O	-1	6402369
es	O	-1	6402369
the	O	-1	6402369
treatment	O	-1	6402369
and	O	-1	6402369
pro@@	O	-1	6402369
vi@@	O	-1	6402369
des	O	-1	6402369
op@@	O	-1	6402369
tim@@	O	-1	6402369
um	O	-1	6402369
prot@@	O	-1	6402369
ection	O	-1	6402369
for	O	-1	6402369
the	O	-1	6402369
urinary	O	-1	6402369
epi@@	O	-1	6402369
the@@	O	-1	6402369
li@@	O	-1	6402369
um@@	O	-1	6402369
.	O	-1	6402369
Pro@@	O	-1	6402369
t@@	O	-1	6402369
ection	O	-1	6402369
with	O	-1	6402369
oral	O	-1	6402369
M@@	B-Chemical	D015080	6402369
ES@@	I-Chemical	-1	6402369
NA	I-Chemical	-1	6402369
is	O	-1	6402369
partic@@	O	-1	6402369
ul@@	O	-1	6402369
arly	O	-1	6402369
su@@	O	-1	6402369
it@@	O	-1	6402369
able	O	-1	6402369
for	O	-1	6402369
out@@	O	-1	6402369
patients.	O	-1	6402369

T@@	O	-1	3973521
im@@	O	-1	3973521
e	O	-1	3973521
course	O	-1	3973521
al@@	O	-1	3973521
ter@@	O	-1	3973521
ations	O	-1	3973521
of	O	-1	3973521
Q@@	O	-1	3973521
T@@	O	-1	3973521
C	O	-1	3973521
interv@@	O	-1	3973521
al	O	-1	3973521
due	O	-1	3973521
to	O	-1	3973521
hy@@	B-Chemical	C027278	3973521
pa@@	I-Chemical	-1	3973521
qu@@	I-Chemical	-1	3973521
e	I-Chemical	-1	3973521
7@@	I-Chemical	-1	3973521
6	I-Chemical	-1	3973521
.	O	-1	3973521
S@@	O	-1	3973521
equ@@	O	-1	3973521
en@@	O	-1	3973521
tial	O	-1	3973521
meas@@	O	-1	3973521
ure@@	O	-1	3973521
ment	O	-1	3973521
of	O	-1	3973521
Q@@	O	-1	3973521
T	O	-1	3973521
interv@@	O	-1	3973521
al	O	-1	3973521
during	O	-1	3973521
left	O	-1	3973521
ventricular	O	-1	3973521
angio@@	O	-1	3973521
graph@@	O	-1	3973521
y	O	-1	3973521
was	O	-1	3973521
m@@	O	-1	3973521
ade	O	-1	3973521
30	O	-1	3973521
secon@@	O	-1	3973521
ds	O	-1	3973521
and	O	-1	3973521
one,	O	-1	3973521
th@@	O	-1	3973521
re@@	O	-1	3973521
e,	O	-1	3973521
five	O	-1	3973521
and	O	-1	3973521
ten	O	-1	3973521
minutes	O	-1	3973521
after	O	-1	3973521
injection	O	-1	3973521
of	O	-1	3973521
hy@@	B-Chemical	C027278	3973521
pa@@	I-Chemical	-1	3973521
qu@@	I-Chemical	-1	3973521
e	I-Chemical	-1	3973521
7@@	I-Chemical	-1	3973521
6	I-Chemical	-1	3973521
.	O	-1	3973521
The	O	-1	3973521
subjects	O	-1	3973521
were	O	-1	3973521
ten	O	-1	3973521
patients	O	-1	3973521
found	O	-1	3973521
to	O	-1	3973521
have	O	-1	3973521
normal	O	-1	3973521
left	O	-1	3973521
ventric@@	O	-1	3973521
le@@	O	-1	3973521
s	O	-1	3973521
and	O	-1	3973521
coronary	O	-1	3973521
arter@@	O	-1	3973521
i@@	O	-1	3973521
es.	O	-1	3973521
Si@@	O	-1	3973521
gn@@	O	-1	3973521
ific@@	O	-1	3973521
ant	O	-1	3973521
Q@@	B-Disease	D008133	3973521
T@@	I-Disease	-1	3973521
C	I-Disease	-1	3973521
prolong@@	I-Disease	-1	3973521
ation	I-Disease	-1	3973521
occurred	O	-1	3973521
in	O	-1	3973521
30	O	-1	3973521
secon@@	O	-1	3973521
ds	O	-1	3973521
to	O	-1	3973521
one	O	-1	3973521
min@@	O	-1	3973521
ute	O	-1	3973521
in	O	-1	3973521
association	O	-1	3973521
with	O	-1	3973521
mark@@	O	-1	3973521
ed	O	-1	3973521
hypotension	B-Disease	D007022	3973521
and	O	-1	3973521
elev@@	O	-1	3973521
ation	O	-1	3973521
of	O	-1	3973521
cardiac	O	-1	3973521
out@@	O	-1	3973521
p@@	O	-1	3973521
ut@@	O	-1	3973521
.	O	-1	3973521

Pro@@	O	-1	3461217
duction	O	-1	3461217
of	O	-1	3461217
auto@@	O	-1	3461217
ch@@	O	-1	3461217
th@@	O	-1	3461217
on@@	O	-1	3461217
ous	O	-1	3461217
pro@@	B-Disease	D011471	3461217
state	I-Disease	-1	3461217
cancer	I-Disease	-1	3461217
in	O	-1	3461217
L@@	O	-1	3461217
ob@@	O	-1	3461217
un@@	O	-1	3461217
d-@@	O	-1	3461217
Wistar	O	-1	3461217
rats	O	-1	3461217
by	O	-1	3461217
treat@@	O	-1	3461217
ments	O	-1	3461217
with	O	-1	3461217
N@@	B-Chemical	D008770	3461217
-@@	I-Chemical	-1	3461217
nit@@	I-Chemical	-1	3461217
ros@@	I-Chemical	-1	3461217
o@@	I-Chemical	-1	3461217
-@@	I-Chemical	-1	3461217
N@@	I-Chemical	-1	3461217
-@@	I-Chemical	-1	3461217
methyl@@	I-Chemical	-1	3461217
ure@@	I-Chemical	-1	3461217
a	I-Chemical	-1	3461217
and	O	-1	3461217
test@@	B-Chemical	D013739	3461217
osterone	I-Chemical	-1	3461217
.	O	-1	3461217
M@@	O	-1	3461217
or@@	O	-1	3461217
e	O	-1	3461217
than	O	-1	3461217
50@@	O	-1	3461217
%	O	-1	3461217
of	O	-1	3461217
L@@	O	-1	3461217
ob@@	O	-1	3461217
un@@	O	-1	3461217
d-@@	O	-1	3461217
Wistar	O	-1	3461217
(@@	O	-1	3461217
L-@@	O	-1	3461217
W@@	O	-1	3461217
)	O	-1	3461217
stra@@	O	-1	3461217
in	O	-1	3461217
rats	O	-1	3461217
developed	O	-1	3461217
larg@@	O	-1	3461217
e,	O	-1	3461217
p@@	O	-1	3461217
al@@	O	-1	3461217
pa@@	O	-1	3461217
ble	O	-1	3461217
pro@@	B-Disease	D011471	3461217
state	I-Disease	-1	3461217
aden@@	I-Disease	-1	3461217
oc@@	I-Disease	-1	3461217
arc@@	I-Disease	-1	3461217
in@@	I-Disease	-1	3461217
om@@	I-Disease	-1	3461217
as	I-Disease	-1	3461217
(	O	-1	3461217
PA@@	B-Disease	D011471	3461217
s	I-Disease	-1	3461217
)	O	-1	3461217
following	O	-1	3461217
treat@@	O	-1	3461217
ments	O	-1	3461217
with	O	-1	3461217
N@@	B-Chemical	D008770	3461217
-@@	I-Chemical	-1	3461217
nit@@	I-Chemical	-1	3461217
ros@@	I-Chemical	-1	3461217
o@@	I-Chemical	-1	3461217
-@@	I-Chemical	-1	3461217
N@@	I-Chemical	-1	3461217
-@@	I-Chemical	-1	3461217
methyl@@	I-Chemical	-1	3461217
ure@@	I-Chemical	-1	3461217
a	I-Chemical	-1	3461217
(C@@	O	-1	3461217
A@@	O	-1	3461217
S:	O	-1	3461217
6@@	O	-1	3461217
8@@	O	-1	3461217
4-@@	O	-1	3461217
9@@	O	-1	3461217
3-@@	O	-1	3461217
5@@	O	-1	3461217
)	O	-1	3461217
and	O	-1	3461217
test@@	B-Chemical	D043343	3461217
osterone	I-Chemical	-1	3461217
pro@@	I-Chemical	-1	3461217
pi@@	I-Chemical	-1	3461217
on@@	I-Chemical	-1	3461217
ate	I-Chemical	-1	3461217
[@@	O	-1	3461217
(	O	-1	3461217
T@@	B-Chemical	D043343	3461217
P	I-Chemical	-1	3461217
)	O	-1	3461217
CA@@	O	-1	3461217
S:	O	-1	3461217
5@@	O	-1	3461217
7-@@	O	-1	3461217
8@@	O	-1	3461217
5-@@	O	-1	3461217
2@@	O	-1	3461217
]@@	O	-1	3461217
,	O	-1	3461217
and	O	-1	3461217
most	O	-1	3461217
of	O	-1	3461217
the	O	-1	3461217
tumor	B-Disease	D009369	3461217
-@@	O	-1	3461217
be@@	O	-1	3461217
ar@@	O	-1	3461217
ing	O	-1	3461217
rats	O	-1	3461217
man@@	O	-1	3461217
if@@	O	-1	3461217
est@@	O	-1	3461217
ed	O	-1	3461217
met@@	O	-1	3461217
ast@@	O	-1	3461217
atic	O	-1	3461217
le@@	O	-1	3461217
sion@@	O	-1	3461217
s.	O	-1	3461217
The	O	-1	3461217
inc@@	O	-1	3461217
ub@@	O	-1	3461217
ation	O	-1	3461217
perio@@	O	-1	3461217
ds	O	-1	3461217
aver@@	O	-1	3461217
aged	O	-1	3461217
1@@	O	-1	3461217
0.@@	O	-1	3461217
6	O	-1	3461217
months.	O	-1	3461217
W@@	O	-1	3461217
i@@	O	-1	3461217
th@@	O	-1	3461217
in	O	-1	3461217
the	O	-1	3461217
same	O	-1	3461217
ti@@	O	-1	3461217
me@@	O	-1	3461217
f@@	O	-1	3461217
ram@@	O	-1	3461217
e,	O	-1	3461217
no	O	-1	3461217
L-@@	O	-1	3461217
W	O	-1	3461217
rat	O	-1	3461217
developed	O	-1	3461217
a	O	-1	3461217
similar	O	-1	3461217
p@@	O	-1	3461217
al@@	O	-1	3461217
pa@@	O	-1	3461217
ble	O	-1	3461217
P@@	B-Disease	D011471	3461217
A	I-Disease	-1	3461217
when	O	-1	3461217
treated	O	-1	3461217
only	O	-1	3461217
with	O	-1	3461217
T@@	B-Chemical	D043343	3461217
P	I-Chemical	-1	3461217
.	O	-1	3461217
In	O	-1	3461217
L-@@	O	-1	3461217
W	O	-1	3461217
rats,	O	-1	3461217
T@@	B-Chemical	D043343	3461217
P	I-Chemical	-1	3461217
ac@@	O	-1	3461217
ted	O	-1	3461217
as	O	-1	3461217
a	O	-1	3461217
tumor	B-Disease	D009369	3461217
enh@@	O	-1	3461217
ance@@	O	-1	3461217
ment	O	-1	3461217
agent@@	O	-1	3461217
,	O	-1	3461217
with	O	-1	3461217
prim@@	O	-1	3461217
ary	O	-1	3461217
em@@	O	-1	3461217
pha@@	O	-1	3461217
sis	O	-1	3461217
on	O	-1	3461217
the	O	-1	3461217
development	O	-1	3461217
of	O	-1	3461217
pro@@	B-Disease	D011471	3461217
state	I-Disease	-1	3461217
cancer	I-Disease	-1	3461217
.	O	-1	3461217

A	O	-1	2840807
dy@@	B-Disease	D004421	2840807
ston@@	I-Disease	-1	2840807
ia	I-Disease	-1	2840807
-@@	O	-1	2840807
like	O	-1	2840807
syndrome	O	-1	2840807
after	O	-1	2840807
neuro@@	O	-1	2840807
p@@	O	-1	2840807
ep@@	O	-1	2840807
ti@@	O	-1	2840807
de	O	-1	2840807
(	O	-1	2840807
M@@	B-Chemical	D009074	2840807
S@@	I-Chemical	-1	2840807
H	I-Chemical	-1	2840807
/	O	-1	2840807
AC@@	B-Chemical	D000324	2840807
T@@	I-Chemical	-1	2840807
H	I-Chemical	-1	2840807
)	O	-1	2840807
stimulation	O	-1	2840807
of	O	-1	2840807
the	O	-1	2840807
rat	O	-1	2840807
loc@@	O	-1	2840807
us	O	-1	2840807
cer@@	O	-1	2840807
ul@@	O	-1	2840807
eu@@	O	-1	2840807
s.	O	-1	2840807
The	O	-1	2840807
mo@@	B-Disease	D009069	2840807
vement	I-Disease	-1	2840807
disor@@	I-Disease	-1	2840807
der	I-Disease	-1	2840807
investigated	O	-1	2840807
in	O	-1	2840807
these	O	-1	2840807
studies	O	-1	2840807
has	O	-1	2840807
some	O	-1	2840807
feat@@	O	-1	2840807
ures	O	-1	2840807
in	O	-1	2840807
common	O	-1	2840807
with	O	-1	2840807
human	O	-1	2840807
i@@	O	-1	2840807
di@@	O	-1	2840807
o@@	O	-1	2840807
path@@	O	-1	2840807
ic	O	-1	2840807
dy@@	B-Disease	D004421	2840807
ston@@	I-Disease	-1	2840807
ia	I-Disease	-1	2840807
,	O	-1	2840807
and	O	-1	2840807
inf@@	O	-1	2840807
orm@@	O	-1	2840807
ation	O	-1	2840807
obtained	O	-1	2840807
in	O	-1	2840807
these	O	-1	2840807
studies	O	-1	2840807
may	O	-1	2840807
be	O	-1	2840807
of	O	-1	2840807
potential	O	-1	2840807
clinical	O	-1	2840807
ben@@	O	-1	2840807
e@@	O	-1	2840807
f@@	O	-1	2840807
it@@	O	-1	2840807
.	O	-1	2840807
The	O	-1	2840807
present	O	-1	2840807
experimental	O	-1	2840807
results	O	-1	2840807
indic@@	O	-1	2840807
ated	O	-1	2840807
that	O	-1	2840807
p@@	O	-1	2840807
ep@@	O	-1	2840807
ti@@	O	-1	2840807
der@@	O	-1	2840807
g@@	O	-1	2840807
ic	O	-1	2840807
stimulation	O	-1	2840807
of	O	-1	2840807
the	O	-1	2840807
L@@	O	-1	2840807
C	O	-1	2840807
resulted	O	-1	2840807
in	O	-1	2840807
a	O	-1	2840807
N@@	O	-1	2840807
E@@	O	-1	2840807
-@@	O	-1	2840807
mediated	O	-1	2840807
inhibition	O	-1	2840807
of	O	-1	2840807
ce@@	O	-1	2840807
re@@	O	-1	2840807
bell@@	O	-1	2840807
ar	O	-1	2840807
P@@	O	-1	2840807
ur@@	O	-1	2840807
k@@	O	-1	2840807
inj@@	O	-1	2840807
e	O	-1	2840807
cells	O	-1	2840807
loc@@	O	-1	2840807
ated	O	-1	2840807
at	O	-1	2840807
ter@@	O	-1	2840807
min@@	O	-1	2840807
als	O	-1	2840807
of	O	-1	2840807
the	O	-1	2840807
cer@@	O	-1	2840807
ul@@	O	-1	2840807
e@@	O	-1	2840807
o@@	O	-1	2840807
-@@	O	-1	2840807
ce@@	O	-1	2840807
re@@	O	-1	2840807
bell@@	O	-1	2840807
ar	O	-1	2840807
path@@	O	-1	2840807
w@@	O	-1	2840807
a@@	O	-1	2840807
y.	O	-1	2840807
However,	O	-1	2840807
it	O	-1	2840807
is	O	-1	2840807
not	O	-1	2840807
cer@@	O	-1	2840807
t@@	O	-1	2840807
ain	O	-1	2840807
as	O	-1	2840807
to	O	-1	2840807
the	O	-1	2840807
follow@@	O	-1	2840807
ing@@	O	-1	2840807
:	O	-1	2840807
(@@	O	-1	2840807
a@@	O	-1	2840807
)	O	-1	2840807
wh@@	O	-1	2840807
at	O	-1	2840807
receptors	O	-1	2840807
were	O	-1	2840807
stimul@@	O	-1	2840807
ated	O	-1	2840807
by	O	-1	2840807
the	O	-1	2840807
AC@@	B-Chemical	D000324	2840807
T@@	I-Chemical	-1	2840807
H	I-Chemical	-1	2840807
N@@	O	-1	2840807
-@@	O	-1	2840807
ter@@	O	-1	2840807
min@@	O	-1	2840807
al	O	-1	2840807
f@@	O	-1	2840807
ra@@	O	-1	2840807
g@@	O	-1	2840807
ments	O	-1	2840807
at	O	-1	2840807
the	O	-1	2840807
L@@	O	-1	2840807
C	O	-1	2840807
that	O	-1	2840807
resulted	O	-1	2840807
in	O	-1	2840807
this	O	-1	2840807
disorder@@	O	-1	2840807
;	O	-1	2840807
(@@	O	-1	2840807
b@@	O	-1	2840807
)	O	-1	2840807
whether	O	-1	2840807
N@@	O	-1	2840807
E@@	O	-1	2840807
,	O	-1	2840807
rele@@	O	-1	2840807
as@@	O	-1	2840807
ed	O	-1	2840807
on@@	O	-1	2840807
to	O	-1	2840807
P@@	O	-1	2840807
ur@@	O	-1	2840807
k@@	O	-1	2840807
inj@@	O	-1	2840807
e	O	-1	2840807
cell	O	-1	2840807
syn@@	O	-1	2840807
ap@@	O	-1	2840807
ses	O	-1	2840807
loc@@	O	-1	2840807
ated	O	-1	2840807
at	O	-1	2840807
ter@@	O	-1	2840807
min@@	O	-1	2840807
als	O	-1	2840807
of	O	-1	2840807
the	O	-1	2840807
cer@@	O	-1	2840807
ul@@	O	-1	2840807
e@@	O	-1	2840807
o@@	O	-1	2840807
-@@	O	-1	2840807
ce@@	O	-1	2840807
re@@	O	-1	2840807
bell@@	O	-1	2840807
ar	O	-1	2840807
path@@	O	-1	2840807
w@@	O	-1	2840807
a@@	O	-1	2840807
y,	O	-1	2840807
did	O	-1	2840807
in@@	O	-1	2840807
de@@	O	-1	2840807
ed	O	-1	2840807
cause	O	-1	2840807
the	O	-1	2840807
long-term	O	-1	2840807
de@@	B-Disease	D003866	2840807
pression	I-Disease	-1	2840807
at	O	-1	2840807
P@@	O	-1	2840807
ur@@	O	-1	2840807
k@@	O	-1	2840807
inj@@	O	-1	2840807
e	O	-1	2840807
cell	O	-1	2840807
syn@@	O	-1	2840807
ap@@	O	-1	2840807
ses	O	-1	2840807
(@@	O	-1	2840807
previously	O	-1	2840807
descri@@	O	-1	2840807
bed	O	-1	2840807
by	O	-1	2840807
o@@	O	-1	2840807
ther@@	O	-1	2840807
s)	O	-1	2840807
that	O	-1	2840807
resulted	O	-1	2840807
in	O	-1	2840807
the	O	-1	2840807
lon@@	O	-1	2840807
g	O	-1	2840807
duration	O	-1	2840807
of	O	-1	2840807
the	O	-1	2840807
mo@@	B-Disease	D009069	2840807
vement	I-Disease	-1	2840807
disor@@	I-Disease	-1	2840807
der	I-Disease	-1	2840807
;	O	-1	2840807
(@@	O	-1	2840807
c@@	O	-1	2840807
)	O	-1	2840807
whether	O	-1	2840807
the	O	-1	2840807
inhibition	O	-1	2840807
of	O	-1	2840807
inhibit@@	O	-1	2840807
ory	O	-1	2840807
P@@	O	-1	2840807
ur@@	O	-1	2840807
k@@	O	-1	2840807
inj@@	O	-1	2840807
e	O	-1	2840807
cells	O	-1	2840807
resulted	O	-1	2840807
in	O	-1	2840807
dis@@	O	-1	2840807
inhibition	O	-1	2840807
or	O	-1	2840807
increased	O	-1	2840807
ex@@	O	-1	2840807
cit@@	O	-1	2840807
ability	O	-1	2840807
of	O	-1	2840807
the	O	-1	2840807
un@@	O	-1	2840807
il@@	O	-1	2840807
ateral	O	-1	2840807
ce@@	O	-1	2840807
re@@	O	-1	2840807
bell@@	O	-1	2840807
ar	O	-1	2840807
f@@	O	-1	2840807
as@@	O	-1	2840807
ti@@	O	-1	2840807
gi@@	O	-1	2840807
al	O	-1	2840807
or	O	-1	2840807
inter@@	O	-1	2840807
pos@@	O	-1	2840807
it@@	O	-1	2840807
us	O	-1	2840807
nucle@@	O	-1	2840807
i@@	O	-1	2840807
,	O	-1	2840807
the	O	-1	2840807
out@@	O	-1	2840807
pu@@	O	-1	2840807
t	O	-1	2840807
t@@	O	-1	2840807
arg@@	O	-1	2840807
et@@	O	-1	2840807
s	O	-1	2840807
of	O	-1	2840807
the	O	-1	2840807
P@@	O	-1	2840807
ur@@	O	-1	2840807
k@@	O	-1	2840807
inj@@	O	-1	2840807
e	O	-1	2840807
cell	O	-1	2840807
ax@@	O	-1	2840807
on@@	O	-1	2840807
s,	O	-1	2840807
that	O	-1	2840807
may	O	-1	2840807
have	O	-1	2840807
been	O	-1	2840807
an	O	-1	2840807
important	O	-1	2840807
cont@@	O	-1	2840807
ri@@	O	-1	2840807
but@@	O	-1	2840807
ing	O	-1	2840807
factor	O	-1	2840807
to	O	-1	2840807
this	O	-1	2840807
disorder@@	O	-1	2840807
.	O	-1	2840807
These	O	-1	2840807
qu@@	O	-1	2840807
es@@	O	-1	2840807
tions	O	-1	2840807
are	O	-1	2840807
cur@@	O	-1	2840807
ren@@	O	-1	2840807
tly	O	-1	2840807
being	O	-1	2840807
investig@@	O	-1	2840807
ated.	O	-1	2840807

D@@	B-Chemical	D020927	2569282
ex@@	I-Chemical	-1	2569282
me@@	I-Chemical	-1	2569282
de@@	I-Chemical	-1	2569282
to@@	I-Chemical	-1	2569282
m@@	I-Chemical	-1	2569282
idine	I-Chemical	-1	2569282
,	O	-1	2569282
act@@	O	-1	2569282
ing	O	-1	2569282
through	O	-1	2569282
central	O	-1	2569282
alpha-@@	O	-1	2569282
2	O	-1	2569282
adren@@	O	-1	2569282
oc@@	O	-1	2569282
e@@	O	-1	2569282
pt@@	O	-1	2569282
or@@	O	-1	2569282
s,	O	-1	2569282
prev@@	O	-1	2569282
ents	O	-1	2569282
o@@	O	-1	2569282
pi@@	O	-1	2569282
ate@@	O	-1	2569282
-induced	O	-1	2569282
musc@@	B-Disease	D009127	2569282
le	I-Disease	-1	2569282
rig@@	I-Disease	-1	2569282
idity	I-Disease	-1	2569282
in	O	-1	2569282
the	O	-1	2569282
rat@@	O	-1	2569282
.	O	-1	2569282
The	O	-1	2569282
high@@	O	-1	2569282
l@@	O	-1	2569282
y-@@	O	-1	2569282
selective	O	-1	2569282
alpha-@@	O	-1	2569282
2	O	-1	2569282
adrenergic	O	-1	2569282
agon@@	O	-1	2569282
ist	O	-1	2569282
de@@	B-Chemical	D020927	2569282
x@@	I-Chemical	-1	2569282
me@@	I-Chemical	-1	2569282
de@@	I-Chemical	-1	2569282
to@@	I-Chemical	-1	2569282
m@@	I-Chemical	-1	2569282
idine	I-Chemical	-1	2569282
(	O	-1	2569282
D-@@	B-Chemical	D020927	2569282
M@@	I-Chemical	-1	2569282
E@@	I-Chemical	-1	2569282
D	I-Chemical	-1	2569282
)	O	-1	2569282
is	O	-1	2569282
cap@@	O	-1	2569282
able	O	-1	2569282
of	O	-1	2569282
induc@@	O	-1	2569282
ing	O	-1	2569282
musc@@	B-Disease	D009123	2569282
le	I-Disease	-1	2569282
f@@	I-Disease	-1	2569282
l@@	I-Disease	-1	2569282
ac@@	I-Disease	-1	2569282
c@@	I-Disease	-1	2569282
idity	I-Disease	-1	2569282
and	O	-1	2569282
anesthe@@	O	-1	2569282
sia	O	-1	2569282
in	O	-1	2569282
rats	O	-1	2569282
and	O	-1	2569282
dog@@	O	-1	2569282
s.	O	-1	2569282
In@@	O	-1	2569282
ten@@	O	-1	2569282
se	O	-1	2569282
gener@@	O	-1	2569282
al@@	O	-1	2569282
ized	O	-1	2569282
musc@@	B-Disease	D009127	2569282
le	I-Disease	-1	2569282
rig@@	I-Disease	-1	2569282
idity	I-Disease	-1	2569282
is	O	-1	2569282
an	O	-1	2569282
un@@	O	-1	2569282
desi@@	O	-1	2569282
ra@@	O	-1	2569282
ble	O	-1	2569282
side	O	-1	2569282
effect	O	-1	2569282
of	O	-1	2569282
pot@@	O	-1	2569282
ent	O	-1	2569282
o@@	O	-1	2569282
pi@@	O	-1	2569282
ate	O	-1	2569282
agon@@	O	-1	2569282
ist@@	O	-1	2569282
s.	O	-1	2569282
Although	O	-1	2569282
the	O	-1	2569282
neuro@@	O	-1	2569282
chem@@	O	-1	2569282
ist@@	O	-1	2569282
r@@	O	-1	2569282
y	O	-1	2569282
of	O	-1	2569282
o@@	O	-1	2569282
pi@@	O	-1	2569282
ate@@	O	-1	2569282
-induced	O	-1	2569282
rig@@	B-Disease	D009127	2569282
idity	I-Disease	-1	2569282
has	O	-1	2569282
y@@	O	-1	2569282
et	O	-1	2569282
to	O	-1	2569282
be	O	-1	2569282
ful@@	O	-1	2569282
ly	O	-1	2569282
el@@	O	-1	2569282
uc@@	O	-1	2569282
id@@	O	-1	2569282
at@@	O	-1	2569282
ed,	O	-1	2569282
rec@@	O	-1	2569282
ent	O	-1	2569282
wor@@	O	-1	2569282
k	O	-1	2569282
suggests	O	-1	2569282
a	O	-1	2569282
role	O	-1	2569282
for	O	-1	2569282
a	O	-1	2569282
central	O	-1	2569282
adrenergic	O	-1	2569282
mechanis@@	O	-1	2569282
m.	O	-1	2569282
In	O	-1	2569282
the	O	-1	2569282
present	O	-1	2569282
study,	O	-1	2569282
the	O	-1	2569282
au@@	O	-1	2569282
th@@	O	-1	2569282
ors	O	-1	2569282
determined	O	-1	2569282
if	O	-1	2569282
treatment	O	-1	2569282
with	O	-1	2569282
D-@@	B-Chemical	D020927	2569282
M@@	I-Chemical	-1	2569282
E@@	I-Chemical	-1	2569282
D	I-Chemical	-1	2569282
prev@@	O	-1	2569282
ents	O	-1	2569282
the	O	-1	2569282
musc@@	B-Disease	D009127	2569282
le	I-Disease	-1	2569282
rig@@	I-Disease	-1	2569282
idity	I-Disease	-1	2569282
caused	O	-1	2569282
by	O	-1	2569282
high-dose	O	-1	2569282
al@@	B-Chemical	D015760	2569282
f@@	I-Chemical	-1	2569282
entan@@	I-Chemical	-1	2569282
il	I-Chemical	-1	2569282
anesthe@@	O	-1	2569282
sia	O	-1	2569282
in	O	-1	2569282
the	O	-1	2569282
rat@@	O	-1	2569282
.	O	-1	2569282
An@@	O	-1	2569282
im@@	O	-1	2569282
als	O	-1	2569282
(n	O	-1	2569282
=	O	-1	2569282
4@@	O	-1	2569282
2)	O	-1	2569282
were	O	-1	2569282
treated	O	-1	2569282
intra@@	O	-1	2569282
per@@	O	-1	2569282
it@@	O	-1	2569282
one@@	O	-1	2569282
ally	O	-1	2569282
with	O	-1	2569282
one	O	-1	2569282
of	O	-1	2569282
the	O	-1	2569282
following	O	-1	2569282
six	O	-1	2569282
reg@@	O	-1	2569282
im@@	O	-1	2569282
ens@@	O	-1	2569282
:	O	-1	2569282
1)	O	-1	2569282
L-@@	O	-1	2569282
M@@	O	-1	2569282
E@@	O	-1	2569282
D	O	-1	2569282
(@@	O	-1	2569282
the	O	-1	2569282
in@@	O	-1	2569282
active	O	-1	2569282
L-@@	O	-1	2569282
is@@	O	-1	2569282
om@@	O	-1	2569282
er	O	-1	2569282
of	O	-1	2569282
me@@	B-Chemical	D020926	2569282
de@@	I-Chemical	-1	2569282
to@@	I-Chemical	-1	2569282
m@@	I-Chemical	-1	2569282
idine	I-Chemical	-1	2569282
),	O	-1	2569282
30	O	-1	2569282
microgram@@	O	-1	2569282
s/@@	O	-1	2569282
kg@@	O	-1	2569282
;	O	-1	2569282
2)	O	-1	2569282
D-@@	B-Chemical	D020927	2569282
M@@	I-Chemical	-1	2569282
E@@	I-Chemical	-1	2569282
D	I-Chemical	-1	2569282
,	O	-1	2569282
10	O	-1	2569282
microgram@@	O	-1	2569282
s/@@	O	-1	2569282
kg@@	O	-1	2569282
;	O	-1	2569282
3@@	O	-1	2569282
)	O	-1	2569282
D-@@	B-Chemical	D020927	2569282
M@@	I-Chemical	-1	2569282
E@@	I-Chemical	-1	2569282
D	I-Chemical	-1	2569282
,	O	-1	2569282
30	O	-1	2569282
microgram@@	O	-1	2569282
s/@@	O	-1	2569282
kg@@	O	-1	2569282
;	O	-1	2569282
4@@	O	-1	2569282
)	O	-1	2569282
D-@@	B-Chemical	D020927	2569282
M@@	I-Chemical	-1	2569282
E@@	I-Chemical	-1	2569282
D	I-Chemical	-1	2569282
[@@	O	-1	2569282
30	O	-1	2569282
microgram@@	O	-1	2569282
s/@@	O	-1	2569282
kg@@	O	-1	2569282
]	O	-1	2569282
and	O	-1	2569282
the	O	-1	2569282
centr@@	O	-1	2569282
al@@	O	-1	2569282
-@@	O	-1	2569282
act@@	O	-1	2569282
ing	O	-1	2569282
alpha-@@	O	-1	2569282
2	O	-1	2569282
antagonist@@	O	-1	2569282
,	O	-1	2569282
id@@	B-Chemical	D019329	2569282
az@@	I-Chemical	-1	2569282
ox@@	I-Chemical	-1	2569282
an	I-Chemical	-1	2569282
[@@	O	-1	2569282
10	O	-1	2569282
mg/kg@@	O	-1	2569282
]@@	O	-1	2569282
;	O	-1	2569282
5@@	O	-1	2569282
)	O	-1	2569282
D-@@	B-Chemical	D020927	2569282
M@@	I-Chemical	-1	2569282
E@@	I-Chemical	-1	2569282
D	I-Chemical	-1	2569282
[@@	O	-1	2569282
30	O	-1	2569282
microgram@@	O	-1	2569282
s/@@	O	-1	2569282
kg@@	O	-1	2569282
]	O	-1	2569282
and	O	-1	2569282
the	O	-1	2569282
peri@@	O	-1	2569282
ph@@	O	-1	2569282
er@@	O	-1	2569282
al@@	O	-1	2569282
-@@	O	-1	2569282
act@@	O	-1	2569282
ing	O	-1	2569282
alpha-@@	O	-1	2569282
2	O	-1	2569282
antagonist	O	-1	2569282
D@@	B-Chemical	C032368	2569282
G@@	I-Chemical	-1	2569282
-@@	I-Chemical	-1	2569282
5@@	I-Chemical	-1	2569282
12@@	I-Chemical	-1	2569282
8	I-Chemical	-1	2569282
[@@	O	-1	2569282
10	O	-1	2569282
mg/kg@@	O	-1	2569282
]@@	O	-1	2569282
,	O	-1	2569282
or@@	O	-1	2569282
;	O	-1	2569282
6@@	O	-1	2569282
)	O	-1	2569282
sal@@	O	-1	2569282
ine.	O	-1	2569282
B@@	O	-1	2569282
as@@	O	-1	2569282
el@@	O	-1	2569282
ine	O	-1	2569282
elect@@	O	-1	2569282
rom@@	O	-1	2569282
y@@	O	-1	2569282
ograph@@	O	-1	2569282
ic	O	-1	2569282
activity	O	-1	2569282
was	O	-1	2569282
recor@@	O	-1	2569282
ded	O	-1	2569282
from	O	-1	2569282
the	O	-1	2569282
gast@@	O	-1	2569282
ro@@	O	-1	2569282
c@@	O	-1	2569282
ne@@	O	-1	2569282
mi@@	O	-1	2569282
us	O	-1	2569282
musc@@	O	-1	2569282
le	O	-1	2569282
before	O	-1	2569282
and	O	-1	2569282
after	O	-1	2569282
drug	O	-1	2569282
treatment.	O	-1	2569282
E@@	O	-1	2569282
ach	O	-1	2569282
rat	O	-1	2569282
was	O	-1	2569282
then	O	-1	2569282
injected	O	-1	2569282
with	O	-1	2569282
al@@	B-Chemical	D015760	2569282
f@@	I-Chemical	-1	2569282
entan@@	I-Chemical	-1	2569282
il	I-Chemical	-1	2569282
(	O	-1	2569282
AL@@	B-Chemical	D015760	2569282
F	I-Chemical	-1	2569282
,	O	-1	2569282
0.@@	O	-1	2569282
5	O	-1	2569282
mg/kg	O	-1	2569282
s@@	O	-1	2569282
c@@	O	-1	2569282
).	O	-1	2569282
AL@@	B-Chemical	D015760	2569282
F	I-Chemical	-1	2569282
injection	O	-1	2569282
resulted	O	-1	2569282
in	O	-1	2569282
a	O	-1	2569282
mark@@	O	-1	2569282
ed	O	-1	2569282
increase	O	-1	2569282
in	O	-1	2569282
h@@	O	-1	2569282
ind@@	O	-1	2569282
lim@@	O	-1	2569282
b	O	-1	2569282
E@@	O	-1	2569282
M@@	O	-1	2569282
G	O	-1	2569282
activity	O	-1	2569282
in	O	-1	2569282
the	O	-1	2569282
L-@@	O	-1	2569282
M@@	O	-1	2569282
E@@	O	-1	2569282
D	O	-1	2569282
treatment	O	-1	2569282
group	O	-1	2569282
which	O	-1	2569282
was	O	-1	2569282
in@@	O	-1	2569282
dist@@	O	-1	2569282
ing@@	O	-1	2569282
u@@	O	-1	2569282
ish@@	O	-1	2569282
able	O	-1	2569282
from	O	-1	2569282
that	O	-1	2569282
seen	O	-1	2569282
in	O	-1	2569282
animals	O	-1	2569282
treated	O	-1	2569282
with	O	-1	2569282
sal@@	O	-1	2569282
ine.	O	-1	2569282
In	O	-1	2569282
contrast@@	O	-1	2569282
,	O	-1	2569282
D-@@	B-Chemical	D020927	2569282
M@@	I-Chemical	-1	2569282
E@@	I-Chemical	-1	2569282
D	I-Chemical	-1	2569282
prevent@@	O	-1	2569282
ed	O	-1	2569282
al@@	B-Chemical	D015760	2569282
f@@	I-Chemical	-1	2569282
entan@@	I-Chemical	-1	2569282
il	I-Chemical	-1	2569282
-induced	O	-1	2569282
musc@@	B-Disease	D009127	2569282
le	I-Disease	-1	2569282
rig@@	I-Disease	-1	2569282
idity	I-Disease	-1	2569282
in	O	-1	2569282
a	O	-1	2569282
dose-@@	O	-1	2569282
dependent	O	-1	2569282
f@@	O	-1	2569282
as@@	O	-1	2569282
hi@@	O	-1	2569282
on@@	O	-1	2569282
.	O	-1	2569282
The	O	-1	2569282
sm@@	O	-1	2569282
all	O	-1	2569282
E@@	O	-1	2569282
M@@	O	-1	2569282
G	O	-1	2569282
values	O	-1	2569282
obtained	O	-1	2569282
in	O	-1	2569282
the	O	-1	2569282
high-dose	O	-1	2569282
D-@@	B-Chemical	D020927	2569282
M@@	I-Chemical	-1	2569282
E@@	I-Chemical	-1	2569282
D	I-Chemical	-1	2569282
group	O	-1	2569282
were	O	-1	2569282
compar@@	O	-1	2569282
able	O	-1	2569282
with	O	-1	2569282
those	O	-1	2569282
recor@@	O	-1	2569282
ded	O	-1	2569282
in	O	-1	2569282
ear@@	O	-1	2569282
li@@	O	-1	2569282
er	O	-1	2569282
studies	O	-1	2569282
from	O	-1	2569282
control	O	-1	2569282
animals	O	-1	2569282
not	O	-1	2569282
given	O	-1	2569282
any	O	-1	2569282
o@@	O	-1	2569282
pi@@	O	-1	2569282
at@@	O	-1	2569282
e.	O	-1	2569282
The	O	-1	2569282
high-dose	O	-1	2569282
D-@@	B-Chemical	D020927	2569282
M@@	I-Chemical	-1	2569282
E@@	I-Chemical	-1	2569282
D	I-Chemical	-1	2569282
animals	O	-1	2569282
were	O	-1	2569282
f@@	O	-1	2569282
l@@	O	-1	2569282
ac@@	O	-1	2569282
c@@	O	-1	2569282
id@@	O	-1	2569282
,	O	-1	2569282
ak@@	B-Disease	D018476	2569282
ine@@	I-Disease	-1	2569282
tic	I-Disease	-1	2569282
,	O	-1	2569282
and	O	-1	2569282
l@@	O	-1	2569282
ac@@	O	-1	2569282
ked	O	-1	2569282
a	O	-1	2569282
star@@	B-Disease	D012021	2569282
t@@	I-Disease	-1	2569282
le	I-Disease	-1	2569282
response	O	-1	2569282
during	O	-1	2569282
the	O	-1	2569282
enti@@	O	-1	2569282
r@@	O	-1	2569282
e	O	-1	2569282
experimental	O	-1	2569282
perio@@	O	-1	2569282
d@@	O	-1	2569282
.@@	O	-1	2569282
(A@@	O	-1	2569282
B@@	O	-1	2569282
S@@	O	-1	2569282
TR@@	O	-1	2569282
AC@@	O	-1	2569282
T	O	-1	2569282
TR@@	O	-1	2569282
UN@@	O	-1	2569282
C@@	O	-1	2569282
AT@@	O	-1	2569282
E@@	O	-1	2569282
D	O	-1	2569282
A@@	O	-1	2569282
T	O	-1	2569282
2@@	O	-1	2569282
50	O	-1	2569282
W@@	O	-1	2569282
O@@	O	-1	2569282
RD@@	O	-1	2569282
S)	O	-1	2569282

S@@	B-Disease	D012640	2343592
e@@	I-Disease	-1	2343592
iz@@	I-Disease	-1	2343592
ure	I-Disease	-1	2343592
activity	O	-1	2343592
with	O	-1	2343592
im@@	B-Chemical	D015378	2343592
i@@	I-Chemical	-1	2343592
pen@@	I-Chemical	-1	2343592
em	I-Chemical	-1	2343592
therap@@	O	-1	2343592
y@@	O	-1	2343592
:	O	-1	2343592
incidence	O	-1	2343592
and	O	-1	2343592
risk	O	-1	2343592
fact@@	O	-1	2343592
or@@	O	-1	2343592
s.	O	-1	2343592
Two	O	-1	2343592
el@@	O	-1	2343592
der@@	O	-1	2343592
ly	O	-1	2343592
patients	O	-1	2343592
with	O	-1	2343592
a	O	-1	2343592
hist@@	O	-1	2343592
ory	O	-1	2343592
of	O	-1	2343592
either	O	-1	2343592
cerebral	B-Disease	D020521	2343592
vascular	I-Disease	-1	2343592
ac@@	I-Disease	-1	2343592
c@@	I-Disease	-1	2343592
id@@	I-Disease	-1	2343592
ent	I-Disease	-1	2343592
(	O	-1	2343592
C@@	B-Disease	D020521	2343592
V@@	I-Disease	-1	2343592
A	I-Disease	-1	2343592
)	O	-1	2343592
or	O	-1	2343592
he@@	B-Disease	D006259	2343592
ad	I-Disease	-1	2343592
tra@@	I-Disease	-1	2343592
um@@	I-Disease	-1	2343592
a	I-Disease	-1	2343592
and	O	-1	2343592
no	O	-1	2343592
evidence	O	-1	2343592
of	O	-1	2343592
renal	B-Disease	D007674	2343592
disease	I-Disease	-1	2343592
developed	O	-1	2343592
seizures	B-Disease	D012640	2343592
while	O	-1	2343592
receiving	O	-1	2343592
maxim@@	O	-1	2343592
um	O	-1	2343592
doses	O	-1	2343592
of	O	-1	2343592
im@@	B-Chemical	C044650	2343592
i@@	I-Chemical	-1	2343592
pen@@	I-Chemical	-1	2343592
em@@	I-Chemical	-1	2343592
/@@	I-Chemical	-1	2343592
c@@	I-Chemical	-1	2343592
il@@	I-Chemical	-1	2343592
ast@@	I-Chemical	-1	2343592
atin	I-Chemical	-1	2343592
.	O	-1	2343592
N@@	O	-1	2343592
either	O	-1	2343592
patient	O	-1	2343592
had	O	-1	2343592
reported	O	-1	2343592
previ@@	O	-1	2343592
ous	O	-1	2343592
seizures	B-Disease	D012640	2343592
or	O	-1	2343592
seizure	B-Disease	D012640	2343592
-@@	O	-1	2343592
like	O	-1	2343592
activity	O	-1	2343592
n@@	O	-1	2343592
or	O	-1	2343592
was	O	-1	2343592
receiving	O	-1	2343592
anti@@	O	-1	2343592
convul@@	O	-1	2343592
s@@	O	-1	2343592
ant	O	-1	2343592
agent@@	O	-1	2343592
s.	O	-1	2343592
All	O	-1	2343592
seizures	B-Disease	D012640	2343592
were	O	-1	2343592
controlled	O	-1	2343592
with	O	-1	2343592
therapeutic	O	-1	2343592
doses	O	-1	2343592
of	O	-1	2343592
pheny@@	B-Chemical	D010672	2343592
to@@	I-Chemical	-1	2343592
in	I-Chemical	-1	2343592
.	O	-1	2343592
B@@	O	-1	2343592
oth	O	-1	2343592
patients	O	-1	2343592
had	O	-1	2343592
received	O	-1	2343592
maxim@@	O	-1	2343592
um	O	-1	2343592
doses	O	-1	2343592
of	O	-1	2343592
other	O	-1	2343592
beta-@@	B-Chemical	D047090	2343592
l@@	I-Chemical	-1	2343592
act@@	I-Chemical	-1	2343592
am	I-Chemical	-1	2343592
anti@@	O	-1	2343592
bio@@	O	-1	2343592
tics	O	-1	2343592
without	O	-1	2343592
evidence	O	-1	2343592
of	O	-1	2343592
seizure	B-Disease	D012640	2343592
activ@@	O	-1	2343592
ity.	O	-1	2343592

The	O	-1	2055425
ability	O	-1	2055425
of	O	-1	2055425
in@@	O	-1	2055425
sul@@	O	-1	2055425
in	O	-1	2055425
treatment	O	-1	2055425
to	O	-1	2055425
re@@	O	-1	2055425
verse	O	-1	2055425
or	O	-1	2055425
prev@@	O	-1	2055425
ent	O	-1	2055425
the	O	-1	2055425
changes	O	-1	2055425
in	O	-1	2055425
urinary	O	-1	2055425
bladder	O	-1	2055425
function	O	-1	2055425
caused	O	-1	2055425
by	O	-1	2055425
st@@	B-Chemical	D013311	2055425
re@@	I-Chemical	-1	2055425
pto@@	I-Chemical	-1	2055425
z@@	I-Chemical	-1	2055425
ot@@	I-Chemical	-1	2055425
oc@@	I-Chemical	-1	2055425
in	I-Chemical	-1	2055425
-induced	O	-1	2055425
dia@@	B-Disease	D003920	2055425
bet@@	I-Disease	-1	2055425
es	I-Disease	-1	2055425
me@@	I-Disease	-1	2055425
ll@@	I-Disease	-1	2055425
it@@	I-Disease	-1	2055425
us	I-Disease	-1	2055425
.	O	-1	2055425
1@@	O	-1	2055425
.	O	-1	2055425
The	O	-1	2055425
effects	O	-1	2055425
of	O	-1	2055425
in@@	O	-1	2055425
sul@@	O	-1	2055425
in	O	-1	2055425
treatment	O	-1	2055425
on	O	-1	2055425
in	O	-1	2055425
viv@@	O	-1	2055425
o	O	-1	2055425
and	O	-1	2055425
in	O	-1	2055425
vit@@	O	-1	2055425
r@@	O	-1	2055425
o	O	-1	2055425
urinary	O	-1	2055425
bladder	O	-1	2055425
function	O	-1	2055425
in	O	-1	2055425
st@@	B-Chemical	D013311	2055425
re@@	I-Chemical	-1	2055425
pto@@	I-Chemical	-1	2055425
z@@	I-Chemical	-1	2055425
ot@@	I-Chemical	-1	2055425
oc@@	I-Chemical	-1	2055425
in	I-Chemical	-1	2055425
-	O	-1	2055425
dia@@	B-Disease	D003920	2055425
be@@	I-Disease	-1	2055425
tic	I-Disease	-1	2055425
rats	O	-1	2055425
were	O	-1	2055425
investig@@	O	-1	2055425
ated.	O	-1	2055425
2@@	O	-1	2055425
.	O	-1	2055425
D@@	B-Disease	D003920	2055425
ia@@	I-Disease	-1	2055425
bet@@	I-Disease	-1	2055425
es	I-Disease	-1	2055425
of	O	-1	2055425
2	O	-1	2055425
months	O	-1	2055425
duration	O	-1	2055425
resulted	O	-1	2055425
in	O	-1	2055425
decreas@@	O	-1	2055425
es	O	-1	2055425
in	O	-1	2055425
body	O	-1	2055425
weight	O	-1	2055425
and	O	-1	2055425
increases	O	-1	2055425
in	O	-1	2055425
flu@@	O	-1	2055425
id	O	-1	2055425
consum@@	O	-1	2055425
p@@	O	-1	2055425
tion,	O	-1	2055425
urine	O	-1	2055425
vol@@	O	-1	2055425
u@@	O	-1	2055425
me,	O	-1	2055425
frequency	O	-1	2055425
of	O	-1	2055425
mic@@	O	-1	2055425
t@@	O	-1	2055425
ur@@	O	-1	2055425
i@@	O	-1	2055425
tion,	O	-1	2055425
and	O	-1	2055425
average	O	-1	2055425
volume	O	-1	2055425
per	O	-1	2055425
mic@@	O	-1	2055425
t@@	O	-1	2055425
ur@@	O	-1	2055425
i@@	O	-1	2055425
tion@@	O	-1	2055425
;	O	-1	2055425
effects	O	-1	2055425
which	O	-1	2055425
were	O	-1	2055425
prevent@@	O	-1	2055425
ed	O	-1	2055425
by	O	-1	2055425
in@@	O	-1	2055425
sul@@	O	-1	2055425
in	O	-1	2055425
treatment.	O	-1	2055425
3@@	O	-1	2055425
.	O	-1	2055425
In@@	O	-1	2055425
sul@@	O	-1	2055425
in	O	-1	2055425
treatment	O	-1	2055425
also	O	-1	2055425
prevent@@	O	-1	2055425
ed	O	-1	2055425
the	O	-1	2055425
increases	O	-1	2055425
in	O	-1	2055425
contrac@@	O	-1	2055425
ti@@	O	-1	2055425
le	O	-1	2055425
responses	O	-1	2055425
of	O	-1	2055425
bladder	O	-1	2055425
body	O	-1	2055425
stri@@	O	-1	2055425
p@@	O	-1	2055425
s	O	-1	2055425
from	O	-1	2055425
dia@@	B-Disease	D003920	2055425
be@@	I-Disease	-1	2055425
tic	I-Disease	-1	2055425
rats	O	-1	2055425
to	O	-1	2055425
nerve	O	-1	2055425
stimul@@	O	-1	2055425
ation,	O	-1	2055425
AT@@	B-Chemical	D000255	2055425
P	I-Chemical	-1	2055425
,	O	-1	2055425
and	O	-1	2055425
be@@	B-Chemical	D018723	2055425
th@@	I-Chemical	-1	2055425
an@@	I-Chemical	-1	2055425
ec@@	I-Chemical	-1	2055425
hol	I-Chemical	-1	2055425
.	O	-1	2055425
4@@	O	-1	2055425
.	O	-1	2055425
D@@	B-Disease	D003920	2055425
ia@@	I-Disease	-1	2055425
bet@@	I-Disease	-1	2055425
es	I-Disease	-1	2055425
of	O	-1	2055425
4	O	-1	2055425
months	O	-1	2055425
duration	O	-1	2055425
also	O	-1	2055425
resulted	O	-1	2055425
in	O	-1	2055425
decreas@@	O	-1	2055425
es	O	-1	2055425
in	O	-1	2055425
body	O	-1	2055425
weigh@@	O	-1	2055425
t,	O	-1	2055425
and	O	-1	2055425
increases	O	-1	2055425
in	O	-1	2055425
flu@@	O	-1	2055425
id	O	-1	2055425
consum@@	O	-1	2055425
p@@	O	-1	2055425
tion,	O	-1	2055425
urine	O	-1	2055425
vol@@	O	-1	2055425
u@@	O	-1	2055425
me,	O	-1	2055425
frequency	O	-1	2055425
of	O	-1	2055425
mic@@	O	-1	2055425
t@@	O	-1	2055425
ur@@	O	-1	2055425
i@@	O	-1	2055425
tion,	O	-1	2055425
and	O	-1	2055425
average	O	-1	2055425
volume	O	-1	2055425
per	O	-1	2055425
mic@@	O	-1	2055425
t@@	O	-1	2055425
ur@@	O	-1	2055425
i@@	O	-1	2055425
tion,	O	-1	2055425
effects	O	-1	2055425
which	O	-1	2055425
were	O	-1	2055425
reversed	O	-1	2055425
by	O	-1	2055425
in@@	O	-1	2055425
sul@@	O	-1	2055425
in	O	-1	2055425
treatment	O	-1	2055425
for	O	-1	2055425
the	O	-1	2055425
f@@	O	-1	2055425
inal	O	-1	2055425
2	O	-1	2055425
months	O	-1	2055425
of	O	-1	2055425
the	O	-1	2055425
study.	O	-1	2055425
5@@	O	-1	2055425
.	O	-1	2055425
In@@	O	-1	2055425
sul@@	O	-1	2055425
in	O	-1	2055425
treatment	O	-1	2055425
reversed	O	-1	2055425
the	O	-1	2055425
increases	O	-1	2055425
in	O	-1	2055425
contrac@@	O	-1	2055425
ti@@	O	-1	2055425
le	O	-1	2055425
responses	O	-1	2055425
of	O	-1	2055425
bladder	O	-1	2055425
body	O	-1	2055425
stri@@	O	-1	2055425
p@@	O	-1	2055425
s	O	-1	2055425
from	O	-1	2055425
dia@@	B-Disease	D003920	2055425
be@@	I-Disease	-1	2055425
tic	I-Disease	-1	2055425
rats	O	-1	2055425
to	O	-1	2055425
nerve	O	-1	2055425
stimul@@	O	-1	2055425
ation,	O	-1	2055425
AT@@	B-Chemical	D000255	2055425
P	I-Chemical	-1	2055425
,	O	-1	2055425
and	O	-1	2055425
be@@	B-Chemical	D018723	2055425
th@@	I-Chemical	-1	2055425
an@@	I-Chemical	-1	2055425
ec@@	I-Chemical	-1	2055425
hol	I-Chemical	-1	2055425
.	O	-1	2055425
6@@	O	-1	2055425
.	O	-1	2055425
The	O	-1	2055425
data	O	-1	2055425
indicate	O	-1	2055425
that	O	-1	2055425
the	O	-1	2055425
effects	O	-1	2055425
of	O	-1	2055425
st@@	B-Chemical	D013311	2055425
re@@	I-Chemical	-1	2055425
pto@@	I-Chemical	-1	2055425
z@@	I-Chemical	-1	2055425
ot@@	I-Chemical	-1	2055425
oc@@	I-Chemical	-1	2055425
in	I-Chemical	-1	2055425
-induced	O	-1	2055425
dia@@	B-Disease	D003920	2055425
bet@@	I-Disease	-1	2055425
es	I-Disease	-1	2055425
on	O	-1	2055425
urinary	O	-1	2055425
bladder	O	-1	2055425
function	O	-1	2055425
are	O	-1	2055425
both	O	-1	2055425
prevent@@	O	-1	2055425
ed	O	-1	2055425
and	O	-1	2055425
reversed	O	-1	2055425
by	O	-1	2055425
in@@	O	-1	2055425
sul@@	O	-1	2055425
in	O	-1	2055425
treatment.	O	-1	2055425

D@@	O	-1	1711760
el@@	O	-1	1711760
ayed	O	-1	1711760
insti@@	O	-1	1711760
tu@@	O	-1	1711760
tion	O	-1	1711760
of	O	-1	1711760
hypertension	B-Disease	D006973	1711760
during	O	-1	1711760
foc@@	O	-1	1711760
al	O	-1	1711760
cerebral	B-Disease	D002545	1711760
ischem@@	I-Disease	-1	1711760
ia	I-Disease	-1	1711760
:	O	-1	1711760
effect	O	-1	1711760
on	O	-1	1711760
brain	B-Disease	D001929	1711760
e@@	I-Disease	-1	1711760
de@@	I-Disease	-1	1711760
ma	I-Disease	-1	1711760
.	O	-1	1711760
The	O	-1	1711760
effect	O	-1	1711760
of	O	-1	1711760
induced	O	-1	1711760
hypertension	B-Disease	D006973	1711760
insti@@	O	-1	1711760
t@@	O	-1	1711760
ut@@	O	-1	1711760
ed	O	-1	1711760
after	O	-1	1711760
a	O	-1	1711760
2-@@	O	-1	1711760
h	O	-1	1711760
del@@	O	-1	1711760
ay	O	-1	1711760
following	O	-1	1711760
mid@@	B-Disease	D020244	1711760
d@@	I-Disease	-1	1711760
le	I-Disease	-1	1711760
cerebral	I-Disease	-1	1711760
artery	I-Disease	-1	1711760
oc@@	I-Disease	-1	1711760
cl@@	I-Disease	-1	1711760
usion	I-Disease	-1	1711760
(	O	-1	1711760
M@@	B-Disease	D020244	1711760
CA@@	I-Disease	-1	1711760
O	I-Disease	-1	1711760
)	O	-1	1711760
on	O	-1	1711760
brain	B-Disease	D001929	1711760
e@@	I-Disease	-1	1711760
de@@	I-Disease	-1	1711760
ma	I-Disease	-1	1711760
formation	O	-1	1711760
and	O	-1	1711760
histo@@	O	-1	1711760
chemical	O	-1	1711760
injury	O	-1	1711760
was	O	-1	1711760
studi@@	O	-1	1711760
ed.	O	-1	1711760
U@@	O	-1	1711760
n@@	O	-1	1711760
der	O	-1	1711760
iso@@	B-Chemical	D007530	1711760
f@@	I-Chemical	-1	1711760
lur@@	I-Chemical	-1	1711760
ane	I-Chemical	-1	1711760
anesthe@@	O	-1	1711760
si@@	O	-1	1711760
a,	O	-1	1711760
the	O	-1	1711760
M@@	O	-1	1711760
C@@	O	-1	1711760
A	O	-1	1711760
of	O	-1	1711760
14	O	-1	1711760
spont@@	O	-1	1711760
ane@@	O	-1	1711760
ously	O	-1	1711760
hypertensive	B-Disease	D006973	1711760
rats	O	-1	1711760
was	O	-1	1711760
oc@@	O	-1	1711760
cl@@	O	-1	1711760
u@@	O	-1	1711760
de@@	O	-1	1711760
d.	O	-1	1711760
In	O	-1	1711760
the	O	-1	1711760
control	O	-1	1711760
group	O	-1	1711760
(n	O	-1	1711760
=	O	-1	1711760
7@@	O	-1	1711760
),	O	-1	1711760
the	O	-1	1711760
mean	O	-1	1711760
arterial	O	-1	1711760
pressure	O	-1	1711760
(@@	O	-1	1711760
MA@@	O	-1	1711760
P)	O	-1	1711760
was	O	-1	1711760
not	O	-1	1711760
man@@	O	-1	1711760
ip@@	O	-1	1711760
ul@@	O	-1	1711760
ated.	O	-1	1711760
In	O	-1	1711760
the	O	-1	1711760
hypertensive	B-Disease	D006973	1711760
group	O	-1	1711760
(n	O	-1	1711760
=	O	-1	1711760
7@@	O	-1	1711760
),	O	-1	1711760
the	O	-1	1711760
MA@@	O	-1	1711760
P	O	-1	1711760
was	O	-1	1711760
elevated	O	-1	1711760
by	O	-1	1711760
2@@	O	-1	1711760
5-@@	O	-1	1711760
30	O	-1	1711760
mm	O	-1	1711760
H@@	O	-1	1711760
g	O	-1	1711760
be@@	O	-1	1711760
g@@	O	-1	1711760
in@@	O	-1	1711760
ning	O	-1	1711760
2	O	-1	1711760
h	O	-1	1711760
after	O	-1	1711760
M@@	B-Disease	D020244	1711760
CA@@	I-Disease	-1	1711760
O	I-Disease	-1	1711760
.	O	-1	1711760
F@@	O	-1	1711760
our	O	-1	1711760
hours	O	-1	1711760
after	O	-1	1711760
M@@	B-Disease	D020244	1711760
CA@@	I-Disease	-1	1711760
O	I-Disease	-1	1711760
,	O	-1	1711760
the	O	-1	1711760
rats	O	-1	1711760
were	O	-1	1711760
k@@	O	-1	1711760
ill@@	O	-1	1711760
ed	O	-1	1711760
and	O	-1	1711760
the	O	-1	1711760
bra@@	O	-1	1711760
ins	O	-1	1711760
h@@	O	-1	1711760
ar@@	O	-1	1711760
ve@@	O	-1	1711760
st@@	O	-1	1711760
ed.	O	-1	1711760
The	O	-1	1711760
bra@@	O	-1	1711760
ins	O	-1	1711760
were	O	-1	1711760
sec@@	O	-1	1711760
tion@@	O	-1	1711760
ed	O	-1	1711760
al@@	O	-1	1711760
ong	O	-1	1711760
cor@@	O	-1	1711760
on@@	O	-1	1711760
al	O	-1	1711760
pl@@	O	-1	1711760
an@@	O	-1	1711760
es	O	-1	1711760
sp@@	O	-1	1711760
an@@	O	-1	1711760
ning	O	-1	1711760
the	O	-1	1711760
di@@	O	-1	1711760
stri@@	O	-1	1711760
bu@@	O	-1	1711760
tion	O	-1	1711760
of	O	-1	1711760
ischem@@	B-Disease	D007511	1711760
ia	I-Disease	-1	1711760
produced	O	-1	1711760
by	O	-1	1711760
M@@	B-Disease	D020244	1711760
CA@@	I-Disease	-1	1711760
O	I-Disease	-1	1711760
.	O	-1	1711760
S@@	O	-1	1711760
p@@	O	-1	1711760
ec@@	O	-1	1711760
if@@	O	-1	1711760
ic	O	-1	1711760
gra@@	O	-1	1711760
v@@	O	-1	1711760
ity	O	-1	1711760
(S@@	O	-1	1711760
G@@	O	-1	1711760
)	O	-1	1711760
was	O	-1	1711760
determined	O	-1	1711760
in	O	-1	1711760
the	O	-1	1711760
sub@@	O	-1	1711760
cor@@	O	-1	1711760
te@@	O	-1	1711760
x	O	-1	1711760
and	O	-1	1711760
in	O	-1	1711760
two	O	-1	1711760
sit@@	O	-1	1711760
es	O	-1	1711760
in	O	-1	1711760
the	O	-1	1711760
cor@@	O	-1	1711760
te@@	O	-1	1711760
x	O	-1	1711760
(@@	O	-1	1711760
cor@@	O	-1	1711760
e	O	-1	1711760
and	O	-1	1711760
peri@@	O	-1	1711760
ph@@	O	-1	1711760
er@@	O	-1	1711760
y	O	-1	1711760
of	O	-1	1711760
the	O	-1	1711760
ischem@@	B-Disease	D007511	1711760
ic	I-Disease	-1	1711760
ter@@	O	-1	1711760
rit@@	O	-1	1711760
or@@	O	-1	1711760
y@@	O	-1	1711760
).	O	-1	1711760
The	O	-1	1711760
ext@@	O	-1	1711760
ent	O	-1	1711760
of	O	-1	1711760
neuron@@	B-Disease	D009410	1711760
al	I-Disease	-1	1711760
injury	I-Disease	-1	1711760
was	O	-1	1711760
determined	O	-1	1711760
by	O	-1	1711760
2@@	B-Chemical	C009591	1711760
,@@	I-Chemical	-1	1711760
3@@	I-Chemical	-1	1711760
,@@	I-Chemical	-1	1711760
5-@@	I-Chemical	-1	1711760
tri@@	I-Chemical	-1	1711760
phenyl@@	I-Chemical	-1	1711760
te@@	I-Chemical	-1	1711760
tra@@	I-Chemical	-1	1711760
z@@	I-Chemical	-1	1711760
ol@@	I-Chemical	-1	1711760
i@@	I-Chemical	-1	1711760
um	I-Chemical	-1	1711760
st@@	O	-1	1711760
ain@@	O	-1	1711760
ing.	O	-1	1711760
In	O	-1	1711760
the	O	-1	1711760
ischem@@	B-Disease	D007511	1711760
ic	I-Disease	-1	1711760
co@@	O	-1	1711760
re,	O	-1	1711760
there	O	-1	1711760
was	O	-1	1711760
no	O	-1	1711760
difference	O	-1	1711760
in	O	-1	1711760
S@@	O	-1	1711760
G	O	-1	1711760
in	O	-1	1711760
the	O	-1	1711760
sub@@	O	-1	1711760
cor@@	O	-1	1711760
te@@	O	-1	1711760
x	O	-1	1711760
and	O	-1	1711760
cor@@	O	-1	1711760
te@@	O	-1	1711760
x	O	-1	1711760
in	O	-1	1711760
the	O	-1	1711760
two	O	-1	1711760
groups.	O	-1	1711760
In	O	-1	1711760
the	O	-1	1711760
peri@@	O	-1	1711760
ph@@	O	-1	1711760
er@@	O	-1	1711760
y	O	-1	1711760
of	O	-1	1711760
the	O	-1	1711760
ischem@@	B-Disease	D007511	1711760
ic	I-Disease	-1	1711760
ter@@	O	-1	1711760
rit@@	O	-1	1711760
or@@	O	-1	1711760
y,	O	-1	1711760
S@@	O	-1	1711760
G	O	-1	1711760
in	O	-1	1711760
the	O	-1	1711760
cor@@	O	-1	1711760
te@@	O	-1	1711760
x	O	-1	1711760
was	O	-1	1711760
greater	O	-1	1711760
(@@	O	-1	1711760
less	O	-1	1711760
e@@	B-Disease	D004487	1711760
de@@	I-Disease	-1	1711760
ma	I-Disease	-1	1711760
accum@@	O	-1	1711760
ul@@	O	-1	1711760
ation@@	O	-1	1711760
)	O	-1	1711760
in	O	-1	1711760
the	O	-1	1711760
hypertensive	B-Disease	D006973	1711760
group	O	-1	1711760
(1@@	O	-1	1711760
.@@	O	-1	1711760
0@@	O	-1	1711760
4@@	O	-1	1711760
1	O	-1	1711760
+/-	O	-1	1711760
0.00@@	O	-1	1711760
1	O	-1	1711760
v@@	O	-1	1711760
s	O	-1	1711760
1.@@	O	-1	1711760
0@@	O	-1	1711760
3@@	O	-1	1711760
9	O	-1	1711760
+/-	O	-1	1711760
0.00@@	O	-1	1711760
1,	O	-1	1711760
P	O	-1	1711760
less	O	-1	1711760
than	O	-1	1711760
0.05@@	O	-1	1711760
).	O	-1	1711760
The	O	-1	1711760
a@@	O	-1	1711760
re@@	O	-1	1711760
a	O	-1	1711760
of	O	-1	1711760
histo@@	O	-1	1711760
chemical	O	-1	1711760
injury	O	-1	1711760
(@@	O	-1	1711760
as	O	-1	1711760
a	O	-1	1711760
perc@@	O	-1	1711760
ent	O	-1	1711760
of	O	-1	1711760
the	O	-1	1711760
cros@@	O	-1	1711760
s-@@	O	-1	1711760
sec@@	O	-1	1711760
tional	O	-1	1711760
a@@	O	-1	1711760
re@@	O	-1	1711760
a	O	-1	1711760
of	O	-1	1711760
the	O	-1	1711760
he@@	O	-1	1711760
mis@@	O	-1	1711760
ph@@	O	-1	1711760
e@@	O	-1	1711760
re@@	O	-1	1711760
)	O	-1	1711760
was	O	-1	1711760
less	O	-1	1711760
in	O	-1	1711760
the	O	-1	1711760
hypertensive	B-Disease	D006973	1711760
group	O	-1	1711760
(3@@	O	-1	1711760
3	O	-1	1711760
+/-	O	-1	1711760
3@@	O	-1	1711760
%	O	-1	1711760
v@@	O	-1	1711760
s	O	-1	1711760
21	O	-1	1711760
+/-	O	-1	1711760
2@@	O	-1	1711760
%,	O	-1	1711760
P	O	-1	1711760
less	O	-1	1711760
than	O	-1	1711760
0.05@@	O	-1	1711760
).	O	-1	1711760
The	O	-1	1711760
data	O	-1	1711760
indicate	O	-1	1711760
that	O	-1	1711760
pheny@@	B-Chemical	D010656	1711760
le@@	I-Chemical	-1	1711760
phrine	I-Chemical	-1	1711760
-induced	O	-1	1711760
hypertension	B-Disease	D006973	1711760
insti@@	O	-1	1711760
t@@	O	-1	1711760
ut@@	O	-1	1711760
ed	O	-1	1711760
2	O	-1	1711760
h	O	-1	1711760
after	O	-1	1711760
M@@	B-Disease	D020244	1711760
CA@@	I-Disease	-1	1711760
O	I-Disease	-1	1711760
does	O	-1	1711760
not	O	-1	1711760
ag@@	O	-1	1711760
gra@@	O	-1	1711760
v@@	O	-1	1711760
ate	O	-1	1711760
e@@	B-Disease	D004487	1711760
de@@	I-Disease	-1	1711760
ma	I-Disease	-1	1711760
in	O	-1	1711760
the	O	-1	1711760
ischem@@	B-Disease	D007511	1711760
ic	I-Disease	-1	1711760
co@@	O	-1	1711760
re,	O	-1	1711760
that	O	-1	1711760
it	O	-1	1711760
impro@@	O	-1	1711760
v@@	O	-1	1711760
es	O	-1	1711760
e@@	B-Disease	D004487	1711760
de@@	I-Disease	-1	1711760
ma	I-Disease	-1	1711760
in	O	-1	1711760
the	O	-1	1711760
peri@@	O	-1	1711760
ph@@	O	-1	1711760
er@@	O	-1	1711760
y	O	-1	1711760
of	O	-1	1711760
the	O	-1	1711760
ischem@@	B-Disease	D007511	1711760
ic	I-Disease	-1	1711760
ter@@	O	-1	1711760
rit@@	O	-1	1711760
or@@	O	-1	1711760
y,	O	-1	1711760
and	O	-1	1711760
that	O	-1	1711760
it	O	-1	1711760
reduc@@	O	-1	1711760
es	O	-1	1711760
the	O	-1	1711760
a@@	O	-1	1711760
re@@	O	-1	1711760
a	O	-1	1711760
of	O	-1	1711760
histo@@	O	-1	1711760
chemical	O	-1	1711760
neuron@@	B-Disease	D009410	1711760
al	I-Disease	-1	1711760
dysfunction	I-Disease	-1	1711760
.	O	-1	1711760

A@@	B-Chemical	D000638	1595783
m@@	I-Chemical	-1	1595783
iodar@@	I-Chemical	-1	1595783
one	I-Chemical	-1	1595783
pulmonary	B-Disease	D008171	1595783
toxicity	I-Disease	-1	1595783
.	O	-1	1595783
A@@	B-Chemical	D000638	1595783
m@@	I-Chemical	-1	1595783
iodar@@	I-Chemical	-1	1595783
one	I-Chemical	-1	1595783
is	O	-1	1595783
an	O	-1	1595783
effective	O	-1	1595783
anti@@	O	-1	1595783
arrhyth@@	O	-1	1595783
mic	O	-1	1595783
agent	O	-1	1595783
wh@@	O	-1	1595783
ose	O	-1	1595783
u@@	O	-1	1595783
til@@	O	-1	1595783
ity	O	-1	1595783
is	O	-1	1595783
lim@@	O	-1	1595783
ited	O	-1	1595783
by	O	-1	1595783
man@@	O	-1	1595783
y	O	-1	1595783
side@@	O	-1	1595783
-@@	O	-1	1595783
effect@@	O	-1	1595783
s,	O	-1	1595783
the	O	-1	1595783
most	O	-1	1595783
pro@@	O	-1	1595783
ble@@	O	-1	1595783
m@@	O	-1	1595783
atic	O	-1	1595783
being	O	-1	1595783
p@@	B-Disease	D011014	1595783
ne@@	I-Disease	-1	1595783
um@@	I-Disease	-1	1595783
on@@	I-Disease	-1	1595783
iti@@	I-Disease	-1	1595783
s	I-Disease	-1	1595783
.	O	-1	1595783
The	O	-1	1595783
pulmonary	B-Disease	D008171	1595783
toxicity	I-Disease	-1	1595783
of	O	-1	1595783
am@@	B-Chemical	D000638	1595783
iodar@@	I-Chemical	-1	1595783
one	I-Chemical	-1	1595783
is	O	-1	1595783
thou@@	O	-1	1595783
ght	O	-1	1595783
to	O	-1	1595783
result	O	-1	1595783
from	O	-1	1595783
direct	O	-1	1595783
injury	O	-1	1595783
related	O	-1	1595783
to	O	-1	1595783
the	O	-1	1595783
intrac@@	O	-1	1595783
ell@@	O	-1	1595783
ular	O	-1	1595783
accum@@	O	-1	1595783
ulation	O	-1	1595783
of	O	-1	1595783
phosph@@	O	-1	1595783
ol@@	O	-1	1595783
i@@	O	-1	1595783
pid	O	-1	1595783
and	O	-1	1595783
T	O	-1	1595783
cell@@	O	-1	1595783
-@@	O	-1	1595783
mediated	O	-1	1595783
hyper@@	B-Disease	D004342	1595783
sensitivity	I-Disease	-1	1595783
p@@	I-Disease	-1	1595783
ne@@	I-Disease	-1	1595783
um@@	I-Disease	-1	1595783
on@@	I-Disease	-1	1595783
iti@@	I-Disease	-1	1595783
s	I-Disease	-1	1595783
hyper@@	B-Disease	D000542	1595783
sensitivity	I-Disease	-1	1595783
p@@	I-Disease	-1	1595783
ne@@	I-Disease	-1	1595783
um@@	I-Disease	-1	1595783
on@@	I-Disease	-1	1595783
iti@@	I-Disease	-1	1595783
s	I-Disease	-1	1595783
.	O	-1	1595783
The	O	-1	1595783
clinical	O	-1	1595783
and	O	-1	1595783
radi@@	O	-1	1595783
ograph@@	O	-1	1595783
ic	O	-1	1595783
feat@@	O	-1	1595783
ures	O	-1	1595783
of	O	-1	1595783
am@@	B-Chemical	D000638	1595783
iodar@@	I-Chemical	-1	1595783
one	I-Chemical	-1	1595783
-induced	O	-1	1595783
pulmonary	B-Disease	D008171	1595783
toxicity	I-Disease	-1	1595783
are	O	-1	1595783
character@@	O	-1	1595783
istic	O	-1	1595783
but	O	-1	1595783
non@@	O	-1	1595783
spec@@	O	-1	1595783
ific@@	O	-1	1595783
.	O	-1	1595783
The	O	-1	1595783
diagnosis	O	-1	1595783
depend@@	O	-1	1595783
s	O	-1	1595783
on	O	-1	1595783
ex@@	O	-1	1595783
cl@@	O	-1	1595783
usion	O	-1	1595783
of	O	-1	1595783
other	O	-1	1595783
enti@@	O	-1	1595783
ti@@	O	-1	1595783
es,	O	-1	1595783
such	O	-1	1595783
as	O	-1	1595783
heart	B-Disease	D006333	1595783
failure	I-Disease	-1	1595783
,	O	-1	1595783
inf@@	B-Disease	D007239	1595783
ection	I-Disease	-1	1595783
,	O	-1	1595783
and	O	-1	1595783
mal@@	B-Disease	D009369	1595783
i@@	I-Disease	-1	1595783
gn@@	I-Disease	-1	1595783
anc@@	I-Disease	-1	1595783
y	I-Disease	-1	1595783
.	O	-1	1595783
W@@	O	-1	1595783
h@@	O	-1	1595783
ile	O	-1	1595783
withdrawal	O	-1	1595783
of	O	-1	1595783
am@@	B-Chemical	D000638	1595783
iodar@@	I-Chemical	-1	1595783
one	I-Chemical	-1	1595783
lead@@	O	-1	1595783
s	O	-1	1595783
to	O	-1	1595783
clinical	O	-1	1595783
impro@@	O	-1	1595783
vement	O	-1	1595783
in	O	-1	1595783
maj@@	O	-1	1595783
or@@	O	-1	1595783
ity	O	-1	1595783
of	O	-1	1595783
cas@@	O	-1	1595783
es,	O	-1	1595783
this	O	-1	1595783
is	O	-1	1595783
not	O	-1	1595783
al@@	O	-1	1595783
w@@	O	-1	1595783
ays	O	-1	1595783
possible	O	-1	1595783
or	O	-1	1595783
adv@@	O	-1	1595783
is@@	O	-1	1595783
able@@	O	-1	1595783
.	O	-1	1595783
D@@	O	-1	1595783
ose	O	-1	1595783
reduction	O	-1	1595783
or	O	-1	1595783
concomit@@	O	-1	1595783
ant	O	-1	1595783
ster@@	B-Chemical	D013256	1595783
oid	I-Chemical	-1	1595783
therapy	O	-1	1595783
may	O	-1	1595783
have	O	-1	1595783
a	O	-1	1595783
role	O	-1	1595783
in	O	-1	1595783
sel@@	O	-1	1595783
ected	O	-1	1595783
patients.	O	-1	1595783

L@@	O	-1	804391
ight	O	-1	804391
ch@@	O	-1	804391
ain	O	-1	804391
proteinuria	B-Disease	D011507	804391
and	O	-1	804391
cell@@	O	-1	804391
ular	O	-1	804391
mediated	O	-1	804391
immun@@	O	-1	804391
ity	O	-1	804391
in	O	-1	804391
ri@@	B-Chemical	D012293	804391
f@@	I-Chemical	-1	804391
amp@@	I-Chemical	-1	804391
in	I-Chemical	-1	804391
treated	O	-1	804391
patients	O	-1	804391
with	O	-1	804391
tub@@	B-Disease	D014376	804391
er@@	I-Disease	-1	804391
c@@	I-Disease	-1	804391
ulo@@	I-Disease	-1	804391
sis	I-Disease	-1	804391
.	O	-1	804391
L@@	O	-1	804391
ight	O	-1	804391
ch@@	O	-1	804391
ain	O	-1	804391
proteinuria	B-Disease	D011507	804391
was	O	-1	804391
found	O	-1	804391
in	O	-1	804391
9	O	-1	804391
of	O	-1	804391
17	O	-1	804391
tub@@	B-Disease	D014376	804391
er@@	I-Disease	-1	804391
c@@	I-Disease	-1	804391
ulo@@	I-Disease	-1	804391
sis	I-Disease	-1	804391
patients	O	-1	804391
treated	O	-1	804391
with	O	-1	804391
ri@@	B-Chemical	D012293	804391
f@@	I-Chemical	-1	804391
amp@@	I-Chemical	-1	804391
in	I-Chemical	-1	804391
.	O	-1	804391
Con@@	O	-1	804391
comit@@	O	-1	804391
ant	O	-1	804391
ass@@	O	-1	804391
ay	O	-1	804391
of	O	-1	804391
cell@@	O	-1	804391
ular	O	-1	804391
mediated	O	-1	804391
immun@@	O	-1	804391
ity	O	-1	804391
in	O	-1	804391
these	O	-1	804391
patients	O	-1	804391
using	O	-1	804391
s@@	O	-1	804391
k@@	O	-1	804391
in	O	-1	804391
test	O	-1	804391
anti@@	O	-1	804391
gen	O	-1	804391
and	O	-1	804391
a	O	-1	804391
lymph@@	O	-1	804391
o@@	O	-1	804391
k@@	O	-1	804391
ine	O	-1	804391
in	O	-1	804391
vit@@	O	-1	804391
r@@	O	-1	804391
o	O	-1	804391
test	O	-1	804391
pro@@	O	-1	804391
vid@@	O	-1	804391
ed	O	-1	804391
results	O	-1	804391
that	O	-1	804391
were	O	-1	804391
differen@@	O	-1	804391
t.	O	-1	804391
R@@	O	-1	804391
es@@	O	-1	804391
p@@	O	-1	804391
on@@	O	-1	804391
se	O	-1	804391
to	O	-1	804391
V@@	O	-1	804391
ar@@	O	-1	804391
id@@	O	-1	804391
ase	O	-1	804391
s@@	O	-1	804391
k@@	O	-1	804391
in	O	-1	804391
test	O	-1	804391
anti@@	O	-1	804391
gen	O	-1	804391
was	O	-1	804391
negative	O	-1	804391
for	O	-1	804391
all	O	-1	804391
e@@	O	-1	804391
ight	O	-1	804391
tub@@	B-Disease	D014376	804391
er@@	I-Disease	-1	804391
c@@	I-Disease	-1	804391
ulo@@	I-Disease	-1	804391
sis	I-Disease	-1	804391
patients	O	-1	804391
test@@	O	-1	804391
ed,	O	-1	804391
but	O	-1	804391
there	O	-1	804391
occurred	O	-1	804391
a	O	-1	804391
hyper@@	O	-1	804391
-@@	O	-1	804391
respon@@	O	-1	804391
si@@	O	-1	804391
ven@@	O	-1	804391
ess	O	-1	804391
of	O	-1	804391
the	O	-1	804391
lymph@@	O	-1	804391
ocy@@	O	-1	804391
tes	O	-1	804391
of	O	-1	804391
these	O	-1	804391
e@@	O	-1	804391
ight	O	-1	804391
patients	O	-1	804391
to	O	-1	804391
ph@@	O	-1	804391
y@@	O	-1	804391
to@@	O	-1	804391
mit@@	O	-1	804391
o@@	O	-1	804391
gen	O	-1	804391
(P@@	O	-1	804391
H@@	O	-1	804391
A@@	O	-1	804391
-@@	O	-1	804391
P@@	O	-1	804391
).	O	-1	804391
as	O	-1	804391
well	O	-1	804391
as	O	-1	804391
of	O	-1	804391
those	O	-1	804391
of	O	-1	804391
seven	O	-1	804391
other	O	-1	804391
tub@@	B-Disease	D014376	804391
er@@	I-Disease	-1	804391
c@@	I-Disease	-1	804391
ulo@@	I-Disease	-1	804391
us	I-Disease	-1	804391
patients.	O	-1	804391
This	O	-1	804391
las@@	O	-1	804391
t	O	-1	804391
find@@	O	-1	804391
ing	O	-1	804391
may	O	-1	804391
be	O	-1	804391
related	O	-1	804391
to	O	-1	804391
time	O	-1	804391
of	O	-1	804391
test@@	O	-1	804391
ing	O	-1	804391
and/or	O	-1	804391
endo@@	O	-1	804391
gen@@	O	-1	804391
ous	O	-1	804391
serum	O	-1	804391
b@@	O	-1	804391
ind@@	O	-1	804391
ing	O	-1	804391
of	O	-1	804391
ri@@	B-Chemical	D012293	804391
f@@	I-Chemical	-1	804391
amp@@	I-Chemical	-1	804391
in	I-Chemical	-1	804391
which	O	-1	804391
could	O	-1	804391
have	O	-1	804391
inhibited	O	-1	804391
mit@@	O	-1	804391
o@@	O	-1	804391
gen	O	-1	804391
activity	O	-1	804391
for	O	-1	804391
the	O	-1	804391
lymph@@	O	-1	804391
ocy@@	O	-1	804391
te@@	O	-1	804391
.	O	-1	804391

In@@	O	-1	28952
iti@@	O	-1	28952
al	O	-1	28952
pot@@	B-Chemical	D011188	28952
assi@@	I-Chemical	-1	28952
um	I-Chemical	-1	28952
loss	O	-1	28952
and	O	-1	28952
hypo@@	B-Disease	D007008	28952
k@@	I-Disease	-1	28952
al@@	I-Disease	-1	28952
a@@	I-Disease	-1	28952
emia	I-Disease	-1	28952
during	O	-1	28952
chlor@@	B-Chemical	D002752	28952
thal@@	I-Chemical	-1	28952
id@@	I-Chemical	-1	28952
one	I-Chemical	-1	28952
administration	O	-1	28952
in	O	-1	28952
patients	O	-1	28952
with	O	-1	28952
es@@	O	-1	28952
sen@@	O	-1	28952
tial	O	-1	28952
hypertension	B-Disease	D006973	28952
:	O	-1	28952
the	O	-1	28952
influence	O	-1	28952
of	O	-1	28952
di@@	O	-1	28952
et@@	O	-1	28952
ary	O	-1	28952
sodium	B-Chemical	D012964	28952
re@@	O	-1	28952
stric@@	O	-1	28952
tion.	O	-1	28952
To	O	-1	28952
investigate	O	-1	28952
the	O	-1	28952
initial	O	-1	28952
pot@@	B-Chemical	D011188	28952
assi@@	I-Chemical	-1	28952
um	I-Chemical	-1	28952
loss	O	-1	28952
and	O	-1	28952
development	O	-1	28952
of	O	-1	28952
hypo@@	B-Disease	D007008	28952
k@@	I-Disease	-1	28952
al@@	I-Disease	-1	28952
a@@	I-Disease	-1	28952
emia	I-Disease	-1	28952
during	O	-1	28952
the	O	-1	28952
administration	O	-1	28952
of	O	-1	28952
an	O	-1	28952
oral	O	-1	28952
di@@	O	-1	28952
ure@@	O	-1	28952
tic@@	O	-1	28952
,	O	-1	28952
met@@	O	-1	28952
ab@@	O	-1	28952
olic	O	-1	28952
b@@	O	-1	28952
al@@	O	-1	28952
ance	O	-1	28952
studies	O	-1	28952
were	O	-1	28952
performed	O	-1	28952
in	O	-1	28952
ten	O	-1	28952
patients	O	-1	28952
with	O	-1	28952
es@@	O	-1	28952
sen@@	O	-1	28952
tial	O	-1	28952
hypertension	B-Disease	D006973	28952
who	O	-1	28952
had	O	-1	28952
shown	O	-1	28952
hypo@@	B-Disease	D007008	28952
k@@	I-Disease	-1	28952
al@@	I-Disease	-1	28952
a@@	I-Disease	-1	28952
emia	I-Disease	-1	28952
under	O	-1	28952
prior	O	-1	28952
oral	O	-1	28952
di@@	O	-1	28952
ure@@	O	-1	28952
tic	O	-1	28952
treatment.	O	-1	28952
Ch@@	B-Chemical	D002752	28952
lor@@	I-Chemical	-1	28952
thal@@	I-Chemical	-1	28952
id@@	I-Chemical	-1	28952
one	I-Chemical	-1	28952
(@@	O	-1	28952
50	O	-1	28952
mg	O	-1	28952
da@@	O	-1	28952
il@@	O	-1	28952
y@@	O	-1	28952
)	O	-1	28952
was	O	-1	28952
given	O	-1	28952
for	O	-1	28952
14	O	-1	28952
days.	O	-1	28952
Si@@	O	-1	28952
x	O	-1	28952
patients	O	-1	28952
received	O	-1	28952
a	O	-1	28952
normal@@	O	-1	28952
-	O	-1	28952
sodium	B-Chemical	D012964	28952
diet	O	-1	28952
and	O	-1	28952
four	O	-1	28952
a	O	-1	28952
low@@	O	-1	28952
-	O	-1	28952
sodium	B-Chemical	D012964	28952
(1@@	O	-1	28952
7	O	-1	28952
m@@	O	-1	28952
mol@@	O	-1	28952
/@@	O	-1	28952
day@@	O	-1	28952
)	O	-1	28952
di@@	O	-1	28952
et@@	O	-1	28952
.	O	-1	28952
All	O	-1	28952
patients	O	-1	28952
had	O	-1	28952
a	O	-1	28952
normal	O	-1	28952
initial	O	-1	28952
total	O	-1	28952
body	O	-1	28952
pot@@	B-Chemical	D011188	28952
assi@@	I-Chemical	-1	28952
um	I-Chemical	-1	28952
(4@@	O	-1	28952
0@@	O	-1	28952
K@@	O	-1	28952
).	O	-1	28952
The	O	-1	28952
electro@@	O	-1	28952
ly@@	O	-1	28952
te	O	-1	28952
b@@	O	-1	28952
al@@	O	-1	28952
anc@@	O	-1	28952
es,	O	-1	28952
weigh@@	O	-1	28952
t,	O	-1	28952
brom@@	O	-1	28952
ide	O	-1	28952
sp@@	O	-1	28952
ac@@	O	-1	28952
e,	O	-1	28952
plasma	O	-1	28952
ren@@	O	-1	28952
in	O	-1	28952
activ@@	O	-1	28952
ity,	O	-1	28952
and	O	-1	28952
al@@	B-Chemical	D000450	28952
do@@	I-Chemical	-1	28952
sterone	I-Chemical	-1	28952
secre@@	O	-1	28952
tion	O	-1	28952
rate	O	-1	28952
were	O	-1	28952
meas@@	O	-1	28952
ure@@	O	-1	28952
d.	O	-1	28952
In	O	-1	28952
both	O	-1	28952
groups	O	-1	28952
a	O	-1	28952
pot@@	B-Chemical	D011188	28952
assi@@	I-Chemical	-1	28952
um	I-Chemical	-1	28952
defic@@	O	-1	28952
it	O	-1	28952
develop@@	O	-1	28952
ed,	O	-1	28952
with	O	-1	28952
pro@@	O	-1	28952
por@@	O	-1	28952
tion@@	O	-1	28952
ally	O	-1	28952
larg@@	O	-1	28952
er	O	-1	28952
los@@	O	-1	28952
ses	O	-1	28952
from	O	-1	28952
the	O	-1	28952
extrac@@	O	-1	28952
ell@@	O	-1	28952
ular	O	-1	28952
than	O	-1	28952
from	O	-1	28952
the	O	-1	28952
intrac@@	O	-1	28952
ell@@	O	-1	28952
ular	O	-1	28952
compar@@	O	-1	28952
t@@	O	-1	28952
ment.	O	-1	28952
In	O	-1	28952
the	O	-1	28952
normal@@	O	-1	28952
-	O	-1	28952
sodium	B-Chemical	D012964	28952
group	O	-1	28952
the	O	-1	28952
high@@	O	-1	28952
est	O	-1	28952
mean	O	-1	28952
pot@@	B-Chemical	D011188	28952
assi@@	I-Chemical	-1	28952
um	I-Chemical	-1	28952
defic@@	O	-1	28952
it	O	-1	28952
was	O	-1	28952
17@@	O	-1	28952
6	O	-1	28952
m@@	O	-1	28952
mo@@	O	-1	28952
l	O	-1	28952
on	O	-1	28952
day	O	-1	28952
9@@	O	-1	28952
,	O	-1	28952
after	O	-1	28952
which	O	-1	28952
some	O	-1	28952
pot@@	B-Chemical	D011188	28952
assi@@	I-Chemical	-1	28952
um	I-Chemical	-1	28952
was	O	-1	28952
reg@@	O	-1	28952
a@@	O	-1	28952
ine@@	O	-1	28952
d@@	O	-1	28952
;	O	-1	28952
in	O	-1	28952
the	O	-1	28952
low@@	O	-1	28952
-	O	-1	28952
sodium	B-Chemical	D012964	28952
group	O	-1	28952
the	O	-1	28952
high@@	O	-1	28952
est	O	-1	28952
defic@@	O	-1	28952
it	O	-1	28952
was	O	-1	28952
27@@	O	-1	28952
6	O	-1	28952
m@@	O	-1	28952
mo@@	O	-1	28952
l	O	-1	28952
on	O	-1	28952
day	O	-1	28952
13@@	O	-1	28952
.	O	-1	28952
The	O	-1	28952
normal@@	O	-1	28952
-	O	-1	28952
sodium	B-Chemical	D012964	28952
group	O	-1	28952
showed	O	-1	28952
an	O	-1	28952
immedi@@	O	-1	28952
ate	O	-1	28952
but	O	-1	28952
tempor@@	O	-1	28952
ary	O	-1	28952
ri@@	O	-1	28952
se	O	-1	28952
of	O	-1	28952
the	O	-1	28952
ren@@	O	-1	28952
in	O	-1	28952
and	O	-1	28952
al@@	B-Chemical	D000450	28952
do@@	I-Chemical	-1	28952
sterone	I-Chemical	-1	28952
level@@	O	-1	28952
s;	O	-1	28952
in	O	-1	28952
the	O	-1	28952
low@@	O	-1	28952
-	O	-1	28952
sodium	B-Chemical	D012964	28952
group	O	-1	28952
ren@@	O	-1	28952
in	O	-1	28952
and	O	-1	28952
al@@	B-Chemical	D000450	28952
do@@	I-Chemical	-1	28952
sterone	I-Chemical	-1	28952
increased	O	-1	28952
more	O	-1	28952
s@@	O	-1	28952
low@@	O	-1	28952
ly	O	-1	28952
but	O	-1	28952
remained	O	-1	28952
elev@@	O	-1	28952
ated.	O	-1	28952
It	O	-1	28952
is	O	-1	28952
concl@@	O	-1	28952
uded	O	-1	28952
that	O	-1	28952
di@@	O	-1	28952
et@@	O	-1	28952
ary	O	-1	28952
sodium	B-Chemical	D012964	28952
re@@	O	-1	28952
stric@@	O	-1	28952
tion	O	-1	28952
increases	O	-1	28952
di@@	O	-1	28952
ure@@	O	-1	28952
tic@@	O	-1	28952
-induced	O	-1	28952
pot@@	B-Chemical	D011188	28952
assi@@	I-Chemical	-1	28952
um	I-Chemical	-1	28952
los@@	O	-1	28952
s,	O	-1	28952
pres@@	O	-1	28952
um@@	O	-1	28952
ably	O	-1	28952
by	O	-1	28952
an	O	-1	28952
increased	O	-1	28952
activity	O	-1	28952
of	O	-1	28952
the	O	-1	28952
ren@@	O	-1	28952
in@@	O	-1	28952
-	O	-1	28952
angiotens@@	B-Chemical	D000809	28952
in	I-Chemical	-1	28952
-	O	-1	28952
al@@	B-Chemical	D000450	28952
do@@	I-Chemical	-1	28952
sterone	I-Chemical	-1	28952
system@@	O	-1	28952
,	O	-1	28952
while	O	-1	28952
sodium	B-Chemical	D012964	28952
de@@	O	-1	28952
li@@	O	-1	28952
very	O	-1	28952
to	O	-1	28952
the	O	-1	28952
dist@@	O	-1	28952
al	O	-1	28952
renal	O	-1	28952
tub@@	O	-1	28952
ul@@	O	-1	28952
es	O	-1	28952
remain@@	O	-1	28952
s	O	-1	28952
suffici@@	O	-1	28952
ently	O	-1	28952
high	O	-1	28952
to	O	-1	28952
al@@	O	-1	28952
low	O	-1	28952
increased	O	-1	28952
pot@@	B-Chemical	D011188	28952
assi@@	I-Chemical	-1	28952
um	I-Chemical	-1	28952
secre@@	O	-1	28952
tion.	O	-1	28952

D@@	O	-1	19893084
y@@	O	-1	19893084
nam@@	O	-1	19893084
ic	O	-1	19893084
response	O	-1	19893084
of	O	-1	19893084
blood	O	-1	19893084
v@@	O	-1	19893084
es@@	O	-1	19893084
se@@	O	-1	19893084
l	O	-1	19893084
in	O	-1	19893084
acute	B-Disease	D058186	19893084
renal	I-Disease	-1	19893084
failure	I-Disease	-1	19893084
.	O	-1	19893084
In	O	-1	19893084
this	O	-1	19893084
study	O	-1	19893084
we	O	-1	19893084
post@@	O	-1	19893084
ul@@	O	-1	19893084
ated	O	-1	19893084
that	O	-1	19893084
during	O	-1	19893084
acute	B-Disease	D058186	19893084
renal	I-Disease	-1	19893084
failure	I-Disease	-1	19893084
induced	O	-1	19893084
by	O	-1	19893084
g@@	B-Chemical	D005839	19893084
ent@@	I-Chemical	-1	19893084
am@@	I-Chemical	-1	19893084
icin	I-Chemical	-1	19893084
the	O	-1	19893084
transi@@	O	-1	19893084
ent	O	-1	19893084
or	O	-1	19893084
dynam@@	O	-1	19893084
ic	O	-1	19893084
response	O	-1	19893084
of	O	-1	19893084
blood	O	-1	19893084
v@@	O	-1	19893084
es@@	O	-1	19893084
sel@@	O	-1	19893084
s	O	-1	19893084
could	O	-1	19893084
be	O	-1	19893084
aff@@	O	-1	19893084
ect@@	O	-1	19893084
ed,	O	-1	19893084
and	O	-1	19893084
that	O	-1	19893084
anti@@	O	-1	19893084
oxid@@	O	-1	19893084
ants	O	-1	19893084
can	O	-1	19893084
prev@@	O	-1	19893084
ent	O	-1	19893084
the	O	-1	19893084
changes	O	-1	19893084
in	O	-1	19893084
dynam@@	O	-1	19893084
ic	O	-1	19893084
responses	O	-1	19893084
of	O	-1	19893084
blood	O	-1	19893084
v@@	O	-1	19893084
es@@	O	-1	19893084
sel@@	O	-1	19893084
s.	O	-1	19893084
The	O	-1	19893084
new	O	-1	19893084
appro@@	O	-1	19893084
ach	O	-1	19893084
to	O	-1	19893084
e@@	O	-1	19893084
x	O	-1	19893084
viv@@	O	-1	19893084
o	O	-1	19893084
blood	O	-1	19893084
v@@	O	-1	19893084
es@@	O	-1	19893084
se@@	O	-1	19893084
l	O	-1	19893084
experim@@	O	-1	19893084
ents	O	-1	19893084
in	O	-1	19893084
which	O	-1	19893084
not	O	-1	19893084
only	O	-1	19893084
the	O	-1	19893084
end	O	-1	19893084
po@@	O	-1	19893084
int@@	O	-1	19893084
s	O	-1	19893084
of	O	-1	19893084
v@@	O	-1	19893084
es@@	O	-1	19893084
sel@@	O	-1	19893084
s	O	-1	19893084
response	O	-1	19893084
within	O	-1	19893084
the	O	-1	19893084
time	O	-1	19893084
interv@@	O	-1	19893084
al	O	-1	19893084
is	O	-1	19893084
conside@@	O	-1	19893084
re@@	O	-1	19893084
d,	O	-1	19893084
but	O	-1	19893084
also	O	-1	19893084
dynam@@	O	-1	19893084
ic@@	O	-1	19893084
s	O	-1	19893084
of	O	-1	19893084
this	O	-1	19893084
respon@@	O	-1	19893084
se@@	O	-1	19893084
,	O	-1	19893084
was	O	-1	19893084
used	O	-1	19893084
in	O	-1	19893084
this	O	-1	19893084
pa@@	O	-1	19893084
per@@	O	-1	19893084
.	O	-1	19893084
Our	O	-1	19893084
results	O	-1	19893084
con@@	O	-1	19893084
fir@@	O	-1	19893084
m	O	-1	19893084
the	O	-1	19893084
al@@	O	-1	19893084
ter@@	O	-1	19893084
ation	O	-1	19893084
in	O	-1	19893084
dynam@@	O	-1	19893084
ic	O	-1	19893084
response	O	-1	19893084
of	O	-1	19893084
blood	O	-1	19893084
v@@	O	-1	19893084
es@@	O	-1	19893084
sel@@	O	-1	19893084
s	O	-1	19893084
during	O	-1	19893084
the	O	-1	19893084
change	O	-1	19893084
of	O	-1	19893084
pressure	O	-1	19893084
in	O	-1	19893084
g@@	B-Chemical	D005839	19893084
ent@@	I-Chemical	-1	19893084
am@@	I-Chemical	-1	19893084
icin	I-Chemical	-1	19893084
-treated	O	-1	19893084
anim@@	O	-1	19893084
al@@	O	-1	19893084
s.	O	-1	19893084
The	O	-1	19893084
ben@@	O	-1	19893084
e@@	O	-1	19893084
fic@@	O	-1	19893084
ial	O	-1	19893084
effects	O	-1	19893084
of	O	-1	19893084
vitamin	B-Chemical	D001205	19893084
C	I-Chemical	-1	19893084
administration	O	-1	19893084
to	O	-1	19893084
g@@	B-Chemical	D005839	19893084
ent@@	I-Chemical	-1	19893084
am@@	I-Chemical	-1	19893084
icin	I-Chemical	-1	19893084
-treated	O	-1	19893084
animals	O	-1	19893084
are	O	-1	19893084
also	O	-1	19893084
con@@	O	-1	19893084
fir@@	O	-1	19893084
m@@	O	-1	19893084
ed	O	-1	19893084
throu@@	O	-1	19893084
gh@@	O	-1	19893084
:	O	-1	19893084
lower	O	-1	19893084
level	O	-1	19893084
of	O	-1	19893084
blood	O	-1	19893084
ure@@	B-Chemical	D014508	19893084
a	I-Chemical	-1	19893084
and	O	-1	19893084
creatinine	B-Chemical	D003404	19893084
and	O	-1	19893084
higher	O	-1	19893084
level	O	-1	19893084
of	O	-1	19893084
pot@@	B-Chemical	D011188	19893084
assi@@	I-Chemical	-1	19893084
um	I-Chemical	-1	19893084
.	O	-1	19893084
The	O	-1	19893084
pressure	O	-1	19893084
dynam@@	O	-1	19893084
ic	O	-1	19893084
responses	O	-1	19893084
of	O	-1	19893084
isol@@	O	-1	19893084
ated	O	-1	19893084
blood	O	-1	19893084
v@@	O	-1	19893084
es@@	O	-1	19893084
sel@@	O	-1	19893084
s	O	-1	19893084
show	O	-1	19893084
a	O	-1	19893084
f@@	O	-1	19893084
ast@@	O	-1	19893084
er	O	-1	19893084
pressure	O	-1	19893084
change	O	-1	19893084
in	O	-1	19893084
g@@	B-Chemical	D005839	19893084
ent@@	I-Chemical	-1	19893084
am@@	I-Chemical	-1	19893084
icin	I-Chemical	-1	19893084
-treated	O	-1	19893084
animals	O	-1	19893084
(@@	O	-1	19893084
8.@@	O	-1	19893084
0@@	O	-1	19893084
7	O	-1	19893084
+/-	O	-1	19893084
1.@@	O	-1	19893084
7	O	-1	19893084
s	O	-1	19893084
vs.	O	-1	19893084
5.@@	O	-1	19893084
6@@	O	-1	19893084
4	O	-1	19893084
+/-	O	-1	19893084
0.@@	O	-1	19893084
1@@	O	-1	19893084
8	O	-1	19893084
s@@	O	-1	19893084
).	O	-1	19893084
V@@	B-Chemical	D001205	19893084
it@@	I-Chemical	-1	19893084
amin	I-Chemical	-1	19893084
C	I-Chemical	-1	19893084
administration	O	-1	19893084
induced	O	-1	19893084
s@@	O	-1	19893084
low@@	O	-1	19893084
do@@	O	-1	19893084
w@@	O	-1	19893084
n	O	-1	19893084
of	O	-1	19893084
pressure	O	-1	19893084
change	O	-1	19893084
bac@@	O	-1	19893084
k	O	-1	19893084
to	O	-1	19893084
the	O	-1	19893084
control	O	-1	19893084
valu@@	O	-1	19893084
es.	O	-1	19893084
The	O	-1	19893084
pressure	O	-1	19893084
dynam@@	O	-1	19893084
ic	O	-1	19893084
pro@@	O	-1	19893084
per@@	O	-1	19893084
ti@@	O	-1	19893084
es,	O	-1	19893084
qu@@	O	-1	19893084
anti@@	O	-1	19893084
t@@	O	-1	19893084
atively	O	-1	19893084
def@@	O	-1	19893084
in@@	O	-1	19893084
ed	O	-1	19893084
by	O	-1	19893084
compar@@	O	-1	19893084
ative	O	-1	19893084
pressure	O	-1	19893084
dynam@@	O	-1	19893084
ic	O	-1	19893084
and	O	-1	19893084
total	O	-1	19893084
pressure	O	-1	19893084
dynam@@	O	-1	19893084
ic@@	O	-1	19893084
,	O	-1	19893084
con@@	O	-1	19893084
fir@@	O	-1	19893084
m	O	-1	19893084
the	O	-1	19893084
al@@	O	-1	19893084
ter@@	O	-1	19893084
ation	O	-1	19893084
in	O	-1	19893084
dynam@@	O	-1	19893084
ic	O	-1	19893084
response	O	-1	19893084
of	O	-1	19893084
blood	O	-1	19893084
v@@	O	-1	19893084
es@@	O	-1	19893084
sel@@	O	-1	19893084
s	O	-1	19893084
during	O	-1	19893084
the	O	-1	19893084
change	O	-1	19893084
of	O	-1	19893084
pressure	O	-1	19893084
in	O	-1	19893084
g@@	B-Chemical	D005839	19893084
ent@@	I-Chemical	-1	19893084
am@@	I-Chemical	-1	19893084
icin	I-Chemical	-1	19893084
-treated	O	-1	19893084
animals	O	-1	19893084
and	O	-1	19893084
ben@@	O	-1	19893084
e@@	O	-1	19893084
fic@@	O	-1	19893084
ial	O	-1	19893084
effects	O	-1	19893084
of	O	-1	19893084
vitamin	B-Chemical	D001205	19893084
C	I-Chemical	-1	19893084
administr@@	O	-1	19893084
ation.	O	-1	19893084

The	O	-1	18513945
hemo@@	O	-1	18513945
dynam@@	O	-1	18513945
ic@@	O	-1	18513945
s	O	-1	18513945
of	O	-1	18513945
oxy@@	B-Chemical	D010121	18513945
t@@	I-Chemical	-1	18513945
oc@@	I-Chemical	-1	18513945
in	I-Chemical	-1	18513945
and	O	-1	18513945
other	O	-1	18513945
vas@@	O	-1	18513945
o@@	O	-1	18513945
active	O	-1	18513945
agents	O	-1	18513945
during	O	-1	18513945
ne@@	O	-1	18513945
ur@@	O	-1	18513945
ax@@	O	-1	18513945
ial	O	-1	18513945
anesthe@@	O	-1	18513945
sia	O	-1	18513945
for	O	-1	18513945
ces@@	O	-1	18513945
a@@	O	-1	18513945
re@@	O	-1	18513945
an	O	-1	18513945
de@@	O	-1	18513945
li@@	O	-1	18513945
ver@@	O	-1	18513945
y@@	O	-1	18513945
:	O	-1	18513945
findings	O	-1	18513945
in	O	-1	18513945
six	O	-1	18513945
cas@@	O	-1	18513945
es.	O	-1	18513945
O@@	B-Chemical	D010121	18513945
x@@	I-Chemical	-1	18513945
y@@	I-Chemical	-1	18513945
t@@	I-Chemical	-1	18513945
oc@@	I-Chemical	-1	18513945
in	I-Chemical	-1	18513945
is	O	-1	18513945
a	O	-1	18513945
common@@	O	-1	18513945
ly	O	-1	18513945
used	O	-1	18513945
u@@	O	-1	18513945
ter@@	O	-1	18513945
oton@@	O	-1	18513945
ic	O	-1	18513945
that	O	-1	18513945
can	O	-1	18513945
cause	O	-1	18513945
significant	O	-1	18513945
and	O	-1	18513945
even	O	-1	18513945
f@@	O	-1	18513945
atal	O	-1	18513945
hypotension	B-Disease	D007022	18513945
,	O	-1	18513945
partic@@	O	-1	18513945
ul@@	O	-1	18513945
arly	O	-1	18513945
when	O	-1	18513945
given	O	-1	18513945
as	O	-1	18513945
a	O	-1	18513945
b@@	O	-1	18513945
ol@@	O	-1	18513945
us.	O	-1	18513945
The	O	-1	18513945
result@@	O	-1	18513945
ing	O	-1	18513945
hypotension	B-Disease	D007022	18513945
can	O	-1	18513945
be	O	-1	18513945
produced	O	-1	18513945
by	O	-1	18513945
a	O	-1	18513945
decrease	O	-1	18513945
in	O	-1	18513945
systemic	O	-1	18513945
vascular	O	-1	18513945
resist@@	O	-1	18513945
ance	O	-1	18513945
or	O	-1	18513945
cardiac	O	-1	18513945
out@@	O	-1	18513945
pu@@	O	-1	18513945
t	O	-1	18513945
through	O	-1	18513945
a	O	-1	18513945
decrease	O	-1	18513945
in	O	-1	18513945
venous	O	-1	18513945
retur@@	O	-1	18513945
n@@	O	-1	18513945
.	O	-1	18513945
P@@	O	-1	18513945
ar@@	O	-1	18513945
t@@	O	-1	18513945
ur@@	O	-1	18513945
i@@	O	-1	18513945
ents	O	-1	18513945
with	O	-1	18513945
normal	O	-1	18513945
volume	O	-1	18513945
stat@@	O	-1	18513945
us,	O	-1	18513945
heart	O	-1	18513945
val@@	O	-1	18513945
v@@	O	-1	18513945
es	O	-1	18513945
and	O	-1	18513945
pulmonary	O	-1	18513945
vas@@	O	-1	18513945
cul@@	O	-1	18513945
at@@	O	-1	18513945
ure	O	-1	18513945
most	O	-1	18513945
often	O	-1	18513945
respon@@	O	-1	18513945
d	O	-1	18513945
to	O	-1	18513945
this	O	-1	18513945
hypotension	B-Disease	D007022	18513945
with	O	-1	18513945
a	O	-1	18513945
com@@	O	-1	18513945
pen@@	O	-1	18513945
s@@	O	-1	18513945
atory	O	-1	18513945
increase	O	-1	18513945
in	O	-1	18513945
heart	O	-1	18513945
rate	O	-1	18513945
and	O	-1	18513945
strok@@	B-Disease	D020521	18513945
e	I-Disease	-1	18513945
vol@@	O	-1	18513945
u@@	O	-1	18513945
me.	O	-1	18513945
O@@	B-Chemical	D010121	18513945
x@@	I-Chemical	-1	18513945
y@@	I-Chemical	-1	18513945
t@@	I-Chemical	-1	18513945
oc@@	I-Chemical	-1	18513945
in	I-Chemical	-1	18513945
-induced	O	-1	18513945
hypotension	B-Disease	D007022	18513945
at	O	-1	18513945
ces@@	O	-1	18513945
a@@	O	-1	18513945
re@@	O	-1	18513945
an	O	-1	18513945
de@@	O	-1	18513945
li@@	O	-1	18513945
very	O	-1	18513945
may	O	-1	18513945
be	O	-1	18513945
inc@@	O	-1	18513945
or@@	O	-1	18513945
rec@@	O	-1	18513945
tly	O	-1	18513945
at@@	O	-1	18513945
tri@@	O	-1	18513945
but@@	O	-1	18513945
ed	O	-1	18513945
to	O	-1	18513945
blood	B-Disease	D006473	18513945
loss	I-Disease	-1	18513945
.	O	-1	18513945
P@@	O	-1	18513945
ul@@	O	-1	18513945
se	O	-1	18513945
po@@	O	-1	18513945
w@@	O	-1	18513945
er	O	-1	18513945
analysis	O	-1	18513945
(@@	O	-1	18513945
also	O	-1	18513945
c@@	O	-1	18513945
all@@	O	-1	18513945
ed	O	-1	18513945
"@@	O	-1	18513945
pul@@	O	-1	18513945
se	O	-1	18513945
cont@@	O	-1	18513945
our	O	-1	18513945
analy@@	O	-1	18513945
si@@	O	-1	18513945
s@@	O	-1	18513945
"@@	O	-1	18513945
)	O	-1	18513945
of	O	-1	18513945
an	O	-1	18513945
arterial	O	-1	18513945
pressure	O	-1	18513945
w@@	O	-1	18513945
a@@	O	-1	18513945
ve	O	-1	18513945
form	O	-1	18513945
al@@	O	-1	18513945
low@@	O	-1	18513945
s	O	-1	18513945
continu@@	O	-1	18513945
ous	O	-1	18513945
evalu@@	O	-1	18513945
ation	O	-1	18513945
of	O	-1	18513945
systemic	O	-1	18513945
vascular	O	-1	18513945
resist@@	O	-1	18513945
ance	O	-1	18513945
and	O	-1	18513945
cardiac	O	-1	18513945
out@@	O	-1	18513945
pu@@	O	-1	18513945
t	O	-1	18513945
in	O	-1	18513945
re@@	O	-1	18513945
al	O	-1	18513945
ti@@	O	-1	18513945
me,	O	-1	18513945
the@@	O	-1	18513945
re@@	O	-1	18513945
by	O	-1	18513945
el@@	O	-1	18513945
uc@@	O	-1	18513945
id@@	O	-1	18513945
ating	O	-1	18513945
the	O	-1	18513945
ca@@	O	-1	18513945
us@@	O	-1	18513945
ative	O	-1	18513945
factors	O	-1	18513945
be@@	O	-1	18513945
h@@	O	-1	18513945
ind	O	-1	18513945
changes	O	-1	18513945
in	O	-1	18513945
blood	O	-1	18513945
pressu@@	O	-1	18513945
re.	O	-1	18513945
P@@	O	-1	18513945
ul@@	O	-1	18513945
se	O	-1	18513945
po@@	O	-1	18513945
w@@	O	-1	18513945
er	O	-1	18513945
analysis	O	-1	18513945
was	O	-1	18513945
con@@	O	-1	18513945
duc@@	O	-1	18513945
ted	O	-1	18513945
in	O	-1	18513945
six	O	-1	18513945
cases	O	-1	18513945
of	O	-1	18513945
ces@@	O	-1	18513945
a@@	O	-1	18513945
re@@	O	-1	18513945
an	O	-1	18513945
de@@	O	-1	18513945
li@@	O	-1	18513945
very	O	-1	18513945
performed	O	-1	18513945
under	O	-1	18513945
ne@@	O	-1	18513945
ur@@	O	-1	18513945
ax@@	O	-1	18513945
ial	O	-1	18513945
anesthe@@	O	-1	18513945
sia.	O	-1	18513945
H@@	B-Disease	D007022	18513945
y@@	I-Disease	-1	18513945
poten@@	I-Disease	-1	18513945
sion	I-Disease	-1	18513945
in	O	-1	18513945
response	O	-1	18513945
to	O	-1	18513945
oxy@@	B-Chemical	D010121	18513945
t@@	I-Chemical	-1	18513945
oc@@	I-Chemical	-1	18513945
in	I-Chemical	-1	18513945
was	O	-1	18513945
associated	O	-1	18513945
with	O	-1	18513945
a	O	-1	18513945
decrease	O	-1	18513945
in	O	-1	18513945
systemic	O	-1	18513945
vascular	O	-1	18513945
resist@@	O	-1	18513945
ance	O	-1	18513945
and	O	-1	18513945
a	O	-1	18513945
com@@	O	-1	18513945
pen@@	O	-1	18513945
s@@	O	-1	18513945
atory	O	-1	18513945
increase	O	-1	18513945
in	O	-1	18513945
strok@@	B-Disease	D020521	18513945
e	I-Disease	-1	18513945
vol@@	O	-1	18513945
u@@	O	-1	18513945
me,	O	-1	18513945
heart	O	-1	18513945
rate	O	-1	18513945
and	O	-1	18513945
cardiac	O	-1	18513945
out@@	O	-1	18513945
p@@	O	-1	18513945
ut@@	O	-1	18513945
.	O	-1	18513945
P@@	O	-1	18513945
ul@@	O	-1	18513945
se	O	-1	18513945
po@@	O	-1	18513945
w@@	O	-1	18513945
er	O	-1	18513945
analysis	O	-1	18513945
may	O	-1	18513945
be	O	-1	18513945
he@@	O	-1	18513945
l@@	O	-1	18513945
p@@	O	-1	18513945
ful	O	-1	18513945
in	O	-1	18513945
determin@@	O	-1	18513945
ing	O	-1	18513945
the	O	-1	18513945
e@@	O	-1	18513945
ti@@	O	-1	18513945
ology	O	-1	18513945
of	O	-1	18513945
and	O	-1	18513945
treat@@	O	-1	18513945
ing	O	-1	18513945
hypotension	B-Disease	D007022	18513945
during	O	-1	18513945
ces@@	O	-1	18513945
a@@	O	-1	18513945
re@@	O	-1	18513945
an	O	-1	18513945
de@@	O	-1	18513945
li@@	O	-1	18513945
very	O	-1	18513945
under	O	-1	18513945
ne@@	O	-1	18513945
ur@@	O	-1	18513945
ax@@	O	-1	18513945
ial	O	-1	18513945
anesthe@@	O	-1	18513945
sia.	O	-1	18513945

E@@	O	-1	18483878
x@@	O	-1	18483878
ag@@	O	-1	18483878
g@@	O	-1	18483878
er@@	O	-1	18483878
ated	O	-1	18483878
expression	O	-1	18483878
of	O	-1	18483878
inflam@@	O	-1	18483878
mat@@	O	-1	18483878
ory	O	-1	18483878
medi@@	O	-1	18483878
at@@	O	-1	18483878
ors	O	-1	18483878
in	O	-1	18483878
vas@@	O	-1	18483878
o@@	O	-1	18483878
active	O	-1	18483878
in@@	O	-1	18483878
test@@	O	-1	18483878
inal	O	-1	18483878
poly@@	O	-1	18483878
p@@	O	-1	18483878
ep@@	O	-1	18483878
ti@@	O	-1	18483878
de	O	-1	18483878
k@@	O	-1	18483878
n@@	O	-1	18483878
oc@@	O	-1	18483878
k@@	O	-1	18483878
out	O	-1	18483878
(V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
mice	O	-1	18483878
with	O	-1	18483878
cyclophosph@@	B-Chemical	D003520	18483878
amide	I-Chemical	-1	18483878
(	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
)@@	O	-1	18483878
-induced	O	-1	18483878
cys@@	B-Disease	D003556	18483878
ti@@	I-Disease	-1	18483878
tis	I-Disease	-1	18483878
.	O	-1	18483878
V@@	O	-1	18483878
as@@	O	-1	18483878
o@@	O	-1	18483878
active	O	-1	18483878
in@@	O	-1	18483878
test@@	O	-1	18483878
inal	O	-1	18483878
poly@@	O	-1	18483878
p@@	O	-1	18483878
ep@@	O	-1	18483878
ti@@	O	-1	18483878
de	O	-1	18483878
(V@@	O	-1	18483878
I@@	O	-1	18483878
P)	O	-1	18483878
is	O	-1	18483878
an	O	-1	18483878
immuno@@	O	-1	18483878
mod@@	O	-1	18483878
ul@@	O	-1	18483878
atory	O	-1	18483878
neuro@@	O	-1	18483878
p@@	O	-1	18483878
ep@@	O	-1	18483878
ti@@	O	-1	18483878
de	O	-1	18483878
di@@	O	-1	18483878
stri@@	O	-1	18483878
but@@	O	-1	18483878
ed	O	-1	18483878
in	O	-1	18483878
mic@@	O	-1	18483878
t@@	O	-1	18483878
ur@@	O	-1	18483878
ition	O	-1	18483878
path@@	O	-1	18483878
w@@	O	-1	18483878
ay@@	O	-1	18483878
s.	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
mice	O	-1	18483878
ex@@	O	-1	18483878
hib@@	O	-1	18483878
it	O	-1	18483878
al@@	O	-1	18483878
te@@	O	-1	18483878
red	O	-1	18483878
bladder	O	-1	18483878
function	O	-1	18483878
and	O	-1	18483878
neuro@@	O	-1	18483878
chemical	O	-1	18483878
pro@@	O	-1	18483878
per@@	O	-1	18483878
ties	O	-1	18483878
in	O	-1	18483878
mic@@	O	-1	18483878
t@@	O	-1	18483878
ur@@	O	-1	18483878
ition	O	-1	18483878
path@@	O	-1	18483878
w@@	O	-1	18483878
ays	O	-1	18483878
after	O	-1	18483878
cyclophosph@@	B-Chemical	D003520	18483878
amide	I-Chemical	-1	18483878
(	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
)@@	O	-1	18483878
-induced	O	-1	18483878
cys@@	B-Disease	D003556	18483878
ti@@	I-Disease	-1	18483878
tis	I-Disease	-1	18483878
.	O	-1	18483878
G@@	O	-1	18483878
i@@	O	-1	18483878
ven	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
's	O	-1	18483878
role	O	-1	18483878
as	O	-1	18483878
an	O	-1	18483878
anti@@	O	-1	18483878
-@@	O	-1	18483878
inflam@@	O	-1	18483878
mat@@	O	-1	18483878
ory	O	-1	18483878
medi@@	O	-1	18483878
at@@	O	-1	18483878
or@@	O	-1	18483878
,	O	-1	18483878
we	O	-1	18483878
hypo@@	O	-1	18483878
the@@	O	-1	18483878
si@@	O	-1	18483878
zed	O	-1	18483878
that	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
mice	O	-1	18483878
wo@@	O	-1	18483878
uld	O	-1	18483878
ex@@	O	-1	18483878
hib@@	O	-1	18483878
it	O	-1	18483878
enhanced	O	-1	18483878
inflam@@	O	-1	18483878
mat@@	O	-1	18483878
ory	O	-1	18483878
medi@@	O	-1	18483878
at@@	O	-1	18483878
or	O	-1	18483878
expression	O	-1	18483878
after	O	-1	18483878
cys@@	B-Disease	D003556	18483878
ti@@	I-Disease	-1	18483878
tis	I-Disease	-1	18483878
.	O	-1	18483878
A	O	-1	18483878
mouse	O	-1	18483878
inflam@@	O	-1	18483878
mat@@	O	-1	18483878
ory	O	-1	18483878
cyto@@	O	-1	18483878
k@@	O	-1	18483878
ine	O	-1	18483878
and	O	-1	18483878
receptor	O	-1	18483878
R@@	O	-1	18483878
T@@	O	-1	18483878
2	O	-1	18483878
prof@@	O	-1	18483878
il@@	O	-1	18483878
er	O	-1	18483878
ar@@	O	-1	18483878
ra@@	O	-1	18483878
y	O	-1	18483878
was	O	-1	18483878
used	O	-1	18483878
to	O	-1	18483878
determine	O	-1	18483878
reg@@	O	-1	18483878
ul@@	O	-1	18483878
ated	O	-1	18483878
trans@@	O	-1	18483878
cri@@	O	-1	18483878
pt@@	O	-1	18483878
s	O	-1	18483878
in	O	-1	18483878
the	O	-1	18483878
urinary	O	-1	18483878
bladder	O	-1	18483878
of	O	-1	18483878
wil@@	O	-1	18483878
d	O	-1	18483878
type	O	-1	18483878
(@@	O	-1	18483878
W@@	O	-1	18483878
T)	O	-1	18483878
and	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
mice	O	-1	18483878
with	O	-1	18483878
or	O	-1	18483878
without	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
-induced	O	-1	18483878
cys@@	B-Disease	D003556	18483878
ti@@	I-Disease	-1	18483878
tis	I-Disease	-1	18483878
(1@@	O	-1	18483878
50	O	-1	18483878
mg/kg@@	O	-1	18483878
;	O	-1	18483878
i.p.@@	O	-1	18483878
;	O	-1	18483878
4@@	O	-1	18483878
8	O	-1	18483878
h@@	O	-1	18483878
).	O	-1	18483878
F@@	O	-1	18483878
our	O	-1	18483878
bin@@	O	-1	18483878
ary	O	-1	18483878
compar@@	O	-1	18483878
is@@	O	-1	18483878
ons	O	-1	18483878
were	O	-1	18483878
ma@@	O	-1	18483878
de@@	O	-1	18483878
:	O	-1	18483878
W@@	O	-1	18483878
T	O	-1	18483878
control	O	-1	18483878
versus	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
treatment	O	-1	18483878
(4@@	O	-1	18483878
8	O	-1	18483878
h@@	O	-1	18483878
),	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
control	O	-1	18483878
versus	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
treatment	O	-1	18483878
(4@@	O	-1	18483878
8	O	-1	18483878
h@@	O	-1	18483878
),	O	-1	18483878
W@@	O	-1	18483878
T	O	-1	18483878
control	O	-1	18483878
versus	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
control@@	O	-1	18483878
,	O	-1	18483878
and	O	-1	18483878
W@@	O	-1	18483878
T	O	-1	18483878
with	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
treatment	O	-1	18483878
(4@@	O	-1	18483878
8	O	-1	18483878
h@@	O	-1	18483878
)	O	-1	18483878
versus	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
with	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
treatment	O	-1	18483878
(4@@	O	-1	18483878
8	O	-1	18483878
h@@	O	-1	18483878
).	O	-1	18483878
The	O	-1	18483878
gen@@	O	-1	18483878
es	O	-1	18483878
presented	O	-1	18483878
re@@	O	-1	18483878
present	O	-1	18483878
(1@@	O	-1	18483878
)	O	-1	18483878
greater	O	-1	18483878
than	O	-1	18483878
1.@@	O	-1	18483878
5-@@	O	-1	18483878
fol@@	O	-1	18483878
d	O	-1	18483878
change	O	-1	18483878
in	O	-1	18483878
either	O	-1	18483878
direc@@	O	-1	18483878
tion	O	-1	18483878
and	O	-1	18483878
(2@@	O	-1	18483878
)	O	-1	18483878
the	O	-1	18483878
p	O	-1	18483878
valu@@	O	-1	18483878
e	O	-1	18483878
is	O	-1	18483878
less	O	-1	18483878
than	O	-1	18483878
0.0@@	O	-1	18483878
5	O	-1	18483878
for	O	-1	18483878
the	O	-1	18483878
compar@@	O	-1	18483878
ison	O	-1	18483878
being	O	-1	18483878
ma@@	O	-1	18483878
de@@	O	-1	18483878
.	O	-1	18483878
S@@	O	-1	18483878
e@@	O	-1	18483878
ver@@	O	-1	18483878
al	O	-1	18483878
reg@@	O	-1	18483878
ul@@	O	-1	18483878
ated	O	-1	18483878
gen@@	O	-1	18483878
es	O	-1	18483878
were	O	-1	18483878
val@@	O	-1	18483878
id@@	O	-1	18483878
ated	O	-1	18483878
using	O	-1	18483878
enz@@	O	-1	18483878
y@@	O	-1	18483878
me@@	O	-1	18483878
-@@	O	-1	18483878
lin@@	O	-1	18483878
ked	O	-1	18483878
immuno@@	O	-1	18483878
ass@@	O	-1	18483878
ays	O	-1	18483878
including	O	-1	18483878
I@@	O	-1	18483878
L-@@	O	-1	18483878
1@@	O	-1	18483878
bet@@	O	-1	18483878
a	O	-1	18483878
and	O	-1	18483878
C@@	O	-1	18483878
X@@	O	-1	18483878
CL@@	O	-1	18483878
1@@	O	-1	18483878
.	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
treatment	O	-1	18483878
significantly	O	-1	18483878
(p	O	-1	18483878
<	O	-1	18483878
or	O	-1	18483878
=	O	-1	18483878
0.00@@	O	-1	18483878
1)	O	-1	18483878
increased	O	-1	18483878
expression	O	-1	18483878
of	O	-1	18483878
C@@	O	-1	18483878
X@@	O	-1	18483878
CL@@	O	-1	18483878
1	O	-1	18483878
and	O	-1	18483878
I@@	O	-1	18483878
L-@@	O	-1	18483878
1@@	O	-1	18483878
bet@@	O	-1	18483878
a	O	-1	18483878
in	O	-1	18483878
the	O	-1	18483878
urinary	O	-1	18483878
bladder	O	-1	18483878
of	O	-1	18483878
W@@	O	-1	18483878
T	O	-1	18483878
and	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
mic@@	O	-1	18483878
e,	O	-1	18483878
but	O	-1	18483878
expression	O	-1	18483878
in	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
mice	O	-1	18483878
with	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
treatment	O	-1	18483878
was	O	-1	18483878
significantly	O	-1	18483878
(p	O	-1	18483878
<	O	-1	18483878
or	O	-1	18483878
=	O	-1	18483878
0.00@@	O	-1	18483878
1)	O	-1	18483878
greater	O	-1	18483878
(@@	O	-1	18483878
4.@@	O	-1	18483878
2@@	O	-1	18483878
-	O	-1	18483878
to	O	-1	18483878
1@@	O	-1	18483878
3-@@	O	-1	18483878
fol@@	O	-1	18483878
d	O	-1	18483878
increas@@	O	-1	18483878
e@@	O	-1	18483878
)	O	-1	18483878
than	O	-1	18483878
that	O	-1	18483878
observed	O	-1	18483878
in	O	-1	18483878
W@@	O	-1	18483878
T	O	-1	18483878
urinary	O	-1	18483878
bladder	O	-1	18483878
(@@	O	-1	18483878
3.@@	O	-1	18483878
6@@	O	-1	18483878
-	O	-1	18483878
to	O	-1	18483878
5-@@	O	-1	18483878
fol@@	O	-1	18483878
d	O	-1	18483878
increas@@	O	-1	18483878
e@@	O	-1	18483878
).	O	-1	18483878
The	O	-1	18483878
data	O	-1	18483878
suggest	O	-1	18483878
that	O	-1	18483878
in	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
mice	O	-1	18483878
with	O	-1	18483878
bladder	B-Disease	D001745	18483878
inflam@@	I-Disease	-1	18483878
m@@	I-Disease	-1	18483878
ation	I-Disease	-1	18483878
,	O	-1	18483878
inflam@@	O	-1	18483878
mat@@	O	-1	18483878
ory	O	-1	18483878
medi@@	O	-1	18483878
at@@	O	-1	18483878
ors	O	-1	18483878
are	O	-1	18483878
increased	O	-1	18483878
ab@@	O	-1	18483878
o@@	O	-1	18483878
ve	O	-1	18483878
that	O	-1	18483878
observed	O	-1	18483878
in	O	-1	18483878
W@@	O	-1	18483878
T	O	-1	18483878
with	O	-1	18483878
C@@	B-Chemical	D003520	18483878
Y@@	I-Chemical	-1	18483878
P	I-Chemical	-1	18483878
.	O	-1	18483878
This	O	-1	18483878
shi@@	O	-1	18483878
ft	O	-1	18483878
in	O	-1	18483878
b@@	O	-1	18483878
al@@	O	-1	18483878
ance	O	-1	18483878
may	O	-1	18483878
cont@@	O	-1	18483878
rib@@	O	-1	18483878
ute	O	-1	18483878
to	O	-1	18483878
increased	O	-1	18483878
bladder	B-Disease	D001745	18483878
dysfunction	I-Disease	-1	18483878
in	O	-1	18483878
V@@	O	-1	18483878
I@@	O	-1	18483878
P@@	O	-1	18483878
(-@@	O	-1	18483878
/@@	O	-1	18483878
-@@	O	-1	18483878
)	O	-1	18483878
mice	O	-1	18483878
with	O	-1	18483878
bladder	B-Disease	D001745	18483878
inflam@@	I-Disease	-1	18483878
m@@	I-Disease	-1	18483878
ation	I-Disease	-1	18483878
and	O	-1	18483878
al@@	O	-1	18483878
te@@	O	-1	18483878
red	O	-1	18483878
neuro@@	O	-1	18483878
chemical	O	-1	18483878
expression	O	-1	18483878
in	O	-1	18483878
mic@@	O	-1	18483878
t@@	O	-1	18483878
ur@@	O	-1	18483878
ition	O	-1	18483878
path@@	O	-1	18483878
w@@	O	-1	18483878
ay@@	O	-1	18483878
s.	O	-1	18483878

In@@	O	-1	17923537
tra@@	O	-1	17923537
oc@@	O	-1	17923537
ular	O	-1	17923537
pressure	O	-1	17923537
in	O	-1	17923537
patients	O	-1	17923537
with	O	-1	17923537
u@@	B-Disease	D014605	17923537
ve@@	I-Disease	-1	17923537
iti@@	I-Disease	-1	17923537
s	I-Disease	-1	17923537
treated	O	-1	17923537
with	O	-1	17923537
flu@@	B-Chemical	D005446	17923537
oc@@	I-Chemical	-1	17923537
in@@	I-Chemical	-1	17923537
ol@@	I-Chemical	-1	17923537
one	I-Chemical	-1	17923537
acet@@	I-Chemical	-1	17923537
on@@	I-Chemical	-1	17923537
ide	I-Chemical	-1	17923537
im@@	O	-1	17923537
pl@@	O	-1	17923537
ant@@	O	-1	17923537
s.	O	-1	17923537
OBJECTIVE:	O	-1	17923537
To	O	-1	17923537
report	O	-1	17923537
the	O	-1	17923537
incidence	O	-1	17923537
and	O	-1	17923537
man@@	O	-1	17923537
ag@@	O	-1	17923537
ement	O	-1	17923537
of	O	-1	17923537
elevated	B-Disease	D009798	17923537
intra@@	I-Disease	-1	17923537
oc@@	I-Disease	-1	17923537
ular	I-Disease	-1	17923537
pressure	I-Disease	-1	17923537
(@@	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P)	O	-1	17923537
in	O	-1	17923537
patients	O	-1	17923537
with	O	-1	17923537
u@@	B-Disease	D014605	17923537
ve@@	I-Disease	-1	17923537
iti@@	I-Disease	-1	17923537
s	I-Disease	-1	17923537
treated	O	-1	17923537
with	O	-1	17923537
the	O	-1	17923537
flu@@	B-Chemical	D005446	17923537
oc@@	I-Chemical	-1	17923537
in@@	I-Chemical	-1	17923537
ol@@	I-Chemical	-1	17923537
one	I-Chemical	-1	17923537
acet@@	I-Chemical	-1	17923537
on@@	I-Chemical	-1	17923537
ide	I-Chemical	-1	17923537
(	O	-1	17923537
F@@	B-Chemical	D005446	17923537
A	I-Chemical	-1	17923537
)	O	-1	17923537
intra@@	O	-1	17923537
vit@@	O	-1	17923537
re@@	O	-1	17923537
al	O	-1	17923537
im@@	O	-1	17923537
pl@@	O	-1	17923537
ant@@	O	-1	17923537
.	O	-1	17923537
D@@	O	-1	17923537
ES@@	O	-1	17923537
I@@	O	-1	17923537
G@@	O	-1	17923537
N@@	O	-1	17923537
:	O	-1	17923537
P@@	O	-1	17923537
o@@	O	-1	17923537
ol@@	O	-1	17923537
ed	O	-1	17923537
data	O	-1	17923537
from	O	-1	17923537
3	O	-1	17923537
mul@@	O	-1	17923537
tic@@	O	-1	17923537
ent@@	O	-1	17923537
er,	O	-1	17923537
double-@@	O	-1	17923537
mas@@	O	-1	17923537
k@@	O	-1	17923537
ed,	O	-1	17923537
random@@	O	-1	17923537
iz@@	O	-1	17923537
ed,	O	-1	17923537
control@@	O	-1	17923537
le@@	O	-1	17923537
d,	O	-1	17923537
phase	O	-1	17923537
2@@	O	-1	17923537
b@@	O	-1	17923537
/@@	O	-1	17923537
3	O	-1	17923537
clinical	O	-1	17923537
tri@@	O	-1	17923537
als	O	-1	17923537
evalu@@	O	-1	17923537
ating	O	-1	17923537
the	O	-1	17923537
safety	O	-1	17923537
and	O	-1	17923537
efficacy	O	-1	17923537
of	O	-1	17923537
the	O	-1	17923537
0.@@	O	-1	17923537
5@@	O	-1	17923537
9@@	O	-1	17923537
-@@	O	-1	17923537
mg	O	-1	17923537
or	O	-1	17923537
2.@@	O	-1	17923537
1-@@	O	-1	17923537
mg	O	-1	17923537
F@@	B-Chemical	D005446	17923537
A	I-Chemical	-1	17923537
intra@@	O	-1	17923537
vit@@	O	-1	17923537
re@@	O	-1	17923537
al	O	-1	17923537
im@@	O	-1	17923537
pl@@	O	-1	17923537
ant	O	-1	17923537
or	O	-1	17923537
standard	O	-1	17923537
therapy	O	-1	17923537
were	O	-1	17923537
analy@@	O	-1	17923537
z@@	O	-1	17923537
ed.	O	-1	17923537
RESULTS:	O	-1	17923537
D@@	O	-1	17923537
uring	O	-1	17923537
the	O	-1	17923537
3-@@	O	-1	17923537
year	O	-1	17923537
follow-@@	O	-1	17923537
up@@	O	-1	17923537
,	O	-1	17923537
7@@	O	-1	17923537
1.@@	O	-1	17923537
0%	O	-1	17923537
of	O	-1	17923537
im@@	O	-1	17923537
pl@@	O	-1	17923537
ant@@	O	-1	17923537
ed	O	-1	17923537
e@@	O	-1	17923537
y@@	O	-1	17923537
es	O	-1	17923537
had	O	-1	17923537
an	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P	O	-1	17923537
increase	O	-1	17923537
of	O	-1	17923537
10	O	-1	17923537
mm	O	-1	17923537
H@@	O	-1	17923537
g	O	-1	17923537
or	O	-1	17923537
more	O	-1	17923537
than	O	-1	17923537
baseline	O	-1	17923537
and	O	-1	17923537
5@@	O	-1	17923537
5.@@	O	-1	17923537
1@@	O	-1	17923537
%,	O	-1	17923537
2@@	O	-1	17923537
4.@@	O	-1	17923537
7@@	O	-1	17923537
%,	O	-1	17923537
and	O	-1	17923537
6.@@	O	-1	17923537
2@@	O	-1	17923537
%	O	-1	17923537
of	O	-1	17923537
e@@	O	-1	17923537
y@@	O	-1	17923537
es	O	-1	17923537
reac@@	O	-1	17923537
h@@	O	-1	17923537
ed	O	-1	17923537
an	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P	O	-1	17923537
of	O	-1	17923537
30	O	-1	17923537
mm	O	-1	17923537
H@@	O	-1	17923537
g	O	-1	17923537
or	O	-1	17923537
mo@@	O	-1	17923537
re,	O	-1	17923537
40	O	-1	17923537
mm	O	-1	17923537
H@@	O	-1	17923537
g	O	-1	17923537
or	O	-1	17923537
mo@@	O	-1	17923537
re,	O	-1	17923537
and	O	-1	17923537
50	O	-1	17923537
mm	O	-1	17923537
H@@	O	-1	17923537
g	O	-1	17923537
or	O	-1	17923537
mo@@	O	-1	17923537
re,	O	-1	17923537
respectively.	O	-1	17923537
T@@	O	-1	17923537
op@@	O	-1	17923537
ical	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P@@	O	-1	17923537
-@@	O	-1	17923537
low@@	O	-1	17923537
ering	O	-1	17923537
medic@@	O	-1	17923537
ation	O	-1	17923537
was	O	-1	17923537
administered	O	-1	17923537
in	O	-1	17923537
7@@	O	-1	17923537
4.@@	O	-1	17923537
8@@	O	-1	17923537
%	O	-1	17923537
of	O	-1	17923537
im@@	O	-1	17923537
pl@@	O	-1	17923537
ant@@	O	-1	17923537
ed	O	-1	17923537
e@@	O	-1	17923537
y@@	O	-1	17923537
es,	O	-1	17923537
and	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P@@	O	-1	17923537
-@@	O	-1	17923537
low@@	O	-1	17923537
ering	O	-1	17923537
surger@@	O	-1	17923537
i@@	O	-1	17923537
es,	O	-1	17923537
most	O	-1	17923537
of	O	-1	17923537
which	O	-1	17923537
were	O	-1	17923537
tra@@	O	-1	17923537
b@@	O	-1	17923537
ec@@	O	-1	17923537
ul@@	O	-1	17923537
ect@@	O	-1	17923537
om@@	O	-1	17923537
i@@	O	-1	17923537
es	O	-1	17923537
(@@	O	-1	17923537
7@@	O	-1	17923537
6.@@	O	-1	17923537
2@@	O	-1	17923537
%),	O	-1	17923537
were	O	-1	17923537
performed	O	-1	17923537
on	O	-1	17923537
3@@	O	-1	17923537
6.@@	O	-1	17923537
6%	O	-1	17923537
of	O	-1	17923537
im@@	O	-1	17923537
pl@@	O	-1	17923537
ant@@	O	-1	17923537
ed	O	-1	17923537
e@@	O	-1	17923537
y@@	O	-1	17923537
es.	O	-1	17923537
In@@	O	-1	17923537
tra@@	O	-1	17923537
oc@@	O	-1	17923537
ular	O	-1	17923537
pressu@@	O	-1	17923537
re@@	O	-1	17923537
-@@	O	-1	17923537
low@@	O	-1	17923537
ering	O	-1	17923537
surger@@	O	-1	17923537
i@@	O	-1	17923537
es	O	-1	17923537
were	O	-1	17923537
considered	O	-1	17923537
a	O	-1	17923537
suc@@	O	-1	17923537
cess	O	-1	17923537
(@@	O	-1	17923537
postoperative	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P	O	-1	17923537
of	O	-1	17923537
6-@@	O	-1	17923537
21	O	-1	17923537
mm	O	-1	17923537
H@@	O	-1	17923537
g	O	-1	17923537
with	O	-1	17923537
or	O	-1	17923537
without	O	-1	17923537
addi@@	O	-1	17923537
tional	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P@@	O	-1	17923537
-@@	O	-1	17923537
low@@	O	-1	17923537
ering	O	-1	17923537
medic@@	O	-1	17923537
ation@@	O	-1	17923537
)	O	-1	17923537
in	O	-1	17923537
8@@	O	-1	17923537
5.@@	O	-1	17923537
1@@	O	-1	17923537
%	O	-1	17923537
of	O	-1	17923537
e@@	O	-1	17923537
y@@	O	-1	17923537
es	O	-1	17923537
at	O	-1	17923537
1	O	-1	17923537
year@@	O	-1	17923537
.	O	-1	17923537
The	O	-1	17923537
rate	O	-1	17923537
of	O	-1	17923537
hy@@	B-Disease	D015814	17923537
pot@@	I-Disease	-1	17923537
on@@	I-Disease	-1	17923537
y	I-Disease	-1	17923537
(@@	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P	O	-1	17923537
<@@	O	-1	17923537
/@@	O	-1	17923537
=	O	-1	17923537
5	O	-1	17923537
mm	O	-1	17923537
H@@	O	-1	17923537
g@@	O	-1	17923537
)	O	-1	17923537
following	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P@@	O	-1	17923537
-@@	O	-1	17923537
low@@	O	-1	17923537
ering	O	-1	17923537
surger@@	O	-1	17923537
y	O	-1	17923537
(4@@	O	-1	17923537
2.@@	O	-1	17923537
5@@	O	-1	17923537
%)	O	-1	17923537
was	O	-1	17923537
not	O	-1	17923537
different	O	-1	17923537
from	O	-1	17923537
that	O	-1	17923537
of	O	-1	17923537
im@@	O	-1	17923537
pl@@	O	-1	17923537
ant@@	O	-1	17923537
ed	O	-1	17923537
e@@	O	-1	17923537
y@@	O	-1	17923537
es	O	-1	17923537
not	O	-1	17923537
subj@@	O	-1	17923537
ected	O	-1	17923537
to	O	-1	17923537
surger@@	O	-1	17923537
y	O	-1	17923537
(3@@	O	-1	17923537
5.@@	O	-1	17923537
4@@	O	-1	17923537
%)	O	-1	17923537
(P	O	-1	17923537
=	O	-1	17923537
.@@	O	-1	17923537
0@@	O	-1	17923537
9@@	O	-1	17923537
).	O	-1	17923537
CONCLUSION:	O	-1	17923537
E@@	O	-1	17923537
lev@@	O	-1	17923537
ated	O	-1	17923537
I@@	O	-1	17923537
O@@	O	-1	17923537
P	O	-1	17923537
is	O	-1	17923537
a	O	-1	17923537
significant	O	-1	17923537
complication	O	-1	17923537
with	O	-1	17923537
the	O	-1	17923537
F@@	O	-1	17923537
A	O	-1	17923537
intra@@	O	-1	17923537
vit@@	O	-1	17923537
re@@	O	-1	17923537
al	O	-1	17923537
im@@	O	-1	17923537
pl@@	O	-1	17923537
ant	O	-1	17923537
but	O	-1	17923537
may	O	-1	17923537
be	O	-1	17923537
controlled	O	-1	17923537
with	O	-1	17923537
medic@@	O	-1	17923537
ation	O	-1	17923537
and	O	-1	17923537
surger@@	O	-1	17923537
y.	O	-1	17923537

P@@	O	-1	15096016
all@@	O	-1	15096016
idal	O	-1	15096016
stimul@@	O	-1	15096016
ation@@	O	-1	15096016
:	O	-1	15096016
an	O	-1	15096016
al@@	O	-1	15096016
tern@@	O	-1	15096016
ative	O	-1	15096016
to	O	-1	15096016
p@@	O	-1	15096016
all@@	O	-1	15096016
id@@	O	-1	15096016
ot@@	O	-1	15096016
om@@	O	-1	15096016
y@@	O	-1	15096016
?	O	-1	15096016
A	O	-1	15096016
res@@	O	-1	15096016
ur@@	O	-1	15096016
gen@@	O	-1	15096016
ce	O	-1	15096016
of	O	-1	15096016
in@@	O	-1	15096016
te@@	O	-1	15096016
res@@	O	-1	15096016
t	O	-1	15096016
in	O	-1	15096016
the	O	-1	15096016
surg@@	O	-1	15096016
ical	O	-1	15096016
treatment	O	-1	15096016
of	O	-1	15096016
Parkinson's	B-Disease	D010300	15096016
disease	I-Disease	-1	15096016
(	O	-1	15096016
P@@	B-Disease	D010300	15096016
D	I-Disease	-1	15096016
)	O	-1	15096016
c@@	O	-1	15096016
am@@	O	-1	15096016
e	O	-1	15096016
with	O	-1	15096016
the	O	-1	15096016
re@@	O	-1	15096016
dis@@	O	-1	15096016
co@@	O	-1	15096016
very	O	-1	15096016
of	O	-1	15096016
po@@	O	-1	15096016
ster@@	O	-1	15096016
o@@	O	-1	15096016
ventr@@	O	-1	15096016
al	O	-1	15096016
p@@	O	-1	15096016
all@@	O	-1	15096016
id@@	O	-1	15096016
ot@@	O	-1	15096016
om@@	O	-1	15096016
y	O	-1	15096016
by	O	-1	15096016
L@@	O	-1	15096016
a@@	O	-1	15096016
it@@	O	-1	15096016
ine@@	O	-1	15096016
n	O	-1	15096016
in	O	-1	15096016
19@@	O	-1	15096016
8@@	O	-1	15096016
5@@	O	-1	15096016
.	O	-1	15096016
L@@	O	-1	15096016
a@@	O	-1	15096016
it@@	O	-1	15096016
in@@	O	-1	15096016
en@@	O	-1	15096016
's	O	-1	15096016
proce@@	O	-1	15096016
d@@	O	-1	15096016
ure	O	-1	15096016
improved	O	-1	15096016
most	O	-1	15096016
symptoms	O	-1	15096016
in	O	-1	15096016
drug@@	O	-1	15096016
-@@	O	-1	15096016
resist@@	O	-1	15096016
ant	O	-1	15096016
P@@	B-Disease	D010300	15096016
D	I-Disease	-1	15096016
,	O	-1	15096016
which	O	-1	15096016
en@@	O	-1	15096016
gen@@	O	-1	15096016
de@@	O	-1	15096016
red	O	-1	15096016
w@@	O	-1	15096016
ide	O	-1	15096016
in@@	O	-1	15096016
te@@	O	-1	15096016
res@@	O	-1	15096016
t	O	-1	15096016
in	O	-1	15096016
the	O	-1	15096016
neuro@@	O	-1	15096016
surg@@	O	-1	15096016
ical	O	-1	15096016
com@@	O	-1	15096016
mun@@	O	-1	15096016
ity.	O	-1	15096016
A@@	O	-1	15096016
no@@	O	-1	15096016
ther	O	-1	15096016
le@@	O	-1	15096016
sion@@	O	-1	15096016
ing	O	-1	15096016
proce@@	O	-1	15096016
d@@	O	-1	15096016
ure,	O	-1	15096016
v@@	O	-1	15096016
ent@@	O	-1	15096016
ro@@	O	-1	15096016
lat@@	O	-1	15096016
eral	O	-1	15096016
thal@@	O	-1	15096016
am@@	O	-1	15096016
ot@@	O	-1	15096016
om@@	O	-1	15096016
y,	O	-1	15096016
has	O	-1	15096016
b@@	O	-1	15096016
ec@@	O	-1	15096016
ome	O	-1	15096016
a	O	-1	15096016
po@@	O	-1	15096016
w@@	O	-1	15096016
er@@	O	-1	15096016
ful	O	-1	15096016
al@@	O	-1	15096016
tern@@	O	-1	15096016
ative	O	-1	15096016
to	O	-1	15096016
stimul@@	O	-1	15096016
ate	O	-1	15096016
the	O	-1	15096016
nucle@@	O	-1	15096016
us	O	-1	15096016
ventr@@	O	-1	15096016
al@@	O	-1	15096016
is	O	-1	15096016
inter@@	O	-1	15096016
medi@@	O	-1	15096016
us,	O	-1	15096016
produc@@	O	-1	15096016
ing	O	-1	15096016
high	O	-1	15096016
long-term	O	-1	15096016
suc@@	O	-1	15096016
cess	O	-1	15096016
rat@@	O	-1	15096016
es	O	-1	15096016
and	O	-1	15096016
low	O	-1	15096016
mor@@	O	-1	15096016
b@@	O	-1	15096016
idity	O	-1	15096016
rat@@	O	-1	15096016
es.	O	-1	15096016
P@@	O	-1	15096016
all@@	O	-1	15096016
idal	O	-1	15096016
stimulation	O	-1	15096016
has	O	-1	15096016
not	O	-1	15096016
me@@	O	-1	15096016
t	O	-1	15096016
with	O	-1	15096016
the	O	-1	15096016
same	O	-1	15096016
suc@@	O	-1	15096016
ces@@	O	-1	15096016
s.	O	-1	15096016
Ac@@	O	-1	15096016
cor@@	O	-1	15096016
ding	O	-1	15096016
to	O	-1	15096016
the	O	-1	15096016
literat@@	O	-1	15096016
ure	O	-1	15096016
p@@	O	-1	15096016
all@@	O	-1	15096016
id@@	O	-1	15096016
ot@@	O	-1	15096016
om@@	O	-1	15096016
y	O	-1	15096016
impro@@	O	-1	15096016
v@@	O	-1	15096016
es	O	-1	15096016
the	O	-1	15096016
"@@	O	-1	15096016
on@@	O	-1	15096016
"	O	-1	15096016
symptoms	O	-1	15096016
of	O	-1	15096016
P@@	B-Disease	D010300	15096016
D	I-Disease	-1	15096016
,	O	-1	15096016
such	O	-1	15096016
as	O	-1	15096016
dyskine@@	B-Disease	D004409	15096016
si@@	I-Disease	-1	15096016
as	I-Disease	-1	15096016
,	O	-1	15096016
as	O	-1	15096016
well	O	-1	15096016
as	O	-1	15096016
the	O	-1	15096016
"@@	O	-1	15096016
o@@	O	-1	15096016
ff@@	O	-1	15096016
"	O	-1	15096016
symptom@@	O	-1	15096016
s,	O	-1	15096016
such	O	-1	15096016
as	O	-1	15096016
rig@@	B-Disease	D009127	15096016
idity	I-Disease	-1	15096016
,	O	-1	15096016
brady@@	B-Disease	D018476	15096016
kine@@	I-Disease	-1	15096016
sia	I-Disease	-1	15096016
,	O	-1	15096016
and	O	-1	15096016
on@@	O	-1	15096016
-@@	O	-1	15096016
of@@	O	-1	15096016
f	O	-1	15096016
f@@	O	-1	15096016
l@@	O	-1	15096016
uc@@	O	-1	15096016
tu@@	O	-1	15096016
ations.	O	-1	15096016
P@@	O	-1	15096016
all@@	O	-1	15096016
idal	O	-1	15096016
stimulation	O	-1	15096016
impro@@	O	-1	15096016
v@@	O	-1	15096016
es	O	-1	15096016
brady@@	B-Disease	D018476	15096016
kine@@	I-Disease	-1	15096016
sia	I-Disease	-1	15096016
and	O	-1	15096016
rig@@	B-Disease	D009127	15096016
idity	I-Disease	-1	15096016
to	O	-1	15096016
a	O	-1	15096016
min@@	O	-1	15096016
or	O	-1	15096016
ext@@	O	-1	15096016
ent@@	O	-1	15096016
;	O	-1	15096016
however,	O	-1	15096016
its	O	-1	15096016
st@@	O	-1	15096016
ren@@	O	-1	15096016
g@@	O	-1	15096016
th	O	-1	15096016
se@@	O	-1	15096016
em@@	O	-1	15096016
s	O	-1	15096016
to	O	-1	15096016
be	O	-1	15096016
in	O	-1	15096016
impro@@	O	-1	15096016
ving	O	-1	15096016
levo@@	B-Chemical	D007980	15096016
dopa	I-Chemical	-1	15096016
-induced	O	-1	15096016
dyskine@@	B-Disease	D004409	15096016
si@@	I-Disease	-1	15096016
as	I-Disease	-1	15096016
.	O	-1	15096016
S@@	O	-1	15096016
tim@@	O	-1	15096016
ulation	O	-1	15096016
often	O	-1	15096016
produc@@	O	-1	15096016
es	O	-1	15096016
an	O	-1	15096016
impro@@	O	-1	15096016
vement	O	-1	15096016
in	O	-1	15096016
the	O	-1	15096016
hyper@@	B-Disease	D006948	15096016
-	I-Disease	-1	15096016
or	I-Disease	-1	15096016
dyskine@@	I-Disease	-1	15096016
tic	I-Disease	-1	15096016
hyper@@	B-Disease	D004409	15096016
-	I-Disease	-1	15096016
or	I-Disease	-1	15096016
dyskine@@	I-Disease	-1	15096016
tic	I-Disease	-1	15096016
up@@	O	-1	15096016
per	O	-1	15096016
lim@@	O	-1	15096016
b@@	O	-1	15096016
s,	O	-1	15096016
but	O	-1	15096016
increases	O	-1	15096016
the	O	-1	15096016
"@@	O	-1	15096016
f@@	O	-1	15096016
re@@	O	-1	15096016
e@@	O	-1	15096016
z@@	O	-1	15096016
ing@@	O	-1	15096016
"	O	-1	15096016
phen@@	O	-1	15096016
om@@	O	-1	15096016
en@@	O	-1	15096016
on	O	-1	15096016
in	O	-1	15096016
the	O	-1	15096016
lower	O	-1	15096016
lim@@	O	-1	15096016
b@@	O	-1	15096016
s	O	-1	15096016
at	O	-1	15096016
the	O	-1	15096016
same	O	-1	15096016
ti@@	O	-1	15096016
me.	O	-1	15096016
Con@@	O	-1	15096016
si@@	O	-1	15096016
der@@	O	-1	15096016
ing	O	-1	15096016
the	O	-1	15096016
sm@@	O	-1	15096016
all	O	-1	15096016
increase	O	-1	15096016
in	O	-1	15096016
the	O	-1	15096016
patient@@	O	-1	15096016
's	O	-1	15096016
in@@	O	-1	15096016
depend@@	O	-1	15096016
ence@@	O	-1	15096016
,	O	-1	15096016
the	O	-1	15096016
high	O	-1	15096016
co@@	O	-1	15096016
st@@	O	-1	15096016
s	O	-1	15096016
of	O	-1	15096016
bil@@	O	-1	15096016
ateral	O	-1	15096016
im@@	O	-1	15096016
pl@@	O	-1	15096016
ant@@	O	-1	15096016
s,	O	-1	15096016
and	O	-1	15096016
the	O	-1	15096016
diff@@	O	-1	15096016
ic@@	O	-1	15096016
ult@@	O	-1	15096016
y	O	-1	15096016
most	O	-1	15096016
patients	O	-1	15096016
experi@@	O	-1	15096016
ence	O	-1	15096016
in	O	-1	15096016
h@@	O	-1	15096016
and@@	O	-1	15096016
l@@	O	-1	15096016
ing	O	-1	15096016
the	O	-1	15096016
de@@	O	-1	15096016
v@@	O	-1	15096016
ic@@	O	-1	15096016
es,	O	-1	15096016
the	O	-1	15096016
qu@@	O	-1	15096016
es@@	O	-1	15096016
tion	O	-1	15096016
ari@@	O	-1	15096016
ses	O	-1	15096016
as	O	-1	15096016
to	O	-1	15096016
whether	O	-1	15096016
bil@@	O	-1	15096016
ateral	O	-1	15096016
p@@	O	-1	15096016
all@@	O	-1	15096016
idal	O	-1	15096016
stimulation	O	-1	15096016
is	O	-1	15096016
a	O	-1	15096016
re@@	O	-1	15096016
al	O	-1	15096016
al@@	O	-1	15096016
tern@@	O	-1	15096016
ative	O	-1	15096016
to	O	-1	15096016
p@@	O	-1	15096016
all@@	O	-1	15096016
id@@	O	-1	15096016
ot@@	O	-1	15096016
om@@	O	-1	15096016
y.	O	-1	15096016

C@@	O	-1	12734532
ase	O	-1	12734532
repor@@	O	-1	12734532
t@@	O	-1	12734532
:	O	-1	12734532
D@@	B-Chemical	D010665	12734532
ex@@	I-Chemical	-1	12734532
atri@@	I-Chemical	-1	12734532
m	I-Chemical	-1	12734532
(	O	-1	12734532
Ph@@	B-Chemical	D010665	12734532
en@@	I-Chemical	-1	12734532
yl@@	I-Chemical	-1	12734532
prop@@	I-Chemical	-1	12734532
an@@	I-Chemical	-1	12734532
ol@@	I-Chemical	-1	12734532
amine	I-Chemical	-1	12734532
)	O	-1	12734532
as	O	-1	12734532
a	O	-1	12734532
cause	O	-1	12734532
of	O	-1	12734532
myocardial	B-Disease	D009203	12734532
infarction	I-Disease	-1	12734532
.	O	-1	12734532
Ph@@	B-Chemical	D010665	12734532
en@@	I-Chemical	-1	12734532
yl@@	I-Chemical	-1	12734532
prop@@	I-Chemical	-1	12734532
an@@	I-Chemical	-1	12734532
ol@@	I-Chemical	-1	12734532
amine	I-Chemical	-1	12734532
(	O	-1	12734532
P@@	B-Chemical	D010665	12734532
P@@	I-Chemical	-1	12734532
A	I-Chemical	-1	12734532
)	O	-1	12734532
is	O	-1	12734532
a	O	-1	12734532
sym@@	O	-1	12734532
pa@@	O	-1	12734532
thetic	O	-1	12734532
amine	B-Chemical	D000588	12734532
used	O	-1	12734532
in	O	-1	12734532
over@@	O	-1	12734532
-@@	O	-1	12734532
the@@	O	-1	12734532
-@@	O	-1	12734532
coun@@	O	-1	12734532
ter	O	-1	12734532
co@@	O	-1	12734532
l@@	O	-1	12734532
d	O	-1	12734532
re@@	O	-1	12734532
medi@@	O	-1	12734532
es	O	-1	12734532
and	O	-1	12734532
weigh@@	O	-1	12734532
t-@@	O	-1	12734532
control	O	-1	12734532
pre@@	O	-1	12734532
par@@	O	-1	12734532
ations	O	-1	12734532
wor@@	O	-1	12734532
l@@	O	-1	12734532
d@@	O	-1	12734532
wi@@	O	-1	12734532
de@@	O	-1	12734532
.	O	-1	12734532
I@@	O	-1	12734532
ts	O	-1	12734532
use	O	-1	12734532
has	O	-1	12734532
been	O	-1	12734532
associated	O	-1	12734532
with	O	-1	12734532
hypertensive	B-Disease	D006973	12734532
episo@@	O	-1	12734532
des	O	-1	12734532
and	O	-1	12734532
hemorrh@@	B-Disease	D006470	12734532
ag@@	I-Disease	-1	12734532
ic	I-Disease	-1	12734532
strok@@	I-Disease	-1	12734532
es	I-Disease	-1	12734532
hemorrh@@	B-Disease	D020521	12734532
ag@@	I-Disease	-1	12734532
ic	I-Disease	-1	12734532
strok@@	I-Disease	-1	12734532
es	I-Disease	-1	12734532
in	O	-1	12734532
youn@@	O	-1	12734532
g@@	O	-1	12734532
er	O	-1	12734532
wom@@	O	-1	12734532
en@@	O	-1	12734532
.	O	-1	12734532
S@@	O	-1	12734532
e@@	O	-1	12734532
ver@@	O	-1	12734532
al	O	-1	12734532
reports	O	-1	12734532
have	O	-1	12734532
lin@@	O	-1	12734532
ked	O	-1	12734532
the	O	-1	12734532
ab@@	O	-1	12734532
use	O	-1	12734532
of	O	-1	12734532
P@@	B-Chemical	D010665	12734532
P@@	I-Chemical	-1	12734532
A	I-Chemical	-1	12734532
with	O	-1	12734532
myocardial	B-Disease	D009202	12734532
injury	I-Disease	-1	12734532
,	O	-1	12734532
es@@	O	-1	12734532
p@@	O	-1	12734532
ec@@	O	-1	12734532
i@@	O	-1	12734532
ally	O	-1	12734532
when	O	-1	12734532
over@@	B-Disease	D062787	12734532
dose	I-Disease	-1	12734532
is	O	-1	12734532
invol@@	O	-1	12734532
ved.	O	-1	12734532
We	O	-1	12734532
report	O	-1	12734532
h@@	O	-1	12734532
ere	O	-1	12734532
the	O	-1	12734532
first	O	-1	12734532
case	O	-1	12734532
of	O	-1	12734532
D@@	B-Chemical	D010665	12734532
ex@@	I-Chemical	-1	12734532
atri@@	I-Chemical	-1	12734532
m	I-Chemical	-1	12734532
(	O	-1	12734532
P@@	B-Chemical	D010665	12734532
P@@	I-Chemical	-1	12734532
A	I-Chemical	-1	12734532
)@@	O	-1	12734532
-induced	O	-1	12734532
myocardial	B-Disease	D009202	12734532
injury	I-Disease	-1	12734532
in	O	-1	12734532
a	O	-1	12734532
youn@@	O	-1	12734532
g	O	-1	12734532
woman	O	-1	12734532
who	O	-1	12734532
was	O	-1	12734532
using	O	-1	12734532
it	O	-1	12734532
at	O	-1	12734532
recomm@@	O	-1	12734532
en@@	O	-1	12734532
ded	O	-1	12734532
doses	O	-1	12734532
for	O	-1	12734532
weight	O	-1	12734532
control@@	O	-1	12734532
.	O	-1	12734532
In	O	-1	12734532
addi@@	O	-1	12734532
tion,	O	-1	12734532
we	O	-1	12734532
revie@@	O	-1	12734532
w	O	-1	12734532
the	O	-1	12734532
7	O	-1	12734532
other	O	-1	12734532
cases	O	-1	12734532
of	O	-1	12734532
P@@	B-Chemical	D010665	12734532
P@@	I-Chemical	-1	12734532
A	I-Chemical	-1	12734532
related	O	-1	12734532
myocardial	B-Disease	D009202	12734532
injury	I-Disease	-1	12734532
that	O	-1	12734532
have	O	-1	12734532
been	O	-1	12734532
reported	O	-1	12734532
so	O	-1	12734532
far@@	O	-1	12734532
.	O	-1	12734532
P@@	O	-1	12734532
hy@@	O	-1	12734532
si@@	O	-1	12734532
ci@@	O	-1	12734532
ans	O	-1	12734532
and	O	-1	12734532
patients	O	-1	12734532
should	O	-1	12734532
be	O	-1	12734532
al@@	O	-1	12734532
er@@	O	-1	12734532
t	O	-1	12734532
to	O	-1	12734532
the	O	-1	12734532
potential	O	-1	12734532
cardiac	O	-1	12734532
risk	O	-1	12734532
associated	O	-1	12734532
with	O	-1	12734532
the	O	-1	12734532
use	O	-1	12734532
of	O	-1	12734532
P@@	B-Chemical	D010665	12734532
P@@	I-Chemical	-1	12734532
A	I-Chemical	-1	12734532
,	O	-1	12734532
even	O	-1	12734532
at	O	-1	12734532
doses	O	-1	12734532
gener@@	O	-1	12734532
ally	O	-1	12734532
considered	O	-1	12734532
to	O	-1	12734532
be	O	-1	12734532
saf@@	O	-1	12734532
e.	O	-1	12734532

R@@	B-Chemical	D018967	12013711
is@@	I-Chemical	-1	12013711
perid@@	I-Chemical	-1	12013711
one	I-Chemical	-1	12013711
-@@	O	-1	12013711
associ@@	O	-1	12013711
at@@	O	-1	12013711
ed,	O	-1	12013711
ben@@	O	-1	12013711
ig@@	O	-1	12013711
n	O	-1	12013711
transi@@	O	-1	12013711
ent	O	-1	12013711
visual	B-Disease	D010468	12013711
dist@@	I-Disease	-1	12013711
urb@@	I-Disease	-1	12013711
anc@@	I-Disease	-1	12013711
es	I-Disease	-1	12013711
in	O	-1	12013711
sch@@	B-Disease	D012559	12013711
iz@@	I-Disease	-1	12013711
oph@@	I-Disease	-1	12013711
ren@@	I-Disease	-1	12013711
ic	I-Disease	-1	12013711
patients	O	-1	12013711
with	O	-1	12013711
a	O	-1	12013711
p@@	O	-1	12013711
ast	O	-1	12013711
hist@@	O	-1	12013711
ory	O	-1	12013711
of	O	-1	12013711
L@@	B-Chemical	D008238	12013711
S@@	I-Chemical	-1	12013711
D	I-Chemical	-1	12013711
ab@@	O	-1	12013711
use.	O	-1	12013711
Two	O	-1	12013711
sch@@	B-Disease	D012559	12013711
iz@@	I-Disease	-1	12013711
oph@@	I-Disease	-1	12013711
ren@@	I-Disease	-1	12013711
ic	I-Disease	-1	12013711
patients,	O	-1	12013711
who	O	-1	12013711
had	O	-1	12013711
a	O	-1	12013711
prior	O	-1	12013711
hist@@	O	-1	12013711
ory	O	-1	12013711
of	O	-1	12013711
L@@	B-Chemical	D008238	12013711
S@@	I-Chemical	-1	12013711
D	I-Chemical	-1	12013711
ab@@	O	-1	12013711
use	O	-1	12013711
and	O	-1	12013711
who	O	-1	12013711
had	O	-1	12013711
previously	O	-1	12013711
developed	O	-1	12013711
EP@@	B-Disease	D001480	12013711
S	I-Disease	-1	12013711
with	O	-1	12013711
cl@@	O	-1	12013711
as@@	O	-1	12013711
sic	O	-1	12013711
anti@@	O	-1	12013711
psycho@@	O	-1	12013711
tic@@	O	-1	12013711
s,	O	-1	12013711
were	O	-1	12013711
suc@@	O	-1	12013711
cess@@	O	-1	12013711
ful@@	O	-1	12013711
ly	O	-1	12013711
treated	O	-1	12013711
with	O	-1	12013711
ris@@	B-Chemical	D018967	12013711
perid@@	I-Chemical	-1	12013711
one	I-Chemical	-1	12013711
.	O	-1	12013711
The@@	O	-1	12013711
y	O	-1	12013711
both	O	-1	12013711
reported	O	-1	12013711
sh@@	O	-1	12013711
ort	O	-1	12013711
episo@@	O	-1	12013711
des	O	-1	12013711
of	O	-1	12013711
transi@@	O	-1	12013711
ent	O	-1	12013711
visual	B-Disease	D010468	12013711
dist@@	I-Disease	-1	12013711
urb@@	I-Disease	-1	12013711
anc@@	I-Disease	-1	12013711
es	I-Disease	-1	12013711
,	O	-1	12013711
which	O	-1	12013711
appe@@	O	-1	12013711
a@@	O	-1	12013711
red	O	-1	12013711
immedi@@	O	-1	12013711
ately	O	-1	12013711
after	O	-1	12013711
star@@	O	-1	12013711
ting	O	-1	12013711
treatment	O	-1	12013711
with	O	-1	12013711
ris@@	B-Chemical	D018967	12013711
perid@@	I-Chemical	-1	12013711
one	I-Chemical	-1	12013711
.	O	-1	12013711
This	O	-1	12013711
imag@@	O	-1	12013711
er@@	O	-1	12013711
y	O	-1	12013711
re@@	O	-1	12013711
se@@	O	-1	12013711
m@@	O	-1	12013711
bl@@	O	-1	12013711
ed	O	-1	12013711
visual	B-Disease	D010468	12013711
dist@@	I-Disease	-1	12013711
urb@@	I-Disease	-1	12013711
anc@@	I-Disease	-1	12013711
es	I-Disease	-1	12013711
previously	O	-1	12013711
experienced	O	-1	12013711
as	O	-1	12013711
"@@	O	-1	12013711
f@@	O	-1	12013711
las@@	O	-1	12013711
h@@	O	-1	12013711
bac@@	O	-1	12013711
k@@	O	-1	12013711
s@@	O	-1	12013711
"	O	-1	12013711
related	O	-1	12013711
to	O	-1	12013711
prior	O	-1	12013711
L@@	B-Chemical	D008238	12013711
S@@	I-Chemical	-1	12013711
D	I-Chemical	-1	12013711
consum@@	O	-1	12013711
p@@	O	-1	12013711
tion.	O	-1	12013711
R@@	B-Chemical	D018967	12013711
is@@	I-Chemical	-1	12013711
perid@@	I-Chemical	-1	12013711
one	I-Chemical	-1	12013711
administration	O	-1	12013711
was	O	-1	12013711
continu@@	O	-1	12013711
ed	O	-1	12013711
and	O	-1	12013711
the	O	-1	12013711
visual	B-Disease	D010468	12013711
dist@@	I-Disease	-1	12013711
urb@@	I-Disease	-1	12013711
anc@@	I-Disease	-1	12013711
es	I-Disease	-1	12013711
gra@@	O	-1	12013711
du@@	O	-1	12013711
ally	O	-1	12013711
wor@@	O	-1	12013711
e	O	-1	12013711
o@@	O	-1	12013711
ff@@	O	-1	12013711
.	O	-1	12013711
D@@	O	-1	12013711
uring	O	-1	12013711
a	O	-1	12013711
si@@	O	-1	12013711
x@@	O	-1	12013711
-@@	O	-1	12013711
mon@@	O	-1	12013711
th	O	-1	12013711
follow-up	O	-1	12013711
perio@@	O	-1	12013711
d,	O	-1	12013711
there	O	-1	12013711
was	O	-1	12013711
no	O	-1	12013711
recur@@	O	-1	12013711
rence	O	-1	12013711
of	O	-1	12013711
visual	B-Disease	D010468	12013711
dist@@	I-Disease	-1	12013711
urb@@	I-Disease	-1	12013711
anc@@	I-Disease	-1	12013711
es	I-Disease	-1	12013711
.	O	-1	12013711
This	O	-1	12013711
phen@@	O	-1	12013711
om@@	O	-1	12013711
en@@	O	-1	12013711
on	O	-1	12013711
may	O	-1	12013711
be	O	-1	12013711
inter@@	O	-1	12013711
pre@@	O	-1	12013711
ted	O	-1	12013711
as	O	-1	12013711
a	O	-1	12013711
ben@@	O	-1	12013711
i@@	O	-1	12013711
gn@@	O	-1	12013711
,	O	-1	12013711
sh@@	O	-1	12013711
ort@@	O	-1	12013711
-term	O	-1	12013711
and	O	-1	12013711
sel@@	O	-1	12013711
f@@	O	-1	12013711
-@@	O	-1	12013711
lim@@	O	-1	12013711
it@@	O	-1	12013711
ing	O	-1	12013711
side	O	-1	12013711
effect	O	-1	12013711
which	O	-1	12013711
does	O	-1	12013711
not	O	-1	12013711
contra@@	O	-1	12013711
indicate	O	-1	12013711
the	O	-1	12013711
use	O	-1	12013711
of	O	-1	12013711
ris@@	B-Chemical	D018967	12013711
perid@@	I-Chemical	-1	12013711
one	I-Chemical	-1	12013711
or	O	-1	12013711
inter@@	O	-1	12013711
f@@	O	-1	12013711
ere	O	-1	12013711
with	O	-1	12013711
treatment.	O	-1	12013711
Con@@	O	-1	12013711
cl@@	O	-1	12013711
u@@	O	-1	12013711
sions	O	-1	12013711
bas@@	O	-1	12013711
ed	O	-1	12013711
on	O	-1	12013711
two	O	-1	12013711
case	O	-1	12013711
reports	O	-1	12013711
should	O	-1	12013711
be	O	-1	12013711
tak@@	O	-1	12013711
en	O	-1	12013711
with	O	-1	12013711
appro@@	O	-1	12013711
pri@@	O	-1	12013711
ate	O	-1	12013711
cau@@	O	-1	12013711
tion.	O	-1	12013711

Ac@@	O	-1	11861791
tiv@@	O	-1	11861791
ation	O	-1	11861791
of	O	-1	11861791
poly@@	B-Chemical	D011064	11861791
(A@@	I-Chemical	-1	11861791
D@@	I-Chemical	-1	11861791
P@@	I-Chemical	-1	11861791
-@@	I-Chemical	-1	11861791
ri@@	I-Chemical	-1	11861791
bo@@	I-Chemical	-1	11861791
se@@	I-Chemical	-1	11861791
)	I-Chemical	-1	11861791
poly@@	O	-1	11861791
mer@@	O	-1	11861791
ase	O	-1	11861791
cont@@	O	-1	11861791
ri@@	O	-1	11861791
but@@	O	-1	11861791
es	O	-1	11861791
to	O	-1	11861791
development	O	-1	11861791
of	O	-1	11861791
dox@@	B-Chemical	D004317	11861791
orub@@	I-Chemical	-1	11861791
icin	I-Chemical	-1	11861791
-induced	O	-1	11861791
heart	B-Disease	D006333	11861791
failure	I-Disease	-1	11861791
.	O	-1	11861791
Ac@@	O	-1	11861791
tiv@@	O	-1	11861791
ation	O	-1	11861791
of	O	-1	11861791
the	O	-1	11861791
nucle@@	O	-1	11861791
ar	O	-1	11861791
enzyme	O	-1	11861791
poly@@	B-Chemical	D011064	11861791
(A@@	I-Chemical	-1	11861791
D@@	I-Chemical	-1	11861791
P@@	I-Chemical	-1	11861791
-@@	I-Chemical	-1	11861791
ri@@	I-Chemical	-1	11861791
bo@@	I-Chemical	-1	11861791
se@@	I-Chemical	-1	11861791
)	I-Chemical	-1	11861791
poly@@	O	-1	11861791
mer@@	O	-1	11861791
ase	O	-1	11861791
(@@	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P)	O	-1	11861791
by	O	-1	11861791
oxid@@	O	-1	11861791
ant@@	O	-1	11861791
-@@	O	-1	11861791
mediated	O	-1	11861791
D@@	O	-1	11861791
NA	O	-1	11861791
damage	O	-1	11861791
is	O	-1	11861791
an	O	-1	11861791
important	O	-1	11861791
path@@	O	-1	11861791
w@@	O	-1	11861791
ay	O	-1	11861791
of	O	-1	11861791
cell	O	-1	11861791
dysfunction	O	-1	11861791
and	O	-1	11861791
tissue	O	-1	11861791
injury	O	-1	11861791
in	O	-1	11861791
condi@@	O	-1	11861791
tions	O	-1	11861791
associated	O	-1	11861791
with	O	-1	11861791
oxid@@	O	-1	11861791
ative	O	-1	11861791
stres@@	O	-1	11861791
s.	O	-1	11861791
In@@	O	-1	11861791
c@@	O	-1	11861791
reas@@	O	-1	11861791
ed	O	-1	11861791
oxid@@	O	-1	11861791
ative	O	-1	11861791
stres@@	O	-1	11861791
s	O	-1	11861791
is	O	-1	11861791
a	O	-1	11861791
major	O	-1	11861791
factor	O	-1	11861791
implic@@	O	-1	11861791
ated	O	-1	11861791
in	O	-1	11861791
the	O	-1	11861791
cardi@@	B-Disease	D066126	11861791
otoxicity	I-Disease	-1	11861791
of	O	-1	11861791
dox@@	B-Chemical	D004317	11861791
orub@@	I-Chemical	-1	11861791
icin	I-Chemical	-1	11861791
(	O	-1	11861791
DO@@	B-Chemical	D004317	11861791
X	I-Chemical	-1	11861791
),	O	-1	11861791
a	O	-1	11861791
wi@@	O	-1	11861791
de@@	O	-1	11861791
ly	O	-1	11861791
used	O	-1	11861791
anti@@	O	-1	11861791
tumor	O	-1	11861791
an@@	B-Chemical	D018943	11861791
th@@	I-Chemical	-1	11861791
rac@@	I-Chemical	-1	11861791
y@@	I-Chemical	-1	11861791
cl@@	I-Chemical	-1	11861791
ine	I-Chemical	-1	11861791
anti@@	O	-1	11861791
bio@@	O	-1	11861791
tic@@	O	-1	11861791
.	O	-1	11861791
Th@@	O	-1	11861791
us,	O	-1	11861791
we	O	-1	11861791
hypo@@	O	-1	11861791
the@@	O	-1	11861791
si@@	O	-1	11861791
zed	O	-1	11861791
that	O	-1	11861791
the	O	-1	11861791
activation	O	-1	11861791
of	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P	O	-1	11861791
may	O	-1	11861791
cont@@	O	-1	11861791
rib@@	O	-1	11861791
ute	O	-1	11861791
to	O	-1	11861791
the	O	-1	11861791
DO@@	B-Chemical	D004317	11861791
X	I-Chemical	-1	11861791
-induced	O	-1	11861791
cardi@@	B-Disease	D066126	11861791
otoxicity	I-Disease	-1	11861791
.	O	-1	11861791
U@@	O	-1	11861791
s@@	O	-1	11861791
ing	O	-1	11861791
a	O	-1	11861791
du@@	O	-1	11861791
al	O	-1	11861791
appro@@	O	-1	11861791
ach	O	-1	11861791
of	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P@@	O	-1	11861791
-1	O	-1	11861791
sup@@	O	-1	11861791
pres@@	O	-1	11861791
sion,	O	-1	11861791
by	O	-1	11861791
gene@@	O	-1	11861791
tic	O	-1	11861791
de@@	O	-1	11861791
le@@	O	-1	11861791
tion	O	-1	11861791
or	O	-1	11861791
pharmac@@	O	-1	11861791
ological	O	-1	11861791
inhibition	O	-1	11861791
with	O	-1	11861791
the	O	-1	11861791
phen@@	O	-1	11861791
an@@	O	-1	11861791
th@@	O	-1	11861791
ri@@	O	-1	11861791
d@@	O	-1	11861791
in@@	O	-1	11861791
one	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P	O	-1	11861791
inhibitor	O	-1	11861791
P@@	B-Chemical	C434926	11861791
J@@	I-Chemical	-1	11861791
3@@	I-Chemical	-1	11861791
4	I-Chemical	-1	11861791
,	O	-1	11861791
we	O	-1	11861791
no@@	O	-1	11861791
w	O	-1	11861791
demon@@	O	-1	11861791
st@@	O	-1	11861791
rate	O	-1	11861791
the	O	-1	11861791
role	O	-1	11861791
of	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P	O	-1	11861791
in	O	-1	11861791
the	O	-1	11861791
development	O	-1	11861791
of	O	-1	11861791
cardiac	B-Disease	D006331	11861791
dysfunction	I-Disease	-1	11861791
induced	O	-1	11861791
by	O	-1	11861791
DO@@	B-Chemical	D004317	11861791
X	I-Chemical	-1	11861791
.	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P@@	O	-1	11861791
-1@@	O	-1	11861791
+/@@	O	-1	11861791
+	O	-1	11861791
and	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P@@	O	-1	11861791
-1@@	O	-1	11861791
-@@	O	-1	11861791
/@@	O	-1	11861791
-	O	-1	11861791
mice	O	-1	11861791
received	O	-1	11861791
a	O	-1	11861791
single	O	-1	11861791
injection	O	-1	11861791
of	O	-1	11861791
DO@@	B-Chemical	D004317	11861791
X	I-Chemical	-1	11861791
(2@@	O	-1	11861791
5	O	-1	11861791
mg/kg	O	-1	11861791
i.@@	O	-1	11861791
p@@	O	-1	11861791
).	O	-1	11861791
F@@	O	-1	11861791
i@@	O	-1	11861791
ve	O	-1	11861791
days	O	-1	11861791
after	O	-1	11861791
DO@@	B-Chemical	D004317	11861791
X	I-Chemical	-1	11861791
administr@@	O	-1	11861791
ation,	O	-1	11861791
left	O	-1	11861791
ventricular	O	-1	11861791
perform@@	O	-1	11861791
ance	O	-1	11861791
was	O	-1	11861791
significantly	O	-1	11861791
depress@@	O	-1	11861791
ed	O	-1	11861791
in	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P@@	O	-1	11861791
-1@@	O	-1	11861791
+/@@	O	-1	11861791
+	O	-1	11861791
mic@@	O	-1	11861791
e,	O	-1	11861791
but	O	-1	11861791
only	O	-1	11861791
to	O	-1	11861791
a	O	-1	11861791
sm@@	O	-1	11861791
all@@	O	-1	11861791
er	O	-1	11861791
ext@@	O	-1	11861791
ent	O	-1	11861791
in	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P@@	O	-1	11861791
-1@@	O	-1	11861791
-@@	O	-1	11861791
/@@	O	-1	11861791
-	O	-1	11861791
on@@	O	-1	11861791
es.	O	-1	11861791
S@@	O	-1	11861791
im@@	O	-1	11861791
il@@	O	-1	11861791
ar	O	-1	11861791
experim@@	O	-1	11861791
ents	O	-1	11861791
were	O	-1	11861791
con@@	O	-1	11861791
duc@@	O	-1	11861791
ted	O	-1	11861791
in	O	-1	11861791
BA@@	O	-1	11861791
L@@	O	-1	11861791
B@@	O	-1	11861791
/@@	O	-1	11861791
c	O	-1	11861791
mice	O	-1	11861791
treated	O	-1	11861791
with	O	-1	11861791
P@@	B-Chemical	C434926	11861791
J@@	I-Chemical	-1	11861791
3@@	I-Chemical	-1	11861791
4	I-Chemical	-1	11861791
or	O	-1	11861791
ve@@	O	-1	11861791
h@@	O	-1	11861791
ic@@	O	-1	11861791
le@@	O	-1	11861791
.	O	-1	11861791
Treat@@	O	-1	11861791
ment	O	-1	11861791
with	O	-1	11861791
a	O	-1	11861791
P@@	B-Chemical	C434926	11861791
J@@	I-Chemical	-1	11861791
3@@	I-Chemical	-1	11861791
4	I-Chemical	-1	11861791
significantly	O	-1	11861791
improved	O	-1	11861791
cardiac	B-Disease	D006331	11861791
dysfunction	I-Disease	-1	11861791
and	O	-1	11861791
increased	O	-1	11861791
the	O	-1	11861791
sur@@	O	-1	11861791
viv@@	O	-1	11861791
al	O	-1	11861791
of	O	-1	11861791
the	O	-1	11861791
anim@@	O	-1	11861791
al@@	O	-1	11861791
s.	O	-1	11861791
In	O	-1	11861791
addition	O	-1	11861791
P@@	B-Chemical	C434926	11861791
J@@	I-Chemical	-1	11861791
3@@	I-Chemical	-1	11861791
4	I-Chemical	-1	11861791
significantly	O	-1	11861791
reduced	O	-1	11861791
the	O	-1	11861791
DO@@	B-Chemical	D004317	11861791
X	I-Chemical	-1	11861791
-induced	O	-1	11861791
increase	O	-1	11861791
in	O	-1	11861791
the	O	-1	11861791
serum	O	-1	11861791
l@@	B-Chemical	D019344	11861791
act@@	I-Chemical	-1	11861791
ate	I-Chemical	-1	11861791
de@@	O	-1	11861791
hydro@@	O	-1	11861791
gen@@	O	-1	11861791
ase	O	-1	11861791
and	O	-1	11861791
creat@@	B-Chemical	D003401	11861791
ine	I-Chemical	-1	11861791
kin@@	O	-1	11861791
ase	O	-1	11861791
ac@@	O	-1	11861791
ti@@	O	-1	11861791
vi@@	O	-1	11861791
ties	O	-1	11861791
but	O	-1	11861791
not	O	-1	11861791
met@@	O	-1	11861791
al@@	O	-1	11861791
lo@@	O	-1	11861791
protein@@	O	-1	11861791
ase	O	-1	11861791
activation	O	-1	11861791
in	O	-1	11861791
the	O	-1	11861791
hear@@	O	-1	11861791
t.	O	-1	11861791
Th@@	O	-1	11861791
us,	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P	O	-1	11861791
activation	O	-1	11861791
cont@@	O	-1	11861791
ri@@	O	-1	11861791
but@@	O	-1	11861791
es	O	-1	11861791
to	O	-1	11861791
the	O	-1	11861791
cardi@@	B-Disease	D066126	11861791
otoxicity	I-Disease	-1	11861791
of	O	-1	11861791
DO@@	B-Chemical	D004317	11861791
X	I-Chemical	-1	11861791
.	O	-1	11861791
PA@@	O	-1	11861791
R@@	O	-1	11861791
P	O	-1	11861791
inhibitors	O	-1	11861791
may	O	-1	11861791
ex@@	O	-1	11861791
er@@	O	-1	11861791
t	O	-1	11861791
protective	O	-1	11861791
effects	O	-1	11861791
against	O	-1	11861791
the	O	-1	11861791
development	O	-1	11861791
of	O	-1	11861791
severe	O	-1	11861791
cardiac	B-Disease	D005117	11861791
complications	I-Disease	-1	11861791
associated	O	-1	11861791
with	O	-1	11861791
the	O	-1	11861791
DO@@	B-Chemical	D004317	11861791
X	I-Chemical	-1	11861791
treatment.	O	-1	11861791

F@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
-induced	O	-1	11302406
t@@	B-Disease	D016171	11302406
or@@	I-Disease	-1	11302406
s@@	I-Disease	-1	11302406
ade	I-Disease	-1	11302406
de	I-Disease	-1	11302406
po@@	I-Disease	-1	11302406
int@@	I-Disease	-1	11302406
es	I-Disease	-1	11302406
.	O	-1	11302406
OBJECTIVE:	O	-1	11302406
To	O	-1	11302406
present	O	-1	11302406
a	O	-1	11302406
case	O	-1	11302406
of	O	-1	11302406
f@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
-@@	O	-1	11302406
associated	O	-1	11302406
t@@	B-Disease	D016171	11302406
or@@	I-Disease	-1	11302406
s@@	I-Disease	-1	11302406
ade	I-Disease	-1	11302406
de	I-Disease	-1	11302406
po@@	I-Disease	-1	11302406
int@@	I-Disease	-1	11302406
es	I-Disease	-1	11302406
(	O	-1	11302406
T@@	B-Disease	D016171	11302406
D@@	I-Disease	-1	11302406
P	I-Disease	-1	11302406
)	O	-1	11302406
and	O	-1	11302406
discus@@	O	-1	11302406
s	O	-1	11302406
f@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
's	O	-1	11302406
role	O	-1	11302406
in	O	-1	11302406
ca@@	O	-1	11302406
using	O	-1	11302406
T@@	B-Disease	D016171	11302406
D@@	I-Disease	-1	11302406
P	I-Disease	-1	11302406
.	O	-1	11302406
CA@@	O	-1	11302406
S@@	O	-1	11302406
E	O	-1	11302406
S@@	O	-1	11302406
U@@	O	-1	11302406
M@@	O	-1	11302406
MA@@	O	-1	11302406
R@@	O	-1	11302406
Y@@	O	-1	11302406
:	O	-1	11302406
A	O	-1	11302406
6@@	O	-1	11302406
8@@	O	-1	11302406
-@@	O	-1	11302406
year-old	O	-1	11302406
wh@@	O	-1	11302406
ite	O	-1	11302406
woman	O	-1	11302406
with	O	-1	11302406
C@@	O	-1	11302406
an@@	O	-1	11302406
di@@	O	-1	11302406
d@@	O	-1	11302406
a	O	-1	11302406
gl@@	O	-1	11302406
ab@@	O	-1	11302406
rat@@	O	-1	11302406
a	O	-1	11302406
isol@@	O	-1	11302406
ated	O	-1	11302406
from	O	-1	11302406
a	O	-1	11302406
pres@@	O	-1	11302406
ac@@	O	-1	11302406
ral	O	-1	11302406
abs@@	O	-1	11302406
cess	O	-1	11302406
developed	O	-1	11302406
T@@	B-Disease	D016171	11302406
D@@	I-Disease	-1	11302406
P	I-Disease	-1	11302406
e@@	O	-1	11302406
ight	O	-1	11302406
days	O	-1	11302406
after	O	-1	11302406
comm@@	O	-1	11302406
enc@@	O	-1	11302406
ing	O	-1	11302406
oral	O	-1	11302406
f@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
The	O	-1	11302406
patient	O	-1	11302406
had	O	-1	11302406
no	O	-1	11302406
other	O	-1	11302406
risk	O	-1	11302406
factors	O	-1	11302406
for	O	-1	11302406
T@@	B-Disease	D016171	11302406
D@@	I-Disease	-1	11302406
P	I-Disease	-1	11302406
,	O	-1	11302406
including	O	-1	11302406
coronary	B-Disease	D003324	11302406
artery	I-Disease	-1	11302406
disease	I-Disease	-1	11302406
,	O	-1	11302406
cardi@@	B-Disease	D009202	11302406
om@@	I-Disease	-1	11302406
yo@@	I-Disease	-1	11302406
pathy	I-Disease	-1	11302406
,	O	-1	11302406
con@@	B-Disease	D006333	11302406
g@@	I-Disease	-1	11302406
es@@	I-Disease	-1	11302406
tive	I-Disease	-1	11302406
heart	I-Disease	-1	11302406
failure	I-Disease	-1	11302406
,	O	-1	11302406
and	O	-1	11302406
electro@@	O	-1	11302406
ly@@	O	-1	11302406
te	O	-1	11302406
abnormal@@	O	-1	11302406
ities	O	-1	11302406
There	O	-1	11302406
was	O	-1	11302406
a	O	-1	11302406
tempor@@	O	-1	11302406
al	O	-1	11302406
association	O	-1	11302406
between	O	-1	11302406
the	O	-1	11302406
initi@@	O	-1	11302406
ation	O	-1	11302406
of	O	-1	11302406
f@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
and	O	-1	11302406
T@@	B-Disease	D016171	11302406
D@@	I-Disease	-1	11302406
P	I-Disease	-1	11302406
.	O	-1	11302406
The	O	-1	11302406
T@@	B-Disease	D016171	11302406
D@@	I-Disease	-1	11302406
P	I-Disease	-1	11302406
resol@@	O	-1	11302406
ved	O	-1	11302406
when	O	-1	11302406
f@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
was	O	-1	11302406
discontinu@@	O	-1	11302406
ed@@	O	-1	11302406
;	O	-1	11302406
however,	O	-1	11302406
the	O	-1	11302406
patient	O	-1	11302406
continu@@	O	-1	11302406
ed	O	-1	11302406
to	O	-1	11302406
have	O	-1	11302406
pre@@	B-Disease	D018879	11302406
mat@@	I-Disease	-1	11302406
ure	I-Disease	-1	11302406
ventricular	I-Disease	-1	11302406
contrac@@	I-Disease	-1	11302406
tions	I-Disease	-1	11302406
and	O	-1	11302406
non@@	O	-1	11302406
su@@	O	-1	11302406
st@@	O	-1	11302406
ained	O	-1	11302406
ventricular	B-Disease	D017180	11302406
tachycardia	I-Disease	-1	11302406
(	O	-1	11302406
N@@	B-Disease	D017180	11302406
S@@	I-Disease	-1	11302406
V@@	I-Disease	-1	11302406
T	I-Disease	-1	11302406
)	O	-1	11302406
un@@	O	-1	11302406
ti@@	O	-1	11302406
l	O	-1	11302406
six	O	-1	11302406
days	O	-1	11302406
after	O	-1	11302406
drug	O	-1	11302406
cess@@	O	-1	11302406
ation	O	-1	11302406
D@@	O	-1	11302406
I@@	O	-1	11302406
S@@	O	-1	11302406
C@@	O	-1	11302406
US@@	O	-1	11302406
S@@	O	-1	11302406
ION@@	O	-1	11302406
:	O	-1	11302406
U@@	O	-1	11302406
se	O	-1	11302406
of	O	-1	11302406
the	O	-1	11302406
N@@	O	-1	11302406
ar@@	O	-1	11302406
an@@	O	-1	11302406
j@@	O	-1	11302406
o	O	-1	11302406
prob@@	O	-1	11302406
ability	O	-1	11302406
s@@	O	-1	11302406
cal@@	O	-1	11302406
e	O	-1	11302406
indic@@	O	-1	11302406
ates	O	-1	11302406
a	O	-1	11302406
prob@@	O	-1	11302406
able	O	-1	11302406
rel@@	O	-1	11302406
ationship	O	-1	11302406
between	O	-1	11302406
the	O	-1	11302406
use	O	-1	11302406
of	O	-1	11302406
f@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
and	O	-1	11302406
the	O	-1	11302406
development	O	-1	11302406
of	O	-1	11302406
T@@	B-Disease	D016171	11302406
D@@	I-Disease	-1	11302406
P	I-Disease	-1	11302406
.	O	-1	11302406
The	O	-1	11302406
possible	O	-1	11302406
mechanism	O	-1	11302406
is	O	-1	11302406
de@@	B-Disease	D003866	11302406
pression	I-Disease	-1	11302406
of	O	-1	11302406
ra@@	O	-1	11302406
pid@@	O	-1	11302406
ly	O	-1	11302406
activ@@	O	-1	11302406
ating	O	-1	11302406
del@@	O	-1	11302406
ayed	O	-1	11302406
rec@@	O	-1	11302406
ti@@	O	-1	11302406
fi@@	O	-1	11302406
er	O	-1	11302406
pot@@	B-Chemical	D011188	11302406
assi@@	I-Chemical	-1	11302406
um	I-Chemical	-1	11302406
cur@@	O	-1	11302406
ren@@	O	-1	11302406
t@@	O	-1	11302406
s.	O	-1	11302406
In	O	-1	11302406
our	O	-1	11302406
patient@@	O	-1	11302406
,	O	-1	11302406
there	O	-1	11302406
was	O	-1	11302406
no	O	-1	11302406
other	O	-1	11302406
e@@	O	-1	11302406
ti@@	O	-1	11302406
ology	O	-1	11302406
identi@@	O	-1	11302406
fied	O	-1	11302406
that	O	-1	11302406
could	O	-1	11302406
expl@@	O	-1	11302406
ain	O	-1	11302406
Q@@	B-Disease	D008133	11302406
T	I-Disease	-1	11302406
prolong@@	I-Disease	-1	11302406
ation	I-Disease	-1	11302406
or	O	-1	11302406
T@@	B-Disease	D016171	11302406
D@@	I-Disease	-1	11302406
P	I-Disease	-1	11302406
The	O	-1	11302406
complete	O	-1	11302406
dis@@	O	-1	11302406
appear@@	O	-1	11302406
ance	O	-1	11302406
of	O	-1	11302406
N@@	B-Disease	D017180	11302406
S@@	I-Disease	-1	11302406
V@@	I-Disease	-1	11302406
T	I-Disease	-1	11302406
and	O	-1	11302406
pre@@	B-Disease	D018879	11302406
mat@@	I-Disease	-1	11302406
ure	I-Disease	-1	11302406
ventricular	I-Disease	-1	11302406
contrac@@	I-Disease	-1	11302406
tions	I-Disease	-1	11302406
followed	O	-1	11302406
by	O	-1	11302406
normal@@	O	-1	11302406
ization	O	-1	11302406
of	O	-1	11302406
Q@@	O	-1	11302406
T	O	-1	11302406
interv@@	O	-1	11302406
al	O	-1	11302406
after	O	-1	11302406
the	O	-1	11302406
drug	O	-1	11302406
was	O	-1	11302406
sto@@	O	-1	11302406
pp@@	O	-1	11302406
ed	O	-1	11302406
st@@	O	-1	11302406
ron@@	O	-1	11302406
g@@	O	-1	11302406
ly	O	-1	11302406
suggests	O	-1	11302406
f@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
as	O	-1	11302406
the	O	-1	11302406
e@@	O	-1	11302406
ti@@	O	-1	11302406
olog@@	O	-1	11302406
y.	O	-1	11302406
CONCLUSIONS:	O	-1	11302406
Clin@@	O	-1	11302406
ici@@	O	-1	11302406
ans	O	-1	11302406
should	O	-1	11302406
be	O	-1	11302406
aw@@	O	-1	11302406
are	O	-1	11302406
that	O	-1	11302406
f@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
,	O	-1	11302406
even	O	-1	11302406
at	O	-1	11302406
low	O	-1	11302406
dos@@	O	-1	11302406
es,	O	-1	11302406
may	O	-1	11302406
cause	O	-1	11302406
prolong@@	B-Disease	D008133	11302406
ation	I-Disease	-1	11302406
of	I-Disease	-1	11302406
the	I-Disease	-1	11302406
Q@@	I-Disease	-1	11302406
T	I-Disease	-1	11302406
interv@@	I-Disease	-1	11302406
al	I-Disease	-1	11302406
,	O	-1	11302406
lead@@	O	-1	11302406
ing	O	-1	11302406
to	O	-1	11302406
T@@	B-Disease	D016171	11302406
D@@	I-Disease	-1	11302406
P	I-Disease	-1	11302406
.	O	-1	11302406
S@@	O	-1	11302406
er@@	O	-1	11302406
ial	O	-1	11302406
electro@@	O	-1	11302406
cardio@@	O	-1	11302406
graph@@	O	-1	11302406
ic	O	-1	11302406
monit@@	O	-1	11302406
or@@	O	-1	11302406
ing	O	-1	11302406
may	O	-1	11302406
be	O	-1	11302406
considered	O	-1	11302406
when	O	-1	11302406
f@@	B-Chemical	D015725	11302406
l@@	I-Chemical	-1	11302406
uc@@	I-Chemical	-1	11302406
on@@	I-Chemical	-1	11302406
azole	I-Chemical	-1	11302406
is	O	-1	11302406
administered	O	-1	11302406
in	O	-1	11302406
patients	O	-1	11302406
who	O	-1	11302406
are	O	-1	11302406
at	O	-1	11302406
risk	O	-1	11302406
for	O	-1	11302406
ventricular	B-Disease	D001145	11302406
arrhyth@@	I-Disease	-1	11302406
mi@@	I-Disease	-1	11302406
as	I-Disease	-1	11302406
.	O	-1	11302406

H@@	O	-1	11058428
igh@@	O	-1	11058428
-@@	O	-1	11058428
dose	O	-1	11058428
methyl@@	B-Chemical	D008775	11058428
pre@@	I-Chemical	-1	11058428
d@@	I-Chemical	-1	11058428
n@@	I-Chemical	-1	11058428
isol@@	I-Chemical	-1	11058428
one	I-Chemical	-1	11058428
may	O	-1	11058428
d@@	O	-1	11058428
o	O	-1	11058428
more	O	-1	11058428
h@@	O	-1	11058428
ar@@	O	-1	11058428
m	O	-1	11058428
for	O	-1	11058428
spinal	B-Disease	D013119	11058428
cor@@	I-Disease	-1	11058428
d	I-Disease	-1	11058428
injury	I-Disease	-1	11058428
.	O	-1	11058428
B@@	O	-1	11058428
ecause	O	-1	11058428
of	O	-1	11058428
the	O	-1	11058428
N@@	O	-1	11058428
ation@@	O	-1	11058428
al	O	-1	11058428
Ac@@	O	-1	11058428
ute	O	-1	11058428
S@@	B-Disease	D013119	11058428
p@@	I-Disease	-1	11058428
inal	I-Disease	-1	11058428
C@@	I-Disease	-1	11058428
or@@	I-Disease	-1	11058428
d	I-Disease	-1	11058428
In@@	I-Disease	-1	11058428
j@@	I-Disease	-1	11058428
ur@@	I-Disease	-1	11058428
y	I-Disease	-1	11058428
S@@	O	-1	11058428
t@@	O	-1	11058428
udi@@	O	-1	11058428
es	O	-1	11058428
(N@@	O	-1	11058428
A@@	O	-1	11058428
S@@	O	-1	11058428
CI@@	O	-1	11058428
S@@	O	-1	11058428
),	O	-1	11058428
high-dose	O	-1	11058428
methyl@@	B-Chemical	D008775	11058428
pre@@	I-Chemical	-1	11058428
d@@	I-Chemical	-1	11058428
n@@	I-Chemical	-1	11058428
isol@@	I-Chemical	-1	11058428
one	I-Chemical	-1	11058428
b@@	O	-1	11058428
ec@@	O	-1	11058428
am@@	O	-1	11058428
e	O	-1	11058428
the	O	-1	11058428
standard	O	-1	11058428
of	O	-1	11058428
car@@	O	-1	11058428
e	O	-1	11058428
for	O	-1	11058428
the	O	-1	11058428
acute	O	-1	11058428
spinal	B-Disease	D013119	11058428
cor@@	I-Disease	-1	11058428
d	I-Disease	-1	11058428
injury	I-Disease	-1	11058428
.	O	-1	11058428
In	O	-1	11058428
the	O	-1	11058428
N@@	O	-1	11058428
A@@	O	-1	11058428
S@@	O	-1	11058428
CI@@	O	-1	11058428
S@@	O	-1	11058428
,	O	-1	11058428
there	O	-1	11058428
was	O	-1	11058428
no	O	-1	11058428
men@@	O	-1	11058428
tion	O	-1	11058428
reg@@	O	-1	11058428
ar@@	O	-1	11058428
ding	O	-1	11058428
the	O	-1	11058428
possib@@	O	-1	11058428
ility	O	-1	11058428
of	O	-1	11058428
acute	O	-1	11058428
cortico@@	B-Chemical	D000305	11058428
ster@@	I-Chemical	-1	11058428
oid	I-Chemical	-1	11058428
my@@	B-Disease	D009135	11058428
o@@	I-Disease	-1	11058428
pathy	I-Disease	-1	11058428
that	O	-1	11058428
high-dose	O	-1	11058428
methyl@@	B-Chemical	D008775	11058428
pre@@	I-Chemical	-1	11058428
d@@	I-Chemical	-1	11058428
n@@	I-Chemical	-1	11058428
isol@@	I-Chemical	-1	11058428
one	I-Chemical	-1	11058428
may	O	-1	11058428
ca@@	O	-1	11058428
use.	O	-1	11058428
The	O	-1	11058428
dos@@	O	-1	11058428
age	O	-1	11058428
of	O	-1	11058428
methyl@@	B-Chemical	D008775	11058428
pre@@	I-Chemical	-1	11058428
d@@	I-Chemical	-1	11058428
n@@	I-Chemical	-1	11058428
isol@@	I-Chemical	-1	11058428
one	I-Chemical	-1	11058428
recomm@@	O	-1	11058428
en@@	O	-1	11058428
ded	O	-1	11058428
by	O	-1	11058428
the	O	-1	11058428
N@@	O	-1	11058428
A@@	O	-1	11058428
S@@	O	-1	11058428
CI@@	O	-1	11058428
S	O	-1	11058428
3	O	-1	11058428
is	O	-1	11058428
the	O	-1	11058428
high@@	O	-1	11058428
est	O	-1	11058428
dose	O	-1	11058428
of	O	-1	11058428
steroid@@	B-Chemical	D013256	11058428
s	I-Chemical	-1	11058428
ev@@	O	-1	11058428
er	O	-1	11058428
being	O	-1	11058428
used	O	-1	11058428
during	O	-1	11058428
a	O	-1	11058428
2-@@	O	-1	11058428
day	O	-1	11058428
period	O	-1	11058428
for	O	-1	11058428
any	O	-1	11058428
clinical	O	-1	11058428
condi@@	O	-1	11058428
tion.	O	-1	11058428
We	O	-1	11058428
hypo@@	O	-1	11058428
the@@	O	-1	11058428
size	O	-1	11058428
that	O	-1	11058428
it	O	-1	11058428
may	O	-1	11058428
cause	O	-1	11058428
some	O	-1	11058428
damage	B-Disease	D009135	11058428
to	I-Disease	-1	11058428
the	I-Disease	-1	11058428
musc@@	I-Disease	-1	11058428
le	I-Disease	-1	11058428
of	O	-1	11058428
spinal	B-Disease	D013119	11058428
cor@@	I-Disease	-1	11058428
d	I-Disease	-1	11058428
injury	I-Disease	-1	11058428
patients.	O	-1	11058428
F@@	O	-1	11058428
ur@@	O	-1	11058428
ther@@	O	-1	11058428
,	O	-1	11058428
ster@@	B-Chemical	D013256	11058428
oid	I-Chemical	-1	11058428
my@@	B-Disease	D009135	11058428
o@@	I-Disease	-1	11058428
pathy	I-Disease	-1	11058428
reco@@	O	-1	11058428
ver@@	O	-1	11058428
s	O	-1	11058428
n@@	O	-1	11058428
at@@	O	-1	11058428
ur@@	O	-1	11058428
ally	O	-1	11058428
and	O	-1	11058428
the	O	-1	11058428
neurolog@@	O	-1	11058428
ical	O	-1	11058428
impro@@	O	-1	11058428
vement	O	-1	11058428
shown	O	-1	11058428
in	O	-1	11058428
the	O	-1	11058428
N@@	O	-1	11058428
A@@	O	-1	11058428
S@@	O	-1	11058428
CI@@	O	-1	11058428
S	O	-1	11058428
may	O	-1	11058428
be	O	-1	11058428
j@@	O	-1	11058428
us@@	O	-1	11058428
t	O	-1	11058428
a	O	-1	11058428
recor@@	O	-1	11058428
ding	O	-1	11058428
of	O	-1	11058428
this	O	-1	11058428
n@@	O	-1	11058428
at@@	O	-1	11058428
ural	O	-1	11058428
motor	O	-1	11058428
recovery	O	-1	11058428
from	O	-1	11058428
the	O	-1	11058428
ster@@	B-Chemical	D013256	11058428
oid	I-Chemical	-1	11058428
my@@	B-Disease	D009135	11058428
o@@	I-Disease	-1	11058428
pathy	I-Disease	-1	11058428
,	O	-1	11058428
in@@	O	-1	11058428
ste@@	O	-1	11058428
ad	O	-1	11058428
of	O	-1	11058428
any	O	-1	11058428
prot@@	O	-1	11058428
ection	O	-1	11058428
that	O	-1	11058428
methyl@@	B-Chemical	D008775	11058428
pre@@	I-Chemical	-1	11058428
d@@	I-Chemical	-1	11058428
n@@	I-Chemical	-1	11058428
isol@@	I-Chemical	-1	11058428
one	I-Chemical	-1	11058428
o@@	O	-1	11058428
ff@@	O	-1	11058428
ers	O	-1	11058428
to	O	-1	11058428
the	O	-1	11058428
spinal	B-Disease	D013119	11058428
cor@@	I-Disease	-1	11058428
d	I-Disease	-1	11058428
injury	I-Disease	-1	11058428
.	O	-1	11058428
To	O	-1	11058428
our	O	-1	11058428
know@@	O	-1	11058428
le@@	O	-1	11058428
d@@	O	-1	11058428
g@@	O	-1	11058428
e,	O	-1	11058428
this	O	-1	11058428
is	O	-1	11058428
the	O	-1	11058428
first	O	-1	11058428
discus@@	O	-1	11058428
sion	O	-1	11058428
con@@	O	-1	11058428
si@@	O	-1	11058428
der@@	O	-1	11058428
ing	O	-1	11058428
the	O	-1	11058428
possib@@	O	-1	11058428
ility	O	-1	11058428
that	O	-1	11058428
the	O	-1	11058428
methyl@@	B-Chemical	D008775	11058428
pre@@	I-Chemical	-1	11058428
d@@	I-Chemical	-1	11058428
n@@	I-Chemical	-1	11058428
isol@@	I-Chemical	-1	11058428
one	I-Chemical	-1	11058428
recomm@@	O	-1	11058428
en@@	O	-1	11058428
ded	O	-1	11058428
by	O	-1	11058428
N@@	O	-1	11058428
A@@	O	-1	11058428
S@@	O	-1	11058428
CI@@	O	-1	11058428
S	O	-1	11058428
may	O	-1	11058428
cause	O	-1	11058428
acute	O	-1	11058428
cortico@@	B-Chemical	D000305	11058428
ster@@	I-Chemical	-1	11058428
oid	I-Chemical	-1	11058428
my@@	B-Disease	D009135	11058428
o@@	I-Disease	-1	11058428
pathy	I-Disease	-1	11058428
.	O	-1	11058428

Pro@@	O	-1	11022397
b@@	O	-1	11022397
ing	O	-1	11022397
peripheral	O	-1	11022397
and	O	-1	11022397
central	O	-1	11022397
cholinergic	O	-1	11022397
system	O	-1	11022397
respon@@	O	-1	11022397
s@@	O	-1	11022397
es.	O	-1	11022397
OBJECTIVE:	O	-1	11022397
The	O	-1	11022397
pharmac@@	O	-1	11022397
ological	O	-1	11022397
response	O	-1	11022397
to	O	-1	11022397
drugs	O	-1	11022397
that	O	-1	11022397
ac@@	O	-1	11022397
t	O	-1	11022397
on	O	-1	11022397
the	O	-1	11022397
cholinergic	O	-1	11022397
system	O	-1	11022397
of	O	-1	11022397
the	O	-1	11022397
i@@	O	-1	11022397
ri@@	O	-1	11022397
s	O	-1	11022397
has	O	-1	11022397
been	O	-1	11022397
used	O	-1	11022397
to	O	-1	11022397
predic@@	O	-1	11022397
t	O	-1	11022397
defic@@	O	-1	11022397
its	O	-1	11022397
in	O	-1	11022397
central	O	-1	11022397
cholinergic	O	-1	11022397
func@@	O	-1	11022397
tion@@	O	-1	11022397
ing	O	-1	11022397
due	O	-1	11022397
to	O	-1	11022397
diseas@@	O	-1	11022397
es	O	-1	11022397
such	O	-1	11022397
as	O	-1	11022397
Al@@	B-Disease	D000544	11022397
z@@	I-Disease	-1	11022397
he@@	I-Disease	-1	11022397
im@@	I-Disease	-1	11022397
er@@	I-Disease	-1	11022397
's	I-Disease	-1	11022397
disease	I-Disease	-1	11022397
,	O	-1	11022397
y@@	O	-1	11022397
et	O	-1	11022397
correl@@	O	-1	11022397
ations	O	-1	11022397
between	O	-1	11022397
central	O	-1	11022397
and	O	-1	11022397
peripheral	O	-1	11022397
responses	O	-1	11022397
have	O	-1	11022397
not	O	-1	11022397
been	O	-1	11022397
pro@@	O	-1	11022397
per@@	O	-1	11022397
ly	O	-1	11022397
studi@@	O	-1	11022397
ed.	O	-1	11022397
This	O	-1	11022397
study	O	-1	11022397
assessed	O	-1	11022397
the	O	-1	11022397
effect	O	-1	11022397
of	O	-1	11022397
normal	O	-1	11022397
ag@@	O	-1	11022397
ing	O	-1	11022397
on	O	-1	11022397
(1@@	O	-1	11022397
)	O	-1	11022397
the	O	-1	11022397
tro@@	B-Chemical	D014331	11022397
p@@	I-Chemical	-1	11022397
ic@@	I-Chemical	-1	11022397
amide	I-Chemical	-1	11022397
-induced	O	-1	11022397
increase	O	-1	11022397
in	O	-1	11022397
pu@@	O	-1	11022397
pi@@	O	-1	11022397
l	O	-1	11022397
di@@	O	-1	11022397
ame@@	O	-1	11022397
ter@@	O	-1	11022397
,	O	-1	11022397
and	O	-1	11022397
(2@@	O	-1	11022397
)	O	-1	11022397
the	O	-1	11022397
rever@@	O	-1	11022397
s@@	O	-1	11022397
al	O	-1	11022397
of	O	-1	11022397
this	O	-1	11022397
effect	O	-1	11022397
with	O	-1	11022397
pilocar@@	B-Chemical	D010862	11022397
pine	I-Chemical	-1	11022397
.	O	-1	11022397
S@@	B-Chemical	D012601	11022397
co@@	I-Chemical	-1	11022397
pol@@	I-Chemical	-1	11022397
amine	I-Chemical	-1	11022397
was	O	-1	11022397
used	O	-1	11022397
as	O	-1	11022397
a	O	-1	11022397
positive	O	-1	11022397
control	O	-1	11022397
to	O	-1	11022397
det@@	O	-1	11022397
ect	O	-1	11022397
ag@@	O	-1	11022397
e-@@	O	-1	11022397
dependent	O	-1	11022397
changes	O	-1	11022397
in	O	-1	11022397
central	O	-1	11022397
cholinergic	O	-1	11022397
func@@	O	-1	11022397
tion@@	O	-1	11022397
ing	O	-1	11022397
in	O	-1	11022397
the	O	-1	11022397
el@@	O	-1	11022397
der@@	O	-1	11022397
ly.	O	-1	11022397
D@@	O	-1	11022397
ES@@	O	-1	11022397
I@@	O	-1	11022397
G@@	O	-1	11022397
N@@	O	-1	11022397
:	O	-1	11022397
R@@	O	-1	11022397
an@@	O	-1	11022397
dom@@	O	-1	11022397
ized	O	-1	11022397
double-bl@@	O	-1	11022397
ind	O	-1	11022397
controlled	O	-1	11022397
tri@@	O	-1	11022397
al.	O	-1	11022397
PA@@	O	-1	11022397
R@@	O	-1	11022397
TI@@	O	-1	11022397
CI@@	O	-1	11022397
PA@@	O	-1	11022397
N@@	O	-1	11022397
T@@	O	-1	11022397
S:	O	-1	11022397
T@@	O	-1	11022397
en	O	-1	11022397
healthy	O	-1	11022397
el@@	O	-1	11022397
der@@	O	-1	11022397
ly	O	-1	11022397
(@@	O	-1	11022397
mean	O	-1	11022397
age	O	-1	11022397
7@@	O	-1	11022397
0@@	O	-1	11022397
)	O	-1	11022397
and	O	-1	11022397
9	O	-1	11022397
youn@@	O	-1	11022397
g	O	-1	11022397
(@@	O	-1	11022397
mean	O	-1	11022397
age	O	-1	11022397
3@@	O	-1	11022397
3@@	O	-1	11022397
)	O	-1	11022397
vol@@	O	-1	11022397
un@@	O	-1	11022397
te@@	O	-1	11022397
ers.	O	-1	11022397
IN@@	O	-1	11022397
TE@@	O	-1	11022397
R@@	O	-1	11022397
V@@	O	-1	11022397
E@@	O	-1	11022397
N@@	O	-1	11022397
T@@	O	-1	11022397
ION@@	O	-1	11022397
S:	O	-1	11022397
P@@	O	-1	11022397
u@@	O	-1	11022397
pi@@	O	-1	11022397
l	O	-1	11022397
di@@	O	-1	11022397
ame@@	O	-1	11022397
ter	O	-1	11022397
was	O	-1	11022397
monit@@	O	-1	11022397
o@@	O	-1	11022397
red	O	-1	11022397
using	O	-1	11022397
a	O	-1	11022397
comp@@	O	-1	11022397
u@@	O	-1	11022397
ter@@	O	-1	11022397
ized	O	-1	11022397
inf@@	O	-1	11022397
ra@@	O	-1	11022397
red	O	-1	11022397
p@@	O	-1	11022397
up@@	O	-1	11022397
il@@	O	-1	11022397
lo@@	O	-1	11022397
me@@	O	-1	11022397
ter	O	-1	11022397
over	O	-1	11022397
4	O	-1	11022397
hour@@	O	-1	11022397
s.	O	-1	11022397
The	O	-1	11022397
study	O	-1	11022397
involved	O	-1	11022397
4	O	-1	11022397
s@@	O	-1	11022397
es@@	O	-1	11022397
sion@@	O	-1	11022397
s.	O	-1	11022397
In	O	-1	11022397
1	O	-1	11022397
s@@	O	-1	11022397
es@@	O	-1	11022397
sion,	O	-1	11022397
tro@@	B-Chemical	D014331	11022397
p@@	I-Chemical	-1	11022397
ic@@	I-Chemical	-1	11022397
amide	I-Chemical	-1	11022397
(2@@	O	-1	11022397
0	O	-1	11022397
micro@@	O	-1	11022397
L@@	O	-1	11022397
,	O	-1	11022397
0.0@@	O	-1	11022397
1@@	O	-1	11022397
%)	O	-1	11022397
was	O	-1	11022397
administered	O	-1	11022397
to	O	-1	11022397
one	O	-1	11022397
e@@	O	-1	11022397
y@@	O	-1	11022397
e	O	-1	11022397
and	O	-1	11022397
placebo	O	-1	11022397
to	O	-1	11022397
the	O	-1	11022397
o@@	O	-1	11022397
ther@@	O	-1	11022397
.	O	-1	11022397
In	O	-1	11022397
an@@	O	-1	11022397
other	O	-1	11022397
s@@	O	-1	11022397
es@@	O	-1	11022397
sion,	O	-1	11022397
tro@@	B-Chemical	D014331	11022397
p@@	I-Chemical	-1	11022397
ic@@	I-Chemical	-1	11022397
amide	I-Chemical	-1	11022397
(2@@	O	-1	11022397
0	O	-1	11022397
micro@@	O	-1	11022397
L@@	O	-1	11022397
,	O	-1	11022397
0.0@@	O	-1	11022397
1@@	O	-1	11022397
%)	O	-1	11022397
was	O	-1	11022397
administered	O	-1	11022397
to	O	-1	11022397
both	O	-1	11022397
e@@	O	-1	11022397
y@@	O	-1	11022397
es,	O	-1	11022397
followed	O	-1	11022397
2@@	O	-1	11022397
3	O	-1	11022397
minutes	O	-1	11022397
lat@@	O	-1	11022397
er	O	-1	11022397
by	O	-1	11022397
the	O	-1	11022397
ap@@	O	-1	11022397
plic@@	O	-1	11022397
ation	O	-1	11022397
of	O	-1	11022397
pilocar@@	B-Chemical	D010862	11022397
pine	I-Chemical	-1	11022397
(2@@	O	-1	11022397
0	O	-1	11022397
micro@@	O	-1	11022397
L@@	O	-1	11022397
,	O	-1	11022397
0.@@	O	-1	11022397
1@@	O	-1	11022397
%)	O	-1	11022397
to	O	-1	11022397
one	O	-1	11022397
e@@	O	-1	11022397
y@@	O	-1	11022397
e	O	-1	11022397
and	O	-1	11022397
placebo	O	-1	11022397
to	O	-1	11022397
the	O	-1	11022397
o@@	O	-1	11022397
ther@@	O	-1	11022397
.	O	-1	11022397
All	O	-1	11022397
e@@	O	-1	11022397
y@@	O	-1	11022397
e	O	-1	11022397
dro@@	O	-1	11022397
p@@	O	-1	11022397
s	O	-1	11022397
were	O	-1	11022397
given	O	-1	11022397
in	O	-1	11022397
a	O	-1	11022397
randomized	O	-1	11022397
or@@	O	-1	11022397
der@@	O	-1	11022397
.	O	-1	11022397
In	O	-1	11022397
2	O	-1	11022397
se@@	O	-1	11022397
par@@	O	-1	11022397
ate	O	-1	11022397
s@@	O	-1	11022397
es@@	O	-1	11022397
sion@@	O	-1	11022397
s,	O	-1	11022397
a	O	-1	11022397
single	O	-1	11022397
dose	O	-1	11022397
of	O	-1	11022397
scopol@@	B-Chemical	D012601	11022397
amine	I-Chemical	-1	11022397
(0.@@	O	-1	11022397
5	O	-1	11022397
mg@@	O	-1	11022397
,	O	-1	11022397
intra@@	O	-1	11022397
ven@@	O	-1	11022397
ous@@	O	-1	11022397
ly@@	O	-1	11022397
)	O	-1	11022397
or	O	-1	11022397
placebo	O	-1	11022397
was	O	-1	11022397
administ@@	O	-1	11022397
e@@	O	-1	11022397
re@@	O	-1	11022397
d,	O	-1	11022397
and	O	-1	11022397
the	O	-1	11022397
effects	O	-1	11022397
on	O	-1	11022397
wor@@	O	-1	11022397
d	O	-1	11022397
rec@@	O	-1	11022397
all	O	-1	11022397
were	O	-1	11022397
measured	O	-1	11022397
using	O	-1	11022397
the	O	-1	11022397
B@@	O	-1	11022397
us@@	O	-1	11022397
ch@@	O	-1	11022397
k@@	O	-1	11022397
e	O	-1	11022397
S@@	O	-1	11022397
el@@	O	-1	11022397
ective	O	-1	11022397
R@@	O	-1	11022397
em@@	O	-1	11022397
ind@@	O	-1	11022397
ing	O	-1	11022397
T@@	O	-1	11022397
est	O	-1	11022397
over	O	-1	11022397
2	O	-1	11022397
hour@@	O	-1	11022397
s.	O	-1	11022397
O@@	O	-1	11022397
U@@	O	-1	11022397
T@@	O	-1	11022397
CO@@	O	-1	11022397
M@@	O	-1	11022397
E	O	-1	11022397
M@@	O	-1	11022397
E@@	O	-1	11022397
A@@	O	-1	11022397
S@@	O	-1	11022397
U@@	O	-1	11022397
R@@	O	-1	11022397
E@@	O	-1	11022397
S:	O	-1	11022397
P@@	O	-1	11022397
u@@	O	-1	11022397
pi@@	O	-1	11022397
l	O	-1	11022397
size	O	-1	11022397
at	O	-1	11022397
time	O	-1	11022397
po@@	O	-1	11022397
int@@	O	-1	11022397
s	O	-1	11022397
after	O	-1	11022397
administration	O	-1	11022397
of	O	-1	11022397
tro@@	B-Chemical	D014331	11022397
p@@	I-Chemical	-1	11022397
ic@@	I-Chemical	-1	11022397
amide	I-Chemical	-1	11022397
and	O	-1	11022397
pilocar@@	B-Chemical	D010862	11022397
pine	I-Chemical	-1	11022397
;	O	-1	11022397
scopol@@	B-Chemical	D012601	11022397
amine	I-Chemical	-1	11022397
-induced	O	-1	11022397
impair@@	B-Disease	D008569	11022397
ment	I-Disease	-1	11022397
in	I-Disease	-1	11022397
wor@@	I-Disease	-1	11022397
d	I-Disease	-1	11022397
rec@@	I-Disease	-1	11022397
all	I-Disease	-1	11022397
.	O	-1	11022397
RESULTS:	O	-1	11022397
There	O	-1	11022397
was	O	-1	11022397
no	O	-1	11022397
significant	O	-1	11022397
difference	O	-1	11022397
between	O	-1	11022397
el@@	O	-1	11022397
der@@	O	-1	11022397
ly	O	-1	11022397
and	O	-1	11022397
youn@@	O	-1	11022397
g	O	-1	11022397
vol@@	O	-1	11022397
un@@	O	-1	11022397
te@@	O	-1	11022397
ers	O	-1	11022397
in	O	-1	11022397
p@@	O	-1	11022397
up@@	O	-1	11022397
ill@@	O	-1	11022397
ary	O	-1	11022397
response	O	-1	11022397
to	O	-1	11022397
tro@@	B-Chemical	D014331	11022397
p@@	I-Chemical	-1	11022397
ic@@	I-Chemical	-1	11022397
amide	I-Chemical	-1	11022397
at	O	-1	11022397
any	O	-1	11022397
time	O	-1	11022397
po@@	O	-1	11022397
in@@	O	-1	11022397
t	O	-1	11022397
(p	O	-1	11022397
>	O	-1	11022397
0.05@@	O	-1	11022397
).	O	-1	11022397
The	O	-1	11022397
el@@	O	-1	11022397
der@@	O	-1	11022397
ly	O	-1	11022397
group	O	-1	11022397
had	O	-1	11022397
a	O	-1	11022397
significantly	O	-1	11022397
greater	O	-1	11022397
pilocar@@	B-Chemical	D010862	11022397
pine	I-Chemical	-1	11022397
-induced	O	-1	11022397
ne@@	O	-1	11022397
t	O	-1	11022397
decrease	O	-1	11022397
in	O	-1	11022397
pu@@	O	-1	11022397
pi@@	O	-1	11022397
l	O	-1	11022397
size	O	-1	11022397
8@@	O	-1	11022397
5,	O	-1	11022397
12@@	O	-1	11022397
5,	O	-1	11022397
1@@	O	-1	11022397
6@@	O	-1	11022397
5	O	-1	11022397
and	O	-1	11022397
2@@	O	-1	11022397
15	O	-1	11022397
minutes	O	-1	11022397
after	O	-1	11022397
administr@@	O	-1	11022397
ation,	O	-1	11022397
compared	O	-1	11022397
with	O	-1	11022397
the	O	-1	11022397
youn@@	O	-1	11022397
g	O	-1	11022397
group	O	-1	11022397
(p	O	-1	11022397
<	O	-1	11022397
0.05@@	O	-1	11022397
).	O	-1	11022397
Com@@	O	-1	11022397
pared	O	-1	11022397
with	O	-1	11022397
the	O	-1	11022397
youn@@	O	-1	11022397
g	O	-1	11022397
group@@	O	-1	11022397
,	O	-1	11022397
the	O	-1	11022397
el@@	O	-1	11022397
der@@	O	-1	11022397
ly	O	-1	11022397
group	O	-1	11022397
had	O	-1	11022397
greater	O	-1	11022397
scopol@@	B-Chemical	D012601	11022397
amine	I-Chemical	-1	11022397
-induced	O	-1	11022397
impair@@	B-Disease	D008569	11022397
ment	I-Disease	-1	11022397
in	I-Disease	-1	11022397
wor@@	I-Disease	-1	11022397
d	I-Disease	-1	11022397
rec@@	I-Disease	-1	11022397
all	I-Disease	-1	11022397
6@@	O	-1	11022397
0@@	O	-1	11022397
,	O	-1	11022397
9@@	O	-1	11022397
0	O	-1	11022397
and	O	-1	11022397
1@@	O	-1	11022397
20	O	-1	11022397
minutes	O	-1	11022397
after	O	-1	11022397
administration	O	-1	11022397
(p	O	-1	11022397
<	O	-1	11022397
0.05@@	O	-1	11022397
).	O	-1	11022397
CONCLUSION:	O	-1	11022397
There	O	-1	11022397
is	O	-1	11022397
an	O	-1	11022397
ag@@	O	-1	11022397
e-@@	O	-1	11022397
related	O	-1	11022397
p@@	O	-1	11022397
up@@	O	-1	11022397
ill@@	O	-1	11022397
ary	O	-1	11022397
response	O	-1	11022397
to	O	-1	11022397
pilocar@@	B-Chemical	D010862	11022397
pine	I-Chemical	-1	11022397
that	O	-1	11022397
is	O	-1	11022397
not	O	-1	11022397
found	O	-1	11022397
with	O	-1	11022397
tro@@	B-Chemical	D014331	11022397
p@@	I-Chemical	-1	11022397
ic@@	I-Chemical	-1	11022397
amide	I-Chemical	-1	11022397
.	O	-1	11022397
Th@@	O	-1	11022397
us,	O	-1	11022397
pilocar@@	B-Chemical	D010862	11022397
pine	I-Chemical	-1	11022397
may	O	-1	11022397
be	O	-1	11022397
use@@	O	-1	11022397
ful	O	-1	11022397
to	O	-1	11022397
ass@@	O	-1	11022397
ess	O	-1	11022397
vari@@	O	-1	11022397
ations	O	-1	11022397
in	O	-1	11022397
central	O	-1	11022397
cholinergic	O	-1	11022397
function	O	-1	11022397
in	O	-1	11022397
el@@	O	-1	11022397
der@@	O	-1	11022397
ly	O	-1	11022397
patients.	O	-1	11022397

A@@	B-Chemical	D000086	10692744
ce@@	I-Chemical	-1	10692744
t@@	I-Chemical	-1	10692744
azol@@	I-Chemical	-1	10692744
amide	I-Chemical	-1	10692744
-induced	O	-1	10692744
G@@	B-Disease	D005862	10692744
er@@	I-Disease	-1	10692744
st@@	I-Disease	-1	10692744
man@@	I-Disease	-1	10692744
n	I-Disease	-1	10692744
syndrome	I-Disease	-1	10692744
.	O	-1	10692744
Ac@@	O	-1	10692744
ute	O	-1	10692744
conf@@	B-Disease	D003221	10692744
usion	I-Disease	-1	10692744
induced	O	-1	10692744
by	O	-1	10692744
acet@@	B-Chemical	D000086	10692744
azol@@	I-Chemical	-1	10692744
amide	I-Chemical	-1	10692744
is	O	-1	10692744
a	O	-1	10692744
well	O	-1	10692744
known	O	-1	10692744
adverse	O	-1	10692744
drug	O	-1	10692744
reaction	O	-1	10692744
in	O	-1	10692744
patients	O	-1	10692744
with	O	-1	10692744
renal	B-Disease	D007674	10692744
impair@@	I-Disease	-1	10692744
ment	I-Disease	-1	10692744
.	O	-1	10692744
We	O	-1	10692744
report	O	-1	10692744
a	O	-1	10692744
case	O	-1	10692744
of	O	-1	10692744
acet@@	B-Chemical	D000086	10692744
azol@@	I-Chemical	-1	10692744
amide	I-Chemical	-1	10692744
-induced	O	-1	10692744
G@@	B-Disease	D005862	10692744
er@@	I-Disease	-1	10692744
st@@	I-Disease	-1	10692744
man@@	I-Disease	-1	10692744
n	I-Disease	-1	10692744
syndrome	I-Disease	-1	10692744
in	O	-1	10692744
a	O	-1	10692744
patient	O	-1	10692744
with	O	-1	10692744
normal	O	-1	10692744
renal	O	-1	10692744
func@@	O	-1	10692744
tion,	O	-1	10692744
to	O	-1	10692744
high@@	O	-1	10692744
li@@	O	-1	10692744
ght	O	-1	10692744
pre@@	O	-1	10692744
dis@@	O	-1	10692744
pos@@	O	-1	10692744
ing	O	-1	10692744
factors	O	-1	10692744
that	O	-1	10692744
are	O	-1	10692744
frequ@@	O	-1	10692744
ently	O	-1	10692744
over@@	O	-1	10692744
lo@@	O	-1	10692744
o@@	O	-1	10692744
k@@	O	-1	10692744
ed.	O	-1	10692744

H@@	B-Disease	D001714	10565806
y@@	I-Disease	-1	10565806
po@@	I-Disease	-1	10565806
man@@	I-Disease	-1	10565806
ia	I-Disease	-1	10565806
-@@	O	-1	10565806
like	O	-1	10565806
syndrome	O	-1	10565806
induced	O	-1	10565806
by	O	-1	10565806
ol@@	B-Chemical	C076029	10565806
an@@	I-Chemical	-1	10565806
z@@	I-Chemical	-1	10565806
apine	I-Chemical	-1	10565806
.	O	-1	10565806
We	O	-1	10565806
report	O	-1	10565806
a	O	-1	10565806
female	O	-1	10565806
patient	O	-1	10565806
with	O	-1	10565806
a	O	-1	10565806
diagnosis	O	-1	10565806
of	O	-1	10565806
a	O	-1	10565806
not	O	-1	10565806
o@@	O	-1	10565806
ther@@	O	-1	10565806
w@@	O	-1	10565806
is@@	O	-1	10565806
e	O	-1	10565806
specif@@	O	-1	10565806
ied	O	-1	10565806
psycho@@	B-Disease	D011618	10565806
tic	I-Disease	-1	10565806
disor@@	I-Disease	-1	10565806
der	I-Disease	-1	10565806
(D@@	O	-1	10565806
S@@	O	-1	10565806
M@@	O	-1	10565806
-@@	O	-1	10565806
I@@	O	-1	10565806
V@@	O	-1	10565806
)	O	-1	10565806
who	O	-1	10565806
developed	O	-1	10565806
hypo@@	B-Disease	D001714	10565806
man@@	I-Disease	-1	10565806
ia	I-Disease	-1	10565806
sh@@	O	-1	10565806
ort@@	O	-1	10565806
ly	O	-1	10565806
after	O	-1	10565806
the	O	-1	10565806
int@@	O	-1	10565806
ro@@	O	-1	10565806
duction	O	-1	10565806
of	O	-1	10565806
ol@@	B-Chemical	C076029	10565806
an@@	I-Chemical	-1	10565806
z@@	I-Chemical	-1	10565806
apine	I-Chemical	-1	10565806
treatment.	O	-1	10565806

Ne@@	O	-1	9061311
ut@@	O	-1	9061311
ro@@	O	-1	9061311
ph@@	O	-1	9061311
il	O	-1	9061311
su@@	B-Chemical	D013481	9061311
per@@	I-Chemical	-1	9061311
ox@@	I-Chemical	-1	9061311
ide	I-Chemical	-1	9061311
and	O	-1	9061311
hydro@@	B-Chemical	D006861	9061311
gen	I-Chemical	-1	9061311
per@@	I-Chemical	-1	9061311
ox@@	I-Chemical	-1	9061311
ide	I-Chemical	-1	9061311
pro@@	O	-1	9061311
duction	O	-1	9061311
in	O	-1	9061311
patients	O	-1	9061311
with	O	-1	9061311
acute	B-Disease	D017114	9061311
liver	I-Disease	-1	9061311
failure	I-Disease	-1	9061311
.	O	-1	9061311
De@@	O	-1	9061311
f@@	O	-1	9061311
ects	O	-1	9061311
in	O	-1	9061311
su@@	B-Chemical	D013481	9061311
per@@	I-Chemical	-1	9061311
ox@@	I-Chemical	-1	9061311
ide	I-Chemical	-1	9061311
and	O	-1	9061311
hydro@@	B-Chemical	D006861	9061311
gen	I-Chemical	-1	9061311
per@@	I-Chemical	-1	9061311
ox@@	I-Chemical	-1	9061311
ide	I-Chemical	-1	9061311
pro@@	O	-1	9061311
duction	O	-1	9061311
may	O	-1	9061311
be	O	-1	9061311
implic@@	O	-1	9061311
ated	O	-1	9061311
in	O	-1	9061311
the	O	-1	9061311
high	O	-1	9061311
incidence	O	-1	9061311
of	O	-1	9061311
bac@@	B-Disease	D001424	9061311
ter@@	I-Disease	-1	9061311
ial	I-Disease	-1	9061311
inf@@	I-Disease	-1	9061311
ec@@	I-Disease	-1	9061311
tions	I-Disease	-1	9061311
in	O	-1	9061311
patients	O	-1	9061311
with	O	-1	9061311
acute	B-Disease	D017114	9061311
liver	I-Disease	-1	9061311
failure	I-Disease	-1	9061311
(	O	-1	9061311
AL@@	B-Disease	D017114	9061311
F	I-Disease	-1	9061311
).	O	-1	9061311
In	O	-1	9061311
the	O	-1	9061311
present	O	-1	9061311
study,	O	-1	9061311
oxy@@	B-Chemical	D010100	9061311
gen	I-Chemical	-1	9061311
ra@@	O	-1	9061311
d@@	O	-1	9061311
ical	O	-1	9061311
pro@@	O	-1	9061311
duction	O	-1	9061311
in	O	-1	9061311
patients	O	-1	9061311
with	O	-1	9061311
AL@@	B-Disease	D017114	9061311
F	I-Disease	-1	9061311
due	O	-1	9061311
to	O	-1	9061311
par@@	B-Chemical	D000082	9061311
acet@@	I-Chemical	-1	9061311
am@@	I-Chemical	-1	9061311
ol	I-Chemical	-1	9061311
over@@	B-Disease	D062787	9061311
dose	I-Disease	-1	9061311
was	O	-1	9061311
compared	O	-1	9061311
with	O	-1	9061311
that	O	-1	9061311
of	O	-1	9061311
healthy	O	-1	9061311
vol@@	O	-1	9061311
un@@	O	-1	9061311
te@@	O	-1	9061311
ers.	O	-1	9061311
Ne@@	O	-1	9061311
ut@@	O	-1	9061311
ro@@	O	-1	9061311
ph@@	O	-1	9061311
il@@	O	-1	9061311
s	O	-1	9061311
from	O	-1	9061311
14	O	-1	9061311
AL@@	B-Disease	D017114	9061311
F	I-Disease	-1	9061311
patients	O	-1	9061311
were	O	-1	9061311
stimul@@	O	-1	9061311
ated	O	-1	9061311
vi@@	O	-1	9061311
a	O	-1	9061311
the	O	-1	9061311
comple@@	O	-1	9061311
ment	O	-1	9061311
receptors	O	-1	9061311
using	O	-1	9061311
z@@	O	-1	9061311
ym@@	O	-1	9061311
os@@	O	-1	9061311
an	O	-1	9061311
op@@	O	-1	9061311
son@@	O	-1	9061311
ized	O	-1	9061311
with	O	-1	9061311
AL@@	B-Disease	D017114	9061311
F	I-Disease	-1	9061311
or	O	-1	9061311
control	O	-1	9061311
ser@@	O	-1	9061311
um@@	O	-1	9061311
.	O	-1	9061311
S@@	B-Chemical	D013481	9061311
u@@	I-Chemical	-1	9061311
per@@	I-Chemical	-1	9061311
ox@@	I-Chemical	-1	9061311
ide	I-Chemical	-1	9061311
and	O	-1	9061311
hydro@@	B-Chemical	D006861	9061311
gen	I-Chemical	-1	9061311
per@@	I-Chemical	-1	9061311
ox@@	I-Chemical	-1	9061311
ide	I-Chemical	-1	9061311
pro@@	O	-1	9061311
duction	O	-1	9061311
by	O	-1	9061311
AL@@	B-Disease	D017114	9061311
F	I-Disease	-1	9061311
ne@@	O	-1	9061311
ut@@	O	-1	9061311
ro@@	O	-1	9061311
ph@@	O	-1	9061311
il@@	O	-1	9061311
s	O	-1	9061311
stimul@@	O	-1	9061311
ated	O	-1	9061311
with	O	-1	9061311
z@@	O	-1	9061311
ym@@	O	-1	9061311
os@@	O	-1	9061311
an	O	-1	9061311
op@@	O	-1	9061311
son@@	O	-1	9061311
ized	O	-1	9061311
with	O	-1	9061311
AL@@	B-Disease	D017114	9061311
F	I-Disease	-1	9061311
serum	O	-1	9061311
was	O	-1	9061311
significantly	O	-1	9061311
reduced	O	-1	9061311
compared	O	-1	9061311
with	O	-1	9061311
the	O	-1	9061311
control	O	-1	9061311
subjects	O	-1	9061311
(P	O	-1	9061311
<	O	-1	9061311
0.0@@	O	-1	9061311
1).	O	-1	9061311
This	O	-1	9061311
def@@	O	-1	9061311
ect	O	-1	9061311
per@@	O	-1	9061311
sist@@	O	-1	9061311
ed	O	-1	9061311
when	O	-1	9061311
z@@	O	-1	9061311
ym@@	O	-1	9061311
os@@	O	-1	9061311
an	O	-1	9061311
op@@	O	-1	9061311
son@@	O	-1	9061311
ized	O	-1	9061311
by	O	-1	9061311
control	O	-1	9061311
serum	O	-1	9061311
was	O	-1	9061311
used	O	-1	9061311
(P	O	-1	9061311
<	O	-1	9061311
0.05@@	O	-1	9061311
).	O	-1	9061311
S@@	B-Chemical	D013481	9061311
u@@	I-Chemical	-1	9061311
per@@	I-Chemical	-1	9061311
ox@@	I-Chemical	-1	9061311
ide	I-Chemical	-1	9061311
and	O	-1	9061311
hydro@@	B-Chemical	D006861	9061311
gen	I-Chemical	-1	9061311
per@@	I-Chemical	-1	9061311
ox@@	I-Chemical	-1	9061311
ide	I-Chemical	-1	9061311
pro@@	O	-1	9061311
duction	O	-1	9061311
in	O	-1	9061311
ne@@	O	-1	9061311
ut@@	O	-1	9061311
ro@@	O	-1	9061311
ph@@	O	-1	9061311
il@@	O	-1	9061311
s	O	-1	9061311
stimul@@	O	-1	9061311
ated	O	-1	9061311
with	O	-1	9061311
form@@	B-Chemical	D009240	9061311
yl@@	I-Chemical	-1	9061311
-@@	I-Chemical	-1	9061311
meth@@	I-Chemical	-1	9061311
i@@	I-Chemical	-1	9061311
on@@	I-Chemical	-1	9061311
yl@@	I-Chemical	-1	9061311
-@@	I-Chemical	-1	9061311
le@@	I-Chemical	-1	9061311
uc@@	I-Chemical	-1	9061311
yl@@	I-Chemical	-1	9061311
-@@	I-Chemical	-1	9061311
phenyl@@	I-Chemical	-1	9061311
al@@	I-Chemical	-1	9061311
an@@	I-Chemical	-1	9061311
ine	I-Chemical	-1	9061311
(	O	-1	9061311
f@@	B-Chemical	D009240	9061311
M@@	I-Chemical	-1	9061311
L@@	I-Chemical	-1	9061311
P	I-Chemical	-1	9061311
)	O	-1	9061311
from	O	-1	9061311
a	O	-1	9061311
further	O	-1	9061311
1@@	O	-1	9061311
8	O	-1	9061311
AL@@	B-Disease	D017114	9061311
F	I-Disease	-1	9061311
patients	O	-1	9061311
was	O	-1	9061311
un@@	O	-1	9061311
affected	O	-1	9061311
compared	O	-1	9061311
with	O	-1	9061311
control	O	-1	9061311
ne@@	O	-1	9061311
ut@@	O	-1	9061311
ro@@	O	-1	9061311
ph@@	O	-1	9061311
il@@	O	-1	9061311
s.	O	-1	9061311
S@@	O	-1	9061311
er@@	O	-1	9061311
um	O	-1	9061311
C@@	O	-1	9061311
3	O	-1	9061311
comple@@	O	-1	9061311
ment	O	-1	9061311
levels	O	-1	9061311
were	O	-1	9061311
significantly	O	-1	9061311
reduced	O	-1	9061311
in	O	-1	9061311
AL@@	B-Disease	D017114	9061311
F	I-Disease	-1	9061311
patients	O	-1	9061311
compared	O	-1	9061311
with	O	-1	9061311
control	O	-1	9061311
subjects	O	-1	9061311
(P	O	-1	9061311
<	O	-1	9061311
0.00@@	O	-1	9061311
0@@	O	-1	9061311
5@@	O	-1	9061311
).	O	-1	9061311
These	O	-1	9061311
results	O	-1	9061311
demon@@	O	-1	9061311
st@@	O	-1	9061311
rate	O	-1	9061311
a	O	-1	9061311
ne@@	O	-1	9061311
ut@@	O	-1	9061311
ro@@	O	-1	9061311
ph@@	O	-1	9061311
il	O	-1	9061311
def@@	O	-1	9061311
ect	O	-1	9061311
in	O	-1	9061311
AL@@	B-Disease	D017114	9061311
F	I-Disease	-1	9061311
due	O	-1	9061311
to	O	-1	9061311
par@@	B-Chemical	D000082	9061311
acet@@	I-Chemical	-1	9061311
am@@	I-Chemical	-1	9061311
ol	I-Chemical	-1	9061311
over@@	B-Disease	D062787	9061311
dose	I-Disease	-1	9061311
,	O	-1	9061311
that	O	-1	9061311
is	O	-1	9061311
comple@@	O	-1	9061311
ment	O	-1	9061311
dependent	O	-1	9061311
but	O	-1	9061311
in@@	O	-1	9061311
dependent	O	-1	9061311
of	O	-1	9061311
serum	O	-1	9061311
comple@@	O	-1	9061311
ment@@	O	-1	9061311
,	O	-1	9061311
possib@@	O	-1	9061311
ly	O	-1	9061311
con@@	O	-1	9061311
n@@	O	-1	9061311
ected	O	-1	9061311
to	O	-1	9061311
the	O	-1	9061311
comple@@	O	-1	9061311
ment	O	-1	9061311
receptor@@	O	-1	9061311
.	O	-1	9061311

A@@	O	-1	8617710
b@@	O	-1	8617710
s@@	O	-1	8617710
ence	O	-1	8617710
of	O	-1	8617710
effect	O	-1	8617710
of	O	-1	8617710
ser@@	B-Chemical	D020280	8617710
tr@@	I-Chemical	-1	8617710
aline	I-Chemical	-1	8617710
on	O	-1	8617710
ti@@	O	-1	8617710
me@@	O	-1	8617710
-@@	O	-1	8617710
bas@@	O	-1	8617710
ed	O	-1	8617710
sensi@@	O	-1	8617710
tiz@@	O	-1	8617710
ation	O	-1	8617710
of	O	-1	8617710
cognitive	B-Disease	D003072	8617710
impair@@	I-Disease	-1	8617710
ment	I-Disease	-1	8617710
with	O	-1	8617710
haloperidol	B-Chemical	D006220	8617710
.	O	-1	8617710
This	O	-1	8617710
double-bl@@	O	-1	8617710
ind@@	O	-1	8617710
,	O	-1	8617710
random@@	O	-1	8617710
iz@@	O	-1	8617710
ed,	O	-1	8617710
placebo@@	O	-1	8617710
-@@	O	-1	8617710
controlled	O	-1	8617710
study	O	-1	8617710
evaluated	O	-1	8617710
the	O	-1	8617710
effects	O	-1	8617710
of	O	-1	8617710
haloperidol	B-Chemical	D006220	8617710
alone	O	-1	8617710
and	O	-1	8617710
haloperidol	B-Chemical	D006220	8617710
plus	O	-1	8617710
ser@@	B-Chemical	D020280	8617710
tr@@	I-Chemical	-1	8617710
aline	I-Chemical	-1	8617710
on	O	-1	8617710
cognitive	O	-1	8617710
and	O	-1	8617710
psych@@	O	-1	8617710
om@@	O	-1	8617710
otor	O	-1	8617710
function	O	-1	8617710
in	O	-1	8617710
24	O	-1	8617710
healthy	O	-1	8617710
male	O	-1	8617710
subj@@	O	-1	8617710
ect@@	O	-1	8617710
s.	O	-1	8617710
METHOD@@	O	-1	8617710
:	O	-1	8617710
All	O	-1	8617710
subjects	O	-1	8617710
received	O	-1	8617710
placebo	O	-1	8617710
on	O	-1	8617710
D@@	O	-1	8617710
ay	O	-1	8617710
1	O	-1	8617710
and	O	-1	8617710
haloperidol	B-Chemical	D006220	8617710
2	O	-1	8617710
mg	O	-1	8617710
on	O	-1	8617710
D@@	O	-1	8617710
ays	O	-1	8617710
2	O	-1	8617710
and	O	-1	8617710
25@@	O	-1	8617710
.	O	-1	8617710
F@@	O	-1	8617710
rom	O	-1	8617710
D@@	O	-1	8617710
ays	O	-1	8617710
9	O	-1	8617710
to	O	-1	8617710
2@@	O	-1	8617710
5,	O	-1	8617710
subjects	O	-1	8617710
were	O	-1	8617710
random@@	O	-1	8617710
ly	O	-1	8617710
as@@	O	-1	8617710
signed	O	-1	8617710
to	O	-1	8617710
either	O	-1	8617710
ser@@	B-Chemical	D020280	8617710
tr@@	I-Chemical	-1	8617710
aline	I-Chemical	-1	8617710
(1@@	O	-1	8617710
2	O	-1	8617710
subj@@	O	-1	8617710
ect@@	O	-1	8617710
s)	O	-1	8617710
or	O	-1	8617710
placebo	O	-1	8617710
(1@@	O	-1	8617710
2	O	-1	8617710
subj@@	O	-1	8617710
ect@@	O	-1	8617710
s@@	O	-1	8617710
);	O	-1	8617710
the	O	-1	8617710
ser@@	B-Chemical	D020280	8617710
tr@@	I-Chemical	-1	8617710
aline	I-Chemical	-1	8617710
dose	O	-1	8617710
was	O	-1	8617710
ti@@	O	-1	8617710
tr@@	O	-1	8617710
ated	O	-1	8617710
from	O	-1	8617710
50	O	-1	8617710
to	O	-1	8617710
2@@	O	-1	8617710
00	O	-1	8617710
mg/@@	O	-1	8617710
day	O	-1	8617710
from	O	-1	8617710
D@@	O	-1	8617710
ays	O	-1	8617710
9	O	-1	8617710
to	O	-1	8617710
1@@	O	-1	8617710
6,	O	-1	8617710
and	O	-1	8617710
remained	O	-1	8617710
at	O	-1	8617710
2@@	O	-1	8617710
00	O	-1	8617710
mg/@@	O	-1	8617710
day	O	-1	8617710
for	O	-1	8617710
the	O	-1	8617710
f@@	O	-1	8617710
inal	O	-1	8617710
10	O	-1	8617710
days	O	-1	8617710
of	O	-1	8617710
the	O	-1	8617710
drug	O	-1	8617710
administration	O	-1	8617710
perio@@	O	-1	8617710
d.	O	-1	8617710
C@@	O	-1	8617710
o@@	O	-1	8617710
gn@@	O	-1	8617710
itive	O	-1	8617710
function	O	-1	8617710
test@@	O	-1	8617710
ing	O	-1	8617710
was	O	-1	8617710
performed	O	-1	8617710
before	O	-1	8617710
dos@@	O	-1	8617710
ing	O	-1	8617710
and	O	-1	8617710
over	O	-1	8617710
a	O	-1	8617710
2@@	O	-1	8617710
4-@@	O	-1	8617710
h@@	O	-1	8617710
our	O	-1	8617710
period	O	-1	8617710
after	O	-1	8617710
dos@@	O	-1	8617710
ing	O	-1	8617710
on	O	-1	8617710
D@@	O	-1	8617710
ays	O	-1	8617710
1,	O	-1	8617710
2,	O	-1	8617710
and	O	-1	8617710
25@@	O	-1	8617710
.	O	-1	8617710
RESULTS:	O	-1	8617710
Im@@	B-Disease	D003072	8617710
pa@@	I-Disease	-1	8617710
ir@@	I-Disease	-1	8617710
ment	I-Disease	-1	8617710
of	I-Disease	-1	8617710
cognitive	I-Disease	-1	8617710
function	I-Disease	-1	8617710
was	O	-1	8617710
observed	O	-1	8617710
6	O	-1	8617710
to	O	-1	8617710
8	O	-1	8617710
hours	O	-1	8617710
after	O	-1	8617710
administration	O	-1	8617710
of	O	-1	8617710
haloperidol	B-Chemical	D006220	8617710
on	O	-1	8617710
D@@	O	-1	8617710
ay	O	-1	8617710
2	O	-1	8617710
but	O	-1	8617710
was	O	-1	8617710
not	O	-1	8617710
ev@@	O	-1	8617710
id@@	O	-1	8617710
ent	O	-1	8617710
2@@	O	-1	8617710
3	O	-1	8617710
hours	O	-1	8617710
after	O	-1	8617710
dos@@	O	-1	8617710
ing.	O	-1	8617710
Whe@@	O	-1	8617710
n	O	-1	8617710
sing@@	O	-1	8617710
le@@	O	-1	8617710
-@@	O	-1	8617710
dose	O	-1	8617710
haloperidol	B-Chemical	D006220	8617710
was	O	-1	8617710
given	O	-1	8617710
ag@@	O	-1	8617710
ain	O	-1	8617710
25	O	-1	8617710
days	O	-1	8617710
lat@@	O	-1	8617710
er,	O	-1	8617710
greater	O	-1	8617710
impair@@	O	-1	8617710
ment	O	-1	8617710
with	O	-1	8617710
ear@@	O	-1	8617710
li@@	O	-1	8617710
er	O	-1	8617710
onset	O	-1	8617710
was	O	-1	8617710
not@@	O	-1	8617710
ed	O	-1	8617710
in	O	-1	8617710
several	O	-1	8617710
tests	O	-1	8617710
in	O	-1	8617710
both	O	-1	8617710
treatment	O	-1	8617710
group@@	O	-1	8617710
s,	O	-1	8617710
suggesting	O	-1	8617710
enh@@	O	-1	8617710
ance@@	O	-1	8617710
ment	O	-1	8617710
of	O	-1	8617710
this	O	-1	8617710
effect@@	O	-1	8617710
.	O	-1	8617710
There	O	-1	8617710
was	O	-1	8617710
no	O	-1	8617710
indic@@	O	-1	8617710
ation	O	-1	8617710
that	O	-1	8617710
ser@@	B-Chemical	D020280	8617710
tr@@	I-Chemical	-1	8617710
aline	I-Chemical	-1	8617710
ex@@	O	-1	8617710
ac@@	O	-1	8617710
er@@	O	-1	8617710
b@@	O	-1	8617710
ated	O	-1	8617710
the	O	-1	8617710
impair@@	O	-1	8617710
ment	O	-1	8617710
produced	O	-1	8617710
by	O	-1	8617710
haloperidol	B-Chemical	D006220	8617710
s@@	O	-1	8617710
inc@@	O	-1	8617710
e	O	-1	8617710
an	O	-1	8617710
equ@@	O	-1	8617710
i@@	O	-1	8617710
val@@	O	-1	8617710
ent	O	-1	8617710
effect	O	-1	8617710
also	O	-1	8617710
occurred	O	-1	8617710
in	O	-1	8617710
the	O	-1	8617710
placebo	O	-1	8617710
group.	O	-1	8617710
Th@@	O	-1	8617710
ree	O	-1	8617710
subjects	O	-1	8617710
(@@	O	-1	8617710
2	O	-1	8617710
on	O	-1	8617710
ser@@	B-Chemical	D020280	8617710
tr@@	I-Chemical	-1	8617710
aline	I-Chemical	-1	8617710
and	O	-1	8617710
1	O	-1	8617710
on	O	-1	8617710
placebo@@	O	-1	8617710
)	O	-1	8617710
with@@	O	-1	8617710
d@@	O	-1	8617710
re@@	O	-1	8617710
w	O	-1	8617710
from	O	-1	8617710
the	O	-1	8617710
study	O	-1	8617710
because	O	-1	8617710
of	O	-1	8617710
side	O	-1	8617710
effects.	O	-1	8617710
T@@	O	-1	8617710
en	O	-1	8617710
subjects	O	-1	8617710
in	O	-1	8617710
each	O	-1	8617710
group	O	-1	8617710
reported	O	-1	8617710
side	O	-1	8617710
effects	O	-1	8617710
related	O	-1	8617710
to	O	-1	8617710
treatment.	O	-1	8617710
The	O	-1	8617710
side	O	-1	8617710
effect	O	-1	8617710
pro@@	O	-1	8617710
fi@@	O	-1	8617710
le@@	O	-1	8617710
s	O	-1	8617710
of	O	-1	8617710
ser@@	B-Chemical	D020280	8617710
tr@@	I-Chemical	-1	8617710
aline	I-Chemical	-1	8617710
and	O	-1	8617710
of	O	-1	8617710
placebo	O	-1	8617710
were	O	-1	8617710
simil@@	O	-1	8617710
ar@@	O	-1	8617710
.	O	-1	8617710
CONCLUSION:	O	-1	8617710
H@@	B-Chemical	D006220	8617710
alo@@	I-Chemical	-1	8617710
perid@@	I-Chemical	-1	8617710
ol	I-Chemical	-1	8617710
produced	O	-1	8617710
a	O	-1	8617710
c@@	O	-1	8617710
le@@	O	-1	8617710
ar	O	-1	8617710
prof@@	O	-1	8617710
ile	O	-1	8617710
of	O	-1	8617710
cognitive	B-Disease	D003072	8617710
impair@@	I-Disease	-1	8617710
ment	I-Disease	-1	8617710
that	O	-1	8617710
was	O	-1	8617710
not	O	-1	8617710
wor@@	O	-1	8617710
sen@@	O	-1	8617710
ed	O	-1	8617710
by	O	-1	8617710
concomit@@	O	-1	8617710
ant	O	-1	8617710
ser@@	B-Chemical	D020280	8617710
tr@@	I-Chemical	-1	8617710
aline	I-Chemical	-1	8617710
administr@@	O	-1	8617710
ation.	O	-1	8617710

C@@	B-Chemical	D002939	8494478
i@@	I-Chemical	-1	8494478
prof@@	I-Chemical	-1	8494478
lo@@	I-Chemical	-1	8494478
x@@	I-Chemical	-1	8494478
ac@@	I-Chemical	-1	8494478
in	I-Chemical	-1	8494478
-induced	O	-1	8494478
nephro@@	B-Disease	D007674	8494478
toxicity	I-Disease	-1	8494478
in	O	-1	8494478
patients	O	-1	8494478
with	O	-1	8494478
cancer	B-Disease	D009369	8494478
.	O	-1	8494478
Ne@@	B-Disease	D007674	8494478
ph@@	I-Disease	-1	8494478
ro@@	I-Disease	-1	8494478
toxicity	I-Disease	-1	8494478
associated	O	-1	8494478
with	O	-1	8494478
ci@@	B-Chemical	D002939	8494478
prof@@	I-Chemical	-1	8494478
lo@@	I-Chemical	-1	8494478
x@@	I-Chemical	-1	8494478
ac@@	I-Chemical	-1	8494478
in	I-Chemical	-1	8494478
is	O	-1	8494478
un@@	O	-1	8494478
common@@	O	-1	8494478
.	O	-1	8494478
F@@	O	-1	8494478
i@@	O	-1	8494478
ve	O	-1	8494478
patients	O	-1	8494478
with	O	-1	8494478
cancer	B-Disease	D009369	8494478
who	O	-1	8494478
developed	O	-1	8494478
acute	B-Disease	D058186	8494478
renal	I-Disease	-1	8494478
failure	I-Disease	-1	8494478
that	O	-1	8494478
followed	O	-1	8494478
treatment	O	-1	8494478
with	O	-1	8494478
ci@@	B-Chemical	D002939	8494478
prof@@	I-Chemical	-1	8494478
lo@@	I-Chemical	-1	8494478
x@@	I-Chemical	-1	8494478
ac@@	I-Chemical	-1	8494478
in	I-Chemical	-1	8494478
are	O	-1	8494478
descri@@	O	-1	8494478
bed	O	-1	8494478
and	O	-1	8494478
an	O	-1	8494478
addi@@	O	-1	8494478
tional	O	-1	8494478
15	O	-1	8494478
cases	O	-1	8494478
reported	O	-1	8494478
in	O	-1	8494478
the	O	-1	8494478
literat@@	O	-1	8494478
ure	O	-1	8494478
are	O	-1	8494478
revie@@	O	-1	8494478
we@@	O	-1	8494478
d.	O	-1	8494478
O@@	O	-1	8494478
ther	O	-1	8494478
than	O	-1	8494478
elev@@	O	-1	8494478
ation	O	-1	8494478
of	O	-1	8494478
serum	O	-1	8494478
creatinine	B-Chemical	D003404	8494478
level@@	O	-1	8494478
s,	O	-1	8494478
character@@	O	-1	8494478
istic	O	-1	8494478
clinical	O	-1	8494478
man@@	O	-1	8494478
if@@	O	-1	8494478
est@@	O	-1	8494478
ations	O	-1	8494478
and	O	-1	8494478
ab@@	O	-1	8494478
normal	O	-1	8494478
labor@@	O	-1	8494478
atory	O	-1	8494478
findings	O	-1	8494478
are	O	-1	8494478
not	O	-1	8494478
frequ@@	O	-1	8494478
ently	O	-1	8494478
present@@	O	-1	8494478
.	O	-1	8494478
A@@	O	-1	8494478
ll@@	O	-1	8494478
ergic	O	-1	8494478
interstitial	B-Disease	D009395	8494478
neph@@	I-Disease	-1	8494478
ritis	I-Disease	-1	8494478
is	O	-1	8494478
be@@	O	-1	8494478
li@@	O	-1	8494478
ev@@	O	-1	8494478
ed	O	-1	8494478
to	O	-1	8494478
be	O	-1	8494478
the	O	-1	8494478
underlying	O	-1	8494478
path@@	O	-1	8494478
olog@@	O	-1	8494478
ic@@	O	-1	8494478
al@@	O	-1	8494478
-@@	O	-1	8494478
pro@@	O	-1	8494478
ces@@	O	-1	8494478
s.	O	-1	8494478
De@@	O	-1	8494478
f@@	O	-1	8494478
in@@	O	-1	8494478
itive	O	-1	8494478
diagnosis	O	-1	8494478
requ@@	O	-1	8494478
i@@	O	-1	8494478
res	O	-1	8494478
perform@@	O	-1	8494478
ance	O	-1	8494478
of	O	-1	8494478
renal	O	-1	8494478
bio@@	O	-1	8494478
psy@@	O	-1	8494478
,	O	-1	8494478
although	O	-1	8494478
this	O	-1	8494478
is	O	-1	8494478
not	O	-1	8494478
al@@	O	-1	8494478
w@@	O	-1	8494478
ays	O	-1	8494478
fe@@	O	-1	8494478
a@@	O	-1	8494478
sib@@	O	-1	8494478
le@@	O	-1	8494478
.	O	-1	8494478
An	O	-1	8494478
impro@@	O	-1	8494478
vement	O	-1	8494478
in	O	-1	8494478
renal	O	-1	8494478
function	O	-1	8494478
that	O	-1	8494478
followed	O	-1	8494478
the	O	-1	8494478
discontinu@@	O	-1	8494478
ation	O	-1	8494478
of	O	-1	8494478
the	O	-1	8494478
o@@	O	-1	8494478
ff@@	O	-1	8494478
en@@	O	-1	8494478
ding	O	-1	8494478
anti@@	O	-1	8494478
bio@@	O	-1	8494478
tic	O	-1	8494478
suppor@@	O	-1	8494478
ts	O	-1	8494478
the	O	-1	8494478
pres@@	O	-1	8494478
um@@	O	-1	8494478
p@@	O	-1	8494478
tive	O	-1	8494478
diagnosis	O	-1	8494478
of	O	-1	8494478
ci@@	B-Chemical	D002939	8494478
prof@@	I-Chemical	-1	8494478
lo@@	I-Chemical	-1	8494478
x@@	I-Chemical	-1	8494478
ac@@	I-Chemical	-1	8494478
in	I-Chemical	-1	8494478
-induced	O	-1	8494478
acute	B-Disease	D058186	8494478
renal	I-Disease	-1	8494478
failure	I-Disease	-1	8494478
.	O	-1	8494478

C@@	O	-1	8475949
ase	O	-1	8475949
repor@@	O	-1	8475949
t@@	O	-1	8475949
:	O	-1	8475949
pent@@	B-Chemical	D010419	8475949
am@@	I-Chemical	-1	8475949
idine	I-Chemical	-1	8475949
and	O	-1	8475949
poly@@	O	-1	8475949
morph@@	O	-1	8475949
ic	O	-1	8475949
ventricular	B-Disease	D017180	8475949
tachycardia	I-Disease	-1	8475949
re@@	O	-1	8475949
v@@	O	-1	8475949
is@@	O	-1	8475949
it@@	O	-1	8475949
ed.	O	-1	8475949
P@@	B-Chemical	D010419	8475949
ent@@	I-Chemical	-1	8475949
am@@	I-Chemical	-1	8475949
idine	I-Chemical	-1	8475949
i@@	I-Chemical	-1	8475949
se@@	I-Chemical	-1	8475949
thi@@	I-Chemical	-1	8475949
on@@	I-Chemical	-1	8475949
ate	I-Chemical	-1	8475949
has	O	-1	8475949
been	O	-1	8475949
associated	O	-1	8475949
with	O	-1	8475949
ventricular	B-Disease	D017180	8475949
tachy@@	I-Disease	-1	8475949
arrhyth@@	I-Disease	-1	8475949
mi@@	I-Disease	-1	8475949
as	I-Disease	-1	8475949
,	O	-1	8475949
including	O	-1	8475949
t@@	B-Disease	D016171	8475949
or@@	I-Disease	-1	8475949
s@@	I-Disease	-1	8475949
ade	I-Disease	-1	8475949
de	I-Disease	-1	8475949
po@@	I-Disease	-1	8475949
int@@	I-Disease	-1	8475949
es	I-Disease	-1	8475949
.	O	-1	8475949
This	O	-1	8475949
ar@@	O	-1	8475949
tic@@	O	-1	8475949
le	O	-1	8475949
reports	O	-1	8475949
two	O	-1	8475949
cases	O	-1	8475949
of	O	-1	8475949
this	O	-1	8475949
complication	O	-1	8475949
and	O	-1	8475949
revie@@	O	-1	8475949
w@@	O	-1	8475949
s	O	-1	8475949
all	O	-1	8475949
reported	O	-1	8475949
cases	O	-1	8475949
to	O	-1	8475949
dat@@	O	-1	8475949
e.	O	-1	8475949
P@@	B-Chemical	D010419	8475949
ent@@	I-Chemical	-1	8475949
am@@	I-Chemical	-1	8475949
idine	I-Chemical	-1	8475949
-induced	O	-1	8475949
t@@	B-Disease	D016171	8475949
or@@	I-Disease	-1	8475949
s@@	I-Disease	-1	8475949
ade	I-Disease	-1	8475949
de	I-Disease	-1	8475949
po@@	I-Disease	-1	8475949
int@@	I-Disease	-1	8475949
es	I-Disease	-1	8475949
may	O	-1	8475949
be	O	-1	8475949
related	O	-1	8475949
to	O	-1	8475949
serum	O	-1	8475949
mag@@	B-Chemical	D008274	8475949
ne@@	I-Chemical	-1	8475949
si@@	I-Chemical	-1	8475949
um	I-Chemical	-1	8475949
levels	O	-1	8475949
and	O	-1	8475949
hypo@@	B-Disease	C537153	8475949
mag@@	I-Disease	-1	8475949
n@@	I-Disease	-1	8475949
es@@	I-Disease	-1	8475949
emia	I-Disease	-1	8475949
may	O	-1	8475949
syn@@	O	-1	8475949
erg@@	O	-1	8475949
is@@	O	-1	8475949
tically	O	-1	8475949
induce	O	-1	8475949
t@@	O	-1	8475949
or@@	O	-1	8475949
sa@@	O	-1	8475949
de@@	O	-1	8475949
.	O	-1	8475949
T@@	B-Disease	D016171	8475949
or@@	I-Disease	-1	8475949
s@@	I-Disease	-1	8475949
ade	I-Disease	-1	8475949
de	I-Disease	-1	8475949
po@@	I-Disease	-1	8475949
int@@	I-Disease	-1	8475949
es	I-Disease	-1	8475949
occurred	O	-1	8475949
after	O	-1	8475949
an	O	-1	8475949
average	O	-1	8475949
of	O	-1	8475949
10	O	-1	8475949
days	O	-1	8475949
of	O	-1	8475949
treatment	O	-1	8475949
with	O	-1	8475949
pent@@	B-Chemical	D010419	8475949
am@@	I-Chemical	-1	8475949
idine	I-Chemical	-1	8475949
.	O	-1	8475949
In	O	-1	8475949
these	O	-1	8475949
patients,	O	-1	8475949
no	O	-1	8475949
other	O	-1	8475949
acute	O	-1	8475949
side	O	-1	8475949
effects	O	-1	8475949
of	O	-1	8475949
pent@@	B-Chemical	D010419	8475949
am@@	I-Chemical	-1	8475949
idine	I-Chemical	-1	8475949
were	O	-1	8475949
obser@@	O	-1	8475949
ved.	O	-1	8475949
T@@	B-Disease	D016171	8475949
or@@	I-Disease	-1	8475949
s@@	I-Disease	-1	8475949
ade	I-Disease	-1	8475949
de	I-Disease	-1	8475949
po@@	I-Disease	-1	8475949
int@@	I-Disease	-1	8475949
es	I-Disease	-1	8475949
can	O	-1	8475949
be	O	-1	8475949
treated	O	-1	8475949
when	O	-1	8475949
reco@@	O	-1	8475949
gn@@	O	-1	8475949
ized	O	-1	8475949
ear@@	O	-1	8475949
ly,	O	-1	8475949
possib@@	O	-1	8475949
ly	O	-1	8475949
without	O	-1	8475949
discontinu@@	O	-1	8475949
ation	O	-1	8475949
of	O	-1	8475949
pent@@	B-Chemical	D010419	8475949
am@@	I-Chemical	-1	8475949
idine	I-Chemical	-1	8475949
.	O	-1	8475949
Whe@@	O	-1	8475949
n	O	-1	8475949
Q@@	B-Disease	D008133	8475949
T@@	I-Disease	-1	8475949
c	I-Disease	-1	8475949
interv@@	I-Disease	-1	8475949
al	I-Disease	-1	8475949
prolong@@	I-Disease	-1	8475949
ation	I-Disease	-1	8475949
is	O	-1	8475949
obser@@	O	-1	8475949
ve@@	O	-1	8475949
d,	O	-1	8475949
early	O	-1	8475949
mag@@	B-Chemical	D008274	8475949
ne@@	I-Chemical	-1	8475949
si@@	I-Chemical	-1	8475949
um	I-Chemical	-1	8475949
sup@@	O	-1	8475949
ple@@	O	-1	8475949
ment@@	O	-1	8475949
ation	O	-1	8475949
is	O	-1	8475949
adv@@	O	-1	8475949
oc@@	O	-1	8475949
ated.	O	-1	8475949

T@@	O	-1	7710775
im@@	O	-1	7710775
e	O	-1	7710775
depend@@	O	-1	7710775
ence	O	-1	7710775
of	O	-1	7710775
plasma	O	-1	7710775
mal@@	B-Chemical	D008315	7710775
on@@	I-Chemical	-1	7710775
di@@	I-Chemical	-1	7710775
al@@	I-Chemical	-1	7710775
de@@	I-Chemical	-1	7710775
hy@@	I-Chemical	-1	7710775
de	I-Chemical	-1	7710775
,	O	-1	7710775
oxy@@	B-Chemical	-1	7710775
pur@@	I-Chemical	-1	7710775
in@@	I-Chemical	-1	7710775
es	I-Chemical	-1	7710775
,	O	-1	7710775
and	O	-1	7710775
nucle@@	B-Chemical	D009705	7710775
o@@	I-Chemical	-1	7710775
side@@	I-Chemical	-1	7710775
s	I-Chemical	-1	7710775
during	O	-1	7710775
in@@	O	-1	7710775
complete	O	-1	7710775
cerebral	B-Disease	D002545	7710775
ischem@@	I-Disease	-1	7710775
ia	I-Disease	-1	7710775
in	O	-1	7710775
the	O	-1	7710775
rat@@	O	-1	7710775
.	O	-1	7710775
In@@	O	-1	7710775
complete	O	-1	7710775
cerebral	B-Disease	D002545	7710775
ischem@@	I-Disease	-1	7710775
ia	I-Disease	-1	7710775
(@@	O	-1	7710775
30	O	-1	7710775
min@@	O	-1	7710775
)	O	-1	7710775
was	O	-1	7710775
induced	O	-1	7710775
in	O	-1	7710775
the	O	-1	7710775
rat	O	-1	7710775
by	O	-1	7710775
bil@@	O	-1	7710775
at@@	O	-1	7710775
er@@	O	-1	7710775
ally	O	-1	7710775
cl@@	O	-1	7710775
amp@@	O	-1	7710775
ing	O	-1	7710775
the	O	-1	7710775
common	O	-1	7710775
ca@@	O	-1	7710775
ro@@	O	-1	7710775
ti@@	O	-1	7710775
d	O	-1	7710775
arter@@	O	-1	7710775
i@@	O	-1	7710775
es.	O	-1	7710775
P@@	O	-1	7710775
er@@	O	-1	7710775
i@@	O	-1	7710775
pheral	O	-1	7710775
venous	O	-1	7710775
blood	O	-1	7710775
sam@@	O	-1	7710775
ple@@	O	-1	7710775
s	O	-1	7710775
were	O	-1	7710775
withdraw@@	O	-1	7710775
n	O	-1	7710775
from	O	-1	7710775
the	O	-1	7710775
fem@@	O	-1	7710775
oral	O	-1	7710775
ve@@	O	-1	7710775
in	O	-1	7710775
four	O	-1	7710775
times	O	-1	7710775
(@@	O	-1	7710775
on@@	O	-1	7710775
ce	O	-1	7710775
every	O	-1	7710775
5	O	-1	7710775
min@@	O	-1	7710775
)	O	-1	7710775
before	O	-1	7710775
ischem@@	B-Disease	D007511	7710775
ia	I-Disease	-1	7710775
(@@	O	-1	7710775
0	O	-1	7710775
ti@@	O	-1	7710775
me@@	O	-1	7710775
)	O	-1	7710775
and	O	-1	7710775
5,	O	-1	7710775
1@@	O	-1	7710775
5,	O	-1	7710775
and	O	-1	7710775
30	O	-1	7710775
min	O	-1	7710775
after	O	-1	7710775
ischem@@	B-Disease	D007511	7710775
ia	I-Disease	-1	7710775
.	O	-1	7710775
P@@	O	-1	7710775
las@@	O	-1	7710775
ma	O	-1	7710775
extrac@@	O	-1	7710775
ts	O	-1	7710775
were	O	-1	7710775
analy@@	O	-1	7710775
zed	O	-1	7710775
by	O	-1	7710775
a	O	-1	7710775
high@@	O	-1	7710775
ly	O	-1	7710775
sensitive	O	-1	7710775
high-@@	O	-1	7710775
perform@@	O	-1	7710775
ance	O	-1	7710775
li@@	O	-1	7710775
qu@@	O	-1	7710775
id	O	-1	7710775
ch@@	O	-1	7710775
rom@@	O	-1	7710775
at@@	O	-1	7710775
ograph@@	O	-1	7710775
ic	O	-1	7710775
meth@@	O	-1	7710775
od	O	-1	7710775
for	O	-1	7710775
the	O	-1	7710775
direct	O	-1	7710775
determin@@	O	-1	7710775
ation	O	-1	7710775
of	O	-1	7710775
mal@@	B-Chemical	D008315	7710775
on@@	I-Chemical	-1	7710775
di@@	I-Chemical	-1	7710775
al@@	I-Chemical	-1	7710775
de@@	I-Chemical	-1	7710775
hy@@	I-Chemical	-1	7710775
de	I-Chemical	-1	7710775
,	O	-1	7710775
oxy@@	B-Chemical	-1	7710775
pur@@	I-Chemical	-1	7710775
in@@	I-Chemical	-1	7710775
es	I-Chemical	-1	7710775
,	O	-1	7710775
and	O	-1	7710775
nucle@@	B-Chemical	D009705	7710775
o@@	I-Chemical	-1	7710775
side@@	I-Chemical	-1	7710775
s	I-Chemical	-1	7710775
.	O	-1	7710775
D@@	O	-1	7710775
uring	O	-1	7710775
ischem@@	B-Disease	D007511	7710775
ia	I-Disease	-1	7710775
,	O	-1	7710775
a	O	-1	7710775
ti@@	O	-1	7710775
me@@	O	-1	7710775
-@@	O	-1	7710775
dependent	O	-1	7710775
increase	O	-1	7710775
of	O	-1	7710775
plasma	O	-1	7710775
oxy@@	B-Chemical	-1	7710775
pur@@	I-Chemical	-1	7710775
in@@	I-Chemical	-1	7710775
es	I-Chemical	-1	7710775
and	O	-1	7710775
nucle@@	B-Chemical	D009705	7710775
o@@	I-Chemical	-1	7710775
side@@	I-Chemical	-1	7710775
s	I-Chemical	-1	7710775
was	O	-1	7710775
obser@@	O	-1	7710775
ved.	O	-1	7710775
P@@	O	-1	7710775
las@@	O	-1	7710775
ma	O	-1	7710775
mal@@	B-Chemical	D008315	7710775
on@@	I-Chemical	-1	7710775
di@@	I-Chemical	-1	7710775
al@@	I-Chemical	-1	7710775
de@@	I-Chemical	-1	7710775
hy@@	I-Chemical	-1	7710775
de	I-Chemical	-1	7710775
,	O	-1	7710775
which	O	-1	7710775
was	O	-1	7710775
present	O	-1	7710775
in	O	-1	7710775
minim@@	O	-1	7710775
al	O	-1	7710775
amoun@@	O	-1	7710775
t	O	-1	7710775
at	O	-1	7710775
z@@	O	-1	7710775
er@@	O	-1	7710775
o	O	-1	7710775
time	O	-1	7710775
(@@	O	-1	7710775
0.05@@	O	-1	7710775
8	O	-1	7710775
m@@	O	-1	7710775
um@@	O	-1	7710775
ol@@	O	-1	7710775
/@@	O	-1	7710775
lit@@	O	-1	7710775
er	O	-1	7710775
plas@@	O	-1	7710775
ma@@	O	-1	7710775
;	O	-1	7710775
S@@	O	-1	7710775
D	O	-1	7710775
0.0@@	O	-1	7710775
1@@	O	-1	7710775
5@@	O	-1	7710775
),	O	-1	7710775
increased	O	-1	7710775
after	O	-1	7710775
5	O	-1	7710775
min	O	-1	7710775
of	O	-1	7710775
ischem@@	B-Disease	D007511	7710775
ia	I-Disease	-1	7710775
,	O	-1	7710775
result@@	O	-1	7710775
ing	O	-1	7710775
in	O	-1	7710775
a	O	-1	7710775
fi@@	O	-1	7710775
ve@@	O	-1	7710775
fol@@	O	-1	7710775
d	O	-1	7710775
increase	O	-1	7710775
after	O	-1	7710775
30	O	-1	7710775
min	O	-1	7710775
of	O	-1	7710775
ca@@	O	-1	7710775
ro@@	O	-1	7710775
ti@@	O	-1	7710775
d	O	-1	7710775
oc@@	O	-1	7710775
cl@@	O	-1	7710775
usion	O	-1	7710775
(0.@@	O	-1	7710775
2@@	O	-1	7710775
9@@	O	-1	7710775
8	O	-1	7710775
m@@	O	-1	7710775
um@@	O	-1	7710775
ol@@	O	-1	7710775
/@@	O	-1	7710775
lit@@	O	-1	7710775
er	O	-1	7710775
plas@@	O	-1	7710775
ma@@	O	-1	7710775
;	O	-1	7710775
S@@	O	-1	7710775
D	O	-1	7710775
0.0@@	O	-1	7710775
7@@	O	-1	7710775
8@@	O	-1	7710775
).	O	-1	7710775
In@@	O	-1	7710775
c@@	O	-1	7710775
reas@@	O	-1	7710775
ed	O	-1	7710775
plasma	O	-1	7710775
mal@@	B-Chemical	D008315	7710775
on@@	I-Chemical	-1	7710775
di@@	I-Chemical	-1	7710775
al@@	I-Chemical	-1	7710775
de@@	I-Chemical	-1	7710775
hy@@	I-Chemical	-1	7710775
de	I-Chemical	-1	7710775
was	O	-1	7710775
also	O	-1	7710775
recor@@	O	-1	7710775
ded	O	-1	7710775
in	O	-1	7710775
two	O	-1	7710775
other	O	-1	7710775
groups	O	-1	7710775
of	O	-1	7710775
animals	O	-1	7710775
subj@@	O	-1	7710775
ected	O	-1	7710775
to	O	-1	7710775
the	O	-1	7710775
same	O	-1	7710775
experimental	O	-1	7710775
model@@	O	-1	7710775
,	O	-1	7710775
one	O	-1	7710775
receiving	O	-1	7710775
20	O	-1	7710775
mg/kg	O	-1	7710775
b@@	O	-1	7710775
.@@	O	-1	7710775
w@@	O	-1	7710775
.	O	-1	7710775
of	O	-1	7710775
the	O	-1	7710775
cyclo@@	O	-1	7710775
oxy@@	O	-1	7710775
gen@@	O	-1	7710775
ase	O	-1	7710775
inhibitor	O	-1	7710775
acet@@	B-Chemical	D001241	7710775
yl@@	I-Chemical	-1	7710775
sal@@	I-Chemical	-1	7710775
ic@@	I-Chemical	-1	7710775
yl@@	I-Chemical	-1	7710775
ate	I-Chemical	-1	7710775
intra@@	O	-1	7710775
ven@@	O	-1	7710775
ously	O	-1	7710775
immedi@@	O	-1	7710775
ately	O	-1	7710775
before	O	-1	7710775
ischem@@	B-Disease	D007511	7710775
ia	I-Disease	-1	7710775
,	O	-1	7710775
the	O	-1	7710775
other	O	-1	7710775
receiving	O	-1	7710775
6@@	O	-1	7710775
50	O	-1	7710775
microgram@@	O	-1	7710775
s/@@	O	-1	7710775
k@@	O	-1	7710775
g	O	-1	7710775
b@@	O	-1	7710775
.@@	O	-1	7710775
w@@	O	-1	7710775
.	O	-1	7710775
of	O	-1	7710775
the	O	-1	7710775
hypoten@@	B-Disease	D007022	7710775
sive	I-Disease	-1	7710775
drug	O	-1	7710775
nitro@@	B-Chemical	D009599	7710775
pr@@	I-Chemical	-1	7710775
us@@	I-Chemical	-1	7710775
side	I-Chemical	-1	7710775
at	O	-1	7710775
a	O	-1	7710775
flow	O	-1	7710775
rate	O	-1	7710775
of	O	-1	7710775
10@@	O	-1	7710775
3	O	-1	7710775
micro@@	O	-1	7710775
liter@@	O	-1	7710775
s/@@	O	-1	7710775
min	O	-1	7710775
intra@@	O	-1	7710775
ven@@	O	-1	7710775
ously	O	-1	7710775
during	O	-1	7710775
ischem@@	B-Disease	D007511	7710775
ia	I-Disease	-1	7710775
,	O	-1	7710775
although	O	-1	7710775
in	O	-1	7710775
this	O	-1	7710775
lat@@	O	-1	7710775
ter	O	-1	7710775
group	O	-1	7710775
mal@@	B-Chemical	D008315	7710775
on@@	I-Chemical	-1	7710775
di@@	I-Chemical	-1	7710775
al@@	I-Chemical	-1	7710775
de@@	I-Chemical	-1	7710775
hy@@	I-Chemical	-1	7710775
de	I-Chemical	-1	7710775
was	O	-1	7710775
significantly	O	-1	7710775
high@@	O	-1	7710775
er.	O	-1	7710775
The	O	-1	7710775
present	O	-1	7710775
data	O	-1	7710775
indicate	O	-1	7710775
that	O	-1	7710775
the	O	-1	7710775
determin@@	O	-1	7710775
ation	O	-1	7710775
of	O	-1	7710775
mal@@	B-Chemical	D008315	7710775
on@@	I-Chemical	-1	7710775
di@@	I-Chemical	-1	7710775
al@@	I-Chemical	-1	7710775
de@@	I-Chemical	-1	7710775
hy@@	I-Chemical	-1	7710775
de	I-Chemical	-1	7710775
,	O	-1	7710775
oxy@@	B-Chemical	-1	7710775
pur@@	I-Chemical	-1	7710775
in@@	I-Chemical	-1	7710775
es	I-Chemical	-1	7710775
,	O	-1	7710775
and	O	-1	7710775
nucle@@	B-Chemical	D009705	7710775
o@@	I-Chemical	-1	7710775
side@@	I-Chemical	-1	7710775
s	I-Chemical	-1	7710775
in	O	-1	7710775
peripheral	O	-1	7710775
blo@@	O	-1	7710775
o@@	O	-1	7710775
d,	O	-1	7710775
may	O	-1	7710775
be	O	-1	7710775
used	O	-1	7710775
to	O	-1	7710775
monit@@	O	-1	7710775
or	O	-1	7710775
the	O	-1	7710775
met@@	O	-1	7710775
ab@@	O	-1	7710775
olic	O	-1	7710775
al@@	O	-1	7710775
ter@@	O	-1	7710775
ations	O	-1	7710775
of	O	-1	7710775
tissu@@	O	-1	7710775
es	O	-1	7710775
occur@@	O	-1	7710775
r@@	O	-1	7710775
ing	O	-1	7710775
during	O	-1	7710775
ischem@@	B-Disease	D007511	7710775
ic	I-Disease	-1	7710775
phen@@	O	-1	7710775
om@@	O	-1	7710775
en@@	O	-1	7710775
a@@	O	-1	7710775
.@@	O	-1	7710775
(A@@	O	-1	7710775
B@@	O	-1	7710775
S@@	O	-1	7710775
TR@@	O	-1	7710775
AC@@	O	-1	7710775
T	O	-1	7710775
TR@@	O	-1	7710775
UN@@	O	-1	7710775
C@@	O	-1	7710775
AT@@	O	-1	7710775
E@@	O	-1	7710775
D	O	-1	7710775
A@@	O	-1	7710775
T	O	-1	7710775
2@@	O	-1	7710775
50	O	-1	7710775
W@@	O	-1	7710775
O@@	O	-1	7710775
RD@@	O	-1	7710775
S)	O	-1	7710775

Ch@@	O	-1	7650771
ol@@	O	-1	7650771
inergic	O	-1	7650771
toxicity	B-Disease	D064420	7650771
result@@	O	-1	7650771
ing	O	-1	7650771
from	O	-1	7650771
oc@@	O	-1	7650771
ular	O	-1	7650771
insti@@	O	-1	7650771
ll@@	O	-1	7650771
ation	O	-1	7650771
of	O	-1	7650771
ec@@	B-Chemical	D004456	7650771
ho@@	I-Chemical	-1	7650771
th@@	I-Chemical	-1	7650771
io@@	I-Chemical	-1	7650771
ph@@	I-Chemical	-1	7650771
ate	I-Chemical	-1	7650771
io@@	I-Chemical	-1	7650771
di@@	I-Chemical	-1	7650771
de	I-Chemical	-1	7650771
e@@	O	-1	7650771
y@@	O	-1	7650771
e	O	-1	7650771
dro@@	O	-1	7650771
p@@	O	-1	7650771
s.	O	-1	7650771
A	O	-1	7650771
patient	O	-1	7650771
developed	O	-1	7650771
a	O	-1	7650771
severe	O	-1	7650771
cholinergic	O	-1	7650771
syndrome	O	-1	7650771
from	O	-1	7650771
the	O	-1	7650771
use	O	-1	7650771
of	O	-1	7650771
ec@@	B-Chemical	D004456	7650771
ho@@	I-Chemical	-1	7650771
th@@	I-Chemical	-1	7650771
io@@	I-Chemical	-1	7650771
ph@@	I-Chemical	-1	7650771
ate	I-Chemical	-1	7650771
io@@	I-Chemical	-1	7650771
di@@	I-Chemical	-1	7650771
de	I-Chemical	-1	7650771
oph@@	O	-1	7650771
thal@@	O	-1	7650771
mic	O	-1	7650771
dro@@	O	-1	7650771
p@@	O	-1	7650771
s,	O	-1	7650771
presented	O	-1	7650771
with	O	-1	7650771
pro@@	O	-1	7650771
found	O	-1	7650771
musc@@	B-Disease	D018908	7650771
le	I-Disease	-1	7650771
we@@	I-Disease	-1	7650771
ak@@	I-Disease	-1	7650771
ness	I-Disease	-1	7650771
and	O	-1	7650771
was	O	-1	7650771
initi@@	O	-1	7650771
ally	O	-1	7650771
given	O	-1	7650771
the	O	-1	7650771
diagnosis	O	-1	7650771
of	O	-1	7650771
my@@	B-Disease	D009157	7650771
as@@	I-Disease	-1	7650771
th@@	I-Disease	-1	7650771
en@@	I-Disease	-1	7650771
ia	I-Disease	-1	7650771
gra@@	I-Disease	-1	7650771
v@@	I-Disease	-1	7650771
is	I-Disease	-1	7650771
.	O	-1	7650771
R@@	O	-1	7650771
ed	O	-1	7650771
blood	O	-1	7650771
cell	O	-1	7650771
and	O	-1	7650771
serum	O	-1	7650771
chol@@	O	-1	7650771
ine@@	O	-1	7650771
ster@@	O	-1	7650771
ase	O	-1	7650771
levels	O	-1	7650771
were	O	-1	7650771
se@@	O	-1	7650771
ve@@	O	-1	7650771
re@@	O	-1	7650771
ly	O	-1	7650771
depress@@	O	-1	7650771
ed	O	-1	7650771
and	O	-1	7650771
symptoms	O	-1	7650771
resol@@	O	-1	7650771
ved	O	-1	7650771
spont@@	O	-1	7650771
ane@@	O	-1	7650771
ously	O	-1	7650771
following	O	-1	7650771
discontinu@@	O	-1	7650771
ation	O	-1	7650771
of	O	-1	7650771
the	O	-1	7650771
e@@	O	-1	7650771
y@@	O	-1	7650771
e	O	-1	7650771
dro@@	O	-1	7650771
p@@	O	-1	7650771
s.	O	-1	7650771

Ac@@	B-Disease	D058186	7565311
ute	I-Disease	-1	7565311
renal	I-Disease	-1	7565311
failure	I-Disease	-1	7565311
in	O	-1	7565311
high	O	-1	7565311
dose	O	-1	7565311
car@@	B-Chemical	D016190	7565311
bo@@	I-Chemical	-1	7565311
pl@@	I-Chemical	-1	7565311
atin	I-Chemical	-1	7565311
chemo@@	O	-1	7565311
therapy.	O	-1	7565311
C@@	B-Chemical	D016190	7565311
ar@@	I-Chemical	-1	7565311
bo@@	I-Chemical	-1	7565311
pl@@	I-Chemical	-1	7565311
atin	I-Chemical	-1	7565311
has	O	-1	7565311
been	O	-1	7565311
reported	O	-1	7565311
to	O	-1	7565311
cause	O	-1	7565311
acute	B-Disease	D058186	7565311
renal	I-Disease	-1	7565311
failure	I-Disease	-1	7565311
when	O	-1	7565311
administered	O	-1	7565311
in	O	-1	7565311
high	O	-1	7565311
doses	O	-1	7565311
to	O	-1	7565311
ad@@	O	-1	7565311
ult	O	-1	7565311
patients.	O	-1	7565311
We	O	-1	7565311
report	O	-1	7565311
a	O	-1	7565311
4	O	-1	7565311
1@@	O	-1	7565311
/@@	O	-1	7565311
2-@@	O	-1	7565311
year-old	O	-1	7565311
gi@@	O	-1	7565311
r@@	O	-1	7565311
l	O	-1	7565311
who	O	-1	7565311
was	O	-1	7565311
treated	O	-1	7565311
with	O	-1	7565311
high-dose	O	-1	7565311
car@@	B-Chemical	D016190	7565311
bo@@	I-Chemical	-1	7565311
pl@@	I-Chemical	-1	7565311
atin	I-Chemical	-1	7565311
for	O	-1	7565311
met@@	O	-1	7565311
ast@@	O	-1	7565311
atic	O	-1	7565311
par@@	O	-1	7565311
am@@	O	-1	7565311
en@@	O	-1	7565311
ing@@	O	-1	7565311
e@@	O	-1	7565311
al	O	-1	7565311
emb@@	B-Disease	D018233	7565311
r@@	I-Disease	-1	7565311
y@@	I-Disease	-1	7565311
on@@	I-Disease	-1	7565311
al	I-Disease	-1	7565311
rh@@	I-Disease	-1	7565311
ab@@	I-Disease	-1	7565311
do@@	I-Disease	-1	7565311
my@@	I-Disease	-1	7565311
os@@	I-Disease	-1	7565311
ar@@	I-Disease	-1	7565311
com@@	I-Disease	-1	7565311
a	I-Disease	-1	7565311
.	O	-1	7565311
Ac@@	B-Disease	D058186	7565311
ute	I-Disease	-1	7565311
renal	I-Disease	-1	7565311
failure	I-Disease	-1	7565311
developed	O	-1	7565311
followed	O	-1	7565311
by	O	-1	7565311
a	O	-1	7565311
s@@	O	-1	7565311
low	O	-1	7565311
partial	O	-1	7565311
recovery	O	-1	7565311
of	O	-1	7565311
renal	O	-1	7565311
func@@	O	-1	7565311
tion.	O	-1	7565311
P@@	O	-1	7565311
os@@	O	-1	7565311
sible	O	-1	7565311
cont@@	O	-1	7565311
ri@@	O	-1	7565311
but@@	O	-1	7565311
ing	O	-1	7565311
factors	O	-1	7565311
are	O	-1	7565311
discus@@	O	-1	7565311
sed.	O	-1	7565311

E@@	B-Disease	D016889	7421734
n@@	I-Disease	-1	7421734
do@@	I-Disease	-1	7421734
me@@	I-Disease	-1	7421734
trial	I-Disease	-1	7421734
carcin@@	I-Disease	-1	7421734
oma	I-Disease	-1	7421734
after	O	-1	7421734
Ho@@	B-Disease	D006689	7421734
d@@	I-Disease	-1	7421734
g@@	I-Disease	-1	7421734
k@@	I-Disease	-1	7421734
in	I-Disease	-1	7421734
disease	I-Disease	-1	7421734
in	O	-1	7421734
child@@	O	-1	7421734
ho@@	O	-1	7421734
o@@	O	-1	7421734
d.	O	-1	7421734
A	O	-1	7421734
3@@	O	-1	7421734
4-@@	O	-1	7421734
year-old	O	-1	7421734
patient	O	-1	7421734
developed	O	-1	7421734
met@@	O	-1	7421734
as@@	O	-1	7421734
tic	O	-1	7421734
endo@@	B-Disease	D016889	7421734
me@@	I-Disease	-1	7421734
trial	I-Disease	-1	7421734
carcin@@	I-Disease	-1	7421734
oma	I-Disease	-1	7421734
after	O	-1	7421734
Ho@@	B-Disease	D006689	7421734
d@@	I-Disease	-1	7421734
g@@	I-Disease	-1	7421734
k@@	I-Disease	-1	7421734
in	I-Disease	-1	7421734
disease	I-Disease	-1	7421734
in	O	-1	7421734
child@@	O	-1	7421734
ho@@	O	-1	7421734
o@@	O	-1	7421734
d.	O	-1	7421734
S@@	O	-1	7421734
he	O	-1	7421734
had	O	-1	7421734
o@@	B-Disease	D010049	7421734
vari@@	I-Disease	-1	7421734
an	I-Disease	-1	7421734
failure	I-Disease	-1	7421734
after	O	-1	7421734
ab@@	O	-1	7421734
domin@@	O	-1	7421734
al	O	-1	7421734
ir@@	O	-1	7421734
radi@@	O	-1	7421734
ation	O	-1	7421734
and	O	-1	7421734
chemotherapy	O	-1	7421734
for	O	-1	7421734
Ho@@	B-Disease	D006689	7421734
d@@	I-Disease	-1	7421734
g@@	I-Disease	-1	7421734
k@@	I-Disease	-1	7421734
in	I-Disease	-1	7421734
disease	I-Disease	-1	7421734
,	O	-1	7421734
and	O	-1	7421734
received	O	-1	7421734
ex@@	O	-1	7421734
o@@	O	-1	7421734
gen@@	O	-1	7421734
ous	O	-1	7421734
est@@	B-Chemical	D004967	7421734
ro@@	I-Chemical	-1	7421734
gen@@	I-Chemical	-1	7421734
s	I-Chemical	-1	7421734
,	O	-1	7421734
a	O	-1	7421734
treatment	O	-1	7421734
implic@@	O	-1	7421734
ated	O	-1	7421734
in	O	-1	7421734
the	O	-1	7421734
development	O	-1	7421734
of	O	-1	7421734
endo@@	B-Disease	D016889	7421734
me@@	I-Disease	-1	7421734
trial	I-Disease	-1	7421734
cancer	I-Disease	-1	7421734
in	O	-1	7421734
men@@	O	-1	7421734
o@@	O	-1	7421734
pa@@	O	-1	7421734
us@@	O	-1	7421734
al	O	-1	7421734
wom@@	O	-1	7421734
en@@	O	-1	7421734
.	O	-1	7421734
Y@@	O	-1	7421734
oun@@	O	-1	7421734
g	O	-1	7421734
women	O	-1	7421734
on	O	-1	7421734
re@@	O	-1	7421734
pl@@	O	-1	7421734
ac@@	O	-1	7421734
ement	O	-1	7421734
est@@	B-Chemical	D004967	7421734
ro@@	I-Chemical	-1	7421734
gen@@	I-Chemical	-1	7421734
s	I-Chemical	-1	7421734
for	O	-1	7421734
o@@	B-Disease	D010049	7421734
vari@@	I-Disease	-1	7421734
an	I-Disease	-1	7421734
failure	I-Disease	-1	7421734
after	O	-1	7421734
cancer	B-Disease	D009369	7421734
therapy	O	-1	7421734
may	O	-1	7421734
also	O	-1	7421734
have	O	-1	7421734
increased	O	-1	7421734
risk	O	-1	7421734
of	O	-1	7421734
endo@@	B-Disease	D016889	7421734
me@@	I-Disease	-1	7421734
trial	I-Disease	-1	7421734
carcin@@	I-Disease	-1	7421734
oma	I-Disease	-1	7421734
and	O	-1	7421734
should	O	-1	7421734
be	O	-1	7421734
examined	O	-1	7421734
perio@@	O	-1	7421734
dic@@	O	-1	7421734
all@@	O	-1	7421734
y.	O	-1	7421734

In@@	O	-1	6732043
duction	O	-1	6732043
of	O	-1	6732043
the	O	-1	6732043
ob@@	B-Disease	D020181	6732043
struc@@	I-Disease	-1	6732043
tive	I-Disease	-1	6732043
sleep	I-Disease	-1	6732043
ap@@	I-Disease	-1	6732043
ne@@	I-Disease	-1	6732043
a	I-Disease	-1	6732043
syndrome	I-Disease	-1	6732043
in	O	-1	6732043
a	O	-1	6732043
woman	O	-1	6732043
by	O	-1	6732043
ex@@	O	-1	6732043
o@@	O	-1	6732043
gen@@	O	-1	6732043
ous	O	-1	6732043
and@@	B-Chemical	D000728	6732043
ro@@	I-Chemical	-1	6732043
gen	I-Chemical	-1	6732043
administr@@	O	-1	6732043
ation.	O	-1	6732043
We	O	-1	6732043
doc@@	O	-1	6732043
um@@	O	-1	6732043
ent@@	O	-1	6732043
ed	O	-1	6732043
a@@	O	-1	6732043
ir@@	O	-1	6732043
w@@	O	-1	6732043
ay	O	-1	6732043
oc@@	O	-1	6732043
cl@@	O	-1	6732043
usion	O	-1	6732043
during	O	-1	6732043
sleep	O	-1	6732043
and	O	-1	6732043
an	O	-1	6732043
ab@@	O	-1	6732043
norm@@	O	-1	6732043
ally	O	-1	6732043
high	O	-1	6732043
sup@@	O	-1	6732043
ra@@	O	-1	6732043
glo@@	O	-1	6732043
t@@	O	-1	6732043
tic	O	-1	6732043
resist@@	O	-1	6732043
ance	O	-1	6732043
while	O	-1	6732043
aw@@	O	-1	6732043
ake	O	-1	6732043
in	O	-1	6732043
a	O	-1	6732043
5@@	O	-1	6732043
4-@@	O	-1	6732043
y@@	O	-1	6732043
r@@	O	-1	6732043
-old	O	-1	6732043
woman	O	-1	6732043
who	O	-1	6732043
had	O	-1	6732043
developed	O	-1	6732043
physi@@	O	-1	6732043
c@@	O	-1	6732043
al	O	-1	6732043
changes	O	-1	6732043
and	O	-1	6732043
the	O	-1	6732043
syndrome	B-Disease	D020181	6732043
of	I-Disease	-1	6732043
ob@@	I-Disease	-1	6732043
struc@@	I-Disease	-1	6732043
tive	I-Disease	-1	6732043
sleep	I-Disease	-1	6732043
ap@@	I-Disease	-1	6732043
ne@@	I-Disease	-1	6732043
a	I-Disease	-1	6732043
while	O	-1	6732043
being	O	-1	6732043
administered	O	-1	6732043
ex@@	O	-1	6732043
o@@	O	-1	6732043
gen@@	O	-1	6732043
ous	O	-1	6732043
and@@	B-Chemical	D000728	6732043
ro@@	I-Chemical	-1	6732043
gen@@	I-Chemical	-1	6732043
s	I-Chemical	-1	6732043
.	O	-1	6732043
Whe@@	O	-1	6732043
n	O	-1	6732043
the	O	-1	6732043
and@@	B-Chemical	D000728	6732043
ro@@	I-Chemical	-1	6732043
gen@@	I-Chemical	-1	6732043
s	I-Chemical	-1	6732043
were	O	-1	6732043
withdraw@@	O	-1	6732043
n@@	O	-1	6732043
,	O	-1	6732043
the	O	-1	6732043
patient@@	O	-1	6732043
's	O	-1	6732043
physi@@	O	-1	6732043
c@@	O	-1	6732043
al	O	-1	6732043
chang@@	O	-1	6732043
es,	O	-1	6732043
symptom@@	O	-1	6732043
s,	O	-1	6732043
sleep	O	-1	6732043
study,	O	-1	6732043
and	O	-1	6732043
sup@@	O	-1	6732043
ra@@	O	-1	6732043
glo@@	O	-1	6732043
t@@	O	-1	6732043
tic	O	-1	6732043
resist@@	O	-1	6732043
ance	O	-1	6732043
all	O	-1	6732043
retur@@	O	-1	6732043
n@@	O	-1	6732043
ed	O	-1	6732043
to	O	-1	6732043
normal@@	O	-1	6732043
.	O	-1	6732043
A	O	-1	6732043
re@@	O	-1	6732043
ch@@	O	-1	6732043
all@@	O	-1	6732043
enge	O	-1	6732043
with	O	-1	6732043
and@@	B-Chemical	D000728	6732043
ro@@	I-Chemical	-1	6732043
gen	I-Chemical	-1	6732043
produced	O	-1	6732043
symptoms	O	-1	6732043
of	O	-1	6732043
ob@@	B-Disease	D020181	6732043
struc@@	I-Disease	-1	6732043
tive	I-Disease	-1	6732043
sleep	I-Disease	-1	6732043
ap@@	I-Disease	-1	6732043
ne@@	I-Disease	-1	6732043
a	I-Disease	-1	6732043
that	O	-1	6732043
ab@@	O	-1	6732043
ated	O	-1	6732043
up@@	O	-1	6732043
on	O	-1	6732043
withdrawal	O	-1	6732043
of	O	-1	6732043
the	O	-1	6732043
h@@	O	-1	6732043
orm@@	O	-1	6732043
one.	O	-1	6732043
Pre@@	O	-1	6732043
vi@@	O	-1	6732043
ous	O	-1	6732043
reports	O	-1	6732043
have	O	-1	6732043
f@@	O	-1	6732043
av@@	O	-1	6732043
o@@	O	-1	6732043
red	O	-1	6732043
a	O	-1	6732043
role	O	-1	6732043
of	O	-1	6732043
and@@	B-Chemical	D000728	6732043
ro@@	I-Chemical	-1	6732043
gen@@	I-Chemical	-1	6732043
s	I-Chemical	-1	6732043
in	O	-1	6732043
the	O	-1	6732043
path@@	O	-1	6732043
o@@	O	-1	6732043
genesis	O	-1	6732043
of	O	-1	6732043
sleep	B-Disease	D012891	6732043
ap@@	I-Disease	-1	6732043
ne@@	I-Disease	-1	6732043
a	I-Disease	-1	6732043
.	O	-1	6732043
Our	O	-1	6732043
report	O	-1	6732043
pro@@	O	-1	6732043
vi@@	O	-1	6732043
des	O	-1	6732043
direct	O	-1	6732043
evidence	O	-1	6732043
for	O	-1	6732043
this	O	-1	6732043
ro@@	O	-1	6732043
le@@	O	-1	6732043
.	O	-1	6732043
S@@	O	-1	6732043
tr@@	O	-1	6732043
uc@@	O	-1	6732043
t@@	O	-1	6732043
ural	O	-1	6732043
and	O	-1	6732043
functional	O	-1	6732043
meas@@	O	-1	6732043
ure@@	O	-1	6732043
ments	O	-1	6732043
indicate	O	-1	6732043
that	O	-1	6732043
and@@	B-Chemical	D000728	6732043
ro@@	I-Chemical	-1	6732043
gen@@	I-Chemical	-1	6732043
s	I-Chemical	-1	6732043
ex@@	O	-1	6732043
er@@	O	-1	6732043
t	O	-1	6732043
a	O	-1	6732043
per@@	O	-1	6732043
mis@@	O	-1	6732043
sive	O	-1	6732043
or	O	-1	6732043
nec@@	O	-1	6732043
ess@@	O	-1	6732043
ary	O	-1	6732043
action	O	-1	6732043
on	O	-1	6732043
the	O	-1	6732043
struct@@	O	-1	6732043
ural	O	-1	6732043
con@@	O	-1	6732043
fi@@	O	-1	6732043
g@@	O	-1	6732043
ur@@	O	-1	6732043
ation	O	-1	6732043
of	O	-1	6732043
the	O	-1	6732043
o@@	O	-1	6732043
ro@@	O	-1	6732043
ph@@	O	-1	6732043
ar@@	O	-1	6732043
yn@@	O	-1	6732043
x	O	-1	6732043
that	O	-1	6732043
pre@@	O	-1	6732043
dis@@	O	-1	6732043
po@@	O	-1	6732043
ses	O	-1	6732043
to	O	-1	6732043
ob@@	O	-1	6732043
struc@@	O	-1	6732043
tion	O	-1	6732043
during	O	-1	6732043
sle@@	O	-1	6732043
ep@@	O	-1	6732043
.	O	-1	6732043
De@@	O	-1	6732043
ve@@	O	-1	6732043
lop@@	O	-1	6732043
ment	O	-1	6732043
of	O	-1	6732043
the	O	-1	6732043
ob@@	B-Disease	D020181	6732043
struc@@	I-Disease	-1	6732043
tive	I-Disease	-1	6732043
sleep	I-Disease	-1	6732043
ap@@	I-Disease	-1	6732043
ne@@	I-Disease	-1	6732043
a	I-Disease	-1	6732043
syndrome	I-Disease	-1	6732043
mus@@	O	-1	6732043
t	O	-1	6732043
be	O	-1	6732043
considered	O	-1	6732043
a	O	-1	6732043
possible	O	-1	6732043
side	O	-1	6732043
effect	O	-1	6732043
of	O	-1	6732043
and@@	B-Chemical	D000728	6732043
ro@@	I-Chemical	-1	6732043
gen	I-Chemical	-1	6732043
therapy.	O	-1	6732043

Eff@@	O	-1	6454943
ect	O	-1	6454943
of	O	-1	6454943
cap@@	B-Chemical	D002216	6454943
to@@	I-Chemical	-1	6454943
pri@@	I-Chemical	-1	6454943
l	I-Chemical	-1	6454943
on	O	-1	6454943
pre-@@	O	-1	6454943
ex@@	O	-1	6454943
ist@@	O	-1	6454943
ing	O	-1	6454943
and	O	-1	6454943
amin@@	B-Chemical	D011692	6454943
on@@	I-Chemical	-1	6454943
ucle@@	I-Chemical	-1	6454943
o@@	I-Chemical	-1	6454943
side	I-Chemical	-1	6454943
-induced	O	-1	6454943
proteinuria	B-Disease	D011507	6454943
in	O	-1	6454943
spont@@	O	-1	6454943
ane@@	O	-1	6454943
ously	O	-1	6454943
hypertensive	B-Disease	D006973	6454943
rats.	O	-1	6454943
Pro@@	B-Disease	D011507	6454943
te@@	I-Disease	-1	6454943
in@@	I-Disease	-1	6454943
uria	I-Disease	-1	6454943
is	O	-1	6454943
a	O	-1	6454943
side	O	-1	6454943
effect	O	-1	6454943
of	O	-1	6454943
cap@@	B-Chemical	D002216	6454943
to@@	I-Chemical	-1	6454943
pri@@	I-Chemical	-1	6454943
l	I-Chemical	-1	6454943
treatment	O	-1	6454943
in	O	-1	6454943
hypertensive	B-Disease	D006973	6454943
patients.	O	-1	6454943
The	O	-1	6454943
possib@@	O	-1	6454943
ility	O	-1	6454943
of	O	-1	6454943
re@@	O	-1	6454943
produc@@	O	-1	6454943
ing	O	-1	6454943
the	O	-1	6454943
same	O	-1	6454943
renal	B-Disease	D007674	6454943
abnormal@@	I-Disease	-1	6454943
ity	I-Disease	-1	6454943
with	O	-1	6454943
cap@@	B-Chemical	D002216	6454943
to@@	I-Chemical	-1	6454943
pri@@	I-Chemical	-1	6454943
l	I-Chemical	-1	6454943
was	O	-1	6454943
examined	O	-1	6454943
in	O	-1	6454943
S@@	O	-1	6454943
H@@	O	-1	6454943
R@@	O	-1	6454943
.	O	-1	6454943
O@@	O	-1	6454943
ral	O	-1	6454943
administration	O	-1	6454943
of	O	-1	6454943
cap@@	B-Chemical	D002216	6454943
to@@	I-Chemical	-1	6454943
pri@@	I-Chemical	-1	6454943
l	I-Chemical	-1	6454943
at	O	-1	6454943
100	O	-1	6454943
mg/kg	O	-1	6454943
for	O	-1	6454943
14	O	-1	6454943
days	O	-1	6454943
fail@@	O	-1	6454943
ed	O	-1	6454943
to	O	-1	6454943
ag@@	O	-1	6454943
gra@@	O	-1	6454943
v@@	O	-1	6454943
ate	O	-1	6454943
proteinuria	B-Disease	D011507	6454943
pre-@@	O	-1	6454943
ex@@	O	-1	6454943
ist@@	O	-1	6454943
ing	O	-1	6454943
in	O	-1	6454943
S@@	O	-1	6454943
H@@	O	-1	6454943
R@@	O	-1	6454943
.	O	-1	6454943
Al@@	O	-1	6454943
so@@	O	-1	6454943
,	O	-1	6454943
cap@@	B-Chemical	D002216	6454943
to@@	I-Chemical	-1	6454943
pri@@	I-Chemical	-1	6454943
l	I-Chemical	-1	6454943
treatment	O	-1	6454943
fail@@	O	-1	6454943
ed	O	-1	6454943
to	O	-1	6454943
potenti@@	O	-1	6454943
ate	O	-1	6454943
or	O	-1	6454943
fac@@	O	-1	6454943
il@@	O	-1	6454943
it@@	O	-1	6454943
ate	O	-1	6454943
development	O	-1	6454943
of	O	-1	6454943
mas@@	O	-1	6454943
sive	O	-1	6454943
proteinuria	B-Disease	D011507	6454943
inv@@	O	-1	6454943
o@@	O	-1	6454943
ked	O	-1	6454943
by	O	-1	6454943
p@@	B-Chemical	D011692	6454943
uro@@	I-Chemical	-1	6454943
m@@	I-Chemical	-1	6454943
ycin	I-Chemical	-1	6454943
amin@@	I-Chemical	-1	6454943
on@@	I-Chemical	-1	6454943
ucle@@	I-Chemical	-1	6454943
o@@	I-Chemical	-1	6454943
side	I-Chemical	-1	6454943
in	O	-1	6454943
S@@	O	-1	6454943
H@@	O	-1	6454943
R@@	O	-1	6454943
.	O	-1	6454943
C@@	B-Chemical	D002216	6454943
ap@@	I-Chemical	-1	6454943
to@@	I-Chemical	-1	6454943
pri@@	I-Chemical	-1	6454943
l	I-Chemical	-1	6454943
had	O	-1	6454943
lit@@	O	-1	6454943
t@@	O	-1	6454943
le	O	-1	6454943
or	O	-1	6454943
no	O	-1	6454943
demon@@	O	-1	6454943
stra@@	O	-1	6454943
ble	O	-1	6454943
effects	O	-1	6454943
on	O	-1	6454943
serum	O	-1	6454943
electro@@	O	-1	6454943
ly@@	O	-1	6454943
te	O	-1	6454943
concentr@@	O	-1	6454943
ation@@	O	-1	6454943
s,	O	-1	6454943
ex@@	O	-1	6454943
cre@@	O	-1	6454943
tion	O	-1	6454943
of	O	-1	6454943
ur@@	O	-1	6454943
ine,	O	-1	6454943
sodium	B-Chemical	D012964	6454943
and	O	-1	6454943
pot@@	B-Chemical	D011188	6454943
assi@@	I-Chemical	-1	6454943
um	I-Chemical	-1	6454943
,	O	-1	6454943
endo@@	O	-1	6454943
gen@@	O	-1	6454943
ous	O	-1	6454943
creatinine	B-Chemical	D003404	6454943
clear@@	O	-1	6454943
ance@@	O	-1	6454943
,	O	-1	6454943
body	O	-1	6454943
weigh@@	O	-1	6454943
t,	O	-1	6454943
and	O	-1	6454943
fo@@	O	-1	6454943
od	O	-1	6454943
and	O	-1	6454943
w@@	O	-1	6454943
at@@	O	-1	6454943
er	O	-1	6454943
consum@@	O	-1	6454943
p@@	O	-1	6454943
tion.	O	-1	6454943
However,	O	-1	6454943
k@@	B-Chemical	D007659	6454943
et@@	I-Chemical	-1	6454943
one	I-Chemical	-1	6454943
bo@@	O	-1	6454943
di@@	O	-1	6454943
es	O	-1	6454943
were	O	-1	6454943
consist@@	O	-1	6454943
ently	O	-1	6454943
present	O	-1	6454943
in	O	-1	6454943
urine	O	-1	6454943
and	O	-1	6454943
several	O	-1	6454943
le@@	O	-1	6454943
thal@@	O	-1	6454943
ities	O	-1	6454943
occurred	O	-1	6454943
during	O	-1	6454943
multiple	O	-1	6454943
dos@@	O	-1	6454943
ing	O	-1	6454943
of	O	-1	6454943
cap@@	B-Chemical	D002216	6454943
to@@	I-Chemical	-1	6454943
pri@@	I-Chemical	-1	6454943
l	I-Chemical	-1	6454943
in	O	-1	6454943
S@@	O	-1	6454943
H@@	O	-1	6454943
R@@	O	-1	6454943
.	O	-1	6454943

E@@	O	-1	6153967
pi@@	O	-1	6153967
le@@	O	-1	6153967
pto@@	O	-1	6153967
genic	O	-1	6153967
pro@@	O	-1	6153967
per@@	O	-1	6153967
ties	O	-1	6153967
of	O	-1	6153967
en@@	B-Chemical	D004737	6153967
f@@	I-Chemical	-1	6153967
lur@@	I-Chemical	-1	6153967
ane	I-Chemical	-1	6153967
and	O	-1	6153967
their	O	-1	6153967
clinical	O	-1	6153967
inter@@	O	-1	6153967
pre@@	O	-1	6153967
t@@	O	-1	6153967
ation.	O	-1	6153967
Th@@	O	-1	6153967
ree	O	-1	6153967
cases	O	-1	6153967
of	O	-1	6153967
E@@	O	-1	6153967
E@@	O	-1	6153967
G	O	-1	6153967
changes	O	-1	6153967
induced	O	-1	6153967
by	O	-1	6153967
single	O	-1	6153967
exposure	O	-1	6153967
to	O	-1	6153967
en@@	B-Chemical	D004737	6153967
f@@	I-Chemical	-1	6153967
lur@@	I-Chemical	-1	6153967
ane	I-Chemical	-1	6153967
anesthe@@	O	-1	6153967
sia	O	-1	6153967
are	O	-1	6153967
repor@@	O	-1	6153967
ted.	O	-1	6153967
In	O	-1	6153967
one	O	-1	6153967
patient@@	O	-1	6153967
,	O	-1	6153967
en@@	B-Chemical	D004737	6153967
f@@	I-Chemical	-1	6153967
lur@@	I-Chemical	-1	6153967
ane	I-Chemical	-1	6153967
administered	O	-1	6153967
during	O	-1	6153967
a	O	-1	6153967
d@@	O	-1	6153967
on@@	O	-1	6153967
or	O	-1	6153967
neph@@	O	-1	6153967
rec@@	O	-1	6153967
to@@	O	-1	6153967
m@@	O	-1	6153967
y	O	-1	6153967
resulted	O	-1	6153967
in	O	-1	6153967
un@@	O	-1	6153967
ex@@	O	-1	6153967
p@@	O	-1	6153967
ected	O	-1	6153967
partial	O	-1	6153967
motor	O	-1	6153967
seizures	B-Disease	D012640	6153967
.	O	-1	6153967
U@@	O	-1	6153967
n@@	O	-1	6153967
ti@@	O	-1	6153967
l	O	-1	6153967
the	O	-1	6153967
cause	O	-1	6153967
of	O	-1	6153967
the	O	-1	6153967
seizures	B-Disease	D012640	6153967
was	O	-1	6153967
cor@@	O	-1	6153967
rec@@	O	-1	6153967
tly	O	-1	6153967
identi@@	O	-1	6153967
fi@@	O	-1	6153967
ed,	O	-1	6153967
the	O	-1	6153967
patient	O	-1	6153967
was	O	-1	6153967
in@@	O	-1	6153967
appro@@	O	-1	6153967
pri@@	O	-1	6153967
ately	O	-1	6153967
treated	O	-1	6153967
with	O	-1	6153967
anti@@	O	-1	6153967
convul@@	O	-1	6153967
s@@	O	-1	6153967
ant@@	O	-1	6153967
s.	O	-1	6153967
Two	O	-1	6153967
other	O	-1	6153967
patients	O	-1	6153967
su@@	O	-1	6153967
ffe@@	O	-1	6153967
red	O	-1	6153967
from	O	-1	6153967
par@@	O	-1	6153967
ti@@	O	-1	6153967
al,	O	-1	6153967
comple@@	O	-1	6153967
x	O	-1	6153967
and	O	-1	6153967
gener@@	O	-1	6153967
al@@	O	-1	6153967
ized	O	-1	6153967
seizures	B-Disease	D012640	6153967
un@@	O	-1	6153967
controlled	O	-1	6153967
by	O	-1	6153967
medic@@	O	-1	6153967
ation.	O	-1	6153967
E@@	B-Disease	D004827	6153967
pi@@	I-Disease	-1	6153967
le@@	I-Disease	-1	6153967
p@@	I-Disease	-1	6153967
tic	I-Disease	-1	6153967
foc@@	O	-1	6153967
i	O	-1	6153967
del@@	O	-1	6153967
ine@@	O	-1	6153967
ated	O	-1	6153967
and	O	-1	6153967
activ@@	O	-1	6153967
ated	O	-1	6153967
by	O	-1	6153967
en@@	B-Chemical	D004737	6153967
f@@	I-Chemical	-1	6153967
lur@@	I-Chemical	-1	6153967
ane	I-Chemical	-1	6153967
were	O	-1	6153967
surg@@	O	-1	6153967
ically	O	-1	6153967
abl@@	O	-1	6153967
ated	O	-1	6153967
and	O	-1	6153967
the	O	-1	6153967
patients	O	-1	6153967
are	O	-1	6153967
no@@	O	-1	6153967
w	O	-1	6153967
seizure	B-Disease	D012640	6153967
-@@	O	-1	6153967
f@@	O	-1	6153967
re@@	O	-1	6153967
e.	O	-1	6153967
Pre@@	O	-1	6153967
vi@@	O	-1	6153967
ous	O	-1	6153967
expos@@	O	-1	6153967
ures	O	-1	6153967
to	O	-1	6153967
en@@	B-Chemical	D004737	6153967
f@@	I-Chemical	-1	6153967
lur@@	I-Chemical	-1	6153967
ane	I-Chemical	-1	6153967
have	O	-1	6153967
to	O	-1	6153967
be	O	-1	6153967
disc@@	O	-1	6153967
los@@	O	-1	6153967
ed	O	-1	6153967
to	O	-1	6153967
av@@	O	-1	6153967
oid	O	-1	6153967
m@@	O	-1	6153967
ist@@	O	-1	6153967
ak@@	O	-1	6153967
es	O	-1	6153967
in	O	-1	6153967
clinical	O	-1	6153967
inter@@	O	-1	6153967
pre@@	O	-1	6153967
t@@	O	-1	6153967
ation	O	-1	6153967
of	O	-1	6153967
the	O	-1	6153967
E@@	O	-1	6153967
E@@	O	-1	6153967
G@@	O	-1	6153967
.	O	-1	6153967
O@@	O	-1	6153967
n	O	-1	6153967
the	O	-1	6153967
other	O	-1	6153967
h@@	O	-1	6153967
and@@	O	-1	6153967
,	O	-1	6153967
en@@	B-Chemical	D004737	6153967
f@@	I-Chemical	-1	6153967
lur@@	I-Chemical	-1	6153967
ane	I-Chemical	-1	6153967
may	O	-1	6153967
pro@@	O	-1	6153967
ve	O	-1	6153967
to	O	-1	6153967
be	O	-1	6153967
a	O	-1	6153967
saf@@	O	-1	6153967
e	O	-1	6153967
f@@	O	-1	6153967
ast	O	-1	6153967
act@@	O	-1	6153967
ing	O	-1	6153967
activ@@	O	-1	6153967
at@@	O	-1	6153967
or	O	-1	6153967
of	O	-1	6153967
epileptic	B-Disease	D004827	6153967
foc@@	O	-1	6153967
i	O	-1	6153967
during	O	-1	6153967
cortico@@	O	-1	6153967
graph@@	O	-1	6153967
y	O	-1	6153967
or	O	-1	6153967
de@@	O	-1	6153967
pt@@	O	-1	6153967
h	O	-1	6153967
electro@@	O	-1	6153967
de	O	-1	6153967
intra@@	O	-1	6153967
o@@	O	-1	6153967
perative	O	-1	6153967
recor@@	O	-1	6153967
d@@	O	-1	6153967
ing@@	O	-1	6153967
s.	O	-1	6153967

Re@@	O	-1	3183120
ver@@	O	-1	3183120
sible	O	-1	3183120
cerebral	B-Disease	D001927	3183120
lesions	I-Disease	-1	3183120
associated	O	-1	3183120
with	O	-1	3183120
ti@@	B-Chemical	C033706	3183120
az@@	I-Chemical	-1	3183120
of@@	I-Chemical	-1	3183120
ur@@	I-Chemical	-1	3183120
in	I-Chemical	-1	3183120
us@@	O	-1	3183120
ag@@	O	-1	3183120
e@@	O	-1	3183120
:	O	-1	3183120
M@@	O	-1	3183120
R	O	-1	3183120
demon@@	O	-1	3183120
str@@	O	-1	3183120
ation.	O	-1	3183120
T@@	B-Chemical	C033706	3183120
i@@	I-Chemical	-1	3183120
az@@	I-Chemical	-1	3183120
of@@	I-Chemical	-1	3183120
ur@@	I-Chemical	-1	3183120
in	I-Chemical	-1	3183120
is	O	-1	3183120
an	O	-1	3183120
experimental	O	-1	3183120
chemo@@	O	-1	3183120
therapeutic	O	-1	3183120
agent	O	-1	3183120
cur@@	O	-1	3183120
ren@@	O	-1	3183120
tly	O	-1	3183120
under@@	O	-1	3183120
go@@	O	-1	3183120
ing	O	-1	3183120
clinical	O	-1	3183120
evalu@@	O	-1	3183120
ation.	O	-1	3183120
We	O	-1	3183120
report	O	-1	3183120
our	O	-1	3183120
results	O	-1	3183120
with	O	-1	3183120
mag@@	O	-1	3183120
ne@@	O	-1	3183120
tic	O	-1	3183120
res@@	O	-1	3183120
on@@	O	-1	3183120
ance	O	-1	3183120
(@@	O	-1	3183120
MR@@	O	-1	3183120
)	O	-1	3183120
in	O	-1	3183120
demon@@	O	-1	3183120
strat@@	O	-1	3183120
ing	O	-1	3183120
reversible	O	-1	3183120
cerebral	B-Disease	D001927	3183120
abnormal@@	I-Disease	-1	3183120
ities	I-Disease	-1	3183120
con@@	O	-1	3183120
current	O	-1	3183120
with	O	-1	3183120
the	O	-1	3183120
use	O	-1	3183120
of	O	-1	3183120
this	O	-1	3183120
drug.	O	-1	3183120
The	O	-1	3183120
abnormal@@	O	-1	3183120
ities	O	-1	3183120
on	O	-1	3183120
M@@	O	-1	3183120
R	O	-1	3183120
were	O	-1	3183120
cor@@	O	-1	3183120
related	O	-1	3183120
with	O	-1	3183120
findings	O	-1	3183120
on	O	-1	3183120
C@@	O	-1	3183120
T	O	-1	3183120
as	O	-1	3183120
well	O	-1	3183120
as	O	-1	3183120
with	O	-1	3183120
cerebral	O	-1	3183120
angio@@	O	-1	3183120
graph@@	O	-1	3183120
y.	O	-1	3183120
The	O	-1	3183120
u@@	O	-1	3183120
til@@	O	-1	3183120
ity	O	-1	3183120
of	O	-1	3183120
M@@	O	-1	3183120
R	O	-1	3183120
in	O	-1	3183120
the	O	-1	3183120
evalu@@	O	-1	3183120
ation	O	-1	3183120
of	O	-1	3183120
patients	O	-1	3183120
receiving	O	-1	3183120
this	O	-1	3183120
new	O	-1	3183120
agent	O	-1	3183120
is	O	-1	3183120
il@@	O	-1	3183120
lu@@	O	-1	3183120
strat@@	O	-1	3183120
ed.	O	-1	3183120

An@@	O	-1	3120485
t@@	O	-1	3120485
agon@@	O	-1	3120485
ism	O	-1	3120485
of	O	-1	3120485
di@@	B-Chemical	D003975	3120485
az@@	I-Chemical	-1	3120485
epam	I-Chemical	-1	3120485
-induced	O	-1	3120485
sed@@	O	-1	3120485
ative	O	-1	3120485
effects	O	-1	3120485
by	O	-1	3120485
R@@	B-Chemical	D005442	3120485
o@@	I-Chemical	-1	3120485
1@@	I-Chemical	-1	3120485
5-@@	I-Chemical	-1	3120485
17@@	I-Chemical	-1	3120485
8@@	I-Chemical	-1	3120485
8	I-Chemical	-1	3120485
in	O	-1	3120485
patients	O	-1	3120485
after	O	-1	3120485
surger@@	O	-1	3120485
y	O	-1	3120485
under	O	-1	3120485
l@@	O	-1	3120485
umb@@	O	-1	3120485
ar	O	-1	3120485
ep@@	O	-1	3120485
id@@	O	-1	3120485
ural	O	-1	3120485
block@@	O	-1	3120485
.	O	-1	3120485
A	O	-1	3120485
double-bl@@	O	-1	3120485
ind	O	-1	3120485
placebo@@	O	-1	3120485
-@@	O	-1	3120485
controlled	O	-1	3120485
investig@@	O	-1	3120485
ation	O	-1	3120485
of	O	-1	3120485
efficacy	O	-1	3120485
and	O	-1	3120485
saf@@	O	-1	3120485
et@@	O	-1	3120485
y.	O	-1	3120485
The	O	-1	3120485
a@@	O	-1	3120485
im	O	-1	3120485
of	O	-1	3120485
this	O	-1	3120485
study	O	-1	3120485
was	O	-1	3120485
to	O	-1	3120485
ass@@	O	-1	3120485
ess	O	-1	3120485
the	O	-1	3120485
efficacy	O	-1	3120485
of	O	-1	3120485
R@@	B-Chemical	D005442	3120485
o@@	I-Chemical	-1	3120485
1@@	I-Chemical	-1	3120485
5-@@	I-Chemical	-1	3120485
17@@	I-Chemical	-1	3120485
8@@	I-Chemical	-1	3120485
8	I-Chemical	-1	3120485
and	O	-1	3120485
a	O	-1	3120485
placebo	O	-1	3120485
in	O	-1	3120485
rever@@	O	-1	3120485
s@@	O	-1	3120485
ing	O	-1	3120485
di@@	B-Chemical	D003975	3120485
az@@	I-Chemical	-1	3120485
epam	I-Chemical	-1	3120485
-induced	O	-1	3120485
effects	O	-1	3120485
after	O	-1	3120485
surger@@	O	-1	3120485
y	O	-1	3120485
under	O	-1	3120485
ep@@	O	-1	3120485
id@@	O	-1	3120485
ural	O	-1	3120485
block@@	O	-1	3120485
,	O	-1	3120485
and	O	-1	3120485
to	O	-1	3120485
evalu@@	O	-1	3120485
ate	O	-1	3120485
the	O	-1	3120485
loc@@	O	-1	3120485
al	O	-1	3120485
toler@@	O	-1	3120485
ance	O	-1	3120485
and	O	-1	3120485
gener@@	O	-1	3120485
al	O	-1	3120485
safety	O	-1	3120485
of	O	-1	3120485
R@@	B-Chemical	D005442	3120485
o@@	I-Chemical	-1	3120485
1@@	I-Chemical	-1	3120485
5-@@	I-Chemical	-1	3120485
17@@	I-Chemical	-1	3120485
8@@	I-Chemical	-1	3120485
8	I-Chemical	-1	3120485
.	O	-1	3120485
F@@	O	-1	3120485
if@@	O	-1	3120485
ty-@@	O	-1	3120485
seven	O	-1	3120485
patients	O	-1	3120485
were	O	-1	3120485
sed@@	O	-1	3120485
ated	O	-1	3120485
with	O	-1	3120485
di@@	B-Chemical	D003975	3120485
az@@	I-Chemical	-1	3120485
epam	I-Chemical	-1	3120485
for	O	-1	3120485
surger@@	O	-1	3120485
y	O	-1	3120485
under	O	-1	3120485
ep@@	O	-1	3120485
id@@	O	-1	3120485
ural	O	-1	3120485
anaesthe@@	O	-1	3120485
sia.	O	-1	3120485
An@@	O	-1	3120485
t@@	O	-1	3120485
agon@@	O	-1	3120485
ism	O	-1	3120485
of	O	-1	3120485
di@@	B-Chemical	D003975	3120485
az@@	I-Chemical	-1	3120485
epam	I-Chemical	-1	3120485
-induced	O	-1	3120485
effects	O	-1	3120485
by	O	-1	3120485
R@@	B-Chemical	D005442	3120485
o@@	I-Chemical	-1	3120485
1@@	I-Chemical	-1	3120485
5-@@	I-Chemical	-1	3120485
17@@	I-Chemical	-1	3120485
8@@	I-Chemical	-1	3120485
8	I-Chemical	-1	3120485
was	O	-1	3120485
investigated	O	-1	3120485
posto@@	O	-1	3120485
per@@	O	-1	3120485
atively	O	-1	3120485
in	O	-1	3120485
a	O	-1	3120485
double-bl@@	O	-1	3120485
ind	O	-1	3120485
placebo@@	O	-1	3120485
-@@	O	-1	3120485
controlled	O	-1	3120485
tri@@	O	-1	3120485
al.	O	-1	3120485
The	O	-1	3120485
patient@@	O	-1	3120485
's	O	-1	3120485
subj@@	O	-1	3120485
ective	O	-1	3120485
assess@@	O	-1	3120485
ment	O	-1	3120485
of	O	-1	3120485
mo@@	O	-1	3120485
od	O	-1	3120485
rat@@	O	-1	3120485
ing,	O	-1	3120485
an	O	-1	3120485
ob@@	O	-1	3120485
j@@	O	-1	3120485
ective	O	-1	3120485
test	O	-1	3120485
of	O	-1	3120485
perform@@	O	-1	3120485
ance@@	O	-1	3120485
,	O	-1	3120485
a	O	-1	3120485
test	O	-1	3120485
for	O	-1	3120485
am@@	B-Disease	D000647	3120485
ne@@	I-Disease	-1	3120485
sia	I-Disease	-1	3120485
,	O	-1	3120485
and	O	-1	3120485
vit@@	O	-1	3120485
al	O	-1	3120485
signs	O	-1	3120485
were	O	-1	3120485
recor@@	O	-1	3120485
ded	O	-1	3120485
for	O	-1	3120485
up	O	-1	3120485
to	O	-1	3120485
3@@	O	-1	3120485
00	O	-1	3120485
min	O	-1	3120485
after	O	-1	3120485
administration	O	-1	3120485
of	O	-1	3120485
the	O	-1	3120485
trial	O	-1	3120485
drug.	O	-1	3120485
No	O	-1	3120485
significant	O	-1	3120485
differences	O	-1	3120485
between	O	-1	3120485
the	O	-1	3120485
two	O	-1	3120485
groups	O	-1	3120485
were	O	-1	3120485
observed	O	-1	3120485
for	O	-1	3120485
mo@@	O	-1	3120485
od	O	-1	3120485
rat@@	O	-1	3120485
ing,	O	-1	3120485
am@@	B-Disease	D000647	3120485
ne@@	I-Disease	-1	3120485
sia	I-Disease	-1	3120485
,	O	-1	3120485
or	O	-1	3120485
vit@@	O	-1	3120485
al	O	-1	3120485
sign@@	O	-1	3120485
s.	O	-1	3120485
The	O	-1	3120485
R@@	B-Chemical	D005442	3120485
o@@	I-Chemical	-1	3120485
1@@	I-Chemical	-1	3120485
5-@@	I-Chemical	-1	3120485
17@@	I-Chemical	-1	3120485
8@@	I-Chemical	-1	3120485
8	I-Chemical	-1	3120485
group	O	-1	3120485
showed	O	-1	3120485
a	O	-1	3120485
significant	O	-1	3120485
impro@@	O	-1	3120485
vement	O	-1	3120485
in	O	-1	3120485
the	O	-1	3120485
perform@@	O	-1	3120485
ance	O	-1	3120485
test	O	-1	3120485
up	O	-1	3120485
to	O	-1	3120485
1@@	O	-1	3120485
20	O	-1	3120485
min	O	-1	3120485
after	O	-1	3120485
administration	O	-1	3120485
of	O	-1	3120485
the	O	-1	3120485
drug.	O	-1	3120485
There	O	-1	3120485
was	O	-1	3120485
no	O	-1	3120485
evidence	O	-1	3120485
of	O	-1	3120485
reaction	O	-1	3120485
at	O	-1	3120485
the	O	-1	3120485
injection	O	-1	3120485
sit@@	O	-1	3120485
e.	O	-1	3120485

E@@	O	-1	2886572
n@@	O	-1	2886572
h@@	O	-1	2886572
anced	O	-1	2886572
stimul@@	O	-1	2886572
us@@	O	-1	2886572
-induced	O	-1	2886572
neuro@@	O	-1	2886572
trans@@	O	-1	2886572
mit@@	O	-1	2886572
ter	O	-1	2886572
over@@	O	-1	2886572
flow	O	-1	2886572
in	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
-induced	O	-1	2886572
hypertensive	B-Disease	D006973	2886572
rats	O	-1	2886572
is	O	-1	2886572
not	O	-1	2886572
mediated	O	-1	2886572
by	O	-1	2886572
pre@@	O	-1	2886572
j@@	O	-1	2886572
unc@@	O	-1	2886572
tional	O	-1	2886572
beta-@@	O	-1	2886572
adren@@	O	-1	2886572
oc@@	O	-1	2886572
e@@	O	-1	2886572
pt@@	O	-1	2886572
or	O	-1	2886572
activ@@	O	-1	2886572
ation.	O	-1	2886572
The	O	-1	2886572
present	O	-1	2886572
study	O	-1	2886572
examin@@	O	-1	2886572
es	O	-1	2886572
the	O	-1	2886572
effect	O	-1	2886572
of	O	-1	2886572
6-@@	O	-1	2886572
day	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
treatment	O	-1	2886572
(@@	O	-1	2886572
100	O	-1	2886572
microgram@@	O	-1	2886572
s/@@	O	-1	2886572
k@@	O	-1	2886572
g	O	-1	2886572
per	O	-1	2886572
h@@	O	-1	2886572
,	O	-1	2886572
s@@	O	-1	2886572
.@@	O	-1	2886572
c@@	O	-1	2886572
.)	O	-1	2886572
on	O	-1	2886572
stimul@@	O	-1	2886572
us@@	O	-1	2886572
-induced	O	-1	2886572
(@@	O	-1	2886572
1	O	-1	2886572
H@@	O	-1	2886572
z@@	O	-1	2886572
)	O	-1	2886572
endo@@	O	-1	2886572
gen@@	O	-1	2886572
ous	O	-1	2886572
neuro@@	O	-1	2886572
trans@@	O	-1	2886572
mit@@	O	-1	2886572
ter	O	-1	2886572
over@@	O	-1	2886572
flow	O	-1	2886572
from	O	-1	2886572
the	O	-1	2886572
isol@@	O	-1	2886572
ated	O	-1	2886572
per@@	O	-1	2886572
f@@	O	-1	2886572
used	O	-1	2886572
kidney	O	-1	2886572
of	O	-1	2886572
ve@@	O	-1	2886572
h@@	O	-1	2886572
ic@@	O	-1	2886572
le@@	O	-1	2886572
-	O	-1	2886572
and	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
-treated	O	-1	2886572
rats.	O	-1	2886572
R@@	O	-1	2886572
en@@	O	-1	2886572
al	O	-1	2886572
cat@@	B-Chemical	D002395	2886572
ech@@	I-Chemical	-1	2886572
ol@@	I-Chemical	-1	2886572
amine	I-Chemical	-1	2886572
sto@@	O	-1	2886572
res	O	-1	2886572
and	O	-1	2886572
stimul@@	O	-1	2886572
us@@	O	-1	2886572
-induced	O	-1	2886572
over@@	O	-1	2886572
flow	O	-1	2886572
in	O	-1	2886572
the	O	-1	2886572
ve@@	O	-1	2886572
h@@	O	-1	2886572
ic@@	O	-1	2886572
le@@	O	-1	2886572
-treated	O	-1	2886572
group	O	-1	2886572
consist@@	O	-1	2886572
ed	O	-1	2886572
of	O	-1	2886572
no@@	B-Chemical	D009638	2886572
re@@	I-Chemical	-1	2886572
p@@	I-Chemical	-1	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
on@@	O	-1	2886572
ly.	O	-1	2886572
However,	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
treatment	O	-1	2886572
resulted	O	-1	2886572
in	O	-1	2886572
the	O	-1	2886572
inc@@	O	-1	2886572
or@@	O	-1	2886572
por@@	O	-1	2886572
ation	O	-1	2886572
of	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
into	O	-1	2886572
renal	O	-1	2886572
cat@@	B-Chemical	D002395	2886572
ech@@	I-Chemical	-1	2886572
ol@@	I-Chemical	-1	2886572
amine	I-Chemical	-1	2886572
sto@@	O	-1	2886572
res	O	-1	2886572
such	O	-1	2886572
that	O	-1	2886572
appro@@	O	-1	2886572
xim@@	O	-1	2886572
ately	O	-1	2886572
4@@	O	-1	2886572
0%	O	-1	2886572
of	O	-1	2886572
the	O	-1	2886572
cat@@	B-Chemical	D002395	2886572
ech@@	I-Chemical	-1	2886572
ol@@	I-Chemical	-1	2886572
amine	I-Chemical	-1	2886572
present	O	-1	2886572
was	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
while	O	-1	2886572
the	O	-1	2886572
no@@	B-Chemical	D009638	2886572
re@@	I-Chemical	-1	2886572
p@@	I-Chemical	-1	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
cont@@	O	-1	2886572
ent	O	-1	2886572
was	O	-1	2886572
reduced	O	-1	2886572
by	O	-1	2886572
a	O	-1	2886572
similar	O	-1	2886572
de@@	O	-1	2886572
gre@@	O	-1	2886572
e.	O	-1	2886572
T@@	O	-1	2886572
ot@@	O	-1	2886572
al	O	-1	2886572
tissue	O	-1	2886572
cat@@	B-Chemical	D002395	2886572
ech@@	I-Chemical	-1	2886572
ol@@	I-Chemical	-1	2886572
amine	I-Chemical	-1	2886572
cont@@	O	-1	2886572
ent	O	-1	2886572
of	O	-1	2886572
the	O	-1	2886572
kidney	O	-1	2886572
on	O	-1	2886572
a	O	-1	2886572
mol@@	O	-1	2886572
ar	O	-1	2886572
b@@	O	-1	2886572
asis	O	-1	2886572
was	O	-1	2886572
un@@	O	-1	2886572
chang@@	O	-1	2886572
ed.	O	-1	2886572
S@@	O	-1	2886572
tim@@	O	-1	2886572
ul@@	O	-1	2886572
us@@	O	-1	2886572
-induced	O	-1	2886572
frac@@	O	-1	2886572
tional	O	-1	2886572
over@@	O	-1	2886572
flow	O	-1	2886572
of	O	-1	2886572
neuro@@	O	-1	2886572
trans@@	O	-1	2886572
mit@@	O	-1	2886572
ter	O	-1	2886572
from	O	-1	2886572
the	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
-treated	O	-1	2886572
kidne@@	O	-1	2886572
ys	O	-1	2886572
was	O	-1	2886572
appro@@	O	-1	2886572
xim@@	O	-1	2886572
ately	O	-1	2886572
tw@@	O	-1	2886572
ic@@	O	-1	2886572
e	O	-1	2886572
normal	O	-1	2886572
and	O	-1	2886572
consist@@	O	-1	2886572
ed	O	-1	2886572
of	O	-1	2886572
both	O	-1	2886572
no@@	B-Chemical	D009638	2886572
re@@	I-Chemical	-1	2886572
p@@	I-Chemical	-1	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
and	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
in	O	-1	2886572
pro@@	O	-1	2886572
por@@	O	-1	2886572
tions	O	-1	2886572
similar	O	-1	2886572
to	O	-1	2886572
those	O	-1	2886572
found	O	-1	2886572
in	O	-1	2886572
the	O	-1	2886572
kidne@@	O	-1	2886572
y.	O	-1	2886572
This	O	-1	2886572
difference	O	-1	2886572
in	O	-1	2886572
frac@@	O	-1	2886572
tional	O	-1	2886572
over@@	O	-1	2886572
flow	O	-1	2886572
between	O	-1	2886572
groups	O	-1	2886572
was	O	-1	2886572
not	O	-1	2886572
affected	O	-1	2886572
by	O	-1	2886572
neuron@@	O	-1	2886572
al	O	-1	2886572
and	O	-1	2886572
ex@@	O	-1	2886572
tran@@	O	-1	2886572
e@@	O	-1	2886572
uron@@	O	-1	2886572
al	O	-1	2886572
u@@	O	-1	2886572
pt@@	O	-1	2886572
ake	O	-1	2886572
block@@	O	-1	2886572
ade@@	O	-1	2886572
.	O	-1	2886572
Pro@@	B-Chemical	D011433	2886572
p@@	I-Chemical	-1	2886572
ran@@	I-Chemical	-1	2886572
o@@	I-Chemical	-1	2886572
lol	I-Chemical	-1	2886572
had	O	-1	2886572
no	O	-1	2886572
effect	O	-1	2886572
on	O	-1	2886572
stimul@@	O	-1	2886572
us@@	O	-1	2886572
-induced	O	-1	2886572
over@@	O	-1	2886572
flow	O	-1	2886572
in	O	-1	2886572
either	O	-1	2886572
group.	O	-1	2886572
Ph@@	B-Chemical	D010646	2886572
ent@@	I-Chemical	-1	2886572
ol@@	I-Chemical	-1	2886572
amine	I-Chemical	-1	2886572
increased	O	-1	2886572
stimul@@	O	-1	2886572
us@@	O	-1	2886572
-induced	O	-1	2886572
over@@	O	-1	2886572
flow	O	-1	2886572
in	O	-1	2886572
both	O	-1	2886572
groups	O	-1	2886572
although	O	-1	2886572
the	O	-1	2886572
inc@@	O	-1	2886572
re@@	O	-1	2886572
ment	O	-1	2886572
in	O	-1	2886572
over@@	O	-1	2886572
flow	O	-1	2886572
was	O	-1	2886572
greater	O	-1	2886572
in	O	-1	2886572
the	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
-treated	O	-1	2886572
group.	O	-1	2886572
In	O	-1	2886572
concl@@	O	-1	2886572
u@@	O	-1	2886572
sion,	O	-1	2886572
chronic	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
treatment	O	-1	2886572
results	O	-1	2886572
in	O	-1	2886572
enhanced	O	-1	2886572
frac@@	O	-1	2886572
tional	O	-1	2886572
neuro@@	O	-1	2886572
trans@@	O	-1	2886572
mit@@	O	-1	2886572
ter	O	-1	2886572
over@@	O	-1	2886572
f@@	O	-1	2886572
low@@	O	-1	2886572
.	O	-1	2886572
However,	O	-1	2886572
ne@@	O	-1	2886572
ither	O	-1	2886572
al@@	O	-1	2886572
ter@@	O	-1	2886572
ations	O	-1	2886572
in	O	-1	2886572
pre@@	O	-1	2886572
j@@	O	-1	2886572
unc@@	O	-1	2886572
tional	O	-1	2886572
beta-@@	O	-1	2886572
adren@@	O	-1	2886572
oc@@	O	-1	2886572
e@@	O	-1	2886572
pt@@	O	-1	2886572
or	O	-1	2886572
influ@@	O	-1	2886572
enc@@	O	-1	2886572
es	O	-1	2886572
n@@	O	-1	2886572
or	O	-1	2886572
al@@	O	-1	2886572
ter@@	O	-1	2886572
ations	O	-1	2886572
in	O	-1	2886572
neuron@@	O	-1	2886572
al	O	-1	2886572
and	O	-1	2886572
ex@@	O	-1	2886572
tran@@	O	-1	2886572
e@@	O	-1	2886572
uron@@	O	-1	2886572
al	O	-1	2886572
u@@	O	-1	2886572
pt@@	O	-1	2886572
ake	O	-1	2886572
mechanisms	O	-1	2886572
appe@@	O	-1	2886572
ar	O	-1	2886572
to	O	-1	2886572
be	O	-1	2886572
respon@@	O	-1	2886572
sible	O	-1	2886572
for	O	-1	2886572
this	O	-1	2886572
al@@	O	-1	2886572
ter@@	O	-1	2886572
ation.	O	-1	2886572
F@@	O	-1	2886572
ur@@	O	-1	2886572
ther@@	O	-1	2886572
mo@@	O	-1	2886572
re,	O	-1	2886572
data	O	-1	2886572
obtained	O	-1	2886572
with	O	-1	2886572
ph@@	B-Chemical	D010646	2886572
ent@@	I-Chemical	-1	2886572
ol@@	I-Chemical	-1	2886572
amine	I-Chemical	-1	2886572
alone	O	-1	2886572
d@@	O	-1	2886572
o	O	-1	2886572
not	O	-1	2886572
suggest	O	-1	2886572
alpha-@@	O	-1	2886572
adren@@	O	-1	2886572
oc@@	O	-1	2886572
e@@	O	-1	2886572
pt@@	O	-1	2886572
or	O	-1	2886572
des@@	O	-1	2886572
en@@	O	-1	2886572
si@@	O	-1	2886572
tiz@@	O	-1	2886572
ation	O	-1	2886572
as	O	-1	2886572
the	O	-1	2886572
cause	O	-1	2886572
of	O	-1	2886572
the	O	-1	2886572
enhanced	O	-1	2886572
neuro@@	O	-1	2886572
trans@@	O	-1	2886572
mit@@	O	-1	2886572
ter	O	-1	2886572
over@@	O	-1	2886572
flow	O	-1	2886572
after	O	-1	2886572
ep@@	B-Chemical	D004837	2886572
ine@@	I-Chemical	-1	2886572
phrine	I-Chemical	-1	2886572
treatment.	O	-1	2886572

O@@	O	-1	1079693
cular	O	-1	1079693
man@@	O	-1	1079693
if@@	O	-1	1079693
est@@	O	-1	1079693
ations	O	-1	1079693
of	O	-1	1079693
j@@	B-Disease	D001171	1079693
u@@	I-Disease	-1	1079693
ven@@	I-Disease	-1	1079693
ile	I-Disease	-1	1079693
r@@	I-Disease	-1	1079693
he@@	I-Disease	-1	1079693
um@@	I-Disease	-1	1079693
at@@	I-Disease	-1	1079693
oid	I-Disease	-1	1079693
arth@@	I-Disease	-1	1079693
ritis	I-Disease	-1	1079693
.	O	-1	1079693
We	O	-1	1079693
followed	O	-1	1079693
2@@	O	-1	1079693
10	O	-1	1079693
cases	O	-1	1079693
of	O	-1	1079693
j@@	B-Disease	D001171	1079693
u@@	I-Disease	-1	1079693
ven@@	I-Disease	-1	1079693
ile	I-Disease	-1	1079693
r@@	I-Disease	-1	1079693
he@@	I-Disease	-1	1079693
um@@	I-Disease	-1	1079693
at@@	I-Disease	-1	1079693
oid	I-Disease	-1	1079693
arth@@	I-Disease	-1	1079693
ritis	I-Disease	-1	1079693
clo@@	O	-1	1079693
se@@	O	-1	1079693
ly	O	-1	1079693
for	O	-1	1079693
e@@	O	-1	1079693
le@@	O	-1	1079693
ven	O	-1	1079693
year@@	O	-1	1079693
s.	O	-1	1079693
Th@@	O	-1	1079693
ir@@	O	-1	1079693
ty-@@	O	-1	1079693
six	O	-1	1079693
of	O	-1	1079693
the	O	-1	1079693
2@@	O	-1	1079693
10	O	-1	1079693
patients	O	-1	1079693
(1@@	O	-1	1079693
7.@@	O	-1	1079693
2@@	O	-1	1079693
%)	O	-1	1079693
developed	O	-1	1079693
i@@	B-Disease	D015863	1079693
ri@@	I-Disease	-1	1079693
doc@@	I-Disease	-1	1079693
yc@@	I-Disease	-1	1079693
li@@	I-Disease	-1	1079693
tis	I-Disease	-1	1079693
.	O	-1	1079693
I@@	B-Disease	D015863	1079693
ri@@	I-Disease	-1	1079693
doc@@	I-Disease	-1	1079693
yc@@	I-Disease	-1	1079693
li@@	I-Disease	-1	1079693
tis	I-Disease	-1	1079693
was	O	-1	1079693
seen	O	-1	1079693
most	O	-1	1079693
frequ@@	O	-1	1079693
ently	O	-1	1079693
in	O	-1	1079693
youn@@	O	-1	1079693
g	O	-1	1079693
female	O	-1	1079693
patients	O	-1	1079693
(@@	O	-1	1079693
0	O	-1	1079693
to	O	-1	1079693
4	O	-1	1079693
year@@	O	-1	1079693
s)	O	-1	1079693
with	O	-1	1079693
the	O	-1	1079693
mon@@	O	-1	1079693
o@@	O	-1	1079693
ar@@	O	-1	1079693
tic@@	O	-1	1079693
ular	O	-1	1079693
or	O	-1	1079693
pa@@	O	-1	1079693
uc@@	O	-1	1079693
i@@	O	-1	1079693
at@@	O	-1	1079693
r@@	O	-1	1079693
ic@@	O	-1	1079693
ular	O	-1	1079693
form	O	-1	1079693
of	O	-1	1079693
the	O	-1	1079693
arth@@	B-Disease	D001168	1079693
ritis	I-Disease	-1	1079693
.	O	-1	1079693
However,	O	-1	1079693
3@@	O	-1	1079693
0%	O	-1	1079693
of	O	-1	1079693
the	O	-1	1079693
patients	O	-1	1079693
developed	O	-1	1079693
u@@	B-Disease	D014605	1079693
ve@@	I-Disease	-1	1079693
iti@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
after	O	-1	1079693
16	O	-1	1079693
years	O	-1	1079693
of	O	-1	1079693
age.	O	-1	1079693
Although	O	-1	1079693
6@@	O	-1	1079693
1@@	O	-1	1079693
%	O	-1	1079693
of	O	-1	1079693
patients	O	-1	1079693
had	O	-1	1079693
a	O	-1	1079693
non@@	O	-1	1079693
cont@@	O	-1	1079693
ri@@	O	-1	1079693
but@@	O	-1	1079693
ory	O	-1	1079693
oc@@	O	-1	1079693
ular	O	-1	1079693
hist@@	O	-1	1079693
ory	O	-1	1079693
on	O	-1	1079693
entr@@	O	-1	1079693
y,	O	-1	1079693
4@@	O	-1	1079693
2@@	O	-1	1079693
%	O	-1	1079693
had	O	-1	1079693
active	O	-1	1079693
u@@	B-Disease	D014605	1079693
ve@@	I-Disease	-1	1079693
iti@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
on	O	-1	1079693
entr@@	O	-1	1079693
y.	O	-1	1079693
Our	O	-1	1079693
appro@@	O	-1	1079693
ach	O	-1	1079693
was	O	-1	1079693
effective	O	-1	1079693
in	O	-1	1079693
det@@	O	-1	1079693
ect@@	O	-1	1079693
ing	O	-1	1079693
u@@	B-Disease	D014605	1079693
ve@@	I-Disease	-1	1079693
iti@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
in	O	-1	1079693
new	O	-1	1079693
cases	O	-1	1079693
and	O	-1	1079693
ex@@	O	-1	1079693
ac@@	O	-1	1079693
er@@	O	-1	1079693
b@@	O	-1	1079693
ations	O	-1	1079693
of	O	-1	1079693
u@@	B-Disease	D014605	1079693
ve@@	I-Disease	-1	1079693
iti@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
in	O	-1	1079693
est@@	O	-1	1079693
abl@@	O	-1	1079693
ished	O	-1	1079693
cas@@	O	-1	1079693
es.	O	-1	1079693
F@@	O	-1	1079693
or@@	O	-1	1079693
ty-@@	O	-1	1079693
four	O	-1	1079693
perc@@	O	-1	1079693
ent	O	-1	1079693
of	O	-1	1079693
patients	O	-1	1079693
with	O	-1	1079693
u@@	B-Disease	D014605	1079693
ve@@	I-Disease	-1	1079693
iti@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
had	O	-1	1079693
one	O	-1	1079693
or	O	-1	1079693
more	O	-1	1079693
identi@@	O	-1	1079693
fi@@	O	-1	1079693
able	O	-1	1079693
signs	O	-1	1079693
or	O	-1	1079693
symptom@@	O	-1	1079693
s,	O	-1	1079693
such	O	-1	1079693
as	O	-1	1079693
red	O	-1	1079693
e@@	O	-1	1079693
y@@	O	-1	1079693
e,	O	-1	1079693
oc@@	B-Disease	D058447	1079693
ular	I-Disease	-1	1079693
pain	I-Disease	-1	1079693
,	O	-1	1079693
decreased	B-Disease	D014786	1079693
visual	I-Disease	-1	1079693
ac@@	I-Disease	-1	1079693
u@@	I-Disease	-1	1079693
ity	I-Disease	-1	1079693
,	O	-1	1079693
or	O	-1	1079693
ph@@	B-Disease	D020795	1079693
ot@@	I-Disease	-1	1079693
oph@@	I-Disease	-1	1079693
ob@@	I-Disease	-1	1079693
ia	I-Disease	-1	1079693
,	O	-1	1079693
in	O	-1	1079693
or@@	O	-1	1079693
der	O	-1	1079693
of	O	-1	1079693
decreas@@	O	-1	1079693
ing	O	-1	1079693
frequ@@	O	-1	1079693
enc@@	O	-1	1079693
y.	O	-1	1079693
E@@	O	-1	1079693
ven	O	-1	1079693
after	O	-1	1079693
early	O	-1	1079693
det@@	O	-1	1079693
ection	O	-1	1079693
and	O	-1	1079693
pro@@	O	-1	1079693
m@@	O	-1	1079693
p@@	O	-1	1079693
t	O	-1	1079693
treatment,	O	-1	1079693
4@@	O	-1	1079693
1@@	O	-1	1079693
%	O	-1	1079693
of	O	-1	1079693
cases	O	-1	1079693
of	O	-1	1079693
u@@	B-Disease	D014605	1079693
ve@@	I-Disease	-1	1079693
iti@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
did	O	-1	1079693
not	O	-1	1079693
respon@@	O	-1	1079693
d	O	-1	1079693
to	O	-1	1079693
more	O	-1	1079693
than	O	-1	1079693
six	O	-1	1079693
months	O	-1	1079693
of	O	-1	1079693
int@@	O	-1	1079693
en@@	O	-1	1079693
sive	O	-1	1079693
to@@	O	-1	1079693
p@@	O	-1	1079693
ical	O	-1	1079693
treatment	O	-1	1079693
with	O	-1	1079693
cortico@@	B-Chemical	D000305	1079693
steroid@@	I-Chemical	-1	1079693
s	I-Chemical	-1	1079693
and	O	-1	1079693
my@@	O	-1	1079693
d@@	O	-1	1079693
ri@@	O	-1	1079693
ati@@	O	-1	1079693
c@@	O	-1	1079693
s.	O	-1	1079693
D@@	O	-1	1079693
es@@	O	-1	1079693
pit@@	O	-1	1079693
e	O	-1	1079693
th@@	O	-1	1079693
is@@	O	-1	1079693
,	O	-1	1079693
there	O	-1	1079693
was	O	-1	1079693
a	O	-1	1079693
d@@	O	-1	1079693
ram@@	O	-1	1079693
atic	O	-1	1079693
decrease	O	-1	1079693
in	O	-1	1079693
the	O	-1	1079693
50@@	O	-1	1079693
%	O	-1	1079693
incidence	O	-1	1079693
of	O	-1	1079693
bl@@	O	-1	1079693
ind@@	O	-1	1079693
ing	O	-1	1079693
complications	O	-1	1079693
of	O	-1	1079693
u@@	B-Disease	D014605	1079693
ve@@	I-Disease	-1	1079693
iti@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
c@@	O	-1	1079693
ited	O	-1	1079693
in	O	-1	1079693
ear@@	O	-1	1079693
li@@	O	-1	1079693
er	O	-1	1079693
studi@@	O	-1	1079693
es.	O	-1	1079693
C@@	B-Disease	D002386	1079693
at@@	I-Disease	-1	1079693
arac@@	I-Disease	-1	1079693
t	I-Disease	-1	1079693
and	O	-1	1079693
b@@	B-Disease	C562399	1079693
and	I-Disease	-1	1079693
k@@	I-Disease	-1	1079693
er@@	I-Disease	-1	1079693
at@@	I-Disease	-1	1079693
o@@	I-Disease	-1	1079693
pathy	I-Disease	-1	1079693
occurred	O	-1	1079693
in	O	-1	1079693
only	O	-1	1079693
2@@	O	-1	1079693
2	O	-1	1079693
and	O	-1	1079693
13@@	O	-1	1079693
%	O	-1	1079693
of	O	-1	1079693
our	O	-1	1079693
group@@	O	-1	1079693
,	O	-1	1079693
respectively.	O	-1	1079693
We	O	-1	1079693
used	O	-1	1079693
ch@@	B-Chemical	D002738	1079693
loro@@	I-Chemical	-1	1079693
qu@@	I-Chemical	-1	1079693
ine	I-Chemical	-1	1079693
or	O	-1	1079693
hydrox@@	B-Chemical	D006886	1079693
y@@	I-Chemical	-1	1079693
ch@@	I-Chemical	-1	1079693
loro@@	I-Chemical	-1	1079693
qu@@	I-Chemical	-1	1079693
ine	I-Chemical	-1	1079693
in	O	-1	1079693
17@@	O	-1	1079693
3	O	-1	1079693
of	O	-1	1079693
2@@	O	-1	1079693
10	O	-1	1079693
cases	O	-1	1079693
and	O	-1	1079693
found	O	-1	1079693
only	O	-1	1079693
one	O	-1	1079693
case	O	-1	1079693
of	O	-1	1079693
ch@@	B-Disease	D012164	1079693
or@@	I-Disease	-1	1079693
io@@	I-Disease	-1	1079693
ret@@	I-Disease	-1	1079693
ino@@	I-Disease	-1	1079693
pathy	I-Disease	-1	1079693
at@@	O	-1	1079693
tri@@	O	-1	1079693
but@@	O	-1	1079693
able	O	-1	1079693
to	O	-1	1079693
these	O	-1	1079693
drug@@	O	-1	1079693
s.	O	-1	1079693
S@@	O	-1	1079693
y@@	O	-1	1079693
st@@	O	-1	1079693
em@@	O	-1	1079693
ically	O	-1	1079693
administered	O	-1	1079693
cortico@@	B-Chemical	D000305	1079693
steroid@@	I-Chemical	-1	1079693
s	I-Chemical	-1	1079693
were	O	-1	1079693
used	O	-1	1079693
in	O	-1	1079693
7@@	O	-1	1079693
5	O	-1	1079693
of	O	-1	1079693
2@@	O	-1	1079693
10	O	-1	1079693
cas@@	O	-1	1079693
es@@	O	-1	1079693
;	O	-1	1079693
a	O	-1	1079693
significant	O	-1	1079693
number	O	-1	1079693
of	O	-1	1079693
po@@	O	-1	1079693
ster@@	O	-1	1079693
ior	O	-1	1079693
sub@@	O	-1	1079693
cap@@	O	-1	1079693
s@@	O	-1	1079693
ular	O	-1	1079693
cat@@	B-Disease	D002386	1079693
ar@@	I-Disease	-1	1079693
act@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
was	O	-1	1079693
f@@	O	-1	1079693
oun@@	O	-1	1079693
d.	O	-1	1079693
T@@	O	-1	1079693
yp@@	O	-1	1079693
ical	O	-1	1079693
k@@	B-Disease	D007637	1079693
er@@	I-Disease	-1	1079693
at@@	I-Disease	-1	1079693
o@@	I-Disease	-1	1079693
con@@	I-Disease	-1	1079693
j@@	I-Disease	-1	1079693
unc@@	I-Disease	-1	1079693
ti@@	I-Disease	-1	1079693
vi@@	I-Disease	-1	1079693
tis	I-Disease	-1	1079693
si@@	O	-1	1079693
c@@	O	-1	1079693
c@@	O	-1	1079693
a	O	-1	1079693
developed	O	-1	1079693
in	O	-1	1079693
three	O	-1	1079693
of	O	-1	1079693
the	O	-1	1079693
u@@	B-Disease	D014605	1079693
ve@@	I-Disease	-1	1079693
iti@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
cas@@	O	-1	1079693
es.	O	-1	1079693
This	O	-1	1079693
association	O	-1	1079693
with	O	-1	1079693
u@@	B-Disease	D014605	1079693
ve@@	I-Disease	-1	1079693
iti@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
and	O	-1	1079693
J@@	O	-1	1079693
R@@	O	-1	1079693
A	O	-1	1079693
was	O	-1	1079693
not	O	-1	1079693
not@@	O	-1	1079693
ed	O	-1	1079693
previ@@	O	-1	1079693
ous@@	O	-1	1079693
ly.	O	-1	1079693
S@@	O	-1	1079693
ur@@	O	-1	1079693
g@@	O	-1	1079693
ical	O	-1	1079693
treatment	O	-1	1079693
of	O	-1	1079693
cat@@	B-Disease	D002386	1079693
ar@@	I-Disease	-1	1079693
act@@	I-Disease	-1	1079693
s	I-Disease	-1	1079693
,	O	-1	1079693
b@@	B-Disease	C562399	1079693
and	I-Disease	-1	1079693
k@@	I-Disease	-1	1079693
er@@	I-Disease	-1	1079693
at@@	I-Disease	-1	1079693
o@@	I-Disease	-1	1079693
pathy	I-Disease	-1	1079693
,	O	-1	1079693
and	O	-1	1079693
gl@@	B-Disease	D005901	1079693
au@@	I-Disease	-1	1079693
com@@	I-Disease	-1	1079693
a	I-Disease	-1	1079693
achi@@	O	-1	1079693
ev@@	O	-1	1079693
ed	O	-1	1079693
un@@	O	-1	1079693
if@@	O	-1	1079693
orm@@	O	-1	1079693
ly	O	-1	1079693
dis@@	O	-1	1079693
cour@@	O	-1	1079693
ag@@	O	-1	1079693
ing	O	-1	1079693
result@@	O	-1	1079693
s.	O	-1	1079693

W@@	B-Disease	D014869	803783
at@@	I-Disease	-1	803783
er	I-Disease	-1	803783
in@@	I-Disease	-1	803783
toxic@@	I-Disease	-1	803783
ation	I-Disease	-1	803783
associated	O	-1	803783
with	O	-1	803783
oxy@@	B-Chemical	D010121	803783
t@@	I-Chemical	-1	803783
oc@@	I-Chemical	-1	803783
in	I-Chemical	-1	803783
administration	O	-1	803783
during	O	-1	803783
sal@@	O	-1	803783
ine-induced	O	-1	803783
abor@@	B-Disease	D000031	803783
tion	I-Disease	-1	803783
.	O	-1	803783
F@@	O	-1	803783
our	O	-1	803783
cases	O	-1	803783
of	O	-1	803783
w@@	B-Disease	D014869	803783
at@@	I-Disease	-1	803783
er	I-Disease	-1	803783
in@@	I-Disease	-1	803783
toxic@@	I-Disease	-1	803783
ation	I-Disease	-1	803783
in	O	-1	803783
con@@	O	-1	803783
n@@	O	-1	803783
ection	O	-1	803783
with	O	-1	803783
oxy@@	B-Chemical	D010121	803783
t@@	I-Chemical	-1	803783
oc@@	I-Chemical	-1	803783
in	I-Chemical	-1	803783
administration	O	-1	803783
during	O	-1	803783
sal@@	O	-1	803783
ine-induced	O	-1	803783
abor@@	B-Disease	D000031	803783
tions	I-Disease	-1	803783
are	O	-1	803783
descri@@	O	-1	803783
be@@	O	-1	803783
d.	O	-1	803783
The	O	-1	803783
mechanism	O	-1	803783
of	O	-1	803783
w@@	B-Disease	D014869	803783
at@@	I-Disease	-1	803783
er	I-Disease	-1	803783
in@@	I-Disease	-1	803783
toxic@@	I-Disease	-1	803783
ation	I-Disease	-1	803783
is	O	-1	803783
discus@@	O	-1	803783
sed	O	-1	803783
in	O	-1	803783
reg@@	O	-1	803783
ard	O	-1	803783
to	O	-1	803783
these	O	-1	803783
cas@@	O	-1	803783
es.	O	-1	803783
O@@	B-Chemical	D010121	803783
x@@	I-Chemical	-1	803783
y@@	I-Chemical	-1	803783
t@@	I-Chemical	-1	803783
oc@@	I-Chemical	-1	803783
in	I-Chemical	-1	803783
administration	O	-1	803783
during	O	-1	803783
mid@@	O	-1	803783
tri@@	O	-1	803783
me@@	O	-1	803783
ster@@	O	-1	803783
-induced	O	-1	803783
abor@@	B-Disease	D000031	803783
tions	I-Disease	-1	803783
is	O	-1	803783
adv@@	O	-1	803783
oc@@	O	-1	803783
ated	O	-1	803783
only	O	-1	803783
if	O	-1	803783
it	O	-1	803783
can	O	-1	803783
be	O	-1	803783
car@@	O	-1	803783
ri@@	O	-1	803783
ed	O	-1	803783
out	O	-1	803783
under	O	-1	803783
ca@@	O	-1	803783
ref@@	O	-1	803783
u@@	O	-1	803783
l	O	-1	803783
observ@@	O	-1	803783
ations	O	-1	803783
of	O	-1	803783
an	O	-1	803783
al@@	O	-1	803783
er@@	O	-1	803783
t	O	-1	803783
n@@	O	-1	803783
ur@@	O	-1	803783
s@@	O	-1	803783
ing	O	-1	803783
st@@	O	-1	803783
aff@@	O	-1	803783
,	O	-1	803783
aw@@	O	-1	803783
are	O	-1	803783
of	O	-1	803783
the	O	-1	803783
symptoms	O	-1	803783
of	O	-1	803783
w@@	B-Disease	D014869	803783
at@@	I-Disease	-1	803783
er	I-Disease	-1	803783
in@@	I-Disease	-1	803783
toxic@@	I-Disease	-1	803783
ation	I-Disease	-1	803783
and	O	-1	803783
in@@	O	-1	803783
struc@@	O	-1	803783
ted	O	-1	803783
to	O	-1	803783
w@@	O	-1	803783
at@@	O	-1	803783
ch	O	-1	803783
the	O	-1	803783
di@@	O	-1	803783
ure@@	O	-1	803783
sis	O	-1	803783
and	O	-1	803783
report	O	-1	803783
such	O	-1	803783
early	O	-1	803783
signs	O	-1	803783
of	O	-1	803783
the	O	-1	803783
syndrome	O	-1	803783
as	O	-1	803783
as@@	B-Disease	D001247	803783
th@@	I-Disease	-1	803783
en@@	I-Disease	-1	803783
ia	I-Disease	-1	803783
,	O	-1	803783
mus@@	O	-1	803783
cular	O	-1	803783
ir@@	B-Disease	D001523	803783
rit@@	I-Disease	-1	803783
ability	I-Disease	-1	803783
,	O	-1	803783
or	O	-1	803783
headac@@	B-Disease	D006261	803783
h@@	I-Disease	-1	803783
es	I-Disease	-1	803783
.	O	-1	803783
The	O	-1	803783
oxy@@	B-Chemical	D010121	803783
t@@	I-Chemical	-1	803783
oc@@	I-Chemical	-1	803783
in	I-Chemical	-1	803783
should	O	-1	803783
be	O	-1	803783
given	O	-1	803783
only	O	-1	803783
in	O	-1	803783
R@@	O	-1	803783
ing@@	O	-1	803783
ers	O	-1	803783
l@@	B-Chemical	D019344	803783
act@@	I-Chemical	-1	803783
ate	I-Chemical	-1	803783
or@@	O	-1	803783
,	O	-1	803783
al@@	O	-1	803783
tern@@	O	-1	803783
at@@	O	-1	803783
el@@	O	-1	803783
y,	O	-1	803783
in	O	-1	803783
R@@	O	-1	803783
ing@@	O	-1	803783
ers	O	-1	803783
l@@	B-Chemical	D019344	803783
act@@	I-Chemical	-1	803783
ate	I-Chemical	-1	803783
and	O	-1	803783
a	O	-1	803783
5	O	-1	803783
per	O	-1	803783
c@@	O	-1	803783
ent	O	-1	803783
de@@	B-Chemical	D005947	803783
x@@	I-Chemical	-1	803783
tro@@	I-Chemical	-1	803783
se	I-Chemical	-1	803783
and	O	-1	803783
w@@	O	-1	803783
at@@	O	-1	803783
er	O	-1	803783
sol@@	O	-1	803783
u@@	O	-1	803783
tions.	O	-1	803783
The	O	-1	803783
urinary	O	-1	803783
out@@	O	-1	803783
pu@@	O	-1	803783
t	O	-1	803783
should	O	-1	803783
be	O	-1	803783
monit@@	O	-1	803783
o@@	O	-1	803783
red	O	-1	803783
and	O	-1	803783
the	O	-1	803783
oxy@@	B-Chemical	D010121	803783
t@@	I-Chemical	-1	803783
oc@@	I-Chemical	-1	803783
in	I-Chemical	-1	803783
administration	O	-1	803783
discontinu@@	O	-1	803783
ed	O	-1	803783
and	O	-1	803783
the	O	-1	803783
serum	O	-1	803783
electro@@	O	-1	803783
ly@@	O	-1	803783
tes	O	-1	803783
ch@@	O	-1	803783
ec@@	O	-1	803783
ked	O	-1	803783
if	O	-1	803783
the	O	-1	803783
urinary	O	-1	803783
out@@	O	-1	803783
pu@@	O	-1	803783
t	O	-1	803783
decreas@@	O	-1	803783
es.	O	-1	803783
The	O	-1	803783
oxy@@	B-Chemical	D010121	803783
t@@	I-Chemical	-1	803783
oc@@	I-Chemical	-1	803783
in	I-Chemical	-1	803783
should	O	-1	803783
not	O	-1	803783
be	O	-1	803783
administered	O	-1	803783
in	O	-1	803783
ex@@	O	-1	803783
cess	O	-1	803783
of	O	-1	803783
3@@	O	-1	803783
6	O	-1	803783
hour@@	O	-1	803783
s.	O	-1	803783
I@@	O	-1	803783
f	O	-1	803783
the	O	-1	803783
patient	O	-1	803783
has	O	-1	803783
not	O	-1	803783
abor@@	O	-1	803783
ted	O	-1	803783
by	O	-1	803783
then	O	-1	803783
the	O	-1	803783
oxy@@	B-Chemical	D010121	803783
t@@	I-Chemical	-1	803783
oc@@	I-Chemical	-1	803783
in	I-Chemical	-1	803783
should	O	-1	803783
be	O	-1	803783
discontinu@@	O	-1	803783
ed	O	-1	803783
for	O	-1	803783
10	O	-1	803783
to	O	-1	803783
12	O	-1	803783
hours	O	-1	803783
in	O	-1	803783
or@@	O	-1	803783
der	O	-1	803783
to	O	-1	803783
per@@	O	-1	803783
form	O	-1	803783
electro@@	O	-1	803783
ly@@	O	-1	803783
te	O	-1	803783
determin@@	O	-1	803783
ations	O	-1	803783
and	O	-1	803783
cor@@	O	-1	803783
rec@@	O	-1	803783
t	O	-1	803783
any	O	-1	803783
electro@@	O	-1	803783
ly@@	O	-1	803783
te	O	-1	803783
im@@	O	-1	803783
b@@	O	-1	803783
al@@	O	-1	803783
ance@@	O	-1	803783
.	O	-1	803783

